Citrus Sinensis ID: 040917

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490----
Protein Sequence
MGCIFSKGQDSDHPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRALSSRSLAHVVT
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccEEEccEEccccccEEEEEEEcccccEEEEEEEEccccccHHHHHHHHHHHHHHHHccccccEEEEEEEEEccccEEEEEEcccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEEcccccccccccccccccccccccccHHcccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHcccccccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHcccccccEEHHHHHHHHHHccccccHHHHHHHHHHHcccccccEEHHHHHHHHccHHHHHcHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccHHHHHHHHHHHcccccccccHHHHHHHHHcccccccccHHHHHHccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccccHcHHHHEEccHHccccccEEEEEEEccccccEEEEHHHHHHHcccHHHHHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccccccEEEccccEEEEccccEEEcccccHHHHcHHHHHHHEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHcccccccccHHHccHHHHHHHHHHccccHHHcccHHHHcccHHHcccHHHccccccccHHHHHHHHHHHccHHHHHHHHHHccccHHHHHHHHHHHHHHcccccccEcHHHHHHHHHHccccccHHHHHHHHHHHcccccccEcHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccEcHHHHHHHHHHccccccccHHHHHHHHHHHcccccccccHHHHHHHHHccccccccccHHHHcccc
Coil and Loop (DISEMBL)
mgcifskgqdsdhpaarHLHDAILGKAYEDVQLHYTIgrevgrgefgITYLctenstglefacksipkrklvkdvekdDVRREIEIMRHlsgqpnivqfkaayeddQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVchskgvmhrdlkpenflfttgdenaVVKATDFGLSAFIEEGKAYReivgspyyiapevlsqsygkeadiWSAGVILYILLCgvppfwaetDQGVAQAILKGeinfqrdpfpsissSAIELVRRMLTQDPKRRITVAQVLehpwlkesgeasdkpiDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTemdtdnsgtltYDELKAGLAKLGSMLTEFDVKQYMQAadidgngtIDYIEFITATMQRHKLQRFENLYKAFQyfdkdnngyiTVDELGKAfkdygmgddATIATIKEIMSEvdrdkdgrisydEFRSMMKCGTQLRALSSRSLAHVVT
Flexible Loop (DISEMBL)
mgcifskgqdsdhpaARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGlefacksipkrklvkdvekdDVRREIEImrhlsgqpnivQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEinfqrdpfpsiSSSAIELVRRMLTQDPKRRITVAQVlehpwlkesgeasdkpiDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLkekftemdtdnsgtLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKeimsevdrdkdgrISYDEFRSMMKCgtqlralssrslahvvt
Low Complexity Region (SEG)
MGCIFSKGQDSDHPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRALSSRSLAHVVT
Disordered region (IsUnstruct)
*****************HLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK********PIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKL************GTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEV*********Y**************************
Disordered Region (DISOPRED)
***************************YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG**********VIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMM*******************
Disordered Region (DISEMBL)
**************AARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRAL**********
Disordered Region (DISPRO)
**********************ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC*****************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGCIFSKGQDSDHPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRALSSRSLAHVVT
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	494	2.2.26 [Sep-21-2011]
Q38868	541	Calcium-dependent protein	yes	no	0.937	0.855	0.703	0.0
Q9C6P3	521	Calcium-dependent protein	no	no	0.939	0.890	0.710	0.0
P53683	533	Calcium-dependent protein	yes	no	0.919	0.851	0.696	0.0
P49101	513	Calcium-dependent protein	N/A	no	0.925	0.890	0.686	0.0
P28582	532	Calcium-dependent protein	N/A	no	0.910	0.845	0.679	0.0
Q9ZSA2	531	Calcium-dependent protein	no	no	0.941	0.875	0.663	0.0
O49717	554	Calcium-dependent protein	no	no	0.925	0.824	0.665	0.0
Q1PFH8	551	Calcium-dependent protein	no	no	0.925	0.829	0.646	0.0
Q3E9C0	523	Calcium-dependent protein	no	no	0.919	0.868	0.621	1e-175
Q9FMP5	528	Calcium-dependent protein	no	no	0.919	0.859	0.619	1e-175

>sp|Q38868|CDPK9_ARATH Calcium-dependent protein kinase 9 OS=Arabidopsis thaliana GN=CPK9 PE=1 SV=1

 Score =  703 bits (1815), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 328/466 (70%), Positives = 397/466 (85%), Gaps = 3/466 (0%)

Query: 14  PAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK 73
           P      ++IL  A+EDV+L YT+G+E+GRG+FG+TYLCTENSTG ++ACKSI K+KLV 
Sbjct: 70  PKTTTKSNSILENAFEDVKLFYTLGKELGRGQFGVTYLCTENSTGKKYACKSISKKKLVT 129

Query: 74  DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSE 133
             +KDD+RREI+IM+HLSGQPNIV+FK AYED++ V++VMELCAGGELFDRI+A+GHY+E
Sbjct: 130 KADKDDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDRIIAKGHYTE 189

Query: 134 RAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY 193
           RAAASV R I+NVV +CH  GV+HRDLKPENFL ++ DE A++KATDFGLS FIEEGK Y
Sbjct: 190 RAAASVCRQIVNVVKICHFMGVLHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGKVY 249

Query: 194 REIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN 253
           R+IVGS YY+APEVL + YGKE DIWSAG+ILYILL GVPPFWAET++G+  AIL+G I+
Sbjct: 250 RDIVGSAYYVAPEVLRRRYGKEVDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGHID 309

Query: 254 FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMK 313
           F+  P+PSISSSA +LVRRMLT DPKRRI+ A VL+HPWL+E GEASDKPID+AV+ RMK
Sbjct: 310 FESQPWPSISSSAKDLVRRMLTADPKRRISAADVLQHPWLREGGEASDKPIDSAVLSRMK 369

Query: 314 QFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLT 373
           QF AMNKLKKLALKVI EN+ TEEIQ LK  F  +DTDNSGT+TY+ELK GLAKLGS LT
Sbjct: 370 QFRAMNKLKKLALKVIAENIDTEEIQGLKAMFANIDTDNSGTITYEELKEGLAKLGSKLT 429

Query: 374 EFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDEL 433
           E +VKQ M AAD+DGNG+IDYIEFITATM RH+L+  ENLYKAFQ+FDKD++GYIT+DEL
Sbjct: 430 EAEVKQLMDAADVDGNGSIDYIEFITATMHRHRLESNENLYKAFQHFDKDSSGYITIDEL 489

Query: 434 GKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT 479
             A K+YGMGDD   ATIKE++S+VD D DGRI+Y+EF +MM+ G 
Sbjct: 490 ESALKEYGMGDD---ATIKEVLSDVDSDNDGRINYEEFCAMMRSGN 532

May play a role in signal transduction pathways that involve calcium as a second messenger.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9C6P3|CDPKX_ARATH Calcium-dependent protein kinase 33 OS=Arabidopsis thaliana GN=CPK33 PE=2 SV=1

 Score =  702 bits (1812), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 332/467 (71%), Positives = 397/467 (85%), Gaps = 3/467 (0%)

Query: 13  HPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV 72
           +PA      AIL K YEDV+L YT+ +E+GRG+FG+TYLCTE STG  FACKSI K+KLV
Sbjct: 51  NPAKHSGAAAILEKPYEDVKLFYTLSKELGRGQFGVTYLCTEKSTGKRFACKSISKKKLV 110

Query: 73  KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYS 132
              +K+D+RREI+IM+HLSGQPNIV+FK AYED++ V++VMELCAGGELFDRI+A+GHYS
Sbjct: 111 TKGDKEDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDRILAKGHYS 170

Query: 133 ERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192
           ERAAASV R I+NVVN+CH  GVMHRDLKPENFL ++ DE A++KATDFGLS FIEEG+ 
Sbjct: 171 ERAAASVCRQIVNVVNICHFMGVMHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGRV 230

Query: 193 YREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI 252
           Y++IVGS YY+APEVL + YGKE DIWSAG+ILYILL GVPPFWAET++G+  AIL+GEI
Sbjct: 231 YKDIVGSAYYVAPEVLKRRYGKEIDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGEI 290

Query: 253 NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRM 312
           +F+  P+PSIS+SA +LVRRMLTQDPKRRI+ A+VL+HPWL+E GEASDKPID+AV+ RM
Sbjct: 291 DFESQPWPSISNSAKDLVRRMLTQDPKRRISAAEVLKHPWLREGGEASDKPIDSAVLSRM 350

Query: 313 KQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSML 372
           KQF AMNKLKKLALKVI EN+ TEEIQ LK  F  +DTDNSGT+TY+ELK GLAKLGS L
Sbjct: 351 KQFRAMNKLKKLALKVIAENIDTEEIQGLKAMFANIDTDNSGTITYEELKEGLAKLGSRL 410

Query: 373 TEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDE 432
           TE +VKQ M AAD+DGNG+IDYIEFITATM RH+L+  EN+YKAFQ+FDKD +GYIT DE
Sbjct: 411 TEAEVKQLMDAADVDGNGSIDYIEFITATMHRHRLESNENVYKAFQHFDKDGSGYITTDE 470

Query: 433 LGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT 479
           L  A K+YGMGDD   ATIKEI+S+VD D DGRI+YDEF +MM+ G 
Sbjct: 471 LEAALKEYGMGDD---ATIKEILSDVDADNDGRINYDEFCAMMRSGN 514

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P53683|CDPK2_ORYSJ Calcium-dependent protein kinase isoform 2 OS=Oryza sativa subsp. japonica GN=CPK2 PE=2 SV=2

 Score =  682 bits (1759), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 319/458 (69%), Positives = 394/458 (86%), Gaps = 4/458 (0%)

Query: 21  DAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDV 80
           D ILGK Y+DV+  Y++G+E+GRG+FG+TYLCTE ++G ++ACKSI KRKLV   +K+D+
Sbjct: 71  DTILGKPYDDVRSVYSLGKELGRGQFGVTYLCTEIASGKQYACKSISKRKLVSKADKEDI 130

Query: 81  RREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVF 140
           RREI+IM+HLSGQ NIV+F+ AYED   VH+VMELCAGGELFDRI+A+GHYSERAAA++ 
Sbjct: 131 RREIQIMQHLSGQQNIVEFRGAYEDKSNVHVVMELCAGGELFDRIIAKGHYSERAAATIC 190

Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP 200
           R ++NVVN+CH  GVMHRDLKPENFL  T +ENA++KATDFGLS FIEEGK YR+IVGS 
Sbjct: 191 RAVVNVVNICHFMGVMHRDLKPENFLLATKEENAMLKATDFGLSVFIEEGKMYRDIVGSA 250

Query: 201 YYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
           YY+APEVL ++YGKE D+WSAGVILYILL GVPPFWAET++G+  AIL+GEI+F+  P+P
Sbjct: 251 YYVAPEVLRRNYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILQGEIDFESQPWP 310

Query: 261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNK 320
           SIS SA +LVR+MLTQDPK+RIT AQVL+HPWL++ GEASDKPID+AV+ RMKQF AMNK
Sbjct: 311 SISESAKDLVRKMLTQDPKKRITSAQVLQHPWLRD-GEASDKPIDSAVLSRMKQFRAMNK 369

Query: 321 LKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQY 380
           LKK+ALKVI  NL  EEI+ LK+ FT MDTDNSGT+TY+ELKAGLAKLGS L+E +VKQ 
Sbjct: 370 LKKMALKVIASNLNEEEIKGLKQMFTNMDTDNSGTITYEELKAGLAKLGSKLSEAEVKQL 429

Query: 381 MQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDY 440
           M+AAD+DGNG+IDY+EFITATM RHKL+R E+L+KAFQYFDKDN+G+IT DEL  A  ++
Sbjct: 430 MEAADVDGNGSIDYVEFITATMHRHKLERDEHLFKAFQYFDKDNSGFITRDELESALIEH 489

Query: 441 GMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG 478
            MGD    +TIK+I+SEVD D DGRI+Y+EF +MM+ G
Sbjct: 490 EMGD---TSTIKDIISEVDTDNDGRINYEEFCAMMRGG 524

May play a role in signal transduction pathways that involve calcium as a second messenger.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P49101|CDPK2_MAIZE Calcium-dependent protein kinase 2 OS=Zea mays GN=CPK2 PE=2 SV=1

 Score =  681 bits (1756), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 316/460 (68%), Positives = 390/460 (84%), Gaps = 3/460 (0%)

Query: 21  DAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDV 80
           D ILGK YEDV+  Y+ G+E+GRG+FG+TYLCTE ++G ++ACKSI KRKLV   +++D+
Sbjct: 51  DTILGKQYEDVRSVYSFGKELGRGQFGVTYLCTEIASGRQYACKSISKRKLVSKADREDI 110

Query: 81  RREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVF 140
           RREI+IM+HLSGQPNIV+F+ AYED   VH+VMELCAGGELFDRI+A+GHY+ERAAA++ 
Sbjct: 111 RREIQIMQHLSGQPNIVEFRGAYEDKSNVHVVMELCAGGELFDRIIAKGHYTERAAATIC 170

Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP 200
           R ++NVVN+CH  GVMHRDLKPENFL  T +ENA++KATDFGLS FIEEGK YR+IVGS 
Sbjct: 171 RAVVNVVNICHFMGVMHRDLKPENFLLATMEENAMLKATDFGLSVFIEEGKMYRDIVGSA 230

Query: 201 YYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
           YY+APEVL +SYGKE D+WSAGVILYILL GVPPFWAE ++G+  AIL  EI+F+  P+P
Sbjct: 231 YYVAPEVLRRSYGKEIDVWSAGVILYILLSGVPPFWAEIEKGIFDAILHEEIDFESQPWP 290

Query: 261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNK 320
           SIS SA +LVR+MLT+DPK+R+T AQVL+H WL+E GEASDKPID+AV+ RMKQF AMNK
Sbjct: 291 SISESAKDLVRKMLTRDPKKRLTSAQVLQHQWLREGGEASDKPIDSAVLSRMKQFRAMNK 350

Query: 321 LKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQY 380
           LKK+ALKVI  NL  EEI+ LK+ F  MDTDNSGT+TY+ELKAGLAKLGS L+E +VKQ 
Sbjct: 351 LKKMALKVIASNLNEEEIKGLKQMFMNMDTDNSGTITYEELKAGLAKLGSKLSEAEVKQL 410

Query: 381 MQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDY 440
           M+AAD+DGNG+IDY+EFITATM RHKL+R E+L+KAFQYFDKDN+G+IT DEL  A  ++
Sbjct: 411 MEAADVDGNGSIDYVEFITATMHRHKLERDEHLFKAFQYFDKDNSGFITRDELESALIEH 470

Query: 441 GMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ 480
            MGD    +TI+EI+SEVD D DGRI+Y+EF +MM+ G Q
Sbjct: 471 EMGD---TSTIREIISEVDTDNDGRINYEEFCAMMRGGMQ 507

May play a role in signal transduction pathways that involve calcium as a second messenger.

Zea mays (taxid: 4577)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P28582|CDPK_DAUCA Calcium-dependent protein kinase OS=Daucus carota PE=2 SV=2

 Score =  664 bits (1712), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 312/459 (67%), Positives = 388/459 (84%), Gaps = 9/459 (1%)

Query: 17  RHLH----DAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV 72
           R +H    + ILGK +ED++  YT+G+E+GRG+FG  Y CTENS+G  +ACKSI KRKLV
Sbjct: 59  RQVHRPESNTILGKPFEDIRGKYTLGKELGRGQFGCVYQCTENSSGQLYACKSILKRKLV 118

Query: 73  KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYS 132
              +K+D++REI+I++HLSGQPNIV+FK  +ED Q VH+VMELCAGGELFDRI+A+GHYS
Sbjct: 119 SKNDKEDIKREIQILQHLSGQPNIVEFKGVFEDRQSVHLVMELCAGGELFDRIIAQGHYS 178

Query: 133 ERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192
           ERAAA++ R I+NVV+VCH  GVMHRDLKPENFL ++ D++A++KATDFGLS FIEEGK 
Sbjct: 179 ERAAATICRQIVNVVHVCHFMGVMHRDLKPENFLLSSKDKDAMLKATDFGLSVFIEEGKV 238

Query: 193 YREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI 252
           YR IVGS YY+APEVL +SYGKE DIWSAGVILYILL GVPPFWAE ++G+  AIL+G I
Sbjct: 239 YRNIVGSAYYVAPEVLRRSYGKEIDIWSAGVILYILLSGVPPFWAENEKGIFDAILEGVI 298

Query: 253 NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRM 312
           +F+ +P+PS+S+SA +LVR+MLTQDP+RRIT AQVL+HPW++E GEASDKPID+AV+ RM
Sbjct: 299 DFESEPWPSVSNSAKDLVRKMLTQDPRRRITSAQVLDHPWMREGGEASDKPIDSAVLSRM 358

Query: 313 KQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSML 372
           KQF AMNKLK+LALKVI E+L  EEI+ LK  F  MDTD SGT+TY+ELK+GLA+LGS L
Sbjct: 359 KQFRAMNKLKQLALKVIAESLSEEEIKGLKSMFANMDTDKSGTITYEELKSGLARLGSKL 418

Query: 373 TEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDE 432
           +E +V+Q M AAD+DGNGTIDY+EFITATM RHKL+ +E  ++AFQYFDKDN+G+IT DE
Sbjct: 419 SEVEVQQLMDAADVDGNGTIDYLEFITATMHRHKLESYE--HQAFQYFDKDNSGFITKDE 476

Query: 433 LGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEF 471
           L  A K+YGMGD+   ATIK+I+SEVD D DGRI+YDEF
Sbjct: 477 LESAMKEYGMGDE---ATIKDIISEVDSDNDGRINYDEF 512

May play a role in signal transduction pathways that involve calcium as a second messenger.

Daucus carota (taxid: 4039)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZSA2|CDPKL_ARATH Calcium-dependent protein kinase 21 OS=Arabidopsis thaliana GN=CPK21 PE=1 SV=1

 Score =  659 bits (1701), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 311/469 (66%), Positives = 389/469 (82%), Gaps = 4/469 (0%)

Query: 11  SDHPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRK 70
           S +P +    D ILGK +ED++  Y++G+E+GRG+FGITY+C E  TG  +ACKSI KRK
Sbjct: 56  SSNPVSVRDPDTILGKPFEDIRKFYSLGKELGRGQFGITYMCKEIGTGNTYACKSILKRK 115

Query: 71  LVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH 130
           L+   +K+DV+REI+IM++LSGQPNIV+ K AYED Q +H+VMELCAGGELFDRI+A+GH
Sbjct: 116 LISKQDKEDVKREIQIMQYLSGQPNIVEIKGAYEDRQSIHLVMELCAGGELFDRIIAQGH 175

Query: 131 YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190
           YSERAAA + R I+NVV +CH  GV+HRDLKPENFL ++ +ENA++KATDFGLS FIEEG
Sbjct: 176 YSERAAAGIIRSIVNVVQICHFMGVVHRDLKPENFLLSSKEENAMLKATDFGLSVFIEEG 235

Query: 191 KAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG 250
           K YR+IVGS YY+APEVL +SYGKE DIWSAGVILYILL GVPPFWAE ++G+   ++KG
Sbjct: 236 KVYRDIVGSAYYVAPEVLRRSYGKEIDIWSAGVILYILLSGVPPFWAENEKGIFDEVIKG 295

Query: 251 EINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIF 310
           EI+F  +P+PSIS SA +LVR+MLT+DPKRRIT AQVLEHPW+K  GEA DKPID+AV+ 
Sbjct: 296 EIDFVSEPWPSISESAKDLVRKMLTKDPKRRITAAQVLEHPWIK-GGEAPDKPIDSAVLS 354

Query: 311 RMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGS 370
           RMKQF AMNKLKKLALKVI E+L  EEI+ LK  F  +DTD SGT+TY+ELK GL +LGS
Sbjct: 355 RMKQFRAMNKLKKLALKVIAESLSEEEIKGLKTMFANIDTDKSGTITYEELKTGLTRLGS 414

Query: 371 MLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITV 430
            L+E +VKQ M+AAD+DGNGTIDY EFI+ATM R+KL R E++YKAFQ+FDKDN+G+IT 
Sbjct: 415 RLSETEVKQLMEAADVDGNGTIDYYEFISATMHRYKLDRDEHVYKAFQHFDKDNSGHITR 474

Query: 431 DELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT 479
           DEL  A K+YGMGD+   A+IKE++SEVD D DGRI+++EF +MM+ G+
Sbjct: 475 DELESAMKEYGMGDE---ASIKEVISEVDTDNDGRINFEEFCAMMRSGS 520

May play a role in signal transduction pathways that involve calcium as a second messenger. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49717|CDPKF_ARATH Calcium-dependent protein kinase 15 OS=Arabidopsis thaliana GN=CPK15 PE=2 SV=1

 Score =  657 bits (1696), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 307/461 (66%), Positives = 383/461 (83%), Gaps = 4/461 (0%)

Query: 21  DAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDV 80
           + ILGK +E+++  YT+G+E+GRG+FGITY C ENSTG  +ACKSI KRKL +  + DDV
Sbjct: 88  ETILGKPFEEIRKLYTLGKELGRGQFGITYTCKENSTGNTYACKSILKRKLTRKQDIDDV 147

Query: 81  RREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVF 140
           +REI+IM++LSGQ NIV+ K AYED Q +H+VMELC G ELFDRI+A+GHYSE+AAA V 
Sbjct: 148 KREIQIMQYLSGQENIVEIKGAYEDRQSIHLVMELCGGSELFDRIIAQGHYSEKAAAGVI 207

Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP 200
           R ++NVV +CH  GV+HRDLKPENFL  + DENA++KATDFGLS FIEEGK YR+IVGS 
Sbjct: 208 RSVLNVVQICHFMGVIHRDLKPENFLLASTDENAMLKATDFGLSVFIEEGKVYRDIVGSA 267

Query: 201 YYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
           YY+APEVL +SYGKE DIWSAG+ILYILLCGVPPFW+ET++G+   I+KGEI+F   P+P
Sbjct: 268 YYVAPEVLRRSYGKEIDIWSAGIILYILLCGVPPFWSETEKGIFNEIIKGEIDFDSQPWP 327

Query: 261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNK 320
           SIS SA +LVR++LT+DPK+RI+ AQ LEHPW++  GEA DKPID+AV+ RMKQF AMNK
Sbjct: 328 SISESAKDLVRKLLTKDPKQRISAAQALEHPWIR-GGEAPDKPIDSAVLSRMKQFRAMNK 386

Query: 321 LKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQY 380
           LKKLALKVI E+L  EEI+ LK  F  MDTD SGT+TY+ELK GLAKLGS LTE +VKQ 
Sbjct: 387 LKKLALKVIAESLSEEEIKGLKTMFANMDTDKSGTITYEELKNGLAKLGSKLTEAEVKQL 446

Query: 381 MQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDY 440
           M+AAD+DGNGTIDYIEFI+ATM R++  R E+++KAFQYFDKDN+G+IT+DEL  A K+Y
Sbjct: 447 MEAADVDGNGTIDYIEFISATMHRYRFDRDEHVFKAFQYFDKDNSGFITMDELESAMKEY 506

Query: 441 GMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQL 481
           GMGD+   A+IKE+++EVD D DGRI+Y+EF +MM+ G  L
Sbjct: 507 GMGDE---ASIKEVIAEVDTDNDGRINYEEFCAMMRSGITL 544

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1PFH8|CDPKJ_ARATH Calcium-dependent protein kinase 19 OS=Arabidopsis thaliana GN=CPK19 PE=2 SV=1

 Score =  637 bits (1642), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 298/461 (64%), Positives = 374/461 (81%), Gaps = 4/461 (0%)

Query: 21  DAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDV 80
           + ILG+ +ED++  Y++GRE+GRG+FGITY+CTE S+G  FACKSI KRKL++  +++DV
Sbjct: 84  EPILGRPFEDIKEKYSLGRELGRGQFGITYICTEISSGKNFACKSILKRKLIRTKDREDV 143

Query: 81  RREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVF 140
           RREI+IM +LSGQPNIV+ K AYED Q VH+VMELC GGELFD+I  RGHYSE+AAA + 
Sbjct: 144 RREIQIMHYLSGQPNIVEIKGAYEDRQSVHLVMELCEGGELFDKITKRGHYSEKAAAEII 203

Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDE-NAVVKATDFGLSAFIEEGKAYREIVGS 199
           R ++ VV +CH  GV+HRDLKPENFL ++ DE ++++KATDFG+S FIEEGK Y +IVGS
Sbjct: 204 RSVVKVVQICHFMGVIHRDLKPENFLLSSKDEASSMLKATDFGVSVFIEEGKVYEDIVGS 263

Query: 200 PYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF 259
            YY+APEVL ++YGK  DIWSAGVILYILLCG PPFWAETD+G+ + IL+GEI+F+ +P+
Sbjct: 264 AYYVAPEVLKRNYGKAIDIWSAGVILYILLCGNPPFWAETDKGIFEEILRGEIDFESEPW 323

Query: 260 PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMN 319
           PSIS SA +LVR ML  DPK+R T AQVLEHPW++E GEASDKPID+AV+ RMKQ  AMN
Sbjct: 324 PSISESAKDLVRNMLKYDPKKRFTAAQVLEHPWIREGGEASDKPIDSAVLSRMKQLRAMN 383

Query: 320 KLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQ 379
           KLKKLA K I +NL  EE++ LK  F  MDTD SGT+TYDELK+GL KLGS LTE +VKQ
Sbjct: 384 KLKKLAFKFIAQNLKEEELKGLKTMFANMDTDKSGTITYDELKSGLEKLGSRLTETEVKQ 443

Query: 380 YMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKD 439
            ++ AD+DGNGTIDYIEFI+ATM R +++R +NL+KAFQ+FDKDN+G+I+  EL  A K+
Sbjct: 444 LLEDADVDGNGTIDYIEFISATMNRFRVEREDNLFKAFQHFDKDNSGFISRQELETAMKE 503

Query: 440 YGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ 480
           Y MGDD     IKEI+SEVD D DG I+Y EF +MMK  +Q
Sbjct: 504 YNMGDD---IMIKEIISEVDADNDGSINYQEFCNMMKSCSQ 541

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3E9C0|CDPKY_ARATH Calcium-dependent protein kinase 34 OS=Arabidopsis thaliana GN=CPK34 PE=2 SV=1

 Score =  614 bits (1584), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 284/457 (62%), Positives = 363/457 (79%), Gaps = 3/457 (0%)

Query: 23  ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR 82
           +LG+  EDV+  YT+G+E+GRG+FG+T+LCT+ +TGL+FACK+I KRKLV   + +DVRR
Sbjct: 56  VLGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIAKRKLVNKEDIEDVRR 115

Query: 83  EIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV 142
           E++IM HL+GQPNIV+ K AYED   VH+VMELCAGGELFDRI+A+GHYSERAAAS+ R 
Sbjct: 116 EVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRT 175

Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           I+ +++ CHS GV+HRDLKPENFL  + DEN+ +KATDFGLS F + G+ +++IVGS YY
Sbjct: 176 IVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYY 235

Query: 203 IAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
           IAPEVL + YG EADIWS GV+LYILLCGVPPFWAE++ G+  AIL G+++F  DP+P I
Sbjct: 236 IAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILSGQVDFSSDPWPVI 295

Query: 263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLK 322
           S  A +LVR+ML  DPK+R+T AQVL HPW+KE GEA D P+D AV+ R+KQF AMN  K
Sbjct: 296 SPQAKDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNFK 355

Query: 323 KLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQ 382
           K+AL+VI   L  EEI  LKE F  MDTDNSGT+T +EL+ GLAK G+ L+E++V+Q M+
Sbjct: 356 KVALRVIAGCLSEEEIMGLKEMFKGMDTDNSGTITLEELRQGLAKQGTRLSEYEVQQLME 415

Query: 383 AADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM 442
           AAD DGNGTIDY EFI ATM  ++L R E+LY AFQ+FDKDN+GYIT +EL +A +++GM
Sbjct: 416 AADADGNGTIDYGEFIAATMHINRLDREEHLYSAFQHFDKDNSGYITTEELEQALREFGM 475

Query: 443 GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT 479
            D      IKEI+SEVD D DGRI+Y+EF +MM+ G 
Sbjct: 476 NDG---RDIKEIISEVDGDNDGRINYEEFVAMMRKGN 509

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FMP5|CDPKH_ARATH Calcium-dependent protein kinase 17 OS=Arabidopsis thaliana GN=CPK17 PE=2 SV=1

 Score =  613 bits (1582), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 283/457 (61%), Positives = 363/457 (79%), Gaps = 3/457 (0%)

Query: 23  ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR 82
           +LG+  EDV+  Y++G+E+GRG+FG+T+LCT+ +TG +FACK+I KRKLV   + +DVRR
Sbjct: 61  VLGRPMEDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVRR 120

Query: 83  EIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV 142
           E++IM HL+GQPNIV+ K AYED   VH+VMELCAGGELFDRI+A+GHYSERAAAS+ R 
Sbjct: 121 EVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRT 180

Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           I+ +V+ CHS GV+HRDLKPENFL    DEN+ +KATDFGLS F + G+ +++IVGS YY
Sbjct: 181 IVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYY 240

Query: 203 IAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
           IAPEVL + YG EADIWS GV+LYILLCGVPPFWAE++ G+  AIL+G ++F  DP+PSI
Sbjct: 241 IAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPSI 300

Query: 263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLK 322
           S  A +LV++ML  DPK+R+T AQVL HPW+KE GEA D P+D AV+ R+KQF AMN  K
Sbjct: 301 SPQAKDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNFK 360

Query: 323 KLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQ 382
           K+AL+VI   L  EEI  LKE F  MDTD+SGT+T +EL+ GLAK G+ L+E++V+Q M+
Sbjct: 361 KVALRVIAGCLSEEEIMGLKEMFKGMDTDSSGTITLEELRQGLAKQGTRLSEYEVQQLME 420

Query: 383 AADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM 442
           AAD DGNGTIDY EFI ATM  ++L R E+LY AFQ+FDKDN+GYIT++EL +A +++GM
Sbjct: 421 AADADGNGTIDYGEFIAATMHINRLDREEHLYSAFQHFDKDNSGYITMEELEQALREFGM 480

Query: 443 GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT 479
            D      IKEI+SEVD D DGRI+YDEF +MM+ G 
Sbjct: 481 NDG---RDIKEIISEVDGDNDGRINYDEFVAMMRKGN 514

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	494
225460973	536	PREDICTED: calcium-dependent protein kin	0.939	0.865	0.721	0.0
255583607	533	calcium-dependent protein kinase, putati	0.939	0.870	0.719	0.0
356553567	539	PREDICTED: calcium-dependent protein kin	0.939	0.860	0.708	0.0
15231140	541	calmodulin-domain protein kinase 9 [Arab	0.937	0.855	0.703	0.0
15223629	521	calcium-dependent protein kinase 33 [Ara	0.939	0.890	0.710	0.0
297830722	541	calmodulin-domain protein kinase 9 [Arab	0.923	0.842	0.710	0.0
356501529	528	PREDICTED: calcium-dependent protein kin	0.939	0.878	0.704	0.0
449470453	519	PREDICTED: calcium-dependent protein kin	0.925	0.880	0.715	0.0
297847416	521	calcium-dependent protein kinase 33 [Ara	0.939	0.890	0.706	0.0
3283996	540	calcium-dependent protein kinase [Nicoti	0.927	0.848	0.710	0.0

>gi|225460973|ref|XP_002278179.1| PREDICTED: calcium-dependent protein kinase 9-like [Vitis vinifera]

 Score =  709 bits (1830), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 337/467 (72%), Positives = 401/467 (85%), Gaps = 3/467 (0%)

Query: 14  PAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK 73
           P   H  D ILGK++EDV+LHYTIG+E+GRG+FG+TYLCTENSTGL++ACKSI KRKLV 
Sbjct: 67  PKPVHRPDTILGKSFEDVKLHYTIGKELGRGQFGVTYLCTENSTGLQYACKSISKRKLVT 126

Query: 74  DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSE 133
             +K+D+RREI+IM+ LSGQPNIV+FK AYED   VH+VMELCAGGELFDRI+A+GHYSE
Sbjct: 127 KNDKEDIRREIQIMQDLSGQPNIVEFKGAYEDRLSVHLVMELCAGGELFDRIIAKGHYSE 186

Query: 134 RAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY 193
           RAAAS+ R I+NVV++CH  GVMHRDLKPENFL ++  ENA++KATDFGLS FIEEGK Y
Sbjct: 187 RAAASICRAIVNVVHICHFMGVMHRDLKPENFLLSSKGENALLKATDFGLSVFIEEGKVY 246

Query: 194 REIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN 253
           R+IVGS YY+APEVL + YGKE DIWSAGVILYILL GVPPFWAET++G+  AIL+G I+
Sbjct: 247 RDIVGSAYYVAPEVLRRRYGKEIDIWSAGVILYILLSGVPPFWAETEKGIFDAILQGHID 306

Query: 254 FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMK 313
           F+  P+PSISSSA +LVR+MLTQDP++RIT AQVLEHPW+KE GEASDKPID+AV+ RMK
Sbjct: 307 FETSPWPSISSSAKDLVRKMLTQDPQKRITSAQVLEHPWIKEDGEASDKPIDSAVLSRMK 366

Query: 314 QFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLT 373
           QF AMNKLKKLALKVI ENL  EEIQ LK  FT MDTD SGT+TY+ELK+GLA+LGS LT
Sbjct: 367 QFRAMNKLKKLALKVIAENLSEEEIQGLKAMFTNMDTDKSGTITYEELKSGLARLGSKLT 426

Query: 374 EFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDEL 433
           E +V+Q M+AAD+DGNGTIDYIEFITAT+ RHKL+R E+L+KAFQYFDKD++G+IT DEL
Sbjct: 427 EAEVQQLMEAADVDGNGTIDYIEFITATVNRHKLERDEHLFKAFQYFDKDSSGFITRDEL 486

Query: 434 GKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ 480
             A K++GMGDD TIA   EI+SEVD D D +I+Y EF SMM+ GTQ
Sbjct: 487 KAAMKEHGMGDDDTIA---EIISEVDTDNDDKINYGEFCSMMRGGTQ 530

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255583607|ref|XP_002532559.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223527714|gb|EEF29820.1| calcium-dependent protein kinase, putative [Ricinus communis]

 Score =  709 bits (1830), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 336/467 (71%), Positives = 398/467 (85%), Gaps = 3/467 (0%)

Query: 14  PAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK 73
           P   H  D IL K YEDV+LHYTIG+E+GRG+FG+TYLCTE STG  +ACKSI KRKLV 
Sbjct: 64  PKPVHKPDTILEKPYEDVKLHYTIGKELGRGQFGVTYLCTEISTGKLYACKSISKRKLVT 123

Query: 74  DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSE 133
             +K+D++REI+IM+HLSGQPNIV+FK AYED Q VH+VMELCAGGELFDRI+A+GHYSE
Sbjct: 124 RNDKEDMKREIQIMQHLSGQPNIVEFKGAYEDKQSVHLVMELCAGGELFDRIIAKGHYSE 183

Query: 134 RAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY 193
           + AAS+ R I+NVV+ CH  GVMHRDLKPENFL ++ D+NA++KATDFGLS FIEEGK Y
Sbjct: 184 KEAASICRSIVNVVHACHFMGVMHRDLKPENFLLSSKDQNALLKATDFGLSVFIEEGKTY 243

Query: 194 REIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN 253
           R+IVGS YY+APEVL + YGKE DIWSAGV+LYILL GVPPFWAE+++G+  AIL+G+I+
Sbjct: 244 RDIVGSAYYVAPEVLRRRYGKEMDIWSAGVMLYILLSGVPPFWAESEKGIFDAILQGDID 303

Query: 254 FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMK 313
           F+  P+P+ISSSA +LVRRMLTQDPK+RIT  QVLEHPWLKE G+ASDKPID+AV+ RMK
Sbjct: 304 FESPPWPTISSSAKDLVRRMLTQDPKKRITSTQVLEHPWLKEGGDASDKPIDSAVLSRMK 363

Query: 314 QFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLT 373
           QF AMNKLKK+ALKVI ENL ++EIQ LK  F  +DTDNSGT+TYDELKAGLA+LGS LT
Sbjct: 364 QFRAMNKLKKMALKVIAENLSSDEIQGLKSMFANIDTDNSGTITYDELKAGLARLGSKLT 423

Query: 374 EFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDEL 433
           E +VKQ M AAD+DGNGTIDY+EFITATM RH+L+R E+LYKAFQYFDKDN+G+IT DEL
Sbjct: 424 ETEVKQLMDAADVDGNGTIDYLEFITATMHRHRLEREEHLYKAFQYFDKDNSGFITRDEL 483

Query: 434 GKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ 480
             A KDY MGDD   ATIKEI+SEVD D DGRI+Y+EF +MMK G Q
Sbjct: 484 ETAMKDYEMGDD---ATIKEIISEVDADNDGRINYEEFCTMMKTGNQ 527

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356553567|ref|XP_003545126.1| PREDICTED: calcium-dependent protein kinase 9-like [Glycine max]

 Score =  706 bits (1822), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 331/467 (70%), Positives = 397/467 (85%), Gaps = 3/467 (0%)

Query: 14  PAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK 73
           P   H HD I GK +EDV+ HYT+G+E+GRG+FG+TYLCTENSTGL++ACKSI +RKLV 
Sbjct: 70  PKHVHNHDTITGKPFEDVKQHYTLGKELGRGQFGVTYLCTENSTGLQYACKSISRRKLVS 129

Query: 74  DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSE 133
             +K+D++REI+IM+HLSGQ NIV+FK A+ED Q VH+VMELCAGGELFDRI+A+GHYSE
Sbjct: 130 RADKEDMKREIQIMQHLSGQSNIVEFKGAFEDKQSVHVVMELCAGGELFDRIIAKGHYSE 189

Query: 134 RAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY 193
           RAAAS+ R I+ VVN CH  GV+HRDLKPENFL ++ D+  ++KATDFGLS FIEEGK Y
Sbjct: 190 RAAASICRQIVKVVNTCHFMGVIHRDLKPENFLLSSKDDKGLLKATDFGLSVFIEEGKVY 249

Query: 194 REIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN 253
           R IVGS YY+APEVL +SYGKEADIWSAGVILYILL GVPPFWAET++G+  AIL+G I+
Sbjct: 250 RNIVGSAYYVAPEVLRRSYGKEADIWSAGVILYILLSGVPPFWAETEKGIFDAILQGHID 309

Query: 254 FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMK 313
           F+  P+PSIS+SA +LVR+ML +DPK+RIT +QVLEHPWLKE G ASDKPID+AV+ RMK
Sbjct: 310 FESSPWPSISNSAKDLVRKMLIKDPKKRITASQVLEHPWLKEGGNASDKPIDSAVLSRMK 369

Query: 314 QFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLT 373
           QF AMNKLKKLALKVI ENL  EEIQ LK  FT +DTDNSGT+TY+EL+AGL +LGS LT
Sbjct: 370 QFRAMNKLKKLALKVIAENLSEEEIQGLKAMFTNIDTDNSGTITYEELRAGLQRLGSKLT 429

Query: 374 EFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDEL 433
           E +V+Q M AAD+DGNGTIDYIEFITATM RH+L+R E+LYKAFQYFDKD +GYIT DEL
Sbjct: 430 ETEVRQLMDAADVDGNGTIDYIEFITATMHRHRLERDEHLYKAFQYFDKDGSGYITRDEL 489

Query: 434 GKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ 480
             A K+YGMGD+   ATI+EI+SEVD D DGRI+Y+EF +MM+ GTQ
Sbjct: 490 EIAMKEYGMGDE---ATIREIISEVDTDNDGRINYEEFCTMMRSGTQ 533

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15231140|ref|NP_188676.1| calmodulin-domain protein kinase 9 [Arabidopsis thaliana] gi|75319414|sp|Q38868.1|CDPK9_ARATH RecName: Full=Calcium-dependent protein kinase 9; AltName: Full=Calmodulin-domain protein kinase CDPK isoform 9 gi|1399265|gb|AAB03242.1| calmodulin-domain protein kinase CDPK isoform 9 [Arabidopsis thaliana] gi|9294561|dbj|BAB02824.1| calmodulin-domain protein kinase CDPK isoform 9 [Arabidopsis thaliana] gi|21539465|gb|AAM53285.1| calmodulin-domain protein kinase CDPK isoform 9 [Arabidopsis thaliana] gi|31711962|gb|AAP68337.1| At3g20410 [Arabidopsis thaliana] gi|332642854|gb|AEE76375.1| calmodulin-domain protein kinase 9 [Arabidopsis thaliana]

 Score =  703 bits (1815), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 328/466 (70%), Positives = 397/466 (85%), Gaps = 3/466 (0%)

Query: 14  PAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK 73
           P      ++IL  A+EDV+L YT+G+E+GRG+FG+TYLCTENSTG ++ACKSI K+KLV 
Sbjct: 70  PKTTTKSNSILENAFEDVKLFYTLGKELGRGQFGVTYLCTENSTGKKYACKSISKKKLVT 129

Query: 74  DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSE 133
             +KDD+RREI+IM+HLSGQPNIV+FK AYED++ V++VMELCAGGELFDRI+A+GHY+E
Sbjct: 130 KADKDDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDRIIAKGHYTE 189

Query: 134 RAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY 193
           RAAASV R I+NVV +CH  GV+HRDLKPENFL ++ DE A++KATDFGLS FIEEGK Y
Sbjct: 190 RAAASVCRQIVNVVKICHFMGVLHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGKVY 249

Query: 194 REIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN 253
           R+IVGS YY+APEVL + YGKE DIWSAG+ILYILL GVPPFWAET++G+  AIL+G I+
Sbjct: 250 RDIVGSAYYVAPEVLRRRYGKEVDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGHID 309

Query: 254 FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMK 313
           F+  P+PSISSSA +LVRRMLT DPKRRI+ A VL+HPWL+E GEASDKPID+AV+ RMK
Sbjct: 310 FESQPWPSISSSAKDLVRRMLTADPKRRISAADVLQHPWLREGGEASDKPIDSAVLSRMK 369

Query: 314 QFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLT 373
           QF AMNKLKKLALKVI EN+ TEEIQ LK  F  +DTDNSGT+TY+ELK GLAKLGS LT
Sbjct: 370 QFRAMNKLKKLALKVIAENIDTEEIQGLKAMFANIDTDNSGTITYEELKEGLAKLGSKLT 429

Query: 374 EFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDEL 433
           E +VKQ M AAD+DGNG+IDYIEFITATM RH+L+  ENLYKAFQ+FDKD++GYIT+DEL
Sbjct: 430 EAEVKQLMDAADVDGNGSIDYIEFITATMHRHRLESNENLYKAFQHFDKDSSGYITIDEL 489

Query: 434 GKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT 479
             A K+YGMGDD   ATIKE++S+VD D DGRI+Y+EF +MM+ G 
Sbjct: 490 ESALKEYGMGDD---ATIKEVLSDVDSDNDGRINYEEFCAMMRSGN 532

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15223629|ref|NP_175485.1| calcium-dependent protein kinase 33 [Arabidopsis thaliana] gi|75333437|sp|Q9C6P3.1|CDPKX_ARATH RecName: Full=Calcium-dependent protein kinase 33 gi|12322336|gb|AAG51192.1|AC079279_13 calcium-dependent protein kinase [Arabidopsis thaliana] gi|46931348|gb|AAT06478.1| At1g50700 [Arabidopsis thaliana] gi|51969388|dbj|BAD43386.1| hypothetical protein [Arabidopsis thaliana] gi|332194460|gb|AEE32581.1| calcium-dependent protein kinase 33 [Arabidopsis thaliana]

 Score =  702 bits (1812), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 332/467 (71%), Positives = 397/467 (85%), Gaps = 3/467 (0%)

Query: 13  HPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV 72
           +PA      AIL K YEDV+L YT+ +E+GRG+FG+TYLCTE STG  FACKSI K+KLV
Sbjct: 51  NPAKHSGAAAILEKPYEDVKLFYTLSKELGRGQFGVTYLCTEKSTGKRFACKSISKKKLV 110

Query: 73  KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYS 132
              +K+D+RREI+IM+HLSGQPNIV+FK AYED++ V++VMELCAGGELFDRI+A+GHYS
Sbjct: 111 TKGDKEDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDRILAKGHYS 170

Query: 133 ERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192
           ERAAASV R I+NVVN+CH  GVMHRDLKPENFL ++ DE A++KATDFGLS FIEEG+ 
Sbjct: 171 ERAAASVCRQIVNVVNICHFMGVMHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGRV 230

Query: 193 YREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI 252
           Y++IVGS YY+APEVL + YGKE DIWSAG+ILYILL GVPPFWAET++G+  AIL+GEI
Sbjct: 231 YKDIVGSAYYVAPEVLKRRYGKEIDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGEI 290

Query: 253 NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRM 312
           +F+  P+PSIS+SA +LVRRMLTQDPKRRI+ A+VL+HPWL+E GEASDKPID+AV+ RM
Sbjct: 291 DFESQPWPSISNSAKDLVRRMLTQDPKRRISAAEVLKHPWLREGGEASDKPIDSAVLSRM 350

Query: 313 KQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSML 372
           KQF AMNKLKKLALKVI EN+ TEEIQ LK  F  +DTDNSGT+TY+ELK GLAKLGS L
Sbjct: 351 KQFRAMNKLKKLALKVIAENIDTEEIQGLKAMFANIDTDNSGTITYEELKEGLAKLGSRL 410

Query: 373 TEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDE 432
           TE +VKQ M AAD+DGNG+IDYIEFITATM RH+L+  EN+YKAFQ+FDKD +GYIT DE
Sbjct: 411 TEAEVKQLMDAADVDGNGSIDYIEFITATMHRHRLESNENVYKAFQHFDKDGSGYITTDE 470

Query: 433 LGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT 479
           L  A K+YGMGDD   ATIKEI+S+VD D DGRI+YDEF +MM+ G 
Sbjct: 471 LEAALKEYGMGDD---ATIKEILSDVDADNDGRINYDEFCAMMRSGN 514

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297830722|ref|XP_002883243.1| calmodulin-domain protein kinase 9 [Arabidopsis lyrata subsp. lyrata] gi|297329083|gb|EFH59502.1| calmodulin-domain protein kinase 9 [Arabidopsis lyrata subsp. lyrata]

 Score =  701 bits (1809), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 326/459 (71%), Positives = 396/459 (86%), Gaps = 3/459 (0%)

Query: 21  DAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDV 80
           ++IL  A+EDV+L YT+G+E+GRG+FG+TYLCTENSTG ++ACKSI K+KLV   +KDD+
Sbjct: 77  NSILENAFEDVKLFYTLGKELGRGQFGVTYLCTENSTGKKYACKSISKKKLVTKADKDDM 136

Query: 81  RREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVF 140
           RREI+IM+HLSGQPNIV+FK AYED++ V++VMELCAGGELFDRI+A+GHYSERAAASV 
Sbjct: 137 RREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDRIIAKGHYSERAAASVC 196

Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP 200
           R I+NVV +CH  GV+HRDLKPENFL ++ DE A++KATDFGLS FIEEGK YR+IVGS 
Sbjct: 197 RQIVNVVKICHFMGVLHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGKVYRDIVGSA 256

Query: 201 YYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
           YY+APEVL + YGKE DIWSAG+ILYILL GVPPFWAET++G+  AIL+G I+F+  P+P
Sbjct: 257 YYVAPEVLRRRYGKEVDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGHIDFESQPWP 316

Query: 261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNK 320
           SIS+SA +LVRRMLT DPKRRI+ A VL+HPWL+E GEASDKPID+AV+ RMKQF AMNK
Sbjct: 317 SISNSAKDLVRRMLTADPKRRISAADVLQHPWLREGGEASDKPIDSAVLSRMKQFRAMNK 376

Query: 321 LKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQY 380
           LKKLALKVI EN+ TEEIQ LK  F  +DTDNSG++TY+ELK GLAKLGS LTE +VKQ 
Sbjct: 377 LKKLALKVIAENIDTEEIQGLKAMFANIDTDNSGSITYEELKEGLAKLGSKLTEAEVKQL 436

Query: 381 MQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDY 440
           M AAD+DGNG+IDYIEFITATM RH+L+  ENLYKAFQ+FDKD++GYIT+DEL  A K+Y
Sbjct: 437 MDAADVDGNGSIDYIEFITATMHRHRLESNENLYKAFQHFDKDSSGYITIDELESALKEY 496

Query: 441 GMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT 479
           GMGDD   ATIKE++S+VD D DGRI+Y+EF +MM+ G 
Sbjct: 497 GMGDD---ATIKEVLSDVDSDNDGRINYEEFCAMMRSGN 532

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356501529|ref|XP_003519577.1| PREDICTED: calcium-dependent protein kinase 33-like isoform 1 [Glycine max]

 Score =  701 bits (1809), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 329/467 (70%), Positives = 396/467 (84%), Gaps = 3/467 (0%)

Query: 14  PAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK 73
           P   H HD I GK +EDV+ HYT+G+E+GRG+FG+TYLCTENSTG ++ACKSI KRKLV 
Sbjct: 59  PKHVHKHDTITGKPFEDVKQHYTLGKELGRGQFGVTYLCTENSTGFQYACKSISKRKLVS 118

Query: 74  DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSE 133
             +K+D++REI+IM+HLSGQ NIV+FK A+ED Q VH+VMELCAGGELFDRI+A+GHYSE
Sbjct: 119 RDDKEDMKREIQIMQHLSGQSNIVEFKGAFEDKQSVHVVMELCAGGELFDRIIAKGHYSE 178

Query: 134 RAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY 193
           RAAAS+ R ++ VVN CH  GV+HRDLKPENFL ++ D+  ++KATDFGLS FIEEGK Y
Sbjct: 179 RAAASICRQVVKVVNTCHFMGVIHRDLKPENFLLSSKDDKGLLKATDFGLSVFIEEGKVY 238

Query: 194 REIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN 253
           R+IVGS YY+APEVL +SYGKEADIWSAGVILYILL GVPPFWAET++G+   IL+G I+
Sbjct: 239 RDIVGSAYYVAPEVLRRSYGKEADIWSAGVILYILLSGVPPFWAETEKGIFDVILQGHID 298

Query: 254 FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMK 313
           F+  P+PSIS+SA +LVR+ML +DPK+RIT AQVLEHPWLKE G ASDKPID+AV+ RMK
Sbjct: 299 FESSPWPSISNSAKDLVRKMLIKDPKKRITAAQVLEHPWLKEGGNASDKPIDSAVLSRMK 358

Query: 314 QFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLT 373
           QF AMNKLKKLALKVI ENL  EEIQ LK  FT +DTDNSGT+TY+EL+AGL +LGS LT
Sbjct: 359 QFRAMNKLKKLALKVIAENLSEEEIQGLKAMFTNIDTDNSGTITYEELRAGLQRLGSKLT 418

Query: 374 EFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDEL 433
           E +V+Q M AAD+DGNGTIDYIEFITATM RH+L+R E+L+KAFQYFDKD +GYIT DEL
Sbjct: 419 EAEVQQLMDAADVDGNGTIDYIEFITATMHRHRLERDEHLHKAFQYFDKDGSGYITRDEL 478

Query: 434 GKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ 480
             A K+YGMG++   ATI+EI+SEVD D DGRI+YDEF +MM+ GTQ
Sbjct: 479 ETAMKEYGMGNE---ATIREIISEVDTDNDGRINYDEFCTMMRSGTQ 522

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449470453|ref|XP_004152931.1| PREDICTED: calcium-dependent protein kinase-like [Cucumis sativus] gi|449532030|ref|XP_004172987.1| PREDICTED: calcium-dependent protein kinase-like [Cucumis sativus]

 Score =  700 bits (1807), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 329/460 (71%), Positives = 393/460 (85%), Gaps = 3/460 (0%)

Query: 21  DAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDV 80
           D ILGK  EDV+LHYTIG+E+GRG+FG+TYLCTENS+G ++ACKSI KRKLV   +K+D+
Sbjct: 58  DTILGKPLEDVKLHYTIGKELGRGQFGVTYLCTENSSGKQYACKSILKRKLVTKNDKEDI 117

Query: 81  RREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVF 140
           RREI IM+HLSGQPNIV+FK AYED   VH++MELCAGGELFDRI+A+GHYSE+AAAS+ 
Sbjct: 118 RREIHIMQHLSGQPNIVEFKGAYEDKLSVHLIMELCAGGELFDRIIAKGHYSEKAAASIC 177

Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP 200
           R I+NVV++CH  GVMHRDLKPENFL  + +E+A++KATDFGLS FIEEGK YR+IVGS 
Sbjct: 178 RSIVNVVHICHFMGVMHRDLKPENFLLASKEEDAMLKATDFGLSVFIEEGKVYRDIVGSA 237

Query: 201 YYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
           YY+APEVL + YGKE D+WSAGV+LYILL GVPPFWAET++G+  +IL+G I+F+ DP+P
Sbjct: 238 YYVAPEVLRRKYGKEIDVWSAGVMLYILLSGVPPFWAETEKGIFDSILQGHIDFESDPWP 297

Query: 261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNK 320
            IS SA +LV+RMLTQDP  RIT AQVLEHPW++E GEASDKPID+AV  R+KQF AMNK
Sbjct: 298 HISPSAKDLVKRMLTQDPANRITSAQVLEHPWMREGGEASDKPIDSAVFTRLKQFRAMNK 357

Query: 321 LKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQY 380
           LKKLALKVI ENL  EEIQ LK  FT MDTD SGT+TY ELK+GLA+LGS L+E +VKQ 
Sbjct: 358 LKKLALKVIAENLSEEEIQGLKAMFTNMDTDKSGTITYAELKSGLARLGSTLSEAEVKQL 417

Query: 381 MQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDY 440
           M+AAD+DGNGTIDYIEFITATM R+KL++ E+LYKAFQ+FDKDN+GYIT DEL  A KDY
Sbjct: 418 MEAADVDGNGTIDYIEFITATMHRYKLEKEEHLYKAFQHFDKDNSGYITRDELKAAMKDY 477

Query: 441 GMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ 480
           GMGD+    TI+EI+SEVD D DGRI+YDEF SMM+ GTQ
Sbjct: 478 GMGDE---ETIREIISEVDADNDGRINYDEFCSMMRSGTQ 514

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297847416|ref|XP_002891589.1| calcium-dependent protein kinase 33 [Arabidopsis lyrata subsp. lyrata] gi|297337431|gb|EFH67848.1| calcium-dependent protein kinase 33 [Arabidopsis lyrata subsp. lyrata]

 Score =  700 bits (1807), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/467 (70%), Positives = 397/467 (85%), Gaps = 3/467 (0%)

Query: 13  HPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV 72
           +PA      AIL K YEDV+L YT+ +E+GRG+FG+TYLCTE ST   FACKSI K+KLV
Sbjct: 51  NPAKHSAAAAILEKPYEDVKLFYTLSKELGRGQFGVTYLCTEKSTRKRFACKSISKKKLV 110

Query: 73  KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYS 132
              +K+D+RREI+IM+HLSGQPNIV+FK AYED++ V++VMELCAGGELFDRI+A+GHYS
Sbjct: 111 TKADKEDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDRILAKGHYS 170

Query: 133 ERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192
           ERAAASV R I+NVVN+CH  GVMHRDLKPENFL ++ DE A++KATDFGLS FIEEG+ 
Sbjct: 171 ERAAASVCRQIVNVVNICHFMGVMHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGRV 230

Query: 193 YREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI 252
           Y++IVGS YY+APEVL + YGKE DIWSAG+ILYILL GVPPFWAET++G+  AIL+GEI
Sbjct: 231 YKDIVGSAYYVAPEVLKRRYGKEIDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGEI 290

Query: 253 NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRM 312
           +F+  P+PSIS+SA +LVRRMLTQDPKRRI+ A+VL+HPWL+E GEASDKPID+AV+ RM
Sbjct: 291 DFESQPWPSISNSAKDLVRRMLTQDPKRRISAAEVLQHPWLREGGEASDKPIDSAVLSRM 350

Query: 313 KQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSML 372
           KQF AMNKLKKLALKVI EN+ TEEIQ LK  F  +DTDNSGT+TY+ELK GLAKLGS L
Sbjct: 351 KQFRAMNKLKKLALKVIAENIDTEEIQGLKAMFANIDTDNSGTITYEELKEGLAKLGSKL 410

Query: 373 TEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDE 432
           TE +VKQ M AAD+DGNG+IDYIEFITATM RH+L+  ENLY+AFQ+FDKD +GYIT+DE
Sbjct: 411 TEAEVKQLMDAADVDGNGSIDYIEFITATMHRHRLESNENLYRAFQHFDKDGSGYITIDE 470

Query: 433 LGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT 479
           L  A K+YGMGDD   ATIKEI+S+VD D DGRI+Y+EF +MM+ G 
Sbjct: 471 LEAALKEYGMGDD---ATIKEILSDVDADNDGRINYEEFCAMMRSGN 514

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|3283996|gb|AAC25423.1| calcium-dependent protein kinase [Nicotiana tabacum]

 Score =  696 bits (1796), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 329/463 (71%), Positives = 401/463 (86%), Gaps = 5/463 (1%)

Query: 18  HLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK 77
           HL++ ILGK +ED++  YT+G+E+GRG+FG+TY CTENSTG  +ACKSI KRKLV+  ++
Sbjct: 77  HLNN-ILGKPFEDIRKQYTLGKELGRGQFGVTYHCTENSTGNPYACKSILKRKLVRKNDR 135

Query: 78  DDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAA 137
           +D++REI+IM+HLSGQPNIV+FK AYED   VH+VMELCAGGELFDRI+ARG+YSE+ AA
Sbjct: 136 EDMKREIQIMQHLSGQPNIVEFKGAYEDRHSVHLVMELCAGGELFDRIIARGYYSEKDAA 195

Query: 138 SVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV 197
            + R I NVVN+CH  GVMHRDLKPENFL T+ DENA +KATDFGLS FIEEGK YR+IV
Sbjct: 196 EIIRQIANVVNICHFMGVMHRDLKPENFLLTSKDENAKLKATDFGLSVFIEEGKVYRDIV 255

Query: 198 GSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
           GS YY+APEVL +SYGKEAD+WSAGVILYILL GVPPFWAET++G+  AILKGEI+FQ D
Sbjct: 256 GSAYYVAPEVLRRSYGKEADVWSAGVILYILLSGVPPFWAETEKGIFNAILKGEIDFQSD 315

Query: 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTA 317
           P+PSIS+SA +L+R+MLTQ+P++R+T AQVLEHPWL+  GEASDKPID+AV+ RMKQF A
Sbjct: 316 PWPSISNSAKDLIRKMLTQEPRKRMTSAQVLEHPWLR-MGEASDKPIDSAVLSRMKQFRA 374

Query: 318 MNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDV 377
           MNKLKKLALKVI ENL  EEI+ LK  F  +DTDNSGT+TY+ELK+GLA+LGS LTE +V
Sbjct: 375 MNKLKKLALKVIAENLSEEEIKGLKAMFANIDTDNSGTITYEELKSGLARLGSKLTETEV 434

Query: 378 KQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAF 437
           KQ M+AAD+DGNGTIDYIEFITATM RH+L+R E+L+KAFQYFDKD++G+IT DEL  A 
Sbjct: 435 KQLMEAADVDGNGTIDYIEFITATMHRHRLERDEHLFKAFQYFDKDHSGFITRDELESAM 494

Query: 438 KDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ 480
           K+YGMGD+   ATIKEI++EVD D DGRI+Y+EF +MM+ GTQ
Sbjct: 495 KEYGMGDE---ATIKEIIAEVDTDNDGRINYEEFCAMMRSGTQ 534

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	494
TAIR|locus:2015846	521	CPK33 "calcium-dependent prote	0.937	0.888	0.712	6.1e-181
TAIR|locus:2092399	541	CPK9 "calmodulin-domain protei	0.921	0.841	0.713	7.8e-181
TAIR|locus:2138897	531	CPK21 "calcium-dependent prote	0.941	0.875	0.663	1.5e-170
TAIR|locus:2036783	551	CPK19 "calcium-dependent prote	0.925	0.829	0.646	9e-164
TAIR|locus:2150225	523	CPK34 "AT5G19360" [Arabidopsis	0.917	0.866	0.622	2.1e-157
TAIR|locus:2177023	528	CPK17 "calcium-dependent prote	0.917	0.857	0.620	8.9e-157
TAIR|locus:2204340	561	CPK29 "calcium-dependent prote	0.917	0.807	0.610	6.3e-156
TAIR|locus:2128409	529	CDPK6 "calcium-dependent prote	0.917	0.856	0.598	3.3e-150
TAIR|locus:2075885	646	CPK2 "calmodulin-domain protei	0.921	0.704	0.562	2.2e-144
TAIR|locus:2827528	544	CPK6 "calcium dependent protei	0.914	0.830	0.574	3.6e-144

TAIR|locus:2015846 CPK33 "calcium-dependent protein kinase 33" [Arabidopsis thaliana (taxid:3702)]

 Score = 1756 (623.2 bits), Expect = 6.1e-181, P = 6.1e-181
 Identities = 332/466 (71%), Positives = 397/466 (85%)

Query:    13 HPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV 72
             +PA      AIL K YEDV+L YT+ +E+GRG+FG+TYLCTE STG  FACKSI K+KLV
Sbjct:    51 NPAKHSGAAAILEKPYEDVKLFYTLSKELGRGQFGVTYLCTEKSTGKRFACKSISKKKLV 110

Query:    73 KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYS 132
                +K+D+RREI+IM+HLSGQPNIV+FK AYED++ V++VMELCAGGELFDRI+A+GHYS
Sbjct:   111 TKGDKEDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDRILAKGHYS 170

Query:   133 ERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192
             ERAAASV R I+NVVN+CH  GVMHRDLKPENFL ++ DE A++KATDFGLS FIEEG+ 
Sbjct:   171 ERAAASVCRQIVNVVNICHFMGVMHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGRV 230

Query:   193 YREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI 252
             Y++IVGS YY+APEVL + YGKE DIWSAG+ILYILL GVPPFWAET++G+  AIL+GEI
Sbjct:   231 YKDIVGSAYYVAPEVLKRRYGKEIDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGEI 290

Query:   253 NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRM 312
             +F+  P+PSIS+SA +LVRRMLTQDPKRRI+ A+VL+HPWL+E GEASDKPID+AV+ RM
Sbjct:   291 DFESQPWPSISNSAKDLVRRMLTQDPKRRISAAEVLKHPWLREGGEASDKPIDSAVLSRM 350

Query:   313 KQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSML 372
             KQF AMNKLKKLALKVI EN+ TEEIQ LK  F  +DTDNSGT+TY+ELK GLAKLGS L
Sbjct:   351 KQFRAMNKLKKLALKVIAENIDTEEIQGLKAMFANIDTDNSGTITYEELKEGLAKLGSRL 410

Query:   373 TEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDE 432
             TE +VKQ M AAD+DGNG+IDYIEFITATM RH+L+  EN+YKAFQ+FDKD +GYIT DE
Sbjct:   411 TEAEVKQLMDAADVDGNGSIDYIEFITATMHRHRLESNENVYKAFQHFDKDGSGYITTDE 470

Query:   433 LGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG 478
             L  A K+YGMGDDATI   KEI+S+VD D DGRI+YDEF +MM+ G
Sbjct:   471 LEAALKEYGMGDDATI---KEILSDVDADNDGRINYDEFCAMMRSG 513

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2092399 CPK9 "calmodulin-domain protein kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 1755 (622.8 bits), Expect = 7.8e-181, P = 7.8e-181
 Identities = 327/458 (71%), Positives = 396/458 (86%)

Query:    21 DAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDV 80
             ++IL  A+EDV+L YT+G+E+GRG+FG+TYLCTENSTG ++ACKSI K+KLV   +KDD+
Sbjct:    77 NSILENAFEDVKLFYTLGKELGRGQFGVTYLCTENSTGKKYACKSISKKKLVTKADKDDM 136

Query:    81 RREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVF 140
             RREI+IM+HLSGQPNIV+FK AYED++ V++VMELCAGGELFDRI+A+GHY+ERAAASV 
Sbjct:   137 RREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDRIIAKGHYTERAAASVC 196

Query:   141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP 200
             R I+NVV +CH  GV+HRDLKPENFL ++ DE A++KATDFGLS FIEEGK YR+IVGS 
Sbjct:   197 RQIVNVVKICHFMGVLHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGKVYRDIVGSA 256

Query:   201 YYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
             YY+APEVL + YGKE DIWSAG+ILYILL GVPPFWAET++G+  AIL+G I+F+  P+P
Sbjct:   257 YYVAPEVLRRRYGKEVDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGHIDFESQPWP 316

Query:   261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNK 320
             SISSSA +LVRRMLT DPKRRI+ A VL+HPWL+E GEASDKPID+AV+ RMKQF AMNK
Sbjct:   317 SISSSAKDLVRRMLTADPKRRISAADVLQHPWLREGGEASDKPIDSAVLSRMKQFRAMNK 376

Query:   321 LKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQY 380
             LKKLALKVI EN+ TEEIQ LK  F  +DTDNSGT+TY+ELK GLAKLGS LTE +VKQ 
Sbjct:   377 LKKLALKVIAENIDTEEIQGLKAMFANIDTDNSGTITYEELKEGLAKLGSKLTEAEVKQL 436

Query:   381 MQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDY 440
             M AAD+DGNG+IDYIEFITATM RH+L+  ENLYKAFQ+FDKD++GYIT+DEL  A K+Y
Sbjct:   437 MDAADVDGNGSIDYIEFITATMHRHRLESNENLYKAFQHFDKDSSGYITIDELESALKEY 496

Query:   441 GMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG 478
             GMGDDATI   KE++S+VD D DGRI+Y+EF +MM+ G
Sbjct:   497 GMGDDATI---KEVLSDVDSDNDGRINYEEFCAMMRSG 531

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=TAS

GO:0005886 "plasma membrane" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2138897 CPK21 "calcium-dependent protein kinase 21" [Arabidopsis thaliana (taxid:3702)]

 Score = 1658 (588.7 bits), Expect = 1.5e-170, P = 1.5e-170
 Identities = 311/469 (66%), Positives = 389/469 (82%)

Query:    11 SDHPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRK 70
             S +P +    D ILGK +ED++  Y++G+E+GRG+FGITY+C E  TG  +ACKSI KRK
Sbjct:    56 SSNPVSVRDPDTILGKPFEDIRKFYSLGKELGRGQFGITYMCKEIGTGNTYACKSILKRK 115

Query:    71 LVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH 130
             L+   +K+DV+REI+IM++LSGQPNIV+ K AYED Q +H+VMELCAGGELFDRI+A+GH
Sbjct:   116 LISKQDKEDVKREIQIMQYLSGQPNIVEIKGAYEDRQSIHLVMELCAGGELFDRIIAQGH 175

Query:   131 YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190
             YSERAAA + R I+NVV +CH  GV+HRDLKPENFL ++ +ENA++KATDFGLS FIEEG
Sbjct:   176 YSERAAAGIIRSIVNVVQICHFMGVVHRDLKPENFLLSSKEENAMLKATDFGLSVFIEEG 235

Query:   191 KAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG 250
             K YR+IVGS YY+APEVL +SYGKE DIWSAGVILYILL GVPPFWAE ++G+   ++KG
Sbjct:   236 KVYRDIVGSAYYVAPEVLRRSYGKEIDIWSAGVILYILLSGVPPFWAENEKGIFDEVIKG 295

Query:   251 EINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIF 310
             EI+F  +P+PSIS SA +LVR+MLT+DPKRRIT AQVLEHPW+K  GEA DKPID+AV+ 
Sbjct:   296 EIDFVSEPWPSISESAKDLVRKMLTKDPKRRITAAQVLEHPWIK-GGEAPDKPIDSAVLS 354

Query:   311 RMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGS 370
             RMKQF AMNKLKKLALKVI E+L  EEI+ LK  F  +DTD SGT+TY+ELK GL +LGS
Sbjct:   355 RMKQFRAMNKLKKLALKVIAESLSEEEIKGLKTMFANIDTDKSGTITYEELKTGLTRLGS 414

Query:   371 MLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITV 430
              L+E +VKQ M+AAD+DGNGTIDY EFI+ATM R+KL R E++YKAFQ+FDKDN+G+IT 
Sbjct:   415 RLSETEVKQLMEAADVDGNGTIDYYEFISATMHRYKLDRDEHVYKAFQHFDKDNSGHITR 474

Query:   431 DELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT 479
             DEL  A K+YGMGD+A+I   KE++SEVD D DGRI+++EF +MM+ G+
Sbjct:   475 DELESAMKEYGMGDEASI---KEVISEVDTDNDGRINFEEFCAMMRSGS 520

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0019903 "protein phosphatase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2036783 CPK19 "calcium-dependent protein kinase 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 1594 (566.2 bits), Expect = 9.0e-164, P = 9.0e-164
 Identities = 298/461 (64%), Positives = 374/461 (81%)

Query:    21 DAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDV 80
             + ILG+ +ED++  Y++GRE+GRG+FGITY+CTE S+G  FACKSI KRKL++  +++DV
Sbjct:    84 EPILGRPFEDIKEKYSLGRELGRGQFGITYICTEISSGKNFACKSILKRKLIRTKDREDV 143

Query:    81 RREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVF 140
             RREI+IM +LSGQPNIV+ K AYED Q VH+VMELC GGELFD+I  RGHYSE+AAA + 
Sbjct:   144 RREIQIMHYLSGQPNIVEIKGAYEDRQSVHLVMELCEGGELFDKITKRGHYSEKAAAEII 203

Query:   141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDE-NAVVKATDFGLSAFIEEGKAYREIVGS 199
             R ++ VV +CH  GV+HRDLKPENFL ++ DE ++++KATDFG+S FIEEGK Y +IVGS
Sbjct:   204 RSVVKVVQICHFMGVIHRDLKPENFLLSSKDEASSMLKATDFGVSVFIEEGKVYEDIVGS 263

Query:   200 PYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF 259
              YY+APEVL ++YGK  DIWSAGVILYILLCG PPFWAETD+G+ + IL+GEI+F+ +P+
Sbjct:   264 AYYVAPEVLKRNYGKAIDIWSAGVILYILLCGNPPFWAETDKGIFEEILRGEIDFESEPW 323

Query:   260 PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMN 319
             PSIS SA +LVR ML  DPK+R T AQVLEHPW++E GEASDKPID+AV+ RMKQ  AMN
Sbjct:   324 PSISESAKDLVRNMLKYDPKKRFTAAQVLEHPWIREGGEASDKPIDSAVLSRMKQLRAMN 383

Query:   320 KLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQ 379
             KLKKLA K I +NL  EE++ LK  F  MDTD SGT+TYDELK+GL KLGS LTE +VKQ
Sbjct:   384 KLKKLAFKFIAQNLKEEELKGLKTMFANMDTDKSGTITYDELKSGLEKLGSRLTETEVKQ 443

Query:   380 YMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKD 439
              ++ AD+DGNGTIDYIEFI+ATM R +++R +NL+KAFQ+FDKDN+G+I+  EL  A K+
Sbjct:   444 LLEDADVDGNGTIDYIEFISATMNRFRVEREDNLFKAFQHFDKDNSGFISRQELETAMKE 503

Query:   440 YGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ 480
             Y MGDD  I   KEI+SEVD D DG I+Y EF +MMK  +Q
Sbjct:   504 YNMGDDIMI---KEIISEVDADNDGSINYQEFCNMMKSCSQ 541

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2150225 CPK34 "AT5G19360" [Arabidopsis thaliana (taxid:3702)]

 Score = 1534 (545.1 bits), Expect = 2.1e-157, P = 2.1e-157
 Identities = 284/456 (62%), Positives = 363/456 (79%)

Query:    23 ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR 82
             +LG+  EDV+  YT+G+E+GRG+FG+T+LCT+ +TGL+FACK+I KRKLV   + +DVRR
Sbjct:    56 VLGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIAKRKLVNKEDIEDVRR 115

Query:    83 EIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV 142
             E++IM HL+GQPNIV+ K AYED   VH+VMELCAGGELFDRI+A+GHYSERAAAS+ R 
Sbjct:   116 EVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRT 175

Query:   143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
             I+ +++ CHS GV+HRDLKPENFL  + DEN+ +KATDFGLS F + G+ +++IVGS YY
Sbjct:   176 IVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYY 235

Query:   203 IAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
             IAPEVL + YG EADIWS GV+LYILLCGVPPFWAE++ G+  AIL G+++F  DP+P I
Sbjct:   236 IAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILSGQVDFSSDPWPVI 295

Query:   263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLK 322
             S  A +LVR+ML  DPK+R+T AQVL HPW+KE GEA D P+D AV+ R+KQF AMN  K
Sbjct:   296 SPQAKDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNFK 355

Query:   323 KLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQ 382
             K+AL+VI   L  EEI  LKE F  MDTDNSGT+T +EL+ GLAK G+ L+E++V+Q M+
Sbjct:   356 KVALRVIAGCLSEEEIMGLKEMFKGMDTDNSGTITLEELRQGLAKQGTRLSEYEVQQLME 415

Query:   383 AADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM 442
             AAD DGNGTIDY EFI ATM  ++L R E+LY AFQ+FDKDN+GYIT +EL +A +++GM
Sbjct:   416 AADADGNGTIDYGEFIAATMHINRLDREEHLYSAFQHFDKDNSGYITTEELEQALREFGM 475

Query:   443 GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG 478
              D   I   KEI+SEVD D DGRI+Y+EF +MM+ G
Sbjct:   476 NDGRDI---KEIISEVDGDNDGRINYEEFVAMMRKG 508

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 1528 (542.9 bits), Expect = 8.9e-157, P = 8.9e-157
 Identities = 283/456 (62%), Positives = 363/456 (79%)

Query:    23 ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR 82
             +LG+  EDV+  Y++G+E+GRG+FG+T+LCT+ +TG +FACK+I KRKLV   + +DVRR
Sbjct:    61 VLGRPMEDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVRR 120

Query:    83 EIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV 142
             E++IM HL+GQPNIV+ K AYED   VH+VMELCAGGELFDRI+A+GHYSERAAAS+ R 
Sbjct:   121 EVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRT 180

Query:   143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
             I+ +V+ CHS GV+HRDLKPENFL    DEN+ +KATDFGLS F + G+ +++IVGS YY
Sbjct:   181 IVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYY 240

Query:   203 IAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
             IAPEVL + YG EADIWS GV+LYILLCGVPPFWAE++ G+  AIL+G ++F  DP+PSI
Sbjct:   241 IAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPSI 300

Query:   263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLK 322
             S  A +LV++ML  DPK+R+T AQVL HPW+KE GEA D P+D AV+ R+KQF AMN  K
Sbjct:   301 SPQAKDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNFK 360

Query:   323 KLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQ 382
             K+AL+VI   L  EEI  LKE F  MDTD+SGT+T +EL+ GLAK G+ L+E++V+Q M+
Sbjct:   361 KVALRVIAGCLSEEEIMGLKEMFKGMDTDSSGTITLEELRQGLAKQGTRLSEYEVQQLME 420

Query:   383 AADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM 442
             AAD DGNGTIDY EFI ATM  ++L R E+LY AFQ+FDKDN+GYIT++EL +A +++GM
Sbjct:   421 AADADGNGTIDYGEFIAATMHINRLDREEHLYSAFQHFDKDNSGYITMEELEQALREFGM 480

Query:   443 GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG 478
              D   I   KEI+SEVD D DGRI+YDEF +MM+ G
Sbjct:   481 NDGRDI---KEIISEVDGDNDGRINYDEFVAMMRKG 513

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2204340 CPK29 "calcium-dependent protein kinase 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 1520 (540.1 bits), Expect = 6.3e-156, P = 6.3e-156
 Identities = 279/457 (61%), Positives = 372/457 (81%)

Query:    23 ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR 82
             IL +   D+   Y + +E+GRG+FGITY CT+ S G E+ACKSI KRKL++  + +DVRR
Sbjct:   100 ILNRPMIDLSALYDLHKELGRGQFGITYKCTDKSNGREYACKSISKRKLIRRKDIEDVRR 159

Query:    83 EIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV 142
             E+ I++HL+GQPNIV+F+ AYED   +H+VMELC+GGELFDRI+ +G YSE+ AA++FR 
Sbjct:   160 EVMILQHLTGQPNIVEFRGAYEDKDNLHLVMELCSGGELFDRIIKKGSYSEKEAANIFRQ 219

Query:   143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
             I+NVV+VCH  GV+HRDLKPENFL  + +E++ +KATDFGLS FIEEGK YR+IVGS YY
Sbjct:   220 IVNVVHVCHFMGVVHRDLKPENFLLVSNEEDSPIKATDFGLSVFIEEGKVYRDIVGSAYY 279

Query:   203 IAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
             +APEVL ++YGKE D+WSAGV+LYILL GVPPFW ET++ + +AIL+G+++ +  P+P+I
Sbjct:   280 VAPEVLHRNYGKEIDVWSAGVMLYILLSGVPPFWGETEKTIFEAILEGKLDLETSPWPTI 339

Query:   263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLK 322
             S SA +L+R+ML +DPK+RIT A+ LEHPW+ ++ + SDKPI++AV+ RMKQF AMNKLK
Sbjct:   340 SESAKDLIRKMLIRDPKKRITAAEALEHPWMTDT-KISDKPINSAVLVRMKQFRAMNKLK 398

Query:   323 KLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQ 382
             KLALKVI ENL  EEI+ LK+ F  MDTD SGT+T+DEL+ GL +LGS LTE ++KQ M+
Sbjct:   399 KLALKVIAENLSEEEIKGLKQTFKNMDTDESGTITFDELRNGLHRLGSKLTESEIKQLME 458

Query:   383 AADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM 442
             AAD+D +GTIDYIEF+TATM RH+L++ ENL +AF+YFDKD +G+IT DEL  +  +YGM
Sbjct:   459 AADVDKSGTIDYIEFVTATMHRHRLEKEENLIEAFKYFDKDRSGFITRDELKHSMTEYGM 518

Query:   443 GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT 479
             GDDATI    E++++VD D DGRI+Y+EF +MM+ GT
Sbjct:   519 GDDATI---DEVINDVDTDNDGRINYEEFVAMMRKGT 552

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

TAIR|locus:2128409 CDPK6 "calcium-dependent protein kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1466 (521.1 bits), Expect = 3.3e-150, P = 3.3e-150
 Identities = 273/456 (59%), Positives = 358/456 (78%)

Query:    23 ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR 82
             ILG+  E+V+  Y  GRE+GRG+FG+TYL T   T  + ACKSIP R+LV   + +DVRR
Sbjct:    66 ILGRPMEEVRRTYEFGRELGRGQFGVTYLVTHKETKQQVACKSIPTRRLVHKDDIEDVRR 125

Query:    83 EIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV 142
             E++IM HLSG  NIV  K AYED   V+++MELC GGELFDRI+++G YSERAAA + R 
Sbjct:   126 EVQIMHHLSGHRNIVDLKGAYEDRHSVNLIMELCEGGELFDRIISKGLYSERAAADLCRQ 185

Query:   143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
             ++ VV+ CHS GVMHRDLKPENFLF + DEN+ +KATDFGLS F + G  ++++VGS YY
Sbjct:   186 MVMVVHSCHSMGVMHRDLKPENFLFLSKDENSPLKATDFGLSVFFKPGDKFKDLVGSAYY 245

Query:   203 IAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
             +APEVL ++YG EADIWSAGVILYILL GVPPFW E + G+  AIL+G+++F  DP+P++
Sbjct:   246 VAPEVLKRNYGPEADIWSAGVILYILLSGVPPFWGENETGIFDAILQGQLDFSADPWPAL 305

Query:   263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLK 322
             S  A +LVR+ML  DPK R+T A+VL HPW++E GEASDKP+D AV+ RMKQF AMNKLK
Sbjct:   306 SDGAKDLVRKMLKYDPKDRLTAAEVLNHPWIREDGEASDKPLDNAVLSRMKQFRAMNKLK 365

Query:   323 KLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQ 382
             K+ALKVI ENL  EEI  LKE F  +DTDN+G +T +EL+ GL KLGS ++E +++Q M+
Sbjct:   366 KMALKVIAENLSEEEIIGLKEMFKSLDTDNNGIVTLEELRTGLPKLGSKISEAEIRQLME 425

Query:   383 AADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM 442
             AAD+DG+G+IDY+EFI+ATM  ++++R ++LY AFQ+FD DN+GYIT++EL  A K Y M
Sbjct:   426 AADMDGDGSIDYLEFISATMHMNRIEREDHLYTAFQFFDNDNSGYITMEELELAMKKYNM 485

Query:   443 GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG 478
             GDD +I   KEI++EVD D+DG+I+Y+EF +MMK G
Sbjct:   486 GDDKSI---KEIIAEVDTDRDGKINYEEFVAMMKKG 518

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=IMP

GO:0010119 "regulation of stomatal movement" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=RCA;IMP

GO:0005515 "protein binding" evidence=IPI

GO:0009651 "response to salt stress" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=RCA

GO:0032880 "regulation of protein localization" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0051049 "regulation of transport" evidence=RCA

TAIR|locus:2075885 CPK2 "calmodulin-domain protein kinase cdpk isoform 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1411 (501.8 bits), Expect = 2.2e-144, P = 2.2e-144
 Identities = 258/459 (56%), Positives = 357/459 (77%)

Query:    21 DAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDV 80
             +++L +  E+ +  Y++GR++G+G+FG T+LC E  TG E+ACKSI KRKL+ D + +DV
Sbjct:   172 ESVLQRKTENFKEFYSLGRKLGQGQFGTTFLCLEKGTGNEYACKSISKRKLLTDEDVEDV 231

Query:    81 RREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVF 140
             RREI+IM HL+G PN++  K AYED   VH+VMELC+GGELFDRI+ RGHY+ER AA + 
Sbjct:   232 RREIQIMHHLAGHPNVISIKGAYEDVVAVHLVMELCSGGELFDRIIQRGHYTERKAAELA 291

Query:   141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP 200
             R I+ V+  CHS GVMHRDLKPENFLF + +E++++K  DFGLS F +  + + ++VGSP
Sbjct:   292 RTIVGVLEACHSLGVMHRDLKPENFLFVSREEDSLLKTIDFGLSMFFKPDEVFTDVVGSP 351

Query:   201 YYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
             YY+APEVL + YG E+D+WSAGVI+YILL GVPPFWAET+QG+ + +L G+++F  DP+P
Sbjct:   352 YYVAPEVLRKRYGPESDVWSAGVIVYILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPWP 411

Query:   261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNK 320
             SIS SA +LVR+ML +DPKRR+T  QVL HPW++  G A DKP+D+AV+ RMKQF+AMNK
Sbjct:   412 SISESAKDLVRKMLVRDPKRRLTAHQVLCHPWVQIDGVAPDKPLDSAVLSRMKQFSAMNK 471

Query:   321 LKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQY 380
              KK+AL+VI E+L  EEI  LK+ F  +D DNSG +T++ELKAGL ++G+ L E ++   
Sbjct:   472 FKKMALRVIAESLSEEEIAGLKQMFKMIDADNSGQITFEELKAGLKRVGANLKESEILDL 531

Query:   381 MQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDY 440
             MQAAD+D +GTIDY EFI AT+  +K++R ++L+ AF YFDKD +G+IT DEL +A +++
Sbjct:   532 MQAADVDNSGTIDYKEFIAATLHLNKIEREDHLFAAFSYFDKDESGFITPDELQQACEEF 591

Query:   441 GMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT 479
             G+ D    A I+E+M +VD+DKDGRI Y+EF +MM+ G+
Sbjct:   592 GVED----ARIEEMMRDVDQDKDGRIDYNEFVAMMQKGS 626

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;NAS

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005789 "endoplasmic reticulum membrane" evidence=IDA

TAIR|locus:2827528 CPK6 "calcium dependent protein kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1409 (501.1 bits), Expect = 3.6e-144, P = 3.6e-144
 Identities = 262/456 (57%), Positives = 347/456 (76%)

Query:    23 ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR 82
             +LG    +++  YT+ R++G+G+FG TYLCT+ +TG+++ACKSI KRKL+   + +DVRR
Sbjct:    73 VLGHKTPNIRDLYTLSRKLGQGQFGTTYLCTDIATGVDYACKSISKRKLISKEDVEDVRR 132

Query:    83 EIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV 142
             EI+IM HL+G  NIV  K AYED  +VHIVMELCAGGELFDRI+ RGHYSER AA + ++
Sbjct:   133 EIQIMHHLAGHKNIVTIKGAYEDPLYVHIVMELCAGGELFDRIIHRGHYSERKAAELTKI 192

Query:   143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
             I+ VV  CHS GVMHRDLKPENFL    D++  +KA DFGLS F + G+ ++++VGSPYY
Sbjct:   193 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFKDVVGSPYY 252

Query:   203 IAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
             +APEVL + YG EAD+W+AGVILYILL GVPPFWAET QG+  A+LKG I+F  DP+P I
Sbjct:   253 VAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGYIDFDTDPWPVI 312

Query:   263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLK 322
             S SA +L+R+ML   P  R+T  +VL HPW+ E+G A D+ +D AV+ R+KQF+AMNKLK
Sbjct:   313 SDSAKDLIRKMLCSSPSERLTAHEVLRHPWICENGVAPDRALDPAVLSRLKQFSAMNKLK 372

Query:   323 KLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQ 382
             K+ALKVI E+L  EEI  L+  F  MDTDNSG +T+DELKAGL + GS L + +++  M+
Sbjct:   373 KMALKVIAESLSEEEIAGLRAMFEAMDTDNSGAITFDELKAGLRRYGSTLKDTEIRDLME 432

Query:   383 AADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM 442
             AAD+D +GTIDY EFI AT+  +KL+R E+L  AFQYFDKD +GYIT+DEL ++  ++GM
Sbjct:   433 AADVDNSGTIDYSEFIAATIHLNKLEREEHLVSAFQYFDKDGSGYITIDELQQSCIEHGM 492

Query:   443 GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG 478
              D      +++I+ EVD+D DGRI Y+EF +MM+ G
Sbjct:   493 TD----VFLEDIIKEVDQDNDGRIDYEEFVAMMQKG 524

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=TAS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA;IMP

GO:0010119 "regulation of stomatal movement" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=RCA;IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006820 "anion transport" evidence=RCA

GO:0006862 "nucleotide transport" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0015696 "ammonium transport" evidence=RCA

GO:0015802 "basic amino acid transport" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0043269 "regulation of ion transport" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
A5A7I7	CDPK4_SOLTU	2, ., 7, ., 1, 1, ., 1	0.5798	0.9170	0.8132	N/A	no
P53683	CDPK2_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.6965	0.9190	0.8517	yes	no
P49101	CDPK2_MAIZE	2, ., 7, ., 1, 1, ., 1	0.6869	0.9251	0.8908	N/A	no
A5A7I8	CDPK5_SOLTU	2, ., 7, ., 1, 1, ., 1	0.5754	0.9170	0.8467	N/A	no
Q38868	CDPK9_ARATH	2, ., 7, ., 1, 1, ., 1	0.7038	0.9372	0.8558	yes	no
P28582	CDPK_DAUCA	2, ., 7, ., 1, 1, ., 1	0.6797	0.9109	0.8458	N/A	no
Q9C6P3	CDPKX_ARATH	2, ., 7, ., 1, 1, ., 1	0.7109	0.9392	0.8905	no	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	494
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-101
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-91
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-62
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-61
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	9e-61
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-59
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-57
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-52
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-51
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-50
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-50
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-49
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-49
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-46
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-45
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-44
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-43
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-43
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-42
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-41
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-41
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-41
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-41
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-41
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-40
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-39
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-39
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-39
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-39
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-38
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-37
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-36
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-36
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-36
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-35
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-35
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-34
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-34
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-34
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-34
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-34
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-34
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-34
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	7e-34
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-34
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-34
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	8e-34
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-33
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-33
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-33
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-33
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-33
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-32
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-32
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-32
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-32
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-32
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-32
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-32
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-31
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-31
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-31
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-31
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-31
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-31
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-31
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-31
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-30
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-30
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-30
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-30
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-30
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-30
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-30
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-30
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-30
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	7e-30
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-30
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-30
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-29
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-29
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-29
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-29
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-29
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-29
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-28
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-28
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-28
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-28
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-28
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-28
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-27
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-27
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-27
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-27
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-27
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-27
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-26
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-26
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-26
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-26
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-26
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-26
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-26
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-26
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-26
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-26
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-26
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-26
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-26
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-26
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-26
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-26
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-25
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-25
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-25
PTZ00184	149	PTZ00184, PTZ00184, calmodulin; Provisional	9e-25
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-24
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-24
COG5126	160	COG5126, FRQ1, Ca2+-binding protein (EF-Hand super	3e-24
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-24
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-24
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-24
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-24
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-24
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-24
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-24
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-24
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-23
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-23
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-23
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-23
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-23
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-23
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-23
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-23
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-23
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-23
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-23
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-23
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-23
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-23
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-23
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-23
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-23
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	9e-23
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-22
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-22
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-22
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-22
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-22
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-22
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-22
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-22
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-22
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-22
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-22
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	9e-22
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-21
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-21
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-21
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-21
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-21
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-21
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-21
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-20
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-20
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-20
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-20
PTZ00183	158	PTZ00183, PTZ00183, centrin; Provisional	1e-19
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-19
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	8e-19
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-18
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	7e-18
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-17
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-17
cd00051	63	cd00051, EFh, EF-hand, calcium binding motif; A di	2e-17
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-17
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-16
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-16
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-15
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-15
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-15
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-15
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-14
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-14
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-14
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-14
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-13
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-13
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-13
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-13
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-13
cd00051	63	cd00051, EFh, EF-hand, calcium binding motif; A di	1e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-12
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-12
pfam13499	60	pfam13499, EF_hand_5, EF-hand domain pair	1e-12
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-12
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-12
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-12
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-11
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-11
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-11
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-10
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-10
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-10
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-10
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-09
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-09
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-09
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-09
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-08
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-08
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-08
pfam13499	60	pfam13499, EF_hand_5, EF-hand domain pair	6e-08
PTZ00184	149	PTZ00184, PTZ00184, calmodulin; Provisional	8e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-07
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-07
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-07
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-07
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	9e-07
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-06
pfam13833	53	pfam13833, EF_hand_6, EF-hand domain pair	2e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-06
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-06
pfam00036	29	pfam00036, efhand, EF hand	2e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-06
smart00054	29	smart00054, EFh, EF-hand, calcium binding motif	4e-06
COG5126	160	COG5126, FRQ1, Ca2+-binding protein (EF-Hand super	7e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-05
pfam13405	30	pfam13405, EF_hand_4, EF-hand domain	2e-05
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	4e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	4e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	7e-05
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	9e-05
pfam13833	53	pfam13833, EF_hand_6, EF-hand domain pair	2e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-04
pfam13405	30	pfam13405, EF_hand_4, EF-hand domain	3e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-04
smart00027	96	smart00027, EH, Eps15 homology domain	5e-04
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-04
pfam00036	29	pfam00036, efhand, EF hand	6e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.001
pfam13202	25	pfam13202, EF_hand_3, EF hand	0.001
cd00052	67	cd00052, EH, Eps15 homology domain; found in prote	0.001
PTZ00183	158	PTZ00183, PTZ00183, centrin; Provisional	0.002
pfam00036	29	pfam00036, efhand, EF hand	0.002
smart00054	29	smart00054, EFh, EF-hand, calcium binding motif	0.002
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	0.002
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.002
cd00052	67	cd00052, EH, Eps15 homology domain; found in prote	0.003
cd00051	63	cd00051, EFh, EF-hand, calcium binding motif; A di	0.004
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  304 bits (781), Expect = e-101
 Identities = 108/260 (41%), Positives = 152/260 (58%), Gaps = 7/260 (2%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y I  ++G G FG  YL  +  TG   A K I K+K+ KD E+  + REI+I++ L   P
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRER--ILREIKILKKL-KHP 57

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NIV+    +ED+  +++VME C GG+LFD +  RG  SE  A    R I++ +   HSKG
Sbjct: 58  NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           ++HRDLKPEN L    DE+  VK  DFGL+  ++ G+     VG+P Y+APEVL  + YG
Sbjct: 118 IVHRDLKPENILL---DEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174

Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRM 273
           K  DIWS GVILY LL G PPF  +         +         P   IS  A +L+R++
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234

Query: 274 LTQDPKRRITVAQVLEHPWL 293
           L +DP++R+T  + L+HP+ 
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  277 bits (711), Expect = 5e-91
 Identities = 107/265 (40%), Positives = 147/265 (55%), Gaps = 11/265 (4%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + R++G G FG  Y      TG   A K + KR   K  +    RREI I+R LS  P
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSH-P 58

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NIV+   A+ED   +++VME C GG+LFD +   G  SE  A  +   I+  +   HS G
Sbjct: 59  NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVL--SQS 211
           ++HRDLKPEN L    DEN VVK  DFGL+   ++   +    VG+P+Y+APEVL     
Sbjct: 119 IIHRDLKPENILL---DENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175

Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQG---VAQAILKGEINFQRDPFPSISSSAIE 268
           YG + D+WS GVILY LL G PPF  E       + + IL   + F    + S S  A +
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235

Query: 269 LVRRMLTQDPKRRITVAQVLEHPWL 293
           L+++ L +DP +R T  ++L+HPW 
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  203 bits (518), Expect = 4e-62
 Identities = 87/266 (32%), Positives = 143/266 (53%), Gaps = 18/266 (6%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            Y I +++G+G FG  YL    S G  +  K I    + +  E++D   E++I++ L+  
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK-EREDALNEVKILKKLN-H 58

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR----GHYSERAAASVFRVIMNVVNV 149
           PNI+++  ++E+   + IVME   GG+L  +I  +      + E      F  +   +  
Sbjct: 59  PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118

Query: 150 CHSKGVMHRDLKPEN-FLFTTGDENAVVKATDFGLSAFIEEGKAY-REIVGSPYYIAPEV 207
            HS+ ++HRD+KP+N FL + G    +VK  DFG+S  +       + +VG+PYY++PE+
Sbjct: 119 LHSRKILHRDIKPQNIFLTSNG----LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174

Query: 208 L-SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI-SSS 265
             ++ Y  ++DIWS G +LY L     PF  E    +A  ILKG+      P PS  SS 
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY----PPIPSQYSSE 230

Query: 266 AIELVRRMLTQDPKRRITVAQVLEHP 291
              LV  +L +DP+ R ++AQ+L+ P
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQILQSP 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  200 bits (511), Expect = 3e-61
 Identities = 93/266 (34%), Positives = 143/266 (53%), Gaps = 31/266 (11%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG   L  +  TG  +A K + K+K++K  E +    E  I+  ++  P IV+  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLH 59

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSE-RA---AASVFRVIMNVVNVC-----H 151
            A++ ++ +++V+E   GGELF  +   G +SE RA   AA +         V      H
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEI---------VLALEYLH 110

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVL-S 209
           S G+++RDLKPEN L    D +  +K TDFGL+     EG       G+P Y+APEVL  
Sbjct: 111 SLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG 167

Query: 210 QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
           + YGK  D WS GV+LY +L G PPF+AE  + + + ILK  + F   P   +S  A +L
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF---PE-FLSPEARDL 223

Query: 270 VRRMLTQDPKRRIT---VAQVLEHPW 292
           +  +L +DP +R+      ++  HP+
Sbjct: 224 ISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  198 bits (505), Expect = 9e-61
 Identities = 88/255 (34%), Positives = 127/255 (49%), Gaps = 44/255 (17%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G G FG  YL  +  TG + A K I K         +++ REIEI++ L+  PNIV+  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNH-PNIVKLY 57

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRD 159
             +ED+  +++VME C GG L D +    G  SE     +   I+  +   HS G++HRD
Sbjct: 58  GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117

Query: 160 LKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY-REIVGSPYYIAPEVLSQ--SYGKEA 216
           LKPEN L     +N  VK  DFGLS  +   K+  + IVG+P Y+APEVL     Y +++
Sbjct: 118 LKPENILLD--SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 217 DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276
           DIWS GVILY L                                       +L+R+ML +
Sbjct: 176 DIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200

Query: 277 DPKRRITVAQVLEHP 291
           DP++R +  ++LEH 
Sbjct: 201 DPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  195 bits (498), Expect = 4e-59
 Identities = 87/268 (32%), Positives = 137/268 (51%), Gaps = 18/268 (6%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK--DDVRREIEIMRHLSG 92
           +T G  +GRG FG  YL  +  TG   A KS+   +L  D E+  + + REI I+  L  
Sbjct: 2   WTRGELLGRGSFGSVYLALDKDTGELMAVKSV---ELSGDSEEELEALEREIRILSSLQ- 57

Query: 93  QPNIVQFKAAYEDDQFVH--IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC 150
            PNIV++  +  D++     I +E  +GG L   +   G   E       R I+  +   
Sbjct: 58  HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE---GKAYREIVGSPYYIAPEV 207
           HS G++HRD+K  N L    D + VVK  DFG +  + +   G+    + G+PY++APEV
Sbjct: 118 HSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 208 LSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSS 265
           +    YG+ ADIWS G  +  +  G PP+    +     A+ K   + +    P  +S  
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYKIGSSGEPPEIPEHLSEE 232

Query: 266 AIELVRRMLTQDPKRRITVAQVLEHPWL 293
           A + +R+ L +DPK+R T  ++L+HP+L
Sbjct: 233 AKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  191 bits (488), Expect = 1e-57
 Identities = 90/268 (33%), Positives = 141/268 (52%), Gaps = 19/268 (7%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           + +G +G  +L  + STG  +A K I K  +++  + D V  E +I+      P +V+  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS-PYVVKLY 59

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
            +++  + +++VME   GG+L   +   G   E  A      I+  +   HS G++HRDL
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119

Query: 161 KPENFLFTTGDENAVVKATDFGLSAFIEEGKAY---------REIVGSPYYIAPEV-LSQ 210
           KP+N L    D N  +K TDFGLS      +           + IVG+P YIAPEV L Q
Sbjct: 120 KPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176

Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
            + K  D WS G ILY  L G+PPF  ET + + Q IL G+I +  D    +S  AI+L+
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234

Query: 271 RRMLTQDPKRRI---TVAQVLEHPWLKE 295
            ++L  DP++R+   ++ ++  HP+ K 
Sbjct: 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKG 262

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  178 bits (454), Expect = 2e-52
 Identities = 86/272 (31%), Positives = 139/272 (51%), Gaps = 26/272 (9%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +   + +G G FG   L     +G  +A K + K K+VK  + + V  E  I++ +   P
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HP 61

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERA----AASVFRVIMNVVNVC 150
            +V    +++DD  +++VME   GGELF  +   G + E      AA V   +       
Sbjct: 62  FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLAL----EYL 117

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LS 209
           HS  +++RDLKPEN L    D +  +K TDFG +  ++    Y  + G+P Y+APE+ LS
Sbjct: 118 HSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR-TY-TLCGTPEYLAPEIILS 172

Query: 210 QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIE 268
           + YGK  D W+ G+++Y +L G PPF+ +    + + IL+G++      FPS  S  A +
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVR-----FPSFFSPDAKD 227

Query: 269 LVRRMLTQDPKRRI-----TVAQVLEHPWLKE 295
           L+R +L  D  +R+      V  +  HPW   
Sbjct: 228 LIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  175 bits (445), Expect = 4e-51
 Identities = 85/284 (29%), Positives = 139/284 (48%), Gaps = 33/284 (11%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E  T  E+A K + KR+L+K+ +   V+ E E++  L+G P
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
            I++    ++D++ ++ V+E    GEL   I   G   E+        I+  +   HSKG
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAF-------IEEGKAYREI----------- 196
           ++HRDLKPEN L    D++  +K TDFG +                  I           
Sbjct: 123 IIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179

Query: 197 ---VGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI 252
              VG+  Y++PE+L+ +  GK +D+W+ G I+Y +L G PPF    +    Q ILK E 
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239

Query: 253 NFQRDPFPSISSSAIELVRRMLTQDPKRRITV----AQVLEHPW 292
           +F  +  P     A +L+ ++L  DP+ R+ V     ++  HP+
Sbjct: 240 SFPPNFPP----DAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  172 bits (439), Expect = 1e-50
 Identities = 84/267 (31%), Positives = 136/267 (50%), Gaps = 22/267 (8%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            + I  ++G+G FG  Y      TG E A K I    L    +K+ +  EI+I++     
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCK-H 56

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHS 152
           PNIV++  +Y     + IVME C+GG L D + +     +E   A V + ++  +   HS
Sbjct: 57  PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-S 211
            G++HRD+K  N L T+   +  VK  DFGLSA + + KA   +VG+PY++APEV++   
Sbjct: 117 NGIIHRDIKAANILLTS---DGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP 173

Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI------SSS 265
           Y  +ADIWS G+    L  G PP+            +K       +  P +      S  
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELP-------PMKALFKIATNGPPGLRNPEKWSDE 226

Query: 266 AIELVRRMLTQDPKRRITVAQVLEHPW 292
             + +++ L ++P++R T  Q+L+HP+
Sbjct: 227 FKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  174 bits (441), Expect = 9e-50
 Identities = 93/299 (31%), Positives = 137/299 (45%), Gaps = 28/299 (9%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            Y I R++G G FG  YL  +       A K + K+   K  E +   REI+I+  L+  
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH---YSERAAASVFRVIMNVVNVC 150
           PNIV+    ++D+  +++VME   GG L D +   G     SE  A  +   I++ +   
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-------AYREIVGSPYYI 203
           HSKG++HRD+KPEN L     +  VVK  DFGL+  + +              VG+P Y+
Sbjct: 118 HSKGIIHRDIKPENILLD--RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 204 APEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG--------- 250
           APEVL           +DIWS G+ LY LL G+PPF  E +       LK          
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235

Query: 251 EINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVI 309
                      IS +A +L++++L +DPK R++ +  L H  L           D    
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKP 294

Length = 384

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  169 bits (431), Expect = 2e-49
 Identities = 83/261 (31%), Positives = 139/261 (53%), Gaps = 16/261 (6%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G G FG   L    S    FA K + KR +V+  +++ +  E EI+   +  P IV+  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLY 59

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
             ++D ++++++ME C GGEL+  +  RG + E  A      ++      H++G+++RDL
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119

Query: 161 KPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSYGKEADIW 219
           KPEN L    D N  VK  DFG +  ++ G+      G+P Y+APE+ L++ Y    D W
Sbjct: 120 KPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176

Query: 220 SAGVILYILLCGVPPFWA--ETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
           S G++LY LL G PPF    E    +   ILKG    +   FP+ I  +A +L++++L +
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE---FPNYIDKAAKDLIKQLLRR 233

Query: 277 DPKRRI-----TVAQVLEHPW 292
           +P+ R+      +  + +H W
Sbjct: 234 NPEERLGNLKGGIKDIKKHKW 254

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  169 bits (429), Expect = 4e-49
 Identities = 81/260 (31%), Positives = 129/260 (49%), Gaps = 10/260 (3%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + + +G FG  YL  + STG  FA K + K  ++   +  +V+ E  IM      P + +
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
              +++   ++++VME   GG+    I   G   E  A      ++  V   H +G++HR
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121

Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEA-D 217
           D+KPEN L    D+   +K TDFGLS     G   ++ VG+P Y+APE +      +  D
Sbjct: 122 DIKPENLLI---DQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDDKMSD 175

Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD 277
            WS G +++  L G PPF AET   V   IL   IN+  +     S  A++L+ R+L  D
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235

Query: 278 PKRRI---TVAQVLEHPWLK 294
           P +R+      ++  HP+ K
Sbjct: 236 PAKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  160 bits (406), Expect = 8e-46
 Identities = 83/263 (31%), Positives = 130/263 (49%), Gaps = 12/263 (4%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +Y +G  +GRG FG+ Y      TG   A K I   K+ ++     + +EI+++++L   
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEE-ALKSIMQEIDLLKNLK-H 58

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PNIV++  + E    ++I++E    G L   I   G + E   A     ++  +   H +
Sbjct: 59  PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVLSQSY 212
           GV+HRD+K  N L TT D   VVK  DFG++    +  K    +VG+PY++APEV+  S 
Sbjct: 119 GVIHRDIKAANIL-TTKDG--VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG 175

Query: 213 GKEA-DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELV 270
              A DIWS G  +  LL G PP++          I    +     P P  IS    + +
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI----VQDDHPPLPEGISPELKDFL 231

Query: 271 RRMLTQDPKRRITVAQVLEHPWL 293
            +   +DP  R T  Q+L+HPW+
Sbjct: 232 MQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  160 bits (407), Expect = 1e-45
 Identities = 80/290 (27%), Positives = 125/290 (43%), Gaps = 37/290 (12%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y I   +G G  GI +   +  TG   A K +  R+L   +  +   REI+ ++     P
Sbjct: 2   YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-NQALREIKALQACQ-HP 59

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHSK 153
            +V+    +       +VME      L + +        E    S  R+++  V   H+ 
Sbjct: 60  YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSA--FIEEGKAYREIVGSPYYIAPEVL--S 209
           G+MHRDLKP N L      + V+K  DFGL+     EE + Y   V + +Y APE+L  +
Sbjct: 119 GIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175

Query: 210 QSYGKEADIWSAGVILYILLCGVPPFWAETD--Q-----------------GVAQAILKG 250
           + Y    D+W+ G I   LL G P F  E D  Q                 G+       
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235

Query: 251 EINFQ-------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
           +I F         + FP  S  A++L++ +L  DP +R++ A+ L HP+ 
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  159 bits (404), Expect = 2e-44
 Identities = 89/301 (29%), Positives = 141/301 (46%), Gaps = 55/301 (18%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +GRG FG  +L  +  TG  +A K + K  ++K  +   VR E +I+   +  P
Sbjct: 3   FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD-ADSP 61

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGEL---------FDRIVARGHYSERAAASVFRVIMN 145
            IV+   +++D++ +++VME   GG+L         F    AR + +E   A        
Sbjct: 62  WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA-------- 113

Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAY----------- 193
            ++  H  G +HRD+KP+N L    D +  +K  DFGL     +                
Sbjct: 114 -LDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169

Query: 194 ------------------REIVGSPYYIAPEVL-SQSYGKEADIWSAGVILYILLCGVPP 234
                                VG+P YIAPEVL    YG E D WS GVILY +L G PP
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Query: 235 FWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVA-QVLEHPWL 293
           F+++T Q     I+  + + +  P P +S  AI+L+ R+L  DP+ R+    ++  HP+ 
Sbjct: 230 FYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288

Query: 294 K 294
           K
Sbjct: 289 K 289

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  154 bits (391), Expect = 1e-43
 Identities = 77/264 (29%), Positives = 132/264 (50%), Gaps = 10/264 (3%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           H+ + R +G+G FG   +  +  T   FA K + K+K V+     +V  E  I++ L+  
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-H 59

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           P +V    +++D++ +++V++L  GG+L   +  +  +SE         I+  +   HSK
Sbjct: 60  PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSY 212
           G++HRD+KP+N L    DE   V  TDF ++  +          G+P Y+APEVL  Q Y
Sbjct: 120 GIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY 176

Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI-SSSAIELVR 271
               D WS GV  Y  L G  P+   +     Q   K E       +P+  S+ AI+ + 
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA--DVLYPATWSTEAIDAIN 234

Query: 272 RMLTQDPKRRI--TVAQVLEHPWL 293
           ++L +DP++R+   +  +  HP+ 
Sbjct: 235 KLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  152 bits (387), Expect = 6e-43
 Identities = 89/279 (31%), Positives = 135/279 (48%), Gaps = 37/279 (13%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            Y +   +G+G FG        S G     K I    +  + EK  +  E+ I+R L   
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELK-H 58

Query: 94  PNIVQFKAAYE-----DDQFVHIVMELCAGGELFDRI----VARGHYSERAAASVFRVIM 144
           PNIV++   Y+      +Q ++IVME C GG+L   I      R +  E     +   ++
Sbjct: 59  PNIVRY---YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL 115

Query: 145 NVVNVCHSKG-----VMHRDLKPEN-FLFTTGDENAVVKATDFGLSAFIEEG----KAYR 194
             +  CH++      V+HRDLKP N FL    D N  VK  DFGL+  +       K Y 
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFL----DANNNVKLGDFGLAKILGHDSSFAKTY- 170

Query: 195 EIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN 253
             VG+PYY++PE L+  SY +++DIWS G ++Y L    PPF A     +A  I +G+  
Sbjct: 171 --VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF- 227

Query: 254 FQRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQVLEHP 291
                 P   SS + E+++ ML  DP +R +  ++L+ P
Sbjct: 228 ---RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  151 bits (384), Expect = 3e-42
 Identities = 91/292 (31%), Positives = 136/292 (46%), Gaps = 42/292 (14%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + +++G G FG  YL     TG   A K + K+K     E+    RE++ +R L+  P
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKF-YSWEECMNLREVKSLRKLNEHP 58

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVCHS 152
           NIV+ K  + ++  ++ V E    G L+  +  R    +SE    S+   I+  +   H 
Sbjct: 59  NIVKLKEVFRENDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            G  HRDLKPEN L +  +   VVK  DFGL+  I     Y + V + +Y APE+L  S 
Sbjct: 118 HGFFHRDLKPENLLVSGPE---VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRST 174

Query: 211 SYGKEADIWSAGVI---LYIL---------------LCGV--PPFWAETDQGVAQAILKG 250
           SY    DIW+ G I   LY L               +C V   P   +  +G     L  
Sbjct: 175 SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK---LAS 231

Query: 251 EINFQ---------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
           ++ F+             P+ S  AI+L++ ML  DPK+R T +Q L+HP+ 
Sbjct: 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  149 bits (379), Expect = 1e-41
 Identities = 87/263 (33%), Positives = 144/263 (54%), Gaps = 11/263 (4%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G G  GI  + T+ STG + A K   K  L K   ++ +  E+ IMR     PNIV+ 
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQRRELLFNEVVIMRDYQ-HPNIVEM 81

Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRD 159
            ++Y     + +VME   GG L D IV     +E   A+V   ++  ++  H++GV+HRD
Sbjct: 82  YSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRD 140

Query: 160 LKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVGSPYYIAPEVLSQS-YGKEAD 217
           +K ++ L T+   +  VK +DFG  A + +E    + +VG+PY++APEV+S+  YG E D
Sbjct: 141 IKSDSILLTS---DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVD 197

Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD 277
           IWS G+++  ++ G PP++ E      + I        ++    +S      + RML +D
Sbjct: 198 IWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLH-KVSPRLRSFLDRMLVRD 256

Query: 278 PKRRITVAQVLEHPWLKESGEAS 300
           P +R T A++L HP+L ++G  S
Sbjct: 257 PAQRATAAELLNHPFLAKAGPPS 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  148 bits (377), Expect = 3e-41
 Identities = 83/294 (28%), Positives = 133/294 (45%), Gaps = 47/294 (15%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHL 90
           Y    ++G G +G+ Y   +  TG   A K I   +L  D E++ +     REI +++ L
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI---RL--DNEEEGIPSTALREISLLKEL 55

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVN 148
              PNIV+       ++ +++V E C     +  D+    G  S     S+   ++  + 
Sbjct: 56  K-HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLA 112

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEV 207
            CHS  ++HRDLKP+N L    + + V+K  DFGL+ AF    + Y   V + +Y APE+
Sbjct: 113 YCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169

Query: 208 L--SQSYGKEADIWSAGVILYILLCGVPPFWA--ETDQ-----------------GVAQA 246
           L  S+ Y    DIWS G I   ++ G P F    E DQ                 GV + 
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229

Query: 247 ILKGEINFQRDP-------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
                  F + P        P +    I+L+ +ML  +P +RI+  + L+HP+ 
Sbjct: 230 PDYKP-TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  149 bits (378), Expect = 5e-41
 Identities = 88/267 (32%), Positives = 133/267 (49%), Gaps = 11/267 (4%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            + I  +VG+G +G  +L  +  TG   A K + K  L K  E   V  E +I+   +  
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKS 60

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
             +V+   A++DD+++++ ME   GG+    +   G  SE  A      +   V+  H  
Sbjct: 61  EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSY 212
           G +HRDLKPENFL    D +  +K TDFGLS  I    A   +VGSP Y+APEVL  + Y
Sbjct: 121 GYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVT-YAN-SVVGSPDYMAPEVLRGKGY 175

Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR----DPFPSISSSAIE 268
               D WS G +LY  LCG PPF   T     + +   +   QR    DP  ++S  A +
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235

Query: 269 LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           L+ +++    +R  ++  +  HP+ KE
Sbjct: 236 LITKLINDPSRRFGSLEDIKNHPFFKE 262

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  147 bits (374), Expect = 7e-41
 Identities = 83/275 (30%), Positives = 140/275 (50%), Gaps = 34/275 (12%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G G  G  Y  T+ +TG E A K +  RK  K++    +  EI IM+     PNIV + 
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL----IINEILIMKDCK-HPNIVDYY 81

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHY---SERAAASVFRVIMNVVNVCHSKGVMH 157
            +Y     + +VME   GG L D  +   ++   +E   A V R ++  +   HS+ V+H
Sbjct: 82  DSYLVGDELWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIH 139

Query: 158 RDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEV-LSQSYGKE 215
           RD+K +N L +   ++  VK  DFG +A + + K+ R  +VG+PY++APEV   + YG +
Sbjct: 140 RDIKSDNILLS---KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPK 196

Query: 216 ADIWSAGVILYILLCGVPPFWAE---------TDQGVAQAILKGEINFQRDPFPSISSSA 266
            DIWS G++   +  G PP+  E         T +G+    LK    +        S   
Sbjct: 197 VDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP--LKNPEKW--------SPEF 246

Query: 267 IELVRRMLTQDPKRRITVAQVLEHPWLKESGEASD 301
            + + + L +DP++R +  ++L+HP+LK++    +
Sbjct: 247 KDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEE 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  147 bits (373), Expect = 8e-41
 Identities = 84/290 (28%), Positives = 128/290 (44%), Gaps = 38/290 (13%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y    ++G G +G+ Y   +  TG   A K I K +   +       REI++++ L+  P
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELN-HP 58

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGG--ELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
           NI++    +     +++V E       +L      +    E    S    ++  +  CHS
Sbjct: 59  NIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHS 116

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--S 209
            G++HRDLKPEN L  T     V+K  DFGL+ +F    + Y   V + +Y APE+L   
Sbjct: 117 HGILHRDLKPENLLINT---EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGD 173

Query: 210 QSYGKEADIWSAGVILYILLCGVP--PFWAETDQ--------GV-AQAILKGEINFQRD- 257
           + Y    DIWS G I   LL   P  P  +E DQ        G     +     +  R+ 
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233

Query: 258 ----P----------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
               P          FP+ S  A++L+ +ML  DP +RIT  Q L HP+ 
Sbjct: 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  146 bits (370), Expect = 2e-40
 Identities = 77/266 (28%), Positives = 125/266 (46%), Gaps = 16/266 (6%)

Query: 37  IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD-VRREIEIMRHLSGQPN 95
             + +G+G  G+ Y      TG  +A K I    +  D E    + RE++ +R     P 
Sbjct: 5   RVKVLGQGSSGVVYKVRHKPTGKIYALKKI---HVDGDEEFRKQLLRELKTLRS-CESPY 60

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK-G 154
           +V+   A+  +  + IV+E   GG L D +   G   E   A + R I+  ++  H+K  
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR-EIVGSPYYIAPE-VLSQSY 212
           ++HRD+KP N L  +  E   VK  DFG+S  +E         VG+  Y++PE +  +SY
Sbjct: 121 IIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESY 177

Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS---ISSSAIEL 269
              ADIWS G+ L     G  PF     Q     +++  I     P       S    + 
Sbjct: 178 SYAADIWSLGLTLLECALGKFPF-LPPGQPSFFELMQ-AICDGPPPSLPAEEFSPEFRDF 235

Query: 270 VRRMLTQDPKRRITVAQVLEHPWLKE 295
           +   L +DPK+R + A++L+HP++K+
Sbjct: 236 ISACLQKDPKKRPSAAELLQHPFIKK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  145 bits (367), Expect = 1e-39
 Identities = 81/295 (27%), Positives = 131/295 (44%), Gaps = 43/295 (14%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIP--KRKLVKDVEKDDVRREIEIMRHLSG 92
           Y  G+++G G + + Y   +  TG   A K I   +RK  KD       REI++++ L  
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK- 60

Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAG---GELFDRIVARGHYSERAAASVFRVIMNVVNV 149
            PNI+     +     +++V E         + D+ +     +     S   + +  +  
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV---LTPADIKSYMLMTLRGLEY 117

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL 208
            HS  ++HRDLKP N L      + V+K  DFGL+ +F    +     V + +Y APE+L
Sbjct: 118 LHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELL 174

Query: 209 --SQSYGKEADIWSAGVILYILLCGVPPFWAETD-------------------QGVAQAI 247
             ++ YG   D+WS G I   LL  VP    ++D                    GV    
Sbjct: 175 FGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS-- 232

Query: 248 LKGEINFQ-------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
           L   + F+       +  FP+ S  A++L++R+LT +P +RIT  Q LEHP+   
Sbjct: 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  144 bits (365), Expect = 2e-39
 Identities = 76/260 (29%), Positives = 136/260 (52%), Gaps = 16/260 (6%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           VG G FG  +L  +  +   +A K +   ++++  ++  V  E  +++ +S  P I++  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLF 67

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
               D +F++++ME   GGELF  +   G +S          I+  +   HSK +++RDL
Sbjct: 68  WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDL 127

Query: 161 KPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKEADIW 219
           KPEN L    D+   +K TDFG +  + + + +  + G+P Y+APEV+ S+ + K  D W
Sbjct: 128 KPENILL---DKEGHIKLTDFGFAKKLRD-RTW-TLCGTPEYLAPEVIQSKGHNKAVDWW 182

Query: 220 SAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPK 279
           + G+++Y +L G PPF+ +   G+ + IL G++ F R     +   A +L++++L  D  
Sbjct: 183 ALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIKKLLVVDRT 238

Query: 280 RRI-----TVAQVLEHPWLK 294
           RR+         V  H W K
Sbjct: 239 RRLGNMKNGADDVKNHRWFK 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  141 bits (358), Expect = 6e-39
 Identities = 82/264 (31%), Positives = 126/264 (47%), Gaps = 12/264 (4%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           HY   R +G+G FG   L            K +   +L  + E+ D   EI I+  L   
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQ-H 58

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCH 151
           PNI+ +   + DD  + I ME   GG L+D+IV +    + E         I++ V+  H
Sbjct: 59  PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLS- 209
             G++HRD+K  N   T      ++K  DFG+S  +    +  E +VG+PYY++PE+   
Sbjct: 119 KAGILHRDIKTLNIFLTKAG---LIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG 175

Query: 210 QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             Y  ++DIW+ G +LY LL     F A     +   I++G        +   SS  I L
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELISL 232

Query: 270 VRRMLTQDPKRRITVAQVLEHPWL 293
           V  +L QDP++R T  +VL+ P L
Sbjct: 233 VHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  141 bits (358), Expect = 8e-39
 Identities = 83/262 (31%), Positives = 132/262 (50%), Gaps = 15/262 (5%)

Query: 38  GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD--DVRREIEIMRHLSGQPN 95
           G+ +G+G FG  YLC +  TG E A K +P      + +K+   +  EI+++++L     
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HER 65

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGV 155
           IVQ+     DD+ + I ME   GG + D++ A G  +E       R I+  V   HS  +
Sbjct: 66  IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMI 125

Query: 156 MHRDLKPENFLFTTGDENAVVKATDFGLSAFIE----EGKAYREIVGSPYYIAPEVLS-Q 210
           +HRD+K  N L    D    VK  DFG S  ++     G   + + G+PY+++PEV+S +
Sbjct: 126 VHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182

Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQ-AILKGEINFQRDPFPSISSSAIEL 269
            YG++AD+WS G  +  +L   PP WAE +   A   I     N Q      +S  A   
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPP-WAEFEAMAAIFKIATQPTNPQLP--SHVSPDARNF 239

Query: 270 VRRMLTQDPKRRITVAQVLEHP 291
           +RR   ++ K+R +  ++L H 
Sbjct: 240 LRRTFVENAKKRPSAEELLRHF 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  139 bits (353), Expect = 4e-38
 Identities = 79/278 (28%), Positives = 132/278 (47%), Gaps = 40/278 (14%)

Query: 38  GREVGRGEFGITYLCTENSTGLEFACKSI----PKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           G ++G G FG  Y      TG   A K I       K +K++       E++++  L   
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIA-----DEMKVLELLK-H 58

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV-IMNVVNVCHS 152
           PN+V++       + V+I ME C+GG L + ++  G   +     V+ + ++  +   HS
Sbjct: 59  PNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEGLAYLHS 117

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-AYRE----IVGSPYYIAPEV 207
            G++HRD+KP N      D N V+K  DFG +  ++       E    + G+P Y+APEV
Sbjct: 118 HGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 208 LSQS----YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF-----QRDP 258
           ++      +G+ ADIWS G ++  +  G  P W+E D           I F      + P
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQ-------IMFHVGAGHKPP 226

Query: 259 FP---SISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
            P    +S    + + R L  DPK+R T +++L+HP++
Sbjct: 227 IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  138 bits (349), Expect = 7e-37
 Identities = 84/265 (31%), Positives = 134/265 (50%), Gaps = 16/265 (6%)

Query: 37  IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNI 96
           +G  +G G FG   +     TG  +A K + KR+++K  +   V +E  I+  LS  P I
Sbjct: 22  MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFI 80

Query: 97  VQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVM 156
           V    +++D+  V+ ++E   GGELF  +   G +    A      ++      HSK ++
Sbjct: 81  VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDII 140

Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKE 215
           +RDLKPEN L    D    VK TDFG +  + + + +  + G+P Y+APEV+ S+ +GK 
Sbjct: 141 YRDLKPENLLL---DNKGHVKVTDFGFAKKVPD-RTF-TLCGTPEYLAPEVIQSKGHGKA 195

Query: 216 ADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT 275
            D W+ GV+LY  + G PPF+ +T   + + IL G + F           A +LV+ +L 
Sbjct: 196 VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRARDLVKGLLQ 251

Query: 276 QDPKRRI-----TVAQVLEHPWLKE 295
            D  +R+      VA V  HP+   
Sbjct: 252 TDHTKRLGTLKGGVADVKNHPYFHG 276

Length = 329

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  135 bits (343), Expect = 1e-36
 Identities = 81/288 (28%), Positives = 139/288 (48%), Gaps = 25/288 (8%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK-----DDVRREIEIMRH 89
           +T+   +G+G FG  Y   +  T    A K I       D+E+     +D+++EI+ +  
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI-------DLEEAEDEIEDIQQEIQFLSQ 55

Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
               P I ++  ++     + I+ME C GG   D ++  G   E   A + R ++  +  
Sbjct: 56  CR-SPYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEY 113

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVL 208
            H +G +HRD+K  N L +   E   VK  DFG+S  +    + R   VG+P+++APEV+
Sbjct: 114 LHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI 170

Query: 209 SQS-YGKEADIWSAGVILYILLCGVPPFWAETD-QGVAQAILKGEI-NFQRDPFPSISSS 265
            QS Y ++ADIWS G+    L  G PP  ++     V   I K    + + + F   S  
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPPL-SDLHPMRVLFLIPKNNPPSLEGNKF---SKP 226

Query: 266 AIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMK 313
             + V   L +DPK R +  ++L+H ++K++ + S   +    I + K
Sbjct: 227 FKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTLLIERIKKWK 274

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  135 bits (342), Expect = 1e-36
 Identities = 78/275 (28%), Positives = 125/275 (45%), Gaps = 28/275 (10%)

Query: 34  HYTIGREVGRGEFGITY--LCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
            Y +   +G G   + Y  +C  N    + A K I   K    V  D++R+E++ M    
Sbjct: 2   DYELIEVIGVGATAVVYAAICLPN--NEKVAIKRIDLEKCQTSV--DELRKEVQAM-SQC 56

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFD---RIVARGHYSERAAASVFRVIMNVVN 148
             PN+V++  ++     + +VM   +GG L D       RG   E   A+V + ++  + 
Sbjct: 57  NHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLE 116

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-----KAYREIVGSPYYI 203
             HS G +HRD+K  N L     E+  VK  DFG+SA + +G     K  +  VG+P ++
Sbjct: 117 YLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173

Query: 204 APEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG-----EINFQR 256
           APEV+ Q   Y  +ADIWS G+    L  G  P+       V    L+      E     
Sbjct: 174 APEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADY 233

Query: 257 DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
             +   S S  +++   L +DP +R T  ++L+H 
Sbjct: 234 KKY---SKSFRKMISLCLQKDPSKRPTAEELLKHK 265

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  134 bits (339), Expect = 2e-36
 Identities = 80/256 (31%), Positives = 128/256 (50%), Gaps = 10/256 (3%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           R VGRG FGI +LC   +       K IP  ++ KD E+   + E ++++ LS  PNI++
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD-ERLAAQNECQVLKLLS-HPNIIE 63

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVCHSKGVM 156
           +   + +D+ + IVME   GG L + I  R +    E      F  I+  ++  H+K ++
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123

Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKE 215
           HRDLK +N L        VVK  DFG+S  +        +VG+P YI+PE+   + Y ++
Sbjct: 124 HRDLKTQNILLDK--HKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQK 181

Query: 216 ADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT 275
           +DIW+ G +LY L      F A     +   I+ G      D +   S    +L+  ML 
Sbjct: 182 SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRY---SPDLRQLILSMLN 238

Query: 276 QDPKRRITVAQVLEHP 291
            DP +R  ++Q++  P
Sbjct: 239 LDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  132 bits (334), Expect = 2e-35
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 16/263 (6%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + +++G+G +G  Y     S    +A K +    +    E++D   EI I+  ++  P
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVN-HP 59

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH----YSERAAASVFRVIMNVVNVC 150
           NI+ +K A+ D   + IVME    G+L   I  R        E+    +F  ++  +   
Sbjct: 60  NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-S 209
           H + ++HRDLK  N L    D   +VK  D G+S  +++  A  +I G+P+Y+APEV   
Sbjct: 120 HEQKILHRDLKSANILLVAND---LVKIGDLGISKVLKKNMAKTQI-GTPHYMAPEVWKG 175

Query: 210 QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI-SSSAIE 268
           + Y  ++DIWS G +LY +    PPF A + Q +   + +G    +  P P I S     
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG----KYPPIPPIYSQDLQN 231

Query: 269 LVRRMLTQDPKRRITVAQVLEHP 291
            +R ML   PK R    ++L  P
Sbjct: 232 FIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  134 bits (339), Expect = 2e-35
 Identities = 88/322 (27%), Positives = 138/322 (42%), Gaps = 70/322 (21%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDV---R--REIEIMR 88
            Y + + +G G +G+     +  TG + A K I       +V  D +   R  REI+++R
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS------NVFDDLIDAKRILREIKLLR 54

Query: 89  HLSGQPNIVQFKA-----AYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVI 143
           HL    NI+         + ED   V+IV EL    +L   I +    ++       +  
Sbjct: 55  HL-RHENIIGLLDILRPPSPEDFNDVYIVTEL-METDLHKVIKSPQPLTDDH----IQYF 108

Query: 144 MNVVNVC------HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI- 196
           +    +       HS  V+HRDLKP N L    + N  +K  DFGL+  ++  +  +   
Sbjct: 109 L--YQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDPDEDEKGFL 163

Query: 197 ---VGSPYYIAPEVL--SQSYGKEADIWSAGVIL--------------YI----LLC--- 230
              V + +Y APE+L  S  Y K  DIWS G I               YI    L+    
Sbjct: 164 TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVL 223

Query: 231 GVPPFWAETDQGVAQAILKGEI-NFQRDP-------FPSISSSAIELVRRMLTQDPKRRI 282
           G P    E  + +     +  + +  + P       FP  S  AI+L+ +ML  DPK+RI
Sbjct: 224 GTPS--EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRI 281

Query: 283 TVAQVLEHPWLKESGEASDKPI 304
           T  + L HP+L +  +  D+P+
Sbjct: 282 TADEALAHPYLAQLHDPEDEPV 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  132 bits (333), Expect = 1e-34
 Identities = 79/264 (29%), Positives = 134/264 (50%), Gaps = 15/264 (5%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLV--KDVEKDDVRREIEIMRHLSGQPNIVQ 98
           +G+G FG  Y   +  T   +A K + K+++V  K+V      R I +   L   P IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            K +++ D  +++V +  +GGELF  +   G +SE  A      ++  +   H   +++R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 159 DLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQSYGKE 215
           DLKPEN L    D    +   DFGLS A + + K      G+  Y+APEVL   + Y K 
Sbjct: 121 DLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKH 177

Query: 216 ADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT 275
            D WS GV+++ + CG  PF+AE  Q + + I  G++ F ++    +S    + V+ +L 
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN---VLSDEGRQFVKGLLN 234

Query: 276 QDPKRRI----TVAQVLEHPWLKE 295
           ++P+ R+       ++ EHP+  +
Sbjct: 235 RNPQHRLGAHRDAVELKEHPFFAD 258

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  130 bits (329), Expect = 1e-34
 Identities = 86/272 (31%), Positives = 133/272 (48%), Gaps = 24/272 (8%)

Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           Q  Y + + +G G +G  Y   + +TG   A K I   KL    + + +++EI +++   
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECR 58

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVNVC 150
             PNIV +  +Y     + IVME C GG L D   V RG  SE   A V R  +  +   
Sbjct: 59  -HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL 117

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLS 209
           H  G +HRD+K  N L T   +   VK  DFG+SA +    A R+  +G+PY++APEV +
Sbjct: 118 HETGKIHRDIKGANILLTEDGD---VKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174

Query: 210 QS----YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI--- 262
                 Y  + DIW+ G+    L    PP +   D    +A+    I+    P P +   
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMF---DLHPMRALFL--ISKSNFPPPKLKDK 229

Query: 263 ---SSSAIELVRRMLTQDPKRRITVAQVLEHP 291
              S    + +++ LT+DPK+R T  ++L+HP
Sbjct: 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  129 bits (326), Expect = 1e-34
 Identities = 88/262 (33%), Positives = 130/262 (49%), Gaps = 21/262 (8%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE---IEIMRHLS 91
           Y + R VG G FG   L    ++  ++A K I   K    VE  D R+E   +  M+H  
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVE--DSRKEAVLLAKMKH-- 57

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGH-YSERAAASVFRVIMNVVNV 149
             PNIV FK ++E D  ++IVME C GG+L  +I + RG  + E      F  +   V  
Sbjct: 58  --PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQH 115

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR-EIVGSPYYIAPEVL 208
            H K V+HRD+K +N   T   +N  VK  DFG +  +    AY    VG+PYY+ PE+ 
Sbjct: 116 IHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW 172

Query: 209 SQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267
               Y  ++DIWS G ILY L     PF A + + +   + +G       P PS  S  +
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK----PLPSHYSYEL 228

Query: 268 E-LVRRMLTQDPKRRITVAQVL 288
             L+++M  ++P+ R +   +L
Sbjct: 229 RSLIKQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  130 bits (329), Expect = 2e-34
 Identities = 77/269 (28%), Positives = 135/269 (50%), Gaps = 17/269 (6%)

Query: 39  REVGRGEFGITYLC---TENSTGLEFACKSIPKRKLV-KDVEKDDVRREIEIMRHLSGQP 94
           R +G G +G  +L      +  G  +A K + K  +V K    +  R E +++  +   P
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
            +V    A++ D  +H++++   GGELF  +  R H++E         I+  ++  H  G
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG 125

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR--EIVGSPYYIAPEVL---S 209
           +++RD+K EN L    D    V  TDFGLS      +  R     G+  Y+APEV+   S
Sbjct: 126 IIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGS 182

Query: 210 QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP-SISSSAIE 268
             + K  D WS GV+ + LL G  PF  + +Q  +Q+ +   I   + PFP ++S+ A +
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRILKSKPPFPKTMSAEARD 241

Query: 269 LVRRMLTQDPKRRI---TVAQVLEHPWLK 294
            ++++L +DPK+R+      ++  HP+ +
Sbjct: 242 FIQKLLEKDPKKRLGANGADEIKNHPFFQ 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  129 bits (326), Expect = 3e-34
 Identities = 73/262 (27%), Positives = 127/262 (48%), Gaps = 25/262 (9%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G G +G  Y      TG   A K +P  + ++++ K     EI I++     P IV++ 
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK-----EISILKQ-CDSPYIVKYY 64

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHSKGVMHRD 159
            +Y  +  + IVME C  G + D +       +E   A++    +  +   HS   +HRD
Sbjct: 65  GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRD 124

Query: 160 LKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLSQS-YGKEAD 217
           +K  N L    +E    K  DFG+S  + +  A R  ++G+P+++APEV+ +  Y  +AD
Sbjct: 125 IKAGNILL---NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKAD 181

Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI------SSSAIELVR 271
           IWS G+    +  G PP+   +D    +AI          P P++      S    + V+
Sbjct: 182 IWSLGITAIEMAEGKPPY---SDIHPMRAIFM----IPNKPPPTLSDPEKWSPEFNDFVK 234

Query: 272 RMLTQDPKRRITVAQVLEHPWL 293
           + L +DP+ R +  Q+L+HP++
Sbjct: 235 KCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  130 bits (327), Expect = 4e-34
 Identities = 83/260 (31%), Positives = 147/260 (56%), Gaps = 11/260 (4%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G G  GI  +  E  +G + A K +  RK  +   ++ +  E+ IMR    Q N+V+ 
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHQ-NVVEM 83

Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRD 159
             +Y   + + ++ME   GG L D IV++   +E   A+V   ++  +   HS+GV+HRD
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRD 142

Query: 160 LKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLSQS-YGKEAD 217
           +K ++ L T    +  VK +DFG  A I +    R+ +VG+PY++APEV+S++ YG E D
Sbjct: 143 IKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199

Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD 277
           IWS G+++  ++ G PP+++++    A   L+     +      IS    + + RMLT++
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSPVQ-AMKRLRDSPPPKLKNAHKISPVLRDFLERMLTRE 258

Query: 278 PKRRITVAQVLEHPWLKESG 297
           P+ R T  ++L+HP+L ++G
Sbjct: 259 PQERATAQELLDHPFLLQTG 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  129 bits (325), Expect = 5e-34
 Identities = 87/270 (32%), Positives = 144/270 (53%), Gaps = 25/270 (9%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G G  GI  + T  S+G   A K   K  L K   ++ +  E+ IMR    + N+V+ 
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHE-NVVEM 82

Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRD 159
             +Y     + +VME   GG L D IV     +E   A+V   ++  ++V H++GV+HRD
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141

Query: 160 LKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVGSPYYIAPEVLSQ-SYGKEAD 217
           +K ++ L T    +  VK +DFG  A + +E    + +VG+PY++APE++S+  YG E D
Sbjct: 142 IKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198

Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP-------SISSSAIELV 270
           IWS G+++  ++ G PP++ E      + I        RD  P        +S S    +
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------RDNLPPKLKNLHKVSPSLKGFL 250

Query: 271 RRMLTQDPKRRITVAQVLEHPWLKESGEAS 300
            R+L +DP +R T A++L+HP+L ++G  S
Sbjct: 251 DRLLVRDPAQRATAAELLKHPFLAKAGPPS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  128 bits (324), Expect = 7e-34
 Identities = 80/261 (30%), Positives = 132/261 (50%), Gaps = 17/261 (6%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL--SGQPNIVQ 98
           +GRG +G  Y      TG   A K I       DV   D++RE+ ++  L  S  PNI +
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS--DIQREVALLSQLRQSQPPNITK 66

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMH 157
           +  +Y     + I+ME   GG +  R + + G  +E+  + + R ++  +   H  GV+H
Sbjct: 67  YYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIH 124

Query: 158 RDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLS--QSYGK 214
           RD+K  N L T       VK  DFG++A + +  + R   VG+PY++APEV++  + Y  
Sbjct: 125 RDIKAANILVTNTGN---VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDT 181

Query: 215 EADIWSAGVILYILLCGVPPFWAETDQGVAQAI-LKGEINFQRDPFPSISSSAIELVRRM 273
           +ADIWS G+ +Y +  G PP+   +D    +A+ L  +    R      S    E V   
Sbjct: 182 KADIWSLGITIYEMATGNPPY---SDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC 238

Query: 274 LTQDPKRRITVAQVLEHPWLK 294
           L ++PK R++  ++L+  W+K
Sbjct: 239 LDEEPKERLSAEELLKSKWIK 259

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  129 bits (327), Expect = 7e-34
 Identities = 75/264 (28%), Positives = 127/264 (48%), Gaps = 14/264 (5%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G+G FG   L     T   +A K + K  +++D + +    E  ++      P + Q
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
             + ++    +  VME   GG+L   I   G + E  A      I+  +   H +G+++R
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120

Query: 159 DLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVLS-QSYGKEA 216
           DLK +N L    D    +K  DFG+    I  G       G+P YIAPE+LS Q YG   
Sbjct: 121 DLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAV 177

Query: 217 DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276
           D W+ GV+LY +L G  PF  + +  + Q+IL+ E+ + R     +S  A  +++  LT+
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSKEAKSILKSFLTK 233

Query: 277 DPKRRITV-----AQVLEHPWLKE 295
           +P++R+         +  HP+ +E
Sbjct: 234 NPEKRLGCLPTGEQDIKGHPFFRE 257

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  128 bits (324), Expect = 8e-34
 Identities = 83/283 (29%), Positives = 138/283 (48%), Gaps = 39/283 (13%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + +   +G G +G  Y      TG   A K +    +++D E+++++ E  I+R  S  P
Sbjct: 8   FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIED-EEEEIKEEYNILRKYSNHP 63

Query: 95  NIVQFKAAY-------EDDQFVHIVMELCAGG---ELFDRIVARGH-YSERAAASVFRVI 143
           NI  F  A+        DDQ + +VMELC GG   +L   +  +G    E   A + R  
Sbjct: 64  NIATFYGAFIKKNPPGNDDQ-LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122

Query: 144 MNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYY 202
           +  +   H   V+HRD+K +N L T   +NA VK  DFG+SA ++     R   +G+PY+
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYW 179

Query: 203 IAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR 256
           +APEV++       SY   +D+WS G+    L  G PP     D    +A+ K      R
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL---CDMHPMRALFK----IPR 232

Query: 257 DPFPSISSSA------IELVRRMLTQDPKRRITVAQVLEHPWL 293
           +P P++ S         + +   L ++ ++R  + ++LEHP++
Sbjct: 233 NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  127 bits (322), Expect = 8e-34
 Identities = 87/266 (32%), Positives = 133/266 (50%), Gaps = 22/266 (8%)

Query: 38  GREVGRGEFGITYLCTENSTGLEFACKSIP-------KRKLVKDVEKDDVRREIEIMRHL 90
           G  +G G FG  Y       G  FA K +         ++ VK +E     +EI ++  L
Sbjct: 5   GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLE-----QEIALLSKL 59

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC 150
              PNIVQ+     ++  ++I +EL  GG L   +   G + E       R I+  +   
Sbjct: 60  Q-HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYL 118

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ 210
           H +  +HRD+K  N L    D N VVK  DFG++  + E    +   GSPY++APEV++Q
Sbjct: 119 HDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQ 175

Query: 211 --SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP-SISSSAI 267
              YG  ADIWS G  +  +  G PP W++  +GVA A+ K   + +  P P  +S  A 
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPP-WSQL-EGVA-AVFKIGRSKELPPIPDHLSDEAK 232

Query: 268 ELVRRMLTQDPKRRITVAQVLEHPWL 293
           + + + L +DP  R T A++LEHP++
Sbjct: 233 DFILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  128 bits (323), Expect = 3e-33
 Identities = 84/261 (32%), Positives = 138/261 (52%), Gaps = 19/261 (7%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL--SGQPNIVQ 98
           +G+G FG   L  E +TG  +A K I K++++  + KD+V   +   R L  +  P +  
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMK-ILKKEVI--IAKDEVAHTLTESRVLQNTRHPFLTA 59

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            K +++    +  VME   GGELF  +     +SE  A      I++ +   HS  V++R
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119

Query: 159 DLKPENFLFTTGDENAVVKATDFGL-SAFIEEGKAYREIVGSPYYIAPEVLSQS-YGKEA 216
           DLK EN +    D++  +K TDFGL    I +G   +   G+P Y+APEVL  + YG+  
Sbjct: 120 DLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176

Query: 217 DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276
           D W  GV++Y ++CG  PF+ +  + + + IL  EI F R    ++S  A  L+  +L +
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 232

Query: 277 DPKRRI-----TVAQVLEHPW 292
           DPK+R+        +++EH +
Sbjct: 233 DPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  127 bits (320), Expect = 3e-33
 Identities = 85/293 (29%), Positives = 131/293 (44%), Gaps = 51/293 (17%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD-DVR----REIEIMRHLSGQP 94
            VG G +G+   C   +TG   A K        K+ E D DV+    RE++++R L    
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKF------KESEDDEDVKKTALREVKVLRQLR-HE 60

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGG--ELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
           NIV  K A+     +++V E       EL +   + G     A  S    ++  +  CHS
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHS 118

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA--YREIVGSPYYIAPEVL-- 208
             ++HRD+KPEN L     E+ V+K  DFG +  +    A    + V + +Y APE+L  
Sbjct: 119 HNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG 175

Query: 209 SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG--------EINFQRDP-- 258
             +YGK  D+W+ G I+  LL G P F  ++D      I K         +  F  +P  
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235

Query: 259 ----FPSI--------------SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
               FP                SS A++ ++  L  DPK R+T  ++L+HP+ 
Sbjct: 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  128 bits (322), Expect = 4e-33
 Identities = 93/323 (28%), Positives = 156/323 (48%), Gaps = 31/323 (9%)

Query: 28  YEDVQLHYTIGREVGRGEFGITYLCT-ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEI 86
           YED    +   R +G G FG   L T +N      A K   K K++K  + D V  E +I
Sbjct: 29  YED----FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKI 84

Query: 87  MRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNV 146
           + +++  P  V    +++D+ ++++V+E   GGE F  +     +           I+ +
Sbjct: 85  LNYIN-HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI 143

Query: 147 VNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE 206
                S  +++RDLKPEN L    D++  +K TDFG +  ++  + Y  + G+P YIAPE
Sbjct: 144 FEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDT-RTY-TLCGTPEYIAPE 198

Query: 207 VL-SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265
           +L +  +GK AD W+ G+ +Y +L G PPF+A     + Q IL+G I F +     + ++
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNN 254

Query: 266 AIELVRRMLTQDPKRRI-----TVAQVLEHPW---------LKESGEASDKPIDTAVIFR 311
              L++++L+ D  +R          V EHPW         L ++ E   KP     +F 
Sbjct: 255 CKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKP-KYKNVFD 313

Query: 312 MKQFTAMNKLKKLALKVIVENLP 334
              F  + +   +A K+  EN P
Sbjct: 314 SSNFERVQEDLTIADKITNENDP 336

Length = 340

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  126 bits (317), Expect = 5e-33
 Identities = 83/270 (30%), Positives = 134/270 (49%), Gaps = 21/270 (7%)

Query: 38  GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK------DDVRREIEIMRHLS 91
           G  +G G FG  YL    S+G   A K +    +    +       D + REI +++ L 
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
              NIVQ+  +  D   ++I +E   GG +   +   G + E    +  R I+  +N  H
Sbjct: 65  -HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH 123

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-------GKAYREIVGSPYYIA 204
           ++G++HRD+K  N L    D    +K +DFG+S  +E          A   + GS +++A
Sbjct: 124 NRGIIHRDIKGANILV---DNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180

Query: 205 PEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263
           PEV+ Q SY ++ADIWS G ++  +L G  P + +  Q   QAI K   N   +   +IS
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP-FPDCTQ--LQAIFKIGENASPEIPSNIS 237

Query: 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
           S AI+ + +    D  +R T A++L+HP+L
Sbjct: 238 SEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  125 bits (316), Expect = 9e-33
 Identities = 86/270 (31%), Positives = 141/270 (52%), Gaps = 25/270 (9%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G G  GI  + TE  TG + A K   K  L K   ++ +  E+ IMR      N+V  
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYH-HENVVDM 84

Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRD 159
             +Y     + +VME   GG L D IV     +E   A+V   ++  ++  H++GV+HRD
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143

Query: 160 LKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVGSPYYIAPEVLSQ-SYGKEAD 217
           +K ++ L T+   +  +K +DFG  A + +E    + +VG+PY++APEV+S+  YG E D
Sbjct: 144 IKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200

Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP-------SISSSAIELV 270
           IWS G+++  ++ G PP++ E      + I        RD  P        +SS     +
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQAMRRI--------RDNLPPRVKDSHKVSSVLRGFL 252

Query: 271 RRMLTQDPKRRITVAQVLEHPWLKESGEAS 300
             ML ++P +R T  ++L+HP+LK +G  S
Sbjct: 253 DLMLVREPSQRATAQELLQHPFLKLAGPPS 282

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  126 bits (319), Expect = 1e-32
 Identities = 88/270 (32%), Positives = 136/270 (50%), Gaps = 25/270 (9%)

Query: 39  REVGRGEFGITYLC---TENSTGLEFACKSIPKRKLV---KDVEKDDVRREI-EIMRHLS 91
           + +G+G +G  +     T   TG  FA K + K  +V   KD       R I E ++H  
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKH-- 59

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
             P IV    A++    +++++E  +GGELF  +   G + E  A      I   +   H
Sbjct: 60  --PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGL-SAFIEEGKAYREIVGSPYYIAPEVLSQ 210
            +G+++RDLKPEN L    D    VK TDFGL    I EG       G+  Y+APE+L +
Sbjct: 118 QQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR 174

Query: 211 S-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
           S +GK  D WS G ++Y +L G PPF AE  +     ILKG++N      P ++  A +L
Sbjct: 175 SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDL 230

Query: 270 VRRMLTQDPKRRI-----TVAQVLEHPWLK 294
           ++++L ++P  R+       A+V  HP+ +
Sbjct: 231 LKKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  125 bits (316), Expect = 1e-32
 Identities = 89/292 (30%), Positives = 138/292 (47%), Gaps = 36/292 (12%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM---RHL 90
            + I  E+G G FG  Y      TGL  A K I   ++  + E +D   EI+I+   +H 
Sbjct: 6   IWEIIGELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSECKH- 61

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNV 149
              PNIV    AY  +  + I++E C GG L   ++      +E     V R ++  +N 
Sbjct: 62  ---PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF 118

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVL 208
            HS  V+HRDLK  N L T   +   VK  DFG+SA  +     R+  +G+PY++APEV+
Sbjct: 119 LHSHKVIHRDLKAGNILLTLDGD---VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVV 175

Query: 209 ------SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
                    Y  +ADIWS G+ L  L    PP     +    + +LK      +   P++
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEPP---HHELNPMRVLLK----ILKSEPPTL 228

Query: 263 ------SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAV 308
                 SSS  + ++  L +DP  R T A++L+HP++ +     +K I   +
Sbjct: 229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS--DNKAIKDLL 278

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  125 bits (314), Expect = 2e-32
 Identities = 85/263 (32%), Positives = 135/263 (51%), Gaps = 13/263 (4%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           YT   ++G+G  G  Y   + +TG E A K +    L +  +K+ +  EI +MR     P
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPKKELIINEILVMRENK-HP 76

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NIV +  +Y     + +VME  AGG L D +V      E   A+V R  +  +   HS  
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 135

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLS-QSY 212
           V+HRD+K +N L      +  VK TDFG  A I   ++ R  +VG+PY++APEV++ ++Y
Sbjct: 136 VIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192

Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAI-LKGEINFQRDPFPSISSSAIELVR 271
           G + DIWS G++   ++ G PP+  E        I   G    Q      +S+   + + 
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIFRDFLN 250

Query: 272 RMLTQDPKRRITVAQVLEHPWLK 294
           R L  D ++R +  ++L+HP+LK
Sbjct: 251 RCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  125 bits (314), Expect = 3e-32
 Identities = 80/246 (32%), Positives = 129/246 (52%), Gaps = 14/246 (5%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG--QPNIVQ 98
           +G+G FG   L  E +TG  +A K + K  ++    KD+V   +   R L     P +  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTRHPFLTA 59

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            K A++    +  VME   GGELF  +     ++E  A      I++ +   HS+ V++R
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119

Query: 159 DLKPENFLFTTGDENAVVKATDFGL-SAFIEEGKAYREIVGSPYYIAPEVLSQS-YGKEA 216
           D+K EN +    D++  +K TDFGL    I +G   +   G+P Y+APEVL  + YG+  
Sbjct: 120 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176

Query: 217 DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276
           D W  GV++Y ++CG  PF+ +  + + + IL  EI F R    ++S  A  L+  +L +
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 232

Query: 277 DPKRRI 282
           DPK+R+
Sbjct: 233 DPKQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  124 bits (313), Expect = 4e-32
 Identities = 80/299 (26%), Positives = 126/299 (42%), Gaps = 54/299 (18%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD----VRREIEIMRHL 90
           Y    ++G G +G  Y      TG   A K     K+  + EK+       REI++++ L
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALK-----KIRMENEKEGFPITAIREIKLLQKL 55

Query: 91  SGQPNIVQFKAAYEDDQ--FVHIVMELC----AGGELFDRIVARGHYSERAAASVFRVIM 144
              PNIV+ K          +++V E       G  L D       ++E       + ++
Sbjct: 56  R-HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLL 110

Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI--EEGKAYREIVGSPYY 202
             +   HS G++HRD+K  N L    + + V+K  DFGL+          Y   V + +Y
Sbjct: 111 EGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSADYTNRVITLWY 167

Query: 203 IAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAI------------- 247
             PE+L  +  YG E D+WS G IL  L  G P F   T+    + I             
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227

Query: 248 ----LKGEINFQ-RDPFPS---------ISSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
               L    N + + P+           I  SA++L+ ++LT DPK+RI+  Q L+H +
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  125 bits (316), Expect = 5e-32
 Identities = 85/263 (32%), Positives = 135/263 (51%), Gaps = 14/263 (5%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +GRG FG   L    S+   +A K + K +++K  +      E +IM H +    IVQ  
Sbjct: 51  IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH-ANSEWIVQLH 109

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
            A++DD+++++VME   GG+L + +++     E+ A      ++  ++  HS G +HRD+
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDV 168

Query: 161 KPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR--EIVGSPYYIAPEVL-SQS----YG 213
           KP+N L    D++  +K  DFG    ++     R    VG+P YI+PEVL SQ     YG
Sbjct: 169 KPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225

Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRM 273
           +E D WS GV LY +L G  PF+A++  G    I+  + +        IS  A +L+   
Sbjct: 226 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAF 285

Query: 274 LTQDPKR--RITVAQVLEHPWLK 294
           LT    R  R  V ++  HP+ K
Sbjct: 286 LTDREVRLGRNGVDEIKSHPFFK 308

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  125 bits (316), Expect = 6e-32
 Identities = 83/301 (27%), Positives = 139/301 (46%), Gaps = 56/301 (18%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +GRG FG   L  +  TG  +A K + K ++++  +   VR E +I+   +  P +V+  
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE-ADNPWVVKLY 67

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
            +++D+ +++++ME   GG++   ++ +  ++E          +  ++  H  G +HRD+
Sbjct: 68  YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDI 127

Query: 161 KPENFLFTTGDENAVVKATDFGL----------------------------------SAF 186
           KP+N L    D    +K +DFGL                                     
Sbjct: 128 KPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184

Query: 187 IEEGKAYREI-----VGSPYYIAPEVLSQS-YGKEADIWSAGVILYILLCGVPPFWAETD 240
            E  K  R       VG+P YIAPEV  Q+ Y KE D WS GVI+Y +L G PPF ++  
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244

Query: 241 QGVAQAILKGEINFQRD-PFPS---ISSSAIELVRRMLTQDPKRRITVAQVLE---HPWL 293
           Q   + I    IN++    FP    +S  A +L++R+   + +RR+    V E   HP+ 
Sbjct: 245 QETYRKI----INWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF 299

Query: 294 K 294
           K
Sbjct: 300 K 300

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 1e-31
 Identities = 88/302 (29%), Positives = 137/302 (45%), Gaps = 61/302 (20%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G+G+ G  +L     TG  FA K + K++++K  +   V  E EI+  L   P +  
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPT 65

Query: 99  FKAAYEDDQFVHIVMELCAGGELFD-RIVARGHY-SERA----AASVFRVIMNVVNVC-- 150
             A+++ + ++ +VM+ C GGELF       G   SE      AA V         +   
Sbjct: 66  LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEV---------LLAL 116

Query: 151 ---HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS----------------------- 184
              H  G+++RDLKPEN L     E+  +  +DF LS                       
Sbjct: 117 EYLHLLGIVYRDLKPENILLH---ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173

Query: 185 ------AFIEEGKAY-REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFW 236
                  F EE        VG+  YIAPEV+S   +G   D W+ G++LY +L G  PF 
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233

Query: 237 AETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI----TVAQVLEHPW 292
                     ILK E+ F     P +SSSA +L+R++L +DP +R+      A++ +HP+
Sbjct: 234 GSNRDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291

Query: 293 LK 294
            +
Sbjct: 292 FR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  123 bits (309), Expect = 2e-31
 Identities = 84/272 (30%), Positives = 139/272 (51%), Gaps = 26/272 (9%)

Query: 41  VGRGEFGITYL---CTENSTGLEFACKSIPKRKLVKDVE-KDDVRREIEIMRHLSGQPNI 96
           +G G +G  +L    T + TG  +A K + K  LV+  +  +  R E  ++ H+   P +
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67

Query: 97  VQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVM 156
           V    A++ +  +H++++  +GGE+F  +  R ++SE         I+  +   H  G++
Sbjct: 68  VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIV 127

Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYR-EIVGSPYYIAPEVL--SQSY 212
           +RD+K EN L    D    V  TDFGLS  F+ E K       G+  Y+APE++     +
Sbjct: 128 YRDIKLENILL---DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGH 184

Query: 213 GKEADIWSAGVILYILLCGVPPFWAE----TDQGVAQAILKGEINFQRDPFPS-ISSSAI 267
           GK  D WS G++++ LL G  PF  E    T   V++ ILK +      PFPS I   A 
Sbjct: 185 GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD-----PPFPSFIGPEAQ 239

Query: 268 ELVRRMLTQDPKRRITVA-----QVLEHPWLK 294
           +L+ ++L +DPK+R+        ++ EHP+ K
Sbjct: 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  120 bits (304), Expect = 3e-31
 Identities = 73/269 (27%), Positives = 129/269 (47%), Gaps = 30/269 (11%)

Query: 36  TIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           T+G+++G G FG  Y            +E A K++ +     + + ++  RE  IMR L 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA--SEQQIEEFLREARIMRKLD 59

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC- 150
             PN+V+      +++ ++IVME   GG+L   +            S+  ++   + +  
Sbjct: 60  -HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP-----KLSLSDLLSFALQIAR 113

Query: 151 -----HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG-SPY-YI 203
                 SK  +HRDL   N L     EN VVK +DFGLS  + +   YR+  G  P  ++
Sbjct: 114 GMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM 170

Query: 204 APEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           APE L +  +  ++D+WS GV+L+ I   G  P+   +++ V + +  G     R P P 
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGY----RLPQPP 226

Query: 262 ISSSAI-ELVRRMLTQDPKRRITVAQVLE 289
                + +L+ +   +DP+ R T ++++E
Sbjct: 227 NCPPELYDLMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  121 bits (305), Expect = 3e-31
 Identities = 86/267 (32%), Positives = 139/267 (52%), Gaps = 11/267 (4%)

Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRH 89
           D +  YT   ++G+G  G  Y   + +TG E A K +    L +  +K+ +  EI +MR 
Sbjct: 16  DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQM---NLQQQPKKELIINEILVMRE 72

Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
            +  PNIV +  +Y     + +VME  AGG L D +V      E   A+V R  +  ++ 
Sbjct: 73  -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDF 130

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVL 208
            HS  V+HRD+K +N L      +  VK TDFG  A I   ++ R  +VG+PY++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187

Query: 209 S-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267
           + ++YG + DIWS G++   ++ G PP+  E        I        ++P   +S+   
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-ERLSAVFR 246

Query: 268 ELVRRMLTQDPKRRITVAQVLEHPWLK 294
           + + R L  D  RR +  ++L+HP+LK
Sbjct: 247 DFLNRCLEMDVDRRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  121 bits (305), Expect = 3e-31
 Identities = 92/295 (31%), Positives = 151/295 (51%), Gaps = 18/295 (6%)

Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRH 89
           D +  YT   ++G+G  G  +   + +TG E A K I    L K  +K+ +  EI +M+ 
Sbjct: 16  DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKE 72

Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
           L   PNIV F  ++     + +VME  AGG L D +V      E   A+V R  +  +  
Sbjct: 73  LK-NPNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEF 130

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVL 208
            H+  V+HRD+K +N L   G + +V K TDFG  A I   ++ R  +VG+PY++APEV+
Sbjct: 131 LHANQVIHRDIKSDNVLL--GMDGSV-KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187

Query: 209 S-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267
           + ++YG + DIWS G++   ++ G PP+  E        I        ++P   +S    
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSPIFR 246

Query: 268 ELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPID--TAVIFRMKQFTAMNK 320
           + + R L  D ++R +  ++L+HP+LK +     KP+   T +I   K+    N+
Sbjct: 247 DFLNRCLEMDVEKRGSAKELLQHPFLKLA-----KPLSSLTPLILAAKEAMKSNR 296

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  121 bits (305), Expect = 5e-31
 Identities = 83/286 (29%), Positives = 134/286 (46%), Gaps = 47/286 (16%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +  G +G  YL     T   FA K I K+ L+   +   V  E +I+   +  P +V   
Sbjct: 9   ISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILT-FAENPFVVSMF 67

Query: 101 AAYEDDQFVHIVMELCAGGE---LFDRI------VARGHYSERAAASVFRVIMNVVNVCH 151
            ++E  + + +VME   GG+   L   I      +AR +++E   A         +   H
Sbjct: 68  CSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLA---------LEYLH 118

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF--------IEEGKAYRE-------- 195
           + G++HRDLKP+N L T+      +K TDFGLS          + EG   ++        
Sbjct: 119 NYGIVHRDLKPDNLLITSMGH---IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175

Query: 196 IVGSPYYIAPEV-LSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF 254
           + G+P YIAPEV L Q YGK  D W+ G+ILY  L G  PF+ +T + +   ++  +I +
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 235

Query: 255 --QRDPFPSISSSAIELVRRMLTQDPKRRI---TVAQVLEHPWLKE 295
               +  P   + A +L+ R+L Q+P  R+      +V +H +   
Sbjct: 236 PEGDEALP---ADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  120 bits (302), Expect = 6e-31
 Identities = 77/265 (29%), Positives = 122/265 (46%), Gaps = 19/265 (7%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
            E+G G  G+        TG   A K+I  R  + +  +  + RE++I+      P IV 
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHK-CNSPYIVG 63

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRI--VARGHYSERAAASVFRVIMNVVNVCHSK-GV 155
           F  A+ ++  + I ME   GG L D+I    +G   ER    +   ++  +   H K  +
Sbjct: 64  FYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122

Query: 156 MHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSYGK 214
           +HRD+KP N L  +  +   +K  DFG+S  +    A +  VG+  Y+APE +    Y  
Sbjct: 123 IHRDVKPSNILVNSRGQ---IKLCDFGVSGQLVNSLA-KTFVGTSSYMAPERIQGNDYSV 178

Query: 215 EADIWSAGVILYILLCGVPPFWAETDQGVA-----QAILKGEINFQRDPFPSISSSAIEL 269
           ++DIWS G+ L  L  G  P+  E D         Q I+       R P    S    + 
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP--PRLPSGKFSPDFQDF 236

Query: 270 VRRMLTQDPKRRITVAQVLEHPWLK 294
           V   L +DP+ R +  ++LEHP++K
Sbjct: 237 VNLCLIKDPRERPSYKELLEHPFIK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  119 bits (302), Expect = 7e-31
 Identities = 76/269 (28%), Positives = 131/269 (48%), Gaps = 29/269 (10%)

Query: 36  TIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           T+G+++G G FG  Y  T     +   +E A K++ +     + + ++  RE  IMR L 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA--SEQQIEEFLREARIMRKLD 59

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC- 150
             PNIV+      +++ + IVME   GG+L D +      +     S+  ++   + +  
Sbjct: 60  -HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL----RKNRPKELSLSDLLSFALQIAR 114

Query: 151 -----HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG-SPY-YI 203
                 SK  +HRDL   N L     EN VVK +DFGLS  + +   Y+   G  P  ++
Sbjct: 115 GMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM 171

Query: 204 APEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           APE L +  +  ++D+WS GV+L+ I   G  P+   ++  V + + KG     R P P 
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGY----RLPKPP 227

Query: 262 ISSSAI-ELVRRMLTQDPKRRITVAQVLE 289
                + +L+ +   +DP+ R T ++++E
Sbjct: 228 NCPPELYKLMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  119 bits (300), Expect = 1e-30
 Identities = 70/264 (26%), Positives = 128/264 (48%), Gaps = 14/264 (5%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + I  ++G+G FG+ +     +    +A K I   K+ +  E+++   E  ++  L    
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAIDEARVLAKLD-SS 59

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVA-RGH-YSERAAASVFRVIMNVVNVCHS 152
            I+++  ++ D   ++IVME    G+L   +   RG    E      F  I+  +   HS
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY-REIVGSPYYIAPEVLS-Q 210
           K ++HRD+K  N      D    VK  D G++  + +   +   IVG+PYY++PE+   +
Sbjct: 120 KKILHRDIKSLNLFLDAYDN---VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176

Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI-EL 269
            Y +++D+W+ GV+LY    G  PF A     +   I++G       P   + S  + +L
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF----PPVSQMYSQQLAQL 232

Query: 270 VRRMLTQDPKRRITVAQVLEHPWL 293
           + + LT+D ++R    Q+L +P L
Sbjct: 233 IDQCLTKDYRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  122 bits (306), Expect = 1e-30
 Identities = 87/271 (32%), Positives = 141/271 (52%), Gaps = 18/271 (6%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + + +GRG FG   L    S+   +A K + K +++K  +      E +IM   +  P
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 103

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
            +VQ   A++DD+++++VME   GG+L + +++     E+ A      ++  ++  HS G
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMG 162

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR--EIVGSPYYIAPEVLSQS- 211
           ++HRD+KP+N L    D++  +K  DFG    ++E    R    VG+P YI+PEVL    
Sbjct: 163 LIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 212 ----YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL--KGEINFQRDPFPSISSS 265
               YG+E D WS GV L+ +L G  PF+A++  G    I+  K  +NF  D    IS  
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED--VEISKH 277

Query: 266 AIELVRRMLTQDPKR--RITVAQVLEHPWLK 294
           A  L+   LT    R  R  V ++ +HP+ K
Sbjct: 278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  121 bits (304), Expect = 1e-30
 Identities = 88/278 (31%), Positives = 130/278 (46%), Gaps = 41/278 (14%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           VGRG FG   +  E +TG  +A K + K  L+          E +I+  +S  P I Q +
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS-ISNSPWIPQLQ 67

Query: 101 AAYEDDQFVHIVMELCAGGEL----------FDRIVARGHYSERAAASVFRVIMNVVNVC 150
            A++D   +++VME   GG+L          FD  +A+ + +E   A         ++  
Sbjct: 68  YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA---------IHSV 118

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI--VGSPYYIAPEVL 208
           H  G +HRD+KPEN L    D    +K  DFG +A +   K       VG+P YIAPEVL
Sbjct: 119 HQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVL 175

Query: 209 SQ-------SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD-PFP 260
           +        +YG E D WS GVI Y ++ G  PF   T       I+    NFQR   FP
Sbjct: 176 TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM----NFQRFLKFP 231

Query: 261 S---ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               +SS  ++L++ +L    K R+    +  HP+  +
Sbjct: 232 EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  119 bits (299), Expect = 1e-30
 Identities = 71/260 (27%), Positives = 136/260 (52%), Gaps = 14/260 (5%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           +++G G FG   L      G ++  K I   K+    E+++ R+E+ ++ ++   PNIVQ
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMK-HPNIVQ 63

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVA-RG-HYSERAAASVFRVIMNVVNVCHSKGVM 156
           ++ ++E++  ++IVM+ C GG+L+ +I A RG  + E      F  I   +   H + ++
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKIL 123

Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-KAYREIVGSPYYIAPEVL-SQSYGK 214
           HRD+K +N   T       +K  DFG++  +    +  R  +G+PYY++PE+  ++ Y  
Sbjct: 124 HRDIKSQNIFLTKD---GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNN 180

Query: 215 EADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI-ELVRRM 273
           ++DIW+ G +LY +      F A   + +   I++G       P  S  S  +  LV ++
Sbjct: 181 KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY----PPVSSHYSYDLRNLVSQL 236

Query: 274 LTQDPKRRITVAQVLEHPWL 293
             ++P+ R +V  +LE  ++
Sbjct: 237 FKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  119 bits (299), Expect = 2e-30
 Identities = 75/273 (27%), Positives = 127/273 (46%), Gaps = 25/273 (9%)

Query: 38  GREVGRGEFGITYLCTENSTGLEFACKS--IPKRKLVKDVEK-----DDVRREIEIMRHL 90
           G  +G+G +G  YL    +TG   A K   +P     +   +       +R EIE ++ L
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC 150
               NIVQ+      ++++ I +E   GG +   +   G + E+        ++  +   
Sbjct: 66  D-HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGL---SAFIEEGKAYREIVGSPYYIAPEV 207
           HSKG++HRDLK +N L    D + + K +DFG+   S  I +      + GS +++APEV
Sbjct: 125 HSKGILHRDLKADNLLV---DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181

Query: 208 L---SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS--- 261
           +   SQ Y  + DIWS G ++  +  G  P W  +D+    A+ K        P P    
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-W--SDEEAIAAMFKLGNKRSAPPIPPDVS 238

Query: 262 --ISSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
             +S  A++ +    T +P  R T  ++L+HP+
Sbjct: 239 MNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  120 bits (301), Expect = 3e-30
 Identities = 84/269 (31%), Positives = 132/269 (49%), Gaps = 23/269 (8%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS---GQPN 95
           R +G+G FG   L     +G  +A K + K  +++D   DDV   +   R LS     P 
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD---DDVECTMTEKRILSLARNHPF 57

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGV 155
           + Q    ++    +  VME   GG+L   I     + E  A      I + +   H KG+
Sbjct: 58  LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGI 117

Query: 156 MHRDLKPENFLFTTGDENAVVKATDFGL-SAFIEEGKAYREIVGSPYYIAPEVLSQS-YG 213
           ++RDLK +N L    D     K  DFG+    I  GK      G+P YIAPE+L +  YG
Sbjct: 118 IYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174

Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
              D W+ GV+LY +LCG  PF AE +  + +AIL  E+      +P+ +S  A+++++ 
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-----VYPTWLSQDAVDILKA 229

Query: 273 MLTQDPKRRI-TVAQ-----VLEHPWLKE 295
            +T++P  R+ ++       +L HP+ KE
Sbjct: 230 FMTKNPTMRLGSLTLGGEEAILRHPFFKE 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  118 bits (297), Expect = 3e-30
 Identities = 77/274 (28%), Positives = 129/274 (47%), Gaps = 25/274 (9%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSI---PKRKLVKDVEKDDVRREIEIMRHLS 91
           +T G  +G+G +G  Y C   + G   A K +       L  + E + ++ E+++++ L 
Sbjct: 2   WTKGEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
              NIVQ+     DD  + I ME   GG +   +   G   E       + I++ V   H
Sbjct: 61  -HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFG-------LSAFIEEGKAYREIVGSPYYIA 204
           +  V+HRD+K  N +      N ++K  DFG       +          + + G+PY++A
Sbjct: 120 NNCVVHRDIKGNNVMLMP---NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 205 PEVLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI- 262
           PEV+++S YG+++DIWS G  ++ +  G PP  A  D+  A       I   R   P + 
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPP-LASMDRLAAMFY----IGAHRGLMPRLP 231

Query: 263 ---SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
              S++AI+ V   LT+D   R +  Q+L H +L
Sbjct: 232 DSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  118 bits (297), Expect = 4e-30
 Identities = 76/268 (28%), Positives = 137/268 (51%), Gaps = 24/268 (8%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + I +++G+G+F + Y       G   A K +   +++    + D  +EI++++ L   P
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HP 62

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYS-------ERAAASVFRVIMNVV 147
           N++++ A++ ++  ++IV+EL   G+L   I    H+        ER     F  + + +
Sbjct: 63  NVIKYLASFIENNELNIVLELADAGDLSRMI---KHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVGSPYYIAPE 206
              HSK +MHRD+KP N +F T     VVK  D GL  F   +  A   +VG+PYY++PE
Sbjct: 120 EHMHSKRIMHRDIKPAN-VFITA--TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 207 VLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQ--GVAQAILKGEINFQRDPFPSIS 263
            + ++ Y  ++DIWS G +LY +     PF+ +      + + I K +      P P+  
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP----PLPADH 232

Query: 264 SSAI--ELVRRMLTQDPKRRITVAQVLE 289
            S    +LV R +  DP++R  ++ VL+
Sbjct: 233 YSEELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  118 bits (298), Expect = 6e-30
 Identities = 84/247 (34%), Positives = 132/247 (53%), Gaps = 15/247 (6%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL--SGQPNIVQ 98
           +G+G FG   L  E +TG  +A K + K  +V    KD+V   +   R L  S  P +  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVA---KDEVAHTLTENRVLQNSRHPFLTA 59

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMH 157
            K +++    +  VME   GGELF  +     +SE  A      I++ ++  HS K V++
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119

Query: 158 RDLKPENFLFTTGDENAVVKATDFGL-SAFIEEGKAYREIVGSPYYIAPEVLSQS-YGKE 215
           RDLK EN +    D++  +K TDFGL    I++G   +   G+P Y+APEVL  + YG+ 
Sbjct: 120 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176

Query: 216 ADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT 275
            D W  GV++Y ++CG  PF+ +  + + + IL  EI F R    ++S  A  L+  +L 
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLSGLLK 232

Query: 276 QDPKRRI 282
           +DPK+R+
Sbjct: 233 KDPKQRL 239

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  117 bits (294), Expect = 7e-30
 Identities = 81/270 (30%), Positives = 136/270 (50%), Gaps = 18/270 (6%)

Query: 33  LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD--DVRREIEIMRHL 90
           +++  G+ +G+G FG  YLC +  TG E A K +       +  K+   +  EI+++++L
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 91  SGQPNIVQFKAAYED--DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVN 148
             +  IVQ+     D  ++ + I ME   GG + D++ A G  +E       R I+  ++
Sbjct: 62  QHE-RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS 120

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE----EGKAYREIVGSPYYIA 204
             HS  ++HRD+K  N L    D    VK  DFG S  ++     G   R + G+PY+++
Sbjct: 121 YLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177

Query: 205 PEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-I 262
           PEV+S + YG++AD+WS G  +  +L   PP WAE +     AI K          PS I
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPP-WAEYE--AMAAIFKIATQPTNPQLPSHI 234

Query: 263 SSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
           S  A + +  +  +  + R +  ++L HP+
Sbjct: 235 SEHARDFLGCIFVE-ARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  117 bits (296), Expect = 8e-30
 Identities = 77/300 (25%), Positives = 121/300 (40%), Gaps = 54/300 (18%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD------VRREIEIMR 88
           Y    E+G G +G  Y   + +TG   A K +        V   +        REI +++
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKV-------RVPLSEEGIPLSTLREIALLK 53

Query: 89  HL--SGQPNIVQF-----KAAYEDDQFVHIVMELC----AGGELFDRIVARGHYSERAAA 137
            L     PNIV+          + +  + +V E      A      +    G        
Sbjct: 54  QLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLAT--YLSKCPKPG-LPPETIK 110

Query: 138 SVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV 197
            + R ++  V+  HS  ++HRDLKP+N L T+  +   VK  DFGL+       A   +V
Sbjct: 111 DLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ---VKIADFGLARIYSFEMALTSVV 167

Query: 198 GSPYYIAPEVLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK------- 249
            + +Y APEVL QS Y    D+WS G I   L    P F   ++      I         
Sbjct: 168 VTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSE 227

Query: 250 ----GEINFQRDPFPS------------ISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
                 ++  R  FPS            I    ++L+++MLT +P +RI+  + L+HP+ 
Sbjct: 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  117 bits (295), Expect = 8e-30
 Identities = 83/267 (31%), Positives = 138/267 (51%), Gaps = 11/267 (4%)

Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRH 89
           D +  YT   ++G+G  G  Y   + +TG E A + +    L +  +K+ +  EI +MR 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRE 73

Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
            +  PNIV +  +Y     + +VME  AGG L D +V      E   A+V R  +  +  
Sbjct: 74  -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR-EIVGSPYYIAPEVL 208
            HS  V+HRD+K +N L      +  VK TDFG  A I   ++ R  +VG+PY++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

Query: 209 S-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267
           + ++YG + DIWS G++   ++ G PP+  E        I        ++P   +S+   
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFR 247

Query: 268 ELVRRMLTQDPKRRITVAQVLEHPWLK 294
           + + R L  D ++R +  ++L+H +LK
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  117 bits (293), Expect = 1e-29
 Identities = 83/267 (31%), Positives = 133/267 (49%), Gaps = 16/267 (5%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD--DVRREIEIMRHLS 91
           ++ +G+ +GRG FG  YLC +  TG E A K +P     ++  K+   +  EI+++++L 
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 92  GQPNIVQFKAAYED--DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
               IVQ+     D  ++ + I +E   GG + D++ A G  +E       R I+  V+ 
Sbjct: 63  -HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE----EGKAYREIVGSPYYIAP 205
            HS  ++HRD+K  N L    D    VK  DFG S  I+     G   + + G+PY+++P
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 206 EVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
           EV+S + YG++AD+WS    +  +L   PP WAE +     AI K      +   P   S
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPP-WAEYE--AMAAIFKIATQPTKPMLPDGVS 235

Query: 265 SAIELVRRMLTQDPKRRITVAQVLEHP 291
            A     + +  + KRR T   +L HP
Sbjct: 236 DACRDFLKQIFVEEKRRPTAEFLLRHP 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  117 bits (296), Expect = 1e-29
 Identities = 76/261 (29%), Positives = 128/261 (49%), Gaps = 14/261 (5%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG   L     T   +A K + K  +++D + +    E  ++      P + Q  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
           + ++    ++ VME   GG+L   I   G + E  A      I   +   HSKG+++RDL
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127

Query: 161 KPENFLFTTGDENAVVKATDFGL-SAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEADI 218
           K +N +    D    +K  DFG+    I  GK  R   G+P YIAPE +  Q YGK  D 
Sbjct: 128 KLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184

Query: 219 WSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278
           W+ GV+LY +L G PPF  E +  + Q+I++  +++ +    S+S  A+ + + +LT+ P
Sbjct: 185 WAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGLLTKHP 240

Query: 279 KRRITVA-----QVLEHPWLK 294
            +R+         + EH + +
Sbjct: 241 AKRLGCGPTGERDIREHAFFR 261

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  117 bits (293), Expect = 2e-29
 Identities = 79/275 (28%), Positives = 144/275 (52%), Gaps = 29/275 (10%)

Query: 41  VGRGEFGITYLCTENS---TGLEFACKSIPKRKLVKDVEK-DDVRREIEIMRHLSGQPNI 96
           +G G +G  +L  + S   +G  +A K + K  +V+  +  +  R E +++ H+   P +
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 97  VQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVM 156
           V    A++ D  +H++++   GGELF  +  R  + E+        I+  +   H  G++
Sbjct: 68  VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGII 127

Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSA-FIEEG--KAYREIVGSPYYIAPEVLS---Q 210
           +RD+K EN L    D N  V  TDFGLS  F E+   +AY    G+  Y+AP+++     
Sbjct: 128 YRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAY-SFCGTIEYMAPDIVRGGDG 183

Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQG----VAQAILKGEINFQRDPFPS-ISSS 265
            + K  D WS GV++Y LL G  PF  + ++     +++ ILK E      P+P  +S+ 
Sbjct: 184 GHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-----PPYPQEMSAL 238

Query: 266 AIELVRRMLTQDPKRRITVA-----QVLEHPWLKE 295
           A ++++R+L +DPK+R+        ++ +HP+ ++
Sbjct: 239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  117 bits (296), Expect = 2e-29
 Identities = 94/349 (26%), Positives = 147/349 (42%), Gaps = 74/349 (21%)

Query: 34  HYTIGREVGRGEFGITYLC----TENSTGLEFACKSIP---------KRKLVKDVEKDDV 80
            Y + +E+G+G +GI  +C     E S     A K I          KR L         
Sbjct: 1   RYELIKELGQGAYGI--VCSARNAETSEEETVAIKKITNVFSKKILAKRAL--------- 49

Query: 81  RREIEIMRHLSGQPNIVQ-------FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSE 133
            RE++++RH  G  NI         F   + +   +++  EL    +L   I +    ++
Sbjct: 50  -RELKLLRHFRGHKNITCLYDMDIVFPGNFNE---LYLYEELMEA-DLHQIIRSGQPLTD 104

Query: 134 RAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA- 192
               S    I+  +   HS  V+HRDLKP N L     E   +K  DFGL+    E    
Sbjct: 105 AHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE---LKICDFGLARGFSENPGE 161

Query: 193 ----YREIVGSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWA--------- 237
                 E V + +Y APE++   QSY K  D+WS G IL  LL   P F           
Sbjct: 162 NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQ 221

Query: 238 ----------ETDQGV----AQAILKGEINFQRDPFPSI----SSSAIELVRRMLTQDPK 279
                     ET   +    AQ  ++   N  + PF SI    +  A++L+ ++L  DP 
Sbjct: 222 ILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPT 281

Query: 280 RRITVAQVLEHPWLKESGEASDKPI-DTAVIFRMKQFTAMNKLKKLALK 327
           +RI+V + LEHP+L    +  D+P+      F  +   +M +L+ + ++
Sbjct: 282 KRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFESEDSMEELRDMIIE 330

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  116 bits (292), Expect = 5e-29
 Identities = 95/321 (29%), Positives = 145/321 (45%), Gaps = 50/321 (15%)

Query: 23  ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR 82
           I G  +E +   Y   + VG G FG+     +  TG   A K I K      V      R
Sbjct: 1   IFGTVFE-ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMK-PFSTPVLAKRTYR 58

Query: 83  EIEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAAS 138
           E+++++HL  + NI+     F +  ED   ++ V EL   G    R++      ++    
Sbjct: 59  ELKLLKHLRHE-NIISLSDIFISPLED---IYFVTELL--GTDLHRLLTSRPLEKQFIQY 112

Query: 139 VFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--AYREI 196
               I+  +   HS GV+HRDLKP N L    +EN  +K  DFGL A I++ +   Y   
Sbjct: 113 FLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGL-ARIQDPQMTGY--- 165

Query: 197 VGSPYYIAPEVLS--QSYGKEADIWSAGVILYILLCGVPPFWAE---------------- 238
           V + YY APE++   Q Y  E DIWSAG I   +L G P F  +                
Sbjct: 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTP 225

Query: 239 TDQGVAQAILKGEINF-----QRDP------FPSISSSAIELVRRMLTQDPKRRITVAQV 287
            D  +     +  + F     +R+P      F +   SAI+L+ +ML  DP++RI+ A+ 
Sbjct: 226 PDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEA 285

Query: 288 LEHPWLKESGEASDKPIDTAV 308
           L HP+L    + +D+P+    
Sbjct: 286 LAHPYLAPYHDPTDEPVAEEK 306

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  117 bits (294), Expect = 5e-29
 Identities = 89/284 (31%), Positives = 140/284 (49%), Gaps = 18/284 (6%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + + +GRG FG   L    ST   +A K + K +++K  +      E +IM   +  P
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 103

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
            +VQ   A++DD+++++VME   GG+L + +++     E+ A      ++  ++  HS G
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 162

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR--EIVGSPYYIAPEVLSQS- 211
            +HRD+KP+N L    D++  +K  DFG    + +    R    VG+P YI+PEVL    
Sbjct: 163 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 212 ----YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL--KGEINFQRDPFPSISSS 265
               YG+E D WS GV LY +L G  PF+A++  G    I+  K  + F  D    IS  
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISKE 277

Query: 266 AIELVRRMLTQDPKR--RITVAQVLEHPWLKESGEASDKPIDTA 307
           A  L+   LT    R  R  V ++  H + K    A +   DT 
Sbjct: 278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTV 321

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 1e-28
 Identities = 85/330 (25%), Positives = 140/330 (42%), Gaps = 61/330 (18%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG   L  +  TG  +A K++ K ++ K  +   V+ E +++   S  P +V   
Sbjct: 9   IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SDSPWVVSLY 67

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
            +++D Q+++++ME   GG+L   ++    +SE          +  +   H  G +HRD+
Sbjct: 68  YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDI 127

Query: 161 KPENFLFTTGDENAVVKATDFGLS------------------------------------ 184
           KP+N L    D    +K +DFGLS                                    
Sbjct: 128 KPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSI 184

Query: 185 -------AFIEEGKAYREI-----VGSPYYIAPEV-LSQSYGKEADIWSAGVILYILLCG 231
                    I   K  R +     VG+P YIAPE+ L Q YG+E D WS G I++  L G
Sbjct: 185 NLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIG 244

Query: 232 VPPFWAETDQGVAQAILKGEINFQRDPFPS---ISSSAIELVRRMLTQDPKR--RITVAQ 286
            PPF +E      + I+          FP    +S  A +L+RR++T    R  R    +
Sbjct: 245 WPPFCSENSHETYRKIINWRETLY---FPDDIHLSVEAEDLIRRLITNAENRLGRGGAHE 301

Query: 287 VLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
           +  HP+ +     + + I    I ++K  T
Sbjct: 302 IKSHPFFRGVDWDTIRQIRAPFIPQLKSIT 331

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  115 bits (288), Expect = 1e-28
 Identities = 72/244 (29%), Positives = 127/244 (52%), Gaps = 10/244 (4%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG   L  E ++G  +A K + K  ++   E      E  ++++ +  P +   K
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTSLK 61

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
            +++    +  VME   GGELF  +     +SE         I++ ++  HS  +++RDL
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121

Query: 161 KPENFLFTTGDENAVVKATDFGL-SAFIEEGKAYREIVGSPYYIAPEVLSQS-YGKEADI 218
           K EN +    D++  +K TDFGL    I +    +   G+P Y+APEVL  + YG+  D 
Sbjct: 122 KLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178

Query: 219 WSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278
           W  GV++Y ++CG  PF+ +  + + + IL  +I F R    ++S+ A  L+  +L +DP
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLIKDP 234

Query: 279 KRRI 282
            +R+
Sbjct: 235 NKRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  113 bits (286), Expect = 1e-28
 Identities = 81/288 (28%), Positives = 129/288 (44%), Gaps = 37/288 (12%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y I  ++G G F          TG  +A K + K    K +E+ +  REI+ +R LS  P
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKH--FKSLEQVNNLREIQALRRLSPHP 58

Query: 95  NIVQFKAAYEDDQF--VHIVMELCAGGELFDRIVARGHY-SERAAASVFRVIMNVVNVCH 151
           NI++      D +   + +V EL     L++ I  R     E+   S    ++  ++  H
Sbjct: 59  NILRLIEVLFDRKTGRLALVFEL-MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL--S 209
             G+ HRD+KPEN L     ++ ++K  DFG    I     Y E + + +Y APE L   
Sbjct: 118 RNGIFHRDIKPENILI----KDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTD 173

Query: 210 QSYGKEADIWSAGVILYILLCGVPPFWA--ETDQ--------GV-AQAILK-----GEIN 253
             YG + DIW+ G + + +L   P F    E DQ        G     +LK       +N
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233

Query: 254 F---QRDP------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
           +    +         P+ S+  ++L++++L  DP  RIT  Q L HP+
Sbjct: 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  114 bits (286), Expect = 3e-28
 Identities = 79/258 (30%), Positives = 123/258 (47%), Gaps = 38/258 (14%)

Query: 42  GRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEI------MRHLSGQPN 95
           GRG FG   L     TG  +A K++ K  ++   E + +  E  I       RH    P 
Sbjct: 8   GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERH----PF 63

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC----- 150
           +V   A ++ +  V  VME  AGG+L   I     +SE       R +     V      
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEP------RAVFYAACVVLGLQY 116

Query: 151 -HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE----IVGSPYYIAP 205
            H   +++RDLK +N L  T      VK  DFGL    +EG  + +      G+P ++AP
Sbjct: 117 LHENKIVYRDLKLDNLLLDT---EGFVKIADFGLC---KEGMGFGDRTSTFCGTPEFLAP 170

Query: 206 EVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
           EVL+  SY +  D W  GV++Y +L G  PF  + ++ V  +I+  E+ + R     +S 
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSR 226

Query: 265 SAIELVRRMLTQDPKRRI 282
            AI ++RR+L ++P+RR+
Sbjct: 227 EAISIMRRLLRRNPERRL 244

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  112 bits (281), Expect = 3e-28
 Identities = 78/266 (29%), Positives = 135/266 (50%), Gaps = 16/266 (6%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD--DVRREIEIMRHLS 91
           ++ +G+ +G+G FG  YLC +  TG E A K +       +  K+   +  EI+++++L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 92  GQPNIVQFKAAYED--DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
            +  IVQ+     D  ++ + I ME   GG + D++ + G  +E       R I+  V+ 
Sbjct: 63  HE-RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE----EGKAYREIVGSPYYIAP 205
            HS  ++HRD+K  N L    D    VK  DFG S  ++     G   + + G+PY+++P
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178

Query: 206 EVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
           EV+S + YG++ADIWS G  +  +L   PP WAE +   A   +  +      P P +S 
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPP-WAEFEAMAAIFKIATQPTNPVLP-PHVSD 236

Query: 265 SAIELVRRMLTQDPKRRITVAQVLEH 290
              + ++R+  +  K R +  ++L H
Sbjct: 237 HCRDFLKRIFVE-AKLRPSADELLRH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  111 bits (279), Expect = 7e-28
 Identities = 90/270 (33%), Positives = 131/270 (48%), Gaps = 19/270 (7%)

Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           Q  + + + +G G +G  Y     +TG   A K I   KL    +   V++EI +M+   
Sbjct: 8   QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCK 64

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
              NIV +  +Y     + I ME C GG L D     G  SE   A V R  +  +   H
Sbjct: 65  -HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLS- 209
           SKG MHRD+K  N L T   +N  VK  DFG+SA I    A R+  +G+PY++APEV + 
Sbjct: 124 SKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAV 180

Query: 210 ---QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAI-LKGEINFQRDPFP---SI 262
                Y +  DIW+ G+    L    PP +   D    +A+ L  + NFQ          
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPMF---DLHPMRALFLMTKSNFQPPKLKDKMKW 237

Query: 263 SSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
           S+S    V+  LT++PK+R T  ++L+HP+
Sbjct: 238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  111 bits (280), Expect = 1e-27
 Identities = 78/275 (28%), Positives = 126/275 (45%), Gaps = 26/275 (9%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
             +G G  G    C   +TG+ FA K+I       D++K  + RE+EI +     P IV+
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQ-ILRELEINKSCK-SPYIVK 63

Query: 99  FKAAYEDDQ--FVHIVMELCAGGELFDRIVAR-----GHYSERAAASVFRVIMNVVNVCH 151
           +  A+ D+    + I ME C GG L D I  +     G   E+    +   ++  ++  H
Sbjct: 64  YYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVLS- 209
           S+ ++HRD+KP N L T       VK  DFG+S   +          G+ +Y+APE +  
Sbjct: 123 SRKIIHRDIKPSNILLTR---KGQVKLCDFGVSGELVNSLAG--TFTGTSFYMAPERIQG 177

Query: 210 QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVA-----QAILKGEI-NFQRDPFPSI- 262
           + Y   +D+WS G+ L  +     PF  E +  +        I+       + +P   I 
Sbjct: 178 KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK 237

Query: 263 -SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
            S    + +++ L +DP RR T   +LEHPW+K  
Sbjct: 238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  111 bits (279), Expect = 1e-27
 Identities = 71/270 (26%), Positives = 124/270 (45%), Gaps = 28/270 (10%)

Query: 39  REVGRGEFGITYLCT---ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           +++G G FG  Y      ++    E A K++ +     + E+ D  +E  +M+ L G PN
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKL-GHPN 57

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV---IMNVVNVC-- 150
           +V+      +++ +++V+E   GG+L D +            S   +   +   + +   
Sbjct: 58  VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 151 ----HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI--- 203
                SK  +HRDL   N L     E+ VVK +DFGLS  + +   YR+  G    I   
Sbjct: 118 MEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174

Query: 204 APEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           APE L    +  ++D+WS GV+L+ I   G  P+   +++ V + + KG     R P P 
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY----RLPKPE 230

Query: 262 ISSSAI-ELVRRMLTQDPKRRITVAQVLEH 290
                + EL+      DP+ R T ++++E 
Sbjct: 231 YCPDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  112 bits (281), Expect = 1e-27
 Identities = 69/244 (28%), Positives = 124/244 (50%), Gaps = 9/244 (3%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG   L     T   +A K + K  +++D + +    E  ++      P + Q  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
           + ++    ++ VME   GG+L   I   G + E  A      I   +   H +G+++RDL
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127

Query: 161 KPENFLFTTGDENAVVKATDFGL-SAFIEEGKAYREIVGSPYYIAPEVLS-QSYGKEADI 218
           K +N +    D    +K  DFG+    + +G   R   G+P YIAPE+++ Q YGK  D 
Sbjct: 128 KLDNVML---DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184

Query: 219 WSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278
           W+ GV+LY +L G PPF  E +  + Q+I++  +++ +    S+S  A+ + + ++T+ P
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGLMTKHP 240

Query: 279 KRRI 282
            +R+
Sbjct: 241 SKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  109 bits (273), Expect = 4e-27
 Identities = 71/265 (26%), Positives = 134/265 (50%), Gaps = 15/265 (5%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y   R VG+G +G   L    + G ++  K +  R   +  E+    +E +++  L   P
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRR-ERKAAEQEAQLLSQLK-HP 59

Query: 95  NIVQFKAAYE-DDQFVHIVMELCAGGELFDRIV-ARGHY-SERAAASVFRVIMNVVNVCH 151
           NIV ++ ++E +D  ++IVM  C GG+L+ ++   +G    E      F  I   +   H
Sbjct: 60  NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEVLS- 209
            K ++HRDLK +N   T  +   ++K  D G++  +E +      ++G+PYY++PE+ S 
Sbjct: 120 EKHILHRDLKTQNVFLTRTN---IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176

Query: 210 QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIE 268
           + Y  ++D+W+ G  +Y +      F A+    +   I++G++     P P   S    E
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL----PPMPKDYSPELGE 232

Query: 269 LVRRMLTQDPKRRITVAQVLEHPWL 293
           L+  ML++ P++R +V  +L  P++
Sbjct: 233 LIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  111 bits (280), Expect = 4e-27
 Identities = 75/308 (24%), Positives = 131/308 (42%), Gaps = 51/308 (16%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            +   + +G G FG   L  +  T   +A K++ K  ++   +   V+ E +I+   +  
Sbjct: 2   MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE-ADN 60

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
             +V+   +++D   ++ VM+   GG++   ++  G + E  A      +   +   H  
Sbjct: 61  EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGL---------SAFIEEGKAYRE--------- 195
           G +HRD+KP+N L    D +  +K TDFGL         S + ++G  +R+         
Sbjct: 121 GFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177

Query: 196 --------------------------IVGSPYYIAPEVLSQS-YGKEADIWSAGVILYIL 228
                                     +VG+P YIAPEVL ++ Y +  D WS GVILY +
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237

Query: 229 LCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKR--RITVAQ 286
           L G PPF A+T       ++  E          +S  A +L+ R+      R  +    +
Sbjct: 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADE 297

Query: 287 VLEHPWLK 294
           +  HP+ K
Sbjct: 298 IKAHPFFK 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  108 bits (272), Expect = 8e-27
 Identities = 73/269 (27%), Positives = 128/269 (47%), Gaps = 23/269 (8%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEF-ACKSIP-------KRKLVKDVEKDDVRREIEI 86
           Y +   +G G FG  Y   + + G    A K I        K K  +D    D+  E+ I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 87  MRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG---GELFDRIVARG-HYSERAAASVFRV 142
           ++     PNIV++   + ++  ++IVM+L  G   GE F+ +  +   ++E    ++F  
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 143 IMNVVNVCH-SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY 201
           ++  +   H  K ++HRDL P N +    D+   V  TDFGL+   +       +VG+  
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDK---VTITDFGLAKQKQPESKLTSVVGTIL 178

Query: 202 YIAPEVL-SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
           Y  PE++ ++ YG++AD+W+ G ILY +    PPF++     +A  I++       +P P
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY----EPLP 234

Query: 261 S--ISSSAIELVRRMLTQDPKRRITVAQV 287
               S    +++   LT D + R  + QV
Sbjct: 235 EGMYSEDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  109 bits (273), Expect = 1e-26
 Identities = 83/278 (29%), Positives = 128/278 (46%), Gaps = 32/278 (11%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+G+G +G  Y      TG+  A K I  R  + + + + +  E++I+ H +  P IV F
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEI--RLELDESKFNQIIMELDIL-HKAVSPYIVDF 64

Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFR-----VIMNVVNVCHSKG 154
             A+  +  V++ ME    G L D++ A G  +E     V R     V+  +  +     
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ---- 210
           ++HRD+KP N L      N  VK  DFG+S  +    A   I G   Y+APE +      
Sbjct: 124 IIHRDVKPTNVLVNG---NGQVKLCDFGVSGNLVASLAKTNI-GCQSYMAPERIKSGGPN 179

Query: 211 ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGV---AQAILKGEINFQRDPF---PS 261
              +Y  ++D+WS G+ +  +  G  P+  ET   +     AI+ G      DP      
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG------DPPTLPSG 233

Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA 299
            S  A + V + L + P RR T AQ+LEHPWL +   A
Sbjct: 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  109 bits (274), Expect = 1e-26
 Identities = 68/244 (27%), Positives = 118/244 (48%), Gaps = 9/244 (3%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG   L    S G  +A K + K+ ++K  E++ +  E  ++      P +V   
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
            +++  + ++ V++   GGELF  +     + E  A      + + +   HS  +++RDL
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122

Query: 161 KPENFLFTTGDENAVVKATDFGL-SAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKEADI 218
           KPEN L    D    V  TDFGL    +E  +      G+P Y+APEVL  + Y +  D 
Sbjct: 123 KPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179

Query: 219 WSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278
           W  G +LY +L G+PPF++     +   IL   +          + +A +L+  +L +D 
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLHKDQ 235

Query: 279 KRRI 282
           +RR+
Sbjct: 236 RRRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  109 bits (273), Expect = 1e-26
 Identities = 75/247 (30%), Positives = 128/247 (51%), Gaps = 15/247 (6%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR--HLSGQPN-IV 97
           +G+G FG   L     T   +A K + K  +++D   DDV   +   R   LSG+P  + 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD---DDVECTMVEKRVLALSGKPPFLT 64

Query: 98  QFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMH 157
           Q  + ++    ++ VME   GG+L  +I   G + E  A      I   +   HSKG+++
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIY 124

Query: 158 RDLKPENFLFTTGDENAVVKATDFGL-SAFIEEGKAYREIVGSPYYIAPEVLS-QSYGKE 215
           RDLK +N +    D    +K  DFG+    + +G   +   G+P YIAPE+++ Q YGK 
Sbjct: 125 RDLKLDNVML---DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKS 181

Query: 216 ADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT 275
            D W+ GV+LY +L G  PF  E +  + Q+I++  + + +    S+S  A+ + + ++T
Sbjct: 182 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMT 237

Query: 276 QDPKRRI 282
           + P +R+
Sbjct: 238 KHPGKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  108 bits (270), Expect = 1e-26
 Identities = 76/262 (29%), Positives = 131/262 (50%), Gaps = 14/262 (5%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           ++ I +++GRG+F   Y  T    G+  A K +    L+    + D  +EI++++ L+  
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-H 61

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRI----VARGHYSERAAASVFRVIMNVVNV 149
           PN++++ A++ +D  ++IV+EL   G+L   I      +    E+     F  + + +  
Sbjct: 62  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVGSPYYIAPEVL 208
            HS+ VMHRD+KP N   T      VVK  D GL  F   +  A   +VG+PYY++PE +
Sbjct: 122 MHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 209 SQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS--ISSS 265
            ++ Y  ++DIWS G +LY +     PF+   D+    ++ K        P PS   S  
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYSEE 236

Query: 266 AIELVRRMLTQDPKRRITVAQV 287
             +LV   +  DP++R  +  V
Sbjct: 237 LRQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  109 bits (273), Expect = 2e-26
 Identities = 70/244 (28%), Positives = 117/244 (47%), Gaps = 9/244 (3%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG   L    +    +A K + K+ ++K  E+  +  E  ++      P +V   
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
            +++    ++ V++   GGELF  +     + E  A      I + +   HS  +++RDL
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122

Query: 161 KPENFLFTTGDENAVVKATDFGL-SAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKEADI 218
           KPEN L    D    +  TDFGL    IE         G+P Y+APEVL  Q Y +  D 
Sbjct: 123 KPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179

Query: 219 WSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278
           W  G +LY +L G+PPF++     +   IL   +  +    P+I++SA  L+  +L +D 
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDR 235

Query: 279 KRRI 282
            +R+
Sbjct: 236 TKRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  107 bits (268), Expect = 2e-26
 Identities = 83/268 (30%), Positives = 130/268 (48%), Gaps = 21/268 (7%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREI---EIMRHLS 91
           Y I +++G G FG  YL    S       K I   K+    EK+  ++E+     M+H  
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKMKH-- 58

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARG-HYSERAAASVFRVIMNVVNV 149
             PNIV F A+++++  + IVME C GG+L  RI   RG  +SE    S F  I   +  
Sbjct: 59  --PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKH 116

Query: 150 CHSKGVMHRDLKPEN-FLFTTGDENAVVKATDFGLSAFIEEGKAY-REIVGSPYYIAPEV 207
            H + ++HRD+K +N FL   G    V K  DFG++  + +        VG+PYY++PE+
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNG---MVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEI 173

Query: 208 L-SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF-PSISSS 265
             ++ Y  + DIWS G +LY L     PF       +   I +G       P  P+ S  
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA----PISPNFSRD 229

Query: 266 AIELVRRMLTQDPKRRITVAQVLEHPWL 293
              L+ ++    P+ R ++  +L+ P+L
Sbjct: 230 LRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  108 bits (270), Expect = 2e-26
 Identities = 81/283 (28%), Positives = 138/283 (48%), Gaps = 38/283 (13%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + I   +G+G +G  Y  T    G   A K +     + DV+ +++  E  I++ L   P
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP---ISDVD-EEIEAEYNILQSLPNHP 79

Query: 95  NIVQFKAA-YEDDQFVH----IVMELCAGG---ELFDRIVARGHYSERAAAS--VFRVIM 144
           N+V+F    Y+ D+ V     +V+ELC GG   EL   ++  G   + A  S  ++  ++
Sbjct: 80  NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139

Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI-VGSPYYI 203
            + ++ H+  ++HRD+K  N L TT      VK  DFG+SA +   +  R   VG+P+++
Sbjct: 140 GLQHL-HNNRIIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 195

Query: 204 APEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
           APEV++       SY    D+WS G+    L  G PP +   D    + + K      R+
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF---DMHPVKTLFK----IPRN 248

Query: 258 PFPSI------SSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
           P P++        S    + + L +D + R +V  +LEHP++K
Sbjct: 249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  107 bits (269), Expect = 2e-26
 Identities = 74/264 (28%), Positives = 130/264 (49%), Gaps = 12/264 (4%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           R +G+G FG    C   +TG  +ACK + K+++ K   +     E +I+  ++ Q  +V 
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ-FVVN 64

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVCHSKGVM 156
              AYE    + +V+ +  GG+L   I   G+  + E  A      I+  +   H +  +
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124

Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKE 215
           +RDLKPEN L    D+   ++ +D GL+  I EG++ R  VG+  Y+APEVL +Q Y   
Sbjct: 125 YRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLS 181

Query: 216 ADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT 275
            D W  G ++Y ++ G  PF    ++   + + +  +  +       S  A  + + +LT
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT 241

Query: 276 QDPKRRI-----TVAQVLEHPWLK 294
           +DPK+R+        +V  HP+ +
Sbjct: 242 KDPKQRLGCQEEGAGEVKRHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  108 bits (272), Expect = 3e-26
 Identities = 92/310 (29%), Positives = 133/310 (42%), Gaps = 51/310 (16%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR--REIEIMRHLSG 92
           Y   + +GRG +GI      + T  + A K I       D   D  R  REI+++RHL  
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN---AFDNRIDAKRTLREIKLLRHLDH 63

Query: 93  QPNIVQFK--------AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
           + N++  K         A+ D   V+IV EL    +L   I +    S+         ++
Sbjct: 64  E-NVIAIKDIMPPPHREAFND---VYIVYEL-MDTDLHQIIRSSQTLSDDHCQYFLYQLL 118

Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYI 203
             +   HS  V+HRDLKP N L    + N  +K  DFGL+    E+G    E V + +Y 
Sbjct: 119 RGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSEKGDFMTEYVVTRWYR 175

Query: 204 APEVL--SQSYGKEADIWSAGVILYILLCGVPPFWA------------------ETDQGV 243
           APE+L     Y    D+WS G I   LL   P F                    E D G 
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235

Query: 244 -----AQAILKGEINFQRDPF----PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
                A+  ++      R  F    P  +  AI+L+ +ML  DP +RITV + L HP+L 
Sbjct: 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295

Query: 295 ESGEASDKPI 304
              + SD+P+
Sbjct: 296 SLHDPSDEPV 305

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  109 bits (273), Expect = 3e-26
 Identities = 82/294 (27%), Positives = 136/294 (46%), Gaps = 45/294 (15%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +GRG FG   L  +  TG  +A K + K  +++  +   +R E +I+    G   +V+  
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW-VVKMF 67

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
            +++D + ++++ME   GG++   ++ +   SE A        +  ++  H  G +HRD+
Sbjct: 68  YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDI 127

Query: 161 KPENFLFTTGDENAVVKATDFGLSAFIEEG---KAYREI--------------------- 196
           KP+N L    D    VK +DFGL   +++    + YR +                     
Sbjct: 128 KPDNLLL---DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184

Query: 197 ------------VGSPYYIAPEVLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGV 243
                       VG+P YIAPEV  Q+ Y K  D WS GVI+Y +L G PPF +ET Q  
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244

Query: 244 AQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI---TVAQVLEHPWLK 294
            + ++  +      P   IS  A +L+ R  T D + RI    V ++  HP+ +
Sbjct: 245 YRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFE 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  106 bits (266), Expect = 4e-26
 Identities = 77/269 (28%), Positives = 128/269 (47%), Gaps = 20/269 (7%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLE---FACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           Y + + +G+G FG  YL  +     E      K IP  +L    E     +E +++  L 
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGEL-NPNETVQANQEAQLLSKLD 60

Query: 92  GQPNIVQFKAAY-EDDQFVHIVMELCAGGELFDRIVARGH----YSERAAASVFRVIMNV 146
             P IV+F A++ E D F  I+ E C G +L  ++    H     SE      F  ++  
Sbjct: 61  -HPAIVKFHASFLERDAFC-IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118

Query: 147 VNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-KAYREIVGSPYYIAP 205
           V+  H + ++HRDLK +N       +N ++K  DFG+S  +           G+PYY++P
Sbjct: 119 VHYMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174

Query: 206 EVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
           E L  Q Y  ++DIWS G ILY + C    F  +    V   I++G      + +    +
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLN 234

Query: 265 SAIELVRRMLTQDPKRRITVAQVLEHPWL 293
           S   +++ ML +DP  R + A++L +P++
Sbjct: 235 S---IMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  108 bits (271), Expect = 5e-26
 Identities = 99/345 (28%), Positives = 151/345 (43%), Gaps = 65/345 (18%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIP--------KRKLVKDVEKDDV 80
            DV   Y     +G G +G+    T   TG++ A K I         +R L         
Sbjct: 1   FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL--------- 51

Query: 81  RREIEIMRHLSGQPNIVQFKA-----AYEDDQFVHIVMELCAGGELFDRIVARGHYSERA 135
            REI+I+R    + NI+         ++E    V+IV EL    +L+ +++   H S   
Sbjct: 52  -REIKILRRFKHE-NIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDH 107

Query: 136 AASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR- 194
                  I+  +   HS  V+HRDLKP N L  T   N  +K  DFGL+   +    +  
Sbjct: 108 IQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT---NCDLKICDFGLARIADPEHDHTG 164

Query: 195 ---EIVGSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ-----G 242
              E V + +Y APE++  S+ Y K  DIWS G IL  +L   P F  +    Q     G
Sbjct: 165 FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILG 224

Query: 243 V----------------AQAILKGEINFQRDP----FPSISSSAIELVRRMLTQDPKRRI 282
           V                A+  +K      + P    FP+    A++L+ +MLT +P +RI
Sbjct: 225 VLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI 284

Query: 283 TVAQVLEHPWLKESGEASDKPIDTAVI-FRMKQFTAMNK--LKKL 324
           TV + L HP+L++  + SD+P+      F  + F  + K  LK+L
Sbjct: 285 TVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELFDDLPKEKLKEL 329

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  107 bits (270), Expect = 5e-26
 Identities = 74/244 (30%), Positives = 118/244 (48%), Gaps = 9/244 (3%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG   L    + G  +A K + K+ ++K  E+  +  E  ++      P +V   
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
            +++    ++ V++   GGELF  +     + E  A      I + +   HS  +++RDL
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122

Query: 161 KPENFLFTTGDENAVVKATDFGL-SAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKEADI 218
           KPEN L    D    V  TDFGL    IE  K      G+P Y+APEVL  Q Y +  D 
Sbjct: 123 KPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179

Query: 219 WSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278
           W  G +LY +L G+PPF++     +   IL   +  +    P+IS SA  L+  +L +D 
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQKDR 235

Query: 279 KRRI 282
            +R+
Sbjct: 236 TKRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  107 bits (268), Expect = 8e-26
 Identities = 72/260 (27%), Positives = 123/260 (47%), Gaps = 13/260 (5%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG      +  T   +A K+I K  +V   E      E  ++  ++  P IV  K
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLK 59

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
            +++  + +++V+    GGELF  +   G +    A      ++  +   H   V++RDL
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119

Query: 161 KPENFLFTTGDENAVVKATDFGLSAF-IEEGKAYREIVGSPYYIAPEVLS-QSYGKEADI 218
           KPEN L    D    +   DFGL    +++        G+P Y+APE+L    Y K  D 
Sbjct: 120 KPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176

Query: 219 WSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278
           W+ GV+LY +L G+PPF+ E    + + IL+  + F           A +L+  +L++DP
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDP 232

Query: 279 KRRITVA---QVLEHPWLKE 295
            RR+      ++  HP+  +
Sbjct: 233 TRRLGYNGAQEIKNHPFFSQ 252

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  107 bits (269), Expect = 8e-26
 Identities = 93/346 (26%), Positives = 147/346 (42%), Gaps = 58/346 (16%)

Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRH 89
           DV   Y     +G G +G+     +  +G + A K IP    V  + K  +R E++I+RH
Sbjct: 2   DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRH 60

Query: 90  LSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
                NI+      +    D + V++VM+L    +L   I +    +E         ++ 
Sbjct: 61  FK-HDNIIAIRDILRPPGADFKDVYVVMDL-MESDLHHIIHSDQPLTEEHIRYFLYQLLR 118

Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG----LSAFIEEGKAY-REIVGSP 200
            +   HS  V+HRDLKP N L    +E+  ++  DFG    LS+   E K +  E V + 
Sbjct: 119 GLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 201 YYIAPEVL--SQSYGKEADIWSAGVI---------------------LYILLCGVPPFWA 237
           +Y APE+L     Y    D+WS G I                     L + + G P    
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS--- 232

Query: 238 ETDQGVAQAI----LKGEI-NFQRDP-------FPSISSSAIELVRRMLTQDPKRRITVA 285
              + V   I    ++  I N  R         FP  S  A++L+ +ML  DP+ RITV 
Sbjct: 233 ---EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVE 289

Query: 286 QVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVE 331
           Q L+HP+L +  +  D+P      F    F A+   ++   + IV+
Sbjct: 290 QALQHPFLAQYHDPDDEP-TCPPPFDFD-FEAIELSREQLKEAIVK 333

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  106 bits (267), Expect = 9e-26
 Identities = 88/307 (28%), Positives = 129/307 (42%), Gaps = 59/307 (19%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD----DVRREIEIMRH 89
            + I  ++G G +G  Y   +  TG   A K     K+  D EK+       REI+I+R 
Sbjct: 8   KFDIIGQIGEGTYGQVYKARDKDTGELVALK-----KVRLDNEKEGFPITAIREIKILRQ 62

Query: 90  LSGQPNIVQFKAAYEDDQ-------------FVHIVMELCAGGELFDRIVARGHYSERAA 136
           L+   NIV  K    D Q              V   M+    G L   +V   H+SE   
Sbjct: 63  LN-HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV---HFSEDHI 118

Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI--EEGKAYR 194
            S  + ++  +N CH K  +HRD+K  N L     +   +K  DFGL+     EE + Y 
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEESRPYT 175

Query: 195 EIVGSPYYIAPEVL--SQSYGKEADIWSAGVILYIL---------------------LCG 231
             V + +Y  PE+L   + YG   D+WS G IL  L                     LCG
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235

Query: 232 --VPPFWAETDQGVAQAILKGEINFQR---DPFPSISSSAIELVRRMLTQDPKRRITVAQ 286
              P  W +  +      +K +  ++R   + F  I + A++L+  MLT DP +R T  +
Sbjct: 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE 295

Query: 287 VLEHPWL 293
            L  PWL
Sbjct: 296 ALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  107 bits (267), Expect = 1e-25
 Identities = 71/260 (27%), Positives = 120/260 (46%), Gaps = 13/260 (5%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG   L      G  +A K + K+ ++   E+  +  E  ++      P +V   
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
            +++  + ++ V++   GGELF  +     + E  A      I + +   HS  +++RDL
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122

Query: 161 KPENFLFTTGDENAVVKATDFGL-SAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKEADI 218
           KPEN L    D    V  TDFGL    I +        G+P Y+APEV+  Q Y    D 
Sbjct: 123 KPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDW 179

Query: 219 WSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278
           W  G +LY +L G+PPF+      +   IL   +  +    P  S +A  ++  +L +D 
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLEKDR 235

Query: 279 KRRITVA----QVLEHPWLK 294
           +RR+       ++ EHP+ +
Sbjct: 236 QRRLGAKEDFLEIQEHPFFE 255

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  103 bits (258), Expect = 5e-25
 Identities = 72/261 (27%), Positives = 126/261 (48%), Gaps = 10/261 (3%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + I +++GRG+F   Y  T        A K +   +++    + D  +EI++++ L+  P
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HP 62

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIV----ARGHYSERAAASVFRVIMNVVNVC 150
           N++++  ++ +D  ++IV+EL   G+L   I      +    ER     F  + + V   
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVGSPYYIAPEVLS 209
           HS+ VMHRD+KP N   T      VVK  D GL  F   +  A   +VG+PYY++PE + 
Sbjct: 123 HSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 210 QS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
           ++ Y  ++DIWS G +LY +     PF+ +     +      + ++   P    S    E
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239

Query: 269 LVRRMLTQDPKRRITVAQVLE 289
           LV   +  DP +R  +  V +
Sbjct: 240 LVSMCIYPDPDQRPDIGYVHQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  103 bits (260), Expect = 8e-25
 Identities = 79/293 (26%), Positives = 124/293 (42%), Gaps = 48/293 (16%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPNI 96
           +G G +GI Y   + ++G   A K     K+  D E+D +     REI ++ +L   PNI
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALK-----KVRMDNERDGIPISSLREITLLLNLR-HPNI 68

Query: 97  VQFKAAYEDDQF--VHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
           V+ K          + +VME C      L D +     +SE     +   ++  +   H 
Sbjct: 69  VELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYLHE 126

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--S 209
             ++HRDLK  N L T   +   +K  DFGL+  +    K     V + +Y APE+L   
Sbjct: 127 NFIIHRDLKVSNLLLT---DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGC 183

Query: 210 QSYGKEADIWSAGVILYILLCGVP--PFWAETDQ-----------------------GVA 244
            +Y    D+W+ G IL  LL   P  P  +E +Q                        V 
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243

Query: 245 QAILKGE-INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
           +  L  +  N  +  FP +S + + L+  +L  DPK+R T  + LE  + KE 
Sbjct: 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|185504 PTZ00184, PTZ00184, calmodulin; Provisional

 Score = 99.5 bits (248), Expect = 9e-25
 Identities = 56/150 (37%), Positives = 86/150 (57%), Gaps = 7/150 (4%)

Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           + + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DG
Sbjct: 1   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60

Query: 389 NGTIDYIEFITATMQRHKLQRF---ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDD 445
           NGTID+ EF+T  M R K++     E + +AF+ FD+D NG+I+  EL     +  +G+ 
Sbjct: 61  NGTIDFPEFLT-LMAR-KMKDTDSEEEIKEAFKVFDRDGNGFISAAELRHVMTN--LGEK 116

Query: 446 ATIATIKEIMSEVDRDKDGRISYDEFRSMM 475
            T   + E++ E D D DG+I+Y+EF  MM
Sbjct: 117 LTDEEVDEMIREADVDGDGQINYEEFVKMM 146

Length = 149

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  102 bits (257), Expect = 1e-24
 Identities = 76/267 (28%), Positives = 131/267 (49%), Gaps = 22/267 (8%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG    C   +TG  +ACK + K++L K   +     E +I+  +S    IV   
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLA 59

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVF---RVIMNVVNVCHSKGVMH 157
            A+E    + +VM L  GG+L   I   G      A ++F   ++I  + ++ H + +++
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHL-HQRRIVY 118

Query: 158 RDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKEA 216
           RDLKPEN L    D++  V+ +D GL+  ++ GK  +   G+P Y+APEVL  + Y    
Sbjct: 119 RDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSV 175

Query: 217 DIWSAGVILYILLCGVPPFWAE----TDQGVAQAILKGEINFQRDPFPSISSSAIELVRR 272
           D ++ G  LY ++ G  PF         + + +  L+  + +        S  A +L   
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDK----FSPEAKDLCEA 231

Query: 273 MLTQDPKRRI-----TVAQVLEHPWLK 294
           +L +DP++R+     +  +V EHP  K
Sbjct: 232 LLQKDPEKRLGCRGGSADEVREHPLFK 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  103 bits (258), Expect = 2e-24
 Identities = 76/269 (28%), Positives = 128/269 (47%), Gaps = 26/269 (9%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG   L     T   +A K + K  +++D + D    E  I+   +  P +    
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIV-ARGHYSERA---AASVFRVIMNVVNVCHSKGVM 156
             ++    +  VME   GG+L  +I  +R     R+   AA V   +M      H  GV+
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALM----FLHRHGVI 118

Query: 157 HRDLKPENFLFTTGDENAVVKATDFGL-SAFIEEGKAYREIVGSPYYIAPEVLS-QSYGK 214
           +RDLK +N L    D     K  DFG+    I  G       G+P YIAPE+L    YG 
Sbjct: 119 YRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGP 175

Query: 215 EADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRM 273
             D W+ GV++Y ++ G PPF A+ +  + ++IL  ++      +P  +S  A+ +++  
Sbjct: 176 SVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV-----LYPVWLSKEAVSILKAF 230

Query: 274 LTQDPKRRI--TVAQ-----VLEHPWLKE 295
           +T++P +R+    +Q     + +HP+ KE
Sbjct: 231 MTKNPNKRLGCVASQGGEDAIKQHPFFKE 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|227455 COG5126, FRQ1, Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]

 Score = 98.5 bits (246), Expect = 3e-24
 Identities = 53/148 (35%), Positives = 85/148 (57%), Gaps = 8/148 (5%)

Query: 332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGT 391
            L  E+IQ+LKE F   D D+ G +  +EL   L  LG   +E ++   +      GN T
Sbjct: 13  QLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEI-NKLFEEIDAGNET 71

Query: 392 IDYIEFITATMQRHKLQRF---ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           +D+ EF+T  M   KL+R    E L +AF+ FDKD++GYI++ EL +  K   +G+  + 
Sbjct: 72  VDFPEFLTV-MSV-KLKRGDKEEELREAFKLFDKDHDGYISIGELRRVLK--SLGERLSD 127

Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMMK 476
             +++++ E D D DG I Y+EF+ ++K
Sbjct: 128 EEVEKLLKEYDEDGDGEIDYEEFKKLIK 155

Length = 160

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  105 bits (262), Expect = 3e-24
 Identities = 74/215 (34%), Positives = 112/215 (52%), Gaps = 30/215 (13%)

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH----YSERAAASVFRVIMNVVNVCH 151
           IV+    ++ D  + ++ME  +GG+L  +I  R      + E     +F  I+  ++  H
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186

Query: 152 SKGVMHRDLKPEN-FLFTTGDENAVVKATDFGLSAFIEEGKAYREIV---------GSPY 201
           S+ +MHRDLK  N FL  TG    ++K  DFG S      K Y + V         G+PY
Sbjct: 187 SRKMMHRDLKSANIFLMPTG----IIKLGDFGFS------KQYSDSVSLDVASSFCGTPY 236

Query: 202 YIAPEVLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
           Y+APE+  +  Y K+AD+WS GVILY LL    PF   + + + Q +L G    + DPFP
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG----KYDPFP 292

Query: 261 -SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
             +SS    L+  +L+++P  R T  Q+L   +LK
Sbjct: 293 CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327

Length = 478

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  101 bits (252), Expect = 4e-24
 Identities = 87/271 (32%), Positives = 129/271 (47%), Gaps = 25/271 (9%)

Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD---VRREIEIMR 88
           Q  Y + + VG G +G  Y      TG       +   K++K    DD   +++EI +++
Sbjct: 8   QHDYELIQRVGSGTYGDVYKARNLHTG------ELAAVKIIKLEPGDDFSLIQQEIFMVK 61

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVN 148
                 NIV +  +Y   + + I ME C GG L D     G  SE   A V R  +  + 
Sbjct: 62  ECK-HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLA 120

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEV 207
             HSKG MHRD+K  N L T   +N  VK  DFG++A I    A R+  +G+PY++APEV
Sbjct: 121 YLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177

Query: 208 LS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAI-LKGEINFQRDPFP-- 260
            +      Y +  DIW+ G+    L    PP +   D    +A+ L  + NFQ       
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPMF---DLHPMRALFLMSKSNFQPPKLKDK 234

Query: 261 -SISSSAIELVRRMLTQDPKRRITVAQVLEH 290
              SS+    V+  LT++PK+R T  ++L H
Sbjct: 235 TKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  101 bits (254), Expect = 4e-24
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 24/216 (11%)

Query: 28  YEDVQLHYTIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           +E   L +   +++G G FG   LC      ++TG + A KS        +  + D  RE
Sbjct: 1   FEKRHLKFI--KQLGEGHFGKVELCRYDPLGDNTGEQVAVKS-LNHSGE-EQHRSDFERE 56

Query: 84  IEIMRHLSGQPNIVQFKA-AYEDDQFVH-IVMELCAGGELFDRIVARGHYSERAAASVFR 141
           IEI+R L    NIV++K    +       ++ME    G L  R   + H  +     +  
Sbjct: 57  IEILRTLD-HENIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRHRDQINLKRLLL 113

Query: 142 V---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY---RE 195
               I   ++   S+  +HRDL   N L    +   +VK +DFGL+  + E K Y   +E
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYYYVKE 170

Query: 196 IVGSP-YYIAPEVLSQS-YGKEADIWSAGVILYILL 229
              SP ++ APE L  S +   +D+WS GV LY L 
Sbjct: 171 PGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  100 bits (252), Expect = 5e-24
 Identities = 78/273 (28%), Positives = 128/273 (46%), Gaps = 35/273 (12%)

Query: 36  TIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
            +G+++G G FG  Y  T       T  + A K++  ++   + E+++   E  IM+ LS
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL--KEGASEEEREEFLEEASIMKKLS 59

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC- 150
             PNIV+        + ++IV E   GG+L D +   G        ++  ++   + +  
Sbjct: 60  -HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE-----KLTLKDLLQMALQIAK 113

Query: 151 -----HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---Y 202
                 SK  +HRDL   N L     EN VVK +DFGLS  I E   YR+  G      +
Sbjct: 114 GMEYLESKNFVHRDLAARNCLV---TENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKW 170

Query: 203 IAPEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
           +APE L    GK   ++D+WS GV+L+ I   G  P+   +++ V + +  G     R P
Sbjct: 171 MAPESL--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGY----RLP 224

Query: 259 FPSISSSAI-ELVRRMLTQDPKRRITVAQVLEH 290
            P      + EL+ +    DP+ R T ++++E 
Sbjct: 225 RPENCPDELYELMLQCWAYDPEDRPTFSELVED 257

Length = 258

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  100 bits (251), Expect = 5e-24
 Identities = 73/265 (27%), Positives = 130/265 (49%), Gaps = 20/265 (7%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +T    +G+G FG  +   +N T    A K I   +   ++E  D+++EI ++      P
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIE--DIQQEITVLSQCD-SP 62

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
            + ++  +Y     + I+ME   GG   D + A G + E   A++ + I+  ++  HS+ 
Sbjct: 63  YVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK 121

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLSQS-Y 212
            +HRD+K  N L +   E   VK  DFG++  + + +  R   VG+P+++APEV+ QS Y
Sbjct: 122 KIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAY 178

Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI----SSSAIE 268
             +ADIWS G+    L  G PP    +D    + +        ++  P++    S    E
Sbjct: 179 DSKADIWSLGITAIELAKGEPP---NSDMHPMRVLF----LIPKNNPPTLTGEFSKPFKE 231

Query: 269 LVRRMLTQDPKRRITVAQVLEHPWL 293
            +   L +DP  R T  ++L+H ++
Sbjct: 232 FIDACLNKDPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  100 bits (252), Expect = 6e-24
 Identities = 82/293 (27%), Positives = 125/293 (42%), Gaps = 43/293 (14%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHL 90
           YT   ++G G +G+ Y      TG   A K I   +L  + E++ V     REI +++ L
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI---RL--ESEEEGVPSTAIREISLLKEL 56

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMEL--CAGGELFDRIVARGHYSERAAASVFRVIMNVVN 148
              PNIV  +     +  ++++ E       +  D +    +       S    I+  + 
Sbjct: 57  Q-HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEV 207
            CHS+ V+HRDLKP+N L    D   V+K  DFGL+ AF    + Y   V + +Y APEV
Sbjct: 116 FCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEV 172

Query: 208 L--SQSYGKEADIWSAGVILYILLCGVPPFW--AETDQ-----------------GVAQ- 245
           L  S  Y    DIWS G I   +    P F   +E DQ                 GV   
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232

Query: 246 -----AILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
                   K +    R    ++    ++L+ +ML  DP +RI+  + L HP+ 
Sbjct: 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  100 bits (251), Expect = 7e-24
 Identities = 81/284 (28%), Positives = 132/284 (46%), Gaps = 40/284 (14%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           VG G +G+   C    T    A K     +  ++V K+   RE++++R L  Q NIV+ K
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEV-KETTLRELKMLRTLK-QENIVELK 66

Query: 101 AAYEDDQFVHIVMELCAGG--ELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            A+     +++V E       EL + +   G   E+  + ++++I   ++ CH   ++HR
Sbjct: 67  EAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQLI-KAIHWCHKNDIVHR 124

Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--AYREIVGSPYYIAPE-VLSQSYGKE 215
           D+KPEN L +  D   V+K  DFG +  + EG    Y E V + +Y +PE +L   YGK 
Sbjct: 125 DIKPENLLISHND---VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181

Query: 216 ADIWSAGVILYILLCGVPPFWAETD-------QGVAQAILKGEIN-FQRDP------FPS 261
            D+WS G IL  L  G P F  E++       Q V   +   ++  F  +P      FP+
Sbjct: 182 VDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPA 241

Query: 262 --------------ISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
                         +S   ++L++ +L  +P  R    Q L HP
Sbjct: 242 VNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  100 bits (252), Expect = 7e-24
 Identities = 78/283 (27%), Positives = 131/283 (46%), Gaps = 37/283 (13%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           VG G +G+   C    TG   A K   + +  K V+K  +R EI +++ L  + N+V   
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHE-NLVNLI 66

Query: 101 AAYEDDQFVHIVMELCAGGELFD-RIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRD 159
             +   + +++V E      L D      G    R    +F+++   +  CHS  ++HRD
Sbjct: 67  EVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQIL-RGIEFCHSHNIIHRD 125

Query: 160 LKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREIVGSPYYIAPEVL--SQSYGKEA 216
           +KPEN L +   ++ VVK  DFG +  +   G+ Y + V + +Y APE+L     YG+  
Sbjct: 126 IKPENILVS---QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAV 182

Query: 217 DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN--------FQRDP---------- 258
           DIW+ G ++  +L G P F  ++D      I+K   N        FQ++P          
Sbjct: 183 DIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEV 242

Query: 259 ---------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
                    FP +S   ++L ++ L  DP  R + +Q+L H +
Sbjct: 243 KEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  105 bits (262), Expect = 7e-24
 Identities = 86/296 (29%), Positives = 138/296 (46%), Gaps = 41/296 (13%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + +++G G FG  +L     T   F  K+I  R L K+ EK  +  E+ +MR L    
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELK-HK 72

Query: 95  NIVQFKAAY--EDDQFVHIVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVN 148
           NIV++   +  + +Q ++I+ME C  G+L   I       G   E A   + R +++ + 
Sbjct: 73  NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132

Query: 149 VCHS-------KGVMHRDLKPENFLFTTG--------------DENAVVKATDFGLSAFI 187
            CH+       + V+HRDLKP+N   +TG              +   + K  DFGLS  I
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192

Query: 188 EEGKAYREIVGSPYYIAPEVL---SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVA 244
                    VG+PYY +PE+L   ++SY  ++D+W+ G I+Y L  G  PF    +   +
Sbjct: 193 GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN--FS 250

Query: 245 QAILKGEINFQRDPFPSISSSAIE---LVRRMLTQDPKRRITVAQVLEHPWLKESG 297
           Q I +     +R P   I   + E   L++ +L    K R +  Q L +  +K  G
Sbjct: 251 QLISE----LKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302

Length = 1021

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  101 bits (253), Expect = 1e-23
 Identities = 82/324 (25%), Positives = 130/324 (40%), Gaps = 60/324 (18%)

Query: 37  IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD-----------VRREIE 85
            G  +G G +G      +  TG   A K +   ++  DV KD              RE++
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           IM  +    NI+     Y +  F+++VM++ A  +L   +  +   +E     +   I+N
Sbjct: 73  IMNEIK-HENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILN 130

Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-----------AFIEEGKAYR 194
            +NV H    MHRDL P N      +   + K  DFGL+              +E    R
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFI---NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 195 EIVGSP----YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE---------- 238
           E + S     +Y APE+L  ++ Y    D+WS G I   LL G P F  E          
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247

Query: 239 ------TDQGVAQAI---LKGEINFQ-----RDPFPSISSSAIELVRRMLTQDPKRRITV 284
                  +    QA    L  E   +     +  FP+ S  AI+L++ +L  +P  RI+ 
Sbjct: 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA 307

Query: 285 AQVLEHPWLKESG---EASDKPID 305
            + L+H + K      + S  P +
Sbjct: 308 KEALKHEYFKSDPLPCDPSQLPFN 331

Length = 335

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 99.8 bits (248), Expect = 1e-23
 Identities = 77/265 (29%), Positives = 131/265 (49%), Gaps = 20/265 (7%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +T   ++G+G FG  +   +N T    A K I   +   ++E  D+++EI ++      P
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE--DIQQEITVLSQCD-SP 62

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
            + ++  +Y  D  + I+ME   GG   D ++  G   E   A++ R I+  ++  HS+ 
Sbjct: 63  YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEK 121

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLSQS-Y 212
            +HRD+K  N L +   E+  VK  DFG++  + + +  R   VG+P+++APEV+ QS Y
Sbjct: 122 KIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI----SSSAIE 268
             +ADIWS G+    L  G PP        V   I K       +P P++    S    E
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN------NP-PTLEGNYSKPLKE 231

Query: 269 LVRRMLTQDPKRRITVAQVLEHPWL 293
            V   L ++P  R T  ++L+H ++
Sbjct: 232 FVEACLNKEPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 99.7 bits (248), Expect = 2e-23
 Identities = 80/294 (27%), Positives = 138/294 (46%), Gaps = 36/294 (12%)

Query: 22  AILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR 81
            I+  ++ D    + I   +G+G +G  +       G + A K +     + D++ +++ 
Sbjct: 7   TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP---IHDID-EEIE 62

Query: 82  REIEIMRHLSGQPNIVQFKAAYEDDQFVH-----IVMELCAGGELFDRI---VARG-HYS 132
            E  I++ LS  PN+V+F   Y      +     +V+ELC GG + D +   + RG    
Sbjct: 63  AEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERME 122

Query: 133 ERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192
           E   A +    +  +   H    +HRD+K  N L TT      VK  DFG+SA +   + 
Sbjct: 123 EPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRL 179

Query: 193 YREI-VGSPYYIAPEV------LSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQ 245
            R   VG+P+++APEV      L  +Y    D+WS G+    L  G PP     D    +
Sbjct: 180 RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMR 236

Query: 246 AILKGEINFQRDPFPSI------SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
           A+ K      R+P P++      S+   + +R+ LT+D ++R TV+ +L+H ++
Sbjct: 237 ALFK----IPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 81/293 (27%), Positives = 127/293 (43%), Gaps = 57/293 (19%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPNI 96
           +G G +G+ + C    TG   A K     K V+  +   ++    REI +++ L   PN+
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLKQLK-HPNL 62

Query: 97  VQFKAAYEDDQFVHIVMELCAGGELFDRIV-------ARGHYSERAAASVFRVIMNVVNV 149
           V     +   + +H+V E C      D  V        RG   E     +    +  VN 
Sbjct: 63  VNLIEVFRRKRKLHLVFEYC------DHTVLNELEKNPRG-VPEHLIKKIIWQTLQAVNF 115

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEVL 208
           CH    +HRD+KPEN L T   +   +K  DFG +  +   G  Y + V + +Y APE+L
Sbjct: 116 CHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELL 172

Query: 209 --SQSYGKEADIWSAGVILYILLCGVP--PFWAETDQ------GVAQAILKGEINFQ--- 255
                YG   D+W+ G +   LL G P  P  ++ DQ       +   I + +  F    
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232

Query: 256 ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
                       R+P    FP+ISS A+  ++  L  DP  R++  ++LEHP+
Sbjct: 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 76/270 (28%), Positives = 120/270 (44%), Gaps = 29/270 (10%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+G G  G  Y      TG   A K +  R   K+ E   +  +++++      P IV+ 
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQMR-RTGNKE-ENKRILMDLDVVLKSHDCPYIVKC 79

Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSK-GVM 156
              +  D  V I MEL +     D+++ R  G   E     +   I+  ++    K GV+
Sbjct: 80  YGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVI 137

Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-----QS 211
           HRD+KP N L    D +  VK  DFG+S  + + KA     G   Y+APE +        
Sbjct: 138 HRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPK 194

Query: 212 YGKEADIWSAGVILYILLCGVPPF-WAETDQGVAQAILKGEINFQRDPFPSISSSA---- 266
           Y   AD+WS G+ L  L  G  P+   +T+  V   IL      Q +P PS+  +     
Sbjct: 195 YDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL------QEEP-PSLPPNEGFSP 247

Query: 267 --IELVRRMLTQDPKRRITVAQVLEHPWLK 294
                V   LT+D ++R    ++L+HP+++
Sbjct: 248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  100 bits (250), Expect = 2e-23
 Identities = 77/259 (29%), Positives = 126/259 (48%), Gaps = 12/259 (4%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG   L     T   FA K++ K  +++D + +    E  ++      P +    
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
             ++  + +  VME   GG+L   I + G + E  A      I+  +   H KG+++RDL
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDL 122

Query: 161 KPENFLFTTGDENAVVKATDFGLSA--FIEEGKAYREIVGSPYYIAPEVL-SQSYGKEAD 217
           K +N L    D++  +K  DFG+       EGKA     G+P YIAPE+L  Q Y +  D
Sbjct: 123 KLDNVLL---DKDGHIKIADFGMCKENMNGEGKA-STFCGTPDYIAPEILKGQKYNESVD 178

Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD 277
            WS GV+LY +L G  PF  E +  +  +IL    +F R     IS  A + + ++  +D
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR----WISKEAKDCLSKLFERD 234

Query: 278 PKRRITVA-QVLEHPWLKE 295
           P +R+ V   + +HP+ + 
Sbjct: 235 PTKRLGVDGDIRQHPFFRG 253

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 2e-23
 Identities = 79/276 (28%), Positives = 132/276 (47%), Gaps = 40/276 (14%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +GRG FG   +    +TG  +A K + K +++K  E    R E +++ +   +  I    
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW-ITNLH 67

Query: 101 AAYEDDQFVHIVMELCAGGELF-------DRI---VARGHYSERAAASVFRVIMNVVNVC 150
            A++D+  +++VM+   GG+L        DR+   +AR + +E   A         ++  
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLA---------IDSV 118

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE--IVGSPYYIAPEVL 208
           H  G +HRD+KP+N L    D+N  ++  DFG    +      +    VG+P YI+PE+L
Sbjct: 119 HQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEIL 175

Query: 209 SQ------SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS- 261
                    YG E D WS GV +Y +L G  PF+AE+       I+  + +FQ   FP  
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ---FPPD 232

Query: 262 ---ISSSAIELVRRMLTQDPKR--RITVAQVLEHPW 292
              +S  A +L+RR++     R  R  +    +HP+
Sbjct: 233 VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  100 bits (249), Expect = 3e-23
 Identities = 76/274 (27%), Positives = 130/274 (47%), Gaps = 20/274 (7%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS---GQPNIV 97
           +G+G FG  +L     T   FA K++ K  ++ D   DDV   +   R LS     P + 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD---DDVECTMVEKRVLSLAWEHPFLT 59

Query: 98  QFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMH 157
                ++  + +  VME   GG+L   I +   +    A      I+  +   HSKG+++
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVY 119

Query: 158 RDLKPENFLFTTGDENAVVKATDFGL--SAFIEEGKAYREIVGSPYYIAPEVL-SQSYGK 214
           RDLK +N L    D +  +K  DFG+     + + K      G+P YIAPE+L  Q Y  
Sbjct: 120 RDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKT-CTFCGTPDYIAPEILLGQKYNT 175

Query: 215 EADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRML 274
             D WS GV+LY +L G  PF    ++ + Q+I      + R     ++  A +++ ++ 
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR----WLTREAKDILVKLF 231

Query: 275 TQDPKRRITV-AQVLEHPWLKES--GEASDKPID 305
            ++P+RR+ V   + +HP+ +E       ++ I+
Sbjct: 232 VREPERRLGVKGDIRQHPFFREIDWSALEEREIE 265

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 98.4 bits (245), Expect = 4e-23
 Identities = 79/262 (30%), Positives = 124/262 (47%), Gaps = 18/262 (6%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G +GI Y   + ST +  A K IP+R          +  EI +  +L    NIVQ+ 
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLK-HRNIVQYL 71

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVAR-GHYSERAAASVF--RVIMNVVNVCHSKGVMH 157
            +  ++ F  I ME   GG L   + ++ G   +     +F  + I+  +   H   ++H
Sbjct: 72  GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131

Query: 158 RDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLSQS---YG 213
           RD+K +N L  T   + VVK +DFG S  +       E   G+  Y+APEV+ +    YG
Sbjct: 132 RDIKGDNVLVNT--YSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYG 189

Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP-FP-SISSSAIELVR 271
             ADIWS G  +  +  G PPF    + G  QA +     F+  P  P S+S+ A   + 
Sbjct: 190 APADIWSLGCTIVEMATGKPPF---IELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246

Query: 272 RMLTQDPKRRITVAQVLEHPWL 293
           R    DP +R +   +L+ P+L
Sbjct: 247 RCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 98.6 bits (245), Expect = 4e-23
 Identities = 78/265 (29%), Positives = 128/265 (48%), Gaps = 20/265 (7%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +T    +G+G FG  Y   +N T    A K I   +   ++E  D+++EI ++      P
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIE--DIQQEITVLSQCD-SP 62

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
            I ++  +Y     + I+ME   GG   D ++  G   E   A++ R I+  ++  HS+ 
Sbjct: 63  YITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSER 121

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLSQS-Y 212
            +HRD+K  N L +   E   VK  DFG++  + + +  R   VG+P+++APEV+ QS Y
Sbjct: 122 KIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI----SSSAIE 268
             +ADIWS G+    L  G PP        V   I K       +  P++    S    E
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK-------NSPPTLEGQYSKPFKE 231

Query: 269 LVRRMLTQDPKRRITVAQVLEHPWL 293
            V   L +DP+ R T  ++L+H ++
Sbjct: 232 FVEACLNKDPRFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 99.7 bits (249), Expect = 5e-23
 Identities = 88/320 (27%), Positives = 137/320 (42%), Gaps = 48/320 (15%)

Query: 23  ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR 82
            L K   +V   Y     VG G +G      +  TG + A K +  R     +      R
Sbjct: 5   ELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL-SRPFQSAIHAKRTYR 63

Query: 83  EIEIMRHLSGQPNIVQ----FKAAYEDDQF--VHIVMELCAGGELFDRIVARGHYSERAA 136
           E+ +++H+    N++     F  A   + F  V++V  L  G +L + IV     S+   
Sbjct: 64  ELRLLKHMD-HENVIGLLDVFTPASSLEDFQDVYLVTHL-MGADL-NNIVKCQKLSDDHI 120

Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYRE 195
             +   I+  +   HS G++HRDLKP N      +E+  +K  DFGL+   + E   Y  
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLARHTDDEMTGY-- 175

Query: 196 IVGSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ--------GV 243
            V + +Y APE++     Y +  DIWS G I+  LL G   F      DQ        G 
Sbjct: 176 -VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234

Query: 244 AQAILKGEI------------------NFQRDPFPSISSSAIELVRRMLTQDPKRRITVA 285
               L  +I                  +F ++ F   +  AI+L+ +ML  DP +RIT A
Sbjct: 235 PDEELLQKISSESARNYIQSLPQMPKKDF-KEVFSGANPLAIDLLEKMLVLDPDKRITAA 293

Query: 286 QVLEHPWLKESGEASDKPID 305
           + L HP+L E  +  D+P+ 
Sbjct: 294 EALAHPYLAEYHDPEDEPVA 313

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 98.0 bits (244), Expect = 5e-23
 Identities = 67/270 (24%), Positives = 124/270 (45%), Gaps = 17/270 (6%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDV----RREIEIMRH 89
            +  G+++G G F   Y   +  TG   A K +   +     E+++V    R+EI +M  
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSS-EQEEVVEALRKEIRLMAR 59

Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
           L+  P+I++   A  +D   ++ +E  AGG +   +   G + E    +    ++  ++ 
Sbjct: 60  LN-HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSY 118

Query: 150 CHSKGVMHRDLKPENFLF-TTGDENAVVKATDFGLSAFIEE-----GKAYREIVGSPYYI 203
            H   ++HRD+K  N L  +TG     ++  DFG +A +       G+   +++G+  ++
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQR---LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175

Query: 204 APEVL-SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
           APEVL  + YG+  D+WS G ++  +    PP+ AE        I K          P  
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH 235

Query: 263 SSSAI-ELVRRMLTQDPKRRITVAQVLEHP 291
            S  + ++  R L   P+ R    ++L+HP
Sbjct: 236 LSPGLRDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 99.7 bits (248), Expect = 5e-23
 Identities = 73/277 (26%), Positives = 124/277 (44%), Gaps = 41/277 (14%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +GRG FG   L  +  TG  +A K + K  +++  +   +R E +I+   +    +V+  
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-ADSLWVVKMF 67

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
            +++D   ++++ME   GG++   ++ +   +E          +  ++  H  G +HRD+
Sbjct: 68  YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDI 127

Query: 161 KPENFLFTTGDENAVVKATDFGLSAFIEEG---KAYREI--------------------- 196
           KP+N L    D    VK +DFGL   +++    + YR +                     
Sbjct: 128 KPDNLLL---DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184

Query: 197 ------------VGSPYYIAPEVLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGV 243
                       VG+P YIAPEV  Q+ Y K  D WS GVI+Y +L G PPF +ET Q  
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244

Query: 244 AQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKR 280
            + ++  +      P   IS  A +L+ R   +   R
Sbjct: 245 YKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHR 281

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 98.2 bits (244), Expect = 5e-23
 Identities = 80/274 (29%), Positives = 132/274 (48%), Gaps = 36/274 (13%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           VG G +G  Y      TG   A K +     V + E+++++ EI +++  S   NI  + 
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHRNIATYY 79

Query: 101 AAY-------EDDQFVHIVMELCAGGELFDRIV-ARGH-YSERAAASVFRVIMNVVNVCH 151
            A+        DDQ + +VME C  G + D +   +G+   E   A + R I+  +   H
Sbjct: 80  GAFIKKSPPGHDDQ-LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH 138

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLS- 209
           +  V+HRD+K +N L T   ENA VK  DFG+SA ++     R   +G+PY++APEV++ 
Sbjct: 139 AHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195

Query: 210 -----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
                 +Y   +DIWS G+    +  G PP     D    +A+        R+P P + S
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPL---CDMHPMRALFL----IPRNPPPKLKS 248

Query: 265 SA-----IELVRRMLTQDPKRRITVAQVLEHPWL 293
                  I+ +   L ++   R +  Q+L+HP++
Sbjct: 249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 98.1 bits (244), Expect = 6e-23
 Identities = 79/284 (27%), Positives = 130/284 (45%), Gaps = 43/284 (15%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           HY   R +G+G FG    C   +TG  +ACK + K+++ K   +     E  I+  ++ +
Sbjct: 4   HY---RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVC- 150
             +V    AYE    + +V+ +  GG+L   I   G+  + E+      R I     +C 
Sbjct: 61  -FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQ------RAIFYAAELCC 113

Query: 151 -----HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAP 205
                  + +++RDLKPEN L    D+   ++ +D GL+  I EG+  R  VG+  Y+AP
Sbjct: 114 GLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAP 170

Query: 206 EVL-SQSYGKEADIWSAGVILYILLCGVPPF--------WAETDQGVAQAILKGEINFQR 256
           EV+ ++ Y    D W  G ++Y ++ G  PF          E D+ V +         Q 
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED--------QE 222

Query: 257 DPFPSISSSAIELVRRMLTQDPKRRI-----TVAQVLEHPWLKE 295
           +     S  A  + R +LT++PK R+       A V +HP  K 
Sbjct: 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 98.2 bits (244), Expect = 6e-23
 Identities = 74/269 (27%), Positives = 128/269 (47%), Gaps = 20/269 (7%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           R +G+G FG    C   +TG  +ACK + K+++ K   +     E +I+  ++ +  +V 
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR-FVVS 64

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC------HS 152
              AYE    + +V+ L  GG+L   I   G     A     R +     +C      H 
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYHMG----EAGFEEGRAVFYAAEICCGLEDLHQ 120

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQS 211
           + +++RDLKPEN L    D++  ++ +D GL+  + EG+  +  VG+  Y+APEV+ ++ 
Sbjct: 121 ERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 177

Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
           Y    D W+ G +LY ++ G  PF     +   + + +     Q +     S  A  L +
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCK 237

Query: 272 RMLTQDPKRRI-----TVAQVLEHPWLKE 295
            +L +DPK R+        +V EHP  K+
Sbjct: 238 MLLCKDPKERLGCQGGGAREVKEHPLFKQ 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 99.0 bits (246), Expect = 6e-23
 Identities = 73/273 (26%), Positives = 123/273 (45%), Gaps = 24/273 (8%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           R +GRG +    L     T   +A K + K  +  D + D V+ E  +    S  P +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
             + ++ +  +  V+E   GG+L   +  +    E  A      I   +N  H +G+++R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 159 DLKPENFLFTTGDENAVVKATDFGL-SAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKEA 216
           DLK +N L    D    +K TD+G+    +  G       G+P YIAPE+L  + YG   
Sbjct: 121 DLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177

Query: 217 DIWSAGVILYILLCGVPPF---------WAETDQGVAQAILKGEINFQRDPFPSISSSAI 267
           D W+ GV+++ ++ G  PF            T+  + Q IL+ +I   R    S+S  A 
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAA 233

Query: 268 ELVRRMLTQDPKRRITV------AQVLEHPWLK 294
            +++  L +DPK R+        A +  HP+ +
Sbjct: 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 98.2 bits (244), Expect = 8e-23
 Identities = 85/281 (30%), Positives = 134/281 (47%), Gaps = 34/281 (12%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+G G FG  Y      TG   A K I  +    + E +D   EIEI+   +  P IV+ 
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCN-HPYIVKL 74

Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVA---RGHYSERAAASVFRVIMNVVNVCHSKGVM 156
             A+  D  + I++E C GG + D I+    RG  +E     + R ++  +   HS  ++
Sbjct: 75  LGAFYWDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVICRQMLEALQYLHSMKII 132

Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVL------S 209
           HRDLK  N L T   +   +K  DFG+SA   +    R+  +G+PY++APEV+       
Sbjct: 133 HRDLKAGNVLLTLDGD---IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189

Query: 210 QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI-- 267
             Y  +ADIWS G+ L  +    PP        V   I K       +P P++S  +   
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS------EP-PTLSQPSKWS 242

Query: 268 ----ELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPI 304
               + ++  L + P+ R + AQ+LEHP++  S   S++P+
Sbjct: 243 MEFRDFLKTALDKHPETRPSAAQLLEHPFV--SSVTSNRPL 281

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 97.5 bits (242), Expect = 9e-23
 Identities = 79/274 (28%), Positives = 132/274 (48%), Gaps = 36/274 (13%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           VG G +G  Y      TG   A K +     V   E++++++EI +++  S   NI  + 
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHRNIATYY 69

Query: 101 AAY-------EDDQFVHIVMELCAGGELFDRIV-ARGH-YSERAAASVFRVIMNVVNVCH 151
            A+        DDQ + +VME C  G + D I   +G+   E   A + R I+  ++  H
Sbjct: 70  GAFIKKNPPGMDDQ-LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 128

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLS- 209
              V+HRD+K +N L T   ENA VK  DFG+SA ++     R   +G+PY++APEV++ 
Sbjct: 129 QHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185

Query: 210 -----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
                 +Y  ++D+WS G+    +  G PP     D    +A+        R+P P + S
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPL---CDMHPMRALFL----IPRNPAPRLKS 238

Query: 265 SAI-----ELVRRMLTQDPKRRITVAQVLEHPWL 293
                     +   L ++  +R T  Q+++HP++
Sbjct: 239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 98.2 bits (244), Expect = 2e-22
 Identities = 78/268 (29%), Positives = 128/268 (47%), Gaps = 38/268 (14%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + I + +GRG FG   +     T   +A K + K +++K  E    R E  ++ +   Q 
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELF-------DRI---VARGHYSERAAASVFRVIM 144
            I     A++D+ ++++VM+   GG+L        DR+   +AR + +E   A       
Sbjct: 63  -ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA------- 114

Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREI-VGSPYY 202
             ++  H    +HRD+KP+N L    D N  ++  DFG      ++G     + VG+P Y
Sbjct: 115 --IHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDY 169

Query: 203 IAPEVLSQ------SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR 256
           I+PE+L         YG E D WS GV +Y +L G  PF+AE+       I+  E  FQ 
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ- 228

Query: 257 DPFPS----ISSSAIELVRRMLTQDPKR 280
             FPS    +S  A +L++R++    +R
Sbjct: 229 --FPSHITDVSEEAKDLIQRLICSRERR 254

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 96.2 bits (239), Expect = 3e-22
 Identities = 67/257 (26%), Positives = 120/257 (46%), Gaps = 30/257 (11%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG        +TG  +ACK + K++L K   +     E EI+  ++  P IV   
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLA 59

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARG----------HYSERAAASVFRVIMNVVNVC 150
            A+E    + +VM L  GG+L   I   G          HYS +    +  +        
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHL-------- 111

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ 210
           HS  +++RD+KPEN L    D+    + +D GL+  +++GK   +  G+  Y+APE+L +
Sbjct: 112 HSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE 168

Query: 211 -SYGKEADIWSAGVILYILLCGVPPFWAETD----QGVAQAILKGEINFQRDPFPSISSS 265
             Y    D ++ G  +Y ++ G  PF    +    + + +  L+ E+ F+   F   +  
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNF---TEE 225

Query: 266 AIELVRRMLTQDPKRRI 282
           + ++ R  L + P+ R+
Sbjct: 226 SKDICRLFLAKKPEDRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 96.5 bits (241), Expect = 3e-22
 Identities = 79/288 (27%), Positives = 125/288 (43%), Gaps = 50/288 (17%)

Query: 44  GEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR--REIEIMRHLSGQPNIVQFK- 100
           G +G+ Y   +  TG   A K +   K+ K+ E   +   REI I+  L   PNIV  K 
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKL---KMEKEKEGFPITSLREINILLKLQ-HPNIVTVKE 71

Query: 101 -AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM----NVVNVCHSKGV 155
                +   +++VME     +L   +       +    S  + +M    + V   H   +
Sbjct: 72  VVVGSNLDKIYMVME-YVEHDLKSLM---ETMKQPFLQSEVKCLMLQLLSGVAHLHDNWI 127

Query: 156 MHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQSY 212
           +HRDLK  N L        ++K  DFGL+  +    K Y ++V + +Y APE+L  ++ Y
Sbjct: 128 LHRDLKTSNLLLN---NRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEY 184

Query: 213 GKEADIWSAGVILYILLCGVPPF--WAETDQ-----------------GVAQAILKGEIN 253
               D+WS G I   LL   P F   +E DQ                 G ++     +  
Sbjct: 185 STAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKT 244

Query: 254 FQRDP-------FP--SISSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
           F + P       FP  S+S +  +L+ R+LT DP +RI+    L+HP+
Sbjct: 245 FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 97.1 bits (241), Expect = 3e-22
 Identities = 78/269 (28%), Positives = 129/269 (47%), Gaps = 40/269 (14%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + I + +GRG FG   +    +    FA K + K +++K  E    R E +++  ++G  
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL--VNGDN 60

Query: 95  N-IVQFKAAYEDDQFVHIVMELCAGGELF-------DRI---VARGHYSERAAASVFRVI 143
             I     A++D+  +++VM+   GG+L        DR+   +AR + +E   A      
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIA------ 114

Query: 144 MNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREI-VGSPY 201
              ++  H    +HRD+KP+N L    D N  ++  DFG     +E+G     + VG+P 
Sbjct: 115 ---IDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 168

Query: 202 YIAPEVLSQ------SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ 255
           YI+PE+L         YG E D WS GV +Y +L G  PF+AE+       I+  +  FQ
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 228

Query: 256 RDPFPS----ISSSAIELVRRMLTQDPKR 280
              FP+    +S  A +L+RR++     R
Sbjct: 229 ---FPAQVTDVSEDAKDLIRRLICSREHR 254

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 95.9 bits (238), Expect = 4e-22
 Identities = 84/275 (30%), Positives = 131/275 (47%), Gaps = 23/275 (8%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+G G FG  Y      TG+  A K I  +    + E +D   EI+I+      PNIV+ 
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCD-HPNIVKL 67

Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVCHSKGVMH 157
             A+  +  + I++E CAGG + D ++       +E     V +  +  +N  H   ++H
Sbjct: 68  LDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126

Query: 158 RDLKPENFLFT-TGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVL------S 209
           RDLK  N LFT  GD    +K  DFG+SA        R+  +G+PY++APEV+       
Sbjct: 127 RDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 210 QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
           + Y  +AD+WS G+ L  +    PP        V   I K E      P    SS   + 
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWSSEFKDF 241

Query: 270 VRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPI 304
           +++ L ++   R T  Q+L+HP++  +   S+KPI
Sbjct: 242 LKKCLEKNVDARWTTTQLLQHPFVTVN---SNKPI 273

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 96.4 bits (240), Expect = 4e-22
 Identities = 74/249 (29%), Positives = 128/249 (51%), Gaps = 18/249 (7%)

Query: 41  VGRGEFGITYLC---TENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQPNI 96
           +G+G FG  +L    T    G  +A K + K  L V+D  +  + R+I    +    P I
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN---HPFI 60

Query: 97  VQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVM 156
           V+   A++ +  ++++++   GG+LF R+     ++E         +   ++  HS G++
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120

Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLS--AFIEEGKAYREIVGSPYYIAPEVLS-QSYG 213
           +RDLKPEN L    DE   +K TDFGLS  +   E KAY    G+  Y+APEV++ + + 
Sbjct: 121 YRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAY-SFCGTVEYMAPEVVNRRGHT 176

Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRM 273
           + AD WS GV+++ +L G  PF  +  +     ILK ++   +     +S  A  L+R +
Sbjct: 177 QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRAL 232

Query: 274 LTQDPKRRI 282
             ++P  R+
Sbjct: 233 FKRNPANRL 241

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 95.7 bits (238), Expect = 4e-22
 Identities = 77/278 (27%), Positives = 132/278 (47%), Gaps = 33/278 (11%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           HY   R +G+G FG    C   +TG  +ACK + K+++ K   +     E +I+  ++  
Sbjct: 4   HY---RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-S 59

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH---YSERAAASVFRVIMNVVNVC 150
             +V    AYE    + +V+ L  GG+L   I   G+     ERA      +   + ++ 
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL- 118

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-S 209
           H + +++RDLKPEN L    D+   ++ +D GL+  I EG+  R  VG+  Y+APEV+ +
Sbjct: 119 HRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKN 175

Query: 210 QSYGKEADIWSAGVILYILLCGVPPF--------WAETDQGVAQAILKGEINFQRDPFPS 261
           + Y    D W  G ++Y ++ G  PF          E ++ V +   +    F       
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKF------- 228

Query: 262 ISSSAIELVRRMLTQDPKRRI-----TVAQVLEHPWLK 294
            S +A  + R++LT+DP  R+        +V  HP+ +
Sbjct: 229 -SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 95.6 bits (238), Expect = 5e-22
 Identities = 79/291 (27%), Positives = 124/291 (42%), Gaps = 45/291 (15%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVE--KDDVRREIEIMRHLSGQPNIVQ 98
           +G G +G  Y   + +TG   A K   K +L  D E       REI +++ LS    IV+
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLSESIYIVR 65

Query: 99  FKAAYEDDQ-----FVHIVME-----LCAGGELFDRIVARGHYSERAAASVFRVIMNVVN 148
                  ++      +++V E     L    +   R   R   ++   + +++++  V +
Sbjct: 66  LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEV 207
            CH  GVMHRDLKP+N L     +  ++K  D GL  AF    K+Y   + + +Y APEV
Sbjct: 126 -CHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEV 182

Query: 208 L--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK--GEINFQRDP----- 258
           L  S  Y    DIWS G I   +    P F  +++      I K  G    Q  P     
Sbjct: 183 LLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKL 242

Query: 259 -----------------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
                             P +S   ++L+++ML  DP +RI+    L HP+
Sbjct: 243 RDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 96.3 bits (239), Expect = 5e-22
 Identities = 72/254 (28%), Positives = 118/254 (46%), Gaps = 18/254 (7%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD-VRREIEIMRHLSGQPNIV 97
           R +GRG +    L         +A K + K++LV D E  D V+ E  +    S  P +V
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVV-KKELVHDDEDIDWVQTEKHVFEQASSNPFLV 59

Query: 98  QFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMH 157
              + ++    + +V+E   GG+L   +  +    E  A      I   +N  H +G+++
Sbjct: 60  GLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIY 119

Query: 158 RDLKPENFLFTTGDENAVVKATDFGL-SAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKE 215
           RDLK +N L    D +  +K TD+G+    +  G       G+P YIAPE+L  + YG  
Sbjct: 120 RDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS 176

Query: 216 ADIWSAGVILYILLCGVPPFWAETD-------QGVAQAILKGEINFQRDPFPSISSSAIE 268
            D W+ GV+++ ++ G  PF   TD         + Q IL+  I   R     +S  A  
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKASH 232

Query: 269 LVRRMLTQDPKRRI 282
           +++  L +DPK R+
Sbjct: 233 VLKGFLNKDPKERL 246

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 97.4 bits (242), Expect = 6e-22
 Identities = 79/315 (25%), Positives = 137/315 (43%), Gaps = 57/315 (18%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L  +  T   +A K++ K+ ++   +   V+ E +I+     +  +V+
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW-VVR 65

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
              +++D   ++ VM+   GG++   ++  G + E  A      +   V   H  G +HR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125

Query: 159 DLKPENFLFTTGDENAVVKATDFGL---------SAFIEEGKAYRE-------------- 195
           D+KP+N L    D +  +K TDFGL         S + + G   R+              
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 196 -------------------------IVGSPYYIAPEVLSQS-YGKEADIWSAGVILYILL 229
                                    +VG+P YIAPEVL ++ Y +  D WS GVILY +L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 230 CGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI---TVAQ 286
            G PPF A+T       ++  + +    P   +S  A +L+ + L + P+ R+      +
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADE 301

Query: 287 VLEHPWLKESGEASD 301
           +  HP+ K    +SD
Sbjct: 302 IKAHPFFKTIDFSSD 316

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 96.4 bits (240), Expect = 7e-22
 Identities = 74/269 (27%), Positives = 120/269 (44%), Gaps = 29/269 (10%)

Query: 38  GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQ 93
              +G G  G  Y      TG  +A K I          +D VR    REIEI+R ++  
Sbjct: 79  VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN------HEDTVRRQICREIEILRDVN-H 131

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PN+V+    ++ +  + +++E   GG L    +A     E+  A V R I++ +   H +
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIA----DEQFLADVARQILSGIAYLHRR 187

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-KAYREIVGSPYYIAPEVLSQSY 212
            ++HRD+KP N L  +      VK  DFG+S  + +        VG+  Y++PE ++   
Sbjct: 188 HIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL 244

Query: 213 ------GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
                 G   DIWS GV +     G  PF     QG   A L   I   + P    ++S 
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPF-GVGRQG-DWASLMCAICMSQPPEAPATASR 302

Query: 267 --IELVRRMLTQDPKRRITVAQVLEHPWL 293
                +   L ++P +R +  Q+L+HP++
Sbjct: 303 EFRHFISCCLQREPAKRWSAMQLLQHPFI 331

Length = 353

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 95.4 bits (237), Expect = 9e-22
 Identities = 69/258 (26%), Positives = 121/258 (46%), Gaps = 12/258 (4%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG   L      G  FA K++ K  ++ D + +    E  ++      P +    
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
             ++  + +  VME   GG+L   I  +G +    A      I+  +   HSKG+++RDL
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122

Query: 161 KPENFLFTTGDENAVVKATDFGLSA--FIEEGKAYREIVGSPYYIAPEVL-SQSYGKEAD 217
           K +N +    D +  +K  DFG+       + +A     G+P YIAPE+L    Y    D
Sbjct: 123 KLDNVML---DRDGHIKIADFGMCKENVFGDNRA-STFCGTPDYIAPEILQGLKYTFSVD 178

Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD 277
            WS GV+LY +L G  PF  + +  + ++I     ++ R     I+  + +++ ++  +D
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR----WITKESKDILEKLFERD 234

Query: 278 PKRRI-TVAQVLEHPWLK 294
           P RR+  V  +  HP+ K
Sbjct: 235 PTRRLGVVGNIRGHPFFK 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 94.5 bits (235), Expect = 1e-21
 Identities = 69/242 (28%), Positives = 103/242 (42%), Gaps = 36/242 (14%)

Query: 82  REIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGG--ELFDRIVARGHYSERAAASV 139
           REI +M+ L    NIV+       +  + +V E       +  D    RG        S 
Sbjct: 47  REISLMKELK-HENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSF 105

Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AF-IEEGKAYREIV 197
              ++  +  CH   V+HRDLKP+N L     E   +K  DFGL+ AF I       E+V
Sbjct: 106 TYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIPVNTFSNEVV 162

Query: 198 GSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK------ 249
            + +Y AP+VL  S++Y    DIWS G I+  ++ G P F    ++     I +      
Sbjct: 163 -TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPT 221

Query: 250 ------------GEINFQRDP-------FPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290
                        +  F R P       FP      I+L+ R+L  +P+ RI+    L+H
Sbjct: 222 ESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281

Query: 291 PW 292
           PW
Sbjct: 282 PW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 94.9 bits (237), Expect = 2e-21
 Identities = 90/327 (27%), Positives = 135/327 (41%), Gaps = 85/327 (25%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV---EKDDVR--REIEIMRH 89
           Y I +++G+G +GI +   +  T    A K I       D      D  R  REI  ++ 
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI------FDAFRNATDAQRTFREIMFLQE 62

Query: 90  LSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV-IM 144
           L   PNIV+     KA  E+D+ +++V E                Y E    +V R  I+
Sbjct: 63  LGDHPNIVKLLNVIKA--ENDKDIYLVFE----------------YMETDLHAVIRANIL 104

Query: 145 NVVNVC-------------HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191
             V+               HS  V+HRDLKP N L    + +  VK  DFGL+  + E +
Sbjct: 105 EDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSLSELE 161

Query: 192 AYREI------VGSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPF-------- 235
              E       V + +Y APE+L  S  Y K  D+WS G IL  +L G P F        
Sbjct: 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ 221

Query: 236 ---------------WAETDQGVAQAILKGEINFQRDP----FPSISSSAIELVRRMLTQ 276
                                  A  +L    +  R P     P  S  A++L++++L  
Sbjct: 222 LEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVF 281

Query: 277 DPKRRITVAQVLEHPWLKESGEASDKP 303
           +P +R+T  + LEHP++ +    SD+P
Sbjct: 282 NPNKRLTAEEALEHPYVAQFHNPSDEP 308

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 72/280 (25%), Positives = 123/280 (43%), Gaps = 29/280 (10%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK-DDVRREIEIM 87
           +D +  +T  RE+G G FG  Y   +  T    A K +      +  EK  D+ +E+  +
Sbjct: 11  DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQDIIKEVRFL 69

Query: 88  RHLSGQPNIVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMN 145
           + L   PN +++K  Y  +    +VME C G   ++ +  V +    E   A++    + 
Sbjct: 70  QQLR-HPNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQ 126

Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAP 205
            +   HS   +HRD+K  N L T   E   VK  DFG ++ +    ++   VG+PY++AP
Sbjct: 127 GLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSPANSF---VGTPYWMAP 180

Query: 206 EVL----SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           EV+       Y  + D+WS G+    L    PP +          I       Q D  P+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------QNDS-PT 233

Query: 262 ISSSA-----IELVRRMLTQDPKRRITVAQVLEHPWLKES 296
           +SS+         V   L + P+ R +  ++L+H ++   
Sbjct: 234 LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 78/296 (26%), Positives = 122/296 (41%), Gaps = 62/296 (20%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPNI 96
           +G G +G+ Y   +  TG   A K I   +L  + E + V     REI +++ L+  PNI
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKI---RL--ETEDEGVPSTAIREISLLKELN-HPNI 60

Query: 97  VQFKAAYEDDQFVHIV-----------MELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           V+       +  +++V           M+      L   ++    Y           ++ 
Sbjct: 61  VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ----------LLQ 110

Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIA 204
            +  CHS  V+HRDLKP+N L    D    +K  DFGL+ AF    + Y   V + +Y A
Sbjct: 111 GIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVRTYTHEVVTLWYRA 167

Query: 205 PEVL--SQSYGKEADIWSAGVILYILLCGVPPFW--AETDQ-----------------GV 243
           PE+L  S+ Y    DIWS G I   ++   P F   +E DQ                 GV
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227

Query: 244 AQ------AILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
                      K          P++    ++L+ +ML  DP +RI+    L+HP+ 
Sbjct: 228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 96.1 bits (239), Expect = 3e-21
 Identities = 69/200 (34%), Positives = 103/200 (51%), Gaps = 16/200 (8%)

Query: 104 EDDQFVHIVMELCAGGELFDRIVARGH----YSERAAASVFRVIMNVVNVCHSKGVMHRD 159
           E+   + +V++    G+L   I +R      + E  A  +F  ++  V+  HSK ++HRD
Sbjct: 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRD 168

Query: 160 LKPENFLFTTGDENAVVKATDFGLS---AFIEEGKAYREIVGSPYYIAPEVLSQS-YGKE 215
           +K  N L  +   N +VK  DFG S   A        R   G+PYY+APE+  +  Y K+
Sbjct: 169 IKSANILLCS---NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK 225

Query: 216 ADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP-SISSSAIELVRRML 274
           AD++S GV+LY LL    PF  E  + V    L G    + DP P SIS    E+V  +L
Sbjct: 226 ADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG----RYDPLPPSISPEMQEIVTALL 281

Query: 275 TQDPKRRITVAQVLEHPWLK 294
           + DPKRR + +++L  P  K
Sbjct: 282 SSDPKRRPSSSKLLNMPICK 301

Length = 496

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 94.7 bits (235), Expect = 4e-21
 Identities = 76/314 (24%), Positives = 132/314 (42%), Gaps = 55/314 (17%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L  +  T   +A K++ K+ ++   +   V+ E +I+     +  +V+
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW-VVK 65

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
              +++D   ++ VM+   GG++   ++    + E  A      +   +   H  G +HR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125

Query: 159 DLKPENFLFTTGDENAVVKATDFGL---------SAFIEEGKAYRE-------------- 195
           D+KP+N L    D +  +K TDFGL         S + ++G   R+              
Sbjct: 126 DIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 196 -------------------------IVGSPYYIAPEV-LSQSYGKEADIWSAGVILYILL 229
                                    +VG+P YIAPEV L + Y +  D WS GVIL+ +L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 230 CGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKR--RITVAQV 287
            G PPF A T       ++  E      P   +S  A++L+ ++     +R  R     +
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302

Query: 288 LEHPWLKESGEASD 301
             HP+  E   +SD
Sbjct: 303 KAHPFFSEVDFSSD 316

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 93.7 bits (233), Expect = 5e-21
 Identities = 81/328 (24%), Positives = 136/328 (41%), Gaps = 59/328 (17%)

Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK-DDVRR 82
           LG  Y D+       R +G G  G+ +   ++      A K I    ++ D +      R
Sbjct: 3   LGSRYMDL-------RPLGCGSNGLVFSAVDSDCDKRVAVKKI----VLTDPQSVKHALR 51

Query: 83  EIEIMRHLSGQPNIVQ-----FKAAYEDDQFVHIVMEL---CAGGELFD----RIVARGH 130
           EI+I+R L    NIV+       +  +  + V  + EL       E  +     ++ +G 
Sbjct: 52  EIKIIRRLD-HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP 110

Query: 131 YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-- 188
            SE  A      ++  +   HS  V+HRDLKP N    T  E+ V+K  DFGL+  ++  
Sbjct: 111 LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--EDLVLKIGDFGLARIVDPH 168

Query: 189 -EGKAY-REIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVA 244
              K Y  E + + +Y +P +L    +Y K  D+W+AG I   +L G P F    +    
Sbjct: 169 YSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228

Query: 245 QAILK---------------------GEINFQ-----RDPFPSISSSAIELVRRMLTQDP 278
           Q IL+                          +     RD  P ++  A++ + ++LT +P
Sbjct: 229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNP 288

Query: 279 KRRITVAQVLEHPWLKESGEASDKPIDT 306
             R+T  + L HP++       D+P+  
Sbjct: 289 MDRLTAEEALMHPYMSCYSCPFDEPVSL 316

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 92.6 bits (230), Expect = 1e-20
 Identities = 77/274 (28%), Positives = 126/274 (45%), Gaps = 26/274 (9%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD-VRREIEIMRHLSGQPNIV 97
           R +GRG +    L     T   +A K I K++LV D E  D V+ E  +    S  P +V
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVI-KKELVNDDEDIDWVQTEKHVFETASNHPFLV 59

Query: 98  QFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMH 157
              + ++ +  +  V+E  +GG+L   +  +    E  A      I   +N  H +G+++
Sbjct: 60  GLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIY 119

Query: 158 RDLKPENFLFTTGDENAVVKATDFGL-SAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKE 215
           RDLK +N L    D    +K TD+G+    I  G       G+P YIAPE+L  + YG  
Sbjct: 120 RDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176

Query: 216 ADIWSAGVILYILLCGVPPF---------WAETDQGVAQAILKGEINFQRDPFPSISSSA 266
            D W+ GV+++ ++ G  PF            T+  + Q IL+ +I   R    S+S  A
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKA 232

Query: 267 IELVRRMLTQDPKRRI------TVAQVLEHPWLK 294
             +++  L +DPK R+          +  HP+ +
Sbjct: 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 81/319 (25%), Positives = 119/319 (37%), Gaps = 66/319 (20%)

Query: 35  YTIGREVGRGEFGITYLC--TENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG 92
           Y I   +GRG +G  Y         G E+A K     K           REI ++R L  
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK- 60

Query: 93  QPNIVQFKAAYEDDQF--VHIVMELCAGGEL----FDRIVARGHYSERAAASVFRVIMNV 146
             N+V     + +     V+++ +           F R   R         S+   I+N 
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 147 VNVCHSKGVMHRDLKPENFLFT-TGDENAVVKATDFGLS--------AFIEEGKAYREIV 197
           V+  HS  V+HRDLKP N L    G E  VVK  D GL+           +       +V
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP----VV 176

Query: 198 GSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVA---------QA 246
            + +Y APE+L  ++ Y K  DIW+ G I   LL   P F     +            + 
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236

Query: 247 ILK---------------------GEINFQRDPFPSIS------------SSAIELVRRM 273
           I +                        +F+   +PS S            S   +L+R++
Sbjct: 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKL 296

Query: 274 LTQDPKRRITVAQVLEHPW 292
           L  DP +RIT  + LEHP+
Sbjct: 297 LEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 89.9 bits (223), Expect = 5e-20
 Identities = 79/286 (27%), Positives = 120/286 (41%), Gaps = 42/286 (14%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K I   +L  D E + V     REI +++ L+  PN
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKI---RL--DTETEGVPSTAIREISLLKELN-HPN 60

Query: 96  IVQFKAAYEDDQFVHIVME-LCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           IV+       +  +++V E L    + F               S    ++  +  CHS  
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQS 211
           V+HRDLKP+N L    +    +K  DFGL+ AF    + Y   V + +Y APE+L   + 
Sbjct: 121 VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177

Query: 212 YGKEADIWSAGVILYILLC--GVPPFWAETDQ-----------------GVAQ-AILKGE 251
           Y    DIWS G I   ++    + P  +E DQ                 GV      K  
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237

Query: 252 I-NFQRDPF----PSISSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
              + R  F    P +     +L+ +ML  DP +RI+    L HP+
Sbjct: 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 89.3 bits (221), Expect = 8e-20
 Identities = 82/290 (28%), Positives = 126/290 (43%), Gaps = 44/290 (15%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG--QPNIV 97
           E+G G +G  Y   +  +G   A KS+  +     +    VR E+ +++ L     PNIV
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNIV 65

Query: 98  QFK---AAYEDDQ-------FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVV 147
           +     A    D+       F H+  +L       D++   G  +E     + R  +  +
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEHVDQDLRT---YLDKVPPPGLPAETIK-DLMRQFLRGL 121

Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV 207
           +  H+  ++HRDLKPEN L T+G +   VK  DFGL+       A   +V + +Y APEV
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQ---VKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178

Query: 208 LSQS-YGKEADIWSAGVILYILLCGVPPFW--AETDQGVAQAILKG---------EINFQ 255
           L QS Y    D+WS G I   +    P F   +E DQ      L G         ++   
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238

Query: 256 RDPF------------PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
           R  F            P I  S  +L+  MLT +P +RI+  + L+HP+ 
Sbjct: 239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|185503 PTZ00183, PTZ00183, centrin; Provisional

 Score = 85.5 bits (212), Expect = 1e-19
 Identities = 49/142 (34%), Positives = 81/142 (57%), Gaps = 3/142 (2%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYI 395
           ++ ++++E F   DTD SGT+   ELK  +  LG    + ++KQ +   D DG+G ID+ 
Sbjct: 14  DQKKEIREAFDLFDTDGSGTIDPKELKVAMRSLGFEPKKEEIKQMIADVDKDGSGKIDFE 73

Query: 396 EFI-TATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI 454
           EF+   T +  +    E + KAF+ FD D  G I++  L +  K+  +G+  T   ++E+
Sbjct: 74  EFLDIMTKKLGERDPREEILKAFRLFDDDKTGKISLKNLKRVAKE--LGETITDEELQEM 131

Query: 455 MSEVDRDKDGRISYDEFRSMMK 476
           + E DR+ DG IS +EF  +MK
Sbjct: 132 IDEADRNGDGEISEEEFYRIMK 153

Length = 158

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 89.1 bits (221), Expect = 2e-19
 Identities = 84/311 (27%), Positives = 132/311 (42%), Gaps = 51/311 (16%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR--REIEIMRHLSG 92
           Y I   +G+G +G+     +  TG + A K I     V +   D  R  REI+++R L  
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIND---VFEHVSDATRILREIKLLRLLR- 57

Query: 93  QPNIVQFK-----AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVV 147
            P+IV+ K      +  + + +++V EL    +L   I A    +          ++  +
Sbjct: 58  HPDIVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116

Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS--AFIEEGKA--YREIVGSPYYI 203
              H+  V HRDLKP+N L    + +  +K  DFGL+  AF +   A  + + V + +Y 
Sbjct: 117 KYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 204 APEVLSQSYGKEA---DIWSAGVILYILLCGVPPF-------------------WAETDQ 241
           APE+    + K     DIWS G I   +L G P F                     ET  
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233

Query: 242 GV----AQAIL-----KGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
            V    A+  L     K  + F +  FP+    A+ L+ R+L  DPK R T  + L  P+
Sbjct: 234 RVRNEKARRYLSSMRKKQPVPFSQK-FPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292

Query: 293 LKESGEASDKP 303
            K   +   +P
Sbjct: 293 FKGLAKVEREP 303

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 87.1 bits (216), Expect = 5e-19
 Identities = 72/305 (23%), Positives = 121/305 (39%), Gaps = 67/305 (21%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           E+G G  G+        +GL  A      RKL+    K  +R    RE++++ H    P 
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMA------RKLIHLEIKPAIRNQIIRELKVL-HECNSPY 60

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG- 154
           IV F  A+  D  + I ME   GG L D+++ +       A  +   I+  +++   +G 
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-------AGRIPENILGKISIAVLRGL 112

Query: 155 --------VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE 206
                   +MHRD+KP N L  +  E   +K  DFG+S  + +  A    VG+  Y++PE
Sbjct: 113 TYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRSYMSPE 168

Query: 207 VLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVA-------QAILKGEINFQRDP 258
            L    Y  ++DIWS G+ L  +  G  P      + +              E +     
Sbjct: 169 RLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSG 228

Query: 259 FPS---------------------------ISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
            P                             S    + V + L ++PK R  + ++ +HP
Sbjct: 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288

Query: 292 WLKES 296
           ++K +
Sbjct: 289 FIKRA 293

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 86.6 bits (214), Expect = 8e-19
 Identities = 71/290 (24%), Positives = 124/290 (42%), Gaps = 20/290 (6%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+G G FG  Y  T + T    A K +       + +  D+ +E++ ++ L   PN +++
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEY 86

Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRD 159
           K  Y  +    +VME C G       V +    E   A++    +  +   HS  ++HRD
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146

Query: 160 LKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL----SQSYGKE 215
           +K  N L T   E   VK  DFG ++      ++   VG+PY++APEV+       Y  +
Sbjct: 147 IKAGNILLT---EPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQYDGK 200

Query: 216 ADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI-NFQRDPFPSISSSAIELVRRML 274
            D+WS G+    L    PP +          I + +    Q + +   + S    V   L
Sbjct: 201 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW---TDSFRGFVDYCL 257

Query: 275 TQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKL 324
            + P+ R   A++L H +++      D+P    +    +   A+ +L  L
Sbjct: 258 QKIPQERPASAELLRHDFVRR-----DRPARVLIDLIQRTKDAVRELDNL 302

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 85.6 bits (212), Expect = 4e-18
 Identities = 90/307 (29%), Positives = 132/307 (42%), Gaps = 69/307 (22%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIP---------KR-----KLVKDVEKDDVRREI 84
           R +G G FG+ +  T+   G   A K +P         KR     K++   + D+V   +
Sbjct: 6   RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65

Query: 85  EIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
           +I++     P+I  F+  Y       +V EL    +L   IV+    S          I+
Sbjct: 66  DILQ----PPHIDPFEEIY-------VVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQIL 113

Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI---VGSPY 201
             +   HS G++HRD+KP N L  +   N V+K  DFGL A +EE    + +   V + Y
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGL-ARVEEPDESKHMTQEVVTQY 169

Query: 202 YIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE---------TD---------- 240
           Y APE+L  S+ Y    DIWS G I   LL     F A+         TD          
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229

Query: 241 ----QGVAQAILKGEINFQRDP-FPSI-------SSSAIELVRRMLTQDPKRRITVAQVL 288
               +G    IL+G     + P  P +       +  A+ L+ RML  DP +RI+ A  L
Sbjct: 230 RSACEGARAHILRGP---HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286

Query: 289 EHPWLKE 295
            HP+L E
Sbjct: 287 AHPYLDE 293

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 83.4 bits (206), Expect = 7e-18
 Identities = 75/264 (28%), Positives = 124/264 (46%), Gaps = 14/264 (5%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQ-PNIVQ 98
           +GRG FG  Y C +  TG  +A K + K+++ +K  E   +   I +    +G  P IV 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
              A+     +  +++L  GG+L   +   G +SE         I+  +   H++ V++R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121

Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEA 216
           DLKP N L    DE+  V+ +D GL+    + K +   VG+  Y+APEVL +  +Y   A
Sbjct: 122 DLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSA 177

Query: 217 DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276
           D +S G +L+ LL G  PF     +     I +  +    +   S S     L+  +L +
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236

Query: 277 DPKRRI-----TVAQVLEHPWLKE 295
           D  RR+        +V EHP+ + 
Sbjct: 237 DVNRRLGCLGRGAQEVKEHPFFRS 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 83.0 bits (205), Expect = 1e-17
 Identities = 70/268 (26%), Positives = 128/268 (47%), Gaps = 19/268 (7%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG    C   +TG  +ACK + K++L K    +    E  I+  +  +  IV   
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSR-FIVSLA 59

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIV-----ARGHYSERAAASVFRVIMNVVNVCHSKGV 155
            A++    + +VM +  GG+L   I        G    RA     ++I  + ++ H + +
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL-HQRRI 118

Query: 156 MHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-YREIVGSPYYIAPEVL-SQSYG 213
           ++RDLKPEN L    D +  V+ +D GL+  +++G++  +   G+P ++APE+L  + Y 
Sbjct: 119 IYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175

Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP-SISSSAIELVRR 272
              D ++ GV LY ++    PF A  ++ V    LK  I      +P   S ++      
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRILNDSVTYPDKFSPASKSFCEA 234

Query: 273 MLTQDPKRRI-----TVAQVLEHPWLKE 295
           +L +DP++R+         +  HP  ++
Sbjct: 235 LLAKDPEKRLGFRDGNCDGLRTHPLFRD 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 83.6 bits (206), Expect = 1e-17
 Identities = 69/271 (25%), Positives = 117/271 (43%), Gaps = 23/271 (8%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
           ED +  +T  RE+G G FG  Y   +  T    A K +       + +  D+ +E++ ++
Sbjct: 21  EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVN 148
            +   PN +++K  Y  +    +VME C G       V +    E   A++    +  + 
Sbjct: 81  RIK-HPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLA 139

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL 208
             HS  ++HRD+K  N L T   E   VK  DFG ++      ++   VG+PY++APEV+
Sbjct: 140 YLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASIASPANSF---VGTPYWMAPEVI 193

Query: 209 ----SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
                  Y  + D+WS G+    L    PP +          I + E        P++ S
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-------PTLQS 246

Query: 265 SAIE-----LVRRMLTQDPKRRITVAQVLEH 290
           +         V   L + P+ R T  ++L+H
Sbjct: 247 NEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 75/290 (25%), Positives = 131/290 (45%), Gaps = 35/290 (12%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G G +G+ Y   +  T    A K I   +  + V    +R EI +++ +    NIV+ 
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQ-HGNIVRL 66

Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSE--RAAASVFRVIMNVVNVCHSKGVMH 157
           +     ++ +++V E     +L   + +   +++  R   +    I+  +  CHS  V+H
Sbjct: 67  QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLH 125

Query: 158 RDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQSYGK 214
           RDLKP+N L         +K  DFGL+ AF    + +   V + +Y APE+L  S+ Y  
Sbjct: 126 RDLKPQNLLIDR--RTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYST 183

Query: 215 EADIWSAGVILYILLCGVPPFW--AETDQGVAQAILKGEINFQ-----------RDPF-- 259
             DIWS G I   ++   P F   +E D+      + G  N +           +  F  
Sbjct: 184 PVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPK 243

Query: 260 ----------PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA 299
                     P++  + ++L+ +ML  DP +RIT    LEH + K+ G+A
Sbjct: 244 WPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA 293

Length = 294

>gnl|CDD|238008 cd00051, EFh, EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands

 Score = 75.7 bits (187), Expect = 2e-17
 Identities = 26/62 (41%), Positives = 40/62 (64%), Gaps = 2/62 (3%)

Query: 415 KAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSM 474
           +AF+ FDKD +G I+ DEL  A K   +G+  +   I E++ EVD+D DG+I ++EF  +
Sbjct: 4   EAFRLFDKDGDGTISADELKAALK--SLGEGLSEEEIDEMIREVDKDGDGKIDFEEFLEL 61

Query: 475 MK 476
           M 
Sbjct: 62  MA 63

Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. Length = 63

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 82.8 bits (204), Expect = 3e-17
 Identities = 81/318 (25%), Positives = 134/318 (42%), Gaps = 48/318 (15%)

Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 8   LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 66

Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQF--VHIVMELCAGGELFDRIVARGHYSERAAA 137
           + +++H+  + N++     F  A   ++F  V++V  L  G +L + IV     ++    
Sbjct: 67  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHL-MGADL-NNIVKCQKLTDDHVQ 123

Query: 138 SVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREI 196
            +   I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+    +E   Y   
Sbjct: 124 FLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGY--- 177

Query: 197 VGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK----- 249
           V + +Y APE++     Y +  DIWS G I+  LL G   F         + IL+     
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237

Query: 250 -----------------------GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQ 286
                                   ++NF  + F   +  A++L+ +ML  D  +RIT AQ
Sbjct: 238 GAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQ 296

Query: 287 VLEHPWLKESGEASDKPI 304
            L H +  +  +  D+P+
Sbjct: 297 ALAHAYFAQYHDPDDEPV 314

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 81.2 bits (200), Expect = 5e-17
 Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 8/199 (4%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQ-PNIVQ 98
           +GRG FG  Y C +  TG  +A K + K+++ +K  E   +   I +    +G  P IV 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
              A+     +  +++L  GG+L   +   G +SE+        I+  +   H++ V++R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121

Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEA 216
           DLKP N L    DE+  V+ +D GL+    + K +   VG+  Y+APEVL +  +Y   A
Sbjct: 122 DLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSSA 177

Query: 217 DIWSAGVILYILLCGVPPF 235
           D +S G +L+ LL G  PF
Sbjct: 178 DWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 80.9 bits (199), Expect = 8e-17
 Identities = 64/264 (24%), Positives = 111/264 (42%), Gaps = 23/264 (8%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           RE+G G FG  Y   +       A K +       + +  D+ +E+  ++ L   PN +Q
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ 79

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
           ++  Y  +    +VME C G       V +    E   A+V    +  +   HS  ++HR
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL----SQSYGK 214
           D+K  N L +   E  +VK  DFG ++ +     +   VG+PY++APEV+       Y  
Sbjct: 140 DVKAGNILLS---EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDG 193

Query: 215 EADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE-----INFQRDPFPSISSSAIEL 269
           + D+WS G+    L    PP +          I + E          + F +   S ++ 
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253

Query: 270 VRRMLTQDPKRRITVAQVLEHPWL 293
           +       P+ R T   +L+H ++
Sbjct: 254 I-------PQDRPTSEVLLKHRFV 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 73/268 (27%), Positives = 116/268 (43%), Gaps = 34/268 (12%)

Query: 36  TIGREVGRGEFGITYLCT---ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG 92
           T+GR +G G+FG  Y        +  +  A K+          EK    +E  IMR    
Sbjct: 9   TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK--FLQEAYIMRQFD- 65

Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHY--SERAAASVFRVIMNVVNVC 150
            P+IV+      ++  V IVMEL   GEL         Y    + +  +  +I+    + 
Sbjct: 66  HPHIVKLIGVITENP-VWIVMELAPLGEL-------RSYLQVNKYSLDLASLILYSYQLS 117

Query: 151 ------HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS-PY-Y 202
                  SK  +HRD+   N L ++ D    VK  DFGLS ++E+   Y+   G  P  +
Sbjct: 118 TALAYLESKRFVHRDIAARNVLVSSPD---CVKLGDFGLSRYLEDESYYKASKGKLPIKW 174

Query: 203 IAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
           +APE ++ + +   +D+W  GV ++ IL+ GV PF    +  V   I  GE    R P P
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE----RLPMP 230

Query: 261 SISSSAI-ELVRRMLTQDPKRRITVAQV 287
                 +  L+ +    DP +R    ++
Sbjct: 231 PNCPPTLYSLMTKCWAYDPSKRPRFTEL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 73/271 (26%), Positives = 118/271 (43%), Gaps = 26/271 (9%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+GRG FG         +G   A K I  R  V + E+  +  +++++   S  P IV+F
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68

Query: 100 KAA--YEDDQFVHIVMELCAGG-ELFDRIV---ARGHYSERAAASVFRVIMNVVNVCHSK 153
             A   E D +  I MEL     + F + V    +    E     +    +  +N  + K
Sbjct: 69  YGALFREGDCW--ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALN--YLK 124

Query: 154 ---GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-- 208
               ++HRD+KP N L    D N  +K  DFG+S  + +  A     G   Y+APE +  
Sbjct: 125 EELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP 181

Query: 209 --SQSYGKEADIWSAGVILYILLCGVPPF--WAETDQGVAQAILKGEI-NFQRDPFPSIS 263
                Y   +D+WS G+ LY +  G  P+  W      + Q ++KG+            S
Sbjct: 182 SARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQ-VVKGDPPILSNSEEREFS 240

Query: 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
            S +  +   L +D  +R    ++LEHP++K
Sbjct: 241 PSFVNFINLCLIKDESKRPKYKELLEHPFIK 271

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 82.2 bits (203), Expect = 2e-16
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 21/222 (9%)

Query: 81  RREIEIMRHLSGQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           RRE  +   L   PNIV    + E     +  V E   G  L + + A G         +
Sbjct: 26  RRETALCARLY-HPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRL 84

Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF------IEEGKAY 193
              +++ +   H++G++HRDLKP+N + +        K  DFG+          +     
Sbjct: 85  MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144

Query: 194 R--EIVGSPYYIAPEVL-SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG 250
           R  E++G+P Y APE L  +     +D+++ G+I    L G       +   VA+ + + 
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGAS---VAEILYQ- 200

Query: 251 EINFQRDPF---PSISSSAI-ELVRRMLTQDPKRRITVAQVL 288
                       P I+   + +++R+ L +DP++R   A  L
Sbjct: 201 --QLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAPAL 240

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 81/268 (30%), Positives = 116/268 (43%), Gaps = 38/268 (14%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
            +GRG FG  +     +     A KS  +  L  D+ K    +E  I++  S  PNIV+ 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSC-RETLPPDL-KAKFLQEARILKQYS-HPNIVRL 58

Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARG---------HYSERAAASVFRVIMNVVNVC 150
                  Q ++IVMEL  GG+    +   G            E AAA         +   
Sbjct: 59  IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAG--------MEYL 110

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY----YIAPE 206
            SK  +HRDL   N L T   E  V+K +DFG+S   E+G  Y    G       + APE
Sbjct: 111 ESKHCIHRDLAARNCLVT---EKNVLKISDFGMSREEEDG-VYASTGGMKQIPVKWTAPE 166

Query: 207 VLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
            L+   Y  E+D+WS G++L+     G  P+   ++Q   +AI +G     R P P +  
Sbjct: 167 ALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG----VRLPCPELCP 222

Query: 265 SAI-ELVRRMLTQDPKRR---ITVAQVL 288
            A+  L+ R    DP +R    TV Q L
Sbjct: 223 DAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 77.5 bits (191), Expect = 7e-16
 Identities = 76/281 (27%), Positives = 118/281 (41%), Gaps = 32/281 (11%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSI---PKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
            ++G G  G         TG   A K +    K  + K +      RE++IM H    P 
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQI-----LRELQIM-HECRSPY 64

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-GHYSE----RAAASVFRVIMNVVNVC 150
           IV F  A+ ++  + + ME    G L DRI  + G        + A +V   +  + NV 
Sbjct: 65  IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLS 209
               +MHRD+KP N L  +  +   +K  DFG+S  +    A    VG+  Y++PE +  
Sbjct: 124 R---IMHRDIKPSNILVNSRGQ---IKLCDFGVSGELINSIA-DTFVGTSTYMSPERIQG 176

Query: 210 QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQA----ILKGEINFQRDPFPSISSS 265
             Y  ++D+WS G+ +  L  G  PF         Q     IL       ++P P + SS
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236

Query: 266 -----AIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASD 301
                  + V   L +DP  R T  Q+   P   ++  AS+
Sbjct: 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASN 277

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 78.5 bits (193), Expect = 8e-16
 Identities = 73/314 (23%), Positives = 132/314 (42%), Gaps = 46/314 (14%)

Query: 26  KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIE 85
           K   +V   Y   ++VG G +G      +  TG + A K +  R    ++      RE+ 
Sbjct: 8   KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAYRELR 66

Query: 86  IMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFR 141
           +++H+  + N++     F      D+F    + +   G    +++     SE     +  
Sbjct: 67  LLKHMKHE-NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVY 125

Query: 142 VIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG--- 198
            ++  +   H+ G++HRDLKP N      +E+  +K  DFGL+      +   E+ G   
Sbjct: 126 QMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLAR-----QTDSEMTGYVV 177

Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVP----------------------- 233
           + +Y APEV+     Y +  DIWS G I+  +L G P                       
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237

Query: 234 PFWAETDQGVAQAILKGEINFQRDPF----PSISSSAIELVRRMLTQDPKRRITVAQVLE 289
            F  +     A+  +K    F++  F    P+ +  A+ ++ +ML  D + RIT A+ L 
Sbjct: 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297

Query: 290 HPWLKESGEASDKP 303
           HP+ +E  +  D+ 
Sbjct: 298 HPYFEEFHDPEDET 311

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 73/286 (25%), Positives = 116/286 (40%), Gaps = 42/286 (14%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVE--KDDVRREIEIMRHLSGQPNIV 97
           ++G G +G  +      T    A K +   +L  D E       REI +++ L    NIV
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELK-HKNIV 62

Query: 98  QFKAAYEDDQFVHIVMELCAGG--ELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGV 155
           +       D+ + +V E C     + FD     G        S    ++  +  CHS  V
Sbjct: 63  RLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHNV 120

Query: 156 MHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQSY 212
           +HRDLKP+N L      N  +K  DFGL+ AF    + Y   V + +Y  P+VL  ++ Y
Sbjct: 121 LHRDLKPQNLLINK---NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 177

Query: 213 GKEADIWSAGVILYILL-CGVPPFWAETDQGVAQAILK-----------GEINFQRDPF- 259
               D+WSAG I   L   G P F         + I +           G          
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237

Query: 260 -------------PSISSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
                        P ++S+  +L++ +L  +P +RI+  + L+HP+
Sbjct: 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 75/333 (22%), Positives = 117/333 (35%), Gaps = 105/333 (31%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD----DVRREIEIMRH 89
            Y I  ++G G FG  Y   +  TG   A K     K++   EKD       REI+I++ 
Sbjct: 9   DYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKILKK 63

Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV------- 142
           L   PN+V                       L D  V R   S+R   SV+ V       
Sbjct: 64  LK-HPNVVP----------------------LIDMAVERPDKSKRKRGSVYMVTPYMDHD 100

Query: 143 -----------------------IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKAT 179
                                  ++  +N  H   ++HRD+K  N L    D   ++K  
Sbjct: 101 LSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIA 157

Query: 180 DFGLSAFIEE------------GKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVIL 225
           DFGL+   +              + Y  +V + +Y  PE+L     Y    DIW  G + 
Sbjct: 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVF 217

Query: 226 YILLCGVPPFWAETDQGVAQAILK--------------------GEINFQRDP------F 259
             +    P    ++D      I K                    G  +F   P      F
Sbjct: 218 AEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF 277

Query: 260 PSISSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
             +    ++L+ ++L+ DP +R+T +  LEHP+
Sbjct: 278 GKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 12/200 (6%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+G G  G+ +  +   +GL  A K I     +K   ++ + RE++++ H    P IV F
Sbjct: 12  ELGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVL-HECNSPYIVGF 68

Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV-FRVIMNVVNVCHSKGVMHR 158
             A+  D  + I ME   GG L   +   G   E+    V   VI  +  +     +MHR
Sbjct: 69  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 128

Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS-YGKEAD 217
           D+KP N L  +  E   +K  DFG+S  + +  A    VG+  Y++PE L  + Y  ++D
Sbjct: 129 DVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSVQSD 184

Query: 218 IWSAGVILYILLCG---VPP 234
           IWS G+ L  +  G   +PP
Sbjct: 185 IWSMGLSLVEMAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 68/318 (21%), Positives = 125/318 (39%), Gaps = 62/318 (19%)

Query: 36  TIGREVGRGEFGIT----YLCTENSTGLEFACKSIPKRKLVKDVEKDDVR--REIEIMRH 89
            +   +G+    +           +T       ++ K  L    ++D     +EI   R 
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHKPTNT-----LVAVKKINLDSCSKEDLKLLQQEIITSRQ 55

Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHY----SERAAASVFRVIMN 145
           L   PNI+ +  ++  D  +++V  L A G   D +  + H+     E A A + + ++N
Sbjct: 56  LQ-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLN 112

Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP----- 200
            ++  HSKG +HR +K  + L  +GD   V+    + +S  I+ GK  R +   P     
Sbjct: 113 ALDYIHSKGFIHRSVKASHILL-SGDGKVVLSGLRYSVS-MIKHGKRQRVVHDFPKSSVK 170

Query: 201 --YYIAPEVLSQS---YGKEADIWSAGVILYILLCGVPPFWAETD---------QGVAQA 246
              +++PEVL Q+   Y +++DI+S G+    L  G  PF  +           +G    
Sbjct: 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF-KDMPATQMLLEKVRGTVPC 229

Query: 247 IL-----------------KGEINFQRDPFPSISSSAI-----ELVRRMLTQDPKRRITV 284
           +L                   E    RD      +        + V   L +DP+ R + 
Sbjct: 230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSA 289

Query: 285 AQVLEHPWLKESGEASDK 302
           +Q+L H + K+    +  
Sbjct: 290 SQLLNHSFFKQCKRRNTS 307

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 29/273 (10%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
            E+GRG +G+        TG   A K I  R  V   E+  +  +++I       P  V 
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMRSVDCPYTVT 64

Query: 99  FKAAYEDDQFVHIVMELCAGG--ELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSK-G 154
           F  A   +  V I ME+      + + ++  +G    E     +   I+  +   HSK  
Sbjct: 65  FYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-----S 209
           V+HRD+KP N L    + N  VK  DFG+S ++ +  A     G   Y+APE +      
Sbjct: 125 VIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQ 181

Query: 210 QSYGKEADIWSAGVILYILLCGVPPF--WAETDQGVAQAILKGEINFQRDPFPSI----- 262
           + Y  ++D+WS G+ +  L  G  P+  W    Q + Q +         +P P +     
Sbjct: 182 KGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--------EEPSPQLPAEKF 233

Query: 263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    + V + L ++ K R    ++L+HP+ + 
Sbjct: 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 77.4 bits (190), Expect = 3e-15
 Identities = 76/307 (24%), Positives = 133/307 (43%), Gaps = 64/307 (20%)

Query: 35  YTIGREVGRGEFGITY--LCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG 92
           Y +G  +G G FG+ Y  +C + S       + +  +K+++D +  +  RE+ IM++L+ 
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTS-------EKVAIKKVLQDPQYKN--RELLIMKNLN- 117

Query: 93  QPNIVQFKAAY--------EDDQFVHIVMELCAGGELFDRIVAR--GHYSER-AAASVFR 141
             NI+  K  Y        E + F+++VME         + V +   HY+    A  +F 
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEF------IPQTVHKYMKHYARNNHALPLFL 171

Query: 142 VIMNVVNVC------HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE 195
           V +    +C      HSK + HRDLKP+N L         +K  DFG +  +  G+    
Sbjct: 172 VKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP--NTHTLKLCDFGSAKNLLAGQRSVS 229

Query: 196 IVGSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAET--DQGVAQAILKG- 250
            + S +Y APE++  + +Y    D+WS G I+  ++ G P F  ++  DQ V    + G 
Sbjct: 230 YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289

Query: 251 ---------EINFQRDPFPSISS-------------SAIELVRRMLTQDPKRRITVAQVL 288
                      N+    FP +                AI  + + L  +P +R+   + L
Sbjct: 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349

Query: 289 EHPWLKE 295
             P+  +
Sbjct: 350 ADPFFDD 356

Length = 440

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 75.3 bits (185), Expect = 4e-15
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 30/208 (14%)

Query: 39  REVGRGEFG-ITYLC---TENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           R +G G FG ++  C     + TG   A K++ KR+  +       ++EI I++ L  + 
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL-KRECGQQNT-SGWKKEINILKTLYHE- 66

Query: 95  NIVQFKAAYED--DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC-- 150
           NIV++K    +   + + ++ME    G L D       Y  +   ++ ++++    +C  
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD-------YLPKHKLNLAQLLLFAQQICEG 119

Query: 151 ----HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY---REIVGSP-YY 202
               HS+  +HRDL   N L    D + +VK  DFGL+  + EG  Y   RE   SP ++
Sbjct: 120 MAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176

Query: 203 IAPEVLSQ-SYGKEADIWSAGVILYILL 229
            A E L +  +   +D+WS GV LY LL
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 72/302 (23%), Positives = 122/302 (40%), Gaps = 62/302 (20%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD----DVRREIEIMRHLSGQPNI 96
           +G+G FG  +      T    A K     K++ + EK+       REI+I++ L    N+
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALK-----KVLMENEKEGFPITALREIKILQLLK-HENV 73

Query: 97  VQF-------KAAYEDDQ-FVHIVMELCA---GGELFDRIVARGHYSERAAASVFRVIMN 145
           V            Y   +   ++V E C     G L ++ V    ++      V ++++N
Sbjct: 74  VNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KFTLSEIKKVMKMLLN 130

Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AF----IEEGKAYREIVGSP 200
            +   H   ++HRD+K  N L T   ++ ++K  DFGL+ AF      +   Y   V + 
Sbjct: 131 GLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187

Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAI--LKGEIN--- 253
           +Y  PE+L   + YG   D+W AG I+  +    P     T+Q     I  L G I    
Sbjct: 188 WYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247

Query: 254 ---------FQRDPFPS-------------ISS-SAIELVRRMLTQDPKRRITVAQVLEH 290
                    F++   P              +    A++L+ ++L  DP +RI     L H
Sbjct: 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307

Query: 291 PW 292
            +
Sbjct: 308 DF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 74.4 bits (183), Expect = 5e-15
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 28/227 (12%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T  +E+G G+FG+ +L       ++ A K I +  +     +DD   E ++M  LS  PN
Sbjct: 7   TFLKELGSGQFGVVHLGKWRGK-IDVAIKMIREGAM----SEDDFIEEAKVMMKLS-HPN 60

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNV-VNVC---- 150
           +VQ        + + IV E  A G L + +  R              ++++  +VC    
Sbjct: 61  LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTE------WLLDMCSDVCEAME 114

Query: 151 --HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI---AP 205
              S G +HRDL   N L   G++N VVK +DFGL+ ++ + + Y    G+ + +    P
Sbjct: 115 YLESNGFIHRDLAARNCL--VGEDN-VVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPP 170

Query: 206 EVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
           EV   S +  ++D+WS GV+++ +   G  P+   ++  V +++  G
Sbjct: 171 EVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG 217

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 76/310 (24%), Positives = 132/310 (42%), Gaps = 47/310 (15%)

Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRH 89
           ++   YT  ++VG G +G      +  TG + A K +  R    ++      RE+ +++H
Sbjct: 12  ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAYRELTLLKH 70

Query: 90  L-----SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVI 143
           +      G  ++     + ++ Q  ++VM         D     GH  SE     +   +
Sbjct: 71  MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM----QTDLQKIMGHPLSEDKVQYLVYQM 126

Query: 144 MNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYY 202
           +  +   HS G++HRDLKP N      +E+  +K  DFGL+   + E   Y   V + +Y
Sbjct: 127 LCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGLARHADAEMTGY---VVTRWY 180

Query: 203 IAPEVLSQ--SYGKEADIWSAGVILYILLCGV-----------------------PPFWA 237
            APEV+     Y +  DIWS G I+  +L G                        P F  
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240

Query: 238 ETDQGVAQAILKGEINFQRDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
           + +   A++ +K    + R      FP  S  A++L+ +ML  D  +R+T  + LEHP+ 
Sbjct: 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300

Query: 294 KESGEASDKP 303
               +A ++ 
Sbjct: 301 DSFRDADEET 310

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 65/263 (24%), Positives = 112/263 (42%), Gaps = 35/263 (13%)

Query: 44  GEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRH--LSGQPNIVQFKA 101
           G+FG   +     T   F  K I          K      IE M H  +   PN ++   
Sbjct: 27  GKFGKVSVLKHKPTQKLFVQKII----------KAKNFNAIEPMVHQLMKDNPNFIKLYY 76

Query: 102 AYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLK 161
           +    +   ++M+    G+LFD +   G  SE     + R ++  +N  H   ++H D+K
Sbjct: 77  SVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIK 136

Query: 162 PENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY-------YIAPE-VLSQSYG 213
            EN L+    +   +   D+GL           +I+G+P        Y +PE +   +Y 
Sbjct: 137 LENVLYDRAKDRIYL--CDYGLC----------KIIGTPSCYDGTLDYFSPEKIKGHNYD 184

Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
              D W+ GV+ Y LL G  PF  + D+ +    L  +   ++ PF   +S +A + V+ 
Sbjct: 185 VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLL-KRQQKKLPFIKNVSKNANDFVQS 243

Query: 273 MLTQD-PKRRITVAQVLEHPWLK 294
           ML  +   R     ++++HP+LK
Sbjct: 244 MLKYNINYRLTNYNEIIKHPFLK 266

Length = 267

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 73.4 bits (180), Expect = 2e-14
 Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 32/210 (15%)

Query: 39  REVGRGEFGITYLC----TENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           R++G G FG   LC      ++TG + A KS+            D+++EIEI+R+L  + 
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHE- 66

Query: 95  NIVQFKAAYEDD--QFVHIVMELCAGGELFDRIVARGHYSERAAASV-FRVIMN-VVNVC 150
           NIV++K    +D    + ++ME    G L +       Y  R    +  +  +   V +C
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-------YLPRNKNKINLKQQLKYAVQIC 119

Query: 151 H------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY---REIVGSP- 200
                  S+  +HRDL   N L    +    VK  DFGL+  IE  K Y   ++ + SP 
Sbjct: 120 KGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV 176

Query: 201 YYIAPEVLSQS-YGKEADIWSAGVILYILL 229
           ++ APE L QS +   +D+WS GV LY LL
Sbjct: 177 FWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 76/272 (27%), Positives = 122/272 (44%), Gaps = 46/272 (16%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
            ++G+G FG  Y         E A K+   R  +    K    +E EI++     PNIV+
Sbjct: 1   EKIGKGNFGDVYKGVLK-GNTEVAVKTC--RSTLPPDLKRKFLQEAEILKQYD-HPNIVK 56

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC------HS 152
                   Q ++IVMEL  GG L   +  R    ++   +V +++   ++         S
Sbjct: 57  LIGVCVQKQPIYIVMELVPGGSLLTFL--RK---KKNRLTVKKLLQMSLDAAAGMEYLES 111

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY------REIVGSPY-YIAP 205
           K  +HRDL   N L     EN V+K +DFG+S   EEG  Y      ++I   P  + AP
Sbjct: 112 KNCIHRDLAARNCLV---GENNVLKISDFGMSR-EEEGGIYTVSDGLKQI---PIKWTAP 164

Query: 206 EVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           E L  +YG+   E+D+WS G++L+     G  P+   ++Q   + I  G     R P P 
Sbjct: 165 EAL--NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG----YRMPAPQ 218

Query: 262 ISSSAIELVRRMLTQ----DPKRRITVAQVLE 289
           +    I    R++ Q    DP+ R + +++  
Sbjct: 219 LCPEEI---YRLMLQCWAYDPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 68/256 (26%), Positives = 112/256 (43%), Gaps = 29/256 (11%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
             T+G  +G GEFG         TG + A K+I       DV       E  +M  L  +
Sbjct: 7   KLTLGEIIGEGEFGAVL--QGEYTGQKVAVKNIK-----CDVTAQAFLEETAVMTKLHHK 59

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH-- 151
            N+V+          ++IVMEL + G L + +  RG    RA  SV +++   ++V    
Sbjct: 60  -NLVRLLGVIL-HNGLYIVMELMSKGNLVNFLRTRG----RALVSVIQLLQFSLDVAEGM 113

Query: 152 ----SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV 207
               SK ++HRDL   N L +   E+ V K +DFGL+                 + APE 
Sbjct: 114 EYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARV--GSMGVDNSKLPVKWTAPEA 168

Query: 208 LSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265
           L    +  ++D+WS GV+L+ +   G  P+   + + V + + KG   ++ +P     + 
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG---YRMEPPEGCPAD 225

Query: 266 AIELVRRMLTQDPKRR 281
              L+      +PK+R
Sbjct: 226 VYVLMTSCWETEPKKR 241

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 73.2 bits (179), Expect = 4e-14
 Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 14/201 (6%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+G G  G+        +GL  A K I     +K   ++ + RE++++ H    P IV F
Sbjct: 12  ELGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVL-HECNSPYIVGF 68

Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIV--ARGHYSERAAASVFRVIMNVVNVCHSKGVMH 157
             A+  D  + I ME   GG L D+++  A+    E        V+  +  +     +MH
Sbjct: 69  YGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMH 127

Query: 158 RDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS-YGKEA 216
           RD+KP N L  +  E   +K  DFG+S  + +  A    VG+  Y++PE L  + Y  ++
Sbjct: 128 RDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSVQS 183

Query: 217 DIWSAGVILYILLCG---VPP 234
           DIWS G+ L  L  G   +PP
Sbjct: 184 DIWSMGLSLVELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 68/281 (24%), Positives = 108/281 (38%), Gaps = 41/281 (14%)

Query: 36  TIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           T+ R +G G FG  Y         ++  L+ A K++P+     + ++ D   E  IM   
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE--SCSEQDESDFLMEALIMSKF 66

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDRIV--ARGHYSERAAASVFRVIMNV 146
           +   NIV+      +     I++EL AGG+L  F R         S      +     +V
Sbjct: 67  N-HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125

Query: 147 VNVCH---SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY- 202
              C        +HRD+   N L T      V K  DFG++         R+I  + YY 
Sbjct: 126 AKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRASYYR 176

Query: 203 -----------IAPEV-LSQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILK 249
                      + PE  L   +  + D+WS GV+L+ I   G  P+   T+Q V + +  
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236

Query: 250 GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290
           G    + DP          ++       P+ R   A +LE 
Sbjct: 237 GG---RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 53/200 (26%), Positives = 86/200 (43%), Gaps = 32/200 (16%)

Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPY 201
           I+  +  CH + V+HRDLKP+N L    +E   +K  DFGL+ A     K Y   V + +
Sbjct: 113 ILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPTKTYSNEVVTLW 169

Query: 202 YIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK---------- 249
           Y  P+VL  S  Y  + D+W  G I + +  G P F   T +     I +          
Sbjct: 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229

Query: 250 ---------GEINFQR---DPF----PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
                       NF +    P     P + +  IEL+ + L  + K+RI+  + ++H + 
Sbjct: 230 PGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289

Query: 294 KESGEASDKPIDTAVIFRMK 313
           +  G       ++  IF +K
Sbjct: 290 RSLGTRIHSLPESISIFSLK 309

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 71.6 bits (176), Expect = 6e-14
 Identities = 69/274 (25%), Positives = 116/274 (42%), Gaps = 38/274 (13%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK-----------DVEKDDVRREI 84
           TI + +G GEFG                  +P +K +            D ++ D   E 
Sbjct: 7   TIEKVIGGGEFGEVCR----------GRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEA 56

Query: 85  EIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDRIVARGHYSERAAASVFRV 142
            IM      PNI++ +      + V I+ E    G L  F R    G ++      + R 
Sbjct: 57  SIMGQFD-HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR-ENDGKFTVGQLVGMLRG 114

Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           I + +        +HRDL   N L    + N V K +DFGLS  +E+ +A     G    
Sbjct: 115 IASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIP 171

Query: 203 I---APEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
           I   APE ++ + +   +D+WS G++++ ++  G  P+W  ++Q V +A+  G     R 
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG----YRL 227

Query: 258 PFPSISSSAI-ELVRRMLTQDPKRRITVAQVLEH 290
           P P    SA+ +L+     +D   R T +Q++  
Sbjct: 228 PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 79/292 (27%), Positives = 124/292 (42%), Gaps = 49/292 (16%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD---DVRREIEIMRHLSG--QP 94
           E+G G +G  +   +   G  F      KR  V+  E+       RE+ ++RHL     P
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVAL---KRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 64

Query: 95  NIVQF----KAAYEDDQ------FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
           N+V+       +  D +      F H+  +L       D++   G  +E     +F+++ 
Sbjct: 65  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETIKDMMFQLLR 121

Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIA 204
            + +  HS  V+HRDLKP+N L T+  +   +K  DFGL+       A   +V + +Y A
Sbjct: 122 GL-DFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLWYRA 177

Query: 205 PEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK-----------GEI 252
           PEVL Q SY    D+WS G I   +    P F   +D      IL             ++
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237

Query: 253 NFQRDPFPSISSSAIE------------LVRRMLTQDPKRRITVAQVLEHPW 292
              R  F S S+  IE            L+ + LT +P +RI+    L HP+
Sbjct: 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 65/261 (24%), Positives = 127/261 (48%), Gaps = 21/261 (8%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T  +E+G G+FG+ +L    +  ++ A K+I +  +     ++D   E ++M  LS  P 
Sbjct: 7   TFMKELGSGQFGVVHLGKWRAQ-IKVAIKAINEGAM----SEEDFIEEAKVMMKLS-HPK 60

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKG 154
           +VQ        + ++IV E    G L + +  R G  S+    S+ + +   +       
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI---APEVLSQS 211
            +HRDL   N L +      VVK +DFG++ ++ + + Y    G+ + +    PEV + S
Sbjct: 121 FIHRDLAARNCLVS---STGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVFNFS 176

Query: 212 -YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI-E 268
            Y  ++D+WS GV+++ +   G  PF  +++  V + I +G   ++    P ++S  + E
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR----PKLASMTVYE 232

Query: 269 LVRRMLTQDPKRRITVAQVLE 289
           ++     + P+ R T A++L 
Sbjct: 233 VMYSCWHEKPEGRPTFAELLR 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 69/261 (26%), Positives = 128/261 (49%), Gaps = 23/261 (8%)

Query: 36  TIGREVGRGEFGITYLCT-ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           T+ +E+G G+FG+ +L         + A K+I +  +     ++D   E ++M  LS  P
Sbjct: 7   TLVQEIGSGQFGLVWLGYWLEKR--KVAIKTIREGAM----SEEDFIEEAQVMMKLS-HP 59

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSK 153
            +VQ      +   + +V E    G L D + A RG +S+     +   +   +    S 
Sbjct: 60  KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS 119

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLSQ 210
            V+HRDL   N L     EN VVK +DFG++ F+ + + Y    G+ +   + +PEV S 
Sbjct: 120 NVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSF 175

Query: 211 S-YGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI- 267
           S Y  ++D+WS GV+++ +   G  P+   ++  V + I  G   ++    P ++S ++ 
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK----PRLASQSVY 231

Query: 268 ELVRRMLTQDPKRRITVAQVL 288
           EL++    + P+ R + + +L
Sbjct: 232 ELMQHCWKERPEDRPSFSLLL 252

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 52/181 (28%), Positives = 81/181 (44%), Gaps = 32/181 (17%)

Query: 147 VNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAP 205
           +N CH + V+HRDLKP+N L    +E   +K  DFGL+ A     K Y   V + +Y  P
Sbjct: 117 LNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPP 173

Query: 206 EVL--SQSYGKEADIWSAGVILYILLCGVPPFWAET---------------DQGVAQAIL 248
           ++L  S  Y  + D+W  G I Y +  G P F   T                +     IL
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233

Query: 249 KGE----INFQR---DPF----PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297
             E     N+ +   D      P + S   EL+ ++L  + ++RI+  + ++HP+    G
Sbjct: 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293

Query: 298 E 298
           E
Sbjct: 294 E 294

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 72.9 bits (179), Expect = 1e-13
 Identities = 78/294 (26%), Positives = 117/294 (39%), Gaps = 52/294 (17%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVE--KDDVRREIEIMRHLS 91
            Y I R +G+G  G  YL  +       A K I  R+ + +    K    RE +I   L 
Sbjct: 3   RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKI--REDLSENPLLKKRFLREAKIAADLI 60

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFD--------RIVARGHY---SERAAASVF 140
             P IV   +   D   V+  M    G  L            +++      S  A  S+F
Sbjct: 61  -HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119

Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE------------ 188
             I   +   HSKGV+HRDLKP+N L     E  ++   D+G + F +            
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVIL---DWGAAIFKKLEEEDLLDIDVD 176

Query: 189 -EGKAYRE------IVGSPYYIAPEVLSQSYGKEA----DIWSAGVILYILLCGVPPFWA 237
                Y        IVG+P Y+APE L    G  A    DI++ GVILY +L    P+  
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLL---GVPASESTDIYALGVILYQMLTLSFPYRR 233

Query: 238 ETDQGVA---QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
           +  + ++     +   E+   R+  P +S    ++  + L  DP  R +  Q L
Sbjct: 234 KKGRKISYRDVILSPIEVAPYREIPPFLS----QIAMKALAVDPAERYSSVQEL 283

Length = 932

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 70/284 (24%), Positives = 127/284 (44%), Gaps = 25/284 (8%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G G  G  Y      T    A K IP   +  +++K  +  E+EI+ +    P I+ F 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIP-LDITVELQKQ-IMSELEIL-YKCDSPYIIGFY 65

Query: 101 AAYEDDQFVHIVMELCAGGEL--FDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            A+  +  + I  E   GG L  + +I    H   R A +V + +  +     S  ++HR
Sbjct: 66  GAFFVENRISICTEFMDGGSLDVYRKIPE--HVLGRIAVAVVKGLTYL----WSLKILHR 119

Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           D+KP N L  T  +   VK  DFG+S  +    A +  VG+  Y+APE +  + YG  +D
Sbjct: 120 DVKPSNMLVNTRGQ---VKLCDFGVSTQLVNSIA-KTYVGTNAYMAPERISGEQYGIHSD 175

Query: 218 IWSAGVILYILLCGVPPF-WAETDQG------VAQAILKGEINFQRDPFPSISSSAIELV 270
           +WS G+    L  G  P+   + +QG      + Q I+  +      P    S   +  +
Sbjct: 176 VWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--PVLPVGQFSEKFVHFI 233

Query: 271 RRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQ 314
            + + + PK R     +++HP++ +  + + + +   V   +++
Sbjct: 234 TQCMRKQPKERPAPENLMDHPFIVQYNDGNAEVVSMWVCRALEE 277

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 64/234 (27%), Positives = 100/234 (42%), Gaps = 32/234 (13%)

Query: 40  EVGRGEFGITY-----LCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           E+G G FG  Y        E  +    A K++ +    K   + + R+E E+M  L   P
Sbjct: 12  ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK--VQQEFRQEAELMSDLQ-HP 68

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVI---------MN 145
           NIV        +Q   ++ E  A G+L + +V    +S+  A S    +         ++
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 146 VV-------NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG 198
           +            S   +HRDL   N L     E   VK +DFGLS  I     YR    
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLV---GEGLTVKISDFGLSRDIYSADYYRVQSK 185

Query: 199 SPY---YIAPE-VLSQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAI 247
           S     ++ PE +L   +  E+DIWS GV+L+ I   G+ P++  ++Q V + I
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 70/264 (26%), Positives = 111/264 (42%), Gaps = 63/264 (23%)

Query: 82  REIEIMRHLSGQPNIVQF------KAAYEDDQFVHIVME-----LCAGGELFDRIVARGH 130
           RE+ +M+ L    NI+        + + E+ Q V++VME     LC       +++    
Sbjct: 64  RELVLMK-LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLC-------QVIQMDL 115

Query: 131 YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190
             ER +  +++++  + ++ HS G++HRDLKP N +  +   +  +K  DFGL+      
Sbjct: 116 DHERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTS 171

Query: 191 KAYREIVGSPYYIAPEV-LSQSYGKEADIWSAGVIL---------------------YIL 228
                 V + YY APEV L   Y +  DIWS G I+                      I 
Sbjct: 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE 231

Query: 229 LCGVPP--FWAETDQGVA--------QAILKGEINFQRDPFPSISSS--------AIELV 270
             G P   F +     V          A    E  F    FP  S S        A +L+
Sbjct: 232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLL 291

Query: 271 RRMLTQDPKRRITVAQVLEHPWLK 294
            +ML  DP++RI+V   L+HP++ 
Sbjct: 292 SKMLVIDPEKRISVDDALQHPYIN 315

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 68/269 (25%), Positives = 112/269 (41%), Gaps = 37/269 (13%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK--DDVRREIEIMRHLS 91
              +G  +G+GEFG   L      G + A K +      KD          E  +M  L 
Sbjct: 7   ELKLGATIGKGEFGDVMLGD--YRGQKVAVKCL------KDDSTAAQAFLAEASVMTTLR 58

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC- 150
             PN+VQ          ++IV E  A G L D + +RG    RA  ++ + +   ++VC 
Sbjct: 59  -HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG----RAVITLAQQLGFALDVCE 113

Query: 151 -----HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI-- 203
                  K  +HRDL   N L     E+ V K +DFGL+      +A +        +  
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAK-----EASQGQDSGKLPVKW 165

Query: 204 -APEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
            APE L +  +  ++D+WS G++L+ I   G  P+     + V   + KG   ++ +   
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---YRMEAPE 222

Query: 261 SISSSAIELVRRMLTQDPKRRITVAQVLE 289
                  ++++     DP +R T  Q+ E
Sbjct: 223 GCPPEVYKVMKDCWELDPAKRPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 71.8 bits (176), Expect = 3e-13
 Identities = 38/101 (37%), Positives = 58/101 (57%), Gaps = 10/101 (9%)

Query: 196 IVGSPYYIAPEVL-SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF 254
           I+G+P Y+APE+L  + +G   D W+ GV L+  L G+PPF  ET Q V Q IL  +I  
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI-- 597

Query: 255 QRDPFP----SISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
              P+P     +S +A   +  +LT DP +R  + ++ +HP
Sbjct: 598 ---PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 75/279 (26%), Positives = 111/279 (39%), Gaps = 58/279 (20%)

Query: 41  VGRGEFGITY---LCTENSTGLE---FACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +G G FG  Y          G      A K++  RK   D EK +  +E  +M + +  P
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNFN-HP 59

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVF-----------RVI 143
           NIV+       ++  +I+MEL  GG+L         Y   A    F            + 
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLL-------SYLRDARVERFGPPLLTLKELLDIC 112

Query: 144 MNVVNVCHSKGVM---HRDLKPENFLFT--TGDENAVVKATDFGLSAFIEEGKAYREIVG 198
           ++V   C     M   HRDL   N L +    D + VVK  DFGL+         R+I  
Sbjct: 113 LDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYK 163

Query: 199 SPYY------------IAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
           S YY            +APE L    +  ++D+WS GV+++ IL  G  P+ A  +Q V 
Sbjct: 164 SDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223

Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRIT 283
           Q +  G    +     +      +L+     QDP  R T
Sbjct: 224 QHVTAGG---RLQKPENCPDKIYQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 70.1 bits (171), Expect = 5e-13
 Identities = 79/313 (25%), Positives = 131/313 (41%), Gaps = 56/313 (17%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G  GI     +   G+  A K +  R            RE+ +++ ++   NI+ 
Sbjct: 27  KPIGSGAQGIVCAAFDTVLGINVAVKKL-SRPFQNQTHAKRAYRELVLLKCVN-HKNIIS 84

Query: 99  F------KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
                  + + E+ Q V++VMEL        +++      ER +  +++++  + ++ HS
Sbjct: 85  LLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGIKHL-HS 141

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQS 211
            G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L   
Sbjct: 142 AGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG 198

Query: 212 YGKEADIWSAGVILYILLCGVPPF--------W-----------AETDQGVAQAILKGEI 252
           Y +  DIWS G I+  L+ G   F        W           AE    +   +     
Sbjct: 199 YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVE 258

Query: 253 NFQRDP------------FPSIS-------SSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
           N  + P            FPS S       S A +L+ +ML  DP +RI+V + L HP++
Sbjct: 259 NRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318

Query: 294 K---ESGEASDKP 303
               +  EA   P
Sbjct: 319 TVWYDPAEAEAPP 331

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|238008 cd00051, EFh, EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands

 Score = 62.6 bits (153), Expect = 1e-12
 Identities = 25/61 (40%), Positives = 38/61 (62%)

Query: 340 KLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFIT 399
           +L+E F   D D  GT++ DELKA L  LG  L+E ++ + ++  D DG+G ID+ EF+ 
Sbjct: 1   ELREAFRLFDKDGDGTISADELKAALKSLGEGLSEEEIDEMIREVDKDGDGKIDFEEFLE 60

Query: 400 A 400
            
Sbjct: 61  L 61

Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. Length = 63

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 52/176 (29%), Positives = 74/176 (42%), Gaps = 35/176 (19%)

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL 208
           CH + V+HRDLKP+N L +   E   +K  DFGL+ A     K Y   V + +Y  P+VL
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVL 175

Query: 209 --SQSYGKEADIWSAGVILYILLCGVPPFWAETD--------------------QGVAQA 246
             S  Y    D+W  G I Y +  G P F   TD                     GV+  
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235

Query: 247 ILKGEINFQRDP-------FPSIS--SSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
                 +F   P        P +       EL  + L  +PK+RI+ A+ ++HP+ 
Sbjct: 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 77/315 (24%), Positives = 130/315 (41%), Gaps = 44/315 (13%)

Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +     + A K +  R     +      RE
Sbjct: 6   LNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKL-SRPFQSLIHARRTYRE 64

Query: 84  IEIMRHLS-----GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAAS 138
           + +++H+      G  ++     + E+   V++V  L  G +L + IV     S+     
Sbjct: 65  LRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNL-MGADL-NNIVKCQKLSDEHVQF 122

Query: 139 VFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIV 197
           +   ++  +   HS G++HRDLKP N      +E+  ++  DFGL+    +E   Y   V
Sbjct: 123 LIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLARQADDEMTGY---V 176

Query: 198 GSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAE--TDQ--------GVAQ 245
            + +Y APE++     Y +  DIWS G I+  LL G   F      DQ        G   
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236

Query: 246 AILKGEIN-------FQRDP----------FPSISSSAIELVRRMLTQDPKRRITVAQVL 288
             +  +I+        Q  P          F   +  AI+L+ +ML  D  +RI+ ++ L
Sbjct: 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296

Query: 289 EHPWLKESGEASDKP 303
            HP+  +  +  D+P
Sbjct: 297 AHPYFSQYHDPEDEP 311

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|222177 pfam13499, EF_hand_5, EF-hand domain pair

 Score = 62.0 bits (151), Expect = 1e-12
 Identities = 25/60 (41%), Positives = 36/60 (60%), Gaps = 2/60 (3%)

Query: 418 QYFDKDNNGYITVDELGKAFKDYG--MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMM 475
           +  DKD +GYI V+EL K  K  G  + D+     I+   +E+D+D DGRIS++EF   M
Sbjct: 1   KLLDKDGDGYIDVEELRKLLKALGLKLTDEEVEELIEADFNEIDKDGDGRISFEEFLEAM 60

Length = 60

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 69.1 bits (169), Expect = 2e-12
 Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 22/159 (13%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + I + + RG FG  YL  + +    +A K + K  ++       V+ E + +  LS  P
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-LSKSP 64

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGEL---------FDRIVARGHYSERAAASVFRVIMN 145
            IV    + +    V++VME   GG++         FD  +A  + SE A A        
Sbjct: 65  FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALA-------- 116

Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS 184
            ++  H  G++HRDLKP+N L +       +K TDFGLS
Sbjct: 117 -LDYLHRHGIIHRDLKPDNMLISNEGH---IKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 26/228 (11%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
             T  +E+G G+FG+           + A K I +  +     +D+   E ++M  LS  
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSM----SEDEFIEEAKVMMKLS-H 58

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH-- 151
             +VQ        + ++IV E  + G L + +   G   + +     +++    +VC   
Sbjct: 59  EKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPS-----QLLEMCKDVCEGM 113

Query: 152 ----SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIA 204
               SK  +HRDL   N L    D+   VK +DFGLS ++ + + Y   VGS +   +  
Sbjct: 114 AYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSP 169

Query: 205 PEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
           PEVL  S +  ++D+W+ GV+++ +   G  P+    +    + + +G
Sbjct: 170 PEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG 217

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 68.2 bits (166), Expect = 2e-12
 Identities = 60/238 (25%), Positives = 105/238 (44%), Gaps = 45/238 (18%)

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+   + + E+ Q V++VMEL        +++      ER +  +++++  + ++ HS G
Sbjct: 83  NVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HSAG 139

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSYG 213
           ++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L   Y 
Sbjct: 140 IIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 196

Query: 214 KEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAILKGE 251
           +  DIWS G I+                      I   G P P + +  Q   +  ++  
Sbjct: 197 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256

Query: 252 INFQRDPFPSI----------------SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
             +    FP +                +S A +L+ +ML  DP +RI+V + L+HP++
Sbjct: 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 67.8 bits (165), Expect = 3e-12
 Identities = 66/256 (25%), Positives = 112/256 (43%), Gaps = 50/256 (19%)

Query: 82  REIEIMR-----HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAA 136
           RE+ +M+     ++ G  N+   + + E+ Q V+IVMEL        +++      ER +
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMS 129

Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI 196
             +++++  + ++ HS G++HRDLKP N +  +   +  +K  DFGL+            
Sbjct: 130 YLLYQMLCGIKHL-HSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPY 185

Query: 197 VGSPYYIAPEV-LSQSYGKEADIWSAGVILYILLCG-----------------------V 232
           V + YY APEV L   Y +  DIWS G I+  ++ G                        
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245

Query: 233 PPFWAETDQGVAQAI--------LKGEINFQRDPFPSIS-------SSAIELVRRMLTQD 277
           P F  +    V   +           E  F    FP+ S       S A +L+ +ML  D
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305

Query: 278 PKRRITVAQVLEHPWL 293
             +RI+V + L+HP++
Sbjct: 306 ASKRISVDEALQHPYI 321

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 63/280 (22%), Positives = 111/280 (39%), Gaps = 41/280 (14%)

Query: 36  TIGREVGRGEFGITYL-----CTENSTGLEFACKSIPKRKLVKDVEKDDVRREI----EI 86
           T+ RE+G+G FG+ Y        +       A K+      V +      R E      +
Sbjct: 9   TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKT------VNENASMRERIEFLNEASV 62

Query: 87  MRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM-- 144
           M+  +   ++V+        Q   +VMEL A G+L   +  R    E             
Sbjct: 63  MKEFN-CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQ 119

Query: 145 NVVNVC----------HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR 194
             + +            +K  +HRDL   N +     E+  VK  DFG++  I E   YR
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMTRDIYETDYYR 176

Query: 195 EIVGS--PY-YIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILK 249
           +      P  ++APE L    +  ++D+WS GV+L+ +      P+   +++ V + ++ 
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236

Query: 250 GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
           G      +  P      +EL+R     +PK R T  +++ 
Sbjct: 237 GGHLDLPENCPDK---LLELMRMCWQYNPKMRPTFLEIVS 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 39/222 (17%)

Query: 28  YEDVQLHYTIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKD--DVR 81
           +E+  L +   +++G+G FG   LC     +++TG   A K     KL     +   D  
Sbjct: 1   FEERHLKFI--QQLGKGNFGSVELCRYDPLQDNTGEVVAVK-----KLQHSTAEHLRDFE 53

Query: 82  REIEIMRHLSGQPNIVQFKA-AYEDDQF-VHIVMELCAGGELFDRIVARGHYSERAAASV 139
           REIEI++ L    NIV++K   Y   +  + +VME    G L D       Y ++    +
Sbjct: 54  REIEILKSLQHD-NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRD-------YLQKHRERL 105

Query: 140 F--RVIMNVVNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191
              ++++    +C       SK  +HRDL   N L    +    VK  DFGL+  + + K
Sbjct: 106 DHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTKVLPQDK 162

Query: 192 AY---REIVGSP-YYIAPEVLSQS-YGKEADIWSAGVILYIL 228
            Y   RE   SP ++ APE L++S +   +D+WS GV+LY L
Sbjct: 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 65/269 (24%), Positives = 103/269 (38%), Gaps = 41/269 (15%)

Query: 39  REVGRGEFGIT---YLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           +E+G G FG         ++   +E A K++ +  +     K +  RE  +M  L   P 
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAG--KKEFLREASVMAQLD-HPC 57

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGV 155
           IV+     + +  + +VMEL   G L   +  R          +   +   +    SK  
Sbjct: 58  IVRLIGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHF 116

Query: 156 MHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY------------I 203
           +HRDL   N L     +    K +DFG+S      +A     GS YY             
Sbjct: 117 VHRDLAARNVLLVNRHQ---AKISDFGMS------RALG--AGSDYYRATTAGRWPLKWY 165

Query: 204 APEVLSQSYGK---EADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPF 259
           APE    +YGK   ++D+WS GV L+     G  P+       V   +  GE    R P 
Sbjct: 166 APE--CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE----RLPR 219

Query: 260 PSISSSAI-ELVRRMLTQDPKRRITVAQV 287
           P      I  ++       P+ R T +++
Sbjct: 220 PEECPQEIYSIMLSCWKYRPEDRPTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 65.7 bits (160), Expect = 5e-12
 Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 14/224 (6%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQP 94
            I + +G GEFG          G      +I   K    + ++ D   E  IM      P
Sbjct: 7   KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HP 65

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHS 152
           NI+  +      + V IV E    G L D  + +  G ++      + R I + +     
Sbjct: 66  NIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD 124

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG--KAYREIVGS-PY-YIAPEVL 208
            G +HRDL   N L  +   N V K +DFGLS  +E+    AY    G  P  + APE +
Sbjct: 125 MGYVHRDLAARNILVNS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181

Query: 209 S-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
           + + +   +D+WS G++++ ++  G  P+W  ++Q V +AI +G
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG 225

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 48/173 (27%), Positives = 72/173 (41%), Gaps = 32/173 (18%)

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL 208
           CH + ++HRDLKP+N L    +E   +K  DFGL+ A     K Y   V + +Y  P+VL
Sbjct: 119 CHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 175

Query: 209 --SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS- 265
             S  Y    D+W  G ILY +  G P F   T +     I +       + +P I+S+ 
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235

Query: 266 -------------------------AIELVRRMLTQDPKRRITVAQVLEHPWL 293
                                     I+L+  +L  + K RI+    L H + 
Sbjct: 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 64/259 (24%), Positives = 109/259 (42%), Gaps = 19/259 (7%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           +G GEFG          G      +I   K    + ++ D   E  IM      PNI+  
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNIIHL 70

Query: 100 KAAYEDDQFVHIVMELCAGGEL--FDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMH 157
           +      + V I+ E    G L  F R    G ++      + R I   +        +H
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVH 129

Query: 158 RDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYI---APEVLS-Q 210
           RDL   N L  +   N V K +DFGLS F+E+  +   Y   +G    I   APE ++ +
Sbjct: 130 RDLAARNILVNS---NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186

Query: 211 SYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
            +   +D+WS G++++ ++  G  P+W  ++Q V  AI   E +++  P     ++  +L
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI---EQDYRLPPPMDCPTALHQL 243

Query: 270 VRRMLTQDPKRRITVAQVL 288
           +     +D   R    Q++
Sbjct: 244 MLDCWQKDRNARPKFGQIV 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 39/231 (16%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
           T+G+ +G G FG   +    + G++   K  PK       K++KD   EKD  D+  E+E
Sbjct: 18  TLGKPLGEGCFGQVVMA--EALGID---KDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 72

Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
           +M+ +    NI+    A   D  +++++E  + G L + + AR       +  + RV   
Sbjct: 73  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE 132

Query: 143 ---IMNVVNVCH----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
                ++V+  +          S+  +HRDL   N L T   EN V+K  DFGL+  +  
Sbjct: 133 QMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNN 189

Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPF 235
              Y++         ++APE L  + Y  ++D+WS GV+++ I   G  P+
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 55/230 (23%), Positives = 95/230 (41%), Gaps = 31/230 (13%)

Query: 35  YTIGREVGRGEFGITYLCTEN--STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG 92
           +T+ R++G G FG  +   E      +  A K +    L+K   + D ++E++ ++ L  
Sbjct: 8   FTLERKLGSGYFGEVW---EGLWKNRVRVAIKILKSDDLLK---QQDFQKEVQALKRLR- 60

Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV---------I 143
             +++   A     + V+I+ EL   G L         +       V  V         +
Sbjct: 61  HKHLISLFAVCSVGEPVYIITELMEKGSLL-------AFLRSPEGQVLPVASLIDMACQV 113

Query: 144 MNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY-Y 202
              +     +  +HRDL   N L     E+ V K  DFGL+  I+E          PY +
Sbjct: 114 AEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW 170

Query: 203 IAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
            APE  S  ++  ++D+WS G++LY +   G  P+    +  V   I  G
Sbjct: 171 TAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG 220

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 26/222 (11%)

Query: 41  VGRGEFGITY---LCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIV 97
           +G+G FG  +   L  +    ++   + +P+   +K + +  + ++ +        PNIV
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYD-------HPNIV 55

Query: 98  QFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVN---VCHSKG 154
           +        Q ++IVMEL  GG+    +  R    E     + +  ++         SK 
Sbjct: 56  KLIGVCTQRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKN 113

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG----KAYREIVGSPYYIAPEVLSQ 210
            +HRDL   N L     EN V+K +DFG+S   ++G       ++I     + APE L+ 
Sbjct: 114 CIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNY 168

Query: 211 S-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
             Y  E+D+WS G++L+     GV P+   T+Q   + + KG
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG 210

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 62.8 bits (153), Expect = 7e-11
 Identities = 66/229 (28%), Positives = 104/229 (45%), Gaps = 37/229 (16%)

Query: 36  TIGREVGRGEFG----ITYLCTENSTGLEFACKSIPKRKLVKD--VEKD--DVRREIEIM 87
           T+G+ +G G FG       +  +N         S    K++KD   EKD  D+  E+E+M
Sbjct: 15  TLGKPLGEGAFGQVVKAEAVGLDNPNE-----TSTVAVKMLKDDATEKDLSDLVSEMEMM 69

Query: 88  RHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM--- 144
           + +    NI+        +  +++V+E  A G L D + AR    E A+    R      
Sbjct: 70  KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129

Query: 145 ---NVVNVCH----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191
              ++V+  +          SK  +HRDL   N L T   E+ V+K  DFGL+  I    
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLARDIHHID 186

Query: 192 AYREIVGS--PY-YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPF 235
            YR+      P  ++APE L  + Y  ++D+WS GV+L+ I   G  P+
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 75/323 (23%), Positives = 130/323 (40%), Gaps = 78/323 (24%)

Query: 38  GREVGRGEFGITYLCT--ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           G +VGRG +G  Y     +     ++A K I    +          REI ++R L   PN
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA-----CREIALLRELK-HPN 59

Query: 96  IVQFKAAY--EDDQFVHIVMELCAGGELFDRIVARGHYSERA-----------AASVFRV 142
           ++  +  +    D+ V ++ +  A  +L+   + + H + +A             S+   
Sbjct: 60  VISLQKVFLSHADRKVWLLFDY-AEHDLWH--IIKFHRASKANKKPVQLPRGMVKSLLYQ 116

Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFT-TGDENAVVKATDFGLSAF----IEEGKAYREIV 197
           I++ ++  H+  V+HRDLKP N L    G E   VK  D G +      ++       +V
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176

Query: 198 GSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPF-------------------- 235
            + +Y APE+L  ++ Y K  DIW+ G I   LL   P F                    
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236

Query: 236 ------------WAETDQGVAQAILKGEINFQRDPFPSIS-------------SSAIELV 270
                       W +  +    + L  +  F+R+ + + S             S A  L+
Sbjct: 237 IFNVMGFPADKDWEDIKKMPEHSTLMKD--FRRNTYTNCSLIKYMEKHKVKPDSKAFHLL 294

Query: 271 RRMLTQDPKRRITVAQVLEHPWL 293
           +++LT DP +RIT  Q ++ P+ 
Sbjct: 295 QKLLTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 46/199 (23%), Positives = 78/199 (39%), Gaps = 44/199 (22%)

Query: 134 RAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY 193
             A  + + I+  +   H++ ++HRD+K EN      D+   V   D G + F     A+
Sbjct: 157 DQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ---VCIGDLGAAQFPVVAPAF 213

Query: 194 REIVGSPYYIAPEVLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI 252
             + G+    APEVL++  Y  +ADIWSAG++L+ +L      + +      + +     
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS 273

Query: 253 N--------------FQRDPFPSISSSAIE--------------------------LVRR 272
           +              F RDP   +    IE                          LV +
Sbjct: 274 HLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHK 333

Query: 273 MLTQDPKRRITVAQVLEHP 291
           MLT D   R +  ++L +P
Sbjct: 334 MLTFDAAMRPSAEEILNYP 352

Length = 357

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 23/204 (11%)

Query: 31  VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK-DDVRREIEIMRH 89
           V++ Y I   +  G  G  ++CT++            K+ +VK V       REI+I++ 
Sbjct: 90  VRMQYNILSSLTPGSEGEVFVCTKHGDEQR-------KKVIVKAVTGGKTPGREIDILKT 142

Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMEL--CAGGELFDRIVARGHYSERAAASVFRVIMNVV 147
           +S    I+    AY     V +VM    C   +LF  +   G      A ++ R ++  +
Sbjct: 143 IS-HRAIINLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPLEQAITIQRRLLEAL 198

Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG----LSAFIEEGKAYREIVGSPYYI 203
              H +G++HRD+K EN +F    ENAV+   DFG    L A  +  + Y    G+    
Sbjct: 199 AYLHGRGIIHRDVKTEN-IFLDEPENAVLG--DFGAACKLDAHPDTPQCY-GWSGTLETN 254

Query: 204 APEVLS-QSYGKEADIWSAGVILY 226
           +PE+L+   Y  + DIWSAG++L+
Sbjct: 255 SPELLALDPYCAKTDIWSAGLVLF 278

Length = 392

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 69/279 (24%), Positives = 117/279 (41%), Gaps = 30/279 (10%)

Query: 28  YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM 87
           +ED++    IG     G FG          GL+        ++   + +  D   E+E++
Sbjct: 1   WEDIKFEDVIGE----GNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVL 56

Query: 88  RHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFD-----RIV------ARGHYSERAA 136
             L   PNI+    A E+  +++I +E    G L D     R++      A+ H +    
Sbjct: 57  CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTL 116

Query: 137 AS--VFRVIMNVVNVCH---SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191
            S  + +   +V         K  +HRDL   N L     EN   K  DFGLS   EE  
Sbjct: 117 TSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFGLSRG-EEVY 172

Query: 192 AYREIVGSPY-YIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAIL 248
             + +   P  ++A E L+ S Y  ++D+WS GV+L+ I+  G  P+   T   + + + 
Sbjct: 173 VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP 232

Query: 249 KGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQV 287
           +G   ++ +   +      EL+R+     P  R   AQ+
Sbjct: 233 QG---YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 39/230 (16%)

Query: 37  IGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIEI 86
           +G+ +G G FG   +    + GL+   K  P R      K++K    EKD  D+  E+E+
Sbjct: 22  LGKPLGEGCFGQVVMA--EAIGLD---KEKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 76

Query: 87  MRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR----------------GH 130
           M+ +    NI+    A   D  +++++E  + G L + + AR                  
Sbjct: 77  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136

Query: 131 YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190
            S +   S    +   +    SK  +HRDL   N L T   E+ V+K  DFGL+  I   
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHI 193

Query: 191 KAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPF 235
             Y++         ++APE L  + Y  ++D+WS GV+L+ I   G  P+
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 60.9 bits (147), Expect = 4e-10
 Identities = 76/325 (23%), Positives = 128/325 (39%), Gaps = 82/325 (25%)

Query: 38  GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQ 93
           G +VGRG +G  Y         E       K   +K +E   +     REI ++R L   
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDE-------KEYALKQIEGTGISMSACREIALLRELK-H 57

Query: 94  PNIVQFKAAY--EDDQFVHIVMELCAGGELFDRIVARGHYSERA-----------AASVF 140
           PN++  +  +    D+ V ++ +  A  +L+   + + H + +A             S+ 
Sbjct: 58  PNVIALQKVFLSHSDRKVWLLFDY-AEHDLWH--IIKFHRASKANKKPMQLPRSMVKSLL 114

Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFT-TGDENAVVKATDFGLSAF----IEEGKAYRE 195
             I++ ++  H+  V+HRDLKP N L    G E   VK  D G +      ++       
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 196 IVGSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPF------------------ 235
           +V + +Y APE+L  ++ Y K  DIW+ G I   LL   P F                  
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL 234

Query: 236 --------------WAETDQGVAQAILKGEINFQRDPFPSIS-------------SSAIE 268
                         W +  +      L+ +  F+R  + + S             S    
Sbjct: 235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKD--FRRTTYANSSLIKYMEKHKVKPDSKVFL 292

Query: 269 LVRRMLTQDPKRRITVAQVLEHPWL 293
           L++++LT DP +RIT  Q L+ P+ 
Sbjct: 293 LLQKLLTMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 66/258 (25%), Positives = 110/258 (42%), Gaps = 19/258 (7%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSG 92
           H T  + +G GEFG  +       G +    +I   K    + ++ D   E  IM   S 
Sbjct: 6   HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH 65

Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVC 150
             NI++ +      +   I+ E    G L D+ +    G +S      + R I   +   
Sbjct: 66  H-NIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-KAYREIVGSPYYI---APE 206
                +HRDL   N L    + N   K +DFGLS  +E+  +      G    I   APE
Sbjct: 124 SDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180

Query: 207 VLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
            ++ + +   +D+WS G++++ ++  G  P+W  ++  V +AI  G     R P P    
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG----FRLPAPMDCP 236

Query: 265 SAI-ELVRRMLTQDPKRR 281
           SA+ +L+ +   QD  RR
Sbjct: 237 SAVYQLMLQCWQQDRARR 254

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 68/262 (25%), Positives = 110/262 (41%), Gaps = 22/262 (8%)

Query: 40  EVGRGEFGITYLCTENSTGLEF---ACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNI 96
           ++G G FG+      +++G +    A K +   KL   +  DD  +E  IM  L    N+
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIM--DDFLKEAAIMHSLD-HENL 58

Query: 97  VQFKAAYEDDQFVHIVMELCAGGELFDRI--VARGHYSERAAASVFRVIMNVVNVCHSKG 154
           ++          + +V EL   G L DR+   A GH+           I N +    SK 
Sbjct: 59  IRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYR--EIVGSPY-YIAPEVLS- 209
            +HRDL   N L  + D+   VK  DFGL  A  +    Y   E +  P+ + APE L  
Sbjct: 118 FIHRDLAARNILLASDDK---VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174

Query: 210 QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI- 267
           +++   +D+W  GV L+ +   G  P+   +   + + I K     +R   P      I 
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK---EGERLERPEACPQDIY 231

Query: 268 ELVRRMLTQDPKRRITVAQVLE 289
            ++ +    +P  R T A + E
Sbjct: 232 NVMLQCWAHNPADRPTFAALRE 253

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 59.9 bits (145), Expect = 5e-10
 Identities = 63/267 (23%), Positives = 117/267 (43%), Gaps = 28/267 (10%)

Query: 35  YTIGREVGRGEFGI---TYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           +T+GR +G+GEFG      L +E+ +  + A K + K  +    + ++  RE   M+   
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59

Query: 92  GQPNIVQF------KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
             PN+++         A        +++     G+L   ++      E     +  ++  
Sbjct: 60  -HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118

Query: 146 VVNVC------HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
           ++++        SK  +HRDL   N +    +EN  V   DFGLS  I  G  YR+   S
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQGCAS 175

Query: 200 PY---YIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINF 254
                ++A E L+ + Y   +D+W+ GV ++ I+  G  P+    +  +   ++KG  N 
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG--NR 233

Query: 255 QRDPFPSISSSAIELVRRMLTQDPKRR 281
            + P P       EL+ +  + +PK R
Sbjct: 234 LKQP-PDCLEDVYELMCQCWSPEPKCR 259

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 59.7 bits (144), Expect = 5e-10
 Identities = 63/266 (23%), Positives = 110/266 (41%), Gaps = 26/266 (9%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G G FG          GL         ++     +  D   E+E++  L   PNI+   
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 101 AAYEDDQFVHIVMELCAGGELFD-----RIV------ARGHYSERAAAS--VFRVIMNVV 147
            A E   ++++ +E    G L D     R++      A  + +    +S  +     +V 
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 148 N---VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY-YI 203
                   K  +HRDL   N L     EN V K  DFGLS   +E    + +   P  ++
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRG-QEVYVKKTMGRLPVRWM 178

Query: 204 APEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           A E L+ S Y   +D+WS GV+L+ I+  G  P+   T   + + + +G   ++ +   +
Sbjct: 179 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEKPLN 235

Query: 262 ISSSAIELVRRMLTQDPKRRITVAQV 287
                 +L+R+   + P  R + AQ+
Sbjct: 236 CDDEVYDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 59.9 bits (145), Expect = 5e-10
 Identities = 63/259 (24%), Positives = 112/259 (43%), Gaps = 19/259 (7%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 63

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSK 153
           +VQ       +   +I+ E    G L D +         A   ++    I + +     K
Sbjct: 64  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 123

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI---APEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G  Y    G+ + I   APE L+ 
Sbjct: 124 NFIHRDLAARNCLVG---ENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAY 179

Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+       V + + KG   ++ +          E
Sbjct: 180 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG---YRMERPEGCPPKVYE 236

Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 237 LMRACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 50/180 (27%), Positives = 72/180 (40%), Gaps = 45/180 (25%)

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL- 208
           H + ++HRDLKP+N L +   E   +K  DFGL+ A     + Y   V + +Y  P+VL 
Sbjct: 120 HGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLL 176

Query: 209 -SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ------RDPFPS 261
            +  Y    DIW AG I   +L G P F      GV+    + E  +        D +P 
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQPAF-----PGVSDVFEQLEKIWTVLGVPTEDTWPG 231

Query: 262 ISS----------------------------SAIELVRRMLTQDPKRRITVAQVLEHPWL 293
           +S                              A +L  +ML   PK RI+    L HP+ 
Sbjct: 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 14/193 (7%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRK--LVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +  F I    T  + G  FAC      +  ++K  ++     E  I+R ++  P+I+Q
Sbjct: 89  IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAIN-HPSIIQ 147

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            K  +  ++F  +++      +L+  + A+ + +     ++ R ++  +   H   ++HR
Sbjct: 148 LKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHR 206

Query: 159 DLKPEN-FLFTTGDENAVVKATDFGLSAF---IEEGKAYREIVGSPYYIAPEVLSQS-YG 213
           D+K EN F+   GD    V   DFG + F   I   K Y    G+    APE+L++  YG
Sbjct: 207 DIKAENIFINHPGD----VCLGDFGAACFPVDINANK-YYGWAGTIATNAPELLARDPYG 261

Query: 214 KEADIWSAGVILY 226
              DIWSAG++L+
Sbjct: 262 PAVDIWSAGIVLF 274

Length = 391

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 33/218 (15%)

Query: 38  GREVGRGEFG-----ITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG 92
           G+ +G G FG       Y  +++   ++ A K +  +      E++ +  E++IM HL  
Sbjct: 40  GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKML--KPTAHSSEREALMSELKIMSHLGN 97

Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH- 151
             NIV    A      + ++ E C  G+L + +         +  ++  ++     V   
Sbjct: 98  HENIVNLLGACTIGGPILVITEYCCYGDLLNFL----RRKRESFLTLEDLLSFSYQVAKG 153

Query: 152 -----SKGVMHRDLKPENFLFTTGDENAVVKATDFGL-------SAFIEEGKAYREIVGS 199
                SK  +HRDL   N L T G    +VK  DFGL       S ++ +G A   +   
Sbjct: 154 MAFLASKNCIHRDLAARNVLLTHGK---IVKICDFGLARDIMNDSNYVVKGNARLPV--- 207

Query: 200 PYYIAPE-VLSQSYGKEADIWSAGVILY-ILLCGVPPF 235
             ++APE + +  Y  E+D+WS G++L+ I   G  P+
Sbjct: 208 -KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 71/275 (25%), Positives = 121/275 (44%), Gaps = 62/275 (22%)

Query: 37  IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNI 96
           + R++G G+FG  ++ T N T  + A K++    +      +   +E +IM+ L     +
Sbjct: 10  LERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGTM----SPEAFLQEAQIMKKLR-HDKL 63

Query: 97  VQFKAAYEDDQFVHIVMELCAGGELFDRI-------------------VARG-HYSERAA 136
           VQ  A   +++ ++IV E  + G L D +                   +A G  Y E   
Sbjct: 64  VQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES-- 121

Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI 196
                   N +         HRDL   N L     EN V K  DFGL+  IE+ + Y   
Sbjct: 122 -------RNYI---------HRDLAARNILV---GENLVCKIADFGLARLIEDDE-YTAR 161

Query: 197 VGSPYYI---APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILK 249
            G+ + I   APE  + +YG+   ++D+WS G++L  I+  G  P+   T++ V + + +
Sbjct: 162 EGAKFPIKWTAPE--AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER 219

Query: 250 GEINFQRDPFPSISSSAI-ELVRRMLTQDPKRRIT 283
           G     R P P      + +L+ +   +DP+ R T
Sbjct: 220 G----YRMPRPPNCPEELYDLMLQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 75/301 (24%), Positives = 130/301 (43%), Gaps = 57/301 (18%)

Query: 39  REVGRGEFGITYL------CTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG 92
           RE+G G FG  +L      C E    L  A K++   K   D  + D  RE E++ +L  
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKIL-VAVKTL---KDASDNARKDFHREAELLTNLQH 66

Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG---------------------HY 131
           + +IV+F     +   + +V E    G+L   + A G                     H 
Sbjct: 67  E-HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 132 SERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191
           +++ AA +  +         S+  +HRDL   N L     EN +VK  DFG+S  +    
Sbjct: 126 AQQIAAGMVYLA--------SQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTD 174

Query: 192 AYREIVGSPY-----YIAPE-VLSQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
            YR  VG        ++ PE ++ + +  E+D+WS GV+L+ I   G  P++  ++  V 
Sbjct: 175 YYR--VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232

Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPI 304
           + I +G +  QR    +      +L+     ++P  R+ + ++  H  L+   +AS   +
Sbjct: 233 ECITQGRV-LQRP--RTCPKEVYDLMLGCWQREPHMRLNIKEI--HSLLQNLAKASPVYL 287

Query: 305 D 305
           D
Sbjct: 288 D 288

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 70/264 (26%), Positives = 111/264 (42%), Gaps = 44/264 (16%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           R++G G+FG  +    N+T    A K++    +    +  D   E +IM+ L   P ++Q
Sbjct: 12  RKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQ 65

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGH-----------YSERAAASVFRVIMNVV 147
             A    ++ ++IV EL   G L + +                 ++ A+   +    N +
Sbjct: 66  LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYI 125

Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI---A 204
                    HRDL   N L     EN + K  DFGL+  I+E   Y    G+ + I   A
Sbjct: 126 ---------HRDLAARNVLV---GENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTA 172

Query: 205 PE-VLSQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
           PE  L   +  ++D+WS G++L  I+  G  P+   T+  V Q + +G     R P P  
Sbjct: 173 PEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG----YRMPCP-- 226

Query: 263 SSSAIELVRRML---TQDPKRRIT 283
                EL   ML    +DP  R T
Sbjct: 227 PGCPKELYDIMLDCWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 73/314 (23%), Positives = 138/314 (43%), Gaps = 42/314 (13%)

Query: 28  YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD- 78
           +E  +   T+G+ +G G FG   +    + G++   K  P +      K++KD   +KD 
Sbjct: 7   WELSRTRLTLGKPLGEGCFGQVVMA--EAIGID---KDKPNKPVTVAVKMLKDDATDKDL 61

Query: 79  -DVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG----HYSE 133
            D+  E+E+M+ +    NI+    A   D  +++++E  + G L + + AR      YS 
Sbjct: 62  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSF 121

Query: 134 RAA------------ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDF 181
                           S    +   +    S+  +HRDL   N L T   E+ V+K  DF
Sbjct: 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADF 178

Query: 182 GLSAFIEEGKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFW 236
           GL+  +     Y++         ++APE L  + Y  ++D+WS GV+L+ I   G  P+ 
Sbjct: 179 GLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238

Query: 237 AETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
               + + + + +G    + D   + +     ++R      P +R T  Q++E      +
Sbjct: 239 GIPVEELFKLLKEGH---RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295

Query: 297 GEASDKPIDTAVIF 310
             ++D+ +D +V F
Sbjct: 296 VTSTDEYLDLSVPF 309

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 68/271 (25%), Positives = 118/271 (43%), Gaps = 35/271 (12%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
           ++++L  TIG+    GEFG   L   +  G + A K I       D        E  +M 
Sbjct: 6   KELKLLQTIGK----GEFGDVML--GDYRGNKVAVKCIKN-----DATAQAFLAEASVMT 54

Query: 89  HLSGQPNIVQFKAA-YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVV 147
            L    N+VQ      E+   ++IV E  A G L D + +RG    R+      ++   +
Sbjct: 55  QLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG----RSVLGGDCLLKFSL 109

Query: 148 NVC------HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY 201
           +VC       +   +HRDL   N L +   E+ V K +DFGL+   +E  + ++    P 
Sbjct: 110 DVCEAMEYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPV 163

Query: 202 -YIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            + APE L +  +  ++D+WS G++L+ I   G  P+     + V   + KG   ++ D 
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDA 220

Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
                    +++++    D   R +  Q+ E
Sbjct: 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 56.9 bits (137), Expect = 7e-09
 Identities = 77/293 (26%), Positives = 124/293 (42%), Gaps = 46/293 (15%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPK----------RKLVKDVEK---DDVRREIEI 86
           ++G G+FG  +LC E     EF  +  P+          + L  DV K   +D  +EI+I
Sbjct: 12  KLGEGQFGEVHLC-EAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70

Query: 87  MRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAA----SVFRV 142
           M  L   PNI++       D  + ++ E    G+L   +  R   S    A    SV   
Sbjct: 71  MSRLK-NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129

Query: 143 IMNVVNVCHSKGV--------MHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR 194
            +  + V  + G+        +HRDL   N L      +  +K  DFG+S  +  G  YR
Sbjct: 130 NLLYMAVQIASGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADFGMSRNLYSGDYYR 186

Query: 195 ---EIVGSPYYIAPE-VLSQSYGKEADIWSAGVILY--ILLCGVPPFWAETDQGVAQAIL 248
                V    ++A E +L   +   +D+W+ GV L+    LC   P+   +D+ V +   
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN-- 244

Query: 249 KGEI--NFQRDPF----PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
            GE   N  R  +    P   S   +L+ R  ++D K R T  ++  H +L+E
Sbjct: 245 TGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI--HHFLRE 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 49/182 (26%), Positives = 75/182 (41%), Gaps = 15/182 (8%)

Query: 51  LCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH 110
           L  +  T   F  K + K            R  + I+ H    PN+V        +  V 
Sbjct: 11  LVMDTRTQQTFILKGLRKSSEYS-------RERLTIIPH--CVPNMVCLHKYIVSEDSVF 61

Query: 111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG 170
           +V++   GG+L+  I    +  E         ++  ++  H +G++ RDL P N L    
Sbjct: 62  LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL--- 118

Query: 171 DENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEA-DIWSAGVILYILL 229
           D+   ++ T F   + +E+     E V    Y APEV   S   EA D WS G IL+ LL
Sbjct: 119 DDRGHIQLTYFSRWSEVED-SCDGEAV-ENMYCAPEVGGISEETEACDWWSLGAILFELL 176

Query: 230 CG 231
            G
Sbjct: 177 TG 178

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 72/280 (25%), Positives = 116/280 (41%), Gaps = 43/280 (15%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQP 94
           RE+G G FG  +L  E         K +   K +K+   +D R    RE E++ +     
Sbjct: 11  RELGEGAFGKVFL-GECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHE 68

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH--- 151
           NIV+F     +     +V E    G+L      R H  + A        M  + +     
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNK--FLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126

Query: 152 -------------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG 198
                        S+  +HRDL   N L      + VVK  DFG+S  +     YR + G
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVGY---DLVVKIGDFGMSRDVYTTDYYR-VGG 182

Query: 199 SPY----YIAPEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
                  ++ PE  S  Y K   E+D+WS GV+L+ I   G  P++  +++ V + I +G
Sbjct: 183 HTMLPIRWMPPE--SIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240

Query: 251 EINFQRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQVLE 289
               QR   P    S + +++     +DP++RI +  + E
Sbjct: 241 -RLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 7/94 (7%)

Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE---EGKAY 193
            +V R +++ ++  H +G++HRD+K EN +   G E+  +   DFG + F         +
Sbjct: 263 TAVARQLLSAIDYIHGEGIIHRDIKTEN-VLVNGPEDICLG--DFGAACFARGSWSTPFH 319

Query: 194 REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILY 226
             I G+    APEVL+   Y    DIWSAG++++
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353

Length = 461

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 56/231 (24%), Positives = 104/231 (45%), Gaps = 39/231 (16%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
            +G+ +G G FG   +    + G++   KS P +      K++KD   +KD  D+  E+E
Sbjct: 15  VLGKPLGEGCFG--QVVRAEAYGID---KSRPDQTVTVAVKMLKDNATDKDLADLISEME 69

Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR----------------G 129
           +M+ +    NI+        +  +++++E  A G L + + AR                 
Sbjct: 70  LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE 129

Query: 130 HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
             S +   S    +   +    S+  +HRDL   N L T   E+ V+K  DFGL+  + +
Sbjct: 130 QLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGVHD 186

Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPF 235
              Y++         ++APE L  + Y  ++D+WS G++++ I   G  P+
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 46/223 (20%)

Query: 39  REVGRGEFGITY---LCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           R +G+G FG  Y   L   +   +  A KS+ +   +++VE+    +E  IM+  S  PN
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ--FLKEGIIMKDFS-HPN 57

Query: 96  IVQFKA-AYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH--- 151
           ++         +    +V+     G+L + I      SE    +V  +I   + V     
Sbjct: 58  VLSLLGICLPSEGSPLVVLPYMKHGDLRNFI-----RSETHNPTVKDLIGFGLQVAKGME 112

Query: 152 ---SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY------ 202
              SK  +HRDL   N +    DE+  VK  DFGL+         R+I    YY      
Sbjct: 113 YLASKKFVHRDLAARNCML---DESFTVKVADFGLA---------RDIYDKEYYSVHNHT 160

Query: 203 --------IAPEVL-SQSYGKEADIWSAGVILYILLC-GVPPF 235
                   +A E L +Q +  ++D+WS GV+L+ L+  G PP+
Sbjct: 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 64/267 (23%), Positives = 109/267 (40%), Gaps = 26/267 (9%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G G FG          GL         ++     +  D   E+E++  L   PNI+   
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 101 AAYEDDQFVHIVMELCAGGELFDRI-------------VARGHYSERAAASVFRVIMNV- 146
            A E   ++++ +E    G L D +             +A    S  ++  +     +V 
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 147 --VNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY-YI 203
             ++    K  +HRDL   N L     EN V K  DFGLS   +E    + +   P  ++
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRG-QEVYVKKTMGRLPVRWM 190

Query: 204 APEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           A E L+ S Y   +D+WS GV+L+ I+  G  P+   T    A+   K    ++ +   +
Sbjct: 191 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKLPQGYRLEKPLN 247

Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVL 288
                 +L+R+   + P  R + AQ+L
Sbjct: 248 CDDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 59/248 (23%), Positives = 104/248 (41%), Gaps = 50/248 (20%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK----DDVRREIEIMRHLSGQPN 95
           E+G   FG  Y       G++ A   +   K +KD+       + ++E  +M  L   PN
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHA--QLVAIKTLKDINNPQQWGEFQQEASLMAELH-HPN 68

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAAS----VFRVIMNVVNVCH 151
           IV        +Q V ++ E    G+L + ++ R  +S+   +S      +  ++  +  H
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 152 -------------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG 198
                        S   +H+DL   N L     E   VK +D GLS         REI  
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQLHVKISDLGLS---------REIYS 176

Query: 199 SPYY------------IAPE-VLSQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
           + YY            + PE ++   +  ++DIWS GV+L+ I   G+ P++  ++Q V 
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236

Query: 245 QAILKGEI 252
           + + K ++
Sbjct: 237 EMVRKRQL 244

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|222177 pfam13499, EF_hand_5, EF-hand domain pair

 Score = 48.9 bits (117), Expect = 6e-08
 Identities = 19/58 (32%), Positives = 30/58 (51%), Gaps = 4/58 (6%)

Query: 347 EMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQ----YMQAADIDGNGTIDYIEFITA 400
            +D D  G +  +EL+  L  LG  LT+ +V++         D DG+G I + EF+ A
Sbjct: 2   LLDKDGDGYIDVEELRKLLKALGLKLTDEEVEELIEADFNEIDKDGDGRISFEEFLEA 59

Length = 60

>gnl|CDD|185504 PTZ00184, PTZ00184, calmodulin; Provisional

 Score = 51.3 bits (123), Expect = 8e-08
 Identities = 25/70 (35%), Positives = 43/70 (61%), Gaps = 2/70 (2%)

Query: 335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDY 394
           +EE  ++KE F   D D +G ++  EL+  +  LG  LT+ +V + ++ AD+DG+G I+Y
Sbjct: 82  SEE--EIKEAFKVFDRDGNGFISAAELRHVMTNLGEKLTDEEVDEMIREADVDGDGQINY 139

Query: 395 IEFITATMQR 404
            EF+   M +
Sbjct: 140 EEFVKMMMSK 149

Length = 149

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 64/281 (22%), Positives = 117/281 (41%), Gaps = 45/281 (16%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPK-----RKLVKDV-EKDDVRREIEIMRH 89
           T+ RE+G+G FG+ Y         E   K + K     R  +K V E   +R  IE +  
Sbjct: 9   TMSRELGQGSFGMVY---------EGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 59

Query: 90  LSGQP-----NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            S        ++V+        Q   ++MEL   G+L   + +     E         + 
Sbjct: 60  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119

Query: 145 NVVNVC----------HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR 194
            ++ +           ++   +HRDL   N +     E+  VK  DFG++  I E   YR
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 176

Query: 195 EIVGSP-----YYIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAI 247
           +  G        +++PE L    +   +D+WS GV+L+ I      P+   +++ V + +
Sbjct: 177 K--GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234

Query: 248 LKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
           ++G +  + D  P +     EL+R     +PK R +  +++
Sbjct: 235 MEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 49/213 (23%)

Query: 70  KLVKDVEKDDVRREIE---IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIV 126
           K +KD  +  +R E +   +MR     PNIV        +Q + ++   C+  +L + +V
Sbjct: 41  KTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLV 100

Query: 127 ARGHYSERAA-------------ASVFRVIMNV---VNVCHSKGVMHRDLKPENFLFTTG 170
            R  +S+  +             A    ++  +   +    S  V+H+DL   N L    
Sbjct: 101 MRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF-- 158

Query: 171 DENAVVKATDFGLSAFIEEGKAYREIVGSPYY------------IAPEVLSQSYGK---E 215
            +   VK +D GL         +RE+  + YY            ++PE +   YGK   +
Sbjct: 159 -DKLNVKISDLGL---------FREVYAADYYKLMGNSLLPIRWMSPEAI--MYGKFSID 206

Query: 216 ADIWSAGVILY-ILLCGVPPFWAETDQGVAQAI 247
           +DIWS GV+L+ +   G+ P+   ++Q V + I
Sbjct: 207 SDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 72/309 (23%), Positives = 119/309 (38%), Gaps = 65/309 (21%)

Query: 34  HYTIGREVGRGEFGITYLCTENST-------GLEFACKSIPK----RKLVKDV---EKDD 79
                 ++G G+FG  +LC  +           E      P     + L  D     ++D
Sbjct: 6   PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65

Query: 80  VRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
             +E++I+  LS  PNI +       D  + ++ME    G+L         + ++  A  
Sbjct: 66  FLKEVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDL-------NQFLQKHVAET 117

Query: 140 FRVIMNV--------VNVC----------HSKGVMHRDLKPENFLFTTGDENAVVKATDF 181
             +  N         + +            S   +HRDL   N L     +N  +K  DF
Sbjct: 118 SGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV---GKNYTIKIADF 174

Query: 182 GLSAFIEEGKAYREIVGSP----YYIAPE-VLSQSYGKEADIWSAGVILY-IL-LCGVPP 234
           G+S  +     YR + G       ++A E VL   +  ++D+W+ GV L+ IL LC   P
Sbjct: 175 GMSRNLYSSDYYR-VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233

Query: 235 FWAETDQGVAQAILKGEINFQRD-------PFPSISSSAI-ELVRRMLTQDPKRRITVAQ 286
           +   TDQ V +       +F RD       P P      I EL+     +D + R T  +
Sbjct: 234 YEHLTDQQVIENA----GHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFRE 289

Query: 287 VLEHPWLKE 295
           +  H +L+ 
Sbjct: 290 I--HLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 41/146 (28%), Positives = 60/146 (41%), Gaps = 29/146 (19%)

Query: 156 MHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE--------- 206
           +HRDL   N L     EN VVK  DFGLS         R I  + YY A E         
Sbjct: 152 VHRDLATRNCLVG---ENMVVKIADFGLS---------RNIYSADYYKASENDAIPIRWM 199

Query: 207 ----VLSQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
               +    Y  E+D+W+ GV+L+ I   G+ P++    + V   +  G +    D  P 
Sbjct: 200 PPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCP- 258

Query: 262 ISSSAIELVRRMLTQDPKRRITVAQV 287
                  L+R   ++ P  R + A +
Sbjct: 259 --LELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 65/273 (23%), Positives = 118/273 (43%), Gaps = 35/273 (12%)

Query: 40  EVGRGEFGITYL--CTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIV 97
           E+G G FG  +L  C       +    ++   K   +  + D +RE E++  L  Q +IV
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQ-HIV 70

Query: 98  QFKAAYEDDQFVHIVMELCAGGEL--FDR-------IVARGHYSERAAASVFRVIMNVVN 148
           +F     + + + +V E    G+L  F R       I+A G        ++ +++     
Sbjct: 71  RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130

Query: 149 VCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY- 201
           +        S   +HRDL   N L     +  VVK  DFG+S  I     YR  VG    
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYR--VGGRTM 185

Query: 202 ----YIAPE-VLSQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG-EINF 254
               ++ PE +L + +  E+DIWS GV+L+ I   G  P++  ++    + I +G E+  
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELER 245

Query: 255 QRDPFPSISSSAIELVRRMLTQDPKRRITVAQV 287
            R    +       +++    ++P++R+ +  +
Sbjct: 246 PR----TCPPEVYAIMQGCWQREPQQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 67/278 (24%), Positives = 123/278 (44%), Gaps = 42/278 (15%)

Query: 39  REVGRGEFGITYL--CTENSTGLEFACKSIPKRKLVKD---VEKDDVRREIEIMRHLSGQ 93
           RE+G G FG  +L  C   S   +   K +   K +KD     + D +RE E++ +L   
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKD---KMLVAVKALKDPTLAARKDFQREAELLTNLQ-H 66

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG-------------HYSERAAASVF 140
            +IV+F     D   + +V E    G+L   + A G                E   + + 
Sbjct: 67  EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126

Query: 141 RVIMNVVN---VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV 197
            +   + +      S+  +HRDL   N L      N +VK  DFG+S  +     YR  V
Sbjct: 127 HIASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDFGMSRDVYSTDYYR--V 181

Query: 198 GSPY-----YIAPE-VLSQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
           G        ++ PE ++ + +  E+D+WS GVIL+ I   G  P++  ++  V + I +G
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241

Query: 251 EINFQRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQV 287
            +  +R   P +    + +++     ++P++R+ + ++
Sbjct: 242 RV-LER---PRVCPKEVYDIMLGCWQREPQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 64/255 (25%), Positives = 114/255 (44%), Gaps = 29/255 (11%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G+G FG  ++ T N T  + A K++    ++ +       +E +IM+ L     +  +
Sbjct: 13  KLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEA----FLQEAQIMKKLRHDKLVPLY 67

Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARG---HYSERAAASVFRVIMNVVNVCHSKGVM 156
               E+   ++IV E    G L D  +  G   +        +   I + +        +
Sbjct: 68  AVVSEEP--IYIVTEFMGKGSLLD-FLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYI 124

Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLSQSYG 213
           HRDL+  N L     +N V K  DFGL+  IE+ + Y    G+ +   + APE  +  YG
Sbjct: 125 HRDLRAANILVG---DNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPE--AALYG 178

Query: 214 K---EADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIE 268
           +   ++D+WS G++L  L+  G  P+    ++ V + + +G     R P P     S  E
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG----YRMPCPQGCPESLHE 234

Query: 269 LVRRMLTQDPKRRIT 283
           L++    +DP  R T
Sbjct: 235 LMKLCWKKDPDERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 47/156 (30%), Positives = 70/156 (44%), Gaps = 36/156 (23%)

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI-------- 203
           S+  +HRDL   N L +   EN VVK  DFGL+         R+I   P Y+        
Sbjct: 192 SRKCIHRDLAARNILLS---ENNVVKICDFGLA---------RDIYKDPDYVRKGSARLP 239

Query: 204 ----APE-VLSQSYGKEADIWSAGVILY-ILLCGVPPF-WAETDQGVAQAILKGEINFQR 256
               APE +  + Y  ++D+WS GV+L+ I   G  P+   + ++   Q +  G     R
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG----TR 295

Query: 257 DPFPSISSSAIELVRRMLT---QDPKRRITVAQVLE 289
              P  ++  I   R ML     DPK R T + ++E
Sbjct: 296 MRAPENATPEIY--RIMLACWQGDPKERPTFSALVE 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 52.4 bits (125), Expect = 4e-07
 Identities = 29/91 (31%), Positives = 49/91 (53%), Gaps = 6/91 (6%)

Query: 138 SVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI- 196
           ++ + ++  V   H K ++HRD+K EN +F   D   V+   DFG +   E+ +   +  
Sbjct: 271 AIMKQLLCAVEYIHDKKLIHRDIKLEN-IFLNCDGKIVLG--DFGTAMPFEKEREAFDYG 327

Query: 197 -VGSPYYIAPEVLSQ-SYGKEADIWSAGVIL 225
            VG+    +PE+L+   Y +  DIWS G+IL
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLIL 358

Length = 501

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 36/157 (22%)

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI-------- 203
           S+  +HRDL   N L +   EN VVK  DFGL+         R+I   P Y+        
Sbjct: 197 SRKCIHRDLAARNILLS---ENNVVKICDFGLA---------RDIYKDPDYVRKGDARLP 244

Query: 204 ----APE-VLSQSYGKEADIWSAGVILY-ILLCGVPPF-WAETDQGVAQAILKGEINFQR 256
               APE +  + Y  ++D+WS GV+L+ I   G  P+   + D+   + + +G     R
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG----TR 300

Query: 257 DPFPSISSSAIELVRRMLT---QDPKRRITVAQVLEH 290
              P  ++   E+ + ML     +P +R T ++++EH
Sbjct: 301 MRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 66/265 (24%), Positives = 119/265 (44%), Gaps = 49/265 (18%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G+G FG  ++ T N T    A K++    +  +       +E ++M+ L  +  +VQ 
Sbjct: 13  KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA----FLQEAQVMKKLRHE-KLVQL 66

Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHY-------------SERAAASVFRVIMNV 146
            A   ++  ++IV E  + G L D +  +G               ++ A+   +   MN 
Sbjct: 67  YAVVSEEP-IYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123

Query: 147 VNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YI 203
           V         HRDL+  N L     EN V K  DFGL+  IE+ + Y    G+ +   + 
Sbjct: 124 V---------HRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWT 170

Query: 204 APEVLSQSYGK---EADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPF 259
           APE  +  YG+   ++D+WS G++L  L   G  P+    ++ V   + +G     R P 
Sbjct: 171 APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG----YRMPC 224

Query: 260 PSISSSAI-ELVRRMLTQDPKRRIT 283
           P     ++ +L+ +   ++P+ R T
Sbjct: 225 PPECPESLHDLMCQCWRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 48/181 (26%), Positives = 79/181 (43%), Gaps = 11/181 (6%)

Query: 77  KDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAA 136
           KD++ RE  +M+ L   P IV+     E + ++ +VMEL   G L   +    H +E+  
Sbjct: 40  KDELLREANVMQQLD-NPYIVRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNI 97

Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI 196
             +   +   +        +HRDL   N L  T       K +DFGLS  +   + Y + 
Sbjct: 98  TELVHQVSMGMKYLEETNFVHRDLAARNVLLVT---QHYAKISDFGLSKALGADENYYKA 154

Query: 197 VGS---PY-YIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKG 250
                 P  + APE ++   +  ++D+WS GV+++     G  P+       V Q I  G
Sbjct: 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG 214

Query: 251 E 251
           E
Sbjct: 215 E 215

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 64/280 (22%), Positives = 115/280 (41%), Gaps = 38/280 (13%)

Query: 36  TIGREVGRGEFGITY---LCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG 92
            +G+ +G GEFG      L  ++ + L+ A K++ K  +    E ++   E   M+    
Sbjct: 2   KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD- 59

Query: 93  QPNI-----VQFKAAYEDDQFVH--IVMELCAGGELFDRIVARGHYSERAAASVF----R 141
            PN+     V F+A+    +     +++     G+L   ++    YS             
Sbjct: 60  HPNVMKLIGVCFEAS-SLQKIPKPMVILPFMKHGDLHSFLL----YSRLGGLPEKLPLQT 114

Query: 142 VIMNVVNVC------HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE 195
           ++  +V++        ++  +HRDL   N +     E+  V   DFGLS  I  G  YR+
Sbjct: 115 LLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQ 171

Query: 196 --IVGSPY-YIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
             I   P  +IA E L+   Y  ++D+W+ GV ++ I   G  P+    +  +   +  G
Sbjct: 172 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG 231

Query: 251 EINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290
             N  + P         +L+      DPK R T  ++ E 
Sbjct: 232 --NRLKQP-EDCLDELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 74/294 (25%), Positives = 121/294 (41%), Gaps = 51/294 (17%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPK-----RKLVKDV-EKDDVRREIEIMRH 89
           T+ RE+G+G FG+ Y         E   + I K     R  VK V E   +R  IE +  
Sbjct: 9   TLLRELGQGSFGMVY---------EGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 59

Query: 90  LSGQP-----NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSE----RAAASVF 140
            S        ++V+        Q   +VMEL A G+L   + +    +E    R   ++ 
Sbjct: 60  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119

Query: 141 RVIMNVVNVC------HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR 194
            +I     +       ++K  +HRDL   N +      +  VK  DFG++  I E   YR
Sbjct: 120 EMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYR 176

Query: 195 EIVGSP-----YYIAPEVLSQ-SYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAI 247
           +  G        ++APE L    +   +D+WS GV+L+ I      P+   +++ V + +
Sbjct: 177 K--GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234

Query: 248 LKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE------HPWLKE 295
           + G    Q D  P   +    L+R     +PK R T  +++       HP   E
Sbjct: 235 MDGGYLDQPDNCPERVTD---LMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 69/264 (26%), Positives = 119/264 (45%), Gaps = 45/264 (17%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           +++G G+FG  ++ T N    + A K++    +      +    E +IM+ L     +VQ
Sbjct: 12  KKLGNGQFGEVWMGTWNGN-TKVAVKTLKPGTM----SPESFLEEAQIMKKLR-HDKLVQ 65

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIV-ARGHY----------SERAAASVFRVIMNVV 147
             A   ++  ++IV E  + G L D +    G            ++ AA   +   MN +
Sbjct: 66  LYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124

Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI---A 204
                    HRDL+  N L   GD   V K  DFGL+  IE+ + Y    G+ + I   A
Sbjct: 125 ---------HRDLRSANIL--VGD-GLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTA 171

Query: 205 PEVLSQSYGK---EADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFP 260
           PE  +  YG+   ++D+WS G++L  L+  G  P+    ++ V + + +G     R P P
Sbjct: 172 PE--AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG----YRMPCP 225

Query: 261 SISSSAI-ELVRRMLTQDPKRRIT 283
                ++ EL+ +   +DP+ R T
Sbjct: 226 QDCPISLHELMLQCWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 50.5 bits (121), Expect = 6e-07
 Identities = 63/270 (23%), Positives = 116/270 (42%), Gaps = 34/270 (12%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDV-------RREIEIMRHLSGQ 93
           +GRGEFG  +L            +      LVK ++K          RRE+++ R LS  
Sbjct: 13  LGRGEFGEVFLAKAKGI----EEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS-H 67

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH-- 151
            N+V+      + +  ++++E    G+L   + A     E+            V +C   
Sbjct: 68  KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTK-QKVALCTQI 126

Query: 152 SKGV--------MHRDLKPENFLFTTGDENAVVKATDFGLS--AFIEEGKAYREIVGSPY 201
           + G+        +HRDL   N L ++  E   VK +   LS   +  E    R  +    
Sbjct: 127 ALGMDHLSNARFVHRDLAARNCLVSSQRE---VKVSLLSLSKDVYNSEYYKLRNALIPLR 183

Query: 202 YIAPE-VLSQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPF 259
           ++APE V    +  ++D+WS GV+++ +   G  PF+  +D+ V   +  G++     P 
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL---PV 240

Query: 260 PSISSSAI-ELVRRMLTQDPKRRITVAQVL 288
           P    S + +L+ R    +PK R + ++++
Sbjct: 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 57/244 (23%), Positives = 102/244 (41%), Gaps = 45/244 (18%)

Query: 40  EVGRGEFGITYLCTENS----TGLEFACKSIPKRKLVKDVE----------KDDVRREIE 85
           ++G G+FG  +LC   +      L+F       R L+  V+          ++D  +E++
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
           I+  L   PNI++      D+  + ++ E    G+L ++ ++  H  ++       V   
Sbjct: 72  ILSRLK-DPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVPPA 129

Query: 143 -----------------IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA 185
                            I + +    S   +HRDL   N L     EN  +K  DFG+S 
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV---GENLTIKIADFGMSR 186

Query: 186 FIEEGKAYR---EIVGSPYYIAPE-VLSQSYGKEADIWSAGVILY--ILLCGVPPFWAET 239
            +  G  YR     V    ++A E +L   +   +D+W+ GV L+  ++LC   P+   T
Sbjct: 187 NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELT 246

Query: 240 DQGV 243
           D+ V
Sbjct: 247 DEQV 250

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 50.3 bits (120), Expect = 9e-07
 Identities = 60/244 (24%), Positives = 102/244 (41%), Gaps = 45/244 (18%)

Query: 36  TIGREVGRGEFGITYLC----TENSTGLEFACKSIPKRKL---VKDVEKD-------DVR 81
           T   ++G G+FG  +LC     E     +F+      + +   VK + +D       D  
Sbjct: 8   TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL 67

Query: 82  REIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFR 141
           +EI+IM  L   PNI++  A       + ++ E    G+L ++ ++R H  + AA     
Sbjct: 68  KEIKIMSRLK-DPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSR-HEPQEAAEKADV 124

Query: 142 VIMNVVNVCH-------------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188
           V ++   +               S   +HRDL   N L     +N  +K  DFG+S  + 
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLY 181

Query: 189 EGKAYREIVGSPYYIAP-------EVLSQSYGKEADIWSAGVILY--ILLCGVPPFWAET 239
            G  YR I G    + P        +L   +   +D+W+ GV L+  + LC   P+   +
Sbjct: 182 SGDYYR-IQGRA--VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238

Query: 240 DQGV 243
           D+ V
Sbjct: 239 DEQV 242

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 38/126 (30%), Positives = 56/126 (44%), Gaps = 17/126 (13%)

Query: 121 LFDRIVARGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGD-------- 171
           L D I+  G +S R  A +       ++  H++  +MH DLKPEN L  T D        
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTN 277

Query: 172 -----ENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSYGKEADIWSAGVIL 225
                +   V+  D G     +E  +   IV + +Y +PEV L   +    D+WS G I+
Sbjct: 278 RALPPDPCRVRICDLG--GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCII 335

Query: 226 YILLCG 231
           Y L  G
Sbjct: 336 YELYTG 341

Length = 467

>gnl|CDD|222407 pfam13833, EF_hand_6, EF-hand domain pair

 Score = 44.8 bits (107), Expect = 2e-06
 Identities = 16/52 (30%), Positives = 28/52 (53%), Gaps = 2/52 (3%)

Query: 425 NGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
            G IT +EL +A     +G   +   +  +  E D D DG+IS++EF  +++
Sbjct: 2   KGLITREELKRALAL--LGISLSEEEVDILFREFDTDGDGKISFEEFCVLLQ 51

Length = 53

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 31/213 (14%)

Query: 36  TIGREVGRGEFG--ITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            +G+ +G GEFG  +     ++ + L+ A K++ K  +    E +D   E   M+     
Sbjct: 2   ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFD-H 59

Query: 94  PNIVQFKAA----YEDDQFVH--IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVV 147
           PN+++         E + +    +++     G+L   ++    YS       +     +V
Sbjct: 60  PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL----YSRLGDCPQYLPTQMLV 115

Query: 148 NV----------CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-- 195
                         SK  +HRDL   N +    +EN  V   DFGLS  I  G  YR+  
Sbjct: 116 KFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYRQGR 172

Query: 196 IVGSPY-YIAPEVLS-QSYGKEADIWSAGVILY 226
           I   P  +IA E L+ + Y  ++D+WS GV ++
Sbjct: 173 IAKMPVKWIAIESLADRVYTTKSDVWSFGVTMW 205

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 55/218 (25%), Positives = 104/218 (47%), Gaps = 15/218 (6%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           +++G G+FG  ++   N++  + A K++    +   V+      E  +M+ L     +V+
Sbjct: 12  KKLGAGQFGEVWMGYYNNS-TKVAVKTLKPGTM--SVQA--FLEEANLMKTLQ-HDKLVR 65

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV-FRV-IMNVVNVCHSKGVM 156
             A    ++ ++I+ E  A G L D + +           + F   I   +     K  +
Sbjct: 66  LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 125

Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-AYREIVGSPY-YIAPEVLS-QSYG 213
           HRDL+  N L +   E+ + K  DFGL+  IE+ +   RE    P  + APE ++  S+ 
Sbjct: 126 HRDLRAANVLVS---ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182

Query: 214 KEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
            ++D+WS G++LY I+  G  P+   ++  V  A+ +G
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG 220

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|200946 pfam00036, efhand, EF hand

 Score = 43.6 bits (104), Expect = 2e-06
 Identities = 12/26 (46%), Positives = 20/26 (76%)

Query: 451 IKEIMSEVDRDKDGRISYDEFRSMMK 476
           +KE   E D+D DG+IS++EF+ ++K
Sbjct: 2   LKEAFKEFDKDGDGKISFEEFKELLK 27

The EF-hands can be divided into two classes: signaling proteins and buffering/transport proteins. The first group is the largest and includes the most well-known members of the family such as calmodulin, troponin C and S100B. These proteins typically undergo a calcium-dependent conformational change which opens a target binding site. The latter group is represented by calbindin D9k and do not undergo calcium dependent conformational changes. Length = 29

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 45/177 (25%), Positives = 68/177 (38%), Gaps = 35/177 (19%)

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL- 208
           H + ++HRDLKP+N L +   E   +K  DFGL+ A       Y   V + +Y  P+VL 
Sbjct: 120 HQRYILHRDLKPQNLLISDTGE---LKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLL 176

Query: 209 -SQSYGKEADIWSAGVILYILLCGVPPFWAETD-QGVAQAILKGEINFQRDPFPSISS-- 264
            S  Y    D+W  G I   ++ GV  F    D Q   + I         D +P + S  
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236

Query: 265 --------------------------SAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
                                      A +L  ++L   PK R++    L H +  +
Sbjct: 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 33/98 (33%), Positives = 47/98 (47%), Gaps = 26/98 (26%)

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI-------- 203
           S+  +HRDL   N L +   EN VVK  DFGL+         R+I   P Y+        
Sbjct: 191 SRKCIHRDLAARNILLS---ENNVVKICDFGLA---------RDIYKDPDYVRKGDARLP 238

Query: 204 ----APE-VLSQSYGKEADIWSAGVILY-ILLCGVPPF 235
               APE +  + Y  ++D+WS GV+L+ I   G  P+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 48.4 bits (115), Expect = 4e-06
 Identities = 62/325 (19%), Positives = 123/325 (37%), Gaps = 67/325 (20%)

Query: 40  EVGRGEFGIT--YLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIV 97
           E+GRG   +T  YL     TG     + I   +   +     ++ E+ ++ H    PNI+
Sbjct: 5   EIGRGFCNLTSVYLARHTPTGTLVTVR-ITDLENCTEEHLKALQNEV-VLSHFFRHPNIM 62

Query: 98  QFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM----NVVNVCHSK 153
                +    ++ ++    A G      + + ++ E  + ++   I+      +N  H  
Sbjct: 63  TSWTVFTTGSWLWVISPFMAYGSA--NSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN 120

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFG-LSAFIEEGKAYREIVGSPYY-------IAP 205
           G +HR++K  + L +    + +V  +    L + +  G+  + +   P +       ++P
Sbjct: 121 GYIHRNIKASHILIS---GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSP 177

Query: 206 EVLSQS---YGKEADIWSAGVILYILLCGVPPF--------------------WAET--- 239
           E+L Q    Y  ++DI+S G+    L  G  PF                       T   
Sbjct: 178 ELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP 237

Query: 240 -------------DQGVAQAILKGEINFQ------RDPFPSISSSAIE-LVRRMLTQDPK 279
                        D G+ ++++   +         R P     S A + LV   L QDP+
Sbjct: 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPE 297

Query: 280 RRITVAQVLEHPWLKESGEASDKPI 304
           +R + + +L H + K+  E +   I
Sbjct: 298 KRPSASSLLSHAFFKQVKEQTQGSI 322

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|197492 smart00054, EFh, EF-hand, calcium binding motif

 Score = 43.1 bits (103), Expect = 4e-06
 Identities = 10/26 (38%), Positives = 18/26 (69%)

Query: 451 IKEIMSEVDRDKDGRISYDEFRSMMK 476
           +KE     D+D DG+I ++EF+ ++K
Sbjct: 2   LKEAFRLFDKDGDGKIDFEEFKDLLK 27

EF-hands are calcium-binding motifs that occur at least in pairs. Links between disease states and genes encoding EF-hands, particularly the S100 subclass, are emerging. Each motif consists of a 12 residue loop flanked on either side by a 12 residue alpha-helix. EF-hands undergo a conformational change unpon binding calcium ions. Length = 29

>gnl|CDD|227455 COG5126, FRQ1, Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]

 Score = 45.8 bits (109), Expect = 7e-06
 Identities = 25/78 (32%), Positives = 42/78 (53%), Gaps = 2/78 (2%)

Query: 325 ALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAA 384
            + V ++    EE  +L+E F   D D+ G ++  EL+  L  LG  L++ +V++ ++  
Sbjct: 80  VMSVKLKRGDKEE--ELREAFKLFDKDHDGYISIGELRRVLKSLGERLSDEEVEKLLKEY 137

Query: 385 DIDGNGTIDYIEFITATM 402
           D DG+G IDY EF     
Sbjct: 138 DEDGDGEIDYEEFKKLIK 155

Length = 160

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 45/160 (28%), Positives = 71/160 (44%), Gaps = 18/160 (11%)

Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHY----SERAAASVFRVIMN 145
           L   PNIV ++A +  D  + +V    A G   D I    H+    SE A A + + ++ 
Sbjct: 55  LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT--HFMDGMSELAIAYILQGVLK 112

Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY--- 202
            ++  H  G +HR +K  + L +  D    +      LS  I  G+  R +   P Y   
Sbjct: 113 ALDYIHHMGYVHRSVKASHILISV-DGKVYLSGLRSNLS-MINHGQRLRVVHDFPKYSVK 170

Query: 203 ----IAPEVLSQS---YGKEADIWSAGVILYILLCGVPPF 235
               ++PEVL Q+   Y  ++DI+S G+    L  G  PF
Sbjct: 171 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|205583 pfam13405, EF_hand_4, EF-hand domain

 Score = 41.4 bits (98), Expect = 2e-05
 Identities = 15/29 (51%), Positives = 21/29 (72%)

Query: 413 LYKAFQYFDKDNNGYITVDELGKAFKDYG 441
           L +AF+ FDKD +GYI+ +EL KA +  G
Sbjct: 2   LREAFKLFDKDGDGYISAEELRKALRSLG 30

Length = 30

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 63/289 (21%), Positives = 117/289 (40%), Gaps = 51/289 (17%)

Query: 37  IGREVGRGEFGITYLCTENSTGLEFACKSIP-----KRKLVKD----VEKDDVRREIEIM 87
           +G+ +G GEFG      +      F  K          K++K+     E  D+  E  ++
Sbjct: 4   LGKTLGEGEFG------KVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLL 57

Query: 88  RHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDRIVAR------GHYSERAAASV 139
           + ++  P++++   A   D  + +++E    G L  F R   +      G    R ++ +
Sbjct: 58  KQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116

Query: 140 FRVIMNVVNVCH--------SKG--------VMHRDLKPENFLFTTGDENAVVKATDFGL 183
                  + +          S+G        ++HRDL   N L   G     +K +DFGL
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEG---RKMKISDFGL 173

Query: 184 SAFIEEGKAY--REIVGSPY-YIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAE 238
           S  + E  +Y  R     P  ++A E L    Y  ++D+WS GV+L+ I+  G  P+   
Sbjct: 174 SRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233

Query: 239 TDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQV 287
             + +   +  G   ++ +   + S     L+     Q+P +R T A +
Sbjct: 234 APERLFNLLKTG---YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 27/79 (34%), Positives = 39/79 (49%), Gaps = 7/79 (8%)

Query: 138 SVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV 197
            V R ++  +   H  G++HRD+KPEN L T    +  VK  DFG +  +  G  +  + 
Sbjct: 313 GVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV---DGQVKIIDFGAAVDMCTGINFNPLY 369

Query: 198 G--SPYYIAPE--VLSQSY 212
           G   P Y  PE  V+ QS 
Sbjct: 370 GMLDPRYSPPEELVMPQSC 388

Length = 507

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 45.6 bits (108), Expect = 4e-05
 Identities = 24/71 (33%), Positives = 41/71 (57%), Gaps = 4/71 (5%)

Query: 138 SVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY--RE 195
           ++ R I+  ++  HS G++HRD+KP+N +F+  + +   K  D G +A +  G  Y  +E
Sbjct: 259 TIMRQILFALDGLHSTGIVHRDVKPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPKE 316

Query: 196 IVGSPYYIAPE 206
            +  P Y APE
Sbjct: 317 FLLDPRYAAPE 327

Length = 566

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 38/123 (30%), Positives = 60/123 (48%), Gaps = 12/123 (9%)

Query: 147 VNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVGS-PY-YI 203
           +N    + ++HRDL   N L  T      VK TDFGL+  +  + K Y    G  P  ++
Sbjct: 122 MNYLEERRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178

Query: 204 APE-VLSQSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           A E +L + Y  ++D+WS GV ++ L+  G  P+       ++  + KGE    R P P 
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQPP 234

Query: 262 ISS 264
           I +
Sbjct: 235 ICT 237

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 43.2 bits (102), Expect = 7e-05
 Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 26/157 (16%)

Query: 149 VCHSKG----VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIA 204
           VC         +HR  K  N L T    + ++K    G  AF    ++       PY++A
Sbjct: 22  VCLQCLGALRELHRQAKSGNILLT---WDGLLKL--DGSVAFKTPEQS----RPDPYFMA 72

Query: 205 PEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF-------QR 256
           PEV+  QSY ++ADI+S G+ LY  L    P     ++    AIL+  +N         R
Sbjct: 73  PEVIQGQSYTEKADIYSLGITLYEALDYELP---YNEERELSAILEILLNGMPADDPRDR 129

Query: 257 DPFPSISS--SAIELVRRMLTQDPKRRITVAQVLEHP 291
                +S+  S  + +R   ++ P+RR      L H 
Sbjct: 130 SNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHC 166

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 43.9 bits (103), Expect = 9e-05
 Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 16/218 (7%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           +++G G+FG  ++ T N    + A K++    +  +        E  +M+ L     +V+
Sbjct: 12  KKLGAGQFGEVWMATYNKH-TKVAVKTMKPGSMSVEAFLA----EANVMKTLQ-HDKLVK 65

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRV-IMNVVNVCHSKGVM 156
             A    +  ++I+ E  A G L D + +  G          F   I   +     +  +
Sbjct: 66  LHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 124

Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-AYREIVGSPY-YIAPEVLSQ-SYG 213
           HRDL+  N L +      V K  DFGL+  IE+ +   RE    P  + APE ++  S+ 
Sbjct: 125 HRDLRAANILVSAS---LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 181

Query: 214 KEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
            ++D+WS G++L  I+  G  P+   ++  V +A+ +G
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 219

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|222407 pfam13833, EF_hand_6, EF-hand domain pair

 Score = 38.6 bits (91), Expect = 2e-04
 Identities = 21/52 (40%), Positives = 29/52 (55%), Gaps = 1/52 (1%)

Query: 353 SGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR 404
            G +T +ELK  LA LG  L+E +V    +  D DG+G I + EF    +QR
Sbjct: 2   KGLITREELKRALALLGISLSEEEVDILFREFDTDGDGKISFEEFCVL-LQR 52

Length = 53

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 40/148 (27%), Positives = 68/148 (45%), Gaps = 20/148 (13%)

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGL-------SAFIEEGKAYREIVGSPYYIA 204
           SK  +HRDL   N L T G    + K  DFGL       S ++ +G A   +     ++A
Sbjct: 232 SKNCIHRDLAARNILLTHG---RITKICDFGLARDIRNDSNYVVKGNARLPV----KWMA 284

Query: 205 PE-VLSQSYGKEADIWSAGVILY-ILLCGVPPF-WAETDQGVAQAILKGEINFQRDPFPS 261
           PE + +  Y  E+D+WS G++L+ I   G  P+     D    + I +G   ++      
Sbjct: 285 PESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG---YRMLSPEC 341

Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLE 289
             S   ++++     DP +R T  Q+++
Sbjct: 342 APSEMYDIMKSCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|205583 pfam13405, EF_hand_4, EF-hand domain

 Score = 37.6 bits (88), Expect = 3e-04
 Identities = 11/30 (36%), Positives = 17/30 (56%)

Query: 340 KLKEKFTEMDTDNSGTLTYDELKAGLAKLG 369
           +L+E F   D D  G ++ +EL+  L  LG
Sbjct: 1   ELREAFKLFDKDGDGYISAEELRKALRSLG 30

Length = 30

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 55/234 (23%), Positives = 100/234 (42%), Gaps = 45/234 (19%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV-EKDDVRREIEIMRHLSGQPNIV 97
           +E+G G FG   L  E ++G   A   + + ++   V E+     E +  R L    N++
Sbjct: 1   KEIGNGWFGKVIL-GEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ-HSNLL 58

Query: 98  QFKAAYEDDQFVHIVMELCAGGELFDRIVARGHY-SERAAASV-----------FRVIMN 145
           Q      +     +VME C  G+L      +G+  S R A  +             + + 
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDL------KGYLRSCRKAELMTPDPTTLQRMACEIALG 112

Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA-------FIEEGKAYREIVG 198
           ++++ H    +H DL   N L T    +  VK  D+GLS        ++   + +  +  
Sbjct: 113 LLHL-HKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL-- 166

Query: 199 SPYYIAPEVLSQSYG--------KEADIWSAGVILYILL-CGVPPFWAETDQGV 243
              +IAPE++ + +G        KE+++WS GV ++ L   G  P+   +D+ V
Sbjct: 167 --RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV 218

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 31/89 (34%), Positives = 44/89 (49%), Gaps = 11/89 (12%)

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY----YIAPE- 206
           SK  +HRDL   N L   G    +VK  DFGL+  I     Y    GS +    ++APE 
Sbjct: 255 SKNCVHRDLAARNVLLAQGK---IVKICDFGLARDIMHDSNYVS-KGSTFLPVKWMAPES 310

Query: 207 VLSQSYGKEADIWSAGVILYIL--LCGVP 233
           +    Y   +D+WS G++L+ +  L G P
Sbjct: 311 IFDNLYTTLSDVWSYGILLWEIFSLGGTP 339

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 16/93 (17%)

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGL-------SAFIEEGKAYREIVGSPYYIA 204
           SK  +HRDL   N L   G    +VK  DFGL       S +I +G  +  +     ++A
Sbjct: 257 SKNCVHRDLAARNVLICEGK---LVKICDFGLARDIMRDSNYISKGSTFLPL----KWMA 309

Query: 205 PE-VLSQSYGKEADIWSAGVILY-ILLCGVPPF 235
           PE + +  Y   +D+WS G++L+ I   G  P+
Sbjct: 310 PESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|197477 smart00027, EH, Eps15 homology domain

 Score = 39.2 bits (92), Expect = 5e-04
 Identities = 21/68 (30%), Positives = 34/68 (50%), Gaps = 2/68 (2%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           +  E+  K ++ F  +D +  GT+T  + K  L K G  L +  + +    ADID +G +
Sbjct: 4   ISPEDKAKYEQIFRSLDKNQDGTVTGAQAKPILLKSG--LPQTLLAKIWNLADIDNDGEL 61

Query: 393 DYIEFITA 400
           D  EF  A
Sbjct: 62  DKDEFALA 69

Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences. Length = 96

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 41.6 bits (98), Expect = 5e-04
 Identities = 39/123 (31%), Positives = 60/123 (48%), Gaps = 12/123 (9%)

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-KAYREIVGS-PY-YIAPE-VL 208
           K ++HRDL   N L  T      VK TDFGL+  ++   K Y    G  P  ++A E +L
Sbjct: 128 KRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184

Query: 209 SQSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267
            + Y  ++D+WS GV ++ L+  G  P+       +   + KGE    R P P I +  +
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE----RLPQPPICTIDV 240

Query: 268 ELV 270
            +V
Sbjct: 241 YMV 243

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|200946 pfam00036, efhand, EF hand

 Score = 36.7 bits (86), Expect = 6e-04
 Identities = 11/27 (40%), Positives = 17/27 (62%)

Query: 413 LYKAFQYFDKDNNGYITVDELGKAFKD 439
           L +AF+ FDKD +G I+ +E  +  K 
Sbjct: 2   LKEAFKEFDKDGDGKISFEEFKELLKK 28

The EF-hands can be divided into two classes: signaling proteins and buffering/transport proteins. The first group is the largest and includes the most well-known members of the family such as calmodulin, troponin C and S100B. These proteins typically undergo a calcium-dependent conformational change which opens a target binding site. The latter group is represented by calbindin D9k and do not undergo calcium dependent conformational changes. Length = 29

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 31/92 (33%), Positives = 44/92 (47%), Gaps = 14/92 (15%)

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY------REIVGSPYYIAP 205
           SK  +HRD+   N L T G    V K  DFGL+  I     Y      R  V    ++AP
Sbjct: 230 SKNCIHRDVAARNVLLTDGR---VAKICDFGLARDIMNDSNYVVKGNARLPVK---WMAP 283

Query: 206 E-VLSQSYGKEADIWSAGVILY-ILLCGVPPF 235
           E +    Y  ++D+WS G++L+ I   G  P+
Sbjct: 284 ESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|205383 pfam13202, EF_hand_3, EF hand

 Score = 36.1 bits (85), Expect = 0.001
 Identities = 7/25 (28%), Positives = 17/25 (68%)

Query: 451 IKEIMSEVDRDKDGRISYDEFRSMM 475
           +K++  + D + DG+IS +E + ++
Sbjct: 1   LKDLFRQFDTNGDGKISKEELKRLL 25

Length = 25

>gnl|CDD|238009 cd00052, EH, Eps15 homology domain; found in proteins implicated in endocytosis, vesicle transport, and signal transduction

 Score = 36.8 bits (86), Expect = 0.001
 Identities = 16/57 (28%), Positives = 27/57 (47%), Gaps = 4/57 (7%)

Query: 415 KAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEF 471
           + F+  D D +G I+ DE        G+      + + +I    D DKDG++  +EF
Sbjct: 3   QIFRSLDPDGDGLISGDEARPFLGKSGL----PRSVLAQIWDLADTDKDGKLDKEEF 55

The alignment contains a pair of EF-hand motifs, typically one of them is canonical and binds to Ca2+, while the other may not bind to Ca2+. A hydrophobic binding pocket is formed by residues from both EF-hand motifs. The EH domain binds to proteins containing NPF (class I), [WF]W or SWG (class II), or H[TS]F (class III) sequence motifs. Length = 67

>gnl|CDD|185503 PTZ00183, PTZ00183, centrin; Provisional

 Score = 38.9 bits (91), Expect = 0.002
 Identities = 23/76 (30%), Positives = 38/76 (50%), Gaps = 3/76 (3%)

Query: 324 LALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQA 383
           +  K + E  P EEI K    F   D D +G ++   LK    +LG  +T+ ++++ +  
Sbjct: 78  IMTKKLGERDPREEILKA---FRLFDDDKTGKISLKNLKRVAKELGETITDEELQEMIDE 134

Query: 384 ADIDGNGTIDYIEFIT 399
           AD +G+G I   EF  
Sbjct: 135 ADRNGDGEISEEEFYR 150

Length = 158

>gnl|CDD|200946 pfam00036, efhand, EF hand

 Score = 35.1 bits (82), Expect = 0.002
 Identities = 13/29 (44%), Positives = 18/29 (62%)

Query: 340 KLKEKFTEMDTDNSGTLTYDELKAGLAKL 368
           +LKE F E D D  G ++++E K  L KL
Sbjct: 1   ELKEAFKEFDKDGDGKISFEEFKELLKKL 29

The EF-hands can be divided into two classes: signaling proteins and buffering/transport proteins. The first group is the largest and includes the most well-known members of the family such as calmodulin, troponin C and S100B. These proteins typically undergo a calcium-dependent conformational change which opens a target binding site. The latter group is represented by calbindin D9k and do not undergo calcium dependent conformational changes. Length = 29

>gnl|CDD|197492 smart00054, EFh, EF-hand, calcium binding motif

 Score = 35.4 bits (83), Expect = 0.002
 Identities = 11/29 (37%), Positives = 15/29 (51%)

Query: 340 KLKEKFTEMDTDNSGTLTYDELKAGLAKL 368
           +LKE F   D D  G + ++E K  L  L
Sbjct: 1   ELKEAFRLFDKDGDGKIDFEEFKDLLKAL 29

EF-hands are calcium-binding motifs that occur at least in pairs. Links between disease states and genes encoding EF-hands, particularly the S100 subclass, are emerging. Each motif consists of a 12 residue loop flanked on either side by a 12 residue alpha-helix. EF-hands undergo a conformational change unpon binding calcium ions. Length = 29

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 58/240 (24%), Positives = 105/240 (43%), Gaps = 38/240 (15%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV-------EKDDVRREIEIMRHLS 91
            E+G G FG   L  E   G+  A      R +VK++       E+    +E++  R L+
Sbjct: 1   DEIGNGWFGKVLL-GEAHRGMSKA------RVVVKELRASATPDEQLLFLQEVQPYRELN 53

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFR-----VIMN 145
             PN++Q      +     +V+E C  G+L + + + RG  ++ A   V +     V   
Sbjct: 54  -HPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112

Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL--SAFIEEGKAYREIVGSPY-Y 202
           ++ + H    +H DL   N   T    +  VK  D+GL    + E+    ++    P  +
Sbjct: 113 LLWL-HQADFIHSDLALRNCQLTA---DLSVKIGDYGLALEQYPEDYYITKDCHAVPLRW 168

Query: 203 IAPEV--------LSQSYGKEADIWSAGVILYILL-CGVPPFWAETDQGV-AQAILKGEI 252
           +APE+        L +   K+++IWS GV ++ L      P+   +D+ V  Q + + +I
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI 228

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 38.5 bits (90), Expect = 0.002
 Identities = 24/125 (19%), Positives = 48/125 (38%), Gaps = 20/125 (16%)

Query: 69  RKLVKDVEKDDVRREIEIMRHLSGQ----PNIVQFKAAYEDDQFVHIVMELCAGGELFDR 124
           +      +  D  RE+ I++ L+ +    P ++   A+ E D + +++ME   G  L   
Sbjct: 27  KINPSREKGADREREVAILQLLARKGLPVPKVL---ASGESDGWSYLLMEWIEGETL--- 80

Query: 125 IVARGHYSERAAASVFRVIMNVVNVCHS---KGVMHRDLKPENFLFTTGDENAVVKATDF 181
                  SE     +   +  ++   H      + H DL P N L   G    ++   D+
Sbjct: 81  ----DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGII---DW 133

Query: 182 GLSAF 186
             + +
Sbjct: 134 EYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|238009 cd00052, EH, Eps15 homology domain; found in proteins implicated in endocytosis, vesicle transport, and signal transduction

 Score = 35.7 bits (83), Expect = 0.003
 Identities = 20/62 (32%), Positives = 28/62 (45%), Gaps = 8/62 (12%)

Query: 342 KEKFTEMDTDNSGTLTYDELKAGLAKLG---SMLTEFDVKQYMQAADIDGNGTIDYIEFI 398
            + F  +D D  G ++ DE +  L K G   S+L      Q    AD D +G +D  EF 
Sbjct: 2   DQIFRSLDPDGDGLISGDEARPFLGKSGLPRSVL-----AQIWDLADTDKDGKLDKEEFA 56

Query: 399 TA 400
            A
Sbjct: 57  IA 58

The alignment contains a pair of EF-hand motifs, typically one of them is canonical and binds to Ca2+, while the other may not bind to Ca2+. A hydrophobic binding pocket is formed by residues from both EF-hand motifs. The EH domain binds to proteins containing NPF (class I), [WF]W or SWG (class II), or H[TS]F (class III) sequence motifs. Length = 67

>gnl|CDD|238008 cd00051, EFh, EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands

 Score = 35.6 bits (83), Expect = 0.004
 Identities = 15/44 (34%), Positives = 23/44 (52%), Gaps = 3/44 (6%)

Query: 323 KLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLA 366
           K ALK + E L  EEI ++     E+D D  G + ++E    +A
Sbjct: 23  KAALKSLGEGLSEEEIDEM---IREVDKDGDGKIDFEEFLELMA 63

Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. Length = 63

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 38.9 bits (90), Expect = 0.004
 Identities = 36/121 (29%), Positives = 61/121 (50%), Gaps = 12/121 (9%)

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGS-PY-YIAPEVLS-Q 210
           ++HRDL   N L  + +    VK TDFGL+  +E + K Y    G  P  ++A E +  +
Sbjct: 130 LVHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186

Query: 211 SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
            +  ++D+WS GV ++ L+  G  P+     + +   + KGE    R P P I +  + +
Sbjct: 187 KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE----RLPQPPICTIDVYM 242

Query: 270 V 270
           V
Sbjct: 243 V 243

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	494
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.98
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.95
COG5126	160	FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
KOG0027	151	consensus Calmodulin and related proteins (EF-Hand	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.9
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
KOG0028	172	consensus Ca2+-binding protein (centrin/caltractin	99.84
PTZ00183	158	centrin; Provisional	99.83
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
KOG0031	171	consensus Myosin regulatory light chain, EF-Hand p	99.82
PRK10345	210	hypothetical protein; Provisional	99.82
smart00090	237	RIO RIO-like kinase.	99.81
PTZ00184	149	calmodulin; Provisional	99.81
KOG0030	152	consensus Myosin essential light chain, EF-Hand pr	99.78
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
KOG0044	193	consensus Ca2+ sensor (EF-Hand superfamily) [Signa	99.77
KOG0034	187	consensus Ca2+/calmodulin-dependent protein phosph	99.77
PRK14879	211	serine/threonine protein kinase; Provisional	99.76
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.74
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.73
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.72
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
KOG0037	221	consensus Ca2+-binding protein, EF-Hand protein su	99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.63
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.62
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.58
KOG0036	463	consensus Predicted mitochondrial carrier protein	99.57
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.51
KOG4223	325	consensus Reticulocalbin, calumenin, DNA supercoil	99.46
KOG3087	229	consensus Serine/threonine protein kinase [General	99.46
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.46
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.45
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.45
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.43
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.42
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.41
KOG0038	189	consensus Ca2+-binding kinase interacting protein	99.33
KOG1243	690	consensus Protein kinase [General function predict	99.32
PLN02964	644	phosphatidylserine decarboxylase	99.29
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.25
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.23
KOG4223	325	consensus Reticulocalbin, calumenin, DNA supercoil	99.22
PF13499	66	EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A	99.18
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.15
COG4248	637	Uncharacterized protein with protein kinase and he	99.14
cd05022	89	S-100A13 S-100A13: S-100A13 domain found in protei	99.1
KOG0027	151	consensus Calmodulin and related proteins (EF-Hand	99.07
cd05022	89	S-100A13 S-100A13: S-100A13 domain found in protei	99.05
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.03
PF13499	66	EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A	99.03
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.02
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.01
KOG0037	221	consensus Ca2+-binding protein, EF-Hand protein su	99.0
cd05027	88	S-100B S-100B: S-100B domain found in proteins sim	99.0
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.0
PTZ00183	158	centrin; Provisional	98.98
KOG0044	193	consensus Ca2+ sensor (EF-Hand superfamily) [Signa	98.98
cd05029	88	S-100A6 S-100A6: S-100A6 domain found in proteins	98.97
cd05027	88	S-100B S-100B: S-100B domain found in proteins sim	98.95
COG5126	160	FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S	98.94
cd05026	93	S-100Z S-100Z: S-100Z domain found in proteins sim	98.94
PTZ00184	149	calmodulin; Provisional	98.93
cd05025	92	S-100A1 S-100A1: S-100A1 domain found in proteins	98.9
KOG0028	172	consensus Ca2+-binding protein (centrin/caltractin	98.87
cd05031	94	S-100A10_like S-100A10_like: S-100A10 domain found	98.87
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.86
smart00027	96	EH Eps15 homology domain. Pair of EF hand motifs t	98.85
PF13833	54	EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A	98.82
KOG0377	631	consensus Protein serine/threonine phosphatase RDG	98.81
PLN02964	644	phosphatidylserine decarboxylase	98.81
PRK09902	216	hypothetical protein; Provisional	98.8
cd05031	94	S-100A10_like S-100A10_like: S-100A10 domain found	98.8
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.79
cd05026	93	S-100Z S-100Z: S-100Z domain found in proteins sim	98.79
cd05029	88	S-100A6 S-100A6: S-100A6 domain found in proteins	98.79
cd05023	89	S-100A11 S-100A11: S-100A11 domain found in protei	98.77
cd00052	67	EH Eps15 homology domain; found in proteins implic	98.76
cd05025	92	S-100A1 S-100A1: S-100A1 domain found in proteins	98.75
smart00027	96	EH Eps15 homology domain. Pair of EF hand motifs t	98.74
cd00213	88	S-100 S-100: S-100 domain, which represents the la	98.74
KOG2562	493	consensus Protein phosphatase 2 regulatory subunit	98.73

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-58  Score=425.28  Aligned_cols=268  Identities=38%  Similarity=0.679  Sum_probs=245.8

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChh----hHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV----EKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~----~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      +...|-+.+.||+|+||.|-+|..+.+|+.||+|++.++......    ......+|+++|++|. ||+|++++++|...
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKDFFEVP  248 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEeeeeecC
Confidence            668899999999999999999999999999999999887654422    3445789999999995 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          107 QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      ...|+||||++||.|.+++..++.+.+...+.+++|++.|+.|||++||+||||||+|||+.++..+..+||+|||+|..
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            99999999999999999999999999999999999999999999999999999999999998766789999999999999


Q ss_pred             cccCcccccccCCcCccChhhhccc----CCCcchhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHcCCccCCCCCCCC
Q 040917          187 IEEGKAYREIVGSPYYIAPEVLSQS----YGKEADIWSAGVILYILLCGVPPFWAETDQG-VAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~Di~slG~il~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~  261 (494)
                      ......+.+.||||.|.|||++.+.    +..++|+||+||++|-+++|.+||....... ..+++.++...+.+..|..
T Consensus       329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~  408 (475)
T KOG0615|consen  329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR  408 (475)
T ss_pred             cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence            8888888999999999999999642    4458999999999999999999998776554 8899999999999999999


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  299 (494)
                      ++++..+||.+||..||++|||++|+|+||||+..+..
T Consensus       409 Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~  446 (475)
T KOG0615|consen  409 ISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCL  446 (475)
T ss_pred             hhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccccc
Confidence            99999999999999999999999999999999976543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.6e-54  Score=414.38  Aligned_cols=262  Identities=37%  Similarity=0.611  Sum_probs=244.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|..++.||+|||+.||.+++..+|+.||+|++.+.........+.+.+|+++.++|+ ||||++++++|++.+.+|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCceEEE
Confidence            57999999999999999999999999999999999988888888999999999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-c
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-K  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-~  191 (494)
                      .|+|+.++|..++++++.+++.++..+++||+.||.|||+++|+|||||..|+|+   +++.++||+|||+|...... .
T Consensus        97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCccc
Confidence            9999999999999999999999999999999999999999999999999999999   78889999999999987644 5


Q ss_pred             ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      ...+.||||.|.|||++.. .++..+||||+||++|-|+.|++||...+-.+.+..|.......|.    .++.++.+||
T Consensus       174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI  249 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLI  249 (592)
T ss_pred             ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHH
Confidence            6678999999999999975 5899999999999999999999999999999999999988777664    6889999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCccCccCcCCCC
Q 040917          271 RRMLTQDPKRRITVAQVLEHPWLKESGEASDK  302 (494)
Q Consensus       271 ~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~  302 (494)
                      .++|++||.+|||++++|.|+||+....+...
T Consensus       250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~l  281 (592)
T KOG0575|consen  250 RKLLRPNPSERPSLDEVLDHPFFKSGFTPARL  281 (592)
T ss_pred             HHHhcCCcccCCCHHHHhcCHhhhCCCcCCCC
Confidence            99999999999999999999999765555443

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-51  Score=399.57  Aligned_cols=323  Identities=56%  Similarity=0.981  Sum_probs=295.4

Q ss_pred             cccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           27 AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      ....+...|.+.+.||.|.||.||+|.++.+|+.+|+|++.+...........+.+|+.+|+++.+||||+.++++|.+.
T Consensus        29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~  108 (382)
T KOG0032|consen   29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP  108 (382)
T ss_pred             ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence            45677889999999999999999999999999999999999888766666789999999999997799999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCC-CCeEEEeecCCcc
Q 040917          107 QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDE-NAVVKATDFGLSA  185 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~-~~~~kL~Dfg~a~  185 (494)
                      ..+++|||+|+||.|.+.+... .+++..+..+++|++.++.|||+.|++||||||+|+|+...+. .+.++++|||++.
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            9999999999999999999876 4999999999999999999999999999999999999976443 4689999999999


Q ss_pred             ccccCcccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          186 FIEEGKAYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      ....+......+||+.|+|||++. ..|+..+|+||+|+++|.|+.|..||++.+..+....+..+...+...+|+.++.
T Consensus       188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~  267 (382)
T KOG0032|consen  188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE  267 (382)
T ss_pred             EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence            887766778899999999999998 5899999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCCcHHHHHHHHHHhhhhHHHHHHHHhhhccCchhHHHhhhhh
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEK  344 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  344 (494)
                      .++++|.+||..||.+|+|+.++|+|||+.........+.......+..++..++++++.+........+   +..++..
T Consensus       268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  344 (382)
T KOG0032|consen  268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKLALRVLAESLS---ISGLKEM  344 (382)
T ss_pred             HHHHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHHHHHHHhhhhh---HHHHHHH
Confidence            9999999999999999999999999999998777777777777777778888888888877767766655   7888888


Q ss_pred             hhccCCCCC
Q 040917          345 FTEMDTDNS  353 (494)
Q Consensus       345 F~~~D~~~~  353 (494)
                      |..+|.+++
T Consensus       345 ~~~~~~~~~  353 (382)
T KOG0032|consen  345 FKLMDTDNN  353 (382)
T ss_pred             HHhhccccc
Confidence            999999887

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-52  Score=383.82  Aligned_cols=256  Identities=29%  Similarity=0.430  Sum_probs=228.3

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC-eEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ-FVHI  111 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~-~~~i  111 (494)
                      .+.+.++.||+|..|+||+|+|+.|++.+|+|++..  ...+....++.+|+++++.. +||||+.+|+.|..+. .++|
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI  155 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISI  155 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEe
Confidence            467788999999999999999999999999999943  33566789999999999999 5999999999999988 5999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +||||+||||.+.++..+++++.....++.+++.||.|||+ ++||||||||+|||+   +..|.|||||||.+....++
T Consensus       156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhh
Confidence            99999999999999988999999999999999999999995 899999999999999   78999999999999887666


Q ss_pred             cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAE-----TDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                       ...+..||..|||||.+.+ .|+.++||||||+.++|+.+|+.||...     ..-+.+..|..+..+..+.  ..+++
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~--~~fS~  309 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE--GEFSP  309 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc--ccCCH
Confidence             5578899999999999987 5999999999999999999999999774     4455666666654333322  24899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      +++.||..||++||.+||++.++++|||++...
T Consensus       310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence            999999999999999999999999999999754

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-53  Score=368.20  Aligned_cols=298  Identities=39%  Similarity=0.740  Sum_probs=270.0

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      +.+.|.+.+.||+|.|+.||++.+..+|+.+|+|++....+... ..+.+.+|+++-+.|+ ||||+++.+.+......|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~~~~y   86 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHY   86 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcC-CCcEeehhhhhcccceeE
Confidence            55789999999999999999999999999999999987665444 7888999999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +|+|+++|+.|..-+..+..+++..+...++||+++|.|+|.+||||||+||.|+++-+.+...-+||+|||+|.....+
T Consensus        87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g  166 (355)
T KOG0033|consen   87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG  166 (355)
T ss_pred             EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence            99999999999877777677899999999999999999999999999999999999988888889999999999988877


Q ss_pred             cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                      .......|||.|+|||++.. +|+..+|||+.|+|+|-|+.|.+||++.+...+++.|..+...++.+.|+.++++.++|
T Consensus       167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L  246 (355)
T KOG0033|consen  167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL  246 (355)
T ss_pred             cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence            77778999999999999975 69999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCCcHHHHHHHHHHhhhhHHHHHHHHhhh
Q 040917          270 VRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIV  330 (494)
Q Consensus       270 i~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  330 (494)
                      |.+||..||.+|.|+.|+|+|||+.+...-....-....+..+++|...++++-..+.-+.
T Consensus       247 vrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLtav~  307 (355)
T KOG0033|consen  247 IRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTVI  307 (355)
T ss_pred             HHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHHHHH
Confidence            9999999999999999999999999754332233336677899999999999866555543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-51  Score=376.38  Aligned_cols=257  Identities=34%  Similarity=0.641  Sum_probs=237.1

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++.+.||.|+||+||.++.+.+++.+|+|++.+.........+....|..+|.+++ ||.|++++-.|++.+..|+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCeEEE
Confidence            378999999999999999999999999999999999888777777889999999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc-ccC
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEG  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~-~~~  190 (494)
                      |++|+.||.|.-++.+.+.+++..+..++.+|+.||.|||+.|||||||||+|||+   +.+|+++|+|||++... ..+
T Consensus       103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcccCC
Confidence            99999999999999999999999999999999999999999999999999999999   79999999999999853 344


Q ss_pred             cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                      ....+.+||+.|||||++.+ .|+..+|+||||+++|+|++|..||.+.+...+.+.+.++....++   ..++...+++
T Consensus       180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls~~ardl  256 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLSEEARDL  256 (357)
T ss_pred             CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCCHHHHHH
Confidence            55667899999999999865 6999999999999999999999999999999999999988744433   2478999999


Q ss_pred             HHHhcccCCCCCC----CHHHHhcCCccCc
Q 040917          270 VRRMLTQDPKRRI----TVAQVLEHPWLKE  295 (494)
Q Consensus       270 i~~~l~~dp~~Rp----s~~eil~~~~~~~  295 (494)
                      ++++|..||++|.    ++.+|-+||||..
T Consensus       257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~  286 (357)
T KOG0598|consen  257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKG  286 (357)
T ss_pred             HHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence            9999999999996    7889999999986

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1e-50  Score=375.02  Aligned_cols=265  Identities=37%  Similarity=0.662  Sum_probs=239.2

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      ...++|.+.+.||+|+||+||+|+++.++..||||.+.+... .....+.+..|+.+|+.|+ ||||+.++++...++.+
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i   84 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFI   84 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeE
Confidence            345789999999999999999999999999999999987765 4457888999999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC-CCC--CeEEEeecCCccc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG-DEN--AVVKATDFGLSAF  186 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~-~~~--~~~kL~Dfg~a~~  186 (494)
                      |+|||||.||+|.+++.+.+.+++.+++.++.||+.|+++||+++||||||||+|||+... ..+  ..+||+|||+|+.
T Consensus        85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999999999999999999999999999999999999999999999999999999754 222  7899999999999


Q ss_pred             cccCcccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          187 IEEGKAYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ..++.-..+.||+|.|||||++. .+|+.|+|+||+|+|+|++++|+.||...+..+....+.++....+..+ ..+++.
T Consensus       165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~~  243 (429)
T KOG0595|consen  165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSNP  243 (429)
T ss_pred             CCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh-hhccCc
Confidence            98887778899999999999984 6899999999999999999999999999999999887776655443322 346677


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      +.+++...+..+|..|.+..+-+.|+++...+
T Consensus       244 ~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  244 LRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            78999999999999999999999999998755

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-51  Score=386.73  Aligned_cols=256  Identities=33%  Similarity=0.627  Sum_probs=238.1

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|.+++.||.|+|++|++|.++.+++.||||++.++....+...+.+.+|-.+|.+|.+||.|++++-.|++...+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            58999999999999999999999999999999999888877777888889999999998899999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      +||+++|.|.++|++.+.+++..+..++.+|+.||.|||++|||||||||+|||+   +.+++++|.|||.|..+.+...
T Consensus       153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~~~  229 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSPSQK  229 (604)
T ss_pred             EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCChhhc
Confidence            9999999999999999999999999999999999999999999999999999999   7999999999999987643221


Q ss_pred             c--------------ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCC
Q 040917          193 Y--------------REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD  257 (494)
Q Consensus       193 ~--------------~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  257 (494)
                      .              .+.+||..|.+||++.. ..++.+|||+||||+|+|+.|.+||.+.++--+.+.|..-...++  
T Consensus       230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp--  307 (604)
T KOG0592|consen  230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP--  307 (604)
T ss_pred             cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC--
Confidence            1              34789999999999975 578999999999999999999999999999999999998877777  


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       258 ~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                        +.+|+.+++||.++|..||.+|+++++|.+||||..
T Consensus       308 --~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  308 --EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             --CCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence              467899999999999999999999999999999986

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=9.7e-51  Score=360.40  Aligned_cols=257  Identities=28%  Similarity=0.557  Sum_probs=224.9

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|+....+|+|+||+||+|+++.||+.||||.+..+. .++....-..+|+++|++|+ |||++.++++|......++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhcceeEEE
Confidence            57888999999999999999999999999999997554 34456777889999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cC
Q 040917          113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EG  190 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~  190 (494)
                      +|||+- ++.+.+.+. ..++.+.+..+++|++.|+.|+|+++++||||||+|||+   ..++.+||||||+|+... ++
T Consensus        80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---ecCCcEEeccchhhHhhcCCc
Confidence            999965 777777654 358999999999999999999999999999999999999   789999999999999877 77


Q ss_pred             cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC--------------Cc--
Q 040917          191 KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG--------------EI--  252 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~--------------~~--  252 (494)
                      ..+..++.|.+|+|||.+.|  +|+..+||||+||++.||++|.+.|.+.++-+.+..|.+.              ..  
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            77888999999999999976  6999999999999999999999999999987766554321              11  


Q ss_pred             ---cCC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          253 ---NFQ--------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       253 ---~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                         .++        +..++.++..+.+|+++||..||++|++-+++|.||||..
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence               111        1124567888999999999999999999999999999964

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-50  Score=364.52  Aligned_cols=301  Identities=29%  Similarity=0.490  Sum_probs=250.8

Q ss_pred             ccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917           26 KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED  105 (494)
Q Consensus        26 ~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~  105 (494)
                      .....+..+|..++.||.|+||.|+.|.++.+|+.||+|.+.. .+.+........+|+.+|+.++ |+||+.+.+++..
T Consensus        15 ~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p   92 (359)
T KOG0660|consen   15 GELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRP   92 (359)
T ss_pred             eeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhc-CCCcceEEeeccc
Confidence            3456677889989999999999999999999999999999852 4556667888999999999996 9999999999865


Q ss_pred             -----CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917          106 -----DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       106 -----~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                           -+.+|+|+|+| +.+|...++.+..++...+..+++||+.||+|+|+.+++||||||+|+++   +.+..+|++|
T Consensus        93 ~~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~D  168 (359)
T KOG0660|consen   93 PSRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICD  168 (359)
T ss_pred             ccccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEecc
Confidence                 45799999999 45888888887779999999999999999999999999999999999999   6788899999


Q ss_pred             cCCcccccc---CcccccccCCcCccChhhhc--ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc------
Q 040917          181 FGLSAFIEE---GKAYREIVGSPYYIAPEVLS--QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK------  249 (494)
Q Consensus       181 fg~a~~~~~---~~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~------  249 (494)
                      ||+|+...+   ...+..++.|.+|+|||++.  ..|+.+.||||+|||+.||++|+..|.|...-..+..+..      
T Consensus       169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~  248 (359)
T KOG0660|consen  169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS  248 (359)
T ss_pred             ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence            999998754   44456788999999999875  3699999999999999999999999988876655544422      


Q ss_pred             -----------------CCccCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCCcHHH
Q 040917          250 -----------------GEINFQRD----PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAV  308 (494)
Q Consensus       250 -----------------~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~~~~~  308 (494)
                                       .....++.    .++..++.+.+|+.+||..||.+|+|++|+|.|||+.....+.+.|.....
T Consensus       249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~  328 (359)
T KOG0660|consen  249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPI  328 (359)
T ss_pred             HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCC
Confidence                             11112221    256789999999999999999999999999999999998888887765544


Q ss_pred             HHHHHHHhhhhHHHHHHHHhhhcc
Q 040917          309 IFRMKQFTAMNKLKKLALKVIVEN  332 (494)
Q Consensus       309 ~~~~~~~~~~~~~~~l~~~~~~~~  332 (494)
                      ........+...|+++...++...
T Consensus       329 ~~~~~~~~~~~~~r~~i~~e~~~~  352 (359)
T KOG0660|consen  329 FDSFEHELTEEELRELIYKEILDF  352 (359)
T ss_pred             CccccccccHHHHHHHHHHHHHhh
Confidence            332222256777888887776553

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-49  Score=350.34  Aligned_cols=253  Identities=32%  Similarity=0.614  Sum_probs=237.3

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|.+++.||.|+||.|-+++++.+|..+|+|++.+.....-...++..+|.++|+.+. ||.++++++.+.+...+|+|
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeEEEE
Confidence            67999999999999999999999999999999999887766667788999999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      |||++||.|..++++.+++++..++.++.||+.|+.|||+++|++|||||+|||+   +.+|++||+|||+|......  
T Consensus       123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r--  197 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR--  197 (355)
T ss_pred             EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecCc--
Confidence            9999999999999999999999999999999999999999999999999999999   79999999999999876433  


Q ss_pred             cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917          193 YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR  271 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  271 (494)
                      ..+.||||.|+|||++. .+|+.++|+|||||++|||+.|..||...++..+.+.|..+...++.    .+++++++||.
T Consensus       198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kdLl~  273 (355)
T KOG0616|consen  198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKDLLK  273 (355)
T ss_pred             EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHHHHH
Confidence            56889999999999886 57999999999999999999999999999999999999999998885    57899999999


Q ss_pred             HhcccCCCCC-----CCHHHHhcCCccCc
Q 040917          272 RMLTQDPKRR-----ITVAQVLEHPWLKE  295 (494)
Q Consensus       272 ~~l~~dp~~R-----ps~~eil~~~~~~~  295 (494)
                      ++|+.|-.+|     ....+|.+||||+.
T Consensus       274 ~LL~vD~t~R~gnlknG~~dIk~H~wF~~  302 (355)
T KOG0616|consen  274 KLLQVDLTKRFGNLKNGVEDIKNHPWFKG  302 (355)
T ss_pred             HHHhhhhHhhhcCcCCCccccccCccccc
Confidence            9999999999     46789999999985

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-48  Score=379.31  Aligned_cols=259  Identities=43%  Similarity=0.753  Sum_probs=234.2

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC--hhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK--DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ...++|.+++.||+|+||.|+.|.+..+|..||+|++.+.....  ......+.+|+.+++++..||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34579999999999999999999999999999999887653221  1346677799999999966999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCC-CeEEEeecCCccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDEN-AVVKATDFGLSAF  186 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~-~~~kL~Dfg~a~~  186 (494)
                      .+++|||||.||.|.+++.+.+++.+..+..+++|++.|+.|||++||+||||||+||++   +.. +.+||+|||++..
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill---d~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL---DGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---cCCCCCEEEeccccccc
Confidence            999999999999999999998999999999999999999999999999999999999999   455 9999999999998


Q ss_pred             c-ccCcccccccCCcCccChhhhccc--C-CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          187 I-EEGKAYREIVGSPYYIAPEVLSQS--Y-GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       187 ~-~~~~~~~~~~~~~~y~aPE~~~~~--~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      . .........+|++.|+|||++.+.  | +.++||||+||++|.|++|..||...........+.++...++..    +
T Consensus       171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~----~  246 (370)
T KOG0583|consen  171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY----L  246 (370)
T ss_pred             cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC----c
Confidence            7 466677889999999999999863  5 578999999999999999999999988888888888887776643    3


Q ss_pred             -CHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          263 -SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       263 -~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                       +++++.++.+||..||.+|+++.++++||||+.
T Consensus       247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  247 LSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence             899999999999999999999999999999997

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-49  Score=384.14  Aligned_cols=257  Identities=39%  Similarity=0.679  Sum_probs=240.8

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      +-|++++.||.|+.|.|-+|++..||+.+|||++.+....++.....+++|+-+|+.+. ||||+.++++|.++.++|+|
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCceEEEE
Confidence            67999999999999999999999999999999998875556666788999999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      .||++||.|.+++...+++++.++..+++||++|+.|+|..+|+||||||+|+|+   +..+.+||+|||+|..-.++..
T Consensus        91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gkl  167 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGKL  167 (786)
T ss_pred             EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccCCcc
Confidence            9999999999999999999999999999999999999999999999999999999   5666699999999998888888


Q ss_pred             cccccCCcCccChhhhccc-C-CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          193 YREIVGSPYYIAPEVLSQS-Y-GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      +.+.||.|+|.|||++.|. | +.++||||+|||||.|+||++||++.+...++.++.++.+..+    ..+|.++.+||
T Consensus       168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~eaQdLL  243 (786)
T KOG0588|consen  168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSEAQDLL  243 (786)
T ss_pred             ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHHHHHHH
Confidence            8999999999999999875 4 6799999999999999999999999999999999999988766    46899999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          271 RRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       271 ~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      .+||..||++|.|.++|++|||+..+.
T Consensus       244 r~ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  244 RRMLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             HHHhccCccccccHHHHhhCchhhcCC
Confidence            999999999999999999999998754

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-50  Score=376.07  Aligned_cols=261  Identities=32%  Similarity=0.507  Sum_probs=228.0

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC-eE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ-FV  109 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~-~~  109 (494)
                      +..+|.+++.||.|.||.||+|..+.+|..||||..++.-..  ...-.-.+|+..|++|..||||+++.+++.++. .+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s--~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc--HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            457999999999999999999999999999999999765432  233345679999999966999999999998877 99


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      |+|||||+ .+|+++++.+ ..+++..+..|++||+.||+|+|++|+.|||+||+|||+   .....+||+|||+|+.+.
T Consensus        86 ~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi---~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   86 YFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI---SGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe---cccceeEecccccccccc
Confidence            99999995 5999999865 459999999999999999999999999999999999999   558899999999999999


Q ss_pred             cCcccccccCCcCccChhhhc--ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC----------
Q 040917          189 EGKAYREIVGSPYYIAPEVLS--QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR----------  256 (494)
Q Consensus       189 ~~~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~----------  256 (494)
                      +.+++..++.|.+|+|||++.  +-|+.+.|+||+|||++|+.+-+..|.|.++-+.+..|..---.+..          
T Consensus       162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La  241 (538)
T KOG0661|consen  162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA  241 (538)
T ss_pred             cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence            999999999999999999985  45999999999999999999999999999988777666431111111          


Q ss_pred             ----------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          257 ----------------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       257 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                                      ..++.++.++.++|.+|+.+||.+||||.++|+||||+...
T Consensus       242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence                            11345789999999999999999999999999999998643

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.4e-48  Score=339.52  Aligned_cols=261  Identities=31%  Similarity=0.498  Sum_probs=226.2

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|...+.||+|.||.||+|++..+|+.||+|.++...... ...-...+|++.|+.++ ||||+.++++|...+...+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~-h~nIi~LiD~F~~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELK-HPNIIELIDVFPHKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHcc-CcchhhhhhhccCCCceEEE
Confidence            47889999999999999999999999999999998776433 34667889999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      +||++. +|...++.. ..++...++.++.++++|++|||++.|+||||||+|+|+   +++|.+||+|||+|+.+.+..
T Consensus        80 fEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   80 FEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             EEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---cCCCcEEeecccchhccCCCC
Confidence            999975 999988764 468999999999999999999999999999999999999   789999999999999876544


Q ss_pred             cc-ccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCC-----------
Q 040917          192 AY-REIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD-----------  257 (494)
Q Consensus       192 ~~-~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-----------  257 (494)
                      .. ...+.|.+|+|||.+-|  .|+..+|+||.|||+.||+.+.+.|.|.++-+++..+.+.--.+.+.           
T Consensus       156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            33 23477999999999865  59999999999999999999999999999888777665432222222           


Q ss_pred             -------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917          258 -------------PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       258 -------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  299 (494)
                                   .++..++++.+|+.+||..||.+|+++.|+|+|+||+..+.+
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p  290 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP  290 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence                         234567888999999999999999999999999999975544

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.6e-48  Score=370.56  Aligned_cols=260  Identities=31%  Similarity=0.562  Sum_probs=236.4

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      -.++|.+++.||+|+||.||+|+.+.||..+|+|+++++.........++..|..+|... ++|.|++++-.|++..++|
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeE
Confidence            347899999999999999999999999999999999999888888889999999999996 6999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-  189 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-  189 (494)
                      +||||++||++..++.+.+.+++..+..++.+++.|+..+|+.|+|||||||+|+||   +..||+||+|||++.-... 
T Consensus       218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhhh
Confidence            999999999999999999999999999999999999999999999999999999999   7999999999999842210 


Q ss_pred             -----------------------Cc-----c-------------------cccccCCcCccChhhhcc-cCCCcchhHHH
Q 040917          190 -----------------------GK-----A-------------------YREIVGSPYYIAPEVLSQ-SYGKEADIWSA  221 (494)
Q Consensus       190 -----------------------~~-----~-------------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~sl  221 (494)
                                             ..     .                   ..+.+|||.|+|||++.+ .|+..+|+|||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                   00     0                   012469999999999976 59999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCccCc
Q 040917          222 GVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI---TVAQVLEHPWLKE  295 (494)
Q Consensus       222 G~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~eil~~~~~~~  295 (494)
                      |||+|||+.|.+||.+.++.+....|.+-...+..+.-..+++++++||.+||. ||++|.   +++||..||||+.
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~  450 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG  450 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence            999999999999999999999999998877666666657788999999999999 999997   5899999999986

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.7e-49  Score=343.35  Aligned_cols=262  Identities=36%  Similarity=0.700  Sum_probs=241.1

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCC--C---ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL--V---KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED  105 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~--~---~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~  105 (494)
                      +-..|.-.+.||.|..++|-++.++.+|+.+|+|++....-  .   .....+...+|+++|+++.+||+|+++.++|+.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            34578888999999999999999999999999999853221  1   222345566899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          106 DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      +...++|+|.|+.|.|.+++...-.++++...+|++|+++|+.|||.++|+||||||+|||+   +++..++|+|||++.
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFAC  171 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEeccceee
Confidence            99999999999999999999888789999999999999999999999999999999999999   678899999999999


Q ss_pred             ccccCcccccccCCcCccChhhhc-------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCC
Q 040917          186 FIEEGKAYREIVGSPYYIAPEVLS-------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP  258 (494)
Q Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (494)
                      ...++...+..||||+|.|||.+.       ..|+..+|+||+|+|+|-|+.|..||+.....-++..|..+...+..+.
T Consensus       172 ~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe  251 (411)
T KOG0599|consen  172 QLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE  251 (411)
T ss_pred             ccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence            999999999999999999999873       2488899999999999999999999999999889999999999999999


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          259 FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       259 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      |.+++...+++|.+||+.||++|.|++|+|.||||..
T Consensus       252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  252 WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            9999999999999999999999999999999999964

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-47  Score=360.79  Aligned_cols=261  Identities=28%  Similarity=0.466  Sum_probs=224.9

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--Ce
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--QF  108 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--~~  108 (494)
                      ..+.|+.++.||+|.||.||+|++..+|+.||+|.+..... .+.......+|+.+|++| +||||+++.++....  ..
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCce
Confidence            34678899999999999999999999999999999976543 234567788999999999 599999999998776  68


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      +|+|+|||+. +|.-++... -.+++.+++.+++||+.||.|||.+||.|||||.+||||   +++|.+||+|||+|++.
T Consensus       193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeec
Confidence            9999999965 888887663 369999999999999999999999999999999999999   78999999999999976


Q ss_pred             ccCc--ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCC-----
Q 040917          188 EEGK--AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP-----  258 (494)
Q Consensus       188 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-----  258 (494)
                      ....  .+...+.|.+|+|||.+.|  .|+.++|+||+|||+.||++|++.|.+.++.+++..|.+.--.+....     
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            5433  5677888999999999987  599999999999999999999999999999988888754221111111     


Q ss_pred             --------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          259 --------------------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       259 --------------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                                          +..++....+|+..||..||.+|.||.++|+++||...+
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p  407 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEP  407 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCC
Confidence                                234678889999999999999999999999999995433

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-46  Score=351.40  Aligned_cols=264  Identities=30%  Similarity=0.473  Sum_probs=229.8

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      +..-...|++...||.|..++||+|+...+++.||||++.......  ..+.+.+|+..++.+ +||||++++..|..+.
T Consensus        21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~   97 (516)
T KOG0582|consen   21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLI-DHPNIVTYHCSFVVDS   97 (516)
T ss_pred             CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhc-CCCCcceEEEEEEecc
Confidence            3444578999999999999999999999999999999998666433  378899999999999 5999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          108 FVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      .+++||.||.+||+.++++..  ..+++..|..+++++++||.|||++|.||||||+.|||+   +.+|.|+|+|||.+.
T Consensus        98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen   98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSA  174 (516)
T ss_pred             eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeee
Confidence            999999999999999999864  348999999999999999999999999999999999999   789999999999876


Q ss_pred             ccccCc-cc----ccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC-
Q 040917          186 FIEEGK-AY----REIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR-  256 (494)
Q Consensus       186 ~~~~~~-~~----~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-  256 (494)
                      .+-... ..    ....||++|+|||++..   .|+.|+||||||++..||.+|+.||....+..++..-+++..+... 
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t  254 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT  254 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc
Confidence            543322 11    34579999999999654   4999999999999999999999999999998887776676654222 


Q ss_pred             -----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          257 -----DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       257 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                           +.....+..++.+|..||..||++|||++++|+|+||+...
T Consensus       255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence                 22234678899999999999999999999999999999754

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-48  Score=343.14  Aligned_cols=246  Identities=33%  Similarity=0.581  Sum_probs=215.6

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeE-EEE-eCCeE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKA-AYE-DDQFV  109 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~-~~~-~~~~~  109 (494)
                      ..+|+|.+.||.|+||+||+|.+..+|..||+|.+.-.. -+....+....|+.+|++|+ ||||+++++ .+. +...+
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~evl   95 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNEVL   95 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccchhh
Confidence            357999999999999999999999999999999997433 45557888999999999995 999999998 444 44458


Q ss_pred             EEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCceEEeeCCCCCeEEEeec
Q 040917          110 HIVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHS--KG--VMHRDLKPENFLFTTGDENAVVKATDF  181 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~--~~--i~H~dikp~NIli~~~~~~~~~kL~Df  181 (494)
                      +||||+|.+|+|...++.    .+.+++.+++.++.|++.||..+|+  ..  |+||||||.||++   +..|.+||+||
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDf  172 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDF  172 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeeccc
Confidence            999999999999988863    3469999999999999999999999  44  8999999999999   68899999999


Q ss_pred             CCccccccCcc-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 040917          182 GLSAFIEEGKA-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF  259 (494)
Q Consensus       182 g~a~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  259 (494)
                      |+++...+... ..+.+|||+||+||.+.+ +|+.+|||||+||++|||+.-+.||.+.+..+....|.++..++.+.  
T Consensus       173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~--  250 (375)
T KOG0591|consen  173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD--  250 (375)
T ss_pred             hhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH--
Confidence            99998766543 356889999999999875 69999999999999999999999999999888889999885543332  


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCH
Q 040917          260 PSISSSAIELVRRMLTQDPKRRITV  284 (494)
Q Consensus       260 ~~~~~~l~~li~~~l~~dp~~Rps~  284 (494)
                      ..+|..+..+|..|+..||+.||+.
T Consensus       251 ~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  251 EHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HHhhhHHHHHHHHHccCCcccCCCc
Confidence            4688999999999999999999987

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-47  Score=356.04  Aligned_cols=257  Identities=34%  Similarity=0.561  Sum_probs=215.1

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC--eE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ--FV  109 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~--~~  109 (494)
                      ..+|..++.||+|+||.||++.+..+|...|+|.+....   ....+.+.+|+.+|.+|+ ||||+++++......  .+
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~   91 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEY   91 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeee
Confidence            356999999999999999999999999999999986542   112677999999999997 999999999854444  69


Q ss_pred             EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCC-CCeEEEeecCCcccc
Q 040917          110 HIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDE-NAVVKATDFGLSAFI  187 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~-~~~~kL~Dfg~a~~~  187 (494)
                      +|+|||++||+|.+++.+.+ ++++..+..+.+||++||.|||++||+|+||||+|||+   +. ++.+||+|||.+...
T Consensus        92 ~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl---~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   92 NIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL---DPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             EeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE---eCCCCeEEeccCcccccc
Confidence            99999999999999999877 79999999999999999999999999999999999999   56 689999999998866


Q ss_pred             cc----CcccccccCCcCccChhhhcccC--CCcchhHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHcCCccCCCCCCC
Q 040917          188 EE----GKAYREIVGSPYYIAPEVLSQSY--GKEADIWSAGVILYILLCGVPPFWAE-TDQGVAQAILKGEINFQRDPFP  260 (494)
Q Consensus       188 ~~----~~~~~~~~~~~~y~aPE~~~~~~--~~~~Di~slG~il~~l~tg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~  260 (494)
                      ..    ........||+.|||||++....  .+++|||||||++.||+||+.||... ...+..-.+....  ..+....
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--~~P~ip~  246 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--SLPEIPD  246 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC--CCCCCCc
Confidence            53    12233578999999999998432  34999999999999999999999763 2222222333332  1223335


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      .+|+++++||.+|+..+|.+||||+++|+|||.....
T Consensus       247 ~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  247 SLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             ccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            6899999999999999999999999999999998644

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.4e-47  Score=340.89  Aligned_cols=264  Identities=26%  Similarity=0.383  Sum_probs=224.2

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--CCeEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--DQFVH  110 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--~~~~~  110 (494)
                      +.|..+..|++|.||.||+|+++.|++.||+|.++...-. ....-...+|+.+|.+.+ ||||+.+-++...  -+.+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek-~GFPItsLREIniLl~~~-H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK-EGFPITSLREINILLKAR-HPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc-CCCcchhHHHHHHHHhcC-CCCeeeeEEEEeccccceee
Confidence            5789999999999999999999999999999999865522 223445678999999995 9999999998764  34799


Q ss_pred             EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          111 IVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      ||||||+. +|..++.+.+ +++..+++.+..|++.|++|||.++|+||||||+|+|+   .+.|.+|++|||+|+...+
T Consensus       154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIADFGLAREYGS  229 (419)
T ss_pred             eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEecccchhhhhcC
Confidence            99999975 9999887765 79999999999999999999999999999999999999   7899999999999998765


Q ss_pred             C-cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCC-------
Q 040917          190 G-KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF-------  259 (494)
Q Consensus       190 ~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------  259 (494)
                      . ..+...+.|.+|+|||.+.+  .|+.+.|+||+|||+.||+++++.|.+.++.+.++.|.+.--.+....|       
T Consensus       230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence            4 44566778999999999976  4999999999999999999999999999998888777532211111111       


Q ss_pred             -------------------C--CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCC
Q 040917          260 -------------------P--SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDK  302 (494)
Q Consensus       260 -------------------~--~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~  302 (494)
                                         +  .+++...+|+..+|..||.+|.||+++|+|+||.+.+.+.+.
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P  373 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDP  373 (419)
T ss_pred             hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCCh
Confidence                               1  145778899999999999999999999999999997765543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.8e-47  Score=364.88  Aligned_cols=255  Identities=31%  Similarity=0.579  Sum_probs=231.2

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..- +.....++.+|+++++.|+ ||||+.++++|+...+.++|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceEEEE
Confidence            579999999999999999999999999999999987653 3446788999999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-  191 (494)
                      +|||.| +|..++...+.++++.+..++.+++.||.|||+++|.|||+||.||++   +..+++|+||||+|+-+..+. 
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~  155 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS  155 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce
Confidence            999987 999999999999999999999999999999999999999999999999   789999999999998765433 


Q ss_pred             ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      ......|||.|||||+..+ +|+..+|+||||||+||+++|++||...+.......|.+....++    ...+..+..|+
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p----~~~S~~f~nfl  231 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP----STASSSFVNFL  231 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc----ccccHHHHHHH
Confidence            3456789999999999875 699999999999999999999999988887777777777655444    47899999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          271 RRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       271 ~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ..+|.+||.+|.++.+++.|||.+...
T Consensus       232 ~gLL~kdP~~RltW~~Ll~HpF~k~~~  258 (808)
T KOG0597|consen  232 QGLLIKDPAQRLTWTDLLGHPFWKGKI  258 (808)
T ss_pred             HHHhhcChhhcccHHHHhcChHHhhhh
Confidence            999999999999999999999998644

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-46  Score=365.65  Aligned_cols=255  Identities=29%  Similarity=0.545  Sum_probs=236.4

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|+||+|++|..+.+++.+|||++++.....+...+....|-+++....+||.++.++.+|+..+++|+|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            78999999999999999999999999999999999998888888999999999999988899999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cCc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~~  191 (494)
                      |||+.||++..+ ...+.+++..+..++..|+.||.|||++||||||||.+|||+   +..|++||+|||++...- .+.
T Consensus       448 mey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  448 MEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMGQGD  523 (694)
T ss_pred             EEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccCCCCC
Confidence            999999995443 344689999999999999999999999999999999999999   789999999999998643 566


Q ss_pred             ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      ...+.||||.|+|||++.+ .|+..+|+|||||++|+|+.|..||.+.+++++.+.|.+....++.    .++.+...++
T Consensus       524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea~~il  599 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEAIAIM  599 (694)
T ss_pred             ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHHHHHH
Confidence            6778999999999999986 5999999999999999999999999999999999999998887774    5789999999


Q ss_pred             HHhcccCCCCCCC-----HHHHhcCCccCc
Q 040917          271 RRMLTQDPKRRIT-----VAQVLEHPWLKE  295 (494)
Q Consensus       271 ~~~l~~dp~~Rps-----~~eil~~~~~~~  295 (494)
                      .++|.+||++|..     +++|..||||+.
T Consensus       600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~  629 (694)
T KOG0694|consen  600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRS  629 (694)
T ss_pred             HHHhccCcccccCCCCCCchhhhhCCcccc
Confidence            9999999999985     578999999986

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-46  Score=355.96  Aligned_cols=253  Identities=29%  Similarity=0.564  Sum_probs=224.0

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++. ||||+++++++.+....++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeEEEE
Confidence            37999999999999999999999999999999997544333334567889999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      |||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++......  
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCC--
Confidence            9999999999999888889999999999999999999999999999999999999   67889999999998765432  


Q ss_pred             cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917          193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR  271 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  271 (494)
                      .....|++.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+..+...++    ..++..+.++|.
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~  230 (291)
T cd05612         155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFP----RHLDLYAKDLIK  230 (291)
T ss_pred             cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCC----ccCCHHHHHHHH
Confidence            234568999999999865 488999999999999999999999999888888888877655443    346889999999


Q ss_pred             HhcccCCCCCCC-----HHHHhcCCccCc
Q 040917          272 RMLTQDPKRRIT-----VAQVLEHPWLKE  295 (494)
Q Consensus       272 ~~l~~dp~~Rps-----~~eil~~~~~~~  295 (494)
                      +||..||.+||+     ++++++||||..
T Consensus       231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         231 KLLVVDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             HHcCCCHHHccCCccCCHHHHhcCccccC
Confidence            999999999995     999999999975

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-45  Score=359.27  Aligned_cols=253  Identities=32%  Similarity=0.614  Sum_probs=224.6

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++ +||||+++++++..++..++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCEEEEE
Confidence            6799999999999999999999999999999999765443334466788999999999 499999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      |||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++......  
T Consensus        97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~--  171 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDR--  171 (329)
T ss_pred             EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCCC--
Confidence            9999999999999888889999999999999999999999999999999999999   67889999999998765332  


Q ss_pred             cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917          193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR  271 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  271 (494)
                      .....|++.|+|||++.+ .++.++|+|||||++|+|++|..||.+.........+..+...++    ..++..+.++|.
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~  247 (329)
T PTZ00263        172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP----NWFDGRARDLVK  247 (329)
T ss_pred             cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCC----CCCCHHHHHHHH
Confidence            234578999999999865 578999999999999999999999998888777777777654433    247889999999


Q ss_pred             HhcccCCCCCCC-----HHHHhcCCccCc
Q 040917          272 RMLTQDPKRRIT-----VAQVLEHPWLKE  295 (494)
Q Consensus       272 ~~l~~dp~~Rps-----~~eil~~~~~~~  295 (494)
                      +||..||.+||+     +.++++||||..
T Consensus       248 ~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        248 GLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            999999999997     799999999986

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-46  Score=360.24  Aligned_cols=258  Identities=33%  Similarity=0.565  Sum_probs=225.8

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ..+...+|+....||+|+.|.||.|....+++.||+|.+....   ....+.+.+|+.+|+.++ |+||+.+++.|...+
T Consensus       268 ~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~d  343 (550)
T KOG0578|consen  268 QGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDLH-HPNIVNFLDSYLVGD  343 (550)
T ss_pred             CCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhcc-chHHHHHHHHhcccc
Confidence            3456689999999999999999999999999999999997654   335678999999999996 999999999999889


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .+++||||++||+|.+.+... .+++.++..++++++.||+|||.+||+|||||.+|||+   ..++.+||+|||++..+
T Consensus       344 eLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---~~~g~vKltDFGFcaqi  419 (550)
T KOG0578|consen  344 ELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---TMDGSVKLTDFGFCAQI  419 (550)
T ss_pred             eeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---ccCCcEEEeeeeeeecc
Confidence            999999999999999988665 59999999999999999999999999999999999999   67888999999999887


Q ss_pred             ccCcc-cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HcCCccCCCCCCCCCCH
Q 040917          188 EEGKA-YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAI-LKGEINFQRDPFPSISS  264 (494)
Q Consensus       188 ~~~~~-~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  264 (494)
                      ..... -.+.+|||+|||||+.. ..|++++||||||+++.||+-|..||...++...+..+ .++......  ...+++
T Consensus       420 ~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~--~~klS~  497 (550)
T KOG0578|consen  420 SEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKN--PEKLSP  497 (550)
T ss_pred             ccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCC--ccccCH
Confidence            65543 34678999999999986 47999999999999999999999999866654444433 344333333  367999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      .+++|+.+||..|+.+|+++.++|+||||+-
T Consensus       498 ~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  498 ELKDFLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             HHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence            9999999999999999999999999999964

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-46  Score=333.24  Aligned_cols=278  Identities=37%  Similarity=0.680  Sum_probs=244.6

Q ss_pred             hhhcccccccccceEee-eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEe
Q 040917           22 AILGKAYEDVQLHYTIG-REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK  100 (494)
Q Consensus        22 ~~~~~~~~~~~~~y~i~-~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~  100 (494)
                      +.+....-.+.++|++- +.||-|-.|.|-.|.++.||+.+|+|++..        .....+|+++--...+||||+.++
T Consensus        50 ~~m~~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~Ii  121 (400)
T KOG0604|consen   50 SDMDFKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSII  121 (400)
T ss_pred             hhcchhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEee
Confidence            33333445577888875 569999999999999999999999999852        334567777766666899999999


Q ss_pred             EEEEe----CCeEEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917          101 AAYED----DQFVHIVMELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA  174 (494)
Q Consensus       101 ~~~~~----~~~~~iv~e~~~g~sL~~~~~~~~~--l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~  174 (494)
                      ++|.+    ...+.+|||.++||.|.+++..++.  +++..+.+|++||+.|+.|||+.+|+||||||+|+|+.++..+.
T Consensus       122 dVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na  201 (400)
T KOG0604|consen  122 DVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNA  201 (400)
T ss_pred             hhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCc
Confidence            99854    4578899999999999999988765  99999999999999999999999999999999999999888899


Q ss_pred             eEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHc
Q 040917          175 VVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD----QGVAQAILK  249 (494)
Q Consensus       175 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~----~~~~~~~~~  249 (494)
                      .+||+|||+|........+.+.+.||+|.|||++.. .|+...|+||+||++|-|+.|.+||.+...    .++...|..
T Consensus       202 ~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~  281 (400)
T KOG0604|consen  202 PLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT  281 (400)
T ss_pred             ceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc
Confidence            999999999998777777788899999999999964 599999999999999999999999987653    467778889


Q ss_pred             CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCCcHH
Q 040917          250 GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTA  307 (494)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~~~~  307 (494)
                      +...|+.+.|..+|+..+++|+.+|..+|++|.|++++++|||+.......+.|+.+.
T Consensus       282 gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t~  339 (400)
T KOG0604|consen  282 GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLSTS  339 (400)
T ss_pred             cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchhh
Confidence            9999999999999999999999999999999999999999999998777777776554

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-46  Score=348.59  Aligned_cols=260  Identities=32%  Similarity=0.608  Sum_probs=226.0

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC-----------hhhHHHHHHHHHHHHHccCCCCccEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK-----------DVEKDDVRREIEIMRHLSGQPNIVQF   99 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~~hp~i~~~   99 (494)
                      ...+|++++.||+|.||.|-+|++..+++.||+|++.+.....           ....+...+|+.+|+++. ||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nVV~L  173 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNVVKL  173 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCeeEE
Confidence            3468999999999999999999999999999999997654321           122467899999999995 9999999


Q ss_pred             eEEEEeC--CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEE
Q 040917          100 KAAYEDD--QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVK  177 (494)
Q Consensus       100 ~~~~~~~--~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~k  177 (494)
                      +++..+.  +.+|+|+|||..|.+.+.-.....++..+++.+++.++.||.|||.+||+||||||+|+|+   ++++++|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl---~~~g~VK  250 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL---SSDGTVK  250 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE---cCCCcEE
Confidence            9999764  5899999999998886543333338999999999999999999999999999999999999   6789999


Q ss_pred             EeecCCcccccc------CcccccccCCcCccChhhhccc-----CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 040917          178 ATDFGLSAFIEE------GKAYREIVGSPYYIAPEVLSQS-----YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQA  246 (494)
Q Consensus       178 L~Dfg~a~~~~~------~~~~~~~~~~~~y~aPE~~~~~-----~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~  246 (494)
                      |+|||.+.....      ........|||.|+|||...+.     .+.+.||||+||+||+|+.|+.||.+....+..+.
T Consensus       251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K  330 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK  330 (576)
T ss_pred             eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence            999999987632      2234457899999999998652     46789999999999999999999999999999999


Q ss_pred             HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          247 ILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      |.+....++..  +.+.+.++++|.+||.+||++|.+..+|..|||....
T Consensus       331 Ivn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  331 IVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            99988887765  4688999999999999999999999999999999864

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-46  Score=324.60  Aligned_cols=254  Identities=32%  Similarity=0.639  Sum_probs=236.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|.++++||.|.||.||.|+.+.++..||+|++.++.........++.+|+++-..|+ ||||++++++|.+...+|++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheeccceeEEE
Confidence            68999999999999999999999999999999999888777778889999999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          113 MELCAGGELFDRIV--ARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       113 ~e~~~g~sL~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +||..+|+|...+.  ...++++.....+++|++.|+.|+|.++++||||||+|+|+   +..+.+|++|||.+...+ .
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~~p-~  176 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP-S  176 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc---CCCCCeeccCCCceeecC-C
Confidence            99999999999998  56679999999999999999999999999999999999999   788999999999998765 3


Q ss_pred             cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                      ..-.+.|||..|.+||...+ .++..+|+|++|++.|+++.|..||...+..+.++.+.+....++    ..++..+.++
T Consensus       177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~~a~dl  252 (281)
T KOG0580|consen  177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISGGAADL  252 (281)
T ss_pred             CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccChhHHHH
Confidence            34457899999999999876 589999999999999999999999999999899999988877776    5789999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          270 VRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       270 i~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      |.+|+..+|.+|.+..+++.|||+..
T Consensus       253 I~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  253 ISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHHHhccCccccccHHHHhhhHHHHh
Confidence            99999999999999999999999975

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-45  Score=358.29  Aligned_cols=257  Identities=33%  Similarity=0.542  Sum_probs=224.4

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++..+. ||||+++++++......|+|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEEEE
Confidence            47999999999999999999999999999999997654333334567889999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      |||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.....  .
T Consensus        80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~--~  154 (333)
T cd05600          80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVT--Y  154 (333)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCccccc--c
Confidence            9999999999999888889999999999999999999999999999999999999   6788999999999875533  2


Q ss_pred             cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCC----CCCCHHHH
Q 040917          193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF----PSISSSAI  267 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~  267 (494)
                      .....|++.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+.........+..    ..++..+.
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~  234 (333)
T cd05600         155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW  234 (333)
T ss_pred             cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence            345678999999999865 5899999999999999999999999988887777666553332222222    25789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          268 ELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      ++|.+||..+|.+||++.++++||||..
T Consensus       235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~  262 (333)
T cd05600         235 DLITKLINDPSRRFGSLEDIKNHPFFKE  262 (333)
T ss_pred             HHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence            9999999999999999999999999986

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-46  Score=344.20  Aligned_cols=258  Identities=39%  Similarity=0.682  Sum_probs=241.3

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ..+..-+|.+.+.||.|.||.|.+|.+..+|+.||||.+++....+.+..-.+.+|++++..| +||||+.++++|.+.+
T Consensus        48 khnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkd  126 (668)
T KOG0611|consen   48 KHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKD  126 (668)
T ss_pred             ccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCc
Confidence            445667999999999999999999999999999999999999998988999999999999999 6999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .+.|||||..||.|++++..++.+++.++..+++||+.|+.|+|+++++|||||.+|||+   +.++.+||+|||++...
T Consensus       127 KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLY  203 (668)
T ss_pred             eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhh
Confidence            999999999999999999999999999999999999999999999999999999999999   78899999999999999


Q ss_pred             ccCcccccccCCcCccChhhhccc-C-CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          188 EEGKAYREIVGSPYYIAPEVLSQS-Y-GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      .....+.+.||+|.|.+||+.+|. | ++.+|.||||+++|-|+.|.+||++........+|.++...-+     .-|..
T Consensus       204 ~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP-----~~PSd  278 (668)
T KOG0611|consen  204 ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP-----ETPSD  278 (668)
T ss_pred             ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC-----CCCch
Confidence            888889999999999999999875 4 6899999999999999999999999999999999988755433     34678


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWLK  294 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~~  294 (494)
                      ..-||.+||..||++|.|+++|-+|=|+.
T Consensus       279 A~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  279 ASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             HHHHHHHHHhcCcccchhHHHHhhhheee
Confidence            99999999999999999999999996664

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.8e-45  Score=357.11  Aligned_cols=249  Identities=31%  Similarity=0.573  Sum_probs=219.0

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG  118 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g  118 (494)
                      +.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++++. ||||+++++++..++..|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999997654333444567788999999995 99999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cCccccccc
Q 040917          119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIV  197 (494)
Q Consensus       119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~~~~~~~~  197 (494)
                      ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.... ........+
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~  156 (323)
T cd05571          80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCccccee
Confidence            9999999888889999999999999999999999999999999999999   678899999999987532 222334567


Q ss_pred             CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 040917          198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ  276 (494)
Q Consensus       198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  276 (494)
                      |++.|+|||++.+ .++.++||||+||++|+|++|+.||...........+......++    ..+++.+.++|.+||..
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~  232 (323)
T cd05571         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence            8999999999865 589999999999999999999999998888777777766654443    45789999999999999


Q ss_pred             CCCCCC-----CHHHHhcCCccCc
Q 040917          277 DPKRRI-----TVAQVLEHPWLKE  295 (494)
Q Consensus       277 dp~~Rp-----s~~eil~~~~~~~  295 (494)
                      ||++||     ++.++++||||..
T Consensus       233 dP~~R~~~~~~~~~~ll~h~~f~~  256 (323)
T cd05571         233 DPKQRLGGGPEDAKEIMEHRFFAS  256 (323)
T ss_pred             CHHHcCCCCCCCHHHHHcCCCcCC
Confidence            999999     8999999999986

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.6e-45  Score=350.19  Aligned_cols=258  Identities=28%  Similarity=0.465  Sum_probs=216.4

Q ss_pred             eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917           35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME  114 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e  114 (494)
                      |++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++++ +||+|+++++++..++..++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEEEEE
Confidence            78899999999999999999999999999998765443333445678899999999 59999999999999999999999


Q ss_pred             ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          115 LCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       115 ~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      |+++|+|..++...  ..+++..+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCCe
Confidence            99999998877543  358999999999999999999999999999999999999   6788999999999987654444


Q ss_pred             cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917          193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR  271 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  271 (494)
                      .....|++.|+|||++.+ .++.++||||+||++|+|++|+.||.+.........+..............+++.+.+|+.
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  237 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR  237 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence            455678999999999864 6899999999999999999999999876543222222221112222233468899999999


Q ss_pred             HhcccCCCCCCC-----HHHHhcCCccCcc
Q 040917          272 RMLTQDPKRRIT-----VAQVLEHPWLKES  296 (494)
Q Consensus       272 ~~l~~dp~~Rps-----~~eil~~~~~~~~  296 (494)
                      +||+.||.+||+     ++++++||||...
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~  267 (285)
T cd05631         238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNI  267 (285)
T ss_pred             HHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence            999999999997     8999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=9.3e-45  Score=359.15  Aligned_cols=259  Identities=28%  Similarity=0.483  Sum_probs=220.1

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++.+.+....|+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEE
Confidence            4799999999999999999999999999999999764433334456788899999999 599999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-  191 (494)
                      |||++||+|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++....... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCccccccccc
Confidence            9999999999999888889999999999999999999999999999999999999   678899999999986432110 


Q ss_pred             -----------------------------------ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCC
Q 040917          192 -----------------------------------AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPF  235 (494)
Q Consensus       192 -----------------------------------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf  235 (494)
                                                         .....+||+.|+|||++.+ .++.++|+|||||++|+|++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                               0123578999999999865 5899999999999999999999999


Q ss_pred             CCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCC---CCCCHHHHhcCCccCcc
Q 040917          236 WAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPK---RRITVAQVLEHPWLKES  296 (494)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~---~Rps~~eil~~~~~~~~  296 (494)
                      .+....+....+.........+....+++.+.++|.+|+. +|.   .||+++++++||||+..
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence            9988888887777643333322234578999999999775 444   46899999999999863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7e-45  Score=355.88  Aligned_cols=254  Identities=30%  Similarity=0.574  Sum_probs=223.8

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCC-cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTG-LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~-~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      .++|++.+.||+|+||.||+|.+..++ ..||+|++.............+.+|+.+++.+. ||||+++++++......+
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCEEE
Confidence            367999999999999999999876654 689999987554434445667889999999995 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +||||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++......
T Consensus       108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeecCCC
Confidence            999999999999999888889999999999999999999999999999999999999   67889999999999765432


Q ss_pred             cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                        .....||+.|+|||++.+ .++.++|+||+||++|+|++|..||.+.+.....+.+..+...++    +.+++.+.++
T Consensus       185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l  258 (340)
T PTZ00426        185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNCKHL  258 (340)
T ss_pred             --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHH
Confidence              235678999999999865 488999999999999999999999999888777788777655443    3578999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHhcCCccCc
Q 040917          270 VRRMLTQDPKRRI-----TVAQVLEHPWLKE  295 (494)
Q Consensus       270 i~~~l~~dp~~Rp-----s~~eil~~~~~~~  295 (494)
                      |.+||..||.+|+     +++++++||||.+
T Consensus       259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN  289 (340)
T ss_pred             HHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            9999999999995     8999999999986

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-45  Score=359.60  Aligned_cols=259  Identities=29%  Similarity=0.567  Sum_probs=222.8

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..+. ||||+++++++..+..+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeEEEE
Confidence            37999999999999999999999999999999997654333344566888999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      |||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++........
T Consensus        80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceecccccc
Confidence            9999999999999888889999999999999999999999999999999999999   6788999999999865322110


Q ss_pred             ---------------------------------------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCC
Q 040917          193 ---------------------------------------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGV  232 (494)
Q Consensus       193 ---------------------------------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~  232 (494)
                                                             ....+||+.|+|||++.+ .++.++|||||||++|+|++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence                                                   012468999999999864 5899999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCccCcc
Q 040917          233 PPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRIT---VAQVLEHPWLKES  296 (494)
Q Consensus       233 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~eil~~~~~~~~  296 (494)
                      .||.+....+....+.........+....+++.+.++|.+|+. +|.+|++   +.++++||||+..
T Consensus       237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9999888877777776544433333334678999999999996 9999998   9999999999863

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=348.80  Aligned_cols=248  Identities=29%  Similarity=0.433  Sum_probs=214.8

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcE-EEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC-eEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLE-FACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ-FVH  110 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~-valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~-~~~  110 (494)
                      ....+.+.||+|+||+||++.++  |+. ||+|++......... ...+.+|+.+|.+|+ ||||+++++++.... ..+
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~~~  116 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACTSPPGSLC  116 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCceE
Confidence            44556677999999999999988  556 999999876654443 788999999999995 999999999998877 799


Q ss_pred             EEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCceEEeeCCCCC-eEEEeecCCccc
Q 040917          111 IVMELCAGGELFDRIVA--RGHYSERAAASVFRVIMNVVNVCHSKG-VMHRDLKPENFLFTTGDENA-VVKATDFGLSAF  186 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~-i~H~dikp~NIli~~~~~~~-~~kL~Dfg~a~~  186 (494)
                      |||||+++|+|.+++..  ...++...+..++.+|+.|+.|||+++ ||||||||.|||+   +.++ ++||+|||+++.
T Consensus       117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSRE  193 (362)
T ss_pred             EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCcccee
Confidence            99999999999999987  578999999999999999999999999 9999999999999   5675 999999999987


Q ss_pred             cccC-cccccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          187 IEEG-KAYREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       187 ~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      .... .......||+.|||||++.+   .|+.++||||||+++|||+||+.||.......+...+......+..+  ...
T Consensus       194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p--~~~  271 (362)
T KOG0192|consen  194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP--KEC  271 (362)
T ss_pred             eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--ccC
Confidence            6544 33344789999999999985   39999999999999999999999999999876766666554443322  238


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ++.+..++.+||..||.+||++.+++.
T Consensus       272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  272 PPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            899999999999999999999999875

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-45  Score=358.76  Aligned_cols=259  Identities=34%  Similarity=0.633  Sum_probs=225.6

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..+. ||||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeEEEE
Confidence            37999999999999999999999999999999997654434345667889999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-  191 (494)
                      |||++|++|.+++...+.++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++....... 
T Consensus        80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccCc
Confidence            9999999999999888889999999999999999999999999999999999999   678899999999987654332 


Q ss_pred             -----------------------------ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 040917          192 -----------------------------AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ  241 (494)
Q Consensus       192 -----------------------------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~  241 (494)
                                                   ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                         1234568999999999875 5899999999999999999999999988887


Q ss_pred             HHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCCccCcc
Q 040917          242 GVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRIT-VAQVLEHPWLKES  296 (494)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~eil~~~~~~~~  296 (494)
                      .....+.........+....+++.+.++|.+||. ||.+||+ +.++++||||+..
T Consensus       237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            7777776633333333334589999999999997 9999999 9999999999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-44  Score=332.24  Aligned_cols=263  Identities=29%  Similarity=0.456  Sum_probs=221.5

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCC-ccEEeEEEEeCC---
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN-IVQFKAAYEDDQ---  107 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~-i~~~~~~~~~~~---  107 (494)
                      ...|..++.||+|.||+||+|+.+.+|+.||+|.+...... +.......+|+.+++.|+ |+| |+.+++++...+   
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~   87 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHR   87 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhC-CCcceEEEEeeeeeccccc
Confidence            45688889999999999999999999999999999755422 234556789999999995 999 999999998877   


Q ss_pred             ---eEEEEEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917          108 ---FVHIVMELCAGGELFDRIVARG----HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       108 ---~~~iv~e~~~g~sL~~~~~~~~----~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                         ..++|+||++ .+|..++....    .++...++.+++||+.||.|||+++|+||||||+||++   ++.|.+||+|
T Consensus        88 ~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaD  163 (323)
T KOG0594|consen   88 GIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLKLAD  163 (323)
T ss_pred             ccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEeeec
Confidence               8999999996 49999998765    47888999999999999999999999999999999999   6799999999


Q ss_pred             cCCccccc-cCcccccccCCcCccChhhhccc--CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCC
Q 040917          181 FGLSAFIE-EGKAYREIVGSPYYIAPEVLSQS--YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD  257 (494)
Q Consensus       181 fg~a~~~~-~~~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  257 (494)
                      ||+|+... +........+|.+|+|||++.+.  |++..||||+|||++||++++..|.+.++.+.+..|.+.--.+...
T Consensus       164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            99998765 44446677889999999999764  9999999999999999999999999999877766664321111111


Q ss_pred             C--------------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCC
Q 040917          258 P--------------------------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS  300 (494)
Q Consensus       258 ~--------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~  300 (494)
                      .                          .+...+...+++.+||+.+|.+|.|+..+|+||||.......
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~  312 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS  312 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence            1                          122335789999999999999999999999999999865443

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.1e-44  Score=357.68  Aligned_cols=259  Identities=27%  Similarity=0.483  Sum_probs=219.2

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      .|++++.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.+. ||||+++++++.+...+++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEEEEE
Confidence            6899999999999999999999999999999997655444445677899999999995 999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc--
Q 040917          114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--  191 (494)
Q Consensus       114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~--  191 (494)
                      ||++||+|.+++.+...+++..+..++.||+.||.|||++||+||||||+||++   +..++++|+|||++.......  
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCccccccccc
Confidence            999999999999888889999999999999999999999999999999999999   678899999999875321000  


Q ss_pred             ----------------------------------------------ccccccCCcCccChhhhcc-cCCCcchhHHHHHH
Q 040917          192 ----------------------------------------------AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVI  224 (494)
Q Consensus       192 ----------------------------------------------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~i  224 (494)
                                                                    ......||+.|+|||++.+ .++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                          0123468999999999864 58999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc--cCCCCCCCHHHHhcCCccCcc
Q 040917          225 LYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT--QDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       225 l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~--~dp~~Rps~~eil~~~~~~~~  296 (494)
                      +|+|++|..||......+....+.........+....+++.+.++|.+|+.  .+|..||++.++++||||...
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            999999999998887766665555433333333344688999999999654  455569999999999999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-44  Score=349.49  Aligned_cols=248  Identities=29%  Similarity=0.540  Sum_probs=217.4

Q ss_pred             ecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCc
Q 040917           41 VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGE  120 (494)
Q Consensus        41 lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~s  120 (494)
                      ||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++ +||||+++++++...+..++||||++|++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            79999999999999999999999999755433444566788899999999 59999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-CcccccccCC
Q 040917          121 LFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREIVGS  199 (494)
Q Consensus       121 L~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~~~~~~~~  199 (494)
                      |.+++...+.++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++..... ........||
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  156 (312)
T cd05585          80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGT  156 (312)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCccccccCC
Confidence            99999888889999999999999999999999999999999999999   6788999999999875322 2223346789


Q ss_pred             cCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCC
Q 040917          200 PYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP  278 (494)
Q Consensus       200 ~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp  278 (494)
                      +.|+|||++.+ .++.++||||+||++|+|++|+.||.+....+....+......++    ..+++.+.++|.+||..||
T Consensus       157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp  232 (312)
T cd05585         157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDP  232 (312)
T ss_pred             cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcCCCH
Confidence            99999999875 589999999999999999999999998888887777776544433    4578999999999999999


Q ss_pred             CCCC---CHHHHhcCCccCcc
Q 040917          279 KRRI---TVAQVLEHPWLKES  296 (494)
Q Consensus       279 ~~Rp---s~~eil~~~~~~~~  296 (494)
                      .+||   ++.++++||||...
T Consensus       233 ~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         233 TRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHcCCCCCHHHHHcCCCcCCC
Confidence            9997   57999999999863

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.7e-44  Score=356.15  Aligned_cols=259  Identities=32%  Similarity=0.528  Sum_probs=224.1

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.++...++
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEE
Confidence            36899999999999999999999999999999999754433334456678899999999 59999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      ||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++.......
T Consensus       121 v~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccCCC
Confidence            99999999999988654 68899999999999999999999999999999999999   678999999999987654322


Q ss_pred             --ccccccCCcCccChhhhcc-----cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          192 --AYREIVGSPYYIAPEVLSQ-----SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       192 --~~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                        ......||+.|+|||++.+     .++.++|+|||||++|+|++|+.||.+.........+.........+....++.
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  276 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISK  276 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCH
Confidence              1234578999999999853     378899999999999999999999999888878787776544444334456899


Q ss_pred             HHHHHHHHhcccCCCC--CCCHHHHhcCCccCc
Q 040917          265 SAIELVRRMLTQDPKR--RITVAQVLEHPWLKE  295 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~  295 (494)
                      .+.++|.+||..+|.+  |++++++++||||+.
T Consensus       277 ~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         277 QAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             HHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence            9999999999999988  999999999999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.5e-44  Score=349.79  Aligned_cols=250  Identities=31%  Similarity=0.571  Sum_probs=218.4

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG  118 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g  118 (494)
                      +.||+|+||.||+|.++.+++.||+|++.+...........+..|..++..+.+||||+++++++...+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999997544333334566778888888876799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cCccccccc
Q 040917          119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIV  197 (494)
Q Consensus       119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~~~~~~~~  197 (494)
                      ++|..++.....+++..+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++.... .........
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFC  157 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   678899999999987532 222233457


Q ss_pred             CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 040917          198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ  276 (494)
Q Consensus       198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  276 (494)
                      |++.|+|||++.+ .++.++|+|||||++|+|++|+.||.+....++...+......++    ..++..+.++|.+||..
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~  233 (320)
T cd05590         158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLSQDAVDILKAFMTK  233 (320)
T ss_pred             cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccc
Confidence            8999999999875 588999999999999999999999999988888888877654433    34789999999999999


Q ss_pred             CCCCCCCH------HHHhcCCccCc
Q 040917          277 DPKRRITV------AQVLEHPWLKE  295 (494)
Q Consensus       277 dp~~Rps~------~eil~~~~~~~  295 (494)
                      ||.+||++      +++++||||..
T Consensus       234 dP~~R~~~~~~~~~~~~~~h~~f~~  258 (320)
T cd05590         234 NPTMRLGSLTLGGEEAILRHPFFKE  258 (320)
T ss_pred             CHHHCCCCCCCCCHHHHHcCCCcCC
Confidence            99999998      99999999985

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.7e-44  Score=359.29  Aligned_cols=258  Identities=28%  Similarity=0.495  Sum_probs=220.5

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+. ||||+++++.+..++.+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEEEEE
Confidence            37999999999999999999999999999999997544333334567889999999994 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC--
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG--  190 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~--  190 (494)
                      |||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++......  
T Consensus        80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCcccccccc
Confidence            9999999999999888889999999999999999999999999999999999999   67889999999987422100  


Q ss_pred             ------------------------------------------cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHH
Q 040917          191 ------------------------------------------KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYI  227 (494)
Q Consensus       191 ------------------------------------------~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~  227 (494)
                                                                .......||+.|+|||++.+ .++.++|||||||++|+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                      00112468999999999865 58999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCccCc
Q 040917          228 LLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI---TVAQVLEHPWLKE  295 (494)
Q Consensus       228 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~eil~~~~~~~  295 (494)
                      |++|+.||.+....+....+..............+++.+.++|.+|+ .+|.+|+   ++.++++||||+.
T Consensus       237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~  306 (376)
T cd05598         237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG  306 (376)
T ss_pred             hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence            99999999988877766666554443333344568899999999976 5999999   9999999999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.3e-44  Score=357.81  Aligned_cols=257  Identities=28%  Similarity=0.518  Sum_probs=220.7

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|.+++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++.+.++...|+||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEEE
Confidence            699999999999999999999999999999999765443344566788999999999 5999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC---
Q 040917          114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG---  190 (494)
Q Consensus       114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~---  190 (494)
                      ||++||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCccccccccc
Confidence            999999999999888889999999999999999999999999999999999999   67889999999987422100   


Q ss_pred             ---------------------------------------------cccccccCCcCccChhhhcc-cCCCcchhHHHHHH
Q 040917          191 ---------------------------------------------KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVI  224 (494)
Q Consensus       191 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~i  224 (494)
                                                                   ......+||+.|+|||++.+ .++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                         00112468999999999864 58999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCccCc
Q 040917          225 LYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRIT---VAQVLEHPWLKE  295 (494)
Q Consensus       225 l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~eil~~~~~~~  295 (494)
                      +|+|++|+.||.+....+....+.........+....+++.+.++|.+|+ .+|.+|++   ++++++||||+.
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~  310 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT  310 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence            99999999999988877766666654444444444578999999999986 59999997   999999999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-44  Score=358.15  Aligned_cols=258  Identities=28%  Similarity=0.530  Sum_probs=218.4

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++++ +||||+++++++.+....|+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEE
Confidence            3799999999999999999999999999999998654433334566788999999999 599999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-  191 (494)
                      |||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++....... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeecccccccccccc
Confidence            9999999999999888889999999999999999999999999999999999999   678899999999985321100 


Q ss_pred             -----------c------------------------------------cccccCCcCccChhhhcc-cCCCcchhHHHHH
Q 040917          192 -----------A------------------------------------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGV  223 (494)
Q Consensus       192 -----------~------------------------------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~  223 (494)
                                 .                                    ....+||+.|+|||++.+ .++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence                       0                                    012468999999999864 5899999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCccCc
Q 040917          224 ILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRR---ITVAQVLEHPWLKE  295 (494)
Q Consensus       224 il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R---ps~~eil~~~~~~~  295 (494)
                      ++|+|++|..||.+....+....+.........+....++..+.++|.+||. +|.+|   +++.++++||||..
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~  310 (377)
T cd05629         237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG  310 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            9999999999998888777766666533333322334578999999999997 67665   59999999999985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.9e-44  Score=348.65  Aligned_cols=255  Identities=29%  Similarity=0.526  Sum_probs=222.1

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+..|++|+.+++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999976543333456678889999999964567889999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cCcc
Q 040917          114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKA  192 (494)
Q Consensus       114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~~~  192 (494)
                      ||++|++|..++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCCc
Confidence            999999999999888889999999999999999999999999999999999999   678899999999986432 2223


Q ss_pred             cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917          193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR  271 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  271 (494)
                      .....|++.|+|||++.+ .++.++|+||+||++|+|++|+.||.+....+....+......++    ..+++.+.+++.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~  233 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICK  233 (324)
T ss_pred             eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            345678999999999875 588999999999999999999999999888888888776554433    357899999999


Q ss_pred             HhcccCCCCCCCH-----HHHhcCCccCc
Q 040917          272 RMLTQDPKRRITV-----AQVLEHPWLKE  295 (494)
Q Consensus       272 ~~l~~dp~~Rps~-----~eil~~~~~~~  295 (494)
                      +||..||.+|++.     .++++||||..
T Consensus       234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~  262 (324)
T cd05587         234 GLLTKHPAKRLGCGPTGERDIREHAFFRR  262 (324)
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            9999999999976     89999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-44  Score=335.01  Aligned_cols=258  Identities=31%  Similarity=0.555  Sum_probs=232.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++++.||.|.-|+||+|..+.++..+|+|++.+..+.......+...|.+||+.+ +||.++.+|..++.+...|++
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEEE
Confidence            6899999999999999999999999999999999988877777788888999999999 699999999999999999999


Q ss_pred             EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-
Q 040917          113 MELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-  189 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-  189 (494)
                      ||||+||+|..+..++  +.+++..+..++.+++.||+|||-.|||+|||||+||||   .++|+|-|+||.++..... 
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCCC
Confidence            9999999999888765  359999999999999999999999999999999999999   7899999999998743210 


Q ss_pred             --------------------------------C-c-----------------------ccccccCCcCccChhhhccc-C
Q 040917          190 --------------------------------G-K-----------------------AYREIVGSPYYIAPEVLSQS-Y  212 (494)
Q Consensus       190 --------------------------------~-~-----------------------~~~~~~~~~~y~aPE~~~~~-~  212 (494)
                                                      . .                       .....+||-.|.|||++.|. .
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                       01234588899999999874 8


Q ss_pred             CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHHh
Q 040917          213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRIT----VAQVL  288 (494)
Q Consensus       213 ~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~eil  288 (494)
                      +.++|+|+|||++|||+.|..||.+.+..+.+..|......++..+  .++..+++||.++|.+||.+|..    |.||.
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            9999999999999999999999999999999999999888888763  78899999999999999999998    99999


Q ss_pred             cCCccCcc
Q 040917          289 EHPWLKES  296 (494)
Q Consensus       289 ~~~~~~~~  296 (494)
                      +||||+..
T Consensus       391 ~HpFF~gV  398 (459)
T KOG0610|consen  391 RHPFFEGV  398 (459)
T ss_pred             cCccccCC
Confidence            99999863

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-45  Score=344.02  Aligned_cols=318  Identities=30%  Similarity=0.538  Sum_probs=261.2

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ...|.+=|.+.+.||+|.|++|.+|++..+|..||||++.+..+.. ....++.+|++.++.++ ||||+++|++.....
T Consensus        13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQT   90 (864)
T KOG4717|consen   13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQT   90 (864)
T ss_pred             ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhc-CcCeeeeeehhcccc
Confidence            3456778999999999999999999999999999999999887643 46788899999999996 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          108 FVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      .+|+|+|+=.||+|.++|.++ ..+.+..+.+++.||+.|+.|+|+.++|||||||+||.+-  ..-|.+||.|||++..
T Consensus        91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNk  168 (864)
T KOG4717|consen   91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNK  168 (864)
T ss_pred             eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeecccccc
Confidence            999999999999999999765 4599999999999999999999999999999999998774  6789999999999999


Q ss_pred             cccCcccccccCCcCccChhhhccc-C-CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          187 IEEGKAYREIVGSPYYIAPEVLSQS-Y-GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      +.++..+...||...|.|||++.|. | .+++||||||||+|.|+.|+.||...++.+.+-.|+......+    ..++.
T Consensus       169 f~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP----shvS~  244 (864)
T KOG4717|consen  169 FQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP----SHVSK  244 (864)
T ss_pred             CCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc----hhhhH
Confidence            9999999999999999999999875 5 5789999999999999999999999988888888876655444    46889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCC--CCcHHHHHHHHHHhhhhHHHHHHHHhhhccCchhHHHhhh
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDK--PIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLK  342 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  342 (494)
                      ++++||..||..||.+|.+.++|.+++|++....+...  |+..       ...    +-.-.+..+.+.+-...+..-.
T Consensus       245 eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iPLvs-------r~~----L~ee~Ha~IIq~Mv~G~IAs~e  313 (864)
T KOG4717|consen  245 ECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTAIPLVS-------RHH----LPEEAHATIIQQMVAGAIASEE  313 (864)
T ss_pred             HHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccccCceee-------hhh----CChHHHHHHHHHHhcccccCHH
Confidence            99999999999999999999999999999975443222  2211       000    1111222222222222222223


Q ss_pred             hhhhccCCCCCCcccHHHHHHH
Q 040917          343 EKFTEMDTDNSGTLTYDELKAG  364 (494)
Q Consensus       343 ~~F~~~D~~~~g~i~~~el~~~  364 (494)
                      .+.+.++.|.=..|+...|..+
T Consensus       314 ~Il~aLe~n~YNhiTATYfLLA  335 (864)
T KOG4717|consen  314 DILRALENNEYNHITATYFLLA  335 (864)
T ss_pred             HHHHHHhccccchhhhHHHHHH
Confidence            4455677887777887776554

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.7e-44  Score=349.71  Aligned_cols=249  Identities=29%  Similarity=0.557  Sum_probs=218.0

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG  118 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g  118 (494)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+. ||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999999999999999997654444445667888999999995 99999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Cccccccc
Q 040917          119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREIV  197 (494)
Q Consensus       119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~~~~~~  197 (494)
                      ++|..++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++..... ........
T Consensus        80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  156 (328)
T cd05593          80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFC  156 (328)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccccccccc
Confidence            9999999888889999999999999999999999999999999999999   6788999999999875322 22233457


Q ss_pred             CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 040917          198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ  276 (494)
Q Consensus       198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  276 (494)
                      |++.|+|||++.+ .++.++|||||||++|+|++|+.||...........+......++    ..++..+.++|.+||..
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~  232 (328)
T cd05593         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSGLLIK  232 (328)
T ss_pred             CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHHHcCC
Confidence            8999999999864 589999999999999999999999998888777777666554433    35789999999999999


Q ss_pred             CCCCCC-----CHHHHhcCCccCc
Q 040917          277 DPKRRI-----TVAQVLEHPWLKE  295 (494)
Q Consensus       277 dp~~Rp-----s~~eil~~~~~~~  295 (494)
                      ||.+||     ++.++++||||..
T Consensus       233 dP~~R~~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         233 DPNKRLGGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCC
Confidence            999997     8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.2e-44  Score=342.69  Aligned_cols=254  Identities=24%  Similarity=0.408  Sum_probs=211.5

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|.+.+.||.|+||.||+|.+..++..||+|++.....  ......+.+|+.+++.+. ||||+++++++......++|
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEEEE
Confidence            579999999999999999999999999999999865432  223456778999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-
Q 040917          113 MELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-  190 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-  190 (494)
                      |||++| +|.+++...+ .++...+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...... 
T Consensus        82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCC
Confidence            999975 8998887654 47899999999999999999999999999999999999   67889999999998754322 


Q ss_pred             cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC------------
Q 040917          191 KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR------------  256 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~------------  256 (494)
                      .......+++.|+|||++.+  .++.++|+||+||++|+|++|+.||.+.+..+....+.........            
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            22234567899999998854  4889999999999999999999999887776655444321110000            


Q ss_pred             --------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          257 --------------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       257 --------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                                    ...+.++.++.++|.+||..||.+|||++++|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                          0123567889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.7e-44  Score=349.08  Aligned_cols=249  Identities=31%  Similarity=0.575  Sum_probs=217.8

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG  118 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g  118 (494)
                      +.||+|+||.||+|.+..+|..||+|++.............+.+|+.+++.+. ||||+++++.+......|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeCCCC
Confidence            46999999999999999999999999997654333344566788999999995 99999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Cccccccc
Q 040917          119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREIV  197 (494)
Q Consensus       119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~~~~~~  197 (494)
                      ++|..++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++..... ........
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  156 (323)
T cd05595          80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   6788999999999865322 22233467


Q ss_pred             CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 040917          198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ  276 (494)
Q Consensus       198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  276 (494)
                      |++.|+|||++.+ .++.++|+|||||++|+|++|+.||...........+......++    ..+++.+.++|.+||..
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~  232 (323)
T cd05595         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccC
Confidence            8999999999864 589999999999999999999999998888777777766554433    35789999999999999


Q ss_pred             CCCCCC-----CHHHHhcCCccCc
Q 040917          277 DPKRRI-----TVAQVLEHPWLKE  295 (494)
Q Consensus       277 dp~~Rp-----s~~eil~~~~~~~  295 (494)
                      ||.+||     ++.++++||||..
T Consensus       233 dP~~R~~~~~~~~~~~l~h~~~~~  256 (323)
T cd05595         233 DPKQRLGGGPSDAKEVMEHRFFLS  256 (323)
T ss_pred             CHHHhCCCCCCCHHHHHcCCCcCC
Confidence            999998     8999999999986

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.2e-44  Score=353.09  Aligned_cols=261  Identities=31%  Similarity=0.530  Sum_probs=222.6

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.++...|
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEE
Confidence            447899999999999999999999999999999999754433333456678899999999 5999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++......
T Consensus       120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceecccC
Confidence            999999999999988654 68999999999999999999999999999999999999   67889999999999765432


Q ss_pred             cc--cccccCCcCccChhhhcc-----cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917          191 KA--YREIVGSPYYIAPEVLSQ-----SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       191 ~~--~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      ..  .....||+.|+|||++.+     .++.++|+||+||++|+|++|..||.+.+..+....+.........+....++
T Consensus       196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s  275 (370)
T cd05621         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS  275 (370)
T ss_pred             CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence            22  234678999999999864     27889999999999999999999999988877777776654433333334678


Q ss_pred             HHHHHHHHHhcccCCCC--CCCHHHHhcCCccCcc
Q 040917          264 SSAIELVRRMLTQDPKR--RITVAQVLEHPWLKES  296 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~~  296 (494)
                      ..+.+++.+||..++.+  |+++.++++||||+..
T Consensus       276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            99999999999865544  8999999999999863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.9e-44  Score=347.60  Aligned_cols=250  Identities=27%  Similarity=0.520  Sum_probs=218.8

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG  118 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g  118 (494)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+.+||||+++++++..++..|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999997654433445566778999998876799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Cccccccc
Q 040917          119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREIV  197 (494)
Q Consensus       119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~~~~~~  197 (494)
                      ++|...+.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++..... ........
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFC  157 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCccccccc
Confidence            9999999888889999999999999999999999999999999999999   6788999999999875322 22233456


Q ss_pred             CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 040917          198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ  276 (494)
Q Consensus       198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  276 (494)
                      |++.|+|||++.+ .++.++|+|||||++|+|++|+.||.+....+....+......++    ..++..+.++|.+||..
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~~  233 (321)
T cd05591         158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP----VWLSKEAVSILKAFMTK  233 (321)
T ss_pred             cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhcc
Confidence            8999999999865 589999999999999999999999999998888888877654433    34789999999999999


Q ss_pred             CCCCCC-------CHHHHhcCCccCc
Q 040917          277 DPKRRI-------TVAQVLEHPWLKE  295 (494)
Q Consensus       277 dp~~Rp-------s~~eil~~~~~~~  295 (494)
                      ||++||       ++.++++||||..
T Consensus       234 dp~~R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         234 NPNKRLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             CHHHcCCCCCCCCCHHHHhcCCccCC
Confidence            999999       8999999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.2e-44  Score=351.07  Aligned_cols=258  Identities=31%  Similarity=0.500  Sum_probs=222.9

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+ +||||+++++++.+....++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEE
Confidence            3699999999999999999999999999999999765443444566788899999998 599999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      |||++|++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCC
Confidence            9999999999999876 679999999999999999999999999999999999999   678899999999997654332


Q ss_pred             cc--ccccCCcCccChhhhc-------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          192 AY--REIVGSPYYIAPEVLS-------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       192 ~~--~~~~~~~~y~aPE~~~-------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      ..  ....+|+.|+|||++.       ..++.++|||||||++|+|++|..||...........+.........+..+.+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV  236 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence            22  2346899999999985       24788999999999999999999999888877777777665433333333568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      +..+.++|.+||. +|.+||++.++++||||..
T Consensus       237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence            8999999999998 9999999999999999986

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-46  Score=346.14  Aligned_cols=255  Identities=30%  Similarity=0.499  Sum_probs=225.2

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      ...|+..+.||+|+||.||+|.+..+++.||+|++.....  ....+.+.+|+.++.+++ +|||.++|+.|..+..+++
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~Lwi   88 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKLWI   88 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcC-cchHHhhhhheeecccHHH
Confidence            3578888999999999999999999999999999976553  335778999999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      +||||.||++.+.++....+.+..+..++++++.|+.|||..+.+|||||+.||++   ...+.+||+|||.+.......
T Consensus        89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~---s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILL---SESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeE---eccCcEEEEecceeeeeechh
Confidence            99999999999999888777999999999999999999999999999999999999   567999999999998876543


Q ss_pred             cc-ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          192 AY-REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       192 ~~-~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                      .. .+.+|||.|||||++.+ .|+.++||||||++.+||.+|.+|+....++.++..|-+...   +..-..+++.+++|
T Consensus       166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~P---P~L~~~~S~~~kEF  242 (467)
T KOG0201|consen  166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAP---PRLDGDFSPPFKEF  242 (467)
T ss_pred             hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCC---CccccccCHHHHHH
Confidence            33 56889999999999986 699999999999999999999999988887655444433322   22223688999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          270 VRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       270 i~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      |..||.+||+.||||.++|+|+|++.
T Consensus       243 V~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  243 VEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             HHHHhhcCcccCcCHHHHhhhHHHHh
Confidence            99999999999999999999999997

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.1e-43  Score=345.96  Aligned_cols=255  Identities=27%  Similarity=0.497  Sum_probs=222.9

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.+..............|..++..+..||+|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            58999999999999999999999999999999976543333345567778888888867899999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Ccc
Q 040917          114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKA  192 (494)
Q Consensus       114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~  192 (494)
                      ||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++..... ...
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCCc
Confidence            999999999999888889999999999999999999999999999999999999   6788999999999875332 222


Q ss_pred             cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917          193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR  271 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  271 (494)
                      .....||+.|+|||++.+ .++.++|+|||||++|+|++|+.||.+.........+......++    ..++..+.+++.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  233 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAICK  233 (323)
T ss_pred             cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CcCCHHHHHHHH
Confidence            334678999999999874 589999999999999999999999999888888888777655443    357899999999


Q ss_pred             HhcccCCCCCCCH-----HHHhcCCccCc
Q 040917          272 RMLTQDPKRRITV-----AQVLEHPWLKE  295 (494)
Q Consensus       272 ~~l~~dp~~Rps~-----~eil~~~~~~~  295 (494)
                      +||..+|.+|++.     .++++||||..
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         234 GLMTKHPGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             HHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence            9999999999984     89999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1e-43  Score=340.67  Aligned_cols=256  Identities=29%  Similarity=0.462  Sum_probs=211.3

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++.+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+++.+. ||||+++++++......++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKLYLV   78 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCC-CccccchhhhEecCCEEEEE
Confidence            379999999999999999999999999999999975432 2334567889999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-  191 (494)
                      |||++++.+..+......++...+..++.|++.||.|||+.||+||||||+||++   +.++.++|+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCccccccccc
Confidence            9999987766555445578999999999999999999999999999999999999   678899999999997654322 


Q ss_pred             -ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc----------------
Q 040917          192 -AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN----------------  253 (494)
Q Consensus       192 -~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~----------------  253 (494)
                       ......+++.|+|||++.+ .++.++|+||+||++|+|++|+.||.+.+..+....+......                
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence             2234568999999999864 5889999999999999999999999887665443332211000                


Q ss_pred             ---CCC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          254 ---FQR---------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       254 ---~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                         .+.         .....++..+.++|.+||..||++|||++++|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence               000         0112367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.5e-43  Score=345.69  Aligned_cols=250  Identities=28%  Similarity=0.505  Sum_probs=212.0

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG  118 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g  118 (494)
                      +.||+|+||.||+|.+..+++.||+|++++...........+..|..++..+.+||||+++++++......|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999999999999999998655444445667888999999997799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc-ccCccccccc
Q 040917          119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIV  197 (494)
Q Consensus       119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~-~~~~~~~~~~  197 (494)
                      ++|..++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++... .........+
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   67889999999998642 2223334567


Q ss_pred             CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET---------DQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      ||+.|+|||++.+ .++.++|+|||||++|+|++|+.||....         .....+.+.......+    ..++..+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~  233 (329)
T cd05588         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAS  233 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCCHHHH
Confidence            8999999999875 58899999999999999999999996321         1123333444433322    35788999


Q ss_pred             HHHHHhcccCCCCCCC------HHHHhcCCccCc
Q 040917          268 ELVRRMLTQDPKRRIT------VAQVLEHPWLKE  295 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps------~~eil~~~~~~~  295 (494)
                      ++|.+||..||.+||+      +.++++||||..
T Consensus       234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            9999999999999987      789999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.3e-43  Score=344.51  Aligned_cols=250  Identities=29%  Similarity=0.536  Sum_probs=218.5

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG  118 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g  118 (494)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+.+|..++..+.+||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999997654333444566778999999886799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cCccccccc
Q 040917          119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIV  197 (494)
Q Consensus       119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~~~~~~~~  197 (494)
                      ++|..++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.... ........+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFC  157 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCccccee
Confidence            9999999888889999999999999999999999999999999999999   678899999999986432 222233456


Q ss_pred             CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 040917          198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ  276 (494)
Q Consensus       198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  276 (494)
                      |++.|+|||++.+ .++.++|+|||||++|+|++|+.||.+.........+......++    ..++..+.++|.+||..
T Consensus       158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~  233 (318)
T cd05570         158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILKSFLTK  233 (318)
T ss_pred             cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHccC
Confidence            8999999999865 589999999999999999999999998888877777766554433    35789999999999999


Q ss_pred             CCCCCCCH-----HHHhcCCccCc
Q 040917          277 DPKRRITV-----AQVLEHPWLKE  295 (494)
Q Consensus       277 dp~~Rps~-----~eil~~~~~~~  295 (494)
                      ||.+||++     .++++||||..
T Consensus       234 dP~~R~s~~~~~~~~ll~~~~~~~  257 (318)
T cd05570         234 NPEKRLGCLPTGEQDIKGHPFFRE  257 (318)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCC
Confidence            99999999     99999999986

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9e-44  Score=351.83  Aligned_cols=259  Identities=30%  Similarity=0.527  Sum_probs=220.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..+ +||+|+++++.+.+...+|+|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence            3699999999999999999999999999999999754433344566788899999999 599999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-  191 (494)
                      |||++||+|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++....... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCcccccccc
Confidence            9999999999999888889999999999999999999999999999999999999   678899999999986432110 


Q ss_pred             -----------------------------------ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCC
Q 040917          192 -----------------------------------AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPF  235 (494)
Q Consensus       192 -----------------------------------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf  235 (494)
                                                         .....+||+.|+|||++.+ .++.++|+|||||++|+|++|..||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence                                               0113468999999999865 5899999999999999999999999


Q ss_pred             CCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCccCcc
Q 040917          236 WAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI---TVAQVLEHPWLKES  296 (494)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~eil~~~~~~~~  296 (494)
                      .+.........+.........+....+++.+.++|.+|+ .||.+|+   ++.++++||||...
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence            998888777777654333322222347899999999977 5999998   48999999999863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.2e-43  Score=346.54  Aligned_cols=259  Identities=28%  Similarity=0.452  Sum_probs=211.0

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC-----Ce
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD-----QF  108 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~-----~~  108 (494)
                      +|++.+.||+|+||.||+|.+..+|..||+|.+..... .......+.+|+.+++.++ ||||+++++++...     ..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCce
Confidence            69999999999999999999999999999999864322 2223456889999999995 99999999987543     35


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      .|+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++....
T Consensus        79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccccccc
Confidence            899999995 6999999888889999999999999999999999999999999999999   678899999999987543


Q ss_pred             cCc----ccccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-------------
Q 040917          189 EGK----AYREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL-------------  248 (494)
Q Consensus       189 ~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~-------------  248 (494)
                      ...    ......+++.|+|||++.+   .++.++|||||||++|+|++|+.||.+.........+.             
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            221    1234578999999999753   58899999999999999999999997765433222111             


Q ss_pred             --------------cCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          249 --------------KGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       249 --------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                                    ..........++.+++.+.+++.+||..||++|||++++|+||||+....
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                          00001111123467888999999999999999999999999999987544

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.9e-43  Score=340.16  Aligned_cols=258  Identities=22%  Similarity=0.350  Sum_probs=207.8

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++.+. ||||+++++++......++|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCC-CCCcCeEEEEEecCCeEEEE
Confidence            689999999999999999999999999999999875432  223446778999999994 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-
Q 040917          113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-  190 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-  190 (494)
                      |||+. ++|.+++... +.++...+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...... 
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCCC
Confidence            99996 5787777654 568999999999999999999999999999999999999   67889999999998654322 


Q ss_pred             cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCcc--------------
Q 040917          191 KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEIN--------------  253 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~--------------  253 (494)
                      .......+++.|+|||++.+  .++.++|+||+||++|+|++|..||.+.... +....+......              
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence            22234567899999999854  4788999999999999999999999875432 222222110000              


Q ss_pred             CCCC--------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          254 FQRD--------------PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       254 ~~~~--------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      +.+.              .....++.+.+++.+||+.||.+|||+.++|+||||++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            0000              0012456789999999999999999999999999998743

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.1e-43  Score=342.67  Aligned_cols=250  Identities=29%  Similarity=0.523  Sum_probs=214.4

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG  118 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g  118 (494)
                      +.||+|+||.||+|.+..+++.||+|+++...............|..++..+.+||||+++++++..+...++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999997654333334555667777777665799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-ccccccc
Q 040917          119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-KAYREIV  197 (494)
Q Consensus       119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-~~~~~~~  197 (494)
                      ++|..++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++...... ......+
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  157 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   67889999999998754322 2233457


Q ss_pred             CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 040917          198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ  276 (494)
Q Consensus       198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  276 (494)
                      ||+.|+|||++.+ .++.++|+|||||++|+|++|..||.+....+....+......++    ..++..+.+++.+||..
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~~l~~  233 (316)
T cd05592         158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSKLFER  233 (316)
T ss_pred             CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence            8999999999875 589999999999999999999999999888877777665433322    35789999999999999


Q ss_pred             CCCCCCCH-HHHhcCCccCc
Q 040917          277 DPKRRITV-AQVLEHPWLKE  295 (494)
Q Consensus       277 dp~~Rps~-~eil~~~~~~~  295 (494)
                      ||.+||++ .++++||||..
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05592         234 DPTKRLGVDGDIRQHPFFRG  253 (316)
T ss_pred             CHHHcCCChHHHHcCcccCC
Confidence            99999986 48889999985

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3e-44  Score=328.76  Aligned_cols=259  Identities=29%  Similarity=0.503  Sum_probs=217.7

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC---
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD---  106 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~---  106 (494)
                      ...-.|.-.+++|+|+||.||+|....+++.||||.+-...-       .-.+|+.+|+.+ +||||+++.-+|...   
T Consensus        21 ~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l-~HpNIV~L~~~f~~~~~~   92 (364)
T KOG0658|consen   21 KVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKL-DHPNIVRLLYFFSSSTES   92 (364)
T ss_pred             ceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhc-CCcCeeeEEEEEEecCCC
Confidence            355679999999999999999999999999999998753321       123599999999 599999999888532   


Q ss_pred             --CeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917          107 --QFVHIVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       107 --~~~~iv~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                        -+..+||||++. +|...++.    +.+++...++-+..||++|+.|||+.||+||||||+|+|++  ...+.+||||
T Consensus        93 d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicD  169 (364)
T KOG0658|consen   93 DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICD  169 (364)
T ss_pred             chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEecc
Confidence              145689999976 99988874    56799999999999999999999999999999999999996  5679999999


Q ss_pred             cCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc---------
Q 040917          181 FGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK---------  249 (494)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~---------  249 (494)
                      ||+|.....+....++.++..|+|||.+-|  .|+.+.||||.||++.||+-|++.|.|.+..+++..+.+         
T Consensus       170 FGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~  249 (364)
T KOG0658|consen  170 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED  249 (364)
T ss_pred             CCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999999888887788899999999999865  599999999999999999999999999888766655432         


Q ss_pred             -----C---C---ccCCCC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917          250 -----G---E---INFQRD-----PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       250 -----~---~---~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  299 (494)
                           .   .   ..+...     .....++++.+|+.++|..+|.+|.++.+++.||||..-..+
T Consensus       250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                 0   0   111111     224578999999999999999999999999999999864433

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.4e-43  Score=343.82  Aligned_cols=252  Identities=30%  Similarity=0.543  Sum_probs=217.0

Q ss_pred             eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHH---HccCCCCccEEeEEEEeCCeEEE
Q 040917           35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR---HLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~---~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      |++.+.||+|++|.||+|.+..+++.||+|++.+.........+.+.+|+.++.   .+ +||||+++++++......|+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQTEDHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEcCCEEEE
Confidence            788999999999999999999999999999997654333334566777777665   45 59999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-C
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-G  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~  190 (494)
                      ||||++|++|..++.. ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++..... .
T Consensus        80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCC
Confidence            9999999999888754 469999999999999999999999999999999999999   6788999999998864322 2


Q ss_pred             cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                      .......|++.|+|||.+.+ .++.++|+|||||++|+|++|+.||.+....+....+......++    ..++..+.++
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l  231 (324)
T cd05589         156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSREAISI  231 (324)
T ss_pred             CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence            22334678999999999865 588999999999999999999999999888888877777655433    3578999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHhcCCccCc
Q 040917          270 VRRMLTQDPKRRI-----TVAQVLEHPWLKE  295 (494)
Q Consensus       270 i~~~l~~dp~~Rp-----s~~eil~~~~~~~  295 (494)
                      |.+||..||.+||     ++.++++||||..
T Consensus       232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~  262 (324)
T cd05589         232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRD  262 (324)
T ss_pred             HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence            9999999999999     6999999999986

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-43  Score=337.55  Aligned_cols=258  Identities=28%  Similarity=0.474  Sum_probs=217.3

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      .|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++.+..+...++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEE
Confidence            488999999999999999999999999999999755443333445677899999999 5999999999999989999999


Q ss_pred             eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          114 ELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       114 e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      ||++|++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||++   ++++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCC
Confidence            999999999887653  358999999999999999999999999999999999999   678899999999987665444


Q ss_pred             ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      ......|++.|+|||++.+ .++.++|+||+||++|+|++|..||.+.........+..............++..+.+++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence            4445578999999999864 588999999999999999999999987765443333322222222222346889999999


Q ss_pred             HHhcccCCCCCC-----CHHHHhcCCccCc
Q 040917          271 RRMLTQDPKRRI-----TVAQVLEHPWLKE  295 (494)
Q Consensus       271 ~~~l~~dp~~Rp-----s~~eil~~~~~~~  295 (494)
                      .+||..||.+||     +++++++||||..
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence            999999999999     9999999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.7e-43  Score=348.86  Aligned_cols=259  Identities=32%  Similarity=0.516  Sum_probs=221.6

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++.+..+...++
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~l  120 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYM  120 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEE
Confidence            47999999999999999999999999999999998754433333456678899999999 59999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      ||||++|++|.+++... .+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.......
T Consensus       121 v~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~~~~  196 (371)
T cd05622         121 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEG  196 (371)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcCcCC
Confidence            99999999999988664 58999999999999999999999999999999999999   678899999999987654322


Q ss_pred             --ccccccCCcCccChhhhcc-----cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          192 --AYREIVGSPYYIAPEVLSQ-----SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       192 --~~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                        ......||+.|+|||++.+     .++.++|||||||++|+|++|..||.+.+.......+.........+..+.++.
T Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  276 (371)
T cd05622         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK  276 (371)
T ss_pred             cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCH
Confidence              1234578999999999853     278899999999999999999999999888878887776554444344457899


Q ss_pred             HHHHHHHHhcccCCCC--CCCHHHHhcCCccCc
Q 040917          265 SAIELVRRMLTQDPKR--RITVAQVLEHPWLKE  295 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~  295 (494)
                      .+.++|.+||..++.+  |++++++++||||+.
T Consensus       277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~  309 (371)
T cd05622         277 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  309 (371)
T ss_pred             HHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence            9999999999854443  789999999999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.3e-43  Score=342.46  Aligned_cols=250  Identities=27%  Similarity=0.492  Sum_probs=214.5

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG  118 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g  118 (494)
                      +.||+|+||.||+|.++.+|+.||+|++................|..++..+.+||||+++++++...+..|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999999999999999997643322234556677888888765799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Cccccccc
Q 040917          119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREIV  197 (494)
Q Consensus       119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~~~~~~  197 (494)
                      ++|..++.....++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++..... ........
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCceeccC
Confidence            9999999888889999999999999999999999999999999999999   6788999999999864321 22234567


Q ss_pred             CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 040917          198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ  276 (494)
Q Consensus       198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  276 (494)
                      |++.|+|||++.+ .++.++|+||+||++|+|++|..||.+.........+......++    ..++..+.++|.+||..
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~  233 (316)
T cd05620         158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP----RWITKESKDILEKLFER  233 (316)
T ss_pred             CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHccC
Confidence            8999999999875 589999999999999999999999998888777777665543332    24788999999999999


Q ss_pred             CCCCCCCH-HHHhcCCccCc
Q 040917          277 DPKRRITV-AQVLEHPWLKE  295 (494)
Q Consensus       277 dp~~Rps~-~eil~~~~~~~  295 (494)
                      ||++||++ +++++||||..
T Consensus       234 dP~~R~~~~~~~~~h~~f~~  253 (316)
T cd05620         234 DPTRRLGVVGNIRGHPFFKT  253 (316)
T ss_pred             CHHHcCCChHHHHcCCCcCC
Confidence            99999998 58999999986

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1e-43  Score=346.52  Aligned_cols=249  Identities=32%  Similarity=0.579  Sum_probs=217.4

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG  118 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g  118 (494)
                      +.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++..+...|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999997654434444566788999999994 99999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cCcccccc
Q 040917          119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREI  196 (494)
Q Consensus       119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~~~~~~~  196 (494)
                      ++|..++.....+++..+..++.||+.||.|||+ +||+||||||+||++   +.++.++|+|||++.... ........
T Consensus        80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~  156 (325)
T cd05594          80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTF  156 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcccccc
Confidence            9999999888889999999999999999999997 799999999999999   678899999999986532 22233345


Q ss_pred             cCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 040917          197 VGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT  275 (494)
Q Consensus       197 ~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  275 (494)
                      .|++.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+......++    ..+++.+.++|.+||.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~  232 (325)
T cd05594         157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLSGLLK  232 (325)
T ss_pred             cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhh
Confidence            78999999999864 589999999999999999999999998888777777766555443    3578999999999999


Q ss_pred             cCCCCCC-----CHHHHhcCCccCc
Q 040917          276 QDPKRRI-----TVAQVLEHPWLKE  295 (494)
Q Consensus       276 ~dp~~Rp-----s~~eil~~~~~~~  295 (494)
                      .||.+|+     ++.++++||||..
T Consensus       233 ~dP~~R~~~~~~~~~~il~h~~~~~  257 (325)
T cd05594         233 KDPKQRLGGGPDDAKEIMQHKFFAG  257 (325)
T ss_pred             cCHHHhCCCCCCCHHHHhcCCCcCC
Confidence            9999997     9999999999986

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.4e-43  Score=346.80  Aligned_cols=255  Identities=30%  Similarity=0.540  Sum_probs=213.7

Q ss_pred             ceEeeeeecccCCeEEEEEEEC---CCCcEEEEEEeccCCCC-ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           34 HYTIGREVGRGEFGITYLCTEN---STGLEFACKSIPKRKLV-KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      +|++++.||+|+||.||+|++.   .+++.||+|++.+.... .......+..|+.+++.+++||+|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999998864   57899999998654321 2233566788999999997799999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      ++||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++.....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCccccc
Confidence            9999999999999999888889999999999999999999999999999999999999   6788999999999875432


Q ss_pred             Cc--ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHcCCccCCCCCCCC
Q 040917          190 GK--AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAET----DQGVAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       190 ~~--~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~  261 (494)
                      ..  ......||+.|+|||++.+  .++.++|||||||++|+|++|+.||....    ...+...+......    ....
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~~  233 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP----FPSF  233 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC----CCCC
Confidence            22  2234578999999999875  37889999999999999999999996432    22333334333222    2246


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCccCc
Q 040917          262 ISSSAIELVRRMLTQDPKRRI-----TVAQVLEHPWLKE  295 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~  295 (494)
                      +++.+.+++.+||..||++||     +++++++||||+.
T Consensus       234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  272 (332)
T cd05614         234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG  272 (332)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            789999999999999999999     8899999999986

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1e-42  Score=340.32  Aligned_cols=259  Identities=25%  Similarity=0.394  Sum_probs=217.3

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+....  .......+.+|+.+++++. ||||+++++++..++..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEE
Confidence            378999999999999999999999999999999987532  2334677999999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      ||||++|++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||++   +.++.++|+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCccccccccc
Confidence            999999999999998888899999999999999999999986 69999999999999   67889999999998755332


Q ss_pred             cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc-----------------
Q 040917          191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI-----------------  252 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~-----------------  252 (494)
                       ......+++.|+|||++.+ .++.++|+|||||++|+|++|+.||......+....+.....                 
T Consensus       158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP  236 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence             2234568999999999875 589999999999999999999999977665544332211000                 


Q ss_pred             ---------------------------cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          253 ---------------------------NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       253 ---------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                                                 ..+......+++++.+||.+||..||++|||+.++++||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                                       001111124678999999999999999999999999999998643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.7e-43  Score=346.66  Aligned_cols=263  Identities=29%  Similarity=0.438  Sum_probs=219.5

Q ss_pred             ccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc-----CCCCccEEe
Q 040917           26 KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS-----GQPNIVQFK  100 (494)
Q Consensus        26 ~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~i~~~~  100 (494)
                      -..+++..+|.|.+.||+|.||.|-+|++..|++.||||+++...    ....+...|+.+|..|.     +.-|+++++
T Consensus       179 v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~  254 (586)
T KOG0667|consen  179 VVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRML  254 (586)
T ss_pred             EecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence            345677789999999999999999999999999999999997544    24566778999999996     246899999


Q ss_pred             EEEEeCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEE
Q 040917          101 AAYEDDQFVHIVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKA  178 (494)
Q Consensus       101 ~~~~~~~~~~iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL  178 (494)
                      ++|...++.|||+|+++ .+|+++++.+.  .++...++.++.||+.||..||+.||||+||||+|||+.. .....||+
T Consensus       255 d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~-~~r~~vKV  332 (586)
T KOG0667|consen  255 DYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKD-PKRSRIKV  332 (586)
T ss_pred             eccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeecc-CCcCceeE
Confidence            99999999999999995 59999999875  5889999999999999999999999999999999999975 34558999


Q ss_pred             eecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc--------
Q 040917          179 TDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK--------  249 (494)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~--------  249 (494)
                      +|||+|....... + .++.+..|+|||++.| +|+.+.||||||||++||++|.+.|.+.++.+++.-|..        
T Consensus       333 IDFGSSc~~~q~v-y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~  410 (586)
T KOG0667|consen  333 IDFGSSCFESQRV-Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK  410 (586)
T ss_pred             EecccccccCCcc-e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence            9999998754432 2 7788999999999876 799999999999999999999999999888776544421        


Q ss_pred             -------------C---Cc----------------------------cCCCC--C----CC-CCCHHHHHHHHHhcccCC
Q 040917          250 -------------G---EI----------------------------NFQRD--P----FP-SISSSAIELVRRMLTQDP  278 (494)
Q Consensus       250 -------------~---~~----------------------------~~~~~--~----~~-~~~~~l~~li~~~l~~dp  278 (494)
                                   .   ..                            ..+..  .    .+ .-...+.+||.+||.+||
T Consensus       411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP  490 (586)
T KOG0667|consen  411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP  490 (586)
T ss_pred             HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence                         0   00                            00000  0    00 123567899999999999


Q ss_pred             CCCCCHHHHhcCCccCcc
Q 040917          279 KRRITVAQVLEHPWLKES  296 (494)
Q Consensus       279 ~~Rps~~eil~~~~~~~~  296 (494)
                      .+|+|+.++|+|||+...
T Consensus       491 ~~R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  491 AERITPAQALNHPFLTGT  508 (586)
T ss_pred             hhcCCHHHHhcCcccccc
Confidence            999999999999999953

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.2e-43  Score=340.44  Aligned_cols=251  Identities=27%  Similarity=0.472  Sum_probs=214.9

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG  118 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g  118 (494)
                      +.||+|+||.||+|.+..+++.||+|++................|..++..+.+||||+++++++...+..++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999997654322334456677888888765799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Cccccccc
Q 040917          119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREIV  197 (494)
Q Consensus       119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~~~~~~  197 (494)
                      |+|..++.....++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++..... ........
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCceeeec
Confidence            9999999887789999999999999999999999999999999999999   6788999999999864322 22233457


Q ss_pred             CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 040917          198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ  276 (494)
Q Consensus       198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  276 (494)
                      ||+.|+|||++.+ .++.++|+||+||++|+|++|..||.+....+....+......++    ..++..+.++|.+||..
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~  233 (316)
T cd05619         158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILVKLFVR  233 (316)
T ss_pred             CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHhcc
Confidence            8999999999865 589999999999999999999999998888777777665443322    24788999999999999


Q ss_pred             CCCCCCCHH-HHhcCCccCcc
Q 040917          277 DPKRRITVA-QVLEHPWLKES  296 (494)
Q Consensus       277 dp~~Rps~~-eil~~~~~~~~  296 (494)
                      ||.+||++. ++++||||...
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         234 EPERRLGVKGDIRQHPFFREI  254 (316)
T ss_pred             CHhhcCCChHHHHcCcccCCC
Confidence            999999996 89999999863

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.6e-43  Score=340.78  Aligned_cols=256  Identities=27%  Similarity=0.501  Sum_probs=221.8

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+..|..++..+.+||+|+++++++...+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            47889999999999999999999999999999976443333345667789999988876788899999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-cc
Q 040917          114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-KA  192 (494)
Q Consensus       114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-~~  192 (494)
                      ||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++...... ..
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCcc
Confidence            999999999999888889999999999999999999999999999999999999   67889999999998754322 22


Q ss_pred             cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917          193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR  271 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  271 (494)
                      .....|++.|+|||++.+ .++.++|+||+||++|+|++|..||.+.......+.+......++    ..++..+.+++.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~  233 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICK  233 (323)
T ss_pred             ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHH
Confidence            234568999999999864 589999999999999999999999999888888888777655433    357899999999


Q ss_pred             HhcccCCCCCCC-----HHHHhcCCccCcc
Q 040917          272 RMLTQDPKRRIT-----VAQVLEHPWLKES  296 (494)
Q Consensus       272 ~~l~~dp~~Rps-----~~eil~~~~~~~~  296 (494)
                      +||..+|.+|++     ..++++||||...
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         234 GLMTKHPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             HHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence            999999999997     5789999999863

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.9e-43  Score=341.98  Aligned_cols=250  Identities=29%  Similarity=0.506  Sum_probs=211.2

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG  118 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g  118 (494)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++.++.+||||+++++++...+..++||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998665444445667888999998886799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cCccccccc
Q 040917          119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIV  197 (494)
Q Consensus       119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~~~~~~~~  197 (494)
                      ++|..++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.... .........
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCcccccc
Confidence            9999998888889999999999999999999999999999999999999   678899999999987532 222334567


Q ss_pred             CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAE---------TDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      ||+.|+|||++.+ .++.++|+|||||++|+|++|+.||...         ......+.+......++    ..++..+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~  233 (329)
T cd05618         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAA  233 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCHHHH
Confidence            8999999999865 5889999999999999999999999521         11223333444333322    35788999


Q ss_pred             HHHHHhcccCCCCCCC------HHHHhcCCccCc
Q 040917          268 ELVRRMLTQDPKRRIT------VAQVLEHPWLKE  295 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps------~~eil~~~~~~~  295 (494)
                      ++|.+||..||.+||+      +.++++||||..
T Consensus       234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~  267 (329)
T cd05618         234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  267 (329)
T ss_pred             HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            9999999999999998      579999999976

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.9e-43  Score=335.42  Aligned_cols=256  Identities=25%  Similarity=0.382  Sum_probs=208.3

Q ss_pred             cceEeeeeecccCCeEEEEEEECC-CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc--CCCCccEEeEEEE-----
Q 040917           33 LHYTIGREVGRGEFGITYLCTENS-TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS--GQPNIVQFKAAYE-----  104 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~-~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~i~~~~~~~~-----  104 (494)
                      .+|++.+.||+|+||.||+|.+.. ++..||+|.+....... .....+.+|+.+++.+.  +||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            379999999999999999999854 47889999986543222 23445667888877764  5999999999885     


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917          105 DDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG  182 (494)
Q Consensus       105 ~~~~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg  182 (494)
                      .....++||||+. ++|.+++...  ..++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg  155 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG  155 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEcccc
Confidence            2456899999996 5898888653  348999999999999999999999999999999999999   678899999999


Q ss_pred             CccccccCcccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC-----
Q 040917          183 LSAFIEEGKAYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR-----  256 (494)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-----  256 (494)
                      ++.............+++.|+|||++. ..++.++|+|||||++|+|++|+.||.+....+....+........+     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            997655444444567899999999985 46889999999999999999999999988877766655432111100     


Q ss_pred             ------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          257 ------------------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       257 ------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                                        ...+.+++.+.+++.+||+.||++|||+.++|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                              0123577889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.3e-43  Score=341.82  Aligned_cols=249  Identities=29%  Similarity=0.552  Sum_probs=212.7

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHH-HHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIE-IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA  117 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~  117 (494)
                      +.||+|+||+||+|.+..+|+.||+|++.+...........+..|.. +++.+ +||||+++++.+...+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            46999999999999999999999999997544333333445555555 45667 59999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Ccccccc
Q 040917          118 GGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREI  196 (494)
Q Consensus       118 g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~~~~~  196 (494)
                      |++|..++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++..... .......
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~  156 (323)
T cd05575          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTF  156 (323)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCCccccc
Confidence            99999999888889999999999999999999999999999999999999   6788999999999865322 2223345


Q ss_pred             cCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 040917          197 VGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT  275 (494)
Q Consensus       197 ~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  275 (494)
                      .|++.|+|||++.+ .++.++|+|||||++|+|++|..||......+....+........    +.++..+.++|.+||.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~  232 (323)
T cd05575         157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQ  232 (323)
T ss_pred             cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhh
Confidence            68999999999865 588999999999999999999999999888887777776544332    4578999999999999


Q ss_pred             cCCCCCCCH----HHHhcCCccCc
Q 040917          276 QDPKRRITV----AQVLEHPWLKE  295 (494)
Q Consensus       276 ~dp~~Rps~----~eil~~~~~~~  295 (494)
                      .||.+||++    .++++||||..
T Consensus       233 ~~p~~R~~~~~~~~~il~~~~~~~  256 (323)
T cd05575         233 KDRTKRLGAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             cCHHhCCCCCCCHHHHHcCCCcCC
Confidence            999999987    69999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.7e-43  Score=346.41  Aligned_cols=258  Identities=21%  Similarity=0.390  Sum_probs=209.2

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|...         ...+.+|+.++++|. ||||+++++++..+...++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAIN-HPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCC-CCCCCCEeEEEEECCeeEE
Confidence            368999999999999999999999999999999753         234678999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-  190 (494)
                      |+|++. ++|..++.....++...+..++.||+.||.|||++||+||||||+||++   +..+.++|+|||++...... 
T Consensus       161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCccccccccc
Confidence            999995 6899988887789999999999999999999999999999999999999   67789999999998643221 


Q ss_pred             -cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHc------------
Q 040917          191 -KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD-------QGVAQAILK------------  249 (494)
Q Consensus       191 -~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~-------~~~~~~~~~------------  249 (494)
                       .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.....       ...+..+..            
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence             22234578999999999865 589999999999999999999988754321       111111110            


Q ss_pred             --------------CCcc--CCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCC
Q 040917          250 --------------GEIN--FQRDP---FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKP  303 (494)
Q Consensus       250 --------------~~~~--~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~  303 (494)
                                    ....  .....   ...++..+.++|.+||+.||.+|||+.++|+||||+..+.+...|
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~  389 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYPNP  389 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCCCCC
Confidence                          0000  00001   123567899999999999999999999999999999866554444

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-42  Score=338.96  Aligned_cols=259  Identities=29%  Similarity=0.514  Sum_probs=217.9

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++++..+...|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEE
Confidence            4799999999999999999999999999999999754433344456688899999999 599999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      |||++|++|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.......
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence            999999999999976 4578999999999999999999999999999999999999   678899999999987554322


Q ss_pred             cc--ccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC-CCCCCCC
Q 040917          192 AY--REIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ-RDPFPSI  262 (494)
Q Consensus       192 ~~--~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~  262 (494)
                      ..  ....||+.|+|||++.      +.++.++|+||+||++|+|++|+.||.+....+....+......+. +...+.+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  236 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV  236 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence            21  2246899999999985      2478899999999999999999999988877777666655433222 2223458


Q ss_pred             CHHHHHHHHHhcccCCCC--CCCHHHHhcCCccCc
Q 040917          263 SSSAIELVRRMLTQDPKR--RITVAQVLEHPWLKE  295 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~  295 (494)
                      +..++++|.+||..++.+  |+++.++++||||..
T Consensus       237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~  271 (331)
T cd05597         237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG  271 (331)
T ss_pred             CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence            999999999998764444  789999999999975

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9e-43  Score=339.48  Aligned_cols=250  Identities=32%  Similarity=0.587  Sum_probs=215.3

Q ss_pred             eeeecccCCeEEEEEEEC---CCCcEEEEEEeccCCCC-ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           38 GREVGRGEFGITYLCTEN---STGLEFACKSIPKRKLV-KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        38 ~~~lg~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      ++.||+|+||.||+|.+.   .+++.||+|++...... .......+.+|+.+++.+. ||||+++++.+..++..|+||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~   79 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLIL   79 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEE
Confidence            367999999999999864   57899999999754321 2223456788999999995 999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Ccc
Q 040917          114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKA  192 (494)
Q Consensus       114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~  192 (494)
                      ||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++..... ...
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~  156 (323)
T cd05584          80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTV  156 (323)
T ss_pred             eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCCc
Confidence            999999999999888889999999999999999999999999999999999999   6788999999999864322 222


Q ss_pred             cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917          193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR  271 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  271 (494)
                      .....|++.|+|||++.+ .++.++|||||||++|+|++|+.||...........+..+....+    +.+++.+.++|.
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~  232 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLLK  232 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            234578999999999865 578899999999999999999999999888877777777654433    457899999999


Q ss_pred             HhcccCCCCCC-----CHHHHhcCCccCc
Q 040917          272 RMLTQDPKRRI-----TVAQVLEHPWLKE  295 (494)
Q Consensus       272 ~~l~~dp~~Rp-----s~~eil~~~~~~~  295 (494)
                      +||..+|++||     ++.++++||||..
T Consensus       233 ~~l~~~p~~R~~~~~~~~~~l~~h~~~~~  261 (323)
T cd05584         233 KLLKRNPSSRLGAGPGDAAEVQSHPFFRH  261 (323)
T ss_pred             HHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence            99999999999     8999999999986

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.7e-44  Score=340.49  Aligned_cols=256  Identities=33%  Similarity=0.556  Sum_probs=231.3

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe-EE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF-VH  110 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~-~~  110 (494)
                      .++|.+++.+|+|+||.++.++++..++.+|+|.+........ .+....+|+.++++++ ||||+.+.+.|..++. .+
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhcc-CCCeeeeccchhcCCceEE
Confidence            3679999999999999999999999999999999987665444 4558889999999996 9999999999998887 99


Q ss_pred             EEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          111 IVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      |||+||+||++.+.++..+  .++++.+..|+.|++.|+.|||+++|.|||||++|||+   ..+..|+|+|||+|....
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL---TKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc---cccCceeecchhhhhhcC
Confidence            9999999999999997654  58999999999999999999999999999999999999   677888999999999887


Q ss_pred             cCc-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917          189 EGK-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       189 ~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (494)
                      +.. ...+..|||.|++||++.+ +|+.++|||||||++|||++-+.+|.+.+-.+....+.++...+.+   ..++.++
T Consensus       158 ~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys~el  234 (426)
T KOG0589|consen  158 PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYSSEL  234 (426)
T ss_pred             CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---ccccHHH
Confidence            766 5567899999999999976 6999999999999999999999999999999998888887733333   4678999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          267 IELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      +.+|..||..+|..||++.++|.+|.+..
T Consensus       235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  235 RSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             HHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence            99999999999999999999999988874

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-43  Score=343.36  Aligned_cols=250  Identities=30%  Similarity=0.551  Sum_probs=214.2

Q ss_pred             ecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc--CCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917           41 VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS--GQPNIVQFKAAYEDDQFVHIVMELCAG  118 (494)
Q Consensus        41 lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~i~~~~~~~~~~~~~~iv~e~~~g  118 (494)
                      ||+|+||+||+|.+..+++.||+|++.+..............|..++..+.  +||||+++++++......|+||||++|
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999999999999999996544333333444556777776654  699999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Cccccccc
Q 040917          119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREIV  197 (494)
Q Consensus       119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~~~~~~  197 (494)
                      ++|..++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++..... ........
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence            9999999888889999999999999999999999999999999999999   6788999999999865322 22234567


Q ss_pred             CCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 040917          198 GSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT  275 (494)
Q Consensus       198 ~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  275 (494)
                      ||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+....+..+...++.   ..+++.+.++|.+||.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~~L~  234 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGLLN  234 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcC
Confidence            8999999999864  4789999999999999999999999998888877777766555443   3478999999999999


Q ss_pred             cCCCCCC----CHHHHhcCCccCcc
Q 040917          276 QDPKRRI----TVAQVLEHPWLKES  296 (494)
Q Consensus       276 ~dp~~Rp----s~~eil~~~~~~~~  296 (494)
                      .||.+||    ++.++++||||...
T Consensus       235 ~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         235 RNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             CCHHHCCCCCCCHHHHhcCccccCC
Confidence            9999998    78999999999863

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.6e-42  Score=338.10  Aligned_cols=250  Identities=27%  Similarity=0.483  Sum_probs=211.6

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG  118 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g  118 (494)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++.++.+||+|+.+++++.....+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998655444445667889999999997799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cCccccccc
Q 040917          119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIV  197 (494)
Q Consensus       119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~~~~~~~~  197 (494)
                      ++|..++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.... ........+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFC  157 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCCceeccc
Confidence            9999998887889999999999999999999999999999999999999   678899999999987532 223334567


Q ss_pred             CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET-------DQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                      ||+.|+|||++.+ .++.++|+|||||++|+|++|..||....       .....+.+.......+    ..++..+.++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~l  233 (327)
T cd05617         158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVKASHV  233 (327)
T ss_pred             CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence            8999999999864 58899999999999999999999995422       1223333333322222    3578999999


Q ss_pred             HHHhcccCCCCCCC------HHHHhcCCccCc
Q 040917          270 VRRMLTQDPKRRIT------VAQVLEHPWLKE  295 (494)
Q Consensus       270 i~~~l~~dp~~Rps------~~eil~~~~~~~  295 (494)
                      +.+||..||.+|++      ++++++||||..
T Consensus       234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~  265 (327)
T cd05617         234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS  265 (327)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence            99999999999998      579999999986

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.5e-42  Score=331.13  Aligned_cols=252  Identities=26%  Similarity=0.461  Sum_probs=206.5

Q ss_pred             ecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCc
Q 040917           41 VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGE  120 (494)
Q Consensus        41 lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~s  120 (494)
                      ||+|+||+||+|.+..+++.||+|.+.............+..|+.+++.+ +||||+++.+++..+...++||||++|++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            79999999999999999999999998755433333446678899999999 59999999999999999999999999999


Q ss_pred             hHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc-ccc
Q 040917          121 LFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-YRE  195 (494)
Q Consensus       121 L~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~-~~~  195 (494)
                      |...+..    ...+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||.+........ ...
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCccccc
Confidence            9887743    3468999999999999999999999999999999999999   6788999999999876543322 234


Q ss_pred             ccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhc
Q 040917          196 IVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRML  274 (494)
Q Consensus       196 ~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  274 (494)
                      ..|++.|+|||++.+ .++.++|+||+||++|+|++|+.||...........+..............++..+.+++.+||
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  236 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL  236 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence            568999999999864 5889999999999999999999999765432211122111111111222458899999999999


Q ss_pred             ccCCCCCC-----CHHHHhcCCccCcc
Q 040917          275 TQDPKRRI-----TVAQVLEHPWLKES  296 (494)
Q Consensus       275 ~~dp~~Rp-----s~~eil~~~~~~~~  296 (494)
                      ..||++||     +++++++||||+..
T Consensus       237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         237 AKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             cCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence            99999999     88999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.2e-42  Score=351.17  Aligned_cols=255  Identities=25%  Similarity=0.407  Sum_probs=206.5

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC----
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD----  106 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~----  106 (494)
                      ...+|++++.||+|+||.||+|.+..+++.||+|++....       ....+|+.+++.+. ||||+++++++...    
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLN-HINIIFLKDYYYTECFKK  135 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcC-CCCCcceeeeEeeccccc
Confidence            3468999999999999999999999999999999885322       22457999999995 99999999887432    


Q ss_pred             ----CeEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEE
Q 040917          107 ----QFVHIVMELCAGGELFDRIV----ARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKA  178 (494)
Q Consensus       107 ----~~~~iv~e~~~g~sL~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL  178 (494)
                          ..+++||||+++ +|.+++.    ....++...+..++.||+.||.|||++||+||||||+||+++  ...+.+||
T Consensus       136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~vkL  212 (440)
T PTZ00036        136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKL  212 (440)
T ss_pred             CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCceee
Confidence                247799999975 7776664    345689999999999999999999999999999999999994  23457999


Q ss_pred             eecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC-----
Q 040917          179 TDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE-----  251 (494)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~-----  251 (494)
                      +|||++.............+++.|+|||++.+  .++.++|||||||++|+|++|..||.+....+....+.+..     
T Consensus       213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99999987655444455678999999998864  58999999999999999999999999887665544443210     


Q ss_pred             ------------ccCCCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          252 ------------INFQRD--------PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       252 ------------~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                                  ..++..        .....|+++.+||.+||..||.+|||+.++|+||||...
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence                        001100        012367889999999999999999999999999999864

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.6e-42  Score=340.27  Aligned_cols=262  Identities=25%  Similarity=0.376  Sum_probs=212.5

Q ss_pred             ccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917           26 KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED  105 (494)
Q Consensus        26 ~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~  105 (494)
                      .....+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.+ +||||+++++++..
T Consensus        17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~   94 (364)
T cd07875          17 DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTP   94 (364)
T ss_pred             cchhchhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhc-CCCCccccceeecc
Confidence            334456789999999999999999999999999999999986543 2233456778899999999 49999999998754


Q ss_pred             C------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEe
Q 040917          106 D------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKAT  179 (494)
Q Consensus       106 ~------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~  179 (494)
                      .      ..+|+||||+++ +|.+.+..  .++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+
T Consensus        95 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~  168 (364)
T cd07875          95 QKSLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKIL  168 (364)
T ss_pred             cccccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEE
Confidence            3      357999999965 77777643  47889999999999999999999999999999999999   678899999


Q ss_pred             ecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc-----
Q 040917          180 DFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN-----  253 (494)
Q Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~-----  253 (494)
                      |||++.............+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+......     
T Consensus       169 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (364)
T cd07875         169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  248 (364)
T ss_pred             eCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            9999986654444445678999999999865 5899999999999999999999999887766554444321100     


Q ss_pred             -----------------CC----------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          254 -----------------FQ----------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       254 -----------------~~----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                                       +.                .......+..++++|.+||..||.+|||+.++|+||||..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                             00                0001113467899999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.2e-42  Score=330.44  Aligned_cols=255  Identities=27%  Similarity=0.449  Sum_probs=207.4

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc--CCCCccEEeEEEEe-----C
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS--GQPNIVQFKAAYED-----D  106 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~i~~~~~~~~~-----~  106 (494)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.+++.++  +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            5899999999999999999999999999999987543222 22344567887777764  59999999998854     3


Q ss_pred             CeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCc
Q 040917          107 QFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS  184 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a  184 (494)
                      ...+++||++.+ +|.+++...  ..++...+..++.|++.||.|||++|++||||||+||++   +.++.++|+|||++
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~  155 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLA  155 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcc
Confidence            468999999975 888888654  348999999999999999999999999999999999999   67889999999999


Q ss_pred             cccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc-----c-----
Q 040917          185 AFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI-----N-----  253 (494)
Q Consensus       185 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~-----~-----  253 (494)
                      .............+++.|+|||++.+ .++.++||||+||++|+|++|+.||.+....+....+.....     .     
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            86654444445668899999998864 589999999999999999999999988776655444332100     0     


Q ss_pred             ------CC-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          254 ------FQ-------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       254 ------~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                            +.       ....+.++..+.++|.+||+.||.+|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                  00       01124578889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1e-42  Score=328.58  Aligned_cols=254  Identities=38%  Similarity=0.691  Sum_probs=212.5

Q ss_pred             eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917           35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME  114 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e  114 (494)
                      |++++.||+|+||+||+|.+..+++.||+|++........ ......+|+.+++++ .||||+++++++......++|||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccc-ccccccccccccccccccccccc
Confidence            8999999999999999999999999999999976543222 233345699999999 59999999999999999999999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc-ccCccc
Q 040917          115 LCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAY  193 (494)
Q Consensus       115 ~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~-~~~~~~  193 (494)
                      ++++++|.+++.....++...+..++.||+.||.+||++|++|+||||+||++   +.++.++|+|||.+... ......
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~~~  155 (260)
T PF00069_consen   79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNENF  155 (260)
T ss_dssp             EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTSEB
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence            99999999999877889999999999999999999999999999999999999   68899999999998753 233344


Q ss_pred             ccccCCcCccChhhhc--ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHcCCccCCCCCCCCCCHHHHH
Q 040917          194 REIVGSPYYIAPEVLS--QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQA---ILKGEINFQRDPFPSISSSAIE  268 (494)
Q Consensus       194 ~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~  268 (494)
                      ....+++.|+|||++.  ..++.++|+||||+++++|++|..||......+....   ................+..+.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD  235 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence            4567899999999987  4689999999999999999999999988743333222   2222222122111223489999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          269 LVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       269 li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      +|.+||+.||++||++.++++||||
T Consensus       236 li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  236 LIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2e-42  Score=342.21  Aligned_cols=266  Identities=25%  Similarity=0.389  Sum_probs=212.6

Q ss_pred             hhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEE
Q 040917           23 ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAA  102 (494)
Q Consensus        23 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~  102 (494)
                      .++...-.+.++|++.+.||+|+||.||+|.+..+|..||+|++.... ........+.+|+.+++.+. ||||++++++
T Consensus        11 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~   88 (359)
T cd07876          11 QVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVN-HKNIISLLNV   88 (359)
T ss_pred             cccchhhhhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCC-CCCEeeeeee
Confidence            344444457789999999999999999999999999999999986543 23334567789999999995 9999999999


Q ss_pred             EEeC------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917          103 YEDD------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV  176 (494)
Q Consensus       103 ~~~~------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~  176 (494)
                      +...      ...|+||||+++ +|...+.  ..++...+..++.||+.||.|||++||+||||||+||++   +.++.+
T Consensus        89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~  162 (359)
T cd07876          89 FTPQKSLEEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTL  162 (359)
T ss_pred             eccCCCccccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCE
Confidence            8643      357999999975 6766653  348899999999999999999999999999999999999   678899


Q ss_pred             EEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc------
Q 040917          177 KATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK------  249 (494)
Q Consensus       177 kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~------  249 (494)
                      +|+|||++.............+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+..      
T Consensus       163 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  242 (359)
T cd07876         163 KILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS  242 (359)
T ss_pred             EEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence            9999999976544444445678999999999865 589999999999999999999999987765433222111      


Q ss_pred             ----------------CCccCCCC----------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          250 ----------------GEINFQRD----------------PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       250 ----------------~~~~~~~~----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                                      .....+..                .....++.+.++|.+||..||.+|||+.++|+||||...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  321 (359)
T cd07876         243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW  321 (359)
T ss_pred             HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence                            11110000                011235778999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.3e-42  Score=329.62  Aligned_cols=255  Identities=29%  Similarity=0.518  Sum_probs=213.3

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++++ +|++|+++++.+...+..++||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCCEEEEEE
Confidence            378889999999999999999999999999998765444443455677899999999 4999999999999999999999


Q ss_pred             eccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          114 ELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       114 e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      ||++|++|.+++...+  .++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++.......
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCc
Confidence            9999999998886433  58999999999999999999999999999999999999   677889999999987654444


Q ss_pred             ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ---GVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      ......|++.|+|||++.+ .++.++|+||+||++|+|++|..||......   +....+...   ........+++.+.
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  233 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---VQEEYSEKFSPDAR  233 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---hhhhcCccCCHHHH
Confidence            4344578999999999864 5889999999999999999999999765432   122222111   11112245788999


Q ss_pred             HHHHHhcccCCCCCCC-----HHHHhcCCccCc
Q 040917          268 ELVRRMLTQDPKRRIT-----VAQVLEHPWLKE  295 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps-----~~eil~~~~~~~  295 (494)
                      +++.+||+.||++|||     ++++++||||..
T Consensus       234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             HHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence            9999999999999999     999999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.3e-42  Score=327.71  Aligned_cols=259  Identities=27%  Similarity=0.487  Sum_probs=218.9

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      .|++.+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.+ +|+||+++.+.+..++..+++|
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCCEEEEEE
Confidence            378889999999999999999999999999999765544444456678899999999 5999999999999999999999


Q ss_pred             eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          114 ELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       114 e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      ||+++++|..++...  ..++...+..++.|++.||.|||++||+||||||+||++   ++++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCC
Confidence            999999999888653  358999999999999999999999999999999999999   667899999999987654444


Q ss_pred             ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      ......|++.|+|||.+.+ .++.++|+||+||++|+|++|..||...........+..............++..+.+++
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC  236 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence            4445678999999999864 588999999999999999999999987766544444433222222233356889999999


Q ss_pred             HHhcccCCCCCCC-----HHHHhcCCccCcc
Q 040917          271 RRMLTQDPKRRIT-----VAQVLEHPWLKES  296 (494)
Q Consensus       271 ~~~l~~dp~~Rps-----~~eil~~~~~~~~  296 (494)
                      .+||..||.+||+     +.++++|+||...
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            9999999999999     8899999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.6e-42  Score=338.14  Aligned_cols=249  Identities=28%  Similarity=0.538  Sum_probs=213.0

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHH-HHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEI-MRHLSGQPNIVQFKAAYEDDQFVHIVMELCA  117 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~  117 (494)
                      +.||+|+||.||+|.+..+|+.||+|++.+...........+..|..+ ++.+ +||||+++++.+...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecCCEEEEEEcCCC
Confidence            469999999999999999999999999976543333344556666654 5667 59999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Ccccccc
Q 040917          118 GGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREI  196 (494)
Q Consensus       118 g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~~~~~  196 (494)
                      |++|..++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++..... .......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~  156 (325)
T cd05604          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTF  156 (325)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCCcccc
Confidence            99999999888889999999999999999999999999999999999999   6788999999999865322 2223456


Q ss_pred             cCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 040917          197 VGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT  275 (494)
Q Consensus       197 ~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  275 (494)
                      .|++.|+|||++.+ .++.++|+|||||++|+|++|..||......+....+........    +..+..+.++|.+||.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~ll~  232 (325)
T cd05604         157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE  232 (325)
T ss_pred             cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHHHHhc
Confidence            78999999999865 588999999999999999999999999888888777776544332    4578999999999999


Q ss_pred             cCCCCCCCH----HHHhcCCccCc
Q 040917          276 QDPKRRITV----AQVLEHPWLKE  295 (494)
Q Consensus       276 ~dp~~Rps~----~eil~~~~~~~  295 (494)
                      .+|.+||++    .++++||||..
T Consensus       233 ~~p~~R~~~~~~~~~i~~h~~f~~  256 (325)
T cd05604         233 KDRQRRLGAKEDFLEIQEHPFFES  256 (325)
T ss_pred             cCHHhcCCCCCCHHHHhcCCCcCC
Confidence            999999977    58999999986

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-43  Score=315.62  Aligned_cols=266  Identities=36%  Similarity=0.616  Sum_probs=234.6

Q ss_pred             cccceEe-eeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           31 VQLHYTI-GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        31 ~~~~y~i-~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      +.+-|++ .+.||+|+|+.|-.|....+|..+|||++.+.   ..+.+..+.+|++++.+.++|+||+.++++|+++..+
T Consensus        75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F  151 (463)
T KOG0607|consen   75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF  151 (463)
T ss_pred             HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence            4455664 56799999999999999999999999999765   4557889999999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      |+|||.+.||+|..+|.++..+++.++.+++++|+.||.+||.+||.||||||+|||...-+.-.-+|||||.+..-+.-
T Consensus       152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~  231 (463)
T KOG0607|consen  152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL  231 (463)
T ss_pred             EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence            99999999999999999999999999999999999999999999999999999999997655667799999988754321


Q ss_pred             --------CcccccccCCcCccChhhhc---c---cCCCcchhHHHHHHHHHHHhCCCCCCCCCh---------------
Q 040917          190 --------GKAYREIVGSPYYIAPEVLS---Q---SYGKEADIWSAGVILYILLCGVPPFWAETD---------------  240 (494)
Q Consensus       190 --------~~~~~~~~~~~~y~aPE~~~---~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~---------------  240 (494)
                              .+.+.+.+|+..|||||+..   +   .|+.++|.||||+|+|-|+.|.+||.+...               
T Consensus       232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ  311 (463)
T KOG0607|consen  232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ  311 (463)
T ss_pred             CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence                    22234567888999999863   2   388999999999999999999999976654               


Q ss_pred             HHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917          241 QGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  299 (494)
                      +.....|..+...|+...|..++.+.+++|..+|..++.+|.++.++++|||++.....
T Consensus       312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            34677888999999999999999999999999999999999999999999999975433

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.8e-42  Score=339.05  Aligned_cols=268  Identities=24%  Similarity=0.371  Sum_probs=214.6

Q ss_pred             hhhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeE
Q 040917           22 AILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKA  101 (494)
Q Consensus        22 ~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~  101 (494)
                      ...++....+.++|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.+. ||||+++++
T Consensus         6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~   83 (355)
T cd07874           6 VEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLN   83 (355)
T ss_pred             eccCchhhhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhC-CCchhceee
Confidence            3444555567789999999999999999999999999999999986543 23334567788999999995 999999999


Q ss_pred             EEEeC------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCe
Q 040917          102 AYEDD------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAV  175 (494)
Q Consensus       102 ~~~~~------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~  175 (494)
                      ++...      ...++||||+++ +|.+.+..  .++...+..++.|++.||.|||++||+||||||+||++   +.++.
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~  157 (355)
T cd07874          84 VFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCT  157 (355)
T ss_pred             eeeccccccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCC
Confidence            88643      357999999975 67776643  48899999999999999999999999999999999999   67889


Q ss_pred             EEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC----
Q 040917          176 VKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG----  250 (494)
Q Consensus       176 ~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~----  250 (494)
                      ++|+|||++.............+++.|+|||++.+ .++.++|+|||||++|+|++|+.||.+....+....+...    
T Consensus       158 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (355)
T cd07874         158 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP  237 (355)
T ss_pred             EEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99999999986654444455678999999999865 5899999999999999999999999877654433222110    


Q ss_pred             ------------------CccCC----------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          251 ------------------EINFQ----------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       251 ------------------~~~~~----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                                        .....                .......+..+.++|.+||..||++|||+.++|+||||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                              00000                00111245678999999999999999999999999999854


Q ss_pred             C
Q 040917          297 G  297 (494)
Q Consensus       297 ~  297 (494)
                      .
T Consensus       318 ~  318 (355)
T cd07874         318 Y  318 (355)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-42  Score=338.11  Aligned_cols=248  Identities=29%  Similarity=0.533  Sum_probs=214.7

Q ss_pred             eeecccCCeEEEEEEE---CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEec
Q 040917           39 REVGRGEFGITYLCTE---NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMEL  115 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~---~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~  115 (494)
                      +.||+|+||.||++.+   ..+|+.||+|++...... ......+.+|+.+++++. ||||+++++++..+...|+||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEcC
Confidence            5799999999999886   357899999999754422 223456778999999994 99999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-cccc
Q 040917          116 CAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-KAYR  194 (494)
Q Consensus       116 ~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-~~~~  194 (494)
                      ++|++|.+++.+...+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++...... ....
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~  156 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAY  156 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCcee
Confidence            9999999999888889999999999999999999999999999999999999   67889999999998765433 2233


Q ss_pred             cccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHh
Q 040917          195 EIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRM  273 (494)
Q Consensus       195 ~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  273 (494)
                      ...|++.|+|||++.+ .++.++|+|||||++|+|++|+.||...........+.+.....+    ..+++.+.++|.+|
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~  232 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRAL  232 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHH
Confidence            4678999999999865 578999999999999999999999998888877777766554433    35789999999999


Q ss_pred             cccCCCCCCC-----HHHHhcCCccCc
Q 040917          274 LTQDPKRRIT-----VAQVLEHPWLKE  295 (494)
Q Consensus       274 l~~dp~~Rps-----~~eil~~~~~~~  295 (494)
                      |..||++||+     +.++++||||..
T Consensus       233 l~~~P~~R~~a~~~~~~~~~~~~~~~~  259 (318)
T cd05582         233 FKRNPANRLGAGPDGVEEIKRHPFFST  259 (318)
T ss_pred             hhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence            9999999999     778999999986

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.1e-42  Score=334.93  Aligned_cols=259  Identities=28%  Similarity=0.489  Sum_probs=218.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|+||.||++.++.+++.||+|++.+...........+.+|+.++..+ +||+|+++++.+.+....++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEE
Confidence            3799999999999999999999999999999998654333333455678899999998 599999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      |||++||+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.......
T Consensus        80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCC
Confidence            999999999999976 4578999999999999999999999999999999999999   678899999999986543222


Q ss_pred             c--cccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC-CCCCCC
Q 040917          192 A--YREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR-DPFPSI  262 (494)
Q Consensus       192 ~--~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~  262 (494)
                      .  .....||+.|+|||++.      +.++.++|+|||||++|+|++|+.||......+....+......... .....+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV  236 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence            2  12356899999999875      34788999999999999999999999988887777777665443322 223468


Q ss_pred             CHHHHHHHHHhcccCCCC--CCCHHHHhcCCccCc
Q 040917          263 SSSAIELVRRMLTQDPKR--RITVAQVLEHPWLKE  295 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~  295 (494)
                      ++.+.+++.+||..++.+  |+++.++++||||..
T Consensus       237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence            999999999999765554  689999999999986

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.4e-42  Score=335.82  Aligned_cols=249  Identities=27%  Similarity=0.524  Sum_probs=211.0

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHH-HHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIE-IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA  117 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~  117 (494)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+..|.. +++.+ +||||+++++++...+..++||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEeCCC
Confidence            46999999999999999999999999997543322223344445544 45667 59999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cCcccccc
Q 040917          118 GGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREI  196 (494)
Q Consensus       118 g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~~~~~~~  196 (494)
                      |++|.+++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.... ........
T Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~~~~~~  156 (325)
T cd05602          80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTF  156 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCCCcccc
Confidence            99999999888889999999999999999999999999999999999999   678899999999987532 22223456


Q ss_pred             cCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 040917          197 VGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT  275 (494)
Q Consensus       197 ~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  275 (494)
                      .|++.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+.......    .+.++..+.++|.+||.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~  232 (325)
T cd05602         157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL----KPNITNSARHLLEGLLQ  232 (325)
T ss_pred             cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCC----CCCCCHHHHHHHHHHcc
Confidence            78999999999875 58899999999999999999999999988887777776654332    24688999999999999


Q ss_pred             cCCCCCCCHH----HHhcCCccCc
Q 040917          276 QDPKRRITVA----QVLEHPWLKE  295 (494)
Q Consensus       276 ~dp~~Rps~~----eil~~~~~~~  295 (494)
                      .||.+||++.    ++++|+||..
T Consensus       233 ~~p~~R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         233 KDRTKRLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             cCHHHCCCCCCCHHHHhcCcccCC
Confidence            9999999876    8999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5.6e-42  Score=334.94  Aligned_cols=259  Identities=27%  Similarity=0.483  Sum_probs=219.0

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|..++..+ +||+|+.+++++...+..|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence            4799999999999999999999999999999998754333333455678899999988 599999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      |||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++.......
T Consensus        80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence            999999999999977 4578999999999999999999999999999999999999   678899999999987654332


Q ss_pred             cc--ccccCCcCccChhhhcc------cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC-CCCCCCC
Q 040917          192 AY--REIVGSPYYIAPEVLSQ------SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ-RDPFPSI  262 (494)
Q Consensus       192 ~~--~~~~~~~~y~aPE~~~~------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~  262 (494)
                      ..  ....|++.|+|||++.+      .++.++|+||+||++|+|++|+.||......+....+......+. +..+..+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV  236 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence            21  23568999999999863      478899999999999999999999998887777777665543332 2233567


Q ss_pred             CHHHHHHHHHhcccCCCC--CCCHHHHhcCCccCc
Q 040917          263 SSSAIELVRRMLTQDPKR--RITVAQVLEHPWLKE  295 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~  295 (494)
                      ++.+.++|.+||..++.+  |++++++++||||..
T Consensus       237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence            899999999999876654  568999999999985

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.6e-42  Score=338.70  Aligned_cols=256  Identities=26%  Similarity=0.433  Sum_probs=208.6

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      ..+|++++.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.+. ||||+++++++...+.+++
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l  149 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQV  149 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCeEEE
Confidence            367889999999999999999999999999999986432  2334677889999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-  190 (494)
                      ||||+++++|.+.    ...++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...... 
T Consensus       150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceeccccc
Confidence            9999999998653    345678888999999999999999999999999999999   67889999999998765432 


Q ss_pred             cccccccCCcCccChhhhcc-----c-CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          191 KAYREIVGSPYYIAPEVLSQ-----S-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~-----~-~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      .......|+..|+|||++..     . .+.++|||||||++|+|++|+.||......+....+..............++.
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR  302 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence            12234578999999998743     1 35689999999999999999999974433222222111111112222346789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      .+.++|.+||..||++||++.++|+||||....
T Consensus       303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            999999999999999999999999999999754

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.2e-41  Score=332.79  Aligned_cols=258  Identities=26%  Similarity=0.418  Sum_probs=214.2

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++.+.||+|+||.||+|.+..++..+|+|.+....  .......+.+|+.+++.+. ||||+++++++..++..++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCEEEE
Confidence            368999999999999999999999999999999986532  2334567899999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      ||||++|++|.+++...+.++...+..++.+++.|+.|||+. +++|+||||+||++   +.++.++|+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhhh
Confidence            999999999999998888899999999999999999999985 79999999999999   57788999999998754322


Q ss_pred             cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc---CC---------------
Q 040917          191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK---GE---------------  251 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~---~~---------------  251 (494)
                       ......+++.|+|||++.+ .++.++|+|||||++|+|++|+.||...........+..   +.               
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (333)
T cd06650         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR  236 (333)
T ss_pred             -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence             2234568899999999875 588999999999999999999999976654433222110   00               


Q ss_pred             ------------------------ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          252 ------------------------INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       252 ------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                                              ...+.......+..+.+||.+||..||++|||+.+++.||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                                    000000112356789999999999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=332.12  Aligned_cols=246  Identities=26%  Similarity=0.402  Sum_probs=213.8

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      ...++.++.||+|.||.||.|.+.. ...||+|.++....    ..+.+.+|+.+|++|+ |++|+++++++..+..+||
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~piyI  278 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM----SPEAFLREAQIMKKLR-HEKLVKLYGVCTKQEPIYI  278 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc----ChhHHHHHHHHHHhCc-ccCeEEEEEEEecCCceEE
Confidence            3556778899999999999999874 44799999975433    4567889999999996 9999999999999888999


Q ss_pred             EEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          112 VMELCAGGELFDRIVA--RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      ||||++.|+|.+++..  ...+.....+.++.||++|++||+++++|||||-+.||||   +++..+||+|||+|+....
T Consensus       279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d  355 (468)
T KOG0197|consen  279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLIGD  355 (468)
T ss_pred             EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccccCC
Confidence            9999999999999986  4568999999999999999999999999999999999999   7889999999999995543


Q ss_pred             Cccccc--ccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          190 GKAYRE--IVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       190 ~~~~~~--~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ......  ..-...|.|||+++ +.++.+||||||||+|+||+| |+.||.+.+..+++..+.++...+.+   +.+|+.
T Consensus       356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P---~~CP~~  432 (468)
T KOG0197|consen  356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP---EGCPDE  432 (468)
T ss_pred             CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC---CCCCHH
Confidence            332211  12245799999987 579999999999999999998 89999999999999999998666555   468999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +-+++..||..+|++|||++.+..
T Consensus       433 vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  433 VYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHHH
Confidence            999999999999999999997654

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.9e-42  Score=331.44  Aligned_cols=258  Identities=25%  Similarity=0.431  Sum_probs=213.0

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|.+.+.||+|+||.||+|.+..++..||+|.+.....  ......+.+|+.++++++ ||||+++++++..++..++|
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeEEEE
Confidence            679999999999999999999999999999999865432  223445778999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      |||+++ +|.+++...+ .++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||.+.......
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCc
Confidence            999975 8888776543 47899999999999999999999999999999999999   678899999999987543222


Q ss_pred             -ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc---------------
Q 040917          192 -AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN---------------  253 (494)
Q Consensus       192 -~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~---------------  253 (494)
                       ......+++.|+|||++.+  .++.++|+||+||++|+|++|+.||.+.+..+....+.+....               
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence             2233567899999998854  4789999999999999999999999887766554444321100               


Q ss_pred             ----CCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          254 ----FQR-------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       254 ----~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                          ++.       ...+.+++++.++|.+||..||.+|||+.++|+||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence                000       11235788999999999999999999999999999999754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7.9e-42  Score=325.65  Aligned_cols=248  Identities=27%  Similarity=0.484  Sum_probs=206.5

Q ss_pred             ecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCc
Q 040917           41 VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGE  120 (494)
Q Consensus        41 lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~s  120 (494)
                      ||+|+||.||+|.++.+|+.||+|++.............+..|+.+++.+ +||||+++++++..+...++||||++|++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            79999999999999999999999999754443333345566799999999 59999999999999999999999999999


Q ss_pred             hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcccccccC
Q 040917          121 LFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG  198 (494)
Q Consensus       121 L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  198 (494)
                      |..++....  .++...+..++.||+.||.|||++|++||||||+||++   +.++.++|+|||++.............+
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeeccCC
Confidence            998886543  48889999999999999999999999999999999999   6788999999999876655444445678


Q ss_pred             CcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHcCCccCCCCCCCCCCHHHHHHHHHh
Q 040917          199 SPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ----GVAQAILKGEINFQRDPFPSISSSAIELVRRM  273 (494)
Q Consensus       199 ~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  273 (494)
                      ++.|+|||++.+ .++.++|+||+||++|+|++|+.||......    .+...........   ....++..+.+++.+|
T Consensus       157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~  233 (277)
T cd05607         157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF---EHQNFTEESKDICRLF  233 (277)
T ss_pred             CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc---ccccCCHHHHHHHHHH
Confidence            999999999864 5899999999999999999999999765432    2222222222221   2246789999999999


Q ss_pred             cccCCCCCCCH----HHHhcCCccCc
Q 040917          274 LTQDPKRRITV----AQVLEHPWLKE  295 (494)
Q Consensus       274 l~~dp~~Rps~----~eil~~~~~~~  295 (494)
                      |+.||++||++    ++++.||||+.
T Consensus       234 L~~~P~~R~~~~~~~~~~~~h~~f~~  259 (277)
T cd05607         234 LAKKPEDRLGSREKNDDPRKHEFFKT  259 (277)
T ss_pred             hccCHhhCCCCccchhhhhcChhhcC
Confidence            99999999999    67889999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.2e-42  Score=333.46  Aligned_cols=249  Identities=28%  Similarity=0.532  Sum_probs=210.7

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHH-HHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIE-IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA  117 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~  117 (494)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+..|.. +++.+ +||||+++++.+...+..++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence            46999999999999999999999999997544333333445555654 56777 59999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Ccccccc
Q 040917          118 GGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREI  196 (494)
Q Consensus       118 g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~~~~~~  196 (494)
                      |++|...+.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++..... .......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~  156 (321)
T cd05603          80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTF  156 (321)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCccccc
Confidence            99999988888889999999999999999999999999999999999999   6788999999999875322 2222345


Q ss_pred             cCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 040917          197 VGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT  275 (494)
Q Consensus       197 ~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  275 (494)
                      .|++.|+|||++.+ .++.++|+|||||++|+|++|..||.+.........+.......+    +..+..+.++|.+||.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~  232 (321)
T cd05603         157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLH  232 (321)
T ss_pred             cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHcc
Confidence            78999999999865 588999999999999999999999998887777777766543332    3567899999999999


Q ss_pred             cCCCCCCCH----HHHhcCCccCc
Q 040917          276 QDPKRRITV----AQVLEHPWLKE  295 (494)
Q Consensus       276 ~dp~~Rps~----~eil~~~~~~~  295 (494)
                      .||.+||++    .++++|+||..
T Consensus       233 ~~p~~R~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         233 KDQRRRLGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             CCHhhcCCCCCCHHHHhCCCCcCC
Confidence            999999875    59999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.4e-42  Score=337.75  Aligned_cols=269  Identities=24%  Similarity=0.416  Sum_probs=216.5

Q ss_pred             hhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEE
Q 040917           23 ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAA  102 (494)
Q Consensus        23 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~  102 (494)
                      .+.+....+.++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++++. ||||++++++
T Consensus         5 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~   82 (343)
T cd07878           5 ELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMK-HENVIGLLDV   82 (343)
T ss_pred             HHhHHHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcC-CCchhhhhhh
Confidence            4455667788999999999999999999999999999999999865332 2223456778999999995 9999999988


Q ss_pred             EEeC------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917          103 YEDD------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV  176 (494)
Q Consensus       103 ~~~~------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~  176 (494)
                      +...      ...|++++++ |++|.+++. ...++...+..++.||+.||.|||++||+||||||+||++   +.++.+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~  157 (343)
T cd07878          83 FTPATSIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCEL  157 (343)
T ss_pred             hcccccccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCE
Confidence            7532      4578999998 778987765 4569999999999999999999999999999999999999   678899


Q ss_pred             EEeecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc--
Q 040917          177 KATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI--  252 (494)
Q Consensus       177 kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~--  252 (494)
                      ||+|||++.....  ......+++.|+|||++.+  .++.++|||||||++|+|++|+.||.+.........+.....  
T Consensus       158 kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (343)
T cd07878         158 RILDFGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP  235 (343)
T ss_pred             EEcCCccceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999999876533  2334578999999999865  488999999999999999999999987665444333321100  


Q ss_pred             ---------------------cCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCC
Q 040917          253 ---------------------NFQR----DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS  300 (494)
Q Consensus       253 ---------------------~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~  300 (494)
                                           ..+.    ..+...++.+.++|.+||..||.+|||+.++|+||||.....+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~  308 (343)
T cd07878         236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE  308 (343)
T ss_pred             CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence                                 0000    01224567789999999999999999999999999998755443

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.8e-41  Score=324.15  Aligned_cols=254  Identities=31%  Similarity=0.613  Sum_probs=222.9

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++.+.||+|++|.||+|.+..+++.||+|++.............+.+|+.+++++. ||||+++++++......++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEEEE
Confidence            36999999999999999999999999999999997655444445677889999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      |||+++++|.+++.....++...+..++.||+.||.|||++|++|+||+|.||++   +.++.++|+|||++......  
T Consensus        80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC--
Confidence            9999999999999888889999999999999999999999999999999999999   67789999999998765443  


Q ss_pred             cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917          193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR  271 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  271 (494)
                      .....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.........+.+..+...++    ..++..+.++|.
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~  230 (290)
T cd05580         155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAKDLIR  230 (290)
T ss_pred             CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC----ccCCHHHHHHHH
Confidence            234568899999998754 578899999999999999999999988877666666665544333    346899999999


Q ss_pred             HhcccCCCCCC-----CHHHHhcCCccCcc
Q 040917          272 RMLTQDPKRRI-----TVAQVLEHPWLKES  296 (494)
Q Consensus       272 ~~l~~dp~~Rp-----s~~eil~~~~~~~~  296 (494)
                      +||..||.+|+     ++.++++||||...
T Consensus       231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  260 (290)
T cd05580         231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGI  260 (290)
T ss_pred             HHccCCHHHccCcccCCHHHHHcCcccccC
Confidence            99999999999     99999999999763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.9e-41  Score=344.95  Aligned_cols=255  Identities=28%  Similarity=0.448  Sum_probs=218.9

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCC-CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENST-GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~-~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      ....|.+.+.||+|++|.||+|.+..+ +..||+|.+...   .......+.+|+.+++.+ +||||+++++++..++..
T Consensus        65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~  140 (478)
T PTZ00267         65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDKL  140 (478)
T ss_pred             cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEECCEE
Confidence            445699999999999999999998877 788999987432   233455678899999999 499999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          110 HIVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      |+||||++||+|.+++..    ..++++..+..++.||+.||.|||++||+||||||+||++   +..+.++|+|||++.
T Consensus       141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~  217 (478)
T PTZ00267        141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSK  217 (478)
T ss_pred             EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCce
Confidence            999999999999987753    3468999999999999999999999999999999999999   678899999999998


Q ss_pred             ccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917          186 FIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       186 ~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (494)
                      .......   ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....++...+..+.....   ...
T Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~  294 (478)
T PTZ00267        218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF---PCP  294 (478)
T ss_pred             ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---Ccc
Confidence            6543221   234568999999999865 589999999999999999999999998888888777766544322   135


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      ++..+.++|.+||..||++||++.+++.|||++.
T Consensus       295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        295 VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            7899999999999999999999999999999975

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-41  Score=318.63  Aligned_cols=255  Identities=30%  Similarity=0.514  Sum_probs=215.0

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC--hhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK--DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      +.|.+.+.||+|++|.||.|.+..+++.|++|.+.......  ......+.+|+.+++++ +||||+++++++..+...+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDETLS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCCeEE
Confidence            46999999999999999999999999999999986543222  12245688899999999 5999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +|+||++|++|.+++...+.++...+..++.+++.|+.|||+.|++||||+|+||++   +.++.++|+|||.+......
T Consensus        81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecccc
Confidence            999999999999999888889999999999999999999999999999999999999   67789999999998754322


Q ss_pred             ccc----ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          191 KAY----REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       191 ~~~----~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ...    ....++..|+|||.+.+ .++.++|+||+|+++|+|++|+.||...........+.......  .....++..
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  235 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP--QLPSHVSPD  235 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC--CCCccCCHH
Confidence            111    23456789999999865 48899999999999999999999997766655544443332221  122467899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      +.++|.+||..+|.+||++.++++||||
T Consensus       236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         236 ARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.3e-41  Score=337.86  Aligned_cols=257  Identities=30%  Similarity=0.445  Sum_probs=212.6

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC-----e
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ-----F  108 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~-----~  108 (494)
                      +|++++.||+|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++.++ ||||+++++++....     .
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~   78 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEE   78 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccce
Confidence            4788999999999999999999999999999986432 22334567889999999995 999999999998766     7


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      .|+|+||+. ++|.+.+.....++...+..++.||+.||.|||++|++||||||+||++   +.++.++|+|||++....
T Consensus        79 ~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          79 IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeecc
Confidence            899999996 5888888777789999999999999999999999999999999999999   678899999999987543


Q ss_pred             cCc--ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc---------------
Q 040917          189 EGK--AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK---------------  249 (494)
Q Consensus       189 ~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~---------------  249 (494)
                      ...  ......+++.|+|||++.+  .++.++||||+||++|+|++|+.||.+.........+..               
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            221  2233467889999999875  378999999999999999999999988776655444322               


Q ss_pred             --------CCccCCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          250 --------GEINFQR-----DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       250 --------~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                              .....+.     ......++.+.++|.+||..||.+|||+.++|+||||...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                    1111110     1123457889999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.3e-41  Score=355.13  Aligned_cols=265  Identities=32%  Similarity=0.538  Sum_probs=217.6

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--  105 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--  105 (494)
                      .+....+|++++.||+|+||+||+|.+..++..||+|++..... .......+..|+.+++.|. ||||+++++++..  
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELK-HKNIVRYIDRFLNKA   85 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEecC
Confidence            44556799999999999999999999999999999999875543 3334677889999999995 9999999998854  


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCceEEeeC----
Q 040917          106 DQFVHIVMELCAGGELFDRIVAR----GHYSERAAASVFRVIMNVVNVCHSK-------GVMHRDLKPENFLFTTG----  170 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~-------~i~H~dikp~NIli~~~----  170 (494)
                      ...+||||||+++++|.+++...    ..+++..++.|+.||+.||.|||+.       +|+||||||+|||+...    
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            45789999999999999988652    5699999999999999999999985       49999999999999531    


Q ss_pred             ----------CCCCeEEEeecCCccccccCcccccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCC
Q 040917          171 ----------DENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWA  237 (494)
Q Consensus       171 ----------~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~  237 (494)
                                +..+.++|+|||++.............||+.|+|||++.+   .++.++|||||||++|+|++|..||..
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                      2245699999999986644433445678999999999853   478999999999999999999999976


Q ss_pred             CChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          238 ETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ...............   ..+....+..+.+||..||..+|.+||++.++|.|||++...
T Consensus       246 ~~~~~qli~~lk~~p---~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        246 ANNFSQLISELKRGP---DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             CCcHHHHHHHHhcCC---CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            655433333222222   222346789999999999999999999999999999998543

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.7e-41  Score=344.30  Aligned_cols=257  Identities=31%  Similarity=0.504  Sum_probs=218.8

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC---
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ---  107 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~---  107 (494)
                      ...+|++.+.||+|+||+||+|.+..+|+.||+|++..... +......+.+|+.++..+ +|+||+++++.+....   
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccC
Confidence            44799999999999999999999999999999999976543 333456788899999999 4999999888764322   


Q ss_pred             -----eEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEE
Q 040917          108 -----FVHIVMELCAGGELFDRIVAR----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKA  178 (494)
Q Consensus       108 -----~~~iv~e~~~g~sL~~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL  178 (494)
                           .+++||||+++|+|.+++...    ..+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEE
Confidence                 478999999999999988643    458999999999999999999999999999999999999   57889999


Q ss_pred             eecCCccccccC---cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccC
Q 040917          179 TDFGLSAFIEEG---KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF  254 (494)
Q Consensus       179 ~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  254 (494)
                      +|||++......   .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....++...+..+....
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~  264 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP  264 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence            999998764322   12234678999999999875 58999999999999999999999999888877777776654432


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          255 QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       255 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      .   .+.+++.+.+++.+||..||.+||++.++++|||++.
T Consensus       265 ~---~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        265 L---PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             C---CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            2   2468899999999999999999999999999999875

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.3e-41  Score=345.56  Aligned_cols=260  Identities=23%  Similarity=0.337  Sum_probs=204.8

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc-----CCCCccEEeEEEE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS-----GQPNIVQFKAAYE  104 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~i~~~~~~~~  104 (494)
                      ...++|++.+.||+|+||+||+|.+..+++.||||++....    ........|+.+++.++     +|++++.+++++.
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34578999999999999999999999999999999986421    12344566787777774     2456888888887


Q ss_pred             eC-CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCC-----------
Q 040917          105 DD-QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGD-----------  171 (494)
Q Consensus       105 ~~-~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~-----------  171 (494)
                      .. .++|+||+++ |++|.+++.+.+.++...+..++.||+.||.|||+ .||+||||||+|||++..+           
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence            54 5789999998 77999999888889999999999999999999998 5999999999999995322           


Q ss_pred             --CCCeEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 040917          172 --ENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL  248 (494)
Q Consensus       172 --~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~  248 (494)
                        ....+||+|||.+....  ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+.
T Consensus       281 ~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  358 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME  358 (467)
T ss_pred             CCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence              12359999999875432  22345678999999999875 58999999999999999999999998877655544332


Q ss_pred             cCCccCCC---------------------------C---------CC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          249 KGEINFQR---------------------------D---------PF--PSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       249 ~~~~~~~~---------------------------~---------~~--~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      .....++.                           .         .+  ...++.+.+||.+||..||.+|||++|+|+|
T Consensus       359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH  438 (467)
T ss_pred             HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence            21110000                           0         00  0113567899999999999999999999999


Q ss_pred             CccCcc
Q 040917          291 PWLKES  296 (494)
Q Consensus       291 ~~~~~~  296 (494)
                      |||...
T Consensus       439 p~~~~~  444 (467)
T PTZ00284        439 PYVLKY  444 (467)
T ss_pred             cccccc
Confidence            999874

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-43  Score=330.22  Aligned_cols=253  Identities=33%  Similarity=0.637  Sum_probs=232.1

Q ss_pred             eeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917           38 GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA  117 (494)
Q Consensus        38 ~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~  117 (494)
                      .+.||+|.||+||-|+++++|+.||||++.+-.+... ..+++.+|+.+|+.+. ||+|+.+.-.++..+.+++|||.+.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~-HPGiV~le~M~ET~ervFVVMEKl~  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLH-HPGIVNLECMFETPERVFVVMEKLH  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcC-CCCeeEEEEeecCCceEEEEehhhc
Confidence            4679999999999999999999999999998887665 4588999999999995 9999999999999999999999997


Q ss_pred             CCchHHHH-H-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccccc
Q 040917          118 GGELFDRI-V-ARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE  195 (494)
Q Consensus       118 g~sL~~~~-~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~  195 (494)
                      | +..+.| . ..+++++.....++.||+.||.|||-++|+|.||||+|||+.+.+....+||||||+|+.+.....-++
T Consensus       647 G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrs  725 (888)
T KOG4236|consen  647 G-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRS  725 (888)
T ss_pred             c-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhh
Confidence            6 555544 3 457899999999999999999999999999999999999998878889999999999999988777788


Q ss_pred             ccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhc
Q 040917          196 IVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRML  274 (494)
Q Consensus       196 ~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  274 (494)
                      .+|||.|.|||++.. .|...-|+||+|+|+|.-++|..||.  ..+++-++|.+..+.+++.+|..+++.+.+||..+|
T Consensus       726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN--EdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LL  803 (888)
T KOG4236|consen  726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN--EDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLL  803 (888)
T ss_pred             hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC--CccchhHHhhccccccCCCchhhcCHHHHHHHHHHH
Confidence            999999999999964 69999999999999999999999995  345688889999999999999999999999999999


Q ss_pred             ccCCCCCCCHHHHhcCCccCc
Q 040917          275 TQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       275 ~~dp~~Rps~~eil~~~~~~~  295 (494)
                      +..-.+|.|.++.|.|||+++
T Consensus       804 qVkm~kRysvdk~lsh~Wlq~  824 (888)
T KOG4236|consen  804 QVKMRKRYSVDKSLSHPWLQD  824 (888)
T ss_pred             HHHHHHhcchHhhccchhhhc
Confidence            999999999999999999997

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6.3e-41  Score=323.50  Aligned_cols=258  Identities=24%  Similarity=0.418  Sum_probs=212.3

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|.+.....  ......+.+|+.+++.+. ||||+++++++......++|
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcC-CCCcceEEEEEecCCeEEEE
Confidence            579999999999999999999999999999999865432  223456778999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      |||+++ +|.+++... ..++...+..++.||+.||.|||++|++|+||||+||++   +.++.++|+|||.+.......
T Consensus        83 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          83 FEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             Eecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCC
Confidence            999974 898887654 468899999999999999999999999999999999999   678899999999987543222


Q ss_pred             -ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc---------------
Q 040917          192 -AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN---------------  253 (494)
Q Consensus       192 -~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~---------------  253 (494)
                       ......+++.|+|||++.+  .++.++|+|||||++|+|++|+.||...+..+....+......               
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence             2233456889999998864  4788999999999999999999999887766554433221100               


Q ss_pred             ----CCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          254 ----FQR-------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       254 ----~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                          .+.       ...+.+++.+.++|.+||..||.+|||+.++|+||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence                000       01235788999999999999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=9.2e-41  Score=319.94  Aligned_cols=256  Identities=29%  Similarity=0.537  Sum_probs=212.9

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|++|.||+|.++.+|+.||+|++..... .......+.+|+.+++++. ||||+++++++......++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKLHLV   78 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEEEEE
Confidence            479999999999999999999999999999999865432 2223456789999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-  191 (494)
                      |||+++++|..++.....+++..+..++.|++.||.|||+.|++||||+|+||++   +.++.++|+|||.+....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCcc
Confidence            9999998888877666679999999999999999999999999999999999999   677899999999998654433 


Q ss_pred             ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc-----------------
Q 040917          192 AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI-----------------  252 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~-----------------  252 (494)
                      ......++..|+|||.+.+  .++.++|+||+|+++++|++|..||.+....+....+.+...                 
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence            2234457889999999864  478899999999999999999999988776544433321100                 


Q ss_pred             --cCCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          253 --NFQR--------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       253 --~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                        ..+.        ..++.++..+.+++.+||..+|++||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence              0000        0124568889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-43  Score=337.37  Aligned_cols=260  Identities=31%  Similarity=0.489  Sum_probs=228.0

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      +..+.|.|+.-||.|+||.||+|.++.++-..|.|++..   .+....+++.-|+++|... +||+|+++++.|..++.+
T Consensus        29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~C-dHP~ivkLl~ayy~enkL  104 (1187)
T KOG0579|consen   29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENKL  104 (1187)
T ss_pred             CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCce
Confidence            455789999999999999999999999999999999853   3456788899999999999 599999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      +|..|||.||.+...+..- ..+++..+..+++|+|+||.|||+++|||||||+.|||+   .-+|.++|+|||.+....
T Consensus       105 wiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~---TldGdirLADFGVSAKn~  181 (1187)
T KOG0579|consen  105 WILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL---TLDGDIRLADFGVSAKNK  181 (1187)
T ss_pred             EEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE---EecCcEeeecccccccch
Confidence            9999999999998888764 469999999999999999999999999999999999999   688999999999886543


Q ss_pred             cC-cccccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917          189 EG-KAYREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       189 ~~-~~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (494)
                      .. ..-.+..|||+|||||+..      .+|++++||||||++|.+|..+.+|-...++..++-.+.+..++....+ ..
T Consensus       182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqP-S~  260 (1187)
T KOG0579|consen  182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQP-SH  260 (1187)
T ss_pred             hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCc-ch
Confidence            22 2234678999999999863      4699999999999999999999999998898888888877655443322 56


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      |+..+.+|+.+||.+||..||++.++|+|||+++.+
T Consensus       261 Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  261 WSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             hhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence            889999999999999999999999999999999754

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.3e-41  Score=318.09  Aligned_cols=252  Identities=29%  Similarity=0.503  Sum_probs=217.9

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|++.+.||+|++|.||+|.+..+++.|++|++.............+.+|+.+++++ +||||+++++.+..+...++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEEEEE
Confidence            589999999999999999999999999999999765544444577899999999999 5999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc
Q 040917          114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY  193 (494)
Q Consensus       114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~  193 (494)
                      ||++|++|.+++.....+++..+..++.+|+.||.|||++|++|+||+|+||++   ++++.++|+|||.+.........
T Consensus        80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~  156 (258)
T cd05578          80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLT  156 (258)
T ss_pred             eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCccc
Confidence            999999999999887789999999999999999999999999999999999999   67889999999998766544344


Q ss_pred             ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          194 REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD---QGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       194 ~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                      ....++..|+|||.+.+ .++.++|+||+|+++|+|++|..||.....   ..........    .....+.++..+.++
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  232 (258)
T cd05578         157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA----DVLYPATWSTEAIDA  232 (258)
T ss_pred             cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccc----cccCcccCcHHHHHH
Confidence            45667889999999865 478999999999999999999999987764   3333222221    122224678999999


Q ss_pred             HHHhcccCCCCCCCH--HHHhcCCcc
Q 040917          270 VRRMLTQDPKRRITV--AQVLEHPWL  293 (494)
Q Consensus       270 i~~~l~~dp~~Rps~--~eil~~~~~  293 (494)
                      |.+||..||.+||++  .++++||||
T Consensus       233 i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         233 INKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHccCChhHcCCccHHHHhcCCCC
Confidence            999999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-40  Score=323.18  Aligned_cols=259  Identities=32%  Similarity=0.579  Sum_probs=220.8

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++.+.||+|++|.||+|.+..+++.||+|.+.............+.+|+.+++.+. ||||+++++.+......++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEEEEE
Confidence            37999999999999999999999999999999998765444345667889999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          113 MELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      |||+.|++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||||+||++   +.++.++|+|||++......
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhccccc
Confidence            9999999999998754  468999999999999999999999999999999999999   56789999999988654221


Q ss_pred             cc------------------------------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 040917          191 KA------------------------------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET  239 (494)
Q Consensus       191 ~~------------------------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~  239 (494)
                      ..                              .....|+..|+|||++.+ .++.++||||||+++|+|++|..||.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            10                              112357888999999865 57889999999999999999999998888


Q ss_pred             hHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHHhcCCccCccC
Q 040917          240 DQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRIT----VAQVLEHPWLKESG  297 (494)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~eil~~~~~~~~~  297 (494)
                      .......+......++..  ..++..+.++|.+||..+|++||+    +.++|+||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         237 RDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             hHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence            776666665544333322  337899999999999999999999    99999999998743

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-42  Score=328.89  Aligned_cols=256  Identities=26%  Similarity=0.442  Sum_probs=224.4

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      +....|.-.+-||+|+||.||.|++..+.+.||||...-+.-.+...-.++..|+..|++|. |||++.+-++|..+...
T Consensus        23 DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~Ta  101 (948)
T KOG0577|consen   23 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHTA  101 (948)
T ss_pred             CHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccchH
Confidence            34456777889999999999999999999999999987655555556678899999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          110 HIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      ++|||||-| |-.+++.- .+++.+-.|..|....+.||.|||+.+.||||||+.|||+   .+.|.|||+|||.|....
T Consensus       102 WLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~  177 (948)
T KOG0577|consen  102 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---SEPGLVKLADFGSASIMA  177 (948)
T ss_pred             HHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---cCCCeeeeccccchhhcC
Confidence            999999965 77777753 3568899999999999999999999999999999999999   789999999999998764


Q ss_pred             cCcccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          189 EGKAYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       189 ~~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      +   .++.+|||+|||||++.    |+|+-++||||||++..+|.-.++|+...+....+--|..+..+...  .+.|+.
T Consensus       178 P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq--s~eWS~  252 (948)
T KOG0577|consen  178 P---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--SNEWSD  252 (948)
T ss_pred             c---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC--CchhHH
Confidence            3   35689999999999984    68999999999999999999999999888888776666655444333  357899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      .++.|+..||++-|.+|||.+++|.|+|...
T Consensus       253 ~F~~Fvd~CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  253 YFRNFVDSCLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             HHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence            9999999999999999999999999999986

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.1e-40  Score=320.83  Aligned_cols=257  Identities=25%  Similarity=0.404  Sum_probs=214.1

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|+||.||+|.+..++..+++|.+....  .......+.+|+.+++++ +||||+++++++..++.+++|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   77 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEISIC   77 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEEEEE
Confidence            36999999999999999999999999999999986432  233456788999999999 599999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      |||++|++|.+++...+.++...+..++.|++.||.|||+ .+++|+||+|.||++   +.++.++|+|||++...... 
T Consensus        78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCccccccc-
Confidence            9999999999999888889999999999999999999997 599999999999999   56788999999998754332 


Q ss_pred             ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccC----------------
Q 040917          192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF----------------  254 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~----------------  254 (494)
                      ......+++.|+|||.+.+ .++.++|+|||||++++|++|+.||...........+.......                
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence            2234568899999999865 48889999999999999999999997655443333222111000                


Q ss_pred             ------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          255 ------------------QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       255 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                                        +..+...++..+.+++.+||..+|++||++.++++||||...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                              011112367889999999999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-40  Score=316.63  Aligned_cols=257  Identities=28%  Similarity=0.482  Sum_probs=218.5

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||.|++|.||+|.+..+++.|++|.+....  .......+.+|+.+++.+. ||||+++++++..+...++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeEEEE
Confidence            47899999999999999999999999999999986543  2234567889999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-c
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-K  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-~  191 (494)
                      +||+++++|.+++... +++...+..++.|++.|+.|||+.+++|+||+|+||++   ++++.++|+|||.+...... .
T Consensus        78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeeccccc
Confidence            9999999999998765 78999999999999999999999999999999999999   67889999999998766443 2


Q ss_pred             ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      ......+++.|+|||.+.+ .++.++|+|||||++|+|++|..||...........+.........  ...++..+.+++
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l  231 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE--GNKFSKPFKDFV  231 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc--ccccCHHHHHHH
Confidence            2234567888999998864 5899999999999999999999999877665555544443222111  122788999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          271 RRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       271 ~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                      .+||..+|++||+++++++||||.....
T Consensus       232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         232 SLCLNKDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             HHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence            9999999999999999999999997543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-41  Score=324.65  Aligned_cols=254  Identities=26%  Similarity=0.474  Sum_probs=203.5

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      +..|++.+.||+||.+.||++..-.. ..+|+|.+.-.. .+....+.+.+|+..|.+|++|.+|+.++++-..++.+|+
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            36799999999999999999996544 456666554322 3556788999999999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          112 VMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      |||+= ..+|..++..... ++.-.+..+..|++.++.++|++||||.||||.|+++    -.|.+||+|||.|..+.+.
T Consensus       438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE----EeeeEEeeeechhcccCcc
Confidence            99975 4588888876654 3335888999999999999999999999999999999    4789999999999877543


Q ss_pred             cc---cccccCCcCccChhhhcc------------cCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcCCccC
Q 040917          191 KA---YREIVGSPYYIAPEVLSQ------------SYGKEADIWSAGVILYILLCGVPPFWAETD-QGVAQAILKGEINF  254 (494)
Q Consensus       191 ~~---~~~~~~~~~y~aPE~~~~------------~~~~~~Di~slG~il~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~  254 (494)
                      ..   ....+||+.||+||.+..            ..++++||||||||+|+|+.|+.||..... ..-+..|.......
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I  592 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI  592 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc
Confidence            22   245789999999998831            157899999999999999999999955442 22223333332211


Q ss_pred             CCCCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          255 QRDPFPSIS--SSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       255 ~~~~~~~~~--~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                         +++.+|  .++.++++.||.+||.+||++.++|+|||++-
T Consensus       593 ---efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  593 ---EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             ---cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence               222222  23899999999999999999999999999985

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.6e-40  Score=311.48  Aligned_cols=252  Identities=27%  Similarity=0.490  Sum_probs=217.5

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|.+.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++.+. ||||+++++++......++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLNIVM   78 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEEEEE
Confidence            488999999999999999999999999999998754433 345677889999999995 999999999999999999999


Q ss_pred             eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          114 ELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       114 e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      ||++|++|.+++...  ..++...+..++.+++.|+.|||++|++|+||+|+||++   +.++.++|+|||++.......
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---eCCCCEEEcccccceeccCcc
Confidence            999999999998764  568999999999999999999999999999999999999   577899999999987654332


Q ss_pred             c-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          192 A-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       192 ~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                      . .....+++.|+|||++.+ .++.++|+|||||++++|++|+.||...........+..+......   ..++..+.++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---QMYSQQLAQL  232 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHH
Confidence            2 223467889999998864 5789999999999999999999999888877766666655432221   2578899999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCcc
Q 040917          270 VRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       270 i~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      +.+||..+|++||++.++++|||+
T Consensus       233 i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         233 IDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.4e-41  Score=316.63  Aligned_cols=254  Identities=31%  Similarity=0.473  Sum_probs=212.8

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++...   ......+.+|+.+++.+ +||||+++++.+......++
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~~~l   83 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDKLWI   83 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEE
Confidence            368999999999999999999999999999999986543   22345678899999999 59999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      +|||+++++|.+++...+.+++..+..++.|++.|+.|||++|++|+||||+||++   +.++.++|+|||.+.......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCcc
Confidence            99999999999999888889999999999999999999999999999999999999   678899999999986543221


Q ss_pred             -ccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC-CCCCCCCHH
Q 040917          192 -AYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR-DPFPSISSS  265 (494)
Q Consensus       192 -~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  265 (494)
                       ......|++.|+|||++.    +.++.++|+|||||++|+|++|..||...................+. .....++..
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS  240 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence             123456889999999873    35888999999999999999999999765544433333333222211 112357889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCc
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPW  292 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~  292 (494)
                      +.++|.+||..+|++||+++++++|||
T Consensus       241 ~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         241 FHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.2e-40  Score=320.30  Aligned_cols=257  Identities=29%  Similarity=0.524  Sum_probs=219.8

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|++.+.||+|++|.||+|.+..+++.|++|.+.............+.+|+.+++.+ +||||+++++.+..+...++||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecCCEEEEEE
Confidence            699999999999999999999999999999998765433333456788999999999 4999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc--
Q 040917          114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--  191 (494)
Q Consensus       114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~--  191 (494)
                      ||++|++|.+++...+.+++..+..++.+++.|+.|||++|++||||+|.||++   +..+.++|+|||.+.......  
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCccc
Confidence            999999999999888889999999999999999999999999999999999999   678899999999876311000  


Q ss_pred             --------------ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC
Q 040917          192 --------------AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR  256 (494)
Q Consensus       192 --------------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  256 (494)
                                    ......++..|+|||.+.+ .++.++|+|||||++|+|++|..||.+....+............+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE  237 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence                          0012356788999998754 5889999999999999999999999988887777776665544443


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCccCc
Q 040917          257 DPFPSISSSAIELVRRMLTQDPKRRIT---VAQVLEHPWLKE  295 (494)
Q Consensus       257 ~~~~~~~~~l~~li~~~l~~dp~~Rps---~~eil~~~~~~~  295 (494)
                      .. ..++..+.++|.+||..+|++||+   +.++|+||||..
T Consensus       238 ~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         238 GD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             cc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence            32 267899999999999999999998   789999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=341.79  Aligned_cols=260  Identities=30%  Similarity=0.483  Sum_probs=216.9

Q ss_pred             hhhhhhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccE
Q 040917           19 LHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ   98 (494)
Q Consensus        19 ~~~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~   98 (494)
                      ......+....--.-+++|.+.|.+|||+.||+|.+...|..||+|.+...   +......+.+|+.+|+.|++|+|||.
T Consensus        23 ~~~~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~   99 (738)
T KOG1989|consen   23 SENYFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVS   99 (738)
T ss_pred             cccCCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceee
Confidence            334555555555567899999999999999999999988899999998543   56678889999999999999999999


Q ss_pred             EeE-EEEe----C--CeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEE
Q 040917           99 FKA-AYED----D--QFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKG--VMHRDLKPENFLF  167 (494)
Q Consensus        99 ~~~-~~~~----~--~~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~dikp~NIli  167 (494)
                      +++ ....    +  -.+.|.||||.||.|.++|..+  ..|++.++++|++++++||.+||..+  |||||||.+|||+
T Consensus       100 yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl  179 (738)
T KOG1989|consen  100 YIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL  179 (738)
T ss_pred             EeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE
Confidence            999 3321    1  2577999999999999999743  45999999999999999999999987  9999999999999


Q ss_pred             eeCCCCCeEEEeecCCccccccCc-cc---------ccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCC
Q 040917          168 TTGDENAVVKATDFGLSAFIEEGK-AY---------REIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVP  233 (494)
Q Consensus       168 ~~~~~~~~~kL~Dfg~a~~~~~~~-~~---------~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~  233 (494)
                         ..+++.||||||.|...-... ..         -....|+.|+|||++.    .+++.|+|||+|||+||-|+....
T Consensus       180 ---s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~  256 (738)
T KOG1989|consen  180 ---SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTT  256 (738)
T ss_pred             ---cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCC
Confidence               678899999999997532222 11         1134689999999984    358999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          234 PFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       234 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      ||......    .|.++...+++.  +.++..+.+||..||+.||.+||++.+++.+
T Consensus       257 PFe~sg~l----aIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  257 PFEESGKL----AILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             CcCcCcce----eEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence            99766443    455666666654  6899999999999999999999999998874

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.1e-40  Score=315.06  Aligned_cols=254  Identities=28%  Similarity=0.463  Sum_probs=211.5

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-----
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-----  105 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-----  105 (494)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.+++++.+||||+++++++..     
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   79 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence            4578999999999999999999999999999999986432    2346788899999999679999999999864     


Q ss_pred             -CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917          106 -DQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG  182 (494)
Q Consensus       106 -~~~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg  182 (494)
                       ....+++|||+.+++|.+++...  ..+++..+..++.|++.|+.|||+++|+|+||+|+||++   +.++.++|+|||
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg  156 (272)
T cd06637          80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFG  156 (272)
T ss_pred             CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccCC
Confidence             24689999999999999998763  358899999999999999999999999999999999999   678899999999


Q ss_pred             CccccccC-cccccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC
Q 040917          183 LSAFIEEG-KAYREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ  255 (494)
Q Consensus       183 ~a~~~~~~-~~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  255 (494)
                      ++...... .......+++.|+|||++.      ..++.++|+||+||++|+|++|..||...........+.....  .
T Consensus       157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~  234 (272)
T cd06637         157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA--P  234 (272)
T ss_pred             CceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCC--C
Confidence            98754322 1223456788999999874      2478899999999999999999999977665544443333221  2


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          256 RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       256 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      ......++..+.+++.+||..+|.+|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            22224678899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.9e-40  Score=313.07  Aligned_cols=255  Identities=28%  Similarity=0.485  Sum_probs=216.1

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||.|++|+||+|.+..++..+++|++.......  ....+.+|+.+++.+. ||||+++++.+...+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEEEEE
Confidence            37999999999999999999999899999999986544222  5678899999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          113 MELCAGGELFDRIVAR---GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      +|+++|++|.+++...   ..+++..+..++.|++.|+.+||++|++||||+|+||++   ++++.++|+|||.+.....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhcc
Confidence            9999999999999764   358999999999999999999999999999999999999   5678899999999876543


Q ss_pred             Cccc-----ccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCC--CC
Q 040917          190 GKAY-----REIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP--FP  260 (494)
Q Consensus       190 ~~~~-----~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~  260 (494)
                      ....     ....++..|+|||.+..  .++.++|+|||||++++|++|+.||...+...................  +.
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK  234 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence            3221     23457889999998864  488999999999999999999999988776665555544432222211  23


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      .+++.+.+++.+||..||++||++.++++||||
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            678999999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1e-40  Score=327.37  Aligned_cols=250  Identities=23%  Similarity=0.372  Sum_probs=200.7

Q ss_pred             ccceEeeeeecccCCeEEEEEEE-----CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           32 QLHYTIGREVGRGEFGITYLCTE-----NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|++....  .......+.+|+.++.++.+||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            36899999999999999999975     2446789999986432  2234567889999999996699999999988654


Q ss_pred             -CeEEEEEeccCCCchHHHHHhc---------------------------------------------------------
Q 040917          107 -QFVHIVMELCAGGELFDRIVAR---------------------------------------------------------  128 (494)
Q Consensus       107 -~~~~iv~e~~~g~sL~~~~~~~---------------------------------------------------------  128 (494)
                       ..+++||||++||+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             4688999999999999988653                                                         


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc---ccccCCc
Q 040917          129 -----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY---REIVGSP  200 (494)
Q Consensus       129 -----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~---~~~~~~~  200 (494)
                           ..++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.........   ....+++
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                 236778889999999999999999999999999999999   56789999999999764332211   1234567


Q ss_pred             CccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH-HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccC
Q 040917          201 YYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQG-VAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD  277 (494)
Q Consensus       201 ~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  277 (494)
                      .|+|||++.+ .++.++|||||||++|+|++ |..||.+..... ....+..+... .  ....+++.+.+++.+||..|
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~d  317 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-R--APENATPEIYRIMLACWQGD  317 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-C--CCCCCCHHHHHHHHHHccCC
Confidence            8999998854 58999999999999999997 999998765433 33333333221 1  12467889999999999999


Q ss_pred             CCCCCCHHHHhc
Q 040917          278 PKRRITVAQVLE  289 (494)
Q Consensus       278 p~~Rps~~eil~  289 (494)
                      |.+|||+.++++
T Consensus       318 p~~RPs~~el~~  329 (338)
T cd05102         318 PKERPTFSALVE  329 (338)
T ss_pred             hhhCcCHHHHHH
Confidence            999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.5e-40  Score=317.35  Aligned_cols=260  Identities=30%  Similarity=0.501  Sum_probs=218.0

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      +.....+|++.+.||+|++|.||+|.+..+++.|++|.+.....   .....+.+|+.+++.+ +||||+++++.+..+.
T Consensus        15 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~~   90 (296)
T cd06654          15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMREN-KNPNIVNYLDSYLVGD   90 (296)
T ss_pred             cCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhC-CCCCEeeEEEEEEeCC
Confidence            45566899999999999999999999999999999999865432   2346688999999999 5999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      ..++||||++|++|.+++.. ..++...+..++.|++.||.|||+.||+||||||+||++   +.++.++|+|||.+...
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~~  166 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQI  166 (296)
T ss_pred             EEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchhc
Confidence            99999999999999998865 468999999999999999999999999999999999999   67789999999988754


Q ss_pred             ccCcc-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          188 EEGKA-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       188 ~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ..... .....+++.|+|||.+.+ .++.++|+|||||++|+|++|+.||...........+...... .......++..
T Consensus       167 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  245 (296)
T cd06654         167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAI  245 (296)
T ss_pred             cccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCC-CCCCccccCHH
Confidence            33221 223467889999998865 4789999999999999999999999877665443333332221 11122467889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      +.+++.+||..+|++||++.++++||||...
T Consensus       246 l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             HHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence            9999999999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.4e-40  Score=316.86  Aligned_cols=254  Identities=28%  Similarity=0.472  Sum_probs=207.4

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+.+++++. ||||+++++++..+...++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEEEEE
Confidence            58999999999999999999999999999999865432 2223467788999999995 999999999999999999999


Q ss_pred             eccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          114 ELCAGGELFDRIVAR---GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       114 e~~~g~sL~~~~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      ||++ ++|.+++...   ..++...+..++.||+.||.|||++|++||||+|+||++   +.++.++|+|||++......
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCC
Confidence            9997 5888887543   458999999999999999999999999999999999999   67889999999998654322


Q ss_pred             c-ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc---------------
Q 040917          191 K-AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI---------------  252 (494)
Q Consensus       191 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~---------------  252 (494)
                      . ......+++.|+|||++.+  .++.++|+|||||++++|++|+.||.+.........+.....               
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            1 1223456889999998864  468899999999999999999999987665433322211000               


Q ss_pred             ----------cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          253 ----------NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       253 ----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                                .........+++++.++|.+||..||.+|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                      00011124578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.1e-40  Score=310.08  Aligned_cols=253  Identities=31%  Similarity=0.526  Sum_probs=217.4

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|++.+.||+|++|.||+|.+..+++.+|+|.+....... .....+.+|+.+++.+. ||||+++++.+......++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEEEEE
Confidence            5899999999999999999999999999999997654333 34677889999999995 999999999999899999999


Q ss_pred             eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          114 ELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       114 e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      ||++|++|.+++...  ..+++..+..++.+++.++.|||++|++|+||+|.||+++  +.++.++|+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCc
Confidence            999999999999764  3489999999999999999999999999999999999995  345678999999998765444


Q ss_pred             ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      ......++..|+|||.+.+ .++.++|+||+|+++++|++|+.||...........+........   ...++..+.+++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li  233 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPI---SDRYSPDLRQLI  233 (256)
T ss_pred             cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCC---CCCcCHHHHHHH
Confidence            4444567889999999864 478899999999999999999999988877666666555433221   135789999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCcc
Q 040917          271 RRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       271 ~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      .+||..+|.+|||+.++++||||
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.7e-40  Score=312.53  Aligned_cols=253  Identities=31%  Similarity=0.525  Sum_probs=213.1

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCCh------hhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD------VEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~------~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      +|.+...||+|++|.||+|.+..+++.||+|.+........      ...+.+.+|+.+++++. ||||+++++++....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSLDAD   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC
Confidence            58889999999999999999999999999998865433221      12356888999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      ..++++||+++++|.+++...+.++...+..++.|++.||.|||++|++||||+|+||++   ++++.++|+|||.+...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKKL  156 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCccc
Confidence            999999999999999999888889999999999999999999999999999999999999   67889999999998765


Q ss_pred             ccCcc-------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 040917          188 EEGKA-------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF  259 (494)
Q Consensus       188 ~~~~~-------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  259 (494)
                      .....       .....+++.|+|||.+.+ .++.++|+||+||++|+|++|+.||...........+.....   +...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~  233 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS---PEIP  233 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC---CcCC
Confidence            42111       112357889999998864 578899999999999999999999987766544444433211   1122


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          260 PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      ..++..+.++|.+||+.+|.+||++.++++||||
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            4578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.4e-40  Score=312.92  Aligned_cols=249  Identities=32%  Similarity=0.626  Sum_probs=214.7

Q ss_pred             ecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCc
Q 040917           41 VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGE  120 (494)
Q Consensus        41 lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~s  120 (494)
                      ||.|++|.||+|.+..+++.|++|++.+...........+.+|+.+++.+ +||||+++++.+.++...++++||++|++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            69999999999999999999999999766554444567899999999999 59999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcccccccCCc
Q 040917          121 LFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP  200 (494)
Q Consensus       121 L~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  200 (494)
                      |.+++.+...++...+..++.||+.||.|||++|++|+||+|+||++   +.++.++|+|||.+.............+++
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  156 (262)
T cd05572          80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTP  156 (262)
T ss_pred             HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccccCCc
Confidence            99999887789999999999999999999999999999999999999   678899999999998765443333456788


Q ss_pred             CccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccC
Q 040917          201 YYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET--DQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD  277 (494)
Q Consensus       201 ~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  277 (494)
                      .|+|||.+.+ .++.++|+||+|+++|+|++|..||....  .......+..+......+  ...+..+.++|.+||..+
T Consensus       157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~  234 (262)
T cd05572         157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP--NYIDKAAKDLIKQLLRRN  234 (262)
T ss_pred             CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC--cccCHHHHHHHHHHccCC
Confidence            9999998764 58899999999999999999999998777  555555555322222221  234889999999999999


Q ss_pred             CCCCCC-----HHHHhcCCccCc
Q 040917          278 PKRRIT-----VAQVLEHPWLKE  295 (494)
Q Consensus       278 p~~Rps-----~~eil~~~~~~~  295 (494)
                      |++||+     +.++++||||++
T Consensus       235 p~~R~~~~~~~~~~l~~~~~~~~  257 (262)
T cd05572         235 PEERLGNLKGGIKDIKKHKWFNG  257 (262)
T ss_pred             hhhCcCCcccCHHHHhcChhhhC
Confidence            999999     999999999986

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.8e-40  Score=319.95  Aligned_cols=263  Identities=29%  Similarity=0.483  Sum_probs=216.3

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCC--ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV--KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      +|++.+.||+|++|.||+|.+..+++.|++|.+......  .......+.+|+.+++.++ ||||+++++++.+....++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCEEEE
Confidence            589999999999999999999999999999999765433  1223456778999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          112 VMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      ||||+ +++|.+++.... .++...+..++.||+.||.|||++|++||||+|+||++   +.++.++|+|||++......
T Consensus        80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeeccCC
Confidence            99999 889999997765 79999999999999999999999999999999999999   67889999999998765433


Q ss_pred             c-ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC------------
Q 040917          191 K-AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ------------  255 (494)
Q Consensus       191 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~------------  255 (494)
                      . ......+++.|+|||.+.+  .++.++|+|||||++++|++|..||.+....+....+........            
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence            2 2233456788999998854  478899999999999999999888877766554444322110000            


Q ss_pred             ------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCC
Q 040917          256 ------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASD  301 (494)
Q Consensus       256 ------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~  301 (494)
                                  ...+...+..+.++|.+||..+|++|||+.++++||||++...+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~  293 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP  293 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence                        0012345788999999999999999999999999999998776543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5e-40  Score=309.78  Aligned_cols=252  Identities=27%  Similarity=0.554  Sum_probs=213.0

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-CCeEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-DQFVHIV  112 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-~~~~~iv  112 (494)
                      .|++.+.||.|++|.||+|.+..+++.||+|.+..... .....+.+.+|+.++++++ |||++++++.+.. +...+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEEEEE
Confidence            48999999999999999999999999999999865433 2334567889999999995 9999999998764 4468999


Q ss_pred             EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          113 MELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      |||+++++|.+++...  ..+++..+..++.+++.|+.+||++|++||||+|+||++   +.++.++|+|||.+......
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEeccc
Confidence            9999999999988763  358999999999999999999999999999999999999   67889999999998765432


Q ss_pred             c-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917          191 K-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE  268 (494)
Q Consensus       191 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  268 (494)
                      . ......+++.|+|||++.+ .++.++|+||+||++++|++|+.||...........+..+....   ....+++.+.+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  232 (257)
T cd08223         156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPELGE  232 (257)
T ss_pred             CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHHH
Confidence            2 2233467889999998864 57889999999999999999999998877666655555543322   22457899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          269 LVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       269 li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      ++.+||..+|++||++.++++||||
T Consensus       233 li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         233 LIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=312.67  Aligned_cols=251  Identities=33%  Similarity=0.566  Sum_probs=212.3

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG  118 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g  118 (494)
                      +.||+|++|.||+|.+..+++.||+|++.+...........+..|..++....+|||++++++++..++..++|+||++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999999999999999987544322223344555665555544799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcccccccC
Q 040917          119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG  198 (494)
Q Consensus       119 ~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  198 (494)
                      ++|.+++...+.++...+..++.|++.||.|||+.+++||||+|+||++   +.++.++|+|||++.....   .....+
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc---cccCCC
Confidence            9999999888889999999999999999999999999999999999999   6778999999998865432   223457


Q ss_pred             CcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccC
Q 040917          199 SPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD  277 (494)
Q Consensus       199 ~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  277 (494)
                      ++.|+|||.+.+ .++.++|+||+|+++|+|++|..||...........+......++......++..+.+++.+||..+
T Consensus       156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  235 (260)
T cd05611         156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD  235 (260)
T ss_pred             CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence            889999999865 4789999999999999999999999888887777776665555544444568999999999999999


Q ss_pred             CCCCCC---HHHHhcCCccCc
Q 040917          278 PKRRIT---VAQVLEHPWLKE  295 (494)
Q Consensus       278 p~~Rps---~~eil~~~~~~~  295 (494)
                      |++||+   ++++++||||.+
T Consensus       236 p~~R~~~~~~~~~l~~~~~~~  256 (260)
T cd05611         236 PAKRLGANGYQEIKSHPFFKS  256 (260)
T ss_pred             HHHccCCCcHHHHHcChHhhc
Confidence            999995   479999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.9e-40  Score=314.56  Aligned_cols=255  Identities=31%  Similarity=0.446  Sum_probs=211.3

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ...+|++++.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++++. ||||+++++++..+...+
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEE
Confidence            3468999999999999999999999999999999986432   123456888999999995 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +||||+++++|.+++.....++...+..++.|++.|+.|||++||+||||+|.||++   +.++.++|+|||++......
T Consensus        83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeeccc
Confidence            999999999999999887889999999999999999999999999999999999999   67788999999998765322


Q ss_pred             c-ccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC-CCCCCCCH
Q 040917          191 K-AYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR-DPFPSISS  264 (494)
Q Consensus       191 ~-~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  264 (494)
                      . ......+++.|+|||.+.    ..++.++|+||+||++|+|++|..||...........+.......+. .....++.
T Consensus       160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06646         160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS  239 (267)
T ss_pred             ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence            2 123356788999999873    34778999999999999999999999655443332222222222111 11235788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCc
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLEHPW  292 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~~~~  292 (494)
                      .+.+++.+||..+|++||+++++|+|+|
T Consensus       240 ~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         240 TFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            9999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.2e-40  Score=318.91  Aligned_cols=263  Identities=31%  Similarity=0.503  Sum_probs=218.5

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ..+...+|++.+.||+|++|.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.+ +||||+++++++....
T Consensus        14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~   89 (297)
T cd06656          14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMREN-KNPNIVNYLDSYLVGD   89 (297)
T ss_pred             cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhC-CCCCEeeEEEEEecCC
Confidence            35566899999999999999999999999999999999864332   2346688899999999 5999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      ..++||||++|++|.+++.+ ..++...+..++.+++.||.|||+.|++||||||+||++   +.++.++|+|||.+...
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~  165 (297)
T cd06656          90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQI  165 (297)
T ss_pred             EEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceEc
Confidence            99999999999999998865 468999999999999999999999999999999999999   67889999999998765


Q ss_pred             ccCcc-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          188 EEGKA-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       188 ~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ..... .....+++.|+|||.+.+ .++.++|+||+||++|++++|..||...........+...... .......++..
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  244 (297)
T cd06656         166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-ELQNPERLSAV  244 (297)
T ss_pred             cCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCC-CCCCccccCHH
Confidence            43322 223467889999998865 5789999999999999999999999776654333222222111 11122457889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  299 (494)
                      +.+++.+||..+|++||++.++++||||+.....
T Consensus       245 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (297)
T cd06656         245 FRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL  278 (297)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence            9999999999999999999999999999975543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.8e-40  Score=315.69  Aligned_cols=241  Identities=18%  Similarity=0.196  Sum_probs=206.7

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe----CCeEEEEEe
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----DQFVHIVME  114 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~----~~~~~iv~e  114 (494)
                      ..||+|+++.||+|..  +|+.||+|++...........+.+.+|+.+++++. ||||+++++++.+    ....++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEEE
Confidence            5689999999999997  58999999997654433334577889999999995 9999999999876    347899999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc
Q 040917          115 LCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY  193 (494)
Q Consensus       115 ~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~  193 (494)
                      |++||+|.+++.....++......++.+++.|+.|||+. +++||||||+||++   +.++.+||+|||++.......  
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc--
Confidence            999999999998888899999999999999999999985 99999999999999   678899999999987543322  


Q ss_pred             ccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          194 REIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       194 ~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      ....+++.|+|||++.+   .++.++|||||||++|+|++|+.||.+.+..++...+......+..+  ...++.+.+++
T Consensus       178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li  255 (283)
T PHA02988        178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIV  255 (283)
T ss_pred             ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHH
Confidence            23467889999999864   68999999999999999999999999888888777776554433322  35789999999


Q ss_pred             HHhcccCCCCCCCHHHHhc
Q 040917          271 RRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       271 ~~~l~~dp~~Rps~~eil~  289 (494)
                      .+||+.||++|||+.++++
T Consensus       256 ~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        256 EACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHhcCCcccCcCHHHHHH
Confidence            9999999999999999986

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=316.18  Aligned_cols=257  Identities=33%  Similarity=0.494  Sum_probs=217.8

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++.+.||+|++|.||+|.+..++..|++|++...   .......+.+|+.+++++. ||||+++++.+..+...++
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeEEE
Confidence            46799999999999999999999989999999998643   3334567889999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          112 VMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      ||||+++++|.+++... ..+++..+..++.|++.|+.|||++||+|+||+|+||++   +.++.++|+|||.+......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhccc
Confidence            99999999999988764 468999999999999999999999999999999999999   67889999999987654322


Q ss_pred             c-ccccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917          191 K-AYREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       191 ~-~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      . ......+++.|+|||.+.      ..++.++|+|||||++|+|++|+.||...........+......... ....++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  235 (280)
T cd06611         157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD-QPSKWS  235 (280)
T ss_pred             ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcC-CcccCC
Confidence            2 223346788999999874      23677999999999999999999999887776665555544322211 124578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      ..+.++|.+||..+|.+||++.++++||||...
T Consensus       236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            999999999999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-42  Score=296.74  Aligned_cols=250  Identities=26%  Similarity=0.410  Sum_probs=206.7

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-----C
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-----D  106 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-----~  106 (494)
                      +.||+|.+.||+|||+.||++.+..++..+|+|.+....   ....+...+|++..+++. ||||++++++...     .
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhccCc
Confidence            479999999999999999999999999999999997654   346788899999999995 9999999887643     3


Q ss_pred             CeEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEEeeCCCCCeEEEee
Q 040917          107 QFVHIVMELCAGGELFDRIVAR----GHYSERAAASVFRVIMNVVNVCHSKG--VMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                      ...||+++|+..|||.+.+...    ..+++..+..|+..|++||++||...  ++||||||.||++   .+.+.++|+|
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl---s~~~~~vl~D  172 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL---SDSGLPVLMD  172 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe---cCCCceEEEe
Confidence            3599999999999999988643    25899999999999999999999998  9999999999999   5689999999


Q ss_pred             cCCcccccc----Cc------ccccccCCcCccChhhhcc----cCCCcchhHHHHHHHHHHHhCCCCCCCCChH--HHH
Q 040917          181 FGLSAFIEE----GK------AYREIVGSPYYIAPEVLSQ----SYGKEADIWSAGVILYILLCGVPPFWAETDQ--GVA  244 (494)
Q Consensus       181 fg~a~~~~~----~~------~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~--~~~  244 (494)
                      ||++....-    ..      .+....+|..|+|||.++-    ..+.++|||||||++|.|+.|..||...-..  .+.
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla  252 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA  252 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence            999876431    11      1123457999999999863    3789999999999999999999999432221  122


Q ss_pred             HHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      -++.++...++..  ..+|+.+.++|++||+.||.+||++.+++.+
T Consensus       253 LAv~n~q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  253 LAVQNAQISIPNS--SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EeeeccccccCCC--CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            2334445555544  3489999999999999999999999999873

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-43  Score=313.23  Aligned_cols=257  Identities=26%  Similarity=0.458  Sum_probs=219.6

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .+-|.+++.||+|+||.||+|.++.+|+.+|+|.+....     ....+..|+.++++.. .|+|+++|+.|-....++|
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sDLWI  105 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSDLWI  105 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcC-CchhhhhhhhhccCCceEe
Confidence            356889999999999999999999999999999986433     6788999999999994 9999999999988889999


Q ss_pred             EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          112 VMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      |||||-.|++.+.+.. ++.+++.++..+++..++||+|||...-+|||||+.|||+   +.+|+.||.|||.|-.....
T Consensus       106 VMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDT  182 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDT  182 (502)
T ss_pred             ehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhh
Confidence            9999998999998874 4679999999999999999999999999999999999999   67899999999999876544


Q ss_pred             cc-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917          191 KA-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE  268 (494)
Q Consensus       191 ~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  268 (494)
                      .. .++..|||.|+|||++.. .|+.++||||||++..+|..|++||....+...+-.+-....+ .......++.++.+
T Consensus       183 MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPP-TF~KPE~WS~~F~D  261 (502)
T KOG0574|consen  183 MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPP-TFKKPEEWSSEFND  261 (502)
T ss_pred             HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCC-CCCChHhhhhHHHH
Confidence            33 246789999999999975 6999999999999999999999999766654332222221111 11112457899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          269 LVRRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       269 li~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                      ||++||.++|++|-|+.++++|||+++.+.
T Consensus       262 Fi~~CLiK~PE~R~TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  262 FIRSCLIKKPEERKTALRLCEHTFIKNAPG  291 (502)
T ss_pred             HHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence            999999999999999999999999998653

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.2e-40  Score=315.73  Aligned_cols=259  Identities=29%  Similarity=0.449  Sum_probs=216.3

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ..+.|++++.||+|++|.||+|.+..+++.|++|.+...   .......+.+|+.+++.+. ||||+++++.+..+...+
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   85 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGKLW   85 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCeEE
Confidence            346799999999999999999999999999999998643   2334677888999999995 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          111 IVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      +||||++|++|..++.+ ...++...+..++.|++.++.|||++|++||||+|+||++   +.++.++|+|||.+.....
T Consensus        86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceeccc
Confidence            99999999999887754 4568999999999999999999999999999999999999   5688999999998865332


Q ss_pred             C-cccccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          190 G-KAYREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       190 ~-~~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      . .......+++.|+|||.+.      ..++.++|+|||||++|+|++|..||...........+........ .....+
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~  241 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-SQPSKW  241 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccC-CCCccc
Confidence            2 1223456788999999874      2367899999999999999999999987776555555444322211 112457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      +..+.++|.+||..+|++||++.++++||||....
T Consensus       242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  276 (292)
T cd06644         242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT  276 (292)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            88999999999999999999999999999998643

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=7e-40  Score=315.20  Aligned_cols=260  Identities=31%  Similarity=0.514  Sum_probs=219.1

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      ....+|++.+.||.|++|.||+|.+..+++.|++|.+....   ......+.+|+.+++.+. ||||+++++++......
T Consensus        16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   91 (296)
T cd06655          16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELK-NPNIVNFLDSFLVGDEL   91 (296)
T ss_pred             CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcC-CCceeeeeeeEecCceE
Confidence            34468999999999999999999999999999999986433   223567889999999995 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      ++|+||++|++|..++... .++...+..++.+++.|+.|||++|++||||+|+||++   +.++.++|+|||++.....
T Consensus        92 ~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          92 FVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhccc
Confidence            9999999999999988654 68999999999999999999999999999999999999   6788999999999875543


Q ss_pred             Ccc-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          190 GKA-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       190 ~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      ... .....+++.|+|||.+.+ .++.++|+|||||++|+|++|+.||...........+....... ......++..+.
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  246 (296)
T cd06655         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLSPIFR  246 (296)
T ss_pred             ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc-cCCcccCCHHHH
Confidence            322 223467889999998864 58899999999999999999999998877655544444332211 112346789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          268 ELVRRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                      ++|.+||..+|.+||++.+++.||||.....
T Consensus       247 ~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         247 DFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             HHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence            9999999999999999999999999997553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.2e-40  Score=318.87  Aligned_cols=254  Identities=26%  Similarity=0.448  Sum_probs=205.7

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|++.+.||+|++|.||+|.+..+|+.|++|.+..... .......+.+|+.+++++. ||||+++++++.+....++|+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceEEEE
Confidence            58999999999999999999999999999999975432 2223456778999999995 999999999999999999999


Q ss_pred             eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917          114 ELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-  191 (494)
Q Consensus       114 e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-  191 (494)
                      ||+++ +|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+||++   +.++.++|+|||.+....... 
T Consensus        79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          79 EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCC
Confidence            99975 88887764 4678999999999999999999999999999999999999   678899999999987543322 


Q ss_pred             ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHcCCc--------------cC
Q 040917          192 AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF-WAETDQGVAQAILKGEI--------------NF  254 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf-~~~~~~~~~~~~~~~~~--------------~~  254 (494)
                      ......+++.|+|||++.+  .++.++|+|||||++|+|++|..|+ .+.+..+....+.+...              .+
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            2233456889999998865  3688999999999999999998885 44443333332211000              00


Q ss_pred             ---C--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          255 ---Q--------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       255 ---~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                         .        ....+.+++.+.++|.+||..||.+|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence               0        01123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.8e-40  Score=313.25  Aligned_cols=251  Identities=24%  Similarity=0.385  Sum_probs=208.2

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+....  .......+.+|+.+++++ +||||+++++.+...+..++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   77 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISIC   77 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEE
Confidence            36889999999999999999999999999999986542  233456788999999999 599999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      |||+++++|..+    ..+++..+..++.|++.|+.|||++||+|+||||+||++   +.++.++|+|||++...... .
T Consensus        78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~-~  149 (279)
T cd06619          78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNS-I  149 (279)
T ss_pred             EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecccc-c
Confidence            999999998654    357889999999999999999999999999999999999   67889999999998755332 2


Q ss_pred             cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHcCCccCCCCCCCCCCH
Q 040917          193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD-------QGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      .....++..|+|||.+.+ .++.++|+|||||++|+|++|+.||.....       ......+.....  +.......++
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  227 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--PVLPVGQFSE  227 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--CCCCCCcCCH
Confidence            234578899999998864 588999999999999999999999965322       122222222211  1122345788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      .+.+++.+||..+|.+||+++++++||||...
T Consensus       228 ~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         228 KFVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            99999999999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=7e-40  Score=313.20  Aligned_cols=257  Identities=29%  Similarity=0.473  Sum_probs=215.8

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      +.|++.+.||+|+||.||+|.+..++..+++|.+....   ......+.+|+.+++.+ +||||+++++.+......++|
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEEEE
Confidence            44889999999999999999999999999999985432   33456788899999999 599999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-
Q 040917          113 MELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-  190 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-  190 (494)
                      +||+++++|..++.+ ...+++..+..++.|++.||.|||+.|++||||+|+||++   +.++.++|+|||++...... 
T Consensus        81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEccccccccccccc
Confidence            999999999887765 4568999999999999999999999999999999999999   67789999999998654322 


Q ss_pred             cccccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          191 KAYREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      .......+++.|+|||++.      ..++.++|+||+||++|+|++|+.||......+....+......... ....++.
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  236 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLA-QPSRWSS  236 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCC-CccccCH
Confidence            1223456889999999873      23678999999999999999999999887776665555444322111 1235789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      .+.++|.+||..+|.+||++.++++||||+...
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence            999999999999999999999999999999643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.8e-40  Score=315.13  Aligned_cols=251  Identities=30%  Similarity=0.517  Sum_probs=208.5

Q ss_pred             ecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCc
Q 040917           41 VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGE  120 (494)
Q Consensus        41 lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~s  120 (494)
                      ||+|+||+||+|.+..+|+.|++|.+.............+.+|+.+++++. ||||+++++.+...+..|+||||++|++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            689999999999999999999999987644333334556678999999995 9999999999999999999999999999


Q ss_pred             hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcccccccC
Q 040917          121 LFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG  198 (494)
Q Consensus       121 L~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  198 (494)
                      |.+++....  .+++..+..++.|++.|+.|||++|++||||+|.||++   ++++.++|+|||.+.............+
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCccccccC
Confidence            999987765  68999999999999999999999999999999999999   6788999999999876544333334567


Q ss_pred             CcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccC
Q 040917          199 SPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD  277 (494)
Q Consensus       199 ~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  277 (494)
                      +..|+|||.+.+ .++.++|+||+||++++|++|+.||...........+..............+++.+.++|.+||..+
T Consensus       157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence            889999999864 5888999999999999999999999766542222222222222222233457899999999999999


Q ss_pred             CCCCC-----CHHHHhcCCccCc
Q 040917          278 PKRRI-----TVAQVLEHPWLKE  295 (494)
Q Consensus       278 p~~Rp-----s~~eil~~~~~~~  295 (494)
                      |.+||     ++.++++||||..
T Consensus       237 p~~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         237 PEKRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             hhHccCCCcccHHHHHhChhhhc
Confidence            99999     8899999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.2e-39  Score=312.95  Aligned_cols=258  Identities=26%  Similarity=0.429  Sum_probs=212.4

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--  106 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--  106 (494)
                      ....++|.+.+.||+|++|.||+|.+..+++.+|+|++....    .....+.+|+.+++++.+|||++++++++...  
T Consensus        18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~   93 (291)
T cd06639          18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK   93 (291)
T ss_pred             CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence            345688999999999999999999999999999999986432    23456788999999996799999999998643  


Q ss_pred             ---CeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEe
Q 040917          107 ---QFVHIVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKAT  179 (494)
Q Consensus       107 ---~~~~iv~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~  179 (494)
                         ...++||||++|++|.+++..    ...+++..+..++.|++.||.|||++|++||||||+||++   +.++.++|+
T Consensus        94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl~  170 (291)
T cd06639          94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKLV  170 (291)
T ss_pred             cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEe
Confidence               368999999999999998753    3468999999999999999999999999999999999999   677889999


Q ss_pred             ecCCccccccCc-ccccccCCcCccChhhhcc------cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc
Q 040917          180 DFGLSAFIEEGK-AYREIVGSPYYIAPEVLSQ------SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI  252 (494)
Q Consensus       180 Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  252 (494)
                      |||.+....... ......++..|+|||.+..      .++.++|+|||||++|+|++|+.||...........+.+...
T Consensus       171 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~  250 (291)
T cd06639         171 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP  250 (291)
T ss_pred             ecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC
Confidence            999987654322 1233467889999998743      267899999999999999999999987766555444444322


Q ss_pred             cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917          253 NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK  294 (494)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  294 (494)
                      .... ....++..+.++|.+||..+|++||++.++++||||+
T Consensus       251 ~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         251 PTLL-HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCCC-cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            2111 1234678899999999999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.6e-40  Score=321.64  Aligned_cols=249  Identities=27%  Similarity=0.467  Sum_probs=192.5

Q ss_pred             eeeecccCCeEEEEEEEC--CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--CCeEEEEE
Q 040917           38 GREVGRGEFGITYLCTEN--STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--DQFVHIVM  113 (494)
Q Consensus        38 ~~~lg~G~~g~Vy~a~~~--~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--~~~~~iv~  113 (494)
                      +..||+|+||.||+|.+.  .+++.||+|.+....     ....+.+|+.+++++. ||||+++++++..  +...+++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEE
Confidence            467999999999999965  467899999986433     2345778999999995 9999999999854  45789999


Q ss_pred             eccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC-CCCCeEEEeecCC
Q 040917          114 ELCAGGELFDRIVAR---------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG-DENAVVKATDFGL  183 (494)
Q Consensus       114 e~~~g~sL~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~-~~~~~~kL~Dfg~  183 (494)
                      ||+. ++|.+++...         ..++...+..++.||+.||.|||++||+||||||+||++... +..+.+||+|||+
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            9995 4888877532         248899999999999999999999999999999999999542 3567899999999


Q ss_pred             ccccccCc----ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHH
Q 040917          184 SAFIEEGK----AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQ---------GVAQAIL  248 (494)
Q Consensus       184 a~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~---------~~~~~~~  248 (494)
                      +.......    ......+|+.|+|||++.+  .++.++|+||+||++|+|++|+.||.+....         .....+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            97654321    2234578999999999864  4789999999999999999999999644321         1111111


Q ss_pred             cCCc-----------c---------------C--------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          249 KGEI-----------N---------------F--------QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       249 ~~~~-----------~---------------~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      +...           .               .        ........+..+.++|.+||+.||.+|||++++|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            0000           0               0        000011234678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.2e-39  Score=306.99  Aligned_cols=252  Identities=32%  Similarity=0.539  Sum_probs=219.0

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|++.+.||.|++|.||.+.+..+++.+++|.+...... ......+.+|+.+++++ +||||+++++++.+....+++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEEEEE
Confidence            699999999999999999999999999999998654432 23456788999999999 5999999999999999999999


Q ss_pred             eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          114 ELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       114 e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      ||++|++|.+++...  ..++...+..++.|++.|+.|||+.|++|+||+|+||++   +.++.++|+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE---eCCCCEEECcCcceEEccccc
Confidence            999999999999765  458999999999999999999999999999999999999   567889999999987654333


Q ss_pred             -ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          192 -AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       192 -~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                       ......+++.|.|||.+.+ .++.++|+||+|+++++|++|..||......+....+..+......   ..++..+.++
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYSSELISL  232 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHH
Confidence             2234568899999998865 4788999999999999999999999888877777777665443322   4678999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCcc
Q 040917          270 VRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       270 i~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      +.+||..+|.+||++.++++|||+
T Consensus       233 i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         233 VHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5e-40  Score=314.82  Aligned_cols=255  Identities=30%  Similarity=0.541  Sum_probs=212.8

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|++.+.||+|++|.||+|.+..+|+.|++|++...... ......+.+|+.+++++. ||||+++++++..+...++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeEEEe
Confidence            589999999999999999999999999999998765432 234567889999999995 999999999999999999999


Q ss_pred             eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917          114 ELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-  191 (494)
Q Consensus       114 e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-  191 (494)
                      ||+ |++|.+++... ..++...+..++.||+.||.|||+.|++|+||+|+||++   +..+.++|+|||.+....... 
T Consensus        79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCC
Confidence            999 99999988653 568999999999999999999999999999999999999   568899999999987654332 


Q ss_pred             -ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc---------------
Q 040917          192 -AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN---------------  253 (494)
Q Consensus       192 -~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~---------------  253 (494)
                       ......++..|+|||.+.+  .++.++||||+||++++|++|..||.+.........+......               
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence             1334567889999998754  3688999999999999999998888777765544433321100               


Q ss_pred             ----CC-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917          254 ----FQ-------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK  294 (494)
Q Consensus       254 ----~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  294 (494)
                          ++       ....+..+..+.++|.+||..+|.+||+++++|+||||.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                00       011235678999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-40  Score=308.77  Aligned_cols=254  Identities=30%  Similarity=0.487  Sum_probs=215.2

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++.+.||.|++|.||+|.+..+++.+++|++.....   .....+.+|+.+++++ +||||+++++.+.....+++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhC-CCCChhceEEEEEeCCEEEE
Confidence            3689999999999999999999999999999999975432   2467788999999999 59999999999999999999


Q ss_pred             EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          112 VMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +|||+++++|.+++... ..++...+..++.|++.|+.|||++|++|+||+|+||++   +.++.++|+|||.+......
T Consensus        78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhh
Confidence            99999999999988776 689999999999999999999999999999999999999   67888999999998765432


Q ss_pred             c-ccccccCCcCccChhhhcc----cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC-CCCCCCCH
Q 040917          191 K-AYREIVGSPYYIAPEVLSQ----SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR-DPFPSISS  264 (494)
Q Consensus       191 ~-~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  264 (494)
                      . ......++..|+|||.+.+    .++.++|+||||+++++|++|+.||...........+......... .....++.
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (262)
T cd06613         155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP  234 (262)
T ss_pred             hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhH
Confidence            2 2233467889999998753    5788999999999999999999999887765555444443222211 11234678


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCc
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLEHPW  292 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~~~~  292 (494)
                      .+.+++.+||..+|.+||++.+++.|+|
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         235 VFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            8999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-41  Score=329.77  Aligned_cols=257  Identities=22%  Similarity=0.439  Sum_probs=221.4

Q ss_pred             cce-EeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCC-CChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC--e
Q 040917           33 LHY-TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ--F  108 (494)
Q Consensus        33 ~~y-~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~--~  108 (494)
                      ++| +....||+|+|-+||+|.|..+|..||+--++...+ .++...+.+..|+++|+.|+ ||||++++++|.+..  .
T Consensus        39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~  117 (632)
T KOG0584|consen   39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKT  117 (632)
T ss_pred             CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCce
Confidence            444 456779999999999999999999999876654443 33445688999999999996 999999999997654  5


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK--GVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      +.+|+|++..|+|..+.++.++++...+..|++||++||.|||++  .|+|||||..||||+  +..|.|||+|+|+|..
T Consensus       118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATL  195 (632)
T ss_pred             eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHH
Confidence            889999999999999999999999999999999999999999988  699999999999997  6789999999999997


Q ss_pred             cccCcccccccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          187 IEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETD-QGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ...+.. ....|||.|||||+....|+..+||||||+.++||+|+..||..... ..+++.+..+..+-.-...  -.++
T Consensus       196 ~r~s~a-ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV--~dPe  272 (632)
T KOG0584|consen  196 LRKSHA-KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV--KDPE  272 (632)
T ss_pred             hhcccc-ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc--CCHH
Confidence            755443 44899999999999999999999999999999999999999976554 4567777776554322221  2578


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      +++||.+||.. ...|||+.|+|.||||...
T Consensus       273 vr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  273 VREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            99999999999 8899999999999999975

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=7.5e-40  Score=310.06  Aligned_cols=254  Identities=28%  Similarity=0.479  Sum_probs=211.5

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCC---ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      +|++.+.||+|+||.||+|.+ .+++.+|+|.+......   .......+.+|+.+++++. ||||+++++++......+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDNTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCCeEE
Confidence            589999999999999999986 47889999998644321   1223456889999999995 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-  189 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-  189 (494)
                      +++||++|++|.+++.+...++...+..++.|++.|+.|||+.+++|+||+|.||++   ++++.++|+|||.+..... 
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhhc
Confidence            999999999999999887789999999999999999999999999999999999999   6788999999998875421 


Q ss_pred             ------CcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          190 ------GKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       190 ------~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                            ........++..|+|||.+.+ .++.++|+|||||++|+|++|..||...........+.......+ .....+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~  234 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP-RLPDSF  234 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC-CCCCCC
Confidence                  111223467889999999865 478999999999999999999999987665544433333211111 222467


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      +..+.++|.+||..+|.+||++.++++||||
T Consensus       235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.9e-40  Score=309.57  Aligned_cols=251  Identities=27%  Similarity=0.496  Sum_probs=212.9

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|++|.||+|.+..++..+++|.+....     ....+.+|+.+++++ +||||+++++++......+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~   76 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWIV   76 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEEE
Confidence            57999999999999999999999999999999986432     267899999999999 599999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      +|++++++|.+++.. ...++...+..++.+++.|+.|||+.+++||||+|+||++   +.++.++|+|||.+.......
T Consensus        77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcccCc
Confidence            999999999999865 4568999999999999999999999999999999999999   678899999999988654433


Q ss_pred             -ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          192 -AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       192 -~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                       ......++..|+|||++.+ .++.++|+||+|+++++|++|+.||...........+....... ......++..+.++
T Consensus       154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  232 (256)
T cd06612         154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPT-LSDPEKWSPEFNDF  232 (256)
T ss_pred             cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCC-CCchhhcCHHHHHH
Confidence             2233457889999999865 58889999999999999999999998776654443332221111 11123467899999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCcc
Q 040917          270 VRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       270 i~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      +.+||..+|++|||+.++|.||||
T Consensus       233 i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         233 VKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHhcChhhCcCHHHHhcCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8e-40  Score=313.46  Aligned_cols=260  Identities=26%  Similarity=0.448  Sum_probs=211.2

Q ss_pred             ccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE-
Q 040917           26 KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE-  104 (494)
Q Consensus        26 ~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~-  104 (494)
                      +......++|++.+.||+|++|.||+|.+..+++.+++|++....    .....+.+|+.+++.+.+||||+++++++. 
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            455667789999999999999999999999999999999975422    134567889999999966999999999873 


Q ss_pred             ----eCCeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917          105 ----DDQFVHIVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV  176 (494)
Q Consensus       105 ----~~~~~~iv~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~  176 (494)
                          .+...++||||++|++|.+++..    ...+++..+..++.|++.|+.|||+++++||||||+||++   +..+.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL---TTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE---CCCCCE
Confidence                34578999999999999987753    3458889999999999999999999999999999999999   567889


Q ss_pred             EEeecCCccccccCc-ccccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc
Q 040917          177 KATDFGLSAFIEEGK-AYREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK  249 (494)
Q Consensus       177 kL~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~  249 (494)
                      +|+|||++....... ......+++.|+|||++.      ..++.++|+||+||++|+|++|..||...........+..
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~  243 (286)
T cd06638         164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR  243 (286)
T ss_pred             EEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc
Confidence            999999987654322 223346889999999874      2378899999999999999999999987665444333322


Q ss_pred             CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          250 GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      .... .......++..+.+++.+||..||++|||+.++++|+||
T Consensus       244 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         244 NPPP-TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             cCCC-cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            2111 111112357889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-40  Score=326.11  Aligned_cols=249  Identities=22%  Similarity=0.338  Sum_probs=198.9

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++++.||+|+||.||+|.+..++..||+|+.....         ...|+.+++++. ||||+++++++......++|
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVN-HPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCC-CCCCcChhheEEeCCeeEEE
Confidence            46999999999999999999999999999999854322         346899999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      +|++. ++|.+++.. ...++...+..++.||+.||.|||++||+||||||+||++   +..+.++|+|||.+.......
T Consensus       136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCc
Confidence            99995 588888765 3568999999999999999999999999999999999999   678899999999987544333


Q ss_pred             ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCC-CCCChH----------HHHHHHHcC---CccCCC
Q 040917          192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPF-WAETDQ----------GVAQAILKG---EINFQR  256 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf-~~~~~~----------~~~~~~~~~---~~~~~~  256 (494)
                      ......||+.|+|||++.+ .++.++|||||||++|+|+++..|+ ......          .+...+...   ...++.
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  291 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR  291 (357)
T ss_pred             ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence            3345678999999999864 5899999999999999999865554 321110          011111100   000110


Q ss_pred             --------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          257 --------------------------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       257 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                                                .....++..+.++|.+||+.||.+|||+.++|+||||+.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                      001245677888999999999999999999999999985

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.1e-40  Score=321.32  Aligned_cols=300  Identities=25%  Similarity=0.417  Sum_probs=235.4

Q ss_pred             hcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEE
Q 040917           24 LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY  103 (494)
Q Consensus        24 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~  103 (494)
                      +....+.+.++|++.+.||+|++|.||+|.+..++..||+|.+.... ........+.+|+.+++.+. ||||+++++++
T Consensus         6 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~   83 (343)
T cd07880           6 VNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMK-HENVIGLLDVF   83 (343)
T ss_pred             hhhhhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCccceeeee
Confidence            34456778899999999999999999999999999999999986432 23334567889999999995 99999999998


Q ss_pred             EeCC------eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEE
Q 040917          104 EDDQ------FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVK  177 (494)
Q Consensus       104 ~~~~------~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~k  177 (494)
                      ....      .+++||+++ |++|.+++.. ..++...+..++.||+.||.|||++||+||||+|+||++   +.++.++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill---~~~~~~k  158 (343)
T cd07880          84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELK  158 (343)
T ss_pred             cCCccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEE
Confidence            6543      468999999 7788887754 578999999999999999999999999999999999999   6788999


Q ss_pred             EeecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc--
Q 040917          178 ATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN--  253 (494)
Q Consensus       178 L~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~--  253 (494)
                      |+|||.+......  .....+++.|+|||.+.+  .++.++|+|||||++|++++|+.||.+.........+.+....  
T Consensus       159 l~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (343)
T cd07880         159 ILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS  236 (343)
T ss_pred             EeecccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9999998765332  233467889999998864  4788999999999999999999999877655444333221111  


Q ss_pred             ---------------------CC----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCCcHHH
Q 040917          254 ---------------------FQ----RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAV  308 (494)
Q Consensus       254 ---------------------~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~~~~~  308 (494)
                                           ..    ....+.++..+.++|.+||..||.+|||+.+++.||||+........+.....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~~  316 (343)
T cd07880         237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPY  316 (343)
T ss_pred             HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCCc
Confidence                                 00    01124577889999999999999999999999999999976544333322233


Q ss_pred             HHHHHH-HhhhhHHHHHHHHhhhcc
Q 040917          309 IFRMKQ-FTAMNKLKKLALKVIVEN  332 (494)
Q Consensus       309 ~~~~~~-~~~~~~~~~l~~~~~~~~  332 (494)
                      ...+.. -.++.+|+.+++..+.+.
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~  341 (343)
T cd07880         317 DDSFDEVDQSLEEWKRLTFTEILSF  341 (343)
T ss_pred             cccHHhhccchHHHHHHHHHHHHhc
Confidence            333333 457788888888877653

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.8e-40  Score=321.00  Aligned_cols=255  Identities=22%  Similarity=0.316  Sum_probs=204.3

Q ss_pred             eeeeeccc--CCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917           37 IGREVGRG--EFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME  114 (494)
Q Consensus        37 i~~~lg~G--~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e  114 (494)
                      +++.||+|  ++++||++.++.+|+.||+|.+..... .......+.+|+.+++.+ +||||+++++++..++..++|||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEEEEe
Confidence            56789999  789999999999999999999965433 233456788899999999 59999999999999999999999


Q ss_pred             ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          115 LCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       115 ~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||++   +.++.++++||+.+........
T Consensus        80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhccccccc
Confidence            99999999998653  458999999999999999999999999999999999999   5678899999986543221100


Q ss_pred             --------cccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC------
Q 040917          193 --------YREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ------  255 (494)
Q Consensus       193 --------~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~------  255 (494)
                              .....++..|+|||++.+   .++.++||||+||++|+|++|+.||..............+.....      
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence                    112345677999999864   488999999999999999999999976655443333222211100      


Q ss_pred             ------------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          256 ------------------------------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       256 ------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                                                          ......+++.+.+++.+||+.||++|||++++++||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                                00012356789999999999999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.1e-39  Score=307.17  Aligned_cols=252  Identities=27%  Similarity=0.574  Sum_probs=216.8

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|++.+.||+|+||.||++.+..+|+.|++|.+...... ......+.+|+.+++++. ||||+++++++...+..++|+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEEEEE
Confidence            699999999999999999999999999999998654332 234567899999999995 999999999999999999999


Q ss_pred             eccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          114 ELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       114 e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      ||+++++|.+.+....  .+++..+..++.|++.|+.|||++|++|+||+|+||++   +.++.++|+|||.+.......
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcch
Confidence            9999999999887643  57899999999999999999999999999999999999   677889999999987654322


Q ss_pred             c-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          192 A-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       192 ~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                      . .....+++.|+|||++.+ .++.++|+|||||++++|++|+.||......+....+..+.....   ...++..+.++
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l  232 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV---SSHYSYDLRNL  232 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---cccCCHHHHHH
Confidence            2 123457888999999864 578899999999999999999999988887777777666544322   24578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCcc
Q 040917          270 VRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       270 i~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      |.+||..+|.+||++.++++||||
T Consensus       233 i~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         233 VSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-40  Score=331.56  Aligned_cols=255  Identities=23%  Similarity=0.399  Sum_probs=205.8

Q ss_pred             ccccceEeeeeecccCCeEEEEEEEC--CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTEN--STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~--~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .+..+|.+++.||.|+||.||+|...  .++..|++|.+...        ....+|+.+++++. ||||+++++++....
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~-h~~iv~~~~~~~~~~  159 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTIS-HRAIINLIHAYRWKS  159 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcC-CCCccceeeeEeeCC
Confidence            35578999999999999999999754  45788999988532        23457999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      ..|++||++. ++|.+++.....++...+..++.||+.||.|||++||+||||||+||++   +..+.++|+|||++...
T Consensus       160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCcccccc
Confidence            9999999995 5898888777789999999999999999999999999999999999999   67889999999998755


Q ss_pred             ccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHc----CCccCCC
Q 040917          188 EEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ---GVAQAILK----GEINFQR  256 (494)
Q Consensus       188 ~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~---~~~~~~~~----~~~~~~~  256 (494)
                      .....   .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....   ..+..+.+    ....++.
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            43221   224568999999999875 5899999999999999999999999765422   11111111    0000000


Q ss_pred             ------------------C--C------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          257 ------------------D--P------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       257 ------------------~--~------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                                        .  .      ...++..+.++|.+||..||++|||+.++|.||||...+
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence                              0  0      013467788999999999999999999999999998643

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=6.9e-40  Score=312.40  Aligned_cols=256  Identities=28%  Similarity=0.472  Sum_probs=216.4

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .+.|+..+.||.|++|.||+|.+..++..||+|++....  .......+.+|+.+++++ +||||+++++++.++...++
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKLWI   79 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEE
Confidence            357889999999999999999999999999999986543  223467788999999999 59999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      ||||++|++|.+++.. .+++...+..++.+++.|+.|||+++++|+||+|+||++   +.++.++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          80 IMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceeccCCc
Confidence            9999999999998865 568999999999999999999999999999999999999   677889999999987654332


Q ss_pred             c-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          192 A-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       192 ~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                      . .....++..|+|||.+.+ .++.++|+|||||++|+|++|..||...........+.....   +.....++..+.++
T Consensus       156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l  232 (277)
T cd06640         156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---PTLTGEFSKPFKEF  232 (277)
T ss_pred             cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCC---CCCchhhhHHHHHH
Confidence            2 223457888999998864 578999999999999999999999987776655544433221   22223567889999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          270 VRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       270 i~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      +.+||..+|++||++.++++||||....
T Consensus       233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         233 IDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             HHHHcccCcccCcCHHHHHhChHhhhcc
Confidence            9999999999999999999999998644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-40  Score=324.22  Aligned_cols=302  Identities=26%  Similarity=0.435  Sum_probs=238.1

Q ss_pred             hhhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeE
Q 040917           22 AILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKA  101 (494)
Q Consensus        22 ~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~  101 (494)
                      +.+.+....+.++|++.+.||+|++|.||+|.+..+++.||+|++..... .......+.+|+.+++.+ +||||+++.+
T Consensus         4 ~~~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~   81 (343)
T cd07851           4 QELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHM-DHENVIGLLD   81 (343)
T ss_pred             hhhccceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhc-cCCCHHHHHH
Confidence            34556667788999999999999999999999999999999999865322 222445677899999999 5999999998


Q ss_pred             EEEeCCe------EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCe
Q 040917          102 AYEDDQF------VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAV  175 (494)
Q Consensus       102 ~~~~~~~------~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~  175 (494)
                      ++.....      .++|+||+ |++|.+++.. ..++...+..++.|++.||.|||+.||+||||+|+||++   +.++.
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~  156 (343)
T cd07851          82 VFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCE  156 (343)
T ss_pred             HhhccccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCC
Confidence            8765543      89999998 6699988865 468999999999999999999999999999999999999   67889


Q ss_pred             EEEeecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc
Q 040917          176 VKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN  253 (494)
Q Consensus       176 ~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  253 (494)
                      ++|+|||.+......  .....++..|+|||.+.+  .++.++|+|||||++|+|++|+.||.+....+....+......
T Consensus       157 ~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~  234 (343)
T cd07851         157 LKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT  234 (343)
T ss_pred             EEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Confidence            999999998765332  234567889999998754  4788999999999999999999999877766555444332110


Q ss_pred             CC-----------------------C----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCCcH
Q 040917          254 FQ-----------------------R----DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDT  306 (494)
Q Consensus       254 ~~-----------------------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~~~  306 (494)
                      ..                       .    .....++..+.++|.+||..+|.+|||+.++++||||.....+.+.+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~  314 (343)
T cd07851         235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAP  314 (343)
T ss_pred             CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccccc
Confidence            00                       0    01134588999999999999999999999999999999876655544433


Q ss_pred             HHHHHHHH-HhhhhHHHHHHHHhhhcc
Q 040917          307 AVIFRMKQ-FTAMNKLKKLALKVIVEN  332 (494)
Q Consensus       307 ~~~~~~~~-~~~~~~~~~l~~~~~~~~  332 (494)
                      .....+.. .-....|+.+...++.+.
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (343)
T cd07851         315 PYDQSFESRDLTVDEWKELVYKEIMNF  341 (343)
T ss_pred             ccCcchhhhhcCHHHHHHHhHHHHHhc
Confidence            33233333 345677888888777653

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.4e-39  Score=308.30  Aligned_cols=255  Identities=29%  Similarity=0.509  Sum_probs=208.9

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC--hhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--CCe
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK--DVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--DQF  108 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--~~~  108 (494)
                      .+|++.+.||+|++|.||+|.+..++..|++|.+.......  ......+.+|+.++++++ ||||+++++++..  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKT   80 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCE
Confidence            36899999999999999999999999999999986543222  223456888999999995 9999999998865  357


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      .++++||+++++|.+++.....++...+..++.|++.||.|||+++++||||+|+||++   +.++.++|+|||++....
T Consensus        81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCccccc
Confidence            88999999999999999887789999999999999999999999999999999999999   677889999999987543


Q ss_pred             cC----cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917          189 EG----KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       189 ~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      ..    .......++..|+|||.+.+ .++.++|+||+||++|+|++|+.||..................  +.....++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~  235 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN--PQLPSHIS  235 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC--CCCchhcC
Confidence            21    11123457889999999865 4789999999999999999999999876655444433322111  11123467


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917          264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLK  294 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  294 (494)
                      +.+..++ +||..+|++||++.++++||||+
T Consensus       236 ~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         236 EHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            8888888 67778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-40  Score=310.86  Aligned_cols=255  Identities=28%  Similarity=0.477  Sum_probs=211.7

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC---
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ---  107 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~---  107 (494)
                      ..++|++.+.||+|++|.||+|.+..+++.+++|++....    ...+.+.+|+.+++++.+||||+++++++....   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            3579999999999999999999999999999999986433    235678899999999967999999999986543   


Q ss_pred             ---eEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917          108 ---FVHIVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       108 ---~~~iv~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                         .+++||||+++++|.+++..    ...++...+..++.|++.||.|||++|++|+||+|+||++   +.++.++|+|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d  156 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVD  156 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEECC
Confidence               58999999999999998865    3468999999999999999999999999999999999999   6678999999


Q ss_pred             cCCccccccCc-ccccccCCcCccChhhhcc------cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc
Q 040917          181 FGLSAFIEEGK-AYREIVGSPYYIAPEVLSQ------SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN  253 (494)
Q Consensus       181 fg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  253 (494)
                      ||.+....... ......+++.|+|||++..      .++.++|+|||||++|+|++|..||...........+......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  236 (275)
T cd06608         157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP  236 (275)
T ss_pred             CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence            99987543322 2234567889999998742      3678999999999999999999999876655555554443222


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          254 FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      ... ....++..+.++|.+||..||++|||+.++++|||+
T Consensus       237 ~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         237 TLK-SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCC-chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            111 112377899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5e-40  Score=314.89  Aligned_cols=258  Identities=26%  Similarity=0.397  Sum_probs=213.3

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|+||.||+|.+..++..||+|.+....  .......+.+|+.+++++ +||||+++++.+...+..++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGAVYMC   77 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCeEEEE
Confidence            36899999999999999999999999999999986432  333456788999999999 599999999999999999999


Q ss_pred             EeccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          113 MELCAGGELFDRIVAR---GHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~---~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      |||++|++|..++...   ..+++..+..++.+++.|+.|||+ .+++|+||+|+||++   +.++.++|+|||.+....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE---CCCCCEEEeecCCccccc
Confidence            9999999998888663   368999999999999999999997 599999999999999   568899999999986543


Q ss_pred             cCcccccccCCcCccChhhhcc-------cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917          189 EGKAYREIVGSPYYIAPEVLSQ-------SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (494)
                      .. ......+++.|+|||.+.+       .++.++|+||+||++|+|++|+.||...........+.......+....+.
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd06622         155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG  233 (286)
T ss_pred             CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence            22 2233457889999998753       257899999999999999999999976655444433322111112222345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ++..+.++|.+||..+|++||++.++++||||....
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence            889999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7e-40  Score=321.18  Aligned_cols=267  Identities=31%  Similarity=0.456  Sum_probs=215.3

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC---
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD---  106 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~---  106 (494)
                      ++..+|.+.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+.+++.+ +||||+++++++...   
T Consensus         2 ~~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~   79 (337)
T cd07858           2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHRE   79 (337)
T ss_pred             ccccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhc-CCCCccchHHheeccccc
Confidence            356789999999999999999999999999999999875432 222355677899999999 599999999987543   


Q ss_pred             --CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCc
Q 040917          107 --QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS  184 (494)
Q Consensus       107 --~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a  184 (494)
                        ...++++||+. ++|.+++...+.++...+..++.|++.||.|||+++++||||+|+||++   +.++.++|+|||++
T Consensus        80 ~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~  155 (337)
T cd07858          80 AFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLA  155 (337)
T ss_pred             ccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCccc
Confidence              35899999995 6899999888889999999999999999999999999999999999999   67789999999998


Q ss_pred             cccccC-cccccccCCcCccChhhhc--ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC-----------
Q 040917          185 AFIEEG-KAYREIVGSPYYIAPEVLS--QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG-----------  250 (494)
Q Consensus       185 ~~~~~~-~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~-----------  250 (494)
                      ...... .......++..|+|||.+.  ..++.++|+|||||++|+|++|+.||.+.........+...           
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            765433 2223456788999999875  35889999999999999999999999776543322222110           


Q ss_pred             ------------CccCC----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCC
Q 040917          251 ------------EINFQ----RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDK  302 (494)
Q Consensus       251 ------------~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~  302 (494)
                                  .....    ....+.+++.+.++|.+||..+|.+|||+.++++||||.....+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~  303 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE  303 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccC
Confidence                        00000    11134678999999999999999999999999999999875544443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.3e-39  Score=313.56  Aligned_cols=258  Identities=27%  Similarity=0.418  Sum_probs=207.6

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe----
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF----  108 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~----  108 (494)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+.+++.+.+||||+++++++.....    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            369999999999999999999999999999999865432 222345688899999999767999999999876555    


Q ss_pred             -EEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917          109 -VHIVMELCAGGELFDRIVAR-----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG  182 (494)
Q Consensus       109 -~~iv~e~~~g~sL~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg  182 (494)
                       .|+||||+++ +|.+++...     ..+++..+..++.||+.||.|||++|++||||+|+||+++  ..++.++|+|||
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg  156 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLG  156 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe--cCCCeEEEeecc
Confidence             8999999986 888887643     3479999999999999999999999999999999999994  237899999999


Q ss_pred             CccccccC-cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccC-----
Q 040917          183 LSAFIEEG-KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF-----  254 (494)
Q Consensus       183 ~a~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-----  254 (494)
                      .+...... .......+++.|+|||.+.+  .++.++|+||||+++|+|++|..||.+.+.......+.......     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW  236 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence            98754322 12223456788999998754  47899999999999999999999998876655443332211000     


Q ss_pred             -------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917          255 -------------------QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK  294 (494)
Q Consensus       255 -------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  294 (494)
                                         .....+.++..+.++|.+||..||.+||++.+++.||||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                               0011245788999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2e-39  Score=306.94  Aligned_cols=254  Identities=27%  Similarity=0.484  Sum_probs=213.8

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|++.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++++. ||||++++++.......++|+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEEEEE
Confidence            699999999999999999999999999999999765432 345778999999999994 999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc
Q 040917          114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY  193 (494)
Q Consensus       114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~  193 (494)
                      ||+++++|.+++.....++...+..++.+++.|+.|||++|++|+||+|.||++   ++++.++|+|||.+.........
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCc
Confidence            999999999999887778999999999999999999999999999999999999   66889999999998765432221


Q ss_pred             -----ccccCCcCccChhhhcc-c---CCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCccCCCCCCCCCC
Q 040917          194 -----REIVGSPYYIAPEVLSQ-S---YGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       194 -----~~~~~~~~y~aPE~~~~-~---~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                           ....+++.|+|||++.+ .   ++.++|+||||++++++++|..||...... .....+.. ......+....++
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  234 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLS  234 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccC
Confidence                 12456889999999864 2   688999999999999999999999765333 22222222 2222222334568


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          264 SSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      ..+.++|.+||+.+|.+||++.+++.|||+
T Consensus       235 ~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         235 PEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.5e-40  Score=310.57  Aligned_cols=258  Identities=24%  Similarity=0.440  Sum_probs=210.6

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC---hhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK---DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      +|+..+.||+|++|.||+|.+..+++.||+|++.......   ......+.+|+.++++++ ||||+++++++...+..+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDSHFN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCCeEE
Confidence            4888999999999999999999999999999986433211   123567889999999995 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +|+||++|++|.+++...+++++..+..++.|++.||.|||++|++|+||+|.||+++  ..+..++|+|||.+......
T Consensus        80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~--~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID--STGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEcccccccccccc
Confidence            9999999999999998888899999999999999999999999999999999999994  23347999999998765432


Q ss_pred             cc-----cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC-CccCCCCCCCCCC
Q 040917          191 KA-----YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG-EINFQRDPFPSIS  263 (494)
Q Consensus       191 ~~-----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  263 (494)
                      ..     .....++..|+|||.+.+ .++.++|+||+|+++++|++|..||...........+... ...........++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS  237 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence            11     123457889999999864 5789999999999999999999999654432222222111 1111122224578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917          264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLK  294 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  294 (494)
                      +.+.+++.+||..+|.+||++.++++||||+
T Consensus       238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            8999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.9e-40  Score=323.29  Aligned_cols=268  Identities=26%  Similarity=0.391  Sum_probs=214.3

Q ss_pred             hhhhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEe
Q 040917           21 DAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK  100 (494)
Q Consensus        21 ~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~  100 (494)
                      ....++....+..+|++.+.||+|++|.||+|.+..+++.||+|.+.+.. ........+.+|+.+++++. ||||++++
T Consensus         4 ~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~   81 (353)
T cd07850           4 SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVN-HKNIIGLL   81 (353)
T ss_pred             eecccchhhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcC-CCCCccee
Confidence            34455555567789999999999999999999999999999999986433 22334566778999999994 99999999


Q ss_pred             EEEEeC------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917          101 AAYEDD------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA  174 (494)
Q Consensus       101 ~~~~~~------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~  174 (494)
                      +++...      ...|+||||+.+ +|.+.+...  ++...+..++.|++.||.|||++|++||||||+||++   +.++
T Consensus        82 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~  155 (353)
T cd07850          82 NVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDC  155 (353)
T ss_pred             eeeccCCCccccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCC
Confidence            988643      357999999965 888877654  8999999999999999999999999999999999999   6788


Q ss_pred             eEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC--
Q 040917          175 VVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE--  251 (494)
Q Consensus       175 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~--  251 (494)
                      .++|+|||.+.............+++.|+|||.+.+ .++.++|+|||||++|+|++|+.||...........+....  
T Consensus       156 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  235 (353)
T cd07850         156 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGT  235 (353)
T ss_pred             CEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999999999986544433344567889999998865 58999999999999999999999998766544333322100  


Q ss_pred             --------------------ccCCCC-----------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917          252 --------------------INFQRD-----------------PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK  294 (494)
Q Consensus       252 --------------------~~~~~~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  294 (494)
                                          ......                 .....++.+.++|.+||..||.+|||+.++|+||||.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~  315 (353)
T cd07850         236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN  315 (353)
T ss_pred             CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence                                000000                 0113466789999999999999999999999999997


Q ss_pred             cc
Q 040917          295 ES  296 (494)
Q Consensus       295 ~~  296 (494)
                      ..
T Consensus       316 ~~  317 (353)
T cd07850         316 VW  317 (353)
T ss_pred             hc
Confidence            53

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.9e-40  Score=312.86  Aligned_cols=254  Identities=28%  Similarity=0.458  Sum_probs=209.7

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE------
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE------  104 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~------  104 (494)
                      ..+.|++.+.||+|+||.||+|.+..+++.+|+|++....    .....+..|+.+++++.+||||+++++++.      
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   89 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG   89 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence            4478999999999999999999999999999999985432    234568889999999977999999999984      


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917          105 DDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG  182 (494)
Q Consensus       105 ~~~~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg  182 (494)
                      .....+++|||+++++|.+++...  ..+++..+..++.||+.|+.|||++||+|+||+|+||++   +.++.++|+|||
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg  166 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFG  166 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCc
Confidence            246789999999999999988753  347888899999999999999999999999999999999   677889999999


Q ss_pred             CccccccC-cccccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC
Q 040917          183 LSAFIEEG-KAYREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ  255 (494)
Q Consensus       183 ~a~~~~~~-~~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  255 (494)
                      .+...... .......+++.|+|||.+.      ..++.++|+|||||++|+|++|..||...........+.....  .
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~  244 (282)
T cd06636         167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP--P  244 (282)
T ss_pred             chhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC--C
Confidence            98754322 1223456888999999874      2478899999999999999999999977665444333332211  1


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          256 RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       256 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      ......++..+.++|.+||..||.+||++.++|+||||
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            11223578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8e-41  Score=324.57  Aligned_cols=260  Identities=36%  Similarity=0.628  Sum_probs=236.4

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      ..-.+.|.+.+.||+|.|++|.+|++..++..||+|.+++...... ....+.+|+++++.| +||||++++.+......
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSL-NHPNIVKLFSVIETEAT  129 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhc-CCcceeeeeeeeeecce
Confidence            3445789999999999999999999999999999999998776554 445599999999999 59999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      +|+||||+.+|.+.+++.+++.+.+..+..++.|++.|++|||+++|+|||||+.||++   +.+..+||+|||++....
T Consensus       130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFD  206 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeec
Confidence            99999999999999999999999999999999999999999999999999999999999   677789999999999998


Q ss_pred             cCcccccccCCcCccChhhhccc--CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917          189 EGKAYREIVGSPYYIAPEVLSQS--YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (494)
                      .+....+.+|++.|.|||++.+.  -++.+|+||+|+++|-|+.|.+||.+.+-.+...-++.+....+.    -++.++
T Consensus       207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~dc  282 (596)
T KOG0586|consen  207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCDC  282 (596)
T ss_pred             ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeechh
Confidence            88888999999999999999874  578999999999999999999999998887776666666665553    467899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          267 IELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      .++|.++|.++|.+|++.+++..|.|.....
T Consensus       283 e~lLrk~lvl~Pskr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  283 EDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             HHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence            9999999999999999999999999998543

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.4e-40  Score=315.24  Aligned_cols=256  Identities=29%  Similarity=0.488  Sum_probs=211.5

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|++|.||+|.+..+++.||+|++....... .....+.+|+.+++.+ +||||+++++++..+...++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   78 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQL-RHENLVNLIEVFRRKKRLYLV   78 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhc-CCcchhhHHHhcccCCeEEEE
Confidence            36999999999999999999999999999999986544322 3456788899999999 499999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-  191 (494)
                      +||+++++|..+......++...+..++.||+.|+.|||+.|++|+||+|+||++   ++++.++|+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCcc
Confidence            9999998888877666679999999999999999999999999999999999999   678899999999987653322 


Q ss_pred             ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc----------------
Q 040917          192 AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN----------------  253 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~----------------  253 (494)
                      ......++..|+|||++.+  .++.++|+||||+++++|++|+.||......+....+......                
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence            2234567889999998864  4678999999999999999999999766654332222210000                


Q ss_pred             ---CC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          254 ---FQ--------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       254 ---~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                         .+        ....+.++..+.+++.+||..+|++||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence               00        01134678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=9.2e-40  Score=309.63  Aligned_cols=248  Identities=25%  Similarity=0.423  Sum_probs=202.3

Q ss_pred             cceEeeeee--cccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           33 LHYTIGREV--GRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        33 ~~y~i~~~l--g~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      .+|.+.+.+  |+|+||.||++.++.++..+|+|.+.......        .|+.....+.+||||+++++.+..++..+
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            467777776  99999999999999999999999986543211        13333333446999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC-eEEEeecCCcccccc
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA-VVKATDFGLSAFIEE  189 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~-~~kL~Dfg~a~~~~~  189 (494)
                      +||||++|++|.+++.....+++..+..++.|++.|+.|||+.|++||||+|+||+++   ..+ .++|+|||.+.....
T Consensus        86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCKIIGT  162 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccceecCC
Confidence            9999999999999998887899999999999999999999999999999999999994   455 899999999875533


Q ss_pred             CcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHcCCccCCCCCCCCCCHHHH
Q 040917          190 GKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVA-QAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       190 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      .   ....++..|+|||++.+ .++.++|+||+|+++|+|++|..||.....+... ..+.... .......+.+++.+.
T Consensus       163 ~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  238 (267)
T PHA03390        163 P---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNAN  238 (267)
T ss_pred             C---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHH
Confidence            2   23457889999999864 5889999999999999999999999865544321 2222211 222233346899999


Q ss_pred             HHHHHhcccCCCCCCC-HHHHhcCCccCc
Q 040917          268 ELVRRMLTQDPKRRIT-VAQVLEHPWLKE  295 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps-~~eil~~~~~~~  295 (494)
                      ++|.+||+.+|.+||+ ++++|+||||++
T Consensus       239 ~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        239 DFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            9999999999999996 699999999974

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=9.7e-40  Score=312.18  Aligned_cols=252  Identities=30%  Similarity=0.519  Sum_probs=206.5

Q ss_pred             eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--CeEEEE
Q 040917           35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--QFVHIV  112 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--~~~~iv  112 (494)
                      |++.+.||+|++|.||+|.+..+++.||+|+++.....  .......+|+.++.++.+||||+++++++.+.  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS--LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC--chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            78899999999999999999999999999998654321  12334457899999997799999999999887  889999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      +||+++ +|.+.+... ..+++..+..++.|++.||.|||++|++||||+|+||++   +. +.++|+|||.+.......
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l---~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI---KD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---cC-CCeEEEecccccccccCC
Confidence            999975 888877653 468999999999999999999999999999999999999   45 999999999998665444


Q ss_pred             ccccccCCcCccChhhhc--ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc-----------------
Q 040917          192 AYREIVGSPYYIAPEVLS--QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI-----------------  252 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~-----------------  252 (494)
                      ......+++.|+|||.+.  +.++.++|+||+||++|+|++|..||.+.+..+....+.....                 
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence            444456788999999764  3478899999999999999999999988776554443321100                 


Q ss_pred             -cCCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          253 -NFQR-------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       253 -~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                       .++.       ...+.++..+.++|.+||..+|++||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence             0000       0123568999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=323.66  Aligned_cols=235  Identities=26%  Similarity=0.428  Sum_probs=208.1

Q ss_pred             eeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917           38 GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA  117 (494)
Q Consensus        38 ~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~  117 (494)
                      .+.||+|+.|.||+++..  ++.||||.++.          .=+.+++-|++|+ ||||+.+.++|.....+|||||||.
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e----------lkETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE----------LKETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhh----------hhhhhHHHHHhcc-CcceeeEeeeecCCceeEEeeeccc
Confidence            466999999999999855  88999998742          2234788899996 9999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccccccc
Q 040917          118 GGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV  197 (494)
Q Consensus       118 g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~  197 (494)
                      .|-|.+.++....++......|..+|+.|+.|||.+.|||||||.-||||   ..+..|||+|||.+............+
T Consensus       196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI---s~~d~VKIsDFGTS~e~~~~STkMSFa  272 (904)
T KOG4721|consen  196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI---SYDDVVKISDFGTSKELSDKSTKMSFA  272 (904)
T ss_pred             cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe---eccceEEeccccchHhhhhhhhhhhhh
Confidence            99999999999999999999999999999999999999999999999999   577899999999998776655566789


Q ss_pred             CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 040917          198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ  276 (494)
Q Consensus       198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  276 (494)
                      ||..|||||++.+ +.+.|+|||||||+||||+||..||.......++-.+-.+....+-+  ..+|+.++-||+.||+-
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvP--stcP~GfklL~Kqcw~s  350 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVP--STCPDGFKLLLKQCWNS  350 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCc--ccCchHHHHHHHHHHhc
Confidence            9999999999975 68999999999999999999999998777766665555555444433  46899999999999999


Q ss_pred             CCCCCCCHHHHhcC
Q 040917          277 DPKRRITVAQVLEH  290 (494)
Q Consensus       277 dp~~Rps~~eil~~  290 (494)
                      .|..|||+.+||.|
T Consensus       351 KpRNRPSFrqil~H  364 (904)
T KOG4721|consen  351 KPRNRPSFRQILLH  364 (904)
T ss_pred             CCCCCccHHHHHHH
Confidence            99999999999998

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.9e-39  Score=308.47  Aligned_cols=256  Identities=26%  Similarity=0.486  Sum_probs=211.8

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC-------hhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK-------DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~-------~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      +|.+.+.||+|++|.||+|.+..+|+.||+|.+.......       ....+.+.+|+.+++.+. |||++++++++...
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFETTE   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEeccC
Confidence            6899999999999999999999999999999885422111       112346788999999995 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          107 QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      ...++||||++|++|.+++...+.++...+..++.||+.||.+||+++++||||+|+||++   +.++.++|+|||.+..
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~~  157 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISKK  157 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeecccccc
Confidence            9999999999999999999888889999999999999999999999999999999999999   6788999999999875


Q ss_pred             cccCc---ccccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC--ccCCCCC
Q 040917          187 IEEGK---AYREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE--INFQRDP  258 (494)
Q Consensus       187 ~~~~~---~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~--~~~~~~~  258 (494)
                      .....   ......++..|+|||.+..   .++.++|+||||++++++++|..||...........+....  ..++...
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV  237 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence            43211   1223457889999998763   37889999999999999999999997655443333322221  2222333


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          259 FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       259 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      .+.++..+.+++.+||..+|++||++.++|+|||+
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            45678999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-39  Score=328.22  Aligned_cols=250  Identities=24%  Similarity=0.382  Sum_probs=201.9

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      ...|.+.+.||+|+||.||+|.+..+++.||+|...         ...+.+|+.++++|. ||||+++++++..+...++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~~~l  237 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLS-HPAVLALLDVRVVGGLTCL  237 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEE
Confidence            457999999999999999999999999999999642         223568999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          112 VMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      ||+++. ++|.+++... ..++...+..++.||+.||.|||++||+||||||+|||+   +..+.++|+|||++......
T Consensus       238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceecccc
Confidence            999995 5888888654 468999999999999999999999999999999999999   67788999999998764332


Q ss_pred             cc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHcCCcc---C-
Q 040917          191 KA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET--------DQGVAQAILKGEIN---F-  254 (494)
Q Consensus       191 ~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~--------~~~~~~~~~~~~~~---~-  254 (494)
                      ..   .....||+.|+|||++.+ .++.++|||||||++|+|++|..|+....        ...+...+......   + 
T Consensus       314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence            11   123568999999999865 58999999999999999999876553321        22233333221110   0 


Q ss_pred             -----------------------CCCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          255 -----------------------QRDPF---PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       255 -----------------------~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                                             ....|   ..++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                   01111   134568999999999999999999999999999974

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.1e-39  Score=311.27  Aligned_cols=251  Identities=29%  Similarity=0.447  Sum_probs=201.9

Q ss_pred             eecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc--CCCCccEEeEEEEeCCeEEEEEeccC
Q 040917           40 EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS--GQPNIVQFKAAYEDDQFVHIVMELCA  117 (494)
Q Consensus        40 ~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~i~~~~~~~~~~~~~~iv~e~~~  117 (494)
                      .||+|+||.||+|.+..+++.||+|.+.+.............+|..+++.+.  +||||+.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999999999999999997654433323334445554444432  58999999999998889999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccccccc
Q 040917          118 GGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV  197 (494)
Q Consensus       118 g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~  197 (494)
                      |++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||++   +.++.++|+|||++....... .....
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~  156 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHASV  156 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccC-ccCcC
Confidence            99999999888889999999999999999999999999999999999999   678899999999986543322 23346


Q ss_pred             CCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 040917          198 GSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT  275 (494)
Q Consensus       198 ~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  275 (494)
                      +++.|+|||.+..  .++.++|+||+||++|+|++|..||......... .+............+.++..+.++|.+||.
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  235 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTVNVELPDSFSPELKSLLEGLLQ  235 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence            8999999998853  4789999999999999999999999754322111 111111111222234678999999999999


Q ss_pred             cCCCCCC-----CHHHHhcCCccCc
Q 040917          276 QDPKRRI-----TVAQVLEHPWLKE  295 (494)
Q Consensus       276 ~dp~~Rp-----s~~eil~~~~~~~  295 (494)
                      .||.+||     ++.++++||||+.
T Consensus       236 ~~p~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         236 RDVSKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             CCHHHhcCCCCCCHHHHHhCccccC
Confidence            9999999     6999999999987

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.4e-39  Score=315.28  Aligned_cols=262  Identities=26%  Similarity=0.423  Sum_probs=213.0

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--CeE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--QFV  109 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--~~~  109 (494)
                      ..+|++.+.||+|++|.||+|.+..+|+.||+|++....... .....+.+|+.++++++ ||||+++++++...  +..
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCCeE
Confidence            468999999999999999999999999999999986543222 22334667999999995 99999999998754  468


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      ++||||+.+ +|.+++... ..++...+..++.||+.||.|||++|++||||+|+||++   +..+.++|+|||.+....
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeecC
Confidence            999999965 888887653 568999999999999999999999999999999999999   678899999999987654


Q ss_pred             cC-cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc------------
Q 040917          189 EG-KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN------------  253 (494)
Q Consensus       189 ~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~------------  253 (494)
                      .. .......+++.|+|||.+.+  .++.++|+||+||++|+|++|..||...+..+....+......            
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            32 12223345788999998854  4789999999999999999999999988877766655432110            


Q ss_pred             -------CCCCC-------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917          254 -------FQRDP-------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       254 -------~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  299 (494)
                             .....       ....++.+.++|.+||..||++|||+.+++.||||+..+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence                   00000       12357889999999999999999999999999999975544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.9e-39  Score=314.02  Aligned_cols=259  Identities=25%  Similarity=0.437  Sum_probs=216.1

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      ..+..+|++.+.||+|++|.||+|.+..+++.|++|++.............+.+|+.+++.+. ||||+++.+++.....
T Consensus        11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~   89 (307)
T cd06607          11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREHT   89 (307)
T ss_pred             CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCCe
Confidence            345578999999999999999999999999999999986544334444567889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .++|+||+.| +|.+.+.. ...+++..+..++.|++.||.|||++|++||||+|+||++   +.++.++|+|||++...
T Consensus        90 ~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~  165 (307)
T cd06607          90 AWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLV  165 (307)
T ss_pred             EEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceec
Confidence            9999999975 77776654 4568999999999999999999999999999999999999   67889999999998754


Q ss_pred             ccCcccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917          188 EEGKAYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      ...   ....+++.|+|||++.    +.++.++|+||||+++|+|++|..||...........+......  ......++
T Consensus       166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~  240 (307)
T cd06607         166 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLSSNDWS  240 (307)
T ss_pred             CCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC--CCCchhhC
Confidence            332   2346788999999873    45888999999999999999999999887766554444333221  11123478


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ..+.++|.+||..+|++||++.+++.||||....
T Consensus       241 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         241 DYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            8999999999999999999999999999999743

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.2e-39  Score=305.40  Aligned_cols=254  Identities=30%  Similarity=0.488  Sum_probs=214.8

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCC--CChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL--VKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      +|+..+.||+|++|.||+|.+..++..|++|.+.....  ........+.+|+.+++.+ +||||+++++++......++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCeEEE
Confidence            58888999999999999999998999999999865332  2233456788999999999 59999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      ++||++|++|.+++.+...++...+..++.|++.|+.|||+.|++|+||+|+||++   +.++.++|+|||.+.......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceeccccc
Confidence            99999999999999887779999999999999999999999999999999999999   678899999999987654443


Q ss_pred             ccccccCCcCccChhhhcc-c-CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          192 AYREIVGSPYYIAPEVLSQ-S-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~-~-~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                      ......+++.|+|||.+.. . ++.++|+|||||++|+|++|+.||...........+.....  .....+.+++.+.++
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l  234 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE--LPPIPDHLSDEAKDF  234 (258)
T ss_pred             cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc--CCCcCCCcCHHHHHH
Confidence            3345567889999998754 3 78999999999999999999999977665444433332111  112224578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCcc
Q 040917          270 VRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       270 i~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      +.+||..+|.+||++.+++.|||+
T Consensus       235 i~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         235 ILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4e-39  Score=305.10  Aligned_cols=255  Identities=29%  Similarity=0.514  Sum_probs=209.6

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCC--CChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--CCe
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL--VKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--DQF  108 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--~~~  108 (494)
                      .+|++.+.||+|+||.||.|.+..++..|++|.+.....  ........+.+|+.+++++. ||||+++++++.+  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCCce
Confidence            579999999999999999999999999999998864321  12233567888999999995 9999999998865  356


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      ++++|||++|++|.+++.+...++...+..++.+++.||.|||+++++|+||+|+||++   +.++.++|+|||.+....
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCccccccc
Confidence            88999999999999999887788999999999999999999999999999999999999   678899999999887543


Q ss_pred             cC----cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917          189 EG----KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       189 ~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      ..    .......++..|+|||++.+ .++.++|+|||||++|+|++|+.||.................  .....+.++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~  235 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--NPVLPPHVS  235 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCC--CCCCchhhC
Confidence            21    11223457889999998864 578999999999999999999999987655544443332211  111223567


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917          264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLK  294 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  294 (494)
                      ..+.++|.+|+. +|.+||+++++++|||+.
T Consensus       236 ~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         236 DHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            889999999994 999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.4e-39  Score=306.81  Aligned_cols=248  Identities=18%  Similarity=0.281  Sum_probs=208.0

Q ss_pred             cceEeeeeecccCCeEEEEEEEC---CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           33 LHYTIGREVGRGEFGITYLCTEN---STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      .+|++.+.||+|+||.||+|.+.   ..+..||+|.++...  .......+.+|+.+++.+ +||||+++++++..+...
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCCc
Confidence            57999999999999999999865   456789999987532  233456788999999999 599999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      ++||||+++++|.+++... ..++...+..++.||+.||.|||++|++||||||+||++   +.++.++++|||.+....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCccccccc
Confidence            9999999999999998764 468999999999999999999999999999999999999   678899999999876533


Q ss_pred             cCcccc--cccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          189 EGKAYR--EIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       189 ~~~~~~--~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      ......  ...++..|+|||.+. +.++.++|||||||++|++++ |..||......+....+..+...   +....+|.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  235 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL---PAPRNCPN  235 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC---CCCCCCCH
Confidence            222111  123456899999875 468999999999999999775 99999998888877777654322   12356889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+.+++.+||..+|.+||++++|++
T Consensus       236 ~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         236 LLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHHHcCCCchhCCCHHHHHH
Confidence            9999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.2e-39  Score=305.47  Aligned_cols=252  Identities=33%  Similarity=0.585  Sum_probs=215.8

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--CCeEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--DQFVHI  111 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--~~~~~i  111 (494)
                      +|++.+.||+|++|.||+|.+..++..|++|++..... .....+.+.+|+.+++.+. ||||+++++.+..  +...++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEE
Confidence            58999999999999999999999999999999875443 3345677889999999995 9999999997753  457899


Q ss_pred             EEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917          112 VMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCH-----SKGVMHRDLKPENFLFTTGDENAVVKATDFG  182 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH-----~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg  182 (494)
                      +|||+++++|.+++..    ..+++...+..++.+|+.||.|||     +.+++|+||+|+||++   +.++.++|+|||
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g  155 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFG  155 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEeccc
Confidence            9999999999998865    356899999999999999999999     8999999999999999   578899999999


Q ss_pred             CccccccCcc-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 040917          183 LSAFIEEGKA-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP  260 (494)
Q Consensus       183 ~a~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (494)
                      .+........ .....+++.|+|||++.+ .++.++|+||||+++++|++|..||.........+.+.......   ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~  232 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR---IPY  232 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC---Ccc
Confidence            9887654433 334568899999999864 57889999999999999999999998888766666666554322   224


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      .++..+.+++.+||..+|.+||++.++++|||+
T Consensus       233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            678999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=319.06  Aligned_cols=266  Identities=32%  Similarity=0.495  Sum_probs=210.8

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC---
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD---  106 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~---  106 (494)
                      ++.++|++.+.||+|++|.||+|.+..+|+.||+|++....  .......+.+|+.+++.++ ||||+++++++...   
T Consensus         2 ~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~   78 (336)
T cd07849           2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFE   78 (336)
T ss_pred             ccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCcCchhheeeccccc
Confidence            35679999999999999999999999999999999986322  2234566788999999995 99999999887543   


Q ss_pred             --CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCc
Q 040917          107 --QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS  184 (494)
Q Consensus       107 --~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a  184 (494)
                        ...++++||+.+ +|.+.+.. ..++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++
T Consensus        79 ~~~~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~  153 (336)
T cd07849          79 SFNDVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLA  153 (336)
T ss_pred             ccceEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECcccce
Confidence              358999999965 88877744 568999999999999999999999999999999999999   67889999999998


Q ss_pred             cccccCcc----cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc---------
Q 040917          185 AFIEEGKA----YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK---------  249 (494)
Q Consensus       185 ~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~---------  249 (494)
                      ........    .....+++.|+|||.+.+  .++.++|+||+||++|+|++|+.||.+.........+..         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED  233 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            76432211    123467889999998643  578999999999999999999999977654332222211         


Q ss_pred             --------------CCccCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCC
Q 040917          250 --------------GEINFQR----DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKP  303 (494)
Q Consensus       250 --------------~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~  303 (494)
                                    .......    ...+..++.+.+++.+||..+|++|||+.++++||||.....+...+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~  305 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEP  305 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcc
Confidence                          0000000    01235678899999999999999999999999999998766554433

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=9e-40  Score=313.79  Aligned_cols=265  Identities=30%  Similarity=0.516  Sum_probs=220.2

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ..+..+.|.....||+|+||.||++.+..++..||+|.+....   ......+.+|+.+++.+ +||||+++++.+...+
T Consensus        17 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~   92 (292)
T cd06658          17 PGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDY-HHENVVDMYNSYLVGD   92 (292)
T ss_pred             cCchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhC-CCCcHHHHHHheecCC
Confidence            3445567777888999999999999999999999999985432   23456788999999999 5999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      ..++||||+++++|.+++.. +.++...+..++.||+.|+.|||++||+||||+|+||++   +.++.++|+|||++...
T Consensus        93 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~  168 (292)
T cd06658          93 ELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQV  168 (292)
T ss_pred             eEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhc
Confidence            99999999999999988754 468999999999999999999999999999999999999   56789999999998654


Q ss_pred             ccCc-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          188 EEGK-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       188 ~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      .... ......+++.|+|||.+.+ .++.++|+||+|+++|+|++|..||...........+...... .......++..
T Consensus       169 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  247 (292)
T cd06658         169 SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP-RVKDSHKVSSV  247 (292)
T ss_pred             ccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-ccccccccCHH
Confidence            3222 1233567889999999864 5889999999999999999999999887766655544432221 11122357889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCC
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASD  301 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~  301 (494)
                      +.+++.+||..||.+|||+.++++||||.....++.
T Consensus       248 ~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~  283 (292)
T cd06658         248 LRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC  283 (292)
T ss_pred             HHHHHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence            999999999999999999999999999998766654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=9.3e-40  Score=309.38  Aligned_cols=255  Identities=28%  Similarity=0.444  Sum_probs=213.1

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|++|.||+|.+..+++.|++|.+.....  ......+.+|+.+++++. ||||+++++.+......+++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   77 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDISIC   77 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEEEE
Confidence            368889999999999999999999999999999875432  235677889999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +||+++++|.+++... ..++...+..++.|++.|+.|||+ .|++|+||+|+||++   +.++.++|+|||.+......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---CCCCCEEEeecccchhhHHH
Confidence            9999999999999876 678999999999999999999999 999999999999999   56889999999998765332


Q ss_pred             cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET-----DQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      .. ....++..|+|||.+.+ .++.++|+||+|+++++|++|..||....     .....+.+......  ..+...++.
T Consensus       155 ~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  231 (265)
T cd06605         155 LA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP--RLPSGKFSP  231 (265)
T ss_pred             Hh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC--CCChhhcCH
Confidence            22 12667889999998865 58899999999999999999999996542     22233333332211  111112788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      .+.++|.+||..+|++|||+.+++.||||+..
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         232 DFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            99999999999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3e-39  Score=309.01  Aligned_cols=257  Identities=25%  Similarity=0.348  Sum_probs=206.1

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++.+.||+|+||.||+|.+..+|+.||+|.+......  .....+..|+..+.+..+||||+++++++..+...+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            3699999999999999999999999999999998754322  23445666776644444799999999999998999999


Q ss_pred             EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          113 MELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      |||++ ++|.+++..    ...+++..+..++.||+.|+.|||++ +++||||||+||++   +.++.++|+|||.+...
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYL  154 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeeccccccc
Confidence            99996 588777654    24689999999999999999999997 99999999999999   67889999999998765


Q ss_pred             ccCcccccccCCcCccChhhhcc-----cCCCcchhHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHcCCccCCCCCCCC
Q 040917          188 EEGKAYREIVGSPYYIAPEVLSQ-----SYGKEADIWSAGVILYILLCGVPPFWAET-DQGVAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~  261 (494)
                      ..........++..|+|||.+.+     .++.++|+||+||++|+|++|+.||.... ..+..........  +..+...
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~  232 (283)
T cd06617         155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS--PQLPAEK  232 (283)
T ss_pred             ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC--CCCCccc
Confidence            43333233567889999998753     36889999999999999999999996432 2223333332211  1112235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      +|..+.++|.+||..+|.+||++.++++||||....
T Consensus       233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            789999999999999999999999999999999744

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.5e-39  Score=322.83  Aligned_cols=250  Identities=22%  Similarity=0.363  Sum_probs=202.0

Q ss_pred             cceEeeeeecccCCeEEEEEEE-----CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           33 LHYTIGREVGRGEFGITYLCTE-----NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .+|++.+.||+|+||.||+|.+     ..++..||+|+++....  ....+.+.+|+.++..+.+||||+++++++....
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            5799999999999999999974     35677899999864332  2245678899999999966999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcC----------------------------------------------------------
Q 040917          108 FVHIVMELCAGGELFDRIVARG----------------------------------------------------------  129 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~----------------------------------------------------------  129 (494)
                      ..++||||++||+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999886432                                                          


Q ss_pred             -----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          130 -----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       130 -----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                                       .++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++........
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE---ECCCcEEEecCccceeccCccc
Confidence                             36778889999999999999999999999999999999   5678899999999876543221


Q ss_pred             c---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          193 Y---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       193 ~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      .   ....++..|+|||++.+ .++.++|+|||||++|+|++ |..||.....................  ....+..+.
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~  347 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLS--PECAPSEMY  347 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCC--CCCCCHHHH
Confidence            1   11234567999999864 68999999999999999998 88999776544333333332222211  134678999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 040917          268 ELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +++.+||..||++|||+.++++
T Consensus       348 ~li~~cl~~dP~~RPs~~eil~  369 (375)
T cd05104         348 DIMKSCWDADPLKRPTFKQIVQ  369 (375)
T ss_pred             HHHHHHccCChhHCcCHHHHHH
Confidence            9999999999999999999986

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.3e-39  Score=309.69  Aligned_cols=260  Identities=26%  Similarity=0.443  Sum_probs=210.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||.|++|.||+|.+..+|+.||+|.+..... .......+.+|+.+++++ +||||+++++++......++|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhc-cCCCEeeEEEEEecCCeEEEE
Confidence            479999999999999999999999999999999865432 222446688899999999 499999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          113 MELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~--l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      |||++ ++|.+++.....  ++...+..++.||+.||.|||+++++|+||+|+||+++  ..++.+||+|||.+......
T Consensus        80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--CCCCEEEEcccccccccCCC
Confidence            99996 488887765443  57888899999999999999999999999999999995  24567999999998754322


Q ss_pred             -cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccC-------------
Q 040917          191 -KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF-------------  254 (494)
Q Consensus       191 -~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-------------  254 (494)
                       .......+++.|+|||.+.+  .++.++|+||+||++|+|++|..||......+....+.......             
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence             12233456889999998864  47889999999999999999999998777655544332210000             


Q ss_pred             --------CC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          255 --------QR----DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       255 --------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                              ..    ...+.+++.+.+++.+||..+|++||++.++++||||....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence                    00    01245788899999999999999999999999999998754

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-39  Score=311.49  Aligned_cols=256  Identities=30%  Similarity=0.507  Sum_probs=211.2

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|++|.||+|.+..+++.|++|++..... .......+.+|+.+++++. ||||+++++++..++..+++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv   78 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLYLV   78 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEEEEE
Confidence            479999999999999999999999999999999865432 2334577899999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-  191 (494)
                      |||++++.+..+......++...+..++.+|+.|+.|||+++++|+||+|+||++   +.++.++|+|||.+....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCcc
Confidence            9999987776666666679999999999999999999999999999999999999   678999999999987655433 


Q ss_pred             -ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC--------------c--
Q 040917          192 -AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE--------------I--  252 (494)
Q Consensus       192 -~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~--------------~--  252 (494)
                       ......++..|+|||++.+  .++.++|+||+|+++|+|++|+.||.+....+....+....              .  
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence             2334567889999998854  47889999999999999999999998766554333221100              0  


Q ss_pred             ---cCCC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          253 ---NFQR---------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       253 ---~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                         ..+.         .....++..+.++|.+||..+|++||+++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence               0000         0011248889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-41  Score=301.09  Aligned_cols=255  Identities=30%  Similarity=0.592  Sum_probs=236.6

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|...+.||+|.||.|-+|+.+.+|+.+|+|++++...-..........|-++|+.-+ ||.+..+--.|+...++|+|
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCceEEEE
Confidence            67999999999999999999999999999999999887766667788889999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc-cccCc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF-IEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~-~~~~~  191 (494)
                      |||..||.|.-++.+...+++..+..+...|+.||.|||+++||+||||.+|.++   +.+|++||.|||++.. +..+.
T Consensus       247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~~g~  323 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIKYGD  323 (516)
T ss_pred             EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhcccccc
Confidence            9999999999999888899999999999999999999999999999999999999   7999999999999875 34556


Q ss_pred             ccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          192 AYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      .....||||.|.|||++. ..|+.++|+|-+||++|+|+.|++||.....+.....|.-....+++    .++++++.++
T Consensus       324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~eAktLL  399 (516)
T KOG0690|consen  324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSPEAKTLL  399 (516)
T ss_pred             eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCHHHHHHH
Confidence            667899999999999996 57999999999999999999999999999999999999999888885    5789999999


Q ss_pred             HHhcccCCCCCC-----CHHHHhcCCccCc
Q 040917          271 RRMLTQDPKRRI-----TVAQVLEHPWLKE  295 (494)
Q Consensus       271 ~~~l~~dp~~Rp-----s~~eil~~~~~~~  295 (494)
                      ..+|.+||.+|.     .+.||..|+||..
T Consensus       400 sGLL~kdP~kRLGgGpdDakEi~~h~FF~~  429 (516)
T KOG0690|consen  400 SGLLKKDPKKRLGGGPDDAKEIMRHRFFAS  429 (516)
T ss_pred             HHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence            999999999996     5889999999985

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.9e-39  Score=305.67  Aligned_cols=254  Identities=29%  Similarity=0.461  Sum_probs=217.8

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|++.+.||+|++|.||+|.+..+++.|++|.+......  .....+.+|+..+.+++ ||||+++++++......++|+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEEEEE
Confidence            689999999999999999999999999999998754422  35678999999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      ||+++++|.+++.....+++..+..++.|++.|+.|||+ .+++||||+|+||++   +.++.++|+|||.+........
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCCC
Confidence            999999999999887889999999999999999999999 999999999999999   6788999999999876544333


Q ss_pred             cc-cccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHcCCccCCCCCCCC-CCHHH
Q 040917          193 YR-EIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET---DQGVAQAILKGEINFQRDPFPS-ISSSA  266 (494)
Q Consensus       193 ~~-~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~-~~~~l  266 (494)
                      .. ...++..|+|||.+.. .++.++|+||||+++|+|++|..||....   ..+....+........   ... ++..+
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l  232 (264)
T cd06623         156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSL---PAEEFSPEF  232 (264)
T ss_pred             cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCC---CcccCCHHH
Confidence            22 4567889999998864 57889999999999999999999997773   3444444443322211   123 78999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          267 IELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      .++|.+||..+|++||++.++++|||++..
T Consensus       233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         233 RDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.4e-39  Score=312.86  Aligned_cols=255  Identities=28%  Similarity=0.453  Sum_probs=209.5

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--CeEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--QFVH  110 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--~~~~  110 (494)
                      ++|++.+.||+|++|.||+|.+..+++.+++|.+...... ......+.+|+.+++++. ||||+++++++...  ...|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcEE
Confidence            5799999999999999999999999999999999754432 223445678999999995 99999999998777  8899


Q ss_pred             EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          111 IVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      +||||+.+ +|.+++.... .++...+..++.||+.||.|||++|++|+||+|+||++   +.++.++|+|||.+.....
T Consensus        83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGS  158 (293)
T ss_pred             EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccC
Confidence            99999975 9998887644 48999999999999999999999999999999999999   6788999999999876544


Q ss_pred             C-cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc-------------
Q 040917          190 G-KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN-------------  253 (494)
Q Consensus       190 ~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~-------------  253 (494)
                      . .......+++.|+|||.+.+  .++.++|+||+|+++++|++|..||...........+......             
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            3 22234557889999998864  3688999999999999999999999877765544433211000             


Q ss_pred             -------------CCCCCCCC--CCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          254 -------------FQRDPFPS--ISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       254 -------------~~~~~~~~--~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                                   .....++.  +++.+.++|.+||..+|++|||+.++|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                         00011222  48889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8e-39  Score=306.25  Aligned_cols=258  Identities=31%  Similarity=0.567  Sum_probs=216.9

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|...+.||+|++|.||+|.+..+++.+++|++....   ......+.+|+.+++.+ +||||+++++++...+..+++
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~~~v   94 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDELWVV   94 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeEEEE
Confidence            45666789999999999999999999999999985322   22355688999999999 599999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-  191 (494)
                      +||++|++|.+++.. .+++...+..++.|++.|+.+||++|++||||+|+||++   +.++.++|+|||.+....... 
T Consensus        95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~  170 (285)
T cd06648          95 MEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVP  170 (285)
T ss_pred             EeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCCc
Confidence            999999999998877 678999999999999999999999999999999999999   678899999999876543321 


Q ss_pred             ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      ......+++.|+|||.+.+ .++.++|+||+|+++++|++|..||...........+......... ....++..+.+++
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li  249 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK-NLHKVSPRLRSFL  249 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCc-ccccCCHHHHHHH
Confidence            2233467889999999865 5889999999999999999999999887766666655544222221 2234789999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917          271 RRMLTQDPKRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       271 ~~~l~~dp~~Rps~~eil~~~~~~~~~~~  299 (494)
                      .+||..+|++||++.++++||||.....+
T Consensus       250 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  278 (285)
T cd06648         250 DRMLVRDPAQRATAAELLNHPFLAKAGPP  278 (285)
T ss_pred             HHHcccChhhCcCHHHHccCcccccCCCc
Confidence            99999999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.7e-39  Score=310.06  Aligned_cols=253  Identities=33%  Similarity=0.647  Sum_probs=219.6

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|.+.+.||+|++|.||+|.+..+++.|++|++.............+.+|+.+++++.+||||+++++++......++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            69999999999999999999999999999999976555455556778899999999955999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc-
Q 040917          114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-  192 (494)
Q Consensus       114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~-  192 (494)
                      |++++++|.+++.+.+.++...+..++.|++.||.+||++|++|+||+|+||++   +.++.++|+|||.+........ 
T Consensus        82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCcccc
Confidence            999999999999888889999999999999999999999999999999999999   6788999999999876533221 


Q ss_pred             --------------------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC
Q 040917          193 --------------------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE  251 (494)
Q Consensus       193 --------------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  251 (494)
                                          .....++..|+|||++.. .++.++|+||||++++++++|..||...........+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  238 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE  238 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence                                112346788999998764 57889999999999999999999998887666666655433


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCcc
Q 040917          252 INFQRDPFPSISSSAIELVRRMLTQDPKRRITV----AQVLEHPWL  293 (494)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~eil~~~~~  293 (494)
                      ..++    ..+++.+.++|.+||..+|.+||++    +++++||||
T Consensus       239 ~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         239 YSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            3322    4568999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-41  Score=312.81  Aligned_cols=255  Identities=32%  Similarity=0.556  Sum_probs=227.6

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ..|+.-+.||.||||.||-|.-+.||+.+|.|.+.+..........-..+|-.+|.++. .|.|+.+--.|...+.+|+|
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCceEEE
Confidence            56888899999999999999999999999999998777666666777889999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          113 MELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +..|.||+|.=+|.+.+  .+++..+..++.+|+.||.+||+.+||+|||||+|||+   ++.|+++|+|+|+|..+..+
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEecCCC
Confidence            99999999988887765  79999999999999999999999999999999999999   78999999999999999999


Q ss_pred             cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD----QGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ......+||.+|||||++.+ .|+...|+|||||++|+|+.|+.||.....    +++-+.+......++    ...+++
T Consensus       341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~----~kFS~e  416 (591)
T KOG0986|consen  341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS----DKFSEE  416 (591)
T ss_pred             CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc----cccCHH
Confidence            88888899999999999874 599999999999999999999999965543    344444444444444    468999


Q ss_pred             HHHHHHHhcccCCCCCC-----CHHHHhcCCccCc
Q 040917          266 AIELVRRMLTQDPKRRI-----TVAQVLEHPWLKE  295 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~  295 (494)
                      ++++...+|.+||.+|.     .++++-+||||+.
T Consensus       417 akslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~  451 (591)
T KOG0986|consen  417 AKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD  451 (591)
T ss_pred             HHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence            99999999999999997     5789999999996

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.3e-39  Score=305.20  Aligned_cols=251  Identities=29%  Similarity=0.525  Sum_probs=209.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++ ||||+++++++...+..+++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeEEEE
Confidence            57999999999999999999999999999999987655445555677889999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          113 MELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      +||+++++|.+++..    ...++...+..++.+++.||.|||++|++|+||+|+||++   +.++.++|+|||.+....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccceecc
Confidence            999999999988753    3447899999999999999999999999999999999999   677889999999987654


Q ss_pred             cCcc-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHcCCccCCCCCCCCCCH
Q 040917          189 EGKA-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD--QGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       189 ~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      .... .....+++.|+|||.+.+ .++.++|+||+|+++|+|++|+.||.....  ......+....  +++.....++.
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  235 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEHYSE  235 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--CCCCChhhcCH
Confidence            3222 223467889999998864 578899999999999999999999965432  33444443322  22222245788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+.+++.+||..+|++||++.++++
T Consensus       236 ~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         236 KLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             HHHHHHHHHCCCCcccCcCHHHHHH
Confidence            9999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.5e-39  Score=308.73  Aligned_cols=259  Identities=24%  Similarity=0.349  Sum_probs=215.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++.+.||+|++|+||+|.+..+|+.||+|++....  .......+.+|+.+++.+. ||||+++++.+.....+++|
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCEEEEE
Confidence            57999999999999999999999999999999986432  2334677899999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      |||+++++|.+++...+.++...+..++.+++.++.|||+ .+++||||+|+||++   ++++.++|+|||++...... 
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~-  157 (284)
T cd06620          82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINS-  157 (284)
T ss_pred             EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhh-
Confidence            9999999999999887789999999999999999999997 599999999999999   67889999999987654222 


Q ss_pred             ccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHHcCCccCCCCCC
Q 040917          192 AYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQ-----------GVAQAILKGEINFQRDPF  259 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~~  259 (494)
                      ......++..|+|||++. +.++.++|+||+||++|+|++|..||......           +....+......  ....
T Consensus       158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  235 (284)
T cd06620         158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP--RLPS  235 (284)
T ss_pred             ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC--CCCc
Confidence            223456889999999875 46888999999999999999999999765542           222222222111  1111


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCC
Q 040917          260 PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS  300 (494)
Q Consensus       260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~  300 (494)
                      ..++..+.+++.+||..||++|||+.++++|+||.....+.
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~  276 (284)
T cd06620         236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS  276 (284)
T ss_pred             hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccc
Confidence            23778999999999999999999999999999998755444

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3e-39  Score=308.99  Aligned_cols=249  Identities=24%  Similarity=0.349  Sum_probs=210.6

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCC-----cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTG-----LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~-----~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .+|++.+.||+|++|.||+|.+...+     ..|++|.+....  .......+.+|+.++..+. ||||+++++++....
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~   81 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQ   81 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCCC
Confidence            57999999999999999999876554     689999986432  3334667889999999995 999999999999888


Q ss_pred             eEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC
Q 040917          108 FVHIVMELCAGGELFDRIVAR----------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD  171 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~  171 (494)
                      ..+++|||+++++|.+++...                ..++...+..++.|++.||.|||++|++|+||||+||++   +
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~  158 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---G  158 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---c
Confidence            999999999999999999764                347888999999999999999999999999999999999   6


Q ss_pred             CCCeEEEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 040917          172 ENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQA  246 (494)
Q Consensus       172 ~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~  246 (494)
                      +++.++|+|||++........   .....+++.|+|||.+. +.++.++|+|||||++|+|++ |..||.+....++...
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            778999999999875432221   12344578899999875 568999999999999999998 9999999888888777


Q ss_pred             HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          247 ILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      +.+......   ...+|..+.+++.+||+.||.+||++.+++++
T Consensus       239 i~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         239 IRSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            766543322   24688999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.2e-39  Score=310.11  Aligned_cols=254  Identities=26%  Similarity=0.433  Sum_probs=207.3

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|++++.||.|++|.||+|.+..+|+.|++|.+..... .......+.+|+.+++++. ||||+++++++.+....++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   78 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVF   78 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEEEEe
Confidence            48999999999999999999999999999999865432 2223467889999999995 999999999999999999999


Q ss_pred             eccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          114 ELCAGGELFDRIVA--RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       114 e~~~g~sL~~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      ||+. ++|.+++..  ...++...+..++.|++.|+.|||+++++|+||+|+||++   +.++.++|+|||.+.......
T Consensus        79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCc
Confidence            9996 588888765  3468999999999999999999999999999999999999   678899999999987543322


Q ss_pred             -ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccC--------------
Q 040917          192 -AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF--------------  254 (494)
Q Consensus       192 -~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--------------  254 (494)
                       ......+++.|+|||.+.+  .++.++|+|||||++|+|+||+.||.+.........+.......              
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence             1223456788999998764  36889999999999999999999998776544333322110000              


Q ss_pred             ----C-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          255 ----Q-------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       255 ----~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                          +       ....+.+++.+.++|.+||..||.+||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                0       01123567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.9e-39  Score=310.21  Aligned_cols=252  Identities=23%  Similarity=0.323  Sum_probs=202.3

Q ss_pred             ccceEeeeeecccCCeEEEEEEECC----------------CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCC
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENS----------------TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN   95 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~----------------~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~   95 (494)
                      .++|++.+.||+|+||.||+|.+..                ++..||+|++....  .......+.+|+.++.+++ |||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~n   80 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLK-DPN   80 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcC-CCC
Confidence            3689999999999999999998643                34579999986532  2334667899999999995 999


Q ss_pred             ccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCce
Q 040917           96 IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG-------------------HYSERAAASVFRVIMNVVNVCHSKGVM  156 (494)
Q Consensus        96 i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~-------------------~l~~~~~~~i~~~i~~~l~~LH~~~i~  156 (494)
                      |+++++++...+..++||||+++++|.+++....                   .++...+..++.||+.||.|||++||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999999899999999999999999886532                   356778899999999999999999999


Q ss_pred             eccCCCCceEEeeCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh--
Q 040917          157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC--  230 (494)
Q Consensus       157 H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t--  230 (494)
                      ||||||+||++   +.++.+||+|||++........   .....++..|+|||++. +.++.++|+|||||++|+|++  
T Consensus       161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             ccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence            99999999999   6788999999999875433221   11234467899999875 568999999999999999986  


Q ss_pred             CCCCCCCCChHHHHHHHHc----CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          231 GVPPFWAETDQGVAQAILK----GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       231 g~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +..||...........+..    ..........+.+|..+.+++.+||..+|.+|||+.+|..
T Consensus       238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            5678887776665544322    1111111122467899999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.2e-39  Score=317.01  Aligned_cols=266  Identities=28%  Similarity=0.444  Sum_probs=212.4

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC----
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD----  106 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~----  106 (494)
                      +..+|++.+.||.|++|.||+|.+..+|+.|++|.+.....   .....+.+|+.+++.+ +||||+++++++...    
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhc-CCCcchhhHhhhccccccc
Confidence            56899999999999999999999999999999999865432   3456788899999999 599999999876543    


Q ss_pred             ----------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917          107 ----------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV  176 (494)
Q Consensus       107 ----------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~  176 (494)
                                ...++|+||++ ++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++  ..++.+
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~  154 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVL  154 (342)
T ss_pred             ccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceE
Confidence                      35789999997 488887754 4689999999999999999999999999999999999995  345689


Q ss_pred             EEeecCCccccccCcc----cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC
Q 040917          177 KATDFGLSAFIEEGKA----YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG  250 (494)
Q Consensus       177 kL~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~  250 (494)
                      +|+|||.+........    .....++..|+|||.+.+  .++.++|+|||||++|+|++|+.||.+....+....+...
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999875432111    122356889999998753  4788999999999999999999999877665544443321


Q ss_pred             Ccc----------------------CCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCC
Q 040917          251 EIN----------------------FQR----DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPI  304 (494)
Q Consensus       251 ~~~----------------------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~  304 (494)
                      ...                      ...    ...+.++..+.++|.+||..||.+|||+.++|+||||+....+.+.|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~  314 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPV  314 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccccC
Confidence            100                      000    012357788999999999999999999999999999997655544444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.5e-39  Score=318.60  Aligned_cols=267  Identities=29%  Similarity=0.459  Sum_probs=215.4

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE----eC
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE----DD  106 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~----~~  106 (494)
                      +..+|.+.+.||+|++|.||+|.+..+|+.||+|++..... .......+.+|+.+++++. ||||+++++++.    ..
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   80 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADF   80 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCC
Confidence            45789999999999999999999999999999999875432 2234567788999999995 999999998875    33


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          107 QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      ...++||||+. ++|.+++.....++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||.+..
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~  156 (334)
T cd07855          81 KDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARG  156 (334)
T ss_pred             ceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEeccccccee
Confidence            57899999995 5899998877789999999999999999999999999999999999999   6788999999999875


Q ss_pred             cccCcc-----cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC---------
Q 040917          187 IEEGKA-----YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG---------  250 (494)
Q Consensus       187 ~~~~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~---------  250 (494)
                      ......     .....++..|+|||.+.+  .++.++|+||+||++|+|++|+.||.+.........+...         
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            432221     123467889999998754  4889999999999999999999999776554332222110         


Q ss_pred             --------------CccCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCC
Q 040917          251 --------------EINFQRD----PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKP  303 (494)
Q Consensus       251 --------------~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~  303 (494)
                                    .......    ..+..+..+.++|.+||+.+|.+||++.+++.||||.....+...+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~  307 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEP  307 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccc
Confidence                          0000000    1245789999999999999999999999999999998766555443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.2e-39  Score=321.25  Aligned_cols=250  Identities=22%  Similarity=0.346  Sum_probs=202.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECCC-----CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           33 LHYTIGREVGRGEFGITYLCTENST-----GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ++|++++.||+|+||.||+|.+..+     +..||+|.+.....  ......+.+|+.+++.+.+||||+++++.+....
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            5799999999999999999986544     35799999975432  2245678899999999956999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhc-----------------------------------------------------------
Q 040917          108 FVHIVMELCAGGELFDRIVAR-----------------------------------------------------------  128 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~-----------------------------------------------------------  128 (494)
                      ..++||||+++|+|.+++...                                                           
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            999999999999999988542                                                           


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc---c
Q 040917          129 -----------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY---R  194 (494)
Q Consensus       129 -----------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~---~  194 (494)
                                 .+++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.........   .
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCcceeecc
Confidence                       136778899999999999999999999999999999999   56789999999998764332211   1


Q ss_pred             cccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHH
Q 040917          195 EIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR  272 (494)
Q Consensus       195 ~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  272 (494)
                      ...+++.|+|||++. +.++.++|||||||++|+|++ |+.||.....................+  ..+|+.+.+++.+
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~  350 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP--DFAPPEIYSIMKM  350 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCC--CCCCHHHHHHHHH
Confidence            223456799999875 468999999999999999997 999997766544433333333222221  3468999999999


Q ss_pred             hcccCCCCCCCHHHHhc
Q 040917          273 MLTQDPKRRITVAQVLE  289 (494)
Q Consensus       273 ~l~~dp~~Rps~~eil~  289 (494)
                      ||..||.+|||+.++++
T Consensus       351 cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         351 CWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999976

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=289.63  Aligned_cols=257  Identities=28%  Similarity=0.408  Sum_probs=217.2

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +.+++..||+|..|+||++..+.+|...|||...+..  +......+++.+.++..-.++|+|++.+++|..+..++|.|
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM  170 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM  170 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence            3456678999999999999999999999999997654  34456778888887776556899999999999999999999


Q ss_pred             eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          114 ELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       114 e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      |.|.. .+..++++ .+++++..+-.+...++.||.||..+ ||+|||+||+|||+   +..|.+||||||.+-....+.
T Consensus       171 elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  171 ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeeccc
Confidence            99843 56555554 45688888999999999999999865 89999999999999   789999999999998877776


Q ss_pred             ccccccCCcCccChhhhcc----cCCCcchhHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917          192 AYREIVGSPYYIAPEVLSQ----SYGKEADIWSAGVILYILLCGVPPFWAE-TDQGVAQAILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (494)
                      ......|-+.|||||.+..    .|+.++|+||||+++++|.||..||.+. ++.+++-.+.+...+..+ .-...++.+
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~-~~~gFSp~F  325 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLP-GHMGFSPDF  325 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCC-cccCcCHHH
Confidence            6677788999999999853    4889999999999999999999999874 445677777775443332 234589999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          267 IELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      .+|+..||++|+.+||.+.++|+|||+....
T Consensus       326 ~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  326 QSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             HHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence            9999999999999999999999999998654

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-39  Score=306.26  Aligned_cols=256  Identities=30%  Similarity=0.530  Sum_probs=213.7

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc--CCCCccEEeEEEEeCCeEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS--GQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .|++.+.||+|++|.||+|.+..+++.|++|.+....  .......+.+|+.+++.+.  .|||++++++++..+...++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            5888999999999999999999999999999986432  2224567888999999995  49999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      ||||++|++|.+++.. ..+++..+..++.+++.|+.|||+.|++|+||+|+||++   +..+.++|+|||.+.......
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE---cCCCCEEEccCCceeecCCCc
Confidence            9999999999998865 478999999999999999999999999999999999999   568899999999987654332


Q ss_pred             c-cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917          192 A-YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE  268 (494)
Q Consensus       192 ~-~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  268 (494)
                      . .....++..|+|||.+.+  .++.++|+|||||++|+|++|..||...........+...  ..+......++..+.+
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  233 (277)
T cd06917         156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLRE  233 (277)
T ss_pred             cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcccCCHHHHH
Confidence            2 233567889999998864  3688999999999999999999999877665444333222  1111112237889999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          269 LVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       269 li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ++.+||..||++||++.+++.||||+...
T Consensus       234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         234 FVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            99999999999999999999999998644

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6e-39  Score=308.23  Aligned_cols=254  Identities=26%  Similarity=0.428  Sum_probs=203.6

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|++|.||+|.++.+++.||+|.+......  .....+.+|+.+++.+. ||||+++++++......++|
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLK-HANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCC-CcceeeEEEEEecCCeEEEE
Confidence            6799999999999999999999999999999998654321  12345678999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-
Q 040917          113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-  190 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-  190 (494)
                      |||+.+ +|.+++... ..++...+..++.|++.||.|||++||+||||+|+||++   +.++.++|+|||.+...... 
T Consensus        82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCCC
Confidence            999975 899888664 468999999999999999999999999999999999999   67889999999998653221 


Q ss_pred             cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHcCCcc--------------
Q 040917          191 KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAET-DQGVAQAILKGEIN--------------  253 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~-~~~~~~~~~~~~~~--------------  253 (494)
                      .......++..|+|||++.+  .++.++|+||+|+++|+|++|..||.... ..+....+.+....              
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence            11122346788999998864  47889999999999999999999997665 22222221110000              


Q ss_pred             -----C-------CCCCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          254 -----F-------QRDPFPSIS--SSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       254 -----~-------~~~~~~~~~--~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                           .       .....+.++  ..+.+++.+||..+|++|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                 0       000112344  788899999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.6e-39  Score=337.05  Aligned_cols=252  Identities=29%  Similarity=0.384  Sum_probs=205.5

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++++. ||||+++++++..++..+++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEEEEE
Confidence            68999999999999999999999999999999997654444445677899999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeec
Q 040917          113 MELCAGGELFDRIVAR-----------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDF  181 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Df  181 (494)
                      |||++|++|.+++...           ...+...+..++.||+.||.|||++||+||||||+||++   +.++.++|+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence            9999999999988642           234567788999999999999999999999999999999   67889999999


Q ss_pred             CCccccccCc-------------------ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 040917          182 GLSAFIEEGK-------------------AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ  241 (494)
Q Consensus       182 g~a~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~  241 (494)
                      |++.......                   ......||+.|+|||++.+ .++.++||||+||++|+|++|..||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            9997652100                   0112468999999999865 5899999999999999999999999876554


Q ss_pred             HHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          242 GVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ......... .+....+...+|+.+.+++.+||..||.+||+..+.+.
T Consensus       238 ki~~~~~i~-~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        238 KISYRDVIL-SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             hhhhhhhcc-ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            433221111 11111233568899999999999999999987665543

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.2e-39  Score=310.95  Aligned_cols=258  Identities=24%  Similarity=0.399  Sum_probs=204.1

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC--
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ--  107 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~--  107 (494)
                      ..-++|++.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+.++++++ ||||+++++++....  
T Consensus         9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   86 (310)
T cd07865           9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKATP   86 (310)
T ss_pred             chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCC-CCCccceEEEEeccccc
Confidence            344689999999999999999999999999999999864332 2223345668999999995 999999999886543  


Q ss_pred             ------eEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917          108 ------FVHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       108 ------~~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                            ..++||||+.+ +|.+.+.... .++...+..++.||+.||.|||++|++|+||+|+||++   +.++.++|+|
T Consensus        87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~d  162 (310)
T cd07865          87 YNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLAD  162 (310)
T ss_pred             ccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEECc
Confidence                  45999999965 8888776543 68999999999999999999999999999999999999   6788999999


Q ss_pred             cCCccccccCcc-----cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc
Q 040917          181 FGLSAFIEEGKA-----YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN  253 (494)
Q Consensus       181 fg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  253 (494)
                      ||.+........     .....++..|+|||.+.+  .++.++|+||+|+++|+|++|..||.+.........+..-...
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS  242 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999876532211     123456788999998764  3688999999999999999999999877665443333221100


Q ss_pred             CCCCC----------------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          254 FQRDP----------------------------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       254 ~~~~~----------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      .+...                            ....+..+.++|.+||..||.+|||++++|+||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            00000                            01125678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.5e-39  Score=305.16  Aligned_cols=249  Identities=35%  Similarity=0.632  Sum_probs=215.5

Q ss_pred             ecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCc
Q 040917           41 VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGE  120 (494)
Q Consensus        41 lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~s  120 (494)
                      ||+|++|.||+|.+..+|+.+++|++.............+.+|+.+++++. ||||+++++.+..+...|+++|+++|++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCCCCc
Confidence            689999999999999999999999997655444456778899999999995 9999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc---------
Q 040917          121 LFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK---------  191 (494)
Q Consensus       121 L~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~---------  191 (494)
                      |.+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||++   +.++.++|+|||++.......         
T Consensus        80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccccccc
Confidence            99999887789999999999999999999999999999999999999   678899999999987543321         


Q ss_pred             ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      ......++..|+|||.... ..+.++|+||||++++++++|..||......+....+..+...++..  ..++..+.+++
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i  234 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI  234 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHHHHHH
Confidence            1223457788999998754 47889999999999999999999999888887777776644433322  23589999999


Q ss_pred             HHhcccCCCCCCCH---HHHhcCCccCc
Q 040917          271 RRMLTQDPKRRITV---AQVLEHPWLKE  295 (494)
Q Consensus       271 ~~~l~~dp~~Rps~---~eil~~~~~~~  295 (494)
                      .+||+.+|.+||++   .++|+||||.+
T Consensus       235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         235 SKLLVPDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             HHHhcCCHhhcCCCccHHHHhcCccccC
Confidence            99999999999999   99999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1e-38  Score=300.57  Aligned_cols=248  Identities=31%  Similarity=0.546  Sum_probs=212.6

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|++.+.||+|++|.||++.+..+++.+|+|.+.....  ....+.+.+|+.+++.+. ||||+++++.+..+...+++|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEE
Confidence            58999999999999999999999999999999864332  234567888999999995 999999999999999999999


Q ss_pred             eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          114 ELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       114 e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      ||+++++|.+++...  ..++...+..++.|++.|+.|||++|++|+||+|+||++   +.++.++|+|||.+.......
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeecccc
Confidence            999999999988653  357899999999999999999999999999999999999   678899999999987654322


Q ss_pred             c-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          192 A-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       192 ~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                      . .....+++.|+|||++.+ .++.++|+||+|+++|+|++|..||...........+..+.....+   ..++..+.++
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l  231 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP---SHYSYELRSL  231 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC---cccCHHHHHH
Confidence            2 234567889999999864 5889999999999999999999999988877776666655443222   3578899999


Q ss_pred             HHHhcccCCCCCCCHHHHhcC
Q 040917          270 VRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       270 i~~~l~~dp~~Rps~~eil~~  290 (494)
                      |.+||..||++||++.++++-
T Consensus       232 i~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         232 IKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHhCCcccCCCHHHHhhc
Confidence            999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.4e-39  Score=310.32  Aligned_cols=255  Identities=29%  Similarity=0.463  Sum_probs=213.5

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      ...|++.+.||+|++|.||+|.+..++..||+|.+.....  ......+.+|+.+++++ +||||+++++++..+...++
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYITRYYGSYLKGTKLWI   79 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcC-CCCccHhhhcccccCCceEE
Confidence            3568888999999999999999999999999999864432  23456789999999999 49999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      ||||+++++|.+++.. ..++...+..++.+++.|+.|||++|++|+||+|+||++   +.++.++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          80 IMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE---eCCCCEEEccccccccccCcc
Confidence            9999999999988755 568999999999999999999999999999999999999   567899999999987654322


Q ss_pred             c-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          192 A-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       192 ~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                      . .....++..|+|||.+.+ .++.++|+|||||++++|++|+.||...........+......   .....++..+.++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l  232 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP---TLEGQYSKPFKEF  232 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC---CCCcccCHHHHHH
Confidence            1 123457889999999865 5788999999999999999999999766655544443332211   1123567889999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          270 VRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       270 i~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      +.+||..+|++||++.++++||||...
T Consensus       233 i~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         233 VEACLNKDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             HHHHccCCcccCcCHHHHHHhHHHHHH
Confidence            999999999999999999999999863

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.4e-39  Score=310.15  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=203.9

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcE--EEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLE--FACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~--valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      .+|++.+.||+|+||.||+|.++.++..  +++|.+..  .........+.+|+.++.++.+||||+++++++...+.++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            4799999999999999999999887765  46666542  2233455678899999999966999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917          111 IVMELCAGGELFDRIVARG----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA  174 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~  174 (494)
                      +||||+++++|.+++...+                .++...+..++.|++.|+.|||++|++||||||+||++   +.++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCC
Confidence            9999999999999987542                47889999999999999999999999999999999999   6788


Q ss_pred             eEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCc
Q 040917          175 VVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEI  252 (494)
Q Consensus       175 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~  252 (494)
                      .++|+|||++..............+..|+|||.+.+ .++.++|||||||++|+|+| |..||.+....+....+.... 
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-  240 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-  240 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC-
Confidence            999999999864321111111223567999998864 47899999999999999998 999998877776665554321 


Q ss_pred             cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          253 NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                        .......+++.+.+++.+||..+|++||++.+++.+
T Consensus       241 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         241 --RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              111223578899999999999999999999999884

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.5e-38  Score=299.59  Aligned_cols=252  Identities=33%  Similarity=0.608  Sum_probs=218.2

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|++.+.||.|++|.||+|.+..++..|++|++..... .......+.+|+++++.+. |||++++.+.+......++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEEEEE
Confidence            58999999999999999999999999999999975443 2345677889999999995 999999999999999999999


Q ss_pred             eccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          114 ELCAGGELFDRIVAR----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       114 e~~~g~sL~~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      |+++|++|.+++...    ..++...+..++.+++.|+.+||++|++|+||+|+||++   +.++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceeeccc
Confidence            999999999998764    678999999999999999999999999999999999999   5678999999999876544


Q ss_pred             Cc-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          190 GK-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       190 ~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      .. ......+++.|+|||.+.+ .++.++|+||+|+++++|++|..||....................   ...++..+.
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  232 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI---PSQYSSELR  232 (258)
T ss_pred             CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCC---CCCCCHHHH
Confidence            32 2233567889999998754 578899999999999999999999988877777666655433222   236789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          268 ELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      +++.+||..+|++||++.++|+||||
T Consensus       233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         233 NLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=9.4e-39  Score=304.60  Aligned_cols=252  Identities=24%  Similarity=0.361  Sum_probs=209.2

Q ss_pred             cceEeeeeecccCCeEEEEEEECC-----CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           33 LHYTIGREVGRGEFGITYLCTENS-----TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ++|++.+.||+|++|.||+|.+..     ++..|++|.+....  .......+.+|+.+++.+ +||||+++++++....
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   82 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKF-NHQNIVRLIGVSFERL   82 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCC
Confidence            679999999999999999999977     78899999885432  233456788999999999 4999999999998888


Q ss_pred             eEEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917          108 FVHIVMELCAGGELFDRIVARG-------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                      ..++||||++|++|.+++....       .++...+..++.||+.|+.|||+++++||||||+||+++..+....++|+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence            8999999999999999987653       478899999999999999999999999999999999996544456799999


Q ss_pred             cCCccccccCccc---ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCC
Q 040917          181 FGLSAFIEEGKAY---REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQ  255 (494)
Q Consensus       181 fg~a~~~~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~  255 (494)
                      ||++.........   .....+..|+|||++. ..++.++|||||||++|+|++ |..||...+.++....+......  
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~--  240 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL--  240 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--
Confidence            9998765322111   1122346799999985 468999999999999999997 99999988887776666543221  


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          256 RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       256 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                       .....+|..+.+++.+||..+|++||++.++++|
T Consensus       241 -~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         241 -DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             1224678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.9e-39  Score=312.75  Aligned_cols=249  Identities=28%  Similarity=0.467  Sum_probs=190.9

Q ss_pred             eeeecccCCeEEEEEEECC--CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE--eCCeEEEEE
Q 040917           38 GREVGRGEFGITYLCTENS--TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE--DDQFVHIVM  113 (494)
Q Consensus        38 ~~~lg~G~~g~Vy~a~~~~--~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~--~~~~~~iv~  113 (494)
                      +..||+|+||.||+|.+..  ++..||+|.+....     ....+.+|+.+++.++ ||||+++++++.  .+...++|+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEE
Confidence            4679999999999999654  66899999986433     2345778999999995 999999999885  356789999


Q ss_pred             eccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC-CCCCeEEEeecCC
Q 040917          114 ELCAGGELFDRIVAR---------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG-DENAVVKATDFGL  183 (494)
Q Consensus       114 e~~~g~sL~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~-~~~~~~kL~Dfg~  183 (494)
                      ||+.+ +|.+.+...         ..+++..+..++.||+.||.|||+.||+||||||+||++..+ +..+.++|+|||+
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            99965 887776421         247889999999999999999999999999999999999542 3567899999999


Q ss_pred             ccccccCc----ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHH
Q 040917          184 SAFIEEGK----AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQ---------GVAQAIL  248 (494)
Q Consensus       184 a~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~---------~~~~~~~  248 (494)
                      +.......    ......+|+.|+|||++.+  .++.++||||+||++|+|+||+.||......         .....+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF  238 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence            97654321    1234567899999999864  4789999999999999999999999654321         0010000


Q ss_pred             cC--------------CccC--------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          249 KG--------------EINF--------------------QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       249 ~~--------------~~~~--------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      ..              ...+                    ........+..+.+++.+||..||.+|||+.|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            00              0000                    000011235668899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-40  Score=322.38  Aligned_cols=253  Identities=28%  Similarity=0.479  Sum_probs=214.1

Q ss_pred             eecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCC
Q 040917           40 EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGG  119 (494)
Q Consensus        40 ~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~  119 (494)
                      .||.|.||+||-|++..++..+|||-+....   ....+-+..|+.+-++|+ |.||++++|.+..++.+-|.||-++||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            4999999999999999999999999996433   223455778999999997 999999999999999999999999999


Q ss_pred             chHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc-ccc
Q 040917          120 ELFDRIVAR-GHY--SERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-YRE  195 (494)
Q Consensus       120 sL~~~~~~~-~~l--~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~-~~~  195 (494)
                      +|.+++... +++  .+.++..+.+||++||+|||++.|||||||-.||||+  .-.|.+||+|||.+.....-.+ ..+
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~TET  735 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCTET  735 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCccccc
Confidence            999999753 667  7899999999999999999999999999999999997  4679999999999876644333 456


Q ss_pred             ccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHH
Q 040917          196 IVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR  272 (494)
Q Consensus       196 ~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  272 (494)
                      ..||..|||||++..   .|+.++|||||||++.||.||++||...... ....+.-+-.+..++....++.+++.||.+
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp-qAAMFkVGmyKvHP~iPeelsaeak~Filr  814 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP-QAAMFKVGMYKVHPPIPEELSAEAKNFILR  814 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-hHhhhhhcceecCCCCcHHHHHHHHHHHHH
Confidence            789999999999963   4999999999999999999999999655443 222333344444444445678889999999


Q ss_pred             hcccCCCCCCCHHHHhcCCccCccCcC
Q 040917          273 MLTQDPKRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       273 ~l~~dp~~Rps~~eil~~~~~~~~~~~  299 (494)
                      |+.++|.+|||+.++|.+||++..++.
T Consensus       815 cFepd~~~R~sA~~LL~DpFlq~~~kk  841 (1226)
T KOG4279|consen  815 CFEPDPCDRPSAKDLLQDPFLQHNNKK  841 (1226)
T ss_pred             HcCCCcccCccHHHhccCcccccCCCC
Confidence            999999999999999999999876433

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.8e-39  Score=309.10  Aligned_cols=257  Identities=25%  Similarity=0.377  Sum_probs=207.0

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|...+.||+|+||.||++.+..+++.||+|.+......  .....+.+|+.++.++.+||||+++++++......+++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            3567788999999999999999999999999998754422  34667889999999996699999999999888889999


Q ss_pred             EeccCCCchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          113 MELCAGGELFDRIV-----ARGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       113 ~e~~~g~sL~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      |||+.+ ++.++..     ....+++..+..++.+++.||.|||+. +++||||||+||++   +..+.++|+|||++..
T Consensus        82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~  157 (288)
T cd06616          82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQ  157 (288)
T ss_pred             EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHH
Confidence            999864 6554332     235689999999999999999999985 99999999999999   5778999999999876


Q ss_pred             cccCcccccccCCcCccChhhhcc----cCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCc-cCCCCCCC
Q 040917          187 IEEGKAYREIVGSPYYIAPEVLSQ----SYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEI-NFQRDPFP  260 (494)
Q Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~-~~~~~~~~  260 (494)
                      ...........+++.|+|||++.+    .++.++|+||+||++|+|++|+.||...... +....+..+.. ........
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd06616         158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER  237 (288)
T ss_pred             hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence            544333344567889999999864    4789999999999999999999999765421 11222222221 11222224


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      .++..+.+|+.+||..+|++|||+.++++||||..
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  272 (288)
T cd06616         238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD  272 (288)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence            57899999999999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.1e-38  Score=304.24  Aligned_cols=249  Identities=29%  Similarity=0.461  Sum_probs=201.9

Q ss_pred             eecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHc--cCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917           40 EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL--SGQPNIVQFKAAYEDDQFVHIVMELCA  117 (494)
Q Consensus        40 ~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l--~~hp~i~~~~~~~~~~~~~~iv~e~~~  117 (494)
                      .||+|+||.||+|.+..+++.||+|++................|..+++.+  .+||+|+.+.+.+......++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999998765433222223344444443333  259999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccccccc
Q 040917          118 GGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV  197 (494)
Q Consensus       118 g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~  197 (494)
                      |++|..++...+.+++..+..++.|++.|+.|||+++++||||+|+||++   +.++.++|+|||++....... .....
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~~-~~~~~  156 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHASV  156 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCccC-CcCcC
Confidence            99999999888889999999999999999999999999999999999999   677899999999987543322 23457


Q ss_pred             CCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHH
Q 040917          198 GSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAET---DQGVAQAILKGEINFQRDPFPSISSSAIELVRR  272 (494)
Q Consensus       198 ~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  272 (494)
                      |+..|+|||.+.+  .++.++|+||+||++|+|++|+.||....   ............    ......++..+.+++.+
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~s~~~~~li~~  232 (278)
T cd05606         157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA----VELPDSFSPELRSLLEG  232 (278)
T ss_pred             CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccC----CCCCCcCCHHHHHHHHH
Confidence            8999999999863  47899999999999999999999997663   222222222211    11223468999999999


Q ss_pred             hcccCCCCCC-----CHHHHhcCCccCcc
Q 040917          273 MLTQDPKRRI-----TVAQVLEHPWLKES  296 (494)
Q Consensus       273 ~l~~dp~~Rp-----s~~eil~~~~~~~~  296 (494)
                      ||..+|.+||     ++.++++||||...
T Consensus       233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             HhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence            9999999999     99999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.7e-39  Score=305.94  Aligned_cols=253  Identities=27%  Similarity=0.475  Sum_probs=208.2

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|++.+.||.|++|.||+|.+..+|..||+|++.....  ......+.+|+.+++++. ||||+++++++...+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEEEEE
Confidence            58999999999999999999999999999999875432  223466778999999995 999999999999999999999


Q ss_pred             eccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          114 ELCAGGELFDRIVAR---GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       114 e~~~g~sL~~~~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      ||+++ +|.+++...   ..+++..+..++.|++.||.|||+.|++||||+|+||++   ++++.++|+|||.+......
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIP  153 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCC
Confidence            99985 888887654   358999999999999999999999999999999999999   67889999999998754322


Q ss_pred             c-ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccC-------------
Q 040917          191 K-AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF-------------  254 (494)
Q Consensus       191 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-------------  254 (494)
                      . ......+++.|+|||++.+  .++.++|+|||||++|+|++|+.||.+....+....+.+.....             
T Consensus       154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence            1 1233456889999998854  36889999999999999999999998877665544332211000             


Q ss_pred             -----CC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          255 -----QR-------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       255 -----~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                           +.       ...+.++..+.+++.+||+.||.+||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                 00       0113457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.8e-38  Score=302.91  Aligned_cols=258  Identities=28%  Similarity=0.455  Sum_probs=208.9

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--CCeEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--DQFVH  110 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--~~~~~  110 (494)
                      ++|...+.||.|++|.||+|.+..+++.+|+|.+.....  ......+.+|+++++++. ||||+++++++..  ...++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeEE
Confidence            368999999999999999999999999999999875432  234677899999999995 9999999998864  34789


Q ss_pred             EEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          111 IVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      +||||++|++|.+++..    ...++...+..++.+|+.||.|||+.|++|+||+|.||++   +..+.++|+|||++..
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~  154 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGE  154 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeecccccc
Confidence            99999999999887643    3458899999999999999999999999999999999999   5678899999999865


Q ss_pred             cccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHcCCccCCC-CCC
Q 040917          187 IEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET-----DQGVAQAILKGEINFQR-DPF  259 (494)
Q Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~-----~~~~~~~~~~~~~~~~~-~~~  259 (494)
                      ...... ....++..|+|||.+.+ .++.++|+|||||++|+|++|..||....     ..+....+......... ...
T Consensus       155 ~~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd06621         155 LVNSLA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG  233 (287)
T ss_pred             cccccc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence            433221 23456788999998864 58899999999999999999999997652     23334443332211111 111


Q ss_pred             --CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          260 --PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       260 --~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                        ..+++.+.+++.+||..+|++|||+.+++.||||+...
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence              23567899999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=305.17  Aligned_cols=267  Identities=27%  Similarity=0.412  Sum_probs=215.0

Q ss_pred             hhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCC-CC----cc
Q 040917           23 ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ-PN----IV   97 (494)
Q Consensus        23 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-p~----i~   97 (494)
                      ++.+..+.+..+|.+++++|+|.||.|-.+.++.++..||||+++.-.    ...+...-|+++++++..+ |+    ++
T Consensus        79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv  154 (415)
T KOG0671|consen   79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCV  154 (415)
T ss_pred             EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence            445556777899999999999999999999999999999999996322    2455667799999999422 22    57


Q ss_pred             EEeEEEEeCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC-----
Q 040917           98 QFKAAYEDDQFVHIVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG-----  170 (494)
Q Consensus        98 ~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~-----  170 (494)
                      .+.++|...++.|||+|.+ |.|+.+++.++.  +++...+..+++|++.++++||+.+++|.||||+||++.+.     
T Consensus       155 ~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~  233 (415)
T KOG0671|consen  155 QMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKT  233 (415)
T ss_pred             eeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEE
Confidence            7788899999999999998 779999998765  58899999999999999999999999999999999998532     


Q ss_pred             ----C--------CCCeEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCC
Q 040917          171 ----D--------ENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWA  237 (494)
Q Consensus       171 ----~--------~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~  237 (494)
                          .        ....|+++|||.|.......  ...+.|.+|+|||++.+ .++.++||||+||||+|++||...|.+
T Consensus       234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt  311 (415)
T KOG0671|consen  234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT  311 (415)
T ss_pred             eccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence                1        24579999999998654333  56788999999999987 799999999999999999999999988


Q ss_pred             CChHHHHHHHHcCCccCCC----------------CCCC--------------------------CCCHHHHHHHHHhcc
Q 040917          238 ETDQGVAQAILKGEINFQR----------------DPFP--------------------------SISSSAIELVRRMLT  275 (494)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~----------------~~~~--------------------------~~~~~l~~li~~~l~  275 (494)
                      ....+.+..+.+--.+++.                ..|+                          .....+.+|+.+||.
T Consensus       312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~  391 (415)
T KOG0671|consen  312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE  391 (415)
T ss_pred             CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence            8866644333211111110                0000                          012347899999999


Q ss_pred             cCCCCCCCHHHHhcCCccCcc
Q 040917          276 QDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       276 ~dp~~Rps~~eil~~~~~~~~  296 (494)
                      .||.+|+|+.|+|.||||...
T Consensus       392 fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  392 FDPARRITLREALSHPFFARL  412 (415)
T ss_pred             cCccccccHHHHhcCHHhhcC
Confidence            999999999999999999864

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8e-39  Score=313.62  Aligned_cols=265  Identities=28%  Similarity=0.434  Sum_probs=214.1

Q ss_pred             cccceEe-eeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChh-----------hHHHHHHHHHHHHHccCCCCccE
Q 040917           31 VQLHYTI-GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV-----------EKDDVRREIEIMRHLSGQPNIVQ   98 (494)
Q Consensus        31 ~~~~y~i-~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~~hp~i~~   98 (494)
                      +.++|.. .+.||+|++|.||+|.+..+++.||+|++.........           ....+.+|+.+++++. ||||++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~   84 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIMG   84 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Ccceee
Confidence            4567764 57799999999999999999999999998654322110           1124678999999995 999999


Q ss_pred             EeEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEE
Q 040917           99 FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKA  178 (494)
Q Consensus        99 ~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL  178 (494)
                      +++++..+...++||||+. ++|.+++.....++...+..++.|++.||.|||++|++|+||+|+||++   +..+.++|
T Consensus        85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~~~kl  160 (335)
T PTZ00024         85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKGICKI  160 (335)
T ss_pred             eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCCCEEE
Confidence            9999999999999999997 5999999887789999999999999999999999999999999999999   67889999


Q ss_pred             eecCCccccccC---------------cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 040917          179 TDFGLSAFIEEG---------------KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQ  241 (494)
Q Consensus       179 ~Dfg~a~~~~~~---------------~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~  241 (494)
                      +|||.+......               .......+++.|+|||.+.+  .++.++|+|||||++|+|++|..||.+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999998754311               11122345788999998864  3688999999999999999999999888776


Q ss_pred             HHHHHHHcCCccCCC------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          242 GVAQAILKGEINFQR------------------------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       242 ~~~~~~~~~~~~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      +....+.........                        ...+..+..+.++|.+||..+|++||+++++|.||||+...
T Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence            555443321110000                        01234578899999999999999999999999999999876


Q ss_pred             cCC
Q 040917          298 EAS  300 (494)
Q Consensus       298 ~~~  300 (494)
                      ...
T Consensus       321 ~~~  323 (335)
T PTZ00024        321 LPC  323 (335)
T ss_pred             CCC
Confidence            543

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.7e-38  Score=302.83  Aligned_cols=254  Identities=29%  Similarity=0.473  Sum_probs=214.6

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      +-|++.+.||+|+||.||+|.+..++..||+|++.....  ......+.+|+.+++++ +||||+++++++..+...++|
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCeEEEE
Confidence            457889999999999999999999999999999864432  23456788999999999 499999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      |||+++++|.+++.. ..++...+..++.+++.++.+||++|++|+||+|.||++   +.++.++|+|||++........
T Consensus        81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchh
Confidence            999999999988865 468999999999999999999999999999999999999   6778899999999865543221


Q ss_pred             -cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          193 -YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       193 -~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                       .....++..|+|||.+.+ .++.++|+||+||++++|++|..||...........+......   .....++..+.+++
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i  233 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPLKEFV  233 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC---CCCcccCHHHHHHH
Confidence             223457889999998864 5788999999999999999999999877766555554433221   12235789999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          271 RRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       271 ~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      .+||..+|.+||++.++++||||...
T Consensus       234 ~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         234 EACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             HHHccCChhhCcCHHHHHhCHHHhhh
Confidence            99999999999999999999999974

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.4e-38  Score=298.17  Aligned_cols=253  Identities=32%  Similarity=0.556  Sum_probs=214.8

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--CeEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--QFVHI  111 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--~~~~i  111 (494)
                      +|++.+.||+|++|.||+|.+..++..|++|++...... ....+.+.+|+.+++++. ||||+++++.+...  ...++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~l   78 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNI   78 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEE
Confidence            588999999999999999999999999999998755432 345678899999999995 99999999999888  88999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      ++|++++++|.+++.....++...+..++.+++.|+.|||+.|++|+||+|+||++   +.++.++|+|||.+.......
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEcccccEEeccccc
Confidence            99999999999999887789999999999999999999999999999999999999   568899999999988765544


Q ss_pred             c---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917          192 A---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD-QGVAQAILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       192 ~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (494)
                      .   .....++..|+|||.+.+ .++.++|+||||+++++|++|..||..... ......+...  .........++..+
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l  233 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS--GEPPEIPEHLSEEA  233 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcccc--CCCcCCCcccCHHH
Confidence            2   344567889999999865 488999999999999999999999977662 2222222211  11112224568999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          267 IELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      .+++.+||..+|++||++.+++.||||
T Consensus       234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         234 KDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6.5e-39  Score=308.60  Aligned_cols=262  Identities=29%  Similarity=0.528  Sum_probs=218.7

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ...-|.....||+|+||.||+|.+..+++.||+|++.....   .....+.+|+.+++.+ +||||+++++++..++..+
T Consensus        19 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~   94 (297)
T cd06659          19 PRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELW   94 (297)
T ss_pred             chhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEE
Confidence            34456667789999999999999999999999999864332   2356688999999999 5999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +++||+++++|..++.. ..++...+..++.|++.||.|||++|++||||+|+||++   +.++.++|+|||++......
T Consensus        95 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~  170 (297)
T cd06659          95 VLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKD  170 (297)
T ss_pred             EEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhcccc
Confidence            99999999999887754 568999999999999999999999999999999999999   67889999999998654332


Q ss_pred             c-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917          191 K-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE  268 (494)
Q Consensus       191 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  268 (494)
                      . ......+++.|+|||.+.+ .++.++|+||+||++++|++|+.||......+....+...... .......++..+.+
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  249 (297)
T cd06659         171 VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKNAHKISPVLRD  249 (297)
T ss_pred             cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-CccccCCCCHHHHH
Confidence            2 2234568899999999864 5889999999999999999999999877766655554433222 22233467889999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCccCccCcCCC
Q 040917          269 LVRRMLTQDPKRRITVAQVLEHPWLKESGEASD  301 (494)
Q Consensus       269 li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~  301 (494)
                      +|.+||..+|.+||++.++++||||.....+.+
T Consensus       250 ~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~  282 (297)
T cd06659         250 FLERMLTREPQERATAQELLDHPFLLQTGLPEC  282 (297)
T ss_pred             HHHHHhcCCcccCcCHHHHhhChhhccCCCccc
Confidence            999999999999999999999999998765544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-39  Score=306.54  Aligned_cols=253  Identities=27%  Similarity=0.465  Sum_probs=208.1

Q ss_pred             eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917           35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME  114 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e  114 (494)
                      |++.+.||.|++|.||+|.+..+|..|++|++..... .......+.+|+.+++.+. |||++++++++......+++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEEEEe
Confidence            6788999999999999999999999999999875432 2223456788999999995 9999999999999999999999


Q ss_pred             ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917          115 LCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-  191 (494)
Q Consensus       115 ~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-  191 (494)
                      |++ ++|.+++....  .+++..+..++.|++.||.|||+++++||||+|+||++   +.++.++|+|||.+....... 
T Consensus        79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCcEEEeecccccccCCCcc
Confidence            995 59999887765  68999999999999999999999999999999999999   568899999999987543221 


Q ss_pred             ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC------------------
Q 040917          192 AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE------------------  251 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~------------------  251 (494)
                      ......+++.|+|||++.+  .++.++|+||||+++|+|++|..||...........+.+..                  
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            1223356788999998754  46889999999999999999999998776544333322210                  


Q ss_pred             -------ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          252 -------INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       252 -------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                             ........+.++..+.++|.+||+.+|.+||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                   001111234677899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=341.02  Aligned_cols=258  Identities=30%  Similarity=0.509  Sum_probs=228.5

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|.|++.||+|+||.|.+++++.+++.||.|++.+-.........-|..|..+|..- +.+=|+.++-.|+++.++|+|
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~LYlV  153 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYLYLV  153 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccceEEE
Confidence            7899999999999999999999999999999999875555555677788899888876 588899999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-  191 (494)
                      |+|++||+|..++.+..++++.-+..++..|+.||..||+.|+|||||||.|||+   +..|++||+|||.+..+.... 
T Consensus       154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~dG~  230 (1317)
T KOG0612|consen  154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDADGT  230 (1317)
T ss_pred             EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcCCCCc
Confidence            9999999999999998889999999999999999999999999999999999999   799999999999998765332 


Q ss_pred             -ccccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          192 -AYREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       192 -~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                       .+...+|||.|.+||++.      +.|++.+|+||+||++|||+.|..||...+--+.+-.|.+....+..+....+|+
T Consensus       231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSe  310 (1317)
T KOG0612|consen  231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSE  310 (1317)
T ss_pred             EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCH
Confidence             234578999999999984      4589999999999999999999999999998888888887743333333456999


Q ss_pred             HHHHHHHHhcccCCCCCCC---HHHHhcCCccCc
Q 040917          265 SAIELVRRMLTQDPKRRIT---VAQVLEHPWLKE  295 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps---~~eil~~~~~~~  295 (494)
                      .+++||.++++ +|+.|..   ++++-.||||.+
T Consensus       311 eakdLI~~ll~-~~e~RLgrngiedik~HpFF~g  343 (1317)
T KOG0612|consen  311 EAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG  343 (1317)
T ss_pred             HHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence            99999999986 5778887   999999999975

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.4e-38  Score=299.93  Aligned_cols=253  Identities=30%  Similarity=0.563  Sum_probs=212.9

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|++.+.||+|++|.||+|.+..+|..||+|.+....... ...+.+.+|+.+++.++ ||||+++++.+......++|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEEEEE
Confidence            5899999999999999999999999999999987543322 24567889999999995 999999999999999999999


Q ss_pred             eccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          114 ELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       114 e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      ||+++++|.+++....  .+++..+..++.+++.|+.|||+++++|+||+|.||+++  +....++|+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc--CCCCeEEecccccchhccCCc
Confidence            9999999999987643  478999999999999999999999999999999999994  233467999999987654332


Q ss_pred             c-cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          192 A-YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       192 ~-~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                      . .....+++.|+|||.+. ..++.++|+||+|+++++|++|..||...........+......   ...+.++..+.++
T Consensus       157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  233 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA---PISPNFSRDLRSL  233 (257)
T ss_pred             ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC---CCCCCCCHHHHHH
Confidence            2 12345788999999875 45889999999999999999999999877766655555443322   1224678899999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCCcc
Q 040917          270 VRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       270 i~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      |.+||..+|++|||+.+++.||||
T Consensus       234 i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         234 ISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.9e-38  Score=305.54  Aligned_cols=256  Identities=25%  Similarity=0.425  Sum_probs=213.9

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      +.+.|...+.||+|++|.||+|.+..+++.|++|.+.............+.+|+.+++.++ |||++++++++.+....+
T Consensus        19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   97 (313)
T cd06633          19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTAW   97 (313)
T ss_pred             HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEEE
Confidence            3355888888999999999999999999999999987654444444567889999999995 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          111 IVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      +||||+.| +|.+.+.. ...++...+..++.||+.|+.|||++|++|+||+|+||++   +.++.++|+|||.+.....
T Consensus        98 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~  173 (313)
T cd06633          98 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSSP  173 (313)
T ss_pred             EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccCC
Confidence            99999965 77777755 4568999999999999999999999999999999999999   6778899999998864322


Q ss_pred             CcccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          190 GKAYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       190 ~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                         .....++..|+|||.+.    +.++.++|+|||||++|+|++|..||...........+......  ....+.++..
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  248 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLQSNEWTDS  248 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCccccCHH
Confidence               23456788999999873    45888999999999999999999999877765555554443222  2222457788


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      +.+++.+||+.+|.+||++.+++.||||...
T Consensus       249 l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         249 FRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            9999999999999999999999999999973

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=305.83  Aligned_cols=253  Identities=30%  Similarity=0.484  Sum_probs=209.6

Q ss_pred             eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--CeEEEE
Q 040917           35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--QFVHIV  112 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--~~~~iv  112 (494)
                      |++.+.||+|++|.||+|.+..+++.+++|.+.... ........+.+|+.+++.+. |||++++++++...  ...++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEE
Confidence            788999999999999999999999999999997654 22334566888999999995 99999999999887  789999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      +||+++ +|.+++... ..++...+..++.||+.|+.+||+.|++|+||+|+||++   ++++.++|+|||.+.......
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCC
Confidence            999975 898888665 578999999999999999999999999999999999999   678899999999987654432


Q ss_pred             --ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCC----------
Q 040917          192 --AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD----------  257 (494)
Q Consensus       192 --~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~----------  257 (494)
                        ......++..|+|||.+.+  .++.++|+||||+++++|++|+.||...........+..........          
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence              1233456788999997754  47899999999999999999999998877665554443211111000          


Q ss_pred             ----------------CCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          258 ----------------PFPS-ISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       258 ----------------~~~~-~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                                      .... ++..+.+++.+||..+|.+||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                            0112 37889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.9e-38  Score=295.56  Aligned_cols=251  Identities=33%  Similarity=0.553  Sum_probs=213.5

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|.+.+.||+|++|.||+|.+..+++.+++|++.....   .....+.+|+.+++.+. ||||+++++++......++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l~~   76 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVM   76 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEE
Confidence            48899999999999999999999999999999965432   34678889999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          114 ELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       114 e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      ||++|++|.+++... ..++...+..++.+++.|+.+||++|++||||+|+||++   +.++.++|+|||.+........
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---ccCCeEEEeecccccccccccc
Confidence            999999999998776 578999999999999999999999999999999999999   5688999999999887654432


Q ss_pred             cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917          193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR  271 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  271 (494)
                      .....++..|+|||.+.+ .++.++|+||||+++++|++|..||..................... ....++..+.++|.
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~  232 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR-NPEKWSDEFKDFLK  232 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcC-cccccCHHHHHHHH
Confidence            344567889999998864 4788999999999999999999999877554444444332221111 11234889999999


Q ss_pred             HhcccCCCCCCCHHHHhcCCc
Q 040917          272 RMLTQDPKRRITVAQVLEHPW  292 (494)
Q Consensus       272 ~~l~~dp~~Rps~~eil~~~~  292 (494)
                      +||..||++|||+.++++|||
T Consensus       233 ~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         233 KCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHccCChhhCCCHHHHhcCCC
Confidence            999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-39  Score=315.12  Aligned_cols=263  Identities=31%  Similarity=0.470  Sum_probs=218.7

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC-----e
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ-----F  108 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~-----~  108 (494)
                      +|++.+.||+|++|.||+|.+..+++.|++|.+.... ........+.+|+.+++.+. ||||+++.+++....     .
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccc
Confidence            6999999999999999999999999999999986532 22334567889999999995 999999999987764     7


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      .|++|+|+++ +|.+++.+...++...+..++.+|+.||.+||++||+||||||.||++   +.++.++|+|||.+....
T Consensus        79 ~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          79 VYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVD  154 (330)
T ss_pred             eEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeec
Confidence            8999999974 899988887789999999999999999999999999999999999999   567999999999998765


Q ss_pred             cCc----ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC------
Q 040917          189 EGK----AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR------  256 (494)
Q Consensus       189 ~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~------  256 (494)
                      ...    ......+++.|+|||++.+  .++.++|+||+|+++++|++|+.||.+....+....+.........      
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            432    2334567889999998864  4788999999999999999999999888776655544332111110      


Q ss_pred             ---------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCC
Q 040917          257 ---------------------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDK  302 (494)
Q Consensus       257 ---------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~  302 (494)
                                           ...+.++..+.++|.+||.++|.+||++.+++.||||+....++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~  301 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE  301 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence                                 0123468889999999999999999999999999999976655443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1e-38  Score=306.68  Aligned_cols=260  Identities=31%  Similarity=0.513  Sum_probs=215.1

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      ....+|.+.+.||+|+||.||++.+..++..|++|.+....   ....+.+.+|+.+++.+. ||||+++++.+...+..
T Consensus        16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~   91 (293)
T cd06647          16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENK-HPNIVNYLDSYLVGDEL   91 (293)
T ss_pred             CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCcE
Confidence            33579999999999999999999998899999999985432   223567889999999995 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      ++|+||+++++|.+++.+. .++...+..++.+++.|+.|||++|++|+||+|+||++   +.++.++|+|||.+.....
T Consensus        92 ~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          92 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             EEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceecccc
Confidence            9999999999999988654 57899999999999999999999999999999999999   6778999999998765433


Q ss_pred             Ccc-cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          190 GKA-YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       190 ~~~-~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      ... .....+++.|+|||.+. +.++.++|+||||+++|++++|..||...........+..... ........++..+.
T Consensus       168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~  246 (293)
T cd06647         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFR  246 (293)
T ss_pred             cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCC-CCCCCccccCHHHH
Confidence            222 22345788899999875 4588999999999999999999999987665443332222211 11112335778899


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          268 ELVRRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                      +++.+||..+|++||++.+++.||||+....
T Consensus       247 ~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~  277 (293)
T cd06647         247 DFLNRCLEMDVEKRGSAKELLQHPFLKIAKP  277 (293)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence            9999999999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-38  Score=304.59  Aligned_cols=248  Identities=23%  Similarity=0.384  Sum_probs=209.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECC-----CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           33 LHYTIGREVGRGEFGITYLCTENS-----TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ++|.+.+.||+|++|.||+|.+..     ++..||+|++....  .......+.+|+.+++.+. ||||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   81 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQ-HENIVKFYGVCTEGD   81 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcC-CCCchheeeEEecCC
Confidence            579999999999999999998753     46889999986433  2334678899999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCC
Q 040917          108 FVHIVMELCAGGELFDRIVARG--------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDEN  173 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~--------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~  173 (494)
                      ..++||||++|++|.+++...+              .++...+..++.|++.|+.|||++|++||||||+||++   +.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~  158 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYD  158 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cCC
Confidence            9999999999999999997542              37888999999999999999999999999999999999   678


Q ss_pred             CeEEEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 040917          174 AVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAIL  248 (494)
Q Consensus       174 ~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~  248 (494)
                      +.++|+|||++........   .....+++.|+|||++. +.++.++|||||||++|+|++ |..||......+....+.
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT  238 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            9999999999875432211   12234567899999886 468999999999999999998 999998888887777777


Q ss_pred             cCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          249 KGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+......   ..++..+.+++.+||..||.+||++.++++
T Consensus       239 ~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         239 QGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             cCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            65443322   467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-38  Score=295.90  Aligned_cols=252  Identities=30%  Similarity=0.545  Sum_probs=216.8

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|++.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|++++.++. |||++++++++......+++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEE
Confidence            589999999999999999999999999999999765432 335678999999999995 999999999999999999999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc-
Q 040917          114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-  192 (494)
Q Consensus       114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~-  192 (494)
                      |++++++|.+++.....+++..+..++.+++.|+.+||++|++||||+|.||++   +.++.++|+|||.+........ 
T Consensus        79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT---TKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---CCCCCEEEeccccceecCCCccc
Confidence            999999999999888889999999999999999999999999999999999999   5678999999999986654332 


Q ss_pred             cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917          193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR  271 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  271 (494)
                      .....++..|+|||...+ .++.++|+||+|+++++|++|..||..................   .....++..+.+++.
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~  232 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP---PLPEGISPELKDFLM  232 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCC---CCCCCCCHHHHHHHH
Confidence            223467889999998754 4788999999999999999999999877655444444332221   222467899999999


Q ss_pred             HhcccCCCCCCCHHHHhcCCcc
Q 040917          272 RMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       272 ~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      +||..+|++||++.++++||||
T Consensus       233 ~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         233 QCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.3e-38  Score=305.69  Aligned_cols=257  Identities=29%  Similarity=0.563  Sum_probs=213.2

Q ss_pred             ceEeeeeecccCCeEEEEEEEC---CCCcEEEEEEeccCCCC-ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           34 HYTIGREVGRGEFGITYLCTEN---STGLEFACKSIPKRKLV-KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      .|++.+.||+|+||.||.|.+.   .+|..||+|++...... .....+.+.+|+.+++++.+||||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4889999999999999999875   47899999998654321 2223567888999999997799999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      ++||||+++++|.+++.....++...+..++.|++.||.|||+.|++||||+|+||++   +.++.++|+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceeccc
Confidence            9999999999999999888889999999999999999999999999999999999999   6788999999999876533


Q ss_pred             Cc--ccccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHcCCccCCCCCCC
Q 040917          190 GK--AYREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETD----QGVAQAILKGEINFQRDPFP  260 (494)
Q Consensus       190 ~~--~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~  260 (494)
                      ..  ......++..|+|||.+..   .++.++|+||+|+++|+|++|..||.....    ..+...+......+    ..
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~  233 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY----PQ  233 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC----Cc
Confidence            22  1223567889999998853   467899999999999999999999964322    33333333333222    23


Q ss_pred             CCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCccCccC
Q 040917          261 SISSSAIELVRRMLTQDPKRRI-----TVAQVLEHPWLKESG  297 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~~~  297 (494)
                      .++..+.+++.+||..+|.+||     ++++++.||||+...
T Consensus       234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            5788999999999999999997     899999999998743

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-38  Score=297.64  Aligned_cols=254  Identities=30%  Similarity=0.527  Sum_probs=211.0

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCC--CChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--Ce
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL--VKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--QF  108 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--~~  108 (494)
                      .+|++.+.||+|++|.||+|.+..++..|++|.+.....  ........+.+|+.+++++. ||||+++++++.+.  ..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKK   80 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCE
Confidence            579999999999999999999999999999998753221  12334567889999999995 99999999998653  46


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      +++++||++|++|.+++...+.++...+..++.|++.|+.|||++|++|+||+|+||++   +.++.++|+|||.+....
T Consensus        81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECccccccccc
Confidence            88999999999999999887788999999999999999999999999999999999999   567889999999987543


Q ss_pred             cC----cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917          189 EG----KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       189 ~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      ..    .......++..|+|||.+.+ .++.++|+|||||++++|++|+.||...........+.....  .+.....++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~p~~~~  235 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT--KPMLPDGVS  235 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCC--CCCCCcccC
Confidence            21    11223457889999999865 478899999999999999999999987766555444433221  122235688


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          264 SSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      +.+.+++.+||. +|..||++.++++|||.
T Consensus       236 ~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         236 DACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1e-38  Score=302.70  Aligned_cols=251  Identities=28%  Similarity=0.546  Sum_probs=208.4

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++.+.||+|++|.||+|.+..++..+++|.+.............+.+|+.+++.+ +||||+++++++..++..+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCeEEEE
Confidence            4689999999999999999999999999999988755444444567888999999999 599999999999999999999


Q ss_pred             EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          113 MELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      |||++|++|.+++..    ...+++..+..++.+|+.|+.|||++|++|+||+|+||++   +.++.++|+|||.+....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccc
Confidence            999999999998863    3458999999999999999999999999999999999999   577899999999987654


Q ss_pred             cCcc-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHcCCccCCCCCCCCCCH
Q 040917          189 EGKA-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ--GVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       189 ~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      .... .....++..|+|||.+.+ .++.++|+||||+++|+|++|..||.+....  .....+...  .+++......++
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  235 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSE  235 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCcccccH
Confidence            3222 234567889999998864 5788999999999999999999999755432  222333222  222223345788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+.+++.+||..+|++|||+.++++
T Consensus       236 ~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         236 ELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.5e-38  Score=298.34  Aligned_cols=247  Identities=23%  Similarity=0.363  Sum_probs=209.0

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      ...|.+.+.||+|++|.||+|.+..+++.|++|++....    .....+.+|+.+++.+. ||||+++++++......++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYI   79 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCCcEE
Confidence            356999999999999999999999999999999986432    23567889999999995 9999999999999899999


Q ss_pred             EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          112 VMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      +|||+++++|.+++...  ..++...+..++.|++.||.|||++|++||||||+||++   ++++.++|+|||.+.....
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCcccccccc
Confidence            99999999999998754  358899999999999999999999999999999999999   6788999999999876543


Q ss_pred             Ccccc--cccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          190 GKAYR--EIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       190 ~~~~~--~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      .....  ....++.|+|||.+.+ .++.++|+|||||++|+|++ |..||.+....+....+.....   ......+|..
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  233 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---MERPEGCPPK  233 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCCHH
Confidence            22111  1223567999998764 58899999999999999998 9999988887777666655322   2223567899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +.+++.+||..+|++||++.++++
T Consensus       234 ~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         234 VYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHHHHccCCcccCCCHHHHHH
Confidence            999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=309.56  Aligned_cols=258  Identities=30%  Similarity=0.491  Sum_probs=202.9

Q ss_pred             ceEeeeeecccCCeEEEEEEECC--CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--CeE
Q 040917           34 HYTIGREVGRGEFGITYLCTENS--TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--QFV  109 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~--~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--~~~  109 (494)
                      +|++.+.||+|++|.||+|.+..  ++..||+|.+.............+.+|+.+++.+. ||||+++++++...  ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCceE
Confidence            58999999999999999999988  89999999997643222334566788999999995 99999999999887  789


Q ss_pred             EEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEee-CCCCCeEEEeecCC
Q 040917          110 HIVMELCAGGELFDRIVAR-----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTT-GDENAVVKATDFGL  183 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~-~~~~~~~kL~Dfg~  183 (494)
                      ++||||+++ +|.+.+...     ..+++..+..++.||+.||.|||+.+|+||||||+||+++. ++..+.++|+|||+
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            999999975 777766432     25889999999999999999999999999999999999942 12289999999999


Q ss_pred             ccccccCcc----cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHH---------HHHHHH
Q 040917          184 SAFIEEGKA----YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQG---------VAQAIL  248 (494)
Q Consensus       184 a~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~---------~~~~~~  248 (494)
                      +........    .....+++.|+|||++.+  .++.++|+|||||++++|++|+.||.+.....         ....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            876533221    223467889999998764  47889999999999999999999997654322         000000


Q ss_pred             cCC---------------------ccCCCCCCC------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          249 KGE---------------------INFQRDPFP------------SISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       249 ~~~---------------------~~~~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      ..-                     ........+            ..+..+.+++.+||..||++|||+.++++||||
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            000                     000001111            456789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-40  Score=317.27  Aligned_cols=250  Identities=21%  Similarity=0.386  Sum_probs=212.1

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ..+...++..||+|.||+||+|.|..   .||||++...... +...+.|.+|+.+|++-+ |.||+-+.|++..... .
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt-~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPT-PEQLQAFKNEVAVLKKTR-HENILLFMGACMNPPL-A  463 (678)
T ss_pred             CHHHhhccceeccccccceeeccccc---ceEEEEEecCCCC-HHHHHHHHHHHHHHhhcc-hhhheeeehhhcCCce-e
Confidence            34677889999999999999999975   5999999766644 447889999999999996 9999999999988776 8


Q ss_pred             EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-
Q 040917          111 IVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-  188 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-  188 (494)
                      ||+.+|+|.+|+.+++-. .++...+.+.|++||+.|+.|||.++|||+|||.+|||+   .+++.|||+|||++.... 
T Consensus       464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~  540 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTR  540 (678)
T ss_pred             eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeeeee
Confidence            999999999999998743 468999999999999999999999999999999999999   677999999999987542 


Q ss_pred             --cCcccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCC-CCCC
Q 040917          189 --EGKAYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD-PFPS  261 (494)
Q Consensus       189 --~~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~  261 (494)
                        .........|...|+|||+++    .+|++.+|||||||++|||++|..||.....+.++-++-++-...... ....
T Consensus       541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~  620 (678)
T KOG0193|consen  541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSN  620 (678)
T ss_pred             eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhcc
Confidence              223334455677899999985    369999999999999999999999999777776666666664433322 2245


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+.++++|+..||..++++||.+.+||.
T Consensus       621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  621 CPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             CHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            7789999999999999999999999987

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.6e-38  Score=303.74  Aligned_cols=254  Identities=25%  Similarity=0.384  Sum_probs=202.1

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|++|.||+|.+..+|..|++|++.....  ......+.+|+.+++.+. |+||+++++++..+...++|
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCeEEEE
Confidence            689999999999999999999999999999999865432  223345678999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      +||+. ++|.+.+... ..++...+..++.|++.||.|||++||+|+||||+||++   +.++.++|+|||++.......
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCCC
Confidence            99996 5777766543 457888899999999999999999999999999999999   678899999999987543221


Q ss_pred             -ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHc--------------CCcc
Q 040917          192 -AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILK--------------GEIN  253 (494)
Q Consensus       192 -~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~--------------~~~~  253 (494)
                       ......+++.|+|||.+.+  .++.++|+|||||++++|++|..||.+.... +....+..              ....
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence             2233456889999998864  4788999999999999999999999765532 11111110              0000


Q ss_pred             CCCC------------CCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          254 FQRD------------PFP--SISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       254 ~~~~------------~~~--~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      +...            .+.  ..+..+.+++.+|+..||.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            0000            001  125688999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.2e-38  Score=296.53  Aligned_cols=245  Identities=25%  Similarity=0.420  Sum_probs=206.4

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++.+.||+|+||.||+|.+. .+..+|+|.+.....    ....+.+|+.+++++. ||||+++++++......++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCEEEE
Confidence            46999999999999999999875 456799998764332    3467889999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      |||++|++|.+++... +.++...+..++.+++.||.|||++|++|+||+|+||++   +.++.++|+|||.+.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCc
Confidence            9999999999988753 468999999999999999999999999999999999999   678899999999887543222


Q ss_pred             cc--ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          192 AY--REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       192 ~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      ..  ....++..|+|||.+.+ .++.++|+||+|+++|+|++ |+.||......+....+..+.....+   ...+..+.
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~  231 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASMTVY  231 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHHHH
Confidence            21  12234567999999864 58899999999999999999 89999888888787777765433222   34678899


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 040917          268 ELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +++.+||..+|++||++.++++
T Consensus       232 ~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         232 EVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3e-38  Score=309.03  Aligned_cols=263  Identities=30%  Similarity=0.438  Sum_probs=210.8

Q ss_pred             ceEeeeeecccCCeEEEEEEECCC--CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe----CC
Q 040917           34 HYTIGREVGRGEFGITYLCTENST--GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----DQ  107 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~--~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~----~~  107 (494)
                      +|++.+.||+|+||.||+|.+..+  +..||+|++.... ........+.+|+.+++++.+||||+++++....    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            589999999999999999999888  9999999986432 2222356678899999999779999999987532    24


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      ..+++++++. ++|.+++.....++...+..++.||+.||.|||++|++||||||+||++   +.++.++|+|||.+...
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGF  155 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceec
Confidence            5789999985 5999999888889999999999999999999999999999999999999   67889999999998754


Q ss_pred             ccCcc-----cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc--------
Q 040917          188 EEGKA-----YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI--------  252 (494)
Q Consensus       188 ~~~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~--------  252 (494)
                      .....     .....+++.|+|||.+.+  .++.++|+||+||++|+|++|..||...........+.....        
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            33211     223468899999998754  578999999999999999999999987665443332221100        


Q ss_pred             -------------------cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCC
Q 040917          253 -------------------NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASD  301 (494)
Q Consensus       253 -------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~  301 (494)
                                         .......+..+..+.+++.+||..||.+|||+.+++.|||+.+...+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~  303 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDD  303 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccc
Confidence                               0001123456789999999999999999999999999999986654433

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=7.3e-40  Score=292.01  Aligned_cols=265  Identities=29%  Similarity=0.458  Sum_probs=207.7

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCc----EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-C
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGL----EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-D  106 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~----~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-~  106 (494)
                      ...|++++.||+|.||.||+|...+++.    .+|+|.++.+..... .....-+|+.+++.|+ ||||+.+..++.. +
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG-iS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG-ISMSACREIALLRELK-HPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC-cCHHHHHHHHHHHHhc-CCcchhHHHHHhccC
Confidence            3579999999999999999996555433    789999976654333 3456678999999996 9999999999876 7


Q ss_pred             CeEEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC-CCCCeEEEee
Q 040917          107 QFVHIVMELCAGGELFDRIVAR-----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG-DENAVVKATD  180 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~-~~~~~~kL~D  180 (494)
                      ..+++++||.+. +|++.|+-.     ..++...+.+|+.||+.|+.|||++.|+||||||+|||+..+ .+.|.|||+|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence            789999999975 999888532     358999999999999999999999999999999999999753 4569999999


Q ss_pred             cCCccccccC----cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChH---------HHHH
Q 040917          181 FGLSAFIEEG----KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQ---------GVAQ  245 (494)
Q Consensus       181 fg~a~~~~~~----~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~---------~~~~  245 (494)
                      +|+++.+.+.    ......+.|.+|+|||.+.|  .||++.|+||+|||+.||+|..+.|.+....         +.++
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9999876542    12345677999999999976  5999999999999999999998888544321         1122


Q ss_pred             HHHcCCccCCCCCCC---------------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCc
Q 040917          246 AILKGEINFQRDPFP---------------------------------SISSSAIELVRRMLTQDPKRRITVAQVLEHPW  292 (494)
Q Consensus       246 ~~~~~~~~~~~~~~~---------------------------------~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~  292 (494)
                      .|.+---.+....|+                                 .-++...+|+.+||+.||.+|.|++++|+|+|
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence            221110011111111                                 12344778999999999999999999999999


Q ss_pred             cCccCcC
Q 040917          293 LKESGEA  299 (494)
Q Consensus       293 ~~~~~~~  299 (494)
                      |.+.+-+
T Consensus       340 F~~d~lp  346 (438)
T KOG0666|consen  340 FTEDPLP  346 (438)
T ss_pred             cccCCCC
Confidence            9987544

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.3e-38  Score=298.54  Aligned_cols=249  Identities=29%  Similarity=0.495  Sum_probs=201.6

Q ss_pred             eeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917           38 GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA  117 (494)
Q Consensus        38 ~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~  117 (494)
                      ...||+|+||.||+|.+..++..|++|.+....   ......+.+|+.++++++ ||||+++++++..++..++|+||++
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~   88 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFMEQVP   88 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEEEecCC
Confidence            457999999999999999999999999986432   224567889999999995 9999999999999999999999999


Q ss_pred             CCchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc-c
Q 040917          118 GGELFDRIVAR-GHY--SERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-Y  193 (494)
Q Consensus       118 g~sL~~~~~~~-~~l--~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~-~  193 (494)
                      +++|.+++... ..+  +...+..++.||+.|+.|||++||+||||||+||+++  ...+.++|+|||.+........ .
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~~~  166 (268)
T cd06624          89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINPCT  166 (268)
T ss_pred             CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCCcc
Confidence            99999998764 445  7888999999999999999999999999999999994  2367899999999875433222 2


Q ss_pred             ccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          194 REIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       194 ~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      ....+++.|+|||.+.+   .++.++|+||+|+++|+|++|..||............ .............+++.+.+++
T Consensus       167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li  245 (268)
T cd06624         167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIHPEIPESLSAEAKNFI  245 (268)
T ss_pred             ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccCCCCCcccCHHHHHHH
Confidence            23457889999998853   3788999999999999999999999754432221111 1101111112235788999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCcc
Q 040917          271 RRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       271 ~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      .+||..+|.+|||+.+++.||||
T Consensus       246 ~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         246 LRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHcCCCchhCCCHHHHHhCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.1e-38  Score=302.47  Aligned_cols=257  Identities=32%  Similarity=0.533  Sum_probs=218.3

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      +....|.+...||+|++|.||+|.+..++..|++|++.....    ....+.+|+.+++.+. ||||+++++.+......
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   90 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLVGDEL   90 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEECCEE
Confidence            456789999999999999999999998999999999964332    4567889999999995 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          110 HIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      ++++||++|++|.+++.... .++...+..++.+++.|+.|||+.|++|+||+|+||++   +.++.++|+|||.+....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhhc
Confidence            99999999999999998876 79999999999999999999999999999999999999   678899999999876543


Q ss_pred             cCc-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917          189 EGK-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       189 ~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (494)
                      ... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|+.||...........+...... .......++..+
T Consensus       168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l  246 (286)
T cd06614         168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWSPEF  246 (286)
T ss_pred             cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCCHHH
Confidence            322 1123456789999998764 5789999999999999999999999877765554444333222 112223478999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          267 IELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      .++|.+||+.+|.+||++.++++|+||..
T Consensus       247 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         247 KDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             HHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.2e-37  Score=302.80  Aligned_cols=256  Identities=25%  Similarity=0.427  Sum_probs=215.9

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      +...|...+.||+|+||.||+|.+..++..||+|.+.............+.+|+.+++.+. |||++++++++..+...+
T Consensus        23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~  101 (317)
T cd06635          23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHTAW  101 (317)
T ss_pred             chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCeEE
Confidence            4456889999999999999999999999999999987654444445567889999999995 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          111 IVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      +||||+.| +|.+.+.. ..+++...+..++.+++.|+.|||++|++||||+|+||++   +.++.++|+|||++.....
T Consensus       102 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635         102 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIASP  177 (317)
T ss_pred             EEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCccccCC
Confidence            99999975 77776654 4568999999999999999999999999999999999999   6778999999998865432


Q ss_pred             CcccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          190 GKAYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       190 ~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      .   ....+++.|+|||.+.    +.++.++|+||+||++|+|++|..||...........+........  ....+++.
T Consensus       178 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  252 (317)
T cd06635         178 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--QSNEWSDY  252 (317)
T ss_pred             c---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--CCccccHH
Confidence            2   2346788999999873    4588899999999999999999999988776666655555433222  22457889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      +.+++.+||..+|.+||++.++++|+|+...
T Consensus       253 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         253 FRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence            9999999999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3e-38  Score=304.19  Aligned_cols=249  Identities=24%  Similarity=0.325  Sum_probs=204.6

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCc--EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGL--EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~--~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ++|++.+.||+|+||.||+|.+..++.  .+++|.++..  ........+.+|+.++.++.+||||+++++++......+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            479999999999999999999877765  4688877532  233345678899999999966999999999999888999


Q ss_pred             EEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917          111 IVMELCAGGELFDRIVARG----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA  174 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~  174 (494)
                      +++||+++++|.+++....                .++...+..++.|++.|+.|||++|++||||||+||++   +.++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENL  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCC
Confidence            9999999999999986542                47888999999999999999999999999999999999   6788


Q ss_pred             eEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCc
Q 040917          175 VVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEI  252 (494)
Q Consensus       175 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~  252 (494)
                      .++|+|||++..............+..|+|||.+.+ .++.++|||||||++|+|++ |..||......+....+.....
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~  236 (297)
T cd05089         157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  236 (297)
T ss_pred             eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence            999999999864322111111222456999998764 58999999999999999997 9999998888777766655422


Q ss_pred             cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          253 NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .   .....++..+.+++.+||..+|.+||+++++++
T Consensus       237 ~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  270 (297)
T cd05089         237 M---EKPRNCDDEVYELMRQCWRDRPYERPPFAQISV  270 (297)
T ss_pred             C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            1   122457899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-38  Score=297.06  Aligned_cols=245  Identities=36%  Similarity=0.655  Sum_probs=213.3

Q ss_pred             ecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCc
Q 040917           41 VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGE  120 (494)
Q Consensus        41 lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~s  120 (494)
                      ||+|++|.||+|.+..+++.+++|++.............+.+|+.+++++. ||||+++++.+..+...++|||++++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            699999999999999899999999997765544445678899999999995 9999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-cccccccCC
Q 040917          121 LFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-KAYREIVGS  199 (494)
Q Consensus       121 L~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-~~~~~~~~~  199 (494)
                      |.+++.....+++..+..++.|++.|+.|||+.+++|+||+|+||++   +..+.++|+|||.+...... .......++
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (250)
T cd05123          80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGT  156 (250)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCCcccCCcCC
Confidence            99999888789999999999999999999999999999999999999   67789999999998765433 223445678


Q ss_pred             cCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCC
Q 040917          200 PYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP  278 (494)
Q Consensus       200 ~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp  278 (494)
                      ..|+|||...+ ..+.++|+||||+++|++++|..||...........+.......+    ...+..+.+++.+||..||
T Consensus       157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~~i~~~l~~~p  232 (250)
T cd05123         157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQKDP  232 (250)
T ss_pred             ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhcCCH
Confidence            89999998865 478899999999999999999999988877666666655333222    3458999999999999999


Q ss_pred             CCCCCH---HHHhcCCcc
Q 040917          279 KRRITV---AQVLEHPWL  293 (494)
Q Consensus       279 ~~Rps~---~eil~~~~~  293 (494)
                      ++||++   +++++||||
T Consensus       233 ~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         233 TKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             hhCCCcccHHHHHhCCCC
Confidence            999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.3e-38  Score=300.82  Aligned_cols=251  Identities=22%  Similarity=0.345  Sum_probs=206.6

Q ss_pred             cccceEeeeeecccCCeEEEEEEEC-----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTEN-----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED  105 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~  105 (494)
                      ..++|++.+.||+|++|.||+|.+.     .++..||+|++....  .......+.+|+.+++.+ +||||+++++++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~   80 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ   80 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC
Confidence            4578999999999999999999864     245679999985432  222355688999999999 59999999999998


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCe
Q 040917          106 DQFVHIVMELCAGGELFDRIVARG----------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAV  175 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~  175 (494)
                      +...++||||+++++|.+++....          .++...+..++.|++.|+.|||++|++||||||+||++   ++++.
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~~  157 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFT  157 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCCC
Confidence            899999999999999999986532          24677889999999999999999999999999999999   67889


Q ss_pred             EEEeecCCccccccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcC
Q 040917          176 VKATDFGLSAFIEEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKG  250 (494)
Q Consensus       176 ~kL~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~  250 (494)
                      ++|+|||++.........   ....+++.|+|||.+.+ .++.++|+|||||++|+|++ |..||.+...+.....+...
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  237 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG  237 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            999999998754332211   12234678999999864 58999999999999999999 78999888887777766655


Q ss_pred             CccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          251 EINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      .....   ...++..+.+++.+||..+|++|||+.+++++
T Consensus       238 ~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         238 GLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            43222   23578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-38  Score=301.58  Aligned_cols=254  Identities=28%  Similarity=0.461  Sum_probs=207.5

Q ss_pred             eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc--CCCCccEEeEEEEeCCe----
Q 040917           35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS--GQPNIVQFKAAYEDDQF----  108 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~i~~~~~~~~~~~~----  108 (494)
                      |++.+.||+|++|.||+|.++.+++.||+|.+..... .......+.+|+.++++++  +||||+++++++.....    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            7889999999999999999998999999999975443 2223455667888887774  49999999999987766    


Q ss_pred             -EEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          109 -VHIVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       109 -~~iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                       .+++||++.+ +|.+++....  .+++..+..++.|++.||.|||+++++|+||+|+||++   +.++.++|+|||.+.
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~  155 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLAR  155 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcce
Confidence             9999999975 8988887643  48999999999999999999999999999999999999   567899999999987


Q ss_pred             ccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc-----CC----
Q 040917          186 FIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN-----FQ----  255 (494)
Q Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~-----~~----  255 (494)
                      ............++..|+|||.+.+ .++.++|+||+||++|+|++|..||.+....+....+......     ++    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            7654443344557889999998864 5788999999999999999999999888776655544321100     00    


Q ss_pred             --------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          256 --------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       256 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                                    ....+.++..+.++|.+||..||.+||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                          00112456788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.5e-38  Score=301.60  Aligned_cols=247  Identities=23%  Similarity=0.407  Sum_probs=208.0

Q ss_pred             cceEeeeeecccCCeEEEEEEEC-----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           33 LHYTIGREVGRGEFGITYLCTEN-----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .+|.+.+.||+|+||.||++.+.     .++..+++|.+...   .......+.+|+.+++++. ||||+++++++....
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   80 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGD   80 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCC
Confidence            57999999999999999999852     34567899988543   2334667899999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917          108 FVHIVMELCAGGELFDRIVARG-------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA  174 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~-------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~  174 (494)
                      ..++||||+++++|.+++...+             .+++..+..++.|++.||.|||++|++||||||+||++   +.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccCC
Confidence            9999999999999999987543             38999999999999999999999999999999999999   6788


Q ss_pred             eEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHc
Q 040917          175 VVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILK  249 (494)
Q Consensus       175 ~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~  249 (494)
                      .++|+|||.+........   .....+++.|+|||.+.+ .++.++|+|||||++|+|++ |..||......+....+.+
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~  237 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  237 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999875533221   112334678999998874 58899999999999999998 8999988888777777776


Q ss_pred             CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          250 GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +......   ..++..+.+++.+||..||.+|||+.++++
T Consensus       238 ~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         238 GRVLQRP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCcCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            6433221   357889999999999999999999999966

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.5e-38  Score=304.46  Aligned_cols=257  Identities=25%  Similarity=0.425  Sum_probs=214.0

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ....|.+.+.||+|++|.||+|.+..+++.|++|.+.............+.+|+.+++.+. |||++++.+++......+
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   91 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW   91 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCeeE
Confidence            3456888999999999999999999999999999986543333344567788999999994 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          111 IVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      +||||+. ++|.+.+.. ...++...+..++.+++.|+.|||+++++||||+|+||++   +.++.++|+|||++.....
T Consensus        92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceeecC
Confidence            9999996 478776654 4468999999999999999999999999999999999999   5678999999999875433


Q ss_pred             CcccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          190 GKAYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       190 ~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      .   ....+++.|+|||.+.    +.++.++|||||||++|+|++|..||...........+........  ....++..
T Consensus       168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  242 (308)
T cd06634         168 A---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEY  242 (308)
T ss_pred             c---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCc--CcccccHH
Confidence            2   2346788999999874    3578899999999999999999999977665555544444333221  12357889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      +.++|.+||..+|.+||++.++++|||+....
T Consensus       243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence            99999999999999999999999999999744

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.7e-38  Score=297.44  Aligned_cols=251  Identities=29%  Similarity=0.544  Sum_probs=209.2

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|++|.||+|.+..+|+.|++|.++............+.+|+.+++++ +|+||+++++.+...+..++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEEEE
Confidence            5799999999999999999999999999999998755444444567889999999999 599999999999999999999


Q ss_pred             EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          113 MELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      |||++|++|.+++..    ...++...+..++.+++.|+.|||+.|++||||+|+||++   +.++.++|+|||.+....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence            999999999998864    2358899999999999999999999999999999999999   678899999999987554


Q ss_pred             cCc-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHcCCccCCCCCCCCCCH
Q 040917          189 EGK-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD--QGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       189 ~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      ... ......+++.|.|||.+.+ .++.++|+|||||++++|++|+.||.....  ......+..+..  ++.+.+.++.
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  235 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY--PPLPADHYSE  235 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC--CCCChhhcCH
Confidence            322 2233567889999998764 588899999999999999999999955432  233333333322  2222236788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+.++|.+||..+|++||++.++++
T Consensus       236 ~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         236 ELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.2e-38  Score=314.25  Aligned_cols=255  Identities=22%  Similarity=0.343  Sum_probs=204.7

Q ss_pred             cccccccceEeeeeecccCCeEEEEEEECCC-----CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeE
Q 040917           27 AYEDVQLHYTIGREVGRGEFGITYLCTENST-----GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKA  101 (494)
Q Consensus        27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~  101 (494)
                      +.+-..++|.+++.||+|+||.||+|.+...     +..||+|++....  .....+.+.+|+.+++++..||||+++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~  108 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG  108 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence            3444467899999999999999999987533     3469999986432  23345678999999999956999999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhc-----------------------------------------------------
Q 040917          102 AYEDDQFVHIVMELCAGGELFDRIVAR-----------------------------------------------------  128 (494)
Q Consensus       102 ~~~~~~~~~iv~e~~~g~sL~~~~~~~-----------------------------------------------------  128 (494)
                      ++......++|||||++|+|.+++..+                                                     
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (400)
T cd05105         109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY  188 (400)
T ss_pred             EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence            999999999999999999999887542                                                     


Q ss_pred             -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 040917          129 -------------------------------------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENF  165 (494)
Q Consensus       129 -------------------------------------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NI  165 (494)
                                                                 ..++...+..++.||+.||.|||+++|+||||||+||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni  268 (400)
T cd05105         189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV  268 (400)
T ss_pred             chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence                                                       1367778889999999999999999999999999999


Q ss_pred             EEeeCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 040917          166 LFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETD  240 (494)
Q Consensus       166 li~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~  240 (494)
                      ++   +.++.++|+|||++........   .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.....
T Consensus       269 ll---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~  345 (400)
T cd05105         269 LL---AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV  345 (400)
T ss_pred             EE---eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence            99   5678899999999875433221   122345678999998864 58999999999999999997 8999977654


Q ss_pred             HHHH-HHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          241 QGVA-QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       241 ~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .... ..+..+ ....  ....++..+.+++.+||..+|++||++.++.+
T Consensus       346 ~~~~~~~~~~~-~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         346 DSTFYNKIKSG-YRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             hHHHHHHHhcC-CCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            4333 333332 2222  22467899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.6e-38  Score=296.22  Aligned_cols=246  Identities=22%  Similarity=0.356  Sum_probs=206.4

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++.+.||+|++|.||.|.+.. +..||+|.+.....    ..+.+.+|+.+++++. ||||+++++++......+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCcEEE
Confidence            579999999999999999998754 55699999864332    3466889999999995 99999999999888889999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      |||+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||++   +.++.++|+|||.+.......
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCc
Confidence            9999999999998764 368999999999999999999999999999999999999   677899999999987543322


Q ss_pred             cc--ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          192 AY--REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       192 ~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      ..  ....++..|+|||.+. +.++.++|+|||||++|+|++ |..||......+....+.++...+..   ...+..+.
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  231 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASEKVY  231 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCHHHH
Confidence            11  1123456799999986 468899999999999999998 99999888877777777665433222   34678999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcC
Q 040917          268 ELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      +++.+||..+|.+||++.+++++
T Consensus       232 ~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         232 AIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHcCCCcccCCCHHHHHHh
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.6e-38  Score=302.60  Aligned_cols=259  Identities=31%  Similarity=0.547  Sum_probs=215.5

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ..|.....||+|++|.||++.+..+++.||+|.+...   .......+.+|+.+++.+. ||||+++++.+...+..+++
T Consensus        20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   95 (292)
T cd06657          20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVV   95 (292)
T ss_pred             HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEEE
Confidence            4455567899999999999999999999999998532   2334667889999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-  191 (494)
                      |||+++++|.+++.. ..++...+..++.|++.|+.|||++|++||||+|+||++   +.++.++|+|||.+....... 
T Consensus        96 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~  171 (292)
T cd06657          96 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP  171 (292)
T ss_pred             EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccccc
Confidence            999999999987654 468999999999999999999999999999999999999   677889999999886553322 


Q ss_pred             ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      ......+++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.+.........+...... .......++..+.+++
T Consensus       172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li  250 (292)
T cd06657         172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-KLKNLHKVSPSLKGFL  250 (292)
T ss_pred             cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc-ccCCcccCCHHHHHHH
Confidence            1233567889999998754 5788999999999999999999999877766555554332221 1112346789999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCccCccCcCC
Q 040917          271 RRMLTQDPKRRITVAQVLEHPWLKESGEAS  300 (494)
Q Consensus       271 ~~~l~~dp~~Rps~~eil~~~~~~~~~~~~  300 (494)
                      .+||..+|.+||++.++++||||.....++
T Consensus       251 ~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~  280 (292)
T cd06657         251 DRLLVRDPAQRATAAELLKHPFLAKAGPPS  280 (292)
T ss_pred             HHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence            999999999999999999999999876443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.4e-38  Score=296.21  Aligned_cols=251  Identities=29%  Similarity=0.510  Sum_probs=216.3

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +|++.+.||+|++|.||++.+..+++.+++|.+...... ......+.+|+.+++.+. ||||+++.+++......++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEEEEe
Confidence            589999999999999999999999999999998754432 334567788999999995 999999999999999999999


Q ss_pred             eccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          114 ELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       114 e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      ||+++++|.+++..    ...++...+..++.+++.||.|||+.|++|+||+|.||++   +.++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~---~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL---VANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---ecCCcEEEeeccchhhhcc
Confidence            99999999998866    3468999999999999999999999999999999999999   5678899999999876654


Q ss_pred             CcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917          190 GKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE  268 (494)
Q Consensus       190 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  268 (494)
                      . ......+++.|+|||.+.+ .++.++|+||+|+++++|++|+.||.....+.....+.........   ..++..+.+
T Consensus       156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (256)
T cd08530         156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP---PIYSQDLQN  231 (256)
T ss_pred             C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc---hhhCHHHHH
Confidence            4 3334567889999999865 4788999999999999999999999988877776666554332221   367899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          269 LVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       269 li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      ++.+||..+|.+||++.++++||++
T Consensus       232 li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         232 FIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.7e-38  Score=299.50  Aligned_cols=245  Identities=29%  Similarity=0.480  Sum_probs=201.4

Q ss_pred             EeeeeecccCCeEEEEEEEC----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           36 TIGREVGRGEFGITYLCTEN----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        36 ~i~~~lg~G~~g~Vy~a~~~----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      ++.+.||.|+||.||+|.+.    ..+..|+||.+...  ......+.+.+|++.++++ +||||+++++++...+..++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccc-cccccccccccccccccccc
Confidence            46789999999999999987    55778999999542  2333578899999999999 59999999999998788999


Q ss_pred             EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          112 VMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      |+||+++|+|.+++...  ..++...+..++.||+.||.|||+++++|++|+++||++   +.++.+||+|||++.....
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence            99999999999999886  679999999999999999999999999999999999999   5788999999999976622


Q ss_pred             Ccc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          190 GKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       190 ~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      ...   .........|+|||.+.. .++.++||||||+++|++++ |+.||.......+...+..+.....   ...++.
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~  232 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI---PDNCPK  232 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS---BTTSBH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccee---ccchhH
Confidence            211   122345678999999864 58999999999999999999 7899998888888877755544222   246789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+.+++..||..+|.+|||+.++++
T Consensus       233 ~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  233 DIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHh
Confidence            9999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-38  Score=310.38  Aligned_cols=272  Identities=26%  Similarity=0.452  Sum_probs=216.4

Q ss_pred             hhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEE
Q 040917           23 ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAA  102 (494)
Q Consensus        23 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~  102 (494)
                      ......+.+.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.++++++ ||||++++++
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~   84 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDV   84 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcC-CCcccceeee
Confidence            344456678899999999999999999999999999999999986532 22223566788999999995 9999999998


Q ss_pred             EEeC------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917          103 YEDD------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV  176 (494)
Q Consensus       103 ~~~~------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~  176 (494)
                      +...      ...+++++++ |++|.+++.. ..++...+..++.|++.||.|||++||+||||||+||++   +.++.+
T Consensus        85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~  159 (345)
T cd07877          85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCEL  159 (345)
T ss_pred             eeecccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCE
Confidence            8543      3477888887 7799887754 468999999999999999999999999999999999999   678899


Q ss_pred             EEeecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc--
Q 040917          177 KATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI--  252 (494)
Q Consensus       177 kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~--  252 (494)
                      +|+|||++.....  ......+++.|+|||.+.+  .++.++|+||+||++|+|++|+.||...........+.....  
T Consensus       160 kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (345)
T cd07877         160 KILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP  237 (345)
T ss_pred             EEecccccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999999875432  2234567889999998754  478899999999999999999999977665443333221100  


Q ss_pred             ---------------------cCCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCC
Q 040917          253 ---------------------NFQR----DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKP  303 (494)
Q Consensus       253 ---------------------~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~  303 (494)
                                           ..+.    ..+...++.+.++|.+||..||.+||++.++++||||+....+...+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~  313 (345)
T cd07877         238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP  313 (345)
T ss_pred             CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccc
Confidence                                 0000    11124578899999999999999999999999999999766555444

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.9e-38  Score=311.22  Aligned_cols=265  Identities=28%  Similarity=0.466  Sum_probs=213.3

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--C
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--Q  107 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--~  107 (494)
                      .+.++|++.+.||+|++|.||+|.+..+|+.+|+|++.... ........+.+|+.+++++.+||||+++++++...  .
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            46689999999999999999999999999999999986432 12223456778999999995599999999988643  4


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      ..++||||+.+ +|.+++... .++...+..++.||+.||.|||++||+||||+|+||++   +.++.++|+|||.+...
T Consensus        83 ~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          83 DIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSL  157 (337)
T ss_pred             eEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchhcc
Confidence            68999999974 999888765 78899999999999999999999999999999999999   67899999999998765


Q ss_pred             ccCc------ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC--------
Q 040917          188 EEGK------AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE--------  251 (494)
Q Consensus       188 ~~~~------~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~--------  251 (494)
                      ....      ......+++.|+|||.+.+  .++.++|+||||+++|+|++|+.||.+....+....+....        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            3322      2223467889999998743  47889999999999999999999998766554333221111        


Q ss_pred             -------------------ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCC
Q 040917          252 -------------------INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS  300 (494)
Q Consensus       252 -------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~  300 (494)
                                         ........+.++..+.++|.+||+.+|++|||+.++++|||++....+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~  305 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPS  305 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCC
Confidence                               1111122345789999999999999999999999999999998754443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.2e-38  Score=309.99  Aligned_cols=251  Identities=22%  Similarity=0.345  Sum_probs=200.4

Q ss_pred             ccceEeeeeecccCCeEEEEEEEC-----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-
Q 040917           32 QLHYTIGREVGRGEFGITYLCTEN-----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-  105 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-  105 (494)
                      .++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .......+.+|+.++.++.+||||+++++++.. 
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            368999999999999999999754     345789999986432  222356678899999999669999999998764 


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc---------------------------------------------------------
Q 040917          106 DQFVHIVMELCAGGELFDRIVAR---------------------------------------------------------  128 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~---------------------------------------------------------  128 (494)
                      +..+++++||+++++|.+++...                                                         
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            45788999999999999988542                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc---cccccCCcC
Q 040917          129 ----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPY  201 (494)
Q Consensus       129 ----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~  201 (494)
                          ..++...+..++.||+.||.|||++||+||||||.||++   +.++.++|+|||++........   .....++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                257888999999999999999999999999999999999   5678899999999976533221   112345678


Q ss_pred             ccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHH-HHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCC
Q 040917          202 YIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVA-QAILKGEINFQRDPFPSISSSAIELVRRMLTQDP  278 (494)
Q Consensus       202 y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp  278 (494)
                      |+|||++. ..++.++|||||||++|+|++ |..||.+....+.. ..+..... ...  ....++.+.+++.+||+.+|
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~l~~~cl~~~p  317 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR-MRA--PEYATPEIYSIMLDCWHNNP  317 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC-CCC--CccCCHHHHHHHHHHccCCh
Confidence            99999875 468999999999999999998 99999775543333 33333222 111  13567899999999999999


Q ss_pred             CCCCCHHHHhcC
Q 040917          279 KRRITVAQVLEH  290 (494)
Q Consensus       279 ~~Rps~~eil~~  290 (494)
                      ++||++.++++|
T Consensus       318 ~~RPs~~ell~~  329 (337)
T cd05054         318 EDRPTFSELVEI  329 (337)
T ss_pred             hhCcCHHHHHHH
Confidence            999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-38  Score=296.59  Aligned_cols=249  Identities=25%  Similarity=0.409  Sum_probs=208.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECCC---CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENST---GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~---~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      ++|++.+.||+|+||.||+|.+..+   ...|++|.+....  .......+.+|+.+++.+. ||||+++++++......
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCce
Confidence            5799999999999999999998654   4579999986433  3334667889999999995 99999999999998999


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      +++|||+++++|.+++... +.++...+..++.+++.|+.|||+++|+||||+|+||++   +.++.++|+|||.+....
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhccc
Confidence            9999999999999998764 468999999999999999999999999999999999999   678899999999998764


Q ss_pred             cCc-ccc--cccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917          189 EGK-AYR--EIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       189 ~~~-~~~--~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      ... ...  ...+++.|+|||.+.+ .++.++|+||||+++|+|++ |..||...........+.......   ....++
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~  234 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP---PPMDCP  234 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCC
Confidence            211 111  1233567999998864 58899999999999999998 999998888777777666542221   124678


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          264 SSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      ..+.+++.+||+.+|++||++.+++++
T Consensus       235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         235 SALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.7e-38  Score=302.12  Aligned_cols=259  Identities=27%  Similarity=0.385  Sum_probs=209.8

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++.+.||+|++|.||+|.+..+++.||+|.+.....  ......+..|+.++.++.+||||+++++++......++
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~   91 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI   91 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence            3679999999999999999999999999999999975432  22345566788777777679999999999999999999


Q ss_pred             EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          112 VMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      +|||+.+ +|.+++.. ...++...+..++.+++.|+.|||+ .||+||||+|+||++   ++++.++|+|||.+.....
T Consensus        92 v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          92 CMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             EeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchhccC
Confidence            9999854 77776655 3568999999999999999999997 599999999999999   6788999999999876544


Q ss_pred             CcccccccCCcCccChhhhcc-----cCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcCCccCCCCCCCCCC
Q 040917          190 GKAYREIVGSPYYIAPEVLSQ-----SYGKEADIWSAGVILYILLCGVPPFWAETD-QGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       190 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      ........+++.|+|||.+.+     .++.++|+||||+++|+|++|+.||..... .+....+......... ....++
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  246 (296)
T cd06618         168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP-PNEGFS  246 (296)
T ss_pred             CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCC-CCCCCC
Confidence            333334457789999998853     378899999999999999999999976433 2334444333222211 122478


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ..+.+++.+||..||.+||++.+++.||||....
T Consensus       247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence            8999999999999999999999999999998643

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1e-37  Score=299.19  Aligned_cols=255  Identities=24%  Similarity=0.347  Sum_probs=208.2

Q ss_pred             ccceEeeeeecccCCeEEEEEEECC-----CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENS-----TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      .++|++.+.||+|+||.||+|.++.     .+..||+|.+....  .......+.+|+.+++.+ +||||+++++++...
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   81 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGF-TCHHVVRLLGVVSKG   81 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCC
Confidence            4789999999999999999997642     35589999886433  222345678899999999 599999999999988


Q ss_pred             CeEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917          107 QFVHIVMELCAGGELFDRIVAR----------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV  176 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~  176 (494)
                      ...++||||+++|+|.+++...          ..++...+..++.|++.||.|||+++++||||||+||++   +.++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCCCcE
Confidence            8999999999999999999653          234567889999999999999999999999999999999   678899


Q ss_pred             EEeecCCccccccCccc---ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCC
Q 040917          177 KATDFGLSAFIEEGKAY---REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGE  251 (494)
Q Consensus       177 kL~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~  251 (494)
                      +|+|||++.........   ....++..|+|||.+. +.++.++|+|||||++|+|++ |..||.+...++....+..+.
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~  238 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG  238 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            99999998754332211   1123466799999875 468999999999999999998 788998888777776665543


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc------CCccCc
Q 040917          252 INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE------HPWLKE  295 (494)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~------~~~~~~  295 (494)
                      ....   ....++.+.+++.+||..+|++|||+.++++      ||||..
T Consensus       239 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         239 YLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             CCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            3221   1356789999999999999999999999987      888875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-38  Score=324.59  Aligned_cols=264  Identities=20%  Similarity=0.276  Sum_probs=195.1

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCC-cEEEEE--------------EeccCCCCChhhHHHHHHHHHHHHHccC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTG-LEFACK--------------SIPKRKLVKDVEKDDVRREIEIMRHLSG   92 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~-~~valK--------------~~~~~~~~~~~~~~~~~~E~~~l~~l~~   92 (494)
                      .+.+.++|++++.||+|+||+||+|..+... ..++.|              .+.+...........+.+|+.+++++. 
T Consensus       143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-  221 (501)
T PHA03210        143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-  221 (501)
T ss_pred             chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-
Confidence            3456689999999999999999998764332 222222              111111112224556889999999994 


Q ss_pred             CCCccEEeEEEEeCCeEEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEE
Q 040917           93 QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLF  167 (494)
Q Consensus        93 hp~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli  167 (494)
                      ||||+++++++......|+|++++. ++|.+++...     .......+..++.||+.||.|||++||+||||||+|||+
T Consensus       222 HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl  300 (501)
T PHA03210        222 HENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL  300 (501)
T ss_pred             CCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            9999999999999999999999995 5787776543     123466788899999999999999999999999999999


Q ss_pred             eeCCCCCeEEEeecCCccccccCcc--cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCC-CC--h-
Q 040917          168 TTGDENAVVKATDFGLSAFIEEGKA--YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWA-ET--D-  240 (494)
Q Consensus       168 ~~~~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~-~~--~-  240 (494)
                         +.++.+||+|||++........  .....|++.|+|||++.+ .++.++|||||||++|+|++|..++.. ..  . 
T Consensus       301 ---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~  377 (501)
T PHA03210        301 ---NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG  377 (501)
T ss_pred             ---CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence               6788999999999976543322  223578999999999865 589999999999999999998764432 21  1 


Q ss_pred             HHHHHHHHcCC---ccCCC------------------C------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          241 QGVAQAILKGE---INFQR------------------D------PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       241 ~~~~~~~~~~~---~~~~~------------------~------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      ..+.+.+....   ..++.                  .      ....++..+.++|.+||..||.+|||+.|+|.||||
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f  457 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF  457 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence            11111111100   00000                  0      001356678888999999999999999999999999


Q ss_pred             Ccc
Q 040917          294 KES  296 (494)
Q Consensus       294 ~~~  296 (494)
                      ...
T Consensus       458 ~~~  460 (501)
T PHA03210        458 SAE  460 (501)
T ss_pred             hcC
Confidence            864

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.5e-38  Score=294.51  Aligned_cols=242  Identities=26%  Similarity=0.385  Sum_probs=200.5

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG  118 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g  118 (494)
                      +.||+|+||.||+|.+..+++.||+|.+....  .......+.+|+.+++.+ +||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEeeccC
Confidence            46999999999999999999999999886432  333567789999999999 599999999999999999999999999


Q ss_pred             CchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcccc---
Q 040917          119 GELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---  194 (494)
Q Consensus       119 ~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~---  194 (494)
                      ++|.+++...+ .+++..+..++.|++.||.|||++|++||||+|.||++   +.++.++|+|||.+..........   
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccccCC
Confidence            99999987644 58999999999999999999999999999999999999   677889999999987543221110   


Q ss_pred             cccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHH
Q 040917          195 EIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR  272 (494)
Q Consensus       195 ~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  272 (494)
                      ....+..|+|||.+. +.++.++|+|||||++|+|++ |..||...........+......   .....++..+.+++.+
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~  231 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL---PCPELCPDAVYRLMER  231 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---CCcccCCHHHHHHHHH
Confidence            112245699999876 458899999999999999997 88999877776665555543222   1224578999999999


Q ss_pred             hcccCCCCCCCHHHHhc
Q 040917          273 MLTQDPKRRITVAQVLE  289 (494)
Q Consensus       273 ~l~~dp~~Rps~~eil~  289 (494)
                      ||..+|++|||+.++++
T Consensus       232 ~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         232 CWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=8.2e-38  Score=295.41  Aligned_cols=245  Identities=21%  Similarity=0.355  Sum_probs=206.6

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++++.||+|++|.||+|.+. .+..|++|.+....    ...+.+.+|+.+++.+. ||||+++++.+...+..+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPIYII   79 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCcEEE
Confidence            68999999999999999999864 56779999876432    23567889999999995 99999999999988999999


Q ss_pred             EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          113 MELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      |||+++++|.+++...  ..++...+..++.+++.||.|||+++++||||+|+||++   +.++.++|+|||.+......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecCCC
Confidence            9999999999998653  457888999999999999999999999999999999999   67889999999999765432


Q ss_pred             ccc--ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917          191 KAY--REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       191 ~~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (494)
                      ...  ....++..|+|||.+. +.++.++|+|||||++|+|++ |..||...........+.....   .+....++..+
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  233 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR---MPRMENCPDEL  233 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHH
Confidence            211  1223456799999876 458889999999999999998 9999988887777776655422   22234688999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhc
Q 040917          267 IELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+++.+||..+|++||+++++++
T Consensus       234 ~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         234 YDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.6e-38  Score=304.99  Aligned_cols=248  Identities=19%  Similarity=0.304  Sum_probs=204.0

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcE----EEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLE----FACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~----valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      .+|++.+.||+|+||.||+|.+..++..    ||+|.+....  .......+.+|+.+++.+. ||||+++++++... .
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~-~   82 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T   82 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-C
Confidence            5799999999999999999998766664    8999986432  3334667889999999994 99999999998765 4


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .+++++|+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++...
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL  159 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEccccccccc
Confidence            67999999999999999764 358899999999999999999999999999999999999   67788999999999865


Q ss_pred             ccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          188 EEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       188 ~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      ......   ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+....++...+..+. ..+.  .+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~  236 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQ--PPIC  236 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC-CCCC--CCCC
Confidence            433221   12233567999998864 68999999999999999997 999998877766555444332 2222  2457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      +..+.+++.+||..+|.+||++.+++.+
T Consensus       237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         237 TIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            7899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.4e-38  Score=308.96  Aligned_cols=266  Identities=27%  Similarity=0.452  Sum_probs=213.8

Q ss_pred             hhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEE
Q 040917           23 ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAA  102 (494)
Q Consensus        23 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~  102 (494)
                      ...++.+.+..+|.+.+.||+|++|.||+|.+..+|+.||+|.+.... ........+.+|+.+++.+ +||||++++++
T Consensus         5 ~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~   82 (342)
T cd07879           5 EVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHM-QHENVIGLLDV   82 (342)
T ss_pred             hhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhc-CCCCccchhhe
Confidence            345566777889999999999999999999999999999999987543 2223345678899999999 49999999999


Q ss_pred             EEeC------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917          103 YEDD------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV  176 (494)
Q Consensus       103 ~~~~------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~  176 (494)
                      +...      ..+++|++|+.. +|..+.  ...++...+..++.|++.||.|||++|++||||+|+||++   +.++.+
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~  156 (342)
T cd07879          83 FTSAVSGDEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCEL  156 (342)
T ss_pred             ecccccCCCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCE
Confidence            8643      346899999964 676654  3468999999999999999999999999999999999999   678899


Q ss_pred             EEeecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc--
Q 040917          177 KATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI--  252 (494)
Q Consensus       177 kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~--  252 (494)
                      +|+|||++.....  ......+++.|+|||.+.+  .++.++|+|||||++|+|++|+.||.+.........+.....  
T Consensus       157 kL~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  234 (342)
T cd07879         157 KILDFGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP  234 (342)
T ss_pred             EEeeCCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999999875432  2234567889999998754  478899999999999999999999988765544443322100  


Q ss_pred             ---------------------cCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          253 ---------------------NFQRD----PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       253 ---------------------~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                                           ..+..    .++..+..+.++|.+||+.||.+||++.+++.||||.....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                                 00111    12456788999999999999999999999999999987543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.5e-38  Score=303.82  Aligned_cols=257  Identities=31%  Similarity=0.497  Sum_probs=208.1

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC---
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ---  107 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~---  107 (494)
                      ..++|++.+.||+|++|.||+|.++.+|+.||+|.+..... .......+.+|+.++++++ ||||+++++++....   
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchhh
Confidence            44789999999999999999999999999999999865432 2223456778999999995 999999999886544   


Q ss_pred             -------eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEe
Q 040917          108 -------FVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKAT  179 (494)
Q Consensus       108 -------~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~  179 (494)
                             ..++|+||+++ ++...+... ..++...+..++.||+.||.|||++||+|+||+|+||++   ++++.++|+
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl~  158 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKLA  158 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEeC
Confidence                   78999999976 777766553 468999999999999999999999999999999999999   678899999


Q ss_pred             ecCCccccccCc--ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC
Q 040917          180 DFGLSAFIEEGK--AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ  255 (494)
Q Consensus       180 Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  255 (494)
                      |||.+.......  ......++..|+|||.+.+  .++.++|+||+||++++|++|+.||......+....+........
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  238 (302)
T cd07864         159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC  238 (302)
T ss_pred             cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            999987654322  1222345778999998854  478899999999999999999999987666554443332110000


Q ss_pred             --------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          256 --------------------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       256 --------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                                                ...+..+|..+.+++.+||..+|.+||++.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                      01123578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-38  Score=295.01  Aligned_cols=243  Identities=26%  Similarity=0.404  Sum_probs=209.1

Q ss_pred             eeecccCCeEEEEEEECCC---CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEec
Q 040917           39 REVGRGEFGITYLCTENST---GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMEL  115 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~---~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~  115 (494)
                      +.||+|+||.||+|.+...   +..|++|.+.......  ....+.+|+.+++.+. ||||+++++++......+++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence            4699999999999999866   9999999997544322  4678899999999996 99999999999998999999999


Q ss_pred             cCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          116 CAGGELFDRIVAR---------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       116 ~~g~sL~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      +++++|.+++...         ..+++..+..++.|++.||.|||++|++||||+|+||++   +.++.++|+|||.+..
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~  154 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRD  154 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccc
Confidence            9999999999875         679999999999999999999999999999999999999   6779999999999987


Q ss_pred             cccCc---ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917          187 IEEGK---AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       187 ~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (494)
                      .....   ......+++.|+|||.+.. .++.++|+||+|+++|+|++ |..||...........+..+....   ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~  231 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLP---KPEY  231 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCcc
Confidence            65432   1233456788999998864 68899999999999999999 699999888877777776633221   2245


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      +|..+.+++.+||..+|.+|||+.+++++
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         232 CPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            68999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=8.4e-38  Score=301.00  Aligned_cols=252  Identities=22%  Similarity=0.293  Sum_probs=207.3

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCC----------------cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCC
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTG----------------LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN   95 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~----------------~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~   95 (494)
                      .++|++++.||+|+||.||+|.+..++                ..||+|.+....  .......+.+|+.++++++ |||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~   80 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLS-DPN   80 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcC-CCC
Confidence            368999999999999999999876544                568999986543  2235677889999999995 999


Q ss_pred             ccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 040917           96 IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG-----------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPEN  164 (494)
Q Consensus        96 i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~N  164 (494)
                      |+++++++..+...++++|++++++|.+++....           .++...+..++.|++.||.|||++|++|+||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999899999999999999999997765           68999999999999999999999999999999999


Q ss_pred             eEEeeCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh--CCCCCCCC
Q 040917          165 FLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC--GVPPFWAE  238 (494)
Q Consensus       165 Ili~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t--g~~pf~~~  238 (494)
                      |++   +.++.++|+|||.+........   .....+++.|+|||.+.+ .++.++|||||||++|+|++  +..||...
T Consensus       161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         161 CLV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             eee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            999   5678999999999875432221   122345678999998764 68999999999999999998  77888877


Q ss_pred             ChHHHHHHHHcC----CccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          239 TDQGVAQAILKG----EINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       239 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ........+...    .........+.+|..+.+++.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            766665555432    111111222456789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-38  Score=300.97  Aligned_cols=253  Identities=33%  Similarity=0.535  Sum_probs=209.0

Q ss_pred             eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917           35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME  114 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e  114 (494)
                      |++.+.||+|++|+||+|....+++.|++|.+......  .......+|+..++++.+||||+++++++..+...++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            78899999999999999999999999999998654321  2233456799999999669999999999999999999999


Q ss_pred             ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          115 LCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       115 ~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      |+ +++|.+.+....  .++...+..++.|++.+|.|||++|++|+||+|.||++   +.++.++|+|||.+........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCC
Confidence            99 779999887764  68999999999999999999999999999999999999   6789999999999987655444


Q ss_pred             cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC---------------
Q 040917          193 YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ---------------  255 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~---------------  255 (494)
                      .....++..|+|||++.+  .++.++|+||||+++++|++|+.||......+....+........               
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            445667889999998743  478999999999999999999999987766554433321100000               


Q ss_pred             -----------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          256 -----------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       256 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                                 ....+..+..+.++|.+||..+|++||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                       00112346889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.4e-38  Score=300.96  Aligned_cols=251  Identities=24%  Similarity=0.359  Sum_probs=208.0

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCC-----CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENST-----GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      .++|++.+.||+|++|.||++.+...     ...+|+|.+....  .......+.+|+.+++++.+||||+++++++..+
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            36899999999999999999997643     3789999986432  2234566889999999995699999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC
Q 040917          107 QFVHIVMELCAGGELFDRIVAR----------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG  170 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~  170 (494)
                      ...+++|||+++++|.+++...                ..++...+..++.|++.||.|||+++|+||||||+||++   
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~---  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV---  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE---
Confidence            9999999999999999998642                357889999999999999999999999999999999999   


Q ss_pred             CCCCeEEEeecCCccccccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 040917          171 DENAVVKATDFGLSAFIEEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQ  245 (494)
Q Consensus       171 ~~~~~~kL~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~  245 (494)
                      +.++.++|+|||.+.........   ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+...
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  245 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  245 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence            67889999999998765432211   11223567999998754 58899999999999999997 999998888777776


Q ss_pred             HHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          246 AILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      .+.......   .....+..+.+++.+||..||.+|||+.+++++
T Consensus       246 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         246 LLKEGYRME---KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHcCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            665543221   123568899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1e-37  Score=301.93  Aligned_cols=253  Identities=24%  Similarity=0.360  Sum_probs=207.4

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECC-------CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeE
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENS-------TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKA  101 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~  101 (494)
                      +-..++|.+++.||+|+||.||+|.+..       ++..+|+|.+....  .......+.+|+.+++.+.+||||+++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~   91 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG   91 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            3345789999999999999999998643       23569999987532  22345678889999999966999999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 040917          102 AYEDDQFVHIVMELCAGGELFDRIVARG----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENF  165 (494)
Q Consensus       102 ~~~~~~~~~iv~e~~~g~sL~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NI  165 (494)
                      ++......++||||+++++|.+++....                .++...+..++.|++.||.|||++|++||||||+||
T Consensus        92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  171 (307)
T cd05098          92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  171 (307)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence            9999999999999999999999997642                378889999999999999999999999999999999


Q ss_pred             EEeeCCCCCeEEEeecCCccccccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 040917          166 LFTTGDENAVVKATDFGLSAFIEEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETD  240 (494)
Q Consensus       166 li~~~~~~~~~kL~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~  240 (494)
                      ++   +.++.++|+|||.+.........   ....+++.|+|||++.+ .++.++|+|||||++|+|++ |..||.+...
T Consensus       172 ll---~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~  248 (307)
T cd05098         172 LV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  248 (307)
T ss_pred             EE---cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence            99   57789999999998755332211   11223468999998864 58899999999999999998 8899988777


Q ss_pred             HHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          241 QGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+....+......   .....++..+.+++.+||..+|.+||++.++++
T Consensus       249 ~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~  294 (307)
T cd05098         249 EELFKLLKEGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  294 (307)
T ss_pred             HHHHHHHHcCCCC---CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            6666665544321   122467899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=311.39  Aligned_cols=247  Identities=32%  Similarity=0.523  Sum_probs=214.3

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      .+.+.|.+...+|.|+|+.|-.+.+..+++..++|++.++..       +..+|+.++....+||||+++.+++.++.+.
T Consensus       319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~  391 (612)
T KOG0603|consen  319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEI  391 (612)
T ss_pred             CcchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCcee
Confidence            466889999999999999999999999999999999976532       2345777777777899999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      |+|||.+.|+-|.+.+...+... ..+..|+.+|+.|+.|||.+|++||||||+|||+.  ++.++++|+|||.+.....
T Consensus       392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCch
Confidence            99999999999999887776555 78888999999999999999999999999999995  4788999999999987655


Q ss_pred             CcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          190 GKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       190 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      .  +.+.+-|..|.|||++.. .|++++||||||++||+|++|+.||...... ++...+..+.+.      ..+|..++
T Consensus       469 ~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~AK  540 (612)
T KOG0603|consen  469 S--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDEAK  540 (612)
T ss_pred             h--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHHHH
Confidence            4  445567889999999875 5999999999999999999999999877766 344444333222      57899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917          268 ELVRRMLTQDPKRRITVAQVLEHPWLK  294 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~~~~~~  294 (494)
                      +||..||+.||.+||++.+++.||||.
T Consensus       541 dLl~~LL~~dP~~Rl~~~~i~~h~w~~  567 (612)
T KOG0603|consen  541 DLLQQLLQVDPALRLGADEIGAHPWFL  567 (612)
T ss_pred             HHHHHhccCChhhCcChhhhccCcchh
Confidence            999999999999999999999999993

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.1e-37  Score=298.07  Aligned_cols=249  Identities=21%  Similarity=0.321  Sum_probs=206.3

Q ss_pred             cceEeeeeecccCCeEEEEEEEC----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           33 LHYTIGREVGRGEFGITYLCTEN----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      .+|++.+.||+|+||.||+|.+.    .++..|++|.+....  .......+.+|+.+++.+. ||||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~   81 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCc
Confidence            46899999999999999999853    456789999986432  2334567889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC
Q 040917          109 VHIVMELCAGGELFDRIVARG-----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD  171 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~-----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~  171 (494)
                      .+++|||+++++|.+++....                 .++...+..++.+++.||.|||++|++||||||+||++   +
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~  158 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---G  158 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---c
Confidence            999999999999999885332                 36788899999999999999999999999999999999   5


Q ss_pred             CCCeEEEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 040917          172 ENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQA  246 (494)
Q Consensus       172 ~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~  246 (494)
                      .++.++|+|||++........   .....++..|+|||.+. +.++.++|+|||||++|+|++ |..||.+.....+...
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            778899999999876433221   12234466799999886 468999999999999999998 9999988877767666


Q ss_pred             HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          247 ILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      +.......   ....+++.+.+++.+||..||.+||++.+++++
T Consensus       239 ~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         239 VRKRQLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            65543322   224678999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.3e-37  Score=303.59  Aligned_cols=266  Identities=31%  Similarity=0.493  Sum_probs=213.7

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-CCe
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-DQF  108 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-~~~  108 (494)
                      .+.++|++.+.||.|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+. ||||+++.+++.. ...
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~   84 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLR-HENIISLSDIFISPLED   84 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecCCCc
Confidence            367899999999999999999999999999999999865432 2234567888999999995 9999999999865 557


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      .++++||+ +++|..++.. ..++...+..++.|++.||.|||+++++||||+|+||++   +.++.++|+|||.+....
T Consensus        85 ~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQD  159 (328)
T ss_pred             EEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccC
Confidence            89999998 5688887754 457888999999999999999999999999999999999   678899999999987543


Q ss_pred             cCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc-----------------
Q 040917          189 EGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK-----------------  249 (494)
Q Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~-----------------  249 (494)
                      .  ......+++.|+|||.+.+  .++.++|+||+||++|+|++|+.||.+.........+.+                 
T Consensus       160 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd07856         160 P--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN  237 (328)
T ss_pred             C--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence            2  2234457889999998754  588999999999999999999999977665332211111                 


Q ss_pred             -------C---CccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCC
Q 040917          250 -------G---EINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPI  304 (494)
Q Consensus       250 -------~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~  304 (494)
                             .   .........+.++..+.++|.+||+.+|++||++.+++.||||.....+...+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~  302 (328)
T cd07856         238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPV  302 (328)
T ss_pred             hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccC
Confidence                   0   000001122457889999999999999999999999999999987666554454

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.5e-37  Score=299.85  Aligned_cols=252  Identities=22%  Similarity=0.364  Sum_probs=205.6

Q ss_pred             cccceEeeeeecccCCeEEEEEEE-----CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTE-----NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED  105 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~  105 (494)
                      ...+|.+.+.||+|+||.||+|.+     ..++..||+|.+....  .....+.+.+|+.+++++.+||||+++++++..
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            346899999999999999999975     3346689999986543  233456789999999999669999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCC
Q 040917          106 DQFVHIVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL  183 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~  183 (494)
                      .+..+++|||+++++|.+++....  .++...+..++.+++.||.|||+++|+|+||||+||++   +.++.++|+|||.
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~  187 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFGL  187 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCcc
Confidence            999999999999999999987643  38999999999999999999999999999999999999   5778999999999


Q ss_pred             ccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCC
Q 040917          184 SAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDP  258 (494)
Q Consensus       184 a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (494)
                      +........   .....+++.|+|||.+. +.++.++||||+||++|+|++ |..||......+.............  .
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~  265 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA--Q  265 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC--C
Confidence            875533221   11234567899999875 458899999999999999998 9999987765544433333222221  2


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       259 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ....++.+.+++.+||..+|++||++.++++
T Consensus       266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            2356889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-38  Score=300.84  Aligned_cols=253  Identities=31%  Similarity=0.529  Sum_probs=209.7

Q ss_pred             eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917           35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME  114 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e  114 (494)
                      |++.+.||+|++|.||+|.+..+++.+++|.+..... .......+.+|+.+++++. ||||+++++++..+...++|+|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEEEEe
Confidence            6788999999999999999999999999999875443 2234677888999999995 9999999999999999999999


Q ss_pred             ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-c
Q 040917          115 LCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-A  192 (494)
Q Consensus       115 ~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-~  192 (494)
                      |+++ +|.+.+... ..++...+..++.+++.||.|||+++++|+||+|+||++   +.++.++|+|||.+....... .
T Consensus        79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~~  154 (283)
T cd05118          79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRP  154 (283)
T ss_pred             ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCccc
Confidence            9976 888877663 578999999999999999999999999999999999999   677899999999987664433 2


Q ss_pred             cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccC----------------
Q 040917          193 YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF----------------  254 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~----------------  254 (494)
                      .....++..|+|||.+.+  .++.++|+||||+++|+|++|+.||...+..+....+.......                
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            233557888999998764  47889999999999999999999998777655443332211100                


Q ss_pred             ---C-------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          255 ---Q-------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       255 ---~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                         +       ....+.++..+.++|.+||..||.+||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence               0       01123467899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-37  Score=296.47  Aligned_cols=249  Identities=23%  Similarity=0.335  Sum_probs=207.4

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCC-----CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENST-----GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      .++|++.+.||+|+||.||+|.+...     +..|++|.+....  .......+.+|+.+++.+ +||||+++++++...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~   81 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVSTG   81 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcCC
Confidence            46899999999999999999998644     4889999986433  223356788899999999 599999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917          107 QFVHIVMELCAGGELFDRIVARG----------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV  176 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~  176 (494)
                      ...++||||+++++|.+++....          .++...+..++.|++.||.|||+++++||||+|+||++   +.++.+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~~  158 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLTV  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCCE
Confidence            99999999999999999986532          36778899999999999999999999999999999999   678899


Q ss_pred             EEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCC
Q 040917          177 KATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGE  251 (494)
Q Consensus       177 kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~  251 (494)
                      +|+|||.+........   .....++..|+|||.+. +.++.++|+|||||++|++++ |..||...+.......+..+.
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  238 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG  238 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence            9999999875433221   12234567899999875 468899999999999999998 999998888877777766443


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          252 INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ....+   ..++..+.+++.+||..+|++|||+.++++
T Consensus       239 ~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         239 HLDLP---ENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCC---CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            22211   346899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.5e-37  Score=292.87  Aligned_cols=241  Identities=24%  Similarity=0.327  Sum_probs=200.7

Q ss_pred             eecccCCeEEEEEEE--CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917           40 EVGRGEFGITYLCTE--NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA  117 (494)
Q Consensus        40 ~lg~G~~g~Vy~a~~--~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~  117 (494)
                      .||+|+||.||+|.+  ..++..+|+|++.... ......+.+.+|+.+++.+ +||||+++++++.. ...++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQL-DNPYIVRMIGICEA-ESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC-CCcEEEEecCC
Confidence            589999999999965  4678899999986443 2333567788999999999 59999999998864 46789999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc----
Q 040917          118 GGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----  193 (494)
Q Consensus       118 g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~----  193 (494)
                      +++|.+++.....++...+..++.|++.|+.|||++|++||||||.||++   +.++.++|+|||.+.........    
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCeeeec
Confidence            99999999887789999999999999999999999999999999999999   56789999999998765433221    


Q ss_pred             ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917          194 REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR  271 (494)
Q Consensus       194 ~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  271 (494)
                      ....+++.|+|||.+.. .++.++|+|||||++|+|++ |..||......+..+.+.++....   ....+++.+.++|.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~  232 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERME---CPQRCPPEMYDLMK  232 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC---CCCCCCHHHHHHHH
Confidence            11223578999998864 57889999999999999998 999998888777777776553321   22468899999999


Q ss_pred             HhcccCCCCCCCHHHHhc
Q 040917          272 RMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       272 ~~l~~dp~~Rps~~eil~  289 (494)
                      +||+.||++||++.+|..
T Consensus       233 ~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         233 LCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHhccCchhCcCHHHHHH
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.2e-38  Score=300.72  Aligned_cols=256  Identities=28%  Similarity=0.527  Sum_probs=209.7

Q ss_pred             ceEeeeeecccCCeEEEEEEEC---CCCcEEEEEEeccCCCC-ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           34 HYTIGREVGRGEFGITYLCTEN---STGLEFACKSIPKRKLV-KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      +|++.+.||+|++|.||+|.+.   .++..||+|++.+.... .......+.+|+.++.++.+||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4889999999999999999864   46789999998754321 2234566889999999997799999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      ++||||++|++|.+++.....++...+..++.|++.+|.|||+.|++||||+|.||++   +.++.++|+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECcccccccc
Confidence            9999999999999999877789999999999999999999999999999999999999   6678999999999876433


Q ss_pred             Cccc--ccccCCcCccChhhhccc---CCCcchhHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHcCCccCCCCCCC
Q 040917          190 GKAY--REIVGSPYYIAPEVLSQS---YGKEADIWSAGVILYILLCGVPPFWAET----DQGVAQAILKGEINFQRDPFP  260 (494)
Q Consensus       190 ~~~~--~~~~~~~~y~aPE~~~~~---~~~~~Di~slG~il~~l~tg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~  260 (494)
                      ....  ....++..|+|||.+.+.   .+.++|+||+|+++++|++|..||....    ..+..+.+.....    ....
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~  233 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP----PFPK  233 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC----CCCc
Confidence            3221  234578899999988643   6889999999999999999999995432    2233333333322    1224


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCccCcc
Q 040917          261 SISSSAIELVRRMLTQDPKRRIT---VAQVLEHPWLKES  296 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~Rps---~~eil~~~~~~~~  296 (494)
                      .++..+.+++.+||+.+|++|||   +.++|+||||+..
T Consensus       234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            57889999999999999999998   5678999999863

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.1e-38  Score=304.13  Aligned_cols=256  Identities=25%  Similarity=0.417  Sum_probs=204.5

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC-----
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD-----  106 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~-----  106 (494)
                      .++|++.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++.++ ||||+++++++...     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLK-HPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcC-CCCccchhhheeccccccc
Confidence            47899999999999999999999999999999998654322 222345678999999995 99999999887433     


Q ss_pred             ---CeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917          107 ---QFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG  182 (494)
Q Consensus       107 ---~~~~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg  182 (494)
                         ..+++|++|+.+ +|...+.. ...++...+..++.|++.||.|||++||+|+||||+||++   ++++.++|+|||
T Consensus        85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg  160 (311)
T cd07866          85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFG  160 (311)
T ss_pred             ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCc
Confidence               357999999965 67766654 3479999999999999999999999999999999999999   678899999999


Q ss_pred             CccccccCcc------------cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 040917          183 LSAFIEEGKA------------YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL  248 (494)
Q Consensus       183 ~a~~~~~~~~------------~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~  248 (494)
                      ++........            .....+++.|+|||.+.+  .++.++|+||+||++|+|++|+.||.+.+.......+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9875432211            112346788999998754  47889999999999999999999998877765544433


Q ss_pred             cCCccCCC--------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          249 KGEINFQR--------------------------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       249 ~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      ........                          ..+..+++.+.++|.+||..||.+|||+.++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            21111000                          0112345778999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.9e-37  Score=295.87  Aligned_cols=247  Identities=19%  Similarity=0.279  Sum_probs=204.4

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCc----EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGL----EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~----~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      .+|++.+.||+|+||+||+|.+..++.    .||+|++....  .......+.+|+.+++.+. ||||+++++++... .
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~   82 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVG-SPYVCRLLGICLTS-T   82 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcCC-C
Confidence            579999999999999999999877776    48999986433  3334667889999999994 99999999998754 4


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .+++++++++|+|.+++... +.++...+..++.|++.||.|||+++++||||||+||++   .+++.++|+|||++...
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~---~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV---KSPNHVKITDFGLARLL  159 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCCCceeec
Confidence            67999999999999998764 468999999999999999999999999999999999999   56778999999998765


Q ss_pred             ccCccc---ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          188 EEGKAY---REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       188 ~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      ......   ....+++.|+|||... ..++.++|||||||++|+|++ |..||...........+........   .+..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~  236 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ---PPIC  236 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---CccC
Confidence            432221   1123456899999875 458999999999999999998 8999988777666665555432222   2467


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +..+.+++.+||..||++||++.++++
T Consensus       237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         237 TIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.4e-40  Score=284.76  Aligned_cols=263  Identities=25%  Similarity=0.427  Sum_probs=214.9

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE------
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE------  104 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~------  104 (494)
                      -...|.-..+||+|.||.||+|+.+++|+.||+|++-... ..........+|+.+|..|+ |+|++.+++++.      
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lk-Henv~nliEic~tk~Tp~   92 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLK-HENVVNLIEICRTKATPT   92 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhccCCc
Confidence            3467888899999999999999999999999999764322 12223455778999999996 999999988774      


Q ss_pred             --eCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeec
Q 040917          105 --DDQFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDF  181 (494)
Q Consensus       105 --~~~~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Df  181 (494)
                        +...+|+|+.+|+. +|.-++.+. -+++..++..++..++.||.|+|.+.|+|||+||.|+||   +.++.++|+||
T Consensus        93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilklADF  168 (376)
T KOG0669|consen   93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKLADF  168 (376)
T ss_pred             ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEeecc
Confidence              23458999999975 888888765 579999999999999999999999999999999999999   78899999999


Q ss_pred             CCcccccc-----CcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccC
Q 040917          182 GLSAFIEE-----GKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF  254 (494)
Q Consensus       182 g~a~~~~~-----~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  254 (494)
                      |+++.+..     .+.+...+.|.+|++||.+.|  .|+++.|||..|||+.+|.|+.+.+.+.++...+..|..---..
T Consensus       169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~  248 (376)
T KOG0669|consen  169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI  248 (376)
T ss_pred             ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence            99965432     223445667999999999876  59999999999999999999999999999888777664322222


Q ss_pred             CCCCCCC-------------------------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917          255 QRDPFPS-------------------------------ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       255 ~~~~~~~-------------------------------~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  299 (494)
                      .+..||+                               -.++..+++.++|..||.+|+.++++|+|.||...+.+
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence            2222221                               13467899999999999999999999999999975533

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=262.63  Aligned_cols=259  Identities=26%  Similarity=0.462  Sum_probs=216.0

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|.-.+.||+|.||+||+|+++.+++.||+|.+..... ++.......+|+-+++.|+ |.||++++++...+...-+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelk-hknivrl~dvlhsdkkltlv   79 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeEEe
Confidence            357778899999999999999999999999999976543 3445677899999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      +|||.. .|..+... ++.++.+.+.+++.|++.|+.++|++++.|||+||+|.++   +.+|.+||.|||+++-+.-.-
T Consensus        80 fe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   80 FEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             HHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCce
Confidence            999954 88887765 4679999999999999999999999999999999999999   789999999999998664332


Q ss_pred             -ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCC--------
Q 040917          192 -AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPF--------  259 (494)
Q Consensus       192 -~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------  259 (494)
                       .....+.|.+|++|.++-+  -|+...|+||.|||+.|+.. |++.|.+..-.+.+..+.+.--.+..+.|        
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence             3345567999999999865  38999999999999999986 67888888877776666432222111111        


Q ss_pred             -----------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          260 -----------------PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       260 -----------------~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                                       |.++..-+++++++|.-+|.+|.+++.+++||||....
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence                             23445568999999999999999999999999998753

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-37  Score=292.66  Aligned_cols=246  Identities=23%  Similarity=0.331  Sum_probs=206.1

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++.+.||+|++|.||+|.+. +++.||+|.+.....    ....+.+|+.+++++. ||||+++++++...+..++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCC-CCCccceeEEEecCCCeee
Confidence            467999999999999999999975 467899999865332    3566889999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          112 VMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      +|||++|++|.+++....  .++...+..++.+++.|+.+||++|++||||||+||++   +.++.++|+|||++.....
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIKE  155 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEccC
Confidence            999999999999997654  68999999999999999999999999999999999999   6788999999999876542


Q ss_pred             Cccc--ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          190 GKAY--REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       190 ~~~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ....  .....+..|+|||.+.+ .++.++|+||||+++++|++ |+.||.+.........+..... .  .....++..
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~  232 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-M--PCPPGCPKE  232 (261)
T ss_pred             CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C--CCCCcCCHH
Confidence            2111  11122357999998764 58899999999999999999 9999988887777666654422 1  122467899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +.+++.+||..+|.+||++.++++
T Consensus       233 ~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         233 LYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHHhhcCcccCCCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-38  Score=299.52  Aligned_cols=253  Identities=29%  Similarity=0.527  Sum_probs=210.2

Q ss_pred             eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917           35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME  114 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e  114 (494)
                      |++.+.||+|++|.||+|.+..+++.|++|++.... ........+.+|+.+++.+. |||++++++++......++|+|
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEEEec
Confidence            677899999999999999999999999999997654 22334567788999999995 9999999999999899999999


Q ss_pred             ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-c
Q 040917          115 LCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-A  192 (494)
Q Consensus       115 ~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-~  192 (494)
                      +++ ++|.+++... ..++...+..++.+++.||.+||++||+||||+|+||++   +.++.++|+|||.+....... .
T Consensus        79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCccc
Confidence            997 4999999876 579999999999999999999999999999999999999   678899999999987654332 2


Q ss_pred             cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc------------------
Q 040917          193 YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI------------------  252 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~------------------  252 (494)
                      .....++..|+|||.+.+  .++.++|+|||||+++++++|..||.+....+....+.....                  
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            233455778999998753  578899999999999999999999988776554443322100                  


Q ss_pred             cC-------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          253 NF-------QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       253 ~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      .+       ....++.++..+.++|.+||..+|++||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            00       001233457889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2e-37  Score=297.60  Aligned_cols=247  Identities=23%  Similarity=0.385  Sum_probs=206.3

Q ss_pred             cceEeeeeecccCCeEEEEEEEC-----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           33 LHYTIGREVGRGEFGITYLCTEN-----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .+|.+.+.||+|+||.||+|.+.     .++..+++|.+....   ......+.+|+.+++++. ||||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCC
Confidence            57999999999999999999854     345678999875332   233467889999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC
Q 040917          108 FVHIVMELCAGGELFDRIVARG----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD  171 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~  171 (494)
                      ..++||||+++++|.+++....                .++...+..++.||+.|+.|||++||+||||||+||++   +
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~  157 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---G  157 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---c
Confidence            9999999999999999997542                37889999999999999999999999999999999999   6


Q ss_pred             CCCeEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 040917          172 ENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQA  246 (494)
Q Consensus       172 ~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~  246 (494)
                      .++.++|+|||++........   .....+++.|+|||.+.+ .++.++|+|||||++|+|++ |..||......+..+.
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            788999999999875433221   122345778999998864 58889999999999999998 9999988887777776


Q ss_pred             HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          247 ILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +..+.....   ...+|..+.+++.+||..+|.+||++.++++
T Consensus       238 ~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         238 ITQGRVLER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HhCCCCCCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            655443322   2356889999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-37  Score=292.42  Aligned_cols=245  Identities=24%  Similarity=0.407  Sum_probs=204.3

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++.+.||+|++|.||+|.+. ++..+|+|++.....    ....+.+|+.+++.+. ||||+++++++......++|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIFIV   77 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCceEEE
Confidence            46899999999999999999886 467899999864332    3456788999999995 99999999999988999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      |||++|++|.+++... ..++...+..++.|++.|+.|||++|++||||||+||++   ++++.++|+|||.+.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceeccccc
Confidence            9999999999998764 468999999999999999999999999999999999999   678899999999987543221


Q ss_pred             cc--ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          192 AY--REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       192 ~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      ..  ....++..|+|||.+. ..++.++|+||||+++|+|++ |..||......+....+...... .  ....+|..+.
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~  231 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL-Y--RPKLAPTEVY  231 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC-C--CCCCCCHHHH
Confidence            11  1112335799999886 468899999999999999998 89999888777776666544221 1  1235789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 040917          268 ELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +++.+||..+|++|||+.++++
T Consensus       232 ~li~~cl~~~p~~Rpt~~~~l~  253 (256)
T cd05059         232 TIMYSCWHEKPEDRPAFKKLLS  253 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.4e-37  Score=292.42  Aligned_cols=245  Identities=23%  Similarity=0.336  Sum_probs=202.8

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++.+.||+|++|.||+|.+..+ ..|++|.+.....    ....+.+|+.+++++. ||||+++++.+.. ...++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~~l   77 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYI   77 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCC-CCCcceEEEEECC-CCcEE
Confidence            37899999999999999999998755 4699999875332    3457889999999995 9999999998754 55789


Q ss_pred             EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          112 VMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      ||||+++++|.+++...  ..++...+..++.+++.||.|||+++++|+||||.||++   +.++.++|+|||.+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIED  154 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceeeccc
Confidence            99999999999999763  347899999999999999999999999999999999999   6788999999999876543


Q ss_pred             Cccc--ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          190 GKAY--REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       190 ~~~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ....  ....++..|+|||... +.++.++|+|||||++|+|++ |..||......+....+.......   ....++..
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  231 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---CPPECPES  231 (262)
T ss_pred             cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCC---CccccCHH
Confidence            2211  1233566799999875 468999999999999999999 888998887776666655432211   12467899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +.+++.+|+..+|.+||++.++++
T Consensus       232 l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         232 LHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHHHccCCcccCCCHHHHHH
Confidence            999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.9e-37  Score=292.72  Aligned_cols=248  Identities=25%  Similarity=0.408  Sum_probs=207.2

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCc---EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGL---EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~---~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      .+|++.+.||+|+||.||+|.+..++.   .+|+|.+....  .......+.+|+.+++++ +||||+++++++..++..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcc
Confidence            579999999999999999999865544   79999986433  233466889999999999 499999999999998999


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      ++||||++|++|.+++... +.++...+..++.|++.|+.+||++|++||||||+||++   +.++.++|+|||.+....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCcccccc
Confidence            9999999999999998765 468999999999999999999999999999999999999   678899999999987654


Q ss_pred             cCccc----ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          189 EGKAY----REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       189 ~~~~~----~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      .....    ....++..|+|||.+.+ .++.++|+|||||++|++++ |..||......+....+.... ..+  ....+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~  234 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-RLP--APMDC  234 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-cCC--CCCCC
Confidence            32211    11122457999999864 68999999999999999886 999998887777776666542 222  22467


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      |+.+.+++.+||..+|.+||++.++++
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         235 PAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.7e-37  Score=298.98  Aligned_cols=251  Identities=23%  Similarity=0.361  Sum_probs=206.4

Q ss_pred             cccceEeeeeecccCCeEEEEEEECC-------CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENS-------TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY  103 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~  103 (494)
                      ..++|.+++.||+|++|.||+|.+..       ....+|+|.+....  .......+.+|+.+++++.+||||+++++++
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            34789999999999999999998632       34579999986432  2234567889999999996699999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEE
Q 040917          104 EDDQFVHIVMELCAGGELFDRIVAR----------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLF  167 (494)
Q Consensus       104 ~~~~~~~iv~e~~~g~sL~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli  167 (494)
                      ......+++|||+++++|.+++...                ..++...+..++.||+.||.|||++|++||||||+||++
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  167 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV  167 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence            9888999999999999999999653                247888999999999999999999999999999999999


Q ss_pred             eeCCCCCeEEEeecCCccccccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 040917          168 TTGDENAVVKATDFGLSAFIEEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQG  242 (494)
Q Consensus       168 ~~~~~~~~~kL~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~  242 (494)
                         +.++.++|+|||.+.........   ....+++.|+|||++.+ .++.++|+|||||++|+|++ |..||.+....+
T Consensus       168 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         168 ---TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             ---cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence               56789999999999765332111   11223457999998764 58899999999999999998 899998888777


Q ss_pred             HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          243 VAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ....+......   .....++..+.+++.+||..+|.+|||+.++++
T Consensus       245 ~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         245 LFKLLREGHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            77766554321   122467889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.7e-37  Score=326.41  Aligned_cols=149  Identities=28%  Similarity=0.467  Sum_probs=137.5

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++++.||+|+||.||+|.+..+++.||+|++.............+..|+.+++.++ ||||+++++++.....+|+|
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCEEEEE
Confidence            67999999999999999999999999999999997665555555678889999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      |||+.|++|.+++...+.++...++.++.||+.||.|||+++|+||||||+|||+   +.++.++|+|||++.
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence            9999999999999887889999999999999999999999999999999999999   577899999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.3e-37  Score=297.63  Aligned_cols=248  Identities=20%  Similarity=0.324  Sum_probs=207.4

Q ss_pred             cceEeeeeecccCCeEEEEEEECCC-----CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           33 LHYTIGREVGRGEFGITYLCTENST-----GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .+|++.+.||.|+||.||+|.+..+     ++.||+|++....  .......+.+|+.++..+. ||||+++++++....
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~   81 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQ   81 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCC
Confidence            4688999999999999999987543     5789999986433  2234567889999999995 999999999999988


Q ss_pred             eEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC
Q 040917          108 FVHIVMELCAGGELFDRIVAR----------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD  171 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~  171 (494)
                      ..++++||+.+++|.+++...                ..++...+..++.|++.||.|||++||+||||||+||++   .
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~  158 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---F  158 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---c
Confidence            999999999999999988532                247888899999999999999999999999999999999   5


Q ss_pred             CCCeEEEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 040917          172 ENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQA  246 (494)
Q Consensus       172 ~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~  246 (494)
                      +++.+||+|||++........   .....+++.|+|||.+. +.++.++|+|||||++|+|++ |..||.+....+....
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM  238 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            678899999999875432221   12234567899999875 568999999999999999998 8889988888888877


Q ss_pred             HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          247 ILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +........+   ..++..+.+++.+||+.+|.+||++.+++.
T Consensus       239 i~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         239 IRNRQVLPCP---DDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             HHcCCcCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            7766543322   467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.1e-37  Score=294.39  Aligned_cols=247  Identities=21%  Similarity=0.338  Sum_probs=208.9

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      ..+|++.+.||.|++|.||+|.+.. +..+++|++....   ......+.+|+.+++.++ ||||+++++++......++
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCC-CcchhheeeeEecCCCeEE
Confidence            3579999999999999999999987 8999999986543   223566889999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          112 VMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      ||||+++++|.+++...  ..++...+..++.+|+.|+.|||++|++|+||+|+||++   +.++.++|+|||.+.....
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhcCC
Confidence            99999999999999753  358999999999999999999999999999999999999   6788999999999876533


Q ss_pred             Cccc-ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917          190 GKAY-REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       190 ~~~~-~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (494)
                      .... ....++..|+|||.+. +.++.++|+||||+++|+|++ |+.||......+....+..+...   .....+++.+
T Consensus       157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  233 (261)
T cd05148         157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM---PCPAKCPQEI  233 (261)
T ss_pred             ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC---CCCCCCCHHH
Confidence            2211 1223456799999876 458889999999999999998 89999888877777776643221   2225678999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhc
Q 040917          267 IELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+++.+||+.||.+|||+.++++
T Consensus       234 ~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         234 YKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.9e-37  Score=298.43  Aligned_cols=251  Identities=23%  Similarity=0.360  Sum_probs=207.5

Q ss_pred             cccceEeeeeecccCCeEEEEEEEC-------CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTEN-------STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY  103 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~-------~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~  103 (494)
                      ...+|++.+.||+|+||.||+|.+.       ..+..||+|.+....  .......+.+|+.+++.+.+||||+++++++
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            3478999999999999999999753       234579999886432  2334567889999999996699999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEE
Q 040917          104 EDDQFVHIVMELCAGGELFDRIVARG----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLF  167 (494)
Q Consensus       104 ~~~~~~~iv~e~~~g~sL~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli  167 (494)
                      ......++||||+++++|.+++....                .++...+..++.||+.||.|||++|++||||||+||++
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili  170 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV  170 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence            99999999999999999999987642                36778889999999999999999999999999999999


Q ss_pred             eeCCCCCeEEEeecCCccccccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 040917          168 TTGDENAVVKATDFGLSAFIEEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQG  242 (494)
Q Consensus       168 ~~~~~~~~~kL~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~  242 (494)
                         +.++.++|+|||.+.........   ....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..+
T Consensus       171 ---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  247 (304)
T cd05101         171 ---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  247 (304)
T ss_pred             ---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence               57789999999998765432211   12234567999998864 58999999999999999998 789998888877


Q ss_pred             HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          243 VAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ....+........   ...++..+.+++.+||..+|.+|||+.++++
T Consensus       248 ~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~  291 (304)
T cd05101         248 LFKLLKEGHRMDK---PANCTNELYMMMRDCWHAIPSHRPTFKQLVE  291 (304)
T ss_pred             HHHHHHcCCcCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            7777655432211   2467899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.6e-37  Score=295.11  Aligned_cols=247  Identities=21%  Similarity=0.366  Sum_probs=205.6

Q ss_pred             cceEeeeeecccCCeEEEEEEEC-----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           33 LHYTIGREVGRGEFGITYLCTEN-----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .+|++.+.||+|+||.||+|...     .++..+++|.+...   .......+.+|+.+++.+ +||||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   80 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVL-QHQHIVRFYGVCTEGR   80 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecCC
Confidence            57889999999999999999743     35678999987543   233567899999999999 5999999999999989


Q ss_pred             eEEEEEeccCCCchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCC
Q 040917          108 FVHIVMELCAGGELFDRIVARG---------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDE  172 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~---------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~  172 (494)
                      ..+++|||+++++|.+++....               .++...+..++.|++.|+.|||++|++||||||+||++   ++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~~  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQ  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---cC
Confidence            9999999999999999987643               37889999999999999999999999999999999999   57


Q ss_pred             CCeEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 040917          173 NAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAI  247 (494)
Q Consensus       173 ~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~  247 (494)
                      ++.++|+|||++........   .....+++.|+|||.+.+ .++.++|+|||||++|+|++ |..||......+....+
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            88999999999865432221   112234678999998764 58999999999999999998 89999887777777666


Q ss_pred             HcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          248 LKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ..+.....   ...+|+.+.+++.+||..||.+||++.++++
T Consensus       238 ~~~~~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQGRELER---PRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcCccCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            55533221   2357899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-37  Score=292.89  Aligned_cols=243  Identities=25%  Similarity=0.355  Sum_probs=198.1

Q ss_pred             eeecccCCeEEEEEEECCCCc--EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEecc
Q 040917           39 REVGRGEFGITYLCTENSTGL--EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELC  116 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~--~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~  116 (494)
                      +.||+|+||.||+|.+..++.  .+++|.+....  .......+.+|+.++.++.+||||+++++++......+++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            368999999999999988776  46888875322  23345678899999999967999999999999988999999999


Q ss_pred             CCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917          117 AGGELFDRIVARG----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       117 ~g~sL~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                      ++++|.+++....                .++...+..++.|++.|+.|||++|++||||||+||++   +.++.++|+|
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~d  155 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIAD  155 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECC
Confidence            9999999987543                37889999999999999999999999999999999999   6788999999


Q ss_pred             cCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCC
Q 040917          181 FGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDP  258 (494)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (494)
                      ||++..............+..|+|||++.. .++.++|+|||||++++|++ |..||.+.+..+....+......   ..
T Consensus       156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~  232 (270)
T cd05047         156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL---EK  232 (270)
T ss_pred             CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCC---CC
Confidence            999853221111111223567999998854 58899999999999999997 99999888777666665443211   12


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       259 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ...++..+.+++.+||..+|.+|||+.+++.
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            2356789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=8.8e-38  Score=305.20  Aligned_cols=255  Identities=20%  Similarity=0.313  Sum_probs=201.1

Q ss_pred             eeeccc--CCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEecc
Q 040917           39 REVGRG--EFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELC  116 (494)
Q Consensus        39 ~~lg~G--~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~  116 (494)
                      ..||.|  ++|+||+|.+..+|+.||+|++...... ....+.+.+|+.+++.+. ||||+++++++..+...++|+||+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEEecc
Confidence            456666  9999999999999999999998754332 234578889999999994 999999999999999999999999


Q ss_pred             CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc-
Q 040917          117 AGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY-  193 (494)
Q Consensus       117 ~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~-  193 (494)
                      .+++|.+++.+.  ..+++..+..++.|++.||.|||++|++||||||+||++   +.++.++++||+.+......... 
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCccc
Confidence            999999988764  348899999999999999999999999999999999999   56789999999765332111000 


Q ss_pred             -------ccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC--------
Q 040917          194 -------REIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ--------  255 (494)
Q Consensus       194 -------~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~--------  255 (494)
                             ....++..|+|||++.+   .++.++|+||+||++|+|++|+.||...................+        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence                   01124567999999864   368899999999999999999999987665443332222111000        


Q ss_pred             -----------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          256 -----------------------------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       256 -----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                                                         ......+++.+.+|+.+||+.||++|||+.++|+||||....+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence                                               0011235678999999999999999999999999999986443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-37  Score=297.69  Aligned_cols=251  Identities=23%  Similarity=0.340  Sum_probs=202.2

Q ss_pred             cceEeeeeecccCCeEEEEEEECCC--------------CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENST--------------GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ   98 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~--------------~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~   98 (494)
                      .+|++.+.||+|+||.||+|.+..+              ...||+|.+....  .......+.+|+++++++. ||||++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~   81 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLK-NPNIIR   81 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCcCe
Confidence            6899999999999999999987543              2358999986432  2334567899999999995 999999


Q ss_pred             EeEEEEeCCeEEEEEeccCCCchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 040917           99 FKAAYEDDQFVHIVMELCAGGELFDRIVARG------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFL  166 (494)
Q Consensus        99 ~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIl  166 (494)
                      +++++......++||||+++++|.+++....            .++...+..++.+++.||.|||++|++||||||+||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9999999999999999999999999886532            3678889999999999999999999999999999999


Q ss_pred             EeeCCCCCeEEEeecCCccccccCccc---ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh--CCCCCCCCCh
Q 040917          167 FTTGDENAVVKATDFGLSAFIEEGKAY---REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC--GVPPFWAETD  240 (494)
Q Consensus       167 i~~~~~~~~~kL~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t--g~~pf~~~~~  240 (494)
                      +   +.++.++|+|||++.........   ....++..|+|||++. +.++.++|+|||||++++|++  +..||.....
T Consensus       162 l---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         162 V---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             E---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            9   56788999999998754322211   1223467899999875 468999999999999999988  6788887776


Q ss_pred             HHHHHHHHc----CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          241 QGVAQAILK----GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       241 ~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ......+..    ..........+..|+.+.+++.+||..+|++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            665544322    1111112223457899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6e-38  Score=323.88  Aligned_cols=254  Identities=30%  Similarity=0.521  Sum_probs=205.3

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE--------
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE--------  104 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~--------  104 (494)
                      .+|.....||+||||.||+|+++-+|..||||.+....  +......+.+|+..+.+| +||||++++..|.        
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCcccc
Confidence            56888999999999999999999999999999997654  455677899999999999 5999998762110        


Q ss_pred             ----------------------------------------------------------e---------------------
Q 040917          105 ----------------------------------------------------------D---------------------  105 (494)
Q Consensus       105 ----------------------------------------------------------~---------------------  105 (494)
                                                                                .                     
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                      0                     


Q ss_pred             ------------------------C--------CeEEEEEeccCCCchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHH
Q 040917          106 ------------------------D--------QFVHIVMELCAGGELFDRIVARGHY-SERAAASVFRVIMNVVNVCHS  152 (494)
Q Consensus       106 ------------------------~--------~~~~iv~e~~~g~sL~~~~~~~~~l-~~~~~~~i~~~i~~~l~~LH~  152 (494)
                                              +        ...||-||||+..+|.+++.++... .....+.++++|++||.|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                    0        2468999999987777777766544 578899999999999999999


Q ss_pred             CCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-------------------cCcccccccCCcCccChhhhcc---
Q 040917          153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-------------------EGKAYREIVGSPYYIAPEVLSQ---  210 (494)
Q Consensus       153 ~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~---  210 (494)
                      .|||||||||.|||+   ++...|||+|||+|....                   +.....+..||.-|.|||++.+   
T Consensus       716 ~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             CceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence            999999999999999   688999999999997611                   1112345779999999999863   


Q ss_pred             -cCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 040917          211 -SYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL  288 (494)
Q Consensus       211 -~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil  288 (494)
                       .|+.|+|+||||++++||+.   ||....+. .++..+.++..+.+...+..--+.-..+|.+|++.||.+||||.|+|
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL  869 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL  869 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence             58999999999999999984   57665554 34556666666555322323335567899999999999999999999


Q ss_pred             cCCccCc
Q 040917          289 EHPWLKE  295 (494)
Q Consensus       289 ~~~~~~~  295 (494)
                      ++.||..
T Consensus       870 ~s~llpp  876 (1351)
T KOG1035|consen  870 NSELLPP  876 (1351)
T ss_pred             hccCCCc
Confidence            9999984

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.9e-37  Score=292.16  Aligned_cols=248  Identities=24%  Similarity=0.404  Sum_probs=206.9

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCc---EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGL---EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~---~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      .+|++.+.||+|+||.||+|.+..++.   .|++|.+....  .......+..|+.+++.+. ||||+++++++..+...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCce
Confidence            469999999999999999999887665   59999986432  3445677899999999995 99999999999998999


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      ++||||+++++|.+++... +.++...+..++.|++.|+.|||++|++|+||+|+||++   +.++.++|+|||.+....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCccccccc
Confidence            9999999999999988753 468999999999999999999999999999999999999   678899999999987543


Q ss_pred             cCccccc---cc---CCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 040917          189 EGKAYRE---IV---GSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFP  260 (494)
Q Consensus       189 ~~~~~~~---~~---~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (494)
                      .......   ..   .+..|+|||.+. +.++.++|+||+||++|++++ |..||......+....+.... .  .+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~-~--~~~~~  234 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY-R--LPPPM  234 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-c--CCCcc
Confidence            3222111   11   134799999986 468899999999999999886 999999888777777664432 1  22234


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          261 SISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+|..+.+++.+||..+|.+||++.+++.
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         235 DCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            67899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-40  Score=340.67  Aligned_cols=264  Identities=28%  Similarity=0.476  Sum_probs=225.3

Q ss_pred             hcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEE
Q 040917           24 LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY  103 (494)
Q Consensus        24 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~  103 (494)
                      +.....++.-+|.-+..||.|.||.||.|.+..+|.-.|+|.+...... ......+.+|..++..+. |||+++++++-
T Consensus      1226 la~~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~ln-HpNlV~YyGVE 1303 (1509)
T KOG4645|consen 1226 LASSLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLN-HPNLVRYYGVE 1303 (1509)
T ss_pred             HHHHhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhcc-CccccccCcee
Confidence            3345567778999999999999999999999999999999999765543 445677899999999995 99999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCC
Q 040917          104 EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL  183 (494)
Q Consensus       104 ~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~  183 (494)
                      ...+..+|.||||+||+|.+.+...+-.++.....+..|++.|++|||++|||||||||+||++   +.+|.+|++|||.
T Consensus      1304 vHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1304 VHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGS 1380 (1509)
T ss_pred             ecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccc
Confidence            9999999999999999999998877777888888899999999999999999999999999999   6788999999999


Q ss_pred             ccccccCc-----ccccccCCcCccChhhhccc----CCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCcc
Q 040917          184 SAFIEEGK-----AYREIVGSPYYIAPEVLSQS----YGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEIN  253 (494)
Q Consensus       184 a~~~~~~~-----~~~~~~~~~~y~aPE~~~~~----~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~  253 (494)
                      |..+.+..     ......||+.|||||++.+.    ...+.|||||||++.||+||+.||.....+ .+.-.+..+..+
T Consensus      1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P 1460 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP 1460 (1509)
T ss_pred             eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC
Confidence            98775442     23457899999999999753    567899999999999999999999766544 333334444333


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          254 FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      ..+   ..++.+.++||.+||..||.+|.++.|+|+|.|-+.
T Consensus      1461 q~P---~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1461 QIP---ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             CCc---hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence            222   348999999999999999999999999999988775

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-40  Score=308.89  Aligned_cols=257  Identities=29%  Similarity=0.552  Sum_probs=237.9

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+.+++..||-||||.|=++.-......+|+|++++.........+++..|-++|...+ .|.|+++|-.|.+..++|+.
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhhh
Confidence            67888999999999999998876555568999999887777767888999999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      ||-|-||.|+..+..++.+...++..++..+++|+.|||.+|||+|||||+|.++   +.+|.+||.|||+|..+.++..
T Consensus       499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCCc
Confidence            9999999999999999999999999999999999999999999999999999999   7899999999999999999999


Q ss_pred             cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917          193 YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR  271 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  271 (494)
                      .++.||||.|.|||++. ...+.++|.||||+++|||++|.+||.+.++...+..|+++......+  ..++....++|+
T Consensus       576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Lik  653 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLIK  653 (732)
T ss_pred             eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHHH
Confidence            99999999999999875 568999999999999999999999999999999999999987766544  468899999999


Q ss_pred             HhcccCCCCCCC-----HHHHhcCCccCc
Q 040917          272 RMLTQDPKRRIT-----VAQVLEHPWLKE  295 (494)
Q Consensus       272 ~~l~~dp~~Rps-----~~eil~~~~~~~  295 (494)
                      ++...+|.+|..     +.+|-+|.||..
T Consensus       654 ~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  654 KLCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             HHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence            999999999986     789999999975

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-37  Score=290.01  Aligned_cols=247  Identities=24%  Similarity=0.369  Sum_probs=207.7

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ..++|++.+.||+|++|.||+|.+. .+..|++|.+.....    ....+.+|+.+++++. ||||+++++++......+
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCC-CCCEeeeeeeeecCCceE
Confidence            3478999999999999999999976 457899999875432    3567889999999995 999999999999888999


Q ss_pred             EEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          111 IVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      +||||+++++|.+++....  .++...+..++.+++.|+.|||++|++|+||+|+||++   +.++.++|+|||.+....
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLIE  154 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccceecc
Confidence            9999999999999997643  68999999999999999999999999999999999999   678999999999987654


Q ss_pred             cCccc--ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          189 EGKAY--REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       189 ~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      .....  .....+..|+|||.+.+ .++.++|+||+|++++++++ |+.||.+.........+........   ....|.
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~  231 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR---PPNCPE  231 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCH
Confidence            32111  12223567999998864 58889999999999999998 9999988887777777655422211   235688


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+.+++.+||..+|.+||++.++++
T Consensus       232 ~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         232 ELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.2e-37  Score=293.23  Aligned_cols=247  Identities=22%  Similarity=0.329  Sum_probs=201.9

Q ss_pred             eEeeeeecccCCeEEEEEEECCCCc--EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe------C
Q 040917           35 YTIGREVGRGEFGITYLCTENSTGL--EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED------D  106 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~~~~~--~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~------~  106 (494)
                      |.+++.||+|+||.||+|.+..++.  .||+|.+.... ........+.+|+.+++.+ +||||+++++++..      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   78 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGY   78 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCC
Confidence            4578899999999999999877765  68999886543 2334567788999999999 59999999997642      1


Q ss_pred             CeEEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917          107 QFVHIVMELCAGGELFDRIVAR------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                      ...+++|||+++++|.+++...      ..++...+..++.|++.||.|||+++|+||||||+||++   +.++.++|+|
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~D  155 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVAD  155 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECC
Confidence            2568999999999999887421      247899999999999999999999999999999999999   6788999999


Q ss_pred             cCCccccccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCC
Q 040917          181 FGLSAFIEEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQ  255 (494)
Q Consensus       181 fg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~  255 (494)
                      ||++.........   ....+++.|+|||...+ .++.++|+|||||++|+|++ |..||.+.........+.++.... 
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-  234 (272)
T cd05075         156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK-  234 (272)
T ss_pred             CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence            9998865433211   12235678999998864 58999999999999999999 889998887777777766654322 


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          256 RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       256 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                        ..+.++..+.+++.+||..||++|||+.++++
T Consensus       235 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~  266 (272)
T cd05075         235 --QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC  266 (272)
T ss_pred             --CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence              12467889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-37  Score=289.46  Aligned_cols=241  Identities=23%  Similarity=0.344  Sum_probs=200.8

Q ss_pred             eeecccCCeEEEEEEECCCC---cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEec
Q 040917           39 REVGRGEFGITYLCTENSTG---LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMEL  115 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~---~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~  115 (494)
                      +.||+|+||.||+|.+..++   ..||+|.+......  .....+.+|+.+++.+ +||||+++++++.. ...++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQL-DHPCIVRLIGVCKG-EPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEcC-CceEEEEEe
Confidence            46999999999999876554   78999998755432  3466788999999999 59999999998764 467899999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcccc-
Q 040917          116 CAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR-  194 (494)
Q Consensus       116 ~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~-  194 (494)
                      +++++|.+++.....+++..+..++.|++.|+.|||.++++|+||||+||++   +.++.++|+|||.+.......... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcccc
Confidence            9999999999888789999999999999999999999999999999999999   678899999999987654332211 


Q ss_pred             ---cccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          195 ---EIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       195 ---~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                         ...++..|+|||.+.+ .++.++|+|||||++|+|++ |..||......+....+......   .....++..+.++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l  230 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL---PRPEECPQEIYSI  230 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC---CCCCCCCHHHHHH
Confidence               1112457999998864 58899999999999999998 99999888877776666554322   1224678999999


Q ss_pred             HHHhcccCCCCCCCHHHHhc
Q 040917          270 VRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       270 i~~~l~~dp~~Rps~~eil~  289 (494)
                      +.+||..+|.+||++.++++
T Consensus       231 i~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         231 MLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-37  Score=292.97  Aligned_cols=247  Identities=21%  Similarity=0.328  Sum_probs=202.9

Q ss_pred             eEeeeeecccCCeEEEEEEECC---CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe---
Q 040917           35 YTIGREVGRGEFGITYLCTENS---TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF---  108 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~~---~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~---  108 (494)
                      |++++.||+|+||.||+|....   ++..||+|.+..... .......+.+|+..++.+ +||||+++++++.....   
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCcccc
Confidence            6788999999999999998764   347899999875432 233456788999999999 49999999998765443   


Q ss_pred             ---EEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEe
Q 040917          109 ---VHIVMELCAGGELFDRIVAR------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKAT  179 (494)
Q Consensus       109 ---~~iv~e~~~g~sL~~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~  179 (494)
                         .++++||+++++|..++...      ..++...+..++.|++.||.|||+++++||||||+||++   ++++.++|+
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~  155 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVA  155 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEEC
Confidence               78999999999999887542      358899999999999999999999999999999999999   678899999


Q ss_pred             ecCCccccccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccC
Q 040917          180 DFGLSAFIEEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINF  254 (494)
Q Consensus       180 Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~  254 (494)
                      |||.+.........   ....++..|+|||.+.+ .++.++|+|||||++|+|++ |..||.+....+..+.+..+....
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK  235 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99998765433211   11234568999998864 58899999999999999999 889998888777777766553322


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          255 QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       255 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .   ...++..+.+++.+||..||.+||++.++++
T Consensus       236 ~---~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~  267 (273)
T cd05035         236 Q---PEDCLDELYDLMYSCWRADPKDRPTFTKLRE  267 (273)
T ss_pred             C---CcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            2   2467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.3e-37  Score=295.16  Aligned_cols=247  Identities=22%  Similarity=0.312  Sum_probs=203.2

Q ss_pred             ceEeeeeecccCCeEEEEEEECC-----CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           34 HYTIGREVGRGEFGITYLCTENS-----TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+....  .......+.+|+.+++.+. ||||+++++.+.....
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCC
Confidence            58899999999999999998753     23568888886433  2234567889999999995 9999999999999899


Q ss_pred             EEEEEeccCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 040917          109 VHIVMELCAGGELFDRIVAR------------------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPEN  164 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~------------------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~N  164 (494)
                      .++++||+.+++|.+++...                        ..++...+..++.|++.||.|||+++++||||||+|
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n  157 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN  157 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence            99999999999999987642                        246788999999999999999999999999999999


Q ss_pred             eEEeeCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 040917          165 FLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAET  239 (494)
Q Consensus       165 Ili~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~  239 (494)
                      |++   ++++.++|+|||++........   .....++..|+|||.+.+ .++.++||||||+++++|++ |..||.+..
T Consensus       158 ill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         158 VLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             EEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            999   5678999999999875432221   112334678999998754 58899999999999999998 999998888


Q ss_pred             hHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          240 DQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+.+.+.+......   .....++..+.+++.+||..+|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         235 PERLFNLLKTGYRM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHHHhCCCCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            77776665543221   122467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.6e-37  Score=292.60  Aligned_cols=247  Identities=19%  Similarity=0.286  Sum_probs=201.4

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcE----EEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLE----FACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~----valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      ++|++.+.||+|+||.||+|.+..++..    |++|.+....  .......+..|+..++++ +||||+++++++.. ..
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~-~~   82 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG-AS   82 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcC-CCCCcceEEEEECC-Cc
Confidence            5799999999999999999999877764    6677764221  222345677888888999 59999999998754 45


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .++++||+++|+|.+++... +.+++..+..++.||+.|+.|||++|++||||||+||++   +.++.++|+|||.+...
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLL  159 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceec
Confidence            77899999999999999764 468999999999999999999999999999999999999   67889999999999754


Q ss_pred             ccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          188 EEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       188 ~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      .....   .....++..|+|||.+. +.++.++|+|||||++|++++ |..||.+.......+.+.++.....+   ...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~  236 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQP---QIC  236 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC---CCC
Confidence            33221   12334567899999885 568999999999999999998 99999888776666655544333222   245


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +..+..++.+||..+|.+|||+.++++
T Consensus       237 ~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         237 TIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=7.4e-37  Score=288.73  Aligned_cols=245  Identities=23%  Similarity=0.339  Sum_probs=202.7

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|.+.+.||+|++|.||+|.+..+ ..+++|.+.....    ....+.+|+.+++++. |||++++++++.. ...++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~~~~   77 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLR-HDKLVPLYAVVSE-EPIYI   77 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCC-CCCeeeEEEEEcC-CCcEE
Confidence            37899999999999999999998654 4699998764332    3466888999999995 9999999998854 56789


Q ss_pred             EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          112 VMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      +|||+++++|.+++....  .++...+..++.+++.||.|||++|++|+||+|+||++   ++++.++|+|||.+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIED  154 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEccC
Confidence            999999999999997643  47889999999999999999999999999999999999   6788999999999876533


Q ss_pred             Cccc--ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          190 GKAY--REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       190 ~~~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ....  ....++..|+|||... +.++.++|+||||+++|+|++ |..||.+....+....+......   ......+..
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM---PCPQGCPES  231 (260)
T ss_pred             CcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccCHH
Confidence            2211  1233466799999876 458899999999999999999 89999888877776666554221   122467899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +.+++.+||..||.+||+++++++
T Consensus       232 ~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         232 LHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.5e-37  Score=294.73  Aligned_cols=248  Identities=23%  Similarity=0.344  Sum_probs=206.4

Q ss_pred             cceEeeeeecccCCeEEEEEEECC-----CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           33 LHYTIGREVGRGEFGITYLCTENS-----TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .+|++.+.||+|+||.||+|.+..     ++..||+|.+....  .......+.+|+.+++++ +||||+++++++..+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~~   81 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DHPNIVKLLGVCAVGK   81 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCC
Confidence            679999999999999999998743     67899999986432  233456788999999999 5999999999999888


Q ss_pred             eEEEEEeccCCCchHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 040917          108 FVHIVMELCAGGELFDRIVARG----------------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENF  165 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~----------------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NI  165 (494)
                      ..++++||+++++|.+++....                      .++...+..++.+++.||.|||+++++||||+|+||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni  161 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC  161 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence            9999999999999999986432                      367788899999999999999999999999999999


Q ss_pred             EEeeCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 040917          166 LFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETD  240 (494)
Q Consensus       166 li~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~  240 (494)
                      ++   +.++.++|+|||.+........   ......+..|+|||.+. +.++.++|+|||||++|+|++ |..||.+...
T Consensus       162 l~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         162 LV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             Ee---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99   6788999999999875432211   11223456799999876 468999999999999999997 8889988888


Q ss_pred             HHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          241 QGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+....+..+.....   ...++..+.+++.+||+.+|++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         239 EEVIYYVRDGNVLSC---PDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            877777665543221   1357899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6.3e-37  Score=288.59  Aligned_cols=246  Identities=29%  Similarity=0.466  Sum_probs=209.0

Q ss_pred             eEeeeeecccCCeEEEEEEECCCC----cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           35 YTIGREVGRGEFGITYLCTENSTG----LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~~~~----~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      +++.+.||.|+||.||+|.+...+    ..||+|++....  .......+.+|+.+++.+ +||||+++++++...+..+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeE
Confidence            357889999999999999998766    899999996443  222467888999999999 6999999999999989999


Q ss_pred             EEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          111 IVMELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~--l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      ++||++++++|.+++.....  ++...+..++.|++.|+.+||+.|++|+||+|+||++   ++++.++|+|||.+....
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLY  154 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceecc
Confidence            99999999999999976544  8999999999999999999999999999999999999   677899999999987655


Q ss_pred             cCccccc--ccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          189 EGKAYRE--IVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       189 ~~~~~~~--~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      .......  ..+++.|+|||.+.+ .++.++|+||+|+++++|++ |..||.........+.+.+.......   ...+.
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~  231 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKP---ENCPP  231 (258)
T ss_pred             cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---CcCCH
Confidence            4322221  235688999998854 58899999999999999998 78999888877777777665433222   34789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+.+++.+||..+|++|||+.++++
T Consensus       232 ~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      232 EIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHHCcCChhhCcCHHHHHh
Confidence            9999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.9e-37  Score=289.92  Aligned_cols=246  Identities=22%  Similarity=0.327  Sum_probs=203.4

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ..++|++.+.||+|++|.||+|.+. .+..||+|.+.....    ..+.+.+|+.+++++ +|||++++++++.. ...+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKL-RHDKLVQLYAVVSE-EPIY   76 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhc-CCCceEEEEeEECC-CCcE
Confidence            3468999999999999999999875 566799999875432    345688999999999 49999999998854 5678


Q ss_pred             EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          111 IVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      ++|||+++++|.+++...  ..++...+..++.+++.||.|||++|++|+||+|+||++   ++++.++|+|||.+....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili---~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV---GDGLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---eCCceEEeCCceeeeecc
Confidence            999999999999998753  358999999999999999999999999999999999999   567899999999987653


Q ss_pred             cCccc--ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          189 EGKAY--REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       189 ~~~~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      .....  ....++..|+|||.+. ..++.++|+||||+++|+|++ |..||.+....+....+......   ......+.
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  230 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM---PCPQDCPI  230 (260)
T ss_pred             CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCcCCH
Confidence            32211  1223456799999875 458899999999999999999 89999888877777766554222   12245789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+.+++.+||..+|.+|||+.++++
T Consensus       231 ~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         231 SLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.4e-37  Score=288.44  Aligned_cols=241  Identities=24%  Similarity=0.345  Sum_probs=201.8

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE-eCCeEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE-DDQFVHI  111 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~-~~~~~~i  111 (494)
                      .+|++.+.||+|++|.||++...  |..|++|.+....     ..+.+.+|+.+++++. |||++++++++. .+...++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCceEE
Confidence            47999999999999999999865  7889999985322     3567889999999994 999999999754 4567899


Q ss_pred             EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          112 VMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      ++||+++++|.+++....  .++...+..++.+++.||.|||++|++||||||+||++   +.++.++|+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccc
Confidence            999999999999987654  37889999999999999999999999999999999999   6788999999999875432


Q ss_pred             CcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          190 GKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       190 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      ..  ....++..|+|||++.+ .++.++|+|||||++|+|++ |+.||......+....+.++..   ....+.+|+.+.
T Consensus       155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  229 (256)
T cd05082         155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPVVY  229 (256)
T ss_pred             cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCCHHHH
Confidence            22  22334567999998865 58899999999999999997 9999988777766666655422   222356789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 040917          268 ELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +++.+||..+|++|||+.++++
T Consensus       230 ~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         230 DVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=6.9e-37  Score=288.93  Aligned_cols=246  Identities=22%  Similarity=0.344  Sum_probs=204.4

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ...+|++++.||+|+||.||+|... +++.||+|.+.....    ....+.+|+.+++++. ||||+++++++.. ...+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~~~   76 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQ-HPRLVRLYAVVTQ-EPIY   76 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcC-CcCeeeEEEEEcc-CCcE
Confidence            4578999999999999999999865 578899999864432    3467889999999995 9999999998754 5689


Q ss_pred             EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          111 IVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      ++|||+++++|.+++...  ..++...+..++.+++.||.|||++|++||||+|+||++   +.++.++|+|||.+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARLIE  153 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceeecC
Confidence            999999999999988653  358889999999999999999999999999999999999   678899999999987654


Q ss_pred             cCccc--ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          189 EGKAY--REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       189 ~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      .....  ....++..|+|||++.+ .++.++|+||||+++|++++ |+.||.+....+....+......   ......+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  230 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM---PRPDNCPE  230 (260)
T ss_pred             CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC---CCCCCCCH
Confidence            22211  12334568999998864 57889999999999999998 99999888877776666544221   12245788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+.+++.+||..+|++||+++++++
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         231 ELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHH
Confidence            9999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-37  Score=288.24  Aligned_cols=242  Identities=25%  Similarity=0.380  Sum_probs=206.1

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++.+.||.|++|.||+|...  |+.||+|.+.....    ....+.+|+.+++.+. ||||+++++++......++|
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCCeEEE
Confidence            57999999999999999999864  88999999964431    4667889999999995 99999999999988899999


Q ss_pred             EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          113 MELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      |||+++++|.+++....  .++...+..++.|++.|+.|||++|++|+||||+||++   +.++.++|+|||.+......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEcccccccccccc
Confidence            99999999999997765  68999999999999999999999999999999999999   67889999999998765322


Q ss_pred             cccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917          191 KAYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE  268 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  268 (494)
                      ..  ....+..|+|||.+. +.++.++|+||||++++++++ |..||...+.......+.....   ......+|+.+.+
T Consensus       156 ~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  230 (256)
T cd05039         156 QD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR---MEAPEGCPPEVYK  230 (256)
T ss_pred             cc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---CCCccCCCHHHHH
Confidence            21  233456799999875 468889999999999999997 9999988877766665554322   1122457899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhc
Q 040917          269 LVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       269 li~~~l~~dp~~Rps~~eil~  289 (494)
                      +|.+||..+|++||++.++++
T Consensus       231 li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         231 VMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHhccChhhCcCHHHHHH
Confidence            999999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.9e-37  Score=300.16  Aligned_cols=252  Identities=23%  Similarity=0.358  Sum_probs=206.6

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCC-------CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENST-------GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY  103 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~-------~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~  103 (494)
                      ...+|++++.||+|+||.||+|.+...       +..||+|.+....  .......+.+|+.+++++.+||||+++++++
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            346899999999999999999986432       2368999886432  2334677889999999996699999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEE
Q 040917          104 EDDQFVHIVMELCAGGELFDRIVARG----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLF  167 (494)
Q Consensus       104 ~~~~~~~iv~e~~~g~sL~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli  167 (494)
                      ......++++||+++++|.+++....                .++...+..++.|++.||.|||++|++||||||+||++
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill  167 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV  167 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence            98889999999999999999987532                36778889999999999999999999999999999999


Q ss_pred             eeCCCCCeEEEeecCCccccccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 040917          168 TTGDENAVVKATDFGLSAFIEEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQG  242 (494)
Q Consensus       168 ~~~~~~~~~kL~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~  242 (494)
                         +.++.++|+|||.+.........   ....++..|+|||++.+ .++.++|||||||++|+|++ |..||.+....+
T Consensus       168 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  244 (334)
T cd05100         168 ---TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  244 (334)
T ss_pred             ---cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence               56789999999998755332211   11223467999998864 58899999999999999998 889999888877


Q ss_pred             HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          243 VAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      ....+.......   .....+..+.+++.+||..+|.+||++.+++++
T Consensus       245 ~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         245 LFKLLKEGHRMD---KPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHcCCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            777765543221   123568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.6e-37  Score=291.84  Aligned_cols=252  Identities=27%  Similarity=0.509  Sum_probs=207.4

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCC--ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV--KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      +|.+.+.||+|++|.||+|.+..++..+++|+++.....  .......+..|+.+++.+. ||||+++++.+......++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDAFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCceEE
Confidence            699999999999999999999888777777776543221  1223445677999999995 9999999999988889999


Q ss_pred             EEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          112 VMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      |+||+++++|.+++..    ...+++..+..++.|++.|+.|||++|++|+||+|+||+++    .+.++|+|||.+...
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~  155 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLL  155 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCceeec
Confidence            9999999999988753    34689999999999999999999999999999999999994    356999999998765


Q ss_pred             ccCcc-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          188 EEGKA-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       188 ~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ..... .....+++.|+|||.+.+ .++.++|+||+|+++++|++|..||...........+..+.....   ...++..
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  232 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL---PETYSRQ  232 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCC---cchhcHH
Confidence            33222 234557889999998764 478899999999999999999999987776665555544332221   2357889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      +.++|.+||..+|++||++.++++||||
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         233 LNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1e-36  Score=289.10  Aligned_cols=248  Identities=24%  Similarity=0.378  Sum_probs=206.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCc---EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGL---EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~---~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      .+|+..+.||+|++|.||+|.+..++.   .+++|.+....  .......+.+|+.+++++. ||||+++.+++......
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCCc
Confidence            478899999999999999999876655   69999886432  2334567889999999994 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      ++||||+++++|.+++... +.++...+..++.+++.|+.|||+.|++|+||||+||++   +.++.++|+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceecc
Confidence            9999999999999998764 568999999999999999999999999999999999999   678899999999987553


Q ss_pred             cCcccc----cccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          189 EGKAYR----EIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       189 ~~~~~~----~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      ......    ....+..|+|||.+.+ .++.++|+|||||++|+|++ |+.||......+....+.....   .+....+
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~~  235 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR---LPAPMDC  235 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC---CCCCCCC
Confidence            322111    1122457999998864 58899999999999999997 9999988888777777765422   1222457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +..+.+++.+||..+|.+||++.++++
T Consensus       236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         236 PSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.8e-37  Score=305.61  Aligned_cols=251  Identities=24%  Similarity=0.342  Sum_probs=203.2

Q ss_pred             ccceEeeeeecccCCeEEEEEEEC-----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           32 QLHYTIGREVGRGEFGITYLCTEN-----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      ..+|.+++.||+|+||.||+|.+.     .++..||+|++....  .......+.+|+.++.++..||||+++++.+...
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            367899999999999999999964     345689999997543  2223456889999999995599999999999998


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC---------------------------------------------------------
Q 040917          107 QFVHIVMELCAGGELFDRIVARG---------------------------------------------------------  129 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~~---------------------------------------------------------  129 (494)
                      ...++||||+++|+|.+++...+                                                         
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            89999999999999999886532                                                         


Q ss_pred             -----------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEe
Q 040917          130 -----------------------------------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFT  168 (494)
Q Consensus       130 -----------------------------------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~  168 (494)
                                                               .++...+..++.||+.||.|||+++++||||||+||++ 
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl-  272 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI-  272 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE-
Confidence                                                     24566778899999999999999999999999999999 


Q ss_pred             eCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 040917          169 TGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGV  243 (494)
Q Consensus       169 ~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~  243 (494)
                        +..+.++|+|||++........   .....+++.|+|||.+.+ .++.++|+|||||++|+|++ |..||......+.
T Consensus       273 --~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~  350 (401)
T cd05107         273 --CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ  350 (401)
T ss_pred             --eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence              5678999999999875432211   122346778999998864 58899999999999999998 8899977665554


Q ss_pred             HHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          244 AQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ............  ....++..+.+++.+||..+|.+||++.+|++
T Consensus       351 ~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~  394 (401)
T cd05107         351 FYNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH  394 (401)
T ss_pred             HHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            444333332222  22457899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.4e-37  Score=302.71  Aligned_cols=251  Identities=22%  Similarity=0.378  Sum_probs=198.9

Q ss_pred             ccceEeeeeecccCCeEEEEEEE-----CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-
Q 040917           32 QLHYTIGREVGRGEFGITYLCTE-----NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-  105 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-  105 (494)
                      .++|++++.||+|+||.||+|.+     ..+++.||+|.+....  .......+.+|+.++.++.+||||+++++++.. 
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            36899999999999999999985     3567899999996433  222456788999999999778999999998754 


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcC--------------------------------------------------------
Q 040917          106 DQFVHIVMELCAGGELFDRIVARG--------------------------------------------------------  129 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~~--------------------------------------------------------  129 (494)
                      +...+++|||+++|+|.+++....                                                        
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence            456889999999999999886431                                                        


Q ss_pred             -----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc---cc
Q 040917          130 -----------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY---RE  195 (494)
Q Consensus       130 -----------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~---~~  195 (494)
                                 .++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.........   ..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcchhhcCC
Confidence                       25677788999999999999999999999999999999   67789999999998764322211   12


Q ss_pred             ccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH-HHHHHHcCCccCCCCCCCCCCHHHHHHHHH
Q 040917          196 IVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQG-VAQAILKGEINFQRDPFPSISSSAIELVRR  272 (494)
Q Consensus       196 ~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  272 (494)
                      ..++..|+|||.+.+ .++.++|+||||+++|+|++ |..||....... ....+..+.. ...+  ...++.+.+++.+
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~  317 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAP--DYTTPEMYQTMLD  317 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC-CCCC--CCCCHHHHHHHHH
Confidence            234567999998754 58999999999999999997 899997654332 3333333322 1111  2367889999999


Q ss_pred             hcccCCCCCCCHHHHhcC
Q 040917          273 MLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       273 ~l~~dp~~Rps~~eil~~  290 (494)
                      ||..+|.+|||+.++++|
T Consensus       318 cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         318 CWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HccCChhhCcCHHHHHHH
Confidence            999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-36  Score=290.27  Aligned_cols=247  Identities=21%  Similarity=0.293  Sum_probs=207.0

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCc----EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGL----EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~----~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      .+|++.+.||+|+||.||+|.+..+|.    .+++|.......  ......+.+|+.+++++ +||||+++++++.. ..
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASV-DHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhC-CCCCcceEEEEEec-Cc
Confidence            689999999999999999999877665    589998765432  33456788999999999 59999999999887 67


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .++|+||+++++|.+++... ..+++..+..++.||+.|+.|||++|++||||+|+||++   +.++.++|+|||.+...
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL  159 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCcccccc
Confidence            89999999999999998764 468999999999999999999999999999999999999   57789999999999765


Q ss_pred             ccCcccc---cccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          188 EEGKAYR---EIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       188 ~~~~~~~---~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      .......   ...++..|+|||.+. +.++.++|+||||++++++++ |+.||.+....++.+.+..+.....+   ...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~  236 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQP---PIC  236 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCC---CCC
Confidence            4332211   122356799999875 468899999999999999998 99999998888877777654332221   346


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +..+.+++.+||..+|..||++.++++
T Consensus       237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         237 TIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=292.95  Aligned_cols=256  Identities=30%  Similarity=0.540  Sum_probs=229.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|..+..||.|+||.|.+|..+.+.+.+|||++++...-.....+--..|-++|......|.++.++.+|+.-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            68999999999999999999999999999999998876555545555667777887765678889999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc-ccCc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~-~~~~  191 (494)
                      |||+.||+|--.+.+-+++.+..+..++.+|+.||-+||++||++||||..|||+   +..|++||.|||++..- ..+.
T Consensus       429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~~~  505 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIFDGV  505 (683)
T ss_pred             EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeecccccccccCCc
Confidence            9999999999999999999999999999999999999999999999999999999   78999999999998753 3444


Q ss_pred             ccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          192 AYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      ...+.+|||.|+|||++. .+|+..+|+||+|++||||+.|+.||.+..+.+..+.|......++.    .+|.++..+.
T Consensus       506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkEAv~ic  581 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKEAVAIC  581 (683)
T ss_pred             ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHHHHHHH
Confidence            556789999999999886 67999999999999999999999999999999999999988887774    6889999999


Q ss_pred             HHhcccCCCCCCC-----HHHHhcCCccCc
Q 040917          271 RRMLTQDPKRRIT-----VAQVLEHPWLKE  295 (494)
Q Consensus       271 ~~~l~~dp~~Rps-----~~eil~~~~~~~  295 (494)
                      +.+|.+.|.+|..     -.+|-.||||..
T Consensus       582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~  611 (683)
T KOG0696|consen  582 KGLLTKHPGKRLGCGPEGERDIREHPFFRR  611 (683)
T ss_pred             HHHhhcCCccccCCCCccccchhhCcchhh
Confidence            9999999999974     357889999985

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-38  Score=304.64  Aligned_cols=251  Identities=24%  Similarity=0.388  Sum_probs=212.3

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCC----cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTG----LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~----~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      .+-.+.+.||+|+||.||+|..+..+    ..||+|...............+.+|+++++.+ +||||++++|+......
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCc
Confidence            44456689999999999999876542    23899998764445566788899999999999 59999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      +++|||+|.||+|.+++.+.+. ++..+...++.+.+.||.|||+++++||||-+.|+|+   ..++.+||+|||++...
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~---~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY---SKKGVVKISDFGLSRAG  312 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee---cCCCeEEeCccccccCC
Confidence            9999999999999999998874 9999999999999999999999999999999999999   66778999999998764


Q ss_pred             ccCcccc-cccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          188 EEGKAYR-EIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       188 ~~~~~~~-~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      ..-.... ...-...|+|||.+. +-|++++||||+||++||+++ |..||.+....++...+.......+.+  ...|.
T Consensus       313 ~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~~~p~  390 (474)
T KOG0194|consen  313 SQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--SKTPK  390 (474)
T ss_pred             cceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--CCCHH
Confidence            3111111 112356899999986 569999999999999999999 788999999999988885554443333  36789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+..++.+|+..+|++||++.++.+
T Consensus       391 ~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  391 ELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHHHhccCChhhccCHHHHHH
Confidence            9999999999999999999999877

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.8e-37  Score=291.46  Aligned_cols=250  Identities=22%  Similarity=0.374  Sum_probs=208.6

Q ss_pred             cceEeeeeecccCCeEEEEEEECC-----CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           33 LHYTIGREVGRGEFGITYLCTENS-----TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .+|++.+.||+|+||.||+|.++.     ..+.|++|.+....  .......+.+|+.+++++ +||||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~   81 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKL-SHKNVVRLLGLCREAE   81 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhc-CCcceeeeEEEECCCC
Confidence            689999999999999999999754     35679999885433  222457789999999999 4999999999999888


Q ss_pred             eEEEEEeccCCCchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEE
Q 040917          108 FVHIVMELCAGGELFDRIVARG---------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKA  178 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL  178 (494)
                      ..++||||+++++|.+++....         .++...+..++.|++.||.|||+++|+||||||.||++   +.++.+++
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l  158 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKV  158 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEE
Confidence            9999999999999999997665         68999999999999999999999999999999999999   57889999


Q ss_pred             eecCCccccccCc--ccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccC
Q 040917          179 TDFGLSAFIEEGK--AYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINF  254 (494)
Q Consensus       179 ~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~  254 (494)
                      +|||.+.......  ......+++.|+|||.+. +.++.++|+||||+++|+|++ |..||...........+..+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL  238 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence            9999986432221  122344567799999875 457889999999999999998 788998777777776666554433


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          255 QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       255 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      ..  ...+|..+.+++.+||..+|.+||++.+++..
T Consensus       239 ~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         239 PV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            22  24678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.2e-36  Score=286.77  Aligned_cols=240  Identities=23%  Similarity=0.353  Sum_probs=197.6

Q ss_pred             eecccCCeEEEEEEEC--CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917           40 EVGRGEFGITYLCTEN--STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA  117 (494)
Q Consensus        40 ~lg~G~~g~Vy~a~~~--~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~  117 (494)
                      .||+|+||.||+|.+.  ..+..||+|++....  .....+.+.+|+.+++++ +||||+++++++.. ...++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~-~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEA-EALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcC-CCeEEEEEeCC
Confidence            3899999999999775  445679999986442  233456789999999999 49999999998864 46889999999


Q ss_pred             CCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc---
Q 040917          118 GGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY---  193 (494)
Q Consensus       118 g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~---  193 (494)
                      +++|.+++.. ...++...+..++.|++.|+.|||++|++||||||+||++   +.++.++|+|||.+.........   
T Consensus        78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccceec
Confidence            9999998875 4468999999999999999999999999999999999999   67889999999998754332221   


Q ss_pred             -ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          194 -REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       194 -~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                       ....+++.|+|||.+.. .++.++|+|||||++|++++ |..||......+....+..+....   ..+..++.+.+++
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li  231 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLD---CPAECPPEMYALM  231 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCCHHHHHHH
Confidence             11123568999998764 68899999999999999996 999999888877777666654322   1245789999999


Q ss_pred             HHhcccCCCCCCCHHHHhc
Q 040917          271 RRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       271 ~~~l~~dp~~Rps~~eil~  289 (494)
                      .+||..+|++||++.++.+
T Consensus       232 ~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         232 KDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=9.7e-37  Score=287.37  Aligned_cols=242  Identities=24%  Similarity=0.359  Sum_probs=202.2

Q ss_pred             eeecccCCeEEEEEEECC-CCc--EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEec
Q 040917           39 REVGRGEFGITYLCTENS-TGL--EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMEL  115 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~-~~~--~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~  115 (494)
                      +.||+|++|.||+|.+.. .+.  .||+|.+......  .....+.+|+.+++++. ||||+++++.+.. ...++++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence            468999999999999865 333  6999999765432  45778899999999995 9999999999988 889999999


Q ss_pred             cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc-
Q 040917          116 CAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-  192 (494)
Q Consensus       116 ~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~-  192 (494)
                      +++++|.+++....  .++...+..++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||.+........ 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEeccccccccccccccc
Confidence            99999999997764  68999999999999999999999999999999999999   5678999999999876543211 


Q ss_pred             ---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          193 ---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       193 ---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                         .....++..|+|||.+.+ .++.++|+|||||++++|++ |+.||...+..+....+........  .....|..+.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  231 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE--RPEACPQDIY  231 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC--CCccCCHHHH
Confidence               112345678999998864 68999999999999999998 9999988887777666654322222  1235789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 040917          268 ELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +++.+||..+|.+||++.++++
T Consensus       232 ~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         232 NVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHCCCCcccCCCHHHHHH
Confidence            9999999999999999999986

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7e-37  Score=292.63  Aligned_cols=247  Identities=24%  Similarity=0.382  Sum_probs=196.0

Q ss_pred             cce-EeeeeecccCCeEEEEEE----ECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--
Q 040917           33 LHY-TIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--  105 (494)
Q Consensus        33 ~~y-~i~~~lg~G~~g~Vy~a~----~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--  105 (494)
                      ++| ++.+.||+|+||+||++.    ...++..||+|++....  .......+.+|+.+++.+ +||||+++++++..  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~   79 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQG   79 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCC
Confidence            455 999999999999998764    34578899999986542  223456788999999999 49999999998765  


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          106 DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      ....+++|||+++++|.+++... .++...+..++.|++.|+.|||++|++||||||+||++   ++++.++|+|||++.
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~  155 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAK  155 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeeccccc
Confidence            34688999999999999998764 59999999999999999999999999999999999999   677899999999987


Q ss_pred             ccccCccc----ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChH--H-------------HHH
Q 040917          186 FIEEGKAY----REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQ--G-------------VAQ  245 (494)
Q Consensus       186 ~~~~~~~~----~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~--~-------------~~~  245 (494)
                      ........    ....++..|+|||.+. +.++.++||||||+++|+|++|..||......  +             ..+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE  235 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence            65432221    1223456799999886 45889999999999999999999998543321  0             000


Q ss_pred             HHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          246 AILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+... ...  .....++..+.+++.+||..+|++|||++++++
T Consensus       236 ~~~~~-~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         236 LLERG-MRL--PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhcC-CCC--CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            11111 111  112457899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.1e-36  Score=289.11  Aligned_cols=248  Identities=26%  Similarity=0.385  Sum_probs=204.7

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCC---CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENST---GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~---~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      ..+|.+.+.||+|++|.||+|.+...   ...|++|......  .....+.+.+|+.+++++. ||||+++++++.+ ..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~-~~   80 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE-NP   80 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC-CC
Confidence            46799999999999999999987544   4568999886433  2334667899999999995 9999999998875 45


Q ss_pred             EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .++||||+++++|.+++.+.. .++...+..++.+++.||.|||++|++||||||+||++   +..+.++|+|||++...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV---SSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE---ecCCCeEEccCceeeec
Confidence            679999999999999997644 58999999999999999999999999999999999999   56789999999998765


Q ss_pred             ccCcccc--cccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917          188 EEGKAYR--EIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       188 ~~~~~~~--~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      .......  ...+++.|+|||.+.+ .++.++|+||||++++++++ |..||......+....+.++....   ..+.+|
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~  234 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP---MPPNCP  234 (270)
T ss_pred             ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCC---CCCCCC
Confidence            4332211  1223467999998764 58899999999999999886 999998888777666665543322   225678


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          264 SSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ..+.+++.+|+..+|.+|||+.+++.
T Consensus       235 ~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         235 PTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.1e-36  Score=284.94  Aligned_cols=245  Identities=26%  Similarity=0.441  Sum_probs=205.8

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++.+.||+|++|.||+|.+. .+..+++|.+.....    ....+.+|+.+++++ +|||++++++++......+++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKL-SHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhC-CCCCeeeEEEEEccCCceEEE
Confidence            47999999999999999999875 477899999864432    245688899999999 499999999999988899999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      +||+++++|.+++... +.++...+..++.+++.++.+||+++++|+||+|+||++   +.++.++|+|||.+.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCc
Confidence            9999999999988764 458999999999999999999999999999999999999   678899999999987543221


Q ss_pred             cc--ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          192 AY--REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       192 ~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      ..  ....++..|+|||.+. +.++.++|+||||+++|+|++ |..||......+....+..+.....+   ...+..+.
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  231 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQSVY  231 (256)
T ss_pred             ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCHHHH
Confidence            11  1223456899999886 468889999999999999998 99999888877777777654333222   23678999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 040917          268 ELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +++.+||..+|++|||+.++++
T Consensus       232 ~l~~~~l~~~p~~Rp~~~~~l~  253 (256)
T cd05112         232 ELMQHCWKERPEDRPSFSLLLH  253 (256)
T ss_pred             HHHHHHcccChhhCCCHHHHHH
Confidence            9999999999999999999986

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.1e-37  Score=297.59  Aligned_cols=256  Identities=24%  Similarity=0.323  Sum_probs=198.4

Q ss_pred             eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917           35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME  114 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e  114 (494)
                      |.+++.+|.|  |.||.+.+..+++.||+|++..... .......+.+|+.+++.++ ||||+++++++...+..+++||
T Consensus         4 ~~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~e   79 (314)
T cd08216           4 TLIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVSP   79 (314)
T ss_pred             hhhhHhhcCC--ceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEEEe
Confidence            3444445444  5566666667899999999976432 3345678999999999995 9999999999999999999999


Q ss_pred             ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          115 LCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       115 ~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+++|+||||||+||++   +.++.++|+|||.+........
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~  156 (314)
T cd08216          80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGK  156 (314)
T ss_pred             ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEecCccceeeccccc
Confidence            99999999998763  458899999999999999999999999999999999999   5678999999998865432111


Q ss_pred             --------cccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC------
Q 040917          193 --------YREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ------  255 (494)
Q Consensus       193 --------~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~------  255 (494)
                              .....++..|+|||++..   .++.++|+||+||++++|++|..||..............+.....      
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (314)
T cd08216         157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY  236 (314)
T ss_pred             cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCch
Confidence                    122345778999999864   478899999999999999999999977654433222111111000      


Q ss_pred             ------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          256 ------------------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       256 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                                              ......++..+.+++.+||..||++|||+.++|+||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                                    000012346788999999999999999999999999998644

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.6e-36  Score=292.13  Aligned_cols=252  Identities=21%  Similarity=0.304  Sum_probs=200.8

Q ss_pred             ccceEeeeeecccCCeEEEEEEECC----------------CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCC
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENS----------------TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN   95 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~----------------~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~   95 (494)
                      ..+|++.+.||+|+||.||+|.+..                ++..||+|.+....  .......+.+|+.+++.+. |||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~-~~~   80 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLK-DPN   80 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCC
Confidence            3679999999999999999986542                34568999986432  2334677899999999995 999


Q ss_pred             ccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 040917           96 IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG-----------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPEN  164 (494)
Q Consensus        96 i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~N  164 (494)
                      |+++++++......+++|||+++++|.+++....           .++...+..++.|++.|+.|||++|++|+||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            9999999999899999999999999999987643           25677899999999999999999999999999999


Q ss_pred             eEEeeCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh--CCCCCCCC
Q 040917          165 FLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC--GVPPFWAE  238 (494)
Q Consensus       165 Ili~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t--g~~pf~~~  238 (494)
                      |++   +.++.++|+|||++........   .....+++.|++||... +.++.++|+|||||++|+|++  |..||...
T Consensus       161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         161 CLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             EEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            999   5788999999999875433221   11223356899999764 568999999999999999998  77899877


Q ss_pred             ChHHHHHHHHc----CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          239 TDQGVAQAILK----GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       239 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ...+.......    .......+....+++.+.+++.+||..||.+||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            76655443321    1111111122457799999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.1e-36  Score=288.83  Aligned_cols=249  Identities=19%  Similarity=0.237  Sum_probs=205.8

Q ss_pred             ccceEeeeeecccCCeEEEEEEECC----CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-C
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENS----TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-D  106 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~----~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-~  106 (494)
                      ..+|++.+.||+|+||.||+|.+..    ++..|++|++...  ........+.+|+.+++++ +||||+++++++.. +
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~   81 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDG   81 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCC
Confidence            3689999999999999999999875    3688999988632  2344567788999999999 59999999998765 4


Q ss_pred             CeEEEEEeccCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEE
Q 040917          107 QFVHIVMELCAGGELFDRIVAR--------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKA  178 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~--------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL  178 (494)
                      ...+++++|+++++|.+++...        ..++...+..++.+++.||.|||+++++|+||||+||++   +.++.++|
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl  158 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKI  158 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEEE
Confidence            6788999999999999998653        348899999999999999999999999999999999999   67789999


Q ss_pred             eecCCccccccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCcc
Q 040917          179 TDFGLSAFIEEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEIN  253 (494)
Q Consensus       179 ~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~  253 (494)
                      +|||++.........   ....++..|+|||.+.+ .++.++|||||||++|++++ |+.||......+....+..+. .
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~  237 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-R  237 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-C
Confidence            999998755332211   12334667999998864 58899999999999999998 999998887776666555432 2


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          254 FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ..  ....+|+.+.+++.+||..+|++|||+.++++
T Consensus       238 ~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         238 LA--QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            22  22457899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.2e-36  Score=282.61  Aligned_cols=241  Identities=25%  Similarity=0.362  Sum_probs=199.3

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG  118 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g  118 (494)
                      ++||+|++|.||+|... ++..||+|.+....  .......+.+|+.+++.+ +||||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEECCCC
Confidence            46899999999999864 68899999986433  233455688999999999 599999999999999999999999999


Q ss_pred             CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc--cc
Q 040917          119 GELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY--RE  195 (494)
Q Consensus       119 ~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~--~~  195 (494)
                      ++|.+++... ..++...+..++.+++.++.|||++|++||||+|+||++   +.++.++|+|||++.........  ..
T Consensus        77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceeccccccccCCC
Confidence            9999988653 457899999999999999999999999999999999999   67889999999998654322111  11


Q ss_pred             ccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHh
Q 040917          196 IVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRM  273 (494)
Q Consensus       196 ~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  273 (494)
                      ..++..|+|||++. +.++.++|+||||+++|++++ |..||...........+......   .....++..+.+++.+|
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~  230 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM---SCPQKCPDDVYKVMQRC  230 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHH
Confidence            23356799999886 458899999999999999998 99999888776666655543221   22245789999999999


Q ss_pred             cccCCCCCCCHHHHhc
Q 040917          274 LTQDPKRRITVAQVLE  289 (494)
Q Consensus       274 l~~dp~~Rps~~eil~  289 (494)
                      |..+|++||++.++++
T Consensus       231 l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         231 WDYKPENRPKFSELQK  246 (250)
T ss_pred             cccCcccCCCHHHHHH
Confidence            9999999999999976

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.8e-36  Score=284.98  Aligned_cols=240  Identities=27%  Similarity=0.393  Sum_probs=202.0

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|+||.||++.  .+++.||+|.+....     ....+.+|+.+++++. |||++++++++..+ ..+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~~~~v   76 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLH-HKNLVRLLGVILHN-GLYIV   76 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCC-CCCcCeEEEEEcCC-CcEEE
Confidence            579999999999999999987  468899999985432     3467889999999995 99999999998765 47899


Q ss_pred             EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          113 MELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      |||+++++|.+++....  .++...+..++.|++.|+.|||++|++||||||+||++   +.++.++|+|||.+......
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMG  153 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceecccc
Confidence            99999999999997653  47899999999999999999999999999999999999   67789999999998754322


Q ss_pred             cccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917          191 KAYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE  268 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  268 (494)
                        ......+..|+|||.+. +.++.++|+|||||++|+|++ |+.||......+....+.++...   .....+|..+.+
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  228 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM---EPPEGCPADVYV  228 (254)
T ss_pred             --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC---CCCCcCCHHHHH
Confidence              12233456799999876 468899999999999999997 99999888887777766554222   123467899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhc
Q 040917          269 LVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       269 li~~~l~~dp~~Rps~~eil~  289 (494)
                      ++.+||..+|.+||++.+++.
T Consensus       229 li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         229 LMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999986

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-36  Score=283.41  Aligned_cols=241  Identities=26%  Similarity=0.369  Sum_probs=200.6

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCC
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG  118 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g  118 (494)
                      +.||+|++|.||+|.+.. ++.|++|.+......  .....+.+|+.+++++. ||||+++++++......++||||++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEcCCC
Confidence            469999999999999887 999999998654322  35677899999999995 99999999999999999999999999


Q ss_pred             CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc---c
Q 040917          119 GELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY---R  194 (494)
Q Consensus       119 ~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~---~  194 (494)
                      ++|.+++... ..++...+..++.+++.++.|||+++++||||+|+||++   +.++.++|+|||.+.........   .
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCcceeccc
Confidence            9999998653 468899999999999999999999999999999999999   67889999999998754321111   1


Q ss_pred             cccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHH
Q 040917          195 EIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR  272 (494)
Q Consensus       195 ~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  272 (494)
                      ....+..|+|||.+. +.++.++|+|||||++|+|++ |..||...........+..... ..  .....+..+.+++.+
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~li~~  230 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR-MP--APQLCPEEIYRLMLQ  230 (251)
T ss_pred             cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC-CC--CCccCCHHHHHHHHH
Confidence            122355799999876 468899999999999999998 8899988777666665554321 11  124578999999999


Q ss_pred             hcccCCCCCCCHHHHhc
Q 040917          273 MLTQDPKRRITVAQVLE  289 (494)
Q Consensus       273 ~l~~dp~~Rps~~eil~  289 (494)
                      ||..+|.+||++.++++
T Consensus       231 ~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         231 CWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HhccChhhCcCHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.9e-36  Score=283.79  Aligned_cols=246  Identities=21%  Similarity=0.346  Sum_probs=203.6

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ..++|++.+.||+|+||.||+|.+. .+..+++|.+....    ...+.+.+|+.+++.+. |+||+++++++.. ...+
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-CCeE
Confidence            4578999999999999999999865 45679999886432    23567889999999995 9999999999887 6789


Q ss_pred             EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          111 IVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      ++|||+++++|.+++...  ..++...+..++.+++.||.|||++|++|+||+|+||++   +..+.++|+|||.+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIE  153 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceeecc
Confidence            999999999999998763  357888899999999999999999999999999999999   678899999999987654


Q ss_pred             cCccc--ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          189 EGKAY--REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       189 ~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      .....  ....++..|+|||.+.. .++.++|+|||||++|++++ |+.||.+.........+......   ......+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  230 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---PRPENCPE  230 (260)
T ss_pred             CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC---CCcccCCH
Confidence            32211  12234567999998864 58889999999999999998 99999888777666666544221   12246789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+.+++.+||..+|++||++.++++
T Consensus       231 ~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         231 ELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.4e-37  Score=311.52  Aligned_cols=247  Identities=26%  Similarity=0.458  Sum_probs=214.2

Q ss_pred             cceEeeeeecccCCeEEEEEEECC-----CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           33 LHYTIGREVGRGEFGITYLCTENS-----TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .+-...+.||+|+||.||+|+-..     ....||||.++...  ....+.+|.+|++++..|+ ||||++++|++..++
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQ-HPNIVRLLGVCREGD  562 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEccCC
Confidence            456678889999999999998543     34579999997433  4447899999999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCC
Q 040917          108 FVHIVMELCAGGELFDRIVARG--------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDEN  173 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~--------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~  173 (494)
                      ..|+|+|||..|+|.+++..+.              +++..+.+.|+.||+.|+.||-++.+|||||-..|.||   +++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---GEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---ccc
Confidence            9999999999999999996532              27889999999999999999999999999999999999   789


Q ss_pred             CeEEEeecCCccccccCcccc---cccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 040917          174 AVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAIL  248 (494)
Q Consensus       174 ~~~kL~Dfg~a~~~~~~~~~~---~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~  248 (494)
                      ..|||+|||+++.+-+.+.+.   ...-..+|||||.+. +.+|.+|||||+||++||+++ |+.||.+.+.+++++.+.
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~  719 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR  719 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence            999999999998765444332   122356899999764 789999999999999999998 899999999999999999


Q ss_pred             cCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 040917          249 KGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL  288 (494)
Q Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil  288 (494)
                      ++.. ...+  ..+|..+.+|+..||..+|.+||++.||=
T Consensus       720 ~g~l-L~~P--e~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  720 AGQL-LSCP--ENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             cCCc-ccCC--CCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            9887 4433  47899999999999999999999999973

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-36  Score=289.98  Aligned_cols=248  Identities=27%  Similarity=0.437  Sum_probs=197.3

Q ss_pred             cceEeeeeecccCCeEEEEEEE----CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--
Q 040917           33 LHYTIGREVGRGEFGITYLCTE----NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--  106 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~----~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--  106 (494)
                      .-|++.+.||+|+||.||+|..    ..++..||+|.+....  .......+.+|+.+++.+. ||||+++.+++...  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   80 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGG   80 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCC
Confidence            3578999999999999999974    4678899999986432  2334567899999999995 99999999998764  


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          107 QFVHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      ...++||||++|++|.+++.... .++...+..++.+++.||.|||++|++||||||+||++   +.++.++|+|||++.
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~  157 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTK  157 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE---cCCCCEEECCCcccc
Confidence            56889999999999999986643 58999999999999999999999999999999999999   567889999999987


Q ss_pred             ccccCccc----ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh---------------HHHHH
Q 040917          186 FIEEGKAY----REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD---------------QGVAQ  245 (494)
Q Consensus       186 ~~~~~~~~----~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~---------------~~~~~  245 (494)
                      ........    ....++..|+|||.+.+ .++.++|+|||||++|+|+++..|......               .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            65432221    23345678999998764 588999999999999999998766532111               11111


Q ss_pred             HHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          246 AILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+..+. .  ......++..+.+++.+||+.+|.+||++.++++
T Consensus       238 ~~~~~~-~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  278 (284)
T cd05079         238 VLEEGK-R--LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE  278 (284)
T ss_pred             HHHcCc-c--CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            111111 1  1123467899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4e-36  Score=285.21  Aligned_cols=251  Identities=27%  Similarity=0.478  Sum_probs=207.7

Q ss_pred             ceEeeeeecccCCeEEEEEEECC-CCcEEEEEEeccCCC-------CChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917           34 HYTIGREVGRGEFGITYLCTENS-TGLEFACKSIPKRKL-------VKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED  105 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~-~~~~valK~~~~~~~-------~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~  105 (494)
                      .|++.+.||+|++|.||+|.+.. +++.+|+|.+.....       ........+.+|+.++.+..+||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48889999999999999999987 788999998854321       1223345677888888764469999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCCCCeEEEee
Q 040917          106 DQFVHIVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                      ++..+++|||++|++|.+++..    ...++...++.++.|++.|+.+||+ .+++|+||+|.||++   +.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEec
Confidence            9999999999999999987743    3468999999999999999999996 689999999999999   6788999999


Q ss_pred             cCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 040917          181 FGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF  259 (494)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  259 (494)
                      ||.+.............++..|+|||.+.+ .++.++|+||||+++|+|++|+.||...........+........  ..
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~  235 (269)
T cd08528         158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL--PE  235 (269)
T ss_pred             ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--Cc
Confidence            999986554444445668889999998864 588999999999999999999999987776666655555433322  22


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          260 PSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ..+++.+.+++.+||..||++||++.++..
T Consensus       236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~  265 (269)
T cd08528         236 GMYSEDVTDVITSCLTPDAEARPDIIQVSA  265 (269)
T ss_pred             ccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence            357899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=279.56  Aligned_cols=296  Identities=26%  Similarity=0.421  Sum_probs=232.9

Q ss_pred             cccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           27 AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      ..-.+..||.-.+.+|.|.. .|..|.+..++++|++|..... ...........+|..++..+. |+||++++.+|...
T Consensus        11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~   87 (369)
T KOG0665|consen   11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQ   87 (369)
T ss_pred             cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhc-ccceeeeeeccCcc
Confidence            45567789999999999999 8999999999999999998665 455556788899999999995 99999999998643


Q ss_pred             ------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917          107 ------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       107 ------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                            ..+|+|||++. .+|.+.+.  -.++..++..++.|+++|++|||+.||+||||||+||++   +.+..+|+.|
T Consensus        88 ~~l~~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~d  161 (369)
T KOG0665|consen   88 KTLEEFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILD  161 (369)
T ss_pred             ccHHHHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeecc
Confidence                  35889999995 49988886  357999999999999999999999999999999999999   7899999999


Q ss_pred             cCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc----------
Q 040917          181 FGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK----------  249 (494)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~----------  249 (494)
                      ||+|+.....-....++.|..|+|||++.+ .+...+||||+||++.||++|+..|.|...-+..-++..          
T Consensus       162 fg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  162 FGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             chhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence            999987655545567888999999999876 499999999999999999999999987765433322211          


Q ss_pred             ------------CC---------ccCCCCCCC-------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccC---ccCc
Q 040917          250 ------------GE---------INFQRDPFP-------SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK---ESGE  298 (494)
Q Consensus       250 ------------~~---------~~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~---~~~~  298 (494)
                                  ..         ..++...|+       .-...+++++.+||..||++|.|++++|+|||++   ...+
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~e  321 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDE  321 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccccc
Confidence                        00         011111111       1235688999999999999999999999999997   3333


Q ss_pred             CCCCCCc-HHHHHHHHHHhhhhHHHHHHHHhhhcc
Q 040917          299 ASDKPID-TAVIFRMKQFTAMNKLKKLALKVIVEN  332 (494)
Q Consensus       299 ~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~~~~  332 (494)
                      ....+.. -.........+ ..+|+.++++++...
T Consensus       322 v~ap~pe~~d~~~d~~~~t-~~e~ke~If~ev~~f  355 (369)
T KOG0665|consen  322 VEAPPPEIYDKQLDEREHT-IEEWKELIFKEVQRF  355 (369)
T ss_pred             ccCCCCchhhhhcccccCC-HHHHHHHHHHHHHhh
Confidence            3322222 11222333333 788988888887654

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5e-36  Score=284.52  Aligned_cols=244  Identities=20%  Similarity=0.269  Sum_probs=192.2

Q ss_pred             eeecccCCeEEEEEEEC--CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEecc
Q 040917           39 REVGRGEFGITYLCTEN--STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELC  116 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~--~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~  116 (494)
                      +.||+|+||.||+|...  .....+++|.+....  .......+.+|+..++.+ +||||+++++.+......++||||+
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEeC
Confidence            35899999999999643  245578888875432  233456788899999999 5999999999999888999999999


Q ss_pred             CCCchHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          117 AGGELFDRIVARGH-----YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       117 ~g~sL~~~~~~~~~-----l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      ++++|.+++.....     .+...+..++.||+.|+.|||++||+||||||+||++   +.++.++|+|||.+.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccch
Confidence            99999999876432     4577888999999999999999999999999999999   678899999999986532221


Q ss_pred             c---cccccCCcCccChhhhcc--------cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCc-cCCCC-
Q 040917          192 A---YREIVGSPYYIAPEVLSQ--------SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEI-NFQRD-  257 (494)
Q Consensus       192 ~---~~~~~~~~~y~aPE~~~~--------~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~-~~~~~-  257 (494)
                      .   .....+++.|+|||++..        .++.++|||||||++|+|++ |..||......+.......... ..+.+ 
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ  234 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence            1   122334667999998742        36789999999999999999 7889988777666555444332 22222 


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       258 ~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ....+++.+.+++..|+ .||++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            22357888999999998 59999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.4e-36  Score=283.78  Aligned_cols=244  Identities=23%  Similarity=0.309  Sum_probs=192.3

Q ss_pred             eeecccCCeEEEEEEEC--CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEecc
Q 040917           39 REVGRGEFGITYLCTEN--STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELC  116 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~--~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~  116 (494)
                      +.||+|+||.||+|.+.  .++..+++|.+....  .......+.+|+.++++++ ||||+++++.+......++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEFC   77 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEECC
Confidence            36899999999999864  456789999886543  2234457888999999995 999999999998888899999999


Q ss_pred             CCCchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          117 AGGELFDRIVARG-----HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       117 ~g~sL~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      ++++|.+++....     .++...+..++.|++.|+.|||+++++|+||||+||++   +..+.++|+|||.+.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCcc
Confidence            9999999986532     35667888999999999999999999999999999999   678899999999986543222


Q ss_pred             cc---ccccCCcCccChhhhcc--------cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcC-CccCCCCC
Q 040917          192 AY---REIVGSPYYIAPEVLSQ--------SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKG-EINFQRDP  258 (494)
Q Consensus       192 ~~---~~~~~~~~y~aPE~~~~--------~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~  258 (494)
                      ..   ....+++.|+|||++.+        .++.++|+||||+++|+|++ |..||......+........ ......+.
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR  234 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence            11   12346778999998753        25789999999999999996 99999877766554433322 22222221


Q ss_pred             -CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          259 -FPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       259 -~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                       ....++.+.+++..|+ .+|++|||+++++.
T Consensus       235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence             1246788999999998 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=295.17  Aligned_cols=249  Identities=24%  Similarity=0.363  Sum_probs=197.1

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC-eEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ-FVHI  111 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~-~~~i  111 (494)
                      ..|.-...||+||||.||+|.... |..||||.+.......   ...|.+|+.++.+++ |||+++++|+|.+.+ ..++
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~~~~~~L  149 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLR-HPNLVKLLGYCLEGGEHRLL  149 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCC-CcCcccEEEEEecCCceEEE
Confidence            567777899999999999999764 4899999876443221   445999999999996 999999999999888 5999


Q ss_pred             EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          112 VMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSK---GVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      |+||++.|+|.+++....  .+++.....|+..++.||.|||..   .|+||||||+|||+   +.+...||+|||+|..
T Consensus       150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~  226 (361)
T KOG1187|consen  150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKL  226 (361)
T ss_pred             EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCccCccc
Confidence            999999999999998765  789999999999999999999985   39999999999999   7899999999999976


Q ss_pred             ccc-Ccccccc-cCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCC---hHHHHHH----HHcCCcc-CC
Q 040917          187 IEE-GKAYREI-VGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAET---DQGVAQA----ILKGEIN-FQ  255 (494)
Q Consensus       187 ~~~-~~~~~~~-~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~---~~~~~~~----~~~~~~~-~~  255 (494)
                      ... ....... .||..|+|||... +..+.++||||||++++|++||+.+.....   ......+    +..+... ..
T Consensus       227 ~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii  306 (361)
T KOG1187|consen  227 GPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV  306 (361)
T ss_pred             CCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence            554 3322233 7999999999885 689999999999999999999998886432   1112221    2221111 11


Q ss_pred             CCCC--CCCC-----HHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          256 RDPF--PSIS-----SSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       256 ~~~~--~~~~-----~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+..  ...+     ..+..+..+|++.+|..||++.++++
T Consensus       307 D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  307 DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            1111  1223     22556788999999999999999754

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.3e-36  Score=289.37  Aligned_cols=247  Identities=20%  Similarity=0.291  Sum_probs=201.4

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCc----EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGL----EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~----~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      ++|++.+.||+|+||.||+|.+..+|.    .||+|.+....  .......+.+|+.+++.+ +||||+++++++... .
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~-~   82 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC-C
Confidence            578999999999999999999887776    46888875433  222345688899999999 599999999998654 4


Q ss_pred             EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .+++++|+++|+|.+++.... .++...+..++.|++.||.|||++||+|+||||+||++   +.++.+||+|||++...
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLARLL  159 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEccccccccc
Confidence            679999999999999987654 58899999999999999999999999999999999999   56778999999999765


Q ss_pred             ccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          188 EEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       188 ~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      .....   .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+.........+..+. .++.  .+..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~  236 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RLPQ--PPIC  236 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CCCC--CCCC
Confidence            43222   112334678999998864 58899999999999999997 899998877666555554432 2222  2456


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +..+.+++.+||..+|++||++.++++
T Consensus       237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~  263 (303)
T cd05110         237 TIDVYMVMVKCWMIDADSRPKFKELAA  263 (303)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            789999999999999999999999877

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=316.33  Aligned_cols=249  Identities=27%  Similarity=0.427  Sum_probs=213.5

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCc-----EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGL-----EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~-----~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      ...-+..+.||+|+||.||.|.-.....     .||+|.+.  ...+......|.+|..+++.+ +||||++++|++.+.
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~--~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLK--RLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDS  767 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecc--ccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCC
Confidence            3567788999999999999998653322     38888876  444667788999999999999 599999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEe
Q 040917          107 QFVHIVMELCAGGELFDRIVAR-------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKAT  179 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~  179 (494)
                      ...+|++|||+||+|..++++.       ..++....+.++.+|++|+.||+++++|||||-+.|+|+   +....+||+
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIa  844 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKIA  844 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEEc
Confidence            9999999999999999999875       248899999999999999999999999999999999999   677999999


Q ss_pred             ecCCccccccCccccc--c-cCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccC
Q 040917          180 DFGLSAFIEEGKAYRE--I-VGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINF  254 (494)
Q Consensus       180 Dfg~a~~~~~~~~~~~--~-~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~  254 (494)
                      |||+|+.+.....++.  . .-...|||||.+. +.++.++|||||||++||++| |..||......++...+.++. ..
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL  923 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RL  923 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-cc
Confidence            9999995443332221  1 2235799999986 779999999999999999998 789999999999998777776 33


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          255 QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       255 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +.+  +.+|..+.+++..||+.+|++||++..|++
T Consensus       924 ~~P--~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  924 DPP--SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCC--CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            322  578999999999999999999999999987

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1e-35  Score=284.67  Aligned_cols=247  Identities=26%  Similarity=0.424  Sum_probs=195.8

Q ss_pred             cceEeeeeecccCCeEEEEEE----ECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--C
Q 040917           33 LHYTIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--D  106 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~----~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--~  106 (494)
                      .+|++.+.||+|+||.||+|.    +..++..|++|.+....   ......+.+|+.+++.++ ||||+++++++..  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~   79 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCC
Confidence            479999999999999999987    45678899999986432   334567889999999995 9999999998643  3


Q ss_pred             CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          107 QFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      ...++|+||+++++|.+++... ..++...+..++.|++.||.|||++|++||||||+||++   +.++.++|+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~  156 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTK  156 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCcccc
Confidence            4688999999999999998764 458999999999999999999999999999999999999   678899999999998


Q ss_pred             ccccCccc----ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHH---------------
Q 040917          186 FIEEGKAY----REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQ---------------  245 (494)
Q Consensus       186 ~~~~~~~~----~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~---------------  245 (494)
                      ........    ....++..|+|||++.+ .++.++|+|||||++++|++|..|+...... ...               
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  235 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVYHL  235 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchHHH
Confidence            65433221    11123345999998864 5889999999999999999987765433221 111               


Q ss_pred             -HHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          246 -AILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       246 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                       .+.......  .....++..+.+++.+||..+|++|||+.++++
T Consensus       236 ~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         236 IELLKNNGRL--PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHhcCCcC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence             111111111  122467899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-37  Score=277.31  Aligned_cols=256  Identities=27%  Similarity=0.497  Sum_probs=227.9

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++...||+|+|+.|..++.++|.+.+|+|++++..+..+...+=...|-.+..+-++||.++.++.+|+.+..+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            68999999999999999999999999999999999988888878888888999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc-ccCc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~-~~~~  191 (494)
                      .||++||+|--.+.+..+++++.+..+...|+.||.|||++||++||||..||++   +..|++||.|+|++... .++.
T Consensus       330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCCCCc
Confidence            9999999998888888899999999999999999999999999999999999999   78999999999998763 4566


Q ss_pred             ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCC-------ChHH-HHHHHHcCCccCCCCCCCCC
Q 040917          192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAE-------TDQG-VAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~-------~~~~-~~~~~~~~~~~~~~~~~~~~  262 (494)
                      ...+.+|||.|.|||++.+ .|...+|+|+||+++++|+.|+.||...       +.++ ..+.++......++    .+
T Consensus       407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr----sl  482 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR----SL  482 (593)
T ss_pred             ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc----ee
Confidence            6678999999999999987 5999999999999999999999999521       2223 34555666555554    45


Q ss_pred             CHHHHHHHHHhcccCCCCCC------CHHHHhcCCccCc
Q 040917          263 SSSAIELVRRMLTQDPKRRI------TVAQVLEHPWLKE  295 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rp------s~~eil~~~~~~~  295 (494)
                      +-....+++..|.+||.+|.      .+.++..|+||..
T Consensus       483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~  521 (593)
T KOG0695|consen  483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS  521 (593)
T ss_pred             ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence            66778899999999999995      5789999999985

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.3e-36  Score=282.62  Aligned_cols=237  Identities=18%  Similarity=0.203  Sum_probs=189.7

Q ss_pred             eeecccCCeEEEEEEECCCC----------cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           39 REVGRGEFGITYLCTENSTG----------LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~----------~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      +.||+|+||.||+|.+..++          ..|++|.+....    .....+.+|+.+++.+. ||||+++++++.. ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLS-HKHLVKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCC-CcchhheeeEEec-CC
Confidence            46899999999999998776          357788765332    12577889999999995 9999999999877 67


Q ss_pred             EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC----CCCeEEEeecCC
Q 040917          109 VHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD----ENAVVKATDFGL  183 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~----~~~~~kL~Dfg~  183 (494)
                      .++||||+++++|.+++.... .++...+..++.||+.||.|||++||+||||||+||+++.+.    ....++|+|||.
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            899999999999999998765 689999999999999999999999999999999999995321    123799999999


Q ss_pred             ccccccCcccccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 040917          184 SAFIEEGKAYREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPF  259 (494)
Q Consensus       184 a~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  259 (494)
                      +.....   .....++..|+|||++.+   .++.++|+|||||++++|++ |..||......+.......... .+    
T Consensus       155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~-~~----  226 (259)
T cd05037         155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR-LP----  226 (259)
T ss_pred             cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCC-CC----
Confidence            876543   223456778999999864   48899999999999999999 5788876654444333332111 11    


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          260 PSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ......+.+++.+||..+|++|||+.++++
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         227 MPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            112378999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.7e-36  Score=280.71  Aligned_cols=228  Identities=23%  Similarity=0.349  Sum_probs=187.3

Q ss_pred             cCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCchHH
Q 040917           44 GEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFD  123 (494)
Q Consensus        44 G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~sL~~  123 (494)
                      |.+|.||+|.+..+++.||+|.+....        ...+|...+... .||||+++++++......++||||++|++|.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   74 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS   74 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence            899999999999999999999996532        123344444445 49999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcccccccCCcCcc
Q 040917          124 RIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI  203 (494)
Q Consensus       124 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~  203 (494)
                      ++.....+++..+..++.|++.||.|||++|++||||||+||++   +.++.++|+|||.+......  .....++..|+
T Consensus        75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhccccc--cccCCcCcccc
Confidence            99887789999999999999999999999999999999999999   67888999999987654332  22344577899


Q ss_pred             Chhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 040917          204 APEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI  282 (494)
Q Consensus       204 aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  282 (494)
                      |||.+.+ .++.++|+||+|+++|+|++|..|+...... .     .......  ..+.+++.+.++|.+||+.||.+||
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~-----~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~R~  221 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I-----NTHTTLN--IPEWVSEEARSLLQQLLQFNPTERL  221 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c-----ccccccC--CcccCCHHHHHHHHHHccCCHHHhc
Confidence            9998864 5889999999999999999999887543221 0     0000111  1134788999999999999999999


Q ss_pred             CH-----HHHhcCCcc
Q 040917          283 TV-----AQVLEHPWL  293 (494)
Q Consensus       283 s~-----~eil~~~~~  293 (494)
                      ++     +++++||||
T Consensus       222 ~~~~~~~~~~~~h~~~  237 (237)
T cd05576         222 GAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCCccchHHHHcCCCC
Confidence            86     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=285.48  Aligned_cols=272  Identities=27%  Similarity=0.481  Sum_probs=206.4

Q ss_pred             hhhhhhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCC-----
Q 040917           19 LHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ-----   93 (494)
Q Consensus        19 ~~~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-----   93 (494)
                      +|++.+++.+.+  +||.+.+.||.|.|++||+|++..+.+.||+|+++..    +...+....|+.+|++++.+     
T Consensus        66 YHpV~IGD~F~~--gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~  139 (590)
T KOG1290|consen   66 YHPVRIGDVFNG--GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDP  139 (590)
T ss_pred             CceeeccccccC--ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCC
Confidence            556666655432  8999999999999999999999999999999999743    34566778899999998733     


Q ss_pred             --CCccEEeEEEE----eCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCc
Q 040917           94 --PNIVQFKAAYE----DDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPEN  164 (494)
Q Consensus        94 --p~i~~~~~~~~----~~~~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~N  164 (494)
                        .+|+++++.|.    ++.++|+|+|+. |.+|+.+|...  +.++...+++|++||+.||.|||.. ||||.||||+|
T Consensus       140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPEN  218 (590)
T KOG1290|consen  140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPEN  218 (590)
T ss_pred             CCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcce
Confidence              46999999985    466999999999 88999999765  4599999999999999999999975 99999999999


Q ss_pred             eEEeeC--------------------------------------------------------------------------
Q 040917          165 FLFTTG--------------------------------------------------------------------------  170 (494)
Q Consensus       165 Ili~~~--------------------------------------------------------------------------  170 (494)
                      ||+..+                                                                          
T Consensus       219 vLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~  298 (590)
T KOG1290|consen  219 VLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEP  298 (590)
T ss_pred             eeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccc
Confidence            998100                                                                          


Q ss_pred             --------------------------------------------------------------------------------
Q 040917          171 --------------------------------------------------------------------------------  170 (494)
Q Consensus       171 --------------------------------------------------------------------------------  170 (494)
                                                                                                      
T Consensus       299 ~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~  378 (590)
T KOG1290|consen  299 NQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNP  378 (590)
T ss_pred             cccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccccc
Confidence                                                                                            


Q ss_pred             ---------CCCCeEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 040917          171 ---------DENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD  240 (494)
Q Consensus       171 ---------~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~  240 (494)
                               ..+..+||+|||.|+...  .....-..|..|+|||++.| .|++.+||||++|+++||.||-..|.....
T Consensus       379 ~v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG  456 (590)
T KOG1290|consen  379 LVNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSG  456 (590)
T ss_pred             ccCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCC
Confidence                     001135666666665431  22233446889999999876 599999999999999999999998843321


Q ss_pred             ------HHHHHHHHc-----------------------CCccCCC--CCCC---------CCC----HHHHHHHHHhccc
Q 040917          241 ------QGVAQAILK-----------------------GEINFQR--DPFP---------SIS----SSAIELVRRMLTQ  276 (494)
Q Consensus       241 ------~~~~~~~~~-----------------------~~~~~~~--~~~~---------~~~----~~l~~li~~~l~~  276 (494)
                            ++.+..+..                       +...-..  .+|+         .+|    ..+.+|+.-||+.
T Consensus       457 ~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef  536 (590)
T KOG1290|consen  457 ENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEF  536 (590)
T ss_pred             CCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhc
Confidence                  222222211                       1110000  0121         122    4577899999999


Q ss_pred             CCCCCCCHHHHhcCCccCccCcC
Q 040917          277 DPKRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       277 dp~~Rps~~eil~~~~~~~~~~~  299 (494)
                      +|++||||.++|+|||+.....+
T Consensus       537 ~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  537 DPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             CccccccHHHHhcCccccCCCCC
Confidence            99999999999999999987654

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.9e-36  Score=284.02  Aligned_cols=245  Identities=26%  Similarity=0.373  Sum_probs=197.6

Q ss_pred             eeecccCCeEEEEEEECCCC------cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           39 REVGRGEFGITYLCTENSTG------LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~------~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      +.||+|++|.||+|.+....      ..+++|.+....  .......+.+|+.+++.+. ||||+++++++......++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEE
Confidence            36899999999999976544      689999886432  1234567889999999994 99999999999988899999


Q ss_pred             EeccCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC--CCCeEEEeecCC
Q 040917          113 MELCAGGELFDRIVAR-------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD--ENAVVKATDFGL  183 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~--~~~~~kL~Dfg~  183 (494)
                      |||++|++|.+++...       ..++...+..++.+++.|+.|||+++++|+||+|+||+++.++  ....++|+|||+
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999998642       2377899999999999999999999999999999999995322  223899999999


Q ss_pred             ccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCC
Q 040917          184 SAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDP  258 (494)
Q Consensus       184 a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (494)
                      +........   .....++..|+|||.+. +.++.++|+|||||++|+|++ |..||......+....+..+...   ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~  234 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL---QK  234 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc---CC
Confidence            875432211   11234467899999886 468999999999999999998 99999887776666655443221   12


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       259 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ...+|..+.+++.+||..+|.+||++.++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            2467899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.6e-36  Score=284.61  Aligned_cols=240  Identities=17%  Similarity=0.228  Sum_probs=191.1

Q ss_pred             eeecccCCeEEEEEEECCCCc-------EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           39 REVGRGEFGITYLCTENSTGL-------EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~-------~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      +.||+|+||.||+|.+...+.       .|++|.+....   ....+.+.+|+.+++.+. ||||+++++++..+...++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEE
Confidence            469999999999999865544       48888875322   234567788999999994 9999999999999888999


Q ss_pred             EEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC-----CCCeEEEeecCCcc
Q 040917          112 VMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD-----ENAVVKATDFGLSA  185 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~-----~~~~~kL~Dfg~a~  185 (494)
                      ||||+++|+|..++..++ .++...+..++.||+.|+.|||++||+||||||+||+++.++     ..+.++++|||.+.
T Consensus        77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999999997654 589999999999999999999999999999999999996422     12358999999986


Q ss_pred             ccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          186 FIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGV-PPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      .....   ....+++.|+|||++.+  .++.++|+|||||++|+|++|. .||........... .......+    ...
T Consensus       157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~~~~~~----~~~  228 (258)
T cd05078         157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YEDRHQLP----APK  228 (258)
T ss_pred             ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHccccCC----CCC
Confidence            54322   23457888999999864  4788999999999999999984 66665555443332 22222222    235


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      +..+.+++.+||+.+|++|||++++++.
T Consensus       229 ~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         229 WTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            5789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=7.1e-36  Score=307.92  Aligned_cols=343  Identities=17%  Similarity=0.252  Sum_probs=220.8

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCC----CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEE-----
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENST----GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAA-----  102 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~----~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~-----  102 (494)
                      .++|.+.+.||+|+||.||+|.+..+    +..||+|.+....     ..+...++  .+.... +.++..+...     
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e--~l~~~~-~~~~~~~~~~~~~~~  202 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNE--RVRRAC-PNSCADFVYGFLEPV  202 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHH--HHHhhc-hhhHHHHHHhhhccc
Confidence            36899999999999999999999988    9999999875322     11111111  111111 2222221111     


Q ss_pred             -EEeCCeEEEEEeccCCCchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 040917          103 -YEDDQFVHIVMELCAGGELFDRIVARGH--------------------YSERAAASVFRVIMNVVNVCHSKGVMHRDLK  161 (494)
Q Consensus       103 -~~~~~~~~iv~e~~~g~sL~~~~~~~~~--------------------l~~~~~~~i~~~i~~~l~~LH~~~i~H~dik  161 (494)
                       .......++|+||+.+++|.+++.....                    .....+..++.||+.||.|||+++|+|||||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK  282 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK  282 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence             2345678999999999999998865421                    1234467899999999999999999999999


Q ss_pred             CCceEEeeCCCCCeEEEeecCCccccccCc--ccccccCCcCccChhhhcc-----------------------cCCCcc
Q 040917          162 PENFLFTTGDENAVVKATDFGLSAFIEEGK--AYREIVGSPYYIAPEVLSQ-----------------------SYGKEA  216 (494)
Q Consensus       162 p~NIli~~~~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~-----------------------~~~~~~  216 (494)
                      |+|||++  +..+.+||+|||++.......  ......+++.|+|||.+..                       .++.++
T Consensus       283 P~NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        283 PQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             HHHEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999995  245789999999997543322  2234678999999997531                       123456


Q ss_pred             hhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc----------CCCC-------CCCCCCHHHHHHHHHhcccCCC
Q 040917          217 DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN----------FQRD-------PFPSISSSAIELVRRMLTQDPK  279 (494)
Q Consensus       217 Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~----------~~~~-------~~~~~~~~l~~li~~~l~~dp~  279 (494)
                      ||||+||++|+|+++..|+..... .....+......          ....       .+...+....+||.+||+.||.
T Consensus       361 DVwSlGviL~el~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSNLI-QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchHHH-HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            999999999999997766532211 111111111100          0000       0011233456899999999999


Q ss_pred             CCCCHHHHhcCCccCccCcCCCCCCcHHHHHHHHHHhhhhHHHHHHHHhhhccCchhHHHhhhhhhhccCCCCCCcccHH
Q 040917          280 RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYD  359 (494)
Q Consensus       280 ~Rps~~eil~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~  359 (494)
                      +|||+.++|+||||........... ........  ..            ......+-.+.+...+..-+++.+|..+.+
T Consensus       440 kR~ta~e~L~Hpff~~~~~~~~~~~-~~~~~~~~--~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~  504 (566)
T PLN03225        440 QRISAKAALAHPYFDREGLLGLSVM-QNLRLQLF--RA------------TQQDYGEAAAWVVFLMAKSGTEKEGGFTEA  504 (566)
T ss_pred             cCCCHHHHhCCcCcCCCCccccccc-cccccccc--hh------------hHHHHHHHHHHHHHHHHhcCCCCCCCccHH
Confidence            9999999999999987432211110 00000000  00            000011222345555666778888999999


Q ss_pred             HHHHHHHhcCCCCCHHHHHH--HHHHhcCCCCCcccchHHHHHHH
Q 040917          360 ELKAGLAKLGSMLTEFDVKQ--YMQAADIDGNGTIDYIEFITATM  402 (494)
Q Consensus       360 el~~~l~~~~~~~~~~~~~~--~~~~~D~~~~g~i~~~ef~~~~~  402 (494)
                      ++..+...-  ...+.+..+  +.+.++.+..|-.++.+++....
T Consensus       505 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  547 (566)
T PLN03225        505 QLQELREKE--PKKKGSAQRNALASALRLQRKGVKTVARTVDEIP  547 (566)
T ss_pred             HHHHhhhhc--CcchhhhhhhhHHHHHhhhhhhhhhhhhhhhccc
Confidence            999977654  223333434  77888888888888888776433

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.6e-35  Score=279.82  Aligned_cols=242  Identities=24%  Similarity=0.339  Sum_probs=193.1

Q ss_pred             eeecccCCeEEEEEEECC---CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE-eCCeEEEEEe
Q 040917           39 REVGRGEFGITYLCTENS---TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE-DDQFVHIVME  114 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~---~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~-~~~~~~iv~e  114 (494)
                      +.||+|+||.||+|.+..   .+..||+|.+....  .......+.+|+.+++.+ +||||+++++++. .+...++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEe
Confidence            468999999999998643   34579999875322  233456788899999999 5999999999765 4556889999


Q ss_pred             ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc--
Q 040917          115 LCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--  191 (494)
Q Consensus       115 ~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~--  191 (494)
                      |+.+++|.+++... ..++...+..++.+++.||.|||+.+++||||||+||++   ++++.++|+|||++.......  
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCcce
Confidence            99999999998764 346778888999999999999999999999999999999   677899999999987543211  


Q ss_pred             ---ccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917          192 ---AYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       192 ---~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (494)
                         ......+++.|+|||.+. ..++.++|||||||++|+|++ |..||......+....+..+.....   ...+|+.+
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  231 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ---PEYCPDPL  231 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHH
Confidence               111234567899999875 468899999999999999999 4677777776666666555432221   13468899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhc
Q 040917          267 IELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+++.+||..+|++||++.++++
T Consensus       232 ~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         232 YEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHH
Confidence            99999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.5e-35  Score=280.11  Aligned_cols=240  Identities=18%  Similarity=0.229  Sum_probs=189.1

Q ss_pred             eeecccCCeEEEEEEECCC------------CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           39 REVGRGEFGITYLCTENST------------GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~------------~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      +.||+|+||.||+|.....            ...|++|++....   ......+.+|+.+++.+. ||||+++++++..+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVS-HKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence            4689999999999985422            3358888875432   234556788999999994 99999999999988


Q ss_pred             CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC----CCCeEEEeec
Q 040917          107 QFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD----ENAVVKATDF  181 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~----~~~~~kL~Df  181 (494)
                      ...++||||+++++|..++... ..++...+..++.||+.|+.|||+++|+||||||.||+++.+.    ....++++||
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            8899999999999998888653 4689999999999999999999999999999999999995321    1224899999


Q ss_pred             CCccccccCcccccccCCcCccChhhhc--ccCCCcchhHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHcCCccCCCCC
Q 040917          182 GLSAFIEEGKAYREIVGSPYYIAPEVLS--QSYGKEADIWSAGVILYILL-CGVPPFWAETDQGVAQAILKGEINFQRDP  258 (494)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~il~~l~-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (494)
                      |.+......   ....++..|+|||.+.  ..++.++|||||||++|+|+ +|..||......+... +.......    
T Consensus       157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~----  228 (262)
T cd05077         157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCML----  228 (262)
T ss_pred             CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccC----
Confidence            998654322   2345778899999885  35889999999999999997 5888887665544322 22222211    


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          259 FPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       259 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      ....+..+.+++.+||..||.+||++.+|+++
T Consensus       229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            12345789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.6e-35  Score=284.54  Aligned_cols=250  Identities=14%  Similarity=0.173  Sum_probs=187.2

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCC---CcEEEEEEeccCCCCChhhH--------HHHHHHHHHHHHccCCCCccE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENST---GLEFACKSIPKRKLVKDVEK--------DDVRREIEIMRHLSGQPNIVQ   98 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~---~~~valK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~~hp~i~~   98 (494)
                      ....+|++.+.||+|+||.||+|.+..+   +..+++|+............        .....+...+..+ +|+++++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~   87 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPK   87 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCc
Confidence            4457999999999999999999998877   67778876532221100000        0111223334455 5999999


Q ss_pred             EeEEEEeCC----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917           99 FKAAYEDDQ----FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA  174 (494)
Q Consensus        99 ~~~~~~~~~----~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~  174 (494)
                      +++++....    ..+++++++. .++.+.+......++..+..++.|++.||.|||+++|+||||||+||++   +..+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~~~  163 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DGNN  163 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCC
Confidence            998765433    4568888874 4777777665557888899999999999999999999999999999999   5678


Q ss_pred             eEEEeecCCccccccCc--------ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHH
Q 040917          175 VVKATDFGLSAFIEEGK--------AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD-QGVA  244 (494)
Q Consensus       175 ~~kL~Dfg~a~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~-~~~~  244 (494)
                      .++|+|||++.......        ......||+.|+|||++.+ .++.++|||||||++++|++|..||.+... ....
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            89999999987643211        1122468999999999875 589999999999999999999999987733 2221


Q ss_pred             --------HHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          245 --------QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       245 --------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                              ..+..+..     ..+..++.+.+++..|+..+|++||++.++++
T Consensus       244 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        244 HAAKCDFIKRLHEGKI-----KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHhHHHHHHHhhhhhh-----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                    22222211     23456899999999999999999999999875

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1e-35  Score=284.57  Aligned_cols=248  Identities=27%  Similarity=0.430  Sum_probs=200.3

Q ss_pred             cceEeeeeecccCCeEEEEEEEC----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--C
Q 040917           33 LHYTIGREVGRGEFGITYLCTEN----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--D  106 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--~  106 (494)
                      .+|++.+.||+|+||.||+|.+.    .++..||+|++......  .....+.+|+.+++.+. ||||+++++++..  .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLD-HENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCC-CCChheEEeeeecCCC
Confidence            57889999999999999999864    34889999998754422  34678999999999994 9999999999876  5


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          107 QFVHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      ...+++|||+++++|.+++.... .++...+..++.|++.||.|||++|++|+||+|.||++   +.++.++|+|||.+.
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~  157 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAK  157 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEccccccc
Confidence            57899999999999999997654 58999999999999999999999999999999999999   567899999999998


Q ss_pred             ccccCccc----ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHH---------------HHH
Q 040917          186 FIEEGKAY----REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQG---------------VAQ  245 (494)
Q Consensus       186 ~~~~~~~~----~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~---------------~~~  245 (494)
                      ........    ....++..|+|||.+. ..++.++|+||||+++++|++|..|+.......               ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            66432211    1123455699999875 458889999999999999999999986543221               112


Q ss_pred             HHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          246 AILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+.. ....+  ....++..+.+++.+||..+|.+||++.++++
T Consensus       238 ~~~~-~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         238 LLKE-GERLP--RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHc-CCcCC--CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            2222 22211  12456789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-37  Score=301.11  Aligned_cols=205  Identities=29%  Similarity=0.513  Sum_probs=181.3

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC----
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD----  106 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~----  106 (494)
                      ..+-|...+.||+||||.||+++++.+|..||+|++.....  ....+..-+|++++++|. ||||++++++-...    
T Consensus        11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~--~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~   87 (732)
T KOG4250|consen   11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS--LRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGL   87 (732)
T ss_pred             CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcc--cchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCc
Confidence            34678889999999999999999999999999999976542  335788899999999996 99999999987543    


Q ss_pred             --CeEEEEEeccCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEee-CCCCCeEEEee
Q 040917          107 --QFVHIVMELCAGGELFDRIVA---RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTT-GDENAVVKATD  180 (494)
Q Consensus       107 --~~~~iv~e~~~g~sL~~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~-~~~~~~~kL~D  180 (494)
                        ....+|||||.||+|+..+.+   ...+++.+++.++..+..|+.|||++||+||||||.||++-. ++.....||+|
T Consensus        88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtD  167 (732)
T KOG4250|consen   88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTD  167 (732)
T ss_pred             ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeec
Confidence              357799999999999999853   346999999999999999999999999999999999999864 33667899999


Q ss_pred             cCCccccccCcccccccCCcCccChhhhc--ccCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 040917          181 FGLSAFIEEGKAYREIVGSPYYIAPEVLS--QSYGKEADIWSAGVILYILLCGVPPFWAE  238 (494)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~  238 (494)
                      ||.|+..+.+....+..||+.|.+||+..  +.|+..+|.|||||++|+..||..||...
T Consensus       168 fG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  168 FGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             ccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            99999998888888999999999999987  56899999999999999999999999543

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-35  Score=282.42  Aligned_cols=239  Identities=18%  Similarity=0.203  Sum_probs=189.3

Q ss_pred             eecccCCeEEEEEEECCC------------------------CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCC
Q 040917           40 EVGRGEFGITYLCTENST------------------------GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN   95 (494)
Q Consensus        40 ~lg~G~~g~Vy~a~~~~~------------------------~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~   95 (494)
                      .||+|+||.||+|....+                        ...|++|++....   ......+.+|+.+++.+. |||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~-h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVS-HIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCC-CCC
Confidence            699999999999875321                        2458888885332   223456778899999995 999


Q ss_pred             ccEEeEEEEeCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC----
Q 040917           96 IVQFKAAYEDDQFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG----  170 (494)
Q Consensus        96 i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~----  170 (494)
                      |+++++++......++||||+++++|..++.. .+.++...+..++.||+.||.|||++||+||||||+||+++..    
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999999988865 4568999999999999999999999999999999999999632    


Q ss_pred             CCCCeEEEeecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHH-HhCCCCCCCCChHHHHHHH
Q 040917          171 DENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYIL-LCGVPPFWAETDQGVAQAI  247 (494)
Q Consensus       171 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l-~tg~~pf~~~~~~~~~~~~  247 (494)
                      .....++++|||.+......   ....++..|+|||.+.+  .++.++|+|||||++|++ ++|..||...........+
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~  234 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY  234 (274)
T ss_pred             CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence            12346899999987543221   22356788999998864  478999999999999998 4789999877665543332


Q ss_pred             HcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          248 LKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      .. ....+    ...++.+.+++.+||..+|++|||+.++|++
T Consensus       235 ~~-~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         235 EK-KHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             Hh-ccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            22 11111    2345789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=3.5e-37  Score=263.73  Aligned_cols=258  Identities=27%  Similarity=0.498  Sum_probs=212.0

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--  106 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--  106 (494)
                      +.-+++|++++.+|+|.++.||.|.+..+++.+++|+++..      ....+.+|+.+|+.|+++|||++++++..+.  
T Consensus        34 wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S  107 (338)
T KOG0668|consen   34 WGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPES  107 (338)
T ss_pred             ccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence            44568999999999999999999999999999999999643      4677999999999999999999999998764  


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          107 QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      ....+|+|++...+...+   .+.++...+...+.++++||.|+|+.||+|||+||.|++++  .....++|+|+|+|.+
T Consensus       108 ktpaLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEF  182 (338)
T KOG0668|consen  108 KTPSLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEF  182 (338)
T ss_pred             cCchhHhhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhh
Confidence            467799999977555443   35688899999999999999999999999999999999996  4567899999999999


Q ss_pred             cccCcccccccCCcCccChhhhc--ccCCCcchhHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHH-------------cC
Q 040917          187 IEEGKAYREIVGSPYYIAPEVLS--QSYGKEADIWSAGVILYILLCGVPPFWAE-TDQGVAQAIL-------------KG  250 (494)
Q Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~-~~~~~~~~~~-------------~~  250 (494)
                      .-++...+-.+.+..|..||.+-  ..|+..-|+|||||.+..|+..+.||... +..+.+-.+.             +-
T Consensus       183 YHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  183 YHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             cCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            98888888888899999999874  46889999999999999999999998433 3333222221             00


Q ss_pred             Cc-----------cCCCCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          251 EI-----------NFQRDPF---------PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       251 ~~-----------~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ..           ...+.+|         .-.++++.+|+.++|..|-++|||+.|++.||||....
T Consensus       263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~  329 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR  329 (338)
T ss_pred             ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence            00           0011111         12468999999999999999999999999999998543

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.5e-35  Score=280.29  Aligned_cols=247  Identities=22%  Similarity=0.360  Sum_probs=199.5

Q ss_pred             eEeeeeecccCCeEEEEEEEC---CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC----
Q 040917           35 YTIGREVGRGEFGITYLCTEN---STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ----  107 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~----  107 (494)
                      |++.+.||+|++|.||+|.+.   .+++.||+|++..... .....+.+.+|+.+++.+. ||||+++++++....    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence            678899999999999999864   3578999999865432 3334677889999999995 999999999885432    


Q ss_pred             --eEEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEe
Q 040917          108 --FVHIVMELCAGGELFDRIVAR------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKAT  179 (494)
Q Consensus       108 --~~~iv~e~~~g~sL~~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~  179 (494)
                        ..+++++|+.+++|..++...      ..++...+..++.|++.|+.|||++||+||||||+||++   +.++.++|+
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~  155 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVA  155 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEEC
Confidence              347889999999998877532      147889999999999999999999999999999999999   678889999


Q ss_pred             ecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccC
Q 040917          180 DFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINF  254 (494)
Q Consensus       180 Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~  254 (494)
                      |||.+........   .....+++.|++||.+.+ .++.++|+|||||++|+|++ |+.||.+....+....+.......
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK  235 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            9999876533221   112234567999998764 57889999999999999999 889998877776666665543221


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          255 QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       255 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .   .+..+..+.+++.+||..+|++|||+.+++.
T Consensus       236 ~---~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         236 Q---PPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             C---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            1   1457789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=272.21  Aligned_cols=259  Identities=23%  Similarity=0.322  Sum_probs=212.9

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +.+-...||.|+||+|++..++.+|+..|||.+.....  ...+.++..|.+...+-.++|||+++++..-.++..+|.|
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM  142 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM  142 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence            34446679999999999999999999999999976543  4467888999998887778999999999998888899999


Q ss_pred             eccCCCchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          114 ELCAGGELFDRIV-----ARGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       114 e~~~g~sL~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      |+|. .||..+-+     ....+++..+..|....+.||.||... +|+|||+||+|||+   +..|.+||||||.+-..
T Consensus       143 ELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  143 ELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQL  218 (361)
T ss_pred             HHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhH
Confidence            9994 46654332     345688998889999999999999865 89999999999999   78999999999998766


Q ss_pred             ccCcccccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcCCccCCCCCC--CC
Q 040917          188 EEGKAYREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETD-QGVAQAILKGEINFQRDPF--PS  261 (494)
Q Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~--~~  261 (494)
                      ..+-....-.|-.+|+|||.+..   .|+-+||+||||++++|+.||+.||.+... .+.+..+..+.++......  -.
T Consensus       219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~  298 (361)
T KOG1006|consen  219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVH  298 (361)
T ss_pred             HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccc
Confidence            54444444567889999999853   489999999999999999999999977654 2444555666555443322  34


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                      ++..+..+|.-||.+|-..||.+.+++++||+.-..+
T Consensus       299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  299 YSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             cCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence            7889999999999999999999999999999986543

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.6e-37  Score=292.68  Aligned_cols=262  Identities=25%  Similarity=0.425  Sum_probs=218.8

Q ss_pred             ccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc-----CCCCccEEe
Q 040917           26 KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS-----GQPNIVQFK  100 (494)
Q Consensus        26 ~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~i~~~~  100 (494)
                      .-.+.+..+|.|....|+|=||+|.+|.++.-|+.||||+|....    .....=+.|+++|++|.     +.-|++.++
T Consensus       425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            334556689999999999999999999999999999999997543    24445567999999996     346899999


Q ss_pred             EEEEeCCeEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEE
Q 040917          101 AAYEDDQFVHIVMELCAGGELFDRIVARG---HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVK  177 (494)
Q Consensus       101 ~~~~~~~~~~iv~e~~~g~sL~~~~~~~~---~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~k  177 (494)
                      ..|...+++|+|+|.+. .+|.+.++..+   .+....+..++.|++.||..|.++||+|.||||.|||++  .....+|
T Consensus       501 r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLK  577 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILK  577 (752)
T ss_pred             HHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceee
Confidence            99999999999999985 59999998765   488899999999999999999999999999999999997  6778999


Q ss_pred             EeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC
Q 040917          178 ATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR  256 (494)
Q Consensus       178 L~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  256 (494)
                      |||||.|...... ....++.+..|+|||++.| +|+..-|+||+||+||||+||+..|.|.+...++...+...-+++.
T Consensus       578 LCDfGSA~~~~en-eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~  656 (752)
T KOG0670|consen  578 LCDFGSASFASEN-EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN  656 (752)
T ss_pred             eccCccccccccc-cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence            9999999876544 3456677888999999877 6999999999999999999999999999998877665432222221


Q ss_pred             CC-------------------------------------------------CCCC-------CHHHHHHHHHhcccCCCC
Q 040917          257 DP-------------------------------------------------FPSI-------SSSAIELVRRMLTQDPKR  280 (494)
Q Consensus       257 ~~-------------------------------------------------~~~~-------~~~l~~li~~~l~~dp~~  280 (494)
                      ..                                                 .+.+       -..+.+|+.+||..||++
T Consensus       657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K  736 (752)
T KOG0670|consen  657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK  736 (752)
T ss_pred             HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence            10                                                 0011       234788999999999999


Q ss_pred             CCCHHHHhcCCccCc
Q 040917          281 RITVAQVLEHPWLKE  295 (494)
Q Consensus       281 Rps~~eil~~~~~~~  295 (494)
                      |.|..++|.||||+.
T Consensus       737 Rit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  737 RITVNQALKHPFITE  751 (752)
T ss_pred             cCCHHHHhcCCcccC
Confidence            999999999999974

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.1e-35  Score=276.90  Aligned_cols=243  Identities=20%  Similarity=0.293  Sum_probs=190.4

Q ss_pred             eecccCCeEEEEEEECCC--CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917           40 EVGRGEFGITYLCTENST--GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA  117 (494)
Q Consensus        40 ~lg~G~~g~Vy~a~~~~~--~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~  117 (494)
                      .||+|+||.||++.....  ...+++|.+....  .......+.+|+.+++.+ +||||+++++.+......++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEecCC
Confidence            599999999999975432  3456677765432  223467889999999999 59999999999998889999999999


Q ss_pred             CCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc--
Q 040917          118 GGELFDRIVAR----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--  191 (494)
Q Consensus       118 g~sL~~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~--  191 (494)
                      +++|.+++.+.    ...+...+..++.||+.||.|||+++++||||||+||++   +.++.++|+|||++.......  
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchhh
Confidence            99999998754    235667788999999999999999999999999999999   678899999999876432211  


Q ss_pred             -ccccccCCcCccChhhhcc--------cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCc-cCCC-CCC
Q 040917          192 -AYREIVGSPYYIAPEVLSQ--------SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEI-NFQR-DPF  259 (494)
Q Consensus       192 -~~~~~~~~~~y~aPE~~~~--------~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~-~~~~-~~~  259 (494)
                       ......++..|+|||++..        .++.++|+|||||++|+|++ +..||......+....+.+... .... ...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE  235 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence             1123457889999998732        35789999999999999997 5678887777666665544332 2222 222


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          260 PSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ..+++.+.+++..|| .+|++||++.++++
T Consensus       236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         236 LPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            357888999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=283.13  Aligned_cols=266  Identities=29%  Similarity=0.460  Sum_probs=222.3

Q ss_pred             cccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhh----HHHHHHHHHHHHHccCCCCccEEeEE
Q 040917           27 AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVE----KDDVRREIEIMRHLSGQPNIVQFKAA  102 (494)
Q Consensus        27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~----~~~~~~E~~~l~~l~~hp~i~~~~~~  102 (494)
                      .-..+.++|-+..+||.|||+.||+|.+...++.||+|+-.......+..    ....-+|.++-+.| +||.|+++|++
T Consensus       457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDy  535 (775)
T KOG1151|consen  457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDY  535 (775)
T ss_pred             cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeee
Confidence            34456789999999999999999999999999999999976555444433    34456899999999 69999999999


Q ss_pred             EE-eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCceEEeeCCCCCeEEEe
Q 040917          103 YE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK--GVMHRDLKPENFLFTTGDENAVVKAT  179 (494)
Q Consensus       103 ~~-~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~i~H~dikp~NIli~~~~~~~~~kL~  179 (494)
                      +. +.+.+|-|+|||+|-+|.-+++.+..++++++..|+-||+.||.||...  .|||-||||.|||+.+.+..|.+||.
T Consensus       536 fslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  536 FSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             eeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence            96 4567899999999999999999999999999999999999999999876  69999999999999887788999999


Q ss_pred             ecCCccccccCcc--------cccccCCcCccChhhhc-c----cCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHH
Q 040917          180 DFGLSAFIEEGKA--------YREIVGSPYYIAPEVLS-Q----SYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQ  245 (494)
Q Consensus       180 Dfg~a~~~~~~~~--------~~~~~~~~~y~aPE~~~-~----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~  245 (494)
                      |||++..+.....        .....||-+|.+||.+- +    ..+.++||||+|||+|..+.|+.||...... ++++
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq  695 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ  695 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence            9999987753221        12356899999999874 2    2688999999999999999999999765443 3332


Q ss_pred             H--HH-cCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          246 A--IL-KGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       246 ~--~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      .  |+ .....|+..  |.++.+...||.+||...-++|....++-.||||..
T Consensus       696 eNTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  696 ENTILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             hhchhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            2  22 233445544  678999999999999999999999999999999974

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.4e-36  Score=289.64  Aligned_cols=258  Identities=28%  Similarity=0.507  Sum_probs=220.8

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .-|..++.||-|+||.|.+|....|...+|.|.+.+......+......-|..||..- +++-|+++|-.|++.+.+|+|
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEE
Confidence            5789999999999999999999999999999999888777777788888999999998 699999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc---
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE---  189 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~---  189 (494)
                      |+|++||++-.++.+.+.+.+..+..++.++.+|+.+.|+.|+|||||||.||||   +.+|+|||.|||++.-+..   
T Consensus       708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceeccc
Confidence            9999999999999999999999999999999999999999999999999999999   7899999999999853210   


Q ss_pred             ------Cc------------------c----------------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHH
Q 040917          190 ------GK------------------A----------------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYIL  228 (494)
Q Consensus       190 ------~~------------------~----------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l  228 (494)
                            +.                  .                ....+||+.|+|||++.. .|+.-+|+||.|||||+|
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence                  00                  0                012458999999999865 699999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCccCc
Q 040917          229 LCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI---TVAQVLEHPWLKE  295 (494)
Q Consensus       229 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~eil~~~~~~~  295 (494)
                      +.|+.||...++.+....+.+=.........-.+++++.++|.++.. .++.|.   .++++..||||+.
T Consensus       865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg  933 (1034)
T KOG0608|consen  865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG  933 (1034)
T ss_pred             hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence            99999998887766555444433333334456789999999988764 567776   4678999999996

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.7e-34  Score=269.06  Aligned_cols=242  Identities=43%  Similarity=0.736  Sum_probs=205.6

Q ss_pred             CCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCchHHH
Q 040917           45 EFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDR  124 (494)
Q Consensus        45 ~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~  124 (494)
                      +||.||+|.+..+++.+++|++.......  ....+.+|+..++++ +|+||+++++.+......++++|++++++|.++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK--KRERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEeccccccc--HHHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence            58999999999999999999997544322  167899999999999 599999999999998999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcccccccCCcCccC
Q 040917          125 IVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIA  204 (494)
Q Consensus       125 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~a  204 (494)
                      +.....++...+..++.+++.++.+||+.+++|+||+|.||++   +.++.++|+|||.+.............++..|+|
T Consensus        78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  154 (244)
T smart00220       78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---DEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA  154 (244)
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---CCCCcEEEccccceeeeccccccccccCCcCCCC
Confidence            9877668999999999999999999999999999999999999   5668999999999987665544455677889999


Q ss_pred             hhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 040917          205 PEVLS-QSYGKEADIWSAGVILYILLCGVPPFWA-ETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI  282 (494)
Q Consensus       205 PE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  282 (494)
                      ||.+. ..++.++|+||+|++++++++|..||.. .......+.+....... ......++..+.+++.+||..+|++||
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp  233 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF-PPPEWKISPEAKDLIRKLLVKDPEKRL  233 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-ccccccCCHHHHHHHHHHccCCchhcc
Confidence            99886 4688899999999999999999999987 44444444444333322 222222789999999999999999999


Q ss_pred             CHHHHhcCCcc
Q 040917          283 TVAQVLEHPWL  293 (494)
Q Consensus       283 s~~eil~~~~~  293 (494)
                      ++.++++||||
T Consensus       234 ~~~~~~~~~~~  244 (244)
T smart00220      234 TAEEALQHPFF  244 (244)
T ss_pred             CHHHHhhCCCC
Confidence            99999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-35  Score=292.54  Aligned_cols=258  Identities=27%  Similarity=0.470  Sum_probs=219.3

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE-----
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE-----  104 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~-----  104 (494)
                      ...+.|.|.+.||.|.+|.||+++++.+++.+|+|+.....    ...+.++.|+++++.++.|||++.++++|.     
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~   91 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG   91 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence            34467999999999999999999999999999999986433    346778889999999999999999999984     


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917          105 DDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG  182 (494)
Q Consensus       105 ~~~~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg  182 (494)
                      .++.+++|||||.|||..+++++-  .++.+..+.-|++.++.|+.+||++.++|||||=.|||+   ...+.|||+|||
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDFG  168 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDFG  168 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE---eccCcEEEeeee
Confidence            356899999999999999999764  468999999999999999999999999999999999999   678999999999


Q ss_pred             CccccccCcc-cccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC
Q 040917          183 LSAFIEEGKA-YREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ  255 (494)
Q Consensus       183 ~a~~~~~~~~-~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  255 (494)
                      .+....+... ..+..|||.|||||++.      ..|+..+|+||||++..||--|.+|+...-+...+-.+.+... +.
T Consensus       169 vSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP-Pk  247 (953)
T KOG0587|consen  169 VSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP-PK  247 (953)
T ss_pred             eeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC-cc
Confidence            9987665433 34578999999999984      2377899999999999999999999987776544333322211 11


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          256 RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       256 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      -..+..++..+.+||..||.+|-++||+..++|.|||+++
T Consensus       248 Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  248 LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            1224568899999999999999999999999999999995

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-35  Score=287.28  Aligned_cols=253  Identities=24%  Similarity=0.345  Sum_probs=213.6

Q ss_pred             cceEeeeeecccCCeEEEEEEECCC---CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENST---GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~---~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      ++.++.++||+|+||.|++|.|...   ...||||++.......  ..++|.+|+.+|.+|+ |||++++|++..+ ...
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~-H~hliRLyGvVl~-qp~  185 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QPA  185 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhcc-CcceeEEeeeecc-chh
Confidence            5677889999999999999998753   3469999997554332  6889999999999995 9999999999987 556


Q ss_pred             EEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          110 HIVMELCAGGELFDRIVA--RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .+|+|++++|+|.+.+.+  ...+.......++.||++|+.||..+++|||||-..|+++   -....|||+|||+.+..
T Consensus       186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlll---asprtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLL---ASPRTVKICDFGLMRAL  262 (1039)
T ss_pred             hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhee---cccceeeeecccceecc
Confidence            799999999999999987  3458889999999999999999999999999999999999   56789999999999876


Q ss_pred             ccCccccccc----CCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917          188 EEGKAYREIV----GSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       188 ~~~~~~~~~~----~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (494)
                      ..+.......    -...|+|||.++ ..++.++|+|++||++|||+| |..||.+...-.+++.+..+ ...+++  +.
T Consensus       263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~-erLpRP--k~  339 (1039)
T KOG0199|consen  263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG-ERLPRP--KY  339 (1039)
T ss_pred             CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc-ccCCCC--CC
Confidence            6544432211    234699999986 579999999999999999998 67999999998898888744 333333  46


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      +++.+.++++.||..+|.+||++..|.+.-+...
T Consensus       340 csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             ChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            8999999999999999999999999987655544

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=291.16  Aligned_cols=248  Identities=25%  Similarity=0.420  Sum_probs=216.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCc---EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGL---EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~---~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      ..-+|.+.||.|.||.||+++.+..|+   .||||.++...  .+..+.+|+.|+.||-++ +||||+++.++......+
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~Pv  705 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKPV  705 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCcee
Confidence            456789999999999999999887764   69999997544  445678899999999999 599999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      .||+|||+.|+|..+++.+ +.++..++..+++-|+.|++||-+.++|||||-+.|||+   +.+-.+|++|||+++...
T Consensus       706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeecc
Confidence            9999999999999999765 579999999999999999999999999999999999999   789999999999999775


Q ss_pred             cCcc-cccccC---CcCccChhhhc-ccCCCcchhHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          189 EGKA-YREIVG---SPYYIAPEVLS-QSYGKEADIWSAGVILYILL-CGVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       189 ~~~~-~~~~~~---~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      .... ..+..|   ..+|.|||.+. ..++.+||+||+|+++||.+ .|..||+..+.+++++.+..+-.-+++   .++
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP---mDC  859 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP---MDC  859 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC---CCC
Confidence            4432 112222   46899999885 67999999999999999965 499999999999999999887444443   578


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      |..+-+|+..||++|-.+||.+.+|++
T Consensus       860 P~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  860 PAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             cHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence            999999999999999999999999987

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-34  Score=276.93  Aligned_cols=248  Identities=25%  Similarity=0.411  Sum_probs=209.0

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCC----CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENST----GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~----~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      -.+.-.+.+.||.|.||.||+|....-    .-.||||+.+...  .....+.|..|..+++.+ +||||++++|++...
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnf-dHphIikLIGv~~e~  463 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVEQ  463 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhC-CCcchhheeeeeecc
Confidence            334455667899999999999975322    3458889887533  334588999999999999 599999999999764


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          107 QFVHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                       ..+||||+++-|.|.+++..+. .++..+..-++.||+.||.|||+..+|||||-..|||+   .+...+||+|||+++
T Consensus       464 -P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLV---sSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  464 -PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILV---SSPQCVKLADFGLSR  539 (974)
T ss_pred             -ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheee---cCcceeeecccchhh
Confidence             5789999999999999998764 58899999999999999999999999999999999999   678899999999999


Q ss_pred             ccccCcccccccC--CcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917          186 FIEEGKAYREIVG--SPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       186 ~~~~~~~~~~~~~--~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (494)
                      .+.....+....|  ...|||||-++ ..++.+||+|=|||.+||+++ |..||.+....+++-.+.++...+.+   +.
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P---~n  616 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCP---PN  616 (974)
T ss_pred             hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCC---CC
Confidence            8876555444344  34699999987 469999999999999999876 88999999888887777777655444   57


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHh
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVL  288 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil  288 (494)
                      +|+.+..++.+||..+|.+||.+.++.
T Consensus       617 CPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  617 CPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             CChHHHHHHHHHhccCcccCCcHHHHH
Confidence            899999999999999999999987764

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=259.98  Aligned_cols=258  Identities=26%  Similarity=0.436  Sum_probs=209.1

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC----
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ----  107 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~----  107 (494)
                      +.+-+..+.||-|+||.||.+.+..+|+.|++|.+.. .+.+-.....+.+|+.+|..++ |.|++..+++.+..+    
T Consensus        52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfF  129 (449)
T KOG0664|consen   52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFF  129 (449)
T ss_pred             cccCCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHH
Confidence            3556667899999999999999999999999999853 3344445677889999999996 999999999886543    


Q ss_pred             -eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          108 -FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       108 -~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                       .+|+++|++. .+|...+..-..++...++.+++||+.||+|||+.+|.||||||.|.++   +++..+||||||+++.
T Consensus       130 qEiYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARv  205 (449)
T KOG0664|consen  130 QELYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLART  205 (449)
T ss_pred             HHHHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccc
Confidence             3668889884 4787777777789999999999999999999999999999999999999   7899999999999987


Q ss_pred             cccCc--ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--------------
Q 040917          187 IEEGK--AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL--------------  248 (494)
Q Consensus       187 ~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~--------------  248 (494)
                      .....  .+...+.|.+|+|||++.|  .|+.+.||||+|||+.||+..+..|...++-+.++.|.              
T Consensus       206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A  285 (449)
T KOG0664|consen  206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA  285 (449)
T ss_pred             cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence            64432  3345567899999999987  49999999999999999999999998777765554442              


Q ss_pred             ---------cCCccCCCCC-------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          249 ---------KGEINFQRDP-------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       249 ---------~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                               ++....+.-.       ...-..+...++.++|.+||++|.+..+++.|+++.+
T Consensus       286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e  348 (449)
T KOG0664|consen  286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE  348 (449)
T ss_pred             hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence                     1111111100       0112345778999999999999999999999999975

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.1e-33  Score=279.03  Aligned_cols=260  Identities=18%  Similarity=0.255  Sum_probs=184.5

Q ss_pred             ccceEeeeeecccCCeEEEEEEEC----------------CCCcEEEEEEeccCCCCCh-----------hhHHHHHHHH
Q 040917           32 QLHYTIGREVGRGEFGITYLCTEN----------------STGLEFACKSIPKRKLVKD-----------VEKDDVRREI   84 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~----------------~~~~~valK~~~~~~~~~~-----------~~~~~~~~E~   84 (494)
                      .++|++.+.||+|+||+||+|...                ..++.||||.+........           ...+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            468999999999999999999752                3456799999864321100           0112233467


Q ss_pred             HHHHHccCCCC-----ccEEeEEEEe--------CCeEEEEEeccCCCchHHHHHhcC----------------------
Q 040917           85 EIMRHLSGQPN-----IVQFKAAYED--------DQFVHIVMELCAGGELFDRIVARG----------------------  129 (494)
Q Consensus        85 ~~l~~l~~hp~-----i~~~~~~~~~--------~~~~~iv~e~~~g~sL~~~~~~~~----------------------  129 (494)
                      .++.+++ |.+     ++++++++..        ....++||||+++++|.+++....                      
T Consensus       224 ~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        224 YMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            7777775 443     3556666532        346789999999999999886421                      


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccccc--ccCCcCccCh
Q 040917          130 --HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE--IVGSPYYIAP  205 (494)
Q Consensus       130 --~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~--~~~~~~y~aP  205 (494)
                        .++...+..++.|++.+|.|||+.+|+||||||+||++   +.++.++|+|||++...........  ..+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence              13456788899999999999999999999999999999   5678999999999875543322222  2347899999


Q ss_pred             hhhccc---------------------C--CCcchhHHHHHHHHHHHhCCC-CCCCCChHH-HH-------H-HHHcCCc
Q 040917          206 EVLSQS---------------------Y--GKEADIWSAGVILYILLCGVP-PFWAETDQG-VA-------Q-AILKGEI  252 (494)
Q Consensus       206 E~~~~~---------------------~--~~~~Di~slG~il~~l~tg~~-pf~~~~~~~-~~-------~-~~~~~~~  252 (494)
                      |.+...                     +  ..+.|+||+||++++|+++.. ||....... ..       . .......
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            987421                     1  124799999999999999875 664322110 00       0 0111111


Q ss_pred             cCCCCCCCCCCHHHHHHHHHhcccCC---CCCCCHHHHhcCCccCc
Q 040917          253 NFQRDPFPSISSSAIELVRRMLTQDP---KRRITVAQVLEHPWLKE  295 (494)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~~l~~dp---~~Rps~~eil~~~~~~~  295 (494)
                      .+....+...++...+++.+||..+|   .+|+|++++|+||||..
T Consensus       460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            22223456678999999999999866   68999999999999964

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=273.09  Aligned_cols=246  Identities=23%  Similarity=0.361  Sum_probs=210.9

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+-.....||.|.||.||.+.|++..-.||||.++...+    ..+.|+.|+.+++.++ |||+++++++|..+..+|||
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeik-HpNLVqLLGVCT~EpPFYIi  341 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPFYII  341 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhc-CccHHHHhhhhccCCCeEEE
Confidence            445567789999999999999999999999999975443    5788999999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          113 MELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +|||..|+|++++.++.  .++.-....++.||..|+.||..+++|||||-+.|.|+   .++..+|+.|||+++++...
T Consensus       342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGD  418 (1157)
T ss_pred             EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCC
Confidence            99999999999998764  37777888999999999999999999999999999999   78899999999999987543


Q ss_pred             cccc--cccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917          191 KAYR--EIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       191 ~~~~--~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (494)
                      ....  ...-...|.|||-+. +.++.++|+|+|||+|||+.| |-.||.+.....++..+.++-..-.+   ..+|+..
T Consensus       419 TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~P---eGCPpkV  495 (1157)
T KOG4278|consen  419 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGP---EGCPPKV  495 (1157)
T ss_pred             ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCC---CCCCHHH
Confidence            2211  122245799999875 568999999999999999987 77999999888777777665333222   5799999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhc
Q 040917          267 IELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+|+..||+++|.+||++.|+-+
T Consensus       496 YeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  496 YELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHHHHHHhcCCcccCccHHHHHH
Confidence            99999999999999999988743

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=271.37  Aligned_cols=251  Identities=24%  Similarity=0.359  Sum_probs=207.8

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .....+++.||+|.||.|-+|.-. .+..||+|.++...  ..+.+..|..|+++|.+|+ ||||+.++++|..++.+++
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA--TKNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEec-CceEEEEeecCccc--chhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCchHH
Confidence            366789999999999999999854 36899999997543  3445788999999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          112 VMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      |+||++.|+|.+++.++.  ........+++.||+.|++||.+.++|||||.+.|+|+   +.++++||+|||+++..-+
T Consensus       613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCccccccccc
Confidence            999999999999998763  23456677899999999999999999999999999999   7899999999999986655


Q ss_pred             Cccccc---ccCCcCccChhhh-cccCCCcchhHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHc---CCc-cCCCCCC
Q 040917          190 GKAYRE---IVGSPYYIAPEVL-SQSYGKEADIWSAGVILYILLC--GVPPFWAETDQGVAQAILK---GEI-NFQRDPF  259 (494)
Q Consensus       190 ~~~~~~---~~~~~~y~aPE~~-~~~~~~~~Di~slG~il~~l~t--g~~pf~~~~~~~~~~~~~~---~~~-~~~~~~~  259 (494)
                      ++.++.   .+-..+|+|||.+ .+.++++||+|++|+++||+++  ...||...+.+.+.+....   ... .......
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P  769 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP  769 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence            544322   2335789999965 6899999999999999999876  6799988888877665422   111 1111122


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          260 PSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +-+|..+.+++.+||..+..+|||++++-.
T Consensus       770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  770 PACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             CcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            467899999999999999999999999854

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=3.8e-34  Score=266.44  Aligned_cols=262  Identities=27%  Similarity=0.465  Sum_probs=207.0

Q ss_pred             hcccccccccceEeeeeecccCCeEEEEEEECC---CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEe
Q 040917           24 LGKAYEDVQLHYTIGREVGRGEFGITYLCTENS---TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK  100 (494)
Q Consensus        24 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~---~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~  100 (494)
                      +.+....+...|+++.+||+|.|++||+|.+..   .+..||+|.+....     ....+.+|+++|..+.++.||+++.
T Consensus        27 l~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~  101 (418)
T KOG1167|consen   27 LRQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLN  101 (418)
T ss_pred             HHhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcch
Confidence            344456677889999999999999999999887   78899999997544     3456899999999999999999999


Q ss_pred             EEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917          101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       101 ~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                      +++..++.+.+|+||++.....++..   .++...+..+++.++.||.++|++|||||||||+|++++  ...+.-.|+|
T Consensus       102 ~~~rnnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvD  176 (418)
T KOG1167|consen  102 GCFRNNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVD  176 (418)
T ss_pred             hhhccCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEe
Confidence            99999999999999999877777663   467899999999999999999999999999999999997  4567789999


Q ss_pred             cCCccccc-----------------c--Cc------------c--------------cccccCCcCccChhhhc--ccCC
Q 040917          181 FGLSAFIE-----------------E--GK------------A--------------YREIVGSPYYIAPEVLS--QSYG  213 (494)
Q Consensus       181 fg~a~~~~-----------------~--~~------------~--------------~~~~~~~~~y~aPE~~~--~~~~  213 (494)
                      ||+|....                 .  +.            .              .-...||++|+|||++.  +.-+
T Consensus       177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt  256 (418)
T KOG1167|consen  177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT  256 (418)
T ss_pred             chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence            99996110                 0  00            0              00245899999999985  4578


Q ss_pred             CcchhHHHHHHHHHHHhCCCCCCCCChH--------------HHHHHH-HcCC---------------------------
Q 040917          214 KEADIWSAGVILYILLCGVPPFWAETDQ--------------GVAQAI-LKGE---------------------------  251 (494)
Q Consensus       214 ~~~Di~slG~il~~l~tg~~pf~~~~~~--------------~~~~~~-~~~~---------------------------  251 (494)
                      +++||||.|+|+..+++++.||......              ++.+.- ..+.                           
T Consensus       257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~  336 (418)
T KOG1167|consen  257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI  336 (418)
T ss_pred             CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence            8999999999999999999999433221              000000 0000                           


Q ss_pred             ---cc--CCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          252 ---IN--FQRDPF-PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       252 ---~~--~~~~~~-~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                         ..  .....+ ...|..+.+++.+||..||.+|.|++++|.||||..
T Consensus       337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence               00  000111 224568999999999999999999999999999995

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=5e-34  Score=285.02  Aligned_cols=250  Identities=31%  Similarity=0.475  Sum_probs=198.3

Q ss_pred             eEeeeeecccCCeE-EEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           35 YTIGREVGRGEFGI-TYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        35 y~i~~~lg~G~~g~-Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      |.-.+.+|.|+.|+ ||+|.-  .|+.||||.+-..      ..+...+|+..|+.=..||||+++++.-.++...||+.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            34456789999886 588884  4889999998432      35567899999998889999999999999999999999


Q ss_pred             eccCCCchHHHHHhcC-C---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC--CCCCeEEEeecCCcccc
Q 040917          114 ELCAGGELFDRIVARG-H---YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG--DENAVVKATDFGLSAFI  187 (494)
Q Consensus       114 e~~~g~sL~~~~~~~~-~---l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~--~~~~~~kL~Dfg~a~~~  187 (494)
                      |+|. .+|.+++...+ .   ......+.+..|+++||++||+.+||||||||+||||...  +....++|+|||++...
T Consensus       583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            9996 59999997631 1   1224567899999999999999999999999999999742  24468999999999887


Q ss_pred             ccCccc----ccccCCcCccChhhhccc-CCCcchhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917          188 EEGKAY----REIVGSPYYIAPEVLSQS-YGKEADIWSAGVILYILLCG-VPPFWAETDQGVAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       188 ~~~~~~----~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~il~~l~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (494)
                      ..+...    ....||-+|+|||++.+. -+.++||+|+||++|+.++| .+||......  ...|.++......... .
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~-~  738 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEP-L  738 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeecc-C
Confidence            655443    345689999999999764 56789999999999998886 8999655443  2345555444332211 1


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      -..++.+||.+|+.++|..||+|.++|.||+|+..
T Consensus       739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            11289999999999999999999999999999963

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.98  E-value=3e-32  Score=230.04  Aligned_cols=219  Identities=25%  Similarity=0.363  Sum_probs=180.9

Q ss_pred             ccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917           26 KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED  105 (494)
Q Consensus        26 ~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~  105 (494)
                      .+.+.-.++...+..||+|++|.|-+.++..+|+..|+|.+..+.  +........+|+.+..+-..+|.++.+++.+..
T Consensus        39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r  116 (282)
T KOG0984|consen   39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR  116 (282)
T ss_pred             CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence            334445567777888999999999999999999999999997544  344678888999988877789999999999988


Q ss_pred             CCeEEEEEeccCCCchHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEee
Q 040917          106 DQFVHIVMELCAGGELFDR----IVARGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                      ...++|.||.+.- ||..+    ++..+.+++..+-+++..++.||.|||++ .++|||+||+|||+   +..|++|+||
T Consensus       117 egdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCD  192 (282)
T KOG0984|consen  117 EGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICD  192 (282)
T ss_pred             cccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcc
Confidence            8999999999953 66543    34556799999999999999999999987 89999999999999   7899999999


Q ss_pred             cCCccccccCcccccccCCcCccChhhhcc-----cCCCcchhHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHcC
Q 040917          181 FGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-----SYGKEADIWSAGVILYILLCGVPPFWAE-TDQGVAQAILKG  250 (494)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~Di~slG~il~~l~tg~~pf~~~-~~~~~~~~~~~~  250 (494)
                      ||.+-...++-...--.|-..|+|||.+..     .|+-++||||||+++.||.+++.||... ++.+.+.++...
T Consensus       193 FGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  193 FGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             cccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            999877655443333457789999999853     4888999999999999999999999644 444555555554

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.3e-31  Score=248.74  Aligned_cols=248  Identities=22%  Similarity=0.356  Sum_probs=193.1

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHc-cCCCCccEEeEEEEeC--
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL-SGQPNIVQFKAAYEDD--  106 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l-~~hp~i~~~~~~~~~~--  106 (494)
                      .+..+-.+.+.||+|.||.||+|.|+  |+.||||++..+      ....+.+|.++++.+ -+|+||+.+++.-..+  
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g  279 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKDNG  279 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc--CCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence            45678899999999999999999998  899999999643      466788899988852 2599999998764322  


Q ss_pred             --CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCceEEeeCCCCCeE
Q 040917          107 --QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK--------GVMHRDLKPENFLFTTGDENAVV  176 (494)
Q Consensus       107 --~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~i~H~dikp~NIli~~~~~~~~~  176 (494)
                        ...++|++|.+.|||.+++.+ ..++......++..++.||++||-.        .|+|||||..||||   .+++.+
T Consensus       280 s~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C  355 (513)
T KOG2052|consen  280 SWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTC  355 (513)
T ss_pred             ceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcE
Confidence              368999999999999999988 4699999999999999999999952        49999999999999   689999


Q ss_pred             EEeecCCccccccCc-----ccccccCCcCccChhhhcccCC-------CcchhHHHHHHHHHHHhC----------CCC
Q 040917          177 KATDFGLSAFIEEGK-----AYREIVGSPYYIAPEVLSQSYG-------KEADIWSAGVILYILLCG----------VPP  234 (494)
Q Consensus       177 kL~Dfg~a~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~-------~~~Di~slG~il~~l~tg----------~~p  234 (494)
                      -|+|+|+|....+..     ..+..+||.+|||||++.....       ..+||||||.++||+...          +.|
T Consensus       356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P  435 (513)
T KOG2052|consen  356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP  435 (513)
T ss_pred             EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence            999999998765431     2346789999999999975432       368999999999998642          567


Q ss_pred             CCCCC-----hHHHHHHHHcCCcc-CCCCCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          235 FWAET-----DQGVAQAILKGEIN-FQRDPFPSIS--SSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       235 f~~~~-----~~~~~~~~~~~~~~-~~~~~~~~~~--~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      |....     .+++.+-+.-.... ..+..|...+  ..+.++++.||..||.-|.|+-.|.+
T Consensus       436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             cccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            75433     33333333222222 2223333332  34678899999999999999877654

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=1.2e-31  Score=298.35  Aligned_cols=240  Identities=21%  Similarity=0.263  Sum_probs=182.0

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      ...|+....||+|+||.||+|.+..++..||+|.+.....       ....|+..++++ +||||+++++++......++
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l-~HpnIv~~~~~~~~~~~~~l  760 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKL-QHPNIVKLIGLCRSEKGAYL  760 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhC-CCCCcceEEEEEEcCCCCEE
Confidence            3456777899999999999999999999999999864321       113468889999 49999999999999899999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH---SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      ||||+++|+|.+++.   .+++..+..++.+++.|+.|||   +.+|+||||||+||++   +.++..++. ++......
T Consensus       761 v~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~---~~~~~~~~~-~~~~~~~~  833 (968)
T PLN00113        761 IHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR-LSLPGLLC  833 (968)
T ss_pred             EEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE---CCCCceEEE-eccccccc
Confidence            999999999999985   3788999999999999999999   6699999999999999   455555554 55443221


Q ss_pred             cCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHc---CC-c-cCCCC---
Q 040917          189 EGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD--QGVAQAILK---GE-I-NFQRD---  257 (494)
Q Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~--~~~~~~~~~---~~-~-~~~~~---  257 (494)
                      .   .....+++.|+|||++.+ .++.++||||+||++|||+||+.||.....  ..+......   .. . ....+   
T Consensus       834 ~---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  910 (968)
T PLN00113        834 T---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR  910 (968)
T ss_pred             c---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcccc
Confidence            1   122367899999998864 589999999999999999999999853321  111111110   00 0 00000   


Q ss_pred             -CC---CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          258 -PF---PSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       258 -~~---~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                       ..   ......+.+++.+||..+|++||++.++++
T Consensus       911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~  946 (968)
T PLN00113        911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK  946 (968)
T ss_pred             CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence             00   011234678899999999999999999987

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=266.81  Aligned_cols=246  Identities=21%  Similarity=0.294  Sum_probs=207.5

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCc----EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGL----EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~----~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      ..+..+.||+|+||+||++.|-..|+    +||+|++...  ........+..|+-.+.+| +|||++++++++.... .
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~  772 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASL-DHPNLLRLLGVCMLST-L  772 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-H
Confidence            35567889999999999999865554    6888887543  3444678899999999999 5999999999997655 7


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      -||++|+++|+|.++++.+ ..+.....+.|..||++|+.|||.+.++||||-+.||||   ..-.++|+.|||++....
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccC
Confidence            7999999999999999865 468899999999999999999999999999999999999   678899999999998765


Q ss_pred             cCccc-cc--ccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917          189 EGKAY-RE--IVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       189 ~~~~~-~~--~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      ..... ..  ..-.+.|+|-|.+. ..|++++||||+||++||++| |..|+.+...+++.+.+..+..-..+   +..+
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqP---piCt  926 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQP---PICT  926 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCC---CCcc
Confidence            43322 11  12245688888876 469999999999999999988 88999999999999888887663322   4678


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          264 SSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      -++.-++.+||..|+..||+++++..
T Consensus       927 iDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  927 IDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHHHhccCcccCccHHHHHH
Confidence            89999999999999999999999865

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1e-32  Score=268.95  Aligned_cols=260  Identities=29%  Similarity=0.468  Sum_probs=225.1

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      +.+++|.+...+|+|.+|.||+|+++.+++..|+|+++...   ......+.+|+-+++.-+ ||||+.+++.|......
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~-h~nivay~gsylr~dkl   87 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRRDKL   87 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCC-CcChHHHHhhhhhhcCc
Confidence            56789999999999999999999999999999999997543   335667888999999885 99999999999988899


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      +|+||||.||+|.+.-.-.+++++.++....+..+.|++|||+.|=+|||||=.||++   .+.+.+||.|||.+..+..
T Consensus        88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill---td~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL---TDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceee---cccCceeecccCchhhhhh
Confidence            9999999999999987777899999999999999999999999999999999999999   7889999999999876643


Q ss_pred             Cc-ccccccCCcCccChhhh----cccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC-CCCCCCC
Q 040917          190 GK-AYREIVGSPYYIAPEVL----SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR-DPFPSIS  263 (494)
Q Consensus       190 ~~-~~~~~~~~~~y~aPE~~----~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  263 (494)
                      .- ......|||+|+|||+.    .+.|...+|+|++|++..++---+.|....-+........+..++++. .....++
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws  244 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS  244 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence            22 22457899999999986    357999999999999999998888887666666666666666555543 2334688


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      +.+-.|++.+|.++|.+||+++.+|.|||....
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            999999999999999999999999999999853

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-30  Score=270.99  Aligned_cols=249  Identities=24%  Similarity=0.396  Sum_probs=207.7

Q ss_pred             cceEeeeeecccCCeEEEEEEEC---C----CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917           33 LHYTIGREVGRGEFGITYLCTEN---S----TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED  105 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~---~----~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~  105 (494)
                      .+..+.+.||+|+||.|++|.-.   .    ....||+|..+.....  ...+.+..|+.+++.+..||||+.+.+.+..
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            34467779999999999998632   1    2567999998755433  4678899999999999889999999999998


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEee
Q 040917          106 DQFVHIVMELCAGGELFDRIVARG----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTT  169 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~  169 (494)
                      .+..++|+||++.|+|.+++..++                .++......++.||+.|+.||++.+++||||-+.|||+  
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi--  451 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI--  451 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe--
Confidence            889999999999999999998765                38889999999999999999999999999999999999  


Q ss_pred             CCCCCeEEEeecCCccccccCcccccc--cC--CcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCC-hHH
Q 040917          170 GDENAVVKATDFGLSAFIEEGKAYREI--VG--SPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAET-DQG  242 (494)
Q Consensus       170 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~--~~--~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~-~~~  242 (494)
                       ..+..+|++|||+|+...........  .+  ...|||||.+.. .|+.+||+||+|+++||++| |..||.+.. ..+
T Consensus       452 -~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~  530 (609)
T KOG0200|consen  452 -TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE  530 (609)
T ss_pred             -cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence             67789999999999865444433211  22  235999999875 69999999999999999998 779998865 666


Q ss_pred             HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          243 VAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +.+.+..+.....+   ..+++++.+++..||..+|++||++.++.+
T Consensus       531 l~~~l~~G~r~~~P---~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  531 LLEFLKEGNRMEQP---EHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHhcCCCCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            66656555443333   346899999999999999999999999987

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=8.5e-32  Score=258.51  Aligned_cols=200  Identities=32%  Similarity=0.576  Sum_probs=177.4

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhh-----HHHHHHHHHHHHHcc--CCCCccEEeEEEEe
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVE-----KDDVRREIEIMRHLS--GQPNIVQFKAAYED  105 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~-----~~~~~~E~~~l~~l~--~hp~i~~~~~~~~~  105 (494)
                      .+|...+.+|.|+||.|++|.++.+...|++|.+.++...-+..     ...+-.|+.+|..|.  .|+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            45999999999999999999999999999999998766432222     233557999999994  49999999999999


Q ss_pred             CCeEEEEEecc-CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCc
Q 040917          106 DQFVHIVMELC-AGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS  184 (494)
Q Consensus       106 ~~~~~iv~e~~-~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a  184 (494)
                      ++.+||+||.- +|.+|.++|...+.+++..+..|++|++.|+++||+.||||||||-+||.+   +.+|.+||+|||.|
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgsa  717 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGSA  717 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccch
Confidence            99999999974 467999999999999999999999999999999999999999999999999   78999999999999


Q ss_pred             cccccCcccccccCCcCccChhhhccc--CCCcchhHHHHHHHHHHHhCCCCCC
Q 040917          185 AFIEEGKAYREIVGSPYYIAPEVLSQS--YGKEADIWSAGVILYILLCGVPPFW  236 (494)
Q Consensus       185 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~pf~  236 (494)
                      ....+++ .....||..|.|||++.|.  .+..-|||+||+++|-++....||.
T Consensus       718 a~~ksgp-fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  718 AYTKSGP-FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhcCCC-cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            8776654 4678999999999999875  4778999999999999999999985

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=7e-31  Score=247.29  Aligned_cols=241  Identities=24%  Similarity=0.358  Sum_probs=189.2

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc-CCCCccEEeEEEEeCC----
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS-GQPNIVQFKAAYEDDQ----  107 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~hp~i~~~~~~~~~~~----  107 (494)
                      ..-.+.++||+|.||.||+|...  ++.||||++.      ....+++.+|-++++... .|+||+++++.-....    
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~  281 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM  281 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc--CceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence            44567889999999999999854  6999999985      335778888888887532 5999999998876544    


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------CCceeccCCCCceEEeeCCCCCeEEE
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS---------KGVMHRDLKPENFLFTTGDENAVVKA  178 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---------~~i~H~dikp~NIli~~~~~~~~~kL  178 (494)
                      .+.+|++|.+.|+|.++++.+ .++.....+++..++.||+|||+         ..|+|||||..||||   .++.+..|
T Consensus       282 eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccI  357 (534)
T KOG3653|consen  282 EYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCI  357 (534)
T ss_pred             ceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEe
Confidence            799999999999999999886 58999999999999999999996         359999999999999   68999999


Q ss_pred             eecCCccccccCccc---ccccCCcCccChhhhcccCC-------CcchhHHHHHHHHHHHhCCC------------CCC
Q 040917          179 TDFGLSAFIEEGKAY---REIVGSPYYIAPEVLSQSYG-------KEADIWSAGVILYILLCGVP------------PFW  236 (494)
Q Consensus       179 ~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~-------~~~Di~slG~il~~l~tg~~------------pf~  236 (494)
                      +|||+|....++...   ...+||.+|||||++.+...       .+.||||+|.++|||++.-.            ||.
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            999999887654432   34789999999999976432       25899999999999998532            232


Q ss_pred             -----CCChHHHHHHHHcCCccCC-CCCCCC--CCHHHHHHHHHhcccCCCCCCCHH
Q 040917          237 -----AETDQGVAQAILKGEINFQ-RDPFPS--ISSSAIELVRRMLTQDPKRRITVA  285 (494)
Q Consensus       237 -----~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~l~~li~~~l~~dp~~Rps~~  285 (494)
                           ..+.+++...+.+....+. +..|..  -...+++.+..||..||+.|.|+.
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence                 2233444444444333222 222211  235688999999999999999985

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=6.9e-29  Score=225.72  Aligned_cols=210  Identities=42%  Similarity=0.747  Sum_probs=183.8

Q ss_pred             ecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCc
Q 040917           41 VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGE  120 (494)
Q Consensus        41 lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~s  120 (494)
                      ||+|++|.||++....+++.+++|++.......  ....+.+|+..++.++ |++|+++++++......++++|++.|++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence            689999999999998889999999997544221  3577999999999995 9999999999998899999999999899


Q ss_pred             hHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCC-CCeEEEeecCCccccccCc-cccccc
Q 040917          121 LFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDE-NAVVKATDFGLSAFIEEGK-AYREIV  197 (494)
Q Consensus       121 L~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~-~~~~kL~Dfg~a~~~~~~~-~~~~~~  197 (494)
                      |.+++... ..++...+..++.+++.++.+||+.|++|+||+|.||++   +. .+.++|+|||.+....... ......
T Consensus        78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~---~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (215)
T cd00180          78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL---DSDNGKVKLADFGLSKLLTSDKSLLKTIV  154 (215)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEE---eCCCCcEEEecCCceEEccCCcchhhccc
Confidence            99998775 468999999999999999999999999999999999999   45 7899999999987654332 123355


Q ss_pred             CCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcc
Q 040917          198 GSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT  275 (494)
Q Consensus       198 ~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  275 (494)
                      +...|.+||.+..  .++.++|+|++|++++++                                   ..+.+++.+|+.
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~  199 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQ  199 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhh
Confidence            6788999999875  678899999999999998                                   578899999999


Q ss_pred             cCCCCCCCHHHHhcCC
Q 040917          276 QDPKRRITVAQVLEHP  291 (494)
Q Consensus       276 ~dp~~Rps~~eil~~~  291 (494)
                      .+|++||++.++++++
T Consensus       200 ~~p~~R~~~~~l~~~~  215 (215)
T cd00180         200 KDPEKRPSAKEILEHL  215 (215)
T ss_pred             CCcccCcCHHHHhhCC
Confidence            9999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=2.4e-28  Score=224.92  Aligned_cols=211  Identities=40%  Similarity=0.728  Sum_probs=180.4

Q ss_pred             eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917           35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME  114 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e  114 (494)
                      |++.+.||+|++|.||+|.+..+++.+++|.+......  .....+.+|+..++++ +|+|++++++.+......++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEEEEe
Confidence            67889999999999999999988999999999754422  2467888999999999 59999999999998889999999


Q ss_pred             ccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc--
Q 040917          115 LCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--  191 (494)
Q Consensus       115 ~~~g~sL~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~--  191 (494)
                      ++++++|.+++..... ++...+..++.+++.++.+||+++++|+||+|.||++   +..+.++|+|||.+.......  
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---GMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeCceeeEecCcccc
Confidence            9999999999987766 8999999999999999999999999999999999999   566899999999988765432  


Q ss_pred             ccccccCCcCccChhhh-c-ccCCCcchhHHHHHHHHHHHhCCCCCCC-CCh-HHHHHHHHcCC
Q 040917          192 AYREIVGSPYYIAPEVL-S-QSYGKEADIWSAGVILYILLCGVPPFWA-ETD-QGVAQAILKGE  251 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~-~-~~~~~~~Di~slG~il~~l~tg~~pf~~-~~~-~~~~~~~~~~~  251 (494)
                      ......++..|++||.+ . ..++.++|+|+||+++++|++|+.||.. ... ..+.+.+..+.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            33445678889999987 3 3477799999999999999999999977 333 35556665553

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-30  Score=227.08  Aligned_cols=243  Identities=27%  Similarity=0.400  Sum_probs=194.2

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEE-EEeCCe
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAA-YEDDQF  108 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~-~~~~~~  108 (494)
                      ++.+.|.|.+.||+|.||.+.+|.++.+++.+++|.++...    .....|.+|...--.|..|.||+.-|++ |+..+.
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~   96 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA   96 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence            45688999999999999999999999999999999997544    3578899999877778789999987775 677778


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      +++++||++.|+|.+-+... .+.+.....++.|++.|+.|+|++++||||||.+||||-. .+...+||||||......
T Consensus        97 YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~-~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen   97 YVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFD-ADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             EEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEec-CCccEEEeeecccccccC
Confidence            99999999999998877554 4788889999999999999999999999999999999954 345599999999987543


Q ss_pred             cCcccccccCCcCccChhhhc----c--cCCCcchhHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHcCCccCCCC
Q 040917          189 EGKAYREIVGSPYYIAPEVLS----Q--SYGKEADIWSAGVILYILLCGVPPFWAETDQ-----GVAQAILKGEINFQRD  257 (494)
Q Consensus       189 ~~~~~~~~~~~~~y~aPE~~~----~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-----~~~~~~~~~~~~~~~~  257 (494)
                      ..-.  ..--+-.|.+||...    +  ...+.+|+|.||+++|..+||..||......     +..+. ....-.-.+.
T Consensus       175 ~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w-~~rk~~~~P~  251 (378)
T KOG1345|consen  175 TTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW-LKRKNPALPK  251 (378)
T ss_pred             ceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH-hcccCccCch
Confidence            2211  122355799999764    2  2578899999999999999999999633221     12222 2222233344


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCC
Q 040917          258 PFPSISSSAIELVRRMLTQDPKRR  281 (494)
Q Consensus       258 ~~~~~~~~l~~li~~~l~~dp~~R  281 (494)
                      .+..+++.+.+++++-|.++|++|
T Consensus       252 ~F~~fs~~a~r~Fkk~lt~~~~dr  275 (378)
T KOG1345|consen  252 KFNPFSEKALRLFKKSLTPRFKDR  275 (378)
T ss_pred             hhcccCHHHHHHHHHhcCCccccc
Confidence            556788999999999999999988

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=1.4e-28  Score=266.46  Aligned_cols=197  Identities=19%  Similarity=0.291  Sum_probs=142.4

Q ss_pred             CCccEEeEEE-------EeCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 040917           94 PNIVQFKAAY-------EDDQFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENF  165 (494)
Q Consensus        94 p~i~~~~~~~-------~~~~~~~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NI  165 (494)
                      +||+.+++.+       .....++.++|++ +++|.+++.. ...++...+..+++||+.||.|||++||+||||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            4666666655       1223567778887 5699999965 34589999999999999999999999999999999999


Q ss_pred             EEee----------------CCCCCeEEEeecCCccccccCc-----------------ccccccCCcCccChhhhcc-c
Q 040917          166 LFTT----------------GDENAVVKATDFGLSAFIEEGK-----------------AYREIVGSPYYIAPEVLSQ-S  211 (494)
Q Consensus       166 li~~----------------~~~~~~~kL~Dfg~a~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~-~  211 (494)
                      |+..                .+..+.+|++|||++.......                 ......+|++|+|||++.+ .
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence            9942                1234567777777775321100                 0011357889999999764 6


Q ss_pred             CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 040917          212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHP  291 (494)
Q Consensus       212 ~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~  291 (494)
                      ++.++|||||||++|||++|..|+....  .....+.....  ++.... ..+....++.+||.++|.+||++.++|+||
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PPQILL-NWPKEASFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--Chhhhh-cCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence            8999999999999999999988874322  12222221111  111111 234567899999999999999999999999


Q ss_pred             ccCcc
Q 040917          292 WLKES  296 (494)
Q Consensus       292 ~~~~~  296 (494)
                      ||...
T Consensus       267 ~~~~~  271 (793)
T PLN00181        267 FINEP  271 (793)
T ss_pred             hhhhh
Confidence            99864

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.95  E-value=3.6e-27  Score=217.10  Aligned_cols=248  Identities=17%  Similarity=0.220  Sum_probs=201.1

Q ss_pred             cceEeeeeecccCCeEEEEEEECCC-----CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-C
Q 040917           33 LHYTIGREVGRGEFGITYLCTENST-----GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-D  106 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-~  106 (494)
                      .|++...++.+|.||.||.|.|+..     .+.|.+|+++..  .++.....+..|.-++..+. |||+.++.++... .
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~s-H~nll~V~~V~ie~~  360 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGAS-HPNLLSVLGVSIEDY  360 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCc-CCCccceeEEEeecc
Confidence            5788889999999999999987643     345677777533  24445667888888888885 9999999998754 4


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEE
Q 040917          107 QFVHIVMELCAGGELFDRIVARG--------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKA  178 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL  178 (494)
                      ...++++.+..-|+|..++..++        .++..++..++.|+..|+.|||++|++|.||-+.|.+|   ++.-.+||
T Consensus       361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqVkl  437 (563)
T KOG1024|consen  361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVKL  437 (563)
T ss_pred             CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeEEe
Confidence            56788899988899999887332        36777888999999999999999999999999999999   67899999


Q ss_pred             eecCCccccccCccc---ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCcc
Q 040917          179 TDFGLSAFIEEGKAY---REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEIN  253 (494)
Q Consensus       179 ~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~  253 (494)
                      +|-.+++..-+....   .+......||+||.+. ..|+.++|+||||+++|||+| |+.||...++.++...++.+-.-
T Consensus       438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRl  517 (563)
T KOG1024|consen  438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL  517 (563)
T ss_pred             ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcccee
Confidence            999888754333211   1223456899999885 569999999999999999998 88999999998888877766443


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          254 FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      -.+   .++|+++..++..||...|++||+++++..
T Consensus       518 aQP---~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  518 AQP---FNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             cCC---CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            222   478999999999999999999999999864

>COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]

Probab=99.94  E-value=7.3e-26  Score=187.86  Aligned_cols=151  Identities=33%  Similarity=0.593  Sum_probs=140.5

Q ss_pred             HhhhccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh-
Q 040917          327 KVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH-  405 (494)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~-  405 (494)
                      ....+.++.+++++|+++|+.+|.|++|.|+..||..+++.+|.++++.++.+++..+|. +.|.|+|.+|+..+.... 
T Consensus         8 ~~~~~~~t~~qi~~lkeaF~l~D~d~~G~I~~~el~~ilr~lg~~~s~~ei~~l~~~~d~-~~~~idf~~Fl~~ms~~~~   86 (160)
T COG5126           8 LLTFTQLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFEEIDA-GNETVDFPEFLTVMSVKLK   86 (160)
T ss_pred             hhhcccCCHHHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHcCCCCcHHHHHHHHHhccC-CCCccCHHHHHHHHHHHhc
Confidence            334567899999999999999999999999999999999999999999999999999999 899999999999998765 


Q ss_pred             hhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccc
Q 040917          406 KLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ  480 (494)
Q Consensus       406 ~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~  480 (494)
                      .....+++.+||+.||.|+||+|+..||+++|+.  +|+.+++++++.+++.+|.|+||.|+|++|...+...+.
T Consensus        87 ~~~~~Eel~~aF~~fD~d~dG~Is~~eL~~vl~~--lge~~~deev~~ll~~~d~d~dG~i~~~eF~~~~~~~~~  159 (160)
T COG5126          87 RGDKEEELREAFKLFDKDHDGYISIGELRRVLKS--LGERLSDEEVEKLLKEYDEDGDGEIDYEEFKKLIKDSPT  159 (160)
T ss_pred             cCCcHHHHHHHHHHhCCCCCceecHHHHHHHHHh--hcccCCHHHHHHHHHhcCCCCCceEeHHHHHHHHhccCC
Confidence            4556789999999999999999999999999998  889999999999999999999999999999999887653

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=9.3e-25  Score=211.78  Aligned_cols=252  Identities=25%  Similarity=0.331  Sum_probs=195.1

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCC-cEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc---CCCCccEEeEEE-EeCCe
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTG-LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS---GQPNIVQFKAAY-EDDQF  108 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~-~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~---~hp~i~~~~~~~-~~~~~  108 (494)
                      +|++.+.||+|+||.||.|.+..++ ..+|+|+........  .. .+..|..++..+.   +.+++..+++.+ ..+..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--PS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--Cc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            8999999999999999999988764 678999876543221  11 5778999999886   347999999999 47778


Q ss_pred             EEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC--CCCeEEEeecCCc
Q 040917          109 VHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD--ENAVVKATDFGLS  184 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~--~~~~~kL~Dfg~a  184 (494)
                      .++||+.+ |.+|.++....  +.++..++..++.|++.+|.+||+.|++||||||+|+++....  ....+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999998 88999988654  4799999999999999999999999999999999999996432  2267999999999


Q ss_pred             cccc---cCc-------c-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc
Q 040917          185 AFIE---EGK-------A-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI  252 (494)
Q Consensus       185 ~~~~---~~~-------~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  252 (494)
                      +...   ...       . .....||..|.++.+..+ ..+++.|+||++-++.++..|..||.+.........+.....
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8321   111       1 123459999999998876 589999999999999999999999976654333333322222


Q ss_pred             cCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          253 NFQRD-PFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       253 ~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ..... .....+..+.++...+-..+...+|.+..+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~  292 (322)
T KOG1164|consen  255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE  292 (322)
T ss_pred             hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence            22211 22345677888888888889999999888766

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=1e-25  Score=199.46  Aligned_cols=162  Identities=26%  Similarity=0.332  Sum_probs=127.1

Q ss_pred             CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccccccc
Q 040917          119 GELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV  197 (494)
Q Consensus       119 ~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~  197 (494)
                      |+|.+++... ..+++..++.++.||+.||.|||+++      ||+||++   +.++.+++  ||.+.......    ..
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~----~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ----SR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc----CC
Confidence            6899999764 45999999999999999999999998      9999999   67788888  99987654322    25


Q ss_pred             CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCccCCC---CCCCCCCH--HHHHHH
Q 040917          198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEINFQR---DPFPSISS--SAIELV  270 (494)
Q Consensus       198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~--~l~~li  270 (494)
                      |++.|+|||++.+ .++.++||||+||++|+|++|+.||...... .....+.........   .....++.  .+.+++
T Consensus        66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  145 (176)
T smart00750       66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM  145 (176)
T ss_pred             CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence            7899999999865 5899999999999999999999999765432 223333322221111   11122333  689999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCccCc
Q 040917          271 RRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       271 ~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      .+||..+|.+||++.++++|+|+..
T Consensus       146 ~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      146 RVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHhcccccccCHHHHHHHHHHHH
Confidence            9999999999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=4.8e-25  Score=190.85  Aligned_cols=250  Identities=19%  Similarity=0.261  Sum_probs=200.1

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      -+.++|++++.||+|+||.+|.|....+|..||+|+-....     ...++..|..+++.|++...|..+..+..+..+-
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN   86 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence            35689999999999999999999999999999999975433     3445788999999999888999999999888899


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      .+||++. |.||.+++.-+ ..++.++++-++-|++.-++|+|.++++||||||+|+|..-+.....+.|+|||+|....
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9999998 88999888644 458999999999999999999999999999999999999655567789999999998654


Q ss_pred             cCcc--------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---cCCc-cCC
Q 040917          189 EGKA--------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL---KGEI-NFQ  255 (494)
Q Consensus       189 ~~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~---~~~~-~~~  255 (494)
                      ....        .....||.+|.+-....+ .-+.+.|+=|+|-++.++..|..||.+.......+...   .... .+.
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i  245 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI  245 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence            3221        124568888988776654 45778999999999999999999998887654444332   2211 122


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 040917          256 RDPFPSISSSAIELVRRMLTQDPKRRITVA  285 (494)
Q Consensus       256 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  285 (494)
                      ...+...|.++.-.+..|-..--++-|...
T Consensus       246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~  275 (341)
T KOG1163|consen  246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYM  275 (341)
T ss_pred             HHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence            234567888888888888777666666654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=4.6e-23  Score=201.18  Aligned_cols=254  Identities=37%  Similarity=0.599  Sum_probs=208.1

Q ss_pred             eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCC-CccEEeEEEEeCCeEEEEE
Q 040917           35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP-NIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp-~i~~~~~~~~~~~~~~iv~  113 (494)
                      |.+.+.||.|+||.||.+.+.   ..+++|.+.............+.+|+.++..+. |+ +++++.+.+......++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEecCCEEEEEE
Confidence            788999999999999999987   789999997766544345778999999999996 66 7999999998777789999


Q ss_pred             eccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC-eEEEeecCCcccccc
Q 040917          114 ELCAGGELFDRIVARG---HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA-VVKATDFGLSAFIEE  189 (494)
Q Consensus       114 e~~~g~sL~~~~~~~~---~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~-~~kL~Dfg~a~~~~~  189 (494)
                      +++.++++.+.+....   .++......++.|++.++.|+|+.+++|||+||+||++   +... .++++|||.+.....
T Consensus        78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~---~~~~~~~~l~dfg~~~~~~~  154 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPD  154 (384)
T ss_pred             ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee---cCCCCeEEEeccCcceecCC
Confidence            9999999997777664   68999999999999999999999999999999999999   4555 799999999875443


Q ss_pred             Cc-------ccccccCCcCccChhhhcc----cCCCcchhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHcCCcc-
Q 040917          190 GK-------AYREIVGSPYYIAPEVLSQ----SYGKEADIWSAGVILYILLCGVPPFWAETD----QGVAQAILKGEIN-  253 (494)
Q Consensus       190 ~~-------~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~pf~~~~~----~~~~~~~~~~~~~-  253 (494)
                      ..       ......++..|++||.+.+    .++...|+||+|++++++++|..||.....    ......+...... 
T Consensus       155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  234 (384)
T COG0515         155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS  234 (384)
T ss_pred             CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence            32       2356788999999999865    578899999999999999999999877763    4444444444333 


Q ss_pred             CCCCCCCCC----CHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          254 FQRDPFPSI----SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       254 ~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      .........    ...+.+++..++..+|..|.+......++|...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence            222221222    257899999999999999999999998866664

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=3.3e-24  Score=193.96  Aligned_cols=249  Identities=20%  Similarity=0.320  Sum_probs=195.3

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      -++-.|+|++.||+|+||.++.+.+..++++||||.-....     ...++..|.+.++.|.+.++|..++-+...+.+-
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N   99 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN   99 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence            46678999999999999999999999999999999875433     4567888999999999899999999999888888


Q ss_pred             EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEee--CCCCCeEEEeecCCccc
Q 040917          110 HIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTT--GDENAVVKATDFGLSAF  186 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~--~~~~~~~kL~Dfg~a~~  186 (494)
                      .+|+|+. |-||.+++.-++ .++.+++..++.|++.-++|+|++.+|+|||||+|+||..  ......|-++|||+|..
T Consensus       100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            9999998 889999887664 5999999999999999999999999999999999999963  23456799999999987


Q ss_pred             cccCcc--------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHcCCc-c
Q 040917          187 IEEGKA--------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQG---VAQAILKGEI-N  253 (494)
Q Consensus       187 ~~~~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~---~~~~~~~~~~-~  253 (494)
                      ......        ..+..||.+||+=.-..| .-+.+.|+=|||-++.+++.|.+||.+.....   -.+.|-.... .
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence            644322        123568999998765544 46788999999999999999999998765433   2333322211 1


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 040917          254 FQRDPFPSISSSAIELVRRMLTQDPKRRITV  284 (494)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  284 (494)
                      .....+..+|.++...+...-..+-.+-|.+
T Consensus       259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY  289 (449)
T KOG1165|consen  259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDY  289 (449)
T ss_pred             CHHHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence            1122344566666666665555555555554

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=2e-24  Score=208.65  Aligned_cols=168  Identities=19%  Similarity=0.228  Sum_probs=129.9

Q ss_pred             cccccccceEeeeeecccCCeEEEEEEECC-CCcEEEEEEeccCCC--CChhhHHHHHHHHHHHHHccCCCCccE-EeEE
Q 040917           27 AYEDVQLHYTIGREVGRGEFGITYLCTENS-TGLEFACKSIPKRKL--VKDVEKDDVRREIEIMRHLSGQPNIVQ-FKAA  102 (494)
Q Consensus        27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~-~~~~valK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~i~~-~~~~  102 (494)
                      ....+..+|.+.+.||+|+||+||+|.++. +++.||+|++.....  ........+.+|+.+++++. |+|+++ +++.
T Consensus        12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~~   90 (365)
T PRK09188         12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLAT   90 (365)
T ss_pred             ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEEc
Confidence            344566889999999999999999999876 678889998753211  12334667999999999995 999885 4432


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCceEEeeCCCCCeEEEeec
Q 040917          103 YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL-KPENFLFTTGDENAVVKATDF  181 (494)
Q Consensus       103 ~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di-kp~NIli~~~~~~~~~kL~Df  181 (494)
                          ...|+||||++|++|.. +.   ...   ...++.+++.+|.|||++||+|||| ||+||++   +.++.++|+||
T Consensus        91 ----~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ikLiDF  156 (365)
T PRK09188         91 ----GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAAVIDF  156 (365)
T ss_pred             ----CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEEEEEC
Confidence                35789999999999963 21   111   1467899999999999999999999 9999999   56678999999


Q ss_pred             CCccccccCcc---------cccccCCcCccChhhhc
Q 040917          182 GLSAFIEEGKA---------YREIVGSPYYIAPEVLS  209 (494)
Q Consensus       182 g~a~~~~~~~~---------~~~~~~~~~y~aPE~~~  209 (494)
                      |+|........         .....+++.|.|||.+.
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            99986543221         13456788899999885

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=5.1e-26  Score=234.03  Aligned_cols=261  Identities=28%  Similarity=0.453  Sum_probs=198.8

Q ss_pred             cce-EeeeeecccCCeEEEEEEECCCCcEEEEEEeccC---CCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           33 LHY-TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR---KLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        33 ~~y-~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~---~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      ..| .....+|.|++|.|+.+......+..+.|.....   ..........+..|+-+-..|. |||++.....+.....
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~~~~  395 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQEIDG  395 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhhccc
Confidence            445 4678899999998988887777776677655421   1111112222455666667785 9999877776655544


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      ..-+||||++ +|..++...+.++...+-.++.|++.||.|+|..||.|||+||+|+++   ...+.+||+|||.+....
T Consensus       396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENGILKIIDFGAASVFR  471 (601)
T ss_pred             chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCCceEEeecCcceeec
Confidence            4455999999 999999888889999999999999999999999999999999999999   678899999999987653


Q ss_pred             cC-----cccccccCCcCccChhhhcc-cCC-CcchhHHHHHHHHHHHhCCCCCCCCChHHHH--HHH---HcCCccCCC
Q 040917          189 EG-----KAYREIVGSPYYIAPEVLSQ-SYG-KEADIWSAGVILYILLCGVPPFWAETDQGVA--QAI---LKGEINFQR  256 (494)
Q Consensus       189 ~~-----~~~~~~~~~~~y~aPE~~~~-~~~-~~~Di~slG~il~~l~tg~~pf~~~~~~~~~--~~~---~~~~~~~~~  256 (494)
                      ..     ......+|+..|.|||++.+ .|. ...||||.|+++..|.+|+.||......+..  ...   .......+.
T Consensus       472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~  551 (601)
T KOG0590|consen  472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN  551 (601)
T ss_pred             cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence            32     22345788999999999875 454 4689999999999999999999766554332  111   011111222


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          257 DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       257 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                      ..+..+|...+.+|.+||+.+|.+|.++++|++.+||+....
T Consensus       552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence            334567888999999999999999999999999999997543

>KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms]

Probab=99.90  E-value=2.9e-23  Score=177.50  Aligned_cols=142  Identities=37%  Similarity=0.629  Sum_probs=131.9

Q ss_pred             chhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhh-----
Q 040917          334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQ-----  408 (494)
Q Consensus       334 ~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~-----  408 (494)
                      +..+...+..+|+.+|++++|+|+..+|..+++.+|..++.+++..+++.+|.+++|.|+++||+.++.......     
T Consensus         3 ~~~~~~el~~~F~~fD~d~~G~i~~~el~~~lr~lg~~~t~~el~~~~~~~D~dg~g~I~~~eF~~l~~~~~~~~~~~~~   82 (151)
T KOG0027|consen    3 SEEQILELKEAFQLFDKDGDGKISVEELGAVLRSLGQNPTEEELRDLIKEIDLDGDGTIDFEEFLDLMEKLGEEKTDEEA   82 (151)
T ss_pred             CHHHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHhhhcccccccc
Confidence            567788999999999999999999999999999999999999999999999999999999999999988754321     


Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ..+++++||+.||.|++|+|+.+||+.+|..  +|++.+.++++.++..+|.|+||.|+|++|+++|..
T Consensus        83 ~~~el~eaF~~fD~d~~G~Is~~el~~~l~~--lg~~~~~~e~~~mi~~~d~d~dg~i~f~ef~~~m~~  149 (151)
T KOG0027|consen   83 SSEELKEAFRVFDKDGDGFISASELKKVLTS--LGEKLTDEECKEMIREVDVDGDGKVNFEEFVKMMSG  149 (151)
T ss_pred             cHHHHHHHHHHHccCCCCcCcHHHHHHHHHH--hCCcCCHHHHHHHHHhcCCCCCCeEeHHHHHHHHhc
Confidence            3458999999999999999999999999999  788999999999999999999999999999998875

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=2.6e-23  Score=186.66  Aligned_cols=174  Identities=17%  Similarity=0.143  Sum_probs=132.3

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHH------HHHHHHHHHHccCCCCccEEeEEEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD------VRREIEIMRHLSGQPNIVQFKAAYE  104 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~------~~~E~~~l~~l~~hp~i~~~~~~~~  104 (494)
                      +.++|++.+.||.|+||.||++..  ++..+|+|++.......+.....      +.+|+..+.++. ||+|..+.+++.
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~~~  105 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDFYL  105 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEeee
Confidence            468999999999999999999765  46689999997655433333333      678999999995 999999988865


Q ss_pred             eC--------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917          105 DD--------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV  176 (494)
Q Consensus       105 ~~--------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~  176 (494)
                      ..        ...+++|||++|.+|.+..    .+++    ....+++.++..+|+.|++|||+||+||++   ++++ +
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili---~~~g-i  173 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIV---SKNG-L  173 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEE---eCCC-E
Confidence            33        3578999999999997763    2333    346689999999999999999999999999   4556 9


Q ss_pred             EEeecCCccccccCcccccccCCcCccChhhhcccCCCcchhHHHHHHHHHHH
Q 040917          177 KATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILL  229 (494)
Q Consensus       177 kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~  229 (494)
                      +|+|||.............          =++...+..++|+||||+++..+.
T Consensus       174 ~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence            9999998765422211100          112234667999999999887654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.90  E-value=7.2e-23  Score=189.35  Aligned_cols=235  Identities=25%  Similarity=0.346  Sum_probs=156.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccC---------CCCccEEeEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG---------QPNIVQFKAAY  103 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~---------hp~i~~~~~~~  103 (494)
                      ..+..++.||.|+++.||.+.+..||+++++|+............+.+.+|......+.+         |-.++..++..
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            356788999999999999999999999999999876554445566777777755544322         22333333433


Q ss_pred             Ee------------CCe-----EEEEEeccCCCchHHHHH---hcCC----CCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 040917          104 ED------------DQF-----VHIVMELCAGGELFDRIV---ARGH----YSERAAASVFRVIMNVVNVCHSKGVMHRD  159 (494)
Q Consensus       104 ~~------------~~~-----~~iv~e~~~g~sL~~~~~---~~~~----l~~~~~~~i~~~i~~~l~~LH~~~i~H~d  159 (494)
                      ..            ...     .+++|+-+. ++|...+.   ....    +.......+..|++..+++||..|++|+|
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd  170 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD  170 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence            21            112     367888875 48876653   2222    22333456668999999999999999999


Q ss_pred             CCCCceEEeeCCCCCeEEEeecCCccccccCcccccccCCcCccChhhhcc---------cCCCcchhHHHHHHHHHHHh
Q 040917          160 LKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ---------SYGKEADIWSAGVILYILLC  230 (494)
Q Consensus       160 ikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~Di~slG~il~~l~t  230 (494)
                      |+|+|+++   +.+|.+.|+||+..........  ....+..|.|||....         .++.+.|.|+||+++|.|..
T Consensus       171 i~~~nfll---~~~G~v~Lg~F~~~~r~g~~~~--~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  171 IKPENFLL---DQDGGVFLGDFSSLVRAGTRYR--CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             -SGGGEEE----TTS-EEE--GGGEEETTEEEE--GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             cceeeEEE---cCCCCEEEcChHHHeecCceee--ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            99999999   7899999999988765433222  1344678999997632         37889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 040917          231 GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRR  281 (494)
Q Consensus       231 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R  281 (494)
                      +..||...........        ....+.++|+.++.+|..+|+.||.+|
T Consensus       246 ~~lPf~~~~~~~~~~~--------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPEW--------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSGG--------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCccccccc--------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            9999977655322111        222345789999999999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.4e-24  Score=212.79  Aligned_cols=239  Identities=28%  Similarity=0.486  Sum_probs=205.1

Q ss_pred             ecccCCeEEEEEEE---CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917           41 VGRGEFGITYLCTE---NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA  117 (494)
Q Consensus        41 lg~G~~g~Vy~a~~---~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~  117 (494)
                      +|+|++|.|+++..   ...++-+++|+..+......... ....|..++...++||.++++.-.++.+...+++.++..
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            78999999998653   45688899999887665554333 667788899999789999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccccccc
Q 040917          118 GGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV  197 (494)
Q Consensus       118 g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~  197 (494)
                      ||.|...+.....+.......+...++-++..+|+.+|+|||+|++||++   +..|++++.|||.++..-....   .|
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~---~c  154 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKI---AC  154 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhh---cc
Confidence            99999888887788888888999999999999999999999999999999   7899999999999987544332   28


Q ss_pred             CCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccC
Q 040917          198 GSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD  277 (494)
Q Consensus       198 ~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  277 (494)
                      ||..|||||+++ .....+|.||+|+++++|+||..||.+    ++...|.+.....+.    .++..+++++..++..+
T Consensus       155 gt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r~  225 (612)
T KOG0603|consen  155 GTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFKRN  225 (612)
T ss_pred             cchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHhhC
Confidence            999999999998 667899999999999999999999977    566667666555553    46788999999999999


Q ss_pred             CCCCCC-----HHHHhcCCccCc
Q 040917          278 PKRRIT-----VAQVLEHPWLKE  295 (494)
Q Consensus       278 p~~Rps-----~~eil~~~~~~~  295 (494)
                      |.+|.-     +.++++|+||+.
T Consensus       226 p~nrLg~~~~~~~eik~h~f~~~  248 (612)
T KOG0603|consen  226 PENRLGAGPDGVDEIKQHEFFQS  248 (612)
T ss_pred             HHHHhccCcchhHHHhccchhee
Confidence            999974     478999999974

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=2.1e-22  Score=179.09  Aligned_cols=142  Identities=18%  Similarity=0.182  Sum_probs=111.2

Q ss_pred             eeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChh-----------------------hHHHHHHHHHHHHHccCCC
Q 040917           38 GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV-----------------------EKDDVRREIEIMRHLSGQP   94 (494)
Q Consensus        38 ~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~~hp   94 (494)
                      ...||+|++|.||+|.+. +|+.||+|+++........                       ......+|+..+.++. ++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA   79 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence            468999999999999987 8999999999754321111                       0123345999999995 77


Q ss_pred             CccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCceEEeeCCCC
Q 040917           95 NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC-HSKGVMHRDLKPENFLFTTGDEN  173 (494)
Q Consensus        95 ~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~i~H~dikp~NIli~~~~~~  173 (494)
                      ++.....+....  .+|||||++|+++.........++...+..++.|++.+|.++ |+.||+||||||+||+++    +
T Consensus        80 ~v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~----~  153 (190)
T cd05147          80 GIPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH----D  153 (190)
T ss_pred             CCCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----C
Confidence            764444333222  379999999887766544556789999999999999999999 799999999999999994    3


Q ss_pred             CeEEEeecCCcccc
Q 040917          174 AVVKATDFGLSAFI  187 (494)
Q Consensus       174 ~~~kL~Dfg~a~~~  187 (494)
                      +.++|+|||+|...
T Consensus       154 ~~v~LiDFG~a~~~  167 (190)
T cd05147         154 GKLYIIDVSQSVEH  167 (190)
T ss_pred             CcEEEEEccccccC
Confidence            67999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=2.2e-23  Score=214.43  Aligned_cols=244  Identities=22%  Similarity=0.316  Sum_probs=181.5

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHH--HHHccCCCCccEEeEEEEeCCeEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEI--MRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~--l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .|...+-||++.|=.|.+|+++. |. |++|++-+...  ......+.+++.-  .... .+||++++.-+...+...|+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p--~~sL~~~~qrL~~ik~~l~-~~pn~lPfqk~~~t~kAAyl   98 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDP--TISLRPFKQRLEEIKFALM-KAPNCLPFQKVLVTDKAAYL   98 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCC--CCCchHHHHHHHHHHHHhh-cCCcccchHHHHHhhHHHHH
Confidence            68889999999999999999864 55 99999876542  2233334433332  3334 59999999888888888899


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc--cc
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI--EE  189 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~--~~  189 (494)
                      |-+|.. .+|++++..++.+..-+.+-|+-|++.||..+|..||+|||||.+|||+   .+..-+.|+||......  +.
T Consensus        99 vRqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi---TSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen   99 VRQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI---TSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE---eeechhhhhcccccCCccCCC
Confidence            999995 5999999999889999999999999999999999999999999999999   67888999999776432  11


Q ss_pred             Ccc--c----ccccCCcCccChhhhcc-----------c-CCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcC
Q 040917          190 GKA--Y----REIVGSPYYIAPEVLSQ-----------S-YGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKG  250 (494)
Q Consensus       190 ~~~--~----~~~~~~~~y~aPE~~~~-----------~-~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~  250 (494)
                      .++  .    .+...-..|.|||.+..           . .+++.||||+||+++||++ |++||.-    ..+-...++
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~  250 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSG  250 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhcc
Confidence            111  1    11223356999998732           1 5789999999999999988 5778731    122222222


Q ss_pred             CccCCCCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          251 EINFQRDPFPS-ISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       251 ~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      ....+...+.. -+..++.+|..|++.||.+|.|+++.|+.
T Consensus       251 ~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  251 NADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             CccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            21111111111 13578999999999999999999999986

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.88  E-value=8.7e-23  Score=209.94  Aligned_cols=223  Identities=30%  Similarity=0.554  Sum_probs=177.0

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      .-...+|..+++|..|++|.||.++|+.+.+.+|+|+ .+...        +.+.  ++... ++|.++           
T Consensus        79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l--------ilRn--ilt~a-~npfvv-----------  135 (1205)
T KOG0606|consen   79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL--------ILRN--ILTFA-GNPFVV-----------  135 (1205)
T ss_pred             CCCccccceeEeeccCCCCceeeeeccccccchhhcc-cccch--------hhhc--ccccc-CCccee-----------
Confidence            3455789999999999999999999999999999954 32221        1111  22222 455544           


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                                |+=..+++.-+.++...        +.+++|||+.||+|||+||.|.+|   ..-|++|+.|||++....
T Consensus       136 ----------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 ----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             ----------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhh
Confidence                      23344455555555443        678999999999999999999999   689999999999986532


Q ss_pred             cCc----------------ccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC
Q 040917          189 EGK----------------AYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE  251 (494)
Q Consensus       189 ~~~----------------~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  251 (494)
                      ...                .....+|||.|.|||++. ..|+..+|+|++|+|+|+++-|..||.+.++++.+..+....
T Consensus       195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~  274 (1205)
T KOG0606|consen  195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD  274 (1205)
T ss_pred             hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence            110                012468999999999875 569999999999999999999999999999999999999988


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCccCcc
Q 040917          252 INFQRDPFPSISSSAIELVRRMLTQDPKRRI---TVAQVLEHPWLKES  296 (494)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~eil~~~~~~~~  296 (494)
                      ..++... ..+++++++++.++|..+|..|.   .+-++.+|+||+..
T Consensus       275 i~wpE~d-ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L  321 (1205)
T KOG0606|consen  275 IEWPEED-EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL  321 (1205)
T ss_pred             ccccccC-cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence            8888774 56889999999999999999995   67788999999863

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=5.4e-23  Score=181.13  Aligned_cols=241  Identities=19%  Similarity=0.240  Sum_probs=193.1

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ....+...|.+...|..|+++|+  |..+++|++..+....+ ...+|..|...|+.+. ||||+++++.+.......+|
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~r-isrdfneefp~lrifs-hpnilpvlgacnsppnlv~i  265 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTAR-ISRDFNEEFPALRIFS-HPNILPVLGACNSPPNLVII  265 (448)
T ss_pred             hhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcchh-hcchhhhhCcceeeec-CCchhhhhhhccCCCCceEe
Confidence            34556677899999999999998  56789999876665444 4567888988898885 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC-c-eeccCCCCceEEeeCCCCCeEEE--eecCCccc
Q 040917          113 MELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVCHSKG-V-MHRDLKPENFLFTTGDENAVVKA--TDFGLSAF  186 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~--l~~~~~~~i~~~i~~~l~~LH~~~-i-~H~dikp~NIli~~~~~~~~~kL--~Dfg~a~~  186 (494)
                      ..|++.|+|++.++....  .+..++.+++.+++.|++|||+.. + ..--|+...|++   +++.+.+|  +|-.++..
T Consensus       266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsfq  342 (448)
T KOG0195|consen  266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSFQ  342 (448)
T ss_pred             eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeeee
Confidence            999999999999987654  577889999999999999999973 3 344588999999   55555555  34433322


Q ss_pred             cccCcccccccCCcCccChhhhccc----CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          187 IEEGKAYREIVGSPYYIAPEVLSQS----YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                            .......|.|++||.+...    --.++|+|||+++++||.|...||...++.+.-..+.-.......  .|.+
T Consensus       343 ------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~i--ppgi  414 (448)
T KOG0195|consen  343 ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHI--PPGI  414 (448)
T ss_pred             ------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccC--CCCc
Confidence                  1233457899999998643    235789999999999999999999999998887777655554433  3689


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHh
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVL  288 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil  288 (494)
                      +....+++.-|+..||.+||.++.++
T Consensus       415 s~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  415 SRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             cHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            99999999999999999999988764

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=3.1e-21  Score=169.37  Aligned_cols=189  Identities=19%  Similarity=0.248  Sum_probs=142.4

Q ss_pred             EeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChh-hHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917           36 TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV-EKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME  114 (494)
Q Consensus        36 ~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~-~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e  114 (494)
                      .+...|++|+||+||.+..  .+.+++.+.+......... ....+.+|+++|++|.+++++++++++    ...+++|+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            4578899999999998774  5788887777544432221 122578999999999767889999886    34689999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCceEEeeCCCCCeEEEeecCCccccccCccc
Q 040917          115 LCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL-KPENFLFTTGDENAVVKATDFGLSAFIEEGKAY  193 (494)
Q Consensus       115 ~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di-kp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~  193 (494)
                      |+.|.+|......      . ...++.+++.+|.++|++||+|||| ||+||++   +.++.++|+|||++.........
T Consensus        79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv---~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV---QEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE---cCCCCEEEEECCCceecCCcchH
Confidence            9999888654311      1 2357889999999999999999999 7999999   56788999999999865433321


Q ss_pred             --------------ccccCCcCccChhhhc--ccCC-CcchhHHHHHHHHHHHhCCCCCCCCCh
Q 040917          194 --------------REIVGSPYYIAPEVLS--QSYG-KEADIWSAGVILYILLCGVPPFWAETD  240 (494)
Q Consensus       194 --------------~~~~~~~~y~aPE~~~--~~~~-~~~Di~slG~il~~l~tg~~pf~~~~~  240 (494)
                                    .-...++.|++|+...  ...+ ...+.++.|+-+|.++|+..+.++..+
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence                          0122577888887532  2333 578999999999999999999876543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=3e-21  Score=172.45  Aligned_cols=144  Identities=15%  Similarity=0.172  Sum_probs=113.1

Q ss_pred             eeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCCh-----------------------hhHHHHHHHHHHHHHccCC
Q 040917           37 IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD-----------------------VEKDDVRREIEIMRHLSGQ   93 (494)
Q Consensus        37 i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~~h   93 (494)
                      +.+.||+|++|.||+|.+. +|+.||+|++........                       ........|...+.++. +
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~   78 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-E   78 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-h
Confidence            3578999999999999987 899999999976531100                       01223467899999995 8


Q ss_pred             CCccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCC
Q 040917           94 PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDE  172 (494)
Q Consensus        94 p~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~  172 (494)
                      +++.....+....  .++||||++|+++.........++...+..++.+++.++.++|+ .||+||||||+||++   + 
T Consensus        79 ~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll---~-  152 (190)
T cd05145          79 AGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY---H-  152 (190)
T ss_pred             CCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE---E-
Confidence            8875544443332  47999999988665443344568889999999999999999999 999999999999999   3 


Q ss_pred             CCeEEEeecCCccccc
Q 040917          173 NAVVKATDFGLSAFIE  188 (494)
Q Consensus       173 ~~~~kL~Dfg~a~~~~  188 (494)
                      ++.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            6789999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=8.5e-22  Score=182.38  Aligned_cols=189  Identities=25%  Similarity=0.414  Sum_probs=141.4

Q ss_pred             CCCCccEEeEEEEe---------------------------CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHH
Q 040917           92 GQPNIVQFKAAYED---------------------------DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM  144 (494)
Q Consensus        92 ~hp~i~~~~~~~~~---------------------------~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~  144 (494)
                      .||||+.+...|.+                           +...|+||..++ .||..++..+. .+.....-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-RSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-CchHHHHHHHHHHH
Confidence            69999999877632                           245889999885 49999997754 57778888999999


Q ss_pred             HHHHHHHHCCceeccCCCCceEEee-CCCCCeEEEeecCCcccccc-------CcccccccCCcCccChhhhcccC----
Q 040917          145 NVVNVCHSKGVMHRDLKPENFLFTT-GDENAVVKATDFGLSAFIEE-------GKAYREIVGSPYYIAPEVLSQSY----  212 (494)
Q Consensus       145 ~~l~~LH~~~i~H~dikp~NIli~~-~~~~~~~kL~Dfg~a~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~----  212 (494)
                      +|+.|||++||.|||+|.+||++.= ++.-..+.++|||.+--..+       ....-...|....+|||+....+    
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            9999999999999999999999963 34557889999998643221       01112345677899999986422    


Q ss_pred             ---CCcchhHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 040917          213 ---GKEADIWSAGVILYILLCGVPPFWAETDQGVA-QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVA  285 (494)
Q Consensus       213 ---~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  285 (494)
                         -.+.|.|+.|.+.||+++...||.+..+.-.- ......+.  + .....+|+.+++++..+|+.||++|+|..
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL--P-alp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL--P-ALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC--C-CCcccCChHHHHHHHHHhcCCccccCCcc
Confidence               24899999999999999999999875432110 11111111  1 12246889999999999999999999864

>KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=4.6e-20  Score=148.79  Aligned_cols=145  Identities=30%  Similarity=0.507  Sum_probs=134.7

Q ss_pred             cCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh-hhhHH
Q 040917          332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH-KLQRF  410 (494)
Q Consensus       332 ~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~-~~~~~  410 (494)
                      .+..++.++++..|..||.+++|+|+..||.-+.+.+|..+.++++..++..+|.++.|.|+|++|...+.... ...+.
T Consensus        26 ~l~~~q~q~i~e~f~lfd~~~~g~iD~~EL~vAmralGFE~~k~ei~kll~d~dk~~~g~i~fe~f~~~mt~k~~e~dt~  105 (172)
T KOG0028|consen   26 ELTEEQKQEIKEAFELFDPDMAGKIDVEELKVAMRALGFEPKKEEILKLLADVDKEGSGKITFEDFRRVMTVKLGERDTK  105 (172)
T ss_pred             cccHHHHhhHHHHHHhhccCCCCcccHHHHHHHHHHcCCCcchHHHHHHHHhhhhccCceechHHHHHHHHHHHhccCcH
Confidence            45677789999999999999999999999999999999999999999999999999999999999999876643 23478


Q ss_pred             HHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      +++..+|+.+|.|++|+|+..+|+.+...  +|+.++++++.++|.++|.++||-|+-+||..+|+++
T Consensus       106 eEi~~afrl~D~D~~Gkis~~~lkrvake--LgenltD~El~eMIeEAd~d~dgevneeEF~~imk~t  171 (172)
T KOG0028|consen  106 EEIKKAFRLFDDDKTGKISQRNLKRVAKE--LGENLTDEELMEMIEEADRDGDGEVNEEEFIRIMKKT  171 (172)
T ss_pred             HHHHHHHHcccccCCCCcCHHHHHHHHHH--hCccccHHHHHHHHHHhcccccccccHHHHHHHHhcC
Confidence            89999999999999999999999999999  8899999999999999999999999999999999864

>PTZ00183 centrin; Provisional

Probab=99.83  E-value=1.1e-19  Score=157.57  Aligned_cols=148  Identities=33%  Similarity=0.561  Sum_probs=133.6

Q ss_pred             ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh-hhhH
Q 040917          331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH-KLQR  409 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~-~~~~  409 (494)
                      ..+++.+++++..+|..+|.+++|.|+..||..++..+|...+..++..+|..+|.+++|.|+|+||+..+.... ....
T Consensus         9 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~g~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~   88 (158)
T PTZ00183          9 PGLTEDQKKEIREAFDLFDTDGSGTIDPKELKVAMRSLGFEPKKEEIKQMIADVDKDGSGKIDFEEFLDIMTKKLGERDP   88 (158)
T ss_pred             CCCCHHHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHhcCCCc
Confidence            346788999999999999999999999999999999999888888999999999999999999999998876532 2334


Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccc
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ  480 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~  480 (494)
                      ...++.+|+.+|.+++|+|+.+||..++..  .+..++++++..++..+|.|++|.|++++|.+++...|.
T Consensus        89 ~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~--~~~~l~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~  157 (158)
T PTZ00183         89 REEILKAFRLFDDDKTGKISLKNLKRVAKE--LGETITDEELQEMIDEADRNGDGEISEEEFYRIMKKTNL  157 (158)
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhcccC
Confidence            567899999999999999999999999998  566789999999999999999999999999999987664

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=1.2e-19  Score=190.56  Aligned_cols=195  Identities=21%  Similarity=0.337  Sum_probs=158.7

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc--CCCCccEEeEEEEeCCeE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS--GQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~i~~~~~~~~~~~~~  109 (494)
                      +..|.|.+.||.|+||.||+|.+.. |+.||||+-+......      ++--.+++.+|+  --+-|..+...+...+.-
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            4789999999999999999999877 9999999976543222      233344555553  124556666666666677


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEee----CCCCCeEEEeecCCcc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTT----GDENAVVKATDFGLSA  185 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~----~~~~~~~kL~Dfg~a~  185 (494)
                      ++|++|.+.|||.+++...+.+++..+..++.|++..|..||..+||||||||.|+++..    +....-++|+|||-+.
T Consensus       770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si  849 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI  849 (974)
T ss_pred             eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence            799999999999999998888999999999999999999999999999999999999953    2346679999999986


Q ss_pred             ccc---cCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCC
Q 040917          186 FIE---EGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVP  233 (494)
Q Consensus       186 ~~~---~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~  233 (494)
                      -+.   .+-.....++|-.+-++|+..| ++++..|.|-|+.+++.|+.|+.
T Consensus       850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            543   3334456778899999999986 59999999999999999998853

>KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton]

Probab=99.82  E-value=2.2e-19  Score=143.63  Aligned_cols=152  Identities=28%  Similarity=0.455  Sum_probs=137.9

Q ss_pred             HHHHHhhhccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHH
Q 040917          323 KLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATM  402 (494)
Q Consensus       323 ~l~~~~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~  402 (494)
                      +.+...+...|.+.++++++..|..+|.|+||.|+++||.+.+..+|..++++++..+++..    .|.|+|.-|+.++-
T Consensus        16 ~rasSnvFamf~q~QIqEfKEAF~~mDqnrDG~IdkeDL~d~~aSlGk~~~d~elDaM~~Ea----~gPINft~FLTmfG   91 (171)
T KOG0031|consen   16 KRASSNVFAMFDQSQIQEFKEAFNLMDQNRDGFIDKEDLRDMLASLGKIASDEELDAMMKEA----PGPINFTVFLTMFG   91 (171)
T ss_pred             ccccchHHHHhhHHHHHHHHHHHHHHhccCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHhC----CCCeeHHHHHHHHH
Confidence            34555566778999999999999999999999999999999999999999999999999874    88999999999987


Q ss_pred             Hhhh-hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccc
Q 040917          403 QRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ  480 (494)
Q Consensus       403 ~~~~-~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~  480 (494)
                      .... ...++.+..||+.||.+++|.|..+.|+++|..  .|++++++++++++..+-.+..|.++|..|..++..+..
T Consensus        92 ekL~gtdpe~~I~~AF~~FD~~~~G~I~~d~lre~Ltt--~gDr~~~eEV~~m~r~~p~d~~G~~dy~~~~~~ithG~~  168 (171)
T KOG0031|consen   92 EKLNGTDPEEVILNAFKTFDDEGSGKIDEDYLRELLTT--MGDRFTDEEVDEMYREAPIDKKGNFDYKAFTYIITHGEK  168 (171)
T ss_pred             HHhcCCCHHHHHHHHHHhcCccCCCccCHHHHHHHHHH--hcccCCHHHHHHHHHhCCcccCCceeHHHHHHHHHcccc
Confidence            7554 345778999999999999999999999999999  899999999999999999999999999999999986654

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=3.4e-19  Score=159.82  Aligned_cols=141  Identities=18%  Similarity=0.281  Sum_probs=109.7

Q ss_pred             EeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc----CCCCccEEeEEEEeCC---e
Q 040917           36 TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS----GQPNIVQFKAAYEDDQ---F  108 (494)
Q Consensus        36 ~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~i~~~~~~~~~~~---~  108 (494)
                      .-.+.||+|++|.||.  +..++.. +||++.....   ...+.+.+|+.+++.+.    +||||+++++++..+.   .
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~   78 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY   78 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence            3457899999999995  6666665 6998865332   24567899999999994    3799999999998763   3


Q ss_pred             -EEEEEec--cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCceEEeeCC-CCCeEEEee-cC
Q 040917          109 -VHIVMEL--CAGGELFDRIVARGHYSERAAASVFRVIMNVV-NVCHSKGVMHRDLKPENFLFTTGD-ENAVVKATD-FG  182 (494)
Q Consensus       109 -~~iv~e~--~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~i~H~dikp~NIli~~~~-~~~~~kL~D-fg  182 (494)
                       +.+|+||  +.+++|.+++.+. .+++.  ..++.+++.++ .|||+++|+||||||+||+++..+ ....++|+| ||
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence             3378999  5579999999664 46555  35678888777 899999999999999999996432 445899999 55


Q ss_pred             Ccc
Q 040917          183 LSA  185 (494)
Q Consensus       183 ~a~  185 (494)
                      ...
T Consensus       156 ~~~  158 (210)
T PRK10345        156 EST  158 (210)
T ss_pred             Ccc
Confidence            443

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=2e-19  Score=165.51  Aligned_cols=146  Identities=19%  Similarity=0.169  Sum_probs=114.7

Q ss_pred             cceEeeeeecccCCeEEEEEE-ECCCCcEEEEEEeccCCCCCh---------------------hhHHHHHHHHHHHHHc
Q 040917           33 LHYTIGREVGRGEFGITYLCT-ENSTGLEFACKSIPKRKLVKD---------------------VEKDDVRREIEIMRHL   90 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~-~~~~~~~valK~~~~~~~~~~---------------------~~~~~~~~E~~~l~~l   90 (494)
                      .-|++.+.||+|++|.||+|. +..+|+.||+|++........                     .....+.+|+.++.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            358899999999999999998 777899999999875432100                     0123467899999999


Q ss_pred             cCC--CCccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCceEE
Q 040917           91 SGQ--PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG-VMHRDLKPENFLF  167 (494)
Q Consensus        91 ~~h--p~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-i~H~dikp~NIli  167 (494)
                      . +  ..+.++++.   . ..++||||++|.+|.........+....+..++.||+.++.+||+.| ++||||||+||++
T Consensus       108 ~-~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli  182 (237)
T smart00090      108 Y-EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV  182 (237)
T ss_pred             H-hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence            5 4  234444442   2 34799999999888766544556677778899999999999999999 9999999999999


Q ss_pred             eeCCCCCeEEEeecCCcccc
Q 040917          168 TTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       168 ~~~~~~~~~kL~Dfg~a~~~  187 (494)
                         + .+.++|+|||.+...
T Consensus       183 ---~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      183 ---H-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             ---E-CCCEEEEEChhhhcc
Confidence               3 678999999998754

>PTZ00184 calmodulin; Provisional

Probab=99.81  E-value=5.7e-19  Score=151.57  Aligned_cols=145  Identities=37%  Similarity=0.641  Sum_probs=129.9

Q ss_pred             ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh-hhhH
Q 040917          331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH-KLQR  409 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~-~~~~  409 (494)
                      ..++.++.+.++..|..+|.+++|.|+..||..++..++..++.+++..+|..+|.+++|.|+|++|+..+.... ....
T Consensus         3 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~l~~~~~~~~~   82 (149)
T PTZ00184          3 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTLMARKMKDTDS   82 (149)
T ss_pred             CccCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHhcCcCCCCcCcHHHHHHHHHHhccCCcH
Confidence            446788899999999999999999999999999999999888888999999999999999999999998877542 2234


Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...+..+|..+|.|++|+|+.+|+..++..  .+..++.++++.++..+|.+++|.|+|+||..++..
T Consensus        83 ~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~--~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~  148 (149)
T PTZ00184         83 EEEIKEAFKVFDRDGNGFISAAELRHVMTN--LGEKLTDEEVDEMIREADVDGDGQINYEEFVKMMMS  148 (149)
T ss_pred             HHHHHHHHHhhCCCCCCeEeHHHHHHHHHH--HCCCCCHHHHHHHHHhcCCCCCCcCcHHHHHHHHhc
Confidence            567899999999999999999999999998  566788999999999999999999999999988763

>KOG0030 consensus Myosin essential light chain, EF-Hand protein superfamily [Cytoskeleton]

Probab=99.78  E-value=1.8e-18  Score=136.03  Aligned_cols=142  Identities=23%  Similarity=0.418  Sum_probs=127.3

Q ss_pred             CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCC--CCCcccchHHHHHHHHhhh---h
Q 040917          333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADID--GNGTIDYIEFITATMQRHK---L  407 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~--~~g~i~~~ef~~~~~~~~~---~  407 (494)
                      +++++..+++.+|..||..+||.|+..+..++++.+|.+|++.++.+.....+.+  +-.+|+|++|+.++....+   .
T Consensus         5 ~~~d~~~e~ke~F~lfD~~gD~ki~~~q~gdvlRalG~nPT~aeV~k~l~~~~~~~~~~~rl~FE~fLpm~q~vaknk~q   84 (152)
T KOG0030|consen    5 FTPDQMEEFKEAFLLFDRTGDGKISGSQVGDVLRALGQNPTNAEVLKVLGQPKRREMNVKRLDFEEFLPMYQQVAKNKDQ   84 (152)
T ss_pred             cCcchHHHHHHHHHHHhccCcccccHHHHHHHHHHhcCCCcHHHHHHHHcCcccchhhhhhhhHHHHHHHHHHHHhcccc
Confidence            5677789999999999999999999999999999999999999999999888776  4578999999998776543   3


Q ss_pred             hHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       408 ~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .+-+++-+.++.||++++|.|...||+++|.+  +|++++++|+++++.-.. |.+|.|+|+.|++-+.+
T Consensus        85 ~t~edfvegLrvFDkeg~G~i~~aeLRhvLtt--lGekl~eeEVe~Llag~e-D~nG~i~YE~fVk~i~~  151 (152)
T KOG0030|consen   85 GTYEDFVEGLRVFDKEGNGTIMGAELRHVLTT--LGEKLTEEEVEELLAGQE-DSNGCINYEAFVKHIMS  151 (152)
T ss_pred             CcHHHHHHHHHhhcccCCcceeHHHHHHHHHH--HHhhccHHHHHHHHcccc-ccCCcCcHHHHHHHHhc
Confidence            45688999999999999999999999999999  889999999999998876 88999999999986653

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=1.7e-18  Score=170.46  Aligned_cols=198  Identities=28%  Similarity=0.402  Sum_probs=158.3

Q ss_pred             HHccCCCCccEEeEEEEeCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCCce
Q 040917           88 RHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGV-MHRDLKPENF  165 (494)
Q Consensus        88 ~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i-~H~dikp~NI  165 (494)
                      +.+ .|.|+.++++.+.++...++|.+||.-|+|.+.+.. ...++......++++|+.|+.|||...| .|+.+++.|.
T Consensus         2 ~~l-~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    2 RQL-DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             ccc-chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            456 499999999999999999999999999999999987 4568899999999999999999999977 9999999999


Q ss_pred             EEeeCCCCCeEEEeecCCccccccC---cccccccCCcCccChhhhccc--------CCCcchhHHHHHHHHHHHhCCCC
Q 040917          166 LFTTGDENAVVKATDFGLSAFIEEG---KAYREIVGSPYYIAPEVLSQS--------YGKEADIWSAGVILYILLCGVPP  234 (494)
Q Consensus       166 li~~~~~~~~~kL~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~--------~~~~~Di~slG~il~~l~tg~~p  234 (494)
                      ++   +....+||.|||+.......   .......-...|.|||.+.+.        .+.+.|+||+|++++++++.+.|
T Consensus        81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99   78999999999998765320   111112234579999998653        46789999999999999999999


Q ss_pred             CCCC----ChHHHHHHHHcCCcc-CCCCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          235 FWAE----TDQGVAQAILKGEIN-FQRDPF--PSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       235 f~~~----~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      |...    ...++...+.++... +.+..+  ...++.+..++..||..+|.+||+++++-.
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            9652    223555666662332 332221  146678999999999999999999998754

>KOG0044 consensus Ca2+ sensor (EF-Hand superfamily) [Signal transduction mechanisms]

Probab=99.77  E-value=5.6e-18  Score=146.24  Aligned_cols=158  Identities=26%  Similarity=0.374  Sum_probs=135.3

Q ss_pred             hccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCC-HHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhh
Q 040917          330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLT-EFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQ  408 (494)
Q Consensus       330 ~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~-~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~  408 (494)
                      .+.++.++++.|++-|..  ...+|.++.++|+.++..++.... +.-...+|..+|.|+||.|+|.||+..+....+++
T Consensus        20 ~t~f~~~ei~~~Yr~Fk~--~cP~G~~~~~~F~~i~~~~fp~gd~~~y~~~vF~~fD~~~dg~i~F~Efi~als~~~rGt   97 (193)
T KOG0044|consen   20 QTKFSKKEIQQWYRGFKN--ECPSGRLTLEEFREIYASFFPDGDASKYAELVFRTFDKNKDGTIDFLEFICALSLTSRGT   97 (193)
T ss_pred             hcCCCHHHHHHHHHHhcc--cCCCCccCHHHHHHHHHHHCCCCCHHHHHHHHHHHhcccCCCCcCHHHHHHHHHHHcCCc
Confidence            356889999999999955  788999999999999999875333 44578899999999999999999999999988888


Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhc----CC-----CCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDY----GM-----GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~----~~-----~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      ..+.++.+|++||.|++|+|+++|+-.++++.    +.     .....++.++.+|..+|.|.||+||++||.+..+..+
T Consensus        98 ~eekl~w~F~lyD~dgdG~It~~Eml~iv~~i~~m~~~~~~~~~~~~~~~~v~~if~k~D~n~Dg~lT~eef~~~~~~d~  177 (193)
T KOG0044|consen   98 LEEKLKWAFRLYDLDGDGYITKEEMLKIVQAIYQMTGSKALPEDEETPEERVDKIFSKMDKNKDGKLTLEEFIEGCKADP  177 (193)
T ss_pred             HHHHhhhhheeecCCCCceEcHHHHHHHHHHHHHHcccccCCcccccHHHHHHHHHHHcCCCCCCcccHHHHHHHhhhCH
Confidence            89999999999999999999999999998752    21     1344566789999999999999999999999999988


Q ss_pred             ccchhhhhhh
Q 040917          480 QLRALSSRSL  489 (494)
Q Consensus       480 ~~~~~~~~~~  489 (494)
                      .+..+.....
T Consensus       178 ~i~~~l~~~~  187 (193)
T KOG0044|consen  178 SILRALEQDP  187 (193)
T ss_pred             HHHHHhhhcc
Confidence            7777665543

>KOG0034 consensus Ca2+/calmodulin-dependent protein phosphatase (calcineurin subunit B), EF-Hand superfamily protein [Signal transduction mechanisms]

Probab=99.77  E-value=2.8e-18  Score=148.31  Aligned_cols=147  Identities=27%  Similarity=0.465  Sum_probs=123.0

Q ss_pred             cCchhHHHhhhhhhhccCCC-CCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCc-ccchHHHHHHHHhhhhhH
Q 040917          332 NLPTEEIQKLKEKFTEMDTD-NSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGT-IDYIEFITATMQRHKLQR  409 (494)
Q Consensus       332 ~~~~~~~~~~~~~F~~~D~~-~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~-i~~~ef~~~~~~~~~~~~  409 (494)
                      .++.+|+.++..+|.++|.+ ++|+|+.+||..+....-.++    ..+++..+|.+++|. |+|++|+..+........
T Consensus        26 ~fs~~EI~~L~~rF~kl~~~~~~g~lt~eef~~i~~~~~Np~----~~rI~~~f~~~~~~~~v~F~~Fv~~ls~f~~~~~  101 (187)
T KOG0034|consen   26 QFSANEIERLYERFKKLDRNNGDGYLTKEEFLSIPELALNPL----ADRIIDRFDTDGNGDPVDFEEFVRLLSVFSPKAS  101 (187)
T ss_pred             ccCHHHHHHHHHHHHHhccccccCccCHHHHHHHHHHhcCcH----HHHHHHHHhccCCCCccCHHHHHHHHhhhcCCcc
Confidence            38899999999999999999 999999999999995433333    457888888888888 999999999988765443


Q ss_pred             -HHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCC------CcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccccc
Q 040917          410 -FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDD------ATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLR  482 (494)
Q Consensus       410 -~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~------~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~  482 (494)
                       .++++-||+.||.+++|+|+.+|+.+++..+ ++..      .-++.++.++.++|.++||+|+++||.+++.+.|.+.
T Consensus       102 ~~~Kl~faF~vYD~~~~G~I~reel~~iv~~~-~~~~~~~~~e~~~~i~d~t~~e~D~d~DG~IsfeEf~~~v~~~P~~~  180 (187)
T KOG0034|consen  102 KREKLRFAFRVYDLDGDGFISREELKQILRMM-VGENDDMSDEQLEDIVDKTFEEADTDGDGKISFEEFCKVVEKQPDLL  180 (187)
T ss_pred             HHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHH-HccCCcchHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHcCccHH
Confidence             3589999999999999999999999999985 3322      2234467789999999999999999999999987654


Q ss_pred             h
Q 040917          483 A  483 (494)
Q Consensus       483 ~  483 (494)
                      +
T Consensus       181 ~  181 (187)
T KOG0034|consen  181 E  181 (187)
T ss_pred             H
Confidence            3

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=1.4e-17  Score=151.88  Aligned_cols=137  Identities=26%  Similarity=0.374  Sum_probs=113.0

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCCh-----hhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD-----VEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      +.||+|++|.||+|.+  .|..|++|+.........     .....+.+|+.++..+. ++++.....++......+++|
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCEEEE
Confidence            5799999999999987  678899998654332221     12345778999999995 888877777776677788999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      ||++|++|.+.+.....    ....++.+++.++.++|+.|++|||++|.||+++    .+.++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence            99999999998865432    7889999999999999999999999999999994    67899999999864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.74  E-value=8.5e-19  Score=169.25  Aligned_cols=175  Identities=29%  Similarity=0.475  Sum_probs=133.9

Q ss_pred             CeEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCC
Q 040917          107 QFVHIVMELCAGGELFDRIVARG---HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL  183 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~~---~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~  183 (494)
                      .+.||.|++|+..+|.+++.++.   ..+......++.|+..|+.|   +|.+|+|+||.||+.   ..+..++|.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~---~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF---SDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccc---ccchhhhhhhhhh
Confidence            36889999999999999997543   36778889999999999999   999999999999999   5667899999999


Q ss_pred             ccccccCc-------ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccC
Q 040917          184 SAFIEEGK-------AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINF  254 (494)
Q Consensus       184 a~~~~~~~-------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~  254 (494)
                      ........       ......||++|++||.+.+ +|+.++||||||+|++++++ -..++...   .....+..+..  
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~g~i--  477 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRDGII--  477 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---HhhhhhhcCCC--
Confidence            87665444       3445789999999999985 69999999999999999987 22333111   11222223322  


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          255 QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       255 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      ++..+.+. +.-..|+.+|+.+.|.+||++.+.--|+|.
T Consensus       478 p~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  478 PPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             ChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            21222233 334579999999999999988777777665

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.74  E-value=3.6e-17  Score=147.64  Aligned_cols=133  Identities=23%  Similarity=0.335  Sum_probs=105.7

Q ss_pred             eecccCCeEEEEEEECCCCcEEEEEEeccCCCCCh-----hhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917           40 EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD-----VEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME  114 (494)
Q Consensus        40 ~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e  114 (494)
                      .||+|++|.||+|.+  ++..|++|+.........     .....+.+|+.++..+. ++++.....++......++|||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEEEEE
Confidence            489999999999984  578999998654332221     12356778999999996 7766554445555666789999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          115 LCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       115 ~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      |++|++|.+++.....       .++.+++.++.+||+.|++|||++|.||+++    .+.++++|||.+..
T Consensus        78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~  138 (199)
T TIGR03724        78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKY  138 (199)
T ss_pred             EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcC
Confidence            9999999988755321       7899999999999999999999999999993    67899999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.73  E-value=3.8e-17  Score=147.17  Aligned_cols=140  Identities=19%  Similarity=0.237  Sum_probs=107.6

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC-------------------hhhHHHHHHHHHHHHHccCCC
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK-------------------DVEKDDVRREIEIMRHLSGQP   94 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~-------------------~~~~~~~~~E~~~l~~l~~hp   94 (494)
                      .|.+.++||+|++|.||+|.+. +|+.||+|++.......                   .........|..++..+. ++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   93 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EE   93 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-Hc
Confidence            3888999999999999999875 79999999876432100                   011223677888999885 65


Q ss_pred             --CccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCC
Q 040917           95 --NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDE  172 (494)
Q Consensus        95 --~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~  172 (494)
                        .+..+++.    ...++||||++|++|.....      ......++.+++.++.++|+.|++||||+|+||++   +.
T Consensus        94 ~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~  160 (198)
T cd05144          94 GFPVPKPIDW----NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DD  160 (198)
T ss_pred             CCCCCceeec----CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cC
Confidence              34444432    34589999999998876432      13456788999999999999999999999999999   56


Q ss_pred             CCeEEEeecCCccccc
Q 040917          173 NAVVKATDFGLSAFIE  188 (494)
Q Consensus       173 ~~~~kL~Dfg~a~~~~  188 (494)
                      ++.++|+|||.+....
T Consensus       161 ~~~~~liDfg~~~~~~  176 (198)
T cd05144         161 DEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCcEEEEECCccccCC
Confidence            8899999999986443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=6.2e-19  Score=181.80  Aligned_cols=260  Identities=27%  Similarity=0.465  Sum_probs=208.7

Q ss_pred             ccceEeeeeecccCCeEEEEEEECC-CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENS-TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~-~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ...|.+.+.||+|+++.|-.+.... +...+|.|.+.... .......++..|..+-+.+.+|+|++.+++...+.+..+
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            3578889999999999999988643 34456666654332 233445666678888888866999999999999999999


Q ss_pred             EEEeccCCCchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCceEEeeCCCCC-eEEEeecCCccc
Q 040917          111 IVMELCAGGELFDRI-VARG-HYSERAAASVFRVIMNVVNVCH-SKGVMHRDLKPENFLFTTGDENA-VVKATDFGLSAF  186 (494)
Q Consensus       111 iv~e~~~g~sL~~~~-~~~~-~l~~~~~~~i~~~i~~~l~~LH-~~~i~H~dikp~NIli~~~~~~~-~~kL~Dfg~a~~  186 (494)
                      +++++..|+++.+.+ .... ..+...+...+.|+..++.|+| ..++.|+||+|+|.++   +..+ .+++.|||+|..
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l---~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL---DESGSALKIADFGLATA  174 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh---ccCCCcccCCCchhhcc
Confidence            999999999999888 5544 6778888999999999999999 9999999999999999   5566 999999999987


Q ss_pred             ccc-Cc---ccccccC-CcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHcCCccCCCCC
Q 040917          187 IEE-GK---AYREIVG-SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVA-QAILKGEINFQRDP  258 (494)
Q Consensus       187 ~~~-~~---~~~~~~~-~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~  258 (494)
                      ... ..   .....+| ++.|.|||...+  ...+..|+||.|+++.-+++|..|+......... .........+...+
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP  254 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence            654 22   2234678 999999999876  3577899999999999999999998655443221 12222223334567


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          259 FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       259 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      |..++....+++.+++..+|..|.+.+++-.+||+..
T Consensus       255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  255 WNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cccCChhhhhcccccccCCchhccccccccccccccc
Confidence            7889999999999999999999999999999999987

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.70  E-value=1.6e-16  Score=164.67  Aligned_cols=140  Identities=19%  Similarity=0.251  Sum_probs=111.1

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCC-----ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV-----KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ..|...+.||+|+||+||++.+.  +..+++|+.......     .......+.+|+.+++.++ |++++....+.....
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~  409 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEEeCC
Confidence            45567899999999999999865  344555543222111     1123456889999999995 999988777776666


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      ..++||||++|++|.+++.        ....++.+++.++.+||+.|++||||||+||++    .++.++|+|||++...
T Consensus       410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl----~~~~~~liDFGla~~~  477 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV----RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----ECCcEEEEeCcccccC
Confidence            7889999999999998875        346789999999999999999999999999999    2567999999998753

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=4.3e-16  Score=139.11  Aligned_cols=140  Identities=19%  Similarity=0.243  Sum_probs=99.3

Q ss_pred             eeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHH---------------------HHHHHHHHHHccCC-C
Q 040917           37 IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD---------------------VRREIEIMRHLSGQ-P   94 (494)
Q Consensus        37 i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~~h-p   94 (494)
                      +.+.||+|++|.||+|.+. +++.||+|++.............                     ...|...+.++..+ .
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999976 89999999987543221111111                     13566667776422 2


Q ss_pred             CccEEeEEEEeCCeEEEEEeccCCCchHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCC
Q 040917           95 NIVQFKAAYEDDQFVHIVMELCAGGELFD-RIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDE  172 (494)
Q Consensus        95 ~i~~~~~~~~~~~~~~iv~e~~~g~sL~~-~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~  172 (494)
                      .+.++++.    ...++||||++|+++.. .+.... . ...+..++.+++.++.++|. .||+|+||||+||++   + 
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili---~-  149 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV---D-  149 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE---E-
Confidence            24444443    23589999999854321 111111 1 16778899999999999999 999999999999999   4 


Q ss_pred             CCeEEEeecCCcccc
Q 040917          173 NAVVKATDFGLSAFI  187 (494)
Q Consensus       173 ~~~~kL~Dfg~a~~~  187 (494)
                      ++.++|+|||.+...
T Consensus       150 ~~~~~liDfg~a~~~  164 (187)
T cd05119         150 DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCcEEEEECcccccc
Confidence            788999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0037 consensus Ca2+-binding protein, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.68  E-value=7.3e-16  Score=131.97  Aligned_cols=132  Identities=25%  Similarity=0.340  Sum_probs=121.5

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhc-CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhc
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKL-GSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAF  417 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~-~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F  417 (494)
                      ..+..+|+..|.|+.|.|+.+||+.+|.+. ...++.+.++-|+..+|.+.+|.|+|+||..+|....      .++.+|
T Consensus        57 ~~~~~~f~~vD~d~sg~i~~~eLq~aLsn~~~~~Fs~~TcrlmI~mfd~~~~G~i~f~EF~~Lw~~i~------~Wr~vF  130 (221)
T KOG0037|consen   57 PQLAGWFQSVDRDRSGRILAKELQQALSNGTWSPFSIETCRLMISMFDRDNSGTIGFKEFKALWKYIN------QWRNVF  130 (221)
T ss_pred             HHHHHHHHhhCccccccccHHHHHHHhhcCCCCCCCHHHHHHHHHHhcCCCCCccCHHHHHHHHHHHH------HHHHHH
Confidence            456788999999999999999999999965 5777889999999999999999999999999998655      799999


Q ss_pred             cccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          418 QYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       418 ~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      +.||.|++|.|+..||+.+|..  +|..++++-.+-+++.+|.-++|.|.+++|+.++...
T Consensus       131 ~~~D~D~SG~I~~sEL~~Al~~--~Gy~Lspq~~~~lv~kyd~~~~g~i~FD~FI~ccv~L  189 (221)
T KOG0037|consen  131 RTYDRDRSGTIDSSELRQALTQ--LGYRLSPQFYNLLVRKYDRFGGGRIDFDDFIQCCVVL  189 (221)
T ss_pred             HhcccCCCCcccHHHHHHHHHH--cCcCCCHHHHHHHHHHhccccCCceeHHHHHHHHHHH
Confidence            9999999999999999999999  7889999999999999998779999999999987753

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.63  E-value=6e-15  Score=136.08  Aligned_cols=138  Identities=22%  Similarity=0.322  Sum_probs=103.2

Q ss_pred             eeec-ccCCeEEEEEEECCCCcEEEEEEeccCCC----------CChhhHHHHHHHHHHHHHccCCCCc--cEEeEEEEe
Q 040917           39 REVG-RGEFGITYLCTENSTGLEFACKSIPKRKL----------VKDVEKDDVRREIEIMRHLSGQPNI--VQFKAAYED  105 (494)
Q Consensus        39 ~~lg-~G~~g~Vy~a~~~~~~~~valK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~~hp~i--~~~~~~~~~  105 (494)
                      ..|| .||.|+||.+...  +..++||.+.....          ........+.+|+.++.+|. +++|  +.++++...
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~~  113 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARVV  113 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeeee
Confidence            4576 8899999998864  78899998853221          11123456788999999995 7775  566665432


Q ss_pred             C-C---eEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917          106 D-Q---FVHIVMELCAG-GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       106 ~-~---~~~iv~e~~~g-~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                      . .   ..++|||+++| .+|.+++.. ..++..    .+.+|+.++.+||++||+||||||.|||+   +.++.++|+|
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv---~~~~~v~LID  185 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILL---DPDGKFWLID  185 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEE---cCCCCEEEEE
Confidence            2 2   23599999997 688887754 345554    35789999999999999999999999999   4566899999


Q ss_pred             cCCcccc
Q 040917          181 FGLSAFI  187 (494)
Q Consensus       181 fg~a~~~  187 (494)
                      ||.+...
T Consensus       186 fg~~~~~  192 (239)
T PRK01723        186 FDRGELR  192 (239)
T ss_pred             CCCcccC
Confidence            9998753

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.62  E-value=6.4e-15  Score=126.47  Aligned_cols=133  Identities=21%  Similarity=0.313  Sum_probs=111.3

Q ss_pred             eeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCC-CCccEEeEEEEeCCeEEEEEec
Q 040917           37 IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ-PNIVQFKAAYEDDQFVHIVMEL  115 (494)
Q Consensus        37 i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-p~i~~~~~~~~~~~~~~iv~e~  115 (494)
                      +++.||+|.++.||++....  ..+++|.......     ...+.+|+..++.+..+ +++++++......+..++++||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            46789999999999999753  7899999854331     46788999999999733 6889998888877889999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          116 CAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK---GVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       116 ~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      ++|+.+..+       +......++.+++.++.++|..   +++|+|++|.||+++   +.+.++++|||.+..
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence            998777543       5567778899999999999985   699999999999994   578899999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.58  E-value=1.7e-15  Score=149.41  Aligned_cols=256  Identities=21%  Similarity=0.255  Sum_probs=198.7

Q ss_pred             ccccceEeeeeecc--cCCeEEEEEEE--CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917           30 DVQLHYTIGREVGR--GEFGITYLCTE--NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED  105 (494)
Q Consensus        30 ~~~~~y~i~~~lg~--G~~g~Vy~a~~--~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~  105 (494)
                      .+...+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+... ........=.+|.....++..|++.++.+..+..
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCccccc
Confidence            34467888899999  99999999888  8899999999854322 2222333345677777778789999998899999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCCceEEeeCCCC-CeEEEe
Q 040917          106 DQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMN----VVNVCHSKGVMHRDLKPENFLFTTGDEN-AVVKAT  179 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~~~-l~~~~~~~i~~~i~~----~l~~LH~~~i~H~dikp~NIli~~~~~~-~~~kL~  179 (494)
                      .+..++-+|+| |.+|..+...... ++...++..+.+...    ||.++|..+++|-|++|.||+.   ..+ ...+++
T Consensus       190 ~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~---~~~~~s~~~~  265 (524)
T KOG0601|consen  190 SGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFT---TSDWTSCKLT  265 (524)
T ss_pred             CCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheec---ccccceeecC
Confidence            99999999999 5688887765444 888899999999999    9999999999999999999999   455 789999


Q ss_pred             ecCCccccccCcccc------cccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHcCC
Q 040917          180 DFGLSAFIEEGKAYR------EIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQGVAQAILKGE  251 (494)
Q Consensus       180 Dfg~a~~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~--~~~~~~~~~~~~~  251 (494)
                      |||+...+..+....      ...+...|++||...+-++...|+|++|.++.+..++..+....  ......   .+  
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~---r~--  340 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL---RQ--  340 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc---cc--
Confidence            999998776554222      12567889999999999999999999999999888776554333  111110   01  


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          252 INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      ...+...+...+..+...+..|+..+|-.|+++..+++++++..
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            11222333455677778999999999999999999999999874

>KOG0036 consensus Predicted mitochondrial carrier protein [Nucleotide transport and metabolism]

Probab=99.57  E-value=3.7e-14  Score=132.00  Aligned_cols=139  Identities=26%  Similarity=0.420  Sum_probs=126.0

Q ss_pred             chhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCC-CCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHH
Q 040917          334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM-LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFEN  412 (494)
Q Consensus       334 ~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~  412 (494)
                      ..+...+++..|+.+|.+++|.++..++...+..+..+ +..+-...+|..+|.|.||.+||+||...+....     .+
T Consensus         9 ~~er~~r~~~lf~~lD~~~~g~~d~~~l~k~~~~l~~~~~~~~~~~~l~~~~d~~~dg~vDy~eF~~Y~~~~E-----~~   83 (463)
T KOG0036|consen    9 DEERDIRIRCLFKELDSKNDGQVDLDQLEKGLEKLDHPKPNYEAAKMLFSAMDANRDGRVDYSEFKRYLDNKE-----LE   83 (463)
T ss_pred             cHHHHHHHHHHHHHhccCCCCceeHHHHHHHHHhcCCCCCchHHHHHHHHhcccCcCCcccHHHHHHHHHHhH-----HH
Confidence            34555689999999999999999999999999999776 6677788999999999999999999998887543     47


Q ss_pred             HHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          413 LYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       413 ~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      +.++|+.+|.+.||.|+..|+.+.|+.  +|.++++++++.++.++|+++++.|+++||...+.-.|
T Consensus        84 l~~~F~~iD~~hdG~i~~~Ei~~~l~~--~gi~l~de~~~k~~e~~d~~g~~~I~~~e~rd~~ll~p  148 (463)
T KOG0036|consen   84 LYRIFQSIDLEHDGKIDPNEIWRYLKD--LGIQLSDEKAAKFFEHMDKDGKATIDLEEWRDHLLLYP  148 (463)
T ss_pred             HHHHHhhhccccCCccCHHHHHHHHHH--hCCccCHHHHHHHHHHhccCCCeeeccHHHHhhhhcCC
Confidence            899999999999999999999999999  67789999999999999999999999999999887665

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.51  E-value=4.3e-13  Score=118.12  Aligned_cols=143  Identities=13%  Similarity=0.133  Sum_probs=103.3

Q ss_pred             eeeecccCCeEEEEEEECC------CCcEEEEEEeccCCC--C-----------------ChhhHHHHH----HHHHHHH
Q 040917           38 GREVGRGEFGITYLCTENS------TGLEFACKSIPKRKL--V-----------------KDVEKDDVR----REIEIMR   88 (494)
Q Consensus        38 ~~~lg~G~~g~Vy~a~~~~------~~~~valK~~~~~~~--~-----------------~~~~~~~~~----~E~~~l~   88 (494)
                      ...||.|--+.||.|....      .+..+|+|+.+.+..  .                 .......+.    +|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4579999999999998653      357999998753211  0                 011233333    8999999


Q ss_pred             HccCC-CCccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCceE
Q 040917           89 HLSGQ-PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC-HSKGVMHRDLKPENFL  166 (494)
Q Consensus        89 ~l~~h-p~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~i~H~dikp~NIl  166 (494)
                      ++... -+++.++++    ...++||||+.+..+..-..+...++......+..+++.++..| |+.|++||||++.||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            98632 456667665    33569999997654432222233456667788899999999998 8999999999999999


Q ss_pred             EeeCCCCCeEEEeecCCccccc
Q 040917          167 FTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       167 i~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      +.    ++.+.|+|||.+....
T Consensus       158 ~~----~~~v~iIDF~qav~~~  175 (197)
T cd05146         158 WH----DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EE----CCcEEEEECCCceeCC
Confidence            94    4679999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG4223 consensus Reticulocalbin, calumenin, DNA supercoiling factor, and related Ca2+-binding proteins of the CREC family (EF-Hand protein superfamily) [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.46  E-value=1.4e-13  Score=125.06  Aligned_cols=135  Identities=26%  Similarity=0.400  Sum_probs=111.5

Q ss_pred             HHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCC-CCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhH-----H
Q 040917          337 EIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM-LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQR-----F  410 (494)
Q Consensus       337 ~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~-----~  410 (494)
                      .+.+..+.|+..|.|++|.++.+||..+|..--.+ +..--+.+.+..+|+|+||.|+++||+.-+........     .
T Consensus       161 m~~rDe~rFk~AD~d~dg~lt~EEF~aFLHPEe~p~M~~iVi~Etl~d~Dkn~DG~I~~eEfigd~~~~~~~~~epeWv~  240 (325)
T KOG4223|consen  161 MIARDEERFKAADQDGDGSLTLEEFTAFLHPEEHPHMKDIVIAETLEDIDKNGDGKISLEEFIGDLYSHEGNEEEPEWVL  240 (325)
T ss_pred             HHHHHHHHHhhcccCCCCcccHHHHHhccChhhcchHHHHHHHHHHhhcccCCCCceeHHHHHhHHhhccCCCCCccccc
Confidence            44566788999999999999999999999875433 23445788899999999999999999998887543211     1


Q ss_pred             HHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHH
Q 040917          411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRS  473 (494)
Q Consensus       411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~  473 (494)
                      .+-...|...|+|+||+++.+|++.|+..  .+....+.+++.++.+.|.|+||++|++|.+.
T Consensus       241 ~Ere~F~~~~DknkDG~L~~dEl~~WI~P--~~~d~A~~EA~hL~~eaD~dkD~kLs~eEIl~  301 (325)
T KOG4223|consen  241 TEREQFFEFRDKNKDGKLDGDELLDWILP--SEQDHAKAEARHLLHEADEDKDGKLSKEEILE  301 (325)
T ss_pred             ccHHHHHHHhhcCCCCccCHHHHhcccCC--CCccHHHHHHHHHhhhhccCccccccHHHHhh
Confidence            22235666789999999999999999988  66677889999999999999999999999876

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.46  E-value=7.8e-13  Score=111.45  Aligned_cols=147  Identities=18%  Similarity=0.216  Sum_probs=112.5

Q ss_pred             eeeeecccCCeEEEEEEECCCCcEEEEEEe-----ccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           37 IGREVGRGEFGITYLCTENSTGLEFACKSI-----PKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        37 i~~~lg~G~~g~Vy~a~~~~~~~~valK~~-----~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      ...++-+|+-+.|+++.+.  |+.++||.=     ...............+|++.+.++. --.|.-..-++.+...-.|
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYGGQI   87 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCCCeE
Confidence            6788999999999999864  888888852     2222333445677888999999886 4466555555555556679


Q ss_pred             EEeccCC-CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          112 VMELCAG-GELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       112 v~e~~~g-~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      +|||++| .++.+++...  ..........+++.|-..+.-||.++|+||||..+||++..++....+.++|||++..
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9999987 4777777543  2233444478899999999999999999999999999998777778889999999754

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.46  E-value=7.6e-13  Score=132.74  Aligned_cols=143  Identities=18%  Similarity=0.205  Sum_probs=97.5

Q ss_pred             eeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC---------------------------hh----h------HHHH
Q 040917           38 GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK---------------------------DV----E------KDDV   80 (494)
Q Consensus        38 ~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~---------------------------~~----~------~~~~   80 (494)
                      .++||+|++|.||+|..+ +|+.||||+.+......                           ..    .      .-++
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            367999999999999875 79999999986432100                           00    0      0124


Q ss_pred             HHHHHHHHHcc----CCCCccEEeEEEEeCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 040917           81 RREIEIMRHLS----GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMN-VVNVCHSKG  154 (494)
Q Consensus        81 ~~E~~~l~~l~----~hp~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~-~l~~LH~~~  154 (494)
                      .+|+..+.++.    ++|+|.-..-+.......++||||++|++|.+..... ....   ...++..++. .+..+|..|
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence            45666555553    3455432222222234568999999999998876432 1222   2345555555 467899999


Q ss_pred             ceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       155 i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      ++|+|+||.||++   ..++.++++|||++...
T Consensus       278 ~~H~D~hPgNilv---~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       278 FFHADLHPGNIFV---LKDGKIIALDFGIVGRL  307 (437)
T ss_pred             ceeCCCCcccEEE---CCCCcEEEEeCCCeeEC
Confidence            9999999999999   67789999999998654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.45  E-value=3.1e-14  Score=147.69  Aligned_cols=261  Identities=26%  Similarity=0.425  Sum_probs=198.7

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      -.+.+.+.+.+.+|+++.++.+.-..+|...+.|+.................+-.++-.. .+|.++...-.+......+
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCCCCCCcc
Confidence            346788888999999999999998888866666665432221111122222222222212 1455554433444556788


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc--
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE--  188 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~--  188 (494)
                      ++++|..|++|...+++-+..+...+...+..+..+.++||...+.|+|++|.|.+.   ...++.++.+|+......  
T Consensus       881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCccccccccccc
Confidence            999999999999999888878888888888889999999999999999999999999   688999999997432110  


Q ss_pred             -----c-----------------C--------cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCC
Q 040917          189 -----E-----------------G--------KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWA  237 (494)
Q Consensus       189 -----~-----------------~--------~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~  237 (494)
                           .                 .        .......+|+.|.+||...+ ......|+|+.|+++++.++|..||..
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                 0                 0        00112457899999998865 578899999999999999999999999


Q ss_pred             CChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH---HHhcCCccCcc
Q 040917          238 ETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVA---QVLEHPWLKES  296 (494)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~---eil~~~~~~~~  296 (494)
                      ...+.+.+.+.+.....+.-+ ...+....+++.+++..+|.+|..+.   ++-.|+||+..
T Consensus      1038 ~tpq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1038 ETPQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred             cchhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence            999999998888877666544 35678899999999999999999887   88999999863

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.45  E-value=4.9e-13  Score=135.56  Aligned_cols=158  Identities=21%  Similarity=0.260  Sum_probs=100.0

Q ss_pred             hhhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCC---------------------------Ch
Q 040917           22 AILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---------------------------KD   74 (494)
Q Consensus        22 ~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~---------------------------~~   74 (494)
                      ..+++..+++-..|.. ++||+|++|+||+|..+.+|+.||||+.++....                           ..
T Consensus       109 ~elG~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~  187 (537)
T PRK04750        109 KALGGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPR  187 (537)
T ss_pred             HHhCCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHH
Confidence            4455555556667877 8999999999999999888999999999754200                           00


Q ss_pred             ----hhHHH------HHHHHHHHHHcc---CCCCccEEeEEEE-eCCeEEEEEeccCCCchHHH--HHhcC----CCCHH
Q 040917           75 ----VEKDD------VRREIEIMRHLS---GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDR--IVARG----HYSER  134 (494)
Q Consensus        75 ----~~~~~------~~~E~~~l~~l~---~hp~i~~~~~~~~-~~~~~~iv~e~~~g~sL~~~--~~~~~----~l~~~  134 (494)
                          .....      +.+|+..+.++.   .+.+.+.+=.++. .....++||||++|+.+.+.  +...+    .+...
T Consensus       188 ~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~  267 (537)
T PRK04750        188 EVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAER  267 (537)
T ss_pred             HHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHH
Confidence                01112      334555555543   1222222223332 24456799999999999764  23322    12222


Q ss_pred             HHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC-CCCCeEEEeecCCcccc
Q 040917          135 AAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG-DENAVVKATDFGLSAFI  187 (494)
Q Consensus       135 ~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~-~~~~~~kL~Dfg~a~~~  187 (494)
                      .+..++.|       +...|++|+|+||.||+++.+ ...+.++++|||++...
T Consensus       268 ~v~~~~~Q-------if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        268 GVEVFFTQ-------VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             HHHHHHHH-------HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence            23333333       446899999999999999532 12349999999998654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.43  E-value=3.1e-14  Score=129.61  Aligned_cols=238  Identities=18%  Similarity=0.212  Sum_probs=154.0

Q ss_pred             EEEEEEECCCCcEEEEEEeccCCCCChhhH-HHHHHHHHHHHHccCCCCccEEeEEEEeC-----CeEEEEEeccCCCch
Q 040917           48 ITYLCTENSTGLEFACKSIPKRKLVKDVEK-DDVRREIEIMRHLSGQPNIVQFKAAYEDD-----QFVHIVMELCAGGEL  121 (494)
Q Consensus        48 ~Vy~a~~~~~~~~valK~~~~~~~~~~~~~-~~~~~E~~~l~~l~~hp~i~~~~~~~~~~-----~~~~iv~e~~~g~sL  121 (494)
                      .||++.++..|.+|+.-.+.-....+...+ +....-...+-++ .|.||++++.++.+.     ....+++||++.|+|
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~  159 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL  159 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence            456666666666666554421111111011 1111112233445 389999999888653     357889999999999


Q ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc---
Q 040917          122 FDRIVAR----GHYSERAAASVFRVIMNVVNVCHSK--GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA---  192 (494)
Q Consensus       122 ~~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~--~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~---  192 (494)
                      ..++++.    ..+......+|+.||+.||.|||+.  .|+|+++....|++   ..++-+|+..-........-..   
T Consensus       160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifi---q~ngLIkig~~ap~s~h~s~~~~~~  236 (458)
T KOG1266|consen  160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFI---QHNGLIKIGSVAPDSTHPSVNSTRE  236 (458)
T ss_pred             HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheee---cCCceEEecccCccccchhhhhhhH
Confidence            9988753    3478899999999999999999987  69999999999999   6778787754322211111000   


Q ss_pred             --cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917          193 --YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPP-FWAETDQGVAQAILKGEINFQRDPFPSISSSAIE  268 (494)
Q Consensus       193 --~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  268 (494)
                        .....+-++|.+||.=. -..+.++|||++|....+|..+..- -.+.+.-..-..+.+......       ...-+.
T Consensus       237 ~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~  309 (458)
T KOG1266|consen  237 AEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRG  309 (458)
T ss_pred             hhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-------CccccC
Confidence              01123567899998532 2456789999999999999877643 222222112122222111111       122356


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          269 LVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       269 li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      ++.+|+...|..||++.+++-||.+=+.
T Consensus       310 ~i~kcl~~eP~~rp~ar~llfHpllfeV  337 (458)
T KOG1266|consen  310 SITKCLEGEPNGRPDARLLLFHPLLFEV  337 (458)
T ss_pred             cCcccccCCCCCCcchhhhhcCceeeec
Confidence            8999999999999999999999988753

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.42  E-value=2.4e-12  Score=109.22  Aligned_cols=134  Identities=24%  Similarity=0.333  Sum_probs=99.3

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC-----hhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEE
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK-----DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVM  113 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~  113 (494)
                      ..+++|+-+.+|.+.+.  |.++++|.=.+..+-.     ........+|+.++.+++ .-.|....-+..+.....|+|
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCEEEE
Confidence            46889999999999763  5567887633222222     223455678999999886 445554444444555566999


Q ss_pred             eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          114 ELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       114 e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      ||++|-.|.+.+...       ...+++.+-..+.-||.+||+||||.++||++.    .+.+.++|||++..
T Consensus        79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGLg~~  140 (204)
T COG3642          79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGLGEF  140 (204)
T ss_pred             EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCcccc
Confidence            999998888887654       245677777888999999999999999999993    44499999999874

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.41  E-value=1.8e-12  Score=113.75  Aligned_cols=129  Identities=15%  Similarity=0.152  Sum_probs=96.2

Q ss_pred             eeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccC
Q 040917           38 GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCA  117 (494)
Q Consensus        38 ~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~  117 (494)
                      ++.|++|.++.||++...  +..|++|+......    ....+..|+.+++.+.+...+.+++....  ...++|||+++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            467899999999999865  78899999754321    12346789999999863333455555443  23479999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          118 GGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGV-----MHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       118 g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i-----~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      |.++...     ..   ....++.+++.++..||+.++     +|||++|.||+++    ++.++++||+.+..
T Consensus        75 G~~l~~~-----~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTE-----DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCccccc-----cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence            9888643     11   123456789999999999985     9999999999994    45799999999763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0038 consensus Ca2+-binding kinase interacting protein (KIP) (EF-Hand protein superfamily) [General function prediction only]

Probab=99.33  E-value=2.6e-11  Score=96.33  Aligned_cols=150  Identities=19%  Similarity=0.335  Sum_probs=110.2

Q ss_pred             hhccCchhHHHhhhhhhhccCCCC-----CC------cccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHH
Q 040917          329 IVENLPTEEIQKLKEKFTEMDTDN-----SG------TLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEF  397 (494)
Q Consensus       329 ~~~~~~~~~~~~~~~~F~~~D~~~-----~g------~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef  397 (494)
                      --+.|+..++-++...|..+.++-     .|      .++.+....+-. +..++-+.   ++.+.+..||.|.++|++|
T Consensus        18 DCTFFtrKdIlrl~~Rf~~L~P~lVP~~~~~~~~~~v~vp~e~i~kMPE-Lkenpfk~---ri~e~FSeDG~GnlsfddF   93 (189)
T KOG0038|consen   18 DCTFFTRKDILRLHKRFYELAPHLVPTDMTGNRPPIVKVPFELIEKMPE-LKENPFKR---RICEVFSEDGRGNLSFDDF   93 (189)
T ss_pred             ccccccHHHHHHHHHHHHHhCcccccccccCCCCCceeecHHHHhhChh-hhcChHHH---HHHHHhccCCCCcccHHHH
Confidence            345678888888888888776651     11      344444443322 23333333   4555566889999999999


Q ss_pred             HHHHHHhhh-hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHH----HHHHHHhCCCCCCceeHHHHH
Q 040917          398 ITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATI----KEIMSEVDRDKDGRISYDEFR  472 (494)
Q Consensus       398 ~~~~~~~~~-~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~----~~~~~~~d~~~dg~i~~~ef~  472 (494)
                      +.+++.... .++.-.+.-||++||.|+|++|...+|...+..+.. ..++++++    ++++.+.|.||||++++.||.
T Consensus        94 lDmfSV~sE~APrdlK~~YAFkIYDfd~D~~i~~~DL~~~l~~lTr-~eLs~eEv~~i~ekvieEAD~DgDgkl~~~eFe  172 (189)
T KOG0038|consen   94 LDMFSVFSEMAPRDLKAKYAFKIYDFDGDEFIGHDDLEKTLTSLTR-DELSDEEVELICEKVIEEADLDGDGKLSFAEFE  172 (189)
T ss_pred             HHHHHHHHhhChHHhhhhheeEEeecCCCCcccHHHHHHHHHHHhh-ccCCHHHHHHHHHHHHHHhcCCCCCcccHHHHH
Confidence            998765432 345556788999999999999999999999998643 34666664    567999999999999999999


Q ss_pred             HHHhcccccch
Q 040917          473 SMMKCGTQLRA  483 (494)
Q Consensus       473 ~~~~~~~~~~~  483 (494)
                      +.+.+.|.+-.
T Consensus       173 ~~i~raPDFls  183 (189)
T KOG0038|consen  173 HVILRAPDFLS  183 (189)
T ss_pred             HHHHhCcchHh
Confidence            99998887543

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.32  E-value=4.2e-11  Score=119.76  Aligned_cols=215  Identities=16%  Similarity=0.195  Sum_probs=148.5

Q ss_pred             EEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcCC
Q 040917           51 LCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH  130 (494)
Q Consensus        51 ~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~  130 (494)
                      .|..+.++.+|.+.+++.+.-   ...+...+-++-++.|+ ||+|+++++.+......|||+|.+  ..|..++++.+ 
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-
Confidence            456667899999999875542   34667788889999996 999999999999999999999998  46776776543 


Q ss_pred             CCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc-cccccCCcCccChhhh
Q 040917          131 YSERAAASVFRVIMNVVNVCH-SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-YREIVGSPYYIAPEVL  208 (494)
Q Consensus       131 l~~~~~~~i~~~i~~~l~~LH-~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~  208 (494)
                        .....--+.||+.||.+|| ..+++|++|..+.|+|   +..|..||++|..+........ .....-.-.|..|+.+
T Consensus       103 --~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~  177 (690)
T KOG1243|consen  103 --KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEI  177 (690)
T ss_pred             --HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhc
Confidence              6677778999999999998 5689999999999999   7899999999988754322111 0111111235555543


Q ss_pred             cccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHH--
Q 040917          209 SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQ--  286 (494)
Q Consensus       209 ~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e--  286 (494)
                      ... +-..|.|-|||++++++.|..+  ......      .         ...+|.....+..+.+.-.+..||....  
T Consensus       178 ~~s-~~s~D~~~Lg~li~el~ng~~~--~~~~~~------~---------~~~ipk~~~~~~~k~~~~~~~~r~n~~~~~  239 (690)
T KOG1243|consen  178 DPS-EWSIDSWGLGCLIEELFNGSLL--TKTDLS------N---------TGKIPKALIELYCKKLGATELKRPNKLRFI  239 (690)
T ss_pred             Ccc-ccchhhhhHHHHHHHHhCcccC--cchhhh------c---------cCccchhHHHHHHHHhccccccccchhhHH
Confidence            211 1235999999999999998332  111110      0         0134445555555555556666665332  


Q ss_pred             --H-hcCCccCc
Q 040917          287 --V-LEHPWLKE  295 (494)
Q Consensus       287 --i-l~~~~~~~  295 (494)
                        + +-|+||++
T Consensus       240 ~~~~~~~gff~n  251 (690)
T KOG1243|consen  240 LECRLLGGFFRN  251 (690)
T ss_pred             HHHHhccccccc
Confidence              2 33888875

>PLN02964 phosphatidylserine decarboxylase

Probab=99.29  E-value=1.5e-11  Score=125.57  Aligned_cols=105  Identities=19%  Similarity=0.261  Sum_probs=94.0

Q ss_pred             ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcC-CCCCHHH---HHHHHHHhcCCCCCcccchHHHHHHHHhhh
Q 040917          331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLG-SMLTEFD---VKQYMQAADIDGNGTIDYIEFITATMQRHK  406 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~-~~~~~~~---~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~  406 (494)
                      +.+..+|++++.+.|..+|.|++|.+    +..+++.+| ..+++++   +.++|+.+|.|++|.|+|+||+.++.....
T Consensus       135 t~f~~kqi~elkeaF~lfD~dgdG~i----Lg~ilrslG~~~pte~e~~fi~~mf~~~D~DgdG~IdfdEFl~lL~~lg~  210 (644)
T PLN02964        135 FDFVTQEPESACESFDLLDPSSSNKV----VGSIFVSCSIEDPVETERSFARRILAIVDYDEDGQLSFSEFSDLIKAFGN  210 (644)
T ss_pred             hhccHHHHHHHHHHHHHHCCCCCCcC----HHHHHHHhCCCCCCHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhcc
Confidence            44677888999999999999999997    999999999 5888776   799999999999999999999998886544


Q ss_pred             hhHHHHHHHhccccccCCCCceeHHHHHHHHhh
Q 040917          407 LQRFENLYKAFQYFDKDNNGYITVDELGKAFKD  439 (494)
Q Consensus       407 ~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~  439 (494)
                      ....+++.++|+.||.|++|+|+.+||.+++..
T Consensus       211 ~~seEEL~eaFk~fDkDgdG~Is~dEL~~vL~~  243 (644)
T PLN02964        211 LVAANKKEELFKAADLNGDGVVTIDELAALLAL  243 (644)
T ss_pred             CCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHh
Confidence            456778999999999999999999999999987

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.25  E-value=2.7e-09  Score=103.73  Aligned_cols=228  Identities=16%  Similarity=0.203  Sum_probs=160.4

Q ss_pred             cccccceEeeeeec--c-cCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE-
Q 040917           29 EDVQLHYTIGREVG--R-GEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE-  104 (494)
Q Consensus        29 ~~~~~~y~i~~~lg--~-G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~-  104 (494)
                      ....+.|.-.-.+.  . --..+.|+|....+|..|++|.++.........   .-.-+++++++. |+||+++.+++. 
T Consensus       269 p~lv~~~~~L~pl~~~~~~~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk---~t~lve~wkkl~-h~NvV~frevf~t  344 (655)
T KOG3741|consen  269 PSLVESFVNLYPLELLNDLFSITTYKATSNVDGNAYVLKRLHGDRDQSTNK---DTSLVEAWKKLC-HTNVVPFREVFLT  344 (655)
T ss_pred             CcchhhhhceeecccccccccceeEeeeeccCCceeeeeeeccccccCccc---chHHHHHHHHhc-cCceeehhhhhhh
Confidence            33344444444433  2 246789999999999999999995444333211   223467899996 999999999886 


Q ss_pred             ---eCCeEEEEEeccCC-CchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 040917          105 ---DDQFVHIVMELCAG-GELFDRIVAR---------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENF  165 (494)
Q Consensus       105 ---~~~~~~iv~e~~~g-~sL~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NI  165 (494)
                         .+..+++|++|+++ ++|.++-...               .+.++..+|.++.|+..||.++|+.|+.-+-|.|.+|
T Consensus       345 ~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kI  424 (655)
T KOG3741|consen  345 YTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKI  424 (655)
T ss_pred             hccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHe
Confidence               34578999999986 5787765322               2367899999999999999999999999999999999


Q ss_pred             EEeeCCCCCeEEEeecCCccccccCcccccccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCC-hHHH-
Q 040917          166 LFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAET-DQGV-  243 (494)
Q Consensus       166 li~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~-~~~~-  243 (494)
                      ++   ..+.+++|...|........+           .+|  +.  --.+-|.=.||.+++.|.||..--+-.. ..+. 
T Consensus       425 lv---~G~~RIriS~C~i~Dvl~~d~-----------~~~--le--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~  486 (655)
T KOG3741|consen  425 LV---TGKMRIRISGCGIMDVLQEDP-----------TEP--LE--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSH  486 (655)
T ss_pred             Ee---eCcceEEEecccceeeecCCC-----------Ccc--hh--HHhhhhHHHHHHHHHHHhhcccccccccchHHHH
Confidence            99   455588888877765443332           011  10  0135689999999999999965422111 1111 


Q ss_pred             HHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          244 AQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      ...+           ...++.+++++|..+...++.+ -++.+++.+
T Consensus       487 ~~~I-----------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  487 LTRI-----------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHh-----------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            1111           1357788999999999998876 788888764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.23  E-value=1.3e-11  Score=122.23  Aligned_cols=255  Identities=20%  Similarity=0.218  Sum_probs=184.4

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEEC-CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTEN-STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~-~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      .....++|..+..||.|.|+.|+.+..+ .++..+++|-+........ ....-..|+-+...+.-|.+++..+..|...
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~-~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~  338 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA-SDIFSLGEVILEAILGSHLPSVGKNSSWSQL  338 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH-hhhcchhhhhHhhHhhcccccCCCCCCcccc
Confidence            4445678999999999999999987755 6788899998765443332 2333445777777777788998888888777


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          107 QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      ...|+=-|||+++++...+.-...+.+...+.+..|++.++.++|+..++|+|++|+||++.+  ..+..++.|||....
T Consensus       339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~--~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISN--DGFFSKLGDFGCWTR  416 (524)
T ss_pred             ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeecc--chhhhhccccccccc
Confidence            777799999999988776655556888889999999999999999999999999999999953  128889999998753


Q ss_pred             cccCcccccccCCcCcc-Chhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917          187 IEEGKAYREIVGSPYYI-APEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       187 ~~~~~~~~~~~~~~~y~-aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      ..-.  .......-++. .+|++..  .+..+.|++|||..+.+..++...-+.....   ..+..+..    ...+...
T Consensus       417 ~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~~~~----p~~~~~~  487 (524)
T KOG0601|consen  417 LAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRSGDT----PNLPGLK  487 (524)
T ss_pred             ccee--cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeecccc----cCCCchH
Confidence            2111  01112233344 3565544  4677999999999999999886543222211   11111111    1123445


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917          264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLK  294 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  294 (494)
                      ..+..+.+.++..++..||++.++..|+-|-
T Consensus       488 ~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  488 LQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            7788889999999999999999998876554

>KOG4223 consensus Reticulocalbin, calumenin, DNA supercoiling factor, and related Ca2+-binding proteins of the CREC family (EF-Hand protein superfamily) [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.22  E-value=5e-11  Score=108.55  Aligned_cols=144  Identities=22%  Similarity=0.316  Sum_probs=115.6

Q ss_pred             hhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh--------h
Q 040917          335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH--------K  406 (494)
Q Consensus       335 ~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~--------~  406 (494)
                      .+...++...+..+|.+++|.|+..|++..+..........+..+-|..+|.|.||.|+|+|+...+....        .
T Consensus        73 ee~~~rl~~l~~~iD~~~Dgfv~~~El~~wi~~s~k~~v~~~~~~~~~~~d~~~Dg~i~~eey~~~~~~~~~~~~~~~d~  152 (325)
T KOG4223|consen   73 EESQERLGKLVPKIDSDSDGFVTESELKAWIMQSQKKYVVEEAARRWDEYDKNKDGFITWEEYLPQTYGRVDLPDEFPDE  152 (325)
T ss_pred             chhHHHHHHHHhhhcCCCCCceeHHHHHHHHHHHHHHHHHHHHHHHHHHhccCccceeeHHHhhhhhhhcccCccccccc
Confidence            44567888999999999999999999999988776555666778889999999999999999998877421        0


Q ss_pred             --hhH----HHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          407 --LQR----FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       407 --~~~----~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                        ...    ...-++-|+.-|.|+||.++.+||..+|..= -...+.+-.+.+.+.+.|.|+||+|+++||+.-|.+..
T Consensus       153 e~~~~~~km~~rDe~rFk~AD~d~dg~lt~EEF~aFLHPE-e~p~M~~iVi~Etl~d~Dkn~DG~I~~eEfigd~~~~~  230 (325)
T KOG4223|consen  153 EDNEEYKKMIARDEERFKAADQDGDGSLTLEEFTAFLHPE-EHPHMKDIVIAETLEDIDKNGDGKISLEEFIGDLYSHE  230 (325)
T ss_pred             hhcHHHHHHHHHHHHHHhhcccCCCCcccHHHHHhccChh-hcchHHHHHHHHHHhhcccCCCCceeHHHHHhHHhhcc
Confidence              011    1234668999999999999999999999751 12345555678899999999999999999999776543

>PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E

Probab=99.18  E-value=7e-11  Score=85.61  Aligned_cols=62  Identities=48%  Similarity=0.824  Sum_probs=53.0

Q ss_pred             HHHHhccccccCCCCceeHHHHHHHHhhcCCCCCC----cHHHHHHHHHHhCCCCCCceeHHHHHHHH
Q 040917          412 NLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDA----TIATIKEIMSEVDRDKDGRISYDEFRSMM  475 (494)
Q Consensus       412 ~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~----~~~~~~~~~~~~d~~~dg~i~~~ef~~~~  475 (494)
                      +++++|+.+|.|++|+|+.+||..++..  .+...    .++.++.++..+|.|+||.|+++||.++|
T Consensus         1 ~l~~~F~~~D~d~~G~i~~~el~~~~~~--~~~~~~~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~   66 (66)
T PF13499_consen    1 RLKEAFKKFDKDGDGYISKEELRRALKH--LGRDMSDEESDEMIDQIFREFDTDGDGRISFDEFLNFM   66 (66)
T ss_dssp             HHHHHHHHHSTTSSSEEEHHHHHHHHHH--TTSHSTHHHHHHHHHHHHHHHTTTSSSSEEHHHHHHHH
T ss_pred             CHHHHHHHHcCCccCCCCHHHHHHHHHH--hcccccHHHHHHHHHHHHHHhCCCCcCCCcHHHHhccC
Confidence            4788999999999999999999999999  44333    34456667999999999999999999875

...

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.15  E-value=4.1e-10  Score=103.33  Aligned_cols=143  Identities=29%  Similarity=0.433  Sum_probs=104.2

Q ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCC-CCccEEeEEEEeC---CeEEEEEe
Q 040917           39 REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ-PNIVQFKAAYEDD---QFVHIVME  114 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-p~i~~~~~~~~~~---~~~~iv~e  114 (494)
                      +.|+.|..+.||++.... |..+++|........  .....+.+|+.+++.+..+ .++.+++.+....   +..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            678999999999998653 689999997644321  1345688999999999632 3456677776553   25689999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 040917          115 LCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS------------------------------------------  152 (494)
Q Consensus       115 ~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~------------------------------------------  152 (494)
                      +++|.++...+.. ..++......++.+++.++..||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999888765432 346666667777777777777773                                          


Q ss_pred             --------------CCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          153 --------------KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       153 --------------~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                                    ..++|||++|.||+++.. ..+.+.++||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence                          236999999999999421 156789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.14  E-value=2.2e-09  Score=101.79  Aligned_cols=239  Identities=18%  Similarity=0.192  Sum_probs=159.9

Q ss_pred             eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEE-----E--EeCC
Q 040917           35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAA-----Y--EDDQ  107 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~-----~--~~~~  107 (494)
                      -..+..||+|+.+.+|..-.-   ...+.|+++.....   ...+   -+..|...-+||-+..-+.+     +  ....
T Consensus        13 i~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa---~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~   83 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPA---AQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGK   83 (637)
T ss_pred             cCCCccccCCccceeeecchh---hchhheeecCCCch---HHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence            346788999999999975432   23567888654421   1111   23334444456554331111     1  1223


Q ss_pred             eEEEEEeccCCCc-hHHHH---Hhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917          108 FVHIVMELCAGGE-LFDRI---VAR---GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       108 ~~~iv~e~~~g~s-L~~~~---~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                      ...+.|..++|.. ...+.   .++   .......+...++.++.+...||..|-+-||++++|+|+   .+++.+.|+|
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV---sd~~~V~LVd  160 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV---SDDSKVVLVD  160 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee---ecCceEEEEc
Confidence            4778888887752 22221   111   235678899999999999999999999999999999999   6788999998


Q ss_pred             cCCccccccCcccccccCCcCccChhhhc-cc-----CCCcchhHHHHHHHHHHHhC-CCCCCCCChH----HHHH-HHH
Q 040917          181 FGLSAFIEEGKAYREIVGSPYYIAPEVLS-QS-----YGKEADIWSAGVILYILLCG-VPPFWAETDQ----GVAQ-AIL  248 (494)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~-----~~~~~Di~slG~il~~l~tg-~~pf~~~~~~----~~~~-~~~  248 (494)
                      -+......++......+|.+.|.+||... +.     -+...|.|-||+++++++.| ++||.+....    ...+ .|.
T Consensus       161 sDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia  240 (637)
T COG4248         161 SDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA  240 (637)
T ss_pred             ccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence            77665555555566678899999999876 32     46789999999999998886 8999654321    0011 111


Q ss_pred             cCC-----------cc-CCCCCCCCCCHHHHHHHHHhccc--CCCCCCCHH
Q 040917          249 KGE-----------IN-FQRDPFPSISSSAIELVRRMLTQ--DPKRRITVA  285 (494)
Q Consensus       249 ~~~-----------~~-~~~~~~~~~~~~l~~li~~~l~~--dp~~Rps~~  285 (494)
                      .+.           .+ +...+|.-+++.+..++.+|+..  ++.-|||++
T Consensus       241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence            111           11 11224566899999999999974  567899874

>cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13

Probab=99.10  E-value=1.5e-10  Score=87.87  Aligned_cols=68  Identities=18%  Similarity=0.286  Sum_probs=60.1

Q ss_pred             HHHHHHhcccccc-CCCCceeHHHHHHHHhhcCCCCCCcH-HHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          410 FENLYKAFQYFDK-DNNGYITVDELGKAFKDYGMGDDATI-ATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       410 ~~~~~~~F~~~D~-d~~G~I~~~el~~~l~~~~~~~~~~~-~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ...+..+|+.||. +++|+|+.+||+.+|..- ++..++. +++++++..+|.|+||+|+|+||..+|.+.
T Consensus         7 i~~l~~~F~~fd~~~~~g~i~~~ELk~ll~~e-lg~~ls~~~~v~~mi~~~D~d~DG~I~F~EF~~l~~~l   76 (89)
T cd05022           7 IETLVSNFHKASVKGGKESLTASEFQELLTQQ-LPHLLKDVEGLEEKMKNLDVNQDSKLSFEEFWELIGEL   76 (89)
T ss_pred             HHHHHHHHHHHhCCCCCCeECHHHHHHHHHHH-hhhhccCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence            4578999999999 999999999999999871 3455677 899999999999999999999999988763

S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu

>KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms]

Probab=99.07  E-value=6.6e-10  Score=94.98  Aligned_cols=104  Identities=25%  Similarity=0.328  Sum_probs=91.0

Q ss_pred             HHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCC---CcHHHH
Q 040917          375 FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDD---ATIATI  451 (494)
Q Consensus       375 ~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~---~~~~~~  451 (494)
                      .++.++|+.+|.|++|.|+-.|+-..+.......+..++..++..+|.|++|.|+..||..++........   ...+++
T Consensus         8 ~el~~~F~~fD~d~~G~i~~~el~~~lr~lg~~~t~~el~~~~~~~D~dg~g~I~~~eF~~l~~~~~~~~~~~~~~~~el   87 (151)
T KOG0027|consen    8 LELKEAFQLFDKDGDGKISVEELGAVLRSLGQNPTEEELRDLIKEIDLDGDGTIDFEEFLDLMEKLGEEKTDEEASSEEL   87 (151)
T ss_pred             HHHHHHHHHHCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHhhhcccccccccHHHH
Confidence            46888999999999999999999998888777778889999999999999999999999999987432221   235689


Q ss_pred             HHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          452 KEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       452 ~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      .++|+.+|.|++|.|+.+|+.++|+..
T Consensus        88 ~eaF~~fD~d~~G~Is~~el~~~l~~l  114 (151)
T KOG0027|consen   88 KEAFRVFDKDGDGFISASELKKVLTSL  114 (151)
T ss_pred             HHHHHHHccCCCCcCcHHHHHHHHHHh
Confidence            999999999999999999999999863

>cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13

Probab=99.05  E-value=4.6e-10  Score=85.28  Aligned_cols=69  Identities=19%  Similarity=0.330  Sum_probs=63.0

Q ss_pred             hHHHhhhhhhhccCC-CCCCcccHHHHHHHHHh-cCCCCCH-HHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          336 EEIQKLKEKFTEMDT-DNSGTLTYDELKAGLAK-LGSMLTE-FDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       336 ~~~~~~~~~F~~~D~-~~~g~i~~~el~~~l~~-~~~~~~~-~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      ..+..+..+|+.||. +++|+|+..||+.++.. +|..++. +++..++..+|.|+||.|+|+||+..+...
T Consensus         5 ~ai~~l~~~F~~fd~~~~~g~i~~~ELk~ll~~elg~~ls~~~~v~~mi~~~D~d~DG~I~F~EF~~l~~~l   76 (89)
T cd05022           5 KAIETLVSNFHKASVKGGKESLTASEFQELLTQQLPHLLKDVEGLEEKMKNLDVNQDSKLSFEEFWELIGEL   76 (89)
T ss_pred             HHHHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHhhhhccCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence            345678899999999 99999999999999999 8887888 899999999999999999999999887754

S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.03  E-value=1.8e-09  Score=97.35  Aligned_cols=140  Identities=22%  Similarity=0.275  Sum_probs=104.6

Q ss_pred             eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCC-------------------CChhhHHHHHHHHHHHHHccCC-C
Q 040917           35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-------------------VKDVEKDDVRREIEIMRHLSGQ-P   94 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~-------------------~~~~~~~~~~~E~~~l~~l~~h-p   94 (494)
                      +.++..||.|.-|.||.|.+. .|.++|+|.-.....                   .-..+.....+|..+|.+|... -
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            567889999999999999976 699999997532110                   0122345677899999999633 2


Q ss_pred             CccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917           95 NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA  174 (494)
Q Consensus        95 ~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~  174 (494)
                      .|++.+++    +...+|||+++|..|...     +++.+....++..|++-+..+-..|++|||+++-||++   +++|
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV---~~dg  239 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV---TEDG  239 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE---ecCC
Confidence            45555543    345699999999766542     23466666777788888887779999999999999999   6788


Q ss_pred             eEEEeecCCcccc
Q 040917          175 VVKATDFGLSAFI  187 (494)
Q Consensus       175 ~~kL~Dfg~a~~~  187 (494)
                      .+.++||-.+...
T Consensus       240 ~~~vIDwPQ~v~~  252 (304)
T COG0478         240 DIVVIDWPQAVPI  252 (304)
T ss_pred             CEEEEeCcccccC
Confidence            9999999887643

>PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E

Probab=99.03  E-value=5.6e-10  Score=80.84  Aligned_cols=62  Identities=32%  Similarity=0.634  Sum_probs=52.7

Q ss_pred             hhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHH----HHHHHHHhcCCCCCcccchHHHHHH
Q 040917          340 KLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD----VKQYMQAADIDGNGTIDYIEFITAT  401 (494)
Q Consensus       340 ~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~----~~~~~~~~D~~~~g~i~~~ef~~~~  401 (494)
                      +++++|+.+|+|++|+|+.+||..++..++...+...    +..+|+.+|.|+||.|+|+||+..+
T Consensus         1 ~l~~~F~~~D~d~~G~i~~~el~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~   66 (66)
T PF13499_consen    1 RLKEAFKKFDKDGDGYISKEELRRALKHLGRDMSDEESDEMIDQIFREFDTDGDGRISFDEFLNFM   66 (66)
T ss_dssp             HHHHHHHHHSTTSSSEEEHHHHHHHHHHTTSHSTHHHHHHHHHHHHHHHTTTSSSSEEHHHHHHHH
T ss_pred             CHHHHHHHHcCCccCCCCHHHHHHHHHHhcccccHHHHHHHHHHHHHHhCCCCcCCCcHHHHhccC
Confidence            4788999999999999999999999999987665544    4556999999999999999998754

...

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.02  E-value=1.3e-08  Score=95.00  Aligned_cols=137  Identities=18%  Similarity=0.129  Sum_probs=95.0

Q ss_pred             eEEEEEEECCCCcEEEEEEeccCCCC---C-----hhhHHHHHHHHHHHHHccCCCCc--cEEeEEEEe-----CCeEEE
Q 040917           47 GITYLCTENSTGLEFACKSIPKRKLV---K-----DVEKDDVRREIEIMRHLSGQPNI--VQFKAAYED-----DQFVHI  111 (494)
Q Consensus        47 g~Vy~a~~~~~~~~valK~~~~~~~~---~-----~~~~~~~~~E~~~l~~l~~hp~i--~~~~~~~~~-----~~~~~i  111 (494)
                      ..|.++..  .|+.|.||........   .     ......+.+|...+.+|. .-+|  +.++.+...     ....++
T Consensus        36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~L  112 (268)
T PRK15123         36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFI  112 (268)
T ss_pred             ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEE
Confidence            34556653  4778999976432210   0     011224778998888885 3233  233444432     235779


Q ss_pred             EEeccCCC-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC----CCCCeEEEeecCCc
Q 040917          112 VMELCAGG-ELFDRIVA--RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG----DENAVVKATDFGLS  184 (494)
Q Consensus       112 v~e~~~g~-sL~~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~----~~~~~~kL~Dfg~a  184 (494)
                      |||+++|. +|.+++..  ....+......++.++...+..||.+||+|+|++++|||++.+    ++...+.|+||+.+
T Consensus       113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~  192 (268)
T PRK15123        113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA  192 (268)
T ss_pred             EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence            99999885 78888754  2345667788999999999999999999999999999999631    34578999999987


Q ss_pred             cc
Q 040917          185 AF  186 (494)
Q Consensus       185 ~~  186 (494)
                      ..
T Consensus       193 ~~  194 (268)
T PRK15123        193 QI  194 (268)
T ss_pred             cc
Confidence            53

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.01  E-value=3.5e-09  Score=93.12  Aligned_cols=130  Identities=20%  Similarity=0.231  Sum_probs=81.8

Q ss_pred             EEEEEEECCCCcEEEEEEeccCCC-----------------------CChhhHHHHHHHHHHHHHccCC-CCccEEeEEE
Q 040917           48 ITYLCTENSTGLEFACKSIPKRKL-----------------------VKDVEKDDVRREIEIMRHLSGQ-PNIVQFKAAY  103 (494)
Q Consensus        48 ~Vy~a~~~~~~~~valK~~~~~~~-----------------------~~~~~~~~~~~E~~~l~~l~~h-p~i~~~~~~~  103 (494)
                      .||.|.. ..|..+|+|+......                       ..........+|.+.|.++... -++++++++.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            3888886 4578999998753211                       0112235567899999999633 2466666553


Q ss_pred             EeCCeEEEEEeccC--CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917          104 EDDQFVHIVMELCA--GGELFDRIVARGHYSERAAASVFRVIMNVVNV-CHSKGVMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       104 ~~~~~~~iv~e~~~--g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                        .+  +|||||++  |..+.. +... .++......++.+++..+.. +|..||+||||++.||+++   . +.+.++|
T Consensus        80 --~~--~ivME~I~~~G~~~~~-l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~---~-~~~~iID  149 (188)
T PF01163_consen   80 --RN--VIVMEYIGEDGVPLPR-LKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD---D-GKVYIID  149 (188)
T ss_dssp             --TT--EEEEE--EETTEEGGC-HHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE---T-TCEEE--
T ss_pred             --CC--EEEEEecCCCccchhh-HHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee---c-ceEEEEe
Confidence              33  49999998  655544 3332 12245566777888885555 6799999999999999994   3 3899999


Q ss_pred             cCCccccc
Q 040917          181 FGLSAFIE  188 (494)
Q Consensus       181 fg~a~~~~  188 (494)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99987543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0037 consensus Ca2+-binding protein, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.00  E-value=5e-09  Score=90.38  Aligned_cols=96  Identities=29%  Similarity=0.406  Sum_probs=84.4

Q ss_pred             hhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHH
Q 040917          335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLY  414 (494)
Q Consensus       335 ~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~  414 (494)
                      ..-++.|+.+|+.+|+|++|.|+..||..+|..+|..++.+-...++..+|..++|.|+|++|+.++....      .+-
T Consensus       120 w~~i~~Wr~vF~~~D~D~SG~I~~sEL~~Al~~~Gy~Lspq~~~~lv~kyd~~~~g~i~FD~FI~ccv~L~------~lt  193 (221)
T KOG0037|consen  120 WKYINQWRNVFRTYDRDRSGTIDSSELRQALTQLGYRLSPQFYNLLVRKYDRFGGGRIDFDDFIQCCVVLQ------RLT  193 (221)
T ss_pred             HHHHHHHHHHHHhcccCCCCcccHHHHHHHHHHcCcCCCHHHHHHHHHHhccccCCceeHHHHHHHHHHHH------HHH
Confidence            45678899999999999999999999999999999999999999999999988899999999999988655      578


Q ss_pred             HhccccccCCCCcee--HHHHHHH
Q 040917          415 KAFQYFDKDNNGYIT--VDELGKA  436 (494)
Q Consensus       415 ~~F~~~D~d~~G~I~--~~el~~~  436 (494)
                      ++|+.+|.+.+|.|+  .++|..+
T Consensus       194 ~~Fr~~D~~q~G~i~~~y~dfl~~  217 (221)
T KOG0037|consen  194 EAFRRRDTAQQGSITISYDDFLQM  217 (221)
T ss_pred             HHHHHhccccceeEEEeHHHHHHH
Confidence            899999999999875  4444443

>cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B

Probab=99.00  E-value=1.1e-09  Score=83.31  Aligned_cols=68  Identities=16%  Similarity=0.412  Sum_probs=59.6

Q ss_pred             HHHHHHhccccc-cCCCC-ceeHHHHHHHHhh----cCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          410 FENLYKAFQYFD-KDNNG-YITVDELGKAFKD----YGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       410 ~~~~~~~F~~~D-~d~~G-~I~~~el~~~l~~----~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ...+.++|+.|| .|++| +|+.+||+.+|+.    + +|...+++++++++..+|.|+||+|+|+||..++...
T Consensus         7 ~~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~-lg~~~~~~~v~~~i~~~D~n~dG~v~f~eF~~li~~~   80 (88)
T cd05027           7 MVALIDVFHQYSGREGDKHKLKKSELKELINNELSHF-LEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAMV   80 (88)
T ss_pred             HHHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHH-hcCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence            457899999998 79999 6999999999997    2 3456788999999999999999999999999887653

S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.00  E-value=2.2e-10  Score=115.09  Aligned_cols=150  Identities=19%  Similarity=0.297  Sum_probs=109.7

Q ss_pred             HHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc-----cc-----ccCCcCccChhhhcc-
Q 040917          143 IMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY-----RE-----IVGSPYYIAPEVLSQ-  210 (494)
Q Consensus       143 i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~-----~~-----~~~~~~y~aPE~~~~-  210 (494)
                      +..|+.++|.. ++||++|.|.+|.+   +..+..||+.|+++....++..+     ..     ......|.|||.+.+ 
T Consensus       108 v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  108 VADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             ccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            33899999976 89999999999999   68899999999988755432111     11     123567999998875 


Q ss_pred             cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccC-CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 040917          211 SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINF-QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL  288 (494)
Q Consensus       211 ~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil  288 (494)
                      ..+.++|++|+||++|.+.. |+..+........... ....... ....-..+|+++++-+.+++..++..||++..++
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-SRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhh-hhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence            46889999999999999994 5555544433222211 1111111 1111257899999999999999999999999999


Q ss_pred             cCCccCcc
Q 040917          289 EHPWLKES  296 (494)
Q Consensus       289 ~~~~~~~~  296 (494)
                      ..|||.+.
T Consensus       264 ~~~ff~D~  271 (700)
T KOG2137|consen  264 SIPFFSDP  271 (700)
T ss_pred             cccccCCc
Confidence            99999864

>PTZ00183 centrin; Provisional

Probab=98.98  E-value=3.5e-09  Score=91.54  Aligned_cols=102  Identities=25%  Similarity=0.332  Sum_probs=85.5

Q ss_pred             HHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHH
Q 040917          375 FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI  454 (494)
Q Consensus       375 ~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~  454 (494)
                      +++..+|..+|.+++|.|+++||...+...........+..+|..+|.+++|.|+..||..++... ......++.++.+
T Consensus        17 ~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~g~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~-~~~~~~~~~l~~~   95 (158)
T PTZ00183         17 KEIREAFDLFDTDGSGTIDPKELKVAMRSLGFEPKKEEIKQMIADVDKDGSGKIDFEEFLDIMTKK-LGERDPREEILKA   95 (158)
T ss_pred             HHHHHHHHHhCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHH-hcCCCcHHHHHHH
Confidence            346778999999999999999998887654332345678999999999999999999999988752 2344567789999


Q ss_pred             HHHhCCCCCCceeHHHHHHHHhc
Q 040917          455 MSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       455 ~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      |..+|.+++|.|+.+||..++..
T Consensus        96 F~~~D~~~~G~i~~~e~~~~l~~  118 (158)
T PTZ00183         96 FRLFDDDKTGKISLKNLKRVAKE  118 (158)
T ss_pred             HHHhCCCCCCcCcHHHHHHHHHH
Confidence            99999999999999999998874

>KOG0044 consensus Ca2+ sensor (EF-Hand superfamily) [Signal transduction mechanisms]

Probab=98.98  E-value=1.4e-09  Score=94.30  Aligned_cols=105  Identities=22%  Similarity=0.284  Sum_probs=87.8

Q ss_pred             hhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh---------
Q 040917          335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH---------  405 (494)
Q Consensus       335 ~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~---------  405 (494)
                      .....-...+|..+|.|++|+|+..||..+|..+-..-.++.+.+.|+.+|.|++|.|+++|++.++....         
T Consensus        60 gd~~~y~~~vF~~fD~~~dg~i~F~Efi~als~~~rGt~eekl~w~F~lyD~dgdG~It~~Eml~iv~~i~~m~~~~~~~  139 (193)
T KOG0044|consen   60 GDASKYAELVFRTFDKNKDGTIDFLEFICALSLTSRGTLEEKLKWAFRLYDLDGDGYITKEEMLKIVQAIYQMTGSKALP  139 (193)
T ss_pred             CCHHHHHHHHHHHhcccCCCCcCHHHHHHHHHHHcCCcHHHHhhhhheeecCCCCceEcHHHHHHHHHHHHHHcccccCC
Confidence            34445677889999999999999999999998876656667788999999999999999999988765421         


Q ss_pred             --hhhHHHHHHHhccccccCCCCceeHHHHHHHHhh
Q 040917          406 --KLQRFENLYKAFQYFDKDNNGYITVDELGKAFKD  439 (494)
Q Consensus       406 --~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~  439 (494)
                        ....++.+..+|+.+|.|+||.||.+||.....+
T Consensus       140 ~~~~~~~~~v~~if~k~D~n~Dg~lT~eef~~~~~~  175 (193)
T KOG0044|consen  140 EDEETPEERVDKIFSKMDKNKDGKLTLEEFIEGCKA  175 (193)
T ss_pred             cccccHHHHHHHHHHHcCCCCCCcccHHHHHHHhhh
Confidence              1224567888999999999999999999988765

>cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6

Probab=98.97  E-value=1.9e-09  Score=82.08  Aligned_cols=69  Identities=19%  Similarity=0.407  Sum_probs=60.9

Q ss_pred             HHHHHHhcccccc-CC-CCceeHHHHHHHHhh-cCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          410 FENLYKAFQYFDK-DN-NGYITVDELGKAFKD-YGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       410 ~~~~~~~F~~~D~-d~-~G~I~~~el~~~l~~-~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ...+-.+|..||. |+ +|+|+.+||+++|+. +.+|.+.++++++++++.+|.|++|+|+|+||+.++.+-
T Consensus         9 ~~~~i~~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~k~t~~ev~~m~~~~D~d~dG~Idf~EFv~lm~~l   80 (88)
T cd05029           9 IGLLVAIFHKYSGREGDKNTLSKKELKELIQKELTIGSKLQDAEIAKLMEDLDRNKDQEVNFQEYVTFLGAL   80 (88)
T ss_pred             HHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHH
Confidence            3568889999998 77 899999999999974 236788999999999999999999999999999988753

S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact

>cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B

Probab=98.95  E-value=2.6e-09  Score=81.34  Aligned_cols=68  Identities=24%  Similarity=0.357  Sum_probs=62.0

Q ss_pred             HHHhhhhhhhccC-CCCCC-cccHHHHHHHHHh-----cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          337 EIQKLKEKFTEMD-TDNSG-TLTYDELKAGLAK-----LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       337 ~~~~~~~~F~~~D-~~~~g-~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      -+..+..+|+.+| .+++| +|+..||+.+++.     +|...+.+++.++++.+|.|++|.|+|+||+..+...
T Consensus         6 ~~~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~lg~~~~~~~v~~~i~~~D~n~dG~v~f~eF~~li~~~   80 (88)
T cd05027           6 AMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAMV   80 (88)
T ss_pred             HHHHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHHhcCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence            4567899999998 79999 6999999999999     8988899999999999999999999999999887654

S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i

>COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]

Probab=98.94  E-value=6.5e-09  Score=87.00  Aligned_cols=106  Identities=25%  Similarity=0.267  Sum_probs=90.9

Q ss_pred             CCCCHHH---HHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCC
Q 040917          370 SMLTEFD---VKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDA  446 (494)
Q Consensus       370 ~~~~~~~---~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~  446 (494)
                      ..++.++   +.+.|..+|.|++|.|++.++..++.......+...+..+|..+|. +.|.|+..+|..++... .....
T Consensus        12 ~~~t~~qi~~lkeaF~l~D~d~~G~I~~~el~~ilr~lg~~~s~~ei~~l~~~~d~-~~~~idf~~Fl~~ms~~-~~~~~   89 (160)
T COG5126          12 TQLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFEEIDA-GNETVDFPEFLTVMSVK-LKRGD   89 (160)
T ss_pred             ccCCHHHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHcCCCCcHHHHHHHHHhccC-CCCccCHHHHHHHHHHH-hccCC
Confidence            3445544   5667888899999999999999998866666678889999999999 99999999999999874 33455


Q ss_pred             cHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          447 TIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       447 ~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +++++.+.|+.+|.|+||+|+..|++..++.
T Consensus        90 ~~Eel~~aF~~fD~d~dG~Is~~eL~~vl~~  120 (160)
T COG5126          90 KEEELREAFKLFDKDHDGYISIGELRRVLKS  120 (160)
T ss_pred             cHHHHHHHHHHhCCCCCceecHHHHHHHHHh
Confidence            7889999999999999999999999999884

>cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z

Probab=98.94  E-value=2.3e-09  Score=82.97  Aligned_cols=68  Identities=18%  Similarity=0.456  Sum_probs=57.7

Q ss_pred             HHHHHHhccccc-cCCCC-ceeHHHHHHHHhhc-C--CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          410 FENLYKAFQYFD-KDNNG-YITVDELGKAFKDY-G--MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       410 ~~~~~~~F~~~D-~d~~G-~I~~~el~~~l~~~-~--~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...+.++|..|| .|++| +|+.+||+.++... +  ++...++.++++++.++|.|+||.|+|+||..+|..
T Consensus         9 ~~~~~~~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD~n~dG~Idf~EF~~l~~~   81 (93)
T cd05026           9 MDTLIRIFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLDSNKDNEVDFNEFVVLVAA   81 (93)
T ss_pred             HHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            457888999998 78998 59999999999762 1  233457789999999999999999999999998875

S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac

>PTZ00184 calmodulin; Provisional

Probab=98.93  E-value=7.1e-09  Score=88.56  Aligned_cols=101  Identities=30%  Similarity=0.319  Sum_probs=84.2

Q ss_pred             HHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHH
Q 040917          376 DVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIM  455 (494)
Q Consensus       376 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~  455 (494)
                      .+...|..+|.+++|.|+++||...+.........+.+..+|..+|.+++|.|+.++|..++... ......+..+..+|
T Consensus        12 ~~~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~l~~~-~~~~~~~~~~~~~F   90 (149)
T PTZ00184         12 EFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTLMARK-MKDTDSEEEIKEAF   90 (149)
T ss_pred             HHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHhcCcCCCCcCcHHHHHHHHHHh-ccCCcHHHHHHHHH
Confidence            46778999999999999999998877654333345678999999999999999999999998752 22234556788999


Q ss_pred             HHhCCCCCCceeHHHHHHHHhc
Q 040917          456 SEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       456 ~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ..+|.+++|.|+.+||..++..
T Consensus        91 ~~~D~~~~g~i~~~e~~~~l~~  112 (149)
T PTZ00184         91 KVFDRDGNGFISAAELRHVMTN  112 (149)
T ss_pred             HhhCCCCCCeEeHHHHHHHHHH
Confidence            9999999999999999998875

>cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1

Probab=98.90  E-value=3.7e-09  Score=81.97  Aligned_cols=69  Identities=22%  Similarity=0.506  Sum_probs=59.3

Q ss_pred             HHHHHHHhccccc-cCCCCc-eeHHHHHHHHhh-cC--CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFD-KDNNGY-ITVDELGKAFKD-YG--MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D-~d~~G~-I~~~el~~~l~~-~~--~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ..+.++++|+.|| .|++|+ |+.+||+.+|+. +|  ++...+++++++++..+|.|++|.|+|+||..++..
T Consensus         7 ~~~~l~~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D~d~~G~I~f~eF~~l~~~   80 (92)
T cd05025           7 AMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELDENGDGEVDFQEFVVLVAA   80 (92)
T ss_pred             HHHHHHHHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence            3467999999997 999995 999999999975 33  233468889999999999999999999999998875

S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins.

>KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning]

Probab=98.87  E-value=1.2e-08  Score=83.22  Aligned_cols=102  Identities=25%  Similarity=0.331  Sum_probs=87.7

Q ss_pred             HHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHH
Q 040917          375 FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI  454 (494)
Q Consensus       375 ~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~  454 (494)
                      .++...|..+|.+++|.|+++|+-..+....-..+.+++..+..-+|++++|+|+.++|.+.+... ++..-+.+++..+
T Consensus        33 q~i~e~f~lfd~~~~g~iD~~EL~vAmralGFE~~k~ei~kll~d~dk~~~g~i~fe~f~~~mt~k-~~e~dt~eEi~~a  111 (172)
T KOG0028|consen   33 QEIKEAFELFDPDMAGKIDVEELKVAMRALGFEPKKEEILKLLADVDKEGSGKITFEDFRRVMTVK-LGERDTKEEIKKA  111 (172)
T ss_pred             hhHHHHHHhhccCCCCcccHHHHHHHHHHcCCCcchHHHHHHHHhhhhccCceechHHHHHHHHHH-HhccCcHHHHHHH
Confidence            458889999999999999999996666554444566788999999999999999999999998753 4444589999999


Q ss_pred             HHHhCCCCCCceeHHHHHHHHhc
Q 040917          455 MSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       455 ~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      |+.+|.|++|+|+..+|..++..
T Consensus       112 frl~D~D~~Gkis~~~lkrvake  134 (172)
T KOG0028|consen  112 FRLFDDDKTGKISQRNLKRVAKE  134 (172)
T ss_pred             HHcccccCCCCcCHHHHHHHHHH
Confidence            99999999999999999998886

>cd05031 S-100A10_like S-100A10_like: S-100A10 domain found in proteins similar to S100A10

Probab=98.87  E-value=3.5e-09  Score=82.38  Aligned_cols=70  Identities=21%  Similarity=0.494  Sum_probs=60.3

Q ss_pred             HHHHHHhcccccc-CC-CCceeHHHHHHHHhh-cC--CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          410 FENLYKAFQYFDK-DN-NGYITVDELGKAFKD-YG--MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       410 ~~~~~~~F~~~D~-d~-~G~I~~~el~~~l~~-~~--~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      ...++.+|..||. |+ +|+|+.+||+.+|.. +|  +|...++++++.++..+|.|++|.|+|+||+.++....
T Consensus         7 ~~~l~~~F~~~D~~dg~dG~Is~~El~~~l~~~~g~~lg~~~s~~ei~~~~~~~D~~~dg~I~f~eF~~l~~~~~   81 (94)
T cd05031           7 MESLILTFHRYAGKDGDKNTLSRKELKKLMEKELSEFLKNQKDPMAVDKIMKDLDQNRDGKVNFEEFVSLVAGLS   81 (94)
T ss_pred             HHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHhHHHhhccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHH
Confidence            4578999999997 97 699999999999985 22  35577889999999999999999999999999887543

S100A10 is a member of the S100 family of EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1_like group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. A unique feature of S100A10 is that it contains mutation in both of the calcium binding sites, making it calcium insensitive. S100A10 has been detected in brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus. Structural data supports the homo- and hetero-dimeric as well as hetero-tetrameric nature of the protein. S100A10 has multiple binding partners in its calcium free state and is therefore involved in many diverse biological functions.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.86  E-value=5.2e-08  Score=87.97  Aligned_cols=111  Identities=19%  Similarity=0.264  Sum_probs=85.6

Q ss_pred             hHHHHHHHHHHHHHccCCCC--ccEEeEEEEeC----CeEEEEEeccCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 040917           76 EKDDVRREIEIMRHLSGQPN--IVQFKAAYEDD----QFVHIVMELCAGG-ELFDRIVARGHYSERAAASVFRVIMNVVN  148 (494)
Q Consensus        76 ~~~~~~~E~~~l~~l~~hp~--i~~~~~~~~~~----~~~~iv~e~~~g~-sL~~~~~~~~~l~~~~~~~i~~~i~~~l~  148 (494)
                      ......+|...+..|. .-+  +++++.+....    ...++|+|+++|. +|.+++.....++......++.++...+.
T Consensus        54 ~~~ra~~E~~~~~~L~-~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   54 RRSRAKREWRNLQRLR-EAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIA  132 (206)
T ss_pred             cchHHHHHHHHHHHHH-HcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHH
Confidence            3456778888888775 323  34455555432    2457999999884 78888877555778888999999999999


Q ss_pred             HHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       149 ~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      -||.+||+|+|++|.|||++.++....+.|+||+-+...
T Consensus       133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999999999999999975444568999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>smart00027 EH Eps15 homology domain

Probab=98.85  E-value=1.2e-08  Score=79.72  Aligned_cols=70  Identities=30%  Similarity=0.383  Sum_probs=63.9

Q ss_pred             CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      ++.+++..+...|..+|.+++|.|+.+|+..+++..+  ++.+++.+++..+|.+++|.|+|+||+.++...
T Consensus         4 ls~~~~~~l~~~F~~~D~d~~G~Is~~el~~~l~~~~--~~~~ev~~i~~~~d~~~~g~I~~~eF~~~~~~~   73 (96)
T smart00027        4 ISPEDKAKYEQIFRSLDKNQDGTVTGAQAKPILLKSG--LPQTLLAKIWNLADIDNDGELDKDEFALAMHLI   73 (96)
T ss_pred             CCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHcC--CCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHHH
Confidence            4678899999999999999999999999999999975  678889999999999999999999999877653

Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences.

>PF13833 EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A 1WLZ_A 1ALV_A 1NX3_A 1ALW_A 1NX2_A 1NX1_A 1NX0_A 1DF0_A

Probab=98.82  E-value=1.5e-08  Score=69.86  Aligned_cols=52  Identities=37%  Similarity=0.606  Sum_probs=47.7

Q ss_pred             CCCceeHHHHHHHHhhcCCCCC-CcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          424 NNGYITVDELGKAFKDYGMGDD-ATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       424 ~~G~I~~~el~~~l~~~~~~~~-~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ++|.|+.++|+.+|..  +|.. +++++++.++..+|.|++|.|+|+||..+++.
T Consensus         1 ~~G~i~~~~~~~~l~~--~g~~~~s~~e~~~l~~~~D~~~~G~I~~~EF~~~~~~   53 (54)
T PF13833_consen    1 KDGKITREEFRRALSK--LGIKDLSEEEVDRLFREFDTDGDGYISFDEFISMMQR   53 (54)
T ss_dssp             SSSEEEHHHHHHHHHH--TTSSSSCHHHHHHHHHHHTTSSSSSEEHHHHHHHHHH
T ss_pred             CcCEECHHHHHHHHHH--hCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Confidence            4799999999999987  5666 99999999999999999999999999998874

...

>KOG0377 consensus Protein serine/threonine phosphatase RDGC/PPEF, contains STphosphatase and EF-hand domains [Signal transduction mechanisms]

Probab=98.81  E-value=4.6e-08  Score=92.29  Aligned_cols=136  Identities=24%  Similarity=0.368  Sum_probs=104.3

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhc-CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh----h------
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKL-GSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK----L------  407 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~-~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~----~------  407 (494)
                      ..+.+.|+.+|.+.+|+|+..+...++..+ |.++.=--+..-.  ...+.||.|.|.+.+..+.....    .      
T Consensus       464 sdL~~eF~~~D~~ksG~lsis~Wa~~mE~i~~L~LPWr~L~~kl--a~~s~d~~v~Y~~~~~~l~~e~~~~ea~~slvet  541 (631)
T KOG0377|consen  464 SDLEDEFRKYDPKKSGKLSISHWAKCMENITGLNLPWRLLRPKL--ANGSDDGKVEYKSTLDNLDTEVILEEAGSSLVET  541 (631)
T ss_pred             hHHHHHHHhcChhhcCeeeHHHHHHHHHHHhcCCCcHHHhhhhc--cCCCcCcceehHhHHHHhhhhhHHHHHHhHHHHH
Confidence            457889999999999999999999999885 5555532222212  23456788999887765432111    0      


Q ss_pred             --hHHHHHHHhccccccCCCCceeHHHHHHHHhhcC--CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          408 --QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYG--MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       408 --~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~--~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                        -....+..+|+++|.|++|.|+.+||+.+..-++  +....+.+++.++-+.+|.|+||.|++.||++.+.
T Consensus       542 LYr~ks~LetiF~~iD~D~SG~isldEF~~a~~l~~sh~~~~i~~~~i~~la~~mD~NkDG~IDlNEfLeAFr  614 (631)
T KOG0377|consen  542 LYRNKSSLETIFNIIDADNSGEISLDEFRTAWKLLSSHMNGAISDDEILELARSMDLNKDGKIDLNEFLEAFR  614 (631)
T ss_pred             HHhchhhHHHHHHHhccCCCCceeHHHHHHHHHHHHhhcCCCcCHHHHHHHHHhhccCCCCcccHHHHHHHHh
Confidence              1234578899999999999999999999887532  33567888999999999999999999999999876

>PLN02964 phosphatidylserine decarboxylase

Probab=98.81  E-value=1.5e-08  Score=103.98  Aligned_cols=127  Identities=13%  Similarity=0.152  Sum_probs=91.9

Q ss_pred             hhhccCCCCCCcccHHHHHHHHHhcCCCC---CHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHH---HHHHHhc
Q 040917          344 KFTEMDTDNSGTLTYDELKAGLAKLGSML---TEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRF---ENLYKAF  417 (494)
Q Consensus       344 ~F~~~D~~~~g~i~~~el~~~l~~~~~~~---~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~---~~~~~~F  417 (494)
                      .|+.+|+++   ++.+++......-...+   ..+++.+.|..+|.|++|.+ ....+..+..  ...++   ..+..+|
T Consensus       112 ~~~~~~~~~---~s~n~lv~~~e~~~t~f~~kqi~elkeaF~lfD~dgdG~i-Lg~ilrslG~--~~pte~e~~fi~~mf  185 (644)
T PLN02964        112 RISVFETNR---LSKNTLVGYCELDLFDFVTQEPESACESFDLLDPSSSNKV-VGSIFVSCSI--EDPVETERSFARRIL  185 (644)
T ss_pred             EEEEEecCC---CCHHHhhhheeecHhhccHHHHHHHHHHHHHHCCCCCCcC-HHHHHHHhCC--CCCCHHHHHHHHHHH
Confidence            566677554   44555554433311112   22457888999999999997 3333222221  11222   2389999


Q ss_pred             cccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          418 QYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       418 ~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      +.+|.|++|.|+.+||..++..  ++...+++++.++|..+|.|++|.|+++||..+++..
T Consensus       186 ~~~D~DgdG~IdfdEFl~lL~~--lg~~~seEEL~eaFk~fDkDgdG~Is~dEL~~vL~~~  244 (644)
T PLN02964        186 AIVDYDEDGQLSFSEFSDLIKA--FGNLVAANKKEELFKAADLNGDGVVTIDELAALLALQ  244 (644)
T ss_pred             HHhCCCCCCeEcHHHHHHHHHH--hccCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHhc
Confidence            9999999999999999999998  5566788999999999999999999999999998874

>PRK09902 hypothetical protein; Provisional

Probab=98.80  E-value=2.3e-07  Score=82.09  Aligned_cols=140  Identities=16%  Similarity=0.155  Sum_probs=100.4

Q ss_pred             cccCCeEEEEEEECCCCcEEEEEEeccCCCCC---hhhHHHHHHHHHHHHHcc--CCCCccEEeEEEE---e--CCeEEE
Q 040917           42 GRGEFGITYLCTENSTGLEFACKSIPKRKLVK---DVEKDDVRREIEIMRHLS--GQPNIVQFKAAYE---D--DQFVHI  111 (494)
Q Consensus        42 g~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~---~~~~~~~~~E~~~l~~l~--~hp~i~~~~~~~~---~--~~~~~i  111 (494)
                      |.||-|-|+.....  |+.+-+|.-......+   +.....+.+|...+.+|.  +-| +.++. ++.   .  .-..+|
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP-VP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI-VPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC-CCccc-eeeeeccCCceEEEE
Confidence            46899999987643  4468888764221111   335788999999999886  223 44444 222   1  224679


Q ss_pred             EEeccCC-CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          112 VMELCAG-GELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       112 v~e~~~g-~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      |+|-+.| .+|.+++...  .+++......++.++..++.-||+.|+.|+|+.+.||+++.++ ...+.++||.-+..
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccch
Confidence            9997754 5887777553  3457777889999999999999999999999999999995322 34599999987653

>cd05031 S-100A10_like S-100A10_like: S-100A10 domain found in proteins similar to S100A10

Probab=98.80  E-value=2.1e-08  Score=77.99  Aligned_cols=68  Identities=24%  Similarity=0.365  Sum_probs=60.1

Q ss_pred             HHhhhhhhhccCC-CC-CCcccHHHHHHHHHh-----cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh
Q 040917          338 IQKLKEKFTEMDT-DN-SGTLTYDELKAGLAK-----LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH  405 (494)
Q Consensus       338 ~~~~~~~F~~~D~-~~-~g~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~  405 (494)
                      ...+..+|..+|. |+ +|+|+..||..+++.     +|..++.+++..+++.+|.+++|.|+|+||+.++....
T Consensus         7 ~~~l~~~F~~~D~~dg~dG~Is~~El~~~l~~~~g~~lg~~~s~~ei~~~~~~~D~~~dg~I~f~eF~~l~~~~~   81 (94)
T cd05031           7 MESLILTFHRYAGKDGDKNTLSRKELKKLMEKELSEFLKNQKDPMAVDKIMKDLDQNRDGKVNFEEFVSLVAGLS   81 (94)
T ss_pred             HHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHhHHHhhccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHH
Confidence            4568899999997 97 799999999999986     46678889999999999999999999999998877543

S100A10 is a member of the S100 family of EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1_like group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. A unique feature of S100A10 is that it contains mutation in both of the calcium binding sites, making it calcium insensitive. S100A10 has been detected in brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus. Structural data supports the homo- and hetero-dimeric as well as hetero-tetrameric nature of the protein. S100A10 has multiple binding partners in its calcium free state and is therefore involved in many diverse biological functions.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.79  E-value=9.7e-08  Score=84.70  Aligned_cols=141  Identities=19%  Similarity=0.180  Sum_probs=92.4

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhH------HHHHHHHHHHHHcc--CCCCccEEeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK------DDVRREIEIMRHLS--GQPNIVQFKAA  102 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~------~~~~~E~~~l~~l~--~hp~i~~~~~~  102 (494)
                      +.++|++.+.+.......|.+..  ..|+.+++|......--.....      +...+++..+.+++  +.-....++-+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            34789999999998888888877  4588999999864331111111      11234444444443  12222222222


Q ss_pred             E-----EeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEE
Q 040917          103 Y-----EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVK  177 (494)
Q Consensus       103 ~-----~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~k  177 (494)
                      .     ......+++|||++|..|.+...    +++    .+...+..++.-||+.|+.|||.+|.|+++.    ++.++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~~~i~  174 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----NNGIR  174 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----CCcEE
Confidence            1     22345668999999988866431    222    2445677788999999999999999999993    44599


Q ss_pred             EeecCCcc
Q 040917          178 ATDFGLSA  185 (494)
Q Consensus       178 L~Dfg~a~  185 (494)
                      ++|++...
T Consensus       175 iID~~~k~  182 (229)
T PF06176_consen  175 IIDTQGKR  182 (229)
T ss_pred             EEECcccc
Confidence            99997754

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z

Probab=98.79  E-value=1.9e-08  Score=77.85  Aligned_cols=69  Identities=22%  Similarity=0.317  Sum_probs=58.4

Q ss_pred             HHHhhhhhhhccC-CCCCC-cccHHHHHHHHHh-c----CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh
Q 040917          337 EIQKLKEKFTEMD-TDNSG-TLTYDELKAGLAK-L----GSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH  405 (494)
Q Consensus       337 ~~~~~~~~F~~~D-~~~~g-~i~~~el~~~l~~-~----~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~  405 (494)
                      -+..+.++|+.|| .|++| +|+.+||+.++.. +    ....+..++.++++.+|.|+||.|+|+||+..+....
T Consensus         8 a~~~~~~~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD~n~dG~Idf~EF~~l~~~l~   83 (93)
T cd05026           8 AMDTLIRIFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLDSNKDNEVDFNEFVVLVAALT   83 (93)
T ss_pred             HHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Confidence            4567888899999 78998 5999999999977 2    3344778899999999999999999999999877543

S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac

>cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6

Probab=98.79  E-value=2.2e-08  Score=76.22  Aligned_cols=69  Identities=23%  Similarity=0.368  Sum_probs=61.0

Q ss_pred             hHHHhhhhhhhccCC-CC-CCcccHHHHHHHHHh---cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          336 EEIQKLKEKFTEMDT-DN-SGTLTYDELKAGLAK---LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       336 ~~~~~~~~~F~~~D~-~~-~g~i~~~el~~~l~~---~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      +.+..+-..|..+|. ++ +|+|+.+||..++..   +|..++.+++.++++.+|.|++|.|+|+||+..+...
T Consensus         7 ~~~~~~i~~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~k~t~~ev~~m~~~~D~d~dG~Idf~EFv~lm~~l   80 (88)
T cd05029           7 QAIGLLVAIFHKYSGREGDKNTLSKKELKELIQKELTIGSKLQDAEIAKLMEDLDRNKDQEVNFQEYVTFLGAL   80 (88)
T ss_pred             HHHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHH
Confidence            455677889999998 67 899999999999973   6888999999999999999999999999999877653

S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact

>cd05023 S-100A11 S-100A11: S-100A11 domain found in proteins similar to S100A11

Probab=98.77  E-value=2.2e-08  Score=76.35  Aligned_cols=69  Identities=19%  Similarity=0.333  Sum_probs=57.9

Q ss_pred             HHHHHHHhccc-cccCCCC-ceeHHHHHHHHhhcC---CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQY-FDKDNNG-YITVDELGKAFKDYG---MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~-~D~d~~G-~I~~~el~~~l~~~~---~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ....+..+|+. +|.|++| +|+.+||+.++....   ++....+.++++++..+|.|+||+|+|+||..+|..
T Consensus         7 ~i~~l~~~F~~y~~~dg~~~~Ls~~Elk~ll~~e~~~~~~~~~~~~~~~~ll~~~D~d~DG~I~f~EF~~l~~~   80 (89)
T cd05023           7 CIESLIAVFQKYAGKDGDSYQLSKTEFLSFMNTELASFTKNQKDPGVLDRMMKKLDLNSDGQLDFQEFLNLIGG   80 (89)
T ss_pred             HHHHHHHHHHHHhccCCCcCeECHHHHHHHHHHhhhHhhcCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHHH
Confidence            34578899998 7788876 999999999998731   134556789999999999999999999999998775

S100A11 is a member of the S-100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A11 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100 proteins have also been associated with a variety of pathological events, including neoplastic transformation and neurodegenerative diseases such as Alzheimer's, usually via over expression of the protein. S100A11 is expressed in smooth muscle and other tissues and involves in calcium-dependent membrane aggregation, which is important for cell vesiculation . As is the case for many other S100 proteins, S

>cd00052 EH Eps15 homology domain; found in proteins implicated in endocytosis, vesicle transport, and signal transduction

Probab=98.76  E-value=1.9e-08  Score=72.99  Aligned_cols=60  Identities=28%  Similarity=0.444  Sum_probs=54.3

Q ss_pred             HHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          414 YKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       414 ~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +++|..+|.|++|.|+.+|+..++...  |  .+++++++++..+|.+++|.|+++||+.++..
T Consensus         2 ~~~F~~~D~~~~G~i~~~el~~~l~~~--g--~~~~~~~~i~~~~d~~~~g~i~~~ef~~~~~~   61 (67)
T cd00052           2 DQIFRSLDPDGDGLISGDEARPFLGKS--G--LPRSVLAQIWDLADTDKDGKLDKEEFAIAMHL   61 (67)
T ss_pred             hHHHHHhCCCCCCcCcHHHHHHHHHHc--C--CCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHH
Confidence            568999999999999999999999984  3  37888999999999999999999999998864

The alignment contains a pair of EF-hand motifs, typically one of them is canonical and binds to Ca2+, while the other may not bind to Ca2+. A hydrophobic binding pocket is formed by residues from both EF-hand motifs. The EH domain binds to proteins containing NPF (class I), [WF]W or SWG (class II), or H[TS]F (class III) sequence motifs.

>cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1

Probab=98.75  E-value=3.8e-08  Score=76.25  Aligned_cols=69  Identities=23%  Similarity=0.361  Sum_probs=59.5

Q ss_pred             HHHhhhhhhhccC-CCCCC-cccHHHHHHHHHh-cC----CCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh
Q 040917          337 EIQKLKEKFTEMD-TDNSG-TLTYDELKAGLAK-LG----SMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH  405 (494)
Q Consensus       337 ~~~~~~~~F~~~D-~~~~g-~i~~~el~~~l~~-~~----~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~  405 (494)
                      -...+.++|+.+| .+++| +|+..||..+++. +|    ..++.+++.++++.+|.|++|.|+|+||+..+....
T Consensus         7 ~~~~l~~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D~d~~G~I~f~eF~~l~~~~~   82 (92)
T cd05025           7 AMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELDENGDGEVDFQEFVVLVAALT   82 (92)
T ss_pred             HHHHHHHHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHH
Confidence            3467899999997 99999 4999999999986 43    456888999999999999999999999998877544

S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins.

>smart00027 EH Eps15 homology domain

Probab=98.74  E-value=3.6e-08  Score=77.07  Aligned_cols=65  Identities=23%  Similarity=0.328  Sum_probs=58.2

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ....+..+|..+|.|++|.|+.+|++.++...+    .+++++++++..+|.+++|.|+++||+.++..
T Consensus         8 ~~~~l~~~F~~~D~d~~G~Is~~el~~~l~~~~----~~~~ev~~i~~~~d~~~~g~I~~~eF~~~~~~   72 (96)
T smart00027        8 DKAKYEQIFRSLDKNQDGTVTGAQAKPILLKSG----LPQTLLAKIWNLADIDNDGELDKDEFALAMHL   72 (96)
T ss_pred             HHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHcC----CCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHH
Confidence            345789999999999999999999999999843    57889999999999999999999999987764

Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences.

>cd00213 S-100 S-100: S-100 domain, which represents the largest family within the superfamily of proteins carrying the Ca-binding EF-hand motif

Probab=98.74  E-value=2.7e-08  Score=76.45  Aligned_cols=70  Identities=24%  Similarity=0.404  Sum_probs=61.8

Q ss_pred             hhHHHhhhhhhhccCC--CCCCcccHHHHHHHHHh-cCCCC----CHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          335 TEEIQKLKEKFTEMDT--DNSGTLTYDELKAGLAK-LGSML----TEFDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       335 ~~~~~~~~~~F~~~D~--~~~g~i~~~el~~~l~~-~~~~~----~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      .++++.++..|..+|+  +++|+|+..+|..+++. +|..+    +.+++..++..+|.+++|.|+|++|+..+...
T Consensus         4 ~~~~~~l~~~F~~~D~~~~~~G~Is~~el~~~l~~~~g~~~~~~~~~~ei~~i~~~~d~~~~g~I~f~eF~~~~~~~   80 (88)
T cd00213           4 EKAIETIIDVFHKYSGKEGDKDTLSKKELKELLETELPNFLKNQKDPEAVDKIMKDLDVNKDGKVDFQEFLVLIGKL   80 (88)
T ss_pred             HHHHHHHHHHHHHHhhccCCCCcCcHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHHH
Confidence            5678889999999999  89999999999999986 55443    58899999999999999999999999987754

Note that this S-100 hierarchy contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. Intracellularly, S100 proteins act as Ca-signaling or Ca-buffering proteins. The most unusual characteristic of certain S100 proteins is their occurrence in extracellular space, where they act in a cytokine-like manner through RAGE, the receptor for advanced glycation products. Structural data suggest that many S100 members exist within cells as homo- or heterodimers and even oligomers; oligomerization contributes to their functional diversification. Upon binding calcium, most S100 proteins change conformation to a more open structure exposing a hydrophobic cleft. This hydrophobic surface represents th

>KOG2562 consensus Protein phosphatase 2 regulatory subunit [RNA processing and modification]

Probab=98.73  E-value=7.1e-08  Score=92.12  Aligned_cols=145  Identities=20%  Similarity=0.300  Sum_probs=113.5

Q ss_pred             hhccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHh----cCCCCCcccchHHHHHHHHh
Q 040917          329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAA----DIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       329 ~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~----D~~~~g~i~~~ef~~~~~~~  404 (494)
                      ..+.|+-+.-..++-.|-.+|+|+||.|+.++|...-...+   +.--++++|...    =.-.+|+++|++|+-.+...
T Consensus       268 ~~~~FS~e~f~viy~kFweLD~Dhd~lidk~~L~ry~d~tl---t~~ivdRIFs~v~r~~~~~~eGrmdykdFv~FilA~  344 (493)
T KOG2562|consen  268 VTRYFSYEHFYVIYCKFWELDTDHDGLIDKEDLKRYGDHTL---TERIVDRIFSQVPRGFTVKVEGRMDYKDFVDFILAE  344 (493)
T ss_pred             hhhheeHHHHHHHHHHHhhhccccccccCHHHHHHHhccch---hhHHHHHHHhhccccceeeecCcccHHHHHHHHHHh
Confidence            34556677777788889999999999999999988766543   455578999933    34579999999999888776


Q ss_pred             hhhhHHHHHHHhccccccCCCCceeHHHHHHHHhh-------cCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          405 HKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKD-------YGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       405 ~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~-------~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      ....+..-+.-+|+.+|.+++|.|+..|++-+...       ++...-.-++.+.+++..+-+-..++|+.++|.+.=+
T Consensus       345 e~k~t~~SleYwFrclDld~~G~Lt~~el~~fyeeq~~rm~~~~~e~l~fed~l~qi~DMvkP~~~~kItLqDlk~skl  423 (493)
T KOG2562|consen  345 EDKDTPASLEYWFRCLDLDGDGILTLNELRYFYEEQLQRMECMGQEALPFEDALCQIRDMVKPEDENKITLQDLKGSKL  423 (493)
T ss_pred             ccCCCccchhhheeeeeccCCCcccHHHHHHHHHHHHHHHHhcCCCcccHHHHHHHHHHHhCccCCCceeHHHHhhccc
Confidence            66556677899999999999999999999887764       3333333355567888888888889999999988433

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	494
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-81
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-81
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-81
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-80
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-79
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-77
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-77
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-72
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-63
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-63
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-56
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-56
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-55
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-55
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-55
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-55
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-55
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-54
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-54
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-54
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-54
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-54
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-53
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-53
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-53
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-53
3soa_A	444	Full-Length Human Camkii Length = 444		3e-53
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-53
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-53
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-52
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-52
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-52
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-52
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-52
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-51
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-51
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-51
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-51
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-51
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-51
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-51
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-51
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-51
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-51
2jam_B	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-51
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-51
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-50
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-50
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-50
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-49
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-49
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-49
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		8e-49
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-49
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-48
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-48
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-46
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-46
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-46
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-46
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-45
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-45
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-45
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-45
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-45
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-45
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-45
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-45
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-44
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-44
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-44
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-44
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-43
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-43
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-43
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-43
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-43
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-43
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-43
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-43
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-43
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-43
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-43
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-42
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-42
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-42
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-42
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-41
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-41
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		7e-41
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-41
2aao_A	166	Regulatory Apparatus Of Calcium Dependent Protein K		1e-40
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-40
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-39
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-39
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-39
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-39
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-39
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-38
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-38
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-38
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-38
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-38
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-38
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-38
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-38
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-38
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-38
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-37
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-37
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-37
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-37
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-37
1s6i_A	188	Ca2+-Regulatory Region (Cld) From Soybean Calcium-D		2e-37
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-37
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-37
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-37
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-37
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-37
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-36
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-36
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-36
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-36
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-36
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-36
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-36
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-36
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-36
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-36
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-36
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-36
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-36
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-36
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-36
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-36
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-36
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-36
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-36
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-36
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-36
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-36
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-36
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-36
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-36
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-36
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-36
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-36
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		8e-36
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-36
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-36
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-35
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-35
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-35
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-35
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-35
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-35
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-34
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-34
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-34
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-33
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-33
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-33
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-33
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-33
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-33
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-32
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-32
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-31
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-31
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-31
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-31
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-31
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-31
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-31
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-31
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-31
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-30
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-30
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-30
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-30
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-30
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-30
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-30
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-30
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-30
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-30
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-30
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-30
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-30
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-30
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-30
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-30
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-30
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-30
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-30
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-30
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-30
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-30
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-30
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-30
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-30
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-30
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-30
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-30
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-30
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-30
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-30
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-30
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-30
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-30
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-30
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-30
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-30
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-30
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-30
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-30
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-30
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-30
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-30
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-30
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-30
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-30
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-30
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-30
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-30
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-30
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-30
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-30
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-30
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-30
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-30
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-30
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-30
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		9e-30
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		9e-30
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-29
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-29
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-29
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-29
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-29
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-29
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-29
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-29
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-29
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-29
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-29
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-29
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-29
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-29
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-29
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-29
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-29
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-29
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-29
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-29
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-29
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-29
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-29
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-29
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-29
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-29
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-29
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-29
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-29
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-28
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-28
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-28
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-28
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-27
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-27
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-27
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-27
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-27
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-27
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-27
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-27
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-27
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-27
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		8e-27
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-27
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-26
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-26
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-26
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-26
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-26
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-26
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-26
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-26
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-26
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-26
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-26
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-26
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-26
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		9e-26
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		9e-26
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-26
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-25
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-25
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-25
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-25
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-25
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-25
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-25
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-25
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-25
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-25
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-25
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-25
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-25
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-25
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-25
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-25
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-25
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-25
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-25
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-25
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-25
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-25
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-25
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-25
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-25
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-25
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-25
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-25
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-25
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-25
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-25
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-25
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-25
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-25
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-25
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-25
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-25
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-25
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-24
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-24
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-24
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-24
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-24
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-24
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-24
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-24
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-23
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-23
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-23
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-22
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-22
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-22
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-22
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-22
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-22
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-22
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-22
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-22
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-22
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-22
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-22
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-22
3pm8_A	197	Cad Domain Of Pff0520w, Calcium Dependent Protein K		4e-22
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-22
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-22
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-22
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-22
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-22
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-22
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-21
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-21
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-21
3o4y_A	196	Crystal Structure Of Cad Domain Of The Plasmodium V		3e-21
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-21
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-21
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-21
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-21
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-21
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-21
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-21
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-21
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-21
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-21
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-21
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-21
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-20
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-20
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-20
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-20
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-20
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-20
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-20
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-20
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-20
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-20
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-20
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-20
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-20
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-20
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-20
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-20
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-20
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-20
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-20
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-20
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-20
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-20
3o77_A	415	The Structure Of Ca2+ Sensor (Case-16) Length = 415		6e-20
3l19_A	214	Crystal Structure Of Calcium Binding Domain Of Cpcd		6e-20
3o78_A	415	The Structure Of Ca2+ Sensor (Case-12) Length = 415		6e-20
3sg6_A	450	Crystal Structure Of Dimeric Gcamp2-Lia(Linker 1) L		6e-20
3ek8_A	449	Calcium-Saturated Gcamp2 T116vG87R MUTANT MONOMER L		6e-20
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-20
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-20
3evu_A	449	Crystal Structure Of Calcium Bound Dimeric Gcamp2,		7e-20
3sg2_A	449	Crystal Structure Of Gcamp2-T116v,D381y Length = 44		7e-20
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-20
3evr_A	411	Crystal Structure Of Calcium Bound Monomeric Gcamp2		8e-20
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-20
3k21_A	191	Crystal Structure Of Carboxy-Terminus Of Pfc0420w L		1e-19
2f2o_A	179	Structure Of Calmodulin Bound To A Calcineurin Pept		1e-19
2wel_D	150	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-19
4djc_A	152	1.35 A Crystal Structure Of The Nav1.5 Diii-Iv-CaCA		2e-19
2ygg_B	150	Complex Of Cambr And Cam Length = 150		2e-19
2be6_A	150	2.0 A Crystal Structure Of The Cav1.2 Iq Domain-CaC		2e-19
1deg_A	142	The Linker Of Des-Glu84 Calmodulin Is Bent As Seen		2e-19
3ekh_A	449	Calcium-Saturated Gcamp2 T116vK378W MUTANT MONOMER		2e-19
1ahr_A	146	Calmodulin Mutant With A Two Residue Deletion In Th		2e-19
1iq5_A	149	CalmodulinNEMATODE CA2+CALMODULIN DEPENDENT KINASE		2e-19
3sg5_A	448	Crystal Structure Of Dimeric Gcamp3-D380y, Qp(Linke		2e-19
3sg4_A	448	Crystal Structure Of Gcamp3-D380y, Lp(Linker 2) Len		2e-19
3sg3_A	449	Crystal Structure Of Gcamp3-D380y Length = 449		2e-19
3sg7_A	448	Crystal Structure Of Gcamp3-Kf(Linker 1) Length = 4		3e-19
1prw_A	149	Crystal Structure Of Bovine Brain Ca++ Calmodulin I		3e-19
1up5_B	148	Chicken Calmodulin Length = 148		3e-19
3khe_A	191	Crystal Structure Of The Calcium-Loaded Calmodulin-		3e-19
1cdl_A	147	Target Enzyme Recognition By Calmodulin: 2.4 Angstr		3e-19
1cdm_A	144	Modulation Of Calmodulin Plasticity In Molecular Re		3e-19
2vay_A	146	Calmodulin Complexed With Cav1.1 Iq Peptide Length		3e-19
3ewt_A	154	Crystal Structure Of Calmodulin Complexed With A Pe		3e-19
1cm1_A	148	Motions Of Calmodulin-Single-Conformer Refinement L		3e-19
4gow_D	144	Crystal Structure Of Ca2+CAM:KV7.4 (KCNQ4) B HELIX		4e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-19
2bkh_B	149	Myosin Vi Nucleotide-Free (Mdinsert2) Crystal Struc		4e-19
2ix7_A	145	Structure Of Apo-Calmodulin Bound To Unconventional		4e-19
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-19
1ooj_A	149	Structural Genomics Of Caenorhabditis Elegans : Cal		5e-19
2lv6_A	148	The Complex Between Ca-calmodulin And Skeletal Musc		5e-19
1xfu_O	149	Crystal Structure Of Anthrax Edema Factor (ef) Trun		6e-19
3u0k_A	440	Crystal Structure Of The Genetically Encoded Calciu		6e-19
2bbm_A	148	Solution Structure Of A Calmodulin-Target Peptide C		6e-19
1y0v_H	146	Crystal Structure Of Anthrax Edema Factor (Ef) In C		6e-19
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-19
2vb6_B	149	Myosin Vi (Md-Insert2-Cam, Delta Insert1) Post-Rigo		6e-19
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		7e-19
1k93_D	144	Crystal Structure Of The Adenylyl Cyclase Domain Of		8e-19
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		8e-19
1exr_A	148	The 1.0 Angstrom Crystal Structure Of Ca+2 Bound Ca		9e-19
1dmo_A	148	Calmodulin, Nmr, 30 Structures Length = 148		1e-18
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-18
2k0j_A	148	Solution Structure Of Cam Complexed To Drp1p Length		2e-18
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-18
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-18
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-18
1clm_A	148	Structure Of Paramecium Tetraurelia Calmodulin At 1		2e-18
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-18
3qrx_A	169	Chlamydomonas Reinhardtii Centrin Bound To Melittin		5e-18
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-18
1qtx_A	148	The 1.65 Angstrom Structure Of Calmodulin Rs20 Pept		6e-18
1vrk_A	148	The 1.9 Angstrom Structure Of E84k-Calmodulin Rs20		7e-18
1qs7_A	145	The 1.8 Angstrom Structure Of Calmodulin Rs20 Pepti		7e-18
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		8e-18
1rfj_A	149	Crystal Structure Of Potato Calmodulin Pcm6 Length		8e-18
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-18
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-18
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		9e-18
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-18
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-17
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-17
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-17
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-17
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-17
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-17
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-17
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-17
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-17
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-17
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-17
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-17
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-17
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-17
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-17
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-17
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-17
1niw_A	148	Crystal Structure Of Endothelial Nitric Oxide Synth		2e-17
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-17
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-17
4aqr_A	149	Crystal Structure Of A Calmodulin In Complex With T		3e-17
1s6j_A	87	N-Terminal Region Of The Ca2+-Saturated Calcium Reg		3e-17
1xfx_O	149	Crystal Structure Of Anthrax Edema Factor (Ef) In C		4e-17
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-17
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-17
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-17
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-17
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-17
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-17
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-17
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-17
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-17
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-17
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-17
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-17
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-17
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-17
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-17
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		9e-17
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-17
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-17
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-16
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-16
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-16
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-16
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-16
1y6w_A	148	Trapped Intermediate Of Calmodulin Length = 148		2e-16
2l1w_A	149	The Solution Structure Of Soybean Calmodulin Isofor		2e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-16
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-16
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-16
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-16
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-16
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-16
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-16
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-16
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-16
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-16
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-16
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-16
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-16
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-16
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-16
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-16
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-16
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-16
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-16
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-16
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-16
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-16
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-16
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-16
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-16
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-16
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-16
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-16
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-16
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-16
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-16
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-16
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-16
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-16
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-16
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-16
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-16
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-16
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-16
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-16
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-16
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-16
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-16
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-16
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-16
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-16
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-16
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-16
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-16
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-16
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-16
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-16
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-16
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-16
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-16
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		8e-16
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-16
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-16
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-16
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-15
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-15
3kf9_A	149	Crystal Structure Of The SdcenSKMLCK COMPLEX Length		1e-15
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-15
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-15
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-15
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-15
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-15
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-15
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-15
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-15
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-15
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-15
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-15
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-15
3ekj_A	449	Calcium-Free Gcamp2 (Calcium Binding Deficient Muta		2e-15
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-15
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-15
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-15
1ggz_A	148	Crystal Structure Of The Calmodulin-Like Protein (H		3e-15
1ggz_A	148	Crystal Structure Of The Calmodulin-Like Protein (H		4e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-15
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-15
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-15
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-15
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-15
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-15
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-15
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-15
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-15
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-15
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-15
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-15
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-15
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-15
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-15
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-14
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-14
1ytz_C	162	Crystal Structure Of Skeletal Muscle Troponin In Th		1e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-14
2w49_0	159	Isometrically Contracting Insect Asynchronous Fligh		1e-14
2lhi_A	176	Solution Structure Of Ca2+CNA1 PEPTIDE-Bound Ycam L		2e-14
4tnc_A	162	Refined Structure Of Chicken Skeletal Muscle Tropon		2e-14
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-14
5tnc_A	162	Refined Crystal Structure Of Troponin C From Turkey		2e-14
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-14
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-14
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-14
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		3e-14
1a2x_A	159	Complex Of Troponin C With A 47 Residue (1-47) Frag		3e-14
4ds7_A	147	Crystal Structure Of Yeast Calmodulin Bound To The		3e-14
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-14
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-14
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		4e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-14
1tcf_A	159	Crystal Structure Of Calcium-Saturated Rabbit Skele		5e-14
1tnw_A	162	Nmr Solution Structure Of Calcium Saturated Skeleta		5e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-14
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		6e-14
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		6e-14
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		7e-14
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		7e-14
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		7e-14
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		7e-14
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-14
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		7e-14
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		7e-14
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		7e-14
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		8e-14
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-14
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		8e-14
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		8e-14
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		8e-14
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		8e-14
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-13
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-13
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-13
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-13
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-13
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-13
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-13
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-13
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-13
2obh_A	143	Centrin-Xpc Peptide Length = 143		5e-13
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		5e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-13
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-13
1lkj_A	146	Nmr Structure Of Apo Calmodulin From Yeast Saccharo		6e-13
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-13
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-13
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		9e-13
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-13
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-13
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-12
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-12
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-12
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-12
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-12
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-12
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-12
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-12
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-12
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-12
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-12
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-12
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-12
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-12
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-12
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-12
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-12
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-12
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-12
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-12
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-12
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-12
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-12
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-12
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		4e-12
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		4e-12
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		4e-12
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		4e-12
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		4e-12
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		4e-12
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		4e-12
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-12
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		5e-12
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		5e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-12
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		5e-12
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		5e-12
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		5e-12
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		5e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-12
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		6e-12
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-12
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-12
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-12
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-12
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-12
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		6e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-12
2p6b_B	156	Crystal Structure Of Human Calcineurin In Complex W		8e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		8e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-12
1tco_B	169	Ternary Complex Of A Calcineurin A Fragment, Calcin		8e-12
1mf8_B	170	Crystal Structure Of Human Calcineurin Complexed Wi		8e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-12
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		9e-12
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-11
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-11
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-11
3ll8_B	155	Crystal Structure Of Calcineurin In Complex With Ak		1e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-11
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-11
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-11
2lmt_A	148	Nmr Structure Of Androcam Length = 148		2e-11
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-11
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-11
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-11
2lan_A	167	Nmr Structure Of Ca2+-Bound Cabp1 N-Domain With Rdc		3e-11
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-11
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-11
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-11
3ox5_A	153	Crystal Structure Of The Calcium Sensor Calcium-Bin		4e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-11
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-11
3ox6_A	153	Crystal Structure Of The Calcium Sensor Calcium-Bin		5e-11
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		5e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-11
3e3r_A	204	Crystal Structure And Biochemical Characterization		6e-11
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		6e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-11
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-11
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		8e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		8e-11
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		9e-11
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		9e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-11
2lhh_A	128	Solution Structure Of Ca2+-Bound Ycam Length = 128		9e-11
2lhh_A	128	Solution Structure Of Ca2+-Bound Ycam Length = 128		5e-05
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-10
2jt0_A	161	Solution Structure Of F104w Cardiac Troponin C Leng		1e-10
2jt3_A	161	Solution Structure Of F153w Cardiac Troponin C Leng		1e-10
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		1e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-10
1aj4_A	161	Structure Of Calcium-Saturated Cardiac Troponin C,		1e-10
1dtl_A	161	Crystal Structure Of Calcium-Saturated (3ca2+) Card		1e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-10
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-10
2ggm_A	172	Human Centrin 2 Xeroderma Pigmentosum Group C Prote		1e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-10
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-10
1la0_A	161	Solution Structure Of Calcium Saturated Cardiac Tro		2e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-10
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-10
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-10
2jtz_A	161	Solution Structure And Chemical Shift Assignments O		3e-10
2jt8_A	161	Solution Structure Of The F153-To-5-Flurotryptophan		3e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-10
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-10
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		4e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-10
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		8e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		8e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		9e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-10
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		9e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-10
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		9e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		9e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		9e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-09
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		2e-09
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		2e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-09
3fwb_A	161	Sac3:sus1:cdc31 Complex Length = 161		3e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-09
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		4e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-09
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		7e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-09
3mse_B	180	Crystal Structure Of C-Terminal Domain Of Pf110239		1e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-08
2gv5_A	161	Crystal Structure Of Sfi1pCDC31P COMPLEX Length = 1		3e-08
2jnf_A	158	Solution Structure Of Fly Troponin C, Isoform F1 Le		5e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-08
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-08
2b1u_A	71	Solution Structure Of Calmodulin-Like Skin Protein		9e-08
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		9e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-07
2lqc_A	77	Nmr Solution Structure Of A Ca2+-Calmodulin With A		1e-07
2lqc_A	77	Nmr Solution Structure Of A Ca2+-Calmodulin With A		3e-06
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-07
3ifk_A	90	Crystal Structure Of Calcium-Saturated Calmodulin N		1e-07
3ifk_A	90	Crystal Structure Of Calcium-Saturated Calmodulin N		4e-06
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-07
3uct_A	79	Structure Of Mn2+-Bound N-Terminal Domain Of Calmod		1e-07
3uct_A	79	Structure Of Mn2+-Bound N-Terminal Domain Of Calmod		3e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-07
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-07
2llo_A	80	Solution Nmr-Derived Structure Of Calmodulin N-Lobe		1e-07
2llo_A	80	Solution Nmr-Derived Structure Of Calmodulin N-Lobe		4e-06
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-07
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-07
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-07

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  300 bits (768), Expect = 1e-81,   Method: Compositional matrix adjust.
 Identities = 169/462 (36%), Positives = 258/462 (55%), Gaps = 22/462 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y   R +G+G FG   LC +  TG E A K I KR++ +  +K+ + RE+++++ L   P
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HP 86
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    +ED  + ++V E+  GGELFD I++R  +SE  AA + R +++ +   H   
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGK 214
           ++HRDLKPEN L  +  ++A ++  DFGLS   E  K  ++ +G+ YYIAPEVL  +Y +
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE 206
Query: 215 EADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRML 274
           + D+WS GVILYILL G PPF    +  + + + KG+  F+   +  +S SA +L+R+ML
Sbjct: 207 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKML 266
Query: 275 TQDPKRRITVAQVLEHPWLKESGE---ASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVE 331
           T  P  RI+    L+H W++   +   + D P     I  ++QF    KL + AL  +  
Sbjct: 267 TYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGS 326
Query: 332 NLPTE-EIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL-------GSML----TEFDVKQ 379
            L ++ E ++L   F +MD +  G L   EL  G  +L        SML     E +V Q
Sbjct: 327 KLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQ 386
Query: 380 YMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKD 439
            + A D D NG I+Y EF+T  M R  L   E L +AF+ FD DN+G I+  EL   F  
Sbjct: 387 VLDAVDFDKNGYIEYSEFVTVAMDRKTLLSRERLERAFRMFDSDNSGKISSTELATIF-- 444
Query: 440 YGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMM--KCGT 479
            G+  D    T K ++SEVD++ DG + +DEF+ M+   CG 
Sbjct: 445 -GVS-DVDSETWKSVLSEVDKNNDGEVDFDEFQQMLLKLCGN 484

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  300 bits (768), Expect = 1e-81,   Method: Compositional matrix adjust.
 Identities = 169/462 (36%), Positives = 258/462 (55%), Gaps = 22/462 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y   R +G+G FG   LC +  TG E A K I KR++ +  +K+ + RE+++++ L   P
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HP 109
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    +ED  + ++V E+  GGELFD I++R  +SE  AA + R +++ +   H   
Sbjct: 110 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 169
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGK 214
           ++HRDLKPEN L  +  ++A ++  DFGLS   E  K  ++ +G+ YYIAPEVL  +Y +
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE 229
Query: 215 EADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRML 274
           + D+WS GVILYILL G PPF    +  + + + KG+  F+   +  +S SA +L+R+ML
Sbjct: 230 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKML 289
Query: 275 TQDPKRRITVAQVLEHPWLKESGE---ASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVE 331
           T  P  RI+    L+H W++   +   + D P     I  ++QF    KL + AL  +  
Sbjct: 290 TYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGS 349
Query: 332 NLPTE-EIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL-------GSML----TEFDVKQ 379
            L ++ E ++L   F +MD +  G L   EL  G  +L        SML     E +V Q
Sbjct: 350 KLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQ 409
Query: 380 YMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKD 439
            + A D D NG I+Y EF+T  M R  L   E L +AF+ FD DN+G I+  EL   F  
Sbjct: 410 VLDAVDFDKNGYIEYSEFVTVAMDRKTLLSRERLERAFRMFDSDNSGKISSTELATIF-- 467
Query: 440 YGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMM--KCGT 479
            G+  D    T K ++SEVD++ DG + +DEF+ M+   CG 
Sbjct: 468 -GVS-DVDSETWKSVLSEVDKNNDGEVDFDEFQQMLLKLCGN 507

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  300 bits (767), Expect = 1e-81,   Method: Compositional matrix adjust.
 Identities = 169/462 (36%), Positives = 258/462 (55%), Gaps = 22/462 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y   R +G+G FG   LC +  TG E A K I KR++ +  +K+ + RE+++++ L   P
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HP 110
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    +ED  + ++V E+  GGELFD I++R  +SE  AA + R +++ +   H   
Sbjct: 111 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 170
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGK 214
           ++HRDLKPEN L  +  ++A ++  DFGLS   E  K  ++ +G+ YYIAPEVL  +Y +
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE 230
Query: 215 EADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRML 274
           + D+WS GVILYILL G PPF    +  + + + KG+  F+   +  +S SA +L+R+ML
Sbjct: 231 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKML 290
Query: 275 TQDPKRRITVAQVLEHPWLKESGE---ASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVE 331
           T  P  RI+    L+H W++   +   + D P     I  ++QF    KL + AL  +  
Sbjct: 291 TYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGS 350
Query: 332 NLPTE-EIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL-------GSML----TEFDVKQ 379
            L ++ E ++L   F +MD +  G L   EL  G  +L        SML     E +V Q
Sbjct: 351 KLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQ 410
Query: 380 YMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKD 439
            + A D D NG I+Y EF+T  M R  L   E L +AF+ FD DN+G I+  EL   F  
Sbjct: 411 VLDAVDFDKNGYIEYSEFVTVAMDRKTLLSRERLERAFRMFDSDNSGKISSTELATIF-- 468
Query: 440 YGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMM--KCGT 479
            G+  D    T K ++SEVD++ DG + +DEF+ M+   CG 
Sbjct: 469 -GVS-DVDSETWKSVLSEVDKNNDGEVDFDEFQQMLLKLCGN 508

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  295 bits (755), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 166/458 (36%), Positives = 256/458 (55%), Gaps = 21/458 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y   +++G G +G   LC +  TG E A K I K  +        +  E+ +++ L   P
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD-HP 64
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    +ED +  ++VME+  GGELFD I+ R  +SE  AA + + +++     H   
Sbjct: 65  NIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHN 124
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGK 214
           ++HRDLKPEN L  +   +A++K  DFGLSA  E G   +E +G+ YYIAPEVL + Y +
Sbjct: 125 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKKYDE 184
Query: 215 EADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRML 274
           + D+WS GVILYILLCG PPF  +TDQ + + + KG+ +F    +  +S  A +LV+ ML
Sbjct: 185 KCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLML 244
Query: 275 TQDPKRRITVAQVLEHPWLKE--SGEASD--KPIDTAVIFRMKQFTAMNKLKKLALKVIV 330
           T +P +RI+  + L HPW+ +  S + +D  K   T  +  MK+F +  KL + A+  + 
Sbjct: 245 TYEPSKRISAEEALNHPWIVKFCSQKHTDVGKHALTGALGNMKKFQSSQKLAQAAMLFMG 304
Query: 331 ENLPT-EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL----GSMLTEFD-------VK 378
             L T EE ++L + F ++D +  G L   EL  G  KL    G  +++ D       V 
Sbjct: 305 SKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRKLMQWKGDTVSDLDSSQIEAEVD 364
Query: 379 QYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFK 438
             +Q+ D D NG I+Y EF+T  M +  L   E L  AFQ FD D +G IT +ELG+ F 
Sbjct: 365 HILQSVDFDRNGYIEYSEFVTVCMDKQLLLSRERLLAAFQQFDSDGSGKITNEELGRLFG 424
Query: 439 DYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
              + D+    T  +++ E D++ DG + ++EF  MM+
Sbjct: 425 VTEVDDE----TWHQVLQECDKNNDGEVDFEEFVEMMQ 458

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  293 bits (751), Expect = 1e-79,   Method: Compositional matrix adjust.
 Identities = 170/455 (37%), Positives = 256/455 (56%), Gaps = 19/455 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y   +++G G +G   LC +  T +E A K I K   V       +  E+ +++ L   P
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEEVAVLKLLD-HP 96
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    +ED +  ++VME   GGELFD I+ R  ++E  AA + + +++ V   H   
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGK 214
           ++HRDLKPEN L  + +++A++K  DFGLSA  E  K  +E +G+ YYIAPEVL + Y +
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDE 216
Query: 215 EADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRML 274
           + D+WS GVIL+ILL G PPF  +TDQ + + + KG+  F    + ++S  A +L+++ML
Sbjct: 217 KCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQML 276
Query: 275 TQDPKRRITVAQVLEHPWLKESGEASDKPID----TAVIFRMKQFTAMNKLKKLALKVIV 330
             D +RRI+  Q LEHPW+KE     +  I+       I  M++F    KL + AL  + 
Sbjct: 277 QFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMA 336
Query: 331 ENLPT-EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL-GSMLTEFDVKQ-------YM 381
             L + EE ++L + F  +D +  G L   EL  G +KL G  +  FD+ Q        +
Sbjct: 337 SKLTSQEETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAIL 396
Query: 382 QAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYG 441
            AAD D NG IDY EF+T  M R  L   + L  AFQ FD+D NG I+VDEL   F   G
Sbjct: 397 GAADFDRNGYIDYSEFVTVAMDRKSLLSKDKLESAFQKFDQDGNGKISVDELASVF---G 453
Query: 442 MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           + D     T KE++S +D + DG + ++EF  M++
Sbjct: 454 L-DHLESKTWKEMISGIDSNNDGDVDFEEFCKMIQ 487

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  286 bits (733), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 165/463 (35%), Positives = 257/463 (55%), Gaps = 27/463 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y I   +G+G FG    C +  T  E+A K I K    K+ +   + RE+E+++ L   P
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLD-HP 81
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++     ED    +IV EL  GGELFD I+ R  +SE  AA + + + + +   H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGK 214
           ++HRDLKPEN L  + +++  +K  DFGLS   ++    ++ +G+ YYIAPEVL  +Y +
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 215 EADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRML 274
           + D+WSAGVILYILL G PPF+ + +  + + +  G+  F    + +IS  A +L+R+ML
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261
Query: 275 TQDPKRRITVAQVLEHPWLK----ESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIV 330
           T  P  RIT  Q LEHPW++    E+   SD P   + +  ++QF A  KL + AL  + 
Sbjct: 262 TFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMA 321
Query: 331 ENLPT-EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL---------------GSMLTE 374
             L T +E ++L E F ++DT+N G L  DEL  G  +                GS + E
Sbjct: 322 SKLTTLDETKQLTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTI-E 380
Query: 375 FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELG 434
             +   M   D+DG+G+I+Y EFI + + R  L   E + +AF+ FDKD +G I+  EL 
Sbjct: 381 DQIDSLMPLLDMDGSGSIEYSEFIASAIDRTILLSRERMERAFKMFDKDGSGKISTKEL- 439
Query: 435 KAFKDYGMGDDAT-IATIKEIMSEVDRDKDGRISYDEFRSMMK 476
             FK +   D +  +  ++ I+ +VD +KDG + ++EF  M++
Sbjct: 440 --FKLFSQADSSIQMEELESIIEQVDNNKDGEVDFNEFVEMLQ 480

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  286 bits (731), Expect = 2e-77,   Method: Compositional matrix adjust.
 Identities = 162/462 (35%), Positives = 250/462 (54%), Gaps = 22/462 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y   R +G+G FG   LC +  TG E A K I KR++ +  +K+ + RE+++++ L   P
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HP 86
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI +    +ED  + ++V E+  GGELFD I++R  +SE  AA + R +++ +   H   
Sbjct: 87  NIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK 146
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGK 214
           ++HRDLKPEN L  +  ++A ++  DFGLS   E  K  ++ +G+ YYIAPEVL  +Y +
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGTYDE 206
Query: 215 EADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRML 274
           + D+WS GVILYILL G PPF    +  + + + KG+  F+   +  +S SA +L+R+ L
Sbjct: 207 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKXL 266
Query: 275 TQDPKRRITVAQVLEHPWLKESGE---ASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVE 331
           T  P  RI+    L+H W++   +   + D P     I  ++QF    KL + AL     
Sbjct: 267 TYVPSXRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYXGS 326
Query: 332 NLPTE-EIQKLKEKFTEMDTDNSGTLTYDELKAGL-----------AKLGSMLTEFDVKQ 379
            L ++ E ++L   F + D +  G L   EL  G            + L +   E +V Q
Sbjct: 327 KLTSQDETKELTAIFHKXDKNGDGQLDRAELIEGYKELXRXKGQDASXLDASAVEHEVDQ 386
Query: 380 YMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKD 439
            + A D D NG I+Y EF+T    R  L   E L +AF+ FD DN+G I+  EL   F  
Sbjct: 387 VLDAVDFDKNGYIEYSEFVTVAXDRKTLLSRERLERAFRXFDSDNSGKISSTELATIF-- 444
Query: 440 YGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMM--KCGT 479
            G+  D    T K ++SEVD++ DG + +DEF+  +   CG 
Sbjct: 445 -GVS-DVDSETWKSVLSEVDKNNDGEVDFDEFQQXLLKLCGN 484

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  268 bits (684), Expect = 6e-72,   Method: Compositional matrix adjust.
 Identities = 156/459 (33%), Positives = 245/459 (53%), Gaps = 27/459 (5%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKL--------VKDVEK--DDVRREIEIMR 88
           R++G G +G   LC E +   E A K I K +          K++EK  +++  EI +++
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVN 148
            L   PNI++    +ED ++ ++V E   GGELF++I+ R  + E  AA++ + I++ + 
Sbjct: 102 SLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGIC 160
Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL 208
             H   ++HRD+KPEN L    +    +K  DFGLS+F  +    R+ +G+ YYIAPEVL
Sbjct: 161 YLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL 220
Query: 209 SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
            + Y ++ D+WS GVI+YILLCG PPF  + DQ + + + KG+  F  + + +IS  A E
Sbjct: 221 KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKE 280
Query: 269 LVRRMLTQDPKRRITVAQVLEHPWLKESG---EASDKPIDTAVIFRMKQFTAMNKLKKLA 325
           L++ MLT D  +R T  + L   W+K+       SD+      +  M++F    KL + A
Sbjct: 281 LIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAA 340
Query: 326 LKVIVENLPT-EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEF--------D 376
           +  I   L T EE ++L + F ++D +  G L   EL  G   L +   E         +
Sbjct: 341 ILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEE 400
Query: 377 VKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKA 436
           V   ++  D D NG I+Y EFI+  M +  L   E L +AF  FD D +G IT +EL   
Sbjct: 401 VDNILKEVDFDKNGYIEYSEFISVCMDKQILFSEERLRRAFNLFDTDKSGKITKEELANL 460
Query: 437 FKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMM 475
           F    + +     T  +++ E D++KD  I +DEF SMM
Sbjct: 461 FGLTSISE----KTWNDVLGEADQNKDNMIDFDEFVSMM 495

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  239 bits (609), Expect = 4e-63,   Method: Compositional matrix adjust.
 Identities = 119/278 (42%), Positives = 171/278 (61%), Gaps = 4/278 (1%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREI 84
           G    D+  +YT+   +GRG +G   +  +  T +  A K IPK   V+DV  D  ++EI
Sbjct: 18  GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY-FVEDV--DRFKQEI 74
Query: 85  EIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
           EIM+ L   PNI++    +ED+  +++VMELC GGELF+R+V +  + E  AA + + ++
Sbjct: 75  EIMKSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL 133
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIA 204
           + V  CH   V HRDLKPENFLF T   ++ +K  DFGL+A  + GK  R  VG+PYY++
Sbjct: 134 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 193
Query: 205 PEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
           P+VL   YG E D WSAGV++Y+LLCG PPF A TD  V   I +G   F    + ++S 
Sbjct: 194 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSP 253
Query: 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDK 302
            A  L+RR+LT+ PK+RIT  Q LEH W ++   +S +
Sbjct: 254 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPR 291

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  238 bits (608), Expect = 4e-63,   Method: Compositional matrix adjust.
 Identities = 119/278 (42%), Positives = 171/278 (61%), Gaps = 4/278 (1%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREI 84
           G    D+  +YT+   +GRG +G   +  +  T +  A K IPK   V+DV  D  ++EI
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY-FVEDV--DRFKQEI 57
Query: 85  EIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
           EIM+ L   PNI++    +ED+  +++VMELC GGELF+R+V +  + E  AA + + ++
Sbjct: 58  EIMKSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL 116
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIA 204
           + V  CH   V HRDLKPENFLF T   ++ +K  DFGL+A  + GK  R  VG+PYY++
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 205 PEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
           P+VL   YG E D WSAGV++Y+LLCG PPF A TD  V   I +G   F    + ++S 
Sbjct: 177 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSP 236
Query: 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDK 302
            A  L+RR+LT+ PK+RIT  Q LEH W ++   +S +
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPR 274

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  217 bits (553), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 124/301 (41%), Positives = 181/301 (60%), Gaps = 13/301 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + +  E+GRG   I Y C +  T   +A K      L K V+K  VR EI ++  LS  P
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKV-----LKKTVDKKIVRTEIGVLLRLS-HP 108
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++ K  +E    + +V+EL  GGELFDRIV +G+YSER AA   + I+  V   H  G
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           ++HRDLKPEN L+ T   +A +K  DFGLS  +E     + + G+P Y APE+L   +YG
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYG 228
Query: 214 KEADIWSAGVILYILLCGVPPFWAET-DQGVAQAILKGEINFQRDPFPSISSSAIELVRR 272
            E D+WS G+I YILLCG  PF+ E  DQ + + IL  E  F    +  +S +A +LVR+
Sbjct: 229 PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRK 288
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASD-KPIDTAVIFRMKQFTAMNKLKKLALKVIVE 331
           ++  DPK+R+T  Q L+HPW+  +G+A++   +DTA   ++++F A  KLK  A+K +V 
Sbjct: 289 LIVLDPKKRLTTFQALQHPWV--TGKAANFVHMDTAQK-KLQEFNARRKLKA-AVKAVVA 344
Query: 332 N 332
           +
Sbjct: 345 S 345

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  216 bits (551), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 114/299 (38%), Positives = 173/299 (57%), Gaps = 5/299 (1%)
Query: 26  KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIE 85
           K  ED++  +     +G G F    L  E +TG  FA K IPK+ L    ++  +  EI 
Sbjct: 15  KQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL--KGKESSIENEIA 72
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           ++R +  + NIV  +  YE    +++VM+L +GGELFDRIV +G Y+E+ A+++ R +++
Sbjct: 73  VLRKIKHE-NIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLD 131
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAP 205
            V   H  G++HRDLKPEN L+ + DE + +  +DFGLS    +G       G+P Y+AP
Sbjct: 132 AVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAP 191
Query: 206 EVLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
           EVL+Q  Y K  D WS GVI YILLCG PPF+ E D  + + ILK E  F    +  IS 
Sbjct: 192 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISD 251
Query: 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKK 323
           SA + +R ++ +DP +R T  Q   HPW+     A +K I  +V  ++++  A +K ++
Sbjct: 252 SAKDFIRNLMEKDPNKRYTCEQAARHPWIA-GDTALNKNIHESVSAQIRKNFAKSKWRQ 309

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  214 bits (544), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 113/299 (37%), Positives = 169/299 (56%), Gaps = 5/299 (1%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSG 92
           +Y +  E+G+G F +   C   +TGLEFA K I  +KL  +D +K  + RE  I R L  
Sbjct: 30  NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK--LEREARICRKLQ- 86
Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
            PNIV+   + +++ F ++V +L  GGELF+ IVAR  YSE  A+   + I+  +  CHS
Sbjct: 87  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 146
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-S 211
            G++HR+LKPEN L  +  + A VK  DFGL+  + + +A+    G+P Y++PEVL +  
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 206
Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
           Y K  DIW+ GVILYILL G PPFW E    +   I  G  ++    + +++  A  L+ 
Sbjct: 207 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 266
Query: 272 RMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIV 330
            MLT +PK+RIT  Q L+ PW+      +        +  +K+F A  KLK   L  ++
Sbjct: 267 SMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMI 325

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  212 bits (540), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 101/255 (39%), Positives = 154/255 (60%), Gaps = 1/255 (0%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           +++G G +G   LC +  TG E A K I K  +        +  E+ +++ L   PNI++
Sbjct: 27  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD-HPNIMK 85
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
               +ED +  ++VME+  GGELFD I+ R  +SE  AA + + +++     H   ++HR
Sbjct: 86  LYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHR 145
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADI 218
           DLKPEN L  +   +A++K  DFGLSA  E G   +E +G+ YYIAPEVL + Y ++ D+
Sbjct: 146 DLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKKYDEKCDV 205
Query: 219 WSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278
           WS GVILYILLCG PPF  +TDQ + + + KG+ +F    +  +S  A +LV+ MLT +P
Sbjct: 206 WSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEP 265
Query: 279 KRRITVAQVLEHPWL 293
            +RI+  + L HPW+
Sbjct: 266 SKRISAEEALNHPWI 280

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  212 bits (540), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 100/260 (38%), Positives = 159/260 (61%), Gaps = 1/260 (0%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y   R +G+G FG   LC +  TG E A K I KR++ +  +K+ + RE+++++ L   P
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HP 92
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    +ED  + ++V E+  GGELFD I++R  +SE  AA + R +++ +   H   
Sbjct: 93  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 152
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGK 214
           ++HRDLKPEN L  +  ++A ++  DFGLS   E  K  ++ +G+ YYIAPEVL  +Y +
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDE 212
Query: 215 EADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRML 274
           + D+WS GVILYILL G PPF    +  + + + KG+  F+   +  +S SA +L+R+ML
Sbjct: 213 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKML 272
Query: 275 TQDPKRRITVAQVLEHPWLK 294
           T  P  RI+    L+H W++
Sbjct: 273 TYVPSMRISARDALDHEWIQ 292

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  212 bits (540), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 114/299 (38%), Positives = 174/299 (58%), Gaps = 6/299 (2%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQ 93
           Y +  E+G+G F +   C +  TG E+A K I  +KL  +D +K  + RE  I R L   
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQK--LEREARICRLLK-H 62
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PNIV+   +  ++ F ++V +L  GGELF+ IVAR +YSE  A+   + I+  VN CH  
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEVLSQ-S 211
           G++HRDLKPEN L  +  + A VK  DFGL+  ++ + +A+    G+P Y++PEVL +  
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
           YGK  D+W+ GVILYILL G PPFW E    + Q I  G  +F    + +++  A +L+ 
Sbjct: 183 YGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 242
Query: 272 RMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIV 330
           +MLT +P +RIT ++ L+HPW+ +    +        +  +K+F A  KLK   L  ++
Sbjct: 243 KMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLKGAILTTML 301

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  212 bits (539), Expect = 5e-55,   Method: Compositional matrix adjust.
 Identities = 114/299 (38%), Positives = 174/299 (58%), Gaps = 6/299 (2%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQ 93
           Y +  E+G+G F +   C +  TG E+A K I  +KL  +D +K  + RE  I R L   
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQK--LEREARICRLLK-H 62
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PNIV+   +  ++ F ++V +L  GGELF+ IVAR +YSE  A+   + I+  VN CH  
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEVLSQ-S 211
           G++HRDLKPEN L  +  + A VK  DFGL+  ++ + +A+    G+P Y++PEVL +  
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
           YGK  D+W+ GVILYILL G PPFW E    + Q I  G  +F    + +++  A +L+ 
Sbjct: 183 YGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 242
Query: 272 RMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIV 330
           +MLT +P +RIT ++ L+HPW+ +    +        +  +K+F A  KLK   L  ++
Sbjct: 243 KMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLKGAILTTML 301

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  208 bits (530), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 106/262 (40%), Positives = 156/262 (59%), Gaps = 5/262 (1%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSG 92
           +Y +  E+G+G F +   C   +TGLEFA K I  +KL  +D +K  + RE  I R L  
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK--LEREARICRKLQ- 63
Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
            PNIV+   + +++ F ++V +L  GGELF+ IVAR  YSE  A+   + I+  +  CHS
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-S 211
            G++HR+LKPEN L  +  + A VK  DFGL+  + + +A+    G+P Y++PEVL +  
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
           Y K  DIW+ GVILYILL G PPFW E    +   I  G  ++    + +++  A  L+ 
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 243
Query: 272 RMLTQDPKRRITVAQVLEHPWL 293
            MLT +PK+RIT  Q L+ PW+
Sbjct: 244 SMLTVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  208 bits (530), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 106/262 (40%), Positives = 156/262 (59%), Gaps = 5/262 (1%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSG 92
           +Y +  E+G+G F +   C   +TGLEFA K I  +KL  +D +K  + RE  I R L  
Sbjct: 6   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK--LEREARICRKLQ- 62
Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
            PNIV+   + +++ F ++V +L  GGELF+ IVAR  YSE  A+   + I+  +  CHS
Sbjct: 63  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 122
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-S 211
            G++HR+LKPEN L  +  + A VK  DFGL+  + + +A+    G+P Y++PEVL +  
Sbjct: 123 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 182
Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
           Y K  DIW+ GVILYILL G PPFW E    +   I  G  ++    + +++  A  L+ 
Sbjct: 183 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 242
Query: 272 RMLTQDPKRRITVAQVLEHPWL 293
            MLT +PK+RIT  Q L+ PW+
Sbjct: 243 SMLTVNPKKRITADQALKVPWI 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  208 bits (530), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 106/262 (40%), Positives = 156/262 (59%), Gaps = 5/262 (1%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSG 92
           +Y +  E+G+G F +   C   +TGLEFA K I  +KL  +D +K  + RE  I R L  
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK--LEREARICRKLQ- 63
Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
            PNIV+   + +++ F ++V +L  GGELF+ IVAR  YSE  A+   + I+  +  CHS
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-S 211
            G++HR+LKPEN L  +  + A VK  DFGL+  + + +A+    G+P Y++PEVL +  
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
           Y K  DIW+ GVILYILL G PPFW E    +   I  G  ++    + +++  A  L+ 
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 243
Query: 272 RMLTQDPKRRITVAQVLEHPWL 293
            MLT +PK+RIT  Q L+ PW+
Sbjct: 244 SMLTVNPKKRITADQALKVPWI 265

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  208 bits (530), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 106/271 (39%), Positives = 161/271 (59%), Gaps = 6/271 (2%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           EDV+ HY +G E+G G+F I   C +  TG E+A K I KR+L    + V ++++ RE+ 
Sbjct: 8   EDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 67
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I+R +   PNI+     +E+   V +++EL +GGELFD +  +   +E  A    + I++
Sbjct: 68  ILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 126
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGD-ENAVVKATDFGLSAFIEEGKAYREIVGSPYYIA 204
            V+  HSK + H DLKPEN +    +  N  +K  DFG++  IE G  ++ I G+P ++A
Sbjct: 127 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 186
Query: 205 PEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263
           PE+++ +  G EAD+WS GVI YILL G  PF  ET Q     I     +F  + F + S
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 246
Query: 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
             A + +RR+L +DPKRR+ +AQ LEH W+K
Sbjct: 247 ELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  207 bits (528), Expect = 7e-54,   Method: Compositional matrix adjust.
 Identities = 115/299 (38%), Positives = 170/299 (56%), Gaps = 5/299 (1%)
Query: 26  KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIE 85
           K  ED++  Y     +G G F    L  +  T    A K I K+ L  + ++  +  EI 
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIA 68
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           ++ H    PNIV     YE    ++++M+L +GGELFDRIV +G Y+ER A+ +   +++
Sbjct: 69  VL-HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAP 205
            V   H  G++HRDLKPEN L+ + DE++ +  +DFGLS   + G       G+P Y+AP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 206 EVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
           EVL+Q  Y K  D WS GVI YILLCG PPF+ E D  + + ILK E  F    +  IS 
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 247
Query: 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKK 323
           SA + +R ++ +DP++R T  Q L+HPW+     A DK I  +V  ++K+  A +K K+
Sbjct: 248 SAKDFIRHLMEKDPEKRFTCEQALQHPWIA-GDTALDKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  207 bits (526), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 115/299 (38%), Positives = 169/299 (56%), Gaps = 5/299 (1%)
Query: 26  KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIE 85
           K  ED++  Y     +G G F    L  +  T    A K I K  L  + ++  +  EI 
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEAL--EGKEGSMENEIA 68
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           ++ H    PNIV     YE    ++++M+L +GGELFDRIV +G Y+ER A+ +   +++
Sbjct: 69  VL-HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAP 205
            V   H  G++HRDLKPEN L+ + DE++ +  +DFGLS   + G       G+P Y+AP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 206 EVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
           EVL+Q  Y K  D WS GVI YILLCG PPF+ E D  + + ILK E  F    +  IS 
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 247
Query: 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKK 323
           SA + +R ++ +DP++R T  Q L+HPW+     A DK I  +V  ++K+  A +K K+
Sbjct: 248 SAKDFIRHLMEKDPEKRFTCEQALQHPWIA-GDTALDKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  207 bits (526), Expect = 1e-53,   Method: Compositional matrix adjust.
 Identities = 115/299 (38%), Positives = 169/299 (56%), Gaps = 5/299 (1%)
Query: 26  KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIE 85
           K  ED++  Y     +G G F    L  +  T    A K I K  L  + ++  +  EI 
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEAL--EGKEGSMENEIA 68
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           ++ H    PNIV     YE    ++++M+L +GGELFDRIV +G Y+ER A+ +   +++
Sbjct: 69  VL-HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAP 205
            V   H  G++HRDLKPEN L+ + DE++ +  +DFGLS   + G       G+P Y+AP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 206 EVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
           EVL+Q  Y K  D WS GVI YILLCG PPF+ E D  + + ILK E  F    +  IS 
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 247
Query: 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKK 323
           SA + +R ++ +DP++R T  Q L+HPW+     A DK I  +V  ++K+  A +K K+
Sbjct: 248 SAKDFIRHLMEKDPEKRFTCEQALQHPWIA-GDTALDKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 105/269 (39%), Positives = 160/269 (59%), Gaps = 6/269 (2%)
Query: 31  VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIEIM 87
           V+ HY +G E+G G+F I   C +  TG E+A K I KR+L    + V ++++ RE+ I+
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 88  RHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVV 147
           R +   PNI+     +E+   V +++EL +GGELFD +  +   +E  A    + I++ V
Sbjct: 63  REIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 148 NVCHSKGVMHRDLKPENFLFTTGD-ENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE 206
           +  HSK + H DLKPEN +    +  N  +K  DFG++  IE G  ++ I G+P ++APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 207 VLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265
           +++ +  G EAD+WS GVI YILL G  PF  ET Q     I     +F  + F + S  
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241
Query: 266 AIELVRRMLTQDPKRRITVAQVLEHPWLK 294
           A + +RR+L +DPKRR+T+AQ LEH W+K
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 114/294 (38%), Positives = 168/294 (57%), Gaps = 6/294 (2%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHL 90
           Q  Y +  E+G+G F +   C +   G E+A K I  +KL  +D +K  + RE  I R L
Sbjct: 21  QSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQK--LEREARICRLL 78
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC 150
              PNIV+   +  ++   +++ +L  GGELF+ IVAR +YSE  A+   + I+  V  C
Sbjct: 79  K-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 137
Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEVLS 209
           H  GV+HRDLKPEN L  +  + A VK  DFGL+  +E E +A+    G+P Y++PEVL 
Sbjct: 138 HQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 197
Query: 210 Q-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
           +  YGK  D+W+ GVILYILL G PPFW E    + Q I  G  +F    + +++  A +
Sbjct: 198 KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 257
Query: 269 LVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLK 322
           L+ +MLT +P +RIT A+ L+HPW+      +        +  +K+F A  KLK
Sbjct: 258 LINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLK 311

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  206 bits (523), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 118/320 (36%), Positives = 180/320 (56%), Gaps = 10/320 (3%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQ 93
           Y +  E+G+G F +   C +   G E+A   I  +KL  +D +K  + RE  I R L   
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK--LEREARICRLLK-H 69
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PNIV+   +  ++   +++ +L  GGELF+ IVAR +YSE  A+   + I+  V  CH  
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEVLSQ-S 211
           GV+HR+LKPEN L  +  + A VK  DFGL+  +E E +A+    G+P Y++PEVL +  
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189
Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
           YGK  D+W+ GVILYILL G PPFW E    + Q I  G  +F    + +++  A +L+ 
Sbjct: 190 YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 249
Query: 272 RMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVE 331
           +MLT +P +RIT A+ L+HPW+      +        +  +K+F A  KLK   L V++ 
Sbjct: 250 KMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVMLA 309
Query: 332 ----NLPTEEIQKLKEKFTE 347
               ++  +EI K+ E+  E
Sbjct: 310 TRNFSVRKQEIIKVTEQLIE 329

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  204 bits (520), Expect = 7e-53,   Method: Compositional matrix adjust.
 Identities = 104/269 (38%), Positives = 159/269 (59%), Gaps = 6/269 (2%)
Query: 31  VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIEIM 87
           V+ HY +G E+G G+F I   C +  TG E+A K I KR+L    + V ++++ RE+ I+
Sbjct: 24  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNIL 83
Query: 88  RHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVV 147
           R +   PNI+     +E+   V +++EL +GGELFD +  +   +E  A    + I++ V
Sbjct: 84  REIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 142
Query: 148 NVCHSKGVMHRDLKPENFLFTTGD-ENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE 206
           +  HSK + H DLKPEN +    +  N  +K  DFG++  IE G  ++ I G+P ++APE
Sbjct: 143 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 202
Query: 207 VLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265
           +++ +  G EAD+WS GVI YILL G  PF  ET Q     I     +F  + F + S  
Sbjct: 203 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 262
Query: 266 AIELVRRMLTQDPKRRITVAQVLEHPWLK 294
           A + +RR+L +DPKRR+ +AQ LEH W+K
Sbjct: 263 AKDFIRRLLVKDPKRRMXIAQSLEHSWIK 291

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  204 bits (519), Expect = 8e-53,   Method: Compositional matrix adjust.
 Identities = 112/291 (38%), Positives = 168/291 (57%), Gaps = 6/291 (2%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQ 93
           Y +  ++G+G F +   C +  TG E+A K I  +KL  +D +K  + RE  I R L   
Sbjct: 6   YQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQK--LEREARICRLLK-H 62
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            NIV+   +  ++ F ++V +L  GGELF+ IVAR +YSE  A+   + I+  V  CH  
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 122
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEVL-SQS 211
           GV+HRDLKPEN L  +  + A VK  DFGL+  ++ + +A+    G+P Y++PEVL  ++
Sbjct: 123 GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEA 182
Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
           YGK  DIW+ GVILYILL G PPFW E    + Q I  G  +F    + +++  A  L+ 
Sbjct: 183 YGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 242
Query: 272 RMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLK 322
           +MLT +P +RIT  + L+HPW+ +    +        +  +K+F A  KLK
Sbjct: 243 QMLTINPAKRITAHEALKHPWVCQRSTVASMMHRQETVECLKKFNARRKLK 293

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  203 bits (517), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 101/261 (38%), Positives = 154/261 (59%), Gaps = 2/261 (0%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y I   +G+G FG    C +  T  E+A K I K    K+ +   + RE+E+++ L   P
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLD-HP 81
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++     ED    +IV EL  GGELFD I+ R  +SE  AA + + + + +   H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGK 214
           ++HRDLKPEN L  + +++  +K  DFGLS   ++    ++ +G+ YYIAPEVL  +Y +
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 215 EADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRML 274
           + D+WSAGVILYILL G PPF+ + +  + + +  G+  F    + +IS  A +L+R+ML
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261
Query: 275 TQDPKRRITVAQVLEHPWLKE 295
           T  P  RIT  Q LEHPW+++
Sbjct: 262 TFHPSLRITATQCLEHPWIQK 282

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  203 bits (517), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 101/261 (38%), Positives = 154/261 (59%), Gaps = 2/261 (0%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y I   +G+G FG    C +  T  E+A K I K    K+ +   + RE+E+++ L   P
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLD-HP 81
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++     ED    +IV EL  GGELFD I+ R  +SE  AA + + + + +   H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGK 214
           ++HRDLKPEN L  + +++  +K  DFGLS   ++    ++ +G+ YYIAPEVL  +Y +
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 215 EADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRML 274
           + D+WSAGVILYILL G PPF+ + +  + + +  G+  F    + +IS  A +L+R+ML
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261
Query: 275 TQDPKRRITVAQVLEHPWLKE 295
           T  P  RIT  Q LEHPW+++
Sbjct: 262 TFHPSLRITATQCLEHPWIQK 282

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  202 bits (515), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 111/284 (39%), Positives = 160/284 (56%), Gaps = 5/284 (1%)
Query: 26  KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIE 85
           K  ED++  Y     +G G F    L  +  T    A K I K  L  + ++  +  EI 
Sbjct: 11  KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEAL--EGKEGSMENEIA 68
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           ++ H    PNIV     YE    ++++M+L +GGELFDRIV +G Y+ER A+ +   +++
Sbjct: 69  VL-HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAP 205
            V   H  G++HRDLKPEN L+ + DE++ +  +DFGLS   + G       G+P Y+AP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 206 EVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
           EVL+Q  Y K  D WS GVI YILLCG PPF+ E D  + + ILK E  F    +  IS 
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 247
Query: 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAV 308
           SA + +R ++ +DP++R T  Q L+HPW+     A DK I  +V
Sbjct: 248 SAKDFIRHLMEKDPEKRFTCEQALQHPWIA-GDTALDKNIHQSV 290

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  202 bits (513), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 112/299 (37%), Positives = 168/299 (56%), Gaps = 6/299 (2%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQ 93
           Y +  E+G+G F +   C + +   E+A K I  +KL  +D +K  + RE  I R L   
Sbjct: 33  YQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQK--LEREARICRLLK-H 89
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PNIV+   +  ++ F ++V +L  GGELF+ IVAR +YSE  A+     I+  VN  H  
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQH 149
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEVLSQ-S 211
            ++HRDLKPEN L  +  + A VK  DFGL+  ++ E +A+    G+P Y++PEVL +  
Sbjct: 150 DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDP 209
Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
           YGK  DIW+ GVILYILL G PPFW E    + Q I  G  +F    + +++  A  L+ 
Sbjct: 210 YGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 269
Query: 272 RMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIV 330
           +MLT +P +RIT  Q L+HPW+ +    +        +  +++F A  KLK   L  ++
Sbjct: 270 QMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKLKGAILTTML 328

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  201 bits (512), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 111/307 (36%), Positives = 170/307 (55%), Gaps = 19/307 (6%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           E+V  +Y  G E+G G+F +   C E STGL++A K I KR+     + V ++D+ RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I++ +   PN++     YE+   V +++EL AGGELFD +  +   +E  A    + I+N
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAV---VKATDFGLSAFIEEGKAYREIVGSPYY 202
            V   HS  + H DLKPEN +    D N     +K  DFGL+  I+ G  ++ I G+P +
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 203 IAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           +APE+++ +  G EAD+WS GVI YILL G  PF  +T Q     +      F+ + F +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDT-AVIFRMKQFTAMNK 320
            S+ A + +RR+L +DPK+R+T+   L+HPW+        KP DT   + R      M K
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI--------KPKDTQQALSRKASAVNMEK 295
Query: 321 LKKLALK 327
            KK A +
Sbjct: 296 FKKFAAR 302

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  199 bits (506), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 102/273 (37%), Positives = 159/273 (58%), Gaps = 10/273 (3%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           E+V  +Y  G E+G G+F +   C E STGL++A K I KR+     + V ++D+ RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I++ +   PN++     YE+   V +++EL AGGELFD +  +   +E  A    + I+N
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAV---VKATDFGLSAFIEEGKAYREIVGSPYY 202
            V   HS  + H DLKPEN +    D N     +K  DFGL+  I+ G  ++ I G+P +
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAF 183
Query: 203 IAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           +APE+++ +  G EAD+WS GVI YILL G  PF  +T Q     +      F+ + F +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
            S+ A + +RR+L +DPK+R+T+   L+HPW+K
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  199 bits (506), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 102/273 (37%), Positives = 159/273 (58%), Gaps = 10/273 (3%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           E+V  +Y  G E+G G+F +   C E STGL++A K I KR+     + V ++D+ RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I++ +   PN++     YE+   V +++EL AGGELFD +  +   +E  A    + I+N
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAV---VKATDFGLSAFIEEGKAYREIVGSPYY 202
            V   HS  + H DLKPEN +    D N     +K  DFGL+  I+ G  ++ I G+P +
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 203 IAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           +APE+++ +  G EAD+WS GVI YILL G  PF  +T Q     +      F+ + F +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
            S+ A + +RR+L +DPK+R+T+   L+HPW+K
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  199 bits (506), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 102/273 (37%), Positives = 159/273 (58%), Gaps = 10/273 (3%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           E+V  +Y  G E+G G+F +   C E STGL++A K I KR+     + V ++D+ RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I++ +   PN++     YE+   V +++EL AGGELFD +  +   +E  A    + I+N
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAV---VKATDFGLSAFIEEGKAYREIVGSPYY 202
            V   HS  + H DLKPEN +    D N     +K  DFGL+  I+ G  ++ I G+P +
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 203 IAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           +APE+++ +  G EAD+WS GVI YILL G  PF  +T Q     +      F+ + F +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
            S+ A + +RR+L +DPK+R+T+   L+HPW+K
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  199 bits (505), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 102/273 (37%), Positives = 159/273 (58%), Gaps = 10/273 (3%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           E+V  +Y  G E+G G+F +   C E STGL++A K I KR+     + V ++D+ RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I++ +   PN++     YE+   V +++EL AGGELFD +  +   +E  A    + I+N
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAV---VKATDFGLSAFIEEGKAYREIVGSPYY 202
            V   HS  + H DLKPEN +    D N     +K  DFGL+  I+ G  ++ I G+P +
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 203 IAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           +APE+++ +  G EAD+WS GVI YILL G  PF  +T Q     +      F+ + F +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
            S+ A + +RR+L +DPK+R+T+   L+HPW+K
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  199 bits (505), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 102/273 (37%), Positives = 159/273 (58%), Gaps = 10/273 (3%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           E+V  +Y  G E+G G+F +   C E STGL++A K I KR+     + V ++D+ RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I++ +   PN++     YE+   V +++EL AGGELFD +  +   +E  A    + I+N
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAV---VKATDFGLSAFIEEGKAYREIVGSPYY 202
            V   HS  + H DLKPEN +    D N     +K  DFGL+  I+ G  ++ I G+P +
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 203 IAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           +APE+++ +  G EAD+WS GVI YILL G  PF  +T Q     +      F+ + F +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
            S+ A + +RR+L +DPK+R+T+   L+HPW+K
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  199 bits (505), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 102/273 (37%), Positives = 159/273 (58%), Gaps = 10/273 (3%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           E+V  +Y  G E+G G+F +   C E STGL++A K I KR+     + V ++D+ RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I++ +   PN++     YE+   V +++EL AGGELFD +  +   +E  A    + I+N
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAV---VKATDFGLSAFIEEGKAYREIVGSPYY 202
            V   HS  + H DLKPEN +    D N     +K  DFGL+  I+ G  ++ I G+P +
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 203 IAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           +APE+++ +  G EAD+WS GVI YILL G  PF  +T Q     +      F+ + F +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
            S+ A + +RR+L +DPK+R+T+   L+HPW+K
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  199 bits (505), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 102/273 (37%), Positives = 159/273 (58%), Gaps = 10/273 (3%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           E+V  +Y  G E+G G+F +   C E STGL++A K I KR+     + V ++D+ RE+ 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I++ +   PN++     YE+   V +++EL AGGELFD +  +   +E  A    + I+N
Sbjct: 66  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAV---VKATDFGLSAFIEEGKAYREIVGSPYY 202
            V   HS  + H DLKPEN +    D N     +K  DFGL+  I+ G  ++ I G+P +
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182
Query: 203 IAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           +APE+++ +  G EAD+WS GVI YILL G  PF  +T Q     +      F+ + F +
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
            S+ A + +RR+L +DPK+R+T+   L+HPW+K
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  199 bits (505), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 102/273 (37%), Positives = 159/273 (58%), Gaps = 10/273 (3%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           E+V  +Y  G E+G G+F +   C E STGL++A K I KR+     + V ++D+ RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I++ +   PN++     YE+   V +++EL AGGELFD +  +   +E  A    + I+N
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAV---VKATDFGLSAFIEEGKAYREIVGSPYY 202
            V   HS  + H DLKPEN +    D N     +K  DFGL+  I+ G  ++ I G+P +
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 203 IAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           +APE+++ +  G EAD+WS GVI YILL G  PF  +T Q     +      F+ + F +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
            S+ A + +RR+L +DPK+R+T+   L+HPW+K
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  199 bits (505), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 102/273 (37%), Positives = 159/273 (58%), Gaps = 10/273 (3%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           E+V  +Y  G E+G G+F +   C E STGL++A K I KR+     + V ++D+ RE+ 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I++ +   PN++     YE+   V +++EL AGGELFD +  +   +E  A    + I+N
Sbjct: 66  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAV---VKATDFGLSAFIEEGKAYREIVGSPYY 202
            V   HS  + H DLKPEN +    D N     +K  DFGL+  I+ G  ++ I G+P +
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182
Query: 203 IAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           +APE+++ +  G EAD+WS GVI YILL G  PF  +T Q     +      F+ + F +
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
            S+ A + +RR+L +DPK+R+T+   L+HPW+K
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  198 bits (504), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 102/273 (37%), Positives = 159/273 (58%), Gaps = 10/273 (3%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           E+V  +Y  G E+G G+F +   C E STGL++A K I KR+     + V ++D+ RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I++ +   PN++     YE+   V +++EL AGGELFD +  +   +E  A    + I+N
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAV---VKATDFGLSAFIEEGKAYREIVGSPYY 202
            V   HS  + H DLKPEN +    D N     +K  DFGL+  I+ G  ++ I G+P +
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 203 IAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           +APE+++ +  G EAD+WS GVI YILL G  PF  +T Q     +      F+ + F +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
            S+ A + +RR+L +DPK+R+T+   L+HPW+K
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  198 bits (503), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 102/273 (37%), Positives = 159/273 (58%), Gaps = 10/273 (3%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           E+V  +Y  G E+G G+F +   C E STGL++A K I KR+     + V ++D+ RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I++ +   PN++     YE+   V +++EL AGGELFD +  +   +E  A    + I+N
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAV---VKATDFGLSAFIEEGKAYREIVGSPYY 202
            V   HS  + H DLKPEN +    D N     +K  DFGL+  I+ G  ++ I G+P +
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 203 IAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           +APE+++ +  G EAD+WS GVI YILL G  PF  +T Q     +      F+ + F +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
            S+ A + +RR+L +DPK+R+T+   L+HPW+K
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  197 bits (500), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 102/273 (37%), Positives = 158/273 (57%), Gaps = 10/273 (3%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           E+V  +Y  G E+G G F +   C E STGL++A K I KR+     + V ++D+ RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I++ +   PN++     YE+   V +++EL AGGELFD +  +   +E  A    + I+N
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAV---VKATDFGLSAFIEEGKAYREIVGSPYY 202
            V   HS  + H DLKPEN +    D N     +K  DFGL+  I+ G  ++ I G+P +
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 203 IAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           +APE+++ +  G EAD+WS GVI YILL G  PF  +T Q     +      F+ + F +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
            S+ A + +RR+L +DPK+R+T+   L+HPW+K
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  196 bits (499), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 102/273 (37%), Positives = 158/273 (57%), Gaps = 10/273 (3%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           E+V  +Y  G E+G G+F +   C E STGL++A K I KR+     + V ++D+ RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I++ +   PN++     YE+   V ++ EL AGGELFD +  +   +E  A    + I+N
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAV---VKATDFGLSAFIEEGKAYREIVGSPYY 202
            V   HS  + H DLKPEN +    D N     +K  DFGL+  I+ G  ++ I G+P +
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLL--DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 203 IAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           +APE+++ +  G EAD+WS GVI YILL G  PF  +T Q     +      F+ + F +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
            S+ A + +RR+L +DPK+R+T+   L+HPW+K
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  195 bits (496), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 109/303 (35%), Positives = 170/303 (56%), Gaps = 19/303 (6%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           + V+  Y IG E+G G+F I   C E STGLE+A K I KR+     + V ++++ RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I+R +   PNI+     YE+   V +++EL +GGELFD +  +   SE  A S  + I++
Sbjct: 68  ILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVV---KATDFGLSAFIEEGKAYREIVGSPYY 202
            VN  H+K + H DLKPEN +    D+N  +   K  DFGL+  IE+G  ++ I G+P +
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLL--DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 203 IAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           +APE+++ +  G EAD+WS GVI YILL G  PF  +T Q     I     +F  + F  
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDT-AVIFRMKQFTAMNK 320
            S  A + +R++L ++ ++R+T+ + L HPW+         P+DT   + R +    +  
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI--------TPVDTQQAMVRRESVVNLEN 296
Query: 321 LKK 323
            KK
Sbjct: 297 FKK 299

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  191 bits (486), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 101/272 (37%), Positives = 159/272 (58%), Gaps = 10/272 (3%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           + V+  Y IG E+G G+F I   C E STGLE+A K I KR+     + V ++++ RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I+R +    N++     YE+   V +++EL +GGELFD +  +   SE  A S  + I++
Sbjct: 68  ILRQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVV---KATDFGLSAFIEEGKAYREIVGSPYY 202
            VN  H+K + H DLKPEN +    D+N  +   K  DFGL+  IE+G  ++ I G+P +
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLL--DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 203 IAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           +APE+++ +  G EAD+WS GVI YILL G  PF  +T Q     I     +F  + F  
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
            S  A + +R++L ++ ++R+T+ + L HPW+
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  191 bits (486), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 101/272 (37%), Positives = 159/272 (58%), Gaps = 10/272 (3%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           + V+  Y IG E+G G+F I   C E STGLE+A K I KR+     + V ++++ RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I+R +    N++     YE+   V +++EL +GGELFD +  +   SE  A S  + I++
Sbjct: 68  ILRQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVV---KATDFGLSAFIEEGKAYREIVGSPYY 202
            VN  H+K + H DLKPEN +    D+N  +   K  DFGL+  IE+G  ++ I G+P +
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLL--DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 203 IAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           +APE+++ +  G EAD+WS GVI YILL G  PF  +T Q     I     +F  + F  
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
            S  A + +R++L ++ ++R+T+ + L HPW+
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  191 bits (486), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 101/272 (37%), Positives = 159/272 (58%), Gaps = 10/272 (3%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           + V+  Y IG E+G G+F I   C E STGLE+A K I KR+     + V ++++ RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I+R +    N++     YE+   V +++EL +GGELFD +  +   SE  A S  + I++
Sbjct: 68  ILRQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVV---KATDFGLSAFIEEGKAYREIVGSPYY 202
            VN  H+K + H DLKPEN +    D+N  +   K  DFGL+  IE+G  ++ I G+P +
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLL--DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 203 IAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           +APE+++ +  G EAD+WS GVI YILL G  PF  +T Q     I     +F  + F  
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
            S  A + +R++L ++ ++R+T+ + L HPW+
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  191 bits (485), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 101/272 (37%), Positives = 159/272 (58%), Gaps = 10/272 (3%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           + V+  Y IG E+G G+F I   C E STGLE+A K I KR+     + V ++++ RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I+R +    N++     YE+   V +++EL +GGELFD +  +   SE  A S  + I++
Sbjct: 68  ILRQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVV---KATDFGLSAFIEEGKAYREIVGSPYY 202
            VN  H+K + H DLKPEN +    D+N  +   K  DFGL+  IE+G  ++ I G+P +
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLL--DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 203 IAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           +APE+++ +  G EAD+WS GVI YILL G  PF  +T Q     I     +F  + F  
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
            S  A + +R++L ++ ++R+T+ + L HPW+
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  191 bits (485), Expect = 9e-49,   Method: Compositional matrix adjust.
 Identities = 101/272 (37%), Positives = 159/272 (58%), Gaps = 10/272 (3%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           + V+  Y IG E+G G+F I   C E STGLE+A K I KR+     + V ++++ RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I+R +    N++     YE+   V +++EL +GGELFD +  +   SE  A S  + I++
Sbjct: 68  ILRQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVV---KATDFGLSAFIEEGKAYREIVGSPYY 202
            VN  H+K + H DLKPEN +    D+N  +   K  DFGL+  IE+G  ++ I G+P +
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLL--DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 203 IAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           +APE+++ +  G EAD+WS GVI YILL G  PF  +T Q     I     +F  + F  
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
            S  A + +R++L ++ ++R+T+ + L HPW+
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  190 bits (483), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 96/266 (36%), Positives = 152/266 (57%), Gaps = 15/266 (5%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSI---PKRKLVKDVE--KDDVRREIEIMRHLSGQPN 95
           +GRG   +   C   +TG EFA K +    +R   + +E  ++  RRE  I+R ++G P+
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGV 155
           I+    +YE   F+ +V +L   GELFD +  +   SE+   S+ R ++  V+  H+  +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNI 221
Query: 156 MHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS---- 211
           +HRDLKPEN L    D+N  ++ +DFG S  +E G+  RE+ G+P Y+APE+L  S    
Sbjct: 222 VHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDET 278
Query: 212 ---YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
              YGKE D+W+ GVIL+ LL G PPFW      + + I++G+  F    +   SS+  +
Sbjct: 279 HPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKD 338
Query: 269 LVRRMLTQDPKRRITVAQVLEHPWLK 294
           L+ R+L  DP+ R+T  Q L+HP+ +
Sbjct: 339 LISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  188 bits (478), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 116/334 (34%), Positives = 172/334 (51%), Gaps = 20/334 (5%)
Query: 28  YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD--VEKDDVRREIE 85
           +EDV   Y +   +G+G F +   C    TG +FA K +   K      +  +D++RE  
Sbjct: 22  FEDV---YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH----YSERAAASVFR 141
           I  H+   P+IV+    Y  D  +++V E   G +L   IV R      YSE  A+   R
Sbjct: 79  IC-HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 142 VIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVGSP 200
            I+  +  CH   ++HRD+KPEN L  + + +A VK  DFG++  + E G      VG+P
Sbjct: 138 QILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTP 197
Query: 201 YYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF 259
           +++APEV+  + YGK  D+W  GVIL+ILL G  PF+  T + + + I+KG+       +
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQW 256
Query: 260 PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMN 319
             IS SA +LVRRML  DP  RITV + L HPWLKE    + K      + ++++F A  
Sbjct: 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARR 316
Query: 320 KLKKLALKVIVENL-------PTEEIQKLKEKFT 346
           KLK   L  +  +        P EE+    E  T
Sbjct: 317 KLKGAVLAAVSSHKFNSFYGDPPEELPDFSEDPT 350

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 107/289 (37%), Positives = 158/289 (54%), Gaps = 21/289 (7%)
Query: 35  YTIGREV-GRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           Y + ++V G G  G    C    TG + A K      L+ D  K   R+E++     SG 
Sbjct: 11  YQLSKQVLGLGVNGKVLECFHRRTGQKCALK------LLYDSPK--ARQEVDHHWQASGG 62
Query: 94  PNIVQFKAAYED----DQFVHIVMELCAGGELFDRIVARGH--YSERAAASVFRVIMNVV 147
           P+IV     YE+     + + I+ME   GGELF RI  RG   ++ER AA + R I   +
Sbjct: 63  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 122
Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV 207
              HS  + HRD+KPEN L+T+ +++AV+K TDFG +    +  A +    +PYY+APEV
Sbjct: 123 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEV 181
Query: 208 L-SQSYGKEADIWSAGVILYILLCGVPPFWAETDQ----GVAQAILKGEINFQRDPFPSI 262
           L  + Y K  D+WS GVI+YILLCG PPF++ T Q    G+ + I  G+  F    +  +
Sbjct: 182 LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 241
Query: 263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFR 311
           S  A +L+R +L  DP  R+T+ Q + HPW+ +S      P+ TA + +
Sbjct: 242 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQ 290

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  183 bits (465), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 101/266 (37%), Positives = 154/266 (57%), Gaps = 8/266 (3%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +   R++G G FG  +L  E S+GLE   K+I K +    V  + +  EIE+++ L   P
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLD-HP 80
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIV---ARGH-YSERAAASVFRVIMNVVNVC 150
           NI++    +ED   ++IVME C GGEL +RIV   ARG   SE   A + + +MN +   
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ 210
           HS+ V+H+DLKPEN LF     ++ +K  DFGL+   +  +      G+  Y+APEV  +
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR 200
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
               + DIWSAGV++Y LL G  PF   + + V Q     E N+  +  P ++  A++L+
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP-LTPQAVDLL 259
Query: 271 RRMLTQDPKRRITVAQVLEHPWLKES 296
           ++MLT+DP+RR + AQVL H W K++
Sbjct: 260 KQMLTKDPERRPSAAQVLHHEWFKQA 285

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  183 bits (465), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 107/289 (37%), Positives = 158/289 (54%), Gaps = 21/289 (7%)
Query: 35  YTIGREV-GRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           Y + ++V G G  G    C    TG + A K      L+ D  K   R+E++     SG 
Sbjct: 30  YQLSKQVLGLGVNGKVLECFHRRTGQKCALK------LLYDSPK--ARQEVDHHWQASGG 81
Query: 94  PNIVQFKAAYED----DQFVHIVMELCAGGELFDRIVARGH--YSERAAASVFRVIMNVV 147
           P+IV     YE+     + + I+ME   GGELF RI  RG   ++ER AA + R I   +
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV 207
              HS  + HRD+KPEN L+T+ +++AV+K TDFG +    +  A +    +PYY+APEV
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEV 200
Query: 208 L-SQSYGKEADIWSAGVILYILLCGVPPFWAETDQ----GVAQAILKGEINFQRDPFPSI 262
           L  + Y K  D+WS GVI+YILLCG PPF++ T Q    G+ + I  G+  F    +  +
Sbjct: 201 LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 260
Query: 263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFR 311
           S  A +L+R +L  DP  R+T+ Q + HPW+ +S      P+ TA + +
Sbjct: 261 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQ 309

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  181 bits (460), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 116/345 (33%), Positives = 173/345 (50%), Gaps = 25/345 (7%)
Query: 28  YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD--VEKDDVRREIE 85
           +EDV   Y +   +G+G F +   C    TG +FA K +   K      +  +D++RE  
Sbjct: 24  FEDV---YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 80
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH----YSERAAASVFR 141
           I  H+   P+IV+    Y  D  +++V E   G +L   IV R      YSE  A+   R
Sbjct: 81  IC-HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 139
Query: 142 VIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVGSP 200
            I+  +  CH   ++HRD+KP   L  + + +A VK   FG++  + E G      VG+P
Sbjct: 140 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP 199
Query: 201 YYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF 259
           +++APEV+  + YGK  D+W  GVIL+ILL G  PF+  T + + + I+KG+       +
Sbjct: 200 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQW 258
Query: 260 PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMN 319
             IS SA +LVRRML  DP  RITV + L HPWLKE    + K      + ++++F A  
Sbjct: 259 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARR 318
Query: 320 KLKKLALKVIVENL-------PTEEIQKLKEKFTEMDTDNSGTLT 357
           KLK   L  +  +        P EE+    E     D  +SG L 
Sbjct: 319 KLKGAVLAAVSSHKFNSFYGDPPEELPDFSE-----DPTSSGLLA 358

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 113/334 (33%), Positives = 169/334 (50%), Gaps = 20/334 (5%)
Query: 28  YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD--VEKDDVRREIE 85
           +EDV   Y +   +G+G F +   C    TG +FA K +   K      +  +D++RE  
Sbjct: 22  FEDV---YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH----YSERAAASVFR 141
           I  H+   P+IV+    Y  D  +++V E   G +L   IV R      YSE  A+   R
Sbjct: 79  IC-HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 142 VIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVGSP 200
            I+  +  CH   ++HRD+KP   L  + + +A VK   FG++  + E G      VG+P
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP 197
Query: 201 YYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF 259
           +++APEV+  + YGK  D+W  GVIL+ILL G  PF+  T + + + I+KG+       +
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQW 256
Query: 260 PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMN 319
             IS SA +LVRRML  DP  RITV + L HPWLKE    + K      + ++++F A  
Sbjct: 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARR 316
Query: 320 KLKKLALKVIVENL-------PTEEIQKLKEKFT 346
           KLK   L  +  +        P EE+    E  T
Sbjct: 317 KLKGAVLAAVSSHKFNSFYGDPPEELPDFSEDPT 350

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  180 bits (456), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 102/286 (35%), Positives = 154/286 (53%), Gaps = 15/286 (5%)
Query: 20  HDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD- 78
           H ++  KA  D    Y + + +G G  G   L  E  T  + A K I KRK      ++ 
Sbjct: 6   HMSVYPKALRD---EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREA 62
Query: 79  ----DVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSER 134
               +V  EIEI++ L+  P I++ K  ++ + + +IV+EL  GGELFD++V      E 
Sbjct: 63  DPALNVETEIEILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEA 120
Query: 135 AAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR 194
                F  ++  V   H  G++HRDLKPEN L ++ +E+ ++K TDFG S  + E    R
Sbjct: 121 TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 180
Query: 195 EIVGSPYYIAPEVL----SQSYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILK 249
            + G+P Y+APEVL    +  Y +  D WS GVIL+I L G PPF     Q  +   I  
Sbjct: 181 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 240
Query: 250 GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
           G+ NF  + +  +S  A++LV+++L  DPK R T  + L HPWL++
Sbjct: 241 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 286

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 145/269 (53%), Gaps = 18/269 (6%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIP-------KRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +GRG   +   C    T  E+A K I          + V+++ ++   +E++I+R +SG 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQEL-REATLKEVDILRKVSGH 83
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PNI+Q K  YE + F  +V +L   GELFD +  +   SE+    + R ++ V+   H  
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 143
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS-- 211
            ++HRDLKPEN L    D++  +K TDFG S  ++ G+  RE+ G+P Y+APE++  S  
Sbjct: 144 NIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN 200
Query: 212 -----YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
                YGKE D+WS GVI+Y LL G PPFW      + + I+ G   F    +   S + 
Sbjct: 201 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTV 260
Query: 267 IELVRRMLTQDPKRRITVAQVLEHPWLKE 295
            +LV R L   P++R T  + L HP+ ++
Sbjct: 261 KDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  179 bits (454), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 145/269 (53%), Gaps = 18/269 (6%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIP-------KRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +GRG   +   C    T  E+A K I          + V+++ ++   +E++I+R +SG 
Sbjct: 12  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQEL-REATLKEVDILRKVSGH 70
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PNI+Q K  YE + F  +V +L   GELFD +  +   SE+    + R ++ V+   H  
Sbjct: 71  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 130
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS-- 211
            ++HRDLKPEN L    D++  +K TDFG S  ++ G+  RE+ G+P Y+APE++  S  
Sbjct: 131 NIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN 187
Query: 212 -----YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
                YGKE D+WS GVI+Y LL G PPFW      + + I+ G   F    +   S + 
Sbjct: 188 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTV 247
Query: 267 IELVRRMLTQDPKRRITVAQVLEHPWLKE 295
            +LV R L   P++R T  + L HP+ ++
Sbjct: 248 KDLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  178 bits (452), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 101/284 (35%), Positives = 153/284 (53%), Gaps = 15/284 (5%)
Query: 22  AILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD--- 78
           ++  KA  D    Y + + +G G  G   L  E  T  + A K I KRK      ++   
Sbjct: 2   SVYPKALRD---EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADP 58
Query: 79  --DVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAA 136
             +V  EIEI++ L+  P I++ K  ++ + + +IV+EL  GGELFD++V      E   
Sbjct: 59  ALNVETEIEILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATC 116
Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI 196
              F  ++  V   H  G++HRDLKPEN L ++ +E+ ++K TDFG S  + E    R +
Sbjct: 117 KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176
Query: 197 VGSPYYIAPEVL----SQSYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGE 251
            G+P Y+APEVL    +  Y +  D WS GVIL+I L G PPF     Q  +   I  G+
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
Query: 252 INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
            NF  + +  +S  A++LV+++L  DPK R T  + L HPWL++
Sbjct: 237 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  178 bits (451), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 101/284 (35%), Positives = 153/284 (53%), Gaps = 15/284 (5%)
Query: 22  AILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD--- 78
           ++  KA  D    Y + + +G G  G   L  E  T  + A K I KRK      ++   
Sbjct: 2   SVYPKALRD---EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADP 58
Query: 79  --DVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAA 136
             +V  EIEI++ L+  P I++ K  ++ + + +IV+EL  GGELFD++V      E   
Sbjct: 59  ALNVETEIEILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATC 116
Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI 196
              F  ++  V   H  G++HRDLKPEN L ++ +E+ ++K TDFG S  + E    R +
Sbjct: 117 KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176
Query: 197 VGSPYYIAPEVL----SQSYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGE 251
            G+P Y+APEVL    +  Y +  D WS GVIL+I L G PPF     Q  +   I  G+
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
Query: 252 INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
            NF  + +  +S  A++LV+++L  DPK R T  + L HPWL++
Sbjct: 237 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  178 bits (451), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 101/284 (35%), Positives = 153/284 (53%), Gaps = 15/284 (5%)
Query: 22  AILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD--- 78
           ++  KA  D    Y + + +G G  G   L  E  T  + A K I KRK      ++   
Sbjct: 1   SVYPKALRD---EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADP 57
Query: 79  --DVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAA 136
             +V  EIEI++ L+  P I++ K  ++ + + +IV+EL  GGELFD++V      E   
Sbjct: 58  ALNVETEIEILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATC 115
Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI 196
              F  ++  V   H  G++HRDLKPEN L ++ +E+ ++K TDFG S  + E    R +
Sbjct: 116 KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 175
Query: 197 VGSPYYIAPEVL----SQSYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGE 251
            G+P Y+APEVL    +  Y +  D WS GVIL+I L G PPF     Q  +   I  G+
Sbjct: 176 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 235
Query: 252 INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
            NF  + +  +S  A++LV+++L  DPK R T  + L HPWL++
Sbjct: 236 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 279

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  178 bits (451), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 101/284 (35%), Positives = 153/284 (53%), Gaps = 15/284 (5%)
Query: 22  AILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD--- 78
           ++  KA  D    Y + + +G G  G   L  E  T  + A K I KRK      ++   
Sbjct: 2   SVYPKALRD---EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADP 58
Query: 79  --DVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAA 136
             +V  EIEI++ L+  P I++ K  ++ + + +IV+EL  GGELFD++V      E   
Sbjct: 59  ALNVETEIEILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATC 116
Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI 196
              F  ++  V   H  G++HRDLKPEN L ++ +E+ ++K TDFG S  + E    R +
Sbjct: 117 KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176
Query: 197 VGSPYYIAPEVL----SQSYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGE 251
            G+P Y+APEVL    +  Y +  D WS GVIL+I L G PPF     Q  +   I  G+
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236
Query: 252 INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
            NF  + +  +S  A++LV+++L  DPK R T  + L HPWL++
Sbjct: 237 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  177 bits (449), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 144/269 (53%), Gaps = 18/269 (6%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIP-------KRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +GRG   +   C    T  E+A K I          + V+++ ++   +E++I+R +SG 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQEL-REATLKEVDILRKVSGH 83
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PNI+Q K  YE + F  +V +L   GELFD +  +   SE+    + R ++ V+   H  
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 143
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS-- 211
            ++HRDLKPEN L    D++  +K TDFG S  ++ G+  R + G+P Y+APE++  S  
Sbjct: 144 NIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMN 200
Query: 212 -----YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
                YGKE D+WS GVI+Y LL G PPFW      + + I+ G   F    +   S + 
Sbjct: 201 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTV 260
Query: 267 IELVRRMLTQDPKRRITVAQVLEHPWLKE 295
            +LV R L   P++R T  + L HP+ ++
Sbjct: 261 KDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  177 bits (448), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 100/284 (35%), Positives = 153/284 (53%), Gaps = 15/284 (5%)
Query: 22  AILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD--- 78
           ++  KA  D    Y + + +G G  G   L  E  T  + A + I KRK      ++   
Sbjct: 141 SVYPKALRD---EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADP 197
Query: 79  --DVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAA 136
             +V  EIEI++ L+  P I++ K  ++ + + +IV+EL  GGELFD++V      E   
Sbjct: 198 ALNVETEIEILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATC 255
Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI 196
              F  ++  V   H  G++HRDLKPEN L ++ +E+ ++K TDFG S  + E    R +
Sbjct: 256 KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 315
Query: 197 VGSPYYIAPEVL----SQSYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGE 251
            G+P Y+APEVL    +  Y +  D WS GVIL+I L G PPF     Q  +   I  G+
Sbjct: 316 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 375
Query: 252 INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
            NF  + +  +S  A++LV+++L  DPK R T  + L HPWL++
Sbjct: 376 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 419

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 100/284 (35%), Positives = 153/284 (53%), Gaps = 15/284 (5%)
Query: 22  AILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD--- 78
           ++  KA  D    Y + + +G G  G   L  E  T  + A + I KRK      ++   
Sbjct: 127 SVYPKALRD---EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADP 183
Query: 79  --DVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAA 136
             +V  EIEI++ L+  P I++ K  ++ + + +IV+EL  GGELFD++V      E   
Sbjct: 184 ALNVETEIEILKKLN-HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATC 241
Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI 196
              F  ++  V   H  G++HRDLKPEN L ++ +E+ ++K TDFG S  + E    R +
Sbjct: 242 KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 301
Query: 197 VGSPYYIAPEVL----SQSYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGE 251
            G+P Y+APEVL    +  Y +  D WS GVIL+I L G PPF     Q  +   I  G+
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 361
Query: 252 INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
            NF  + +  +S  A++LV+++L  DPK R T  + L HPWL++
Sbjct: 362 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 91/253 (35%), Positives = 141/253 (55%), Gaps = 13/253 (5%)
Query: 70  KLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----DQFVHIVMELCAGGELFDRI 125
           K+++D  K   RRE+E+    S  P+IV+    YE+     + + IVME   GGELF RI
Sbjct: 47  KMLQDCPK--ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 104
Query: 126 VARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL 183
             RG   ++ER A+ + + I   +   HS  + HRD+KPEN L+T+   NA++K TDFG 
Sbjct: 105 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 164
Query: 184 SAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKEADIWSAGVILYILLCGVPPFWAE---- 238
           +       +  E   +PYY+APEVL  + Y K  D+WS GVI+YILLCG PPF++     
Sbjct: 165 AKETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 224
Query: 239 TDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298
              G+   I  G+  F    +  +S     L+R +L  +P +R+T+ + + HPW+ +S +
Sbjct: 225 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 284
Query: 299 ASDKPIDTAVIFR 311
               P+ T+ + +
Sbjct: 285 VPQTPLHTSRVLK 297

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 90/253 (35%), Positives = 140/253 (55%), Gaps = 13/253 (5%)
Query: 70  KLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----DQFVHIVMELCAGGELFDRI 125
           K+++D  K   RRE+E+    S  P+IV+    YE+     + + IVME   GGELF RI
Sbjct: 93  KMLQDCPK--ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 150
Query: 126 VARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL 183
             RG   ++ER A+ + + I   +   HS  + HRD+KPEN L+T+   NA++K TDFG 
Sbjct: 151 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210
Query: 184 SAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKEADIWSAGVILYILLCGVPPFWAE---- 238
           +       +      +PYY+APEVL  + Y K  D+WS GVI+YILLCG PPF++     
Sbjct: 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 270
Query: 239 TDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298
              G+   I  G+  F    +  +S     L+R +L  +P +R+T+ + + HPW+ +S +
Sbjct: 271 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330
Query: 299 ASDKPIDTAVIFR 311
               P+ T+ + +
Sbjct: 331 VPQTPLHTSRVLK 343

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 90/253 (35%), Positives = 140/253 (55%), Gaps = 13/253 (5%)
Query: 70  KLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----DQFVHIVMELCAGGELFDRI 125
           K+++D  K   RRE+E+    S  P+IV+    YE+     + + IVME   GGELF RI
Sbjct: 99  KMLQDCPK--ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 156
Query: 126 VARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL 183
             RG   ++ER A+ + + I   +   HS  + HRD+KPEN L+T+   NA++K TDFG 
Sbjct: 157 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 216
Query: 184 SAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKEADIWSAGVILYILLCGVPPFWAE---- 238
           +       +      +PYY+APEVL  + Y K  D+WS GVI+YILLCG PPF++     
Sbjct: 217 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 276
Query: 239 TDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298
              G+   I  G+  F    +  +S     L+R +L  +P +R+T+ + + HPW+ +S +
Sbjct: 277 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 336
Query: 299 ASDKPIDTAVIFR 311
               P+ T+ + +
Sbjct: 337 VPQTPLHTSRVLK 349

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 90/253 (35%), Positives = 140/253 (55%), Gaps = 13/253 (5%)
Query: 70  KLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----DQFVHIVMELCAGGELFDRI 125
           K+++D  K   RRE+E+    S  P+IV+    YE+     + + IVME   GGELF RI
Sbjct: 49  KMLQDCPK--ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 106
Query: 126 VARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL 183
             RG   ++ER A+ + + I   +   HS  + HRD+KPEN L+T+   NA++K TDFG 
Sbjct: 107 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 184 SAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKEADIWSAGVILYILLCGVPPFWAE---- 238
           +       +      +PYY+APEVL  + Y K  D+WS GVI+YILLCG PPF++     
Sbjct: 167 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 226
Query: 239 TDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298
              G+   I  G+  F    +  +S     L+R +L  +P +R+T+ + + HPW+ +S +
Sbjct: 227 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 286
Query: 299 ASDKPIDTAVIFR 311
               P+ T+ + +
Sbjct: 287 VPQTPLHTSRVLK 299

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 90/253 (35%), Positives = 140/253 (55%), Gaps = 13/253 (5%)
Query: 70  KLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----DQFVHIVMELCAGGELFDRI 125
           K+++D  K   RRE+E+    S  P+IV+    YE+     + + IVME   GGELF RI
Sbjct: 48  KMLQDCPK--ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 105
Query: 126 VARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL 183
             RG   ++ER A+ + + I   +   HS  + HRD+KPEN L+T+   NA++K TDFG 
Sbjct: 106 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 165
Query: 184 SAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKEADIWSAGVILYILLCGVPPFWAE---- 238
           +       +      +PYY+APEVL  + Y K  D+WS GVI+YILLCG PPF++     
Sbjct: 166 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 225
Query: 239 TDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298
              G+   I  G+  F    +  +S     L+R +L  +P +R+T+ + + HPW+ +S +
Sbjct: 226 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 285
Query: 299 ASDKPIDTAVIFR 311
               P+ T+ + +
Sbjct: 286 VPQTPLHTSRVLK 298

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 90/253 (35%), Positives = 140/253 (55%), Gaps = 13/253 (5%)
Query: 70  KLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----DQFVHIVMELCAGGELFDRI 125
           K+++D  K   RRE+E+    S  P+IV+    YE+     + + IVME   GGELF RI
Sbjct: 47  KMLQDCPK--ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 104
Query: 126 VARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL 183
             RG   ++ER A+ + + I   +   HS  + HRD+KPEN L+T+   NA++K TDFG 
Sbjct: 105 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 164
Query: 184 SAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKEADIWSAGVILYILLCGVPPFWAE---- 238
           +       +      +PYY+APEVL  + Y K  D+WS GVI+YILLCG PPF++     
Sbjct: 165 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 224
Query: 239 TDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298
              G+   I  G+  F    +  +S     L+R +L  +P +R+T+ + + HPW+ +S +
Sbjct: 225 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 284
Query: 299 ASDKPIDTAVIFR 311
               P+ T+ + +
Sbjct: 285 VPQTPLHTSRVLK 297

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 90/253 (35%), Positives = 140/253 (55%), Gaps = 13/253 (5%)
Query: 70  KLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----DQFVHIVMELCAGGELFDRI 125
           K+++D  K   RRE+E+    S  P+IV+    YE+     + + IVME   GGELF RI
Sbjct: 49  KMLQDCPK--ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 106
Query: 126 VARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL 183
             RG   ++ER A+ + + I   +   HS  + HRD+KPEN L+T+   NA++K TDFG 
Sbjct: 107 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 184 SAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKEADIWSAGVILYILLCGVPPFWAE---- 238
           +       +      +PYY+APEVL  + Y K  D+WS GVI+YILLCG PPF++     
Sbjct: 167 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 226
Query: 239 TDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298
              G+   I  G+  F    +  +S     L+R +L  +P +R+T+ + + HPW+ +S +
Sbjct: 227 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 286
Query: 299 ASDKPIDTAVIFR 311
               P+ T+ + +
Sbjct: 287 VPQTPLHTSRVLK 299

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 90/253 (35%), Positives = 140/253 (55%), Gaps = 13/253 (5%)
Query: 70  KLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----DQFVHIVMELCAGGELFDRI 125
           K+++D  K   RRE+E+    S  P+IV+    YE+     + + IVME   GGELF RI
Sbjct: 54  KMLQDCPK--ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 111
Query: 126 VARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL 183
             RG   ++ER A+ + + I   +   HS  + HRD+KPEN L+T+   NA++K TDFG 
Sbjct: 112 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 171
Query: 184 SAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKEADIWSAGVILYILLCGVPPFWAE---- 238
           +       +      +PYY+APEVL  + Y K  D+WS GVI+YILLCG PPF++     
Sbjct: 172 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 231
Query: 239 TDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298
              G+   I  G+  F    +  +S     L+R +L  +P +R+T+ + + HPW+ +S +
Sbjct: 232 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 291
Query: 299 ASDKPIDTAVIFR 311
               P+ T+ + +
Sbjct: 292 VPQTPLHTSRVLK 304

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 90/253 (35%), Positives = 140/253 (55%), Gaps = 13/253 (5%)
Query: 70  KLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----DQFVHIVMELCAGGELFDRI 125
           K+++D  K   RRE+E+    S  P+IV+    YE+     + + IVME   GGELF RI
Sbjct: 55  KMLQDCPK--ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 112
Query: 126 VARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL 183
             RG   ++ER A+ + + I   +   HS  + HRD+KPEN L+T+   NA++K TDFG 
Sbjct: 113 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 172
Query: 184 SAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKEADIWSAGVILYILLCGVPPFWAE---- 238
           +       +      +PYY+APEVL  + Y K  D+WS GVI+YILLCG PPF++     
Sbjct: 173 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 232
Query: 239 TDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298
              G+   I  G+  F    +  +S     L+R +L  +P +R+T+ + + HPW+ +S +
Sbjct: 233 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 292
Query: 299 ASDKPIDTAVIFR 311
               P+ T+ + +
Sbjct: 293 VPQTPLHTSRVLK 305

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 90/253 (35%), Positives = 140/253 (55%), Gaps = 13/253 (5%)
Query: 70  KLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----DQFVHIVMELCAGGELFDRI 125
           K+++D  K   RRE+E+    S  P+IV+    YE+     + + IVME   GGELF RI
Sbjct: 53  KMLQDCPK--ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 110
Query: 126 VARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL 183
             RG   ++ER A+ + + I   +   HS  + HRD+KPEN L+T+   NA++K TDFG 
Sbjct: 111 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 170
Query: 184 SAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKEADIWSAGVILYILLCGVPPFWAE---- 238
           +       +      +PYY+APEVL  + Y K  D+WS GVI+YILLCG PPF++     
Sbjct: 171 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 230
Query: 239 TDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298
              G+   I  G+  F    +  +S     L+R +L  +P +R+T+ + + HPW+ +S +
Sbjct: 231 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 290
Query: 299 ASDKPIDTAVIFR 311
               P+ T+ + +
Sbjct: 291 VPQTPLHTSRVLK 303

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 90/253 (35%), Positives = 140/253 (55%), Gaps = 13/253 (5%)
Query: 70  KLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----DQFVHIVMELCAGGELFDRI 125
           K+++D  K   RRE+E+    S  P+IV+    YE+     + + IVME   GGELF RI
Sbjct: 63  KMLQDCPK--ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 120
Query: 126 VARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL 183
             RG   ++ER A+ + + I   +   HS  + HRD+KPEN L+T+   NA++K TDFG 
Sbjct: 121 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 180
Query: 184 SAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKEADIWSAGVILYILLCGVPPFWAE---- 238
           +       +      +PYY+APEVL  + Y K  D+WS GVI+YILLCG PPF++     
Sbjct: 181 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 240
Query: 239 TDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298
              G+   I  G+  F    +  +S     L+R +L  +P +R+T+ + + HPW+ +S +
Sbjct: 241 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 300
Query: 299 ASDKPIDTAVIFR 311
               P+ T+ + +
Sbjct: 301 VPQTPLHTSRVLK 313

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  172 bits (435), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 98/268 (36%), Positives = 146/268 (54%), Gaps = 19/268 (7%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y +  ++G G + +   C   +T +EFA K I       D  K D   EIEI+      P
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKII-------DKSKRDPTEEIEILLRYGQHP 76
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI+  K  Y+D ++V++V EL  GGEL D+I+ +  +SER A++V   I   V   H++G
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG 136
Query: 155 VMHRDLKPENFLFTTGDENA-VVKATDFGLSAFIEEGKAYREIVGSPYY----IAPEVLS 209
           V+HRDLKP N L+     N   ++  DFG   F ++ +A   ++ +P Y    +APEVL 
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFG---FAKQLRAENGLLMTPCYTANFVAPEVLE 193
Query: 210 -QSYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKGEINFQRDPFPSISSS 265
            Q Y    DIWS GV+LY +L G  PF     +T + +   I  G+ +     + S+S +
Sbjct: 194 RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT 253
Query: 266 AIELVRRMLTQDPKRRITVAQVLEHPWL 293
           A +LV +ML  DP +R+T A VL HPW+
Sbjct: 254 AKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 94/289 (32%), Positives = 157/289 (54%), Gaps = 18/289 (6%)
Query: 34  HYTIG---REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           HY +    + +G G F I   C    +   FA K I KR       + + ++EI  ++  
Sbjct: 9   HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLC 62
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC 150
            G PNIV+    + D     +VMEL  GGELF+RI  + H+SE  A+ + R +++ V+  
Sbjct: 63  EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF-IEEGKAYREIVGSPYYIAPEVLS 209
           H  GV+HRDLKPEN LFT  ++N  +K  DFG +     + +  +    + +Y APE+L+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN 182
Query: 210 QS-YGKEADIWSAGVILYILLCGVPPFWAE-------TDQGVAQAILKGEINFQRDPFPS 261
           Q+ Y +  D+WS GVILY +L G  PF +        +   + + I KG+ +F+ + + +
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN 242
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIF 310
           +S  A +L++ +LT DP +R+ ++ +  + WL++  + S  P+ T  I 
Sbjct: 243 VSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDIL 291

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 96/270 (35%), Positives = 145/270 (53%), Gaps = 19/270 (7%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y +   +G G +     C   +T +E+A K I       D  K D   EIEI+      P
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVI-------DKSKRDPSEEIEILLRYGQHP 81
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI+  K  Y+D + V++V EL  GGEL D+I+ +  +SER A+ V   I   V   HS+G
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG 141
Query: 155 VMHRDLKPENFLFTTGDENA-VVKATDFGLSAFIEEGKAYREIVGSPYY----IAPEVLS 209
           V+HRDLKP N L+     N   ++  DFG   F ++ +A   ++ +P Y    +APEVL 
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFG---FAKQLRAENGLLMTPCYTANFVAPEVLK 198
Query: 210 -QSYGKEADIWSAGVILYILLCGVPPFW---AETDQGVAQAILKGEINFQRDPFPSISSS 265
            Q Y +  DIWS G++LY +L G  PF    ++T + +   I  G+       + ++S +
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSET 258
Query: 266 AIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
           A +LV +ML  DP +R+T  QVL+HPW+ +
Sbjct: 259 AKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  169 bits (427), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 96/270 (35%), Positives = 145/270 (53%), Gaps = 19/270 (7%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y +   +G G +     C   +T +E+A K I       D  K D   EIEI+      P
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVI-------DKSKRDPSEEIEILLRYGQHP 81
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI+  K  Y+D + V++V EL  GGEL D+I+ +  +SER A+ V   I   V   HS+G
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG 141
Query: 155 VMHRDLKPENFLFTTGDENA-VVKATDFGLSAFIEEGKAYREIVGSPYY----IAPEVLS 209
           V+HRDLKP N L+     N   ++  DFG   F ++ +A   ++ +P Y    +APEVL 
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFG---FAKQLRAENGLLMTPCYTANFVAPEVLK 198
Query: 210 -QSYGKEADIWSAGVILYILLCGVPPFW---AETDQGVAQAILKGEINFQRDPFPSISSS 265
            Q Y +  DIWS G++LY +L G  PF    ++T + +   I  G+       + ++S +
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSET 258
Query: 266 AIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
           A +LV +ML  DP +R+T  QVL+HPW+ +
Sbjct: 259 AKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  167 bits (422), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 97/268 (36%), Positives = 143/268 (53%), Gaps = 19/268 (7%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y +  ++G G + +   C   +T  EFA K I       D  K D   EIEI+      P
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKII-------DKSKRDPTEEIEILLRYGQHP 76
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI+  K  Y+D ++V++V EL  GGEL D+I+ +  +SER A++V   I   V   H++G
Sbjct: 77  NIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG 136
Query: 155 VMHRDLKPENFLFTTGDENA-VVKATDFGLSAFIEEGKAYREIVGSPYY----IAPEVLS 209
           V+HRDLKP N L+     N   ++  DFG   F ++ +A   ++ +P Y    +APEVL 
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFG---FAKQLRAENGLLXTPCYTANFVAPEVLE 193
Query: 210 -QSYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKGEINFQRDPFPSISSS 265
            Q Y    DIWS GV+LY  L G  PF     +T + +   I  G+ +     + S+S +
Sbjct: 194 RQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT 253
Query: 266 AIELVRRMLTQDPKRRITVAQVLEHPWL 293
           A +LV + L  DP +R+T A VL HPW+
Sbjct: 254 AKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 93/262 (35%), Positives = 138/262 (52%), Gaps = 7/262 (2%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           HY I  E+G G FG+ +  TE +TG  FA K +       + +K+ VR+EI+ M  L   
Sbjct: 52  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKEIQTMSVLR-H 107
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIV-ARGHYSERAAASVFRVIMNVVNVCHS 152
           P +V    A+EDD  + ++ E  +GGELF+++       SE  A    R +   +   H 
Sbjct: 108 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 167
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQS 211
              +H DLKPEN +FTT   N + K  DFGL+A ++  ++ +   G+  + APEV   + 
Sbjct: 168 NNYVHLDLKPENIMFTTKRSNEL-KLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 226
Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G   D+WS GV+ YILL G+ PF  E D    + +   + N     F  IS    + +R
Sbjct: 227 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 286
Query: 272 RMLTQDPKRRITVAQVLEHPWL 293
           ++L  DP  R+T+ Q LEHPWL
Sbjct: 287 KLLLADPNTRMTIHQALEHPWL 308

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  165 bits (417), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 89/253 (35%), Positives = 133/253 (52%), Gaps = 13/253 (5%)
Query: 70  KLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----DQFVHIVMELCAGGELFDRI 125
           K ++D  K   RRE+E+    S  P+IV+    YE+     + + IV E   GGELF RI
Sbjct: 93  KXLQDCPK--ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRI 150
Query: 126 VARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL 183
             RG   ++ER A+ + + I   +   HS  + HRD+KPEN L+T+   NA++K TDFG 
Sbjct: 151 QDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210
Query: 184 SAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKEADIWSAGVILYILLCGVPPFWAE---- 238
           +       +      +PYY+APEVL  + Y K  D WS GVI YILLCG PPF++     
Sbjct: 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLA 270
Query: 239 TDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298
              G    I  G+  F    +  +S     L+R +L  +P +R T+ +   HPW+ +S +
Sbjct: 271 ISPGXKTRIRXGQYEFPNPEWSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTK 330
Query: 299 ASDKPIDTAVIFR 311
               P+ T+ + +
Sbjct: 331 VPQTPLHTSRVLK 343

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  164 bits (416), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 93/262 (35%), Positives = 138/262 (52%), Gaps = 7/262 (2%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           HY I  E+G G FG+ +  TE +TG  FA K +       + +K+ VR+EI+ M  L   
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKEIQTMSVLR-H 213
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIV-ARGHYSERAAASVFRVIMNVVNVCHS 152
           P +V    A+EDD  + ++ E  +GGELF+++       SE  A    R +   +   H 
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQS 211
              +H DLKPEN +FTT   N + K  DFGL+A ++  ++ +   G+  + APEV   + 
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNEL-KLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 332
Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G   D+WS GV+ YILL G+ PF  E D    + +   + N     F  IS    + +R
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 392
Query: 272 RMLTQDPKRRITVAQVLEHPWL 293
           ++L  DP  R+T+ Q LEHPWL
Sbjct: 393 KLLLADPNTRMTIHQALEHPWL 414

>pdb|2AAO|A Chain A, Regulatory Apparatus Of Calcium Dependent Protein Kinase From Arabidopsis Thaliana Length = 166

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 83/167 (49%), Positives = 118/167 (70%), Gaps = 4/167 (2%)
Query: 313 KQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSML 372
           KQF+A NK KK AL+VI E+L  EEI  LKE F  +D D SG +T++ELKAGL ++G+ L
Sbjct: 1   KQFSAXNKFKKXALRVIAESLSEEEIAGLKEXFNXIDADKSGQITFEELKAGLKRVGANL 60
Query: 373 TEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDE 432
            E ++    QAAD+D +GTIDY EFI AT+  +K++R ++L+ AF YFDKD +GYIT DE
Sbjct: 61  KESEILDLXQAADVDNSGTIDYKEFIAATLHLNKIEREDHLFAAFTYFDKDGSGYITPDE 120
Query: 433 LGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT 479
           L +A +++G+ D      I+E+  +VD+D DGRI Y+EF +  + G+
Sbjct: 121 LQQACEEFGVED----VRIEELXRDVDQDNDGRIDYNEFVAXXQKGS 163

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  161 bits (407), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 96/264 (36%), Positives = 140/264 (53%), Gaps = 10/264 (3%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           HY +G  +G G FG   +     TG + A K + ++K+        +RREI+ ++ L   
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK-LFRH 75
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           P+I++          + +VME  +GGELFD I   G   E+ +  +F+ I++ V+ CH  
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSY- 212
            V+HRDLKPEN L    D +   K  DFGLS  + +G+  R   GSP Y APEV+S    
Sbjct: 136 MVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLY 192
Query: 213 -GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G E DIWS+GVILY LLCG  PF  +    + + I  G     +     ++ S I L++
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ----YLNPSVISLLK 248
Query: 272 RMLTQDPKRRITVAQVLEHPWLKE 295
            ML  DP +R T+  + EH W K+
Sbjct: 249 HMLQVDPMKRATIKDIREHEWFKQ 272

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 92/298 (30%), Positives = 161/298 (54%), Gaps = 12/298 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y I  ++GRGEFGI + C E S+   +  K +     VK  ++  V++EI I+ +++   
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK----VKGTDQVLVKKEISIL-NIARHR 61
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVNVCHSK 153
           NI+    ++E  + + ++ E  +G ++F+RI  +    +ER   S    +   +   HS 
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYG 213
            + H D++PEN ++ T   ++ +K  +FG +  ++ G  +R +  +P Y APEV      
Sbjct: 122 NIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 214 KEA-DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR 272
             A D+WS G ++Y+LL G+ PF AET+Q + + I+  E  F  + F  IS  A++ V R
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIV 330
           +L ++ K R+T ++ L+HPWLK+  E     + T VI  +K     + L K  L ++V
Sbjct: 241 LLVKERKSRMTASEALQHPWLKQKIER----VSTKVIRTLKHRRYYHTLIKKDLNMVV 294

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 97/263 (36%), Positives = 141/263 (53%), Gaps = 11/263 (4%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +Y I + +G G FG   L    +TG + A K I K+ L K   +  + REI  +R L   
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-H 73
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           P+I++     +    + +V+E  AG ELFD IV R   SE+ A   F+ I++ V  CH  
Sbjct: 74  PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 132
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSY- 212
            ++HRDLKPEN L    DE+  VK  DFGLS  + +G   +   GSP Y APEV+S    
Sbjct: 133 KIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 189
Query: 213 -GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G E D+WS GVILY++LC   PF  E+   + + I  G     +     +S  A  L++
Sbjct: 190 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIK 245
Query: 272 RMLTQDPKRRITVAQVLEHPWLK 294
           RML  +P  RI++ ++++  W K
Sbjct: 246 RMLIVNPLNRISIHEIMQDDWFK 268

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 97/263 (36%), Positives = 141/263 (53%), Gaps = 11/263 (4%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +Y I + +G G FG   L    +TG + A K I K+ L K   +  + REI  +R L   
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-H 72
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           P+I++     +    + +V+E  AG ELFD IV R   SE+ A   F+ I++ V  CH  
Sbjct: 73  PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 131
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSY- 212
            ++HRDLKPEN L    DE+  VK  DFGLS  + +G   +   GSP Y APEV+S    
Sbjct: 132 KIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 188
Query: 213 -GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G E D+WS GVILY++LC   PF  E+   + + I  G     +     +S  A  L++
Sbjct: 189 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIK 244
Query: 272 RMLTQDPKRRITVAQVLEHPWLK 294
           RML  +P  RI++ ++++  W K
Sbjct: 245 RMLIVNPLNRISIHEIMQDDWFK 267

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 97/263 (36%), Positives = 141/263 (53%), Gaps = 11/263 (4%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +Y I + +G G FG   L    +TG + A K I K+ L K   +  + REI  +R L   
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-H 67
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           P+I++     +    + +V+E  AG ELFD IV R   SE+ A   F+ I++ V  CH  
Sbjct: 68  PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 126
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSY- 212
            ++HRDLKPEN L    DE+  VK  DFGLS  + +G   +   GSP Y APEV+S    
Sbjct: 127 KIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 183
Query: 213 -GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G E D+WS GVILY++LC   PF  E+   + + I  G     +     +S  A  L++
Sbjct: 184 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIK 239
Query: 272 RMLTQDPKRRITVAQVLEHPWLK 294
           RML  +P  RI++ ++++  W K
Sbjct: 240 RMLIVNPLNRISIHEIMQDDWFK 262

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 97/263 (36%), Positives = 141/263 (53%), Gaps = 11/263 (4%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +Y I + +G G FG   L    +TG + A K I K+ L K   +  + REI  +R L   
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-H 63
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           P+I++     +    + +V+E  AG ELFD IV R   SE+ A   F+ I++ V  CH  
Sbjct: 64  PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 122
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSY- 212
            ++HRDLKPEN L    DE+  VK  DFGLS  + +G   +   GSP Y APEV+S    
Sbjct: 123 KIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 179
Query: 213 -GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G E D+WS GVILY++LC   PF  E+   + + I  G     +     +S  A  L++
Sbjct: 180 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIK 235
Query: 272 RMLTQDPKRRITVAQVLEHPWLK 294
           RML  +P  RI++ ++++  W K
Sbjct: 236 RMLIVNPLNRISIHEIMQDDWFK 258

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 96/264 (36%), Positives = 135/264 (51%), Gaps = 10/264 (3%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           HY +G  +G G FG   +     TG + A K + ++K+        ++REI+ ++ L   
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRH 70
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           P+I++            +VME  +GGELFD I   G   E  A  +F+ I++ V+ CH  
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSY- 212
            V+HRDLKPEN L    D +   K  DFGLS  + +G+  R+  GSP Y APEV+S    
Sbjct: 131 MVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLY 187
Query: 213 -GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G E DIWS GVILY LLCG  PF  E    + + I  G           ++ S   L+ 
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE----YLNRSVATLLM 243
Query: 272 RMLTQDPKRRITVAQVLEHPWLKE 295
            ML  DP +R T+  + EH W K+
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 96/264 (36%), Positives = 134/264 (50%), Gaps = 10/264 (3%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           HY +G  +G G FG   +     TG + A K + ++K+        ++REI+ ++ L   
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRH 70
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           P+I++            +VME  +GGELFD I   G   E  A  +F+ I++ V+ CH  
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSY- 212
            V+HRDLKPEN L    D +   K  DFGLS  + +G+  R   GSP Y APEV+S    
Sbjct: 131 MVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 213 -GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G E DIWS GVILY LLCG  PF  E    + + I  G           ++ S   L+ 
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE----YLNRSVATLLM 243
Query: 272 RMLTQDPKRRITVAQVLEHPWLKE 295
            ML  DP +R T+  + EH W K+
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 96/323 (29%), Positives = 163/323 (50%), Gaps = 56/323 (17%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL----VKDVEKDDV 80
           G +  ++Q  Y +   +G+G +G+  +  EN T    A K + K K+     KDVE+  +
Sbjct: 18  GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER--I 75
Query: 81  RREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRI--------------V 126
           + E+ +M+ L   PNI +    YED+Q++ +VMELC GG L D++              V
Sbjct: 76  KTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDV 134
Query: 127 ARGHYS--------------------------ERAAASVFRVIMNVVNVCHSKGVMHRDL 160
            +                              E+  +++ R I + ++  H++G+ HRD+
Sbjct: 135 VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDI 194
Query: 161 KPENFLFTTGDENAVVKATDFGLSA---FIEEGKAYREIV--GSPYYIAPEVLS---QSY 212
           KPENFLF+T +++  +K  DFGLS     +  G+ Y      G+PY++APEVL+   +SY
Sbjct: 195 KPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253
Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR 272
           G + D WSAGV+L++LL G  PF    D      +L  ++ F+   +  +S  A +L+  
Sbjct: 254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSN 313
Query: 273 MLTQDPKRRITVAQVLEHPWLKE 295
           +L ++   R    + L+HPW+ +
Sbjct: 314 LLNRNVDERFDAMRALQHPWISQ 336

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 97/273 (35%), Positives = 147/273 (53%), Gaps = 12/273 (4%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +Y + + +G+G F    L     TG E A K I K +L        + RE+ IM+ L+  
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-H 70
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PNIV+     E ++ ++++ME  +GGE+FD +VA G   E+ A S FR I++ V  CH K
Sbjct: 71  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 130
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSY 212
            ++HRDLK EN L    D +  +K  DFG S     G       GSP Y APE+   + Y
Sbjct: 131 RIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKY 187
Query: 213 -GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G E D+WS GVILY L+ G  PF  +  + + + +L+G+    R PF  +S+    L++
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLK 243
Query: 272 RMLTQDPKRRITVAQVLEHPWLKESGEASD-KP 303
           R L  +P +R T+ Q+++  W+    E  + KP
Sbjct: 244 RFLVLNPIKRGTLEQIMKDRWINAGHEEDELKP 276

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  155 bits (393), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 90/271 (33%), Positives = 147/271 (54%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR-HP 72
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR 132
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +   N  +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 133 VIHRDIKPENLLLGS---NGELKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHD 188
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G+PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFT-----FPDFVTEGARDLISR 243
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +  +R+T+A+VLEHPW+K +   S KP
Sbjct: 244 LLKHNASQRLTLAEVLEHPWIKAN---SSKP 271

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  155 bits (391), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 90/271 (33%), Positives = 147/271 (54%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR-HP 72
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR 132
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +   N  +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 133 VIHRDIKPENLLLGS---NGELKIADFGWSVHAPSSRR-DTLCGTLDYLPPEMIEGRMHD 188
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G+PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFT-----FPDFVTEGARDLISR 243
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +  +R+T+A+VLEHPW+K +   S KP
Sbjct: 244 LLKHNASQRLTLAEVLEHPWIKAN---SSKP 271

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  155 bits (391), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 93/262 (35%), Positives = 144/262 (54%), Gaps = 11/262 (4%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +Y + + +G+G F    L     TG E A + I K +L        + RE+ IM+ L+  
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQL-NSSSLQKLFREVRIMKVLN-H 72
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PNIV+     E ++ +++VME  +GGE+FD +VA G   E+ A + FR I++ V  CH K
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSY 212
            ++HRDLK EN L    D +  +K  DFG S     G    E  GSP Y APE+   + Y
Sbjct: 133 FIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKY 189
Query: 213 -GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G E D+WS GVILY L+ G  PF  +  + + + +L+G+    R PF  +S+    L++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLK 245
Query: 272 RMLTQDPKRRITVAQVLEHPWL 293
           + L  +P +R T+ Q+++  W+
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWM 267

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  154 bits (390), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 87/263 (33%), Positives = 139/263 (52%), Gaps = 7/263 (2%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +Y I  E+G G FG+ + C E +TG  F  K I        ++K  V+ EI IM  L   
Sbjct: 52  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFI---NTPYPLDKYTVKNEISIMNQLH-H 107
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHS 152
           P ++    A+ED   + +++E  +GGELFDRI A  +  SE    +  R     +   H 
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QS 211
             ++H D+KPEN +  T   ++V K  DFGL+  +   +  +    +  + APE++  + 
Sbjct: 168 HSIVHLDIKPENIMCETKKASSV-KIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 226
Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G   D+W+ GV+ Y+LL G+ PF  E D    Q + + +  F  D F S+S  A + ++
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 286
Query: 272 RMLTQDPKRRITVAQVLEHPWLK 294
            +L ++P++R+TV   LEHPWLK
Sbjct: 287 NLLQKEPRKRLTVHDALEHPWLK 309

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  154 bits (390), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E       A K + K +L K+  +  +RREIEI  HL   P
Sbjct: 17  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HP 75
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D + +++++E    GEL+  +   G + E+ +A+    + + ++ CH + 
Sbjct: 76  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 135
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L     E   +K  DFG S      +  R + G+  Y+ PE++  +++ 
Sbjct: 136 VIHRDIKPENLLMGYKGE---LKIADFGWSVHAPSLRR-RXMCGTLDYLPPEMIEGKTHD 191
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRM 273
           ++ D+W AGV+ Y  L G+PPF + +     + I+  ++ F     P +S  + +L+ ++
Sbjct: 192 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDLISKL 247
Query: 274 LTQDPKRRITVAQVLEHPWLKESGEASDKPI 304
           L   P +R+ +  V+EHPW+K +      P+
Sbjct: 248 LRYHPPQRLPLKGVMEHPWVKANSRRVLPPV 278

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 96/273 (35%), Positives = 147/273 (53%), Gaps = 12/273 (4%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +Y + + +G+G F    L     TG E A K I K +L        + RE+ IM+ L+  
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-H 73
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PNIV+     E ++ ++++ME  +GGE+FD +VA G   E+ A S FR I++ V  CH K
Sbjct: 74  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSY 212
            ++HRDLK EN L    D +  +K  DFG S     G       G+P Y APE+   + Y
Sbjct: 134 RIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 213 -GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G E D+WS GVILY L+ G  PF  +  + + + +L+G+    R PF  +S+    L++
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLK 246
Query: 272 RMLTQDPKRRITVAQVLEHPWLKESGEASD-KP 303
           R L  +P +R T+ Q+++  W+    E  + KP
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWINAGHEEDELKP 279

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 84/252 (33%), Positives = 130/252 (51%), Gaps = 32/252 (12%)
Query: 70  KLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----DQFVHIVMELCAGGELFDRI 125
           K+++D  K   RRE+E+    S  P+IV+    YE+     + + IVME   GGELF RI
Sbjct: 49  KMLQDCPK--ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 106
Query: 126 VARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL 183
             RG   ++ER A+ + + I   +   HS  + HRD+KPEN L+T+   NA++K TDFG 
Sbjct: 107 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 184 SAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAE----T 239
                               A E   + Y K  D+WS GVI+YILLCG PPF++      
Sbjct: 167 --------------------AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 206
Query: 240 DQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA 299
             G+   I  G+  F    +  +S     L+R +L  +P +R+T+ + + HPW+ +S + 
Sbjct: 207 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266
Query: 300 SDKPIDTAVIFR 311
              P+ T+ + +
Sbjct: 267 PQTPLHTSRVLK 278

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 93/262 (35%), Positives = 143/262 (54%), Gaps = 11/262 (4%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +Y + + +G+G F    L     TG E A K I K +L        + RE+ IM+ L+  
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQL-NSSSLQKLFREVRIMKVLN-H 72
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PNIV+     E ++ +++VME  +GGE+FD +VA G   E+ A + FR I++ V  CH K
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSY 212
            ++HRDLK EN L    D +  +K  DFG S     G       GSP Y APE+   + Y
Sbjct: 133 FIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 213 -GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G E D+WS GVILY L+ G  PF  +  + + + +L+G+    R PF  +S+    L++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLK 245
Query: 272 RMLTQDPKRRITVAQVLEHPWL 293
           + L  +P +R T+ Q+++  W+
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWM 267

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 93/262 (35%), Positives = 143/262 (54%), Gaps = 11/262 (4%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +Y + + +G+G F    L     TG E A K I K +L        + RE+ IM+ L+  
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQL-NSSSLQKLFREVRIMKVLN-H 72
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PNIV+     E ++ +++VME  +GGE+FD +VA G   E+ A + FR I++ V  CH K
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSY 212
            ++HRDLK EN L    D +  +K  DFG S     G       GSP Y APE+   + Y
Sbjct: 133 FIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 213 -GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G E D+WS GVILY L+ G  PF  +  + + + +L+G+    R PF  +S+    L++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLK 245
Query: 272 RMLTQDPKRRITVAQVLEHPWL 293
           + L  +P +R T+ Q+++  W+
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWM 267

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 93/262 (35%), Positives = 143/262 (54%), Gaps = 11/262 (4%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +Y + + +G+G F    L     TG E A K I K +L        + RE+ IM+ L+  
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQL-NSSSLQKLFREVRIMKVLN-H 65
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PNIV+     E ++ +++VME  +GGE+FD +VA G   E+ A + FR I++ V  CH K
Sbjct: 66  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQK 125
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSY 212
            ++HRDLK EN L    D +  +K  DFG S     G       GSP Y APE+   + Y
Sbjct: 126 FIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 182
Query: 213 -GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G E D+WS GVILY L+ G  PF  +  + + + +L+G+    R PF  +S+    L++
Sbjct: 183 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLK 238
Query: 272 RMLTQDPKRRITVAQVLEHPWL 293
           + L  +P +R T+ Q+++  W+
Sbjct: 239 KFLILNPSKRGTLEQIMKDRWM 260

>pdb|1S6I|A Chain A, Ca2+-Regulatory Region (Cld) From Soybean Calcium-Dependent Protein Kinase-Alpha (Cdpk) In The Presence Of Ca2+ And The Junction Domain (Jd) Length = 188

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 80/147 (54%), Positives = 105/147 (71%), Gaps = 4/147 (2%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            E L  EEI  LKE F  +DTDNSGT+T+DELK GL ++GS L E ++K  M AADID +
Sbjct: 1   AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKS 60
Query: 390 GTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA 449
           GTIDY EFI AT+  +KL+R ENL  AF YFDKD +GYIT+DE+ +A KD+G+ D     
Sbjct: 61  GTIDYGEFIAATVHLNKLEREENLVSAFSYFDKDGSGYITLDEIQQACKDFGLDD----I 116
Query: 450 TIKEIMSEVDRDKDGRISYDEFRSMMK 476
            I +++ E+D+D DG+I Y EF +MM+
Sbjct: 117 HIDDMIKEIDQDNDGQIDYGEFAAMMR 143

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  153 bits (386), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 143/262 (54%), Gaps = 11/262 (4%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +Y + + +G+G F    L     TG E A + I K +L        + RE+ IM+ L+  
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQL-NSSSLQKLFREVRIMKVLN-H 72
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PNIV+     E ++ +++VME  +GGE+FD +VA G   E+ A + FR I++ V  CH K
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSY 212
            ++HRDLK EN L    D +  +K  DFG S     G       GSP Y APE+   + Y
Sbjct: 133 FIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 213 -GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G E D+WS GVILY L+ G  PF  +  + + + +L+G+    R PF  +S+    L++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLK 245
Query: 272 RMLTQDPKRRITVAQVLEHPWL 293
           + L  +P +R T+ Q+++  W+
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWM 267

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 144/271 (53%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    GE++  +     + E+  A+    + N ++ CHSK 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 134 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-XXLXGTLDYLPPEMIEGRMHD 189
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 244
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 245 LLKHNPSQRPMLREVLEHPWITAN---SSKP 272

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 143/262 (54%), Gaps = 11/262 (4%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +Y + + +G+G F    L     TG E A K I K +L        + RE+ IM+ L+  
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQL-NSSSLQKLFREVRIMKVLN-H 72
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PNIV+     E ++ +++VME  +GGE+FD +VA G   E+ A + FR I++ V  CH K
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSY 212
            ++HRDLK EN L    D +  +K  DFG S     G       G+P Y APE+   + Y
Sbjct: 133 FIVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKY 189
Query: 213 -GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G E D+WS GVILY L+ G  PF  +  + + + +L+G+    R PF  +S+    L++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLK 245
Query: 272 RMLTQDPKRRITVAQVLEHPWL 293
           + L  +P +R T+ Q+++  W+
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWM 267

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 144/271 (53%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    GE++  +     + E+  A+    + N ++ CHSK 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 134 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHD 189
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 244
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 245 LLKHNPSQRPMLREVLEHPWITAN---SSKP 272

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  151 bits (382), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 144/271 (53%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +   E+ G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-TELCGTLDYLPPEMIEGRMHD 184
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 239
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITAN---SSKP 267

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  151 bits (381), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 87/270 (32%), Positives = 143/270 (52%), Gaps = 13/270 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E ++    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 69  NILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKK 128
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-AALCGTLDYLPPEMIEGRMHD 184
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRM 273
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E  F       ++  A +L+ R+
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 274 LTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 241 LKHNPSQRPMLREVLEHPWITAN---SSKP 267

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 146/271 (53%), Gaps = 10/271 (3%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + I R +G+G+FG  YL  E       A K + K +L K+  +  +RREIEI  HL   P
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HP 74
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D + +++++E    GEL+  +   G + E+ +A+    + + ++ CH + 
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 134
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSYG 213
           V+HRD+KPEN L     E   +K  DFG S      +  R + G+  Y+ PE++  +++ 
Sbjct: 135 VIHRDIKPENLLMGYKGE---LKIADFGWSVHAPSLRR-RXMCGTLDYLPPEMIEGKTHD 190
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRM 273
           ++ D+W AGV+ Y  L G+PPF + +     + I+  ++ F     P +S  + +L+ ++
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDLISKL 246
Query: 274 LTQDPKRRITVAQVLEHPWLKESGEASDKPI 304
           L   P +R+ +  V+EHPW+K +      P+
Sbjct: 247 LRYHPPQRLPLKGVMEHPWVKANSRRVLPPV 277

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 144/271 (53%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +   ++ G+  Y+ PE++  + + 
Sbjct: 134 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-TDLCGTLDYLPPEMIEGRMHD 189
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 244
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 245 LLKHNPSQRPMLREVLEHPWITAN---SSKP 272

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  150 bits (379), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 144/271 (53%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +   ++ G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-TDLCGTLDYLPPEMIEGRMHD 184
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 239
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITAN---SSKP 267

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  150 bits (379), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 144/271 (53%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +   ++ G+  Y+ PE++  + + 
Sbjct: 130 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-TDLCGTLDYLPPEMIEGRMHD 185
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 240
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITAN---SSKP 268

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  150 bits (379), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 141/269 (52%), Gaps = 9/269 (3%)
Query: 31  VQLHYTIGRE--VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
           V   YT+ +   +G G FG  + C E +TGL+ A K I  R + KD  K++V+ EI +M 
Sbjct: 85  VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KD--KEEVKNEISVMN 141
Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVV 147
            L    N++Q   A+E    + +VME   GGELFDRI+   +  +E       + I   +
Sbjct: 142 QLD-HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGI 200
Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV 207
              H   ++H DLKPEN L    D   + K  DFGL+   +  +  +   G+P ++APEV
Sbjct: 201 RHMHQMYILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVNFGTPEFLAPEV 259
Query: 208 LSQSYGK-EADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
           ++  +     D+WS GVI Y+LL G+ PF  + D      IL    + + + F  IS  A
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319
Query: 267 IELVRRMLTQDPKRRITVAQVLEHPWLKE 295
            E + ++L ++   RI+ ++ L+HPWL +
Sbjct: 320 KEFISKLLIKEKSWRISASEALKHPWLSD 348

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 144/271 (53%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +   ++ G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-TDLCGTLDYLPPEMIEGRMHD 184
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 239
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITAN---SSKP 267

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 100/312 (32%), Positives = 161/312 (51%), Gaps = 39/312 (12%)
Query: 21  DAILGKAYEDVQLHYTIGREV-GRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD 79
           D++ GK +ED+   Y +  E+ G G +           G E+A K I K+       +  
Sbjct: 4   DSLPGK-FEDM---YKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQA---GHSRSR 56
Query: 80  VRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           V RE+E +    G  NI++    +EDD   ++V E   GG +   I  + H++ER A+ V
Sbjct: 57  VFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRV 116
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI--- 196
            R +   ++  H+KG+ HRDLKPEN L  + ++ + VK  DF L + ++   +   I   
Sbjct: 117 VRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTP 176
Query: 197 -----VGSPYYIAPEVL------SQSYGKEADIWSAGVILYILLCGVPPFWAET------ 239
                 GS  Y+APEV+      +  Y K  D+WS GV+LYI+L G PPF          
Sbjct: 177 ELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGW 236
Query: 240 DQG---------VAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290
           D+G         + ++I +G+  F    +  ISS A +L+ ++L +D K+R++ AQVL+H
Sbjct: 237 DRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQH 296
Query: 291 PWLKESGEASDK 302
           PW++  G+A +K
Sbjct: 297 PWVQ--GQAPEK 306

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 88/274 (32%), Positives = 145/274 (52%), Gaps = 15/274 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 130 VIHRDIKPENLLLGSAGE---LKIADFGWSCHAPSSRR-TTLSGTLDYLPPEMIEGRMHD 185
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 240
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKPIDT 306
           +L  +P +R  + +VLEHPW+  +   S KP ++
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITAN---SSKPSNS 271

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 70
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 130
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 131 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-XXLCGTLDYLPPEMIEGRMHD 186
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 241
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 242 LLKHNPSQRPMLREVLEHPWITAN---SSKP 269

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 134 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHD 189
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 244
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 245 LLKHNPSQRPMLREVLEHPWITAN---SSKP 272

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  149 bits (377), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 87/270 (32%), Positives = 143/270 (52%), Gaps = 13/270 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +   ++ G+  Y+ PE++  + + 
Sbjct: 132 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-DDLCGTLDYLPPEMIEGRMHD 187
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRM 273
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E  F       ++  A +L+ R+
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 243
Query: 274 LTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 244 LKHNPSQRPMLREVLEHPWITAN---SSKP 270

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  149 bits (377), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 85
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 86  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 145
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 146 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHD 201
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 202 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 256
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 257 LLKHNPSQRPMLREVLEHPWITAN---SSKP 284

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  149 bits (377), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-XXLCGTLDYLPPEMIEGRMHD 184
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 239
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITAN---SSKP 267

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  149 bits (377), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 132 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHD 187
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 242
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 243 LLKHNPSQRPMLREVLEHPWITAN---SSKP 270

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 140/261 (53%), Gaps = 12/261 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 94
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 95  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 154
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +   ++ G+  Y+ PE++  + + 
Sbjct: 155 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-DDLCGTLDYLPPEMIEGRMHD 210
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 265
Query: 273 MLTQDPKRRITVAQVLEHPWL 293
           +L  +P +R  + +VLEHPW+
Sbjct: 266 LLKHNPSQRPMLREVLEHPWI 286

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 139/261 (53%), Gaps = 12/261 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 132 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-XXLCGTLDYLPPEMIEGRMHD 187
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 242
Query: 273 MLTQDPKRRITVAQVLEHPWL 293
           +L  +P +R  + +VLEHPW+
Sbjct: 243 LLKHNPSQRPMLREVLEHPWI 263

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 67
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 68  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 127
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 128 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHD 183
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 184 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 238
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 239 LLKHNPSQRPMLREVLEHPWITAN---SSKP 266

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 136/261 (52%), Gaps = 4/261 (1%)
Query: 38  GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIV 97
            +E+GRG+F +   C   STG E+A K + KR+  +D  + ++  EI ++      P ++
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC-RAEILHEIAVLELAKSCPRVI 92
Query: 98  QFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGV 155
                YE+   + +++E  AGGE+F   +       SE     + + I+  V   H   +
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNI 152
Query: 156 MHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSYGK 214
           +H DLKP+N L ++      +K  DFG+S  I      REI+G+P Y+APE+L+      
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITT 212
Query: 215 EADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRML 274
             D+W+ G+I Y+LL    PF  E +Q     I +  +++  + F S+S  A + ++ +L
Sbjct: 213 ATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLL 272
Query: 275 TQDPKRRITVAQVLEHPWLKE 295
            ++P++R T    L H WL++
Sbjct: 273 VKNPEKRPTAEICLSHSWLQQ 293

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 72
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 132
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 133 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHD 188
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 189 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 243
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 244 LLKHNPSQRPMLREVLEHPWITAN---SSKP 271

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 139/261 (53%), Gaps = 12/261 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 132 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHD 187
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 242
Query: 273 MLTQDPKRRITVAQVLEHPWL 293
           +L  +P +R  + +VLEHPW+
Sbjct: 243 LLKHNPSQRPMLREVLEHPWI 263

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 132 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-AALCGTLDYLPPEMIEGRMHD 187
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 242
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 243 LLKHNPSQRPMLREVLEHPWITAN---SSKP 270

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  149 bits (376), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-AALCGTLDYLPPEMIEGRMHD 184
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 239
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITAN---SSKP 267

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  149 bits (376), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHD 184
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 239
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITAN---SSKP 267

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  149 bits (376), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-TXLCGTLDYLPPEMIEGRMHD 184
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 239
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITAN---SSKP 267

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  149 bits (376), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 130 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-DTLCGTLDYLPPEMIEGRMHD 185
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 240
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITAN---SSKP 268

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  149 bits (376), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 142/271 (52%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +    + G+  Y+ PE +  + + 
Sbjct: 134 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-TTLCGTLDYLPPEXIEGRXHD 189
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 244
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 245 LLKHNPSQRPXLREVLEHPWITAN---SSKP 272

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  149 bits (376), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 94
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 95  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 154
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 155 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHD 210
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 265
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 266 LLKHNPSQRPMLREVLEHPWITAN---SSKP 293

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  148 bits (373), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 70
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 130
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  +FG S      +    + G+  Y+ PE++  + + 
Sbjct: 131 VIHRDIKPENLLLGSAGE---LKIANFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHD 186
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 241
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 242 LLKHNPSQRPMLREVLEHPWITAN---SSKP 269

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  147 bits (372), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 143/271 (52%), Gaps = 15/271 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  +FG S      +    + G+  Y+ PE++  + + 
Sbjct: 132 VIHRDIKPENLLLGSAGE---LKIANFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHD 187
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 242
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +L  +P +R  + +VLEHPW+  +   S KP
Sbjct: 243 LLKHNPSQRPMLREVLEHPWITAN---SSKP 270

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  147 bits (372), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 99/256 (38%), Positives = 137/256 (53%), Gaps = 10/256 (3%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y  GR +G+G F   Y  T+  T   FA K +PK  L+K  +K+ +  EI I + L   P
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD-NP 86
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           ++V F   +EDD FV++V+E+C    L +    R   +E  A    R  +  V   H+  
Sbjct: 87  HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 146
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEVLS-QSY 212
           V+HRDLK  N LF   D +  VK  DFGL+  IE +G+  +++ G+P YIAPEVL  + +
Sbjct: 147 VIHRDLKLGN-LFLNDDMD--VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGH 203
Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR 272
             E DIWS G ILY LL G PPF     +     I K E +  R     I+  A  L+RR
Sbjct: 204 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIRR 259
Query: 273 MLTQDPKRRITVAQVL 288
           ML  DP  R +VA++L
Sbjct: 260 MLHADPTLRPSVAELL 275

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 99/256 (38%), Positives = 137/256 (53%), Gaps = 10/256 (3%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y  GR +G+G F   Y  T+  T   FA K +PK  L+K  +K+ +  EI I + L   P
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD-NP 102
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           ++V F   +EDD FV++V+E+C    L +    R   +E  A    R  +  V   H+  
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEVLS-QSY 212
           V+HRDLK  N LF   D +  VK  DFGL+  IE +G+  +++ G+P YIAPEVL  + +
Sbjct: 163 VIHRDLKLGN-LFLNDDMD--VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGH 219
Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR 272
             E DIWS G ILY LL G PPF     +     I K E +  R     I+  A  L+RR
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIRR 275
Query: 273 MLTQDPKRRITVAQVL 288
           ML  DP  R +VA++L
Sbjct: 276 MLHADPTLRPSVAELL 291

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 138/261 (52%), Gaps = 12/261 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E       A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 65
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 66  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 125
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYG 213
           V+HRD+KPEN L  +  E   +K  DFG S      +    + G+  Y+ PE++  + + 
Sbjct: 126 VIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHD 181
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRR 272
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E       FP  ++  A +L+ R
Sbjct: 182 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 236
Query: 273 MLTQDPKRRITVAQVLEHPWL 293
           +L  +P +R  + +VLEHPW+
Sbjct: 237 LLKHNPSQRPMLREVLEHPWI 257

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 99/256 (38%), Positives = 136/256 (53%), Gaps = 10/256 (3%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y  GR +G+G F   Y  T+  T   FA K +PK  L+K  +K+ +  EI I + L   P
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD-NP 102
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           ++V F   +EDD FV++V+E+C    L +    R   +E  A    R  +  V   H+  
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEVLS-QSY 212
           V+HRDLK  N LF   D +  VK  DFGL+  IE +G+  + + G+P YIAPEVL  + +
Sbjct: 163 VIHRDLKLGN-LFLNDDMD--VKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGH 219
Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR 272
             E DIWS G ILY LL G PPF     +     I K E +  R     I+  A  L+RR
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIRR 275
Query: 273 MLTQDPKRRITVAQVL 288
           ML  DP  R +VA++L
Sbjct: 276 MLHADPTLRPSVAELL 291

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 99/256 (38%), Positives = 136/256 (53%), Gaps = 10/256 (3%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y  GR +G+G F   Y  T+  T   FA K +PK  L+K  +K+ +  EI I + L   P
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD-NP 102
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           ++V F   +EDD FV++V+E+C    L +    R   +E  A    R  +  V   H+  
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEVLS-QSY 212
           V+HRDLK  N LF   D +  VK  DFGL+  IE +G+  + + G+P YIAPEVL  + +
Sbjct: 163 VIHRDLKLGN-LFLNDDMD--VKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGH 219
Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR 272
             E DIWS G ILY LL G PPF     +     I K E +  R     I+  A  L+RR
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASALIRR 275
Query: 273 MLTQDPKRRITVAQVL 288
           ML  DP  R +VA++L
Sbjct: 276 MLHADPTLRPSVAELL 291

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  146 bits (368), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 103/323 (31%), Positives = 157/323 (48%), Gaps = 27/323 (8%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y I   +G G FG   L T   T  + A K I ++ L K      V REI  ++ L   P
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HP 69
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           +I++          + +V+E  AGGELFD IV +   +E      F+ I+  +  CH   
Sbjct: 70  HIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSY-- 212
           ++HRDLKPEN L    D+N  VK  DFGLS  + +G   +   GSP Y APEV++     
Sbjct: 129 IVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVR 271
           G E D+WS G++LY++L G  PF    D+ +     K  +N      P  +S  A  L+R
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPF---DDEFIPNLFKK--VNSCVYVMPDFLSPGAQSLIR 240
Query: 272 RMLTQDPKRRITVAQVLEHPW--------LKESGEASDKPIDTAVIFRMKQFTAMNKLKK 323
           RM+  DP +RIT+ ++   PW        L+   E      D+ ++ ++ +    ++   
Sbjct: 241 RMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSE--- 297
Query: 324 LALKVIVENLPTEEIQKLKEKFT 346
                IVE L ++E  ++KE + 
Sbjct: 298 ---DYIVEALRSDENNEVKEAYN 317

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  145 bits (365), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 97/273 (35%), Positives = 149/273 (54%), Gaps = 12/273 (4%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +Y + + +G+G F    L     TG E A K I K +L        + RE+ IM+ L+  
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQL-NPTSLQKLFREVRIMKILN-H 73
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PNIV+     E ++ +++VME  +GGE+FD +VA G   E+ A + FR I++ V  CH K
Sbjct: 74  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 133
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSY 212
            ++HRDLK EN L   GD N  +K  DFG S     G       GSP Y APE+   + Y
Sbjct: 134 YIVHRDLKAENLLL-DGDMN--IKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKY 190
Query: 213 -GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G E D+WS GVILY L+ G  PF  +  + + + +L+G+    R PF  +S+    L++
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YMSTDCENLLK 246
Query: 272 RMLTQDPKRRITVAQVLEHPWLKESGEASD-KP 303
           ++L  +P +R ++ Q+++  W+    E  + KP
Sbjct: 247 KLLVLNPIKRGSLEQIMKDRWMNVGHEEEELKP 279

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 90/261 (34%), Positives = 138/261 (52%), Gaps = 11/261 (4%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +Y + + +G+G F    L     TG E A K I K +L        + RE+ I + L+  
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQL-NSSSLQKLFREVRIXKVLN-H 72
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PNIV+     E ++ +++V E  +GGE+FD +VA G   E+ A + FR I++ V  CH K
Sbjct: 73  PNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQK 132
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSY 212
            ++HRDLK EN L    D +  +K  DFG S     G       G+P Y APE+   + Y
Sbjct: 133 FIVHRDLKAENLLL---DADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKY 189
Query: 213 -GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G E D+WS GVILY L+ G  PF  +  + + + +L+G+    R PF   S+    L++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPF-YXSTDCENLLK 245
Query: 272 RMLTQDPKRRITVAQVLEHPW 292
           + L  +P +R T+ Q+ +  W
Sbjct: 246 KFLILNPSKRGTLEQIXKDRW 266

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 150/282 (53%), Gaps = 15/282 (5%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           +G+  ED    + +G  +G+G F   Y      TGLE A K I K+ + K      V+ E
Sbjct: 6   IGEKIED----FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNE 61
Query: 84  IEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRV 142
           ++I   L   P+I++    +ED  +V++V+E+C  GE+   +  R   +SE  A      
Sbjct: 62  VKIHCQLK-HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPY 201
           I+  +   HS G++HRDL   N L T    N  +K  DFGL+  ++   + +  + G+P 
Sbjct: 121 IITGMLYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177
Query: 202 YIAPEVLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
           YI+PE+ ++S +G E+D+WS G + Y LL G PPF  +T +     ++  +  ++   F 
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD--YEMPSFL 235
Query: 261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDK 302
           SI   A +L+ ++L ++P  R++++ VL+HP++  +     K
Sbjct: 236 SI--EAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSK 275

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 92/263 (34%), Positives = 135/263 (51%), Gaps = 10/263 (3%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + +++G G FG+  L  +  +    A K I + + + +    +V+REI   R L   P
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDE----NVKREIINHRSLR-HP 74
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NIV+FK        + IVME  +GGELF+RI   G +SE  A   F+ +++ V+ CH+  
Sbjct: 75  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 134
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY- 212
           V HRDLK EN L   G     +K  DFG S         +  VG+P YIAPEV L + Y 
Sbjct: 135 VCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 193
Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR--DPFPSISSSAIELV 270
           GK AD+WS GV LY++L G  PF    +    +  +   +N Q     +  IS     L+
Sbjct: 194 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLI 253
Query: 271 RRMLTQDPKRRITVAQVLEHPWL 293
            R+   DP +RI++ ++  H W 
Sbjct: 254 SRIFVADPAKRISIPEIRNHEWF 276

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 92/263 (34%), Positives = 134/263 (50%), Gaps = 10/263 (3%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + +++G G FG+  L  +  +    A K I + + +      +V+REI   R L   P
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAA----NVKREIINHRSLR-HP 75
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NIV+FK        + IVME  +GGELF+RI   G +SE  A   F+ +++ V+ CH+  
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY- 212
           V HRDLK EN L   G     +K  DFG S         +  VG+P YIAPEV L + Y 
Sbjct: 136 VCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 194
Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR--DPFPSISSSAIELV 270
           GK AD+WS GV LY++L G  PF    +    +  +   +N Q     +  IS     L+
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLI 254
Query: 271 RRMLTQDPKRRITVAQVLEHPWL 293
            R+   DP +RI++ ++  H W 
Sbjct: 255 SRIFVADPAKRISIPEIRNHEWF 277

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 91/263 (34%), Positives = 135/263 (51%), Gaps = 10/263 (3%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + +++G G FG+  L  +  +    A K I + + + +    +V+REI   R L   P
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDE----NVKREIINHRSLR-HP 75
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NIV+FK        + IVME  +GGELF+RI   G +SE  A   F+ +++ V+ CH+  
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY- 212
           V HRDLK EN L   G     +K   FG S         ++ VG+P YIAPEV L + Y 
Sbjct: 136 VCHRDLKLENTLL-DGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYD 194
Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR--DPFPSISSSAIELV 270
           GK AD+WS GV LY++L G  PF    +    +  +   +N Q     +  IS     L+
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLI 254
Query: 271 RRMLTQDPKRRITVAQVLEHPWL 293
            R+   DP +RI++ ++  H W 
Sbjct: 255 SRIFVADPAKRISIPEIRNHEWF 277

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 143/270 (52%), Gaps = 10/270 (3%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K ++ K+  +  +RREIEI  HL   P
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH-HP 83
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D + +++++E    GEL+  +     + E+  A++   + + +  CH K 
Sbjct: 84  NILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKK 143
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSYG 213
           V+HRD+KPEN L     E  +    DFG S      +  + + G+  Y+ PE++  + + 
Sbjct: 144 VIHRDIKPENLLLGLKGELKI---ADFGWSVHAPSLRR-KTMCGTLDYLPPEMIEGRMHN 199
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRM 273
           ++ D+W  GV+ Y LL G PPF + +     + I+K ++ F      S+ + A +L+ ++
Sbjct: 200 EKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFP----ASVPTGAQDLISKL 255
Query: 274 LTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           L  +P  R+ +AQV  HPW++ +      P
Sbjct: 256 LRHNPSERLPLAQVSAHPWVRANSRRVLPP 285

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 91/263 (34%), Positives = 134/263 (50%), Gaps = 10/263 (3%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + +++G G FG+  L  +  +    A K I + + + +    +V+REI   R L   P
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDE----NVKREIINHRSLR-HP 75
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NIV+FK        + IVME  +GGELF+RI   G +SE  A   F+ +++ V+ CH+  
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY- 212
           V HRDLK EN L   G     +K   FG S         +  VG+P YIAPEV L + Y 
Sbjct: 136 VCHRDLKLENTLL-DGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 194
Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR--DPFPSISSSAIELV 270
           GK AD+WS GV LY++L G  PF    +    +  +   +N Q     +  IS     L+
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLI 254
Query: 271 RRMLTQDPKRRITVAQVLEHPWL 293
            R+   DP +RI++ ++  H W 
Sbjct: 255 SRIFVADPAKRISIPEIRNHEWF 277

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 94/265 (35%), Positives = 133/265 (50%), Gaps = 14/265 (5%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y   +++G G FG+  L  +  T    A K I +   + +    +V+REI   R L   P
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE----NVQREIINHRSLR-HP 76
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NIV+FK        + I+ME  +GGEL++RI   G +SE  A   F+ +++ V+ CHS  
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY- 212
           + HRDLK EN L   G     +K  DFG S         +  VG+P YIAPEV L Q Y 
Sbjct: 137 ICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD 195
Query: 213 GKEADIWSAGVILYILLCGVPPFWAETD----QGVAQAILKGEINFQRDPFPSISSSAIE 268
           GK AD+WS GV LY++L G  PF    +    +   Q IL  + +   D    IS     
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD--IRISPECCH 253
Query: 269 LVRRMLTQDPKRRITVAQVLEHPWL 293
           L+ R+   DP  RI++ ++  H W 
Sbjct: 254 LISRIFVADPATRISIPEIKTHSWF 278

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  138 bits (348), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 101/321 (31%), Positives = 163/321 (50%), Gaps = 39/321 (12%)
Query: 21  DAILGKAYEDVQLHYTIGREV-GRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD 79
           D+  G+ +EDV   Y +  +V G G       C    T  E+A K I K+       +  
Sbjct: 4   DSFSGR-FEDV---YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSR 56
Query: 80  VRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           V RE+E++    G  N+++    +E++   ++V E   GG +   I  R H++E  A+ V
Sbjct: 57  VFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV 116
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI--- 196
            + + + ++  H+KG+ HRDLKPEN L    ++ + VK  DFGL + I+       I   
Sbjct: 117 VQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTP 176
Query: 197 -----VGSPYYIAPEVL------SQSYGKEADIWSAGVILYILLCGVPPFWAET------ 239
                 GS  Y+APEV+      +  Y K  D+WS GVILYILL G PPF          
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236
Query: 240 DQGVA---------QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290
           D+G A         ++I +G+  F    +  IS +A +L+ ++L +D K+R++ AQVL+H
Sbjct: 237 DRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296
Query: 291 PWLKESGEASDKPIDTAVIFR 311
           PW++  G A +  + T ++ +
Sbjct: 297 PWVQ--GCAPENTLPTPMVLQ 315

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 91/263 (34%), Positives = 133/263 (50%), Gaps = 10/263 (3%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + +++G G FG+  L  +       A K I + + + +    +V+REI   R L   P
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDE----NVKREIINHRSLR-HP 75
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NIV+FK        + IVME  +GGELF+RI   G +SE  A   F+ +++ V+  H+  
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQ 135
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY- 212
           V HRDLK EN L   G     +K  DFG S         +  VG+P YIAPEV L + Y 
Sbjct: 136 VAHRDLKLENTLL-DGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYD 194
Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR--DPFPSISSSAIELV 270
           GK AD+WS GV LY++L G  PF    +    +  +   +N Q     +  IS     L+
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLI 254
Query: 271 RRMLTQDPKRRITVAQVLEHPWL 293
            R+   DP +RI++ ++  H W 
Sbjct: 255 SRIFVADPAKRISIPEIRNHEWF 277

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 100/321 (31%), Positives = 162/321 (50%), Gaps = 39/321 (12%)
Query: 21  DAILGKAYEDVQLHYTIGREV-GRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD 79
           D+  G+ +EDV   Y +  +V G G       C    T  E+A K I K+       +  
Sbjct: 4   DSFSGR-FEDV---YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSR 56
Query: 80  VRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           V RE+E++    G  N+++    +E++   ++V E   GG +   I  R H++E  A+ V
Sbjct: 57  VFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV 116
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI--- 196
            + + + ++  H+KG+ HRDLKPEN L    ++ + VK  DF L + I+       I   
Sbjct: 117 VQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 197 -----VGSPYYIAPEVL------SQSYGKEADIWSAGVILYILLCGVPPFWAET------ 239
                 GS  Y+APEV+      +  Y K  D+WS GVILYILL G PPF          
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236
Query: 240 DQGVA---------QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290
           D+G A         ++I +G+  F    +  IS +A +L+ ++L +D K+R++ AQVL+H
Sbjct: 237 DRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296
Query: 291 PWLKESGEASDKPIDTAVIFR 311
           PW++  G A +  + T ++ +
Sbjct: 297 PWVQ--GCAPENTLPTPMVLQ 315

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 85/270 (31%), Positives = 134/270 (49%), Gaps = 22/270 (8%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV--KDVEK-DDVRREIEIMRHLS 91
           + I R +G G FG  +L      G  +A K + K  +V  K VE  +D R  + I+ H  
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH-- 65
Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
             P I++    ++D Q + ++M+   GGELF  +     +    A      +   +   H
Sbjct: 66  --PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-Q 210
           SK +++RDLKPEN L    D+N  +K TDFG + ++ +      + G+P YIAPEV+S +
Sbjct: 124 SKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPD--VTYXLCGTPDYIAPEVVSTK 178
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
            Y K  D WS G+++Y +L G  PF+        + IL  E+ F     P  +    +L+
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLL 234
Query: 271 RRMLTQDPKRRITVAQ-----VLEHPWLKE 295
            R++T+D  +R+   Q     V  HPW KE
Sbjct: 235 SRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 82/252 (32%), Positives = 134/252 (53%), Gaps = 12/252 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F  T L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 90
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
             V+    ++DD+ ++  +     GEL   I   G + E         I++ +   H KG
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYR--EIVGSPYYIAPEVLSQ- 210
           ++HRDLKPEN L    +E+  ++ TDFG +  +  E K  R    VG+  Y++PE+L++ 
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           S  K +D+W+ G I+Y L+ G+PPF A  +  + Q I+K E +F    FP     A +LV
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 263
Query: 271 RRMLTQDPKRRI 282
            ++L  D  +R+
Sbjct: 264 EKLLVLDATKRL 275

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 136/271 (50%), Gaps = 10/271 (3%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G F   +  ++  T   FA K +PK  L+K  +++ +  EI I R L+ Q ++V F 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-HVVGFH 83
Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
             +ED+ FV +V+ELC    L +    R   +E  A    R I+      H   V+HRDL
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 161 KPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEVLSQS-YGKEADI 218
           K  N      +E+  VK  DFGL+  +E +G+  + + G+P YIAPEVLS+  +  E D+
Sbjct: 144 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 200
Query: 219 WSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278
           WS G I+Y LL G PPF     +     I K E +  +     I+  A  L+++ML  DP
Sbjct: 201 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH----INPVAASLIQKMLQTDP 256
Query: 279 KRRITVAQVLEHPWLKESGEASDKPIDTAVI 309
             R T+ ++L   +       +  PI    I
Sbjct: 257 TARPTINELLNDEFFTSGYIPARLPITCLTI 287

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  132 bits (332), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 136/271 (50%), Gaps = 10/271 (3%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G F   +  ++  T   FA K +PK  L+K  +++ +  EI I R L+ Q ++V F 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-HVVGFH 83
Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
             +ED+ FV +V+ELC    L +    R   +E  A    R I+      H   V+HRDL
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 161 KPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEVLSQS-YGKEADI 218
           K  N      +E+  VK  DFGL+  +E +G+  + + G+P YIAPEVLS+  +  E D+
Sbjct: 144 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 200
Query: 219 WSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278
           WS G I+Y LL G PPF     +     I K E +  +     I+  A  L+++ML  DP
Sbjct: 201 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH----INPVAASLIQKMLQTDP 256
Query: 279 KRRITVAQVLEHPWLKESGEASDKPIDTAVI 309
             R T+ ++L   +       +  PI    I
Sbjct: 257 TARPTINELLNDEFFTSGYIPARLPITCLTI 287

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  132 bits (331), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 136/271 (50%), Gaps = 10/271 (3%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G F   +  ++  T   FA K +PK  L+K  +++ +  EI I R L+ Q ++V F 
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-HVVGFH 87
Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
             +ED+ FV +V+ELC    L +    R   +E  A    R I+      H   V+HRDL
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 147
Query: 161 KPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEVLSQS-YGKEADI 218
           K  N      +E+  VK  DFGL+  +E +G+  + + G+P YIAPEVLS+  +  E D+
Sbjct: 148 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 204
Query: 219 WSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278
           WS G I+Y LL G PPF     +     I K E +  +     I+  A  L+++ML  DP
Sbjct: 205 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH----INPVAASLIQKMLQTDP 260
Query: 279 KRRITVAQVLEHPWLKESGEASDKPIDTAVI 309
             R T+ ++L   +       +  PI    I
Sbjct: 261 TARPTINELLNDEFFTSGYIPARLPITCLTI 291

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  132 bits (331), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  E +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN +    D+   +K TDFGL+  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLMI---DQQGYIKVTDFGLAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  131 bits (330), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 136/271 (50%), Gaps = 10/271 (3%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G F   +  ++  T   FA K +PK  L+K  +++ +  EI I R L+ Q ++V F 
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-HVVGFH 105
Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
             +ED+ FV +V+ELC    L +    R   +E  A    R I+      H   V+HRDL
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 165
Query: 161 KPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEVLSQS-YGKEADI 218
           K  N      +E+  VK  DFGL+  +E +G+  + + G+P YIAPEVLS+  +  E D+
Sbjct: 166 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 222
Query: 219 WSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278
           WS G I+Y LL G PPF     +     I K E +  +     I+  A  L+++ML  DP
Sbjct: 223 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 278
Query: 279 KRRITVAQVLEHPWLKESGEASDKPIDTAVI 309
             R T+ ++L   +       +  PI    I
Sbjct: 279 TARPTINELLNDEFFTSGYIPARLPITCLTI 309

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  131 bits (330), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 136/271 (50%), Gaps = 10/271 (3%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G F   +  ++  T   FA K +PK  L+K  +++ +  EI I R L+ Q ++V F 
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-HVVGFH 81
Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
             +ED+ FV +V+ELC    L +    R   +E  A    R I+      H   V+HRDL
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 141
Query: 161 KPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEVLSQS-YGKEADI 218
           K  N      +E+  VK  DFGL+  +E +G+  + + G+P YIAPEVLS+  +  E D+
Sbjct: 142 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 198
Query: 219 WSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278
           WS G I+Y LL G PPF     +     I K E +  +     I+  A  L+++ML  DP
Sbjct: 199 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH----INPVAASLIQKMLQTDP 254
Query: 279 KRRITVAQVLEHPWLKESGEASDKPIDTAVI 309
             R T+ ++L   +       +  PI    I
Sbjct: 255 TARPTINELLNDEFFTSGYIPARLPITCLTI 285

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  131 bits (329), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 136/271 (50%), Gaps = 10/271 (3%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G F   +  ++  T   FA K +PK  L+K  +++ +  EI I R L+ Q ++V F 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-HVVGFH 107
Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
             +ED+ FV +V+ELC    L +    R   +E  A    R I+      H   V+HRDL
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 167
Query: 161 KPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEVLSQS-YGKEADI 218
           K  N      +E+  VK  DFGL+  +E +G+  + + G+P YIAPEVLS+  +  E D+
Sbjct: 168 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 224
Query: 219 WSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278
           WS G I+Y LL G PPF     +     I K E +  +     I+  A  L+++ML  DP
Sbjct: 225 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDP 280
Query: 279 KRRITVAQVLEHPWLKESGEASDKPIDTAVI 309
             R T+ ++L   +       +  PI    I
Sbjct: 281 TARPTINELLNDEFFTSGYIPARLPITCLTI 311

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 140/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 92
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME  AGGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 93  LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 152
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    DE   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 153 DLKPENLLI---DEQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 207
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 208 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 262
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 263 DLTKRFGNLKNGVNDIKNHKWF 284

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  FA K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  FA K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  FA K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKDGVNDIKNHKWF 297

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 12/252 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 89
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
             V+    ++DD+ ++  +     GEL   I   G + E         I++ +   H KG
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYR--EIVGSPYYIAPEVLSQ- 210
           ++HRDLKPEN L    +E+  ++ TDFG +  +  E K  R    VG+  Y++PE+L++ 
Sbjct: 150 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 206
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           S  K +D+W+ G I+Y L+ G+PPF A  +  + Q I+K E +F    FP     A +LV
Sbjct: 207 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 262
Query: 271 RRMLTQDPKRRI 282
            ++L  D  +R+
Sbjct: 263 EKLLVLDATKRL 274

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 140/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME  AGGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLAGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 145/263 (55%), Gaps = 11/263 (4%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G G  GI  + T  S+G   A K   K  L K   ++ +  E+ IMR    + N+V+ 
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHE-NVVEM 86
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRD 159
             +Y     + +VME   GG L D IV     +E   A+V   ++  ++V H++GV+HRD
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 145
Query: 160 LKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLSQ-SYGKEAD 217
           +K ++ L T    +  VK +DFG  A + +    R+ +VG+PY++APE++S+  YG E D
Sbjct: 146 IKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 202
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD 277
           IWS G+++  ++ G PP++ E     A  +++  +  +      +S S    + R+L +D
Sbjct: 203 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 261
Query: 278 PKRRITVAQVLEHPWLKESGEAS 300
           P +R T A++L+HP+L ++G  +
Sbjct: 262 PAQRATAAELLKHPFLAKAGPPA 284

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 12/252 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 89
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
             V+    ++DD+ ++  +     GEL   I   G + E         I++ +   H KG
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYR--EIVGSPYYIAPEVLSQ- 210
           ++HRDLKPEN L    +E+  ++ TDFG +  +  E K  R    VG+  Y++PE+L++ 
Sbjct: 150 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 206
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           S  K +D+W+ G I+Y L+ G+PPF A  +  + Q I+K E +F    FP     A +LV
Sbjct: 207 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 262
Query: 271 RRMLTQDPKRRI 282
            ++L  D  +R+
Sbjct: 263 EKLLVLDATKRL 274

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 145/263 (55%), Gaps = 11/263 (4%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G G  GI  + T  S+G   A K   K  L K   ++ +  E+ IMR    + N+V+ 
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHE-NVVEM 82
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRD 159
             +Y     + +VME   GG L D IV     +E   A+V   ++  ++V H++GV+HRD
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 141
Query: 160 LKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLSQ-SYGKEAD 217
           +K ++ L T    +  VK +DFG  A + +    R+ +VG+PY++APE++S+  YG E D
Sbjct: 142 IKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 198
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD 277
           IWS G+++  ++ G PP++ E     A  +++  +  +      +S S    + R+L +D
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 257
Query: 278 PKRRITVAQVLEHPWLKESGEAS 300
           P +R T A++L+HP+L ++G  +
Sbjct: 258 PAQRATAAELLKHPFLAKAGPPA 280

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 140/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  E +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN +    D+   ++ TDFGL+  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLMI---DQQGYIQVTDFGLAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 140/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME  AGGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLXGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 145/263 (55%), Gaps = 11/263 (4%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G G  GI  + T  S+G   A K   K  L K   ++ +  E+ IMR    + N+V+ 
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHE-NVVEM 91
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRD 159
             +Y     + +VME   GG L D IV     +E   A+V   ++  ++V H++GV+HRD
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 150
Query: 160 LKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLSQ-SYGKEAD 217
           +K ++ L T    +  VK +DFG  A + +    R+ +VG+PY++APE++S+  YG E D
Sbjct: 151 IKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 207
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD 277
           IWS G+++  ++ G PP++ E     A  +++  +  +      +S S    + R+L +D
Sbjct: 208 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 266
Query: 278 PKRRITVAQVLEHPWLKESGEAS 300
           P +R T A++L+HP+L ++G  +
Sbjct: 267 PAQRATAAELLKHPFLAKAGPPA 289

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 140/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME  AGGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 12/252 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 74
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
             V+    ++DD+ ++  +     GEL   I   G + E         I++ +   H KG
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 134
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYR--EIVGSPYYIAPEVLSQ- 210
           ++HRDLKPEN L    +E+  ++ TDFG +  +  E K  R    VG+  Y++PE+L++ 
Sbjct: 135 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 191
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           S  K +D+W+ G I+Y L+ G+PPF A  +  + Q I+K E +F    FP     A +LV
Sbjct: 192 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 247
Query: 271 RRMLTQDPKRRI 282
            ++L  D  +R+
Sbjct: 248 EKLLVLDATKRL 259

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 140/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME  AGGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKDGVNDIKNHKWF 297

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 140/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 106
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME  AGGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 167 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 221
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 276
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 277 DLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 12/252 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 90
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
             V+    ++DD+ ++  +     GEL   I   G + E         I++ +   H KG
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYR--EIVGSPYYIAPEVLSQ- 210
           ++HRDLKPEN L    +E+  ++ TDFG +  +  E K  R    VG+  Y++PE+L++ 
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           S  K +D+W+ G I+Y L+ G+PPF A  +  + Q I+K E +F    FP     A +LV
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 263
Query: 271 RRMLTQDPKRRI 282
            ++L  D  +R+
Sbjct: 264 EKLLVLDATKRL 275

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 12/252 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 92
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
             V+    ++DD+ ++  +     GEL   I   G + E         I++ +   H KG
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYR--EIVGSPYYIAPEVLSQ- 210
           ++HRDLKPEN L    +E+  ++ TDFG +  +  E K  R    VG+  Y++PE+L++ 
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           S  K +D+W+ G I+Y L+ G+PPF A  +  + Q I+K E +F    FP     A +LV
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 265
Query: 271 RRMLTQDPKRRI 282
            ++L  D  +R+
Sbjct: 266 EKLLVLDATKRL 277

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 12/252 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 90
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
             V+    ++DD+ ++  +     GEL   I   G + E         I++ +   H KG
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYR--EIVGSPYYIAPEVLSQ- 210
           ++HRDLKPEN L    +E+  ++ TDFG +  +  E K  R    VG+  Y++PE+L++ 
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           S  K +D+W+ G I+Y L+ G+PPF A  +  + Q I+K E +F    FP     A +LV
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 263
Query: 271 RRMLTQDPKRRI 282
            ++L  D  +R+
Sbjct: 264 EKLLVLDATKRL 275

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 12/252 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 93
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
             V+    ++DD+ ++  +     GEL   I   G + E         I++ +   H KG
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYR--EIVGSPYYIAPEVLSQ- 210
           ++HRDLKPEN L    +E+  ++ TDFG +  +  E K  R    VG+  Y++PE+L++ 
Sbjct: 154 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 210
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           S  K +D+W+ G I+Y L+ G+PPF A  +  + Q I+K E +F    FP     A +LV
Sbjct: 211 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 266
Query: 271 RRMLTQDPKRRI 282
            ++L  D  +R+
Sbjct: 267 EKLLVLDATKRL 278

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 145/263 (55%), Gaps = 11/263 (4%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G G  GI  + T  S+G   A K   K  L K   ++ +  E+ IMR    + N+V+ 
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHE-NVVEM 93
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRD 159
             +Y     + +VME   GG L D IV     +E   A+V   ++  ++V H++GV+HRD
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 152
Query: 160 LKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLSQ-SYGKEAD 217
           +K ++ L T    +  VK +DFG  A + +    R+ +VG+PY++APE++S+  YG E D
Sbjct: 153 IKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 209
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD 277
           IWS G+++  ++ G PP++ E     A  +++  +  +      +S S    + R+L +D
Sbjct: 210 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 268
Query: 278 PKRRITVAQVLEHPWLKESGEAS 300
           P +R T A++L+HP+L ++G  +
Sbjct: 269 PAQRATAAELLKHPFLAKAGPPA 291

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 140/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME  AGGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 12/252 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 92
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
             V+    ++DD+ ++  +     GEL   I   G + E         I++ +   H KG
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYR--EIVGSPYYIAPEVLSQ- 210
           ++HRDLKPEN L    +E+  ++ TDFG +  +  E K  R    VG+  Y++PE+L++ 
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           S  K +D+W+ G I+Y L+ G+PPF A  +  + Q I+K E +F    FP     A +LV
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 265
Query: 271 RRMLTQDPKRRI 282
            ++L  D  +R+
Sbjct: 266 EKLLVLDATKRL 277

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 106
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN +    D+   +K TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 167 DLKPENLMI---DQQGYIKVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 221
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 276
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 277 DLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 12/252 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 67
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
             V+    ++DD+ ++  +     GEL   I   G + E         I++ +   H KG
Sbjct: 68  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 127
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYR--EIVGSPYYIAPEVLSQ- 210
           ++HRDLKPEN L    +E+  ++ TDFG +  +  E K  R    VG+  Y++PE+L++ 
Sbjct: 128 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 184
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           S  K +D+W+ G I+Y L+ G+PPF A  +  + Q I+K E +F    FP     A +LV
Sbjct: 185 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 240
Query: 271 RRMLTQDPKRRI 282
            ++L  D  +R+
Sbjct: 241 EKLLVLDATKRL 252

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 140/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME  AGGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 12/252 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 90
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
             V+    ++DD+ ++  +     GEL   I   G + E         I++ +   H KG
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYR--EIVGSPYYIAPEVLSQ- 210
           ++HRDLKPEN L    +E+  ++ TDFG +  +  E K  R    VG+  Y++PE+L++ 
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK 207
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           S  K +D+W+ G I+Y L+ G+PPF A  +  + Q I+K E +F    FP     A +LV
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 263
Query: 271 RRMLTQDPKRRI 282
            ++L  D  +R+
Sbjct: 264 EKLLVLDATKRL 275

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 145/263 (55%), Gaps = 11/263 (4%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G G  GI  + T  S+G   A K   K  L K   ++ +  E+ IMR    + N+V+ 
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHE-NVVEM 136
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRD 159
             +Y     + +VME   GG L D IV     +E   A+V   ++  ++V H++GV+HRD
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 195
Query: 160 LKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLSQ-SYGKEAD 217
           +K ++ L T    +  VK +DFG  A + +    R+ +VG+PY++APE++S+  YG E D
Sbjct: 196 IKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 252
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD 277
           IWS G+++  ++ G PP++ E     A  +++  +  +      +S S    + R+L +D
Sbjct: 253 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 311
Query: 278 PKRRITVAQVLEHPWLKESGEAS 300
           P +R T A++L+HP+L ++G  +
Sbjct: 312 PAQRATAAELLKHPFLAKAGPPA 334

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 12/252 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 92
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
             V+    ++DD+ ++  +     GEL   I   G + E         I++ +   H KG
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYR--EIVGSPYYIAPEVLSQ- 210
           ++HRDLKPEN L    +E+  ++ TDFG +  +  E K  R    VG+  Y++PE+L++ 
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           S  K +D+W+ G I+Y L+ G+PPF A  +  + Q I+K E +F    FP     A +LV
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 265
Query: 271 RRMLTQDPKRRI 282
            ++L  D  +R+
Sbjct: 266 EKLLVLDATKRL 277

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 12/252 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 68
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
             V+    ++DD+ ++  +     GEL   I   G + E         I++ +   H KG
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYR--EIVGSPYYIAPEVLSQ- 210
           ++HRDLKPEN L    +E+  ++ TDFG +  +  E K  R    VG+  Y++PE+L++ 
Sbjct: 129 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 185
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           S  K +D+W+ G I+Y L+ G+PPF A  +  + Q I+K E +F    FP     A +LV
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 241
Query: 271 RRMLTQDPKRRI 282
            ++L  D  +R+
Sbjct: 242 EKLLVLDATKRL 253

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 12/252 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 97
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
             V+    ++DD+ ++  +     GEL   I   G + E         I++ +   H KG
Sbjct: 98  FFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 157
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYR--EIVGSPYYIAPEVLSQ- 210
           ++HRDLKPEN L    +E+  ++ TDFG +  +  E K  R    VG+  Y++PE+L++ 
Sbjct: 158 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 214
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           S  K +D+W+ G I+Y L+ G+PPF A  +  + Q I+K E +F    FP     A +LV
Sbjct: 215 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 270
Query: 271 RRMLTQDPKRRI 282
            ++L  D  +R+
Sbjct: 271 EKLLVLDATKRL 282

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 106
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 167 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 221
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 276
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 277 DLTKRFGNLKNGVNDIXNHKWF 298

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 140/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME  AGGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 145/263 (55%), Gaps = 11/263 (4%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G G  GI  + T  S+G   A K   K  L K   ++ +  E+ IMR    + N+V+ 
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHE-NVVEM 213
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRD 159
             +Y     + +VME   GG L D IV     +E   A+V   ++  ++V H++GV+HRD
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 272
Query: 160 LKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLSQ-SYGKEAD 217
           +K ++ L T    +  VK +DFG  A + +    R+ +VG+PY++APE++S+  YG E D
Sbjct: 273 IKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 329
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD 277
           IWS G+++  ++ G PP++ E     A  +++  +  +      +S S    + R+L +D
Sbjct: 330 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 388
Query: 278 PKRRITVAQVLEHPWLKESGEAS 300
           P +R T A++L+HP+L ++G  +
Sbjct: 389 PAQRATAAELLKHPFLAKAGPPA 411

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 140/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME  AGGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLPNGVNDIKNHKWF 297

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 12/252 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 93
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
             V+    ++DD+ ++  +     GEL   I   G + E         I++ +   H KG
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYR--EIVGSPYYIAPEVLSQ- 210
           ++HRDLKPEN L    +E+  ++ TDFG +  +  E K  R    VG+  Y++PE+L++ 
Sbjct: 154 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 210
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           S  K +D+W+ G I+Y L+ G+PPF A  +  + Q I+K E +F    FP     A +LV
Sbjct: 211 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 266
Query: 271 RRMLTQDPKRRI 282
            ++L  D  +R+
Sbjct: 267 EKLLVLDATKRL 278

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 12/252 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 69
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
             V+    ++DD+ ++  +     GEL   I   G + E         I++ +   H KG
Sbjct: 70  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 129
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYR--EIVGSPYYIAPEVLSQ- 210
           ++HRDLKPEN L    +E+  ++ TDFG +  +  E K  R    VG+  Y++PE+L++ 
Sbjct: 130 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 186
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           S  K +D+W+ G I+Y L+ G+PPF A  +  + Q I+K E +F    FP     A +LV
Sbjct: 187 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 242
Query: 271 RRMLTQDPKRRI 282
            ++L  D  +R+
Sbjct: 243 EKLLVLDATKRL 254

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 12/252 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 70
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
             V+    ++DD+ ++  +     GEL   I   G + E         I++ +   H KG
Sbjct: 71  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 130
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYR--EIVGSPYYIAPEVLSQ- 210
           ++HRDLKPEN L    +E+  ++ TDFG +  +  E K  R    VG+  Y++PE+L++ 
Sbjct: 131 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 187
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           S  K +D+W+ G I+Y L+ G+PPF A  +  + Q I+K E +F    FP     A +LV
Sbjct: 188 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 243
Query: 271 RRMLTQDPKRRI 282
            ++L  D  +R+
Sbjct: 244 EKLLVLDATKRL 255

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 98
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 158
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 159 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 213
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 214 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 268
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 269 DLTKRFGNLKNGVNDIKNHKWF 290

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 106
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 167 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 221
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 276
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 277 DLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 106
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 167 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 221
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 276
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 277 DLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN +    D+   +K TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLMI---DQQGYIKVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 138/262 (52%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 126
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME  AGGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 186
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  ++   A   + G+P Y+APE +LS+ Y K  D
Sbjct: 187 DLKPENLLI---DQQGYIQVTDFGFAKRVK--GATWTLCGTPEYLAPEIILSKGYNKAVD 241
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 242 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 296
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 297 DLTKRFGNLKNGVNDIKNHKWF 318

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 68  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 126
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 127 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 186
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 187 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 241
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 242 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 296
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 297 DLTKRFGNLKNGVNDIKNHKWF 318

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 133/252 (52%), Gaps = 12/252 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 95
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
             V+    ++DD+ ++  +     GEL   I   G + E         I++ +   H KG
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 155
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYR--EIVGSPYYIAPEVLSQ- 210
           ++HRDLKPEN L    +E+  ++ TDFG +  +  E K  R    VG+  Y++PE+L++ 
Sbjct: 156 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 212
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           S  K +D+W+ G I+Y L+ G+PPF A  +  + Q I+K E +F    FP     A +LV
Sbjct: 213 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFP----KARDLV 268
Query: 271 RRMLTQDPKRRI 282
            ++L  D  +R+
Sbjct: 269 EKLLVLDATKRL 280

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  129 bits (323), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 140/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME  AGGE+F  +   G ++E  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 106
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 167 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-TLCGTPEYLAPEIILSKGYNKAVD 221
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 276
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 277 DLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKDGVNDIKNHKWF 297

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 33  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 91
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 92  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 151
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 152 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-TLCGTPEYLAPEIILSKGYNKAVD 206
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 207 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 261
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 262 DLTKRFGNLKDGVNDIKNHKWF 283

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 106
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 167 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 221
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 276
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 277 DLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 138/262 (52%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   +K  DFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIKVADFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  128 bits (322), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 100
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME  AGGE+F  +   G + E  A      I+      HS  +++R
Sbjct: 101 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 160
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 161 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 215
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 216 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 270
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 271 DLTKRFGNLKNGVNDIKNHKWF 292

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  128 bits (321), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 126
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME  AGGE+F  +   G + E  A      I+      HS  +++R
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 186
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 187 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 241
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 242 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 296
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 297 DLTKRFGNLKNGVNDIKNHKWF 318

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  128 bits (321), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME  AGGE+F  +   G + E  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  128 bits (321), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME  AGGE+F  +   G + E  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  128 bits (321), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN +    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLMI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  128 bits (321), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME  AGGE+F  +   G + E  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P + +
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLTK 106
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN +    D+   +K TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 167 DLKPENLMI---DQQGYIKVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 221
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 276
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 277 DLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 140/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME  AGGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN +    D+   ++ TDFG +  + +G+ +  + G+P Y+APE ++S+ Y K  D
Sbjct: 166 DLKPENLII---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIIISKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P + +
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLTK 106
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN +    D+   +K TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 167 DLKPENLMI---DQQGYIKVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 221
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 276
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 277 DLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 137/262 (52%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           R +G G FG   L     TG  +A K + K+K+VK  + +    E  I + ++  P +V+
Sbjct: 48  RTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF-PFLVK 106
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++V+E   GGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 107 LEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   +K  DFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 167 DLKPENLLI---DQQGYIKVADFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 221
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 276
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 277 DLTKRFGNLKNGVNDIKNHKWF 298

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/252 (31%), Positives = 132/252 (52%), Gaps = 12/252 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 92
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
             V+    ++DD+ ++  +     GEL   I   G + E         I++ +   H KG
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYR--EIVGSPYYIAPEVLSQ- 210
           ++HRDLKPEN L    +E+  ++ TDFG +  +  E K  R    VG+  Y++PE+L++ 
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           S  K +D+W+ G I+Y L+ G+PPF A  +  +   I+K E +F    FP     A +LV
Sbjct: 210 SAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFP----KARDLV 265
Query: 271 RRMLTQDPKRRI 282
            ++L  D  +R+
Sbjct: 266 EKLLVLDATKRL 277

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME  AGGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+AP  +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPAIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 98
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G + E  A      I+      HS  +++R
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 158
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 159 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 213
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 214 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 268
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 269 DLTKRFGNLKNGVNDIKNHKWF 290

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/252 (31%), Positives = 132/252 (52%), Gaps = 12/252 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 92
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
             V+    ++DD+ ++  +     G L   I   G + E         I++ +   H KG
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYR--EIVGSPYYIAPEVLSQ- 210
           ++HRDLKPEN L    +E+  ++ TDFG +  +  E K  R    VG+  Y++PE+L++ 
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 209
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           S  K +D+W+ G I+Y L+ G+PPF A  +  + Q I+K E +F    FP     A +LV
Sbjct: 210 SASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 265
Query: 271 RRMLTQDPKRRI 282
            ++L  D  +R+
Sbjct: 266 EKLLVLDATKRL 277

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G + E  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN +    D+   +K TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLMI---DQQGYIKVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 143/283 (50%), Gaps = 15/283 (5%)
Query: 5   FSKGQDSDHPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACK 64
           F  G  SD+  A  +  ++    +      +   + +G+G FG   L  E +TG  +A K
Sbjct: 123 FRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMK 182
Query: 65  SIPKRKLVKDVEKDDVRREIEIMRHL--SGQPNIVQFKAAYEDDQFVHIVMELCAGGELF 122
            + K  +V    KD+V   +   R L  S  P +   K +++    +  VME   GGELF
Sbjct: 183 ILKKEVIVA---KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 239
Query: 123 DRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDF 181
             +     +SE  A      I++ ++  HS K V++RDLK EN +    D++  +K TDF
Sbjct: 240 FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDF 296
Query: 182 GLSA-FIEEGKAYREIVGSPYYIAPEVLSQS-YGKEADIWSAGVILYILLCGVPPFWAET 239
           GL    I++G   +   G+P Y+APEVL  + YG+  D W  GV++Y ++CG  PF+ + 
Sbjct: 297 GLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 356
Query: 240 DQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI 282
            + + + IL  EI F R    ++   A  L+  +L +DPK+R+
Sbjct: 357 HEKLFELILMEEIRFPR----TLGPEAKSLLSGLLKKDPKQRL 395

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 143/283 (50%), Gaps = 15/283 (5%)
Query: 5   FSKGQDSDHPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACK 64
           F  G  SD+  A  +  ++    +      +   + +G+G FG   L  E +TG  +A K
Sbjct: 120 FRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMK 179
Query: 65  SIPKRKLVKDVEKDDVRREIEIMRHL--SGQPNIVQFKAAYEDDQFVHIVMELCAGGELF 122
            + K  +V    KD+V   +   R L  S  P +   K +++    +  VME   GGELF
Sbjct: 180 ILKKEVIVA---KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 236
Query: 123 DRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDF 181
             +     +SE  A      I++ ++  HS K V++RDLK EN +    D++  +K TDF
Sbjct: 237 FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDF 293
Query: 182 GLSA-FIEEGKAYREIVGSPYYIAPEVLSQS-YGKEADIWSAGVILYILLCGVPPFWAET 239
           GL    I++G   +   G+P Y+APEVL  + YG+  D W  GV++Y ++CG  PF+ + 
Sbjct: 294 GLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353
Query: 240 DQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI 282
            + + + IL  EI F R    ++   A  L+  +L +DPK+R+
Sbjct: 354 HEKLFELILMEEIRFPR----TLGPEAKSLLSGLLKKDPKQRL 392

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/252 (31%), Positives = 132/252 (52%), Gaps = 12/252 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 92
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
             V+    ++DD+ ++  +     GEL   I   G + E         I++ +   H KG
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYR--EIVGSPYYIAPEVLSQ- 210
           ++HRDLKPEN L    +E+  ++ TDFG +  +  E K  R    VG+  Y++PE+L++ 
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           S  K +D+W+ G I+Y L+ G+PPF A  +  +   I+K E +F    FP     A +LV
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFP----KARDLV 265
Query: 271 RRMLTQDPKRRI 282
            ++L  D  +R+
Sbjct: 266 EKLLVLDATKRL 277

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 148/266 (55%), Gaps = 23/266 (8%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G G  GI  L  E  +G + A K +  RK  +   ++ +  E+ IMR      N+V+ 
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQ-HFNVVEM 107
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRD 159
             +Y   + + ++ME   GG L D IV++   +E   A+V   ++  +   H++GV+HRD
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRD 166
Query: 160 LKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLSQS-YGKEAD 217
           +K ++ L T    +  VK +DFG  A I +    R+ +VG+PY++APEV+S+S Y  E D
Sbjct: 167 IKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVD 223
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS------AIELVR 271
           IWS G+++  ++ G PP+++++     QA+ +     +  P P + +S        + + 
Sbjct: 224 IWSLGIMVIEMVDGEPPYFSDSP---VQAMKR----LRDSPPPKLKNSHKVSPVLRDFLE 276
Query: 272 RMLTQDPKRRITVAQVLEHPWLKESG 297
           RML +DP+ R T  ++L+HP+L ++G
Sbjct: 277 RMLVRDPQERATAQELLDHPFLLQTG 302

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 140/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME  AGGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKR-----RITVAQVLEHPWL 293
           D  +     +  V  +  H W 
Sbjct: 276 DLTKAFGNLKNGVNDIKNHKWF 297

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  127 bits (319), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 134/259 (51%), Gaps = 19/259 (7%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG--QPNIVQ 98
           +G+G FG   L  E +TG  +A K + K  ++    KD+V   +   R L     P +  
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTRHPFLTA 74
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            K A++    +  VME   GGELF  +     ++E  A      I++ +   HS+ V++R
Sbjct: 75  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 134
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVLSQS-YGKEA 216
           D+K EN +    D++  +K TDFGL    I +G   +   G+P Y+APEVL  + YG+  
Sbjct: 135 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAV 191
Query: 217 DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276
           D W  GV++Y ++CG  PF+ +  + + + IL  EI F R    ++S  A  L+  +L +
Sbjct: 192 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 247
Query: 277 DPKRRI-----TVAQVLEH 290
           DPK+R+        +V+EH
Sbjct: 248 DPKQRLGGGPSDAKEVMEH 266

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GG++F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   +K  DFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIKVADFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 134/259 (51%), Gaps = 19/259 (7%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG--QPNIVQ 98
           +G+G FG   L  E +TG  +A K + K  ++    KD+V   +   R L     P +  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTRHPFLTA 69
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            K A++    +  VME   GGELF  +     ++E  A      I++ +   HS+ V++R
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVLSQS-YGKEA 216
           D+K EN +    D++  +K TDFGL    I +G   +   G+P Y+APEVL  + YG+  
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAV 186
Query: 217 DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276
           D W  GV++Y ++CG  PF+ +  + + + IL  EI F R    ++S  A  L+  +L +
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 242
Query: 277 DPKRRI-----TVAQVLEH 290
           DPK+R+        +V+EH
Sbjct: 243 DPKQRLGGGPSDAKEVMEH 261

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GG++F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   +K  DFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIKVADFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 147/285 (51%), Gaps = 31/285 (10%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G G  GI  + TE  TG + A K   K  L K   ++ +  E+ IMR      N+V  
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYH-HDNVVDM 107
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRD 159
            ++Y     + +VME   GG L D IV     +E   A+V   ++  ++  H++GV+HRD
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 166
Query: 160 LKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVGSPYYIAPEVLSQ-SYGKEAD 217
           +K ++ L T+   +  +K +DFG  A + +E    + +VG+PY++APEV+S+  YG E D
Sbjct: 167 IKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVD 223
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-------ISSSAIELV 270
           IWS G+++  ++ G PP++ E      + I        RD  P        +SS     +
Sbjct: 224 IWSLGIMVIEMIDGEPPYFNEPPLQAMRRI--------RDSLPPRVKDLHKVSSVLRGFL 275
Query: 271 RRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQF 315
             ML ++P +R T  ++L HP+LK +G  S       ++  M+Q+
Sbjct: 276 DLMLVREPSQRATAQELLGHPFLKLAGPPS------CIVPLMRQY 314

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 106
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G + E  A      I+      HS  +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 167 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 221
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 276
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 277 DLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G + E  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 134/259 (51%), Gaps = 19/259 (7%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG--QPNIVQ 98
           +G+G FG   L  E +TG  +A K + K  ++    KD+V   +   R L     P +  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTRHPFLTA 69
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            K A++    +  VME   GGELF  +     ++E  A      I++ +   HS+ V++R
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVLSQS-YGKEA 216
           D+K EN +    D++  +K TDFGL    I +G   +   G+P Y+APEVL  + YG+  
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAV 186
Query: 217 DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276
           D W  GV++Y ++CG  PF+ +  + + + IL  EI F R    ++S  A  L+  +L +
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 242
Query: 277 DPKRRI-----TVAQVLEH 290
           DPK+R+        +V+EH
Sbjct: 243 DPKQRLGGGPSDAKEVMEH 261

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 138/262 (52%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G + E  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 134/259 (51%), Gaps = 19/259 (7%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG--QPNIVQ 98
           +G+G FG   L  E +TG  +A K + K  ++    KD+V   +   R L     P +  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTRHPFLTA 69
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            K A++    +  VME   GGELF  +     ++E  A      I++ +   HS+ V++R
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVLSQS-YGKEA 216
           D+K EN +    D++  +K TDFGL    I +G   +   G+P Y+APEVL  + YG+  
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186
Query: 217 DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276
           D W  GV++Y ++CG  PF+ +  + + + IL  EI F R    ++S  A  L+  +L +
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 242
Query: 277 DPKRRI-----TVAQVLEH 290
           DPK+R+        +V+EH
Sbjct: 243 DPKQRLGGGPSDAKEVMEH 261

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 134/259 (51%), Gaps = 19/259 (7%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG--QPNIVQ 98
           +G+G FG   L  E +TG  +A K + K  ++    KD+V   +   R L     P +  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTRHPFLTA 69
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            K A++    +  VME   GGELF  +     ++E  A      I++ +   HS+ V++R
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVLSQS-YGKEA 216
           D+K EN +    D++  +K TDFGL    I +G   +   G+P Y+APEVL  + YG+  
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAV 186
Query: 217 DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276
           D W  GV++Y ++CG  PF+ +  + + + IL  EI F R    ++S  A  L+  +L +
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 242
Query: 277 DPKRRI-----TVAQVLEH 290
           DPK+R+        +V+EH
Sbjct: 243 DPKQRLGGGPSDAKEVMEH 261

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 134/259 (51%), Gaps = 19/259 (7%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG--QPNIVQ 98
           +G+G FG   L  E +TG  +A K + K  ++    KD+V   +   R L     P +  
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTRHPFLTA 72
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            K A++    +  VME   GGELF  +     ++E  A      I++ +   HS+ V++R
Sbjct: 73  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 132
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVLSQS-YGKEA 216
           D+K EN +    D++  +K TDFGL    I +G   +   G+P Y+APEVL  + YG+  
Sbjct: 133 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 189
Query: 217 DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276
           D W  GV++Y ++CG  PF+ +  + + + IL  EI F R    ++S  A  L+  +L +
Sbjct: 190 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 245
Query: 277 DPKRRI-----TVAQVLEH 290
           DPK+R+        +V+EH
Sbjct: 246 DPKQRLGGGPSDAKEVMEH 264

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 139/262 (53%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  P +V+
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVK 105
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME  AGGE+F  +   G +SE  A      I+      HS  +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN L    D+   ++ TDFG +  + +G+ +  + G+P  +APE +LS+ Y K  D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRV-KGRTW-XLCGTPEALAPEIILSKGYNKAVD 220
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 275
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 134/259 (51%), Gaps = 19/259 (7%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG--QPNIVQ 98
           +G+G FG   L  E +TG  +A K + K  ++    KD+V   +   R L     P +  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTRHPFLTA 69
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            K A++    +  VME   GGELF  +     ++E  A      I++ +   HS+ V++R
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVLSQS-YGKEA 216
           D+K EN +    D++  +K TDFGL    I +G   +   G+P Y+APEVL  + YG+  
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186
Query: 217 DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276
           D W  GV++Y ++CG  PF+ +  + + + IL  EI F R    ++S  A  L+  +L +
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 242
Query: 277 DPKRRI-----TVAQVLEH 290
           DPK+R+        +V+EH
Sbjct: 243 DPKQRLGGGPSDAKEVMEH 261

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  126 bits (316), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 137/262 (52%), Gaps = 18/262 (6%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           + +G G FG   L     TG  +A K + K+K+VK  + +    E  I++ ++  P + +
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLTK 106
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
            + +++D+  +++VME   GGE+F  +   G + E  A      I+      HS  +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEAD 217
           DLKPEN +    D+   +K TDFG +  + +G+ +  + G+P Y+APE +LS+ Y K  D
Sbjct: 167 DLKPENLMI---DQQGYIKVTDFGFAKRV-KGRTW-XLCGTPEYLAPEIILSKGYNKAVD 221
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRMLTQ 276
            W+ GV++Y +  G PPF+A+    + + I+ G++      FPS  SS   +L+R +L  
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-----FPSHFSSDLKDLLRNLLQV 276
Query: 277 DPKRRI-----TVAQVLEHPWL 293
           D  +R       V  +  H W 
Sbjct: 277 DLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 83/247 (33%), Positives = 131/247 (53%), Gaps = 15/247 (6%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL--SGQPNIVQ 98
           +G+G FG   L  E +TG  +A K + K  +V    KD+V   +   R L  S  P +  
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVA---KDEVAHTLTENRVLQNSRHPFLTA 74
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMH 157
            K +++    +  VME   GGELF  +     +SE  A      I++ ++  HS K V++
Sbjct: 75  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 134
Query: 158 RDLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVLSQS-YGKE 215
           RDLK EN +    D++  +K TDFGL    I++G   +   G+P Y+APEVL  + YG+ 
Sbjct: 135 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRA 191
Query: 216 ADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT 275
            D W  GV++Y ++CG  PF+ +  + + + IL  EI F R    ++   A  L+  +L 
Sbjct: 192 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSLLSGLLK 247
Query: 276 QDPKRRI 282
           +DPK+R+
Sbjct: 248 KDPKQRL 254

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 83/247 (33%), Positives = 131/247 (53%), Gaps = 15/247 (6%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL--SGQPNIVQ 98
           +G+G FG   L  E +TG  +A K + K  +V    KD+V   +   R L  S  P +  
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVA---KDEVAHTLTENRVLQNSRHPFLTA 72
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMH 157
            K +++    +  VME   GGELF  +     +SE  A      I++ ++  HS K V++
Sbjct: 73  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 132
Query: 158 RDLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVLSQS-YGKE 215
           RDLK EN +    D++  +K TDFGL    I++G   +   G+P Y+APEVL  + YG+ 
Sbjct: 133 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRA 189
Query: 216 ADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT 275
            D W  GV++Y ++CG  PF+ +  + + + IL  EI F R    ++   A  L+  +L 
Sbjct: 190 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSLLSGLLK 245
Query: 276 QDPKRRI 282
           +DPK+R+
Sbjct: 246 KDPKQRL 252

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 83/247 (33%), Positives = 131/247 (53%), Gaps = 15/247 (6%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL--SGQPNIVQ 98
           +G+G FG   L  E +TG  +A K + K  +V    KD+V   +   R L  S  P +  
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVA---KDEVAHTLTENRVLQNSRHPFLTA 73
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMH 157
            K +++    +  VME   GGELF  +     +SE  A      I++ ++  HS K V++
Sbjct: 74  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 133
Query: 158 RDLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVLSQS-YGKE 215
           RDLK EN +    D++  +K TDFGL    I++G   +   G+P Y+APEVL  + YG+ 
Sbjct: 134 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRA 190
Query: 216 ADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT 275
            D W  GV++Y ++CG  PF+ +  + + + IL  EI F R    ++   A  L+  +L 
Sbjct: 191 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSLLSGLLK 246
Query: 276 QDPKRRI 282
           +DPK+R+
Sbjct: 247 KDPKQRL 253

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 88/284 (30%), Positives = 146/284 (51%), Gaps = 18/284 (6%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + + +GRG FG   L    ++   +A K + K +++K  +      E +IM   +  P
Sbjct: 77  YDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 135
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
            +VQ   A++DD+++++VME   GG+L + +++     E+ A      ++  ++  HS G
Sbjct: 136 WVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMG 194
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GKAYREI-VGSPYYIAPEVLSQS- 211
           ++HRD+KP+N L    D++  +K  DFG    ++E G  + +  VG+P YI+PEVL    
Sbjct: 195 LIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQG 251
Query: 212 ----YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL--KGEINFQRDPFPSISSS 265
               YG+E D WS GV L+ +L G  PF+A++  G    I+  K  + F  D    IS  
Sbjct: 252 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPED--AEISKH 309
Query: 266 AIELVRRMLTQDPKR--RITVAQVLEHPWLKESGEASDKPIDTA 307
           A  L+   LT    R  R  V ++ +HP+ K      D   +TA
Sbjct: 310 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETA 353

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 91/280 (32%), Positives = 144/280 (51%), Gaps = 25/280 (8%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
           ED ++ YTIG     G +G        S G     K +    +  + EK  +  E+ ++R
Sbjct: 6   EDYEVLYTIGT----GSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLR 60
Query: 89  HLSGQPNIVQFKAAYED--DQFVHIVMELCAGGELFDRIVA----RGHYSERAAASVFRV 142
            L   PNIV++     D  +  ++IVME C GG+L   I      R +  E     V   
Sbjct: 61  ELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 143 IMNVVNVCHSKG-----VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY-REI 196
           +   +  CH +      V+HRDLKP N +F  G +N  VK  DFGL+  +   + + +E 
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPAN-VFLDGKQN--VKLGDFGLARILNHDEDFAKEF 176
Query: 197 VGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ 255
           VG+PYY++PE +++ SY +++DIWS G +LY L   +PPF A + + +A  I +G+  F+
Sbjct: 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--FR 234
Query: 256 RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
           R P+   S    E++ RML      R +V ++LE+P + E
Sbjct: 235 RIPY-RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 89/284 (31%), Positives = 140/284 (49%), Gaps = 18/284 (6%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + + +GRG FG   L    ST   +A K + K +++K  +      E +IM   +  P
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSP 134
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
            +VQ   A++DD+++++VME   GG+L + +++     E+ A      ++  ++  HS G
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 193
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR--EIVGSPYYIAPEVLSQS- 211
            +HRD+KP+N L    D++  +K  DFG    + +    R    VG+P YI+PEVL    
Sbjct: 194 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 212 ----YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL--KGEINFQRDPFPSISSS 265
               YG+E D WS GV LY +L G  PF+A++  G    I+  K  + F  D    IS  
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISKE 308
Query: 266 AIELVRRMLTQDPKR--RITVAQVLEHPWLKESGEASDKPIDTA 307
           A  L+   LT    R  R  V ++  H + K    A +   DT 
Sbjct: 309 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTV 352

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 89/284 (31%), Positives = 140/284 (49%), Gaps = 18/284 (6%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + + +GRG FG   L    ST   +A K + K +++K  +      E +IM   +  P
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSP 134
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
            +VQ   A++DD+++++VME   GG+L + +++     E+ A      ++  ++  HS G
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 193
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR--EIVGSPYYIAPEVLSQS- 211
            +HRD+KP+N L    D++  +K  DFG    + +    R    VG+P YI+PEVL    
Sbjct: 194 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 212 ----YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL--KGEINFQRDPFPSISSS 265
               YG+E D WS GV LY +L G  PF+A++  G    I+  K  + F  D    IS  
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISKE 308
Query: 266 AIELVRRMLTQDPKR--RITVAQVLEHPWLKESGEASDKPIDTA 307
           A  L+   LT    R  R  V ++  H + K    A +   DT 
Sbjct: 309 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTV 352

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 89/284 (31%), Positives = 140/284 (49%), Gaps = 18/284 (6%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + + +GRG FG   L    ST   +A K + K +++K  +      E +IM   +  P
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSP 129
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
            +VQ   A++DD+++++VME   GG+L + +++     E+ A      ++  ++  HS G
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMG 188
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR--EIVGSPYYIAPEVLSQS- 211
            +HRD+KP+N L    D++  +K  DFG    + +    R    VG+P YI+PEVL    
Sbjct: 189 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 212 ----YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL--KGEINFQRDPFPSISSS 265
               YG+E D WS GV LY +L G  PF+A++  G    I+  K  + F  D    IS  
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISKE 303
Query: 266 AIELVRRMLTQDPKR--RITVAQVLEHPWLKESGEASDKPIDTA 307
           A  L+   LT    R  R  V ++  H + K    A +   DT 
Sbjct: 304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTV 347

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 147/290 (50%), Gaps = 20/290 (6%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y   +++G G FG   L      G ++  K I   ++    E+++ RRE+ ++ ++   P
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANMK-HP 83
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVCHS 152
           NIVQ++ ++E++  ++IVM+ C GG+LF RI A+    + E      F  I   +   H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-KAYREIVGSPYYIAPEVL-SQ 210
           + ++HRD+K +N   T   ++  V+  DFG++  +    +  R  +G+PYY++PE+  ++
Sbjct: 144 RKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI----SSSA 266
            Y  ++DIW+ G +LY L      F A + + +   I+ G        FP +    S   
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-------FPPVSLHYSYDL 253
Query: 267 IELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
             LV ++  ++P+ R +V  +LE  ++ +  E    P   A  F +K F+
Sbjct: 254 RSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFS 303

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 91/294 (30%), Positives = 150/294 (51%), Gaps = 18/294 (6%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRH 89
           D +  YT   ++G+G  G  Y   + +TG E A + +    L +  +K+ +  EI +MR 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRE 73
Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
            +  PNIV +  +Y     + +VME  AGG L D +V      E   A+V R  +  +  
Sbjct: 74  -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR-EIVGSPYYIAPEVL 208
            HS  V+HRD+K +N L      +  VK TDFG  A I   ++ R E+VG+PY++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVV 188
Query: 209 S-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267
           + ++YG + DIWS G++   ++ G PP+  E        I        ++P   +S+   
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFR 247
Query: 268 ELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPID--TAVIFRMKQFTAMN 319
           + + R L  D ++R +  ++L+H +LK +     KP+   T +I   K+ T  N
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIA-----KPLSSLTPLIAAAKEATKNN 296

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 90/280 (32%), Positives = 143/280 (51%), Gaps = 25/280 (8%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
           ED ++ YTIG     G +G        S G     K +    +  + EK  +  E+ ++R
Sbjct: 6   EDYEVLYTIGT----GSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLR 60
Query: 89  HLSGQPNIVQFKAAYED--DQFVHIVMELCAGGELFDRIVA----RGHYSERAAASVFRV 142
            L   PNIV++     D  +  ++IVME C GG+L   I      R +  E     V   
Sbjct: 61  ELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 143 IMNVVNVCHSKG-----VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY-REI 196
           +   +  CH +      V+HRDLKP N +F  G +N  VK  DFGL+  +    ++ +  
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPAN-VFLDGKQN--VKLGDFGLARILNHDTSFAKTF 176
Query: 197 VGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ 255
           VG+PYY++PE +++ SY +++DIWS G +LY L   +PPF A + + +A  I +G+  F+
Sbjct: 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--FR 234
Query: 256 RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
           R P+   S    E++ RML      R +V ++LE+P + E
Sbjct: 235 RIPY-RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 90/280 (32%), Positives = 143/280 (51%), Gaps = 25/280 (8%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
           ED ++ YTIG     G +G        S G     K +    +  + EK  +  E+ ++R
Sbjct: 6   EDYEVLYTIGT----GSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLR 60
Query: 89  HLSGQPNIVQFKAAYED--DQFVHIVMELCAGGELFDRIVA----RGHYSERAAASVFRV 142
            L   PNIV++     D  +  ++IVME C GG+L   I      R +  E     V   
Sbjct: 61  ELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 143 IMNVVNVCHSKG-----VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY-REI 196
           +   +  CH +      V+HRDLKP N +F  G +N  VK  DFGL+  +    ++ +  
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPAN-VFLDGKQN--VKLGDFGLARILNHDTSFAKAF 176
Query: 197 VGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ 255
           VG+PYY++PE +++ SY +++DIWS G +LY L   +PPF A + + +A  I +G+  F+
Sbjct: 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--FR 234
Query: 256 RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
           R P+   S    E++ RML      R +V ++LE+P + E
Sbjct: 235 RIPY-RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 126/244 (51%), Gaps = 9/244 (3%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG   L     T   +A K + K  +++D + +    E  ++  L   P + Q  
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
           + ++    ++ VME   GG+L   I   G + E  A      I   +   H +G+++RDL
Sbjct: 87  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDL 146
Query: 161 KPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVLS-QSYGKEADI 218
           K +N +    D    +K  DFG+    + +G   RE  G+P YIAPE+++ Q YGK  D 
Sbjct: 147 KLDNVML---DSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDW 203
Query: 219 WSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278
           W+ GV+LY +L G PPF  E +  + Q+I++  +++ +    S+S  A+ + + ++T+ P
Sbjct: 204 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGLMTKHP 259
Query: 279 KRRI 282
            +R+
Sbjct: 260 AKRL 263

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  118 bits (296), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 90/297 (30%), Positives = 151/297 (50%), Gaps = 18/297 (6%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRH 89
           D +  YT   ++G+G  G  Y   + +TG E A + +    L +  +K+ +  EI +MR 
Sbjct: 18  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRE 74
Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
            +  PNIV +  +Y     + +VME  AGG L D +V      E   A+V R  +  +  
Sbjct: 75  -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 132
Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVL 208
            HS  V+HRD+K +N L      +  VK TDFG  A I   ++ R  +VG+PY++APEV+
Sbjct: 133 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV 189
Query: 209 S-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267
           + ++YG + DIWS G++   ++ G PP+  E        I        ++P   +S+   
Sbjct: 190 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFR 248
Query: 268 ELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPID--TAVIFRMKQFTAMNKLK 322
           + + R L  D ++R +  ++++H +LK +     KP+   T +I   K+ T  N L+
Sbjct: 249 DFLNRCLEMDVEKRGSAKELIQHQFLKIA-----KPLSSLTPLIAAAKEATKNNHLE 300

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 149/294 (50%), Gaps = 18/294 (6%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRH 89
           D +  YT   ++G+G  G  Y   + +TG E A + +    L +  +K+ +  EI +MR 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRE 73
Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
            +  PNIV +  +Y     + +VME  AGG L D +V      E   A+V R  +  +  
Sbjct: 74  -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVL 208
            HS  V+HRD+K +N L      +  VK TDFG  A I   ++ R  +VG+PY++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV 188
Query: 209 S-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267
           + ++YG + DIWS G++   ++ G PP+  E        I        ++P   +S+   
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFR 247
Query: 268 ELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPID--TAVIFRMKQFTAMN 319
           + + R L  D ++R +  ++L+H +LK +     KP+   T +I   K+ T  N
Sbjct: 248 DFLNRCLEMDVEKRGSAKELLQHQFLKIA-----KPLSSLTPLIAAAKEATKNN 296

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 149/294 (50%), Gaps = 18/294 (6%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRH 89
           D +  YT   ++G+G  G  Y   + +TG E A + +    L +  +K+ +  EI +MR 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRE 73
Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
            +  PNIV +  +Y     + +VME  AGG L D +V      E   A+V R  +  +  
Sbjct: 74  -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVL 208
            HS  V+HRD+K +N L      +  VK TDFG  A I   ++ R  +VG+PY++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 209 S-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267
           + ++YG + DIWS G++   ++ G PP+  E        I        ++P   +S+   
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFR 247
Query: 268 ELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPID--TAVIFRMKQFTAMN 319
           + + R L  D ++R +  ++L+H +LK +     KP+   T +I   K+ T  N
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIA-----KPLSSLTPLIAAAKEATKNN 296

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 135/253 (53%), Gaps = 16/253 (6%)
Query: 41  VGRGEFGITYLCTENS---TGLEFACKSIPKRKLVKDVEK-DDVRREIEIMRHLSGQPNI 96
           +G G +G  +L  + S   TG  +A K + K  +V+  +  +  R E +++ H+   P +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 97  VQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVM 156
           V    A++ +  +H++++   GGELF  +  R  ++E         I+  +   H  G++
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGII 181
Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSA-FI--EEGKAYREIVGSPYYIAPEVL---SQ 210
           +RD+K EN L    D N  V  TDFGLS  F+  E  +AY +  G+  Y+AP+++     
Sbjct: 182 YRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAY-DFCGTIEYMAPDIVRGGDS 237
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIEL 269
            + K  D WS GV++Y LL G  PF  + ++  +QA +   I     P+P  +S+ A +L
Sbjct: 238 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKSEPPYPQEMSALAKDL 296
Query: 270 VRRMLTQDPKRRI 282
           ++R+L +DPK+R+
Sbjct: 297 IQRLLMKDPKKRL 309

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 151/297 (50%), Gaps = 18/297 (6%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRH 89
           D +  YT   ++G+G  G  Y   + +TG E A + +    L +  +K+ +  EI +MR 
Sbjct: 18  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRE 74
Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
            +  PNIV +  +Y     + +VME  AGG L D +V      E   A+V R  +  +  
Sbjct: 75  -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 132
Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVL 208
            HS  V+HR++K +N L      +  VK TDFG  A I   ++ R  +VG+PY++APEV+
Sbjct: 133 LHSNQVIHRNIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 189
Query: 209 S-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267
           + ++YG + DIWS G++   ++ G PP+  E        I        ++P   +S+   
Sbjct: 190 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFR 248
Query: 268 ELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPID--TAVIFRMKQFTAMNKLK 322
           + + R L  D ++R +  ++++H +LK +     KP+   T +I   K+ T  N L+
Sbjct: 249 DFLNRCLEMDVEKRGSAKELIQHQFLKIA-----KPLSSLTPLIAAAKEATKNNHLE 300

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  115 bits (289), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 136/291 (46%), Gaps = 24/291 (8%)
Query: 26  KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPK-RKLVKDVEKDDVRREI 84
           K  E  +  Y +G  +G+G FG  +     +  L+ A K IP+ R L      D V   +
Sbjct: 24  KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 85  EIMRHL-----SGQPNIVQFKAAYEDDQFVHIVME-LCAGGELFDRIVARGHYSERAAAS 138
           E+          G P +++    +E  +   +V+E      +LFD I  +G   E  +  
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC 143
Query: 139 VFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG 198
            F  ++  +  CHS+GV+HRD+K EN L          K  DFG  A + + + Y +  G
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILIDL--RRGCAKLIDFGSGALLHD-EPYTDFDG 200
Query: 199 SPYYIAPEVLS--QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR 256
           +  Y  PE +S  Q +   A +WS G++LY ++CG  PF  E D    Q IL+ E++F  
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF--ERD----QEILEAELHFPA 254
Query: 257 DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTA 307
                +S     L+RR L   P  R ++ ++L  PW++   E  D P++ +
Sbjct: 255 ----HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE--DVPLNPS 299

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  115 bits (289), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 137/278 (49%), Gaps = 20/278 (7%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR-- 82
           GK  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R  
Sbjct: 43  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 102
Query: 83  -EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
            E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S 
Sbjct: 103 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 162
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
           F  ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGT 219
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I++G++ F++ 
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIRGQVFFRQ- 272
Query: 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               +SS    L+R  L   P  R T  ++  HPW+++
Sbjct: 273 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 307

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  115 bits (289), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 126/265 (47%), Gaps = 15/265 (5%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           R +G+G FG   L     TG  +A K + K  +++D + +    E  I+      P + Q
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
               ++    +  VME   GG+L   I     + E  A      I++ +   H KG+++R
Sbjct: 89  LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYR 148
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVLSQS-YGKEA 216
           DLK +N L    D     K  DFG+    I  G       G+P YIAPE+L +  YG   
Sbjct: 149 DLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAV 205
Query: 217 DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276
           D W+ GV+LY +LCG  PF AE +  + +AIL  E+ +       +   A  +++  +T+
Sbjct: 206 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGILKSFMTK 261
Query: 277 DPKRRI-TVAQ-----VLEHPWLKE 295
           +P  R+ ++ Q     +L HP+ KE
Sbjct: 262 NPTMRLGSLTQGGEHAILRHPFFKE 286

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 137/278 (49%), Gaps = 20/278 (7%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR-- 82
           GK  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R  
Sbjct: 15  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 74
Query: 83  -EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
            E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S 
Sbjct: 75  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 134
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
           F  ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+
Sbjct: 135 FWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGT 191
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I++G++ F++ 
Sbjct: 192 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIRGQVFFRQ- 244
Query: 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               +SS    L+R  L   P  R T  ++  HPW+++
Sbjct: 245 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 279

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 137/278 (49%), Gaps = 20/278 (7%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR-- 82
           GK  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R  
Sbjct: 16  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 75
Query: 83  -EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
            E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S 
Sbjct: 76  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 135
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
           F  ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGT 192
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I++G++ F++ 
Sbjct: 193 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIRGQVFFRQ- 245
Query: 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               +SS    L+R  L   P  R T  ++  HPW+++
Sbjct: 246 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 280

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 12/263 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G G +G   L     T    A K +  ++ V   E  ++++EI I + L+ + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEIXINKMLNHE- 64
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS 211
           + HRD+KPEN L    DE   +K +DFGL+         R   ++ G+  Y+APE+L + 
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             + +  D+WS G++L  +L G  P W +      +     E     +P+  I S+ + L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 270 VRRMLTQDPKRRITVAQVLEHPW 292
           + ++L ++P  RIT+  + +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 12/263 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G G +G   L     T    A K +  ++ V   E  ++++EI I + L+ + 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEIXINKMLNHE- 65
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS 211
           + HRD+KPEN L    DE   +K +DFGL+         R   ++ G+  Y+APE+L + 
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 182
Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             + +  D+WS G++L  +L G  P W +      +     E     +P+  I S+ + L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 270 VRRMLTQDPKRRITVAQVLEHPW 292
           + ++L ++P  RIT+  + +  W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 137/278 (49%), Gaps = 20/278 (7%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR-- 82
           GK  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R  
Sbjct: 28  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 87
Query: 83  -EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
            E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S 
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
           F  ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGT 204
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I++G++ F++ 
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIRGQVFFRQ- 257
Query: 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               +SS    L+R  L   P  R T  ++  HPW+++
Sbjct: 258 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 292

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 12/263 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G G +G   L     T    A K +  ++ V   E  ++++EI I + L+ + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEIXINKMLNHE- 64
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS 211
           + HRD+KPEN L    DE   +K +DFGL+         R   ++ G+  Y+APE+L + 
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             + +  D+WS G++L  +L G  P W +      +     E     +P+  I S+ + L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 270 VRRMLTQDPKRRITVAQVLEHPW 292
           + ++L ++P  RIT+  + +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 137/278 (49%), Gaps = 20/278 (7%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR-- 82
           GK  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R  
Sbjct: 35  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 94
Query: 83  -EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
            E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S 
Sbjct: 95  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 154
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
           F  ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDFGSGALLKD-TVYTDFDGT 211
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I++G++ F++ 
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIRGQVFFRQ- 264
Query: 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               +SS    L+R  L   P  R T  ++  HPW+++
Sbjct: 265 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 137/277 (49%), Gaps = 20/277 (7%)
Query: 26  KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR--- 82
           K  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R   
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 83  EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASVF 140
           E+ +++ +S G   +++    +E  D FV I+  +    +LFD I  RG   E  A S F
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFF 120
Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP 200
             ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+ 
Sbjct: 121 WQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGTR 177
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I++G++ F++  
Sbjct: 178 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIRGQVFFRQ-- 229
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
              +SS    L+R  L   P  R T  ++  HPW+++
Sbjct: 230 --RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 264

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  114 bits (286), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 135/274 (49%), Gaps = 25/274 (9%)
Query: 35  YTIGREVGRGEFGITYLC---TENSTGLEFACKSIPKRKLV---KDVEKDDVRREI-EIM 87
           + + R +G+G +G  +     T  +TG  FA K + K  +V   KD       R I E +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 88  RHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVV 147
           +H    P IV    A++    +++++E  +GGELF ++   G + E  A      I   +
Sbjct: 79  KH----PFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL 134
Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPE 206
              H KG+++RDLKPEN +    +    VK TDFGL    I +G       G+  Y+APE
Sbjct: 135 GHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE 191
Query: 207 VLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265
           +L +S + +  D WS G ++Y +L G PPF  E  +     ILK ++N      P ++  
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQE 247
Query: 266 AIELVRRMLTQDPKRRIT-----VAQVLEHPWLK 294
           A +L++++L ++   R+        +V  HP+ +
Sbjct: 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  114 bits (286), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 12/263 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G G +G   L     T    A K +  ++ V   E  ++++EI I + L+ + 
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE- 63
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  G
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS 211
           + HRD+KPEN L    DE   +K +DFGL+         R   ++ G+  Y+APE+L + 
Sbjct: 124 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             + +  D+WS G++L  +L G  P W +      +     E     +P+  I S+ + L
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239
Query: 270 VRRMLTQDPKRRITVAQVLEHPW 292
           + ++L ++P  RIT+  + +  W
Sbjct: 240 LHKILVENPSARITIPDIKKDRW 262

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  114 bits (286), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 12/263 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G G +G   L     T    A K +  ++ V   E  ++++EI I + L+ + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE- 64
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS 211
           + HRD+KPEN L    DE   +K +DFGL+         R   ++ G+  Y+APE+L + 
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             + +  D+WS G++L  +L G  P W +      +     E     +P+  I S+ + L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 270 VRRMLTQDPKRRITVAQVLEHPW 292
           + ++L ++P  RIT+  + +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 12/263 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G G +G   L     T    A K +  ++ V   E  ++++EI I + L+ + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE- 64
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS 211
           + HRD+KPEN L    DE   +K +DFGL+         R   ++ G+  Y+APE+L + 
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             + +  D+WS G++L  +L G  P W +      +     E     +P+  I S+ + L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 270 VRRMLTQDPKRRITVAQVLEHPW 292
           + ++L ++P  RIT+  + +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 12/263 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G G +G   L     T    A K +  ++ V   E  ++++EI I + L+ + 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE- 65
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS 211
           + HRD+KPEN L    DE   +K +DFGL+         R   ++ G+  Y+APE+L + 
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             + +  D+WS G++L  +L G  P W +      +     E     +P+  I S+ + L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 270 VRRMLTQDPKRRITVAQVLEHPW 292
           + ++L ++P  RIT+  + +  W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 12/263 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G G +G   L     T    A K +  ++ V   E  ++++EI I + L+ + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE- 64
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS 211
           + HRD+KPEN L    DE   +K +DFGL+         R   ++ G+  Y+APE+L + 
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             + +  D+WS G++L  +L G  P W +      +     E     +P+  I S+ + L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 270 VRRMLTQDPKRRITVAQVLEHPW 292
           + ++L ++P  RIT+  + +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 12/263 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G G +G   L     T    A K +  ++ V   E  ++++EI I + L+ + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE- 64
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS 211
           + HRD+KPEN L    DE   +K +DFGL+         R   ++ G+  Y+APE+L + 
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             + +  D+WS G++L  +L G  P W +      +     E     +P+  I S+ + L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 270 VRRMLTQDPKRRITVAQVLEHPW 292
           + ++L ++P  RIT+  + +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 12/263 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G G +G   L     T    A K +  ++ V   E  ++++EI I + L+ + 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE- 65
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS 211
           + HRD+KPEN L    DE   +K +DFGL+         R   ++ G+  Y+APE+L + 
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             + +  D+WS G++L  +L G  P W +      +     E     +P+  I S+ + L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 270 VRRMLTQDPKRRITVAQVLEHPW 292
           + ++L ++P  RIT+  + +  W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 12/263 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G G +G   L     T    A K +  ++ V   E  ++++EI I + L+ + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE- 64
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS 211
           + HRD+KPEN L    DE   +K +DFGL+         R   ++ G+  Y+APE+L + 
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             + +  D+WS G++L  +L G  P W +      +     E     +P+  I S+ + L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 270 VRRMLTQDPKRRITVAQVLEHPW 292
           + ++L ++P  RIT+  + +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 132/263 (50%), Gaps = 12/263 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G G +G   L     T    A K +  ++ V   E  ++++EI I + L+ + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE- 64
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS 211
           + HRD+KPEN L    DE   +K +DFGL+         R   ++ G+  Y+APE+L + 
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             + +  D+WS G++L  +L G  P+   +D     +  K +  +  +P+  I S+ + L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYL-NPWKKIDSAPLAL 240
Query: 270 VRRMLTQDPKRRITVAQVLEHPW 292
           + ++L ++P  RIT+  + +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 135/274 (49%), Gaps = 25/274 (9%)
Query: 35  YTIGREVGRGEFGITYLC---TENSTGLEFACKSIPKRKLV---KDVEKDDVRREI-EIM 87
           + + R +G+G +G  +     T  +TG  FA K + K  +V   KD       R I E +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 88  RHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVV 147
           +H    P IV    A++    +++++E  +GGELF ++   G + E  A      I   +
Sbjct: 79  KH----PFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL 134
Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPE 206
              H KG+++RDLKPEN +    +    VK TDFGL    I +G       G+  Y+APE
Sbjct: 135 GHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPE 191
Query: 207 VLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265
           +L +S + +  D WS G ++Y +L G PPF  E  +     ILK ++N      P ++  
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQE 247
Query: 266 AIELVRRMLTQDPKRRIT-----VAQVLEHPWLK 294
           A +L++++L ++   R+        +V  HP+ +
Sbjct: 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 12/263 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G G +G   L     T    A K +  ++ V   E  ++++EI I + L+ + 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE- 65
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS 211
           + HRD+KPEN L    DE   +K +DFGL+         R   ++ G+  Y+APE+L + 
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             + +  D+WS G++L  +L G  P W +      +     E     +P+  I S+ + L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 270 VRRMLTQDPKRRITVAQVLEHPW 292
           + ++L ++P  RIT+  + +  W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 12/263 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G G +G   L     T    A K +  ++ V   E  ++++EI I + L+ + 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE- 65
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS 211
           + HRD+KPEN L    DE   +K +DFGL+         R   ++ G+  Y+APE+L + 
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             + +  D+WS G++L  +L G  P W +      +     E     +P+  I S+ + L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 270 VRRMLTQDPKRRITVAQVLEHPW 292
           + ++L ++P  RIT+  + +  W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 12/263 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G G +G   L     T    A K +  ++ V   E  ++++EI I + L+ + 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE- 65
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS 211
           + HRD+KPEN L    DE   +K +DFGL+         R   ++ G+  Y+APE+L + 
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             + +  D+WS G++L  +L G  P W +      +     E     +P+  I S+ + L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 270 VRRMLTQDPKRRITVAQVLEHPW 292
           + ++L ++P  RIT+  + +  W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 12/263 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G G +G   L     T    A K +  ++ V   E  ++++EI I + L+ + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE- 64
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS 211
           + HRD+KPEN L    DE   +K +DFGL+         R   ++ G+  Y+APE+L + 
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             + +  D+WS G++L  +L G  P W +      +     E     +P+  I S+ + L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 270 VRRMLTQDPKRRITVAQVLEHPW 292
           + ++L ++P  RIT+  + +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 141/300 (47%), Gaps = 38/300 (12%)
Query: 25  GKAYEDVQLH-YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV-------- 75
           G + + VQL+ YT+  E+G+G +G+  L    +    +A K + K+KL++          
Sbjct: 4   GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 76  ---------------EKDDVRREIEIMRHLSGQPNIVQFKAAYED--DQFVHIVMELCAG 118
                            + V +EI I++ L   PN+V+     +D  +  +++V EL   
Sbjct: 64  RGTRPAPGGCIQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQ 122
Query: 119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKA 178
           G + + +      SE  A   F+ ++  +   H + ++HRD+KP N L     E+  +K 
Sbjct: 123 GPVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKI 178
Query: 179 TDFGLS-AFIEEGKAYREIVGSPYYIAPEVLSQS----YGKEADIWSAGVILYILLCGVP 233
            DFG+S  F          VG+P ++APE LS++     GK  D+W+ GV LY  + G  
Sbjct: 179 ADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238
Query: 234 PFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
           PF  E    +   I    + F   P   I+    +L+ RML ++P+ RI V ++  HPW+
Sbjct: 239 PFMDERIMCLHSKIKSQALEFPDQP--DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 12/263 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G G +G   L     T    A K +  ++ V   E  ++++EI I + L+ + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE- 64
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS 211
           + HRD+KPEN L    DE   +K +DFGL+         R   ++ G+  Y+APE+L + 
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             + +  D+WS G++L  +L G  P W +      +     E     +P+  I S+ + L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 270 VRRMLTQDPKRRITVAQVLEHPW 292
           + ++L ++P  RIT+  + +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 12/263 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G G +G   L     T    A K +  ++ V   E  ++++EI I + L+ + 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE- 65
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS 211
           + HRD+KPEN L    DE   +K +DFGL+         R   ++ G+  Y+APE+L + 
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             + +  D+WS G++L  +L G  P W +      +     E     +P+  I S+ + L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 270 VRRMLTQDPKRRITVAQVLEHPW 292
           + ++L ++P  RIT+  + +  W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 129/263 (49%), Gaps = 12/263 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G G +G   L     T    A K +  ++ V   E  ++++EI I + L+ + 
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE- 64
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS 211
           + HRD+KPEN L    DE   +K +DFGL+         R   ++ G+  Y+APE+L + 
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             + +  D+WS G++L  +L G  P W +      +     E     +P+  I S+ + L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 270 VRRMLTQDPKRRITVAQVLEHPW 292
           + ++L ++P  RIT+  + +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 136/278 (48%), Gaps = 20/278 (7%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR-- 82
           GK  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R  
Sbjct: 28  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 87
Query: 83  -EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
            E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S 
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
           F  ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGT 204
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I+ G++ F++ 
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIGGQVFFRQ- 257
Query: 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               +SS    L+R  L   P  R T  ++  HPW+++
Sbjct: 258 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 292

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 136/278 (48%), Gaps = 20/278 (7%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR-- 82
           GK  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R  
Sbjct: 28  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 87
Query: 83  -EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
            E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S 
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
           F  ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGT 204
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I+ G++ F++ 
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIGGQVFFRQ- 257
Query: 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               +SS    L+R  L   P  R T  ++  HPW+++
Sbjct: 258 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 292

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 136/278 (48%), Gaps = 20/278 (7%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR-- 82
           GK  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R  
Sbjct: 29  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 88
Query: 83  -EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
            E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S 
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
           F  ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGT 205
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I+ G++ F++ 
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIGGQVFFRQ- 258
Query: 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               +SS    L+R  L   P  R T  ++  HPW+++
Sbjct: 259 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 293

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 136/278 (48%), Gaps = 20/278 (7%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR-- 82
           GK  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R  
Sbjct: 29  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 88
Query: 83  -EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
            E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S 
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
           F  ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGT 205
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I+ G++ F++ 
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIGGQVFFRQ- 258
Query: 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               +SS    L+R  L   P  R T  ++  HPW+++
Sbjct: 259 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 293

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 136/278 (48%), Gaps = 20/278 (7%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR-- 82
           GK  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R  
Sbjct: 16  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 75
Query: 83  -EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
            E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S 
Sbjct: 76  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 135
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
           F  ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGT 192
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I++G++ F++ 
Sbjct: 193 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIRGQVFFRQ- 245
Query: 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               +S     L+R  L   P  R T  ++  HPW+++
Sbjct: 246 ---RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 280

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 136/278 (48%), Gaps = 20/278 (7%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR-- 82
           GK  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R  
Sbjct: 48  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 107
Query: 83  -EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
            E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S 
Sbjct: 108 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 167
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
           F  ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+
Sbjct: 168 FWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDFGSGALLKD-TVYTDFDGT 224
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I++G++ F++ 
Sbjct: 225 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIRGQVFFRQ- 277
Query: 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               +S     L+R  L   P  R T  ++  HPW+++
Sbjct: 278 ---RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 312

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 136/278 (48%), Gaps = 20/278 (7%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR-- 82
           GK  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R  
Sbjct: 15  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 74
Query: 83  -EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
            E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S 
Sbjct: 75  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 134
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
           F  ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+
Sbjct: 135 FWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGT 191
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I++G++ F++ 
Sbjct: 192 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIRGQVFFRQ- 244
Query: 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               +S     L+R  L   P  R T  ++  HPW+++
Sbjct: 245 ---RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 279

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 136/278 (48%), Gaps = 20/278 (7%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR-- 82
           GK  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R  
Sbjct: 43  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 102
Query: 83  -EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
            E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S 
Sbjct: 103 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 162
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
           F  ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGT 219
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I++G++ F++ 
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIRGQVFFRQ- 272
Query: 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               +S     L+R  L   P  R T  ++  HPW+++
Sbjct: 273 ---RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 307

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 136/277 (49%), Gaps = 20/277 (7%)
Query: 26  KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR--- 82
           K  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R   
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 83  EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASVF 140
           E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S F
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 121
Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP 200
             ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+ 
Sbjct: 122 WQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGTR 178
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I++G++ F++  
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIRGQVFFRQ-- 230
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
              +SS    L+R  L   P  R T  ++  HPW+++
Sbjct: 231 --RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 265

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 136/278 (48%), Gaps = 20/278 (7%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR-- 82
           GK  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R  
Sbjct: 16  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 75
Query: 83  -EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
            E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S 
Sbjct: 76  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 135
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
           F  ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGT 192
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I++G++ F++ 
Sbjct: 193 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIRGQVFFRQ- 245
Query: 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               +S     L+R  L   P  R T  ++  HPW+++
Sbjct: 246 ---RVSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQD 280

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 136/277 (49%), Gaps = 20/277 (7%)
Query: 26  KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR--- 82
           K  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R   
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 83  EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASVF 140
           E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S F
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 121
Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP 200
             ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+ 
Sbjct: 122 WQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGTR 178
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I++G++ F++  
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIRGQVFFRQ-- 230
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
              +SS    L+R  L   P  R T  ++  HPW+++
Sbjct: 231 --RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 265

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 128/263 (48%), Gaps = 12/263 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G G +G   L     T    A K +  ++ V   E  ++++EI I   L+ + 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINAMLNHE- 65
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS 211
           + HRD+KPEN L    DE   +K +DFGL+         R   ++ G+  Y+APE+L + 
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             + +  D+WS G++L  +L G  P W +      +     E     +P+  I S+ + L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 270 VRRMLTQDPKRRITVAQVLEHPW 292
           + ++L ++P  RIT+  + +  W
Sbjct: 242 LHKILVENPSARITIPDIKKDRW 264

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 136/277 (49%), Gaps = 20/277 (7%)
Query: 26  KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR--- 82
           K  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R   
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 83  EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASVF 140
           E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S F
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 121
Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP 200
             ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+ 
Sbjct: 122 WQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGTR 178
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I++G++ F++  
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIRGQVFFRQ-- 230
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
              +SS    L+R  L   P  R T  ++  HPW+++
Sbjct: 231 --RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 265

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 136/277 (49%), Gaps = 20/277 (7%)
Query: 26  KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR--- 82
           K  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R   
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 83  EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASVF 140
           E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S F
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 120
Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP 200
             ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+ 
Sbjct: 121 WQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGTR 177
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I++G++ F++  
Sbjct: 178 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIRGQVFFRQ-- 229
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
              +SS    L+R  L   P  R T  ++  HPW+++
Sbjct: 230 --RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 264

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 128/263 (48%), Gaps = 12/263 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G G  G   L     T    A K +  ++ V   E  ++++EI I + L+ + 
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE- 64
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS 211
           + HRD+KPEN L    DE   +K +DFGL+         R   ++ G+  Y+APE+L + 
Sbjct: 125 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             + +  D+WS G++L  +L G  P W +      +     E     +P+  I S+ + L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 270 VRRMLTQDPKRRITVAQVLEHPW 292
           + ++L ++P  RIT+  + +  W
Sbjct: 241 LHKILVENPSARITIPDIKKDRW 263

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 135/278 (48%), Gaps = 20/278 (7%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR-- 82
           GK  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R  
Sbjct: 28  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 87
Query: 83  -EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
            E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S 
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
           F  ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGT 204
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I+ G++ F++ 
Sbjct: 205 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIGGQVFFRQ- 257
Query: 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               +S     L+R  L   P  R T  ++  HPW+++
Sbjct: 258 ---RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 292

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 135/278 (48%), Gaps = 20/278 (7%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR-- 82
           GK  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R  
Sbjct: 29  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 88
Query: 83  -EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
            E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S 
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
           F  ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGT 205
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I+ G++ F++ 
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIGGQVFFRQ- 258
Query: 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               +S     L+R  L   P  R T  ++  HPW+++
Sbjct: 259 ---RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 293

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 135/278 (48%), Gaps = 20/278 (7%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR-- 82
           GK  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R  
Sbjct: 29  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 88
Query: 83  -EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
            E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S 
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
           F  ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGT 205
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I+ G++ F++ 
Sbjct: 206 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIGGQVFFRQ- 258
Query: 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               +S     L+R  L   P  R T  ++  HPW+++
Sbjct: 259 ---RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 293

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 135/274 (49%), Gaps = 20/274 (7%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR---EIE 85
           E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R   E+ 
Sbjct: 3   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 62
Query: 86  IMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVI 143
           +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S F  +
Sbjct: 63  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 122
Query: 144 MNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI 203
           +  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+  Y 
Sbjct: 123 LEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGTRVYS 179
Query: 204 APEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
            PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I++G++ F++     
Sbjct: 180 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIRGQVFFRQ----R 229
Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
           +SS    L+R  L   P  R T  ++  HPW+++
Sbjct: 230 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 263

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  112 bits (279), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 131/275 (47%), Gaps = 22/275 (8%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD-----VRREIEIMRH 89
           Y+    +G G FG  +   +     E   K I K K+++D   +D     V  EI I+  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMELCAGG-ELFDRIVARGHYSERAAASVFRVIMNVVN 148
           +    NI++    +E+  F  +VME    G +LF  I       E  A+ +FR +++ V 
Sbjct: 86  VE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL 208
               K ++HRD+K EN +     E+  +K  DFG +A++E GK +    G+  Y APEVL
Sbjct: 145 YLRLKDIIHRDIKDENIVIA---EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVL 201
Query: 209 --SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
             +   G E ++WS GV LY L+    PF  E ++ V  AI          P   +S   
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEENPF-CELEETVEAAI---------HPPYLVSKEL 251
Query: 267 IELVRRMLTQDPKRRITVAQVLEHPWLKESGEASD 301
           + LV  +L   P+RR T+ +++  PW+ +    +D
Sbjct: 252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLAD 286

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 118/244 (48%), Gaps = 9/244 (3%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG   L    +  + +A K + K+ ++K  E+  +  E  ++      P +V   
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
            +++    ++ V++   GGELF  +     + E  A      I + +   HS  +++RDL
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 165
Query: 161 KPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVL-SQSYGKEADI 218
           KPEN L    D    +  TDFGL    IE         G+P Y+APEVL  Q Y +  D 
Sbjct: 166 KPENILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDW 222
Query: 219 WSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278
           W  G +LY +L G+PPF++     +   IL   +  +    P+I++SA  L+  +L +D 
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDR 278
Query: 279 KRRI 282
            +R+
Sbjct: 279 TKRL 282

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 132/295 (44%), Gaps = 36/295 (12%)
Query: 37  IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNI 96
           IG+ +G G +G+ + C    TG   A K   + +    V K    REI +++ L   PN+
Sbjct: 8   IGK-IGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLK-HPNL 64
Query: 97  VQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVM 156
           V     +   + +H+V E C    L +    +    E    S+    +  VN CH    +
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCI 124
Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEVL--SQSYG 213
           HRD+KPEN L T   +++V+K  DFG +  +      Y + V + +Y +PE+L     YG
Sbjct: 125 HRDVKPENILIT---KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYG 181
Query: 214 KEADIWSAGVILYILLCGVPPFWAETD--------QGVAQAILKGEINFQR--------- 256
              D+W+ G +   LL GVP +  ++D        + +   I + +  F           
Sbjct: 182 PPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI 241
Query: 257 -DP---------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASD 301
            DP         FP+IS  A+ L++  L  DP  R+T  Q+L HP+ +   E  D
Sbjct: 242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED 296

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 135/277 (48%), Gaps = 20/277 (7%)
Query: 26  KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR--- 82
           K  E ++  Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R   
Sbjct: 24  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 83
Query: 83  EIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASVF 140
           E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S F
Sbjct: 84  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 143
Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP 200
             ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+ 
Sbjct: 144 WQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGTR 200
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I++G++ F++  
Sbjct: 201 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIRGQVFFRQ-- 252
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
              +S     L+R  L   P  R T  ++  HPW+++
Sbjct: 253 --RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 287

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 132/268 (49%), Gaps = 20/268 (7%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR---EIEIMRHLS 91
           Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R   E+ +++ +S
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 92  -GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
            G   +++    +E  D FV I+       +LFD I  RG   E  A S F  ++  V  
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL- 208
           CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+  Y  PE + 
Sbjct: 126 CHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIR 182
Query: 209 -SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267
             + +G+ A +WS G++LY ++CG  PF  E D    + I++G++ F++     +SS   
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIRGQVFFRQ----RVSSECQ 232
Query: 268 ELVRRMLTQDPKRRITVAQVLEHPWLKE 295
            L+R  L   P  R T  ++  HPW+++
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 134/267 (50%), Gaps = 20/267 (7%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           ++ I +++GRG+F   Y       G+  A K +    L+    + D  +EI++++ L+  
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-H 91
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHY-------SERAAASVFRVIMNV 146
           PN++++ A++ +D  ++IV+EL   G+L  R++   H+        ER     F  + + 
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDL-SRMIK--HFKKQKRLIPERTVWKYFVQLCSA 148
Query: 147 VNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVGSPYYIAP 205
           +   HS+ VMHRD+KP N   T      VVK  D GL  F   +  A   +VG+PYY++P
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
Query: 206 EVLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS--I 262
           E + ++ Y  ++DIWS G +LY +     PF+   D+    ++ K        P PS   
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHY 263
Query: 263 SSSAIELVRRMLTQDPKRRITVAQVLE 289
           S    +LV   +  DP++R  V  V +
Sbjct: 264 SEELRQLVNMCINPDPEKRPDVTYVYD 290

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 136/273 (49%), Gaps = 11/273 (4%)
Query: 29  EDVQL-HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM 87
           EDV   H+ I R +G+G FG   +  +N T   +A K + K+K V+  E  +V +E++IM
Sbjct: 10  EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIM 69
Query: 88  RHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVV 147
           + L   P +V    +++D++ + +V++L  GG+L   +    H+ E         ++  +
Sbjct: 70  QGLE-HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMAL 128
Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV 207
           +   ++ ++HRD+KP+N L    DE+  V  TDF ++A +        + G+  Y+APE+
Sbjct: 129 DYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEM 185
Query: 208 LSQ----SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263
            S      Y    D WS GV  Y LL G  P+   +     + +   E      P  + S
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP-SAWS 244
Query: 264 SSAIELVRRMLTQDPKRRIT-VAQVLEHPWLKE 295
              + L++++L  +P +R + ++ V   P++ +
Sbjct: 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 132/256 (51%), Gaps = 18/256 (7%)
Query: 34  HYTIGREVGRGEFGITYLC---TENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRH 89
           H+ + + +G+G FG  +L    T   +G  +A K + K  L V+D  +  + R+I     
Sbjct: 29  HFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILAD-- 86
Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
               P +V+   A++ +  ++++++   GG+LF R+     ++E         +   ++ 
Sbjct: 87  -VNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDH 145
Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS--AFIEEGKAYREIVGSPYYIAPEV 207
            HS G+++RDLKPEN L    DE   +K TDFGLS  A   E KAY    G+  Y+APEV
Sbjct: 146 LHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKEAIDHEKKAY-SFCGTVEYMAPEV 201
Query: 208 LS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
           ++ Q +   AD WS GV+++ +L G  PF  +  +     ILK ++   +     +S+ A
Sbjct: 202 VNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQ----FLSTEA 257
Query: 267 IELVRRMLTQDPKRRI 282
             L+R +  ++P  R+
Sbjct: 258 QSLLRALFKRNPANRL 273

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 131/268 (48%), Gaps = 20/268 (7%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR---EIEIMRHLS 91
           Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R   E+ +++ +S
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 92  -GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
            G   +++    +E  D FV I+       +LFD I  RG   E  A S F  ++  V  
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL- 208
           CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+  Y  PE + 
Sbjct: 126 CHNXGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIR 182
Query: 209 -SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267
             + +G+ A +WS G++LY ++CG  PF  E D    + I++G++ F++     +S    
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIRGQVFFRQ----RVSXECQ 232
Query: 268 ELVRRMLTQDPKRRITVAQVLEHPWLKE 295
            L+R  L   P  R T  ++  HPW+++
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 131/268 (48%), Gaps = 20/268 (7%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR---EIEIMRHLS 91
           Y +G  +G G FG  Y     S  L  A K + K ++    E  +  R   E+ +++ +S
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 92  -GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
            G   +++    +E  D FV I+       +LFD I  RG   E  A S F  ++  V  
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL- 208
           CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+  Y  PE + 
Sbjct: 126 CHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIR 182
Query: 209 -SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267
             + +G+ A +WS G++LY ++CG  PF  E D    + I+ G++ F++     +SS   
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIGGQVFFRQ----RVSSECQ 232
Query: 268 ELVRRMLTQDPKRRITVAQVLEHPWLKE 295
            L+R  L   P  R T  ++  HPW+++
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 122/244 (50%), Gaps = 9/244 (3%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG   L     T   +A K + K  +++D + +    E  ++      P + Q  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
           + ++    ++ VME   GG+L   I   G + E  A      I   +    SKG+++RDL
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147
Query: 161 KPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVLS-QSYGKEADI 218
           K +N +    D    +K  DFG+    I +G   +   G+P YIAPE+++ Q YGK  D 
Sbjct: 148 KLDNVML---DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDW 204
Query: 219 WSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278
           W+ GV+LY +L G  PF  E +  + Q+I++  + + +    S+S  A+ + + ++T+ P
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHP 260
Query: 279 KRRI 282
            +R+
Sbjct: 261 GKRL 264

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 122/244 (50%), Gaps = 9/244 (3%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG   L     T   +A K + K  +++D + +    E  ++      P + Q  
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
           + ++    ++ VME   GG+L   I   G + E  A      I   +    SKG+++RDL
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468
Query: 161 KPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVLS-QSYGKEADI 218
           K +N +    D    +K  DFG+    I +G   +   G+P YIAPE+++ Q YGK  D 
Sbjct: 469 KLDNVML---DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDW 525
Query: 219 WSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDP 278
           W+ GV+LY +L G  PF  E +  + Q+I++  + + +    S+S  A+ + + ++T+ P
Sbjct: 526 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHP 581
Query: 279 KRRI 282
            +R+
Sbjct: 582 GKRL 585

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 141/295 (47%), Gaps = 32/295 (10%)
Query: 17  RHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVE 76
           + L +  L K  E+V   + +  ++G G +G  Y      TG   A K +P       VE
Sbjct: 16  KKLDEDSLTKQPEEV---FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-------VE 65
Query: 77  KD--DVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH-YSE 133
            D  ++ +EI IM+     P++V++  +Y  +  + IVME C  G + D I  R    +E
Sbjct: 66  SDLQEIIKEISIMQQCDS-PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTE 124
Query: 134 RAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY 193
              A++ +  +  +   H    +HRD+K  N L  T       K  DFG++  + +  A 
Sbjct: 125 DEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNT---EGHAKLADFGVAGQLTDXMAK 181
Query: 194 RE-IVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE 251
           R  ++G+P+++APEV+ +  Y   ADIWS G+    +  G PP+    D    +AI    
Sbjct: 182 RNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY---ADIHPMRAIFMIP 238
Query: 252 INFQRDPFPSI------SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS 300
            N    P P+       S +  + V++ L + P++R T  Q+L+HP+++ +   S
Sbjct: 239 TN----PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 136/290 (46%), Gaps = 18/290 (6%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
           ED +LH    + +G+G FG  +L     T   FA K++ K  ++ D + +    E  ++ 
Sbjct: 18  EDFELH----KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 73
Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVN 148
                P +      ++  + +  VME   GG+L   I +   +    A      I+  + 
Sbjct: 74  LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 133
Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-YREIVGSPYYIAPEV 207
             HSKG+++RDLK +N L    D++  +K  DFG+      G A   E  G+P YIAPE+
Sbjct: 134 FLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEI 190
Query: 208 -LSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
            L Q Y    D WS GV+LY +L G  PF  + ++ +  +I      + R     +   A
Sbjct: 191 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEA 246
Query: 267 IELVRRMLTQDPKRRITV-AQVLEHPWLKESG--EASDKPIDTAVIFRMK 313
            +L+ ++  ++P++R+ V   + +HP  +E    E   K ID    FR K
Sbjct: 247 KDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPP--FRPK 294

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 132/308 (42%), Gaps = 52/308 (16%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNI---- 96
           +G G +G+    T   TG   A K I      K +      REI+I++H   +  I    
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 97  VQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVM 156
           +Q   ++E+   V+I+ EL        R+++    S+          +  V V H   V+
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVI 134
Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-----------YREIVGSPYYIAP 205
           HRDLKP N L  +   N  +K  DFGL+  I+E  A             E V + +Y AP
Sbjct: 135 HRDLKPSNLLINS---NCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAP 191
Query: 206 EVL--SQSYGKEADIWSAGVILYILLCGVPPF-----------------WAETDQGV--- 243
           EV+  S  Y +  D+WS G IL  L    P F                    +D  +   
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCI 251
Query: 244 ----AQAILKGEINFQRDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               A+  +K    +   P    FP ++   I+L++RML  DP +RIT  + LEHP+L+ 
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311
Query: 296 SGEASDKP 303
             + +D+P
Sbjct: 312 YHDPNDEP 319

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 128/249 (51%), Gaps = 18/249 (7%)
Query: 41  VGRGEFGITYLCTENSTG---LEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQPNI 96
           +G+G FG  +L  + S       +A K + K  L V+D  +  + R+I +       P I
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE---VNHPFI 88
Query: 97  VQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVM 156
           V+   A++ +  ++++++   GG+LF R+     ++E         +   ++  HS G++
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 148
Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLS--AFIEEGKAYREIVGSPYYIAPEVLS-QSYG 213
           +RDLKPEN L    DE   +K TDFGLS  +   E KAY    G+  Y+APEV++ + + 
Sbjct: 149 YRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAY-SFCGTVEYMAPEVVNRRGHT 204
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRM 273
           + AD WS GV+++ +L G  PF  +  +     ILK ++   +     +S  A  L+R +
Sbjct: 205 QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRML 260
Query: 274 LTQDPKRRI 282
             ++P  R+
Sbjct: 261 FKRNPANRL 269

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 128/249 (51%), Gaps = 18/249 (7%)
Query: 41  VGRGEFGITYLCTENSTG---LEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQPNI 96
           +G+G FG  +L  + S       +A K + K  L V+D  +  + R+I +       P I
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE---VNHPFI 88
Query: 97  VQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVM 156
           V+   A++ +  ++++++   GG+LF R+     ++E         +   ++  HS G++
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 148
Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLS--AFIEEGKAYREIVGSPYYIAPEVLS-QSYG 213
           +RDLKPEN L    DE   +K TDFGLS  +   E KAY    G+  Y+APEV++ + + 
Sbjct: 149 YRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAY-SFCGTVEYMAPEVVNRRGHT 204
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRM 273
           + AD WS GV+++ +L G  PF  +  +     ILK ++   +     +S  A  L+R +
Sbjct: 205 QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRML 260
Query: 274 LTQDPKRRI 282
             ++P  R+
Sbjct: 261 FKRNPANRL 269

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 132/308 (42%), Gaps = 52/308 (16%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNI---- 96
           +G G +G+    T   TG   A K I      K +      REI+I++H   +  I    
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 97  VQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVM 156
           +Q   ++E+   V+I+ EL        R+++    S+          +  V V H   V+
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVI 134
Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-----------YREIVGSPYYIAP 205
           HRDLKP N L  +   N  +K  DFGL+  I+E  A             E V + +Y AP
Sbjct: 135 HRDLKPSNLLINS---NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAP 191
Query: 206 EVL--SQSYGKEADIWSAGVILYILLCGVPPF-----------------WAETDQGV--- 243
           EV+  S  Y +  D+WS G IL  L    P F                    +D  +   
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCI 251
Query: 244 ----AQAILKGEINFQRDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               A+  +K    +   P    FP ++   I+L++RML  DP +RIT  + LEHP+L+ 
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311
Query: 296 SGEASDKP 303
             + +D+P
Sbjct: 312 YHDPNDEP 319

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 132/308 (42%), Gaps = 52/308 (16%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNI---- 96
           +G G +G+    T   TG   A K I      K +      REI+I++H   +  I    
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 97  VQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVM 156
           +Q   ++E+   V+I+ EL        R+++    S+          +  V V H   V+
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVI 134
Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-----------YREIVGSPYYIAP 205
           HRDLKP N L  +   N  +K  DFGL+  I+E  A             E V + +Y AP
Sbjct: 135 HRDLKPSNLLINS---NCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAP 191
Query: 206 EVL--SQSYGKEADIWSAGVILYILLCGVPPF-----------------WAETDQGV--- 243
           EV+  S  Y +  D+WS G IL  L    P F                    +D  +   
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCI 251
Query: 244 ----AQAILKGEINFQRDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               A+  +K    +   P    FP ++   I+L++RML  DP +RIT  + LEHP+L+ 
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311
Query: 296 SGEASDKP 303
             + +D+P
Sbjct: 312 YHDPNDEP 319

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 128/249 (51%), Gaps = 18/249 (7%)
Query: 41  VGRGEFGITYLCTENSTG---LEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQPNI 96
           +G+G FG  +L  + S       +A K + K  L V+D  +  + R+I +       P I
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE---VNHPFI 89
Query: 97  VQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVM 156
           V+   A++ +  ++++++   GG+LF R+     ++E         +   ++  HS G++
Sbjct: 90  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 149
Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLS--AFIEEGKAYREIVGSPYYIAPEVLS-QSYG 213
           +RDLKPEN L    DE   +K TDFGLS  +   E KAY    G+  Y+APEV++ + + 
Sbjct: 150 YRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAY-SFCGTVEYMAPEVVNRRGHT 205
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRM 273
           + AD WS GV+++ +L G  PF  +  +     ILK ++   +     +S  A  L+R +
Sbjct: 206 QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRML 261
Query: 274 LTQDPKRRI 282
             ++P  R+
Sbjct: 262 FKRNPANRL 270

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 25/288 (8%)
Query: 25  GKAYEDVQLH-YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           GKA   + L  + + R +GRG +    L     T   +A K + K  +  D + D V+ E
Sbjct: 11  GKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE 70
Query: 84  IEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVI 143
             +    S  P +V   + ++ +  +  V+E   GG+L   +  +    E  A      I
Sbjct: 71  KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 130
Query: 144 MNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYY 202
              +N  H +G+++RDLK +N L    D    +K TD+G+    +  G       G+P Y
Sbjct: 131 SLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNY 187
Query: 203 IAPEVL-SQSYGKEADIWSAGVILYILLCGVPPF---------WAETDQGVAQAILKGEI 252
           IAPE+L  + YG   D W+ GV+++ ++ G  PF            T+  + Q IL+ +I
Sbjct: 188 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 247
Query: 253 NFQRDPFPSISSSAIELVRRMLTQDPKRRITV------AQVLEHPWLK 294
              R    S+S  A  +++  L +DPK R+        A +  HP+ +
Sbjct: 248 RIPR----SMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFR 291

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 90/287 (31%), Positives = 133/287 (46%), Gaps = 38/287 (13%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G G +G+ Y   +N+ G  FA K I   K  + +    +R EI I++ L    NIV+ 
Sbjct: 9   KIGEGTYGVVY-KAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELK-HSNIVKL 65
Query: 100 KAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMH 157
                  + + +V E       +L D  V  G      A S    ++N +  CH + V+H
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 158 RDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQSYGK 214
           RDLKP+N L     E   +K  DFGL+ AF    + Y   V + +Y AP+VL  S+ Y  
Sbjct: 124 RDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 215 EADIWSAGVILYILLCGVP--PFWAETDQ--------GVAQA--------ILKGEINFQ- 255
             DIWS G I   ++ G P  P  +E DQ        G   +        + K + NF  
Sbjct: 181 TIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 256 RDPFP------SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
            +P P       +  S I+L+ +ML  DP +RIT  Q LEH + KE+
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 90/288 (31%), Positives = 133/288 (46%), Gaps = 38/288 (13%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G G +G+ Y   +N+ G  FA K I   K  + +    +R EI I++ L    NIV+ 
Sbjct: 9   KIGEGTYGVVY-KAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELK-HSNIVKL 65
Query: 100 KAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMH 157
                  + + +V E       +L D  V  G      A S    ++N +  CH + V+H
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 158 RDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQSYGK 214
           RDLKP+N L     E   +K  DFGL+ AF    + Y   V + +Y AP+VL  S+ Y  
Sbjct: 124 RDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 215 EADIWSAGVILYILLCGVP--PFWAETDQ--------GVAQA--------ILKGEINFQ- 255
             DIWS G I   ++ G P  P  +E DQ        G   +        + K + NF  
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 256 RDPFP------SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297
            +P P       +  S I+L+ +ML  DP +RIT  Q LEH + KE+ 
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 96/337 (28%), Positives = 156/337 (46%), Gaps = 50/337 (14%)
Query: 11  SDHPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRK 70
           SD PA R L D I   A  D    + +   VG G +G  Y      TG   A K      
Sbjct: 4   SDSPA-RSL-DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIK------ 55
Query: 71  LVKDV---EKDDVRREIEIMRHLSGQPNIVQFKAAY-------EDDQFVHIVMELCAGGE 120
            V DV   E++++++EI +++  S   NI  +  A+        DDQ + +VME C  G 
Sbjct: 56  -VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ-LWLVMEFCGAGS 113
Query: 121 LFDRIV-ARGH-YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKA 178
           + D I   +G+   E   A + R I+  ++  H   V+HRD+K +N L T   ENA VK 
Sbjct: 114 VTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKL 170
Query: 179 TDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCG 231
            DFG+SA ++     R   +G+PY++APEV++       +Y  ++D+WS G+    +  G
Sbjct: 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
Query: 232 VPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI-----ELVRRMLTQDPKRRITVAQ 286
            PP     D    +A+        R+P P + S          +   L ++  +R    Q
Sbjct: 231 APPL---CDMHPMRALFL----IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQ 283
Query: 287 VLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKK 323
           +++HP+++      D+P +  V  ++K      K K+
Sbjct: 284 LMKHPFIR------DQPNERQVRIQLKDHIDRTKKKR 314

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 89/288 (30%), Positives = 133/288 (46%), Gaps = 38/288 (13%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G G +G+ Y   +N+ G  FA K I   K  + +    +R EI I++ L    NIV+ 
Sbjct: 9   KIGEGTYGVVY-KAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELK-HSNIVKL 65
Query: 100 KAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMH 157
                  + + +V E       +L D  V  G      A S    ++N +  CH + V+H
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 158 RDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQSYGK 214
           RDLKP+N L     E   +K  DFGL+ AF    + Y   + + +Y AP+VL  S+ Y  
Sbjct: 124 RDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 215 EADIWSAGVILYILLCGVP--PFWAETDQ--------GVAQA--------ILKGEINFQ- 255
             DIWS G I   ++ G P  P  +E DQ        G   +        + K + NF  
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 256 RDPFP------SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297
            +P P       +  S I+L+ +ML  DP +RIT  Q LEH + KE+ 
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 122/236 (51%), Gaps = 19/236 (8%)
Query: 79  DVRREIEIMRHLSGQPNIVQFKAAY--EDDQFVHIVMELCAGG--ELFDRIVARGHYSER 134
           +V++EI+++R L  + N++Q       E+ Q +++VME C  G  E+ D +  +  +   
Sbjct: 52  NVKKEIQLLRRLRHK-NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVC 109
Query: 135 AAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-- 192
            A   F  +++ +   HS+G++H+D+KP N L TTG     +K +  G++  +    A  
Sbjct: 110 QAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG---GTLKISALGVAEALHPFAADD 166
Query: 193 -YREIVGSPYYIAPEV---LSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL 248
             R   GSP +  PE+   L    G + DIWSAGV LY +  G+ PF  +    + + I 
Sbjct: 167 TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG 226
Query: 249 KGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPI 304
           KG      D  P +S    +L++ ML  +P +R ++ Q+ +H W ++    ++ P+
Sbjct: 227 KGSYAIPGDCGPPLS----DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV 278

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 130/288 (45%), Gaps = 25/288 (8%)
Query: 25  GKAYEDVQLH-YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           GKA   + L  + + R +GRG +    L     T   +A + + K  +  D + D V+ E
Sbjct: 43  GKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE 102
Query: 84  IEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVI 143
             +    S  P +V   + ++ +  +  V+E   GG+L   +  +    E  A      I
Sbjct: 103 KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 162
Query: 144 MNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYY 202
              +N  H +G+++RDLK +N L    D    +K TD+G+    +  G       G+P Y
Sbjct: 163 SLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNY 219
Query: 203 IAPEVL-SQSYGKEADIWSAGVILYILLCGVPPF---------WAETDQGVAQAILKGEI 252
           IAPE+L  + YG   D W+ GV+++ ++ G  PF            T+  + Q IL+ +I
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279
Query: 253 NFQRDPFPSISSSAIELVRRMLTQDPKRRITV------AQVLEHPWLK 294
              R    S+S  A  +++  L +DPK R+        A +  HP+ +
Sbjct: 280 RIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323

>pdb|3PM8|A Chain A, Cad Domain Of Pff0520w, Calcium Dependent Protein Kinase Length = 197

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 94/172 (54%)
Query: 304 IDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKA 363
           + + ++  +K F   N+LKK+AL +I ++L   EI  L+  F  +D DNSGTL+  E+  
Sbjct: 22  LSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNIFIALDVDNSGTLSSQEILD 81
Query: 364 GLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKD 423
           GL K+G      D+ Q ++  D + +G I Y +F+ AT+ +    + E     F++FD D
Sbjct: 82  GLKKIGYQKIPPDIHQVLRDIDSNASGQIHYTDFLAATIDKQTYLKKEVCLIPFKFFDID 141
Query: 424 NNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMM 475
            NG I+V+EL + F    + +      I  ++ EVD + DG I + EF  MM
Sbjct: 142 GNGKISVEELKRIFGRDDIENPLIDKAIDSLLQEVDLNGDGEIDFHEFMLMM 193

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 139/294 (47%), Gaps = 49/294 (16%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVK----DVEK-----DDVRREIEIMRHLS 91
           + R ++ +  +    +T +  A    PK++ V     ++EK     D++ +EI+ M    
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFD---RIVARGHYS-----ERAAASVFRVI 143
             PNIV +  ++     + +VM+L +GG + D    IVA+G +      E   A++ R +
Sbjct: 72  -HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 144 MNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG------KAYREIV 197
           +  +   H  G +HRD+K  N L     E+  V+  DFG+SAF+  G      K  +  V
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 198 GSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ 255
           G+P ++APEV+ Q   Y  +ADIWS G+    L  G  P+       V        +  Q
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM------LTLQ 241
Query: 256 RDPFPSISS-------------SAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
            DP PS+ +             S  +++   L +DP++R T A++L H + +++
Sbjct: 242 NDP-PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 139/294 (47%), Gaps = 49/294 (16%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVK----DVEK-----DDVRREIEIMRHLS 91
           + R ++ +  +    +T +  A    PK++ V     ++EK     D++ +EI+ M    
Sbjct: 7   INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 66
Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFD---RIVARGHYS-----ERAAASVFRVI 143
             PNIV +  ++     + +VM+L +GG + D    IVA+G +      E   A++ R +
Sbjct: 67  -HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 125
Query: 144 MNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG------KAYREIV 197
           +  +   H  G +HRD+K  N L     E+  V+  DFG+SAF+  G      K  +  V
Sbjct: 126 LEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 198 GSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ 255
           G+P ++APEV+ Q   Y  +ADIWS G+    L  G  P+       V        +  Q
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM------LTLQ 236
Query: 256 RDPFPSISS-------------SAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
            DP PS+ +             S  +++   L +DP++R T A++L H + +++
Sbjct: 237 NDP-PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 289

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 125/277 (45%), Gaps = 24/277 (8%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + R +GRG +    L     T   +A K + K  +  D + D V+ E  +    S  P
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
            +V   + ++ +  +  V+E   GG+L   +  +    E  A      I   +N  H +G
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVL-SQSY 212
           +++RDLK +N L    D    +K TD+G+    +  G       G+P YIAPE+L  + Y
Sbjct: 131 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 187
Query: 213 GKEADIWSAGVILYILLCGVPPF---------WAETDQGVAQAILKGEINFQRDPFPSIS 263
           G   D W+ GV+++ ++ G  PF            T+  + Q IL+ +I   R    S+S
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLS 243
Query: 264 SSAIELVRRMLTQDPKRRITV------AQVLEHPWLK 294
             A  +++  L +DPK R+        A +  HP+ +
Sbjct: 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 136/278 (48%), Gaps = 20/278 (7%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD---VR 81
           GK  E ++  Y +G  +G G  G  Y     S  L  A K + K ++    E  +   V 
Sbjct: 43  GKEKEPLESQYQVGPLLGSGGSGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 102
Query: 82  REIEIMRHLS-GQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
            E+ +++ +S G   +++    +E  D FV I+       +LFD I  RG   E  A S 
Sbjct: 103 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 162
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
           F  ++  V  CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKD-TVYTDFDGT 219
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             Y  PE +   + +G+ A +WS G++LY ++CG  PF  E D    + I++G++ F++ 
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHD----EEIIRGQVFFRQ- 272
Query: 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               +SS    L+R  L   P  R T  ++  HPW+++
Sbjct: 273 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 307

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 125/277 (45%), Gaps = 24/277 (8%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + R +GRG +    L     T   +A K + K  +  D + D V+ E  +    S  P
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
            +V   + ++ +  +  V+E   GG+L   +  +    E  A      I   +N  H +G
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 126
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVL-SQSY 212
           +++RDLK +N L    D    +K TD+G+    +  G       G+P YIAPE+L  + Y
Sbjct: 127 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 183
Query: 213 GKEADIWSAGVILYILLCGVPPF---------WAETDQGVAQAILKGEINFQRDPFPSIS 263
           G   D W+ GV+++ ++ G  PF            T+  + Q IL+ +I   R    S+S
Sbjct: 184 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLS 239
Query: 264 SSAIELVRRMLTQDPKRRITV------AQVLEHPWLK 294
             A  +++  L +DPK R+        A +  HP+ +
Sbjct: 240 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 276

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 136/291 (46%), Gaps = 20/291 (6%)
Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
           ED  LH    + +G+G FG  +L     T   FA K++ K  ++ D + +    E  ++ 
Sbjct: 17  EDFILH----KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 72
Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYS-ERAAASVFRVIMNVV 147
                P +      ++  + +  VME   GG+L   I +   +   RA      +I+ + 
Sbjct: 73  LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL- 131
Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-YREIVGSPYYIAPE 206
              HSKG+++RDLK +N L    D++  +K  DFG+      G A      G+P YIAPE
Sbjct: 132 QFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPE 188
Query: 207 V-LSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265
           + L Q Y    D WS GV+LY +L G  PF  + ++ +  +I      + R     +   
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKE 244
Query: 266 AIELVRRMLTQDPKRRITV-AQVLEHPWLKESG--EASDKPIDTAVIFRMK 313
           A +L+ ++  ++P++R+ V   + +HP  +E    E   K ID    FR K
Sbjct: 245 AKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPP--FRPK 293

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 145/316 (45%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 40  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR--TLREIKILLR 97
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V++V  L  G +L+ +++   H S          I+
Sbjct: 98  FRHENIIGINDIIR-APTIEQMKDVYLVTHL-MGADLY-KLLKTQHLSNDHICYFLYQIL 154
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 155 RGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 271
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 272 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 331
Query: 292 WLKESGEASDKPIDTA 307
           +L++  + SD+PI  A
Sbjct: 332 YLEQYYDPSDEPIAEA 347

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 87/273 (31%), Positives = 131/273 (47%), Gaps = 28/273 (10%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + I  E+G G FG  Y      TG   A K I  +    + E +D   EIEI+      P
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILA-TCDHP 68
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVA---RGHYSERAAASVFRVIMNVVNVCH 151
            IV+   AY  D  + I++E C GG + D I+    RG  +E     V R ++  +N  H
Sbjct: 69  YIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVVCRQMLEALNFLH 126
Query: 152 SKGVMHRDLKPENFLFTT-GDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVL- 208
           SK ++HRDLK  N L T  GD    ++  DFG+SA  ++  +     +G+PY++APEV+ 
Sbjct: 127 SKRIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 182
Query: 209 -----SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263
                   Y  +ADIWS G+ L  +    PP        V   I K +      P    S
Sbjct: 183 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP----S 238
Query: 264 SSAIE---LVRRMLTQDPKRRITVAQVLEHPWL 293
             ++E    ++  L ++P+ R + AQ+LEHP++
Sbjct: 239 KWSVEFRDFLKIALDKNPETRPSAAQLLEHPFV 271

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 87/273 (31%), Positives = 131/273 (47%), Gaps = 28/273 (10%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + I  E+G G FG  Y      TG   A K I  +    + E +D   EIEI+      P
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILA-TCDHP 76
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVA---RGHYSERAAASVFRVIMNVVNVCH 151
            IV+   AY  D  + I++E C GG + D I+    RG  +E     V R ++  +N  H
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVVCRQMLEALNFLH 134
Query: 152 SKGVMHRDLKPENFLFTT-GDENAVVKATDFGLSA-FIEEGKAYREIVGSPYYIAPEVL- 208
           SK ++HRDLK  N L T  GD    ++  DFG+SA  ++  +     +G+PY++APEV+ 
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 209 -----SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263
                   Y  +ADIWS G+ L  +    PP        V   I K +      P    S
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP----S 246
Query: 264 SSAIE---LVRRMLTQDPKRRITVAQVLEHPWL 293
             ++E    ++  L ++P+ R + AQ+LEHP++
Sbjct: 247 KWSVEFRDFLKIALDKNPETRPSAAQLLEHPFV 279

>pdb|3O4Y|A Chain A, Crystal Structure Of Cad Domain Of The Plasmodium Vivax Cdpk, Pvx_11610 Length = 196

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/178 (35%), Positives = 100/178 (56%), Gaps = 7/178 (3%)
Query: 304 IDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKA 363
           ID  V+   K +  M + +KLA+ +I +     ++QKLK  F  +D +  G +T  +L+ 
Sbjct: 20  IDIHVLENFKNYALMLRFQKLAMTIIAQQSNDYDVQKLKAAFLHLDEEGKGNITKLQLRK 79
Query: 364 GLAKLGSML-TEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDK 422
           GL + G ML   FD+   +   D DG+G IDY EF+ A + R +L + + +Y AF+ FD 
Sbjct: 80  GLERSGLMLPPNFDL--LLDQIDSDGSGNIDYTEFLAAAIDRRQLSK-KLIYCAFRVFDV 136
Query: 423 DNNGYITVDELGKA-FKDYGMGD--DATIATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
           DN+G IT  EL    F     G+  +  +  +K+++ EVD++ DG+I + EF  MMK 
Sbjct: 137 DNDGEITTAELAHVLFNGNKRGNITERDVNQVKKMIREVDKNGDGKIDFYEFSEMMKL 194

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 134/280 (47%), Gaps = 23/280 (8%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + I  E+G G FG  Y      T +  A K I  +    + E +D   EI+I+      P
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILAS-CDHP 94
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVCHS 152
           NIV+   A+  +  + I++E CAGG + D ++       +E     V +  ++ +N  H 
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 153 KGVMHRDLKPENFLFTT-GDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVL-- 208
             ++HRDLK  N LFT  GD    +K  DFG+SA        R+  +G+PY++APEV+  
Sbjct: 154 NKIIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMC 209
Query: 209 ----SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
                + Y  +AD+WS G+ L  +    PP        V   I K E      P    SS
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWSS 268
Query: 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPI 304
           +  + +++ L ++   R T +Q+L+HP++      S+KPI
Sbjct: 269 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD---SNKPI 305

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 134/280 (47%), Gaps = 23/280 (8%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + I  E+G G FG  Y      T +  A K I  +    + E +D   EI+I+      P
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILAS-CDHP 94
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVCHS 152
           NIV+   A+  +  + I++E CAGG + D ++       +E     V +  ++ +N  H 
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 153 KGVMHRDLKPENFLFTT-GDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVL-- 208
             ++HRDLK  N LFT  GD    +K  DFG+SA        R+  +G+PY++APEV+  
Sbjct: 154 NKIIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 209
Query: 209 ----SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
                + Y  +AD+WS G+ L  +    PP        V   I K E      P    SS
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWSS 268
Query: 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPI 304
           +  + +++ L ++   R T +Q+L+HP++      S+KPI
Sbjct: 269 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD---SNKPI 305

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 134/280 (47%), Gaps = 23/280 (8%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + I  E+G G FG  Y      T +  A K I  +    + E +D   EI+I+      P
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILAS-CDHP 94
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVCHS 152
           NIV+   A+  +  + I++E CAGG + D ++       +E     V +  ++ +N  H 
Sbjct: 95  NIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 153 KGVMHRDLKPENFLFTT-GDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVL-- 208
             ++HRDLK  N LFT  GD    +K  DFG+SA        R+  +G+PY++APEV+  
Sbjct: 154 NKIIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMC 209
Query: 209 ----SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
                + Y  +AD+WS G+ L  +    PP        V   I K E      P    SS
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWSS 268
Query: 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPI 304
           +  + +++ L ++   R T +Q+L+HP++      S+KPI
Sbjct: 269 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD---SNKPI 305

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 127/267 (47%), Gaps = 22/267 (8%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G +GI Y   + S  +  A K IP+R          +  EI + +HL  + NIVQ+ 
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHK-NIVQYL 85
Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHY-----SERAAASVFRVIMNVVNVCHSKGV 155
            ++ ++ F+ I ME   GG L    + R  +     +E+      + I+  +   H   +
Sbjct: 86  GSFSENGFIKIFMEQVPGGSL--SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 156 MHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVL---SQS 211
           +HRD+K +N L  T   + V+K +DFG S  +       E   G+  Y+APE++    + 
Sbjct: 144 VHRDIKGDNVLINT--YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP-FP-SISSSAIEL 269
           YGK ADIWS G  +  +  G PPF+   + G  QA +     F+  P  P S+S+ A   
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPFY---ELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 258
Query: 270 VRRMLTQDPKRRITVAQVLEHPWLKES 296
           + +    DP +R     +L   +LK S
Sbjct: 259 ILKCFEPDPDKRACANDLLVDEFLKVS 285

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 90/317 (28%), Positives = 142/317 (44%), Gaps = 57/317 (17%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREI 84
           GK  E  ++ YT  + +G G FG+ +      +  E A K + + K  K+       RE+
Sbjct: 32  GKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKN-------REL 83
Query: 85  EIMRHLSGQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAAS 138
           +IMR +   PN+V  KA +      +D+ F+++V+E     E   R  A  HY++     
Sbjct: 84  QIMR-IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP--ETVYR--ASRHYAKLKQTM 138
Query: 139 VFRVI-------MNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191
              +I       +  +   HS G+ HRD+KP+N L      + V+K  DFG +  +  G+
Sbjct: 139 PMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP--PSGVLKLIDFGSAKILIAGE 196
Query: 192 AYREIVGSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAET--DQGVA--- 244
                + S YY APE++  + +Y    DIWS G ++  L+ G P F  E+  DQ V    
Sbjct: 197 PNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK 256
Query: 245 -------QAILKGEINFQRDPFPSI-------------SSSAIELVRRMLTQDPKRRITV 284
                  + I     N+    FP I                AI+L+ R+L   P  R+T 
Sbjct: 257 VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA 316
Query: 285 AQVLEHPWLKE--SGEA 299
            + L HP+  E  +GEA
Sbjct: 317 IEALCHPFFDELRTGEA 333

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 129/267 (48%), Gaps = 25/267 (9%)
Query: 31  VQLH---YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM 87
           ++LH   + I + +GRG FG   +    +    FA K + K +++K  E    R E +++
Sbjct: 69  MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL 128
Query: 88  RHLSGQPN-IVQFKAAYEDDQFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMN 145
             ++G    I     A++DD  +++VM+   GG+L   +        E  A      ++ 
Sbjct: 129 --VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREI-VGSPYYI 203
            ++  H    +HRD+KP+N L    D N  ++  DFG     +E+G     + VG+P YI
Sbjct: 187 AIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 204 APEVLSQ------SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
           +PE+L         YG E D WS GV +Y +L G  PF+AE+       I+  +  FQ  
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ-- 301
Query: 258 PFPS----ISSSAIELVRRMLTQDPKR 280
            FP+    +S +A +L+RR++     R
Sbjct: 302 -FPTQVTDVSENAKDLIRRLICSREHR 327

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 145/316 (45%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR--TLREIKILLR 77
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 78  FRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQIL 134
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 135 RGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 251
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 252 LNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 311
Query: 292 WLKESGEASDKPIDTA 307
           +L++  + SD+PI  A
Sbjct: 312 YLEQYYDPSDEPIAEA 327

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 145/316 (45%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR--TLREIKILLR 77
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 78  FRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQIL 134
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 135 RGLKYIHSANVLHRDLKPSNLLLNTTXD---LKIXDFGLARVADPDHDHTGFLTEYVATR 191
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 251
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 252 LNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 311
Query: 292 WLKESGEASDKPIDTA 307
           +L++  + SD+PI  A
Sbjct: 312 YLEQYYDPSDEPIAEA 327

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 144/316 (45%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 22  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR--TLREIKILLA 79
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 80  FRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQIL 136
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 137 RGLKYIHSANVLHRDLKPSNLLLNTTSD---LKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 253
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 254 LNCGINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 313
Query: 292 WLKESGEASDKPIDTA 307
           +L +  + SD+PI  A
Sbjct: 314 YLAQYYDPSDEPIAEA 329

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 126/265 (47%), Gaps = 22/265 (8%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G +GI Y   + S  +  A K IP+R          +  EI + +HL  + NIVQ+ 
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHK-NIVQYL 71
Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHY-----SERAAASVFRVIMNVVNVCHSKGV 155
            ++ ++ F+ I ME   GG L    + R  +     +E+      + I+  +   H   +
Sbjct: 72  GSFSENGFIKIFMEQVPGGSL--SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 129
Query: 156 MHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVL---SQS 211
           +HRD+K +N L  T   + V+K +DFG S  +       E   G+  Y+APE++    + 
Sbjct: 130 VHRDIKGDNVLINT--YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 187
Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP-FP-SISSSAIEL 269
           YGK ADIWS G  +  +  G PPF+   + G  QA +     F+  P  P S+S+ A   
Sbjct: 188 YGKAADIWSLGCTIIEMATGKPPFY---ELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 244
Query: 270 VRRMLTQDPKRRITVAQVLEHPWLK 294
           + +    DP +R     +L   +LK
Sbjct: 245 ILKCFEPDPDKRACANDLLVDEFLK 269

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 145/316 (45%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR--TLREIKILLR 77
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 78  FRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQIL 134
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 135 RGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 251
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 252 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 311
Query: 292 WLKESGEASDKPIDTA 307
           +L++  + SD+PI  A
Sbjct: 312 YLEQYYDPSDEPIAEA 327

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 142/316 (44%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I               REI+I+  
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYXQRTLREIKILLR 81
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 82  FRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQIL 138
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315
Query: 292 WLKESGEASDKPIDTA 307
           +L++  + SD+PI  A
Sbjct: 316 YLEQYYDPSDEPIAEA 331

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 131/268 (48%), Gaps = 23/268 (8%)
Query: 29  EDVQLH---YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIE 85
           +++QLH   + I + +GRG FG   +    +T   +A K + K +++K  E    R E +
Sbjct: 67  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 126
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIM 144
           ++ +   Q  I     A++D+  +++VM+   GG+L   +        E  A      ++
Sbjct: 127 VLVNGDCQ-WITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMV 185
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREI-VGSPYY 202
             ++  H    +HRD+KP+N L    D N  ++  DFG    + ++G     + VG+P Y
Sbjct: 186 LAIDSIHQLHYVHRDIKPDNVLL---DVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDY 242
Query: 203 IAPEVLSQ------SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR 256
           I+PE+L         YG E D WS GV +Y +L G  PF+AE+       I+  E  FQ 
Sbjct: 243 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ- 301
Query: 257 DPFPS----ISSSAIELVRRMLTQDPKR 280
             FPS    +S  A +L++R++    +R
Sbjct: 302 --FPSHVTDVSEEAKDLIQRLICSRERR 327

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 145/316 (45%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR--TLREIKILLR 81
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 82  FRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQIL 138
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315
Query: 292 WLKESGEASDKPIDTA 307
           +L++  + SD+PI  A
Sbjct: 316 YLEQYYDPSDEPIAEA 331

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 131/268 (48%), Gaps = 23/268 (8%)
Query: 29  EDVQLH---YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIE 85
           +++QLH   + I + +GRG FG   +    +T   +A K + K +++K  E    R E +
Sbjct: 83  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 142
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIM 144
           ++ +   Q  I     A++D+  +++VM+   GG+L   +        E  A      ++
Sbjct: 143 VLVNGDCQW-ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMV 201
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREI-VGSPYY 202
             ++  H    +HRD+KP+N L    D N  ++  DFG    + ++G     + VG+P Y
Sbjct: 202 LAIDSIHQLHYVHRDIKPDNVLL---DVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDY 258
Query: 203 IAPEVLSQ------SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR 256
           I+PE+L         YG E D WS GV +Y +L G  PF+AE+       I+  E  FQ 
Sbjct: 259 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ- 317
Query: 257 DPFPS----ISSSAIELVRRMLTQDPKR 280
             FPS    +S  A +L++R++    +R
Sbjct: 318 --FPSHVTDVSEEAKDLIQRLICSRERR 343

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 145/316 (45%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 28  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR--TLREIKILLR 85
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 86  FRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQIL 142
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 143 RGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATR 199
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 200 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 259
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 260 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 319
Query: 292 WLKESGEASDKPIDTA 307
           +L++  + SD+PI  A
Sbjct: 320 YLEQYYDPSDEPIAEA 335

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 145/316 (45%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR--TLREIKILLR 77
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 78  FRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQIL 134
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 135 RGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 251
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 252 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 311
Query: 292 WLKESGEASDKPIDTA 307
           +L++  + SD+PI  A
Sbjct: 312 YLEQYYDPSDEPIAEA 327

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 132/293 (45%), Gaps = 43/293 (14%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKR---KLVKDVEKDDVRREIEIMRHLSGQPNIV 97
           VG G +G+   C    TG   A K   +    K+VK +      REI++++ L  + N+V
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKI----AMREIKLLKQLRHE-NLV 87
Query: 98  QFKAAYEDDQFVHIVMELCAGGELFD-RIVARGHYSERAAASVFRVIMNVVNVCHSKGVM 156
                 +  +  ++V E      L D  +   G   +     +F++I N +  CHS  ++
Sbjct: 88  NLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQII-NGIGFCHSHNII 146
Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQSYG 213
           HRD+KPEN L +   ++ VVK  DFG +      G+ Y + V + +Y APE+L     YG
Sbjct: 147 HRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYG 203
Query: 214 KEADIWSAGVILYILLCGVPPFWAETD--------QGVAQAILKGEINFQRDP------- 258
           K  D+W+ G ++  +  G P F  ++D          +   I + +  F ++P       
Sbjct: 204 KAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL 263
Query: 259 ------------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA 299
                       +P +S   I+L ++ L  DP +R   A++L H + +  G A
Sbjct: 264 PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 145/316 (45%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 22  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR--TLREIKILLR 79
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 80  FRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQIL 136
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 137 RGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 253
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 254 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 313
Query: 292 WLKESGEASDKPIDTA 307
           +L++  + SD+PI  A
Sbjct: 314 YLEQYYDPSDEPIAEA 329

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 145/316 (45%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR--TLREIKILLR 77
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 78  FRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQIL 134
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 135 RGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 251
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 252 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 311
Query: 292 WLKESGEASDKPIDTA 307
           +L++  + SD+PI  A
Sbjct: 312 YLEQYYDPSDEPIAEA 327

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 145/316 (45%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 25  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR--TLREIKILLR 82
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 83  FRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQIL 139
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 140 RGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATR 196
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 256
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 257 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 316
Query: 292 WLKESGEASDKPIDTA 307
           +L++  + SD+PI  A
Sbjct: 317 YLEQYYDPSDEPIAEA 332

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 145/316 (45%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 26  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR--TLREIKILLR 83
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 84  FRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQIL 140
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 141 RGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATR 197
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 198 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 257
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 258 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 317
Query: 292 WLKESGEASDKPIDTA 307
           +L++  + SD+PI  A
Sbjct: 318 YLEQYYDPSDEPIAEA 333

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 145/316 (45%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 17  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR--TLREIKILLR 74
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 75  FRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQIL 131
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 132 RGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATR 188
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 189 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 248
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 249 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 308
Query: 292 WLKESGEASDKPIDTA 307
           +L++  + SD+PI  A
Sbjct: 309 YLEQYYDPSDEPIAEA 324

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 145/316 (45%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR--TLREIKILLR 81
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 82  FRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQIL 138
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315
Query: 292 WLKESGEASDKPIDTA 307
           +L++  + SD+PI  A
Sbjct: 316 YLEQYYDPSDEPIAEA 331

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 145/316 (45%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 18  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR--TLREIKILLR 75
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 76  FRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQIL 132
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 133 RGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 249
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 250 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 309
Query: 292 WLKESGEASDKPIDTA 307
           +L++  + SD+PI  A
Sbjct: 310 YLEQYYDPSDEPIAEA 325

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 145/316 (45%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR--TLREIKILLR 81
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 82  FRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQIL 138
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLXEXVATR 195
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315
Query: 292 WLKESGEASDKPIDTA 307
           +L++  + SD+PI  A
Sbjct: 316 YLEQYYDPSDEPIAEA 331

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 145/316 (45%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 25  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR--TLREIKILLR 82
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 83  FRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQIL 139
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 140 RGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLXEXVATR 196
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 256
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 257 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 316
Query: 292 WLKESGEASDKPIDTA 307
           +L++  + SD+PI  A
Sbjct: 317 YLEQYYDPSDEPIAEA 332

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 145/316 (45%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 40  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR--TLREIKILLR 97
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 98  FRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQIL 154
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 155 RGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 271
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 272 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 331
Query: 292 WLKESGEASDKPIDTA 307
           +L++  + SD+PI  A
Sbjct: 332 YLEQYYDPSDEPIAEA 347

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 144/316 (45%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 22  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR--TLREIKILLA 79
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 80  FRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQIL 136
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 137 RGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 253
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 254 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 313
Query: 292 WLKESGEASDKPIDTA 307
           +L +  + SD+PI  A
Sbjct: 314 YLAQYYDPSDEPIAEA 329

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 90/317 (28%), Positives = 142/317 (44%), Gaps = 48/317 (15%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 18  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR--TLREIKILLR 75
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 76  FRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQIL 132
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 133 RGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL---------- 248
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +        IL          
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQED 249
Query: 249 ------------------KGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290
                             K ++ + R  FP+  S A++L+ +MLT +P +RI V Q L H
Sbjct: 250 LNCIINLKARNYLLSLPHKNKVPWNR-LFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 308
Query: 291 PWLKESGEASDKPIDTA 307
           P+L++  + SD+PI  A
Sbjct: 309 PYLEQYYDPSDEPIAEA 325

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 145/316 (45%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR--TLREIKILLR 81
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 82  FRHENIIGINDIIR-APTIEQMKDVYIVQDL-METDLY-KLLKCQHLSNDHICYFLYQIL 138
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315
Query: 292 WLKESGEASDKPIDTA 307
           +L++  + SD+PI  A
Sbjct: 316 YLEQYYDPSDEPIAEA 331

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 92/316 (29%), Positives = 145/316 (45%), Gaps = 46/316 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-- 87
           DV   YT    +G G +G+     +N   +  A + I   +     ++    REI+I+  
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQR--TLREIKILLR 81
Query: 88  -RH--LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
            RH  + G  +I++     E  + V+IV +L    +L+ +++   H S          I+
Sbjct: 82  FRHENIIGINDIIR-APTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQIL 138
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
             +   HS  V+HRDLKP N L  T  +   +K  DFGL+   +    +     E V + 
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ---------GVAQAI 247
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ           +Q  
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255
Query: 248 LKGEINFQ------------RDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           L   IN +            + P    FP+  S A++L+ +MLT +P +RI V Q L HP
Sbjct: 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315
Query: 292 WLKESGEASDKPIDTA 307
           +L++  + SD+PI  A
Sbjct: 316 YLEQYYDPSDEPIAEA 331

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 124/267 (46%), Gaps = 17/267 (6%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+G G  G+ +  +   +GL  A K I     +K   ++ + RE++++ H    P IV F
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVL-HECNSPYIVGF 69
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV-FRVIMNVVNVCHSKGVMHR 158
             A+  D  + I ME   GG L   +   G   E+    V   VI  +  +     +MHR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS-YGKEAD 217
           D+KP N L  +  E   +K  DFG+S  + +  A    VG+  Y++PE L  + Y  ++D
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 218 IWSAGVILYILLCG---VPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL----- 269
           IWS G+ L  +  G   +PP  A+ D     AI +       +P P + S    L     
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 245
Query: 270 VRRMLTQDPKRRITVAQVLEHPWLKES 296
           V + L ++P  R  + Q++ H ++K S
Sbjct: 246 VNKCLIKNPAERADLKQLMVHAFIKRS 272

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 14/285 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +T   ++G+G FG  +   +N T    A K I       + E +D+++EI ++      P
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS-P 80
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
            + ++  +Y  D  + I+ME   GG   D ++  G   E   A++ R I+  ++  HS+ 
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLSQS-Y 212
            +HRD+K  N L +   E+  VK  DFG++  + + +  R   VG+P+++APEV+ QS Y
Sbjct: 140 KIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAY 196
Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR 272
             +ADIWS G+    L  G PP        V   I K         +   S    E V  
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNY---SKPLKEFVEA 253
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTA 317
            L ++P  R T  ++L+H ++  + + +     T +I R K++ A
Sbjct: 254 CLNKEPSFRPTAKELLKHKFILRNAKKTS--YLTELIDRYKRWKA 296

>pdb|3O77|A Chain A, The Structure Of Ca2+ Sensor (Case-16) Length = 415

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 55/148 (37%), Positives = 83/148 (56%), Gaps = 3/148 (2%)
Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
           + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGNG
Sbjct: 269 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNG 328
Query: 391 TIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA 449
           TID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T  
Sbjct: 329 TIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDE 386
Query: 450 TIKEIMSEVDRDKDGRISYDEFRSMMKC 477
            + E++ E D D DG+++Y+EF  MM  
Sbjct: 387 EVDEMIREADIDGDGQVNYEEFVQMMTA 414

>pdb|3L19|A Chain A, Crystal Structure Of Calcium Binding Domain Of Cpcdpk3, Cgd5_820 Length = 214

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 71/192 (36%), Positives = 100/192 (52%), Gaps = 15/192 (7%)
Query: 294 KESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPT-EEIQKLKEKFTEMDTDN 352
           KESG   + P     I  M++F    KL + AL  +   L + EE ++L + F  +D + 
Sbjct: 19  KESG--IELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKELTDIFRHIDKNG 76
Query: 353 SGTLTYDELKAGLAKL-GSMLTEFDVKQY-------MQAADIDGNGTIDYIEFITATMQR 404
            G L   EL  G +KL G  +  FD+ Q        + AAD D NG IDY EF+T  M R
Sbjct: 77  DGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYSEFVTVAMDR 136
Query: 405 HKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDG 464
             L   + L  AFQ FD+D NG I+VDEL   F   G+ D     T KE++S +D + DG
Sbjct: 137 KSLLSKDKLESAFQKFDQDGNGKISVDELASVF---GL-DHLESKTWKEMISGIDSNNDG 192
Query: 465 RISYDEFRSMMK 476
            + ++EF  M++
Sbjct: 193 DVDFEEFCKMIQ 204

>pdb|3O78|A Chain A, The Structure Of Ca2+ Sensor (Case-12) Length = 415

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 55/148 (37%), Positives = 83/148 (56%), Gaps = 3/148 (2%)
Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
           + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGNG
Sbjct: 269 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNG 328
Query: 391 TIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA 449
           TID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T  
Sbjct: 329 TIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDE 386
Query: 450 TIKEIMSEVDRDKDGRISYDEFRSMMKC 477
            + E++ E D D DG+++Y+EF  MM  
Sbjct: 387 EVDEMIREADIDGDGQVNYEEFVQMMTA 414

>pdb|3SG6|A Chain A, Crystal Structure Of Dimeric Gcamp2-Lia(Linker 1) Length = 450

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 55/148 (37%), Positives = 83/148 (56%), Gaps = 3/148 (2%)
Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
           + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGNG
Sbjct: 304 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNG 363
Query: 391 TIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA 449
           TID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T  
Sbjct: 364 TIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDE 421
Query: 450 TIKEIMSEVDRDKDGRISYDEFRSMMKC 477
            + E++ E D D DG+++Y+EF  MM  
Sbjct: 422 EVDEMIREADIDGDGQVNYEEFVQMMTA 449

>pdb|3EK8|A Chain A, Calcium-Saturated Gcamp2 T116vG87R MUTANT MONOMER Length = 449

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 55/148 (37%), Positives = 83/148 (56%), Gaps = 3/148 (2%)
Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
           + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGNG
Sbjct: 303 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNG 362
Query: 391 TIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA 449
           TID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T  
Sbjct: 363 TIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDE 420
Query: 450 TIKEIMSEVDRDKDGRISYDEFRSMMKC 477
            + E++ E D D DG+++Y+EF  MM  
Sbjct: 421 EVDEMIREADIDGDGQVNYEEFVQMMTA 448

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 14/285 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +T   ++G+G FG  +   +N T    A K I       + E +D+++EI ++      P
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS-P 65
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
            + ++  +Y  D  + I+ME   GG   D ++  G   E   A++ R I+  ++  HS+ 
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLSQS-Y 212
            +HRD+K  N L +   E+  VK  DFG++  + + +  R   VG+P+++APEV+ QS Y
Sbjct: 125 KIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAY 181
Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR 272
             +ADIWS G+    L  G PP        V   I K         +   S    E V  
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNY---SKPLKEFVEA 238
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTA 317
            L ++P  R T  ++L+H ++  + + +     T +I R K++ A
Sbjct: 239 CLNKEPSFRPTAKELLKHKFILRNAKKTS--YLTELIDRYKRWKA 281

>pdb|3EVU|A Chain A, Crystal Structure Of Calcium Bound Dimeric Gcamp2, (#1) Length = 449

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 55/148 (37%), Positives = 83/148 (56%), Gaps = 3/148 (2%)
Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
           + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGNG
Sbjct: 303 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNG 362
Query: 391 TIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA 449
           TID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T  
Sbjct: 363 TIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDE 420
Query: 450 TIKEIMSEVDRDKDGRISYDEFRSMMKC 477
            + E++ E D D DG+++Y+EF  MM  
Sbjct: 421 EVDEMIREADIDGDGQVNYEEFVQMMTA 448

>pdb|3SG2|A Chain A, Crystal Structure Of Gcamp2-T116v,D381y Length = 449

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 55/148 (37%), Positives = 83/148 (56%), Gaps = 3/148 (2%)
Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
           + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGNG
Sbjct: 303 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNG 362
Query: 391 TIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA 449
           TID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T  
Sbjct: 363 TIDFPEFLTMMARKMKYTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDE 420
Query: 450 TIKEIMSEVDRDKDGRISYDEFRSMMKC 477
            + E++ E D D DG+++Y+EF  MM  
Sbjct: 421 EVDEMIREADIDGDGQVNYEEFVQMMTA 448

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 14/285 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +T   ++G+G FG  +   +N T    A K I       + E +D+++EI ++      P
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS-P 65
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
            + ++  +Y  D  + I+ME   GG   D ++  G   E   A++ R I+  ++  HS+ 
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLSQS-Y 212
            +HRD+K  N L +   E+  VK  DFG++  + + +  R   VG+P+++APEV+ QS Y
Sbjct: 125 KIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 181
Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR 272
             +ADIWS G+    L  G PP        V   I K         +   S    E V  
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNY---SKPLKEFVEA 238
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTA 317
            L ++P  R T  ++L+H ++  + + +     T +I R K++ A
Sbjct: 239 CLNKEPSFRPTAKELLKHKFILRNAKKTS--YLTELIDRYKRWKA 281

>pdb|3EVR|A Chain A, Crystal Structure Of Calcium Bound Monomeric Gcamp2 Length = 411

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 55/148 (37%), Positives = 83/148 (56%), Gaps = 3/148 (2%)
Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
           + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGNG
Sbjct: 266 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNG 325
Query: 391 TIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA 449
           TID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T  
Sbjct: 326 TIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDE 383
Query: 450 TIKEIMSEVDRDKDGRISYDEFRSMMKC 477
            + E++ E D D DG+++Y+EF  MM  
Sbjct: 384 EVDEMIREADIDGDGQVNYEEFVQMMTA 411

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 130/265 (49%), Gaps = 20/265 (7%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +T   ++G+G FG  +   +N T    A K I       + E +D+++EI ++      P
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCD-SP 85
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
            + ++  +Y  D  + I+ME   GG   D ++  G   E   A++ R I+  ++  HS+ 
Sbjct: 86  YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEK 144
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLSQS-Y 212
            +HRD+K  N L +   E+  VK  DFG++  + + +  R   VG+P+++APEV+ QS Y
Sbjct: 145 KIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 201
Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI----SSSAIE 268
             +ADIWS G+    L  G PP        V   I K       +P P++    S    E
Sbjct: 202 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK------NNP-PTLEGNYSKPLKE 254
Query: 269 LVRRMLTQDPKRRITVAQVLEHPWL 293
            V   L ++P  R T  ++L+H ++
Sbjct: 255 FVEACLNKEPSFRPTAKELLKHKFI 279

>pdb|3K21|A Chain A, Crystal Structure Of Carboxy-Terminus Of Pfc0420w Length = 191

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/174 (35%), Positives = 96/174 (55%), Gaps = 7/174 (4%)
Query: 308 VIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAK 367
           V+   K +  + K +KLA+ +I +     +++KLK  F  +D D  G +T ++LK GL K
Sbjct: 21  VLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLVLDEDGKGYITKEQLKKGLEK 80
Query: 368 LGSMLT-EFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNG 426
            G  L   FD+   +   D DG+G IDY EFI A + R +L + + +Y AF+ FD DN+G
Sbjct: 81  DGLKLPYNFDL--LLDQIDSDGSGKIDYTEFIAAALDRKQLSK-KLIYCAFRVFDVDNDG 137
Query: 427 YITVDELGKAFKDYGMGDDAT---IATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
            IT  EL     +     + T   +  +K ++ +VD++ DG+I + EF  MMK 
Sbjct: 138 EITTAELAHILYNGNKKGNITQRDVNRVKRMIRDVDKNNDGKIDFHEFSEMMKL 191

>pdb|2F2O|A Chain A, Structure Of Calmodulin Bound To A Calcineurin Peptide: A New Way Of Making An Old Binding Mode Length = 179

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 84/150 (56%), Gaps = 3/150 (2%)
Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           + + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DG
Sbjct: 1   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 389 NGTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
           NGTID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T
Sbjct: 61  NGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLT 118
Query: 448 IATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
              + E++ E D D DG+++Y+EF  MM  
Sbjct: 119 DEEVDEMIREADIDGDGQVNYEEFVQMMTA 148

>pdb|2WEL|D Chain D, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 150

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 84/150 (56%), Gaps = 3/150 (2%)
Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           + + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DG
Sbjct: 2   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 61
Query: 389 NGTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
           NGTID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T
Sbjct: 62  NGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLT 119
Query: 448 IATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
              + E++ E D D DG+++Y+EF  MM  
Sbjct: 120 DEEVDEMIREADIDGDGQVNYEEFVQMMTA 149

>pdb|4DJC|A Chain A, 1.35 A Crystal Structure Of The Nav1.5 Diii-Iv-CaCAM COMPLEX Length = 152

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/152 (36%), Positives = 84/152 (55%), Gaps = 3/152 (1%)
Query: 327 KVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADI 386
             + + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D 
Sbjct: 2   NAMADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDA 61
Query: 387 DGNGTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDD 445
           DGNGTID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+ 
Sbjct: 62  DGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEK 119
Query: 446 ATIATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
            T   + E++ E D D DG+++Y+EF  MM  
Sbjct: 120 LTDEEVDEMIREADIDGDGQVNYEEFVQMMTA 151

>pdb|2YGG|B Chain B, Complex Of Cambr And Cam Length = 150

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 84/150 (56%), Gaps = 3/150 (2%)
Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           + + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DG
Sbjct: 1   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 389 NGTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
           NGTID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T
Sbjct: 61  NGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLT 118
Query: 448 IATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
              + E++ E D D DG+++Y+EF  MM  
Sbjct: 119 DEEVDEMIREADIDGDGQVNYEEFVQMMTA 148

>pdb|2BE6|A Chain A, 2.0 A Crystal Structure Of The Cav1.2 Iq Domain-CaCAM COMPLEX Length = 150

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 84/150 (56%), Gaps = 3/150 (2%)
Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           + + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DG
Sbjct: 1   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 389 NGTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
           NGTID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T
Sbjct: 61  NGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLT 118
Query: 448 IATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
              + E++ E D D DG+++Y+EF  MM  
Sbjct: 119 DEEVDEMIREADIDGDGQVNYEEFVQMMTA 148

>pdb|1DEG|A Chain A, The Linker Of Des-Glu84 Calmodulin Is Bent As Seen In The Crystal Structure Length = 142

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 53/142 (37%), Positives = 81/142 (57%), Gaps = 2/142 (1%)
Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYI 395
           E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGNGTID+ 
Sbjct: 3   EQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFP 62
Query: 396 EFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIM 455
           EF+T   ++ K    E + +AF+ FDKD NGYI+  EL     +  +G+  T   + E++
Sbjct: 63  EFLTMMARKMKDTDSEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDEEVDEMI 120
Query: 456 SEVDRDKDGRISYDEFRSMMKC 477
            E + D DG+++Y+EF  MM  
Sbjct: 121 REANIDGDGQVNYEEFVQMMTA 142

>pdb|3EKH|A Chain A, Calcium-Saturated Gcamp2 T116vK378W MUTANT MONOMER Length = 449

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/148 (37%), Positives = 82/148 (55%), Gaps = 3/148 (2%)
Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
           + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGNG
Sbjct: 303 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNG 362
Query: 391 TIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA 449
           TID+ EF+T   +  K     E + +AF+ FDKD NGYI+  EL     +  +G+  T  
Sbjct: 363 TIDFPEFLTMMARWMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDE 420
Query: 450 TIKEIMSEVDRDKDGRISYDEFRSMMKC 477
            + E++ E D D DG+++Y+EF  MM  
Sbjct: 421 EVDEMIREADIDGDGQVNYEEFVQMMTA 448

>pdb|1AHR|A Chain A, Calmodulin Mutant With A Two Residue Deletion In The Central Helix Length = 146

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/148 (37%), Positives = 83/148 (56%), Gaps = 3/148 (2%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGN
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 390 GTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA 449
           GTID+ EF+T  M R      E + +AF+ FDKD NG+I+  EL     +  +G+  T  
Sbjct: 61  GTIDFPEFLTM-MARKMKDSEEEIREAFRVFDKDGNGFISAAELRHVMTN--LGEKLTDE 117
Query: 450 TIKEIMSEVDRDKDGRISYDEFRSMMKC 477
            + E++ E D D DG+++Y+EF +MM  
Sbjct: 118 EVDEMIREADIDGDGQVNYEEFVTMMTS 145

>pdb|1IQ5|A Chain A, CalmodulinNEMATODE CA2+CALMODULIN DEPENDENT KINASE KINASE Fragment Length = 149

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/150 (36%), Positives = 84/150 (56%), Gaps = 3/150 (2%)
Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           + + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DG
Sbjct: 1   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 389 NGTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
           NGTID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T
Sbjct: 61  NGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLT 118
Query: 448 IATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
              + E++ E D D DG+++Y+EF  MM  
Sbjct: 119 DEEVDEMIREADIDGDGQVNYEEFVQMMTA 148

>pdb|3SG5|A Chain A, Crystal Structure Of Dimeric Gcamp3-D380y, Qp(Linker 1), Lp(Linker 2) Length = 448

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 84/150 (56%), Gaps = 3/150 (2%)
Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           + + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DG
Sbjct: 300 LPDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 359
Query: 389 NGTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
           +GTID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T
Sbjct: 360 DGTIDFPEFLTMMARKMKYTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLT 417
Query: 448 IATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
              + E++ E D D DG+++Y+EF  MM  
Sbjct: 418 DEEVDEMIREADIDGDGQVNYEEFVQMMTA 447

>pdb|3SG4|A Chain A, Crystal Structure Of Gcamp3-D380y, Lp(Linker 2) Length = 448

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 84/150 (56%), Gaps = 3/150 (2%)
Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           + + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DG
Sbjct: 300 LPDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 359
Query: 389 NGTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
           +GTID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T
Sbjct: 360 DGTIDFPEFLTMMARKMKYTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLT 417
Query: 448 IATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
              + E++ E D D DG+++Y+EF  MM  
Sbjct: 418 DEEVDEMIREADIDGDGQVNYEEFVQMMTA 447

>pdb|3SG3|A Chain A, Crystal Structure Of Gcamp3-D380y Length = 449

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 54/148 (36%), Positives = 83/148 (56%), Gaps = 3/148 (2%)
Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
           + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DG+G
Sbjct: 303 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGDG 362
Query: 391 TIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA 449
           TID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T  
Sbjct: 363 TIDFPEFLTMMARKMKYTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDE 420
Query: 450 TIKEIMSEVDRDKDGRISYDEFRSMMKC 477
            + E++ E D D DG+++Y+EF  MM  
Sbjct: 421 EVDEMIREADIDGDGQVNYEEFVQMMTA 448

>pdb|3SG7|A Chain A, Crystal Structure Of Gcamp3-Kf(Linker 1) Length = 448

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 54/148 (36%), Positives = 83/148 (56%), Gaps = 3/148 (2%)
Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
           + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DG+G
Sbjct: 302 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGDG 361
Query: 391 TIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA 449
           TID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T  
Sbjct: 362 TIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDE 419
Query: 450 TIKEIMSEVDRDKDGRISYDEFRSMMKC 477
            + E++ E D D DG+++Y+EF  MM  
Sbjct: 420 EVDEMIREADIDGDGQVNYEEFVQMMTA 447

>pdb|1PRW|A Chain A, Crystal Structure Of Bovine Brain Ca++ Calmodulin In A Compact Form Length = 149

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 55/149 (36%), Positives = 83/149 (55%), Gaps = 3/149 (2%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGN
Sbjct: 2   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 61
Query: 390 GTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           GTID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T 
Sbjct: 62  GTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEXLTD 119
Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
             + E++ E D D DG+++Y+EF  MM  
Sbjct: 120 EEVDEMIREADIDGDGQVNYEEFVQMMTA 148

>pdb|1UP5|B Chain B, Chicken Calmodulin Length = 148

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 55/149 (36%), Positives = 83/149 (55%), Gaps = 3/149 (2%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGN
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 390 GTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           GTID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T 
Sbjct: 61  GTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEXLTD 118
Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
             + E++ E D D DG+++Y+EF  MM  
Sbjct: 119 EEVDEMIREADIDGDGQVNYEEFVQMMTA 147

>pdb|3KHE|A Chain A, Crystal Structure Of The Calcium-Loaded Calmodulin-Like Domain Of The Cdpk, 541.M00134 From Toxoplasma Gondii Length = 191

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/183 (33%), Positives = 95/183 (51%), Gaps = 16/183 (8%)
Query: 306 TAVIFRMKQFTAMNKLKKLALKVIVENLPT-EEIQKLKEKFTEMDTDNSGTLTYDELKAG 364
           T  +  MK+F +  KL + A+  +   L T EE ++L + F ++D +  G L   EL  G
Sbjct: 6   TGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEG 65
Query: 365 LAKL----GSMLTEFDVKQY-------MQAADIDGNGTIDYIEFITATMQRHKLQRFENL 413
             KL    G  +++ D  Q        +Q+ D D NG I+Y EF+T  M +  L   E L
Sbjct: 66  YRKLMQWKGDTVSDLDSSQIEAEVDHILQSVDFDRNGYIEYSEFVTVCMDKQLLLSRERL 125
Query: 414 YKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRS 473
             AFQ FD D +G IT +ELG+ F    + D+    T  +++ E D++ DG + ++EF  
Sbjct: 126 LAAFQQFDSDGSGKITNEELGRLFGVTEVDDE----TWHQVLQECDKNNDGEVDFEEFVE 181
Query: 474 MMK 476
           MM+
Sbjct: 182 MMQ 184

>pdb|1CDL|A Chain A, Target Enzyme Recognition By Calmodulin: 2.4 Angstroms Structure Of A Calmodulin-Peptide Complex Length = 147

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 55/149 (36%), Positives = 83/149 (55%), Gaps = 3/149 (2%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGN
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 390 GTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           GTID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T 
Sbjct: 61  GTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTD 118
Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
             + E++ E D D DG+++Y+EF  MM  
Sbjct: 119 EEVDEMIREADIDGDGQVNYEEFVQMMTA 147

>pdb|1CDM|A Chain A, Modulation Of Calmodulin Plasticity In Molecular Recognition On The Basis Of X-Ray Structures Length = 144

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 55/146 (37%), Positives = 82/146 (56%), Gaps = 3/146 (2%)
Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGNGTI
Sbjct: 1   LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI 60
Query: 393 DYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATI 451
           D+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T   +
Sbjct: 61  DFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDEEV 118
Query: 452 KEIMSEVDRDKDGRISYDEFRSMMKC 477
            E++ E D D DG+++Y+EF  MM  
Sbjct: 119 DEMIREADIDGDGQVNYEEFVQMMTA 144

>pdb|2VAY|A Chain A, Calmodulin Complexed With Cav1.1 Iq Peptide Length = 146

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 55/146 (37%), Positives = 82/146 (56%), Gaps = 3/146 (2%)
Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGNGTI
Sbjct: 2   LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI 61
Query: 393 DYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATI 451
           D+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T   +
Sbjct: 62  DFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDEEV 119
Query: 452 KEIMSEVDRDKDGRISYDEFRSMMKC 477
            E++ E D D DG+++Y+EF  MM  
Sbjct: 120 DEMIREADIDGDGQVNYEEFVQMMTA 145

>pdb|3EWT|A Chain A, Crystal Structure Of Calmodulin Complexed With A Peptide Length = 154

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 55/149 (36%), Positives = 83/149 (55%), Gaps = 3/149 (2%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGN
Sbjct: 7   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 66
Query: 390 GTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           GTID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T 
Sbjct: 67  GTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTD 124
Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
             + E++ E D D DG+++Y+EF  MM  
Sbjct: 125 EEVDEMIREADIDGDGQVNYEEFVQMMTA 153

>pdb|1CM1|A Chain A, Motions Of Calmodulin-Single-Conformer Refinement Length = 148

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 55/149 (36%), Positives = 83/149 (55%), Gaps = 3/149 (2%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGN
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 390 GTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           GTID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T 
Sbjct: 61  GTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTD 118
Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
             + E++ E D D DG+++Y+EF  MM  
Sbjct: 119 EEVDEMIREADIDGDGQVNYEEFVQMMTA 147

>pdb|4GOW|D Chain D, Crystal Structure Of Ca2+CAM:KV7.4 (KCNQ4) B HELIX COMPLEX Length = 144

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 55/144 (38%), Positives = 82/144 (56%), Gaps = 3/144 (2%)
Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGNGTI
Sbjct: 2   LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI 61
Query: 393 DYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATI 451
           D+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T   +
Sbjct: 62  DFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDEEV 119
Query: 452 KEIMSEVDRDKDGRISYDEFRSMM 475
            E++ E D D DG+++Y+EF  MM
Sbjct: 120 DEMIREADIDGDGQVNYEEFVQMM 143

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 121/261 (46%), Gaps = 18/261 (6%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSI--PKRKLVKDVEKDDVRREIEIMRHLSG 92
           Y I  ++G G     YL  +    ++ A K+I  P R+  + +++    RE+     LS 
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR--FEREVHNSSQLSH 70
Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
           Q NIV      E+D   ++VME   G  L + I + G  S   A +    I++ +   H 
Sbjct: 71  Q-NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR--EIVGSPYYIAPEVLSQ 210
             ++HRD+KP+N L    D N  +K  DFG++  + E    +   ++G+  Y +PE   Q
Sbjct: 130 MRIVHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE---Q 183
Query: 211 SYGKE----ADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI-NFQRDPFPSISSS 265
           + G+      DI+S G++LY +L G PPF  ET   +A   ++  + N   D    I  S
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243
Query: 266 AIELVRRMLTQDPKRRITVAQ 286
              ++ R   +D   R    Q
Sbjct: 244 LSNVILRATEKDKANRYKTIQ 264

>pdb|2BKH|B Chain B, Myosin Vi Nucleotide-Free (Mdinsert2) Crystal Structure Length = 149

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 85/150 (56%), Gaps = 3/150 (2%)
Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           + + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DG
Sbjct: 1   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 389 NGTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
           NGTID+ EF+T   ++ K     E + +AF+ FDKD NG+I+  EL     +  +G+  T
Sbjct: 61  NGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGFISAAELRHVMTN--LGEKLT 118
Query: 448 IATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
              + E++ E D D DG+++Y+EF +MM  
Sbjct: 119 DEEVDEMIREADIDGDGQVNYEEFVTMMTS 148

>pdb|2IX7|A Chain A, Structure Of Apo-Calmodulin Bound To Unconventional Myosin V Length = 145

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 55/146 (37%), Positives = 83/146 (56%), Gaps = 3/146 (2%)
Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
           + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGNG
Sbjct: 1   DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNG 60
Query: 391 TIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA 449
           TID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T  
Sbjct: 61  TIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDE 118
Query: 450 TIKEIMSEVDRDKDGRISYDEFRSMM 475
            + E++ E D D DG+++Y+EF  MM
Sbjct: 119 EVDEMIREADIDGDGQVNYEEFVQMM 144

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG  Y   +N T    A K I       + E +D+++EI ++      P I ++ 
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS-PYITRYF 83
Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
            +Y     + I+ME   GG   D ++  G   E   A++ R I+  ++  HS+  +HRD+
Sbjct: 84  GSYLKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDI 142
Query: 161 KPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLSQS-YGKEADI 218
           K  N L +   E   VK  DFG++  + + +  R   VG+P+++APEV+ QS Y  +ADI
Sbjct: 143 KAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADI 199
Query: 219 WSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI----SSSAIELVRRML 274
           WS G+    L  G PP    +D    + +        ++  P++    S    E V   L
Sbjct: 200 WSLGITAIELAKGEPP---NSDLHPMRVLFL----IPKNSPPTLEGQHSKPFKEFVEACL 252
Query: 275 TQDPKRRITVAQVLEH 290
            +DP+ R T  ++L+H
Sbjct: 253 NKDPRFRPTAKELLKH 268

>pdb|1OOJ|A Chain A, Structural Genomics Of Caenorhabditis Elegans : Calmodulin Length = 149

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 85/150 (56%), Gaps = 3/150 (2%)
Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           + + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DG
Sbjct: 1   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 389 NGTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
           NGTID+ EF+T   ++ K     E + +AF+ FDKD NG+I+  EL     +  +G+  T
Sbjct: 61  NGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGFISAAELRHVMTN--LGEKLT 118
Query: 448 IATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
              + E++ E D D DG+++Y+EF +MM  
Sbjct: 119 DEEVDEMIREADIDGDGQVNYEEFVTMMTT 148

>pdb|2LV6|A Chain A, The Complex Between Ca-calmodulin And Skeletal Muscle Myosin Light Chain Kinase From Combination Of Nmr And Aqueous And Contrast-matched Saxs Data Length = 148

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 54/149 (36%), Positives = 84/149 (56%), Gaps = 3/149 (2%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGN
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 390 GTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           GTID+ EF+T   ++ K     E + +AF+ FDKD NG+I+  EL     +  +G+  T 
Sbjct: 61  GTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGFISAAELRHVMTN--LGEKLTD 118
Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
             + E++ E D D DG+++Y+EF +MM  
Sbjct: 119 EEVDEMIREADIDGDGQVNYEEFVTMMTA 147

>pdb|1XFU|O Chain O, Crystal Structure Of Anthrax Edema Factor (ef) Truncation Mutant, Ef-delta 64 In Complex With Calmodulin Length = 149

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 84/150 (56%), Gaps = 3/150 (2%)
Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           + + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DG
Sbjct: 1   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 389 NGTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
           NGTID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T
Sbjct: 61  NGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLT 118
Query: 448 IATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
              + +++ E D D DG+++Y+EF  MM  
Sbjct: 119 DEEVDQMIREADIDGDGQVNYEEFVQMMTA 148

>pdb|3U0K|A Chain A, Crystal Structure Of The Genetically Encoded Calcium Indicator Rcamp Length = 440

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 82/146 (56%), Gaps = 3/146 (2%)
Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
           + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DG+G
Sbjct: 294 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGDG 353
Query: 391 TIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA 449
           TID+ EF+    ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T  
Sbjct: 354 TIDFPEFLIMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDE 411
Query: 450 TIKEIMSEVDRDKDGRISYDEFRSMM 475
            + E++ E D D DG+++Y+EF  MM
Sbjct: 412 EVDEMIREADIDGDGQVNYEEFVQMM 437

>pdb|2BBM|A Chain A, Solution Structure Of A Calmodulin-Target Peptide Complex By Multidimensional Nmr Length = 148

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 54/149 (36%), Positives = 84/149 (56%), Gaps = 3/149 (2%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGN
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 390 GTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           GTID+ EF+T   ++ K     E + +AF+ FDKD NG+I+  EL     +  +G+  T 
Sbjct: 61  GTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGFISAAELRHVMTN--LGEKLTD 118
Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
             + E++ E D D DG+++Y+EF +MM  
Sbjct: 119 EEVDEMIREADIDGDGQVNYEEFVTMMTS 147

>pdb|1Y0V|H Chain H, Crystal Structure Of Anthrax Edema Factor (Ef) In Complex With Calmodulin And Pyrophosphate Length = 146

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 54/143 (37%), Positives = 81/143 (56%), Gaps = 3/143 (2%)
Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYI 395
           E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGNGTID+ 
Sbjct: 5   EQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFP 64
Query: 396 EFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI 454
           EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T   + E+
Sbjct: 65  EFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDEEVDEM 122
Query: 455 MSEVDRDKDGRISYDEFRSMMKC 477
           + E D D DG+++Y+EF  MM  
Sbjct: 123 IREADIDGDGQVNYEEFVQMMTA 145

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 122/264 (46%), Gaps = 17/264 (6%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+G G  G+ +  +   +GL  A K I     +K   ++ + RE++++ H    P IV F
Sbjct: 32  ELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL-HECNSPYIVGF 88
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV-FRVIMNVVNVCHSKGVMHR 158
             A+  D  + I ME   GG L   +   G   E+    V   VI  +  +     +MHR
Sbjct: 89  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 148
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS-YGKEAD 217
           D+KP N L  +  E   +K  DFG+S  + +  A    VG+  Y++PE L  + Y  ++D
Sbjct: 149 DVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSVQSD 204
Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL-----VRR 272
           IWS G+ L  +  G  P  + +       +L   +N   +P P + S    L     V +
Sbjct: 205 IWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVN---EPPPKLPSGVFSLEFQDFVNK 261
Query: 273 MLTQDPKRRITVAQVLEHPWLKES 296
            L ++P  R  + Q++ H ++K S
Sbjct: 262 CLIKNPAERADLKQLMVHAFIKRS 285

>pdb|2VB6|B Chain B, Myosin Vi (Md-Insert2-Cam, Delta Insert1) Post-Rigor State ( Crystal Form 2) Length = 149

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 54/150 (36%), Positives = 85/150 (56%), Gaps = 3/150 (2%)
Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           + + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DG
Sbjct: 1   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 389 NGTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
           NGTID+ EF+T   ++ K     E + +AF+ FDKD NG+I+  EL     +  +G+  T
Sbjct: 61  NGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGFISAAELRHVMTN--LGEKLT 118
Query: 448 IATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
              + E++ E D D DG+++Y+EF +MM  
Sbjct: 119 DEEVDEMIRESDIDGDGQVNYEEFVTMMTS 148

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 130/297 (43%), Gaps = 49/297 (16%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + R++GRG++   +     +   +   K      ++K V+K+ ++REI+I+ +L G P
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVK------ILKPVKKNKIKREIKILENLRGGP 92
Query: 95  NIVQFKAAYED--DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
           NI+      +D   +   +V E     +          Y  R        I+  ++ CHS
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE---ILKALDYCHS 149
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            G+MHRD+KP N +     E+  ++  D+GL+ F   G+ Y   V S Y+  PE+L   Q
Sbjct: 150 MGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG---------EINFQRDP 258
            Y    D+WS G +L  ++    PF+      DQ V  A + G         + N + DP
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 259 -FPSI---------------------SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
            F  I                     S  A++ + ++L  D + R+T  + +EHP+ 
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1K93|D Chain D, Crystal Structure Of The Adenylyl Cyclase Domain Of Anthrax Edema Factor (Ef) In Complex With Calmodulin Length = 144

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 54/143 (37%), Positives = 81/143 (56%), Gaps = 3/143 (2%)
Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYI 395
           E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGNGTID+ 
Sbjct: 3   EQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFP 62
Query: 396 EFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI 454
           EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T   + E+
Sbjct: 63  EFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDEEVDEM 120
Query: 455 MSEVDRDKDGRISYDEFRSMMKC 477
           + E D D DG+++Y+EF  MM  
Sbjct: 121 IREADIDGDGQVNYEEFVQMMTA 143

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 137/285 (48%), Gaps = 14/285 (4%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +T    +G+G FG  +   +N T    A K I   +   ++E   +++EI ++       
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIED--IQQEITVLSQCDSS- 81
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
            + ++  +Y     + I+ME   GG   D + A G + E   A++ + I+  ++  HS+ 
Sbjct: 82  YVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK 140
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLSQS-Y 212
            +HRD+K  N L +   E   VK  DFG++  + + +  R   VG+P+++APEV+ QS Y
Sbjct: 141 KIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAY 197
Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR 272
             +ADIWS G+    L  G PP    +D    + +     N         + S  E +  
Sbjct: 198 DSKADIWSLGITAIELAKGEPP---NSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDA 254
Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTA 317
            L +DP  R T  ++L+H ++ ++ + +     T +I R K++ A
Sbjct: 255 CLNKDPSFRPTAKELLKHKFIVKNSKKTS--YLTELIDRFKRWKA 297

>pdb|1EXR|A Chain A, The 1.0 Angstrom Crystal Structure Of Ca+2 Bound Calmodulin Length = 148

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 56/147 (38%), Positives = 81/147 (55%), Gaps = 3/147 (2%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            E L  E+I + KE F   D D  GT+T  EL   +  LG   TE +++  +   D DGN
Sbjct: 1   AEQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 390 GTIDYIEFITATMQRHKLQRF-ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           GTID+ EF++   ++ K Q   E L +AF+ FD+D NG I+  EL     +  +G+  T 
Sbjct: 61  GTIDFPEFLSLMARKMKEQDSEEELIEAFKVFDRDGNGLISAAELRHVMTN--LGEKLTD 118
Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMM 475
             + E++ E D D DG I+Y+EF  MM
Sbjct: 119 DEVDEMIREADIDGDGHINYEEFVRMM 145

>pdb|1DMO|A Chain A, Calmodulin, Nmr, 30 Structures Length = 148

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/149 (36%), Positives = 83/149 (55%), Gaps = 3/149 (2%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGN
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 390 GTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           GTID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T 
Sbjct: 61  GTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTD 118
Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
             + E++ E + D DG+++Y+EF  MM  
Sbjct: 119 EEVDEMIREANIDGDGQVNYEEFVQMMTA 147

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 130/270 (48%), Gaps = 22/270 (8%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           R +G+G FG    C   +TG  +ACK + K+++ K   +     E +I+  ++ +  +V 
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR-FVVS 248
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSKGVM 156
              AYE    + +V+ L  GG+L   I   G      A +VF    I   +   H + ++
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIV 308
Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKE 215
           +RDLKPEN L    D++  ++ +D GL+  + EG+  +  VG+  Y+APEV+ ++ Y   
Sbjct: 309 YRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365
Query: 216 ADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-----ISSSAIELV 270
            D W+ G +LY ++ G  PF     Q   + I + E+       P       S  A  L 
Sbjct: 366 PDWWALGCLLYEMIAGQSPF-----QQRKKKIKREEVERLVKEVPEEYSERFSPQARSLC 420
Query: 271 RRMLTQDPKRRI-----TVAQVLEHPWLKE 295
            ++L +DP  R+     +  +V EHP  K+
Sbjct: 421 SQLLCKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|2K0J|A Chain A, Solution Structure Of Cam Complexed To Drp1p Length = 148

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/149 (36%), Positives = 83/149 (55%), Gaps = 3/149 (2%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DG+
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGD 60
Query: 390 GTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           GTID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T 
Sbjct: 61  GTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTD 118
Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
             + E++ E D D DG+++Y+EF  MM  
Sbjct: 119 EEVDEMIREADIDGDGQVNYEEFVQMMTA 147

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 136/296 (45%), Gaps = 45/296 (15%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD-VRR 82
           +G+  E  +L   + R +  G F   Y   +  +G E+A K    R L  + EK+  + +
Sbjct: 19  VGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALK----RLLSNEEEKNRAIIQ 74
Query: 83  EIEIMRHLSGQPNIVQFKAAY-----EDD----QFVHIVMELCAGG--ELFDRIVARGHY 131
           E+  M+ LSG PNIVQF +A      E D    +F+ ++ ELC G   E   ++ +RG  
Sbjct: 75  EVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFL-LLTELCKGQLVEFLKKMESRGPL 133
Query: 132 SERAAASVFRVIMNVVNVCHSK--GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
           S      +F      V   H +   ++HRDLK EN L +       +K  DFG +  I  
Sbjct: 134 SCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN---QGTIKLCDFGSATTISH 190
Query: 190 GKAY------REIV-------GSPYYIAPEVL----SQSYGKEADIWSAGVILYILLCGV 232
              Y      R +V        +P Y  PE++    +   G++ DIW+ G ILY+L    
Sbjct: 191 YPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
Query: 233 PPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
            PF    + G    I+ G+ +    P  +  +    L+R ML  +P+ R+++A+V+
Sbjct: 251 HPF----EDGAKLRIVNGKYSI--PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 130/270 (48%), Gaps = 22/270 (8%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           R +G+G FG    C   +TG  +ACK + K+++ K   +     E +I+  ++ +  +V 
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR-FVVS 248
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSKGVM 156
              AYE    + +V+ L  GG+L   I   G      A +VF    I   +   H + ++
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIV 308
Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSYGKE 215
           +RDLKPEN L    D++  ++ +D GL+  + EG+  +  VG+  Y+APEV+ ++ Y   
Sbjct: 309 YRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365
Query: 216 ADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-----ISSSAIELV 270
            D W+ G +LY ++ G  PF     Q   + I + E+       P       S  A  L 
Sbjct: 366 PDWWALGCLLYEMIAGQSPF-----QQRKKKIKREEVERLVKEVPEEYSERFSPQARSLC 420
Query: 271 RRMLTQDPKRRI-----TVAQVLEHPWLKE 295
            ++L +DP  R+     +  +V EHP  K+
Sbjct: 421 SQLLCKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/313 (26%), Positives = 146/313 (46%), Gaps = 46/313 (14%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRH 89
           DV   YT  + +G G +G+     ++      A K I   +     ++    REI+I+  
Sbjct: 40  DVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQR--TLREIQILLR 97
Query: 90  LSGQPNIVQFK-----AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
              + N++  +     +  E  + V+IV +L    +L+  + ++   ++     +++++ 
Sbjct: 98  FRHE-NVIGIRDILRASTLEAMRDVYIVQDLMET-DLYKLLKSQQLSNDHICYFLYQILR 155
Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSP 200
            +  + HS  V+HRDLKP N L  T      +K  DFGL+   +    +     E V + 
Sbjct: 156 GLKYI-HSANVLHRDLKPSNLLINT---TCDLKICDFGLARIADPEHDHTGFLTEXVATR 211
Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ-----GVAQAILKGE 251
           +Y APE++  S+ Y K  DIWS G IL  +L   P F  +   DQ     G+  +  + +
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 271
Query: 252 IN----------FQRDP----------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           +N           Q  P          FP   S A++L+ RMLT +P +RITV + L HP
Sbjct: 272 LNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHP 331
Query: 292 WLKESGEASDKPI 304
           +L++  + +D+P+
Sbjct: 332 YLEQYYDPTDEPV 344

>pdb|1CLM|A Chain A, Structure Of Paramecium Tetraurelia Calmodulin At 1.8 Angstroms Resolution Length = 148

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/147 (37%), Positives = 81/147 (55%), Gaps = 3/147 (2%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            + L  E+I + KE F   D D  GT+T  EL   +  LG   TE +++  +   D DGN
Sbjct: 1   AQELTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 390 GTIDYIEFITATMQRHKLQRF-ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           GTID+ EF++   ++ K Q   E L +AF+ FD+D NG I+  EL     +  +G+  T 
Sbjct: 61  GTIDFPEFLSLMARKMKEQDSEEELIEAFKVFDRDGNGLISAAELRHVMTN--LGEKLTD 118
Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMM 475
             + E++ E D D DG I+Y+EF  MM
Sbjct: 119 DEVDEMIREADIDGDGHINYEEFVRMM 145

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 128/285 (44%), Gaps = 52/285 (18%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSI--PKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           +GRG FG+ +          +A K I  P R+L ++     V RE++ +  L   P IV+
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE----KVMREVKALAKLE-HPGIVR 67
Query: 99  FKAAYEDDQ------------FVHIVMELCAGGELFDRIVARGHYSER---AAASVFRVI 143
           +  A+ +              +++I M+LC    L D +  R    ER       +F  I
Sbjct: 68  YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127
Query: 144 MNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI------- 196
              V   HSKG+MHRDLKP N  FT  D   VVK  DFGL   +++ +  + +       
Sbjct: 128 AEAVEFLHSKGLMHRDLKPSNIFFTMDD---VVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 197 ------VGSPYYIAPE-VLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK 249
                 VG+  Y++PE +   SY  + DI+S G+IL+ LL    PF  + ++      ++
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER------VR 235
Query: 250 GEINFQRDPFPSISSSAIE----LVRRMLTQDPKRRITVAQVLEH 290
              + +   FP + +        +V+ ML+  P  R     ++E+
Sbjct: 236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280

>pdb|3QRX|A Chain A, Chlamydomonas Reinhardtii Centrin Bound To Melittin Length = 169

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 54/145 (37%), Positives = 87/145 (60%), Gaps = 3/145 (2%)
Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E+ Q+++E F   DTD SGT+   ELK  +  LG    + ++K+ +   D DG+GTI
Sbjct: 22  LTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGFEPKKEEIKKMISEIDKDGSGTI 81
Query: 393 DYIEFIT-ATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATI 451
           D+ EF+T  T +  +    E + KAF+ FD DN+G IT+ +L +  K+  +G++ T   +
Sbjct: 82  DFEEFLTMMTAKMGERDSREEILKAFRLFDDDNSGTITIKDLRRVAKE--LGENLTEEEL 139
Query: 452 KEIMSEVDRDKDGRISYDEFRSMMK 476
           +E+++E DR+ D  I  DEF  +MK
Sbjct: 140 QEMIAEADRNDDNEIDEDEFIRIMK 164

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 34/288 (11%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G G +G  Y   +  T    A K I      + V    +R E+ +++ L  + NI++ 
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQHR-NIIEL 98
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRD 159
           K+    +  +H++ E  A  +L   +      S R   S    ++N VN CHS+  +HRD
Sbjct: 99  KSVIHHNHRLHLIFEY-AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRD 157
Query: 160 LKPENFLFTTGD--ENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQSYGK 214
           LKP+N L +  D  E  V+K  DFGL+ AF    + +   + + +Y  PE+L  S+ Y  
Sbjct: 158 LKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYST 217
Query: 215 EADIWSAGVILYILLCGVPPFW--AETDQ--------GVAQAILKGEINFQRD---PFPS 261
             DIWS   I   +L   P F   +E DQ        G+        +    D    FP 
Sbjct: 218 SVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPK 277
Query: 262 ISSSAIELV-------------RRMLTQDPKRRITVAQVLEHPWLKES 296
                ++ V               ML  DP +RI+    LEHP+   +
Sbjct: 278 FRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325

>pdb|1QTX|A Chain A, The 1.65 Angstrom Structure Of Calmodulin Rs20 Peptide Complex Length = 148

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 53/147 (36%), Positives = 82/147 (55%), Gaps = 3/147 (2%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGN
Sbjct: 1   ADQLTDEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 390 GTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           GTID+ EF+    ++ K     E L +AF+ FDKD NG+I+  EL     +  +G+  T 
Sbjct: 61  GTIDFPEFLNLMARKMKDTDSEEELKEAFRVFDKDGNGFISAAELRHVMTN--LGEKLTD 118
Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMM 475
             + E++ E D D DG+++Y+EF  +M
Sbjct: 119 EEVDEMIREADVDGDGQVNYEEFVQVM 145

>pdb|1VRK|A Chain A, The 1.9 Angstrom Structure Of E84k-Calmodulin Rs20 Peptide Complex Length = 148

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 53/147 (36%), Positives = 82/147 (55%), Gaps = 3/147 (2%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGN
Sbjct: 1   ADQLTDEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 390 GTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           GTID+ EF+    ++ K     E L +AF+ FDKD NG+I+  EL     +  +G+  T 
Sbjct: 61  GTIDFPEFLNLMARKMKDTDSEEKLKEAFRVFDKDGNGFISAAELRHVMTN--LGEKLTD 118
Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMM 475
             + E++ E D D DG+++Y+EF  +M
Sbjct: 119 EEVDEMIREADVDGDGQVNYEEFVQVM 145

>pdb|1QS7|A Chain A, The 1.8 Angstrom Structure Of Calmodulin Rs20 Peptide Complex Length = 145

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 53/144 (36%), Positives = 81/144 (56%), Gaps = 3/144 (2%)
Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGNGTI
Sbjct: 1   LTDEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI 60
Query: 393 DYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATI 451
           D+ EF+    ++ K     E L +AF+ FDKD NG+I+  EL     +  +G+  T   +
Sbjct: 61  DFPEFLNLMARKMKDTDSEEELKEAFRVFDKDGNGFISAAELRHVMTN--LGEKLTDEEV 118
Query: 452 KEIMSEVDRDKDGRISYDEFRSMM 475
            E++ E D D DG+++Y+EF  +M
Sbjct: 119 DEMIREADVDGDGQVNYEEFVQVM 142

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 43/308 (13%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + + K  K+       RE++IMR L 
Sbjct: 47  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD 99
Query: 92  GQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
              NIV+ +  +      +D+ ++++V++     E   R VAR +   +    V  V   
Sbjct: 100 -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYR-VARHYSRAKQTLPVIYVKLY 155
Query: 143 ---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S
Sbjct: 156 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICS 213
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
            YY APE++  +  Y    D+WSAG +L  LL G P F    D GV Q +   ++     
Sbjct: 214 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKV----- 266
Query: 258 PFPSISSSAIELVRRMLTQDPK-RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
               + +   E +R M   +P        Q+  HPW K        P   A+  R+ ++T
Sbjct: 267 ----LGTPTREQIREM---NPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYT 318
Query: 317 AMNKLKKL 324
              +L  L
Sbjct: 319 PTARLTPL 326

>pdb|1RFJ|A Chain A, Crystal Structure Of Potato Calmodulin Pcm6 Length = 149

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 82/148 (55%), Gaps = 3/148 (2%)
Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           + + L  ++I + KE F+  D D  G +T  EL   +  LG   TE +++  +   D DG
Sbjct: 1   MADQLTEDQISEFKEAFSLFDKDGDGCITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 389 NGTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
           NGTID+ EF+    ++ K     E L +AF+ FDKD NG+I+  EL     +  +G+  T
Sbjct: 61  NGTIDFPEFLNLMARKMKDTDSEEELKEAFRVFDKDQNGFISAAELRHVMTN--LGEKLT 118
Query: 448 IATIKEIMSEVDRDKDGRISYDEFRSMM 475
              + E++ E D D DG+I+YDEF  +M
Sbjct: 119 DEEVDEMIREADVDGDGQINYDEFVKVM 146

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 122/267 (45%), Gaps = 27/267 (10%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+G G  G+ +  +   +GL  A K I     +K   ++ + RE++++ H    P IV F
Sbjct: 16  ELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL-HECNSPYIVGF 72
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV-FRVIMNVVNVCHSKGVMHR 158
             A+  D  + I ME   GG L   +   G   E+    V   VI  +  +     +MHR
Sbjct: 73  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 132
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS-YGKEAD 217
           D+KP N L  +  E   +K  DFG+S  + +  A  E VG+  Y++PE L  + Y  ++D
Sbjct: 133 DVKPSNILVNSRGE---IKLCDFGVSGQLIDEMA-NEFVGTRSYMSPERLQGTHYSVQSD 188
Query: 218 IWSAGVILYILLCG---VPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL----- 269
           IWS G+ L  +  G    PP           AI +       +P P + S+   L     
Sbjct: 189 IWSMGLSLVEMAVGRYPRPPM----------AIFELLDYIVNEPPPKLPSAVFSLEFQDF 238
Query: 270 VRRMLTQDPKRRITVAQVLEHPWLKES 296
           V + L ++P  R  + Q++ H ++K S
Sbjct: 239 VNKCLIKNPAERADLKQLMVHAFIKRS 265

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 43/308 (13%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + + K  K+       RE++IMR L 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD 105
Query: 92  GQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
              NIV+ +  +      +D+ ++++V++     E   R VAR +   +    V  V   
Sbjct: 106 -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYR-VARHYSRAKQTLPVIYVKLY 161
Query: 143 ---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S
Sbjct: 162 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICS 219
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
            YY APE++  +  Y    D+WSAG +L  LL G P F    D GV Q +   ++     
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKV----- 272
Query: 258 PFPSISSSAIELVRRMLTQDPK-RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
               + +   E +R M   +P        Q+  HPW K        P   A+  R+ ++T
Sbjct: 273 ----LGTPTREQIREM---NPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYT 324
Query: 317 AMNKLKKL 324
              +L  L
Sbjct: 325 PTARLTPL 332

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 43/308 (13%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + + K  K+       RE++IMR L 
Sbjct: 24  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD 76
Query: 92  GQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
              NIV+ +  +      +D+ ++++V++     E   R VAR +   +    V  V   
Sbjct: 77  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYR-VARHYSRAKQTLPVIYVKLY 132
Query: 143 ---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S
Sbjct: 133 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICS 190
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
            YY APE++  +  Y    D+WSAG +L  LL G P F    D GV Q +   ++     
Sbjct: 191 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVEIIKV----- 243
Query: 258 PFPSISSSAIELVRRMLTQDPK-RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
               + +   E +R M   +P        Q+  HPW K        P   A+  R+ ++T
Sbjct: 244 ----LGTPTREQIREM---NPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYT 295
Query: 317 AMNKLKKL 324
              +L  L
Sbjct: 296 PTARLTPL 303

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 43/308 (13%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + + K  K+       RE++IMR L 
Sbjct: 31  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD 83
Query: 92  GQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
              NIV+ +  +      +D+ ++++V++     E   R VAR +   +    V  V   
Sbjct: 84  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYR-VARHYSRAKQTLPVIYVKLY 139
Query: 143 ---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S
Sbjct: 140 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICS 197
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
            YY APE++  +  Y    D+WSAG +L  LL G P F    D GV Q +   ++     
Sbjct: 198 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVEIIKV----- 250
Query: 258 PFPSISSSAIELVRRMLTQDPK-RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
               + +   E +R M   +P        Q+  HPW K        P   A+  R+ ++T
Sbjct: 251 ----LGTPTREQIREM---NPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYT 302
Query: 317 AMNKLKKL 324
              +L  L
Sbjct: 303 PTARLTPL 310

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 43/308 (13%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + + K  K+       RE++IMR L 
Sbjct: 32  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD 84
Query: 92  GQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
              NIV+ +  +      +D+ ++++V++     E   R VAR +   +    V  V   
Sbjct: 85  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYR-VARHYSRAKQTLPVIYVKLY 140
Query: 143 ---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S
Sbjct: 141 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICS 198
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
            YY APE++  +  Y    D+WSAG +L  LL G P F    D GV Q +   ++     
Sbjct: 199 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVEIIKV----- 251
Query: 258 PFPSISSSAIELVRRMLTQDPK-RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
               + +   E +R M   +P        Q+  HPW K        P   A+  R+ ++T
Sbjct: 252 ----LGTPTREQIREM---NPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYT 303
Query: 317 AMNKLKKL 324
              +L  L
Sbjct: 304 PTARLTPL 311

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 43/308 (13%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + + K  K+       RE++IMR L 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD 105
Query: 92  GQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
              NIV+ +  +      +D+ ++++V++     E   R VAR +   +    V  V   
Sbjct: 106 -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYR-VARHYSRAKQTLPVIYVKLY 161
Query: 143 ---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S
Sbjct: 162 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICS 219
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
            YY APE++  +  Y    D+WSAG +L  LL G P F    D GV Q +   ++     
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKV----- 272
Query: 258 PFPSISSSAIELVRRMLTQDPK-RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
               + +   E +R M   +P        Q+  HPW K        P   A+  R+ ++T
Sbjct: 273 ----LGTPTREQIREM---NPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYT 324
Query: 317 AMNKLKKL 324
              +L  L
Sbjct: 325 PTARLTPL 332

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 43/308 (13%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + + K  K+       RE++IMR L 
Sbjct: 38  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD 90
Query: 92  GQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
              NIV+ +  +      +D+ ++++V++     E   R VAR +   +    V  V   
Sbjct: 91  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYR-VARHYSRAKQTLPVIYVKLY 146
Query: 143 ---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S
Sbjct: 147 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICS 204
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
            YY APE++  +  Y    D+WSAG +L  LL G P F    D GV Q +   ++     
Sbjct: 205 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVEIIKV----- 257
Query: 258 PFPSISSSAIELVRRMLTQDPK-RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
               + +   E +R M   +P        Q+  HPW K        P   A+  R+ ++T
Sbjct: 258 ----LGTPTREQIREM---NPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYT 309
Query: 317 AMNKLKKL 324
              +L  L
Sbjct: 310 PTARLTPL 317

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 43/308 (13%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + + K  K+       RE++IMR L 
Sbjct: 27  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD 79
Query: 92  GQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
              NIV+ +  +      +D+ ++++V++     E   R VAR +   +    V  V   
Sbjct: 80  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYR-VARHYSRAKQTLPVIYVKLY 135
Query: 143 ---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S
Sbjct: 136 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICS 193
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
            YY APE++  +  Y    D+WSAG +L  LL G P F    D GV Q +   ++     
Sbjct: 194 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVEIIKV----- 246
Query: 258 PFPSISSSAIELVRRMLTQDPK-RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
               + +   E +R M   +P        Q+  HPW K        P   A+  R+ ++T
Sbjct: 247 ----LGTPTREQIREM---NPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYT 298
Query: 317 AMNKLKKL 324
              +L  L
Sbjct: 299 PTARLTPL 306

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 43/308 (13%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + + K  K+       RE++IMR L 
Sbjct: 31  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD 83
Query: 92  GQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
              NIV+ +  +      +D+ ++++V++     E   R VAR +   +    V  V   
Sbjct: 84  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYR-VARHYSRAKQTLPVIYVKLY 139
Query: 143 ---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S
Sbjct: 140 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICS 197
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
            YY APE++  +  Y    D+WSAG +L  LL G P F    D GV Q +   ++     
Sbjct: 198 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVEIIKV----- 250
Query: 258 PFPSISSSAIELVRRMLTQDPK-RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
               + +   E +R M   +P        Q+  HPW K        P   A+  R+ ++T
Sbjct: 251 ----LGTPTREQIREM---NPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYT 302
Query: 317 AMNKLKKL 324
              +L  L
Sbjct: 303 PTARLTPL 310

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 43/308 (13%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + + K  K+       RE++IMR L 
Sbjct: 55  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD 107
Query: 92  GQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
              NIV+ +  +      +D+ ++++V++     E   R VAR +   +    V  V   
Sbjct: 108 -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYR-VARHYSRAKQTLPVIYVKLY 163
Query: 143 ---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S
Sbjct: 164 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICS 221
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
            YY APE++  +  Y    D+WSAG +L  LL G P F    D GV Q +   ++     
Sbjct: 222 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKV----- 274
Query: 258 PFPSISSSAIELVRRMLTQDPK-RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
               + +   E +R M   +P        Q+  HPW K        P   A+  R+ ++T
Sbjct: 275 ----LGTPTREQIREM---NPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYT 326
Query: 317 AMNKLKKL 324
              +L  L
Sbjct: 327 PTARLTPL 334

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 43/308 (13%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + + K  K+       RE++IMR L 
Sbjct: 98  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD 150
Query: 92  GQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
              NIV+ +  +      +D+ ++++V++     E   R VAR +   +    V  V   
Sbjct: 151 -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYR-VARHYSRAKQTLPVIYVKLY 206
Query: 143 ---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S
Sbjct: 207 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICS 264
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
            YY APE++  +  Y    D+WSAG +L  LL G P F    D GV Q +   ++     
Sbjct: 265 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKV----- 317
Query: 258 PFPSISSSAIELVRRMLTQDPK-RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
               + +   E +R M   +P        Q+  HPW K        P   A+  R+ ++T
Sbjct: 318 ----LGTPTREQIREM---NPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYT 369
Query: 317 AMNKLKKL 324
              +L  L
Sbjct: 370 PTARLTPL 377

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 43/308 (13%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + + K  K+       RE++IMR L 
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-------RELQIMRKLD 71
Query: 92  GQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
              NIV+ +  +      +D+ ++++V++     E   R VAR +   +    V  V   
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYR-VARHYSRAKQTLPVIYVKLY 127
Query: 143 ---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S
Sbjct: 128 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
            YY APE++  +  Y    D+WSAG +L  LL G P F    D GV Q +   ++     
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVEIIKV----- 238
Query: 258 PFPSISSSAIELVRRMLTQDPK-RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
               + +   E +R M   +P        Q+  HPW K        P   A+  R+ ++T
Sbjct: 239 ----LGTPTREQIREM---NPNYTEFAFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYT 290
Query: 317 AMNKLKKL 324
              +L  L
Sbjct: 291 PTARLTPL 298

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 43/308 (13%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + + K  K+       RE++IMR L 
Sbjct: 20  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD 72
Query: 92  GQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
              NIV+ +  +      +D+ ++++V++     E   R VAR +   +    V  V   
Sbjct: 73  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYR-VARHYSRAKQTLPVIYVKLY 128
Query: 143 ---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S
Sbjct: 129 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICS 186
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
            YY APE++  +  Y    D+WSAG +L  LL G P F    D GV Q +   ++     
Sbjct: 187 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVEIIKV----- 239
Query: 258 PFPSISSSAIELVRRMLTQDPK-RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
               + +   E +R M   +P        Q+  HPW K        P   A+  R+ ++T
Sbjct: 240 ----LGTPTREQIREM---NPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYT 291
Query: 317 AMNKLKKL 324
              +L  L
Sbjct: 292 PTARLTPL 299

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 43/308 (13%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + + K  K+       RE++IMR L 
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD 71
Query: 92  GQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
              NIV+ +  +      +D+ ++++V++     E   R VAR +   +    V  V   
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYR-VARHYSRAKQTLPVIYVKLY 127
Query: 143 ---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S
Sbjct: 128 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICS 185
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
            YY APE++  +  Y    D+WSAG +L  LL G P F    D GV Q +   ++     
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVEIIKV----- 238
Query: 258 PFPSISSSAIELVRRMLTQDPK-RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
               + +   E +R M   +P        Q+  HPW K        P   A+  R+ ++T
Sbjct: 239 ----LGTPTREQIREM---NPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYT 290
Query: 317 AMNKLKKL 324
              +L  L
Sbjct: 291 PTARLTPL 298

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 43/308 (13%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + + K  K+       RE++IMR L 
Sbjct: 57  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD 109
Query: 92  GQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
              NIV+ +  +      +D+ ++++V++     E   R VAR +   +    V  V   
Sbjct: 110 -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYR-VARHYSRAKQTLPVIYVKLY 165
Query: 143 ---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S
Sbjct: 166 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICS 223
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
            YY APE++  +  Y    D+WSAG +L  LL G P F    D GV Q +   ++     
Sbjct: 224 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG--DSGVDQLVEIIKV----- 276
Query: 258 PFPSISSSAIELVRRMLTQDPK-RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
               + +   E +R M   +P        Q+  HPW K        P   A+  R+ ++T
Sbjct: 277 ----LGTPTREQIREM---NPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYT 328
Query: 317 AMNKLKKL 324
              +L  L
Sbjct: 329 PTARLTPL 336

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 43/308 (13%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + + K  K+       RE++IMR L 
Sbjct: 23  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD 75
Query: 92  GQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
              NIV+ +  +      +D+ ++++V++     E   R VAR +   +    V  V   
Sbjct: 76  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYR-VARHYSRAKQTLPVIYVKLY 131
Query: 143 ---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S
Sbjct: 132 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICS 189
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
            YY APE++  +  Y    D+WSAG +L  LL G P F    D GV Q +   ++     
Sbjct: 190 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVEIIKV----- 242
Query: 258 PFPSISSSAIELVRRMLTQDPK-RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
               + +   E +R M   +P        Q+  HPW K        P   A+  R+ ++T
Sbjct: 243 ----LGTPTREQIREM---NPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYT 294
Query: 317 AMNKLKKL 324
              +L  L
Sbjct: 295 PTARLTPL 302

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 43/308 (13%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + + K  K+       RE++IMR L 
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD 71
Query: 92  GQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
              NIV+ +  +      +D+ ++++V++     E   R VAR +   +    V  V   
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYR-VARHYSRAKQTLPVIYVKLY 127
Query: 143 ---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S
Sbjct: 128 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICS 185
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
            YY APE++  +  Y    D+WSAG +L  LL G P F    D GV Q +   ++     
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVEIIKV----- 238
Query: 258 PFPSISSSAIELVRRMLTQDPK-RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
               + +   E +R M   +P        Q+  HPW K        P   A+  R+ ++T
Sbjct: 239 ----LGTPTREQIREM---NPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYT 290
Query: 317 AMNKLKKL 324
              +L  L
Sbjct: 291 PTARLTPL 298

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 43/308 (13%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + + K  K+       RE++IMR L 
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-------RELQIMRKLD 71
Query: 92  GQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
              NIV+ +  +      +D+ ++++V++     E   R VAR +   +    V  V   
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYR-VARHYSRAKQTLPVIYVKLY 127
Query: 143 ---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S
Sbjct: 128 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
            YY APE++  +  Y    D+WSAG +L  LL G P F    D GV Q +   ++     
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVEIIKV----- 238
Query: 258 PFPSISSSAIELVRRMLTQDPK-RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
               + +   E +R M   +P        Q+  HPW K        P   A+  R+ ++T
Sbjct: 239 ----LGTPTREQIREM---NPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYT 290
Query: 317 AMNKLKKL 324
              +L  L
Sbjct: 291 PTARLTPL 298

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 43/308 (13%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + + K  K+       RE++IMR L 
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD 71
Query: 92  GQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
              NIV+ +  +      +D+ ++++V++     E   R VAR +   +    V  V   
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYR-VARHYSRAKQTLPVIYVKLY 127
Query: 143 ---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S
Sbjct: 128 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
            YY APE++  +  Y    D+WSAG +L  LL G P F    D GV Q +   ++     
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVEIIKV----- 238
Query: 258 PFPSISSSAIELVRRMLTQDPK-RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
               + +   E +R M   +P        Q+  HPW K        P   A+  R+ ++T
Sbjct: 239 ----LGTPTREQIREM---NPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYT 290
Query: 317 AMNKLKKL 324
              +L  L
Sbjct: 291 PTARLTPL 298

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 135/308 (43%), Gaps = 43/308 (13%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + + K  K+       RE++IMR L 
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-------RELQIMRKLD 71
Query: 92  GQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
              NIV+ +  +      +D+ ++++V++           VAR +   +    V  V   
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYR---VARHYSRAKQTLPVIYVKLY 127
Query: 143 ---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S
Sbjct: 128 MYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICS 185
Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
            YY APE++  +  Y    D+WSAG +L  LL G P F    D GV Q +   ++     
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVEIIKV----- 238
Query: 258 PFPSISSSAIELVRRMLTQDPK-RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
               + +   E +R M   +P        Q+  HPW K        P   A+  R+ ++T
Sbjct: 239 ----LGTPTREQIREM---NPNYTEFAFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYT 290
Query: 317 AMNKLKKL 324
              +L  L
Sbjct: 291 PTARLTPL 298

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 134/306 (43%), Gaps = 39/306 (12%)
Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + + K  K+       RE++IMR L 
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD 71
Query: 92  GQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV----- 142
              NIV+    F ++ E    V++ + L    E   R VAR +   +    V  V     
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYR-VARHYSRAKQTLPVIYVKLYMY 129
Query: 143 -IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY 201
            +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 187
Query: 202 YIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF 259
           Y APE++  +  Y    D+WSAG +L  LL G P F    D GV Q +   ++       
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVEIIKV------- 238
Query: 260 PSISSSAIELVRRMLTQDPK-RRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAM 318
             + +   E +R M   +P        Q+  HPW K        P   A+  R+ ++T  
Sbjct: 239 --LGTPTREQIREM---NPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYTPT 292
Query: 319 NKLKKL 324
            +L  L
Sbjct: 293 ARLTPL 298

>pdb|1NIW|A Chain A, Crystal Structure Of Endothelial Nitric Oxide Synthase Peptide Bound To Calmodulin Length = 148

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/143 (37%), Positives = 79/143 (55%), Gaps = 3/143 (2%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            + L  E+I + KE F+  D D  GT+T  EL      LG   TE +++  +   D DGN
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVXRSLGQNPTEAELQDXINEVDADGN 60
Query: 390 GTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           GTID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T 
Sbjct: 61  GTIDFPEFLTXXARKXKDTDSEEEIREAFRVFDKDGNGYISAAELRHVXTN--LGEKLTD 118
Query: 449 ATIKEIMSEVDRDKDGRISYDEF 471
             + E + E D D DG+++Y+EF
Sbjct: 119 EEVDEXIREADIDGDGQVNYEEF 141

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 129/291 (44%), Gaps = 47/291 (16%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           +VG G +G+ Y   ++S G   A K I   +L  D E + +     REI +++ L   PN
Sbjct: 28  KVGEGTYGVVYK-AKDSQGRIVALKRI---RL--DAEDEGIPSTAIREISLLKELH-HPN 80
Query: 96  IVQFKAAYEDDQFVHIVMELCAGG--ELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV        ++ + +V E       ++ D     G    +    +++++  V + CH  
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAH-CHQH 138
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            ++HRDLKP+N L  +   +  +K  DFGL+ AF    ++Y   V + +Y AP+VL  S+
Sbjct: 139 RILHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK--GEIN--------------- 253
            Y    DIWS G I   ++ G P F   TD      I    G  N               
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 254 -----FQRDPF----PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
                F++ P+    P      I+L+  ML  DP +RI+    + HP+ K+
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 129/291 (44%), Gaps = 47/291 (16%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           +VG G +G+ Y   ++S G   A K I   +L  D E + +     REI +++ L   PN
Sbjct: 28  KVGEGTYGVVYK-AKDSQGRIVALKRI---RL--DAEDEGIPSTAIREISLLKELH-HPN 80
Query: 96  IVQFKAAYEDDQFVHIVMELCAGG--ELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV        ++ + +V E       ++ D     G    +    +++++  V + CH  
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAH-CHQH 138
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            ++HRDLKP+N L  +   +  +K  DFGL+ AF    ++Y   V + +Y AP+VL  S+
Sbjct: 139 RILHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK--GEIN--------------- 253
            Y    DIWS G I   ++ G P F   TD      I    G  N               
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 254 -----FQRDPF----PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
                F++ P+    P      I+L+  ML  DP +RI+    + HP+ K+
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>pdb|4AQR|A Chain A, Crystal Structure Of A Calmodulin In Complex With The Regulatory Domain Of A Plasma-Membrane Ca2+-Atpase Length = 149

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 82/148 (55%), Gaps = 3/148 (2%)
Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           + + L  ++I + KE F+  D D  G +T  EL   +  LG   TE +++  +   D DG
Sbjct: 1   MADQLTDDQISEFKEAFSLFDKDGDGCITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60
Query: 389 NGTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
           NGTID+ EF+    ++ K     E L +AF+ FDKD NG+I+  EL     +  +G+  T
Sbjct: 61  NGTIDFPEFLNLMARKMKDTDSEEELKEAFRVFDKDQNGFISAAELRHVMTN--LGEKLT 118
Query: 448 IATIKEIMSEVDRDKDGRISYDEFRSMM 475
              + E++ E D D DG+I+Y+EF  +M
Sbjct: 119 DEEVDEMIREADVDGDGQINYEEFVKVM 146

>pdb|1S6J|A Chain A, N-Terminal Region Of The Ca2+-Saturated Calcium Regulatory Domain (Cld) From Soybean Calcium-Dependent Protein Kinase- Alpha (Cdpk) Length = 87

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 45/77 (58%), Positives = 55/77 (71%)
Query: 327 KVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADI 386
           K + E L  EEI  LKE F  +DTDNSGT+T+DELK GL ++GS L E ++K  M AADI
Sbjct: 11  KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADI 70
Query: 387 DGNGTIDYIEFITATMQ 403
           D +GTIDY EFI AT+ 
Sbjct: 71  DKSGTIDYGEFIAATVH 87

>pdb|1XFX|O Chain O, Crystal Structure Of Anthrax Edema Factor (Ef) In Complex With Calmodulin In The Presence Of 10 Millimolar Exogenously Added Calcium Chloride Length = 149

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 52/143 (36%), Positives = 79/143 (55%), Gaps = 3/143 (2%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            + L  E+I + KE F+  D D  GT+T  EL      LG   TE +++  +   D DGN
Sbjct: 2   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVXRSLGQNPTEAELQDXINEVDADGN 61
Query: 390 GTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           GTID+ EF+T   ++ K     E + +AF+ FDKD NGYI+  EL     +  +G+  T 
Sbjct: 62  GTIDFPEFLTXXARKXKDTDSEEEIREAFRVFDKDGNGYISAAELRHVXTN--LGEKLTD 119
Query: 449 ATIKEIMSEVDRDKDGRISYDEF 471
             + + + E D D DG+++Y+EF
Sbjct: 120 EEVDQXIREADIDGDGQVNYEEF 142

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 119/246 (48%), Gaps = 39/246 (15%)
Query: 83  EIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERA------- 135
           EI+++      PN++++  +   D+F++I +ELC    L D + ++    E         
Sbjct: 76  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYN 134
Query: 136 AASVFRVIMNVVNVCHSKGVMHRDLKPENFLFT----------TGDENAVVKATDFGLSA 185
             S+ R I + V   HS  ++HRDLKP+N L +          TG EN  +  +DFGL  
Sbjct: 135 PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 194
Query: 186 FIEEGK-AYREIVGSPY----YIAPEVLSQS----YGKEADIWSAGVILYILLC-GVPPF 235
            ++ G+  +R  + +P     + APE+L +S      +  DI+S G + Y +L  G  PF
Sbjct: 195 KLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF 254
Query: 236 WAETDQGVAQAILKG-----EINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290
             +  +     I++G     E+    D   S+ + A +L+ +M+  DP +R T  +VL H
Sbjct: 255 GDKYSR--ESNIIRGIFSLDEMKCLHD--RSLIAEATDLISQMIDHDPLKRPTAMKVLRH 310
Query: 291 P--WLK 294
           P  W K
Sbjct: 311 PLFWPK 316

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 119/246 (48%), Gaps = 39/246 (15%)
Query: 83  EIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERA------- 135
           EI+++      PN++++  +   D+F++I +ELC    L D + ++    E         
Sbjct: 76  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYN 134
Query: 136 AASVFRVIMNVVNVCHSKGVMHRDLKPENFLFT----------TGDENAVVKATDFGLSA 185
             S+ R I + V   HS  ++HRDLKP+N L +          TG EN  +  +DFGL  
Sbjct: 135 PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 194
Query: 186 FIEEGK-AYREIVGSPY----YIAPEVLSQS----YGKEADIWSAGVILYILLC-GVPPF 235
            ++ G+  +R  + +P     + APE+L +S      +  DI+S G + Y +L  G  PF
Sbjct: 195 KLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF 254
Query: 236 WAETDQGVAQAILKG-----EINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290
             +  +     I++G     E+    D   S+ + A +L+ +M+  DP +R T  +VL H
Sbjct: 255 GDKYSR--ESNIIRGIFSLDEMKCLHD--RSLIAEATDLISQMIDHDPLKRPTAMKVLRH 310
Query: 291 P--WLK 294
           P  W K
Sbjct: 311 PLFWPK 316

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 126/265 (47%), Gaps = 24/265 (9%)
Query: 28  YEDVQLHYTIGREVGRGEFGIT----YLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           YE  +    +GR +G G+FG      Y+  EN   L  A K+   +    D  ++   +E
Sbjct: 33  YEIQRERIELGRCIGEGQFGDVHQGIYMSPENP-ALAVAIKTC--KNCTSDSVREKFLQE 89
Query: 84  IEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV- 142
              MR     P+IV+      ++  V I+MELC  GEL   +  R +  + A+  ++   
Sbjct: 90  ALTMRQFD-HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 147
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS-PY 201
           +   +    SK  +HRD+   N L ++ D    VK  DFGLS ++E+   Y+   G  P 
Sbjct: 148 LSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPI 204
Query: 202 -YIAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEI-NFQRD 257
            ++APE ++ + +   +D+W  GV ++ IL+ GV PF     QGV    + G I N +R 
Sbjct: 205 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERL 259
Query: 258 PF-PSISSSAIELVRRMLTQDPKRR 281
           P  P+   +   L+ +    DP RR
Sbjct: 260 PMPPNCPPTLYSLMTKCWAYDPSRR 284

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 130/301 (43%), Gaps = 49/301 (16%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD---DVRREIEIMRHL 90
            Y    E+G G +G  +   +   G  F      KR  V+  E+       RE+ ++RHL
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVAL---KRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 91  SG--QPNIVQF----KAAYEDDQ------FVHIVMELCAGGELFDRIVARGHYSERAAAS 138
                PN+V+       +  D +      F H+  +L       D++   G  +E     
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETIKDM 125
Query: 139 VFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG 198
           +F+++  + +  HS  V+HRDLKP+N L T+  +   +K  DFGL+       A   +V 
Sbjct: 126 MFQLLRGL-DFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVV 181
Query: 199 SPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAI-----LKGEI 252
           + +Y APEVL Q SY    D+WS G I   +    P F   +D      I     L GE 
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 253 NFQRD------PFPSISSSAIE------------LVRRMLTQDPKRRITVAQVLEHPWLK 294
           ++ RD       F S S+  IE            L+ + LT +P +RI+    L HP+ +
Sbjct: 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301
Query: 295 E 295
           +
Sbjct: 302 D 302

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 8/205 (3%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQ 93
           +++ R +GRG FG  Y C +  TG  +A K + K+++ +K  E   +   I +    +G 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 94  -PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
            P IV    A+     +  +++L  GG+L   +   G +SE         I+  +   H+
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-- 210
           + V++RDLKP N L    DE+  V+ +D GL+    + K +   VG+  Y+APEVL +  
Sbjct: 311 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 366
Query: 211 SYGKEADIWSAGVILYILLCGVPPF 235
           +Y   AD +S G +L+ LL G  PF
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 8/205 (3%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQ 93
           +++ R +GRG FG  Y C +  TG  +A K + K+++ +K  E   +   I +    +G 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 94  -PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
            P IV    A+     +  +++L  GG+L   +   G +SE         I+  +   H+
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-- 210
           + V++RDLKP N L    DE+  V+ +D GL+    + K +   VG+  Y+APEVL +  
Sbjct: 311 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 366
Query: 211 SYGKEADIWSAGVILYILLCGVPPF 235
           +Y   AD +S G +L+ LL G  PF
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 8/205 (3%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQ 93
           +++ R +GRG FG  Y C +  TG  +A K + K+++ +K  E   +   I +    +G 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 94  -PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
            P IV    A+     +  +++L  GG+L   +   G +SE         I+  +   H+
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-- 210
           + V++RDLKP N L    DE+  V+ +D GL+    + K +   VG+  Y+APEVL +  
Sbjct: 311 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 366
Query: 211 SYGKEADIWSAGVILYILLCGVPPF 235
           +Y   AD +S G +L+ LL G  PF
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 8/205 (3%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQ 93
           +++ R +GRG FG  Y C +  TG  +A K + K+++ +K  E   +   I +    +G 
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 249
Query: 94  -PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
            P IV    A+     +  +++L  GG+L   +   G +SE         I+  +   H+
Sbjct: 250 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 309
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-- 210
           + V++RDLKP N L    DE+  V+ +D GL+    + K +   VG+  Y+APEVL +  
Sbjct: 310 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGV 365
Query: 211 SYGKEADIWSAGVILYILLCGVPPF 235
           +Y   AD +S G +L+ LL G  PF
Sbjct: 366 AYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 126/265 (47%), Gaps = 24/265 (9%)
Query: 28  YEDVQLHYTIGREVGRGEFGIT----YLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           YE  +    +GR +G G+FG      Y+  EN   L  A K+   +    D  ++   +E
Sbjct: 7   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENP-ALAVAIKTC--KNCTSDSVREKFLQE 63
Query: 84  IEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV- 142
              MR     P+IV+      ++  V I+MELC  GEL   +  R +  + A+  ++   
Sbjct: 64  ALTMRQFD-HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 121
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS-PY 201
           +   +    SK  +HRD+   N L ++ D    VK  DFGLS ++E+   Y+   G  P 
Sbjct: 122 LSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPI 178
Query: 202 -YIAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEI-NFQRD 257
            ++APE ++ + +   +D+W  GV ++ IL+ GV PF     QGV    + G I N +R 
Sbjct: 179 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERL 233
Query: 258 PF-PSISSSAIELVRRMLTQDPKRR 281
           P  P+   +   L+ +    DP RR
Sbjct: 234 PMPPNCPPTLYSLMTKCWAYDPSRR 258

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 126/265 (47%), Gaps = 24/265 (9%)
Query: 28  YEDVQLHYTIGREVGRGEFGIT----YLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           YE  +    +GR +G G+FG      Y+  EN   L  A K+   +    D  ++   +E
Sbjct: 8   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENP-ALAVAIKTC--KNCTSDSVREKFLQE 64
Query: 84  IEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV- 142
              MR     P+IV+      ++  V I+MELC  GEL   +  R +  + A+  ++   
Sbjct: 65  ALTMRQFD-HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 122
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS-PY 201
           +   +    SK  +HRD+   N L ++ D    VK  DFGLS ++E+   Y+   G  P 
Sbjct: 123 LSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPI 179
Query: 202 -YIAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEI-NFQRD 257
            ++APE ++ + +   +D+W  GV ++ IL+ GV PF     QGV    + G I N +R 
Sbjct: 180 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERL 234
Query: 258 PF-PSISSSAIELVRRMLTQDPKRR 281
           P  P+   +   L+ +    DP RR
Sbjct: 235 PMPPNCPPTLYSLMTKCWAYDPSRR 259

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 127/269 (47%), Gaps = 32/269 (11%)
Query: 28  YEDVQLHYTIGREVGRGEFGIT----YLCTENSTGLEFACKSIPKRKLVKDVEKDDVR-- 81
           YE  +    +GR +G G+FG      Y+  EN   L  A K+       K+   D VR  
Sbjct: 10  YEIQRERIELGRCIGEGQFGDVHQGIYMSPENP-ALAVAIKT------CKNCTSDSVREK 62
Query: 82  --REIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
             +E   MR     P+IV+      ++  V I+MELC  GEL   +  R +  + A+  +
Sbjct: 63  FLQEALTMRQFD-HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLIL 120
Query: 140 FRV-IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG 198
           +   +   +    SK  +HRD+   N L ++ D    VK  DFGLS ++E+   Y+   G
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKG 177
Query: 199 S-PY-YIAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEI-N 253
             P  ++APE ++ + +   +D+W  GV ++ IL+ GV PF     QGV    + G I N
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIEN 232
Query: 254 FQRDPF-PSISSSAIELVRRMLTQDPKRR 281
            +R P  P+   +   L+ +    DP RR
Sbjct: 233 GERLPMPPNCPPTLYSLMTKCWAYDPSRR 261

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 111/225 (49%), Gaps = 16/225 (7%)
Query: 82  REIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFR 141
           RE++++R     PN++++    +D QF +I +ELCA        V +  ++      +  
Sbjct: 66  REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA--TLQEYVEQKDFAHLGLEPITL 123
Query: 142 VIMNVVNVC--HSKGVMHRDLKPENFLFTTGDENAVVKA--TDFGLSAFIEEGK---AYR 194
           +      +   HS  ++HRDLKP N L +  + +  +KA  +DFGL   +  G+   + R
Sbjct: 124 LQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 195 E-IVGSPYYIAPEVLSQSYGKE----ADIWSAGVILYILLC-GVPPFWAETDQGVAQAIL 248
             + G+  +IAPE+LS+   +      DI+SAG + Y ++  G  PF  ++ Q  A  +L
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF-GKSLQRQANILL 242
Query: 249 KGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
                    P       A EL+ +M+  DP++R +   VL+HP+ 
Sbjct: 243 GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 127/269 (47%), Gaps = 32/269 (11%)
Query: 28  YEDVQLHYTIGREVGRGEFGIT----YLCTENSTGLEFACKSIPKRKLVKDVEKDDVR-- 81
           YE  +    +GR +G G+FG      Y+  EN   L  A K+       K+   D VR  
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENP-ALAVAIKT------CKNCTSDSVREK 57
Query: 82  --REIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
             +E   MR     P+IV+      ++  V I+MELC  GEL   +  R +  + A+  +
Sbjct: 58  FLQEALTMRQFD-HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLIL 115
Query: 140 FRV-IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG 198
           +   +   +    SK  +HRD+   N L ++ D    VK  DFGLS ++E+   Y+   G
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKG 172
Query: 199 S-PY-YIAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEI-N 253
             P  ++APE ++ + +   +D+W  GV ++ IL+ GV PF     QGV    + G I N
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIEN 227
Query: 254 FQRDPF-PSISSSAIELVRRMLTQDPKRR 281
            +R P  P+   +   L+ +    DP RR
Sbjct: 228 GERLPMPPNCPPTLYSLMTKCWAYDPSRR 256

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 130/301 (43%), Gaps = 49/301 (16%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD---DVRREIEIMRHL 90
            Y    E+G G +G  +   +   G  F      KR  V+  E+       RE+ ++RHL
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVAL---KRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 91  SG--QPNIVQF----KAAYEDDQ------FVHIVMELCAGGELFDRIVARGHYSERAAAS 138
                PN+V+       +  D +      F H+  +L       D++   G  +E     
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETIKDM 125
Query: 139 VFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG 198
           +F+++  + +  HS  V+HRDLKP+N L T+  +   +K  DFGL+       A   +V 
Sbjct: 126 MFQLLRGL-DFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVV 181
Query: 199 SPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAI-----LKGEI 252
           + +Y APEVL Q SY    D+WS G I   +    P F   +D      I     L GE 
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 253 NFQRD------PFPSISSSAIE------------LVRRMLTQDPKRRITVAQVLEHPWLK 294
           ++ RD       F S S+  IE            L+ + LT +P +RI+    L HP+ +
Sbjct: 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301
Query: 295 E 295
           +
Sbjct: 302 D 302

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 126/265 (47%), Gaps = 24/265 (9%)
Query: 28  YEDVQLHYTIGREVGRGEFGIT----YLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           YE  +    +GR +G G+FG      Y+  EN   L  A K+   +    D  ++   +E
Sbjct: 2   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENP-ALAVAIKTC--KNCTSDSVREKFLQE 58
Query: 84  IEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV- 142
              MR     P+IV+      ++  V I+MELC  GEL   +  R +  + A+  ++   
Sbjct: 59  ALTMRQFD-HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 116
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS-PY 201
           +   +    SK  +HRD+   N L ++ D    VK  DFGLS ++E+   Y+   G  P 
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 202 -YIAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEI-NFQRD 257
            ++APE ++ + +   +D+W  GV ++ IL+ GV PF     QGV    + G I N +R 
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERL 228
Query: 258 PF-PSISSSAIELVRRMLTQDPKRR 281
           P  P+   +   L+ +    DP RR
Sbjct: 229 PMPPNCPPTLYSLMTKCWAYDPSRR 253

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 120/250 (48%), Gaps = 43/250 (17%)
Query: 83  EIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERA------- 135
           EI+++      PN++++  +   D+F++I +ELC    L D + ++    E         
Sbjct: 58  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYN 116
Query: 136 AASVFRVIMNVVNVCHSKGVMHRDLKPENFLFT----------TGDENAVVKATDFGLSA 185
             S+ R I + V   HS  ++HRDLKP+N L +          TG EN  +  +DFGL  
Sbjct: 117 PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 186 FIEEGK-AYREIVGSPY----YIAPEVLSQSYG--------KEADIWSAGVILYILLC-G 231
            ++ G+ ++R  + +P     + APE+L +S          +  DI+S G + Y +L  G
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 232 VPPFWAETDQGVAQAILKG-----EINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQ 286
             PF  +  +     I++G     E+    D   S+ + A +L+ +M+  DP +R T  +
Sbjct: 237 KHPFGDKYSR--ESNIIRGIFSLDEMKCLHD--RSLIAEATDLISQMIDHDPLKRPTAMK 292
Query: 287 VLEHP--WLK 294
           VL HP  W K
Sbjct: 293 VLRHPLFWPK 302

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 129/300 (43%), Gaps = 49/300 (16%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD---DVRREIEIMRHL 90
            Y    E+G G +G  +   +   G  F      KR  V+  E+       RE+ ++RHL
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVAL---KRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 91  SG--QPNIVQF----KAAYEDDQ------FVHIVMELCAGGELFDRIVARGHYSERAAAS 138
                PN+V+       +  D +      F H+  +L       D++   G  +E     
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETIKDM 125
Query: 139 VFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG 198
           +F+++  + +  HS  V+HRDLKP+N L T+  +   +K  DFGL+       A   +V 
Sbjct: 126 MFQLLRGL-DFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVV 181
Query: 199 SPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAI-----LKGEI 252
           + +Y APEVL Q SY    D+WS G I   +    P F   +D      I     L GE 
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 253 NFQRD------PFPSISSSAIE------------LVRRMLTQDPKRRITVAQVLEHPWLK 294
           ++ RD       F S S+  IE            L+ + LT +P +RI+    L HP+ +
Sbjct: 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 125/290 (43%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 64
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E  +    +  D     G       + +F+++  +   CHS 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 123
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKPEN L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 124 RVLHRDLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 124/298 (41%), Gaps = 53/298 (17%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSI--PKRKLVKDVEKDDVRREIEIMRHLSG--QPN 95
           E+G G +G  Y   +  +G   A KS+  P              RE+ ++R L     PN
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 96  IVQFK---AAYEDDQ-------FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           +V+     A    D+       F H+  +L       D+    G  +E     + R  + 
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQDL---RTYLDKAPPPGLPAE-TIKDLMRQFLR 131
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAP 205
            ++  H+  ++HRDLKPEN L T+G     VK  DFGL+       A   +V + +Y AP
Sbjct: 132 GLDFLHANCIVHRDLKPENILVTSG---GTVKLADFGLARIYSYQMALTPVVVTLWYRAP 188
Query: 206 EVLSQS-YGKEADIWSAGVILY------ILLC---------------GVPPFWAETDQGV 243
           EVL QS Y    D+WS G I         L C               G+PP   E D   
Sbjct: 189 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP---EDDWPR 245
Query: 244 AQAILKGEINFQRDP------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
             ++ +G     R P       P +  S  +L+  MLT +P +RI+  + L+H +L +
Sbjct: 246 DVSLPRGAFP-PRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 127/269 (47%), Gaps = 32/269 (11%)
Query: 28  YEDVQLHYTIGREVGRGEFGIT----YLCTENSTGLEFACKSIPKRKLVKDVEKDDVR-- 81
           YE  +    +GR +G G+FG      Y+  EN   +  A K+       K+   D VR  
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENP-AMAVAIKT------CKNCTSDSVREK 57
Query: 82  --REIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
             +E   MR     P+IV+      ++  V I+MELC  GEL   +  R +  + A+  +
Sbjct: 58  FLQEALTMRQFD-HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLIL 115
Query: 140 FRV-IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG 198
           +   +   +    SK  +HRD+   N L ++ D    VK  DFGLS ++E+   Y+   G
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKG 172
Query: 199 S-PY-YIAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEI-N 253
             P  ++APE ++ + +   +D+W  GV ++ IL+ GV PF     QGV    + G I N
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIEN 227
Query: 254 FQRDPF-PSISSSAIELVRRMLTQDPKRR 281
            +R P  P+   +   L+ +    DP RR
Sbjct: 228 GERLPMPPNCPPTLYSLMTKCWAYDPSRR 256

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 125/290 (43%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 66
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E  +    +  D     G       + +F+++  +   CHS 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 125
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKPEN L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 126 RVLHRDLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 110/240 (45%), Gaps = 43/240 (17%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS--G 92
           + + R  G+G FG   L  E STG+  A K     K+++D    +  RE++IM+ L+   
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIK-----KVIQDPRFRN--RELQIMQDLAVLH 77
Query: 93  QPNIVQFKAAY-------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAAS------- 138
            PNIVQ ++ +         D ++++VME     +   R   R +Y  + A         
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHR-CCRNYYRRQVAPPPILIKVF 134
Query: 139 VFRVIMNV-------VNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191
           +F++I ++       VNVCH      RD+KP N L    D    +K  DFG +  +   +
Sbjct: 135 LFQLIRSIGCLHLPSVNVCH------RDIKPHNVLVNEAD--GTLKLCDFGSAKKLSPSE 186
Query: 192 AYREIVGSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK 249
                + S YY APE++  +Q Y    DIWS G I   ++ G P F  +   G    I++
Sbjct: 187 PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 87/350 (24%), Positives = 139/350 (39%), Gaps = 79/350 (22%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREI 84
           G+    V   Y + +++G+G +GI +   +  TG   A K I         +     REI
Sbjct: 1   GRVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-AFQNSTDAQRTFREI 59
Query: 85  EIMRHLSGQPNIVQFKAAY--EDDQFVHIVMELCAGGELFDRIVARGHYSERAAAS-VFR 141
            I+  LSG  NIV        ++D+ V++V +     E     V R +  E      V  
Sbjct: 60  MILTELSGHENIVNLLNVLRADNDRDVYLVFDYM---ETDLHAVIRANILEPVHKQYVVY 116
Query: 142 VIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREI---- 196
            ++ V+   HS G++HRD+KP N L         VK  DFGLS +F+   +    I    
Sbjct: 117 QLIKVIKYLHSGGLLHRDMKPSNILLNA---ECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 197 -----------------VGSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWA 237
                            V + +Y APE+L  S  Y K  D+WS G IL  +LCG P F  
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233
Query: 238 ETDQGVAQAILKGEINF-------------------------------QRD--------- 257
            +     + I+ G I+F                               +RD         
Sbjct: 234 SSTMNQLERII-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLL 292
Query: 258 ----PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
               P    +  A++L+ ++L  +P +RI+    L+HP++      +++P
Sbjct: 293 LKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEP 342

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 21/219 (9%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + I + +GRG F    +     TG  +A K + K  ++K  E    R E +++ +   + 
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN-GDRR 121
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV----IMNVVNVC 150
            I Q   A++D+ ++++VME   GG+L   +     + ER  A + R     I+  ++  
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDLLTLL---SKFGERIPAEMARFYLAEIVMAIDSV 178
Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV--GSPYYIAPEVL 208
           H  G +HRD+KP+N L    D    ++  DFG    +      R +V  G+P Y++PE+L
Sbjct: 179 HRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL 235
Query: 209 S--------QSYGKEADIWSAGVILYILLCGVPPFWAET 239
                     SYG E D W+ GV  Y +  G  PF+A++
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274

>pdb|1Y6W|A Chain A, Trapped Intermediate Of Calmodulin Length = 148

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/143 (36%), Positives = 78/143 (54%), Gaps = 3/143 (2%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            + L  E+I + KE F+  D D  GT+T  EL      LG   TE +++  +   D DGN
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVXRSLGCNPTEAELQDXINEVDADGN 60
Query: 390 GTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           GTI++ EF+T   +  K     E + +AF+ FDKD NGYI+  EL     +  +G+  T 
Sbjct: 61  GTINFPEFLTXXARCXKDTDSEEEIREAFRVFDKDGNGYISAAELRHVXTN--LGEKLTD 118
Query: 449 ATIKEIMSEVDRDKDGRISYDEF 471
             + E + E D D DG+++Y+EF
Sbjct: 119 EEVDEXIREADIDGDGQVNYEEF 141

>pdb|2L1W|A Chain A, The Solution Structure Of Soybean Calmodulin Isoform 4 Complexed With The Vacuolar Calcium Atpase Bca1 Peptide Length = 149

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 79/144 (54%), Gaps = 3/144 (2%)
Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E+I   KE F   D D  G +T +EL   +  L    TE +++  +   D DGNGTI
Sbjct: 4   LSEEQIVDFKEAFGLFDKDGDGCITVEELATVIRSLDQNPTEEELQDMISEVDADGNGTI 63
Query: 393 DYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATI 451
           ++ EF++   ++ K     E L +AF+ FDKD NGYI+  EL        +G+  T   +
Sbjct: 64  EFDEFLSLMAKKVKDTDAEEELKEAFKVFDKDQNGYISASELRHVM--INLGEKLTDEEV 121
Query: 452 KEIMSEVDRDKDGRISYDEFRSMM 475
           ++++ E D D DG+++Y+EF  MM
Sbjct: 122 EQMIKEADLDGDGQVNYEEFVKMM 145

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 64
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 123
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKPEN L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 124 RVLHRDLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 63
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 122
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKPEN L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 123 RVLHRDLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 125/290 (43%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 65
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E  +    +  D     G       + +F+++  +   CHS 
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 124
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 125 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 119/250 (47%), Gaps = 43/250 (17%)
Query: 83  EIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERA------- 135
           EI+++      PN++++  +   D+F++I +ELC    L D + ++    E         
Sbjct: 58  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYN 116
Query: 136 AASVFRVIMNVVNVCHSKGVMHRDLKPENFLFT----------TGDENAVVKATDFGLSA 185
             S+ R I + V   HS  ++HRDLKP+N L +          TG EN  +  +DFGL  
Sbjct: 117 PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 186 FIEEGK-AYREIVGSPY----YIAPEVLSQSYG--------KEADIWSAGVILYILLC-G 231
            ++ G+  +R  + +P     + APE+L +S          +  DI+S G + Y +L  G
Sbjct: 177 KLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 232 VPPFWAETDQGVAQAILKG-----EINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQ 286
             PF  +  +     I++G     E+    D   S+ + A +L+ +M+  DP +R T  +
Sbjct: 237 KHPFGDKYSR--ESNIIRGIFSLDEMKCLHD--RSLIAEATDLISQMIDHDPLKRPTAMK 292
Query: 287 VLEHP--WLK 294
           VL HP  W K
Sbjct: 293 VLRHPLFWPK 302

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 125/290 (43%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 66
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E  +    +  D     G       + +F+++  +   CHS 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 125
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 126 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 65
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 124
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKPEN L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 125 RVLHRDLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 125/265 (47%), Gaps = 24/265 (9%)
Query: 28  YEDVQLHYTIGREVGRGEFGIT----YLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           YE  +    +GR +G G+FG      Y+  EN   +  A K+   +    D  ++   +E
Sbjct: 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENP-AMAVAIKTC--KNCTSDSVREKFLQE 441
Query: 84  IEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV- 142
              MR     P+IV+      ++  V I+MELC  GEL   +  R    + A+  ++   
Sbjct: 442 ALTMRQFD-HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS-PY 201
           +   +    SK  +HRD+   N L ++ D    VK  DFGLS ++E+   Y+   G  P 
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 202 -YIAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEI-NFQRD 257
            ++APE ++ + +   +D+W  GV ++ IL+ GV PF     QGV    + G I N +R 
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERL 611
Query: 258 PF-PSISSSAIELVRRMLTQDPKRR 281
           P  P+   +   L+ +    DP RR
Sbjct: 612 PMPPNCPPTLYSLMTKCWAYDPSRR 636

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 13/211 (6%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + +   +G G FG         TG + A K   +    K+ E+  +  EI+IM+ L+  P
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL--EIQIMKKLN-HP 72
Query: 95  NIVQFKAAYEDDQ------FVHIVMELCAGGEL---FDRIVARGHYSERAAASVFRVIMN 145
           N+V  +   +  Q         + ME C GG+L    ++        E    ++   I +
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAP 205
            +   H   ++HRDLKPEN +   G +  + K  D G +  +++G+   E VG+  Y+AP
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 206 EVLSQ-SYGKEADIWSAGVILYILLCGVPPF 235
           E+L Q  Y    D WS G + +  + G  PF
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 13/211 (6%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + +   +G G FG         TG + A K   +    K+ E+  +  EI+IM+ L+  P
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL--EIQIMKKLN-HP 73
Query: 95  NIVQFKAAYEDDQ------FVHIVMELCAGGEL---FDRIVARGHYSERAAASVFRVIMN 145
           N+V  +   +  Q         + ME C GG+L    ++        E    ++   I +
Sbjct: 74  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 133
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAP 205
            +   H   ++HRDLKPEN +   G +  + K  D G +  +++G+   E VG+  Y+AP
Sbjct: 134 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 193
Query: 206 EVLSQ-SYGKEADIWSAGVILYILLCGVPPF 235
           E+L Q  Y    D WS G + +  + G  PF
Sbjct: 194 ELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 134/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 13  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 71
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 72  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 199 SPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++  +  Y +  DIWS G I+  LL G   F                     
Sbjct: 185 TRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 244
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 245 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 13  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 71
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 72  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL 130
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 244
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 245 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 125/290 (43%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 63
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  + + CHS 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGL-SFCHSH 122
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 123 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 11/202 (5%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           RE+G G FG  Y   +       A K +       + +  D+ +E+  ++ L   PN +Q
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ 118
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
           ++  Y  +    +VME C G       V +    E   A+V    +  +   HS  ++HR
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 178
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL----SQSYGK 214
           D+K  N L +   E  +VK  DFG ++ +     +   VG+PY++APEV+       Y  
Sbjct: 179 DVKAGNILLS---EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDG 232
Query: 215 EADIWSAGVILYILLCGVPPFW 236
           + D+WS G+    L    PP +
Sbjct: 233 KVDVWSLGITCIELAERKPPLF 254

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 13  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 71
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 72  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFL 130
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E++ +K  DFGL    + E   Y   V 
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDSELKILDFGLCRHTDDEMTGY---VA 184
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 244
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 245 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 13  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 71
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 72  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL 130
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKILDFGLARHTDDEMTGY---VA 184
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 244
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 245 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 63
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 122
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 123 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 134/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 19  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 77
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 78  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E++ +K  DFGL+   + E   Y   V 
Sbjct: 137 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDSELKILDFGLARHTDDEMTGY---VA 190
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 250
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 251 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 309
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 310 AHAYFAQYHDPDDEPV 325

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 62
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 121
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 122 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 134/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 15  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 73
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 74  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E++ +K  DFGL+   + E   Y   V 
Sbjct: 133 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDSELKILDFGLARHTDDEMTGY---VA 186
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 246
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 247 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 305
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 306 AHAYFAQYHDPDDEPV 321

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 63
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 122
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 123 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXK 179
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 67
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 68  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 126
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 127 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 183
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 243
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 244 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 67
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 68  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 126
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 127 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 183
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 243
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 244 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 125/294 (42%), Gaps = 52/294 (17%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG--QPNIV 97
           E+G G +G  Y   +  +G   A KS+      + +    VR E+ ++R L     PN+V
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLEAFEHPNVV 69
Query: 98  QFK---AAYEDDQ-------FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVV 147
           +     A    D+       F H+  +L       D+    G  +E     + R  +  +
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQDL---RTYLDKAPPPGLPAE-TIKDLMRQFLRGL 125
Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV 207
           +  H+  ++HRDLKPEN L T+G     VK  DFGL+       A   +V + +Y APEV
Sbjct: 126 DFLHANCIVHRDLKPENILVTSG---GTVKLADFGLARIYSYQMALAPVVVTLWYRAPEV 182
Query: 208 LSQS-YGKEADIWSAGVILY------ILLC---------------GVPPFWAETDQGVAQ 245
           L QS Y    D+WS G I         L C               G+PP   E D     
Sbjct: 183 LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP---EDDWPRDV 239
Query: 246 AILKGEINFQRDP------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
           ++ +G     R P       P +  S  +L+  MLT +P +RI+  + L+H +L
Sbjct: 240 SLPRGAFP-PRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 66
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 125
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 126 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 64
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 123
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 124 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 64
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 123
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 124 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 63
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 122
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 123 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 63
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 122
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 123 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 63
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 122
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 123 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 26/235 (11%)
Query: 78  DDVRREIEIMRHLSGQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAA 136
           D  R EI  +  L    + +     YE  DQ++++VME C   +L   +  +        
Sbjct: 99  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 157
Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY--- 193
            S ++ ++  V+  H  G++H DLKP NFL   G    ++K  DFG++  ++        
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVK 213
Query: 194 REIVGSPYYIAPEVLS-QSYGKE-----------ADIWSAGVILYILLCGVPPFWAETDQ 241
              VG+  Y+ PE +   S  +E           +D+WS G ILY +  G  PF    +Q
Sbjct: 214 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
Query: 242 -GVAQAILKGEINFQRDPFPSISSSAIE-LVRRMLTQDPKRRITVAQVLEHPWLK 294
                AI+      +   FP I    ++ +++  L +DPK+RI++ ++L HP+++
Sbjct: 274 ISKLHAIIDPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 70
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 129
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 130 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXK 186
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 187 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 246
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 247 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 70
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 129
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 130 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 186
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 187 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 246
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 247 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 63
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 122
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 123 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 62
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 121
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 122 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 62
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 121
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 122 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 64
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 123
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 124 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 180
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 65
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 124
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 125 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 66
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 125
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 126 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 65
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 124
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 125 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 11/202 (5%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           RE+G G FG  Y   +       A K +       + +  D+ +E+  ++ L   PN +Q
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ 79
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
           ++  Y  +    +VME C G       V +    E   A+V    +  +   HS  ++HR
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL----SQSYGK 214
           D+K  N L +   E  +VK  DFG ++ +     +   VG+PY++APEV+       Y  
Sbjct: 140 DVKAGNILLS---EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDG 193
Query: 215 EADIWSAGVILYILLCGVPPFW 236
           + D+WS G+    L    PP +
Sbjct: 194 KVDVWSLGITCIELAERKPPLF 215

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 62
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 121
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 122 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 63
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 122
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 123 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 124/265 (46%), Gaps = 24/265 (9%)
Query: 28  YEDVQLHYTIGREVGRGEFGIT----YLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           YE  +    +GR +G G+FG      Y+  EN   +  A K+   +    D  ++   +E
Sbjct: 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENP-AMAVAIKTC--KNCTSDSVREKFLQE 441
Query: 84  IEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV- 142
              MR     P+IV+      ++  V I+MELC  GEL   +  R    + A+  ++   
Sbjct: 442 ALTMRQFD-HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS-PY 201
           +   +    SK  +HRD+   N L +  D    VK  DFGLS ++E+   Y+   G  P 
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSATD---CVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 202 -YIAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEI-NFQRD 257
            ++APE ++ + +   +D+W  GV ++ IL+ GV PF     QGV    + G I N +R 
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIENGERL 611
Query: 258 PF-PSISSSAIELVRRMLTQDPKRR 281
           P  P+   +   L+ +    DP RR
Sbjct: 612 PMPPNCPPTLYSLMTKCWAYDPSRR 636

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 13  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 71
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 72  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 244
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 245 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 13  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 71
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 72  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 244
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 245 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 24  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 82
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 83  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 141
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 142 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGY---VA 195
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 196 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 255
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 256 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 314
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 315 AHAYFAQYHDPDDEPV 330

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 13  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 71
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 72  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 244
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 245 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 26/235 (11%)
Query: 78  DDVRREIEIMRHLSGQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAA 136
           D  R EI  +  L    + +     YE  DQ++++VME C   +L   +  +        
Sbjct: 99  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 157
Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY--- 193
            S ++ ++  V+  H  G++H DLKP NFL   G    ++K  DFG++  ++        
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVK 213
Query: 194 REIVGSPYYIAPEVLS-QSYGKE-----------ADIWSAGVILYILLCGVPPFWAETDQ 241
              VG+  Y+ PE +   S  +E           +D+WS G ILY +  G  PF    +Q
Sbjct: 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
Query: 242 -GVAQAILKGEINFQRDPFPSISSSAIE-LVRRMLTQDPKRRITVAQVLEHPWLK 294
                AI+      +   FP I    ++ +++  L +DPK+RI++ ++L HP+++
Sbjct: 274 ISKLHAIIDPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 13  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 71
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 72  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 244
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 245 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 125/294 (42%), Gaps = 52/294 (17%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG--QPNIV 97
           E+G G +G  Y   +  +G   A KS+      + +    VR E+ ++R L     PN+V
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLEAFEHPNVV 69
Query: 98  QFK---AAYEDDQ-------FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVV 147
           +     A    D+       F H+  +L       D+    G  +E     + R  +  +
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQDLRT---YLDKAPPPGLPAE-TIKDLMRQFLRGL 125
Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV 207
           +  H+  ++HRDLKPEN L T+G     VK  DFGL+       A   +V + +Y APEV
Sbjct: 126 DFLHANCIVHRDLKPENILVTSG---GTVKLADFGLARIYSYQMALDPVVVTLWYRAPEV 182
Query: 208 LSQS-YGKEADIWSAGVILY------ILLC---------------GVPPFWAETDQGVAQ 245
           L QS Y    D+WS G I         L C               G+PP   E D     
Sbjct: 183 LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP---EDDWPRDV 239
Query: 246 AILKGEINFQRDP------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
           ++ +G     R P       P +  S  +L+  MLT +P +RI+  + L+H +L
Sbjct: 240 SLPRGAFP-PRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 13  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 71
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 72  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 244
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 245 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 26/235 (11%)
Query: 78  DDVRREIEIMRHLSGQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAA 136
           D  R EI  +  L    + +     YE  DQ++++VME C   +L   +  +        
Sbjct: 99  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 157
Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY--- 193
            S ++ ++  V+  H  G++H DLKP NFL   G    ++K  DFG++  ++        
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVK 213
Query: 194 REIVGSPYYIAPEVLS-QSYGKE-----------ADIWSAGVILYILLCGVPPFWAETDQ 241
              VG+  Y+ PE +   S  +E           +D+WS G ILY +  G  PF    +Q
Sbjct: 214 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
Query: 242 -GVAQAILKGEINFQRDPFPSISSSAIE-LVRRMLTQDPKRRITVAQVLEHPWLK 294
                AI+      +   FP I    ++ +++  L +DPK+RI++ ++L HP+++
Sbjct: 274 ISKLHAIIDPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 20  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 78
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 79  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMTGY---VA 191
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 252 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 311 AHAYFAQYHDPDDEPV 326

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 13  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 71
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 72  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 244
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 245 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 19  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 77
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 78  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 137 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGY---VA 190
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 250
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 251 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 309
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 310 AHAYFAQYHDPDDEPV 325

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 18  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 76
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 77  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 136 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMTGY---VA 189
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 249
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 250 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 308
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 309 AHAYFAQYHDPDDEPV 324

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 18  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 76
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 77  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 136 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMTGY---VA 189
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 249
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 250 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 308
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 309 AHAYFAQYHDPDDEPV 324

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 15  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 73
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 74  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 133 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGY---VA 186
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 246
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 247 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 305
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 306 AHAYFAQYHDPDDEPV 321

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 12  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 70
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 71  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 129
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 130 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMTGY---VA 183
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 184 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 243
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 244 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 302
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 303 AHAYFAQYHDPDDEPV 318

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 24  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 82
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 83  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 141
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 142 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDXELKILDFGLARHTDDEMTGY---VA 195
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 196 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 255
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 256 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 314
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 315 AHAYFAQYHDPDDEPV 330

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 20  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 78
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 79  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+    +E   Y   V 
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTADEMTGY---VA 191
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 252 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 311 AHAYFAQYHDPDDEPV 326

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 113/270 (41%), Gaps = 25/270 (9%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+GRG +G         +G   A K I  R  V + E+  +  +++++   S  P IVQF
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRI------VARGHYSERAAASVFRVIMNVVNVCHSK 153
             A   +    I MEL +    FD+       V      E     +    +  +N  H K
Sbjct: 87  YGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALN--HLK 142
Query: 154 ---GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS- 209
               ++HRD+KP N L    D +  +K  DFG+S  + +  A     G   Y+APE +  
Sbjct: 143 ENLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP 199
Query: 210 ----QSYGKEADIWSAGVILYILLCGVPPF--WAETDQGVAQAILKGEINFQRDPFPSIS 263
               Q Y   +D+WS G+ LY L  G  P+  W      + Q +               S
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFS 259
Query: 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
            S I  V   LT+D  +R    ++L+HP++
Sbjct: 260 PSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 19  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 77
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 78  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 137 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMTGY---VA 190
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 250
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 251 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 309
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 310 AHAYFAQYHDPDDEPV 325

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 10  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 68
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 69  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 127
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 128 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMTGY---VA 181
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 182 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 241
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 242 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 300
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 301 AHAYFAQYHDPDDEPV 316

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 10  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 68
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 69  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 127
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 128 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMTGY---VA 181
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 182 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 241
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 242 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 300
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 301 AHAYFAQYHDPDDEPV 316

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 13  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 71
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 72  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 244
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 245 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 36  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 94
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 95  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 153
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 154 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMXGY---VA 207
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 208 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 267
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 268 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 326
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 327 AHAYFAQYHDPDDEPV 342

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 25  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 83
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 84  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 142
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 143 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGY---VA 196
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 256
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 257 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 315
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 316 AHAYFAQYHDPDDEPV 331

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 25  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 83
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 84  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 142
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 143 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGY---VA 196
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 256
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 257 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 315
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 316 AHAYFAQYHDPDDEPV 331

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 33  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 91
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 92  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 150
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 151 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGY---VA 204
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 264
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 265 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 323
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 324 AHAYFAQYHDPDDEPV 339

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 15  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 73
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 74  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 133 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGY---VA 186
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 246
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 247 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 305
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 306 AHAYFAQYHDPDDEPV 321

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 20  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 78
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 79  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+    +E   Y   V 
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTADEMTGY---VA 191
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 252 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 311 AHAYFAQYHDPDDEPV 326

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 125/269 (46%), Gaps = 32/269 (11%)
Query: 28  YEDVQLHYTIGREVGRGEFGIT----YLCTENSTGLEFACKSIPKRKLVKDVEKDDVR-- 81
           YE  +    +GR +G G+FG      Y+  EN   +  A K+       K+   D VR  
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENP-AMAVAIKT------CKNCTSDSVREK 57
Query: 82  --REIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
             +E   MR     P+IV+      ++  V I+MELC  GEL   +  R    + A+  +
Sbjct: 58  FLQEALTMRQFD-HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLIL 115
Query: 140 FRV-IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG 198
           +   +   +    SK  +HRD+   N L +  D    VK  DFGLS ++E+   Y+   G
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSATD---CVKLGDFGLSRYMEDSTYYKASKG 172
Query: 199 S-PY-YIAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEI-N 253
             P  ++APE ++ + +   +D+W  GV ++ IL+ GV PF     QGV    + G I N
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIEN 227
Query: 254 FQRDPF-PSISSSAIELVRRMLTQDPKRR 281
            +R P  P+   +   L+ +    DP RR
Sbjct: 228 GERLPMPPNCPPTLYSLMTKCWAYDPSRR 256

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 18  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 76
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 77  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 136 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKILDFGLARHTDDEMTGY---VA 189
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 249
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 250 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 308
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 309 AHAYFAQYHDPDDEPV 324

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 11  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 69
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 70  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 128
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 129 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGY---VA 182
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 183 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 242
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 243 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 301
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 302 AHAYFAQYHDPDDEPV 317

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 9   LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 67
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 68  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMTGY---VA 180
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 241 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 300 AHAYFAQYHDPDDEPV 315

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 125/294 (42%), Gaps = 52/294 (17%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG--QPNIV 97
           E+G G +G  Y   +  +G   A KS+      + +    VR E+ ++R L     PN+V
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLEAFEHPNVV 69
Query: 98  QFK---AAYEDDQ-------FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVV 147
           +     A    D+       F H+  +L       D+    G  +E     + R  +  +
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQDLRT---YLDKAPPPGLPAE-TIKDLMRQFLRGL 125
Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV 207
           +  H+  ++HRDLKPEN L T+G     VK  DFGL+       A   +V + +Y APEV
Sbjct: 126 DFLHANCIVHRDLKPENILVTSG---GTVKLADFGLARIYSYQMALFPVVVTLWYRAPEV 182
Query: 208 LSQS-YGKEADIWSAGVILY------ILLC---------------GVPPFWAETDQGVAQ 245
           L QS Y    D+WS G I         L C               G+PP   E D     
Sbjct: 183 LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP---EDDWPRDV 239
Query: 246 AILKGEINFQRDP------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
           ++ +G     R P       P +  S  +L+  MLT +P +RI+  + L+H +L
Sbjct: 240 SLPRGAFP-PRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 15  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 73
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 74  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 133 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGY---VA 186
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 246
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 247 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 305
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 306 AHAYFAQYHDPDDEPV 321

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 20  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 78
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 79  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+    +E   Y   V 
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTADEMTGY---VA 191
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 252 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 311 AHAYFAQYHDPDDEPV 326

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 36  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 94
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 95  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 153
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 154 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGY---VA 207
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 208 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 267
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 268 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 326
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 327 AHAYFAQYHDPDDEPV 342

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 32  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 90
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 91  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 149
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 150 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGY---VA 203
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 204 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 263
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 264 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 322
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 323 AHAYFAQYHDPDDEPV 338

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 123/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 66
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E          D     G       + +F+++  +   CHS 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 125
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 126 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 26/235 (11%)
Query: 78  DDVRREIEIMRHLSGQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAA 136
           D  R EI  +  L    + +     YE  DQ++++VME C   +L   +  +        
Sbjct: 52  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 110
Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY--- 193
            S ++ ++  V+  H  G++H DLKP NFL   G    ++K  DFG++  ++        
Sbjct: 111 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVK 166
Query: 194 REIVGSPYYIAPEVLS-QSYGKE-----------ADIWSAGVILYILLCGVPPFWAETDQ 241
              VG+  Y+ PE +   S  +E           +D+WS G ILY +  G  PF    +Q
Sbjct: 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226
Query: 242 -GVAQAILKGEINFQRDPFPSISSSAIE-LVRRMLTQDPKRRITVAQVLEHPWLK 294
                AI+      +   FP I    ++ +++  L +DPK+RI++ ++L HP+++
Sbjct: 227 ISKLHAIIDPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 26/235 (11%)
Query: 78  DDVRREIEIMRHLSGQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAA 136
           D  R EI  +  L    + +     YE  DQ++++VME C   +L   +  +        
Sbjct: 71  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 129
Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY--- 193
            S ++ ++  V+  H  G++H DLKP NFL   G    ++K  DFG++  ++        
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDXXXVVK 185
Query: 194 REIVGSPYYIAPEVLS-QSYGKE-----------ADIWSAGVILYILLCGVPPFWAETDQ 241
              VG+  Y+ PE +   S  +E           +D+WS G ILY +  G  PF    +Q
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245
Query: 242 -GVAQAILKGEINFQRDPFPSISSSAIE-LVRRMLTQDPKRRITVAQVLEHPWLK 294
                AI+      +   FP I    ++ +++  L +DPK+RI++ ++L HP+++
Sbjct: 246 ISKLHAIIDPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 26/235 (11%)
Query: 78  DDVRREIEIMRHLSGQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAA 136
           D  R EI  +  L    + +     YE  DQ++++VME C   +L   +  +        
Sbjct: 71  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 129
Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY--- 193
            S ++ ++  V+  H  G++H DLKP NFL   G    ++K  DFG++  ++        
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVK 185
Query: 194 REIVGSPYYIAPEVLS-QSYGKE-----------ADIWSAGVILYILLCGVPPFWAETDQ 241
              VG+  Y+ PE +   S  +E           +D+WS G ILY +  G  PF    +Q
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245
Query: 242 -GVAQAILKGEINFQRDPFPSISSSAIE-LVRRMLTQDPKRRITVAQVLEHPWLK 294
                AI+      +   FP I    ++ +++  L +DPK+RI++ ++L HP+++
Sbjct: 246 ISKLHAIIDPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 76/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     +G G +G      +  TGL  A K +  R     +      RE
Sbjct: 18  LNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 76
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 77  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 136 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKILDFGLARHTDDEMTGY---VA 189
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 249
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 250 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 308
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 309 AHAYFAQYHDPDDEPV 324

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/315 (23%), Positives = 132/315 (41%), Gaps = 42/315 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 13  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 71
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 72  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   ++       V +
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMT--GXVAT 185
Query: 200 PYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF---------------------- 235
            +Y APE++     Y +  DIWS G I+  LL G   F                      
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 236 -----WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
                 +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L 
Sbjct: 246 LLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 304
Query: 290 HPWLKESGEASDKPI 304
           H +  +  +  D+P+
Sbjct: 305 HAYFAQYHDPDDEPV 319

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 84/323 (26%), Positives = 134/323 (41%), Gaps = 51/323 (15%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR--REIEIM 87
           DV   Y I   +G G +G+        TG + A K IP      DV  +  R  RE++I+
Sbjct: 51  DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPN---AFDVVTNAKRTLRELKIL 107
Query: 88  RHLSGQPNIVQFK------AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFR 141
           +H     NI+  K        Y + + V++V++L    +L   I +    +         
Sbjct: 108 KHFKHD-NIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLY 165
Query: 142 VIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-----YREI 196
            ++  +   HS  V+HRDLKP N L    +EN  +K  DFG++  +    A       E 
Sbjct: 166 QLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGLCTSPAEHQYFMTEY 222
Query: 197 VGSPYYIAPEVL--SQSYGKEADIWSAGVI---------------------LYILLCGVP 233
           V + +Y APE++     Y +  D+WS G I                     L +++ G P
Sbjct: 223 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP 282
Query: 234 ------PFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQV 287
                    AE  +   Q++   +       +P     A+ L+ RML  +P  RI+ A  
Sbjct: 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA 342
Query: 288 LEHPWLKESGEASDKPIDTAVIF 310
           L HP+L +  +  D+P D A  F
Sbjct: 343 LRHPFLAKYHDPDDEP-DCAPPF 364

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K + K      +      RE
Sbjct: 25  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSK-PFQSIIHAKRTYRE 83
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 84  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 142
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 143 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGY---VA 196
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 256
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 257 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 315
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 316 AHAYFAQYHDPDDEPV 331

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 26/235 (11%)
Query: 78  DDVRREIEIMRHLSGQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAA 136
           D  R EI  +  L    + +     YE  DQ++++VME C   +L   +  +        
Sbjct: 55  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 113
Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY--- 193
            S ++ ++  V+  H  G++H DLKP NFL   G    ++K  DFG++  ++        
Sbjct: 114 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVK 169
Query: 194 REIVGSPYYIAPEVLS-QSYGKE-----------ADIWSAGVILYILLCGVPPFWAETDQ 241
              VG+  Y+ PE +   S  +E           +D+WS G ILY +  G  PF    +Q
Sbjct: 170 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 229
Query: 242 -GVAQAILKGEINFQRDPFPSISSSAIE-LVRRMLTQDPKRRITVAQVLEHPWLK 294
                AI+      +   FP I    ++ +++  L +DPK+RI++ ++L HP+++
Sbjct: 230 ISKLHAIIDPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 26/235 (11%)
Query: 78  DDVRREIEIMRHLSGQPNIVQFKAAYE-DDQFVHIVMELCAGGELFDRIVARGHYSERAA 136
           D  R EI  +  L    + +     YE  DQ++++VME C   +L   +  +        
Sbjct: 51  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 109
Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY--- 193
            S ++ ++  V+  H  G++H DLKP NFL   G    ++K  DFG++  ++        
Sbjct: 110 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVK 165
Query: 194 REIVGSPYYIAPEVLS-QSYGKE-----------ADIWSAGVILYILLCGVPPFWAETDQ 241
              VG+  Y+ PE +   S  +E           +D+WS G ILY +  G  PF    +Q
Sbjct: 166 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 225
Query: 242 -GVAQAILKGEINFQRDPFPSISSSAIE-LVRRMLTQDPKRRITVAQVLEHPWLK 294
                AI+      +   FP I    ++ +++  L +DPK+RI++ ++L HP+++
Sbjct: 226 ISKLHAIIDPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 66
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 67  IVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 125
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 126 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|3KF9|A Chain A, Crystal Structure Of The SdcenSKMLCK COMPLEX Length = 149

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/147 (36%), Positives = 84/147 (57%), Gaps = 7/147 (4%)
Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E+ Q+++E F   DTD SGT+   ELK  +  LG    + ++K+ +   D DG+GTI
Sbjct: 2   LTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGFEPKKEEIKKMIADIDKDGSGTI 61
Query: 393 DYIEFI---TATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA 449
           D+ EF+   TA M     +  E + KAF+ FD D  G I+   L +  K+  +G++ T  
Sbjct: 62  DFEEFLQMMTAKMGERDSR--EEIMKAFRLFDDDETGKISFKNLKRVAKE--LGENMTDE 117
Query: 450 TIKEIMSEVDRDKDGRISYDEFRSMMK 476
            ++E++ E DRD DG ++ +EF  +MK
Sbjct: 118 ELQEMIDEADRDGDGEVNEEEFFRIMK 144

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 119/280 (42%), Gaps = 37/280 (13%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIP--KRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           +G G+F   Y   + +T    A K I    R   KD       REI++++ LS  PNI+ 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIG 76
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNV--VNVCHSKGVM 156
              A+     + +V +        + I+         +     ++M +  +   H   ++
Sbjct: 77  LLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 134
Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQSYG 213
           HRDLKP N L    DEN V+K  DFGL+ +F    +AY   V + +Y APE+L  ++ YG
Sbjct: 135 HRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYG 191
Query: 214 KEADIWSAGVILYILLCGVPPFWAETD-----------------QGVAQAILKGEINFQR 256
              D+W+ G IL  LL  VP    ++D                 Q      L   + F+ 
Sbjct: 192 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 251
Query: 257 DP-------FPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
            P       F +     ++L++ +   +P  RIT  Q L+
Sbjct: 252 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/316 (24%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 13  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 71
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 72  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  D+GL+   + E   Y   V 
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDYGLARHTDDEMTGY---VA 184
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 244
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 245 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 84/323 (26%), Positives = 134/323 (41%), Gaps = 51/323 (15%)
Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR--REIEIM 87
           DV   Y I   +G G +G+        TG + A K IP      DV  +  R  RE++I+
Sbjct: 52  DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPN---AFDVVTNAKRTLRELKIL 108
Query: 88  RHLSGQPNIVQFK------AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFR 141
           +H     NI+  K        Y + + V++V++L    +L   I +    +         
Sbjct: 109 KHFKHD-NIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLY 166
Query: 142 VIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-----YREI 196
            ++  +   HS  V+HRDLKP N L    +EN  +K  DFG++  +    A       E 
Sbjct: 167 QLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGLCTSPAEHQYFMTEY 223
Query: 197 VGSPYYIAPEVL--SQSYGKEADIWSAGVI---------------------LYILLCGVP 233
           V + +Y APE++     Y +  D+WS G I                     L +++ G P
Sbjct: 224 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP 283
Query: 234 ------PFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQV 287
                    AE  +   Q++   +       +P     A+ L+ RML  +P  RI+ A  
Sbjct: 284 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA 343
Query: 288 LEHPWLKESGEASDKPIDTAVIF 310
           L HP+L +  +  D+P D A  F
Sbjct: 344 LRHPFLAKYHDPDDEP-DCAPPF 365

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/315 (23%), Positives = 132/315 (41%), Gaps = 42/315 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TG   A K +  R     +      RE
Sbjct: 13  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRE 71
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 72  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   ++  A    V +
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMA--GFVAT 185
Query: 200 PYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF---------------------- 235
            +Y APE++     Y +  DIWS G I+  LL G   F                      
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 236 -----WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
                 +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L 
Sbjct: 246 LLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 304
Query: 290 HPWLKESGEASDKPI 304
           H +  +  +  D+P+
Sbjct: 305 HAYFAQYHDPDDEPV 319

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 123/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG   A K     K+  D E + V     REI +++ L+  PN
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKELN-HPN 62
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E          D     G       + +F+++  +   CHS 
Sbjct: 63  IVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 121
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 122 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 125/269 (46%), Gaps = 32/269 (11%)
Query: 28  YEDVQLHYTIGREVGRGEFGIT----YLCTENSTGLEFACKSIPKRKLVKDVEKDDVR-- 81
           YE  +    +GR +G G+FG      Y+  EN   +  A K+       K+   D VR  
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENP-AMAVAIKT------CKNCTSDSVREK 57
Query: 82  --REIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
             +E   MR     P+IV+      ++  V I+MELC  GEL   +  R    + A+  +
Sbjct: 58  FLQEALTMRQFD-HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLIL 115
Query: 140 FRV-IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG 198
           +   +   +    SK  +HRD+   N L ++ D    VK  DFGLS ++E+    +   G
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTXXKASKG 172
Query: 199 S-PY-YIAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEI-N 253
             P  ++APE ++ + +   +D+W  GV ++ IL+ GV PF     QGV    + G I N
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIEN 227
Query: 254 FQRDPF-PSISSSAIELVRRMLTQDPKRR 281
            +R P  P+   +   L+ +    DP RR
Sbjct: 228 GERLPMPPNCPPTLYSLMTKCWAYDPSRR 256

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/329 (23%), Positives = 137/329 (41%), Gaps = 46/329 (13%)
Query: 11  SDHPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRK 70
           S  PA    +   + K   +V+  Y   + VG G +G      +  TG + A K +  R 
Sbjct: 3   SPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRP 61
Query: 71  LVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ----FVHIVMELCAGGELFDRIV 126
              ++      RE+ +++H+  + N++     +  D+    F    + +   G    +++
Sbjct: 62  FQSELFAKRAYRELRLLKHMRHE-NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM 120
Query: 127 ARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186
                 E     +   ++  +   H+ G++HRDLKP N      +E+  +K  DFGL+  
Sbjct: 121 KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLAR- 176
Query: 187 IEEGKAYREIVG---SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCG---------- 231
               +A  E+ G   + +Y APEV+     Y +  DIWS G I+  ++ G          
Sbjct: 177 ----QADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 232
Query: 232 -----------VPP--FWAETDQGVAQAILKGEINFQRDPFPSI----SSSAIELVRRML 274
                       PP  F        A+  +KG    ++  F SI    S  A+ L+ +ML
Sbjct: 233 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKML 292
Query: 275 TQDPKRRITVAQVLEHPWLKESGEASDKP 303
             D ++R+T  + L HP+ +   +  D+P
Sbjct: 293 VLDAEQRVTAGEALAHPYFESLHDTEDEP 321

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG     + +   K+  D E + V     REI +++ L+  PN
Sbjct: 10  KIGEGTYGVVYKARNKLTG-----EVVALXKIRLDTETEGVPSTAIREISLLKELN-HPN 63
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 122
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 123 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHLSGQPN 95
           ++G G +G+ Y      TG     + +   K+  D E + V     REI +++ L+  PN
Sbjct: 9   KIGEGTYGVVYKARNKLTG-----EVVALXKIRLDTETEGVPSTAIREISLLKELN-HPN 62
Query: 96  IVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           IV+       +  +++V E       +  D     G       + +F+++  +   CHS 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSH 121
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQ 210
            V+HRDLKP+N L  T      +K  DFGL+ AF    + Y   V + +Y APE+L   +
Sbjct: 122 RVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 211 SYGKEADIWSAGVILYILLC--GVPPFWAETDQ--------GVAQAILKGEINFQRDPFP 260
            Y    DIWS G I   ++    + P  +E DQ        G    ++   +    D  P
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 261 SISSSAIE---------------LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           S    A +               L+ +ML  DP +RI+    L HP+ ++
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/315 (23%), Positives = 132/315 (41%), Gaps = 42/315 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TG   A K +  R     +      RE
Sbjct: 9   LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRE 67
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 68  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   ++  A    V +
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMA--GFVAT 181
Query: 200 PYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF---------------------- 235
            +Y APE++     Y +  DIWS G I+  LL G   F                      
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 236 -----WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
                 +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L 
Sbjct: 242 LLKKISSESARNYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
Query: 290 HPWLKESGEASDKPI 304
           H +  +  +  D+P+
Sbjct: 301 HAYFAQYHDPDDEPV 315

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 127/299 (42%), Gaps = 49/299 (16%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+G G  G+ +  +   +GL  A K I     +K   ++ + RE++++ H    P IV F
Sbjct: 75  ELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVL-HECNSPYIVGF 131
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV-FRVIMNVVNVCHSKGVMHR 158
             A+  D  + I ME   GG L   +   G   E+    V   VI  +  +     +MHR
Sbjct: 132 YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 191
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS-YGKEAD 217
           D+KP N L  +  E   +K  DFG+S  + +  A    VG+  Y++PE L  + Y  ++D
Sbjct: 192 DVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSVQSD 247
Query: 218 IWSAGVILYILLCG---VPP---------FWAETDQGVAQ-------------------- 245
           IWS G+ L  +  G   +PP         F  + +   A+                    
Sbjct: 248 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSR 307
Query: 246 ---AILKGEINFQRDPFPSISSSAIEL-----VRRMLTQDPKRRITVAQVLEHPWLKES 296
              AI +       +P P + S+   L     V + L ++P  R  + Q++ H ++K S
Sbjct: 308 PPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 366

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/315 (23%), Positives = 132/315 (41%), Gaps = 42/315 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TG   A K +  R     +      RE
Sbjct: 13  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRE 71
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 72  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   ++  A    V +
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMA--GFVAT 185
Query: 200 PYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF---------------------- 235
            +Y APE++     Y +  DIWS G I+  LL G   F                      
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 236 -----WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
                 +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L 
Sbjct: 246 LLKKISSESARNYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 304
Query: 290 HPWLKESGEASDKPI 304
           H +  +  +  D+P+
Sbjct: 305 HAYFAQYHDPDDEPV 319

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 126/299 (42%), Gaps = 49/299 (16%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+G G  G+ +  +   +GL  A K I     +K   ++ + RE++++ H    P IV F
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL-HECNSPYIVGF 96
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV-FRVIMNVVNVCHSKGVMHR 158
             A+  D  + I ME   GG L   +   G   E+    V   VI  +  +     +MHR
Sbjct: 97  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 156
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS-YGKEAD 217
           D+KP N L  +  E   +K  DFG+S  + +  A    VG+  Y++PE L  + Y  ++D
Sbjct: 157 DVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSVQSD 212
Query: 218 IWSAGVILYILLCG---VPP---------FWAETDQGVAQ-------------------- 245
           IWS G+ L  +  G   +PP         F  + +   A+                    
Sbjct: 213 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSR 272
Query: 246 ---AILKGEINFQRDPFPSISSSAIEL-----VRRMLTQDPKRRITVAQVLEHPWLKES 296
              AI +       +P P + S    L     V + L ++P  R  + Q++ H ++K S
Sbjct: 273 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 126/299 (42%), Gaps = 49/299 (16%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+G G  G+ +  +   +GL  A K I     +K   ++ + RE++++ H    P IV F
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL-HECNSPYIVGF 69
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV-FRVIMNVVNVCHSKGVMHR 158
             A+  D  + I ME   GG L   +   G   E+    V   VI  +  +     +MHR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS-YGKEAD 217
           D+KP N L  +  E   +K  DFG+S  + +  A    VG+  Y++PE L  + Y  ++D
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 218 IWSAGVILYILLCG---VPP---------FWAETDQGVAQ-------------------- 245
           IWS G+ L  +  G   +PP         F  + +   A+                    
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSR 245
Query: 246 ---AILKGEINFQRDPFPSISSSAIEL-----VRRMLTQDPKRRITVAQVLEHPWLKES 296
              AI +       +P P + S    L     V + L ++P  R  + Q++ H ++K S
Sbjct: 246 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 126/299 (42%), Gaps = 49/299 (16%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+G G  G+ +  +   +GL  A K I     +K   ++ + RE++++ H    P IV F
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL-HECNSPYIVGF 69
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV-FRVIMNVVNVCHSKGVMHR 158
             A+  D  + I ME   GG L   +   G   E+    V   VI  +  +     +MHR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS-YGKEAD 217
           D+KP N L  +  E   +K  DFG+S  + +  A    VG+  Y++PE L  + Y  ++D
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 218 IWSAGVILYILLCG---VPP---------FWAETDQGVAQ-------------------- 245
           IWS G+ L  +  G   +PP         F  + +   A+                    
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSR 245
Query: 246 ---AILKGEINFQRDPFPSISSSAIEL-----VRRMLTQDPKRRITVAQVLEHPWLKES 296
              AI +       +P P + S    L     V + L ++P  R  + Q++ H ++K S
Sbjct: 246 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304

>pdb|3EKJ|A Chain A, Calcium-Free Gcamp2 (Calcium Binding Deficient Mutant) Length = 449

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 79/148 (53%), Gaps = 3/148 (2%)
Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
           + L  E+I + KE F+  D D  G +T  +L   +  LG   TE +++  +     DGNG
Sbjct: 303 DQLTEEQIAEFKEAFSLFDKDGDGGITTKQLGTVMRSLGQNPTEAELQDMINEVGADGNG 362
Query: 391 TIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA 449
           TID+ +F+T   ++ K     E + +AF+ F KD NGYI+  +L     +  +G+  T  
Sbjct: 363 TIDFPQFLTMMARKMKDTDSEEEIREAFRVFGKDGNGYISAAQLRHVMTN--LGEKLTDE 420
Query: 450 TIKEIMSEVDRDKDGRISYDEFRSMMKC 477
            + E++ E   D DG+++Y++F  MM  
Sbjct: 421 EVDEMIREAGIDGDGQVNYEQFVQMMTA 448

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/316 (24%), Positives = 132/316 (41%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TG   A K +  R     +      RE
Sbjct: 9   LAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRE 67
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 68  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFL 126
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMTGY---VA 180
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 241 ELLKKISSESARNYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 300 AHAYFAQYHDPDDEPV 315

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 126/299 (42%), Gaps = 49/299 (16%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+G G  G+ +  +   +GL  A K I     +K   ++ + RE++++ H    P IV F
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVL-HECNSPYIVGF 69
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV-FRVIMNVVNVCHSKGVMHR 158
             A+  D  + I ME   GG L   +   G   E+    V   VI  +  +     +MHR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS-YGKEAD 217
           D+KP N L  +  E   +K  DFG+S  + +  A    VG+  Y++PE L  + Y  ++D
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 218 IWSAGVILYILLCG---VPP---------FWAETDQGVAQ-------------------- 245
           IWS G+ L  +  G   +PP         F  + +   A+                    
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSR 245
Query: 246 ---AILKGEINFQRDPFPSISSSAIEL-----VRRMLTQDPKRRITVAQVLEHPWLKES 296
              AI +       +P P + S    L     V + L ++P  R  + Q++ H ++K S
Sbjct: 246 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/315 (24%), Positives = 128/315 (40%), Gaps = 44/315 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  +GL+ A K +  R     +      RE
Sbjct: 42  LNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKL-SRPFQSIIHAKRTYRE 100
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 101 LRLLKHMKHE-NVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 159
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+    +E   Y   V 
Sbjct: 160 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGY---VA 213
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK------- 249
           + +Y APE++     Y    DIWS G I+  LL G   F         Q I++       
Sbjct: 214 TRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPA 273
Query: 250 ---------------------GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                                 + NF  D F   +  A++L+ +ML  D  +RIT ++ L
Sbjct: 274 SVISRMPSHEARNYINSLPQMPKRNFA-DVFIGANPLAVDLLEKMLVLDTDKRITASEAL 332
Query: 289 EHPWLKESGEASDKP 303
            HP+  +  +  D+P
Sbjct: 333 AHPYFSQYHDPDDEP 347

>pdb|1GGZ|A Chain A, Crystal Structure Of The Calmodulin-Like Protein (Hclp) From Human Epithelial Cells Length = 148

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 77/143 (53%), Gaps = 3/143 (2%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            + L  E++ + KE F+  D D  G +T  EL   +  LG   TE +++  M   D DGN
Sbjct: 1   ADQLTEEQVTEFKEAFSLFDKDGDGCITTRELGTVMRSLGQNPTEAELRDMMSEIDRDGN 60
Query: 390 GTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           GT+D+ EF+    ++ K     E + +AF+ FDKD NG+++  EL        +G+  + 
Sbjct: 61  GTVDFPEFLGMMARKMKDTDNEEEIREAFRVFDKDGNGFVSAAELRHVM--TRLGEKLSD 118
Query: 449 ATIKEIMSEVDRDKDGRISYDEF 471
             + E++   D D DG+++Y+EF
Sbjct: 119 EEVDEMIRAADTDGDGQVNYEEF 141

>pdb|1GGZ|A Chain A, Crystal Structure Of The Calmodulin-Like Protein (Hclp) From Human Epithelial Cells Length = 148

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 26/61 (42%), Positives = 39/61 (63%), Gaps = 2/61 (3%)
Query: 415 KAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSM 474
           +AF  FDKD +G IT  ELG   +   +G + T A ++++MSE+DRD +G + + EF  M
Sbjct: 14  EAFSLFDKDGDGCITTRELGTVMR--SLGQNPTEAELRDMMSEIDRDGNGTVDFPEFLGM 71
Query: 475 M 475
           M
Sbjct: 72  M 72

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 126/299 (42%), Gaps = 49/299 (16%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+G G  G+ +  +   +GL  A K I     +K   ++ + RE++++ H    P IV F
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVL-HECNSPYIVGF 69
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV-FRVIMNVVNVCHSKGVMHR 158
             A+  D  + I ME   GG L   +   G   E+    V   VI  +  +     +MHR
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS-YGKEAD 217
           D+KP N L  +  E   +K  DFG+S  + +  A    VG+  Y++PE L  + Y  ++D
Sbjct: 130 DVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 218 IWSAGVILYILLCG---VPP---------FWAETDQGVAQ-------------------- 245
           IWS G+ L  +  G   +PP         F  + +   A+                    
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSR 245
Query: 246 ---AILKGEINFQRDPFPSISSSAIEL-----VRRMLTQDPKRRITVAQVLEHPWLKES 296
              AI +       +P P + S    L     V + L ++P  R  + Q++ H ++K S
Sbjct: 246 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVE--KDDVRREIEIMRHLSGQPNIV 97
           ++G G +G  +      T    A K +   +L  D E       REI +++ L  + NIV
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELKHK-NIV 64
Query: 98  QFKAAYEDDQFVHIVMELCAGG--ELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGV 155
           +       D+ + +V E C     + FD     G        S    ++  +  CHS+ V
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 156 MHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQSY 212
           +HRDLKP+N L    + N  +K  DFGL+ AF    + Y   V + +Y  P+VL  ++ Y
Sbjct: 123 LHRDLKPQNLLI---NRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 213 GKEADIWSAGVILYILLCGVPPFWAETD------------------QGVAQAILKGEINF 254
               D+WSAG I   L     P +   D                  Q  +   L     +
Sbjct: 180 STSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 255 QRDP--------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
              P         P ++++  +L++ +L  +P +RI+  + L+HP+  +
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 123/264 (46%), Gaps = 38/264 (14%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRK--LVKDVEKDDVRREIEI-MRHLS--GQPN 95
           VGRG FG+              CK+  + K   +K +E +  R+   + +R LS    PN
Sbjct: 16  VGRGAFGVV-------------CKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPN 62
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG-----HYSERAAASVFRVIMNVVNVC 150
           IV+   A  +   V +VME   GG L++  V  G     +Y+   A S        V   
Sbjct: 63  IVKLYGACLNP--VCLVMEYAEGGSLYN--VLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 151 HS---KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV 207
           HS   K ++HRDLKP N L   G    V+K  DFG +  I+      +  GS  ++APEV
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQTHMTNNK--GSAAWMAPEV 174
Query: 208 LSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
              S Y ++ D++S G+IL+ ++    PF  +   G A  I+    N  R P        
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPF--DEIGGPAFRIMWAVHNGTRPPLIKNLPKP 232
Query: 267 IE-LVRRMLTQDPKRRITVAQVLE 289
           IE L+ R  ++DP +R ++ ++++
Sbjct: 233 IESLMTRCWSKDPSQRPSMEEIVK 256

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 123/264 (46%), Gaps = 38/264 (14%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRK--LVKDVEKDDVRREIEI-MRHLS--GQPN 95
           VGRG FG+              CK+  + K   +K +E +  R+   + +R LS    PN
Sbjct: 17  VGRGAFGVV-------------CKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPN 63
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG-----HYSERAAASVFRVIMNVVNVC 150
           IV+   A  +   V +VME   GG L++  V  G     +Y+   A S        V   
Sbjct: 64  IVKLYGACLNP--VCLVMEYAEGGSLYN--VLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 151 HS---KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV 207
           HS   K ++HRDLKP N L   G    V+K  DFG +  I+      +  GS  ++APEV
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQTHMTNNK--GSAAWMAPEV 175
Query: 208 LSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
              S Y ++ D++S G+IL+ ++    PF  +   G A  I+    N  R P        
Sbjct: 176 FEGSNYSEKCDVFSWGIILWEVITRRKPF--DEIGGPAFRIMWAVHNGTRPPLIKNLPKP 233
Query: 267 IE-LVRRMLTQDPKRRITVAQVLE 289
           IE L+ R  ++DP +R ++ ++++
Sbjct: 234 IESLMTRCWSKDPSQRPSMEEIVK 257

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 115/264 (43%), Gaps = 27/264 (10%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSI--PKRKLVKDVEKDDVRREIEIMRH--LSGQPNI 96
           +G G +G  +       G  +A K    P R       KD  R+  E+  H  +   P  
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG-----PKDRARKLAEVGSHEKVGQHPCC 119
Query: 97  VQFKAAYEDDQFVHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGV 155
           V+ + A+E+   +++  ELC G  L     A G    E       R  +  +   HS+G+
Sbjct: 120 VRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGL 178
Query: 156 MHRDLKPEN-FLFTTGDENAVVKATDFGLSAFIEEGKAYREIV--GSPYYIAPEVLSQSY 212
           +H D+KP N FL   G      K  DFGL   +E G A    V  G P Y+APE+L  SY
Sbjct: 179 VHLDVKPANIFLGPRGR----CKLGDFGL--LVELGTAGAGEVQEGDPRYMAPELLQGSY 232
Query: 213 GKEADIWSAGVILYILLCGVP-PFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
           G  AD++S G+ +  + C +  P   E  Q + Q  L  E          +SS    ++ 
Sbjct: 233 GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTA------GLSSELRSVLV 286
Query: 272 RMLTQDPKRRITVAQVLEHPWLKE 295
            ML  DPK R T   +L  P L++
Sbjct: 287 MMLEPDPKLRATAEALLALPVLRQ 310

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/316 (24%), Positives = 132/316 (41%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TG   A K +  R     +      RE
Sbjct: 19  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRE 77
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 78  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 137 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMTGY---VA 190
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 250
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 251 ELLKKISSESARNYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 309
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 310 AHAYFAQYHDPDDEPV 325

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/316 (24%), Positives = 132/316 (41%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 13  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 71
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 72  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K   FGL+   + E   Y   V 
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILGFGLARHTDDEMTGY---VA 184
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 244
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 245 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/316 (24%), Positives = 132/316 (41%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TG   A K +  R     +      RE
Sbjct: 13  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRE 71
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 72  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 244
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 245 ELLKKISSESARNYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/316 (24%), Positives = 132/316 (41%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TG   A K +  R     +      RE
Sbjct: 9   LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRE 67
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 68  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTDDEMTGY---VA 180
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 241 ELLKKISSESARNYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 300 AHAYFAQYHDPDDEPV 315

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 76/316 (24%), Positives = 132/316 (41%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TG   A K +  R     +      RE
Sbjct: 32  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRE 90
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 91  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 149
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 150 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGY---VA 203
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 204 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 263
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 264 ELLKKISSESARNYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 322
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 323 AHAYFAQYHDPDDEPV 338

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 76/316 (24%), Positives = 132/316 (41%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TG   A K +  R     +      RE
Sbjct: 23  LNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRE 81
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 82  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 140
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 141 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGY---VA 194
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 195 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 254
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 255 ELLKKISSESARNYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 313
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 314 AHAYFAQYHDPDDEPV 329

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 76/316 (24%), Positives = 132/316 (41%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TG   A K +  R     +      RE
Sbjct: 33  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRE 91
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 92  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 150
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   + E   Y   V 
Sbjct: 151 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGY---VA 204
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 264
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 265 ELLKKISSESARNYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 323
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 324 AHAYFAQYHDPDDEPV 339

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 128/289 (44%), Gaps = 36/289 (12%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG--QPNIVQ 98
           +GRG FG  +   +  TG + A K +          + +V R  E+M   +G   P IV 
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV----------RLEVFRAEELMA-CAGLTSPRIVP 130
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
              A  +  +V+I MEL  GG L   +  +G   E  A       +  +   HS+ ++H 
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHG 190
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV------GSPYYIAPE-VLSQS 211
           D+K +N L ++   +A +   DFG +  ++     ++++      G+  ++APE VL +S
Sbjct: 191 DVKADNVLLSSDGSHAAL--CDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS 248
Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
              + D+WS+  ++  +L G  P W +  +G     +  E    R+  PS +    + ++
Sbjct: 249 CDAKVDVWSSCCMMLHMLNGCHP-WTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQ 307
Query: 272 RMLTQDPKRRITVAQV-------------LEHPWLKESGEASDKPIDTA 307
             L ++P  R++ A++             L+ PW  E  E    P + A
Sbjct: 308 EGLRKEPIHRVSAAELGGKVNRALQQVGGLKSPWRGEYKEPRHPPPNQA 356

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTT 169
           +IVME   G  L D +   G  + + A  V       +N  H  G++HRD+KP N L + 
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISA 151
Query: 170 GDENAVVKATDFGLS-AFIEEGKAYRE---IVGSPYYIAPE-VLSQSYGKEADIWSAGVI 224
            +    VK  DFG++ A  + G +  +   ++G+  Y++PE     S    +D++S G +
Sbjct: 152 TN---AVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 225 LYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS------ISSSAIELVRRMLTQDP 278
           LY +L G PPF  ++   VA        + + DP P       +S+    +V + L ++P
Sbjct: 209 LYEVLTGEPPFTGDSPVSVAYQ------HVREDPIPPSARHEGLSADLDAVVLKALAKNP 262
Query: 279 KRRITVAQVLEHPWLK-ESGEASDKP 303
           + R   A  +    ++  +GE  + P
Sbjct: 263 ENRYQTAAEMRADLVRVHNGEPPEAP 288

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 109/239 (45%), Gaps = 26/239 (10%)
Query: 81  RREIEIMRHLSGQPNIVQFKAAYEDD----QFVHIVMELCAGGELFDRIVARGHYSERAA 136
           RRE +    L+  P IV   A  E +       +IVME   G  L D +   G  + + A
Sbjct: 60  RREAQNAAALN-HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYRE 195
             V       +N  H  G++HRD+KP N + +  +    VK  DFG++ A  + G +  +
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQ 175
Query: 196 ---IVGSPYYIAPE-VLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE 251
              ++G+  Y++PE     S    +D++S G +LY +L G PPF  ++   VA       
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ----- 230
Query: 252 INFQRDPFPS------ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK-ESGEASDKP 303
            + + DP P       +S+    +V + L ++P+ R   A  +    ++  +GE  + P
Sbjct: 231 -HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 76/316 (24%), Positives = 132/316 (41%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 13  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 71
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 72  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  D GL+   + E   Y   V 
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDAGLARHTDDEMTGY---VA 184
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 244
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 245 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTT 169
           +IVME   G  L D +   G  + + A  V       +N  H  G++HRD+KP N + + 
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 170 GDENAVVKATDFGLS-AFIEEGKAYRE---IVGSPYYIAPE-VLSQSYGKEADIWSAGVI 224
            +    VK  DFG++ A  + G +  +   ++G+  Y++PE     S    +D++S G +
Sbjct: 152 TN---AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 225 LYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS------ISSSAIELVRRMLTQDP 278
           LY +L G PPF  ++   VA        + + DP P       +S+    +V + L ++P
Sbjct: 209 LYEVLTGEPPFTGDSPDSVAYQ------HVREDPIPPSARHEGLSADLDAVVLKALAKNP 262
Query: 279 KRRITVAQVLEHPWLK-ESGEASDKP 303
           + R   A  +    ++  +GE  + P
Sbjct: 263 ENRYQTAAEMRADLVRVHNGEPPEAP 288

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 76/316 (24%), Positives = 132/316 (41%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 13  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 71
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 72  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  D GL+   + E   Y   V 
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDRGLARHTDDEMTGY---VA 184
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 244
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 245 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 76/316 (24%), Positives = 132/316 (41%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 13  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 71
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 72  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  D GL+   + E   Y   V 
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDGGLARHTDDEMTGY---VA 184
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 244
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 245 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 74/315 (23%), Positives = 131/315 (41%), Gaps = 42/315 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TG   A K +  R     +      RE
Sbjct: 33  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRE 91
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 92  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 150
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+   ++       V +
Sbjct: 151 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDD--EMXGXVAT 205
Query: 200 PYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF---------------------- 235
            +Y APE++     Y +  DIWS G I+  LL G   F                      
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 265
Query: 236 -----WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
                 +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L 
Sbjct: 266 LLKKISSESARNYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 324
Query: 290 HPWLKESGEASDKPI 304
           H +  +  +  D+P+
Sbjct: 325 HAYFAQYHDPDDEPV 339

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 126/252 (50%), Gaps = 14/252 (5%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           R +GRG FG  + C   +TG  +ACK + K++L K         E +I+  +  +  IV 
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR-FIVS 249
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIV-----ARGHYSERAAASVFRVIMNVVNVCHSK 153
              A+E    + +VM +  GG++   I        G    RA     +++  + ++ H +
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL-HQR 308
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-YREIVGSPYYIAPE-VLSQS 211
            +++RDLKPEN L    D++  V+ +D GL+  ++ G+   +   G+P ++APE +L + 
Sbjct: 309 NIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP-SISSSAIELV 270
           Y    D ++ GV LY ++    PF A  ++ V    LK  +  Q   +P   S ++ +  
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSPASKDFC 424
Query: 271 RRMLTQDPKRRI 282
             +L +DP++R+
Sbjct: 425 EALLQKDPEKRL 436

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 126/252 (50%), Gaps = 14/252 (5%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           R +GRG FG  + C   +TG  +ACK + K++L K         E +I+  +  +  IV 
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR-FIVS 249
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIV-----ARGHYSERAAASVFRVIMNVVNVCHSK 153
              A+E    + +VM +  GG++   I        G    RA     +++  + ++ H +
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL-HQR 308
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-YREIVGSPYYIAPE-VLSQS 211
            +++RDLKPEN L    D++  V+ +D GL+  ++ G+   +   G+P ++APE +L + 
Sbjct: 309 NIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP-SISSSAIELV 270
           Y    D ++ GV LY ++    PF A  ++ V    LK  +  Q   +P   S ++ +  
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSPASKDFC 424
Query: 271 RRMLTQDPKRRI 282
             +L +DP++R+
Sbjct: 425 EALLQKDPEKRL 436

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 126/252 (50%), Gaps = 14/252 (5%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           R +GRG FG  + C   +TG  +ACK + K++L K         E +I+  +  +  IV 
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR-FIVS 249
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIV-----ARGHYSERAAASVFRVIMNVVNVCHSK 153
              A+E    + +VM +  GG++   I        G    RA     +++  + ++ H +
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL-HQR 308
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-YREIVGSPYYIAPE-VLSQS 211
            +++RDLKPEN L    D++  V+ +D GL+  ++ G+   +   G+P ++APE +L + 
Sbjct: 309 NIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP-SISSSAIELV 270
           Y    D ++ GV LY ++    PF A  ++ V    LK  +  Q   +P   S ++ +  
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSPASKDFC 424
Query: 271 RRMLTQDPKRRI 282
             +L +DP++R+
Sbjct: 425 EALLQKDPEKRL 436

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 120/267 (44%), Gaps = 23/267 (8%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+GRG +G+        +G   A K I  R  V   E+  +  +++I       P  V F
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 115
Query: 100 KAAYEDDQFVHIVMEL--CAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHSK-GV 155
             A   +  V I MEL   +  + + +++ +G    E     +   I+  +   HSK  V
Sbjct: 116 YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 175
Query: 156 MHRDLKPENFLFTTGDENAV--VKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS---- 209
           +HRD+KP N L      NA+  VK  DFG+S ++ +  A     G   Y+APE ++    
Sbjct: 176 IHRDVKPSNVLI-----NALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELN 230
Query: 210 -QSYGKEADIWSAGVILYILLCGVPPF--WAETDQGVAQAILKGEINFQRDPFPSISSSA 266
            + Y  ++DIWS G+ +  L     P+  W    Q + Q + +       D F   S+  
Sbjct: 231 QKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF---SAEF 287
Query: 267 IELVRRMLTQDPKRRITVAQVLEHPWL 293
           ++   + L ++ K R T  ++++HP+ 
Sbjct: 288 VDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 126/252 (50%), Gaps = 14/252 (5%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           R +GRG FG  + C   +TG  +ACK + K++L K         E +I+  +  +  IV 
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR-FIVS 249
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIV-----ARGHYSERAAASVFRVIMNVVNVCHSK 153
              A+E    + +VM +  GG++   I        G    RA     +++  + ++ H +
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL-HQR 308
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-YREIVGSPYYIAPE-VLSQS 211
            +++RDLKPEN L    D++  V+ +D GL+  ++ G+   +   G+P ++APE +L + 
Sbjct: 309 NIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP-SISSSAIELV 270
           Y    D ++ GV LY ++    PF A  ++ V    LK  +  Q   +P   S ++ +  
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSPASKDFC 424
Query: 271 RRMLTQDPKRRI 282
             +L +DP++R+
Sbjct: 425 EALLQKDPEKRL 436

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTT 169
           +IVME   G  L D +   G  + + A  V       +N  H  G++HRD+KP N + + 
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 170 GDENAVVKATDFGLS-AFIEEGKAYRE---IVGSPYYIAPE-VLSQSYGKEADIWSAGVI 224
            +    VK  DFG++ A  + G +  +   ++G+  Y++PE     S    +D++S G +
Sbjct: 152 TN---AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 225 LYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS------ISSSAIELVRRMLTQDP 278
           LY +L G PPF  ++   VA        + + DP P       +S+    +V + L ++P
Sbjct: 209 LYEVLTGEPPFTGDSPVSVAYQ------HVREDPIPPSARHEGLSADLDAVVLKALAKNP 262
Query: 279 KRRITVAQVLEHPWLK-ESGEASDKP 303
           + R   A  +    ++  +GE  + P
Sbjct: 263 ENRYQTAAEMRADLVRVHNGEPPEAP 288

>pdb|1YTZ|C Chain C, Crystal Structure Of Skeletal Muscle Troponin In The Ca2+- Activated State Length = 162

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 6/148 (4%)
Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E I + K  F   D D  G ++  EL   +  LG   T+ ++   ++  D DG+GTI
Sbjct: 14  LSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTI 73
Query: 393 DYIEFITATMQRHKL----QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           D+ EF+   +++ K     +  E L   F+ FDK+ +G+I ++ELG+  +    G+  T 
Sbjct: 74  DFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILR--ATGEHVTE 131
Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMMK 476
             I+++M + D++ DGRI +DEF  MM+
Sbjct: 132 EDIEDLMKDSDKNNDGRIDFDEFLKMME 159

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTT 169
           +IVME   G  L D +   G  + + A  V       +N  H  G++HRD+KP N + + 
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 170 GDENAVVKATDFGLS-AFIEEGKAYRE---IVGSPYYIAPE-VLSQSYGKEADIWSAGVI 224
            +    VK  DFG++ A  + G +  +   ++G+  Y++PE     S    +D++S G +
Sbjct: 152 TN---AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 225 LYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS------ISSSAIELVRRMLTQDP 278
           LY +L G PPF  ++   VA        + + DP P       +S+    +V + L ++P
Sbjct: 209 LYEVLTGEPPFTGDSPVSVAYQ------HVREDPIPPSARHEGLSADLDAVVLKALAKNP 262
Query: 279 KRRITVAQVLEHPWLK-ESGEASDKP 303
           + R   A  +    ++  +GE  + P
Sbjct: 263 ENRYQTAAEMRADLVRVHNGEPPEAP 288

>pdb|2W49|0 Chain 0, Isometrically Contracting Insect Asynchronous Flight Muscle Length = 159

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 6/148 (4%)
Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E I + K  F   D D  G ++  EL   +  LG   T+ ++   ++  D DG+GTI
Sbjct: 11  LSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTI 70
Query: 393 DYIEFITATMQRHKL----QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           D+ EF+   +++ K     +  E L   F+ FDK+ +G+I ++ELG+  +    G+  T 
Sbjct: 71  DFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILR--ATGEHVTE 128
Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMMK 476
             I+++M + D++ DGRI +DEF  MM+
Sbjct: 129 EDIEDLMKDSDKNNDGRIDFDEFLKMME 156

>pdb|2LHI|A Chain A, Solution Structure Of Ca2+CNA1 PEPTIDE-Bound Ycam Length = 176

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 87/164 (53%), Gaps = 8/164 (4%)
Query: 332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGT 391
           NL  E+I + KE F   D DN+G+++  EL   +  LG   +E +V   M   D+DGN  
Sbjct: 4   NLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQ 63
Query: 392 IDYIEFITATMQRHKLQRFEN-LYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIAT 450
           I++ EF+    ++ K    E  L +AF+ FDK+ +G I+  EL        +G+  T A 
Sbjct: 64  IEFSEFLALMSRQLKSNDSEQELLEAFKVFDKNGDGLISAAELKHVL--TSIGEKLTDAE 121
Query: 451 IKEIMSEVDRDKDGRISYDEFRSMM----KCGTQLRALSSRSLA 490
           + +++ EV  D  G I+  +F +++      GT+ +AL ++ LA
Sbjct: 122 VDDMLREVS-DGSGEINIQQFAALLSKGSSTGTRRKALRNKILA 164

>pdb|4TNC|A Chain A, Refined Structure Of Chicken Skeletal Muscle Troponin C In The Two-Calcium State At 2-Angstroms Resolution Length = 162

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 6/148 (4%)
Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E I + K  F   D D  G ++  EL   +  LG   T+ ++   ++  D DG+GTI
Sbjct: 14  LSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTI 73
Query: 393 DYIEFITATMQRHKL----QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           D+ EF+   +++ K     +  E L   F+ FDK+ +G+I ++ELG+  +    G+  T 
Sbjct: 74  DFEEFLVMMVRQMKEDAKGKSEEELADCFRIFDKNADGFIDIEELGEILR--ATGEHVTE 131
Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMMK 476
             I+++M + D++ DGRI +DEF  MM+
Sbjct: 132 EDIEDLMKDSDKNNDGRIDFDEFLKMME 159

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 120/267 (44%), Gaps = 23/267 (8%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+GRG +G+        +G   A K I  R  V   E+  +  +++I       P  V F
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 100 KAAYEDDQFVHIVMEL--CAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHSK-GV 155
             A   +  V I MEL   +  + + +++ +G    E     +   I+  +   HSK  V
Sbjct: 72  YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 156 MHRDLKPENFLFTTGDENAV--VKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS---- 209
           +HRD+KP N L      NA+  VK  DFG+S ++ +  A     G   Y+APE ++    
Sbjct: 132 IHRDVKPSNVLI-----NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELN 186
Query: 210 -QSYGKEADIWSAGVILYILLCGVPPF--WAETDQGVAQAILKGEINFQRDPFPSISSSA 266
            + Y  ++DIWS G+ +  L     P+  W    Q + Q + +       D F   S+  
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF---SAEF 243
Query: 267 IELVRRMLTQDPKRRITVAQVLEHPWL 293
           ++   + L ++ K R T  ++++HP+ 
Sbjct: 244 VDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|5TNC|A Chain A, Refined Crystal Structure Of Troponin C From Turkey Skeletal Muscle At 2.0 Angstroms Resolution Length = 162

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 6/148 (4%)
Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E I + K  F   D D  G ++  EL   +  LG   T+ ++   ++  D DG+GTI
Sbjct: 14  LSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTI 73
Query: 393 DYIEFITATMQRHKL----QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           D+ EF+   +++ K     +  E L   F+ FDK+ +G+I ++ELG+  +    G+  T 
Sbjct: 74  DFEEFLVMMVRQMKEDAKGKSEEELEDCFRIFDKNADGFIDIEELGEILR--ATGEHVTE 131
Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMMK 476
             I+++M + D++ DGRI +DEF  MM+
Sbjct: 132 EDIEDLMKDSDKNNDGRIDFDEFLKMME 159

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVE--KDDVRREIEIMRHLSGQPNIV 97
           ++G G +G  +      T    A K +   +L  D E       REI +++ L  + NIV
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELKHK-NIV 64
Query: 98  QFKAAYEDDQFVHIVMELCAGG--ELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGV 155
           +       D+ + +V E C     + FD     G        S    ++  +  CHS+ V
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 156 MHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQSY 212
           +HRDLKP+N L    + N  +K  +FGL+ AF    + Y   V + +Y  P+VL  ++ Y
Sbjct: 123 LHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 213 GKEADIWSAGVILYILLCGVPPFWAETD------------------QGVAQAILKGEINF 254
               D+WSAG I   L     P +   D                  Q  +   L     +
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 255 QRDP--------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
              P         P ++++  +L++ +L  +P +RI+  + L+HP+  +
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 84/325 (25%), Positives = 128/325 (39%), Gaps = 74/325 (22%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK--DDVRREIEIMRHL-S 91
           Y I   +G G FG    C ++  G           K+VK+V++  +  R EI+++ HL +
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAV-----KIVKNVDRYCEAARSEIQVLEHLNT 70
Query: 92  GQPN----IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERA--AASVFRVIMN 145
             PN     VQ    +E    + IV EL  G   +D I   G    R      +   I  
Sbjct: 71  TDPNSTFRCVQMLEWFEHHGHICIVFEL-LGLSTYDFIKENGFLPFRLDHIRKMAYQICK 129
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDE----------------NAVVKATDFGLSAFIEE 189
            VN  HS  + H DLKPEN LF   D                 N  +K  DFG + + +E
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE 189
Query: 190 GKAYREIVGSPYYIAPEV-LSQSYGKEADIWSAGVIL---YILLCGVPPFWAETDQGVAQ 245
             +   +V + +Y APEV L+  + +  D+WS G IL   Y+     P   ++    + +
Sbjct: 190 HHS--TLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247
Query: 246 AIL-----------KGEINFQRD-------------------PFPSISSSA-------IE 268
            IL           +    F  D                   P      S         +
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307
Query: 269 LVRRMLTQDPKRRITVAQVLEHPWL 293
           L+++ML  DP +RIT+ + L+HP+ 
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFF 332

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/333 (22%), Positives = 139/333 (41%), Gaps = 57/333 (17%)
Query: 16  ARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSI----PKR-- 69
           + ++H   LG  Y D+       + +G G  G+ +   +N      A K I    P+   
Sbjct: 1   SMNIHGFDLGSRYMDL-------KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK 53
Query: 70  ------KLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFD 123
                 K+++ ++ D++ +  EI+     Q  +     +  +   V+IV E         
Sbjct: 54  HALREIKIIRRLDHDNIVKVFEILGPSGSQ--LTDDVGSLTELNSVYIVQEYMETD--LA 109
Query: 124 RIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL 183
            ++ +G   E  A      ++  +   HS  V+HRDLKP N    T  E+ V+K  DFGL
Sbjct: 110 NVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGL 167
Query: 184 SAFIEEGKAYR----EIVGSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCG------ 231
           +  ++   +++    E + + +Y +P +L    +Y K  D+W+AG I   +L G      
Sbjct: 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAG 227
Query: 232 -------------VPPFWAETDQGVAQAI---LKGEINFQRDPF----PSISSSAIELVR 271
                        +P    E  Q +   I   ++ ++     P     P IS  A++ + 
Sbjct: 228 AHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLE 287
Query: 272 RMLTQDPKRRITVAQVLEHPWLKESGEASDKPI 304
           ++LT  P  R+T  + L HP++       D+PI
Sbjct: 288 QILTFSPMDRLTAEEALSHPYMSIYSFPMDEPI 320

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 39/204 (19%)
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           I+  ++ CHS G+MHRD+KP N +     E+  ++  D+GL+ F   G+ Y   V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 203 IAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG------- 250
             PE+L   Q Y    D+WS G +L  ++    PF+      DQ V  A + G       
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 251 --EINFQRDP-FPSI---------------------SSSAIELVRRMLTQDPKRRITVAQ 286
             + N + DP F  I                     S  A++ + ++L  D + R+T  +
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 287 VLEHPWLKESGEASDKPI-DTAVI 309
            +EHP+     +   +P  D AV+
Sbjct: 318 AMEHPYFYPVVKEQSQPCADNAVL 341

>pdb|1A2X|A Chain A, Complex Of Troponin C With A 47 Residue (1-47) Fragment Of Troponin I Length = 159

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 80/148 (54%), Gaps = 6/148 (4%)
Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E I + K  F   D D  G ++  EL   +  LG   T+ ++   ++  D DG+GTI
Sbjct: 11  LSEEMIAEFKAAFDMFDADGGGDISVKELGTVMRMLGQTPTKEELDAIIEEVDEDGSGTI 70
Query: 393 DYIEFITATMQRHKL----QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           D+ EF+   +++ K     +  E L + F+ FD++ +GYI  +EL + F+    G+  T 
Sbjct: 71  DFEEFLVMMVRQMKEDAKGKSEEELAECFRIFDRNADGYIDAEELAEIFR--ASGEHVTD 128
Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMMK 476
             I+ +M + D++ DGRI +DEF  MM+
Sbjct: 129 EEIESLMKDGDKNNDGRIDFDEFLKMME 156

>pdb|4DS7|A Chain A, Crystal Structure Of Yeast Calmodulin Bound To The C-Terminal Fragment Of Spindle Pole Body Protein Spc110 Length = 147

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 78/146 (53%), Gaps = 4/146 (2%)
Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
           +NL  E+I + KE F   D DNSG+++  EL   +  LG   +E +V   M   D+DGN 
Sbjct: 3   QNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEIDVDGNH 62
Query: 391 TIDYIEFITATMQRHKLQRFEN-LYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA 449
            I++ EF+    ++ K    E  L +AF+ FDK+ +G I+  EL        +G+  T A
Sbjct: 63  AIEFSEFLALMSRQLKCNDSEQELLEAFKVFDKNGDGLISAAELKHVL--TSIGEKLTDA 120
Query: 450 TIKEIMSEVDRDKDGRISYDEFRSMM 475
            + E++ EV  D  G I+  +F +++
Sbjct: 121 EVDEMLREV-SDGSGEINIKQFAALL 145

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 119/256 (46%), Gaps = 23/256 (8%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG--QPNIVQ 98
           +GRG FG  +   +  TG + A K +          + +V R  E+M   +G   P IV 
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV----------RLEVFRAEELMA-CAGLTSPRIVP 149
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
              A  +  +V+I MEL  GG L   +  +G   E  A       +  +   HS+ ++H 
Sbjct: 150 LYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHG 209
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEE---GKAYRE---IVGSPYYIAPE-VLSQS 211
           D+K +N L ++   +A +   DFG +  ++    GK+      I G+  ++APE VL +S
Sbjct: 210 DVKADNVLLSSDGSHAAL--CDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS 267
Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
              + D+WS+  ++  +L G  P W +  +G     +  E    R+  PS +    + ++
Sbjct: 268 CDAKVDVWSSCCMMLHMLNGCHP-WTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQ 326
Query: 272 RMLTQDPKRRITVAQV 287
             L ++P  R++ A++
Sbjct: 327 EGLRKEPIHRVSAAEL 342

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 89/187 (47%), Gaps = 20/187 (10%)
Query: 110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTT 169
           +IVME   G  L D +   G  + + A  V       +N  H  G++HRD+KP N + + 
Sbjct: 109 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 168
Query: 170 GDENAVVKATDFGLS-AFIEEGKAYRE---IVGSPYYIAPE-VLSQSYGKEADIWSAGVI 224
            +    VK  DFG++ A  + G +  +   ++G+  Y++PE     S    +D++S G +
Sbjct: 169 TN---AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 225
Query: 225 LYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS------ISSSAIELVRRMLTQDP 278
           LY +L G PPF  ++   VA        + + DP P       +S+    +V + L ++P
Sbjct: 226 LYEVLTGEPPFTGDSPVSVAYQ------HVREDPIPPSARHEGLSADLDAVVLKALAKNP 279
Query: 279 KRRITVA 285
           + R   A
Sbjct: 280 ENRYQTA 286

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/316 (23%), Positives = 131/316 (41%), Gaps = 44/316 (13%)
Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TG   A K +  R     +      RE
Sbjct: 13  LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRE 71
Query: 84  IEIMRHLSGQPNIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+  + N++     F  A   ++F  + +     G   + IV     ++     +
Sbjct: 72  LRLLKHMKHE-NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVG 198
              I+  +   HS  ++HRDLKP N      +E+  +K  DF L+   + E   Y   V 
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFYLARHTDDEMTGY---VA 184
Query: 199 SPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF--------------------- 235
           + +Y APE++     Y +  DIWS G I+  LL G   F                     
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 244
Query: 236 ------WAETDQGVAQAILK-GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  +E+ +   Q++ +  ++NF  + F   +  A++L+ +ML  D  +RIT AQ L
Sbjct: 245 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 303
Query: 289 EHPWLKESGEASDKPI 304
            H +  +  +  D+P+
Sbjct: 304 AHAYFAQYHDPDDEPV 319

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 85/187 (45%), Gaps = 38/187 (20%)
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           I+  ++ CHS G+MHRD+KP N L     E+  ++  D+GL+ F   G+ Y   V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVLIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 203 IAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG------- 250
             PE+L   Q Y    D+WS G +L  ++    PF+      DQ V  A + G       
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 251 --EINFQRDP-FPSI---------------------SSSAIELVRRMLTQDPKRRITVAQ 286
             + N + DP F  I                     S  A++ + ++L  D + R+T  +
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 287 VLEHPWL 293
            +EHP+ 
Sbjct: 318 AMEHPYF 324

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 118/261 (45%), Gaps = 23/261 (8%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ---PNIV 97
           +G GEFG        + G + +C +I   K +K    +  RRE      + GQ   PNI+
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAI---KTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 98  QFKAAYEDDQFVHIVMELCAGGEL--FDRIVARGHYSERAAASVFRVIMNVVNVCHSKGV 155
           + +    +   V I+ E    G L  F R+   G ++      + R I + +        
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLAEMSY 137
Query: 156 MHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPY---YIAPEVLS 209
           +HRDL   N L  +   N V K +DFGLS F+EE  +   Y   +G      + APE ++
Sbjct: 138 VHRDLAARNILVNS---NLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIA 194
Query: 210 -QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267
            + +   +D WS G++++ ++  G  P+W  ++Q V  AI   E +++  P P   +S  
Sbjct: 195 FRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAI---EQDYRLPPPPDCPTSLH 251
Query: 268 ELVRRMLTQDPKRRITVAQVL 288
           +L+     +D   R    QV+
Sbjct: 252 QLMLDCWQKDRNARPRFPQVV 272

>pdb|1TCF|A Chain A, Crystal Structure Of Calcium-Saturated Rabbit Skeletal Troponin C Length = 159

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 80/148 (54%), Gaps = 6/148 (4%)
Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E I + K  F   D D  G ++  EL   +  LG   T+ ++   ++  D DG+GTI
Sbjct: 11  LSEEMIAEFKAAFDMFDADGGGDISVKELGTVMRMLGQTPTKEELDAIIEEVDEDGSGTI 70
Query: 393 DYIEFITATMQRHKL----QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           D+ EF+   +++ K     +  E L + F+ FD++ +GYI  +EL + F+    G+  T 
Sbjct: 71  DFEEFLVMMVRQMKEDAKGKSEEELAELFRIFDRNADGYIDAEELAEIFR--ASGEHVTD 128
Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMMK 476
             I+ +M + D++ DGRI +DEF  MM+
Sbjct: 129 EEIESLMKDGDKNNDGRIDFDEFLKMME 156

>pdb|1TNW|A Chain A, Nmr Solution Structure Of Calcium Saturated Skeletal Muscle Troponin C Length = 162

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 80/148 (54%), Gaps = 6/148 (4%)
Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E I + K  F   D D  G ++  EL   +  LG   T+ ++   ++  D DG+GTI
Sbjct: 14  LSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTI 73
Query: 393 DYIEFITATMQRHKL----QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           D+ EF+   +++ K     +  E L   F+ FDK+ +G+I ++ELG+  +    G+    
Sbjct: 74  DFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILR--ATGEHVIE 131
Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMMK 476
             I+++M + D++ DGRI +DEF  MM+
Sbjct: 132 EDIEDLMKDSDKNNDGRIDFDEFLKMME 159

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 124/302 (41%), Gaps = 60/302 (19%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           ++G G +   Y     +TG+  A K +   KL  ++       REI +M+ L  + NIV+
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIREISLMKELKHE-NIVR 67
Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVN---------- 148
               Y+    +H   +L    E  D  + +   S     +   + +N+V           
Sbjct: 68  L---YD---VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 149 -VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPE 206
             CH   ++HRDLKP+N L    ++   +K  DFGL+ AF      +   V + +Y AP+
Sbjct: 122 AFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 207 VL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL---------------- 248
           VL  S++Y    DIWS G IL  ++ G P F    D+   + I                 
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238
Query: 249 --KGEINFQRDPFP-------------SISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
             K   N Q+ P P              +  + ++ +  +L  +P  R++  Q L HPW 
Sbjct: 239 LPKYNPNIQQRP-PRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297
Query: 294 KE 295
            E
Sbjct: 298 AE 299

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 38/187 (20%)
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           I+  ++ CHS G+MHRD+KP N +     E+  ++  D+GL+ F   G+ Y   V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 203 IAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG------- 250
             PE+L   Q Y    D+WS G +L  ++    PF+      DQ V  A + G       
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 251 --EINFQRDP-FPSI---------------------SSSAIELVRRMLTQDPKRRITVAQ 286
             + N + DP F  I                     S  A++ + ++L  D + R+T  +
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 287 VLEHPWL 293
            +EHP+ 
Sbjct: 318 AMEHPYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 38/187 (20%)
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           I+  ++ CHS G+MHRD+KP N +     E+  ++  D+GL+ F   G+ Y   V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 203 IAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG------- 250
             PE+L   Q Y    D+WS G +L  ++    PF+      DQ V  A + G       
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 251 --EINFQRDP-FPSI---------------------SSSAIELVRRMLTQDPKRRITVAQ 286
             + N + DP F  I                     S  A++ + ++L  D + R+T  +
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 287 VLEHPWL 293
            +EHP+ 
Sbjct: 318 AMEHPYF 324

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 38/187 (20%)
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           I+  ++ CHS G+MHRD+KP N +     E+  ++  D+GL+ F   G+ Y   V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 203 IAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG------- 250
             PE+L   Q Y    D+WS G +L  ++    PF+      DQ V  A + G       
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 251 --EINFQRDP-FPSI---------------------SSSAIELVRRMLTQDPKRRITVAQ 286
             + N + DP F  I                     S  A++ + ++L  D + R+T  +
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 287 VLEHPWL 293
            +EHP+ 
Sbjct: 318 AMEHPYF 324

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 38/187 (20%)
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           I+  ++ CHS G+MHRD+KP N +     E+  ++  D+GL+ F   G+ Y   V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 203 IAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG------- 250
             PE+L   Q Y    D+WS G +L  ++    PF+      DQ V  A + G       
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 251 --EINFQRDP-FPSI---------------------SSSAIELVRRMLTQDPKRRITVAQ 286
             + N + DP F  I                     S  A++ + ++L  D + R+T  +
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 287 VLEHPWL 293
            +EHP+ 
Sbjct: 318 AMEHPYF 324

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 38/187 (20%)
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           I+  ++ CHS G+MHRD+KP N +     E+  ++  D+GL+ F   G+ Y   V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 203 IAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG------- 250
             PE+L   Q Y    D+WS G +L  ++    PF+      DQ V  A + G       
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 251 --EINFQRDP-FPSI---------------------SSSAIELVRRMLTQDPKRRITVAQ 286
             + N + DP F  I                     S  A++ + ++L  D + R+T  +
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 287 VLEHPWL 293
            +EHP+ 
Sbjct: 318 AMEHPYF 324

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 38/187 (20%)
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           I+  ++ CHS G+MHRD+KP N +     E+  ++  D+GL+ F   G+ Y   V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 203 IAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG------- 250
             PE+L   Q Y    D+WS G +L  ++    PF+      DQ V  A + G       
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 251 --EINFQRDP-FPSI---------------------SSSAIELVRRMLTQDPKRRITVAQ 286
             + N + DP F  I                     S  A++ + ++L  D + R+T  +
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 287 VLEHPWL 293
            +EHP+ 
Sbjct: 318 AMEHPYF 324

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 77/312 (24%), Positives = 132/312 (42%), Gaps = 54/312 (17%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP---- 94
           + +G G  GI     +   G+  A K +  R            RE+ +++ ++ +     
Sbjct: 28  KPIGSGAQGIVCAAFDTVLGINVAVKKL-SRPFQNQTHAKRAYRELVLLKCVNHKNIISL 86
Query: 95  -NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            N+   +   E+ Q V++VMEL        +++      ER +  +++++  + ++ HS 
Sbjct: 87  LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGIKHL-HSA 143
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY 212
           G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L   Y
Sbjct: 144 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMGY 200
Query: 213 GKEADIWSAGVILYILLCGVPPF--------WAE------TDQGVAQAILKGEI-NF--Q 255
            +  DIWS G I+  L+ G   F        W +      T      A L+  + N+   
Sbjct: 201 KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVEN 260
Query: 256 RDPFPSI---------------------SSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
           R  +P I                     +S A +L+ +ML  DP +RI+V + L HP++ 
Sbjct: 261 RPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 320
Query: 295 ---ESGEASDKP 303
              +  EA   P
Sbjct: 321 VWYDPAEAEAPP 332

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 38/187 (20%)
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           I+  ++ CHS G+MHRD+KP N +     E+  ++  D+GL+ F   G+ Y   V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 203 IAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG------- 250
             PE+L   Q Y    D+WS G +L  ++    PF+      DQ V  A + G       
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 251 --EINFQRDP-FPSI---------------------SSSAIELVRRMLTQDPKRRITVAQ 286
             + N + DP F  I                     S  A++ + ++L  D + R+T  +
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 287 VLEHPWL 293
            +EHP+ 
Sbjct: 318 AMEHPYF 324

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 84/325 (25%), Positives = 127/325 (39%), Gaps = 74/325 (22%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK--DDVRREIEIMRHL-S 91
           Y I   +G G FG    C ++  G           K+VK+V++  +  R EI+++ HL +
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAV-----KIVKNVDRYCEAARSEIQVLEHLNT 70
Query: 92  GQPN----IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERA--AASVFRVIMN 145
             PN     VQ    +E    + IV EL  G   +D I   G    R      +   I  
Sbjct: 71  TDPNSTFRCVQMLEWFEHHGHICIVFEL-LGLSTYDFIKENGFLPFRLDHIRKMAYQICK 129
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDE----------------NAVVKATDFGLSAFIEE 189
            VN  HS  + H DLKPEN LF   D                 N  +K  DFG + + +E
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE 189
Query: 190 GKAYREIVGSPYYIAPEV-LSQSYGKEADIWSAGVIL---YILLCGVPPFWAETDQGVAQ 245
             +   +V   +Y APEV L+  + +  D+WS G IL   Y+     P   ++    + +
Sbjct: 190 HHS--TLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247
Query: 246 AIL-----------KGEINFQRD-------------------PFPSISSSA-------IE 268
            IL           +    F  D                   P      S         +
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307
Query: 269 LVRRMLTQDPKRRITVAQVLEHPWL 293
           L+++ML  DP +RIT+ + L+HP+ 
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFF 332

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 38/187 (20%)
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           I+  ++ CHS G+MHRD+KP N +     E+  ++  D+GL+ F   G+ Y   V S Y+
Sbjct: 139 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 196
Query: 203 IAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG------- 250
             PE+L   Q Y    D+WS G +L  ++    PF+      DQ V  A + G       
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256
Query: 251 --EINFQRDP-FPSI---------------------SSSAIELVRRMLTQDPKRRITVAQ 286
             + N + DP F  I                     S  A++ + ++L  D + R+T  +
Sbjct: 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316
Query: 287 VLEHPWL 293
            +EHP+ 
Sbjct: 317 AMEHPYF 323

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 38/187 (20%)
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           I+  ++ CHS G+MHRD+KP N +     E+  ++  D+GL+ F   G+ Y   V S Y+
Sbjct: 140 ILKALDYCHSMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 197
Query: 203 IAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG------- 250
             PE+L   Q Y    D+WS G +L  ++    PF+      DQ V  A + G       
Sbjct: 198 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 257
Query: 251 --EINFQRDP-FPSI---------------------SSSAIELVRRMLTQDPKRRITVAQ 286
             + N + DP F  I                     S  A++ + ++L  D + R+T  +
Sbjct: 258 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 317
Query: 287 VLEHPWL 293
            +EHP+ 
Sbjct: 318 AMEHPYF 324

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 118/272 (43%), Gaps = 32/272 (11%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+G G  G  +      TG   A K +  R+     E   +  +++++      P IVQ 
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSK-GVM 156
              +  +  V I MEL   G   +++  R  G   ER    +   I+  +     K GV+
Sbjct: 90  FGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVI 147
Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS----- 211
           HRD+KP N L    DE   +K  DFG+S  + + KA     G   Y+APE +        
Sbjct: 148 HRDVKPSNILL---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKP 204
Query: 212 -YGKEADIWSAGVILYILLCGVPPFW-AETDQGVAQAILK-------GEINFQRDPFPSI 262
            Y   AD+WS G+ L  L  G  P+   +TD  V   +L+       G + F  D F S 
Sbjct: 205 DYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGD-FQS- 262
Query: 263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
                  V+  LT+D ++R    ++LEH ++K
Sbjct: 263 ------FVKDCLTKDHRKRPKYNKLLEHSFIK 288

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 38/187 (20%)
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           I+  ++ CHS G+MHRD+KP N +     E+  ++  D+GL+ F   G+ Y   V S Y+
Sbjct: 139 ILKALDYCHSMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 196
Query: 203 IAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG------- 250
             PE+L   Q Y    D+WS G +L  ++    PF+      DQ V  A + G       
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256
Query: 251 --EINFQRDP-FPSI---------------------SSSAIELVRRMLTQDPKRRITVAQ 286
             + N + DP F  I                     S  A++ + ++L  D + R+T  +
Sbjct: 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316
Query: 287 VLEHPWL 293
            +EHP+ 
Sbjct: 317 AMEHPYF 323

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 136/305 (44%), Gaps = 49/305 (16%)
Query: 35  YTIGREVGRGEFGITYLCTENST--GLEFACKSIPKRKLVKDVEK------------DDV 80
           Y I R + +G+F    LC +++    L+   KS+ ++K  +D  K            DD 
Sbjct: 33  YRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKK--RDFTKSNNDKISIKSKYDDF 90
Query: 81  RREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDR--IVARGHYSE--- 133
           + E++I+  +  +  +         D+ V+I+ E      +  FD    V   +Y+    
Sbjct: 91  KNELQIITDIKNEYCLTCEGIITNYDE-VYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 134 -RAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191
            +    + + ++N  +  H+ K + HRD+KP N L    D+N  VK +DFG S ++ + K
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYMVDKK 206
Query: 192 AYREIVGSPYYIAPEVLSQ--SY-GKEADIWSAGVILYILLCGVPPF-----WAETDQGV 243
             +   G+  ++ PE  S   SY G + DIWS G+ LY++   V PF       E    +
Sbjct: 207 I-KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265
Query: 244 AQAILKGEINFQRDPFP-----------SISSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
               ++  ++     +P            +S+  I+ ++  L ++P  RIT    L+H W
Sbjct: 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325
Query: 293 LKESG 297
           L ++ 
Sbjct: 326 LADTN 330

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 38/187 (20%)
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           I+  ++ CHS G+MHRD+KP N +     E+  ++  D+GL+ F   G+ Y   V S Y+
Sbjct: 138 ILKALDYCHSMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 195
Query: 203 IAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG------- 250
             PE+L   Q Y    D+WS G +L  ++    PF+      DQ V  A + G       
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255
Query: 251 --EINFQRDP-FPSI---------------------SSSAIELVRRMLTQDPKRRITVAQ 286
             + N + DP F  I                     S  A++ + ++L  D + R+T  +
Sbjct: 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315
Query: 287 VLEHPWL 293
            +EHP+ 
Sbjct: 316 AMEHPYF 322

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 38/187 (20%)
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           I+  ++ CHS G+MHRD+KP N +     E+  ++  D+GL+ F   G+ Y   V S Y+
Sbjct: 145 ILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 202
Query: 203 IAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG------- 250
             PE+L   Q Y    D+WS G +L  ++    PF+      DQ V  A + G       
Sbjct: 203 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 262
Query: 251 --EINFQRDP-FPSI---------------------SSSAIELVRRMLTQDPKRRITVAQ 286
             + N + DP F  I                     S  A++ + ++L  D + R+T  +
Sbjct: 263 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 322
Query: 287 VLEHPWL 293
            +EHP+ 
Sbjct: 323 AMEHPYF 329

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/312 (24%), Positives = 131/312 (41%), Gaps = 54/312 (17%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP---- 94
           + +G G  GI     +   G+  A K +  R            RE+ +++ ++ +     
Sbjct: 30  KPIGSGAQGIVCAAFDTVLGINVAVKKL-SRPFQNQTHAKRAYRELVLLKCVNHKNIISL 88
Query: 95  -NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            N+   +   E+ Q V++VMEL        +++      ER +  +++++  + ++ HS 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGIKHL-HSA 145
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY 212
           G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L   Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGY 202
Query: 213 GKEADIWSAGVILYILLCGVPPF--------WAE------TDQGVAQAILKGEI-NF--Q 255
               DIWS G I+  L+ G   F        W +      T      A L+  + N+   
Sbjct: 203 AANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVEN 262
Query: 256 RDPFPSI---------------------SSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
           R  +P I                     +S A +L+ +ML  DP +RI+V + L HP++ 
Sbjct: 263 RPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 322
Query: 295 ---ESGEASDKP 303
              +  EA   P
Sbjct: 323 VWYDPAEAEAPP 334

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 125/282 (44%), Gaps = 25/282 (8%)
Query: 19  LHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD 78
           LH A+    +        +G ++GRG FG  +     +     A KS  +  L  D+ K 
Sbjct: 100 LHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDL-KA 157
Query: 79  DVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAAS 138
              +E  I++  S  PNIV+        Q ++IVMEL  GG+    +   G  +     +
Sbjct: 158 KFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--ARLRVKT 214
Query: 139 VFRVIMNV---VNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE 195
           + +++ +    +    SK  +HRDL   N L T   E  V+K +DFG+S   EE      
Sbjct: 215 LLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSR--EEADGVXA 269
Query: 196 IVGS----PY-YIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAIL 248
             G     P  + APE L+   Y  E+D+WS G++L+     G  P+   ++Q   + + 
Sbjct: 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329
Query: 249 KGEINFQRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQVLE 289
           KG     R P P +   A+  L+ +    +P +R + + + +
Sbjct: 330 KG----GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/314 (25%), Positives = 134/314 (42%), Gaps = 58/314 (18%)
Query: 39  REVGRGEFGITYLCTENSTGLE--FACKSIPKRKLVKDVEKDDVRREIEIMR-----HLS 91
           + +G G  GI  +C      LE   A K +  R            RE+ +M+     ++ 
Sbjct: 30  KPIGSGAQGI--VCAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMKVVNHKNII 86
Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
           G  N+   + + E+ Q V+IVMEL        +++      ER +  ++++++ + ++ H
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLVGIKHL-H 143
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQ 210
           S G++HRDLKP N +  +   +A +K  DFGL+            V + YY APEV L  
Sbjct: 144 SAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 211 SYGKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAIL 248
            Y +  DIWS GVI+                      I   G P P + +  Q   +  +
Sbjct: 201 GYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 249 KGEINFQ----RDPFPSI------------SSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
           +    +        FP +            +S A +L+ +ML  D  +RI+V + L+HP+
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 293 LK---ESGEASDKP 303
           +    +  EA   P
Sbjct: 321 INVWYDPSEAEAPP 334

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 39/204 (19%)
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           ++  ++ CHSKG+MHRD+KP N +     +   ++  D+GL+ F    + Y   V S Y+
Sbjct: 141 LLKALDYCHSKGIMHRDVKPHNVMI--DHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYF 198
Query: 203 IAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG------- 250
             PE+L   Q Y    D+WS G +L  ++    PF+      DQ V  A + G       
Sbjct: 199 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGY 258
Query: 251 --EINFQRDPFPS----------------------ISSSAIELVRRMLTQDPKRRITVAQ 286
             + +   DP  +                      +S  A++L+ ++L  D ++R+T  +
Sbjct: 259 LKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKE 318
Query: 287 VLEHPWLKESGEASDKP-IDTAVI 309
            +EHP+     +   +P  D AV+
Sbjct: 319 AMEHPYFYPVVKEQSQPSADNAVL 342

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/312 (24%), Positives = 131/312 (41%), Gaps = 54/312 (17%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR-----HLSGQ 93
           + +G G  GI     +       A K +  R            RE+ +M+     ++ G 
Sbjct: 30  KPIGSGAQGIVVAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            N+   + + E+ Q V+IVMEL        +++      ER +  ++++++ + ++ HS 
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLVGIKHL-HSA 145
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY 212
           G++HRDLKP N +  +   +A +K  DFGL+            V + YY APEV L   Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 213 GKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAILKG 250
            +  DIWS GVI+                      I   G P P + +  Q   +  ++ 
Sbjct: 203 KENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 251 EINFQ----RDPFPSI------------SSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
              +        FP +            +S A +L+ +ML  D  +RI+V + L+HP++ 
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322
Query: 295 ---ESGEASDKP 303
              +  EA   P
Sbjct: 323 VWYDPSEAEAPP 334

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 118/263 (44%), Gaps = 14/263 (5%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+GRG F   Y   +  T +E A   +  RKL K  E+   + E E ++ L   PNIV+F
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEXLKGLQ-HPNIVRF 90
Query: 100 KAAYED----DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG- 154
             ++E      + + +V EL   G L   +        +   S  R I+  +   H++  
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 155 -VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYG 213
            ++HRDLK +N +F TG   +V K  D GL A ++     + ++G+P + APE   + Y 
Sbjct: 151 PIIHRDLKCDN-IFITGPTGSV-KIGDLGL-ATLKRASFAKAVIGTPEFXAPEXYEEKYD 207
Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI-ELVRR 272
           +  D+++ G           P+     Q  AQ   +     +   F  ++   + E++  
Sbjct: 208 ESVDVYAFGXCXLEXATSEYPY--SECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 265
Query: 273 MLTQDPKRRITVAQVLEHPWLKE 295
            + Q+   R ++  +L H + +E
Sbjct: 266 CIRQNKDERYSIKDLLNHAFFQE 288

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G     +      TG  FA K       ++ V  D   RE E+++ L+ + NIV+  
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVLKKLNHK-NIVKLF 73
Query: 101 AAYEDDQFVH--IVMELCAGGELFDRIVARGH---YSERAAASVFRVIMNVVNVCHSKGV 155
           A  E+    H  ++ME C  G L+  +    +     E     V R ++  +N     G+
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI 133
Query: 156 MHRDLKPENFLFTTG-DENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS--- 211
           +HR++KP N +   G D  +V K TDFG +  +E+ + +  + G+  Y+ P++  ++   
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLR 193
Query: 212 ------YGKEADIWSAGVILYILLCGVPPF 235
                 YG   D+WS GV  Y    G  PF
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 125/282 (44%), Gaps = 25/282 (8%)
Query: 19  LHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD 78
           LH A+    +        +G ++GRG FG  +     +     A KS  +  L  D+ K 
Sbjct: 100 LHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDL-KA 157
Query: 79  DVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAAS 138
              +E  I++  S  PNIV+        Q ++IVMEL  GG+    +   G  +     +
Sbjct: 158 KFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--ARLRVKT 214
Query: 139 VFRVIMNV---VNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE 195
           + +++ +    +    SK  +HRDL   N L T   E  V+K +DFG+S   EE      
Sbjct: 215 LLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSR--EEADGVYA 269
Query: 196 IVGS----PY-YIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAIL 248
             G     P  + APE L+   Y  E+D+WS G++L+     G  P+   ++Q   + + 
Sbjct: 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329
Query: 249 KGEINFQRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQVLE 289
           KG     R P P +   A+  L+ +    +P +R + + + +
Sbjct: 330 KG----GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G     +      TG  FA K       ++ V  D   RE E+++ L+   NIV+  
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVLKKLN-HKNIVKLF 73
Query: 101 AAYEDDQFVH--IVMELCAGGELFDRIVARGH---YSERAAASVFRVIMNVVNVCHSKGV 155
           A  E+    H  ++ME C  G L+  +    +     E     V R ++  +N     G+
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI 133
Query: 156 MHRDLKPENFLFTTG-DENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS--- 211
           +HR++KP N +   G D  +V K TDFG +  +E+ + +  + G+  Y+ P++  ++   
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYERAVLR 193
Query: 212 ------YGKEADIWSAGVILYILLCGVPPF 235
                 YG   D+WS GV  Y    G  PF
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 119/269 (44%), Gaps = 25/269 (9%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSI---PKRKLVKDVEKDDVRREIEIMRHLSG 92
           T+   +G G FG  Y       G E A K+    P   + + +E  +VR+E ++   L  
Sbjct: 10  TLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIE--NVRQEAKLFAMLK- 64
Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
            PNI+  +     +  + +VME   GG L +R+++          +    I   +N  H 
Sbjct: 65  HPNIIALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHD 123
Query: 153 KGV---MHRDLKPENFLFT----TGD-ENAVVKATDFGLSAFIEEGKAYREIVGSPY-YI 203
           + +   +HRDLK  N L       GD  N ++K TDFGL+   E  +  +      Y ++
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSAAGAYAWM 181
Query: 204 APEVLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
           APEV+  S + K +D+WS GV+L+ LL G  PF       VA  +   ++     P PS 
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL---PIPST 238
Query: 263 SSSAI-ELVRRMLTQDPKRRITVAQVLEH 290
                 +L+      DP  R +   +L+ 
Sbjct: 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 13/218 (5%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+G G  G+        +GL  A K I     +K   ++ + RE++++ H    P IV F
Sbjct: 23  ELGAGNGGVVTKVQHRPSGLIMARKLI--HLEIKPAIRNQIIRELQVL-HECNSPYIVGF 79
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV-FRVIMNVVNVCHSKGVMHR 158
             A+  D  + I ME   GG L   +       E     V   V+  +  +     +MHR
Sbjct: 80  YGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHR 139
Query: 159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS-YGKEAD 217
           D+KP N L  +  E   +K  DFG+S  + +  A    VG+  Y+APE L  + Y  ++D
Sbjct: 140 DVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRSYMAPERLQGTHYSVQSD 195
Query: 218 IWSAGVILYILLCG----VPPFWAETDQGVAQAILKGE 251
           IWS G+ L  L  G     PP   E +    + ++ GE
Sbjct: 196 IWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGE 233

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 117/261 (44%), Gaps = 23/261 (8%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ---PNIV 97
           +G GEFG        + G + +C +I   K +K    +  RRE      + GQ   PNI+
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAI---KTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 98  QFKAAYEDDQFVHIVMELCAGGEL--FDRIVARGHYSERAAASVFRVIMNVVNVCHSKGV 155
           + +    +   V I+ E    G L  F R+   G ++      + R I + +        
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLAEMSY 139
Query: 156 MHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS-----PY-YIAPEVLS 209
           +HRDL   N L  +   N V K +DFGLS F+EE  +      S     P  + APE ++
Sbjct: 140 VHRDLAARNILVNS---NLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIA 196
Query: 210 -QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267
            + +   +D WS G++++ ++  G  P+W  ++Q V  AI   E +++  P P   +S  
Sbjct: 197 FRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAI---EQDYRLPPPPDCPTSLH 253
Query: 268 ELVRRMLTQDPKRRITVAQVL 288
           +L+     +D   R    QV+
Sbjct: 254 QLMLDCWQKDRNARPRFPQVV 274

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 84/194 (43%), Gaps = 32/194 (16%)
Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL 208
           CH + V+HRDLKP+N L    +E   +K  DFGL+ A     K Y   V + +Y  P++L
Sbjct: 116 CHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDIL 172
Query: 209 --SQSYGKEADIWSAGVILYILLCGVPPFWAET---------------DQGVAQAILKGE 251
             S  Y  + D+W  G I Y +  G P F   T                +     IL  E
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232
Query: 252 ----INFQR-------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS 300
                N+ +          P + S   +L+ ++L  + + RI+    ++HP+    GE  
Sbjct: 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI 292
Query: 301 DKPIDTAVIFRMKQ 314
            K  DT  IF +K+
Sbjct: 293 HKLPDTTSIFALKE 306

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 132/298 (44%), Gaps = 36/298 (12%)
Query: 10  DSDHPAARHLH--DAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIP 67
           D D P   +L+   A+ G   +       I  ++G G FG  +    +  G + A K + 
Sbjct: 12  DYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKIL- 68
Query: 68  KRKLVKDVEKDDVR---REIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDR 124
              + +D   + V    RE+ IM+ L   PNIV F  A      + IV E  + G L+ R
Sbjct: 69  ---MEQDFHAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-R 123
Query: 125 IV----ARGHYSERAAASVFRVIMNVVNVCHSKG--VMHRDLKPENFLFTTGDENAVVKA 178
           ++    AR    ER   S+   +   +N  H++   ++HR+LK  N L    D+   VK 
Sbjct: 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKV 180
Query: 179 TDFGLS-----AFIEEGKAYREIVGSPYYIAPEVLSQSYGKE-ADIWSAGVILYILLCGV 232
            DFGLS      F+    A     G+P ++APEVL      E +D++S GVIL+ L    
Sbjct: 181 CDFGLSRLKASTFLSSKSA----AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
Query: 233 PPFWAETDQGVAQAILKGEINFQRDPFP-SISSSAIELVRRMLTQDPKRRITVAQVLE 289
            P W   +   AQ +       +R   P +++     ++    T +P +R + A +++
Sbjct: 237 QP-WGNLNP--AQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/139 (33%), Positives = 70/139 (50%), Gaps = 20/139 (14%)
Query: 108 FVHIVMELCAGGELFDRIVARGHYSER---AAASVFRVIMNVVNVCHSKGVMHRDLKPEN 164
           +++I M+LC    L D +  R    +R       +F  I   V   HSKG+MHRDLKP N
Sbjct: 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSN 194
Query: 165 FLFTTGDENAVVKATDFGLSAFIEEGKAYREI-------------VGSPYYIAPE-VLSQ 210
             FT  D   VVK  DFGL   +++ +  + +             VG+  Y++PE +   
Sbjct: 195 IFFTMDD---VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGN 251
Query: 211 SYGKEADIWSAGVILYILL 229
           +Y  + DI+S G+IL+ LL
Sbjct: 252 NYSHKVDIFSLGLILFELL 270

>pdb|2OBH|A Chain A, Centrin-Xpc Peptide Length = 143

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 79/142 (55%), Gaps = 3/142 (2%)
Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYI 395
           E+ Q+++E F   D D +GT+   ELK  +  LG    + ++K+ +   D +G G +++ 
Sbjct: 3   EQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFG 62
Query: 396 EFITATMQR-HKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI 454
           +F+T   Q+  +    E + KAF+ FD D  G I+   L +  K+  +G++ T   ++E+
Sbjct: 63  DFLTVMTQKMSEKDTKEEILKAFKLFDDDETGKISFKNLKRVAKE--LGENLTDEELQEM 120
Query: 455 MSEVDRDKDGRISYDEFRSMMK 476
           + E DRD DG +S  EF  +MK
Sbjct: 121 IDEADRDGDGEVSEQEFLRIMK 142

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 85/187 (45%), Gaps = 38/187 (20%)
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           ++  ++ CHSKG+MHRD+KP N +     +   ++  D+GL+ F    + Y   V S Y+
Sbjct: 146 LLKALDYCHSKGIMHRDVKPHNVMIDH--QQKKLRLIDWGLAEFYHPAQEYNVRVASRYF 203
Query: 203 IAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG------- 250
             PE+L   Q Y    D+WS G +L  ++    PF+      DQ V  A + G       
Sbjct: 204 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGY 263
Query: 251 --EINFQRDPFPS----------------------ISSSAIELVRRMLTQDPKRRITVAQ 286
             + +   DP  +                      +S  A++L+ ++L  D ++R+T  +
Sbjct: 264 LKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKE 323
Query: 287 VLEHPWL 293
            +EHP+ 
Sbjct: 324 AMEHPYF 330

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSER-AAASVFRVIMNVVNVCHSK 153
           N V+   A +    + I ME C  G L+D I +     +R     +FR I+  ++  HS+
Sbjct: 76  NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ 135
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI---------------VG 198
           G++HRDLKP N      DE+  VK  DFGL+  +       ++               +G
Sbjct: 136 GIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIG 192
Query: 199 SPYYIAPEVLSQS--YGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEINFQ 255
           +  Y+A EVL  +  Y ++ D++S G+I + ++    PF    ++  + + +    I F 
Sbjct: 193 TAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFP 249
Query: 256 RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
            D   +      +++R ++  DP +R     +L   WL
Sbjct: 250 PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 133/314 (42%), Gaps = 58/314 (18%)
Query: 39  REVGRGEFGITYLCTENSTGLE--FACKSIPKRKLVKDVEKDDVRREIEIMR-----HLS 91
           + +G G  GI  +C      LE   A K +  R            RE+ +M+     ++ 
Sbjct: 30  KPIGSGAQGI--VCAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMKVVNHKNII 86
Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
           G  N+   + + E+ Q V+IVMEL        +++      ER +  ++++++ + ++ H
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLVGIKHL-H 143
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQ 210
           S G++HRDLKP N +  +   +A +K  DFGL+            V + YY APEV L  
Sbjct: 144 SAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 211 SYGKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAIL 248
            Y +  DIWS G I+                      I   G P P + +  Q   +  +
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 249 KGEINFQ----RDPFPSI------------SSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
           +    +        FP +            +S A +L+ +ML  D  +RI+V + L+HP+
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 293 LK---ESGEASDKP 303
           +    +  EA   P
Sbjct: 321 INVWYDPSEAEAPP 334

>pdb|1LKJ|A Chain A, Nmr Structure Of Apo Calmodulin From Yeast Saccharomyces Cerevisiae Length = 146

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 77/145 (53%), Gaps = 4/145 (2%)
Query: 332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGT 391
           NL  E+I + KE F   D DN+G+++  EL   +  LG   +E +V   M   D+DGN  
Sbjct: 3   NLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQ 62
Query: 392 IDYIEFITATMQRHKLQRFEN-LYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIAT 450
           I++ EF+    ++ K    E  L +AF+ FDK+ +G I+  EL        +G+  T A 
Sbjct: 63  IEFSEFLALMSRQLKSNDSEQELLEAFKVFDKNGDGLISAAELKHVL--TSIGEKLTDAE 120
Query: 451 IKEIMSEVDRDKDGRISYDEFRSMM 475
           + +++ EV  D  G I+  +F +++
Sbjct: 121 VDDMLREV-SDGSGEINIQQFAALL 144

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 130/313 (41%), Gaps = 48/313 (15%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y     VG G +G      +  +G + A K +  R    ++      RE+ +++H+  + 
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-SRPFQSEIFAKRAYRELLLLKHMQHE- 83
Query: 95  NIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC 150
           N++     F  A     F    + +        +I+      E+    V++++  +    
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGL-KYI 142
Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEVL- 208
           HS GV+HRDLKP N      +E+  +K  DFGL+   + E   Y   V + +Y APEV+ 
Sbjct: 143 HSAGVVHRDLKPGNL---AVNEDCELKILDFGLARHADAEMTGY---VVTRWYRAPEVIL 196
Query: 209 -SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ--------GVAQAILKGEIN---- 253
               Y +  DIWS G I+  +L G   F  +   DQ        GV       ++N    
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256
Query: 254 ---FQRDP----------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK-----E 295
               Q  P          FP  S  A +L+ +ML  D  +R+T AQ L HP+ +     E
Sbjct: 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE 316
Query: 296 SGEASDKPIDTAV 308
               + +P D ++
Sbjct: 317 EETEAQQPFDDSL 329

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 130/313 (41%), Gaps = 48/313 (15%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y     VG G +G      +  +G + A K +  R    ++      RE+ +++H+  + 
Sbjct: 44  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-SRPFQSEIFAKRAYRELLLLKHMQHE- 101
Query: 95  NIVQ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC 150
           N++     F  A     F    + +        +I+      E+    V++++  +    
Sbjct: 102 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGL-KYI 160
Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEVL- 208
           HS GV+HRDLKP N      +E+  +K  DFGL+   + E   Y   V + +Y APEV+ 
Sbjct: 161 HSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAEMTGY---VVTRWYRAPEVIL 214
Query: 209 -SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ--------GVAQAILKGEIN---- 253
               Y +  DIWS G I+  +L G   F  +   DQ        GV       ++N    
Sbjct: 215 SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 274
Query: 254 ---FQRDP----------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK-----E 295
               Q  P          FP  S  A +L+ +ML  D  +R+T AQ L HP+ +     E
Sbjct: 275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE 334
Query: 296 SGEASDKPIDTAV 308
               + +P D ++
Sbjct: 335 EETEAQQPFDDSL 347

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 132/314 (42%), Gaps = 58/314 (18%)
Query: 39  REVGRGEFGITYLCTENSTGLE--FACKSIPKRKLVKDVEKDDVRREIEIMR-----HLS 91
           + +G G  GI  +C      LE   A K +  R            RE+ +M+     ++ 
Sbjct: 30  KPIGSGAQGI--VCAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
           G  N+   + + E+ Q V+IVMEL        +++      ER +  +++++  + ++ H
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLCGIKHL-H 143
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQ 210
           S G++HRDLKP N +  +   +A +K  DFGL+            V + YY APEV L  
Sbjct: 144 SAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 211 SYGKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAIL 248
            Y +  DIWS G I+                      I   G P P + +  Q   +  +
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 249 KGEINFQ----RDPFPSI------------SSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
           +    +        FP +            +S A +L+ +ML  D  +RI+V + L+HP+
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 293 LK---ESGEASDKP 303
           +    +  EA   P
Sbjct: 321 INVWYDPSEAEAPP 334

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 133/314 (42%), Gaps = 58/314 (18%)
Query: 39  REVGRGEFGITYLCTENSTGLE--FACKSIPKRKLVKDVEKDDVRREIEIMR-----HLS 91
           + +G G  GI  +C      LE   A K +  R            RE+ +M+     ++ 
Sbjct: 30  KPIGSGAQGI--VCAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
           G  N+   + + E+ Q V+IVMEL        +++      ER +  +++++  + ++ H
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-H 143
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQ 210
           S G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L  
Sbjct: 144 SAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGM 200
Query: 211 SYGKEADIWSAGVILYILLC---------------------GVP-PFWAETDQGVAQAIL 248
            Y +  DIWS G I+  ++C                     G P P + +  Q   +  +
Sbjct: 201 GYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYV 260
Query: 249 KGEINFQ----RDPFPSI------------SSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
           +    +        FP +            +S A +L+ +ML  D  +RI+V + L+HP+
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 293 LK---ESGEASDKP 303
           +    +  EA   P
Sbjct: 321 INVWYDPSEAEAPP 334

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 132/314 (42%), Gaps = 58/314 (18%)
Query: 39  REVGRGEFGITYLCTENSTGLE--FACKSIPKRKLVKDVEKDDVRREIEIMR-----HLS 91
           + +G G  GI  +C      LE   A K +  R            RE+ +M+     ++ 
Sbjct: 30  KPIGSGAQGI--VCAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMKVVNHKNII 86
Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
           G  N+   + + E+ Q V+IVMEL        +++      ER +  +++++  + ++ H
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLCGIKHL-H 143
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQ 210
           S G++HRDLKP N +  +   +A +K  DFGL+            V + YY APEV L  
Sbjct: 144 SAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 211 SYGKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAIL 248
            Y +  DIWS G I+                      I   G P P + +  Q   +  +
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 249 KGEINFQ----RDPFPSI------------SSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
           +    +        FP +            +S A +L+ +ML  D  +RI+V + L+HP+
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 293 LK---ESGEASDKP 303
           +    +  EA   P
Sbjct: 321 INVWYDPSEAEAPP 334

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/316 (23%), Positives = 137/316 (43%), Gaps = 62/316 (19%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD----VRREIEIMR-----H 89
           + +G G  GI  +C      LE   +++  +KL +  +         RE+ +M+     +
Sbjct: 24  KPIGSGAQGI--VCAAYDAILE---RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
           + G  N+   + + E+ Q V+IVMEL        +++      ER +  +++++  + ++
Sbjct: 79  IIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL 136
Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-L 208
            HS G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L
Sbjct: 137 -HSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 209 SQSYGKEADIWSAGVILYILLC---------------------GVP-PFWAETDQGVAQA 246
              Y +  D+WS G I+  ++C                     G P P + +  Q   + 
Sbjct: 193 GMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRT 252
Query: 247 ILKGEINFQ----RDPFPSI------------SSSAIELVRRMLTQDPKRRITVAQVLEH 290
            ++    +        FP +            +S A +L+ +ML  D  +RI+V + L+H
Sbjct: 253 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 312
Query: 291 PWLK---ESGEASDKP 303
           P++    +  EA   P
Sbjct: 313 PYINVWYDPSEAEAPP 328

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 133/314 (42%), Gaps = 58/314 (18%)
Query: 39  REVGRGEFGITYLCTENSTGLE--FACKSIPKRKLVKDVEKDDVRREIEIMR-----HLS 91
           + +G G  GI  +C      LE   A K +  R            RE+ +M+     ++ 
Sbjct: 35  KPIGSGAQGI--VCAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNII 91
Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
           G  N+   + + E+ Q V+IVMEL        +++      ER +  +++++  + ++ H
Sbjct: 92  GLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-H 148
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQ 210
           S G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L  
Sbjct: 149 SAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 205
Query: 211 SYGKEADIWSAGVILYILLC---------------------GVP-PFWAETDQGVAQAIL 248
            Y +  D+WS G I+  ++C                     G P P + +  Q   +  +
Sbjct: 206 GYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 265
Query: 249 KGEINFQ----RDPFPSI------------SSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
           +    +        FP +            +S A +L+ +ML  D  +RI+V + L+HP+
Sbjct: 266 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 325
Query: 293 LK---ESGEASDKP 303
           +    +  EA   P
Sbjct: 326 INVWYDPSEAEAPP 339

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 128/278 (46%), Gaps = 35/278 (12%)
Query: 38  GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIV 97
           G  +G+G FG     T   TG     K + +     +  +    +E+++MR L   PN++
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLE-HPNVL 70
Query: 98  QFKAAYEDDQFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVM 156
           +F      D+ ++ + E   GG L   I +    Y      S  + I + +   HS  ++
Sbjct: 71  KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNII 130
Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE---------------IVGSPY 201
           HRDL   N L     EN  V   DFGL+  + + K   E               +VG+PY
Sbjct: 131 HRDLNSHNCLVR---ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 202 YIAPEVLS-QSYGKEADIWSAGVILYILLCGV---PPFWAET-DQGVAQAILKGEINFQR 256
           ++APE+++ +SY ++ D++S G++L  ++  V   P +   T D G+    ++G ++  R
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN---VRGFLD--R 242
Query: 257 DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
              P+   S   +  R    DP++R +  + LEH WL+
Sbjct: 243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVK-LEH-WLE 278

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 122/299 (40%), Gaps = 42/299 (14%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           R VG G +G      +     + A K +  R     +      RE+ +++HL  + N++ 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKL-SRPFQSLIHARRTYRELRLLKHLKHE-NVIG 91
Query: 99  ----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
               F  A   + F  + +     G   + IV     S+     +   ++  +   HS G
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG 151
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVGSPYYIAPEVLSQ--S 211
           ++HRDLKP N      +E++ ++  DFGL+    EE   Y   V + +Y APE++     
Sbjct: 152 IIHRDLKPSN---VAVNEDSELRILDFGLARQADEEMTGY---VATRWYRAPEIMLNWMH 205
Query: 212 YGKEADIWSAGVILYILLCG-----------------------VPPFWAETDQGVAQAIL 248
           Y +  DIWS G I+  LL G                        P   A+     A+  +
Sbjct: 206 YNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYI 265
Query: 249 KGEINFQRDPFPSI----SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           +      +    SI    +  AI+L+ RML  D  +R++ A+ L H +  +  +  D+P
Sbjct: 266 QSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEP 324

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 51/299 (17%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP---- 94
           + +G G  GI     +       A K +  R            RE+ +M+ ++ +     
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 95  -NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            N+   +   E+ Q V++VMEL        +++      ER +  +++++  + ++ HS 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYLLYQMLCGIKHL-HSA 145
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY 212
           G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L   Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 213 GKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAILKG 250
            +  DIWS G I+                      I   G P P + +  Q   +  ++ 
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 251 EINFQRDPFPSI----------------SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
              +    FP +                +S A +L+ +ML  DP +RI+V   L+HP++
Sbjct: 263 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 51/299 (17%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP---- 94
           + +G G  GI     +       A K +  R            RE+ +M+ ++ +     
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 95  -NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            N+   +   E+ Q V++VMEL        +++      ER +  +++++  + ++ HS 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYLLYQMLXGIKHL-HSA 145
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY 212
           G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L   Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 213 GKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAILKG 250
            +  DIWS G I+                      I   G P P + +  Q   +  ++ 
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 251 EINFQRDPFPSI----------------SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
              +    FP +                +S A +L+ +ML  DP +RI+V   L+HP++
Sbjct: 263 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 133/314 (42%), Gaps = 58/314 (18%)
Query: 39  REVGRGEFGITYLCTENSTGLE--FACKSIPKRKLVKDVEKDDVRREIEIMR-----HLS 91
           + +G G  GI  +C      LE   A K +  R            RE+ +M+     ++ 
Sbjct: 30  KPIGSGAQGI--VCAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
           G  N+   + + E+ Q V+IVMEL        +++      ER +  +++++  + ++ H
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-H 143
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQ 210
           S G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L  
Sbjct: 144 SAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGM 200
Query: 211 SYGKEADIWSAGVILYILLC---------------------GVP-PFWAETDQGVAQAIL 248
            Y +  D+WS G I+  ++C                     G P P + +  Q   +  +
Sbjct: 201 GYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 260
Query: 249 KGEINFQ----RDPFPSI------------SSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
           +    +        FP +            +S A +L+ +ML  D  +RI+V + L+HP+
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 293 LK---ESGEASDKP 303
           +    +  EA   P
Sbjct: 321 INVWYDPSEAEAPP 334

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 51/299 (17%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP---- 94
           + +G G  GI     +       A K +  R            RE+ +M+ ++ +     
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 95  -NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            N+   +   E+ Q V++VMEL        +++      ER +  +++++  + ++ HS 
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HSA 183
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY 212
           G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L   Y
Sbjct: 184 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 240
Query: 213 GKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAILKG 250
            +  DIWS G I+                      I   G P P + +  Q   +  ++ 
Sbjct: 241 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 300
Query: 251 EINFQRDPFPSI----------------SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
              +    FP +                +S A +L+ +ML  DP +RI+V   L+HP++
Sbjct: 301 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 110/218 (50%), Gaps = 35/218 (16%)
Query: 39  REVGRGEFGITY---LCTENSTGLEFACKSIPKRKLVKDVEKD--------DVRREIEIM 87
           +++G+G FG+ +   L  + S     A KS+    ++ D E +        + +RE+ IM
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSV---VAIKSL----ILGDSEGETEMIEKFQEFQREVFIM 77
Query: 88  RHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVV 147
            +L+  PNIV+      +     +VME    G+L+ R++ + H  + +     R+++++ 
Sbjct: 78  SNLN-HPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVK--LRLMLDIA 132
Query: 148 -----NVCHSKGVMHRDLKPENFLFTTGDENAVV--KATDFGLSAFIEEGKAYREIVGSP 200
                    +  ++HRDL+  N    + DENA V  K  DFGLS   +   +   ++G+ 
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNF 190
Query: 201 YYIAPEVLS---QSYGKEADIWSAGVILYILLCGVPPF 235
            ++APE +    +SY ++AD +S  +ILY +L G  PF
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 51/299 (17%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP---- 94
           + +G G  GI     +       A K +  R            RE+ +M+ ++ +     
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 95  -NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            N+   +   E+ Q V++VMEL        +++      ER +  +++++  + ++ HS 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYLLYQMLXGIKHL-HSA 145
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY 212
           G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L   Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 213 GKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAILKG 250
            +  DIWS G I+                      I   G P P + +  Q   +  ++ 
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 251 EINFQRDPFPSI----------------SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
              +    FP +                +S A +L+ +ML  DP +RI+V   L+HP++
Sbjct: 263 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 51/299 (17%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP---- 94
           + +G G  GI     +       A K +  R            RE+ +M+ ++ +     
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 95  -NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            N+   +   E+ Q V++VMEL        +++      ER +  +++++  + ++ HS 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HSA 145
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY 212
           G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L   Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 213 GKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAILKG 250
            +  DIWS G I+                      I   G P P + +  Q   +  ++ 
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 251 EINFQRDPFPSI----------------SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
              +    FP +                +S A +L+ +ML  DP +RI+V   L+HP++
Sbjct: 263 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 126/300 (42%), Gaps = 44/300 (14%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS-----GQ 93
           R VG G +G      +     + A K +  R     +      RE+ +++HL      G 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKL-SRPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            ++     + ED   V++V  L  G +L + +  +    E     V++++  +    HS 
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQALSDEHVQFLVYQLLRGL-KYIHSA 150
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVGSPYYIAPEVLSQ-- 210
           G++HRDLKP N      +E++ ++  DFGL+    EE   Y   V + +Y APE++    
Sbjct: 151 GIIHRDLKPSN---VAVNEDSELRILDFGLARQADEEMTGY---VATRWYRAPEIMLNWM 204
Query: 211 SYGKEADIWSAGVILYILLCG-----------------------VPPFWAETDQGVAQAI 247
            Y +  DIWS G I+  LL G                        P   A+     A+  
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 248 LKGEINFQRDPFPSI----SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           ++      +    SI    +  AI+L+ RML  D  +R++ A+ L H +  +  +  D+P
Sbjct: 265 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEP 324

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 116/267 (43%), Gaps = 23/267 (8%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+GRG +G+        +G   A K I  R  V   E+  +  +++I       P  V F
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRI--RATVNSQEQKRLLXDLDISXRTVDCPFTVTF 98
Query: 100 KAAYEDDQFVHIVMEL--CAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHSK-GV 155
             A   +  V I  EL   +  + + +++ +G    E     +   I+  +   HSK  V
Sbjct: 99  YGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 158
Query: 156 MHRDLKPENFLFTTGDENAV--VKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS---- 209
           +HRD+KP N L      NA+  VK  DFG+S ++ +  A     G   Y APE ++    
Sbjct: 159 IHRDVKPSNVLI-----NALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELN 213
Query: 210 -QSYGKEADIWSAGVILYILLCGVPPF--WAETDQGVAQAILKGEINFQRDPFPSISSSA 266
            + Y  ++DIWS G+    L     P+  W    Q + Q + +       D F   S+  
Sbjct: 214 QKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF---SAEF 270
Query: 267 IELVRRMLTQDPKRRITVAQVLEHPWL 293
           ++   + L ++ K R T  ++ +HP+ 
Sbjct: 271 VDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 51/299 (17%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP---- 94
           + +G G  GI     +       A K +  R            RE+ +M+ ++ +     
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 95  -NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            N+   +   E+ Q V++VMEL        +++      ER +  +++++  + ++ HS 
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HSA 183
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY 212
           G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L   Y
Sbjct: 184 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 240
Query: 213 GKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAILKG 250
            +  DIWS G I+                      I   G P P + +  Q   +  ++ 
Sbjct: 241 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 300
Query: 251 EINFQRDPFPSI----------------SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
              +    FP +                +S A +L+ +ML  DP +RI+V   L+HP++
Sbjct: 301 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 51/299 (17%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP---- 94
           + +G G  GI     +       A K +  R            RE+ +M+ ++ +     
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 95  -NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            N+   +   E+ Q V++VMEL        +++      ER +  +++++  + ++ HS 
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYLLYQMLXGIKHL-HSA 138
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY 212
           G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L   Y
Sbjct: 139 GIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 213 GKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAILKG 250
            +  DIWS G I+                      I   G P P + +  Q   +  ++ 
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255
Query: 251 EINFQRDPFPSI----------------SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
              +    FP +                +S A +L+ +ML  DP +RI+V   L+HP++
Sbjct: 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 126/300 (42%), Gaps = 44/300 (14%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS-----GQ 93
           R VG G +G      +     + A K +  R     +      RE+ +++HL      G 
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKL-SRPFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            ++     + ED   V++V  L  G +L + +  +    E     V++++  +  + HS 
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQALSDEHVQFLVYQLLRGLKYI-HSA 142
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVGSPYYIAPEVLSQ-- 210
           G++HRDLKP N      +E+  ++  DFGL+    EE   Y   V + +Y APE++    
Sbjct: 143 GIIHRDLKPSN---VAVNEDCELRILDFGLARQADEEMTGY---VATRWYRAPEIMLNWM 196
Query: 211 SYGKEADIWSAGVILYILLCG-----------------------VPPFWAETDQGVAQAI 247
            Y +  DIWS G I+  LL G                        P   A+     A+  
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 256
Query: 248 LKGEINFQRDPFPSI----SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
           ++      +    SI    +  AI+L+ RML  D  +R++ A+ L H +  +  +  D+P
Sbjct: 257 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEP 316

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 51/299 (17%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP---- 94
           + +G G  GI     +       A K +  R            RE+ +M+ ++ +     
Sbjct: 31  KPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIISL 89
Query: 95  -NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            N+   +   E+ Q V++VMEL        +++      ER +  +++++  + ++ HS 
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HSA 146
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY 212
           G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L   Y
Sbjct: 147 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 213 GKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAILKG 250
            +  DIWS G I+                      I   G P P + +  Q   +  ++ 
Sbjct: 204 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 263
Query: 251 EINFQRDPFPSI----------------SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
              +    FP +                +S A +L+ +ML  DP +RI+V   L+HP++
Sbjct: 264 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 51/299 (17%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP---- 94
           + +G G  GI     +       A K +  R            RE+ +M+ ++ +     
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 95  -NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            N+   +   E+ Q V++VMEL        +++      ER +  +++++  + ++ HS 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HSA 145
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY 212
           G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L   Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 213 GKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAILKG 250
            +  DIWS G I+                      I   G P P + +  Q   +  ++ 
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 251 EINFQRDPFPSI----------------SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
              +    FP +                +S A +L+ +ML  DP +RI+V   L+HP++
Sbjct: 263 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 51/299 (17%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP---- 94
           + +G G  GI     +       A K +  R            RE+ +M+ ++ +     
Sbjct: 29  KPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIISL 87
Query: 95  -NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            N+   +   E+ Q V++VMEL        +++      ER +  +++++  + ++ HS 
Sbjct: 88  LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HSA 144
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY 212
           G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L   Y
Sbjct: 145 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 201
Query: 213 GKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAILKG 250
            +  DIWS G I+                      I   G P P + +  Q   +  ++ 
Sbjct: 202 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 261
Query: 251 EINFQRDPFPSI----------------SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
              +    FP +                +S A +L+ +ML  DP +RI+V   L+HP++
Sbjct: 262 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 320

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 96/225 (42%), Gaps = 34/225 (15%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +Y I   +GRG +G  YL  + +T    A K +  R     ++   + REI I+  L   
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV-NRMFEDLIDCKRILREITILNRLKSD 85
Query: 94  PNIVQFKAAYEDDQF----VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
             I  +     DD      ++IV+E+ A  +L          +E    ++   ++   N 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEI-ADSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI----------------EEGKAY 193
            H  G++HRDLKP N L    +++  VK  DFGL+  I                E G   
Sbjct: 145 IHESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 194 REI-------VGSPYYIAPE--VLSQSYGKEADIWSAGVILYILL 229
           + +       V + +Y APE  +L ++Y K  DIWS G I   LL
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 18/37 (48%), Positives = 26/37 (70%)
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
           +PSIS   I L+  ML  +P +RIT+ Q L+HP+LK+
Sbjct: 331 YPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 131/314 (41%), Gaps = 58/314 (18%)
Query: 39  REVGRGEFGITYLCTENSTGLE--FACKSIPKRKLVKDVEKDDVRREIEIMR-----HLS 91
           + +G G  GI  +C      LE   A K +  R            RE+ +M+     ++ 
Sbjct: 30  KPIGSGAQGI--VCAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
           G  N+   + + E+ Q V+IVMEL        +++      ER +  +++++  + ++ H
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLCGIKHL-H 143
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQ 210
           S G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L  
Sbjct: 144 SAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 211 SYGKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAIL 248
            Y +  DIWS G I+                      I   G P P + +  Q   +  +
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 249 KGEINFQ----RDPFPSI------------SSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
           +    +        FP +            +S A +L+ +ML  D  +RI+V + L+HP+
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 293 LK---ESGEASDKP 303
           +    +  EA   P
Sbjct: 321 INVWYDPSEAEAPP 334

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/322 (22%), Positives = 130/322 (40%), Gaps = 51/322 (15%)
Query: 16  ARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV 75
           A   +   +G +   V   Y   + +G G  GI     +       A K +  R      
Sbjct: 1   ANQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQT 59
Query: 76  EKDDVRREIEIMRHLSGQP-----NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH 130
                 RE+ +M+ ++ +      N+   +   E+ Q V++VMEL        +++    
Sbjct: 60  HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMEL 117
Query: 131 YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190
             ER +  +++++  + ++ HS G++HRDLKP N +  +   +  +K  DFGL+      
Sbjct: 118 DHERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTS 173
Query: 191 KAYREIVGSPYYIAPEV-LSQSYGKEADIWSAGVIL---------------------YIL 228
                 V + YY APEV L   Y +  DIWS G I+                      I 
Sbjct: 174 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 233
Query: 229 LCGVP-PFWAETDQGVAQAILKGEINFQRDPFPSI----------------SSSAIELVR 271
             G P P + +  Q   +  ++    +    FP +                +S A +L+ 
Sbjct: 234 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 293
Query: 272 RMLTQDPKRRITVAQVLEHPWL 293
           +ML  DP +RI+V   L+HP++
Sbjct: 294 KMLVIDPAKRISVDDALQHPYI 315

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 51/299 (17%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP---- 94
           + +G G  GI     +       A K +  R            RE+ +M+ ++ +     
Sbjct: 31  KPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIISL 89
Query: 95  -NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            N+   +   E+ Q V++VMEL        +++      ER +  +++++  + ++ HS 
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HSA 146
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY 212
           G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L   Y
Sbjct: 147 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 213 GKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAILKG 250
            +  DIWS G I+                      I   G P P + +  Q   +  ++ 
Sbjct: 204 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 263
Query: 251 EINFQRDPFPSI----------------SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
              +    FP +                +S A +L+ +ML  DP +RI+V   L+HP++
Sbjct: 264 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 51/299 (17%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP---- 94
           + +G G  GI     +       A K +  R            RE+ +M+ ++ +     
Sbjct: 30  KPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 95  -NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            N+   +   E+ Q V++VMEL        +++      ER +  +++++  + ++ HS 
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HSA 145
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY 212
           G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L   Y
Sbjct: 146 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 213 GKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAILKG 250
            +  DIWS G I+                      I   G P P + +  Q   +  ++ 
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 251 EINFQRDPFPSI----------------SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
              +    FP +                +S A +L+ +ML  DP +RI+V   L+HP++
Sbjct: 263 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 51/299 (17%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP---- 94
           + +G G  GI     +       A K +  R            RE+ +M+ ++ +     
Sbjct: 24  KPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIISL 82
Query: 95  -NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            N+   +   E+ Q V++VMEL        +++      ER +  +++++  + ++ HS 
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HSA 139
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY 212
           G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L   Y
Sbjct: 140 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 196
Query: 213 GKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAILKG 250
            +  DIWS G I+                      I   G P P + +  Q   +  ++ 
Sbjct: 197 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 256
Query: 251 EINFQRDPFPSI----------------SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
              +    FP +                +S A +L+ +ML  DP +RI+V   L+HP++
Sbjct: 257 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 51/299 (17%)
Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP---- 94
           + +G G  GI     +       A K +  R            RE+ +M+ ++ +     
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 95  -NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            N+   +   E+ Q V++VMEL        +++      ER +  +++++  + ++ HS 
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HSA 138
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSY 212
           G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L   Y
Sbjct: 139 GIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 213 GKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAILKG 250
            +  DIWS G I+                      I   G P P + +  Q   +  ++ 
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255
Query: 251 EINFQRDPFPSI----------------SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
              +    FP +                +S A +L+ +ML  DP +RI+V   L+HP++
Sbjct: 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 135/305 (44%), Gaps = 49/305 (16%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + R+VGRG++      +E   G+          K++K V+K  ++REI+I+++L G P
Sbjct: 33  YEVVRKVGRGKY------SEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGP 86
Query: 95  NIVQFKAAYED--DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
           NIV+      D   +   ++ E        D  V     ++         ++  ++ CHS
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 143
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS--Q 210
           +G+MHRD+KP N +     E   ++  D+GL+ F   GK Y   V S Y+  PE+L   Q
Sbjct: 144 QGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG-------------EINF 254
            Y    D+WS G +   ++    PF+      DQ V  A + G             E++ 
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 255 Q---------RDPFPS---------ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
           Q         R P+           +S  AI+ + ++L  D + R+T  + + HP+ ++ 
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQV 321
Query: 297 GEASD 301
             A +
Sbjct: 322 RAAEN 326

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 135/305 (44%), Gaps = 49/305 (16%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + R+VGRG++      +E   G+          K++K V+K  ++REI+I+++L G P
Sbjct: 33  YEVVRKVGRGKY------SEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGP 86
Query: 95  NIVQFKAAYED--DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
           NIV+      D   +   ++ E        D  V     ++         ++  ++ CHS
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 143
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS--Q 210
           +G+MHRD+KP N +     E   ++  D+GL+ F   GK Y   V S Y+  PE+L   Q
Sbjct: 144 QGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG-------------EINF 254
            Y    D+WS G +   ++    PF+      DQ V  A + G             E++ 
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 255 Q---------RDPFPS---------ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
           Q         R P+           +S  AI+ + ++L  D + R+T  + + HP+ ++ 
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQV 321
Query: 297 GEASD 301
             A +
Sbjct: 322 RAAEN 326

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 135/305 (44%), Gaps = 49/305 (16%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + R+VGRG++      +E   G+          K++K V+K  ++REI+I+++L G P
Sbjct: 33  YEVVRKVGRGKY------SEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGP 86
Query: 95  NIVQFKAAYED--DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
           NIV+      D   +   ++ E        D  V     ++         ++  ++ CHS
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 143
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS--Q 210
           +G+MHRD+KP N +     E   ++  D+GL+ F   GK Y   V S Y+  PE+L   Q
Sbjct: 144 QGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG-------------EINF 254
            Y    D+WS G +   ++    PF+      DQ V  A + G             E++ 
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 255 Q---------RDPFPS---------ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
           Q         R P+           +S  AI+ + ++L  D + R+T  + + HP+ ++ 
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQV 321
Query: 297 GEASD 301
             A +
Sbjct: 322 RAAEN 326

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 135/305 (44%), Gaps = 49/305 (16%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + R+VGRG++      +E   G+          K++K V+K  ++REI+I+++L G P
Sbjct: 35  YEVVRKVGRGKY------SEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGP 88
Query: 95  NIVQFKAAYED--DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
           NIV+      D   +   ++ E        D  V     ++         ++  ++ CHS
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 145
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS--Q 210
           +G+MHRD+KP N +     E   ++  D+GL+ F   GK Y   V S Y+  PE+L   Q
Sbjct: 146 QGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 203
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG-------------EINF 254
            Y    D+WS G +   ++    PF+      DQ V  A + G             E++ 
Sbjct: 204 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 263
Query: 255 Q---------RDPFPS---------ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
           Q         R P+           +S  AI+ + ++L  D + R+T  + + HP+ ++ 
Sbjct: 264 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQV 323
Query: 297 GEASD 301
             A +
Sbjct: 324 RAAEN 328

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 135/305 (44%), Gaps = 49/305 (16%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + R+VGRG++      +E   G+          K++K V+K  ++REI+I+++L G P
Sbjct: 34  YEVVRKVGRGKY------SEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGP 87
Query: 95  NIVQFKAAYED--DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
           NIV+      D   +   ++ E        D  V     ++         ++  ++ CHS
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 144
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS--Q 210
           +G+MHRD+KP N +     E   ++  D+GL+ F   GK Y   V S Y+  PE+L   Q
Sbjct: 145 QGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG-------------EINF 254
            Y    D+WS G +   ++    PF+      DQ V  A + G             E++ 
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 262
Query: 255 Q---------RDPFPS---------ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
           Q         R P+           +S  AI+ + ++L  D + R+T  + + HP+ ++ 
Sbjct: 263 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQV 322
Query: 297 GEASD 301
             A +
Sbjct: 323 RAAEN 327

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 135/305 (44%), Gaps = 49/305 (16%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + R+VGRG++      +E   G+          K++K V+K  ++REI+I+++L G P
Sbjct: 34  YEVVRKVGRGKY------SEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGP 87
Query: 95  NIVQFKAAYED--DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
           NIV+      D   +   ++ E        D  V     ++         ++  ++ CHS
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 144
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS--Q 210
           +G+MHRD+KP N +     E   ++  D+GL+ F   GK Y   V S Y+  PE+L   Q
Sbjct: 145 QGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG-------------EINF 254
            Y    D+WS G +   ++    PF+      DQ V  A + G             E++ 
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 262
Query: 255 Q---------RDPFPS---------ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
           Q         R P+           +S  AI+ + ++L  D + R+T  + + HP+ ++ 
Sbjct: 263 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQV 322
Query: 297 GEASD 301
             A +
Sbjct: 323 RAAEN 327

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/331 (22%), Positives = 135/331 (40%), Gaps = 65/331 (19%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD--DVRREIEIMR---- 88
           Y++G+ +G G FGI     +  +G  FA K + +    K+ E D   V   + I++    
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 89  -------------------HLSGQPNIVQFK-----AAYEDDQFVHIVMELCAGG--ELF 122
                               L G+ N V             +++++++ME       ++ 
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 123 DRIVARGHYSERAAASVFRV-IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDF 181
              +  G        S++   +   V   HS G+ HRD+KP+N L  + D    +K  DF
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN--TLKLCDF 186
Query: 182 GLSAFIEEGKAYREIVGSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAET 239
           G +  +   +     + S +Y APE++  +  Y    D+WS G +   L+ G P F  ET
Sbjct: 187 GSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGET 246
Query: 240 --DQGV----------AQAILKGEINFQRDPFPSI-------------SSSAIELVRRML 274
             DQ V           + +++   ++    FP++              S AI+L+ ++L
Sbjct: 247 SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306
Query: 275 TQDPKRRITVAQVLEHPW---LKESGEASDK 302
             +P  RI   + + HP+   L+ S E+  K
Sbjct: 307 RYEPDLRINPYEAMAHPFFDHLRNSYESEVK 337

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 135/305 (44%), Gaps = 49/305 (16%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + R+VGRG++      +E   G+          K++K V+K  ++REI+I+++L G P
Sbjct: 33  YEVVRKVGRGKY------SEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGP 86
Query: 95  NIVQFKAAYED--DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
           NIV+      D   +   ++ E        D  V     ++         ++  ++ CHS
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 143
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS--Q 210
           +G+MHRD+KP N +     E   ++  D+GL+ F   GK Y   V S Y+  PE+L   Q
Sbjct: 144 QGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG-------------EINF 254
            Y    D+WS G +   ++    PF+      DQ V  A + G             E++ 
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 255 Q---------RDPFPS---------ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
           Q         R P+           +S  AI+ + ++L  D + R+T  + + HP+ ++ 
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQV 321
Query: 297 GEASD 301
             A +
Sbjct: 322 RAAEN 326

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 135/305 (44%), Gaps = 49/305 (16%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + R+VGRG++      +E   G+          K++K V+K  ++REI+I+++L G P
Sbjct: 33  YEVVRKVGRGKY------SEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLMGGP 86
Query: 95  NIVQFKAAYED--DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
           NIV+      D   +   ++ E        D  V     ++         ++  ++ CHS
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 143
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS--Q 210
           +G+MHRD+KP N +     E   ++  D+GL+ F   GK Y   V S Y+  PE+L   Q
Sbjct: 144 QGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG-------------EINF 254
            Y    D+WS G +   ++    PF+      DQ V  A + G             E++ 
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 255 Q---------RDPFPS---------ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
           Q         R P+           +S  AI+ + ++L  D + R+T  + + HP+ ++ 
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQV 321
Query: 297 GEASD 301
             A +
Sbjct: 322 RAAEN 326

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 135/305 (44%), Gaps = 49/305 (16%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + R+VGRG++      +E   G+          K++K V+K  ++REI+I+++L G P
Sbjct: 54  YEVVRKVGRGKY------SEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGP 107
Query: 95  NIVQFKAAYED--DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
           NIV+      D   +   ++ E        D  V     ++         ++  ++ CHS
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 164
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS--Q 210
           +G+MHRD+KP N +     E   ++  D+GL+ F   GK Y   V S Y+  PE+L   Q
Sbjct: 165 QGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 222
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG-------------EINF 254
            Y    D+WS G +   ++    PF+      DQ V  A + G             E++ 
Sbjct: 223 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIELDP 282
Query: 255 Q---------RDPFPS---------ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
           Q         R P+           +S  AI+ + ++L  D + R+T  + + HP+ ++ 
Sbjct: 283 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQV 342
Query: 297 GEASD 301
             A +
Sbjct: 343 RAAEN 347

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 118/278 (42%), Gaps = 36/278 (12%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G GEFG  + C +   G  +A K   K+ L   V++ +  RE+     L    ++V++
Sbjct: 16  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 74
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVAR----GHYSERAAASVFRVIMNVVNVCHSKGV 155
            +A+ +D  + I  E C GG L D I        ++ E     +   +   +   HS  +
Sbjct: 75  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 134
Query: 156 MHRDLKPENFLFT----------TGDEN------AVVKATDFGLSAFIEEGKAYREIVGS 199
           +H D+KP N   +           GDE+       + K  D G    I   +      G 
Sbjct: 135 VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---GD 191
Query: 200 PYYIAPEVLSQSYGK--EADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             ++A EVL ++Y    +ADI++  + + +   G  P     DQ         EI   R 
Sbjct: 192 SRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQW-------HEIRQGRL 243
Query: 258 P-FPSI-SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
           P  P + S    EL++ M+  DP+RR +   +++H  L
Sbjct: 244 PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 281

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 31/219 (14%)
Query: 28  YEDVQLHYTIGREVGRGEFGITYLC----TENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           +E+  L Y    ++G+G FG   LC      ++TG   A K +   +     ++ D +RE
Sbjct: 7   FEERHLKYI--SQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQRE 61
Query: 84  IEIMRHLSGQPNIVQFKAAY--EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFR 141
           I+I++ L     IV+++        Q + +VME    G L D +        RA     R
Sbjct: 62  IQILKALHSD-FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-----QRHRARLDASR 115
Query: 142 VIMNVVNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY-- 193
           +++    +C       S+  +HRDL   N L    +  A VK  DFGL+  +   K Y  
Sbjct: 116 LLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYV 172
Query: 194 -REIVGSP-YYIAPEVLSQS-YGKEADIWSAGVILYILL 229
            RE   SP ++ APE LS + + +++D+WS GV+LY L 
Sbjct: 173 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 211

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 25/218 (11%)
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSER-AAASVFRVIMNVVNVCHSK 153
           N V+   A +    + I ME C    L+D I +     +R     +FR I+  ++  HS+
Sbjct: 76  NFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ 135
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI---------------VG 198
           G++HRDLKP N      DE+  VK  DFGL+  +       ++               +G
Sbjct: 136 GIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIG 192
Query: 199 SPYYIAPEVLSQS--YGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEINFQ 255
           +  Y+A EVL  +  Y ++ D++S G+I + ++    PF    ++  + + +    I F 
Sbjct: 193 TAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFP 249
Query: 256 RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
            D   +      +++R ++  DP +R     +L   WL
Sbjct: 250 PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 118/278 (42%), Gaps = 36/278 (12%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G GEFG  + C +   G  +A K   K+ L   V++ +  RE+     L    ++V++
Sbjct: 16  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 74
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVAR----GHYSERAAASVFRVIMNVVNVCHSKGV 155
            +A+ +D  + I  E C GG L D I        ++ E     +   +   +   HS  +
Sbjct: 75  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 134
Query: 156 MHRDLKPENFLFT----------TGDEN------AVVKATDFGLSAFIEEGKAYREIVGS 199
           +H D+KP N   +           GDE+       + K  D G    I   +      G 
Sbjct: 135 VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---GD 191
Query: 200 PYYIAPEVLSQSYGK--EADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             ++A EVL ++Y    +ADI++  + + +   G  P     DQ         EI   R 
Sbjct: 192 SRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQW-------HEIRQGRL 243
Query: 258 P-FPSI-SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
           P  P + S    EL++ M+  DP+RR +   +++H  L
Sbjct: 244 PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 281

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 133/299 (44%), Gaps = 49/299 (16%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y + R+VGRG++      +E   G+          K++K V+K  ++REI+I+++L G P
Sbjct: 33  YEVVRKVGRGKY------SEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGP 86
Query: 95  NIVQFKAAYED--DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
           NIV+      D   +   ++ E        D  V     ++         ++  ++ CHS
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNT---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 143
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS--Q 210
           +G+MHRD+KP N +     E   ++  D+GL+ F   GK Y   V S Y+  PE+L   Q
Sbjct: 144 QGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 211 SYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG-------------EINF 254
            Y    D+WS G +   ++    PF+      DQ V  A + G             E++ 
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 255 Q---------RDPFPS---------ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
           Q         R P+           +S  AI+ + ++L  D + R+T  + + HP+ ++
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 118/278 (42%), Gaps = 36/278 (12%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G GEFG  + C +   G  +A K   K+ L   V++ +  RE+     L    ++V++
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVAR----GHYSERAAASVFRVIMNVVNVCHSKGV 155
            +A+ +D  + I  E C GG L D I        ++ E     +   +   +   HS  +
Sbjct: 77  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 136
Query: 156 MHRDLKPENFLFT----------TGDEN------AVVKATDFGLSAFIEEGKAYREIVGS 199
           +H D+KP N   +           GDE+       + K  D G    I   +      G 
Sbjct: 137 VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---GD 193
Query: 200 PYYIAPEVLSQSYG--KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             ++A EVL ++Y    +ADI++  + + +   G  P     DQ         EI   R 
Sbjct: 194 SRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQW-------HEIRQGRL 245
Query: 258 P-FPSI-SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
           P  P + S    EL++ M+  DP+RR +   +++H  L
Sbjct: 246 PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 118/278 (42%), Gaps = 36/278 (12%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           ++G GEFG  + C +   G  +A K   K+ L   V++ +  RE+     L    ++V++
Sbjct: 14  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 72
Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVAR----GHYSERAAASVFRVIMNVVNVCHSKGV 155
            +A+ +D  + I  E C GG L D I        ++ E     +   +   +   HS  +
Sbjct: 73  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 132
Query: 156 MHRDLKPENFLFT----------TGDEN------AVVKATDFGLSAFIEEGKAYREIVGS 199
           +H D+KP N   +           GDE+       + K  D G    I   +      G 
Sbjct: 133 VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---GD 189
Query: 200 PYYIAPEVLSQSYGK--EADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD 257
             ++A EVL ++Y    +ADI++  + + +   G  P     DQ         EI   R 
Sbjct: 190 SRFLANEVLQENYTHLPKADIFALALTV-VXAAGAEPLPRNGDQW-------HEIRQGRL 241
Query: 258 P-FPSI-SSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
           P  P + S    EL++ M+  DP+RR +   +++H  L
Sbjct: 242 PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 279

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 88/188 (46%), Gaps = 28/188 (14%)
Query: 111 IVMELCAGGELFDRIVAR-GHYSERAAA-SVFRVIMNVVNVCHSKGVMHRDLKPENFLFT 168
           I ME C  G L   I  R G   ++  A  +F  I   V+  HSK ++HRDLKP N    
Sbjct: 111 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLV 170
Query: 169 TGDENAVVKATDFGL-SAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEADIWSAGVILY 226
              +   VK  DFGL ++   +GK  R   G+  Y++PE + SQ YGKE D+++ G+IL 
Sbjct: 171 ---DTKQVKIGDFGLVTSLKNDGKRTRS-KGTLRYMSPEQISSQDYGKEVDLYALGLILA 226
Query: 227 ILL--CG----VPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKR 280
            LL  C        F+ +   G+   I                     L++++L++ P+ 
Sbjct: 227 ELLHVCDTAFETSKFFTDLRDGIISDIF--------------DKKEKTLLQKLLSKKPED 272
Query: 281 RITVAQVL 288
           R   +++L
Sbjct: 273 RPNTSEIL 280

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 31/219 (14%)
Query: 28  YEDVQLHYTIGREVGRGEFGITYLC----TENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           +E+  L Y    ++G+G FG   LC      ++TG   A K +   +     ++ D +RE
Sbjct: 8   FEERHLKYI--SQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQRE 62
Query: 84  IEIMRHLSGQPNIVQFKAAY--EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFR 141
           I+I++ L     IV+++        Q + +VME    G L D +        RA     R
Sbjct: 63  IQILKALHSD-FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-----QRHRARLDASR 116
Query: 142 VIMNVVNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY-- 193
           +++    +C       S+  +HRDL   N L    +  A VK  DFGL+  +   K Y  
Sbjct: 117 LLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYV 173
Query: 194 -REIVGSP-YYIAPEVLSQS-YGKEADIWSAGVILYILL 229
            RE   SP ++ APE LS + + +++D+WS GV+LY L 
Sbjct: 174 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 31/219 (14%)
Query: 28  YEDVQLHYTIGREVGRGEFGITYLC----TENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           +E+  L Y    ++G+G FG   LC      ++TG   A K +   +     ++ D +RE
Sbjct: 20  FEERHLKYI--SQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQRE 74
Query: 84  IEIMRHLSGQPNIVQFKAAY--EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFR 141
           I+I++ L     IV+++        Q + +VME    G L D +        RA     R
Sbjct: 75  IQILKALHSD-FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-----QRHRARLDASR 128
Query: 142 VIMNVVNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY-- 193
           +++    +C       S+  +HRDL   N L    +  A VK  DFGL+  +   K Y  
Sbjct: 129 LLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYV 185
Query: 194 -REIVGSP-YYIAPEVLSQS-YGKEADIWSAGVILYILL 229
            RE   SP ++ APE LS + + +++D+WS GV+LY L 
Sbjct: 186 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 82/350 (23%), Positives = 141/350 (40%), Gaps = 88/350 (25%)
Query: 19  LHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD 78
            H A  G+ Y+D +  Y + R++G G F   +L  +       A K +   K+  +  +D
Sbjct: 7   FHPAFKGEPYKDAR--YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED 64
Query: 79  DVRREIEIMRHLSGQPNIVQFKAAYED-----DQF-------VHIVMELCAGGELFDRIV 126
               EI++++ ++   N  +            D F       VH+VM     GE    ++
Sbjct: 65  ----EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALI 120
Query: 127 ARGHYSERAAASVF-----RVIMNVVNVCHSK-GVMHRDLKPENFLFTTGD--ENAV-VK 177
            +  Y  R    ++     + ++  ++  H + G++H D+KPEN L    D  EN + +K
Sbjct: 121 KK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 178
Query: 178 ATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSYGKEADIWSAGVILYILLCGVPPFW 236
             D G + + +E   Y   + +  Y +PEV L   +G  ADIWS   +++ L+ G   F 
Sbjct: 179 IADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG--DFL 234
Query: 237 AETDQG---------VAQAI-LKGEI---------------------------------- 252
            E D+G         +AQ I L GE+                                  
Sbjct: 235 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLED 294
Query: 253 ------NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
                  F +D    IS    + +  ML  DP++R     ++ HPWLK++
Sbjct: 295 VLTEKYKFSKDEAKEIS----DFLSPMLQLDPRKRADAGGLVNHPWLKDT 340

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 131/314 (41%), Gaps = 58/314 (18%)
Query: 39  REVGRGEFGITYLCTENSTGLE--FACKSIPKRKLVKDVEKDDVRREIEIMR-----HLS 91
           + +G G  GI  +C      LE   A K +  R            RE+ +M+     ++ 
Sbjct: 30  KPIGSGAQGI--VCAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
           G  N+   + + E+ Q V+IVMEL        +++      ER +  +++++  + ++ H
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-H 143
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQ 210
           S G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L  
Sbjct: 144 SAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 211 SYGKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAIL 248
            Y +  DIWS G I+                      I   G P P + +  Q   +  +
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 249 KGEINFQ----RDPFPSI------------SSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
           +    +        FP +            +S A +L+ +ML  D  +RI+V + L+HP+
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 293 LK---ESGEASDKP 303
           +    +  EA   P
Sbjct: 321 INVWYDPSEAEAPP 334

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 123/273 (45%), Gaps = 38/273 (13%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITY---LCTENSTGLEFACKSIPKRKLVKDVEKDDVR 81
           G A EDV L+    R +G G FG  Y           +  A K+  K   + + EK    
Sbjct: 8   GIAREDVVLN----RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK--FM 61
Query: 82  REIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAAS--V 139
            E  IM++L   P+IV+     E++    I+MEL   GEL       GHY ER   S  V
Sbjct: 62  SEAVIMKNLD-HPHIVKLIGIIEEEP-TWIIMELYPYGEL-------GHYLERNKNSLKV 112
Query: 140 FRVIMNVVNVC------HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY 193
             +++  + +C       S   +HRD+   N L  + +    VK  DFGLS +IE+   Y
Sbjct: 113 LTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKLGDFGLSRYIEDEDYY 169
Query: 194 REIVGS-PY-YIAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILK 249
           +  V   P  +++PE ++ + +   +D+W   V ++ IL  G  PF+   ++ V   + K
Sbjct: 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 229
Query: 250 GEINFQRDPFPSISSSAI-ELVRRMLTQDPKRR 281
           G+    R P P +    +  L+ R    DP  R
Sbjct: 230 GD----RLPKPDLCPPVLYTLMTRCWDYDPSDR 258

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 131/314 (41%), Gaps = 58/314 (18%)
Query: 39  REVGRGEFGITYLCTENSTGLE--FACKSIPKRKLVKDVEKDDVRREIEIMR-----HLS 91
           + +G G  GI  +C      LE   A K +  R            RE+ +M+     ++ 
Sbjct: 31  KPIGSGAQGI--VCAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNII 87
Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
           G  N+   + + E+ Q V+IVMEL        +++      ER +  +++++  + ++ H
Sbjct: 88  GLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-H 144
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQ 210
           S G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L  
Sbjct: 145 SAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 211 SYGKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAIL 248
            Y +  DIWS G I+                      I   G P P + +  Q   +  +
Sbjct: 202 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 261
Query: 249 KGEINFQ----RDPFPSI------------SSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
           +    +        FP +            +S A +L+ +ML  D  +RI+V + L+HP+
Sbjct: 262 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321
Query: 293 LK---ESGEASDKP 303
           +    +  EA   P
Sbjct: 322 INVWYDPSEAEAPP 335

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 131/314 (41%), Gaps = 58/314 (18%)
Query: 39  REVGRGEFGITYLCTENSTGLE--FACKSIPKRKLVKDVEKDDVRREIEIMR-----HLS 91
           + +G G  GI  +C      LE   A K +  R            RE+ +M+     ++ 
Sbjct: 30  KPIGSGAQGI--VCAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
           G  N+   + + E+ Q V+IVMEL        +++      ER +  +++++  + ++ H
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-H 143
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQ 210
           S G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L  
Sbjct: 144 SAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 211 SYGKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAIL 248
            Y +  DIWS G I+                      I   G P P + +  Q   +  +
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 260
Query: 249 KGEINFQ----RDPFPSI------------SSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
           +    +        FP +            +S A +L+ +ML  D  +RI+V + L+HP+
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 293 LK---ESGEASDKP 303
           +    +  EA   P
Sbjct: 321 INVWYDPSEAEAPP 334

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 112/259 (43%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFD--RIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           +VQ       +   +I++E    G L D  R   R   S      +   I + +     K
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G  Y    G+ +   + APE L+ 
Sbjct: 131 NFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERP--EGCPEKVYE 243
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 244 LMRACWQWNPSDRPSFAEI 262

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 112/259 (43%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFD--RIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           +VQ       +   +I++E    G L D  R   R   S      +   I + +     K
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G  Y    G+ +   + APE L+ 
Sbjct: 131 NFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERP--EGCPEKVYE 243
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 244 LMRACWQWNPSDRPSFAEI 262

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 123/273 (45%), Gaps = 38/273 (13%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITY---LCTENSTGLEFACKSIPKRKLVKDVEKDDVR 81
           G A EDV L+    R +G G FG  Y           +  A K+  K   + + EK    
Sbjct: 4   GIAREDVVLN----RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK--FM 57
Query: 82  REIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAAS--V 139
            E  IM++L   P+IV+     E++    I+MEL   GEL       GHY ER   S  V
Sbjct: 58  SEAVIMKNLD-HPHIVKLIGIIEEEP-TWIIMELYPYGEL-------GHYLERNKNSLKV 108
Query: 140 FRVIMNVVNVC------HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY 193
             +++  + +C       S   +HRD+   N L  + +    VK  DFGLS +IE+   Y
Sbjct: 109 LTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKLGDFGLSRYIEDEDYY 165
Query: 194 REIVGS-PY-YIAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILK 249
           +  V   P  +++PE ++ + +   +D+W   V ++ IL  G  PF+   ++ V   + K
Sbjct: 166 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 225
Query: 250 GEINFQRDPFPSISSSAI-ELVRRMLTQDPKRR 281
           G+    R P P +    +  L+ R    DP  R
Sbjct: 226 GD----RLPKPDLCPPVLYTLMTRCWDYDPSDR 254

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 82/349 (23%), Positives = 141/349 (40%), Gaps = 88/349 (25%)
Query: 20  HDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD 79
           H A  G+ Y+D +  Y + R++G G F   +L  +       A K +   K+  +  +D 
Sbjct: 8   HPAFKGEPYKDAR--YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED- 64
Query: 80  VRREIEIMRHLSGQPNIVQFKAAYED-----DQF-------VHIVMELCAGGELFDRIVA 127
              EI++++ ++   N  +            D F       VH+VM     GE    ++ 
Sbjct: 65  ---EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK 121
Query: 128 RGHYSERAAASVF-----RVIMNVVNVCHSK-GVMHRDLKPENFLFTTGD--ENAV-VKA 178
           +  Y  R    ++     + ++  ++  H + G++H D+KPEN L    D  EN + +K 
Sbjct: 122 K--YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI 179
Query: 179 TDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSYGKEADIWSAGVILYILLCGVPPFWA 237
            D G + + +E   Y   + +  Y +PEV L   +G  ADIWS   +++ L+ G   F  
Sbjct: 180 ADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG--DFLF 235
Query: 238 ETDQG---------VAQAI-LKGEI----------------------------------- 252
           E D+G         +AQ I L GE+                                   
Sbjct: 236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 295
Query: 253 -----NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
                 F +D    IS    + +  ML  DP++R     ++ HPWLK++
Sbjct: 296 LTEKYKFSKDEAKEIS----DFLSPMLQLDPRKRADAGGLVNHPWLKDT 340

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 123/273 (45%), Gaps = 38/273 (13%)
Query: 25  GKAYEDVQLHYTIGREVGRGEFGITY---LCTENSTGLEFACKSIPKRKLVKDVEKDDVR 81
           G A EDV L+    R +G G FG  Y           +  A K+  K   + + EK    
Sbjct: 20  GIAREDVVLN----RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK--FM 73
Query: 82  REIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAAS--V 139
            E  IM++L   P+IV+     E++    I+MEL   GEL       GHY ER   S  V
Sbjct: 74  SEAVIMKNLD-HPHIVKLIGIIEEEP-TWIIMELYPYGEL-------GHYLERNKNSLKV 124
Query: 140 FRVIMNVVNVC------HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY 193
             +++  + +C       S   +HRD+   N L  + +    VK  DFGLS +IE+   Y
Sbjct: 125 LTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKLGDFGLSRYIEDEDYY 181
Query: 194 REIVGS-PY-YIAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILK 249
           +  V   P  +++PE ++ + +   +D+W   V ++ IL  G  PF+   ++ V   + K
Sbjct: 182 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 241
Query: 250 GEINFQRDPFPSISSSAI-ELVRRMLTQDPKRR 281
           G+    R P P +    +  L+ R    DP  R
Sbjct: 242 GD----RLPKPDLCPPVLYTLMTRCWDYDPSDR 270

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 130/285 (45%), Gaps = 42/285 (14%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
           T+G+ +G G FG   +    + G++   K  PK       K++KD   EKD  D+  E+E
Sbjct: 38  TLGKPLGEGAFGQVVMA--EAVGID---KDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 92
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
           +M+ +    NI+    A   D  +++++E  + G L + + AR       +  + RV   
Sbjct: 93  MMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 143 ---IMNVVNVCH----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
                ++V+  +          S+  +HRDL   N L T   EN V+K  DFGL+  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 209
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
              Y++         ++APE L  + Y  ++D+WS GV+++ I   G  P+     + + 
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
           + + +G    + D   + ++    ++R      P +R T  Q++E
Sbjct: 270 KLLKEGH---RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2P6B|B Chain B, Crystal Structure Of Human Calcineurin In Complex With Pvivit Peptide Length = 156

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 82/144 (56%), Gaps = 10/144 (6%)
Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           +  +EI++L ++F ++D DNSG+L+ +E  +    L  +     V++ +   D DGNG +
Sbjct: 1   MDADEIKRLGKRFKKLDLDNSGSLSVEEFMS----LPELQQNPLVQRVIDIFDTDGNGEV 56
Query: 393 DYIEFITATMQRH-KLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATI 451
           D+ EFI    Q   K  + + L  AF+ +D D +GYI+  EL +  K   +G++     +
Sbjct: 57  DFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLK-MMVGNNLKDTQL 115
Query: 452 KEIMSEV----DRDKDGRISYDEF 471
           ++I+ +     D+D DGRIS++EF
Sbjct: 116 QQIVDKTIINADKDGDGRISFEEF 139

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 131/314 (41%), Gaps = 58/314 (18%)
Query: 39  REVGRGEFGITYLCTENSTGLE--FACKSIPKRKLVKDVEKDDVRREIEIMR-----HLS 91
           + +G G  GI  +C      LE   A K +  R            RE+ +M+     ++ 
Sbjct: 32  KPIGSGAQGI--VCAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNII 88
Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
           G  N+   + + E+ Q V+IVMEL        +++      ER +  +++++  + ++ H
Sbjct: 89  GLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-H 145
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQ 210
           S G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L  
Sbjct: 146 SAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGM 202
Query: 211 SYGKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAIL 248
            Y +  DIWS G I+                      I   G P P + +  Q   +  +
Sbjct: 203 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 262
Query: 249 KGEINFQ----RDPFPSI------------SSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
           +    +        FP +            +S A +L+ +ML  D  +RI+V + L+HP+
Sbjct: 263 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 322
Query: 293 LK---ESGEASDKP 303
           +    +  EA   P
Sbjct: 323 INVWYDPSEAEAPP 336

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 19/209 (9%)
Query: 36  TIGREVGRGEFGITYLCT-ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           T+G+ +G G FG  Y         ++    + P  + ++       + E+ ++R  +   
Sbjct: 15  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAF-----KNEVGVLRK-TRHV 68
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVNVCHSK 153
           NI+ F   Y     + IV + C G  L+  +  +   +  +    + R     ++  H+K
Sbjct: 69  NILLF-MGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK 127
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVL-- 208
            ++HRDLK  N       E+  VK  DFGL+           + ++ GS  ++APEV+  
Sbjct: 128 SIIHRDLKSNNIFL---HEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 184
Query: 209 --SQSYGKEADIWSAGVILYILLCGVPPF 235
             S  Y  ++D+++ G++LY L+ G  P+
Sbjct: 185 QDSNPYSFQSDVYAFGIVLYELMTGQLPY 213

>pdb|1TCO|B Chain B, Ternary Complex Of A Calcineurin A Fragment, Calcineurin B, Fkbp12 And The Immunosuppressant Drug Fk506 (tacrolimus) Length = 169

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 83/148 (56%), Gaps = 10/148 (6%)
Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           +  +   +EI++L ++F ++D DNSG+L+ +E  +    L  +     V++ +   D DG
Sbjct: 10  MCSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMS----LPELQQNPLVQRVIDIFDTDG 65
Query: 389 NGTIDYIEFITATMQRH-KLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
           NG +D+ EFI    Q   K  + + L  AF+ +D D +GYI+  EL +  K   +G++  
Sbjct: 66  NGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLK-MMVGNNLK 124
Query: 448 IATIKEIMSEV----DRDKDGRISYDEF 471
              +++I+ +     D+D DGRIS++EF
Sbjct: 125 DTQLQQIVDKTIINADKDGDGRISFEEF 152

>pdb|1MF8|B Chain B, Crystal Structure Of Human Calcineurin Complexed With Cyclosporin A And Human Cyclophilin Length = 170

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 83/148 (56%), Gaps = 10/148 (6%)
Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           +  +   +EI++L ++F ++D DNSG+L+ +E  +    L  +     V++ +   D DG
Sbjct: 11  MCSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMS----LPELQQNPLVQRVIDIFDTDG 66
Query: 389 NGTIDYIEFITATMQRH-KLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
           NG +D+ EFI    Q   K  + + L  AF+ +D D +GYI+  EL +  K   +G++  
Sbjct: 67  NGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLK-MMVGNNLK 125
Query: 448 IATIKEIMSEV----DRDKDGRISYDEF 471
              +++I+ +     D+D DGRIS++EF
Sbjct: 126 DTQLQQIVDKTIINADKDGDGRISFEEF 153

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 129/285 (45%), Gaps = 42/285 (14%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
           T+G+ +G G FG   +    + G++   K  PK       K++KD   EKD  D+  E+E
Sbjct: 38  TLGKPLGEGAFGQVVMA--EAVGID---KDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 92
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
           +M+ +    NI+    A   D  +++++E  + G L + + AR       +  + RV   
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 143 ---IMNVVNVCH----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
                ++V+  +          S+  +HRDL   N L T   EN V+K  DFGL+  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 209
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
              Y+          ++APE L  + Y  ++D+WS GV+++ I   G  P+     + + 
Sbjct: 210 IDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
           + + +G    + D   + ++    ++R      P +R T  Q++E
Sbjct: 270 KLLKEGH---RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 112/259 (43%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSK 153
           +VQ       +   +I++E    G L D +         A   ++    I + +     K
Sbjct: 76  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G  Y    G+ +   + APE L+ 
Sbjct: 136 NFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERP--EGCPEKVYE 248
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 249 LMRACWQWNPSDRPSFAEI 267

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 109/218 (50%), Gaps = 35/218 (16%)
Query: 39  REVGRGEFGITY---LCTENSTGLEFACKSIPKRKLVKDVEKD--------DVRREIEIM 87
           +++G+G FG+ +   L  + S     A KS+    ++ D E +        + +RE+ IM
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSV---VAIKSL----ILGDSEGETEMIEKFQEFQREVFIM 77
Query: 88  RHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVV 147
            +L+  PNIV+      +     +VME    G+L+ R++ + H  + +     R+++++ 
Sbjct: 78  SNLN-HPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVK--LRLMLDIA 132
Query: 148 -----NVCHSKGVMHRDLKPENFLFTTGDENAVV--KATDFGLSAFIEEGKAYREIVGSP 200
                    +  ++HRDL+  N    + DENA V  K  DFG S   +   +   ++G+ 
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ--QSVHSVSGLLGNF 190
Query: 201 YYIAPEVLS---QSYGKEADIWSAGVILYILLCGVPPF 235
            ++APE +    +SY ++AD +S  +ILY +L G  PF
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 122/297 (41%), Gaps = 59/297 (19%)
Query: 18  HLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK 77
           H  D   G  +++++L       +G G FG  +       G  +  K +           
Sbjct: 3   HTVDKRFGMDFKEIEL-------IGSGGFGQVFKAKHRIDGKTYVIKRVK-------YNN 48
Query: 78  DDVRREIEIMRHLSGQPNIVQFKAAYE----------------DDQFVHIVMELCAGGEL 121
           +   RE++ +  L    NIV +   ++                  + + I ME C  G L
Sbjct: 49  EKAEREVKALAKLD-HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTL 107
Query: 122 FDRIVAR-GHYSERAAA-SVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKAT 179
              I  R G   ++  A  +F  I   V+  HSK +++RDLKP N       +   VK  
Sbjct: 108 EQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIG 164
Query: 180 DFGL-SAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEADIWSAGVILYILL--CG---- 231
           DFGL ++   +GK  R   G+  Y++PE + SQ YGKE D+++ G+IL  LL  C     
Sbjct: 165 DFGLVTSLKNDGKRXRS-KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223
Query: 232 VPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
              F+ +   G+   I                     L++++L++ P+ R   +++L
Sbjct: 224 TSKFFTDLRDGIISDIF--------------DKKEKTLLQKLLSKKPEDRPNTSEIL 266

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 111/259 (42%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFD--RIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           +VQ       +   +I+ E    G L D  R   R   S      +   I + +     K
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 135
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G  Y    G+ +   + APE L+ 
Sbjct: 136 NFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERP--EGCPEKVYE 248
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 249 LMRACWQWNPSDRPSFAEI 267

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 111/259 (42%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFD--RIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           +VQ       +   +I+ E    G L D  R   R   S      +   I + +     K
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G  Y    G+ +   + APE L+ 
Sbjct: 131 NFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERP--EGCPEKVYE 243
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 244 LMRACWQWNPSDRPSFAEI 262

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 124/260 (47%), Gaps = 21/260 (8%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T  +E+G G+FG+ +L    +   + A K+I +  +     +DD   E E+M  LS  P 
Sbjct: 30  TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIKEGSM----SEDDFIEEAEVMMKLS-HPK 83
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVNVCHSKG 154
           +VQ      +   + +V E    G L D +   RG ++      +   +   +       
Sbjct: 84  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 143
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLSQS 211
           V+HRDL   N L     EN V+K +DFG++ F+ + + Y    G+ +   + +PEV S S
Sbjct: 144 VIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS 199
Query: 212 -YGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI-E 268
            Y  ++D+WS GV+++ +   G  P+   ++  V + I  G   ++    P ++S+ + +
Sbjct: 200 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK----PRLASTHVYQ 255
Query: 269 LVRRMLTQDPKRRITVAQVL 288
           ++     + P+ R   +++L
Sbjct: 256 IMNHCWKERPEDRPAFSRLL 275

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 111/259 (42%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 17  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 71
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSK 153
           +VQ       +   +I+ E    G L D +         A   ++    I + +     K
Sbjct: 72  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 131
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G  Y    G+ +   + APE L+ 
Sbjct: 132 NFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPESLAY 187
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERP--EGCPEKVYE 244
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 245 LMRACWQWNPSDRPSFAEI 263

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 130/285 (45%), Gaps = 42/285 (14%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
           T+G+ +G G FG   +    + G++   K  PK       K++KD   EKD  D+  E+E
Sbjct: 38  TLGKPLGEGAFGQVVMA--EAVGID---KDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 92
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
           +M+ +    NI+    A   D  +++++E  + G L + + AR       +  + RV   
Sbjct: 93  MMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 143 ---IMNVVNVCH----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
                ++V+  +          S+  +HRDL   N L T   EN V+K  DFGL+  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 209
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
              Y++         ++APE L  + Y  ++D+WS GV+++ I   G  P+     + + 
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
           + + +G    + D   + ++    ++R      P +R T  Q++E
Sbjct: 270 KLLKEGH---RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 109/218 (50%), Gaps = 35/218 (16%)
Query: 39  REVGRGEFGITY---LCTENSTGLEFACKSIPKRKLVKDVEKD--------DVRREIEIM 87
           +++G+G FG+ +   L  + S     A KS+    ++ D E +        + +RE+ IM
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSV---VAIKSL----ILGDSEGETEMIEKFQEFQREVFIM 77
Query: 88  RHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVV 147
            +L+  PNIV+      +     +VME    G+L+ R++ + H  + +     R+++++ 
Sbjct: 78  SNLN-HPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVK--LRLMLDIA 132
Query: 148 -----NVCHSKGVMHRDLKPENFLFTTGDENAVV--KATDFGLSAFIEEGKAYREIVGSP 200
                    +  ++HRDL+  N    + DENA V  K  DF LS   +   +   ++G+ 
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ--QSVHSVSGLLGNF 190
Query: 201 YYIAPEVLS---QSYGKEADIWSAGVILYILLCGVPPF 235
            ++APE +    +SY ++AD +S  +ILY +L G  PF
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 111/259 (42%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 72
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSK 153
           +VQ       +   +I+ E    G L D +         A   ++    I + +     K
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 132
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G  Y    G+ +   + APE L+ 
Sbjct: 133 NFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPESLAY 188
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERP--EGCPEKVYE 245
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 246 LMRACWQWNPSDRPSFAEI 264

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 112/260 (43%), Gaps = 23/260 (8%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y+       L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 35  TMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 89
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV----IMNVVNVCH 151
           +VQ       +   +IV E    G L D +  R    E   A V       I + +    
Sbjct: 90  LVQLLGVCTLEPPFYIVTEYMPYGNLLDYL--RECNREEVTAVVLLYMATQISSAMEYLE 147
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVL 208
            K  +HRDL   N L     EN VVK  DFGLS  +  G  Y    G+ +   + APE L
Sbjct: 148 KKNFIHRDLAARNCLV---GENHVVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESL 203
Query: 209 S-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
           +  ++  ++D+W+ GV+L+ I   G+ P+       V   + KG    Q +  P      
Sbjct: 204 AYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGCP---PKV 260
Query: 267 IELVRRMLTQDPKRRITVAQ 286
            EL+R      P  R + A+
Sbjct: 261 YELMRACWKWSPADRPSFAE 280

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 127/285 (44%), Gaps = 50/285 (17%)
Query: 39  REVGRGEFGITYLC----TENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           R++G G FG   LC      ++TG + A KS+        +   D+++EIEI+R+L  + 
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA--DLKKEIEILRNLYHE- 71
Query: 95  NIVQFKAAYEDD--QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH- 151
           NIV++K    +D    + ++ME    G L + +        +   ++ + +   V +C  
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-----KNKNKINLKQQLKYAVQICKG 126
Query: 152 -----SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE---EGKAYREIVGSP-YY 202
                S+  +HRDL   N L  +  +   VK  DFGL+  IE   E    ++   SP ++
Sbjct: 127 MDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKEXXTVKDDRDSPVFW 183
Query: 203 IAPEVLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK------GEINF- 254
            APE L QS +   +D+WS GV L+ LL      + ++D       LK      G++   
Sbjct: 184 YAPECLMQSKFYIASDVWSFGVTLHELLT-----YCDSDSSPMALFLKMIGPTHGQMTVT 238
Query: 255 ---------QRDPF-PSISSSAIELVRRMLTQDPKRRITVAQVLE 289
                    +R P  P+      +L+R+     P  R +   ++E
Sbjct: 239 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 39  REVGRGEFGITYLC----TENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           R++G G FG   LC      ++TG + A KS+        +   D+++EIEI+R+L  + 
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA--DLKKEIEILRNLYHE- 83
Query: 95  NIVQFKAAYEDD--QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH- 151
           NIV++K    +D    + ++ME    G L + +        +   ++ + +   V +C  
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-----KNKNKINLKQQLKYAVQICKG 138
Query: 152 -----SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE---EGKAYREIVGSP-YY 202
                S+  +HRDL   N L  +  +   VK  DFGL+  IE   E    ++   SP ++
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKEXXTVKDDRDSPVFW 195
Query: 203 IAPEVLSQS-YGKEADIWSAGVILYILL 229
            APE L QS +   +D+WS GV L+ LL
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELL 223

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 111/245 (45%), Gaps = 26/245 (10%)
Query: 36  TIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           TI R +G GEFG   +C+          L  A K++  +    + ++ D   E  IM   
Sbjct: 25  TIERVIGAGEFG--EVCSGRLKLPGKRELPVAIKTL--KVGYTEKQRRDFLGEASIMGQF 80
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVN 148
              PNI+  +      + V IV E    G L D  + +  G ++      + R I   + 
Sbjct: 81  D-HPNIIHLEGVVTKSKPVMIVTEYMENGSL-DTFLKKNDGQFTVIQLVGMLRGISAGMK 138
Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--AYREIVGS-PY-YIA 204
                G +HRDL   N L  +   N V K +DFGLS  +E+    AY    G  P  + A
Sbjct: 139 YLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 195
Query: 205 PEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
           PE ++ + +   +D+WS G++++ ++  G  P+W  T+Q V +A+ +G     R P P  
Sbjct: 196 PEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEG----YRLPSPMD 251
Query: 263 SSSAI 267
             +A+
Sbjct: 252 CPAAL 256

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 111/259 (42%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFD--RIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           +VQ       +   +I+ E    G L D  R   R   S      +   I + +     K
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G  Y    G+ +   + APE L+ 
Sbjct: 131 NFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERP--EGCPEKVYE 243
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 244 LMRACWQWNPSDRPSFAEI 262

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 36  TIGREVGRGEFGITYLCT-ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           T+G+ +G G FG  Y         ++    + P  + ++       + E+ ++R  +   
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAF-----KNEVGVLRK-TRHV 80
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSK 153
           NI+ F   Y     + IV + C G  L+  + A    +  +    + R     ++  H+K
Sbjct: 81  NILLF-MGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK 139
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS---AFIEEGKAYREIVGSPYYIAPEVL-- 208
            ++HRDLK  N       E+  VK  DFGL+   +       + ++ GS  ++APEV+  
Sbjct: 140 SIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 209 --SQSYGKEADIWSAGVILYILLCGVPPF 235
             S  Y  ++D+++ G++LY L+ G  P+
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 111/259 (42%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 29  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 83
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSK 153
           +VQ       +   +I+ E    G L D +         A   ++    I + +     K
Sbjct: 84  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 143
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G  Y    G+ +   + APE L+ 
Sbjct: 144 NFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAY 199
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 200 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERP--EGCPEKVYE 256
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 257 LMRACWQWNPSDRPSFAEI 275

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 130/285 (45%), Gaps = 42/285 (14%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
           T+G+ +G G FG   +    + G++   K  PK       K++KD   EKD  D+  E+E
Sbjct: 25  TLGKPLGEGCFGQVVMA--EAVGID---KDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 79
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
           +M+ +    NI+    A   D  +++++E  + G L + + AR       +  + RV   
Sbjct: 80  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 139
Query: 143 ---IMNVVNVCH----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
                ++V+  +          S+  +HRDL   N L T   EN V+K  DFGL+  I  
Sbjct: 140 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVT---ENNVMKIADFGLARDINN 196
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
              Y++         ++APE L  + Y  ++D+WS GV+++ I   G  P+     + + 
Sbjct: 197 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 256
Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
           + + +G    + D   + ++    ++R      P +R T  Q++E
Sbjct: 257 KLLKEGH---RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 298

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 111/259 (42%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 72
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSK 153
           +VQ       +   +I+ E    G L D +         A   ++    I + +     K
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 132
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G  Y    G+ +   + APE L+ 
Sbjct: 133 NFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAY 188
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERP--EGCPEKVYE 245
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 246 LMRACWQWNPSDRPSFAEI 264

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 131/314 (41%), Gaps = 58/314 (18%)
Query: 39  REVGRGEFGITYLCTENSTGLE--FACKSIPKRKLVKDVEKDDVRREIEIMR-----HLS 91
           + +G G  GI  +C      LE   A K +  R            RE+ +M+     ++ 
Sbjct: 30  KPIGSGAQGI--VCAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
           G  N+   + + E+ Q V+IVMEL        +++      ER +  +++++  + ++ H
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-H 143
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQ 210
           S G++HRDLKP N +  +   +  +K  DFGL+            V + YY APEV L  
Sbjct: 144 SAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGM 200
Query: 211 SYGKEADIWSAGVIL---------------------YILLCGVP-PFWAETDQGVAQAIL 248
            Y +  DIWS G I+                      I   G P P + +  Q   +  +
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 260
Query: 249 KGEINFQ----RDPFPSI------------SSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
           +    +        FP +            +S A +L+ +ML  D  +RI+V + L+HP+
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 293 LK---ESGEASDKP 303
           +    +  EA   P
Sbjct: 321 INVWYDPSEAEAPP 334

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 111/259 (42%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSK 153
           +VQ       +   +I+ E    G L D +         A   ++    I + +     K
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G  Y    G+ +   + APE L+ 
Sbjct: 136 NFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERP--EGCPEKVYE 248
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 249 LMRACWQWNPSDRPSFAEI 267

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 111/259 (42%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 72
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSK 153
           +VQ       +   +I+ E    G L D +         A   ++    I + +     K
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 132
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G  Y    G+ +   + APE L+ 
Sbjct: 133 NFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAY 188
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERP--EGCPEKVYE 245
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 246 LMRACWQWNPSDRPSFAEI 264

>pdb|3LL8|B Chain B, Crystal Structure Of Calcineurin In Complex With Akap79 Peptide Length = 155

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 81/142 (57%), Gaps = 10/142 (7%)
Query: 335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDY 394
            +EI++L ++F ++D DNSG+L+ +E  +    L  +     V++ +   D DGNG +D+
Sbjct: 2   ADEIKRLGKRFKKLDLDNSGSLSVEEFMS----LPELQQNPLVQRVIDIFDTDGNGEVDF 57
Query: 395 IEFITATMQRH-KLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKE 453
            EFI    Q   K  + + L  AF+ +D D +GYI+  EL +  K   +G++     +++
Sbjct: 58  KEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLK-MMVGNNLKDTQLQQ 116
Query: 454 IMSEV----DRDKDGRISYDEF 471
           I+ +     D+D DGRIS++EF
Sbjct: 117 IVDKTIINADKDGDGRISFEEF 138

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 39/231 (16%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
           T+G+ +G G FG   +    + G++   K  PK       K++KD   EKD  D+  E+E
Sbjct: 84  TLGKPLGEGCFGQVVMA--EAVGID---KDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 138
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
           +M+ +    NI+    A   D  +++++E  + G L + + AR       +  + RV   
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 143 ---IMNVVNVCH----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
                ++V+  +          S+  +HRDL   N L T   EN V+K  DFGL+  I  
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 255
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPF 235
              Y++         ++APE L  + Y  ++D+WS GV+++ I   G  P+
Sbjct: 256 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 130/285 (45%), Gaps = 42/285 (14%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
           T+G+ +G G FG   +    + G++   K  PK       K++KD   EKD  D+  E+E
Sbjct: 30  TLGKPLGEGCFGQVVMA--EAVGID---KDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 84
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
           +M+ +    NI+    A   D  +++++E  + G L + + AR       +  + RV   
Sbjct: 85  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 144
Query: 143 ---IMNVVNVCH----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
                ++V+  +          S+  +HRDL   N L T   EN V+K  DFGL+  I  
Sbjct: 145 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 201
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
              Y++         ++APE L  + Y  ++D+WS GV+++ I   G  P+     + + 
Sbjct: 202 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 261
Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
           + + +G    + D   + ++    ++R      P +R T  Q++E
Sbjct: 262 KLLKEGH---RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 303

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 111/259 (42%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSK 153
           +VQ       +   +I+ E    G L D +         A   ++    I + +     K
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G  Y    G+ +   + APE L+ 
Sbjct: 136 NFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERP--EGCPEKVYE 248
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 249 LMRACWQWNPSDRPSFAEI 267

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 38  GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR----EIEIMRHLSGQ 93
           G ++G G FG+ Y    N+T +     ++ K   + D+  +++++    EI++M     +
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTV-----AVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVA---RGHYSERAAASVFRVIMNVVNVC 150
            N+V+      D   + +V      G L DR+         S      + +   N +N  
Sbjct: 91  -NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE---EGKAYREIVGSPYYIAPEV 207
           H    +HRD+K  N L    DE    K +DFGL+   E   +      IVG+  Y+APE 
Sbjct: 150 HENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEA 206
Query: 208 LSQSYGKEADIWSAGVILYILLCGVP 233
           L      ++DI+S GV+L  ++ G+P
Sbjct: 207 LRGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 111/259 (42%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 20  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 74
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSK 153
           +VQ       +   +I+ E    G L D +         A   ++    I + +     K
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 134
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G  Y    G+ +   + APE L+ 
Sbjct: 135 NFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERP--EGCPEKVYE 247
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 248 LMRACWQWNPSDRPSFAEI 266

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 130/285 (45%), Gaps = 42/285 (14%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
           T+G+ +G G FG   +    + G++   K  PK       K++KD   EKD  D+  E+E
Sbjct: 38  TLGKPLGEGAFGQVVMA--EAVGID---KDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 92
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
           +M+ +    NI+    A   D  +++++E  + G L + + AR       +  + RV   
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 143 ---IMNVVNVCH----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
                ++V+  +          S+  +HRDL   N L T   EN V++  DFGL+  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMRIADFGLARDINN 209
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
              Y++         ++APE L  + Y  ++D+WS GV+++ I   G  P+     + + 
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
           + + +G    + D   + ++    ++R      P +R T  Q++E
Sbjct: 270 KLLKEGH---RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 111/259 (42%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSK 153
           +VQ       +   +I+ E    G L D +         A   ++    I + +     K
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 130
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G  Y    G+ +   + APE L+ 
Sbjct: 131 NFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERP--EGCPEKVYE 243
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 244 LMRACWQWNPSDRPSFAEI 262

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 130/285 (45%), Gaps = 42/285 (14%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
           T+G+ +G G FG   +    + G++   K  PK       K++KD   EKD  D+  E+E
Sbjct: 27  TLGKPLGEGCFGQVVMA--EAVGID---KDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 81
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
           +M+ +    NI+    A   D  +++++E  + G L + + AR       +  + RV   
Sbjct: 82  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 141
Query: 143 ---IMNVVNVCH----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
                ++V+  +          S+  +HRDL   N L T   EN V+K  DFGL+  I  
Sbjct: 142 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 198
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
              Y++         ++APE L  + Y  ++D+WS GV+++ I   G  P+     + + 
Sbjct: 199 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 258
Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
           + + +G    + D   + ++    ++R      P +R T  Q++E
Sbjct: 259 KLLKEGH---RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 300

>pdb|2LMT|A Chain A, Nmr Structure Of Androcam Length = 148

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 77/145 (53%), Gaps = 5/145 (3%)
Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E+I + K+ F + D + +G +   EL   +  LG   TE +++  +  A+ + NG +
Sbjct: 4   LTEEQIAEFKDAFVQFDKEGTGKIATRELGTLMRTLGQNPTEAELQDLIAEAENNNNGQL 63
Query: 393 DYIEF--ITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIAT 450
           ++ EF  I A   R      E + +AF+ FD+D +G+I+  EL   F    +G+  T   
Sbjct: 64  NFTEFCGIMAKQMRETDTE-EEMREAFKIFDRDGDGFISPAEL--RFVMINLGEKVTDEE 120
Query: 451 IKEIMSEVDRDKDGRISYDEFRSMM 475
           I E++ E D D DG I+Y+EF  M+
Sbjct: 121 IDEMIREADFDGDGMINYEEFVWMI 145

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 38  GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR----EIEIMRHLSGQ 93
           G ++G G FG+ Y    N+T +     ++ K   + D+  +++++    EI++M     +
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTV-----AVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVA---RGHYSERAAASVFRVIMNVVNVC 150
            N+V+      D   + +V      G L DR+         S      + +   N +N  
Sbjct: 91  -NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE---EGKAYREIVGSPYYIAPEV 207
           H    +HRD+K  N L    DE    K +DFGL+   E   +      IVG+  Y+APE 
Sbjct: 150 HENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEA 206
Query: 208 LSQSYGKEADIWSAGVILYILLCGVP 233
           L      ++DI+S GV+L  ++ G+P
Sbjct: 207 LRGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 111/259 (42%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSK 153
           +VQ       +   +I+ E    G L D +         A   ++    I + +     K
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 130
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G  Y    G+ +   + APE L+ 
Sbjct: 131 NFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERP--EGCPEKVYE 243
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 244 LMRACWQWNPSDRPSFAEI 262

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 38  GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR----EIEIMRHLSGQ 93
           G ++G G FG+ Y    N+T +     ++ K   + D+  +++++    EI++M     +
Sbjct: 30  GNKMGEGGFGVVYKGYVNNTTV-----AVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 84
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVA---RGHYSERAAASVFRVIMNVVNVC 150
            N+V+      D   + +V      G L DR+         S      + +   N +N  
Sbjct: 85  -NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 143
Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE---EGKAYREIVGSPYYIAPEV 207
           H    +HRD+K  N L    DE    K +DFGL+   E   +      IVG+  Y+APE 
Sbjct: 144 HENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEA 200
Query: 208 LSQSYGKEADIWSAGVILYILLCGVP 233
           L      ++DI+S GV+L  ++ G+P
Sbjct: 201 LRGEITPKSDIYSFGVVLLEIITGLP 226

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 36  TIGREVGRGEFGITYLCT-ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           T+G+ +G G FG  Y         ++    + P  + ++       + E+ ++R  +   
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAF-----KNEVGVLRK-TRHV 80
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSK 153
           NI+ F   Y     + IV + C G  L+  + A    +  +    + R     ++  H+K
Sbjct: 81  NILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK 139
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS---AFIEEGKAYREIVGSPYYIAPEVL-- 208
            ++HRDLK  N       E+  VK  DFGL+   +       + ++ GS  ++APEV+  
Sbjct: 140 SIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 209 --SQSYGKEADIWSAGVILYILLCGVPPF 235
             S  Y  ++D+++ G++LY L+ G  P+
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 126/265 (47%), Gaps = 31/265 (11%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+ +E+G G+FG+  L        + A K I +  +     +D+  +E + M  LS  P 
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSM----SEDEFFQEAQTMMKLS-HPK 64
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH---- 151
           +V+F      +  ++IV E  + G L + + + G   E +     +++    +VC     
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPS-----QLLEMCYDVCEGMAF 119
Query: 152 --SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPE 206
             S   +HRDL   N L    D +  VK +DFG++ ++ + + Y   VG+ +   + APE
Sbjct: 120 LESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKWSAPE 175
Query: 207 VLSQ-SYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
           V     Y  ++D+W+ G++++ +   G  P+   T+  V   + +G   ++    P ++S
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR----PHLAS 231
Query: 265 SAI-ELVRRMLTQDPKRRITVAQVL 288
             I +++     + P++R T  Q+L
Sbjct: 232 DTIYQIMYSCWHELPEKRPTFQQLL 256

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 111/259 (42%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 68
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFD--RIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           +VQ       +   +I+ E    G L D  R   R   S      +   I + +     K
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G  +    G+ +   + APE L+ 
Sbjct: 129 NFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTFTAHAGAKFPIKWTAPESLAY 184
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDPSQVYELLEKDYRMERP--EGCPEKVYE 241
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 242 LMRACWQWNPSDRPSFAEI 260

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/319 (24%), Positives = 131/319 (41%), Gaps = 76/319 (23%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD----DVRREIEIMRHLSGQPN 95
           ++G+G FG  +      TG + A K     K++ + EK+       REI+I++ L  + N
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQLLKHE-N 78
Query: 96  IVQF------KAAYED--DQFVHIVMELC----AGGELFDRIVARGHYSERAAASVFRVI 143
           +V        KA+  +     +++V + C    AG  L   ++ +   SE     V +++
Sbjct: 79  VVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAG--LLSNVLVKFTLSE--IKRVMQML 134
Query: 144 MNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-----YREIVG 198
           +N +   H   ++HRD+K  N L T    + V+K  DFGL+      K      Y   V 
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 199 SPYYIAPEVL--SQSYGKEADIWSAGVILYIL---------------------LCG--VP 233
           + +Y  PE+L   + YG   D+W AG I+  +                     LCG   P
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 251
Query: 234 PFWAETD-----------QGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI 282
             W   D           +G  + +      + RDP+      A++L+ ++L  DP +RI
Sbjct: 252 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPY------ALDLIDKLLVLDPAQRI 305
Query: 283 TVAQVLEHPWLKESGEASD 301
                L H +       SD
Sbjct: 306 DSDDALNHDFFWSDPMPSD 324

>pdb|2LAN|A Chain A, Nmr Structure Of Ca2+-Bound Cabp1 N-Domain With Rdc Length = 167

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 78/149 (52%), Gaps = 6/149 (4%)
Query: 332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGT 391
           +L  EEI++L+E F E D D  G +   +L   +  +G M TE ++ +  Q  +++  G 
Sbjct: 18  SLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNLGGH 77
Query: 392 IDYIEFITAT-----MQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDA 446
           +D+ +F+         +   +   + L  AF+ FD + +G I+  EL +A +   +G   
Sbjct: 78  VDFDDFVELMGPKLLAETADMIGVKELRDAFREFDTNGDGEISTSELREAMRKL-LGHQV 136
Query: 447 TIATIKEIMSEVDRDKDGRISYDEFRSMM 475
               I+EI+ +VD + DGR+ ++EF  MM
Sbjct: 137 GHRDIEEIIRDVDLNGDGRVDFEEFVRMM 165

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/319 (24%), Positives = 131/319 (41%), Gaps = 76/319 (23%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD----DVRREIEIMRHLSGQPN 95
           ++G+G FG  +      TG + A K     K++ + EK+       REI+I++ L  + N
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQLLKHE-N 78
Query: 96  IVQF------KAAYED--DQFVHIVMELC----AGGELFDRIVARGHYSERAAASVFRVI 143
           +V        KA+  +     +++V + C    AG  L   ++ +   SE     V +++
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSE--IKRVMQML 134
Query: 144 MNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-----YREIVG 198
           +N +   H   ++HRD+K  N L T    + V+K  DFGL+      K      Y   V 
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 199 SPYYIAPEVL--SQSYGKEADIWSAGVILYIL---------------------LCG--VP 233
           + +Y  PE+L   + YG   D+W AG I+  +                     LCG   P
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 251
Query: 234 PFWAETD-----------QGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI 282
             W   D           +G  + +      + RDP+      A++L+ ++L  DP +RI
Sbjct: 252 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPY------ALDLIDKLLVLDPAQRI 305
Query: 283 TVAQVLEHPWLKESGEASD 301
                L H +       SD
Sbjct: 306 DSDDALNHDFFWSDPMPSD 324

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 130/285 (45%), Gaps = 42/285 (14%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
           T+G+ +G G FG   +    + G++   K  PK       K++KD   E+D  D+  E+E
Sbjct: 38  TLGKPLGEGAFGQVVMA--EAVGID---KDKPKEAVTVAVKMLKDDATEEDLSDLVSEME 92
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
           +M+ +    NI+    A   D  +++++E  + G L + + AR       +  + RV   
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 143 ---IMNVVNVCH----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
                ++V+  +          S+  +HRDL   N L T   EN V+K  DFGL+  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 209
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
              Y++         ++APE L  + Y  ++D+WS GV+++ I   G  P+     + + 
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
           + + +G    + D   + ++    ++R      P +R T  Q++E
Sbjct: 270 KLLKEGH---RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/319 (24%), Positives = 131/319 (41%), Gaps = 76/319 (23%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD----DVRREIEIMRHLSGQPN 95
           ++G+G FG  +      TG + A K     K++ + EK+       REI+I++ L  + N
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQLLKHE-N 77
Query: 96  IVQF------KAAYED--DQFVHIVMELC----AGGELFDRIVARGHYSERAAASVFRVI 143
           +V        KA+  +     +++V + C    AG  L   ++ +   SE     V +++
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSE--IKRVMQML 133
Query: 144 MNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-----YREIVG 198
           +N +   H   ++HRD+K  N L T    + V+K  DFGL+      K      Y   V 
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 190
Query: 199 SPYYIAPEVL--SQSYGKEADIWSAGVILYIL---------------------LCG--VP 233
           + +Y  PE+L   + YG   D+W AG I+  +                     LCG   P
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250
Query: 234 PFWAETD-----------QGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI 282
             W   D           +G  + +      + RDP+      A++L+ ++L  DP +RI
Sbjct: 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPY------ALDLIDKLLVLDPAQRI 304
Query: 283 TVAQVLEHPWLKESGEASD 301
                L H +       SD
Sbjct: 305 DSDDALNHDFFWSDPMPSD 323

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 107/231 (46%), Gaps = 39/231 (16%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
           T+G+ +G G FG   +    + G++   K  PK       K++KD   EKD  D+  E+E
Sbjct: 38  TLGKPLGEGAFGQVVMA--EAVGID---KDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 92
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
           +M+ +    NI+    A   D  +++++E  + G L + + AR       +  + RV   
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEE 152
Query: 143 ---IMNVVNVCH----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
                ++V+  +          S+  +HRDL   N L T   EN V+K  DFGL+  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 209
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPF 235
               ++         ++APE L  + Y  ++D+WS GV+++ I   G  P+
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/319 (24%), Positives = 131/319 (41%), Gaps = 76/319 (23%)
Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD----DVRREIEIMRHLSGQPN 95
           ++G+G FG  +      TG + A K     K++ + EK+       REI+I++ L  + N
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQLLKHE-N 78
Query: 96  IVQF------KAAYED--DQFVHIVMELC----AGGELFDRIVARGHYSERAAASVFRVI 143
           +V        KA+  +     +++V + C    AG  L   ++ +   SE     V +++
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSE--IKRVMQML 134
Query: 144 MNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-----YREIVG 198
           +N +   H   ++HRD+K  N L T    + V+K  DFGL+      K      Y   V 
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 199 SPYYIAPEVL--SQSYGKEADIWSAGVILYIL---------------------LCG--VP 233
           + +Y  PE+L   + YG   D+W AG I+  +                     LCG   P
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 251
Query: 234 PFWAETD-----------QGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI 282
             W   D           +G  + +      + RDP+      A++L+ ++L  DP +RI
Sbjct: 252 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPY------ALDLIDKLLVLDPAQRI 305
Query: 283 TVAQVLEHPWLKESGEASD 301
                L H +       SD
Sbjct: 306 DSDDALNHDFFWSDPMPSD 324

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 110/259 (42%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G+FG  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 14  TMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 68
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFD--RIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           +VQ       +   +I+ E    G L D  R   R   S      +   I + +     K
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G       G+ +   + APE L+ 
Sbjct: 129 NFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAY 184
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDPSQVYELLEKDYRMERP--EGCPEKVYE 241
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 242 LMRACWQWNPSDRPSFAEI 260

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 129/285 (45%), Gaps = 42/285 (14%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
           T+G+ +G G FG   +    + G++   K  PK       K++KD   EKD  D+  E+E
Sbjct: 38  TLGKPLGEGAFGQVVMA--EAVGID---KDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 92
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
           +M+ +    NI+    A   D  +++++   + G L + + AR       +  + RV   
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 143 ---IMNVVNVCH----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
                ++V+  +          S+  +HRDL   N L T   EN V+K  DFGL+  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 209
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
              Y++         ++APE L  + Y  ++D+WS GV+++ I   G  P+     + + 
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
           + + +G    + D   + ++    ++R      P +R T  Q++E
Sbjct: 270 KLLKEGH---RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 33/225 (14%)
Query: 37  IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV---EKDDVRREIEIMRHLSGQ 93
            G+ +G G FG     T    G E A   +  + L       EK+ +  E++IM HL   
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSER-AAASVFRVIMNVVNVCH- 151
            NIV    A      V ++ E C  G+L + +  +    E   A ++    ++  ++ H 
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHF 169
Query: 152 ------------SKGVMHRDLKPENFLFTTGDENAVVKATDFGL-------SAFIEEGKA 192
                       SK  +HRD+   N L T G    V K  DFGL       S +I +G A
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 193 YREIVGSPYYIAPE-VLSQSYGKEADIWSAGVILY-ILLCGVPPF 235
              +     ++APE +    Y  ++D+WS G++L+ I   G+ P+
Sbjct: 227 RLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 128/263 (48%), Gaps = 27/263 (10%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T  +E+G G+FG+ +L    +   + A K+I +  +     ++D   E E+M  LS  P 
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPK 63
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVN---VCH 151
           +VQ      +   + +V E    G L D +   RG +   AA ++  + ++V        
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF---AAETLLGMCLDVCEGMAYLE 120
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVL 208
              V+HRDL   N L     EN V+K +DFG++ F+ + + Y    G+ +   + +PEV 
Sbjct: 121 EASVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVF 176
Query: 209 SQS-YGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
           S S Y  ++D+WS GV+++ +   G  P+   ++  V + I  G   ++    P ++S+ 
Sbjct: 177 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK----PRLASTH 232
Query: 267 I-ELVRRMLTQDPKRRITVAQVL 288
           + +++     + P+ R   +++L
Sbjct: 233 VYQIMNHCWKERPEDRPAFSRLL 255

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
            +G+ +G G FG   L    + GL+   K  P R      K++K    EKD  D+  E+E
Sbjct: 72  VLGKPLGEGAFGQVVLA--EAIGLD---KDKPNRVTKVAVKMLKSDATEKDLSDLISEME 126
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-----------GHYSER 134
           +M+ +    NI+    A   D  +++++E  + G L + + AR            H  E 
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 135 AAASVFRV-----IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
             +S   V     +   +    SK  +HRDL   N L T   E+ V+K  DFGL+  I  
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHH 243
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
              Y++         ++APE L  + Y  ++D+WS GV+L+ I   G  P+     + + 
Sbjct: 244 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303
Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
           + + +G    + D   + ++    ++R      P +R T  Q++E
Sbjct: 304 KLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 345

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 79/340 (23%), Positives = 136/340 (40%), Gaps = 84/340 (24%)
Query: 38  GREVGRGEFGITYLCTENSTGLE--FACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           G +VGRG +G  Y         +  +A K I    +          REI ++R L   PN
Sbjct: 26  GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-----CREIALLRELK-HPN 79
Query: 96  IVQFKAAY--EDDQFVHIVMELCAGGELFDRIVARGHYSERA-----------AASVFRV 142
           ++  +  +    D+ V ++ +  A  +L+   + + H + +A             S+   
Sbjct: 80  VISLQKVFLSHADRKVWLLFDY-AEHDLWH--IIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFT-TGDENAVVKATDFGLSAF----IEEGKAYREIV 197
           I++ ++  H+  V+HRDLKP N L    G E   VK  D G +      ++       +V
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 198 GSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPF-------------------- 235
            + +Y APE+L  ++ Y K  DIW+ G I   LL   P F                    
Sbjct: 197 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256
Query: 236 ------------WAETDQGVAQAILKGEINFQRDPFPSIS-------------SSAIELV 270
                       W +  +    + L    +F+R+ + + S             S A  L+
Sbjct: 257 IFNVMGFPADKDWEDIKKMPEHSTLMK--DFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL 314
Query: 271 RRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIF 310
           +++LT DP +RIT  Q ++ P+  E       P+ T+ +F
Sbjct: 315 QKLLTMDPIKRITSEQAMQDPYFLED------PLPTSDVF 348

>pdb|3OX5|A Chain A, Crystal Structure Of The Calcium Sensor Calcium-Binding Protein 1 (Cabp1) Length = 153

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 78/149 (52%), Gaps = 6/149 (4%)
Query: 332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGT 391
           +L  EEI++L+E F E D D  G +   +L   +  +G M TE ++ +  Q  +++  G 
Sbjct: 4   SLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNLGGH 63
Query: 392 IDYIEFITAT-----MQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDA 446
           +D+ +F+         +   +   + L  AF+ FD + +G I+  EL +A +   +G   
Sbjct: 64  VDFDDFVELMGPKLLAETADMIGVKELRDAFREFDTNGDGEISTSELREAMRKL-LGHQV 122
Query: 447 TIATIKEIMSEVDRDKDGRISYDEFRSMM 475
               I+EI+ +VD + DGR+ ++EF  MM
Sbjct: 123 GHRDIEEIIRDVDLNGDGRVDFEEFVRMM 151

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
            +G+ +G G FG   L    + GL+   K  P R      K++K    EKD  D+  E+E
Sbjct: 31  VLGKPLGEGAFGQVVLA--EAIGLD---KDKPNRVTKVAVKMLKSDATEKDLSDLISEME 85
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-----------GHYSER 134
           +M+ +    NI+    A   D  +++++E  + G L + + AR            H  E 
Sbjct: 86  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEE 145
Query: 135 AAASVFRV-----IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
             +S   V     +   +    SK  +HRDL   N L T   E+ V+K  DFGL+  I  
Sbjct: 146 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHH 202
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
              Y++         ++APE L  + Y  ++D+WS GV+L+ I   G  P+     + + 
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
           + + +G    + D   + ++    ++R      P +R T  Q++E
Sbjct: 263 KLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
            +G+ +G G FG   L    + GL+   K  P R      K++K    EKD  D+  E+E
Sbjct: 31  VLGKPLGEGAFGQVVLA--EAIGLD---KDKPNRVTKVAVKMLKSDATEKDLSDLISEME 85
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-----------GHYSER 134
           +M+ +    NI+    A   D  +++++E  + G L + + AR            H  E 
Sbjct: 86  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 145
Query: 135 AAASVFRV-----IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
             +S   V     +   +    SK  +HRDL   N L T   E+ V+K  DFGL+  I  
Sbjct: 146 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHH 202
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
              Y++         ++APE L  + Y  ++D+WS GV+L+ I   G  P+     + + 
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
           + + +G    + D   + ++    ++R      P +R T  Q++E
Sbjct: 263 KLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
            +G+ +G G FG   L    + GL+   K  P R      K++K    EKD  D+  E+E
Sbjct: 20  VLGKPLGEGAFGQVVLA--EAIGLD---KDKPNRVTKVAVKMLKSDATEKDLSDLISEME 74
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-----------GHYSER 134
           +M+ +    NI+    A   D  +++++E  + G L + + AR            H  E 
Sbjct: 75  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 134
Query: 135 AAASVFRV-----IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
             +S   V     +   +    SK  +HRDL   N L T   E+ V+K  DFGL+  I  
Sbjct: 135 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHH 191
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
              Y++         ++APE L  + Y  ++D+WS GV+L+ I   G  P+     + + 
Sbjct: 192 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 251
Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
           + + +G    + D   + ++    ++R      P +R T  Q++E
Sbjct: 252 KLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 293

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 18/225 (8%)
Query: 27  AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEI 86
            ++ V   Y + + +G+G FG      ++      A K +   K       +++R    I
Sbjct: 91  PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----I 146
Query: 87  MRHLSGQP-----NIVQFKAAYEDDQFVHIVMELCAGG--ELFDRIVARGHYSERAAASV 139
           + HL  Q      N++     +     + +  EL +    EL  +   +G +S       
Sbjct: 147 LEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKF 205
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              I+  ++  H   ++H DLKPEN L      + + K  DFG S + E  + Y  I  S
Sbjct: 206 AHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGI-KVIDFGSSCY-EHQRVYTXIQ-S 262
Query: 200 PYYIAPEV-LSQSYGKEADIWSAGVILYILLCGVP--PFWAETDQ 241
            +Y APEV L   YG   D+WS G IL  LL G P  P   E DQ
Sbjct: 263 RFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 107/231 (46%), Gaps = 39/231 (16%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
           T+G+ +G G FG   +    + G++   K  PK       K++KD   EKD  D+  E+E
Sbjct: 38  TLGKPLGEGAFGQVVMA--EAVGID---KDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 92
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
           +M+ +    NI+    A   D  +++++E  + G L + + AR       +  + RV   
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 143 ---IMNVVNVCH----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
                ++V+  +          S+  +HRDL   N L T   EN V+K  DFGL+  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 209
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPF 235
               ++         ++APE L  + Y  ++D+WS GV+++ I   G  P+
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
            +G+ +G G FG   L    + GL+   K  P R      K++K    EKD  D+  E+E
Sbjct: 31  VLGKPLGEGAFGQVVLA--EAIGLD---KDKPNRVTKVAVKMLKSDATEKDLSDLISEME 85
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-----------GHYSER 134
           +M+ +    NI+    A   D  +++++E  + G L + + AR            H  E 
Sbjct: 86  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEE 145
Query: 135 AAASVFRV-----IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
             +S   V     +   +    SK  +HRDL   N L T   E+ V+K  DFGL+  I  
Sbjct: 146 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHH 202
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
              Y++         ++APE L  + Y  ++D+WS GV+L+ I   G  P+     + + 
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
           + + +G    + D   + ++    ++R      P +R T  Q++E
Sbjct: 263 KLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 111/259 (42%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 68
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFD--RIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           +VQ       +   +I++E    G L D  R   R   S      +   I + +     K
Sbjct: 69  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G       G+ +   + APE L+ 
Sbjct: 129 NFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAY 184
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDPSQVYELLEKDYRMERP--EGCPEKVYE 241
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 242 LMRACWQWNPSDRPSFAEI 260

>pdb|3OX6|A Chain A, Crystal Structure Of The Calcium Sensor Calcium-Binding Protein 1 (Cabp1) Length = 153

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 79/154 (51%), Gaps = 16/154 (10%)
Query: 332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGT 391
           +L  EEI++L+E F E D D  G +   +L   +  +G M TE ++ +  Q  +++  G 
Sbjct: 4   SLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNLGGH 63
Query: 392 IDYIEFI----------TATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYG 441
           +D+ +F+          TA M   K      L  AF+ FD + +G I+  EL +A +   
Sbjct: 64  VDFDDFVELMGPKLLAETADMIGVK-----ELRDAFREFDTNGDGEISTSELREAMRAL- 117
Query: 442 MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMM 475
           +G       I+EI+ +VD + DGR+ ++EF  MM
Sbjct: 118 LGHQVGHRDIEEIIRDVDLNGDGRVDFEEFVRMM 151

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 18/224 (8%)
Query: 28  YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM 87
           ++ V   Y + + +G+G FG      ++      A K +   K       +++R    I+
Sbjct: 92  HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----IL 147
Query: 88  RHLSGQP-----NIVQFKAAYEDDQFVHIVMELCAGG--ELFDRIVARGHYSERAAASVF 140
            HL  Q      N++     +     + +  EL +    EL  +   +G +S        
Sbjct: 148 EHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFA 206
Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP 200
             I+  ++  H   ++H DLKPEN L      + + K  DFG S + E  + Y  I  S 
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGI-KVIDFGSSCY-EHQRVYTXI-QSR 263
Query: 201 YYIAPEV-LSQSYGKEADIWSAGVILYILLCGVP--PFWAETDQ 241
           +Y APEV L   YG   D+WS G IL  LL G P  P   E DQ
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
            +G+ +G G FG   L    + GL+   K  P R      K++K    EKD  D+  E+E
Sbjct: 16  VLGKPLGEGAFGQVVLA--EAIGLD---KDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-----------GHYSER 134
           +M+ +    NI+    A   D  +++++E  + G L + + AR            H  E 
Sbjct: 71  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEE 130
Query: 135 AAASVFRV-----IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
             +S   V     +   +    SK  +HRDL   N L T   E+ V+K  DFGL+  I  
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHH 187
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
              Y++         ++APE L  + Y  ++D+WS GV+L+ I   G  P+     + + 
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247
Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
           + + +G    + D   + ++    ++R      P +R T  Q++E
Sbjct: 248 KLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 129/285 (45%), Gaps = 42/285 (14%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
           T+G+ +G G FG   +    + G++   K  PK       K++KD   EKD  D+  E+E
Sbjct: 38  TLGKPLGEGAFGQVVMA--EAVGID---KDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 92
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--- 142
           +M+ +    NI+    A   D  +++++   + G L + + AR       +  + RV   
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 143 ---IMNVVNVCH----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
                ++V+  +          S+  +HRDL   N L T   EN V+K  DFGL+  I  
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINN 209
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
              Y++         ++APE L  + Y  ++D+WS GV+++ I   G  P+     + + 
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
           + + +G    + D   + ++    ++R      P +R T  Q++E
Sbjct: 270 KLLKEGH---RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 18/225 (8%)
Query: 27  AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEI 86
            ++ V   Y + + +G+G FG      ++      A K +   K       +++R    I
Sbjct: 91  PHDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----I 146
Query: 87  MRHLSGQP-----NIVQFKAAYEDDQFVHIVMELCAGG--ELFDRIVARGHYSERAAASV 139
           + HL  Q      N++     +     + +  EL +    EL  +   +G +S       
Sbjct: 147 LEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKF 205
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              I+  ++  H   ++H DLKPEN L      + + K  DFG S + E  + Y  I  S
Sbjct: 206 AHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGI-KVIDFGSSCY-EHQRVYXXIQ-S 262
Query: 200 PYYIAPEV-LSQSYGKEADIWSAGVILYILLCGVP--PFWAETDQ 241
            +Y APEV L   YG   D+WS G IL  LL G P  P   E DQ
Sbjct: 263 RFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 128/263 (48%), Gaps = 27/263 (10%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T  +E+G G+FG+ +L    +   + A K+I +  +     ++D   E E+M  LS  P 
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPK 63
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVN---VCH 151
           +VQ      +   + +V E    G L D +   RG +   AA ++  + ++V        
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF---AAETLLGMCLDVCEGMAYLE 120
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVL 208
              V+HRDL   N L     EN V+K +DFG++ F+ + + Y    G+ +   + +PEV 
Sbjct: 121 EACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVF 176
Query: 209 SQS-YGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
           S S Y  ++D+WS GV+++ +   G  P+   ++  V + I  G   ++    P ++S+ 
Sbjct: 177 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK----PRLASTH 232
Query: 267 I-ELVRRMLTQDPKRRITVAQVL 288
           + +++     + P+ R   +++L
Sbjct: 233 VYQIMNHCWKERPEDRPAFSRLL 255

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 128/263 (48%), Gaps = 27/263 (10%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T  +E+G G+FG+ +L    +   + A K+I +  +     ++D   E E+M  LS  P 
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPK 61
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVN---VCH 151
           +VQ      +   + +V E    G L D +   RG +   AA ++  + ++V        
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF---AAETLLGMCLDVCEGMAYLE 118
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVL 208
              V+HRDL   N L     EN V+K +DFG++ F+ + + Y    G+ +   + +PEV 
Sbjct: 119 EACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVF 174
Query: 209 SQS-YGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
           S S Y  ++D+WS GV+++ +   G  P+   ++  V + I  G   ++    P ++S+ 
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK----PRLASTH 230
Query: 267 I-ELVRRMLTQDPKRRITVAQVL 288
           + +++     + P+ R   +++L
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLL 253

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
            +G+ +G G FG   L    + GL+   K  P R      K++K    EKD  D+  E+E
Sbjct: 24  VLGKPLGEGAFGQVVLA--EAIGLD---KDKPNRVTKVAVKMLKSDATEKDLSDLISEME 78
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-----------GHYSER 134
           +M+ +    NI+    A   D  +++++E  + G L + + AR            H  E 
Sbjct: 79  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 138
Query: 135 AAASVFRV-----IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
             +S   V     +   +    SK  +HRDL   N L T   E+ V+K  DFGL+  I  
Sbjct: 139 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHH 195
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
              Y++         ++APE L  + Y  ++D+WS GV+L+ I   G  P+     + + 
Sbjct: 196 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 255
Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
           + + +G    + D   + ++    ++R      P +R T  Q++E
Sbjct: 256 KLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 297

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
            +G+ +G G FG   L    + GL+   K  P R      K++K    EKD  D+  E+E
Sbjct: 23  VLGKPLGEGAFGQVVLA--EAIGLD---KDKPNRVTKVAVKMLKSDATEKDLSDLISEME 77
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-----------GHYSER 134
           +M+ +    NI+    A   D  +++++E  + G L + + AR            H  E 
Sbjct: 78  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 137
Query: 135 AAASVFRV-----IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
             +S   V     +   +    SK  +HRDL   N L T   E+ V+K  DFGL+  I  
Sbjct: 138 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHH 194
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
              Y++         ++APE L  + Y  ++D+WS GV+L+ I   G  P+     + + 
Sbjct: 195 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 254
Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
           + + +G    + D   + ++    ++R      P +R T  Q++E
Sbjct: 255 KLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 296

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/287 (23%), Positives = 121/287 (42%), Gaps = 24/287 (8%)
Query: 13  HPAARHLHDAILGKA-----YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIP 67
           +PA +     I G +     +E  +   T+  ++G G++G  Y        L  A K++ 
Sbjct: 195 YPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK 254
Query: 68  KRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFD--RI 125
           +  +    E ++  +E  +M+ +   PN+VQ       +   +I+ E    G L D  R 
Sbjct: 255 EDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE 309
Query: 126 VARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA 185
             R   S      +   I + +     K  +HR+L   N L     EN +VK  DFGLS 
Sbjct: 310 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSR 366
Query: 186 FIEEGKAYREIVGSPY---YIAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETD 240
            +  G  Y    G+ +   + APE L+   +  ++D+W+ GV+L+ I   G+ P+    D
Sbjct: 367 LM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-PGID 424
Query: 241 QGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQV 287
                 +L+ +   +R           EL+R     +P  R + A++
Sbjct: 425 LSQVYELLEKDYRMERP--EGCPEKVYELMRACWQWNPSDRPSFAEI 469

>pdb|3E3R|A Chain A, Crystal Structure And Biochemical Characterization Of Recombinant Human Calcyphosine Delineates A Novel Ef-hand-containing Protein Family Length = 204

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 71/141 (50%), Gaps = 6/141 (4%)
Query: 338 IQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEF 397
           IQ L   F ++D D S +L  DE + GLAKLG +L + + +   +  D +G+GT+D  EF
Sbjct: 36  IQGLARFFRQLDRDGSRSLDADEFRQGLAKLGLVLDQAEAEGVCRKWDRNGSGTLDLEEF 95
Query: 398 ITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDEL-----GKAFKDYGMGDDATIATIK 452
           + A        R   +  AF   D+  +G +TVD+L     G+A      G+      ++
Sbjct: 96  LRALRPPMSQAREAVIAAAFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEVLR 155
Query: 453 EIMSEVD-RDKDGRISYDEFR 472
             +   D  +KDG+++  EF+
Sbjct: 156 RFLDNFDSSEKDGQVTLAEFQ 176

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 75/334 (22%), Positives = 127/334 (38%), Gaps = 84/334 (25%)
Query: 31  VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK--DDVRREIEIMR 88
           +Q  Y I   +G G FG    C +++ G     KS    K++++V K  +  R EI +++
Sbjct: 49  LQERYEIVGNLGEGTFGKVVECLDHARG-----KSQVALKIIRNVGKYREAARLEINVLK 103
Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDR----IVARGHYSERAAASVFRV-- 142
            +  +    +F      D F +    +C   EL  +     +   ++       V  +  
Sbjct: 104 KIKEKDKENKFLCVLMSDWF-NFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAY 162
Query: 143 -IMNVVNVCHSKGVMHRDLKPENFLFTTGD----------------ENAVVKATDFGLSA 185
            + + +   H   + H DLKPEN LF   +                +N  ++  DFG + 
Sbjct: 163 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 222
Query: 186 FIEEGKAYREIVGSPYYIAPEV-LSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVA 244
           F  E   +  IV + +Y  PEV L   + +  D+WS G IL+    G   F  +T +   
Sbjct: 223 FDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF--QTHENRE 278
Query: 245 QAILKGEINFQRDPFPS-----------------------------------ISSSAIE- 268
             ++  +I     P PS                                   + S  ++ 
Sbjct: 279 HLVMMEKI---LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 335
Query: 269 ---------LVRRMLTQDPKRRITVAQVLEHPWL 293
                    L+RRML  DP +RIT+A+ L HP+ 
Sbjct: 336 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 369

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 114/265 (43%), Gaps = 23/265 (8%)
Query: 37  IGREVGRGEFGIT---YLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           I + +G GEFG     +L       +  A K++  +    + ++ D   E  IM      
Sbjct: 37  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFD-H 93
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCH 151
           PN++  +        V I+ E    G L D  + +  G ++      + R I   +    
Sbjct: 94  PNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 152
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPY---YIAP 205
               +HRDL   N L  +   N V K +DFGLS F+E+  +   Y   +G      + AP
Sbjct: 153 DMNYVHRDLAARNILVNS---NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 209
Query: 206 EVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263
           E +  + +   +D+WS G++++ ++  G  P+W  T+Q V  AI   E +++  P     
Sbjct: 210 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI---EQDYRLPPPMDCP 266
Query: 264 SSAIELVRRMLTQDPKRRITVAQVL 288
           S+  +L+     +D   R    Q++
Sbjct: 267 SALHQLMLDCWQKDRNHRPKFGQIV 291

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 36  TIGREVGRGEFGITYLCT-ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           T+G+ +G G FG  Y         ++    + P  + ++       + E+ ++R  +   
Sbjct: 38  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAF-----KNEVGVLRK-TRHV 91
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVNVCHSK 153
           NI+ F   Y     + IV + C G  L+  + +    +       + R     ++  H+K
Sbjct: 92  NILLF-MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 150
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVL-- 208
            ++HRDLK  N       E+  VK  DFGL+           + ++ GS  ++APEV+  
Sbjct: 151 SIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 207
Query: 209 --SQSYGKEADIWSAGVILYILLCGVPPF 235
                Y  ++D+++ G++LY L+ G  P+
Sbjct: 208 QDKNPYSFQSDVYAFGIVLYELMTGQLPY 236

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 128/263 (48%), Gaps = 27/263 (10%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T  +E+G G+FG+ +L    +   + A K+I +  +     ++D   E E+M  LS  P 
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPK 66
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVN---VCH 151
           +VQ      +   + +V E    G L D +   RG +   AA ++  + ++V        
Sbjct: 67  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF---AAETLLGMCLDVCEGMAYLE 123
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVL 208
              V+HRDL   N L     EN V+K +DFG++ F+ + + Y    G+ +   + +PEV 
Sbjct: 124 EACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVF 179
Query: 209 SQS-YGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
           S S Y  ++D+WS GV+++ +   G  P+   ++  V + I  G   ++    P ++S+ 
Sbjct: 180 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK----PRLASTH 235
Query: 267 I-ELVRRMLTQDPKRRITVAQVL 288
           + +++     + P+ R   +++L
Sbjct: 236 VYQIMNHCWRERPEDRPAFSRLL 258

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 75/334 (22%), Positives = 127/334 (38%), Gaps = 84/334 (25%)
Query: 31  VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK--DDVRREIEIMR 88
           +Q  Y I   +G G FG    C +++ G     KS    K++++V K  +  R EI +++
Sbjct: 26  LQERYEIVGNLGEGTFGKVVECLDHARG-----KSQVALKIIRNVGKYREAARLEINVLK 80
Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDR----IVARGHYSERAAASVFRV-- 142
            +  +    +F      D F +    +C   EL  +     +   ++       V  +  
Sbjct: 81  KIKEKDKENKFLCVLMSDWF-NFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAY 139
Query: 143 -IMNVVNVCHSKGVMHRDLKPENFLFTTGD----------------ENAVVKATDFGLSA 185
            + + +   H   + H DLKPEN LF   +                +N  ++  DFG + 
Sbjct: 140 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 199
Query: 186 FIEEGKAYREIVGSPYYIAPEV-LSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVA 244
           F  E   +  IV + +Y  PEV L   + +  D+WS G IL+    G   F  +T +   
Sbjct: 200 FDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF--QTHENRE 255
Query: 245 QAILKGEINFQRDPFPS-----------------------------------ISSSAIE- 268
             ++  +I     P PS                                   + S  ++ 
Sbjct: 256 HLVMMEKI---LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 312
Query: 269 ---------LVRRMLTQDPKRRITVAQVLEHPWL 293
                    L+RRML  DP +RIT+A+ L HP+ 
Sbjct: 313 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 346

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 92/225 (40%), Gaps = 33/225 (14%)
Query: 37  IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV---EKDDVRREIEIMRHLSGQ 93
            G+ +G G FG     T    G E A   +  + L       EK+ +  E++IM HL   
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRI--------------VARGHYSERAAASV 139
            NIV    A      V ++ E C  G+L + +              +A    S R     
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL-------SAFIEEGKA 192
              +   +    SK  +HRD+   N L T G    V K  DFGL       S +I +G A
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 193 YREIVGSPYYIAPE-VLSQSYGKEADIWSAGVILY-ILLCGVPPF 235
              +     ++APE +    Y  ++D+WS G++L+ I   G+ P+
Sbjct: 227 RLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 128/263 (48%), Gaps = 27/263 (10%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T  +E+G G+FG+ +L    +   + A K+I +  +     ++D   E E+M  LS  P 
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPK 64
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVN---VCH 151
           +VQ      +   + +V E    G L D +   RG +   AA ++  + ++V        
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLF---AAETLLGMCLDVCEGMAYLE 121
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVL 208
              V+HRDL   N L     EN V+K +DFG++ F+ + + Y    G+ +   + +PEV 
Sbjct: 122 EACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVF 177
Query: 209 SQS-YGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
           S S Y  ++D+WS GV+++ +   G  P+   ++  V + I  G   ++    P ++S+ 
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK----PRLASTH 233
Query: 267 I-ELVRRMLTQDPKRRITVAQVL 288
           + +++     + P+ R   +++L
Sbjct: 234 VYQIMNHCWRERPEDRPAFSRLL 256

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 36  TIGREVGRGEFGITYLCT-ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           T+G+ +G G FG  Y         ++    + P  + ++       + E+ ++R  +   
Sbjct: 39  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAF-----KNEVGVLRK-TRHV 92
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVNVCHSK 153
           NI+ F   Y     + IV + C G  L+  + +    +       + R     ++  H+K
Sbjct: 93  NILLF-MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVL-- 208
            ++HRDLK  N       E+  VK  DFGL+           + ++ GS  ++APEV+  
Sbjct: 152 SIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 209 --SQSYGKEADIWSAGVILYILLCGVPPF 235
                Y  ++D+++ G++LY L+ G  P+
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 36  TIGREVGRGEFGITYLCT-ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           T+G+ +G G FG  Y         ++    + P  + ++       + E+ ++R  +   
Sbjct: 16  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAF-----KNEVGVLRK-TRHV 69
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVNVCHSK 153
           NI+ F   Y     + IV + C G  L+  + +    +       + R     ++  H+K
Sbjct: 70  NILLF-MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 128
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVL-- 208
            ++HRDLK  N       E+  VK  DFGL+           + ++ GS  ++APEV+  
Sbjct: 129 SIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 185
Query: 209 --SQSYGKEADIWSAGVILYILLCGVPPF 235
                Y  ++D+++ G++LY L+ G  P+
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 36  TIGREVGRGEFGITYLCT-ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           T+G+ +G G FG  Y         ++    + P  + ++       + E+ ++R  +   
Sbjct: 16  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAF-----KNEVGVLRK-TRHV 69
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVNVCHSK 153
           NI+ F   Y     + IV + C G  L+  + +    +       + R     ++  H+K
Sbjct: 70  NILLF-MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 128
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVL-- 208
            ++HRDLK  N       E+  VK  DFGL+           + ++ GS  ++APEV+  
Sbjct: 129 SIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 185
Query: 209 --SQSYGKEADIWSAGVILYILLCGVPPF 235
                Y  ++D+++ G++LY L+ G  P+
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 111/259 (42%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 17  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 71
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSK 153
           +VQ       +   +I++E    G L D +         A   ++    I + +     K
Sbjct: 72  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 131
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G       G+ +   + APE L+ 
Sbjct: 132 NFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAY 187
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERP--EGCPEKVYE 244
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 245 LMRACWQWNPSDRPSFAEI 263

>pdb|2LHH|A Chain A, Solution Structure Of Ca2+-Bound Ycam Length = 128

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 38/111 (34%), Positives = 58/111 (52%), Gaps = 1/111 (0%)
Query: 332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGT 391
           NL  E+I + KE F   D DN+G+++  EL   +  LG   +E +V   M   D+DGN  
Sbjct: 3   NLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQ 62
Query: 392 IDYIEFITATMQRHKLQRFEN-LYKAFQYFDKDNNGYITVDELGKAFKDYG 441
           I++ EF+    ++ K    E  L +AF+ FDK+ +G I+  EL       G
Sbjct: 63  IEFSEFLALMSRQLKSNDSEQELLEAFKVFDKNGDGLISAAELKHVLTSIG 113

>pdb|2LHH|A Chain A, Solution Structure Of Ca2+-Bound Ycam Length = 128

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 22/68 (32%), Positives = 39/68 (57%), Gaps = 2/68 (2%)
Query: 408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRIS 467
           ++     +AF  FDKDNNG I+  EL    +  G+    + A + ++M+E+D D + +I 
Sbjct: 7   EQIAEFKEAFALFDKDNNGSISSSELATVMRSLGL--SPSEAEVNDLMNEIDVDGNHQIE 64
Query: 468 YDEFRSMM 475
           + EF ++M
Sbjct: 65  FSEFLALM 72

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 36  TIGREVGRGEFGITYLCT-ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           T+G+ +G G FG  Y         ++    + P  + ++       + E+ ++R  +   
Sbjct: 13  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAF-----KNEVGVLRK-TRHV 66
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVNVCHSK 153
           NI+ F   Y     + IV + C G  L+  + +    +       + R     ++  H+K
Sbjct: 67  NILLF-MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 125
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVL-- 208
            ++HRDLK  N       E+  VK  DFGL+           + ++ GS  ++APEV+  
Sbjct: 126 SIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 182
Query: 209 --SQSYGKEADIWSAGVILYILLCGVPPF 235
                Y  ++D+++ G++LY L+ G  P+
Sbjct: 183 QDKNPYSFQSDVYAFGIVLYELMTGQLPY 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 36  TIGREVGRGEFGITYLCT-ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           T+G+ +G G FG  Y         ++    + P  + ++       + E+ ++R  +   
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAF-----KNEVGVLRK-TRHV 64
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVNVCHSK 153
           NI+ F   Y     + IV + C G  L+  + +    +       + R     ++  H+K
Sbjct: 65  NILLF-MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVL-- 208
            ++HRDLK  N       E+  VK  DFGL+           + ++ GS  ++APEV+  
Sbjct: 124 SIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 209 --SQSYGKEADIWSAGVILYILLCGVPPF 235
                Y  ++D+++ G++LY L+ G  P+
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|2JT0|A Chain A, Solution Structure Of F104w Cardiac Troponin C Length = 161

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 70/128 (54%), Gaps = 6/128 (4%)
Query: 353 SGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR----HKLQ 408
            G+++  EL   +  LG   T  ++++ +   D DG+GT+D+ EF+   ++      K +
Sbjct: 33  DGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGK 92
Query: 409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISY 468
             E L   F+ +DK+ +GYI +DEL    +    G+  T   I+E+M + D++ DGRI Y
Sbjct: 93  SEEELSDLFRMWDKNADGYIDLDELKIMLQ--ATGETITEDDIEELMKDGDKNNDGRIDY 150
Query: 469 DEFRSMMK 476
           DEF   MK
Sbjct: 151 DEFLEFMK 158

>pdb|2JT3|A Chain A, Solution Structure Of F153w Cardiac Troponin C Length = 161

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 70/128 (54%), Gaps = 6/128 (4%)
Query: 353 SGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR----HKLQ 408
            G+++  EL   +  LG   T  ++++ +   D DG+GT+D+ EF+   ++      K +
Sbjct: 33  DGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGK 92
Query: 409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISY 468
             E L   F+ FDK+ +GYI +DEL    +    G+  T   I+E+M + D++ DGRI Y
Sbjct: 93  SEEELSDLFRMFDKNADGYIDLDELKIMLQ--ATGETITEDDIEELMKDGDKNNDGRIDY 150
Query: 469 DEFRSMMK 476
           DE+   MK
Sbjct: 151 DEWLEFMK 158

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/334 (22%), Positives = 127/334 (38%), Gaps = 84/334 (25%)
Query: 31  VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK--DDVRREIEIMR 88
           +Q  Y I   +G G FG    C +++ G     KS    K++++V K  +  R EI +++
Sbjct: 17  LQERYEIVGNLGEGTFGKVVECLDHARG-----KSQVALKIIRNVGKYREAARLEINVLK 71
Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDR----IVARGHYSERAAASVFRV-- 142
            +  +    +F      D F +    +C   EL  +     +   ++       V  +  
Sbjct: 72  KIKEKDKENKFLCVLMSDWF-NFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAY 130
Query: 143 -IMNVVNVCHSKGVMHRDLKPENFLFTTGD----------------ENAVVKATDFGLSA 185
            + + +   H   + H DLKPEN LF   +                +N  ++  DFG + 
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 186 FIEEGKAYREIVGSPYYIAPEV-LSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVA 244
           F  E   +  IV + +Y  PEV L   + +  D+WS G IL+    G   F  +T +   
Sbjct: 191 FDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF--QTHENRE 246
Query: 245 QAILKGEINFQRDPFPS-----------------------------------ISSSAIE- 268
             ++  +I     P PS                                   + S  ++ 
Sbjct: 247 HLVMMEKI---LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 303
Query: 269 ---------LVRRMLTQDPKRRITVAQVLEHPWL 293
                    L+RRML  DP +RIT+A+ L HP+ 
Sbjct: 304 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 337

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 18/202 (8%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           VGRG FG  +   +  TG + A         VK V  +  R E  +       P IV   
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCA---------VKKVRLEVFRVEELVACAGLSSPRIVPLY 116
Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
            A  +  +V+I MEL  GG L   I   G   E  A       +  +   H++ ++H D+
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 161 KPENFLFTTGDENAVVKATDFGLSAFIEE---GKAYRE---IVGSPYYIAPE-VLSQSYG 213
           K +N L ++    A +   DFG +  ++    GK+      I G+  ++APE V+ +   
Sbjct: 177 KADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 214 KEADIWSAGVILYILLCGVPPF 235
            + DIWS+  ++  +L G  P+
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHPW 256

>pdb|1AJ4|A Chain A, Structure Of Calcium-Saturated Cardiac Troponin C, Nmr, 1 Structure Length = 161

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 70/128 (54%), Gaps = 6/128 (4%)
Query: 353 SGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR----HKLQ 408
            G+++  EL   +  LG   T  ++++ +   D DG+GT+D+ EF+   ++      K +
Sbjct: 33  DGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGK 92
Query: 409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISY 468
             E L   F+ FDK+ +GYI ++EL    +    G+  T   I+E+M + D++ DGRI Y
Sbjct: 93  TEEELSDLFRMFDKNADGYIDLEELKIMLQ--ATGETITEDDIEELMKDGDKNNDGRIDY 150
Query: 469 DEFRSMMK 476
           DEF   MK
Sbjct: 151 DEFLEFMK 158

>pdb|1DTL|A Chain A, Crystal Structure Of Calcium-Saturated (3ca2+) Cardiac Troponin C Complexed With The Calcium Sensitizer Bepridil At 2.15 A Resolution Length = 161

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 70/128 (54%), Gaps = 6/128 (4%)
Query: 353 SGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR----HKLQ 408
            G+++  EL   +  LG   T  ++++ +   D DG+GT+D+ EF+   ++      K +
Sbjct: 33  DGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGK 92
Query: 409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISY 468
             E L   F+ FDK+ +GYI ++EL    +    G+  T   I+E+M + D++ DGRI Y
Sbjct: 93  SEEELSDLFRMFDKNADGYIDLEELKIMLQ--ATGETITEDDIEELMKDGDKNNDGRIDY 150
Query: 469 DEFRSMMK 476
           DEF   MK
Sbjct: 151 DEFLEFMK 158

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 122/267 (45%), Gaps = 27/267 (10%)
Query: 36  TIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           +I + VG GEFG   +C+      +   +  A K++  +    + ++ D   E  IM   
Sbjct: 48  SIDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQF 103
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVN 148
              PNI++ +      + V IV E    G L D  + +    ++      + R I + + 
Sbjct: 104 D-HPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--AYREIVGS-PY-YIA 204
                G +HRDL   N L  +   N V K +DFGLS  +E+    AY    G  P  + +
Sbjct: 162 YLSDMGAVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 205 PEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
           PE ++ + +   +D+WS G++L+ ++  G  P+W  ++Q V +A+ +G     R P P  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG----YRLPPPMD 274
Query: 263 SSSAI-ELVRRMLTQDPKRRITVAQVL 288
             +A+ +L+     +D   R    Q++
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 111/259 (42%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 262 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 316
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSK 153
           +VQ       +   +I+ E    G L D +         A   ++    I + +     K
Sbjct: 317 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 376
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HR+L   N L     EN +VK  DFGLS  +  G  Y    G+ +   + APE L+ 
Sbjct: 377 NFIHRNLAARNCLV---GENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAY 432
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 433 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERP--EGCPEKVYE 489
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 490 LMRACWQWNPSDRPSFAEI 508

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 16/221 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T  +E+G G+FG+           + A K I +  +     +D+   E ++M +LS +  
Sbjct: 12  TFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHE-K 65
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHSKG 154
           +VQ        + + I+ E  A G L + +    H +  +    + + +   +    SK 
Sbjct: 66  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLSQS 211
            +HRDL   N L    ++  VVK +DFGLS ++ + + Y   VGS +   +  PEVL  S
Sbjct: 126 FLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYS 181
Query: 212 -YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
            +  ++DIW+ GV+++ I   G  P+   T+   A+ I +G
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 222

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 18/202 (8%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           VGRG FG  +   +  TG + A         VK V  +  R E  +       P IV   
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCA---------VKKVRLEVFRVEELVACAGLSSPRIVPLY 132
Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
            A  +  +V+I MEL  GG L   I   G   E  A       +  +   H++ ++H D+
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 192
Query: 161 KPENFLFTTGDENAVVKATDFGLSAFIEE---GKAYRE---IVGSPYYIAPE-VLSQSYG 213
           K +N L ++    A +   DFG +  ++    GK+      I G+  ++APE V+ +   
Sbjct: 193 KADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 250
Query: 214 KEADIWSAGVILYILLCGVPPF 235
            + DIWS+  ++  +L G  P+
Sbjct: 251 AKVDIWSSCCMMLHMLNGCHPW 272

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 113/242 (46%), Gaps = 40/242 (16%)
Query: 14  PAARHLH-DAILGKAYEDV------QLHYTIGREVGRGEFGITYLC----TENSTGLEFA 62
           P   +L+    +G A+ED       + H    +++G+G FG   +C     +++TG   A
Sbjct: 15  PTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVA 74
Query: 63  CKSIPKRKLVKDVEKD--DVRREIEIMRHLSGQPNIVQFKAA--YEDDQFVHIVMELCAG 118
            K     KL    E+   D  REIEI++ L    NIV++K        + + ++ME    
Sbjct: 75  VK-----KLQHSTEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPY 128
Query: 119 GELFDRIVARGHYSERAAASVFRVIMNVVNVCH------SKGVMHRDLKPENFLFTTGDE 172
           G L D +     + ER      +++     +C       +K  +HRDL   N L    +E
Sbjct: 129 GSLRDYLQK---HKERIDH--IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE--NE 181
Query: 173 NAVVKATDFGLSAFIEEGK---AYREIVGSP-YYIAPEVLSQS-YGKEADIWSAGVILYI 227
           N V K  DFGL+  + + K     +E   SP ++ APE L++S +   +D+WS GV+LY 
Sbjct: 182 NRV-KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 240
Query: 228 LL 229
           L 
Sbjct: 241 LF 242

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 16/221 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T  +E+G G+FG+           + A K I +  +     +D+   E ++M +LS +  
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHE-K 60
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHSKG 154
           +VQ        + + I+ E  A G L + +    H +  +    + + +   +    SK 
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLSQS 211
            +HRDL   N L    ++  VVK +DFGLS ++ + + Y   VGS +   +  PEVL  S
Sbjct: 121 FLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYS 176
Query: 212 -YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
            +  ++DIW+ GV+++ I   G  P+   T+   A+ I +G
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 217

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 36  TIGREVGRGEFGITYLCT-ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           T+G+ +G G FG  Y         ++    + P  + ++       + E+ ++R  +   
Sbjct: 31  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAF-----KNEVGVLRK-TRHV 84
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVNVCHSK 153
           NI+ F   Y     + IV + C G  L+  + +    +       + R     ++  H+K
Sbjct: 85  NILLF-MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 143
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS---AFIEEGKAYREIVGSPYYIAPEVL-- 208
            ++HRDLK  N       E+  VK  DFGL+   +       + ++ GS  ++APEV+  
Sbjct: 144 SIIHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 200
Query: 209 --SQSYGKEADIWSAGVILYILLCGVPPF 235
                Y  ++D+++ G++LY L+ G  P+
Sbjct: 201 QDKNPYSFQSDVYAFGIVLYELMTGQLPY 229

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
           +P++V      E D  +++   L  G +L   +  +G  +   A ++ R I + ++  H+
Sbjct: 93  EPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHA 152
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR--EIVGSPYYIAPEVLSQ 210
            G  HRD+KPEN L +  D   +V   DFG+++   + K  +    VG+ YY APE  S+
Sbjct: 153 AGATHRDVKPENILVSADDFAYLV---DFGIASATTDEKLTQLGNTVGTLYYXAPERFSE 209
Query: 211 SYGK-EADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE- 268
           S+    ADI++   +LY  L G PP+     QG   ++    IN Q  P PS     I  
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPPY-----QGDQLSVXGAHIN-QAIPRPSTVRPGIPV 263
Query: 269 ----LVRRMLTQDPKRR 281
               ++ R   ++P+ R
Sbjct: 264 AFDAVIARGXAKNPEDR 280

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 36  TIGREVGRGEFGITYLCT-ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           T+G+ +G G FG  Y         ++    + P  + ++       + E+ ++R  +   
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAF-----KNEVGVLRK-TRHV 64
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVNVCHSK 153
           NI+ F   Y     + IV + C G  L+  + +    +       + R     ++  H+K
Sbjct: 65  NILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVL-- 208
            ++HRDLK  N       E+  VK  DFGL+           + ++ GS  ++APEV+  
Sbjct: 124 SIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 209 --SQSYGKEADIWSAGVILYILLCGVPPF 235
                Y  ++D+++ G++LY L+ G  P+
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 14/223 (6%)
Query: 37  IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQPN 95
           I R +G GEFG          G      +I   K+   + ++ D   E  IM      PN
Sbjct: 47  IERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFD-HPN 105
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSK 153
           +V  +      + V IV+E    G L D  + +  G ++      + R I   +      
Sbjct: 106 VVHLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADM 164
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPY---YIAPEVLS 209
           G +HRDL   N L  +   N V K +DFGLS  IE + +A     G      + APE + 
Sbjct: 165 GYVHRDLAARNILVNS---NLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQ 221
Query: 210 -QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
            + +   +D+WS G++++ ++  G  P+W  ++Q V +AI +G
Sbjct: 222 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG 264

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 36  TIGREVGRGEFGITYLCT-ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           T+G+ +G G FG  Y         ++    + P  + ++       + E+ ++R  +   
Sbjct: 39  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAF-----KNEVGVLRK-TRHV 92
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVNVCHSK 153
           NI+ F   Y     + IV + C G  L+  + +    +       + R     ++  H+K
Sbjct: 93  NILLF-MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS---AFIEEGKAYREIVGSPYYIAPEVL-- 208
            ++HRDLK  N       E+  VK  DFGL+   +       + ++ GS  ++APEV+  
Sbjct: 152 SIIHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 209 --SQSYGKEADIWSAGVILYILLCGVPPF 235
                Y  ++D+++ G++LY L+ G  P+
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 16/221 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T  +E+G G+FG+           + A K I +  +     +D+   E ++M +LS +  
Sbjct: 11  TFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHE-K 64
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHSKG 154
           +VQ        + + I+ E  A G L + +    H +  +    + + +   +    SK 
Sbjct: 65  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 124
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLSQS 211
            +HRDL   N L    ++  VVK +DFGLS ++ + + Y   VGS +   +  PEVL  S
Sbjct: 125 FLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYS 180
Query: 212 -YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
            +  ++DIW+ GV+++ I   G  P+   T+   A+ I +G
Sbjct: 181 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 221

>pdb|2GGM|A Chain A, Human Centrin 2 Xeroderma Pigmentosum Group C Protein Complex Length = 172

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 76/145 (52%), Gaps = 3/145 (2%)
Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E+ Q+++E F   D D +GT+   ELK     LG    + ++K+ +   D +G G  
Sbjct: 25  LTEEQKQEIREAFDLFDADGTGTIDVKELKVAXRALGFEPKKEEIKKXISEIDKEGTGKX 84
Query: 393 DYIEFITATMQRHKLQRF-ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATI 451
           ++ +F+T   Q+   +   E + KAF+ FD D  G I+   L +  K+  +G++ T   +
Sbjct: 85  NFGDFLTVXTQKXSEKDTKEEILKAFKLFDDDETGKISFKNLKRVAKE--LGENLTDEEL 142
Query: 452 KEIMSEVDRDKDGRISYDEFRSMMK 476
           +E + E DRD DG +S  EF  + K
Sbjct: 143 QEXIDEADRDGDGEVSEQEFLRIXK 167

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 122/267 (45%), Gaps = 27/267 (10%)
Query: 36  TIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           +I + VG GEFG   +C+      +   +  A K++  +    + ++ D   E  IM   
Sbjct: 46  SIDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQF 101
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVN 148
              PNI++ +      + V IV E    G L D  + +    ++      + R I + + 
Sbjct: 102 D-HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 159
Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--AYREIVGS-PY-YIA 204
                G +HRDL   N L  +   N V K +DFGLS  +E+    AY    G  P  + +
Sbjct: 160 YLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 216
Query: 205 PEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
           PE ++ + +   +D+WS G++L+ ++  G  P+W  ++Q V +A+ +G     R P P  
Sbjct: 217 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG----YRLPPPMD 272
Query: 263 SSSAI-ELVRRMLTQDPKRRITVAQVL 288
             +A+ +L+     +D   R    Q++
Sbjct: 273 CPAALYQLMLDCWQKDRNNRPKFEQIV 299

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 122/267 (45%), Gaps = 27/267 (10%)
Query: 36  TIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           +I + VG GEFG   +C+      +   +  A K++  +    + ++ D   E  IM   
Sbjct: 48  SIDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQF 103
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVN 148
              PNI++ +      + V IV E    G L D  + +    ++      + R I + + 
Sbjct: 104 D-HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--AYREIVGS-PY-YIA 204
                G +HRDL   N L  +   N V K +DFGLS  +E+    AY    G  P  + +
Sbjct: 162 YLSDMGFVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 205 PEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
           PE ++ + +   +D+WS G++L+ ++  G  P+W  ++Q V +A+ +G     R P P  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG----YRLPPPMD 274
Query: 263 SSSAI-ELVRRMLTQDPKRRITVAQVL 288
             +A+ +L+     +D   R    Q++
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 16/221 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T  +E+G G+FG+           + A K I +  +     +D+   E ++M +LS +  
Sbjct: 18  TFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHE-K 71
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHSKG 154
           +VQ        + + I+ E  A G L + +    H +  +    + + +   +    SK 
Sbjct: 72  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 131
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLSQS 211
            +HRDL   N L    ++  VVK +DFGLS ++ + + Y   VGS +   +  PEVL  S
Sbjct: 132 FLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYS 187
Query: 212 -YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
            +  ++DIW+ GV+++ I   G  P+   T+   A+ I +G
Sbjct: 188 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 228

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 110/259 (42%), Gaps = 19/259 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   PN
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSK 153
           +VQ       +   +I+ E    G L D +         A   ++    I + +     K
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLS- 209
             +HRDL   N L     EN +VK  DFGLS  +  G       G+ +   + APE L+ 
Sbjct: 136 NFIHRDLAARNCLV---GENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAY 191
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +  ++D+W+ GV+L+ I   G+ P+    D      +L+ +   +R           E
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERP--EGCPEKVYE 248
Query: 269 LVRRMLTQDPKRRITVAQV 287
           L+R     +P  R + A++
Sbjct: 249 LMRACWQWNPSDRPSFAEI 267

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 16/221 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T  +E+G G+FG+           + A K I +  +     +D+   E ++M +LS +  
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHE-K 80
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHSKG 154
           +VQ        + + I+ E  A G L + +    H +  +    + + +   +    SK 
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLSQS 211
            +HRDL   N L    ++  VVK +DFGLS ++ + + Y   VGS +   +  PEVL  S
Sbjct: 141 FLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYS 196
Query: 212 -YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
            +  ++DIW+ GV+++ I   G  P+   T+   A+ I +G
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 122/267 (45%), Gaps = 27/267 (10%)
Query: 36  TIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           +I + VG GEFG   +C+      +   +  A K++  +    + ++ D   E  IM   
Sbjct: 48  SIDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQF 103
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVN 148
              PNI++ +      + V IV E    G L D  + +    ++      + R I + + 
Sbjct: 104 D-HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--AYREIVGS-PY-YIA 204
                G +HRDL   N L  +   N V K +DFGLS  +E+    AY    G  P  + +
Sbjct: 162 YLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 205 PEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
           PE ++ + +   +D+WS G++L+ ++  G  P+W  ++Q V +A+ +G     R P P  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG----YRLPPPMD 274
Query: 263 SSSAI-ELVRRMLTQDPKRRITVAQVL 288
             +A+ +L+     +D   R    Q++
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 122/267 (45%), Gaps = 27/267 (10%)
Query: 36  TIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           +I + VG GEFG   +C+      +   +  A K++  +    + ++ D   E  IM   
Sbjct: 48  SIDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQF 103
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVN 148
              PNI++ +      + V IV E    G L D  + +    ++      + R I + + 
Sbjct: 104 D-HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--AYREIVGS-PY-YIA 204
                G +HRDL   N L  +   N V K +DFGLS  +E+    AY    G  P  + +
Sbjct: 162 YLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 205 PEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
           PE ++ + +   +D+WS G++L+ ++  G  P+W  ++Q V +A+ +G     R P P  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG----YRLPPPMD 274
Query: 263 SSSAI-ELVRRMLTQDPKRRITVAQVL 288
             +A+ +L+     +D   R    Q++
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 122/267 (45%), Gaps = 27/267 (10%)
Query: 36  TIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           +I + VG GEFG   +C+      +   +  A K++  +    + ++ D   E  IM   
Sbjct: 48  SIDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQF 103
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVN 148
              PNI++ +      + V IV E    G L D  + +    ++      + R I + + 
Sbjct: 104 D-HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--AYREIVGS-PY-YIA 204
                G +HRDL   N L  +   N V K +DFGLS  +E+    AY    G  P  + +
Sbjct: 162 YLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 205 PEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
           PE ++ + +   +D+WS G++L+ ++  G  P+W  ++Q V +A+ +G     R P P  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG----YRLPPPMD 274
Query: 263 SSSAI-ELVRRMLTQDPKRRITVAQVL 288
             +A+ +L+     +D   R    Q++
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 122/267 (45%), Gaps = 27/267 (10%)
Query: 36  TIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           +I + VG GEFG   +C+      +   +  A K++  +    + ++ D   E  IM   
Sbjct: 48  SIDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQF 103
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVN 148
              PNI++ +      + V IV E    G L D  + +    ++      + R I + + 
Sbjct: 104 D-HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--AYREIVGS-PY-YIA 204
                G +HRDL   N L  +   N V K +DFGLS  +E+    AY    G  P  + +
Sbjct: 162 YLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 205 PEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
           PE ++ + +   +D+WS G++L+ ++  G  P+W  ++Q V +A+ +G     R P P  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG----YRLPPPMD 274
Query: 263 SSSAI-ELVRRMLTQDPKRRITVAQVL 288
             +A+ +L+     +D   R    Q++
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 31/219 (14%)
Query: 28  YEDVQLHYTIGREVGRGEFGITYLC----TENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           +E+  L Y    ++G+G FG   LC      ++TG   A K +   +     ++ D +RE
Sbjct: 4   FEERHLKYI--SQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQRE 58
Query: 84  IEIMRHLSGQPNIVQFKA-AYEDDQF-VHIVMELCAGGELFDRIVARGHYSERAAASVFR 141
           I+I++ L     IV+++  +Y   +  + +VME    G L D +        RA     R
Sbjct: 59  IQILKALHSD-FIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFL-----QRHRARLDASR 112
Query: 142 VIMNVVNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK---A 192
           +++    +C       S+  +HRDL   N L    +  A VK  DFGL+  +   K    
Sbjct: 113 LLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDXXV 169
Query: 193 YREIVGSP-YYIAPEVLSQS-YGKEADIWSAGVILYILL 229
            RE   SP ++ APE LS + + +++D+WS GV+LY L 
Sbjct: 170 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 208

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 36  TIGREVGRGEFGITYLCT-ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           T+G+ +G G FG  Y         ++    + P  + ++       + E+ ++R  +   
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAF-----KNEVGVLRK-TRHV 64
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVNVCHSK 153
           NI+ F   Y     + IV + C G  L+  + +    +       + R     ++  H+K
Sbjct: 65  NILLF-MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLS---AFIEEGKAYREIVGSPYYIAPEVL-- 208
            ++HRDLK  N       E+  VK  DFGL+   +       + ++ GS  ++APEV+  
Sbjct: 124 SIIHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 209 --SQSYGKEADIWSAGVILYILLCGVPPF 235
                Y  ++D+++ G++LY L+ G  P+
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 122/267 (45%), Gaps = 27/267 (10%)
Query: 36  TIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           +I + VG GEFG   +C+      +   +  A K++  +    + ++ D   E  IM   
Sbjct: 48  SIDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQF 103
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVN 148
              PNI++ +      + V IV E    G L D  + +    ++      + R I + + 
Sbjct: 104 D-HPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--AYREIVGS-PY-YIA 204
                G +HRDL   N L  +   N V K +DFGLS  +E+    AY    G  P  + +
Sbjct: 162 YLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 205 PEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
           PE ++ + +   +D+WS G++L+ ++  G  P+W  ++Q V +A+ +G     R P P  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG----YRLPPPMD 274
Query: 263 SSSAI-ELVRRMLTQDPKRRITVAQVL 288
             +A+ +L+     +D   R    Q++
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 106/257 (41%), Gaps = 45/257 (17%)
Query: 26  KAYEDV-QLH--YTIGREVGRGEFGITYLCTEN-STGLEFACKSIPKRKLVKDVEKDDVR 81
           K YE V QL   + I  ++G G F   YL T     G E   + I  + L+       + 
Sbjct: 11  KLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPE---EKIALKHLIPTSHPIRIA 67
Query: 82  REIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERA-AASVF 140
            E++ +    GQ N++  K  +  +  V I M         D + +      R    ++F
Sbjct: 68  AELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLF 127
Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--------- 191
           + +  +    H  G++HRD+KP NFL+    +   +   DFGL+    + K         
Sbjct: 128 KALKRI----HQFGIVHRDVKPSNFLYNRRLKKYAL--VDFGLAQGTHDTKIELLKFVQS 181
Query: 192 ----------------AYREIV----GSPYYIAPEVLSQSYGKEA--DIWSAGVILYILL 229
                           + R+ V    G+P + APEVL++   +    D+WSAGVI   LL
Sbjct: 182 EAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241
Query: 230 CGVPPFWAETDQGVAQA 246
            G  PF+  +D   A A
Sbjct: 242 SGRYPFYKASDDLTALA 258

>pdb|1LA0|A Chain A, Solution Structure Of Calcium Saturated Cardiac Troponin C In The Troponin C-Troponin I Complex Length = 161

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 69/128 (53%), Gaps = 6/128 (4%)
Query: 353 SGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQ----RHKLQ 408
            G ++  EL   +  LG   T  ++++ +   D DG+GT+D+ EF+   ++      K +
Sbjct: 33  DGCISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRCMKDDSKGK 92
Query: 409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISY 468
             E L   F+ FDK+ +GYI ++EL    +    G+  T   I+E+M + D++ DGRI Y
Sbjct: 93  TEEELSDLFRMFDKNADGYIDLEELKIMLQ--ATGETITEDDIEELMKDGDKNNDGRIDY 150
Query: 469 DEFRSMMK 476
           DEF   MK
Sbjct: 151 DEFLEFMK 158

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 123/269 (45%), Gaps = 27/269 (10%)
Query: 34  HYTIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
           + +I + VG GEFG   +C+      +   +  A K++  +    + ++ D   E  IM 
Sbjct: 17  NISIDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMG 72
Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNV 146
                PNI++ +      + V IV E    G L D  + +    ++      + R I + 
Sbjct: 73  QFD-HPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 147 VNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--AYREIVGS-PY-Y 202
           +      G +HRDL   N L    + N V K +DFGLS  +E+    AY    G  P  +
Sbjct: 131 MKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 187
Query: 203 IAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
            +PE ++ + +   +D+WS G++L+ ++  G  P+W  ++Q V +A+ +G     R P P
Sbjct: 188 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG----YRLPPP 243
Query: 261 SISSSAI-ELVRRMLTQDPKRRITVAQVL 288
               +A+ +L+     +D   R    Q++
Sbjct: 244 MDCPAALYQLMLDCWQKDRNNRPKFEQIV 272

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 33/215 (15%)
Query: 34  HYTIGREVGRGEFGITYLC----TENSTGLEFACKSIPKRKLVKDVEKD--DVRREIEIM 87
           H    +++G+G FG   +C     +++TG   A K     KL    E+   D  REIEI+
Sbjct: 14  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEIL 68
Query: 88  RHLSGQPNIVQFKAA--YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           + L    NIV++K        + + ++ME    G L D + A   ++ER      +++  
Sbjct: 69  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQA---HAERIDH--IKLLQY 122
Query: 146 VVNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK---AYREI 196
              +C       +K  +HRDL   N L    +EN V K  DFGL+  + + K     +E 
Sbjct: 123 TSQICKGMEYLGTKRYIHRDLATRNILVE--NENRV-KIGDFGLTKVLPQDKEXXKVKEP 179
Query: 197 VGSP-YYIAPEVLSQS-YGKEADIWSAGVILYILL 229
             SP ++ APE L++S +   +D+WS GV+LY L 
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 214

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 123/269 (45%), Gaps = 27/269 (10%)
Query: 34  HYTIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
           + +I + VG GEFG   +C+      +   +  A K++  +    + ++ D   E  IM 
Sbjct: 34  NISIDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMG 89
Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNV 146
                PNI++ +      + V IV E    G L D  + +    ++      + R I + 
Sbjct: 90  QFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASG 147
Query: 147 VNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--AYREIVGS-PY-Y 202
           +      G +HRDL   N L    + N V K +DFGLS  +E+    AY    G  P  +
Sbjct: 148 MKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 204
Query: 203 IAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
            +PE ++ + +   +D+WS G++L+ ++  G  P+W  ++Q V +A+ +G     R P P
Sbjct: 205 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG----YRLPPP 260
Query: 261 SISSSAI-ELVRRMLTQDPKRRITVAQVL 288
               +A+ +L+     +D   R    Q++
Sbjct: 261 MDCPAALYQLMLDCWQKDRNNRPKFEQIV 289

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 94/229 (41%), Gaps = 45/229 (19%)
Query: 37  IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV---EKDDVRREIEIMRHLSGQ 93
            G+ +G G FG     T    G E A   +  + L       EK+ +  E++IM HL   
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 101
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG------------------HYSERA 135
            NIV    A      V ++ E C  G+L + +  +                   H+S + 
Sbjct: 102 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 161
Query: 136 AASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL-------SAFIE 188
           A  +  +         SK  +HRD+   N L T G    V K  DFGL       S +I 
Sbjct: 162 AQGMAFLA--------SKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDSNYIV 210
Query: 189 EGKAYREIVGSPYYIAPE-VLSQSYGKEADIWSAGVILY-ILLCGVPPF 235
           +G A   +     ++APE +    Y  ++D+WS G++L+ I   G+ P+
Sbjct: 211 KGNARLPV----KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 255

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 14/223 (6%)
Query: 37  IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQPN 95
           I + +G GEFG          G    C +I   K    D ++ D   E  IM      PN
Sbjct: 33  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFD-HPN 91
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSK 153
           I+  +      + V I+ E    G L D  + +  G ++      + R I + +      
Sbjct: 92  IIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 150
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--AYREIVGS-PY-YIAPEVLS 209
             +HRDL   N L  +   N V K +DFG+S  +E+    AY    G  P  + APE ++
Sbjct: 151 SAVHRDLAARNILVNS---NLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 207
Query: 210 -QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
            + +   +D+WS G++++ ++  G  P+W  ++Q V +AI +G
Sbjct: 208 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG 250

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSER-AAASVFRVIMNVVNVCHSK 153
           N V+   A +    + I  E C    L+D I +     +R     +FR I+  ++  HS+
Sbjct: 76  NFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ 135
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI---------------VG 198
           G++HR+LKP N      DE+  VK  DFGL+  +       ++               +G
Sbjct: 136 GIIHRNLKPXNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIG 192
Query: 199 SPYYIAPEVLSQS--YGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEINFQ 255
           +  Y+A EVL  +  Y ++ D +S G+I +     + PF    ++  + + +    I F 
Sbjct: 193 TAXYVATEVLDGTGHYNEKIDXYSLGIIFF---EXIYPFSTGXERVNILKKLRSVSIEFP 249
Query: 256 RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
            D   +      +++R ++  DP +R     +L   WL
Sbjct: 250 PDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 123/269 (45%), Gaps = 27/269 (10%)
Query: 34  HYTIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
           + +I + VG GEFG   +C+      +   +  A K++  +    + ++ D   E  IM 
Sbjct: 17  NISIDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMG 72
Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNV 146
                PNI++ +      + V IV E    G L D  + +    ++      + R I + 
Sbjct: 73  QFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 147 VNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--AYREIVGS-PY-Y 202
           +      G +HRDL   N L    + N V K +DFGLS  +E+    AY    G  P  +
Sbjct: 131 MKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 187
Query: 203 IAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
            +PE ++ + +   +D+WS G++L+ ++  G  P+W  ++Q V +A+ +G     R P P
Sbjct: 188 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG----YRLPPP 243
Query: 261 SISSSAI-ELVRRMLTQDPKRRITVAQVL 288
               +A+ +L+     +D   R    Q++
Sbjct: 244 MDCPAALYQLMLDCWQKDRNNRPKFEQIV 272

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 129/314 (41%), Gaps = 62/314 (19%)
Query: 31  VQLHYTIGREVGRGEFGITYLCT-ENSTGLEFACK----SIPKRKLVKDVEKD----DVR 81
           +Q  YT+ R +  G +G   +C   +S G+  A K    ++   + V  +        V 
Sbjct: 20  MQSPYTVQRFISSGSYGA--VCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 82  REIEIMRHLSGQPNIVQFKAAYEDDQFVHI----VMELCAGGELFDRIVARGHYSERAAA 137
           REI ++ H    PNI+  +     D FVH     + +L    EL    +A+  + +R   
Sbjct: 78  REIRLLNHFH-HPNILGLR-----DIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVI 131
Query: 138 S-------VFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190
           S       ++ +++ + +V H  GV+HRDL P N L     +N  +   DF L+      
Sbjct: 132 SPQHIQYFMYHILLGL-HVLHEAGVVHRDLHPGNILLA---DNNDITICDFNLAREDTAD 187
Query: 191 KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL 248
                 V   +Y APE++ Q   + K  D+WSAG ++  +      F   T       I+
Sbjct: 188 ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247
Query: 249 K----------------GEINFQRDPF------------PSISSSAIELVRRMLTQDPKR 280
           +                   ++ R+              P+    A++L+ +ML  +P+R
Sbjct: 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307
Query: 281 RITVAQVLEHPWLK 294
           RI+  Q L HP+ +
Sbjct: 308 RISTEQALRHPYFE 321

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/314 (23%), Positives = 129/314 (41%), Gaps = 62/314 (19%)
Query: 31  VQLHYTIGREVGRGEFGITYLCT-ENSTGLEFACK----SIPKRKLVKDVEKD----DVR 81
           +Q  YT+ R +  G +G   +C   +S G+  A K    ++   + V  +        V 
Sbjct: 20  MQSPYTVQRFISSGSYGA--VCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 82  REIEIMRHLSGQPNIVQFKAAYEDDQFVHI----VMELCAGGELFDRIVARGHYSERAAA 137
           REI ++ H    PNI+  +     D FVH     + +L    EL    +A+  + +R   
Sbjct: 78  REIRLLNHFH-HPNILGLR-----DIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVI 131
Query: 138 S-------VFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190
           S       ++ +++ + +V H  GV+HRDL P N L     +N  +   DF L+      
Sbjct: 132 SPQHIQYFMYHILLGL-HVLHEAGVVHRDLHPGNILLA---DNNDITICDFNLAREDTAD 187
Query: 191 KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL 248
                 V   +Y APE++ Q   + K  D+WSAG ++  +      F   T       I+
Sbjct: 188 ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247
Query: 249 K----------------GEINFQRDPF------------PSISSSAIELVRRMLTQDPKR 280
           +                   ++ R+              P+    A++L+ +ML  +P+R
Sbjct: 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307
Query: 281 RITVAQVLEHPWLK 294
           RI+  Q L HP+ +
Sbjct: 308 RISTEQALRHPYFE 321

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 85/183 (46%), Gaps = 13/183 (7%)
Query: 76  EKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDRIVARGHYSE 133
           ++ D   E  IM      PNI++ +      +   IV E    G L  F R    G ++ 
Sbjct: 93  QRRDFLSEASIMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTI 150
Query: 134 RAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-- 191
                + R +   +      G +HRDL   N L    D N V K +DFGLS  +E+    
Sbjct: 151 MQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDA 207
Query: 192 AYREIVGS-PY-YIAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAI 247
           AY    G  P  + APE ++ +++   +D+WS GV+++ +L  G  P+W  T++ V  ++
Sbjct: 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
Query: 248 LKG 250
            +G
Sbjct: 268 EEG 270

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 94/229 (41%), Gaps = 45/229 (19%)
Query: 37  IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV---EKDDVRREIEIMRHLSGQ 93
            G+ +G G FG     T    G E A   +  + L       EK+ +  E++IM HL   
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG------------------HYSERA 135
            NIV    A      V ++ E C  G+L + +  +                   H+S + 
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 169
Query: 136 AASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL-------SAFIE 188
           A  +  +         SK  +HRD+   N L T G    V K  DFGL       S +I 
Sbjct: 170 AQGMAFLA--------SKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDSNYIV 218
Query: 189 EGKAYREIVGSPYYIAPE-VLSQSYGKEADIWSAGVILY-ILLCGVPPF 235
           +G A   +     ++APE +    Y  ++D+WS G++L+ I   G+ P+
Sbjct: 219 KGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 263

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 18/202 (8%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +GRG FG  +   +  TG + A         VK V  +  R E  +       P IV   
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCA---------VKKVRLEVFRVEELVACAGLSSPRIVPLY 130
Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
            A  +  +V+I MEL  GG L   I   G   E  A       +  +   H++ ++H D+
Sbjct: 131 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 190
Query: 161 KPENFLFTTGDENAVVKATDFGLSAFIEE---GKAYRE---IVGSPYYIAPE-VLSQSYG 213
           K +N L ++    A +   DFG +  ++    GK+      I G+  ++APE V+ +   
Sbjct: 191 KADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 248
Query: 214 KEADIWSAGVILYILLCGVPPF 235
            + DIWS+  ++  +L G  P+
Sbjct: 249 AKVDIWSSCCMMLHMLNGCHPW 270

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 14/223 (6%)
Query: 37  IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQPN 95
           I + +G GEFG          G    C +I   K    D ++ D   E  IM      PN
Sbjct: 18  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFD-HPN 76
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSK 153
           I+  +      + V I+ E    G L D  + +  G ++      + R I + +      
Sbjct: 77  IIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 135
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--AYREIVGS-PY-YIAPEVLS 209
             +HRDL   N L  +   N V K +DFG+S  +E+    AY    G  P  + APE ++
Sbjct: 136 SYVHRDLAARNILVNS---NLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 192
Query: 210 -QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
            + +   +D+WS G++++ ++  G  P+W  ++Q V +AI +G
Sbjct: 193 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG 235

>pdb|2JTZ|A Chain A, Solution Structure And Chemical Shift Assignments Of The F104-To-5-Flurotryptophan Mutant Of Cardiac Troponin C Length = 161

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 69/128 (53%), Gaps = 6/128 (4%)
Query: 353 SGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR----HKLQ 408
            G+++  EL   +  LG   T  ++++ +   D DG+GT+D+ EF+   ++      K +
Sbjct: 33  DGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGK 92
Query: 409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISY 468
             E L   F+  DK+ +GYI +DEL    +    G+  T   I+E+M + D++ DGRI Y
Sbjct: 93  SEEELSDLFRMXDKNADGYIDLDELKIMLQ--ATGETITEDDIEELMKDGDKNNDGRIDY 150
Query: 469 DEFRSMMK 476
           DEF   MK
Sbjct: 151 DEFLEFMK 158

>pdb|2JT8|A Chain A, Solution Structure Of The F153-To-5-Flurotryptophan Mutant Of Human Cardiac Troponin C Length = 161

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 69/128 (53%), Gaps = 6/128 (4%)
Query: 353 SGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR----HKLQ 408
            G+++  EL   +  LG   T  ++++ +   D DG+GT+D+ EF+   ++      K +
Sbjct: 33  DGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGK 92
Query: 409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISY 468
             E L   F+ FDK+ +GYI +DEL    +    G+  T   I+E+M + D++ DGRI Y
Sbjct: 93  SEEELSDLFRMFDKNADGYIDLDELKIMLQ--ATGETITEDDIEELMKDGDKNNDGRIDY 150
Query: 469 DEFRSMMK 476
           DE    MK
Sbjct: 151 DEXLEFMK 158

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 14/223 (6%)
Query: 37  IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQPN 95
           I + +G GEFG          G    C +I   K    D ++ D   E  IM      PN
Sbjct: 12  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFD-HPN 70
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSK 153
           I+  +      + V I+ E    G L D  + +  G ++      + R I + +      
Sbjct: 71  IIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 129
Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--AYREIVGS-PY-YIAPEVLS 209
             +HRDL   N L  +   N V K +DFG+S  +E+    AY    G  P  + APE ++
Sbjct: 130 SYVHRDLAARNILVNS---NLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 186
Query: 210 -QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
            + +   +D+WS G++++ ++  G  P+W  ++Q V +AI +G
Sbjct: 187 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG 229

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 34  HYTIGREVGRGEFGITYLC----TENSTGLEFACKSIPKRKLVKDVEKD--DVRREIEIM 87
           H    +++G+G FG   +C     +++TG   A K     KL    E+   D  REIEI+
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEIL 65
Query: 88  RHLSGQPNIVQFKAA--YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           + L    NIV++K        + + ++ME    G L D +     + ER      +++  
Sbjct: 66  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDH--IKLLQY 119
Query: 146 VVNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY---REI 196
              +C       +K  +HRDL   N L    +EN V K  DFGL+  + + K +   +E 
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVE--NENRV-KIGDFGLTKVLPQDKEFFKVKEP 176
Query: 197 VGSP-YYIAPEVLSQS-YGKEADIWSAGVILYILL 229
             SP ++ APE L++S +   +D+WS GV+LY L 
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 125/285 (43%), Gaps = 42/285 (14%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR------KLVKD--VEKD--DVRREIE 85
            +G+ +G G FG   L    + GL+   K  P R      K++K    EKD  D+  E+E
Sbjct: 31  VLGKPLGEGAFGQVVLA--EAIGLD---KDKPNRVTKVAVKMLKSDATEKDLSDLISEME 85
Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-----------GHYSER 134
           +M+ +    NI+    A   D  +++++E  + G L + + AR            H  E 
Sbjct: 86  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEE 145
Query: 135 AAASVFRV-----IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
             +S   V     +   +    SK  +HRDL   N L T   E+ V+K  DFGL+  I  
Sbjct: 146 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHH 202
Query: 190 GKAYREIVGSPY---YIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVA 244
               ++         ++APE L  + Y  ++D+WS GV+L+ I   G  P+     + + 
Sbjct: 203 IDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
           + + +G    + D   + ++    ++R      P +R T  Q++E
Sbjct: 263 KLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 38  GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR----EIEIMRHLSGQ 93
           G + G G FG+ Y    N+T +     ++ K   + D+  +++++    EI++      +
Sbjct: 27  GNKXGEGGFGVVYKGYVNNTTV-----AVKKLAAMVDITTEELKQQFDQEIKVXAKCQHE 81
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIV---ARGHYSERAAASVFRVIMNVVNVC 150
            N+V+      D   + +V      G L DR+         S      + +   N +N  
Sbjct: 82  -NLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFL 140
Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE---EGKAYREIVGSPYYIAPEV 207
           H    +HRD+K  N L    DE    K +DFGL+   E   +      IVG+  Y APE 
Sbjct: 141 HENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEA 197
Query: 208 LSQSYGKEADIWSAGVILYILLCGVP 233
           L      ++DI+S GV+L  ++ G+P
Sbjct: 198 LRGEITPKSDIYSFGVVLLEIITGLP 223

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 122/267 (45%), Gaps = 27/267 (10%)
Query: 36  TIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           +I + VG GEFG   +C+      +   +  A K++  +    + ++ D   E  IM   
Sbjct: 48  SIDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQF 103
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVN 148
              PNI++ +      + V IV E    G L D  + +    ++      + R I + + 
Sbjct: 104 D-HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--AYREIVGS-PY-YIA 204
                G +HRDL   N L  +   N V K +DFGL+  +E+    AY    G  P  + +
Sbjct: 162 YLSDMGYVHRDLAARNILINS---NLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 205 PEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
           PE ++ + +   +D+WS G++L+ ++  G  P+W  ++Q V +A+ +G     R P P  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG----YRLPPPMD 274
Query: 263 SSSAI-ELVRRMLTQDPKRRITVAQVL 288
             +A+ +L+     +D   R    Q++
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 34  HYTIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKD--DVRREIEIM 87
           H    +++G+G FG   +C     +++TG   A K     KL    E+   D  REIEI+
Sbjct: 12  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEIL 66
Query: 88  RHLSGQPNIVQFKAA--YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           + L    NIV++K        + + ++ME    G L D +     + ER      +++  
Sbjct: 67  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDH--IKLLQY 120
Query: 146 VVNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY---REI 196
              +C       +K  +HR+L   N L    +EN V K  DFGL+  + + K Y   +E 
Sbjct: 121 TSQICKGMEYLGTKRYIHRNLATRNILVE--NENRV-KIGDFGLTKVLPQDKEYYKVKEP 177
Query: 197 VGSP-YYIAPEVLSQS-YGKEADIWSAGVILYILL 229
             SP ++ APE L++S +   +D+WS GV+LY L 
Sbjct: 178 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 212

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 78/344 (22%), Positives = 135/344 (39%), Gaps = 75/344 (21%)
Query: 31  VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK--DDVRREIEIMR 88
           +Q  Y I   +G G FG    C ++  G      +    K++K+VEK  +  R EI ++ 
Sbjct: 31  LQERYEIVSTLGEGTFGRVVQCVDHRRG-----GARVALKIIKNVEKYKEAARLEINVLE 85
Query: 89  HLSGQ-PN----IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH--YSERAAASVFR 141
            ++ + P+     VQ    ++    + I  EL  G   FD +    +  Y       +  
Sbjct: 86  KINEKDPDNKNLCVQMFDWFDYHGHMCISFEL-LGLSTFDFLKDNNYLPYPIHQVRHMAF 144
Query: 142 VIMNVVNVCHSKGVMHRDLKPENFLFTTGD----------------ENAVVKATDFGLSA 185
            +   V   H   + H DLKPEN LF   D                ++  V+  DFG + 
Sbjct: 145 QLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSAT 204
Query: 186 FIEEGKAYREIVGSPYYIAPEV-LSQSYGKEADIWSAGVILYILLCGVPPFWAETDQ--- 241
           F  E  +   IV + +Y APEV L   + +  D+WS G I++    G   F    ++   
Sbjct: 205 FDHEHHS--TIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHL 262
Query: 242 GVAQAIL------------------KGEINFQRD------------PFPSISSSAIE--- 268
            + + IL                  +G +++  +            P     +S  E   
Sbjct: 263 AMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHH 322
Query: 269 ----LVRRMLTQDPKRRITVAQVLEHPWL-KESGEASDKPIDTA 307
               L+  ML  +P +R+T+ + L+HP+  +   E  +K  D++
Sbjct: 323 QLFDLIESMLEYEPAKRLTLGEALQHPFFARLRAEPPNKLWDSS 366

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 121/267 (45%), Gaps = 27/267 (10%)
Query: 36  TIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           +I + VG GEFG   +C+      +   +  A K++  +    + ++ D   E  IM   
Sbjct: 48  SIDKVVGAGEFG--EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQF 103
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVN 148
              PNI++ +      + V IV E    G L D  + +    ++      + R I + + 
Sbjct: 104 D-HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK--AYREIVGS-PY-YIA 204
                G +HRDL   N L  +   N V K +DFGL   +E+    AY    G  P  + +
Sbjct: 162 YLSDMGYVHRDLAARNILINS---NLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 205 PEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
           PE ++ + +   +D+WS G++L+ ++  G  P+W  ++Q V +A+ +G     R P P  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG----YRLPPPMD 274
Query: 263 SSSAI-ELVRRMLTQDPKRRITVAQVL 288
             +A+ +L+     +D   R    Q++
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 119/261 (45%), Gaps = 24/261 (9%)
Query: 41  VGRGEFGITYL-CTENSTG---LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNI 96
           +G GEFG  Y    + S+G   +  A K++  +    + ++ D   E  IM   S   NI
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMGQFSHH-NI 108
Query: 97  VQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKG 154
           ++ +      + + I+ E    G L D+ +    G +S      + R I   +    +  
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGAL-DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPY---YIAPEVLS- 209
            +HRDL   N L    + N V K +DFGLS  +E + +A     G      + APE +S 
Sbjct: 168 YVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI- 267
           + +   +D+WS G++++ ++  G  P+W  ++  V +AI  G     R P P    SAI 
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG----FRLPTPMDCPSAIY 280
Query: 268 ELVRRMLTQDPKRRITVAQVL 288
           +L+ +   Q+  RR   A ++
Sbjct: 281 QLMMQCWQQERARRPKFADIV 301

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 33/215 (15%)
Query: 34  HYTIGREVGRGEFGITYLC----TENSTGLEFACKSIPKRKLVKDVEKD--DVRREIEIM 87
           H    R++G+G FG   +C     +++TG   A K     KL    E+   D  REIEI+
Sbjct: 14  HLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEIL 68
Query: 88  RHLSGQPNIVQFKAA--YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           + L    NIV++K        + + ++ME    G L + +     + ER      +++  
Sbjct: 69  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQK---HKERIDH--IKLLQY 122
Query: 146 VVNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK---AYREI 196
              +C       +K  +HRDL   N L    +EN V K  DFGL+  + + K     +E 
Sbjct: 123 TSQICKGMEYLGTKRYIHRDLATRNILVE--NENRV-KIGDFGLTKVLPQDKEXXKVKEP 179
Query: 197 VGSP-YYIAPEVLSQS-YGKEADIWSAGVILYILL 229
             SP ++ APE L++S +   +D+WS GV+LY L 
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 214

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 76  EKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDRIVARGHYSE 133
           ++ D   E  IM      PNI++ +      +   IV E    G L  F R    G ++ 
Sbjct: 93  QRRDFLSEASIMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTI 150
Query: 134 RAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-A 192
                + R +   +      G +HRDL   N L    D N V K +DFGLS  +E+   A
Sbjct: 151 MQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDA 207
Query: 193 YREIVGSPY---YIAPEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAI 247
                G      + APE ++ +++   +D+WS GV+++ +L  G  P+W  T++ V  ++
Sbjct: 208 AXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
Query: 248 LKG 250
            +G
Sbjct: 268 EEG 270

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 113/266 (42%), Gaps = 23/266 (8%)
Query: 37  IGREVGRGEFGIT---YLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           I + +G GEFG     +L       +  A K++  +    + ++ D   E  IM      
Sbjct: 11  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFD-H 67
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCH 151
           PN++  +        V I+ E    G L D  + +  G ++      + R I   +    
Sbjct: 68  PNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 126
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPY---YIAP 205
               +HR L   N L  +   N V K +DFGLS F+E+  +   Y   +G      + AP
Sbjct: 127 DMNYVHRALAARNILVNS---NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 183
Query: 206 EVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263
           E +  + +   +D+WS G++++ ++  G  P+W  T+Q V  AI   E +++  P     
Sbjct: 184 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI---EQDYRLPPPMDCP 240
Query: 264 SSAIELVRRMLTQDPKRRITVAQVLE 289
           S+  +L+     +D   R    Q++ 
Sbjct: 241 SALHQLMLDCWQKDRNHRPKFGQIVN 266

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 33/215 (15%)
Query: 34  HYTIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKD--DVRREIEIM 87
           H    +++G+G FG   +C     +++TG   A K     KL    E+   D  REIEI+
Sbjct: 14  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEIL 68
Query: 88  RHLSGQPNIVQFKAA--YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           + L    NIV++K        + + ++ME    G L D +     + ER      +++  
Sbjct: 69  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDH--IKLLQY 122
Query: 146 VVNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK---AYREI 196
              +C       +K  +HRDL   N L    +EN V K  DFGL+  + + K     +E 
Sbjct: 123 TSQICKGMEYLGTKRYIHRDLATRNILVE--NENRV-KIGDFGLTKVLPQDKEXXKVKEP 179
Query: 197 VGSP-YYIAPEVLSQS-YGKEADIWSAGVILYILL 229
             SP ++ APE L++S +   +D+WS GV+LY L 
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 214

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 13/163 (7%)
Query: 81  RREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASV 139
           R E+ ++R  +   NI+ F      D    IV + C G  L+  + V    +       +
Sbjct: 80  RNEVAVLRK-TRHVNILLFMGYMTKDNLA-IVTQWCEGSSLYKHLHVQETKFQMFQLIDI 137
Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI--- 196
            R     ++  H+K ++HRD+K  N       E   VK  DFGL+         +++   
Sbjct: 138 ARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRWSGSQQVEQP 194
Query: 197 VGSPYYIAPEVL----SQSYGKEADIWSAGVILYILLCGVPPF 235
            GS  ++APEV+    +  +  ++D++S G++LY L+ G  P+
Sbjct: 195 TGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 33/215 (15%)
Query: 34  HYTIGREVGRGEFGITYLC----TENSTGLEFACKSIPKRKLVKDVEKD--DVRREIEIM 87
           H    +++G+G FG   +C     +++TG   A K     KL    E+   D  REIEI+
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEIL 65
Query: 88  RHLSGQPNIVQFKAA--YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           + L    NIV++K        + + ++ME    G L D +     + ER      +++  
Sbjct: 66  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDH--IKLLQY 119
Query: 146 VVNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK---AYREI 196
              +C       +K  +HRDL   N L    +EN V K  DFGL+  + + K     +E 
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVE--NENRV-KIGDFGLTKVLPQDKEXXKVKEP 176
Query: 197 VGSP-YYIAPEVLSQS-YGKEADIWSAGVILYILL 229
             SP ++ APE L++S +   +D+WS GV+LY L 
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 16/221 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T  +E+G G+FG+           + A K I +  +     +D+   E ++M +LS +  
Sbjct: 12  TFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHE-K 65
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHSKG 154
           +VQ        + + I+ E  A G L + +    H +  +    + + +   +    SK 
Sbjct: 66  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLSQS 211
            +HRDL   N L    ++  VVK +DFGLS ++ + + Y    GS +   +  PEVL  S
Sbjct: 126 FLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSRGSKFPVRWSPPEVLMYS 181
Query: 212 -YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
            +  ++DIW+ GV+++ I   G  P+   T+   A+ I +G
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 222

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 33/215 (15%)
Query: 34  HYTIGREVGRGEFGITYLC----TENSTGLEFACKSIPKRKLVKDVEKD--DVRREIEIM 87
           H    +++G+G FG   +C     +++TG   A K     KL    E+   D  REIEI+
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEIL 65
Query: 88  RHLSGQPNIVQFKAA--YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           + L    NIV++K        + + ++ME    G L D +     + ER      +++  
Sbjct: 66  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDH--IKLLQY 119
Query: 146 VVNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK---AYREI 196
              +C       +K  +HRDL   N L    +EN V K  DFGL+  + + K     +E 
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVE--NENRV-KIGDFGLTKVLPQDKEXXKVKEP 176
Query: 197 VGSP-YYIAPEVLSQS-YGKEADIWSAGVILYILL 229
             SP ++ APE L++S +   +D+WS GV+LY L 
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 33/215 (15%)
Query: 34  HYTIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKD--DVRREIEIM 87
           H    +++G+G FG   +C     +++TG   A K     KL    E+   D  REIEI+
Sbjct: 10  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEIL 64
Query: 88  RHLSGQPNIVQFKAAYED--DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           + L    NIV++K        + + ++ME    G L D +     + ER      +++  
Sbjct: 65  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDH--IKLLQY 118
Query: 146 VVNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK---AYREI 196
              +C       +K  +HRDL   N L    +EN V K  DFGL+  + + K     +E 
Sbjct: 119 TSQICKGMEYLGTKRYIHRDLATRNILVE--NENRV-KIGDFGLTKVLPQDKEXXKVKEP 175
Query: 197 VGSP-YYIAPEVLSQS-YGKEADIWSAGVILYILL 229
             SP ++ APE L++S +   +D+WS GV+LY L 
Sbjct: 176 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 210

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 33/215 (15%)
Query: 34  HYTIGREVGRGEFGITYLC----TENSTGLEFACKSIPKRKLVKDVEKD--DVRREIEIM 87
           H    +++G+G FG   +C     +++TG   A K     KL    E+   D  REIEI+
Sbjct: 9   HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEIL 63
Query: 88  RHLSGQPNIVQFKAA--YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           + L    NIV++K        + + ++ME    G L D +     + ER      +++  
Sbjct: 64  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDH--IKLLQY 117
Query: 146 VVNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK---AYREI 196
              +C       +K  +HRDL   N L    +EN V K  DFGL+  + + K     +E 
Sbjct: 118 TSQICKGMEYLGTKRYIHRDLATRNILVE--NENRV-KIGDFGLTKVLPQDKEXXKVKEP 174
Query: 197 VGSP-YYIAPEVLSQS-YGKEADIWSAGVILYILL 229
             SP ++ APE L++S +   +D+WS GV+LY L 
Sbjct: 175 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 209

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 33/215 (15%)
Query: 34  HYTIGREVGRGEFGITYLC----TENSTGLEFACKSIPKRKLVKDVEKD--DVRREIEIM 87
           H    +++G+G FG   +C     +++TG   A K     KL    E+   D  REIEI+
Sbjct: 17  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEIL 71
Query: 88  RHLSGQPNIVQFKAA--YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           + L    NIV++K        + + ++ME    G L D +     + ER      +++  
Sbjct: 72  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDH--IKLLQY 125
Query: 146 VVNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK---AYREI 196
              +C       +K  +HRDL   N L    +EN V K  DFGL+  + + K     +E 
Sbjct: 126 TSQICKGMEYLGTKRYIHRDLATRNILVE--NENRV-KIGDFGLTKVLPQDKEXXKVKEP 182
Query: 197 VGSP-YYIAPEVLSQS-YGKEADIWSAGVILYILL 229
             SP ++ APE L++S +   +D+WS GV+LY L 
Sbjct: 183 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 217

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 33/215 (15%)
Query: 34  HYTIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKD--DVRREIEIM 87
           H    +++G+G FG   +C     +++TG   A K     KL    E+   D  REIEI+
Sbjct: 16  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEIL 70
Query: 88  RHLSGQPNIVQFKAA--YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           + L    NIV++K        + + ++ME    G L D +     + ER      +++  
Sbjct: 71  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDH--IKLLQY 124
Query: 146 VVNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK---AYREI 196
              +C       +K  +HRDL   N L    +EN V K  DFGL+  + + K     +E 
Sbjct: 125 TSQICKGMEYLGTKRYIHRDLATRNILVE--NENRV-KIGDFGLTKVLPQDKEXXKVKEP 181
Query: 197 VGSP-YYIAPEVLSQS-YGKEADIWSAGVILYILL 229
             SP ++ APE L++S +   +D+WS GV+LY L 
Sbjct: 182 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 216

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y +GR++G G FG  YL T+ + G E A K     + VK  +   +  E +I + + G  
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL----ECVK-TKHPQLHIESKIYKMMQGGV 63
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGG--ELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
            I   +    +  +  +VMEL      +LF+    +  +S +    +   +++ +   HS
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS 121
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-----YRE---IVGSPYYIA 204
           K  +HRD+KP+NFL   G +  +V   DFGL+    + +      YRE   + G+  Y +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 205 PEV-LSQSYGKEADIWSAGVILYILLCGVPPF 235
               L     +  D+ S G +L     G  P+
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 213

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 33/215 (15%)
Query: 34  HYTIGREVGRGEFGITYLC----TENSTGLEFACKSIPKRKLVKDVEKD--DVRREIEIM 87
           H    +++G+G FG   +C     +++TG   A K     KL    E+   D  REIEI+
Sbjct: 15  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEIL 69
Query: 88  RHLSGQPNIVQFKAA--YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           + L    NIV++K        + + ++ME    G L D +     + ER      +++  
Sbjct: 70  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDH--IKLLQY 123
Query: 146 VVNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK---AYREI 196
              +C       +K  +HRDL   N L    +EN V K  DFGL+  + + K     +E 
Sbjct: 124 TSQICKGMEYLGTKRYIHRDLATRNILVE--NENRV-KIGDFGLTKVLPQDKEXXKVKEP 180
Query: 197 VGSP-YYIAPEVLSQS-YGKEADIWSAGVILYILL 229
             SP ++ APE L++S +   +D+WS GV+LY L 
Sbjct: 181 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 215

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y +GR++G G FG  YL T+ + G E A K     + VK  +   +  E +I + + G  
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL----ECVK-TKHPQLHIESKIYKMMQGGV 65
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGG--ELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
            I   +    +  +  +VMEL      +LF+    +  +S +    +   +++ +   HS
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS 123
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-----YRE---IVGSPYYIA 204
           K  +HRD+KP+NFL   G +  +V   DFGL+    + +      YRE   + G+  Y +
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 205 PEV-LSQSYGKEADIWSAGVILYILLCGVPPF 235
               L     +  D+ S G +L     G  P+
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 33/215 (15%)
Query: 34  HYTIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKD--DVRREIEIM 87
           H    +++G+G FG   +C     +++TG   A K     KL    E+   D  REIEI+
Sbjct: 18  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEIL 72
Query: 88  RHLSGQPNIVQFKAA--YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           + L    NIV++K        + + ++ME    G L D +     + ER      +++  
Sbjct: 73  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDH--IKLLQY 126
Query: 146 VVNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK---AYREI 196
              +C       +K  +HRDL   N L    +EN V K  DFGL+  + + K     +E 
Sbjct: 127 TSQICKGMEYLGTKRYIHRDLATRNILVE--NENRV-KIGDFGLTKVLPQDKEXXKVKEP 183
Query: 197 VGSP-YYIAPEVLSQS-YGKEADIWSAGVILYILL 229
             SP ++ APE L++S +   +D+WS GV+LY L 
Sbjct: 184 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 218

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 93/227 (40%), Gaps = 35/227 (15%)
Query: 37  IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV---EKDDVRREIEIMRHLSGQ 93
            G+ +G G FG     T    G E A   +  + L       EK+ +  E++IM HL   
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-----------GHYSERAAAS---- 138
            NIV    A      V ++ E C  G+L + +  +            H  E   +S    
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLL 169
Query: 139 -VFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL-------SAFIEEG 190
                +   +    SK  +HRD+   N L T G    V K  DFGL       S +I +G
Sbjct: 170 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDSNYIVKG 226
Query: 191 KAYREIVGSPYYIAPE-VLSQSYGKEADIWSAGVILY-ILLCGVPPF 235
            A   +     ++APE +    Y  ++D+WS G++L+ I   G+ P+
Sbjct: 227 NARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 269

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 33/215 (15%)
Query: 34  HYTIGREVGRGEFGITYLC----TENSTGLEFACKSIPKRKLVKDVEKD--DVRREIEIM 87
           H    +++G+G FG   +C     +++TG   A K     KL    E+   D  REIEI+
Sbjct: 29  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEIL 83
Query: 88  RHLSGQPNIVQFKAA--YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           + L    NIV++K        + + ++ME    G L D +     + ER      +++  
Sbjct: 84  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDH--IKLLQY 137
Query: 146 VVNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK---AYREI 196
              +C       +K  +HRDL   N L    +EN V K  DFGL+  + + K     +E 
Sbjct: 138 TSQICKGMEYLGTKRYIHRDLATRNILVE--NENRV-KIGDFGLTKVLPQDKEXXKVKEP 194
Query: 197 VGSP-YYIAPEVLSQS-YGKEADIWSAGVILYILL 229
             SP ++ APE L++S +   +D+WS GV+LY L 
Sbjct: 195 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 229

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 16/221 (7%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T  +E+G G+FG+           + A K I +  +     +D+   E ++M +LS +  
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHE-K 80
Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHSKG 154
           +VQ        + + I+ E  A G L + +    H +  +    + + +   +    SK 
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY---YIAPEVLSQS 211
            +HRDL   N L    ++  VVK +DFGLS ++ + +     VGS +   +  PEVL  S
Sbjct: 141 FLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEETSS-VGSKFPVRWSPPEVLMYS 196
Query: 212 -YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
            +  ++DIW+ GV+++ I   G  P+   T+   A+ I +G
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 33/215 (15%)
Query: 34  HYTIGREVGRGEFGITYLC----TENSTGLEFACKSIPKRKLVKDVEKD--DVRREIEIM 87
           H    +++G+G FG   +C     +++TG   A K     KL    E+   D  REIEI+
Sbjct: 29  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK-----KLQHSTEEHLRDFEREIEIL 83
Query: 88  RHLSGQPNIVQFKAA--YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           + L    NIV++K        + + ++ME    G L D +     + ER      +++  
Sbjct: 84  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDH--IKLLQY 137
Query: 146 VVNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK---AYREI 196
              +C       +K  +HRDL   N L    +EN V K  DFGL+  + + K     +E 
Sbjct: 138 TSQICKGMEYLGTKRYIHRDLATRNILVE--NENRV-KIGDFGLTKVLPQDKEXXKVKEP 194
Query: 197 VGSP-YYIAPEVLSQS-YGKEADIWSAGVILYILL 229
             SP ++ APE L++S +   +D+WS GV+LY L 
Sbjct: 195 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 229

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 115/270 (42%), Gaps = 32/270 (11%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR---EIEIMRHLSGQPNIV 97
           +G G FG          GL         +++ +   KDD R    E+E++  L   PNI+
Sbjct: 33  IGEGNFGQVLKARIKKDGLRM---DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 98  QFKAAYEDDQFVHIVMELCAGGELFDRI-------------VARGHYSERAAASVFRVIM 144
               A E   ++++ +E    G L D +             +A    S  ++  +     
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 145 NV---VNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY 201
           +V   ++    K  +HRDL   N L     EN V K  DFGLS   +E    + +   P 
Sbjct: 150 DVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRG-QEVYVKKTMGRLPV 205
Query: 202 -YIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            ++A E L+ S Y   +D+WS GV+L+ I+  G  P+   T   + + + +G   ++ + 
Sbjct: 206 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEK 262
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVL 288
             +      +L+R+   + P  R + AQ+L
Sbjct: 263 PLNCDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 115/270 (42%), Gaps = 32/270 (11%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR---EIEIMRHLSGQPNIV 97
           +G G FG          GL         +++ +   KDD R    E+E++  L   PNI+
Sbjct: 23  IGEGNFGQVLKARIKKDGLRM---DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 98  QFKAAYEDDQFVHIVMELCAGGELFDRI-------------VARGHYSERAAASVFRVIM 144
               A E   ++++ +E    G L D +             +A    S  ++  +     
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 145 NV---VNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY 201
           +V   ++    K  +HRDL   N L     EN V K  DFGLS   +E    + +   P 
Sbjct: 140 DVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRG-QEVYVKKTMGRLPV 195
Query: 202 -YIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            ++A E L+ S Y   +D+WS GV+L+ I+  G  P+   T   + + + +G   ++ + 
Sbjct: 196 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEK 252
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVL 288
             +      +L+R+   + P  R + AQ+L
Sbjct: 253 PLNCDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 128/302 (42%), Gaps = 53/302 (17%)
Query: 36  TIGREVGRGEFGITYL------CTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRH 89
            + RE+G G FG  +L      C E    L  A K++   K   D  + D  RE E++ +
Sbjct: 16  VLKRELGEGAFGKVFLAECYNLCPEQDKIL-VAVKTL---KDASDNARKDFHREAELLTN 71
Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG-------------------- 129
           L  + +IV+F     +   + +V E    G+L   + A G                    
Sbjct: 72  LQHE-HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQM 130
Query: 130 -HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188
            H +++ AA +  +         S+  +HRDL   N L     EN +VK  DFG+S  + 
Sbjct: 131 LHIAQQIAAGMVYLA--------SQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVY 179
Query: 189 EGKAYR---EIVGSPYYIAPE-VLSQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGV 243
               YR     +    ++ PE ++ + +  E+D+WS GV+L+ I   G  P++  ++  V
Sbjct: 180 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 239
Query: 244 AQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
            + I +G +  QR    +      EL+     ++P  R  +  +  H  L+   +AS   
Sbjct: 240 IECITQGRV-LQRP--RTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLAKASPVY 294
Query: 304 ID 305
           +D
Sbjct: 295 LD 296

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 127/280 (45%), Gaps = 36/280 (12%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           HY   +++G G F    L      G  +A K I   +     ++++ +RE ++ R L   
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHR-LFNH 85
Query: 94  PNIVQFKAAYEDDQFVH----IVMELCAGGELFD---RIVARGHY-SERAAASVFRVIMN 145
           PNI++  A    ++       +++     G L++   R+  +G++ +E     +   I  
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDE------------NAVVKATDFGLSAFIEEGKAY 193
            +   H+KG  HRDLKP N L   GDE             A +       +  +++  A 
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILL--GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 194 REIVGSPYYIAPEVLS-QSYG---KEADIWSAGVILYILLCGVPPFWAETDQGVAQAI-L 248
           R  +    Y APE+ S QS+    +  D+WS G +LY ++ G  P+     +G + A+ +
Sbjct: 204 RCTIS---YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260
Query: 249 KGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
           + +++  +   P  SS+  +L+  M+T DP +R  +  +L
Sbjct: 261 QNQLSIPQS--PRHSSALWQLLNSMMTVDPHQRPHIPLLL 298

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 31  VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           V +HY +GR +G G FG+ +  T      + A K  P+R     +   D  R  +++   
Sbjct: 7   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLR--DEYRTYKLLAGC 64
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMEL-CAGGELFDRIVARGH-YSERAAASVFRVIMNVVN 148
           +G PN+  F       + +H V+ +   G  L D +   G  +S +  A   + ++  V 
Sbjct: 65  TGIPNVYYF-----GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 119
Query: 149 VCHSKGVMHRDLKPENFLF-TTGDENA-VVKATDFGLSAF-----IEEGKAYRE---IVG 198
             H K +++RD+KP+NFL      +NA ++   DFG+  F      ++   YRE   + G
Sbjct: 120 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 179
Query: 199 SPYYIAPEV-LSQSYGKEADIWSAGVILYILLCGVPPF 235
           +  Y++    L +   +  D+ + G +    L G  P+
Sbjct: 180 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 217

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 31  VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           V +HY +GR +G G FG+ +  T      + A K  P+R     +   D  R  +++   
Sbjct: 8   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLR--DEYRTYKLLAGC 65
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMEL-CAGGELFDRIVARGH-YSERAAASVFRVIMNVVN 148
           +G PN+  F       + +H V+ +   G  L D +   G  +S +  A   + ++  V 
Sbjct: 66  TGIPNVYYF-----GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 120
Query: 149 VCHSKGVMHRDLKPENFLF-TTGDENA-VVKATDFGLSAF-----IEEGKAYRE---IVG 198
             H K +++RD+KP+NFL      +NA ++   DFG+  F      ++   YRE   + G
Sbjct: 121 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 199 SPYYIAPEV-LSQSYGKEADIWSAGVILYILLCGVPPF 235
           +  Y++    L +   +  D+ + G +    L G  P+
Sbjct: 181 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 101/265 (38%), Gaps = 53/265 (20%)
Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +Y I   +GRG +G  YL  + +     A K +  R     ++   + REI I+  L   
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKV-NRMFEDLIDCKRILREITILNRLKSD 87
Query: 94  PNIVQFKAAYEDDQF----VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
             I        +D      ++IV+E+ A  +L          +E+   ++   ++     
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEI-ADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKF 146
Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI------------- 196
            H  G++HRDLKP N L    +++  VK  DFGL+  I   K    +             
Sbjct: 147 IHESGIIHRDLKPANCLL---NQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPG 203
Query: 197 -------------VGSPYYIAPE--VLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQ 241
                        V + +Y APE  +L ++Y    DIWS G I   LL            
Sbjct: 204 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL------------ 251
Query: 242 GVAQAILKGEINFQRDPFPSISSSA 266
                ++K  IN   + FP    S+
Sbjct: 252 ----NMMKSHINNPTNRFPLFPGSS 272

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 38/222 (17%)
Query: 37  IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD------VRREIEIMRHL 90
           IG  +G+G FG  Y    +    E A + I       D+E+D+       +RE+   R  
Sbjct: 37  IGELIGKGRFGQVYHGRWHG---EVAIRLI-------DIERDNEDQLKAFKREVMAYRQ- 85
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIV-ARGHYSERAAASVFRVIMNVVNV 149
           +   N+V F  A      + I+  LC G  L+  +  A+          + + I+  +  
Sbjct: 86  TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL---SAFIEEGK---AYREIVGSPYYI 203
            H+KG++H+DLK +N  +    +N  V  TDFGL   S  ++ G+     R   G   ++
Sbjct: 146 LHAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201
Query: 204 APEVLSQ----------SYGKEADIWSAGVILYILLCGVPPF 235
           APE++ Q           + K +D+++ G I Y L     PF
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243

>pdb|3FWB|A Chain A, Sac3:sus1:cdc31 Complex Length = 161

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E+ Q++ E F+  D +N G L Y ELK  +  LG  L + ++   +   D +G   +
Sbjct: 17  LLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKREILDLIDEYDSEGRHLM 76
Query: 393 DYIEFITATMQRHKLQR--FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIAT 450
            Y +F    M    L+R   + + +AFQ FD D+ G I++  L +  K+  +G+  T   
Sbjct: 77  KYDDFYI-VMGEKILKRDPLDEIKRAFQLFDDDHTGKISIKNLRRVAKE--LGETLTDEE 133
Query: 451 IKEIMSEVDRDKDGRISYDEF 471
           ++ ++ E D D DG I+ +EF
Sbjct: 134 LRAMIEEFDLDGDGEINENEF 154

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 93/234 (39%), Gaps = 42/234 (17%)
Query: 37  IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV---EKDDVRREIEIMRHLSGQ 93
            G+ +G G FG     T    G E A   +  + L       EK+ +  E++IM HL   
Sbjct: 35  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 94
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRI-----------VARGHYSE--------- 133
            NIV    A      V ++ E C  G+L + +           +A G   E         
Sbjct: 95  ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRP 154
Query: 134 ---RAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL------- 183
              R        +   +    SK  +HRD+   N L T G    V K  DFGL       
Sbjct: 155 LELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMND 211
Query: 184 SAFIEEGKAYREIVGSPYYIAPE-VLSQSYGKEADIWSAGVILY-ILLCGVPPF 235
           S +I +G A   +     ++APE +    Y  ++D+WS G++L+ I   G+ P+
Sbjct: 212 SNYIVKGNARLPV----KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 261

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 115/270 (42%), Gaps = 32/270 (11%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR---EIEIMRHLSGQPNIV 97
           +G G FG          GL         +++ +   KDD R    E+E++  L   PNI+
Sbjct: 30  IGEGNFGQVLKARIKKDGLRM---DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 98  QFKAAYEDDQFVHIVMELCAGGELFDRI-------------VARGHYSERAAASVFRVIM 144
               A E   ++++ +E    G L D +             +A    S  ++  +     
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 145 NV---VNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY 201
           +V   ++    K  +HR+L   N L     EN V K  DFGLS   +E    + +   P 
Sbjct: 147 DVARGMDYLSQKQFIHRNLAARNILV---GENYVAKIADFGLSRG-QEVYVKKTMGRLPV 202
Query: 202 -YIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            ++A E L+ S Y   +D+WS GV+L+ I+  G  P+   T   + + + +G   ++ + 
Sbjct: 203 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEK 259
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVL 288
             +      +L+R+   + P  R + AQ+L
Sbjct: 260 PLNCDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 115/271 (42%), Gaps = 23/271 (8%)
Query: 36  TIGREVGRGEFGITYL-----CTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           T+ R +G G FG  Y         + + L+ A K++P+  +  + ++ D   E  I+  L
Sbjct: 34  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKL 91
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDRIVAR--GHYSERAAASVFRVIMNV 146
           + Q NIV+            I++EL AGG+L  F R         S  A   +  V  ++
Sbjct: 92  NHQ-NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 147 VNVCH---SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE---IVGSP 200
              C        +HRD+   N L T      V K  DFG++  I     YR+    +   
Sbjct: 151 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 210
Query: 201 YYIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            ++ PE   +  +  + D WS GV+L+ I   G  P+ ++++Q V + +  G    + DP
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG---RMDP 267
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
             +       ++ +     P+ R   A +LE
Sbjct: 268 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 18/212 (8%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y +GR++G G FG  YL    ++G E A K     + VK  +   +  E +  + + G  
Sbjct: 11  YRLGRKIGSGSFGDIYLGANIASGEEVAIK----LECVK-TKHPQLHIESKFYKMMQGGV 65
Query: 95  NIVQFKAAYEDDQFVHIVMELCAGG--ELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
            I   K    +  +  +VMEL      +LF+    +  +S +    +   +++ +   HS
Sbjct: 66  GIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS 123
Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-----YRE---IVGSPYYIA 204
           K  +HRD+KP+NFL   G +  +V   DFGL+    + +      YRE   + G+  Y +
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 205 PEV-LSQSYGKEADIWSAGVILYILLCGVPPF 235
               L     +  D+ S G +L     G  P+
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 115/271 (42%), Gaps = 23/271 (8%)
Query: 36  TIGREVGRGEFGITYL-----CTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           T+ R +G G FG  Y         + + L+ A K++P+  +  + ++ D   E  I+  L
Sbjct: 48  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKL 105
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDRIVAR--GHYSERAAASVFRVIMNV 146
           + Q NIV+            I++EL AGG+L  F R         S  A   +  V  ++
Sbjct: 106 NHQ-NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 147 VNVCH---SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE---IVGSP 200
              C        +HRD+   N L T      V K  DFG++  I     YR+    +   
Sbjct: 165 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 224
Query: 201 YYIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            ++ PE   +  +  + D WS GV+L+ I   G  P+ ++++Q V + +  G    + DP
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG---RMDP 281
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
             +       ++ +     P+ R   A +LE
Sbjct: 282 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 114/271 (42%), Gaps = 23/271 (8%)
Query: 36  TIGREVGRGEFGITYL-----CTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           T+ R +G G FG  Y         + + L+ A K++P+  +  + ++ D   E  I+   
Sbjct: 48  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKF 105
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDRIVAR--GHYSERAAASVFRVIMNV 146
           + Q NIV+            I+MEL AGG+L  F R         S  A   +  V  ++
Sbjct: 106 NHQ-NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 147 VNVCH---SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE---IVGSP 200
              C        +HRD+   N L T      V K  DFG++  I     YR+    +   
Sbjct: 165 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 224
Query: 201 YYIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            ++ PE   +  +  + D WS GV+L+ I   G  P+ ++++Q V + +  G    + DP
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG---RMDP 281
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
             +       ++ +     P+ R   A +LE
Sbjct: 282 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 20/213 (9%)
Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACK-SIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           + +GR++G G FG  YL T   T  E A K    K K  + + +  + R   I++  +G 
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYR---ILQGGTGI 65
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGG--ELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
           PN+  F    E D  V +VM+L      +LF+   +R   S +    +   ++N V   H
Sbjct: 66  PNVRWF--GVEGDYNV-LVMDLLGPSLEDLFN-FCSR-KLSLKTVLMLADQMINRVEFVH 120
Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-----YRE---IVGSPYYI 203
           SK  +HRD+KP+NFL   G     V   DFGL+    +        YRE   + G+  Y 
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 204 APEV-LSQSYGKEADIWSAGVILYILLCGVPPF 235
           +    L     +  D+ S G +L   L G  P+
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 114/271 (42%), Gaps = 23/271 (8%)
Query: 36  TIGREVGRGEFGITYL-----CTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           T+ R +G G FG  Y         + + L+ A K++P+  +  + ++ D   E  I+   
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKF 90
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDRIVAR--GHYSERAAASVFRVIMNV 146
           + Q NIV+            I+MEL AGG+L  F R         S  A   +  V  ++
Sbjct: 91  NHQ-NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 147 VNVCH---SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE---IVGSP 200
              C        +HRD+   N L T      V K  DFG++  I     YR+    +   
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 201 YYIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            ++ PE   +  +  + D WS GV+L+ I   G  P+ ++++Q V + +  G    + DP
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG---RMDP 266
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
             +       ++ +     P+ R   A +LE
Sbjct: 267 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|3MSE|B Chain B, Crystal Structure Of C-Terminal Domain Of Pf110239 Length = 180

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 75/145 (51%), Gaps = 7/145 (4%)
Query: 335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDY 394
              I+ + E F ++DT+++G+L++ E+   LA +G  + ++D+ + +QA DI+  G I Y
Sbjct: 35  NNHIKYINELFYKLDTNHNGSLSHREIYTVLASVG--IKKWDINRILQALDINDRGNITY 92
Query: 395 IEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGD---DATIATI 451
            EF+    +   ++    L  AF   DKD +GYI+  ++     D  + +   D    ++
Sbjct: 93  TEFMAGCYRWKNIES-TFLKAAFNKIDKDEDGYISKSDIVSLVHDKVLDNNDIDNFFLSV 151
Query: 452 KEIMSEVDRDK-DGRISYDEFRSMM 475
             I   + R+    +IS+ EF+  M
Sbjct: 152 HSIKKGIPREHIINKISFQEFKDYM 176

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 23/271 (8%)
Query: 36  TIGREVGRGEFGITYL-----CTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           T+ R +G G FG  Y         + + L+ A K++P+  +  + ++ D   E  I+   
Sbjct: 34  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKF 91
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDRIVAR--GHYSERAAASVFRVIMNV 146
           + Q NIV+            I++EL AGG+L  F R         S  A   +  V  ++
Sbjct: 92  NHQ-NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 147 VNVCH---SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE---IVGSP 200
              C        +HRD+   N L T      V K  DFG++  I     YR+    +   
Sbjct: 151 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPV 210
Query: 201 YYIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            ++ PE   +  +  + D WS GV+L+ I   G  P+ ++++Q V + +  G    + DP
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG---RMDP 267
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
             +       ++ +     P+ R   A +LE
Sbjct: 268 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 23/271 (8%)
Query: 36  TIGREVGRGEFGITYL-----CTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           T+ R +G G FG  Y         + + L+ A K++P+  +  + ++ D   E  I+   
Sbjct: 40  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKF 97
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDRIVAR--GHYSERAAASVFRVIMNV 146
           + Q NIV+            I++EL AGG+L  F R         S  A   +  V  ++
Sbjct: 98  NHQ-NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 156
Query: 147 VNVCH---SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE---IVGSP 200
              C        +HRD+   N L T      V K  DFG++  I     YR+    +   
Sbjct: 157 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 216
Query: 201 YYIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            ++ PE   +  +  + D WS GV+L+ I   G  P+ ++++Q V + +  G    + DP
Sbjct: 217 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG---RMDP 273
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
             +       ++ +     P+ R   A +LE
Sbjct: 274 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 304

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 23/271 (8%)
Query: 36  TIGREVGRGEFGITYL-----CTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           T+ R +G G FG  Y         + + L+ A K++P+  +  + ++ D   E  I+   
Sbjct: 60  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKF 117
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDRIVAR--GHYSERAAASVFRVIMNV 146
           + Q NIV+            I++EL AGG+L  F R         S  A   +  V  ++
Sbjct: 118 NHQ-NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 176
Query: 147 VNVCH---SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE---IVGSP 200
              C        +HRD+   N L T      V K  DFG++  I     YR+    +   
Sbjct: 177 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 236
Query: 201 YYIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            ++ PE   +  +  + D WS GV+L+ I   G  P+ ++++Q V + +  G    + DP
Sbjct: 237 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG---RMDP 293
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
             +       ++ +     P+ R   A +LE
Sbjct: 294 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 324

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 23/271 (8%)
Query: 36  TIGREVGRGEFGITYL-----CTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           T+ R +G G FG  Y         + + L+ A K++P+  +  + ++ D   E  I+   
Sbjct: 34  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKF 91
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDRIVAR--GHYSERAAASVFRVIMNV 146
           + Q NIV+            I++EL AGG+L  F R         S  A   +  V  ++
Sbjct: 92  NHQ-NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 147 VNVCH---SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE---IVGSP 200
              C        +HRD+   N L T      V K  DFG++  I     YR+    +   
Sbjct: 151 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 210
Query: 201 YYIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            ++ PE   +  +  + D WS GV+L+ I   G  P+ ++++Q V + +  G    + DP
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG---RMDP 267
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
             +       ++ +     P+ R   A +LE
Sbjct: 268 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 298

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 23/271 (8%)
Query: 36  TIGREVGRGEFGITYL-----CTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           T+ R +G G FG  Y         + + L+ A K++P+  +  + ++ D   E  I+   
Sbjct: 50  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKF 107
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDRIVAR--GHYSERAAASVFRVIMNV 146
           + Q NIV+            I++EL AGG+L  F R         S  A   +  V  ++
Sbjct: 108 NHQ-NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 166
Query: 147 VNVCH---SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE---IVGSP 200
              C        +HRD+   N L T      V K  DFG++  I     YR+    +   
Sbjct: 167 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 226
Query: 201 YYIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            ++ PE   +  +  + D WS GV+L+ I   G  P+ ++++Q V + +  G    + DP
Sbjct: 227 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG---RMDP 283
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
             +       ++ +     P+ R   A +LE
Sbjct: 284 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 314

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 23/271 (8%)
Query: 36  TIGREVGRGEFGITYL-----CTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           T+ R +G G FG  Y         + + L+ A K++P+  +  + ++ D   E  I+   
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKF 131
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDRIVAR--GHYSERAAASVFRVIMNV 146
           + Q NIV+            I++EL AGG+L  F R         S  A   +  V  ++
Sbjct: 132 NHQ-NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 147 VNVCH---SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE---IVGSP 200
              C        +HRD+   N L T      V K  DFG++  I     YR+    +   
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250
Query: 201 YYIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            ++ PE   +  +  + D WS GV+L+ I   G  P+ ++++Q V + +  G    + DP
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG---RMDP 307
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
             +       ++ +     P+ R   A +LE
Sbjct: 308 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 338

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 23/271 (8%)
Query: 36  TIGREVGRGEFGITYL-----CTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           T+ R +G G FG  Y         + + L+ A K++P+  +  + ++ D   E  I+   
Sbjct: 25  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKF 82
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDRIVAR--GHYSERAAASVFRVIMNV 146
           + Q NIV+            I++EL AGG+L  F R         S  A   +  V  ++
Sbjct: 83  NHQ-NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 141
Query: 147 VNVCH---SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE---IVGSP 200
              C        +HRD+   N L T      V K  DFG++  I     YR+    +   
Sbjct: 142 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 201
Query: 201 YYIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            ++ PE   +  +  + D WS GV+L+ I   G  P+ ++++Q V + +  G    + DP
Sbjct: 202 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG---RMDP 258
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
             +       ++ +     P+ R   A +LE
Sbjct: 259 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 289

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 23/271 (8%)
Query: 36  TIGREVGRGEFGITYL-----CTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           T+ R +G G FG  Y         + + L+ A K++P+  +  + ++ D   E  I+   
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKF 90
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDRIVAR--GHYSERAAASVFRVIMNV 146
           + Q NIV+            I++EL AGG+L  F R         S  A   +  V  ++
Sbjct: 91  NHQ-NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 147 VNVCH---SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE---IVGSP 200
              C        +HRD+   N L T      V K  DFG++  I     YR+    +   
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 201 YYIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            ++ PE   +  +  + D WS GV+L+ I   G  P+ ++++Q V + +  G    + DP
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG---RMDP 266
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
             +       ++ +     P+ R   A +LE
Sbjct: 267 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 297

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 23/271 (8%)
Query: 36  TIGREVGRGEFGITYL-----CTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           T+ R +G G FG  Y         + + L+ A K++P+  +  + ++ D   E  I+   
Sbjct: 48  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VYSEQDELDFLMEALIISKF 105
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDRIVAR--GHYSERAAASVFRVIMNV 146
           + Q NIV+            I++EL AGG+L  F R         S  A   +  V  ++
Sbjct: 106 NHQ-NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 147 VNVCH---SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE---IVGSP 200
              C        +HRD+   N L T      V K  DFG++  I     YR+    +   
Sbjct: 165 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 224
Query: 201 YYIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            ++ PE   +  +  + D WS GV+L+ I   G  P+ ++++Q V + +  G    + DP
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG---RMDP 281
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
             +       ++ +     P+ R   A +LE
Sbjct: 282 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 312

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 23/271 (8%)
Query: 36  TIGREVGRGEFGITYL-----CTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           T+ R +G G FG  Y         + + L+ A K++P+  +  + ++ D   E  I+   
Sbjct: 51  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKF 108
Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDRIVAR--GHYSERAAASVFRVIMNV 146
           + Q NIV+            I++EL AGG+L  F R         S  A   +  V  ++
Sbjct: 109 NHQ-NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 167
Query: 147 VNVCH---SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE---IVGSP 200
              C        +HRD+   N L T      V K  DFG++  I     YR+    +   
Sbjct: 168 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 227
Query: 201 YYIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            ++ PE   +  +  + D WS GV+L+ I   G  P+ ++++Q V + +  G    + DP
Sbjct: 228 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG---RMDP 284
Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
             +       ++ +     P+ R   A +LE
Sbjct: 285 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 315

>pdb|2GV5|A Chain A, Crystal Structure Of Sfi1pCDC31P COMPLEX Length = 161

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 69/140 (49%), Gaps = 3/140 (2%)
Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E+ Q++ E F+  D +N G L Y ELK     LG  L + ++   +   D +G    
Sbjct: 17  LLEEQKQEIYEAFSLFDXNNDGFLDYHELKVAXKALGFELPKREILDLIDEYDSEGRHLX 76
Query: 393 DYIEFITATMQR-HKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATI 451
            Y +F     ++  K    + + +AFQ FD D+ G I++  L +  K+  +G+  T   +
Sbjct: 77  KYDDFYIVXGEKILKRDPLDEIKRAFQLFDDDHTGKISIKNLRRVAKE--LGETLTDEEL 134
Query: 452 KEIMSEVDRDKDGRISYDEF 471
           +  + E D D DG I+ +EF
Sbjct: 135 RAXIEEFDLDGDGEINENEF 154

>pdb|2JNF|A Chain A, Solution Structure Of Fly Troponin C, Isoform F1 Length = 158

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 83/161 (51%), Gaps = 16/161 (9%)
Query: 330 VENLPTEEIQKLKEKFTEMDT-DNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           V  L + +++ L+  F + +T + SG ++ D++   L  LG   T+  ++Q +   D  G
Sbjct: 4   VSKLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEFDPFG 63
Query: 389 NGTIDY-------IEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYG 441
           NG ID+         F+   +   ++Q+   L +AF+ +DK+ NGYI+ D + +   +  
Sbjct: 64  NGDIDFDSFKIIGARFLGEEVNPEQMQQ--ELREAFRLYDKEGNGYISTDVMREILAEL- 120
Query: 442 MGDDATIAT--IKEIMSEVDRDKDGRISYDEFRSMMKCGTQ 480
              D T+++  +  ++ E+D D  G + ++EF  +M  G +
Sbjct: 121 ---DETLSSEDLDAMIDEIDADGSGTVDFEEFMGVMTGGDE 158

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 102/236 (43%), Gaps = 46/236 (19%)
Query: 37  IGREVGRGEFG-----ITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
            G+ +G G FG       Y  ++    ++ A K + ++      E++ +  E+++M  L 
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMMTQLG 106
Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIM------ 144
              NIV    A      ++++ E C  G+L + + + R  +SE       +  +      
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 145 NVVN----VCHS------------KGVMHRDLKPENFLFTTGDENAVVKATDFGL----- 183
           NV+     +C +            K  +HRDL   N L T G    VVK  DFGL     
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK---VVKICDFGLARDIM 223
Query: 184 --SAFIEEGKAYREIVGSPYYIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPF 235
             S ++  G A   +     ++APE L +  Y  ++D+WS G++L+ I   GV P+
Sbjct: 224 SDSNYVVRGNARLPVK----WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/276 (22%), Positives = 121/276 (43%), Gaps = 32/276 (11%)
Query: 36  TIGREVGRGEFGITYL--CTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            + RE+G G FG  +L  C   S   +    ++   K      + D +RE E++ +L  +
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77
Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH-------------YSERAAASVF 140
            +IV+F     D   + +V E    G+L   + A G                E   + + 
Sbjct: 78  -HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 141 RVIMNVVN---VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR--- 194
            +   + +      S+  +HRDL   N L      N +VK  DFG+S  +     YR   
Sbjct: 137 HIASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDFGMSRDVYSTDYYRVGG 193
Query: 195 EIVGSPYYIAPE-VLSQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEI 252
             +    ++ PE ++ + +  E+D+WS GVIL+ I   G  P++  ++  V + I +G +
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRV 253
Query: 253 NFQRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQV 287
             +R   P +    + +++     ++P++R+ + ++
Sbjct: 254 -LER---PRVCPKEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 128/288 (44%), Gaps = 48/288 (16%)
Query: 37  IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR---REIEIMRHLSGQ 93
           +G+ +GRG FG               C+++  + L +     + R    E++I+ H+   
Sbjct: 33  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 94  PNIVQF-KAAYEDDQFVHIVMELCAGGELFDRIVARGH----YSERAAASVFRVIMNVVN 148
            N+V    A  +    + +++E C  G L   + ++ +    Y E A   +++  + + +
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKE-APEDLYKDFLTLEH 151
Query: 149 -VCHS------------KGVMHRDLKPENFLFTTGDENAVVKATDFGLSA-------FIE 188
            +C+S            +  +HRDL   N L +   E  VVK  DFGL+        ++ 
Sbjct: 152 LICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVR 208
Query: 189 EGKAYREIVGSPYYIAPE-VLSQSYGKEADIWSAGVILY-ILLCGVPPF-WAETDQGVAQ 245
           +G A   +     ++APE +  + Y  ++D+WS GV+L+ I   G  P+   + D+   +
Sbjct: 209 KGDARLPL----KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 264
Query: 246 AILKGEINFQRDPFPSISSSAIELVRRMLT---QDPKRRITVAQVLEH 290
            + +G     R P      +  E+ + ML     +P +R T ++++EH
Sbjct: 265 RLKEG--TRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 306

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 126/283 (44%), Gaps = 40/283 (14%)
Query: 18  HLHDAILGK-AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVE 76
           H+    L K A+E  +    +  ++G+G FG  ++ T N T    A K++    +  +  
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA- 59
Query: 77  KDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-GHY---- 131
                +E ++M+ L  +  +VQ  A   ++  ++IVME  + G L D +    G Y    
Sbjct: 60  ---FLQEAQVMKKLRHE-KLVQLYAVVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLP 114
Query: 132 ------SERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA 185
                 ++ A+   +   MN V         HRDL+  N L     EN V K  DFGL+ 
Sbjct: 115 QLVDMAAQIASGMAYVERMNYV---------HRDLRAANILV---GENLVCKVADFGLAR 162
Query: 186 FIEEGKAYREIVGSPY---YIAPE-VLSQSYGKEADIWSAGVILYILLC-GVPPFWAETD 240
            IE+ + Y    G+ +   + APE  L   +  ++D+WS G++L  L   G  P+    +
Sbjct: 163 LIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221
Query: 241 QGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRIT 283
           + V   + +G   ++    P    S  +L+ +   +DP+ R T
Sbjct: 222 REVLDQVERG---YRMPCPPECPESLHDLMCQCWRKDPEERPT 261

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 125/286 (43%), Gaps = 39/286 (13%)
Query: 14  PAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK 73
           P ++     +   A+E  +    +  ++G+G FG  ++ T N T    A K++       
Sbjct: 166 PTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKP----G 220
Query: 74  DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-GHY- 131
           ++  +   +E ++M+ L  +  +VQ  A   ++  ++IV E  + G L D +    G Y 
Sbjct: 221 NMSPEAFLQEAQVMKKLRHE-KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYL 278
Query: 132 ---------SERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG 182
                    ++ A+   +   MN V         HRDL+  N L     EN V K  DFG
Sbjct: 279 RLPQLVDMAAQIASGMAYVERMNYV---------HRDLRAANILV---GENLVCKVADFG 326
Query: 183 LSAFIEEGKAYREIVGSPY---YIAPE-VLSQSYGKEADIWSAGVILYILLC-GVPPFWA 237
           L   IE+ + Y    G+ +   + APE  L   +  ++D+WS G++L  L   G  P+  
Sbjct: 327 LGRLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 385
Query: 238 ETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRIT 283
             ++ V   + +G   ++    P    S  +L+ +   +DP+ R T
Sbjct: 386 MVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKDPEERPT 428

>pdb|2B1U|A Chain A, Solution Structure Of Calmodulin-Like Skin Protein C Terminal Domain Length = 71

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 27/66 (40%), Positives = 42/66 (63%), Gaps = 2/66 (3%)
Query: 410 FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYD 469
            E+L  AF+ FD+D +G+ITVDEL +A    G+G       +  ++ E D D+DGR++Y+
Sbjct: 5   LEDLQVAFRAFDQDGDGHITVDELRRAMA--GLGQPLPQEELDAMIREADVDQDGRVNYE 62
Query: 470 EFRSMM 475
           EF  M+
Sbjct: 63  EFARML 68

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 87/200 (43%), Gaps = 26/200 (13%)
Query: 93  QPNIVQFKAAYE-----DDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV-IMNV 146
            P+IVQ     E      D   +IVME   GG+   R  ++G     A A  + + I+  
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYV-GGQSLKR--SKGQKLPVAEAIAYLLEILPA 194
Query: 147 VNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE 206
           ++  HS G+++ DLKPEN + T       +K  D G  + I    ++  + G+P + APE
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLT----EEQLKLIDLGAVSRI---NSFGYLYGTPGFQAPE 247
Query: 207 VLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
           ++        DI++ G  L  L   +P        G+           + DP      S 
Sbjct: 248 IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------EDDPVLKTYDSY 297
Query: 267 IELVRRMLTQDPKRRITVAQ 286
             L+RR +  DP++R T A+
Sbjct: 298 GRLLRRAIDPDPRQRFTTAE 317

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/298 (21%), Positives = 130/298 (43%), Gaps = 29/298 (9%)
Query: 11  SDHPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYL-----CTENSTGLEFACKS 65
           S +P      D  +   +E  +   T+ RE+G+G FG+ Y        ++      A K+
Sbjct: 3   SVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT 62
Query: 66  IPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRI 125
           + +   ++  E+ +   E  +M+  +   ++V+        Q   ++MEL   G+L   +
Sbjct: 63  VNEAASMR--ERIEFLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
Query: 126 ----VARGHYSERAAASVFRVIMNVVNVC------HSKGVMHRDLKPENFLFTTGDENAV 175
                A  +    A  S+ ++I     +       ++   +HRDL   N +     E+  
Sbjct: 120 RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFT 176
Query: 176 VKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS-YGKEADIWSAGVILY-ILLC 230
           VK  DFG++  I E   YR   + +    +++PE L    +   +D+WS GV+L+ I   
Sbjct: 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 236
Query: 231 GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
              P+   +++ V + +++G +  + D  P +     EL+R     +PK R +  +++
Sbjct: 237 AEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 291

>pdb|2LQC|A Chain A, Nmr Solution Structure Of A Ca2+-Calmodulin With A Binding Motif (Nscate) Peptide From The N-Terminal Cytoplasmic Domain Of The L-Type Voltage-Cated Calcium Channel Alpha1c Subunit Length = 77

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 43/77 (55%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGN
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 390 GTIDYIEFITATMQRHK 406
           GTID+ EF+T   ++ K
Sbjct: 61  GTIDFPEFLTMMARKMK 77

>pdb|2LQC|A Chain A, Nmr Solution Structure Of A Ca2+-Calmodulin With A Binding Motif (Nscate) Peptide From The N-Terminal Cytoplasmic Domain Of The L-Type Voltage-Cated Calcium Channel Alpha1c Subunit Length = 77

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 25/61 (40%), Positives = 39/61 (63%), Gaps = 2/61 (3%)
Query: 415 KAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSM 474
           +AF  FDKD +G IT  ELG   +   +G + T A ++++++EVD D +G I + EF +M
Sbjct: 14  EAFSLFDKDGDGTITTKELGTVMR--SLGQNPTEAELQDMINEVDADGNGTIDFPEFLTM 71
Query: 475 M 475
           M
Sbjct: 72  M 72

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 128/285 (44%), Gaps = 44/285 (15%)
Query: 18  HLHDAILGK-AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVE 76
           H+    L K A+E  +    +  ++G+G FG  ++ T N T    A K++    +  +  
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA- 59
Query: 77  KDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-GHY---- 131
                +E ++M+ L  +  +VQ  A   ++  ++IV+E  + G L D +    G Y    
Sbjct: 60  ---FLQEAQVMKKLRHE-KLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 132 ------SERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA 185
                 ++ A+   +   MN V         HRDL+  N L     EN V K  DFGL+ 
Sbjct: 115 QLVDMAAQIASGMAYVERMNYV---------HRDLRAANILV---GENLVCKVADFGLAR 162
Query: 186 FIEEGKAYREIVGSPY---YIAPEVLSQSYGK---EADIWSAGVILYILLC-GVPPFWAE 238
            IE+ + Y    G+ +   + APE  +  YG+   ++D+WS G++L  L   G  P+   
Sbjct: 163 LIEDNE-YTARQGAKFPIKWTAPE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219
Query: 239 TDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRIT 283
            ++ V   + +G   ++    P    S  +L+ +   +DP+ R T
Sbjct: 220 VNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKDPEERPT 261

>pdb|3IFK|A Chain A, Crystal Structure Of Calcium-Saturated Calmodulin N-Terminal Domain Fragment, Residues 1-90 Length = 90

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 43/77 (55%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGN
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 390 GTIDYIEFITATMQRHK 406
           GTID+ EF+T   ++ K
Sbjct: 61  GTIDFPEFLTMMARKMK 77

>pdb|3IFK|A Chain A, Crystal Structure Of Calcium-Saturated Calmodulin N-Terminal Domain Fragment, Residues 1-90 Length = 90

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 25/61 (40%), Positives = 39/61 (63%), Gaps = 2/61 (3%)
Query: 415 KAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSM 474
           +AF  FDKD +G IT  ELG   +   +G + T A ++++++EVD D +G I + EF +M
Sbjct: 14  EAFSLFDKDGDGTITTKELGTVMR--SLGQNPTEAELQDMINEVDADGNGTIDFPEFLTM 71
Query: 475 M 475
           M
Sbjct: 72  M 72

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 84/192 (43%), Gaps = 21/192 (10%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+GEFG   L       +   C       +  D        E  +M  L    N+VQ  
Sbjct: 20  IGKGEFGDVMLGDYRGNKVAVKC-------IKNDATAQAFLAEASVMTQLR-HSNLVQLL 71
Query: 101 AA-YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV---CHSKGVM 156
               E+   ++IV E  A G L D + +RG  S      + +  ++V            +
Sbjct: 72  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFV 130
Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY-YIAPEVLSQS-YGK 214
           HRDL   N L +   E+ V K +DFGL+   +E  + ++    P  + APE L ++ +  
Sbjct: 131 HRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREAAFST 184
Query: 215 EADIWSAGVILY 226
           ++D+WS G++L+
Sbjct: 185 KSDVWSFGILLW 196

>pdb|3UCT|A Chain A, Structure Of Mn2+-Bound N-Terminal Domain Of Calmodulin In The Presence Of Zn2+ Length = 79

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 43/77 (55%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGN
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 390 GTIDYIEFITATMQRHK 406
           GTID+ EF+T   ++ K
Sbjct: 61  GTIDFPEFLTMMARKMK 77

>pdb|3UCT|A Chain A, Structure Of Mn2+-Bound N-Terminal Domain Of Calmodulin In The Presence Of Zn2+ Length = 79

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 25/61 (40%), Positives = 39/61 (63%), Gaps = 2/61 (3%)
Query: 415 KAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSM 474
           +AF  FDKD +G IT  ELG   +   +G + T A ++++++EVD D +G I + EF +M
Sbjct: 14  EAFSLFDKDGDGTITTKELGTVMR--SLGQNPTEAELQDMINEVDADGNGTIDFPEFLTM 71
Query: 475 M 475
           M
Sbjct: 72  M 72

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/288 (21%), Positives = 127/288 (44%), Gaps = 29/288 (10%)
Query: 21  DAILGKAYEDVQLHYTIGREVGRGEFGITYL-----CTENSTGLEFACKSIPKRKLVKDV 75
           D  +   +E  +   T+ RE+G+G FG+ Y        ++      A K++ +   ++  
Sbjct: 3   DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-- 60
Query: 76  EKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRI----VARGHY 131
           E+ +   E  +M+  +   ++V+        Q   ++MEL   G+L   +     A  + 
Sbjct: 61  ERIEFLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANN 119
Query: 132 SERAAASVFRVIMNVVNVC------HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA 185
              A  S+ ++I     +       ++   +HRDL   N +     E+  VK  DFG++ 
Sbjct: 120 PVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTR 176
Query: 186 FIEEGKAYR---EIVGSPYYIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETD 240
            I E   YR   + +    +++PE L    +   +D+WS GV+L+ I      P+   ++
Sbjct: 177 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 236
Query: 241 QGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
           + V + +++G +  + D  P +     EL+R     +PK R +  +++
Sbjct: 237 EQVLRFVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 281

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/288 (21%), Positives = 127/288 (44%), Gaps = 29/288 (10%)
Query: 21  DAILGKAYEDVQLHYTIGREVGRGEFGITYL-----CTENSTGLEFACKSIPKRKLVKDV 75
           D  +   +E  +   T+ RE+G+G FG+ Y        ++      A K++ +   ++  
Sbjct: 4   DVFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-- 61
Query: 76  EKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSER- 134
           E+ +   E  +M+  +   ++V+        Q   ++MEL   G+L   + +     E  
Sbjct: 62  ERIEFLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENN 120
Query: 135 ---AAASVFRVIMNVVNVC------HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA 185
              A  S+ ++I     +       ++   +HRDL   N +     E+  VK  DFG++ 
Sbjct: 121 PVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTR 177
Query: 186 FIEEGKAYR---EIVGSPYYIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETD 240
            I E   YR   + +    +++PE L    +   +D+WS GV+L+ I      P+   ++
Sbjct: 178 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 237
Query: 241 QGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
           + V + +++G +  + D  P +     EL+R     +PK R +  +++
Sbjct: 238 EQVLRFVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 282

>pdb|2LLO|A Chain A, Solution Nmr-Derived Structure Of Calmodulin N-Lobe Bound With Er Alpha Peptide Length = 80

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 43/77 (55%)
Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
            + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGN
Sbjct: 1   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 60
Query: 390 GTIDYIEFITATMQRHK 406
           GTID+ EF+T   ++ K
Sbjct: 61  GTIDFPEFLTMMARKMK 77

>pdb|2LLO|A Chain A, Solution Nmr-Derived Structure Of Calmodulin N-Lobe Bound With Er Alpha Peptide Length = 80

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 25/61 (40%), Positives = 39/61 (63%), Gaps = 2/61 (3%)
Query: 415 KAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSM 474
           +AF  FDKD +G IT  ELG   +   +G + T A ++++++EVD D +G I + EF +M
Sbjct: 14  EAFSLFDKDGDGTITTKELGTVMR--SLGQNPTEAELQDMINEVDADGNGTIDFPEFLTM 71
Query: 475 M 475
           M
Sbjct: 72  M 72

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 115/274 (41%), Gaps = 31/274 (11%)
Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV-EKDDVRREIEIMRHLSGQP 94
           T+ RE+G+G FG+ Y         +        R  VK V E   +R  IE +   S   
Sbjct: 19  TLLRELGQGSFGMVY----EGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMK 74
Query: 95  -----NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSE----RAAASVFRVIMN 145
                ++V+        Q   +VMEL A G+L   + +    +E    R   ++  +I  
Sbjct: 75  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 134
Query: 146 VVNVC------HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EI 196
              +       ++K  +HRDL   N +      +  VK  DFG++  I E   YR   + 
Sbjct: 135 AAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKG 191
Query: 197 VGSPYYIAPEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINF 254
           +    ++APE L    +   +D+WS GV+L+ I      P+   +++ V + ++ G    
Sbjct: 192 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 251
Query: 255 QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
           Q D  P       +L+R     +PK R T  +++
Sbjct: 252 QPDNCP---ERVTDLMRMCWQFNPKMRPTFLEIV 282

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 105/246 (42%), Gaps = 50/246 (20%)
Query: 70  KLVKDVEKDDVRREIE---IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIV 126
           K +KD  +  +R E     ++R     PN+V        DQ + ++   C+ G+L + +V
Sbjct: 45  KTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLV 104
Query: 127 ARGHYSERAAASVFRVIMNVV---NVCH-------------SKGVMHRDLKPENFLFTTG 170
            R  +S+  +    R + + +   +  H             S  V+H+DL   N L    
Sbjct: 105 MRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY-- 162
Query: 171 DENAVVKATDFGLSAFIEEGKAYREIVGSPYY------------IAPEVLSQSYGK---E 215
            +   VK +D GL         +RE+  + YY            +APE +   YGK   +
Sbjct: 163 -DKLNVKISDLGL---------FREVYAADYYKLLGNSLLPIRWMAPEAI--MYGKFSID 210
Query: 216 ADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRM 273
           +DIWS GV+L+ +   G+ P+   ++Q V + I   ++    D  P+ + +  IE     
Sbjct: 211 SDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEF 270
Query: 274 LTQDPK 279
            ++ P+
Sbjct: 271 PSRRPR 276

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/298 (21%), Positives = 130/298 (43%), Gaps = 29/298 (9%)
Query: 11  SDHPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYL-----CTENSTGLEFACKS 65
           S +P      D  +   +E  +   T+ RE+G+G FG+ Y        ++      A K+
Sbjct: 3   SVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT 62
Query: 66  IPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRI 125
           + +   ++  E+ +   E  +M+  +   ++V+        Q   ++MEL   G+L   +
Sbjct: 63  VNEAASMR--ERIEFLNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
Query: 126 VARGHYSER----AAASVFRVIMNVVNVC------HSKGVMHRDLKPENFLFTTGDENAV 175
            +     E     A  S+ ++I     +       ++   +HRDL   N +     E+  
Sbjct: 120 RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFT 176
Query: 176 VKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVLSQS-YGKEADIWSAGVILY-ILLC 230
           VK  DFG++  I E   YR   + +    +++PE L    +   +D+WS GV+L+ I   
Sbjct: 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 236
Query: 231 GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
              P+   +++ V + +++G +  + D  P +     EL+R     +PK R +  +++
Sbjct: 237 AEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 291

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 105/246 (42%), Gaps = 50/246 (20%)
Query: 70  KLVKDVEKDDVRREIE---IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIV 126
           K +KD  +  +R E     ++R     PN+V        DQ + ++   C+ G+L + +V
Sbjct: 62  KTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLV 121
Query: 127 ARGHYSERAAASVFRVIMNVV---NVCH-------------SKGVMHRDLKPENFLFTTG 170
            R  +S+  +    R + + +   +  H             S  V+H+DL   N L    
Sbjct: 122 MRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY-- 179
Query: 171 DENAVVKATDFGLSAFIEEGKAYREIVGSPYY------------IAPEVLSQSYGK---E 215
            +   VK +D GL         +RE+  + YY            +APE +   YGK   +
Sbjct: 180 -DKLNVKISDLGL---------FREVYAADYYKLLGNSLLPIRWMAPEAI--MYGKFSID 227
Query: 216 ADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELVRRM 273
           +DIWS GV+L+ +   G+ P+   ++Q V + I   ++    D  P+ + +  IE     
Sbjct: 228 SDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEF 287
Query: 274 LTQDPK 279
            ++ P+
Sbjct: 288 PSRRPR 293

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 127/285 (44%), Gaps = 44/285 (15%)
Query: 18  HLHDAILGK-AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVE 76
           H+    L K A+E  +    +  ++G+G FG  ++ T N T    A K++    +  +  
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA- 59
Query: 77  KDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-GHY---- 131
                +E ++M+ L  +  +VQ  A   ++  ++IV E  + G L D +    G Y    
Sbjct: 60  ---FLQEAQVMKKLRHE-KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 132 ------SERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA 185
                 ++ A+   +   MN V         HRDL+  N L     EN V K  DFGL+ 
Sbjct: 115 QLVDMAAQIASGMAYVERMNYV---------HRDLRAANILV---GENLVCKVADFGLAR 162
Query: 186 FIEEGKAYREIVGSPY---YIAPEVLSQSYGK---EADIWSAGVILYILLC-GVPPFWAE 238
            IE+ + Y    G+ +   + APE  +  YG+   ++D+WS G++L  L   G  P+   
Sbjct: 163 LIEDNE-YTARQGAKFPIKWTAPE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219
Query: 239 TDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRIT 283
            ++ V   + +G   ++    P    S  +L+ +   +DP+ R T
Sbjct: 220 VNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKDPEERPT 261

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 83/192 (43%), Gaps = 21/192 (10%)
Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+GEFG   L       +   C       +  D        E  +M  L    N+VQ  
Sbjct: 29  IGKGEFGDVMLGDYRGNKVAVKC-------IKNDATAQAFLAEASVMTQLR-HSNLVQLL 80
Query: 101 AA-YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV---CHSKGVM 156
               E+   ++IV E  A G L D + +RG  S      + +  ++V            +
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFV 139
Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY-YIAPEVLSQS-YGK 214
           HRDL   N L +   E+ V K +DFGL+   +E  + ++    P  + APE L +  +  
Sbjct: 140 HRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFST 193
Query: 215 EADIWSAGVILY 226
           ++D+WS G++L+
Sbjct: 194 KSDVWSFGILLW 205
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	494
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	0.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	0.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	0.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	0.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	0.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	0.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	0.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-174
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-173
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-171
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-169
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-167
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-167
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-167
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-167
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-164
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-163
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-163
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-163
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-163
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-163
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-161
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-160
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-158
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-156
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-156
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-156
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-155
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-155
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-150
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-149
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-144
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-142
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-105
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-102
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-96
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-96
3pm8_A	197	PFCDPK2, calcium-dependent protein kinase 2; malar	1e-92
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-92
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-92
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-89
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-88
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-88
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-88
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-88
3k21_A	191	PFCDPK3, calcium-dependent protein kinase 3; calci	4e-88
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-88
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-88
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-87
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-86
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-86
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-85
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-85
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-85
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-84
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-84
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-83
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-83
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-83
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-81
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-81
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-81
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-81
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-81
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-80
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-80
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-79
3khe_A	191	Calmodulin-like domain protein kinase isoform 3; c	4e-78
2aao_A	166	CDPK, calcium-dependent protein kinase, isoform AK	4e-77
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-75
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-72
2a19_B	284	Interferon-induced, double-stranded RNA-activated	9e-72
3mse_B	180	Calcium-dependent protein kinase, putative; CDPKS,	2e-70
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-69
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-68
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	2e-67
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	6e-44
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	3e-20
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-66
3e3r_A	204	Calcyphosin, calcyphosine; human calcyphosine, EF-	4e-66
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-65
1s6i_A	188	CDPK, calcium-dependent protein kinase SK5; EF-han	1e-63
1s6i_A	188	CDPK, calcium-dependent protein kinase SK5; EF-han	1e-18
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-62
3cs1_A	219	Flagellar calcium-binding protein; myristoylated,	3e-59
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-57
3sjs_A	220	URE3-BP sequence specific DNA binding protein; EF-	2e-55
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-54
1jfj_A	134	Ehcabp, calcium-binding protein; EF-hand, helix-lo	2e-53
1jfj_A	134	Ehcabp, calcium-binding protein; EF-hand, helix-lo	2e-09
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-53
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-53
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-53
1dtl_A	161	Cardiac troponin C; helix-turn-helix, structural p	5e-53
3fwb_A	161	Cell division control protein 31; gene gating, com	1e-52
3qrx_A	169	Centrin; calcium-binding, EF-hand, cell division,	3e-52
3ox6_A	153	Calcium-binding protein 1; EF-hand, calcium-sensor	4e-52
3ox6_A	153	Calcium-binding protein 1; EF-hand, calcium-sensor	4e-09
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-52
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-52
1top_A	162	Troponin C; contractIle system protein; 1.78A {Gal	2e-51
1top_A	162	Troponin C; contractIle system protein; 1.78A {Gal	4e-11
2jnf_A	158	Troponin C; stretch activated muscle contraction,	4e-51
2jnf_A	158	Troponin C; stretch activated muscle contraction,	5e-11
2obh_A	143	Centrin-2; DNA repair complex EF hand superfamily	7e-51
1qv0_A	195	Obelin, OBL; photoprotein, bioluminescence, atomic	2e-50
1qv0_A	195	Obelin, OBL; photoprotein, bioluminescence, atomic	1e-12
1qv0_A	195	Obelin, OBL; photoprotein, bioluminescence, atomic	2e-10
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-50
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-50
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-50
2f2o_A	179	Calmodulin fused with calmodulin-binding domain of	1e-49
2f2o_A	179	Calmodulin fused with calmodulin-binding domain of	6e-21
4ds7_A	147	Calmodulin, CAM; protein binding, metal binding, s	3e-49
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-49
2bl0_C	142	Myosin regulatory light chain; muscle protein, sli	3e-48
3ll8_B	155	Calcineurin subunit B type 1; protein-peptide dock	4e-48
3ll8_B	155	Calcineurin subunit B type 1; protein-peptide dock	4e-07
3ll8_B	155	Calcineurin subunit B type 1; protein-peptide dock	2e-05
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-48
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	9e-48
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-47
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-06
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-47
1exr_A	148	Calmodulin; high resolution, disorder, metal trans	2e-47
1exr_A	148	Calmodulin; high resolution, disorder, metal trans	1e-10
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-47
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-47
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-47
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-46
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-46
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-46
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-46
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-46
2ggz_A	211	Guanylyl cyclase-activating protein 3; EF hand, gu	5e-46
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-46
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-46
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-46
2zfd_A	226	Calcineurin B-like protein 2; calcium binding prot	1e-45
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-45
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-45
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-45
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-45
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-45
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-45
2hpk_A	208	Photoprotein berovin; structural genomics, PSI, pr	5e-45
2hpk_A	208	Photoprotein berovin; structural genomics, PSI, pr	6e-10
2hpk_A	208	Photoprotein berovin; structural genomics, PSI, pr	1e-09
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-44
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-44
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-44
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-44
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-44
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-44
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-43
1q80_A	174	SCP, sarcoplasmic calcium-binding protein; all-alp	3e-43
1q80_A	174	SCP, sarcoplasmic calcium-binding protein; all-alp	3e-13
2ehb_A	207	Calcineurin B-like protein 4; protein complex, Ca(	4e-43
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-42
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-42
1y1x_A	191	Leishmania major homolog of programmed cell death	4e-42
1y1x_A	191	Leishmania major homolog of programmed cell death	8e-20
1y1x_A	191	Leishmania major homolog of programmed cell death	2e-05
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-42
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-41
2mys_B	166	Myosin; muscle protein, motor protein; HET: MLY; 2	2e-41
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-41
1wdc_B	156	Scallop myosin; calcium binding protein, muscle pr	2e-40
3j04_B	143	Myosin regulatory light chain 2, smooth muscle MA	4e-40
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-40
1nya_A	176	Calerythrin; EF-hand, metal binding protein; NMR {	1e-39
1nya_A	176	Calerythrin; EF-hand, metal binding protein; NMR {	2e-13
3dd4_A	229	KV channel-interacting protein 4; EF-hands protein	1e-39
3dd4_A	229	KV channel-interacting protein 4; EF-hands protein	6e-07
2r2i_A	198	Guanylyl cyclase-activating protein 1; EF hand, GC	1e-39
2hps_A	186	Coelenterazine-binding protein with bound coelent;	2e-39
2hps_A	186	Coelenterazine-binding protein with bound coelent;	9e-11
2hps_A	186	Coelenterazine-binding protein with bound coelent;	8e-10
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-39
3akb_A	166	Putative calcium binding protein; EF-hand, metal b	2e-39
3akb_A	166	Putative calcium binding protein; EF-hand, metal b	8e-10
3akb_A	166	Putative calcium binding protein; EF-hand, metal b	2e-09
2f33_A	263	Calbindin; EF-hand, Ca2+-binding, metal binding pr	2e-39
2f33_A	263	Calbindin; EF-hand, Ca2+-binding, metal binding pr	5e-32
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-39
1jba_A	204	GCAP-2, protein (guanylate cyclase activating prot	6e-39
1jba_A	204	GCAP-2, protein (guanylate cyclase activating prot	1e-06
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-38
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-38
1bu3_A	109	Calcium-binding protein; 1.65A {Merluccius bilinea	2e-38
1bu3_A	109	Calcium-binding protein; 1.65A {Merluccius bilinea	3e-11
1uhk_A	191	Aequorin 2, aequorin; EF-hand motif, complex, lumi	4e-38
1uhk_A	191	Aequorin 2, aequorin; EF-hand motif, complex, lumi	6e-15
5pal_A	109	Parvalbumin; calcium-binding protein; 1.54A {Triak	4e-38
5pal_A	109	Parvalbumin; calcium-binding protein; 1.54A {Triak	4e-10
2pvb_A	108	Protein (parvalbumin); calcium binding protein, me	8e-38
2pvb_A	108	Protein (parvalbumin); calcium binding protein, me	8e-11
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-38
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-37
3fs7_A	109	Parvalbumin, thymic; calcium-binding protein, EF-h	2e-37
3fs7_A	109	Parvalbumin, thymic; calcium-binding protein, EF-h	1e-11
2znd_A	172	Programmed cell death protein 6; penta-EF-hand pro	2e-37
2znd_A	172	Programmed cell death protein 6; penta-EF-hand pro	2e-21
2znd_A	172	Programmed cell death protein 6; penta-EF-hand pro	1e-15
2znd_A	172	Programmed cell death protein 6; penta-EF-hand pro	5e-06
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-37
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-37
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-37
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-37
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-37
2bl0_B	145	Myosin regulatory light chain; muscle protein, sli	8e-37
2bl0_B	145	Myosin regulatory light chain; muscle protein, sli	5e-11
2jul_A	256	Calsenilin; EF-hand, calcium, LXXLL, DNA binding p	1e-36
2jul_A	256	Calsenilin; EF-hand, calcium, LXXLL, DNA binding p	5e-07
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-36
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-36
2bec_A	202	Calcineurin B homologous protein 2; calcineurin-ho	5e-36
2bec_A	202	Calcineurin B homologous protein 2; calcineurin-ho	1e-08
3sg6_A	450	Gcamp2, myosin light chain kinase, green fluoresce	6e-36
3sg6_A	450	Gcamp2, myosin light chain kinase, green fluoresce	2e-18
3sg6_A	450	Gcamp2, myosin light chain kinase, green fluoresce	9e-11
3sg6_A	450	Gcamp2, myosin light chain kinase, green fluoresce	5e-05
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-36
2ct9_A	208	Calcium-binding protein P22; EF-hand, metal bindin	1e-35
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-35
1pva_A	110	Parvalbumin; calcium binding; 1.65A {Esox lucius}	3e-35
1pva_A	110	Parvalbumin; calcium binding; 1.65A {Esox lucius}	8e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-35
2be4_A	272	Hypothetical protein LOC449832; DR.36843, BC083168	6e-35
2be4_A	272	Hypothetical protein LOC449832; DR.36843, BC083168	7e-30
2be4_A	272	Hypothetical protein LOC449832; DR.36843, BC083168	5e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-35
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	8e-35
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	9e-35
2ovk_B	153	RLC, myosin regulatory light chain LC-2, mantle mu	9e-35
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-34
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-34
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-34
1m45_A	148	MLC1P, myosin light chain; protein-peptide complex	4e-34
1m45_A	148	MLC1P, myosin light chain; protein-peptide complex	6e-11
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-34
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-34
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-34
2l2e_A	190	Calcium-binding protein NCS-1; NCS1P, myristoylate	6e-34
2l2e_A	190	Calcium-binding protein NCS-1; NCS1P, myristoylate	4e-07
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	9e-34
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-33
1bjf_A	193	Neurocalcin delta; calcium-binding, myristoylation	1e-33
1bjf_A	193	Neurocalcin delta; calcium-binding, myristoylation	2e-05
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-33
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-33
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-33
2ccm_A	191	Calexcitin; EF hand, calcium, signaling protein; 1	9e-33
2ccm_A	191	Calexcitin; EF hand, calcium, signaling protein; 1	1e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-32
1w7j_B	151	Myosin light chain 1; motor protein, unconventiona	2e-32
1w7j_B	151	Myosin light chain 1; motor protein, unconventiona	7e-10
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-32
3dtp_E	196	RLC, myosin regulatory light chain; muscle protein	2e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-32
2mys_C	149	Myosin; muscle protein, motor protein; HET: MLY; 2	6e-32
2qac_A	146	Myosin A tail domain interacting protein MTIP; mal	1e-31
2qac_A	146	Myosin A tail domain interacting protein MTIP; mal	1e-08
1wdc_C	156	Scallop myosin; calcium binding protein, muscle pr	2e-31
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-31
1ggw_A	140	Protein (CDC4P); light chain, cytokinesis, cell cy	4e-31
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-31
2ovk_C	159	Myosin catalytic light chain LC-1, mantle muscle,	8e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-30
1alv_A	173	Calpain, S-camld; calcium binding, calmodulin like	3e-30
1alv_A	173	Calpain, S-camld; calcium binding, calmodulin like	2e-21
1alv_A	173	Calpain, S-camld; calcium binding, calmodulin like	2e-09
1alv_A	173	Calpain, S-camld; calcium binding, calmodulin like	3e-04
2kyc_A	108	Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p	7e-30
2kyc_A	108	Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p	7e-24
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-29
1s6j_A	87	CDPK, calcium-dependent protein kinase SK5; EF-han	1e-29
1s6j_A	87	CDPK, calcium-dependent protein kinase SK5; EF-han	2e-21
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-29
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-29
1s1e_A	224	KV channel interacting protein 1; kchip, calcium-b	3e-28
1s1e_A	224	KV channel interacting protein 1; kchip, calcium-b	2e-06
1rwy_A	109	Parvalbumin alpha; EF-hand, calcium-binding, calci	6e-28
1rwy_A	109	Parvalbumin alpha; EF-hand, calcium-binding, calci	2e-25
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-28
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-27
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-27
1rro_A	108	RAT oncomodulin; calcium-binding protein; 1.30A {R	4e-27
1rro_A	108	RAT oncomodulin; calcium-binding protein; 1.30A {R	4e-23
2sas_A	185	Sarcoplasmic calcium-binding protein; 2.40A {Branc	4e-27
2sas_A	185	Sarcoplasmic calcium-binding protein; 2.40A {Branc	3e-09
2sas_A	185	Sarcoplasmic calcium-binding protein; 2.40A {Branc	5e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-27
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-27
3h4s_E	135	KCBP interacting Ca2+-binding protein; kinesin, mo	2e-26
3h4s_E	135	KCBP interacting Ca2+-binding protein; kinesin, mo	1e-08
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-26
1gjy_A	167	Sorcin, CP-22, V19; calcium binding, calcium-bindi	1e-25
1gjy_A	167	Sorcin, CP-22, V19; calcium binding, calcium-bindi	1e-15
1gjy_A	167	Sorcin, CP-22, V19; calcium binding, calcium-bindi	2e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-25
1g8i_A	190	Frequenin, neuronal calcium sensor 1; calcium bind	2e-25
1g8i_A	190	Frequenin, neuronal calcium sensor 1; calcium bind	2e-06
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-25
2d8n_A	207	Recoverin; structural genomics, NPPSFA, national p	5e-25
2d8n_A	207	Recoverin; structural genomics, NPPSFA, national p	2e-04
1fpw_A	190	Yeast frequenin, calcium-binding protein NCS-1; EF	8e-25
1fpw_A	190	Yeast frequenin, calcium-binding protein NCS-1; EF	3e-07
1s6c_A	183	KV4 potassium channel-interacting protein kchip1B;	2e-24
1s6c_A	183	KV4 potassium channel-interacting protein kchip1B;	4e-07
1s6c_A	183	KV4 potassium channel-interacting protein kchip1B;	3e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-24
1juo_A	198	Sorcin; calcium-binding proteins, penta-EF-hand, P	8e-24
1juo_A	198	Sorcin; calcium-binding proteins, penta-EF-hand, P	1e-15
1juo_A	198	Sorcin; calcium-binding proteins, penta-EF-hand, P	8e-11
1juo_A	198	Sorcin; calcium-binding proteins, penta-EF-hand, P	6e-04
2b1u_A	71	Calmodulin-like protein 5; CLSP, calmodulin-like S	1e-23
2b1u_A	71	Calmodulin-like protein 5; CLSP, calmodulin-like S	3e-13
1c7v_A	81	CAVP, calcium vector protein; EF-hand family, calc	4e-23
1c7v_A	81	CAVP, calcium vector protein; EF-hand family, calc	2e-12
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-23
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-22
1k94_A	165	Grancalcin; penta-EF-hand protein, calcium binding	3e-22
1k94_A	165	Grancalcin; penta-EF-hand protein, calcium binding	1e-16
1k94_A	165	Grancalcin; penta-EF-hand protein, calcium binding	9e-11
2pmy_A	91	RAS and EF-hand domain-containing protein; rasef,	3e-22
2pmy_A	91	RAS and EF-hand domain-containing protein; rasef,	2e-18
2d58_A	107	Allograft inflammatory factor 1; EF-hand, metal bi	4e-22
2d58_A	107	Allograft inflammatory factor 1; EF-hand, metal bi	9e-19
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-22
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-22
2joj_A	77	Centrin protein; N-terminal domain, centrin soluti	1e-21
2joj_A	77	Centrin protein; N-terminal domain, centrin soluti	2e-17
1k9u_A	78	Polcalcin PHL P 7; pollen allergen, calcium-bindin	1e-21
1k9u_A	78	Polcalcin PHL P 7; pollen allergen, calcium-bindin	9e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-21
1yx7_A	83	Calsensin, LAN3-6 antigen; calcium-binding protein	2e-21
1yx7_A	83	Calsensin, LAN3-6 antigen; calcium-binding protein	4e-11
2kn2_A	92	Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco	3e-21
2kn2_A	92	Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco	8e-15
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-21
2kz2_A	94	Calmodulin, CAM; TR2C, metal binding protein; NMR	4e-21
2kz2_A	94	Calmodulin, CAM; TR2C, metal binding protein; NMR	4e-12
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-21
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-21
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-06
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-21
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-21
2jjz_A	150	Ionized calcium-binding adapter molecule 2; EF-han	6e-21
2jjz_A	150	Ionized calcium-binding adapter molecule 2; EF-han	2e-17
3li6_A	66	Calcium-binding protein; calcium signaling protein	8e-21
3li6_A	66	Calcium-binding protein; calcium signaling protein	7e-15
3li6_A	66	Calcium-binding protein; calcium signaling protein	6e-12
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-20
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-20
1wlz_A	105	DJBP, CAP-binding protein complex interacting prot	2e-20
1wlz_A	105	DJBP, CAP-binding protein complex interacting prot	1e-17
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-20
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-20
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-20
2opo_A	86	Polcalcin CHE A 3; calcium-binding protein, dimer,	5e-20
2opo_A	86	Polcalcin CHE A 3; calcium-binding protein, dimer,	6e-20
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-20
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-20
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-20
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-19
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-19
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-19
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-19
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-19
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-19
1wy9_A	147	Allograft inflammatory factor 1; EF-hand, calucium	2e-19
1wy9_A	147	Allograft inflammatory factor 1; EF-hand, calucium	3e-17
1tiz_A	67	Calmodulin-related protein, putative; helix-turn-h	3e-19
1tiz_A	67	Calmodulin-related protein, putative; helix-turn-h	1e-16
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-19
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-19
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-19
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-19
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-19
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-19
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-19
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-19
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-19
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-19
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-18
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-18
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-18
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-18
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-18
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-18
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-18
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-18
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-18
1qx2_A	76	Vitamin D-dependent calcium-binding protein, INTE;	3e-18
1qx2_A	76	Vitamin D-dependent calcium-binding protein, INTE;	1e-08
1dgu_A	183	Calcium-saturated CIB; helical, EF-hands, blood cl	3e-18
1dgu_A	183	Calcium-saturated CIB; helical, EF-hands, blood cl	8e-04
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-18
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-18
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-18
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-17
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-17
1avs_A	90	Troponin C; muscle contraction, calcium-activated,	1e-17
1avs_A	90	Troponin C; muscle contraction, calcium-activated,	7e-17
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-17
3a4u_B	143	Multiple coagulation factor deficiency protein 2;	2e-17
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-17
2l4h_A	214	Calcium and integrin-binding protein 1; metal bind	3e-17
2l4h_A	214	Calcium and integrin-binding protein 1; metal bind	3e-04
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-16
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-16
2ktg_A	85	Calmodulin, putative; ehcam, Ca-binding protein, p	1e-16
2ktg_A	85	Calmodulin, putative; ehcam, Ca-binding protein, p	7e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-16
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-16
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-16
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-16
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-16
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-15
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-13
1iq3_A	110	Ralbp1-interacting protein (partner of ralbp1); EF	4e-12
1iq3_A	110	Ralbp1-interacting protein (partner of ralbp1); EF	3e-10
1c07_A	95	Protein (epidermal growth factor receptor pathway	5e-12
1c07_A	95	Protein (epidermal growth factor receptor pathway	2e-10
2i7a_A	174	Calpain 13; calcium-dependent cytoplasmic cysteine	1e-11
2i7a_A	174	Calpain 13; calcium-dependent cytoplasmic cysteine	1e-10
1fi6_A	92	EH domain protein REPS1; EPS15 homology domain, EF	3e-11
1fi6_A	92	EH domain protein REPS1; EPS15 homology domain, EF	8e-11
2kgr_A	111	Intersectin-1; structure, alternative splicing, ca	6e-11
2kgr_A	111	Intersectin-1; structure, alternative splicing, ca	2e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-10
1qjt_A	99	EH1, epidermal growth factor receptor substrate su	5e-09
1qjt_A	99	EH1, epidermal growth factor receptor substrate su	2e-07
1qxp_A	900	MU-like calpain; M-calpain, MU-calpain, catalytic	7e-09
1qxp_A	900	MU-like calpain; M-calpain, MU-calpain, catalytic	1e-08
1qxp_A	900	MU-like calpain; M-calpain, MU-calpain, catalytic	1e-08
1qxp_A	900	MU-like calpain; M-calpain, MU-calpain, catalytic	3e-06
3fia_A	121	Intersectin-1; EH 1 domain, NESG, structural genom	1e-08
3fia_A	121	Intersectin-1; EH 1 domain, NESG, structural genom	1e-07
3bow_A	714	Calpain-2 catalytic subunit; cysteine protease, in	1e-08
3bow_A	714	Calpain-2 catalytic subunit; cysteine protease, in	8e-06
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-07
1snl_A	103	Nucleobindin 1, calnuc; EF-hand, calcium-binding,	5e-08
1djx_A	624	PLC-D1, phosphoinositide-specific phospholipase C,	1e-07
1cb1_A	78	Calbindin D9K; calcium-binding protein; NMR {Sus s	3e-07
1cb1_A	78	Calbindin D9K; calcium-binding protein; NMR {Sus s	5e-04
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-07
1eh2_A	106	EPS15; calcium binding, signaling domain, NPF bind	8e-07
1eh2_A	106	EPS15; calcium binding, signaling domain, NPF bind	4e-06
1sjj_A	863	Actinin; 3-helix bundle, calponin homology domain,	5e-06
1a4p_A	96	S100A10; S100 family, EF-hand protein, ligand of a	7e-06
2jq6_A	139	EH domain-containing protein 1; metal binding prot	9e-06
2jq6_A	139	EH domain-containing protein 1; metal binding prot	3e-04
1xk4_C	113	Calgranulin B; S100 family, heterotetramer, metal	2e-05
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-05
4eto_A	93	Protein S100-A4; calcium-binding protein, EF-hand,	7e-05
2lnk_A	113	Protein S100-A4; EF-hand, calcium binding, all alp	7e-05
2lnk_A	113	Protein S100-A4; EF-hand, calcium binding, all alp	5e-04
2h2k_A	106	Protein S100-A13; calcium binding protein, metal b	8e-05
1xk4_A	93	Calgranulin A; S100 family, heterotetramer, metal	8e-05
1xk4_A	93	Calgranulin A; S100 family, heterotetramer, metal	1e-04
3zwh_A	104	Protein S100-A4; Ca-binding protein-motor protein	1e-04
3nxa_A	100	Protein S100-A16; S100 family, calcium binding pro	1e-04
3nxa_A	100	Protein S100-A16; S100 family, calcium binding pro	2e-04
1k2h_A	93	S100A1, S-100 protein, alpha chain; non-covalent h	2e-04
3a8r_A	179	Putative uncharacterized protein; EF-hand, membran	3e-04
3a8r_A	179	Putative uncharacterized protein; EF-hand, membran	8e-04
1qls_A	99	S100C protein, calgizzarin; metal-binding protein/	4e-04
2kax_A	92	Protein S100-A5; EF-hand, calcium binding protien,	4e-04
3rm1_A	92	Protein S100-B; alpha-helical, EF hand, metal bind	5e-04

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  681 bits (1760), Expect = 0.0
 Identities = 162/475 (34%), Positives = 255/475 (53%), Gaps = 20/475 (4%)

Query: 21  DAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDV 80
              +  +       Y   R +G+G FG   LC +  TG E A K I KR++ +  +K+ +
Sbjct: 14  GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL 73

Query: 81  RREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVF 140
            RE+++++ L   PNI++    +ED  + ++V E+  GGELFD I++R  +SE  AA + 
Sbjct: 74  LREVQLLKQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII 132

Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP 200
           R +++ +   H   ++HRDLKPEN L  +  ++A ++  DFGLS   E  K  ++ +G+ 
Sbjct: 133 RQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTA 192

Query: 201 YYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
           YYIAPEVL  +Y ++ D+WS GVILYILL G PPF    +  + + + KG+  F+   + 
Sbjct: 193 YYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK 252

Query: 261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK---ESGEASDKPIDTAVIFRMKQFTA 317
            +S SA +L+R+MLT  P  RI+    L+H W++   +   + D P     I  ++QF  
Sbjct: 253 KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQG 312

Query: 318 MNKLKKLALKVIVENLPT-EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAK--------- 367
             KL + AL  +   L + +E ++L   F +MD +  G L   EL  G  +         
Sbjct: 313 TQKLAQAALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDA 372

Query: 368 --LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNN 425
             L +   E +V Q + A D D NG I+Y EF+T  M R  L   E L +AF+ FD DN+
Sbjct: 373 SMLDASAVEHEVDQVLDAVDFDKNGYIEYSEFVTVAMDRKTLLSRERLERAFRMFDSDNS 432

Query: 426 GYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ 480
           G I+  EL   F    +  +    T K ++SEVD++ DG + +DEF+ M+     
Sbjct: 433 GKISSTELATIFGVSDVDSE----TWKSVLSEVDKNNDGEVDFDEFQQMLLKLCG 483

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  681 bits (1759), Expect = 0.0
 Identities = 156/484 (32%), Positives = 247/484 (51%), Gaps = 27/484 (5%)

Query: 21  DAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV----- 75
              + K    +   Y   R++G G +G   LC E +   E A K I K +  K       
Sbjct: 24  GMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDN 83

Query: 76  -----EKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH 130
                  +++  EI +++ L   PNI++    +ED ++ ++V E   GGELF++I+ R  
Sbjct: 84  KNIEKFHEEIYNEISLLKSLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK 142

Query: 131 YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190
           + E  AA++ + I++ +   H   ++HRD+KPEN L    +    +K  DFGLS+F  + 
Sbjct: 143 FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202

Query: 191 KAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG 250
              R+ +G+ YYIAPEVL + Y ++ D+WS GVI+YILLCG PPF  + DQ + + + KG
Sbjct: 203 YKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262

Query: 251 EINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE---SGEASDKPIDTA 307
           +  F  + + +IS  A EL++ MLT D  +R T  + L   W+K+   +   SD+     
Sbjct: 263 KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCG 322

Query: 308 VIFRMKQFTAMNKLKKLALKVIVENLPT-EEIQKLKEKFTEMDTDNSGTLTYDELKAGLA 366
            +  M++F    KL + A+  I   L T EE ++L + F ++D +  G L   EL  G  
Sbjct: 323 ALSNMRKFEGSQKLAQAAILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYN 382

Query: 367 KLGSM--------LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQ 418
            L +           E +V   ++  D D NG I+Y EFI+  M +  L   E L +AF 
Sbjct: 383 VLRNFKNELGELKNVEEEVDNILKEVDFDKNGYIEYSEFISVCMDKQILFSEERLRRAFN 442

Query: 419 YFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG 478
            FD D +G IT +EL   F    + +     T  +++ E D++KD  I +DEF SMM   
Sbjct: 443 LFDTDKSGKITKEELANLFGLTSISEK----TWNDVLGEADQNKDNMIDFDEFVSMMHKI 498

Query: 479 TQLR 482
              +
Sbjct: 499 CDHK 502

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  679 bits (1753), Expect = 0.0
 Identities = 162/471 (34%), Positives = 251/471 (53%), Gaps = 23/471 (4%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
                 Y I   +G+G FG    C +  T  E+A K I K    K+ +   + RE+E+++
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLK 76

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVN 148
            L   PNI++     ED    +IV EL  GGELFD I+ R  +SE  AA + + + + + 
Sbjct: 77  KLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL 208
             H   ++HRDLKPEN L  + +++  +K  DFGLS   ++    ++ +G+ YYIAPEVL
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195

Query: 209 SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +Y ++ D+WSAGVILYILL G PPF+ + +  + + +  G+  F    + +IS  A +
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255

Query: 269 LVRRMLTQDPKRRITVAQVLEHPWLK----ESGEASDKPIDTAVIFRMKQFTAMNKLKKL 324
           L+R+MLT  P  RIT  Q LEHPW++    E+   SD P   + +  ++QF A  KL + 
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQA 315

Query: 325 ALKVIVENLPT-EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL--------------G 369
           AL  +   L T +E ++L E F ++DT+N G L  DEL  G  +                
Sbjct: 316 ALLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNE 375

Query: 370 SMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYIT 429
               E  +   M   D+DG+G+I+Y EFI + + R  L   E + +AF+ FDKD +G I+
Sbjct: 376 GSTIEDQIDSLMPLLDMDGSGSIEYSEFIASAIDRTILLSRERMERAFKMFDKDGSGKIS 435

Query: 430 VDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ 480
             EL K F             ++ I+ +VD +KDG + ++EF  M++   +
Sbjct: 436 TKELFKLFSQADSSIQM--EELESIIEQVDNNKDGEVDFNEFVEMLQNFVR 484

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  671 bits (1734), Expect = 0.0
 Identities = 165/469 (35%), Positives = 252/469 (53%), Gaps = 19/469 (4%)

Query: 21  DAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDV 80
              +      +   Y   +++G G +G   LC +  T +E A K I K  +        +
Sbjct: 25  GMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV-STSSNSKL 83

Query: 81  RREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVF 140
             E+ +++ L   PNI++    +ED +  ++VME   GGELFD I+ R  ++E  AA + 
Sbjct: 84  LEEVAVLKLLD-HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVII 142

Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP 200
           + +++ V   H   ++HRDLKPEN L  + +++A++K  DFGLSA  E  K  +E +G+ 
Sbjct: 143 KQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTA 202

Query: 201 YYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
           YYIAPEVL + Y ++ D+WS GVIL+ILL G PPF  +TDQ + + + KG+  F    + 
Sbjct: 203 YYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK 262

Query: 261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS----DKPIDTAVIFRMKQFT 316
           ++S  A +L+++ML  D +RRI+  Q LEHPW+KE         + P     I  M++F 
Sbjct: 263 NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQ 322

Query: 317 AMNKLKKLALKVIVENLPT-EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGS----- 370
              KL + AL  +   L + EE ++L + F  +D +  G L   EL  G +KL       
Sbjct: 323 NSQKLAQAALLYMASKLTSQEETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAV 382

Query: 371 ---MLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGY 427
                 E +V   + AAD D NG IDY EF+T  M R  L   + L  AFQ FD+D NG 
Sbjct: 383 FDLPQIESEVDAILGAADFDRNGYIDYSEFVTVAMDRKSLLSKDKLESAFQKFDQDGNGK 442

Query: 428 ITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           I+VDEL   F    +       T KE++S +D + DG + ++EF  M++
Sbjct: 443 ISVDELASVFGLDHLESK----TWKEMISGIDSNNDGDVDFEEFCKMIQ 487

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  613 bits (1582), Expect = 0.0
 Identities = 125/455 (27%), Positives = 209/455 (45%), Gaps = 25/455 (5%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
                 Y +  E+G+G F +   C +   G E+A   I  +KL    +   + RE  I R
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSAR-DHQKLEREARICR 65

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVN 148
            L   PNIV+   +  ++   +++ +L  GGELF+ IVAR +YSE  A+   + I+  V 
Sbjct: 66  LLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL 124

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEV 207
            CH  GV+HR+LKPEN L  +  + A VK  DFGL+  +E E +A+    G+P Y++PEV
Sbjct: 125 HCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184

Query: 208 LSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
           L +  YGK  D+W+ GVILYILL G PPFW E    + Q I  G  +F    + +++  A
Sbjct: 185 LRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244

Query: 267 IELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLAL 326
            +L+ +MLT +P +RIT A+ L+HPW+      +        +  +K+F A  KLK   L
Sbjct: 245 KDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAIL 304

Query: 327 KVIVEN--LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAA 384
            V++        + + +K     ++  ++G   ++                 +  +   A
Sbjct: 305 TVMLATRNFSVRKQEIIKVTEQLIEAISNG--DFESYTKMCDP--------GMTAFEPEA 354

Query: 385 DIDGNGTIDYIEFITATM-QRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMG 443
             +    +D+  F    +  R+       +     +   D +  I    + +     G+ 
Sbjct: 355 LGNLVEGLDFHRFYFENLWSRNSKPVHTTILNPHIHLMGDESACIAYIRITQYLDAGGIP 414

Query: 444 DDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG 478
                 T +   + V   +DG+    +     + G
Sbjct: 415 R-----TAQSEETRVWHRRDGKW---QIVHFHRSG 441

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  521 bits (1344), Expect = 0.0
 Identities = 114/349 (32%), Positives = 173/349 (49%), Gaps = 7/349 (2%)

Query: 23  ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRR 82
            +  A      +Y +  E+G+G F +   C   +TGLEFA K I  +KL    +   + R
Sbjct: 19  FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLER 77

Query: 83  EIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV 142
           E  I R L   PNIV+   + +++ F ++V +L  GGELF+ IVAR  YSE  A+   + 
Sbjct: 78  EARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ 136

Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           I+  +  CHS G++HR+LKPEN L  +  + A VK  DFGL+  + + +A+    G+P Y
Sbjct: 137 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 196

Query: 203 IAPEVLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           ++PEVL +  Y K  DIW+ GVILYILL G PPFW E    +   I  G  ++    + +
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 256

Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKL 321
           ++  A  L+  MLT +PK+RIT  Q L+ PW+      +        +  +K+F A  KL
Sbjct: 257 VTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKL 316

Query: 322 KKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGS 370
           K   L  ++       +  L             +    E       +  
Sbjct: 317 KGAILTTMIAT---RNLSNLGRNLLNKKEQGPPSTIK-ESSESSQTIDD 361

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  513 bits (1324), Expect = 0.0
 Identities = 113/350 (32%), Positives = 169/350 (48%), Gaps = 12/350 (3%)

Query: 14  PAARHLHDAILGKAYEDVQL--HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL 71
           P        IL  A +DV     Y +   +G+G F +   C    TG +FA K +   K 
Sbjct: 3   PGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKF 62

Query: 72  VK--DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG 129
                +  +D++RE  I   L   P+IV+    Y  D  +++V E   G +L   IV R 
Sbjct: 63  TSSPGLSTEDLKREASICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA 121

Query: 130 H----YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA 185
                YSE  A+   R I+  +  CH   ++HRD+KP   L  + + +A VK   FG++ 
Sbjct: 122 DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181

Query: 186 -FIEEGKAYREIVGSPYYIAPEVLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGV 243
              E G      VG+P+++APEV+ +  YGK  D+W  GVIL+ILL G  PF+  T + +
Sbjct: 182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERL 240

Query: 244 AQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
            + I+KG+       +  IS SA +LVRRML  DP  RITV + L HPWLKE    + K 
Sbjct: 241 FEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKI 300

Query: 304 IDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNS 353
                + ++++F A  KLK   L  +  +          E+  +   D +
Sbjct: 301 HLPETVEQLRKFNARRKLKGAVLAAVSSHKFNSFYGDPPEELPDFSEDPT 350

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  493 bits (1271), Expect = e-174
 Identities = 120/329 (36%), Positives = 179/329 (54%), Gaps = 10/329 (3%)

Query: 6   SKGQDSDHPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKS 65
                +   A+      I G   + +   + +  E+GRG   I Y C +  T   +A K 
Sbjct: 26  VTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKV 85

Query: 66  IPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRI 125
           + K       +K  VR EI ++  LS  PNI++ K  +E    + +V+EL  GGELFDRI
Sbjct: 86  LKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFETPTEISLVLELVTGGELFDRI 139

Query: 126 VARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA 185
           V +G+YSER AA   + I+  V   H  G++HRDLKPEN L+ T   +A +K  DFGLS 
Sbjct: 140 VEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199

Query: 186 FIEEGKAYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAET-DQGV 243
            +E     + + G+P Y APE+L   +YG E D+WS G+I YILLCG  PF+ E  DQ +
Sbjct: 200 IVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM 259

Query: 244 AQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
            + IL  E  F    +  +S +A +LVR+++  DPK+R+T  Q L+HPW+   G+A++  
Sbjct: 260 FRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT--GKAANFV 317

Query: 304 IDTAVIFRMKQFTAMNKLKKLALKVIVEN 332
                  ++++F A  KLK     V+  +
Sbjct: 318 HMDTAQKKLQEFNARRKLKAAVKAVVASS 346

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  488 bits (1258), Expect = e-173
 Identities = 109/329 (33%), Positives = 169/329 (51%), Gaps = 16/329 (4%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD---VEKDDVRREIE 85
           E+V  +Y  G E+G G+F +   C E STGL++A K I KR+       V ++D+ RE+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66

Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I++ +   PN++     YE+   V +++EL AGGELFD +  +   +E  A    + I+N
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125

Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGD-ENAVVKATDFGLSAFIEEGKAYREIVGSPYYIA 204
            V   HS  + H DLKPEN +    +     +K  DFGL+  I+ G  ++ I G+P ++A
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185

Query: 205 PEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263
           PE+++    G EAD+WS GVI YILL G  PF  +T Q     +      F+ + F + S
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245

Query: 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKK 323
           + A + +RR+L +DPK+R+T+   L+HPW+K              + R      M K KK
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ-------QALSRKASAVNMEKFKK 298

Query: 324 LALKVIVENLPTEEIQKLKEKFTEMDTDN 352
            A +    N        L + F     + 
Sbjct: 299 FAARKKSNNGSGGG---LNDIFEAQKIEW 324

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  483 bits (1246), Expect = e-171
 Identities = 84/310 (27%), Positives = 155/310 (50%), Gaps = 6/310 (1%)

Query: 21  DAILGKAYEDVQLHYTI-GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD 79
           + +  ++ E+    Y +  +E+GRG+F +   C   STG E+A K + KR+  +D  + +
Sbjct: 16  ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD-CRAE 74

Query: 80  VRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAA 137
           +  EI ++      P ++     YE+   + +++E  AGGE+F   +       SE    
Sbjct: 75  ILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI 134

Query: 138 SVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV 197
            + + I+  V   H   ++H DLKP+N L ++      +K  DFG+S  I      REI+
Sbjct: 135 RLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM 194

Query: 198 GSPYYIAPEVLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR 256
           G+P Y+APE+L+        D+W+ G+I Y+LL    PF  E +Q     I +  +++  
Sbjct: 195 GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE 254

Query: 257 DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG-EASDKPIDTAVIFRMKQF 315
           + F S+S  A + ++ +L ++P++R T    L H WL++   E    P +T+   + +  
Sbjct: 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDH 314

Query: 316 TAMNKLKKLA 325
           +  +   K +
Sbjct: 315 SVRSSEDKTS 324

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  483 bits (1245), Expect = e-169
 Identities = 103/357 (28%), Positives = 168/357 (47%), Gaps = 23/357 (6%)

Query: 11  SDHPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRK 70
                  H+   +  K    +  +    + +G G  G         T  +FA K +    
Sbjct: 40  PQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP 99

Query: 71  LVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----DQFVHIVMELCAGGELFDRIV 126
                     RRE+E+    S  P+IV+    YE+     + + IVME   GGELF RI 
Sbjct: 100 --------KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ 151

Query: 127 ARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS 184
            RG   ++ER A+ + + I   +   HS  + HRD+KPEN L+T+   NA++K TDFG +
Sbjct: 152 DRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211

Query: 185 AFIEEGKAYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAE----T 239
                  +      +PYY+APEVL  + Y K  D+WS GVI+YILLCG PPF++      
Sbjct: 212 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 271

Query: 240 DQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA 299
             G+   I  G+  F    +  +S     L+R +L  +P +R+T+ + + HPW+ +S + 
Sbjct: 272 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331

Query: 300 SDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTL 356
              P+ T+ + +  +    +  +++   +    +  E+I K+K+     D  N   L
Sbjct: 332 PQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQI-KIKKI---EDASNPLLL 384

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  475 bits (1224), Expect = e-167
 Identities = 88/317 (27%), Positives = 160/317 (50%), Gaps = 12/317 (3%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
           +++   Y I  ++GRGEFGI + C E S+   +  K +  +      ++  V++EI I+ 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILN 56

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVV 147
                 NI+    ++E  + + ++ E  +G ++F+RI       +ER   S    +   +
Sbjct: 57  IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115

Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV 207
              HS  + H D++PEN ++ T   ++ +K  +FG +  ++ G  +R +  +P Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174

Query: 208 LSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
                     D+WS G ++Y+LL G+ PF AET+Q + + I+  E  F  + F  IS  A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234

Query: 267 IELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLAL 326
           ++ V R+L ++ K R+T ++ L+HPWLK+      + + T VI  +K     + L K  L
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQ----KIERVSTKVIRTLKHRRYYHTLIKKDL 290

Query: 327 KVIVENLPTEEIQKLKE 343
            ++V          ++ 
Sbjct: 291 NMVVSAARISCGGAIRS 307

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  472 bits (1216), Expect = e-167
 Identities = 117/280 (41%), Positives = 172/280 (61%), Gaps = 4/280 (1%)

Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREI 84
           G    D+  +YT+   +GRG +G   +  +  T +  A K IPK  + +DV+    ++EI
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVD--RFKQEI 57

Query: 85  EIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
           EIM+ L   PNI++    +ED+  +++VMELC GGELF+R+V +  + E  AA + + ++
Sbjct: 58  EIMKSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL 116

Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIA 204
           + V  CH   V HRDLKPENFLF T   ++ +K  DFGL+A  + GK  R  VG+PYY++
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176

Query: 205 PEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
           P+VL   YG E D WSAGV++Y+LLCG PPF A TD  V   I +G   F    + ++S 
Sbjct: 177 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236

Query: 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPI 304
            A  L+RR+LT+ PK+RIT  Q LEH W ++   +S + +
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  474 bits (1222), Expect = e-167
 Identities = 111/346 (32%), Positives = 180/346 (52%), Gaps = 10/346 (2%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD---VEKDDVRREIE 85
           + V+  Y IG E+G G+F I   C E STGLE+A K I KR+       V ++++ RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67

Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I+R +   PNI+     YE+   V +++EL +GGELFD +  +   SE  A S  + I++
Sbjct: 68  ILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126

Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGD-ENAVVKATDFGLSAFIEEGKAYREIVGSPYYIA 204
            VN  H+K + H DLKPEN +    +     +K  DFGL+  IE+G  ++ I G+P ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186

Query: 205 PEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263
           PE+++    G EAD+WS GVI YILL G  PF  +T Q     I     +F  + F   S
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246

Query: 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLKE--SGEASDKPIDTAVIFRMKQFTAMNKL 321
             A + +R++L ++ ++R+T+ + L HPW+    + +A  +      +   K+     + 
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRW 306

Query: 322 KKLALKVIVEN-LPTEEIQKLKEK-FTEMDTDNSGTLTYDELKAGL 365
           K     V + N L    ++K+  +   ++    S T      +  L
Sbjct: 307 KLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTEENIARRKAL 352

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  466 bits (1201), Expect = e-164
 Identities = 100/335 (29%), Positives = 165/335 (49%), Gaps = 20/335 (5%)

Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L +        Y +  ++G G + +   C   +T +EFA K I K K        D   E
Sbjct: 13  LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEE 65

Query: 84  IEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVI 143
           IEI+      PNI+  K  Y+D ++V++V EL  GGEL D+I+ +  +SER A++V   I
Sbjct: 66  IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTI 125

Query: 144 MNVVNVCHSKGVMHRDLKPENFLFTTGDENA-VVKATDFGLSAFIE-EGKAYREIVGSPY 201
              V   H++GV+HRDLKP N L+     N   ++  DFG +  +  E         +  
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN 185

Query: 202 YIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKGEINFQRD 257
           ++APEVL  Q Y    DIWS GV+LY +L G  PF     +T + +   I  G+ +    
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245

Query: 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQ--- 314
            + S+S +A +LV +ML  DP +R+T A VL HPW+    +     ++      + +   
Sbjct: 246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAM 305

Query: 315 ---FTAMNKLKKLALKVIVENLPTEEIQKLKEKFT 346
              ++A+N+ +   L+ +  +   +  + +K+  +
Sbjct: 306 AATYSALNRNQSPVLEPVGRSTLAQR-RGIKKITS 339

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  462 bits (1191), Expect = e-163
 Identities = 104/275 (37%), Positives = 154/275 (56%), Gaps = 3/275 (1%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
                +Y +  E+G+G F +   C   +TGLEFA K I  +KL    +   + RE  I R
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICR 60

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVN 148
            L   PNIV+   + +++ F ++V +L  GGELF+ IVAR  YSE  A+   + I+  + 
Sbjct: 61  KLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 119

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL 208
            CHS G++HR+LKPEN L  +  + A VK  DFGL+  + + +A+    G+P Y++PEVL
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179

Query: 209 SQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267
            +  Y K  DIW+ GVILYILL G PPFW E    +   I  G  ++    + +++  A 
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239

Query: 268 ELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDK 302
            L+  MLT +PK+RIT  Q L+ PW+      +  
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWICNRERVASA 274

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  462 bits (1190), Expect = e-163
 Identities = 106/283 (37%), Positives = 162/283 (57%), Gaps = 6/283 (2%)

Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD---VEKDDVRREIEI 86
            V+ HY +G E+G G+F I   C +  TG E+A K I KR+L      V ++++ RE+ I
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 87  MRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNV 146
           +R +   PNI+     +E+   V +++EL +GGELFD +  +   +E  A    + I++ 
Sbjct: 62  LREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120

Query: 147 VNVCHSKGVMHRDLKPENFLFTTGD-ENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAP 205
           V+  HSK + H DLKPEN +    +  N  +K  DFG++  IE G  ++ I G+P ++AP
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180

Query: 206 EVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
           E+++    G EAD+WS GVI YILL G  PF  ET Q     I     +F  + F + S 
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240

Query: 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTA 307
            A + +RR+L +DPKRR+T+AQ LEH W+K     + +  D+ 
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDSG 283

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  462 bits (1190), Expect = e-163
 Identities = 100/267 (37%), Positives = 152/267 (56%), Gaps = 2/267 (0%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
                 Y I   +G+G FG    C +  T  E+A K I K       +   + RE+E+++
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLK 76

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVN 148
            L   PNI++     ED    +IV EL  GGELFD I+ R  +SE  AA + + + + + 
Sbjct: 77  KLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL 208
             H   ++HRDLKPEN L  + +++  +K  DFGLS   ++    ++ +G+ YYIAPEVL
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195

Query: 209 SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
             +Y ++ D+WSAGVILYILL G PPF+ + +  + + +  G+  F    + +IS  A +
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255

Query: 269 LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           L+R+MLT  P  RIT  Q LEHPW+++
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQK 282

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  463 bits (1193), Expect = e-163
 Identities = 97/313 (30%), Positives = 159/313 (50%), Gaps = 25/313 (7%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
               + +G G F I   C    +   FA K I KR         + ++EI  ++   G P
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLCEGHP 66

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NIV+    + D     +VMEL  GGELF+RI  + H+SE  A+ + R +++ V+  H  G
Sbjct: 67  NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG 126

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVGSPYYIAPEVLS-QSY 212
           V+HRDLKPEN LFT  ++N  +K  DFG +     + +  +    + +Y APE+L+   Y
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGY 186

Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQ-------GVAQAILKGEINFQRDPFPSISSS 265
            +  D+WS GVILY +L G  PF +            + + I KG+ +F+ + + ++S  
Sbjct: 187 DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQE 246

Query: 266 AIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPI---------DTAVIFRMK-QF 315
           A +L++ +LT DP +R+ ++ +  + WL++  + S  P+           AV   +K  F
Sbjct: 247 AKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATF 306

Query: 316 TAMNKLKKLALKV 328
            A NK K+    +
Sbjct: 307 HAFNKYKREGFCL 319

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  462 bits (1192), Expect = e-163
 Identities = 101/309 (32%), Positives = 168/309 (54%), Gaps = 9/309 (2%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD---VEKDDVRREIE 85
           + V+  Y IG E+G G+F I   C E STGLE+A K I KR+       V ++++ RE+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67

Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I+R +    N++     YE+   V +++EL +GGELFD +  +   SE  A S  + I++
Sbjct: 68  ILRQVLH-HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126

Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDEN-AVVKATDFGLSAFIEEGKAYREIVGSPYYIA 204
            VN  H+K + H DLKPEN +    +     +K  DFGL+  IE+G  ++ I G+P ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186

Query: 205 PEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263
           PE+++    G EAD+WS GVI YILL G  PF  +T Q     I     +F  + F   S
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246

Query: 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLK--ESGEASDKPIDTAVIFRMKQFTAMNKL 321
             A + +R++L ++ ++R+T+ + L HPW+   ++ +A  +      +   ++     + 
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRW 306

Query: 322 KKLALKVIV 330
           K  +  ++ 
Sbjct: 307 KL-SFSIVS 314

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  459 bits (1183), Expect = e-161
 Identities = 95/278 (34%), Positives = 150/278 (53%), Gaps = 15/278 (5%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVE-----KDDVRRE 83
           ++    Y     +GRG   +   C   +TG EFA K +         E     ++  RRE
Sbjct: 90  KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRE 149

Query: 84  IEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVI 143
             I+R ++G P+I+    +YE   F+ +V +L   GELFD +  +   SE+   S+ R +
Sbjct: 150 THILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSL 209

Query: 144 MNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI 203
           +  V+  H+  ++HRDLKPEN L    D+N  ++ +DFG S  +E G+  RE+ G+P Y+
Sbjct: 210 LEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYL 266

Query: 204 APEVLS-------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR 256
           APE+L          YGKE D+W+ GVIL+ LL G PPFW      + + I++G+  F  
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS 326

Query: 257 DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
             +   SS+  +L+ R+L  DP+ R+T  Q L+HP+ +
Sbjct: 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  454 bits (1170), Expect = e-160
 Identities = 92/292 (31%), Positives = 143/292 (48%), Gaps = 16/292 (5%)

Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKD------ 78
             +      +Y     +GRG   +   C    T  E+A K I          ++      
Sbjct: 9   SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68

Query: 79  DVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAAS 138
              +E++I+R +SG PNI+Q K  YE + F  +V +L   GELFD +  +   SE+    
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 128

Query: 139 VFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG 198
           + R ++ V+   H   ++HRDLKPEN L    D++  +K TDFG S  ++ G+  RE+ G
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCG 185

Query: 199 SPYYIAPEVLS-------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE 251
           +P Y+APE++          YGKE D+WS GVI+Y LL G PPFW      + + I+ G 
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245

Query: 252 INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
             F    +   S +  +LV R L   P++R T  + L HP+ ++      + 
Sbjct: 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRH 297

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  450 bits (1161), Expect = e-158
 Identities = 98/272 (36%), Positives = 153/272 (56%), Gaps = 8/272 (2%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
             +   +   R++G G FG  +L  E S+GLE   K+I K +    +E   +  EIE+++
Sbjct: 18  GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME--QIEAEIEVLK 75

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR----GHYSERAAASVFRVIM 144
            L   PNI++    +ED   ++IVME C GGEL +RIV+        SE   A + + +M
Sbjct: 76  SLD-HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134

Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIA 204
           N +   HS+ V+H+DLKPEN LF     ++ +K  DFGL+   +  +      G+  Y+A
Sbjct: 135 NALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMA 194

Query: 205 PEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
           PEV  +    + DIWSAGV++Y LL G  PF   + + V Q     E N+  +  P ++ 
Sbjct: 195 PEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP-LTP 253

Query: 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
            A++L+++MLT+DP+RR + AQVL H W K++
Sbjct: 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  456 bits (1175), Expect = e-156
 Identities = 104/353 (29%), Positives = 158/353 (44%), Gaps = 13/353 (3%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
           + V  HY I  E+G G FG+ +  TE +TG  FA K +         +K+ VR+EI+ M 
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMS 209

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVV 147
            L   P +V    A+EDD  + ++ E  +GGELF+++       SE  A    R +   +
Sbjct: 210 VLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 268

Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV 207
              H    +H DLKPEN +FTT   N + K  DFGL+A ++  ++ +   G+  + APEV
Sbjct: 269 CHMHENNYVHLDLKPENIMFTTKRSNEL-KLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 327

Query: 208 LSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
                 G   D+WS GV+ YILL G+ PF  E D    + +   + N     F  IS   
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387

Query: 267 IELVRRMLTQDPKRRITVAQVLEHPWLKE-SGEASDKPIDTAVIFRMKQFTAMNKLKKLA 325
            + +R++L  DP  R+T+ Q LEHPWL   +    D  I ++   R  +     K K  A
Sbjct: 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS---RYTKIRDSIKTKYDA 444

Query: 326 LKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVK 378
               +   P   I            + S    + +      +        +V 
Sbjct: 445 WPEPL--PPLGRISNYSSLRKHRPQEYSIRDAFWDRSEAQPRFIVKPYGTEVG 495

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  445 bits (1147), Expect = e-156
 Identities = 101/321 (31%), Positives = 158/321 (49%), Gaps = 18/321 (5%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV-----KDVEKDDVRRE 83
           + ++  Y + + +G G  G   L  E  T  + A K I KRK       +     +V  E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 84  IEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVI 143
           IEI++ L+  P I++ K  ++ +   +IV+EL  GGELFD++V      E      F  +
Sbjct: 66  IEILKKLN-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123

Query: 144 MNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI 203
           +  V   H  G++HRDLKPEN L ++ +E+ ++K TDFG S  + E    R + G+P Y+
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183

Query: 204 APEVLSQS----YGKEADIWSAGVILYILLCGVPPFWAE-TDQGVAQAILKGEINFQRDP 258
           APEVL       Y +  D WS GVIL+I L G PPF    T   +   I  G+ NF  + 
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243

Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAM 318
           +  +S  A++LV+++L  DPK R T  + L HPWL+      D+ +       + +    
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ------DEDMKRKFQDLLSEENES 297

Query: 319 NKLKKLALKVIVENLPTEEIQ 339
             L ++  +         E +
Sbjct: 298 TALPQVLAQPSTSRKRPREGE 318

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  447 bits (1152), Expect = e-156
 Identities = 93/334 (27%), Positives = 155/334 (46%), Gaps = 28/334 (8%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
             V  +Y I  E+G G FG+ + C E +TG  F  K I     +   +K  V+ EI IM 
Sbjct: 47  GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMN 103

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVV 147
            L   P ++    A+ED   + +++E  +GGELFDRI A  +  SE    +  R     +
Sbjct: 104 QLH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 162

Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV 207
              H   ++H D+KPEN +  T  + + VK  DFGL+  +   +  +    +  + APE+
Sbjct: 163 KHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 221

Query: 208 LSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
           + +   G   D+W+ GV+ Y+LL G+ PF  E D    Q + + +  F  D F S+S  A
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 281

Query: 267 IELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIF---------------- 310
            + ++ +L ++P++R+TV   LEHPWLK         I ++                   
Sbjct: 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAP 341

Query: 311 -----RMKQFTAMNKLKKLALKVIVENLPTEEIQ 339
                R+  F+++ K +    ++       +E  
Sbjct: 342 QPAIGRIANFSSLRKHRPQEYQIYDSYFDRKEAV 375

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  444 bits (1143), Expect = e-155
 Identities = 92/308 (29%), Positives = 151/308 (49%), Gaps = 35/308 (11%)

Query: 34  HYTIGREV-GRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG 92
            Y +  +V G G       C    T  E+A K I K+       +  V RE+E++    G
Sbjct: 13  VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQG 69

Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
             N+++    +E++   ++V E   GG +   I  R H++E  A+ V + + + ++  H+
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI--------VGSPYYIA 204
           KG+ HRDLKPEN L    ++ + VK  DF L + I+       I         GS  Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189

Query: 205 PEVL------SQSYGKEADIWSAGVILYILLCGVPPFWAETD---------------QGV 243
           PEV+      +  Y K  D+WS GVILYILL G PPF                      +
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249

Query: 244 AQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
            ++I +G+  F    +  IS +A +L+ ++L +D K+R++ AQVL+HPW++  G A +  
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ--GCAPENT 307

Query: 304 IDTAVIFR 311
           + T ++ +
Sbjct: 308 LPTPMVLQ 315

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  444 bits (1143), Expect = e-155
 Identities = 105/323 (32%), Positives = 166/323 (51%), Gaps = 23/323 (7%)

Query: 29  EDVQLHYTIGREV-GRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM 87
             V   Y + ++V G G  G    C    TG + A K +              R+E++  
Sbjct: 24  YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHH 75

Query: 88  RHLSGQPNIVQFKAAYED----DQFVHIVMELCAGGELFDRIVARGH--YSERAAASVFR 141
              SG P+IV     YE+     + + I+ME   GGELF RI  RG   ++ER AA + R
Sbjct: 76  WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135

Query: 142 VIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY 201
            I   +   HS  + HRD+KPEN L+T+ +++AV+K TDFG +    +    +    +PY
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPY 194

Query: 202 YIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQ----GVAQAILKGEINFQR 256
           Y+APEVL  + Y K  D+WS GVI+YILLCG PPF++ T Q    G+ + I  G+  F  
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254

Query: 257 DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT 316
             +  +S  A +L+R +L  DP  R+T+ Q + HPW+ +S      P+ TA + + +   
Sbjct: 255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQ-EDKD 313

Query: 317 AMNKLKKLALKVI-VENLPTEEI 338
             +++K+     +    +  +++
Sbjct: 314 HWDEVKEEMTSALATMRVDYDQV 336

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  430 bits (1109), Expect = e-150
 Identities = 91/322 (28%), Positives = 146/322 (45%), Gaps = 39/322 (12%)

Query: 18  HLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK 77
           H+   +  K    +  +    + +G G  G         T  +FA K +           
Sbjct: 3   HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP------- 55

Query: 78  DDVRREIEIMRHLSGQPNIVQFKAAYED----DQFVHIVMELCAGGELFDRIVARGH--Y 131
              RRE+E+    S  P+IV+    YE+     + + IVME   GGELF RI  RG   +
Sbjct: 56  -KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 114

Query: 132 SERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191
           +ER A+ + + I   +   HS  + HRD+KPEN L+T+   NA++K TDFG         
Sbjct: 115 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-------- 166

Query: 192 AYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAE----TDQGVAQAI 247
                       A E   + Y K  D+WS GVI+YILLCG PPF++        G+   I
Sbjct: 167 ------------AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 214

Query: 248 LKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTA 307
             G+  F    +  +S     L+R +L  +P +R+T+ + + HPW+ +S +    P+ T+
Sbjct: 215 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 274

Query: 308 VIFRMKQFTAMNKLKKLALKVI 329
            + +  +      +K+     +
Sbjct: 275 RVLKEDKE-RWEDVKEEMTSAL 295

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  429 bits (1106), Expect = e-149
 Identities = 95/320 (29%), Positives = 153/320 (47%), Gaps = 16/320 (5%)

Query: 10  DSDHPAARHLHDAILGKAYEDVQLHYTIGR--EVGRGEFGITYLCTENSTGLEFACKSIP 67
           D   P A   H  +  K    V   YT+ +   +G G FG  + C E +TGL+ A K I 
Sbjct: 65  DIPAPPAPFDHRIVTAK-QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK 123

Query: 68  KRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVA 127
            R +    +K++V+ EI +M  L    N++Q   A+E    + +VME   GGELFDRI+ 
Sbjct: 124 TRGMK---DKEEVKNEISVMNQLD-HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID 179

Query: 128 RGH-YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186
             +  +E       + I   +   H   ++H DLKPEN L    D   + K  DFGL+  
Sbjct: 180 ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQI-KIIDFGLARR 238

Query: 187 IEEGKAYREIVGSPYYIAPEVLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQ 245
            +  +  +   G+P ++APEV++        D+WS GVI Y+LL G+ PF  + D     
Sbjct: 239 YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN 298

Query: 246 AILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPID 305
            IL    + + + F  IS  A E + ++L ++   RI+ ++ L+HPWL       D  + 
Sbjct: 299 NILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS------DHKLH 352

Query: 306 TAVIFRMKQFTAMNKLKKLA 325
           + +  + K+    +    + 
Sbjct: 353 SRLSAQKKKNRGSDAQDFVT 372

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  416 bits (1071), Expect = e-144
 Identities = 94/340 (27%), Positives = 162/340 (47%), Gaps = 52/340 (15%)

Query: 13  HPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV 72
           H ++   +    G +  ++Q  Y +   +G+G +G+  +  EN T    A K + K K+ 
Sbjct: 6   HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65

Query: 73  KDVEKD--DVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH 130
           +   KD   ++ E+ +M+ L   PNI +    YED+Q++ +VMELC GG L D++     
Sbjct: 66  QINPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFID 124

Query: 131 ----------------------------------------YSERAAASVFRVIMNVVNVC 150
                                                     E+  +++ R I + ++  
Sbjct: 125 DSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-----EGKAYREIVGSPYYIAP 205
           H++G+ HRD+KPENFLF+T +++  +K  DFGLS         E        G+PY++AP
Sbjct: 185 HNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

Query: 206 EVLS---QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
           EVL+   +SYG + D WSAGV+L++LL G  PF    D      +L  ++ F+   +  +
Sbjct: 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVL 303

Query: 263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDK 302
           S  A +L+  +L ++   R    + L+HPW+ +  +   K
Sbjct: 304 SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYK 343

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  414 bits (1067), Expect = e-142
 Identities = 97/279 (34%), Positives = 148/279 (53%), Gaps = 12/279 (4%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV-----KDVEKDDVRRE 83
           + ++  Y + + +G G  G   L  E  T  + A + I KRK       +     +V  E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190

Query: 84  IEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVI 143
           IEI++ L+  P I++ K  ++ +   +IV+EL  GGELFD++V      E      F  +
Sbjct: 191 IEILKKLN-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248

Query: 144 MNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI 203
           +  V   H  G++HRDLKPEN L ++ +E+ ++K TDFG S  + E    R + G+P Y+
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308

Query: 204 APEVLSQ----SYGKEADIWSAGVILYILLCGVPPFWAE-TDQGVAQAILKGEINFQRDP 258
           APEVL       Y +  D WS GVIL+I L G PPF    T   +   I  G+ NF  + 
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368

Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG 297
           +  +S  A++LV+++L  DPK R T  + L HPWL++  
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  319 bits (818), Expect = e-105
 Identities = 77/423 (18%), Positives = 157/423 (37%), Gaps = 34/423 (8%)

Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ +     +G G  G T +        + A K I               RE++++R   
Sbjct: 23  KISFCPKDVLGHGAEG-TIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESD 75

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVC 150
             PN++++    +D QF +I +ELC    L + +  +   +      ++ +   + +   
Sbjct: 76  EHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKA--TDFGLSAFIEEGKAYRE----IVGSPYYIA 204
           HS  ++HRDLKP N L +  + +  +KA  +DFGL   +  G+        + G+  +IA
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194

Query: 205 PEVLSQS----YGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPF 259
           PE+LS+          DI+SAG + Y ++  G  PF     +     +    ++    P 
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC-LHPE 253

Query: 260 PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMN 319
                 A EL+ +M+  DP++R +   VL+HP+     +      D  V  R+++ +   
Sbjct: 254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQD--VSDRIEKESLDG 311

Query: 320 KLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKA---GLAKLGSMLTEFD 376
            + K   +     +  +  + +       D     T     ++     +        E  
Sbjct: 312 PIVKQLERGGRAVVKMDWRENITVPLQT-DLRKFRTYKGGSVRDLLRAMRNKKHHYRELP 370

Query: 377 VKQYMQAADIDGNGTIDYIE--FITATMQRHKLQRF----ENLYKAFQYFDKDNNGYITV 430
            +       +  +  + Y    F       ++              + +   +    +T 
Sbjct: 371 AEVRETLGTLP-DDFVCYFTSRFPHLLAHTYRAMELCSHERLFQPYYFHEPPEPQPPVTP 429

Query: 431 DEL 433
           D L
Sbjct: 430 DAL 432

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  312 bits (802), Expect = e-102
 Identities = 76/342 (22%), Positives = 138/342 (40%), Gaps = 48/342 (14%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
           + ++      + +G G  G       +  G   A K +           D    EI+++ 
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC------DIALMEIKLLT 63

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERA-------AASVFR 141
                PN++++  +   D+F++I +ELC    L D + ++    E           S+ R
Sbjct: 64  ESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLR 122

Query: 142 VIMNVVNVCHSKGVMHRDLKPENFLFTT----------GDENAVVKATDFGLSAFIEEGK 191
            I + V   HS  ++HRDLKP+N L +T          G EN  +  +DFGL   ++ G+
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182

Query: 192 AY-----REIVGSPYYIAPEVLSQS--------YGKEADIWSAGVILYILLC-GVPPFWA 237
           +          G+  + APE+L +S          +  DI+S G + Y +L  G  PF  
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242

Query: 238 ETDQGVAQAILKGEINF---QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
           +  +     I++G  +    +     S+ + A +L+ +M+  DP +R T  +VL HP   
Sbjct: 243 KYSR--ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300

Query: 295 ESGEASDKPIDTAVIF----RMKQFTAMNKLKKLALKVIVEN 332
              +  +  +  +       R      + K    +  VI   
Sbjct: 301 PKSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFVIPSG 342

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  292 bits (749), Expect = 7e-96
 Identities = 88/264 (33%), Positives = 132/264 (50%), Gaps = 10/264 (3%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            Y  GR +G+G F   +  ++  T   FA K +PK  L+K  +++ +  EI I R L+  
Sbjct: 42  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-H 100

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            ++V F   +ED+ FV +V+ELC    L +    R   +E  A    R I+      H  
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLS-QS 211
            V+HRDLK  N      +E+  VK  DFGL+  +E     ++ + G+P YIAPEVLS + 
Sbjct: 161 RVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 217

Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
           +  E D+WS G I+Y LL G PPF     +     I K E +    P   I+  A  L++
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---P-KHINPVAASLIQ 273

Query: 272 RMLTQDPKRRITVAQVLEHPWLKE 295
           +ML  DP  R T+ ++L   +   
Sbjct: 274 KMLQTDPTARPTINELLNDEFFTS 297

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  290 bits (745), Expect = 9e-96
 Identities = 88/264 (33%), Positives = 132/264 (50%), Gaps = 10/264 (3%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            Y  GR +G+G F   +  ++  T   FA K +PK  L+K  +++ +  EI I R L+  
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-H 74

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            ++V F   +ED+ FV +V+ELC    L +    R   +E  A    R I+      H  
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLS-QS 211
            V+HRDLK  N      +E+  VK  DFGL+  +E     ++ + G+P YIAPEVLS + 
Sbjct: 135 RVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 191

Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
           +  E D+WS G I+Y LL G PPF     +     I K E +    P   I+  A  L++
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---P-KHINPVAASLIQ 247

Query: 272 RMLTQDPKRRITVAQVLEHPWLKE 295
           +ML  DP  R T+ ++L   +   
Sbjct: 248 KMLQTDPTARPTINELLNDEFFTS 271

>3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197

 Score =  279 bits (715), Expect = 1e-92
 Identities = 60/192 (31%), Positives = 97/192 (50%), Gaps = 1/192 (0%)

Query: 286 QVLEHPWLKE-SGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEK 344
               H   +E         + + ++  +K F   N+LKK+AL +I ++L   EI  L+  
Sbjct: 3   HHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNI 62

Query: 345 FTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR 404
           F  +D DNSGTL+  E+  GL K+G      D+ Q ++  D + +G I Y +F+ AT+ +
Sbjct: 63  FIALDVDNSGTLSSQEILDGLKKIGYQKIPPDIHQVLRDIDSNASGQIHYTDFLAATIDK 122

Query: 405 HKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDG 464
               + E     F++FD D NG I+V+EL + F    + +      I  ++ EVD + DG
Sbjct: 123 QTYLKKEVCLIPFKFFDIDGNGKISVEELKRIFGRDDIENPLIDKAIDSLLQEVDLNGDG 182

Query: 465 RISYDEFRSMMK 476
            I + EF  MM 
Sbjct: 183 EIDFHEFMLMMS 194

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  283 bits (725), Expect = 2e-92
 Identities = 61/299 (20%), Positives = 113/299 (37%), Gaps = 43/299 (14%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + +   +G+G     +      TG  FA K       ++ V+     RE E+++ L+   
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV--QMREFEVLKKLN-HK 67

Query: 95  NIVQFKAAYEDD--QFVHIVMELCAGGELFDRIVARGH---YSERAAASVFRVIMNVVNV 149
           NIV+  A  E+   +   ++ME C  G L+  +    +     E     V R ++  +N 
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 150 CHSKGVMHRDLKPENFLFTTG-DENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL 208
               G++HR++KP N +   G D  +V K TDFG +  +E+ + +  + G+  Y+ P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 209 S---------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK---------- 249
                     + YG   D+WS GV  Y    G  PF         + ++           
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 250 ---------GEINFQRDPF------PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
                    G I++  D          +      ++  +L  D ++     Q       
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  280 bits (719), Expect = 5e-92
 Identities = 79/265 (29%), Positives = 137/265 (51%), Gaps = 11/265 (4%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            + +G  +G+G F   Y      TGLE A K I K+ + K      V+ E++I   L   
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-H 70

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHS 152
           P+I++    +ED  +V++V+E+C  GE+   +  R   +SE  A      I+  +   HS
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLS-Q 210
            G++HRDL   N L      N  +K  DFGL+  ++        + G+P YI+PE+ +  
Sbjct: 131 HGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187

Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
           ++G E+D+WS G + Y LL G PPF  +T +     ++  +      P   +S  A +L+
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM---P-SFLSIEAKDLI 243

Query: 271 RRMLTQDPKRRITVAQVLEHPWLKE 295
            ++L ++P  R++++ VL+HP++  
Sbjct: 244 HQLLRRNPADRLSLSSVLDHPFMSR 268

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  273 bits (701), Expect = 5e-89
 Identities = 64/291 (21%), Positives = 120/291 (41%), Gaps = 41/291 (14%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +     +G+G FG             +A K I   +     +   +  E+ ++  L+   
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLN-HQ 62

Query: 95  NIVQFKAAYEDDQ-------------FVHIVMELCAGGELFDRIVARGHYSER-AAASVF 140
            +V++ AA+ + +              + I ME C  G L+D I +     +R     +F
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122

Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI---- 196
           R I+  ++  HS+G++HRDLKP N      DE+  VK  DFGL+  +       ++    
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 197 -----------VGSPYYIAPEVLSQS--YGKEADIWSAGVILYILLCGVPPFWAETDQGV 243
                      +G+  Y+A EVL  +  Y ++ D++S G+I + ++   P         +
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNI 237

Query: 244 AQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
            + +    I F  D   +      +++R ++  DP +R     +L   WL 
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  271 bits (696), Expect = 1e-88
 Identities = 84/262 (32%), Positives = 138/262 (52%), Gaps = 10/262 (3%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   P
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSYG 213
           V+HRD+KPEN L         +K  DFG S      +   ++ G+  Y+ PE++  + + 
Sbjct: 130 VIHRDIKPENLLL---GSAGELKIADFGWSVHAPSSRRT-DLCGTLDYLPPEMIEGRMHD 185

Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRM 273
           ++ D+WS GV+ Y  L G PPF A T Q   + I + E  F   P   ++  A +L+ R+
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF---P-DFVTEGARDLISRL 241

Query: 274 LTQDPKRRITVAQVLEHPWLKE 295
           L  +P +R  + +VLEHPW+  
Sbjct: 242 LKHNPSQRPMLREVLEHPWITA 263

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  272 bits (698), Expect = 2e-88
 Identities = 65/293 (22%), Positives = 123/293 (41%), Gaps = 28/293 (9%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            Y+I +++G G     +    N     +A K +   +       D  R EI  +  L   
Sbjct: 29  IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQH 86

Query: 94  -PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
              I++       DQ++++VME C   +L   +  +         S ++ ++  V+  H 
Sbjct: 87  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA--YRE-IVGSPYYIAPEVLS 209
            G++H DLKP NFL      + ++K  DFG++  ++       ++  VG+  Y+ PE + 
Sbjct: 146 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201

Query: 210 QS------------YGKEADIWSAGVILYILLCGVPPFWAETDQGVA-QAILKGEINFQR 256
                            ++D+WS G ILY +  G  PF    +Q     AI+        
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI-- 259

Query: 257 DPFPS-ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAV 308
             FP        ++++  L +DPK+RI++ ++L HP+++      ++      
Sbjct: 260 -EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 311

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  275 bits (704), Expect = 2e-88
 Identities = 65/357 (18%), Positives = 124/357 (34%), Gaps = 43/357 (12%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + +   +G+G     +      TG  FA K       ++ V+     RE E+++ L+   
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV--QMREFEVLKKLN-HK 67

Query: 95  NIVQFKAAYEDD--QFVHIVMELCAGGELFDRIVARGH---YSERAAASVFRVIMNVVNV 149
           NIV+  A  E+   +   ++ME C  G L+  +    +     E     V R ++  +N 
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 150 CHSKGVMHRDLKPENFLFTTG-DENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL 208
               G++HR++KP N +   G D  +V K TDFG +  +E+ + +  + G+  Y+ P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 209 S---------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK---------- 249
                     + YG   D+WS GV  Y    G  PF         + ++           
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 250 ---------GEINFQRDPF------PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
                    G I++  D          +      ++  +L  D ++     Q        
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307

Query: 295 ESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTD 351
                        +        + N        V  +       Q+L  +   +  +
Sbjct: 308 LHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLE 364

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  270 bits (693), Expect = 3e-88
 Identities = 75/276 (27%), Positives = 130/276 (47%), Gaps = 14/276 (5%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            + + + +G G +G   L     T    A K +  ++ V   E   +++EI I + L+  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLN-H 64

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI---VGSPYYIAPEVLS- 209
           G+ HRD+KPEN L    DE   +K +DFGL+         R +    G+  Y+APE+L  
Sbjct: 125 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181

Query: 210 QSY-GKEADIWSAGVILYILLCGVPPFWAETDQGVA-QAILKGEINFQRDPFPSISSSAI 267
           + +  +  D+WS G++L  +L G  P+   +D         + +     +P+  I S+ +
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKKIDSAPL 239

Query: 268 ELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
            L+ ++L ++P  RIT+  + +  W  +  +   K 
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275

>3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191

 Score =  267 bits (684), Expect = 4e-88
 Identities = 62/192 (32%), Positives = 98/192 (51%), Gaps = 5/192 (2%)

Query: 288 LEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTE 347
           + H     SG  +       V+   K +  + K +KLA+ +I +     +++KLK  F  
Sbjct: 1   MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLV 60

Query: 348 MDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKL 407
           +D D  G +T ++LK GL K G  L   +    +   D DG+G IDY EFI A + R +L
Sbjct: 61  LDEDGKGYITKEQLKKGLEKDGLKLPY-NFDLLLDQIDSDGSGKIDYTEFIAAALDRKQL 119

Query: 408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI---ATIKEIMSEVDRDKDG 464
            + + +Y AF+ FD DN+G IT  EL     +     + T      +K ++ +VD++ DG
Sbjct: 120 SK-KLIYCAFRVFDVDNDGEITTAELAHILYNGNKKGNITQRDVNRVKRMIRDVDKNNDG 178

Query: 465 RISYDEFRSMMK 476
           +I + EF  MMK
Sbjct: 179 KIDFHEFSEMMK 190

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  272 bits (698), Expect = 5e-88
 Identities = 71/335 (21%), Positives = 135/335 (40%), Gaps = 34/335 (10%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            Y+I +++G G     +    N     +A K +   +       D  R EI  +  L   
Sbjct: 10  IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQH 67

Query: 94  -PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
              I++       DQ++++VME C   +L   +  +         S ++ ++  V+  H 
Sbjct: 68  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA--YRE-IVGSPYYIAPEVLS 209
            G++H DLKP NFL      + ++K  DFG++  ++       ++  VG+  Y+ PE + 
Sbjct: 127 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182

Query: 210 QS------------YGKEADIWSAGVILYILLCGVPPFWAETDQGVA-QAILKGEINFQR 256
                            ++D+WS G ILY +  G  PF    +Q     AI+        
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI-- 240

Query: 257 DPFPS-ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTA------VI 309
             FP        ++++  L +DPK+RI++ ++L HP+++      ++           V+
Sbjct: 241 -EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVL 299

Query: 310 FRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEK 344
            ++    + N + K A  +       E       K
Sbjct: 300 GQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSK 334

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  269 bits (691), Expect = 7e-88
 Identities = 82/275 (29%), Positives = 148/275 (53%), Gaps = 10/275 (3%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + IGR +G+G+FG  YL  E       A K + K +L K+  +  +RREIEI  HL   P
Sbjct: 16  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HP 74

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NI++    + D + +++++E    GEL+  +   G + E+ +A+    + + ++ CH + 
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 134

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSYG 213
           V+HRD+KPEN L         +K  DFG S      +  R + G+  Y+ PE++  +++ 
Sbjct: 135 VIHRDIKPENLLM---GYKGELKIADFGWSVHAPSLRR-RTMCGTLDYLPPEMIEGKTHD 190

Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRM 273
           ++ D+W AGV+ Y  L G+PPF + +     + I+  ++ F   P P +S  + +L+ ++
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF---P-PFLSDGSKDLISKL 246

Query: 274 LTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAV 308
           L   P +R+ +  V+EHPW+K +      P+  + 
Sbjct: 247 LRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQST 281

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  269 bits (691), Expect = 3e-87
 Identities = 75/276 (27%), Positives = 130/276 (47%), Gaps = 14/276 (5%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            + + + +G G +G   L     T    A K +  ++ V   E   +++EI I + L+  
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLN-H 64

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI---VGSPYYIAPEVLS- 209
           G+ HRD+KPEN L    DE   +K +DFGL+         R +    G+  Y+APE+L  
Sbjct: 125 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181

Query: 210 QSY-GKEADIWSAGVILYILLCGVPPFWAETDQGVA-QAILKGEINFQRDPFPSISSSAI 267
           + +  +  D+WS G++L  +L G  P+   +D         + +     +P+  I S+ +
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKKIDSAPL 239

Query: 268 ELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
            L+ ++L ++P  RIT+  + +  W  +  +   K 
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  270 bits (692), Expect = 1e-86
 Identities = 72/335 (21%), Positives = 135/335 (40%), Gaps = 34/335 (10%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            Y+I +++G G     +    N     +A K +   +       D  R EI  +  L   
Sbjct: 57  IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQH 114

Query: 94  -PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
              I++       DQ++++VME C   +L   +  +         S ++ ++  V+  H 
Sbjct: 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA--YRE-IVGSPYYIAPEVLS 209
            G++H DLKP NFL   G    ++K  DFG++  ++       ++  VG+  Y+ PE + 
Sbjct: 174 HGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229

Query: 210 QS------------YGKEADIWSAGVILYILLCGVPPFWAETDQGVA-QAILKGEINFQR 256
                            ++D+WS G ILY +  G  PF    +Q     AI+        
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI-- 287

Query: 257 DPFPS-ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTA------VI 309
             FP        ++++  L +DPK+RI++ ++L HP+++      ++           V+
Sbjct: 288 -EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVL 346

Query: 310 FRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEK 344
            ++    + N + K A  +       E       K
Sbjct: 347 GQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSK 381

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  268 bits (687), Expect = 1e-86
 Identities = 94/293 (32%), Positives = 147/293 (50%), Gaps = 20/293 (6%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +Y + + +G+G F    L     TG E A K I K +L        + RE+ IM+ L+  
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-H 73

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PNIV+     E ++ ++++ME  +GGE+FD +VA G   E+ A S FR I++ V  CH K
Sbjct: 74  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSY 212
            ++HRDLK EN L    D +  +K  DFG S     G       G+P Y APE+   + Y
Sbjct: 134 RIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190

Query: 213 -GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G E D+WS GVILY L+ G  PF  +  + + + +L+G+  ++   +  +S+    L++
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK--YRIPFY--MSTDCENLLK 246

Query: 272 RMLTQDPKRRITVAQVLEHPWLKE---------SGEASDKPIDTAVIFRMKQF 315
           R L  +P +R T+ Q+++  W+             E      D   I  M   
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGM 299

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  265 bits (678), Expect = 4e-85
 Identities = 80/280 (28%), Positives = 133/280 (47%), Gaps = 22/280 (7%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD-----VRREIEIMR 88
            Y+    +G G FG  +   +     E   K I K K+++D   +D     V  EI I+ 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMEL-CAGGELFDRIVARGHYSERAAASVFRVIMNVV 147
            +    NI++    +E+  F  +VME   +G +LF  I       E  A+ +FR +++ V
Sbjct: 85  RVE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143

Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV 207
                K ++HRD+K EN +     E+  +K  DFG +A++E GK +    G+  Y APEV
Sbjct: 144 GYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200

Query: 208 LS-QSY-GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265
           L    Y G E ++WS GV LY L+    PF       + +  ++  I     P+  +S  
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPF-----CELEE-TVEAAI---HPPYL-VSKE 250

Query: 266 AIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPID 305
            + LV  +L   P+RR T+ +++  PW+ +    +D   +
Sbjct: 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWE 290

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  263 bits (675), Expect = 6e-85
 Identities = 84/297 (28%), Positives = 136/297 (45%), Gaps = 20/297 (6%)

Query: 6   SKGQDSDHPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKS 65
            +G         H      GK  E ++  Y +G  +G G FG  Y     S  L  A K 
Sbjct: 16  PRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 75

Query: 66  IPKRKLVKDVEKDD---VRREIEIMRHLS-GQPNIVQFKAAYEDDQFVHIVMELCAG-GE 120
           + K ++    E  +   V  E+ +++ +S G   +++    +E      +++E      +
Sbjct: 76  VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQD 135

Query: 121 LFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD 180
           LFD I  RG   E  A S F  ++  V  CH+ GV+HRD+K EN L         +K  D
Sbjct: 136 LFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLID 193

Query: 181 FGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSY-GKEADIWSAGVILYILLCGVPPFWAE 238
           FG  A +++   Y +  G+  Y  PE +    Y G+ A +WS G++LY ++CG  PF  E
Sbjct: 194 FGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--E 250

Query: 239 TDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
            D    + I++G++ F       +SS    L+R  L   P  R T  ++  HPW+++
Sbjct: 251 HD----EEIIRGQVFF---R-QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  261 bits (670), Expect = 9e-85
 Identities = 98/265 (36%), Positives = 137/265 (51%), Gaps = 12/265 (4%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           HY +G  +G G FG   +     TG + A K + ++K+        ++REI+ ++     
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-H 70

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           P+I++            +VME  +GGELFD I   G   E  A  +F+ I++ V+ CH  
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSY 212
            V+HRDLKPEN L    D +   K  DFGLS  + +G+  R   GSP Y APEV+S + Y
Sbjct: 131 MVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187

Query: 213 -GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELV 270
            G E DIWS GVILY LLCG  PF  E    + + I  G   F     P  ++ S   L+
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV--FY---IPEYLNRSVATLL 242

Query: 271 RRMLTQDPKRRITVAQVLEHPWLKE 295
             ML  DP +R T+  + EH W K+
Sbjct: 243 MHMLQVDPLKRATIKDIREHEWFKQ 267

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  263 bits (673), Expect = 1e-84
 Identities = 77/279 (27%), Positives = 128/279 (45%), Gaps = 22/279 (7%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD---VRREIEIMRHL 90
            Y +G  +G+G FG  +     +  L+ A K IP+ +++      D      E+ ++  +
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 91  SGQ---PNIVQFKAAYEDDQFVHIVMEL-CAGGELFDRIVARGHYSERAAASVFRVIMNV 146
                 P +++    +E  +   +V+E      +LFD I  +G   E  +   F  ++  
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151

Query: 147 VNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE 206
           +  CHS+GV+HRD+K EN L          K  DFG  A + +   Y +  G+  Y  PE
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDL--RRGCAKLIDFGSGALLHDEP-YTDFDGTRVYSPPE 208

Query: 207 VLS-QSY-GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
            +S   Y    A +WS G++LY ++CG  PF  E D    Q IL+ E++F   P   +S 
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPF--ERD----QEILEAELHF---PA-HVSP 258

Query: 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
               L+RR L   P  R ++ ++L  PW++   E     
Sbjct: 259 DCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN 297

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  264 bits (677), Expect = 1e-84
 Identities = 94/269 (34%), Positives = 134/269 (49%), Gaps = 18/269 (6%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            Y   +++G G FG+  L  +  T    A K I +   + +    +V+REI   R L   
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE----NVQREIINHRSLR-H 75

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PNIV+FK        + I+ME  +GGEL++RI   G +SE  A   F+ +++ V+ CHS 
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM 135

Query: 154 GVMHRDLKPENFLFTTGDENAV--VKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-Q 210
            + HRDLK EN L    D +    +K  DFG S         +  VG+P YIAPEVL  Q
Sbjct: 136 QICHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQ 192

Query: 211 SY-GKEADIWSAGVILYILLCGVPPFWAETD----QGVAQAILKGEINFQRDPFPSISSS 265
            Y GK AD+WS GV LY++L G  PF    +    +   Q IL  + +   D    IS  
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR--ISPE 250

Query: 266 AIELVRRMLTQDPKRRITVAQVLEHPWLK 294
              L+ R+   DP  RI++ ++  H W  
Sbjct: 251 CCHLISRIFVADPATRISIPEIKTHSWFL 279

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  260 bits (666), Expect = 2e-83
 Identities = 94/291 (32%), Positives = 142/291 (48%), Gaps = 19/291 (6%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            Y I   +G G FG   L T   T  + A K I ++ L K      V REI  ++ L   
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-H 68

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           P+I++          + +V+E  AGGELFD IV +   +E      F+ I+  +  CH  
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSY 212
            ++HRDLKPEN L    D+N  VK  DFGLS  + +G   +   GSP Y APEV++ + Y
Sbjct: 128 KIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY 184

Query: 213 -GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G E D+WS G++LY++L G  PF  E    + + +      +    F  +S  A  L+R
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV--YVMPDF--LSPGAQSLIR 240

Query: 272 RMLTQDPKRRITVAQVLEHPWLKE--------SGEASDKPIDTAVIFRMKQ 314
           RM+  DP +RIT+ ++   PW             E      D+ ++ ++ +
Sbjct: 241 RMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGE 291

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  263 bits (673), Expect = 9e-83
 Identities = 102/293 (34%), Positives = 148/293 (50%), Gaps = 21/293 (7%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           HY +G  +G G FG   +     TG + A K + ++K+        +RREI+ ++     
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-H 75

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           P+I++          + +VME  +GGELFD I   G   E+ +  +F+ I++ V+ CH  
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSY 212
            V+HRDLKPEN L    D +   K  DFGLS  + +G+  R   GSP Y APEV+S + Y
Sbjct: 136 MVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 192

Query: 213 -GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIELV 270
            G E DIWS+GVILY LLCG  PF  +    + + I  G   F     P  ++ S I L+
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--FY---TPQYLNPSVISLL 247

Query: 271 RRMLTQDPKRRITVAQVLEHPWLK---------ESGEASDKPIDTAVIFRMKQ 314
           + ML  DP +R T+  + EH W K         E    S   ID   +  + +
Sbjct: 248 KHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCE 300

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  257 bits (657), Expect = 1e-81
 Identities = 46/313 (14%), Positives = 84/313 (26%), Gaps = 44/313 (14%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL--- 90
              +   +  G+  + +L  +     +FA K           E + +         L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 91  --------------------SGQPNIVQFKAAYEDDQFVH--IVMELCAG------GELF 122
                                 QP   Q     +D    +  ++M   +         L 
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 123 DRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG 182
              V RG     A   +   ++ +     SKG++H    P+N        +  +   D  
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVS 239

Query: 183 LSAFIEEGKAYREIVGSPYYIAPEVLSQS---YGKEADIWSAGVILYILLCGVPPFWAET 239
                + G           Y   E L+ S   +    + W  G+ +Y + C   PF   T
Sbjct: 240 ALW--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297

Query: 240 DQGVAQAILKGEINFQRDPF-----PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
                            D         +      L+ R L  D +RR+   + +E P   
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357

Query: 295 ESGEASDKPIDTA 307
           +        + T 
Sbjct: 358 QLQNEISSSLSTG 370

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  256 bits (655), Expect = 1e-81
 Identities = 67/324 (20%), Positives = 122/324 (37%), Gaps = 49/324 (15%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK--------------DD 79
            Y I R + +G+F    LC +      +A K   K  L K  +               DD
Sbjct: 32  DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 80  VRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH--------Y 131
            + E++I+  +      +  +    +   V+I+ E      +                  
Sbjct: 90  FKNELQIITDIK-NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148

Query: 132 SERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190
             +    + + ++N  +  H+ K + HRD+KP N L    D+N  VK +DFG S ++ + 
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYMVDK 205

Query: 191 KAYREIVGSPYYIAPEVLSQS---YGKEADIWSAGVILYILLCGVPPFWAETDQGVA-QA 246
           K  +   G+  ++ PE  S      G + DIWS G+ LY++   V PF  +         
Sbjct: 206 KI-KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264

Query: 247 ILKGEINF---------------QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           I    I +                      +S+  I+ ++  L ++P  RIT    L+H 
Sbjct: 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324

Query: 292 WLKESGEASDKPIDTAVIFRMKQF 315
           WL ++     +     +  + K+ 
Sbjct: 325 WLADTNIEDLREFSKELYKKRKKL 348

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  265 bits (677), Expect = 3e-81
 Identities = 62/271 (22%), Positives = 110/271 (40%), Gaps = 16/271 (5%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            + +   +G G FG         TG + A K   +    K+ E+     EI+IM+ L+  
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER--WCLEIQIMKKLN-H 71

Query: 94  PNIVQFKAAYEDDQFVH------IVMELCAGGELFDRIVARGH---YSERAAASVFRVIM 144
           PN+V  +   +  Q +       + ME C GG+L   +    +     E    ++   I 
Sbjct: 72  PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131

Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIA 204
           + +   H   ++HRDLKPEN +   G +  + K  D G +  +++G+   E VG+  Y+A
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191

Query: 205 PEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263
           PE+L  + Y    D WS G + +  + G  PF            ++ + N          
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE-HIVVYDDL 250

Query: 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
           + A++    +    P     +       WL+
Sbjct: 251 TGAVKFSSVL--PTPNHLSGILAGKLERWLQ 279

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  251 bits (644), Expect = 8e-81
 Identities = 81/276 (29%), Positives = 128/276 (46%), Gaps = 23/276 (8%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            Y +   +G G +G        S G     K +    +  + EK  +  E+ ++R L   
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-H 64

Query: 94  PNIVQFKAAYED--DQFVHIVMELCAGGELFDRIV----ARGHYSERAAASVFRVIMNVV 147
           PNIV++     D  +  ++IVME C GG+L   I      R +  E     V   +   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 148 NVCHSKG-----VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPY 201
             CH +      V+HRDLKP N           VK  DFGL+  +    ++ +  VG+PY
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSFAKTFVGTPY 181

Query: 202 YIAPEVL-SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
           Y++PE +   SY +++DIWS G +LY L   +PPF A + + +A  I +G+        P
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF----RRIP 237

Query: 261 SI-SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
              S    E++ RML      R +V ++LE+P + E
Sbjct: 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  252 bits (645), Expect = 9e-81
 Identities = 79/291 (27%), Positives = 135/291 (46%), Gaps = 37/291 (12%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK---------------- 77
            YT+  E+G+G +G+  L    +    +A K + K+KL++                    
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 78  -------DDVRREIEIMRHLSGQPNIVQFKAAYED--DQFVHIVMELCAGGELFDRIVAR 128
                  + V +EI I++ L   PN+V+     +D  +  +++V EL   G + + +   
Sbjct: 74  IQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTL 131

Query: 129 GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188
              SE  A   F+ ++  +   H + ++HRD+KP N L     E+  +K  DFG+S   +
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV---GEDGHIKIADFGVSNEFK 188

Query: 189 EGKAY-REIVGSPYYIAPEVLS---QSY-GKEADIWSAGVILYILLCGVPPFWAETDQGV 243
              A     VG+P ++APE LS   + + GK  D+W+ GV LY  + G  PF  E    +
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248

Query: 244 AQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
              I    + F     P I+    +L+ RML ++P+ RI V ++  HPW+ 
Sbjct: 249 HSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  254 bits (649), Expect = 2e-80
 Identities = 42/308 (13%), Positives = 87/308 (28%), Gaps = 58/308 (18%)

Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL- 90
                 G  +G+ +       T+  TG  F        +         ++ E+  +R L 
Sbjct: 72  PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131

Query: 91  -----------------------SGQPNIVQFKAAYEDDQF--VHIVMELCA------GG 119
                                    +  +++ +    D        +           G 
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191

Query: 120 ELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKAT 179
            L             A   +   ++ ++   H  G++H  L+P + +    D+   V  T
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLT 248

Query: 180 DFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS------------YGKEADIWSAGVILYI 227
            F          A      S  +  PE+ ++                  D W+ G+++Y 
Sbjct: 249 GFEHLV---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305

Query: 228 LLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQV 287
           + C   P   +   G ++ I +   N        I      L+   L    + R+   Q 
Sbjct: 306 IWCADLPITKDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYPKEDRLLPLQA 357

Query: 288 LEHPWLKE 295
           +E P  ++
Sbjct: 358 METPEYEQ 365

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  251 bits (643), Expect = 9e-80
 Identities = 71/267 (26%), Positives = 135/267 (50%), Gaps = 14/267 (5%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            Y   +++G G FG   L      G ++  K I   ++    E+++ RRE+ ++ ++   
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK-H 82

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCH 151
           PNIVQ++ ++E++  ++IVM+ C GG+LF RI A+    + E      F  I   +   H
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVL-S 209
            + ++HRD+K +N   T   ++  V+  DFG++  +          +G+PYY++PE+  +
Sbjct: 143 DRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199

Query: 210 QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIE 268
           + Y  ++DIW+ G +LY L      F A + + +   I+ G       P     S     
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF----PPVSLHYSYDLRS 255

Query: 269 LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           LV ++  ++P+ R +V  +LE  ++ +
Sbjct: 256 LVSQLFKRNPRDRPSVNSILEKGFIAK 282

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  249 bits (637), Expect = 2e-79
 Identities = 67/264 (25%), Positives = 105/264 (39%), Gaps = 13/264 (4%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            +     +G G +G  +       G  +A K           ++     E+     +   
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQH 116

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHY-SERAAASVFRVIMNVVNVCHS 152
           P  V+ + A+E+   +++  ELC G  L     A G    E       R  +  +   HS
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSY 212
           +G++H D+KP N            K  DFGL   +    A     G P Y+APE+L  SY
Sbjct: 176 QGLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSY 232

Query: 213 GKEADIWSAGVILYILLCGVP-PFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
           G  AD++S G+ +  + C +  P   E  Q + Q  L  E          +SS    ++ 
Sbjct: 233 GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF------TAGLSSELRSVLV 286

Query: 272 RMLTQDPKRRITVAQVLEHPWLKE 295
            ML  DPK R T   +L  P L++
Sbjct: 287 MMLEPDPKLRATAEALLALPVLRQ 310

>3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191

 Score =  241 bits (617), Expect = 4e-78
 Identities = 62/193 (32%), Positives = 96/193 (49%), Gaps = 16/193 (8%)

Query: 302 KPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPT-EEIQKLKEKFTEMDTDNSGTLTYDE 360
           K   T  +  MK+F +  KL + A+  +   L T EE ++L + F ++D +  G L   E
Sbjct: 2   KHALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKE 61

Query: 361 LKAGLAK-----------LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQR 409
           L  G  K           L S   E +V   +Q+ D D NG I+Y EF+T  M +  L  
Sbjct: 62  LIEGYRKLMQWKGDTVSDLDSSQIEAEVDHILQSVDFDRNGYIEYSEFVTVCMDKQLLLS 121

Query: 410 FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYD 469
            E L  AFQ FD D +G IT +ELG+ F    + D+    T  +++ E D++ DG + ++
Sbjct: 122 RERLLAAFQQFDSDGSGKITNEELGRLFGVTEVDDE----TWHQVLQECDKNNDGEVDFE 177

Query: 470 EFRSMMKCGTQLR 482
           EF  MM+    ++
Sbjct: 178 EFVEMMQKICDVK 190

>2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} Length = 166

 Score =  238 bits (609), Expect = 4e-77
 Identities = 88/167 (52%), Positives = 124/167 (74%), Gaps = 4/167 (2%)

Query: 313 KQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSML 372
           KQF+AMNK KK+AL+VI E+L  EEI  LKE F  +D D SG +T++ELKAGL ++G+ L
Sbjct: 1   KQFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANL 60

Query: 373 TEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDE 432
            E ++   MQAAD+D +GTIDY EFI AT+  +K++R ++L+ AF YFDKD +GYIT DE
Sbjct: 61  KESEILDLMQAADVDNSGTIDYKEFIAATLHLNKIEREDHLFAAFTYFDKDGSGYITPDE 120

Query: 433 LGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT 479
           L +A +++G+ D      I+E+M +VD+D DGRI Y+EF +MM+ G+
Sbjct: 121 LQQACEEFGVEDV----RIEELMRDVDQDNDGRIDYNEFVAMMQKGS 163

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  238 bits (610), Expect = 2e-75
 Identities = 72/282 (25%), Positives = 134/282 (47%), Gaps = 20/282 (7%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD-VRREIEIMRHLSG 92
            Y +G  +G G +G      ++ T    A K + K+KL +    +  V++EI+++R L  
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR- 64

Query: 93  QPNIVQFK--AAYEDDQFVHIVMELCAGG--ELFDRIVARGHYSERAAASVFRVIMNVVN 148
             N++Q       E+ Q +++VME C  G  E+ D +     +    A   F  +++ + 
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDGLE 123

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV---GSPYYIAP 205
             HS+G++H+D+KP N L         +K +  G++  +    A        GSP +  P
Sbjct: 124 YLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180

Query: 206 EVLS--QSY-GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
           E+ +   ++ G + DIWSAGV LY +  G+ PF  +    + + I KG       P    
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI---P-GDC 236

Query: 263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPI 304
                +L++ ML  +P +R ++ Q+ +H W ++    ++ P+
Sbjct: 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV 278

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  231 bits (592), Expect = 1e-72
 Identities = 75/273 (27%), Positives = 128/273 (46%), Gaps = 18/273 (6%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           ++ I +++GRG+F   Y       G+  A K +    L+    + D  +EI++++ L+  
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-H 91

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG----HYSERAAASVFRVIMNVVNV 149
           PN++++ A++ +D  ++IV+EL   G+L   I           ER     F  + + +  
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVL 208
            HS+ VMHRD+KP N   T      VVK  D GL  F          +VG+PYY++PE +
Sbjct: 152 MHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208

Query: 209 -SQSYGKEADIWSAGVILYILLCGVPPFWAETD--QGVAQAILKGEINFQRDPFPS--IS 263
               Y  ++DIWS G +LY +     PF+ +      + + I + +      P PS   S
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY----PPLPSDHYS 264

Query: 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
               +LV   +  DP++R  V  V +      +
Sbjct: 265 EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  228 bits (584), Expect = 9e-72
 Identities = 64/280 (22%), Positives = 111/280 (39%), Gaps = 38/280 (13%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +     +G G FG  +       G  +  K +           +   RE++ +  L    
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY-------NNEKAEREVKALAKLD-HV 64

Query: 95  NIVQFKAAYED----------------DQFVHIVMELCAGGELFDRIVAR--GHYSERAA 136
           NIV +   ++                  + + I ME C  G L   I  R      +  A
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124

Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI 196
             +F  I   V+  HSK +++RDLKP N       +   VK  DFGL   ++        
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDGKRTRS 181

Query: 197 VGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ 255
            G+  Y++PE +S Q YGKE D+++ G+IL  LL      + ET +     +  G I+  
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF-ETSK-FFTDLRDGIIS-- 237

Query: 256 RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
                        L++++L++ P+ R   +++L    + +
Sbjct: 238 ----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273

>3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180

 Score =  221 bits (565), Expect = 2e-70
 Identities = 45/183 (24%), Positives = 87/183 (47%), Gaps = 17/183 (9%)

Query: 304 IDTAVIFRMKQFTAMNKLKKLALKVIVENLPT--EEIQKLKEKFTEMDTDNSGTLTYDEL 361
           I   V+  MK +   + ++ + + ++   L      I+ + E F ++DT+++G+L++ E+
Sbjct: 2   ISPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREI 61

Query: 362 KAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFD 421
              LA +G  + ++D+ + +QA DI+  G I Y EF+    +   ++    L  AF   D
Sbjct: 62  YTVLASVG--IKKWDINRILQALDINDRGNITYTEFMAGCYRWKNIES-TFLKAAFNKID 118

Query: 422 KDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDG--------RISYDEFRS 473
           KD +GYI+  ++     D  + ++     I      V   K G        +IS+ EF+ 
Sbjct: 119 KDEDGYISKSDIVSLVHDKVLDNN----DIDNFFLSVHSIKKGIPREHIINKISFQEFKD 174

Query: 474 MMK 476
            M 
Sbjct: 175 YML 177

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  222 bits (568), Expect = 5e-69
 Identities = 59/282 (20%), Positives = 106/282 (37%), Gaps = 32/282 (11%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           HY   +++G G F    L      G  +A K I   +     ++++ +RE ++ R     
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ---DREEAQREADMHRLF-NH 85

Query: 94  PNIVQFKAAYEDDQF----VHIVMELCAGGELFDRIVAR----GHYSERAAASVFRVIMN 145
           PNI++  A    ++       +++     G L++ I          +E     +   I  
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145

Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE---------- 195
            +   H+KG  HRDLKP N L     +       D G                       
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 196 IVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQG-VAQAILKG 250
              +  Y APE+ S        +  D+WS G +LY ++ G  P+     +G      ++ 
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262

Query: 251 EINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
           +++      P  SS+  +L+  M+T DP +R  +  +L    
Sbjct: 263 QLSI--PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  221 bits (564), Expect = 3e-68
 Identities = 78/315 (24%), Positives = 129/315 (40%), Gaps = 43/315 (13%)

Query: 8   GQDSDHPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIP 67
           G  S   A+       +G+  E  +L   + R +  G F   Y   +  +G E+A K + 
Sbjct: 3   GPGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL 62

Query: 68  KRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY--------EDDQFVHIVMELCAGG 119
             +   + +   + +E+  M+ LSG PNIVQF +A                ++ ELC  G
Sbjct: 63  SNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC-KG 118

Query: 120 ELFDRIV---ARGHYSERAAASVFRVIMNVVNVCHSKG--VMHRDLKPENFLFTTGDENA 174
           +L + +    +RG  S      +F      V   H +   ++HRDLK EN L        
Sbjct: 119 QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQG 175

Query: 175 VVKATDFGLSAFIEEGKAYR-------------EIVGSPYYIAPEVLS----QSYGKEAD 217
            +K  DFG +  I     Y                  +P Y  PE++        G++ D
Sbjct: 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQD 235

Query: 218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQD 277
           IW+ G ILY+L     PF    + G    I+ G+ +    P  +  +    L+R ML  +
Sbjct: 236 IWALGCILYLLCFRQHPF----EDGAKLRIVNGKYSIP--PHDTQYTVFHSLIRAMLQVN 289

Query: 278 PKRRITVAQVLEHPW 292
           P+ R+++A+V+    
Sbjct: 290 PEERLSIAEVVHQLQ 304

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323

 Score =  218 bits (557), Expect = 2e-67
 Identities = 39/228 (17%), Positives = 76/228 (33%), Gaps = 18/228 (7%)

Query: 260 PSISSSAIELVRRMLTQDPKR--RITVAQVLEHPW--LKESGEASDKPIDTAVIFRMKQF 315
             I+    E   ++   D K        +  E      +    A  + + + +       
Sbjct: 44  AQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLASLLKDLEDDA 103

Query: 316 TAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEF 375
           +  N+L+          L  E+   L++ F       SG  ++ +LK  LAK    + E 
Sbjct: 104 SGYNRLR-----PSKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEG 158

Query: 376 DVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGK 435
            +K+     + D  G + YI  +        L         F+  D ++NG ++  E  +
Sbjct: 159 PLKKLFVMVENDTKGRMSYITLVAVANDLAALV------ADFRKIDTNSNGTLSRKEFRE 212

Query: 436 AFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRA 483
            F   G       +    +    D D+   + + E+  +  C   LR 
Sbjct: 213 HFVRLGFDKK---SVQDALFRYADEDESDDVGFSEYVHLGLCLLVLRI 257

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323

 Score =  156 bits (397), Expect = 6e-44
 Identities = 29/141 (20%), Positives = 61/141 (43%), Gaps = 8/141 (5%)

Query: 335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDY 394
             ++  L   F ++DT+++GTL+  E +    +LG            + AD D +  + +
Sbjct: 184 ANDLAALVADFRKIDTNSNGTLSRKEFREHFVRLGFDKKS-VQDALFRYADEDESDDVGF 242

Query: 395 IEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI 454
            E++   +    L+        + + D D +G ++ +E+ K  +D  + +       +  
Sbjct: 243 SEYVHLGLCLLVLR------ILYAFADFDKSGQLSKEEVQKVLEDAHIPES-ARKKFEHQ 295

Query: 455 MSEVDRDKDGRISYDEFRSMM 475
            S VD D    +SY EF  ++
Sbjct: 296 FSVVDVDDSKSLSYQEFVMLV 316

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323

 Score = 90.3 bits (224), Expect = 3e-20
 Identities = 24/179 (13%), Positives = 56/179 (31%), Gaps = 13/179 (7%)

Query: 308 VIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAK 367
           +  ++   +  +K  +  L+  +     ++ Q+ K K  E D          E      +
Sbjct: 24  LQKKLDHTSFAHKEDRDRLEAQI----AQKEQEQKAKLAEYDQKVQNEFDARERAERERE 79

Query: 368 LG---SMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDN 424
                +   +  +   ++  + D +G                 +    L + F       
Sbjct: 80  AARGDAAAEKQRLASLLKDLEDDASGYNRLRPS----KPMLSEEDTNILRQLFLSSAVSG 135

Query: 425 NGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRA 483
           +G  +  +L +        D      +K++   V+ D  GR+SY    ++      L A
Sbjct: 136 SGKFSFQDLKQVLAK--YADTIPEGPLKKLFVMVENDTKGRMSYITLVAVANDLAALVA 192

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  216 bits (551), Expect = 1e-66
 Identities = 71/291 (24%), Positives = 124/291 (42%), Gaps = 42/291 (14%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +   + +GRG FG+ +          +A K I      +++ ++ V RE++ +  L   P
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HP 63

Query: 95  NIVQFKAAYEDDQ------------FVHIVMELCAGGELFDRIVARGHYS---ERAAASV 139
            IV++  A+ +              +++I M+LC    L D +  R             +
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI--- 196
           F  I   V   HSKG+MHRDLKP N  FT    + VVK  DFGL   +++ +  + +   
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 197 ----------VGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQG-VA 244
                     VG+  Y++PE +   SY  + DI+S G+IL+ LL    PF  + ++    
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237

Query: 245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
             +   +       F         +V+ ML+  P  R     ++E+   ++
Sbjct: 238 TDVRNLKF---PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285

>3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} Length = 204

 Score =  211 bits (538), Expect = 4e-66
 Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 14/187 (7%)

Query: 296 SGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGT 355
           SG     P+ + +         M KL+   L           IQ L   F ++D D S +
Sbjct: 2   SGLVPRGPLGSHMD---AVDATMEKLRAQCLSRGAS-----GIQGLARFFRQLDRDGSRS 53

Query: 356 LTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYK 415
           L  DE + GLAKLG +L + + +   +  D +G+GT+D  EF+ A        R   +  
Sbjct: 54  LDADEFRQGLAKLGLVLDQAEAEGVCRKWDRNGSGTLDLEEFLRALRPPMSQAREAVIAA 113

Query: 416 AFQYFDKDNNGYITVDELGKAFKDYG-----MGDDATIATIKEIMSEVD-RDKDGRISYD 469
           AF   D+  +G +TVD+L   +          G+      ++  +   D  +KDG+++  
Sbjct: 114 AFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEVLRRFLDNFDSSEKDGQVTLA 173

Query: 470 EFRSMMK 476
           EF+    
Sbjct: 174 EFQDYYS 180

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  211 bits (538), Expect = 5e-65
 Identities = 60/288 (20%), Positives = 112/288 (38%), Gaps = 34/288 (11%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            +    ++G GEFG  + C +   G  +A K   K+ L   V++ +  RE+     L   
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRS-KKPLAGSVDEQNALREVYAHAVLGQH 70

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR----GHYSERAAASVFRVIMNVVNV 149
            ++V++ +A+ +D  + I  E C GG L D I        ++ E     +   +   +  
Sbjct: 71  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130

Query: 150 CHSKGVMHRDLKPENFLFT----------------TGDENAVVKATDFGLSAFIEEGKAY 193
            HS  ++H D+KP N   +                      + K  D G    I   +  
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 190

Query: 194 REIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE 251
               G   ++A EVL +  ++  +ADI++  + +       P             I +G 
Sbjct: 191 ---EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HEIRQGR 244

Query: 252 INFQRDPFPS-ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298
           +       P  +S    EL++ M+  DP+RR +   +++H  L  +  
Sbjct: 245 L----PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288

>1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 188

 Score =  203 bits (520), Expect = 1e-63
 Identities = 81/159 (50%), Positives = 109/159 (68%), Gaps = 4/159 (2%)

Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
           E L  EEI  LKE F  +DTDNSGT+T+DELK GL ++GS L E ++K  M AADID +G
Sbjct: 2   ERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSG 61

Query: 391 TIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIAT 450
           TIDY EFI AT+  +KL+R ENL  AF YFDKD +GYIT+DE+ +A KD+G+ D      
Sbjct: 62  TIDYGEFIAATVHLNKLEREENLVSAFSYFDKDGSGYITLDEIQQACKDFGLDDI----H 117

Query: 451 IKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRALSSRSL 489
           I +++ E+D+D DG+I Y EF +MM+       +  R++
Sbjct: 118 IDDMIKEIDQDNDGQIDYGEFAAMMRKRKGNGGIGRRTM 156

>1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 188

 Score = 83.0 bits (206), Expect = 1e-18
 Identities = 27/107 (25%), Positives = 42/107 (39%), Gaps = 10/107 (9%)

Query: 335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDY 394
            E  + L   F+  D D SG +T DE++      G  L +  +   ++  D D +G IDY
Sbjct: 78  LEREENLVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIKEIDQDNDGQIDY 135

Query: 395 IEFIT--------ATMQRHKLQRFENLYKAFQYFDKDNNGYITVDEL 433
            EF            + R  +++  NL  A    D  +N  I     
Sbjct: 136 GEFAAMMRKRKGNGGIGRRTMRKTLNLRDALGLVDNGSNQVIEGYFK 182

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  208 bits (531), Expect = 1e-62
 Identities = 39/301 (12%), Positives = 82/301 (27%), Gaps = 51/301 (16%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL---- 90
              G  +G+ +       T+  TG  F        +         ++ E+  +R L    
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 91  --------------------SGQPNIVQFKAAYEDDQFVH--IVMELCAG------GELF 122
                                 +  +++ +    D   +    +              L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 123 DRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG 182
                       A   +   ++ ++   H  G++H  L+P + +    D+   V  T F 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFE 256

Query: 183 LSAFIEEGKAYR--EIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPP 234
                              P   A  +L              D W+ G+ +Y + C   P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

Query: 235 FWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
              +   G ++ I +           +I      L+   L    + R+   Q +E P  +
Sbjct: 317 NTDDAALGGSEWIFRSC--------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368

Query: 295 E 295
           +
Sbjct: 369 Q 369

>3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} Length = 219

 Score =  193 bits (493), Expect = 3e-59
 Identities = 39/194 (20%), Positives = 74/194 (38%), Gaps = 15/194 (7%)

Query: 297 GEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPT----EEIQKLKEKFTEMDTDN 352
           G    K   +       +     K +K A + I + +P     E  Q+  E F + D + 
Sbjct: 2   GACGSKGSTSDKGLASDKDGKKAKDRKEAWERIRQAIPREKTAEAKQRRIELFKKFDKNE 61

Query: 353 SGTLTYDELKAGLAK-LGSMLTEFDVKQYMQAA---------DIDGNGTIDYIEFITATM 402
           +G L YDE+ +G  + L        V+   + A          ++  G+ D++EF+   +
Sbjct: 62  TGKLCYDEVYSGCLEVLKLDEFTSRVRDITKRAFDKSRTLGSKLENKGSEDFVEFLEFRL 121

Query: 403 QRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDK 462
               +  F  L   F   D   N  +  +E  +A         A +     +  E+D++ 
Sbjct: 122 MLCYIYDFFELTVMFDEIDASGNMLVDEEEFKRAVPKLEAW-GAKVEDPAALFKELDKNG 180

Query: 463 DGRISYDEFRSMMK 476
            G +++DEF +   
Sbjct: 181 TGSVTFDEFAAWAS 194

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  191 bits (487), Expect = 4e-57
 Identities = 82/275 (29%), Positives = 135/275 (49%), Gaps = 26/275 (9%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   P
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 90

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSE-RA---AASVFRVIMNVVNVC 150
             V+    ++DD+ ++  +     GEL   I   G + E       A +   +  +    
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL---- 146

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYRE--IVGSPYYIAPEV 207
           H KG++HRDLKPEN L    +E+  ++ TDFG +     E K  R    VG+  Y++PE+
Sbjct: 147 HGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203

Query: 208 L-SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
           L  +S  K +D+W+ G I+Y L+ G+PPF A  +  + Q I+K E +F   P       A
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF---P-EKFFPKA 259

Query: 267 IELVRRMLTQDPKRRIT------VAQVLEHPWLKE 295
            +LV ++L  D  +R+          +  HP+ + 
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220

 Score =  183 bits (467), Expect = 2e-55
 Identities = 31/195 (15%), Positives = 66/195 (33%), Gaps = 12/195 (6%)

Query: 290 HPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMD 349
            P +      + +PI  + +     +     ++      ++  +P ++  ++ + F  +D
Sbjct: 2   QPPVANFCLWNLQPIQGSWMGAACIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVD 61

Query: 350 TDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQR 409
            D SGTL  +EL  G    G  L+     + M+  D D NG I + EF+           
Sbjct: 62  RDRSGTLEINELMMGQFPGGIRLSPQTALRMMRIFDTDFNGHISFYEFMAMYKFM----- 116

Query: 410 FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYD 469
            E  Y  F    +  +G +   E+  A +  G   +        ++  +          +
Sbjct: 117 -ELAYNLFVMNARARSGTLEPHEILPALQQLGFYIN---QRTSLLLHRLFARGMAFCDLN 172

Query: 470 EFRSMMKCGTQLRAL 484
            +   +         
Sbjct: 173 CW---IAICAFAAQT 184

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  185 bits (470), Expect = 3e-54
 Identities = 48/287 (16%), Positives = 94/287 (32%), Gaps = 37/287 (12%)

Query: 34  HYTIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
              +   +G G F   Y  T     +     +F  K           E     + +E ++
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMERLK 122

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHY-----SERAAASVFRVI 143
               Q   ++F +A+       +V EL + G L + I    +       +    S    +
Sbjct: 123 PSM-QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181

Query: 144 MNVVNVCHSKGVMHRDLKPENFLFTT--------GDENAVVKATDFGLSA---FIEEGKA 192
           + ++   H   ++H D+KP+NF+            D +A +   D G S       +G  
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241

Query: 193 YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE 251
           +     +  +   E+LS + +  + D +     +Y +L G                 K E
Sbjct: 242 FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG-----ECKPE 296

Query: 252 INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHP---WLKE 295
             F+R P   + +   E    ML       +    +L        ++
Sbjct: 297 GLFRRLPHLDMWN---EFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340

>1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A Length = 134

 Score =  175 bits (446), Expect = 2e-53
 Identities = 35/138 (25%), Positives = 64/138 (46%), Gaps = 9/138 (6%)

Query: 341 LKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITA 400
            +  F E+D +  G ++Y+E+KA ++K  ++  E  ++   ++ D DGNG ID  EF   
Sbjct: 2   AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKF 61

Query: 401 TMQRHKLQRF---ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSE 457
                          L   ++  D D +G +T +E+   FK +G+        + E + +
Sbjct: 62  YGSIQGQDLSDDKIGLKVLYKLMDVDGDGKLTKEEVTSFFKKHGIEK------VAEQVMK 115

Query: 458 VDRDKDGRISYDEFRSMM 475
            D + DG I+ +EF    
Sbjct: 116 ADANGDGYITLEEFLEFS 133

>1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A Length = 134

 Score = 55.2 bits (134), Expect = 2e-09
 Identities = 19/65 (29%), Positives = 31/65 (47%), Gaps = 4/65 (6%)

Query: 335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDY 394
           +++   LK  +  MD D  G LT +E+ +   K G       V + +  AD +G+G I  
Sbjct: 71  SDDKIGLKVLYKLMDVDGDGKLTKEEVTSFFKKHG----IEKVAEQVMKADANGDGYITL 126

Query: 395 IEFIT 399
            EF+ 
Sbjct: 127 EEFLE 131

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  180 bits (459), Expect = 3e-53
 Identities = 74/271 (27%), Positives = 124/271 (45%), Gaps = 20/271 (7%)

Query: 38  GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIV 97
              +G+G +GI Y   + S  +  A K IP            +  EI + +HL    NIV
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIP---ERDSRYSQPLHEEIALHKHLK-HKNIV 82

Query: 98  QFKAAYEDDQFVHIVMELCAGGELFDRIVARG---HYSERAAASVFRVIMNVVNVCHSKG 154
           Q+  ++ ++ F+ I ME   GG L   + ++      +E+      + I+  +   H   
Sbjct: 83  QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEVLSQS-- 211
           ++HRD+K +N L  T   + V+K +DFG S  +       E   G+  Y+APE++ +   
Sbjct: 143 IVHRDIKGDNVLINT--YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200

Query: 212 -YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD--PFP-SISSSAI 267
            YGK ADIWS G  +  +  G PP + E  +  A A+ K  +   +     P S+S+ A 
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPP-FYELGEPQA-AMFK--VGMFKVHPEIPESMSAEAK 256

Query: 268 ELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298
             + +    DP +R     +L   +LK S +
Sbjct: 257 AFILKCFEPDPDKRACANDLLVDEFLKVSSK 287

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  181 bits (461), Expect = 4e-53
 Identities = 63/278 (22%), Positives = 110/278 (39%), Gaps = 27/278 (9%)

Query: 28  YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM 87
           Y +     T    VGRG FG  +   +  TG + A K +        +E      E+   
Sbjct: 53  YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV-------RLEVFR-VEELVAC 104

Query: 88  RHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVV 147
             LS  P IV    A  +  +V+I MEL  GG L   I   G   E  A       +  +
Sbjct: 105 AGLS-SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGL 163

Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE------IVGSPY 201
              H++ ++H D+K +N L ++  + +     DFG +  ++     +       I G+  
Sbjct: 164 EYLHTRRILHGDVKADNVLLSS--DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221

Query: 202 YIAPEVLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
           ++APEV+       + DIWS+  ++  +L G  P W +  +      LK  I  +  P  
Sbjct: 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP-WTQYFR--GPLCLK--IASEPPPIR 276

Query: 261 ----SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
               S +    + ++  L ++P  R +  ++       
Sbjct: 277 EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  180 bits (458), Expect = 4e-53
 Identities = 64/266 (24%), Positives = 119/266 (44%), Gaps = 14/266 (5%)

Query: 37  IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNI 96
              E+GRG F   Y   +  T +E A   +  RKL K  E+   + E E+++ L   PNI
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQ-HPNI 87

Query: 97  VQFKAAYED----DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
           V+F  ++E      + + +V EL   G L   +        +   S  R I+  +   H+
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 153 KG--VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ 210
           +   ++HRDLK +N   T       VK  D GL+       A + ++G+P ++APE+  +
Sbjct: 148 RTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATLKRASFA-KAVIGTPEFMAPEMYEE 204

Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI-EL 269
            Y +  D+++ G+ +  +     P+     Q  AQ   +     +   F  ++   + E+
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSEC--QNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262

Query: 270 VRRMLTQDPKRRITVAQVLEHPWLKE 295
           +   + Q+   R ++  +L H + +E
Sbjct: 263 IEGCIRQNKDERYSIKDLLNHAFFQE 288

>1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... Length = 161

 Score =  175 bits (446), Expect = 5e-53
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 11/164 (6%)

Query: 318 MNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTD-NSGTLTYDELKAGLAKLGSMLTEFD 376
           M+ + K      VE L  E+  + K  F         G+++  EL   +  LG   T  +
Sbjct: 1   MDDIYK----AAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEE 56

Query: 377 VKQYMQAADIDGNGTIDYIEFITATMQ----RHKLQRFENLYKAFQYFDKDNNGYITVDE 432
           +++ +   D DG+GT+D+ EF+   ++      K +  E L   F+ FDK+ +GYI ++E
Sbjct: 57  LQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADGYIDLEE 116

Query: 433 LGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           L    +    G+  T   I+E+M + D++ DGRI YDEF   MK
Sbjct: 117 LKIMLQA--TGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMK 158

>3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161

 Score =  174 bits (443), Expect = 1e-52
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 4/161 (2%)

Query: 318 MNKLKK-LALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD 376
           M+K +  L    +   L  E+ Q++ E F+  D +N G L Y ELK  +  LG  L + +
Sbjct: 1   MSKNRSSLQSGPLNSELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKRE 60

Query: 377 VKQYMQAADIDGNGTIDYIEFIT-ATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGK 435
           +   +   D +G   + Y +F      +  K    + + +AFQ FD D+ G I++  L +
Sbjct: 61  ILDLIDEYDSEGRHLMKYDDFYIVMGEKILKRDPLDEIKRAFQLFDDDHTGKISIKNLRR 120

Query: 436 AFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
             K+  +G+  T   ++ ++ E D D DG I+ +EF ++  
Sbjct: 121 VAKE--LGETLTDEELRAMIEEFDLDGDGEINENEFIAICT 159

>3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A Length = 169

 Score =  173 bits (441), Expect = 3e-52
 Identities = 54/145 (37%), Positives = 87/145 (60%), Gaps = 3/145 (2%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E+ Q+++E F   DTD SGT+   ELK  +  LG    + ++K+ +   D DG+GTI
Sbjct: 22  LTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGFEPKKEEIKKMISEIDKDGSGTI 81

Query: 393 DYIEFIT-ATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATI 451
           D+ EF+T  T +  +    E + KAF+ FD DN+G IT+ +L +  K+  +G++ T   +
Sbjct: 82  DFEEFLTMMTAKMGERDSREEILKAFRLFDDDNSGTITIKDLRRVAKE--LGENLTEEEL 139

Query: 452 KEIMSEVDRDKDGRISYDEFRSMMK 476
           +E+++E DR+ D  I  DEF  +MK
Sbjct: 140 QEMIAEADRNDDNEIDEDEFIRIMK 164

>3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153

 Score =  172 bits (439), Expect = 4e-52
 Identities = 43/153 (28%), Positives = 79/153 (51%), Gaps = 6/153 (3%)

Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           +  +L  EEI++L+E F E D D  G +   +L   +  +G M TE ++ +  Q  +++ 
Sbjct: 1   MDRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNL 60

Query: 389 NGTIDYIEFITATMQRHKLQ-----RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMG 443
            G +D+ +F+     +   +       + L  AF+ FD + +G I+  EL +A +   +G
Sbjct: 61  GGHVDFDDFVELMGPKLLAETADMIGVKELRDAFREFDTNGDGEISTSELREAMRAL-LG 119

Query: 444 DDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
                  I+EI+ +VD + DGR+ ++EF  MM 
Sbjct: 120 HQVGHRDIEEIIRDVDLNGDGRVDFEEFVRMMS 152

>3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153

 Score = 54.5 bits (132), Expect = 4e-09
 Identities = 22/79 (27%), Positives = 46/79 (58%), Gaps = 2/79 (2%)

Query: 327 KVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGL-AKLGSMLTEFDVKQYMQAAD 385
           K++ E      +++L++ F E DT+  G ++  EL+  + A LG  +   D+++ ++  D
Sbjct: 76  KLLAETADMIGVKELRDAFREFDTNGDGEISTSELREAMRALLGHQVGHRDIEEIIRDVD 135

Query: 386 IDGNGTIDYIEFITATMQR 404
           ++G+G +D+ EF+   M R
Sbjct: 136 LNGDGRVDFEEFV-RMMSR 153

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  179 bits (457), Expect = 5e-52
 Identities = 70/279 (25%), Positives = 129/279 (46%), Gaps = 34/279 (12%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           H+ I R +G+G FG   +  +N T   +A K + K+K V+  E  +V +E++IM+ L   
Sbjct: 16  HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-H 74

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAA----ASVFRVIMNVVNV 149
           P +V    +++D++ + +V++L  GG+L   +    H+ E         +         V
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICEL---------V 125

Query: 150 C-----HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIA 204
                  ++ ++HRD+KP+N L    DE+  V  TDF ++A +        + G+  Y+A
Sbjct: 126 MALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMA 182

Query: 205 PEVLSQS----YGKEADIWSAGVILYILLCGVPPFWAETDQGVA---QAILKGEINFQRD 257
           PE+ S      Y    D WS GV  Y LL G  P+   +               + +   
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY--- 239

Query: 258 PFPSISSSAIELVRRMLTQDPKRRI-TVAQVLEHPWLKE 295
           P  + S   + L++++L  +P +R   ++ V   P++ +
Sbjct: 240 P-SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  178 bits (453), Expect = 8e-52
 Identities = 79/271 (29%), Positives = 141/271 (52%), Gaps = 24/271 (8%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           +   + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  P
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FP 101

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSE-RA---AASVFRVIMNVVNVC 150
            +V+ + +++D+  +++VME  AGGE+F  +   G +SE  A   AA +      +    
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL---- 157

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-S 209
           HS  +++RDLKPEN L    D+   ++ TDFG +  ++ G+ +  + G+P  +APE++ S
Sbjct: 158 HSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTW-TLCGTPEALAPEIILS 212

Query: 210 QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
           + Y K  D W+ GV++Y +  G PPF+A+    + + I+ G++ F   P    SS   +L
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF---P-SHFSSDLKDL 268

Query: 270 VRRMLTQDPKRRI-----TVAQVLEHPWLKE 295
           +R +L  D  +R       V  +  H W   
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299

>1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... Length = 162

 Score =  171 bits (435), Expect = 2e-51
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 7/154 (4%)

Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
             L  E I + K  F   D D  G ++  EL   +  LG   T+ ++   ++  D DG+G
Sbjct: 12  AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSG 71

Query: 391 TIDYIEFITATMQRHKLQRF----ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDA 446
           TID+ EF+   +++ K        E L   F+ FDK+ +G+I ++ELG+  +    G+  
Sbjct: 72  TIDFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILRA--TGEHV 129

Query: 447 TIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ 480
           T   I+++M + D++ DGRI +DEF  MM+ G Q
Sbjct: 130 TEEDIEDLMKDSDKNNDGRIDFDEFLKMME-GVQ 162

>1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... Length = 162

 Score = 60.3 bits (147), Expect = 4e-11
 Identities = 19/76 (25%), Positives = 39/76 (51%)

Query: 324 LALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQA 383
           + ++ + E+   +  ++L   F   D +  G +  +EL   L   G  +TE D++  M+ 
Sbjct: 81  MMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKD 140

Query: 384 ADIDGNGTIDYIEFIT 399
           +D + +G ID+ EF+ 
Sbjct: 141 SDKNNDGRIDFDEFLK 156

>2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A Length = 158

 Score =  170 bits (432), Expect = 4e-51
 Identities = 39/157 (24%), Positives = 79/157 (50%), Gaps = 8/157 (5%)

Query: 330 VENLPTEEIQKLKEKFTEMDT-DNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           V  L + +++ L+  F + +T + SG ++ D++   L  LG   T+  ++Q +   D  G
Sbjct: 4   VSKLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEFDPFG 63

Query: 389 NGTIDYIEFITATMQR-----HKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMG 443
           NG ID+  F     +      +  Q  + L +AF+ +DK+ NGYI+ D + +   +  + 
Sbjct: 64  NGDIDFDSFKIIGARFLGEEVNPEQMQQELREAFRLYDKEGNGYISTDVMREILAE--LD 121

Query: 444 DDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ 480
           +  +   +  ++ E+D D  G + ++EF  +M  G +
Sbjct: 122 ETLSSEDLDAMIDEIDADGSGTVDFEEFMGVMTGGDE 158

>2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A Length = 158

 Score = 59.9 bits (146), Expect = 5e-11
 Identities = 23/75 (30%), Positives = 41/75 (54%)

Query: 325 ALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAA 384
           A  +  E  P +  Q+L+E F   D + +G ++ D ++  LA+L   L+  D+   +   
Sbjct: 77  ARFLGEEVNPEQMQQELREAFRLYDKEGNGYISTDVMREILAELDETLSSEDLDAMIDEI 136

Query: 385 DIDGNGTIDYIEFIT 399
           D DG+GT+D+ EF+ 
Sbjct: 137 DADGSGTVDFEEFMG 151

>2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143

 Score =  168 bits (429), Expect = 7e-51
 Identities = 45/142 (31%), Positives = 79/142 (55%), Gaps = 3/142 (2%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYI 395
           E+ Q+++E F   D D +GT+   ELK  +  LG    + ++K+ +   D +G G +++ 
Sbjct: 3   EQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFG 62

Query: 396 EFIT-ATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI 454
           +F+T  T +  +    E + KAF+ FD D  G I+   L +  K+  +G++ T   ++E+
Sbjct: 63  DFLTVMTQKMSEKDTKEEILKAFKLFDDDETGKISFKNLKRVAKE--LGENLTDEELQEM 120

Query: 455 MSEVDRDKDGRISYDEFRSMMK 476
           + E DRD DG +S  EF  +MK
Sbjct: 121 IDEADRDGDGEVSEQEFLRIMK 142

>1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195

 Score =  169 bits (431), Expect = 2e-50
 Identities = 39/175 (22%), Positives = 62/175 (35%), Gaps = 23/175 (13%)

Query: 322 KKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAG-----LAKLGSMLTEFD 376
            K A+K+  +      I++ K  F  +D + +G +T DE+ +       AKL +   +  
Sbjct: 3   SKYAVKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTK 62

Query: 377 VKQYMQAADIDGNGT-----IDYIEFITATMQRHKLQR-----------FENLYKAFQYF 420
             Q    A   G G      I + +F+    Q    +             E     F  F
Sbjct: 63  RHQVCVEAFFRGCGMEYGKEIAFPQFLDGWKQLATSELKKWARNEPTLIREWGDAVFDIF 122

Query: 421 DKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMM 475
           DKD +G IT+DE     K  G+    +    +      D D  G +  DE     
Sbjct: 123 DKDGSGTITLDEWKAYGKISGISP--SQEDCEATFRHCDLDNAGDLDVDEMTRQH 175

>1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195

 Score = 65.5 bits (160), Expect = 1e-12
 Identities = 24/87 (27%), Positives = 34/87 (39%)

Query: 316 TAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEF 375
               +L    LK    N PT   +     F   D D SGT+T DE KA     G   ++ 
Sbjct: 90  DGWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQE 149

Query: 376 DVKQYMQAADIDGNGTIDYIEFITATM 402
           D +   +  D+D  G +D  E     +
Sbjct: 150 DCEATFRHCDLDNAGDLDVDEMTRQHL 176

>1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195

 Score = 59.4 bits (144), Expect = 2e-10
 Identities = 14/72 (19%), Positives = 23/72 (31%), Gaps = 8/72 (11%)

Query: 413 LYKAFQYFDKDNNGYITVDELGKAFKDYGM---GDDATIATIKEIMSEVDRDKDG----- 464
               F + D + NG IT+DE+     D                ++  E      G     
Sbjct: 22  HKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGMEYGK 81

Query: 465 RISYDEFRSMMK 476
            I++ +F    K
Sbjct: 82  EIAFPQFLDGWK 93

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  173 bits (441), Expect = 2e-50
 Identities = 81/274 (29%), Positives = 146/274 (53%), Gaps = 11/274 (4%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
            D +L      ++G G  GI  L  E  +G + A K +    L K   ++ +  E+ IMR
Sbjct: 41  GDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMR 97

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVN 148
                 N+V+   +Y   + + ++ME   GG L D IV++   +E   A+V   ++  + 
Sbjct: 98  DYQ-HFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALA 155

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEV 207
             H++GV+HRD+K ++ L T    +  VK +DFG  A I +    R+ +VG+PY++APEV
Sbjct: 156 YLHAQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEV 212

Query: 208 LSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
           +S+S Y  E DIWS G+++  ++ G PP+++++     + +        ++    +S   
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS-HKVSPVL 271

Query: 267 IELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS 300
            + + RML +DP+ R T  ++L+HP+L ++G   
Sbjct: 272 RDFLERMLVRDPQERATAQELLDHPFLLQTGLPE 305

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  173 bits (440), Expect = 3e-50
 Identities = 81/271 (29%), Positives = 132/271 (48%), Gaps = 24/271 (8%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + I R +G G FG  +L      G  +A K + K  +V+  + +    E  ++  ++  P
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HP 66

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSE-RA---AASVFRVIMNVVNVC 150
            I++    ++D Q + ++M+   GGELF  +     +    A   AA V   +  +    
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL---- 122

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-S 209
           HSK +++RDLKPEN L    D+N  +K TDFG +           + G+P YIAPEV+ +
Sbjct: 123 HSKDIIYRDLKPENILL---DKNGHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVST 177

Query: 210 QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
           + Y K  D WS G+++Y +L G  PF+        + IL  E+ F   P P  +    +L
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF---P-PFFNEDVKDL 233

Query: 270 VRRMLTQDPKRRI-----TVAQVLEHPWLKE 295
           + R++T+D  +R+         V  HPW KE
Sbjct: 234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  171 bits (435), Expect = 8e-50
 Identities = 84/281 (29%), Positives = 136/281 (48%), Gaps = 25/281 (8%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
            D +  YT   ++G+G  G  Y   + +TG E A + +    L +  +K+ +  EI +MR
Sbjct: 16  GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 72

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVN 148
                PNIV +  +Y     + +VME  AGG L D +V      E   A+V R  +  + 
Sbjct: 73  ENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALE 130

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEV 207
             HS  V+HRD+K +N L      +  VK TDFG  A I   ++ R  +VG+PY++APEV
Sbjct: 131 FLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187

Query: 208 LSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAI-------LKGEINFQRDPF 259
           +++  YG + DIWS G++   ++ G PP+  E        I       L+          
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL----- 242

Query: 260 PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS 300
              S+   + + R L  D ++R +  ++L+H +LK +   S
Sbjct: 243 ---SAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS 280

>2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179

 Score =  167 bits (425), Expect = 1e-49
 Identities = 54/149 (36%), Positives = 82/149 (55%), Gaps = 3/149 (2%)

Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           + + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DG
Sbjct: 1   MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG 60

Query: 389 NGTIDYIEFIT-ATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
           NGTID+ EF+T    +       E + +AF+ FDKD NGYI+  EL     +  +G+  T
Sbjct: 61  NGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLT 118

Query: 448 IATIKEIMSEVDRDKDGRISYDEFRSMMK 476
              + E++ E D D DG+++Y+EF  MM 
Sbjct: 119 DEEVDEMIREADIDGDGQVNYEEFVQMMT 147

>2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179

 Score = 89.1 bits (222), Expect = 6e-21
 Identities = 28/111 (25%), Positives = 52/111 (46%), Gaps = 7/111 (6%)

Query: 324 LALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQA 383
           +  + + +    EE   ++E F   D D +G ++  EL+  +  LG  LT+ +V + ++ 
Sbjct: 72  MMARKMKDTDSEEE---IREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIRE 128

Query: 384 ADIDGNGTIDYIEFI---TATMQ-RHKLQRFENLYKAFQYFDKDNNGYITV 430
           ADIDG+G ++Y EF+   TA         R E +    +   K    +  +
Sbjct: 129 ADIDGDGQVNYEEFVQMMTAKGGGGGAAARKEVIRNKIRAIGKMARVFSVL 179

>4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 1f54_A 1f55_A Length = 147

 Score =  164 bits (419), Expect = 3e-49
 Identities = 48/150 (32%), Positives = 78/150 (52%), Gaps = 6/150 (4%)

Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           + +NL  E+I + KE F   D DNSG+++  EL   +  LG   +E +V   M   D+DG
Sbjct: 1   MSQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEIDVDG 60

Query: 389 NGTIDYIEFITATMQRHKLQR--FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDA 446
           N  I++ EF+   M R        + L +AF+ FDK+ +G I+  EL        +G+  
Sbjct: 61  NHAIEFSEFLAL-MSRQLKCNDSEQELLEAFKVFDKNGDGLISAAELKHVLTS--IGEKL 117

Query: 447 TIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           T A + E++ EV  D  G I+  +F +++ 
Sbjct: 118 TDAEVDEMLREVS-DGSGEINIKQFAALLS 146

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  172 bits (437), Expect = 7e-49
 Identities = 84/269 (31%), Positives = 131/269 (48%), Gaps = 24/269 (8%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +GRG FG   L    ST   +A K + K +++K  +      E +IM   +  P +VQ  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLF 135

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSE-RA---AASVFRVIMNVVNVCHSKGVM 156
            A++DD+++++VME   GG+L   +++     E  A    A V   +  +    HS G +
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAI----HSMGFI 190

Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE--IVGSPYYIAPEVLSQ---- 210
           HRD+KP+N L    D++  +K  DFG    + +    R    VG+P YI+PEVL      
Sbjct: 191 HRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247

Query: 211 -SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             YG+E D WS GV LY +L G  PF+A++  G    I+  + +        IS  A  L
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 307

Query: 270 VRRMLTQDPKRRIT---VAQVLEHPWLKE 295
           +   LT D + R+    V ++  H + K 
Sbjct: 308 ICAFLT-DREVRLGRNGVEEIKRHLFFKN 335

>2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 142

 Score =  161 bits (411), Expect = 3e-48
 Identities = 36/142 (25%), Positives = 65/142 (45%), Gaps = 4/142 (2%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYI 395
           +++ + KE F   D++ +G +T + L+  L + G  +      +    AD  GNG I + 
Sbjct: 3   DQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEADATGNGKIQFP 62

Query: 396 EFIT-ATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI 454
           EF++    +  +    + L +AF+ FD +  GYI    L  A  +  +GD        E 
Sbjct: 63  EFLSMMGRRMKQTTSEDILRQAFRTFDPEGTGYIPKAALQDALLN--LGDRLKPHEFAEF 120

Query: 455 MSEVDRDKDGRISYDEFRSMMK 476
           +   + +  G+I YD F + M 
Sbjct: 121 LGITETE-KGQIRYDNFINTMF 141

>3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* Length = 155

 Score =  162 bits (412), Expect = 4e-48
 Identities = 44/145 (30%), Positives = 78/145 (53%), Gaps = 8/145 (5%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYI 395
           +EI++L ++F ++D DNSG+L+ +E  +      + L    V++ +   D DGNG +D+ 
Sbjct: 3   DEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQNPL----VQRVIDIFDTDGNGEVDFK 58

Query: 396 EFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDY---GMGDDATIATI 451
           EFI    Q      + + L  AF+ +D D +GYI+  EL +  K      + D      +
Sbjct: 59  EFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIV 118

Query: 452 KEIMSEVDRDKDGRISYDEFRSMMK 476
            + +   D+D DGRIS++EF +++ 
Sbjct: 119 DKTIINADKDGDGRISFEEFCAVVG 143

>3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* Length = 155

 Score = 48.8 bits (117), Expect = 4e-07
 Identities = 21/88 (23%), Positives = 36/88 (40%), Gaps = 8/88 (9%)

Query: 325 ALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL-GSMLTEFDVKQY--- 380
            +         E+  KL+  F   D D  G ++  EL   L  + G+ L +  ++Q    
Sbjct: 63  GVSQFSVKGDKEQ--KLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDK 120

Query: 381 -MQAADIDGNGTIDYIEFITATMQRHKL 407
            +  AD DG+G I + EF    +    +
Sbjct: 121 TIINADKDGDGRISFEEFCAV-VGGLDI 147

>3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* Length = 155

 Score = 44.1 bits (105), Expect = 2e-05
 Identities = 26/132 (19%), Positives = 51/132 (38%), Gaps = 15/132 (11%)

Query: 326 LKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAA- 384
              + E      +Q++       DTD +G + + E   G+++      + D +Q ++ A 
Sbjct: 28  FMSLPELQQNPLVQRV---IDIFDTDGNGEVDFKEFIEGVSQ---FSVKGDKEQKLRFAF 81

Query: 385 ---DIDGNGTIDYIEF--ITATMQRHKL---QRFENLYKAFQYFDKDNNGYITVDELGKA 436
              D+D +G I   E   +   M  + L   Q  + + K     DKD +G I+ +E    
Sbjct: 82  RIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAV 141

Query: 437 FKDYGMGDDATI 448
                +     +
Sbjct: 142 VGGLDIHKKMVV 153

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  167 bits (424), Expect = 4e-48
 Identities = 76/270 (28%), Positives = 130/270 (48%), Gaps = 12/270 (4%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
            D +  +T   ++G+G FG  +   +N T    A K I   +   + E +D+++EI ++ 
Sbjct: 18  ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLS 75

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVN 148
                P + ++  +Y  D  + I+ME   GG   D ++  G   E   A++ R I+  ++
Sbjct: 76  QCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLD 133

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPEV 207
             HS+  +HRD+K  N L +   E+  VK  DFG++  + + +  R   VG+P+++APEV
Sbjct: 134 YLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 190

Query: 208 LSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
           + QS Y  +ADIWS G+    L  G PP        V   I K         +   S   
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNY---SKPL 247

Query: 267 IELVRRMLTQDPKRRITVAQVLEHPWLKES 296
            E V   L ++P  R T  ++L+H ++  +
Sbjct: 248 KEFVEACLNKEPSFRPTAKELLKHKFILRN 277

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  167 bits (426), Expect = 9e-48
 Identities = 78/265 (29%), Positives = 122/265 (46%), Gaps = 19/265 (7%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG   L     TG  +A K + K  +++D + +    E  I+      P + Q  
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSKGVMHR 158
             ++    +  VME   GG+L   I     + E  A   F    I++ +   H KG+++R
Sbjct: 91  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA--RFYAAEIISALMFLHDKGIIYR 148

Query: 159 DLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVLS-QSYGKEA 216
           DLK +N L    D     K  DFG+    I  G       G+P YIAPE+L    YG   
Sbjct: 149 DLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAV 205

Query: 217 DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276
           D W+ GV+LY +LCG  PF AE +  + +AIL  E+ +       +   A  +++  +T+
Sbjct: 206 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGILKSFMTK 261

Query: 277 DPKRRI------TVAQVLEHPWLKE 295
           +P  R+          +L HP+ KE
Sbjct: 262 NPTMRLGSLTQGGEHAILRHPFFKE 286

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  166 bits (422), Expect = 1e-47
 Identities = 60/252 (23%), Positives = 99/252 (39%), Gaps = 28/252 (11%)

Query: 61  FACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGE 120
           +         L      D    +I  M   S   N V          +++I M+LC    
Sbjct: 89  WLKDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKNTVGQLQPSSPKVYLYIQMQLCRKEN 147

Query: 121 LFDRIVARGHYSER---AAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVK 177
           L D +  R    +R       +F  I   V   HSKG+MHRDLKP N  F     + VVK
Sbjct: 148 LKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVK 204

Query: 178 ATDFGLSAFIEEGKAYREI-------------VGSPYYIAPEVLS-QSYGKEADIWSAGV 223
             DFGL   +++ +  + +             VG+  Y++PE +   +Y  + DI+S G+
Sbjct: 205 VGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGL 264

Query: 224 ILYILLCGVPPFWAETDQG-VAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRI 282
           IL+ LL     F  + ++  +   +   +       F         +V+ ML+  P  R 
Sbjct: 265 ILFELLY---SFSTQMERVRIITDVRNLKFP---LLFTQKYPQEHMMVQDMLSPSPTERP 318

Query: 283 TVAQVLEHPWLK 294
               ++E+   +
Sbjct: 319 EATDIIENAIFE 330

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 17/83 (20%), Positives = 36/83 (43%), Gaps = 3/83 (3%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            +   + +GRG FG+ +          +A K I      +++ ++ V RE++ +  L   
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-H 63

Query: 94  PNIVQFKAAYEDDQFVHIVMELC 116
           P IV++  A+ +        E+ 
Sbjct: 64  PGIVRYFNAWLETPPEKWQEEMD 86

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  167 bits (424), Expect = 1e-47
 Identities = 69/260 (26%), Positives = 122/260 (46%), Gaps = 14/260 (5%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG  +L     T   FA K++ K  ++ D + +    E  ++      P +    
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSKGVMHR 158
             ++  + +  VME   GG+L   I +   +    A   F    I+  +   HSKG+++R
Sbjct: 85  CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA--TFYAAEIILGLQFLHSKGIVYR 142

Query: 159 DLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVLS-QSYGKEA 216
           DLK +N L    D++  +K  DFG+    +          G+P YIAPE+L  Q Y    
Sbjct: 143 DLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSV 199

Query: 217 DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276
           D WS GV+LY +L G  PF  + ++ +  +I      + R     +   A +L+ ++  +
Sbjct: 200 DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLLVKLFVR 255

Query: 277 DPKRRITVAQ-VLEHPWLKE 295
           +P++R+ V   + +HP  +E
Sbjct: 256 EPEKRLGVRGDIRQHPLFRE 275

>1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... Length = 148

 Score =  160 bits (407), Expect = 2e-47
 Identities = 56/147 (38%), Positives = 81/147 (55%), Gaps = 5/147 (3%)

Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
           E L  E+I + KE F   D D  GT+T  EL   +  LG   TE +++  +   D DGNG
Sbjct: 2   EQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNG 61

Query: 391 TIDYIEFITATMQRHKLQR--FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           TID+ EF++  M R   ++   E L +AF+ FD+D NG I+  EL     +  +G+  T 
Sbjct: 62  TIDFPEFLSL-MARKMKEQDSEEELIEAFKVFDRDGNGLISAAELRHVMTN--LGEKLTD 118

Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMM 475
             + E++ E D D DG I+Y+EF  MM
Sbjct: 119 DEVDEMIREADIDGDGHINYEEFVRMM 145

>1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... Length = 148

 Score = 59.0 bits (144), Expect = 1e-10
 Identities = 23/64 (35%), Positives = 38/64 (59%)

Query: 341 LKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITA 400
           L E F   D D +G ++  EL+  +  LG  LT+ +V + ++ ADIDG+G I+Y EF+  
Sbjct: 85  LIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADIDGDGHINYEEFVRM 144

Query: 401 TMQR 404
            + +
Sbjct: 145 MVSK 148

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  165 bits (421), Expect = 5e-47
 Identities = 74/264 (28%), Positives = 129/264 (48%), Gaps = 18/264 (6%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG   L     T   +A K + K  +++D + +    E  ++      P + Q  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSKGVMHR 158
           + ++    ++ VME   GG+L   I   G + E  A  VF    I   +    SKG+++R
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA--VFYAAEIAIGLFFLQSKGIIYR 145

Query: 159 DLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVLS-QSYGKEA 216
           DLK +N +    D    +K  DFG+    I +G   +   G+P YIAPE+++ Q YGK  
Sbjct: 146 DLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV 202

Query: 217 DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276
           D W+ GV+LY +L G  PF  E +  + Q+I++  + +   P  S+S  A+ + + ++T+
Sbjct: 203 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KSMSKEAVAICKGLMTK 258

Query: 277 DPKRRI-----TVAQVLEHPWLKE 295
            P +R+         + EH + + 
Sbjct: 259 HPGKRLGCGPEGERDIKEHAFFRY 282

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  168 bits (426), Expect = 5e-47
 Identities = 76/271 (28%), Positives = 124/271 (45%), Gaps = 24/271 (8%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +GRG FG   +    +    FA K + K +++K  E    R E +++ +      I    
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLH 140

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIV-ARGHYSE-RA---AASVFRVIMNVVNVCHSKGV 155
            A++DD  +++VM+   GG+L   +        E  A    A +   I +V    H    
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV----HQLHY 196

Query: 156 MHRDLKPENFLFTTGDENAVVKATDFGLSA-FIEEGKAY-REIVGSPYYIAPEVL----- 208
           +HRD+KP+N L    D N  ++  DFG     +E+G       VG+P YI+PE+L     
Sbjct: 197 VHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253

Query: 209 -SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSA 266
               YG E D WS GV +Y +L G  PF+AE+       I+  +  FQ     + +S +A
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENA 313

Query: 267 IELVRRMLTQDPKR--RITVAQVLEHPWLKE 295
            +L+RR++     R  +  +    +HP+   
Sbjct: 314 KDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  164 bits (416), Expect = 6e-47
 Identities = 81/286 (28%), Positives = 125/286 (43%), Gaps = 28/286 (9%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
            D    + I  E+G G FG  Y      TG   A K I       + E +D   EIEI+ 
Sbjct: 15  LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILA 71

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHY-SERAAASVFRVIMNVV 147
                P IV+   AY  D  + I++E C GG +   ++      +E     V R ++  +
Sbjct: 72  TCD-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEAL 130

Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPE 206
           N  HSK ++HRDLK  N L T       ++  DFG+SA   +    R+  +G+PY++APE
Sbjct: 131 NFLHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187

Query: 207 VLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
           V+         Y  +ADIWS G+ L  +    PP        V   I        +   P
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI-------AKSDPP 240

Query: 261 SI------SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS 300
           ++      S    + ++  L ++P+ R + AQ+LEHP++       
Sbjct: 241 TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  163 bits (415), Expect = 1e-46
 Identities = 69/282 (24%), Positives = 130/282 (46%), Gaps = 27/282 (9%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
           +  +  + +  ++G G +G  Y      TG   A K +P   +  D++  ++ +EI IM+
Sbjct: 25  KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQ--EIIKEISIMQ 79

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHY-SERAAASVFRVIMNVV 147
                P++V++  +Y  +  + IVME C  G + D I  R    +E   A++ +  +  +
Sbjct: 80  QCD-SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGL 138

Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAPE 206
              H    +HRD+K  N L          K  DFG++  + +  A R  ++G+P+++APE
Sbjct: 139 EYLHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE 195

Query: 207 VLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAI-------LKGEINFQRDP 258
           V+ +  Y   ADIWS G+    +  G PP+           I        +    +    
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW---- 251

Query: 259 FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS 300
               S +  + V++ L + P++R T  Q+L+HP+++ +   S
Sbjct: 252 ----SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  163 bits (415), Expect = 2e-46
 Identities = 79/273 (28%), Positives = 134/273 (49%), Gaps = 33/273 (12%)

Query: 41  VGRGEFGITYLC---TENSTGLEFACKSIPKRKLVKDVEKDDV------RREIEIMRHLS 91
           +G+G +G  +     T  +TG  FA K + K  +V++    D       R  +E ++H  
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN--AKDTAHTKAERNILEEVKH-- 80

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNV 149
             P IV    A++    +++++E  +GGELF ++   G + E  A   F +  I   +  
Sbjct: 81  --PFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA--CFYLAEISMALGH 136

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL 208
            H KG+++RDLKPEN +    +    VK TDFGL    I +G       G+  Y+APE+L
Sbjct: 137 LHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEIL 193

Query: 209 S-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267
               + +  D WS G ++Y +L G PPF  E  +     ILK ++N    P P ++  A 
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL---P-PYLTQEAR 249

Query: 268 ELVRRMLTQDPKRRI-----TVAQVLEHPWLKE 295
           +L++++L ++   R+        +V  HP+ + 
Sbjct: 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  163 bits (416), Expect = 2e-46
 Identities = 85/270 (31%), Positives = 137/270 (50%), Gaps = 31/270 (11%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDV------RREIEIMRHLSGQP 94
           +G+G FG   L  E +TG  +A K + K  ++    KD+V       R ++  RH    P
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVII---AKDEVAHTVTESRVLQNTRH----P 65

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHS 152
            +   K A++    +  VME   GGELF  +     ++E  A   F    I++ +   HS
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA--RFYGAEIVSALEYLHS 123

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVLS-Q 210
           + V++RD+K EN +    D++  +K TDFGL    I +G   +   G+P Y+APEVL   
Sbjct: 124 RDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 211 SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV 270
            YG+  D W  GV++Y ++CG  PF+ +  + + + IL  EI F R    ++S  A  L+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLL 236

Query: 271 RRMLTQDPKRRI-----TVAQVLEHPWLKE 295
             +L +DPK+R+        +V+EH +   
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  164 bits (418), Expect = 3e-46
 Identities = 94/394 (23%), Positives = 161/394 (40%), Gaps = 57/394 (14%)

Query: 11  SDHPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRK 70
            D P       A  GK  E  ++ YT  + +G G FG+ +      +  E A K + +  
Sbjct: 18  LDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQ-- 74

Query: 71  LVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDR 124
                +K    RE++IMR +   PN+V  KA +      +D+ F+++V+E      ++  
Sbjct: 75  -----DKRFKNRELQIMRIVK-HPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRA 127

Query: 125 IVARGHYSERAAASVFRVIM----NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD 180
                   +     + ++ M      +   HS G+ HRD+KP+N L      + V+K  D
Sbjct: 128 SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP--PSGVLKLID 185

Query: 181 FGLSAFIEEGKAYREIVGSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE 238
           FG +  +  G+     + S YY APE++  + +Y    DIWS G ++  L+ G P F  E
Sbjct: 186 FGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245

Query: 239 T--DQGVAQAILK----------GEIN----------FQRDPF-----PSISSSAIELVR 271
           +  DQ V   I+K            +N           +  PF     P     AI+L+ 
Sbjct: 246 SGIDQLV--EIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLIS 303

Query: 272 RMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVE 331
           R+L   P  R+T  + L HP+  E      +  +   +  +  +T   +   +   +I  
Sbjct: 304 RLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWT--KEELSVRPDLISR 361

Query: 332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGL 365
            +P     +L  +    D  N   +  + LK  L
Sbjct: 362 LVPQHAEAELLSRGI--DVHNFQPIPLESLKVTL 393

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  170 bits (431), Expect = 4e-46
 Identities = 75/271 (27%), Positives = 122/271 (45%), Gaps = 24/271 (8%)

Query: 39  REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ--PNI 96
           R +GRG FG  Y C +  TG  +A K + K+++     +     E  ++  +S    P I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254

Query: 97  VQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSKG 154
           V    A+     +  +++L  GG+L   +   G +SE      F    I+  +   H++ 
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM--RFYAAEIILGLEHMHNRF 312

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS--QSY 212
           V++RDLKP N L    DE+  V+ +D GL+    + K +   VG+  Y+APEVL    +Y
Sbjct: 313 VVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVAY 368

Query: 213 GKEADIWSAGVILYILLCGVPPFWAETD---QGVAQAILKGEINFQRDPFPSISSSAIEL 269
              AD +S G +L+ LL G  PF          + +  L   +     P  S S     L
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL---P-DSFSPELRSL 424

Query: 270 VRRMLTQDPKRRI-----TVAQVLEHPWLKE 295
           +  +L +D  RR+        +V E P+ + 
Sbjct: 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455

>2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} Length = 211

 Score =  158 bits (402), Expect = 5e-46
 Identities = 40/173 (23%), Positives = 69/173 (39%), Gaps = 7/173 (4%)

Query: 322 KKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLG-SMLTEFDVKQY 380
              ++    + +PT+E       F  M    SG  T  E K  L   G +      + Q 
Sbjct: 5   NGKSIAGDQKAVPTQETHVWYRTF--MMEYPSGLQTLHEFKTLLGLQGLNQKANKHIDQV 62

Query: 381 MQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDY 440
               D + +G +D++EFI A     + +  + L   F+ +D D NG I  +EL   F   
Sbjct: 63  YNTFDTNKDGFVDFLEFIAAVNLIMQEKMEQKLKWYFKLYDADGNGSIDKNELLDMFMAV 122

Query: 441 ----GMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRALSSRSL 489
               G    +    I  +  ++D + DG ++ +EF + M     L  +  +S 
Sbjct: 123 QALNGQQTLSPEEFINLVFHKIDINNDGELTLEEFINGMAKDQDLLEIVYKSF 175

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  169 bits (429), Expect = 5e-46
 Identities = 73/264 (27%), Positives = 129/264 (48%), Gaps = 18/264 (6%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG   L     T   +A K + K  +++D + +    E  ++      P + Q  
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHSKGVMHR 158
           + ++    ++ VME   GG+L   I   G + E  A  VF    I   +    SKG+++R
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA--VFYAAEIAIGLFFLQSKGIIYR 466

Query: 159 DLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVLS-QSYGKEA 216
           DLK +N +    D    +K  DFG+    I +G   +   G+P YIAPE+++ Q YGK  
Sbjct: 467 DLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV 523

Query: 217 DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ 276
           D W+ GV+LY +L G  PF  E +  + Q+I++  + + +    S+S  A+ + + ++T+
Sbjct: 524 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTK 579

Query: 277 DPKRRI-----TVAQVLEHPWLKE 295
            P +R+         + EH + + 
Sbjct: 580 HPGKRLGCGPEGERDIKEHAFFRY 603

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  164 bits (416), Expect = 7e-46
 Identities = 68/270 (25%), Positives = 118/270 (43%), Gaps = 20/270 (7%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +GRG F    +     TG  +A K + K  ++K  E    R E +++ +   +  I Q  
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLH 127

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRD 159
            A++D+ ++++VME   GG+L   +   G       A      I+  ++  H  G +HRD
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRD 187

Query: 160 LKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE--IVGSPYYIAPEVL--------S 209
           +KP+N L    D    ++  DFG    +      R    VG+P Y++PE+L        +
Sbjct: 188 IKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGT 244

Query: 210 QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIE 268
            SYG E D W+ GV  Y +  G  PF+A++       I+  + +         +   A +
Sbjct: 245 GSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARD 304

Query: 269 LVRRMLTQDPKRRIT---VAQVLEHPWLKE 295
            ++R+L   P+ R+          HP+   
Sbjct: 305 FIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  160 bits (408), Expect = 8e-46
 Identities = 71/292 (24%), Positives = 120/292 (41%), Gaps = 28/292 (9%)

Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREI 84
              +   +  Y +   +G G   +           + A K I   K       D++ +EI
Sbjct: 7   ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEI 64

Query: 85  EIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFD--------RIVARGHYSERAA 136
           + M      PNIV +  ++     + +VM+L +GG + D             G   E   
Sbjct: 65  QAMSQCH-HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123

Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE- 195
           A++ R ++  +   H  G +HRD+K  N L     E+  V+  DFG+SAF+  G      
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRN 180

Query: 196 -----IVGSPYYIAPEVLSQS--YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL 248
                 VG+P ++APEV+ Q   Y  +ADIWS G+    L  G  P+       V    L
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL 240

Query: 249 KG------EINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
           +            ++       S  +++   L +DP++R T A++L H + +
Sbjct: 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292

>2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A Length = 226

 Score =  158 bits (401), Expect = 1e-45
 Identities = 41/205 (20%), Positives = 80/205 (39%), Gaps = 13/205 (6%)

Query: 302 KPIDTAVI--FRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTD--NSGTLT 357
           K + T+V+  F +  +     L    L          EI+ L E F ++ +   + G + 
Sbjct: 9   KHLCTSVLGCFDLDLYKQSGGLGDPELLARDTVFSVSEIEALYELFKKISSAVIDDGLIN 68

Query: 358 YDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITA-TMQRHKLQRFENLYKA 416
            +E +  L K     + F   +     D   NG + + EF  A ++        + ++ +
Sbjct: 69  KEEFQLALFKTNKKESLF-ADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFS 127

Query: 417 FQYFDKDNNGYITVDELGKAFKDY------GMGDDATIATIKEIMSEVDRDKDGRISYDE 470
           FQ +D    G+I   E+ +            + D      I +   E D   DG+I  +E
Sbjct: 128 FQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKIDKEE 187

Query: 471 FRSMMKCGTQ-LRALSSRSLAHVVT 494
           +RS++      L+ ++ + L  + T
Sbjct: 188 WRSLVLRHPSLLKNMTLQYLKDITT 212

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  162 bits (412), Expect = 1e-45
 Identities = 74/264 (28%), Positives = 125/264 (47%), Gaps = 21/264 (7%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG   L    +  + +A K + K+ ++K  E+  +  E  ++      P +V   
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSE-RA---AASVFRVIMNVVNVCHSKGVM 156
            +++    ++ V++   GGELF  +     + E RA   AA     I + +   HS  ++
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE----IASALGYLHSLNIV 161

Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL-SQSYGK 214
           +RDLKPEN L    D    +  TDFGL    IE         G+P Y+APEVL  Q Y +
Sbjct: 162 YRDLKPENILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDR 218

Query: 215 EADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRML 274
             D W  G +LY +L G+PPF++     +   IL   +  +    P+I++SA  L+  +L
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLL 274

Query: 275 TQDPKRRI----TVAQVLEHPWLK 294
            +D  +R+       ++  H +  
Sbjct: 275 QKDRTKRLGAKDDFMEIKSHVFFS 298

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  161 bits (409), Expect = 2e-45
 Identities = 71/272 (26%), Positives = 119/272 (43%), Gaps = 24/272 (8%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +GRG +    L     T   +A K + K  +  D + D V+ E  +    S  P +V   
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
           + ++ +  +  V+E   GG+L   +  +    E  A      I   +N  H +G+++RDL
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 136

Query: 161 KPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVLS-QSYGKEADI 218
           K +N L    D    +K TD+G+    +  G       G+P YIAPE+L  + YG   D 
Sbjct: 137 KLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 193

Query: 219 WSAGVILYILLCGVPPFWAETDQGVA---------QAILKGEINFQRDPFPSISSSAIEL 269
           W+ GV+++ ++ G  PF                  Q IL+ +I   R    S+S  A  +
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAASV 249

Query: 270 VRRMLTQDPKRRI------TVAQVLEHPWLKE 295
           ++  L +DPK R+        A +  HP+ + 
Sbjct: 250 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  160 bits (407), Expect = 3e-45
 Identities = 74/274 (27%), Positives = 131/274 (47%), Gaps = 37/274 (13%)

Query: 41  VGRGEFGITYLC---TENSTGLEFACKSIPKRKLVKDVEKDDV-----RREIEIMRHLSG 92
           +G+G FG  +L    + +     +A K + K  L     +D V     R  +  + H   
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV---RDRVRTKMERDILVEVNH--- 85

Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSE-RA---AASVFRVIMNVVN 148
            P IV+   A++ +  ++++++   GG+LF R+     ++E       A +   + ++  
Sbjct: 86  -PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL-- 142

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEV 207
             HS G+++RDLKPEN L    DE   +K TDFGLS   I+  K      G+  Y+APEV
Sbjct: 143 --HSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197

Query: 208 LS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
           ++ + + + AD WS GV+++ +L G  PF  +  +     ILK ++     P   +S  A
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM---P-QFLSPEA 253

Query: 267 IELVRRMLTQDPKRRI-----TVAQVLEHPWLKE 295
             L+R +  ++P  R+      V ++  H +   
Sbjct: 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  160 bits (406), Expect = 3e-45
 Identities = 75/291 (25%), Positives = 117/291 (40%), Gaps = 17/291 (5%)

Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREI 84
           G+ Y+          E+G G  G  +      TG   A K + +       E   +  ++
Sbjct: 17  GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDL 74

Query: 85  EIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
           +++      P IVQ    +  +  V I MEL        +   +G   ER    +   I+
Sbjct: 75  DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIV 134

Query: 145 NVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI 203
             +     K GV+HRD+KP N L    DE   +K  DFG+S  + + KA     G   Y+
Sbjct: 135 KALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYM 191

Query: 204 APEVLS------QSYGKEADIWSAGVILYILLCGVPPFWA-ETDQGVAQAILKGEINFQR 256
           APE +         Y   AD+WS G+ L  L  G  P+   +TD  V   +L+ E     
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP 251

Query: 257 DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTA 307
                 S      V+  LT+D ++R    ++LEH ++K         +D A
Sbjct: 252 GH-MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK---RYETLEVDVA 298

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  160 bits (406), Expect = 3e-45
 Identities = 78/310 (25%), Positives = 133/310 (42%), Gaps = 35/310 (11%)

Query: 11  SDHPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRK 70
           +    AR L +  L  A  D    + +   VG G +G  Y      TG   A K +    
Sbjct: 3   ASDSPARSLDEIDLS-ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--- 58

Query: 71  LVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH------IVMELCAGGELFD- 123
            V   E++++++EI +++  S   NI  +  A+             +VME C  G + D 
Sbjct: 59  -VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117

Query: 124 -RIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG 182
            +        E   A + R I+  ++  H   V+HRD+K +N L T   ENA VK  DFG
Sbjct: 118 IKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFG 174

Query: 183 LSAFIEEGKAYRE-IVGSPYYIAPEVLSQ------SYGKEADIWSAGVILYILLCGVPPF 235
           +SA ++     R   +G+PY++APEV++       +Y  ++D+WS G+    +  G PP 
Sbjct: 175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

Query: 236 WAETDQGVAQAILKGEINFQRDPFPSI-----SSSAIELVRRMLTQDPKRRITVAQVLEH 290
                      I        R+P P +     S      +   L ++  +R    Q+++H
Sbjct: 235 CDMHPMRALFLI-------PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287

Query: 291 PWLKESGEAS 300
           P++++     
Sbjct: 288 PFIRDQPNER 297

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  165 bits (419), Expect = 5e-45
 Identities = 73/269 (27%), Positives = 128/269 (47%), Gaps = 24/269 (8%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +G+G FG    C   +TG  +ACK + K+++ K   +     E +I+  ++    +V   
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLA 250

Query: 101 AAYEDDQFVHIVMELCAGGELFDRI--VARGHYSERAAASVFRV--IMNVVNVCHSKGVM 156
            AYE    + +V+ L  GG+L   I  + +  + E  A  VF    I   +   H + ++
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA--VFYAAEICCGLEDLHRERIV 308

Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSYGKE 215
           +RDLKPEN L    D++  ++ +D GL+  + EG+  +  VG+  Y+APEV+  + Y   
Sbjct: 309 YRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365

Query: 216 ADIWSAGVILYILLCGVPPFWAETDQG----VAQAILKGEINFQRDPFPSISSSAIELVR 271
            D W+ G +LY ++ G  PF     +     V + + +    +        S  A  L  
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE----RFSPQARSLCS 421

Query: 272 RMLTQDPKRRI-----TVAQVLEHPWLKE 295
           ++L +DP  R+     +  +V EHP  K+
Sbjct: 422 QLLCKDPAERLGCRGGSAREVKEHPLFKK 450

>2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208

 Score =  155 bits (394), Expect = 5e-45
 Identities = 27/170 (15%), Positives = 62/170 (36%), Gaps = 24/170 (14%)

Query: 327 KVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD---------V 377
           +  VE+L  + + +L ++F   D D+ G +  DE+     ++  ++   D         V
Sbjct: 24  QFNVEDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAV 83

Query: 378 KQYMQAADIDGNGTIDYIEFITATMQRHKLQRF-----------ENLYKAFQYFDKDNNG 426
           + +     ++    +   +++ A     + +R                  +   D D +G
Sbjct: 84  RVFFLHKGVEPVNGLLREDWVEANRVFAEAERERERRGEPSLIALLSNSYYDVLDDDGDG 143

Query: 427 YITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
            + VDEL    K + +  +           + D DK G++   E   + +
Sbjct: 144 TVDVDELKTMMKAFDVPQE----AAYTFFEKADTDKSGKLERTELVHLFR 189

>2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208

 Score = 57.9 bits (140), Expect = 6e-10
 Identities = 15/85 (17%), Positives = 30/85 (35%), Gaps = 2/85 (2%)

Query: 316 TAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEF 375
            A     +   +      P+         +  +D D  GT+  DELK  +      + + 
Sbjct: 105 EANRVFAEAERERERRGEPSLIALLSNSYYDVLDDDGDGTVDVDELKTMMKAFD--VPQE 162

Query: 376 DVKQYMQAADIDGNGTIDYIEFITA 400
               + + AD D +G ++  E +  
Sbjct: 163 AAYTFFEKADTDKSGKLERTELVHL 187

>2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208

 Score = 57.1 bits (138), Expect = 1e-09
 Identities = 22/119 (18%), Positives = 40/119 (33%), Gaps = 13/119 (10%)

Query: 338 IQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD-------VKQYMQAA----DI 386
              ++  F     +    L  ++             E +       +     +     D 
Sbjct: 80  RDAVRVFFLHKGVEPVNGLLREDWVEANRVFAEAERERERRGEPSLIALLSNSYYDVLDD 139

Query: 387 DGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDD 445
           DG+GT+D  E  T  M+   + + E  Y  F+  D D +G +   EL   F+ + M   
Sbjct: 140 DGDGTVDVDELKTM-MKAFDVPQ-EAAYTFFEKADTDKSGKLERTELVHLFRKFWMEPY 196

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  158 bits (402), Expect = 2e-44
 Identities = 67/281 (23%), Positives = 117/281 (41%), Gaps = 23/281 (8%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
           +D +  ++  RE+G G FG  Y   +       A K +       + +  D+ +E+  ++
Sbjct: 50  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVN 148
            L   PN +Q++  Y  +    +VME C G       V +    E   A+V    +  + 
Sbjct: 110 KLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 168

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL 208
             HS  ++HRD+K  N L +   E  +VK  DFG ++ +    A    VG+PY++APEV+
Sbjct: 169 YLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIM--APA-NSFVGTPYWMAPEVI 222

Query: 209 SQS----YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI-- 262
                  Y  + D+WS G+    L    PP +          I +       +  P++  
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------NES-PALQS 275

Query: 263 ---SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS 300
              S      V   L + P+ R T   +L+H ++      +
Sbjct: 276 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 316

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  159 bits (405), Expect = 2e-44
 Identities = 71/272 (26%), Positives = 122/272 (44%), Gaps = 24/272 (8%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +GRG +    L     T   +A + + K  +  D + D V+ E  +    S  P +V   
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDL 160
           + ++ +  +  V+E   GG+L   +  +    E  A      I   +N  H +G+++RDL
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 179

Query: 161 KPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVLS-QSYGKEADI 218
           K +N L    D    +K TD+G+    +  G       G+P YIAPE+L  + YG   D 
Sbjct: 180 KLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 236

Query: 219 WSAGVILYILLCGVPPFW---------AETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
           W+ GV+++ ++ G  PF            T+  + Q IL+ +I     P  S+S  A  +
Sbjct: 237 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P-RSLSVKAASV 292

Query: 270 VRRMLTQDPKRRI------TVAQVLEHPWLKE 295
           ++  L +DPK R+        A +  HP+ + 
Sbjct: 293 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  157 bits (400), Expect = 3e-44
 Identities = 69/282 (24%), Positives = 115/282 (40%), Gaps = 24/282 (8%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+GRG +G         +G   A K I     V + E+  +  +++++   S  P IVQF
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRST--VDEKEQKQLLMDLDVVMRSSDCPYIVQF 86

Query: 100 KAAYEDDQFVHIVMELCAGGELFDRIVAR------GHYSERAAASVFRVIMNVVNVCHSK 153
             A   +    I MEL +    FD+              E     +    +  +N     
Sbjct: 87  YGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144

Query: 154 G-VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS- 211
             ++HRD+KP N L      +  +K  DFG+S  + +  A     G   Y+APE +  S 
Sbjct: 145 LKIIHRDIKPSNILLD---RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA 201

Query: 212 ----YGKEADIWSAGVILYILLCGVPPFWA-ETDQGVAQAILKGEI-NFQRDPFPSISSS 265
               Y   +D+WS G+ LY L  G  P+    +       ++KG+            S S
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPS 261

Query: 266 AIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTA 307
            I  V   LT+D  +R    ++L+HP++       ++ ++ A
Sbjct: 262 FINFVNLCLTKDESKRPKYKELLKHPFIL---MYEERAVEVA 300

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  162 bits (411), Expect = 4e-44
 Identities = 68/279 (24%), Positives = 124/279 (44%), Gaps = 41/279 (14%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK 100
           +GRG FG  + C   +TG  +ACK + K++L K         E +I+  +     IV   
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLA 251

Query: 101 AAYEDDQFVHIVMELCAGGELFDRIVARGHYS-----ERA---AASVFRVIMNVVNVC-- 150
            A+E    + +VM +  GG++   I      +      RA    A +         V   
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI---------VSGL 302

Query: 151 ---HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPE 206
              H + +++RDLKPEN L    D++  V+ +D GL+          +   G+P ++APE
Sbjct: 303 EHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE 359

Query: 207 VL-SQSYGKEADIWSAGVILYILLCGVPPFWAE----TDQGVAQAILKGEINFQRDPFPS 261
           +L  + Y    D ++ GV LY ++    PF A      ++ + Q +L+  + +   P   
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY---P-DK 415

Query: 262 ISSSAIELVRRMLTQDPKRRI-----TVAQVLEHPWLKE 295
            S ++ +    +L +DP++R+     +   +  HP  ++
Sbjct: 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  160 bits (406), Expect = 4e-44
 Identities = 85/270 (31%), Positives = 138/270 (51%), Gaps = 32/270 (11%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDV------RREIEIMRHLSGQP 94
           +G+G FG   L  E +TG  +A K + K  +V    KD+V       R ++  RH    P
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIV---AKDEVAHTLTENRVLQNSRH----P 208

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV--IMNVVNVCHS 152
            +   K +++    +  VME   GGELF  +     +SE  A   F    I++ ++  HS
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA--RFYGAEIVSALDYLHS 266

Query: 153 -KGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVLS- 209
            K V++RDLK EN +    D++  +K TDFGL    I++G   +   G+P Y+APEVL  
Sbjct: 267 EKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 323

Query: 210 QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
             YG+  D W  GV++Y ++CG  PF+ +  + + + IL  EI F R    ++   A  L
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSL 379

Query: 270 VRRMLTQDPKRRI-----TVAQVLEHPWLK 294
           +  +L +DPK+R+        ++++H +  
Sbjct: 380 LSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  157 bits (399), Expect = 2e-43
 Identities = 80/341 (23%), Positives = 139/341 (40%), Gaps = 63/341 (18%)

Query: 31  VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSI---PKRKLVKDVEKDDVRREIEIM 87
            ++ YT  + +G G FG+ Y      +G   A K +    + K           RE++IM
Sbjct: 52  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----------RELQIM 101

Query: 88  RHLSGQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFR 141
           R L    NIV+ +  +      +D+ ++++V++      ++          +       +
Sbjct: 102 RKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVK 159

Query: 142 VIM----NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV 197
           + M      +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     +
Sbjct: 160 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSYI 217

Query: 198 GSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAET--DQGVAQAILK---- 249
            S YY APE++  +  Y    D+WSAG +L  LL G P F  ++  DQ V   I+K    
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV--EIIKVLGT 275

Query: 250 ------GEIN----------FQRDPF-----PSISSSAIELVRRMLTQDPKRRITVAQVL 288
                  E+N           +  P+     P     AI L  R+L   P  R+T  +  
Sbjct: 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335

Query: 289 EHPWLKESGEASDKPIDTAVI-----FRMKQFTAMNKLKKL 324
            H +  E  + + K  +         F  ++ ++   L  +
Sbjct: 336 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI 376

>1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174

 Score =  150 bits (380), Expect = 3e-43
 Identities = 28/157 (17%), Positives = 52/157 (33%), Gaps = 20/157 (12%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTE-----------FDVKQYMQAA 384
             +QK+K  F  +D D  G +T  + ++   +                            
Sbjct: 3   LWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLT 62

Query: 385 DIDGNGTIDYIEFITATMQRHKLQRFENLYK-----AFQYFDKDNNGYITVDELGKAFKD 439
            + G   ID   FI +  +  K    +++ +      F+  D + +  I+ DE G  F  
Sbjct: 63  AVAGGKGIDETTFINSMKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGM 122

Query: 440 YGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
            G+               +D + DG +S +EF     
Sbjct: 123 LGLDKT----MAPASFDAIDTNNDGLLSLEEFVIAGS 155

>1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174

 Score = 66.7 bits (163), Expect = 3e-13
 Identities = 19/139 (13%), Positives = 45/139 (32%), Gaps = 14/139 (10%)

Query: 321 LKKLALKVIVE-NLPTEEIQKLKEKFTEM------DTDNSGTLTYDELKAGLAKLGSMLT 373
            + +A +   E  +  E  + L +  T +             +        + ++     
Sbjct: 28  FESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVAGGKGIDETTFINSMKEMVKNPE 87

Query: 374 EFD-VKQYMQAA----DIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYI 428
               V+  +       D + +  I   E+         L +      +F   D +N+G +
Sbjct: 88  AKSVVEGPLPLFFRAVDTNEDNNISRDEYGIF-FGMLGLDK-TMAPASFDAIDTNNDGLL 145

Query: 429 TVDELGKAFKDYGMGDDAT 447
           +++E   A  D+ M D  +
Sbjct: 146 SLEEFVIAGSDFFMNDGDS 164

>2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A Length = 207

 Score =  150 bits (381), Expect = 4e-43
 Identities = 34/200 (17%), Positives = 78/200 (39%), Gaps = 13/200 (6%)

Query: 307 AVIFRMKQFTAMNKLKKLALKVIVE--NLPTEEIQKLKEKFTEMDTD--NSGTLTYDELK 362
             + + K+  AM        +++        EE++ L E F ++ +   + G +  +E +
Sbjct: 3   CSVSKKKKKNAMRPPGYEDPELLASVTPFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQ 62

Query: 363 AGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITA-TMQRHKLQRFENLYKAFQYFD 421
             L +  +    F   +     D+  NG I++ EF+ +  +        E +  AF+ +D
Sbjct: 63  LALFRNRNRRNLF-ADRIFDVFDVKRNGVIEFGEFVRSLGVFHPSAPVHEKVKFAFKLYD 121

Query: 422 KDNNGYITVDELGKAFKDYGMGDDATI------ATIKEIMSEVDRDKDGRISYDEFRSMM 475
               G+I  +EL +         +  +        + +   + DR  DG+I  DE++  +
Sbjct: 122 LRQTGFIEREELKEMVVALLHESELVLSEDMIEVMVDKAFVQADRKNDGKIDIDEWKDFV 181

Query: 476 KCGTQ-LRALSSRSLAHVVT 494
                 ++ ++   L  +  
Sbjct: 182 SLNPSLIKNMTLPYLKDINR 201

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  152 bits (387), Expect = 1e-42
 Identities = 77/305 (25%), Positives = 126/305 (41%), Gaps = 47/305 (15%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHL 90
           Y    ++G G +G+ + C    TG   A K     K ++  +   ++    REI +++ L
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLKQL 59

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVN 148
              PN+V     +   + +H+V E C        DR   +    E    S+    +  VN
Sbjct: 60  K-HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVN 116

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEV 207
            CH    +HRD+KPEN L     +++V+K  DFG +         Y + V + +Y +PE+
Sbjct: 117 FCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173

Query: 208 L--SQSYGKEADIWSAGVILYILLCGVPPF--WAETDQ-----------------GVAQA 246
           L     YG   D+W+ G +   LL GVP +   ++ DQ                   +  
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233

Query: 247 ILKGEINFQ--------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298
                +              FP+IS  A+ L++  L  DP  R+T  Q+L HP+ +   E
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293

Query: 299 ASDKP 303
             D  
Sbjct: 294 IEDLA 298

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  151 bits (384), Expect = 2e-42
 Identities = 67/277 (24%), Positives = 118/277 (42%), Gaps = 22/277 (7%)

Query: 40  EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF 99
           E+GRG +G+        +G   A K I  R  V   E+  +  +++I       P  V F
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71

Query: 100 KAAYEDDQFVHIVMELCAGG--ELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKG-V 155
             A   +  V I MEL      + + +++ +     E     +   I+  +   HSK  V
Sbjct: 72  YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131

Query: 156 MHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-----Q 210
           +HRD+KP N L    +    VK  DFG+S ++ +  A     G   Y+APE ++     +
Sbjct: 132 IHRDVKPSNVLI---NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQK 188

Query: 211 SYGKEADIWSAGVILYILLCGVPPFWA-ETDQGVAQAILKGEI-NFQRDPFPSISSSAIE 268
            Y  ++DIWS G+ +  L     P+ +  T     + +++        D F   S+  ++
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF---SAEFVD 245

Query: 269 LVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPID 305
              + L ++ K R T  ++++HP+         K  D
Sbjct: 246 FTSQCLKKNSKERPTYPELMQHPFFT---LHESKGTD 279

>1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 Length = 191

 Score =  147 bits (373), Expect = 4e-42
 Identities = 32/151 (21%), Positives = 65/151 (43%), Gaps = 8/151 (5%)

Query: 332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGT 391
                + Q+L E F  +DTD SG ++  EL A L+  G   +    ++ +   D + +G 
Sbjct: 20  ARHMNDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGE 79

Query: 392 IDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATI 451
           I + EF         ++      + F+  D   +G +  +E+  A      G   +  T 
Sbjct: 80  ITFDEFKDLHHFILSMR------EGFRKRDSSGDGRLDSNEVRAALLS--SGYQVSEQTF 131

Query: 452 KEIMSEVDRDKDGRISYDEFRSMMKCGTQLR 482
           + +M + DR + G + +D++  +     ++R
Sbjct: 132 QALMRKFDRQRRGSLGFDDYVELSIFVCRVR 162

>1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 Length = 191

 Score = 86.2 bits (214), Expect = 8e-20
 Identities = 18/94 (19%), Positives = 43/94 (45%), Gaps = 6/94 (6%)

Query: 338 IQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEF 397
           I  ++E F + D+   G L  +E++A L   G  ++E   +  M+  D    G++ + ++
Sbjct: 92  ILSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQRRGSLGFDDY 151

Query: 398 ITATMQRHKLQRFENLYKAFQYFDKDNNGYITVD 431
           +  ++          +   F ++D++  G +T  
Sbjct: 152 VELSI------FVCRVRNVFAFYDRERTGQVTFT 179

>1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 Length = 191

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 16/80 (20%), Positives = 27/80 (33%), Gaps = 11/80 (13%)

Query: 325 ALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAA 384
           AL      +  +  Q L  KF   D    G+L +D+       +  +   F         
Sbjct: 118 ALLSSGYQVSEQTFQALMRKF---DRQRRGSLGFDDYVELSIFVCRVRNVFAFY------ 168

Query: 385 DIDGNG--TIDYIEFITATM 402
           D +  G  T  +  FI  ++
Sbjct: 169 DRERTGQVTFTFDTFIGGSV 188

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  152 bits (385), Expect = 7e-42
 Identities = 75/277 (27%), Positives = 140/277 (50%), Gaps = 33/277 (11%)

Query: 41  VGRGEFGITYLC---TENSTGLEFACKSIPKRKLV-KDVEKDDVRREIEIMRHLSGQPNI 96
           +G G +G  +L    + + TG  +A K + K  +V K    +  R E +++ H+   P +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 97  VQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSE-RA---AASVFRVIMNVVNVCHS 152
           V    A++ +  +H++++   GGELF  +  R  ++E         +   + ++    H 
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHL----HK 177

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLS--AFIEEGKAYREIVGSPYYIAPEVL-- 208
            G+++RD+K EN L    D N  V  TDFGLS     +E +   +  G+  Y+AP+++  
Sbjct: 178 LGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 234

Query: 209 -SQSYGKEADIWSAGVILYILLCGVPPFWAETDQG----VAQAILKGEINFQRDPFPSIS 263
               + K  D WS GV++Y LL G  PF  + ++     +++ ILK E  +   P   +S
Sbjct: 235 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---P-QEMS 290

Query: 264 SSAIELVRRMLTQDPKRRI-----TVAQVLEHPWLKE 295
           + A +L++R+L +DPK+R+        ++ EH + ++
Sbjct: 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  151 bits (383), Expect = 2e-41
 Identities = 55/354 (15%), Positives = 118/354 (33%), Gaps = 63/354 (17%)

Query: 27  AYEDVQLHYTIGREVGRGE--FGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREI 84
           ++      Y +   +G+G        L     TG     + I       +     ++ E+
Sbjct: 19  SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE-MVTFLQGEL 77

Query: 85  EIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFD--RIVARGHYSERAAASVFRV 142
            + +  +  PNIV ++A +  D  + +V    A G   D          +E A A + + 
Sbjct: 78  HVSKLFN-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQG 136

Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR-------- 194
           ++  ++  H  G +HR +K  + L +    +  V  +    +  +      +        
Sbjct: 137 VLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193

Query: 195 EIVGSPYYIAPEVLSQS---YGKEADIWSAGVILYILLCGVPPF---------------- 235
             V    +++PEVL Q+   Y  ++DI+S G+    L  G  PF                
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253

Query: 236 --------------------WAETDQGVAQAILKGEINFQRDPFPSI------SSSAIEL 269
                                +  + G++ ++            PS       S      
Sbjct: 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHF 313

Query: 270 VRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKK 323
           V + L ++P  R + + +L H + K+    + + +   ++  +   T     + 
Sbjct: 314 VEQCLQRNPDARPSASTLLNHSFFKQIKRRASEAL-PELLRPVTPITNFEGSQS 366

>2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B Length = 166

 Score =  145 bits (367), Expect = 2e-41
 Identities = 32/154 (20%), Positives = 57/154 (37%), Gaps = 8/154 (5%)

Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           +       EI+  KE FT +D +  G +  D+L+   A +G +  + +    M     + 
Sbjct: 15  VFSMFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAM---IKEA 71

Query: 389 NGTIDYIEFITATMQRHKLQR--FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDA 446
           +G I++  F+T             + +  AF+  D D  G I    L +       G   
Sbjct: 72  SGPINFTVFLTM-FGEKLKGADPEDVIMGAFKVLDPDGKGSIKKSFLEELLTT--GGGRF 128

Query: 447 TIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ 480
           T   IK + +    D  G + Y     ++  G  
Sbjct: 129 TPEEIKNMWAAFPPDVAGNVDYKNICYVITHGED 162

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  150 bits (381), Expect = 2e-41
 Identities = 71/325 (21%), Positives = 122/325 (37%), Gaps = 52/325 (16%)

Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREI 84
            K  E     +    E+G G  G+ +  +   +GL  A K I     +K   ++ + RE+
Sbjct: 25  QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIREL 82

Query: 85  EIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
           +++ H    P IV F  A+  D  + I ME   GG L   +   G   E+    V   ++
Sbjct: 83  QVL-HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 141

Query: 145 NVVNVCHSKG-VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI 203
             +     K  +MHRD+KP N L    +    +K  DFG+S  + +  A    VG+  Y+
Sbjct: 142 KGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 197

Query: 204 APEVLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
           +PE L  + Y  ++DIWS G+ L  +  G  P      + +             +  P  
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257

Query: 263 ----------------------------------------SSSAIELVRRMLTQDPKRRI 282
                                                   S    + V + L ++P  R 
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 317

Query: 283 TVAQVLEHPWLKESGEASDKPIDTA 307
            + Q++ H ++K    +  + +D A
Sbjct: 318 DLKQLMVHAFIK---RSDAEEVDFA 339

>1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... Length = 156

 Score =  141 bits (359), Expect = 2e-40
 Identities = 31/158 (19%), Positives = 73/158 (46%), Gaps = 10/158 (6%)

Query: 325 ALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAA 384
           A   ++  LP ++IQ++KE F+ +D D  G ++ +++KA   +LG    + ++   ++  
Sbjct: 4   AASGVLTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK-- 61

Query: 385 DIDGNGTIDYIEFITATMQRHKLQR--FENLYKAFQYFDKDNNGYITVDELGKAFKDYGM 442
             +  G +++  F++             E +  AF  FD+     + ++ +    ++  M
Sbjct: 62  --EAPGPLNFTMFLSI-FSDKLSGTDSEETIRNAFAMFDEQETKKLNIEYIKDLLEN--M 116

Query: 443 GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ 480
           GD+     ++    E   +  G+  Y +F +M+K   +
Sbjct: 117 GDNFNKDEMRMTFKEAPVE-GGKFDYVKFTAMIKGSGE 153

>3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} Length = 143

 Score =  140 bits (356), Expect = 4e-40
 Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 9/150 (6%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
               +IQ+ KE F  +D +  G +  ++L   LA +G   T+  ++  M     +  G I
Sbjct: 1   FDQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEYLEGMMS----EAPGPI 56

Query: 393 DYIEFITATMQRHKLQR--FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIAT 450
           ++  F+T             + +  AF  FD++ +G+I  D L +      MGD  T   
Sbjct: 57  NFTMFLTM-FGEKLNGTDPEDVIRNAFACFDEEASGFIHEDHLRELLTT--MGDRFTDEE 113

Query: 451 IKEIMSEVDRDKDGRISYDEFRSMMKCGTQ 480
           + E+  E   DK G  +Y EF  ++K G +
Sbjct: 114 VDEMYREAPIDKKGNFNYVEFTRILKHGAK 143

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  146 bits (371), Expect = 4e-40
 Identities = 71/305 (23%), Positives = 120/305 (39%), Gaps = 51/305 (16%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHL 90
           Y     VG G +G+   C    TG   A K     K ++  +   V+    REI++++ L
Sbjct: 27  YENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLLKQL 81

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVN 148
               N+V      +  +  ++V E       +  +          +        I+N + 
Sbjct: 82  R-HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIG 138

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEV 207
            CHS  ++HRD+KPEN L     ++ VVK  DFG +      G+ Y + V + +Y APE+
Sbjct: 139 FCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195

Query: 208 L--SQSYGKEADIWSAGVILYILLCGVPPFWA--ETDQ-----------------GVAQA 246
           L     YGK  D+W+ G ++  +  G P F    + DQ                    + 
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK- 254

Query: 247 ILKGEINFQ----------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
                   +             +P +S   I+L ++ L  DP +R   A++L H + +  
Sbjct: 255 -NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313

Query: 297 GEASD 301
           G A  
Sbjct: 314 GFAER 318

>1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 Length = 176

 Score =  140 bits (355), Expect = 1e-39
 Identities = 30/165 (18%), Positives = 57/165 (34%), Gaps = 27/165 (16%)

Query: 335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL----GSMLTEFDVKQYM--------- 381
                +LK++F   D D +G L   + +     +    G      +V+            
Sbjct: 3   AIASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDY 62

Query: 382 --QAADIDGNGTIDYIEFITATMQRHKLQRFEN--------LYKAFQYFDKDNNGYITVD 431
             + A +  +G++   +FI  T      Q   +        +       DK+ +G I  D
Sbjct: 63  LAKEAGVGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINAD 122

Query: 432 ELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           E        GM          E  ++VD + +G +S DE  + ++
Sbjct: 123 EFAAWLTALGMSKA----EAAEAFNQVDTNGNGELSLDELLTAVR 163

>1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 Length = 176

 Score = 67.1 bits (164), Expect = 2e-13
 Identities = 27/131 (20%), Positives = 50/131 (38%), Gaps = 18/131 (13%)

Query: 331 ENLPTEEIQKLKEKFT--------EMDTDNSGTLTYDELKAGLAKLGSMLTEFD----VK 378
           ++    E+Q LK  F         E    + G+LT ++       L     E      + 
Sbjct: 42  KDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFIRVTENLIFEQGEASFNRVLG 101

Query: 379 QYMQAA----DIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELG 434
             ++      D + +G I+  EF    +    + +     +AF   D + NG +++DEL 
Sbjct: 102 PVVKGIVGMCDKNADGQINADEFAAW-LTALGMSK-AEAAEAFNQVDTNGNGELSLDELL 159

Query: 435 KAFKDYGMGDD 445
            A +D+  G  
Sbjct: 160 TAVRDFHFGRL 170

>3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A Length = 229

 Score =  142 bits (359), Expect = 1e-39
 Identities = 42/206 (20%), Positives = 84/206 (40%), Gaps = 14/206 (6%)

Query: 282 ITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKL 341
           + +  VL    L++ G   +  ++ +V   ++  T  ++ + L L         +E+Q L
Sbjct: 11  VLIVIVLFVKLLEQFG-LIEAGLEDSVEDELEMATVRHRPEALELLEAQSKFTKKELQIL 69

Query: 342 KEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYM-QAADIDGNGTIDYIEFITA 400
              F   +   SG +  +  K   ++            ++  A D D NG + + +FI  
Sbjct: 70  YRGF--KNECPSGVVNEETFKEIYSQFFPQGDSTTYAHFLFNAFDTDHNGAVSFEDFIKG 127

Query: 401 TMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFK----------DYGMGDDATIAT 450
                +    E L  AF  +D + +GYIT +E+    K             + +DA    
Sbjct: 128 LSILLRGTVQEKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQH 187

Query: 451 IKEIMSEVDRDKDGRISYDEFRSMMK 476
           ++    ++D++KDG ++ DEF    +
Sbjct: 188 VETFFQKMDKNKDGVVTIDEFIESCQ 213

>3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A Length = 229

 Score = 49.5 bits (118), Expect = 6e-07
 Identities = 20/95 (21%), Positives = 40/95 (42%), Gaps = 18/95 (18%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD------------VKQYMQAADI 386
           +KL   F   D +  G +T +E+   +  +  M+ +              V+ + Q  D 
Sbjct: 138 EKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDK 197

Query: 387 DGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFD 421
           + +G +   EFI +       Q+ EN+ ++ Q F+
Sbjct: 198 NKDGVVTIDEFIES------CQKDENIMRSMQLFE 226

>2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} Length = 198

 Score =  141 bits (356), Expect = 1e-39
 Identities = 45/172 (26%), Positives = 71/172 (41%), Gaps = 10/172 (5%)

Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLG-SMLTEFDVKQYMQAADIDG 388
           VE L   E  +  +KF  M    SG LT  E K        S      V+Q  +  D + 
Sbjct: 8   VEELSATECHQWYKKF--MTECPSGQLTLYEFKQFFGLKNLSPSANKYVEQMFETFDFNK 65

Query: 389 NGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDEL----GKAFKDYGMGD 444
           +G ID++E++ A     K +  + L   F+ +D D NG I   EL              +
Sbjct: 66  DGYIDFMEYVAALSLVLKGKVDQKLRWYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNE 125

Query: 445 DATI-ATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRALSSRSL--AHVV 493
             T       +  ++D + DG +S +EF   ++    L  + +RSL   H+V
Sbjct: 126 AMTAEEFTNMVFDKIDINGDGELSLEEFMEGVQKDEVLLDILTRSLDLTHIV 177

>2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186

 Score =  140 bits (355), Expect = 2e-39
 Identities = 26/164 (15%), Positives = 56/164 (34%), Gaps = 18/164 (10%)

Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSML---------TEFDVKQ 379
           I E+     ++K+K +   +D    G ++ ++ +    ++  +          T  +  +
Sbjct: 4   ITESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQEFLR 63

Query: 380 YMQAADIDGNGTIDYIEFITATMQRH-------KLQRFENLYKAFQYFDKDNNGYITVDE 432
                 +     I   E                K          +   D D +GY+++ E
Sbjct: 64  VADQLGLAPGVRISVEEAAVNATDSLLKMKGEEKAMAVIQSLIMYDCIDTDKDGYVSLPE 123

Query: 433 LGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
                +   +G D T        + +D +K+G+IS DEF   + 
Sbjct: 124 FKAFLQA--VGPDLTDDKAITCFNTLDFNKNGQISRDEFLVTVN 165

>2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186

 Score = 60.1 bits (146), Expect = 9e-11
 Identities = 17/70 (24%), Positives = 28/70 (40%), Gaps = 1/70 (1%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYI 395
             + +    +  +DTD  G ++  E KA L  +G  LT+          D + NG I   
Sbjct: 99  MAVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLTDDKAITCFNTLDFNKNGQISRD 158

Query: 396 EFITATMQRH 405
           EF+   +   
Sbjct: 159 EFLVT-VNDF 167

>2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186

 Score = 57.1 bits (138), Expect = 8e-10
 Identities = 21/119 (17%), Positives = 35/119 (29%), Gaps = 7/119 (5%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLA-KLGSMLTEFDVKQYM------QAADIDG 388
           E  Q+      ++       ++ +E        L  M  E      +         D D 
Sbjct: 56  ETRQEFLRVADQLGLAPGVRISVEEAAVNATDSLLKMKGEEKAMAVIQSLIMYDCIDTDK 115

Query: 389 NGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
           +G +   EF             +     F   D + NG I+ DE      D+  G + T
Sbjct: 116 DGYVSLPEFKAFLQAVGPDLTDDKAITCFNTLDFNKNGQISRDEFLVTVNDFLFGLEET 174

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  144 bits (364), Expect = 2e-39
 Identities = 70/283 (24%), Positives = 118/283 (41%), Gaps = 33/283 (11%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
            +   VGRG FG+           + A K     ++  + E+     E+  +  ++  PN
Sbjct: 11  EVEEVVGRGAFGVVCKAKWR--AKDVAIK-----QIESESERKAFIVELRQLSRVN-HPN 62

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNV---VNVCHS 152
           IV+   A  +   V +VME   GG L++ +          AA      +     V   HS
Sbjct: 63  IVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120

Query: 153 ---KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL- 208
              K ++HRDLKP N L        V+K  DFG +  I+         GS  ++APEV  
Sbjct: 121 MQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQTHMTNN--KGSAAWMAPEVFE 176

Query: 209 SQSYGKEADIWSAGVILYILLCGVPPFW--AETDQGVAQAILKGEINFQRDPFPSISSSA 266
             +Y ++ D++S G+IL+ ++    PF         +  A+  G     R P        
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT----RPPLIKNLPKP 232

Query: 267 I-ELVRRMLTQDPKRRIT---VAQVLEHPWLKESGEASDKPID 305
           I  L+ R  ++DP +R +   + +++ H  L      +D+P+ 
Sbjct: 233 IESLMTRCWSKDPSQRPSMEEIVKIMTH--LMRYFPGADEPLQ 273

>3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A Length = 166

 Score =  139 bits (352), Expect = 2e-39
 Identities = 31/163 (19%), Positives = 61/163 (37%), Gaps = 26/163 (15%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSML---------------TEFDVKQY 380
           E  +++  +FT  D D +G +   +       + +                  E   +  
Sbjct: 1   EYERRIAARFTTFDQDGNGHIDRSDFSGAAKAMLAEFGVAARSDRGQALYGGAEALWQGL 60

Query: 381 MQAADIDGNGTIDYIEFITATMQRHKLQR-------FENLYKAFQYFDKDNNGYITVDEL 433
              AD DG+  I   EF+T  ++R + +           L+ A    D D +G +TV + 
Sbjct: 61  AGIADRDGDQRITREEFVTGAVKRLRDKPDRFAEMARPFLHAALGVADTDGDGAVTVADT 120

Query: 434 GKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
            +A   +G+ +D      ++  + +D D DG++   E      
Sbjct: 121 ARALTAFGVPED----LARQAAAALDTDGDGKVGETEIVPAFA 159

>3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A Length = 166

 Score = 56.7 bits (137), Expect = 8e-10
 Identities = 23/109 (21%), Positives = 39/109 (35%), Gaps = 9/109 (8%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAK-LGSMLTEFD--VKQYMQAA----DIDGNGT 391
              +      D D    +T +E   G  K L      F    + ++ AA    D DG+G 
Sbjct: 55  ALWQGLAGIADRDGDQRITREEFVTGAVKRLRDKPDRFAEMARPFLHAALGVADTDGDGA 114

Query: 392 IDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDY 440
           +   +   A +    +   +   +A    D D +G +   E+  AF  Y
Sbjct: 115 VTVADTARA-LTAFGVPE-DLARQAAAALDTDGDGKVGETEIVPAFARY 161

>3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A Length = 166

 Score = 55.9 bits (135), Expect = 2e-09
 Identities = 18/75 (24%), Positives = 27/75 (36%), Gaps = 3/75 (4%)

Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
           +         L       DTD  G +T  +    L   G  + E   +Q   A D DG+G
Sbjct: 90  DRFAEMARPFLHAALGVADTDGDGAVTVADTARALTAFG--VPEDLARQAAAALDTDGDG 147

Query: 391 TIDYIEFITATMQRH 405
            +   E + A   R+
Sbjct: 148 KVGETEIVPA-FARY 161

>2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263

 Score =  142 bits (360), Expect = 2e-39
 Identities = 29/165 (17%), Positives = 59/165 (35%), Gaps = 21/165 (12%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD------VKQYMQAADI 386
                  +  E +   D D SG L   EL+  + +L     +        +K ++     
Sbjct: 10  SSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQARKKAGLELSPEMKTFVDQYGQ 69

Query: 387 DGNGTIDYIEFIT---------ATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAF 437
             +G I  +E               +  +L+  E   K ++ +D D++G+I  +EL    
Sbjct: 70  RDDGKIGIVELAHVLPTEENFLLLFRCQQLKSCEEFMKTWRKYDTDHSGFIETEELKNFL 129

Query: 438 KDYGMGDDATIAT------IKEIMSEVDRDKDGRISYDEFRSMMK 476
           KD     + T+           ++   D + DG++   E   ++ 
Sbjct: 130 KDLLEKANKTVDDTKLAEYTDLMLKLFDSNNDGKLELTEMARLLP 174

>2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263

 Score =  122 bits (308), Expect = 5e-32
 Identities = 36/235 (15%), Positives = 82/235 (34%), Gaps = 26/235 (11%)

Query: 261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNK 320
            +    ++ + + L Q  K+           ++ + G+  D  I       + +   +  
Sbjct: 32  YLEGKELQNLIQELLQARKKAGLELSPEMKTFVDQYGQRDDGKIG------IVELAHVLP 85

Query: 321 LKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEF----- 375
            ++  L +       +  ++  + + + DTD+SG +  +ELK  L  L     +      
Sbjct: 86  TEENFLLLFRCQ-QLKSCEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTK 144

Query: 376 ---DVKQYMQAADIDGNGTIDYIEFITATMQRHKL--------QRFENLYKAFQYFDKDN 424
                   ++  D + +G ++  E       +              +   KAF+ +D+D 
Sbjct: 145 LAEYTDLMLKLFDSNNDGKLELTEMARLLPVQENFLLKFQGIKMCGKEFNKAFELYDQDG 204

Query: 425 NGYITVDELGKAFKDYG--MGDDATIATIKEIM-SEVDRDKDGRISYDEFRSMMK 476
           NGYI  +EL    KD       +  I  I     + +     G++   +   ++ 
Sbjct: 205 NGYIDENELDALLKDLCEKNKQELDINNISTYKKNIMALSDGGKLYRTDLALILS 259

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  144 bits (365), Expect = 2e-39
 Identities = 71/307 (23%), Positives = 126/307 (41%), Gaps = 55/307 (17%)

Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRH 89
             Q  Y + R++GRG++   +     +   +   K +      K V+K  ++REI+I+ +
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL------KPVKKKKIKREIKILEN 86

Query: 90  LSGQPNIVQFKAAYEDDQ---FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNV 146
           L G PNI+      +D        +   +      F ++      ++         I+  
Sbjct: 87  LRGGPNIITLADIVKDPVSRTPALVFEHV--NNTDFKQLYQT--LTDYDIRFYMYEILKA 142

Query: 147 VNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE 206
           ++ CHS G+MHRD+KP N +     E+  ++  D+GL+ F   G+ Y   V S Y+  PE
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 200

Query: 207 VL--SQSYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILK-----------G 250
           +L   Q Y    D+WS G +L  ++    PF+      DQ     I K            
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIAKVLGTEDLYDYID 258

Query: 251 EINFQRDP----------------------FPSISSSAIELVRRMLTQDPKRRITVAQVL 288
           + N + DP                         +S  A++ + ++L  D + R+T  + +
Sbjct: 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 318

Query: 289 EHPWLKE 295
           EHP+   
Sbjct: 319 EHPYFYT 325

>1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 Length = 204

 Score =  139 bits (352), Expect = 6e-39
 Identities = 38/156 (24%), Positives = 63/156 (40%), Gaps = 17/156 (10%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYI 395
            ++Q+  +KF  ++   SGTL   E K       +      V+   +A D +G+ TID++
Sbjct: 22  AQLQEWYKKF--LEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAFDTNGDNTIDFL 79

Query: 396 EFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDEL--------------GKAFKDYG 441
           E++ A     +      L   F+ +DKD NG I   EL                  +   
Sbjct: 80  EYVAALNLVLRGTLEHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQ 139

Query: 442 MGDDATI-ATIKEIMSEVDRDKDGRISYDEFRSMMK 476
            G   T    +  I   VD + DG++S +EF    +
Sbjct: 140 QGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGAR 175

>1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 Length = 204

 Score = 48.3 bits (115), Expect = 1e-06
 Identities = 18/100 (18%), Positives = 31/100 (31%), Gaps = 23/100 (23%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD-----------------VKQYM 381
            KLK  F   D D +G +   EL   +  +  +                      V +  
Sbjct: 95  HKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIF 154

Query: 382 QAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFD 421
              D +G+G +   EF+         +R + + K  Q   
Sbjct: 155 LLVDENGDGQLSLNEFVEG------ARRDKWVMKMLQMDL 188

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  140 bits (355), Expect = 2e-38
 Identities = 64/270 (23%), Positives = 123/270 (45%), Gaps = 23/270 (8%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDV----RREIEIMRHLS 91
              +++G+G FG+ +           A KS+       + E  +     +RE+ IM +L+
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNV---VN 148
             PNIV+      +     +VME    G+L+ R++ + H      +   R+++++   + 
Sbjct: 82  -HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIE 136

Query: 149 VCHSKG--VMHRDLKPENFLFTTGDENA--VVKATDFGLSAFIEEGKAYREIVGSPYYIA 204
              ++   ++HRDL+  N    + DENA    K  DFGLS   +   +   ++G+  ++A
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMA 194

Query: 205 PEVL---SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           PE +    +SY ++AD +S  +ILY +L G  P + E   G  + I        R   P 
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGP-FDEYSYGKIKFINMIREEGLRPTIPE 253

Query: 262 ISSSAI-ELVRRMLTQDPKRRITVAQVLEH 290
                +  ++    + DPK+R   + +++ 
Sbjct: 254 DCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 Length = 109

 Score =  134 bits (340), Expect = 2e-38
 Identities = 28/110 (25%), Positives = 48/110 (43%), Gaps = 5/110 (4%)

Query: 368 LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGY 427
              +L + DV   ++A +     + +Y  F        K    +++ KAF   D+D +G+
Sbjct: 3   FSGILADADVAAALKACE--AADSFNYKAFFAKVGLTAKSA--DDIKKAFFVIDQDKSGF 58

Query: 428 ITVDELGKAFKDYGM-GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           I  DEL    + +       T A  K  +   D D DG I  DE+ +++K
Sbjct: 59  IEEDELKLFLQVFSAGARALTDAETKAFLKAGDSDGDGAIGVDEWAALVK 108

>1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 Length = 109

 Score = 59.2 bits (144), Expect = 3e-11
 Identities = 22/70 (31%), Positives = 35/70 (50%), Gaps = 3/70 (4%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM---LTEFDVKQYMQAADIDGN 389
           L  +    +K+ F  +D D SG +  DELK  L    +    LT+ + K +++A D DG+
Sbjct: 36  LTAKSADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARALTDAETKAFLKAGDSDGD 95

Query: 390 GTIDYIEFIT 399
           G I   E+  
Sbjct: 96  GAIGVDEWAA 105

>1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191

 Score =  136 bits (345), Expect = 4e-38
 Identities = 32/162 (19%), Positives = 55/162 (33%), Gaps = 23/162 (14%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAK-----LGSMLTEFDVKQYMQAADIDGNG 390
             I + K  F  +D +++G ++ DE+    +      LG+   +    +    A   G G
Sbjct: 13  RWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAG 72

Query: 391 T-----IDYIEFITATMQRHKLQRFEN-----------LYKAFQYFDKDNNGYITVDELG 434
                  D+  +I    +    +  +                F   DKD NG IT+DE  
Sbjct: 73  MKYGVETDWPAYIEGWKKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWK 132

Query: 435 KAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
              K    G   +    +E     D D+ G++  DE      
Sbjct: 133 AYTKA--AGIIQSSEDCEETFRVCDIDESGQLDVDEMTRQHL 172

>1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191

 Score = 72.1 bits (177), Expect = 6e-15
 Identities = 29/143 (20%), Positives = 51/143 (35%), Gaps = 8/143 (5%)

Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQF-TAMNK 320
           +   A ++V   L   P++     +     +   +G       D         +     K
Sbjct: 38  MVYKASDIVINNLGATPEQA-KRHKDAVEAFFGGAGMKYGVETD------WPAYIEGWKK 90

Query: 321 LKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQY 380
           L    L+   +N PT         F  +D D +G +T DE KA     G + +  D ++ 
Sbjct: 91  LATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEET 150

Query: 381 MQAADIDGNGTIDYIEFITATMQ 403
            +  DID +G +D  E     + 
Sbjct: 151 FRVCDIDESGQLDVDEMTRQHLG 173

>5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 Length = 109

 Score =  133 bits (338), Expect = 4e-38
 Identities = 29/112 (25%), Positives = 47/112 (41%), Gaps = 5/112 (4%)

Query: 368 LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGY 427
           +  +L   D+ + +        GT DY  F      + K      + + F+  DKD +G+
Sbjct: 2   MTKVLKADDINKAIS--AFKDPGTFDYKRFFHLVGLKGKTD--AQVKEVFEILDKDQSGF 57

Query: 428 ITVDELGKAFKDYGM-GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG 478
           I  +EL    K +   G D      K +++  D D DG+I  DEF  M+   
Sbjct: 58  IEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKIGADEFAKMVAQA 109

>5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 Length = 109

 Score = 56.0 bits (136), Expect = 4e-10
 Identities = 20/64 (31%), Positives = 30/64 (46%), Gaps = 3/64 (4%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM---LTEFDVKQYMQAADIDGNGTIDYI 395
            ++KE F  +D D SG +  +ELK  L    +    L + + K  + A D D +G I   
Sbjct: 41  AQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKIGAD 100

Query: 396 EFIT 399
           EF  
Sbjct: 101 EFAK 104

>2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A Length = 108

 Score =  133 bits (336), Expect = 8e-38
 Identities = 30/106 (28%), Positives = 49/106 (46%), Gaps = 5/106 (4%)

Query: 372 LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVD 431
           L + DV   + A       +  + EF        K    +++ KAF   D+D +G+I  D
Sbjct: 6   LKDADVAAALAACS--AADSFKHKEFFAKVGLASKSL--DDVKKAFYVIDQDKSGFIEED 61

Query: 432 ELGKAFKDYGM-GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           EL    +++       T A  K  +++ D+D DG I  DEF +M+K
Sbjct: 62  ELKLFLQNFSPSARALTDAETKAFLADGDKDGDGMIGVDEFAAMIK 107

>2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A Length = 108

 Score = 58.0 bits (141), Expect = 8e-11
 Identities = 22/70 (31%), Positives = 34/70 (48%), Gaps = 3/70 (4%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM---LTEFDVKQYMQAADIDGN 389
           L ++ +  +K+ F  +D D SG +  DELK  L         LT+ + K ++   D DG+
Sbjct: 35  LASKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKDGD 94

Query: 390 GTIDYIEFIT 399
           G I   EF  
Sbjct: 95  GMIGVDEFAA 104

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  139 bits (353), Expect = 8e-38
 Identities = 66/267 (24%), Positives = 117/267 (43%), Gaps = 26/267 (9%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
            I  ++G G FG  +    +  G + A K + ++    +   +   RE+ IM+ L   PN
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNE-FLREVAIMKRLR-HPN 95

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNV-VNVC---- 150
           IV F  A      + IV E  + G L+  +    H S        R  +++  +V     
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLL----HKSGAREQLDERRRLSMAYDVAKGMN 151

Query: 151 --HSKG--VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-IVGSPYYIAP 205
             H++   ++HR+LK  N L    D+   VK  DFGLS          +   G+P ++AP
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAP 208

Query: 206 EVL-SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
           EVL  +   +++D++S GVIL+ L     P+    +   AQ +       +R   P   +
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPW---GNLNPAQVVAAVGFKCKRLEIPRNLN 265

Query: 265 SAI-ELVRRMLTQDPKRRITVAQVLEH 290
             +  ++    T +P +R + A +++ 
Sbjct: 266 PQVAAIIEGCWTNEPWKRPSFATIMDL 292

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  140 bits (354), Expect = 1e-37
 Identities = 72/316 (22%), Positives = 121/316 (38%), Gaps = 49/316 (15%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD-----VRREIEIMRH 89
           Y    ++G G +   Y      T    A K I   +L    E ++       RE+ +++ 
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RL----EHEEGAPCTAIREVSLLKD 56

Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVV 147
           L    NIV        ++ + +V E       +  D        +          ++  +
Sbjct: 57  LK-HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC--GNIINMHNVKLFLFQLLRGL 113

Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPE 206
             CH + V+HRDLKP+N L    +E   +K  DFGL+ A     K Y   V + +Y  P+
Sbjct: 114 AYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPD 170

Query: 207 VL--SQSYGKEADIWSAGVILYILLCGVPPFWA--ETDQ-----------------GVAQ 245
           +L  S  Y  + D+W  G I Y +  G P F      +Q                 G+  
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230

Query: 246 AILKGEINFQRDP-------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298
                  N+ +          P + S   +L+ ++L  + + RI+    ++HP+    GE
Sbjct: 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290

Query: 299 ASDKPIDTAVIFRMKQ 314
              K  DT  IF +K+
Sbjct: 291 RIHKLPDTTSIFALKE 306

>3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} PDB: 2kqy_A Length = 109

 Score =  131 bits (333), Expect = 2e-37
 Identities = 26/110 (23%), Positives = 51/110 (46%), Gaps = 5/110 (4%)

Query: 368 LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGY 427
           +  +L+  D++  + +       + +Y  F +      K    + + K F   D+D +G+
Sbjct: 3   ITDILSAKDIESALSS--CQAADSFNYKSFFSTVGLSSKTP--DQIKKVFGILDQDKSGF 58

Query: 428 ITVDELGKAFKDYGMGDDA-TIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           I  +EL    K++       T A  K  ++  D D DG+I  +EF+S++K
Sbjct: 59  IEEEELQLFLKNFSSSARVLTSAETKAFLAAGDTDGDGKIGVEEFQSLVK 108

>3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} PDB: 2kqy_A Length = 109

 Score = 60.4 bits (147), Expect = 1e-11
 Identities = 22/70 (31%), Positives = 37/70 (52%), Gaps = 3/70 (4%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGS---MLTEFDVKQYMQAADIDGN 389
           L ++   ++K+ F  +D D SG +  +EL+  L    S   +LT  + K ++ A D DG+
Sbjct: 36  LSSKTPDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARVLTSAETKAFLAAGDTDGD 95

Query: 390 GTIDYIEFIT 399
           G I   EF +
Sbjct: 96  GKIGVEEFQS 105

>2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A Length = 172

 Score =  134 bits (339), Expect = 2e-37
 Identities = 30/143 (20%), Positives = 56/143 (39%), Gaps = 9/143 (6%)

Query: 334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM-LTEFDVKQYMQAADIDGNGTI 392
              +   L   F  +D D SG ++  EL+  L+           V+  +   D +    +
Sbjct: 2   ALPDQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGV 61

Query: 393 DYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIK 452
           ++ EF          Q        F+ +D+DN+G I  +EL +A      G   +     
Sbjct: 62  NFSEFTGVWKYITDWQ------NVFRTYDRDNSGMIDKNELKQALSG--FGYRLSDQFHD 113

Query: 453 EIMSEVDRDKDGRISYDEFRSMM 475
            ++ + DR   G+I++D+F    
Sbjct: 114 ILIRKFDRQGRGQIAFDDFIQGC 136

>2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A Length = 172

 Score = 90.4 bits (225), Expect = 2e-21
 Identities = 26/95 (27%), Positives = 42/95 (44%), Gaps = 6/95 (6%)

Query: 338 IQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEF 397
           I   +  F   D DNSG +  +ELK  L+  G  L++      ++  D  G G I + +F
Sbjct: 73  ITDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDF 132

Query: 398 ITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDE 432
           I   +        + L   F+ +D D +G+I V  
Sbjct: 133 IQGCI------VLQRLTDIFRRYDTDQDGWIQVSY 161

>2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A Length = 172

 Score = 73.8 bits (182), Expect = 1e-15
 Identities = 20/73 (27%), Positives = 34/73 (46%), Gaps = 1/73 (1%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE 470
             L+  FQ  DKD +G I+  EL +A  +          T++ I+S  DR+    +++ E
Sbjct: 7   SFLWNVFQRVDKDRSGVISDTELQQALSNGT-WTPFNPVTVRSIISMFDRENKAGVNFSE 65

Query: 471 FRSMMKCGTQLRA 483
           F  + K  T  + 
Sbjct: 66  FTGVWKYITDWQN 78

>2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A Length = 172

 Score = 45.7 bits (109), Expect = 5e-06
 Identities = 15/82 (18%), Positives = 27/82 (32%), Gaps = 11/82 (13%)

Query: 323 KLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQ 382
           K AL      L  +    L     + D    G + +D+   G   L  +   F       
Sbjct: 97  KQALSGFGYRLSDQFHDIL---IRKFDRQGRGQIAFDDFIQGCIVLQRLTDIFRRY---- 149

Query: 383 AADIDGNG--TIDYIEFITATM 402
             D D +G   + Y ++++   
Sbjct: 150 --DTDQDGWIQVSYEQYLSMVF 169

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  140 bits (354), Expect = 2e-37
 Identities = 72/351 (20%), Positives = 133/351 (37%), Gaps = 90/351 (25%)

Query: 28  YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSI---PKRKLVKDVEKDDVRREI 84
            E     Y++G+ +G G FGI     +  +G  FA K +   P+ K           RE+
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN----------REL 51

Query: 85  EIMRHLSGQPNIVQFK--------------------------------------AAYEDD 106
           +IM+ L    NI++                                             +
Sbjct: 52  DIMKVLD-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQN 110

Query: 107 QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM----NVVNVCHSKGVMHRDLKP 162
           ++++++ME      L   + +          ++  + +      V   HS G+ HRD+KP
Sbjct: 111 KYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKP 169

Query: 163 ENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL--SQSYGKEADIWS 220
           +N L  +  ++  +K  DFG +  +   +     + S +Y APE++  +  Y    D+WS
Sbjct: 170 QNLLVNS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWS 227

Query: 221 AGVILYILLCGVPPFWAET--DQGVAQAILK----------GEIN--FQRDPFPSIS--- 263
            G +   L+ G P F  ET  DQ V   I++            +N  +    FP++    
Sbjct: 228 IGCVFGELILGKPLFSGETSIDQLV--RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKD 285

Query: 264 ----------SSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPI 304
                     S AI+L+ ++L  +P  RI   + + HP+      + +  +
Sbjct: 286 WRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEV 336

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  138 bits (350), Expect = 3e-37
 Identities = 80/298 (26%), Positives = 125/298 (41%), Gaps = 46/298 (15%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDV----RREIEIMRHL 90
           Y    ++G G +G  Y   +  T    A K I   +L  + E++ V     RE+ +++ L
Sbjct: 36  YRRITKLGEGTYGEVYKAIDTVTNETVAIKRI---RL--EHEEEGVPGTAIREVSLLKEL 90

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC 150
               NI++ K+    +  +H++ E     +L   +      S R   S    ++N VN C
Sbjct: 91  Q-HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFC 148

Query: 151 HSKGVMHRDLKPENFLFTTGD--ENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEV 207
           HS+  +HRDLKP+N L +  D  E  V+K  DFGL+ AF    + +   + + +Y  PE+
Sbjct: 149 HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEI 208

Query: 208 L--SQSYGKEADIWSAGVILYILLCGVPPFWA--ETDQ-----------------GVAQA 246
           L  S+ Y    DIWS   I   +L   P F    E DQ                 GV   
Sbjct: 209 LLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA- 267

Query: 247 ILKG---------EINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
            L               +R     +    ++L+  ML  DP +RI+    LEHP+   
Sbjct: 268 -LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  138 bits (349), Expect = 4e-37
 Identities = 82/317 (25%), Positives = 131/317 (41%), Gaps = 50/317 (15%)

Query: 17  RHLHDAILGKA---YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK 73
            H H    G+    ++ +   Y    +VG G +G+ Y    +S G   A K I   +L  
Sbjct: 2   HHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAK-DSQGRIVALKRI---RL-- 55

Query: 74  DVEKDDV----RREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAG--GELFDRIVA 127
           D E + +     REI +++ L   PNIV        ++ + +V E       ++ D    
Sbjct: 56  DAEDEGIPSTAIREISLLKELH-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN-- 112

Query: 128 RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AF 186
           +    +         ++  V  CH   ++HRDLKP+N L    + +  +K  DFGL+ AF
Sbjct: 113 KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAF 169

Query: 187 IEEGKAYREIVGSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWA--ETDQ- 241
               ++Y   V + +Y AP+VL  S+ Y    DIWS G I   ++ G P F    + DQ 
Sbjct: 170 GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL 229

Query: 242 ----------------GVAQAILKGEINFQ-------RDPFPSISSSAIELVRRMLTQDP 278
                            V +  L  +  FQ           P      I+L+  ML  DP
Sbjct: 230 PKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDP 289

Query: 279 KRRITVAQVLEHPWLKE 295
            +RI+    + HP+ K+
Sbjct: 290 NKRISARDAMNHPYFKD 306

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  137 bits (347), Expect = 4e-37
 Identities = 87/298 (29%), Positives = 129/298 (43%), Gaps = 50/298 (16%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDV----RREIEIMRHL 90
           Y    ++G G +G+ Y    N+ G  FA K I   +L  + E + +     REI I++ L
Sbjct: 4   YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKI---RL--EKEDEGIPSTTIREISILKEL 57

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVN 148
               NIV+        + + +V E       +L D     G      A S    ++N + 
Sbjct: 58  K-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIA 114

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEV 207
            CH + V+HRDLKP+N L    +    +K  DFGL+ AF    + Y   + + +Y AP+V
Sbjct: 115 YCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171

Query: 208 L--SQSYGKEADIWSAGVILYILLCGVPPFWA--ETDQ-----------------GVAQA 246
           L  S+ Y    DIWS G I   ++ G P F    E DQ                  V + 
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE- 230

Query: 247 ILKG-EINFQRDP-------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
            L   + NF              +  S I+L+ +ML  DP +RIT  Q LEH + KE+
Sbjct: 231 -LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  136 bits (346), Expect = 6e-37
 Identities = 72/298 (24%), Positives = 124/298 (41%), Gaps = 50/298 (16%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDV----RREIEIMRHL 90
           Y    ++G G +G  +      T    A K +   +L  D + + V     REI +++ L
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRV---RL--DDDDEGVPSSALREICLLKEL 58

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVN 148
               NIV+       D+ + +V E C     + FD     G        S    ++  + 
Sbjct: 59  K-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLG 115

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEV 207
            CHS+ V+HRDLKP+N L    + N  +K  +FGL+ AF    + Y   V + +Y  P+V
Sbjct: 116 FCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172

Query: 208 L--SQSYGKEADIWSAGVILYILLCGVPPFWA---ETDQ-----------------GVAQ 245
           L  ++ Y    D+WSAG I   L     P +      DQ                  + +
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232

Query: 246 AILKGEINFQRDP--------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
             L     +   P         P ++++  +L++ +L  +P +RI+  + L+HP+  +
Sbjct: 233 --LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 145

 Score =  131 bits (333), Expect = 8e-37
 Identities = 40/149 (26%), Positives = 67/149 (44%), Gaps = 7/149 (4%)

Query: 335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDY 394
           T    +++E F   D DN G ++ +EL + L  LG   T  ++       +       D 
Sbjct: 1   TASADQIQECFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKGQLNAKE---FDL 57

Query: 395 IEFIT--ATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIK 452
             F T      +   ++ + +  AF+  DK+ NG I   EL +   +  +GD  T + ++
Sbjct: 58  ATFKTVYRKPIKTPTEQSKEMLDAFRALDKEGNGTIQEAELRQLLLN--LGDALTSSEVE 115

Query: 453 EIMSEVDRDKDGRISYDEFRSMMKCGTQL 481
           E+M EV    DG I+Y+ F  M+  G  L
Sbjct: 116 ELMKEVSVSGDGAINYESFVDMLVTGYPL 144

>2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 145

 Score = 59.8 bits (146), Expect = 5e-11
 Identities = 22/74 (29%), Positives = 42/74 (56%)

Query: 334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTID 393
           PTE+ +++ + F  +D + +GT+   EL+  L  LG  LT  +V++ M+   + G+G I+
Sbjct: 71  PTEQSKEMLDAFRALDKEGNGTIQEAELRQLLLNLGDALTSSEVEELMKEVSVSGDGAIN 130

Query: 394 YIEFITATMQRHKL 407
           Y  F+   +  + L
Sbjct: 131 YESFVDMLVTGYPL 144

>2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} Length = 256

 Score =  135 bits (340), Expect = 1e-36
 Identities = 45/252 (17%), Positives = 84/252 (33%), Gaps = 26/252 (10%)

Query: 236 WAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
             E  +        G +       P     +I+  R   T+    R  +       W+  
Sbjct: 4   TKEAVKAS-----DGNLLGDPGRIPLSKRESIKWQRPRFTRQALMRCCL-----IKWILS 53

Query: 296 SGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGT 355
           S          + +           L +L  +        +E+Q L   F   +   +G 
Sbjct: 54  SAAPQGSDSSDSELELSTVRHQPEGLDQLQAQ---TKFTKKELQSLYRGF--KNECPTGL 108

Query: 356 LTYDELKAGLAKLGSMLTE-FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLY 414
           +  D  K   ++                A D DGNG I + +F+       +    E L 
Sbjct: 109 VDEDTFKLIYSQFFPQGDATTYAHFLFNAFDADGNGAIHFEDFVVGLSILLRGTVHEKLK 168

Query: 415 KAFQYFDKDNNGYITVDELGKAFK----------DYGMGDDATIATIKEIMSEVDRDKDG 464
            AF  +D + +G IT +E+    K             + +DA +  ++    ++DR++DG
Sbjct: 169 WAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILREDAPLEHVERFFQKMDRNQDG 228

Query: 465 RISYDEFRSMMK 476
            ++ DEF    +
Sbjct: 229 VVTIDEFLETCQ 240

>2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} Length = 256

 Score = 50.0 bits (119), Expect = 5e-07
 Identities = 21/95 (22%), Positives = 39/95 (41%), Gaps = 18/95 (18%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDEL----KAGLAKLGSMLTEFD--------VKQYMQAADI 386
           +KLK  F   D +  G +T +E+    K+    +G               V+++ Q  D 
Sbjct: 165 EKLKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILREDAPLEHVERFFQKMDR 224

Query: 387 DGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFD 421
           + +G +   EF+         Q+ EN+  + Q F+
Sbjct: 225 NQDGVVTIDEFLET------CQKDENIMNSMQLFE 253

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  137 bits (347), Expect = 1e-36
 Identities = 72/296 (24%), Positives = 121/296 (40%), Gaps = 45/296 (15%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHL 90
           Y     +G G+F   Y   + +T    A K I  +   +   KD +     REI++++ L
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKI--KLGHRSEAKDGINRTALREIKLLQEL 69

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVFRVIMNVVN 148
           S  PNI+    A+     + +V +        +          +     +   + +  + 
Sbjct: 70  S-HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLE 126

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEV 207
             H   ++HRDLKP N L    DEN V+K  DFGL+ +F    +AY   V + +Y APE+
Sbjct: 127 YLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183

Query: 208 L--SQSYGKEADIWSAGVILYILLCGVPPFWAET--DQ-----------------GVAQA 246
           L  ++ YG   D+W+ G IL  LL  VP    ++  DQ                  +   
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS- 242

Query: 247 ILKGEINFQRDP-------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
            L   + F+  P       F +     ++L++ +   +P  RIT  Q L+  +   
Sbjct: 243 -LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  137 bits (346), Expect = 2e-36
 Identities = 72/325 (22%), Positives = 123/325 (37%), Gaps = 59/325 (18%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
                 + + R  G+G FG   L  E STG+  A K + +    +        RE++IM+
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQ 71

Query: 89  HLSGQ--PNIVQFKAAY-------EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
            L+    PNIVQ ++ +         D ++++VME      L                 +
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPIL 130

Query: 140 FRVIM----NVVNVCH--SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY 193
            +V +      +   H  S  V HRD+KP N L      +  +K  DFG +  +   +  
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE--ADGTLKLCDFGSAKKLSPSEPN 188

Query: 194 REIVGSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAET--DQGVAQAILK 249
              + S YY APE++  +Q Y    DIWS G I   ++ G P F  +    Q     I++
Sbjct: 189 VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH--EIVR 246

Query: 250 ----------GEIN--FQRDPFPSI----------------SSSAIELVRRMLTQDPKRR 281
                      ++N         +                 +  A +L+  +L   P+ R
Sbjct: 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEER 306

Query: 282 ITVAQVLEHPWLKESGEASDKPIDT 306
           +   + L HP+  E  + + K  + 
Sbjct: 307 MKPYEALCHPYFDELHDPATKLPNN 331

>2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} Length = 202

 Score =  131 bits (332), Expect = 5e-36
 Identities = 34/180 (18%), Positives = 70/180 (38%), Gaps = 24/180 (13%)

Query: 332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGT 391
                 + +L  +F  +D +  G L+  +L+   A   + L +    + +++   DG+  
Sbjct: 22  GFSQASLLRLHHRFRALDRNKKGYLSRMDLQQIGALAVNPLGD----RIIESFFPDGSQR 77

Query: 392 IDYIEFITATMQRHKLQ-----------------RFENLYKAFQYFDKDNNGYITVDELG 434
           +D+  F+        ++                 R   L+ AFQ +D D +G I+  E+ 
Sbjct: 78  VDFPGFVRVLAHFRPVEDEDTETQDPKKPEPLNSRRNKLHYAFQLYDLDRDGKISRHEML 137

Query: 435 ---KAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRALSSRSLAH 491
              +      + ++         + E D D DG +S+ EF   ++     + +S R L H
Sbjct: 138 QVLRLMVGVQVTEEQLENIADRTVQEADEDGDGAVSFVEFTKSLEKMDVEQKMSIRILKH 197

>2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} Length = 202

 Score = 54.4 bits (131), Expect = 1e-08
 Identities = 20/101 (19%), Positives = 39/101 (38%), Gaps = 6/101 (5%)

Query: 312 MKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL-GS 370
           +  F  +                     KL   F   D D  G ++  E+   L  + G 
Sbjct: 87  LAHFRPVEDEDTETQDPKKPEPLNSRRNKLHYAFQLYDLDRDGKISRHEMLQVLRLMVGV 146

Query: 371 MLTEFDVKQY----MQAADIDGNGTIDYIEFITATMQRHKL 407
            +TE  ++      +Q AD DG+G + ++EF  + +++  +
Sbjct: 147 QVTEEQLENIADRTVQEADEDGDGAVSFVEFTKS-LEKMDV 186

>3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450

 Score =  137 bits (347), Expect = 6e-36
 Identities = 56/148 (37%), Positives = 82/148 (55%), Gaps = 5/148 (3%)

Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
           + L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGNG
Sbjct: 304 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNG 363

Query: 391 TIDYIEFITATMQRHKLQR--FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           TID+ EF+T  M R        E + +AF+ FDKD NGYI+  EL     +  +G+  T 
Sbjct: 364 TIDFPEFLT-MMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTD 420

Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMMK 476
             + E++ E D D DG+++Y+EF  MM 
Sbjct: 421 EEVDEMIREADIDGDGQVNYEEFVQMMT 448

>3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450

 Score = 86.5 bits (214), Expect = 2e-18
 Identities = 35/143 (24%), Positives = 66/143 (46%), Gaps = 9/143 (6%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
             +   +   ++ T    D+    T  E+K    +  +++   ++K      D   +G I
Sbjct: 241 FKSAMPEGYIQERTIFFKDDGNYKTRAEVKF---EGDTLVNRIELKGI----DFKEDGNI 293

Query: 393 DYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIK 452
              +    T  +   ++     +AF  FDKD +G IT  ELG   +   +G + T A ++
Sbjct: 294 LGHKLEYNTRDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMR--SLGQNPTEAELQ 351

Query: 453 EIMSEVDRDKDGRISYDEFRSMM 475
           ++++EVD D +G I + EF +MM
Sbjct: 352 DMINEVDADGNGTIDFPEFLTMM 374

>3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450

 Score = 63.0 bits (153), Expect = 9e-11
 Identities = 37/144 (25%), Positives = 66/144 (45%), Gaps = 21/144 (14%)

Query: 261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNK 320
           +I++  +  V R L Q+P      A++ +   + E     +  ID        +F  M  
Sbjct: 328 TITTKELGTVMRSLGQNPTE----AELQDM--INEVDADGNGTID------FPEFLTMMA 375

Query: 321 LKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQY 380
            K      + +    EEI   +E F   D D +G ++  EL+  +  LG  LT+ +V + 
Sbjct: 376 RK------MKDTDSEEEI---REAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEM 426

Query: 381 MQAADIDGNGTIDYIEFITATMQR 404
           ++ ADIDG+G ++Y EF+     +
Sbjct: 427 IREADIDGDGQVNYEEFVQMMTAK 450

>3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450

 Score = 44.5 bits (105), Expect = 5e-05
 Identities = 19/101 (18%), Positives = 30/101 (29%), Gaps = 31/101 (30%)

Query: 406 KLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATI-------------- 451
           K    E   +    F KD+  Y T  E+        + +   +  I              
Sbjct: 242 KSAMPEGYIQERTIFFKDDGNYKTRAEVKFEGDT--LVNRIELKGIDFKEDGNILGHKLE 299

Query: 452 ---------------KEIMSEVDRDKDGRISYDEFRSMMKC 477
                          KE  S  D+D DG I+  E  ++M+ 
Sbjct: 300 YNTRDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRS 340

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  134 bits (339), Expect = 8e-36
 Identities = 63/283 (22%), Positives = 112/283 (39%), Gaps = 39/283 (13%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
             G  +G+G FG     T   TG     K + +     +  +    +E+++MR L   PN
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLE-HPN 68

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC----- 150
           +++F      D+ ++ + E   GG L   I       +       RV     ++      
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRGII----KSMDSQYPWSQRVSF-AKDIASGMAY 123

Query: 151 -HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-------------- 195
            HS  ++HRDL   N L     EN  V   DFGL+  + + K   E              
Sbjct: 124 LHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180

Query: 196 -IVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN 253
            +VG+PY++APE+++ +SY ++ D++S G++L  ++  V                     
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD--PDYLPRTMDFGLNVRG 238

Query: 254 FQRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQVLEHPWLKE 295
           F     P     +   +  R    DP++R +  ++    WL+ 
Sbjct: 239 FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLET 279

>2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A Length = 208

 Score =  130 bits (329), Expect = 1e-35
 Identities = 35/182 (19%), Positives = 74/182 (40%), Gaps = 25/182 (13%)

Query: 316 TAMNKLKKLALKVIVE--NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLT 373
            A   L+   L+ I +       +I +L  +FT +D   +GTL+ ++ +       + L 
Sbjct: 4   RASTLLRDEELEEIKKETGFSHSQITRLYSRFTSLDKGENGTLSREDFQRIPELAINPLG 63

Query: 374 EFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQ----------------RFENLYKAF 417
           +    + + A   +G   +++  F+        ++                R   L+ AF
Sbjct: 64  D----RIINAFFSEGEDQVNFRGFMRTLAHFRPIEDNEKSKDVNGPEPLNSRSNKLHFAF 119

Query: 418 QYFDKDNNGYITVDELGKAFKDY---GMGDDATIATIKEIMSEVDRDKDGRISYDEFRSM 474
           + +D D +  I+ DEL +  +      + D+   +     + E D+D D  IS+ EF  +
Sbjct: 120 RLYDLDKDDKISRDELLQVLRMMVGVNISDEQLGSIADRTIQEADQDGDSAISFTEFVKV 179

Query: 475 MK 476
           ++
Sbjct: 180 LE 181

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  133 bits (337), Expect = 2e-35
 Identities = 59/274 (21%), Positives = 110/274 (40%), Gaps = 32/274 (11%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
            IG  +G+G FG  Y    +    E A + I   +  +D  K   +RE+   R      N
Sbjct: 36  EIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKA-FKREVMAYRQTR-HEN 90

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVNVCHSKG 154
           +V F  A      + I+  LC G  L+  +  A+          + + I+  +   H+KG
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI------VGSPYYIAPEVL 208
           ++H+DLK +N  +    +N  V  TDFGL +     +A R         G   ++APE++
Sbjct: 151 ILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206

Query: 209 SQS----------YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            Q           + K +D+++ G I Y L     PF  +  + +   +  G     +  
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM----KPN 262

Query: 259 FP--SISSSAIELVRRMLTQDPKRRITVAQVLEH 290
                +     +++      + + R T  ++++ 
Sbjct: 263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296

>1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A Length = 110

 Score =  126 bits (318), Expect = 3e-35
 Identities = 29/110 (26%), Positives = 53/110 (48%), Gaps = 5/110 (4%)

Query: 368 LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGY 427
              +L   D+K+ + A  +   G+ ++ +F  A +    +    ++ K F+  D D +G+
Sbjct: 3   AKDLLKADDIKKALDA--VKAEGSFNHKKFF-ALVGLKAMSA-NDVKKVFKAIDADASGF 58

Query: 428 ITVDELGKAFKDYGM-GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           I  +EL    K +   G D T A  K  +   D+D DG+I  DEF +++ 
Sbjct: 59  IEEEELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGKIGIDEFETLVH 108

>1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A Length = 110

 Score = 63.7 bits (156), Expect = 8e-13
 Identities = 29/104 (27%), Positives = 43/104 (41%), Gaps = 4/104 (3%)

Query: 299 ASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTY 358
           A D      +   +    A           +V  L       +K+ F  +D D SG +  
Sbjct: 3   AKDLLKADDIKKALDAVKAEGSFNHKKFFALV-GLKAMSANDVKKVFKAIDADASGFIEE 61

Query: 359 DELKAGLAKL---GSMLTEFDVKQYMQAADIDGNGTIDYIEFIT 399
           +ELK  L      G  LT+ + K +++AAD DG+G I   EF T
Sbjct: 62  EELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGKIGIDEFET 105

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  133 bits (337), Expect = 5e-35
 Identities = 77/362 (21%), Positives = 141/362 (38%), Gaps = 63/362 (17%)

Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIP---------KRKLVKDVEKDDV 80
           +V+  Y   + VG G +G      +  TG + A K +          KR           
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY--------- 72

Query: 81  RREIEIMRHLSGQPNIVQ----FKAAYEDDQF--VHIVMELCAGGELFDRIVARGHYSER 134
            RE+ +++H+    N++     F      D F   ++VM    G +L  +++      E 
Sbjct: 73  -RELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPF-MGTDL-GKLMKHEKLGED 128

Query: 135 AAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR 194
               +   ++  +   H+ G++HRDLKP N      +E+  +K  DFGL+   +      
Sbjct: 129 RIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADSEMT-- 183

Query: 195 EIVGSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAET--DQ--------- 241
             V + +Y APEV+     Y +  DIWS G I+  ++ G   F      DQ         
Sbjct: 184 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243

Query: 242 ------------GVAQAILKGEINFQRDP----FPSISSSAIELVRRMLTQDPKRRITVA 285
                         A+  +KG    ++        + S  A+ L+ +ML  D ++R+T  
Sbjct: 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 303

Query: 286 QVLEHPWLKESGEASDKPIDTAVIFRMKQFT-AMNKLKKLALKVIVENLPTEEIQKLKEK 344
           + L HP+ +   +  D+P               +++ K++  K ++   P  ++     K
Sbjct: 304 EALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSK 363

Query: 345 FT 346
            T
Sbjct: 364 ET 365

>2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A Length = 272

 Score =  130 bits (329), Expect = 6e-35
 Identities = 31/172 (18%), Positives = 58/172 (33%), Gaps = 27/172 (15%)

Query: 332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD----------VKQYM 381
                +     + +   D D++G +   EL      +   L   D           K +M
Sbjct: 4   AFANLDAAGFLQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKDKITDERVQQIKKSFM 63

Query: 382 QAADIDGNGTIDYIEF-----------ITATMQRHKLQRFENLYKAFQYFDKDNNGYITV 430
            A D   +G +   E            +    +   L       K ++ +D D++GYI+ 
Sbjct: 64  SAYDATFDGRLQIEELANMILPQEENFLLIFRREAPLDNSVEFMKIWRKYDADSSGYISA 123

Query: 431 DELGKAFKDYGMGDDATIAT------IKEIMSEVDRDKDGRISYDEFRSMMK 476
            EL    KD  +     I           +M   D++KDGR+  ++   ++ 
Sbjct: 124 AELKNFLKDLFLQHKKKIPPNKLDEYTDAMMKIFDKNKDGRLDLNDLARILA 175

>2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A Length = 272

 Score =  117 bits (293), Expect = 7e-30
 Identities = 30/187 (16%), Positives = 65/187 (34%), Gaps = 26/187 (13%)

Query: 316 TAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM---- 371
             +   ++  L +     P +   +  + + + D D+SG ++  ELK  L  L       
Sbjct: 81  NMILPQEENFLLIFRREAPLDNSVEFMKIWRKYDADSSGYISAAELKNFLKDLFLQHKKK 140

Query: 372 ----LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH------------KLQRFENLYK 415
                 +      M+  D + +G +D  +       +             +++R  +  K
Sbjct: 141 IPPNKLDEYTDAMMKIFDKNKDGRLDLNDLARILALQENFLLQFKMDASSQVERKRDFEK 200

Query: 416 AFQYFDKDNNGYITVDELGKAFKDYGMGDDATI------ATIKEIMSEVDRDKDGRISYD 469
            F ++D    G +   E+    KD       +I         + +++  D +KDG+I   
Sbjct: 201 IFAHYDVSRTGALEGPEVDGFVKDMMELVRPSISGGDLDKFRECLLTHCDMNKDGKIQKS 260

Query: 470 EFRSMMK 476
           E    + 
Sbjct: 261 ELALCLG 267

>2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A Length = 272

 Score = 65.5 bits (159), Expect = 5e-12
 Identities = 24/86 (27%), Positives = 35/86 (40%), Gaps = 8/86 (9%)

Query: 413 LYKAFQYFDKDNNGYITVDELGKAFKDYGMG--------DDATIATIKEIMSEVDRDKDG 464
             + +Q+FD D+NGYI   EL   F+             D+      K  MS  D   DG
Sbjct: 13  FLQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKDKITDERVQQIKKSFMSAYDATFDG 72

Query: 465 RISYDEFRSMMKCGTQLRALSSRSLA 490
           R+  +E  +M+    +   L  R  A
Sbjct: 73  RLQIEELANMILPQEENFLLIFRREA 98

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  132 bits (335), Expect = 7e-35
 Identities = 79/349 (22%), Positives = 135/349 (38%), Gaps = 67/349 (19%)

Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIP---------KRKLVKDVEKDDV 80
           ++   Y     VG G +G      +  +G + A K +          KR           
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--------- 71

Query: 81  RREIEIMRHLSGQPNIVQ----FKAAYEDDQF--VHIVMELCAGGELFDRIVARGHYSER 134
            RE+ +++H+    N++     F  A     F   ++VM      +L   +     +SE 
Sbjct: 72  -RELLLLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPF-MQTDLQKIM--GLKFSEE 126

Query: 135 AAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR 194
               +   ++  +   HS GV+HRDLKP N      +E+  +K  DFGL+   +      
Sbjct: 127 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAEMT-- 181

Query: 195 EIVGSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAET--DQ--------- 241
             V + +Y APEV+     Y +  DIWS G I+  +L G   F  +   DQ         
Sbjct: 182 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 241

Query: 242 ------------GVAQAILKGEINFQRDP----FPSISSSAIELVRRMLTQDPKRRITVA 285
                         A++ ++      R      FP  S  A +L+ +ML  D  +R+T A
Sbjct: 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 301

Query: 286 QVLEHPWLKESGEASDKPIDTAVI---FRMKQFTAMNKLKKLALKVIVE 331
           Q L HP+ +   +  ++             ++ T +++ K+   K IV 
Sbjct: 302 QALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLT-VDEWKQHIYKEIVN 349

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  130 bits (329), Expect = 8e-35
 Identities = 43/270 (15%), Positives = 93/270 (34%), Gaps = 33/270 (12%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
               ++     G  +       G +   K +  R       +D    E   +R  S  PN
Sbjct: 13  NFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRD-FNEECPRLRIFS-HPN 68

Query: 96  IVQFKAAYEDDQFVH--IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC--- 150
           ++    A +     H  ++      G L++ +    H          + +   +++    
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVL----HEGTNFVVDQSQAVKFALDMARGM 124

Query: 151 ---HSKG--VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAP 205
              H+    +    L   + +    DE+   + +   +    +        + +P ++AP
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFSFQSPGR----MYAPAWVAP 177

Query: 206 EVL----SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           E L      +  + AD+WS  V+L+ L+    PF    D    +  +K  +   R   P 
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPF---ADLSNMEIGMKVALEGLRPTIPP 234

Query: 262 -ISSSAIELVRRMLTQDPKRRITVAQVLEH 290
            IS    +L++  + +DP +R     ++  
Sbjct: 235 GISPHVSKLMKICMNEDPAKRPKFDMIVPI 264

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  132 bits (335), Expect = 9e-35
 Identities = 73/345 (21%), Positives = 131/345 (37%), Gaps = 61/345 (17%)

Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK------DDVR-- 81
            +Q  YT+ R +  G +G       +S G+  A K +                    R  
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77

Query: 82  REIEIMRHLSGQPNIVQFK-----AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAA 136
           REI ++ H    PNI+  +             +++V EL    +L  +++    + +R  
Sbjct: 78  REIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTEL-MRTDL-AQVI----HDQRIV 130

Query: 137 ASVFRV------IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190
            S   +      I+  ++V H  GV+HRDL P N L     +N  +   DF L+      
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTAD 187

Query: 191 KAYREIVGSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAET--DQ----- 241
                 V   +Y APE++   + + K  D+WSAG ++  +      F   T  +Q     
Sbjct: 188 ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247

Query: 242 ----------------GVAQAILKGEINFQ-----RDPFPSISSSAIELVRRMLTQDPKR 280
                             A+  L+  ++           P+    A++L+ +ML  +P+R
Sbjct: 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307

Query: 281 RITVAQVLEHPWLKESGEASDKPIDTAVIFRM-KQFTAMNKLKKL 324
           RI+  Q L HP+ +   +  D     +  F   +  T +  + K+
Sbjct: 308 RISTEQALRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDMHKI 352

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  131 bits (331), Expect = 1e-34
 Identities = 67/312 (21%), Positives = 116/312 (37%), Gaps = 54/312 (17%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD-----VRREIEIMRH 89
           +    ++G G +   Y     +TG+  A K +   KL    + ++       REI +M+ 
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEV---KL----DSEEGTPSTAIREISLMKE 59

Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMELCAGG-----ELFDRIVARGHYSERAAASVFRVIM 144
           L    NIV+       +  + +V E          +                      ++
Sbjct: 60  LK-HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 145 NVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYI 203
             +  CH   ++HRDLKP+N L    ++   +K  DFGL+ AF      +   V + +Y 
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR 175

Query: 204 APEVL--SQSYGKEADIWSAGVILYILLCGVPPFWA--ETDQ-----------------G 242
           AP+VL  S++Y    DIWS G IL  ++ G P F    + +Q                  
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS 235

Query: 243 VAQ------AILKGEIN-----FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
           V +       I +          Q      +  + ++ +  +L  +P  R++  Q L HP
Sbjct: 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295

Query: 292 WLKESGEASDKP 303
           W  E    +   
Sbjct: 296 WFAEYYHHASMG 307

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  131 bits (331), Expect = 1e-34
 Identities = 78/328 (23%), Positives = 129/328 (39%), Gaps = 68/328 (20%)

Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIP-------KRKLVKDVEKDDVRR 82
           D+   Y   + +G G  G+ +   +N      A K I        K  L          R
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL----------R 57

Query: 83  EIEIMRHLSGQPNIV--------------QFKAAYEDDQFVHIVMELCAGGELFDRIVAR 128
           EI+I+R L    NIV                  +  +   V+IV E     +L   ++ +
Sbjct: 58  EIKIIRRLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-METDL-ANVLEQ 114

Query: 129 GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188
           G   E  A      ++  +   HS  V+HRDLKP N    T  E+ V+K  DFGL+  ++
Sbjct: 115 GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMD 172

Query: 189 EGKAYR----EIVGSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAET--D 240
              +++    E + + +Y +P +L    +Y K  D+W+AG I   +L G   F      +
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232

Query: 241 Q--------------------GVAQAILKGEINFQRDP----FPSISSSAIELVRRMLTQ 276
           Q                     V    ++ ++     P     P IS  A++ + ++LT 
Sbjct: 233 QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTF 292

Query: 277 DPKRRITVAQVLEHPWLKESGEASDKPI 304
            P  R+T  + L HP++       D+PI
Sbjct: 293 SPMDRLTAEEALSHPYMSIYSFPMDEPI 320

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  132 bits (334), Expect = 1e-34
 Identities = 82/360 (22%), Positives = 141/360 (39%), Gaps = 65/360 (18%)

Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIP---------KRKLVKDVEKDDV 80
           +V   Y     VG G +G      +  TGL  A K +          KR           
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--------- 76

Query: 81  RREIEIMRHLSGQPNIVQ----FKAAYEDDQF--VHIVMELCAGGELFDRIVARGHYSER 134
            RE+ +++H+    N++     F  A   ++F  V++V  L  G +L + IV     ++ 
Sbjct: 77  -RELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADL-NNIVKCQKLTDD 132

Query: 135 AAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR 194
               +   I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+    +     
Sbjct: 133 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTADEMT-- 187

Query: 195 EIVGSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ--------- 241
             V + +Y APE++     Y +  DIWS G I+  LL G   F      DQ         
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247

Query: 242 ------------GVAQAILKGEINFQRDP----FPSISSSAIELVRRMLTQDPKRRITVA 285
                         A+  ++      +      F   +  A++L+ +ML  D  +RIT A
Sbjct: 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 307

Query: 286 QVLEHPWLKESGEASDKPIDTAVIFRM--KQFTAMNKLKKLALKVIVENLPTEEIQKLKE 343
           Q L H +  +  +  D+P+       +  +    +++ K L    ++  +P    Q+  E
Sbjct: 308 QALAHAYFAQYHDPDDEPVADPYDQSLESRDLL-IDEWKSLTYDEVISFVPPPLDQEEME 366

>1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A Length = 148

 Score =  124 bits (314), Expect = 4e-34
 Identities = 33/148 (22%), Positives = 64/148 (43%), Gaps = 11/148 (7%)

Query: 337 EIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQA-ADIDGNGTIDYI 395
             +  K+ FT  D    G +  D L   L  +G   T   V+  + A + +    ++   
Sbjct: 2   ATRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLD 61

Query: 396 EFITATMQRHKLQR-------FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           +     ++ ++ +         E+  KAFQ FDK++ G ++V +L        +G+  T 
Sbjct: 62  QITGL-IEVNEKELDATTKAKTEDFVKAFQVFDKESTGKVSVGDLRYMLTG--LGEKLTD 118

Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           A + E++  V+ D +G I Y +F   + 
Sbjct: 119 AEVDELLKGVEVDSNGEIDYKKFIEDVL 146

>1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A Length = 148

 Score = 59.5 bits (145), Expect = 6e-11
 Identities = 18/64 (28%), Positives = 37/64 (57%)

Query: 341 LKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITA 400
             + F   D +++G ++  +L+  L  LG  LT+ +V + ++  ++D NG IDY +FI  
Sbjct: 85  FVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIED 144

Query: 401 TMQR 404
            +++
Sbjct: 145 VLRQ 148

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  128 bits (325), Expect = 5e-34
 Identities = 58/270 (21%), Positives = 108/270 (40%), Gaps = 29/270 (10%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+G+ +G G FG  Y    +    + A K +          +   + E+ ++R      N
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTR-HVN 81

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVI---MNVVNVCH 151
           I+ F       Q   IV + C G  L+  +  +   +  +    + R     M+ +   H
Sbjct: 82  ILLFMGYSTAPQLA-IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL---H 137

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI---VGSPYYIAPEVL 208
           +K ++HRDLK  N       E+  VK  DFGL+          +     GS  ++APEV+
Sbjct: 138 AKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 209 ----SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
               S  Y  ++D+++ G++LY L+ G  P+         Q I              + S
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPY--SNINNRDQIIEMVGRGSLSPDLSKVRS 252

Query: 265 SAIELVRRMLTQ----DPKRRITVAQVLEH 290
           +  + ++R++ +        R +  ++L  
Sbjct: 253 NCPKRMKRLMAECLKKKRDERPSFPRILAE 282

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  130 bits (330), Expect = 5e-34
 Identities = 97/372 (26%), Positives = 150/372 (40%), Gaps = 68/372 (18%)

Query: 9   QDSDHPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIP- 67
                 AA      + G+ ++ V   YT    +G G +G+     +N   +  A K I  
Sbjct: 5   HHMAAAAAAGPEM-VRGQVFD-VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP 62

Query: 68  -------KRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK-----AAYEDDQFVHIVMEL 115
                  +R L          REI+I+       NI+           E  + V+IV +L
Sbjct: 63  FEHQTYCQRTL----------REIKILLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDL 111

Query: 116 CAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAV 175
               +L  +++   H S          I+  +   HS  V+HRDLKP N L    +    
Sbjct: 112 -METDL-YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCD 166

Query: 176 VKATDFGLSAFIEEGKAYR----EIVGSPYYIAPEVL--SQSYGKEADIWSAGVILYILL 229
           +K  DFGL+   +    +     E V + +Y APE++  S+ Y K  DIWS G IL  +L
Sbjct: 167 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

Query: 230 CGVPPFWAET--DQ--------GV-------------AQAILKGEINFQRDP----FPSI 262
              P F  +   DQ        G              A+  L    +  + P    FP+ 
Sbjct: 227 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNA 286

Query: 263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVI---FRMKQFTAMN 319
            S A++L+ +MLT +P +RI V Q L HP+L++  + SD+PI  A       +       
Sbjct: 287 DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLP-KE 345

Query: 320 KLKKLALKVIVE 331
           KLK+L  +    
Sbjct: 346 KLKELIFEETAR 357

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  129 bits (326), Expect = 6e-34
 Identities = 73/301 (24%), Positives = 114/301 (37%), Gaps = 49/301 (16%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR-------REIEIM 87
           Y    E+G G +G  Y   +  +G   A KS+   ++                 RE+ ++
Sbjct: 11  YEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RV--PNGGGGGGGLPISTVREVALL 65

Query: 88  RHLSGQ--PNIVQFK-----AAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAAS 138
           R L     PN+V+       +  + +  V +V E          D+    G         
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKD 124

Query: 139 VFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG 198
           + R  +  ++  H+  ++HRDLKPEN L         VK  DFGL+       A   +V 
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKLADFGLARIYSYQMALTPVVV 181

Query: 199 SPYYIAPEVLSQS-YGKEADIWSAGVILYILLCGVPPFWA--ETDQ-------------- 241
           + +Y APEVL QS Y    D+WS G I   +    P F    E DQ              
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241

Query: 242 ---GVAQ----AILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
                      A         +   P +  S  +L+  MLT +P +RI+  + L+H +L 
Sbjct: 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301

Query: 295 E 295
           +
Sbjct: 302 K 302

>2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} Length = 190

 Score =  125 bits (316), Expect = 6e-34
 Identities = 44/173 (25%), Positives = 75/173 (43%), Gaps = 15/173 (8%)

Query: 317 AMNKLKKLALKVIVE--NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTE 374
           + +KL +  L+ +V       +E+Q+  + F       SG L   E +    +       
Sbjct: 4   SQSKLSQDQLQDLVRSTRFDKKELQQWYKGF--FKDCPSGHLNKSEFQKIYKQFFPFGDP 61

Query: 375 -FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDEL 433
               +      D D NG ID+ EFI A     + +  + L  AFQ +D DNNG I+ DE+
Sbjct: 62  SAFAEYVFNVFDADKNGYIDFKEFICALSVTSRGELNDKLIWAFQLYDLDNNGLISYDEM 121

Query: 434 GKAFKD-YGMG---------DDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
            +     Y M          +D     + +I + +D++KDG+++ +EF    K
Sbjct: 122 LRIVDAIYKMVGSMVKLPEDEDTPEKRVNKIFNMMDKNKDGQLTLEEFCEGSK 174

>2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} Length = 190

 Score = 49.4 bits (118), Expect = 4e-07
 Identities = 19/106 (17%), Positives = 35/106 (33%), Gaps = 20/106 (18%)

Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD------------ 376
           +       +  KL   F   D DN+G ++YDE+   +  +  M+                
Sbjct: 91  VTSRGELND--KLIWAFQLYDLDNNGLISYDEMLRIVDAIYKMVGSMVKLPEDEDTPEKR 148

Query: 377 VKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDK 422
           V +     D + +G +   EF          +R   +  A   +D 
Sbjct: 149 VNKIFNMMDKNKDGQLTLEEFCEG------SKRDPTIVSALSLYDG 188

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  127 bits (321), Expect = 1e-33
 Identities = 65/269 (24%), Positives = 106/269 (39%), Gaps = 25/269 (9%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSI-PKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           T+   +G G FG  Y         E A K+             ++VR+E ++   L   P
Sbjct: 10  TLEEIIGIGGFGKVYRAFWIGD--EVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HP 66

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNV---VNVCH 151
           NI+  +     +  + +VME   GG L   +             +    + +   +N  H
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLH 122

Query: 152 SKG---VMHRDLKPENFL-----FTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI 203
            +    ++HRDLK  N L           N ++K TDFGL+             G+  ++
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-TKMSAAGAYAWM 181

Query: 204 APEVL-SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
           APEV+ +  + K +D+WS GV+L+ LL G  PF       VA  +   +      P PS 
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK---LALPIPST 238

Query: 263 SSSAI-ELVRRMLTQDPKRRITVAQVLEH 290
                 +L+      DP  R +   +L+ 
Sbjct: 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 Length = 193

 Score =  124 bits (314), Expect = 1e-33
 Identities = 42/171 (24%), Positives = 78/171 (45%), Gaps = 15/171 (8%)

Query: 319 NKLKKLALKVIVE--NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTE-F 375
           +KL+   ++ ++E  +    EIQ+  + F  +    SG L+ +E K              
Sbjct: 6   SKLRPEVMQDLLESTDFTEHEIQEWYKGF--LRDCPSGHLSMEEFKKIYGNFFPYGDASK 63

Query: 376 DVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGK 435
             +   +  D +G+GTID+ EFI A     + +  + L  AF  +D D NGYI+  E+ +
Sbjct: 64  FAEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLE 123

Query: 436 AFK---------DYGMGDDATIATI-KEIMSEVDRDKDGRISYDEFRSMMK 476
             +              D++T     ++I  ++D ++DG++S +EF    K
Sbjct: 124 IVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRDGKLSLEEFIRGAK 174

>1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 Length = 193

 Score = 44.4 bits (105), Expect = 2e-05
 Identities = 16/93 (17%), Positives = 35/93 (37%), Gaps = 18/93 (19%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD------------VKQYMQAADI 386
           QKLK  F+  D D +G ++  E+   +  +  M++                ++  +  D 
Sbjct: 99  QKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDT 158

Query: 387 DGNGTIDYIEFITATMQRHKLQRFENLYKAFQY 419
           + +G +   EFI         +   ++ +  Q 
Sbjct: 159 NRDGKLSLEEFIRG------AKSDPSIVRLLQC 185

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  126 bits (319), Expect = 3e-33
 Identities = 69/258 (26%), Positives = 112/258 (43%), Gaps = 22/258 (8%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVE-KDDVRREIEIMRHLSGQ 93
           Y I  ++G G     YL  +    ++ A K        +  E      RE+     LS  
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLS-H 70

Query: 94  PNIVQFKAAY---EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC 150
            NIV   +     E+D   ++VME   G  L + I + G  S   A +    I++ +   
Sbjct: 71  QNIV---SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHA 127

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR--EIVGSPYYIAPEVL 208
           H   ++HRD+KP+N L      N  +K  DFG++  + E    +   ++G+  Y +PE  
Sbjct: 128 HDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE-- 182

Query: 209 SQSYGKEA----DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI-NFQRDPFPSIS 263
            Q+ G+      DI+S G++LY +L G PPF  ET   +A   ++  + N   D    I 
Sbjct: 183 -QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP 241

Query: 264 SSAIELVRRMLTQDPKRR 281
            S   ++ R   +D   R
Sbjct: 242 QSLSNVILRATEKDKANR 259

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  130 bits (328), Expect = 3e-33
 Identities = 74/335 (22%), Positives = 122/335 (36%), Gaps = 71/335 (21%)

Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIP---------KRKLVKDVEKDDV 80
            V   Y   + +G G  GI     +       A K +          KR           
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--------- 109

Query: 81  RREIEIMRHLSGQPNIVQ----FKAAYEDDQF--VHIVMELCAGGELFDRIVARGHYSER 134
            RE+ +M+ +    NI+     F      ++F  V++VMEL     L   I  +      
Sbjct: 110 -RELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVI--QMELDHE 164

Query: 135 AAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR 194
             + +   ++  +   HS G++HRDLKP N +      +  +K  DFGL+          
Sbjct: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMT 221

Query: 195 EIVGSPYYIAPEV-LSQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ--------GV 243
             V + YY APEV L   Y +  DIWS G I+  ++     F      DQ        G 
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281

Query: 244 ------------AQAILKGEINFQRDPFPSI----------------SSSAIELVRRMLT 275
                        +  ++    +    FP +                +S A +L+ +ML 
Sbjct: 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 341

Query: 276 QDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIF 310
            DP +RI+V   L+HP++    + ++       I+
Sbjct: 342 IDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIY 376

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  127 bits (322), Expect = 7e-33
 Identities = 75/335 (22%), Positives = 121/335 (36%), Gaps = 71/335 (21%)

Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIP---------KRKLVKDVEKDDV 80
            V   Y   + +G G  GI     +       A K +          KR           
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--------- 72

Query: 81  RREIEIMRHLSGQPNIVQ----FKAAYEDDQF--VHIVMELCAGGELFDRIVARGHYSER 134
            RE+ +M+ +    NI+     F      ++F  V+IVMEL     L   I  +      
Sbjct: 73  -RELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVI--QMELDHE 127

Query: 135 AAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR 194
             + +   ++  +   HS G++HRDLKP N +      +  +K  DFGL+          
Sbjct: 128 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMT 184

Query: 195 EIVGSPYYIAPEV-LSQSYGKEADIWSAGVILYILLCGVPPFWAE--TDQ--------GV 243
             V + YY APEV L   Y +  DIWS G I+  ++ G   F      DQ        G 
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 244

Query: 244 ------------AQAILKGEINFQRDPFPSI----------------SSSAIELVRRMLT 275
                        +  ++    +    F  +                +S A +L+ +ML 
Sbjct: 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 304

Query: 276 QDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIF 310
            D  +RI+V + L+HP++    + S+       I 
Sbjct: 305 IDASKRISVDEALQHPYINVWYDPSEAEAPPPKIP 339

>2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} Length = 191

 Score =  122 bits (308), Expect = 9e-33
 Identities = 18/174 (10%), Positives = 49/174 (28%), Gaps = 29/174 (16%)

Query: 328 VIVENLPTEEIQKLKEKFTEM-DTDNSGTLTYDELKAGLAKLGSMLT------------- 373
           +    L   +  K+   F    D ++ G + +D+ +  + K+ ++ +             
Sbjct: 1   MAAHQLSDFQRNKILRVFNTFYDCNHDGVIEWDDFELAIKKICNLHSWPTDGKKHNEARA 60

Query: 374 --EFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFEN---------LYKAFQYFDK 422
             +       + AD + +  +   E++    +  K               +   F   D 
Sbjct: 61  TLKLIWDGLRKYADENEDEQVTKEEWLKMWAECVKSVEKGESLPEWLTKYMNFMFDVNDT 120

Query: 423 DNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
             +  I   E    +  YG+               +       ++ + F  +  
Sbjct: 121 SGDNIIDKHEYSTVYMSYGIPKS----DCDAAFDTLSDGGKTMVTREIFARLWT 170

>2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} Length = 191

 Score = 65.6 bits (160), Expect = 1e-12
 Identities = 15/114 (13%), Positives = 36/114 (31%), Gaps = 11/114 (9%)

Query: 345 FTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD---------VKQYMQAADIDGNGTIDYI 395
               D +    +T +E     A+    + + +         +       D  G+  ID  
Sbjct: 70  RKYADENEDEQVTKEEWLKMWAECVKSVEKGESLPEWLTKYMNFMFDVNDTSGDNIIDKH 129

Query: 396 EFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA 449
           E+ T     + + +  +   AF          +T +   + + +Y + +D    
Sbjct: 130 EYSTV-YMSYGIPK-SDCDAAFDTLSDGGKTMVTREIFARLWTEYFVSNDRGAK 181

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  126 bits (319), Expect = 1e-32
 Identities = 86/329 (26%), Positives = 134/329 (40%), Gaps = 70/329 (21%)

Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIP--------KRKLVKDVEKDDVR 81
           ++   + +   +G G +G+    T   TG   A K I          R L          
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL---------- 57

Query: 82  REIEIMRHLSGQPNIVQFK-----AAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAA 136
           REI+I++H     NI+         ++E+   V+I+ EL    +L  R+++    S+   
Sbjct: 58  REIKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQEL-MQTDL-HRVISTQMLSDDHI 114

Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI 196
                  +  V V H   V+HRDLKP N L    + N  +K  DFGL+  I+E  A    
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSE 171

Query: 197 VGSP-----------YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPF-------- 235
                          +Y APEV+  S  Y +  D+WS G IL  L    P F        
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231

Query: 236 -----------WAETDQGV-----AQAILKGEINFQRDP----FPSISSSAIELVRRMLT 275
                       ++ D        A+  +K    +   P    FP ++   I+L++RML 
Sbjct: 232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLV 291

Query: 276 QDPKRRITVAQVLEHPWLKESGEASDKPI 304
            DP +RIT  + LEHP+L+   + +D+P 
Sbjct: 292 FDPAKRITAKEALEHPYLQTYHDPNDEPE 320

>1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C Length = 151

 Score =  120 bits (303), Expect = 2e-32
 Identities = 31/149 (20%), Positives = 63/149 (42%), Gaps = 10/149 (6%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADID--GNG 390
              +++++ KE F   D    G + Y +    +  LG   T  +V + +     D   + 
Sbjct: 4   FNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSR 63

Query: 391 TIDYIEFITATMQRHKLQR----FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDA 446
            +D+  F+   +Q     R    +E+  + F+ FDK+ NG +   EL        +G+  
Sbjct: 64  RVDFETFLPM-LQAVAKNRGQGTYEDYLEGFRVFDKEGNGKVMGAELRHVLTT--LGEKM 120

Query: 447 TIATIKEIMSEVDRDKDGRISYDEFRSMM 475
           T   ++ ++     D +G I+Y+ F   +
Sbjct: 121 TEEEVETVL-AGHEDSNGCINYEAFLKHI 148

>1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C Length = 151

 Score = 56.4 bits (137), Expect = 7e-10
 Identities = 20/70 (28%), Positives = 33/70 (47%), Gaps = 1/70 (1%)

Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           + +N      +   E F   D + +G +   EL+  L  LG  +TE +V+  + A   D 
Sbjct: 77  VAKNRGQGTYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVET-VLAGHEDS 135

Query: 389 NGTIDYIEFI 398
           NG I+Y  F+
Sbjct: 136 NGCINYEAFL 145

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  125 bits (316), Expect = 2e-32
 Identities = 66/299 (22%), Positives = 116/299 (38%), Gaps = 47/299 (15%)

Query: 35  YTIGREVGRGEFGITYLCTE-NSTGLEFACKSIPKRKLVKDVEKDDV----RREIEIMRH 89
           Y    E+G G +G  +   +  + G   A K +   ++     ++ +     RE+ ++RH
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRV---RV--QTGEEGMPLSTIREVAVLRH 67

Query: 90  LSGQ--PNIVQFK-----AAYEDDQFVHIVMELCAG--GELFDRIVARGHYSERAAASVF 140
           L     PN+V+       +  + +  + +V E          D++             + 
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMM 126

Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP 200
             ++  ++  HS  V+HRDLKP+N L      +  +K  DFGL+       A   +V + 
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTL 183

Query: 201 YYIAPEVLSQS-YGKEADIWSAGVILYILLCGVPPFWA--ETDQ---------------- 241
           +Y APEVL QS Y    D+WS G I   +    P F    + DQ                
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243

Query: 242 -GVAQAILKGEINFQRDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
                   +   +    P       I     +L+ + LT +P +RI+    L HP+ ++
Sbjct: 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302

>3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} Length = 196

 Score =  121 bits (305), Expect = 2e-32
 Identities = 30/150 (20%), Positives = 65/150 (43%), Gaps = 10/150 (6%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
               ++Q+ KE F  +D D  G ++ ++++A    LG + TE ++   +     +  G I
Sbjct: 51  FTQHQVQEFKEAFQLIDQDKDGFISKNDIRATFDSLGRLCTEQELDSMVA----EAPGPI 106

Query: 393 DYIEFITATMQRHKLQR--FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIAT 450
           ++  F+T             + +  AF  FD + +G    + L ++      G+  +   
Sbjct: 107 NFTMFLTI-FGDRIAGTDEEDVIVNAFNLFD-EGDGKCKEETLKRSLTT--WGEKFSQDE 162

Query: 451 IKEIMSEVDRDKDGRISYDEFRSMMKCGTQ 480
           + + +SE   D +G I   +F  ++  G +
Sbjct: 163 VDQALSEAPIDGNGLIDIKKFAQILTKGAK 192

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  124 bits (314), Expect = 3e-32
 Identities = 67/263 (25%), Positives = 113/263 (42%), Gaps = 27/263 (10%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVE-KDDVRREIEIMRHLSGQ 93
           Y +G  +G G     +L  +     + A K + +  L +D       RRE +    L+  
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALN-H 71

Query: 94  PNIVQFKAAY---EDD----QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNV 146
           P IV   A Y   E +       +IVME   G  L D +   G  + + A  V       
Sbjct: 72  PAIV---AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128

Query: 147 VNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSPYY 202
           +N  H  G++HRD+KP N + +       VK  DFG++  I +          ++G+  Y
Sbjct: 129 LNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185

Query: 203 IAPEVLSQSYGKEA----DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
           ++PE   Q+ G       D++S G +LY +L G PPF  ++   VA   ++ +       
Sbjct: 186 LSPE---QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 242

Query: 259 FPSISSSAIELVRRMLTQDPKRR 281
              +S+    +V + L ++P+ R
Sbjct: 243 HEGLSADLDAVVLKALAKNPENR 265

>2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* Length = 149

 Score =  118 bits (299), Expect = 6e-32
 Identities = 30/149 (20%), Positives = 57/149 (38%), Gaps = 10/149 (6%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADID--GNG 390
                    KE F   D      +T  ++      LG   T  ++ + +     +     
Sbjct: 2   FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNAA 61

Query: 391 TIDYIEFITATMQRHKLQR----FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDA 446
            I + EF+   +Q     +    FE+  +  + FDK+ NG +   EL        +G+  
Sbjct: 62  AITFEEFLPM-LQAAANNKDQGTFEDFVEGLRVFDKEGNGTVMGAELRHVLAT--LGEKM 118

Query: 447 TIATIKEIMSEVDRDKDGRISYDEFRSMM 475
           T   ++E+M   + D +G I+Y+ F   +
Sbjct: 119 TEEEVEELMKGQE-DSNGCINYEAFVKHI 146

>2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A Length = 146

 Score =  117 bits (296), Expect = 1e-31
 Identities = 24/145 (16%), Positives = 51/145 (35%), Gaps = 11/145 (7%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
              E++ +   +    +  + G ++ D       KLG   +  D K+  +         +
Sbjct: 9   QLEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGLAPSSIDEKKIKE----LYGDNL 64

Query: 393 DYIEFITATMQRHKLQR--FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIAT 450
            Y +++   +      +   E L K F +FD +  GY+T  ++         GD  T   
Sbjct: 65  TYEQYLEY-LSICVHDKDNVEELIKMFAHFDNNCTGYLTKSQMKNILTT--WGDALTDQE 121

Query: 451 IKEIMSEVDRDKDGRISYDEFRSMM 475
             + ++      +  I Y  F   +
Sbjct: 122 AIDALNAF--SSEDNIDYKLFCEDI 144

>2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A Length = 146

 Score = 52.6 bits (127), Expect = 1e-08
 Identities = 18/70 (25%), Positives = 32/70 (45%), Gaps = 2/70 (2%)

Query: 334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTID 393
             + +++L + F   D + +G LT  ++K  L   G  LT+ +    + A   + N  ID
Sbjct: 79  DKDNVEELIKMFAHFDNNCTGYLTKSQMKNILTTWGDALTDQEAIDALNAFSSEDN--ID 136

Query: 394 YIEFITATMQ 403
           Y  F    +Q
Sbjct: 137 YKLFCEDILQ 146

>1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... Length = 156

 Score =  117 bits (296), Expect = 2e-31
 Identities = 35/153 (22%), Positives = 63/153 (41%), Gaps = 9/153 (5%)

Query: 333 LPTEEIQKLKEKFTEMD--TDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
           L  +EI  LK+ F   D      G +   +L      LG      DV   +      G  
Sbjct: 3   LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFA-VGGTHKMGEK 61

Query: 391 TIDYIEFITATMQRHKLQR--FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           ++ + EF+ A       ++  F +  +AF+ FD++  G+I+  EL        +G+  + 
Sbjct: 62  SLPFEEFLPAYEGLMDCEQGTFADYMEAFKTFDREGQGFISGAELRHVLTA--LGERLSD 119

Query: 449 ATIKEIMSEVD--RDKDGRISYDEFRSMMKCGT 479
             + EI+   D   D +G + Y++F   +  G 
Sbjct: 120 EDVDEIIKLTDLQEDLEGNVKYEDFVKKVMAGP 152

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  122 bits (309), Expect = 3e-31
 Identities = 69/324 (21%), Positives = 119/324 (36%), Gaps = 72/324 (22%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR----REIEIMRHL 90
           Y    ++G+G FG  +      TG + A K +    +  + EK+       REI+I++ L
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKV---LM--ENEKEGFPITALREIKILQLL 73

Query: 91  SGQPNIVQFK--------AAYEDDQFVHIVMELC----AGGELFDRIVARGHYSERAAAS 138
               N+V                   +++V + C    AG  L   +     ++      
Sbjct: 74  K-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFTLSEIKR 128

Query: 139 VFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIV 197
           V ++++N +   H   ++HRD+K  N L      + V+K  DFGL+ AF     +     
Sbjct: 129 VMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQP--- 182

Query: 198 GSPY--------YIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQ------ 241
            + Y        Y  PE+L   + YG   D+W AG I+  +    P     T+Q      
Sbjct: 183 -NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 241

Query: 242 -------------GVAQAILKGEINFQ-------RDPFPSI--SSSAIELVRRMLTQDPK 279
                         V    L  ++          +D   +      A++L+ ++L  DP 
Sbjct: 242 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 301

Query: 280 RRITVAQVLEHPWLKESGEASDKP 303
           +RI     L H +       SD  
Sbjct: 302 QRIDSDDALNHDFFWSDPMPSDLK 325

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  121 bits (306), Expect = 3e-31
 Identities = 66/258 (25%), Positives = 112/258 (43%), Gaps = 22/258 (8%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVE-KDDVRREIEIMRHLSG 92
            Y + R VGRG  G  Y   +       A K +    L  D   +  ++RE      L  
Sbjct: 35  PYRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQ- 92

Query: 93  QPNIVQFKAAY---EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
           +P++V     +   E D  +++ M L  G +L   +  +G  +   A ++ R I + ++ 
Sbjct: 93  EPHVV---PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR--EIVGSPYYIAPEV 207
            H+ G  HRD+KPEN L +  D        DFG+++   + K  +    VG+ YY+APE 
Sbjct: 150 AHAAGATHRDVKPENILVSADD---FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE- 205

Query: 208 LSQSYGKEA----DIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263
             +     A    DI++   +LY  L G PP+  +    V  A +   I       P I 
Sbjct: 206 --RFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIP 262

Query: 264 SSAIELVRRMLTQDPKRR 281
            +   ++ R + ++P+ R
Sbjct: 263 VAFDAVIARGMAKNPEDR 280

>1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 Length = 140

 Score =  116 bits (292), Expect = 4e-31
 Identities = 31/145 (21%), Positives = 56/145 (38%), Gaps = 12/145 (8%)

Query: 335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDY 394
           + +    K+ F+  D   +G +    +   L   G   T  ++ +     +      +D 
Sbjct: 1   STDDSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEI----ESTLPAEVDM 56

Query: 395 IEFITATMQRHKLQR----FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIAT 450
            +F+   + R          E   K FQ FDKD  G I V EL        +G+  +   
Sbjct: 57  EQFLQV-LNRPNGFDMPGDPEEFVKGFQVFDKDATGMIGVGELRYVLT--SLGEKLSNEE 113

Query: 451 IKEIMSEVDRDKDGRISYDEFRSMM 475
           + E++  V    DG ++Y +F  M+
Sbjct: 114 MDELLKGVPVK-DGMVNYHDFVQMI 137

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  122 bits (309), Expect = 5e-31
 Identities = 69/322 (21%), Positives = 113/322 (35%), Gaps = 70/322 (21%)

Query: 37  IGREVGRGEFGITY--LCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
            G +VGRG +G  Y     +     ++A K     ++          REI ++R L   P
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALK-----QIEGTGISMSACREIALLRELK-HP 78

Query: 95  NIVQFKAAYED--DQFVHIVME--------LCAGGELFDRIVARGHYSERAAASVFRVIM 144
           N++  +  +    D+ V ++ +        +                      S+   I+
Sbjct: 79  NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 145 NVVNVCHSKGVMHRDLKPENFLFTT-GDENAVVKATDFGLS-AFIEEGKAY----REIVG 198
           + ++  H+  V+HRDLKP N L    G E   VK  D G +  F    K        +V 
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV- 197

Query: 199 SPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE----- 251
           + +Y APE+L  ++ Y K  DIW+ G I   LL   P F    +          +     
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257

Query: 252 --------------------------------------INFQRDPFPSISSSAIELVRRM 273
                                                 I +         S A  L++++
Sbjct: 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKL 317

Query: 274 LTQDPKRRITVAQVLEHPWLKE 295
           LT DP +RIT  Q ++ P+  E
Sbjct: 318 LTMDPIKRITSEQAMQDPYFLE 339

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  124 bits (314), Expect = 1e-30
 Identities = 59/256 (23%), Positives = 94/256 (36%), Gaps = 34/256 (13%)

Query: 35  YTIGREVGRGEFGITYLCT-ENSTGLEFACKSIPKRKLVKDVEKDDV---RREIEIMRHL 90
           Y +   +  G  G  YL    N  G     K      LV   + +       E + +  +
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKG-----LVHSGDAEAQAMAMAERQFLAEV 136

Query: 91  SGQPNIVQ-----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
              P+IVQ            D   +IVME   G  L              A +    I+ 
Sbjct: 137 V-HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILP 193

Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAP 205
            ++  HS G+++ DLKPEN + T       +K  D G  + I    ++  + G+P + AP
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLTEEQ----LKLIDLGAVSRIN---SFGYLYGTPGFQAP 246

Query: 206 EVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265
           E++        DI++ G  L  L   +P        G+           + DP      S
Sbjct: 247 EIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------EDDPVLKTYDS 296

Query: 266 AIELVRRMLTQDPKRR 281
              L+RR +  DP++R
Sbjct: 297 YGRLLRRAIDPDPRQR 312

>1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A Length = 173

 Score =  114 bits (288), Expect = 3e-30
 Identities = 30/148 (20%), Positives = 58/148 (39%), Gaps = 18/148 (12%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD--------VKQYMQAADID 387
           EE+++ +  F ++  D+   ++  EL   L K+ +   +           +  +   D D
Sbjct: 1   EEVRQFRRLFAQLAGDD-MEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSD 59

Query: 388 GNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
             G + + EF        K Q        ++ FD D +G I   EL  AF+  G   +  
Sbjct: 60  TTGKLGFEEFKYLWNNIKKWQ------AIYKQFDVDRSGTIGSSELPGAFEAAGFHLN-- 111

Query: 448 IATIKEIMSEVDRDKDGRISYDEFRSMM 475
              +  ++     D+ G + +D F S +
Sbjct: 112 -EHLYSMIIRRYSDEGGNMDFDNFISCL 138

>1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A Length = 173

 Score = 90.6 bits (225), Expect = 2e-21
 Identities = 26/98 (26%), Positives = 43/98 (43%), Gaps = 7/98 (7%)

Query: 335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDY 394
              I+K +  + + D D SGT+   EL       G  L E  +   +     D  G +D+
Sbjct: 73  WNNIKKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNE-HLYSMIIRRYSDEGGNMDF 131

Query: 395 IEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDE 432
             FI+  +      R + +++AF+  DKD  G I V+ 
Sbjct: 132 DNFISCLV------RLDAMFRAFKSLDKDGTGQIQVNI 163

>1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A Length = 173

 Score = 55.5 bits (134), Expect = 2e-09
 Identities = 13/80 (16%), Positives = 31/80 (38%), Gaps = 7/80 (8%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGM------GDDATIATIKEIMSEVDRDKDG 464
               + F     D+   ++  EL                D   I T + +++ +D D  G
Sbjct: 4   RQFRRLFAQLAGDD-MEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTG 62

Query: 465 RISYDEFRSMMKCGTQLRAL 484
           ++ ++EF+ +     + +A+
Sbjct: 63  KLGFEEFKYLWNNIKKWQAI 82

>1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A Length = 173

 Score = 40.5 bits (95), Expect = 3e-04
 Identities = 17/80 (21%), Positives = 33/80 (41%), Gaps = 12/80 (15%)

Query: 325 ALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAA 384
           A +    +L       +  +++    D  G + +D   + L +L +M   F      ++ 
Sbjct: 102 AFEAAGFHLNEHLYSMIIRRYS----DEGGNMDFDNFISCLVRLDAMFRAF------KSL 151

Query: 385 DIDGNGTI--DYIEFITATM 402
           D DG G I  +  E++  TM
Sbjct: 152 DKDGTGQIQVNIQEWLQLTM 171

>2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A Length = 108

 Score =  111 bits (280), Expect = 7e-30
 Identities = 25/110 (22%), Positives = 48/110 (43%), Gaps = 5/110 (4%)

Query: 368 LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGY 427
           L  +L+  D+   ++  D     +    +F    +     +    L + F+  D D +G+
Sbjct: 2   LTDILSPSDIAAALR--DCQAPDSFSPKKFFQ--ISGMSKKSSSQLKEIFRILDNDQSGF 57

Query: 428 ITVDELGKAFKDYGMGDDA-TIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           I  DEL    + +  G    T +  K  ++  D D DG+I  +EF+ M++
Sbjct: 58  IEEDELKYFLQRFESGARVLTASETKTFLAAADHDGDGKIGAEEFQEMVQ 107

>2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A Length = 108

 Score = 95.0 bits (237), Expect = 7e-24
 Identities = 29/103 (28%), Positives = 45/103 (43%), Gaps = 4/103 (3%)

Query: 300 SDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYD 359
           +D    + +   ++   A +         I   +  +   +LKE F  +D D SG +  D
Sbjct: 3   TDILSPSDIAAALRDCQAPDSFSPKKFFQISG-MSKKSSSQLKEIFRILDNDQSGFIEED 61

Query: 360 ELKAGLAKLGSM---LTEFDVKQYMQAADIDGNGTIDYIEFIT 399
           ELK  L +  S    LT  + K ++ AAD DG+G I   EF  
Sbjct: 62  ELKYFLQRFESGARVLTASETKTFLAAADHDGDGKIGAEEFQE 104

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  118 bits (298), Expect = 1e-29
 Identities = 69/334 (20%), Positives = 125/334 (37%), Gaps = 86/334 (25%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK--DDVRREIEIMRHLS- 91
           Y + R++G G F   +L  +       A K      +V+  +   +    EI++++ ++ 
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMK------IVRGDKVYTEAAEDEIKLLQRVND 74

Query: 92  ---------GQPNIVQFKAAYEDDQFVH---------IVMELCAGGELFDRIVARGH--Y 131
                    G  +I++       D F H         +V E+  G  L   I    H   
Sbjct: 75  ADNTKEDSMGANHILKLL-----DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGI 128

Query: 132 SERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENA---VVKATDFGLSAFI 187
                  + + ++  ++  H + G++H D+KPEN L    D       +K  D G + + 
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188

Query: 188 EEGKAYREIVGSPYYIAPEV-LSQSYGKEADIWSAGVILYILLCGVPPF-------WAET 239
           +E      I  +  Y +PEV L   +G  ADIWS   +++ L+ G   F       + + 
Sbjct: 189 DE-HYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246

Query: 240 DQGVAQAI-LKGEI-------------------------NFQRDPFPSISSSA------- 266
           D  +AQ I L GE+                           +  P   + +         
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306

Query: 267 ----IELVRRMLTQDPKRRITVAQVLEHPWLKES 296
                + +  ML  DP++R     ++ HPWLK++
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340

>1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 87

 Score =  110 bits (277), Expect = 1e-29
 Identities = 45/77 (58%), Positives = 55/77 (71%)

Query: 327 KVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADI 386
           K + E L  EEI  LKE F  +DTDNSGT+T+DELK GL ++GS L E ++K  M AADI
Sbjct: 11  KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADI 70

Query: 387 DGNGTIDYIEFITATMQ 403
           D +GTIDY EFI AT+ 
Sbjct: 71  DKSGTIDYGEFIAATVH 87

>1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 87

 Score = 87.6 bits (218), Expect = 2e-21
 Identities = 29/91 (31%), Positives = 42/91 (46%), Gaps = 8/91 (8%)

Query: 387 DGNGTIDYIEFITATMQRHKL--QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGD 444
             +G ID  +   A     +L  +    L + F+  D DN+G IT DEL    K   +G 
Sbjct: 1   HSSGHIDDDDKHMA----ERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKR--VGS 54

Query: 445 DATIATIKEIMSEVDRDKDGRISYDEFRSMM 475
           +   + IK++M   D DK G I Y EF +  
Sbjct: 55  ELMESEIKDLMDAADIDKSGTIDYGEFIAAT 85

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  118 bits (297), Expect = 2e-29
 Identities = 79/358 (22%), Positives = 127/358 (35%), Gaps = 93/358 (25%)

Query: 25  GKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIP---------KRKLVKDV 75
           G+    V   Y + +++G+G +GI +   +  TG   A K I          +R      
Sbjct: 1   GRVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF---- 56

Query: 76  EKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF--VHIVMELCAGGELFDRIVARGHYSE 133
                 REI I+  LSG  NIV        D    V++V +     +L   ++       
Sbjct: 57  ------REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY-METDL-HAVIRANILEP 108

Query: 134 RAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY 193
                V   ++ V+   HS G++HRD+KP N L    +    VK  DFGLS      +  
Sbjct: 109 VHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRV 165

Query: 194 REIVGSP----------------------YYIAPEVL--SQSYGKEADIWSAGVILYILL 229
              +                         +Y APE+L  S  Y K  D+WS G IL  +L
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225

Query: 230 CGVP-----------------------------------------PFWAETDQGVAQAIL 248
           CG P                                             E  Q   + I 
Sbjct: 226 CGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIF 285

Query: 249 KGEINF--QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPI 304
               N   + +P    +  A++L+ ++L  +P +RI+    L+HP++      +++P 
Sbjct: 286 TKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPN 343

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  119 bits (299), Expect = 2e-29
 Identities = 87/413 (21%), Positives = 144/413 (34%), Gaps = 99/413 (23%)

Query: 9   QDSDHPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPK 68
               H + R        K    V  +Y I   +GRG +G  YL  + +T    A K + +
Sbjct: 3   HHHHHSSGRENLYFQGIKNVH-VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR 61

Query: 69  RKLVKDVEKDDVR--REIEIMRHLSGQPNIVQFK-----AAYEDDQFVHIVMELCAGGEL 121
              + +   D  R  REI I+  L     I++               ++IV+E+ A  +L
Sbjct: 62  ---MFEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDDLLKFDELYIVLEI-ADSDL 116

Query: 122 FDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDF 181
                     +E    ++   ++   N  H  G++HRDLKP N L    +++  VK  DF
Sbjct: 117 KKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDF 173

Query: 182 GLSAFIEEGKAYREIVGSP-----------------------YYIAPEVL--SQSYGKEA 216
           GL+  I   K    +                           +Y APE++   ++Y K  
Sbjct: 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI 233

Query: 217 DIWSAGVILYILLCGVPPFWAET------------------------------DQ----- 241
           DIWS G I   LL  +     +                               DQ     
Sbjct: 234 DIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIF 293

Query: 242 ----------------GVAQAILKGEINFQRDPF----PSISSSAIELVRRMLTQDPKRR 281
                                 +K   + +        PSIS   I L+  ML  +P +R
Sbjct: 294 NIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKR 353

Query: 282 ITVAQVLEHPWLKESGEASDKPI-DTAVIFRMKQFTAMNK--LKKLALKVIVE 331
           IT+ Q L+HP+LK+  +   +      +I     +  +++  L+ + LK +  
Sbjct: 354 ITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQS 406

>1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 Length = 224

 Score =  110 bits (277), Expect = 3e-28
 Identities = 36/188 (19%), Positives = 69/188 (36%), Gaps = 13/188 (6%)

Query: 300 SDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYD 359
             +P    +   ++     ++ + L       N    E+Q L   F   +   SG +  +
Sbjct: 15  QRRPSKDKIEDELEMTMVCHRPEGLEQLEAQTNFTKRELQVLYRGF--KNECPSGVVNEE 72

Query: 360 ELKAGLAKLGSMLTEFDVKQYM-QAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQ 418
             K   A+            Y+  A D    G++ + +F+TA     +    E L   F 
Sbjct: 73  TFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFN 132

Query: 419 YFDKDNNGYITVDELGKAFK---------DYGMGDDATIATI-KEIMSEVDRDKDGRISY 468
            +D + +GYI  +E+    K          Y +  + T          ++D++KDG ++ 
Sbjct: 133 LYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTL 192

Query: 469 DEFRSMMK 476
           DEF    +
Sbjct: 193 DEFLESCQ 200

>1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 Length = 224

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 19/96 (19%), Positives = 36/96 (37%), Gaps = 18/96 (18%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDEL----KAGLAKLGSMLTEFD--------VKQYMQAADI 386
           +KL+  F   D +  G +  +E+    KA    +G               V  + Q  D 
Sbjct: 125 EKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDK 184

Query: 387 DGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDK 422
           + +G +   EF+ +       Q  +N+ ++ Q F  
Sbjct: 185 NKDGIVTLDEFLES------CQEDDNIMRSLQLFQN 214

>1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A Length = 109

 Score =  106 bits (267), Expect = 6e-28
 Identities = 29/110 (26%), Positives = 54/110 (49%), Gaps = 5/110 (4%)

Query: 368 LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGY 427
           +  +L+  D+K+ + A       + D+ +F      + K    +++ K F   DKD +G+
Sbjct: 2   MTDLLSAEDIKKAIGAFTAAD--SFDHKKFFQMVGLKKKSA--DDVKKVFHILDKDKSGF 57

Query: 428 ITVDELGKAFKDYG-MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           I  DELG   K +     D +    K +M+  D+D DG+I  +EF +++ 
Sbjct: 58  IEEDELGSILKGFSSDARDLSAKETKTLMAAGDKDGDGKIGVEEFSTLVA 107

>1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A Length = 109

 Score = 99.7 bits (249), Expect = 2e-25
 Identities = 29/103 (28%), Positives = 43/103 (41%), Gaps = 4/103 (3%)

Query: 300 SDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYD 359
           +D      +   +  FTA +         +V  L  +    +K+ F  +D D SG +  D
Sbjct: 3   TDLLSAEDIKKAIGAFTAADSFDHKKFFQMV-GLKKKSADDVKKVFHILDKDKSGFIEED 61

Query: 360 ELKAGLAKLGSM---LTEFDVKQYMQAADIDGNGTIDYIEFIT 399
           EL + L    S    L+  + K  M A D DG+G I   EF T
Sbjct: 62  ELGSILKGFSSDARDLSAKETKTLMAAGDKDGDGKIGVEEFST 104

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  112 bits (281), Expect = 8e-28
 Identities = 57/301 (18%), Positives = 106/301 (35%), Gaps = 63/301 (20%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEI-----MRHL 90
           T+   VG+G +G  +  +        A K    R      ++    RE E+     +RH 
Sbjct: 11  TLLECVGKGRYGEVWRGSWQGE--NVAVKIFSSR------DEKSWFRETELYNTVMLRH- 61

Query: 91  SGQPNIVQFKAAYEDDQFVH----IVMELCAGGELFDRIVARGHYSERAAASVFRVI--- 143
               NI+ F A+    +       ++      G L+D  +        +   +   I   
Sbjct: 62  ---ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLSIASG 117

Query: 144 -----MNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREI-- 196
                + +        + HRDLK +N L     +N      D GL+    +     ++  
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGN 174

Query: 197 ---VGSPYYIAPEVL-------SQSYGKEADIWSAGVILYILLCGV----------PPFW 236
              VG+  Y+APEVL            K  DIW+ G++L+ +   +          PPF+
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234

Query: 237 AETDQGVAQAILKGEINFQ--RDPFPSISSSA------IELVRRMLTQDPKRRITVAQVL 288
                  +   ++  +     R   P+   S        +L++    Q+P  R+T  ++ 
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294

Query: 289 E 289
           +
Sbjct: 295 K 295

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  111 bits (278), Expect = 3e-27
 Identities = 66/313 (21%), Positives = 107/313 (34%), Gaps = 87/313 (27%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEI-----MRHL 90
            +   +G+G FG  +       G E A K    R      E+    RE EI     +RH 
Sbjct: 45  VLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR------EERSWFREAEIYQTVMLRH- 95

Query: 91  SGQPNIVQFKAAYEDDQFVH----IVMELCAGGELFD-------------RI---VARG- 129
               NI+ F AA   D        +V +    G LFD             ++    A G 
Sbjct: 96  ---ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGL 152

Query: 130 ---HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186
              H             M +V       + HRDLK +N L     +N      D GL+  
Sbjct: 153 AHLH-------------MEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVR 196

Query: 187 IEEGKAYREI-----VGSPYYIAPEVLSQS-------YGKEADIWSAGVILYILLCGV-- 232
            +      +I     VG+  Y+APEVL  S         K ADI++ G++ + +      
Sbjct: 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256

Query: 233 --------PPFWAETDQGVAQAILKGEINFQ--RDPFPSISSSA------IELVRRMLTQ 276
                    P++       +   ++  +  Q  R   P+   S        +++R     
Sbjct: 257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 316

Query: 277 DPKRRITVAQVLE 289
           +   R+T  ++ +
Sbjct: 317 NGAARLTALRIKK 329

>1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A Length = 108

 Score =  103 bits (260), Expect = 4e-27
 Identities = 25/110 (22%), Positives = 46/110 (41%), Gaps = 5/110 (4%)

Query: 368 LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGY 427
           +  +L+  D+   +Q        T +  +F   +           +   F++ D D +GY
Sbjct: 2   ITDILSAEDIAAALQECQ--DPDTFEPQKFFQTSGLSKMSA--SQVKDIFRFIDNDQSGY 57

Query: 428 ITVDELGKAFKDYG-MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           +  DEL    + +     + T +  K +M   D D DG+I  DEF+ M+ 
Sbjct: 58  LDGDELKYFLQKFQSDARELTESETKSLMDAADNDGDGKIGADEFQEMVH 107

>1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A Length = 108

 Score = 93.1 bits (232), Expect = 4e-23
 Identities = 32/103 (31%), Positives = 44/103 (42%), Gaps = 8/103 (7%)

Query: 300 SDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYD 359
           S + I  A    +++    +  +          L      ++K+ F  +D D SG L  D
Sbjct: 7   SAEDIAAA----LQECQDPDTFEPQKF-FQTSGLSKMSASQVKDIFRFIDNDQSGYLDGD 61

Query: 360 ELKAGLAKLGSM---LTEFDVKQYMQAADIDGNGTIDYIEFIT 399
           ELK  L K  S    LTE + K  M AAD DG+G I   EF  
Sbjct: 62  ELKYFLQKFQSDARELTESETKSLMDAADNDGDGKIGADEFQE 104

>2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 Length = 185

 Score =  106 bits (266), Expect = 4e-27
 Identities = 16/166 (9%), Positives = 55/166 (33%), Gaps = 29/166 (17%)

Query: 336 EEIQKLKEKFTEM-DTDNSGTLTYDELKAGLAKLGSM---------------LTEFDVKQ 379
            + QK+K  F    D ++ G++  ++ +  + +   +                 E + + 
Sbjct: 5   FQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRD 64

Query: 380 YMQAADIDGNGTIDYIEFITATMQRHKLQRFEN---------LYKAFQYFDKDNNGYITV 430
               ADI+ +  + + E++    +     +            +   F+  D   +G + +
Sbjct: 65  LKGRADINKDDVVSWEEYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDL 124

Query: 431 DELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           +E     K++ +        +  + + +          + ++ +  
Sbjct: 125 EEFQNYCKNFQLQCA----DVPAVYNVITDGGKVTFDLNRYKELYY 166

>2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 Length = 185

 Score = 55.7 bits (134), Expect = 3e-09
 Identities = 13/111 (11%), Positives = 33/111 (29%), Gaps = 11/111 (9%)

Query: 345 FTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD---------VKQYMQAADIDGNGTIDYI 395
               D +    ++++E  A   K  +               +    +  D+ G+G +D  
Sbjct: 66  KGRADINKDDVVSWEEYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLE 125

Query: 396 EFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDA 446
           EF     +  +LQ   ++   +            ++   + +        A
Sbjct: 126 EFQNY-CKNFQLQC-ADVPAVYNVITDGGKVTFDLNRYKELYYRLLTSPAA 174

>2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 Length = 185

 Score = 54.9 bits (132), Expect = 5e-09
 Identities = 13/70 (18%), Positives = 20/70 (28%), Gaps = 2/70 (2%)

Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
            +LP     ++   F  MD    G +  +E +         L   DV          G  
Sbjct: 97  ADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCADVPAVYNVITDGGKV 154

Query: 391 TIDYIEFITA 400
           T D   +   
Sbjct: 155 TFDLNRYKEL 164

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  111 bits (280), Expect = 7e-27
 Identities = 73/331 (22%), Positives = 113/331 (34%), Gaps = 85/331 (25%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK--DDVRREIEIMRHLS- 91
           Y + + +G+G FG      ++      A K      +V++ ++       EI I+ HL  
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALK------MVRNEKRFHRQAAEEIRILEHLRK 152

Query: 92  ----GQPNIVQFKAAYEDDQFVH-----IVMELCAGGELFDRIVARGH--YSERAAASVF 140
                  N++        + F       +  EL     L++ I       +S        
Sbjct: 153 QDKDNTMNVIHML-----ENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFA 206

Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP 200
             I+  ++  H   ++H DLKPEN L      + + K  DFG S+  E  + Y  I  S 
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGI-KVIDFG-SSCYEHQRVYTYIQ-SR 263

Query: 201 YYIAPEV-LSQSYGKEADIWSAGVILYIL---------------------LCGVPPFW-- 236
           +Y APEV L   YG   D+WS G IL  L                     L G+P     
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323

Query: 237 ----------------------AETDQGVAQAILKGEINFQRDPFPSISSSA-------- 266
                                   +D  V     +      R P  S             
Sbjct: 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383

Query: 267 --IELVRRMLTQDPKRRITVAQVLEHPWLKE 295
             ++ +++ L  DP  R+T  Q L HPWL+ 
Sbjct: 384 LFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  109 bits (275), Expect = 8e-27
 Identities = 59/313 (18%), Positives = 102/313 (32%), Gaps = 87/313 (27%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEI-----MRHL 90
            + +++G+G +G  ++        + A K           E+    RE EI     MRH 
Sbjct: 40  QMVKQIGKGRYGEVWMGKWRGE--KVAVKVFFTT------EEASWFRETEIYQTVLMRH- 90

Query: 91  SGQPNIVQFKAAYEDDQFVH----IVMELCAGGELFDRI----------------VARG- 129
               NI+ F AA            ++ +    G L+D +                   G 
Sbjct: 91  ---ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGL 147

Query: 130 ---HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186
              H               + +      + HRDLK +N L     +N      D GL+  
Sbjct: 148 CHLH-------------TEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVK 191

Query: 187 IEEGKAYREI-----VGSPYYIAPEVL-------SQSYGKEADIWSAGVILYILLCGV-- 232
                   +I     VG+  Y+ PEVL              AD++S G+IL+ +      
Sbjct: 192 FISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251

Query: 233 --------PPFWAETDQGVAQAILKGEINFQ--RDPFPSISSSA------IELVRRMLTQ 276
                    P+        +   ++  +  +  R  FP+  SS        +L+      
Sbjct: 252 GGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAH 311

Query: 277 DPKRRITVAQVLE 289
           +P  R+T  +V +
Sbjct: 312 NPASRLTALRVKK 324

>3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} Length = 135

 Score =  103 bits (258), Expect = 2e-26
 Identities = 19/104 (18%), Positives = 37/104 (35%), Gaps = 2/104 (1%)

Query: 374 EFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRF-ENLYKAFQYFDKDNNGYITVDE 432
           E   K  +            Y + +    ++  ++ F   L K F          IT + 
Sbjct: 2   EPTEKSMLLETTSTTKMETKYEDMLPVMAEKMDVEEFVSELCKGFSLLADPERHLITAES 61

Query: 433 LGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           L +     G+ +  +    + ++ E D D DG ++  EF  +M 
Sbjct: 62  LRRNSGILGI-EGMSKEDAQGMVREGDLDGDGALNQTEFCVLMV 104

>3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} Length = 135

 Score = 52.7 bits (127), Expect = 1e-08
 Identities = 14/66 (21%), Positives = 32/66 (48%), Gaps = 1/66 (1%)

Query: 335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGS-MLTEFDVKQYMQAADIDGNGTID 393
            E + +L + F+ +       +T + L+     LG   +++ D +  ++  D+DG+G ++
Sbjct: 36  EEFVSELCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQGMVREGDLDGDGALN 95

Query: 394 YIEFIT 399
             EF  
Sbjct: 96  QTEFCV 101

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  106 bits (266), Expect = 6e-26
 Identities = 40/278 (14%), Positives = 74/278 (26%), Gaps = 36/278 (12%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y +    G       +   + +   + A   +  + ++ D    +       +  +  +P
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KP 91

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
            + +            +V E   GG L +  VA    S   A    + +    +  H  G
Sbjct: 92  GVARVLDVVHTRAGGLVVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAADAAHRAG 149

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGK 214
           V      P     +                    +G      +  P  +           
Sbjct: 150 VALSIDHPSRVRVSI-------------------DGDVV---LAYPATMPDA------NP 181

Query: 215 EADIWSAGVILYILLCGVPPFWAETDQG---VAQAILKGEINFQRDPFPSISSSAIELVR 271
           + DI   G  LY LL    P      +     A+    G+     D    I      +  
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA 241

Query: 272 RMLTQDPKRR--ITVAQVLEHPWLKESGEASDKPIDTA 307
           R +  D   R   T+  +++             PID A
Sbjct: 242 RSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEA 279

>1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 Length = 167

 Score =  101 bits (254), Expect = 1e-25
 Identities = 30/143 (20%), Positives = 53/143 (37%), Gaps = 16/143 (11%)

Query: 338 IQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLT--EFD---VKQYMQAADIDGNGTI 392
           +  L   F  +     G +  DEL+  L + G       F+    +  +   D D +GT+
Sbjct: 1   MDPLYGYFASV-AGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTM 59

Query: 393 DYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIK 452
            + EF       +  +      + F  FD D +G +   EL KA    G        T+ 
Sbjct: 60  GFNEFKELWAVLNGWR------QHFISFDSDRSGTVDPQELQKALTTMGFRL--NPQTVN 111

Query: 453 EIMSEVDRDKDGRISYDEFRSMM 475
            I         G+I++D++ +  
Sbjct: 112 SIAKRYST--SGKITFDDYIACC 132

>1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 Length = 167

 Score = 73.6 bits (181), Expect = 1e-15
 Identities = 19/95 (20%), Positives = 36/95 (37%), Gaps = 8/95 (8%)

Query: 338 IQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEF 397
           +   ++ F   D+D SGT+   EL+  L  +G  L        + A     +G I + ++
Sbjct: 71  LNGWRQHFISFDSDRSGTVDPQELQKALTTMGFRLNP-QTVNSI-AKRYSTSGKITFDDY 128

Query: 398 ITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDE 432
           I   +      +   L  +F+  D    G +    
Sbjct: 129 IACCV------KLRALTDSFRRRDSAQQGMVNFSY 157

>1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 Length = 167

 Score = 55.9 bits (135), Expect = 2e-09
 Identities = 17/72 (23%), Positives = 31/72 (43%), Gaps = 5/72 (6%)

Query: 417 FQYFDK--DNNGYITVDELGKAFKDYGMGDDAT---IATIKEIMSEVDRDKDGRISYDEF 471
           + YF      +G I  DEL +     G+        + T + ++S +DRD  G + ++EF
Sbjct: 5   YGYFASVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEF 64

Query: 472 RSMMKCGTQLRA 483
           + +       R 
Sbjct: 65  KELWAVLNGWRQ 76

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  106 bits (267), Expect = 1e-25
 Identities = 70/332 (21%), Positives = 114/332 (34%), Gaps = 84/332 (25%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK--DDVRREIEIMRHL-- 90
           Y I   +G G FG    C +++ G           K++++V K  +  R EI +++ +  
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVA-----LKIIRNVGKYREAARLEINVLKKIKE 75

Query: 91  ---SGQPNIVQFKAAYEDDQFVH-----IVMELCAGGELFDRIVARGH--YSERAAASVF 140
                +   V        D F       I  EL  G   F+ +       Y       + 
Sbjct: 76  KDKENKFLCVLMS-----DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMA 129

Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGD----------------ENAVVKATDFGLS 184
             + + +   H   + H DLKPEN LF   +                +N  ++  DFG +
Sbjct: 130 YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189

Query: 185 AFIEEGKAYREIVGSPYYIAPEV-LSQSYGKEADIWSAGVILYILLCGVPPFWAETDQG- 242
            F  E      IV + +Y  PEV L   + +  D+WS G IL+    G   F    ++  
Sbjct: 190 TFDHEHHTT--IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247

Query: 243 ---------------VAQAILKGEINFQRDPFPSISSSA--------------------- 266
                          + +   +         +   SS                       
Sbjct: 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH 307

Query: 267 ---IELVRRMLTQDPKRRITVAQVLEHPWLKE 295
               +L+RRML  DP +RIT+A+ L HP+   
Sbjct: 308 VQLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339

>1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A Length = 190

 Score =  102 bits (255), Expect = 2e-25
 Identities = 36/170 (21%), Positives = 66/170 (38%), Gaps = 15/170 (8%)

Query: 320 KLKKLALKVIVE--NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTE-FD 376
           KLK   ++ +        +E+Q+  + F  +    SG L     +    +          
Sbjct: 7   KLKPEVVEELTRKTYFTEKEVQQWYKGF--IKDCPSGQLDAAGFQKIYKQFFPFGDPTKF 64

Query: 377 VKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKA 436
                   D + +G I++ EFI A     +    E L  AF+ +D DN+GYIT +E+   
Sbjct: 65  ATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDLDNDGYITRNEMLDI 124

Query: 437 FKDYGM---------GDDATIATI-KEIMSEVDRDKDGRISYDEFRSMMK 476
                           ++ T       I + +D++ DG+++  EF+   K
Sbjct: 125 VDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKLTLQEFQEGSK 174

>1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A Length = 190

 Score = 47.5 bits (113), Expect = 2e-06
 Identities = 17/95 (17%), Positives = 34/95 (35%), Gaps = 18/95 (18%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD------------VKQYMQAADI 386
           +KL+  F   D DN G +T +E+   +  +  M+                V +     D 
Sbjct: 99  EKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDK 158

Query: 387 DGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFD 421
           + +G +   EF          +   ++ +A   +D
Sbjct: 159 NADGKLTLQEFQ------EGSKADPSIVQALSLYD 187

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  106 bits (266), Expect = 3e-25
 Identities = 70/268 (26%), Positives = 116/268 (43%), Gaps = 31/268 (11%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
            +G ++GRG FG  +     +     A KS   R+ +    K    +E  I++  S  PN
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSC--RETLPPDLKAKFLQEARILKQYS-HPN 173

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC----- 150
           IV+        Q ++IVMEL  GG+    +   G         V  ++  V +       
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGMEY 228

Query: 151 -HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI---APE 206
             SK  +HRDL   N L T   E  V+K +DFG+S    +G            +   APE
Sbjct: 229 LESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE 285

Query: 207 VLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
            L  +YG+   E+D+WS G++L+     G  P+   ++Q   + + KG     R P P +
Sbjct: 286 AL--NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG----RLPCPEL 339

Query: 263 SSSAI-ELVRRMLTQDPKRRITVAQVLE 289
              A+  L+ +    +P +R + + + +
Sbjct: 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367

>2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A Length = 207

 Score =  101 bits (253), Expect = 5e-25
 Identities = 32/173 (18%), Positives = 66/173 (38%), Gaps = 17/173 (9%)

Query: 319 NKLKKLALKVIVE--NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD 376
             L K  L+ +        EE+    + F  +    +G +T  + ++  AK         
Sbjct: 14  GALSKEILEELQLNTKFSEEELCSWYQSF--LKDCPTGRITQQQFQSIYAKFFPDTDPKA 71

Query: 377 VKQYM-QAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDEL-- 433
             Q++ ++ D + +GT+D+ E++ A       +  + L  AF  +D D NG I+ +E+  
Sbjct: 72  YAQHVFRSFDSNLDGTLDFKEYVIALHMTTAGKTNQKLEWAFSLYDVDGNGTISKNEVLE 131

Query: 434 ---------GKAFKDYGMGDDATIATI-KEIMSEVDRDKDGRISYDEFRSMMK 476
                              D+ T     ++I     ++ D +++  EF     
Sbjct: 132 IVMAIFKMITPEDVKLLPDDENTPEKRAEKIWKYFGKNDDDKLTEKEFIEGTL 184

>2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A Length = 207

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 16/95 (16%), Positives = 36/95 (37%), Gaps = 20/95 (21%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD--------------VKQYMQAA 384
           QKL+  F+  D D +GT++ +E+   +  +  M+T  D               ++  +  
Sbjct: 107 QKLEWAFSLYDVDGNGTISKNEVLEIVMAIFKMITPEDVKLLPDDENTPEKRAEKIWKYF 166

Query: 385 DIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQY 419
             + +  +   EFI            + + +  Q+
Sbjct: 167 GKNDDDKLTEKEFIEG------TLANKEILRLIQF 195

>1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A Length = 190

 Score =  100 bits (250), Expect = 8e-25
 Identities = 43/170 (25%), Positives = 70/170 (41%), Gaps = 15/170 (8%)

Query: 320 KLKKLALKVIVE--NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDV 377
           KL K  L  + +       EIQ+  + F  +    SG L  ++      +     +  D 
Sbjct: 7   KLSKDDLTCLKQSTYFDRREIQQWHKGF--LRDCPSGQLAREDFVKIYKQFFPFGSPEDF 64

Query: 378 KQYM-QAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKA 436
             ++    D D NG I + EFIT      +    E L  AF+ +D +++GYIT DE+   
Sbjct: 65  ANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDGYITFDEMLTI 124

Query: 437 FK----------DYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
                            +      +K+I   +D+++DG I+ DEFR   K
Sbjct: 125 VASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYITLDEFREGSK 174

>1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A Length = 190

 Score = 49.9 bits (119), Expect = 3e-07
 Identities = 19/96 (19%), Positives = 36/96 (37%), Gaps = 18/96 (18%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD------------VKQYMQAADI 386
           +KL   F   D ++ G +T+DE+   +A +  M+                VK+  +  D 
Sbjct: 99  EKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDK 158

Query: 387 DGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDK 422
           + +G I   EF          +   ++  A   +D 
Sbjct: 159 NEDGYITLDEFR------EGSKVDPSIIGALNLYDG 188

>1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E Length = 183

 Score = 99.1 bits (247), Expect = 2e-24
 Identities = 33/152 (21%), Positives = 59/152 (38%), Gaps = 13/152 (8%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYM-QAADIDGNGTIDY 394
            E+Q L   F   +   SG +  +  K   A+            Y+  A D    G++ +
Sbjct: 18  RELQVLYRGF--KNEXPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKF 75

Query: 395 IEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFK---------DYGMGDD 445
            +F+TA     +    E L   F  +D + +GYI  +E+    K          Y +  +
Sbjct: 76  EDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKE 135

Query: 446 ATIATI-KEIMSEVDRDKDGRISYDEFRSMMK 476
            T          ++D++KDG ++ DEF    +
Sbjct: 136 DTPRQHVDVFFQKMDKNKDGIVTLDEFLESXQ 167

>1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E Length = 183

 Score = 49.4 bits (118), Expect = 4e-07
 Identities = 19/108 (17%), Positives = 42/108 (38%), Gaps = 12/108 (11%)

Query: 345 FTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR 404
           F   DT  +G++ +++    L+ L        ++      DI+ +G I+  E +      
Sbjct: 62  FNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAI 121

Query: 405 HKLQRFENLY------------KAFQYFDKDNNGYITVDELGKAFKDY 440
           + +                     FQ  DK+ +G +T+DE  ++ ++ 
Sbjct: 122 YDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESXQED 169

>1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E Length = 183

 Score = 46.7 bits (111), Expect = 3e-06
 Identities = 19/95 (20%), Positives = 36/95 (37%), Gaps = 18/95 (18%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDEL----KAGLAKLGSMLTEFD--------VKQYMQAADI 386
           +KL+  F   D +  G +  +E+    KA    +G               V  + Q  D 
Sbjct: 92  EKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDK 151

Query: 387 DGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFD 421
           + +G +   EF+ +       Q  +N+ ++ Q F 
Sbjct: 152 NKDGIVTLDEFLES------XQEDDNIMRSLQLFQ 180

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  101 bits (254), Expect = 6e-24
 Identities = 79/331 (23%), Positives = 125/331 (37%), Gaps = 84/331 (25%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK--DDVRREIEIMRHL-- 90
           Y I   +G G FG    C ++  G       +   K+VK+V++  +  R EI+++ HL  
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVA--V---KIVKNVDRYCEAARSEIQVLEHLNT 70

Query: 91  ---SGQPNIVQFKAAYEDDQFVH-----IVMELCAGGELFDRIVARGH--YSERAAASVF 140
              +     VQ       + F H     IV EL  G   +D I   G   +       + 
Sbjct: 71  TDPNSTFRCVQML-----EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMA 124

Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGD----------------ENAVVKATDFGLS 184
             I   VN  HS  + H DLKPEN LF   D                 N  +K  DFG +
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184

Query: 185 AFIEEGKAYREIVGSPYYIAPEV-LSQSYGKEADIWSAGVILYILLCGVPPFWAETDQG- 242
            + +E  +   +V + +Y APEV L+  + +  D+WS G IL     G   F     +  
Sbjct: 185 TYDDEHHST--LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242

Query: 243 ---------------VAQAILKGEINFQRDPFPSISSS---------------------- 265
                          + +   +   +  R  +   SS+                      
Sbjct: 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH 302

Query: 266 --AIELVRRMLTQDPKRRITVAQVLEHPWLK 294
               +L+++ML  DP +RIT+ + L+HP+  
Sbjct: 303 ERLFDLIQKMLEYDPAKRITLREALKHPFFD 333

>1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A Length = 198

 Score = 97.9 bits (244), Expect = 8e-24
 Identities = 31/148 (20%), Positives = 55/148 (37%), Gaps = 16/148 (10%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLT--EFD---VKQYMQAADID 387
            P +    L   F        G +  DEL+  L + G       F+    +  +   D D
Sbjct: 27  FPGQTQDPLYGYF-AAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRD 85

Query: 388 GNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
            +GT+ + EF       +  +      + F  FD D +G +   EL KA     MG   +
Sbjct: 86  MSGTMGFNEFKELWAVLNGWR------QHFISFDTDRSGTVDPQELQKALTT--MGFRLS 137

Query: 448 IATIKEIMSEVDRDKDGRISYDEFRSMM 475
              +  I        +G+I++D++ +  
Sbjct: 138 PQAVNSIAKRYST--NGKITFDDYIACC 163

>1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A Length = 198

 Score = 74.4 bits (183), Expect = 1e-15
 Identities = 21/94 (22%), Positives = 37/94 (39%), Gaps = 8/94 (8%)

Query: 338 IQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEF 397
           +   ++ F   DTD SGT+   EL+  L  +G  L+   V    +      NG I + ++
Sbjct: 102 LNGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRY--STNGKITFDDY 159

Query: 398 ITATMQRHKLQRFENLYKAFQYFDKDNNGYITVD 431
           I   +      +   L  +F+  D    G +   
Sbjct: 160 IACCV------KLRALTDSFRRRDTAQQGVVNFP 187

>1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A Length = 198

 Score = 60.2 bits (146), Expect = 8e-11
 Identities = 19/80 (23%), Positives = 33/80 (41%), Gaps = 4/80 (5%)

Query: 408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT---IATIKEIMSEVDRDKDG 464
           Q  + LY  F       +G I  DEL +     G+        + T + ++S +DRD  G
Sbjct: 30  QTQDPLYGYFA-AVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSG 88

Query: 465 RISYDEFRSMMKCGTQLRAL 484
            + ++EF+ +       R  
Sbjct: 89  TMGFNEFKELWAVLNGWRQH 108

>1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A Length = 198

 Score = 40.1 bits (94), Expect = 6e-04
 Identities = 16/80 (20%), Positives = 32/80 (40%), Gaps = 13/80 (16%)

Query: 325 ALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAA 384
           AL  +   L  + +  + +++       +G +T+D+  A   KL ++   F      +  
Sbjct: 128 ALTTMGFRLSPQAVNSIAKRY-----STNGKITFDDYIACCVKLRALTDSF------RRR 176

Query: 385 DIDGNGTI--DYIEFITATM 402
           D    G +   Y +FI   M
Sbjct: 177 DTAQQGVVNFPYDDFIQCVM 196

>2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} Length = 71

 Score = 92.9 bits (232), Expect = 1e-23
 Identities = 26/66 (39%), Positives = 41/66 (62%), Gaps = 2/66 (3%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE 470
           E+L  AF+ FD+D +G+ITVDEL +A     +G       +  ++ E D D+DGR++Y+E
Sbjct: 6   EDLQVAFRAFDQDGDGHITVDELRRAMAG--LGQPLPQEELDAMIREADVDQDGRVNYEE 63

Query: 471 FRSMMK 476
           F  M+ 
Sbjct: 64  FARMLA 69

>2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} Length = 71

 Score = 63.7 bits (156), Expect = 3e-13
 Identities = 20/64 (31%), Positives = 35/64 (54%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYI 395
             ++ L+  F   D D  G +T DEL+  +A LG  L + ++   ++ AD+D +G ++Y 
Sbjct: 3   AGLEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREADVDQDGRVNYE 62

Query: 396 EFIT 399
           EF  
Sbjct: 63  EFAR 66

>1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A Length = 81

 Score = 92.2 bits (230), Expect = 4e-23
 Identities = 22/71 (30%), Positives = 35/71 (49%), Gaps = 1/71 (1%)

Query: 406 KLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGR 465
           +    E + +AF+ FD + +G I  DE     +  G  +  T A ++E M E D D +G 
Sbjct: 3   RQDDEEEILRAFKVFDANGDGVIDFDEFKFIMQKVGE-EPLTDAEVEEAMKEADEDGNGV 61

Query: 466 ISYDEFRSMMK 476
           I   EF  ++K
Sbjct: 62  IDIPEFMDLIK 72

>1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A Length = 81

 Score = 61.8 bits (151), Expect = 2e-12
 Identities = 23/75 (30%), Positives = 43/75 (57%), Gaps = 2/75 (2%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLG-SMLTEFDVKQYMQAADIDGNGT 391
           +  ++ +++   F   D +  G + +DE K  + K+G   LT+ +V++ M+ AD DGNG 
Sbjct: 2   VRQDDEEEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGV 61

Query: 392 IDYIEFITATMQRHK 406
           ID  EF+   +++ K
Sbjct: 62  IDIPEFM-DLIKKSK 75

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 98.9 bits (247), Expect = 7e-23
 Identities = 60/338 (17%), Positives = 115/338 (34%), Gaps = 92/338 (27%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK--DDVRREIEIMRHLSG 92
           + + R++G G FG   LC        +A K      +V++++K     + E +I++ +  
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVK------VVRNIKKYTRSAKIEADILKKIQN 90

Query: 93  QP----NIVQFKAAYEDDQFVH-----IVMELCAGGELFDRIVARGH--YSERAAASVFR 141
                 NIV++       +F++     ++ E   G  L++ I    +  +          
Sbjct: 91  DDINNNNIVKYH-----GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCI 144

Query: 142 VIMNVVNVCHSKGVMHRDLKPENFLFTTGD----------------------ENAVVKAT 179
            I+  +N      + H DLKPEN L                           ++  +K  
Sbjct: 145 EILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204

Query: 180 DFGLSAFIEEGKAYREIVGSPYYIAPEV-LSQSYGKEADIWSAGVILYIL---------- 228
           DFG + F  +   +  I+ +  Y APEV L+  +   +D+WS G +L  L          
Sbjct: 205 DFGCATF--KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262

Query: 229 -----------LCGVPPFW---------------------AETDQGVAQAILKGEINFQR 256
                      +    P                       A  +   +   +K       
Sbjct: 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322

Query: 257 DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK 294
                      + +  +L  DP  R + A++L+H +L+
Sbjct: 323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 97.5 bits (243), Expect = 1e-22
 Identities = 62/311 (19%), Positives = 100/311 (32%), Gaps = 83/311 (26%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEI-----MRHL 90
            +     RG FG  +           A K  P +      +K   + E E+     M+H 
Sbjct: 27  QLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ------DKQSWQNEYEVYSLPGMKH- 77

Query: 91  SGQPNIVQFKAAYEDDQFVH----IVMELCAGGELFD-------------RI---VARG- 129
               NI+QF  A +    V     ++      G L D              I   +ARG 
Sbjct: 78  ---ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGL 134

Query: 130 ---HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186
              H          +             + HRD+K +N L      N      DFGL+  
Sbjct: 135 AYLHEDIPGLKDGHKP-----------AISHRDIKSKNVLL---KNNLTACIADFGLALK 180

Query: 187 IEEGKAY---REIVGSPYYIAPEVL------SQSYGKEADIWSAGVILYILLCG------ 231
            E GK+       VG+  Y+APEVL       +      D+++ G++L+ L         
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240

Query: 232 -----VPPFWAETDQGVAQAILKGEINFQ--RDPFPS------ISSSAIELVRRMLTQDP 278
                + PF  E  Q  +   ++  +  +  R             +   E +      D 
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300

Query: 279 KRRITVAQVLE 289
           + R++   V E
Sbjct: 301 EARLSAGCVGE 311

>1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A Length = 165

 Score = 92.4 bits (230), Expect = 3e-22
 Identities = 27/140 (19%), Positives = 54/140 (38%), Gaps = 16/140 (11%)

Query: 341 LKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLT--EFD---VKQYMQAADIDGNGTIDYI 395
           +   F+ +     G +  +EL+  L + G   T   F     +  +   D D  G + + 
Sbjct: 2   VYTYFSAV-AGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFN 60

Query: 396 EFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIM 455
            F       +  +      + F   D+D +G +   EL +A     MG   +  T+  I+
Sbjct: 61  AFKELWAALNAWK------ENFMTVDQDGSGTVEHHELRQAIGL--MGYRLSPQTLTTIV 112

Query: 456 SEVDRDKDGRISYDEFRSMM 475
               +  +GRI +D++ +  
Sbjct: 113 KRYSK--NGRIFFDDYVACC 130

>1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A Length = 165

 Score = 76.6 bits (189), Expect = 1e-16
 Identities = 19/95 (20%), Positives = 37/95 (38%), Gaps = 8/95 (8%)

Query: 338 IQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEF 397
           +   KE F  +D D SGT+ + EL+  +  +G  L+   +   ++      NG I + ++
Sbjct: 69  LNAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRY--SKNGRIFFDDY 126

Query: 398 ITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDE 432
           +   +      +   L   F+  D    G      
Sbjct: 127 VACCV------KLRALTDFFRKRDHLQQGSANFIY 155

>1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A Length = 165

 Score = 59.7 bits (145), Expect = 9e-11
 Identities = 12/72 (16%), Positives = 32/72 (44%), Gaps = 5/72 (6%)

Query: 417 FQYFDK--DNNGYITVDELGKAFKDYGMGDDAT---IATIKEIMSEVDRDKDGRISYDEF 471
           + YF      +G +  +EL +     G+    +   + T + +++ +DRD  G++ ++ F
Sbjct: 3   YTYFSAVAGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAF 62

Query: 472 RSMMKCGTQLRA 483
           + +       + 
Sbjct: 63  KELWAALNAWKE 74

>2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} Length = 91

 Score = 90.1 bits (224), Expect = 3e-22
 Identities = 20/85 (23%), Positives = 34/85 (40%), Gaps = 2/85 (2%)

Query: 315 FTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTE 374
               +   +  L     +   EE+ +L+  F   D + SG L  +E +A   +L   +  
Sbjct: 3   HHHHHSSGRENLYFQGADGDGEELARLRSVFAACDANRSGRLEREEFRALCTELR--VRP 60

Query: 375 FDVKQYMQAADIDGNGTIDYIEFIT 399
            D +   Q  D D +G I + EF  
Sbjct: 61  ADAEAVFQRLDADRDGAITFQEFAR 85

>2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} Length = 91

 Score = 79.3 bits (196), Expect = 2e-18
 Identities = 12/69 (17%), Positives = 25/69 (36%), Gaps = 4/69 (5%)

Query: 408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRIS 467
           +    L   F   D + +G +  +E      +  +         + +   +D D+DG I+
Sbjct: 24  EELARLRSVFAACDANRSGRLEREEFRALCTELRVRPA----DAEAVFQRLDADRDGAIT 79

Query: 468 YDEFRSMMK 476
           + EF     
Sbjct: 80  FQEFARGFL 88

>2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} Length = 107

 Score = 90.1 bits (224), Expect = 4e-22
 Identities = 21/92 (22%), Positives = 41/92 (44%), Gaps = 3/92 (3%)

Query: 311 RMKQFTAMNKLKKLAL---KVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAK 367
           + +Q   ++++ K  L   K   +     +++  KEK+ E D + +G +    LK  L K
Sbjct: 1   KAQQEERLDEINKQFLDDPKYSSDEDLPSKLEGFKEKYMEFDLNGNGDIDIMSLKRMLEK 60

Query: 368 LGSMLTEFDVKQYMQAADIDGNGTIDYIEFIT 399
           LG   T  ++K+ +         T  Y +F+ 
Sbjct: 61  LGVPKTHLELKKLIGEVSSGSGETFSYPDFLR 92

>2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} Length = 107

 Score = 80.5 bits (199), Expect = 9e-19
 Identities = 17/66 (25%), Positives = 29/66 (43%), Gaps = 2/66 (3%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE 470
           E   + +  FD + NG I +  L +  +   +G   T   +K+++ EV        SY +
Sbjct: 32  EGFKEKYMEFDLNGNGDIDIMSLKRMLE--KLGVPKTHLELKKLIGEVSSGSGETFSYPD 89

Query: 471 FRSMMK 476
           F  MM 
Sbjct: 90  FLRMML 95

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 97.5 bits (243), Expect = 6e-22
 Identities = 63/270 (23%), Positives = 111/270 (41%), Gaps = 35/270 (12%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+  ++G G++G  Y        L  A K++ +      +E ++  +E  +M+ +   PN
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPN 277

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHY---SERAAASVFRVIMNVVNVC-- 150
           +VQ       +   +I+ E    G L D       Y     R   S   ++     +   
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLD-------YLRECNRQEVSAVVLLYMATQISSA 330

Query: 151 ----HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI--- 203
                 K  +HR+L   N L     EN +VK  DFGLS  +     Y    G+ + I   
Sbjct: 331 MEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWT 386

Query: 204 APEVLSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           APE L+ + +  ++D+W+ GV+L+ I   G+ P+       V + + K      R   P 
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY----RMERPE 442

Query: 262 ISSSAI-ELVRRMLTQDPKRRITVAQVLEH 290
                + EL+R     +P  R + A++ + 
Sbjct: 443 GCPEKVYELMRACWQWNPSDRPSFAEIHQA 472

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 96.5 bits (240), Expect = 8e-22
 Identities = 63/374 (16%), Positives = 115/374 (30%), Gaps = 128/374 (34%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFA---CKSIPKRKLVKDVEKDDVRREIEIMRHL 90
            Y + R++G G F   +L  +       A    KS            +    EI +++ +
Sbjct: 38  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH-------YTETALDEIRLLKSV 90

Query: 91  S-------GQPNIVQFKAAYEDDQFVH---------IVMELCAGGELFDRIVARGH--YS 132
                    +  +VQ       D F           +V E+  G  L   I+   +    
Sbjct: 91  RNSDPNDPNREMVVQLL-----DDFKISGVNGTHICMVFEV-LGHHLLKWIIKSNYQGLP 144

Query: 133 ERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGD-------------------- 171
                 + + ++  ++  H+K  ++H D+KPEN L +  +                    
Sbjct: 145 LPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204

Query: 172 --------------------------ENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAP 205
                                     E   VK  D G + ++ +   + E + +  Y + 
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSL 262

Query: 206 EV-LSQSYGKEADIWSAGVILYILLCGVPPF-------WAETDQGVAQ--AIL------- 248
           EV +   Y   ADIWS   + + L  G   F       +   +  +A    +L       
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322

Query: 249 -------------KGE-INFQRDPFPSISSSAIE--------------LVRRMLTQDPKR 280
                        KG+  +  +     +    +E               +  ML   P++
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEK 382

Query: 281 RITVAQVLEHPWLK 294
           R T A+ L HPWL 
Sbjct: 383 RATAAECLRHPWLN 396

>2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} Length = 77

 Score = 87.9 bits (219), Expect = 1e-21
 Identities = 24/77 (31%), Positives = 41/77 (53%), Gaps = 1/77 (1%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E+ Q++KE F   DT+ +G++ Y ELK  +  LG  + + ++ + M   D +GNG I
Sbjct: 1   LSEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNEYDREGNGYI 60

Query: 393 DYIEFITATMQRHKLQR 409
            + +F+   M      R
Sbjct: 61  GFDDFLDI-MTEKIKNR 76

>2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} Length = 77

 Score = 76.0 bits (188), Expect = 2e-17
 Identities = 22/65 (33%), Positives = 35/65 (53%), Gaps = 2/65 (3%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE 470
           + + +AF  FD +  G I   EL  A +   +G D     I E+M+E DR+ +G I +D+
Sbjct: 7   QEIKEAFDLFDTNKTGSIDYHELKVAMR--ALGFDVKKPEILELMNEYDREGNGYIGFDD 64

Query: 471 FRSMM 475
           F  +M
Sbjct: 65  FLDIM 69

>1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 Length = 78

 Score = 87.6 bits (218), Expect = 1e-21
 Identities = 19/66 (28%), Positives = 36/66 (54%), Gaps = 3/66 (4%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE 470
           +++ + F+ FD + +G I++ EL  A +  G         ++ +M+E+D D DG I ++E
Sbjct: 3   DDMERIFKRFDTNGDGKISLSELTDALRTLGSTSA---DEVQRMMAEIDTDGDGFIDFNE 59

Query: 471 FRSMMK 476
           F S   
Sbjct: 60  FISFCN 65

>1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 Length = 78

 Score = 68.4 bits (168), Expect = 9e-15
 Identities = 23/77 (29%), Positives = 38/77 (49%), Gaps = 3/77 (3%)

Query: 341 LKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITA 400
           ++  F   DT+  G ++  EL   L  LGS   + +V++ M   D DG+G ID+ EFI  
Sbjct: 5   MERIFKRFDTNGDGKISLSELTDALRTLGSTSAD-EVQRMMAEIDTDGDGFIDFNEFI-- 61

Query: 401 TMQRHKLQRFENLYKAF 417
           +         +++ K F
Sbjct: 62  SFCNANPGLMKDVAKVF 78

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 96.0 bits (239), Expect = 2e-21
 Identities = 76/421 (18%), Positives = 134/421 (31%), Gaps = 110/421 (26%)

Query: 11  SDHPAARHLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRK 70
             H +++         +   +   Y I   +G G +G      +       A K I +  
Sbjct: 31  KQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-- 88

Query: 71  LVKDVEKDDVR--REIEIMRHLSGQPNIVQFK-----AAYEDDQFVHIVMELCAGGELFD 123
            V +   D  R  REI I+  L+   ++V+          E    +++V+E+ A  +   
Sbjct: 89  -VFEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDVEKFDELYVVLEI-ADSDFKK 145

Query: 124 RIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL 183
                 + +E    ++   ++  V   HS G++HRDLKP N L    +++  VK  DFGL
Sbjct: 146 LFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGL 202

Query: 184 SAFIEEGKAYREIVGSP----------------------------YYIAPEVL--SQSYG 213
           +  ++  +     +                               +Y APE++   ++Y 
Sbjct: 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYT 262

Query: 214 KEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI------ 267
           +  D+WS G I   LL  +    A         +  G   F   P     +         
Sbjct: 263 EAIDVWSIGCIFAELLNMIKENVAYHADR--GPLFPGSSCFPLSPDQKAGNDFKFHTRGN 320

Query: 268 ------------------------ELVRRMLTQDPKR----------------------- 280
                                   E  +R +   PKR                       
Sbjct: 321 RDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRM 380

Query: 281 -------RITVAQVLEHPWLKESGEASDKPI-DTAVIFRMKQFTAMNK--LKKLALKVIV 330
                  RIT+ + L HP+ KE   A  +      V      +  M++  L+   +K I 
Sbjct: 381 LVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQ 440

Query: 331 E 331
            
Sbjct: 441 R 441

>1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A Length = 83

 Score = 87.3 bits (217), Expect = 2e-21
 Identities = 17/70 (24%), Positives = 30/70 (42%), Gaps = 4/70 (5%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYG----MGDDATIATIKEIMSEVDRDKDGRI 466
             L  AF+  D + +GY+T  EL            +  D       +++   D++ DG+I
Sbjct: 7   AELEAAFKKLDANGDGYVTALELQTFMVTLDAYKALSKDKVKEASAKLIKMADKNSDGKI 66

Query: 467 SYDEFRSMMK 476
           S +EF +   
Sbjct: 67  SKEEFLNANA 76

>1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A Length = 83

 Score = 58.0 bits (141), Expect = 4e-11
 Identities = 15/78 (19%), Positives = 33/78 (42%), Gaps = 7/78 (8%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSML------TEFDVKQYMQAADI 386
           +  +   +L+  F ++D +  G +T  EL+  +  L +         +    + ++ AD 
Sbjct: 1   MACKVKAELEAAFKKLDANGDGYVTALELQTFMVTLDAYKALSKDKVKEASAKLIKMADK 60

Query: 387 DGNGTIDYIEFITATMQR 404
           + +G I   EF+ A    
Sbjct: 61  NSDGKISKEEFLNA-NAE 77

>2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} Length = 92

 Score = 87.3 bits (217), Expect = 3e-21
 Identities = 26/66 (39%), Positives = 41/66 (62%), Gaps = 2/66 (3%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE 470
           E L +AF+ FDKD NGYI+  EL     +  +G+  T   +++++ E D D DG+++Y+E
Sbjct: 9   EELKEAFKVFDKDQNGYISASELRHVMIN--LGEKLTDEEVEQMIKEADLDGDGQVNYEE 66

Query: 471 FRSMMK 476
           F  MM 
Sbjct: 67  FVKMMM 72

>2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} Length = 92

 Score = 68.8 bits (169), Expect = 8e-15
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 3/89 (3%)

Query: 332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGT 391
           ++ T+  ++LKE F   D D +G ++  EL+  +  LG  LT+ +V+Q ++ AD+DG+G 
Sbjct: 2   HMDTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEADLDGDGQ 61

Query: 392 IDYIEFI---TATMQRHKLQRFENLYKAF 417
           ++Y EF+              +  L + F
Sbjct: 62  VNYEEFVKMMMTVRGGGGGNGWSRLRRKF 90

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 92.3 bits (230), Expect = 3e-21
 Identities = 65/270 (24%), Positives = 125/270 (46%), Gaps = 39/270 (14%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T  +E+G G+FG+ +L    +   + A K+I +      + ++D   E E+M  LS  P 
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIRE----GAMSEEDFIEEAEVMMKLS-HPK 64

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHY--SERAAASVFRVIMNVVNVCH-- 151
           +VQ      +   + +V E    G L D       Y  ++R   +   ++   ++VC   
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSD-------YLRTQRGLFAAETLLGMCLDVCEGM 117

Query: 152 ----SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI---A 204
                  V+HRDL   N L     EN V+K +DFG++ F+ +   Y    G+ + +   +
Sbjct: 118 AYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWAS 173

Query: 205 PEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
           PEV   S+ +   ++D+WS GV+++ +   G  P+   ++  V + I  G     R   P
Sbjct: 174 PEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF----RLYKP 227

Query: 261 SISSSAI-ELVRRMLTQDPKRRITVAQVLE 289
            ++S+ + +++     + P+ R   +++L 
Sbjct: 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLR 257

>2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} Length = 94

 Score = 86.9 bits (216), Expect = 4e-21
 Identities = 26/87 (29%), Positives = 42/87 (48%), Gaps = 2/87 (2%)

Query: 389 NGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           +      E +            E + +AF+  DKD NGYI+  EL     +  +G+  T 
Sbjct: 7   HHHGSSGENLYFQSLMKDTDSEEEIREAFRVEDKDGNGYISAAELRHVMTN--LGEKLTD 64

Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMM 475
             + E++ E D D DG+++Y+EF  MM
Sbjct: 65  EEVDEMIREADIDGDGQVNYEEFVQMM 91

>2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} Length = 94

 Score = 61.1 bits (149), Expect = 4e-12
 Identities = 22/70 (31%), Positives = 42/70 (60%)

Query: 335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDY 394
           T+  ++++E F   D D +G ++  EL+  +  LG  LT+ +V + ++ ADIDG+G ++Y
Sbjct: 25  TDSEEEIREAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNY 84

Query: 395 IEFITATMQR 404
            EF+     +
Sbjct: 85  EEFVQMMTAK 94

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 93.1 bits (232), Expect = 4e-21
 Identities = 52/273 (19%), Positives = 101/273 (36%), Gaps = 36/273 (13%)

Query: 36  TIGREVGRGEFGI----TYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
              + +G G FG      ++       +  A K +  R+        ++  E  +M  + 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD 75

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
             P++ +          V ++ +L   G L D +  R H   +       ++   V +  
Sbjct: 76  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV--REH---KDNIGSQYLLNWCVQIAK 128

Query: 152 ------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI-- 203
                  + ++HRDL   N L         VK TDFGL+  +   +      G    I  
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185

Query: 204 -APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            A E +   +     ++D+WS GV ++ ++  G  P+       ++  + KGE    R P
Sbjct: 186 MALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLP 239

Query: 259 FPSISSSAI-ELVRRMLTQDPKRRITVAQVLEH 290
            P I +  +  ++R+    D   R    +++  
Sbjct: 240 QPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 94.0 bits (234), Expect = 4e-21
 Identities = 50/225 (22%), Positives = 87/225 (38%), Gaps = 32/225 (14%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK--DDVRREIEIMRHLS 91
            Y I   +G+G FG      +       A K      ++K+ +   +  + E+ ++  ++
Sbjct: 55  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK------IIKNKKAFLNQAQIEVRLLELMN 108

Query: 92  -----GQPNIVQFKAAYEDDQFVH-----IVMELCAGGELFDRIVARGH--YSERAAASV 139
                 +  IV  K       F+      +V E+     L+D +        S       
Sbjct: 109 KHDTEMKYYIVHLK-----RHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKF 162

Query: 140 FRVIMNVVNVCHSK--GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV 197
            + +   +    +    ++H DLKPEN L     + + +K  DFG S+     + Y+ I 
Sbjct: 163 AQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFG-SSCQLGQRIYQYIQ 220

Query: 198 GSPYYIAPEV-LSQSYGKEADIWSAGVILYILLCGVPPFWAETDQ 241
            S +Y +PEV L   Y    D+WS G IL  +  G P F    + 
Sbjct: 221 -SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 12/32 (37%), Positives = 19/32 (59%)

Query: 267 IELVRRMLTQDPKRRITVAQVLEHPWLKESGE 298
            +L+ RML  DPK RI     L+H + K++ +
Sbjct: 350 KDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 91.9 bits (229), Expect = 5e-21
 Identities = 63/230 (27%), Positives = 103/230 (44%), Gaps = 34/230 (14%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T  +E+G G+FG+           + A K I +      + +D+   E ++M +LS    
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKE----GSMSEDEFIEEAKVMMNLS-HEK 80

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHY--SERAAASVFRVIMNVVNVCH-- 151
           +VQ        + + I+ E  A G L +       Y    R      +++    +VC   
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLN-------YLREMRHRFQTQQLLEMCKDVCEAM 133

Query: 152 ----SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI---A 204
               SK  +HRDL   N L    ++  VVK +DFGLS ++ +   Y   VGS + +    
Sbjct: 134 EYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSP 189

Query: 205 PEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
           PEVL   Y K   ++DIW+ GV+++ I   G  P+   T+   A+ I +G
Sbjct: 190 PEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 91.9 bits (229), Expect = 6e-21
 Identities = 67/271 (24%), Positives = 113/271 (41%), Gaps = 37/271 (13%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD--VEKDDVRREIEIMRHLSGQ 93
           T+  ++G G++G  Y        L  A K++      K+  +E ++  +E  +M+ +   
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTMEVEEFLKEAAVMKEIK-H 68

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH-- 151
           PN+VQ       +   +I+ E    G L D +  R     R   S   ++     +    
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--REC--NRQEVSAVVLLYMATQISSAM 124

Query: 152 ----SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI---A 204
                K  +HRDL   N L     EN +VK  DFGLS  +     Y    G+ + I   A
Sbjct: 125 EYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTA 180

Query: 205 PEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
           PE L  +Y K   ++D+W+ GV+L+ I   G+ P+       V + + K      R   P
Sbjct: 181 PESL--AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY----RMERP 234

Query: 261 SISSSAI-ELVRRMLTQDPKRRITVAQVLEH 290
                 + EL+R     +P  R + A++ + 
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQA 265

>2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A Length = 150

 Score = 88.4 bits (219), Expect = 6e-21
 Identities = 27/125 (21%), Positives = 46/125 (36%), Gaps = 16/125 (12%)

Query: 313 KQFTAMNKLKKLALKVIVEN-----------LPTEEIQKLKEKFTEMDTDNSGTLTYDEL 361
           K F  +   ++  L  I                 E++   KEK+ E D +N G +    L
Sbjct: 13  KAFGILKARQERRLAEINREFLCDQKYSDEENLPEKLTAFKEKYMEFDLNNEGEIDLMSL 72

Query: 362 KAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFD 421
           K  + KLG   T  ++K+ +       + TI Y +F+   M   +      + K    F+
Sbjct: 73  KRMMEKLGVPKTHLEMKKMISEVTGGVSDTISYRDFVNM-MLGKR----SAVLKLVMMFE 127

Query: 422 KDNNG 426
              N 
Sbjct: 128 GKANE 132

>2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A Length = 150

 Score = 78.4 bits (193), Expect = 2e-17
 Identities = 18/69 (26%), Positives = 33/69 (47%), Gaps = 2/69 (2%)

Query: 408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRIS 467
           ++     + +  FD +N G I +  L +  +   +G   T   +K+++SEV       IS
Sbjct: 47  EKLTAFKEKYMEFDLNNEGEIDLMSLKRMME--KLGVPKTHLEMKKMISEVTGGVSDTIS 104

Query: 468 YDEFRSMMK 476
           Y +F +MM 
Sbjct: 105 YRDFVNMML 113

>3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66

 Score = 84.9 bits (211), Expect = 8e-21
 Identities = 19/60 (31%), Positives = 34/60 (56%)

Query: 341 LKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITA 400
            +  F E+D +  G ++Y+E+KA ++K  ++  E  ++   ++ D DGNG ID  EF   
Sbjct: 2   AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKF 61

>3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66

 Score = 68.4 bits (168), Expect = 7e-15
 Identities = 11/64 (17%), Positives = 23/64 (35%), Gaps = 2/64 (3%)

Query: 413 LYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFR 472
               F+  D + +G ++ +E+                 ++ I   +D D +G I  +EF 
Sbjct: 2   AEALFKEIDVNGDGAVSYEEVKAFVSK--KRAIKNEQLLQLIFKSIDADGNGEIDQNEFA 59

Query: 473 SMMK 476
               
Sbjct: 60  KFYG 63

>3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66

 Score = 59.9 bits (146), Expect = 6e-12
 Identities = 14/62 (22%), Positives = 28/62 (45%)

Query: 377 VKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKA 436
            +   +  D++G+G + Y E      ++  ++  + L   F+  D D NG I  +E  K 
Sbjct: 2   AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKF 61

Query: 437 FK 438
           + 
Sbjct: 62  YG 63

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 56/278 (20%), Positives = 111/278 (39%), Gaps = 34/278 (12%)

Query: 36  TIGREVGRGEFGITYLCT---ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG 92
           T+GR +G+GEFG         E+ + ++ A K + K  ++   + ++  RE   M+    
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFD- 83

Query: 93  QPNIVQFKAA------YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNV 146
            P++ +                  +++     G+L   ++A           +  ++  +
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143

Query: 147 VNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP 200
           V++        S+  +HRDL   N +     E+  V   DFGLS  I  G  YR+   S 
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCML---AEDMTVCVADFGLSRKIYSGDYYRQGCASK 200

Query: 201 YYI---APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEIN 253
             +   A E L  +       +D+W+ GV ++ I+  G  P+    +  +   ++ G   
Sbjct: 201 LPVKWLALESL--ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG--- 255

Query: 254 FQRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQVLEH 290
             R   P      + +L+ +  + DPK+R +   +   
Sbjct: 256 -NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRME 292

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 91.8 bits (228), Expect = 1e-20
 Identities = 60/315 (19%), Positives = 96/315 (30%), Gaps = 80/315 (25%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEI-----MRHL 90
            +   +GRG +G  Y  + +      A K            + +   E  I     M H 
Sbjct: 16  KLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFA------NRQNFINEKNIYRVPLMEH- 66

Query: 91  SGQPNIVQFKAAYEDDQFVH-----IVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
               NI +F    E           +VME    G L   +            S  R+  +
Sbjct: 67  ---DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHS 119

Query: 146 VVN------------VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY 193
           V                +   + HRDL   N L      +     +DFGLS  +   +  
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLV 176

Query: 194 RE---------IVGSPYYIAPEVLS--------QSYGKEADIWSAGVILYILLCGV---- 232
           R           VG+  Y+APEVL         +S  K+ D+++ G+I + +        
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236

Query: 233 ---------PPFWAETDQGVAQAILKGEINFQ--RDPFPSISSSAIELVRRMLT------ 275
                      F  E         ++  ++ +  R  FP         VR +        
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296

Query: 276 -QDPKRRITVAQVLE 289
            QD + R+T     E
Sbjct: 297 DQDAEARLTAQXAEE 311

>1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 Length = 105

 Score = 85.6 bits (212), Expect = 2e-20
 Identities = 14/78 (17%), Positives = 28/78 (35%), Gaps = 2/78 (2%)

Query: 398 ITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSE 457
           I A + +     +  + + F+ FD      I+ +E              T      + +E
Sbjct: 11  ILARLHKAVTSHYHAITQEFENFDTMKTNTISREEFRAICNRRVQ--ILTDEQFDRLWNE 68

Query: 458 VDRDKDGRISYDEFRSMM 475
           +  +  GR+ Y +F S  
Sbjct: 69  MPVNAKGRLKYPDFLSRF 86

>1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 Length = 105

 Score = 77.1 bits (190), Expect = 1e-17
 Identities = 12/76 (15%), Positives = 32/76 (42%)

Query: 325 ALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAA 384
            +   +    T     + ++F   DT  + T++ +E +A   +   +LT+    +     
Sbjct: 10  DILARLHKAVTSHYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEM 69

Query: 385 DIDGNGTIDYIEFITA 400
            ++  G + Y +F++ 
Sbjct: 70  PVNAKGRLKYPDFLSR 85

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 55/277 (19%), Positives = 110/277 (39%), Gaps = 33/277 (11%)

Query: 36  TIGREVGRGEFGITYLCT---ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG 92
            +G+ +G GEFG         E+ T L+ A K++ K       E ++   E   M+  S 
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFS- 94

Query: 93  QPNIVQ-----FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVV 147
            PN+++      + + +      +++     G+L   ++     +      +  ++  +V
Sbjct: 95  HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154

Query: 148 NVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY 201
           ++        ++  +HRDL   N +     ++  V   DFGLS  I  G  YR+   +  
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCML---RDDMTVCVADFGLSKKIYSGDYYRQGRIAKM 211

Query: 202 YI---APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINF 254
            +   A E L  +      ++D+W+ GV ++ I   G+ P+    +  +   +L G    
Sbjct: 212 PVKWIAIESL--ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG---- 265

Query: 255 QRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQVLEH 290
            R   P      + E++      DP  R T + +   
Sbjct: 266 HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 89.9 bits (224), Expect = 2e-20
 Identities = 65/270 (24%), Positives = 122/270 (45%), Gaps = 39/270 (14%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
           T+ +E+G G+FG+  L        + A K I +  +     +D+  +E + M  LS  P 
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSM----SEDEFFQEAQTMMKLS-HPK 64

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHY--SERAAASVFRVIMNVVNVCH-- 151
           +V+F      +  ++IV E  + G L +       Y  S        +++    +VC   
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLN-------YLRSHGKGLEPSQLLEMCYDVCEGM 117

Query: 152 ----SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI---A 204
               S   +HRDL   N L    D +  VK +DFG++ ++ + +     VG+ + +   A
Sbjct: 118 AFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQYVSS-VGTKFPVKWSA 173

Query: 205 PEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
           PEV    Y K   ++D+W+ G++++ +   G  P+   T+  V   + +G     R   P
Sbjct: 174 PEVF--HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH----RLYRP 227

Query: 261 SISSSAI-ELVRRMLTQDPKRRITVAQVLE 289
            ++S  I +++     + P++R T  Q+L 
Sbjct: 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLS 257

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 90.1 bits (224), Expect = 4e-20
 Identities = 65/278 (23%), Positives = 112/278 (40%), Gaps = 35/278 (12%)

Query: 36  TIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           T+ R +G G FG  Y         + + L+ A K++   ++  + ++ D   E  I+   
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKF 90

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDRIVARGHYSERAAASVFRVIMNVVN 148
           +   NIV+            I+MEL AGG+L  F R   R   S+ ++ ++  ++    +
Sbjct: 91  N-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARD 148

Query: 149 VCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           +            +HRD+   N L T      V K  DFG++  I     YR   G    
Sbjct: 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR--KGGCAM 206

Query: 203 I-----APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEIN 253
           +      PE      G    + D WS GV+L+ I   G  P+ ++++Q V + +  G   
Sbjct: 207 LPVKWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG--- 261

Query: 254 FQRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQVLEH 290
             R   P      +  ++ +     P+ R   A +LE 
Sbjct: 262 -GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298

>2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A Length = 86

 Score = 83.5 bits (207), Expect = 5e-20
 Identities = 24/71 (33%), Positives = 37/71 (52%), Gaps = 3/71 (4%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE 470
            +  + F+ FD + +G I+  ELG A K  G     T   ++ +M+E+D D DG IS+DE
Sbjct: 11  ADRERIFKRFDTNGDGKISSSELGDALKTLGS---VTPDEVRRMMAEIDTDGDGFISFDE 67

Query: 471 FRSMMKCGTQL 481
           F    +    L
Sbjct: 68  FTDFARANRGL 78

>2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A Length = 86

 Score = 83.5 bits (207), Expect = 6e-20
 Identities = 23/89 (25%), Positives = 39/89 (43%), Gaps = 3/89 (3%)

Query: 329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG 388
           +      ++I   +  F   DT+  G ++  EL   L  LG  +T  +V++ M   D DG
Sbjct: 1   MAAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTDG 59

Query: 389 NGTIDYIEFITATMQRHKLQRFENLYKAF 417
           +G I + EF      R      +++ K F
Sbjct: 60  DGFISFDEFT--DFARANRGLVKDVSKIF 86

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 90.1 bits (224), Expect = 6e-20
 Identities = 64/278 (23%), Positives = 112/278 (40%), Gaps = 35/278 (12%)

Query: 36  TIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           T+ R +G G FG  Y         + + L+ A K++   ++  + ++ D   E  I+   
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKF 131

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGEL--FDRIVARGHYSERAAASVFRVIMNVVN 148
           +   NIV+            I++EL AGG+L  F R   R   S+ ++ ++  ++    +
Sbjct: 132 N-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARD 189

Query: 149 VCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           +            +HRD+   N L T      V K  DFG++  I     YR   G    
Sbjct: 190 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR--KGGCAM 247

Query: 203 I-----APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEIN 253
           +      PE      G    + D WS GV+L+ I   G  P+ ++++Q V + +  G   
Sbjct: 248 LPVKWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG--- 302

Query: 254 FQRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQVLEH 290
             R   P      +  ++ +     P+ R   A +LE 
Sbjct: 303 -GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 91.2 bits (226), Expect = 8e-20
 Identities = 61/221 (27%), Positives = 91/221 (41%), Gaps = 27/221 (12%)

Query: 31  VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           V   + +GR++G G FG  YL T   T  E A K           +   +  E +I R L
Sbjct: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKIYRIL 59

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAG---GELFDRIVARGHYSERAAASVFRVIMNVV 147
            G   I   +    +  +  +VM+L  G    +LF+        S +    +   ++N V
Sbjct: 60  QGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRV 116

Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-----AYRE---IVGS 199
              HSK  +HRD+KP+NFL   G     V   DFGL+    +        YRE   + G+
Sbjct: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176

Query: 200 PYYIAPEVLSQSYGKEA----DIWSAGVILYILLCGVPPFW 236
             Y +   ++   G E     D+ S G +L   L G  P W
Sbjct: 177 ARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-W 213

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 88.9 bits (221), Expect = 8e-20
 Identities = 61/277 (22%), Positives = 108/277 (38%), Gaps = 41/277 (14%)

Query: 36  TIGREVGRGEFGITY---LCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG 92
                +GRG FG  Y   L   +   +  A KS+   ++    E      E  IM+  S 
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFS- 84

Query: 93  QPNIVQFKAA-YEDDQFVHIVMELCAGGEL--FDRIVARGHYSERAAASVFRVIMNVVNV 149
            PN++         +    +V+     G+L  F R       +E    +V  +I   + V
Sbjct: 85  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-------NETHNPTVKDLIGFGLQV 137

Query: 150 CH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI 203
                   SK  +HRDL   N +    DE   VK  DFGL+  + + + Y     +   +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 194

Query: 204 -----APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINF 254
                A E  S    K   ++D+WS GV+L+ ++  G PP+       +   +L+G    
Sbjct: 195 PVKWMALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG---- 248

Query: 255 QRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQVLEH 290
           +R   P      + E++ +      + R + ++++  
Sbjct: 249 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 91.1 bits (226), Expect = 1e-19
 Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 34/270 (12%)

Query: 36  TIGREVGRGEFGITY---LCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG 92
            +GR +G G+FG  +     +  +  +  A K+   +    D  ++   +E   MR    
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREKFLQEALTMRQFD- 449

Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC-- 150
            P+IV+      ++  V I+MELC  GEL   +  +     + +  +  +I+    +   
Sbjct: 450 HPHIVKLIGVITENP-VWIIMELCTLGELRSFL--QVR---KFSLDLASLILYAYQLSTA 503

Query: 151 ----HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG-SPY-YIA 204
                SK  +HRD+   N L +    N  VK  DFGLS ++E+   Y+   G  P  ++A
Sbjct: 504 LAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560

Query: 205 PEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
           PE +  ++ +    +D+W  GV ++ IL+ GV PF    +  V   I  GE    R P P
Sbjct: 561 PESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----RLPMP 614

Query: 261 SISSSAI-ELVRRMLTQDPKRRITVAQVLE 289
                 +  L+ +    DP RR    ++  
Sbjct: 615 PNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 87.6 bits (218), Expect = 1e-19
 Identities = 67/272 (24%), Positives = 114/272 (41%), Gaps = 38/272 (13%)

Query: 36  TIGREVGRGEFGITY---LCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG 92
            + R +G G FG  Y           +  A K+   +K      K+    E  IM++L  
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAVIMKNLD- 71

Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH- 151
            P+IV+     E++    I+MEL   GEL   +    +   + +  V  +++  + +C  
Sbjct: 72  HPHIVKLIGIIEEEP-TWIIMELYPYGELGHYL--ERN---KNSLKVLTLVLYSLQICKA 125

Query: 152 -----SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS-PYYI-- 203
                S   +HRD+   N L         VK  DFGLS +IE+   Y+  V   P  I  
Sbjct: 126 MAYLESINCVHRDIAVRNILV---ASPECVKLGDFGLSRYIEDEDYYKASVTRLP--IKW 180

Query: 204 -APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            +PE +  ++ +    +D+W   V ++ IL  G  PF+   ++ V   + KG+    R P
Sbjct: 181 MSPESI--NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD----RLP 234

Query: 259 FPSISSSAI-ELVRRMLTQDPKRRITVAQVLE 289
            P +    +  L+ R    DP  R    +++ 
Sbjct: 235 KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVC 266

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 52/273 (19%), Positives = 95/273 (34%), Gaps = 36/273 (13%)

Query: 36  TIGREVGRGEFGI----TYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
              + +G G FG      ++    S  +    K I             V   +  +  L 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAIGSLD 73

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
              +IV+          + +V +    G L D +  R H   R A     ++   V +  
Sbjct: 74  -HAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHV--RQH---RGALGPQLLLNWGVQIAK 126

Query: 152 ------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI-- 203
                   G++HR+L   N L       + V+  DFG++  +           +   I  
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183

Query: 204 -APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            A E +   +GK   ++D+WS GV ++ ++  G  P+       V   + KGE    R  
Sbjct: 184 MALESI--HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE----RLA 237

Query: 259 FPSISSSAI-ELVRRMLTQDPKRRITVAQVLEH 290
            P I +  +  ++ +    D   R T  ++   
Sbjct: 238 QPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 70/270 (25%), Positives = 118/270 (43%), Gaps = 34/270 (12%)

Query: 36  TIGREVGRGEFGITY---LCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG 92
            +GR +G G+FG  +     +  +  L  A K+   +    D  ++   +E   MR    
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQFD- 74

Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH- 151
            P+IV+      ++  V I+MELC  GEL   +  +     + +  +  +I+    +   
Sbjct: 75  HPHIVKLIGVITENP-VWIIMELCTLGELRSFL--QVR---KYSLDLASLILYAYQLSTA 128

Query: 152 -----SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG-SPY-YIA 204
                SK  +HRD+   N L +    N  VK  DFGLS ++E+   Y+   G  P  ++A
Sbjct: 129 LAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 185

Query: 205 PEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
           PE +  ++ +    +D+W  GV ++ IL+ GV PF    +  V   I  GE    R P P
Sbjct: 186 PESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----RLPMP 239

Query: 261 SISSSAI-ELVRRMLTQDPKRRITVAQVLE 289
                 +  L+ +    DP RR    ++  
Sbjct: 240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 51/273 (18%), Positives = 100/273 (36%), Gaps = 36/273 (13%)

Query: 36  TIGREVGRGEFGI----TYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
              + +G G FG      ++       +  A K +  R+        ++  E  +M  + 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVD 75

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC- 150
             P++ +          V ++ +L   G L D +  R H   +       ++   V +  
Sbjct: 76  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV--REH---KDNIGSQYLLNWCVQIAK 128

Query: 151 -----HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI-- 203
                  + ++HRDL   N L         VK TDFGL+  +   +      G    I  
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185

Query: 204 -APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            A E +   +     ++D+WS GV ++ ++  G  P+       ++  + KGE    R P
Sbjct: 186 MALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLP 239

Query: 259 FPSISSSAI-ELVRRMLTQDPKRRITVAQVLEH 290
            P I +  +  ++ +    D   R    +++  
Sbjct: 240 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 36/239 (15%), Positives = 64/239 (26%), Gaps = 37/239 (15%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIP-KRKLVKDV---EKDDVRREIEIMRHLS 91
                +G+G F   +       G            K++        +       +M  LS
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
              ++V             +V E    G L   +  + + +         V   +    H
Sbjct: 71  -HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMH 127

Query: 152 ---SKGVMHRDLKPENFL-----FTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY- 202
                 ++H ++  +N L              +K +D G+S           ++      
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS---------ITVLPKDILQ 178

Query: 203 -----IAPEVLSQSYGK----EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGE 251
                + PE +     K      D WS G  L+ I   G  P  A   Q   Q      
Sbjct: 179 ERIPWVPPECI--ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH 235

>1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A Length = 147

 Score = 83.4 bits (206), Expect = 2e-19
 Identities = 21/99 (21%), Positives = 39/99 (39%), Gaps = 5/99 (5%)

Query: 378 KQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAF 437
            Q  +  +      +D  ++        KL+ F+     +  FD + NG I +  L +  
Sbjct: 18  AQQEERLEGINKQFLDDPKYSNDEDLPSKLEAFK---VKYMEFDLNGNGDIDIMSLKRML 74

Query: 438 KDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           +   +G   T   +K ++ EV    +   SY +F  MM 
Sbjct: 75  EK--LGVPKTHLELKRLIREVSSGSEETFSYSDFLRMML 111

>1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A Length = 147

 Score = 77.6 bits (191), Expect = 3e-17
 Identities = 22/113 (19%), Positives = 46/113 (40%), Gaps = 2/113 (1%)

Query: 311 RMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGS 370
           + ++   +NK      K   +     +++  K K+ E D + +G +    LK  L KLG 
Sbjct: 20  QEERLEGINKQFLDDPKYSNDEDLPSKLEAFKVKYMEFDLNGNGDIDIMSLKRMLEKLGV 79

Query: 371 MLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKD 423
             T  ++K+ ++        T  Y +F+   M   K      +   ++  +K+
Sbjct: 80  PKTHLELKRLIREVSSGSEETFSYSDFL--RMMLGKRSAILRMILMYEEKNKE 130

>1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 Length = 67

 Score = 80.6 bits (200), Expect = 3e-19
 Identities = 17/64 (26%), Positives = 32/64 (50%), Gaps = 2/64 (3%)

Query: 413 LYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFR 472
             + F+ FDK+ +G +++DE  +           T   I +   E+D D +G ++ DEF 
Sbjct: 3   AKRVFEKFDKNKDGKLSLDEFREVALA--FSPYFTQEDIVKFFEEIDVDGNGELNADEFT 60

Query: 473 SMMK 476
           S ++
Sbjct: 61  SCIE 64

>1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 Length = 67

 Score = 73.3 bits (181), Expect = 1e-16
 Identities = 16/64 (25%), Positives = 32/64 (50%), Gaps = 1/64 (1%)

Query: 341 LKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITA 400
            K  F + D +  G L+ DE +          T+ D+ ++ +  D+DGNG ++  EF + 
Sbjct: 3   AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSC 62

Query: 401 TMQR 404
            +++
Sbjct: 63  -IEK 65

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 56/278 (20%), Positives = 109/278 (39%), Gaps = 35/278 (12%)

Query: 36  TIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           T+ RE+G+G FG+ Y        ++      A K++   +     E+ +   E  +M+  
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEF 85

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC 150
               ++V+        Q   ++MEL   G+L   + +               +  ++ + 
Sbjct: 86  -NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 151 H----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSP 200
                      +   +HRDL   N +     E+  VK  DFG++  I E   YR+     
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYRKGGKGL 201

Query: 201 YYI---APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEIN 253
             +   +PE L    G     +D+WS GV+L+ I      P+   +++ V + +++G   
Sbjct: 202 LPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG--- 256

Query: 254 FQRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQVLEH 290
                 P      + EL+R     +PK R +  +++  
Sbjct: 257 -GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 23/219 (10%)

Query: 31  VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           V   Y +GR++G G FG  YL T+ + G E A K           +   +  E +I + +
Sbjct: 7   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMM 61

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFD-RIVARGHYSERAAASVFRVIMNVVNV 149
            G   I   +    +  +  +VMEL  G  L D        +S +    +   +++ +  
Sbjct: 62  QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-----AYRE---IVGSPY 201
            HSK  +HRD+KP+NFL   G +  +V   DFGL+    + +      YRE   + G+  
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180

Query: 202 YIAPEVLSQSYGKEA----DIWSAGVILYILLCGVPPFW 236
           Y +   ++   G E     D+ S G +L     G  P W
Sbjct: 181 YAS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLP-W 215

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 68/278 (24%), Positives = 115/278 (41%), Gaps = 46/278 (16%)

Query: 36  TIGREVGRGEFGI----TYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           T  + +G GEFG         +     +  A K++  +    + ++ D   E  IM   S
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMGQFS 104

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHY--SERAAASVFRVIMNVVNV 149
              NI++ +      + + I+ E    G L         +   +    SV +++  +  +
Sbjct: 105 -HHNIIRLEGVISKYKPMMIITEYMENGALDK-------FLREKDGEFSVLQLVGMLRGI 156

Query: 150 CH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-AYREIVGSPYY 202
                   +   +HRDL   N L    + N V K +DFGLS  +E+   A     G    
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213

Query: 203 I---APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQ 255
           I   APE +  SY K    +D+WS G++++ ++  G  P+W  ++  V +AI  G     
Sbjct: 214 IRWTAPEAI--SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF---- 267

Query: 256 RDPFPSISSSAI-ELVRRMLT---QDPKRRITVAQVLE 289
           R P P    SAI +L   M+    Q+  RR   A ++ 
Sbjct: 268 RLPTPMDCPSAIYQL---MMQCWQQERARRPKFADIVS 302

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 89.2 bits (221), Expect = 4e-19
 Identities = 63/284 (22%), Positives = 119/284 (41%), Gaps = 34/284 (11%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
            +  ++G+G FG  ++ T N T    A K++        +  +   +E ++M+ L     
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKP----GTMSPEAFLQEAQVMKKLR-HEK 323

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC----- 150
           +VQ  A   ++  ++IV E  + G L D +  +G         + +++     +      
Sbjct: 324 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFL--KGE--TGKYLRLPQLVDMAAQIASGMAY 378

Query: 151 -HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS-PY-YIAPEV 207
                 +HRDL+  N L     EN V K  DFGL+  IE+ +         P  + APE 
Sbjct: 379 VERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435

Query: 208 LSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265
                +  ++D+WS G++L  +   G  P+    ++ V   + +G     R P P     
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY----RMPCPPECPE 491

Query: 266 AI-ELVRRMLTQDPKRRIT---VAQVLEHPWLKESGEASDKPID 305
           ++ +L+ +   ++P+ R T   +   LE      S E   +P +
Sbjct: 492 SLHDLMCQCWRKEPEERPTFEYLQAFLED--YFTSTEPQYQPGE 533

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 87.8 bits (218), Expect = 5e-19
 Identities = 60/233 (25%), Positives = 101/233 (43%), Gaps = 30/233 (12%)

Query: 36  TIGREVGRGEFGITYLCTENSTG---LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG 92
           +I + VG GEFG              +  A K++  +    + ++ D   E  IM     
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFD- 104

Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH- 151
            PNI++ +      + V IV E    G L   +  R H    A  +V +++  +  +   
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKH---DAQFTVIQLVGMLRGIASG 159

Query: 152 -----SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-AYREIVGSPYYI-- 203
                  G +HRDL   N L    + N V K +DFGL   +E+   A     G    I  
Sbjct: 160 MKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216

Query: 204 -APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGE 251
            +PE +  +Y K    +D+WS G++L+ ++  G  P+W  ++Q V +A+ +G 
Sbjct: 217 TSPEAI--AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 86.6 bits (215), Expect = 5e-19
 Identities = 60/284 (21%), Positives = 108/284 (38%), Gaps = 54/284 (19%)

Query: 36  TIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
              +++G+G FG   +C     +++TG   A K +   +   +    D  REIEI++ L 
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQ 69

Query: 92  GQPNIVQFKAA--YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
              NIV++K        + + ++ME    G L D +  + H   +      +++     +
Sbjct: 70  -HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKH---KERIDHIKLLQYTSQI 123

Query: 150 C------HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-AYREIVGSPYY 202
           C       +K  +HRDL   N L    +    VK  DFGL+  + + K  ++        
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180

Query: 203 I---APEVLSQSYGK---EADIWSAGVILY----------------ILLCGVPPFWAETD 240
           I   APE L  +  K    +D+WS GV+LY                + + G         
Sbjct: 181 IFWYAPESL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238

Query: 241 QGVAQAILKGEINFQRDPFPSISSSAI-ELVRRMLTQDPKRRIT 283
             + + +        R P P      I  ++      +  +R +
Sbjct: 239 FHLIELLKNNG----RLPRPDGCPDEIYMIMTECWNNNVNQRPS 278

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 87.0 bits (216), Expect = 5e-19
 Identities = 64/292 (21%), Positives = 112/292 (38%), Gaps = 58/292 (19%)

Query: 36  TIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
              +++G+G FG   +C     +++TG   A K +   +   +    D  REIEI++ L 
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQ 100

Query: 92  GQPNIVQFKAA--YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
              NIV++K        + + ++ME    G L D +  + H   +      +++     +
Sbjct: 101 -HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKH---KERIDHIKLLQYTSQI 154

Query: 150 C------HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY---REIVGSP 200
           C       +K  +HRDL   N L    +    VK  DFGL+  + + K Y   +E   SP
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211

Query: 201 YYI---APEVLSQSYGK---EADIWSAGVILY----------------ILLCGVPPFWAE 238
             I   APE L  +  K    +D+WS GV+LY                + + G       
Sbjct: 212 --IFWYAPESL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267

Query: 239 TDQGVAQAILKGEINFQRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQVLE 289
               + + +        R P P      I  ++      +  +R +   +  
Sbjct: 268 IVFHLIELLKNNG----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 87.0 bits (216), Expect = 5e-19
 Identities = 55/235 (23%), Positives = 96/235 (40%), Gaps = 34/235 (14%)

Query: 36  TIGREVGRGEFGITY---LCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG 92
            I + +G G+ G      L       +  A K++  +    + ++ D   E  IM     
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMGQFD- 108

Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHY--SERAAASVFRVIMNVVNVC 150
            PNI++ +      +   IV E    G L         +  +     ++ +++  +  V 
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDT-------FLRTHDGQFTIMQLVGMLRGVG 161

Query: 151 H------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-AYREIVGSPYYI 203
                    G +HRDL   N L    D N V K +DFGLS  +E+   A     G    I
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI 218

Query: 204 ---APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGE 251
              APE +  ++      +D+WS GV+++ +L  G  P+W  T++ V  ++ +G 
Sbjct: 219 RWTAPEAI--AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY 271

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 86.1 bits (214), Expect = 6e-19
 Identities = 64/287 (22%), Positives = 110/287 (38%), Gaps = 47/287 (16%)

Query: 36  TIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
               E+G   FG  Y                A K++  +   +   +++ R E  +   L
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAMLRARL 69

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRV------IM 144
              PN+V        DQ + ++   C+ G+L + +V R  +S+  +    R         
Sbjct: 70  Q-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 145 NVVNVCH----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR 194
           + V++            S  V+H+DL   N L     +   VK +D GL   +     Y+
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLFREVYAADYYK 185

Query: 195 EIVGSPYYI---APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAI 247
            +  S   I   APE +   YGK   ++DIWS GV+L+ +   G+ P+   ++Q V + I
Sbjct: 186 LLGNSLLPIRWMAPEAI--MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 243

Query: 248 LKGEINFQRDPFPSISSSAI-ELVRRMLT---QDPKRRITVAQVLEH 290
                  Q  P P    + +  L   M+    + P RR     +   
Sbjct: 244 RNR----QVLPCPDDCPAWVYAL---MIECWNEFPSRRPRFKDIHSR 283

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 87.9 bits (218), Expect = 7e-19
 Identities = 63/284 (22%), Positives = 119/284 (41%), Gaps = 34/284 (11%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
            +  ++G+G FG  ++ T N T    A K++        +  +   +E ++M+ L     
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKP----GTMSPEAFLQEAQVMKKLR-HEK 240

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC----- 150
           +VQ  A   ++  ++IV E  + G L D +  +G         + +++     +      
Sbjct: 241 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFL--KGE--TGKYLRLPQLVDMAAQIASGMAY 295

Query: 151 -HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS-PY-YIAPEV 207
                 +HRDL+  N L     EN V K  DFGL+  IE+ +         P  + APE 
Sbjct: 296 VERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352

Query: 208 LSQS-YGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS 265
                +  ++D+WS G++L  +   G  P+    ++ V   + +G     R P P     
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY----RMPCPPECPE 408

Query: 266 AI-ELVRRMLTQDPKRRIT---VAQVLEHPWLKESGEASDKPID 305
           ++ +L+ +   ++P+ R T   +   LE      S E   +P +
Sbjct: 409 SLHDLMCQCWRKEPEERPTFEYLQAFLED--YFTSTEPQYQPGE 450

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 59/272 (21%), Positives = 94/272 (34%), Gaps = 33/272 (12%)

Query: 36  TIGREVGRGEFGITY---LCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG 92
            +  ++G G FG+         +   +  A K +    L +    DD  RE+  M  L  
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD- 79

Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC-- 150
             N+++          + +V EL   G L DR+  R H   +    +  +    V V   
Sbjct: 80  HRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRL--RKH---QGHFLLGTLSRYAVQVAEG 133

Query: 151 ----HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-KAYREIVGSPYYI-- 203
                SK  +HRDL   N L        +VK  DFGL   + +    Y            
Sbjct: 134 MGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190

Query: 204 -APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
            APE L          +D W  GV L+ +   G  P+       +   I   +   +R P
Sbjct: 191 CAPESL--KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI---DKEGERLP 245

Query: 259 FPSISSSAI-ELVRRMLTQDPKRRITVAQVLE 289
            P      I  ++ +     P+ R T   + +
Sbjct: 246 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 68/283 (24%), Positives = 112/283 (39%), Gaps = 52/283 (18%)

Query: 36  TIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
              R++G G FG   LC      ++TG + A KS+  +         D+++EIEI+R+L 
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEILRNLY 81

Query: 92  GQPNIVQFKAA--YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
              NIV++K     +    + ++ME    G L + +    +   +   ++ + +   V +
Sbjct: 82  -HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKN---KNKINLKQQLKYAVQI 135

Query: 150 C------HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-AYREIVGSPYY 202
           C       S+  +HRDL   N L    +    VK  DFGL+  IE  K  Y         
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192

Query: 203 I---APEVLSQSYGK---EADIWSAGVILY---------------ILLCGVPPFWAETDQ 241
           +   APE L     K    +D+WS GV L+                L    P     T  
Sbjct: 193 VFWYAPECL--MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250

Query: 242 GVAQAILKGEINFQRDPFPSISSSAI-ELVRRMLTQDPKRRIT 283
            +   + +G+    R P P      + +L+R+     P  R +
Sbjct: 251 RLVNTLKEGK----RLPCPPNCPDEVYQLMRKCWEFQPSNRTS 289

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 52/221 (23%), Positives = 93/221 (42%), Gaps = 25/221 (11%)

Query: 31  VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           V +HY +GR +G G FG+ +  T      + A K  P+       +   +R E    + L
Sbjct: 8   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLL 62

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFD-RIVARGHYSERAAASVFRVIMNVVNV 149
           +G   I       ++     +V++L  G  L D   +    +S +  A   + ++  V  
Sbjct: 63  AGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121

Query: 150 CHSKGVMHRDLKPENFLF--TTGDENAVVKATDFGLSAFIEEGK-----AYRE---IVGS 199
            H K +++RD+KP+NFL          ++   DFG+  F  +        YRE   + G+
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181

Query: 200 PYYIAPEVLSQSYGKEA----DIWSAGVILYILLCGVPPFW 236
             Y++   ++   G+E     D+ + G +    L G  P W
Sbjct: 182 ARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP-W 218

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 87.1 bits (216), Expect = 1e-18
 Identities = 63/285 (22%), Positives = 123/285 (43%), Gaps = 38/285 (13%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
            + +++G G+FG  ++ T N    + A K++        +  +    E  +M+ L     
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKP----GSMSVEAFLAEANVMKTLQ-HDK 244

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH---- 151
           +V+  A    +  ++I+ E  A G L D + +     E +   + ++I     +      
Sbjct: 245 LVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAF 299

Query: 152 --SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI---APE 206
              +  +HRDL+  N L      + V K  DFGL+  IE+ + Y    G+ + I   APE
Sbjct: 300 IEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPE 355

Query: 207 VLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI 262
            +  ++G    ++D+WS G++L  I+  G  P+   ++  V +A+ +G     R P P  
Sbjct: 356 AI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY----RMPRPEN 409

Query: 263 SSSAI-ELVRRMLTQDPKRRIT---VAQVLEHPWLKESGEASDKP 303
               +  ++ R     P+ R T   +  VL+  +     +  + P
Sbjct: 410 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP 454

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 65/304 (21%), Positives = 114/304 (37%), Gaps = 55/304 (18%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR--------KLVKDV---EKDDVRREI 84
            +  E+G G FG  +L           C ++           K +K+     + D +RE 
Sbjct: 44  VLKWELGEGAFGKVFLAE---------CHNLLPEQDKMLVAVKALKEASESARQDFQREA 94

Query: 85  EIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFD-----RIVARGHYSERAAASV 139
           E++  L    +IV+F     + + + +V E    G+L          A+        A  
Sbjct: 95  ELLTMLQ-HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153

Query: 140 FRVIMNVVNVCH----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
              +  ++ V                +HRDL   N L     +  VVK  DFG+S  I  
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGLVVKIGDFGMSRDIYS 210

Query: 190 GKAYREIVGSPYYI---APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQG 242
              YR    +   I    PE +   Y K   E+D+WS GV+L+ I   G  P++  ++  
Sbjct: 211 TDYYRVGGRTMLPIRWMPPESI--LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268

Query: 243 VAQAILKGEINFQRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQVLEHPWLKESGEASD 301
               I +G    +    P      +  ++R    ++P++R ++  V     L+   +A  
Sbjct: 269 AIDCITQG----RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR--LQALAQAPP 322

Query: 302 KPID 305
             +D
Sbjct: 323 VYLD 326

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 66/268 (24%), Positives = 106/268 (39%), Gaps = 37/268 (13%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
            + + +G+GEFG   L        + A K I   K   D        E  +M  L    N
Sbjct: 24  KLLQTIGKGEFGDVMLGDYRGN--KVAVKCI---K--NDATAQAFLAEASVMTQLR-HSN 75

Query: 96  IVQFKAA-YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH--- 151
           +VQ      E+   ++IV E  A G L D +  R     R+      ++   ++VC    
Sbjct: 76  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSR--GRSVLGGDCLLKFSLDVCEAME 131

Query: 152 ---SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY-YIAPEV 207
                  +HRDL   N L     E+ V K +DFGL+      +   ++   P  + APE 
Sbjct: 132 YLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEA 185

Query: 208 LSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263
           L     K   ++D+WS G++L+ I   G  P+     + V   + KG     +   P   
Sbjct: 186 L--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG----YKMDAPDGC 239

Query: 264 SSAI-ELVRRMLTQDPKRRITVAQVLEH 290
             A+ E+++     D   R +  Q+ E 
Sbjct: 240 PPAVYEVMKNCWHLDAAMRPSFLQLREQ 267

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 63/243 (25%), Positives = 98/243 (40%), Gaps = 38/243 (15%)

Query: 36  TIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
               ++G+G FG   LC      ++TG   A K +   +     ++ D +REI+I++ L 
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILKALH 82

Query: 92  GQPNIVQFKAAYEDDQF--VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
               IV+++          + +VME    G L D +  + H   RA     R+++    +
Sbjct: 83  -SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRH---RARLDASRLLLYSSQI 136

Query: 150 C------HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY---REIVGSP 200
           C       S+  +HRDL   N L       A VK  DFGL+  +   K Y   RE   SP
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193

Query: 201 YYI---APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEIN 253
             I   APE L  S      ++D+WS GV+LY +            +        +    
Sbjct: 194 --IFWYAPESL--SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA 249

Query: 254 FQR 256
             R
Sbjct: 250 LSR 252

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 86.6 bits (215), Expect = 2e-18
 Identities = 67/267 (25%), Positives = 109/267 (40%), Gaps = 37/267 (13%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
            + + +G+GEFG   L        + A K I K     D        E  +M  L    N
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGN--KVAVKCI-KN----DATAQAFLAEASVMTQLR-HSN 247

Query: 96  IVQFKAA-YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC---- 150
           +VQ      E+   ++IV E  A G L D + +RG    R+      ++   ++VC    
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAME 303

Query: 151 --HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPY-YIAPEV 207
                  +HRDL   N L +   E+ V K +DFGL+      +   ++   P  + APE 
Sbjct: 304 YLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEA 357

Query: 208 LSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263
           L     K   ++D+WS G++L+ I   G  P+     + V   + KG     +   P   
Sbjct: 358 L--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG----YKMDAPDGC 411

Query: 264 SSAI-ELVRRMLTQDPKRRITVAQVLE 289
             A+ ++++     D   R T  Q+ E
Sbjct: 412 PPAVYDVMKNCWHLDAATRPTFLQLRE 438

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 72/305 (23%), Positives = 120/305 (39%), Gaps = 61/305 (20%)

Query: 36  TIGREVGRGEFGITYLC----TENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
              R++G G FG   L     T + TG   A K++  +       +   ++EI+I+R L 
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADAGPQHRSGWKQEIDILRTLY 91

Query: 92  GQPNIVQFKAA--YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
              +I+++K          + +VME    G L D       Y  R +  + ++++    +
Sbjct: 92  -HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD-------YLPRHSIGLAQLLLFAQQI 143

Query: 150 C------HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY---REIVGSP 200
           C      H++  +HRDL   N L      + +VK  DFGL+  + EG  Y   RE   SP
Sbjct: 144 CEGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 200

Query: 201 YYI---APEVLSQSYGK---EADIWSAGVILY---------------ILLCGVPPFWAET 239
             +   APE L     K    +D+WS GV LY                L          T
Sbjct: 201 --VFWYAPECL--KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256

Query: 240 DQGVAQAILKGEINFQRDPFPSISSSAI-ELVRRMLTQDPKRRIT---VAQVLEHPWLKE 295
              + + + +G    +R P P    + +  L++     +   R T   +  +L+    K 
Sbjct: 257 VLRLTELLERG----ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312

Query: 296 SGEAS 300
            G+A 
Sbjct: 313 QGQAP 317

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 50/227 (22%), Positives = 95/227 (41%), Gaps = 28/227 (12%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN 95
            +   +G G+FG  ++   N    + A KS+ +      +  D    E  +M+ L     
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHT-KVAVKSLKQG----SMSPDAFLAEANLMKQLQ-HQR 69

Query: 96  IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH---- 151
           +V+  A    +  ++I+ E    G L D +  +         ++ +++     +      
Sbjct: 70  LVRLYAVVTQEP-IYIITEYMENGSLVDFL--KTP--SGIKLTINKLLDMAAQIAEGMAF 124

Query: 152 --SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS-PY-YIAPEV 207
              +  +HRDL+  N L     +    K  DFGL+  IE+ +         P  + APE 
Sbjct: 125 IEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181

Query: 208 LSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
           +  +YG    ++D+WS G++L  I+  G  P+   T+  V Q + +G
Sbjct: 182 I--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

>1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A Length = 76

 Score = 78.0 bits (193), Expect = 3e-18
 Identities = 22/72 (30%), Positives = 39/72 (54%), Gaps = 2/72 (2%)

Query: 411 ENLYKAFQYFDKD--NNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISY 468
           E +  AF+ F     +   I+ +EL    +  G      ++T+ E++ EVD++ DG +S+
Sbjct: 5   EEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSF 64

Query: 469 DEFRSMMKCGTQ 480
           +EF  MMK  +Q
Sbjct: 65  EEFLVMMKKISQ 76

>1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A Length = 76

 Score = 50.7 bits (122), Expect = 1e-08
 Identities = 16/66 (24%), Positives = 33/66 (50%), Gaps = 3/66 (4%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEF--DVKQYMQAADIDGNGTID 393
           EEI+   E F   +  +   ++ +ELK  +  LG  L +    + + ++  D +G+G + 
Sbjct: 5   EEIKGAFEVFAAKE-GDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVS 63

Query: 394 YIEFIT 399
           + EF+ 
Sbjct: 64  FEEFLV 69

>1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* Length = 183

 Score = 81.4 bits (201), Expect = 3e-18
 Identities = 25/162 (15%), Positives = 59/162 (36%), Gaps = 29/162 (17%)

Query: 336 EEIQKLKEKFTE--------MDTDNSGTLTYDELKAGLAKLGSMLTE-----FDVKQYMQ 382
           +EI     +F E        +++     + ++++ +      +   E     F       
Sbjct: 17  QEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILSLPELKANPFKERICRVFSTS---- 72

Query: 383 AADIDGNGTIDYIEFITA-TMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFK--- 438
                   ++ + +F+   ++           + AF+ FD D++G +  ++L +      
Sbjct: 73  ----PAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLT 128

Query: 439 ----DYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
               D  +        I  I+ E D D+DG I+  EF+ ++ 
Sbjct: 129 GEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVIS 170

>1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* Length = 183

 Score = 39.8 bits (93), Expect = 8e-04
 Identities = 11/58 (18%), Positives = 24/58 (41%), Gaps = 1/58 (1%)

Query: 321 LKKLALKVIVENLPTEEIQKLKEK-FTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDV 377
           +  L  +     L   E+++L +    E D D  GT+   E +  +++     + F +
Sbjct: 124 VNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVISRSPDFASSFKI 181

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 63/282 (22%), Positives = 103/282 (36%), Gaps = 46/282 (16%)

Query: 29  EDVQLHYTIGREVGRGEFGITY--LCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEI 86
           + + L     +E+G G FG                A K + K +      KD++  E  +
Sbjct: 16  KLLTL---EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANV 71

Query: 87  MRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNV 146
           M+ L   P IV+     E +    +VME+   G L   +    H              N+
Sbjct: 72  MQQLD-NPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVK----------DKNI 119

Query: 147 VNVCH----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-AYRE 195
           + + H              +HRDL   N L          K +DFGLS  +   +  Y+ 
Sbjct: 120 IELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKA 176

Query: 196 IVGSPYYI---APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAIL 248
                + +   APE +  +Y K   ++D+WS GV+++     G  P+       V   + 
Sbjct: 177 QTHGKWPVKWYAPECI--NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234

Query: 249 KGEINFQRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQVLE 289
           KGE    R   P+     + +L+    T D + R   A V  
Sbjct: 235 KGE----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 84.8 bits (210), Expect = 4e-18
 Identities = 60/277 (21%), Positives = 106/277 (38%), Gaps = 41/277 (14%)

Query: 36  TIGREVGRGEFGITY---LCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG 92
                +GRG FG  Y   L   +   +  A KS+   ++    E      E  IM+  S 
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFS- 148

Query: 93  QPNIVQFKAA-YEDDQFVHIVMELCAGGEL--FDRIVARGHYSERAAASVFRVIMNVVNV 149
            PN++         +    +V+     G+L  F R       +E    +V  +I   + V
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-------NETHNPTVKDLIGFGLQV 201

Query: 150 CH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI 203
                   SK  +HRDL   N +    DE   VK  DFGL+  + + +       +   +
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 258

Query: 204 -----APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINF 254
                A E L     K   ++D+WS GV+L+ ++  G PP+       +   +L+G    
Sbjct: 259 PVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--- 313

Query: 255 QRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQVLEH 290
            R   P      + E++ +      + R + ++++  
Sbjct: 314 -RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 83.1 bits (206), Expect = 6e-18
 Identities = 65/289 (22%), Positives = 116/289 (40%), Gaps = 54/289 (18%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR--------KLVKDV---EKDDVRREI 84
            + RE+G G FG  +L           C ++           K +KD     + D +RE 
Sbjct: 18  VLKRELGEGAFGKVFLAE---------CYNLSPTKDKMLVAVKALKDPTLAARKDFQREA 68

Query: 85  EIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIM 144
           E++ +L    +IV+F     D   + +V E    G+L   + A G  +        R   
Sbjct: 69  ELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127

Query: 145 NVVNVCH----------------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE 188
             + +                  S+  +HRDL   N L      N +VK  DFG+S  + 
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMSRDVY 184

Query: 189 EGKAYREIVGSPYYI---APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQ 241
               YR    +   I    PE +   Y K   E+D+WS GVIL+ I   G  P++  ++ 
Sbjct: 185 STDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 242

Query: 242 GVAQAILKGEINFQRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQVLE 289
            V + I +G    +    P +    + +++     ++P++R+ + ++ +
Sbjct: 243 EVIECITQG----RVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 85.0 bits (210), Expect = 1e-17
 Identities = 58/276 (21%), Positives = 100/276 (36%), Gaps = 45/276 (16%)

Query: 36  TIGREVGRGEFGITY---LCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG 92
               E+G G FG              ++ A K +  ++  +  + +++ RE +IM  L  
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQ-IDVAIKVL--KQGTEKADTEEMMREAQIMHQLD- 394

Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH- 151
            P IV+     + +  + +VME+  GG L   +V +              + NV  + H 
Sbjct: 395 NPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIP---------VSNVAELLHQ 444

Query: 152 ---------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-AYREIVGSPY 201
                     K  +HR+L   N L          K +DFGLS  +      Y       +
Sbjct: 445 VSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKW 501

Query: 202 YI---APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINF 254
            +   APE +  ++ K    +D+WS GV ++  L  G  P+       V   I +G+   
Sbjct: 502 PLKWYAPECI--NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--- 556

Query: 255 QRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQVLE 289
            R   P      +  L+        + R     V +
Sbjct: 557 -RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 52/224 (23%), Positives = 90/224 (40%), Gaps = 31/224 (13%)

Query: 31  VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           V  ++ +G+++G G FG   L     T    A K +   K         +  E    + L
Sbjct: 7   VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMK----SRAPQLHLEYRFYKQL 61

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGG----ELFDRIVARGHYSERAAASVFRVIMNV 146
                I Q        ++  +V+EL   G    +LFD       +S +    +   +++ 
Sbjct: 62  GSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDL--CDRTFSLKTVLMIAIQLISR 117

Query: 147 VNVCHSKGVMHRDLKPENFLFTTGDENA--VVKATDFGLSAFIEEGK-----AYRE---I 196
           +   HSK +++RD+KPENFL          V+   DF L+    + +      YRE   +
Sbjct: 118 MEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL 177

Query: 197 VGSPYYIAPEVLSQSYGKEA----DIWSAGVILYILLCGVPPFW 236
            G+  Y++   ++   GKE     D+ + G +    L G  P W
Sbjct: 178 TGTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLP-W 217

>1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A Length = 90

 Score = 76.9 bits (190), Expect = 1e-17
 Identities = 27/84 (32%), Positives = 39/84 (46%), Gaps = 10/84 (11%)

Query: 400 ATMQRHKLQRFENL-------YK-AFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATI 451
           A+M   + +    L       +K AF  FD D  G I+  ELG   +   +G + T   +
Sbjct: 1   ASMTDQQAEARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMR--MLGQNPTKEEL 58

Query: 452 KEIMSEVDRDKDGRISYDEFRSMM 475
             I+ EVD D  G I ++EF  MM
Sbjct: 59  DAIIEEVDEDGSGTIDFEEFLVMM 82

>1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A Length = 90

 Score = 74.6 bits (184), Expect = 7e-17
 Identities = 22/69 (31%), Positives = 34/69 (49%)

Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
             L  E I + K  F   D D  G ++  EL   +  LG   T+ ++   ++  D DG+G
Sbjct: 12  AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSG 71

Query: 391 TIDYIEFIT 399
           TID+ EF+ 
Sbjct: 72  TIDFEEFLV 80

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 59/282 (20%), Positives = 105/282 (37%), Gaps = 46/282 (16%)

Query: 29  EDVQLHYTIGREVGRGEFGITY--LCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEI 86
           +++ +      E+G G FG     +       ++ A K +  ++  +  + +++ RE +I
Sbjct: 9   DNLLI---ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQI 63

Query: 87  MRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNV 146
           M  L   P IV+     + +  + +VME+  GG L   +V +              + NV
Sbjct: 64  MHQLD-NPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIP---------VSNV 112

Query: 147 VNVCH----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-AYRE 195
             + H           K  +HRDL   N L          K +DFGLS  +      Y  
Sbjct: 113 AELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTA 169

Query: 196 IVGSPYYI---APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAIL 248
                + +   APE +  ++ K    +D+WS GV ++  L  G  P+       V   I 
Sbjct: 170 RSAGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

Query: 249 KGEINFQRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQVLE 289
           +G+    R   P      +  L+        + R     V +
Sbjct: 228 QGK----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 265

>3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C Length = 143

 Score = 78.5 bits (193), Expect = 2e-17
 Identities = 25/119 (21%), Positives = 48/119 (40%), Gaps = 27/119 (22%)

Query: 359 DELKAGLAKLGSMLTEFDVK-QYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAF 417
           + L+  + K  + ++  +++  Y +  D DGN  +D +E  TA    HK +         
Sbjct: 51  EHLEGVINKPEAEMSPQELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEG-------- 102

Query: 418 QYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
                +    ++ DEL              I  I  ++ + D++ DG I Y EF   ++
Sbjct: 103 ----SEQAPLMSEDEL--------------INIIDGVLRDDDKNNDGYIDYAEFAKSLQ 143

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 59/277 (21%), Positives = 114/277 (41%), Gaps = 41/277 (14%)

Query: 36  TIGREVGRGEFGITY---LCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG 92
              R +G+G FG+ Y      +    ++ A KS+   ++ +  + +   RE  +MR L+ 
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGLN- 80

Query: 93  QPNIVQFKAA-YEDDQFVHIVMELCAGGELFDRIVARGHY--SERAAASVFRVIMNVVNV 149
            PN++         +   H+++     G+L         +  S +   +V  +I   + V
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQ-------FIRSPQRNPTVKDLISFGLQV 133

Query: 150 CH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI 203
                    +  +HRDL   N +    DE+  VK  DFGL+  I + + Y         +
Sbjct: 134 ARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDILDREYYSVQQHRHARL 190

Query: 204 -----APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINF 254
                A E L     +   ++D+WS GV+L+ +L  G PP+       +   + +G    
Sbjct: 191 PVKWTALESL--QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG---- 244

Query: 255 QRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQVLEH 290
           +R P P     ++ +++++    DP  R T   ++  
Sbjct: 245 RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281

>2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A Length = 214

 Score = 79.5 bits (196), Expect = 3e-17
 Identities = 25/162 (15%), Positives = 59/162 (36%), Gaps = 29/162 (17%)

Query: 336 EEIQKLKEKFTEM--------DTDNSGTLTYDELKAGLAKLGSMLTE-----FDVKQYMQ 382
           +EI     +F E+        ++     + ++++ +      +   E     F       
Sbjct: 48  QEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILSLPELKANPFKERICRVFSTS---- 103

Query: 383 AADIDGNGTIDYIEFITA-TMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFK--- 438
                   ++ + +F+   ++           + AF+ FD D++G +  ++L +      
Sbjct: 104 ----PAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLT 159

Query: 439 ----DYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
               D  +        I  I+ E D D+DG I+  EF+ ++ 
Sbjct: 160 GEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVIS 201

>2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A Length = 214

 Score = 41.4 bits (97), Expect = 3e-04
 Identities = 11/56 (19%), Positives = 23/56 (41%), Gaps = 1/56 (1%)

Query: 321 LKKLALKVIVENLPTEEIQKLKEK-FTEMDTDNSGTLTYDELKAGLAKLGSMLTEF 375
           +  L  +     L   E+++L +    E D D  GT+   E +  +++     + F
Sbjct: 155 VNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVISRSPDFASSF 210

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 65/299 (21%), Positives = 107/299 (35%), Gaps = 71/299 (23%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR--------KLVK----DVEKDDVRRE 83
             G+ +G G FG     T            + K         K++K      EK+ +  E
Sbjct: 49  QFGKTLGAGAFGKVVEAT---------AFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99

Query: 84  IEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFD----RIVARGHYSERAAASV 139
           ++IM HL    NIV    A      V ++ E C  G+L +    +          A A+ 
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159

Query: 140 FRVIMNVVNVCH----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
                ++++             SK  +HRD+   N L T      V K  DFGL+     
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLA----- 211

Query: 190 GKAYREIVGSPYYI------------APEVLS-QSYGKEADIWSAGVILY-ILLCGVPPF 235
               R+I+    YI            APE +    Y  ++D+WS G++L+ I   G+ P+
Sbjct: 212 ----RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

Query: 236 W-AETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLT---QDPKRRITVAQVLEH 290
                +    + +  G     +   P+ +   I  +  M      +P  R T  Q+   
Sbjct: 268 PGILVNSKFYKLVKDG----YQMAQPAFAPKNIYSI--MQACWALEPTHRPTFQQICSF 320

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 55/245 (22%), Positives = 101/245 (41%), Gaps = 37/245 (15%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR---KLVKD----VEKDDVRREIEIMR 88
            +G+ +G G FG   L    + GL+    +   +   K++K      +  D+  E+E+M+
Sbjct: 72  VLGKPLGEGAFGQVVLAE--AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 129

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVN 148
            +    NI+    A   D  +++++E  + G L + + AR       + +        ++
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189

Query: 149 VCH----------------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192
                              SK  +HRDL   N L T   E+ V+K  DFGL+  I     
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDY 246

Query: 193 YREIVGSPYYI---APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQ 245
           Y++       +   APE L         ++D+WS GV+L+ I   G  P+     + + +
Sbjct: 247 YKKTTNGRLPVKWMAPEAL--FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304

Query: 246 AILKG 250
            + +G
Sbjct: 305 LLKEG 309

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 61/316 (19%), Positives = 110/316 (34%), Gaps = 69/316 (21%)

Query: 36  TIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
              R++G G FG  +                A K +  ++      + D +RE  +M   
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEF 107

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC 150
              PNIV+        + + ++ E  A G+L + + +   ++  + +         V+  
Sbjct: 108 D-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 151 H------------------------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF 186
                                     +  +HRDL   N L     EN VVK  DFGLS  
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLS-- 221

Query: 187 IEEGKAYREIVGSPYY------------IAPEVLSQSYGK---EADIWSAGVILY-ILLC 230
                  R I  + YY            + PE +   Y +   E+D+W+ GV+L+ I   
Sbjct: 222 -------RNIYSADYYKADGNDAIPIRWMPPESI--FYNRYTTESDVWAYGVVLWEIFSY 272

Query: 231 GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQVLE 289
           G+ P++    + V   +  G         P      +  L+R   ++ P  R +   +  
Sbjct: 273 GLQPYYGMAHEEVIYYVRDG----NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328

Query: 290 HPWLKESGEASDKPID 305
              L+   E ++  + 
Sbjct: 329 I--LQRMCERAEGTVG 342

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 47/218 (21%), Positives = 83/218 (38%), Gaps = 32/218 (14%)

Query: 36  TIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
           + G+ +G G FG     T     ++   +  A K +  +      E++ +  E++++ +L
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKVLSYL 83

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFD------------RIVARGHYSERAAAS 138
               NIV    A        ++ E C  G+L +            +        +  A  
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 139 VFRVIMNVVNVCH------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192
           +  ++     V        SK  +HRDL   N L T      + K  DFGL+  I+    
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIKNDSN 200

Query: 193 YREIVGSPYYI---APEVLS-QSYGKEADIWSAGVILY 226
           Y     +   +   APE +    Y  E+D+WS G+ L+
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 66/281 (23%), Positives = 110/281 (39%), Gaps = 40/281 (14%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEF--ACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
                +G G FG          GL    A K +  ++     +  D   E+E++  L   
Sbjct: 28  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCKLGHH 85

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFD-----RIVARGHYSERAAASVFRV-IMNVV 147
           PNI+    A E   ++++ +E    G L D     R++        A ++   +    ++
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145

Query: 148 NVCH----------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV 197
           +              K  +HRDL   N L     EN V K  DFGLS   E    Y +  
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEV---YVKKT 199

Query: 198 GS--PY-YIAPEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKG 250
               P  ++A E L  +Y      +D+WS GV+L+ I+  G  P+   T   + + + +G
Sbjct: 200 MGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 257

Query: 251 EINFQRDPFPSISSSAI-ELVRRMLTQDPKRRITVAQVLEH 290
                R   P      + +L+R+   + P  R + AQ+L  
Sbjct: 258 ----YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 53/243 (21%), Positives = 100/243 (41%), Gaps = 33/243 (13%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIP---K--RKLVKDVEKDDVRREIEIMRHL 90
           T+G+ +G G FG   +        +   +++    K  +    + +  D+  E+E+M+ +
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC 150
               NI+    A   D  +++++E  + G L + + AR       +  + RV    +   
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 151 H----------------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR 194
                            S+  +HRDL   N L T   EN V+K  DFGL+  I     Y+
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNIDYYK 214

Query: 195 EIVGSPYYI---APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFWAETDQGVAQAI 247
           +       +   APE L         ++D+WS GV+++ I   G  P+     + + + +
Sbjct: 215 KTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272

Query: 248 LKG 250
            +G
Sbjct: 273 KEG 275

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 56/254 (22%), Positives = 100/254 (39%), Gaps = 55/254 (21%)

Query: 36  TIGREVGRGEFGITYLCT-------ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
           T+G+ +G G FG   +         +    +  A K +  +    + +  D+  E+E+M+
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEMEMMK 141

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVN 148
            +    NI+    A   D  +++++E  + G L + + AR       +  + RV    + 
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201

Query: 149 VCH----------------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA 192
                              S+  +HRDL   N L T   EN V+K  DFGL+        
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLA-------- 250

Query: 193 YREIVGSPYYI------------APEVLSQSYGK---EADIWSAGVILY-ILLCGVPPFW 236
            R+I    YY             APE L         ++D+WS GV+++ I   G  P+ 
Sbjct: 251 -RDINNIDYYKKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307

Query: 237 AETDQGVAQAILKG 250
               + + + + +G
Sbjct: 308 GIPVEELFKLLKEG 321

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 76.9 bits (190), Expect = 9e-16
 Identities = 53/243 (21%), Positives = 101/243 (41%), Gaps = 33/243 (13%)

Query: 36  TIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
            +G+ +GRG FG           + +T    A K +  ++     E   +  E++I+ H+
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHI 87

Query: 91  SGQPNIVQFKAA-YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
               N+V    A  +    + +++E C  G L   + ++ +       +   +  + + +
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147

Query: 150 CH----------------SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY 193
            H                S+  +HRDL   N L +   E  VVK  DFGL+  I +   Y
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDY 204

Query: 194 REIVGSPYYI---APEVLS-QSYGKEADIWSAGVILY-ILLCGVPPFWA-ETDQGVAQAI 247
                +   +   APE +  + Y  ++D+WS GV+L+ I   G  P+   + D+   + +
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264

Query: 248 LKG 250
            +G
Sbjct: 265 KEG 267

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 51/230 (22%), Positives = 81/230 (35%), Gaps = 51/230 (22%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR--------KLVKD----VEKDDVRRE 83
             G+ +G G FG     T            I K         K++K+     E++ +  E
Sbjct: 48  EFGKVLGSGAFGKVMNAT---------AYGISKTGVSIQVAVKMLKEKADSSEREALMSE 98

Query: 84  IEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFD-----RIVARGHYSERAAAS 138
           +++M  L    NIV    A      ++++ E C  G+L +     R        E     
Sbjct: 99  LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158

Query: 139 VFRVIMNVVNVCH------------------SKGVMHRDLKPENFLFTTGDENAVVKATD 180
                 ++  +                     K  +HRDL   N L T      VVK  D
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICD 215

Query: 181 FGLSAFIEEGKAYREIVGSPYYI---APEVLS-QSYGKEADIWSAGVILY 226
           FGL+  I     Y     +   +   APE L    Y  ++D+WS G++L+
Sbjct: 216 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 265

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 75.2 bits (185), Expect = 6e-15
 Identities = 32/185 (17%), Positives = 70/185 (37%), Gaps = 36/185 (19%)

Query: 31  VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
               + +G+++G G FG+ YL    +   + A   +     V+  E   +  E++  + +
Sbjct: 35  EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK----VEYQENGPLFSELKFYQRV 90

Query: 91  SGQPNIVQFKA------------------AYEDDQFVHIVMELCAGGELFDRIVARGHYS 132
           + +  I ++                     ++   +  +VME   G +L       G + 
Sbjct: 91  AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFK 149

Query: 133 ERAAASVFRV---IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE 189
           +    +V ++   +++V+   H    +H D+K  N L    + +  V   D+GLS     
Sbjct: 150 KS---TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-QVYLADYGLS----- 200

Query: 190 GKAYR 194
              Y 
Sbjct: 201 -YRYC 204

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 48/267 (17%), Positives = 89/267 (33%), Gaps = 76/267 (28%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKR--------KLVKD----VEKDDVRRE 83
            +G+ +G GEFG     T            +  R        K++K+     E  D+  E
Sbjct: 26  VLGKTLGEGEFGKVVKAT---------AFHLKGRAGYTTVAVKMLKENASPSELRDLLSE 76

Query: 84  IEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVI 143
             +++ +   P++++   A   D  + +++E    G L   +            S     
Sbjct: 77  FNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135

Query: 144 MNVVNVCH------------------------SKGVMHRDLKPENFLFTTGDENAVVKAT 179
            + ++                              ++HRDL   N L     E   +K +
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKIS 192

Query: 180 DFGLSAFIEEGKAYREIVGSPYY------------IAPEVLSQSYGK---EADIWSAGVI 224
           DFGLS         R++     Y            +A E L         ++D+WS GV+
Sbjct: 193 DFGLS---------RDVYEEDSYVKRSQGRIPVKWMAIESL--FDHIYTTQSDVWSFGVL 241

Query: 225 LY-ILLCGVPPFWAETDQGVAQAILKG 250
           L+ I+  G  P+     + +   +  G
Sbjct: 242 LWEIVTLGGNPYPGIPPERLFNLLKTG 268

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 43/234 (18%), Positives = 77/234 (32%), Gaps = 39/234 (16%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGL--------EFACKSIPK--------RKLVKDVEK 77
            + +     R   GI Y     ST          +F+ K   K            +  + 
Sbjct: 43  QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102

Query: 78  DDVRREIEIMR-HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFD--RIVARGHYSER 134
             V +  ++    L   P  + F      D++  +V+    G  L     +  +   SER
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGF--GVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSER 159

Query: 135 AAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGK-- 191
           +   V   +++ +   H    +H ++  EN      D++  V    +G +  +   GK  
Sbjct: 160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQS-QVTLAGYGFAFRYCPSGKHV 218

Query: 192 AYRE-----IVGSPYYIAPEVLSQSYGKEA----DIWSAGVILYILLCGVPPFW 236
           AY E       G   +I+   +    G       D+ S G  +   L G  P W
Sbjct: 219 AYVEGSRSPHEGDLEFIS---MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP-W 268

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 69.0 bits (169), Expect = 6e-13
 Identities = 44/232 (18%), Positives = 78/232 (33%), Gaps = 35/232 (15%)

Query: 34  HYTIGREVGRGEFGITYLCTENS-----TGLEFACKSIPKR--------KLVKDVEKDDV 80
            + +G  +G+G FG  YL   NS     +      K  P          K  +   K + 
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95

Query: 81  RREIEIMRHLS--GQPNIVQF-KAAYEDDQFVHIVMELCAGGELFDRIVARG-HYSERAA 136
            ++    R L   G P              +  ++M+   G +L     A    +S +  
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTV 154

Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGK---- 191
             +   I++++   H    +H D+K  N L    + +  V   D+GL+  +  EG     
Sbjct: 155 LQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD-QVYLVDYGLAYRYCPEGVHKAY 213

Query: 192 AYRE---IVGSPYYIAPEVLSQSYGKEA----DIWSAGVILYILLCGVPPFW 236
           A        G+  + +   +    G       D+   G  +   L G  P W
Sbjct: 214 AADPKRCHDGTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGHLP-W 261

>1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 Length = 110

 Score = 61.7 bits (150), Expect = 4e-12
 Identities = 14/68 (20%), Positives = 28/68 (41%), Gaps = 2/68 (2%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           +  E+ +    +F  +  D S  ++    K    K  S L+  ++    + +D D +G +
Sbjct: 16  ITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTK--SKLSIPELSYIWELSDADCDGAL 73

Query: 393 DYIEFITA 400
              EF  A
Sbjct: 74  TLPEFCAA 81

>1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 Length = 110

 Score = 56.7 bits (137), Expect = 3e-10
 Identities = 12/69 (17%), Positives = 23/69 (33%), Gaps = 7/69 (10%)

Query: 408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRIS 467
           + + N    F+    D + +I+       F    +        +  I    D D DG ++
Sbjct: 22  EYYVNQ---FRSLQPDPSSFISGSVAKNFFTKSKLSIP----ELSYIWELSDADCDGALT 74

Query: 468 YDEFRSMMK 476
             EF +   
Sbjct: 75  LPEFCAAFH 83

>1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 Length = 95

 Score = 61.3 bits (149), Expect = 5e-12
 Identities = 15/68 (22%), Positives = 24/68 (35%), Gaps = 2/68 (2%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           +   E  K  E F + D D  G ++  E++    K G  L    +       D    G +
Sbjct: 4   VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG--LPSTLLAHIWSLCDTKDCGKL 61

Query: 393 DYIEFITA 400
              +F  A
Sbjct: 62  SKDQFALA 69

>1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 Length = 95

 Score = 56.6 bits (137), Expect = 2e-10
 Identities = 15/69 (21%), Positives = 30/69 (43%), Gaps = 7/69 (10%)

Query: 408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRIS 467
            +++ +   F   DKD +G+++  E+ + F   G+        +  I S  D    G++S
Sbjct: 10  AKYDEI---FLKTDKDMDGFVSGLEVREIFLKTGLPST----LLAHIWSLCDTKDCGKLS 62

Query: 468 YDEFRSMMK 476
            D+F     
Sbjct: 63  KDQFALAFH 71

>2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} Length = 174

 Score = 62.3 bits (151), Expect = 1e-11
 Identities = 22/153 (14%), Positives = 49/153 (32%), Gaps = 18/153 (11%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD------VKQYMQAADIDGNGTI 392
                  + +       +   +L+  L +        D       +  +   ++  NG +
Sbjct: 5   HHHHHHSSGL-VPRGSDIDATQLQGLLNQELLTGPPGDMFSLDECRSLVALMELKVNGRL 63

Query: 393 DYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA-TI 451
           D  EF     +    Q        FQ     + G +   +L KA ++        I+  +
Sbjct: 64  DQEEFARLWKRLVHYQ------HVFQKVQ-TSPGVLLSSDLWKAIENTDFLRGIFISREL 116

Query: 452 KEIMSEVDRDKDGRISYDEFRSMMKCGTQLRAL 484
             +++    D  GR+S+      +    +L A+
Sbjct: 117 LHLVTLRYSDSVGRVSFPSL---VCFLMRLEAM 146

>2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} Length = 174

 Score = 59.2 bits (143), Expect = 1e-10
 Identities = 18/99 (18%), Positives = 35/99 (35%), Gaps = 11/99 (11%)

Query: 338 IQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEF---DVKQYMQAADIDGNGTIDY 394
           +   +  F ++   + G L   +L   +     +   F   ++   +     D  G + +
Sbjct: 75  LVHYQHVFQKVQ-TSPGVLLSSDLWKAIENTDFLRGIFISRELLHLVTLRYSDSVGRVSF 133

Query: 395 IEFITATMQRHKLQRFENLYKAFQYFDKDNNG-YITVDE 432
              +   M      R E + K F+   KD  G Y+T  E
Sbjct: 134 PSLVCFLM------RLEAMAKTFRNLSKDGKGLYLTEME 166

>1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 Length = 92

 Score = 59.0 bits (143), Expect = 3e-11
 Identities = 14/68 (20%), Positives = 26/68 (38%), Gaps = 2/68 (2%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           +  E+ Q    +F  +  D +G +     K    K    L   ++    + +D D +G +
Sbjct: 3   ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDFDKDGAL 60

Query: 393 DYIEFITA 400
              EF  A
Sbjct: 61  TLDEFCAA 68

>1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 Length = 92

 Score = 57.4 bits (139), Expect = 8e-11
 Identities = 15/66 (22%), Positives = 24/66 (36%), Gaps = 4/66 (6%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE 470
           +     F+    D NG+I      + F    +        +  I    D DKDG ++ DE
Sbjct: 9   QYYVNQFKTIQPDLNGFIPGSAAKEFFTKSKLPIL----ELSHIWELSDFDKDGALTLDE 64

Query: 471 FRSMMK 476
           F +   
Sbjct: 65  FCAAFH 70

>2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} Length = 111

 Score = 58.6 bits (142), Expect = 6e-11
 Identities = 19/68 (27%), Positives = 30/68 (44%), Gaps = 2/68 (2%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           +P     K ++ F   D   SG LT  + +  L +  S L +  +      +DID +G +
Sbjct: 8   VPQSSRLKYRQLFNSHDKTMSGHLTGPQARTILMQ--SSLPQAQLASIWNLSDIDQDGKL 65

Query: 393 DYIEFITA 400
              EFI A
Sbjct: 66  TAEEFILA 73

>2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} Length = 111

 Score = 57.5 bits (139), Expect = 2e-10
 Identities = 14/69 (20%), Positives = 28/69 (40%), Gaps = 7/69 (10%)

Query: 408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRIS 467
            ++  L   F   DK  +G++T  +         +        +  I +  D D+DG+++
Sbjct: 14  LKYRQL---FNSHDKTMSGHLTGPQARTILMQSSLPQA----QLASIWNLSDIDQDGKLT 66

Query: 468 YDEFRSMMK 476
            +EF   M 
Sbjct: 67  AEEFILAMH 75

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 62.9 bits (152), Expect = 1e-10
 Identities = 81/572 (14%), Positives = 154/572 (26%), Gaps = 194/572 (33%)

Query: 60  EFACKSIPK--RKLVKDVEKDDV----------RREIEIMRHLSGQPNIVQ-F------- 99
            F CK +    + ++   E D +           R    +  LS Q  +VQ F       
Sbjct: 32  NFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTL--LSKQEEMVQKFVEEVLRI 89

Query: 100 -------KAAYEDDQ-------FVHIVMELCAGGELFDRI-VARGH-YSE-RAAASVFRV 142
                      E  Q       ++     L    ++F +  V+R   Y + R A    R 
Sbjct: 90  NYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRP 149

Query: 143 IMNVV--------------NVCHSKGVMHR------------------DLKPENFLFTTG 170
             NV+              +VC S  V  +                   L+    L    
Sbjct: 150 AKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQI 209

Query: 171 DENAVVKA-TDFGLSAFIEEGKAY--REIVGSPYYIAPEVLSQSYGKEADIWSAGVILY- 226
           D N   ++     +   I   +A   R +   PY     VL        ++ +A      
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL-------NVQNAKAWNAF 262

Query: 227 -----ILLCGVPPFWAET--DQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPK 279
                ILL         T   + V    L                 +++     LT D  
Sbjct: 263 NLSCKILL---------TTRFKQVTDF-LSAATTTHI---------SLDHHSMTLTPDEV 303

Query: 280 RRITVAQVLEHPWLKESGEASD-KPIDTAVI-FRMKQFTAM---------NKLKKLALKV 328
           + + + + L+        E     P   ++I   ++   A          +KL    ++ 
Sbjct: 304 KSL-LLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTT-IIES 361

Query: 329 IVENLPTEEIQKLKEKFT------------------EMDTD------------------- 351
            +  L   E +K+ ++ +                  ++                      
Sbjct: 362 SLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQP 421

Query: 352 NSGTLT----YDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI-----DYI-EFI--- 398
              T++    Y ELK  L    ++     V  Y      D +  I      Y    I   
Sbjct: 422 KESTISIPSIYLELKVKLENEYALHRSI-VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHH 480

Query: 399 -TATMQRHKLQRFENLYKAFQYFDK-------DNNGYITVDELGKAFKDYGMGDDATIAT 450
                   ++  F  ++  F++ ++         N   ++    +  K Y          
Sbjct: 481 LKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFY---------- 530

Query: 451 IKEIMSEVDRDKDGRI-SYDEFRSMMKCGTQL 481
            K  + + D   +  + +  +F  + K    L
Sbjct: 531 -KPYICDNDPKYERLVNAILDF--LPKIEENL 559

>1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 Length = 99

 Score = 52.9 bits (127), Expect = 5e-09
 Identities = 13/63 (20%), Positives = 24/63 (38%), Gaps = 4/63 (6%)

Query: 414 YKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRS 473
            K ++  +  N G +   +     K  G+ D      + +I    D D  G +S  EF  
Sbjct: 14  EKYYRQVEAGNTGRVLALDAAAFLKKSGLPDL----ILGKIWDLADTDGKGVLSKQEFFV 69

Query: 474 MMK 476
            ++
Sbjct: 70  ALR 72

>1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 Length = 99

 Score = 48.3 bits (115), Expect = 2e-07
 Identities = 15/69 (21%), Positives = 29/69 (42%), Gaps = 2/69 (2%)

Query: 332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGT 391
              +      ++ + +++  N+G +   +  A L K  S L +  + +    AD DG G 
Sbjct: 4   TQLSSGNPVYEKYYRQVEAGNTGRVLALDAAAFLKK--SGLPDLILGKIWDLADTDGKGV 61

Query: 392 IDYIEFITA 400
           +   EF  A
Sbjct: 62  LSKQEFFVA 70

>1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 Length = 900

 Score = 57.5 bits (138), Expect = 7e-09
 Identities = 24/94 (25%), Positives = 44/94 (46%), Gaps = 7/94 (7%)

Query: 338 IQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEF 397
           I+K +  +   +TD SGT+  +EL       G  L +  +   +     D  G +D+  F
Sbjct: 803 IKKWQGIYKRFETDRSGTIGSNELPGAFEAAGFHLNQ-HIYSMIIRRYSDETGNMDFDNF 861

Query: 398 ITATMQRHKLQRFENLYKAFQYFDKDNNGYITVD 431
           I+  +      R + +++AF+  DK+  G I V+
Sbjct: 862 ISCLV------RLDAMFRAFRSLDKNGTGQIQVN 889

>1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 Length = 900

 Score = 56.7 bits (136), Expect = 1e-08
 Identities = 33/163 (20%), Positives = 59/163 (36%), Gaps = 27/163 (16%)

Query: 338 IQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEF 397
           I+     F + D D SG+++  E++  +   G  L    + Q + A   D    ID+  F
Sbjct: 606 IRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPC-QLHQVIVARFADDELIIDFDNF 664

Query: 398 ITATMQRHKLQRFENLYKAFQYFDKDNNGYITVD----------ELGKAFKDYGMGDDAT 447
           +   +      R E L+K F+  D +N G I +D              A  ++       
Sbjct: 665 VRCLV------RLEILFKIFKQLDPENTGTIQLDLISWLSFSVLGKLAAAIEHHHHHHMH 718

Query: 448 IATIKEIMSEVDR----------DKDGRISYDEFRSMMKCGTQ 480
            + I+   SE +R            D  +S  E  +++     
Sbjct: 719 YSNIEANESEEERQFRKLFVQLAGDDMEVSATELMNILNKVVT 761

>1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 Length = 900

 Score = 56.7 bits (136), Expect = 1e-08
 Identities = 31/166 (18%), Positives = 67/166 (40%), Gaps = 27/166 (16%)

Query: 330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD--------VKQYM 381
           +E   +EE ++ ++ F ++   +   ++  EL   L K+ +   +           +  +
Sbjct: 722 IEANESEEERQFRKLFVQLA-GDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMV 780

Query: 382 QAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYG 441
              D D  G + + EF      ++     +     ++ F+ D +G I  +EL  AF+  G
Sbjct: 781 AVMDSDTTGKLGFEEF------KYLWNNIKKWQGIYKRFETDRSGTIGSNELPGAFEAAG 834

Query: 442 MG-DDATIATIKEIMSEVDR--DKDGRISYDEFRSMMKCGTQLRAL 484
              +    + I      + R  D+ G + +D F   + C  +L A+
Sbjct: 835 FHLNQHIYSMI------IRRYSDETGNMDFDNF---ISCLVRLDAM 871

>1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 Length = 900

 Score = 49.0 bits (116), Expect = 3e-06
 Identities = 34/162 (20%), Positives = 59/162 (36%), Gaps = 27/162 (16%)

Query: 334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD--------VKQYMQAAD 385
             E     K  F+++   +   ++  EL+  L ++ S   +           +  +   D
Sbjct: 529 EEEIDDNFKTLFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMD 587

Query: 386 IDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMG-D 444
            DGNG +  +EF           R  N    F+ FD D +G ++  E+  A +  G    
Sbjct: 588 RDGNGKLGLVEF------NILWNRIRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLP 641

Query: 445 DATIATIKEIMSEVDR--DKDGRISYDEFRSMMKCGTQLRAL 484
                 I      V R  D +  I +D F   ++C  +L  L
Sbjct: 642 CQLHQVI------VARFADDELIIDFDNF---VRCLVRLEIL 674

>3fia_A Intersectin-1; EH 1 domain, NESG, structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 1.45A {Homo sapiens} PDB: 2khn_A Length = 121

 Score = 52.5 bits (126), Expect = 1e-08
 Identities = 18/68 (26%), Positives = 33/68 (48%), Gaps = 3/68 (4%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           +  EE  K  ++F  +    SG +T D+ +    +  S L +  + Q    AD++ +G +
Sbjct: 27  ITVEERAKHDQQFHSLK-PISGFITGDQARNFFFQ--SGLPQPVLAQIWALADMNNDGRM 83

Query: 393 DYIEFITA 400
           D +EF  A
Sbjct: 84  DQVEFSIA 91

>3fia_A Intersectin-1; EH 1 domain, NESG, structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 1.45A {Homo sapiens} PDB: 2khn_A Length = 121

 Score = 49.1 bits (117), Expect = 1e-07
 Identities = 16/69 (23%), Positives = 29/69 (42%), Gaps = 8/69 (11%)

Query: 408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRIS 467
            + +  + +     K  +G+IT D+    F   G+        + +I +  D + DGR+ 
Sbjct: 33  AKHDQQFHS----LKPISGFITGDQARNFFFQSGLPQP----VLAQIWALADMNNDGRMD 84

Query: 468 YDEFRSMMK 476
             EF   MK
Sbjct: 85  QVEFSIAMK 93

>3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L Length = 714

 Score = 56.7 bits (136), Expect = 1e-08
 Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 7/94 (7%)

Query: 338 IQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEF 397
           IQK ++ + E+D D SGT+   E++  L + G  L    + Q + A   D    ID+  F
Sbjct: 604 IQKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPC-QLHQVIVARFADDELIIDFDNF 662

Query: 398 ITATMQRHKLQRFENLYKAFQYFDKDNNGYITVD 431
           +   +      R E L+K F+  D +N G I +D
Sbjct: 663 VRCLV------RLEILFKIFKQLDPENTGTIQLD 690

>3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L Length = 714

 Score = 47.5 bits (112), Expect = 8e-06
 Identities = 25/111 (22%), Positives = 42/111 (37%), Gaps = 18/111 (16%)

Query: 377 VKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKA 436
            K  +   D DG+G +   EF           + +   K ++  D D +G +   E+ KA
Sbjct: 577 CKIMVDMLDEDGSGKLGLKEF------YILWTKIQKYQKIYREIDVDRSGTMNSYEMRKA 630

Query: 437 FKDYGMG-DDATIATIKEIMSEVDR--DKDGRISYDEFRSMMKCGTQLRAL 484
            ++ G          I      V R  D +  I +D F   ++C  +L  L
Sbjct: 631 LEEAGFKLPCQLHQVI------VARFADDELIIDFDNF---VRCLVRLEIL 672

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 55.3 bits (134), Expect = 1e-08
 Identities = 41/162 (25%), Positives = 68/162 (41%), Gaps = 32/162 (19%)

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAY--REIVGSPYYIAPE- 206
           H++ ++HRD+K  N L    DEN V K TDFG+S    E  + +    + G+  YI PE 
Sbjct: 156 HTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEY 212

Query: 207 VLSQSYGKEADIWSAGVILYILLCGVPPF-------------WAET--DQGVAQAI---- 247
            +     +++D++S GV+L+ +LC                  WA    + G  + I    
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272

Query: 248 LKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
           L  +I       P       +   + L    + R ++  VL 
Sbjct: 273 LADKIR------PESLRKFGDTAVKCLALSSEDRPSMGDVLW 308

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 18/148 (12%)

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYI---APEVL 208
           S+  +HRDL   N L +   E  VVK  DFGL+  I +   Y     +   +   APE +
Sbjct: 211 SRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 267

Query: 209 SQS-YGKEADIWSAGVILY-ILLCGVPPFWA-ETDQGVAQAILKGEINFQRDPFPSISSS 265
               Y  ++D+WS GV+L+ I   G  P+   + D+   + + +G     R   P  ++ 
Sbjct: 268 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG----TRMRAPDYTTP 323

Query: 266 AIELVRRMLT---QDPKRRITVAQVLEH 290
             E+ + ML     +P +R T ++++EH
Sbjct: 324 --EMYQTMLDCWHGEPSQRPTFSELVEH 349

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 20/93 (21%), Positives = 40/93 (43%), Gaps = 6/93 (6%)

Query: 36  TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD----VEKDDVRREIEIMRHLS 91
            +G+ +GRG FG               C+++   K++K+     E   +  E++I+ H+ 
Sbjct: 25  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILIHIG 83

Query: 92  GQPNIVQFKAAY-EDDQFVHIVMELCAGGELFD 123
              N+V    A  +    + +++E C  G L  
Sbjct: 84  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 116

>1snl_A Nucleobindin 1, calnuc; EF-hand, calcium-binding, metal binding protein; NMR {Homo sapiens} SCOP: a.39.1.7 Length = 103

 Score = 49.9 bits (119), Expect = 5e-08
 Identities = 18/86 (20%), Positives = 32/86 (37%), Gaps = 15/86 (17%)

Query: 405 HKLQRFENLYKAFQYFDKDNNGYITVDELGKAF-----KDYGMGDDATIATIKE------ 453
               RF N    F   D +++G +   EL   F     K Y   ++       E      
Sbjct: 15  LDPNRF-NPKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRM 73

Query: 454 ---IMSEVDRDKDGRISYDEFRSMMK 476
              +M  VD ++D  ++ +EF +  +
Sbjct: 74  REHVMKNVDTNQDRLVTLEEFLASTQ 99

>1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A Length = 624

 Score = 53.0 bits (126), Expect = 1e-07
 Identities = 19/151 (12%), Positives = 54/151 (35%), Gaps = 12/151 (7%)

Query: 332 NLPTEEIQK--LKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
           ++   +  +  +     + D +    + + ELK  L +L   + +   ++  +  D    
Sbjct: 2   SMDQRQKLQHWIHSCLRKADKNKDNKMNFKELKDFLKELNIQVDDGYARKIFRECDHSQT 61

Query: 390 GTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAF-----KDYGMGD 444
            +++  E  T       L +   + +AF+     +   ++V+ L   F     ++   G 
Sbjct: 62  DSLEDEEIETFY---KMLTQRAEIDRAFEEA-AGSAETLSVERLVT-FLQHQQREEEAGP 116

Query: 445 DATIATIKEIMSEVDRDKDGRISYDEFRSMM 475
              ++ I+            +++ D F   +
Sbjct: 117 ALALSLIERYEPSETAKAQRQMTKDGFLMYL 147

>1cb1_A Calbindin D9K; calcium-binding protein; NMR {Sus scrofa} SCOP: a.39.1.1 Length = 78

 Score = 47.0 bits (112), Expect = 3e-07
 Identities = 14/72 (19%), Positives = 35/72 (48%), Gaps = 2/72 (2%)

Query: 411 ENLYKAFQYFDKD--NNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISY 468
             L   F+ +     +   ++ +EL +  +           T+ ++  E+D++ DG +S+
Sbjct: 7   AELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSF 66

Query: 469 DEFRSMMKCGTQ 480
           +EF+ ++K  +Q
Sbjct: 67  EEFQVLVKKISQ 78

>1cb1_A Calbindin D9K; calcium-binding protein; NMR {Sus scrofa} SCOP: a.39.1.1 Length = 78

 Score = 38.1 bits (89), Expect = 5e-04
 Identities = 12/51 (23%), Positives = 22/51 (43%), Gaps = 2/51 (3%)

Query: 351 DNSGTLTYDELKAGLAK-LGSMLT-EFDVKQYMQAADIDGNGTIDYIEFIT 399
            +   L+ +ELK  +     S+L     +    Q  D +G+G + + EF  
Sbjct: 21  GDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQV 71

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 51.0 bits (123), Expect = 3e-07
 Identities = 40/162 (24%), Positives = 65/162 (40%), Gaps = 33/162 (20%)

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAY---REIVGSPYYIAPE 206
           H    +HRD+K  N L    DE    K +DFGL+ A  +  +     R IVG+  Y+APE
Sbjct: 150 HENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQTVMTSR-IVGTTAYMAPE 205

Query: 207 VLSQSYGKEADIWSAGVILYILLCGVPPF-----------WAETDQGVAQAILKGEINFQ 255
            L      ++DI+S GV+L  ++ G+P                      + I   E   +
Sbjct: 206 ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI-------KEEIEDEEKTIE 258

Query: 256 R--DP----FPSIS-SSAIELVRRMLTQDPKRRITVAQVLEH 290
              D       S S  +   +  + L +   +R  + +V + 
Sbjct: 259 DYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 51.4 bits (122), Expect = 3e-07
 Identities = 40/270 (14%), Positives = 72/270 (26%), Gaps = 74/270 (27%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK-----DDVRREIEIMRH 89
                ++G G FG  +    + T    A K I                +++  EI I + 
Sbjct: 22  LQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79

Query: 90  LSGQ--------PNIVQFKAAY------------------------------EDDQFVHI 111
           LS             +   + +                                D  + I
Sbjct: 80  LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139

Query: 112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTG 170
           V+E   GG   +++  +   S   A S+   +   + V  +     HRDL   N L    
Sbjct: 140 VLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT 198

Query: 171 DENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLC 230
                               K +  + G    I       S G +  I      L  L  
Sbjct: 199 SLK-----------------KLHYTLNGKSSTIP------SCGLQVSIIDYT--LSRLER 233

Query: 231 GVPPFWAETDQGVAQAILKGEINFQRDPFP 260
                + +      + +  G+ ++Q D + 
Sbjct: 234 DGIVVFCDVSM--DEDLFTGDGDYQFDIYR 261

>1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A Length = 106

 Score = 46.7 bits (111), Expect = 8e-07
 Identities = 12/70 (17%), Positives = 28/70 (40%), Gaps = 8/70 (11%)

Query: 408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRIS 467
            +++ ++ +        NG+++ D++     +  +  D     +  +    D D DG + 
Sbjct: 15  AKYDAIFDSLS----PVNGFLSGDKVKPVLLNSKLPVD----ILGRVWELSDIDHDGMLD 66

Query: 468 YDEFRSMMKC 477
            DEF   M  
Sbjct: 67  RDEFAVAMFL 76

>1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A Length = 106

 Score = 44.8 bits (106), Expect = 4e-06
 Identities = 19/81 (23%), Positives = 34/81 (41%), Gaps = 3/81 (3%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           +  E+  K    F  +    +G L+ D++K  L    S L    + +  + +DID +G +
Sbjct: 9   VKPEDKAKYDAIFDSLS-PVNGFLSGDKVKPVLLN--SKLPVDILGRVWELSDIDHDGML 65

Query: 393 DYIEFITATMQRHKLQRFENL 413
           D  EF  A    +     E +
Sbjct: 66  DRDEFAVAMFLVYCALEKEPV 86

>1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1 Length = 863

 Score = 48.4 bits (114), Expect = 5e-06
 Identities = 34/212 (16%), Positives = 80/212 (37%), Gaps = 25/212 (11%)

Query: 268 ELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALK 327
           E  R+   +  +++      +  PW++   E   +           Q   +N L++    
Sbjct: 597 EHARQQQNERLRKQFGAQANVIGPWIQTKMEEIGRISIEMHGTLEDQ---LNHLRQYEKS 653

Query: 328 VIVENLPTEEIQKLKEKFTE-MDTDNSGT-LTYDELKAGLAKLGSMLTEF--DVKQYMQA 383
           ++      ++++   ++  E +  DN  T  T + ++ G  +L + +     +V+  +  
Sbjct: 654 IVNYKPKIDQLEGDHQQIQEALIFDNKHTNYTMEHIRVGWEQLLTTIARTINEVENQILT 713

Query: 384 ADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMG 443
            D  G             + + ++  F     +F +FD+   G +  ++         MG
Sbjct: 714 RDAKG-------------ISQEQMNEFR---ASFNHFDRKKTGMMDCEDFRACLIS--MG 755

Query: 444 DDATIATIKEIMSEVDRDKDGRISYDEFRSMM 475
            +   A    IMS VD ++ G +++  F   M
Sbjct: 756 YNMGEAEFARIMSIVDPNRMGVVTFQAFIDFM 787

>1a4p_A S100A10; S100 family, EF-hand protein, ligand of annexin II, calcium/phospholipid binding protein, calcium-phospholipid protein complex; 2.25A {Homo sapiens} SCOP: a.39.1.2 PDB: 1bt6_A Length = 96

 Score = 43.6 bits (103), Expect = 7e-06
 Identities = 15/68 (22%), Positives = 33/68 (48%), Gaps = 4/68 (5%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKD---YGMGDDATIATIKEIMSEVDRDKDGRIS 467
           E +   F  F  D  GY+T ++L    +      + +      + +IM ++D+ +DG++ 
Sbjct: 9   ETMMFTFHKFAGDK-GYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVG 67

Query: 468 YDEFRSMM 475
           +  F S++
Sbjct: 68  FQSFFSLI 75

>2jq6_A EH domain-containing protein 1; metal binding protein; NMR {Homo sapiens} PDB: 2kff_A 2kfg_A 2kfh_A 2ksp_A Length = 139

 Score = 44.5 bits (105), Expect = 9e-06
 Identities = 13/70 (18%), Positives = 23/70 (32%), Gaps = 8/70 (11%)

Query: 408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRIS 467
             ++ ++          NG IT     K      + +      + +I    D DKDG + 
Sbjct: 51  PTYDEIFYTLS----PVNGKITGANAKKEMVKSKLPNT----VLGKIWKLADVDKDGLLD 102

Query: 468 YDEFRSMMKC 477
            +EF      
Sbjct: 103 DEEFALANHL 112

>2jq6_A EH domain-containing protein 1; metal binding protein; NMR {Homo sapiens} PDB: 2kff_A 2kfg_A 2kfh_A 2ksp_A Length = 139

 Score = 39.9 bits (93), Expect = 3e-04
 Identities = 17/79 (21%), Positives = 29/79 (36%), Gaps = 3/79 (3%)

Query: 335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDY 394
            ++     E F  +    +G +T    K  + K  S L    + +  + AD+D +G +D 
Sbjct: 47  GKDKPTYDEIFYTLS-PVNGKITGANAKKEMVK--SKLPNTVLGKIWKLADVDKDGLLDD 103

Query: 395 IEFITATMQRHKLQRFENL 413
            EF  A            L
Sbjct: 104 EEFALANHLIKVKLEGHEL 122

>1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A* Length = 113

 Score = 43.0 bits (101), Expect = 2e-05
 Identities = 14/71 (19%), Positives = 32/71 (45%), Gaps = 6/71 (8%)

Query: 411 ENLYKAFQ-YFDKD-NNGYITVDELGKA----FKDYGMGDDATIATIKEIMSEVDRDKDG 464
           E +   F  Y  K  +   +   E  +      +++   ++     I+ IM ++D + D 
Sbjct: 12  ETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADK 71

Query: 465 RISYDEFRSMM 475
           ++S++EF  +M
Sbjct: 72  QLSFEEFIMLM 82

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 45.7 bits (109), Expect = 2e-05
 Identities = 29/90 (32%), Positives = 43/90 (47%), Gaps = 9/90 (10%)

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY---REIVGSPYYIAPE 206
           C  K ++HRD+K  N L    DE       DFGL+  ++    +     + G+  +IAPE
Sbjct: 151 CDPK-IIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPE 205

Query: 207 VLSQSYGKE-ADIWSAGVILYILLCGVPPF 235
            LS     E  D++  GV+L  L+ G   F
Sbjct: 206 YLSTGKSSEKTDVFGYGVMLLELITGQRAF 235

>4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A* Length = 93

 Score = 40.9 bits (96), Expect = 7e-05
 Identities = 12/70 (17%), Positives = 29/70 (41%), Gaps = 5/70 (7%)

Query: 411 ENLYKAFQ-YFDKD-NNGYITVDELGKAFKD---YGMGDDATIATIKEIMSEVDRDKDGR 465
           + +   F  Y  K+ +   +   EL +         +G     A  +++MS +D ++D  
Sbjct: 10  DVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNE 69

Query: 466 ISYDEFRSMM 475
           + + E+   +
Sbjct: 70  VDFQEYCVFL 79

>2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A Length = 113

 Score = 41.5 bits (97), Expect = 7e-05
 Identities = 11/81 (13%), Positives = 31/81 (38%), Gaps = 5/81 (6%)

Query: 400 ATMQRHKLQRFENLYKAFQYF--DKDNNGYITVDELGKAFKD---YGMGDDATIATIKEI 454
            +M     +  + +   F  +   + +   +   EL +         +G     A  +++
Sbjct: 11  GSMACPLEKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKL 70

Query: 455 MSEVDRDKDGRISYDEFRSMM 475
           MS +D ++D  + + E+   +
Sbjct: 71  MSNLDSNRDNEVDFQEYCVFL 91

>2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A Length = 113

 Score = 38.8 bits (90), Expect = 5e-04
 Identities = 12/56 (21%), Positives = 21/56 (37%), Gaps = 5/56 (8%)

Query: 349 DTDNSGTLTYDELKAGLAK-----LGSMLTEFDVKQYMQAADIDGNGTIDYIEFIT 399
              +   L   ELK  L +     LG    E   ++ M   D + +  +D+ E+  
Sbjct: 34  KEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCV 89

>2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A Length = 106

 Score = 41.0 bits (96), Expect = 8e-05
 Identities = 9/67 (13%), Positives = 29/67 (43%), Gaps = 2/67 (2%)

Query: 411 ENLYKAFQ-YFDKD-NNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISY 468
           E +   F  +  ++     ++V+E  +            + ++ E M  +D ++D  + +
Sbjct: 22  ETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKF 81

Query: 469 DEFRSMM 475
           +E+  ++
Sbjct: 82  NEYWRLI 88

>1xk4_A Calgranulin A; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1mr8_A Length = 93

 Score = 40.5 bits (95), Expect = 8e-05
 Identities = 11/67 (16%), Positives = 24/67 (35%), Gaps = 3/67 (4%)

Query: 411 ENLYKAFQ-YFDKD-NNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISY 468
            ++   +  Y     N   +  D+L K  +                  E+D + DG +++
Sbjct: 10  NSIIDVYHKYSLIKGNFHAVYRDDLKKLLET-ESPQYIRKKGADVWFKELDINTDGAVNF 68

Query: 469 DEFRSMM 475
            EF  ++
Sbjct: 69  QEFLILV 75

>1xk4_A Calgranulin A; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1mr8_A Length = 93

 Score = 40.1 bits (94), Expect = 1e-04
 Identities = 10/50 (20%), Positives = 22/50 (44%), Gaps = 1/50 (2%)

Query: 351 DNSGTLTYDELKAGLAK-LGSMLTEFDVKQYMQAADIDGNGTIDYIEFIT 399
            N   +  D+LK  L       + +     + +  DI+ +G +++ EF+ 
Sbjct: 24  GNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQEFLI 73

>3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens} Length = 104

 Score = 40.2 bits (94), Expect = 1e-04
 Identities = 12/70 (17%), Positives = 29/70 (41%), Gaps = 5/70 (7%)

Query: 411 ENLYKAFQ-YFDKD-NNGYITVDELGKAFKD---YGMGDDATIATIKEIMSEVDRDKDGR 465
           + +   F  Y  K+ +   +   EL +         +G     A  +++MS +D ++D  
Sbjct: 13  DVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDSNRDNE 72

Query: 466 ISYDEFRSMM 475
           + + E+   +
Sbjct: 73  VDFQEYCVFL 82

>3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A Length = 100

 Score = 40.2 bits (94), Expect = 1e-04
 Identities = 10/61 (16%), Positives = 21/61 (34%), Gaps = 5/61 (8%)

Query: 344 KFTEMDTDNSGTLTYDELKAGLAK-----LGSMLTEFDVKQYMQAADIDGNGTIDYIEFI 398
           K+    +     ++    +  L K     L          + +Q  D + +G I + E+ 
Sbjct: 19  KYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDANHDGRISFDEYW 78

Query: 399 T 399
           T
Sbjct: 79  T 79

>3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A Length = 100

 Score = 39.8 bits (93), Expect = 2e-04
 Identities = 10/67 (14%), Positives = 27/67 (40%), Gaps = 3/67 (4%)

Query: 412 NLYKAFQYFDKDNNGYITVDELGKAFKD---YGMGDDATIATIKEIMSEVDRDKDGRISY 468
             +  +          I+     +  +    + + D        +++  +D + DGRIS+
Sbjct: 15  ENFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDANHDGRISF 74

Query: 469 DEFRSMM 475
           DE+ +++
Sbjct: 75  DEYWTLI 81

>1k2h_A S100A1, S-100 protein, alpha chain; non-covalent homodimer, X-type four-helix bundle, metal binding protein; NMR {Rattus norvegicus} SCOP: a.39.1.2 PDB: 1zfs_A 2k2f_A 2kbm_A 2l0p_A 2jpt_A Length = 93

 Score = 39.4 bits (92), Expect = 2e-04
 Identities = 14/70 (20%), Positives = 29/70 (41%), Gaps = 5/70 (7%)

Query: 411 ENLYKAFQ-YFDKD-NNGYITVDELGKAFKD---YGMGDDATIATIKEIMSEVDRDKDGR 465
           E L   F  +  K+ +   ++  EL    +      +        + +IM E+D + DG 
Sbjct: 9   ETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGE 68

Query: 466 ISYDEFRSMM 475
           + + EF  ++
Sbjct: 69  VDFQEFVVLV 78

>3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} Length = 179

 Score = 40.4 bits (94), Expect = 3e-04
 Identities = 21/93 (22%), Positives = 37/93 (39%), Gaps = 8/93 (8%)

Query: 349 DTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEF---ITATMQRH 405
                  LT DELK    +L     +  ++ +    D + +G +   E    I  +   +
Sbjct: 72  RGIVKQVLTKDELKDFYEQLTDQGFDNRLRTFFDMVDKNADGRLTAEEVKEIIALSASAN 131

Query: 406 KLQRFEN---LYKA--FQYFDKDNNGYITVDEL 433
           KL + +     Y A   +  D  N GYI +++L
Sbjct: 132 KLSKIKERADEYTALIMEELDPTNLGYIEMEDL 164

>3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} Length = 179

 Score = 39.7 bits (92), Expect = 8e-04
 Identities = 30/169 (17%), Positives = 59/169 (34%), Gaps = 14/169 (8%)

Query: 316 TAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEF 375
           +A   LK   L+ +   +  +    ++++F ++  D  G L        +   GS   EF
Sbjct: 7   SAAVALK--GLQFVTAKVGNDGWAAVEKRFNQLQVD--GVLLRSRFGKCIGMDGS--DEF 60

Query: 376 DVKQYMQAADIDG--NGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDEL 433
            V+ +   A   G     +   E      Q         L   F   DK+ +G +T +E+
Sbjct: 61  AVQMFDSLARKRGIVKQVLTKDELKDFYEQLTDQGFDNRLRTFFDMVDKNADGRLTAEEV 120

Query: 434 GKAFKDYGMGDDATIAT------IKEIMSEVDRDKDGRISYDEFRSMMK 476
            +        +  +            IM E+D    G I  ++  +++ 
Sbjct: 121 KEIIALSASANKLSKIKERADEYTALIMEELDPTNLGYIEMEDLEALLL 169

>1qls_A S100C protein, calgizzarin; metal-binding protein/inhibitor, S100 family, EF-hand protein, complex (ligand/annexin), ligand of annexin II; 2.3A {Sus scrofa} SCOP: a.39.1.2 PDB: 1nsh_A Length = 99

 Score = 38.7 bits (90), Expect = 4e-04
 Identities = 15/70 (21%), Positives = 28/70 (40%), Gaps = 5/70 (7%)

Query: 411 ENLYKAFQYF--DKDNNGYITVDELGKAFKD---YGMGDDATIATIKEIMSEVDRDKDGR 465
           E+L   FQ       NN  I+  E              +      +  +M ++D D DG+
Sbjct: 13  ESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQ 72

Query: 466 ISYDEFRSMM 475
           + + EF +++
Sbjct: 73  LDFQEFLNLI 82

>2kax_A Protein S100-A5; EF-hand, calcium binding protien, calcium, polymorphism, structural genomics, spine2, structural proteomics in europe, spine; NMR {Homo sapiens} PDB: 2kay_A Length = 92

 Score = 38.6 bits (90), Expect = 4e-04
 Identities = 10/67 (14%), Positives = 28/67 (41%), Gaps = 2/67 (2%)

Query: 411 ENLYKAFQYF--DKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISY 468
             +   F  +   + +   ++  EL +  K      +   ++I ++M  +D++ D  I +
Sbjct: 10  TTMVTTFHKYSGREGSKLTLSRKELKELIKKELCLGEMKESSIDDLMKSLDKNSDQEIDF 69

Query: 469 DEFRSMM 475
            E+   +
Sbjct: 70  KEYSVFL 76

>3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ... Length = 92

 Score = 38.2 bits (89), Expect = 5e-04
 Identities = 11/70 (15%), Positives = 28/70 (40%), Gaps = 5/70 (7%)

Query: 411 ENLYKAFQ-YFDKD-NNGYITVDELGKAFKD---YGMGDDATIATIKEIMSEVDRDKDGR 465
             L   F  Y  ++ +   +   EL +   +   + + +      + ++M  +D + DG 
Sbjct: 9   VALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSNGDGE 68

Query: 466 ISYDEFRSMM 475
             + EF + +
Sbjct: 69  CDFQEFMAFV 78

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	494
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3pm8_A	197	PFCDPK2, calcium-dependent protein kinase 2; malar	99.94
3k21_A	191	PFCDPK3, calcium-dependent protein kinase 3; calci	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
2lhi_A	176	Calmodulin, serine/threonine-protein phosphatase c	99.92
2lmt_A	148	Calmodulin-related protein 97A; spermatogenesis, m	99.92
2obh_A	143	Centrin-2; DNA repair complex EF hand superfamily	99.92
3i5g_C	159	Myosin catalytic light chain LC-1, mantle muscle;	99.91
3u0k_A	440	Rcamp; fluorescent protein, calcium binding, EF-ha	99.91
1exr_A	148	Calmodulin; high resolution, disorder, metal trans	99.91
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
3khe_A	191	Calmodulin-like domain protein kinase isoform 3; c	99.9
2aao_A	166	CDPK, calcium-dependent protein kinase, isoform AK	99.89
3qrx_A	169	Centrin; calcium-binding, EF-hand, cell division,	99.89
3i5g_B	153	Myosin regulatory light chain LC-2, mantle muscle;	99.89
4ds7_A	147	Calmodulin, CAM; protein binding, metal binding, s	99.89
3mse_B	180	Calcium-dependent protein kinase, putative; CDPKS,	99.89
3fwb_A	161	Cell division control protein 31; gene gating, com	99.89
2jnf_A	158	Troponin C; stretch activated muscle contraction,	99.89
1dtl_A	161	Cardiac troponin C; helix-turn-helix, structural p	99.89
3sjs_A	220	URE3-BP sequence specific DNA binding protein; EF-	99.89
2bl0_C	142	Myosin regulatory light chain; muscle protein, sli	99.88
1m45_A	148	MLC1P, myosin light chain; protein-peptide complex	99.88
1top_A	162	Troponin C; contractIle system protein; 1.78A {Gal	99.88
3ox6_A	153	Calcium-binding protein 1; EF-hand, calcium-sensor	99.88
2f2o_A	179	Calmodulin fused with calmodulin-binding domain of	99.88
1wdc_C	156	Scallop myosin; calcium binding protein, muscle pr	99.88
2ovk_C	159	Myosin catalytic light chain LC-1, mantle muscle,	99.87
3j04_B	143	Myosin regulatory light chain 2, smooth muscle MA	99.87
2mys_C	149	Myosin; muscle protein, motor protein; HET: MLY; 2	99.87
1s6i_A	188	CDPK, calcium-dependent protein kinase SK5; EF-han	99.86
1w7j_B	151	Myosin light chain 1; motor protein, unconventiona	99.86
2mys_B	166	Myosin; muscle protein, motor protein; HET: MLY; 2	99.86
1nya_A	176	Calerythrin; EF-hand, metal binding protein; NMR {	99.85
1qv0_A	195	Obelin, OBL; photoprotein, bioluminescence, atomic	99.85
1wdc_B	156	Scallop myosin; calcium binding protein, muscle pr	99.85
3e3r_A	204	Calcyphosin, calcyphosine; human calcyphosine, EF-	99.85
2bl0_B	145	Myosin regulatory light chain; muscle protein, sli	99.85
1uhk_A	191	Aequorin 2, aequorin; EF-hand motif, complex, lumi	99.84
2ccm_A	191	Calexcitin; EF hand, calcium, signaling protein; 1	99.84
2ovk_B	153	RLC, myosin regulatory light chain LC-2, mantle mu	99.84
3dtp_E	196	RLC, myosin regulatory light chain; muscle protein	99.84
2znd_A	172	Programmed cell death protein 6; penta-EF-hand pro	99.84
1y1x_A	191	Leishmania major homolog of programmed cell death	99.84
2hpk_A	208	Photoprotein berovin; structural genomics, PSI, pr	99.84
2bec_A	202	Calcineurin B homologous protein 2; calcineurin-ho	99.84
2ct9_A	208	Calcium-binding protein P22; EF-hand, metal bindin	99.83
3ll8_B	155	Calcineurin subunit B type 1; protein-peptide dock	99.83
1s6c_A	183	KV4 potassium channel-interacting protein kchip1B;	99.83
3akb_A	166	Putative calcium binding protein; EF-hand, metal b	99.82
1ggw_A	140	Protein (CDC4P); light chain, cytokinesis, cell cy	99.82
1jba_A	204	GCAP-2, protein (guanylate cyclase activating prot	99.82
3cs1_A	219	Flagellar calcium-binding protein; myristoylated,	99.82
1alv_A	173	Calpain, S-camld; calcium binding, calmodulin like	99.82
2sas_A	185	Sarcoplasmic calcium-binding protein; 2.40A {Branc	99.82
3sg6_A	450	Gcamp2, myosin light chain kinase, green fluoresce	99.82
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.82
2zfd_A	226	Calcineurin B-like protein 2; calcium binding prot	99.82
1q80_A	174	SCP, sarcoplasmic calcium-binding protein; all-alp	99.81
2i7a_A	174	Calpain 13; calcium-dependent cytoplasmic cysteine	99.81
2lvv_A	226	Flagellar calcium-binding protein TB-24; EF-hand,	99.81
1juo_A	198	Sorcin; calcium-binding proteins, penta-EF-hand, P	99.81
1s1e_A	224	KV channel interacting protein 1; kchip, calcium-b	99.81
3dd4_A	229	KV channel-interacting protein 4; EF-hands protein	99.81
1jfj_A	134	Ehcabp, calcium-binding protein; EF-hand, helix-lo	99.81
2qac_A	146	Myosin A tail domain interacting protein MTIP; mal	99.81
2ehb_A	207	Calcineurin B-like protein 4; protein complex, Ca(	99.81
1dgu_A	183	Calcium-saturated CIB; helical, EF-hands, blood cl	99.81
1gjy_A	167	Sorcin, CP-22, V19; calcium binding, calcium-bindi	99.8
2ggz_A	211	Guanylyl cyclase-activating protein 3; EF hand, gu	99.8
3a8r_A	179	Putative uncharacterized protein; EF-hand, membran	99.8
2r2i_A	198	Guanylyl cyclase-activating protein 1; EF hand, GC	99.8
2l2e_A	190	Calcium-binding protein NCS-1; NCS1P, myristoylate	99.79
1k94_A	165	Grancalcin; penta-EF-hand protein, calcium binding	99.79
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	99.79
2l4h_A	214	Calcium and integrin-binding protein 1; metal bind	99.78
1g8i_A	190	Frequenin, neuronal calcium sensor 1; calcium bind	99.78
2hps_A	186	Coelenterazine-binding protein with bound coelent;	99.78
2d8n_A	207	Recoverin; structural genomics, NPPSFA, national p	99.77
1bjf_A	193	Neurocalcin delta; calcium-binding, myristoylation	99.76
1fpw_A	190	Yeast frequenin, calcium-binding protein NCS-1; EF	99.76
2jul_A	256	Calsenilin; EF-hand, calcium, LXXLL, DNA binding p	99.76
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	99.75
2f33_A	263	Calbindin; EF-hand, Ca2+-binding, metal binding pr	99.75
2f33_A	263	Calbindin; EF-hand, Ca2+-binding, metal binding pr	99.74
2be4_A	272	Hypothetical protein LOC449832; DR.36843, BC083168	99.74
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.72
2be4_A	272	Hypothetical protein LOC449832; DR.36843, BC083168	99.72
3bow_A	714	Calpain-2 catalytic subunit; cysteine protease, in	99.71
2pvb_A	108	Protein (parvalbumin); calcium binding protein, me	99.66
3fs7_A	109	Parvalbumin, thymic; calcium-binding protein, EF-h	99.66
1bu3_A	109	Calcium-binding protein; 1.65A {Merluccius bilinea	99.66
1djx_A	624	PLC-D1, phosphoinositide-specific phospholipase C,	99.64
5pal_A	109	Parvalbumin; calcium-binding protein; 1.54A {Triak	99.64
1pva_A	110	Parvalbumin; calcium binding; 1.65A {Esox lucius}	99.64
1rro_A	108	RAT oncomodulin; calcium-binding protein; 1.30A {R	99.63
1rwy_A	109	Parvalbumin alpha; EF-hand, calcium-binding, calci	99.63
1sjj_A	863	Actinin; 3-helix bundle, calponin homology domain,	99.63
1qxp_A	900	MU-like calpain; M-calpain, MU-calpain, catalytic	99.6
3h4s_E	135	KCBP interacting Ca2+-binding protein; kinesin, mo	99.6
2d8n_A	207	Recoverin; structural genomics, NPPSFA, national p	99.59
2kyc_A	108	Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p	99.55
1y1x_A	191	Leishmania major homolog of programmed cell death	99.53
2znd_A	172	Programmed cell death protein 6; penta-EF-hand pro	99.52
2zkm_X	799	1-phosphatidylinositol-4,5-bisphosphate phosphodie	99.51
2l2e_A	190	Calcium-binding protein NCS-1; NCS1P, myristoylate	99.48
1bjf_A	193	Neurocalcin delta; calcium-binding, myristoylation	99.48
2i7a_A	174	Calpain 13; calcium-dependent cytoplasmic cysteine	99.48
1qxp_A	900	MU-like calpain; M-calpain, MU-calpain, catalytic	99.47
1eg3_A	261	Dystrophin; EF-hand like domain, WW domain, struct	99.46
3a4u_B	143	Multiple coagulation factor deficiency protein 2;	99.46
2ggz_A	211	Guanylyl cyclase-activating protein 3; EF hand, gu	99.44
3sjs_A	220	URE3-BP sequence specific DNA binding protein; EF-	99.43
1alv_A	173	Calpain, S-camld; calcium binding, calmodulin like	99.42
1fpw_A	190	Yeast frequenin, calcium-binding protein NCS-1; EF	99.41
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.4
2kld_A	123	Polycystin-2; PC2, PKD2, calcium binding domain, E	99.39
1gjy_A	167	Sorcin, CP-22, V19; calcium binding, calcium-bindi	99.38
1s6c_A	183	KV4 potassium channel-interacting protein kchip1B;	99.38
1k94_A	165	Grancalcin; penta-EF-hand protein, calcium binding	99.37
2lv7_A	100	Calcium-binding protein 7; metal binding protein;	99.35
1juo_A	198	Sorcin; calcium-binding proteins, penta-EF-hand, P	99.35
1s1e_A	224	KV channel interacting protein 1; kchip, calcium-b	99.34
1g8i_A	190	Frequenin, neuronal calcium sensor 1; calcium bind	99.34
2lv7_A	100	Calcium-binding protein 7; metal binding protein;	99.33
2r2i_A	198	Guanylyl cyclase-activating protein 1; EF hand, GC	99.33
1s6j_A	87	CDPK, calcium-dependent protein kinase SK5; EF-han	99.31
1wy9_A	147	Allograft inflammatory factor 1; EF-hand, calucium	99.3
1jfj_A	134	Ehcabp, calcium-binding protein; EF-hand, helix-lo	99.3
2ehb_A	207	Calcineurin B-like protein 4; protein complex, Ca(	99.3
4drw_A	121	Protein S100-A10/annexin A2 chimeric protein; atyp	99.29
2jjz_A	150	Ionized calcium-binding adapter molecule 2; EF-han	99.29
3nso_A	101	Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta	99.29
2opo_A	86	Polcalcin CHE A 3; calcium-binding protein, dimer,	99.27
3ohm_B	885	1-phosphatidylinositol-4,5-bisphosphate phosphodi	99.27
2kn2_A	92	Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco	99.26
2jjz_A	150	Ionized calcium-binding adapter molecule 2; EF-han	99.26
3khe_A	191	Calmodulin-like domain protein kinase isoform 3; c	99.25
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
1jba_A	204	GCAP-2, protein (guanylate cyclase activating prot	99.22
2jul_A	256	Calsenilin; EF-hand, calcium, LXXLL, DNA binding p	99.22
3n22_A	98	Protein S100-A2; EF-hand, calcium-binding, zinc-bi	99.22
1nya_A	176	Calerythrin; EF-hand, metal binding protein; NMR {	99.21
2bl0_C	142	Myosin regulatory light chain; muscle protein, sli	99.21
3zwh_A	104	Protein S100-A4; Ca-binding protein-motor protein	99.2
4eto_A	93	Protein S100-A4; calcium-binding protein, EF-hand,	99.2
2opo_A	86	Polcalcin CHE A 3; calcium-binding protein, dimer,	99.2
3dd4_A	229	KV channel-interacting protein 4; EF-hands protein	99.2
2obh_A	143	Centrin-2; DNA repair complex EF hand superfamily	99.19
2ktg_A	85	Calmodulin, putative; ehcam, Ca-binding protein, p	99.19
2b1u_A	71	Calmodulin-like protein 5; CLSP, calmodulin-like S	99.18
1tiz_A	67	Calmodulin-related protein, putative; helix-turn-h	99.18
3pm8_A	197	PFCDPK2, calcium-dependent protein kinase 2; malar	99.17
2lmt_A	148	Calmodulin-related protein 97A; spermatogenesis, m	99.17
1avs_A	90	Troponin C; muscle contraction, calcium-activated,	99.16
3qrx_A	169	Centrin; calcium-binding, EF-hand, cell division,	99.16
2kz2_A	94	Calmodulin, CAM; TR2C, metal binding protein; NMR	99.16
4ds7_A	147	Calmodulin, CAM; protein binding, metal binding, s	99.15
1avs_A	90	Troponin C; muscle contraction, calcium-activated,	99.15
2lnk_A	113	Protein S100-A4; EF-hand, calcium binding, all alp	99.15
2sas_A	185	Sarcoplasmic calcium-binding protein; 2.40A {Branc	99.14
2joj_A	77	Centrin protein; N-terminal domain, centrin soluti	99.14
1exr_A	148	Calmodulin; high resolution, disorder, metal trans	99.14
3bow_A	714	Calpain-2 catalytic subunit; cysteine protease, in	99.14
3e3r_A	204	Calcyphosin, calcyphosine; human calcyphosine, EF-	99.14
2joj_A	77	Centrin protein; N-terminal domain, centrin soluti	99.14
2bec_A	202	Calcineurin B homologous protein 2; calcineurin-ho	99.13
2ktg_A	85	Calmodulin, putative; ehcam, Ca-binding protein, p	99.13
3u0k_A	440	Rcamp; fluorescent protein, calcium binding, EF-ha	99.13
1j7q_A	86	CAVP, calcium vector protein; EF-hand family, calc	99.13
2lhi_A	176	Calmodulin, serine/threonine-protein phosphatase c	99.13
3fs7_A	109	Parvalbumin, thymic; calcium-binding protein, EF-h	99.13
3sg6_A	450	Gcamp2, myosin light chain kinase, green fluoresce	99.13
3nso_A	101	Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta	99.12
1wlz_A	105	DJBP, CAP-binding protein complex interacting prot	99.12
1fi6_A	92	EH domain protein REPS1; EPS15 homology domain, EF	99.12
1dtl_A	161	Cardiac troponin C; helix-turn-helix, structural p	99.12
3ll8_B	155	Calcineurin subunit B type 1; protein-peptide dock	99.12
1m45_A	148	MLC1P, myosin light chain; protein-peptide complex	99.11
3akb_A	166	Putative calcium binding protein; EF-hand, metal b	99.11
5pal_A	109	Parvalbumin; calcium-binding protein; 1.54A {Triak	99.11
1k9u_A	78	Polcalcin PHL P 7; pollen allergen, calcium-bindin	99.11
3fwb_A	161	Cell division control protein 31; gene gating, com	99.1
2jnf_A	158	Troponin C; stretch activated muscle contraction,	99.1
1s6i_A	188	CDPK, calcium-dependent protein kinase SK5; EF-han	99.1
1fi6_A	92	EH domain protein REPS1; EPS15 homology domain, EF	99.1
2zfd_A	226	Calcineurin B-like protein 2; calcium binding prot	99.1
1c07_A	95	Protein (epidermal growth factor receptor pathway	99.09
3qr0_A	816	Phospholipase C-beta (PLC-beta); PH domain, EF han	99.09
2kn2_A	92	Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco	99.09
2ccm_A	191	Calexcitin; EF hand, calcium, signaling protein; 1	99.09
1wdc_C	156	Scallop myosin; calcium binding protein, muscle pr	99.09
3nxa_A	100	Protein S100-A16; S100 family, calcium binding pro	99.09
2aao_A	166	CDPK, calcium-dependent protein kinase, isoform AK	99.09
2y5i_A	99	S100Z, S100 calcium binding protein Z; metal-bindi	99.09
1k9u_A	78	Polcalcin PHL P 7; pollen allergen, calcium-bindin	99.09
1xk4_C	113	Calgranulin B; S100 family, heterotetramer, metal	99.08
2bl0_B	145	Myosin regulatory light chain; muscle protein, sli	99.08
2f2o_A	179	Calmodulin fused with calmodulin-binding domain of	99.08
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.08
1top_A	162	Troponin C; contractIle system protein; 1.78A {Gal	99.08
3mse_B	180	Calcium-dependent protein kinase, putative; CDPKS,	99.08
3n22_A	98	Protein S100-A2; EF-hand, calcium-binding, zinc-bi	99.08
3h4s_E	135	KCBP interacting Ca2+-binding protein; kinesin, mo	99.08
3k21_A	191	PFCDPK3, calcium-dependent protein kinase 3; calci	99.08
1c7v_A	81	CAVP, calcium vector protein; EF-hand family, calc	99.08
2hpk_A	208	Photoprotein berovin; structural genomics, PSI, pr	99.08
1j55_A	95	S-100P protein; metal binding protein; 2.00A {Homo	99.08
2lnk_A	113	Protein S100-A4; EF-hand, calcium binding, all alp	99.07
1bu3_A	109	Calcium-binding protein; 1.65A {Merluccius bilinea	99.07
4drw_A	121	Protein S100-A10/annexin A2 chimeric protein; atyp	99.06
1rwy_A	109	Parvalbumin alpha; EF-hand, calcium-binding, calci	99.06
1tiz_A	67	Calmodulin-related protein, putative; helix-turn-h	99.06
3ox6_A	153	Calcium-binding protein 1; EF-hand, calcium-sensor	99.06
1w7j_B	151	Myosin light chain 1; motor protein, unconventiona	99.06
1eh2_A	106	EPS15; calcium binding, signaling domain, NPF bind	99.05
2mys_C	149	Myosin; muscle protein, motor protein; HET: MLY; 2	99.05
2d58_A	107	Allograft inflammatory factor 1; EF-hand, metal bi	99.05
1c07_A	95	Protein (epidermal growth factor receptor pathway	99.05
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.05
3li6_A	66	Calcium-binding protein; calcium signaling protein	99.05
2b1u_A	71	Calmodulin-like protein 5; CLSP, calmodulin-like S	99.05
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.05
3rm1_A	92	Protein S100-B; alpha-helical, EF hand, metal bind	99.04
2kgr_A	111	Intersectin-1; structure, alternative splicing, ca	99.04
2pvb_A	108	Protein (parvalbumin); calcium binding protein, me	99.04
2kgr_A	111	Intersectin-1; structure, alternative splicing, ca	99.03
2pmy_A	91	RAS and EF-hand domain-containing protein; rasef,	99.03
2pmy_A	91	RAS and EF-hand domain-containing protein; rasef,	99.03
3a4u_B	143	Multiple coagulation factor deficiency protein 2;	99.03
3zwh_A	104	Protein S100-A4; Ca-binding protein-motor protein	99.03
1qjt_A	99	EH1, epidermal growth factor receptor substrate su	99.02
2wcb_A	95	Protein S100-A12; calcium signalling, HOST-parasit	99.02
1qx2_A	76	Vitamin D-dependent calcium-binding protein, INTE;	99.02
4eto_A	93	Protein S100-A4; calcium-binding protein, EF-hand,	99.02
2kz2_A	94	Calmodulin, CAM; TR2C, metal binding protein; NMR	99.02
2y5i_A	99	S100Z, S100 calcium binding protein Z; metal-bindi	99.02
2kax_A	92	Protein S100-A5; EF-hand, calcium binding protien,	99.02
2h2k_A	106	Protein S100-A13; calcium binding protein, metal b	99.01
1rro_A	108	RAT oncomodulin; calcium-binding protein; 1.30A {R	99.01
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.01
1j7q_A	86	CAVP, calcium vector protein; EF-hand family, calc	99.01
3rm1_A	92	Protein S100-B; alpha-helical, EF hand, metal bind	99.0
1s6j_A	87	CDPK, calcium-dependent protein kinase SK5; EF-han	99.0
1qjt_A	99	EH1, epidermal growth factor receptor substrate su	98.99
1j55_A	95	S-100P protein; metal binding protein; 2.00A {Homo	98.99
1iq3_A	110	Ralbp1-interacting protein (partner of ralbp1); EF	98.99
2h2k_A	106	Protein S100-A13; calcium binding protein, metal b	98.99
1pva_A	110	Parvalbumin; calcium binding; 1.65A {Esox lucius}	98.98
1eh2_A	106	EPS15; calcium binding, signaling domain, NPF bind	98.98

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.8e-75  Score=600.39  Aligned_cols=450  Identities=36%  Similarity=0.644  Sum_probs=400.2

Q ss_pred             hhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEE
Q 040917           23 ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAA  102 (494)
Q Consensus        23 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~  102 (494)
                      ........+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++++ +||||++++++
T Consensus        16 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~   94 (484)
T 3nyv_A           16 FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEF   94 (484)
T ss_dssp             ---CCCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEE
T ss_pred             eeccCCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEE
Confidence            34445567788999999999999999999999999999999999876655555678899999999999 59999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917          103 YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG  182 (494)
Q Consensus       103 ~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg  182 (494)
                      +......++||||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++..+..+.+||+|||
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  174 (484)
T 3nyv_A           95 FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG  174 (484)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred             EEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence            99999999999999999999999988899999999999999999999999999999999999999765567899999999


Q ss_pred             CccccccCcccccccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          183 LSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      ++.............||+.|+|||++.+.++.++|||||||++|+|++|..||.+....++...+.++...+..+.+..+
T Consensus       175 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  254 (484)
T 3nyv_A          175 LSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV  254 (484)
T ss_dssp             HHHHBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGS
T ss_pred             eeEEcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccC
Confidence            99877666556667899999999999999999999999999999999999999999999999999998887777777889


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCc---CCCCCCcHHHHHHHHHHhhhhHHHHHHHHhhhccC-chhHH
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE---ASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENL-PTEEI  338 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~  338 (494)
                      ++.+.+||.+||..||.+|||+.++|+||||+....   ....|.....+.+++++...+++++.+...+...+ +.++.
T Consensus       255 s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~  334 (484)
T 3nyv_A          255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDET  334 (484)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHH
Confidence            999999999999999999999999999999986543   22455567788889999999999999999888765 78899


Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHH----HHHhcCCCCC-------HHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhh
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKA----GLAKLGSMLT-------EFDVKQYMQAADIDGNGTIDYIEFITATMQRHKL  407 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~----~l~~~~~~~~-------~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~  407 (494)
                      ++++++|..+|.|++|.|+.+||..    +++.+|..++       .+++.++|..+|.|++|.|+|+||+..+......
T Consensus       335 ~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~~g~i~~~Ef~~~~~~~~~~  414 (484)
T 3nyv_A          335 KELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKNGYIEYSEFVTVAMDRKTL  414 (484)
T ss_dssp             HHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTCCTTSEEEHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCcCCCceEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCCCCCCeEeHHHHHHHHHhcccc
Confidence            9999999999999999999999954    4455577777       7889999999999999999999999988876555


Q ss_pred             hHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       408 ~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...+.+..+|+.||.|++|+|+.+||+.++..    ..+++++++++|..+|.|+||+|+|+||..+|..
T Consensus       415 ~~~~~~~~~F~~~D~d~dG~I~~~El~~~l~~----~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~~~  480 (484)
T 3nyv_A          415 LSRERLERAFRMFDSDNSGKISSTELATIFGV----SDVDSETWKSVLSEVDKNNDGEVDFDEFQQMLLK  480 (484)
T ss_dssp             HHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHH----TTCCHHHHHHHHHHHCTTCCSEEEHHHHHHHHHH
T ss_pred             CcHHHHHHHHHHHCCCCCCcCCHHHHHHHHHh----cCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHh
Confidence            66788999999999999999999999999986    3568899999999999999999999999998875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.6e-75  Score=599.60  Aligned_cols=452  Identities=34%  Similarity=0.587  Sum_probs=397.3

Q ss_pred             hhhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCCh----------hhHHHHHHHHHHHHHcc
Q 040917           22 AILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD----------VEKDDVRREIEIMRHLS   91 (494)
Q Consensus        22 ~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~   91 (494)
                      ..+....+.+.++|++++.||+|+||+||+|.++.+++.||+|++.+......          .....+.+|+.+++++.
T Consensus        25 ~~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  104 (504)
T 3q5i_A           25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD  104 (504)
T ss_dssp             GGCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred             heeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence            44555667788999999999999999999999999999999999976543221          34577899999999995


Q ss_pred             CCCCccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC
Q 040917           92 GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD  171 (494)
Q Consensus        92 ~hp~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~  171 (494)
                       ||||+++++++.+....++|||||+|++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus       105 -hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          105 -HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN  183 (504)
T ss_dssp             -CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTT
T ss_pred             -CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCC
Confidence             9999999999999999999999999999999998888999999999999999999999999999999999999996544


Q ss_pred             CCCeEEEeecCCccccccCcccccccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC
Q 040917          172 ENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE  251 (494)
Q Consensus       172 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  251 (494)
                      ....+||+|||++.............||+.|+|||++.+.++.++||||+||++|+|++|..||.+....++...+..+.
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  263 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK  263 (504)
T ss_dssp             CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence            44589999999998776665666778999999999999889999999999999999999999999999999999999888


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCC---CCcHHHHHHHHHHhhhhHHHHHHHHh
Q 040917          252 INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDK---PIDTAVIFRMKQFTAMNKLKKLALKV  328 (494)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~  328 (494)
                      ..++...+..+|+.+.++|.+||..||.+|||+.++|+||||+........   +.....+.+++++...+++++.+...
T Consensus       264 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~  343 (504)
T 3q5i_A          264 YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILF  343 (504)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHH
T ss_pred             CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            777766677899999999999999999999999999999999875543221   12235577788888899999999888


Q ss_pred             hhccC-chhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhc--------CCCCCHHHHHHHHHHhcCCCCCcccchHHHH
Q 040917          329 IVENL-PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL--------GSMLTEFDVKQYMQAADIDGNGTIDYIEFIT  399 (494)
Q Consensus       329 ~~~~~-~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~--------~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~  399 (494)
                      +...+ +.+++++++++|+.+|.|++|+|+.+||..++..+        +...+.+++..+|..+|.|+||.|+|+||+.
T Consensus       344 i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~  423 (504)
T 3q5i_A          344 IGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNGYIEYSEFIS  423 (504)
T ss_dssp             HHHHTSCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTTCSSSEEHHHHHH
T ss_pred             hhccCCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCCCCCcEeHHHHHH
Confidence            87766 88999999999999999999999999999999887        5567788999999999999999999999999


Q ss_pred             HHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          400 ATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       400 ~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      .+.........+.++.+|+.||.|++|+|+.+||+.++..    ..+++++++++|..+|.|+||+|+|+||..+|...
T Consensus       424 ~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~El~~~l~~----~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~  498 (504)
T 3q5i_A          424 VCMDKQILFSEERLRRAFNLFDTDKSGKITKEELANLFGL----TSISEKTWNDVLGEADQNKDNMIDFDEFVSMMHKI  498 (504)
T ss_dssp             HHSCHHHHTCHHHHHHHHHHHCTTCCSEECHHHHHHHTTC----SCCCHHHHHHHHHTTCSSCSSSEEHHHHHHHHHHH
T ss_pred             HHHhhhcccCHHHHHHHHHHhcCCCCCcCcHHHHHHHHhh----CCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHh
Confidence            8876544455678999999999999999999999999976    24789999999999999999999999999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.5e-75  Score=601.82  Aligned_cols=451  Identities=37%  Similarity=0.629  Sum_probs=396.0

Q ss_pred             hhhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeE
Q 040917           22 AILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKA  101 (494)
Q Consensus        22 ~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~  101 (494)
                      ..+......+.++|++++.||+|+||+||+|.+..++..||+|++.+...... ....+.+|+.+++.+. ||||+++++
T Consensus        26 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~-hpniv~~~~  103 (494)
T 3lij_A           26 MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLD-HPNIMKLYD  103 (494)
T ss_dssp             GGCCCCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCC-CTTBCCEEE
T ss_pred             heeecCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCC-CCCCCeEEE
Confidence            45555667788899999999999999999999999999999999976543222 3567889999999995 999999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeec
Q 040917          102 AYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDF  181 (494)
Q Consensus       102 ~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Df  181 (494)
                      ++.+....++|||||+||+|.+.+.....+++..+..++.||+.||.|||++||+||||||+||+++..+..+.+||+||
T Consensus       104 ~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  183 (494)
T 3lij_A          104 FFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDF  183 (494)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             EEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEEC
Confidence            99999999999999999999999988888999999999999999999999999999999999999975555678999999


Q ss_pred             CCccccccCcccccccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917          182 GLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (494)
                      |++............+||+.|+|||++.+.++.++||||+||++|+|++|..||.+....++...+..+...+....+..
T Consensus       184 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  263 (494)
T 3lij_A          184 GLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKN  263 (494)
T ss_dssp             TTCEECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTT
T ss_pred             CCCeECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhccc
Confidence            99987766666667789999999999998899999999999999999999999999999999999999888888777889


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC----CCCCCcHHHHHHHHHHhhhhHHHHHHHHhhhccC-chh
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA----SDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENL-PTE  336 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~-~~~  336 (494)
                      +++.+.++|.+||..||.+|||+.++|+||||+.....    ...+.....+.+++++...+++++.+...++..+ +.+
T Consensus       264 ~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~~~~~~  343 (494)
T 3lij_A          264 VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQE  343 (494)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHHSCCHH
T ss_pred             CCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHhcccHH
Confidence            99999999999999999999999999999999864221    2234445667788889999999999998888776 889


Q ss_pred             HHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCC--------CCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhh
Q 040917          337 EIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGS--------MLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQ  408 (494)
Q Consensus       337 ~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~--------~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~  408 (494)
                      ++++++++|+.+|.|++|.|+.+||..++..++.        ..+.+++..+|..+|.|++|.|+|+||+..+.......
T Consensus       344 ~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~~EF~~~~~~~~~~~  423 (494)
T 3lij_A          344 ETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYSEFVTVAMDRKSLL  423 (494)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHSCHHHHT
T ss_pred             HHHHHHHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhhhccc
Confidence            9999999999999999999999999999998854        44578899999999999999999999999877655555


Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ..+.+..+|+.||.|++|+|+.+||+.++..    ..+++++++++|..+|.|+||+|+|+||..+|...
T Consensus       424 ~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~----~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~  489 (494)
T 3lij_A          424 SKDKLESAFQKFDQDGNGKISVDELASVFGL----DHLESKTWKEMISGIDSNNDGDVDFEEFCKMIQKL  489 (494)
T ss_dssp             CHHHHHHHHHHHCTTCSSEECHHHHHHHC-C----CSCCCHHHHHHHHTTCSSSSSSEEHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHCCCCCCcCCHHHHHHHHHh----cCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHhh
Confidence            6678999999999999999999999999875    45788899999999999999999999999998853

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.2e-75  Score=601.61  Aligned_cols=447  Identities=35%  Similarity=0.634  Sum_probs=376.1

Q ss_pred             cccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           27 AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      ....+.++|++++.||+|+||+||+|.+..+++.||+|++.+..... .....+.+|+.+++++. ||||+++++++.+.
T Consensus        16 ~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~   93 (486)
T 3mwu_A           16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLD-HPNIMKLFEILEDS   93 (486)
T ss_dssp             TCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred             ccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcC
Confidence            34567889999999999999999999999999999999986543222 24677899999999995 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          107 QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      ...++|||||+|++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+||+++..+..+.+||+|||++..
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            99999999999999999998888999999999999999999999999999999999999997655677899999999987


Q ss_pred             cccCcccccccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917          187 IEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (494)
                      ...........||+.|+|||++.+.++.++|||||||++|+|++|..||.+....++...+..+...+..+.+..+++.+
T Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  253 (486)
T 3mwu_A          174 FQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA  253 (486)
T ss_dssp             BCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred             CCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHH
Confidence            76655556678999999999999999999999999999999999999999999999999999888877777778899999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCC----CCCcHHHHHHHHHHhhhhHHHHHHHHhhhccC-chhHHHhh
Q 040917          267 IELVRRMLTQDPKRRITVAQVLEHPWLKESGEASD----KPIDTAVIFRMKQFTAMNKLKKLALKVIVENL-PTEEIQKL  341 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~  341 (494)
                      .++|.+||..||.+|||+.++|+||||+.......    .+.......+++++...+++++.+...++..+ +.++++++
T Consensus       254 ~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~~~~l  333 (486)
T 3mwu_A          254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQL  333 (486)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHHH
Confidence            99999999999999999999999999987543322    12223456677888888899998888888766 88999999


Q ss_pred             hhhhhccCCCCCCcccHHHHHHHHH----hcCCCCC----------HHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhh
Q 040917          342 KEKFTEMDTDNSGTLTYDELKAGLA----KLGSMLT----------EFDVKQYMQAADIDGNGTIDYIEFITATMQRHKL  407 (494)
Q Consensus       342 ~~~F~~~D~~~~g~i~~~el~~~l~----~~~~~~~----------~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~  407 (494)
                      +++|+.+|.|++|.|+.+||..++.    .+|..++          .+++..+|..+|.|+||.|+|+||+..+......
T Consensus       334 ~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~Ef~~~~~~~~~~  413 (486)
T 3mwu_A          334 TEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDMDGSGSIEYSEFIASAIDRTIL  413 (486)
T ss_dssp             HHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHCTTCCSSBCHHHHHHHHSCTTTT
T ss_pred             HHHHHHhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhcCCCCCcCcHHHHHHHHHhhhcc
Confidence            9999999999999999999965554    4466555          7889999999999999999999999887765555


Q ss_pred             hHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       408 ~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...+.+..+|+.||.|+||+|+.+||+.++..  .|..+++++++++|..+|.|+||.|+|+||..+|..
T Consensus       414 ~~~~~~~~~F~~~D~d~dG~Is~~El~~~l~~--~g~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~  481 (486)
T 3mwu_A          414 LSRERMERAFKMFDKDGSGKISTKELFKLFSQ--ADSSIQMEELESIIEQVDNNKDGEVDFNEFVEMLQN  481 (486)
T ss_dssp             CCHHHHHHHHHHHCSSCSSSBCSSCC----------------------CCCCSSCSSSBCHHHHHHHHHH
T ss_pred             chHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH--cCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHH
Confidence            56678999999999999999999999999998  667889999999999999999999999999998874

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.4e-61  Score=454.71  Aligned_cols=257  Identities=30%  Similarity=0.557  Sum_probs=233.4

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.++++|. ||||+++++++.+++.+||
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~yi  109 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYF  109 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEE
Confidence            367999999999999999999999999999999998655444445778999999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-  190 (494)
                      |||||+||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++++||+|||+|...... 
T Consensus       110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTT
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCCC
Confidence            99999999999999998999999999999999999999999999999999999999   67899999999999876432 


Q ss_pred             --cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          191 --KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       191 --~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                        ....+.+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..++...+.+....++    ..+++.++
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  262 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKAR  262 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTCCHHHH
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----cccCHHHH
Confidence              23456789999999999975 599999999999999999999999999999999999988876554    46899999


Q ss_pred             HHHHHhcccCCCCCCCHHH------HhcCCccCcc
Q 040917          268 ELVRRMLTQDPKRRITVAQ------VLEHPWLKES  296 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~e------il~~~~~~~~  296 (494)
                      +||.+||.+||.+|||++|      +++||||++.
T Consensus       263 dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i  297 (311)
T 4aw0_A          263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  297 (311)
T ss_dssp             HHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence            9999999999999999988      5899999863

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6e-60  Score=442.54  Aligned_cols=254  Identities=38%  Similarity=0.669  Sum_probs=214.8

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++++.||+|+||+||+|.++.+|+.||+|++.+...........+.+|+.++++++ ||||+++++++.+++.+|+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEEE
Confidence            68999999999999999999999999999999998776655556778999999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      |||| +|+|.+++.+++++++..+..++.||+.||.|||++||+||||||+|||+   +.++++||+|||+|........
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC--------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecCCCCc
Confidence            9999 67999999999999999999999999999999999999999999999999   6788999999999987766555


Q ss_pred             cccccCCcCccChhhhccc-C-CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          193 YREIVGSPYYIAPEVLSQS-Y-GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      ....+||+.|+|||++.+. + +.++||||+||++|+|++|+.||.+.+...+.+.+.++...++    ..+|+.+.+||
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li  243 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAAGLI  243 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHH
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence            6678899999999999764 4 6799999999999999999999999998888888888765543    46899999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCccCc
Q 040917          271 RRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       271 ~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      .+||..||++|||++|+|+||||+.
T Consensus       244 ~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          244 KRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHHccCChhHCcCHHHHHcCccccc
Confidence            9999999999999999999999974

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.4e-59  Score=449.89  Aligned_cols=257  Identities=27%  Similarity=0.554  Sum_probs=224.9

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.++++|+ ||||+++++++.+++.+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEEE
Confidence            689999999999999999999999999999999987654 3345778999999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          113 MELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      ||||+||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|......
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCC
Confidence            99999999999997543  47899999999999999999999999999999999999   67899999999999876543


Q ss_pred             c-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917          191 K-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE  268 (494)
Q Consensus       191 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  268 (494)
                      . .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..++...+.++....   ....+|+.+.+
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---~~~~~s~~~~~  255 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP---VSLHYSYDLRS  255 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CCTTSCHHHHH
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---CCccCCHHHHH
Confidence            2 2345789999999999976 59999999999999999999999999999999988888876542   23578999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          269 LVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       269 li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ||.+||..||.+|||+.++|+||||+...
T Consensus       256 li~~~L~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          256 LVSQLFKRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             HHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence            99999999999999999999999998643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.2e-58  Score=444.30  Aligned_cols=261  Identities=30%  Similarity=0.539  Sum_probs=230.9

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      +...+|++.+.||+|+||+||+|.++.+|+.||||++......   ..+.+.+|+.++++|. ||||+++++++.+++.+
T Consensus        71 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~  146 (346)
T 4fih_A           71 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDEL  146 (346)
T ss_dssp             CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred             ChhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence            3457899999999999999999999999999999999755432   3456889999999995 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      |||||||+||+|.+++.+ +++++..+..++.||+.||.|||++||+||||||+|||+   +.++++||+|||+|.....
T Consensus       147 ~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          147 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             EEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred             EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCC
Confidence            999999999999998876 579999999999999999999999999999999999999   6789999999999987654


Q ss_pred             C-cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          190 G-KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       190 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      . ......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..+....+..... .....+..+++.+.
T Consensus       223 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~  301 (346)
T 4fih_A          223 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLK  301 (346)
T ss_dssp             SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHHHH
T ss_pred             CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHHHH
Confidence            3 33456789999999999975 699999999999999999999999999998888887766533 22334467899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917          268 ELVRRMLTQDPKRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  299 (494)
                      +||.+||..||.+|||+.|+|+||||++...+
T Consensus       302 dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p  333 (346)
T 4fih_A          302 GFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  333 (346)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence            99999999999999999999999999975533

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.5e-58  Score=435.40  Aligned_cols=256  Identities=23%  Similarity=0.423  Sum_probs=220.1

Q ss_pred             cce-EeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe----CC
Q 040917           33 LHY-TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----DQ  107 (494)
Q Consensus        33 ~~y-~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~----~~  107 (494)
                      ++| ++.+.||+|+||+||+|.++.++..||+|++..... .......+.+|+.++++|+ ||||+++++++.+    +.
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~  102 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCc
Confidence            455 788899999999999999999999999999976553 3345678999999999995 9999999999865    35


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG--VMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      .+|||||||+||+|.+++.+.+.+++..+..++.||+.||.|||++|  |+||||||+|||++  +.++.+||+|||+|.
T Consensus       103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred             EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCCE
Confidence            68999999999999999999889999999999999999999999998  99999999999994  246899999999997


Q ss_pred             ccccCcccccccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHcCCccCCCCCCCCCCH
Q 040917          186 FIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQG-VAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      .... ......+||+.|+|||++.+.|+.++|||||||++|+|+||+.||.+..... +...+..+..+.  .....+++
T Consensus       181 ~~~~-~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~--~~~~~~~~  257 (290)
T 3fpq_A          181 LKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDKVAIP  257 (290)
T ss_dssp             GCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--GGGGCCCH
T ss_pred             eCCC-CccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC--CCCccCCH
Confidence            5433 3445678999999999999899999999999999999999999997765544 444444443221  12245788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      .+.+||.+||..||++|||+.++|+||||++
T Consensus       258 ~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            9999999999999999999999999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.9e-57  Score=447.09  Aligned_cols=262  Identities=30%  Similarity=0.539  Sum_probs=231.9

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      .+...+|++.+.||+|+||.||+|.++.+|+.||||++......   ..+.+.+|+.+|+.|. ||||+++++++.+++.
T Consensus       147 ~dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~  222 (423)
T 4fie_A          147 GDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDE  222 (423)
T ss_dssp             SCGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred             CChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCC-CCCCCceEEEEEECCE
Confidence            34567899999999999999999999999999999999765432   3456889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      +|||||||+||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|....
T Consensus       223 ~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~  298 (423)
T 4fie_A          223 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVS  298 (423)
T ss_dssp             EEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECC
Confidence            9999999999999998865 569999999999999999999999999999999999999   678999999999998764


Q ss_pred             cC-cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917          189 EG-KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       189 ~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (494)
                      .. ......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..+....+...... ....+..+++.+
T Consensus       299 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~~~~~~~~s~~~  377 (423)
T 4fie_A          299 KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPSL  377 (423)
T ss_dssp             SSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSCTTSSCHHH
T ss_pred             CCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCcccccCCHHH
Confidence            43 33456789999999999975 5999999999999999999999999999988888877665332 233456789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917          267 IELVRRMLTQDPKRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  299 (494)
                      .+||.+||..||.+|||+.|+|+||||++...+
T Consensus       378 ~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p  410 (423)
T 4fie_A          378 KGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  410 (423)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence            999999999999999999999999999975533

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4e-58  Score=436.09  Aligned_cols=255  Identities=27%  Similarity=0.501  Sum_probs=221.0

Q ss_pred             cceEeeeeecccCCeEEEEEEEC---CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           33 LHYTIGREVGRGEFGITYLCTEN---STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      .+|++++.||+|+||+||+|++.   .+++.||+|++.+...... ....+.+|+.++++|. ||||+++++++.+++.+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCC-CTTEECEEEEEEETTEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence            68999999999999999999874   4688999999976543222 2346788999999995 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      |+|||||+||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++++||+|||+|.....
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC---
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceeccC
Confidence            9999999999999999998999999999999999999999999999999999999999   6789999999999986433


Q ss_pred             -CcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          190 -GKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       190 -~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                       .......+||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.+.+..++...+.+....++    ..+|+.+.
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  254 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQ  254 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred             CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CcCCHHHH
Confidence             333456789999999999875 599999999999999999999999999999999998888765543    46899999


Q ss_pred             HHHHHhcccCCCCCCC-----HHHHhcCCccCcc
Q 040917          268 ELVRRMLTQDPKRRIT-----VAQVLEHPWLKES  296 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps-----~~eil~~~~~~~~  296 (494)
                      +||.+||.+||++|||     ++|+++||||+..
T Consensus       255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            9999999999999998     5899999999863

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.5e-57  Score=432.40  Aligned_cols=254  Identities=25%  Similarity=0.371  Sum_probs=221.6

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ..|++.+.||+|+||.||+|+++.+|+.||+|+++.....        .+|+.++++|+ ||||+++++++.+++.+|||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~-HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLS-SPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCC-CCCCCcEEEEEEECCEEEEE
Confidence            5799999999999999999999999999999999765432        36999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC-eEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA-VVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~-~~kL~Dfg~a~~~~~~~  191 (494)
                      ||||+||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++ ++||+|||+|.......
T Consensus       129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL---SSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE---CTTSCCEEECCCTTCEEC----
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---eCCCCEEEEeeCCCCeEccCCC
Confidence            9999999999999998899999999999999999999999999999999999999   5555 69999999998764322


Q ss_pred             c------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          192 A------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       192 ~------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      .      ....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..++...+......+. ..++.+|+
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~  284 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPPSCAP  284 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSCTTSCH
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcCccCCH
Confidence            1      123579999999999975 599999999999999999999999998887777777777654432 23467899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHH-------------hcCCccCccCcC
Q 040917          265 SAIELVRRMLTQDPKRRITVAQV-------------LEHPWLKESGEA  299 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~ei-------------l~~~~~~~~~~~  299 (494)
                      .+.++|.+||.+||.+|||+.|+             |+|||+....+|
T Consensus       285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P  332 (336)
T 4g3f_A          285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP  332 (336)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence            99999999999999999999997             689999876544

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-55  Score=432.55  Aligned_cols=267  Identities=27%  Similarity=0.408  Sum_probs=227.0

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe---
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED---  105 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~---  105 (494)
                      .++.++|++++.||+|+||+||+|.++.+|+.||||++.+... .......+.+|+.+|++|+ ||||+++++++..   
T Consensus        50 ~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~  127 (398)
T 4b99_A           50 FDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVP  127 (398)
T ss_dssp             CCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSC
T ss_pred             CCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcC-CCCcceEeeeeecccc
Confidence            3566899999999999999999999999999999999975442 3345677889999999995 9999999999753   


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917          106 ---DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG  182 (494)
Q Consensus       106 ---~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg  182 (494)
                         .+.+|||||||+ |+|.+++...+.+++..+..+++||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus       128 ~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFG  203 (398)
T 4b99_A          128 YGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFG  203 (398)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCT
T ss_pred             cccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeecc
Confidence               357899999996 5899999888899999999999999999999999999999999999999   688999999999


Q ss_pred             CccccccC-----cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC
Q 040917          183 LSAFIEEG-----KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ  255 (494)
Q Consensus       183 ~a~~~~~~-----~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  255 (494)
                      +|......     ......+||+.|+|||++.+  .++.++||||+||++|+|++|+.||.+.+..+.+..+......+.
T Consensus       204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~  283 (398)
T 4b99_A          204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS  283 (398)
T ss_dssp             TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99865332     22345789999999999865  479999999999999999999999999998888777754322111


Q ss_pred             CC---------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCC
Q 040917          256 RD---------------------------PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASD  301 (494)
Q Consensus       256 ~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~  301 (494)
                      ..                           .++.+++.+.+||.+||..||.+|||+.|+|+||||+....+.+
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~  356 (398)
T 4b99_A          284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDD  356 (398)
T ss_dssp             GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGG
T ss_pred             hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCcc
Confidence            10                           12467899999999999999999999999999999997654443

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.9e-54  Score=418.95  Aligned_cols=261  Identities=26%  Similarity=0.444  Sum_probs=213.1

Q ss_pred             ccccccccceEeeeeecccCCeEEEEEEEC---CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEE
Q 040917           26 KAYEDVQLHYTIGREVGRGEFGITYLCTEN---STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAA  102 (494)
Q Consensus        26 ~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~  102 (494)
                      +...++.++|++++.||+|+||+||+|.++   .+++.||+|.+....     ....+.+|+.+++.+.+||||++++++
T Consensus        14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~   88 (361)
T 4f9c_A           14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYC   88 (361)
T ss_dssp             HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEE
T ss_pred             HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEE
Confidence            344567789999999999999999999875   468899999986533     345688999999999779999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917          103 YEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG  182 (494)
Q Consensus       103 ~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg  182 (494)
                      +.+.+++|+|||||+|++|.+++   +.+++..+..+++||+.||.|||++||+||||||+|||++  .+.+.+||+|||
T Consensus        89 ~~~~~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFG  163 (361)
T 4f9c_A           89 FRKNDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFG  163 (361)
T ss_dssp             EEETTEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCT
T ss_pred             EEECCEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCC
Confidence            99999999999999999999988   4589999999999999999999999999999999999995  344799999999


Q ss_pred             CccccccCc-----------------------------ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhC
Q 040917          183 LSAFIEEGK-----------------------------AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCG  231 (494)
Q Consensus       183 ~a~~~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg  231 (494)
                      +|.......                             .....+||+.|+|||++.+  .|+.++||||+||++|+|++|
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            997543211                             1234579999999999865  489999999999999999999


Q ss_pred             CCCCCCCCh-HHHHHHHHcC--------------------------------------C------------ccCCCCCCC
Q 040917          232 VPPFWAETD-QGVAQAILKG--------------------------------------E------------INFQRDPFP  260 (494)
Q Consensus       232 ~~pf~~~~~-~~~~~~~~~~--------------------------------------~------------~~~~~~~~~  260 (494)
                      +.||..... .+.+..+...                                      .            .......+.
T Consensus       244 ~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  323 (361)
T 4f9c_A          244 RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN  323 (361)
T ss_dssp             CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence            999965443 3333222110                                      0            000112356


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      .+|+++.+||.+||..||.+|||++|+|+||||++.
T Consensus       324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          324 EVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             TCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             cCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            789999999999999999999999999999999863

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=6.1e-54  Score=409.10  Aligned_cols=253  Identities=28%  Similarity=0.510  Sum_probs=199.8

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC-----
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ-----  107 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~-----  107 (494)
                      .+|++++.||+|+||+||+|.++.+|+.||+|++....  .....+.+.+|+.++++|+ ||||+++++++...+     
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC-----
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCccccc
Confidence            57999999999999999999999999999999996543  3445678999999999995 999999999986543     


Q ss_pred             -------eEEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEE
Q 040917          108 -------FVHIVMELCAGGELFDRIVARGH---YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVK  177 (494)
Q Consensus       108 -------~~~iv~e~~~g~sL~~~~~~~~~---l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~k  177 (494)
                             ..|+|||||+||+|.+++.....   .+...+..++.||+.||.|||++||+||||||+|||+   +.++.+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vK  158 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVK  158 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEE
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEE
Confidence                   47999999999999999987654   3456788999999999999999999999999999999   6788999


Q ss_pred             EeecCCccccccCcc-------------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH-H
Q 040917          178 ATDFGLSAFIEEGKA-------------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ-G  242 (494)
Q Consensus       178 L~Dfg~a~~~~~~~~-------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~  242 (494)
                      |+|||+|........             ....+||+.|+|||++.+ .|+.++|||||||++|+|++   ||.+.... .
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~  235 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR  235 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence            999999986543221             123579999999999975 59999999999999999996   77653322 1


Q ss_pred             HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          243 VAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ....+.....  + +.++..++.+.+||.+||+.||.+|||+.++|+||||++..
T Consensus       236 ~~~~~~~~~~--p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          236 TLTDVRNLKF--P-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHHHHHTTCC--C-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HHHHHhcCCC--C-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            2222333221  1 12234567788999999999999999999999999998743

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.4e-53  Score=439.33  Aligned_cols=267  Identities=35%  Similarity=0.633  Sum_probs=241.9

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .+++.++|++++.||+|+||.||+|.++.+|+.||+|++....   ....+.+.+|+.+|+.|+ ||||+++++++.+..
T Consensus       152 ~~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~  227 (573)
T 3uto_A          152 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDN  227 (573)
T ss_dssp             SSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSS
T ss_pred             CCcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECC
Confidence            3456689999999999999999999999999999999996543   334677899999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          108 FVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      .+|||||||+||+|.+++.. .+.+++..+..+++||+.||.|||++||+||||||+|||++. +..+.+||+|||+|..
T Consensus       228 ~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAH  306 (573)
T ss_dssp             EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEE
T ss_pred             EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeE
Confidence            99999999999999999864 457999999999999999999999999999999999999953 2357899999999998


Q ss_pred             cccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          187 IEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ..........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+....+.+....++...++.+++.
T Consensus       307 ~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  386 (573)
T 3uto_A          307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED  386 (573)
T ss_dssp             CCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred             ccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            877766677899999999999875 5899999999999999999999999999999999999998888777777889999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  299 (494)
                      +.+||.+||..||.+|||+.|+|+||||+....+
T Consensus       387 ~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~  420 (573)
T 3uto_A          387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  420 (573)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence            9999999999999999999999999999975433

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=6.4e-53  Score=401.39  Aligned_cols=251  Identities=24%  Similarity=0.408  Sum_probs=216.7

Q ss_pred             cceEeeeeecccCCeEEEEEEEC-----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           33 LHYTIGREVGRGEFGITYLCTEN-----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .+|.+.+.||+|+||+||+|.+.     .++..||||+++..   +....+.+.+|+.++++|+ ||||+++++++.+++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCC
Confidence            67999999999999999999875     35788999999643   3445778999999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917          108 FVHIVMELCAGGELFDRIVAR-------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA  174 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~-------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~  174 (494)
                      ..+||||||+||+|.+++...             ..+++..+..++.||+.||.|||+++|+||||||+|||+   +.++
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~~  165 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENL  165 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CCCC
Confidence            999999999999999999764             258999999999999999999999999999999999999   6789


Q ss_pred             eEEEeecCCccccccCccc---ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHc
Q 040917          175 VVKATDFGLSAFIEEGKAY---REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILK  249 (494)
Q Consensus       175 ~~kL~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~  249 (494)
                      .+||+|||+|+........   ....||+.|+|||++. +.|+.++|||||||++|||+| |+.||.+.+..++...+.+
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            9999999999865443322   2346899999999986 569999999999999999998 8999999999999888887


Q ss_pred             CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          250 GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      +.....+   ..+|+.+.+++.+||+.||++|||+.+++.  |+++
T Consensus       246 ~~~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~~i~~--~L~~  286 (299)
T 4asz_A          246 GRVLQRP---RTCPQEVYELMLGCWQREPHMRKNIKGIHT--LLQN  286 (299)
T ss_dssp             TCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             CCCCCCC---ccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHHH
Confidence            7543222   468999999999999999999999999954  7664

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-52  Score=396.84  Aligned_cols=249  Identities=21%  Similarity=0.370  Sum_probs=205.8

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .+++++.+.||+|+||+||+|.+..   .||||+++... .+....+.+.+|+.++++|+ ||||+++++++.. +.++|
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~~~~i  108 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-DNLAI  108 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-CeEEE
Confidence            3688999999999999999998653   59999987544 34445778999999999995 9999999998864 56789


Q ss_pred             EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          112 VMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      |||||+||+|.+++... .++++..+..++.||+.||.|||+++|+||||||+|||+   +.++.+||+|||+|......
T Consensus       109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC----
T ss_pred             EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCceecccC
Confidence            99999999999999764 579999999999999999999999999999999999999   57889999999999865432


Q ss_pred             ---cccccccCCcCccChhhhcc----cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC--CCCCCC
Q 040917          191 ---KAYREIVGSPYYIAPEVLSQ----SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ--RDPFPS  261 (494)
Q Consensus       191 ---~~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~  261 (494)
                         ......+||+.|+|||++.+    .|+.++|||||||++|||+||+.||.+.+.......+.......+  ....+.
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~  265 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKN  265 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTT
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Confidence               22345689999999999853    489999999999999999999999988776655544443332222  233457


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +|+.+.+++.+||..||++|||+.++++
T Consensus       266 ~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          266 CPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             SCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            8999999999999999999999998765

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.6e-52  Score=428.69  Aligned_cols=255  Identities=28%  Similarity=0.460  Sum_probs=219.7

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHH---HHHHHccCCCCccEEeEEEEeCCe
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREI---EIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~---~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++.+.............+|.   .+++.+ +||||+++++++.+.+.
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~~~  266 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDK  266 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEECCE
Confidence            37899999999999999999999999999999999765443333344455554   444555 59999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      +|+|||||+||+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++++||+|||+|....
T Consensus       267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECS
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeeecC
Confidence            99999999999999999999999999999999999999999999999999999999999   788999999999998765


Q ss_pred             cCcccccccCCcCccChhhhc-c-cCCCcchhHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHcCCccCCCCCCCCCC
Q 040917          189 EGKAYREIVGSPYYIAPEVLS-Q-SYGKEADIWSAGVILYILLCGVPPFWAET---DQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       189 ~~~~~~~~~~~~~y~aPE~~~-~-~~~~~~Di~slG~il~~l~tg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      .. ...+.+||+.|+|||++. + .|+.++|||||||++|+|++|..||.+..   ...+...+......++    ..+|
T Consensus       344 ~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p----~~~S  418 (689)
T 3v5w_A          344 KK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFS  418 (689)
T ss_dssp             SC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----TTSC
T ss_pred             CC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----ccCC
Confidence            43 335678999999999985 3 58999999999999999999999997643   3344555555544433    4689


Q ss_pred             HHHHHHHHHhcccCCCCCCC-----HHHHhcCCccCc
Q 040917          264 SSAIELVRRMLTQDPKRRIT-----VAQVLEHPWLKE  295 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps-----~~eil~~~~~~~  295 (494)
                      +++++||.+||..||.+|++     +++|++||||+.
T Consensus       419 ~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence            99999999999999999998     799999999986

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.2e-52  Score=397.43  Aligned_cols=250  Identities=21%  Similarity=0.326  Sum_probs=215.9

Q ss_pred             ccceEeeeeecccCCeEEEEEEEC-----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           32 QLHYTIGREVGRGEFGITYLCTEN-----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      ..++++.+.||+|+||+||+|.+.     .+++.||||+++...  .....+.+.+|+.++++|+ ||||+++++++..+
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKD  101 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEEC
Confidence            367899999999999999999864     467899999996543  3335678999999999995 99999999999998


Q ss_pred             CeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC
Q 040917          107 QFVHIVMELCAGGELFDRIVAR----------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG  170 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~  170 (494)
                      +..+||||||++|+|.+++...                ..+++..+..++.||+.||.|||+++|+||||||+|||+   
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl---  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV---  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE---
Confidence            9999999999999999999653                358899999999999999999999999999999999999   


Q ss_pred             CCCCeEEEeecCCccccccCc---ccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 040917          171 DENAVVKATDFGLSAFIEEGK---AYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQ  245 (494)
Q Consensus       171 ~~~~~~kL~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~  245 (494)
                      ++++.+||+|||+|+......   ......||+.|+|||++. +.|+.++|||||||++|||+| |..||.+.+..++..
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            678999999999998654332   223467899999999886 579999999999999999998 899999999999988


Q ss_pred             HHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          246 AILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      .+.++.....   .+.+|+.+.+++.+||..||++|||+.+|+++
T Consensus       259 ~i~~~~~~~~---p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRNRQVLPC---PDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8877654322   24689999999999999999999999999873

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9.9e-52  Score=416.69  Aligned_cols=299  Identities=37%  Similarity=0.674  Sum_probs=261.9

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      ..+.++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.+ +||||+++++++.+.+.
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~   84 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLL-KHPNIVRLHDSISEEGH   84 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECSSE
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEECCE
Confidence            3466899999999999999999999999999999999976553 233466789999999999 49999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      .++||||++||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+||+++....++.+||+|||++....
T Consensus        85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            99999999999999999998899999999999999999999999999999999999999755467899999999997665


Q ss_pred             cCc-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917          189 EGK-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       189 ~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (494)
                      ... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+..+...++...++.+++.+
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  244 (444)
T 3soa_A          165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA  244 (444)
T ss_dssp             TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence            432 2345689999999999876 59999999999999999999999999999999999999998888888888999999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCCcHHHHHHHHHHhhhhHHHHHHHHhh
Q 040917          267 IELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVI  329 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  329 (494)
                      .++|.+||..||.+|||+.++|+||||+..............+..++++...++++..+...+
T Consensus       245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~~~~~  307 (444)
T 3soa_A          245 KDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVM  307 (444)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTCSCEE
T ss_pred             HHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999865443333444667778888888888887666655

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.3e-52  Score=399.11  Aligned_cols=247  Identities=21%  Similarity=0.355  Sum_probs=209.2

Q ss_pred             cceEeeeeecccCCeEEEEEEEC-----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           33 LHYTIGREVGRGEFGITYLCTEN-----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .+|.+.+.||+|+||+||+|.++     .+++.||||+++..   +....+.+.+|+.++++|+ ||||+++++++.+.+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQ-HQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence            67999999999999999999875     36889999999643   3445678999999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCC
Q 040917          108 FVHIVMELCAGGELFDRIVAR---------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDE  172 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~  172 (494)
                      ..+||||||+||+|.+++...               +++++..+..++.||+.||.|||+++|+||||||+|||+   +.
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~~  193 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---GQ  193 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ET
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---CC
Confidence            999999999999999998753               358999999999999999999999999999999999999   67


Q ss_pred             CCeEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 040917          173 NAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAI  247 (494)
Q Consensus       173 ~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~  247 (494)
                      ++.+||+|||+|+.......   .....||+.|+|||++.+ .++.++|||||||++|||+| |+.||.+.+..++...+
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            89999999999986543322   234678999999999875 69999999999999999999 89999999998888888


Q ss_pred             HcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          248 LKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .++.....   ...+|+.+.+++.+||..||++|||+.++++
T Consensus       274 ~~g~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~  312 (329)
T 4aoj_A          274 TQGRELER---PRACPPEVYAIMRGCWQREPQQRHSIKDVHA  312 (329)
T ss_dssp             HHTCCCCC---CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred             HcCCCCCC---cccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            77643222   2468999999999999999999999999987

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.1e-51  Score=402.16  Aligned_cols=301  Identities=37%  Similarity=0.698  Sum_probs=261.2

Q ss_pred             cccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           27 AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      ....+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.+. ||||+++++++.+.
T Consensus        23 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~  100 (362)
T 2bdw_A           23 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEE  100 (362)
T ss_dssp             -CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred             CCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeC
Confidence            345567899999999999999999999999999999999976553 3335677899999999995 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          107 QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      ...++||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++..+.+||+|||++..
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          101 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             SEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            99999999999999999998888899999999999999999999999999999999999997555567899999999987


Q ss_pred             cccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          187 IEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ...........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+..+...++...+..+++.
T Consensus       181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  260 (362)
T 2bdw_A          181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE  260 (362)
T ss_dssp             CTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred             ecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            765555556789999999999876 5899999999999999999999999999998888888888887777777789999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCCcHHHHHHHHHHhhhhHHHHHHHHhh
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVI  329 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  329 (494)
                      +.++|.+||..||.+|||+.++|+||||..................++++...++++......+
T Consensus       261 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  324 (362)
T 2bdw_A          261 AKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTM  324 (362)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999864433333334556667777777777776554443

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.6e-51  Score=396.45  Aligned_cols=251  Identities=21%  Similarity=0.339  Sum_probs=210.8

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCC-----CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENST-----GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-  105 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-  105 (494)
                      .++|++++.||+|+||+||+|.+..+     ++.||+|.+....  .......+.+|+.++.++..||||+++++++.. 
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            47899999999999999999997654     4679999996543  333467799999999999756999999999865 


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEee
Q 040917          106 DQFVHIVMELCAGGELFDRIVAR----------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTT  169 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~  169 (494)
                      +..++||||||+||+|.++++..                ..+++..+..++.||+.||.|||+++|+||||||+|||+  
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl--  218 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--  218 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee--
Confidence            45789999999999999999753                247899999999999999999999999999999999999  


Q ss_pred             CCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCCh-HHH
Q 040917          170 GDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETD-QGV  243 (494)
Q Consensus       170 ~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~-~~~  243 (494)
                       +.++.+||+|||+|+.......   .....||+.|+|||++. +.|+.++|||||||++|||+| |+.||.+... +.+
T Consensus       219 -~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~  297 (353)
T 4ase_A          219 -SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  297 (353)
T ss_dssp             -CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred             -CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence             6788999999999986543322   23457899999999986 469999999999999999998 8999988664 444


Q ss_pred             HHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          244 AQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      ...+..+.....   ...+|+.+.+++.+||..||++|||+.+|++|
T Consensus       298 ~~~i~~g~~~~~---p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          298 CRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCCCCC---CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            555555432222   24678999999999999999999999999986

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.6e-50  Score=394.37  Aligned_cols=267  Identities=38%  Similarity=0.706  Sum_probs=238.5

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCCh---hhHHHHHHHHHHHHHccCCCCccEEeEEEE
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD---VEKDDVRREIEIMRHLSGQPNIVQFKAAYE  104 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~  104 (494)
                      ...+.++|++++.||+|+||.||+|.+..+|+.||+|++.+......   .....+.+|+.+++++. ||||+++++++.
T Consensus         7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~   85 (361)
T 2yab_A            7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYE   85 (361)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred             CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEE
Confidence            34577899999999999999999999999999999999976543221   23578999999999995 999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC-CCCeEEEeecCC
Q 040917          105 DDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD-ENAVVKATDFGL  183 (494)
Q Consensus       105 ~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~-~~~~~kL~Dfg~  183 (494)
                      +....++||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++ ....+||+|||+
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            9999999999999999999998888899999999999999999999999999999999999995211 122899999999


Q ss_pred             ccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          184 SAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       184 a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      +............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+......++...+..+
T Consensus       166 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (361)
T 2yab_A          166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT  245 (361)
T ss_dssp             CEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             ceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCC
Confidence            987766555566789999999999875 6899999999999999999999999999999999998888777666666789


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      ++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus       246 s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence            999999999999999999999999999999985

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.5e-49  Score=386.18  Aligned_cols=258  Identities=35%  Similarity=0.621  Sum_probs=233.3

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.+. ||||+++++++...+..+
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~   90 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKTLY   90 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEE
Confidence            45789999999999999999999999999999999976543 3445677889999999995 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++......
T Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSSS
T ss_pred             EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCCC
Confidence            999999999999999888899999999999999999999999999999999999999   67889999999999877666


Q ss_pred             cccccccCCcCccChhhhccc-C-CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917          191 KAYREIVGSPYYIAPEVLSQS-Y-GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE  268 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  268 (494)
                      ......+||+.|+|||++.+. + +.++||||+||++|+|++|+.||.+.+..+....+..+....+    ..+++.+.+
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  243 (328)
T 3fe3_A          168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----FYMSTDCEN  243 (328)
T ss_dssp             CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHH
Confidence            666677899999999998754 4 4789999999999999999999999999888888888765544    357899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          269 LVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       269 li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      +|.+||..||.+|||++++++||||....
T Consensus       244 li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          244 LLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            99999999999999999999999998644

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.7e-49  Score=386.49  Aligned_cols=296  Identities=38%  Similarity=0.677  Sum_probs=236.6

Q ss_pred             cccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           27 AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      ..+.+.++|++.+.||+|+||.||+|.+..+++.||+|++....     ..+.+.+|+.+++++. ||||+++++++...
T Consensus        47 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  120 (349)
T 2w4o_A           47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFETP  120 (349)
T ss_dssp             BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCC-CTTBCCEEEEEECS
T ss_pred             ccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCC-CCCCcceeeeEecC
Confidence            34567789999999999999999999999999999999997533     3456788999999995 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          107 QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      ...++||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++..+.++.+||+|||++..
T Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          121 TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             SEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            99999999999999999998888899999999999999999999999999999999999996444588999999999987


Q ss_pred             cccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHcCCccCCCCCCCCCCH
Q 040917          187 IEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQG-VAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      ...........||+.|+|||++.+ .++.++|||||||++|+|++|..||....... ....+......+....+..++.
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  280 (349)
T 2w4o_A          201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL  280 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred             cCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence            655444456778999999999875 58999999999999999999999997766554 5666777666666666778999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCCcHHHHHHHHHHhhhhHHHHHHHHhhh
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIV  330 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  330 (494)
                      .+.++|.+||..||++|||+.++|+||||.......  ........+++++...+++++......+
T Consensus       281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (349)
T 2w4o_A          281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF--VHMDTAQKKLQEFNARRKLKAAVKAVVA  344 (349)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCC--SCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCcccCCCccch--hhhcchHHHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999754332  2235566677778777778776655544

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.1e-49  Score=391.41  Aligned_cols=298  Identities=35%  Similarity=0.611  Sum_probs=239.8

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCC--ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV--KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      ..+.++|++.+.||+|+||.||+|.++.+|+.||+|++......  .....+.+.+|+.+++.++ ||||+++++++...
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~   98 (351)
T 3c0i_A           20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSSD   98 (351)
T ss_dssp             CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred             CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEeC
Confidence            34568999999999999999999999999999999998643221  1224677899999999995 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917          107 QFVHIVMELCAGGELFDRIVAR----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG  182 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg  182 (494)
                      +..|+||||++|++|.+.+...    ..+++..+..++.||+.||.|||++||+||||||+||+++.++....+||+|||
T Consensus        99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A           99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999999998877543    248999999999999999999999999999999999999654555679999999


Q ss_pred             CccccccCcc-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 040917          183 LSAFIEEGKA-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP  260 (494)
Q Consensus       183 ~a~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (494)
                      ++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. .......+..+........++
T Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~  257 (351)
T 3c0i_A          179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWS  257 (351)
T ss_dssp             TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHT
T ss_pred             ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccc
Confidence            9987654332 345679999999999875 5899999999999999999999999875 445666677766655554556


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCCcHHHHHHHHHHhhhhHHHHHHHHh
Q 040917          261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKV  328 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  328 (494)
                      .+++.+.++|.+||..||.+|||+.++|+||||+................+++++...++++......
T Consensus       258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  325 (351)
T 3c0i_A          258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAA  325 (351)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCHHHHHHHHHHHHHHC--------
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccchHHHHHHHHHHHHHHHHHHHHHH
Confidence            78999999999999999999999999999999986433222222244555666666666665544333

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-49  Score=385.59  Aligned_cols=264  Identities=31%  Similarity=0.620  Sum_probs=237.0

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      ++.++|++++.||+|+||.||+|.+..+++.||+|++...    ......+.+|+.+++.+. ||||+++++++.+....
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIAR-HRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCC-CCCCCeEeEEEecCCEE
Confidence            4668999999999999999999999999999999998643    234567889999999995 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          110 HIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      ++||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++. +.++.++|+|||++....
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc-CCCCCEEEEECCCCeECC
Confidence            99999999999999997653 6999999999999999999999999999999999999953 126899999999998876


Q ss_pred             cCcccccccCCcCccChhhhccc-CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          189 EGKAYREIVGSPYYIAPEVLSQS-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      .........+|+.|+|||++.+. ++.++|||||||++|+|++|..||.+....+....+......++...++.+|+.+.
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T 1tki_A          156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence            66555667899999999998764 78999999999999999999999999999999999988877777666678999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917          268 ELVRRMLTQDPKRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  299 (494)
                      ++|.+||..||.+|||+.++|+||||+.....
T Consensus       236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  267 (321)
T 1tki_A          236 DFVDRLLVKERKSRMTASEALQHPWLKQKIER  267 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGG
T ss_pred             HHHHHHcCCChhHCcCHHHHhcChhhccCccc
Confidence            99999999999999999999999999875443

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.3e-49  Score=388.37  Aligned_cols=257  Identities=30%  Similarity=0.534  Sum_probs=226.9

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++.+...........+.+|..+++.+.+||||+++++++.+.+..|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            36899999999999999999999999999999999765433444567788999999998779999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cC
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EG  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~  190 (494)
                      ||||++||+|..++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++++||+|||++.... ..
T Consensus       102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC--
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecccCC
Confidence            99999999999999988899999999999999999999999999999999999999   678999999999997533 23


Q ss_pred             cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                      ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..++...+......++    ..+++.+.++
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l  254 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLHEDATGI  254 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred             ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Confidence            33456789999999999875 599999999999999999999999999999999999988766554    3578999999


Q ss_pred             HHHhcccCCCCCCCH------HHHhcCCccCc
Q 040917          270 VRRMLTQDPKRRITV------AQVLEHPWLKE  295 (494)
Q Consensus       270 i~~~l~~dp~~Rps~------~eil~~~~~~~  295 (494)
                      |.+||..||.+||++      +++++||||+.
T Consensus       255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             HHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence            999999999999999      89999999986

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.6e-49  Score=387.60  Aligned_cols=260  Identities=34%  Similarity=0.562  Sum_probs=209.5

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      ....++|++++.||+|+||.||+|.+..+++.||+|++.....    ....+.+|+.+++.++ ||||+++++++.....
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~   90 (361)
T 3uc3_A           16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLR-HPNIVRFKEVILTPTH   90 (361)
T ss_dssp             CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred             CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhCC-CCCCCcEEEEEeeCCE
Confidence            3455899999999999999999999999999999999975432    2356889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      .++||||++|++|.+++...+.++...+..++.||+.||.|||++||+||||||+||+++. +..+.+||+|||++....
T Consensus        91 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           91 LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS-SSSCCEEECCCCCC----
T ss_pred             EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-CCCceEEEeecCcccccc
Confidence            9999999999999999988888999999999999999999999999999999999999942 223459999999987544


Q ss_pred             cCcccccccCCcCccChhhhcc-cCCC-cchhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHcCCccCCCCCCCCC
Q 040917          189 EGKAYREIVGSPYYIAPEVLSQ-SYGK-EADIWSAGVILYILLCGVPPFWAETD----QGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~-~~~~-~~Di~slG~il~~l~tg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      .........||+.|+|||++.+ .++. ++|||||||++|+|++|+.||.+...    ......+......++.  ...+
T Consensus       170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  247 (361)
T 3uc3_A          170 LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD--DIRI  247 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT--TSCC
T ss_pred             ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC--cCCC
Confidence            4444455679999999999865 4544 48999999999999999999977543    3444445444433332  2468


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      ++.+.+||.+||..||.+|||+.++++||||...
T Consensus       248 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          248 SPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            9999999999999999999999999999999754

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.7e-49  Score=383.03  Aligned_cols=266  Identities=38%  Similarity=0.720  Sum_probs=235.4

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC---hhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK---DVEKDDVRREIEIMRHLSGQPNIVQFKAAYED  105 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~  105 (494)
                      +.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.......   ......+.+|+.+++++. ||||+++++++..
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~   85 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN   85 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence            457789999999999999999999999999999999997654322   124678999999999995 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC-CCCeEEEeecCCc
Q 040917          106 DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD-ENAVVKATDFGLS  184 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~-~~~~~kL~Dfg~a  184 (494)
                      ....++||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++ ....+||+|||++
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            999999999999999999998888899999999999999999999999999999999999995321 2238999999999


Q ss_pred             cccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917          185 AFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       185 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      .............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+......++...++.++
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (326)
T 2y0a_A          166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS  245 (326)
T ss_dssp             EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred             eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence            87765555556789999999999874 68999999999999999999999999999888888887766665555556789


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      ..+.++|.+||..||.+|||+.++|+||||+.
T Consensus       246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  277 (326)
T 2y0a_A          246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  277 (326)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence            99999999999999999999999999999985

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.2e-49  Score=373.94  Aligned_cols=267  Identities=43%  Similarity=0.778  Sum_probs=240.7

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ...+.++|++.+.||+|+||.||+|.+..++..||+|++.....   ...+.+.+|+.+++++ +||||+++++++....
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~   79 (277)
T 3f3z_A            4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSL-DHPNIIRLYETFEDNT   79 (277)
T ss_dssp             --CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred             hhhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhC-CCCCEeeEEEEEecCC
Confidence            45677899999999999999999999999999999999975432   2366789999999999 5999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      ..++||||++|++|.+++.....+++..+..++.|++.||.|||++||+||||||+||++..++.++.++|+|||.+...
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           80 DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             eEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            99999999999999999988888999999999999999999999999999999999999965567789999999999877


Q ss_pred             ccCcccccccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          188 EEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      ..........+|+.|+|||++.+.++.++||||||+++|+|++|..||......+....+..+...++...+..+++.+.
T Consensus       160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T 3f3z_A          160 KPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE  239 (277)
T ss_dssp             CTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred             cCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence            66655566789999999999988899999999999999999999999999999888888888877766655567899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          268 ELVRRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                      ++|.+||..||.+|||+.++|+||||++...
T Consensus       240 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  270 (277)
T 3f3z_A          240 SLIRRLLTKSPKQRITSLQALEHEWFEKQLS  270 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence            9999999999999999999999999986443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.3e-48  Score=380.51  Aligned_cols=255  Identities=31%  Similarity=0.562  Sum_probs=228.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++...+..|+|
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCEEEEE
Confidence            68999999999999999999999999999999997643323335677889999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cCc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~~  191 (494)
                      |||++||+|..++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++++||+|||++.... ...
T Consensus        84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhcccCCC
Confidence            9999999999999888889999999999999999999999999999999999999   678999999999997532 333


Q ss_pred             ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      .....+||+.|+|||++.+ .++.++|+|||||++|+|++|..||.+.........+......++    ..+++.+.++|
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li  236 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLL  236 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence            4456789999999999865 589999999999999999999999999988888888877655544    36789999999


Q ss_pred             HHhcccCCCCCC-----CHHHHhcCCccCc
Q 040917          271 RRMLTQDPKRRI-----TVAQVLEHPWLKE  295 (494)
Q Consensus       271 ~~~l~~dp~~Rp-----s~~eil~~~~~~~  295 (494)
                      .+||..||.+||     +++++++||||..
T Consensus       237 ~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence            999999999999     9999999999985

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.5e-48  Score=370.67  Aligned_cols=267  Identities=39%  Similarity=0.759  Sum_probs=241.6

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++ ||||+++++++......
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFH   80 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcCCEE
Confidence            467899999999999999999999999999999999976543 3345677889999999995 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      ++||||++|++|.+.+.....++...+..++.|++.||.|||++||+||||||+||+++.++..+.++|+|||.+.....
T Consensus        81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            99999999999999998888899999999999999999999999999999999999996555566799999999987766


Q ss_pred             CcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917          190 GKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE  268 (494)
Q Consensus       190 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  268 (494)
                      ........+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+..+...++...+..+++.+.+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T 3kk8_A          161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS  240 (284)
T ss_dssp             SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred             CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence            555556789999999999875 5899999999999999999999999999999888888888888777777889999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          269 LVRRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       269 li~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                      +|.+||..||.+|||+.++|+||||+....
T Consensus       241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          241 LIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             HHHHHcccChhhCCCHHHHhcCccccCChh
Confidence            999999999999999999999999987543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-48  Score=370.81  Aligned_cols=265  Identities=37%  Similarity=0.640  Sum_probs=227.1

Q ss_pred             cccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           27 AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      ...++.++|.+.+.||+|+||.||+|.+..++..||+|++.....  ......+.+|+.++++++ ||||+++++++...
T Consensus        16 ~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~   92 (285)
T 3is5_A           16 FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDY   92 (285)
T ss_dssp             ESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECS
T ss_pred             CCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCC-CchHHhHHHheecC
Confidence            455677899999999999999999999999999999999976542  234678899999999995 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917          107 QFVHIVMELCAGGELFDRIVAR----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG  182 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg  182 (494)
                      ...++||||++|++|.+.+...    ..++...+..++.||+.||.|||++||+||||||+||+++..+..+.++|+|||
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg  172 (285)
T 3is5_A           93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG  172 (285)
T ss_dssp             SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence            9999999999999999988543    679999999999999999999999999999999999999755567889999999


Q ss_pred             CccccccCcccccccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          183 LSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      ++.............+++.|+|||++.+.++.++|||||||++|+|++|..||.+....+...........+... ...+
T Consensus       173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~  251 (285)
T 3is5_A          173 LAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPL  251 (285)
T ss_dssp             CCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCC
T ss_pred             cceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCcC
Confidence            998766555555677899999999998889999999999999999999999999998887777666554444332 2457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      ++.+.++|.+||..||.+|||+.++|+||||+.
T Consensus       252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            899999999999999999999999999999985

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.9e-48  Score=384.08  Aligned_cols=256  Identities=28%  Similarity=0.502  Sum_probs=223.0

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|..++.++.+||||+++++++.+....|+|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            68999999999999999999999999999999998766555445566888999999886799999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc-ccCc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~-~~~~  191 (494)
                      |||++||+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++++||+|||++... ....
T Consensus       132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~  208 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGD  208 (396)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTC
T ss_pred             EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeecccCCC
Confidence            9999999999999988899999999999999999999999999999999999999   68899999999999763 3344


Q ss_pred             ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHcCCccCCCCCCCC
Q 040917          192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAE---------TDQGVAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~~  261 (494)
                      .....+||+.|+|||++.+ .++.++|+|||||++|+|++|+.||...         ......+.+......++    ..
T Consensus       209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~  284 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RS  284 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC----TT
T ss_pred             ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC----Cc
Confidence            4556789999999999875 5899999999999999999999999643         22334555666554444    35


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH------HHHhcCCccCc
Q 040917          262 ISSSAIELVRRMLTQDPKRRITV------AQVLEHPWLKE  295 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~------~eil~~~~~~~  295 (494)
                      +++.+.++|.+||..||.+||++      .++++||||+.
T Consensus       285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence            88999999999999999999985      79999999985

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.4e-48  Score=379.76  Aligned_cols=258  Identities=26%  Similarity=0.455  Sum_probs=229.3

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++.+...........+..|..++..+.+||||+++++++.+....|+
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            37899999999999999999999999999999999764332233466788899999987569999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-C
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-G  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~  190 (494)
                      ||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++++||+|||++..... .
T Consensus        96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcccCC
Confidence            99999999999999988889999999999999999999999999999999999999   6788999999999975432 2


Q ss_pred             cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                      ......+||+.|+|||++.+ .++.++|+|||||++|+|++|..||.+.+..++...+......++    ..+++.+.++
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  248 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDL  248 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred             CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC----cccCHHHHHH
Confidence            33456789999999999875 589999999999999999999999999999888888877655443    3578999999


Q ss_pred             HHHhcccCCCCCCCHH-HHhcCCccCcc
Q 040917          270 VRRMLTQDPKRRITVA-QVLEHPWLKES  296 (494)
Q Consensus       270 i~~~l~~dp~~Rps~~-eil~~~~~~~~  296 (494)
                      |.+||..||.+||++. ++++||||+..
T Consensus       249 i~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          249 LVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             HHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHHhcCCHhHcCCChHHHHcCccccCC
Confidence            9999999999999998 99999999863

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-48  Score=382.42  Aligned_cols=266  Identities=33%  Similarity=0.610  Sum_probs=236.9

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ...+.++|++.+.||+|+||.||+|.+..+|+.||+|++....   ......+.+|+.+++.+. ||||+++++++.+..
T Consensus        46 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~  121 (387)
T 1kob_A           46 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKY  121 (387)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSS
T ss_pred             CCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCC
Confidence            3456789999999999999999999999999999999996532   234567889999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          108 FVHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      ..++||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++. +..+.+||+|||++..
T Consensus       122 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEeccccee
Confidence            9999999999999999887653 6899999999999999999999999999999999999953 2457899999999987


Q ss_pred             cccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          187 IEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ...........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+......+....+..+++.
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  280 (387)
T 1kob_A          201 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE  280 (387)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred             cCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence            765555556689999999999875 5899999999999999999999999999988888888888777777777889999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                      +.++|.+||..||.+|||+.++|+||||+....
T Consensus       281 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          281 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence            999999999999999999999999999997543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.1e-47  Score=375.67  Aligned_cols=256  Identities=28%  Similarity=0.498  Sum_probs=225.6

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+|..+++++.+||||+++++++.+....|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            68999999999999999999999999999999998776666666778899999999986699999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cCc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~~  191 (494)
                      |||++|++|..++.+.+.+++..+..++.||+.||.|||++||+||||||+||++   +.++++||+|||++.... ...
T Consensus        89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCBCSCCTTC
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccccccCCCC
Confidence            9999999999999888889999999999999999999999999999999999999   678999999999997532 333


Q ss_pred             ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHcCCccCCCCCCCC
Q 040917          192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAE---------TDQGVAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~~  261 (494)
                      .....+||+.|+|||++.+ .++.++|+|||||++|+|++|+.||...         ......+.+......++    ..
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~  241 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RS  241 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC----TT
T ss_pred             cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC----CC
Confidence            3456789999999999875 5899999999999999999999999752         33344555555544433    46


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCH------HHHhcCCccCc
Q 040917          262 ISSSAIELVRRMLTQDPKRRITV------AQVLEHPWLKE  295 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~------~eil~~~~~~~  295 (494)
                      ++..+.++|.+||..||.+||++      .++++||||+.
T Consensus       242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence            88999999999999999999995      89999999985

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.4e-48  Score=375.27  Aligned_cols=271  Identities=34%  Similarity=0.661  Sum_probs=214.9

Q ss_pred             cccceEee---eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           31 VQLHYTIG---REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        31 ~~~~y~i~---~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      +..+|.+.   +.||+|+||.||+|.+..+++.||+|++...      ....+.+|+.+++.+.+||||+++++++.+..
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~   79 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL   79 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence            34567775   7899999999999999999999999998642      35677899999999977999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      ..|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++....++|+|||++...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~  159 (325)
T 3kn6_A           80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK  159 (325)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred             EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence            99999999999999999999888999999999999999999999999999999999999975444558999999999765


Q ss_pred             ccC-cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHcCCccCCCCC
Q 040917          188 EEG-KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD-------QGVAQAILKGEINFQRDP  258 (494)
Q Consensus       188 ~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~-------~~~~~~~~~~~~~~~~~~  258 (494)
                      ... .......+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+...       .+....+..+...+....
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (325)
T 3kn6_A          160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA  239 (325)
T ss_dssp             CC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred             CCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence            433 22345678999999999865 589999999999999999999999976443       456677777766666555


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCCcHH
Q 040917          259 FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTA  307 (494)
Q Consensus       259 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~~~~  307 (494)
                      +..+++.+.++|.+||..||.+|||+.++++||||+.....+..+....
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~~~~~~  288 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTP  288 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCSCCSHH
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCCCCCCC
Confidence            5678999999999999999999999999999999998776666665443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-48  Score=372.79  Aligned_cols=253  Identities=31%  Similarity=0.587  Sum_probs=227.8

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++.+....|+|
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEEE
Confidence            6899999999999999999999999999999999764432333466788999999999 599999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      |||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++++||+|||++.....  .
T Consensus        85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~--~  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPD--V  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSS--C
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCC--c
Confidence            9999999999999988889999999999999999999999999999999999999   6789999999999986543  2


Q ss_pred             cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917          193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR  271 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  271 (494)
                      ....+||+.|+|||++.+ .++.++|+|||||++|+|++|..||.+.........+......++    +.+++.+.++|.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~  235 (318)
T 1fot_A          160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS  235 (318)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred             cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHH
Confidence            345679999999999875 589999999999999999999999999998888888887765544    467899999999


Q ss_pred             HhcccCCCCCC-----CHHHHhcCCccCc
Q 040917          272 RMLTQDPKRRI-----TVAQVLEHPWLKE  295 (494)
Q Consensus       272 ~~l~~dp~~Rp-----s~~eil~~~~~~~  295 (494)
                      +||..||.+||     +++++++||||+.
T Consensus       236 ~lL~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          236 RLITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             HHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence            99999999999     9999999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.8e-48  Score=377.19  Aligned_cols=265  Identities=35%  Similarity=0.629  Sum_probs=230.3

Q ss_pred             cccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           27 AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      ....+.++|++.+.||+|+||.||+|.++.+|+.||+|++.+...       ...+|+.++.++.+||||+++++++.+.
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~   88 (342)
T 2qr7_A           16 NSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDG   88 (342)
T ss_dssp             ---CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred             cccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence            445677899999999999999999999999999999999975432       1346888898886799999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC-CCCCeEEEeecCCcc
Q 040917          107 QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG-DENAVVKATDFGLSA  185 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~-~~~~~~kL~Dfg~a~  185 (494)
                      ...|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++... +..+.+||+|||++.
T Consensus        89 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           89 KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            9999999999999999999888889999999999999999999999999999999999998532 223569999999998


Q ss_pred             ccccC-cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCC---CChHHHHHHHHcCCccCCCCCCC
Q 040917          186 FIEEG-KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKGEINFQRDPFP  260 (494)
Q Consensus       186 ~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~---~~~~~~~~~~~~~~~~~~~~~~~  260 (494)
                      ..... ......++|+.|+|||++.+ .++.++|||||||++|+|++|..||.+   ....++...+..+...+....++
T Consensus       169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  248 (342)
T 2qr7_A          169 QLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN  248 (342)
T ss_dssp             ECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred             cCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence            65433 23345678999999999875 488999999999999999999999976   45667788888888877777778


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                      .+++.+.++|.+||..||.+|||+.++++||||.....
T Consensus       249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  286 (342)
T 2qr7_A          249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ  286 (342)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence            89999999999999999999999999999999976443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.2e-47  Score=368.10  Aligned_cols=261  Identities=30%  Similarity=0.492  Sum_probs=225.2

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ......+|++.+.||+|+||+||+|.+..+++.||+|++.....   ...+.+.+|+.+++.+. ||||+++++++...+
T Consensus        15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   90 (297)
T 3fxz_A           15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGD   90 (297)
T ss_dssp             SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred             cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCC-CCCCCeEeEEEEECC
Confidence            34566899999999999999999999999999999999865432   23567889999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      ..++||||++|++|.+++... .+++..+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++...
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~  166 (297)
T 3fxz_A           91 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQI  166 (297)
T ss_dssp             EEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred             EEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceec
Confidence            999999999999999998765 68999999999999999999999999999999999999   67889999999998765


Q ss_pred             ccCc-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          188 EEGK-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       188 ~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      .... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+........ .....+++.
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  245 (297)
T 3fxz_A          167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSAI  245 (297)
T ss_dssp             CSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SCGGGSCHH
T ss_pred             CCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-CCccccCHH
Confidence            4332 2344678999999999864 589999999999999999999999998887766655544332211 122468899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      +.++|.+||..||.+|||+.++|+||||+...
T Consensus       246 ~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          246 FRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence            99999999999999999999999999999644

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.6e-48  Score=378.92  Aligned_cols=257  Identities=27%  Similarity=0.489  Sum_probs=229.5

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++++.||+|+||.||+|.++.+++.||+|++.+...........+..|..++..+.+||+|+++++++...+..|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            37899999999999999999999999999999999765433333567788899999988679999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cC
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EG  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~  190 (494)
                      ||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++++||+|||++.... ..
T Consensus        99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCcccccccCC
Confidence            99999999999999988889999999999999999999999999999999999999   678999999999997632 23


Q ss_pred             cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                      ......+||+.|+|||++.+ .++.++|+|||||++|+|++|+.||.+.+..++...+......++    ..+++.+.++
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  251 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAI  251 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred             cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence            33456789999999999864 689999999999999999999999999999888888888766544    3689999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHhcCCccCc
Q 040917          270 VRRMLTQDPKRRIT-----VAQVLEHPWLKE  295 (494)
Q Consensus       270 i~~~l~~dp~~Rps-----~~eil~~~~~~~  295 (494)
                      |.+||..||.+||+     ++++++||||+.
T Consensus       252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            99999999999994     699999999985

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.1e-49  Score=383.08  Aligned_cols=257  Identities=35%  Similarity=0.596  Sum_probs=221.8

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++ ||||+++++++......+
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~   85 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPTDIV   85 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEE
Confidence            4578999999999999999999999999999999997543322333467889999999995 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +||||+ +|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.....+
T Consensus        86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTTTTS
T ss_pred             EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceeccCC
Confidence            999999 67999999888899999999999999999999999999999999999999   67889999999999877666


Q ss_pred             cccccccCCcCccChhhhccc-C-CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917          191 KAYREIVGSPYYIAPEVLSQS-Y-GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE  268 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  268 (494)
                      ......+||+.|+|||++.+. + ++++|||||||++|+|++|..||.+.........+....    ......+++.+.+
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~----~~~p~~~s~~~~~  237 (336)
T 3h4j_B          162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV----YVMPDFLSPGAQS  237 (336)
T ss_dssp             BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSC----CCCCTTSCHHHHH
T ss_pred             cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC----CCCcccCCHHHHH
Confidence            666677899999999998764 3 789999999999999999999997765443322222211    1122457899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          269 LVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       269 li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      +|.+||..||.+|||+.++++||||+..
T Consensus       238 li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          238 LIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            9999999999999999999999999853

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=379.15  Aligned_cols=257  Identities=26%  Similarity=0.526  Sum_probs=226.6

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+....|
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~   91 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEEDMF   91 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEE
Confidence            347899999999999999999999999999999999765433344567888999999999 5999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +||||++||+|..++.....+++..+..++.||+.||.|||++||+||||||+||++   +.+++++|+|||++......
T Consensus        92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeeccCC
Confidence            999999999999999988889999999999999999999999999999999999999   68899999999999877666


Q ss_pred             cccccccCCcCccChhhhcc----cCCCcchhHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHcCCccCCCCCCCCCC
Q 040917          191 KAYREIVGSPYYIAPEVLSQ----SYGKEADIWSAGVILYILLCGVPPFWAET---DQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      ......+||+.|+|||++.+    .++.++|||||||++|+|++|..||....   .......+......++    ..++
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~~~s  244 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWS  244 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----TTSC
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----CcCC
Confidence            66667889999999999853    48999999999999999999999997543   3444555555444333    4678


Q ss_pred             HHHHHHHHHhcccCCCCCCC-HHHHhcCCccCc
Q 040917          264 SSAIELVRRMLTQDPKRRIT-VAQVLEHPWLKE  295 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps-~~eil~~~~~~~  295 (494)
                      +.+.++|.+||..||.+||+ ++++++||||..
T Consensus       245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence            99999999999999999998 899999999986

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.2e-47  Score=376.05  Aligned_cols=255  Identities=29%  Similarity=0.549  Sum_probs=229.8

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++.+....|
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~  117 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEE
Confidence            447899999999999999999999999999999999765433333567788999999999 5999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +||||++|++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+||++   +.+++++|+|||++......
T Consensus       118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceeccCC
Confidence            999999999999999988889999999999999999999999999999999999999   67889999999999865432


Q ss_pred             cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                        ....+||+.|+|||++.+ .++.++|+|||||++|+|++|..||.+....+....+..+...++    ..+++.+.++
T Consensus       195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l  268 (350)
T 1rdq_E          195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDL  268 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHH
T ss_pred             --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Confidence              345679999999999865 589999999999999999999999999998888888888765544    4689999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHhcCCccCc
Q 040917          270 VRRMLTQDPKRRIT-----VAQVLEHPWLKE  295 (494)
Q Consensus       270 i~~~l~~dp~~Rps-----~~eil~~~~~~~  295 (494)
                      |.+||..||.+||+     ++++++||||..
T Consensus       269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            99999999999998     999999999985

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.5e-47  Score=371.88  Aligned_cols=264  Identities=38%  Similarity=0.713  Sum_probs=233.8

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCCh---hhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD---VEKDDVRREIEIMRHLSGQPNIVQFKAAYED  105 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~  105 (494)
                      ..+.++|++++.||+|+||.||+|.+..+|+.||+|++........   .....+.+|+.+++++. ||||+++++++..
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~   86 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYEN   86 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEec
Confidence            4466899999999999999999999999999999999976543221   24678999999999995 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC----eEEEeec
Q 040917          106 DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA----VVKATDF  181 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~----~~kL~Df  181 (494)
                      ....++||||++|++|.+++.....++...+..++.||+.||.|||++||+||||||+||+++   .++    .++|+||
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~---~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLIDF  163 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEECCC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe---cCCCCcCCEEEccC
Confidence            999999999999999999998888899999999999999999999999999999999999994   444    8999999


Q ss_pred             CCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 040917          182 GLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP  260 (494)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (494)
                      |++.............||+.|+|||++.+ .++.++|+|||||++|+|++|..||.+....+....+......++...+.
T Consensus       164 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  243 (321)
T 2a2a_A          164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS  243 (321)
T ss_dssp             TTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             ccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence            99987665555556779999999999874 58999999999999999999999999999888888887766555544445


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      .+++.+.++|.+||..||.+|||+.++++||||+..
T Consensus       244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence            789999999999999999999999999999999853

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.3e-47  Score=371.40  Aligned_cols=266  Identities=33%  Similarity=0.575  Sum_probs=220.6

Q ss_pred             cccccceEee-eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           29 EDVQLHYTIG-REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        29 ~~~~~~y~i~-~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ..+.++|++. +.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.++.++.+||||+++++++...+
T Consensus         8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~   84 (316)
T 2ac3_A            8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED   84 (316)
T ss_dssp             CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            3466889995 78999999999999999999999999997543   2346778999999999657999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      ..++||||++|++|.+++.....++...+..++.||+.||.|||++||+||||||+||+++.++....+||+|||++...
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            99999999999999999988888999999999999999999999999999999999999964333455999999998754


Q ss_pred             ccCc--------ccccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCCh-------------
Q 040917          188 EEGK--------AYREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETD-------------  240 (494)
Q Consensus       188 ~~~~--------~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~-------------  240 (494)
                      ....        ......||+.|+|||++.      ..++.++|||||||++|+|++|..||.+...             
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            3211        122346899999999985      3488999999999999999999999977642             


Q ss_pred             --HHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          241 --QGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       241 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                        ......+..+...++...+..+++.+.++|.+||..||.+|||+.++|+||||+...
T Consensus       245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence              335556666655555444457899999999999999999999999999999999753

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.6e-48  Score=367.88  Aligned_cols=268  Identities=37%  Similarity=0.697  Sum_probs=239.0

Q ss_pred             cccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           27 AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      ..+.+.++|++++.||+|++|.||+|.+..+++.||+|++...... ......+.+|+.+++++ +||||+++++++...
T Consensus        16 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   93 (287)
T 2wei_A           16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKL-DHPNIMKLFEILEDS   93 (287)
T ss_dssp             HTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS
T ss_pred             HHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCC
Confidence            3556678999999999999999999999999999999999754432 23567889999999999 599999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          107 QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      ...++|||++++++|.+.+.....++...+..++.||+.||.|||++|++||||||+||+++..+..+.++|+|||++..
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A           94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            99999999999999999998888899999999999999999999999999999999999997544566899999999987


Q ss_pred             cccCcccccccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917          187 IEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (494)
                      ...........+++.|+|||++.+.++.++|+||||+++|+|++|..||.+....+....+..+...+..+.+..+++.+
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (287)
T 2wei_A          174 FQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA  253 (287)
T ss_dssp             BCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred             ecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHH
Confidence            65544445566889999999998889999999999999999999999999999888888888877666655567889999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          267 IELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      .++|.+||..||.+|||+.++|+||||+..
T Consensus       254 ~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          254 KDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            999999999999999999999999999864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.1e-48  Score=385.94  Aligned_cols=261  Identities=31%  Similarity=0.510  Sum_probs=227.6

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ..++|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+....|
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~  145 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLY  145 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEE
Confidence            347899999999999999999999999999999999753322222334578899999999 5999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||++   +.++++||+|||++......
T Consensus       146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeeccC
Confidence            99999999999998876 469999999999999999999999999999999999999   68899999999999765443


Q ss_pred             cc--cccccCCcCccChhhhccc-----CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917          191 KA--YREIVGSPYYIAPEVLSQS-----YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       191 ~~--~~~~~~~~~y~aPE~~~~~-----~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      ..  ....+||+.|+|||++.+.     ++.++|||||||++|+|++|+.||.+.+..+....+.+.......+....++
T Consensus       222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s  301 (410)
T 3v8s_A          222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS  301 (410)
T ss_dssp             SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred             CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence            32  2357899999999998642     7889999999999999999999999999988888887765444444446789


Q ss_pred             HHHHHHHHHhcccCCCC--CCCHHHHhcCCccCcc
Q 040917          264 SSAIELVRRMLTQDPKR--RITVAQVLEHPWLKES  296 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~~  296 (494)
                      +.+.+||.+||..+|.+  ||++++|++||||+..
T Consensus       302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            99999999999999988  9999999999999863

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.4e-47  Score=373.06  Aligned_cols=275  Identities=29%  Similarity=0.557  Sum_probs=237.9

Q ss_pred             hhhcccccccccceEee-eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEe
Q 040917           22 AILGKAYEDVQLHYTIG-REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK  100 (494)
Q Consensus        22 ~~~~~~~~~~~~~y~i~-~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~  100 (494)
                      ....+..+++.++|.+. +.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.+.+||||++++
T Consensus        17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~   95 (327)
T 3lm5_A           17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLH   95 (327)
T ss_dssp             CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            34445667788999998 899999999999999999999999999976543 2334678899999999998789999999


Q ss_pred             EEEEeCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEE
Q 040917          101 AAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKA  178 (494)
Q Consensus       101 ~~~~~~~~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL  178 (494)
                      +++......++||||++|++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.....+.++|
T Consensus        96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL  175 (327)
T 3lm5_A           96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKI  175 (327)
T ss_dssp             EEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEE
T ss_pred             EEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEE
Confidence            9999999999999999999999988543  56999999999999999999999999999999999999954334789999


Q ss_pred             eecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCC
Q 040917          179 TDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD  257 (494)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  257 (494)
                      +|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+......+...
T Consensus       176 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  255 (327)
T 3lm5_A          176 VDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE  255 (327)
T ss_dssp             CCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             eeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch
Confidence            99999987765555556789999999999874 58999999999999999999999999999888888888877777777


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       258 ~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      .+..+++.+.++|.+||..||.+|||++++|+||||+...
T Consensus       256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          256 TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence            7788999999999999999999999999999999998643

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.6e-47  Score=362.81  Aligned_cols=259  Identities=25%  Similarity=0.445  Sum_probs=215.5

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++++.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.++++++ ||||+++++++.++...++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEEEEE
Confidence            589999999999999999999999999999999976543 3335677889999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-
Q 040917          113 MELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-  190 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-  190 (494)
                      |||++| +|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...... 
T Consensus        80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCC
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCcc
Confidence            999976 56555544 5689999999999999999999999999999999999999   67889999999999765432 


Q ss_pred             cccccccCCcCccChhhhcc-c-CCCcchhHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHcCCccCCC-----------
Q 040917          191 KAYREIVGSPYYIAPEVLSQ-S-YGKEADIWSAGVILYILLCGVPP-FWAETDQGVAQAILKGEINFQR-----------  256 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~-~-~~~~~Di~slG~il~~l~tg~~p-f~~~~~~~~~~~~~~~~~~~~~-----------  256 (494)
                      .......+|+.|+|||++.+ . ++.++|||||||++|+|++|..| |.+....+....+.+.......           
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            22344678999999999864 3 79999999999999999988877 5555555555555331111110           


Q ss_pred             --------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          257 --------------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       257 --------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                                    ...+.+++.+.+||.+||..||.+|||++++|+||||++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                          11235789999999999999999999999999999999743

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=9.9e-47  Score=362.13  Aligned_cols=267  Identities=34%  Similarity=0.667  Sum_probs=236.1

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC------hhhHHHHHHHHHHHHHccCCCCccEEeE
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK------DVEKDDVRREIEIMRHLSGQPNIVQFKA  101 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~------~~~~~~~~~E~~~l~~l~~hp~i~~~~~  101 (494)
                      ...+.++|++.+.||+|++|.||+|.+..+|+.||+|++.......      ......+.+|+.+++++.+||||+++++
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~   91 (298)
T 1phk_A           12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD   91 (298)
T ss_dssp             ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence            4456789999999999999999999999999999999997543211      1235667899999999977999999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeec
Q 040917          102 AYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDF  181 (494)
Q Consensus       102 ~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Df  181 (494)
                      ++......++||||+++++|.+++.....++...+..++.||+.||.|||++|++||||+|+||++   +.++.++|+||
T Consensus        92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~df  168 (298)
T 1phk_A           92 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDF  168 (298)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCC
T ss_pred             eeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEecc
Confidence            999999999999999999999999888889999999999999999999999999999999999999   67889999999


Q ss_pred             CCccccccCcccccccCCcCccChhhhc-------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccC
Q 040917          182 GLSAFIEEGKAYREIVGSPYYIAPEVLS-------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF  254 (494)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  254 (494)
                      |.+.............+++.|+|||++.       ..++.++||||||+++|+|++|..||...........+..+...+
T Consensus       169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  248 (298)
T 1phk_A          169 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF  248 (298)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             cchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence            9998766555555677899999999874       247889999999999999999999999998888888888877776


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          255 QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       255 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ....+..++..+.++|.+||..||.+|||+.++|+||||+...
T Consensus       249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence            6666677899999999999999999999999999999999643

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.9e-48  Score=369.13  Aligned_cols=247  Identities=21%  Similarity=0.263  Sum_probs=191.0

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC----
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ----  107 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~----  107 (494)
                      ..+|.+.+.||+|+||+||+|.+  +|+.||||++....    ......+.|+..+.+++ ||||+++++++..++    
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCCce
Confidence            46799999999999999999997  48999999986432    12223345666667784 999999999997543    


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCceEEeeCCCCCeEEEe
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK--------GVMHRDLKPENFLFTTGDENAVVKAT  179 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~i~H~dikp~NIli~~~~~~~~~kL~  179 (494)
                      .+|||||||+||+|.+++... .+++..+..++.|++.||.|||++        +|+||||||+|||+   +.++.+||+
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~  150 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA  150 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEEC
T ss_pred             EEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEE
Confidence            689999999999999999764 689999999999999999999987        99999999999999   688999999


Q ss_pred             ecCCccccccCcc-----cccccCCcCccChhhhcc-------cCCCcchhHHHHHHHHHHHhCCCCCCCC---------
Q 040917          180 DFGLSAFIEEGKA-----YREIVGSPYYIAPEVLSQ-------SYGKEADIWSAGVILYILLCGVPPFWAE---------  238 (494)
Q Consensus       180 Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~-------~~~~~~Di~slG~il~~l~tg~~pf~~~---------  238 (494)
                      |||+|........     ....+||+.|+|||++.+       .++.++|||||||++|||+||..||...         
T Consensus       151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~  230 (303)
T 3hmm_A          151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence            9999986543322     224579999999999864       3677999999999999999997665321         


Q ss_pred             ------ChHHHHHHHHcCCccCCCCC-C--CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          239 ------TDQGVAQAILKGEINFQRDP-F--PSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       239 ------~~~~~~~~~~~~~~~~~~~~-~--~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                            ..+.+...+......+..+. +  ...+..+.+++.+||..||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                  12233333333322211110 0  112356889999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2e-47  Score=377.20  Aligned_cols=264  Identities=36%  Similarity=0.711  Sum_probs=233.8

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC-----hhhHHHHHHHHHHHHHccCCCCccEEeEEE
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK-----DVEKDDVRREIEIMRHLSGQPNIVQFKAAY  103 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~  103 (494)
                      ..+.++|++.+.||+|++|.||+|.+..+|+.||||++.......     ......+.+|+.+++++.+||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            445578999999999999999999999999999999986543211     122456788999999996699999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCC
Q 040917          104 EDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL  183 (494)
Q Consensus       104 ~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~  183 (494)
                      ......++||||++|++|.+++.....++...+..++.||+.||.|||+.||+||||||+||++   +.++.++|+|||+
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~  246 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGF  246 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCc
Confidence            9999999999999999999999888889999999999999999999999999999999999999   6788999999999


Q ss_pred             ccccccCcccccccCCcCccChhhhcc-------cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC
Q 040917          184 SAFIEEGKAYREIVGSPYYIAPEVLSQ-------SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR  256 (494)
Q Consensus       184 a~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  256 (494)
                      +.............||+.|+|||++.+       .++.++|||||||++|+|++|..||...........+..+...+..
T Consensus       247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  326 (365)
T 2y7j_A          247 SCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS  326 (365)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred             ccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            987766555566789999999998853       4788999999999999999999999998888888888777666655


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          257 DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       257 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      +.+..++..+.++|.+||..||.+|||+.++|+||||+.
T Consensus       327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            555678999999999999999999999999999999973

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7e-47  Score=364.98  Aligned_cols=265  Identities=26%  Similarity=0.397  Sum_probs=217.2

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCC--ChhhHHHHHHHHHHHHHcc--CCCCccEEeEEEE
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV--KDVEKDDVRREIEIMRHLS--GQPNIVQFKAAYE  104 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~--~~~~~~~~~~E~~~l~~l~--~hp~i~~~~~~~~  104 (494)
                      ..+.++|++++.||+|+||+||+|.+..+++.||+|++......  .......+.+|+.++++++  +||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            34568999999999999999999999999999999998643321  1112345677888877774  4999999999997


Q ss_pred             eCC-----eEEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEE
Q 040917          105 DDQ-----FVHIVMELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVK  177 (494)
Q Consensus       105 ~~~-----~~~iv~e~~~g~sL~~~~~~~~~--l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~k  177 (494)
                      ...     ..++|||++. ++|.+++.....  +++..+..++.||+.||.|||++||+||||||+||++   +.++.+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~k  160 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVK  160 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCEE
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEE
Confidence            654     5899999997 499999987654  8999999999999999999999999999999999999   6788999


Q ss_pred             EeecCCccccccCcccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC
Q 040917          178 ATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR  256 (494)
Q Consensus       178 L~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  256 (494)
                      |+|||++.............+|+.|+|||++. ..++.++|||||||++|+|++|+.||.+....+....+.......+.
T Consensus       161 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (308)
T 3g33_A          161 LADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  240 (308)
T ss_dssp             ECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             EeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            99999998766555556678999999999985 46899999999999999999999999999888777766542221111


Q ss_pred             CC-----------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          257 DP-----------------------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       257 ~~-----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ..                       .+.+++.+.++|.+||..||.+|||+.++|+||||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            11                       245789999999999999999999999999999999743

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-47  Score=377.30  Aligned_cols=307  Identities=22%  Similarity=0.380  Sum_probs=232.9

Q ss_pred             hhhhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEe
Q 040917           21 DAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK  100 (494)
Q Consensus        21 ~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~  100 (494)
                      ...+......+..+|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++ ||||++++
T Consensus        13 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~   90 (367)
T 1cm8_A           13 RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLL   90 (367)
T ss_dssp             CEECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCS
T ss_pred             EEEecCceeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CcCCCCce
Confidence            34455566778899999999999999999999999999999999996533 34445677899999999995 99999999


Q ss_pred             EEEEeC------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917          101 AAYEDD------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA  174 (494)
Q Consensus       101 ~~~~~~------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~  174 (494)
                      +++...      ..+|+||||+ |++|.+++.. ..++...+..++.||+.||.|||++||+||||||+||++   +.++
T Consensus        91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~  165 (367)
T 1cm8_A           91 DVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDC  165 (367)
T ss_dssp             EEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTC
T ss_pred             eeEecCCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCC
Confidence            999765      3469999999 7899998876 579999999999999999999999999999999999999   6788


Q ss_pred             eEEEeecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc
Q 040917          175 VVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI  252 (494)
Q Consensus       175 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  252 (494)
                      .+||+|||++.....  ......+|+.|+|||++.+  .++.++||||+||++|+|++|+.||.+....+....+.....
T Consensus       166 ~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g  243 (367)
T 1cm8_A          166 ELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG  243 (367)
T ss_dssp             CEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             CEEEEeeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999999999986543  2345678999999999865  589999999999999999999999998887766655533111


Q ss_pred             c-----------------------CC----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCCc
Q 040917          253 N-----------------------FQ----RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPID  305 (494)
Q Consensus       253 ~-----------------------~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~~  305 (494)
                      .                       ..    ...++.+++.+.+||.+||..||.+|||+.++|+||||+....+...+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~  323 (367)
T 1cm8_A          244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQV  323 (367)
T ss_dssp             CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CC
T ss_pred             CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCC
Confidence            0                       00    11235678999999999999999999999999999999976544333222


Q ss_pred             HHHHHHHH-HHhhhhHHHHHHHHhhhccCchh
Q 040917          306 TAVIFRMK-QFTAMNKLKKLALKVIVENLPTE  336 (494)
Q Consensus       306 ~~~~~~~~-~~~~~~~~~~l~~~~~~~~~~~~  336 (494)
                      ........ .......|+++...++...-+..
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (367)
T 1cm8_A          324 QKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPR  355 (367)
T ss_dssp             CCCCCC-----CCHHHHHHHHHHHHHTCCC--
T ss_pred             CCCCCChhhhcCCHHHHHHHHHHHHHHhcccc
Confidence            11000000 12334566666666666544433

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.3e-47  Score=379.88  Aligned_cols=268  Identities=35%  Similarity=0.658  Sum_probs=220.1

Q ss_pred             cccccceEee-eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--
Q 040917           29 EDVQLHYTIG-REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--  105 (494)
Q Consensus        29 ~~~~~~y~i~-~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--  105 (494)
                      ..+.++|.+. +.||+|+||.||+|.+..+|+.||+|++..        ...+.+|+.++.++.+||||+++++++..  
T Consensus        57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--------chhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            3456778887 789999999999999999999999999852        23467889888766679999999999875  


Q ss_pred             --CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeec
Q 040917          106 --DQFVHIVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDF  181 (494)
Q Consensus       106 --~~~~~iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Df  181 (494)
                        ...+|+||||++||+|.+++...+  .+++..+..++.||+.||.|||++||+||||||+||+++..+.++.+||+||
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence              567899999999999999997653  5999999999999999999999999999999999999964444789999999


Q ss_pred             CCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHcCCccCCC
Q 040917          182 GLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ----GVAQAILKGEINFQR  256 (494)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~----~~~~~~~~~~~~~~~  256 (494)
                      |++............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....    .....+..+...++.
T Consensus       209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~  288 (400)
T 1nxk_A          209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  288 (400)
T ss_dssp             TTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred             ccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence            99987655555556788999999999864 6899999999999999999999999766532    245556667666666


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCC
Q 040917          257 DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPI  304 (494)
Q Consensus       257 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~  304 (494)
                      ..+..+++.+.+||.+||..||.+|||+.++++||||.........+.
T Consensus       289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~  336 (400)
T 1nxk_A          289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL  336 (400)
T ss_dssp             TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSCCCBC
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCCCCcc
Confidence            667789999999999999999999999999999999987554444433

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.4e-47  Score=387.14  Aligned_cols=258  Identities=37%  Similarity=0.641  Sum_probs=231.2

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ..++|.+++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+. ||||+++++++......+
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~   92 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSDIF   92 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence            4578999999999999999999999999999999997544323334667899999999995 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++......
T Consensus        93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEECCTT
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhhcccc
Confidence            999999999999999888889999999999999999999999999999999999999   67889999999999877665


Q ss_pred             cccccccCCcCccChhhhccc--CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917          191 KAYREIVGSPYYIAPEVLSQS--YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE  268 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  268 (494)
                      ......+||+.|+|||++.+.  .+.++|||||||++|+|++|..||.+.........+..+....+    ..+++.+.+
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  245 (476)
T 2y94_A          170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLNPSVIS  245 (476)
T ss_dssp             CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCCHHHHH
T ss_pred             ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCCHHHHH
Confidence            555677899999999999764  36899999999999999999999999888888888877654432    357899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          269 LVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       269 li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      +|.+||..||.+|||+.++++||||+..
T Consensus       246 Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          246 LLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            9999999999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=6.3e-47  Score=365.60  Aligned_cols=264  Identities=26%  Similarity=0.464  Sum_probs=217.6

Q ss_pred             cccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           27 AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      ..+.+.++|++++.||+|+||+||+|.+. +|+.||+|++..... .......+.+|+.+++++. ||||+++++++.+.
T Consensus        15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~   91 (311)
T 3niz_A           15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELH-HPNIVSLIDVIHSE   91 (311)
T ss_dssp             CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCC-CTTBCCEEEEECCS
T ss_pred             eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcC-CCCEeeeeeEEccC
Confidence            45678899999999999999999999985 599999999965432 2334577889999999995 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          107 QFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      ...++||||++| +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.
T Consensus        92 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           92 RCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLAR  167 (311)
T ss_dssp             SCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred             CEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCce
Confidence            999999999975 888877654 459999999999999999999999999999999999999   678899999999998


Q ss_pred             ccccC-cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCC-----
Q 040917          186 FIEEG-KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD-----  257 (494)
Q Consensus       186 ~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-----  257 (494)
                      ..... .......+|+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+........+.     
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV  247 (311)
T ss_dssp             ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred             ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence            65432 22344578999999999864  48999999999999999999999998887766655553311111110     


Q ss_pred             ---------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          258 ---------------------PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       258 ---------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                                           ..+.+++.+.+||.+||..||.+|||+.++|+||||++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                                 1234678999999999999999999999999999999743

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.2e-46  Score=362.61  Aligned_cols=264  Identities=38%  Similarity=0.714  Sum_probs=232.7

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||+|++.....   .....+.+|+.+++++. ||||+++++++.....
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   80 (304)
T 2jam_A            5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIK-HENIVTLEDIYESTTH   80 (304)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred             cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCC-CCCeeehhhhcccCCE
Confidence            4567899999999999999999999999999999999975432   23456889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      .++||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++...+..+.++|+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            99999999999999999888889999999999999999999999999999999999999654567899999999987543


Q ss_pred             cCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          189 EGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      .. ......+++.|+|||++.+ .++.++|||||||++|+|++|..||...........+..+...++...+..+++.+.
T Consensus       161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  239 (304)
T 2jam_A          161 NG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK  239 (304)
T ss_dssp             CB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred             CC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence            32 2344578999999999865 588999999999999999999999999998888888888777766666678999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          268 ELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ++|.+||..||.+|||+.++|+||||....
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          240 DFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            999999999999999999999999998644

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-47  Score=379.19  Aligned_cols=266  Identities=29%  Similarity=0.473  Sum_probs=213.1

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ..++.++|++++.||+|+||.||+|.+..+|+.||+|++... .........+.+|+.+++++.+||||+++++++...+
T Consensus         4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~   82 (388)
T 3oz6_A            4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN   82 (388)
T ss_dssp             CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred             cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence            345678999999999999999999999999999999998643 3344566778899999999977999999999997544


Q ss_pred             --eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          108 --FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       108 --~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                        .+|+||||++ ++|..++.. ..++...+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.
T Consensus        83 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           83 DRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSR  157 (388)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred             CCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCcccc
Confidence              7899999997 489888876 479999999999999999999999999999999999999   678899999999997


Q ss_pred             cccc----------------------CcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 040917          186 FIEE----------------------GKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQ  241 (494)
Q Consensus       186 ~~~~----------------------~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~  241 (494)
                      ....                      .......+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            5432                      112234679999999999864  5899999999999999999999999998887


Q ss_pred             HHHHHHHcCCccCC------------------------------C-------------CCCCCCCHHHHHHHHHhcccCC
Q 040917          242 GVAQAILKGEINFQ------------------------------R-------------DPFPSISSSAIELVRRMLTQDP  278 (494)
Q Consensus       242 ~~~~~~~~~~~~~~------------------------------~-------------~~~~~~~~~l~~li~~~l~~dp  278 (494)
                      +....+......+.                              .             .+...+++.+.+||.+||..||
T Consensus       238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence            77666542111000                              0             0123678999999999999999


Q ss_pred             CCCCCHHHHhcCCccCccCcC
Q 040917          279 KRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       279 ~~Rps~~eil~~~~~~~~~~~  299 (494)
                      .+|||+.++|+||||+....+
T Consensus       318 ~~R~t~~e~l~Hp~~~~~~~~  338 (388)
T 3oz6_A          318 NKRISANDALKHPFVSIFHNP  338 (388)
T ss_dssp             GGSCCHHHHTTSTTTTTTCCG
T ss_pred             ccCCCHHHHhCCHHHHHhcCC
Confidence            999999999999999865433

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.3e-47  Score=373.44  Aligned_cols=257  Identities=26%  Similarity=0.515  Sum_probs=219.0

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHH-HHccCCCCccEEeEEEEeCCeE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM-RHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l-~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      ..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+..|..++ +.+ +||||+++++++.+.+..
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~~~~  114 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKL  114 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECSSEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeCCEE
Confidence            347899999999999999999999999999999999876654444556667777764 556 599999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-  188 (494)
                      |+||||++||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+||++   +.++++||+|||++.... 
T Consensus       115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGBC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCcccccccc
Confidence            9999999999999999988889999999999999999999999999999999999999   678999999999997532 


Q ss_pred             cCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          189 EGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      ........+||+.|+|||++.+ .++.++|+|||||++|+|++|..||.+.+..+....+......++    +.++..+.
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~  267 (373)
T 2r5t_A          192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSAR  267 (373)
T ss_dssp             CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCHHHH
T ss_pred             CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHH
Confidence            2333456789999999999875 589999999999999999999999999998888888887755443    46889999


Q ss_pred             HHHHHhcccCCCCCCCH----HHHhcCCccCc
Q 040917          268 ELVRRMLTQDPKRRITV----AQVLEHPWLKE  295 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~----~eil~~~~~~~  295 (494)
                      ++|.+||..||.+||++    .++++||||+.
T Consensus       268 ~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          268 HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             HHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             HHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence            99999999999999987    69999999985

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.2e-47  Score=383.55  Aligned_cols=262  Identities=28%  Similarity=0.485  Sum_probs=226.1

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ..++|++++.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+....|
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~  150 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNLY  150 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEEE
Confidence            457899999999999999999999999999999999753322222334478899999999 5999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          111 IVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      +||||++||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++++||+|||++.....
T Consensus       151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~  227 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLME  227 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred             EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhccc
Confidence            99999999999999987 4679999999999999999999999999999999999999   6889999999999976543


Q ss_pred             Ccc--cccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC-CCCCC
Q 040917          190 GKA--YREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ-RDPFP  260 (494)
Q Consensus       190 ~~~--~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~  260 (494)
                      ...  ....+||+.|+|||++.      +.++.++|||||||++|+|++|+.||.+.+..+....+......+. +..+.
T Consensus       228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  307 (437)
T 4aw2_A          228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT  307 (437)
T ss_dssp             TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred             CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence            322  23467999999999985      3589999999999999999999999999998888888866433222 22235


Q ss_pred             CCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCccCcc
Q 040917          261 SISSSAIELVRRMLTQDPKR--RITVAQVLEHPWLKES  296 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~--Rps~~eil~~~~~~~~  296 (494)
                      .+++.+.+||.+||..+|.+  ||+++++++||||+..
T Consensus       308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence            68999999999999998888  9999999999999863

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.6e-47  Score=373.71  Aligned_cols=261  Identities=33%  Similarity=0.606  Sum_probs=226.1

Q ss_pred             ccccceEe--eeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           30 DVQLHYTI--GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        30 ~~~~~y~i--~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .+...|.+  .+.||+|+||.||+|.+..+|+.||+|++....   ......+.+|+.+++++. ||||+++++++...+
T Consensus        84 ~~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~  159 (373)
T 2x4f_A           84 AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLD-HANLIQLYDAFESKN  159 (373)
T ss_dssp             CGGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSS
T ss_pred             ccccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECC
Confidence            34455666  678999999999999999999999999997543   235677899999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          108 FVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      ..++||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++.. +..+.+||+|||++..
T Consensus       160 ~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~  238 (373)
T 2x4f_A          160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARR  238 (373)
T ss_dssp             EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCcee
Confidence            999999999999999988654 46899999999999999999999999999999999999954 3467899999999987


Q ss_pred             cccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          187 IEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ...........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+......++...++.+++.
T Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  318 (373)
T 2x4f_A          239 YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE  318 (373)
T ss_dssp             CCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHH
T ss_pred             cCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHH
Confidence            766555556679999999999864 5889999999999999999999999999988888888887766666666789999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      +.+||.+||..||.+|||+.++|+||||+.
T Consensus       319 ~~~li~~~L~~dp~~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          319 AKEFISKLLIKEKSWRISASEALKHPWLSD  348 (373)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence            999999999999999999999999999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=7.9e-47  Score=360.05  Aligned_cols=265  Identities=40%  Similarity=0.742  Sum_probs=227.8

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCCh---hhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD---VEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      +.++|++++.||+|+||.||+|.+..+++.||+|++........   ...+.+.+|+.+++++. ||||+++++++....
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   81 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFENKT   81 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecCCC
Confidence            45789999999999999999999999999999999976543221   24678999999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC-CCCeEEEeecCCccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD-ENAVVKATDFGLSAF  186 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~-~~~~~kL~Dfg~a~~  186 (494)
                      ..++||||+++++|.+++.....++...+..++.||+.||.|||++|++||||||+||+++.++ ....++|+|||.+..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence            9999999999999999998888899999999999999999999999999999999999995321 233899999999987


Q ss_pred             cccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          187 IEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ...........+++.|+|||++.+ .++.++|+||||+++|+|++|..||.+....+....+......+....++.+++.
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T 3bhy_A          162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL  241 (283)
T ss_dssp             CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred             ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence            655555556678999999999864 6899999999999999999999999999888888777776555544444678999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      +.+++.+||..||.+|||+.++|+||||+..
T Consensus       242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            9999999999999999999999999999863

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=7.5e-47  Score=359.48  Aligned_cols=259  Identities=32%  Similarity=0.602  Sum_probs=225.9

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++++.||+|+||.||+|.+..++..||+|++.............+.+|+.+++++. ||||+++++++.+....++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCCEEEE
Confidence            478999999999999999999999999999999996544333334667889999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      ||||+++++|.+++.....++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++...... 
T Consensus        87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~~~-  162 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSS-  162 (279)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC----
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccCCcc-
Confidence            99999999999999888889999999999999999999999999999999999999   67889999999988654333 


Q ss_pred             ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      ......+++.|+|||++.+ .++.++||||||+++|+|++|..||......+....+......++    ..+++.+.++|
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li  238 (279)
T 3fdn_A          163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLI  238 (279)
T ss_dssp             -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHH
T ss_pred             cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC----CcCCHHHHHHH
Confidence            2245678999999999875 478899999999999999999999999988888887776655443    35789999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917          271 RRMLTQDPKRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       271 ~~~l~~dp~~Rps~~eil~~~~~~~~~~~  299 (494)
                      .+||..||.+|||+.++|+||||+.....
T Consensus       239 ~~~l~~~p~~Rps~~e~l~h~~~~~~~~~  267 (279)
T 3fdn_A          239 SRLLKHNPSQRPMLREVLEHPWITANSSK  267 (279)
T ss_dssp             HHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred             HHHhccChhhCCCHHHHhhCccccCCccC
Confidence            99999999999999999999999975543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.7e-47  Score=367.25  Aligned_cols=259  Identities=28%  Similarity=0.517  Sum_probs=217.7

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      +.++|++++.||+|+||.||+|.+..+++.||+|++......  ...+.+.+|+.+++.+. ||||+++++++...+..+
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~   81 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY   81 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEE
Confidence            557999999999999999999999999999999999654322  23466889999999995 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeeccceeccC
Confidence            999999999999999887789999999999999999999999999999999999999   67889999999999765322


Q ss_pred             c---ccccccCCcCccChhhhccc--CCCcchhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHcCCccCCCCCCCCCCH
Q 040917          191 K---AYREIVGSPYYIAPEVLSQS--YGKEADIWSAGVILYILLCGVPPFWAETDQGV-AQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       191 ~---~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      .   ......||+.|+|||++.+.  ++.++|||||||++|+|++|..||........ .........  ....+..+++
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  236 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDS  236 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT--TSTTGGGSCH
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc--cCCccccCCH
Confidence            2   22356789999999998653  47789999999999999999999987665322 222222221  2223457899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      .+.++|.+||..||.+|||+.++++||||+...
T Consensus       237 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          237 APLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            999999999999999999999999999998654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.5e-47  Score=383.84  Aligned_cols=256  Identities=30%  Similarity=0.555  Sum_probs=218.3

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+. ||||+++++++...+..++
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETTEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCCEEEE
Confidence            478999999999999999999999999999999997654334444567788999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-c
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-E  189 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~  189 (494)
                      ||||++|++|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+|||+   +.++.+||+|||++.... .
T Consensus       226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTTCC-
T ss_pred             EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceeccCC
Confidence            99999999999999888899999999999999999999998 999999999999999   678899999999997633 2


Q ss_pred             CcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917          190 GKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE  268 (494)
Q Consensus       190 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  268 (494)
                      .......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+......++    ..+++.+.+
T Consensus       303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~  378 (446)
T 4ejn_A          303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAKS  378 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHH
Confidence            333455789999999999864 689999999999999999999999999998888888877765544    357899999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHhcCCccCc
Q 040917          269 LVRRMLTQDPKRRI-----TVAQVLEHPWLKE  295 (494)
Q Consensus       269 li~~~l~~dp~~Rp-----s~~eil~~~~~~~  295 (494)
                      +|.+||..||.+||     +++++++||||..
T Consensus       379 li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~  410 (446)
T 4ejn_A          379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG  410 (446)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence            99999999999999     9999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.3e-47  Score=378.19  Aligned_cols=261  Identities=26%  Similarity=0.461  Sum_probs=223.5

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++.+...........+.+|..++..+ +||||+++++++.+.+..|
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~  137 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYLY  137 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEEE
Confidence            347899999999999999999999999999999999754322222344578899999999 5999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          111 IVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      +||||++||+|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+||++   +.++++||+|||++.....
T Consensus       138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~~  214 (412)
T 2vd5_A          138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRA  214 (412)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheeccC
Confidence            9999999999999998754 79999999999999999999999999999999999999   6789999999999976544


Q ss_pred             Ccc--cccccCCcCccChhhhc--------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCC-C
Q 040917          190 GKA--YREIVGSPYYIAPEVLS--------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD-P  258 (494)
Q Consensus       190 ~~~--~~~~~~~~~y~aPE~~~--------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-~  258 (494)
                      ...  ....+||+.|+|||++.        +.++.++|+|||||++|+|++|+.||.+.+..+....+.+.......+ .
T Consensus       215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  294 (412)
T 2vd5_A          215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV  294 (412)
T ss_dssp             TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred             CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence            332  23457999999999986        358999999999999999999999999999888887776543222211 2


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCccCcc
Q 040917          259 FPSISSSAIELVRRMLTQDPKRR---ITVAQVLEHPWLKES  296 (494)
Q Consensus       259 ~~~~~~~l~~li~~~l~~dp~~R---ps~~eil~~~~~~~~  296 (494)
                      ...+|+.+.++|.+||. +|.+|   |+++++++||||+..
T Consensus       295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence            24689999999999999 99998   599999999999863

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=361.82  Aligned_cols=262  Identities=29%  Similarity=0.533  Sum_probs=217.6

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.++++++ ||||+++++++...+..++
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRLHL   79 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCC-CCCccchhheeecCCeEEE
Confidence            468999999999999999999999999999999986544 33345677889999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-  190 (494)
                      ||||+++++|.+++.....++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||.+...... 
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC---
T ss_pred             EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCcc
Confidence            99999999999988878889999999999999999999999999999999999999   67889999999999865432 


Q ss_pred             cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc----------------
Q 040917          191 KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI----------------  252 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~----------------  252 (494)
                      .......+++.|+|||++.+  .++.++|||||||++|+|++|..||.+....+....+.+...                
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence            22345678999999999864  579999999999999999999999998887766554432110                


Q ss_pred             ---cCCCC--------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          253 ---NFQRD--------PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       253 ---~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                         ..+..        .++.++..+.++|.+||..||.+|||++++|+||||++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence               00000        12468899999999999999999999999999999997543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.3e-46  Score=363.11  Aligned_cols=256  Identities=29%  Similarity=0.543  Sum_probs=215.8

Q ss_pred             ccceEeeeeecccCCeEEEEEEEC---CCCcEEEEEEeccCCCC-ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           32 QLHYTIGREVGRGEFGITYLCTEN---STGLEFACKSIPKRKLV-KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .++|++.+.||+|+||.||+|.+.   .+++.||+|++.+.... .......+.+|+.+++.+. ||||+++++++...+
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTGG   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcCC
Confidence            478999999999999999999985   68999999999765432 2224556788999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      ..|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSCC---
T ss_pred             EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCccccc
Confidence            999999999999999999988889999999999999999999999999999999999999   67889999999998754


Q ss_pred             cc-CcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          188 EE-GKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       188 ~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      .. ........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+.+....++    +.+++.
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~  247 (327)
T 3a62_A          172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQE  247 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTSCHH
T ss_pred             ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHH
Confidence            32 223345678999999999864 589999999999999999999999999998888888877655443    467899


Q ss_pred             HHHHHHHhcccCCCCCC-----CHHHHhcCCccCc
Q 040917          266 AIELVRRMLTQDPKRRI-----TVAQVLEHPWLKE  295 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~  295 (494)
                      +.++|.+||..||.+||     ++.++++||||+.
T Consensus       248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence            99999999999999999     8899999999985

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=361.28  Aligned_cols=256  Identities=30%  Similarity=0.583  Sum_probs=215.8

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC-----------------------hhhHHHHHHHHHHHH
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK-----------------------DVEKDDVRREIEIMR   88 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~   88 (494)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.......                       ....+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            478999999999999999999999999999999997654221                       112356889999999


Q ss_pred             HccCCCCccEEeEEEEe--CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceE
Q 040917           89 HLSGQPNIVQFKAAYED--DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFL  166 (494)
Q Consensus        89 ~l~~hp~i~~~~~~~~~--~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIl  166 (494)
                      ++. ||||+++++++..  ....++||||+++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+||+
T Consensus        92 ~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil  169 (298)
T 2zv2_A           92 KLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL  169 (298)
T ss_dssp             TCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             hCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence            995 9999999999986  568999999999999988653 457999999999999999999999999999999999999


Q ss_pred             EeeCCCCCeEEEeecCCccccccCc-ccccccCCcCccChhhhccc----CCCcchhHHHHHHHHHHHhCCCCCCCCChH
Q 040917          167 FTTGDENAVVKATDFGLSAFIEEGK-AYREIVGSPYYIAPEVLSQS----YGKEADIWSAGVILYILLCGVPPFWAETDQ  241 (494)
Q Consensus       167 i~~~~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~Di~slG~il~~l~tg~~pf~~~~~~  241 (494)
                      +   +.++.+||+|||++....... ......||+.|+|||++.+.    ++.++|||||||++|+|++|+.||......
T Consensus       170 ~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  246 (298)
T 2zv2_A          170 V---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM  246 (298)
T ss_dssp             E---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             E---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence            9   678899999999998654432 23456789999999998653    377899999999999999999999988877


Q ss_pred             HHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917          242 GVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK  294 (494)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  294 (494)
                      .....+......++.  .+.+++.+.++|.+||..||.+|||+.++++||||+
T Consensus       247 ~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          247 CLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            777777665544432  357899999999999999999999999999999996

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.5e-46  Score=359.18  Aligned_cols=256  Identities=29%  Similarity=0.474  Sum_probs=213.0

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++++.||+|+||.||+|.+ .+|+.||+|++..... .......+.+|+.++++++ ||||+++++++...+..++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeEEEE
Confidence            5899999999999999999998 6799999999965442 2223467889999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-
Q 040917          113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-  190 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-  190 (494)
                      |||+++ +|.+++... +.++...+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...... 
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC--
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCccc
Confidence            999976 999988764 579999999999999999999999999999999999999   67889999999998765322 


Q ss_pred             cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC------------
Q 040917          191 KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR------------  256 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~------------  256 (494)
                      .......+|+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+.+.......            
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence            22334578999999999864  4899999999999999999999999988877766555431100000            


Q ss_pred             -------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          257 -------------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       257 -------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                                   .....+++.+.++|.+||..||.+|||+.++|+||||++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                         012457899999999999999999999999999999985

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7.3e-46  Score=355.40  Aligned_cols=265  Identities=33%  Similarity=0.531  Sum_probs=233.8

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+ +||||+++++++...+..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCEE
Confidence            3557999999999999999999999999999999999876655566678899999999999 599999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      ++||||++|++|.+++.....++...+..++.|++.||.|||++|++||||||+||++   +.++.++|+|||.+.....
T Consensus        91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCceeccc
Confidence            9999999999999999888889999999999999999999999999999999999999   6788999999999976542


Q ss_pred             C-cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          190 G-KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       190 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      . .......+++.|+|||++.+ .++.++|+||||+++|+|++|..||......+....+.......+    ..+++.+.
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  243 (294)
T 2rku_A          168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAA  243 (294)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHH
T ss_pred             CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----cccCHHHH
Confidence            2 22344578999999999865 588999999999999999999999999888777777766544333    36789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCC
Q 040917          268 ELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDK  302 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~  302 (494)
                      ++|.+||..||.+|||+.++++||||.....+...
T Consensus       244 ~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~~  278 (294)
T 2rku_A          244 SLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL  278 (294)
T ss_dssp             HHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCC
T ss_pred             HHHHHHcccChhhCcCHHHHhhChheecCCcCCCC
Confidence            99999999999999999999999999976655443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.1e-47  Score=385.25  Aligned_cols=267  Identities=25%  Similarity=0.368  Sum_probs=214.0

Q ss_pred             hhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEE
Q 040917           23 ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAA  102 (494)
Q Consensus        23 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~  102 (494)
                      ..++....+.++|++++.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+ +||||++++++
T Consensus        52 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  129 (464)
T 3ttj_A           52 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIISLLNV  129 (464)
T ss_dssp             EC--CEEEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHC-CCTTBCCCSEE
T ss_pred             ecCCcceeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhC-CCCCCCcEEEE
Confidence            344445567789999999999999999999999999999999997542 3444577888999999999 59999999999


Q ss_pred             EEeC------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917          103 YEDD------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV  176 (494)
Q Consensus       103 ~~~~------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~  176 (494)
                      +...      ..+|+||||+++ +|.+.+.  ..++...+..++.||+.||.|||++||+||||||+||++   +.++.+
T Consensus       130 ~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~  203 (464)
T 3ttj_A          130 FTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTL  203 (464)
T ss_dssp             ECSCCSTTTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCE
T ss_pred             EccCCccccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCE
Confidence            9654      467999999976 5766663  358999999999999999999999999999999999999   678899


Q ss_pred             EEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccC-
Q 040917          177 KATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF-  254 (494)
Q Consensus       177 kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-  254 (494)
                      ||+|||++............+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+....... 
T Consensus       204 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~  283 (464)
T 3ttj_A          204 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC  283 (464)
T ss_dssp             EECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             EEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9999999987766555566789999999999865 68999999999999999999999999988776666554311110 


Q ss_pred             ---------------------CCCCC----CC------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          255 ---------------------QRDPF----PS------------ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       255 ---------------------~~~~~----~~------------~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                                           ....+    +.            .++.+.+||.+||..||.+|||++++|+||||....
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence                                 00000    00            145689999999999999999999999999998643

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.8e-46  Score=365.38  Aligned_cols=264  Identities=26%  Similarity=0.445  Sum_probs=213.5

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      ...++|++++.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.++++++ ||||+++++++..+...
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCC-CTTBCCEEEEEEETTEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcC-CCCcceEEEEEecCCEE
Confidence            345789999999999999999999999999999999975442 2334566788999999995 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC--CCCCeEEEeecCCcccc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG--DENAVVKATDFGLSAFI  187 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~--~~~~~~kL~Dfg~a~~~  187 (494)
                      ++||||++| +|.+++...+.++...+..++.||+.||.|||++||+||||||+||+++.+  +..+.+||+|||++...
T Consensus       109 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          109 HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            999999975 999999988889999999999999999999999999999999999999642  34567999999999765


Q ss_pred             ccC-cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCC----
Q 040917          188 EEG-KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP----  260 (494)
Q Consensus       188 ~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----  260 (494)
                      ... .......+|+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+....+...........++    
T Consensus       188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (329)
T 3gbz_A          188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA  267 (329)
T ss_dssp             C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence            422 22344567999999999865  48999999999999999999999999988877766654322111111111    


Q ss_pred             ----------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          261 ----------------------SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       261 ----------------------~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                                            .+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence                                  167899999999999999999999999999999974

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.6e-46  Score=356.66  Aligned_cols=262  Identities=31%  Similarity=0.635  Sum_probs=229.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++. ||||+++++++...+..++|
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCEEEEE
Confidence            68999999999999999999999999999999996543323334567899999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      |||+++++|.+++...+.++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++...... .
T Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~-~  168 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAPSL-R  168 (284)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECSSS-C
T ss_pred             EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccCccc-c
Confidence            9999999999999888889999999999999999999999999999999999999   67889999999998755432 2


Q ss_pred             cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917          193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR  271 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  271 (494)
                      .....+++.|+|||++.+ .++.++|+||||+++|+|++|..||......+....+......++    +.++..+.++|.
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~  244 (284)
T 2vgo_A          169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDLIS  244 (284)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHH
T ss_pred             cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHHHHHHH
Confidence            345678999999999875 589999999999999999999999999888877777776554433    467899999999


Q ss_pred             HhcccCCCCCCCHHHHhcCCccCccCcCCCCC
Q 040917          272 RMLTQDPKRRITVAQVLEHPWLKESGEASDKP  303 (494)
Q Consensus       272 ~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~  303 (494)
                      +||..||.+|||+.++++||||+........|
T Consensus       245 ~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~  276 (284)
T 2vgo_A          245 KLLRYHPPQRLPLKGVMEHPWVKANSRRVLPP  276 (284)
T ss_dssp             HHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCC
T ss_pred             HHhhcCHhhCCCHHHHhhCHHHHhhccccCCC
Confidence            99999999999999999999999765544433

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.3e-46  Score=362.76  Aligned_cols=260  Identities=24%  Similarity=0.427  Sum_probs=206.1

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++....  .......+.+|+.++++++ ||||+++++++..++..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELK-HENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCeEEE
Confidence            368999999999999999999999999999999997544  2223467889999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          112 VMELCAGGELFDRIVAR------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      ||||++| +|.+++...      ..++...+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.
T Consensus        81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~  156 (317)
T 2pmi_A           81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLAR  156 (317)
T ss_dssp             EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCE
T ss_pred             EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCccce
Confidence            9999985 999988654      358999999999999999999999999999999999999   678899999999997


Q ss_pred             ccccC-cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC------
Q 040917          186 FIEEG-KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR------  256 (494)
Q Consensus       186 ~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~------  256 (494)
                      ..... .......+|+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+.........      
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            65432 22345678999999999864  4899999999999999999999999998887776665431110000      


Q ss_pred             ------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          257 ------------------------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       257 ------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                                              .....++..+.+||.+||..||.+|||+.++|+||||++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  302 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH  302 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence                                    011257889999999999999999999999999999997543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.6e-47  Score=381.39  Aligned_cols=264  Identities=37%  Similarity=0.667  Sum_probs=217.2

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC-----hhhHHHHHHHHHHHHHccCCCCccEEeEEEE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK-----DVEKDDVRREIEIMRHLSGQPNIVQFKAAYE  104 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~  104 (494)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||+|++.......     ......+.+|+.+++++ +||||+++++++.
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEE
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEe
Confidence            45689999999999999999999999999999999997654321     11223578999999999 5999999999986


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCc
Q 040917          105 DDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS  184 (494)
Q Consensus       105 ~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a  184 (494)
                      . ...++||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++..+....+||+|||++
T Consensus       211 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a  289 (419)
T 3i6u_A          211 A-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  289 (419)
T ss_dssp             S-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred             c-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence            4 557899999999999999988888999999999999999999999999999999999999965555667999999999


Q ss_pred             cccccCcccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCccCCCCCC
Q 040917          185 AFIEEGKAYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEINFQRDPF  259 (494)
Q Consensus       185 ~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  259 (494)
                      .............||+.|+|||++.    ..++.++|||||||++|+|++|..||...... .....+..+...+.+..+
T Consensus       290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~  369 (419)
T 3i6u_A          290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  369 (419)
T ss_dssp             TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred             eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence            8776555556678999999999984    35788999999999999999999999765433 344555565555554445


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          260 PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      ..+++.+.++|.+||..||.+|||+.++|+||||+.
T Consensus       370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            678999999999999999999999999999999985

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.3e-46  Score=372.21  Aligned_cols=264  Identities=20%  Similarity=0.301  Sum_probs=217.6

Q ss_pred             ccccceEeeeeeccc--CCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           30 DVQLHYTIGREVGRG--EFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G--~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .-.++|++++.||+|  +||.||+|.+..+|+.||+|++..... .......+.+|+.+++.+. ||||+++++++...+
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~   99 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADN   99 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEECC
Confidence            345799999999999  999999999999999999999976543 3445678889999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          108 FVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      ..++||||++|++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||.+.
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~  176 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNL  176 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCE
T ss_pred             EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccce
Confidence            999999999999999999875  679999999999999999999999999999999999999   678899999999886


Q ss_pred             ccccCc--------ccccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccC
Q 040917          186 FIEEGK--------AYREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF  254 (494)
Q Consensus       186 ~~~~~~--------~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  254 (494)
                      ......        ......||+.|+|||++.+   .++.++|||||||++|+|++|+.||.+.........+..+....
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  256 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC  256 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred             eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence            542211        1123468899999999865   58999999999999999999999998766554443322211110


Q ss_pred             ------------------------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCc
Q 040917          255 ------------------------------------------QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPW  292 (494)
Q Consensus       255 ------------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~  292 (494)
                                                                .......+++.+.+||.+||..||.+|||+.++|+|||
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~  336 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  336 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence                                                      01123457889999999999999999999999999999


Q ss_pred             cCccCc
Q 040917          293 LKESGE  298 (494)
Q Consensus       293 ~~~~~~  298 (494)
                      |+....
T Consensus       337 f~~~~~  342 (389)
T 3gni_B          337 FKQIKR  342 (389)
T ss_dssp             GGGC--
T ss_pred             HHHHhh
Confidence            987543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.8e-47  Score=371.56  Aligned_cols=269  Identities=33%  Similarity=0.648  Sum_probs=227.3

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCC--CChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL--VKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED  105 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~  105 (494)
                      ...+.++|++.+.||+|+||.||+|.+..++..||+|++.....  ........+.+|+.++++++ ||||+++++++.+
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~   99 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYED   99 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhhcc
Confidence            34577899999999999999999999999999999999865432  12335678999999999995 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc----------------------------------------CCCCHHHHHHHHHHHHH
Q 040917          106 DQFVHIVMELCAGGELFDRIVAR----------------------------------------GHYSERAAASVFRVIMN  145 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~----------------------------------------~~l~~~~~~~i~~~i~~  145 (494)
                      ....++||||++|++|.+++...                                        ..+++..+..++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            99999999999999999988421                                        11357788899999999


Q ss_pred             HHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-----ccccccCCcCccChhhhc---ccCCCcch
Q 040917          146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-----AYREIVGSPYYIAPEVLS---QSYGKEAD  217 (494)
Q Consensus       146 ~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-----~~~~~~~~~~y~aPE~~~---~~~~~~~D  217 (494)
                      ||.|||++||+||||||+||+++. +..+.++|+|||++.......     ......||+.|+|||++.   ..++.++|
T Consensus       180 ~l~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          180 ALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999999999999999999999942 123389999999997653321     123567899999999986   45889999


Q ss_pred             hHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          218 IWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       218 i~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ||||||++|+|++|+.||.+....+....+......+....+..+++.+.++|.+||..||.+||++.++|+||||+...
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            99999999999999999999999888888888877777666667899999999999999999999999999999999754


Q ss_pred             c
Q 040917          298 E  298 (494)
Q Consensus       298 ~  298 (494)
                      .
T Consensus       339 ~  339 (345)
T 3hko_A          339 D  339 (345)
T ss_dssp             S
T ss_pred             H
Confidence            3

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1e-45  Score=360.99  Aligned_cols=263  Identities=33%  Similarity=0.538  Sum_probs=232.9

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      ....+|.+++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++.+.+..
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  116 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFV  116 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeE
Confidence            3457999999999999999999999999999999999876655666678899999999999 499999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      ++||||++|++|.+++.....++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.....
T Consensus       117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred             EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCceeccc
Confidence            9999999999999999888889999999999999999999999999999999999999   6788999999999976542


Q ss_pred             C-cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          190 G-KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       190 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      . .......+++.|+|||++.+ .++.++|||||||++|+|++|..||......+....+.......+    ..+++.+.
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  269 (335)
T 2owb_A          194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAA  269 (335)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHH
T ss_pred             CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHH
Confidence            2 22344678999999999865 588999999999999999999999998888777777766554433    35789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCccCccCcCC
Q 040917          268 ELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS  300 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~  300 (494)
                      ++|.+||..||.+|||+.++|+||||.....+.
T Consensus       270 ~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~  302 (335)
T 2owb_A          270 SLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  302 (335)
T ss_dssp             HHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             HHHHHHccCChhHCcCHHHHhcCccccCCCccc
Confidence            999999999999999999999999998765444

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.1e-46  Score=365.98  Aligned_cols=264  Identities=37%  Similarity=0.680  Sum_probs=219.8

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCC-----ChhhHHHHHHHHHHHHHccCCCCccEEeEEEE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV-----KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE  104 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~  104 (494)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++......     .......+.+|+.+++++ +||||+++++++.
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~   85 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEE
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEc
Confidence            3567899999999999999999999999999999999754321     112234578999999999 5999999999997


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCc
Q 040917          105 DDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS  184 (494)
Q Consensus       105 ~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a  184 (494)
                      .+. .++||||++|++|.+++.....++...+..++.||+.||.|||++||+||||||+||+++.++....++|+|||++
T Consensus        86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence            665 8999999999999999988888999999999999999999999999999999999999965444567999999999


Q ss_pred             cccccCcccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCccCCCCCC
Q 040917          185 AFIEEGKAYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEINFQRDPF  259 (494)
Q Consensus       185 ~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  259 (494)
                      .............|++.|+|||++.    ..++.++|||||||++|+|++|..||...... .....+..+...+.+..+
T Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (322)
T 2ycf_A          165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  244 (322)
T ss_dssp             EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred             eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence            8765544445567899999999973    45889999999999999999999999765443 334445555444433334


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          260 PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      ..+++.+.++|.+||..||.+|||+.++|+||||+.
T Consensus       245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            578999999999999999999999999999999985

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.6e-46  Score=355.07  Aligned_cols=259  Identities=37%  Similarity=0.628  Sum_probs=219.2

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ..++|++.+.||+|++|.||+|.+..+|+.||+|++.............+.+|+.+++.+. ||||+++++++......+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   87 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTPTDFF   87 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCeEE
Confidence            3478999999999999999999999999999999996543323334667889999999995 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +||||++|++|.+++...+.++...+..++.||+.||.|||++|++|+||||+||++   +.++.++|+|||.+......
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGCCCC-
T ss_pred             EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccccccCCC
Confidence            999999999999999888889999999999999999999999999999999999999   67889999999999876555


Q ss_pred             cccccccCCcCccChhhhccc-C-CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917          191 KAYREIVGSPYYIAPEVLSQS-Y-GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE  268 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  268 (494)
                      .......+++.|+|||++.+. + +.++|+||||+++|+|++|..||...........+.......+    ..++..+.+
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~  240 (276)
T 2h6d_A          165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSVAT  240 (276)
T ss_dssp             ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCHHHHH
Confidence            444556789999999998764 3 5799999999999999999999998888877777766544332    357899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          269 LVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       269 li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      +|.+||..||.+|||+.++++||||+...
T Consensus       241 li~~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          241 LLMHMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHHHccCChhhCCCHHHHHhChhhccCc
Confidence            99999999999999999999999998643

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=9.5e-47  Score=387.83  Aligned_cols=257  Identities=28%  Similarity=0.511  Sum_probs=225.1

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ...+|++.+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++.+....|
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCCEEE
Confidence            3478999999999999999999999999999999997654333334667889999999994 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          111 IVMELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~--l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      +||||++||+|.+++...+.  +++..+..++.||+.||.|||++||+||||||+||++   +.++++||+|||++....
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccceecc
Confidence            99999999999999976543  9999999999999999999999999999999999999   678999999999998776


Q ss_pred             cCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHcCCccCCCCCCCCCC
Q 040917          189 EGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET----DQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      ........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..    ...+...+......++    ..++
T Consensus       338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~~s  413 (576)
T 2acx_A          338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFS  413 (576)
T ss_dssp             TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TTSC
T ss_pred             cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----ccCC
Confidence            5555566789999999999875 58999999999999999999999998763    3445555554433332    4689


Q ss_pred             HHHHHHHHHhcccCCCCCC-----CHHHHhcCCccCc
Q 040917          264 SSAIELVRRMLTQDPKRRI-----TVAQVLEHPWLKE  295 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~  295 (494)
                      +.+.++|.+||..||.+||     ++.++++||||+.
T Consensus       414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence            9999999999999999999     8999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.3e-46  Score=358.25  Aligned_cols=257  Identities=25%  Similarity=0.360  Sum_probs=212.2

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      +.+.++|++.+.||+|+||+||+|.+..+|+.||+|++..... ..........|+..+.++.+||||+++++++.....
T Consensus        53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~  131 (311)
T 3p1a_A           53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI  131 (311)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence            3455789999999999999999999999999999999865432 333445566677777666569999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .++||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             EEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTCEEC
T ss_pred             EEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceeeeec
Confidence            99999999 66998888764 459999999999999999999999999999999999999   67889999999999876


Q ss_pred             ccCcccccccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          188 EEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      ..........||+.|+|||++.+.++.++|||||||++|+|++|..|+....   ....+.....  +......+++.+.
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~l~  282 (311)
T 3p1a_A          208 GTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYL--PPEFTAGLSSELR  282 (311)
T ss_dssp             C------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCC--CHHHHTTSCHHHH
T ss_pred             ccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCC--CcccccCCCHHHH
Confidence            5555555567899999999999899999999999999999999977765432   2333333322  1112346889999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          268 ELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      ++|.+||..||.+|||+.++|+||||+.
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          283 SVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            9999999999999999999999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=8.9e-46  Score=364.00  Aligned_cols=264  Identities=23%  Similarity=0.389  Sum_probs=220.8

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-----
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-----  105 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-----  105 (494)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++ ||||+++++++..     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   92 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLK-HENVVNLIEICRTKASPY   92 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC----
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhcc-CCCcccHhheeecccccc
Confidence            457999999999999999999999999999999998765432 224556788999999995 9999999999876     


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeec
Q 040917          106 ---DQFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDF  181 (494)
Q Consensus       106 ---~~~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Df  181 (494)
                         .+..++||||++| +|.+.+... ..++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+||
T Consensus        93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Df  168 (351)
T 3mi9_A           93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADF  168 (351)
T ss_dssp             ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCC
T ss_pred             ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEccc
Confidence               4568999999976 777776553 579999999999999999999999999999999999999   67889999999


Q ss_pred             CCcccccc-----CcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccC
Q 040917          182 GLSAFIEE-----GKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF  254 (494)
Q Consensus       182 g~a~~~~~-----~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  254 (494)
                      |++.....     ........||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.........+.......
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  248 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99976542     122234578999999999864  47999999999999999999999999998887777765543333


Q ss_pred             CCCCCCC----------------------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCC
Q 040917          255 QRDPFPS----------------------------ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS  300 (494)
Q Consensus       255 ~~~~~~~----------------------------~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~  300 (494)
                      +...++.                            .++.+.+||.+||..||.+|||+.++|+||||+....+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  322 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS  322 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence            3333322                            267799999999999999999999999999999765443

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1e-45  Score=362.29  Aligned_cols=259  Identities=25%  Similarity=0.429  Sum_probs=224.1

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      +....+|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.++++++ ||||+++++++...+.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  128 (348)
T 1u5q_A           50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHT  128 (348)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred             cchhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCe
Confidence            345678999999999999999999999999999999997655444445677899999999995 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIV-ARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .++||||+. |+|.+++. ....+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++...
T Consensus       129 ~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~  204 (348)
T 1u5q_A          129 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIM  204 (348)
T ss_dssp             EEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSS
T ss_pred             EEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEeeccCceec
Confidence            999999997 48888775 35679999999999999999999999999999999999999   57789999999999765


Q ss_pred             ccCcccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917          188 EEGKAYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      ...   ....||+.|+|||++.    +.++.++|||||||++|+|++|+.||...........+........  ....++
T Consensus       205 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~  279 (348)
T 1u5q_A          205 APA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWS  279 (348)
T ss_dssp             SSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--CCTTSC
T ss_pred             CCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCCCCC
Confidence            432   3457899999999983    4689999999999999999999999998887776666665543322  224688


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      +.+.++|.+||..||.+|||+.++++||||....
T Consensus       280 ~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          280 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence            9999999999999999999999999999998643

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.1e-45  Score=351.47  Aligned_cols=259  Identities=23%  Similarity=0.405  Sum_probs=220.1

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe----
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----  105 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~----  105 (494)
                      .-...|++.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++++. ||||+++++++..    
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~  100 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKG  100 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSS
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccCC
Confidence            344679999999999999999999999999999999976543 3445778899999999995 9999999999865    


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEEeeCCCCCeEEEeecCC
Q 040917          106 DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG--VMHRDLKPENFLFTTGDENAVVKATDFGL  183 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~dikp~NIli~~~~~~~~~kL~Dfg~  183 (494)
                      ....++||||+++++|.+++.....++...+..++.||+.||.|||++|  |+||||||+||+++  ..++.++|+|||+
T Consensus       101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~  178 (290)
T 1t4h_A          101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGL  178 (290)
T ss_dssp             CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTG
T ss_pred             CceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCC
Confidence            4578999999999999999998888999999999999999999999999  99999999999994  2678999999999


Q ss_pred             ccccccCcccccccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHcCCccCCCCCCCCC
Q 040917          184 SAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGV-AQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       184 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  262 (494)
                      +...... ......+++.|+|||++.+.++.++|||||||++|+|++|+.||........ ...+..+.....  .....
T Consensus       179 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~  255 (290)
T 1t4h_A          179 ATLKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKVA  255 (290)
T ss_dssp             GGGCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG--GGGCC
T ss_pred             ccccccc-ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccc--cCCCC
Confidence            9754333 3345678999999999988899999999999999999999999987555443 333333322211  12356


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      ++.+.++|.+||..||.+|||+.++|+||||++
T Consensus       256 ~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          256 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            789999999999999999999999999999986

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.9e-46  Score=378.93  Aligned_cols=264  Identities=26%  Similarity=0.401  Sum_probs=202.2

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--  105 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--  105 (494)
                      ...+.++|++++.||+|+||.||+|.+..+++.||+|++... .........+.+|+.+++++. ||||+++++++..  
T Consensus        48 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  125 (458)
T 3rp9_A           48 DWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKD  125 (458)
T ss_dssp             SCCSCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSC
T ss_pred             cCccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCC
Confidence            345678999999999999999999999999999999999653 234445678899999999994 9999999999843  


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917          106 ---DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG  182 (494)
Q Consensus       106 ---~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg  182 (494)
                         ....|+||||+ +++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus       126 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFG  201 (458)
T 3rp9_A          126 VEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFG  201 (458)
T ss_dssp             TTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCT
T ss_pred             cccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccc
Confidence               35799999998 56999999888889999999999999999999999999999999999999   678899999999


Q ss_pred             CccccccCc----------------------------ccccccCCcCccChhhhc--ccCCCcchhHHHHHHHHHHHh--
Q 040917          183 LSAFIEEGK----------------------------AYREIVGSPYYIAPEVLS--QSYGKEADIWSAGVILYILLC--  230 (494)
Q Consensus       183 ~a~~~~~~~----------------------------~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~il~~l~t--  230 (494)
                      ++.......                            .....+||+.|+|||++.  ..++.++|||||||++|+|++  
T Consensus       202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence            998653211                            223457899999999863  459999999999999999998  


Q ss_pred             ---------CCCCCCCCCh--------------------HHHHHHHHc-----------------------CCc----cC
Q 040917          231 ---------GVPPFWAETD--------------------QGVAQAILK-----------------------GEI----NF  254 (494)
Q Consensus       231 ---------g~~pf~~~~~--------------------~~~~~~~~~-----------------------~~~----~~  254 (494)
                               |+.+|.+...                    .+.+..+..                       ...    ..
T Consensus       282 ~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (458)
T 3rp9_A          282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTD  361 (458)
T ss_dssp             TTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCC
T ss_pred             cccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCC
Confidence                     6777765441                    111111110                       000    00


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          255 QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       255 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ....++.+++.+.+||.+||..||.+|||++++|+||||+...
T Consensus       362 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          362 LAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             GGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence            0112456789999999999999999999999999999999754

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-46  Score=363.52  Aligned_cols=260  Identities=24%  Similarity=0.405  Sum_probs=212.4

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.....  ......+.+|+.++++++ ||||+++++++......++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEEEEE
Confidence            579999999999999999999999999999999864331  111223457999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-
Q 040917          113 MELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-  190 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-  190 (494)
                      |||++| +|.+++...+ .++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++...... 
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC----
T ss_pred             eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCc
Confidence            999975 9988887654 58999999999999999999999999999999999999   67889999999998755422 


Q ss_pred             cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCC----------
Q 040917          191 KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP----------  258 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~----------  258 (494)
                      .......+|+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+.+.........          
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence            22334578999999999864  589999999999999999999999999988877766654222221111          


Q ss_pred             ----------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917          259 ----------------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       259 ----------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  299 (494)
                                      .+.+++.+.+||.+||..||.+|||+.++|+||||.+..+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence                            23568899999999999999999999999999999976544

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=354.96  Aligned_cols=260  Identities=30%  Similarity=0.572  Sum_probs=199.0

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.++++++ ||||+++++++...+..
T Consensus         8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A            8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYV   86 (278)
T ss_dssp             SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSEE
T ss_pred             cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCeE
Confidence            34468999999999999999999999999999999996543322334577899999999995 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      ++||||+++++|.+++... ..++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||.+....
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeecc
Confidence            9999999999999999865 568999999999999999999999999999999999999   678899999999997654


Q ss_pred             cC-cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917          189 EG-KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       189 ~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (494)
                      .. .......+++.|+|||++.+ .++.++|+||||+++|+|++|+.||...........+.....    .....++..+
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~  239 (278)
T 3cok_A          164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY----EMPSFLSIEA  239 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCC----CCCTTSCHHH
T ss_pred             CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhccc----CCccccCHHH
Confidence            32 22234568999999998865 578999999999999999999999987665544433322221    1224578999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          267 IELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      .++|.+||..||.+|||+.++++||||....
T Consensus       240 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          240 KDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            9999999999999999999999999998644

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.2e-45  Score=370.73  Aligned_cols=266  Identities=30%  Similarity=0.466  Sum_probs=213.3

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC-
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD-  106 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~-  106 (494)
                      ..++.++|++++.||+|+||.||+|.+..+++.||+|++... .........+.+|+.++++++ ||||+++++++... 
T Consensus        21 ~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~   98 (432)
T 3n9x_A           21 NVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDD   98 (432)
T ss_dssp             GCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSC
T ss_pred             cceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCC
Confidence            345778999999999999999999999999999999999753 234445678999999999995 99999999999765 


Q ss_pred             ----CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917          107 ----QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG  182 (494)
Q Consensus       107 ----~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg  182 (494)
                          ...|+||||++ ++|.+++.....++...+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||
T Consensus        99 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFG  174 (432)
T 3n9x_A           99 LLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFG  174 (432)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCT
T ss_pred             CCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCC
Confidence                57999999996 5999999888889999999999999999999999999999999999999   678899999999


Q ss_pred             CccccccCc-----------------------ccccccCCcCccChhhhc--ccCCCcchhHHHHHHHHHHHhC------
Q 040917          183 LSAFIEEGK-----------------------AYREIVGSPYYIAPEVLS--QSYGKEADIWSAGVILYILLCG------  231 (494)
Q Consensus       183 ~a~~~~~~~-----------------------~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg------  231 (494)
                      ++.......                       .....+||+.|+|||++.  ..++.++|||||||++|+|++|      
T Consensus       175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  254 (432)
T 3n9x_A          175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN  254 (432)
T ss_dssp             TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred             CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence            998654322                       124567899999999863  4599999999999999999984      


Q ss_pred             -----CCCCCCCCh-----------------HHHHHHH------------------------HcCCccCCC---CCCCCC
Q 040917          232 -----VPPFWAETD-----------------QGVAQAI------------------------LKGEINFQR---DPFPSI  262 (494)
Q Consensus       232 -----~~pf~~~~~-----------------~~~~~~~------------------------~~~~~~~~~---~~~~~~  262 (494)
                           ..+|.+...                 .+.+..+                        .......+.   ..++.+
T Consensus       255 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (432)
T 3n9x_A          255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSI  334 (432)
T ss_dssp             SGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTS
T ss_pred             ccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCC
Confidence                 444433320                 1111111                        111000000   013568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  299 (494)
                      ++.+.+||.+||..||.+|||++++|+||||+....+
T Consensus       335 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  371 (432)
T 3n9x_A          335 SDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK  371 (432)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence            9999999999999999999999999999999976544

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.2e-46  Score=369.61  Aligned_cols=271  Identities=26%  Similarity=0.434  Sum_probs=210.0

Q ss_pred             hhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEE
Q 040917           23 ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAA  102 (494)
Q Consensus        23 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~  102 (494)
                      .+.+....+.++|++++.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++ ||||++++++
T Consensus        19 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~   96 (367)
T 2fst_X           19 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDV   96 (367)
T ss_dssp             EETTEEEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEE
T ss_pred             eecCcccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CCCCCcEEEE
Confidence            355567778899999999999999999999999999999999996533 34445677889999999995 9999999999


Q ss_pred             EEeC------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917          103 YEDD------QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV  176 (494)
Q Consensus       103 ~~~~------~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~  176 (494)
                      +...      ...++|++++ |++|.+++.. ..++...+..++.||+.||.|||++||+||||||+||++   +.++.+
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~  171 (367)
T 2fst_X           97 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCEL  171 (367)
T ss_dssp             ECSCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCE
T ss_pred             EecCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCE
Confidence            8653      5689999999 7799988865 579999999999999999999999999999999999999   678899


Q ss_pred             EEeecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc-
Q 040917          177 KATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN-  253 (494)
Q Consensus       177 kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~-  253 (494)
                      ||+|||++.....  ......+|+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+.+.... 
T Consensus       172 kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p  249 (367)
T 2fst_X          172 KILDFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP  249 (367)
T ss_dssp             EECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             EEeeccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999999976533  2345678999999999865  5899999999999999999999999998877666555431100 


Q ss_pred             ----------------------CCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCC
Q 040917          254 ----------------------FQRD----PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDK  302 (494)
Q Consensus       254 ----------------------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~  302 (494)
                                            .+..    .++..++.+.+||.+||..||.+|||+.++|+||||.....+.+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~  324 (367)
T 2fst_X          250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE  324 (367)
T ss_dssp             CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGC
T ss_pred             CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCC
Confidence                                  0110    124578899999999999999999999999999999976554443

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=9.7e-47  Score=364.47  Aligned_cols=264  Identities=24%  Similarity=0.367  Sum_probs=223.5

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++ +||||+++++++....
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~   85 (311)
T 3ork_A            7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAET   85 (311)
T ss_dssp             CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEE
T ss_pred             cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccC
Confidence            345778999999999999999999999999999999999876555555667889999999999 4999999999986543


Q ss_pred             ----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCC
Q 040917          108 ----FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL  183 (494)
Q Consensus       108 ----~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~  183 (494)
                          ..|+||||++|++|.+++...+.++...+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||+
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~  162 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGI  162 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---ETTSCEEECCCSC
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE---cCCCCEEEeeccC
Confidence                358999999999999999988889999999999999999999999999999999999999   5678999999999


Q ss_pred             ccccccCc----ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCC
Q 040917          184 SAFIEEGK----AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP  258 (494)
Q Consensus       184 a~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (494)
                      +.......    ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.................+...
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR  242 (311)
T ss_dssp             C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc
Confidence            97654322    1223568999999999875 589999999999999999999999999988877776666555444434


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          259 FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       259 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      ...+++.+.++|.+||..||.+||++.+++.|+|++.
T Consensus       243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            4678999999999999999999999999999999974

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3e-46  Score=364.45  Aligned_cols=256  Identities=30%  Similarity=0.543  Sum_probs=219.7

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCCh-----hhHHHHHHHHHHHHHccCCCCccEEeEE
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD-----VEKDDVRREIEIMRHLSGQPNIVQFKAA  102 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~hp~i~~~~~~  102 (494)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||+|++........     .....+.+|+.+++++ +||||++++++
T Consensus        19 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~   97 (335)
T 3dls_A           19 EGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDI   97 (335)
T ss_dssp             TTHHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEE
T ss_pred             CcccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEE
Confidence            34567899999999999999999999999999999999976543221     1334567899999999 49999999999


Q ss_pred             EEeCCeEEEEEeccCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeec
Q 040917          103 YEDDQFVHIVMELCAGG-ELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDF  181 (494)
Q Consensus       103 ~~~~~~~~iv~e~~~g~-sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Df  181 (494)
                      +...+..++|||++.+| +|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+||
T Consensus        98 ~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Df  174 (335)
T 3dls_A           98 FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDF  174 (335)
T ss_dssp             EECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCC
T ss_pred             EeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeec
Confidence            99999999999998766 999999888889999999999999999999999999999999999999   67889999999


Q ss_pred             CCccccccCcccccccCCcCccChhhhccc-C-CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 040917          182 GLSAFIEEGKAYREIVGSPYYIAPEVLSQS-Y-GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF  259 (494)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  259 (494)
                      |++.............||+.|+|||++.+. + +.++|||||||++|+|++|..||......      ...    .....
T Consensus       175 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~----~~~~~  244 (335)
T 3dls_A          175 GSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VEA----AIHPP  244 (335)
T ss_dssp             TTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TTT----CCCCS
T ss_pred             ccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hhh----ccCCC
Confidence            999877666555667899999999998753 4 78999999999999999999999653221      111    11122


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          260 PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ..+++.+.++|.+||..||.+|||+.++++||||+...
T Consensus       245 ~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          245 YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence            45789999999999999999999999999999998643

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.6e-46  Score=392.46  Aligned_cols=257  Identities=27%  Similarity=0.491  Sum_probs=231.3

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++++.||+|+||.||+|.++.+++.||+|++.+...........+..|..++..+..||+|+.+++++.+.+.+|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            36899999999999999999999999999999999764333333456788899999988779999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc-cC
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EG  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~-~~  190 (494)
                      ||||++||+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++++||+|||++.... ..
T Consensus       420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECCCTT
T ss_pred             EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeeccccCC
Confidence            99999999999999988899999999999999999999999999999999999999   678999999999997532 33


Q ss_pred             cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                      ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..++...+......++    ..+++.+.+|
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  572 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAI  572 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC----TTSCHHHHHH
T ss_pred             cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHH
Confidence            34456789999999999874 699999999999999999999999999999999999988776655    3689999999


Q ss_pred             HHHhcccCCCCCCCH-----HHHhcCCccCc
Q 040917          270 VRRMLTQDPKRRITV-----AQVLEHPWLKE  295 (494)
Q Consensus       270 i~~~l~~dp~~Rps~-----~eil~~~~~~~  295 (494)
                      |.+||..||.+||++     ++|++||||+.
T Consensus       573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             HHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence            999999999999997     99999999985

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.1e-45  Score=360.38  Aligned_cols=263  Identities=27%  Similarity=0.460  Sum_probs=219.1

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      +....++|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++++. ||||+++++++....
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   97 (331)
T 4aaa_A           20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKK   97 (331)
T ss_dssp             CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred             hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCC
Confidence            4445689999999999999999999999999999999986544 33445667889999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      ..++||||+++++|..+......++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++...
T Consensus        98 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~  174 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTL  174 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC---
T ss_pred             EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceee
Confidence            999999999999998887777789999999999999999999999999999999999999   67889999999999765


Q ss_pred             ccC-cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc------------
Q 040917          188 EEG-KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI------------  252 (494)
Q Consensus       188 ~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~------------  252 (494)
                      ... .......+++.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+.....            
T Consensus       175 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (331)
T 4aaa_A          175 AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK  254 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             cCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence            432 23345678999999999875  578999999999999999999999998887665544432100            


Q ss_pred             -------cCCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          253 -------NFQR--------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       253 -------~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                             ..+.        ...+.+++.+.++|.+||..||.+|||+.++|+||||+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence                   0000        012467899999999999999999999999999999986

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.3e-45  Score=365.54  Aligned_cols=258  Identities=24%  Similarity=0.451  Sum_probs=215.5

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccC-CCCccEEeEEEEeCCeE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG-QPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-hp~i~~~~~~~~~~~~~  109 (494)
                      ...+|++++.||+|+||.||+|.+.. ++.||+|++..... .......+.+|+.+++++.. ||||+++++++......
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~  131 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  131 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence            34679999999999999999999865 99999999976543 34456789999999999963 69999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      ++||| +.+++|.+++.....++...+..++.||+.||.|||++||+||||||+|||++    ++.+||+|||++.....
T Consensus       132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSCCC--
T ss_pred             EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCccccccC
Confidence            99999 56789999999888899999999999999999999999999999999999993    47899999999986643


Q ss_pred             Ccc---cccccCCcCccChhhhcc------------cCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCcc
Q 040917          190 GKA---YREIVGSPYYIAPEVLSQ------------SYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEIN  253 (494)
Q Consensus       190 ~~~---~~~~~~~~~y~aPE~~~~------------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~  253 (494)
                      ...   ....+||+.|+|||++.+            .++.++|||||||++|+|++|..||...... .....+......
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~  286 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  286 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence            321   234679999999999854            5888999999999999999999999876443 444555544333


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          254 FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ...+  ...+..+.++|.+||..||.+|||+.++|+||||+...
T Consensus       287 ~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          287 IEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             CCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             CCCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            3222  23478999999999999999999999999999998644

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.3e-45  Score=354.27  Aligned_cols=256  Identities=29%  Similarity=0.539  Sum_probs=222.1

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ..|...+.||+|+||.||+|.+..+|+.||+|++....   ....+.+.+|+.++++++ ||||+++++++...+..++|
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  120 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVL  120 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEE
Confidence            46889999999999999999999999999999996543   234667889999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-  191 (494)
                      |||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++....... 
T Consensus       121 ~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~  196 (321)
T 2c30_A          121 MEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP  196 (321)
T ss_dssp             ECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC
T ss_pred             EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCcc
Confidence            999999999998765 469999999999999999999999999999999999999   678899999999987654332 


Q ss_pred             ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+........ .....+++.+.++|
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li  275 (321)
T 2c30_A          197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-KNSHKVSPVLRDFL  275 (321)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-TTGGGSCHHHHHHH
T ss_pred             ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-CccccCCHHHHHHH
Confidence            2345678999999999865 589999999999999999999999998888777766655433221 12245789999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          271 RRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       271 ~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      .+||..||.+|||+.++++||||....
T Consensus       276 ~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          276 ERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             HHHccCChhhCcCHHHHhcChhhccCC
Confidence            999999999999999999999998644

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.9e-45  Score=351.14  Aligned_cols=262  Identities=26%  Similarity=0.398  Sum_probs=220.5

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      ..+.++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.++++++ ||||+++++++...+.
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~   85 (294)
T 4eqm_A            7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEEDDC   85 (294)
T ss_dssp             SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEECSSE
T ss_pred             hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeeeeCCe
Confidence            346689999999999999999999999999999999997666556666788999999999995 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      .++||||++|++|.+++...+.++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++....
T Consensus        86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSSTTC-
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCccccc
Confidence            99999999999999999988889999999999999999999999999999999999999   678899999999997654


Q ss_pred             cCc--ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC-CCCCCCCCH
Q 040917          189 EGK--AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ-RDPFPSISS  264 (494)
Q Consensus       189 ~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  264 (494)
                      ...  ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.................. ....+.+|+
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ  242 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred             cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence            332  2234568999999999875 588999999999999999999999999887766555554433222 223457899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLEHPWLK  294 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~  294 (494)
                      .+.++|.+||..||.+||+..+.+.++|..
T Consensus       243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          243 SLSNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             HHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             HHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            999999999999999999665555555554

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.4e-45  Score=376.66  Aligned_cols=257  Identities=26%  Similarity=0.487  Sum_probs=223.6

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      -.++|++.+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++++. ||||+++++++......|
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCCEEE
Confidence            3478999999999999999999999999999999997654333334677889999999994 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          111 IVMELCAGGELFDRIVAR----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      +||||++||+|..++...    ..+++..+..++.||+.||.|||++||+||||||+||++   +.++++||+|||++..
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~~  338 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVE  338 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEE
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceeee
Confidence            999999999999998764    369999999999999999999999999999999999999   6789999999999987


Q ss_pred             cccCcc-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHcCCccCCCCCCC
Q 040917          187 IEEGKA-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET----DQGVAQAILKGEINFQRDPFP  260 (494)
Q Consensus       187 ~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~  260 (494)
                      ...... ....+||+.|+|||++.+ .++.++|+|||||++|+|++|..||.+..    ...+...+......++    .
T Consensus       339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~  414 (543)
T 3c4z_A          339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----D  414 (543)
T ss_dssp             CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----T
T ss_pred             ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----c
Confidence            654433 234589999999999875 58999999999999999999999998753    3556666666544433    4


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCccCc
Q 040917          261 SISSSAIELVRRMLTQDPKRRIT-----VAQVLEHPWLKE  295 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~Rps-----~~eil~~~~~~~  295 (494)
                      .+++.+.++|.+||..||.+||+     ++++++||||+.
T Consensus       415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence            68999999999999999999996     589999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.9e-45  Score=362.99  Aligned_cols=262  Identities=22%  Similarity=0.361  Sum_probs=218.9

Q ss_pred             ccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc----CCCCccEEeE
Q 040917           26 KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS----GQPNIVQFKA  101 (494)
Q Consensus        26 ~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~i~~~~~  101 (494)
                      +....+.++|++++.||+|+||.||+|.+..+++.||+|++...    .........|+.+++.+.    +||||+++++
T Consensus        28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            34456678999999999999999999999999999999999632    234566788999999995    4999999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC---------
Q 040917          102 AYEDDQFVHIVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG---------  170 (494)
Q Consensus       102 ~~~~~~~~~iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~---------  170 (494)
                      ++...+..++||||+ |++|.+++....  .++...+..++.||+.||.|||++||+||||||+||+++..         
T Consensus       104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~  182 (360)
T 3llt_A          104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV  182 (360)
T ss_dssp             EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred             eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence            999999999999999 889999998754  48999999999999999999999999999999999999521         


Q ss_pred             -------------CCCCeEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCC
Q 040917          171 -------------DENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFW  236 (494)
Q Consensus       171 -------------~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~  236 (494)
                                   ...+.+||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.
T Consensus       183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             ECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             hcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence                         1278899999999976433  2345678999999999865 68999999999999999999999999


Q ss_pred             CCChHHHHHHHHcCCccCCCC---------------------CCC---------------------CCCHHHHHHHHHhc
Q 040917          237 AETDQGVAQAILKGEINFQRD---------------------PFP---------------------SISSSAIELVRRML  274 (494)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~---------------------~~~---------------------~~~~~l~~li~~~l  274 (494)
                      +....+....+.......+..                     .++                     ..++.+.+||.+||
T Consensus       261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  340 (360)
T 3llt_A          261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL  340 (360)
T ss_dssp             CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred             CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence            888777666554322211100                     000                     12367889999999


Q ss_pred             ccCCCCCCCHHHHhcCCccC
Q 040917          275 TQDPKRRITVAQVLEHPWLK  294 (494)
Q Consensus       275 ~~dp~~Rps~~eil~~~~~~  294 (494)
                      ..||.+|||+.++|+||||+
T Consensus       341 ~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          341 QIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CSSGGGSCCHHHHTTSGGGC
T ss_pred             cCChhhCCCHHHHhcCcccC
Confidence            99999999999999999996

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.5e-45  Score=364.78  Aligned_cols=269  Identities=25%  Similarity=0.373  Sum_probs=212.8

Q ss_pred             hhhhhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEE
Q 040917           20 HDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF   99 (494)
Q Consensus        20 ~~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~   99 (494)
                      ++..+++....+.++|++++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.+. ||||+++
T Consensus        12 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~   89 (371)
T 2xrw_A           12 YSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGL   89 (371)
T ss_dssp             EEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCE
T ss_pred             eEeecCCcccchhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcC-CCCccce
Confidence            344455555567789999999999999999999999999999999997543 33445677889999999995 9999999


Q ss_pred             eEEEEeCC------eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCC
Q 040917          100 KAAYEDDQ------FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDEN  173 (494)
Q Consensus       100 ~~~~~~~~------~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~  173 (494)
                      ++++....      ..++||||++| +|.+.+.  ..++...+..++.||+.||.|||++||+||||||+||++   +.+
T Consensus        90 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~  163 (371)
T 2xrw_A           90 LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSD  163 (371)
T ss_dssp             EEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTT
T ss_pred             EEeeccccccccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCC
Confidence            99997654      78999999975 8888775  458999999999999999999999999999999999999   678


Q ss_pred             CeEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc
Q 040917          174 AVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI  252 (494)
Q Consensus       174 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  252 (494)
                      +.+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+.....
T Consensus       164 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~  243 (371)
T 2xrw_A          164 CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG  243 (371)
T ss_dssp             SCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CC
T ss_pred             CCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            8999999999987655444456788999999999875 589999999999999999999999999888776666654321


Q ss_pred             cCCC-----------------CC--------------CCC-------CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917          253 NFQR-----------------DP--------------FPS-------ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK  294 (494)
Q Consensus       253 ~~~~-----------------~~--------------~~~-------~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  294 (494)
                      ...+                 ..              ++.       .+..+.+||.+||..||.+|||++++|+||||+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  323 (371)
T 2xrw_A          244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  323 (371)
T ss_dssp             CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred             CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence            1100                 00              000       146789999999999999999999999999998


Q ss_pred             cc
Q 040917          295 ES  296 (494)
Q Consensus       295 ~~  296 (494)
                      ..
T Consensus       324 ~~  325 (371)
T 2xrw_A          324 VW  325 (371)
T ss_dssp             TT
T ss_pred             hh
Confidence            53

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.5e-46  Score=371.25  Aligned_cols=260  Identities=28%  Similarity=0.476  Sum_probs=211.2

Q ss_pred             ccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917           26 KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED  105 (494)
Q Consensus        26 ~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~  105 (494)
                      ...+....+|++++.||+|+||.||+|.+..+++ ||+|++......       ..+|+.+++.++ ||||+++++++..
T Consensus        33 ~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~-h~niv~l~~~~~~  103 (394)
T 4e7w_A           33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVK-HPNVVDLKAFFYS  103 (394)
T ss_dssp             SSCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCC-CTTBCCEEEEEEE
T ss_pred             CCCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCC-CCCcceEEEEEEe
Confidence            3445566899999999999999999999987766 888877543211       236999999995 9999999999854


Q ss_pred             CC------eEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCe
Q 040917          106 DQ------FVHIVMELCAGGELFDRIV----ARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAV  175 (494)
Q Consensus       106 ~~------~~~iv~e~~~g~sL~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~  175 (494)
                      ..      ..++||||+++ ++...+.    ....++...+..++.||+.||.|||++||+||||||+||+++  ..++.
T Consensus       104 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~  180 (394)
T 4e7w_A          104 NGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGV  180 (394)
T ss_dssp             ESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTE
T ss_pred             cCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCc
Confidence            33      38899999987 4444332    246799999999999999999999999999999999999994  36889


Q ss_pred             EEEeecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC--
Q 040917          176 VKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE--  251 (494)
Q Consensus       176 ~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~--  251 (494)
                      +||+|||++.............+|+.|+|||++.+  .++.++||||+||++|+|++|+.||.+.+..+....+.+..  
T Consensus       181 ~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~  260 (394)
T 4e7w_A          181 LKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT  260 (394)
T ss_dssp             EEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             EEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999999987665555566788999999999864  48999999999999999999999999988776665554310  


Q ss_pred             ---------------ccCCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          252 ---------------INFQR--------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       252 ---------------~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                                     ..++.        ...+.+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence                           00000        01234789999999999999999999999999999998643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8.1e-45  Score=346.82  Aligned_cols=258  Identities=22%  Similarity=0.344  Sum_probs=213.9

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+..+..+.+||||+++++++...+..
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~   86 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM   86 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence            3557899999999999999999999999999999999765433 335677889999999995699999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC--------------
Q 040917          110 HIVMELCAGGELFDRIVAR----GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD--------------  171 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~--------------  171 (494)
                      ++||||++|++|.+++...    ..+++..+..++.||+.||.|||++||+||||||+||+++.++              
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            9999999999999999765    6689999999999999999999999999999999999995322              


Q ss_pred             --CCCeEEEeecCCccccccCcccccccCCcCccChhhhccc--CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 040917          172 --ENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS--YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAI  247 (494)
Q Consensus       172 --~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~  247 (494)
                        ....++|+|||.+.......   ...+|+.|+|||++.+.  ++.++|||||||++|+|++|..|+....   ....+
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~  240 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEI  240 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHH
T ss_pred             cCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHH
Confidence              45689999999998654432   34589999999998754  5579999999999999999988764432   23444


Q ss_pred             HcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          248 LKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ..+....   ....+++.+.++|.+||..||.+|||+.++++||||+...
T Consensus       241 ~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          241 RQGRLPR---IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             HTTCCCC---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             HcCCCCC---CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence            4443322   2246889999999999999999999999999999999643

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.3e-45  Score=358.58  Aligned_cols=269  Identities=37%  Similarity=0.689  Sum_probs=195.6

Q ss_pred             cccccccceEeee-eecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHH-HHHccCCCCccEEeEEEE
Q 040917           27 AYEDVQLHYTIGR-EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEI-MRHLSGQPNIVQFKAAYE  104 (494)
Q Consensus        27 ~~~~~~~~y~i~~-~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~hp~i~~~~~~~~  104 (494)
                      ....+.++|.+.+ .||+|+||.||+|.+..+|+.||+|++...        ....+|+.. ++.+ +||||+++++++.
T Consensus        22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~e~~~~~~~~-~h~~i~~~~~~~~   92 (336)
T 3fhr_A           22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQAS-GGPHIVCILDVYE   92 (336)
T ss_dssp             BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--------HHHHHHHHHHHHHT-TSTTBCCEEEEEE
T ss_pred             CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--------HHHHHHHHHHHHhc-CCCChHHHHHHHh
Confidence            3445778999965 699999999999999999999999998542        122334443 3444 6999999999997


Q ss_pred             e----CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEE
Q 040917          105 D----DQFVHIVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKA  178 (494)
Q Consensus       105 ~----~~~~~iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL  178 (494)
                      .    ....++||||++|++|.+++....  .+++..+..++.||+.||.|||++||+||||||+||+++.++..+.++|
T Consensus        93 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl  172 (336)
T 3fhr_A           93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKL  172 (336)
T ss_dssp             EEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred             hccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEE
Confidence            6    456899999999999999998754  5999999999999999999999999999999999999975555778999


Q ss_pred             eecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHcCCcc
Q 040917          179 TDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGV----AQAILKGEIN  253 (494)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~----~~~~~~~~~~  253 (494)
                      +|||++...... ......+|+.|+|||++.+ .++.++|||||||++|+|++|..||........    ...+......
T Consensus       173 ~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  251 (336)
T 3fhr_A          173 TDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG  251 (336)
T ss_dssp             CCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred             eccccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence            999999765432 2345678999999999854 588899999999999999999999977665443    2233334444


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCCc
Q 040917          254 FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPID  305 (494)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~~  305 (494)
                      .+...+..+++.+.++|.+||..||.+|||+.++|+||||+........+..
T Consensus       252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~  303 (336)
T 3fhr_A          252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLH  303 (336)
T ss_dssp             CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCCBCS
T ss_pred             cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCCccc
Confidence            4555567889999999999999999999999999999999976555544443

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.3e-44  Score=352.67  Aligned_cols=255  Identities=26%  Similarity=0.490  Sum_probs=212.7

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--CCeE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--DQFV  109 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--~~~~  109 (494)
                      .++|++++.||+|+||.||+|.+..+++.||+|++...      ....+.+|+.+++++++||||+++++++..  ....
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            48899999999999999999999999999999998632      356789999999999779999999999987  6678


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      ++||||+++++|.+++.   .++...+..++.||+.||.|||++||+||||||+||+++  .....++|+|||++.....
T Consensus       109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECCT
T ss_pred             EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcCC
Confidence            99999999999988873   489999999999999999999999999999999999995  2344899999999987666


Q ss_pred             CcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCCh-HHHHHH-------------HHcCCcc
Q 040917          190 GKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETD-QGVAQA-------------ILKGEIN  253 (494)
Q Consensus       190 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~-~~~~~~-------------~~~~~~~  253 (494)
                      ........+++.|+|||++.+  .++.++|||||||++|+|++|+.||..... .+....             +......
T Consensus       184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence            555566788999999999864  589999999999999999999999954432 222211             1111111


Q ss_pred             CC--------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          254 FQ--------------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       254 ~~--------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ..                    ......+++.+.+||.+||..||.+|||++++|+||||+...
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence            10                    011123789999999999999999999999999999999754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4e-45  Score=346.85  Aligned_cols=260  Identities=27%  Similarity=0.509  Sum_probs=220.4

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      +.++|++++.||+|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++.+. ||||+++++++...+..+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   81 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY   81 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCCEEE
Confidence            44789999999999999999999999999999999965442  234678899999999995 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +||||++|++|.+++.....++...+..++.|++.||.|||++|++||||||+||++   +.++.++|+|||.+......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred             EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCccccCCC
Confidence            999999999999999877789999999999999999999999999999999999999   67889999999999765332


Q ss_pred             c---ccccccCCcCccChhhhcc-c-CCCcchhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHcCCccCCCCCCCCCCH
Q 040917          191 K---AYREIVGSPYYIAPEVLSQ-S-YGKEADIWSAGVILYILLCGVPPFWAETDQG-VAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       191 ~---~~~~~~~~~~y~aPE~~~~-~-~~~~~Di~slG~il~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      .   ......+++.|+|||++.+ . ++.++|+||||+++|+|++|..||....... ....+......  ...+..+++
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  236 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWKKIDS  236 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--STTGGGSCH
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--cCchhhcCH
Confidence            2   2234578999999999865 3 3678999999999999999999998765432 22333332221  223356899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                      .+.++|.+||..||.+|||+.++++||||+....
T Consensus       237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          237 APLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence            9999999999999999999999999999997543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=354.45  Aligned_cols=261  Identities=23%  Similarity=0.423  Sum_probs=213.0

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCC-CCccEEeEEEEeCC
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ-PNIVQFKAAYEDDQ  107 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-p~i~~~~~~~~~~~  107 (494)
                      .....+|++++.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.+++++..| |||+++++++....
T Consensus         5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~   82 (343)
T 3dbq_A            5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ   82 (343)
T ss_dssp             ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence            445678999999999999999999984 689999999976543 344567889999999999622 99999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      ..++|||+ .+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++    ++.+||+|||++...
T Consensus        83 ~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           83 YIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC
T ss_pred             EEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeeccccccc
Confidence            99999994 5789999999988999999999999999999999999999999999999993    578999999999866


Q ss_pred             ccCcc---cccccCCcCccChhhhc------------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCC
Q 040917          188 EEGKA---YREIVGSPYYIAPEVLS------------QSYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGE  251 (494)
Q Consensus       188 ~~~~~---~~~~~~~~~y~aPE~~~------------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~  251 (494)
                      .....   .....||+.|+|||++.            +.++.++|||||||++|+|++|+.||...... .....+....
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  237 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN  237 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC
Confidence            43322   23467899999999985            35788999999999999999999999775443 3333333332


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          252 INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                      ....  .....+..+.++|.+||..||.+|||+.++|+||||+....
T Consensus       238 ~~~~--~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  282 (343)
T 3dbq_A          238 HEIE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  282 (343)
T ss_dssp             SCCC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred             cccC--CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence            2222  22345788999999999999999999999999999986443

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.7e-45  Score=359.03  Aligned_cols=254  Identities=26%  Similarity=0.474  Sum_probs=206.3

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC---
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ---  107 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~---  107 (494)
                      +.++|++++.||+|+||.||+|.++.+|+.||+|++....  .....+.+.+|+.++++++ ||||+++++++....   
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~   80 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPEK   80 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccch
Confidence            4578999999999999999999999999999999997544  3335678999999999995 999999999985533   


Q ss_pred             ------------------------------------------------------eEEEEEeccCCCchHHHHHhcCC---
Q 040917          108 ------------------------------------------------------FVHIVMELCAGGELFDRIVARGH---  130 (494)
Q Consensus       108 ------------------------------------------------------~~~iv~e~~~g~sL~~~~~~~~~---  130 (494)
                                                                            ..++||||++|++|.+++.....   
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~  160 (332)
T 3qd2_B           81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED  160 (332)
T ss_dssp             HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred             hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence                                                                  38999999999999999987543   


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-------------cccccc
Q 040917          131 YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-------------AYREIV  197 (494)
Q Consensus       131 l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-------------~~~~~~  197 (494)
                      .+...+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.......             ......
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV  237 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence            4566789999999999999999999999999999999   678899999999998765432             123356


Q ss_pred             CCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhccc
Q 040917          198 GSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQ  276 (494)
Q Consensus       198 ~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  276 (494)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..|+..  .......+.....   +..+...++.+.++|.+||..
T Consensus       238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~  312 (332)
T 3qd2_B          238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKF---PLLFTQKYPQEHMMVQDMLSP  312 (332)
T ss_dssp             -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCC---CHHHHHHCHHHHHHHHHHHCS
T ss_pred             CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCC---CcccccCChhHHHHHHHHccC
Confidence            8999999999865 589999999999999999998776521  1112222222211   111234567889999999999


Q ss_pred             CCCCCCCHHHHhcCCccCc
Q 040917          277 DPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       277 dp~~Rps~~eil~~~~~~~  295 (494)
                      ||.+|||+.++|+||||++
T Consensus       313 ~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          313 SPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             SGGGSCCHHHHHHSTTCCC
T ss_pred             CCCcCCCHHHHhhchhhhc
Confidence            9999999999999999985

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=350.83  Aligned_cols=261  Identities=27%  Similarity=0.457  Sum_probs=217.4

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--  105 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--  105 (494)
                      .....++|++++.||+|+||.||+|.+..+|+.||+|++.....    ....+.+|+.+++++.+||||+++++++..  
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            44567899999999999999999999999999999999865432    346788999999999669999999999976  


Q ss_pred             ----CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEe
Q 040917          106 ----DQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKAT  179 (494)
Q Consensus       106 ----~~~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~  179 (494)
                          ....++||||+++++|.+++...  ..++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~  171 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLV  171 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEEC
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEEe
Confidence                46899999999999999999764  468999999999999999999999999999999999999   678899999


Q ss_pred             ecCCccccccCc-ccccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc
Q 040917          180 DFGLSAFIEEGK-AYREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI  252 (494)
Q Consensus       180 Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  252 (494)
                      |||++....... ......+++.|+|||++.      ..++.++|||||||++|+|++|..||...........+.....
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  251 (326)
T 2x7f_A          172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA  251 (326)
T ss_dssp             CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred             eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Confidence            999987654322 223457899999999985      3588999999999999999999999988887766655554432


Q ss_pred             cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          253 NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      .  ......+++.+.++|.+||..||.+||++.++++||||+..+
T Consensus       252 ~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          252 P--RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             C--CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             c--cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence            2  222356899999999999999999999999999999998643

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-45  Score=358.68  Aligned_cols=265  Identities=26%  Similarity=0.402  Sum_probs=213.8

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC--hhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK--DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++.......  ......+.+|+.+++.+. ||||+++++++....
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKS   85 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTT
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEeeCC
Confidence            34578999999999999999999999999999999997543211  112346788999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          108 FVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      ..++||||+++ +|...+... ..+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++..
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKS  161 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGST
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEeccccee
Confidence            99999999976 888888664 358999999999999999999999999999999999999   6788999999999986


Q ss_pred             cccC-cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCC-----
Q 040917          187 IEEG-KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP-----  258 (494)
Q Consensus       187 ~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-----  258 (494)
                      .... .......+|+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+....+...........     
T Consensus       162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence            5432 23345678999999999864  478999999999999999999999999888777666644211111111     


Q ss_pred             -------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917          259 -------------------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       259 -------------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  299 (494)
                                         +..++..+.++|.+||..||.+|||+.++|+||||...+.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence                               14567899999999999999999999999999999875443

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=7e-45  Score=359.29  Aligned_cols=265  Identities=30%  Similarity=0.448  Sum_probs=220.1

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC-
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD-  106 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~-  106 (494)
                      .-.+..+|++++.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.++++++ ||||+++++++... 
T Consensus        22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~   98 (364)
T 3qyz_A           22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPT   98 (364)
T ss_dssp             BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSS
T ss_pred             eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCC
Confidence            3445689999999999999999999999999999999996432  3445677899999999995 99999999999654 


Q ss_pred             ----CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917          107 ----QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG  182 (494)
Q Consensus       107 ----~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg  182 (494)
                          ...++|||+++| +|.+++.. ..++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||
T Consensus        99 ~~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg  173 (364)
T 3qyz_A           99 IEQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFG  173 (364)
T ss_dssp             TTTCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCT
T ss_pred             ccccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCc
Confidence                468999999975 99998866 469999999999999999999999999999999999999   678899999999


Q ss_pred             CccccccCcc----cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccC--
Q 040917          183 LSAFIEEGKA----YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINF--  254 (494)
Q Consensus       183 ~a~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--  254 (494)
                      ++........    .....||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+.......  
T Consensus       174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  253 (364)
T 3qyz_A          174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ  253 (364)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred             ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9986543322    234578999999998743  48999999999999999999999998887766555543210000  


Q ss_pred             ---------------------CC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCC
Q 040917          255 ---------------------QR----DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS  300 (494)
Q Consensus       255 ---------------------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~  300 (494)
                                           ..    ...+.+++.+.+||.+||..||.+|||+.++|+||||+....+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~  324 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS  324 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcc
Confidence                                 00    01246789999999999999999999999999999999764433

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=348.68  Aligned_cols=260  Identities=25%  Similarity=0.464  Sum_probs=215.3

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .....++|++.+.||+|+||.||+|.+..+|+.||+|++....     ....+.+|+.+++++ +||||+++++++...+
T Consensus        24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   97 (314)
T 3com_A           24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQC-DSPHVVKYYGSYFKNT   97 (314)
T ss_dssp             ------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTC-CCTTBCCEEEEEEETT
T ss_pred             hhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhC-CCCCCccEEEEEEeCC
Confidence            4456789999999999999999999999999999999997533     345688999999999 5999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          108 FVHIVMELCAGGELFDRIV-ARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      ..++||||++|++|.+++. ....++...+..++.+|+.||.|||++|++|+||||+||++   +.++.++|+|||.+..
T Consensus        98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~  174 (314)
T 3com_A           98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQ  174 (314)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchh
Confidence            9999999999999999987 45679999999999999999999999999999999999999   6788999999999976


Q ss_pred             cccCc-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          187 IEEGK-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       187 ~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      ..... ......+++.|+|||++.+ .++.++||||||+++|+|++|..||...........+........ .....++.
T Consensus       175 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  253 (314)
T 3com_A          175 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF-RKPELWSD  253 (314)
T ss_dssp             CBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSGGGSCH
T ss_pred             hhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCccc-CCcccCCH
Confidence            54332 2234578999999999865 589999999999999999999999988877665554444322211 12245789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      .+.++|.+||..||.+|||+.++++||||+...
T Consensus       254 ~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          254 NFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            999999999999999999999999999998644

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.5e-44  Score=344.51  Aligned_cols=260  Identities=28%  Similarity=0.469  Sum_probs=226.1

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .....++|++++.||+|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++.+ +||||+++++++....
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~   93 (303)
T 3a7i_A           17 KADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDT   93 (303)
T ss_dssp             EECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETT
T ss_pred             CCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCC
Confidence            34556789999999999999999999999999999999975543  23467899999999999 5999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      ..++||||++|++|.+++.. +.++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||.+...
T Consensus        94 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~  169 (303)
T 3a7i_A           94 KLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQL  169 (303)
T ss_dssp             EEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred             eEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceec
Confidence            99999999999999998865 579999999999999999999999999999999999999   67889999999999765


Q ss_pred             ccCc-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          188 EEGK-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       188 ~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      .... ......+++.|+|||++.+ .++.++|+||||+++|+|++|..||...........+.......   ....++..
T Consensus       170 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  246 (303)
T 3a7i_A          170 TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT---LEGNYSKP  246 (303)
T ss_dssp             BTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---CCSSCCHH
T ss_pred             CccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC---CccccCHH
Confidence            4332 2234578999999999865 58899999999999999999999999888877766665543322   22468899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      +.++|.+||..||.+|||+.++++||||....
T Consensus       247 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          247 LKEFVEACLNKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence            99999999999999999999999999998644

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-45  Score=361.79  Aligned_cols=256  Identities=29%  Similarity=0.539  Sum_probs=216.1

Q ss_pred             cceEeeeeecccCCeEEEEEEEC---CCCcEEEEEEeccCCCC-ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           33 LHYTIGREVGRGEFGITYLCTEN---STGLEFACKSIPKRKLV-KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      ++|++.+.||+|+||.||+|.+.   .+++.||+|++...... .......+.+|+.+++++.+||||+++++++.....
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            78999999999999999999984   58999999998754321 112344567799999999779999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      .++||||++|++|.+++.....++...+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++....
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEECC
T ss_pred             EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCeecc
Confidence            99999999999999999988889999999999999999999999999999999999999   678899999999997653


Q ss_pred             cCc--ccccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHcCCccCCCCCC
Q 040917          189 EGK--AYREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAET----DQGVAQAILKGEINFQRDPF  259 (494)
Q Consensus       189 ~~~--~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~----~~~~~~~~~~~~~~~~~~~~  259 (494)
                      ...  ......||+.|+|||++.+   .++.++|||||||++|+|++|..||....    ...+...+......    ..
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----~~  286 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP----YP  286 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC----CC
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC----CC
Confidence            322  2234678999999999874   37889999999999999999999996543    33344444443322    22


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCccCc
Q 040917          260 PSISSSAIELVRRMLTQDPKRRI-----TVAQVLEHPWLKE  295 (494)
Q Consensus       260 ~~~~~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~  295 (494)
                      ..++..+.++|.+||..||.+||     +++++++||||+.
T Consensus       287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence            56889999999999999999999     9999999999985

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.5e-45  Score=361.13  Aligned_cols=255  Identities=25%  Similarity=0.438  Sum_probs=211.8

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-----
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-----  105 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-----  105 (494)
                      ...+|++++.||+|+||.||+|.+..+|+.||+|++......       ..+|+.+++.+. ||||+++++++..     
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLD-HVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCC-CTTBCCEEEEEEEC----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcC-CCCccchhheeeecCccc
Confidence            457899999999999999999999999999999998643321       236999999994 9999999999843     


Q ss_pred             ---------------------------------CCeEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q 040917          106 ---------------------------------DQFVHIVMELCAGGELFDRIV----ARGHYSERAAASVFRVIMNVVN  148 (494)
Q Consensus       106 ---------------------------------~~~~~iv~e~~~g~sL~~~~~----~~~~l~~~~~~~i~~~i~~~l~  148 (494)
                                                       ....++||||++| +|.+.+.    ....++...+..++.||+.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                             3458899999985 7766654    3567999999999999999999


Q ss_pred             HHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHH
Q 040917          149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILY  226 (494)
Q Consensus       149 ~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~  226 (494)
                      |||++||+||||||+||+++  ..++.+||+|||++.............+|+.|+|||++.+  .++.++||||+||++|
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence            99999999999999999995  3578999999999987666555566788999999998865  4899999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHcCCc-----------------cCCCC--------CCCCCCHHHHHHHHHhcccCCCCC
Q 040917          227 ILLCGVPPFWAETDQGVAQAILKGEI-----------------NFQRD--------PFPSISSSAIELVRRMLTQDPKRR  281 (494)
Q Consensus       227 ~l~tg~~pf~~~~~~~~~~~~~~~~~-----------------~~~~~--------~~~~~~~~l~~li~~~l~~dp~~R  281 (494)
                      +|++|+.||.+....+....+.+...                 .++..        ....+++.+.+||.+||..||.+|
T Consensus       234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            99999999999888776665543100                 11100        113478899999999999999999


Q ss_pred             CCHHHHhcCCccCcc
Q 040917          282 ITVAQVLEHPWLKES  296 (494)
Q Consensus       282 ps~~eil~~~~~~~~  296 (494)
                      ||+.++|+||||+..
T Consensus       314 ~t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          314 INPYEAMAHPFFDHL  328 (383)
T ss_dssp             CCHHHHHTSGGGHHH
T ss_pred             CCHHHHhcCHHHHHH
Confidence            999999999999853

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.2e-44  Score=346.48  Aligned_cols=262  Identities=30%  Similarity=0.454  Sum_probs=219.4

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ...+.++|++++.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.+. ||||+++++++...+
T Consensus        14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   89 (302)
T 2j7t_A           14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCD-HPYIVKLLGAYYHDG   89 (302)
T ss_dssp             SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC-
T ss_pred             ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeCC
Confidence            4456789999999999999999999999999999999986432   234677889999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          108 FVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      ..++||||++|++|.+++.. ...++...+..++.||+.||.|||++|++||||||+||++   +.++.++|+|||++..
T Consensus        90 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A           90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAK  166 (302)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHH
T ss_pred             eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCcc
Confidence            99999999999999998875 4569999999999999999999999999999999999999   6788999999998754


Q ss_pred             cccC-cccccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 040917          187 IEEG-KAYREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF  259 (494)
Q Consensus       187 ~~~~-~~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  259 (494)
                      .... .......+++.|+|||++.      ..++.++|||||||++|+|++|..||...........+........ ...
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~  245 (302)
T 2j7t_A          167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LTP  245 (302)
T ss_dssp             HHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSG
T ss_pred             ccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CCc
Confidence            3211 1223456899999999873      3588999999999999999999999998888777666665543222 122


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          260 PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ..++..+.++|.+||..||.+|||+.++++||||+...
T Consensus       246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          246 SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             cccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            45789999999999999999999999999999999744

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.3e-44  Score=364.36  Aligned_cols=261  Identities=25%  Similarity=0.410  Sum_probs=216.3

Q ss_pred             cccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc-----CCCCccEEeE
Q 040917           27 AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS-----GQPNIVQFKA  101 (494)
Q Consensus        27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~i~~~~~  101 (494)
                      ..+.+..+|++++.||+|+||.||+|.+..+++.||+|++...    ......+.+|+.+++.++     +||||+.+++
T Consensus        91 ~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~  166 (429)
T 3kvw_A           91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE  166 (429)
T ss_dssp             TTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred             CCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence            4566788999999999999999999999999999999999642    234567888999998885     4779999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCe--EE
Q 040917          102 AYEDDQFVHIVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAV--VK  177 (494)
Q Consensus       102 ~~~~~~~~~iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~--~k  177 (494)
                      ++......++|||++. ++|.+++....  .++...+..++.||+.||.|||++||+||||||+|||+   +.++.  +|
T Consensus       167 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl---~~~~~~~vk  242 (429)
T 3kvw_A          167 NFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL---KQQGRSGIK  242 (429)
T ss_dssp             EEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE---SSTTSCCEE
T ss_pred             ecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---ccCCCcceE
Confidence            9999999999999996 59999987754  48999999999999999999999999999999999999   44554  99


Q ss_pred             EeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC-
Q 040917          178 ATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ-  255 (494)
Q Consensus       178 L~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-  255 (494)
                      |+|||++.....  ......+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+.......+ 
T Consensus       243 L~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~  320 (429)
T 3kvw_A          243 VIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ  320 (429)
T ss_dssp             ECCCTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             EeecccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence            999999975432  2345678999999999865 589999999999999999999999999888776655432100000 


Q ss_pred             -----------------------------------------------CC-------CCCCCCHHHHHHHHHhcccCCCCC
Q 040917          256 -----------------------------------------------RD-------PFPSISSSAIELVRRMLTQDPKRR  281 (494)
Q Consensus       256 -----------------------------------------------~~-------~~~~~~~~l~~li~~~l~~dp~~R  281 (494)
                                                                     +.       .....++.+.+||.+||..||.+|
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R  400 (429)
T 3kvw_A          321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR  400 (429)
T ss_dssp             HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence                                                           00       001237889999999999999999


Q ss_pred             CCHHHHhcCCccCccC
Q 040917          282 ITVAQVLEHPWLKESG  297 (494)
Q Consensus       282 ps~~eil~~~~~~~~~  297 (494)
                      ||+.++|+||||+...
T Consensus       401 pta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          401 MTPGQALRHPWLRRRL  416 (429)
T ss_dssp             CCHHHHHTSTTTC---
T ss_pred             CCHHHHhCChhhccCC
Confidence            9999999999999743

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.1e-45  Score=351.96  Aligned_cols=260  Identities=23%  Similarity=0.394  Sum_probs=214.2

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC-
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ-  107 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~-  107 (494)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|++......  ...+.+.+|+.++++++ ||||+++++++.... 
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   81 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTT   81 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTT
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcC-CCCcceEEEEeecCCC
Confidence            34568999999999999999999999999999999999754422  23567789999999995 999999999998655 


Q ss_pred             -eEEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEee-CCCCCeEEEeecC
Q 040917          108 -FVHIVMELCAGGELFDRIVARGH---YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTT-GDENAVVKATDFG  182 (494)
Q Consensus       108 -~~~iv~e~~~g~sL~~~~~~~~~---l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~-~~~~~~~kL~Dfg  182 (494)
                       ..++||||++|++|.+++.....   ++...+..++.||+.||.|||++||+||||||+||++.. .+..+.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence             78999999999999999976433   899999999999999999999999999999999999842 3456789999999


Q ss_pred             CccccccCcccccccCCcCccChhhhc---------ccCCCcchhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHc
Q 040917          183 LSAFIEEGKAYREIVGSPYYIAPEVLS---------QSYGKEADIWSAGVILYILLCGVPPFWAETD----QGVAQAILK  249 (494)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~----~~~~~~~~~  249 (494)
                      ++.............||+.|+|||++.         ..++.++|||||||++|+|++|..||.....    .+....+..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            998776665556677999999999874         4588999999999999999999999964332    334444443


Q ss_pred             CCccC-------------------C--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 040917          250 GEINF-------------------Q--RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHP  291 (494)
Q Consensus       250 ~~~~~-------------------~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~  291 (494)
                      +....                   +  ......++..+.++|.+||..||++|||++++|+||
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            32210                   0  011122456788999999999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.8e-44  Score=355.90  Aligned_cols=260  Identities=26%  Similarity=0.418  Sum_probs=220.2

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      +-..++|++.+.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++++ +||||+++++++...+.
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  105 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGE  105 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEETTE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEECCE
Confidence            445689999999999999999999999999999999997543  344567899999999999 59999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .++||||++|++|.+++...+.++...+..++.+++.||.|||+. ||+||||||+||++   +.++.++|+|||++...
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~  182 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQL  182 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHH
T ss_pred             EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCCccc
Confidence            999999999999999999888899999999999999999999996 99999999999999   67889999999998754


Q ss_pred             ccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------------------
Q 040917          188 EEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAI-------------------  247 (494)
Q Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~-------------------  247 (494)
                      ... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........+                   
T Consensus       183 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          183 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             HHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             ccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence            322 2234678999999999875 5899999999999999999999999877665432221                   


Q ss_pred             -----------------------HcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          248 -----------------------LKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       248 -----------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                                             .....  +..+...++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             CcccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence                                   11111  1112234788999999999999999999999999999998643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.4e-46  Score=368.99  Aligned_cols=250  Identities=16%  Similarity=0.172  Sum_probs=203.9

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc--CCCCccEEe-------E
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS--GQPNIVQFK-------A  101 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~i~~~~-------~  101 (494)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++  +||||++++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            3588999999999999999999999999999999998665555556788999995555443  599999988       7


Q ss_pred             EEEeCC-----------------eEEEEEeccCCCchHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHCCcee
Q 040917          102 AYEDDQ-----------------FVHIVMELCAGGELFDRIVARGHYSE-------RAAASVFRVIMNVVNVCHSKGVMH  157 (494)
Q Consensus       102 ~~~~~~-----------------~~~iv~e~~~g~sL~~~~~~~~~l~~-------~~~~~i~~~i~~~l~~LH~~~i~H  157 (494)
                      ++...+                 ..|+||||+ +|+|.+++...+.++.       ..+..++.||+.||.|||++||+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  229 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  229 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            766553                 288999999 6799999987655555       788889999999999999999999


Q ss_pred             ccCCCCceEEeeCCCCCeEEEeecCCccccccCcccccccCCcCccChhhhcc------------cCCCcchhHHHHHHH
Q 040917          158 RDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ------------SYGKEADIWSAGVIL  225 (494)
Q Consensus       158 ~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~------------~~~~~~Di~slG~il  225 (494)
                      |||||+|||+   +.++.+||+|||++.....  ......| +.|+|||++.+            .++.++|||||||++
T Consensus       230 rDikp~NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          230 TYLRPVDIVL---DQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             SCCCGGGEEE---CTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             CCCCHHHEEE---cCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            9999999999   6778999999999985332  3345567 99999999864            489999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          226 YILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       226 ~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      |+|++|+.||.+.........+        ...++.+++.+.++|.+||..||.+|||+.++++||||+.
T Consensus       304 ~elltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          304 YWIWCADLPITKDAALGGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHHHSSCCC------CCSGGG--------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHHHCCCCCcccccccchhhh--------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            9999999999765543222111        1223578999999999999999999999999999999985

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.4e-44  Score=342.97  Aligned_cols=259  Identities=25%  Similarity=0.316  Sum_probs=199.2

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+..+...++.+ +||||+++++++...+..+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTV-DCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSSEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeeccCCEE
Confidence            45789999999999999999999999999999999965432 222233334444446666 6999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          111 IVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      +||||++| +|.+++..    ...+++..+..++.|++.||.|||++ ||+||||||+||++   +.++.++|+|||++.
T Consensus        83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~  158 (290)
T 3fme_A           83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGISG  158 (290)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC----
T ss_pred             EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCCcc
Confidence            99999975 88776653    46799999999999999999999998 99999999999999   678899999999998


Q ss_pred             ccccCcccccccCCcCccChhhhc-----ccCCCcchhHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHcCCccCCCCCC
Q 040917          186 FIEEGKAYREIVGSPYYIAPEVLS-----QSYGKEADIWSAGVILYILLCGVPPFWAE-TDQGVAQAILKGEINFQRDPF  259 (494)
Q Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~Di~slG~il~~l~tg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~  259 (494)
                      ............+|+.|+|||++.     ..++.++|||||||++|+|++|+.||... ...............  ....
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~  236 (290)
T 3fme_A          159 YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP--QLPA  236 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC--CCCT
T ss_pred             cccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC--Cccc
Confidence            765554445567899999999962     35888999999999999999999999763 333333333333222  2222


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          260 PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ..+++.+.+++.+||..||.+|||+.++++||||+...
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence            46899999999999999999999999999999998643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.2e-44  Score=346.13  Aligned_cols=260  Identities=26%  Similarity=0.400  Sum_probs=212.0

Q ss_pred             cccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           27 AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      ..+-...+|++.+.||+|+||.||+|.+  +|..||+|++..... .......+.+|+.++++++ ||||+++++++...
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~  106 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQP  106 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECST
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEC
Confidence            3444558999999999999999999986  488999999976543 3445677899999999995 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEEeeCCCCCeEEEeec
Q 040917          107 QFVHIVMELCAGGELFDRIVARGH---YSERAAASVFRVIMNVVNVCHSKG--VMHRDLKPENFLFTTGDENAVVKATDF  181 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~~~---l~~~~~~~i~~~i~~~l~~LH~~~--i~H~dikp~NIli~~~~~~~~~kL~Df  181 (494)
                      ...++||||++|++|.+++...+.   ++...+..++.||+.||.|||++|  |+||||||+||++   +.++.+||+||
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~Df  183 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDF  183 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECCC
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECCC
Confidence            999999999999999999976543   899999999999999999999999  9999999999999   67889999999


Q ss_pred             CCccccccCc-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 040917          182 GLSAFIEEGK-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF  259 (494)
Q Consensus       182 g~a~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  259 (494)
                      |++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+....+.........  .
T Consensus       184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--~  261 (309)
T 3p86_A          184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI--P  261 (309)
T ss_dssp             C-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCC--C
T ss_pred             CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC--C
Confidence            9997544322 2234678999999999875 5899999999999999999999999998888777666543333222  2


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCccCc
Q 040917          260 PSISSSAIELVRRMLTQDPKRRITVAQVLE--HPWLKE  295 (494)
Q Consensus       260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~--~~~~~~  295 (494)
                      ..+++.+.++|.+||..||.+|||+.++++  .++++.
T Consensus       262 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            468999999999999999999999999988  455554

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=349.77  Aligned_cols=267  Identities=27%  Similarity=0.407  Sum_probs=213.9

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE---
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE---  104 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~---  104 (494)
                      ...+.++|++++.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.+++++. ||||+++++++.   
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~   81 (320)
T 2i6l_A            6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLD-HDNIVKVFEILGPSG   81 (320)
T ss_dssp             CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTS
T ss_pred             cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcC-CCCeeEEEEeccccc
Confidence            456778999999999999999999999999999999998643   3445678899999999995 999999999873   


Q ss_pred             -----------eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCC
Q 040917          105 -----------DDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDEN  173 (494)
Q Consensus       105 -----------~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~  173 (494)
                                 .....++||||++ ++|.+++.. +.++...+..++.||+.||.|||++||+||||||+||+++  ..+
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~  157 (320)
T 2i6l_A           82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--TED  157 (320)
T ss_dssp             CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTT
T ss_pred             cccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCC
Confidence                       3468899999997 599998865 5789999999999999999999999999999999999995  356


Q ss_pred             CeEEEeecCCccccccC----cccccccCCcCccChhhhc--ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 040917          174 AVVKATDFGLSAFIEEG----KAYREIVGSPYYIAPEVLS--QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAI  247 (494)
Q Consensus       174 ~~~kL~Dfg~a~~~~~~----~~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~  247 (494)
                      +.+||+|||.+......    .......+++.|+|||++.  ..++.++|||||||++|+|++|+.||.+....+....+
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  237 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI  237 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            79999999999865422    1223456789999999875  45889999999999999999999999988877666555


Q ss_pred             HcCCccC----------------------CC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCC
Q 040917          248 LKGEINF----------------------QR----DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASD  301 (494)
Q Consensus       248 ~~~~~~~----------------------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~  301 (494)
                      .......                      +.    ...+.++..+.++|.+||..||.+|||+.++|+||||+....+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~  317 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMD  317 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC---
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccC
Confidence            4322110                      00    012468999999999999999999999999999999997665544


Q ss_pred             C
Q 040917          302 K  302 (494)
Q Consensus       302 ~  302 (494)
                      .
T Consensus       318 ~  318 (320)
T 2i6l_A          318 E  318 (320)
T ss_dssp             -
T ss_pred             C
Confidence            3

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.6e-44  Score=352.07  Aligned_cols=265  Identities=31%  Similarity=0.470  Sum_probs=218.3

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC-
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD-  106 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~-  106 (494)
                      ...+.++|++.+.||+|+||.||+|.+..+|+.||+|++...  ........+.+|+.++++++ ||||+++++++... 
T Consensus         6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   82 (353)
T 2b9h_A            6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFK-HENIITIFNIQRPDS   82 (353)
T ss_dssp             CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSC
T ss_pred             ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCc-CCCcCCeeeeecccc
Confidence            445778999999999999999999999999999999999643  23445667889999999995 99999999988653 


Q ss_pred             ----CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917          107 ----QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG  182 (494)
Q Consensus       107 ----~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg  182 (494)
                          ...++||||+. ++|.+++.. ..++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||
T Consensus        83 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg  157 (353)
T 2b9h_A           83 FENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFG  157 (353)
T ss_dssp             STTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCT
T ss_pred             cCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEecc
Confidence                67899999997 599988876 579999999999999999999999999999999999999   678899999999


Q ss_pred             CccccccCcc-----------cccccCCcCccChhhhc--ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHc
Q 040917          183 LSAFIEEGKA-----------YREIVGSPYYIAPEVLS--QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILK  249 (494)
Q Consensus       183 ~a~~~~~~~~-----------~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~  249 (494)
                      ++........           .....||+.|+|||++.  ..++.++|||||||++|+|++|+.||.+.........+..
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  237 (353)
T 2b9h_A          158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG  237 (353)
T ss_dssp             TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence            9976542211           12346899999999875  4589999999999999999999999998887655544322


Q ss_pred             CCc------------------------cCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCC
Q 040917          250 GEI------------------------NFQRD----PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS  300 (494)
Q Consensus       250 ~~~------------------------~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~  300 (494)
                      ...                        ..+..    .++.+++.+.++|.+||..||.+|||+.++|+||||+....+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN  316 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence            100                        00000    1246889999999999999999999999999999999755443

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.3e-45  Score=363.58  Aligned_cols=266  Identities=27%  Similarity=0.436  Sum_probs=199.9

Q ss_pred             cccccccceEe-eeeecccCCeEEEEEEEC--CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEE
Q 040917           27 AYEDVQLHYTI-GREVGRGEFGITYLCTEN--STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY  103 (494)
Q Consensus        27 ~~~~~~~~y~i-~~~lg~G~~g~Vy~a~~~--~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~  103 (494)
                      ....+.+.|.+ ++.||+|+||.||+|.++  .+++.||+|++....     ....+.+|+.++++++ ||||+++++++
T Consensus        14 ~~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~-hpniv~~~~~~   87 (405)
T 3rgf_A           14 ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-----ISMSACREIALLRELK-HPNVISLQKVF   87 (405)
T ss_dssp             HCCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-----CCHHHHHHHHHHHHCC-CTTBCCCCEEE
T ss_pred             hhhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-----CCHHHHHHHHHHHhcC-CCCeeeEeeEE
Confidence            45566778998 558999999999999966  578999999996543     2346788999999995 99999999999


Q ss_pred             Ee--CCeEEEEEeccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC-C
Q 040917          104 ED--DQFVHIVMELCAGGELFDRIVAR---------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG-D  171 (494)
Q Consensus       104 ~~--~~~~~iv~e~~~g~sL~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~-~  171 (494)
                      ..  ....++||||++| +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+||++... +
T Consensus        88 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~  166 (405)
T 3rgf_A           88 LSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGP  166 (405)
T ss_dssp             EETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSST
T ss_pred             ecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCC
Confidence            54  6789999999965 888877532         148999999999999999999999999999999999999643 4


Q ss_pred             CCCeEEEeecCCccccccC----cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChH----
Q 040917          172 ENAVVKATDFGLSAFIEEG----KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQ----  241 (494)
Q Consensus       172 ~~~~~kL~Dfg~a~~~~~~----~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~----  241 (494)
                      ..+.+||+|||++......    .......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....    
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  246 (405)
T 3rgf_A          167 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS  246 (405)
T ss_dssp             TTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred             CCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccc
Confidence            5689999999999865432    22345678999999999865  4899999999999999999999999766542    


Q ss_pred             -----HHHHHHHcCCccCCCCCC----------------------------------CCCCHHHHHHHHHhcccCCCCCC
Q 040917          242 -----GVAQAILKGEINFQRDPF----------------------------------PSISSSAIELVRRMLTQDPKRRI  282 (494)
Q Consensus       242 -----~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~l~~li~~~l~~dp~~Rp  282 (494)
                           +.+..+......+....|                                  ...++.+.+||.+||..||.+||
T Consensus       247 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~  326 (405)
T 3rgf_A          247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI  326 (405)
T ss_dssp             CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC
T ss_pred             ccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC
Confidence                 233332221111111111                                  12267889999999999999999


Q ss_pred             CHHHHhcCCccCccCcC
Q 040917          283 TVAQVLEHPWLKESGEA  299 (494)
Q Consensus       283 s~~eil~~~~~~~~~~~  299 (494)
                      |+.++|+||||...+.+
T Consensus       327 ta~e~L~hp~f~~~~~~  343 (405)
T 3rgf_A          327 TSEQAMQDPYFLEDPLP  343 (405)
T ss_dssp             CHHHHHTSGGGTSSSCC
T ss_pred             CHHHHhcChhhccCCCC
Confidence            99999999999875433

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=6.8e-44  Score=346.86  Aligned_cols=263  Identities=25%  Similarity=0.387  Sum_probs=217.9

Q ss_pred             cccceEeeeeecccCCeEEEEEEEC-CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc--CCCCccEEeEEEE---
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTEN-STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS--GQPNIVQFKAAYE---  104 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~-~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~i~~~~~~~~---  104 (494)
                      ..++|++.+.||+|+||.||+|.+. .+|+.||+|++....... .....+.+|+.+++.+.  +||||+++++++.   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            4578999999999999999999995 678999999987543221 12334667888877774  5999999999987   


Q ss_pred             --eCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917          105 --DDQFVHIVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       105 --~~~~~~iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                        .....++||||++ ++|.+++....  .++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEec
Confidence              4567999999997 59999987753  48999999999999999999999999999999999999   6788999999


Q ss_pred             cCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc-----C
Q 040917          181 FGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN-----F  254 (494)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~-----~  254 (494)
                      ||++.............+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+......     +
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence            999987655444456678999999999864 5899999999999999999999999998887766665431100     0


Q ss_pred             ------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          255 ------------------QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       255 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                                        .....+.++..+.++|.+||..||.+|||+.++|+||||+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence                              01123568899999999999999999999999999999987543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.4e-44  Score=355.12  Aligned_cols=266  Identities=26%  Similarity=0.425  Sum_probs=219.0

Q ss_pred             hhhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeE
Q 040917           22 AILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKA  101 (494)
Q Consensus        22 ~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~  101 (494)
                      .........+..+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++ ||||+++++
T Consensus        31 ~~~~~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~  108 (371)
T 4exu_A           31 QDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLD  108 (371)
T ss_dssp             EEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSE
T ss_pred             eeeccceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcC-CCCchhhhh
Confidence            3444556678899999999999999999999999999999999997543 34445678889999999995 999999999


Q ss_pred             EEEeCCeE------EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCe
Q 040917          102 AYEDDQFV------HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAV  175 (494)
Q Consensus       102 ~~~~~~~~------~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~  175 (494)
                      ++......      ++||||+. ++|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.
T Consensus       109 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~  182 (371)
T 4exu_A          109 VFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCE  182 (371)
T ss_dssp             EECSCSSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCC
T ss_pred             heeccCCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCC
Confidence            99876544      99999997 58887763  359999999999999999999999999999999999999   67889


Q ss_pred             EEEeecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc
Q 040917          176 VKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN  253 (494)
Q Consensus       176 ~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  253 (494)
                      ++|+|||++.....  ......+|+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+......
T Consensus       183 ~kL~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~  260 (371)
T 4exu_A          183 LKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV  260 (371)
T ss_dssp             EEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EEEEecCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99999999976533  2345678999999999865  5899999999999999999999999988877666555331110


Q ss_pred             -----------------------CCC----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          254 -----------------------FQR----DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       254 -----------------------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                                             ...    ..++.+++.+.+||.+||..||.+|||+.++|+||||+...
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                                   000    01245789999999999999999999999999999998643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.1e-44  Score=345.92  Aligned_cols=259  Identities=26%  Similarity=0.480  Sum_probs=217.7

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCC-ChhhHHHHHHHHHHHHHccCCCCccEEeEEEE--eCC
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV-KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE--DDQ  107 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~--~~~  107 (494)
                      +.++|++++.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.++++++ ||||+++++++.  ...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC---
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCC
Confidence            457899999999999999999999999999999999754321 1234677899999999995 999999999984  455


Q ss_pred             eEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          108 FVHIVMELCAGGELFDRIVA--RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      ..++||||++++ |.+++..  ...++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||.+.
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAE  157 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred             eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeecccccc
Confidence            789999999875 7777765  3568999999999999999999999999999999999999   678899999999997


Q ss_pred             cccc---CcccccccCCcCccChhhhccc---CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 040917          186 FIEE---GKAYREIVGSPYYIAPEVLSQS---YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF  259 (494)
Q Consensus       186 ~~~~---~~~~~~~~~~~~y~aPE~~~~~---~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  259 (494)
                      ....   ........+++.|+|||++.+.   ++.++||||||+++|+|++|..||.+....+....+.......+    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----  233 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP----  233 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC----
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC----
Confidence            6542   2222345689999999998652   47799999999999999999999999888888887777654333    


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          260 PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                      ..+++.+.++|.+||..||.+|||+.++++||||+....
T Consensus       234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            467899999999999999999999999999999986543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.2e-45  Score=358.76  Aligned_cols=262  Identities=25%  Similarity=0.462  Sum_probs=222.8

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChh--------------hHHHHHHHHHHHHHccCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV--------------EKDDVRREIEIMRHLSGQ   93 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~--------------~~~~~~~E~~~l~~l~~h   93 (494)
                      .....++|++++.||+|+||.||+|.+  +|+.||+|++.........              ....+.+|+.++++++ |
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h  102 (348)
T 2pml_X           26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-N  102 (348)
T ss_dssp             SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-C
T ss_pred             cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-C
Confidence            334558999999999999999999998  8999999998754322211              1278999999999995 9


Q ss_pred             CCccEEeEEEEeCCeEEEEEeccCCCchHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCc
Q 040917           94 PNIVQFKAAYEDDQFVHIVMELCAGGELFDR------IVA--RGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPEN  164 (494)
Q Consensus        94 p~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~------~~~--~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~N  164 (494)
                      |||+++++++...+..++||||++|++|.++      +..  ...++...+..++.||+.||.|||+ +||+||||||+|
T Consensus       103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N  182 (348)
T 2pml_X          103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN  182 (348)
T ss_dssp             TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred             CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence            9999999999999999999999999999998      655  5679999999999999999999999 999999999999


Q ss_pred             eEEeeCCCCCeEEEeecCCccccccCcccccccCCcCccChhhhccc--CCC-cchhHHHHHHHHHHHhCCCCCCCCCh-
Q 040917          165 FLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQS--YGK-EADIWSAGVILYILLCGVPPFWAETD-  240 (494)
Q Consensus       165 Ili~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~-~~Di~slG~il~~l~tg~~pf~~~~~-  240 (494)
                      |++   +.++.++|+|||.+...... ......+++.|+|||++.+.  ++. ++|||||||++|+|++|..||..... 
T Consensus       183 il~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  258 (348)
T 2pml_X          183 ILM---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL  258 (348)
T ss_dssp             EEE---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred             EEE---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence            999   67889999999999865443 33456789999999998754  445 99999999999999999999988877 


Q ss_pred             HHHHHHHHcCCccCCCCC---------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          241 QGVAQAILKGEINFQRDP---------------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~---------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      .+....+......++...               ...++..+.++|.+||..||.+|||+.++++||||+..
T Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            677777766655444211               14688999999999999999999999999999999964

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.6e-44  Score=355.12  Aligned_cols=265  Identities=23%  Similarity=0.322  Sum_probs=217.4

Q ss_pred             hcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCC-----ccE
Q 040917           24 LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN-----IVQ   98 (494)
Q Consensus        24 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~-----i~~   98 (494)
                      ..+..+.+.++|++.+.||+|+||+||+|.+..+++.||+|++...    ......+.+|+.+++.+..|++     |+.
T Consensus        45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~  120 (382)
T 2vx3_A           45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVH  120 (382)
T ss_dssp             CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred             EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence            3445667789999999999999999999999999999999999642    2345677889999998865654     899


Q ss_pred             EeEEEEeCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCceEEeeCCCCC
Q 040917           99 FKAAYEDDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCH--SKGVMHRDLKPENFLFTTGDENA  174 (494)
Q Consensus        99 ~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH--~~~i~H~dikp~NIli~~~~~~~  174 (494)
                      +++++...+..++||||++| +|.+++...  ..++...+..++.||+.||.|||  +.||+||||||+||++.. +..+
T Consensus       121 ~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~  198 (382)
T 2vx3_A          121 LKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRS  198 (382)
T ss_dssp             EEEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSC
T ss_pred             eeeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCC
Confidence            99999999999999999965 999999765  35899999999999999999999  579999999999999943 2467


Q ss_pred             eEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc
Q 040917          175 VVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN  253 (494)
Q Consensus       175 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  253 (494)
                      .+||+|||++.....  ......+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+......
T Consensus       199 ~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  276 (382)
T 2vx3_A          199 AIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI  276 (382)
T ss_dssp             CEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred             cEEEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            899999999986543  2345678999999999875 5899999999999999999999999998887776665432110


Q ss_pred             CC-----------------------------------CCCCCC-------------------------CCHHHHHHHHHh
Q 040917          254 FQ-----------------------------------RDPFPS-------------------------ISSSAIELVRRM  273 (494)
Q Consensus       254 ~~-----------------------------------~~~~~~-------------------------~~~~l~~li~~~  273 (494)
                      .+                                   +.....                         .++.+.+||.+|
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m  356 (382)
T 2vx3_A          277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRM  356 (382)
T ss_dssp             CCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHh
Confidence            00                                   000000                         013689999999


Q ss_pred             cccCCCCCCCHHHHhcCCccCcc
Q 040917          274 LTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       274 l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      |..||.+|||+.++|+||||+..
T Consensus       357 L~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          357 LDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             TCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             cCCChhhCCCHHHHhcCcccccC
Confidence            99999999999999999999864

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.3e-44  Score=340.37  Aligned_cols=258  Identities=31%  Similarity=0.539  Sum_probs=220.7

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--CCeE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--DQFV  109 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--~~~~  109 (494)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++ ||||+++++++..  ....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGTEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCceE
Confidence            4689999999999999999999999999999999976543 3445678999999999995 9999999998754  5689


Q ss_pred             EEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCceEEeeCCCCCeEEEee
Q 040917          110 HIVMELCAGGELFDRIVAR----GHYSERAAASVFRVIMNVVNVCHSKG-----VMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~-----i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                      ++||||++|++|.+++...    ..+++..++.++.|++.||.|||++|     |+||||||+||++   +.++.++|+|
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~d  159 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGD  159 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEECC
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEec
Confidence            9999999999999998753    34899999999999999999999999     9999999999999   6788999999


Q ss_pred             cCCccccccCcc-cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCC
Q 040917          181 FGLSAFIEEGKA-YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP  258 (494)
Q Consensus       181 fg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (494)
                      ||.+........ .....+++.|+|||++.+ .++.++||||||+++|+|++|..||...........+..+.....   
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---  236 (279)
T 2w5a_A          160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---  236 (279)
T ss_dssp             CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---
T ss_pred             CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC---
Confidence            999876543322 234568999999999865 588999999999999999999999999888877777776654322   


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          259 FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       259 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ...+++.+.++|.+||..||.+|||+.++|+|+|+....
T Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            246789999999999999999999999999999998643

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.1e-45  Score=360.68  Aligned_cols=258  Identities=15%  Similarity=0.177  Sum_probs=198.8

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc-CCCCccEEe-------EEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS-GQPNIVQFK-------AAY  103 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~hp~i~~~~-------~~~  103 (494)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.|+ +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            346999999999999999999999999999999998766545556777888977666664 499987754       555


Q ss_pred             EeC-----------------CeEEEEEeccCCCchHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHHCCceecc
Q 040917          104 EDD-----------------QFVHIVMELCAGGELFDRIVAR-GHYSERAA------ASVFRVIMNVVNVCHSKGVMHRD  159 (494)
Q Consensus       104 ~~~-----------------~~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~------~~i~~~i~~~l~~LH~~~i~H~d  159 (494)
                      ...                 ...|+||||++ ++|.+++... ..++....      ..++.||+.||.|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            433                 34899999998 7999999764 23455555      67779999999999999999999


Q ss_pred             CCCCceEEeeCCCCCeEEEeecCCccccccCcccccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCC
Q 040917          160 LKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFW  236 (494)
Q Consensus       160 ikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~  236 (494)
                      |||+|||+   +.++.+||+|||++......  .....+|+.|+|||++.+   .++.++|||||||++|+|++|+.||.
T Consensus       220 ikp~NIll---~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          220 FTPDNLFI---MPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             CSGGGEEE---CTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CCHHHEEE---CCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            99999999   67889999999999865432  224567799999999864   58999999999999999999999997


Q ss_pred             CCChHHHH--HH---HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          237 AETDQGVA--QA---ILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       237 ~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      +.......  ..   ............++.+++.+.++|.+||..||++|||+.++|+||||+.
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence            76432100  00   0111112222334578999999999999999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.7e-44  Score=358.00  Aligned_cols=256  Identities=28%  Similarity=0.463  Sum_probs=210.0

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC----
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD----  106 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~----  106 (494)
                      ...+|++.+.||+|+||.||+|.+..+|+.||+|++.....       ...+|+.+++.++ ||||+++++++...    
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~  123 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKK  123 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEEETTT
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcC-CCCccceeeEEeccCCCC
Confidence            34589999999999999999999999999999999864321       1336999999995 99999999988531    


Q ss_pred             --CeEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917          107 --QFVHIVMELCAGGELFDRIV----ARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       107 --~~~~iv~e~~~g~sL~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                        ...++||||+++ +|.+.+.    ....++...+..++.||+.||.|||++||+||||||+|||++  .+.+.+||+|
T Consensus       124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~kl~D  200 (420)
T 1j1b_A          124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCD  200 (420)
T ss_dssp             TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEEECC
T ss_pred             cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEEecc
Confidence              246799999976 6666554    246799999999999999999999999999999999999995  3456899999


Q ss_pred             cCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC--------
Q 040917          181 FGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG--------  250 (494)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~--------  250 (494)
                      ||++.............+|+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+.+..+.+.        
T Consensus       201 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          201 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             CTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             chhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999987655555556788999999999864  5899999999999999999999999998876655554331        


Q ss_pred             ---------CccCCC---C-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          251 ---------EINFQR---D-----PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       251 ---------~~~~~~---~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                               ...++.   .     ..+.+++.+.+||.+||..||.+||++.++|+||||....
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence                     001110   0     1135689999999999999999999999999999998643

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.9e-44  Score=347.02  Aligned_cols=262  Identities=27%  Similarity=0.475  Sum_probs=198.7

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      -..++|++.+.||+|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++++. ||||+++++++...+..
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCC-CTTBCCEEEEEESSSCE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcC-CCCEeeEEEEEeecCCc
Confidence            345789999999999999999999999999999999865432  224567888999999995 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeec
Q 040917          110 HIVMELCAGGELFDRIVA--------RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDF  181 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Df  181 (494)
                      ++||||++|++|.+++..        ...++...+..++.||+.||.|||++|++||||||+||++   +.++.++|+||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~df  165 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADF  165 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCC
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEEec
Confidence            999999999999998864        3458999999999999999999999999999999999999   67889999999


Q ss_pred             CCccccccCc------ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc
Q 040917          182 GLSAFIEEGK------AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN  253 (494)
Q Consensus       182 g~a~~~~~~~------~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  253 (494)
                      |.+.......      ......+++.|+|||++.+  .++.++|||||||++|+|++|..||..................
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  245 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP  245 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence            9987553321      1234568999999999864  5899999999999999999999999887776655544443322


Q ss_pred             CC------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          254 FQ------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       254 ~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      ..      ......+++.+.++|.+||..||.+|||+.++++||||+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence            21      122356889999999999999999999999999999998643

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=347.40  Aligned_cols=261  Identities=26%  Similarity=0.424  Sum_probs=215.6

Q ss_pred             cccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           27 AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      ....+..+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+. ||||+++++++...
T Consensus        18 ~~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   95 (353)
T 3coi_A           18 TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPA   95 (353)
T ss_dssp             EEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred             cccccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCcccHhheEecc
Confidence            44557789999999999999999999999999999999997543 34445677889999999995 99999999999765


Q ss_pred             Ce------EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917          107 QF------VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       107 ~~------~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                      ..      .++||||+. ++|.+++.  ..++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|
T Consensus        96 ~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~D  169 (353)
T 3coi_A           96 SSLRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILD  169 (353)
T ss_dssp             SSGGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECS
T ss_pred             cccccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEee
Confidence            43      589999997 58887763  358999999999999999999999999999999999999   6788999999


Q ss_pred             cCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC-------
Q 040917          181 FGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE-------  251 (494)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~-------  251 (494)
                      ||++......  .....+|+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+.+..       
T Consensus       170 fg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  247 (353)
T 3coi_A          170 FGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  247 (353)
T ss_dssp             TTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred             cccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9999764332  345678999999999864  58999999999999999999999999888766555443210       


Q ss_pred             ----------------ccC----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          252 ----------------INF----QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       252 ----------------~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                                      ...    ....++.+++.+.++|.+||..||.+|||+.++|+||||+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence                            000    1122356789999999999999999999999999999998644

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.1e-44  Score=353.66  Aligned_cols=265  Identities=26%  Similarity=0.389  Sum_probs=209.5

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCC--------ChhhHHHHHHHHHHHHHccCCCCccEE
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV--------KDVEKDDVRREIEIMRHLSGQPNIVQF   99 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~--------~~~~~~~~~~E~~~l~~l~~hp~i~~~   99 (494)
                      ...+.++|++++.||+|+||.||+|.+.. |..||+|++......        .......+.+|+.++++++ ||||+++
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~   94 (362)
T 3pg1_A           17 LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGL   94 (362)
T ss_dssp             HHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCCC
T ss_pred             HHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCccce
Confidence            44567899999999999999999999865 999999998654322        1223477899999999995 9999999


Q ss_pred             eEEEEe-----CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCC
Q 040917          100 KAAYED-----DQFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDEN  173 (494)
Q Consensus       100 ~~~~~~-----~~~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~  173 (494)
                      ++++..     ....++||||++ ++|.+.+... ..++...+..++.||+.||.|||++||+||||||+||++   +.+
T Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~  170 (362)
T 3pg1_A           95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADN  170 (362)
T ss_dssp             SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTT
T ss_pred             eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cCC
Confidence            999843     347899999997 5888877654 368999999999999999999999999999999999999   678


Q ss_pred             CeEEEeecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCC
Q 040917          174 AVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGE  251 (494)
Q Consensus       174 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  251 (494)
                      +.++|+|||++.............+++.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+....
T Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  250 (362)
T 3pg1_A          171 NDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV  250 (362)
T ss_dssp             CCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             CCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence            8999999999986555555556678999999998864  58999999999999999999999999888776665553211


Q ss_pred             c------------------------cCCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          252 I------------------------NFQRD----PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       252 ~------------------------~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                      .                        ..+..    ..+.+++.+.++|.+||..||.+|||+.++|+||||+....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  325 (362)
T 3pg1_A          251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD  325 (362)
T ss_dssp             CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence            1                        00000    12456889999999999999999999999999999997543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.5e-44  Score=350.78  Aligned_cols=261  Identities=25%  Similarity=0.380  Sum_probs=203.4

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC----
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ----  107 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~----  107 (494)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.....    ......+++..+..+ +||||+++++++....    
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTT----CCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCT
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc----ccHHHHHHHHHHHhc-CCCCcccHHHhhhccccccc
Confidence            3689999999999999999999999999999999865432    233456778888888 4999999999986533    


Q ss_pred             ---eEEEEEeccCCCchHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCceEEeeCCCCCeEEE
Q 040917          108 ---FVHIVMELCAGGELFDRI----VARGHYSERAAASVFRVIMNVVNVCH--SKGVMHRDLKPENFLFTTGDENAVVKA  178 (494)
Q Consensus       108 ---~~~iv~e~~~g~sL~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~i~H~dikp~NIli~~~~~~~~~kL  178 (494)
                         ..++||||+++ +|...+    .....++...+..++.|++.||.|||  ++||+||||||+||+++  ..++.+||
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl  173 (360)
T 3e3p_A           97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKL  173 (360)
T ss_dssp             TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEE
T ss_pred             cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEE
Confidence               38899999987 554433    34567899999999999999999999  99999999999999994  24789999


Q ss_pred             eecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC-
Q 040917          179 TDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ-  255 (494)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-  255 (494)
                      +|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.........+.+...... 
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (360)
T 3e3p_A          174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR  253 (360)
T ss_dssp             CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence            99999987766555556778999999999854  389999999999999999999999999888777666543111100 


Q ss_pred             ---------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCC
Q 040917          256 ---------------------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS  300 (494)
Q Consensus       256 ---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~  300 (494)
                                                 .......++.+.+||.+||..||.+|||+.++|+||||+....+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  325 (360)
T 3e3p_A          254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA  325 (360)
T ss_dssp             HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred             HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence                                       011123567899999999999999999999999999999765443

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=9e-44  Score=351.36  Aligned_cols=260  Identities=22%  Similarity=0.302  Sum_probs=219.4

Q ss_pred             cccccceEeeeeecccCCeEEEEEE-----ECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEE
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY  103 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~-----~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~  103 (494)
                      +-...+|++++.||+|+||.||+|.     +..++..||+|++...  ........+.+|+.+++++ +||||+++++++
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~  143 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKF-NHQNIVRCIGVS  143 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhC-CCCCCCeEEEEE
Confidence            3445889999999999999999999     4557889999999643  2344566788999999999 499999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917          104 EDDQFVHIVMELCAGGELFDRIVARG-------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV  176 (494)
Q Consensus       104 ~~~~~~~iv~e~~~g~sL~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~  176 (494)
                      ......++||||++|++|.+++....       .++...+..++.||+.||.|||++||+||||||+||+++.++....+
T Consensus       144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence            99888999999999999999997653       48999999999999999999999999999999999999654456679


Q ss_pred             EEeecCCccccccC---cccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCC
Q 040917          177 KATDFGLSAFIEEG---KAYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGE  251 (494)
Q Consensus       177 kL~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~  251 (494)
                      ||+|||++......   .......+|+.|+|||++. +.++.++|||||||++|+|++ |..||.+....+....+..+.
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~  303 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG  303 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            99999999754322   1223356788999999885 468999999999999999998 999999999888888887765


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917          252 INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK  294 (494)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  294 (494)
                      ....   ...++..+.+++.+||..||.+|||+.+++++.++.
T Consensus       304 ~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          304 RMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            4322   246789999999999999999999999999986664

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.7e-43  Score=340.06  Aligned_cols=254  Identities=25%  Similarity=0.468  Sum_probs=209.5

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-----
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-----  105 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-----  105 (494)
                      +.++|++++.||+|+||.||+|.+..+++.||+|++...    ......+.+|+.+++++. ||||+++++++..     
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchh
Confidence            457899999999999999999999999999999998532    335677889999999995 9999999998854     


Q ss_pred             --------CCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917          106 --------DQFVHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV  176 (494)
Q Consensus       106 --------~~~~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~  176 (494)
                              ....++||||++|++|.+++.... .++...++.++.||+.||.|||++||+||||||+||++   +.++.+
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~  155 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNV  155 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCE
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCE
Confidence                    357899999999999999998644 57889999999999999999999999999999999999   678899


Q ss_pred             EEeecCCccccccC---------------cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCC-
Q 040917          177 KATDFGLSAFIEEG---------------KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAE-  238 (494)
Q Consensus       177 kL~Dfg~a~~~~~~---------------~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~-  238 (494)
                      +|+|||.+......               .......+++.|+|||++.+  .++.++|||||||++|+|++   ||... 
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~  232 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM  232 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence            99999998765321               12234568999999999864  58999999999999999998   55432 


Q ss_pred             ChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          239 TDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      ........+......++.......+..+.++|.+||..||.+|||+.++++||||+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            233445555555555555555667889999999999999999999999999999985

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3e-43  Score=343.99  Aligned_cols=264  Identities=28%  Similarity=0.434  Sum_probs=216.6

Q ss_pred             ccccccccceEeeeeecccCCeEEEEEEE-CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCC------CccE
Q 040917           26 KAYEDVQLHYTIGREVGRGEFGITYLCTE-NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP------NIVQ   98 (494)
Q Consensus        26 ~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~-~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp------~i~~   98 (494)
                      +..+.+.++|++.+.||+|+||.||+|.+ ..+++.||+|++...    ......+.+|+.+++.+. |+      ++++
T Consensus         7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~-~~~~~~~~~i~~   81 (339)
T 1z57_A            7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLN-TTDPNSTFRCVQ   81 (339)
T ss_dssp             STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHH-HHCTTCTTCBCC
T ss_pred             ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhh-hcCCCCceeeEe
Confidence            34556778999999999999999999998 568899999998632    234677889999999885 54      5999


Q ss_pred             EeEEEEeCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCC----
Q 040917           99 FKAAYEDDQFVHIVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDE----  172 (494)
Q Consensus        99 ~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~----  172 (494)
                      +++++...+..++||||+ +++|.+++...+  .++...+..++.||+.||.|||++||+||||||+||+++..+.    
T Consensus        82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~  160 (339)
T 1z57_A           82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY  160 (339)
T ss_dssp             EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred             eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence            999999999999999999 889999998765  6889999999999999999999999999999999999953211    


Q ss_pred             ------------CCeEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 040917          173 ------------NAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET  239 (494)
Q Consensus       173 ------------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~  239 (494)
                                  .+.++|+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|+|++|..||....
T Consensus       161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          161 NPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             C----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             CCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                        66899999999976433  2345678999999999865 68999999999999999999999999888


Q ss_pred             hHHHHHHHHcCCccCCC----------------------------------------CCCCCCCHHHHHHHHHhcccCCC
Q 040917          240 DQGVAQAILKGEINFQR----------------------------------------DPFPSISSSAIELVRRMLTQDPK  279 (494)
Q Consensus       240 ~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~l~~li~~~l~~dp~  279 (494)
                      ..+....+.......+.                                        ......++.+.++|.+||..||.
T Consensus       239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  318 (339)
T 1z57_A          239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA  318 (339)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence            77655444321111100                                        00112346788999999999999


Q ss_pred             CCCCHHHHhcCCccCccC
Q 040917          280 RRITVAQVLEHPWLKESG  297 (494)
Q Consensus       280 ~Rps~~eil~~~~~~~~~  297 (494)
                      +|||+.++|+||||+...
T Consensus       319 ~Rpt~~ell~hp~f~~~~  336 (339)
T 1z57_A          319 KRITLREALKHPFFDLLK  336 (339)
T ss_dssp             TSCCHHHHTTSGGGGGGG
T ss_pred             cccCHHHHhcCHHHHHHh
Confidence            999999999999998643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.7e-43  Score=348.20  Aligned_cols=251  Identities=23%  Similarity=0.347  Sum_probs=214.6

Q ss_pred             cccceEeeeeecccCCeEEEEEEEC-------CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTEN-------STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY  103 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~-------~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~  103 (494)
                      ..++|++++.||+|+||.||+|.+.       .++..||+|++....  .......+.+|+.+++++.+||||+++++++
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            3478999999999999999999874       345679999996542  3445678999999999995599999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEE
Q 040917          104 EDDQFVHIVMELCAGGELFDRIVARG----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLF  167 (494)
Q Consensus       104 ~~~~~~~iv~e~~~g~sL~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli  167 (494)
                      ...+..|+||||++||+|.+++....                .++...+..++.||+.||.|||++||+||||||+||++
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  236 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence            99999999999999999999998653                37889999999999999999999999999999999999


Q ss_pred             eeCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 040917          168 TTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQG  242 (494)
Q Consensus       168 ~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~  242 (494)
                         +.++.+||+|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+
T Consensus       237 ---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          237 ---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             ---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             ---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence               6788999999999986543322   223456788999998864 58999999999999999999 999999988887


Q ss_pred             HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          243 VAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ....+..+....   ....++..+.++|.+||..||.+||++.++++
T Consensus       314 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~  357 (370)
T 2psq_A          314 LFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  357 (370)
T ss_dssp             HHHHHHTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            777776654322   22468899999999999999999999999987

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.5e-43  Score=344.03  Aligned_cols=262  Identities=21%  Similarity=0.349  Sum_probs=198.6

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCc---EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGL---EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~---~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      -..++|++++.||+|+||.||+|.+..++.   .||+|++...... ......+.+|+.+++++ +||||+++++++...
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEF-DHPHVAKLVGVSLRS   97 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHC-CCCceehhhceeecc
Confidence            345789999999999999999999887765   8999999754433 33567899999999999 599999999999876


Q ss_pred             CeE------EEEEeccCCCchHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917          107 QFV------HIVMELCAGGELFDRIVARG------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA  174 (494)
Q Consensus       107 ~~~------~iv~e~~~g~sL~~~~~~~~------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~  174 (494)
                      ...      ++||||+++++|.+++....      .++...+..++.||+.||.|||++||+||||||+||++   +.++
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~~  174 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDM  174 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTS
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCCC
Confidence            654      89999999999999986543      58999999999999999999999999999999999999   6788


Q ss_pred             eEEEeecCCccccccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHc
Q 040917          175 VVKATDFGLSAFIEEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILK  249 (494)
Q Consensus       175 ~~kL~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~  249 (494)
                      .++|+|||++.........   ....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~  254 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG  254 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence            9999999999765443322   23345778999999865 58999999999999999999 9999999888888777766


Q ss_pred             CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCC-------HHHHhcCCccCccCcC
Q 040917          250 GEINFQRDPFPSISSSAIELVRRMLTQDPKRRIT-------VAQVLEHPWLKESGEA  299 (494)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-------~~eil~~~~~~~~~~~  299 (494)
                      ......   .+.+++.+.+++.+||..||.+|||       .+++++|||+....+.
T Consensus       255 ~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~  308 (323)
T 3qup_A          255 GNRLKQ---PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD  308 (323)
T ss_dssp             TCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred             CCCCCC---CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence            543322   2568899999999999999999999       7788999999975543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.6e-43  Score=342.35  Aligned_cols=250  Identities=23%  Similarity=0.374  Sum_probs=213.9

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcE---EEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLE---FACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~---valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ..++|++.+.||+|+||.||+|.+..+++.   ||+|++....  .......+.+|+.+++++. ||||+++++++...+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRGR  123 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECGGG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence            457999999999999999999999866554   9999996433  3445678999999999995 999999999999988


Q ss_pred             eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          108 FVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      ..++||||++|++|.+++... ..++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++..
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCEE
T ss_pred             ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCcccc
Confidence            999999999999999999654 579999999999999999999999999999999999999   6788999999999986


Q ss_pred             cccCcc----cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 040917          187 IEEGKA----YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFP  260 (494)
Q Consensus       187 ~~~~~~----~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (494)
                      ......    .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||......+....+..+....   ...
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~  277 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP---APM  277 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---CCT
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC---CCC
Confidence            543321    12234577899999987 468999999999999999999 999999999888888777653322   224


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          261 SISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+++.+.++|.+||..||.+|||+.++++
T Consensus       278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          278 GCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            68999999999999999999999999987

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.6e-43  Score=339.09  Aligned_cols=257  Identities=25%  Similarity=0.374  Sum_probs=209.0

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++. ||||+++++++...+
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDG  107 (309)
T ss_dssp             -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETT
T ss_pred             CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCC
Confidence            3344578999999999999999999999999999999997655445555678999999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      ..++||||++|++|.+++...+.++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++...
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC----
T ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCccc
Confidence            999999999999999999988889999999999999999999999999999999999999   67889999999998765


Q ss_pred             ccCc--ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          188 EEGK--AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       188 ~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      ....  ......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+ ......+....+.+|+
T Consensus       185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  263 (309)
T 2h34_A          185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVRPGIPV  263 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCCGGGTSTTCCT
T ss_pred             cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCCccccCCCCCH
Confidence            4332  2234568999999999864 5889999999999999999999999887665443333 3333333334467899


Q ss_pred             HHHHHHHHhcccCCCCCC-CHHHHhc
Q 040917          265 SAIELVRRMLTQDPKRRI-TVAQVLE  289 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rp-s~~eil~  289 (494)
                      .+.++|.+||..||.+|| +++++++
T Consensus       264 ~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          264 AFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            999999999999999999 8888775

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=7.3e-43  Score=329.91  Aligned_cols=248  Identities=23%  Similarity=0.384  Sum_probs=214.4

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      -.++|++.+.||+|+||.||+|.+. ++..||+|++.....    ....+.+|+.+++++. ||||+++++++......+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLS-HPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCceE
Confidence            3478999999999999999999876 577899999975432    3467899999999995 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          111 IVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      +||||++|++|.+++...+ .++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||.+.....
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECCT
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecch
Confidence            9999999999999997754 49999999999999999999999999999999999999   6788999999999976544


Q ss_pred             Cccc--ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          190 GKAY--REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       190 ~~~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ....  ....+++.|+|||++.+ .++.++||||||+++|+|++ |..||...........+........+   ..+++.
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  233 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASDT  233 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSCHH
T ss_pred             hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcChHH
Confidence            3221  23345678999999875 68999999999999999999 99999999888887777666543333   356899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      +.+++.+||..||.+|||+.+++++
T Consensus       234 l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          234 IYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999984

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=8.6e-43  Score=337.13  Aligned_cols=264  Identities=23%  Similarity=0.435  Sum_probs=213.2

Q ss_pred             cccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccC-CCCccEEeEEEEe
Q 040917           27 AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSG-QPNIVQFKAAYED  105 (494)
Q Consensus        27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-hp~i~~~~~~~~~  105 (494)
                      .......+|++.+.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.+++++.. ||||+++++++..
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   99 (313)
T 3cek_A           22 SMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   99 (313)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred             eeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence            34445578999999999999999999985 589999999975543 34456788999999999963 6999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          106 DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      ....++||| +.+++|.+++.....++...+..++.||+.||.|||++||+||||||+||+++    ++.++|+|||++.
T Consensus       100 ~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~  174 (313)
T 3cek_A          100 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIAN  174 (313)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSC
T ss_pred             CCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeeccccc
Confidence            999999999 55789999999888899999999999999999999999999999999999994    4789999999998


Q ss_pred             ccccCcc---cccccCCcCccChhhhcc------------cCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHc
Q 040917          186 FIEEGKA---YREIVGSPYYIAPEVLSQ------------SYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILK  249 (494)
Q Consensus       186 ~~~~~~~---~~~~~~~~~y~aPE~~~~------------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~  249 (494)
                      .......   .....|++.|+|||++.+            .++.++|||||||++|+|++|..||...... .....+..
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  254 (313)
T 3cek_A          175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  254 (313)
T ss_dssp             C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred             cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence            6543221   234568999999999864            5788999999999999999999999776443 23333333


Q ss_pred             CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917          250 GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  299 (494)
                      ......  .....+..+.++|.+||..||.+|||+.++|+||||+....+
T Consensus       255 ~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  302 (313)
T 3cek_A          255 PNHEIE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  302 (313)
T ss_dssp             TTSCCC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred             cccccC--CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence            322222  123457899999999999999999999999999999875433

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.1e-43  Score=330.65  Aligned_cols=247  Identities=24%  Similarity=0.410  Sum_probs=213.6

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      ..+|++.+.||+|+||.||+|.+. +++.||+|++.....    ..+.+.+|+.++++++ ||||+++++++.+....++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l   82 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICL   82 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCceEE
Confidence            378999999999999999999987 577899999975432    3467899999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          112 VMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      ||||++|++|.+++... ..++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCH
T ss_pred             EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEecccccccccccc
Confidence            99999999999999654 458999999999999999999999999999999999999   67789999999999765432


Q ss_pred             c--ccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917          191 K--AYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       191 ~--~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (494)
                      .  ......+++.|+|||++. ..++.++|+||||+++|+|++ |..||......+....+........+   ..+++.+
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  236 (269)
T 4hcu_A          160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHV  236 (269)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTSCHHH
T ss_pred             ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCC---CcCCHHH
Confidence            2  122345677899999986 468999999999999999999 99999999988888877765333222   4578999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcC
Q 040917          267 IELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      .+++.+||..||.+|||+.+++++
T Consensus       237 ~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          237 YQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCCcccCcCHHHHHHH
Confidence            999999999999999999999984

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.3e-43  Score=354.56  Aligned_cols=262  Identities=22%  Similarity=0.378  Sum_probs=207.8

Q ss_pred             cccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc-------CCCCccEE
Q 040917           27 AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS-------GQPNIVQF   99 (494)
Q Consensus        27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~-------~hp~i~~~   99 (494)
                      ..+.+.++|++.+.||+|+||+||+|.+..+++.||+|++...    ......+.+|+.++++++       +||||+++
T Consensus        31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~  106 (397)
T 1wak_A           31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQL  106 (397)
T ss_dssp             TTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred             hhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence            3455678999999999999999999999999999999999632    335677889999999995       27889999


Q ss_pred             eEEEE----eCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeCC-
Q 040917          100 KAAYE----DDQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGD-  171 (494)
Q Consensus       100 ~~~~~----~~~~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~~-  171 (494)
                      ++++.    .....++||||+ +++|.+.+...  ..++...+..++.||+.||.|||++ ||+||||||+|||++.++ 
T Consensus       107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~  185 (397)
T 1wak_A          107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ  185 (397)
T ss_dssp             EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHH
T ss_pred             ecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccch
Confidence            99987    456899999999 55777766554  4699999999999999999999998 999999999999995211 


Q ss_pred             ---------------------------------------------CCCeEEEeecCCccccccCcccccccCCcCccChh
Q 040917          172 ---------------------------------------------ENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPE  206 (494)
Q Consensus       172 ---------------------------------------------~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE  206 (494)
                                                                   ....++|+|||.+......  .....||+.|+|||
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE  263 (397)
T 1wak_A          186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHH
T ss_pred             hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCCh
Confidence                                                         1137999999999765432  34567899999999


Q ss_pred             hhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHcCCccCC---------------C--------
Q 040917          207 VLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD------QGVAQAILKGEINFQ---------------R--------  256 (494)
Q Consensus       207 ~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~------~~~~~~~~~~~~~~~---------------~--------  256 (494)
                      ++.+ .++.++|||||||++|+|++|+.||.....      ......+.......+               .        
T Consensus       264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence            9875 589999999999999999999999976552      222222211000000               0        


Q ss_pred             ---------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          257 ---------------DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       257 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                                     ......+..+.+||.+||..||.+|||+.++|+||||++
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                           000122456889999999999999999999999999973

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.7e-43  Score=342.99  Aligned_cols=261  Identities=30%  Similarity=0.551  Sum_probs=216.1

Q ss_pred             hcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCCh---hhHHHHHHHHHHHHHcc-CCCCccEE
Q 040917           24 LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD---VEKDDVRREIEIMRHLS-GQPNIVQF   99 (494)
Q Consensus        24 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~---~~~~~~~~E~~~l~~l~-~hp~i~~~   99 (494)
                      ..+..+.+.++|++++.||+|+||.||+|.+..+++.||+|++........   .....+.+|+.+++++. +||||+++
T Consensus        34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~  113 (320)
T 3a99_A           34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL  113 (320)
T ss_dssp             ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred             cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence            344556678999999999999999999999999999999999976543221   12244667999999996 36999999


Q ss_pred             eEEEEeCCeEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEE
Q 040917          100 KAAYEDDQFVHIVMELCAG-GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKA  178 (494)
Q Consensus       100 ~~~~~~~~~~~iv~e~~~g-~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL  178 (494)
                      ++++...+..++|+|++.+ ++|.+++...+.++...+..++.||+.||.|||++||+||||||+||+++  ..++.+||
T Consensus       114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL  191 (320)
T 3a99_A          114 LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKL  191 (320)
T ss_dssp             EEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEE
T ss_pred             EEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEE
Confidence            9999999999999999976 89999998888899999999999999999999999999999999999994  26789999


Q ss_pred             eecCCccccccCcccccccCCcCccChhhhcc-c-CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC
Q 040917          179 TDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-S-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR  256 (494)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~-~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  256 (494)
                      +|||++...... ......||+.|+|||++.+ . .+.++|||||||++|+|++|..||....      .+......+  
T Consensus       192 ~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~--  262 (320)
T 3a99_A          192 IDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFF--  262 (320)
T ss_dssp             CCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCC--
T ss_pred             eeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccc--
Confidence            999999866433 2345678999999998864 3 3678999999999999999999996532      122222222  


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          257 DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       257 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                        ...+++.+.++|.+||..||.+|||+.++++||||+...
T Consensus       263 --~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          263 --RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             --SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             --cccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence              246889999999999999999999999999999999743

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=341.47  Aligned_cols=248  Identities=26%  Similarity=0.441  Sum_probs=208.6

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++++.||+|+||+||+|.+..+++.||+|++...   .......+.+|+.++++++ ||||+++++++.++...++
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l   84 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRLNF   84 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCeeEE
Confidence            37899999999999999999999999999999998542   3456778999999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          112 VMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      ||||++|++|.+++.. ...++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++......
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC--
T ss_pred             EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceecccc
Confidence            9999999999999987 4679999999999999999999999999999999999999   67889999999999765432


Q ss_pred             ccc---------------ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHc
Q 040917          191 KAY---------------REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGV-----AQAILK  249 (494)
Q Consensus       191 ~~~---------------~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~-----~~~~~~  249 (494)
                      ...               ....||+.|+|||++.+ .++.++|||||||++|+|++|..||........     ......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence            211               14568999999999875 589999999999999999999999865432110     000000


Q ss_pred             CCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917          250 GEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK  294 (494)
Q Consensus       250 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  294 (494)
                            ....+.+|+.+.+++.+||..||++|||+.++++  |+.
T Consensus       242 ------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~  278 (310)
T 3s95_A          242 ------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLE  278 (310)
T ss_dssp             ------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred             ------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHH
Confidence                  0112467889999999999999999999999988  554

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.2e-43  Score=347.97  Aligned_cols=254  Identities=22%  Similarity=0.346  Sum_probs=210.5

Q ss_pred             cccccceEeeeeecccCCeEEEEEE-----ECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEE
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY  103 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~-----~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~  103 (494)
                      +-..++|++++.||+|+||.||+|.     +..+++.||+|++....  .......+.+|+.++.++.+||||+++++++
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~   95 (359)
T 3vhe_A           18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC   95 (359)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence            3345899999999999999999999     56677999999997543  3334677899999999997799999999999


Q ss_pred             EeCC-eEEEEEeccCCCchHHHHHhcCC----------------------------------------------------
Q 040917          104 EDDQ-FVHIVMELCAGGELFDRIVARGH----------------------------------------------------  130 (494)
Q Consensus       104 ~~~~-~~~iv~e~~~g~sL~~~~~~~~~----------------------------------------------------  130 (494)
                      ...+ ..++||||++||+|.+++.....                                                    
T Consensus        96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence            7754 58999999999999999976543                                                    


Q ss_pred             --------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc---c
Q 040917          131 --------------YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA---Y  193 (494)
Q Consensus       131 --------------l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~---~  193 (494)
                                    ++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++........   .
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRK  252 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccchhc
Confidence                          8899999999999999999999999999999999999   6788999999999976533222   2


Q ss_pred             ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHH-HHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          194 REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVA-QAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       194 ~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      ....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....... ..+..... ..  ....+++.+.+++
T Consensus       253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~l~~li  329 (359)
T 3vhe_A          253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MR--APDYTTPEMYQTM  329 (359)
T ss_dssp             --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-CC--CCTTCCHHHHHHH
T ss_pred             cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC-CC--CCCCCCHHHHHHH
Confidence            3456788999999886 468999999999999999998 99999887654443 33333322 22  1245789999999


Q ss_pred             HHhcccCCCCCCCHHHHhcC
Q 040917          271 RRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       271 ~~~l~~dp~~Rps~~eil~~  290 (494)
                      .+||..||.+|||+.++++|
T Consensus       330 ~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          330 LDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhhCCCHHHHHHH
Confidence            99999999999999999984

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=7.9e-43  Score=334.38  Aligned_cols=255  Identities=27%  Similarity=0.478  Sum_probs=206.9

Q ss_pred             eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917           35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME  114 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e  114 (494)
                      |.....||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.+. ||||+++++++...+..++|||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEEEEEE
Confidence            334458999999999999999999999999986543   234577889999999995 9999999999999999999999


Q ss_pred             ccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          115 LCAGGELFDRIVARG---HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       115 ~~~g~sL~~~~~~~~---~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      |++|++|.+++....   .++...+..++.||+.||.|||++||+||||||+||+++  ..++.++|+|||.+.......
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC--
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCC
Confidence            999999999997652   467889999999999999999999999999999999995  237899999999997654322


Q ss_pred             -ccccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHcCCccCCCCCCCCCCHHH
Q 040917          192 -AYREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVA-QAILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       192 -~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l  266 (494)
                       ......|++.|+|||++.+   .++.++||||||+++|+|++|+.||......... .....  ..........+++.+
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  255 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM--FKVHPEIPESMSAEA  255 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH--HCCCCCCCTTSCHHH
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc--ccccccccccCCHHH
Confidence             2234578999999999864   2788999999999999999999999765433221 11111  111222235689999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          267 IELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      .++|.+||..||++|||+.++|+||||+...
T Consensus       256 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          256 KAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             HHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             HHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence            9999999999999999999999999998644

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.5e-43  Score=343.51  Aligned_cols=249  Identities=19%  Similarity=0.232  Sum_probs=206.3

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      +..+|++.+.||+|+||.||+|.+..+|+.||+|++.....     ...+.+|+.++++|.+||||+++++++......+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   81 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA   81 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence            45789999999999999999999999999999999865432     2357889999999966999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCe-----EEEeecCCc
Q 040917          111 IVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAV-----VKATDFGLS  184 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~-----~kL~Dfg~a  184 (494)
                      +||||+ |++|.+++... ..++...+..++.||+.||.|||++||+||||||+||+++   .++.     ++|+|||++
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~---~~~~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG---RPGNKTQQVIHIIDFALA  157 (330)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---CGGGTCTTSEEECCCTTC
T ss_pred             EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---cCCCCCCceEEEEEcccc
Confidence            999999 89999999863 6799999999999999999999999999999999999994   4444     999999999


Q ss_pred             cccccCcc--------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHcCCc
Q 040917          185 AFIEEGKA--------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD---QGVAQAILKGEI  252 (494)
Q Consensus       185 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~---~~~~~~~~~~~~  252 (494)
                      ........        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...   .+....+.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~  237 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR  237 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence            86543221        235678999999999875 589999999999999999999999987543   333344433222


Q ss_pred             cCCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          253 NFQRD-PFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       253 ~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ..+.. ....+| .+.+++..||..||.+||+++++++
T Consensus       238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            22211 122345 8999999999999999999998876

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=344.20  Aligned_cols=254  Identities=24%  Similarity=0.348  Sum_probs=217.8

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCC-------CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeE
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENST-------GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKA  101 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~-------~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~  101 (494)
                      +-..++|.+++.||+|+||.||+|.+..+       +..||+|++....  .......+.+|+.+++++.+||||+++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  142 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG  142 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence            44558999999999999999999997543       3579999997543  34456788999999999966999999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 040917          102 AYEDDQFVHIVMELCAGGELFDRIVARG----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENF  165 (494)
Q Consensus       102 ~~~~~~~~~iv~e~~~g~sL~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NI  165 (494)
                      ++...+..++||||++|++|.+++....                .+++..+..++.||+.||.|||++||+||||||+||
T Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  222 (382)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence            9999999999999999999999998754                489999999999999999999999999999999999


Q ss_pred             EEeeCCCCCeEEEeecCCccccccCc---ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 040917          166 LFTTGDENAVVKATDFGLSAFIEEGK---AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETD  240 (494)
Q Consensus       166 li~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~  240 (494)
                      ++   +.++.+||+|||++.......   ......+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+...
T Consensus       223 ll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~  299 (382)
T 3tt0_A          223 LV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  299 (382)
T ss_dssp             EE---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             EE---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99   678899999999998654332   2233456788999999865 58999999999999999999 9999999988


Q ss_pred             HHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          241 QGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      .+....+..+.....   ...+++.+.++|.+||..||.+|||+.+++++
T Consensus       300 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          300 EELFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            888877766543322   24688999999999999999999999999983

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=336.33  Aligned_cols=264  Identities=28%  Similarity=0.377  Sum_probs=199.6

Q ss_pred             ccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917           26 KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED  105 (494)
Q Consensus        26 ~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~  105 (494)
                      +.+..-.++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+..+..+++.+ +||||+++++++..
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~   95 (318)
T 2dyl_A           18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSH-DCPYIVQCFGTFIT   95 (318)
T ss_dssp             SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEEC
T ss_pred             hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhc-CCCceeeEEEEEec
Confidence            3444455789999999999999999999999999999999975432 222233344444566667 59999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEeecCC
Q 040917          106 DQFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATDFGL  183 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~Dfg~  183 (494)
                      ....++||||+ ++.+..+... ...++...+..++.||+.||.|||++ ||+||||||+||++   +.++.++|+|||+
T Consensus        96 ~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~  171 (318)
T 2dyl_A           96 NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGI  171 (318)
T ss_dssp             SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTT
T ss_pred             CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCC
Confidence            99999999999 5555555543 46799999999999999999999995 99999999999999   6788999999999


Q ss_pred             ccccccCcccccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHcCCccCCC
Q 040917          184 SAFIEEGKAYREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAE-TDQGVAQAILKGEINFQR  256 (494)
Q Consensus       184 a~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~-~~~~~~~~~~~~~~~~~~  256 (494)
                      +.............+++.|+|||++.      ..++.++|||||||++|+|++|..||... ...+....+........+
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  251 (318)
T 2dyl_A          172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP  251 (318)
T ss_dssp             C--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC
T ss_pred             chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC
Confidence            97665544445567899999999984      35788999999999999999999999874 444555555554333222


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          257 DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       257 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                       ....+++.+.++|.+||..||.+||++.++++||||+..
T Consensus       252 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          252 -GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             -SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             -ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence             224689999999999999999999999999999999864

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.4e-43  Score=336.69  Aligned_cols=256  Identities=20%  Similarity=0.311  Sum_probs=211.2

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||+|++....     ....+.+|+.+++.+.+|||++++++++....
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   79 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   79 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence            3446689999999999999999999999999999999986543     23357889999999977999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC--CCCCeEEEeecCCc
Q 040917          108 FVHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG--DENAVVKATDFGLS  184 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~--~~~~~~kL~Dfg~a  184 (494)
                      ..++||||+ |++|.+++...+ .++...+..++.||+.||.|||++||+||||||+||+++.+  .....++|+|||++
T Consensus        80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            999999999 899999998754 59999999999999999999999999999999999999532  22345999999999


Q ss_pred             cccccCcc--------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHcCCc
Q 040917          185 AFIEEGKA--------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET---DQGVAQAILKGEI  252 (494)
Q Consensus       185 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~---~~~~~~~~~~~~~  252 (494)
                      ........        .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..   .......+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  238 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence            86543321        234568999999999875 58999999999999999999999998743   3333333332222


Q ss_pred             cCC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          253 NFQ-RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       253 ~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ..+ ....+.+|+.+.+++.+||..||.+||++.++++
T Consensus       239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            111 1123468899999999999999999999999987

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.3e-42  Score=330.91  Aligned_cols=250  Identities=23%  Similarity=0.370  Sum_probs=212.6

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      .-...+|++++.||+|+||.||+|.+. ++..||+|++.....    ....+.+|+.+++++. ||||+++++++.....
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   93 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRP   93 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCC-CCCEeeEEEEEecCCC
Confidence            334579999999999999999999886 677899999975432    3467889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .++||||++|++|.+++.. ...++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||.+...
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGB
T ss_pred             eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEccccccccc
Confidence            9999999999999999976 4579999999999999999999999999999999999999   67889999999999765


Q ss_pred             ccCcc--cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917          188 EEGKA--YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       188 ~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      .....  .....+++.|+|||++. ..++.++|+||||+++|+|++ |+.||...........+........+   ...+
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~  247 (283)
T 3gen_A          171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLAS  247 (283)
T ss_dssp             CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTCC
T ss_pred             cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---CcCC
Confidence            43221  12344577899999986 468999999999999999998 99999999988888777766443332   4568


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          264 SSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      +.+.+++.+||..||.+|||+.++++|
T Consensus       248 ~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          248 EKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999999999974

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.1e-43  Score=340.36  Aligned_cols=268  Identities=22%  Similarity=0.288  Sum_probs=221.0

Q ss_pred             hhhhcccccccccceEeeeeecccCCeEEEEEE-----ECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCC
Q 040917           21 DAILGKAYEDVQLHYTIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN   95 (494)
Q Consensus        21 ~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~-----~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~   95 (494)
                      .+.+.+..+-..++|++++.||+|+||.||+|.     +..++..||+|++....  .......+.+|+.+++++ +|||
T Consensus        18 sss~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~   94 (327)
T 2yfx_A           18 TSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKF-NHQN   94 (327)
T ss_dssp             EECGGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHC-CCTT
T ss_pred             ccchhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhC-CCCC
Confidence            445555555667899999999999999999999     55678899999996432  344567788999999999 5999


Q ss_pred             ccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEe
Q 040917           96 IVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG-------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFT  168 (494)
Q Consensus        96 i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~  168 (494)
                      |+++++++......++||||++|++|.+++....       .++...+..++.||+.||.|||++||+||||||+||+++
T Consensus        95 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~  174 (327)
T 2yfx_A           95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT  174 (327)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred             CCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEe
Confidence            9999999999888999999999999999998753       488999999999999999999999999999999999996


Q ss_pred             eCCCCCeEEEeecCCccccccCc---ccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 040917          169 TGDENAVVKATDFGLSAFIEEGK---AYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGV  243 (494)
Q Consensus       169 ~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~  243 (494)
                      ..+....++|+|||++.......   ......+++.|+|||++. +.++.++|||||||++|+|++ |..||......+.
T Consensus       175 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  254 (327)
T 2yfx_A          175 CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV  254 (327)
T ss_dssp             CSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             cCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH
Confidence            54456789999999987543222   122345788999999885 468999999999999999998 9999999888888


Q ss_pred             HHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917          244 AQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK  294 (494)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  294 (494)
                      ...+..+.....   ...++..+.++|.+||..||.+||++.+++++.|+.
T Consensus       255 ~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          255 LEFVTSGGRMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             HHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhcCCCCCC---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            777776543322   246889999999999999999999999999987765

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.1e-42  Score=332.15  Aligned_cols=250  Identities=33%  Similarity=0.635  Sum_probs=200.9

Q ss_pred             ccccccceEee-eeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-
Q 040917           28 YEDVQLHYTIG-REVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-  105 (494)
Q Consensus        28 ~~~~~~~y~i~-~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-  105 (494)
                      ...+.++|.+. +.||+|+||.||+|.+..+++.||+|++..        ...+.+|+.++.++.+||||+++++++.. 
T Consensus        12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--------cHHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            34566788887 789999999999999999999999999853        23567899888666579999999999976 


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917          106 ---DQFVHIVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       106 ---~~~~~iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                         ....++||||++|++|.+++....  .++...+..++.||+.||.|||++||+||||||+||+++..+.++.++|+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence               678999999999999999998764  699999999999999999999999999999999999996444478999999


Q ss_pred             cCCccccccCcccccccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC----CccCCC
Q 040917          181 FGLSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG----EINFQR  256 (494)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~----~~~~~~  256 (494)
                      ||++.....                    ..++.++|||||||++|+|++|..||.+.........+...    ....+.
T Consensus       164 fg~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  223 (299)
T 3m2w_A          164 FGFAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  223 (299)
T ss_dssp             CTTCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred             ccccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence            999864321                    33677899999999999999999999776554332111111    111111


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCCc
Q 040917          257 DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPID  305 (494)
Q Consensus       257 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~~  305 (494)
                      ..+..+++.+.++|.+||..||.+|||+.++|+||||+........+..
T Consensus       224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~  272 (299)
T 3m2w_A          224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH  272 (299)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCBCS
T ss_pred             hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCCCc
Confidence            1124689999999999999999999999999999999987665555543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.2e-42  Score=337.42  Aligned_cols=257  Identities=21%  Similarity=0.325  Sum_probs=218.1

Q ss_pred             cccccccccceEeeeeecccCCeEEEEEEEC-----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEE
Q 040917           25 GKAYEDVQLHYTIGREVGRGEFGITYLCTEN-----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQF   99 (494)
Q Consensus        25 ~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~   99 (494)
                      .+..+...++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .......+.+|+.+++.+. ||||+++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~   93 (322)
T 1p4o_A           17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRL   93 (322)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCE
T ss_pred             hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcC-CCCEeee
Confidence            3344556689999999999999999999876     467899999996433  3334567889999999995 9999999


Q ss_pred             eEEEEeCCeEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEee
Q 040917          100 KAAYEDDQFVHIVMELCAGGELFDRIVAR----------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTT  169 (494)
Q Consensus       100 ~~~~~~~~~~~iv~e~~~g~sL~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~  169 (494)
                      ++++......++||||++|++|.+++...          ..++...+..++.||+.||.|||++||+||||||+||++  
T Consensus        94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli--  171 (322)
T 1p4o_A           94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--  171 (322)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE--
T ss_pred             EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE--
Confidence            99999988999999999999999998653          356899999999999999999999999999999999999  


Q ss_pred             CCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 040917          170 GDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVA  244 (494)
Q Consensus       170 ~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~  244 (494)
                       +.++.++|+|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.......
T Consensus       172 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  250 (322)
T 1p4o_A          172 -AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL  250 (322)
T ss_dssp             -CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred             -cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH
Confidence             6788999999999976543322   123356788999999864 58999999999999999999 89999998888887


Q ss_pred             HHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      ..+..+.....   ...++..+.++|.+||..||.+|||+.+++++
T Consensus       251 ~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          251 RFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            77776544322   24688999999999999999999999999875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.4e-42  Score=341.51  Aligned_cols=262  Identities=26%  Similarity=0.404  Sum_probs=213.7

Q ss_pred             cccccccceEeeeeecccCCeEEEEEEECCCC-cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCC------ccEE
Q 040917           27 AYEDVQLHYTIGREVGRGEFGITYLCTENSTG-LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN------IVQF   99 (494)
Q Consensus        27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~-~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~------i~~~   99 (494)
                      ..+.+.++|++.+.||+|+||.||+|.+..++ ..||+|++...    ......+.+|+.+++.+. |++      ++.+
T Consensus        13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~   87 (355)
T 2eu9_A           13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIK-EKDKENKFLCVLM   87 (355)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHH-HHCTTSCSCBCCE
T ss_pred             cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHh-hcCCCCceeEEEe
Confidence            34456789999999999999999999998777 68999999632    235677888999999996 544      8999


Q ss_pred             eEEEEeCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC-------
Q 040917          100 KAAYEDDQFVHIVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG-------  170 (494)
Q Consensus       100 ~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~-------  170 (494)
                      ++++......++||||+ +++|.+.+....  .++...+..++.||+.||.|||++||+||||||+||++...       
T Consensus        88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence            99999999999999999 567777776653  69999999999999999999999999999999999999432       


Q ss_pred             ---------CCCCeEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 040917          171 ---------DENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD  240 (494)
Q Consensus       171 ---------~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~  240 (494)
                               +..+.++|+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...
T Consensus       167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          167 EHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             CC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                     2568899999999976433  2345678999999999864 689999999999999999999999998887


Q ss_pred             HHHHHHHHcCCccCCC----------------------------------------CCCCCCCHHHHHHHHHhcccCCCC
Q 040917          241 QGVAQAILKGEINFQR----------------------------------------DPFPSISSSAIELVRRMLTQDPKR  280 (494)
Q Consensus       241 ~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~l~~li~~~l~~dp~~  280 (494)
                      .+....+.......+.                                        ......+..+.+||.+||..||.+
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            6655444321111100                                        000112457889999999999999


Q ss_pred             CCCHHHHhcCCccCcc
Q 040917          281 RITVAQVLEHPWLKES  296 (494)
Q Consensus       281 Rps~~eil~~~~~~~~  296 (494)
                      |||+.++|+||||+..
T Consensus       325 Rpt~~e~l~hp~f~~~  340 (355)
T 2eu9_A          325 RITLAEALLHPFFAGL  340 (355)
T ss_dssp             SCCHHHHTTSGGGGGC
T ss_pred             CcCHHHHhcChhhcCC
Confidence            9999999999999964

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.7e-42  Score=327.89  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=202.5

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC-hhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK-DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      .++|++.+.||+|+||.||+|.+.  +..||+|++....... ......+.+|+.+++.++ ||||+++++++...+..+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC--CE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCCceE
Confidence            368999999999999999999975  8899999987543222 233577889999999995 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCceEEeeCC-----CCCeEEEeecC
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG---VMHRDLKPENFLFTTGD-----ENAVVKATDFG  182 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~dikp~NIli~~~~-----~~~~~kL~Dfg  182 (494)
                      +||||++|++|.+++. ...++...+..++.|++.||.|||++|   |+||||||+||+++...     ..+.++|+|||
T Consensus        83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            9999999999998885 457999999999999999999999999   89999999999995321     26789999999


Q ss_pred             CccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917          183 LSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (494)
                      .+........ ....|++.|+|||++.+ .++.++||||||+++|+|++|+.||.+.........+.........  ...
T Consensus       162 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~  238 (271)
T 3dtc_A          162 LAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI--PST  238 (271)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC--CTT
T ss_pred             cccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC--Ccc
Confidence            9976543322 34578999999999865 5899999999999999999999999998887777666665444332  256


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      +++.+.+++.+||..||.+|||+.+++++
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            88999999999999999999999999873

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.2e-42  Score=330.78  Aligned_cols=252  Identities=27%  Similarity=0.404  Sum_probs=203.8

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCC---CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENST---GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE  104 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~---~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~  104 (494)
                      ++-..++|++++.||+|+||.||+|.+..+   +..||+|++....  .......+.+|+.+++++. ||||+++++++.
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~   86 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT   86 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCccceEEEEEc
Confidence            455668999999999999999999998654   4569999986432  3445678899999999995 999999999985


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCC
Q 040917          105 DDQFVHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL  183 (494)
Q Consensus       105 ~~~~~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~  183 (494)
                       ++..++||||+++++|.+++.... .++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||+
T Consensus        87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~  162 (281)
T 1mp8_A           87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGL  162 (281)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC---
T ss_pred             -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE---CCCCCEEECcccc
Confidence             456789999999999999997654 68999999999999999999999999999999999999   4678999999999


Q ss_pred             ccccccCccc--ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 040917          184 SAFIEEGKAY--REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPF  259 (494)
Q Consensus       184 a~~~~~~~~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  259 (494)
                      +.........  ....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+..+....   ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~---~~  239 (281)
T 1mp8_A          163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MP  239 (281)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CC
T ss_pred             ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC---CC
Confidence            9865443221  2334577899999986 468999999999999999996 999999888877777776654322   22


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          260 PSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +.+|+.+.+++.+||..||.+|||+.++++
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  269 (281)
T 1mp8_A          240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKA  269 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            578999999999999999999999999987

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-42  Score=340.83  Aligned_cols=252  Identities=23%  Similarity=0.334  Sum_probs=216.7

Q ss_pred             cccccceEeeeeecccCCeEEEEEEEC-----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEE
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTEN-----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY  103 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~  103 (494)
                      +-..++|++++.||+|+||.||+|.+.     .+++.||+|++....  .......+.+|+.+++++ +||||+++++++
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~  119 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DNPNIVKLLGVC  119 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE
Confidence            445589999999999999999999987     455899999997543  344567899999999999 599999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 040917          104 EDDQFVHIVMELCAGGELFDRIVAR------------------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRD  159 (494)
Q Consensus       104 ~~~~~~~iv~e~~~g~sL~~~~~~~------------------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~d  159 (494)
                      ......++||||++|++|.+++...                        ..++...++.++.||+.||.|||++||+|||
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D  199 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  199 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            9999999999999999999999764                        4689999999999999999999999999999


Q ss_pred             CCCCceEEeeCCCCCeEEEeecCCccccccCc---ccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCC
Q 040917          160 LKPENFLFTTGDENAVVKATDFGLSAFIEEGK---AYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPP  234 (494)
Q Consensus       160 ikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~p  234 (494)
                      |||+||++   +.++.++|+|||++.......   ......+++.|+|||++. +.++.++|||||||++|+|++ |..|
T Consensus       200 lkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          200 LATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CCcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence            99999999   678899999999997653322   123355788999999886 468999999999999999999 9999


Q ss_pred             CCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          235 FWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       235 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      |.+....+....+..+.....   ...++..+.+++.+||..||.+|||+.++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          277 YYGMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             TTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCChHHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            999998888887776654322   2468899999999999999999999999987

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-42  Score=336.15  Aligned_cols=251  Identities=21%  Similarity=0.306  Sum_probs=214.6

Q ss_pred             cccceEeeeeecccCCeEEEEEEE-----CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTE-----NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED  105 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~  105 (494)
                      ...+|++.+.||+|+||.||+|.+     ..++..||+|++....  .......+.+|+.+++++. ||||+++++++..
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~   97 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQ   97 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCceeeEEEEEec
Confidence            457999999999999999999998     3456899999997433  3445678899999999995 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 040917          106 DQFVHIVMELCAGGELFDRIVARGH------------------------YSERAAASVFRVIMNVVNVCHSKGVMHRDLK  161 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~~~------------------------l~~~~~~~i~~~i~~~l~~LH~~~i~H~dik  161 (494)
                      .+..++||||++|++|.+++.....                        ++...+..++.||+.||.|||++||+|||||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik  177 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA  177 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence            9999999999999999999986543                        8899999999999999999999999999999


Q ss_pred             CCceEEeeCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCC
Q 040917          162 PENFLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFW  236 (494)
Q Consensus       162 p~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~  236 (494)
                      |+||++   +.++.++|+|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.
T Consensus       178 p~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          178 ARNILV---AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             GGGEEE---ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             hheEEE---cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999   5778999999999976543322   123456788999998864 58999999999999999999 999999


Q ss_pred             CCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          237 AETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      +.........+.......   ....+++.+.++|.+||..||.+|||+.+++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          255 GIPPERLFNLLKTGHRME---RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             TCCGGGHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHhhcCCcCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            888877777766654322   225689999999999999999999999999873

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.7e-43  Score=346.99  Aligned_cols=249  Identities=24%  Similarity=0.369  Sum_probs=213.7

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++++. ||||+++++++......++
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSSSSCEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecCCCcEE
Confidence            478999999999999999999999999999999986432  3334567889999999995 9999999999998889999


Q ss_pred             EEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          112 VMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      ||||++|++|.+++...+ .++...+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++......
T Consensus       190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTS
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceecCCC
Confidence            999999999999997654 58999999999999999999999999999999999999   67889999999998754332


Q ss_pred             ccc---ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          191 KAY---REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       191 ~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ...   ....+++.|+|||++. +.++.++|||||||++|+|++ |..||.+.........+..+.....   ...+|+.
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  343 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC---PELCPDA  343 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC---CTTCCHH
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHH
Confidence            211   1123467899999986 468999999999999999998 9999999988877777766543222   2457899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +.+++.+||..||.+|||+.++++
T Consensus       344 l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          344 VFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.1e-42  Score=331.27  Aligned_cols=254  Identities=29%  Similarity=0.533  Sum_probs=204.1

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++++. ||||+++++++...+..
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~  107 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNEL  107 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCcE
Confidence            34578999999999999999999999999999999998655555666788999999999995 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          110 HIVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      ++||||+++++|.+++..    ...++...+..++.||+.||.|||++|++||||||+||++   +.++.++|+|||++.
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~  184 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGR  184 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC----
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEecccee
Confidence            999999999999998864    4568999999999999999999999999999999999999   678899999999987


Q ss_pred             ccccCc-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHcCCccCCCCCCCC
Q 040917          186 FIEEGK-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET--DQGVAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       186 ~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~  261 (494)
                      ...... ......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+..  .......+.....  +......
T Consensus       185 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~  262 (310)
T 2wqm_A          185 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDH  262 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCS--CCCCTTT
T ss_pred             eecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccC--CCCcccc
Confidence            654322 2234568999999999864 58899999999999999999999997643  2334444444332  2223356


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +++.+.++|.+||..||.+|||+.++++
T Consensus       263 ~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          263 YSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            8999999999999999999999999987

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.3e-42  Score=329.88  Aligned_cols=252  Identities=23%  Similarity=0.364  Sum_probs=207.0

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhH----HHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK----DDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~----~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...........    ..+.+|+.+++++. ||||+++++++.+.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHNP   95 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEETTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheeecCC
Confidence            34789999999999999999999999999999999976543332221    67889999999995 99999999999766


Q ss_pred             CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEEeeCC--CCCeEEEeec
Q 040917          107 QFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKG--VMHRDLKPENFLFTTGD--ENAVVKATDF  181 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~dikp~NIli~~~~--~~~~~kL~Df  181 (494)
                      .  ++||||+++++|.+.+... ..++...+..++.|++.||.|||++|  |+||||||+||+++.++  ....++|+||
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            5  5999999999998888654 46999999999999999999999999  99999999999995321  1234999999


Q ss_pred             CCccccccCcccccccCCcCccChhhhc---ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHcCCccCCC
Q 040917          182 GLSAFIEEGKAYREIVGSPYYIAPEVLS---QSYGKEADIWSAGVILYILLCGVPPFWAETDQGV--AQAILKGEINFQR  256 (494)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~--~~~~~~~~~~~~~  256 (494)
                      |++.....  ......+++.|+|||++.   ..++.++|||||||++|+|++|+.||........  ...+......  .
T Consensus       174 g~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~  249 (287)
T 4f0f_A          174 GLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR--P  249 (287)
T ss_dssp             TTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC--C
T ss_pred             Cccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC--C
Confidence            99975433  334567899999999983   3478899999999999999999999987654433  3333333222  2


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          257 DPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       257 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .....+|+.+.++|.+||..||.+|||+.++++
T Consensus       250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            233578999999999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=8.5e-43  Score=339.33  Aligned_cols=260  Identities=26%  Similarity=0.383  Sum_probs=192.1

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHH-HHHHccCCCCccEEeEEEEeCCeE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIE-IMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++....  .......+..|+. +++.+ +||||+++++++...+..
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~~~~   96 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFREGDC   96 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEECSSEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeCCce
Confidence            3478999999999999999999999999999999997543  2334455666666 45555 699999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeCCCCCeEEEeecCC
Q 040917          110 HIVMELCAGGELFDRIVA-----RGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENAVVKATDFGL  183 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~~~~~~~kL~Dfg~  183 (494)
                      ++||||++| +|.+++..     ...++...+..++.|++.||.|||++ ||+||||||+||++   +.++.+||+|||+
T Consensus        97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~  172 (327)
T 3aln_A           97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFGI  172 (327)
T ss_dssp             EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE---ETTTEEEECCCSS
T ss_pred             EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE---cCCCCEEEccCCC
Confidence            999999976 88877763     46789999999999999999999999 99999999999999   5788999999999


Q ss_pred             ccccccCcccccccCCcCccChhhhc-----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCc-cCCC
Q 040917          184 SAFIEEGKAYREIVGSPYYIAPEVLS-----QSYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEI-NFQR  256 (494)
Q Consensus       184 a~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~-~~~~  256 (494)
                      +.............|++.|+|||++.     ..++.++|||||||++|+|++|..||...... +....+..+.. .+..
T Consensus       173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  252 (327)
T 3aln_A          173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN  252 (327)
T ss_dssp             SCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCC
T ss_pred             ceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCC
Confidence            98765444444457899999999983     35889999999999999999999999765432 11111111111 1122


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          257 DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       257 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      .....+++.+.++|.+||..||.+|||+.++++||||....
T Consensus       253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence            22346899999999999999999999999999999998644

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-42  Score=340.78  Aligned_cols=255  Identities=20%  Similarity=0.331  Sum_probs=210.7

Q ss_pred             cccccceEeeeeecccCCeEEEEEEE-----CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEE
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTE-----NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY  103 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~  103 (494)
                      +-..++|++++.||+|+||.||+|.+     ..++..||+|++....  .......+.+|+.+++++.+||||+++++++
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            33458999999999999999999997     3467789999997433  2234577899999999995699999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 040917          104 EDDQFVHIVMELCAGGELFDRIVARG-----------------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDL  160 (494)
Q Consensus       104 ~~~~~~~iv~e~~~g~sL~~~~~~~~-----------------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di  160 (494)
                      ...+..++||||++|++|.+++....                       .++...+..++.||+.||.|||++||+||||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di  198 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  198 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            99999999999999999999997653                       2789999999999999999999999999999


Q ss_pred             CCCceEEeeCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCC
Q 040917          161 KPENFLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPF  235 (494)
Q Consensus       161 kp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf  235 (494)
                      ||+||++   +.++.++|+|||++........   .....+|+.|+|||++. +.++.++|||||||++|+|++ |..||
T Consensus       199 kp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          199 AARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             SGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ChhhEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            9999999   5788999999999976543322   22345678899999885 468999999999999999998 99999


Q ss_pred             CCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          236 WAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      .+...................  ...+++.+.++|.+||..||.+|||+.+++++
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          276 PGIPVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             TTCCCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCcHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            887755544444444333222  24678999999999999999999999999984

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-43  Score=338.98  Aligned_cols=263  Identities=29%  Similarity=0.583  Sum_probs=204.8

Q ss_pred             hhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCCh---hhHHHHHHHHHHHHHcc---CCCCc
Q 040917           23 ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD---VEKDDVRREIEIMRHLS---GQPNI   96 (494)
Q Consensus        23 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~---~~~~~~~~E~~~l~~l~---~hp~i   96 (494)
                      ...+..+.+.++|++.+.||+|+||.||+|.+..+++.||+|++........   .....+.+|+.++.++.   +||||
T Consensus        21 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i  100 (312)
T 2iwi_A           21 PGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV  100 (312)
T ss_dssp             ------------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSB
T ss_pred             CCccchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCe
Confidence            3344566778999999999999999999999999999999999975543221   12334567999999983   49999


Q ss_pred             cEEeEEEEeCCeEEEEEec-cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCe
Q 040917           97 VQFKAAYEDDQFVHIVMEL-CAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAV  175 (494)
Q Consensus        97 ~~~~~~~~~~~~~~iv~e~-~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~  175 (494)
                      +++++++...+..++|+|+ +.+++|.+++...+.++...+..++.||+.||.|||++||+||||||+||+++  ..++.
T Consensus       101 ~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~  178 (312)
T 2iwi_A          101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGC  178 (312)
T ss_dssp             CCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTE
T ss_pred             eeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCe
Confidence            9999999988899999999 78999999999888899999999999999999999999999999999999994  26789


Q ss_pred             EEEeecCCccccccCcccccccCCcCccChhhhcc-cC-CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc
Q 040917          176 VKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SY-GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN  253 (494)
Q Consensus       176 ~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  253 (494)
                      ++|+|||++...... ......+++.|+|||++.+ .+ +.++|||||||++|+|++|+.||....      .+......
T Consensus       179 ~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~  251 (312)
T 2iwi_A          179 AKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELH  251 (312)
T ss_dssp             EEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCC
T ss_pred             EEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccC
Confidence            999999999866543 3345678999999998864 33 458999999999999999999996432      12222222


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          254 FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       254 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                      +    ...++..+.++|.+||..||++|||+.++++||||+...+
T Consensus       252 ~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          252 F----PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             C----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             C----cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence            2    2467899999999999999999999999999999997543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.2e-42  Score=338.24  Aligned_cols=250  Identities=24%  Similarity=0.343  Sum_probs=210.6

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEE--EEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEF--ACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~v--alK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ++|++.+.||+|+||.||+|.+..++..+  ++|.+....  .......+.+|+.+++++.+||||+++++++...+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            78999999999999999999999888865  999886432  23345678899999999966999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917          111 IVMELCAGGELFDRIVARG----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA  174 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~  174 (494)
                      +||||++|++|.+++....                .++...++.++.||+.||.|||++||+||||||+||++   +.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCC
Confidence            9999999999999997654                68999999999999999999999999999999999999   6778


Q ss_pred             eEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCc
Q 040917          175 VVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEI  252 (494)
Q Consensus       175 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~  252 (494)
                      .++|+|||++.............+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+..
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~  259 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  259 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence            999999999875433333334456789999999865 57999999999999999998 9999999888877776655422


Q ss_pred             cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          253 NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      .   .....+++.+.++|.+||..||.+|||+.+++++
T Consensus       260 ~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          260 L---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             C---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            1   2224688999999999999999999999999874

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.7e-42  Score=335.00  Aligned_cols=254  Identities=21%  Similarity=0.338  Sum_probs=212.9

Q ss_pred             cccccceEeeeeecccCCeEEEEEEE-----CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEE
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTE-----NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY  103 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~  103 (494)
                      +-..++|++++.||+|+||.||+|.+     ..+++.||+|++....  .....+.+.+|+.+++++.+||||+++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   96 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence            34457999999999999999999985     4678899999997543  2335678899999999996699999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 040917          104 EDDQFVHIVMELCAGGELFDRIVARG------------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENF  165 (494)
Q Consensus       104 ~~~~~~~iv~e~~~g~sL~~~~~~~~------------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NI  165 (494)
                      ...+..++||||+++++|.+++....                  .++...+..++.||+.||.|||++||+||||||+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  176 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI  176 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence            99999999999999999999997654                  389999999999999999999999999999999999


Q ss_pred             EEeeCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 040917          166 LFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETD  240 (494)
Q Consensus       166 li~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~  240 (494)
                      ++   +.++.++|+|||++........   .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+...
T Consensus       177 l~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          177 LL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             EE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             EE---cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            99   5788999999999986644332   12344678899999875 468999999999999999999 9999987765


Q ss_pred             HHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          241 QGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ...............  ....++..+.+++.+||..||.+|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  300 (313)
T 1t46_A          254 DSKFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (313)
T ss_dssp             SHHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhHHHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            444444333322222  22468899999999999999999999999997

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.6e-42  Score=334.53  Aligned_cols=251  Identities=23%  Similarity=0.351  Sum_probs=214.1

Q ss_pred             cccceEeeeeecccCCeEEEEEEEC-------CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTEN-------STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY  103 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~-------~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~  103 (494)
                      ..++|++++.||+|+||.||+|.+.       .++..||+|++....  .......+.+|+.+++++.+||||+++++++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            4589999999999999999999976       467789999997543  3445677899999999996699999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEE
Q 040917          104 EDDQFVHIVMELCAGGELFDRIVARG----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLF  167 (494)
Q Consensus       104 ~~~~~~~iv~e~~~g~sL~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli  167 (494)
                      ...+..++||||++|++|.+++....                .++...+..++.||+.||.|||++||+||||||+||++
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  190 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence            99999999999999999999997654                38899999999999999999999999999999999999


Q ss_pred             eeCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHH
Q 040917          168 TTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQG  242 (494)
Q Consensus       168 ~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~  242 (494)
                         +.++.+||+|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+
T Consensus       191 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          191 ---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             ---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             ---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence               6788999999999976544322   123446788999998864 58999999999999999999 999999988888


Q ss_pred             HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          243 VAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ....+..+....   ....++..+.++|.+||..||.+|||+.++++
T Consensus       268 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  311 (334)
T 2pvf_A          268 LFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  311 (334)
T ss_dssp             HHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            777776654322   22468899999999999999999999999997

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.9e-42  Score=328.46  Aligned_cols=251  Identities=23%  Similarity=0.356  Sum_probs=216.9

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .+-...+|++.+.||+|+||.||+|.+..++..||+|++....    .....+.+|+.++++++ ||||+++++++....
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   82 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREP   82 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCC-CCCEeeEEEEEccCC
Confidence            3445688999999999999999999999999999999996432    24677899999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          108 FVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      ..++||||++|++|.+++...  ..++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||.+.
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~  159 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSR  159 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGGG
T ss_pred             CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccce
Confidence            999999999999999999864  348999999999999999999999999999999999999   677899999999998


Q ss_pred             ccccCcc--cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917          186 FIEEGKA--YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       186 ~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (494)
                      .......  .....+++.|+|||++. ..++.++||||||+++|+|++ |..||...........+......   .....
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~  236 (288)
T 3kfa_A          160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPEG  236 (288)
T ss_dssp             TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCTT
T ss_pred             eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC---CCCCC
Confidence            6543322  22345678899999986 468999999999999999999 99999888877776666554322   22256


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +|+.+.+++.+||..||.+|||+.++++
T Consensus       237 ~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          237 CPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            8999999999999999999999999987

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.3e-42  Score=344.25  Aligned_cols=261  Identities=22%  Similarity=0.409  Sum_probs=207.3

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc----------CCCCccEEeE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS----------GQPNIVQFKA  101 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------~hp~i~~~~~  101 (494)
                      .++|++++.||+|+||.||+|.+..+++.||+|++...    ......+.+|+.+++++.          +||||+++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            37899999999999999999999999999999999642    234667889999999885          2789999999


Q ss_pred             EEEeCC----eEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCceEEeeC---C
Q 040917          102 AYEDDQ----FVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTG---D  171 (494)
Q Consensus       102 ~~~~~~----~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~dikp~NIli~~~---~  171 (494)
                      ++....    ..++|||++ |++|.+++...  ..++...+..++.||+.||.|||++ ||+||||||+||+++..   +
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence            987644    789999999 88999999763  4599999999999999999999998 99999999999999632   2


Q ss_pred             CCCeEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh------HHHH
Q 040917          172 ENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD------QGVA  244 (494)
Q Consensus       172 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~------~~~~  244 (494)
                      ..+.++|+|||++......  .....+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+...      ....
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  250 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  250 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             CcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence            4458999999999765432  344578999999999875 589999999999999999999999976542      1222


Q ss_pred             HHHHcCCccCC--------------------------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 040917          245 QAILKGEINFQ--------------------------------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQ  286 (494)
Q Consensus       245 ~~~~~~~~~~~--------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  286 (494)
                      ..+.......+                                      ......+++.+.+||.+||..||.+|||+.+
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence            22211000000                                      0001124567889999999999999999999


Q ss_pred             HhcCCccCccCcC
Q 040917          287 VLEHPWLKESGEA  299 (494)
Q Consensus       287 il~~~~~~~~~~~  299 (494)
                      +|+||||+.....
T Consensus       331 ll~hp~f~~~~~~  343 (373)
T 1q8y_A          331 LVNHPWLKDTLGM  343 (373)
T ss_dssp             HHTCGGGTTCTTC
T ss_pred             HhhChhhhcccCc
Confidence            9999999975433

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=8.3e-42  Score=326.70  Aligned_cols=249  Identities=22%  Similarity=0.306  Sum_probs=210.4

Q ss_pred             ccceEeee-eecccCCeEEEEEE--ECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           32 QLHYTIGR-EVGRGEFGITYLCT--ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        32 ~~~y~i~~-~lg~G~~g~Vy~a~--~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      ..+|++.+ .||+|+||.||+|.  ...+++.||+|++..... .......+.+|+.+++.+. ||||+++++++ ..+.
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGIC-EAES   91 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-ESSS
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-CCCC
Confidence            47899999 99999999999995  466789999999975432 3334678999999999995 99999999999 5567


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      .++||||+++++|.+++...+.++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++....
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECC
T ss_pred             cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE---eCCCcEEEccCCcceeec
Confidence            88999999999999999988889999999999999999999999999999999999999   467899999999997654


Q ss_pred             cCccc----ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          189 EGKAY----REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       189 ~~~~~----~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      .....    ....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+..+....   ....+
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~  245 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGC  245 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTC
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCCCC
Confidence            33221    12345688999999864 58889999999999999999 999999998888777776654322   22468


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ++.+.++|.+||..||.+|||+.++++
T Consensus       246 ~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          246 PREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999999987

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.2e-42  Score=330.28  Aligned_cols=249  Identities=22%  Similarity=0.353  Sum_probs=201.5

Q ss_pred             cccceEeeeeecccCCeEEEEEE----ECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-
Q 040917           31 VQLHYTIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-  105 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~----~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-  105 (494)
                      ...+|++++.||+|+||.||+|.    +..+++.||+|++...   .......+.+|+.++++++ ||||+++++++.. 
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA   83 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECHH
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence            45899999999999999999998    5678999999998643   3445677899999999995 9999999999854 


Q ss_pred             -CCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCC
Q 040917          106 -DQFVHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL  183 (494)
Q Consensus       106 -~~~~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~  183 (494)
                       ....++||||+++++|.+++.... .++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||+
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGL  160 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCS
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE---cCCCeEEEccCcc
Confidence             346899999999999999997754 49999999999999999999999999999999999999   5678999999999


Q ss_pred             ccccccCcc----cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH----------------H
Q 040917          184 SAFIEEGKA----YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ----------------G  242 (494)
Q Consensus       184 a~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~----------------~  242 (494)
                      +........    .....+++.|+|||++.+ .++.++||||||+++|+|++|..|+......                .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            986543322    123346778999999864 6899999999999999999999998643321                1


Q ss_pred             HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          243 VAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ....+.... .  ......+|+.+.+++.+||..||.+|||+.++++
T Consensus       241 ~~~~~~~~~-~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          241 LIELLKNNG-R--LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHTTC-C--CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhccC-c--CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            112222221 1  1223568999999999999999999999999986

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.9e-42  Score=335.45  Aligned_cols=249  Identities=20%  Similarity=0.294  Sum_probs=203.5

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEE----EEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEF----ACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~v----alK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ..+|++.+.||+|+||.||+|.+..+++.+    |+|.+....  .......+.+|+.+++++. ||||+++++++....
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCC-BTTBCCEEEEEESSS
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence            378999999999999999999998887765    777664322  2335678999999999995 999999999998765


Q ss_pred             eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          108 FVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                       .++|++++++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++..
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKL  166 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTHHHH
T ss_pred             -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE---CCCCCEEEccCcceeE
Confidence             77999999999999999874 569999999999999999999999999999999999999   5678999999999976


Q ss_pred             cccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917          187 IEEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       187 ~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (494)
                      .......   ....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.........+..+.....   .+.
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~  243 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPI  243 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CTT
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC---Ccc
Confidence            5433222   23345779999998864 58999999999999999999 9999998888777776665543222   246


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      ++..+.+++.+||..||.+||++.+++++
T Consensus       244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          244 CTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             BCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            78999999999999999999999999874

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=345.62  Aligned_cols=258  Identities=23%  Similarity=0.388  Sum_probs=211.1

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC-
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ-  107 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~-  107 (494)
                      ....++|++.+.||+|+||.||+|.+..+|+.||+|++.....  ....+.+.+|+.++++++ ||||+++++++.... 
T Consensus         5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~   81 (396)
T 4eut_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTT   81 (396)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTT
T ss_pred             CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCCCeEEEeeccCCC
Confidence            4567899999999999999999999999999999999975432  224567789999999995 999999999998655 


Q ss_pred             -eEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEee-CCCCCeEEEeecC
Q 040917          108 -FVHIVMELCAGGELFDRIVARG---HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTT-GDENAVVKATDFG  182 (494)
Q Consensus       108 -~~~iv~e~~~g~sL~~~~~~~~---~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~-~~~~~~~kL~Dfg  182 (494)
                       ..++||||++|++|.+++....   .++...+..++.||+.||.|||++||+||||||+||++.. .+..+.+||+|||
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG  161 (396)
T 4eut_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (396)
T ss_dssp             CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred             CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence             7899999999999999987543   2899999999999999999999999999999999999842 3456789999999


Q ss_pred             CccccccCcccccccCCcCccChhhhc---------ccCCCcchhHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHc
Q 040917          183 LSAFIEEGKAYREIVGSPYYIAPEVLS---------QSYGKEADIWSAGVILYILLCGVPPFWAE----TDQGVAQAILK  249 (494)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~Di~slG~il~~l~tg~~pf~~~----~~~~~~~~~~~  249 (494)
                      ++.............||+.|+|||++.         ..++.++|||||||++|+|++|+.||...    ...+....+..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            998776655555677999999999885         35778999999999999999999999643    23345555544


Q ss_pred             CCccCC---------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          250 GEINFQ---------------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       250 ~~~~~~---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +.....                     ......++..+.++|.+||..||++||++.++++
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            432110                     0001224567889999999999999999999754

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.4e-42  Score=340.52  Aligned_cols=249  Identities=24%  Similarity=0.402  Sum_probs=203.3

Q ss_pred             ccceEeeeeecccCCeEEEEEEEC---CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           32 QLHYTIGREVGRGEFGITYLCTEN---STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~---~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      ..+|++.+.||+|+||.||+|.+.   .++..||+|++....  .......+.+|+.+++++. ||||+++++++.....
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCc
Confidence            368999999999999999999876   567789999996532  3445678999999999995 9999999999999889


Q ss_pred             EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .++||||++|++|.+++...+ .++...+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred             eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCcccccc
Confidence            999999999999999997654 69999999999999999999999999999999999999   67889999999999865


Q ss_pred             ccCccc----ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917          188 EEGKAY----REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       188 ~~~~~~----~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (494)
                      ......    ....+++.|+|||++. +.++.++|||||||++|+|++ |+.||......++...+..+....   ....
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~---~~~~  274 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP---PPMD  274 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC---CCTT
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCcc
Confidence            433211    1223467899999986 468999999999999999997 999999998888877776553222   2246


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ++..+.+++.+||..||.+||++.++++
T Consensus       275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          275 CPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             CBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            8899999999999999999999999987

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.8e-42  Score=322.20  Aligned_cols=246  Identities=24%  Similarity=0.407  Sum_probs=212.8

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      ..+|++.+.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.++++++ ||||+++++++...+..++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   80 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICL   80 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSCEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCeEE
Confidence            368999999999999999999986 678899999975432    3467899999999995 9999999999999889999


Q ss_pred             EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          112 VMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      ||||++|++|.+++... ..++...+..++.|++.||.|||++|++||||||+||++   +.++.++|+|||.+......
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCH
T ss_pred             EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEcccccccccccc
Confidence            99999999999999765 468999999999999999999999999999999999999   67789999999998765332


Q ss_pred             c--ccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917          191 K--AYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       191 ~--~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (494)
                      .  ......+++.|+|||++. ..++.++|+||||+++|+|++ |..||......+....+..+.....+   ..+++.+
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~l  234 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHV  234 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTSCHHH
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCC---ccCcHHH
Confidence            1  112345677899999986 468999999999999999999 89999998888888777765433222   4578999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhc
Q 040917          267 IELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+++.+||..||.+|||+.++++
T Consensus       235 ~~li~~~l~~~p~~Rps~~~ll~  257 (267)
T 3t9t_A          235 YQIMNHCWRERPEDRPAFSRLLR  257 (267)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999987

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.9e-42  Score=336.48  Aligned_cols=248  Identities=19%  Similarity=0.272  Sum_probs=207.0

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcE----EEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLE----FACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~----valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      .+|++.+.||+|+||.||+|.+..+++.    |++|.+....  .......+.+|+.+++++. ||||+++++++.. ..
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~   88 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCPG-SS   88 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCC-CTTBCCEEEEECB-SS
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC-Cc
Confidence            6899999999999999999999888876    6777764332  1223345678999999995 9999999999864 56


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .++||||+++++|.+++... +.++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++...
T Consensus        89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGGS
T ss_pred             cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCccccc
Confidence            88999999999999999764 478999999999999999999999999999999999999   67889999999999876


Q ss_pred             ccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          188 EEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       188 ~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      .....   .....+++.|+|||++. +.++.++|||||||++|+|++ |..||.+.........+........+   ..+
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~  242 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP---QIC  242 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC---TTB
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC---CcC
Confidence            43322   23455778999999986 468999999999999999999 99999988887777777665433322   346


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      +..+.+++.+||..||.+|||+.+++++
T Consensus       243 ~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          243 TIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             CTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7889999999999999999999999885

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.9e-42  Score=332.93  Aligned_cols=252  Identities=21%  Similarity=0.343  Sum_probs=209.6

Q ss_pred             cccceEeeeeecccCCeEEEEEEE-----CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTE-----NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED  105 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~  105 (494)
                      ..++|++++.||+|+||.||+|.+     ..+++.||+|++....  .......+.+|+.+++++.+||||+++++++..
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  102 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK  102 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence            457999999999999999999985     4577899999997543  333456789999999999769999999999876


Q ss_pred             CC-eEEEEEeccCCCchHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEe
Q 040917          106 DQ-FVHIVMELCAGGELFDRIVARGH----------------YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFT  168 (494)
Q Consensus       106 ~~-~~~iv~e~~~g~sL~~~~~~~~~----------------l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~  168 (494)
                      .+ ..++||||++|++|.+++.....                ++...+..++.||+.||.|||++||+||||||+||++ 
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~-  181 (316)
T 2xir_A          103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-  181 (316)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE-
Confidence            54 58999999999999999987543                7899999999999999999999999999999999999 


Q ss_pred             eCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChH-H
Q 040917          169 TGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQ-G  242 (494)
Q Consensus       169 ~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~-~  242 (494)
                        +.++.++|+|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.... .
T Consensus       182 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  259 (316)
T 2xir_A          182 --SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  259 (316)
T ss_dssp             --CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             --CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence              6778999999999976543322   223456889999998864 68999999999999999998 99999876643 3


Q ss_pred             HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          243 VAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      ....+..+....   ....+++.+.+++.+||..||.+|||+.++++|
T Consensus       260 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          260 FCRRLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhccCccCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            344444432221   124578999999999999999999999999984

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.9e-42  Score=329.01  Aligned_cols=253  Identities=21%  Similarity=0.295  Sum_probs=204.9

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCC-ccEEeEEEEeCCe
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN-IVQFKAAYEDDQF  108 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~-i~~~~~~~~~~~~  108 (494)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++.....     ...+.+|+.+++.+. |++ +..+..+......
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~-~~~~i~~~~~~~~~~~~   79 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQ-GGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHT-TSTTCCCEEEEEEETTE
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhh-cCCCCCccccccCCCCc
Confidence            456899999999999999999999999999999999865432     235889999999997 555 4555555577788


Q ss_pred             EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .++||||+ +++|.+++.. ...++...+..++.||+.||.|||++||+||||||+||+++..+.++.++|+|||++...
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            99999999 8899999974 457999999999999999999999999999999999999954346789999999999865


Q ss_pred             ccCcc--------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHcCCccCC
Q 040917          188 EEGKA--------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD---QGVAQAILKGEINFQ  255 (494)
Q Consensus       188 ~~~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~---~~~~~~~~~~~~~~~  255 (494)
                      .....        .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+...   ......+.......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            44322        234578999999999875 589999999999999999999999976432   122222222222111


Q ss_pred             -CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          256 -RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       256 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                       ......+|+.+.+++.+||..||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence             1112467899999999999999999999999987

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.3e-42  Score=328.33  Aligned_cols=247  Identities=15%  Similarity=0.221  Sum_probs=203.5

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCC-------cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTG-------LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE  104 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~-------~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~  104 (494)
                      .++|++.+.||+|+||.||+|.+..++       ..||+|++....   ....+.+.+|+.++++++ ||||+++++++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~   82 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLS-HKHLVLNYGVCV   82 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSC-CTTBCCEEEEEC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCC-CCCEeEEEEEEE
Confidence            479999999999999999999998877       479999986432   335678999999999995 999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCC-----CCeEEE
Q 040917          105 DDQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDE-----NAVVKA  178 (494)
Q Consensus       105 ~~~~~~iv~e~~~g~sL~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~-----~~~~kL  178 (494)
                      ..+..++||||++|++|.+++...+. ++...+..++.||+.||.|||++||+||||||+||+++.+..     .+.++|
T Consensus        83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence            99999999999999999999987654 999999999999999999999999999999999999964221     123999


Q ss_pred             eecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHcCCccCC
Q 040917          179 TDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGV-PPFWAETDQGVAQAILKGEINFQ  255 (494)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~-~pf~~~~~~~~~~~~~~~~~~~~  255 (494)
                      +|||.+......   ....+++.|+|||++.+  .++.++|||||||++|+|++|. .||........... .......+
T Consensus       163 ~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~-~~~~~~~~  238 (289)
T 4fvq_A          163 SDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF-YEDRHQLP  238 (289)
T ss_dssp             CCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHTTCCCC
T ss_pred             ccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH-hhccCCCC
Confidence            999998754332   23457889999999864  5899999999999999999955 55555444433333 33322222


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          256 RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       256 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                          ...++.+.+++.+||..||.+|||+.+++++
T Consensus       239 ----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          239 ----APKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             ----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                3457889999999999999999999999983

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.3e-42  Score=326.68  Aligned_cols=247  Identities=24%  Similarity=0.425  Sum_probs=209.1

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe----
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----  105 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~----  105 (494)
                      .+..+|++++.||+|+||.||+|.+..+++.||+|++....       ..+.+|+.+++++. ||||+++++++..    
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   79 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYNGCWDGFDYD   79 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCC-CTTBCCEEEEEEEEEEC
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCC-CCCEEEEeeeEeccccC
Confidence            45678999999999999999999999999999999996432       24678999999995 9999999998854    


Q ss_pred             ------------CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC
Q 040917          106 ------------DQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD  171 (494)
Q Consensus       106 ------------~~~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~  171 (494)
                                  ....++||||+++++|.+++...  ..++...+..++.||+.||.|||++||+||||||+||++   +
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~  156 (284)
T 2a19_B           80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---V  156 (284)
T ss_dssp             ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---E
T ss_pred             cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE---c
Confidence                        44589999999999999999754  579999999999999999999999999999999999999   4


Q ss_pred             CCCeEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC
Q 040917          172 ENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG  250 (494)
Q Consensus       172 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~  250 (494)
                      .++.++|+|||.+.............+++.|+|||++.+ .++.++||||||+++|+|++|..|+...  ......+...
T Consensus       157 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~  234 (284)
T 2a19_B          157 DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG  234 (284)
T ss_dssp             ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT
T ss_pred             CCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc
Confidence            678999999999987655544455678999999999865 5899999999999999999999887421  2223333332


Q ss_pred             CccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          251 EINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       251 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      .      ....++..+.++|.+||..||.+|||+.+++++.+.-.
T Consensus       235 ~------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          235 I------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             C------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             c------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            1      12457899999999999999999999999999877654

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.3e-41  Score=323.73  Aligned_cols=252  Identities=23%  Similarity=0.309  Sum_probs=208.7

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECC---CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENS---TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED  105 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~---~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~  105 (494)
                      .-..++|++.+.||+|+||.||+|.+..   ++..||+|++....  .......+.+|+.++++++ ||||+++++++..
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~   84 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEE   84 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECS
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCC-CCCcceEEEEEcC
Confidence            3445789999999999999999998653   34569999987543  3345678999999999995 9999999999875


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCc
Q 040917          106 DQFVHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS  184 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a  184 (494)
                      + ..++||||++|++|.+++...+ .++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++
T Consensus        85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~  160 (281)
T 3cc6_A           85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV---ASPECVKLGDFGLS  160 (281)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---EETTEEEECCCCGG
T ss_pred             C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---CCCCcEEeCccCCC
Confidence            4 4689999999999999997654 59999999999999999999999999999999999999   46789999999999


Q ss_pred             cccccCcc--cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 040917          185 AFIEEGKA--YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFP  260 (494)
Q Consensus       185 ~~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (494)
                      ........  .....+++.|+|||++. ..++.++|||||||++|+|++ |+.||......+....+..+.....   ..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~  237 (281)
T 3cc6_A          161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK---PD  237 (281)
T ss_dssp             GCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC---CT
T ss_pred             cccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC---CC
Confidence            76543322  12345678899999986 468999999999999999998 9999988777777766665533222   24


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          261 SISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      .+++.+.+++.+||..||.+|||+.+++++
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            578999999999999999999999999973

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=8.5e-42  Score=333.13  Aligned_cols=255  Identities=23%  Similarity=0.348  Sum_probs=212.3

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCc-----EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEE
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGL-----EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAA  102 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~-----~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~  102 (494)
                      .+-...+|++.+.||+|+||.||+|.+..++.     .||+|++....  .......+.+|+.+++++.+||||++++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            34445789999999999999999999977665     79999996543  333567789999999999559999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEe
Q 040917          103 YEDDQFVHIVMELCAGGELFDRIVAR--------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFT  168 (494)
Q Consensus       103 ~~~~~~~~iv~e~~~g~sL~~~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~  168 (494)
                      +...+..++||||+++++|.+++...              ..++...+..++.||+.||.|||++||+||||||+||++ 
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~-  197 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL-  197 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE-
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE-
Confidence            99989999999999999999998653              357999999999999999999999999999999999999 


Q ss_pred             eCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 040917          169 TGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGV  243 (494)
Q Consensus       169 ~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~  243 (494)
                        +.++.++|+|||++........   .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+......
T Consensus       198 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          198 --TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             --EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             --CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence              5678999999999976543322   12344678899999886 468999999999999999998 9999987765554


Q ss_pred             HHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          244 AQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ...+.........  ....++.+.+++.+||..||.+|||+.++++
T Consensus       276 ~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          276 FYKLVKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            4444443332222  2457899999999999999999999999987

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-41  Score=323.43  Aligned_cols=249  Identities=22%  Similarity=0.349  Sum_probs=211.1

Q ss_pred             ccceEeee-eecccCCeEEEEEEEC--CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           32 QLHYTIGR-EVGRGEFGITYLCTEN--STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        32 ~~~y~i~~-~lg~G~~g~Vy~a~~~--~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      .++|.+.+ .||+|+||.||+|.+.  .++..||+|++....  .......+.+|+.+++++ +||||+++++++. .+.
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~   83 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQL-DNPYIVRLIGVCQ-AEA   83 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEE-SSS
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhC-CCCCEeEEEEEec-CCC
Confidence            46788887 9999999999999864  468889999997542  344577899999999999 4999999999994 556


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .++||||+++++|.+++... ..++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++...
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEEC
T ss_pred             cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE---cCCCCEEECcccceeee
Confidence            89999999999999998654 459999999999999999999999999999999999999   46789999999999866


Q ss_pred             ccCccc----ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917          188 EEGKAY----REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       188 ~~~~~~----~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (494)
                      ......    ....+++.|+|||++. ..++.++|||||||++|+|++ |+.||......+....+..+....   ..+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~  237 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPPE  237 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC---CCTT
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCC---CCCC
Confidence            433221    2234578899999986 468999999999999999998 999999988888877776654322   2257


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      +|+.+.++|.+||..||.+||++.+++++
T Consensus       238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~  266 (287)
T 1u59_A          238 CPPELYALMSDCWIYKWEDRPDFLTVEQR  266 (287)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            89999999999999999999999999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.2e-41  Score=341.63  Aligned_cols=258  Identities=27%  Similarity=0.438  Sum_probs=200.8

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ...+...|.+.+.||+|+||+||.+. ..+|+.||+|++...      ..+.+.+|+.+++++.+||||+++++++....
T Consensus        10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   82 (434)
T 2rio_A           10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDR   82 (434)
T ss_dssp             SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            44566788889999999999998754 467999999998542      24567889999998756999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC----------
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYS-------ERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG----------  170 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~-------~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~----------  170 (494)
                      ..++|||||. |+|.+++.......       ...+..++.||+.||.|||++||+||||||+||+++..          
T Consensus        83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence            9999999996 59999997654322       22356799999999999999999999999999999642          


Q ss_pred             CCCCeEEEeecCCccccccCcc-----cccccCCcCccChhhhcc--------cCCCcchhHHHHHHHHHHHh-CCCCCC
Q 040917          171 DENAVVKATDFGLSAFIEEGKA-----YREIVGSPYYIAPEVLSQ--------SYGKEADIWSAGVILYILLC-GVPPFW  236 (494)
Q Consensus       171 ~~~~~~kL~Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~--------~~~~~~Di~slG~il~~l~t-g~~pf~  236 (494)
                      +....++|+|||++........     .....||+.|+|||++.+        .++.++|||||||++|+|++ |..||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence            2456899999999987654322     224578999999999853        47899999999999999999 999997


Q ss_pred             CCChHHHHHHHHcCCccCCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          237 AETDQGVAQAILKGEINFQRDP---FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      ......  ..+..+........   ...+++.+.++|.+||..||.+|||+.++++||||+.
T Consensus       242 ~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          242 DKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             STTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             CchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            665443  23334333322211   1134578999999999999999999999999999975

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.2e-41  Score=343.16  Aligned_cols=243  Identities=23%  Similarity=0.337  Sum_probs=208.4

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC-eE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ-FV  109 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~-~~  109 (494)
                      -..+|++.+.||+|+||.||+|.+.  |+.||+|+++...     ....+.+|+.++++++ ||||+++++++.... ..
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  262 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGL  262 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCC-CTTBCCEEEEEECTTSCE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhcc-CCCEEEEEEEEEcCCCce
Confidence            3478999999999999999999975  7899999997533     3567899999999995 999999999987654 79


Q ss_pred             EEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          110 HIVMELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~--l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      ++||||+++|+|.+++...+.  ++...+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...
T Consensus       263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~  339 (450)
T 1k9a_A          263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEA  339 (450)
T ss_dssp             EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCcccc
Confidence            999999999999999987654  7999999999999999999999999999999999999   67889999999999754


Q ss_pred             ccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          188 EEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ....  ....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....++...+.++....   ....+|+.
T Consensus       340 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~---~p~~~~~~  414 (450)
T 1k9a_A          340 SSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---APDGCPPA  414 (450)
T ss_dssp             C--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCC---CCTTCCHH
T ss_pred             cccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCcCCHH
Confidence            3322  23356889999999864 68999999999999999998 999999888877777776653322   22568999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +.++|.+||..||.+|||+.++++
T Consensus       415 l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          415 VYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-42  Score=346.69  Aligned_cols=254  Identities=25%  Similarity=0.409  Sum_probs=197.6

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|.+.+.||+|+||+||. ....+++.||||++.....      ..+.+|+.+++.+.+||||+++++++.+....|+|
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            5799999999999999764 3346799999999864332      22567999999996699999999999999999999


Q ss_pred             EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC--CCCCeEEEeecCCcccccc
Q 040917          113 MELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG--DENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~--~~~~~~kL~Dfg~a~~~~~  189 (494)
                      ||||. ++|.+++.... ..+...+..++.||+.||.|||++||+||||||+||+++..  +....++|+|||++.....
T Consensus        97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            99996 59999987654 35556678999999999999999999999999999999632  2344688999999986643


Q ss_pred             Cc----ccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 040917          190 GK----AYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFP  260 (494)
Q Consensus       190 ~~----~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (494)
                      ..    ......||+.|+|||++.    ..++.++|||||||++|+|++ |..||...........+...... ......
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~  254 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLD-CLHPEK  254 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCT-TSCTTC
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcc-ccCccc
Confidence            32    223467899999999986    347789999999999999999 89999665554332222111111 111112


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      ..+..+.++|.+||..||.+|||+.++++||||+.
T Consensus       255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          255 HEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             HHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             cccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            34566889999999999999999999999999985

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.4e-41  Score=320.42  Aligned_cols=250  Identities=21%  Similarity=0.334  Sum_probs=212.4

Q ss_pred             cccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           27 AYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        27 ~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      ..+....+|++++.||+|+||.||+|.+. ++..||+|++....    ...+.+.+|+.+++++. ||||+++++++.. 
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-   79 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-   79 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhCC-CcCcceEEEEEcC-
Confidence            34555689999999999999999999975 57789999986543    23567899999999995 9999999999864 


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCc
Q 040917          107 QFVHIVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS  184 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a  184 (494)
                      +..++||||++|++|.+++....  .++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||.+
T Consensus        80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~  156 (279)
T 1qpc_A           80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLA  156 (279)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTC
T ss_pred             CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCccc
Confidence            45789999999999999986543  68999999999999999999999999999999999999   67889999999999


Q ss_pred             cccccCccc--ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 040917          185 AFIEEGKAY--REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFP  260 (494)
Q Consensus       185 ~~~~~~~~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (494)
                      .........  ....+++.|+|||++. +.++.++||||||+++|+|++ |..||.+....+....+..+....   ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~  233 (279)
T 1qpc_A          157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPD  233 (279)
T ss_dssp             EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCT
T ss_pred             ccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC---Ccc
Confidence            866433221  2344677899999986 468999999999999999999 999999988888877776653322   224


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          261 SISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+++.+.+++.+||..||++|||+.++++
T Consensus       234 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          234 NCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            68899999999999999999999999987

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=330.40  Aligned_cols=248  Identities=20%  Similarity=0.303  Sum_probs=204.3

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEE----EEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEF----ACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~v----alK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .++|++++.||+|+||.||+|.+..+++.|    ++|.+....  .......+.+|+.+++++. ||||+++++++....
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEESSS
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEecCC
Confidence            378999999999999999999998888866    556554322  3335678999999999995 999999999998765


Q ss_pred             eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          108 FVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                       .++|++++.+++|.+++... ..++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++..
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKL  166 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTC---
T ss_pred             -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE---cCCCCEEEccCcceeE
Confidence             78999999999999999764 569999999999999999999999999999999999999   5678999999999986


Q ss_pred             cccCccc---ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917          187 IEEGKAY---REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       187 ~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (494)
                      .......   ....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.........+........   .+.
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~  243 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPI  243 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CTT
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---Ccc
Confidence            5432221   23445778999998864 58999999999999999999 9999999888877777666543322   246


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ++..+.++|.+||..||.+|||+.++++
T Consensus       244 ~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          244 CTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            7899999999999999999999999987

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-41  Score=328.06  Aligned_cols=251  Identities=24%  Similarity=0.364  Sum_probs=207.5

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCC----cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTG----LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED  105 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~----~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~  105 (494)
                      -...+|++.+.||+|+||.||+|.+..++    ..||+|++....  .......+.+|+.+++++. ||||+++++++..
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~  117 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISK  117 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECS
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEec
Confidence            34578999999999999999999986553    459999996433  3345667899999999995 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCc
Q 040917          106 DQFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS  184 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a  184 (494)
                      .+..++||||++|++|.+++... ..++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~  194 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLS  194 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC-
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCcc
Confidence            89999999999999999999765 569999999999999999999999999999999999999   67889999999999


Q ss_pred             cccccCcc----cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCC
Q 040917          185 AFIEEGKA----YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDP  258 (494)
Q Consensus       185 ~~~~~~~~----~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (494)
                      ........    .....+++.|+|||++. ..++.++|||||||++|+|++ |..||......++...+..+....   .
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~---~  271 (333)
T 1mqb_A          195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP---T  271 (333)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---C
T ss_pred             hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC---C
Confidence            86543221    11234577899999986 468999999999999999998 999999988888877776653222   2


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       259 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ...+++.+.+++.+||..||.+||++.++++
T Consensus       272 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  302 (333)
T 1mqb_A          272 PMDCPSAIYQLMMQCWQQERARRPKFADIVS  302 (333)
T ss_dssp             CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            2468899999999999999999999999987

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.4e-41  Score=321.36  Aligned_cols=246  Identities=16%  Similarity=0.243  Sum_probs=210.7

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC--Ce
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD--QF  108 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~--~~  108 (494)
                      ..++|++.+.||+|+||.||+|.+.  ++.||+|++..... .......+.+|+.++++++ ||||+++++++...  ..
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   83 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAPH   83 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTSSS
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCCCC
Confidence            3478999999999999999999985  88999999976543 3345677999999999995 99999999999876  78


Q ss_pred             EEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEEeeCCCCCeEEEeecCCc
Q 040917          109 VHIVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKG--VMHRDLKPENFLFTTGDENAVVKATDFGLS  184 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~dikp~NIli~~~~~~~~~kL~Dfg~a  184 (494)
                      .++||||++|++|.+++....  .++...+..++.||+.||.|||++|  ++||||||+||++   +.++.++|+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVK  160 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSC
T ss_pred             eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEeccce
Confidence            899999999999999998765  4899999999999999999999999  9999999999999   67888999988876


Q ss_pred             cccccCcccccccCCcCccChhhhccc-C---CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 040917          185 AFIEEGKAYREIVGSPYYIAPEVLSQS-Y---GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP  260 (494)
Q Consensus       185 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~---~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (494)
                      .....    ....+|+.|+|||++.+. +   +.++|||||||++|+|++|+.||...........+........  ...
T Consensus       161 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~  234 (271)
T 3kmu_A          161 FSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT--IPP  234 (271)
T ss_dssp             CTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC--CCT
T ss_pred             eeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC--CCC
Confidence            54322    345689999999998653 3   3379999999999999999999999888877766665544332  235


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          261 SISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+++.+.+++.+||..||.+|||+.++++
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          235 GISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            68999999999999999999999999987

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.8e-41  Score=324.02  Aligned_cols=253  Identities=22%  Similarity=0.426  Sum_probs=199.5

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .+-..++|++.+.||+|+||.||+|.+..   .||+|++.... ........+.+|+.+++++. ||||++++++. ...
T Consensus        19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~~~   92 (289)
T 3og7_A           19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTR-HVNILLFMGYS-TAP   92 (289)
T ss_dssp             CBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE-CSS
T ss_pred             CccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccC-CCHHHHHHHHHHHHHHHhCC-CCcEEEEEeec-cCC
Confidence            34455789999999999999999998643   59999997544 33445678999999999995 99999999965 455


Q ss_pred             eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          108 FVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      ..++||||++|++|.+++... ..++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++..
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~  169 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATE  169 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC----
T ss_pred             ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEEccceeccc
Confidence            688999999999999998543 468999999999999999999999999999999999999   5678999999999875


Q ss_pred             ccc---CcccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHcCCccCC-CC
Q 040917          187 IEE---GKAYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGV-AQAILKGEINFQ-RD  257 (494)
Q Consensus       187 ~~~---~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~-~~~~~~~~~~~~-~~  257 (494)
                      ...   ........||+.|+|||++.    ..++.++|||||||++|+|++|+.||........ ...+..+..... ..
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
T 3og7_A          170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK  249 (289)
T ss_dssp             --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred             cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence            432   22223456899999999985    3578899999999999999999999987665443 444444433322 22


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       258 ~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ....+|+.+.+++.+||..||.+|||+.++++
T Consensus       250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            23468899999999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.4e-42  Score=332.77  Aligned_cols=247  Identities=21%  Similarity=0.269  Sum_probs=198.3

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC----
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ----  107 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~----  107 (494)
                      ..+|++.+.||+|+||.||+|.+.  ++.||+|++....    .......+|+.++++++ ||||+++++++....    
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~   95 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSVDV   95 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCC-CCCchhhcceeccCCCCCc
Confidence            478999999999999999999876  7899999996432    23455667898999995 999999999997643    


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CceeccCCCCceEEeeCCCCCeEE
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK----------GVMHRDLKPENFLFTTGDENAVVK  177 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------~i~H~dikp~NIli~~~~~~~~~k  177 (494)
                      ..++||||+++|+|.+++... .++...+..++.|++.||.|||+.          ||+||||||+||++   +.++.+|
T Consensus        96 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~k  171 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTAC  171 (322)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEE
T ss_pred             eEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEE
Confidence            479999999999999999764 599999999999999999999999          99999999999999   6788999


Q ss_pred             EeecCCccccccCcc---cccccCCcCccChhhhcc------cCCCcchhHHHHHHHHHHHhCCCCCCCCCh--------
Q 040917          178 ATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ------SYGKEADIWSAGVILYILLCGVPPFWAETD--------  240 (494)
Q Consensus       178 L~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~------~~~~~~Di~slG~il~~l~tg~~pf~~~~~--------  240 (494)
                      |+|||++........   .....||+.|+|||++.+      .++.++|||||||++|+|++|+.||.+...        
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            999999976543322   233578999999999864      456789999999999999999999965422        


Q ss_pred             --------HHHHHHHHcCCccCCCCC-C--CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          241 --------QGVAQAILKGEINFQRDP-F--PSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       241 --------~~~~~~~~~~~~~~~~~~-~--~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                              ......+........... +  ...++.+.++|.+||..||.+|||+.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                    222222222222111110 0  112345999999999999999999999987

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=8.6e-42  Score=327.25  Aligned_cols=254  Identities=21%  Similarity=0.303  Sum_probs=200.0

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++.....     ...+.+|+.+++.+.+++++..+..++......
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence            456899999999999999999999999999999998764432     234788999999997444455555566778899


Q ss_pred             EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          110 HIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      ++||||+ +++|.+++.. ...++...+..++.||+.||.|||++||+||||||+||+++..+..+.+||+|||++....
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9999999 8899999874 4579999999999999999999999999999999999999544567889999999998654


Q ss_pred             cCcc--------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHcCCccCC-
Q 040917          189 EGKA--------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ---GVAQAILKGEINFQ-  255 (494)
Q Consensus       189 ~~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~---~~~~~~~~~~~~~~-  255 (494)
                      ....        .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....   .....+.......+ 
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence            4322        224578999999999875 5889999999999999999999999765432   12222222111111 


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          256 RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       256 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ......+|+.+.+++.+||..||.+|||+.++++
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            1112467899999999999999999999999987

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.6e-41  Score=348.00  Aligned_cols=248  Identities=23%  Similarity=0.353  Sum_probs=214.3

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      -..+|++.+.||+|+||.||+|.+..++..||+|++.....    ..+.+.+|+.++++++ ||||+++++++......+
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~  292 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFY  292 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcC-CCCEeeEEEEEecCCcEE
Confidence            34789999999999999999999999999999999975432    4677999999999995 999999999999888999


Q ss_pred             EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          111 IVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      +||||+++|+|.+++...  ..++...+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEECCT
T ss_pred             EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccceecc
Confidence            999999999999999864  358999999999999999999999999999999999999   678899999999998654


Q ss_pred             cCcc--cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          189 EGKA--YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       189 ~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      ....  .....+++.|+|||++. +.++.++|||||||++|+|++ |..||.+.....+...+..+...   .....+|+
T Consensus       370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  446 (495)
T 1opk_A          370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPEGCPE  446 (495)
T ss_dssp             TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCTTCCH
T ss_pred             CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCH
Confidence            3221  12334567899999986 468999999999999999999 99999988887777766554322   22256899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+.++|.+||..||.+|||+.++++
T Consensus       447 ~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          447 KVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCcChhHCcCHHHHHH
Confidence            9999999999999999999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2e-41  Score=327.58  Aligned_cols=251  Identities=21%  Similarity=0.300  Sum_probs=202.6

Q ss_pred             cccceEeeeeecccCCeEEEEEEECC---CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENS---TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~---~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ...+|++++.||+|+||.||+|.+..   ++..||+|++..... .......+.+|+.++++++ ||||+++++++....
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEMS  109 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC--
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCC-CCCeeeeeEEEeecc
Confidence            34789999999999999999998765   566899999975442 3345677899999999995 999999999987654


Q ss_pred             -----eEEEEEeccCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeE
Q 040917          108 -----FVHIVMELCAGGELFDRIVA------RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVV  176 (494)
Q Consensus       108 -----~~~iv~e~~~g~sL~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~  176 (494)
                           ..++||||+++++|.+++..      ...++...++.++.||+.||.|||++||+||||||+||++   +.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcE
Confidence                 35899999999999999843      3468999999999999999999999999999999999999   678899


Q ss_pred             EEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCC
Q 040917          177 KATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGE  251 (494)
Q Consensus       177 kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~  251 (494)
                      +|+|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.........+..+.
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  266 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH  266 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence            9999999976543321   123456788999999865 58999999999999999999 899999888877777776654


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          252 INFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       252 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ...   ....+++.+.++|.+||..||.+|||+.++++
T Consensus       267 ~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  301 (313)
T 3brb_A          267 RLK---QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL  301 (313)
T ss_dssp             CCC---CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             CCC---CCccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            322   22568899999999999999999999999987

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.7e-41  Score=322.40  Aligned_cols=242  Identities=24%  Similarity=0.349  Sum_probs=200.5

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC-CeEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD-QFVH  110 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~-~~~~  110 (494)
                      .++|++.+.||+|++|.||+|.+.  |+.||+|++....     ..+.+.+|+.++++++ ||||+++++++... +..+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   91 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLY   91 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CCE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCCceE
Confidence            478999999999999999999875  8899999986432     4567899999999995 99999999987544 4789


Q ss_pred             EEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          111 IVMELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~--l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      +||||+++++|.+++.....  ++...+..++.|++.||.|||++|++||||||+||++   +.++.++|+|||++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC-----
T ss_pred             EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeecccccccc
Confidence            99999999999999976543  8999999999999999999999999999999999999   678899999999987554


Q ss_pred             cCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917          189 EGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (494)
                      ...  ....+++.|+|||++.+ .++.++||||||+++|+|++ |..||......+....+..+..   ......+++.+
T Consensus       169 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l  243 (278)
T 1byg_A          169 STQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPAV  243 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCCHHH
T ss_pred             ccc--cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCcccCCHHH
Confidence            322  23456889999999864 58999999999999999998 9999998887777666655422   22235689999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhc
Q 040917          267 IELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .++|.+||..||.+|||+.++++
T Consensus       244 ~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          244 YEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCChhhCCCHHHHHH
Confidence            99999999999999999999987

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.9e-42  Score=335.96  Aligned_cols=255  Identities=21%  Similarity=0.302  Sum_probs=206.5

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .+...++|++.+.||+|+||.||+|.+. +++.||+|++....   ......+.+|+.+++.++ ||||+++++++...+
T Consensus        34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           34 LEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCR-HPHLVSLIGFCDERN  108 (321)
T ss_dssp             CCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCC-CTTBCCEEEECCCTT
T ss_pred             HHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCC
Confidence            4556689999999999999999999964 68999999986532   235677899999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCC
Q 040917          108 FVHIVMELCAGGELFDRIVARG----HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL  183 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~----~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~  183 (494)
                      ..++||||++|++|.+++....    .++...+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeeccc
Confidence            9999999999999999886543    48999999999999999999999999999999999999   6788999999999


Q ss_pred             ccccccCc---ccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHH-------HHHHcCCc
Q 040917          184 SAFIEEGK---AYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVA-------QAILKGEI  252 (494)
Q Consensus       184 a~~~~~~~---~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~-------~~~~~~~~  252 (494)
                      +.......   ......||+.|+|||++. +.++.++|||||||++|+|++|+.||......+..       ........
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL  265 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence            97643221   123345899999999885 56899999999999999999999999765432211       11111111


Q ss_pred             cC------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          253 NF------QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       253 ~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      ..      .....+..+..+.+++.+||..||++|||+.+++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            10      011112345678899999999999999999999974

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.5e-41  Score=324.05  Aligned_cols=249  Identities=26%  Similarity=0.405  Sum_probs=202.4

Q ss_pred             ccceEeeeeecccCCeEEEEEE----ECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC-
Q 040917           32 QLHYTIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD-  106 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~----~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~-  106 (494)
                      ..+|++++.||+|+||.||+|.    +..+++.||+|++....  .......+.+|+.+++.++ ||||+++++++... 
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDG   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC--
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecCC
Confidence            3679999999999999999999    57789999999997543  2334678899999999995 99999999999876 


Q ss_pred             -CeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCc
Q 040917          107 -QFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS  184 (494)
Q Consensus       107 -~~~~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a  184 (494)
                       ...++||||+++++|.+++.. ...++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLT  173 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTC
T ss_pred             CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE---cCCCCEEECccccc
Confidence             678999999999999999954 4569999999999999999999999999999999999999   56789999999999


Q ss_pred             cccccCcc----cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCC--------------h-HHHH
Q 040917          185 AFIEEGKA----YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAET--------------D-QGVA  244 (494)
Q Consensus       185 ~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~--------------~-~~~~  244 (494)
                      ........    .....+|+.|+|||++.+ .++.++|||||||++|+|++|..|+....              . ....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            87654332    223557888999998864 58889999999999999999998763221              1 1122


Q ss_pred             HHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ..+.... .  ....+.+++.+.++|.+||..||.+|||+.++++
T Consensus       254 ~~~~~~~-~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          254 NTLKEGK-R--LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHTTC-C--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHhccC-C--CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            2222222 1  1223578999999999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=5.4e-42  Score=338.63  Aligned_cols=256  Identities=16%  Similarity=0.195  Sum_probs=194.6

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCC-----CcEEEEEEeccCCCCCh--------hhHHHHHHHHHHHHHccCCCCcc
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENST-----GLEFACKSIPKRKLVKD--------VEKDDVRREIEIMRHLSGQPNIV   97 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~-----~~~valK~~~~~~~~~~--------~~~~~~~~E~~~l~~l~~hp~i~   97 (494)
                      ..++|++++.||+|+||.||+|.+..+     ++.||+|++........        ........|+..+..+ .||||+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~~iv  111 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL-KYLGVP  111 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC-SCCCSC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc-cCCCCC
Confidence            445999999999999999999998764     58899999864321000        0001122333444455 399999


Q ss_pred             EEeEEEEeC----CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCC
Q 040917           98 QFKAAYEDD----QFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDE  172 (494)
Q Consensus        98 ~~~~~~~~~----~~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~  172 (494)
                      ++++++...    ...++||||+ |++|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++. +.
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~~  189 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-KN  189 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-SC
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-CC
Confidence            999998764    4689999999 99999999876 57999999999999999999999999999999999999952 26


Q ss_pred             CCeEEEeecCCccccccCccc--------ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH-H
Q 040917          173 NAVVKATDFGLSAFIEEGKAY--------REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ-G  242 (494)
Q Consensus       173 ~~~~kL~Dfg~a~~~~~~~~~--------~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~  242 (494)
                      .+.+||+|||++.........        ....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.... .
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            789999999999765432211        23458999999999875 4899999999999999999999999854322 2


Q ss_pred             HHHHHHc----CCccCC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          243 VAQAILK----GEINFQ--RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       243 ~~~~~~~----~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .......    ......  ......+|+.+.+++..||..||.+||++.++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            2111110    000000  0011467899999999999999999999999886

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.8e-41  Score=324.33  Aligned_cols=254  Identities=22%  Similarity=0.351  Sum_probs=204.9

Q ss_pred             ccceEeeeeecccCCeEEEEEEECC-CCc--EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENS-TGL--EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~-~~~--~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      ..+|++.+.||+|+||.||+|.+.. +++  .||+|++.............+.+|+.+++++. ||||+++++++.... 
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS-
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC-
Confidence            4789999999999999999998643 333  68999987655445556788999999999995 999999999998765 


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .++|+|++++++|.+++... ..++...+..++.||+.||.|||++|++||||||+||++   +.++.++|+|||++...
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEEC
T ss_pred             ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---cCCCCEEEccccccccc
Confidence            78999999999999998764 568999999999999999999999999999999999999   46789999999999766


Q ss_pred             ccCcc----cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917          188 EEGKA----YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       188 ~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (494)
                      .....    .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+.......+.  ...
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~  249 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PED  249 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTT
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--CcC
Confidence            43322    123456778999999864 57899999999999999999 99999999988888877766544332  257


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLK  294 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  294 (494)
                      ++..+.++|.+||..||.+|||+.++++  ++.
T Consensus       250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~  280 (291)
T 1u46_A          250 CPQDIYNVMVQCWAHKPEDRPTFVALRD--FLL  280 (291)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHH--HHH
Confidence            8999999999999999999999999998  444

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.1e-41  Score=326.77  Aligned_cols=249  Identities=24%  Similarity=0.387  Sum_probs=202.5

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe----CC
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----DQ  107 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~----~~  107 (494)
                      ..+|++++.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.+++.+ +||||+++++++..    ..
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCc
Confidence            47899999999999999999999999999999998643   344567889999999999 59999999999862    34


Q ss_pred             eEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCC
Q 040917          108 FVHIVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL  183 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~  183 (494)
                      ..++||||+++++|.+++..    ...+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||.
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCc
Confidence            78999999999999998875    4569999999999999999999999999999999999999   6788999999999


Q ss_pred             ccccccCcc----------cccccCCcCccChhhhcc----cCCCcchhHHHHHHHHHHHhCCCCCCCCCh--HHHHHHH
Q 040917          184 SAFIEEGKA----------YREIVGSPYYIAPEVLSQ----SYGKEADIWSAGVILYILLCGVPPFWAETD--QGVAQAI  247 (494)
Q Consensus       184 a~~~~~~~~----------~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~pf~~~~~--~~~~~~~  247 (494)
                      +........          .....|++.|+|||++.+    .++.++|||||||++|+|++|..||.....  ......+
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  260 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV  260 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence            875432111          123457999999999864    268999999999999999999999943111  0111222


Q ss_pred             HcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          248 LKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      .. ...  .+..+.+++.+.++|.+||..||.+|||+.+++++
T Consensus       261 ~~-~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          261 QN-QLS--IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HC-C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hc-cCC--CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            22 222  22235689999999999999999999999999984

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.5e-41  Score=341.43  Aligned_cols=247  Identities=21%  Similarity=0.341  Sum_probs=211.4

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      -...+|++.+.||+|+||.||+|.+. .+..||+|++....    ...+.+.+|+.++++++ ||||+++++++. ....
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSSC
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCC-CCCEeeEEEEEe-CCcc
Confidence            34578999999999999999999986 47789999997543    24678999999999995 999999999986 5678


Q ss_pred             EEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          110 HIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      ++||||+++|+|.+++...  ..++...+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVI  334 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGGGGB
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCceEc
Confidence            9999999999999999754  368999999999999999999999999999999999999   67889999999999865


Q ss_pred             ccCcc--cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917          188 EEGKA--YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       188 ~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      .....  .....+++.|+|||++. +.++.++|||||||++|+|++ |+.||.+....++...+..+.....   ...+|
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---~~~~~  411 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR---PENCP  411 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC---CTTSC
T ss_pred             CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCC
Confidence            43221  12234567899999986 568999999999999999999 9999999998888888776533222   24689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          264 SSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +.+.++|.+||..||++|||+.++++
T Consensus       412 ~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          412 EELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHH
Confidence            99999999999999999999999876

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.4e-42  Score=336.07  Aligned_cols=257  Identities=17%  Similarity=0.193  Sum_probs=197.0

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECC---CCcEEEEEEeccCCCCCh--------hhHHHHHHHHHHHHHccCCCCccE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENS---TGLEFACKSIPKRKLVKD--------VEKDDVRREIEIMRHLSGQPNIVQ   98 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~---~~~~valK~~~~~~~~~~--------~~~~~~~~E~~~l~~l~~hp~i~~   98 (494)
                      ...++|++++.||+|+||.||+|.+..   ++..||+|++........        .....+.+|+..++.+ +||||++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~  112 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPL  112 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCC
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcce
Confidence            345789999999999999999999987   889999999875431100        1123356778888888 4999999


Q ss_pred             EeEEEEe----CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917           99 FKAAYED----DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA  174 (494)
Q Consensus        99 ~~~~~~~----~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~  174 (494)
                      +++++..    ....++||||+ |++|.+++...+.++...+..++.||+.||.|||++||+||||||+||+++.+ ..+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~  190 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NPD  190 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS-STT
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC-CCC
Confidence            9999987    77899999999 99999999877789999999999999999999999999999999999999531 223


Q ss_pred             eEEEeecCCccccccCc--------ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCC--ChHHH
Q 040917          175 VVKATDFGLSAFIEEGK--------AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAE--TDQGV  243 (494)
Q Consensus       175 ~~kL~Dfg~a~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~--~~~~~  243 (494)
                      .++|+|||++.......        ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.  .....
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            99999999997653321        1134578999999999876 4899999999999999999999999653  22222


Q ss_pred             HHHHHcCCccCCC-----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          244 AQAILKGEINFQR-----DPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       244 ~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ...........+.     .....+|+.+.++|.+||..||.+|||+.++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            1111111001110     011268899999999999999999999999987

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.1e-41  Score=327.43  Aligned_cols=247  Identities=25%  Similarity=0.391  Sum_probs=205.1

Q ss_pred             cceEeeeeecccCCeEEEEEE----ECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE--eC
Q 040917           33 LHYTIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE--DD  106 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~----~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~--~~  106 (494)
                      .+|++.+.||+|+||.||+|.    +..+++.||+|++...   .......+.+|+.+++++ +||||+++++++.  ..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSS
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCC
Confidence            699999999999999999999    5678999999999643   334567789999999999 5999999999886  45


Q ss_pred             CeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          107 QFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      ...++||||++|++|.+++.. ...++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||.+.
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLAK  175 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCGGGCE
T ss_pred             ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE---CCCCCEEEcccccce
Confidence            679999999999999999976 3469999999999999999999999999999999999999   567899999999998


Q ss_pred             ccccCcc----cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH---------------HHHH
Q 040917          186 FIEEGKA----YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ---------------GVAQ  245 (494)
Q Consensus       186 ~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~---------------~~~~  245 (494)
                      .......    .....+++.|+|||++.+ .++.++|||||||++|+|++|..||......               ....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE  255 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence            6543322    123457788999999865 5789999999999999999999998654332               1222


Q ss_pred             HHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          246 AILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+..+. .  ....+.+++.+.++|.+||..||.+|||+.++++
T Consensus       256 ~~~~~~-~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  296 (327)
T 3lxl_A          256 LLEEGQ-R--LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP  296 (327)
T ss_dssp             HHHTTC-C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Hhhccc-C--CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            222221 1  1223578999999999999999999999999965

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4e-41  Score=328.69  Aligned_cols=254  Identities=29%  Similarity=0.511  Sum_probs=191.2

Q ss_pred             hcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEE
Q 040917           24 LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY  103 (494)
Q Consensus        24 ~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~  103 (494)
                      .++..+-...+|++.+.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.+++++.+||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~   95 (337)
T 3ll6_A           19 VGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA   95 (337)
T ss_dssp             TTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             hcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccc
Confidence            3344444557999999999999999999999999999999998543   3345677889999999997799999999998


Q ss_pred             E--------eCCeEEEEEeccCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEEeeC
Q 040917          104 E--------DDQFVHIVMELCAGGELFDRIVA---RGHYSERAAASVFRVIMNVVNVCHSKG--VMHRDLKPENFLFTTG  170 (494)
Q Consensus       104 ~--------~~~~~~iv~e~~~g~sL~~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~dikp~NIli~~~  170 (494)
                      .        ....+++||||+. |+|.+++..   .+.++...+..++.||+.||.|||++|  |+||||||+||++   
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---  171 (337)
T 3ll6_A           96 SIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---  171 (337)
T ss_dssp             EECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---
T ss_pred             cccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---
Confidence            4        3446899999996 599888865   456999999999999999999999999  9999999999999   


Q ss_pred             CCCCeEEEeecCCccccccCccc-------------ccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCC
Q 040917          171 DENAVVKATDFGLSAFIEEGKAY-------------REIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVP  233 (494)
Q Consensus       171 ~~~~~~kL~Dfg~a~~~~~~~~~-------------~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~  233 (494)
                      +.++.++|+|||++.........             ....+|+.|+|||++.    ..++.++|||||||++|+|++|+.
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~  251 (337)
T 3ll6_A          172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH  251 (337)
T ss_dssp             CTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCC
Confidence            67889999999999865432221             1345899999999973    357889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          234 PFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       234 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      ||.......+..    ....  .......+..+.++|.+||..||.+|||+.+++++
T Consensus       252 p~~~~~~~~~~~----~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          252 PFEDGAKLRIVN----GKYS--IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             CC----------------CC--CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCcchhHHHhhc----Cccc--CCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            997655433222    2222  12234567889999999999999999999999985

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.1e-42  Score=359.02  Aligned_cols=261  Identities=25%  Similarity=0.409  Sum_probs=210.1

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe------
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED------  105 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~------  105 (494)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++....  .......+.+|+.+++++. ||||+++++++..      
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCCCT
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccccccC
Confidence            378999999999999999999999999999999986532  3445677899999999995 9999999998754      


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917          106 DQFVHIVMELCAGGELFDRIVARG---HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG  182 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~~---~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg  182 (494)
                      ++..++||||++|++|.+++....   .+++..+..++.+++.||.|||++||+||||||+||+++.++....++|+|||
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            667899999999999999997654   58999999999999999999999999999999999999755555679999999


Q ss_pred             CccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHH---------HH-----
Q 040917          183 LSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQ---------AI-----  247 (494)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~---------~~-----  247 (494)
                      .+.............|++.|+|||++.+ .++.++|||||||++|+|++|..||..........         .+     
T Consensus       170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  249 (676)
T 3qa8_A          170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD  249 (676)
T ss_dssp             CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred             cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence            9987766555566789999999999864 68999999999999999999999997654321110         00     


Q ss_pred             HcCCccC------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          248 LKGEINF------QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       248 ~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      ..+...+      +......+++.+.++|.+||..||.+|||+.++++||||+.
T Consensus       250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence            0111111      11112236788999999999999999999999999999974

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=9e-41  Score=320.63  Aligned_cols=250  Identities=22%  Similarity=0.312  Sum_probs=206.8

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCC---CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEE-EeC
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENST---GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAY-EDD  106 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~---~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~-~~~  106 (494)
                      -..+|++.+.||+|+||.||+|.+..+   +..||+|.+...  ........+.+|+.+++++. ||||+++++++ ..+
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   99 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSE   99 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSS
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcCC
Confidence            346899999999999999999997543   345899998643  24445678899999999995 99999999986 455


Q ss_pred             CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          107 QFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      +..++||||++|++|.+++... ..++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||.+.
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLAR  176 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGC
T ss_pred             CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECcccccc
Confidence            6789999999999999999763 458999999999999999999999999999999999999   678899999999997


Q ss_pred             ccccCcc-----cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCC
Q 040917          186 FIEEGKA-----YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDP  258 (494)
Q Consensus       186 ~~~~~~~-----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (494)
                      .......     .....+++.|+|||++.+ .++.++|+||||+++|+|++ +..||......+....+..+.....+  
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  254 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP--  254 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC--
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC--
Confidence            6543221     223456788999999864 68999999999999999999 66777777776666666665443332  


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          259 FPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       259 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                       ..+|..+.+++.+||..||.+|||+.++++
T Consensus       255 -~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          255 -EYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             457899999999999999999999999987

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4e-41  Score=323.51  Aligned_cols=247  Identities=23%  Similarity=0.357  Sum_probs=195.9

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHH--ccCCCCccEEeEEEEe--
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRH--LSGQPNIVQFKAAYED--  105 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~hp~i~~~~~~~~~--  105 (494)
                      .+.++|++.+.||+|+||.||+|.+  +++.||+|++...      ....+..|.+++..  + +||||+++++++..  
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVML-RHENILGFIASDMTSR   75 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCC-CCTTBCCEEEEEEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhc-cCcCeeeEEEeecccc
Confidence            4568999999999999999999987  5899999998532      34556677777777  6 59999999998654  


Q ss_pred             --CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCceEEeeCCCCCe
Q 040917          106 --DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH--------SKGVMHRDLKPENFLFTTGDENAV  175 (494)
Q Consensus       106 --~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~i~H~dikp~NIli~~~~~~~~  175 (494)
                        ....++||||+++++|.+++.. ..++...+..++.||+.||.|||        ++||+||||||+||++   +.++.
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~  151 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQ  151 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSC
T ss_pred             CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCC
Confidence              3468999999999999999954 57999999999999999999999        9999999999999999   67889


Q ss_pred             EEEeecCCccccccCccc-----ccccCCcCccChhhhccc-------CCCcchhHHHHHHHHHHHhC----------CC
Q 040917          176 VKATDFGLSAFIEEGKAY-----REIVGSPYYIAPEVLSQS-------YGKEADIWSAGVILYILLCG----------VP  233 (494)
Q Consensus       176 ~kL~Dfg~a~~~~~~~~~-----~~~~~~~~y~aPE~~~~~-------~~~~~Di~slG~il~~l~tg----------~~  233 (494)
                      +||+|||++.........     ....||+.|+|||++.+.       ++.++|||||||++|+|++|          ..
T Consensus       152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~  231 (301)
T 3q4u_A          152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP  231 (301)
T ss_dssp             EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence            999999999765433221     234789999999998653       45689999999999999999          88


Q ss_pred             CCCCCCh----HHHHHHHHcCCccCCCCC----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          234 PFWAETD----QGVAQAILKGEINFQRDP----FPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       234 pf~~~~~----~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ||.....    ..............+..+    ....++.+.+++.+||..||.+|||+.++++
T Consensus       232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            8854322    122222222211111111    0124577999999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-40  Score=318.52  Aligned_cols=248  Identities=23%  Similarity=0.319  Sum_probs=205.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCc---EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe-
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGL---EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF-  108 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~---~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~-  108 (494)
                      -.|++.+.||+|+||.||+|.+..++.   .||+|++...  ......+.+.+|+.+++++. ||||+++++++...+. 
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   97 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEGL   97 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSSC
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecCCCC
Confidence            468888999999999999999765544   7999998643  23445678899999999995 9999999999976554 


Q ss_pred             EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .++||||+.+++|.+++.. ...++...+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||++...
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDI  174 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTT
T ss_pred             cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCcccc
Confidence            4899999999999999976 3568999999999999999999999999999999999999   67889999999999755


Q ss_pred             ccCc-----ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 040917          188 EEGK-----AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCG-VPPFWAETDQGVAQAILKGEINFQRDPFP  260 (494)
Q Consensus       188 ~~~~-----~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (494)
                      ....     ......+++.|+|||.+.+ .++.++|||||||++|+|++| ..||...........+........   ..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~  251 (298)
T 3pls_A          175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ---PE  251 (298)
T ss_dssp             TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC---CT
T ss_pred             cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC---Cc
Confidence            3322     2233557889999999875 589999999999999999995 555666666666666655443222   24


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          261 SISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+++.+.+++.+||..||.+|||+.++++
T Consensus       252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          252 YCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            67899999999999999999999999987

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1e-40  Score=338.44  Aligned_cols=252  Identities=22%  Similarity=0.328  Sum_probs=209.0

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ..++|++.+.||+|+||.||+|.+.. +..||+|++.....    ..+.+.+|+.++++++ ||||+++++++.. +..+
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-~~~~  254 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIY  254 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEcC-CceE
Confidence            44789999999999999999999875 46799999975432    3567899999999995 9999999999876 6688


Q ss_pred             EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          111 IVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      +||||+++|+|.+++...  ..++...+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++....
T Consensus       255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIE  331 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC---
T ss_pred             EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccceecC
Confidence            999999999999999643  468999999999999999999999999999999999999   678899999999998654


Q ss_pred             cCcc--cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          189 EGKA--YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       189 ~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      ....  .....+++.|+|||++. +.++.++|||||||++|+|++ |..||.+....++...+..+....   ..+.+|+
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~---~~~~~~~  408 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---CPPECPE  408 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTSCH
T ss_pred             CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCH
Confidence            3221  12334577899999886 568999999999999999999 999999999888888877653322   2246899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc--CCccCc
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLE--HPWLKE  295 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~--~~~~~~  295 (494)
                      .+.++|.+||..||++|||++++++  ..++..
T Consensus       409 ~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          409 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            9999999999999999999999987  344443

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=319.30  Aligned_cols=240  Identities=27%  Similarity=0.432  Sum_probs=193.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++.+.||+|+||.||+|.+.  ++.||+|++...     .....+.+|+.+++++. ||||+++++++.+  ..++|
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~lv   77 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVN-HPNIVKLYGACLN--PVCLV   77 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCC-CTTBCCEEEBCTT--TTEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC--CcEEE
Confidence            68999999999999999999975  789999998532     25677899999999995 9999999998864  46899


Q ss_pred             EeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          113 MELCAGGELFDRIVARG---HYSERAAASVFRVIMNVVNVCHS---KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~---~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      |||++|++|.+++....   .++...+..++.|++.||.|||+   +||+||||||+||+++  .+...+||+|||++..
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACD  155 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE--TTTTEEEECCCCC---
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe--CCCCEEEEcccccccc
Confidence            99999999999997654   37899999999999999999999   8999999999999995  2333589999999875


Q ss_pred             cccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHcCCccCCCCCCCCCC
Q 040917          187 IEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ--GVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      ....  .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||......  .....+..+..   ......+|
T Consensus       156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  230 (307)
T 2eva_A          156 IQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR---PPLIKNLP  230 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC---CCCBTTCC
T ss_pred             cccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC---CCcccccC
Confidence            4332  234568999999999875 5899999999999999999999999755432  23333333322   22235689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          264 SSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +.+.+++.+||..||.+|||+.++++
T Consensus       231 ~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          231 KPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999999999987

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.2e-41  Score=330.73  Aligned_cols=245  Identities=15%  Similarity=0.174  Sum_probs=199.9

Q ss_pred             ccceEeeeeecccCCeEEEEEEECC--------CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccE-----
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENS--------TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQ-----   98 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~--------~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~-----   98 (494)
                      .++|++.+.||+|+||.||+|.+..        .++.||+|++...        ..+.+|+.+++++. ||||++     
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~-h~niv~~~~~~  111 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAA-KPLQVNKWKKL  111 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHC-CHHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhc-ccchhhhhhhh
Confidence            5799999999999999999999987        4899999998643        34778999999995 988887     


Q ss_pred             ----------EeEEEEe-CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 040917           99 ----------FKAAYED-DQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENF  165 (494)
Q Consensus        99 ----------~~~~~~~-~~~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NI  165 (494)
                                +++++.. +...++||||+ |++|.+++...  ..++...+..++.||+.||.|||++||+||||||+||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI  190 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI  190 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence                      6777766 67899999999 99999999876  6799999999999999999999999999999999999


Q ss_pred             EEeeCCCCC--eEEEeecCCccccccCcc--------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCC
Q 040917          166 LFTTGDENA--VVKATDFGLSAFIEEGKA--------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPP  234 (494)
Q Consensus       166 li~~~~~~~--~~kL~Dfg~a~~~~~~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~p  234 (494)
                      +++   .++  .++|+|||++........        .....||+.|+|||++.+ .++.++|||||||++|+|++|+.|
T Consensus       191 l~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          191 FVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             EEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             EEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            994   555  899999999976543221        123478999999999875 689999999999999999999999


Q ss_pred             CCCCC--hHHHHHHHH---cCCccCC--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          235 FWAET--DQGVAQAIL---KGEINFQ--RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       235 f~~~~--~~~~~~~~~---~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      |....  ...+.....   .....+.  ...+..+++.+.++|.+||..||.+|||+.++++
T Consensus       268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            98764  222322221   1111111  1122357899999999999999999999999987

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.3e-41  Score=324.27  Aligned_cols=249  Identities=24%  Similarity=0.388  Sum_probs=203.5

Q ss_pred             cccce-EeeeeecccCCeEEEEEE----ECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917           31 VQLHY-TIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED  105 (494)
Q Consensus        31 ~~~~y-~i~~~lg~G~~g~Vy~a~----~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~  105 (494)
                      +..+| ++++.||+|+||.||+|.    +..+++.||+|++....  .......+.+|+.+++++. ||||+++++++.+
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~  104 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLY-HEHIIKYKGCCED  104 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CcchhhEEEEEec
Confidence            55566 999999999999998775    34578999999997542  3445678999999999995 9999999999987


Q ss_pred             --CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCC
Q 040917          106 --DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL  183 (494)
Q Consensus       106 --~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~  183 (494)
                        ....++||||+++++|.+++... .++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||+
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          105 AGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFGL  180 (318)
T ss_dssp             TTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGG
T ss_pred             CCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCccc
Confidence              46889999999999999998765 59999999999999999999999999999999999999   6788999999999


Q ss_pred             ccccccCcc----cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH---------------HH
Q 040917          184 SAFIEEGKA----YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ---------------GV  243 (494)
Q Consensus       184 a~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~---------------~~  243 (494)
                      +........    .....+++.|+|||++.+ .++.++|||||||++|+|++|..||......               ..
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  260 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL  260 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred             cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence            987654322    223457788999999865 5889999999999999999999999654321               11


Q ss_pred             HHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          244 AQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ...+.... .  ......++..+.++|.+||..||.+|||+.++++
T Consensus       261 ~~~~~~~~-~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          261 TELLERGE-R--LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHTTC-C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccc-C--CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            12222221 1  2223568999999999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=7.7e-41  Score=340.00  Aligned_cols=254  Identities=22%  Similarity=0.293  Sum_probs=208.3

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      .+.++|++++.||+|+||.||+|.+..+++.||||++.....     ...+.+|+.+++.|..++++..+..++......
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            356899999999999999999999999999999999865442     234788999999998667788888888888899


Q ss_pred             EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          110 HIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      ++||||+ |++|.+++.. ...++...++.++.||+.||.|||++||+||||||+|||+...+..+.+||+|||++....
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            9999999 8899999975 4579999999999999999999999999999999999999544467899999999998654


Q ss_pred             cCcc--------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHcCCccCC-
Q 040917          189 EGKA--------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETD---QGVAQAILKGEINFQ-  255 (494)
Q Consensus       189 ~~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~---~~~~~~~~~~~~~~~-  255 (494)
                      ....        .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+...   ...+..+........ 
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            4322        125678999999999875 589999999999999999999999987543   222222222111111 


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          256 RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       256 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ......++..+.++|..||..+|.+||++.+|++
T Consensus       238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            1112467899999999999999999999998765

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.4e-41  Score=323.08  Aligned_cols=250  Identities=24%  Similarity=0.356  Sum_probs=203.5

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCC-CChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKL-VKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .|..++.||+|+||.||+|.+  +++.||+|++..... ........+.+|+.++++++ ||||+++++++...+..++|
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv  108 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLV  108 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceEEE
Confidence            355669999999999999986  588999999875432 23345678999999999995 99999999999998999999


Q ss_pred             EeccCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          113 MELCAGGELFDRIVA---RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      |||++|++|.+++..   ...++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.....
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~  185 (307)
T 2nru_A          109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEK  185 (307)
T ss_dssp             EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred             EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeeccccccccc
Confidence            999999999999864   3458999999999999999999999999999999999999   6788999999999876543


Q ss_pred             Ccc---cccccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHcCCccC-------C
Q 040917          190 GKA---YREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQG----VAQAILKGEINF-------Q  255 (494)
Q Consensus       190 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~----~~~~~~~~~~~~-------~  255 (494)
                      ...   .....|++.|+|||++.+.++.++|+||||+++|+|++|..||.......    +...+.......       .
T Consensus       186 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (307)
T 2nru_A          186 FAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM  265 (307)
T ss_dssp             CSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred             ccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence            221   23356899999999998889999999999999999999999997654322    222222211100       0


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          256 RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       256 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .......+..+.+++.+||..||.+|||+.++++
T Consensus       266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~  299 (307)
T 2nru_A          266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ  299 (307)
T ss_dssp             SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            1111234567899999999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=6.3e-41  Score=325.95  Aligned_cols=258  Identities=19%  Similarity=0.218  Sum_probs=202.9

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .....++|++.+.||+|+||.||+|.+. +|+.||+|++.......  ....+.+|+.+++.+. ||||+++++++....
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~  100 (326)
T 3uim_A           25 LQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG--GELQFQTEVEMISMAV-HRNLLRLRGFCMTPT  100 (326)
T ss_dssp             HHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCC-CTTBCCCCEEECCSS
T ss_pred             HHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch--HHHHHHHHHHHHHhcc-CCCccceEEEEecCC
Confidence            4445689999999999999999999854 68999999997544222  2335889999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCceEEeeCCCCCeEEEee
Q 040917          108 FVHIVMELCAGGELFDRIVARG----HYSERAAASVFRVIMNVVNVCHSK---GVMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~----~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                      ..++||||++|++|.+++....    .++...+..++.|++.||.|||++   ||+||||||+||++   +.++.++|+|
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~kl~D  177 (326)
T 3uim_A          101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGD  177 (326)
T ss_dssp             CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEEECC
T ss_pred             ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEEecc
Confidence            9999999999999999997643    389999999999999999999999   99999999999999   6788999999


Q ss_pred             cCCccccccCcc--cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHcCCc
Q 040917          181 FGLSAFIEEGKA--YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAE-----TDQGVAQAILKGEI  252 (494)
Q Consensus       181 fg~a~~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~-----~~~~~~~~~~~~~~  252 (494)
                      ||++........  .....||+.|+|||++. +.++.++|||||||++|+|++|..||...     ........+.....
T Consensus       178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  257 (326)
T 3uim_A          178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK  257 (326)
T ss_dssp             CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred             CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence            999986543222  23455899999999985 46899999999999999999999999421     11111111111000


Q ss_pred             cC--C--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCc
Q 040917          253 NF--Q--------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPW  292 (494)
Q Consensus       253 ~~--~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~  292 (494)
                      ..  .        .......+..+.+++.+||..||.+|||+.++++|-.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            00  0        0001122467899999999999999999999998543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-40  Score=329.61  Aligned_cols=248  Identities=22%  Similarity=0.312  Sum_probs=198.6

Q ss_pred             cceEeeeeecccCCeEEEEEEECCC---CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE-eCCe
Q 040917           33 LHYTIGREVGRGEFGITYLCTENST---GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE-DDQF  108 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~---~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~-~~~~  108 (494)
                      ..|++.+.||+|+||.||+|.+..+   +..||+|.+...  ........+.+|+.++++++ ||||+++++++. .++.
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCCSSC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCCC
Confidence            5689999999999999999987543   346899998643  23345678999999999995 999999999864 4557


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .++||||+++++|.+++... ..++...+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDM  242 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred             eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeeccccccc
Confidence            88999999999999999764 358899999999999999999999999999999999999   67889999999999765


Q ss_pred             ccCcc-----cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 040917          188 EEGKA-----YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFP  260 (494)
Q Consensus       188 ~~~~~-----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (494)
                      .....     .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||......+....+..+.....+   .
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p---~  319 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---E  319 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCC---T
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCC---C
Confidence            33221     123456788999999864 68999999999999999999 67888877766666666665433222   4


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          261 SISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+|+.+.+++.+||..||.+|||+.++++
T Consensus       320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~  348 (373)
T 3c1x_A          320 YCPDPLYEVMLKCWHPKAEMRPSFSELVS  348 (373)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            67899999999999999999999999987

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.6e-40  Score=345.88  Aligned_cols=242  Identities=22%  Similarity=0.309  Sum_probs=205.4

Q ss_pred             eeecccCCeEEEEEEE--CCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEecc
Q 040917           39 REVGRGEFGITYLCTE--NSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELC  116 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~--~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~  116 (494)
                      +.||+|+||.||+|.+  ..+++.||||+++... ........+.+|+.++++++ ||||+++++++.. +..++||||+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-~~~~lv~E~~  451 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVMEMA  451 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSEEEEEECC
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-CCEEEEEEcc
Confidence            4799999999999954  4667899999997543 23345678999999999995 9999999999965 4578999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc----
Q 040917          117 AGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA----  192 (494)
Q Consensus       117 ~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~----  192 (494)
                      ++++|.+++.....++...+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++........    
T Consensus       452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCTTHHHHTTC-------
T ss_pred             CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE---eCCCCEEEEEcCCccccccCcccccc
Confidence            999999999988889999999999999999999999999999999999999   5678999999999976543322    


Q ss_pred             cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      .....+++.|+|||++.+ .++.++|||||||++|+|++ |+.||.+....++...+..+.....+   ..+|+.+.++|
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p---~~~~~~l~~li  605 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP---AGCPREMYDLM  605 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---TTCCHHHHHHH
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CCCCHHHHHHH
Confidence            122345788999999875 68999999999999999998 99999999998888888776533222   46889999999


Q ss_pred             HHhcccCCCCCCCHHHHhc
Q 040917          271 RRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       271 ~~~l~~dp~~Rps~~eil~  289 (494)
                      .+||..||++||++.++++
T Consensus       606 ~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          606 NLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHTCSSTTTSCCHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999976

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=9.7e-41  Score=323.59  Aligned_cols=261  Identities=22%  Similarity=0.345  Sum_probs=212.9

Q ss_pred             hhhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeE
Q 040917           22 AILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKA  101 (494)
Q Consensus        22 ~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~  101 (494)
                      +...+..+-..++|++.+.||+|+||.||+|.+..   .||+|++...... ......+.+|+.++++++ ||||+++++
T Consensus        22 ~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~   96 (319)
T 2y4i_B           22 SIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQTR-HENVVLFMG   96 (319)
T ss_dssp             CCCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCC-CTTBCCCCE
T ss_pred             ccccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCC-CCCEeEEEE
Confidence            34444455556899999999999999999999864   4999998754322 223455778999999995 999999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEee
Q 040917          102 AYEDDQFVHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATD  180 (494)
Q Consensus       102 ~~~~~~~~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~D  180 (494)
                      ++......++||||++|++|.+++...+ .++...+..++.||+.||.|||++||+||||||+||+++    ++.++|+|
T Consensus        97 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~D  172 (319)
T 2y4i_B           97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITD  172 (319)
T ss_dssp             EEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECC
T ss_pred             EEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEee
Confidence            9999999999999999999999997654 689999999999999999999999999999999999993    56899999


Q ss_pred             cCCcccccc------CcccccccCCcCccChhhhcc----------cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 040917          181 FGLSAFIEE------GKAYREIVGSPYYIAPEVLSQ----------SYGKEADIWSAGVILYILLCGVPPFWAETDQGVA  244 (494)
Q Consensus       181 fg~a~~~~~------~~~~~~~~~~~~y~aPE~~~~----------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~  244 (494)
                      ||++.....      ........|++.|+|||++.+          .++.++|||||||++|+|++|..||.........
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~  252 (319)
T 2y4i_B          173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII  252 (319)
T ss_dssp             CSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH
T ss_pred             cCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999765421      112233458899999999853          3688999999999999999999999998888877


Q ss_pred             HHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          245 QAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      ..+..+.....  ....++..+.+++.+||..||.+|||+.++++  .+..
T Consensus       253 ~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~  299 (319)
T 2y4i_B          253 WQMGTGMKPNL--SQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEK  299 (319)
T ss_dssp             HHHHTTCCCCC--CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTT
T ss_pred             HHhccCCCCCC--CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHH
Confidence            77766543322  22367899999999999999999999999998  4544

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.5e-40  Score=318.77  Aligned_cols=249  Identities=22%  Similarity=0.368  Sum_probs=203.2

Q ss_pred             cccceEeeeeecccCCeEEEEEE----ECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           31 VQLHYTIGREVGRGEFGITYLCT----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~----~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      ...+|++++.||+|+||.||+|.    +..+++.||+|++...   .......+.+|+.++++++ ||||+++++++...
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA  114 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC-
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEec
Confidence            34789999999999999999998    4678999999999653   3345678999999999995 99999999998654


Q ss_pred             C--eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCC
Q 040917          107 Q--FVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL  183 (494)
Q Consensus       107 ~--~~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~  183 (494)
                      .  ..++||||++|++|.+++... ..++...+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||+
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGL  191 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTT
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---cCCCcEEEecCcc
Confidence            3  688999999999999999876 458999999999999999999999999999999999999   5678999999999


Q ss_pred             ccccccCccc----ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH----------------H
Q 040917          184 SAFIEEGKAY----REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ----------------G  242 (494)
Q Consensus       184 a~~~~~~~~~----~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~----------------~  242 (494)
                      +.........    ....+++.|+|||++.+ .++.++|||||||++|+|++|..|+......                .
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            9876443221    22346778999999864 5889999999999999999999988543211                1


Q ss_pred             HHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          243 VAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +...+.... ..  .....+|+.+.++|.+||..||.+|||+.++++
T Consensus       272 ~~~~~~~~~-~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          272 LIELLKNNG-RL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHTTC-CC--CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhhcCC-CC--CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            112222221 11  123568999999999999999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.9e-40  Score=339.44  Aligned_cols=247  Identities=23%  Similarity=0.321  Sum_probs=210.7

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      -..++|++.+.||+|+||.||+|.+.. +..||||++.....    ..+.+.+|+.++++|+ ||||+++++++.. ...
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~~~  336 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPI  336 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEee-ccc
Confidence            345789999999999999999999875 46799999975432    3567899999999995 9999999999876 668


Q ss_pred             EEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          110 HIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      ++||||+++|+|.+++...  ..++...+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLI  413 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTTTC
T ss_pred             eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEcccccceec
Confidence            8999999999999999743  468999999999999999999999999999999999999   67789999999999865


Q ss_pred             ccCcc--cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917          188 EEGKA--YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       188 ~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      .....  .....++..|+|||++. +.++.++|||||||++|+|++ |+.||.+....++...+..+....   ....++
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~---~~~~~~  490 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---CPPECP  490 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCC
T ss_pred             CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCC
Confidence            43211  12234577899999886 568999999999999999999 999999999888888877653322   224688


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          264 SSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ..+.++|.+||..||++|||+.++++
T Consensus       491 ~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          491 ESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999999999987

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=341.91  Aligned_cols=247  Identities=22%  Similarity=0.347  Sum_probs=205.6

Q ss_pred             cceEeee-eecccCCeEEEEEEEC--CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           33 LHYTIGR-EVGRGEFGITYLCTEN--STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        33 ~~y~i~~-~lg~G~~g~Vy~a~~~--~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      .++.+.+ .||+|+||.||+|.++  .++..||+|+++...  .......+.+|+.++++++ ||||+++++++.. +..
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-SSE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-CCe
Confidence            4566666 8999999999999875  456779999997543  2335778999999999995 9999999999976 568


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      ++||||++||+|.+++... ..++...+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCSTTTTCC
T ss_pred             EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE---cCCCcEEEeeccCccccc
Confidence            9999999999999998654 459999999999999999999999999999999999999   567899999999998654


Q ss_pred             cCccc----ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          189 EGKAY----REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       189 ~~~~~----~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      .....    ....+++.|+|||++. +.++.++|||||||++|+|++ |+.||.+....++...+..+.....   ...+
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~  564 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPEC  564 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCC---CTTC
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---CCcC
Confidence            33221    1223467899999986 569999999999999999998 9999999998888888877643222   2468


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      |+.+.++|.+||..||.+||++.++++
T Consensus       565 ~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          565 PPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             CHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999854

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.4e-40  Score=325.12  Aligned_cols=245  Identities=19%  Similarity=0.220  Sum_probs=194.9

Q ss_pred             cccceEeeeeecccCCeEEEEE-----EECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc--CCCCccEEeEEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLC-----TENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS--GQPNIVQFKAAY  103 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a-----~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~i~~~~~~~  103 (494)
                      ...+|++.+.||+|+||.||+|     .+..+++.||+|++...      ....+.+|+.+++.+.  .|+||+.+++++
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            3478999999999999999999     46778999999998643      3456788888888884  289999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEee--------C
Q 040917          104 EDDQFVHIVMELCAGGELFDRIVA-----RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTT--------G  170 (494)
Q Consensus       104 ~~~~~~~iv~e~~~g~sL~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~--------~  170 (494)
                      ...+..++||||++||+|.+++..     ...+++..+..++.||+.||.|||++||+||||||+|||++.        +
T Consensus       137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred             ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999999974     456999999999999999999999999999999999999943        1


Q ss_pred             CCCCeEEEeecCCccccc---cCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 040917          171 DENAVVKATDFGLSAFIE---EGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQA  246 (494)
Q Consensus       171 ~~~~~~kL~Dfg~a~~~~---~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~  246 (494)
                      +..+.+||+|||++....   ........+||+.|+|||++.+ .++.++|||||||++|+|++|+.||........   
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---  293 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---  293 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence            227899999999996543   2333445679999999999875 489999999999999999999999954432100   


Q ss_pred             HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          247 ILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                        .....+..   ...++.+.+++..||..+|.+|++..+.+.
T Consensus       294 --~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          294 --KPEGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             --EECSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             --eechhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence              00011111   123678899999999999999966544444

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.7e-40  Score=320.88  Aligned_cols=248  Identities=23%  Similarity=0.323  Sum_probs=201.3

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHH--ccCCCCccEEeEEEEeCC
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRH--LSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~hp~i~~~~~~~~~~~  107 (494)
                      .+.++|++.+.||+|+||.||+|.+  +|+.||+|++...      ....+.+|++++..  + +||||+++++++....
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVML-RHENILGFIAADNKDN  109 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCC-CCTTBCCEEEEEECCC
T ss_pred             cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhc-CCCcEEEEEeeecccC
Confidence            4557999999999999999999997  4899999998532      34667889999988  5 5999999999998765


Q ss_pred             ----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCceEEeeCCCCCe
Q 040917          108 ----FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH--------SKGVMHRDLKPENFLFTTGDENAV  175 (494)
Q Consensus       108 ----~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~i~H~dikp~NIli~~~~~~~~  175 (494)
                          ..++||||+++++|.+++.+. .++...++.++.|++.||.|||        ++||+||||||+||++   +.++.
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~  185 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGT  185 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSC
T ss_pred             CccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCC
Confidence                799999999999999999764 6899999999999999999999        8999999999999999   67889


Q ss_pred             EEEeecCCccccccCcc-----cccccCCcCccChhhhccc-------CCCcchhHHHHHHHHHHHhC----------CC
Q 040917          176 VKATDFGLSAFIEEGKA-----YREIVGSPYYIAPEVLSQS-------YGKEADIWSAGVILYILLCG----------VP  233 (494)
Q Consensus       176 ~kL~Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-------~~~~~Di~slG~il~~l~tg----------~~  233 (494)
                      ++|+|||++........     .....||+.|+|||++.+.       ++.++|||||||++|+|++|          ..
T Consensus       186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~  265 (342)
T 1b6c_B          186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  265 (342)
T ss_dssp             EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence            99999999976544332     2345789999999998753       33689999999999999999          78


Q ss_pred             CCCCCC-----hHHHHHHHHcCCccCCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          234 PFWAET-----DQGVAQAILKGEINFQRDP---FPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       234 pf~~~~-----~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      ||....     .......+.........+.   ....+..+.+++.+||..||.+|||+.+++++
T Consensus       266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             CccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            886642     2333443333222211110   01234678999999999999999999999973

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-39  Score=317.92  Aligned_cols=251  Identities=20%  Similarity=0.307  Sum_probs=194.7

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc-CCCCccEEeEEEEeC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS-GQPNIVQFKAAYEDD  106 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~hp~i~~~~~~~~~~  106 (494)
                      ...+.++|++.+.||+|+||.||+|.+.  ++.||+|++...      .......|.+++..+. +||||+++++++...
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            3456689999999999999999999975  899999998532      2344455666555442 599999999999877


Q ss_pred             ----CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCceEEeeCCCCC
Q 040917          107 ----QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK--------GVMHRDLKPENFLFTTGDENA  174 (494)
Q Consensus       107 ----~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~i~H~dikp~NIli~~~~~~~  174 (494)
                          ...++||||++|++|.+++... .++...+..++.|++.||.|||++        ||+||||||+||++   +.++
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~  179 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNG  179 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTS
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCC
Confidence                7899999999999999999664 699999999999999999999999        99999999999999   6788


Q ss_pred             eEEEeecCCccccccCccc-----ccccCCcCccChhhhccc-CCC------cchhHHHHHHHHHHHhC----------C
Q 040917          175 VVKATDFGLSAFIEEGKAY-----REIVGSPYYIAPEVLSQS-YGK------EADIWSAGVILYILLCG----------V  232 (494)
Q Consensus       175 ~~kL~Dfg~a~~~~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~------~~Di~slG~il~~l~tg----------~  232 (494)
                      .+||+|||++.........     ....||+.|+|||++.+. .+.      ++|||||||++|+|++|          .
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            9999999999765432221     245789999999998754 333      38999999999999999          6


Q ss_pred             CCCCCCCh-----HHHHHHHHcCCccCCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          233 PPFWAETD-----QGVAQAILKGEINFQRDP---FPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       233 ~pf~~~~~-----~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      .||.....     ......+.........+.   ...+++.+.+++.+||..||.+|||+.+++++
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            77754321     222222222211111110   11356779999999999999999999999983

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.3e-40  Score=313.47  Aligned_cols=228  Identities=14%  Similarity=0.069  Sum_probs=189.6

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      -+.++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++.++ +||||+++++++...+..
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~  106 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTRAGG  106 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEECCcE
Confidence            4668999999999999999999999999999999999876655555668899999999999 599999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      |+||||++|++|.+++...  .....+..++.||+.||.|||++||+||||||+||++   +.++.++|++++       
T Consensus       107 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll---~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV---SIDGDVVLAYPA-------  174 (286)
T ss_dssp             EEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---ETTSCEEECSCC-------
T ss_pred             EEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE---cCCCCEEEEecc-------
Confidence            9999999999999998543  4667889999999999999999999999999999999   567889887443       


Q ss_pred             CcccccccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHcCCccCCCCCCCCCCHHH
Q 040917          190 GKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQ---AILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       190 ~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l  266 (494)
                                  |++|      ++.++|||||||++|+|++|+.||.+....+...   ..............+.+|+.+
T Consensus       175 ------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (286)
T 3uqc_A          175 ------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI  236 (286)
T ss_dssp             ------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred             ------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence                        2332      6789999999999999999999998765432110   000111111111235689999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhc
Q 040917          267 IELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .++|.+||..||.+| |+.++++
T Consensus       237 ~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          237 SAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             HHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             HHHHHHHcccCCccC-CHHHHHH
Confidence            999999999999999 9999988

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.6e-39  Score=339.50  Aligned_cols=251  Identities=26%  Similarity=0.390  Sum_probs=209.9

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCC---CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENST---GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED  105 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~---~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~  105 (494)
                      +-..++|++++.||+|+||.||+|.+..+   +..||+|++....  .......+.+|+.+++++. ||||+++++++..
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~  462 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVITE  462 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEec
Confidence            34457899999999999999999998654   4579999986432  3445678999999999995 9999999999854


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCc
Q 040917          106 DQFVHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS  184 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a  184 (494)
                       +..++||||++||+|.+++...+ .++...+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++
T Consensus       463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl---~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLS  538 (656)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCCC
T ss_pred             -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE---eCCCCEEEEecCCC
Confidence             56889999999999999997654 68999999999999999999999999999999999999   46789999999999


Q ss_pred             cccccCccc--ccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 040917          185 AFIEEGKAY--REIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFP  260 (494)
Q Consensus       185 ~~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (494)
                      .........  ....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+.....   .+
T Consensus       539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~---~~  615 (656)
T 2j0j_A          539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM---PP  615 (656)
T ss_dssp             CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCC---CT
T ss_pred             eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC---Cc
Confidence            866443222  22345788999999864 68999999999999999997 9999999988888877776543322   24


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          261 SISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+|+.+.++|.+||..||.+|||+.++++
T Consensus       616 ~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          616 NCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            68899999999999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=318.29  Aligned_cols=252  Identities=21%  Similarity=0.308  Sum_probs=189.2

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHH--HHccCCCCccEEeEEEEe-----
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIM--RHLSGQPNIVQFKAAYED-----  105 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l--~~l~~hp~i~~~~~~~~~-----  105 (494)
                      ++|++++.||+|+||.||+|.+  +++.||+|++...      ....+..|..++  ..+ +||||+++++.+..     
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~   83 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA------NRQNFINEKNIYRVPLM-EHDNIARFIVGDERVTADG   83 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG------GHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTS
T ss_pred             HHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc------chhhHHHHHHHHHHHhc-cCcchhhheecccccccCC
Confidence            7899999999999999999976  5899999998632      233444454443  346 59999999986542     


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCceEEeeCCCCCeE
Q 040917          106 DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK---------GVMHRDLKPENFLFTTGDENAVV  176 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~i~H~dikp~NIli~~~~~~~~~  176 (494)
                      ...+++||||++||+|.+++... ..+...+..++.||+.||.|||+.         ||+||||||+||++   +.++.+
T Consensus        84 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~  159 (336)
T 3g2f_A           84 RMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTC  159 (336)
T ss_dssp             CEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCE
T ss_pred             CceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcE
Confidence            33678999999999999999765 458999999999999999999999         99999999999999   678899


Q ss_pred             EEeecCCccccccCc---------ccccccCCcCccChhhhcc--------cCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 040917          177 KATDFGLSAFIEEGK---------AYREIVGSPYYIAPEVLSQ--------SYGKEADIWSAGVILYILLCGVPPFWAET  239 (494)
Q Consensus       177 kL~Dfg~a~~~~~~~---------~~~~~~~~~~y~aPE~~~~--------~~~~~~Di~slG~il~~l~tg~~pf~~~~  239 (494)
                      ||+|||++.......         ......||+.|+|||++.+        .++.++|||||||++|+|++|..||....
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            999999997654321         1224568999999999864        35678999999999999999977653221


Q ss_pred             h------------------HHHHHHHHcCCccCC-CCCCC---CCCHHHHHHHHHhcccCCCCCCCHHHHhc------CC
Q 040917          240 D------------------QGVAQAILKGEINFQ-RDPFP---SISSSAIELVRRMLTQDPKRRITVAQVLE------HP  291 (494)
Q Consensus       240 ~------------------~~~~~~~~~~~~~~~-~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~eil~------~~  291 (494)
                      .                  ......+........ +..++   .+++.+.++|.+||..||.+|||+.++++      ++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            1                  111111211111111 11111   13457999999999999999999999954      56


Q ss_pred             ccCccC
Q 040917          292 WLKESG  297 (494)
Q Consensus       292 ~~~~~~  297 (494)
                      |-++..
T Consensus       320 ~~~~~~  325 (336)
T 3g2f_A          320 WERNKS  325 (336)
T ss_dssp             CCC---
T ss_pred             HHhccc
Confidence            666543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=6.8e-40  Score=328.55  Aligned_cols=247  Identities=16%  Similarity=0.164  Sum_probs=192.2

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCC-CCcc--------------
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ-PNIV--------------   97 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-p~i~--------------   97 (494)
                      ..|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+. | +|..              
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~-~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR-GIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGST-TCCSHHHHHHHTCBCCCCEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc-cCCCHHHHHHhcccccchhh
Confidence            45889999999999999999999999999999987554444445677899999999885 4 2211              


Q ss_pred             -------EEeEEEEe-----CCeEEEEEeccCCCchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 040917           98 -------QFKAAYED-----DQFVHIVMELCAGGELFDRIVA-------RGHYSERAAASVFRVIMNVVNVCHSKGVMHR  158 (494)
Q Consensus        98 -------~~~~~~~~-----~~~~~iv~e~~~g~sL~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~  158 (494)
                             .+..++..     ...++++|+++ +++|.+++..       ...++...+..++.||+.||.|||++||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                   11111111     22467888876 5799988842       2246778899999999999999999999999


Q ss_pred             cCCCCceEEeeCCCCCeEEEeecCCccccccCcccccccCCcCccChhhh----------cc-cCCCcchhHHHHHHHHH
Q 040917          159 DLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL----------SQ-SYGKEADIWSAGVILYI  227 (494)
Q Consensus       159 dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~----------~~-~~~~~~Di~slG~il~~  227 (494)
                      ||||+|||+   +.++.+||+|||++......  ....+| +.|+|||++          .+ .++.++|||||||++|+
T Consensus       236 DiKp~NILl---~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          236 YLRPVDIVL---DQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CCCGGGEEE---CTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             CcccceEEE---ecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            999999999   67888999999998765433  345567 999999998          32 37889999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          228 LLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       228 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      |++|+.||...........+        ...+..+|+.+.++|.+||..||.+||++.++++||||+.
T Consensus       310 lltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSGGG--------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHCCCCCCCcchhhhHHHH--------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            99999999776543322211        1123468899999999999999999999999999999975

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.3e-40  Score=325.05  Aligned_cols=251  Identities=19%  Similarity=0.193  Sum_probs=197.1

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCC-----ChhhHHHHHHHHHHHHHcc--------CCCCccE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV-----KDVEKDDVRREIEIMRHLS--------GQPNIVQ   98 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~--------~hp~i~~   98 (494)
                      .++|++++.||+|+||+||+|.+  +|+.||+|++......     .......+.+|+.+++.++        +||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            36899999999999999999998  6899999999765421     2334578899999999986        4888888


Q ss_pred             EeEEEE------------------------------eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 040917           99 FKAAYE------------------------------DDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVN  148 (494)
Q Consensus        99 ~~~~~~------------------------------~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~  148 (494)
                      +.+++.                              .....|+||||+++|++.+.+.+ ..+++..+..++.||+.||.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence            887753                              26789999999999987777644 56899999999999999999


Q ss_pred             HHH-HCCceeccCCCCceEEeeCC-----------------CCCeEEEeecCCccccccCcccccccCCcCccChhhhcc
Q 040917          149 VCH-SKGVMHRDLKPENFLFTTGD-----------------ENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ  210 (494)
Q Consensus       149 ~LH-~~~i~H~dikp~NIli~~~~-----------------~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~  210 (494)
                      ||| ++||+||||||+|||++.++                 ....+||+|||+|......    ...||+.|+|||++.+
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred             HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence            999 99999999999999996432                 1238999999999865432    3478999999999988


Q ss_pred             cCCCcchhHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHcCCccCC---CCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 040917          211 SYGKEADIWSAGVI-LYILLCGVPPFWAETD-QGVAQAILKGEINFQ---RDPFPSISSSAIELVRRMLTQDPKRRITVA  285 (494)
Q Consensus       211 ~~~~~~Di~slG~i-l~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  285 (494)
                      ..+.++||||++++ .+++++|..||..... ......+........   ...++.+++.+.+||.+||..|     |+.
T Consensus       252 ~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~  326 (336)
T 2vuw_A          252 DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT  326 (336)
T ss_dssp             CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred             CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence            77899999998777 7778889999843211 112223332111111   1112346788999999999976     999


Q ss_pred             HHh-cCCccC
Q 040917          286 QVL-EHPWLK  294 (494)
Q Consensus       286 eil-~~~~~~  294 (494)
                      ++| +||||+
T Consensus       327 e~l~~Hp~f~  336 (336)
T 2vuw_A          327 DLLCQHSLFK  336 (336)
T ss_dssp             HHHHHCGGGC
T ss_pred             HHHhcCCCcC
Confidence            999 999995

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.3e-39  Score=344.91  Aligned_cols=244  Identities=24%  Similarity=0.322  Sum_probs=201.1

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECC-CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENS-TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~-~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      +.+.++|++.+.||+|+||.||+|.+.. +|+.||+|++....  .......+.+|+.+++++. ||||+++++++...+
T Consensus        76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~  152 (681)
T 2pzi_A           76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHTD  152 (681)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEEC
T ss_pred             CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeecC
Confidence            4566899999999999999999999976 79999999986432  3345667889999999995 999999999998655


Q ss_pred             e-----EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917          108 F-----VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG  182 (494)
Q Consensus       108 ~-----~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg  182 (494)
                      .     .|+||||++|++|.+++..  .++...+..++.||+.||.|||++||+||||||+||+++   . +.+||+|||
T Consensus       153 ~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~---~-~~~kl~DFG  226 (681)
T 2pzi_A          153 RHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---E-EQLKLIDLG  226 (681)
T ss_dssp             TTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---S-SCEEECCCT
T ss_pred             CCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe---C-CcEEEEecc
Confidence            4     7999999999999987754  799999999999999999999999999999999999994   3 489999999


Q ss_pred             CccccccCcccccccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          183 LSAFIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      ++......   ....||+.|+|||++.+.++.++|||||||++|+|++|..||.+....         ... ........
T Consensus       227 ~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~-~~~~~~~~  293 (681)
T 2pzi_A          227 AVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLP-EDDPVLKT  293 (681)
T ss_dssp             TCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCC-TTCHHHHH
T ss_pred             cchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccc---------ccc-cccccccc
Confidence            99865433   446789999999999887899999999999999999999888642211         000 01111124


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLK  294 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~  294 (494)
                      ++.+.++|.+||..||.+||+..+.+.|+|+.
T Consensus       294 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          294 YDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            57899999999999999999998888888874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.3e-31  Score=277.51  Aligned_cols=232  Identities=16%  Similarity=0.136  Sum_probs=158.0

Q ss_pred             eecccCCeEEEEEEECCCCcEEEEEEeccCCCCC-------hhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           40 EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK-------DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        40 ~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~-------~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+..|+.|.+..++...+|+.|++|++.+.....       ......+.+|+++|+++..|+||+++++++.+++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            3667888888888888889999999997653222       233566899999999998899999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-c
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-K  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-~  191 (494)
                      |||++|++|.+++.+.++++..   +|+.||+.||.|+|++|||||||||+|||+   +.++.+||+|||+|...... .
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~~  394 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDCS  394 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---C
T ss_pred             EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCCCc
Confidence            9999999999999998888765   478999999999999999999999999999   67889999999999865433 2


Q ss_pred             ccccccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917          192 AYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR  271 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  271 (494)
                      .....+||+.|+|||++.+.+..++|+||+|++++.+.++..++        ...+...    +..     ...+..+..
T Consensus       395 ~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~~----~~~-----~~~~~~l~~  457 (569)
T 4azs_A          395 WPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQE----PVE-----RWNFVLLLA  457 (569)
T ss_dssp             CSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH--------HHHHHTS----CGG-----GCSHHHHHH
T ss_pred             cccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh--------HHHhhcC----CCC-----CCcHHHHHH
Confidence            33557899999999999998889999999999988776554332        1111110    000     012345556


Q ss_pred             HhcccCCCCCCCHHHHhcCCccC
Q 040917          272 RMLTQDPKRRITVAQVLEHPWLK  294 (494)
Q Consensus       272 ~~l~~dp~~Rps~~eil~~~~~~  294 (494)
                      .+...+|..||.......++|..
T Consensus       458 ~l~~~~~~~~~~~~~~~~~~~~~  480 (569)
T 4azs_A          458 LFEKKAKLPSAEQQRGATEQWII  480 (569)
T ss_dssp             HHHTGGGSCCGGGSSCCHHHHHH
T ss_pred             HHhCCCCCCCCChhhhccchhHH
Confidence            66667777777666666666554

>3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1}

Probab=99.94  E-value=2.6e-27  Score=212.20  Aligned_cols=189  Identities=31%  Similarity=0.487  Sum_probs=153.0

Q ss_pred             cCCccCccCcCCCCCCcHHHHHHHHHHhhhhHHHHHHHHhhhccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhc
Q 040917          289 EHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL  368 (494)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~  368 (494)
                      .|||..... ....|+...++.+++++...+++++.+...++..++.+++..+.+.|..+|.|++|+|+.+||..++..+
T Consensus         8 ~~~~~~~~~-~~~~~l~~~~~~~l~~f~~~~~lk~~~l~~i~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~   86 (197)
T 3pm8_A            8 SSGRENLYF-QGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNIFIALDVDNSGTLSSQEILDGLKKI   86 (197)
T ss_dssp             ----------CCSCCCCTTHHHHHHHTTTSCHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred             cchHhhhcc-CCCCCCCHHHHHHHHHHHHccHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHh
Confidence            489998755 3467777889999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcH
Q 040917          369 GSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI  448 (494)
Q Consensus       369 ~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~  448 (494)
                      |..++..++..+|..+|.|++|.|+|+||+..+.........+.++.+|+.||.|++|+|+.+||+.++..++.+..+++
T Consensus        87 g~~~~~~~~~~l~~~~D~d~~g~I~~~EF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~~~~  166 (197)
T 3pm8_A           87 GYQKIPPDIHQVLRDIDSNASGQIHYTDFLAATIDKQTYLKKEVCLIPFKFFDIDGNGKISVEELKRIFGRDDIENPLID  166 (197)
T ss_dssp             C----CHHHHHHHHC-------CEEHHHHHHTTCCHHHHCSHHHHHHHHHHHCTTCSSEECHHHHHHHHC----CCHHHH
T ss_pred             CCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCCH
Confidence            99889999999999999999999999999998766555556778999999999999999999999999998533677899


Q ss_pred             HHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          449 ATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       449 ~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ++++.++..+|.|+||.|+|+||..+|++.
T Consensus       167 ~~~~~l~~~~D~d~dG~Is~~EF~~~l~~~  196 (197)
T 3pm8_A          167 KAIDSLLQEVDLNGDGEIDFHEFMLMMSKK  196 (197)
T ss_dssp             HHHHHHHHHHCTTCSSSEEHHHHHHHHHCC
T ss_pred             HHHHHHHHHHcCCCCCcCcHHHHHHHHHcC
Confidence            999999999999999999999999999864

>3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A

Probab=99.94  E-value=4.6e-26  Score=203.07  Aligned_cols=185  Identities=32%  Similarity=0.532  Sum_probs=157.1

Q ss_pred             cCCccCccCcCCCCCCcHHHHHHHHHHhhhhHHHHHHHHhhhccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhc
Q 040917          289 EHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL  368 (494)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~  368 (494)
                      .|||+..... ...++...++.+++++...+++++.+...+++.++.+++.++.++|..+|.|++|+|+.+||..+++.+
T Consensus         3 ~~~~~~~~~~-~~~~l~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~   81 (191)
T 3k21_A            3 HHHHHSSGRE-NLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLVLDEDGKGYITKEQLKKGLEKD   81 (191)
T ss_dssp             ------------CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHT
T ss_pred             CCccccCCcc-ccccccHHHHHHHHHHHhhHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHc
Confidence            4777765432 234556688999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcH
Q 040917          369 GSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI  448 (494)
Q Consensus       369 ~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~  448 (494)
                      |..++ .++..+|..+|.|++|.|+|+||+..+..... ...+.+..+|+.+|.|++|+|+.+||+.++...+.+..+++
T Consensus        82 g~~~~-~~~~~l~~~~D~d~~g~i~~~EF~~~~~~~~~-~~~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~l~~  159 (191)
T 3k21_A           82 GLKLP-YNFDLLLDQIDSDGSGKIDYTEFIAAALDRKQ-LSKKLIYCAFRVFDVDNDGEITTAELAHILYNGNKKGNITQ  159 (191)
T ss_dssp             TCCCC-TTHHHHHHHHCTTCSSSEEHHHHHHHHSCGGG-CCHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHSSSCSCCCH
T ss_pred             CCCcH-HHHHHHHHHhCCCCCCeEeHHHHHHHHHhhhh-ccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHhcCCCCCCCH
Confidence            98888 88999999999999999999999998755432 44567999999999999999999999999998656667776


Q ss_pred             ---HHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          449 ---ATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       449 ---~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                         +++++++..+|.|+||.|+|+||..+|+
T Consensus       160 ~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~~  190 (191)
T 3k21_A          160 RDVNRVKRMIRDVDKNNDGKIDFHEFSEMMK  190 (191)
T ss_dssp             HHHHHHHHHHHHHCSSSSSSBCHHHHHHHHC
T ss_pred             hHHHHHHHHHHHhcCCCCCeECHHHHHHHHc
Confidence               3688999999999999999999999875

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=2.3e-26  Score=237.06  Aligned_cols=184  Identities=18%  Similarity=0.178  Sum_probs=143.1

Q ss_pred             EeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChh-----hHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           36 TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV-----EKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        36 ~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ...+.||+|+||.||+|.  ..+..+++|...........     ..+.+.+|+.++++++ ||||+++..+.......|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~  415 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLDNKR  415 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETTTTE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCCccE
Confidence            346689999999999995  45889999987554332221     2455789999999995 999995555555666779


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +||||++|++|.+++..        +..++.|++.||.|||++||+||||||+||++   +.  .+||+|||++......
T Consensus       416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl---~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF---DK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE---SS--SEEECCCTTCEECCCH
T ss_pred             EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE---CC--eEEEEECccCEECCCc
Confidence            99999999999998865        56899999999999999999999999999999   34  9999999999876543


Q ss_pred             cc--------cccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCC
Q 040917          191 KA--------YREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPF  235 (494)
Q Consensus       191 ~~--------~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf  235 (494)
                      ..        .....||+.|+|||++..   .|+..+|+||..+-..+-+.++.+|
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            22        135678999999999864   4788899999998888888777766

>2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae}

Probab=99.92  E-value=3.2e-25  Score=194.44  Aligned_cols=150  Identities=31%  Similarity=0.553  Sum_probs=137.7

Q ss_pred             hccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-hh
Q 040917          330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-LQ  408 (494)
Q Consensus       330 ~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~~  408 (494)
                      +++++.+++.+++++|..+|+|++|+|+..||..+++.+|..++..++..++..+|.+++|.|+|.||+..+..... ..
T Consensus         2 a~~Lt~eqi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~~~~d~d~~~~i~~~ef~~~~~~~~~~~~   81 (176)
T 2lhi_A            2 SSNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSND   81 (176)
T ss_dssp             CCCCCTTGGGHHHHHHHTTCSSCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTTCSSCSSSBCTTHHHHHHTSSCCSSH
T ss_pred             CCcCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCChhHHHHHHHHHHhCcCCCccchHHHHHHHHHHhcccCC
Confidence            35688999999999999999999999999999999999999999999999999999999999999999988765433 33


Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccccc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLR  482 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~  482 (494)
                      ..+.+..+|+.||.|++|+|+.+||+.+|..  ++..++++++++++..+| |+||+|+|+||.++|+++....
T Consensus        82 ~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~--~g~~~~~~ei~~l~~~~d-d~dG~I~~~EF~~~m~k~~~~~  152 (176)
T 2lhi_A           82 SEQELLEAFKVFDKNGDGLISAAELKHVLTS--IGEKLTDAEVDDMLREVS-DGSGEINIQQFAALLSKGSSTG  152 (176)
T ss_dssp             HHHHHHHHHHHHCSSCSSSBCHHHHHHHHHT--TTCCCCHHHHHHHHHHHH-TTSSCBCTTHHHHHHTCCSSCS
T ss_pred             cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH--cCcccchHHHHHHHHhhc-CCCCeEeHHHHHHHHHhcCCcc
Confidence            5678999999999999999999999999998  778999999999999999 9999999999999998866543

>2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A

Probab=99.92  E-value=7.8e-25  Score=186.67  Aligned_cols=144  Identities=29%  Similarity=0.538  Sum_probs=133.8

Q ss_pred             cCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-hhHH
Q 040917          332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-LQRF  410 (494)
Q Consensus       332 ~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~~~~  410 (494)
                      .++.+++++++.+|..+|+|++|+|+..||..+++.+|..++..++..++..+|.+++|.|++.||+..+..... ....
T Consensus         3 ~lt~eqi~el~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~   82 (148)
T 2lmt_A            3 ELTEEQIAEFKDAFVQFDKEGTGKIATRELGTLMRTLGQNPTEAELQDLIAEAENNNNGQLNFTEFCGIMAKQMRETDTE   82 (148)
T ss_dssp             SCCSHHHHHHHHHHHHHHCSSCCEEEGGGHHHHHHHHTCCCCHHHHHHHHHHHHTTSTTEEEHHHHHHHHHHTTTTTTTH
T ss_pred             CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCchHHHHHHHHHhcccCCCCcccHHHHHHHHHHHhcccCcH
Confidence            478899999999999999999999999999999999999999999999999999999999999999998876543 3456


Q ss_pred             HHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +.++.+|+.||.|++|+|+.+||+.+|..  +|..++++++++++..+|.|+||+|+|+||+++|.+
T Consensus        83 ~~l~~aF~~~D~d~~G~I~~~El~~~l~~--~g~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~m~~  147 (148)
T 2lmt_A           83 EEMREAFKIFDRDGDGFISPAELRFVMIN--LGEKVTDEEIDEMIREADFDGDGMINYEEFVWMISQ  147 (148)
T ss_dssp             HHHHHHHHHHHSSCSSEECHHHHHHHHHH--HTCCCCHHHHHHHHHHHCCSCCSSEEHHHHHHHHTT
T ss_pred             HHHHHHHHHHCCCCcCcCcHHHHHHHHHH--cCccccHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence            78999999999999999999999999999  667899999999999999999999999999998864

>2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A

Probab=99.92  E-value=3.4e-24  Score=181.60  Aligned_cols=140  Identities=32%  Similarity=0.583  Sum_probs=128.7

Q ss_pred             hhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-hhHHHHH
Q 040917          335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-LQRFENL  413 (494)
Q Consensus       335 ~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~~~~~~~  413 (494)
                      .+++.+++++|..+|.|++|+|+.+||..+++.+|..++..++..++..+|.|++|.|+|+||+..+..... ......+
T Consensus         2 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~l   81 (143)
T 2obh_A            2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKDTKEEI   81 (143)
T ss_dssp             HHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeeeHHHHHHHHHHHhccccHHHHH
Confidence            567889999999999999999999999999999999999999999999999999999999999998765433 2345679


Q ss_pred             HHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          414 YKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       414 ~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      +.+|+.||.|++|+|+.+||+.++..  +|..++++++++++..+|.|+||.|+|+||+.+|.
T Consensus        82 ~~~F~~~D~d~~G~I~~~el~~~l~~--~g~~~~~~~~~~~~~~~D~d~dG~I~~~eF~~~~~  142 (143)
T 2obh_A           82 LKAFKLFDDDETGKISFKNLKRVAKE--LGENLTDEELQEMIDEADRDGDGEVSEQEFLRIMK  142 (143)
T ss_dssp             HHHHHHHCTTCSSSBCHHHHHHHHHH--TTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHC
T ss_pred             HHHHHHhCCCCCCcCcHHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHc
Confidence            99999999999999999999999999  67789999999999999999999999999999875

>3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C

Probab=99.91  E-value=1.6e-24  Score=186.58  Aligned_cols=145  Identities=23%  Similarity=0.350  Sum_probs=130.2

Q ss_pred             cCchhHHHhhhhhhhccCC--CCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh---
Q 040917          332 NLPTEEIQKLKEKFTEMDT--DNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK---  406 (494)
Q Consensus       332 ~~~~~~~~~~~~~F~~~D~--~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~---  406 (494)
                      .++.+++++++.+|..||.  |++|+|+..||..+|+.+|..++.+++..++. .|.+++|.|+|+||+..+.....   
T Consensus         2 qLt~eqi~elre~F~~fD~~~d~dG~I~~~El~~~lr~lG~~~t~~el~~~~~-~d~~~~g~i~f~eFl~~~~~~~~~~~   80 (159)
T 3i5g_C            2 QLTKDEIEEVREVFDLFDFWDGRDGDVDAAKVGDLLRCLGMNPTEAQVHQHGG-TKKMGEKAYKLEEILPIYEEMSSKDT   80 (159)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHTTSSSCEEGGGHHHHHHHTTCCCCHHHHHTTTC-CSSTTSCEECHHHHHHHHHHHTTCCT
T ss_pred             CCCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHc-ccccCCCcccHHHHHHHHHHhhcccc
Confidence            4688999999999999995  89999999999999999999999999988764 47788999999999998876432   


Q ss_pred             hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCC--CCCCceeHHHHHHHHhccc
Q 040917          407 LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDR--DKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       407 ~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~--~~dg~i~~~ef~~~~~~~~  479 (494)
                      ....++++.+|+.||.|++|+|+.+||+++|..  +|.+++++++++++..+|.  |+||+|+|+||++.|.++|
T Consensus        81 ~~~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~--~g~~ls~~e~~~l~~~~D~~~d~dG~I~~~EF~~~m~~~p  153 (159)
T 3i5g_C           81 GTAADEFMEAFKTFDREGQGLISSAEIRNVLKM--LGERITEDQCNDIFTFCDIREDIDGNIKYEDLMKKVMAGP  153 (159)
T ss_dssp             TCCHHHHHHHHHHHCTTSSSEECHHHHHHHHHH--SSSCCCHHHHHHHHHHTTCCCCSSCCEEHHHHHHHHHHCS
T ss_pred             cchHHHHHHHHHHHhcCCCCcCcHHHHHHHHHH--hCCCCCHHHHHHHHHHhCcCCCCCCeEeHHHHHHHHHCCC
Confidence            334678999999999999999999999999999  7789999999999999985  8899999999999998765

>3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor}

Probab=99.91  E-value=4.2e-24  Score=204.78  Aligned_cols=153  Identities=35%  Similarity=0.601  Sum_probs=136.1

Q ss_pred             HHHHHhhhccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHH
Q 040917          323 KLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATM  402 (494)
Q Consensus       323 ~l~~~~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~  402 (494)
                      .+.+.=....++.+|+++++++|+.+|.|++|+|+.+||..+|+.+|..++++++.++|+.+|.|++|.|+|+||+..+.
T Consensus       286 Tl~wePs~E~Lt~EEI~ELREaF~~fDkDgdG~IS~eELk~aLrsLG~~~TeeEI~~Lf~~~D~DgDG~IdFeEFl~lms  365 (440)
T 3u0k_A          286 TKGWEPTRDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGDGTIDFPEFLIMMA  365 (440)
T ss_dssp             EEEECCBCBCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCSSSEEHHHHHHHHH
T ss_pred             hhhhHhhHhhhhHHHHHHHHHHHHHHcCCCCCEECHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence            33444445678999999999999999999999999999999999999999999999999999999999999999999887


Q ss_pred             Hhhh-hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          403 QRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       403 ~~~~-~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .... ....++++++|+.||.|++|+|+.+||+++|..  +|..+++++++++|..+|.|+||+|+|+||+++|.+
T Consensus       366 ~~lk~~d~eeeLreAFk~fDkDgdG~IS~eELr~vL~~--lGe~LSdeEIdeLfke~D~DgDGkIsyeEFvkmMtS  439 (440)
T 3u0k_A          366 RKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTA  439 (440)
T ss_dssp             TC------CHHHHHHHHHHCTTCSSEECHHHHHHHHHH--HTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHC-
T ss_pred             HHhcCCChHHHHHHHHHHHCCCCcCcCCHHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHhCC
Confidence            6433 334567999999999999999999999999999  677899999999999999999999999999998853

>1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ...

Probab=99.91  E-value=2.2e-23  Score=177.62  Aligned_cols=145  Identities=38%  Similarity=0.633  Sum_probs=132.9

Q ss_pred             ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-hhH
Q 040917          331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-LQR  409 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~~~  409 (494)
                      ..++.+++.+++..|..+|.|++|+|+.+||..+++.+|..++..++..++..+|.|++|.|+|+||+..+..... ...
T Consensus         2 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~   81 (148)
T 1exr_A            2 EQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLSLMARKMKEQDS   81 (148)
T ss_dssp             CCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHhcccCCCc
Confidence            3467888999999999999999999999999999999999999999999999999999999999999998876432 345


Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...+..+|+.+|.|++|+|+.+||+.+|..  +|..++++++++++..+|.|+||.|+|+||+.+|..
T Consensus        82 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~--~g~~~~~~~~~~~~~~~d~d~dg~i~~~eF~~~~~~  147 (148)
T 1exr_A           82 EEELIEAFKVFDRDGNGLISAAELRHVMTN--LGEKLTDDEVDEMIREADIDGDGHINYEEFVRMMVS  147 (148)
T ss_dssp             HHHHHHHHHHHSTTCSSCBCHHHHHHHHHH--TTCCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHHHC
T ss_pred             HHHHHHHHHHhCCCCCCcCCHHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHcc
Confidence            567899999999999999999999999999  677899999999999999999999999999998864

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=8.4e-24  Score=199.98  Aligned_cols=146  Identities=21%  Similarity=0.225  Sum_probs=114.5

Q ss_pred             eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCCh---------------hhHHHHHHHHHHHHHccCCCCccEE
Q 040917           35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD---------------VEKDDVRREIEIMRHLSGQPNIVQF   99 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~~hp~i~~~   99 (494)
                      |.+++.||+|+||.||+|.+ .+|+.||+|++........               .....+.+|+.+++++. |   +++
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~---~~v  166 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-G---LAV  166 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-T---SSS
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-C---CCc
Confidence            34449999999999999999 8899999999964321111               23567889999999996 4   444


Q ss_pred             eEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEe
Q 040917          100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKAT  179 (494)
Q Consensus       100 ~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~  179 (494)
                      .+++.. +..++||||++|++|.+ +.      ......++.|++.||.|||++||+||||||+||++   + ++.++|+
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl---~-~~~vkl~  234 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---S-EEGIWII  234 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---E-TTEEEEC
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE---E-CCcEEEE
Confidence            444443 44589999999999988 41      12345799999999999999999999999999999   5 7899999


Q ss_pred             ecCCccccccCcccccccCCcCccChhhhc
Q 040917          180 DFGLSAFIEEGKAYREIVGSPYYIAPEVLS  209 (494)
Q Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~  209 (494)
                      |||++..            +..+.|||.+.
T Consensus       235 DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          235 DFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             CCTTCEE------------TTSTTHHHHHH
T ss_pred             ECCCCeE------------CCCCCHHHHHH
Confidence            9999863            34578898774

>3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii}

Probab=99.90  E-value=8.2e-24  Score=188.46  Aligned_cols=172  Identities=34%  Similarity=0.532  Sum_probs=155.6

Q ss_pred             CCcHHHHHHHHHHhhhhHHHHHHHHhhhccC-chhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhc-----------CC
Q 040917          303 PIDTAVIFRMKQFTAMNKLKKLALKVIVENL-PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL-----------GS  370 (494)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~-----------~~  370 (494)
                      |+....+.+++++...+.+++.+...+...+ +.+++.++.++|..+|.|++|.|+.+||..++..+           +.
T Consensus         3 ~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~   82 (191)
T 3khe_A            3 HALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRKLMQWKGDTVSDLDS   82 (191)
T ss_dssp             CHHHHHHHHHHHCCCCCHHHHHHHHHHHHHSSCTTTTHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHC-----CCHHHH
T ss_pred             hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHhhcccccccccc
Confidence            4556788899999999999999999998888 88999999999999999999999999999999987           65


Q ss_pred             CCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHH
Q 040917          371 MLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIAT  450 (494)
Q Consensus       371 ~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~  450 (494)
                      .++..++..+|..+|.|++|.|+|+||+..+.........+.+..+|+.+|.|++|+|+.+||..++.    +..+++++
T Consensus        83 ~~~~~~~~~~~~~~D~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~----~~~~~~~~  158 (191)
T 3khe_A           83 SQIEAEVDHILQSVDFDRNGYIEYSEFVTVCMDKQLLLSRERLLAAFQQFDSDGSGKITNEELGRLFG----VTEVDDET  158 (191)
T ss_dssp             HHHHHHHHHHHHHTCTTCSSSEEHHHHHHHHSCHHHHCCHHHHHHHHHHHCTTCSSEECHHHHHHHTT----SSCCCHHH
T ss_pred             hhhHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhcccchHHHHHHHHHHHCCCCcCcCCHHHHHHHHc----cCCCCHHH
Confidence            66778899999999999999999999999886655555667899999999999999999999999997    45789999


Q ss_pred             HHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          451 IKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       451 ~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ++.++..+|.|+||.|+|+||..++...
T Consensus       159 ~~~~~~~~D~~~dg~i~~~eF~~~~~~~  186 (191)
T 3khe_A          159 WHQVLQECDKNNDGEVDFEEFVEMMQKI  186 (191)
T ss_dssp             HHHHHHHHCTTCSSSEEHHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            9999999999999999999999998763

>2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana}

Probab=99.89  E-value=2.7e-23  Score=180.63  Aligned_cols=162  Identities=53%  Similarity=0.885  Sum_probs=137.4

Q ss_pred             HHhhhhHHHHHHHHhhhccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCccc
Q 040917          314 QFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTID  393 (494)
Q Consensus       314 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~  393 (494)
                      ++..++.+++.+...+...++++++.++.++|..+|.+++|+|+.+||..++..++..++..++..+|..+|.+++|.|+
T Consensus         2 ~f~~~~~~~~~~~~~~~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~   81 (166)
T 2aao_A            2 QFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANLKESEILDLMQAADVDNSGTID   81 (166)
T ss_dssp             ----CHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHHGGGGTCCCCHHHHHHHHHHHCTTCCSSBC
T ss_pred             chhhHHHHHHHHHHHHHHhCCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEc
Confidence            45677888899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             chHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHH
Q 040917          394 YIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRS  473 (494)
Q Consensus       394 ~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~  473 (494)
                      |+||+..+...........+..+|+.+|.|++|+|+.+||+.++..+|    +++++++.++..+|.|+||.|+|+||..
T Consensus        82 ~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~----~~~~~~~~~~~~~d~~~dg~i~~~eF~~  157 (166)
T 2aao_A           82 YKEFIAATLHLNKIEREDHLFAAFTYFDKDGSGYITPDELQQACEEFG----VEDVRIEELMRDVDQDNDGRIDYNEFVA  157 (166)
T ss_dssp             HHHHHHHHTTCHHHHTTHHHHHHHHHHCTTCSSSBCHHHHHHHTCC------------CCHHHHHCTTCSSSBCHHHHHH
T ss_pred             HHHHHHHHHHHhhcccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC----CCHHHHHHHHHHhCCCCCCcEeHHHHHH
Confidence            999998876544444456799999999999999999999999998843    4678899999999999999999999999


Q ss_pred             HHhccc
Q 040917          474 MMKCGT  479 (494)
Q Consensus       474 ~~~~~~  479 (494)
                      ++...+
T Consensus       158 ~~~~~~  163 (166)
T 2aao_A          158 MMQKGS  163 (166)
T ss_dssp             HHC---
T ss_pred             HHHhcc
Confidence            988643

>3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A

Probab=99.89  E-value=1.6e-22  Score=176.32  Aligned_cols=148  Identities=36%  Similarity=0.582  Sum_probs=133.5

Q ss_pred             ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-hhH
Q 040917          331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-LQR  409 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~~~  409 (494)
                      ..++.+++.++.++|..+|.|++|.|+.+||..++..+|..++..++..+|..+|.|++|.|+|+||+..+..... ...
T Consensus        20 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~   99 (169)
T 3qrx_A           20 VGLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGFEPKKEEIKKMISEIDKDGSGTIDFEEFLTMMTAKMGERDS   99 (169)
T ss_dssp             CCCCHHHHHHHHHHHHHHCTTCCSEECHHHHHHHHHHTSCCCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHhcccCc
Confidence            4578899999999999999999999999999999999999999999999999999999999999999998876433 334


Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccc
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ  480 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~  480 (494)
                      ...+..+|+.+|.|++|+|+.+||+.++..  .|..+++++++.++..+|.|+||.|+|+||..+++..+.
T Consensus       100 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~--~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~~  168 (169)
T 3qrx_A          100 REEILKAFRLFDDDNSGTITIKDLRRVAKE--LGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKKTSL  168 (169)
T ss_dssp             HHHHHHHHHHHCTTCSSSBCHHHHHHHHHH--TTCCCCHHHHHHHHHHHCCSSSSCBCHHHHHHHHC----
T ss_pred             HHHHHHHHHHhCCCCCCcCCHHHHHHHHHH--cCCCCCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHhccC
Confidence            567899999999999999999999999999  667899999999999999999999999999999987653

>3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B

Probab=99.89  E-value=3.1e-23  Score=177.25  Aligned_cols=141  Identities=23%  Similarity=0.459  Sum_probs=127.1

Q ss_pred             cCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-hhHH
Q 040917          332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-LQRF  410 (494)
Q Consensus       332 ~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~~~~  410 (494)
                      .++.+++++++.+|+.+|+|++|+|+..||..+++.+|..++..++..++.    +.+|.|+|.+|+..+..... ....
T Consensus         9 ~Lt~~qi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~~----~~~~~i~f~ef~~~~~~~~~~~~~~   84 (153)
T 3i5g_B            9 KLSQRQMQELKEAFTMIDQDRDGFIGMEDLKDMFSSLGRVPPDDELNAMLK----ECPGQLNFTAFLTLFGEKVSGTDPE   84 (153)
T ss_dssp             TCCHHHHHHHHHHHHHHCCSTTSCCCHHHHHHHHHHTTSCCCHHHHHHHHH----TSSSCCCSHHHHHTTTTTTTTCCCH
T ss_pred             CCCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCccHHHHHHHHH----hccCCccHHHHHHHHHhhhcccccH
Confidence            478999999999999999999999999999999999999999988877665    46788999999998876543 2356


Q ss_pred             HHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      +.++.+|+.||.|++|+|+.+||+++|..  +|.+++++++++++..+|.| ||+|+|+||+++|.+..
T Consensus        85 ~~l~~aF~~fD~d~~G~I~~~el~~~l~~--~g~~ls~~ei~~~~~~~D~~-dG~I~y~EF~~~m~~~~  150 (153)
T 3i5g_B           85 DALRNAFSMFDEDGQGFIPEDYLKDLLEN--MGDNFSKEEIKNVWKDAPLK-NKQFNYNKMVDIKGKAE  150 (153)
T ss_dssp             HHHHHHHHTTCSSCSSCCCHHHHHHHHHS--SSSCCCHHHHHHHHTTCCEE-TTEECHHHHHHHHHCSC
T ss_pred             HHHHHHHhccccCCCCeEeHHHHHHHHHH--cCCcCCHHHHHHHHHHhCCC-cCEEcHHHHHHHhcCCC
Confidence            78999999999999999999999999998  77899999999999999987 99999999999998754

>4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A

Probab=99.89  E-value=2.1e-22  Score=171.07  Aligned_cols=144  Identities=33%  Similarity=0.574  Sum_probs=132.0

Q ss_pred             hccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-hh
Q 040917          330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-LQ  408 (494)
Q Consensus       330 ~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~~  408 (494)
                      .+.++.+++.++.++|..+|.+++|+|+.+||..++..+|..++..++..+|..+|.+++|.|+|+||+..+..... ..
T Consensus         2 ~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~ef~~~~~~~~~~~~   81 (147)
T 4ds7_A            2 SQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEIDVDGNHAIEFSEFLALMSRQLKCND   81 (147)
T ss_dssp             --CCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHHHHHTHH
T ss_pred             CCcCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHHhccCCC
Confidence            45688999999999999999999999999999999999999999999999999999999999999999998876433 34


Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      ....+..+|+.+|.|++|+|+.+||+.++..  +|..+++++++.++..+| |++|.|+|+||..+++
T Consensus        82 ~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~--~~~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~l~  146 (147)
T 4ds7_A           82 SEQELLEAFKVFDKNGDGLISAAELKHVLTS--IGEKLTDAEVDEMLREVS-DGSGEINIKQFAALLS  146 (147)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHH--TTCCCCHHHHHHHHHHHS-SSCSSEEHHHHHHHTT
T ss_pred             cHHHHHHHHHHhCCCCCCeECHHHHHHHHHH--cCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHHh
Confidence            5577899999999999999999999999998  677899999999999999 9999999999999875

>3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum}

Probab=99.89  E-value=8.7e-23  Score=180.05  Aligned_cols=166  Identities=25%  Similarity=0.475  Sum_probs=146.9

Q ss_pred             HHHHHHHHHHhhhhHHHHHHHHhhhccCc--hhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHH
Q 040917          306 TAVIFRMKQFTAMNKLKKLALKVIVENLP--TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQA  383 (494)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~  383 (494)
                      ..++.+++.+...+.+++.+...+...++  .+++..++++|..+|.|++|+|+.+||..++..+|..  ..++..+|..
T Consensus         4 ~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~~--~~~~~~~~~~   81 (180)
T 3mse_B            4 PNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREIYTVLASVGIK--KWDINRILQA   81 (180)
T ss_dssp             HHHHHHHHHHTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTCC--HHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhHHHHHHHHHHHHHccCCHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCC--HHHHHHHHHH
Confidence            56788899999999999999999998887  8999999999999999999999999999999999854  5789999999


Q ss_pred             hcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCC
Q 040917          384 ADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKD  463 (494)
Q Consensus       384 ~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~d  463 (494)
                      +|.|++|.|+|+||+..+...... ....+..+|+.+|.|++|+|+.+||+.++.    +..++++++++++..+|.|+|
T Consensus        82 ~D~d~~g~i~~~Ef~~~~~~~~~~-~~~~~~~~F~~~D~d~~G~I~~~El~~~l~----~~~~~~~~~~~~~~~~d~~~d  156 (180)
T 3mse_B           82 LDINDRGNITYTEFMAGCYRWKNI-ESTFLKAAFNKIDKDEDGYISKSDIVSLVH----DKVLDNNDIDNFFLSVHSIKK  156 (180)
T ss_dssp             HCTTCCSEECHHHHHHHHSCCTTC---CHHHHHHHHHCTTCSSCBCHHHHHHHTT----TSSCCHHHHHHHHHHHHTC--
T ss_pred             hCCCCCCcCcHHHHHHHHHhcccC-CHHHHHHHHHHHCCCCCCCCCHHHHHHHHc----CCCCCHHHHHHHHHHhhhccC
Confidence            999999999999999887654332 236789999999999999999999999997    356789999999999999988


Q ss_pred             --------CceeHHHHHHHHhcc
Q 040917          464 --------GRISYDEFRSMMKCG  478 (494)
Q Consensus       464 --------g~i~~~ef~~~~~~~  478 (494)
                              |.|+|+||+.+|.+.
T Consensus       157 ~~~~~~~~G~i~~~eF~~~l~~~  179 (180)
T 3mse_B          157 GIPREHIINKISFQEFKDYMLST  179 (180)
T ss_dssp             -------CCCBCHHHHHHHHHTT
T ss_pred             cccccccCCeeeHHHHHHHHHhc
Confidence                    999999999998753

>3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A

Probab=99.89  E-value=1.6e-22  Score=174.73  Aligned_cols=149  Identities=28%  Similarity=0.482  Sum_probs=136.4

Q ss_pred             HhhhccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh-
Q 040917          327 KVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH-  405 (494)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~-  405 (494)
                      ......++.+++.++.++|..+|.+++|+|+.+||..+++.+|..++..++..+|..+|.+++|.|+|+||+..+.... 
T Consensus        11 ~~~~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~   90 (161)
T 3fwb_A           11 GPLNSELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKREILDLIDEYDSEGRHLMKYDDFYIVMGEKIL   90 (161)
T ss_dssp             TTTTTTSCHHHHHHHHHHHHHHCTTSSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSCEEHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCcCCCCeEeHHHHHHHHHHHHh
Confidence            3445568899999999999999999999999999999999999999999999999999999999999999999887643 


Q ss_pred             hhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          406 KLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       406 ~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .......+..+|+.+|.|++|+|+.+||+.++..  +|..+++++++.++..+|.|++|.|+|+||+.++..
T Consensus        91 ~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~--~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~  160 (161)
T 3fwb_A           91 KRDPLDEIKRAFQLFDDDHTGKISIKNLRRVAKE--LGETLTDEELRAMIEEFDLDGDGEINENEFIAICTD  160 (161)
T ss_dssp             TCCHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH--TTCCCCHHHHHHHHHTTCSSSSSSEEHHHHHHHHHH
T ss_pred             cCCcHHHHHHHHHHHcCCCCCeEeHHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhc
Confidence            2345678999999999999999999999999999  677899999999999999999999999999998874

>2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A

Probab=99.89  E-value=7.5e-23  Score=176.26  Aligned_cols=147  Identities=25%  Similarity=0.487  Sum_probs=133.9

Q ss_pred             ccCchhHHHhhhhhhhccC-CCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhh--
Q 040917          331 ENLPTEEIQKLKEKFTEMD-TDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKL--  407 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D-~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~--  407 (494)
                      ..++++++.++.++|..+| .+++|+|+.+||..+++.+|..++..++..+|..+|.+++|.|+|+||+..+......  
T Consensus         5 ~~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~~~~~~   84 (158)
T 2jnf_A            5 SKLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEFDPFGNGDIDFDSFKIIGARFLGEEV   84 (158)
T ss_dssp             TTSCHHHHHHHHHHHHHSBCSSSCSSEEHHHHHHHHHHTTCSCSHHHHHHHHHHHCTTCCSEECHHHHHHHHHHHCCCCC
T ss_pred             hhCCHHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcccc
Confidence            4567889999999999999 9999999999999999999999999999999999999999999999999988765322  


Q ss_pred             ---hHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          408 ---QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       408 ---~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                         .....++.+|+.+|.|++|+|+.+||+.++..  +|..+++++++.++..+|.|+||.|+|+||+.++.+.+
T Consensus        85 ~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~--~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~~  157 (158)
T 2jnf_A           85 NPEQMQQELREAFRLYDKEGNGYISTDVMREILAE--LDETLSSEDLDAMIDEIDADGSGTVDFEEFMGVMTGGD  157 (158)
T ss_dssp             CTTTTSSTHHHHHHHHCSSSSSSEEHHHHHHHHHH--HCTTCCHHHHHHHHHHHCSSCCSEECSHHHHHHTSSCC
T ss_pred             chhhHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHH--hCCcCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHhccC
Confidence               34557899999999999999999999999998  56788999999999999999999999999999987653

>1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ...

Probab=99.89  E-value=2.1e-22  Score=173.99  Aligned_cols=148  Identities=32%  Similarity=0.541  Sum_probs=133.7

Q ss_pred             hhhccCchhHHHhhhhhhhccCCCC-CCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh-
Q 040917          328 VIVENLPTEEIQKLKEKFTEMDTDN-SGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH-  405 (494)
Q Consensus       328 ~~~~~~~~~~~~~~~~~F~~~D~~~-~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~-  405 (494)
                      .+...++.+++.++.++|..+|.++ +|.|+.+||..++..+|..++..++..+|..+|.|++|.|+|+||+..+.... 
T Consensus         7 ~~~~~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~   86 (161)
T 1dtl_A            7 AAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMK   86 (161)
T ss_dssp             TGGGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHC
T ss_pred             HHHhhCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhc
Confidence            3456678999999999999999999 99999999999999999999999999999999999999999999999887654 


Q ss_pred             ---hhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          406 ---KLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       406 ---~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                         .......+..+|+.+|.|++|+|+.+||+.++..  .|..+++++++.++..+|.|+||.|+|+||..++.+
T Consensus        87 ~~~~~~~~~~~~~~F~~~D~d~~G~i~~~El~~~l~~--~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~  159 (161)
T 1dtl_A           87 DDSKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQA--TGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKG  159 (161)
T ss_dssp             -----CHHHHHHHHHHHHCTTCSSEEEHHHHGGGGTT--C--CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHC
T ss_pred             ccccchHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHc
Confidence               2345677999999999999999999999999998  667889999999999999999999999999998874

>3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A

Probab=99.89  E-value=1.3e-22  Score=184.68  Aligned_cols=166  Identities=19%  Similarity=0.207  Sum_probs=147.5

Q ss_pred             HHHHhhhhHHHHHHHHhhhccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCc
Q 040917          312 MKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGT  391 (494)
Q Consensus       312 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~  391 (494)
                      ...+.....+++..+..+...++.+++++++++|..+|.|++|+|+.+||..+++.+|..++.+++..++..+|.|++|.
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~l~~~e~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D~d~dg~  103 (220)
T 3sjs_A           24 ACIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVDRDRSGTLEINELMMGQFPGGIRLSPQTALRMMRIFDTDFNGH  103 (220)
T ss_dssp             HHHHHSCHHHHTSTTGGGGGGCCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHCCBGGGBCCCHHHHHHHHHHHCTTCSSC
T ss_pred             hhccCCChhHHHHHHHHHHhcCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCc
Confidence            44455666678888888889999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHH
Q 040917          392 IDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEF  471 (494)
Q Consensus       392 i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef  471 (494)
                      |+|+||+..+...      ..++.+|+.+|.|++|+|+.+||+.++..  +|..+++++++.++..+| |+||.|+|+||
T Consensus       104 I~~~EF~~~~~~~------~~l~~~F~~~D~d~~G~I~~~El~~~l~~--~g~~~~~~~~~~l~~~~d-d~dg~I~~~eF  174 (220)
T 3sjs_A          104 ISFYEFMAMYKFM------ELAYNLFVMNARARSGTLEPHEILPALQQ--LGFYINQRTSLLLHRLFA-RGMAFCDLNCW  174 (220)
T ss_dssp             BCHHHHHHHHHHH------HHHHHHHHHHCCSSTTEECHHHHHHHHHH--HTCCCCHHHHHHHHHHHC---CCSEEHHHH
T ss_pred             CCHHHHHHHHHHH------HHHHHHHHHHCCCCCCCCcHHHHHHHHHH--hCCCCCHHHHHHHHHHhc-CCCCcCcHHHH
Confidence            9999999987753      46899999999999999999999999999  567899999999999999 99999999999


Q ss_pred             HHHHhcccccchhhh
Q 040917          472 RSMMKCGTQLRALSS  486 (494)
Q Consensus       472 ~~~~~~~~~~~~~~~  486 (494)
                      ++++.....+...+.
T Consensus       175 ~~~~~~l~~~~~~F~  189 (220)
T 3sjs_A          175 IAICAFAAQTRSAYQ  189 (220)
T ss_dssp             HHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHH
Confidence            999987655554443

>2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum}

Probab=99.88  E-value=1.2e-22  Score=171.69  Aligned_cols=139  Identities=27%  Similarity=0.491  Sum_probs=127.8

Q ss_pred             hhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh-hhhHHHHH
Q 040917          335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH-KLQRFENL  413 (494)
Q Consensus       335 ~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~-~~~~~~~~  413 (494)
                      ++++.++.++|..+|.+++|+|+.+||..++..+|..++..++..+|..+|.|++|.|+|+||+..+.... .......+
T Consensus         2 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~   81 (142)
T 2bl0_C            2 DDQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEADATGNGKIQFPEFLSMMGRRMKQTTSEDIL   81 (142)
T ss_dssp             CHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHTTCCCHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCcCCCCeeeHHHHHHHHHHHhcCCChHHHH
Confidence            56788999999999999999999999999999999999999999999999999999999999999887632 23356689


Q ss_pred             HHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          414 YKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       414 ~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      ..+|+.+|.|++|+|+.+||+.++..  +|..+++++++.++..+| |++|.|+|+||+.+|.
T Consensus        82 ~~~F~~~D~d~~G~i~~~el~~~l~~--~g~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~~~  141 (142)
T 2bl0_C           82 RQAFRTFDPEGTGYIPKAALQDALLN--LGDRLKPHEFAEFLGITE-TEKGQIRYDNFINTMF  141 (142)
T ss_dssp             HHHHHHTCCSSCSCEEHHHHHHHHHH--SSSCCCHHHHHHHHHHHC-CSSSEECSHHHHTTTC
T ss_pred             HHHHHHHCCCCCCcCcHHHHHHHHHH--cCCCCCHHHHHHHHHHhC-CCCCcEeHHHHHHHHc
Confidence            99999999999999999999999999  667899999999999999 9999999999988764

>1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A

Probab=99.88  E-value=7.4e-23  Score=174.26  Aligned_cols=139  Identities=24%  Similarity=0.365  Sum_probs=124.3

Q ss_pred             HHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHh-cCCCCCcccchHHHHHHHHh------hhhhH
Q 040917          337 EIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAA-DIDGNGTIDYIEFITATMQR------HKLQR  409 (494)
Q Consensus       337 ~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~-D~~~~g~i~~~ef~~~~~~~------~~~~~  409 (494)
                      ++++++++|..+|.|++|+|+.+||..+++.+|..++..++..+|..+ |.+++|.|+|+||+..+...      .....
T Consensus         2 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~   81 (148)
T 1m45_A            2 ATRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLDQITGLIEVNEKELDATTKAK   81 (148)
T ss_dssp             -CCCCTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGGCCC
T ss_pred             hHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHhhCCCCCCeEcHHHHHHHHHHHHhhcccccccc
Confidence            456788999999999999999999999999999999999999999999 99999999999999988765      23344


Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...+..+|+.+|.|++|+|+.+||+.++..  +|..+++++++.++..+|.|+||.|+|+||+.+|..
T Consensus        82 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~--~g~~~~~~~~~~~~~~~d~d~dg~i~~~eF~~~~~~  147 (148)
T 1m45_A           82 TEDFVKAFQVFDKESTGKVSVGDLRYMLTG--LGEKLTDAEVDELLKGVEVDSNGEIDYKKFIEDVLR  147 (148)
T ss_dssp             THHHHHHHHTTCSSSSSEEEHHHHHHHHHH--STTCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHHC
T ss_pred             HHHHHHHHHHhCCCCCCcCCHHHHHHHHHH--cCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence            578999999999999999999999999999  677899999999999999999999999999998874

>1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ...

Probab=99.88  E-value=7.6e-22  Score=170.60  Aligned_cols=147  Identities=33%  Similarity=0.589  Sum_probs=134.3

Q ss_pred             hhccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhh-
Q 040917          329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKL-  407 (494)
Q Consensus       329 ~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~-  407 (494)
                      +...++++++.++.++|..+|.|++|.|+..||..++..+|..++..++..+|..+|.+++|.|+|+||+..+...... 
T Consensus        10 ~~~~ls~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~   89 (162)
T 1top_A           10 ARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKED   89 (162)
T ss_dssp             HHHHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTSCCEEEHHHHHHHHHHHHHHH
T ss_pred             hhhhcCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHcCCCCCcEeHHHHHHHHHHHhccc
Confidence            4456889999999999999999999999999999999999999999999999999999999999999999987764322 


Q ss_pred             h---HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          408 Q---RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       408 ~---~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .   ....+..+|+.+|.|++|+|+.+||+.++..  .|..+++++++.++..+|.|+||.|+|+||+.++..
T Consensus        90 ~~~~~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~--~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~  160 (162)
T 1top_A           90 AKGKSEEELANCFRIFDKNADGFIDIEELGEILRA--TGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMMEG  160 (162)
T ss_dssp             HHHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHT--TTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHS
T ss_pred             cccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhh
Confidence            1   4567899999999999999999999999998  667889999999999999999999999999998874

>3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A

Probab=99.88  E-value=1.3e-22  Score=173.46  Aligned_cols=146  Identities=29%  Similarity=0.541  Sum_probs=131.7

Q ss_pred             hccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhh-
Q 040917          330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQ-  408 (494)
Q Consensus       330 ~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~-  408 (494)
                      .+.+++++++++.++|..+|.+++|.|+.+||..++..+|..++..++..+|..+|.+++|.|+|+||+..+....... 
T Consensus         2 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~   81 (153)
T 3ox6_A            2 DRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNLGGHVDFDDFVELMGPKLLAET   81 (153)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHCSSSCCHHHHHHHHHHTTCCCCHHHHHHHHHHHHTTSTTCCCHHHHHHHHHHHHTTCC
T ss_pred             cccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCccCcHHHHHHHHHHHhhccc
Confidence            4567899999999999999999999999999999999999999999999999999999999999999999886543221 


Q ss_pred             ----HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          409 ----RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       409 ----~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                          ....+..+|+.+|.|++|+|+.+||+.++... .|..+++++++.++..+|.|+||.|+|+||..+++
T Consensus        82 ~~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~-~~~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~  152 (153)
T 3ox6_A           82 ADMIGVKELRDAFREFDTNGDGEISTSELREAMRAL-LGHQVGHRDIEEIIRDVDLNGDGRVDFEEFVRMMS  152 (153)
T ss_dssp             HHHHCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH-HSSCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHTC
T ss_pred             cccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH-hcCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHh
Confidence                24678999999999999999999999999872 24578999999999999999999999999999875

>2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A

Probab=99.88  E-value=5.2e-22  Score=174.77  Aligned_cols=147  Identities=37%  Similarity=0.646  Sum_probs=130.4

Q ss_pred             hccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-hh
Q 040917          330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-LQ  408 (494)
Q Consensus       330 ~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~~  408 (494)
                      +..++.+++.++.++|..+|.|++|.|+.+||..++..+|..++..++..+|..+|.|++|.|+|+||+..+..... ..
T Consensus         2 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~EF~~~~~~~~~~~~   81 (179)
T 2f2o_A            2 ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTD   81 (179)
T ss_dssp             ----CCSHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHH
T ss_pred             cccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCCCcHHHHHHHHHHHccCcc
Confidence            34577889999999999999999999999999999999999999999999999999999999999999998876532 33


Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ....+..+|+.+|.|++|+|+.+||+.++..  +|..+++++++.++..+|.|+||.|+|+||..++...
T Consensus        82 ~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~--~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~  149 (179)
T 2f2o_A           82 SEEEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK  149 (179)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHH--C--CCCHHHHHHHHHHHCTTCSSSEEHHHHHHHSCC-
T ss_pred             cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH--hCCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHc
Confidence            5567899999999999999999999999999  6678899999999999999999999999999998764

>1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ...

Probab=99.88  E-value=2.2e-22  Score=173.03  Aligned_cols=145  Identities=23%  Similarity=0.396  Sum_probs=133.0

Q ss_pred             cCchhHHHhhhhhhhccCC--CCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh--h
Q 040917          332 NLPTEEIQKLKEKFTEMDT--DNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK--L  407 (494)
Q Consensus       332 ~~~~~~~~~~~~~F~~~D~--~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~--~  407 (494)
                      .++++++.++.++|..+|.  +++|+|+.+||..+++.+|..++..++..+ ..+|.+++|.|+|+||+..+.....  .
T Consensus         2 ~ls~~~~~~l~~~F~~~D~~~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l-~~~D~~~~g~i~~~eF~~~~~~~~~~~~   80 (156)
T 1wdc_C            2 KLSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAV-GGTHKMGEKSLPFEEFLPAYEGLMDCEQ   80 (156)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHT-TCCSSTTSCEECHHHHHHHHHHHTTSCC
T ss_pred             CCCHHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHH-HhhCCCCCCeeeHHHHHHHHHHHhhccC
Confidence            4678899999999999999  999999999999999999999999999999 9999999999999999998877543  3


Q ss_pred             hHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHH--hCCCCCCceeHHHHHHHHhccc
Q 040917          408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSE--VDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       408 ~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~--~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      .....+..+|+.+|.|++|+|+.+||+.++..  +|..+++++++.++..  +|.|++|.|+|+||+.++...+
T Consensus        81 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~--~g~~~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~~  152 (156)
T 1wdc_C           81 GTFADYMEAFKTFDREGQGFISGAELRHVLTA--LGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFVKKVMAGP  152 (156)
T ss_dssp             CCHHHHHHHHHTTCSSSSSEEEHHHHHHHHHH--SSSCCCHHHHHHHHHHHTCCCCTTSEEEHHHHHHHHHHCS
T ss_pred             ChHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH--cCCCCCHHHHHHHHHHhCCCCCCCCcEeHHHHHHHHhcCC
Confidence            45678999999999999999999999999999  6678999999999999  9999999999999999998754

>3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus}

Probab=99.87  E-value=3.5e-22  Score=169.00  Aligned_cols=141  Identities=28%  Similarity=0.476  Sum_probs=127.9

Q ss_pred             CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-hhHHH
Q 040917          333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-LQRFE  411 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~~~~~  411 (494)
                      ++.++++++.++|..+|.|++|+|+.+||..+++.+|..++..++..++..    ++|.|+|+||+..+..... .....
T Consensus         1 ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~----~~g~i~~~eF~~~~~~~~~~~~~~~   76 (143)
T 3j04_B            1 FDQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEYLEGMMSE----APGPINFTMFLTMFGEKLNGTDPED   76 (143)
T ss_dssp             CCHHHHHHHHHHHTTTCSSCTTCCCHHHHHHHHHHTSCCCCHHHHHTTTTT----SSSCCCHHHHHHHHHHTTTSSCCHH
T ss_pred             CCHHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHh----CCCCcCHHHHHHHHHHHhccCCcHH
Confidence            467889999999999999999999999999999999999999888887765    8999999999998886433 33557


Q ss_pred             HHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          412 NLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       412 ~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      .+..+|+.+|.|++|+|+.+||+.++..  +|..+++++++.++..+|.|+||.|+|+||+.+|.+.+
T Consensus        77 ~l~~~F~~~D~d~~G~I~~~El~~~l~~--~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~~  142 (143)
T 3j04_B           77 VIRNAFACFDEEASGFIHEDHLRELLTT--MGDRFTDEEVDEMYREAPIDKKGNFNYVEFTRILKHGA  142 (143)
T ss_dssp             HHHHHHTTSCSSSCCCCCTTTHHHHHHT--SSSCCCHHHHHHHHHHTTCCSSSCCCSTHHHHHHHSSC
T ss_pred             HHHHHHHHHCCCCCCeEcHHHHHHHHHH--cCCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHhccC
Confidence            8999999999999999999999999998  67789999999999999999999999999999998754

>2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C*

Probab=99.87  E-value=1.9e-21  Score=165.54  Aligned_cols=141  Identities=21%  Similarity=0.408  Sum_probs=129.4

Q ss_pred             CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHh---cCCCCCcccchHHHHHHHHh---hh
Q 040917          333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAA---DIDGNGTIDYIEFITATMQR---HK  406 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~---D~~~~g~i~~~ef~~~~~~~---~~  406 (494)
                      ++++++.++.++|..+|.+++|+|+.+||..++..+|..++..++..++..+   |.++ |.|+|+||+..+...   ..
T Consensus         2 l~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~~~~d~~~-g~i~~~eF~~~~~~~~~~~~   80 (149)
T 2mys_C            2 FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNA-AAITFEEFLPMLQAAANNKD   80 (149)
T ss_pred             CCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhhhccccC-CcCcHHHHHHHHHHHhccCC
Confidence            5678899999999999999999999999999999999999999999999999   9999 999999999988764   22


Q ss_pred             hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          407 LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       407 ~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ......+..+|+.+|.|++|+|+.+||+.++..  +|..+++++++.++.. |.|++|.|+|+||+.+|.+
T Consensus        81 ~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~--~g~~~~~~~~~~~~~~-d~~~dg~i~~~eF~~~~~~  148 (149)
T 2mys_C           81 QGTFEDFVEGLRVFDKEGNGTVMGAELRHVLAT--LGEKMTEEEVEELMKG-QEDSNGCINYEAFVKHIMS  148 (149)
T ss_pred             cchHHHHHHHHHHhCCCCCceEcHHHHHHHHHH--hCCCCCHHHHHHHHhh-CCCCCCcEeHHHHHHHHhc
Confidence            345577899999999999999999999999999  5678899999999999 9999999999999998874

>1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5

Probab=99.86  E-value=8.6e-23  Score=181.29  Aligned_cols=145  Identities=54%  Similarity=0.851  Sum_probs=129.6

Q ss_pred             ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHH
Q 040917          331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRF  410 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~  410 (494)
                      +.++.++++++.++|..+|.|++|.|+.+||..++..+|..++..++..+|..+|.|++|.|+|+||+..+.........
T Consensus         2 ~~ls~~~~~~l~~~F~~~D~d~dG~I~~~E~~~~l~~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~~~~~~~   81 (188)
T 1s6i_A            2 ERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLERE   81 (188)
T ss_dssp             CSSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCCC
T ss_pred             CCCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCeEeHHHHHHHHHHHhccCHH
Confidence            45678889999999999999999999999999999999999999999999999999999999999999887654333334


Q ss_pred             HHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      ..+..+|+.+|.|++|+|+.+||+.++..+|    +++++++.++..+|.|+||.|+|+||+.+|....
T Consensus        82 ~~l~~~F~~~D~d~dG~Is~~El~~~l~~~g----~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~~~~~  146 (188)
T 1s6i_A           82 ENLVSAFSYFDKDGSGYITLDEIQQACKDFG----LDDIHIDDMIKEIDQDNDGQIDYGEFAAMMRKRK  146 (188)
T ss_dssp             CSTHHHHHHTTTTCSSEEEHHHHHHTTTTTT----CCTTHHHHHHHHHCSSSSSEEETTHHHHTTSCCC
T ss_pred             HHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC----CCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHcC
Confidence            5689999999999999999999999999844    4667899999999999999999999999987544

>1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C

Probab=99.86  E-value=1.7e-22  Score=172.57  Aligned_cols=143  Identities=21%  Similarity=0.423  Sum_probs=121.5

Q ss_pred             cCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCC--CCCcccchHHHHHHHHhhh---
Q 040917          332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADID--GNGTIDYIEFITATMQRHK---  406 (494)
Q Consensus       332 ~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~--~~g~i~~~ef~~~~~~~~~---  406 (494)
                      .++++++++++++|..+|.|++|+|+.+||..+++.+|..++..++..+|..+|.+  ++|.|+|+||+..+.....   
T Consensus         3 ~ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~~~~g~i~~~eF~~~~~~~~~~~~   82 (151)
T 1w7j_B            3 EFNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNRG   82 (151)
T ss_dssp             --------CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC---
T ss_pred             CCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCcCcCCCCcCcHHHHHHHHHHHhccCC
Confidence            35778899999999999999999999999999999999999999999999999999  9999999999998876532   


Q ss_pred             hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          407 LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       407 ~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ......+..+|+.+|.|++|+|+.+||+.++..  +|..+++++++.++..+| |+||.|+|+||+.+|.+
T Consensus        83 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~--~g~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~~~~  150 (151)
T 1w7j_B           83 QGTYEDYLEGFRVFDKEGNGKVMGAELRHVLTT--LGEKMTEEEVETVLAGHE-DSNGCINYEAFLKHILS  150 (151)
T ss_dssp             -----CCHHHHHTTCTTSSSEEEHHHHHHHHHH--SSSCCCHHHHHHHHTTCC-CTTSEEEHHHHHHHTC-
T ss_pred             CCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH--cCCCCCHHHHHHHHHhcc-CCCCeEeHHHHHHHHhc
Confidence            123456788999999999999999999999999  567899999999999999 99999999999998764

>2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B

Probab=99.86  E-value=3.4e-21  Score=167.34  Aligned_cols=143  Identities=23%  Similarity=0.395  Sum_probs=129.1

Q ss_pred             ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCC-CCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-hh
Q 040917          331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGS-MLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-LQ  408 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~-~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~~  408 (494)
                      ..++.+++.++..+|..+|.|++|+|+.+||..+++.+|. .++..++..++...    +|.|+|+||+..+..... ..
T Consensus        17 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~l~~~~----dg~i~~~eF~~~~~~~~~~~~   92 (166)
T 2mys_B           17 SMFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIKEA----SGPINFTVFLTMFGEKLKGAD   92 (166)
T ss_pred             hhCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHC----CCCcCHHHHHHHHHHHhccCC
Confidence            3678889999999999999999999999999999999999 99999999998864    799999999998876432 23


Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      ....+..+|+.||.|++|+|+.+||+.++..  +|..+++++++.++..+|.|+||.|+|+||+.+|....
T Consensus        93 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~--~g~~~~~~~~~~~~~~~D~d~dg~I~~~eF~~~~~~~~  161 (166)
T 2mys_B           93 PEDVIMGAFKVLDPDGKGSIKKSFLEELLTT--GGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYVITHGE  161 (166)
T ss_pred             cHHHHHHHHHHhCCCCCcceeHHHHHHHHHH--cCCCCCHHHHHHHHHhcCCCCCCeEeHHHHHHHHHhcc
Confidence            5578999999999999999999999999998  66789999999999999999999999999999998654

>1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5

Probab=99.85  E-value=5.3e-21  Score=167.65  Aligned_cols=142  Identities=21%  Similarity=0.280  Sum_probs=126.3

Q ss_pred             chhHHHhhhhhhhccCCCCCCcccHHHHHH----HHHhcCCCCCHHHHH-----------HHHHHhcCCCCCcccchHHH
Q 040917          334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKA----GLAKLGSMLTEFDVK-----------QYMQAADIDGNGTIDYIEFI  398 (494)
Q Consensus       334 ~~~~~~~~~~~F~~~D~~~~g~i~~~el~~----~l~~~~~~~~~~~~~-----------~~~~~~D~~~~g~i~~~ef~  398 (494)
                      +.+++++++++|..+|.|++|+|+.+||..    +++.+|..++..++.           .+|..+|.|++|.|+++||+
T Consensus         2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~~~~~l~~~g~~~~~~~~~~l~~~~~~~~~~lf~~~D~d~dg~i~~~Ef~   81 (176)
T 1nya_A            2 TAIASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFI   81 (176)
T ss_dssp             CSHHHHHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHHH
T ss_pred             cHHHHHHHHHHHHHHcCCCCCcccHHHHHHHHHHHHHHcCCCCCcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHH
Confidence            567889999999999999999999999999    788889999888876           88999999999999999999


Q ss_pred             HHHHHhhhhh--------HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHH
Q 040917          399 TATMQRHKLQ--------RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE  470 (494)
Q Consensus       399 ~~~~~~~~~~--------~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~e  470 (494)
                      ..+.......        ....++.+|+.+|.|++|+|+.+||+.++..+  |  +++++++.+|..+|.|+||.|+|+|
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~--g--~~~~~~~~~~~~~D~d~dg~i~~~e  157 (176)
T 1nya_A           82 RVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTAL--G--MSKAEAAEAFNQVDTNGNGELSLDE  157 (176)
T ss_dssp             HHHHHHHSSSCHHHHHHHHHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHT--T--CCHHHHHHHHHHHCTTCSSEEEHHH
T ss_pred             HHHHHHhcCCchhhHHHHHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHh--C--CCHHHHHHHHHHhCCCCCCCCcHHH
Confidence            9887643221        13568999999999999999999999999994  4  7899999999999999999999999


Q ss_pred             HHHHHhccc
Q 040917          471 FRSMMKCGT  479 (494)
Q Consensus       471 f~~~~~~~~  479 (494)
                      |..++....
T Consensus       158 f~~~~~~~~  166 (176)
T 1nya_A          158 LLTAVRDFH  166 (176)
T ss_dssp             HHHHHSCCS
T ss_pred             HHHHHHHHh
Confidence            999998643

>1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A*

Probab=99.85  E-value=1.9e-21  Score=173.71  Aligned_cols=149  Identities=22%  Similarity=0.261  Sum_probs=124.0

Q ss_pred             HhhhccCchhHHHhhhhhhhccCCCCCCcccHHHHH-----HHHHhcCCCCCHH-----HHHHHHHHhcCCCCCcccchH
Q 040917          327 KVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELK-----AGLAKLGSMLTEF-----DVKQYMQAADIDGNGTIDYIE  396 (494)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~-----~~l~~~~~~~~~~-----~~~~~~~~~D~~~~g~i~~~e  396 (494)
                      ..+...++.++++++.++|..+|.|++|+|+.+||.     .+++.+|..++..     ++..+|..+|.|++|.|+|+|
T Consensus         8 ~~~~~~~s~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~E   87 (195)
T 1qv0_A            8 KLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGMEYGKEIAFPQ   87 (195)
T ss_dssp             CCSCCTTCHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHHHHHHTTCCTTCCBCHHH
T ss_pred             hcCcccCCHHHHHHHHHHHhHcCCCCCCcCcHHHHHHHHHHHHHHHcCCCccHHHHHHHHHHHHHHHcCCCCCceEcHHH
Confidence            334455689999999999999999999999999999     7888889887766     588899999999999999999


Q ss_pred             HHHHHHHhhhhh-------HHHHH----HHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCc
Q 040917          397 FITATMQRHKLQ-------RFENL----YKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGR  465 (494)
Q Consensus       397 f~~~~~~~~~~~-------~~~~~----~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~  465 (494)
                      |+..+.......       ..+.+    ..+|+.+|.|++|+|+.+||+.++..  +|..++++++++++..+|.|+||.
T Consensus        88 F~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~--~g~~~~~~~~~~~~~~~D~d~dg~  165 (195)
T 1qv0_A           88 FLDGWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKI--SGISPSQEDCEATFRHCDLDNAGD  165 (195)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCHHHHHHHHHHHHTC----CEECHHHHHHHHHH--HSSCCCHHHHHHHHHHSCCCTTSC
T ss_pred             HHHHHHHHHhhhhhcccccHHHHHHHHHHHHHHHhcCCCCCcCcHHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCc
Confidence            999876543211       01123    38999999999999999999999999  567889999999999999999999


Q ss_pred             eeHHHHHHHHhc
Q 040917          466 ISYDEFRSMMKC  477 (494)
Q Consensus       466 i~~~ef~~~~~~  477 (494)
                      |+|+||+..+..
T Consensus       166 i~~~eF~~~~~~  177 (195)
T 1qv0_A          166 LDVDEMTRQHLG  177 (195)
T ss_dssp             EEHHHHHHHHHH
T ss_pred             CCHHHHHHHHHH
Confidence            999999998875

>1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ...

Probab=99.85  E-value=7.2e-21  Score=163.48  Aligned_cols=145  Identities=21%  Similarity=0.451  Sum_probs=126.9

Q ss_pred             hhhccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh-h
Q 040917          328 VIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH-K  406 (494)
Q Consensus       328 ~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~-~  406 (494)
                      .+...++.+++..++.+|..+|.|++|+|+.+||..+++.+|..++..++..++.    +++|.|+|+||+..+.... .
T Consensus         7 ~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~----~~~g~i~~~eF~~~~~~~~~~   82 (156)
T 1wdc_B            7 GVLTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK----EAPGPLNFTMFLSIFSDKLSG   82 (156)
T ss_dssp             -----CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHT----TSSSCCCHHHHHHHHHHHTCS
T ss_pred             chhccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHH----hCCCcCcHHHHHHHHHHHhcC
Confidence            3445678899999999999999999999999999999999999999998888885    4789999999999887643 2


Q ss_pred             hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          407 LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       407 ~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      ......+..+|+.||.|++|+|+.+||+.+|..  +|..+++++++.++..+|.| ||.|+|+||+.+|....
T Consensus        83 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~--~g~~~~~~~~~~~~~~~d~~-dg~i~~~eF~~~~~~~~  152 (156)
T 1wdc_B           83 TDSEETIRNAFAMFDEQETKKLNIEYIKDLLEN--MGDNFNKDEMRMTFKEAPVE-GGKFDYVKFTAMIKGSG  152 (156)
T ss_dssp             CCCHHHHHHHHHTTCTTCCSCEEHHHHHHHHHH--SSSCCCHHHHHHHHHHCCEE-TTEECHHHHHHHHHTSC
T ss_pred             CChHHHHHHHHHHHCcCCCCccCHHHHHHHHHH--hCCCCCHHHHHHHHHhcCCC-CCEEeHHHHHHHHhcCc
Confidence            334567999999999999999999999999999  66789999999999999999 99999999999998754

>3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens}

Probab=99.85  E-value=2.1e-21  Score=174.73  Aligned_cols=146  Identities=28%  Similarity=0.454  Sum_probs=125.9

Q ss_pred             chhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHH
Q 040917          334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENL  413 (494)
Q Consensus       334 ~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~  413 (494)
                      ...++.++.++|..+|.|++|+|+.+||..++..+|..++..++..+|..+|.|++|.|+|+||+..+...........+
T Consensus        32 ~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~~~~~~~~~~~~  111 (204)
T 3e3r_A           32 GASGIQGLARFFRQLDRDGSRSLDADEFRQGLAKLGLVLDQAEAEGVCRKWDRNGSGTLDLEEFLRALRPPMSQAREAVI  111 (204)
T ss_dssp             --------CHHHHHHCTTCCSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHTSCCCCHHHHHHH
T ss_pred             CchhHHHHHHHHHHHccCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHhhcCchHHHHH
Confidence            35778899999999999999999999999999999999999999999999999999999999999988765555566789


Q ss_pred             HHhccccccCCCCceeHHHHHHHHhhcC-----CCCCCcHHHHHHHHHHhCC-CCCCceeHHHHHHHHhccc
Q 040917          414 YKAFQYFDKDNNGYITVDELGKAFKDYG-----MGDDATIATIKEIMSEVDR-DKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       414 ~~~F~~~D~d~~G~I~~~el~~~l~~~~-----~~~~~~~~~~~~~~~~~d~-~~dg~i~~~ef~~~~~~~~  479 (494)
                      ..+|+.+|.|++|+|+.+||..++..++     .+...++++++.++..+|. |+||.|+|+||..++....
T Consensus       112 ~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~D~~d~dg~Is~~EF~~~~~~~~  183 (204)
T 3e3r_A          112 AAAFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEVLRRFLDNFDSSEKDGQVTLAEFQDYYSGVS  183 (204)
T ss_dssp             HHHHHHHCTTCSSEECHHHHHHHCCCTTCHHHHTTSSCHHHHHHHHHHHHSCSSCCSCEEHHHHHHHHHHHH
T ss_pred             HHHHHHhCcCCCCeEeHHHHHHHHccccCCccccCCCChHHHHHHHHHHhhccCCCCcCcHHHHHHHHHHcC
Confidence            9999999999999999999999998531     4667888899999999998 9999999999999998643

>2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum}

Probab=99.85  E-value=5.7e-21  Score=161.80  Aligned_cols=133  Identities=29%  Similarity=0.462  Sum_probs=122.4

Q ss_pred             hhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh--hhhhHHHHHHHhcc
Q 040917          341 LKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR--HKLQRFENLYKAFQ  418 (494)
Q Consensus       341 ~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~--~~~~~~~~~~~~F~  418 (494)
                      ++++|..+|.|++|.|+.+||..+++.+|..++..++..++..   +++|.|+|+||+..+...  ........+..+|+
T Consensus         7 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~---~~~g~i~~~eF~~~~~~~~~~~~~~~~~l~~~F~   83 (145)
T 2bl0_B            7 IQECFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKGQ---LNAKEFDLATFKTVYRKPIKTPTEQSKEMLDAFR   83 (145)
T ss_dssp             HHHHHHHHCTTCSSCEEGGGHHHHHHHTTCCCCHHHHHHHHHH---HTSSEECHHHHHHHHTSCCCCGGGGHHHHHHHHH
T ss_pred             HHHHHHHhCCCCcCccCHHHHHHHHHHhCCCCCHHHHHHHHHh---cCCCeEcHHHHHHHHHHHhhcCcccHHHHHHHHH
Confidence            8999999999999999999999999999999999999999987   789999999999988765  33445678999999


Q ss_pred             ccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          419 YFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       419 ~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      .+|.|++|+|+.+||+.++..  .|..+++++++.++..+|.|+||.|+|+||+.++..+
T Consensus        84 ~~D~d~~G~i~~~e~~~~l~~--~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~~  141 (145)
T 2bl0_B           84 ALDKEGNGTIQEAELRQLLLN--LGDALTSSEVEELMKEVSVSGDGAINYESFVDMLVTG  141 (145)
T ss_dssp             HHCSSSSSEEEHHHHHHHHHH--SSSCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHHHS
T ss_pred             HhCCCCCCeEcHHHHHHHHHH--cCCCCCHHHHHHHHHHcCCCCCCcEeHHHHHHHHHhc
Confidence            999999999999999999999  5677899999999999999999999999999998864

>1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A

Probab=99.84  E-value=5.1e-21  Score=170.20  Aligned_cols=144  Identities=22%  Similarity=0.253  Sum_probs=125.9

Q ss_pred             cCchhHHHhhhhhhhccCCCCCCcccHHHHH-----HHHHhcCCCCCHH-----HHHHHHHHhcCCCCCcccchHHHHHH
Q 040917          332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELK-----AGLAKLGSMLTEF-----DVKQYMQAADIDGNGTIDYIEFITAT  401 (494)
Q Consensus       332 ~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~-----~~l~~~~~~~~~~-----~~~~~~~~~D~~~~g~i~~~ef~~~~  401 (494)
                      ..+.++++++.++|..+|.|++|+|+.+||.     .+++.+|..++..     ++..+|..+|.|++|.|+|+||+..+
T Consensus         9 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EF~~~~   88 (191)
T 1uhk_A            9 FDNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGMKYGVETDWPAYIEGW   88 (191)
T ss_dssp             TTCHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHTTCCTTCEEEHHHHHHHH
T ss_pred             cCCHHHHHHHHHHHhhccCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHHHhCcCCCCcCcHHHHHHHH
Confidence            3477889999999999999999999999999     8899999888877     68899999999999999999999887


Q ss_pred             HHhhhhh-------HHHHH----HHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHH
Q 040917          402 MQRHKLQ-------RFENL----YKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE  470 (494)
Q Consensus       402 ~~~~~~~-------~~~~~----~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~e  470 (494)
                      .......       ..+.+    ..+|+.+|.|++|+|+.+||+.++..  +|..+++++++.++..+|.|+||.|+|+|
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~--~g~~~~~~~~~~~~~~~D~d~dG~i~~~e  166 (191)
T 1uhk_A           89 KKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKA--AGIIQSSEDCEETFRVCDIDESGQLDVDE  166 (191)
T ss_dssp             HHHHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH--HTSCCSHHHHHHHHHHSCCCTTSCEEHHH
T ss_pred             HHHhcchhhhhhhhhHHHHHHHHHHHHHHhcCCCCCcCcHHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCcCcHHH
Confidence            6543211       11123    38999999999999999999999999  56678999999999999999999999999


Q ss_pred             HHHHHhc
Q 040917          471 FRSMMKC  477 (494)
Q Consensus       471 f~~~~~~  477 (494)
                      |+.++..
T Consensus       167 F~~~~~~  173 (191)
T 1uhk_A          167 MTRQHLG  173 (191)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9998875

>2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii}

Probab=99.84  E-value=1.5e-20  Score=167.22  Aligned_cols=144  Identities=13%  Similarity=0.187  Sum_probs=128.4

Q ss_pred             hccCchhHHHhhhhhhhcc-CCCCCCcccHHHHHHHHHhc----CCCCCHHHHHHHH-----------HHhcCCCCCccc
Q 040917          330 VENLPTEEIQKLKEKFTEM-DTDNSGTLTYDELKAGLAKL----GSMLTEFDVKQYM-----------QAADIDGNGTID  393 (494)
Q Consensus       330 ~~~~~~~~~~~~~~~F~~~-D~~~~g~i~~~el~~~l~~~----~~~~~~~~~~~~~-----------~~~D~~~~g~i~  393 (494)
                      +..++..+.+++.++|..+ |.|++|+|+.+||..++..+    |..++..++..++           ..+|.|++|.|+
T Consensus         3 ~~~ls~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~~~~~D~d~dG~i~   82 (191)
T 2ccm_A            3 AHQLSDFQRNKILRVFNTFYDCNHDGVIEWDDFELAIKKICNLHSWPTDGKKHNEARATLKLIWDGLRKYADENEDEQVT   82 (191)
T ss_dssp             CCCCCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTCSSCEE
T ss_pred             hhhccHHHHHHHHHhccccccCCCCCeeeHHHHHHHHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCeEC
Confidence            3456788899999999999 99999999999999999998    8888888888888           999999999999


Q ss_pred             chHHHHHHHHhhh---------hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCC
Q 040917          394 YIEFITATMQRHK---------LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDG  464 (494)
Q Consensus       394 ~~ef~~~~~~~~~---------~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg  464 (494)
                      ++||+..+.....         ......+..+|+.+|.|++|+|+.+||..++..+  |  +++++++.+|..+|.|+||
T Consensus        83 ~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~I~~~E~~~~l~~~--g--~~~~~~~~~~~~~D~d~dG  158 (191)
T 2ccm_A           83 KEEWLKMWAECVKSVEKGESLPEWLTKYMNFMFDVNDTSGDNIIDKHEYSTVYMSY--G--IPKSDCDAAFDTLSDGGKT  158 (191)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHCTTCSSBCCHHHHHHHHHTT--T--CCHHHHHHHHHHHTTTTTS
T ss_pred             HHHHHHHHHHHhccccchhhchHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHh--C--CCHHHHHHHHHHhCCCCCC
Confidence            9999998776432         2335678999999999999999999999999984  4  7889999999999999999


Q ss_pred             ceeHHHHHHHHhc
Q 040917          465 RISYDEFRSMMKC  477 (494)
Q Consensus       465 ~i~~~ef~~~~~~  477 (494)
                      .|+++||..++..
T Consensus       159 ~i~~~Ef~~~~~~  171 (191)
T 2ccm_A          159 MVTREIFARLWTE  171 (191)
T ss_dssp             CCBHHHHHHHHHH
T ss_pred             CcCHHHHHHHHHH
Confidence            9999999998875

>3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia}

Probab=99.84  E-value=5.5e-21  Score=170.85  Aligned_cols=145  Identities=21%  Similarity=0.380  Sum_probs=130.9

Q ss_pred             hhccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-h
Q 040917          329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-L  407 (494)
Q Consensus       329 ~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~  407 (494)
                      ....++.+++..+.++|..+|.|++|+|+..||..+++.+|..++..++..++..+    +|.|+|+||+..+..... .
T Consensus        47 ~~~~ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~l~~~~----~g~i~~~eF~~~~~~~~~~~  122 (196)
T 3dtp_E           47 VFAMFTQHQVQEFKEAFQLIDQDKDGFISKNDIRATFDSLGRLCTEQELDSMVAEA----PGPINFTMFLTIFGDRIAGT  122 (196)
T ss_dssp             SSCSSCTTTHHHHHHHHHHHCCSCSSBCCHHHHHHHHHTTSCCCCHHHHHHHHTTS----SSCCBHHHHHHHHHHCCCSS
T ss_pred             hhhhCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHc----cCCCcHHHHHHHHHHHhcCC
Confidence            34567889999999999999999999999999999999999999999999998876    899999999998876432 3


Q ss_pred             hHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccc
Q 040917          408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ  480 (494)
Q Consensus       408 ~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~  480 (494)
                      .....+..+|+.||.|++|+|+.+||+.+| .  +|..+++++++.++..+|.|+||.|+|+||+++|...+.
T Consensus       123 ~~~~~l~~~F~~~D~d~~G~Is~~El~~~l-~--~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~l~~~~~  192 (196)
T 3dtp_E          123 DEEDVIVNAFNLFDEGDGKCKEETLKRSLT-T--WGEKFSQDEVDQALSEAPIDGNGLIDIKKFAQILTKGAK  192 (196)
T ss_dssp             CCHHHHHHHHHTTCSSSSCCBHHHHHHHHH-H--SSSCCCHHHHHHHHHSSCEETTEECHHHHHHHHHSSCCB
T ss_pred             CcHHHHHHHHHHHCCCCCCcCcHHHHHHHH-H--cCCCCCHHHHHHHHHHcCCCCCCEEeHHHHHHHHHcCCc
Confidence            345689999999999999999999999999 8  677899999999999999999999999999999987654

>2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A

Probab=99.84  E-value=1.1e-20  Score=165.22  Aligned_cols=139  Identities=22%  Similarity=0.347  Sum_probs=124.7

Q ss_pred             hHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcC-CCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHH
Q 040917          336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLG-SMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLY  414 (494)
Q Consensus       336 ~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~-~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~  414 (494)
                      .+.+++.++|..+|.|++|+|+.+||..+++.++ ..++..++..+|..+|.|++|.|+|+||+..+...      ..++
T Consensus         4 ~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~ef~~~~~~~------~~~~   77 (172)
T 2znd_A            4 PDQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKYI------TDWQ   77 (172)
T ss_dssp             --CHHHHHHHHHHCTTCSSCEEHHHHHHHCCCSSSSCCCHHHHHHHHHHHCSSSSSEECHHHHHHHHHHH------HHHH
T ss_pred             cchhHHHHHHHHhCCCCCCcCcHHHHHHHHHhcCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHH------HHHH
Confidence            3557789999999999999999999999999988 77899999999999999999999999999877642      4789


Q ss_pred             HhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccccc
Q 040917          415 KAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLR  482 (494)
Q Consensus       415 ~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~  482 (494)
                      .+|+.+|.|++|+|+.+||..++..  +|..+++++++.++..+|.|+||.|+|+||..++.....+.
T Consensus        78 ~~F~~~D~d~~G~i~~~el~~~l~~--~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~~~~~~  143 (172)
T 2znd_A           78 NVFRTYDRDNSGMIDKNELKQALSG--FGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVLQRLT  143 (172)
T ss_dssp             HHHHHHCTTCSSEECHHHHHHHHHH--TTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHH
T ss_pred             HHHHHHCCCCCCccCHHHHHHHHHH--cCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999  56788999999999999999999999999999887643333

>1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8

Probab=99.84  E-value=1.2e-20  Score=167.97  Aligned_cols=139  Identities=23%  Similarity=0.382  Sum_probs=125.9

Q ss_pred             HHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhc
Q 040917          338 IQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAF  417 (494)
Q Consensus       338 ~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F  417 (494)
                      .+++.++|..+|.|++|.|+.+||..++...+..++.+++..+|..+|.|++|.|+|+||+..+...      ..++.+|
T Consensus        26 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~------~~~~~~F   99 (191)
T 1y1x_A           26 NQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGEITFDEFKDLHHFI------LSMREGF   99 (191)
T ss_dssp             TSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH------HHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHH------HHHHHHH
Confidence            4678999999999999999999999999888888999999999999999999999999999887642      4789999


Q ss_pred             cccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccccchh
Q 040917          418 QYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRAL  484 (494)
Q Consensus       418 ~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~~~  484 (494)
                      +.+|.|++|+|+.+||+.++..  .|..+++++++.++..+|.|+||.|+|+||..++.....+..+
T Consensus       100 ~~~D~d~~G~i~~~e~~~~l~~--~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~~~~~~~  164 (191)
T 1y1x_A          100 RKRDSSGDGRLDSNEVRAALLS--SGYQVSEQTFQALMRKFDRQRRGSLGFDDYVELSIFVCRVRNV  164 (191)
T ss_dssp             HHHCTTSSSCBCHHHHHHHHHT--TSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHHH
T ss_pred             HHhCCCCCCeEcHHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHHHHHHHH
Confidence            9999999999999999999998  6678899999999999999999999999999998865444333

>2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola}

Probab=99.84  E-value=6.8e-21  Score=172.02  Aligned_cols=143  Identities=18%  Similarity=0.317  Sum_probs=120.7

Q ss_pred             ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCC--CCCHHHHHHHH-------HHhcCCCCCcccchHHHHHH
Q 040917          331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGS--MLTEFDVKQYM-------QAADIDGNGTIDYIEFITAT  401 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~--~~~~~~~~~~~-------~~~D~~~~g~i~~~ef~~~~  401 (494)
                      ..++.+++.++.++|..+|.|++|+|+.+||..++..+|.  .++.+++..++       ..+|.|++|.|+|+||+..+
T Consensus        28 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~~~~~~~~~~l~~~~~~lf~~~D~d~dg~i~~~EF~~~~  107 (208)
T 2hpk_A           28 EDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAVRVFFLHKGVEPVNGLLREDWVEAN  107 (208)
T ss_dssp             --------CHHHHHHHHHCTTCSSEECHHHHTHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHTTCBTTTBEEGGGHHHHH
T ss_pred             HHcCHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHhhcCCCHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence            5677888999999999999999999999999999999987  88999999999       99999999999999999987


Q ss_pred             H---------Hhh-hhhHHHH-HHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHH
Q 040917          402 M---------QRH-KLQRFEN-LYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE  470 (494)
Q Consensus       402 ~---------~~~-~~~~~~~-~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~e  470 (494)
                      .         ... ......+ ++.+|+.+|.|++|+|+.+||+.++..+  |  +++++++.++..+|.|+||.|+|+|
T Consensus       108 ~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~--g--~~~~~~~~~~~~~D~d~dG~I~~~E  183 (208)
T 2hpk_A          108 RVFAEAERERERRGEPSLIALLSNSYYDVLDDDGDGTVDVDELKTMMKAF--D--VPQEAAYTFFEKADTDKSGKLERTE  183 (208)
T ss_dssp             HHHHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHT--T--SCTTHHHHHHHHHCTTCCSSBCHHH
T ss_pred             HHHhhhhhhhhccCChHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHh--C--cCHHHHHHHHHHhCCCCCCcCcHHH
Confidence            6         211 1122333 7899999999999999999999999994  4  6788999999999999999999999


Q ss_pred             HHHHHhc
Q 040917          471 FRSMMKC  477 (494)
Q Consensus       471 f~~~~~~  477 (494)
                      |..++..
T Consensus       184 F~~~~~~  190 (208)
T 2hpk_A          184 LVHLFRK  190 (208)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9998875

>2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens}

Probab=99.84  E-value=7.3e-21  Score=170.96  Aligned_cols=142  Identities=23%  Similarity=0.351  Sum_probs=127.3

Q ss_pred             cCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh------
Q 040917          332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH------  405 (494)
Q Consensus       332 ~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~------  405 (494)
                      .++.+++++++++|..+|.|++|+|+.+||..+ ..+|..++   +..+|..+|.|++|.|+|+||+..+....      
T Consensus        22 ~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~-~~lg~~~~---~~~l~~~~D~d~dg~i~~~EF~~~~~~~~~~~~~~   97 (202)
T 2bec_A           22 GFSQASLLRLHHRFRALDRNKKGYLSRMDLQQI-GALAVNPL---GDRIIESFFPDGSQRVDFPGFVRVLAHFRPVEDED   97 (202)
T ss_dssp             CCCHHHHHHHHHHHHHHCSSCSSCCCHHHHHTC-HHHHHSTT---HHHHHHTTSCSSCCCCCHHHHHHHHGGGSCCCHHH
T ss_pred             CCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-HhcCCCcc---HHHHHHHhCCCCCCcCcHHHHHHHHHHhcccchhc
Confidence            578899999999999999999999999999999 77776655   88999999999999999999999887654      


Q ss_pred             -----------hhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCC-CCCCcHHHHHHHHHH----hCCCCCCceeHH
Q 040917          406 -----------KLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM-GDDATIATIKEIMSE----VDRDKDGRISYD  469 (494)
Q Consensus       406 -----------~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~-~~~~~~~~~~~~~~~----~d~~~dg~i~~~  469 (494)
                                 .......++.+|+.+|.|++|+|+.+||+.++..  + |..+++++++.++..    +|.|+||.|+|+
T Consensus        98 ~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~--~~g~~~~~~~~~~~~~~~~~~~D~d~dG~Is~~  175 (202)
T 2bec_A           98 TETQDPKKPEPLNSRRNKLHYAFQLYDLDRDGKISRHEMLQVLRL--MVGVQVTEEQLENIADRTVQEADEDGDGAVSFV  175 (202)
T ss_dssp             HC-----CCCCTTSHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH--SCCSCCCHHHHHHHHHHHHHHHCSSCSSSEEHH
T ss_pred             ccccccccccccccHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHcCCCCCCcCcHH
Confidence                       3345678999999999999999999999999999  5 678899999998888    999999999999


Q ss_pred             HHHHHHhccc
Q 040917          470 EFRSMMKCGT  479 (494)
Q Consensus       470 ef~~~~~~~~  479 (494)
                      ||+.++....
T Consensus       176 EF~~~~~~~~  185 (202)
T 2bec_A          176 EFTKSLEKMD  185 (202)
T ss_dssp             HHHHTTTTSC
T ss_pred             HHHHHHHHhC
Confidence            9999888643

>2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A

Probab=99.83  E-value=9.5e-21  Score=171.05  Aligned_cols=156  Identities=22%  Similarity=0.361  Sum_probs=133.9

Q ss_pred             ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhh---
Q 040917          331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKL---  407 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~---  407 (494)
                      ..++.+++++++.+|..+|.|++|+|+.+||..++ .+|..+..   .+++..+|.+++|.|+|+||+..+......   
T Consensus        21 ~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~~-~lg~~~~~---~~l~~~~d~~~~g~i~~~EF~~~~~~~~~~~~~   96 (208)
T 2ct9_A           21 TGFSHSQITRLYSRFTSLDKGENGTLSREDFQRIP-ELAINPLG---DRIINAFFSEGEDQVNFRGFMRTLAHFRPIEDN   96 (208)
T ss_dssp             HCCCHHHHHHHHHHHHHHCTTCSSEECTGGGGGCH-HHHTSTTH---HHHHHTTSCTTCSCEEHHHHHHHHHTTSCCC--
T ss_pred             CCCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCCCCcH---HHHHHHHcCCCCCcCcHHHHHHHHHhhccccch
Confidence            45788999999999999999999999999999965 56666554   467899999999999999999988764321   


Q ss_pred             -------------hHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHH----HHHhCCCCCCceeHHH
Q 040917          408 -------------QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI----MSEVDRDKDGRISYDE  470 (494)
Q Consensus       408 -------------~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~----~~~~d~~~dg~i~~~e  470 (494)
                                   .....++.+|+.||.|++|+|+.+||+.++..+ .|..+++++++.+    +..+|.|+||.|+|+|
T Consensus        97 ~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~-~g~~~s~~~~~~l~~~~~~~~D~d~dG~Is~~E  175 (208)
T 2ct9_A           97 EKSKDVNGPEPLNSRSNKLHFAFRLYDLDKDDKISRDELLQVLRMM-VGVNISDEQLGSIADRTIQEADQDGDSAISFTE  175 (208)
T ss_dssp             ---------CCTTSHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHH-SCTTCCHHHHHHHHHHHHHHHCSSSSSSEEHHH
T ss_pred             hhhcccccccccccHHHHHHHHHHHHCCCCCCEEcHHHHHHHHHHH-hCCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHH
Confidence                         256789999999999999999999999999983 2677899998887    9999999999999999


Q ss_pred             HHHHHhcccccchhhhhhhhc
Q 040917          471 FRSMMKCGTQLRALSSRSLAH  491 (494)
Q Consensus       471 f~~~~~~~~~~~~~~~~~~~~  491 (494)
                      |+.++...+....++-+.|..
T Consensus       176 F~~~~~~~~~~~~~~~~~~~~  196 (208)
T 2ct9_A          176 FVKVLEKVDVEQKMSIRFLHK  196 (208)
T ss_dssp             HHHTTTTSCGGGSHHHHHHHH
T ss_pred             HHHHHhccChHHHhhHHHHHH
Confidence            999999888877777776654

>3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B*

Probab=99.83  E-value=1.9e-20  Score=160.52  Aligned_cols=144  Identities=33%  Similarity=0.554  Sum_probs=124.5

Q ss_pred             chhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh-hhhHHHH
Q 040917          334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH-KLQRFEN  412 (494)
Q Consensus       334 ~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~-~~~~~~~  412 (494)
                      ++++++++++.|..+|.|++|+|+.+|| ..+..++..+   ++..+|..+|.+++|.|+|+||+..+.... .......
T Consensus         1 s~~~~~~l~~~F~~~D~d~~G~i~~~el-~~l~~~~~~~---~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~   76 (155)
T 3ll8_B            1 DADEIKRLGKRFKKLDLDNSGSLSVEEF-MSLPELQQNP---LVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQK   76 (155)
T ss_dssp             CCHHHHHHHHHHHHHCTTCSSSBCHHHH-TTSGGGTTCT---THHHHHHHHCTTCSSSBCHHHHHHHHGGGCSSCCHHHH
T ss_pred             CHHHHHHHHHHHHHhCcCCCCeEcHHHH-HHhhccccch---HHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCHHHH
Confidence            3578899999999999999999999999 6677766554   688899999999999999999999887653 2345678


Q ss_pred             HHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHH----hCCCCCCceeHHHHHHHHhcccccc
Q 040917          413 LYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSE----VDRDKDGRISYDEFRSMMKCGTQLR  482 (494)
Q Consensus       413 ~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~----~d~~~dg~i~~~ef~~~~~~~~~~~  482 (494)
                      ++.+|+.+|.|++|+|+.+||+.++..+ .+..+++++++.++..    +|.|+||.|+|+||..++.....-.
T Consensus        77 ~~~~F~~~D~d~~G~i~~~e~~~~l~~~-~~~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~~~~  149 (155)
T 3ll8_B           77 LRFAFRIYDMDKDGYISNGELFQVLKMM-VGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVVGGLDIHK  149 (155)
T ss_dssp             HHHHHHHHCTTCSSCBCHHHHHHHHHHH-HGGGSCHHHHHHHHHHHHHHHCTTSSSSBCHHHHHHHHGGGCGGG
T ss_pred             HHHHHHHhCCCCCCcCcHHHHHHHHHHH-hccCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHhccCchh
Confidence            9999999999999999999999999873 2567889999999888    9999999999999999998755433

>1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E

Probab=99.83  E-value=1e-19  Score=160.75  Aligned_cols=154  Identities=21%  Similarity=0.321  Sum_probs=129.8

Q ss_pred             hccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCC-CCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhh
Q 040917          330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM-LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQ  408 (494)
Q Consensus       330 ~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~  408 (494)
                      ...++.++++.+.+.|..+  |++|.|+.+||..++..++.. .+..++..+|..+|.|++|.|+++||+..+.......
T Consensus        12 ~~~~s~~~i~~l~~~fd~~--d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~   89 (183)
T 1s6c_A           12 QTNFTKRELQVLYRGFKNE--XPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGT   89 (183)
T ss_dssp             HSSCCHHHHHHHHHHHHHH--CTTSEECHHHHHHHHHHHSTTSCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCC
T ss_pred             hcCCCHHHHHHHHHHHHHh--CCCCcCCHHHHHHHHHHHcCCCChHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHcCCC
Confidence            3457888888888877765  689999999999999999765 7888999999999999999999999999888765555


Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhc----C------CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDY----G------MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~----~------~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ....+..+|+.+|.|++|+|+.+||..++..+    |      +.....+++++++|..+|.|+||.|+++||..++...
T Consensus        90 ~~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i~~~Ef~~~~~~~  169 (183)
T 1s6c_A           90 VHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESXQED  169 (183)
T ss_dssp             HHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTTCSSEECHHHHHHHTTSC
T ss_pred             HHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHHHhccccCcCccHHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHhcC
Confidence            67789999999999999999999999999874    3      1122234889999999999999999999999999987


Q ss_pred             cccchhh
Q 040917          479 TQLRALS  485 (494)
Q Consensus       479 ~~~~~~~  485 (494)
                      +.+....
T Consensus       170 ~~~~~~l  176 (183)
T 1s6c_A          170 DNIMRSL  176 (183)
T ss_dssp             CHHHHHH
T ss_pred             hHHHHHH
Confidence            7655544

>3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A

Probab=99.82  E-value=6.7e-20  Score=158.90  Aligned_cols=137  Identities=22%  Similarity=0.349  Sum_probs=118.4

Q ss_pred             HHHhhhhhhhccCCCCCCcccHHHHHHHH----HhcCCCCCHHHHHHH-----------HHHhcCCCCCcccchHHHHHH
Q 040917          337 EIQKLKEKFTEMDTDNSGTLTYDELKAGL----AKLGSMLTEFDVKQY-----------MQAADIDGNGTIDYIEFITAT  401 (494)
Q Consensus       337 ~~~~~~~~F~~~D~~~~g~i~~~el~~~l----~~~~~~~~~~~~~~~-----------~~~~D~~~~g~i~~~ef~~~~  401 (494)
                      +++++.++|..+|.|++|+|+.+||..++    +.+|..++..++..+           |..+|.|++|.|+++||+..+
T Consensus         2 ~~~~l~~~F~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~f~~~D~d~~g~i~~~ef~~~~   81 (166)
T 3akb_A            2 YERRIAARFTTFDQDGNGHIDRSDFSGAAKAMLAEFGVAARSDRGQALYGGAEALWQGLAGIADRDGDQRITREEFVTGA   81 (166)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTSSSCEEHHHHHHTH
T ss_pred             HHHHHHHHHhHHcCCCCCCcCHHHHHHHHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence            46788999999999999999999999975    456888888777644           799999999999999999887


Q ss_pred             HHhhhhh-------HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHH
Q 040917          402 MQRHKLQ-------RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSM  474 (494)
Q Consensus       402 ~~~~~~~-------~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~  474 (494)
                      .......       ....++.+|+.+|.|++|+|+.+||..++..+  |  +++++++.++..+|.|+||.|+|+||..+
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~E~~~~l~~~--~--~~~~~~~~~~~~~D~d~dg~i~~~ef~~~  157 (166)
T 3akb_A           82 VKRLRDKPDRFAEMARPFLHAALGVADTDGDGAVTVADTARALTAF--G--VPEDLARQAAAALDTDGDGKVGETEIVPA  157 (166)
T ss_dssp             HHHHHHSHHHHHHHHHHHHHHHHHHHCSSSSSCCBHHHHHHHHHHT--T--CCHHHHHHHHHHHCTTCSSBCCHHHHHHH
T ss_pred             HHHhccCccchHHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHh--C--CCHHHHHHHHHHhCCCCCCcCcHHHHHHH
Confidence            6643222       13458999999999999999999999999994  4  78999999999999999999999999998


Q ss_pred             Hhc
Q 040917          475 MKC  477 (494)
Q Consensus       475 ~~~  477 (494)
                      +..
T Consensus       158 ~~~  160 (166)
T 3akb_A          158 FAR  160 (166)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            864

>1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5

Probab=99.82  E-value=9.6e-21  Score=159.47  Aligned_cols=134  Identities=23%  Similarity=0.367  Sum_probs=119.9

Q ss_pred             HHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh---hhHHHHH
Q 040917          337 EIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK---LQRFENL  413 (494)
Q Consensus       337 ~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~---~~~~~~~  413 (494)
                      ++++++++|..+|.|++|+|+.+||..+++.+|..++..++..++.    +++|.|+|+||+..+.....   ......+
T Consensus         3 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~----~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~   78 (140)
T 1ggw_A            3 DDSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIES----TLPAEVDMEQFLQVLNRPNGFDMPGDPEEF   78 (140)
T ss_dssp             CCTTTHHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHHHHT----TSCSSEEHHHHHHHHCTTSSSSSSCCHHHH
T ss_pred             hHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHh----CCCCcCcHHHHHHHHHHHhcccCcccHHHH
Confidence            3567899999999999999999999999999999999998888876    88999999999998876432   1234679


Q ss_pred             HHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          414 YKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       414 ~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ..+|+.+|.|++|+|+.+||+.++..  +|..+++++++.++..+|. +||.|+|+||+.+|..
T Consensus        79 ~~~F~~~D~d~~G~i~~~el~~~l~~--~g~~~~~~~~~~~~~~~d~-~dg~i~~~eF~~~~~~  139 (140)
T 1ggw_A           79 VKGFQVFDKDATGMIGVGELRYVLTS--LGEKLSNEEMDELLKGVPV-KDGMVNYHDFVQMILA  139 (140)
T ss_dssp             HHHHHTTCSSCSSCCCHHHHHHHHHH--HHSCSCHHHHHHHHHHTTC-SSCCSTTTHHHHHHHC
T ss_pred             HHHHHHhCCCCCCcEeHHHHHHHHHH--cCCCCCHHHHHHHHHhccC-CCCcEeHHHHHHHHhc
Confidence            99999999999999999999999998  5667899999999999999 9999999999999875

>1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5

Probab=99.82  E-value=3.8e-20  Score=166.55  Aligned_cols=154  Identities=23%  Similarity=0.275  Sum_probs=134.0

Q ss_pred             hhHHHhhhhhhhccCCC-CCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHH
Q 040917          335 TEEIQKLKEKFTEMDTD-NSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENL  413 (494)
Q Consensus       335 ~~~~~~~~~~F~~~D~~-~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~  413 (494)
                      .-..+++..+|..+|.+ ++|+|+.+||..+++.++...+.+++..+|..+|.|++|.|+++||+..+.........+.+
T Consensus        18 ~~~~~el~~~f~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~   97 (204)
T 1jba_A           18 AADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKL   97 (204)
T ss_dssp             HHHHHHHHHHHHHHHSSSTTCCEEHHHHHHHHHCCSSSTTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHH
T ss_pred             CCCHHHHHHHHHHHHhhCCCCCcCHHHHHHHHHHhcCCCcHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHHccCCHHHHH
Confidence            44566778899999999 89999999999999999988888999999999999999999999999988876554556789


Q ss_pred             HHhccccccCCCCceeHHHHHHHHhhc----CC-----------CCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          414 YKAFQYFDKDNNGYITVDELGKAFKDY----GM-----------GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       414 ~~~F~~~D~d~~G~I~~~el~~~l~~~----~~-----------~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ..+|+.+|.|++|+|+.+||..++..+    |.           ....++++++.+|..+|.|+||.|+++||..++...
T Consensus        98 ~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~g~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~~  177 (204)
T 1jba_A           98 KWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGARRD  177 (204)
T ss_dssp             HHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHHHHHTTT
T ss_pred             HHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCccccccccCchhhHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHcC
Confidence            999999999999999999999999874    10           112567789999999999999999999999999988


Q ss_pred             cccchhhhhh
Q 040917          479 TQLRALSSRS  488 (494)
Q Consensus       479 ~~~~~~~~~~  488 (494)
                      +.+..+....
T Consensus       178 ~~~~~~~~~~  187 (204)
T 1jba_A          178 KWVMKMLQMD  187 (204)
T ss_dssp             TTHHHHHHSS
T ss_pred             hHHHHHHHhc
Confidence            8877776543

>3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi}

Probab=99.82  E-value=9.1e-21  Score=172.56  Aligned_cols=148  Identities=22%  Similarity=0.381  Sum_probs=124.4

Q ss_pred             hhccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHh-cCCCCCHHHHHHHHHHh---------cCCCCCcccchHHH
Q 040917          329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAK-LGSMLTEFDVKQYMQAA---------DIDGNGTIDYIEFI  398 (494)
Q Consensus       329 ~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~-~~~~~~~~~~~~~~~~~---------D~~~~g~i~~~ef~  398 (494)
                      +...++.++++++..+|..+|.|++|+|+.+||..++.. +|..++..++..++..+         |.|++|.|+|+||+
T Consensus        38 ~~~~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~d~~g~I~~~EF~  117 (219)
T 3cs1_A           38 IPREKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLEVLKLDEFTSRVRDITKRAFDKSRTLGSKLENKGSEDFVEFL  117 (219)
T ss_dssp             SCCSSSHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCGGGTCSCHHHHHHHHHHHHHHHHHHHHTSCCCSSBCHH
T ss_pred             hcccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhCCCccHHHHHHHHHHHHHHHHhhhhccCCCCcCCHHHHH
Confidence            445678899999999999999999999999999999988 68776665565544322         34889999999999


Q ss_pred             HHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCC-CCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          399 TATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGD-DATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~-~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ..+...........++.+|+.||.|++|+|+.+||+.++..  +|. .+++++++.+|..+|.|+||.|+|+||+.+|..
T Consensus       118 ~~~~~~~~~~~~~~l~~~F~~~D~d~~G~Is~~El~~~l~~--~g~~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~~~~  195 (219)
T 3cs1_A          118 EFRLMLCYIYDFFELTVMFDEIDASGNMLVDEEEFKRAVPK--LEAWGAKVEDPAALFKELDKNGTGSVTFDEFAAWASA  195 (219)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCSSSSSEEEHHHHHHHHHH--HHHHTCCCSCHHHHHHHHCTTSSSEEEHHHHHHHHHH
T ss_pred             HHHHHHhccchHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH--hcccCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHH
Confidence            88655444345678999999999999999999999999998  444 567778999999999999999999999999886


Q ss_pred             c
Q 040917          478 G  478 (494)
Q Consensus       478 ~  478 (494)
                      .
T Consensus       196 ~  196 (219)
T 3cs1_A          196 V  196 (219)
T ss_dssp             H
T ss_pred             h
Confidence            3

>1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A

Probab=99.82  E-value=2.3e-20  Score=163.37  Aligned_cols=139  Identities=20%  Similarity=0.276  Sum_probs=124.5

Q ss_pred             hHHHhhhhhhhccCCCCCCcccHHHHHHHHHhc-C-------CCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhh
Q 040917          336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL-G-------SMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKL  407 (494)
Q Consensus       336 ~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~-~-------~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~  407 (494)
                      +++++++++|..+| +++|+|+.+||..+++.+ |       ..++.+++..++..+|.|++|.|+|+||+..+...   
T Consensus         1 e~~~~l~~~F~~~D-d~~G~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~---   76 (173)
T 1alv_A            1 EEVRQFRRLFAQLA-GDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNNI---   76 (173)
T ss_dssp             CHHHHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH---
T ss_pred             CchhHHHHHHHHHh-CCCCCcCHHHHHHHHHHhhhcccccccCCCCHHHHHHHHHHHcCCCCCccCHHHHHHHHHHH---
Confidence            36788999999999 999999999999999997 6       67889999999999999999999999999887743   


Q ss_pred             hHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccccchh
Q 040917          408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRAL  484 (494)
Q Consensus       408 ~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~~~  484 (494)
                         ..++.+|+.+|.|++|+|+.+||+.++..  +|..+++++++.++..+| |++|.|+|+||+.++.....+..+
T Consensus        77 ---~~~~~~F~~~D~d~~G~i~~~el~~~l~~--~g~~~~~~~~~~~~~~~d-d~dg~i~~~eF~~~~~~~~~~~~~  147 (173)
T 1alv_A           77 ---KKWQAIYKQFDVDRSGTIGSSELPGAFEA--AGFHLNEHLYSMIIRRYS-DEGGNMDFDNFISCLVRLDAMFRA  147 (173)
T ss_dssp             ---HHHHHHHHHHCTTCCSSBCTTTHHHHHHH--HTCCCCHHHHHHHHHHHT-CSSSCBCHHHHHHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHHHCCCCCCCCCHHHHHHHHHH--cCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHHHHHHHHHHH
Confidence               47899999999999999999999999999  567889999999999999 999999999999988765444333

>2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5

Probab=99.82  E-value=4e-20  Score=163.39  Aligned_cols=141  Identities=14%  Similarity=0.259  Sum_probs=124.4

Q ss_pred             CchhHHHhhhhhhhcc-CCCCCCcccHHHHHHHHHhcC----CCCCHHHHHHH-----------HHHhcCCCCCcccchH
Q 040917          333 LPTEEIQKLKEKFTEM-DTDNSGTLTYDELKAGLAKLG----SMLTEFDVKQY-----------MQAADIDGNGTIDYIE  396 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~-D~~~~g~i~~~el~~~l~~~~----~~~~~~~~~~~-----------~~~~D~~~~g~i~~~e  396 (494)
                      ++.++.+++..+|..+ |.|++|+|+.+||..++..++    ..++..++..+           |..+|.|++|.|+++|
T Consensus         2 ls~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~f~~~D~d~dG~I~~~E   81 (185)
T 2sas_A            2 LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEE   81 (185)
T ss_dssp             CCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHH
T ss_pred             cCHHHHHHHHHHHHHheeCCCCCeEcHHHHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCCeEcHHH
Confidence            4678889999999999 999999999999999999987    78888887755           9999999999999999


Q ss_pred             HHHHHHHhhhh---------hHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCcee
Q 040917          397 FITATMQRHKL---------QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRIS  467 (494)
Q Consensus       397 f~~~~~~~~~~---------~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~  467 (494)
                      |+..+......         .....+..+|+.+|.|++|+|+.+||..++..+|    +++++++.+|..+|.|+||.|+
T Consensus        82 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~g----~~~~~~~~~~~~~D~d~dG~i~  157 (185)
T 2sas_A           82 YLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ----LQCADVPAVYNVITDGGKVTFD  157 (185)
T ss_dssp             HHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC----CCCSSHHHHHHHHHTTTTSCCS
T ss_pred             HHHHHHHHhccccchhhhhHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhC----CCHHHHHHHHHHhcCCCCCcCc
Confidence            99887664321         2446789999999999999999999999998854    4667899999999999999999


Q ss_pred             HHHHHHHHhc
Q 040917          468 YDEFRSMMKC  477 (494)
Q Consensus       468 ~~ef~~~~~~  477 (494)
                      ++||+.++..
T Consensus       158 ~~ef~~~~~~  167 (185)
T 2sas_A          158 LNRYKELYYR  167 (185)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999998875

>3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A

Probab=99.82  E-value=7.1e-20  Score=180.34  Aligned_cols=144  Identities=38%  Similarity=0.656  Sum_probs=129.9

Q ss_pred             cCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-hhHH
Q 040917          332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-LQRF  410 (494)
Q Consensus       332 ~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~~~~  410 (494)
                      .++.+++++++++|+.+|.|++|.|+.+||..+++.++..++.+++..+|+.+|.|++|.|+|+||+..+..... ....
T Consensus       305 ~ls~eei~el~~~F~~fD~D~dG~Is~~EL~~~L~~lg~~~s~eel~~Lf~~~D~DgdG~IsfeEFl~ll~~~~~~~~~~  384 (450)
T 3sg6_A          305 QLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSE  384 (450)
T ss_dssp             CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTSSSSEEHHHHHHHHHC------CH
T ss_pred             cCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhccCCCCcccHHHHHHHHHhhccccchh
Confidence            457788899999999999999999999999999999999999999999999999999999999999998875432 3345


Q ss_pred             HHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +.++.+|+.+|.|++|+|+.+||+.+|..  .+..+++++++.++..+|.|+||.|+|+||+.+|..
T Consensus       385 e~l~~aFk~fD~D~dG~Is~eELr~~L~~--lG~~ls~eei~~Lf~~~D~D~DG~IsfdEFv~~L~~  449 (450)
T 3sg6_A          385 EEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTA  449 (450)
T ss_dssp             HHHHHHHHHHCTTCSSEECHHHHHHHHHH--HTCCCCHHHHHHHHHHHCTTSSSSEEHHHHHHHHC-
T ss_pred             hHHHHHHHHhCCCCCCeEeHHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHhc
Confidence            67899999999999999999999999999  567899999999999999999999999999998863

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.82  E-value=6e-20  Score=171.44  Aligned_cols=141  Identities=14%  Similarity=0.115  Sum_probs=107.8

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcE--EEEEEeccCCCCC---------------------hhhHHHHHHHHHHHHHc
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLE--FACKSIPKRKLVK---------------------DVEKDDVRREIEIMRHL   90 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~--valK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l   90 (494)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||+|++.......                     ......+.+|+.++.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            488999999999999999998778999  9999975432110                     01124678899999999


Q ss_pred             cCCCCc--cEEeEEEEeCCeEEEEEeccCC-C----chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCC
Q 040917           91 SGQPNI--VQFKAAYEDDQFVHIVMELCAG-G----ELFDRIVARGHYSERAAASVFRVIMNVVNVCH-SKGVMHRDLKP  162 (494)
Q Consensus        91 ~~hp~i--~~~~~~~~~~~~~~iv~e~~~g-~----sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~i~H~dikp  162 (494)
                      . |+++  +.+++.    ...++||||+.+ |    +|.+....   .++..+..++.|++.+|.||| ++||+||||||
T Consensus       128 ~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          128 K-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             H-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             H-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            6 7654  334432    245799999942 3    66655422   234567889999999999999 99999999999


Q ss_pred             CceEEeeCCCCCeEEEeecCCcccc
Q 040917          163 ENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       163 ~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .|||+   +.  .++|+|||+|...
T Consensus       200 ~NILl---~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMY---ID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEE---SS--SEEECCCTTCEET
T ss_pred             HHEEE---cC--cEEEEECcccccC
Confidence            99999   34  8999999999754

>2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A

Probab=99.82  E-value=1.6e-19  Score=165.24  Aligned_cols=153  Identities=22%  Similarity=0.338  Sum_probs=128.7

Q ss_pred             ccCchhHHHhhhhhhhccCCC--CCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh-hh
Q 040917          331 ENLPTEEIQKLKEKFTEMDTD--NSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH-KL  407 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~--~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~-~~  407 (494)
                      ..++.++++++.+.|..+|.|  ++|.|+.+||..++.. ........+.++|..+|.|++|.|+|+||+..+.... ..
T Consensus        40 ~~ls~~ei~~l~~~F~~~D~d~~~~G~I~~~El~~~l~~-~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~  118 (226)
T 2zfd_A           40 TVFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFK-TNKKESLFADRVFDLFDTKHNGILGFEEFARALSVFHPNA  118 (226)
T ss_dssp             SSCCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHHS-CSSCCCHHHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTS
T ss_pred             CCCCHHHHHHHHHHHHHhCcccCCCCeEcHHHHHHHHhc-cCcccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHccCC
Confidence            467899999999999999999  9999999999999987 3233345678899999999999999999999887654 23


Q ss_pred             hHHHHHHHhccccccCCCCceeHHHHHHHHhhc--CCCCCCcHHHHHHHH----HHhCCCCCCceeHHHHHHHHhccccc
Q 040917          408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDY--GMGDDATIATIKEIM----SEVDRDKDGRISYDEFRSMMKCGTQL  481 (494)
Q Consensus       408 ~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~--~~~~~~~~~~~~~~~----~~~d~~~dg~i~~~ef~~~~~~~~~~  481 (494)
                      ...+.++.+|+.+|.|++|+|+.+||..++..+  ..|..++++++++++    ..+|.|+||.|+|+||..++...+.+
T Consensus       119 ~~~~~l~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~EF~~~~~~~~~~  198 (226)
T 2zfd_A          119 PIDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKIDKEEWRSLVLRHPSL  198 (226)
T ss_dssp             CHHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEECHHHHHHHHHHSGGG
T ss_pred             CHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhChHH
Confidence            456789999999999999999999999999621  156778888876554    59999999999999999999987765


Q ss_pred             chh
Q 040917          482 RAL  484 (494)
Q Consensus       482 ~~~  484 (494)
                      ...
T Consensus       199 ~~~  201 (226)
T 2zfd_A          199 LKN  201 (226)
T ss_dssp             GGG
T ss_pred             HHH
Confidence            443

>1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A

Probab=99.81  E-value=5.1e-20  Score=161.11  Aligned_cols=137  Identities=22%  Similarity=0.284  Sum_probs=121.0

Q ss_pred             hhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcC----CCCCHHH-H--------HHHHHHhcCCCCCcccchHHHHHH
Q 040917          335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLG----SMLTEFD-V--------KQYMQAADIDGNGTIDYIEFITAT  401 (494)
Q Consensus       335 ~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~----~~~~~~~-~--------~~~~~~~D~~~~g~i~~~ef~~~~  401 (494)
                      .+++++++.+|..+|.|++|+|+.+||..++..++    ..++..+ +        ..+|..+|  ++|.|+|+||+..+
T Consensus         2 ~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~l~~~~D--~~g~i~~~EF~~~~   79 (174)
T 1q80_A            2 DLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVA--GGKGIDETTFINSM   79 (174)
T ss_dssp             HHHHHHHHHHHHHHCTTCSSEESHHHHHHHHHHHHHHSSCCTTHHHHHHHHHHHHHHHTGGGTT--TTSCEEHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCCCcEeHHHHHHHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHhcC--CCCeEcHHHHHHHH
Confidence            56788999999999999999999999999999987    8888877 6        35788888  89999999999988


Q ss_pred             HHhhh-----hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          402 MQRHK-----LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       402 ~~~~~-----~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      .....     ......++.+|+.+|.|++|+|+.+||+.++..+|    +++++++.++..+|.|+||.|+|+||..++.
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g----~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~  155 (174)
T 1q80_A           80 KEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLG----LDKTMAPASFDAIDTNNDGLLSLEEFVIAGS  155 (174)
T ss_dssp             HHHTTSTTCHHHHHTHHHHHHHHHCTTSSSSBCHHHHHHHHHHHT----CCGGGHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred             HHHcCcccHHHHHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHcC----CCHHHHHHHHHHhCCCCCceEeHHHHHHHHH
Confidence            76543     23456789999999999999999999999999853    5778899999999999999999999999886


Q ss_pred             c
Q 040917          477 C  477 (494)
Q Consensus       477 ~  477 (494)
                      .
T Consensus       156 ~  156 (174)
T 1q80_A          156 D  156 (174)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens}

Probab=99.81  E-value=1.1e-19  Score=158.57  Aligned_cols=129  Identities=16%  Similarity=0.193  Sum_probs=113.1

Q ss_pred             hccCCCCCCcccHHHHHHHHHhc------CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccc
Q 040917          346 TEMDTDNSGTLTYDELKAGLAKL------GSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQY  419 (494)
Q Consensus       346 ~~~D~~~~g~i~~~el~~~l~~~------~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~  419 (494)
                      +.-+.|++|+|+.+||+.+|+.+      |..++.+++..++..+|.|++|.|+|+||+..+...      ..++.+|+.
T Consensus        11 ~~~~~~~dG~I~~~EL~~~l~~l~~~~~~g~~~~~~~~~~l~~~~D~d~~G~I~f~EF~~~~~~~------~~l~~aF~~   84 (174)
T 2i7a_A           11 SSGLVPRGSDIDATQLQGLLNQELLTGPPGDMFSLDECRSLVALMELKVNGRLDQEEFARLWKRL------VHYQHVFQK   84 (174)
T ss_dssp             -CCSCC-CCCEEHHHHHHHHHHHHC-----CCCCHHHHHHHHHHHCSSCSSEECHHHHHHHHHHH------HHHHHHHHH
T ss_pred             ccccCCCCCcCCHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHH------HHHHHHHHH
Confidence            34578999999999999999998      668889999999999999999999999999877643      478999999


Q ss_pred             cccCCCCceeHHHHHHHHhhcCC----CCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccccchh
Q 040917          420 FDKDNNGYITVDELGKAFKDYGM----GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRAL  484 (494)
Q Consensus       420 ~D~d~~G~I~~~el~~~l~~~~~----~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~~~  484 (494)
                      || |++|+|+.+||+.+|..  +    |..+++++++.++..+| |+||.|+|+||+.++.....+..+
T Consensus        85 fD-d~~G~I~~~El~~~l~~--l~~~~G~~~~~~~~~~l~~~~d-d~dG~I~~~EF~~~~~~~~~~~~~  149 (174)
T 2i7a_A           85 VQ-TSPGVLLSSDLWKAIEN--TDFLRGIFISRELLHLVTLRYS-DSVGRVSFPSLVCFLMRLEAMAKT  149 (174)
T ss_dssp             HC-SBTTBEEGGGHHHHHHT--CGGGTTCCCCHHHHHHHHHHHS-CTTSEECHHHHHHHHHHHHHHHHH
T ss_pred             hc-CCCCcCCHHHHHHHHHH--hHhccCCCCCHHHHHHHHHHHc-CCCCeEcHHHHHHHHHHHHHHHHH
Confidence            99 99999999999999998  5    77889999999999999 999999999999998865444433

>2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei}

Probab=99.81  E-value=3.6e-20  Score=169.42  Aligned_cols=149  Identities=21%  Similarity=0.323  Sum_probs=123.9

Q ss_pred             hhccCchhHHHhhhhhhhccCCCCCCcccHHHHHH-HHHhcCCCCCHHHHHHHHHHh---------cCCCCCcccchHHH
Q 040917          329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKA-GLAKLGSMLTEFDVKQYMQAA---------DIDGNGTIDYIEFI  398 (494)
Q Consensus       329 ~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~-~l~~~~~~~~~~~~~~~~~~~---------D~~~~g~i~~~ef~  398 (494)
                      +...++.+++.+++++|..+|.|++|+|+.+||.. +++.+|..++..++..++..+         |.|++|.|+|+||+
T Consensus        41 l~~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~lg~~~~~~~~~~~~~~~f~~~~~~~~D~d~~G~I~~~EF~  120 (226)
T 2lvv_A           41 IPRDKDAESKSRRIELFKQFDTNGTGKLGFREVLDGCYGILKLDEFTTHLPDIVQRAFDKAKDLGNKVKGVGEEDLVEFL  120 (226)
T ss_dssp             SCSSCCHHHHHHHHHHHHHHGGGSCSCBCSHHHHHHHHHTTCCTTTSSSCHHHHHHHHHHHHHHHHHHSCCCCCSCBCHH
T ss_pred             hchhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhcccCCCCCCCCcCCHHHHH
Confidence            44567899999999999999999999999999998 556678777766666666666         99999999999999


Q ss_pred             HHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCC-CCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          399 TATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM-GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       399 ~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~-~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ..+...........+..+|+.||.|++|+|+.+||+.+|..++. +...  ++++.+|..+|.|+||.|+|+||+.+|..
T Consensus       121 ~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~g~~~--~e~~~~~~~~D~d~dG~Is~~EF~~~~~~  198 (226)
T 2lvv_A          121 EFRLMLCYIYDIFELTVMFDTMDKDGSLLLELQEFKEALPKLKEWGVDI--TDATTVFNEIDTNGSGVVTFDEFSCWAVT  198 (226)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHSCSSCCEECHHHHHHHHHHHHHHTCCC--CSCHHHHHHHCCSCSSCEEHHHHHHHHHH
T ss_pred             HHHHHHHhccCHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHHhhcCCCH--HHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence            96544444445568999999999999999999999999987410 2223  35899999999999999999999999986


Q ss_pred             cc
Q 040917          478 GT  479 (494)
Q Consensus       478 ~~  479 (494)
                      ..
T Consensus       199 ~~  200 (226)
T 2lvv_A          199 KK  200 (226)
T ss_dssp             HH
T ss_pred             cC
Confidence            43

>1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A

Probab=99.81  E-value=7.5e-20  Score=163.78  Aligned_cols=141  Identities=21%  Similarity=0.301  Sum_probs=126.3

Q ss_pred             CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCC-----CCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhh
Q 040917          333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGS-----MLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKL  407 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~-----~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~  407 (494)
                      .++.+++++++ |..+|.|++|+|+.+||..+++.+|.     .++.+++..+|..+|.|++|.|+|+||+..+...   
T Consensus        27 ~~~~~~~~l~~-F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~eF~~~~~~~---  102 (198)
T 1juo_A           27 FPGQTQDPLYG-YFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVL---  102 (198)
T ss_dssp             CTTCCCCTTHH-HHHHHHTTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH---
T ss_pred             CCccccHHHHH-HHHHhCCCCCcCCHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhCCCCCCeECHHHHHHHHHHH---
Confidence            45667888999 99999999999999999999999886     6789999999999999999999999999887643   


Q ss_pred             hHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccccchh
Q 040917          408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRAL  484 (494)
Q Consensus       408 ~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~~~  484 (494)
                         ..++.+|+.+|.|++|+|+.+||+.++..  +|..+++++++.++..+  |+||.|+|+||+.++.....+..+
T Consensus       103 ---~~~~~~F~~~D~d~~G~I~~~el~~~l~~--~g~~~~~~~~~~l~~~~--d~dg~i~~~eF~~~~~~~~~~~~~  172 (198)
T 1juo_A          103 ---NGWRQHFISFDTDRSGTVDPQELQKALTT--MGFRLSPQAVNSIAKRY--STNGKITFDDYIACCVKLRALTDS  172 (198)
T ss_dssp             ---HHHHHHHHTTCTTCCSEECHHHHHHHHHH--TTCCCCHHHHHHHHHHT--CSSSSEEHHHHHHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHHhCCCCCCcCCHHHHHHHHHH--hCCCCCHHHHHHHHHHh--CCCCeEcHHHHHHHHHHHHHHHHH
Confidence               47899999999999999999999999999  66788999999999999  899999999999988765444443

>1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5

Probab=99.81  E-value=4.6e-19  Score=161.74  Aligned_cols=153  Identities=22%  Similarity=0.322  Sum_probs=130.0

Q ss_pred             ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCC-CCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhH
Q 040917          331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM-LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQR  409 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~  409 (494)
                      ..++.++++.+.+.|...  +++|.|+.+||..++..++.. .+..++..+|+.+|.|++|.|+|+||+..+........
T Consensus        46 ~~~s~~ei~~l~~~Fd~~--d~~G~I~~~E~~~~l~~l~~~~~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~l~~~~~~~~  123 (224)
T 1s1e_A           46 TNFTKRELQVLYRGFKNE--CPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTV  123 (224)
T ss_dssp             SSCCHHHHHHHHHHHHHH--CTTSCBCHHHHHHHHHTTCTTSCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHCCH
T ss_pred             cCCCHHHHHHHHHHHHhh--CCCCCCCHHHHHHHHHHhcCCCCcHHHHHHHHHHhcCCCCCcEeHHHHHHHHHHHccCCH
Confidence            347888888877777654  489999999999999998754 68889999999999999999999999998887655566


Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhhc----C------CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKDY----G------MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~----~------~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      .+.++.+|+.+|.|++|+|+.+||..++..+    |      +....++++++++|..+|.|+||.|+++||..++...+
T Consensus       124 ~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~~~~~  203 (224)
T 1s1e_A          124 HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQEDD  203 (224)
T ss_dssp             HHHHHHHHHHHCTTCCSEECHHHHHHHHHHHHHHHTTCCCGGGCSSSHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHTCH
T ss_pred             HHHHHHHHHHHcCCCCCeECHHHHHHHHHHHHHHhcccCCCCCCHhHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhCH
Confidence            7789999999999999999999999999874    3      22233458899999999999999999999999999877


Q ss_pred             ccchhh
Q 040917          480 QLRALS  485 (494)
Q Consensus       480 ~~~~~~  485 (494)
                      .+....
T Consensus       204 ~l~~~l  209 (224)
T 1s1e_A          204 NIMRSL  209 (224)
T ss_dssp             HHHHHH
T ss_pred             HHHHHh
Confidence            654443

>3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A

Probab=99.81  E-value=1.6e-19  Score=165.34  Aligned_cols=152  Identities=22%  Similarity=0.321  Sum_probs=128.5

Q ss_pred             cCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhc-CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHH
Q 040917          332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL-GSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRF  410 (494)
Q Consensus       332 ~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~-~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~  410 (494)
                      .++.++++.+.+.|..  .+++|.|+.+||..++..+ +...+...+..+|..+|.|++|.|+|+||+..+.........
T Consensus        60 ~~s~~ei~~l~~~F~~--~d~~G~Is~~ef~~~l~~~~~~~~~~~~~~~lf~~~D~d~~G~I~~~Ef~~~l~~~~~~~~~  137 (229)
T 3dd4_A           60 KFTKKELQILYRGFKN--ECPSGVVNEETFKEIYSQFFPQGDSTTYAHFLFNAFDTDHNGAVSFEDFIKGLSILLRGTVQ  137 (229)
T ss_dssp             HHHHHHHHHHHHHHHT--TCCSCCCCHHHHHHHHHHHSCSSSHHHHHHHHHHTTCSSCCSSCCHHHHHHHHHHHHHSCHH
T ss_pred             CCCHHHHHHHHHHHHh--hCCCCCcCHHHHHHHHHHHCCCCCcHHHHHHHHHHcCCCCCCeEeHHHHHHHHHHHcCCChH
Confidence            3577888999999866  5788999999999999985 455566778899999999999999999999998876666667


Q ss_pred             HHHHHhccccccCCCCceeHHHHHHHHhhcC----------CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccc
Q 040917          411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYG----------MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ  480 (494)
Q Consensus       411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~----------~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~  480 (494)
                      +.++.+|+.||.|++|+|+.+||..++..++          .+...++++++.+|..+|.|+||.|+|+||...+...+.
T Consensus       138 ~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~~~~~~  217 (229)
T 3dd4_A          138 EKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDKNKDGVVTIDEFIESCQKDEN  217 (229)
T ss_dssp             HHHHHHHHHHCTTCSSCCBHHHHHHHHHHHHHHCC-----------CCTHHHHHHHHHCSSCSSBCCHHHHHHHHHTCHH
T ss_pred             HHHHHHHHHhCCCCCCeECHHHHHHHHHHHHHHhccccCCCcchhhHHHHHHHHHHHhcCCCCCcEeHHHHHHHHHhCHH
Confidence            8899999999999999999999999998731          145677789999999999999999999999999998776


Q ss_pred             cchhh
Q 040917          481 LRALS  485 (494)
Q Consensus       481 ~~~~~  485 (494)
                      +..+.
T Consensus       218 ~~~~~  222 (229)
T 3dd4_A          218 IMRSM  222 (229)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            65543

>1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A

Probab=99.81  E-value=7.3e-20  Score=152.48  Aligned_cols=129  Identities=27%  Similarity=0.410  Sum_probs=114.0

Q ss_pred             hhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHH---HhhhhhHHHHHHHhc
Q 040917          341 LKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATM---QRHKLQRFENLYKAF  417 (494)
Q Consensus       341 ~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~---~~~~~~~~~~~~~~F  417 (494)
                      +.++|..+|.+++|+|+.+||..++..++..++.+++..+|+.+|.+++|.|+++||+..+.   ..........+..+|
T Consensus         2 l~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~f   81 (134)
T 1jfj_A            2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIGLKVLY   81 (134)
T ss_dssp             HHHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHHHHHHH
T ss_pred             HHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhcccccCCCHHHHHHHH
Confidence            57889999999999999999999999999888999999999999999999999999998874   222223445699999


Q ss_pred             cccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHH
Q 040917          418 QYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMM  475 (494)
Q Consensus       418 ~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~  475 (494)
                      +.+|.|++|+|+.+||..++..  .+...    ++.++..+|.|+||.|+|+||..++
T Consensus        82 ~~~D~d~~G~i~~~e~~~~l~~--~~~~~----~~~~~~~~D~~~dg~i~~~ef~~~l  133 (134)
T 1jfj_A           82 KLMDVDGDGKLTKEEVTSFFKK--HGIEK----VAEQVMKADANGDGYITLEEFLEFS  133 (134)
T ss_dssp             HHHCCSSSSEEEHHHHHHHHTT--TTCHH----HHHHHHHHHCSSSSEEEHHHHHHHH
T ss_pred             HHHCCCCCCccCHHHHHHHHHH--hCHHH----HHHHHHHhCCCCCCcEeHHHHHHHh
Confidence            9999999999999999999998  44322    8999999999999999999999876

>2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A

Probab=99.81  E-value=1.2e-19  Score=153.99  Aligned_cols=135  Identities=19%  Similarity=0.271  Sum_probs=122.2

Q ss_pred             chhHHHhhhhhhhccCCCC-CCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh-hhhHHH
Q 040917          334 PTEEIQKLKEKFTEMDTDN-SGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH-KLQRFE  411 (494)
Q Consensus       334 ~~~~~~~~~~~F~~~D~~~-~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~-~~~~~~  411 (494)
                      ..+++.+++.+|..+|.|+ +|+|+..||..+++.+|..++..++..++..+|.+    |+|+||+..+.... ......
T Consensus         9 ~~~~~~~l~~~F~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~----i~~~eF~~~~~~~~~~~~~~~   84 (146)
T 2qac_A            9 QLEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGLAPSSIDEKKIKELYGDN----LTYEQYLEYLSICVHDKDNVE   84 (146)
T ss_dssp             HHHHHSCHHHHHHHHHHHCBTTBEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSE----ECHHHHHHHHHHTCCTTCCHH
T ss_pred             HHHHHHHHHHHHHHhCccCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC----CCHHHHHHHHHHHhcCcchHH
Confidence            3466778999999999999 99999999999999999999999999999999877    99999999887643 233466


Q ss_pred             HHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          412 NLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       412 ~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      .+..+|+.+|.|++|+|+.+||+.++..  +|..+++++++.++..+  |+||.|+|+||+.+|.
T Consensus        85 ~l~~~F~~~D~d~~G~I~~~el~~~l~~--~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~l~  145 (146)
T 2qac_A           85 ELIKMFAHFDNNCTGYLTKSQMKNILTT--WGDALTDQEAIDALNAF--SSEDNIDYKLFCEDIL  145 (146)
T ss_dssp             HHHHHHHTTCTTCSSEEEHHHHHHHHHH--SSSCCCHHHHHHHHHHH--CSSSEEEHHHHHHHHT
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHH--hCCCCCHHHHHHHHHHc--CCCCcCcHHHHHHHHh
Confidence            7999999999999999999999999999  67789999999999999  9999999999999875

>2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A

Probab=99.81  E-value=3.9e-19  Score=160.31  Aligned_cols=152  Identities=21%  Similarity=0.359  Sum_probs=127.6

Q ss_pred             ccCchhHHHhhhhhhhccCCC--CCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-h
Q 040917          331 ENLPTEEIQKLKEKFTEMDTD--NSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-L  407 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~--~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~  407 (494)
                      ..++.++++++.+.|..+|.|  ++|.|+.+||..++.. ........+.++|..+|.|++|.|+|+||+..+..... .
T Consensus        29 ~~~s~~~~~~l~~~F~~~D~d~~~~G~i~~~e~~~~l~~-~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~  107 (207)
T 2ehb_A           29 TPFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQLALFR-NRNRRNLFADRIFDVFDVKRNGVIEFGEFVRSLGVFHPSA  107 (207)
T ss_dssp             SSCCHHHHHHHHHHHHHHTTSSSCSSCEEHHHHHHHHHS-CTTCCCHHHHHHHHHHCTTCSSEECHHHHHHHHGGGSTTS
T ss_pred             CCCCHHHHHHHHHHHHHhccccCCCCccCHHHHHHHHhc-cccccHHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHccCC
Confidence            467899999999999999999  9999999999999987 32334456788999999999999999999998876542 3


Q ss_pred             hHHHHHHHhccccccCCCCceeHHHHHHHHhhc--CCCCCCcHHHHHHH----HHHhCCCCCCceeHHHHHHHHhccccc
Q 040917          408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDY--GMGDDATIATIKEI----MSEVDRDKDGRISYDEFRSMMKCGTQL  481 (494)
Q Consensus       408 ~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~--~~~~~~~~~~~~~~----~~~~d~~~dg~i~~~ef~~~~~~~~~~  481 (494)
                      ...+.+..+|+.+|.|++|+|+.+||..++..+  ..|..+++++++.+    |..+|.|+||.|+|+||..++...+.+
T Consensus       108 ~~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~  187 (207)
T 2ehb_A          108 PVHEKVKFAFKLYDLRQTGFIEREELKEMVVALLHESELVLSEDMIEVMVDKAFVQADRKNDGKIDIDEWKDFVSLNPSL  187 (207)
T ss_dssp             CHHHHHHHHHHHHCTTCCSSEEHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHCGGG
T ss_pred             CHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHcccccCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhChHH
Confidence            456779999999999999999999999999631  13567788777555    469999999999999999999987754


Q ss_pred             ch
Q 040917          482 RA  483 (494)
Q Consensus       482 ~~  483 (494)
                      ..
T Consensus       188 ~~  189 (207)
T 2ehb_A          188 IK  189 (207)
T ss_dssp             GG
T ss_pred             HH
Confidence            43

>1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A*

Probab=99.81  E-value=6.4e-20  Score=162.05  Aligned_cols=149  Identities=17%  Similarity=0.275  Sum_probs=127.5

Q ss_pred             ccCchhHHHhhhhhhhccCC-----CC-C--CcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCc-ccchHHHHHH
Q 040917          331 ENLPTEEIQKLKEKFTEMDT-----DN-S--GTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGT-IDYIEFITAT  401 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~-----~~-~--g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~-i~~~ef~~~~  401 (494)
                      ..++.+++..+.+.|..+|.     |+ +  |+|+.+||.. +..+|..++..   +++..+|.|++|. |+|+||+..+
T Consensus        12 ~~ls~~~~~~l~~~F~~~D~~~~~~~~~~~~G~i~~~el~~-l~~~g~~~~~~---~l~~~~D~d~~G~~I~~~EF~~~~   87 (183)
T 1dgu_A           12 TFLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILS-LPELKANPFKE---RICRVFSTSPAKDSLSFEDFLDLL   87 (183)
T ss_dssp             CSCCHHHHHHHHHHHHHHSCSTTCSSCCCTTTCSCHHHHHT-STTSSSCTTHH---HHHHHHSCSSSSCCCCHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHHHHhCccccccccccccCcCcHHHHHH-HHhhhcCcHHH---HHHHHhCCCCCCCEecHHHHHHHH
Confidence            45788999999999999999     68 8  9999999999 98888887754   5788899999999 9999999988


Q ss_pred             HHhhhh-hHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCC---CCCcHHHHHH----HHHHhCCCCCCceeHHHHHH
Q 040917          402 MQRHKL-QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMG---DDATIATIKE----IMSEVDRDKDGRISYDEFRS  473 (494)
Q Consensus       402 ~~~~~~-~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~---~~~~~~~~~~----~~~~~d~~~dg~i~~~ef~~  473 (494)
                      ...... .....++.+|+.||.|++|+|+.+||+.++..++..   ..+++++++.    ++..+|.|+||.|+|+||..
T Consensus        88 ~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~  167 (183)
T 1dgu_A           88 SVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQH  167 (183)
T ss_dssp             HHHSTTCCHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHSSSCCCHHHHHHHHHHHHHHHHHHCTTSSSEEEHHHHHH
T ss_pred             HHhcCCCCHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhcccccCCCCHHHHHHHHHHHHHHhCCCCCCeEcHHHHHH
Confidence            765433 345689999999999999999999999999984320   2578888875    99999999999999999999


Q ss_pred             HHhcccccch
Q 040917          474 MMKCGTQLRA  483 (494)
Q Consensus       474 ~~~~~~~~~~  483 (494)
                      ++...+.+..
T Consensus       168 ~~~~~~~~~~  177 (183)
T 1dgu_A          168 VISRSPDFAS  177 (183)
T ss_dssp             HHCSSCHHHH
T ss_pred             HHHhChHHHH
Confidence            9998765443

>1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8

Probab=99.80  E-value=3.3e-19  Score=154.96  Aligned_cols=133  Identities=22%  Similarity=0.277  Sum_probs=118.8

Q ss_pred             hhhhhccCCCCCCcccHHHHHHHHHhcCC-----CCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHh
Q 040917          342 KEKFTEMDTDNSGTLTYDELKAGLAKLGS-----MLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKA  416 (494)
Q Consensus       342 ~~~F~~~D~~~~g~i~~~el~~~l~~~~~-----~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~  416 (494)
                      .+.|..+|.|++|+|+.+||..+++.+|.     .++..++..+|..+|.|++|.|+|+||+..+...      ..++.+
T Consensus         4 ~~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~------~~~~~~   77 (167)
T 1gjy_A            4 LYGYFASVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVL------NGWRQH   77 (167)
T ss_dssp             THHHHHHHCCTTSCBCHHHHHHHHHHHTCSTTSCCCCHHHHHHHHHHHCTTCCSCBCHHHHHHHHHHH------HHHHHH
T ss_pred             HHHHHHHHcCCCCcCCHHHHHHHHHhhcccCCCCCcCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHH------HHHHHH
Confidence            34588999999999999999999999886     6789999999999999999999999999887643      478999


Q ss_pred             ccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccccchh
Q 040917          417 FQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRAL  484 (494)
Q Consensus       417 F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~~~  484 (494)
                      |+.+|.|++|+|+.+||+.++..  +|..+++++++.++..+  |++|.|+|+||..++.....+..+
T Consensus        78 F~~~D~d~~G~i~~~el~~~l~~--~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~~~~~~~~~~~  141 (167)
T 1gjy_A           78 FISFDSDRSGTVDPQELQKALTT--MGFRLNPQTVNSIAKRY--STSGKITFDDYIACCVKLRALTDS  141 (167)
T ss_dssp             HHHHCTTCCSEECHHHHHHHHHT--TTCCCCHHHHHHHHHHT--CBTTBEEHHHHHHHHHHHHHHHHH
T ss_pred             HHHhCCCCCCcCCHHHHHHHHHH--cCCCCCHHHHHHHHHHh--CcCCcCcHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999998  66788999999999999  899999999999988765444433

>2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens}

Probab=99.80  E-value=4.8e-20  Score=166.79  Aligned_cols=148  Identities=23%  Similarity=0.307  Sum_probs=123.6

Q ss_pred             HhhhhhhhccCCC-CCCcccHHHHHHHHHhcCCCCCH-HHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHh
Q 040917          339 QKLKEKFTEMDTD-NSGTLTYDELKAGLAKLGSMLTE-FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKA  416 (494)
Q Consensus       339 ~~~~~~F~~~D~~-~~g~i~~~el~~~l~~~~~~~~~-~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~  416 (494)
                      +++..+|+.+|.+ ++|+|+.+||..+++.++..+.. +++..+|..+|.|++|.|+|+||+..+.........+.+..+
T Consensus        19 ~ei~~~f~~fD~~~~~G~is~~El~~~l~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~l~~~   98 (211)
T 2ggz_A           19 QETHVWYRTFMMEYPSGLQTLHEFKTLLGLQGLNQKANKHIDQVYNTFDTNKDGFVDFLEFIAAVNLIMQEKMEQKLKWY   98 (211)
T ss_dssp             -----CCCSHHHHCTTSEEEHHHHHHHTTCCSCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHSCSSHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCcchHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhccCchHHHHHHH
Confidence            3457788899988 89999999999999998876544 458999999999999999999999988876555567789999


Q ss_pred             ccccccCCCCceeHHHHHHHHhhcC-CC--CCCcH-HHHHHHHHHhCCCCCCceeHHHHHHHHhcccccchhhh
Q 040917          417 FQYFDKDNNGYITVDELGKAFKDYG-MG--DDATI-ATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRALSS  486 (494)
Q Consensus       417 F~~~D~d~~G~I~~~el~~~l~~~~-~~--~~~~~-~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~~~~~  486 (494)
                      |+.+|.|++|+|+.+||..++..++ .+  ...+. +.++.+|..+|.|+||.|+|+||+.++...+.+..+..
T Consensus        99 F~~~D~d~~G~I~~~E~~~~l~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~  172 (211)
T 2ggz_A           99 FKLYDADGNGSIDKNELLDMFMAVQALNGQQTLSPEEFINLVFHKIDINNDGELTLEEFINGMAKDQDLLEIVY  172 (211)
T ss_dssp             HHHHCTTCSSSBCHHHHHHHHHHHTTSSCCCSCTHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHTTTTTHHHHH
T ss_pred             HHHhcCCCCCcCcHHHHHHHHHHHHhhcCCccccHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHhCHHHHHHHh
Confidence            9999999999999999999998842 11  34444 45899999999999999999999999998887777665

>3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group}

Probab=99.80  E-value=2e-19  Score=157.98  Aligned_cols=140  Identities=14%  Similarity=0.147  Sum_probs=117.9

Q ss_pred             chhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhc---CCCCCcccchHHHHHHHHhhhhhHH
Q 040917          334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAAD---IDGNGTIDYIEFITATMQRHKLQRF  410 (494)
Q Consensus       334 ~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D---~~~~g~i~~~ef~~~~~~~~~~~~~  410 (494)
                      +..++.++++.|..+|  ++|+|+.+||..++   |..++...+..+|..+|   .+++|.|+++||+..+.........
T Consensus        23 ~~~~~~~~~~~F~~~D--~dG~I~~~el~~~l---g~~~~~~~~~~i~~~~d~~~~~~~~~i~~~ef~~~~~~~~~~~~~   97 (179)
T 3a8r_A           23 GNDGWAAVEKRFNQLQ--VDGVLLRSRFGKCI---GMDGSDEFAVQMFDSLARKRGIVKQVLTKDELKDFYEQLTDQGFD   97 (179)
T ss_dssp             CCCCHHHHHHHHHHHC--BTTBEEGGGHHHHH---TCCSCHHHHHHHHHHHHHHHTCCSSEECHHHHHHHHHHHHCCCHH
T ss_pred             chhhHHHHHHHHhccC--CCCCCcHHHHHHHH---CCCCcHHHHHHHHHHHHHhccCCCCCcCHHHHHHHHHHHcCCCHH
Confidence            4467788999999999  89999999999965   67778888889999887   5678899999999887654434456


Q ss_pred             HHHHHhccccccCCCCceeHHHHHHHHh-hcCCCCC-C------cHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccc
Q 040917          411 ENLYKAFQYFDKDNNGYITVDELGKAFK-DYGMGDD-A------TIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ  480 (494)
Q Consensus       411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~-~~~~~~~-~------~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~  480 (494)
                      +.++.+|+.||.|++|+|+.+||+.+|. .  +|.. +      ++++++.++..+|.|+||.|+|+||..++...+.
T Consensus        98 ~~l~~~F~~~D~d~dG~Is~~El~~~l~~~--~g~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~p~  173 (179)
T 3a8r_A           98 NRLRTFFDMVDKNADGRLTAEEVKEIIALS--ASANKLSKIKERADEYTALIMEELDPTNLGYIEMEDLEALLLQSPS  173 (179)
T ss_dssp             HHHHHHHHHHCTTCSSCBCHHHHHHHHHHH--HHTTHHHHHHHHHHHHHHHHHHHHSTTCCSEECHHHHHHHHC----
T ss_pred             HHHHHHHHHHCCCCCCcCCHHHHHHHHHHH--hccccccccccchHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhCcc
Confidence            7899999999999999999999999998 7  4444 4      7889999999999999999999999999987554

>2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus}

Probab=99.80  E-value=1.3e-19  Score=162.12  Aligned_cols=148  Identities=23%  Similarity=0.291  Sum_probs=125.5

Q ss_pred             HhhhhhhhccCCC-CCCcccHHHHHHHHHhcCCCCCH-HHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHh
Q 040917          339 QKLKEKFTEMDTD-NSGTLTYDELKAGLAKLGSMLTE-FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKA  416 (494)
Q Consensus       339 ~~~~~~F~~~D~~-~~g~i~~~el~~~l~~~~~~~~~-~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~  416 (494)
                      +++..+|..+|.+ ++|+|+.+||..+++.++..+.. +++..+|..+|.|++|.|+++||+..+...........+..+
T Consensus        14 ~el~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~   93 (198)
T 2r2i_A           14 TECHQWYKKFMTECPSGQLTLYEFKQFFGLKNLSPSANKYVEQMFETFDFNKDGYIDFMEYVAALSLVLKGKVDQKLRWY   93 (198)
T ss_dssp             SCHHHHHHHHHHHCTTSEECHHHHHHHHTCCSCCHHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHSSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCcchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHccCchHHHHHHH
Confidence            3457778888888 89999999999999998876654 458999999999999999999999988876555567789999


Q ss_pred             ccccccCCCCceeHHHHHHHHhhcCC----CCCCcH-HHHHHHHHHhCCCCCCceeHHHHHHHHhcccccchhhh
Q 040917          417 FQYFDKDNNGYITVDELGKAFKDYGM----GDDATI-ATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRALSS  486 (494)
Q Consensus       417 F~~~D~d~~G~I~~~el~~~l~~~~~----~~~~~~-~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~~~~~  486 (494)
                      |+.+|.|++|+|+.+||..++..++.    ....+. +.++.+|..+|.|+||.|+++||+.++...+.+..+..
T Consensus        94 F~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~  168 (198)
T 2r2i_A           94 FKLYDVDGNGCIDRGELLNIIKAIRAINRCNEAMTAEEFTNMVFDKIDINGDGELSLEEFMEGVQKDEVLLDILT  168 (198)
T ss_dssp             HHHHCTTCSSCEEHHHHHHHHHHTTGGGGSSSCCCHHHHHHHHHHHHCTTCSSEECHHHHHHHHTTCHHHHHHHH
T ss_pred             HHHhcCCCCCcCcHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHcCHHHHHHHh
Confidence            99999999999999999999998420    034454 45899999999999999999999999998776666554

>2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe}

Probab=99.79  E-value=2.9e-19  Score=158.76  Aligned_cols=146  Identities=26%  Similarity=0.361  Sum_probs=124.7

Q ss_pred             hhhhhhhccCCC-CCCcccHHHHHHHHHhcCCC-CCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhc
Q 040917          340 KLKEKFTEMDTD-NSGTLTYDELKAGLAKLGSM-LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAF  417 (494)
Q Consensus       340 ~~~~~F~~~D~~-~~g~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F  417 (494)
                      ++.++|..+|.+ ++|+|+.+||..++..++.. .+..++..+|..+|.|++|.|+++||+..+.........+.+..+|
T Consensus        26 el~~~f~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f  105 (190)
T 2l2e_A           26 ELQQWYKGFFKDCPSGHLNKSEFQKIYKQFFPFGDPSAFAEYVFNVFDADKNGYIDFKEFICALSVTSRGELNDKLIWAF  105 (190)
T ss_dssp             HHHHHHHHHHHHSCCCEECHHHHHHHHHHHCCCSCHHHHHHHHHHHHCSSSTTCEEHHHHHHHHTTSSCSCSHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCCCccHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHH
Confidence            456678888999 89999999999999998644 4566799999999999999999999999887655445667899999


Q ss_pred             cccccCCCCceeHHHHHHHHhhc----C------CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccccchhh
Q 040917          418 QYFDKDNNGYITVDELGKAFKDY----G------MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRALS  485 (494)
Q Consensus       418 ~~~D~d~~G~I~~~el~~~l~~~----~------~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~~~~  485 (494)
                      +.+|.|++|+|+.+||..++..+    |      .+...++++++++|..+|.|+||.|+++||..++...+.+....
T Consensus       106 ~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~l  183 (190)
T 2l2e_A          106 QLYDLDNNGLISYDEMLRIVDAIYKMVGSMVKLPEDEDTPEKRVNKIFNMMDKNKDGQLTLEEFCEGSKRDPTIVSAL  183 (190)
T ss_dssp             HHHCTTSCSCBCHHHHHHHHHHHHHHHHHHSCCCSSCCCTHHHHHHHHHHHTCCSSCCBCHHHHHHHHHTCTHHHHHH
T ss_pred             hHccCCCCCcCcHHHHHHHHHHHHHHhccccCcccccccHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhCcHHHHHH
Confidence            99999999999999999999761    1      23457888999999999999999999999999999887655543

>1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A

Probab=99.79  E-value=2.8e-19  Score=155.07  Aligned_cols=129  Identities=20%  Similarity=0.271  Sum_probs=117.2

Q ss_pred             hhhhccCCCCCCcccHHHHHHHHHhcCC-----CCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhc
Q 040917          343 EKFTEMDTDNSGTLTYDELKAGLAKLGS-----MLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAF  417 (494)
Q Consensus       343 ~~F~~~D~~~~g~i~~~el~~~l~~~~~-----~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F  417 (494)
                      +.|..+|.|++|.|+.+||..+++.+|.     .++..++..++..+|.|++|.|+|+||+..+...      ..++.+|
T Consensus         3 ~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~------~~~~~~F   76 (165)
T 1k94_A            3 YTYFSAVAGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFKELWAAL------NAWKENF   76 (165)
T ss_dssp             HHHHHHHHGGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHH------HHHHHHH
T ss_pred             HHHHHHhCCCCCcCCHHHHHHHHHHhccccCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHH------HHHHHHH
Confidence            4688999999999999999999999986     6789999999999999999999999999877643      4789999


Q ss_pred             cccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccccc
Q 040917          418 QYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQL  481 (494)
Q Consensus       418 ~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~  481 (494)
                      +.+|.|++|+|+.+||+.++..  +|..+++++++.++..+  |++|.|+|+||..++.....+
T Consensus        77 ~~~D~d~~G~i~~~el~~~l~~--~g~~~~~~~~~~~~~~~--d~dg~i~~~eF~~~~~~~~~~  136 (165)
T 1k94_A           77 MTVDQDGSGTVEHHELRQAIGL--MGYRLSPQTLTTIVKRY--SKNGRIFFDDYVACCVKLRAL  136 (165)
T ss_dssp             HHHCTTCCSBCCHHHHHHHHHH--TTCCCCHHHHHHHHHHH--CBTTBCBHHHHHHHHHHHHHH
T ss_pred             HHhCCCCCceECHHHHHHHHHH--hCCCCCHHHHHHHHHHh--CCCCeEcHHHHHHHHHHHHHH
Confidence            9999999999999999999999  66788999999999999  899999999999988765333

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A

Probab=99.79  E-value=2.4e-20  Score=179.22  Aligned_cols=202  Identities=17%  Similarity=0.317  Sum_probs=151.1

Q ss_pred             CCHHHHHHHHHhc---ccCCCCCCCHHHHhcC------CccCccCcCCCCC-----------------------CcHHHH
Q 040917          262 ISSSAIELVRRML---TQDPKRRITVAQVLEH------PWLKESGEASDKP-----------------------IDTAVI  309 (494)
Q Consensus       262 ~~~~l~~li~~~l---~~dp~~Rps~~eil~~------~~~~~~~~~~~~~-----------------------~~~~~~  309 (494)
                      +++.+.+|.+++.   ..+|+.|...++.+.|      +|+...++....+                       .....+
T Consensus        17 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~a~g~~~~e~q~~~~vl   96 (323)
T 1ij5_A           17 VHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLASLL   96 (323)
T ss_dssp             HHHHHHHHHHHHTTCCCC-----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChhhhhHHHHHHHHhhcCCCCCcchhhHHHH
Confidence            3466777888887   8899999999999888      8887653221100                       000112


Q ss_pred             HHHH-HHhhhhHHHHHHHHhhhccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCC
Q 040917          310 FRMK-QFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDG  388 (494)
Q Consensus       310 ~~~~-~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~  388 (494)
                      .+++ .+..++.+++     +...++.+++..+..+|..+|.|++|+|+..||..+|..+|..++..++..+|..+|.|+
T Consensus        97 ~~l~~~f~~~~~lkk-----~~~~Ls~~e~~~l~~~F~~~D~d~dG~Is~~El~~~L~~lg~~~~~~~i~~l~~~~D~d~  171 (323)
T 1ij5_A           97 KDLEDDASGYNRLRP-----SKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVENDT  171 (323)
T ss_dssp             HHC------------------CCCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHHHCC
T ss_pred             HHHHHHHHHhhhHHH-----HHHhCCHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCC
Confidence            2222 2222333322     345788999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHH-HHHHhCCCCCCcee
Q 040917          389 NGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKE-IMSEVDRDKDGRIS  467 (494)
Q Consensus       389 ~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~-~~~~~d~~~dg~i~  467 (494)
                      +|.|+|.+|+..+      .....+..+|..||.|++|+|+.+||..+|  +  |..++..++.. ++..+|.|+||.|+
T Consensus       172 ~G~I~f~ef~~l~------~~~~~l~~~F~~~D~d~dG~Is~~El~~~l--~--g~~~~~~ei~~~l~~~~D~d~dG~Is  241 (323)
T 1ij5_A          172 KGRMSYITLVAVA------NDLAALVADFRKIDTNSNGTLSRKEFREHF--V--RLGFDKKSVQDALFRYADEDESDDVG  241 (323)
T ss_dssp             SSTHHHHHHTTSH------HHHHTSCCCHHHHCTTCCSEECHHHHHHHH--H--HTTCCCHHHHHHHHHHHCTTCSSCEE
T ss_pred             CCcCcHHHHHhhh------hHHHHHHHHHHHHCCCCCCcCcHHHHHHHH--c--CCCCCHHHHHHHHHHHhcCCCCCEEe
Confidence            9999999998654      234467889999999999999999999999  2  34567888999 99999999999999


Q ss_pred             HHHHHHHHhcc
Q 040917          468 YDEFRSMMKCG  478 (494)
Q Consensus       468 ~~ef~~~~~~~  478 (494)
                      |+||..++...
T Consensus       242 ~~EF~~~l~~~  252 (323)
T 1ij5_A          242 FSEYVHLGLCL  252 (323)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999887643

>2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A

Probab=99.78  E-value=7.9e-20  Score=165.52  Aligned_cols=151  Identities=17%  Similarity=0.271  Sum_probs=127.0

Q ss_pred             hccCchhHHHhhhhhhhccCC-----CC-C--CcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCc-ccchHHHHH
Q 040917          330 VENLPTEEIQKLKEKFTEMDT-----DN-S--GTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGT-IDYIEFITA  400 (494)
Q Consensus       330 ~~~~~~~~~~~~~~~F~~~D~-----~~-~--g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~-i~~~ef~~~  400 (494)
                      ...++.++++++.+.|..+|.     |+ +  |+|+.+||.. +..++..+..+   ++|..+|.|++|. |+|+||+..
T Consensus        42 ~t~~s~~ei~~l~~~F~~~D~~~~~~d~~~~dG~I~~~E~~~-l~~lg~~~~~~---~lf~~~D~d~dG~~I~f~EF~~~  117 (214)
T 2l4h_A           42 LTFLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILS-LPELKANPFKE---RICRVFSTSPAKDSLSFEDFLDL  117 (214)
T ss_dssp             CCSCCHHHHHHHHHHHHHHSCGGGCCHHHHTTSEECHHHHTT-CHHHHTSTTHH---HHHHHHCCSSSCCSEEHHHHHHH
T ss_pred             hCCCCHHHHHHHHHHHHHhCcccccccccccCCcCCHHHHHH-hhccCCChHHH---HHHHHhCcCCCCCEecHHHHHHH
Confidence            356899999999999999999     66 6  9999999999 88888777653   6789999999999 999999998


Q ss_pred             HHHhhhh-hHHHHHHHhccccccCCCCceeHHHHHHHHhhcCC---CCCCcHHHHH----HHHHHhCCCCCCceeHHHHH
Q 040917          401 TMQRHKL-QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM---GDDATIATIK----EIMSEVDRDKDGRISYDEFR  472 (494)
Q Consensus       401 ~~~~~~~-~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~---~~~~~~~~~~----~~~~~~d~~~dg~i~~~ef~  472 (494)
                      +...... ...+.++.+|+.||.|++|+|+.+||+.++..++.   +..+++++++    .++..+|.|+||.|+|+||+
T Consensus       118 ~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~s~~e~~~~~~~~~~~~D~d~dG~Is~~EF~  197 (214)
T 2l4h_A          118 LSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQ  197 (214)
T ss_dssp             HHHTSSCSCHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHSSSCTTCSCTHHHHHHHHHHHHHCCSCCSSBCSHHHH
T ss_pred             HHHHcCCCCHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhccccCCCCCHHHHHHHHHHHHHHhCCCCCCcCCHHHHH
Confidence            8865432 34568999999999999999999999999987431   1256666665    49999999999999999999


Q ss_pred             HHHhcccccchh
Q 040917          473 SMMKCGTQLRAL  484 (494)
Q Consensus       473 ~~~~~~~~~~~~  484 (494)
                      .++...+.+..+
T Consensus       198 ~~~~~~p~~~~~  209 (214)
T 2l4h_A          198 HVISRSPDFASS  209 (214)
T ss_dssp             HHHHTCHHHHHH
T ss_pred             HHHHhChHHHHh
Confidence            999987765444

>1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A

Probab=99.78  E-value=5.9e-19  Score=156.72  Aligned_cols=150  Identities=21%  Similarity=0.310  Sum_probs=124.6

Q ss_pred             cCchhHHHhhhhhhhccCCC-CCCcccHHHHHHHHHhc-CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhH
Q 040917          332 NLPTEEIQKLKEKFTEMDTD-NSGTLTYDELKAGLAKL-GSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQR  409 (494)
Q Consensus       332 ~~~~~~~~~~~~~F~~~D~~-~~g~i~~~el~~~l~~~-~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~  409 (494)
                      .++.+++   ..+|..+|.+ ++|.|+.+||..++..+ +...+...+..+|..+|.|++|.|+++||+..+........
T Consensus        21 ~~~~~~i---~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~ef~~~~~~~~~~~~   97 (190)
T 1g8i_A           21 YFTEKEV---QQWYKGFIKDCPSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIEFSEFIQALSVTSRGTL   97 (190)
T ss_dssp             SSCHHHH---HHHHHHHHHHCTTSEEEHHHHHHHHHHHCTTSCTHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCH
T ss_pred             CCCHHHH---HHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCCChHHHHHHHHHHHhcCCCCeEeHHHHHHHHHHhcCCCH
Confidence            4455555   4555666666 89999999999999987 33356678999999999999999999999998877655566


Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhhc----C------CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKDY----G------MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~----~------~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      .+.+..+|+.+|.|++|+|+.+||..++..+    |      .+...++++++++|..+|.|+||.|+++||..++...+
T Consensus        98 ~~~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i~~~ef~~~~~~~~  177 (190)
T 1g8i_A           98 DEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKLTLQEFQEGSKADP  177 (190)
T ss_dssp             HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSSCSSEEEHHHHHHHHHHCH
T ss_pred             HHHHHHHHHhhcCCCCCeECHHHHHHHHHHHHHHhCCccCCccccccHHHHHHHHHHHhcCCCCCcEeHHHHHHHHHhCh
Confidence            7789999999999999999999999999872    2      23457888999999999999999999999999999877


Q ss_pred             ccchh
Q 040917          480 QLRAL  484 (494)
Q Consensus       480 ~~~~~  484 (494)
                      .+...
T Consensus       178 ~~~~~  182 (190)
T 1g8i_A          178 SIVQA  182 (190)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            65443

>2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A

Probab=99.78  E-value=8.4e-20  Score=161.64  Aligned_cols=143  Identities=16%  Similarity=0.275  Sum_probs=121.1

Q ss_pred             ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhc------CCCCCHHHHHHH---------HHHhcCCCCCcccch
Q 040917          331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL------GSMLTEFDVKQY---------MQAADIDGNGTIDYI  395 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~------~~~~~~~~~~~~---------~~~~D~~~~g~i~~~  395 (494)
                      ..++.+++++++++|..+|.|++|+|+.+||..+++.+      |..++..++..+         |..+|.|++|.|+++
T Consensus         6 ~~l~~~~~~~l~~~F~~~D~d~dG~i~~~El~~~l~~~~~~~~~g~~~~~~~~~~l~~~~~~~~~f~~~D~d~dg~I~~~   85 (186)
T 2hps_A            6 ESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQEFLRVADQLGLAPGVRISVEEAAVNA   85 (186)
T ss_dssp             HHHHHHHHHHHHHHHHTTCTTCSSEEEHHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHTCCTTCEEEHHHHHHHH
T ss_pred             ccccHHHHHHHHHHhhhcCCCCCCccCHHHHHHHHHHHHHHHHcCCCCCcHHHHHHHHHHHHHHHHHhcCCCCCCcccHH
Confidence            44567889999999999999999999999999999876      777788888887         599999999999999


Q ss_pred             HHHHHHHHhhh-hhHHHHHHHhc--cccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHH
Q 040917          396 EFITATMQRHK-LQRFENLYKAF--QYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFR  472 (494)
Q Consensus       396 ef~~~~~~~~~-~~~~~~~~~~F--~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~  472 (494)
                      |  ..+..... .....++..+|  ..||.|++|+|+.+||+.++..  .|..+++++++.+|..+|.|+||+|+|+||+
T Consensus        86 E--~~~~~~~~~~~~~~~~~~~f~~~~fD~d~~G~I~~~E~~~~l~~--~g~~~~~~~~~~~~~~~D~d~dG~i~~~ef~  161 (186)
T 2hps_A           86 T--DSLLKMKGEEKAMAVIQSLIMYDCIDTDKDGYVSLPEFKAFLQA--VGPDLTDDKAITCFNTLDFNKNGQISRDEFL  161 (186)
T ss_dssp             H--HHHHHCCTHHHHHTTHHHHHHHHHHCTTCSSEEEHHHHHHHHHH--HCTTCCHHHHHHHHHHHCTTCSSEEEHHHHH
T ss_pred             H--HHHHHhcCChHHHHHHHHHHHHHHccCCCCCcCCHHHHHHHHHH--hCCCCCHHHHHHHHHHHcCCCCCcCcHHHHH
Confidence            9  44433221 22234555666  7789999999999999999999  5677899999999999999999999999999


Q ss_pred             HHHhc
Q 040917          473 SMMKC  477 (494)
Q Consensus       473 ~~~~~  477 (494)
                      .++..
T Consensus       162 ~~~~~  166 (186)
T 2hps_A          162 VTVND  166 (186)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            98875

>2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A

Probab=99.77  E-value=4.7e-19  Score=159.73  Aligned_cols=150  Identities=19%  Similarity=0.225  Sum_probs=123.8

Q ss_pred             CchhHHHhhhhhhhccCCC-CCCcccHHHHHHHHHhcCCC-CCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHH
Q 040917          333 LPTEEIQKLKEKFTEMDTD-NSGTLTYDELKAGLAKLGSM-LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRF  410 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~-~~g~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~  410 (494)
                      ++.++   +..+|..+|.+ ++|.|+.+||..++..++.. .+..++..+|..+|.|++|.|+++||+..+.........
T Consensus        30 ~~~~~---i~~~f~~~d~~~~~G~i~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~  106 (207)
T 2d8n_A           30 FSEEE---LCSWYQSFLKDCPTGRITQQQFQSIYAKFFPDTDPKAYAQHVFRSFDSNLDGTLDFKEYVIALHMTTAGKTN  106 (207)
T ss_dssp             CCHHH---HHHHHHHHHHHCTTSEEEHHHHHHHHHHTCTTSCCHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHSCSSSS
T ss_pred             CCHHH---HHHHHHHHHhhCCCCCCCHHHHHHHHHHhccCCCcHHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHH
Confidence            44554   45566667777 79999999999999998764 678889999999999999999999999988765444455


Q ss_pred             HHHHHhccccccCCCCceeHHHHHHHHhhcC--CC----CC------CcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYG--MG----DD------ATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~--~~----~~------~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      +.+..+|+.+|.|++|+|+.+||..++..+.  +|    ..      ..+++++.+|..+|.|+||+|+|+||..++...
T Consensus       107 ~~~~~~f~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~l~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~  186 (207)
T 2d8n_A          107 QKLEWAFSLYDVDGNGTISKNEVLEIVMAIFKMITPEDVKLLPDDENTPEKRAEKIWKYFGKNDDDKLTEKEFIEGTLAN  186 (207)
T ss_dssp             TTHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCHHHHHTSCTTTSSHHHHHHHHHHHTTCCTTCCEEHHHHHHHHHHC
T ss_pred             HHHHHHHHHhcCCCCCeEcHHHHHHHHHHHHHHhccccCCCcccccccHHHHHHHHHHHcCCCCCCcCcHHHHHHHHHhC
Confidence            6789999999999999999999999998730  03    22      335779999999999999999999999999987


Q ss_pred             cccchhh
Q 040917          479 TQLRALS  485 (494)
Q Consensus       479 ~~~~~~~  485 (494)
                      +.+..+.
T Consensus       187 ~~~~~~~  193 (207)
T 2d8n_A          187 KEILRLI  193 (207)
T ss_dssp             HHHHHHH
T ss_pred             hHHHHHH
Confidence            7655544

>1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5

Probab=99.76  E-value=1.7e-18  Score=154.23  Aligned_cols=151  Identities=25%  Similarity=0.357  Sum_probs=123.4

Q ss_pred             cCchhHHHhhhhhhhccCCC-CCCcccHHHHHHHHHhcCCCC-CHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhH
Q 040917          332 NLPTEEIQKLKEKFTEMDTD-NSGTLTYDELKAGLAKLGSML-TEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQR  409 (494)
Q Consensus       332 ~~~~~~~~~~~~~F~~~D~~-~~g~i~~~el~~~l~~~~~~~-~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~  409 (494)
                      .++.+++   ..+|..+|.+ ++|.|+.+||..++..++... ....+..+|..+|.|++|.|+++||+..+........
T Consensus        21 ~~~~~~i---~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~   97 (193)
T 1bjf_A           21 DFTEHEI---QEWYKGFLRDCPSGHLSMEEFKKIYGNFFPYGDASKFAEHVFRTFDANGDGTIDFREFIIALSVTSRGKL   97 (193)
T ss_dssp             SCCHHHH---HHHHHHHHHHSTTSEEEHHHHHHHHTTTSSSSCCHHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCH
T ss_pred             CCCHHHH---HHHHHHHHHHCCCCCcCHHHHHHHHHHhcCcCChHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCH
Confidence            3555555   4566677877 899999999999999987654 4667899999999999999999999998877655556


Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhhcC--CC--CCC------cHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKDYG--MG--DDA------TIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~--~~--~~~------~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      ...+..+|+.+|.|++|+|+.+||..++..+.  .|  ..+      .+..+..+|..+|.|+||.|+++||..++...+
T Consensus        98 ~~~~~~~f~~~D~d~~G~I~~~E~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~  177 (193)
T 1bjf_A           98 EQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRDGKLSLEEFIRGAKSDP  177 (193)
T ss_dssp             HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTTCSSEECHHHHHHHHHHCT
T ss_pred             HHHHHHHHhhcCCCCCCeECHHHHHHHHHHHHHHhccccCCCcccccHHHHHHHHHHHhCCCCCCeEeHHHHHHHHhcCH
Confidence            77899999999999999999999999997620  12  122      345689999999999999999999999998766


Q ss_pred             ccchhh
Q 040917          480 QLRALS  485 (494)
Q Consensus       480 ~~~~~~  485 (494)
                      .+..+.
T Consensus       178 ~~~~~~  183 (193)
T 1bjf_A          178 SIVRLL  183 (193)
T ss_dssp             HHHHTT
T ss_pred             HHHHHh
Confidence            555443

>1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A

Probab=99.76  E-value=6.9e-18  Score=149.80  Aligned_cols=152  Identities=26%  Similarity=0.344  Sum_probs=125.3

Q ss_pred             cCchhHHHhhhhhhhccCCC-CCCcccHHHHHHHHHhcCC-CCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhH
Q 040917          332 NLPTEEIQKLKEKFTEMDTD-NSGTLTYDELKAGLAKLGS-MLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQR  409 (494)
Q Consensus       332 ~~~~~~~~~~~~~F~~~D~~-~~g~i~~~el~~~l~~~~~-~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~  409 (494)
                      .++.++++.+.+.   ||.+ ++|.|+.+||..++..++. ..+.+.+..+|..+|.|++|.|+++||...+........
T Consensus        21 ~~~~~~i~~~~~~---fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~   97 (190)
T 1fpw_A           21 YFDRREIQQWHKG---FLRDCPSGQLAREDFVKIYKQFFPFGSPEDFANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTL   97 (190)
T ss_dssp             CSTHHHHHHHHHH---HHHHCTTCCEEHHHHHHHHHHHCTTSCCSHHHHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCS
T ss_pred             CCCHHHHHHHHHH---HHHHCCCCcCcHHHHHHHHHHHcCCCCcHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHHccCCc
Confidence            4566666555554   4554 8999999999999999853 345567999999999999999999999998876554445


Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhhc----C------CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKDY----G------MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~----~------~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      .+.+..+|+.+|.|++|+|+.+||..++..+    |      .+...++++++.+|..+|.|+||.|+++||..++...+
T Consensus        98 ~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~  177 (190)
T 1fpw_A           98 EEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYITLDEFREGSKVDP  177 (190)
T ss_dssp             THHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTCSSEEEHHHHHHHHHSST
T ss_pred             HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHHHhccccCcccccchHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhCh
Confidence            6789999999999999999999999999872    2      12347788999999999999999999999999999888


Q ss_pred             ccchhhh
Q 040917          480 QLRALSS  486 (494)
Q Consensus       480 ~~~~~~~  486 (494)
                      .+..+..
T Consensus       178 ~~~~~~~  184 (190)
T 1fpw_A          178 SIIGALN  184 (190)
T ss_dssp             THHHHHH
T ss_pred             HHHHHHh
Confidence            7665543

>2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus}

Probab=99.76  E-value=9.6e-18  Score=156.33  Aligned_cols=153  Identities=23%  Similarity=0.352  Sum_probs=130.3

Q ss_pred             ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcC-CCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhH
Q 040917          331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLG-SMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQR  409 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~-~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~  409 (494)
                      ..++.++++.+.+.|..  .+++|.|+.+||..++..++ ...+..++..+|..+|.|++|.|+++||+..+........
T Consensus        86 ~~~s~~ei~~l~~~fd~--~~~~G~I~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~  163 (256)
T 2jul_A           86 TKFTKKELQSLYRGFKN--ECPTGLVDEDTFKLIYSQFFPQGDATTYAHFLFNAFDADGNGAIHFEDFVVGLSILLRGTV  163 (256)
T ss_dssp             TTSCHHHHHHHHHHHHH--HCTTSSEEHHHHHHHHHHHCCSSCCHHHHHHHHHHSSCSCCSEECSHHHHHHHHHHHSCCH
T ss_pred             hCCCHHHHHHHHHHHHh--hCCCCcCCHHHHHHHHHHHcccCCcHHHHHHHHHHhccCCCCcCcHHHHHHHHHHHhccCh
Confidence            34778888887777764  25899999999999999985 5567788999999999999999999999999887655556


Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhhc----C------CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKDY----G------MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~----~------~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      .+.+..+|+.+|.|++|+|+.+||..++..+    |      .....++++++.+|..+|.|+||.|+++||+.+++..+
T Consensus       164 ~~~l~~~F~~~D~d~dG~I~~~Ef~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~~~  243 (256)
T 2jul_A          164 HEKLKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILREDAPLEHVERFFQKMDRNQDGVVTIDEFLETCQKDE  243 (256)
T ss_dssp             HHHHHHHHHHTCCSSSSCBCHHHHHHHHHHHHHHCCCCCSCCSCCCCHHHHHHHHHHHSCCSTTCSBCHHHHHHHHHHCS
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCCcccchhhHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhCH
Confidence            7889999999999999999999999999874    3      12455788999999999999999999999999999877


Q ss_pred             ccchhh
Q 040917          480 QLRALS  485 (494)
Q Consensus       480 ~~~~~~  485 (494)
                      .+....
T Consensus       244 ~l~~~l  249 (256)
T 2jul_A          244 NIMNSM  249 (256)
T ss_dssp             SHHHHH
T ss_pred             HHHHHH
Confidence            765544

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A

Probab=99.75  E-value=2.1e-18  Score=165.72  Aligned_cols=132  Identities=20%  Similarity=0.351  Sum_probs=121.7

Q ss_pred             hHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHH-HHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHH
Q 040917          336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQ-YMQAADIDGNGTIDYIEFITATMQRHKLQRFENLY  414 (494)
Q Consensus       336 ~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~-~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~  414 (494)
                      .....+...|..+|.|++|+|+.+||..++  +|..++..++.. +|..+|.|++|.|+|+||+..+....      .+.
T Consensus       185 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l--~g~~~~~~ei~~~l~~~~D~d~dG~Is~~EF~~~l~~~~------~l~  256 (323)
T 1ij5_A          185 NDLAALVADFRKIDTNSNGTLSRKEFREHF--VRLGFDKKSVQDALFRYADEDESDDVGFSEYVHLGLCLL------VLR  256 (323)
T ss_dssp             HHHHTSCCCHHHHCTTCCSEECHHHHHHHH--HHTTCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHH------HHH
T ss_pred             hHHHHHHHHHHHHCCCCCCcCcHHHHHHHH--cCCCCCHHHHHHHHHHHhcCCCCCEEeHHHHHHHHHHHH------HHH
Confidence            566788999999999999999999999999  788888889999 99999999999999999999887544      789


Q ss_pred             HhccccccCCCCceeHHHHHHHH-hhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          415 KAFQYFDKDNNGYITVDELGKAF-KDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       415 ~~F~~~D~d~~G~I~~~el~~~l-~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .+|+.||.|++|+|+.+||..++ ..  +|..+++++++.+|..+|.|+||.|+|+||+.+|..
T Consensus       257 ~~F~~~D~d~dG~Is~~El~~~l~~~--~g~~ls~~e~~~l~~~~D~d~dG~Is~~EF~~~~~~  318 (323)
T 1ij5_A          257 ILYAFADFDKSGQLSKEEVQKVLEDA--HIPESARKKFEHQFSVVDVDDSKSLSYQEFVMLVLL  318 (323)
T ss_dssp             HHHHHTCSSSCSSEEHHHHHHHHHHT--TCCGGGCSTHHHHHHHHTTTTCSEECHHHHHHHHHH
T ss_pred             HHHHHhCCCCCCCccHHHHHHHHHHH--cCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHH
Confidence            99999999999999999999999 88  567788889999999999999999999999998874

>2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A

Probab=99.75  E-value=9.4e-19  Score=163.86  Aligned_cols=147  Identities=20%  Similarity=0.343  Sum_probs=125.3

Q ss_pred             ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCH------HHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTE------FDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~------~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      ..++..+.+++..+|..+|.|++|+|+.+||..+++.+|..++.      .++..+|..+|.|++|.|+|+||+..+...
T Consensus         8 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~l~~~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~Ef~~~~~~~   87 (263)
T 2f33_A            8 LQSSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQARKKAGLELSPEMKTFVDQYGQRDDGKIGIVELAHVLPTE   87 (263)
T ss_dssp             TTTSCCCHHHHHHHHHHHCTTCSSSBCSHHHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHTTGGGCCBCHHHHHHHTTSC
T ss_pred             hhcCcccHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHHHhhcCCCccchHHHHHHHHHHhCCCCCCcCcHHHHHHHHhhh
Confidence            34667778889999999999999999999999999988655443      778999999999999999999999887532


Q ss_pred             ---------hhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcC--CCCCCcHHHHHH----HHHHhCCCCCCceeHH
Q 040917          405 ---------HKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYG--MGDDATIATIKE----IMSEVDRDKDGRISYD  469 (494)
Q Consensus       405 ---------~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~--~~~~~~~~~~~~----~~~~~d~~~dg~i~~~  469 (494)
                               ........++.+|+.+|.|++|+|+.+||..+|..+.  .|..++++++..    ++..+|.|++|.|+|+
T Consensus        88 ~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~  167 (263)
T 2f33_A           88 ENFLLLFRCQQLKSCEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTKLAEYTDLMLKLFDSNNDGKLELT  167 (263)
T ss_dssp             TTHHHHHGGGTSSCHHHHHHHHTTSSTTTCSSBCHHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHTCSSSSSCBCHH
T ss_pred             hhHHHHHHHhhccHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHHHhhcCCCCCHHHHHHHHHHHHHhcCCCCCCeEcHH
Confidence                     2234566799999999999999999999999999831  056778888876    9999999999999999


Q ss_pred             HHHHHHhc
Q 040917          470 EFRSMMKC  477 (494)
Q Consensus       470 ef~~~~~~  477 (494)
                      ||..++..
T Consensus       168 ef~~~~~~  175 (263)
T 2f33_A          168 EMARLLPV  175 (263)
T ss_dssp             HHHHHSCT
T ss_pred             HHHHHHHH
Confidence            99988753

>2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A

Probab=99.74  E-value=2.5e-18  Score=160.90  Aligned_cols=142  Identities=21%  Similarity=0.355  Sum_probs=121.9

Q ss_pred             HHHhhhhhhhccCCCCCCcccHHHHHHHHHhc----CCCCCHHHHHH----HHHHhcCCCCCcccchHHHHHHHH-----
Q 040917          337 EIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL----GSMLTEFDVKQ----YMQAADIDGNGTIDYIEFITATMQ-----  403 (494)
Q Consensus       337 ~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~----~~~~~~~~~~~----~~~~~D~~~~g~i~~~ef~~~~~~-----  403 (494)
                      ....+..+|..+|.+++|+|+.+||..++..+    |..++..++..    ++..+|.|++|.|+|+||+..+..     
T Consensus       101 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~  180 (263)
T 2f33_A          101 SCEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTKLAEYTDLMLKLFDSNNDGKLELTEMARLLPVQENFL  180 (263)
T ss_dssp             CHHHHHHHHTTSSTTTCSSBCHHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHTCSSSSSCBCHHHHHHHSCTTTCSH
T ss_pred             HHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHHHhhcCCCCCHHHHHHHHHHHHHhcCCCCCCeEcHHHHHHHHHHHHHHH
Confidence            34568899999999999999999999999988    88899888876    999999999999999999887653     


Q ss_pred             --h-hhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCC--CCCCcHHHHHHHHHH-hCCCCCCceeHHHHHHHHhc
Q 040917          404 --R-HKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM--GDDATIATIKEIMSE-VDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       404 --~-~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~--~~~~~~~~~~~~~~~-~d~~~dg~i~~~ef~~~~~~  477 (494)
                        . ........+..+|+.+|.|++|+|+.+||+.++..++.  +..+++++++.++.. +|.|+||.|+|+||+.+|..
T Consensus       181 ~~~~~~~~~~~~~~~~F~~~D~d~~G~is~~El~~~l~~~~~~~~~~~~~~e~~~~~~~~~D~d~dG~i~~~EF~~~~~~  260 (263)
T 2f33_A          181 LKFQGIKMCGKEFNKAFELYDQDGNGYIDENELDALLKDLCEKNKQELDINNISTYKKNIMALSDGGKLYRTDLALILSA  260 (263)
T ss_dssp             HHHHHTCCCHHHHHHHHHHHCCSSSSCEEHHHHHHHHHHHHHHCTTTCCTTTHHHHHHHHHTTSBTTEECGGGTHHHHCC
T ss_pred             HHhcCcchHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhhccCCCCeEcHHHHHHHHhc
Confidence              1 12234567999999999999999999999999987431  226788899999987 79999999999999999986


Q ss_pred             c
Q 040917          478 G  478 (494)
Q Consensus       478 ~  478 (494)
                      .
T Consensus       261 ~  261 (263)
T 2f33_A          261 G  261 (263)
T ss_dssp             S
T ss_pred             c
Confidence            4

>2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A

Probab=99.74  E-value=3e-18  Score=161.27  Aligned_cols=142  Identities=19%  Similarity=0.283  Sum_probs=120.8

Q ss_pred             HHhhhhhhhccCCCCCCcccHHHHHHHHHhc----CCCCCHHHHH----HHHHHhcCCCCCcccchHHHHHHHHh-----
Q 040917          338 IQKLKEKFTEMDTDNSGTLTYDELKAGLAKL----GSMLTEFDVK----QYMQAADIDGNGTIDYIEFITATMQR-----  404 (494)
Q Consensus       338 ~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~----~~~~~~~~~~----~~~~~~D~~~~g~i~~~ef~~~~~~~-----  404 (494)
                      ...+..+|..+|.|++|+|+.+||..++..+    |..++.+++.    .+|..+|.|++|.|+|+||+..+...     
T Consensus       103 ~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~~~~~~~  182 (272)
T 2be4_A          103 SVEFMKIWRKYDADSSGYISAAELKNFLKDLFLQHKKKIPPNKLDEYTDAMMKIFDKNKDGRLDLNDLARILALQENFLL  182 (272)
T ss_dssp             HHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEEEHHHHGGGSCCSSCSST
T ss_pred             HHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHhccCCCCcCcHHHHHHHHhhhHHHHh
Confidence            4568899999999999999999999999988    8888888765    49999999999999999998876430     


Q ss_pred             -------hhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCC--CCCCcHHHHHH----HHHHhCCCCCCceeHHHH
Q 040917          405 -------HKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM--GDDATIATIKE----IMSEVDRDKDGRISYDEF  471 (494)
Q Consensus       405 -------~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~--~~~~~~~~~~~----~~~~~d~~~dg~i~~~ef  471 (494)
                             ........+..+|+.+|.|++|+|+.+||..++..++.  +..+++++++.    ++..+|.|+||.|+|+||
T Consensus       183 ~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~~D~d~dG~is~~EF  262 (272)
T 2be4_A          183 QFKMDASSQVERKRDFEKIFAHYDVSRTGALEGPEVDGFVKDMMELVRPSISGGDLDKFRECLLTHCDMNKDGKIQKSEL  262 (272)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHCTTCCSEEETHHHHHHHHHHHHHHSSSCCHHHHHHHHHHHHHHHCCSTTCEEEHHHH
T ss_pred             hhhhhhccccccHHHHHHHHHHhCCCCCCeecHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHH
Confidence                   12234567999999999999999999999999987432  22678888877    999999999999999999


Q ss_pred             HHHHhccc
Q 040917          472 RSMMKCGT  479 (494)
Q Consensus       472 ~~~~~~~~  479 (494)
                      ..++...|
T Consensus       263 ~~~~~~~p  270 (272)
T 2be4_A          263 ALCLGLKH  270 (272)
T ss_dssp             HHHTTCCC
T ss_pred             HHHHccCC
Confidence            99988654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.72  E-value=1.2e-17  Score=161.81  Aligned_cols=144  Identities=15%  Similarity=0.207  Sum_probs=101.6

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCC-----------Chh--------hHHHHHHHHHHHHHccCCC
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV-----------KDV--------EKDDVRREIEIMRHLSGQP   94 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~-----------~~~--------~~~~~~~E~~~l~~l~~hp   94 (494)
                      -|+++..||+|++|.||+|.+. +|+.||||+++.....           ...        ..-....|...|.++. ++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~  173 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EE  173 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HT
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hc
Confidence            3999999999999999999985 6999999997643210           000        0112345778888884 44


Q ss_pred             CccEEeEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCC--
Q 040917           95 NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDE--  172 (494)
Q Consensus        95 ~i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~--  172 (494)
                      ++....-+....  .+|||||++|++|..+.      .......++.||+.+|.+||++|||||||||.|||++.+..  
T Consensus       174 gv~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          174 GFPVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             TCSCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCCCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence            443222222222  26999999998886542      12234578899999999999999999999999999964221  


Q ss_pred             -----CCeEEEeecCCcccc
Q 040917          173 -----NAVVKATDFGLSAFI  187 (494)
Q Consensus       173 -----~~~~kL~Dfg~a~~~  187 (494)
                           ...+.|+||+.+...
T Consensus       246 d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEET
T ss_pred             cccccccceEEEEeCCcccC
Confidence                 114889999988753

>2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A

Probab=99.72  E-value=7.2e-18  Score=158.62  Aligned_cols=146  Identities=22%  Similarity=0.380  Sum_probs=122.3

Q ss_pred             cCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHH----hcCC--CCCHHHHHH----HHHHhcCCCCCcccchHHHHHH
Q 040917          332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLA----KLGS--MLTEFDVKQ----YMQAADIDGNGTIDYIEFITAT  401 (494)
Q Consensus       332 ~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~----~~~~--~~~~~~~~~----~~~~~D~~~~g~i~~~ef~~~~  401 (494)
                      .++..+.++++.+|..+|.|++|+|+.+||..+++    .+|.  .++.+++..    +|..+|.|++|.|+|+||+..+
T Consensus         4 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~lg~~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~   83 (272)
T 2be4_A            4 AFANLDAAGFLQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKDKITDERVQQIKKSFMSAYDATFDGRLQIEELANMI   83 (272)
T ss_dssp             CCCCCCHHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHHSTTSCCCHHHHHHHHHHHSCHHHHTCCSEEEHHHHHHHH
T ss_pred             HHHhcCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhcCCCCCcEeHHHHHHHH
Confidence            45566777899999999999999999999999999    8898  889888766    4578899999999999999884


Q ss_pred             H-----------HhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcC--CCCCCcHHHHH----HHHHHhCCCCCC
Q 040917          402 M-----------QRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYG--MGDDATIATIK----EIMSEVDRDKDG  464 (494)
Q Consensus       402 ~-----------~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~--~~~~~~~~~~~----~~~~~~d~~~dg  464 (494)
                      .           ..........++.+|+.+|.|++|+|+.+||..++..+.  .|..+++++++    .++..+|.|++|
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~D~~~dg  163 (272)
T 2be4_A           84 LPQEENFLLIFRREAPLDNSVEFMKIWRKYDADSSGYISAAELKNFLKDLFLQHKKKIPPNKLDEYTDAMMKIFDKNKDG  163 (272)
T ss_dssp             SCHHHHHHHHHHHHSCCCCHHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSS
T ss_pred             hhhhHHHHHHHhhccCcccHHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHhccCCCC
Confidence            2           221234457799999999999999999999999998731  15677777765    499999999999


Q ss_pred             ceeHHHHHHHHhc
Q 040917          465 RISYDEFRSMMKC  477 (494)
Q Consensus       465 ~i~~~ef~~~~~~  477 (494)
                      .|+++||...+..
T Consensus       164 ~i~~~ef~~~~~~  176 (272)
T 2be4_A          164 RLDLNDLARILAL  176 (272)
T ss_dssp             EEEHHHHGGGSCC
T ss_pred             cCcHHHHHHHHhh
Confidence            9999999988754

>3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L

Probab=99.71  E-value=2.6e-17  Score=174.29  Aligned_cols=138  Identities=18%  Similarity=0.245  Sum_probs=126.8

Q ss_pred             CchhH-HHhhhhhhhccCCCCCCcccHHHHHHHHHhc--------CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHH
Q 040917          333 LPTEE-IQKLKEKFTEMDTDNSGTLTYDELKAGLAKL--------GSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQ  403 (494)
Q Consensus       333 ~~~~~-~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~--------~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~  403 (494)
                      ++.++ .+++++.|..+| +++|.|+.+||..+++.+        +..++.+++..++..+|.|++|.|+|+||+..+..
T Consensus       525 ls~~e~~~~l~~~F~~~D-d~dG~Is~~El~~~L~~l~~~~~~~~g~~~s~~~~~~l~~~~D~d~~G~I~f~EF~~l~~~  603 (714)
T 3bow_A          525 ANEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDEDGSGKLGLKEFYILWTK  603 (714)
T ss_dssp             CSGGGCCHHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHTTCTTSCCSCCCHHHHHHHHHHHCCSSCSSBCHHHHHHHHHH
T ss_pred             CChhhHHHHHHHHHHHHc-CCCCcCCHHHHHHHHHHHhhhcccccCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence            56677 889999999999 999999999999999997        77899999999999999999999999999998875


Q ss_pred             hhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccc
Q 040917          404 RHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ  480 (494)
Q Consensus       404 ~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~  480 (494)
                      .      ..++.+|+.||.|++|+|+.+||+.+|..  +|..+++++++.++..+| |+||.|+|+||+.++.....
T Consensus       604 ~------~~l~~~F~~~D~d~dG~Is~~El~~~L~~--~G~~ls~~~~~~l~~~~D-d~dG~Isf~EF~~~l~~~~~  671 (714)
T 3bow_A          604 I------QKYQKIYREIDVDRSGTMNSYEMRKALEE--AGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRLEI  671 (714)
T ss_dssp             H------HHHHHHHHHHCTTCCSSEEHHHHHHHHHH--TTEECCHHHHHHHHHHHS-CTTCEECHHHHHHHHHHHHH
T ss_pred             H------HHHHHHHHHhCCCCCCeECHHHHHHHHHH--cCCCCCHHHHHHHHHHhC-CCCCeEcHHHHHHHHHHHHH
Confidence            3      57899999999999999999999999999  667889999999999999 99999999999999876443

>2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A

Probab=99.66  E-value=3e-16  Score=125.48  Aligned_cols=105  Identities=28%  Similarity=0.441  Sum_probs=92.6

Q ss_pred             hcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCC-CCC
Q 040917          367 KLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM-GDD  445 (494)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~-~~~  445 (494)
                      .+|. ++.+++..++..+|  ++|.|+|+||+..+...  ......++.+|+.||.|++|+|+.+||+.++..++. |..
T Consensus         2 slG~-~~~~e~~~l~~~~d--~~g~i~~~eF~~~~~~~--~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~   76 (108)
T 2pvb_A            2 SFAG-LKDADVAAALAACS--AADSFKHKEFFAKVGLA--SKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARA   76 (108)
T ss_dssp             CCTT-SCHHHHHHHHHHTC--STTCCCHHHHHHHHTGG--GSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCC
T ss_pred             CcCC-CCHHHHHHHHHHhC--CCCcCcHHHHHHHHhCC--hhHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccCCC
Confidence            4678 89999999999998  78999999999887432  334668999999999999999999999999998421 677


Q ss_pred             CcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          446 ATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       446 ~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      +++++++.++..+|.|+||.|+|+||..++.
T Consensus        77 ~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~  107 (108)
T 2pvb_A           77 LTDAETKAFLADGDKDGDGMIGVDEFAAMIK  107 (108)
T ss_dssp             CCHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred             CCHHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence            8999999999999999999999999999876

>3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A

Probab=99.66  E-value=1.5e-16  Score=127.48  Aligned_cols=105  Identities=24%  Similarity=0.449  Sum_probs=93.1

Q ss_pred             cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCC-CCCC
Q 040917          368 LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM-GDDA  446 (494)
Q Consensus       368 ~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~-~~~~  446 (494)
                      ++..++.+++.+++..+|  ++|.|+|+||+..+...  ....+.++.+|+.||.|++|+|+.+||+.++..++. +..+
T Consensus         3 l~~~~~~~ei~~~~~~~D--~~g~i~~~eF~~~~~~~--~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~   78 (109)
T 3fs7_A            3 ITDILSAKDIESALSSCQ--AADSFNYKSFFSTVGLS--SKTPDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARVL   78 (109)
T ss_dssp             GGGTSCHHHHHHHHHHTC--STTCCCHHHHHHHHTCT--TCCHHHHHHHHHHHSTTCSSSBCHHHHHTTGGGTCTTSCCC
T ss_pred             ccCcCCHHHHHHHHHhcC--CCCcCcHHHHHHHHhcC--CCcHHHHHHHHHHHCCCCCCeEeHHHHHHHHHHHhcccccC
Confidence            466789999999999998  79999999999887642  235668999999999999999999999999998421 6789


Q ss_pred             cHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          447 TIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       447 ~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      ++++++.++..+|.|+||+|+|+||..+++
T Consensus        79 ~~~~~~~~~~~~D~~~dg~i~~~EF~~~~~  108 (109)
T 3fs7_A           79 TSAETKAFLAAGDTDGDGKIGVEEFQSLVK  108 (109)
T ss_dssp             CHHHHHHHHHHHCTTCSSSBCHHHHHHHHT
T ss_pred             CHHHHHHHHHHhCCCCCCcCcHHHHHHHHh
Confidence            999999999999999999999999999886

>1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4

Probab=99.66  E-value=4.1e-16  Score=124.91  Aligned_cols=106  Identities=25%  Similarity=0.427  Sum_probs=93.5

Q ss_pred             hcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCC-CCC
Q 040917          367 KLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM-GDD  445 (494)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~-~~~  445 (494)
                      ++|..++.+++..++..+|  ++|.|+|+||+..+...  ......++.+|+.||.|++|+|+.+||+.++..++. +..
T Consensus         2 slg~~~~~~e~~~~~~~~d--~~g~i~~~eF~~~~~~~--~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~   77 (109)
T 1bu3_A            2 AFSGILADADVAAALKACE--AADSFNYKAFFAKVGLT--AKSADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARA   77 (109)
T ss_dssp             CCSCSSCHHHHHHHHHHTC--STTCCCHHHHHHHHTGG--GSCHHHHHHHHHHHCTTCSSSEEHHHHHTHHHHHSTTCCC
T ss_pred             cccccCCHHHHHHHHHHhC--CCCcCcHHHHHHHHHcC--hhhHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCC
Confidence            3678899999999999998  89999999999877432  234668999999999999999999999999998521 677


Q ss_pred             CcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          446 ATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       446 ~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      +++++++.++..+|.|+||.|+|+||..++.
T Consensus        78 ~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~  108 (109)
T 1bu3_A           78 LTDAETKAFLKAGDSDGDGAIGVDEWAALVK  108 (109)
T ss_dssp             CCHHHHHHHHHHHCTTCSSEECHHHHHHHHT
T ss_pred             CCHHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence            8999999999999999999999999999875

>1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A

Probab=99.64  E-value=1e-16  Score=165.94  Aligned_cols=136  Identities=13%  Similarity=0.168  Sum_probs=67.6

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhcc
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQ  418 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~  418 (494)
                      ..++++|..+|.|++|+|+.+||..+++.+|..++.+++..+|+.+|.|++|.|+|+||+..+.....   .+++.++|+
T Consensus        11 ~~l~~~F~~fD~d~dG~Is~~El~~~l~~lg~~~s~~el~~lf~~~D~d~~G~I~f~EF~~~~~~l~~---~~el~~aF~   87 (624)
T 1djx_A           11 HWIHSCLRKADKNKDNKMNFKELKDFLKELNIQVDDGYARKIFRECDHSQTDSLEDEEIETFYKMLTQ---RAEIDRAFE   87 (624)
T ss_dssp             ---------------------------------------------------------CTTHHHHHHTC---CHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhcc---HHHHHHHHH
Confidence            35789999999999999999999999999999999999999999999999999999999998876432   357999999


Q ss_pred             ccccCCCCceeHHHHHHHHhhcCCCCC-CcHHHHHHHHHHhCCC----CCCceeHHHHHHHHhccc
Q 040917          419 YFDKDNNGYITVDELGKAFKDYGMGDD-ATIATIKEIMSEVDRD----KDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       419 ~~D~d~~G~I~~~el~~~l~~~~~~~~-~~~~~~~~~~~~~d~~----~dg~i~~~ef~~~~~~~~  479 (494)
                      .||.+ +|+|+.+||+++|... .|+. ++++++++++..+|.|    ++|.|+|+||.++|.+..
T Consensus        88 ~fD~~-~G~Is~~EL~~fL~~~-qge~~ls~ee~~~ii~~~d~d~~~~~dG~Is~deF~~~L~s~~  151 (624)
T 1djx_A           88 EAAGS-AETLSVERLVTFLQHQ-QREEEAGPALALSLIERYEPSETAKAQRQMTKDGFLMYLLSAD  151 (624)
T ss_dssp             HHHTT-SSSEEHHHHHHHHHHT-SCCSSCSHHHHHHHHHHHCCCHHHHHTTEECHHHHHHHHHSTT
T ss_pred             HhcCC-CCeecHHHHHHHHHHH-hCCCCCCHHHHHHHHHHhCCChhhccCCCCCHHHHHHHhcCcc
Confidence            99986 8999999999999973 3555 8999999999999998    799999999999998643

>5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4

Probab=99.64  E-value=3.8e-16  Score=125.05  Aligned_cols=106  Identities=27%  Similarity=0.447  Sum_probs=93.0

Q ss_pred             cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCC-CCCC
Q 040917          368 LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM-GDDA  446 (494)
Q Consensus       368 ~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~-~~~~  446 (494)
                      ++..++.+++..+++.+|.  +|.|+|+||+..+...  ....+.++.+|+.||.|++|+|+.+||+.++..++. +..+
T Consensus         2 l~~~~s~~ei~~~~~~~d~--~g~i~~~eF~~~~~~~--~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~g~~~   77 (109)
T 5pal_A            2 MTKVLKADDINKAISAFKD--PGTFDYKRFFHLVGLK--GKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDL   77 (109)
T ss_dssp             GGGTSCHHHHHHHHHHTCS--TTCCCHHHHHHHHTCT--TCCHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCC
T ss_pred             CCCcCCHHHHHHHHHHhCC--CCcCcHHHHHHHHhhc--cCcHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHcCCCC
Confidence            4567889999999999987  8999999999987642  335668999999999999999999999999998421 7788


Q ss_pred             cHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          447 TIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       447 ~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ++++++.++..+|.|+||.|+|+||..+|.+
T Consensus        78 ~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~  108 (109)
T 5pal_A           78 NDTETKALLAAGDSDHDGKIGADEFAKMVAQ  108 (109)
T ss_dssp             CHHHHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred             CHHHHHHHHHHhCCCCCCcCcHHHHHHHHHh
Confidence            9999999999999999999999999998864

>1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A

Probab=99.64  E-value=3.3e-16  Score=125.68  Aligned_cols=107  Identities=27%  Similarity=0.456  Sum_probs=93.3

Q ss_pred             hcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCC-CCC
Q 040917          367 KLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM-GDD  445 (494)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~-~~~  445 (494)
                      .+|..++.+++..++..+|  ++|.|+|+||+..+..  .......++.+|+.||.|++|+|+.+||+.++..++. +..
T Consensus         2 alG~~~t~~e~~~~~~~~d--~~g~i~~~ef~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~   77 (110)
T 1pva_A            2 AAKDLLKADDIKKALDAVK--AEGSFNHKKFFALVGL--KAMSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRD   77 (110)
T ss_dssp             CHHHHSCHHHHHHHHHHTC--STTCCCHHHHHHHHTC--TTSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCC
T ss_pred             cccccCCHHHHHHHHHhcC--CCCcCcHHHHHHHHcc--CcchHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhhcCCC
Confidence            4566789999999999998  8899999999988742  2334578999999999999999999999999998421 677


Q ss_pred             CcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          446 ATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       446 ~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +++++++.++..+|.|++|.|+|+||..++..
T Consensus        78 ~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~  109 (110)
T 1pva_A           78 LTDAETKAFLKAADKDGDGKIGIDEFETLVHE  109 (110)
T ss_dssp             CCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred             CCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHh
Confidence            89999999999999999999999999998864

>1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A

Probab=99.63  E-value=6.4e-16  Score=123.52  Aligned_cols=105  Identities=24%  Similarity=0.429  Sum_probs=91.8

Q ss_pred             cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCC-CCCC
Q 040917          368 LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM-GDDA  446 (494)
Q Consensus       368 ~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~-~~~~  446 (494)
                      ++..++.+++..++..+|  ++|.|+|+||+..+..  .......++.+|+.||.|++|+|+.+||+.++..++. +..+
T Consensus         2 l~~~~t~~e~~~~~~~~d--~~g~i~~~eF~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~   77 (108)
T 1rro_A            2 ITDILSAEDIAAALQECQ--DPDTFEPQKFFQTSGL--SKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDAREL   77 (108)
T ss_dssp             GGGTSCHHHHHHHHHHTC--STTCCCHHHHHHHHSG--GGSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCC
T ss_pred             ccccCCHHHHHHHHHHcc--CCCCcCHHHHHHHHhc--CcccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhccCCC
Confidence            456788999999999998  8999999999988742  2334567999999999999999999999999998531 5778


Q ss_pred             cHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          447 TIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       447 ~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      ++++++.++..+|.|+||.|+|+||..++.
T Consensus        78 ~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~  107 (108)
T 1rro_A           78 TESETKSLMDAADNDGDGKIGADEFQEMVH  107 (108)
T ss_dssp             CHHHHHHHHHHHCCSSSSSEEHHHHHHHHT
T ss_pred             CHHHHHHHHHHhCCCCCCcCcHHHHHHHHc
Confidence            999999999999999999999999999875

>1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A

Probab=99.63  E-value=4.6e-16  Score=124.59  Aligned_cols=105  Identities=27%  Similarity=0.477  Sum_probs=91.9

Q ss_pred             CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCC-CCCCc
Q 040917          369 GSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM-GDDAT  447 (494)
Q Consensus       369 ~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~-~~~~~  447 (494)
                      |..++.+++..++..+|  ++|.|+|+||+..+...  ......++.+|+.||.|++|+|+.+||+.++..++. +..++
T Consensus         3 g~~~t~~e~~~~~~~~d--~~g~i~~~eF~~~~~~~--~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~   78 (109)
T 1rwy_A            3 TDLLSAEDIKKAIGAFT--AADSFDHKKFFQMVGLK--KKSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLS   78 (109)
T ss_dssp             HHHSCHHHHHHHHHTTC--STTCCCHHHHHHHHTGG--GSCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCC
T ss_pred             CCcCCHHHHHHHHHHcC--CCCcEeHHHHHHHHhcC--cchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHhccCCCCC
Confidence            45678899999999998  89999999999887432  335678999999999999999999999999998532 66789


Q ss_pred             HHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          448 IATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       448 ~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +++++.++..+|.|+||.|+|+||..++..
T Consensus        79 ~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~  108 (109)
T 1rwy_A           79 AKETKTLMAAGDKDGDGKIGVEEFSTLVAE  108 (109)
T ss_dssp             HHHHHHHHHHHCTTCSSSEEHHHHHHHHHT
T ss_pred             HHHHHHHHHHHCCCCCCcCCHHHHHHHHHc
Confidence            999999999999999999999999998864

>1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1

Probab=99.63  E-value=7.6e-16  Score=168.21  Aligned_cols=143  Identities=17%  Similarity=0.359  Sum_probs=127.0

Q ss_pred             hhhccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-
Q 040917          328 VIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-  406 (494)
Q Consensus       328 ~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-  406 (494)
                      .....++..+...+...|..+|.|++|+|+.+||..++..+|..++..++..+|..+|.|+||.|+|+||+..+..... 
T Consensus       714 ~~~~~l~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~~~  793 (863)
T 1sjj_A          714 RDAKGISQEQMNEFRASFNHFDRKKTGMMDCEDFRACLISMGYNMGEAEFARIMSIVDPNRMGVVTFQAFIDFMSRETAD  793 (863)
T ss_dssp             CCCCCSSHHHHHHHHHHHTTTCSSSSSEEESTTHHHHHHHHTCCCCTHHHHHHHHHHCTTSCSEEETTHHHHTHHHHSTT
T ss_pred             hhccCCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcC
Confidence            3455678889999999999999999999999999999999999999999999999999999999999999998876432 


Q ss_pred             hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCC-----CCCceeHHHHHHHHhcccc
Q 040917          407 LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRD-----KDGRISYDEFRSMMKCGTQ  480 (494)
Q Consensus       407 ~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~-----~dg~i~~~ef~~~~~~~~~  480 (494)
                      ....+.+..+|+.| .|++|+|+.+||+.+|.         +++++.++..+|.+     +||.|+|+||..+|...+.
T Consensus       794 ~~~~~~l~~aF~~~-~d~~G~Is~~El~~~l~---------~~~~~~l~~~~d~~~~~~~~dg~I~~~eF~~~~~~~~~  862 (863)
T 1sjj_A          794 TDTADQVMASFKIL-AGDKNYITVDELRRELP---------PDQAEYCIARMAPYNGRDAVPGALDYMSFSTALYGESD  862 (863)
T ss_dssp             CSSSHHHHHHHHGG-GTSSSEEEHHHHHHHSC---------HHHHHHHHHHSEECCSSCCCTTEEESHHHHHHHSCCSC
T ss_pred             CCCHHHHHHHHHHH-hCCCCcCcHHHHHHHCC---------HHHHHHHHHHcchhcCCCCCCCceeHHHHHHHHhcCCC
Confidence            23446789999999 89999999999999873         57899999999986     7999999999999987654

>1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3

Probab=99.60  E-value=6.5e-16  Score=168.76  Aligned_cols=133  Identities=20%  Similarity=0.275  Sum_probs=110.9

Q ss_pred             HHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCC--------CCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhh
Q 040917          337 EIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGS--------MLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQ  408 (494)
Q Consensus       337 ~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~--------~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~  408 (494)
                      +.+++++.|..+| +++|.|+.+||..+|+.++.        .++.+++..++..+|.|++|.|+|+||+..+...    
T Consensus       532 ~~~~l~~~F~~~D-~~dG~Is~~El~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~d~~G~I~~~EF~~~~~~~----  606 (900)
T 1qxp_A          532 IDDNFKTLFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDRDGNGKLGLVEFNILWNRI----  606 (900)
T ss_dssp             ---------CCCC-CSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC--CCCCCSSSHHHHHHHH----
T ss_pred             HHHHHHHHHHHHc-CCCCcCCHHHHHHHHHHhhcccccccCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHH----
Confidence            3788999999999 99999999999999999865        7889999999999999999999999999887754    


Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                        ..++.+|+.||.|++|+|+.+||+.+|..  +|..+++++++.++..+| |+||.|+|+||+.++....
T Consensus       607 --~~l~~~F~~~D~d~~G~Is~~El~~~l~~--~g~~l~~~~~~~l~~~~d-d~dg~I~~~eF~~~~~~~~  672 (900)
T 1qxp_A          607 --RNYLTIFRKFDLDKSGSMSAYEMRMAIEA--AGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRLE  672 (900)
T ss_dssp             --HHHHHHHGGGCTTCCSCCBHHHHHHHHHH--TTEECCHHHHHHHHHHTS-CSSSBCCHHHHHHHHHHHH
T ss_pred             --HHHHHHHHhhCCCCCCeECHHHHHHHHHH--hCCCCCHHHHHHHHHHhC-CCCCeEcHHHHHHHHHHHH
Confidence              57899999999999999999999999999  667889999999999999 9999999999999887543

>3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana}

Probab=99.60  E-value=1.2e-15  Score=127.21  Aligned_cols=100  Identities=17%  Similarity=0.234  Sum_probs=68.0

Q ss_pred             HHHHHHHhcCCCCCcccchHHHHHHHHhh-hhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCC-CCCcHHHHHHH
Q 040917          377 VKQYMQAADIDGNGTIDYIEFITATMQRH-KLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMG-DDATIATIKEI  454 (494)
Q Consensus       377 ~~~~~~~~D~~~~g~i~~~ef~~~~~~~~-~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~-~~~~~~~~~~~  454 (494)
                      +.++|..+|.|++|.|+|+||+..+.... .......++.+|+.||.|++|+|+.+||+.++..  +| ..+++++++.+
T Consensus         5 ~~~l~~~~D~d~~G~I~~~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~--~g~~~~~~~e~~~~   82 (135)
T 3h4s_E            5 EKSMLLETTSTTKMETKYEDMLPVMAEKMDVEEFVSELCKGFSLLADPERHLITAESLRRNSGI--LGIEGMSKEDAQGM   82 (135)
T ss_dssp             --------------CCCC-----------CHHHHHHHHHHHHHHHSBTTTTBBCHHHHHHHGGG--GTCCCCCHHHHHHH
T ss_pred             HHHHHHHHcCCCCCcEeHHHHHHHHHHHccccchHHHHHHHHHHHCCCCCCcCCHHHHHHHHHH--hCCCCCCHHHHHHH
Confidence            46789999999999999999999887643 2335678999999999999999999999999999  66 48899999999


Q ss_pred             HHHhCCCCCCceeHHHHHHHHhcc
Q 040917          455 MSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       455 ~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      +..+|.|+||.|+|+||..+|...
T Consensus        83 ~~~~D~d~dG~I~~~EF~~~~~~~  106 (135)
T 3h4s_E           83 VREGDLDGDGALNQTEFCVLMVRL  106 (135)
T ss_dssp             HHHHCSSCSSSBCHHHHHHHHHHH
T ss_pred             HHHhCCCCCCCCcHHHHHHHHHHh
Confidence            999999999999999999998863

>2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A

Probab=99.59  E-value=3.1e-15  Score=134.55  Aligned_cols=127  Identities=20%  Similarity=0.186  Sum_probs=112.8

Q ss_pred             ccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCC-CCCcccchHHHHHHHHhhhh-hHHHHHHHhccccccCC
Q 040917          347 EMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADID-GNGTIDYIEFITATMQRHKL-QRFENLYKAFQYFDKDN  424 (494)
Q Consensus       347 ~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~-~~g~i~~~ef~~~~~~~~~~-~~~~~~~~~F~~~D~d~  424 (494)
                      .++.+++|.|+.+++..+++.++  ++.+++..+|..+|.+ ++|.|+++||...+...... .....+..+|+.+|.|+
T Consensus         7 ~mg~~~~g~l~~~el~~~~~~~~--~~~~~i~~~f~~~d~~~~~G~i~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D~d~   84 (207)
T 2d8n_A            7 GMGNSKSGALSKEILEELQLNTK--FSEEELCSWYQSFLKDCPTGRITQQQFQSIYAKFFPDTDPKAYAQHVFRSFDSNL   84 (207)
T ss_dssp             -CTTCCTTCCCHHHHHHHHHHSS--CCHHHHHHHHHHHHHHCTTSEEEHHHHHHHHHHTCTTSCCHHHHHHHHHHHCTTC
T ss_pred             hhccccCCCCCHHHHHHHHHHcC--CCHHHHHHHHHHHHhhCCCCCCCHHHHHHHHHHhccCCCcHHHHHHHHHHhcCCC
Confidence            58899999999999999999987  5889999999999998 79999999999988765332 45577999999999999


Q ss_pred             CCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          425 NGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       425 ~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +|.|+.+||..++..+  +...+++++..+|..+|.|++|.|+++||..++..
T Consensus        85 ~G~i~~~Ef~~~~~~~--~~~~~~~~~~~~f~~~D~d~~G~I~~~E~~~~l~~  135 (207)
T 2d8n_A           85 DGTLDFKEYVIALHMT--TAGKTNQKLEWAFSLYDVDGNGTISKNEVLEIVMA  135 (207)
T ss_dssp             CSEEEHHHHHHHHHHH--SCSSSSTTHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred             CCeEeHHHHHHHHHHH--cCCCHHHHHHHHHHHhcCCCCCeEcHHHHHHHHHH
Confidence            9999999999999984  44567778999999999999999999999998875

>2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A

Probab=99.55  E-value=4e-16  Score=124.72  Aligned_cols=105  Identities=22%  Similarity=0.391  Sum_probs=90.9

Q ss_pred             cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCC-CCCC
Q 040917          368 LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM-GDDA  446 (494)
Q Consensus       368 ~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~-~~~~  446 (494)
                      ++..++.+++..++..+|  ++|.|+|+||+..+...  ......++.+|+.||.|++|+|+.+||+.++..++. +..+
T Consensus         2 l~~~~~~~e~~~l~~~~d--~~g~i~~~eF~~~~~~~--~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~   77 (108)
T 2kyc_A            2 LTDILSPSDIAAALRDCQ--APDSFSPKKFFQISGMS--KKSSSQLKEIFRILDNDQSGFIEEDELKYFLQRFESGARVL   77 (108)
T ss_dssp             TTSSSCHHHHHHHHTTSC--STTTCCHHHHHHHHTCT--TCCSSSHHHHCSSSCSCCSSCCCGGGTTTSHHHHSSSCCCC
T ss_pred             ccccCCHHHHHHHHHHcC--CCCcCCHHHHHHHHhhC--cccHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhhccCCC
Confidence            567789999999999998  89999999999887422  223457899999999999999999999999998521 5678


Q ss_pred             cHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          447 TIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       447 ~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      ++++++.++..+|.|++|+|+|+||..++.
T Consensus        78 ~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~  107 (108)
T 2kyc_A           78 TASETKTFLAAADHDGDGKIGAEEFQEMVQ  107 (108)
T ss_dssp             CTTTTHHHHTTTCCSSSSCCCSSHHHHHHH
T ss_pred             CHHHHHHHHHHhCCCCCCcCCHHHHHHHHh
Confidence            888999999999999999999999999876

>1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8

Probab=99.53  E-value=4.8e-14  Score=125.03  Aligned_cols=125  Identities=18%  Similarity=0.305  Sum_probs=108.1

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhcc
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQ  418 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~  418 (494)
                      ..+..+|..+|.|++|.|+.+||..++...      .++..+|..+|.|++|.|+.+||...+.......+.+++..+|+
T Consensus        63 ~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~------~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~  136 (191)
T 1y1x_A           63 ATTEKLLHMYDKNHSGEITFDEFKDLHHFI------LSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMR  136 (191)
T ss_dssp             HHHHHHHHHHCTTCSSSBCHHHHHHHHHHH------HHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCeEcHHHHHHHHHHH------HHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHH
Confidence            345667888999999999999999988753      57889999999999999999999988876543445678899999


Q ss_pred             ccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCc--eeHHHHHHHHhc
Q 040917          419 YFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGR--ISYDEFRSMMKC  477 (494)
Q Consensus       419 ~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~--i~~~ef~~~~~~  477 (494)
                      .+|.|++|.|+.+||..++...        ..+.++|..+|.|++|.  ++++||+.++..
T Consensus       137 ~~D~d~dg~i~~~eF~~~~~~~--------~~~~~~F~~~D~d~dG~i~~~~~eF~~~~~~  189 (191)
T 1y1x_A          137 KFDRQRRGSLGFDDYVELSIFV--------CRVRNVFAFYDRERTGQVTFTFDTFIGGSVS  189 (191)
T ss_dssp             HHCTTCSSSBCHHHHHHHHHHH--------HHHHHHHHHHCTTCCSEEEEEHHHHHHHHHH
T ss_pred             HhCCCCCCeEeHHHHHHHHHHH--------HHHHHHHHHhCcCCCceEEeeHHHHHHHHHh
Confidence            9999999999999999999762        57889999999999999  789999998764

>2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A

Probab=99.52  E-value=7.5e-14  Score=121.47  Aligned_cols=124  Identities=20%  Similarity=0.285  Sum_probs=105.4

Q ss_pred             hhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccc
Q 040917          340 KLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQY  419 (494)
Q Consensus       340 ~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~  419 (494)
                      .+..+|..+|.+++|.|+.+||..++...      .++..+|..+|.|++|.|+.+||...+.......+...+..+|+.
T Consensus        45 ~~~~l~~~~D~~~~g~i~~~ef~~~~~~~------~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~  118 (172)
T 2znd_A           45 TVRSIISMFDRENKAGVNFSEFTGVWKYI------TDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRK  118 (172)
T ss_dssp             HHHHHHHHHCSSSSSEECHHHHHHHHHHH------HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCcCCHHHHHHHHHHH------HHHHHHHHHHCCCCCCccCHHHHHHHHHHcCCCCCHHHHHHHHHH
Confidence            44566778899999999999999988753      568889999999999999999999888765444456778999999


Q ss_pred             cccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCcee--HHHHHHHHhc
Q 040917          420 FDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRIS--YDEFRSMMKC  477 (494)
Q Consensus       420 ~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~--~~ef~~~~~~  477 (494)
                      +|.|++|.|+.+||..++...        +.+..+|..+|.|++|.|+  ++||+.++..
T Consensus       119 ~d~~~dg~i~~~eF~~~~~~~--------~~~~~~F~~~D~d~dG~i~~~~~ef~~~~~~  170 (172)
T 2znd_A          119 FDRQGRGQIAFDDFIQGCIVL--------QRLTDIFRRYDTDQDGWIQVSYEQYLSMVFS  170 (172)
T ss_dssp             HCTTCSSSEEHHHHHHHHHHH--------HHHHHHHHHHCTTSSSCCCCCHHHHHHHHHT
T ss_pred             hCCCCCCcCcHHHHHHHHHHH--------HHHHHHHHHhCCCCCCeEeeeHHHHHHHHHh
Confidence            999999999999999998762        5788999999999999995  7899887764

>2zkm_X 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-2; phospholipase C, phosphoinositide phospholipase, PLC-beta-2, calcium, coiled coil; 1.62A {Homo sapiens} SCOP: a.39.1.7 b.7.1.1 b.55.1.1 c.1.18.1 PDB: 2fju_B

Probab=99.51  E-value=3.9e-14  Score=150.21  Aligned_cols=135  Identities=11%  Similarity=0.153  Sum_probs=101.2

Q ss_pred             hHHHhhhhhhh--ccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcC-------CCCCcccchHHHHHHHHhhh
Q 040917          336 EEIQKLKEKFT--EMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADI-------DGNGTIDYIEFITATMQRHK  406 (494)
Q Consensus       336 ~~~~~~~~~F~--~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~-------~~~g~i~~~ef~~~~~~~~~  406 (494)
                      .....+++.|.  .+|+|++|.|+..||..+++.     .++++.++++.+|.       +++|.|+|+||+..+.... 
T Consensus       143 ~~~~~Lk~~F~~~~fD~d~dG~Is~~EL~~~l~~-----~~~ev~~li~~~d~~~~~~D~d~~g~idf~EF~~~~~~l~-  216 (799)
T 2zkm_X          143 SRSTFLDKILVKLKMQLNSEGKIPVKNFFQMFPA-----DRKRVEAALSACHLPKGKNDAINPEDFPEPVYKSFLMSLC-  216 (799)
T ss_dssp             CHHHHHHHHHHHHHHSCCTTSCEEHHHHHHHSCS-----CHHHHHHHHHHTTCCCCTTCEECGGGCCHHHHHHHHHHHS-
T ss_pred             cHHHHHHHHhHHhccCCCCCCeECHHHHHHHHhh-----hHHHHHHHHHHhCcCccccccCCCCcCCHHHHHHHHHHcc-
Confidence            34567888899  799999999999999999875     46889999999985       7889999999999887643 


Q ss_pred             hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCC---------CcHHHHHHHHHHhCCC----CCCceeHHHHHH
Q 040917          407 LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDD---------ATIATIKEIMSEVDRD----KDGRISYDEFRS  473 (494)
Q Consensus       407 ~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~---------~~~~~~~~~~~~~d~~----~dg~i~~~ef~~  473 (494)
                        ..++++++|+.||.|++|+|+.+||+++|... .|+.         +++++++++|.++|.|    ++|.|+|+||.+
T Consensus       217 --~r~el~~aF~~fD~d~~g~Is~~eL~~fL~~~-Qge~~~~~~~~~~~t~ee~~~iI~~~d~d~~~~~dg~is~eeF~~  293 (799)
T 2zkm_X          217 --PRPEIDEIFTSYHAKAKPYMTKEHLTKFINQK-QRDSRLNSLLFPPARPDQVQGLIDKYEPSGINAQRGQLSPEGMVW  293 (799)
T ss_dssp             --CCHHHHTTCC--------CCCHHHHHHHHHHT-CC---------------CHHHHHHHHCCC--------CCHHHHHH
T ss_pred             --CHHHHHHHHHHhccCCCCeEcHHHHHHHHHHh-cCCcccccccccCCCHHHHHHHHHHhhcccccccCCccchhhhhh
Confidence              23679999999999999999999999999983 1454         7888999999999998    899999999999


Q ss_pred             HHhccc
Q 040917          474 MMKCGT  479 (494)
Q Consensus       474 ~~~~~~  479 (494)
                      +|.+..
T Consensus       294 ~L~S~~  299 (799)
T 2zkm_X          294 FLCGPE  299 (799)
T ss_dssp             HHHSTT
T ss_pred             cccCcc
Confidence            998743

>2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe}

Probab=99.48  E-value=1.7e-13  Score=121.22  Aligned_cols=123  Identities=22%  Similarity=0.252  Sum_probs=108.4

Q ss_pred             CCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCC-CCCcccchHHHHHHHHhhh-hhHHHHHHHhccccccCCCCce
Q 040917          351 DNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADID-GNGTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYI  428 (494)
Q Consensus       351 ~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~-~~g~i~~~ef~~~~~~~~~-~~~~~~~~~~F~~~D~d~~G~I  428 (494)
                      +.+|.|+.+++..+.+..+  ++.+++.++|..+|.+ ++|.|+++||...+..... ......+..+|+.+|.|++|.|
T Consensus         3 ~~~~~l~~~el~~~~~~~~--~~~~el~~~f~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i   80 (190)
T 2l2e_A            3 KSQSKLSQDQLQDLVRSTR--FDKKELQQWYKGFFKDCPSGHLNKSEFQKIYKQFFPFGDPSAFAEYVFNVFDADKNGYI   80 (190)
T ss_dssp             CSSCCSCHHHHHHHHHHHC--SCSHHHHHHHHHHHHHSCCCEECHHHHHHHHHHHCCCSCHHHHHHHHHHHHCSSSTTCE
T ss_pred             cccccCCHHHHHHHHHhcC--CCHHHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCCCccHHHHHHHHHhcCCCCCeE
Confidence            4678999999999998875  4778899999999999 8999999999998876532 2355678999999999999999


Q ss_pred             eHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          429 TVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       429 ~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +.+||..++..  .+...+.+++..+|..+|.|++|.|+++||..++..
T Consensus        81 ~~~ef~~~~~~--~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~  127 (190)
T 2l2e_A           81 DFKEFICALSV--TSRGELNDKLIWAFQLYDLDNNGLISYDEMLRIVDA  127 (190)
T ss_dssp             EHHHHHHHHTT--SSCSCSHHHHHHHHHHHCTTSCSCBCHHHHHHHHHH
T ss_pred             eHHHHHHHHHH--HcCCCHHHHHHHHHhHccCCCCCcCcHHHHHHHHHH
Confidence            99999999998  556678889999999999999999999999998875

>1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5

Probab=99.48  E-value=4.7e-14  Score=125.17  Aligned_cols=119  Identities=20%  Similarity=0.310  Sum_probs=96.0

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh---------h---
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH---------K---  406 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~---------~---  406 (494)
                      ..+..+|..+|.|++|.|+..||..++..++...+.+++..+|..+|.|++|.|+++||...+....         .   
T Consensus        63 ~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~E~~~~~~~~~~~~g~~~~~~~~~  142 (193)
T 1bjf_A           63 KFAEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDE  142 (193)
T ss_dssp             HHHHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGG
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCHHHHHHHHHhhcCCCCCCeECHHHHHHHHHHHHHHhccccCCCccc
Confidence            4567889999999999999999999999988877888899999999999999999999998876531         0   


Q ss_pred             hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCce
Q 040917          407 LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRI  466 (494)
Q Consensus       407 ~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i  466 (494)
                      ......+..+|+.+|.|++|+|+.+||..++..        ..++.+++ .+|.|+||+|
T Consensus       143 ~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~--------~~~~~~~~-~~D~~~dG~i  193 (193)
T 1bjf_A          143 STPEKRTEKIFRQMDTNRDGKLSLEEFIRGAKS--------DPSIVRLL-QCDPSSAGQF  193 (193)
T ss_dssp             SSHHHHHHHHHHHSCTTCSSEECHHHHHHHHHH--------CTHHHHTT-CC--------
T ss_pred             ccHHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc--------CHHHHHHh-ccCCCCCCCC
Confidence            123466899999999999999999999999975        23688899 9999999986

>2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens}

Probab=99.48  E-value=2.2e-13  Score=118.45  Aligned_cols=122  Identities=14%  Similarity=0.180  Sum_probs=103.3

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh----hhhhHHHHHH
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR----HKLQRFENLY  414 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~----~~~~~~~~~~  414 (494)
                      ..+..+|..+|.|++|.|+.+||..++...      .++..+|..+| |++|.|+.+||..++...    ....+.+.+.
T Consensus        46 ~~~~~l~~~~D~d~~G~I~f~EF~~~~~~~------~~l~~aF~~fD-d~~G~I~~~El~~~l~~l~~~~G~~~~~~~~~  118 (174)
T 2i7a_A           46 DECRSLVALMELKVNGRLDQEEFARLWKRL------VHYQHVFQKVQ-TSPGVLLSSDLWKAIENTDFLRGIFISRELLH  118 (174)
T ss_dssp             HHHHHHHHHHCSSCSSEECHHHHHHHHHHH------HHHHHHHHHHC-SBTTBEEGGGHHHHHHTCGGGTTCCCCHHHHH
T ss_pred             HHHHHHHHHHCCCCCCcCCHHHHHHHHHHH------HHHHHHHHHhc-CCCCcCCHHHHHHHHHHhHhccCCCCCHHHHH
Confidence            355677888999999999999999987753      57889999999 999999999999888765    3334566788


Q ss_pred             HhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCC-ceeHHHHHHHHh
Q 040917          415 KAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDG-RISYDEFRSMMK  476 (494)
Q Consensus       415 ~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg-~i~~~ef~~~~~  476 (494)
                      .+++.+| |++|.|+.+||..++..  .      ..+.++|+.+|.|++| .++++||+..+.
T Consensus       119 ~l~~~~d-d~dG~I~~~EF~~~~~~--~------~~~~~~F~~~D~d~~GI~~~~~Ef~~~~~  172 (174)
T 2i7a_A          119 LVTLRYS-DSVGRVSFPSLVCFLMR--L------EAMAKTFRNLSKDGKGLYLTEMEWMSLVM  172 (174)
T ss_dssp             HHHHHHS-CTTSEECHHHHHHHHHH--H------HHHHHHHHHHCSSSSCCCCCHHHHHHHHH
T ss_pred             HHHHHHc-CCCCeEcHHHHHHHHHH--H------HHHHHHHHHhCCCCCCceecHHHHHHHHH
Confidence            9999999 99999999999999875  2      4688999999999999 449999988764

>1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3

Probab=99.47  E-value=8.5e-14  Score=152.08  Aligned_cols=138  Identities=19%  Similarity=0.289  Sum_probs=110.3

Q ss_pred             HHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-----------
Q 040917          338 IQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-----------  406 (494)
Q Consensus       338 ~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-----------  406 (494)
                      ++.+..+|+.+|.|++|+|+.+||..++..+|..++.+++..++..+| |++|.|+|+||+..+.....           
T Consensus       606 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~l~~~~~~~l~~~~d-d~dg~I~~~eF~~~~~~~~~l~~~F~~~D~d  684 (900)
T 1qxp_A          606 IRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRLEILFKIFKQLDPE  684 (900)
T ss_dssp             HHHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHHTS-CSSSBCCHHHHHHHHHHHHHHHHHHHHSCSS
T ss_pred             HHHHHHHHHhhCCCCCCeECHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCeEcHHHHHHHHHHHHHHHHHHHhhCCC
Confidence            367899999999999999999999999999999999999999999999 99999999999887753210           


Q ss_pred             ------------------------------------------hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCC--
Q 040917          407 ------------------------------------------LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM--  442 (494)
Q Consensus       407 ------------------------------------------~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~--  442 (494)
                                                                ......++.+|..+|.+ +|.|+.+||+++|..++.  
T Consensus       685 ~~G~It~~~~efl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~~-~G~Is~~El~~~L~~~~~~~  763 (900)
T 1qxp_A          685 NTGTIQLDLISWLSFSVLGKLAAAIEHHHHHHMHYSNIEANESEEERQFRKLFVQLAGD-DMEVSATELMNILNKVVTRH  763 (900)
T ss_dssp             CCSCEEEEHHHHHHHTCC--------------CCCCCC--------------CCCCTTC-SSCBCHHHHTTTSCC----C
T ss_pred             CCceEEecHHHHHHHhhhccccccccccccccccccCCCCCChHHHHHHHHHHHHhcCC-CCccCHHHHHHHHHHhcccc
Confidence                                                      00123456678888776 788899999999987431  


Q ss_pred             ----CCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          443 ----GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       443 ----~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                          ....+.++++.++..+|.|+||.|+|+||..++..
T Consensus       764 ~~~~~~~~s~~~~~~l~~~~D~d~dG~Is~~EF~~l~~~  802 (900)
T 1qxp_A          764 PDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNN  802 (900)
T ss_dssp             CSCC--CCCHHHHHHHHHHHCCSSSSSBCSHHHHHHHHH
T ss_pred             cccccCCCCHHHHHHHHHHHCCCCCCeECHHHHHHHHHH
Confidence                14677889999999999999999999999998864

>1eg3_A Dystrophin; EF-hand like domain, WW domain, structural protein; 2.00A {Homo sapiens} SCOP: a.39.1.7 a.39.1.7 b.72.1.1 PDB: 1eg4_A

Probab=99.46  E-value=4.9e-13  Score=121.41  Aligned_cols=161  Identities=14%  Similarity=0.226  Sum_probs=118.3

Q ss_pred             hhhhHHHHHHHHhhhccCchhHHHhhhhhhhccCC-CCCCcccHHHHHHHHHhcCC--------CCC-----HHHHHHHH
Q 040917          316 TAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDT-DNSGTLTYDELKAGLAKLGS--------MLT-----EFDVKQYM  381 (494)
Q Consensus       316 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~F~~~D~-~~~g~i~~~el~~~l~~~~~--------~~~-----~~~~~~~~  381 (494)
                      +...+++.+........++-..   +..+|+.+.. .++..++..++..+|..+..        ...     +.-+..+|
T Consensus        62 Rta~klr~lq~~~~l~lv~l~~---~~~~f~~~~l~~~~~~l~~~~l~~~L~~lY~~l~~~~p~~v~~~~~~~~~a~~lf  138 (261)
T 1eg3_A           62 RTAMKLRRLQKALCLDLLSLSA---ACDALDQHNLKQNDQPMDILQIINCLTTIYDRLEQEHNNLVNVPLCVDMCLNWLL  138 (261)
T ss_dssp             HHHHHHHHHHHHTTGGGCCHHH---HHHHHHHTTCCCTTSEEEHHHHHHHHHHHHHHHHHHSTTTCCHHHHHHHHHHHHH
T ss_pred             HHHHhhHhhhhhheeceeeHHH---HHHHHHHcCCCCCCCCCCHHHHHHHHHHHHHHHHhhCcCcCCchhhHHHHHHHHH
Confidence            3344444444444444444333   3444444333 36678999999888776521        122     12256699


Q ss_pred             HHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhh-------cC----CCCCCcHHH
Q 040917          382 QAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKD-------YG----MGDDATIAT  450 (494)
Q Consensus       382 ~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~-------~~----~~~~~~~~~  450 (494)
                      +.+|.|++|.|+|.||+..+.....+..+++++.+|+.|| |++|+|+.+|+..++.+       +|    +++...+..
T Consensus       139 ~~FD~~~~G~I~f~ef~~aLs~l~rG~leeKL~w~F~lyD-D~~G~I~~~El~~il~~i~~i~~~vge~~~~~~~~~e~~  217 (261)
T 1eg3_A          139 NVYDTGRTGRIRVLSFKTGIISLCKAHLEDKYRYLFKQVA-SSTGFCDQRRLGLLLHDSIQIPRQLGEVASFGGSNIEPS  217 (261)
T ss_dssp             HHHCTTCCSEEEHHHHHHHHHHTSSSCHHHHHHHHHHHHS-CTTSCBCHHHHHHHHHHHHHHHHHTTCGGGGTCSCCHHH
T ss_pred             HHccCCCCceEeHHHHHHHHHHHcCCCHHHHHHHHHheee-CCCCCCcHHHHHHHHHHHHHHHHhcCCcccCCCCCHHHH
Confidence            9999999999999999999988777788889999999999 99999999999999964       12    133456778


Q ss_pred             HHHHHHHhCCCCCCceeHHHHHHHHhcccccc
Q 040917          451 IKEIMSEVDRDKDGRISYDEFRSMMKCGTQLR  482 (494)
Q Consensus       451 ~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~  482 (494)
                      ++.+|..+|  +||.|+.+||+.-++..+++.
T Consensus       218 v~~~F~~~d--~dg~It~~EFl~~~~~dp~il  247 (261)
T 1eg3_A          218 VRSCFQFAN--NKPEIEAALFLDWMRLEPQSM  247 (261)
T ss_dssp             HHHHHHHTT--TCSCBCHHHHHHHHHTCCTTT
T ss_pred             HHHHHHhCC--CCCcCCHHHHHHHHHhCcHHH
Confidence            999999995  899999999999999877644

>3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C

Probab=99.46  E-value=3.4e-14  Score=119.46  Aligned_cols=97  Identities=20%  Similarity=0.219  Sum_probs=52.7

Q ss_pred             HHHHHhcCCCCCcccchHHHHHHHHhhh-----hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCC------CCCCc
Q 040917          379 QYMQAADIDGNGTIDYIEFITATMQRHK-----LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM------GDDAT  447 (494)
Q Consensus       379 ~~~~~~D~~~~g~i~~~ef~~~~~~~~~-----~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~------~~~~~  447 (494)
                      .+|..+|.|++|.|+++||+..+.....     ....+.++.+|+.||.|++|+|+.+||..++..++.      +..++
T Consensus        31 ~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~g~~~s  110 (143)
T 3a4u_B           31 SQPGSMGLDKNTVHDQEHIMEHLEGVINKPEAEMSPQELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPLMS  110 (143)
T ss_dssp             --------------------------------CCCHHHHHHHHHHHTCTTCSSCEEHHHHHHTCC-------------CC
T ss_pred             HHHHHhCCCCCCcCcHHHHHHHHHHHhcccccccCHHHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHhhhccccCCCCC
Confidence            4677778888888888888766654321     134567889999999999999999999999987421      35678


Q ss_pred             HHHHHHHH----HHhCCCCCCceeHHHHHHHH
Q 040917          448 IATIKEIM----SEVDRDKDGRISYDEFRSMM  475 (494)
Q Consensus       448 ~~~~~~~~----~~~d~~~dg~i~~~ef~~~~  475 (494)
                      ++++++++    ..+|.|+||+|+++||..+|
T Consensus       111 ~~e~~~~~~~~f~~~D~d~dG~Is~~EF~~~~  142 (143)
T 3a4u_B          111 EDELINIIDGVLRDDDKNNDGYIDYAEFAKSL  142 (143)
T ss_dssp             HHHHHHHHHHHHHHHCTTCSSEECHHHHHC--
T ss_pred             HHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHH
Confidence            88886655    99999999999999998765

>2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens}

Probab=99.44  E-value=2.8e-13  Score=122.10  Aligned_cols=131  Identities=21%  Similarity=0.338  Sum_probs=108.8

Q ss_pred             chhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh------hh
Q 040917          334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH------KL  407 (494)
Q Consensus       334 ~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~------~~  407 (494)
                      .......+..+|..+|.|++|.|+.+||..++..++.....+++..+|..+|.|++|.|+++||...+....      ..
T Consensus        52 ~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~~~~~~  131 (211)
T 2ggz_A           52 NQKANKHIDQVYNTFDTNKDGFVDFLEFIAAVNLIMQEKMEQKLKWYFKLYDADGNGSIDKNELLDMFMAVQALNGQQTL  131 (211)
T ss_dssp             CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHSCSSHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHTTSSCCCSC
T ss_pred             CcchHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhccCchHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCccc
Confidence            344556688999999999999999999999999988777788899999999999999999999999887652      22


Q ss_pred             hHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       408 ~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      ...+.+..+|+.+|.|++|.|+.+||..++..  .      .++.+++..       .++|++|+..|....
T Consensus       132 ~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~--~------~~~~~~~~~-------~~d~~~f~~~~~~~~  188 (211)
T 2ggz_A          132 SPEEFINLVFHKIDINNDGELTLEEFINGMAK--D------QDLLEIVYK-------SFDFSNVLRVICNGK  188 (211)
T ss_dssp             THHHHHHHHHHHHCTTCSSSBCHHHHHHHHHT--T------TTTHHHHHH-------HSCTTHHHHHHHHHC
T ss_pred             cHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHh--C------HHHHHHHhc-------cCCHHHHHHHHhcCC
Confidence            34456899999999999999999999999975  1      245666663       345899999998754

>3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A

Probab=99.43  E-value=3.5e-13  Score=122.24  Aligned_cols=123  Identities=12%  Similarity=0.081  Sum_probs=103.6

Q ss_pred             hhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccc
Q 040917          340 KLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQY  419 (494)
Q Consensus       340 ~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~  419 (494)
                      .+..+|..+|.|++|.|+.+||..++...      +++..+|..+|.|++|.|+.+||...+.......+.+++..+|+.
T Consensus        88 ~~~~l~~~~D~d~dg~I~~~EF~~~~~~~------~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~  161 (220)
T 3sjs_A           88 TALRMMRIFDTDFNGHISFYEFMAMYKFM------ELAYNLFVMNARARSGTLEPHEILPALQQLGFYINQRTSLLLHRL  161 (220)
T ss_dssp             HHHHHHHHHCTTCSSCBCHHHHHHHHHHH------HHHHHHHHHHCCSSTTEECHHHHHHHHHHHTCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCcCCHHHHHHHHHHH------HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHH
Confidence            45667778899999999999999998874      668899999999999999999999888765544456678999999


Q ss_pred             cccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHh-CCCCCC------ceeHHHHHHHHhc
Q 040917          420 FDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEV-DRDKDG------RISYDEFRSMMKC  477 (494)
Q Consensus       420 ~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~-d~~~dg------~i~~~ef~~~~~~  477 (494)
                      +| |++|.|+.+||.+++..+        ..+..+|..+ |.+++|      .|+|+||+..+..
T Consensus       162 ~d-d~dg~I~~~eF~~~~~~l--------~~~~~~F~~~~D~~~~G~i~~~~~i~~~ef~~~~~~  217 (220)
T 3sjs_A          162 FA-RGMAFCDLNCWIAICAFA--------AQTRSAYQMIFMNPYYGPMKPFNPMEFGKFLDVVTS  217 (220)
T ss_dssp             HC---CCSEEHHHHHHHHHHH--------HHHHHHHHHHHTSGGGCSCCCCCHHHHHHHHHHHHH
T ss_pred             hc-CCCCcCcHHHHHHHHHHH--------HHHHHHHHHhcccCCCCCcccccceeHHHHHHHHHH
Confidence            99 999999999999999762        2578899999 999999      8999999987763

>1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A

Probab=99.42  E-value=6e-13  Score=115.84  Aligned_cols=122  Identities=17%  Similarity=0.263  Sum_probs=101.3

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhcc
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQ  418 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~  418 (494)
                      ..+..+|..+|.+++|.|+.+||..++...      +++..+|..+|.|++|.|+.+||...+.......+...+..+|+
T Consensus        47 ~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~------~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~  120 (173)
T 1alv_A           47 DTCRSMVAVMDSDTTGKLGFEEFKYLWNNI------KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIR  120 (173)
T ss_dssp             HHHHHHHHHHCTTCSSSBCHHHHHHHHHHH------HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCccCHHHHHHHHHHH------HHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCCCCHHHHHHHHH
Confidence            455677788999999999999999888753      57888999999999999999999888876544445567888999


Q ss_pred             ccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          419 YFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       419 ~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      .+| |++|.|+.+||..++..        ...+..+|..+|.|++|.|+.+ |...+.
T Consensus       121 ~~d-d~dg~i~~~eF~~~~~~--------~~~~~~~F~~~D~d~~G~i~~~-~~~~l~  168 (173)
T 1alv_A          121 RYS-DEGGNMDFDNFISCLVR--------LDAMFRAFKSLDKDGTGQIQVN-IQEWLQ  168 (173)
T ss_dssp             HHT-CSSSCBCHHHHHHHHHH--------HHHHHHHHHHHSSSCCSEEEEE-HHHHHH
T ss_pred             Hhc-CCCCcCcHHHHHHHHHH--------HHHHHHHHHHhCCCCCCeecHh-HHHHHH
Confidence            999 99999999999999876        2578899999999999999866 555544

>1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A

Probab=99.41  E-value=5.7e-13  Score=117.80  Aligned_cols=123  Identities=20%  Similarity=0.279  Sum_probs=105.2

Q ss_pred             CCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCC-CCCcccchHHHHHHHHhhh-hhHHHHHHHhccccccCCCCce
Q 040917          351 DNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADID-GNGTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYI  428 (494)
Q Consensus       351 ~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~-~~g~i~~~ef~~~~~~~~~-~~~~~~~~~~F~~~D~d~~G~I  428 (494)
                      ++.+.|+.+++..+.+..  .++.+++..+|..+|.+ ++|.|+++||...+..... ......+..+|+.+|.|++|.|
T Consensus         3 ~~~~~l~~~~l~~l~~~~--~~~~~~i~~~~~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i   80 (190)
T 1fpw_A            3 AKTSKLSKDDLTCLKQST--YFDRREIQQWHKGFLRDCPSGQLAREDFVKIYKQFFPFGSPEDFANHLFTVFDKDNNGFI   80 (190)
T ss_dssp             CCSCCSTTHHHHHHTTTC--CSTHHHHHHHHHHHHHHCTTCCEEHHHHHHHHHHHCTTSCCSHHHHHHHHTCCSSCSSEE
T ss_pred             cccCCCCHHHHHHHHHhc--CCCHHHHHHHHHHHHHHCCCCcCcHHHHHHHHHHHcCCCCcHHHHHHHHHHHCCCCCCcE
Confidence            456789999999987764  46889999999999987 8999999999998876522 2234568999999999999999


Q ss_pred             eHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          429 TVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       429 ~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +.+||..++..+  +...+++++..+|..+|.|++|.|+++||..++..
T Consensus        81 ~~~ef~~~~~~~--~~~~~~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~  127 (190)
T 1fpw_A           81 HFEEFITVLSTT--SRGTLEEKLSWAFELYDLNHDGYITFDEMLTIVAS  127 (190)
T ss_dssp             CHHHHHHHHHHH--SCCCSTHHHHHHHHHHCSSCSSEEEHHHHHHHHHH
T ss_pred             eHHHHHHHHHHH--ccCCcHHHHHHHHHHhcCCCCCcCcHHHHHHHHHH
Confidence            999999999984  44567789999999999999999999999998875

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.40  E-value=3.2e-12  Score=119.32  Aligned_cols=141  Identities=18%  Similarity=0.187  Sum_probs=112.2

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ..|++...++.|+.+.||++...  +..+++|+.......   ....+.+|+.+++.|.++..+.+++++....+..|+|
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            46899999999999999999743  789999998643211   1235889999999997677788999999988899999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS----------------------------------------  152 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~----------------------------------------  152 (494)
                      ||+++|.+|.+.+.     +......++.++..++..||+                                        
T Consensus        89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            99999999876531     222334778899999999998                                        


Q ss_pred             -------------------CCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          153 -------------------KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       153 -------------------~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                                         ..++|||++|.||+++   ++..+.|+||+.+..
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhccc
Confidence                               4489999999999994   445567999998753

>2kld_A Polycystin-2; PC2, PKD2, calcium binding domain, EF hand, cytosolic, calcium, coiled coil, disease mutation, glycoprotein, ION transport; NMR {Homo sapiens} PDB: 2kle_A 2kq6_A 2y4q_A

Probab=99.39  E-value=6.4e-14  Score=114.17  Aligned_cols=102  Identities=22%  Similarity=0.292  Sum_probs=53.7

Q ss_pred             HHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHH-----HHHHhh-hhhHHHHHHHhccccccCCCCceeHHHHHHHHh
Q 040917          365 LAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFIT-----ATMQRH-KLQRFENLYKAFQYFDKDNNGYITVDELGKAFK  438 (494)
Q Consensus       365 l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~-----~~~~~~-~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~  438 (494)
                      ++.+|.+++..++..++...    +|.|+|+||+.     .+.... ......+++++|+.||    |+|+.+||+.+|.
T Consensus         2 lr~lG~~~t~~ei~~~~~~~----~g~i~f~EF~~~~~~~~~~~~~~~~~~~~~l~~aF~~fD----G~I~~~El~~~l~   73 (123)
T 2kld_A            2 STAIGINDTYSEVKSDLAQQ----KAEMELSDLIRKGYHKALVKLKLKKNTVDDISESLRQGG----GKLNFDELRQDLK   73 (123)
T ss_dssp             -----------------------------------------------------CCSCSSTTTT----TCEEHHHHHHHTT
T ss_pred             hhhcCCCCCHHHHHHHHHHc----CCCccHHHHHhHhHHHHHHHhhcChhHHHHHHHHHHHhC----CCCCHHHHHHHHH
Confidence            56788889999999998866    88999999998     554432 2223456888999998    9999999999999


Q ss_pred             hcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          439 DYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      .  +|.  +++++++++..+|.|+||.|+|+||..+|...
T Consensus        74 ~--lG~--t~~ei~~~~~~~D~d~dG~I~~~EF~~~~~~~  109 (123)
T 2kld_A           74 G--KGH--TDAEIEAIFTKYDQDGDQELTEHEHQQMRDDL  109 (123)
T ss_dssp             T--CCS--SHHHHHHHHHHHSSSSCCEECSHHHHHCSCTT
T ss_pred             H--hCC--CHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHH
Confidence            8  554  88999999999999999999999999987653

>1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8

Probab=99.38  E-value=1.8e-12  Score=112.04  Aligned_cols=120  Identities=20%  Similarity=0.259  Sum_probs=98.8

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhcc
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQ  418 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~  418 (494)
                      ..+..+|..+|.+++|.|+.+||..++...      +.+..+|..+|.|++|.|+.+||...+.......+.+.+..+|.
T Consensus        42 ~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~------~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~  115 (167)
T 1gjy_A           42 ETCRLMVSMLDRDMSGTMGFNEFKELWAVL------NGWRQHFISFDSDRSGTVDPQELQKALTTMGFRLNPQTVNSIAK  115 (167)
T ss_dssp             HHHHHHHHHHCTTCCSCBCHHHHHHHHHHH------HHHHHHHHHHCTTCCSEECHHHHHHHHHTTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCcCCHHHHHHHHHHH------HHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHH
Confidence            455677888999999999999999988763      57889999999999999999999888775443345567788888


Q ss_pred             ccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHH--HHHHH
Q 040917          419 YFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYD--EFRSM  474 (494)
Q Consensus       419 ~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~--ef~~~  474 (494)
                      .+  |++|.|+.+||..++...        ..+..+|..+|.|++|.|+.+  +|+..
T Consensus       116 ~~--d~dg~i~~~eF~~~~~~~--------~~~~~~F~~~D~d~~G~i~~~~~~~l~~  163 (167)
T 1gjy_A          116 RY--STSGKITFDDYIACCVKL--------RALTDSFRRRDSAQQGMVNFSYDDFIQC  163 (167)
T ss_dssp             HT--CBTTBEEHHHHHHHHHHH--------HHHHHHHHHHCTTCCSEEEEEHHHHHHH
T ss_pred             Hh--CcCCcCcHHHHHHHHHHH--------HHHHHHHHHhCCCCCeeEEeeHHHHHHH
Confidence            77  889999999999999762        578899999999999999865  44443

>1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E

Probab=99.38  E-value=1.2e-12  Score=115.06  Aligned_cols=118  Identities=15%  Similarity=0.164  Sum_probs=98.1

Q ss_pred             ccHHHHHHHHHhcCCCCCHHHHHHHHHHhcC-CCCCcccchHHHHHHHHhhhh-hHHHHHHHhccccccCCCCceeHHHH
Q 040917          356 LTYDELKAGLAKLGSMLTEFDVKQYMQAADI-DGNGTIDYIEFITATMQRHKL-QRFENLYKAFQYFDKDNNGYITVDEL  433 (494)
Q Consensus       356 i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~-~~~g~i~~~ef~~~~~~~~~~-~~~~~~~~~F~~~D~d~~G~I~~~el  433 (494)
                      ++.+++..+.+..+  ++.+++.+++..+|. |++|.|+++||...+...... .....+..+|+.+|.|++|.|+.+||
T Consensus         1 l~~~el~~l~~~~~--~s~~~i~~l~~~fd~~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef   78 (183)
T 1s6c_A            1 HRPEGLEQLEAQTN--FTKRELQVLYRGFKNEXPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDF   78 (183)
T ss_dssp             -----CHHHHHHSS--CCHHHHHHHHHHHHHHCTTSEECHHHHHHHHHHHSTTSCCHHHHHHHHHHHCTTCSSCEEHHHH
T ss_pred             CChHHHHHHHHhcC--CCHHHHHHHHHHHHHhCCCCcCCHHHHHHHHHHHcCCCChHHHHHHHHHHhCCCCCCcEeHHHH
Confidence            45677888887765  488899999999998 899999999999988765432 45678899999999999999999999


Q ss_pred             HHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          434 GKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       434 ~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ..++..  .+...+.+++..+|..+|.|++|.|+++||..++..
T Consensus        79 ~~~~~~--~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~  120 (183)
T 1s6c_A           79 VTALSI--LLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKA  120 (183)
T ss_dssp             HHHHHH--HHHCCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHH
T ss_pred             HHHHHH--HcCCCHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHH
Confidence            999987  334567788999999999999999999999998875

>1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A

Probab=99.37  E-value=1.8e-12  Score=111.82  Aligned_cols=121  Identities=17%  Similarity=0.273  Sum_probs=98.6

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhcc
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQ  418 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~  418 (494)
                      ..+..+|..+|.+++|.|+.+||..++...      +++..+|..+|.|++|.|+.+||...+.......+.+++..+|.
T Consensus        40 ~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~------~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~  113 (165)
T 1k94_A           40 ETCRIMIAMLDRDHTGKMGFNAFKELWAAL------NAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVK  113 (165)
T ss_dssp             HHHHHHHHHHCTTCSSCBCHHHHHHHHHHH------HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcCCHHHHHHHHHHH------HHHHHHHHHhCCCCCceECHHHHHHHHHHhCCCCCHHHHHHHHH
Confidence            355677788899999999999999888753      57888999999999999999999888776543345567788888


Q ss_pred             ccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          419 YFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       419 ~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      .+  |++|.|+.+||..++...        ..+.++|..+|.|++|.|+.+ |...+.
T Consensus       114 ~~--d~dg~i~~~eF~~~~~~~--------~~~~~~F~~~D~d~~G~i~~~-~~~~l~  160 (165)
T 1k94_A          114 RY--SKNGRIFFDDYVACCVKL--------RALTDFFRKRDHLQQGSANFI-YDDFLQ  160 (165)
T ss_dssp             HH--CBTTBCBHHHHHHHHHHH--------HHHHHHHHTTCTTCCSEEEEE-HHHHHH
T ss_pred             Hh--CCCCeEcHHHHHHHHHHH--------HHHHHHHHHhCCCCCCeEeee-HHHHHH
Confidence            77  889999999999998762        578889999999999999766 666554

>2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens}

Probab=99.35  E-value=8.2e-13  Score=103.11  Aligned_cols=71  Identities=31%  Similarity=0.653  Sum_probs=67.1

Q ss_pred             ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHH
Q 040917          331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITAT  401 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~  401 (494)
                      ..++.++.++++++|+.+|+|++|+|+.+||..+++.+|..++.+++..+|+.+|.|+||.|+|+||+.++
T Consensus        28 ~~l~~~~~~el~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~ei~~l~~~~D~d~dG~I~~~EF~~~m   98 (100)
T 2lv7_A           28 VDIPEDELEEIREAFKVFDRDGNGFISKQELGTAMRSLGYMPNEVELEVIIQRLDMDGDGQVDFEEFVTLL   98 (100)
T ss_dssp             CCCCGGGHHHHHHHHHHTCSSCSSCBCHHHHHHHHHHHTCCCCTTTHHHHHHHHCSSCSSSBCHHHHHHHT
T ss_pred             ccCCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCeEeHHHHHHHh
Confidence            34678899999999999999999999999999999999999999999999999999999999999999865

>1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A

Probab=99.35  E-value=3.8e-12  Score=113.38  Aligned_cols=122  Identities=21%  Similarity=0.274  Sum_probs=97.5

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhcc
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQ  418 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~  418 (494)
                      ..+..+|..+|.|++|.|+.+||..++...      +++..+|..+|.|++|.|+.+||...+.......+..++..+|+
T Consensus        73 ~~~~~l~~~~D~d~~g~i~~~eF~~~~~~~------~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~  146 (198)
T 1juo_A           73 ETCRLMVSMLDRDMSGTMGFNEFKELWAVL------NGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAK  146 (198)
T ss_dssp             HHHHHHHHHHCTTCSSCEEHHHHHHHHHHH------HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCeECHHHHHHHHHHH------HHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHH
Confidence            345667778899999999999999888753      57888999999999999999999888776543345567788888


Q ss_pred             ccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeH--HHHHHHHh
Q 040917          419 YFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISY--DEFRSMMK  476 (494)
Q Consensus       419 ~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~--~ef~~~~~  476 (494)
                      .+  |++|.|+.+||..++...        ..+.++|..+|.|++|.|+.  .+|+.++.
T Consensus       147 ~~--d~dg~i~~~eF~~~~~~~--------~~~~~~F~~~D~d~~G~is~~~~~~l~~~~  196 (198)
T 1juo_A          147 RY--STNGKITFDDYIACCVKL--------RALTDSFRRRDTAQQGVVNFPYDDFIQCVM  196 (198)
T ss_dssp             HT--CSSSSEEHHHHHHHHHHH--------HHHHHHHHHTCTTCCSEEEEEHHHHHHHHT
T ss_pred             Hh--CCCCeEcHHHHHHHHHHH--------HHHHHHHHHhCCCCCCeEeecHHHHHHHHh
Confidence            77  889999999999988762        46788899999999999887  66665443

>1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5

Probab=99.34  E-value=1.7e-12  Score=118.01  Aligned_cols=122  Identities=15%  Similarity=0.138  Sum_probs=99.6

Q ss_pred             CCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCC-CCCcccchHHHHHHHHhhh-hhHHHHHHHhccccccCCCCcee
Q 040917          352 NSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADID-GNGTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYIT  429 (494)
Q Consensus       352 ~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~-~~g~i~~~ef~~~~~~~~~-~~~~~~~~~~F~~~D~d~~G~I~  429 (494)
                      ..+.++.+++..+....+  ++.+++..++..+|.+ ++|.|+++||...+..... ......+..+|+.+|.|++|.|+
T Consensus        30 ~~~~l~~~~l~~l~~~~~--~s~~ei~~l~~~Fd~~d~~G~I~~~E~~~~l~~l~~~~~~~~~~~~~f~~~D~d~~G~I~  107 (224)
T 1s1e_A           30 TMVCHRPEGLEQLEAQTN--FTKRELQVLYRGFKNECPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVK  107 (224)
T ss_dssp             --------CHHHHHHHSS--CCHHHHHHHHHHHHHHCTTSCBCHHHHHHHHHTTCTTSCCHHHHHHHHHHHCTTCSSCBC
T ss_pred             CccCCCHHHHHHHHHHcC--CCHHHHHHHHHHHHhhCCCCCCCHHHHHHHHHHhcCCCCcHHHHHHHHHHhcCCCCCcEe
Confidence            457899999999998876  7889999999999984 9999999999988876533 24567889999999999999999


Q ss_pred             HHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          430 VDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       430 ~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .+||..++..+  +....++++..+|..+|.|++|.|+++||..++..
T Consensus       108 ~~Ef~~~l~~~--~~~~~~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~  153 (224)
T 1s1e_A          108 FEDFVTALSIL--LRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKA  153 (224)
T ss_dssp             HHHHHHHHHHH--HHCCHHHHHHHHHHHHCTTCCSEECHHHHHHHHHH
T ss_pred             HHHHHHHHHHH--ccCCHHHHHHHHHHHHcCCCCCeECHHHHHHHHHH
Confidence            99999999873  34457788999999999999999999999998875

>1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A

Probab=99.34  E-value=3.6e-12  Score=112.60  Aligned_cols=122  Identities=20%  Similarity=0.202  Sum_probs=103.7

Q ss_pred             CCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCC-CCCcccchHHHHHHHHhhh-hhHHHHHHHhccccccCCCCcee
Q 040917          352 NSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADID-GNGTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYIT  429 (494)
Q Consensus       352 ~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~-~~g~i~~~ef~~~~~~~~~-~~~~~~~~~~F~~~D~d~~G~I~  429 (494)
                      ..+.++.+++..+....+  ++.+++..+|..+|.+ ++|.|+++||...+..... ......+..+|+.+|.|++|.|+
T Consensus         4 ~~~~l~~~~l~~l~~~~~--~~~~~i~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~   81 (190)
T 1g8i_A            4 SNSKLKPEVVEELTRKTY--FTEKEVQQWYKGFIKDCPSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIE   81 (190)
T ss_dssp             CCCSCCHHHHHHHHHTSS--SCHHHHHHHHHHHHHHCTTSEEEHHHHHHHHHHHCTTSCTHHHHHHHHHHHCTTCSSEEE
T ss_pred             ccccCCHHHHHHHHHccC--CCHHHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCCChHHHHHHHHHHHhcCCCCeEe
Confidence            455788999988887654  5788999999999998 8999999999998876521 23445689999999999999999


Q ss_pred             HHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          430 VDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       430 ~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .+||..++..+  +...+.+++..+|..+|.|++|.|+++||..++..
T Consensus        82 ~~ef~~~~~~~--~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~l~~  127 (190)
T 1g8i_A           82 FSEFIQALSVT--SRGTLDEKLRWAFKLYDLDNDGYITRNEMLDIVDA  127 (190)
T ss_dssp             HHHHHHHHHHH--HHCCHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHh--cCCCHHHHHHHHHHhhcCCCCCeECHHHHHHHHHH
Confidence            99999999873  34467788999999999999999999999998875

>2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens}

Probab=99.33  E-value=8e-13  Score=103.17  Aligned_cols=65  Identities=32%  Similarity=0.714  Sum_probs=60.4

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHH
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMM  475 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~  475 (494)
                      ...+++++|+.||.|++|+|+.+||+.+|..  +|..++++++++++..+|.|+||.|+|+||+.+|
T Consensus        34 ~~~el~~~F~~~D~d~~G~I~~~El~~~l~~--lg~~~~~~ei~~l~~~~D~d~dG~I~~~EF~~~m   98 (100)
T 2lv7_A           34 ELEEIREAFKVFDRDGNGFISKQELGTAMRS--LGYMPNEVELEVIIQRLDMDGDGQVDFEEFVTLL   98 (100)
T ss_dssp             GHHHHHHHHHHTCSSCSSCBCHHHHHHHHHH--HTCCCCTTTHHHHHHHHCSSCSSSBCHHHHHHHT
T ss_pred             HHHHHHHHHHHHcCCCCCcCCHHHHHHHHHH--hCCCCCHHHHHHHHHHHCCCCCCeEeHHHHHHHh
Confidence            4567999999999999999999999999999  5678899999999999999999999999999876

>2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus}

Probab=99.33  E-value=5e-12  Score=112.58  Aligned_cols=106  Identities=19%  Similarity=0.306  Sum_probs=92.2

Q ss_pred             chhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh-------h
Q 040917          334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH-------K  406 (494)
Q Consensus       334 ~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~-------~  406 (494)
                      .......+..+|..+|.|++|.|+..||..++..++...+.+++..+|..+|.|++|.|+++||...+....       .
T Consensus        47 ~~~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~  126 (198)
T 2r2i_A           47 SPSANKYVEQMFETFDFNKDGYIDFMEYVAALSLVLKGKVDQKLRWYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNEA  126 (198)
T ss_dssp             CHHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHSSCCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHTTGGGGSSSC
T ss_pred             CcchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHccCchHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCCch
Confidence            344456688999999999999999999999999998888888999999999999999999999999887653       2


Q ss_pred             hhHHHHHHHhccccccCCCCceeHHHHHHHHhh
Q 040917          407 LQRFENLYKAFQYFDKDNNGYITVDELGKAFKD  439 (494)
Q Consensus       407 ~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~  439 (494)
                      ....+.+..+|+.+|.|++|.|+.+||..++..
T Consensus       127 ~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~  159 (198)
T 2r2i_A          127 MTAEEFTNMVFDKIDINGDGELSLEEFMEGVQK  159 (198)
T ss_dssp             CCHHHHHHHHHHHHCTTCSSEECHHHHHHHHTT
T ss_pred             hhHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHc
Confidence            233456899999999999999999999999864

>1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5

Probab=99.31  E-value=3.2e-13  Score=103.01  Aligned_cols=85  Identities=33%  Similarity=0.500  Sum_probs=70.2

Q ss_pred             CCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCce
Q 040917          387 DGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRI  466 (494)
Q Consensus       387 ~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i  466 (494)
                      |++|.|+|+|++  +...........++.+|+.+|.|++|+|+.+||+.++..  ++...++++++.++..+|.|++|.|
T Consensus         1 ~~~G~i~~~e~~--~~~~l~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~--~~~~~~~~~~~~l~~~~d~~~~g~i   76 (87)
T 1s6j_A            1 HSSGHIDDDDKH--MAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKR--VGSELMESEIKDLMDAADIDKSGTI   76 (87)
T ss_dssp             CCSSSSSSHHHH--SSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHT--TTSSCCHHHHHHHHHHHCTTCSSEE
T ss_pred             CCCCccCccHHH--HHHHCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCcC
Confidence            578999999932  222222223346889999999999999999999999999  6678899999999999999999999


Q ss_pred             eHHHHHHHH
Q 040917          467 SYDEFRSMM  475 (494)
Q Consensus       467 ~~~ef~~~~  475 (494)
                      +|+||+.++
T Consensus        77 ~~~eF~~~~   85 (87)
T 1s6j_A           77 DYGEFIAAT   85 (87)
T ss_dssp             CHHHHTTCC
T ss_pred             cHHHHHHHH
Confidence            999997654

>1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A

Probab=99.30  E-value=2.9e-12  Score=108.18  Aligned_cols=89  Identities=19%  Similarity=0.386  Sum_probs=77.7

Q ss_pred             hhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHH
Q 040917          335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLY  414 (494)
Q Consensus       335 ~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~  414 (494)
                      .++..++..+|..+|.|++|+|+.+||..++..+|..++..++..+|..+|.|++|.|+|+||+..+...     ...+.
T Consensus        44 ~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D~d~dg~I~~~eF~~~~~~~-----~~~~~  118 (147)
T 1wy9_A           44 PSKLEAFKVKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHLELKRLIREVSSGSEETFSYSDFLRMMLGK-----RSAIL  118 (147)
T ss_dssp             HHHHHHHHHHHTTSCCCTTSSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCTTEECHHHHHHHHCSS-----GGGGG
T ss_pred             HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHh-----HHHHH
Confidence            5788899999999999999999999999999999999999999999999999999999999999887643     23688


Q ss_pred             HhccccccCCCCce
Q 040917          415 KAFQYFDKDNNGYI  428 (494)
Q Consensus       415 ~~F~~~D~d~~G~I  428 (494)
                      .+|+.||.|++|..
T Consensus       119 ~aF~~~D~d~~g~~  132 (147)
T 1wy9_A          119 RMILMYEEKNKEHK  132 (147)
T ss_dssp             GGGGGCCCC-----
T ss_pred             HHHHHHccCCCCCC
Confidence            99999999999984

>1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A

Probab=99.30  E-value=4.6e-12  Score=104.69  Aligned_cols=102  Identities=23%  Similarity=0.382  Sum_probs=87.2

Q ss_pred             HHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhc-CCCCCCcHHHHHHHH
Q 040917          377 VKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDY-GMGDDATIATIKEIM  455 (494)
Q Consensus       377 ~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~-~~~~~~~~~~~~~~~  455 (494)
                      +.++|..+|.|++|.|+++||...+.......+...+..+|+.+|.|++|.|+.+||..++..+ ......+..++..+|
T Consensus         2 l~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~f   81 (134)
T 1jfj_A            2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIGLKVLY   81 (134)
T ss_dssp             HHHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHHHHHHH
T ss_pred             HHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhcccccCCCHHHHHHHH
Confidence            5689999999999999999999988765555567789999999999999999999999999621 133345667799999


Q ss_pred             HHhCCCCCCceeHHHHHHHHhcc
Q 040917          456 SEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       456 ~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ..+|.|++|.|+++||..++...
T Consensus        82 ~~~D~d~~G~i~~~e~~~~l~~~  104 (134)
T 1jfj_A           82 KLMDVDGDGKLTKEEVTSFFKKH  104 (134)
T ss_dssp             HHHCCSSSSEEEHHHHHHHHTTT
T ss_pred             HHHCCCCCCccCHHHHHHHHHHh
Confidence            99999999999999999998864

>2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A

Probab=99.30  E-value=7.5e-12  Score=112.23  Aligned_cols=125  Identities=17%  Similarity=0.193  Sum_probs=92.1

Q ss_pred             CCCCCcccHHHHHHHHHhcCCCCCH-HHHHHHHHHhcCC--CCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCC
Q 040917          350 TDNSGTLTYDELKAGLAKLGSMLTE-FDVKQYMQAADID--GNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNG  426 (494)
Q Consensus       350 ~~~~g~i~~~el~~~l~~~~~~~~~-~~~~~~~~~~D~~--~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G  426 (494)
                      +|++|.|+.+++..+....+..... .++..+|..+|.|  ++|.|+++||...+.. ........+..+|+.+|.|++|
T Consensus        11 ~~~~g~l~~~el~~l~~~~~~s~~~~~~l~~~F~~~D~d~~~~G~i~~~e~~~~l~~-~~~~~~~~~~~~f~~~D~d~~g   89 (207)
T 2ehb_A           11 KNAMRPPGYEDPELLASVTPFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQLALFR-NRNRRNLFADRIFDVFDVKRNG   89 (207)
T ss_dssp             ----------CHHHHHHHSSCCHHHHHHHHHHHHHHTTSSSCSSCEEHHHHHHHHHS-CTTCCCHHHHHHHHHHCTTCSS
T ss_pred             hccccccCHHHHHHHHHhCCCCHHHHHHHHHHHHHhccccCCCCccCHHHHHHHHhc-cccccHHHHHHHHHHhcCCCCC
Confidence            4789999999999998876532221 2366788999999  9999999999988764 2222234567899999999999


Q ss_pred             ceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          427 YITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       427 ~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      .|+.+||..++...+. .....+++..+|..+|.|++|.|+.+||..++.
T Consensus        90 ~i~~~Ef~~~~~~~~~-~~~~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~  138 (207)
T 2ehb_A           90 VIEFGEFVRSLGVFHP-SAPVHEKVKFAFKLYDLRQTGFIEREELKEMVV  138 (207)
T ss_dssp             EECHHHHHHHHGGGST-TSCHHHHHHHHHHHHCTTCCSSEEHHHHHHHHH
T ss_pred             eEeHHHHHHHHHHHcc-CCCHHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence            9999999999987421 334677899999999999999999999999885

>4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens}

Probab=99.29  E-value=6.3e-12  Score=100.83  Aligned_cols=105  Identities=21%  Similarity=0.302  Sum_probs=75.5

Q ss_pred             hHHHhhhhhhhccCCCCCCcccHHHHHHHHHh-----cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHH
Q 040917          336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAK-----LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRF  410 (494)
Q Consensus       336 ~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~  410 (494)
                      ..++.+..+|+.||.| +|+|+.+||+.+++.     ++...+.+++.++++.+|.|+||.|+|+||+..+.....    
T Consensus        12 ~~ie~l~~~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~~~~~~~~v~~~i~~~D~d~DG~IdF~EF~~lm~~l~~----   86 (121)
T 4drw_A           12 HAMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGLTI----   86 (121)
T ss_dssp             HHHHHHHHTTGGGSCT-TCSCCHHHHHHHTTTSCHHHHTTSSCTTHHHHHHHHHCTTCSSCCCHHHHHHHHHHHHH----
T ss_pred             HHHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHHhhhhcccCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHH----
Confidence            4568899999999988 899999999999987     688888899999999999999999999999998886543    


Q ss_pred             HHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCC
Q 040917          411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKD  463 (494)
Q Consensus       411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~d  463 (494)
                       .-.+.|....+.++.+...                 +..+.++|+++|.|||
T Consensus        87 -~~he~f~~~~k~~~~~~~~-----------------d~~~~e~~~~~d~~gd  121 (121)
T 4drw_A           87 -ACNDYFVVHMKQENLYFQG-----------------DSTVHEILSKLSLEGD  121 (121)
T ss_dssp             -HHHHHHTTSCC--------------------------CCHHHHHHHCCC---
T ss_pred             -HHHHHHHHHHHHhccCCCC-----------------chHHHHHHHHhcccCC
Confidence             1234555444333332221                 2246677777776665

>2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A

Probab=99.29  E-value=2.9e-12  Score=108.57  Aligned_cols=89  Identities=25%  Similarity=0.396  Sum_probs=73.7

Q ss_pred             hhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHH
Q 040917          335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLY  414 (494)
Q Consensus       335 ~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~  414 (494)
                      ..+..++..+|..+|.|++|+|+.+||..++..+|..++.+++..++..+|.|++|.|+|+||+..+...     ...+.
T Consensus        46 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~~D~d~dg~I~~~eF~~~~~~~-----~~~i~  120 (150)
T 2jjz_A           46 PEKLTAFKEKYMEFDLNNEGEIDLMSLKRMMEKLGVPKTHLEMKKMISEVTGGVSDTISYRDFVNMMLGK-----RSAVL  120 (150)
T ss_dssp             HHHHHHHHHHHTTSCCCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHHTTSCSSBCHHHHHHHHHSS-----SCCHH
T ss_pred             HHHHHHHHHHHHHhCCCCcCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHh-----HHHHH
Confidence            4677889999999999999999999999999999999999999999999999999999999999988754     23689


Q ss_pred             HhccccccCCCCce
Q 040917          415 KAFQYFDKDNNGYI  428 (494)
Q Consensus       415 ~~F~~~D~d~~G~I  428 (494)
                      .+|+.||.|++|+-
T Consensus       121 ~aF~~~D~d~~G~~  134 (150)
T 2jjz_A          121 KLVMMFEGKANESS  134 (150)
T ss_dssp             HHHHC---------
T ss_pred             HHHHHHcCCCCCCC
Confidence            99999999999984

>3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A

Probab=99.29  E-value=4.7e-12  Score=98.41  Aligned_cols=69  Identities=16%  Similarity=0.293  Sum_probs=61.9

Q ss_pred             HHHHHHHhccccc-cCCC-CceeHHHHHHHHhh-cC--CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFD-KDNN-GYITVDELGKAFKD-YG--MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D-~d~~-G~I~~~el~~~l~~-~~--~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ....++++|+.|| .|++ |+|+.+||+.+|.. ++  +|...+++++++++.++|.|+||.|+|+||+.+|.+
T Consensus         8 ~i~~l~~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~~~~   81 (101)
T 3nso_A            8 AVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLAC   81 (101)
T ss_dssp             HHHHHHHHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHCCCSCEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence            4467999999997 8987 99999999999985 54  567889999999999999999999999999998875

>2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A

Probab=99.27  E-value=1.2e-11  Score=93.84  Aligned_cols=85  Identities=26%  Similarity=0.429  Sum_probs=71.9

Q ss_pred             hccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhH
Q 040917          330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQR  409 (494)
Q Consensus       330 ~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~  409 (494)
                      ...+++++..++..+|..+|.|++|+|+.+||..++..+| .++.+++..+|..+|.|++|.|+|+||+..+.....  .
T Consensus         2 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g-~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~~--~   78 (86)
T 2opo_A            2 AAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTDGDGFISFDEFTDFARANRG--L   78 (86)
T ss_dssp             ----CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCTTCSSEECHHHHHHHHHHCTT--T
T ss_pred             CccCCHhhHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcC-CCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHCcc--H
Confidence            3556788899999999999999999999999999999999 899999999999999999999999999998876432  2


Q ss_pred             HHHHHHhc
Q 040917          410 FENLYKAF  417 (494)
Q Consensus       410 ~~~~~~~F  417 (494)
                      ...+.++|
T Consensus        79 ~~~~~~aF   86 (86)
T 2opo_A           79 VKDVSKIF   86 (86)
T ss_dssp             HHHHHHHC
T ss_pred             HHHHHHhC
Confidence            34566655

>3ohm_B 1-phosphatidylinositol-4,5-bisphosphate phosphodi beta-3; PH domain, EF hand, TIM barrel, C2 domain, GTPase, lipase, C binding, GTP binding; HET: GDP; 2.70A {Homo sapiens}

Probab=99.27  E-value=1.5e-11  Score=130.25  Aligned_cols=133  Identities=9%  Similarity=0.163  Sum_probs=114.1

Q ss_pred             HHhhhhhhhc--cCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCC-------CCCcccchHHHHHHHHhhhhh
Q 040917          338 IQKLKEKFTE--MDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADID-------GNGTIDYIEFITATMQRHKLQ  408 (494)
Q Consensus       338 ~~~~~~~F~~--~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~-------~~g~i~~~ef~~~~~~~~~~~  408 (494)
                      ...+.+.|..  +|+|++|.|+..++..+++.     ..+++..+++.+|.+       ++|.|+|+||+..+.....  
T Consensus       149 ~~~L~kaf~~~~~D~n~dGkIs~kel~~~l~~-----~~~~v~~l~~~~d~~~~~~d~~~~g~i~feEF~~f~~~l~~--  221 (885)
T 3ohm_B          149 NTFLRKAYTKLKLQVNQDGRIPVKNILKMFSA-----DKKRVETALESCGLKFNRSESIRPDEFSLEIFERFLNKLCL--  221 (885)
T ss_dssp             HHHHHHHHHHHHHSCCTTSCEEHHHHHHTTGG-----GHHHHHHHHHTTTCCCSTTCEECGGGCCHHHHHHHHHHHSC--
T ss_pred             HHHHHHHHHHhcCccCCCCccCHHHHHHHHhc-----CHHHHHHHHHHhCCCccccccCCCCcCCHHHHHHHHHhcCC--
Confidence            4567778887  89999999999999998875     467899999999987       8899999999998875432  


Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCC---------CCcHHHHHHHHHHhCCC----CCCceeHHHHHHHH
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGD---------DATIATIKEIMSEVDRD----KDGRISYDEFRSMM  475 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~---------~~~~~~~~~~~~~~d~~----~dg~i~~~ef~~~~  475 (494)
                       .++++++|+.||.+++|+|+.+||+++|.... ++         ..+++++.++|..++.+    ++|.+++++|.++|
T Consensus       222 -R~EI~eiF~~ydsd~~g~mT~~EL~~FL~~~Q-~e~~~~e~~~~~~t~e~~~~iI~k~e~~~~~~~~g~LsldgF~~yL  299 (885)
T 3ohm_B          222 -RPDIDKILLEIGAKGKPYLTLEQLMDFINQKQ-RDPRLNEVLYPPLRPSQARLLIEKYEPNQQFLERDQMSMEGFSRYL  299 (885)
T ss_dssp             -CHHHHHHHHHTTCCSTTCEEHHHHHHHHHHHS-SCTTSCTTTSCCCCHHHHHHHHHHHCCCHHHHHTTEECHHHHHHHH
T ss_pred             -HHHHHHHHHHHhcCCCCccCHHHHHHHHHHhc-CcccccccccccCCHHHHHHHHHHhcCChhhhccCccchhhhhhhc
Confidence             35799999999999999999999999999842 22         36889999999999998    79999999999999


Q ss_pred             hccc
Q 040917          476 KCGT  479 (494)
Q Consensus       476 ~~~~  479 (494)
                      .+..
T Consensus       300 ~S~~  303 (885)
T 3ohm_B          300 GGEE  303 (885)
T ss_dssp             TSTT
T ss_pred             cCcc
Confidence            8643

>2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max}

Probab=99.26  E-value=2.2e-11  Score=93.70  Aligned_cols=86  Identities=31%  Similarity=0.568  Sum_probs=75.3

Q ss_pred             CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhh---hH
Q 040917          333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKL---QR  409 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~---~~  409 (494)
                      .+.++...+..+|..+|.+++|+|+.+||..++..+|..++.+++..+|..+|.|++|.|+|+||+..+......   ..
T Consensus         3 ~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~dg~i~~~eF~~~~~~~~~~~~~~~   82 (92)
T 2kn2_A            3 MDTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEADLDGDGQVNYEEFVKMMMTVRGGGGGNG   82 (92)
T ss_dssp             CCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCCSSEEHHHHHHHHHHHTTTCCCHH
T ss_pred             CCccHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhccCCCCCch
Confidence            456778899999999999999999999999999999999999999999999999999999999999988765433   23


Q ss_pred             HHHHHHhcc
Q 040917          410 FENLYKAFQ  418 (494)
Q Consensus       410 ~~~~~~~F~  418 (494)
                      ..+++.+|+
T Consensus        83 ~~~l~~aF~   91 (92)
T 2kn2_A           83 WSRLRRKFS   91 (92)
T ss_dssp             HHHHHHHHT
T ss_pred             HHHHHHHhc
Confidence            456777775

>2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A

Probab=99.26  E-value=5.7e-12  Score=106.77  Aligned_cols=95  Identities=22%  Similarity=0.298  Sum_probs=79.6

Q ss_pred             CCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHH
Q 040917          372 LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATI  451 (494)
Q Consensus       372 ~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~  451 (494)
                      ++.+++.+++..+|.+++    +.+|...      ......++.+|+.||.|++|+|+.+||+.+|..  +|...+++++
T Consensus        21 ~~~~~~~~i~~~~d~~~~----~~~~~~l------~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~--~g~~~~~~e~   88 (150)
T 2jjz_A           21 RQERRLAEINREFLCDQK----YSDEENL------PEKLTAFKEKYMEFDLNNEGEIDLMSLKRMMEK--LGVPKTHLEM   88 (150)
T ss_dssp             HHHHHHHHHHHHHHTCGG----GSSCTTH------HHHHHHHHHHHTTSCCCTTSSBCHHHHHHHHHH--TTCCCCHHHH
T ss_pred             CcHHHHHHHHHHhccCCC----chhhHhH------HHHHHHHHHHHHHhCCCCcCcCCHHHHHHHHHH--cCCCCCHHHH
Confidence            456788999999987764    3333222      234567999999999999999999999999999  6678899999


Q ss_pred             HHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          452 KEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       452 ~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ++++..+|.|++|.|+|+||..++...
T Consensus        89 ~~l~~~~D~d~dg~I~~~eF~~~~~~~  115 (150)
T 2jjz_A           89 KKMISEVTGGVSDTISYRDFVNMMLGK  115 (150)
T ss_dssp             HHHHHHHHTTSCSSBCHHHHHHHHHSS
T ss_pred             HHHHHHHCCCCCCcEeHHHHHHHHHHh
Confidence            999999999999999999999998763

>3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii}

Probab=99.25  E-value=2.5e-11  Score=107.14  Aligned_cols=119  Identities=21%  Similarity=0.251  Sum_probs=94.8

Q ss_pred             ccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh-----------hhhhHHHHHHHhccccccCC
Q 040917          356 LTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR-----------HKLQRFENLYKAFQYFDKDN  424 (494)
Q Consensus       356 i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~-----------~~~~~~~~~~~~F~~~D~d~  424 (494)
                      +...-+..+-..+.......++.++|..+|.|++|.|+++||...+...           ........+..+|+.+|.|+
T Consensus        21 ~~~~~l~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~  100 (191)
T 3khe_A           21 LAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRKLMQWKGDTVSDLDSSQIEAEVDHILQSVDFDR  100 (191)
T ss_dssp             HHHHHHHHHHHHSSCTTTTHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHC-----CCHHHHHHHHHHHHHHHHHTCTTC
T ss_pred             HHHHHHHHHHHHHcCHHHHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHhhcccccccccchhhHHHHHHHHHHhCCCC
Confidence            3333344333444233445678999999999999999999999887765           33445678899999999999


Q ss_pred             CCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          425 NGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       425 ~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      +|.|+.+||..++..  .......+.+..+|..+|.|++|.|+.+||..++.
T Consensus       101 ~g~i~~~ef~~~~~~--~~~~~~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~  150 (191)
T 3khe_A          101 NGYIEYSEFVTVCMD--KQLLLSRERLLAAFQQFDSDGSGKITNEELGRLFG  150 (191)
T ss_dssp             SSSEEHHHHHHHHSC--HHHHCCHHHHHHHHHHHCTTCSSEECHHHHHHHTT
T ss_pred             CCcCCHHHHHHHHHH--hcccchHHHHHHHHHHHCCCCcCcCCHHHHHHHHc
Confidence            999999999999865  23345677899999999999999999999999988

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.23  E-value=7.3e-11  Score=109.78  Aligned_cols=136  Identities=11%  Similarity=0.105  Sum_probs=99.2

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCC-ccEEeEEEEeCCeEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN-IVQFKAAYEDDQFVHI  111 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~-i~~~~~~~~~~~~~~i  111 (494)
                      ..|.+....+.|..+.||++.. .+|..+++|+....      ....+.+|+.+++.+..++- +.+++.+....+..++
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~   92 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL   92 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence            4566655555677799999964 45778999997543      12347789999999975522 5668888887778899


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------------
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG-------------------------------------  154 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------  154 (494)
                      |||+++|.+|.  .   ...+.   ..++.++...+..||+..                                     
T Consensus        93 v~e~i~G~~l~--~---~~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           93 LLGEVPGQDLL--S---SHLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             EEECCSSEETT--T---SCCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             EEEecCCcccC--c---CcCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            99999998884  2   11222   255667777777777643                                     


Q ss_pred             ---------------------ceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          155 ---------------------VMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       155 ---------------------i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                                           ++|||++|.||+++   ++..+.|+||+.+..
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhccc
Confidence                                 99999999999994   445566999998753

>1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5

Probab=99.22  E-value=2e-11  Score=109.23  Aligned_cols=105  Identities=15%  Similarity=0.137  Sum_probs=91.3

Q ss_pred             CCHHHHHHHHHHhcCC-CCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHH
Q 040917          372 LTEFDVKQYMQAADID-GNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIAT  450 (494)
Q Consensus       372 ~~~~~~~~~~~~~D~~-~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~  450 (494)
                      ++.+++.++|..+|.+ ++|.|+++||...+...........+..+|+.+|.|++|.|+.+||..++..+  +...+.++
T Consensus        19 ~~~~el~~~f~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~--~~~~~~~~   96 (204)
T 1jba_A           19 ADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLV--LRGTLEHK   96 (204)
T ss_dssp             HHHHHHHHHHHHHHSSSTTCCEEHHHHHHHHHCCSSSTTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHH--SSCCCTHH
T ss_pred             CCHHHHHHHHHHHHhhCCCCCcCHHHHHHHHHHhcCCCcHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHH--ccCCHHHH
Confidence            4567889999999999 89999999999888765444556778999999999999999999999999984  44567788


Q ss_pred             HHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          451 IKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       451 ~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      +..+|..+|.|++|.|+++||..++...
T Consensus        97 ~~~~F~~~D~d~~G~I~~~E~~~~l~~~  124 (204)
T 1jba_A           97 LKWTFKIYDKDRNGCIDRQELLDIVESI  124 (204)
T ss_dssp             HHHHHHHHCSSCSSCBCHHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence            9999999999999999999999988753

>2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus}

Probab=99.22  E-value=1.7e-11  Score=113.88  Aligned_cols=122  Identities=19%  Similarity=0.165  Sum_probs=99.6

Q ss_pred             CCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCC-CCCcccchHHHHHHHHhh-hhhHHHHHHHhccccccCCCCcee
Q 040917          352 NSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADID-GNGTIDYIEFITATMQRH-KLQRFENLYKAFQYFDKDNNGYIT  429 (494)
Q Consensus       352 ~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~-~~g~i~~~ef~~~~~~~~-~~~~~~~~~~~F~~~D~d~~G~I~  429 (494)
                      ..+.++.+++..+....+  ++.+++..+|..+|.+ ++|.|+++||...+.... .......+..+|+.+|.|++|.|+
T Consensus        70 ~~~~l~~e~l~~l~~~~~--~s~~ei~~l~~~fd~~~~~G~I~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D~d~dG~I~  147 (256)
T 2jul_A           70 STVRHQPEGLDQLQAQTK--FTKKELQSLYRGFKNECPTGLVDEDTFKLIYSQFFPQGDATTYAHFLFNAFDADGNGAIH  147 (256)
T ss_dssp             ------CTHHHHHHHHTT--SCHHHHHHHHHHHHHHCTTSSEEHHHHHHHHHHHCCSSCCHHHHHHHHHHSSCSCCSEEC
T ss_pred             ccccCCHHHHHHHHHHhC--CCHHHHHHHHHHHHhhCCCCcCCHHHHHHHHHHHcccCCcHHHHHHHHHHhccCCCCcCc
Confidence            334577778888777654  6888999999999875 899999999999887653 233456789999999999999999


Q ss_pred             HHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          430 VDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       430 ~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .+||..++..+  +...+++++..+|..+|.|++|.|+++||..++..
T Consensus       148 ~~Ef~~~l~~~--~~~~~~~~l~~~F~~~D~d~dG~I~~~Ef~~~l~~  193 (256)
T 2jul_A          148 FEDFVVGLSIL--LRGTVHEKLKWAFNLYDINKDGCITKEEMLAIMKS  193 (256)
T ss_dssp             SHHHHHHHHHH--HSCCHHHHHHHHHHHTCCSSSSCBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHH--hccChHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence            99999999883  44567889999999999999999999999998874

>1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5

Probab=99.21  E-value=5.4e-11  Score=103.43  Aligned_cols=98  Identities=23%  Similarity=0.234  Sum_probs=85.4

Q ss_pred             hhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCH--------HHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHH
Q 040917          341 LKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTE--------FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFEN  412 (494)
Q Consensus       341 ~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~--------~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~  412 (494)
                      +..+|..+|.|++|.|+.+||..++.........        ..+..+|..+|.|++|.|+++||...+....  .+.+.
T Consensus        60 ~~~lf~~~D~d~dg~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g--~~~~~  137 (176)
T 1nya_A           60 FDYLAKEAGVGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAE  137 (176)
T ss_dssp             HHHHHHHHTSCTTCCBCHHHHHHHHHHHHSSSCHHHHHHHHHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT--CCHHH
T ss_pred             HHHHHHHhCCCCCCeEcHHHHHHHHHHHhcCCchhhHHHHHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhC--CCHHH
Confidence            4488999999999999999999999887544443        5688999999999999999999998887654  45677


Q ss_pred             HHHhccccccCCCCceeHHHHHHHHhhc
Q 040917          413 LYKAFQYFDKDNNGYITVDELGKAFKDY  440 (494)
Q Consensus       413 ~~~~F~~~D~d~~G~I~~~el~~~l~~~  440 (494)
                      +..+|+.+|.|++|.|+.+||..++..+
T Consensus       138 ~~~~~~~~D~d~dg~i~~~ef~~~~~~~  165 (176)
T 1nya_A          138 AAEAFNQVDTNGNGELSLDELLTAVRDF  165 (176)
T ss_dssp             HHHHHHHHCTTCSSEEEHHHHHHHHSCC
T ss_pred             HHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence            9999999999999999999999999874

>2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum}

Probab=99.21  E-value=5.4e-11  Score=99.53  Aligned_cols=103  Identities=16%  Similarity=0.128  Sum_probs=88.5

Q ss_pred             HHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHH
Q 040917          375 FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI  454 (494)
Q Consensus       375 ~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~  454 (494)
                      .++..+|..+|.|++|.|+++||...+.......+...+..+|+.+|.|++|.|+.+||..++... .......+.+..+
T Consensus         6 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~-~~~~~~~~~~~~~   84 (142)
T 2bl0_C            6 SEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEADATGNGKIQFPEFLSMMGRR-MKQTTSEDILRQA   84 (142)
T ss_dssp             HHHHHHHHHHCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHH-HTTCCCHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCcCCCCeeeHHHHHHHHHHH-hcCCChHHHHHHH
Confidence            457889999999999999999999888765544566789999999999999999999999999852 1233467789999


Q ss_pred             HHHhCCCCCCceeHHHHHHHHhcc
Q 040917          455 MSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       455 ~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      |..+|.|++|.|+.+||..++...
T Consensus        85 F~~~D~d~~G~i~~~el~~~l~~~  108 (142)
T 2bl0_C           85 FRTFDPEGTGYIPKAALQDALLNL  108 (142)
T ss_dssp             HHHTCCSSCSCEEHHHHHHHHHHS
T ss_pred             HHHHCCCCCCcCcHHHHHHHHHHc
Confidence            999999999999999999998753

>3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens}

Probab=99.20  E-value=2.7e-11  Score=94.82  Aligned_cols=70  Identities=16%  Similarity=0.393  Sum_probs=60.6

Q ss_pred             HHHHHHHhccccc-cCCC-CceeHHHHHHHHhh-cC--CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          409 RFENLYKAFQYFD-KDNN-GYITVDELGKAFKD-YG--MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       409 ~~~~~~~~F~~~D-~d~~-G~I~~~el~~~l~~-~~--~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ...+++++|+.|| .|++ |+|+.+||+.+|.. +|  ++...+++++++++..+|.|+||+|+|+||+.+|.+.
T Consensus        11 ~~~~l~~aF~~fD~~dgd~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~m~~~   85 (104)
T 3zwh_A           11 ALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSSI   85 (104)
T ss_dssp             HHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGSCSSCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHcchhccCCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHH
Confidence            4468999999997 6775 89999999999985 44  3556789999999999999999999999999988753

>4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A*

Probab=99.20  E-value=2.4e-11  Score=93.25  Aligned_cols=69  Identities=17%  Similarity=0.475  Sum_probs=58.3

Q ss_pred             HHHHHHHhccccc-cCCC-CceeHHHHHHHHhh-cC--CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFD-KDNN-GYITVDELGKAFKD-YG--MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D-~d~~-G~I~~~el~~~l~~-~~--~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ....++++|+.|| .|++ |+|+.+||+.++.. +|  ++...++++++++++.+|.|+||+|+|+||+.+|.+
T Consensus         8 ~~~~l~~~F~~fd~~dg~~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~~~~   81 (93)
T 4eto_A            8 ALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSC   81 (93)
T ss_dssp             HHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGC---CCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcccCCCCCeECHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHH
Confidence            4568999999998 6875 89999999999985 44  345668999999999999999999999999998875

>2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A

Probab=99.20  E-value=4.4e-11  Score=90.73  Aligned_cols=69  Identities=33%  Similarity=0.637  Sum_probs=63.5

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ  480 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~  480 (494)
                      ....++.+|+.+|.|++|+|+.+||+.+|..  +| ..++++++.++..+|.|+||.|+|+||..++...+.
T Consensus         9 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~--~g-~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~~   77 (86)
T 2opo_A            9 DIADRERIFKRFDTNGDGKISSSELGDALKT--LG-SVTPDEVRRMMAEIDTDGDGFISFDEFTDFARANRG   77 (86)
T ss_dssp             HHHHHHHHHHHHCTTCSSEEEHHHHHHHHHT--TT-TCCHHHHHHHHHHHCTTCSSEECHHHHHHHHHHCTT
T ss_pred             hHHHHHHHHHHHCCCCCCCcCHHHHHHHHHH--cC-CCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHCcc
Confidence            4567899999999999999999999999999  56 789999999999999999999999999999987654

>3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A

Probab=99.20  E-value=2.8e-11  Score=110.37  Aligned_cols=113  Identities=20%  Similarity=0.271  Sum_probs=93.9

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh------------h
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH------------K  406 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~------------~  406 (494)
                      ..+.++|+.+|.|++|.|+.+||..++.........+.+..+|..+|.|++|.|+++||...+....            .
T Consensus       102 ~~~~~lf~~~D~d~~G~I~~~Ef~~~l~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~~~~~  181 (229)
T 3dd4_A          102 TYAHFLFNAFDTDHNGAVSFEDFIKGLSILLRGTVQEKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKE  181 (229)
T ss_dssp             HHHHHHHHTTCSSCCSSCCHHHHHHHHHHHHHSCHHHHHHHHHHHHCTTCSSCCBHHHHHHHHHHHHHHCC---------
T ss_pred             HHHHHHHHHcCCCCCCeEeHHHHHHHHHHHcCCChHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHHHHhccccCCCcch
Confidence            3467889999999999999999999998876666678899999999999999999999998876541            1


Q ss_pred             hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhC
Q 040917          407 LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVD  459 (494)
Q Consensus       407 ~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d  459 (494)
                      ......+..+|+.+|.|+||.|+.+||..++..        ...+.+.+..+|
T Consensus       182 ~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~~~--------~~~~~~~~~~~D  226 (229)
T 3dd4_A          182 DAPRQHVETFFQKMDKNKDGVVTIDEFIESCQK--------DENIMRSMQLFE  226 (229)
T ss_dssp             --CCTHHHHHHHHHCSSCSSBCCHHHHHHHHHT--------CHHHHHHHHHHT
T ss_pred             hhHHHHHHHHHHHhcCCCCCcEeHHHHHHHHHh--------CHHHHHHHHhcc
Confidence            123357899999999999999999999999985        135667777776

>2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A

Probab=99.19  E-value=2.2e-11  Score=102.29  Aligned_cols=102  Identities=23%  Similarity=0.335  Sum_probs=85.2

Q ss_pred             HHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHH
Q 040917          375 FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI  454 (494)
Q Consensus       375 ~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~  454 (494)
                      .++.++|..+|.|++|.|+.+||...+.......+..++..+|+.+|.|++|.|+.+||..++... .....+.+++..+
T Consensus         6 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~-~~~~~~~~~l~~~   84 (143)
T 2obh_A            6 QEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFGDFLTVMTQK-MSEKDTKEEILKA   84 (143)
T ss_dssp             HHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTTTCCSEEEHHHHHHHHHHH-HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeeeHHHHHHHHHHH-hccccHHHHHHHH
Confidence            457889999999999999999999888765544566788999999999999999999999887641 1111234678899


Q ss_pred             HHHhCCCCCCceeHHHHHHHHhc
Q 040917          455 MSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       455 ~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      |..+|.|++|.|+.+||..++..
T Consensus        85 F~~~D~d~~G~I~~~el~~~l~~  107 (143)
T 2obh_A           85 FKLFDDDETGKISFKNLKRVAKE  107 (143)
T ss_dssp             HHHHCTTCSSSBCHHHHHHHHHH
T ss_pred             HHHhCCCCCCcCcHHHHHHHHHH
Confidence            99999999999999999998875

>2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens}

Probab=99.18  E-value=4.3e-11  Score=87.08  Aligned_cols=67  Identities=39%  Similarity=0.699  Sum_probs=61.5

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ..+.++.+|+.+|.|++|+|+.+||..++..  ++..+++++++.++..+|.|++|.|+|+||..++..
T Consensus         4 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~--~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~   70 (71)
T 2b1u_A            4 GLEDLQVAFRAFDQDGDGHITVDELRRAMAG--LGQPLPQEELDAMIREADVDQDGRVNYEEFARMLAQ   70 (71)
T ss_dssp             THHHHHHHHTTSCCSSSSEEEHHHHHHHGGG--TTCSSCHHHHHHHHHHCCSSSSSEEETTHHHHHHTC
T ss_pred             cHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHhh
Confidence            3457899999999999999999999999999  567889999999999999999999999999998763

>1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5

Probab=99.18  E-value=3.8e-11  Score=86.24  Aligned_cols=64  Identities=27%  Similarity=0.458  Sum_probs=59.5

Q ss_pred             HHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          412 NLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       412 ~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +++.+|+.+|.|++|+|+.+||..++..  ++...++++++.++..+|.|++|.|+++||..++..
T Consensus         2 ~l~~~F~~~D~d~~G~i~~~el~~~l~~--~~~~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~   65 (67)
T 1tiz_A            2 SAKRVFEKFDKNKDGKLSLDEFREVALA--FSPYFTQEDIVKFFEEIDVDGNGELNADEFTSCIEK   65 (67)
T ss_dssp             THHHHHHHHCTTSSSCEEHHHHHHHHHH--TCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHHHHT
T ss_pred             HHHHHHHHHCCCCCCcCcHHHHHHHHHH--hCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence            4688999999999999999999999999  667889999999999999999999999999998874

>3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1}

Probab=99.17  E-value=2.3e-11  Score=108.15  Aligned_cols=102  Identities=17%  Similarity=0.198  Sum_probs=76.7

Q ss_pred             HHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHH
Q 040917          375 FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI  454 (494)
Q Consensus       375 ~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~  454 (494)
                      .++.++|..+|.|++|.|+++||...+...........+..+|+.+|.|++|.|+.+||..++..  ......++.+..+
T Consensus        57 ~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~l~~~~D~d~~g~I~~~EF~~~~~~--~~~~~~~~~l~~~  134 (197)
T 3pm8_A           57 NNLRNIFIALDVDNSGTLSSQEILDGLKKIGYQKIPPDIHQVLRDIDSNASGQIHYTDFLAATID--KQTYLKKEVCLIP  134 (197)
T ss_dssp             HHHHHHHHHHCTTCSSEECHHHHHHHHHHHC----CHHHHHHHHC-------CEEHHHHHHTTCC--HHHHCSHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHH--HHhhhhHHHHHHH
Confidence            34678999999999999999999998876544455678999999999999999999999988754  2223456789999


Q ss_pred             HHHhCCCCCCceeHHHHHHHHhcc
Q 040917          455 MSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       455 ~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      |..+|.|++|.|+.+||..++...
T Consensus       135 F~~~D~d~~G~Is~~El~~~l~~~  158 (197)
T 3pm8_A          135 FKFFDIDGNGKISVEELKRIFGRD  158 (197)
T ss_dssp             HHHHCTTCSSEECHHHHHHHHC--
T ss_pred             HHHHCCCCCCCCCHHHHHHHHHhc
Confidence            999999999999999999998864

>2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A

Probab=99.17  E-value=1.2e-10  Score=98.42  Aligned_cols=101  Identities=25%  Similarity=0.262  Sum_probs=88.1

Q ss_pred             HHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHH
Q 040917          376 DVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIM  455 (494)
Q Consensus       376 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~  455 (494)
                      +++++|..+|.|++|.|+++||...+...........+..+|..+|.+++|.|+..|+..++... .....+++++..+|
T Consensus        11 el~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~-~~~~~~~~~l~~aF   89 (148)
T 2lmt_A           11 EFKDAFVQFDKEGTGKIATRELGTLMRTLGQNPTEAELQDLIAEAENNNNGQLNFTEFCGIMAKQ-MRETDTEEEMREAF   89 (148)
T ss_dssp             HHHHHHHHHHCSSCCEEEGGGHHHHHHHHTCCCCHHHHHHHHHHHHTTSTTEEEHHHHHHHHHHT-TTTTTTHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCchHHHHHHHHHhcccCCCCcccHHHHHHHHHHH-hcccCcHHHHHHHH
Confidence            46778999999999999999999888776655667789999999999999999999999988763 34455678899999


Q ss_pred             HHhCCCCCCceeHHHHHHHHhc
Q 040917          456 SEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       456 ~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ..+|.|++|.|+.+||..++..
T Consensus        90 ~~~D~d~~G~I~~~El~~~l~~  111 (148)
T 2lmt_A           90 KIFDRDGDGFISPAELRFVMIN  111 (148)
T ss_dssp             HHHHSSCSSEECHHHHHHHHHH
T ss_pred             HHHCCCCcCcCcHHHHHHHHHH
Confidence            9999999999999999998875

>1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A

Probab=99.16  E-value=7.9e-11  Score=90.19  Aligned_cols=76  Identities=29%  Similarity=0.470  Sum_probs=70.1

Q ss_pred             hhccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          329 IVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       329 ~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      +...++.++...+..+|..+|.|++|+|+..||..+++.+|..++.+++..+|..+|.|++|.|+|+||+..+...
T Consensus        10 ~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~D~~~dg~i~~~eF~~~~~~~   85 (90)
T 1avs_A           10 ARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQ   85 (90)
T ss_dssp             HHHHBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHHHH
T ss_pred             HHHhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHH
Confidence            3445788899999999999999999999999999999999999999999999999999999999999999887653

>3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A

Probab=99.16  E-value=3.9e-11  Score=103.66  Aligned_cols=103  Identities=25%  Similarity=0.327  Sum_probs=86.3

Q ss_pred             HHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHH
Q 040917          375 FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI  454 (494)
Q Consensus       375 ~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~  454 (494)
                      .++.++|..+|.|++|.|+.+||...+.......+...+..+|..+|.|++|.|+.+||..++... .......+.+..+
T Consensus        28 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~-~~~~~~~~~~~~~  106 (169)
T 3qrx_A           28 QEIREAFDLFDTDGSGTIDAKELKVAMRALGFEPKKEEIKKMISEIDKDGSGTIDFEEFLTMMTAK-MGERDSREEILKA  106 (169)
T ss_dssp             HHHHHHHHHHCTTCCSEECHHHHHHHHHHTSCCCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHHHH-HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH-hcccCcHHHHHHH
Confidence            347789999999999999999999888765544566789999999999999999999999998752 1122235678889


Q ss_pred             HHHhCCCCCCceeHHHHHHHHhcc
Q 040917          455 MSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       455 ~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      |..+|.|++|.|+.+||..++...
T Consensus       107 F~~~D~d~~G~i~~~el~~~l~~~  130 (169)
T 3qrx_A          107 FRLFDDDNSGTITIKDLRRVAKEL  130 (169)
T ss_dssp             HHHHCTTCSSSBCHHHHHHHHHHT
T ss_pred             HHHhCCCCCCcCCHHHHHHHHHHc
Confidence            999999999999999999998753

>2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus}

Probab=99.16  E-value=5.2e-11  Score=91.96  Aligned_cols=79  Identities=32%  Similarity=0.492  Sum_probs=66.8

Q ss_pred             HHHHHHHhh-hhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHH
Q 040917          397 FITATMQRH-KLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMM  475 (494)
Q Consensus       397 f~~~~~~~~-~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~  475 (494)
                      |+..+.... .....++++.+|+.||.|++|+|+.+||+.+|..  ++...+++++++++..+|.|+||.|+|+||..++
T Consensus        14 ~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~--~g~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~~   91 (94)
T 2kz2_A           14 ENLYFQSLMKDTDSEEEIREAFRVEDKDGNGYISAAELRHVMTN--LGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMM   91 (94)
T ss_dssp             CTHHHHHHHCCCSCHHHHHHHHHHHCTTCCSCBCHHHHHHHHHH--HTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred             HHHHHHHHhcCCCHHHHHHHHHHHHCCCCcCcCCHHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence            444444332 2345678999999999999999999999999999  5667899999999999999999999999999988


Q ss_pred             hc
Q 040917          476 KC  477 (494)
Q Consensus       476 ~~  477 (494)
                      ..
T Consensus        92 ~~   93 (94)
T 2kz2_A           92 TA   93 (94)
T ss_dssp             HC
T ss_pred             hc
Confidence            64

>4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A

Probab=99.15  E-value=5.5e-11  Score=99.97  Aligned_cols=102  Identities=19%  Similarity=0.192  Sum_probs=86.3

Q ss_pred             HHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHH
Q 040917          376 DVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIM  455 (494)
Q Consensus       376 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~  455 (494)
                      ++..+|..+|.|++|.|+.+||...+.......+...+..+|+.+|.|++|.|+.+||..++... .......+.+..+|
T Consensus        12 ~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~ef~~~~~~~-~~~~~~~~~~~~~F   90 (147)
T 4ds7_A           12 EFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEIDVDGNHAIEFSEFLALMSRQ-LKCNDSEQELLEAF   90 (147)
T ss_dssp             HHHHHHHHHCTTCSSEEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHHH-HHTHHHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHHh-ccCCCcHHHHHHHH
Confidence            46778999999999999999999888765545566789999999999999999999999999752 12233556788999


Q ss_pred             HHhCCCCCCceeHHHHHHHHhcc
Q 040917          456 SEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       456 ~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ..+|.|++|.|+.+||..++...
T Consensus        91 ~~~D~d~~G~i~~~e~~~~l~~~  113 (147)
T 4ds7_A           91 KVFDKNGDGLISAAELKHVLTSI  113 (147)
T ss_dssp             HHHCTTCSSEECHHHHHHHHHHT
T ss_pred             HHhCCCCCCeECHHHHHHHHHHc
Confidence            99999999999999999998853

>1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A

Probab=99.15  E-value=5.7e-11  Score=90.98  Aligned_cols=68  Identities=34%  Similarity=0.608  Sum_probs=62.4

Q ss_pred             hHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       408 ~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .....++.+|..||.|++|+|+.+||..+|..  +|...++++++.++..+|.|++|.|+|+||+.++..
T Consensus        17 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~--~g~~~~~~~~~~l~~~~D~~~dg~i~~~eF~~~~~~   84 (90)
T 1avs_A           17 EMIAEFKAAFDMFDADGGGDISTKELGTVMRM--LGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVR   84 (90)
T ss_dssp             HHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH--TTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            34567899999999999999999999999999  667889999999999999999999999999998874

>2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A

Probab=99.15  E-value=4.6e-11  Score=94.76  Aligned_cols=69  Identities=17%  Similarity=0.495  Sum_probs=60.7

Q ss_pred             HHHHHHHhccccc-cCCCC-ceeHHHHHHHHhh-cC--CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFD-KDNNG-YITVDELGKAFKD-YG--MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D-~d~~G-~I~~~el~~~l~~-~~--~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ..++++++|+.|| .|++| +|+.+||+.+|.. ++  +|...+++++++++..+|.|+||.|+|+||+.+|..
T Consensus        20 ~~~~l~~aF~~fD~~dgdGG~Is~~EL~~~l~~~l~~~lg~~~t~~ev~~li~~~D~dgdG~Idf~EF~~~m~~   93 (113)
T 2lnk_A           20 ALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSC   93 (113)
T ss_dssp             HHHHHHHHHHHTTTTTSCTTCBCHHHHHHHHHHHCGGGGTTCCCTTHHHHHHHHHCSSSSSCBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcchhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHH
Confidence            4567999999999 89997 9999999999974 33  455678889999999999999999999999998875

>2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5

Probab=99.14  E-value=7.5e-11  Score=103.35  Aligned_cols=104  Identities=13%  Similarity=0.103  Sum_probs=81.7

Q ss_pred             HHHHHHHHHh-cCCCCCcccchHHHHHHHHhh----hhhHHHHHH-----------HhccccccCCCCceeHHHHHHHHh
Q 040917          375 FDVKQYMQAA-DIDGNGTIDYIEFITATMQRH----KLQRFENLY-----------KAFQYFDKDNNGYITVDELGKAFK  438 (494)
Q Consensus       375 ~~~~~~~~~~-D~~~~g~i~~~ef~~~~~~~~----~~~~~~~~~-----------~~F~~~D~d~~G~I~~~el~~~l~  438 (494)
                      .++..+|..+ |.|++|.|+++||...+....    ...+...+.           .+|+.+|.|++|.|+.+||..++.
T Consensus         8 ~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~   87 (185)
T 2sas_A            8 QKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEEYLAMWE   87 (185)
T ss_dssp             HHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHH
T ss_pred             HHHHHHHHHheeCCCCCeEcHHHHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCCeEcHHHHHHHHH
Confidence            4578899999 999999999999988776543    222222333           449999999999999999999987


Q ss_pred             hcCCC-------CCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          439 DYGMG-------DDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       439 ~~~~~-------~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      .....       .......+..+|..+|.|+||.|+++||..++...
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~  134 (185)
T 2sas_A           88 KTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNF  134 (185)
T ss_dssp             HHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHTTSS
T ss_pred             HHhccccchhhhhHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHh
Confidence            63111       12345788999999999999999999999998753

>2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus}

Probab=99.14  E-value=6.4e-11  Score=87.67  Aligned_cols=71  Identities=30%  Similarity=0.560  Sum_probs=66.3

Q ss_pred             chhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       334 ~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      +.++...+..+|..+|.+++|+|+.+||..++..+|..++.+++..+|..+|.|++|.|+|+||+..+...
T Consensus         2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~   72 (77)
T 2joj_A            2 SEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNEYDREGNGYIGFDDFLDIMTEK   72 (77)
T ss_dssp             CHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCHHHHHHHHHHHHCCSSSSEEEHHHHHHHHTHH
T ss_pred             CHHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHH
Confidence            56788899999999999999999999999999999999999999999999999999999999999887643

>1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ...

Probab=99.14  E-value=5.5e-11  Score=100.36  Aligned_cols=102  Identities=26%  Similarity=0.279  Sum_probs=84.5

Q ss_pred             HHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHH
Q 040917          376 DVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIM  455 (494)
Q Consensus       376 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~  455 (494)
                      ++..+|..+|.|++|.|+.+||...+.......+...+..+|+.+|.|++|.|+.+||..++... .....+.+++..+|
T Consensus        11 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~-~~~~~~~~~l~~~F   89 (148)
T 1exr_A           11 EFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLSLMARK-MKEQDSEEELIEAF   89 (148)
T ss_dssp             HHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHH-HHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHhc-ccCCCcHHHHHHHH
Confidence            46788999999999999999999888765544556778999999999999999999999888642 11123456788899


Q ss_pred             HHhCCCCCCceeHHHHHHHHhcc
Q 040917          456 SEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       456 ~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ..+|.|++|.|+.+||..++...
T Consensus        90 ~~~D~d~~G~I~~~el~~~l~~~  112 (148)
T 1exr_A           90 KVFDRDGNGLISAAELRHVMTNL  112 (148)
T ss_dssp             HHHSTTCSSCBCHHHHHHHHHHT
T ss_pred             HHhCCCCCCcCCHHHHHHHHHHh
Confidence            99999999999999999988753

>3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L

Probab=99.14  E-value=8.2e-11  Score=124.65  Aligned_cols=124  Identities=19%  Similarity=0.222  Sum_probs=106.8

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhcc
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQ  418 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~  418 (494)
                      ..+..+|..+|.|++|.|+.+||..++..+      +++..+|..+|.|++|.|+.+||...+.......+.+.+..+|.
T Consensus       575 ~~~~~l~~~~D~d~~G~I~f~EF~~l~~~~------~~l~~~F~~~D~d~dG~Is~~El~~~L~~~G~~ls~~~~~~l~~  648 (714)
T 3bow_A          575 ETCKIMVDMLDEDGSGKLGLKEFYILWTKI------QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQVIVA  648 (714)
T ss_dssp             HHHHHHHHHHCCSSCSSBCHHHHHHHHHHH------HHHHHHHHHHCTTCCSSEEHHHHHHHHHHTTEECCHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHHH------HHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHH
Confidence            345677888999999999999999998865      67899999999999999999999988876544445678899999


Q ss_pred             ccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          419 YFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       419 ~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .+| |++|.|+.+||..++..        .+.+.++|..+|.|++|.|+.+|+..++..
T Consensus       649 ~~D-d~dG~Isf~EF~~~l~~--------~~~l~~~F~~~D~d~dG~Is~~el~~l~~~  698 (714)
T 3bow_A          649 RFA-DDELIIDFDNFVRCLVR--------LEILFKIFKQLDPENTGTIQLDLISWLSFS  698 (714)
T ss_dssp             HHS-CTTCEECHHHHHHHHHH--------HHHHHHHHSSSCSSCCSEEEEEHHHHHHHH
T ss_pred             HhC-CCCCeEcHHHHHHHHHH--------HHHHHHHHHHhCCCCCCcEEHHHHHHHHHH
Confidence            999 99999999999999975        247889999999999999999998776553

>3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens}

Probab=99.14  E-value=3.6e-11  Score=107.37  Aligned_cols=117  Identities=19%  Similarity=0.229  Sum_probs=92.0

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh-------hhhhHHH
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR-------HKLQRFE  411 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~-------~~~~~~~  411 (494)
                      ..+..+|..+|.|++|.|+.+||..++.........+.+..+|..+|.|++|.|+.+||...+...       ......+
T Consensus        73 ~~~~~~~~~~D~d~dg~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~  152 (204)
T 3e3r_A           73 AEAEGVCRKWDRNGSGTLDLEEFLRALRPPMSQAREAVIAAAFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDE  152 (204)
T ss_dssp             HHHHHHHHHHCTTCSSSBCHHHHHHHTSCCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHCCCTTCHHHHTTSSCHHH
T ss_pred             HHHHHHHHHhccCCCCcCcHHHHHHHHHhhcCchHHHHHHHHHHHhCcCCCCeEeHHHHHHHHccccCCccccCCCChHH
Confidence            346777888999999999999999998776544455678999999999999999999999887532       1223556


Q ss_pred             HHHHhcccccc-CCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHH
Q 040917          412 NLYKAFQYFDK-DNNGYITVDELGKAFKDYGMGDDATIATIKEIMS  456 (494)
Q Consensus       412 ~~~~~F~~~D~-d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~  456 (494)
                      .+..+|+.+|. |++|.|+.+||..++..++. ...++++++.++.
T Consensus       153 ~~~~~~~~~D~~d~dg~Is~~EF~~~~~~~~~-~~~~d~~f~~~~~  197 (204)
T 3e3r_A          153 VLRRFLDNFDSSEKDGQVTLAEFQDYYSGVSA-SMNTDEEFVAMMT  197 (204)
T ss_dssp             HHHHHHHHHSCSSCCSCEEHHHHHHHHHHHHH-HCSSHHHHHHHHH
T ss_pred             HHHHHHHHhhccCCCCcCcHHHHHHHHHHcCc-cCCChHHHHHHHH
Confidence            78999999998 99999999999999987431 2234555555544

>2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus}

Probab=99.14  E-value=8.9e-11  Score=86.89  Aligned_cols=67  Identities=33%  Similarity=0.575  Sum_probs=61.4

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ....++.+|+.+|.|++|+|+.+||+.++..  +|...++++++.++..+|.|++|.|+|+||..++..
T Consensus         5 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~--~g~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~   71 (77)
T 2joj_A            5 QKQEIKEAFDLFDTNKTGSIDYHELKVAMRA--LGFDVKKPEILELMNEYDREGNGYIGFDDFLDIMTE   71 (77)
T ss_dssp             HHHHHHHHHHHHCCSSSSEEEHHHHHHHHHH--HTCCCHHHHHHHHHHHHCCSSSSEEEHHHHHHHHTH
T ss_pred             HHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH--hCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence            4467899999999999999999999999999  566789999999999999999999999999998864

>2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens}

Probab=99.13  E-value=5.8e-11  Score=105.97  Aligned_cols=123  Identities=11%  Similarity=0.087  Sum_probs=91.5

Q ss_pred             CCCcccHHHHHHHHHhcCCCCC-HHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeH
Q 040917          352 NSGTLTYDELKAGLAKLGSMLT-EFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITV  430 (494)
Q Consensus       352 ~~g~i~~~el~~~l~~~~~~~~-~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~  430 (494)
                      +++.++.+++..+....+.... ..++.++|..+|.|++|.|+++||... .......   .+..+|..+|.|++|.|+.
T Consensus         5 ~s~~l~~~~~~~~~~~~~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~-~~lg~~~---~~~~l~~~~D~d~dg~i~~   80 (202)
T 2bec_A            5 SSHAAVIPDGDSIRRETGFSQASLLRLHHRFRALDRNKKGYLSRMDLQQI-GALAVNP---LGDRIIESFFPDGSQRVDF   80 (202)
T ss_dssp             ------CCSTTTHHHHHCCCHHHHHHHHHHHHHHCSSCSSCCCHHHHHTC-HHHHHST---THHHHHHTTSCSSCCCCCH
T ss_pred             ccCCcCHHHHHHHHHccCCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-HhcCCCc---cHHHHHHHhCCCCCCcCcH
Confidence            3445777777777776653222 133677899999999999999999887 3222111   2888999999999999999


Q ss_pred             HHHHHHHhhcCCC---------------CCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          431 DELGKAFKDYGMG---------------DDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       431 ~el~~~l~~~~~~---------------~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      +||..++......               .....+.+..+|..+|.|++|.|+.+||..++...
T Consensus        81 ~EF~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~  143 (202)
T 2bec_A           81 PGFVRVLAHFRPVEDEDTETQDPKKPEPLNSRRNKLHYAFQLYDLDRDGKISRHEMLQVLRLM  143 (202)
T ss_dssp             HHHHHHHGGGSCCCHHHHC-----CCCCTTSHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHS
T ss_pred             HHHHHHHHHhcccchhcccccccccccccccHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHh
Confidence            9999999874210               34456788999999999999999999999998754

>3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor}

Probab=99.13  E-value=9.3e-11  Score=112.79  Aligned_cols=100  Identities=27%  Similarity=0.298  Sum_probs=84.3

Q ss_pred             HHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHH
Q 040917          377 VKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMS  456 (494)
Q Consensus       377 ~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~  456 (494)
                      ++++|..+|.|++|.|+.+||..++.......+..++..+|+.+|.|++|.|+.+||..++... .....+++++.++|+
T Consensus       304 LREaF~~fDkDgdG~IS~eELk~aLrsLG~~~TeeEI~~Lf~~~D~DgDG~IdFeEFl~lms~~-lk~~d~eeeLreAFk  382 (440)
T 3u0k_A          304 FKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGDGTIDFPEFLIMMARK-MKDTDSEEEIREAFR  382 (440)
T ss_dssp             HHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCSSSEEHHHHHHHHHTC-------CHHHHHHHH
T ss_pred             HHHHHHHHcCCCCCEECHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH-hcCCChHHHHHHHHH
Confidence            6789999999999999999999888776555567789999999999999999999999988752 223335568899999


Q ss_pred             HhCCCCCCceeHHHHHHHHhc
Q 040917          457 EVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       457 ~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .+|.|++|.|+.+||..++..
T Consensus       383 ~fDkDgdG~IS~eELr~vL~~  403 (440)
T 3u0k_A          383 VFDKDGNGYISAAELRHVMTN  403 (440)
T ss_dssp             HHCTTCSSEECHHHHHHHHHH
T ss_pred             HHCCCCcCcCCHHHHHHHHHH
Confidence            999999999999999998875

>1j7q_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1j7r_A

Probab=99.13  E-value=9.7e-11  Score=88.80  Aligned_cols=74  Identities=18%  Similarity=0.172  Sum_probs=68.5

Q ss_pred             hccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHH---HHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD---VKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       330 ~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~---~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      ...++.+++.++..+|..+|.+++|+|+..||..+++.+|..++..+   +..++..+|.|++|.|+| ||+..+...
T Consensus         5 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~~d~~~~g~i~~-eF~~~~~~~   81 (86)
T 1j7q_A            5 ARALGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQTYTKRETEAIMKEARGPKGDKKNIGPE-EWLTLCSKW   81 (86)
T ss_dssp             CCCCSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSCCCSHHHHHHHHHHHHCSSCSSCCBCTT-HHHHHHHHH
T ss_pred             cccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCCHHHHHHHHHHHHHhCCCCCCcCCH-HHHHHHHHH
Confidence            34567888999999999999999999999999999999999999999   999999999999999999 999887654

>2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae}

Probab=99.13  E-value=1.2e-10  Score=101.34  Aligned_cols=102  Identities=20%  Similarity=0.218  Sum_probs=88.3

Q ss_pred             HHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHH
Q 040917          376 DVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIM  455 (494)
Q Consensus       376 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~  455 (494)
                      ++.++|..+|.|++|.|+++||...+.......+..++..++..+|.|++|.|+..||..++... .....+++++..+|
T Consensus        12 elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~~~~d~d~~~~i~~~ef~~~~~~~-~~~~~~~~~l~~aF   90 (176)
T 2lhi_A           12 EFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQ-LKSNDSEQELLEAF   90 (176)
T ss_dssp             HHHHHHHTTCSSCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTTCSSCSSSBCTTHHHHHHTSS-CCSSHHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCChhHHHHHHHHHHhCcCCCccchHHHHHHHHHHh-cccCCcHHHHHHHH
Confidence            46788999999999999999999888776655677889999999999999999999999988763 23344567899999


Q ss_pred             HHhCCCCCCceeHHHHHHHHhcc
Q 040917          456 SEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       456 ~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ..+|.|++|.|+.+||..++...
T Consensus        91 ~~fD~d~~G~I~~~el~~~l~~~  113 (176)
T 2lhi_A           91 KVFDKNGDGLISAAELKHVLTSI  113 (176)
T ss_dssp             HHHCSSCSSSBCHHHHHHHHHTT
T ss_pred             HHhCCCCCCcCcHHHHHHHHHHc
Confidence            99999999999999999998753

>3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A

Probab=99.13  E-value=6.8e-11  Score=94.15  Aligned_cols=95  Identities=17%  Similarity=0.182  Sum_probs=78.7

Q ss_pred             hhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh---hhhhHHHHHHHh
Q 040917          340 KLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR---HKLQRFENLYKA  416 (494)
Q Consensus       340 ~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~---~~~~~~~~~~~~  416 (494)
                      ++.++|..+|  ++|.|+.+||..++..  .....+++..+|..+|.|++|.|+.+||...+...   ....+.+++..+
T Consensus        11 ei~~~~~~~D--~~g~i~~~eF~~~~~~--~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~   86 (109)
T 3fs7_A           11 DIESALSSCQ--AADSFNYKSFFSTVGL--SSKTPDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARVLTSAETKAF   86 (109)
T ss_dssp             HHHHHHHHTC--STTCCCHHHHHHHHTC--TTCCHHHHHHHHHHHSTTCSSSBCHHHHHTTGGGTCTTSCCCCHHHHHHH
T ss_pred             HHHHHHHhcC--CCCcCcHHHHHHHHhc--CCCcHHHHHHHHHHHCCCCCCeEeHHHHHHHHHHHhcccccCCHHHHHHH
Confidence            3455566667  8999999999998865  33467789999999999999999999998877655   333456789999


Q ss_pred             ccccccCCCCceeHHHHHHHHh
Q 040917          417 FQYFDKDNNGYITVDELGKAFK  438 (494)
Q Consensus       417 F~~~D~d~~G~I~~~el~~~l~  438 (494)
                      |+.+|.|++|.|+.+||..+++
T Consensus        87 ~~~~D~~~dg~i~~~EF~~~~~  108 (109)
T 3fs7_A           87 LAAGDTDGDGKIGVEEFQSLVK  108 (109)
T ss_dssp             HHHHCTTCSSSBCHHHHHHHHT
T ss_pred             HHHhCCCCCCcCcHHHHHHHHh
Confidence            9999999999999999999875

>3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A

Probab=99.13  E-value=3.9e-11  Score=118.22  Aligned_cols=128  Identities=27%  Similarity=0.305  Sum_probs=101.1

Q ss_pred             hccCCCCCCcccHHHHHHHHHhcCCCCCH---HHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhcccccc
Q 040917          346 TEMDTDNSGTLTYDELKAGLAKLGSMLTE---FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDK  422 (494)
Q Consensus       346 ~~~D~~~~g~i~~~el~~~l~~~~~~~~~---~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~  422 (494)
                      ..+|.+.+|.|...++.....   ..++.   +++.++|..+|.|++|.|+.+||...+.........+.+..+|+.+|.
T Consensus       283 k~iD~de~g~i~~~e~~~~~~---~~ls~eei~el~~~F~~fD~D~dG~Is~~EL~~~L~~lg~~~s~eel~~Lf~~~D~  359 (450)
T 3sg6_A          283 KGIDFKEDGNILGHKLEYNTR---DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDA  359 (450)
T ss_dssp             EEESCCTTSTTTTTCBCCC------CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCT
T ss_pred             ccCCccccccchhhhhhhhhc---ccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhcc
Confidence            458888999888777643221   12333   457889999999999999999999988775555566789999999999


Q ss_pred             CCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          423 DNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       423 d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      |++|.|+.+||..++... .......+.+..+|..+|.|++|.|+.+||..++..
T Consensus       360 DgdG~IsfeEFl~ll~~~-~~~~~~~e~l~~aFk~fD~D~dG~Is~eELr~~L~~  413 (450)
T 3sg6_A          360 DGNGTIDFPEFLTMMARK-MKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN  413 (450)
T ss_dssp             TSSSSEEHHHHHHHHHC-------CHHHHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred             CCCCcccHHHHHHHHHhh-ccccchhhHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            999999999999999763 223445678999999999999999999999999875

>3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A

Probab=99.12  E-value=8.1e-11  Score=91.39  Aligned_cols=69  Identities=20%  Similarity=0.311  Sum_probs=61.8

Q ss_pred             hHHHhhhhhhhccC-CCCC-CcccHHHHHHHHHh-----cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          336 EEIQKLKEKFTEMD-TDNS-GTLTYDELKAGLAK-----LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       336 ~~~~~~~~~F~~~D-~~~~-g~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      +.+..+..+|+.|| +|++ |+|+.+||+.+++.     +|..++.+++.++++.+|.|+||.|+|+||+..+...
T Consensus         7 ~~i~~l~~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~~~~~   82 (101)
T 3nso_A            7 QAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLACL   82 (101)
T ss_dssp             HHHHHHHHHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHCCCSCEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence            45678999999997 8887 99999999999986     4677889999999999999999999999999887753

>1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7

Probab=99.12  E-value=1.1e-10  Score=92.16  Aligned_cols=86  Identities=14%  Similarity=0.222  Sum_probs=72.6

Q ss_pred             CcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHH
Q 040917          390 GTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYD  469 (494)
Q Consensus       390 g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~  469 (494)
                      ..++++++...+..... .....++.+|+.||.|++|+|+.+||+.+|..  ++..+++++++.++..+|.|++|.|+|+
T Consensus         4 ~~~~~~~~~~~l~~~~~-~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~--~g~~~~~~e~~~l~~~~d~~~~g~i~~~   80 (105)
T 1wlz_A            4 MATADRDILARLHKAVT-SHYHAITQEFENFDTMKTNTISREEFRAICNR--RVQILTDEQFDRLWNEMPVNAKGRLKYP   80 (105)
T ss_dssp             CTTCCHHHHHHHHHHHH-HTHHHHHHHHHHHCTTCSSCBCHHHHHHHHHH--HTCCCCHHHHHHHHTTSCBCTTSCBCHH
T ss_pred             cchhHHHHHHHHHHHHH-chHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH--hCCCCCHHHHHHHHHHcCCCCCCCCcHH
Confidence            34677888777665432 24567999999999999999999999999999  5667899999999999999999999999


Q ss_pred             HHHHHHhcc
Q 040917          470 EFRSMMKCG  478 (494)
Q Consensus       470 ef~~~~~~~  478 (494)
                      ||..++...
T Consensus        81 eF~~~~~~~   89 (105)
T 1wlz_A           81 DFLSRFSSE   89 (105)
T ss_dssp             HHHHHHC--
T ss_pred             HHHHHHhcc
Confidence            999988753

>1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6

Probab=99.12  E-value=1.5e-10  Score=88.86  Aligned_cols=70  Identities=20%  Similarity=0.266  Sum_probs=63.8

Q ss_pred             CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      ++.++..++.++|+.+|+|++|+|+.+|+..+++.+|  ++.+++.+++..+|.|++|.|+|+||+..+...
T Consensus         3 ls~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g--~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~~~   72 (92)
T 1fi6_A            3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDFDKDGALTLDEFCAAFHLV   72 (92)
T ss_dssp             CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS--SCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence            3577889999999999999999999999999999987  678899999999999999999999999887643

>1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ...

Probab=99.12  E-value=8.5e-11  Score=100.55  Aligned_cols=102  Identities=17%  Similarity=0.245  Sum_probs=85.7

Q ss_pred             HHHHHHHHhcCCC-CCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCC--CCCCcHHHHH
Q 040917          376 DVKQYMQAADIDG-NGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM--GDDATIATIK  452 (494)
Q Consensus       376 ~~~~~~~~~D~~~-~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~--~~~~~~~~~~  452 (494)
                      ++..+|..+|.|+ +|.|+.+||...+.......+...+..+|+.+|.|++|.|+.+||..++.....  ......+.+.
T Consensus        19 ~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~   98 (161)
T 1dtl_A           19 EFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELS   98 (161)
T ss_dssp             HHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHC-----CHHHHHH
T ss_pred             HHHHHHHHHcCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhcccccchHHHHHH
Confidence            4678999999999 999999999998876554456678999999999999999999999999976311  0234567789


Q ss_pred             HHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          453 EIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       453 ~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .+|..+|.|++|.|+.+||..++..
T Consensus        99 ~~F~~~D~d~~G~i~~~El~~~l~~  123 (161)
T 1dtl_A           99 DLFRMFDKNADGYIDLEELKIMLQA  123 (161)
T ss_dssp             HHHHHHCTTCSSEEEHHHHGGGGTT
T ss_pred             HHHHHhCCCCCCcCcHHHHHHHHHH
Confidence            9999999999999999999998865

>3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B*

Probab=99.12  E-value=1.9e-10  Score=97.66  Aligned_cols=103  Identities=18%  Similarity=0.269  Sum_probs=85.1

Q ss_pred             hhhhhhhccCCCCCCcccHHHHHHHHHhcCCC-CCHHHHHHHHHHhcCCCCCcccchHHHHHHHH-hhhhhHHHHHHHhc
Q 040917          340 KLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM-LTEFDVKQYMQAADIDGNGTIDYIEFITATMQ-RHKLQRFENLYKAF  417 (494)
Q Consensus       340 ~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~-~~~~~~~~~~~~~F  417 (494)
                      .+..+|..+|.+++|.|+.+||..++...... ...+.+..+|..+|.|++|.|+.+||...+.. .....+...+..+|
T Consensus        39 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~  118 (155)
T 3ll8_B           39 LVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIV  118 (155)
T ss_dssp             THHHHHHHHCTTCSSSBCHHHHHHHHGGGCSSCCHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHGGGSCHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccCCCHHHHHHHH
Confidence            45678889999999999999999999887544 34567899999999999999999999988876 33333445566666


Q ss_pred             cc----cccCCCCceeHHHHHHHHhhcCC
Q 040917          418 QY----FDKDNNGYITVDELGKAFKDYGM  442 (494)
Q Consensus       418 ~~----~D~d~~G~I~~~el~~~l~~~~~  442 (494)
                      +.    +|.|++|.|+.+||..++..+++
T Consensus       119 ~~~~~~~D~~~dg~i~~~eF~~~~~~~~~  147 (155)
T 3ll8_B          119 DKTIINADKDGDGRISFEEFCAVVGGLDI  147 (155)
T ss_dssp             HHHHHHHCTTSSSSBCHHHHHHHHGGGCG
T ss_pred             HHHHHHhCCCCCCcCcHHHHHHHHhccCc
Confidence            66    99999999999999999998544

>1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A

Probab=99.11  E-value=1.7e-10  Score=97.16  Aligned_cols=100  Identities=11%  Similarity=0.083  Sum_probs=83.6

Q ss_pred             hhhhhhhcc-CCCCCCcccHHHHHHHHHhc------CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHH
Q 040917          340 KLKEKFTEM-DTDNSGTLTYDELKAGLAKL------GSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFEN  412 (494)
Q Consensus       340 ~~~~~F~~~-D~~~~g~i~~~el~~~l~~~------~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~  412 (494)
                      .+..+|..+ |.+++|.|+.+||..++...      ......+.+..+|..+|.|++|.|+.+||...+.......+.++
T Consensus        41 ~~~~l~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~  120 (148)
T 1m45_A           41 LVQDIINADSSLRDASSLTLDQITGLIEVNEKELDATTKAKTEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAE  120 (148)
T ss_dssp             HHHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGGCCCTHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHH
T ss_pred             HHHHHHHHhhCCCCCCeEcHHHHHHHHHHHHhhccccccccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHH
Confidence            456678889 99999999999999998876      44556678999999999999999999999998876544445678


Q ss_pred             HHHhccccccCCCCceeHHHHHHHHhh
Q 040917          413 LYKAFQYFDKDNNGYITVDELGKAFKD  439 (494)
Q Consensus       413 ~~~~F~~~D~d~~G~I~~~el~~~l~~  439 (494)
                      +..+|+.+|.|++|.|+.+||..++..
T Consensus       121 ~~~~~~~~d~d~dg~i~~~eF~~~~~~  147 (148)
T 1m45_A          121 VDELLKGVEVDSNGEIDYKKFIEDVLR  147 (148)
T ss_dssp             HHHHHTTCCCCTTSEEEHHHHHHHHHC
T ss_pred             HHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence            999999999999999999999998863

>3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A

Probab=99.11  E-value=1.4e-10  Score=99.69  Aligned_cols=98  Identities=20%  Similarity=0.180  Sum_probs=82.5

Q ss_pred             hhhhhhccCCCCCCcccHHHHHHHHHhcCCCCC-------HHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHH
Q 040917          341 LKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLT-------EFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENL  413 (494)
Q Consensus       341 ~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~-------~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~  413 (494)
                      +..+|..+|.+++|.|+.+||..++.......+       ...+..+|..+|.|++|.|+.+||...+....  .+.+.+
T Consensus        57 ~~~~f~~~D~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~E~~~~l~~~~--~~~~~~  134 (166)
T 3akb_A           57 WQGLAGIADRDGDQRITREEFVTGAVKRLRDKPDRFAEMARPFLHAALGVADTDGDGAVTVADTARALTAFG--VPEDLA  134 (166)
T ss_dssp             HHHHHHHHCTTSSSCEEHHHHHHTHHHHHHHSHHHHHHHHHHHHHHHHHHHCSSSSSCCBHHHHHHHHHHTT--CCHHHH
T ss_pred             HHHHHHHhCCCCCCcCcHHHHHHHHHHHhccCccchHHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhC--CCHHHH
Confidence            347899999999999999999998877533221       23388899999999999999999998887654  456779


Q ss_pred             HHhccccccCCCCceeHHHHHHHHhhc
Q 040917          414 YKAFQYFDKDNNGYITVDELGKAFKDY  440 (494)
Q Consensus       414 ~~~F~~~D~d~~G~I~~~el~~~l~~~  440 (494)
                      ..+|+.+|.|++|.|+.+||..++..+
T Consensus       135 ~~~~~~~D~d~dg~i~~~ef~~~~~~~  161 (166)
T 3akb_A          135 RQAAAALDTDGDGKVGETEIVPAFARY  161 (166)
T ss_dssp             HHHHHHHCTTCSSBCCHHHHHHHHHHH
T ss_pred             HHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence            999999999999999999999999763

>5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4

Probab=99.11  E-value=2e-10  Score=91.37  Aligned_cols=100  Identities=20%  Similarity=0.218  Sum_probs=81.3

Q ss_pred             CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh---hhhhH
Q 040917          333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR---HKLQR  409 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~---~~~~~  409 (494)
                      ++.+++   .++|..+|.  +|.|+.+||..++..  .....+++..+|..+|.|++|.|+.+||...+...   ....+
T Consensus         6 ~s~~ei---~~~~~~~d~--~g~i~~~eF~~~~~~--~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~g~~~~   78 (109)
T 5pal_A            6 LKADDI---NKAISAFKD--PGTFDYKRFFHLVGL--KGKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLN   78 (109)
T ss_dssp             SCHHHH---HHHHHHTCS--TTCCCHHHHHHHHTC--TTCCHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCC
T ss_pred             CCHHHH---HHHHHHhCC--CCcCcHHHHHHHHhh--ccCcHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHcCCCCC
Confidence            445554   555556676  899999999998864  23467789999999999999999999998888765   33445


Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhh
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKD  439 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~  439 (494)
                      .+++..+|+.+|.|++|.|+.+||..++..
T Consensus        79 ~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~  108 (109)
T 5pal_A           79 DTETKALLAAGDSDHDGKIGADEFAKMVAQ  108 (109)
T ss_dssp             HHHHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHh
Confidence            678999999999999999999999998864

>1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10

Probab=99.11  E-value=6e-11  Score=88.14  Aligned_cols=67  Identities=28%  Similarity=0.632  Sum_probs=61.2

Q ss_pred             HHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccc
Q 040917          411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ  480 (494)
Q Consensus       411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~  480 (494)
                      ++++.+|+.+|.|++|+|+.+||..++..  +| ..++++++.++..+|.|+||.|+|+||..++...+.
T Consensus         3 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~--~g-~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~~~~   69 (78)
T 1k9u_A            3 DDMERIFKRFDTNGDGKISLSELTDALRT--LG-STSADEVQRMMAEIDTDGDGFIDFNEFISFCNANPG   69 (78)
T ss_dssp             CHHHHHHHHHCTTCSSEECHHHHHHHHHH--HH-TCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHCHH
T ss_pred             HHHHHHHHHHCCCCCCcCcHHHHHHHHHH--hC-CCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHCch
Confidence            36889999999999999999999999999  45 789999999999999999999999999999887543

>3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A

Probab=99.10  E-value=2e-10  Score=98.11  Aligned_cols=101  Identities=17%  Similarity=0.264  Sum_probs=86.5

Q ss_pred             HHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHH
Q 040917          376 DVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIM  455 (494)
Q Consensus       376 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~  455 (494)
                      ++..+|..+|.+++|.|+++||...+.......+...+..+|..+|.|++|.|+.+||..++... .......+.+..+|
T Consensus        24 ~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~-~~~~~~~~~~~~~F  102 (161)
T 3fwb_A           24 EIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKREILDLIDEYDSEGRHLMKYDDFYIVMGEK-ILKRDPLDEIKRAF  102 (161)
T ss_dssp             HHHHHHHHHCTTSSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSCEEHHHHHHHHHHH-HHTCCHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCcCCCCeEeHHHHHHHHHHH-HhcCCcHHHHHHHH
Confidence            46789999999999999999999888776545566789999999999999999999999998752 12234567889999


Q ss_pred             HHhCCCCCCceeHHHHHHHHhc
Q 040917          456 SEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       456 ~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ..+|.|++|.|+.+||..++..
T Consensus       103 ~~~D~d~~G~i~~~el~~~l~~  124 (161)
T 3fwb_A          103 QLFDDDHTGKISIKNLRRVAKE  124 (161)
T ss_dssp             HHHCTTCSSEECHHHHHHHHHH
T ss_pred             HHHcCCCCCeEeHHHHHHHHHH
Confidence            9999999999999999999885

>2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A

Probab=99.10  E-value=1.9e-10  Score=98.00  Aligned_cols=101  Identities=16%  Similarity=0.166  Sum_probs=85.9

Q ss_pred             HHHHHHHHhc-CCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCC----CcHHH
Q 040917          376 DVKQYMQAAD-IDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDD----ATIAT  450 (494)
Q Consensus       376 ~~~~~~~~~D-~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~----~~~~~  450 (494)
                      ++..+|..+| .|++|.|+.+||...+.......+...+..+|+.+|.|++|.|+.+||..++..... ..    .....
T Consensus        14 ~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~~~-~~~~~~~~~~~   92 (158)
T 2jnf_A           14 LLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEFDPFGNGDIDFDSFKIIGARFLG-EEVNPEQMQQE   92 (158)
T ss_dssp             HHHHHHHHSBCSSSCSSEEHHHHHHHHHHTTCSCSHHHHHHHHHHHCTTCCSEECHHHHHHHHHHHCC-CCCCTTTTSST
T ss_pred             HHHHHHHHhCCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhc-cccchhhHHHH
Confidence            4678999999 999999999999988876554456678899999999999999999999999976421 11    34557


Q ss_pred             HHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          451 IKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       451 ~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +..+|..+|.|++|.|+.+||..++..
T Consensus        93 ~~~~F~~~D~d~~G~I~~~el~~~l~~  119 (158)
T 2jnf_A           93 LREAFRLYDKEGNGYISTDVMREILAE  119 (158)
T ss_dssp             HHHHHHHHCSSSSSSEEHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCeEcHHHHHHHHHH
Confidence            899999999999999999999998875

>1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5

Probab=99.10  E-value=4.7e-11  Score=105.30  Aligned_cols=101  Identities=21%  Similarity=0.200  Sum_probs=85.3

Q ss_pred             HHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHH
Q 040917          376 DVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIM  455 (494)
Q Consensus       376 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~  455 (494)
                      ++.++|..+|.|++|.|+++||...+.......+..++..+|+.+|.|++|.|+.+||..++..+  ......+.+..+|
T Consensus        11 ~l~~~F~~~D~d~dG~I~~~E~~~~l~~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~--~~~~~~~~l~~~F   88 (188)
T 1s6i_A           11 GLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAATVHL--NKLEREENLVSAF   88 (188)
T ss_dssp             SHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTCTTCSSEECHHHHHHHHTTS--SSSCCCCSTHHHH
T ss_pred             HHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCeEeHHHHHHHHHHH--hccCHHHHHHHHH
Confidence            47889999999999999999999887765444456778999999999999999999999998763  2223345688999


Q ss_pred             HHhCCCCCCceeHHHHHHHHhcc
Q 040917          456 SEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       456 ~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ..+|.|++|.|+.+||..++...
T Consensus        89 ~~~D~d~dG~Is~~El~~~l~~~  111 (188)
T 1s6i_A           89 SYFDKDGSGYITLDEIQQACKDF  111 (188)
T ss_dssp             HHTTTTCSSEEEHHHHHHTTTTT
T ss_pred             HHHCCCCCCcCcHHHHHHHHHHc
Confidence            99999999999999999988753

>1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6

Probab=99.10  E-value=2.1e-10  Score=88.04  Aligned_cols=65  Identities=25%  Similarity=0.353  Sum_probs=58.6

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...+++++|+.||.|++|+|+.+|++.++..+|    ++++++++++..+|.|+||.|+|+||..+|..
T Consensus         7 ~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g----~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~~   71 (92)
T 1fi6_A            7 QRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK----LPILELSHIWELSDFDKDGALTLDEFCAAFHL   71 (92)
T ss_dssp             HHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS----SCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC----CCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence            345789999999999999999999999999853    57889999999999999999999999998764

>2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A

Probab=99.10  E-value=2e-10  Score=104.50  Aligned_cols=120  Identities=15%  Similarity=0.159  Sum_probs=90.2

Q ss_pred             cccHHHHHHHHHhcCCCCC-HHHHHHHHHHhcCC--CCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHH
Q 040917          355 TLTYDELKAGLAKLGSMLT-EFDVKQYMQAADID--GNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVD  431 (494)
Q Consensus       355 ~i~~~el~~~l~~~~~~~~-~~~~~~~~~~~D~~--~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~  431 (494)
                      .++.+++..+....+.... ..++..+|..+|.|  ++|.|+.+||...+.. ........+..+|+.+|.|++|.|+.+
T Consensus        27 ~l~~~~~~~l~~~~~ls~~ei~~l~~~F~~~D~d~~~~G~I~~~El~~~l~~-~~~~~~~~~~~~f~~~D~d~dG~I~~~  105 (226)
T 2zfd_A           27 SGGLGDPELLARDTVFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFK-TNKKESLFADRVFDLFDTKHNGILGFE  105 (226)
T ss_dssp             -----CTHHHHHHSSCCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHHS-CSSCCCHHHHHHHHHHCSSCSSSBCHH
T ss_pred             cCCHHHHHHHHHhCCCCHHHHHHHHHHHHHhCcccCCCCeEcHHHHHHHHhc-cCcccHHHHHHHHHHHcCCCCCcCcHH
Confidence            3555777777766543221 13366789999999  9999999999988764 212223456779999999999999999


Q ss_pred             HHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          432 ELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       432 el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      ||..++...+ ......+++..+|..+|.|++|.|+++||..++.
T Consensus       106 Ef~~~~~~~~-~~~~~~~~l~~~F~~~D~d~~G~Is~~E~~~~l~  149 (226)
T 2zfd_A          106 EFARALSVFH-PNAPIDDKIHFSFQLYDLKQQGFIERQEVKQMVV  149 (226)
T ss_dssp             HHHHHHHHTS-TTSCHHHHHHHHHHHHCTTSSSSEEHHHHHHHHH
T ss_pred             HHHHHHHHHc-cCCCHHHHHHHHHHHhCCCCCCcccHHHHHHHHH
Confidence            9999998742 1335677899999999999999999999999885

>1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6

Probab=99.09  E-value=1.8e-10  Score=89.02  Aligned_cols=69  Identities=22%  Similarity=0.219  Sum_probs=63.2

Q ss_pred             CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHH
Q 040917          333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQ  403 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~  403 (494)
                      ++.++..++.++|..+|+|++|+|+.+|+..+++.+|  ++.+++.++|..+|.|++|.|+|+||+..+..
T Consensus         4 ls~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g--~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~~   72 (95)
T 1c07_A            4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG--LPSTLLAHIWSLCDTKDCGKLSKDQFALAFHL   72 (95)
T ss_dssp             SCSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT--CCHHHHHHHHHHHCTTCSSSEETTTHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHH
Confidence            3567889999999999999999999999999999886  67889999999999999999999999988754

>3qr0_A Phospholipase C-beta (PLC-beta); PH domain, EF hand, C2 domain, TIM barrel domain, hydrolase, calcium binding, phospholipid binding; 2.00A {Sepia officinalis} PDB: 3qr1_A

Probab=99.09  E-value=1.5e-10  Score=122.23  Aligned_cols=126  Identities=12%  Similarity=0.187  Sum_probs=104.2

Q ss_pred             ccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHh-------cCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccc
Q 040917          347 EMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAA-------DIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQY  419 (494)
Q Consensus       347 ~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~-------D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~  419 (494)
                      .+|+|++|.|+..|+..+++..+.  ...++.++++..       |.+++|.|+|+||+..+....   ..++++++|+.
T Consensus       163 ~fd~n~dG~Is~kEl~~~l~~~~~--~~~el~~~~~~~~~~~~k~D~~~~g~L~FeEF~~f~~~L~---~R~EI~eiF~~  237 (816)
T 3qr0_A          163 TTVEMEKNKIPVKAIQKCLSKDKD--DRARISKALEKIGWPSGKNDAIDLKAFDFDTFFKFYLALL---ERSEIEGIFKE  237 (816)
T ss_dssp             HHTSCCSSEEEHHHHHHHHCSCHH--HHHHHHHHHHHHTSCCSTTCEEETTTCCHHHHHHHHHHHC---CCTHHHHHHHH
T ss_pred             hccCCCCCCCCHHHHHHHHHhcCC--hHHHHHHHHHHhcccccccccCCCCcCCHHHHHHHHHhcC---CHHHHHHHHHH
Confidence            379999999999999998876431  135678888887       577889999999999887643   23479999999


Q ss_pred             cccCCCCceeHHHHHHHHhhcCCCCC---------CcHHHHHHHHHHhCC--C----CCCceeHHHHHHHHhccc
Q 040917          420 FDKDNNGYITVDELGKAFKDYGMGDD---------ATIATIKEIMSEVDR--D----KDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       420 ~D~d~~G~I~~~el~~~l~~~~~~~~---------~~~~~~~~~~~~~d~--~----~dg~i~~~ef~~~~~~~~  479 (494)
                      ||.|++|+|+. ||+++|...+ ++.         .+++++++++..++.  +    ++|.+++++|.++|.+..
T Consensus       238 y~~dg~~~mT~-eL~~FL~~~Q-~E~~~~~~~~~~~t~e~~~~iI~kye~~~~~~~~~~g~LsldgF~~yL~S~~  310 (816)
T 3qr0_A          238 LSKNKGNITTV-MFRDFLNDMQ-RHPSLHKTLFPLYTDAQCEALINDYESAVNKKGKKKGQLTKEGLLYFLMCEE  310 (816)
T ss_dssp             HTTTSSSEEHH-HHHHHHHHTS-SCTTSCTTTSCCCCHHHHHHHHHHHHHHHHGGGCBTTEECHHHHHHHHHSGG
T ss_pred             HccCCCCcccH-HHHHHHHHhC-CccccccccccccCHHHHHHHHHHhccccchhhhccCCccHHHHHHHhhccc
Confidence            99999999999 9999999843 233         678999999999886  5    789999999999998653

>2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max}

Probab=99.09  E-value=2.3e-10  Score=87.98  Aligned_cols=68  Identities=38%  Similarity=0.671  Sum_probs=62.5

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ....++.+|+.||.|++|+|+.+||+.+|..  ++..+++++++.++..+|.|++|.|+|+||+.++...
T Consensus         7 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~--~g~~~~~~~~~~l~~~~d~~~dg~i~~~eF~~~~~~~   74 (92)
T 2kn2_A            7 AEEELKEAFKVFDKDQNGYISASELRHVMIN--LGEKLTDEEVEQMIKEADLDGDGQVNYEEFVKMMMTV   74 (92)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHH--TTCCCCHHHHHHHHHHHCSSCCSSEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCeEcHHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhc
Confidence            4567899999999999999999999999999  6678899999999999999999999999999988753

>2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii}

Probab=99.09  E-value=1.6e-10  Score=101.97  Aligned_cols=104  Identities=15%  Similarity=0.171  Sum_probs=81.3

Q ss_pred             HHHHHHHHHh-cCCCCCcccchHHHHHHHHh----hhhhHHHHHHHhc-----------cccccCCCCceeHHHHHHHHh
Q 040917          375 FDVKQYMQAA-DIDGNGTIDYIEFITATMQR----HKLQRFENLYKAF-----------QYFDKDNNGYITVDELGKAFK  438 (494)
Q Consensus       375 ~~~~~~~~~~-D~~~~g~i~~~ef~~~~~~~----~~~~~~~~~~~~F-----------~~~D~d~~G~I~~~el~~~l~  438 (494)
                      .++..+|..+ |.|++|.|+++||...+...    ....+...+..+|           +.+|.|++|.|+.+||..++.
T Consensus        12 ~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~~   91 (191)
T 2ccm_A           12 NKILRVFNTFYDCNHDGVIEWDDFELAIKKICNLHSWPTDGKKHNEARATLKLIWDGLRKYADENEDEQVTKEEWLKMWA   91 (191)
T ss_dssp             HHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHH
T ss_pred             HHHHHhccccccCCCCCeeeHHHHHHHHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCeECHHHHHHHHH
Confidence            3478899999 99999999999998877654    2222333445555           899999999999999999887


Q ss_pred             hcCC----C---CCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          439 DYGM----G---DDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       439 ~~~~----~---~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ....    .   .......+..+|..+|.|++|.|+++||..++...
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~I~~~E~~~~l~~~  138 (191)
T 2ccm_A           92 ECVKSVEKGESLPEWLTKYMNFMFDVNDTSGDNIIDKHEYSTVYMSY  138 (191)
T ss_dssp             HHHHHHHTTCCCCHHHHHHHHHHHHHHCTTCSSBCCHHHHHHHHHTT
T ss_pred             HHhccccchhhchHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHh
Confidence            6310    0   12334678899999999999999999999998754

>1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ...

Probab=99.09  E-value=3.9e-10  Score=95.90  Aligned_cols=102  Identities=20%  Similarity=0.224  Sum_probs=86.3

Q ss_pred             HHHHHHHHhcC--CCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHH
Q 040917          376 DVKQYMQAADI--DGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKE  453 (494)
Q Consensus       376 ~~~~~~~~~D~--~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~  453 (494)
                      ++.++|..+|.  |++|.|+.+||...+.......+..++..+ ..+|.|++|.|+.+||..++.............+..
T Consensus        10 ~l~~~F~~~D~~~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l-~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~l~~   88 (156)
T 1wdc_C           10 DLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAV-GGTHKMGEKSLPFEEFLPAYEGLMDCEQGTFADYME   88 (156)
T ss_dssp             HHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHT-TCCSSTTSCEECHHHHHHHHHHHTTSCCCCHHHHHH
T ss_pred             HHHHHHHHHccCCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHH-HhhCCCCCCeeeHHHHHHHHHHHhhccCChHHHHHH
Confidence            46789999999  999999999999988765544456678888 999999999999999999998742111456778999


Q ss_pred             HHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          454 IMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       454 ~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      +|..+|.|++|.|+.+||..++...
T Consensus        89 ~F~~~D~d~~G~I~~~el~~~l~~~  113 (156)
T 1wdc_C           89 AFKTFDREGQGFISGAELRHVLTAL  113 (156)
T ss_dssp             HHHTTCSSSSSEEEHHHHHHHHHHS
T ss_pred             HHHHhCCCCCCcCcHHHHHHHHHHc
Confidence            9999999999999999999998753

>3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A

Probab=99.09  E-value=1.6e-10  Score=89.89  Aligned_cols=69  Identities=17%  Similarity=0.342  Sum_probs=58.5

Q ss_pred             HHHHHHHhccccccCC---CCceeHHHHHHHHhhcC---CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFDKDN---NGYITVDELGKAFKDYG---MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~---~G~I~~~el~~~l~~~~---~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ....++++|+.||.++   +|+|+.+||+.+|...+   ++...+++++++++.++|.|+||+|+|+||+.+|.+
T Consensus         9 ~i~~l~~~F~~fD~~~g~~~G~Is~~EL~~~l~~~~~~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~m~~   83 (100)
T 3nxa_A            9 AVIVLVENFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDANHDGRISFDEYWTLIGG   83 (100)
T ss_dssp             HHHHHHHHHHHTSCTTCSCTTCBCHHHHHHHHHHHSTTTTCSSHHHHHHHHHHHHSCCCSSCCBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCcCCCCCCeEcHHHHHHHHHHHccccccccccHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence            4467999999999964   79999999999998632   223344789999999999999999999999999875

>2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana}

Probab=99.09  E-value=8.1e-11  Score=101.28  Aligned_cols=101  Identities=20%  Similarity=0.210  Sum_probs=84.5

Q ss_pred             HHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHH
Q 040917          376 DVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIM  455 (494)
Q Consensus       376 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~  455 (494)
                      ++..+|..+|.|++|.|+++||...+.......+...+..+|+.+|.|++|.|+.+||..++..  .......+.+..+|
T Consensus        28 ~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~--~~~~~~~~~~~~~F  105 (166)
T 2aao_A           28 GLKEMFNMIDADKSGQITFEELKAGLKRVGANLKESEILDLMQAADVDNSGTIDYKEFIAATLH--LNKIEREDHLFAAF  105 (166)
T ss_dssp             HHHHHHHHHCTTCCSSBCHHHHHHHGGGGTCCCCHHHHHHHHHHHCTTCCSSBCHHHHHHHHTT--CHHHHTTHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHH--HhhcccHHHHHHHH
Confidence            4677999999999999999999988776544445667899999999999999999999999875  22223446789999


Q ss_pred             HHhCCCCCCceeHHHHHHHHhcc
Q 040917          456 SEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       456 ~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ..+|.|++|.|+.+||..++...
T Consensus       106 ~~~D~d~~G~i~~~e~~~~l~~~  128 (166)
T 2aao_A          106 TYFDKDGSGYITPDELQQACEEF  128 (166)
T ss_dssp             HHHCTTCSSSBCHHHHHHHTCC-
T ss_pred             HHhCCCCCCcCcHHHHHHHHHHc
Confidence            99999999999999999988753

>2y5i_A S100Z, S100 calcium binding protein Z; metal-binding protein, EF-hand, calcium regulation, oligomer neuronal development, spine2; 2.03A {Danio rerio}

Probab=99.09  E-value=2e-10  Score=89.32  Aligned_cols=69  Identities=16%  Similarity=0.414  Sum_probs=60.5

Q ss_pred             HHHHHHHhccccc-cCCCC-ceeHHHHHHHHhh-cC--CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFD-KDNNG-YITVDELGKAFKD-YG--MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D-~d~~G-~I~~~el~~~l~~-~~--~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ....++.+|+.|| .|++| +|+.+||+.+|.. ++  +|...+++++++++..+|.|+||.|+|+||+.++..
T Consensus         8 ~~~~l~~~F~~fDd~dg~gG~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~   81 (99)
T 2y5i_A            8 AMDALITVFHNYSGSEGDKYKLSKGELKELLNAELTDFLMSQKDPMLVEKIMNDLDSNKDNEVDFNEFVVLVAA   81 (99)
T ss_dssp             HHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSGGGGTTSCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH
Confidence            3467899999997 89998 9999999999985 22  356778999999999999999999999999998875

>1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10

Probab=99.09  E-value=1.8e-10  Score=85.54  Aligned_cols=76  Identities=29%  Similarity=0.517  Sum_probs=65.1

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhc
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAF  417 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F  417 (494)
                      +++..+|..+|.+++|+|+.+||..++..+| .++.+++..++..+|.|++|.|+|+||+..+.....  ....+.++|
T Consensus         3 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~~g-~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~~~~--~~~~~~~aF   78 (78)
T 1k9u_A            3 DDMERIFKRFDTNGDGKISLSELTDALRTLG-STSADEVQRMMAEIDTDGDGFIDFNEFISFCNANPG--LMKDVAKVF   78 (78)
T ss_dssp             CHHHHHHHHHCTTCSSEECHHHHHHHHHHHH-TCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHCHH--HHHHHHTTC
T ss_pred             HHHHHHHHHHCCCCCCcCcHHHHHHHHHHhC-CCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHCch--hHHHHHhcC
Confidence            4578899999999999999999999999999 899999999999999999999999999998876432  223455554

>1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A*

Probab=99.08  E-value=2.2e-10  Score=91.64  Aligned_cols=88  Identities=17%  Similarity=0.206  Sum_probs=64.5

Q ss_pred             hHHHhhhhhhhccCC-CCCC-cccHHHHHHHHH-hcCCC-----CCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhh
Q 040917          336 EEIQKLKEKFTEMDT-DNSG-TLTYDELKAGLA-KLGSM-----LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKL  407 (494)
Q Consensus       336 ~~~~~~~~~F~~~D~-~~~g-~i~~~el~~~l~-~~~~~-----~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~  407 (494)
                      +++..+..+|+.+|. |++| +|+.+||..+++ .+|..     ++..++..+|..+|.|+||.|+|+||+..+....  
T Consensus         9 ~~~~~l~~~F~~fD~~dgdG~~Is~~El~~~l~~~lg~~~~~~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~~--   86 (113)
T 1xk4_C            9 RNIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMARLT--   86 (113)
T ss_dssp             HHHHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHH--
T ss_pred             HHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhhcccccCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHHHH--
Confidence            456789999999995 9999 999999999999 67742     5788999999999999999999999999887543  


Q ss_pred             hHHHHHHHhccccccCCCCcee
Q 040917          408 QRFENLYKAFQYFDKDNNGYIT  429 (494)
Q Consensus       408 ~~~~~~~~~F~~~D~d~~G~I~  429 (494)
                         ......|...| +++|.=.
T Consensus        87 ---~~~~~~f~~~~-~~~g~~~  104 (113)
T 1xk4_C           87 ---WASHEKMHEGD-EGPGHHH  104 (113)
T ss_dssp             ---HHHHC--------------
T ss_pred             ---HHHHHHHhhCC-CCCcccc
Confidence               25677888888 8888543

>2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum}

Probab=99.08  E-value=4.4e-10  Score=94.16  Aligned_cols=104  Identities=13%  Similarity=0.127  Sum_probs=85.7

Q ss_pred             CCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHH
Q 040917          372 LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATI  451 (494)
Q Consensus       372 ~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~  451 (494)
                      ++.+++.++|..+|.|++|.|+.+||...+.......+...+..+|..   |++|.|+.+||..++.............+
T Consensus         2 ls~~el~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~---~~~g~i~~~eF~~~~~~~~~~~~~~~~~l   78 (145)
T 2bl0_B            2 ASADQIQECFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKGQ---LNAKEFDLATFKTVYRKPIKTPTEQSKEM   78 (145)
T ss_dssp             CCHHHHHHHHHHHCTTCSSCEEGGGHHHHHHHTTCCCCHHHHHHHHHH---HTSSEECHHHHHHHHTSCCCCGGGGHHHH
T ss_pred             CCHHHHHHHHHHhCCCCcCccCHHHHHHHHHHhCCCCCHHHHHHHHHh---cCCCeEcHHHHHHHHHHHhhcCcccHHHH
Confidence            456679999999999999999999999888765444455667777776   88999999999999986310334567789


Q ss_pred             HHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          452 KEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       452 ~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ..+|..+|.|++|.|+.+||..++...
T Consensus        79 ~~~F~~~D~d~~G~i~~~e~~~~l~~~  105 (145)
T 2bl0_B           79 LDAFRALDKEGNGTIQEAELRQLLLNL  105 (145)
T ss_dssp             HHHHHHHCSSSSSEEEHHHHHHHHHHS
T ss_pred             HHHHHHhCCCCCCeEcHHHHHHHHHHc
Confidence            999999999999999999999998754

>2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A

Probab=99.08  E-value=1.5e-10  Score=101.02  Aligned_cols=103  Identities=27%  Similarity=0.289  Sum_probs=86.3

Q ss_pred             HHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHH
Q 040917          375 FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI  454 (494)
Q Consensus       375 ~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~  454 (494)
                      .++..+|..+|.|++|.|+.+||...+.......+...+..+|+.+|.|++|.|+.+||..++... .......+.+..+
T Consensus        11 ~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~EF~~~~~~~-~~~~~~~~~~~~~   89 (179)
T 2f2o_A           11 AEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARK-MKDTDSEEEIREA   89 (179)
T ss_dssp             HHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH-HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCCCcHHHHHHHHHHH-ccCcccHHHHHHH
Confidence            457889999999999999999999988765544556788999999999999999999999988752 1112245578899


Q ss_pred             HHHhCCCCCCceeHHHHHHHHhcc
Q 040917          455 MSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       455 ~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      |..+|.|++|.|+.+||..++...
T Consensus        90 F~~~D~d~~G~I~~~E~~~~l~~~  113 (179)
T 2f2o_A           90 FRVFDKDGNGYISAAELRHVMTNL  113 (179)
T ss_dssp             HHHHCTTCSSEECHHHHHHHHHHC
T ss_pred             HHHhCCCCCCcCcHHHHHHHHHHh
Confidence            999999999999999999988753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.08  E-value=5.9e-10  Score=108.91  Aligned_cols=143  Identities=22%  Similarity=0.393  Sum_probs=104.8

Q ss_pred             eeeeecccCCeEEEEEEECCCCcEEEEEEec--cCCCCChhhHHHHHHHHHHHHHccC-CCCccEEeEEEEeC---CeEE
Q 040917           37 IGREVGRGEFGITYLCTENSTGLEFACKSIP--KRKLVKDVEKDDVRREIEIMRHLSG-QPNIVQFKAAYEDD---QFVH  110 (494)
Q Consensus        37 i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~--~~~~~~~~~~~~~~~E~~~l~~l~~-hp~i~~~~~~~~~~---~~~~  110 (494)
                      .++.|+.|.++.||++...  +..+++|+..  .....  .....+.+|+.+++.|.. +..+.+++.++.+.   +..+
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            4677899999999998854  5689999875  32211  124568889999999963 34578888888765   3478


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS--------------------------------------  152 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--------------------------------------  152 (494)
                      +|||+++|.++.+..  ...++......++.++..+|..||+                                      
T Consensus       118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999999998875421  2346788888999999999999997                                      


Q ss_pred             --------------------CCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          153 --------------------KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       153 --------------------~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                                          ..++|||++|.||+++.++ ...+.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~-~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE-PRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS-SCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC-CcEEEEECcccccc
Confidence                                3589999999999995211 13468999998763

>1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ...

Probab=99.08  E-value=1.4e-10  Score=99.29  Aligned_cols=103  Identities=21%  Similarity=0.263  Sum_probs=85.7

Q ss_pred             HHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCC---cHHHH
Q 040917          375 FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDA---TIATI  451 (494)
Q Consensus       375 ~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~---~~~~~  451 (494)
                      .++.++|..+|.|++|.|+++||...+.......+...+..+|+.+|.|++|.|+.+||..++.... ....   ....+
T Consensus        20 ~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~-~~~~~~~~~~~~   98 (162)
T 1top_A           20 AEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQM-KEDAKGKSEEEL   98 (162)
T ss_dssp             HHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTSCCEEEHHHHHHHHHHHH-HHHHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHcCCCCCcEeHHHHHHHHHHHh-ccccccccHHHH
Confidence            3477899999999999999999999887655445667889999999999999999999999987521 0111   45568


Q ss_pred             HHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          452 KEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       452 ~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ..+|..+|.|++|.|+.+||..++...
T Consensus        99 ~~~F~~~D~d~~G~I~~~e~~~~l~~~  125 (162)
T 1top_A           99 ANCFRIFDKNADGFIDIEELGEILRAT  125 (162)
T ss_dssp             HHHHHHHCTTCSSCBCHHHHHHHHHTT
T ss_pred             HHHHHHhCCCCCCcCcHHHHHHHHHHh
Confidence            899999999999999999999998764

>3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum}

Probab=99.08  E-value=3.6e-10  Score=98.78  Aligned_cols=98  Identities=19%  Similarity=0.275  Sum_probs=83.1

Q ss_pred             HHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHH
Q 040917          375 FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI  454 (494)
Q Consensus       375 ~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~  454 (494)
                      .++.++|..+|.|++|.|+++||...+.....  ....+..+|..+|.|++|.|+.+||..++...  . ...++.+..+
T Consensus        39 ~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~--~~~~~~~~~~~~D~d~~g~i~~~Ef~~~~~~~--~-~~~~~~~~~~  113 (180)
T 3mse_B           39 KYINELFYKLDTNHNGSLSHREIYTVLASVGI--KKWDINRILQALDINDRGNITYTEFMAGCYRW--K-NIESTFLKAA  113 (180)
T ss_dssp             HHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTC--CHHHHHHHHHHHCTTCCSEECHHHHHHHHSCC--T-TC--CHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCC--CHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhc--c-cCCHHHHHHH
Confidence            45788999999999999999999988875432  24678999999999999999999999988763  1 2344689999


Q ss_pred             HHHhCCCCCCceeHHHHHHHHhc
Q 040917          455 MSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       455 ~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      |..+|.|++|.|+.+||..++..
T Consensus       114 F~~~D~d~~G~I~~~El~~~l~~  136 (180)
T 3mse_B          114 FNKIDKDEDGYISKSDIVSLVHD  136 (180)
T ss_dssp             HHHHCTTCSSCBCHHHHHHHTTT
T ss_pred             HHHHCCCCCCCCCHHHHHHHHcC
Confidence            99999999999999999999883

>3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana}

Probab=99.08  E-value=3.3e-11  Score=100.03  Aligned_cols=98  Identities=10%  Similarity=-0.029  Sum_probs=60.8

Q ss_pred             hhhhhccCCCCCCcccHHHHHHHHHhc-CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh-hhhHHHHHHHhccc
Q 040917          342 KEKFTEMDTDNSGTLTYDELKAGLAKL-GSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH-KLQRFENLYKAFQY  419 (494)
Q Consensus       342 ~~~F~~~D~~~~g~i~~~el~~~l~~~-~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~-~~~~~~~~~~~F~~  419 (494)
                      +++|..+|.|++|.|+.+||..++... ......+++...|..+|.|++|.|+.+||...+.... ...+.+++..+|+.
T Consensus         6 ~~l~~~~D~d~~G~I~~~EF~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~e~~~~~~~   85 (135)
T 3h4s_E            6 KSMLLETTSTTKMETKYEDMLPVMAEKMDVEEFVSELCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQGMVRE   85 (135)
T ss_dssp             -------------CCCC-----------CHHHHHHHHHHHHHHHSBTTTTBBCHHHHHHHGGGGTCCCCCHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCCcEeHHHHHHHHHHHccccchHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHH
Confidence            567888999999999999998887653 2222346688899999999999999999988876654 24456778999999


Q ss_pred             cccCCCCceeHHHHHHHHhh
Q 040917          420 FDKDNNGYITVDELGKAFKD  439 (494)
Q Consensus       420 ~D~d~~G~I~~~el~~~l~~  439 (494)
                      +|.|++|.|+.+||..++..
T Consensus        86 ~D~d~dG~I~~~EF~~~~~~  105 (135)
T 3h4s_E           86 GDLDGDGALNQTEFCVLMVR  105 (135)
T ss_dssp             HCSSCSSSBCHHHHHHHHHH
T ss_pred             hCCCCCCCCcHHHHHHHHHH
Confidence            99999999999999999876

>3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A

Probab=99.08  E-value=3e-10  Score=100.35  Aligned_cols=99  Identities=21%  Similarity=0.174  Sum_probs=85.2

Q ss_pred             HHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHH
Q 040917          375 FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI  454 (494)
Q Consensus       375 ~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~  454 (494)
                      .++.++|..+|.|++|.|+.+||...+.......+ ..+..+|+.+|.|++|.|+.+||..++...  . ...++.+..+
T Consensus        52 ~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~~~~-~~~~~l~~~~D~d~~g~i~~~EF~~~~~~~--~-~~~~~~l~~~  127 (191)
T 3k21_A           52 EKLKSTFLVLDEDGKGYITKEQLKKGLEKDGLKLP-YNFDLLLDQIDSDGSGKIDYTEFIAAALDR--K-QLSKKLIYCA  127 (191)
T ss_dssp             HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCC-TTHHHHHHHHCTTCSSSEEHHHHHHHHSCG--G-GCCHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCcHHHHHHHHHHcCCCcH-HHHHHHHHHhCCCCCCeEeHHHHHHHHHhh--h-hccHHHHHHH
Confidence            45788999999999999999999998876543333 678899999999999999999999988652  1 3567889999


Q ss_pred             HHHhCCCCCCceeHHHHHHHHhc
Q 040917          455 MSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       455 ~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      |..+|.|++|.|+.+||..++..
T Consensus       128 F~~~D~d~~G~Is~~El~~~l~~  150 (191)
T 3k21_A          128 FRVFDVDNDGEITTAELAHILYN  150 (191)
T ss_dssp             HHHHSTTCSSCBCHHHHHHHHHH
T ss_pred             HHHhCCCCCCcCCHHHHHHHHHh
Confidence            99999999999999999999875

>1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A

Probab=99.08  E-value=1.1e-10  Score=87.44  Aligned_cols=68  Identities=34%  Similarity=0.506  Sum_probs=61.7

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCC-CCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMG-DDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~-~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      ....++ +|..||.|++|+|+.+||..++..  +| ..+++++++.++..+|.|++|.|+|+||..++....
T Consensus         7 ~~~~l~-~F~~~D~d~~G~i~~~el~~~l~~--~g~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~~~~   75 (81)
T 1c7v_A            7 EEEILR-AFKVFDANGDGVIDFDEFKFIMQK--VGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLIKKSK   75 (81)
T ss_dssp             CHHHHH-HHHHHSCSGGGEECHHHHHHHSST--TTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHHHCC-
T ss_pred             HHHHHH-HHHHHCCCCCCcCCHHHHHHHHHH--hCCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhhh
Confidence            456789 999999999999999999999998  66 788999999999999999999999999999988643

>2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola}

Probab=99.08  E-value=2e-10  Score=102.92  Aligned_cols=102  Identities=19%  Similarity=0.211  Sum_probs=82.7

Q ss_pred             HHHHHHHHhcCCCCCcccchHHHHHHHHhhh--hhHHHHHHHhc-------cccccCCCCceeHHHHHHHHh--------
Q 040917          376 DVKQYMQAADIDGNGTIDYIEFITATMQRHK--LQRFENLYKAF-------QYFDKDNNGYITVDELGKAFK--------  438 (494)
Q Consensus       376 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~--~~~~~~~~~~F-------~~~D~d~~G~I~~~el~~~l~--------  438 (494)
                      ++.++|..+|.|++|.|+.+||...+.....  ..+.+++..+|       +.+|.|++|.|+.+||..++.        
T Consensus        37 ~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~~~~~~~~~~l~~~~~~lf~~~D~d~dg~i~~~EF~~~~~~~~~~~~~  116 (208)
T 2hpk_A           37 RLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAVRVFFLHKGVEPVNGLLREDWVEANRVFAEAERE  116 (208)
T ss_dssp             HHHHHHHHHCTTCSSEECHHHHTHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHTTCBTTTBEEGGGHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHHhhcCCCHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhhhhhh
Confidence            4788999999999999999999888776443  34455677777       999999999999999999886        


Q ss_pred             -hcCCCCCCcHHH-HHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          439 -DYGMGDDATIAT-IKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       439 -~~~~~~~~~~~~-~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                       .+. ......++ +..+|..+|.|++|.|+.+||..++...
T Consensus       117 ~~~~-~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~  157 (208)
T 2hpk_A          117 RERR-GEPSLIALLSNSYYDVLDDDGDGTVDVDELKTMMKAF  157 (208)
T ss_dssp             HHHT-TCCCHHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHT
T ss_pred             hhcc-CChHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHh
Confidence             321 22233444 7899999999999999999999998754

>1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A

Probab=99.08  E-value=1.8e-10  Score=88.96  Aligned_cols=69  Identities=12%  Similarity=0.331  Sum_probs=55.5

Q ss_pred             HHHHHHHhccccc-cCC-CCceeHHHHHHHHhh-cC--CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFD-KDN-NGYITVDELGKAFKD-YG--MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D-~d~-~G~I~~~el~~~l~~-~~--~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ....++.+|+.|| .|+ +|+|+.+||+.+|.. ++  +|...+++++++++..+|.|+||.|+|+||+.+|..
T Consensus         7 ~~~~l~~~F~~fD~~dgd~G~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~   80 (95)
T 1j55_A            7 AMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAA   80 (95)
T ss_dssp             HHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHHhHhhcccccCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH
Confidence            3467899999999 788 589999999999985 22  345678889999999999999999999999998874

>2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A

Probab=99.07  E-value=2.8e-10  Score=90.22  Aligned_cols=71  Identities=18%  Similarity=0.283  Sum_probs=63.4

Q ss_pred             chhHHHhhhhhhhccC-CCCCC-cccHHHHHHHHHh-----cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          334 PTEEIQKLKEKFTEMD-TDNSG-TLTYDELKAGLAK-----LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       334 ~~~~~~~~~~~F~~~D-~~~~g-~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      ...++..+..+|+.|| +|++| +|+.+||..+++.     +|..++++++.++++.+|.|+||.|+|+||+..+...
T Consensus        17 ~~~~~~~l~~aF~~fD~~dgdGG~Is~~EL~~~l~~~l~~~lg~~~t~~ev~~li~~~D~dgdG~Idf~EF~~~m~~~   94 (113)
T 2lnk_A           17 LEKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCI   94 (113)
T ss_dssp             HHHHHHHHHHHHHHTTTTTSCTTCBCHHHHHHHHHHHCGGGGTTCCCTTHHHHHHHHHCSSSSSCBCHHHHHHHHHHH
T ss_pred             chhHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcchhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHH
Confidence            3466788999999999 89997 9999999999986     6777888899999999999999999999999987753

>1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4

Probab=99.07  E-value=3.1e-10  Score=90.23  Aligned_cols=95  Identities=18%  Similarity=0.153  Sum_probs=77.4

Q ss_pred             hhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh---hhhhHHHHHHHh
Q 040917          340 KLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR---HKLQRFENLYKA  416 (494)
Q Consensus       340 ~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~---~~~~~~~~~~~~  416 (494)
                      .+..+|..+|  ++|.|+.+||..++...  ....+++..+|..+|.|++|.|+.+||...+...   ....+..++..+
T Consensus        11 e~~~~~~~~d--~~g~i~~~eF~~~~~~~--~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~   86 (109)
T 1bu3_A           11 DVAAALKACE--AADSFNYKAFFAKVGLT--AKSADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARALTDAETKAF   86 (109)
T ss_dssp             HHHHHHHHTC--STTCCCHHHHHHHHTGG--GSCHHHHHHHHHHHCTTCSSSEEHHHHHTHHHHHSTTCCCCCHHHHHHH
T ss_pred             HHHHHHHHhC--CCCcCcHHHHHHHHHcC--hhhHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCCCCHHHHHHH
Confidence            3455566677  89999999999987543  2356778999999999999999999998888765   333456788999


Q ss_pred             ccccccCCCCceeHHHHHHHHh
Q 040917          417 FQYFDKDNNGYITVDELGKAFK  438 (494)
Q Consensus       417 F~~~D~d~~G~I~~~el~~~l~  438 (494)
                      |+.+|.|++|.|+.+||..++.
T Consensus        87 ~~~~D~~~dg~i~~~eF~~~~~  108 (109)
T 1bu3_A           87 LKAGDSDGDGAIGVDEWAALVK  108 (109)
T ss_dssp             HHHHCTTCSSEECHHHHHHHHT
T ss_pred             HHHhCCCCCCcEeHHHHHHHHh
Confidence            9999999999999999998875

>4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens}

Probab=99.06  E-value=2.1e-10  Score=91.88  Aligned_cols=69  Identities=22%  Similarity=0.456  Sum_probs=60.1

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhc---CCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDY---GMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~---~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ..+.+..+|+.||.| +|+|+.+||+.+|...   .++...+++++++++..+|.|+||+|+|+||+.+|.+.
T Consensus        13 ~ie~l~~~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~~~~~~~~v~~~i~~~D~d~DG~IdF~EF~~lm~~l   84 (121)
T 4drw_A           13 AMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGL   84 (121)
T ss_dssp             HHHHHHHTTGGGSCT-TCSCCHHHHHHHTTTSCHHHHTTSSCTTHHHHHHHHHCTTCSSCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHHhhhhcccCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHH
Confidence            346789999999988 8999999999999752   13567788899999999999999999999999988753

>1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A

Probab=99.06  E-value=4.2e-10  Score=89.44  Aligned_cols=96  Identities=17%  Similarity=0.140  Sum_probs=78.7

Q ss_pred             hhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh---hhhhHHHHHHHh
Q 040917          340 KLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR---HKLQRFENLYKA  416 (494)
Q Consensus       340 ~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~---~~~~~~~~~~~~  416 (494)
                      ++..+|..+|  ++|.|+.+||..++...  ....+++..+|..+|.|++|.|+.+||...+...   ....+.+++..+
T Consensus        10 e~~~~~~~~d--~~g~i~~~eF~~~~~~~--~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~   85 (109)
T 1rwy_A           10 DIKKAIGAFT--AADSFDHKKFFQMVGLK--KKSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTL   85 (109)
T ss_dssp             HHHHHHHTTC--STTCCCHHHHHHHHTGG--GSCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHH
T ss_pred             HHHHHHHHcC--CCCcEeHHHHHHHHhcC--cchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHhccCCCCCHHHHHHH
Confidence            3455566677  89999999999988543  3456789999999999999999999999888765   333456778999


Q ss_pred             ccccccCCCCceeHHHHHHHHhh
Q 040917          417 FQYFDKDNNGYITVDELGKAFKD  439 (494)
Q Consensus       417 F~~~D~d~~G~I~~~el~~~l~~  439 (494)
                      |+.+|.|++|.|+.+||..++..
T Consensus        86 ~~~~D~~~dg~i~~~eF~~~~~~  108 (109)
T 1rwy_A           86 MAAGDKDGDGKIGVEEFSTLVAE  108 (109)
T ss_dssp             HHHHCTTCSSSEEHHHHHHHHHT
T ss_pred             HHHHCCCCCCcCCHHHHHHHHHc
Confidence            99999999999999999998864

>1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5

Probab=99.06  E-value=2.4e-10  Score=81.97  Aligned_cols=63  Identities=25%  Similarity=0.508  Sum_probs=59.4

Q ss_pred             hhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHH
Q 040917          340 KLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATM  402 (494)
Q Consensus       340 ~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~  402 (494)
                      ++..+|+.+|.+++|+|+.+||..++..+|..++.+++..+|..+|.|++|.|+|+||+..+.
T Consensus         2 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~   64 (67)
T 1tiz_A            2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSCIE   64 (67)
T ss_dssp             THHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHH
Confidence            567899999999999999999999999999999999999999999999999999999998765

>3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A

Probab=99.06  E-value=2.6e-10  Score=96.43  Aligned_cols=102  Identities=17%  Similarity=0.275  Sum_probs=85.2

Q ss_pred             HHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCC---CcHHHHH
Q 040917          376 DVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDD---ATIATIK  452 (494)
Q Consensus       376 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~---~~~~~~~  452 (494)
                      ++..+|..+|.|++|.|+.+||...+.......+...+..+|+.+|.|++|.|+.+||..++........   ...+.+.
T Consensus        12 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~   91 (153)
T 3ox6_A           12 ELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNLGGHVDFDDFVELMGPKLLAETADMIGVKELR   91 (153)
T ss_dssp             HHHHHHHHHHHHCSSSCCHHHHHHHHHHTTCCCCHHHHHHHHHHHHTTSTTCCCHHHHHHHHHHHHTTCCHHHHCHHHHH
T ss_pred             HHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCccCcHHHHHHHHHHHhhccccccccHHHHH
Confidence            3677899999999999999999988876654556678899999999999999999999999975222111   1256788


Q ss_pred             HHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          453 EIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       453 ~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .+|..+|.|++|.|+.+||..++..
T Consensus        92 ~~F~~~D~d~~G~i~~~el~~~l~~  116 (153)
T 3ox6_A           92 DAFREFDTNGDGEISTSELREAMRA  116 (153)
T ss_dssp             HHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred             HHHHHhCCCCCCcCcHHHHHHHHHH
Confidence            9999999999999999999998875

>1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C

Probab=99.06  E-value=1.8e-10  Score=97.34  Aligned_cols=103  Identities=14%  Similarity=0.153  Sum_probs=83.9

Q ss_pred             HHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccC--CCCceeHHHHHHHHhhcCC-CCCCcHHHHH
Q 040917          376 DVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKD--NNGYITVDELGKAFKDYGM-GDDATIATIK  452 (494)
Q Consensus       376 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d--~~G~I~~~el~~~l~~~~~-~~~~~~~~~~  452 (494)
                      ++..+|..+|.|++|.|+++||...+.......+...+..+|..+|.|  ++|.|+.+||..++..... ......+.+.
T Consensus        11 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~l~   90 (151)
T 1w7j_B           11 EFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNRGQGTYEDYL   90 (151)
T ss_dssp             CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC--------CCH
T ss_pred             HHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCcCcCCCCcCcHHHHHHHHHHHhccCCCCcHHHHH
Confidence            478899999999999999999998887655445567899999999999  9999999999999987321 1122345677


Q ss_pred             HHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          453 EIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       453 ~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      .+|..+|.|++|.|+.+||..++...
T Consensus        91 ~~F~~~D~d~~G~I~~~el~~~l~~~  116 (151)
T 1w7j_B           91 EGFRVFDKEGNGKVMGAELRHVLTTL  116 (151)
T ss_dssp             HHHHTTCTTSSSEEEHHHHHHHHHHS
T ss_pred             HHHHHhCCCCCCcCcHHHHHHHHHHc
Confidence            89999999999999999999998754

>1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A

Probab=99.05  E-value=5e-10  Score=87.94  Aligned_cols=69  Identities=25%  Similarity=0.280  Sum_probs=63.3

Q ss_pred             CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      ++.++..++.++|+.+|+ ++|+|+.+|+..++..+|  ++.+++.++|...|.|+||.|+|+||+.++...
T Consensus         9 ls~~e~~~~~~~F~~~D~-~dG~Is~~el~~~l~~~g--l~~~el~~i~~~~D~d~dG~id~~EF~~~m~~~   77 (106)
T 1eh2_A            9 VKPEDKAKYDAIFDSLSP-VNGFLSGDKVKPVLLNSK--LPVDILGRVWELSDIDHDGMLDRDEFAVAMFLV   77 (106)
T ss_dssp             SCHHHHHHHHHHHTTSCC-SSSCCBHHHHHHHHHTTT--CCHHHHHHHHHHHCSSCSSBCCHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHhCC-CCCeEcHHHHHHHHHHcC--CCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHH
Confidence            467888999999999999 999999999999999986  678899999999999999999999999887643

>2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C*

Probab=99.05  E-value=6e-10  Score=93.73  Aligned_cols=103  Identities=16%  Similarity=0.132  Sum_probs=86.6

Q ss_pred             HHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhcccc---ccCCCCceeHHHHHHHHhhcC-CCCCCcHHH
Q 040917          375 FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYF---DKDNNGYITVDELGKAFKDYG-MGDDATIAT  450 (494)
Q Consensus       375 ~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~---D~d~~G~I~~~el~~~l~~~~-~~~~~~~~~  450 (494)
                      .++..+|..+|.|++|.|+++||...+.......+...+..+|+.+   |.|+ |.|+.+||..++.... .........
T Consensus         8 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~~~~d~~~-g~i~~~eF~~~~~~~~~~~~~~~~~~   86 (149)
T 2mys_C            8 DDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNA-AAITFEEFLPMLQAAANNKDQGTFED   86 (149)
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhhhccccC-CcCcHHHHHHHHHHHhccCCcchHHH
Confidence            3477899999999999999999988877655445567889999999   9999 9999999999998731 223445678


Q ss_pred             HHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          451 IKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       451 ~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      +..+|..+|.|++|.|+.+||..++...
T Consensus        87 ~~~~F~~~D~d~~G~i~~~el~~~l~~~  114 (149)
T 2mys_C           87 FVEGLRVFDKEGNGTVMGAELRHVLATL  114 (149)
T ss_pred             HHHHHHHhCCCCCceEcHHHHHHHHHHh
Confidence            8999999999999999999999998763

>2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens}

Probab=99.05  E-value=5e-10  Score=88.71  Aligned_cols=68  Identities=25%  Similarity=0.434  Sum_probs=62.5

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ....++.+|..||.|++|+|+.+||..++..  +|...++++++.++..+|.|++|.|+|+||..++...
T Consensus        30 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~--~g~~~~~~~~~~l~~~~D~d~dg~i~~~eF~~~~~~~   97 (107)
T 2d58_A           30 KLEGFKEKYMEFDLNGNGDIDIMSLKRMLEK--LGVPKTHLELKKLIGEVSSGSGETFSYPDFLRMMLGK   97 (107)
T ss_dssp             HHHHHHHHHTTSCCCTTSCEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHCSSSSSEECHHHHHHHHSSS
T ss_pred             HHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHc
Confidence            3457899999999999999999999999999  6778899999999999999999999999999988753

>1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6

Probab=99.05  E-value=2.1e-10  Score=88.59  Aligned_cols=65  Identities=23%  Similarity=0.309  Sum_probs=58.6

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...+++++|+.||.|++|+|+.+|++.++..+|    ++++++++++..+|.|+||+|+|+||..+|..
T Consensus         8 ~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g----~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~~   72 (95)
T 1c07_A            8 EKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG----LPSTLLAHIWSLCDTKDCGKLSKDQFALAFHL   72 (95)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT----CCHHHHHHHHHHHCTTCSSSEETTTHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcC----CCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHH
Confidence            346789999999999999999999999999843    57889999999999999999999999988754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.05  E-value=3.1e-10  Score=116.23  Aligned_cols=123  Identities=20%  Similarity=0.242  Sum_probs=94.5

Q ss_pred             CCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh--------hhHHHHHHHhccccccCC
Q 040917          353 SGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK--------LQRFENLYKAFQYFDKDN  424 (494)
Q Consensus       353 ~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~--------~~~~~~~~~~F~~~D~d~  424 (494)
                      ...+....+..+...+......+++.++|..+|.|+||.|+++||...+.....        .....++..+|+.+|.|+
T Consensus       333 ~~kl~~a~l~~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~  412 (504)
T 3q5i_A          333 SQKLAQAAILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDK  412 (504)
T ss_dssp             CSHHHHHHHHHHHHHTSCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTTC
T ss_pred             HHHHHHHHHHHhhccCCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCCC
Confidence            333444444333333322222345788999999999999999999887765422        245678999999999999


Q ss_pred             CCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          425 NGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       425 ~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +|.|+.+||..++..  .....+++++..+|..+|.|+||.|+.+||..++..
T Consensus       413 dG~I~~~EF~~~~~~--~~~~~~~~~~~~~F~~~D~d~dG~Is~~El~~~l~~  463 (504)
T 3q5i_A          413 NGYIEYSEFISVCMD--KQILFSEERLRRAFNLFDTDKSGKITKEELANLFGL  463 (504)
T ss_dssp             SSSEEHHHHHHHHSC--HHHHTCHHHHHHHHHHHCTTCCSEECHHHHHHHTTC
T ss_pred             CCcEeHHHHHHHHHh--hhcccCHHHHHHHHHHhcCCCCCcCcHHHHHHHHhh
Confidence            999999999999875  233456788999999999999999999999998875

>3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica}

Probab=99.05  E-value=4e-11  Score=85.83  Aligned_cols=62  Identities=18%  Similarity=0.300  Sum_probs=56.3

Q ss_pred             HHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          414 YKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       414 ~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +.+|+.+|.|++|+|+.+||..++..  ++...++++++.++..+|.|++|.|+++||..++..
T Consensus         3 ~~~F~~~D~d~~G~i~~~e~~~~l~~--~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~   64 (66)
T 3li6_A            3 EALFKEIDVNGDGAVSYEEVKAFVSK--KRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGS   64 (66)
T ss_dssp             CHHHHHHCTTCSSSCCHHHHHHHHHH--HHHHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHTC
T ss_pred             HHHHHHHCCCCCCcccHHHHHHHHHH--ccCCCcHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence            56899999999999999999999998  456778889999999999999999999999998874

>2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens}

Probab=99.05  E-value=2.9e-10  Score=82.56  Aligned_cols=66  Identities=30%  Similarity=0.578  Sum_probs=61.4

Q ss_pred             HHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHH
Q 040917          337 EIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATM  402 (494)
Q Consensus       337 ~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~  402 (494)
                      ....+..+|..+|.+++|+|+.+||..++..+|..++.+++..+|..+|.|++|.|+|+||+..+.
T Consensus         4 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~   69 (71)
T 2b1u_A            4 GLEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREADVDQDGRVNYEEFARMLA   69 (71)
T ss_dssp             THHHHHHHHTTSCCSSSSEEEHHHHHHHGGGTTCSSCHHHHHHHHHHCCSSSSSEEETTHHHHHHT
T ss_pred             cHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHh
Confidence            356788999999999999999999999999999999999999999999999999999999988764

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.05  E-value=2.3e-10  Score=116.82  Aligned_cols=102  Identities=23%  Similarity=0.295  Sum_probs=86.2

Q ss_pred             HHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh--------hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCC
Q 040917          374 EFDVKQYMQAADIDGNGTIDYIEFITATMQRHK--------LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDD  445 (494)
Q Consensus       374 ~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~--------~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~  445 (494)
                      .+++.++|..+|.|+||.|+++||...+.....        ......+..+|+.+|.|++|.|+.+||..++..  ....
T Consensus       345 ~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~~EF~~~~~~--~~~~  422 (494)
T 3lij_A          345 TKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYSEFVTVAMD--RKSL  422 (494)
T ss_dssp             HHHHHHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHSC--HHHH
T ss_pred             HHHHHHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHh--hhcc
Confidence            346888999999999999999999887765432        234677999999999999999999999999875  2334


Q ss_pred             CcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          446 ATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       446 ~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .+++++..+|..+|.|+||.|+.+||..++..
T Consensus       423 ~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~  454 (494)
T 3lij_A          423 LSKDKLESAFQKFDQDGNGKISVDELASVFGL  454 (494)
T ss_dssp             TCHHHHHHHHHHHCTTCSSEECHHHHHHHC-C
T ss_pred             ccHHHHHHHHHHHCCCCCCcCCHHHHHHHHHh
Confidence            56788999999999999999999999998874

>3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ...

Probab=99.04  E-value=4.3e-10  Score=86.35  Aligned_cols=68  Identities=16%  Similarity=0.388  Sum_probs=59.4

Q ss_pred             HHHHHHHhccccccCCCC---ceeHHHHHHHHhh-cC--CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFDKDNNG---YITVDELGKAFKD-YG--MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G---~I~~~el~~~l~~-~~--~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ....++.+|+.|| +++|   +|+.+||+.+|.. ++  +|...+++++++++..+|.|+||+|+|+||+.++.+
T Consensus         7 ~~~~l~~~F~~~D-~~dG~~g~Is~~EL~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I~f~EF~~~~~~   80 (92)
T 3rm1_A            7 AVVALIDVFHQYS-GREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSNGDGECDFQEFMAFVAM   80 (92)
T ss_dssp             HHHHHHHHHHHHH-TSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHc-cCCCCcCeECHHHHHHHHHHHhhhhccCcccHHHHHHHHHHHcCCCCCCCcHHHHHHHHHH
Confidence            3467899999999 7777   9999999999987 11  356788999999999999999999999999998875

>2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens}

Probab=99.04  E-value=5.5e-10  Score=88.86  Aligned_cols=70  Identities=27%  Similarity=0.320  Sum_probs=63.6

Q ss_pred             CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      ++.++.+++..+|+.+|+|++|+|+.+||..++.  +..++.+++..+|..+|.|+||.|+|+||+..+...
T Consensus         8 ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~--~~~~~~~~~~~i~~~~D~d~dG~I~~~EF~~~~~~~   77 (111)
T 2kgr_A            8 VPQSSRLKYRQLFNSHDKTMSGHLTGPQARTILM--QSSLPQAQLASIWNLSDIDQDGKLTAEEFILAMHLI   77 (111)
T ss_dssp             SCHHHHHHHHHHHHTTSCSSCCEEEHHHHHHHHH--TTCCCHHHHHHHHHHHCSSCCSEEEHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHH--hCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHH
Confidence            4567888999999999999999999999999998  667889999999999999999999999999887643

>2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A

Probab=99.04  E-value=3.1e-10  Score=90.09  Aligned_cols=95  Identities=20%  Similarity=0.147  Sum_probs=75.8

Q ss_pred             hhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh---hhhhHHHHHHHh
Q 040917          340 KLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR---HKLQRFENLYKA  416 (494)
Q Consensus       340 ~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~---~~~~~~~~~~~~  416 (494)
                      .+..+|..+|  ++|.|+.+||..++...  ....+++..+|..+|.|++|.|+.+||...+...   ....+.+++..+
T Consensus        10 e~~~l~~~~d--~~g~i~~~eF~~~~~~~--~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~   85 (108)
T 2pvb_A           10 DVAAALAACS--AADSFKHKEFFAKVGLA--SKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAF   85 (108)
T ss_dssp             HHHHHHHHTC--STTCCCHHHHHHHHTGG--GSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHH
T ss_pred             HHHHHHHHhC--CCCcCcHHHHHHHHhCC--hhHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccCCCCCHHHHHHH
Confidence            4455566677  78999999999887543  2356778999999999999999999998877654   233456778999


Q ss_pred             ccccccCCCCceeHHHHHHHHh
Q 040917          417 FQYFDKDNNGYITVDELGKAFK  438 (494)
Q Consensus       417 F~~~D~d~~G~I~~~el~~~l~  438 (494)
                      |+.+|.|++|.|+.+||..++.
T Consensus        86 ~~~~D~~~dg~i~~~eF~~~~~  107 (108)
T 2pvb_A           86 LADGDKDGDGMIGVDEFAAMIK  107 (108)
T ss_dssp             HHHHCTTCSSSBCHHHHHHHHH
T ss_pred             HHHhCCCCCCcEeHHHHHHHHh
Confidence            9999999999999999998775

>2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens}

Probab=99.03  E-value=6.4e-10  Score=88.50  Aligned_cols=65  Identities=22%  Similarity=0.261  Sum_probs=58.5

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...+++.+|+.||.|++|+|+.+||+.+|..    ..++++++++++..+|.|+||+|+|+||..+|..
T Consensus        12 ~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~----~~~~~~~~~~i~~~~D~d~dG~I~~~EF~~~~~~   76 (111)
T 2kgr_A           12 SRLKYRQLFNSHDKTMSGHLTGPQARTILMQ----SSLPQAQLASIWNLSDIDQDGKLTAEEFILAMHL   76 (111)
T ss_dssp             HHHHHHHHHHTTSCSSCCEEEHHHHHHHHHT----TCCCHHHHHHHHHHHCSSCCSEEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCcCcHHHHHHHHHh----CCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHH
Confidence            3467899999999999999999999999984    3568899999999999999999999999998764

>2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens}

Probab=99.03  E-value=4.6e-10  Score=86.03  Aligned_cols=65  Identities=20%  Similarity=0.378  Sum_probs=59.0

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ....++.+|+.||.|++|+|+.+||..+|..+  |  .++++++.++..+|.|+||.|+|+||..++..
T Consensus        25 ~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~--g--~~~~~~~~~~~~~D~d~dg~I~~~EF~~~~~~   89 (91)
T 2pmy_A           25 ELARLRSVFAACDANRSGRLEREEFRALCTEL--R--VRPADAEAVFQRLDADRDGAITFQEFARGFLG   89 (91)
T ss_dssp             HHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHT--T--CCHHHHHHHHHHHCTTCSSEECHHHHTHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHc--C--cCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHH
Confidence            45678999999999999999999999999994  4  57889999999999999999999999998763

>2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens}

Probab=99.03  E-value=3.2e-10  Score=86.97  Aligned_cols=70  Identities=27%  Similarity=0.435  Sum_probs=64.0

Q ss_pred             cCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHH
Q 040917          332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQ  403 (494)
Q Consensus       332 ~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~  403 (494)
                      .++.++...+..+|..+|.|++|+|+.+||..+++.+|  ++.+++..+|..+|.|++|.|+|+||+..+..
T Consensus        20 ~l~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g--~~~~~~~~~~~~~D~d~dg~I~~~EF~~~~~~   89 (91)
T 2pmy_A           20 DGDGEELARLRSVFAACDANRSGRLEREEFRALCTELR--VRPADAEAVFQRLDADRDGAITFQEFARGFLG   89 (91)
T ss_dssp             HHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTT--CCHHHHHHHHHHHCTTCSSEECHHHHTHHHHH
T ss_pred             cCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHcC--cCHHHHHHHHHHhCCCCCCCEeHHHHHHHHHH
Confidence            34677889999999999999999999999999999998  68889999999999999999999999987653

>3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C

Probab=99.03  E-value=8.6e-11  Score=98.48  Aligned_cols=99  Identities=23%  Similarity=0.272  Sum_probs=48.3

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCC----C-CCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-------
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGS----M-LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-------  406 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~----~-~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-------  406 (494)
                      ..-...|..+|.|++|.|+.+||..++.....    . ...+++..+|..+|.|++|.|+++||...+.....       
T Consensus        27 ~~~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~g  106 (143)
T 3a4u_B           27 AASFSQPGSMGLDKNTVHDQEHIMEHLEGVINKPEAEMSPQELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQA  106 (143)
T ss_dssp             ------------------------------------CCCHHHHHHHHHHHTCTTCSSCEEHHHHHHTCC-----------
T ss_pred             CCCHHHHHHhCCCCCCcCcHHHHHHHHHHHhcccccccCHHHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHhhhccccC
Confidence            34457899999999999999999998876521    1 23467889999999999999999999887654310       


Q ss_pred             -hhHHHH----HHHhccccccCCCCceeHHHHHHHH
Q 040917          407 -LQRFEN----LYKAFQYFDKDNNGYITVDELGKAF  437 (494)
Q Consensus       407 -~~~~~~----~~~~F~~~D~d~~G~I~~~el~~~l  437 (494)
                       ..+.++    +..+|+.+|.|+||.|+.+||..++
T Consensus       107 ~~~s~~e~~~~~~~~f~~~D~d~dG~Is~~EF~~~~  142 (143)
T 3a4u_B          107 PLMSEDELINIIDGVLRDDDKNNDGYIDYAEFAKSL  142 (143)
T ss_dssp             --CCHHHHHHHHHHHHHHHCTTCSSEECHHHHHC--
T ss_pred             CCCCHHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHH
Confidence             111222    3667899999999999999998765

>3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens}

Probab=99.03  E-value=5.5e-10  Score=87.31  Aligned_cols=71  Identities=17%  Similarity=0.244  Sum_probs=61.0

Q ss_pred             hhHHHhhhhhhhccC-CCCC-CcccHHHHHHHHHh-cC----CCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh
Q 040917          335 TEEIQKLKEKFTEMD-TDNS-GTLTYDELKAGLAK-LG----SMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH  405 (494)
Q Consensus       335 ~~~~~~~~~~F~~~D-~~~~-g~i~~~el~~~l~~-~~----~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~  405 (494)
                      ...+..+..+|+.|| .|++ |+|+.+||..+++. +|    ..++.+++.++++.+|.|+||.|+|+||+..+....
T Consensus         9 e~~~~~l~~aF~~fD~~dgd~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~m~~~~   86 (104)
T 3zwh_A            9 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSSIA   86 (104)
T ss_dssp             HHHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGSCSSCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHcchhccCCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHH
Confidence            356678899999997 7775 89999999999986 54    456889999999999999999999999999887543

>1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6

Probab=99.02  E-value=2e-10  Score=89.36  Aligned_cols=63  Identities=19%  Similarity=0.231  Sum_probs=57.7

Q ss_pred             HHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ..++++|+.||.|++|+|+.+|++.+|..++    ++++++++++..+|.|+||.|+|+||..+|..
T Consensus        11 ~~~~~~F~~~D~d~dG~Is~~el~~~l~~~~----l~~~~l~~i~~~~D~d~dG~i~~~EF~~~~~~   73 (99)
T 1qjt_A           11 PVYEKYYRQVEAGNTGRVLALDAAAFLKKSG----LPDLILGKIWDLADTDGKGVLSKQEFFVALRL   73 (99)
T ss_dssp             THHHHHHHHHCCTTSSCCCSHHHHHHHHTSS----SCHHHHHHHHHHHCCSSSSSCCSHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCcCCHHHHHHHHHHcC----CCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHH
Confidence            4689999999999999999999999999843    57889999999999999999999999998864

>2wcb_A Protein S100-A12; calcium signalling, HOST-parasite response, metal binding PR; 1.73A {Homo sapiens} PDB: 1odb_A* 2wc8_A 2wcf_A 2wce_A 1e8a_A 1gqm_A

Probab=99.02  E-value=1.8e-10  Score=88.93  Aligned_cols=69  Identities=19%  Similarity=0.394  Sum_probs=59.5

Q ss_pred             HHHHHHHhccccc-cCCCC-ceeHHHHHHHHhh-cC--CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFD-KDNNG-YITVDELGKAFKD-YG--MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D-~d~~G-~I~~~el~~~l~~-~~--~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...+++.+|+.|| .|++| +|+.+||+.+|.. ++  +|...+++++++++..+|.|+||.|+|+||+.++..
T Consensus        10 ~~~~l~~~F~~fD~~dg~gg~I~~~El~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I~f~EF~~~~~~   83 (95)
T 2wcb_A           10 HLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAI   83 (95)
T ss_dssp             HHHHHHHHHHHHHTSSSSTTEEEHHHHHHHHHHHTHHHHHHCCCHHHHHHHHTTSSSSTTSEEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCCCccCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHH
Confidence            3457899999999 89998 9999999999975 21  234578899999999999999999999999998864

>1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A

Probab=99.02  E-value=1.2e-10  Score=85.86  Aligned_cols=66  Identities=33%  Similarity=0.607  Sum_probs=59.8

Q ss_pred             HHHHHHhcccc-ccCCC-CceeHHHHHHHHhhcCCCCCC--cHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          410 FENLYKAFQYF-DKDNN-GYITVDELGKAFKDYGMGDDA--TIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       410 ~~~~~~~F~~~-D~d~~-G~I~~~el~~~l~~~~~~~~~--~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...++.+|+.| |.|++ |+|+.+||+.+|..  +|..+  ++++++.++..+|.|++|.|+|+||..++..
T Consensus         4 ~~~l~~~F~~~~D~d~~~G~i~~~el~~~l~~--~g~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~   73 (76)
T 1qx2_A            4 PEEIKGAFEVFAAKEGDPNQISKEELKLVMQT--LGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMMKK   73 (76)
T ss_dssp             HHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHH--HGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcccCCCcCeECHHHHHHHHHH--hCCCcCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHH
Confidence            45789999999 99999 99999999999998  45566  7788999999999999999999999998874

>4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A*

Probab=99.02  E-value=5.3e-10  Score=85.70  Aligned_cols=71  Identities=17%  Similarity=0.232  Sum_probs=59.7

Q ss_pred             hhHHHhhhhhhhccC-CCCC-CcccHHHHHHHHHh-cC----CCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh
Q 040917          335 TEEIQKLKEKFTEMD-TDNS-GTLTYDELKAGLAK-LG----SMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH  405 (494)
Q Consensus       335 ~~~~~~~~~~F~~~D-~~~~-g~i~~~el~~~l~~-~~----~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~  405 (494)
                      ...+..+.++|+.|| .|++ |+|+.+||+.+++. +|    ...+.+++.++++.+|.|+||.|+|+||+..+....
T Consensus         6 e~~~~~l~~~F~~fd~~dg~~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~~~~~~   83 (93)
T 4eto_A            6 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIA   83 (93)
T ss_dssp             HHHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGC---CCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHcccCCCCCeECHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHHH
Confidence            345678899999998 6774 89999999999986 54    456788999999999999999999999999887543

>2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus}

Probab=99.02  E-value=5.1e-10  Score=86.32  Aligned_cols=68  Identities=32%  Similarity=0.614  Sum_probs=62.6

Q ss_pred             hhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHH
Q 040917          335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATM  402 (494)
Q Consensus       335 ~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~  402 (494)
                      ....+++..+|..+|.|++|+|+.+||..+++.+|..++.+++..+|..+|.|++|.|+|+||+..+.
T Consensus        25 ~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~~~   92 (94)
T 2kz2_A           25 TDSEEEIREAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMT   92 (94)
T ss_dssp             CSCHHHHHHHHHHHCTTCCSCBCHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHh
Confidence            34456788999999999999999999999999999999999999999999999999999999998764

>2y5i_A S100Z, S100 calcium binding protein Z; metal-binding protein, EF-hand, calcium regulation, oligomer neuronal development, spine2; 2.03A {Danio rerio}

Probab=99.02  E-value=9.7e-10  Score=85.41  Aligned_cols=71  Identities=21%  Similarity=0.277  Sum_probs=62.9

Q ss_pred             hhHHHhhhhhhhccC-CCCCC-cccHHHHHHHHHh-----cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh
Q 040917          335 TEEIQKLKEKFTEMD-TDNSG-TLTYDELKAGLAK-----LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH  405 (494)
Q Consensus       335 ~~~~~~~~~~F~~~D-~~~~g-~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~  405 (494)
                      .+++..+..+|+.|| .|++| +|+.+||..+++.     +|..++..++..++..+|.|+||.|+|+||+..+....
T Consensus         6 ~~~~~~l~~~F~~fDd~dg~gG~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~~   83 (99)
T 2y5i_A            6 EGAMDALITVFHNYSGSEGDKYKLSKGELKELLNAELTDFLMSQKDPMLVEKIMNDLDSNKDNEVDFNEFVVLVAALT   83 (99)
T ss_dssp             HHHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSGGGGTTSCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHH
Confidence            345778999999997 89998 9999999999987     67778999999999999999999999999998877543

>2kax_A Protein S100-A5; EF-hand, calcium binding protien, calcium, polymorphism, structural genomics, spine2, structural proteomics in europe, spine; NMR {Homo sapiens} PDB: 2kay_A

Probab=99.02  E-value=3.7e-10  Score=86.72  Aligned_cols=67  Identities=16%  Similarity=0.460  Sum_probs=58.9

Q ss_pred             HHHHHHhccccc-cCCCC-ceeHHHHHHHHhhc-CCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          410 FENLYKAFQYFD-KDNNG-YITVDELGKAFKDY-GMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       410 ~~~~~~~F~~~D-~d~~G-~I~~~el~~~l~~~-~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...++.+|+.|| .|++| +|+.+||+.+|... +++. .++.+++.++..+|.|+||.|+|+||+.++..
T Consensus         9 ~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~~~~~-~~~~~i~~~~~~~D~d~dG~I~f~EF~~~~~~   78 (92)
T 2kax_A            9 LTTMVTTFHKYSGREGSKLTLSRKELKELIKKELCLGE-MKESSIDDLMKSLDKNSDQEIDFKEYSVFLTM   78 (92)
T ss_dssp             HHHHHHHHHHHHTTSSCSSEEEHHHHHHHHHHHSCCTT-TCCTTHHHHHHHHTTTCSSEEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhCCCCCeeCHHHHHHHHHHHcCCCC-CCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence            457899999999 99999 99999999999862 2233 67788999999999999999999999998875

>2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A

Probab=99.01  E-value=2.6e-10  Score=89.59  Aligned_cols=71  Identities=17%  Similarity=0.309  Sum_probs=60.4

Q ss_pred             hHHHhhhhhhhccC-CCCC-CcccHHHHHHHHHh-cCCCCC-HHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh
Q 040917          336 EEIQKLKEKFTEMD-TDNS-GTLTYDELKAGLAK-LGSMLT-EFDVKQYMQAADIDGNGTIDYIEFITATMQRHK  406 (494)
Q Consensus       336 ~~~~~~~~~F~~~D-~~~~-g~i~~~el~~~l~~-~~~~~~-~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~  406 (494)
                      +++..+.++|+.|| .|++ |+|+.+||..+++. +|...+ .+++.+++..+|.|+||.|+|+||+..+.....
T Consensus        19 ~~~~~l~~aF~~fD~~dg~~G~Is~~EL~~~l~~~lg~~~~~~~ev~~li~~~D~d~dG~Idf~EF~~~~~~~~~   93 (106)
T 2h2k_A           19 ESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGELAK   93 (106)
T ss_dssp             HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCTTTTTTCCCHHHHHHHHCTTCSSSEEHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcCcCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHHHH
Confidence            45678999999999 7986 79999999999986 664443 467999999999999999999999998876544

>1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A

Probab=99.01  E-value=4.2e-10  Score=89.29  Aligned_cols=100  Identities=18%  Similarity=0.161  Sum_probs=79.0

Q ss_pred             cCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh---hhhh
Q 040917          332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR---HKLQ  408 (494)
Q Consensus       332 ~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~---~~~~  408 (494)
                      .++.+++   .++|..+|  ++|.|+.+||..++...  ....+++..+|..+|.|++|.|+.+||...+...   ....
T Consensus         5 ~~t~~e~---~~~~~~~d--~~g~i~~~eF~~~~~~~--~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~   77 (108)
T 1rro_A            5 ILSAEDI---AAALQECQ--DPDTFEPQKFFQTSGLS--KMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDAREL   77 (108)
T ss_dssp             TSCHHHH---HHHHHHTC--STTCCCHHHHHHHHSGG--GSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCC
T ss_pred             cCCHHHH---HHHHHHcc--CCCCcCHHHHHHHHhcC--cccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhccCCC
Confidence            3445554   44555666  89999999999987532  3356789999999999999999999998877654   2234


Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHh
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFK  438 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~  438 (494)
                      +..++..+|+.+|.|++|.|+.+||..++.
T Consensus        78 ~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~  107 (108)
T 1rro_A           78 TESETKSLMDAADNDGDGKIGADEFQEMVH  107 (108)
T ss_dssp             CHHHHHHHHHHHCCSSSSSEEHHHHHHHHT
T ss_pred             CHHHHHHHHHHhCCCCCCcCcHHHHHHHHc
Confidence            567799999999999999999999998874

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.01  E-value=6.5e-10  Score=105.91  Aligned_cols=182  Identities=17%  Similarity=0.243  Sum_probs=123.6

Q ss_pred             eeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCC--ccEEeEEEEeCC---eEEEE
Q 040917           38 GREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN--IVQFKAAYEDDQ---FVHIV  112 (494)
Q Consensus        38 ~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~--i~~~~~~~~~~~---~~~iv  112 (494)
                      ++.++.|..+.||++.     ..+++|+....     .....+.+|..+++.+..+..  +..++.......   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            4569999999999863     46899986422     346778999999999853433  344444433332   35789


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS----------------------------------------  152 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~----------------------------------------  152 (494)
                      |++++|.+|.....  ..++......++.++...+..||+                                        
T Consensus        95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99999998875433  346788888888899888888886                                        


Q ss_pred             ------------------CCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcccccccCCcCc---cChhhhc--
Q 040917          153 ------------------KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY---IAPEVLS--  209 (494)
Q Consensus       153 ------------------~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y---~aPE~~~--  209 (494)
                                        ..++|||++|.||+++.+ ....+.++||+.+.........   .....+   .+|+...  
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl---~~~~~~~~~~~~~~~~~~  248 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDF---ISLMEDDEEYGMEFVSKI  248 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHH---HTTCCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHH---HHHHhhccccCHHHHHHH
Confidence                              136999999999999521 1456889999998653221111   111111   2333221  


Q ss_pred             -ccCC------------CcchhHHHHHHHHHHHhCCCCC
Q 040917          210 -QSYG------------KEADIWSAGVILYILLCGVPPF  235 (494)
Q Consensus       210 -~~~~------------~~~Di~slG~il~~l~tg~~pf  235 (494)
                       ..|.            ...+.|+++.+++.+.+|..+|
T Consensus       249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             1121            1258999999999999998776

>1j7q_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1j7r_A

Probab=99.01  E-value=4e-10  Score=85.38  Aligned_cols=66  Identities=17%  Similarity=0.200  Sum_probs=60.5

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHH---HHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIAT---IKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~---~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ....++.+|..||.|++|+|+.+||..+|..  +|...++.+   ++.++..+|.|++|.|+| ||..++..
T Consensus        12 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~--~g~~~~~~~~~~~~~~~~~~d~~~~g~i~~-eF~~~~~~   80 (86)
T 1j7q_A           12 EKDECMKIFDIFDRNAENIAPVSDTMDMLTK--LGQTYTKRETEAIMKEARGPKGDKKNIGPE-EWLTLCSK   80 (86)
T ss_dssp             HHHHHHHHHHHHSTTTTSCBCHHHHHHHHHH--TSCCCSHHHHHHHHHHHHCSSCSSCCBCTT-HHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH--HcCCCCHHHHHHHHHHHHHhCCCCCCcCCH-HHHHHHHH
Confidence            3567899999999999999999999999999  667889999   999999999999999999 99998864

>3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ...

Probab=99.00  E-value=8.1e-10  Score=84.77  Aligned_cols=69  Identities=23%  Similarity=0.368  Sum_probs=62.1

Q ss_pred             hHHHhhhhhhhccCCCCCC---cccHHHHHHHHHh-----cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh
Q 040917          336 EEIQKLKEKFTEMDTDNSG---TLTYDELKAGLAK-----LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH  405 (494)
Q Consensus       336 ~~~~~~~~~F~~~D~~~~g---~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~  405 (494)
                      ..+..+..+|+.+| +++|   +|+.+||..+++.     +|..++.+++.++++.+|.|+||.|+|+||+..+....
T Consensus         6 ~~~~~l~~~F~~~D-~~dG~~g~Is~~EL~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I~f~EF~~~~~~l~   82 (92)
T 3rm1_A            6 KAVVALIDVFHQYS-GREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSNGDGECDFQEFMAFVAMIT   82 (92)
T ss_dssp             HHHHHHHHHHHHHH-TSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHc-cCCCCcCeECHHHHHHHHHHHhhhhccCcccHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHH
Confidence            45678899999999 7666   9999999999999     88889999999999999999999999999999887543

>1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5

Probab=99.00  E-value=1.4e-10  Score=88.16  Aligned_cols=71  Identities=61%  Similarity=0.863  Sum_probs=65.0

Q ss_pred             hccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHH
Q 040917          330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITA  400 (494)
Q Consensus       330 ~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~  400 (494)
                      ...++..+...+..+|..+|.+++|+|+..||..++..+|..++.+++..+|..+|.+++|.|+|+||+..
T Consensus        14 ~~~l~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~   84 (87)
T 1s6j_A           14 AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAA   84 (87)
T ss_dssp             SSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSSEECHHHHTTC
T ss_pred             HHHCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHH
Confidence            34456677788999999999999999999999999999999999999999999999999999999999764

>1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6

Probab=98.99  E-value=4.7e-10  Score=87.24  Aligned_cols=66  Identities=23%  Similarity=0.311  Sum_probs=60.6

Q ss_pred             hHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHH
Q 040917          336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQ  403 (494)
Q Consensus       336 ~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~  403 (494)
                      ++..++..+|+.+|+|++|+|+.+|+..+++.++  ++.+++.++|..+|.|++|.|+|+||+..+..
T Consensus         8 ~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~~--l~~~~l~~i~~~~D~d~dG~i~~~EF~~~~~~   73 (99)
T 1qjt_A            8 SGNPVYEKYYRQVEAGNTGRVLALDAAAFLKKSG--LPDLILGKIWDLADTDGKGVLSKQEFFVALRL   73 (99)
T ss_dssp             TTCTHHHHHHHHHCCTTSSCCCSHHHHHHHHTSS--SCHHHHHHHHHHHCCSSSSSCCSHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHH
Confidence            5567899999999999999999999999999886  57889999999999999999999999988764

>1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A

Probab=98.99  E-value=5.4e-10  Score=86.24  Aligned_cols=70  Identities=24%  Similarity=0.359  Sum_probs=57.0

Q ss_pred             hhHHHhhhhhhhccC-CCC-CCcccHHHHHHHHHh-----cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          335 TEEIQKLKEKFTEMD-TDN-SGTLTYDELKAGLAK-----LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       335 ~~~~~~~~~~F~~~D-~~~-~g~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      .+++..+..+|+.|| .|+ +|+|+.+||..+++.     +|..++.+++..++..+|.|+||.|+|+||+..+...
T Consensus         5 ~~~~~~l~~~F~~fD~~dgd~G~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~~~   81 (95)
T 1j55_A            5 ETAMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAAI   81 (95)
T ss_dssp             HHHHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHHhHhhcccccCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHH
Confidence            356778999999999 788 589999999999987     4666788889999999999999999999999988754

>1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6

Probab=98.99  E-value=2.4e-10  Score=90.58  Aligned_cols=65  Identities=20%  Similarity=0.282  Sum_probs=57.9

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...+++++|+.||.|++|+|+.+|++.+|..++    ++++++++++..+|.|+||.|+|+||..+|..
T Consensus        20 ~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~g----l~~~el~~i~~~~D~d~dG~I~~~EF~~~m~~   84 (110)
T 1iq3_A           20 QREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK----LSIPELSYIWELSDADCDGALTLPEFCAAFHL   84 (110)
T ss_dssp             SHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS----CSSCCHHHHHHHHCSSSCSEEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcC----CCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHH
Confidence            346789999999999999999999999998843    46678999999999999999999999998764

>2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A

Probab=98.99  E-value=4.2e-10  Score=88.39  Aligned_cols=68  Identities=15%  Similarity=0.370  Sum_probs=56.7

Q ss_pred             HHHHHHHhccccc-cCCC-CceeHHHHHHHHhhcCCCCCC-cHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFD-KDNN-GYITVDELGKAFKDYGMGDDA-TIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D-~d~~-G~I~~~el~~~l~~~~~~~~~-~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...+++++|+.|| .|++ |+|+.+||+.+|... +|... +++++++++..+|.|+||.|+|+||+.+|..
T Consensus        20 ~~~~l~~aF~~fD~~dg~~G~Is~~EL~~~l~~~-lg~~~~~~~ev~~li~~~D~d~dG~Idf~EF~~~~~~   90 (106)
T 2h2k_A           20 SIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQ-LPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGE   90 (106)
T ss_dssp             HHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHH-CTTTTTTCCCHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHH-cCcCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHH
Confidence            3467999999999 7986 799999999999751 23222 2468999999999999999999999998874

>1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A

Probab=98.98  E-value=8.3e-10  Score=87.86  Aligned_cols=96  Identities=20%  Similarity=0.241  Sum_probs=76.5

Q ss_pred             hhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh---hhhhHHHHHHHh
Q 040917          340 KLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR---HKLQRFENLYKA  416 (494)
Q Consensus       340 ~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~---~~~~~~~~~~~~  416 (494)
                      .+..+|..+|  ++|.|+.+||..++..  .....+++..+|..+|.|++|.|+.+||...+...   ....+.+++..+
T Consensus        11 e~~~~~~~~d--~~g~i~~~ef~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~   86 (110)
T 1pva_A           11 DIKKALDAVK--AEGSFNHKKFFALVGL--KAMSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAF   86 (110)
T ss_dssp             HHHHHHHHTC--STTCCCHHHHHHHHTC--TTSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHH
T ss_pred             HHHHHHHhcC--CCCcCcHHHHHHHHcc--CcchHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhhcCCCCCHHHHHHH
Confidence            3445555667  8899999999998743  23456778999999999999999999998877655   223456778999


Q ss_pred             ccccccCCCCceeHHHHHHHHhh
Q 040917          417 FQYFDKDNNGYITVDELGKAFKD  439 (494)
Q Consensus       417 F~~~D~d~~G~I~~~el~~~l~~  439 (494)
                      |+.+|.|++|.|+.+||..++..
T Consensus        87 ~~~~d~~~dg~i~~~eF~~~~~~  109 (110)
T 1pva_A           87 LKAADKDGDGKIGIDEFETLVHE  109 (110)
T ss_dssp             HHHHCTTCSSSBCHHHHHHHHHC
T ss_pred             HHHhCCCCCCeEcHHHHHHHHHh
Confidence            99999999999999999988764

>1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A

Probab=98.98  E-value=1.3e-09  Score=85.65  Aligned_cols=64  Identities=19%  Similarity=0.280  Sum_probs=57.6

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...+++++|+.||+ ++|+|+.+|++.+|..+  |  ++++++.+++..+|.|+||.|+|+||..+|..
T Consensus        13 e~~~~~~~F~~~D~-~dG~Is~~el~~~l~~~--g--l~~~el~~i~~~~D~d~dG~id~~EF~~~m~~   76 (106)
T 1eh2_A           13 DKAKYDAIFDSLSP-VNGFLSGDKVKPVLLNS--K--LPVDILGRVWELSDIDHDGMLDRDEFAVAMFL   76 (106)
T ss_dssp             HHHHHHHHHTTSCC-SSSCCBHHHHHHHHHTT--T--CCHHHHHHHHHHHCSSCSSBCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCC-CCCeEcHHHHHHHHHHc--C--CCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHH
Confidence            34578999999999 99999999999999984  3  57889999999999999999999999988764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	494
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-90
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-87
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-84
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-84
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-83
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-80
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-79
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-78
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-77
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-77
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-77
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-76
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-76
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-72
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-72
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-69
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-69
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-68
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-68
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-66
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-66
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-65
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-64
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-63
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-62
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-62
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-61
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-60
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-60
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-60
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-59
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	8e-59
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-58
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-58
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-58
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	9e-58
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-57
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-56
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-55
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-55
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-55
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-55
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-54
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-54
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-53
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-53
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-52
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-52
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-50
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-50
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-49
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-48
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-47
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-47
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-46
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-43
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-43
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-40
d2obha1	141	a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapien	4e-29
d2obha1	141	a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapien	7e-08
d1bjfa_	181	a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId	6e-29
d1bjfa_	181	a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId	1e-05
d1exra_	146	a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetr	1e-28
d1exra_	146	a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetr	9e-07
d1lkja_	146	a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom	3e-28
d1dtla_	156	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	8e-28
d1topa_	162	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	1e-27
d1topa_	162	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	1e-04
d1g8ia_	187	a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1	2e-27
d1g8ia_	187	a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1	5e-05
d1fpwa_	190	a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1	1e-25
d1fpwa_	190	a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1	2e-09
d1fpwa_	190	a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1	6e-06
d1s6ia_	182	a.39.1.5 (A:) Calcium-dependent protein kinase sk5	2e-25
d1jbaa_	189	a.39.1.5 (A:) Guanylate cyclase activating protein	2e-24
d1jbaa_	189	a.39.1.5 (A:) Guanylate cyclase activating protein	9e-07
d1jbaa_	189	a.39.1.5 (A:) Guanylate cyclase activating protein	3e-06
d1pvaa_	109	a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax	9e-24
d1pvaa_	109	a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax	1e-10
d2pvba_	107	a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax	2e-23
d2pvba_	107	a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax	6e-10
d1s6ca_	178	a.39.1.5 (A:) Kchip1, Kv4 potassium channel-intera	6e-23
d1s6ca_	178	a.39.1.5 (A:) Kchip1, Kv4 potassium channel-intera	1e-07
d1s6ca_	178	a.39.1.5 (A:) Kchip1, Kv4 potassium channel-intera	1e-04
d2zfda1	183	a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {	7e-23
d5pala_	109	a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis	3e-22
d5pala_	109	a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis	3e-10
d1rroa_	108	a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus)	4e-22
d1rroa_	108	a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus)	1e-10
d2scpa_	174	a.39.1.5 (A:) Sarcoplasmic calcium-binding protein	1e-21
d2scpa_	174	a.39.1.5 (A:) Sarcoplasmic calcium-binding protein	4e-07
d2scpa_	174	a.39.1.5 (A:) Sarcoplasmic calcium-binding protein	0.003
d1w7jb1	139	a.39.1.5 (B:11-149) Myosin Essential Chain {Human	1e-21
d1w7jb1	139	a.39.1.5 (B:11-149) Myosin Essential Chain {Human	2e-06
d1w7jb1	139	a.39.1.5 (B:11-149) Myosin Essential Chain {Human	5e-04
d1nyaa_	176	a.39.1.5 (A:) Calerythrin {Saccharopolyspora eryth	2e-21
d1rwya_	109	a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [Ta	3e-21
d1rwya_	109	a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [Ta	2e-10
d1uhka1	187	a.39.1.5 (A:3-189) Calcium-regulated photoprotein	8e-21
d1uhka1	187	a.39.1.5 (A:3-189) Calcium-regulated photoprotein	2e-07
d1uhka1	187	a.39.1.5 (A:3-189) Calcium-regulated photoprotein	2e-05
d1qxpa2	188	a.39.1.8 (A:515-702) Calpain large subunit, C-term	2e-20
d1qxpa2	188	a.39.1.8 (A:515-702) Calpain large subunit, C-term	4e-14
d1qxpa2	188	a.39.1.8 (A:515-702) Calpain large subunit, C-term	3e-06
d1qxpa2	188	a.39.1.8 (A:515-702) Calpain large subunit, C-term	5e-04
d1xo5a_	180	a.39.1.5 (A:) Calcium- and integrin-binding protei	3e-20
d1omra_	201	a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId:	4e-20
d1omra_	201	a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId:	1e-05
d1omra_	201	a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId:	2e-04
d1qv0a_	189	a.39.1.5 (A:) Calcium-regulated photoprotein {Hydr	1e-19
d1qv0a_	189	a.39.1.5 (A:) Calcium-regulated photoprotein {Hydr	1e-06
d1qv0a_	189	a.39.1.5 (A:) Calcium-regulated photoprotein {Hydr	0.002
d2sasa_	185	a.39.1.5 (A:) Sarcoplasmic calcium-binding protein	1e-19
d2sasa_	185	a.39.1.5 (A:) Sarcoplasmic calcium-binding protein	6e-06
d2sasa_	185	a.39.1.5 (A:) Sarcoplasmic calcium-binding protein	3e-05
d2sasa_	185	a.39.1.5 (A:) Sarcoplasmic calcium-binding protein	8e-05
d1s6ja_	87	a.39.1.5 (A:) Calcium-dependent protein kinase sk5	4e-18
d1s6ja_	87	a.39.1.5 (A:) Calcium-dependent protein kinase sk5	3e-14
d1juoa_	172	a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId:	1e-17
d1juoa_	172	a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId:	2e-10
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-17
d1k94a_	165	a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [Ta	2e-17
d1k94a_	165	a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [Ta	3e-13
d1k94a_	165	a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [Ta	1e-08
d1k94a_	165	a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [Ta	2e-04
d1df0a1	186	a.39.1.8 (A:515-700) Calpain large subunit, C-term	4e-17
d1df0a1	186	a.39.1.8 (A:515-700) Calpain large subunit, C-term	5e-12
d1df0a1	186	a.39.1.8 (A:515-700) Calpain large subunit, C-term	2e-06
d1wdcc_	152	a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop	8e-17
d1ggwa_	140	a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharo	1e-16
d1ggwa_	140	a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharo	0.004
d1auib_	165	a.39.1.5 (B:) Calcineurin regulatory subunit (B-ch	1e-16
d1wdcb_	142	a.39.1.5 (B:) Myosin Essential Chain {Bay scallop	1e-16
d1oqpa_	77	a.39.1.5 (A:) Caltractin (centrin 2) {Green algae	2e-16
d1oqpa_	77	a.39.1.5 (A:) Caltractin (centrin 2) {Green algae	9e-13
d1oqpa_	77	a.39.1.5 (A:) Caltractin (centrin 2) {Green algae	3e-05
d1c7va_	68	a.39.1.5 (A:) Calcium vector protein {Amphioxus (B	2e-16
d1c7va_	68	a.39.1.5 (A:) Calcium vector protein {Amphioxus (B	5e-13
d1m45a_	146	a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's ye	2e-16
d1m45a_	146	a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's ye	0.001
d1m45a_	146	a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's ye	0.004
d1jfja_	134	a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histoly	3e-16
d1jc2a_	75	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	6e-16
d1jc2a_	75	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	2e-11
d1cb1a_	78	a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [Tax	1e-15
d1cb1a_	78	a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [Tax	5e-10
d1fi5a_	81	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus),	4e-15
d1fi5a_	81	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus),	2e-10
d1fi5a_	81	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus),	1e-05
d2zkmx1	170	a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human	5e-15
d2zkmx1	170	a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human	2e-07
d1tiza_	67	a.39.1.5 (A:) Calmodulin-related protein T21P5.17	1e-14
d1tiza_	67	a.39.1.5 (A:) Calmodulin-related protein T21P5.17	3e-11
d1tiza_	67	a.39.1.5 (A:) Calmodulin-related protein T21P5.17	1e-06
d1ij5a_	321	a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-bind	1e-14
d1ij5a_	321	a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-bind	2e-14
d1ij5a_	321	a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-bind	4e-07
d1f54a_	77	a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom	2e-14
d1f54a_	77	a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom	9e-13
d1alva_	173	a.39.1.8 (A:) Calpain small (regulatory) subunit (	2e-14
d1alva_	173	a.39.1.8 (A:) Calpain small (regulatory) subunit (	2e-11
d1qx2a_	76	a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [Tax	3e-14
d1qx2a_	76	a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [Tax	9e-09
d2opoa1	81	a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Che	6e-14
d2opoa1	81	a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Che	3e-13
d2opoa1	81	a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Che	5e-05
d1fw4a_	65	a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId:	9e-14
d1fw4a_	65	a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId:	9e-11
d1avsa_	81	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	1e-13
d1avsa_	81	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	4e-13
d1wrka1	82	a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens)	2e-13
d1wrka1	82	a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens)	1e-11
d1yuta1	98	a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sa	6e-13
d1yuta1	98	a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sa	3e-07
d1wlza1	83	a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {H	1e-12
d1wlza1	83	a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {H	3e-10
d2pq3a1	73	a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [T	2e-12
d2pq3a1	73	a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [T	5e-12
d3c1va1	93	a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sa	2e-12
d3c1va1	93	a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sa	6e-08
d1y1xa_	182	a.39.1.8 (A:) Programmed cell death 6 protein-like	3e-12
d1y1xa_	182	a.39.1.8 (A:) Programmed cell death 6 protein-like	9e-07
d1a4pa_	92	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	3e-12
d1a4pa_	92	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	3e-07
d1ksoa_	93	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	4e-12
d1ksoa_	93	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	1e-04
d1xk4a1	87	a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sa	5e-12
d1xk4a1	87	a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sa	3e-05
d1snla_	99	a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo	7e-12
d1snla_	99	a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo	1e-08
d2fcea1	61	a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [	9e-12
d2fcea1	61	a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [	6e-10
d1zfsa1	93	a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus no	2e-11
d1zfsa1	93	a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus no	1e-06
d1hqva_	181	a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mous	2e-11
d1hqva_	181	a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mous	9e-09
d1hqva_	181	a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mous	0.004
d1k8ua_	89	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	4e-11
d1k8ua_	89	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	2e-04
d1qjta_	99	a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId:	4e-09
d1qjta_	99	a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId:	6e-05
d1c07a_	95	a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId:	4e-09
d1c07a_	95	a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId:	4e-09
d1e8aa_	87	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	5e-09
d1e8aa_	87	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	9e-05
d2jxca1	95	a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [	2e-08
d2jxca1	95	a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [	7e-08
d1psra_	100	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	3e-08
d1psra_	100	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	2e-05
d1fi6a_	92	a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId:	7e-08
d1fi6a_	92	a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId:	3e-07
d2hf5a1	33	a.39.1.5 (A:81-113) Troponin C {Human (Homo sapien	4e-06
d1iq3a_	110	a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9	4e-06
d1iq3a_	110	a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9	5e-06
d1qlsa_	95	a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa),	2e-04
d1qlsa_	95	a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa),	0.004
d3cr5x1	90	a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos tauru	6e-04
d3cr5x1	90	a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos tauru	0.004
d1xk4c1	83	a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sa	0.001
d1j55a_	94	a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien	0.002

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  274 bits (703), Expect = 8e-90
 Identities = 113/299 (37%), Positives = 167/299 (55%), Gaps = 5/299 (1%)

Query: 26  KAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIE 85
           K  ED++  Y     +G G F    L  +  T    A K I K+ L        +  EI 
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS--MENEIA 59

Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           ++  +   PNIV     YE    ++++M+L +GGELFDRIV +G Y+ER A+ +   +++
Sbjct: 60  VLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 118

Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAP 205
            V   H  G++HRDLKPEN L+ + DE++ +  +DFGLS   + G       G+P Y+AP
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 178

Query: 206 EVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
           EVL+ + Y K  D WS GVI YILLCG PPF+ E D  + + ILK E  F    +  IS 
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238

Query: 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKK 323
           SA + +R ++ +DP++R T  Q L+HPW+     A DK I  +V  ++K+  A +K K+
Sbjct: 239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD-TALDKNIHQSVSEQIKKNFAKSKWKQ 296

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  268 bits (687), Expect = 2e-87
 Identities = 90/318 (28%), Positives = 161/318 (50%), Gaps = 12/318 (3%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
           +++   Y I  ++GRGEFGI + C E S+   +  K +      K  ++  V++EI I+ 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILN 56

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVV 147
                 NI+    ++E  + + ++ E  +G ++F+RI       +ER   S    +   +
Sbjct: 57  IAR-HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115

Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV 207
              HS  + H D++PEN ++ T   ++ +K  +FG +  ++ G  +R +  +P Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174

Query: 208 LS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
                     D+WS G ++Y+LL G+ PF AET+Q + + I+  E  F  + F  IS  A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234

Query: 267 IELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLAL 326
           ++ V R+L ++ K R+T ++ L+HPWLK+  E     + T VI  +K     + L K  L
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIE----RVSTKVIRTLKHRRYYHTLIKKDL 290

Query: 327 KVIVENLPTEEIQKLKEK 344
            ++V          ++ +
Sbjct: 291 NMVVSAARISCGGAIRSQ 308

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  262 bits (671), Expect = 2e-84
 Identities = 89/284 (31%), Positives = 146/284 (51%), Gaps = 7/284 (2%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           +Y I  E+G G FG+ + C E +TG  F  K I     +   +K  V+ EI IM  L   
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLH-H 85

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHS 152
           P ++    A+ED   + +++E  +GGELFDRI A  +  SE    +  R     +   H 
Sbjct: 86  PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QS 211
             ++H D+KPEN +  T  + + VK  DFGL+  +   +  +    +  + APE++  + 
Sbjct: 146 HSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 204

Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G   D+W+ GV+ Y+LL G+ PF  E D    Q + + +  F  D F S+S  A + ++
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264

Query: 272 RMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQF 315
            +L ++P++R+TV   LEHPWLK         I ++   +++Q 
Sbjct: 265 NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQK 308

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  261 bits (667), Expect = 8e-84
 Identities = 92/264 (34%), Positives = 138/264 (52%), Gaps = 7/264 (2%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           HY I  E+G G FG+ +  TE +TG  FA K +       + +K+ VR+EI+ M  L   
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-H 82

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIV-ARGHYSERAAASVFRVIMNVVNVCHS 152
           P +V    A+EDD  + ++ E  +GGELF+++       SE  A    R +   +   H 
Sbjct: 83  PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQS 211
              +H DLKPEN +FTT   +  +K  DFGL+A ++  ++ +   G+  + APEV   + 
Sbjct: 143 NNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 201

Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
            G   D+WS GV+ YILL G+ PF  E D    + +   + N     F  IS    + +R
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261

Query: 272 RMLTQDPKRRITVAQVLEHPWLKE 295
           ++L  DP  R+T+ Q LEHPWL  
Sbjct: 262 KLLLADPNTRMTIHQALEHPWLTP 285

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  256 bits (656), Expect = 3e-83
 Identities = 92/275 (33%), Positives = 141/275 (51%), Gaps = 16/275 (5%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD------VRREIEIM 87
           +Y     +GRG   +   C    T  E+A K I          ++         +E++I+
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 88  RHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVV 147
           R +SG PNI+Q K  YE + F  +V +L   GELFD +  +   SE+    + R ++ V+
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123

Query: 148 NVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEV 207
              H   ++HRDLKPEN L    D++  +K TDFG S  ++ G+  RE+ G+P Y+APE+
Sbjct: 124 CALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180

Query: 208 LS-------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP 260
           +          YGKE D+WS GVI+Y LL G PPFW      + + I+ G   F    + 
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240

Query: 261 SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
             S +  +LV R L   P++R T  + L HP+ ++
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  249 bits (637), Expect = 1e-80
 Identities = 83/264 (31%), Positives = 137/264 (51%), Gaps = 10/264 (3%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            + IGR +G+G+FG  YL  E  +    A K + K +L K   +  +RRE+EI  HL   
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-H 65

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           PNI++    + D   V++++E    G ++  +     + E+  A+    + N ++ CHSK
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSY 212
            V+HRD+KPEN L         +K  DFG S      +    + G+  Y+ PE++  + +
Sbjct: 126 RVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEGRMH 181

Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR 272
            ++ D+WS GV+ Y  L G PPF A T Q   + I + E  F       ++  A +L+ R
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISR 237

Query: 273 MLTQDPKRRITVAQVLEHPWLKES 296
           +L  +P +R  + +VLEHPW+  +
Sbjct: 238 LLKHNPSQRPMLREVLEHPWITAN 261

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  248 bits (634), Expect = 1e-79
 Identities = 100/272 (36%), Positives = 157/272 (57%), Gaps = 6/272 (2%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---KDVEKDDVRREIE 85
           E+V  +Y  G E+G G+F +   C E STGL++A K I KR+     + V ++D+ RE+ 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65

Query: 86  IMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
           I++ +   PN++     YE+   V +++EL AGGELFD +  +   +E  A    + I+N
Sbjct: 66  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124

Query: 146 VVNVCHSKGVMHRDLKPENFLFTT-GDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIA 204
            V   HS  + H DLKPEN +          +K  DFGL+  I+ G  ++ I G+P ++A
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 184

Query: 205 PEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263
           PE+++ +  G EAD+WS GVI YILL G  PF  +T Q     +      F+ + F + S
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244

Query: 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
           + A + +RR+L +DPK+R+T+   L+HPW+K 
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  246 bits (629), Expect = 2e-78
 Identities = 96/316 (30%), Positives = 156/316 (49%), Gaps = 19/316 (6%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
               + +G G  G         T  +FA K +              RRE+E+    S  P
Sbjct: 14  KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCP 65

Query: 95  NIVQFKAAYED----DQFVHIVMELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVN 148
           +IV+    YE+     + + IVME   GGELF RI  RG   ++ER A+ + + I   + 
Sbjct: 66  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL 208
             HS  + HRD+KPEN L+T+   NA++K TDFG +       +      +PYY+APEVL
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 185

Query: 209 -SQSYGKEADIWSAGVILYILLCGVPPFWAETDQ----GVAQAILKGEINFQRDPFPSIS 263
             + Y K  D+WS GVI+YILLCG PPF++        G+   I  G+  F    +  +S
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245

Query: 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKK 323
                L+R +L  +P +R+T+ + + HPW+ +S +    P+ T+ + +  +    +  ++
Sbjct: 246 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 305

Query: 324 LALKVIVENLPTEEIQ 339
           +   +    +  E+I+
Sbjct: 306 MTSALATMRVDYEQIK 321

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (616), Expect = 4e-77
 Identities = 78/266 (29%), Positives = 134/266 (50%), Gaps = 12/266 (4%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            +  G+ +G G F    L  E +T  E+A K + KR ++K+ +   V RE ++M  L   
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-H 67

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           P  V+    ++DD+ ++  +     GEL   I   G + E         I++ +   H K
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI---EEGKAYREIVGSPYYIAPEVLS- 209
           G++HRDLKPEN L    +E+  ++ TDFG +  +    +       VG+  Y++PE+L+ 
Sbjct: 128 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

Query: 210 QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
           +S  K +D+W+ G I+Y L+ G+PPF A  +  + Q I+K E +F           A +L
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK----FFPKARDL 240

Query: 270 VRRMLTQDPKRRITVAQVLEHPWLKE 295
           V ++L  D  +R+   ++  +  LK 
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (614), Expect = 5e-77
 Identities = 74/267 (27%), Positives = 132/267 (49%), Gaps = 12/267 (4%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            + + + +G G +G   L     T    A K +  ++ V   E  ++++EI I + L+  
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLN-H 62

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
            N+V+F     +    ++ +E C+GGELFDRI       E  A   F  +M  V   H  
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI---EEGKAYREIVGSPYYIAPEVLSQ 210
           G+ HRD+KPEN L    DE   +K +DFGL+         +   ++ G+  Y+APE+L +
Sbjct: 123 GITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179

Query: 211 S--YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
              + +  D+WS G++L  +L G  P+   +D     +  K +  +  +P+  I S+ + 
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LNPWKKIDSAPLA 238

Query: 269 LVRRMLTQDPKRRITVAQVLEHPWLKE 295
           L+ ++L ++P  RIT+  + +  W  +
Sbjct: 239 LLHKILVENPSARITIPDIKKDRWYNK 265

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (616), Expect = 5e-77
 Identities = 83/277 (29%), Positives = 137/277 (49%), Gaps = 11/277 (3%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
            D +  YT   ++G+G  G  Y   + +TG E A + +  ++     +K+ +  EI +MR
Sbjct: 16  GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMR 72

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVN 148
                PNIV +  +Y     + +VME  AGG L D +V      E   A+V R  +  + 
Sbjct: 73  ENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALE 130

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE-EGKAYREIVGSPYYIAPEV 207
             HS  V+HRD+K +N L      +  VK TDFG  A I  E      +VG+PY++APEV
Sbjct: 131 FLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187

Query: 208 LS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
           ++ ++YG + DIWS G++   ++ G PP+  E        I        ++P   +S+  
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIF 246

Query: 267 IELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKP 303
            + + R L  D ++R +  ++L+H +LK +   S   
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (611), Expect = 2e-76
 Identities = 83/292 (28%), Positives = 133/292 (45%), Gaps = 25/292 (8%)

Query: 28  YEDVQL------HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVR 81
           YE V         + I  E+G G FG  Y      T +  A K I  +    + E +D  
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYM 57

Query: 82  REIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH-YSERAAASVF 140
            EI+I+      PNIV+   A+  +  + I++E CAGG +   ++      +E     V 
Sbjct: 58  VEIDILASCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 116

Query: 141 RVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR-EIVGS 199
           +  ++ +N  H   ++HRDLK  N LF     +  +K  DFG+SA        R   +G+
Sbjct: 117 KQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGT 173

Query: 200 PYYIAPEVL------SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN 253
           PY++APEV+       + Y  +AD+WS G+ L  +    PP        V   I K E  
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP 233

Query: 254 FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPID 305
               P    SS+  + +++ L ++   R T +Q+L+HP++      S+KPI 
Sbjct: 234 TLAQP-SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT---VDSNKPIR 281

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  239 bits (610), Expect = 6e-76
 Identities = 71/304 (23%), Positives = 124/304 (40%), Gaps = 17/304 (5%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
           +D +  ++  RE+G G FG  Y   +       A K +       + +  D+ +E+  ++
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVN 148
            L   PN +Q++  Y  +    +VME C G       V +    E   A+V    +  + 
Sbjct: 71  KLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL 208
             HS  ++HRD+K  N L     E  +VK  DFG ++ +    ++   VG+PY++APEV+
Sbjct: 130 YLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVI 183

Query: 209 S----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
                  Y  + D+WS G+    L    PP +          I + E           S 
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--SPALQSGHWSE 241

Query: 265 SAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFT-AMNKLKK 323
                V   L + P+ R T   +L+H ++          +   +I R K     ++ L+ 
Sbjct: 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVL---RERPPTVIMDLIQRTKDAVRELDNLQY 298

Query: 324 LALK 327
             +K
Sbjct: 299 RKMK 302

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (579), Expect = 6e-72
 Identities = 81/272 (29%), Positives = 129/272 (47%), Gaps = 21/272 (7%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y +   +G G +G        S G     K +    + +  EK  +  E+ ++R L   P
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELK-HP 63

Query: 95  NIVQFKAAYED--DQFVHIVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVN 148
           NIV++     D  +  ++IVME C GG+L   I      R +  E     V   +   + 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 149 VCHSKG-----VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY-REIVGSPYY 202
            CH +      V+HRDLKP N      D    VK  DFGL+  +    ++ +  VG+PYY
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 180

Query: 203 IAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS 261
           ++PE ++  SY +++DIWS G +LY L   +PPF A + + +A  I +G+    R     
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---RRIPYR 237

Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLEHPWL 293
            S    E++ RML      R +V ++LE+P +
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (579), Expect = 7e-72
 Identities = 59/266 (22%), Positives = 112/266 (42%), Gaps = 12/266 (4%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
                E+GRG F   Y   +  T +E A   +  RKL K  E+   + E E+++ L   P
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQ-HP 68

Query: 95  NIVQFKAAYED----DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVC 150
           NIV+F  ++E      + + +V EL   G L   +        +   S  R I+  +   
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 128

Query: 151 HSKG--VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL 208
           H++   ++HRDLK +N   T       VK  D GL+       A + ++G+P ++APE+ 
Sbjct: 129 HTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRASFA-KAVIGTPEFMAPEMY 185

Query: 209 SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
            + Y +  D+++ G+ +  +     P+    +       +   +               E
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD-KVAIPEVKE 244

Query: 269 LVRRMLTQDPKRRITVAQVLEHPWLK 294
           ++   + Q+   R ++  +L H + +
Sbjct: 245 IIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (569), Expect = 1e-69
 Identities = 70/264 (26%), Positives = 125/264 (47%), Gaps = 10/264 (3%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           + + + +G+G FG  +L     T   FA K++ K  ++ D + +    E  ++      P
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
            +      ++  + +  VME   GG+L   I +   +    A      I+  +   HSKG
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR-EIVGSPYYIAPEVLS-QSY 212
           +++RDLK +N L    D++  +K  DFG+      G A      G+P YIAPE+L  Q Y
Sbjct: 124 IVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180

Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR 272
               D WS GV+LY +L G  PF  + ++ +  +I      + R     +   A +L+ +
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW----LEKEAKDLLVK 236

Query: 273 MLTQDPKRRITVA-QVLEHPWLKE 295
           +  ++P++R+ V   + +HP  +E
Sbjct: 237 LFVREPEKRLGVRGDIRQHPLFRE 260

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (565), Expect = 4e-69
 Identities = 68/305 (22%), Positives = 118/305 (38%), Gaps = 49/305 (16%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            +    E+G G  G+ +  +   +GL  A K I      K   ++ + RE++++   +  
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-S 63

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           P IV F  A+  D  + I ME   GG L   +   G   E+    V   ++  +     K
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123

Query: 154 -GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QS 211
             +MHRD+KP N L    +    +K  DFG+S  + +  A    VG+  Y++PE L    
Sbjct: 124 HKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQGTH 179

Query: 212 YGKEADIWSAGVILYILLCGVPPFWAET---DQGVAQAILKGEINF-------------- 254
           Y  ++DIWS G+ L  +  G  P         + +    ++G+                 
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239

Query: 255 -----------------------QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHP 291
                                   + P    S    + V + L ++P  R  + Q++ H 
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299

Query: 292 WLKES 296
           ++K S
Sbjct: 300 FIKRS 304

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (554), Expect = 4e-68
 Identities = 75/269 (27%), Positives = 128/269 (47%), Gaps = 20/269 (7%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD---VRREIEIMRHL 90
            Y +G  +G G FG  Y     S  L  A K + K ++    E  +   V  E+ +++ +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 91  SGQ-PNIVQFKAAYEDDQFVHIVMELCAGG-ELFDRIVARGHYSERAAASVFRVIMNVVN 148
           S     +++    +E      +++E      +LFD I  RG   E  A S F  ++  V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL 208
            CH+ GV+HRD+K EN L         +K  DFG  A +++   Y +  G+  Y  PE +
Sbjct: 125 HCHNCGVLHRDIKDENILIDL--NRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWI 181

Query: 209 S--QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA 266
              + +G+ A +WS G++LY ++CG  PF  + +      I++G++ F+      +SS  
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR----QRVSSEC 231

Query: 267 IELVRRMLTQDPKRRITVAQVLEHPWLKE 295
             L+R  L   P  R T  ++  HPW+++
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  218 bits (557), Expect = 5e-68
 Identities = 78/268 (29%), Positives = 131/268 (48%), Gaps = 16/268 (5%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            + I R +G G FG  +L      G  +A K + K  +V+  + +    E  ++  ++  
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-H 63

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           P I++    ++D Q + ++M+   GGELF  +     +    A      +   +   HSK
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSY 212
            +++RDLKPEN L    D+N  +K TDFG + ++ +      + G+P YIAPEV+S + Y
Sbjct: 124 DIIYRDLKPENILL---DKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPY 178

Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR 272
            K  D WS G+++Y +L G  PF+        + IL  E+ F     P  +    +L+ R
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLSR 234

Query: 273 MLTQDPKRRI-----TVAQVLEHPWLKE 295
           ++T+D  +R+         V  HPW KE
Sbjct: 235 LITRDLSQRLGNLQNGTEDVKNHPWFKE 262

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  213 bits (543), Expect = 2e-66
 Identities = 58/267 (21%), Positives = 106/267 (39%), Gaps = 7/267 (2%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            Y +G  +G G     +L  +     + A K +              RRE +    L+  
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-H 66

Query: 94  PNIVQFKAAYEDD----QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
           P IV      E +       +IVME   G  L D +   G  + + A  V       +N 
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFG-LSAFIEEGKAYREIVGSPYYIAPEVL 208
            H  G++HRD+KP N + +  +   V+       ++           ++G+  Y++PE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 209 S-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI 267
              S    +D++S G +LY +L G PPF  ++   VA   ++ +          +S+   
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246

Query: 268 ELVRRMLTQDPKRRITVAQVLEHPWLK 294
            +V + L ++P+ R   A  +    ++
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRADLVR 273

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  214 bits (547), Expect = 7e-66
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 14/271 (5%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS-- 91
            +++ R +GRG FG  Y C +  TG  +A K + K+++     +     E  ++  +S  
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 92  GQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
             P IV    A+     +  +++L  GG+L   +   G +SE         I+  +   H
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-- 209
           ++ V++RDLKP N L    DE+  V+ +D GL+    + K +   VG+  Y+APEVL   
Sbjct: 125 NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKG 180

Query: 210 QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL 269
            +Y   AD +S G +L+ LL G  PF     +   + I +  +    +   S S     L
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRSL 239

Query: 270 VRRMLTQDPKRRITV-----AQVLEHPWLKE 295
           +  +L +D  RR+        +V E P+ + 
Sbjct: 240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (539), Expect = 5e-65
 Identities = 79/269 (29%), Positives = 133/269 (49%), Gaps = 15/269 (5%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            +   + +G+G FG   L  E +TG  +A K + K  ++   E      E  ++++    
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-H 64

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           P +   K A++    +  VME   GGELF  +     ++E  A      I++ +   HS+
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVGSPYYIAPEVLS-QS 211
            V++RD+K EN +    D++  +K TDFGL      +G   +   G+P Y+APEVL    
Sbjct: 125 DVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR 271
           YG+  D W  GV++Y ++CG  PF+ +  + + + IL  EI F R     +S  A  L+ 
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLA 237

Query: 272 RMLTQDPKRRI-----TVAQVLEHPWLKE 295
            +L +DPK+R+        +V+EH +   
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 1e-64
 Identities = 88/353 (24%), Positives = 140/353 (39%), Gaps = 51/353 (14%)

Query: 30  DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRH 89
           DV   YT    +G G +G+     +N   +  A K I   +     ++    REI+I+  
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR--TLREIKILLR 62

Query: 90  LSGQPNIVQFKAAYEDDQFVH----IVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
                NI+                  ++    G +L+  +    H S          I+ 
Sbjct: 63  FR-HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILR 120

Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR----EIVGSPY 201
            +   HS  V+HRDLKP N L    +    +K  DFGL+   +    +     E V + +
Sbjct: 121 GLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 202 YIAPEVLSQS--YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP- 258
           Y APE++  S  Y K  DIWS G IL  +L   P F  +        IL    +  ++  
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237

Query: 259 --------------------------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPW 292
                                     FP+  S A++L+ +MLT +P +RI V Q L HP+
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297

Query: 293 LKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKF 345
           L++  + SD+PI  A     K    ++ L K  LK ++     EE  + +  +
Sbjct: 298 LEQYYDPSDEPIAEAPF---KFDMELDDLPKEKLKELIF----EETARFQPGY 343

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 2e-63
 Identities = 55/267 (20%), Positives = 103/267 (38%), Gaps = 19/267 (7%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
             T+G+ +G G FG  Y    +      A K +         +    + E+ ++R     
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTR-H 63

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVNVCHS 152
            NI+ F   Y     + IV + C G  L+  + +    +       + R     ++  H+
Sbjct: 64  VNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE---IVGSPYYIAPEVLS 209
           K ++HRDLK  N       E+  VK  DFGL+          +   + GS  ++APEV+ 
Sbjct: 123 KSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 210 QS----YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP--FPSIS 263
                 Y  ++D+++ G++LY L+ G  P+    ++     ++              +  
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239

Query: 264 SSAIELVRRMLTQDPKRRITVAQVLEH 290
            +   L+   L +    R    Q+L  
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILAS 266

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 1e-62
 Identities = 68/284 (23%), Positives = 110/284 (38%), Gaps = 33/284 (11%)

Query: 41  VGRGEFGITYLCTENSTGLEFACKSIPKRKL--VKDVEKDDVRREIEIMRHLSGQPNIVQ 98
           +G G+F   Y   + +T    A K I        KD       REI++++ LS  PNI+ 
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIG 64

Query: 99  FKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHR 158
              A+     + +V +                 +     +   + +  +   H   ++HR
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 124

Query: 159 DLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVLS--QSYGKE 215
           DLKP N L    DEN V+K  DFGL+ +F    +AY   V + +Y APE+L   + YG  
Sbjct: 125 DLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181

Query: 216 ADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ-------------------- 255
            D+W+ G IL  LL  VP    ++D      I +                          
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241

Query: 256 ----RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
                  F +     ++L++ +   +P  RIT  Q L+  +   
Sbjct: 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 4e-62
 Identities = 71/276 (25%), Positives = 138/276 (50%), Gaps = 17/276 (6%)

Query: 34  HYTIGREVGRGEFGITYLC---TENSTGLEFACKSIPKRKLVKDVE-KDDVRREIEIMRH 89
           ++ + + +G G +G  +L    + + TG  +A K + K  +V+  +  +  R E +++ H
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNV 149
           +   P +V    A++ +  +H++++   GGELF  +  R  ++E         I+  +  
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE--EGKAYREIVGSPYYIAPEV 207
            H  G+++RD+K EN L    D N  V  TDFGLS      E +   +  G+  Y+AP++
Sbjct: 145 LHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201

Query: 208 LS---QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISS 264
           +      + K  D WS GV++Y LL G  PF  + ++     I +  +  +      +S+
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 261

Query: 265 SAIELVRRMLTQDPKRRI-----TVAQVLEHPWLKE 295
            A +L++R+L +DPK+R+        ++ EH + ++
Sbjct: 262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 7e-61
 Identities = 64/311 (20%), Positives = 113/311 (36%), Gaps = 48/311 (15%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            Y    ++G+G FG  +      TG + A K +      K+       REI+I++ L   
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-H 68

Query: 94  PNIVQFKAAYEDDQF--------VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMN 145
            N+V                   +++V + C              ++      V ++++N
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA-----YREIVGSP 200
            +   H   ++HRD+K  N L      + V+K  DFGL+      K      Y   V + 
Sbjct: 129 GLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 201 YYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP 258
           +Y  PE+L   + YG   D+W AG I+  +    P     T+Q     I +   +   + 
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245

Query: 259 FPSI----------------------------SSSAIELVRRMLTQDPKRRITVAQVLEH 290
           +P++                               A++L+ ++L  DP +RI     L H
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305

Query: 291 PWLKESGEASD 301
            +       SD
Sbjct: 306 DFFWSDPMPSD 316

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 4e-60
 Identities = 77/336 (22%), Positives = 132/336 (39%), Gaps = 48/336 (14%)

Query: 32  QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS 91
           ++ YT  + +G G FG+ Y      +G   A K + +       +K    RE++IMR L 
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------DKRFKNRELQIMRKLD 71

Query: 92  GQPNIVQFKAAY------EDDQFVHIVMELCAGG---ELFDRIVARGHYSERAAASVFRV 142
              NIV+ +  +      +D+ ++++V++               A+              
Sbjct: 72  -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130

Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYY 202
           +   +   HS G+ HRD+KP+N L     + AV+K  DFG +  +  G+     + S YY
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188

Query: 203 IAPEVLSQS--YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG---------- 250
            APE++  +  Y    D+WSAG +L  LL G P F  ++       I+K           
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248

Query: 251 ---------------EINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
                             + +   P     AI L  R+L   P  R+T  +   H +  E
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308

Query: 296 SGEASDKPIDTAVIFRMKQFTA--MNKLKKLALKVI 329
             + + K  +      +  FT   ++    LA  +I
Sbjct: 309 LRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILI 344

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  197 bits (501), Expect = 6e-60
 Identities = 55/288 (19%), Positives = 105/288 (36%), Gaps = 22/288 (7%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            Y +GR++G G FG  YL T+ + G E A K    +      +   +  E +I + + G 
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGG 62

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
             I   +    +  +  +VMEL               +S +    +   +++ +   HSK
Sbjct: 63  VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY--------REIVGSPYYIAP 205
             +HRD+KP+NFL   G +  +V   DFGL+    + + +        + + G+  Y + 
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182

Query: 206 EVL-SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP----FP 260
                    +  D+ S G +L     G  P+         Q   +        P      
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242

Query: 261 SISSSAIELVRRMLTQDPKRRIT---VAQVLEHPWLKESGEASDKPID 305
              S     +    +     +     + Q+  + + ++ G + D   D
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ-GFSYDYVFD 289

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 8e-60
 Identities = 68/344 (19%), Positives = 132/344 (38%), Gaps = 45/344 (13%)

Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           + K   +V+  Y   + VG G +G      +  TG + A K +  R    ++      RE
Sbjct: 9   VTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRE 67

Query: 84  IEIMRHLSGQPNIVQFKAAYEDDQF------VHIVMELCAGGELFDRIVARGHYSERAAA 137
           + +++H+    N++     +  D+        ++VM     G    +++      E    
Sbjct: 68  LRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQ 124

Query: 138 SVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIV 197
            +   ++  +   H+ G++HRDLKP N      +E+  +K  DFGL+   +        V
Sbjct: 125 FLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADS--EMTGYV 179

Query: 198 GSPYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ 255
            + +Y APEV+     Y +  DIWS G I+  ++ G   F         + I+K      
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239

Query: 256 ---------------------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVL 288
                                           + S  A+ L+ +ML  D ++R+T  + L
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299

Query: 289 EHPWLKESGEASDKPIDTAVIFRMKQFT-AMNKLKKLALKVIVE 331
            HP+ +   +  D+P               +++ K++  K ++ 
Sbjct: 300 AHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLS 343

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  193 bits (492), Expect = 7e-59
 Identities = 78/289 (26%), Positives = 120/289 (41%), Gaps = 34/289 (11%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y    ++G G +G+ Y   +N+ G  FA K I   K  + +      REI I++ L    
Sbjct: 4   YHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPST-TIREISILKELK-HS 60

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NIV+        + + +V E           V  G      A S    ++N +  CH + 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLSAFI-EEGKAYREIVGSPYYIAPEVL--SQS 211
           V+HRDLKP+N L    +    +K  DFGL+       + Y   + + +Y AP+VL  S+ 
Sbjct: 121 VLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 212 YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI--------- 262
           Y    DIWS G I   ++ G P F   ++      I +         +P++         
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237

Query: 263 ----------------SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
                             S I+L+ +ML  DP +RIT  Q LEH + KE
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  195 bits (495), Expect = 8e-59
 Identities = 69/300 (23%), Positives = 122/300 (40%), Gaps = 49/300 (16%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            Y + R++GRG++   +     +   +   K +   K      K  ++REI+I+ +L G 
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGG 89

Query: 94  PNIVQFKAAYED--DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCH 151
           PNI+      +D   +   +V E     +           ++         I+  ++ CH
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-- 209
           S G+MHRD+KP N +     E+  ++  D+GL+ F   G+ Y   V S Y+  PE+L   
Sbjct: 147 SMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204

Query: 210 QSYGKEADIWSAGVILYILLCGVPPFWA---ETDQGVAQAILKG---------------- 250
           Q Y    D+WS G +L  ++    PF+      DQ V  A + G                
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264

Query: 251 ---------------EINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
                          E     +    +S  A++ + ++L  D + R+T  + +EHP+   
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 2e-58
 Identities = 65/294 (22%), Positives = 111/294 (37%), Gaps = 35/294 (11%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            Y    E+G G +G  +   +   G  F      + +  ++       RE+ ++RHL   
Sbjct: 8   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67

Query: 94  --PNIVQFK-----AAYEDDQFVHIVMELCAGGEL-FDRIVARGHYSERAAASVFRVIMN 145
             PN+V+       +  + +  + +V E        +   V            +   ++ 
Sbjct: 68  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127

Query: 146 VVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAP 205
            ++  HS  V+HRDLKP+N L      +  +K  DFGL+       A   +V + +Y AP
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 206 EVL-SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP---- 260
           EVL   SY    D+WS G I   +    P F   +D      IL        + +P    
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244

Query: 261 -------------------SISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
                               I     +L+ + LT +P +RI+    L HP+ ++
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (487), Expect = 5e-58
 Identities = 66/290 (22%), Positives = 114/290 (39%), Gaps = 34/290 (11%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
           Y    ++G G +G  +      T    A K +      + V      REI +++ L    
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS-ALREICLLKELKH-K 61

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG 154
           NIV+       D+ + +V E C            G        S    ++  +  CHS+ 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 155 VMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVL--SQS 211
           V+HRDLKP+N L    + N  +K  +FGL+ AF    + Y   V + +Y  P+VL  ++ 
Sbjct: 122 VLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 212 YGKEADIWSAGVILYILLCG-VPPFWAETDQGVAQAILKGEINFQRDP------------ 258
           Y    D+WSAG I   L     P F         + I +       +             
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 259 -------------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
                         P ++++  +L++ +L  +P +RI+  + L+HP+  +
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  193 bits (492), Expect = 5e-58
 Identities = 76/268 (28%), Positives = 135/268 (50%), Gaps = 16/268 (5%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
            +   + +G G FG   L     +G  +A K + K+K+VK  + +    E  I++ ++  
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-F 100

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
           P +V+ + +++D+  +++VME  AGGE+F  +   G +SE  A      I+      HS 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160

Query: 154 GVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVL-SQSY 212
            +++RDLKPEN L    D+   ++ TDFG +  ++       + G+P  +APE++ S+ Y
Sbjct: 161 DLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSKGY 215

Query: 213 GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVRR 272
            K  D W+ GV++Y +  G PPF+A+    + + I+ G++ F        SS   +L+R 
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLLRN 271

Query: 273 MLTQDPKRRI-----TVAQVLEHPWLKE 295
           +L  D  +R       V  +  H W   
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWFAT 299

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 9e-58
 Identities = 74/345 (21%), Positives = 129/345 (37%), Gaps = 41/345 (11%)

Query: 24  LGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE 83
           L K   +V   Y     VG G +G      +  TGL  A K +  R     +      RE
Sbjct: 9   LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRE 67

Query: 84  IEIMRHLSGQPNIVQFKAAYEDDQ----FVHIVMELCAGGELFDRIVARGHYSERAAASV 139
           + +++H+    N++     +   +    F  + +     G   + IV     ++     +
Sbjct: 68  LRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126

Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
              I+  +   HS  ++HRDLKP N      +E+  +K  DFGL+            V +
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHT--DDEMTGYVAT 181

Query: 200 PYYIAPEVL--SQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ-- 255
            +Y APE++     Y +  DIWS G I+  LL G   F         + IL+        
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241

Query: 256 -------------------------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290
                                     + F   +  A++L+ +ML  D  +RIT AQ L H
Sbjct: 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301

Query: 291 PWLKESGEASDKPIDTAVIFRMKQFT-AMNKLKKLALKVIVENLP 334
            +  +  +  D+P+        +     +++ K L    ++  +P
Sbjct: 302 AYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 6e-57
 Identities = 69/291 (23%), Positives = 112/291 (38%), Gaps = 34/291 (11%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           ++    ++G G +G+ Y      TG   A K I      + V      REI +++ L+  
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPST-AIREISLLKELN-H 60

Query: 94  PNIVQFKAAYEDDQFVHIVMELCA-GGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
           PNIV+       +  +++V E      + F    A          S    ++  +  CHS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLS-AFIEEGKAYREIVGSPYYIAPEVLSQS 211
             V+HRDLKP+N L    +    +K  DFGL+ AF    + Y   V + +Y APE+L   
Sbjct: 121 HRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177

Query: 212 --YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDP----------- 258
             Y    DIWS G I   ++     F  +++      I +                    
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

Query: 259 --------------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
                          P +      L+ +ML  DP +RI+    L HP+ ++
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 1e-56
 Identities = 60/263 (22%), Positives = 109/263 (41%), Gaps = 19/263 (7%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
             T  +E+G G+FG+           + A K I +  +     +D+   E ++M +LS  
Sbjct: 5   DLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-H 58

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRI-VARGHYSERAAASVFRVIMNVVNVCHS 152
             +VQ        + + I+ E  A G L + +   R  +  +    + + +   +    S
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE--IVGSPYYIAPEVL-S 209
           K  +HRDL   N L    ++  VVK +DFGLS ++ + +            +  PEVL  
Sbjct: 119 KQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175

Query: 210 QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAI 267
             +  ++DIW+ GV+++ I   G  P+   T+   A+ I +G     R   P   S    
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----RLYRPHLASEKVY 231

Query: 268 ELVRRMLTQDPKRRITVAQVLEH 290
            ++     +    R T   +L +
Sbjct: 232 TIMYSCWHEKADERPTFKILLSN 254

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 1e-55
 Identities = 59/262 (22%), Positives = 101/262 (38%), Gaps = 21/262 (8%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
              + + +G+GEFG   L      G + A K      +  D        E  +M  L   
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDY--RGNKVAVK-----CIKNDATAQAFLAEASVMTQLR-H 59

Query: 94  PNIVQFKAA-YEDDQFVHIVMELCAGGELFDRIVARGH--YSERAAASVFRVIMNVVNVC 150
            N+VQ      E+   ++IV E  A G L D + +RG               +   +   
Sbjct: 60  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119

Query: 151 HSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS- 209
                +HRDL   N L     E+ V K +DFGL+      +   +      + APE L  
Sbjct: 120 EGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQDTGK--LPVKWTAPEALRE 174

Query: 210 QSYGKEADIWSAGVILYILL-CGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
           + +  ++D+WS G++L+ +   G  P+     + V   + KG   ++ D       +  E
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPAVYE 231

Query: 269 LVRRMLTQDPKRRITVAQVLEH 290
           +++     D   R +  Q+ E 
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQ 253

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 1e-55
 Identities = 64/271 (23%), Positives = 118/271 (43%), Gaps = 20/271 (7%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
             T  +E+G G+FG+ +L        + A K+I +  +     ++D   E E+M  LS  
Sbjct: 6   ELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-H 59

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVIMNVVNVCHS 152
           P +VQ      +   + +V E    G L D +  +   ++      +   +   +     
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE--IVGSPYYIAPEVLSQ 210
             V+HRDL   N L     EN V+K +DFG++ F+ + +            + +PEV S 
Sbjct: 120 ACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176

Query: 211 S-YGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAI 267
           S Y  ++D+WS GV+++ +   G  P+   ++  V + I  G     R   P   S+   
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF----RLYKPRLASTHVY 232

Query: 268 ELVRRMLTQDPKRRITVAQVLEH-PWLKESG 297
           +++     + P+ R   +++L     + ESG
Sbjct: 233 QIMNHCWKERPEDRPAFSRLLRQLAEIAESG 263

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-55
 Identities = 56/273 (20%), Positives = 97/273 (35%), Gaps = 19/273 (6%)

Query: 34  HYTIGREVGRGEFGITYLCT---ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
              +  ++G G FG+         +   +  A K +    L +    DD  RE+  M  L
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNV 149
               N+++            +V EL   G L DR+    GH+     +     +   +  
Sbjct: 69  D-HRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY----REIVGSPYYIAP 205
             SK  +HRDL   N L        +VK  DFGL   + +   +            + AP
Sbjct: 127 LESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 206 EVL-SQSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSIS 263
           E L ++++   +D W  GV L+ +   G  P+       +   I K      R       
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP--EDCP 241

Query: 264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLKES 296
                ++ +     P+ R T   + +  +L E+
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFVALRD--FLLEA 272

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 4e-55
 Identities = 59/268 (22%), Positives = 101/268 (37%), Gaps = 22/268 (8%)

Query: 39  REVGRGEFGITYLCT--ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNI 96
           +E+G G FG                A K + K +      KD++  E  +M+ L   P I
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLD-NPYI 70

Query: 97  VQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVM 156
           V+     E + ++ +VME+   G L   +    H  ++    +   +   +        +
Sbjct: 71  VRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 129

Query: 157 HRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE----IVGSPYYIAPEVL-SQS 211
           HRDL   N L          K +DFGLS  +   + Y +          + APE +    
Sbjct: 130 HRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 212 YGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIEL 269
           +  ++D+WS GV+++     G  P+       V   + KGE    R   P+       +L
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE----RMGCPAGCPREMYDL 242

Query: 270 VRRMLTQDPKRRITVAQV---LEHPWLK 294
           +    T D + R   A V   L + +  
Sbjct: 243 MNLCWTYDVENRPGFAAVELRLRNYYYD 270

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 5e-55
 Identities = 64/294 (21%), Positives = 106/294 (36%), Gaps = 28/294 (9%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP 94
                 +G G FG          GL         ++     +  D   E+E++  L   P
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 95  NIVQFKAAYEDDQFVHIVMELCAGGELFDRI----------------VARGHYSERAAAS 138
           NI+    A E   ++++ +E    G L D +                      S +    
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 139 VFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVG 198
               +   ++    K  +HRDL   N L     EN V K  DFGLS   E          
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRL 188

Query: 199 SPYYIAPEVLSQS-YGKEADIWSAGVILYILL-CGVPPFWAETDQGVAQAILKGEINFQR 256
              ++A E L+ S Y   +D+WS GV+L+ ++  G  P+   T   + + + +G     R
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY----R 244

Query: 257 DPFPS-ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVI 309
              P        +L+R+   + P  R + AQ+L    L    E     ++T + 
Sbjct: 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS--LNRMLEERKTYVNTTLY 296

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 1e-54
 Identities = 51/288 (17%), Positives = 99/288 (34%), Gaps = 36/288 (12%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV---EKDDVRREIEIMRHL 90
           +   G+ +G G FG     T            +  + L +     E++ +  E+++M  L
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH-------------------- 130
               NIV    A      ++++ E C  G+L + + ++                      
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 131 ---YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI 187
               +          +   +     K  +HRDL   N L        VVK  DFGL+  I
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDI 214

Query: 188 EEGKAYR---EIVGSPYYIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQG 242
                Y           ++APE L    Y  ++D+WS G++L+ I   GV P+       
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 243 VAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290
               +++      +  +   +     +++     D ++R +   +   
Sbjct: 275 NFYKLIQNGFKMDQPFY--ATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 1e-54
 Identities = 59/272 (21%), Positives = 110/272 (40%), Gaps = 23/272 (8%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
              +  ++G+G FG  ++ T N T    A K++    +      +   +E ++M+ L   
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM----SPEAFLQEAQVMKKLR-H 71

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCH 151
             +VQ  A   ++  ++IV E  + G L D +      +        +   I + +    
Sbjct: 72  EKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE--IVGSPYYIAPEVLS 209
               +HRDL+  N L     EN V K  DFGL+  IE+ +            + APE   
Sbjct: 131 RMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187

Query: 210 -QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSA 266
              +  ++D+WS G++L  L   G  P+    ++ V   + +G     R P P     S 
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY----RMPCPPECPESL 243

Query: 267 IELVRRMLTQDPKRRITVAQVLE--HPWLKES 296
            +L+ +   ++P+ R T   +      +   +
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  181 bits (461), Expect = 5e-54
 Identities = 62/282 (21%), Positives = 110/282 (39%), Gaps = 17/282 (6%)

Query: 19  LHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPK-RKLVKDVEK 77
            ++A+   A E       I + +G GEFG          G      +I   +    + ++
Sbjct: 12  PNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR 71

Query: 78  DDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-GHYSERAA 136
            D   E  IM      PN++  +        V I+ E    G L   +    G ++    
Sbjct: 72  RDFLSEASIMGQFD-HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL 130

Query: 137 ASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE- 195
             + R I   +        +HRDL   N L    + N V K +DFGLS F+E+  +    
Sbjct: 131 VGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTY 187

Query: 196 -----IVGSPYYIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAIL 248
                      + APE +  + +   +D+WS G++++ ++  G  P+W  T+Q V  AI 
Sbjct: 188 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 247

Query: 249 KGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290
           +    ++  P     S+  +L+     +D   R    Q++  
Sbjct: 248 QD---YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 2e-53
 Identities = 68/266 (25%), Positives = 111/266 (41%), Gaps = 20/266 (7%)

Query: 34  HYTIGREVGRGEFGITYLCT---ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHL 90
              +GR +G G+FG  +        +  L  A K+   +    D  ++   +E   MR  
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQF 65

Query: 91  SGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNV 149
              P+IV+      ++  V I+MELC  GEL   +  R       +       +   +  
Sbjct: 66  D-HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123

Query: 150 CHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR--EIVGSPYYIAPEV 207
             SK  +HRD+   N L      N  VK  DFGLS ++E+   Y+  +      ++APE 
Sbjct: 124 LESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180

Query: 208 LS-QSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISS 264
           ++ + +   +D+W  GV ++ IL+ GV PF    +  V   I  GE    R P P     
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----RLPMPPNCPP 236

Query: 265 SAIELVRRMLTQDPKRRITVAQVLEH 290
           +   L+ +    DP RR    ++   
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-53
 Identities = 60/273 (21%), Positives = 99/273 (36%), Gaps = 24/273 (8%)

Query: 39  REVGRGEFGITYLCT--ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNI 96
            E+G G FG             ++ A K + +     D E  ++ RE +IM  L   P I
Sbjct: 15  IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE--EMMREAQIMHQLD-NPYI 71

Query: 97  VQFKAAYEDDQFVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGV 155
           V+     + +    +VME+  GG L   +V  R        A +   +   +     K  
Sbjct: 72  VRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130

Query: 156 MHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE----IVGSPYYIAPEVLS-Q 210
           +HRDL   N L          K +DFGLS  +    +Y            + APE ++ +
Sbjct: 131 VHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187

Query: 211 SYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSAIE 268
            +   +D+WS GV ++  L  G  P+       V   I +G+    R   P         
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK----RMECPPECPPELYA 243

Query: 269 LVRRMLTQDPKRRIT---VAQVLEHPWLKESGE 298
           L+        + R     V Q +   +   + +
Sbjct: 244 LMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  179 bits (454), Expect = 3e-53
 Identities = 58/270 (21%), Positives = 106/270 (39%), Gaps = 17/270 (6%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
             T+  ++G G++G  Y        L  A K++ +  +    E ++  +E  +M+ +   
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-H 72

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHY--SERAAASVFRVIMNVVNVCH 151
           PN+VQ       +   +I+ E    G L D +        S      +   I + +    
Sbjct: 73  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE--IVGSPYYIAPEVLS 209
            K  +HRDL   N L     EN +VK  DFGLS  +                + APE L+
Sbjct: 133 KKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189

Query: 210 -QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE 268
              +  ++D+W+ GV+L+ +       +   D      +L+ +   +R           E
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP--EGCPEKVYE 247

Query: 269 LVRRMLTQDPKRRITVAQVLE--HPWLKES 296
           L+R     +P  R + A++ +      +ES
Sbjct: 248 LMRACWQWNPSDRPSFAEIHQAFETMFQES 277

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  176 bits (447), Expect = 4e-52
 Identities = 49/289 (16%), Positives = 97/289 (33%), Gaps = 22/289 (7%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
           HY +GR +G G FG+ +  T      + A K  P+R      +   +R E    + L+G 
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGC 60

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSK 153
             I       ++     +V++L          +    +S +  A   + ++  V   H K
Sbjct: 61  TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120

Query: 154 GVMHRDLKPENFLFTTGD--ENAVVKATDFGLSAFIEEGKA--------YREIVGSPYYI 203
            +++RD+KP+NFL    +     ++   DFG+  F  +            + + G+  Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 204 APEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF--- 259
           +      +   +  D+ + G +    L G  P+         Q   +     Q  P    
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240

Query: 260 -PSISSSAIELVRRMLTQDPKRRITVAQVLE--HPWLKESGEASDKPID 305
                    + +                +       L+      D+  D
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD 289

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 5e-52
 Identities = 54/263 (20%), Positives = 103/263 (39%), Gaps = 21/263 (7%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ 93
              +   +G G+FG  ++   N    + A KS+ +  +      D    E  +M+ L   
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-H 67

Query: 94  PNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCH 151
             +V+  A    +  ++I+ E    G L D +        +      +   I   +    
Sbjct: 68  QRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 152 SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE--IVGSPYYIAPEVLS 209
            +  +HRDL+  N L     +    K  DFGL+  IE+ +            + APE ++
Sbjct: 127 ERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183

Query: 210 -QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSA 266
             ++  ++D+WS G++L  ++  G  P+   T+  V Q + +G     R   P       
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY----RMVRPDNCPEEL 239

Query: 267 IELVRRMLTQDPKRRITVAQVLE 289
            +L+R    + P+ R T   +  
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRS 262

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 6e-52
 Identities = 68/338 (20%), Positives = 121/338 (35%), Gaps = 53/338 (15%)

Query: 18  HLHDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEK 77
             +   +G +   V   Y   + +G G  GI     +       A K +  R        
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHA 60

Query: 78  DDVRREIEIMRHLSGQPNIVQFKAAY------EDDQFVHIVMELCAGGELFDRIVARGHY 131
               RE+ +M+ ++   NI+     +      E+ Q V++VMEL            +   
Sbjct: 61  KRAYRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMEL 116

Query: 132 SERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191
                + +   ++  +   HS G++HRDLKP N +      +  +K  DFGL+       
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSF 173

Query: 192 AYREIVGSPYYIAPE-VLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG 250
                V + YY APE +L   Y +  DIWS G I+  ++     F           +++ 
Sbjct: 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

Query: 251 ----------------------EINFQRDPFPSI----------------SSSAIELVRR 272
                                    +    FP +                +S A +L+ +
Sbjct: 234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 293

Query: 273 MLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIF 310
           ML  DP +RI+V   L+HP++    + ++       I+
Sbjct: 294 MLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIY 331

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 6e-50
 Identities = 58/283 (20%), Positives = 106/283 (37%), Gaps = 32/283 (11%)

Query: 34  HYTIGREVGRGEFGITYLCTENST-------GLEFACKSIPKRKLVKDVEKDDVRREIEI 86
              +G+ +G G FG   L               + A K +      KD+   D+  E+E+
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEM 71

Query: 87  MRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRI----------------VARGH 130
           M+ +    NI+    A   D  +++++E  + G L + +                     
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 131 YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190
            S +   S    +   +    SK  +HRDL   N L T  +   +           I+  
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 191 KAYREIVGSPYYIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAIL 248
           K          ++APE L  + Y  ++D+WS GV+L+ I   G  P+     + + + + 
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251

Query: 249 KGEINFQRDPFPS-ISSSAIELVRRMLTQDPKRRITVAQVLEH 290
           +G     R   PS  ++    ++R      P +R T  Q++E 
Sbjct: 252 EGH----RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 8e-50
 Identities = 48/264 (18%), Positives = 93/264 (35%), Gaps = 16/264 (6%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPK--RKLVKDVEKDDVRREIEIMRHLSG 92
           +   + +G G FG  Y       G +       K  R+        ++  E  +M  +  
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD- 69

Query: 93  QPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS 152
            P++ +            I   +  G  L      + +   +   +    I   +N    
Sbjct: 70  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 153 KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---EIVGSPYYIAPEVL- 208
           + ++HRDL   N L         VK TDFGL+  +   +             ++A E + 
Sbjct: 130 RRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186

Query: 209 SQSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPS-ISSSA 266
            + Y  ++D+WS GV ++ L+  G  P+       ++  + KGE    R P P   +   
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQPPICTIDV 242

Query: 267 IELVRRMLTQDPKRRITVAQVLEH 290
             ++ +    D   R    +++  
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIE 266

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 2e-49
 Identities = 53/284 (18%), Positives = 99/284 (34%), Gaps = 35/284 (12%)

Query: 34  HYTIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
             + G+ +G G FG     T     ++   +  A K +         E++ +  E++++ 
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLS 81

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH------------------ 130
           +L    NIV    A        ++ E C  G+L + +  +                    
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 131 YSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG 190
                  S    +   +    SK  +HRDL   N L        + K  DFGL+  I+  
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKND 198

Query: 191 KAYR---EIVGSPYYIAPEVLSQSY-GKEADIWSAGVILYILLC-GVPPFWAETDQGVAQ 245
             Y           ++APE +       E+D+WS G+ L+ L   G  P+          
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258

Query: 246 AILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
            ++K              +   ++++     DP +R T  Q+++
Sbjct: 259 KMIKEGFRMLSPEH--APAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  167 bits (423), Expect = 1e-48
 Identities = 58/296 (19%), Positives = 104/296 (35%), Gaps = 45/296 (15%)

Query: 34  HYTIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
           +    R++G G FG  +                A K + +        + D +RE  +M 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHY----------------- 131
                PNIV+        + + ++ E  A G+L + + +   +                 
Sbjct: 72  EFD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130

Query: 132 -------SERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS 184
                  S      + R +   +     +  +HRDL   N L     EN VVK  DFGLS
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLS 187

Query: 185 AFIEEGKAYRE---IVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAET 239
             I     Y+          ++ PE +    Y  E+D+W+ GV+L+ +   G+ P++   
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247

Query: 240 DQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE 295
            + V   +  G I        +       L+R   ++ P  R +   +     L+ 
Sbjct: 248 HEEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQR 298

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 1e-47
 Identities = 63/268 (23%), Positives = 114/268 (42%), Gaps = 22/268 (8%)

Query: 34  HYTIGREVGRGEFGITYLCTENSTG----LEFACKSIPKRKLVKDVEKDDVRREIEIMRH 89
             T  + +G GEFG  Y     ++     +  A K++  +    + ++ D   E  IM  
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMGQ 65

Query: 90  LSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVN 148
            S   NI++ +      + + I+ E    G L   +  + G +S      + R I   + 
Sbjct: 66  FS-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 149 VCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR----EIVGSPYYIA 204
              +   +HRDL   N L    + N V K +DFGLS  +E+                + A
Sbjct: 125 YLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 205 PEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPS- 261
           PE +S + +   +D+WS G++++ ++  G  P+W  ++  V +AI  G     R P P  
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF----RLPTPMD 237

Query: 262 ISSSAIELVRRMLTQDPKRRITVAQVLE 289
             S+  +L+ +   Q+  RR   A ++ 
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVS 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 2e-47
 Identities = 59/288 (20%), Positives = 120/288 (41%), Gaps = 35/288 (12%)

Query: 34  HYTIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
             T+ RE+G+G FG+ Y        ++      A K++ +   ++  E+ +   E  +M+
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMK 78

Query: 89  HLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGH----------YSERAAAS 138
             +   ++V+        Q   ++MEL   G+L   + +              S      
Sbjct: 79  EFNC-HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 139 VFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYR---E 195
           +   I + +   ++   +HRDL   N +     E+  VK  DFG++  I E   YR   +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 196 IVGSPYYIAPEVL-SQSYGKEADIWSAGVILY-ILLCGVPPFWAETDQGVAQAILKGEIN 253
            +    +++PE L    +   +D+WS GV+L+ I      P+   +++ V + +++G + 
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL- 253

Query: 254 FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE------HPWLKE 295
              D   +      EL+R     +PK R +  +++        P  +E
Sbjct: 254 --LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 4e-46
 Identities = 58/275 (21%), Positives = 109/275 (39%), Gaps = 25/275 (9%)

Query: 29  EDVQLHYTIGREVGRGEFGITYLCT---ENSTGLEFACKSIPKRKLVKDVEKDDVRREIE 85
             + +H+     +GRG FG  Y  T    +   +  A KS+ +   + +V       E  
Sbjct: 25  SSLIVHF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTEGI 80

Query: 86  IMRHLSGQPNIVQFK-AAYEDDQFVHIVMELCAGGELFDRIVARGH-YSERAAASVFRVI 143
           IM+  S  PN++         +    +V+     G+L + I    H  + +        +
Sbjct: 81  IMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 139

Query: 144 MNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYRE-----IVG 198
              +    SK  +HRDL   N +    DE   VK  DFGL+  + + +            
Sbjct: 140 AKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196

Query: 199 SPYYIAPEVL-SQSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQR 256
              ++A E L +Q +  ++D+WS GV+L+ L+  G PP+       +   +L+G     R
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR----R 252

Query: 257 DPFPS-ISSSAIELVRRMLTQDPKRRITVAQVLEH 290
              P        E++ +      + R + ++++  
Sbjct: 253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 3e-43
 Identities = 60/297 (20%), Positives = 101/297 (34%), Gaps = 53/297 (17%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ- 93
             +   +G+G FG  +       G E A K    R      E+    RE EI + +  + 
Sbjct: 5   IVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRH 56

Query: 94  PNIVQFKAAYEDDQF----VHIVMELCAGGELFDRIVARGHYSERA-------AASVFRV 142
            NI+ F AA   D      + +V +    G LFD +       E         A+ +  +
Sbjct: 57  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116

Query: 143 IMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-----AYREIV 197
            M +V       + HRDLK +N L     +N      D GL+   +        A    V
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173

Query: 198 GSPYYIAPEVL-------SQSYGKEADIWSAGVILYILLCGVPPFWAETDQG-------- 242
           G+  Y+APEVL            K ADI++ G++ + +           D          
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233

Query: 243 ---VAQAILKGEINFQRDP-------FPSISSSAIELVRRMLTQDPKRRITVAQVLE 289
                + + K     +  P                +++R     +   R+T  ++ +
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 9e-43
 Identities = 54/284 (19%), Positives = 107/284 (37%), Gaps = 34/284 (11%)

Query: 34  HYTIGREVGRGEFGITYLCT-----ENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR 88
              +G+ +GRG FG           + +T    A K + +     +     +  E++I+ 
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR--ALMSELKILI 71

Query: 89  HLSGQPNIVQFKAA-YEDDQFVHIVMELCAGGELFDRIVARGHY---------------- 131
           H+    N+V    A  +    + +++E C  G L   + ++ +                 
Sbjct: 72  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131

Query: 132 SERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK 191
           +          +   +    S+  +HRDL   N L     E  VVK  DFGL+  I +  
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDP 188

Query: 192 AY---REIVGSPYYIAPEVL-SQSYGKEADIWSAGVILYILLCGV-PPFWAETDQGVAQA 246
            Y    +      ++APE +  + Y  ++D+WS GV+L+ +      P+           
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248

Query: 247 ILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH 290
            LK     +   +   +    + +      +P +R T ++++EH
Sbjct: 249 RLKEGTRMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  147 bits (372), Expect = 1e-40
 Identities = 60/347 (17%), Positives = 121/347 (34%), Gaps = 68/347 (19%)

Query: 20  HDAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDD 79
           H A  G+ Y+D +  Y + R++G G F   +L  +       A K +   K+      + 
Sbjct: 2   HPAFKGEPYKDAR--YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEA 55

Query: 80  VRREIEIMRHLS----------GQPNIVQFKAAYED--DQFVHIVMELCAGG---ELFDR 124
              EI++++ ++          G  +I++    +       VH+VM     G       +
Sbjct: 56  AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK 115

Query: 125 IVARGHYSERAAASVFRVIMNVVNVCHSK-GVMHRDLKPENFLFTTGDENA-VVKATDFG 182
                         + + ++  ++  H + G++H D+KPEN L    D    +++     
Sbjct: 116 KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIAD 175

Query: 183 LSAFIEEGKAYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAETDQ 241
           L       + Y   + +  Y +PEVL    +G  ADIWS   +++ L+ G   F  +   
Sbjct: 176 LGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 235

Query: 242 GVAQAI--------------------------------------------LKGEINFQRD 257
              +                                              L+  +  +  
Sbjct: 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK 295

Query: 258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPI 304
                +    + +  ML  DP++R     ++ HPWLK++    +  +
Sbjct: 296 FSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 342

>d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} Length = 141

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 4e-29
 Identities = 44/141 (31%), Positives = 78/141 (55%), Gaps = 3/141 (2%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYI 395
           E+ Q+++E F   D D +GT+   ELK  +  LG    + ++K+ +   D +G G +++ 
Sbjct: 3   EQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFG 62

Query: 396 EFITATMQR-HKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI 454
           +F+T   Q+  +    E + KAF+ FD D  G I+   L +  K+  +G++ T   ++E+
Sbjct: 63  DFLTVMTQKMSEKDTKEEILKAFKLFDDDETGKISFKNLKRVAKE--LGENLTDEELQEM 120

Query: 455 MSEVDRDKDGRISYDEFRSMM 475
           + E DRD DG +S  EF  +M
Sbjct: 121 IDEADRDGDGEVSEQEFLRIM 141

>d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} Length = 141

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.6 bits (117), Expect = 7e-08
 Identities = 17/64 (26%), Positives = 36/64 (56%)

Query: 335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDY 394
            +  +++ + F   D D +G +++  LK    +LG  LT+ ++++ +  AD DG+G +  
Sbjct: 75  KDTKEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRDGDGEVSE 134

Query: 395 IEFI 398
            EF+
Sbjct: 135 QEFL 138

>d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} Length = 181

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Neurocalcin
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  110 bits (275), Expect = 6e-29
 Identities = 40/170 (23%), Positives = 74/170 (43%), Gaps = 15/170 (8%)

Query: 320 KLKKLALKVIVE--NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD- 376
           KL+   ++ ++E  +    EIQ+  + F  +    SG L+ +E K               
Sbjct: 3   KLRPEVMQDLLESTDFTEHEIQEWYKGF--LRDCPSGHLSMEEFKKIYGNFFPYGDASKF 60

Query: 377 VKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKA 436
            +   +  D +G+GTID+ EFI A     + +  + L  AF  +D D NGYI+  E+ + 
Sbjct: 61  AEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLEI 120

Query: 437 FKDYGM----------GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
            +               +       ++I  ++D ++DG++S +EF    K
Sbjct: 121 VQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRDGKLSLEEFIRGAK 170

>d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} Length = 181

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Neurocalcin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 44.0 bits (103), Expect = 1e-05
 Identities = 23/164 (14%), Positives = 51/164 (31%), Gaps = 21/164 (12%)

Query: 268 ELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALK 327
           E  +  L   P   +++ +  +           D       +FR         +      
Sbjct: 25  EWYKGFLRDCPSGHLSMEEFKK--IYGNFFPYGDASKFAEHVFRTFDANGDGTIDFREFI 82

Query: 328 VIVENL-PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM------------LTE 374
           + +      +  QKLK  F+  D D +G ++  E+   +  +  M              E
Sbjct: 83  IALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPE 142

Query: 375 FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQ 418
              ++  +  D + +G +   EFI         +   ++ +  Q
Sbjct: 143 KRTEKIFRQMDTNRDGKLSLEEFIRG------AKSDPSIVRLLQ 180

>d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} Length = 146

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]

 Score =  108 bits (271), Expect = 1e-28
 Identities = 54/146 (36%), Positives = 79/146 (54%), Gaps = 3/146 (2%)

Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
           E L  E+I + KE F   D D  GT+T  EL   +  LG   TE +++  +   D DGNG
Sbjct: 1   EQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNG 60

Query: 391 TIDYIEFITA-TMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA 449
           TID+ EF++    +  +    E L +AF+ FD+D NG I+  EL     +  +G+  T  
Sbjct: 61  TIDFPEFLSLMARKMKEQDSEEELIEAFKVFDRDGNGLISAAELRHVMTN--LGEKLTDD 118

Query: 450 TIKEIMSEVDRDKDGRISYDEFRSMM 475
            + E++ E D D DG I+Y+EF  MM
Sbjct: 119 EVDEMIREADIDGDGHINYEEFVRMM 144

>d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} Length = 146

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]

 Score = 46.4 bits (109), Expect = 9e-07
 Identities = 25/67 (37%), Positives = 38/67 (56%), Gaps = 2/67 (2%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE 470
               +AF  FDKD +G IT  ELG       +G + T A ++++++EVD D +G I + E
Sbjct: 9   AEFKEAFALFDKDGDGTITTKELGTVM--RSLGQNPTEAELQDMINEVDADGNGTIDFPE 66

Query: 471 FRSMMKC 477
           F S+M  
Sbjct: 67  FLSLMAR 73

>d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (268), Expect = 3e-28
 Identities = 45/147 (30%), Positives = 76/147 (51%), Gaps = 4/147 (2%)

Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
            NL  E+I + KE F   D DN+G+++  EL   +  LG   +E +V   M   D+DGN 
Sbjct: 2   SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNH 61

Query: 391 TIDYIEFITA-TMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA 449
            I++ EF+   + Q       + L +AF+ FDK+ +G I+  EL        +G+  T A
Sbjct: 62  QIEFSEFLALMSRQLKSNDSEQELLEAFKVFDKNGDGLISAAELKHVLTS--IGEKLTDA 119

Query: 450 TIKEIMSEVDRDKDGRISYDEFRSMMK 476
            + +++ EV  D  G I+  +F +++ 
Sbjct: 120 EVDDMLREVS-DGSGEINIQQFAALLS 145

>d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 156

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score =  106 bits (265), Expect = 8e-28
 Identities = 49/155 (31%), Positives = 77/155 (49%), Gaps = 7/155 (4%)

Query: 327 KVIVENLPTEEIQKLKEKFTEMDTD-NSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAAD 385
           K  VE L  E+  + K  F         G+++  EL   +  LG   T  ++++ +   D
Sbjct: 2   KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVD 61

Query: 386 IDGNGTIDYIEFITATMQRHKLQRF----ENLYKAFQYFDKDNNGYITVDELGKAFKDYG 441
            DG+GT+D+ EF+   ++  K        E L   F+ FDK+ +GYI ++EL    +  G
Sbjct: 62  EDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQATG 121

Query: 442 MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
                T   I+E+M + D++ DGRI YDEF   MK
Sbjct: 122 E--TITEDDIEELMKDGDKNNDGRIDYDEFLEFMK 154

>d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 162

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score =  106 bits (264), Expect = 1e-27
 Identities = 48/148 (32%), Positives = 80/148 (54%), Gaps = 6/148 (4%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E I + K  F   D D  G ++  EL   +  LG   T+ ++   ++  D DG+GTI
Sbjct: 14  LSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTI 73

Query: 393 DYIEFITATMQRH----KLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI 448
           D+ EF+   +++     K +  E L   F+ FDK+ +G+I ++ELG+       G+  T 
Sbjct: 74  DFEEFLVMMVRQMKEDAKGKSEEELANCFRIFDKNADGFIDIEELGEIL--RATGEHVTE 131

Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMMK 476
             I+++M + D++ DGRI +DEF  MM+
Sbjct: 132 EDIEDLMKDSDKNNDGRIDFDEFLKMME 159

>d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 162

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 40.7 bits (94), Expect = 1e-04
 Identities = 23/67 (34%), Positives = 30/67 (44%), Gaps = 2/67 (2%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE 470
                AF  FD D  G I+  ELG   +  G   + T   +  I+ EVD D  G I ++E
Sbjct: 20  AEFKAAFDMFDADGGGDISTKELGTVMRMLGQ--NPTKEELDAIIEEVDEDGSGTIDFEE 77

Query: 471 FRSMMKC 477
           F  MM  
Sbjct: 78  FLVMMVR 84

>d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} Length = 187

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 2e-27
 Identities = 35/170 (20%), Positives = 66/170 (38%), Gaps = 15/170 (8%)

Query: 320 KLKKLALKVIVE--NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD- 376
           KLK   ++ +        +E+Q+  + F  +    SG L     +    +          
Sbjct: 4   KLKPEVVEELTRKTYFTEKEVQQWYKGF--IKDCPSGQLDAAGFQKIYKQFFPFGDPTKF 61

Query: 377 VKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKA 436
                   D + +G I++ EFI A     +    E L  AF+ +D DN+GYIT +E+   
Sbjct: 62  ATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDLDNDGYITRNEMLDI 121

Query: 437 FKDYGM----------GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
                            ++     +  I + +D++ DG+++  EF+   K
Sbjct: 122 VDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKLTLQEFQEGSK 171

>d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} Length = 187

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.1 bits (98), Expect = 5e-05
 Identities = 15/90 (16%), Positives = 30/90 (33%), Gaps = 18/90 (20%)

Query: 345 FTEMDTDNSGTLTYDELKAGLAKLGSMLTEF------------DVKQYMQAADIDGNGTI 392
           F   D DN G +T +E+   +  +  M+                V +     D + +G +
Sbjct: 102 FKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKL 161

Query: 393 DYIEFITATMQRHKLQRFENLYKAFQYFDK 422
              EF          +   ++ +A   +D 
Sbjct: 162 TLQEFQEG------SKADPSIVQALSLYDG 185

>d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 190

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  101 bits (252), Expect = 1e-25
 Identities = 43/170 (25%), Positives = 69/170 (40%), Gaps = 15/170 (8%)

Query: 320 KLKKLALKVIVE--NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLT-EFD 376
           KL K  L  + +       EIQ+  + F  +    SG L  ++      +     + E  
Sbjct: 7   KLSKDDLTCLKQSTYFDRREIQQWHKGF--LRDCPSGQLAREDFVKIYKQFFPFGSPEDF 64

Query: 377 VKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDEL--- 433
                   D D NG I + EFIT      +    E L  AF+ +D +++GYIT DE+   
Sbjct: 65  ANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDGYITFDEMLTI 124

Query: 434 -------GKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
                    +       +      +K+I   +D+++DG I+ DEFR   K
Sbjct: 125 VASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYITLDEFREGSK 174

>d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 190

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 54.8 bits (131), Expect = 2e-09
 Identities = 28/119 (23%), Positives = 49/119 (41%), Gaps = 15/119 (12%)

Query: 334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTID 393
           P +    L   FT  D DN+G + ++E    L+       E  +    +  D++ +G I 
Sbjct: 61  PEDFANHL---FTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDGYIT 117

Query: 394 YIEFITATMQRHKL------------QRFENLYKAFQYFDKDNNGYITVDELGKAFKDY 440
           + E +T     +K+                 + K F+  DK+ +GYIT+DE  +  K  
Sbjct: 118 FDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYITLDEFREGSKVD 176

>d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 190

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 44.8 bits (105), Expect = 6e-06
 Identities = 20/96 (20%), Positives = 37/96 (38%), Gaps = 18/96 (18%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSML------------TEFDVKQYMQAADI 386
           +KL   F   D ++ G +T+DE+   +A +  M+             E  VK+  +  D 
Sbjct: 99  EKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDK 158

Query: 387 DGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDK 422
           + +G I   EF          +   ++  A   +D 
Sbjct: 159 NEDGYITLDEFREG------SKVDPSIIGALNLYDG 188

>d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 182

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

 Score =  100 bits (250), Expect = 2e-25
 Identities = 81/159 (50%), Positives = 109/159 (68%), Gaps = 4/159 (2%)

Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
           E L  EEI  LKE F  +DTDNSGT+T+DELK GL ++GS L E ++K  M AADID +G
Sbjct: 2   ERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSG 61

Query: 391 TIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIAT 450
           TIDY EFI AT+  +KL+R ENL  AF YFDKD +GYIT+DE+ +A KD+G+ D      
Sbjct: 62  TIDYGEFIAATVHLNKLEREENLVSAFSYFDKDGSGYITLDEIQQACKDFGLDDI----H 117

Query: 451 IKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRALSSRSL 489
           I +++ E+D+D DG+I Y EF +MM+       +  R++
Sbjct: 118 IDDMIKEIDQDNDGQIDYGEFAAMMRKRKGNGGIGRRTM 156

>d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} Length = 189

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Guanylate cyclase activating protein 2, GCAP-2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 98.4 bits (244), Expect = 2e-24
 Identities = 35/162 (21%), Positives = 62/162 (38%), Gaps = 16/162 (9%)

Query: 331 ENLPTEEIQKLKEKFTEMDTD-NSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN 389
             +   +  +L+E + +   +  SGTL   E K       +      V+   +A D +G+
Sbjct: 13  GAVGAADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAFDTNGD 72

Query: 390 GTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFK----------- 438
            TID++E++ A     +      L   F+ +DKD NG I   EL    +           
Sbjct: 73  NTIDFLEYVAALNLVLRGTLEHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSV 132

Query: 439 ----DYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
               +           +  I   VD + DG++S +EF    +
Sbjct: 133 EVEAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGAR 174

>d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} Length = 189

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Guanylate cyclase activating protein 2, GCAP-2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 47.2 bits (111), Expect = 9e-07
 Identities = 10/66 (15%), Positives = 28/66 (42%), Gaps = 3/66 (4%)

Query: 413 LYKAFQYFDKD-NNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEF 471
           L + ++ F ++  +G + + E  + FK     +      ++ +    D + D  I + E+
Sbjct: 23  LQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQY--VEAMFRAFDTNGDNTIDFLEY 80

Query: 472 RSMMKC 477
            + +  
Sbjct: 81  VAALNL 86

>d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} Length = 189

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Guanylate cyclase activating protein 2, GCAP-2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 45.6 bits (107), Expect = 3e-06
 Identities = 27/135 (20%), Positives = 52/135 (38%), Gaps = 20/135 (14%)

Query: 323 KLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQ 382
           K   KV      T+ ++ +   F   DT+   T+ + E  A L  +     E  +K   +
Sbjct: 45  KRFFKVPDNEEATQYVEAM---FRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFK 101

Query: 383 AADIDGNGTIDYIEFITATMQRHKLQR-----------------FENLYKAFQYFDKDNN 425
             D D NG ID  E +      +KL++                  E + + F   D++ +
Sbjct: 102 IYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENGD 161

Query: 426 GYITVDELGKAFKDY 440
           G ++++E  +  +  
Sbjct: 162 GQLSLNEFVEGARRD 176

>d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 109

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

 Score = 93.4 bits (232), Expect = 9e-24
 Identities = 28/110 (25%), Positives = 51/110 (46%), Gaps = 5/110 (4%)

Query: 368 LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGY 427
              +L   D+K+ + A  +   G+ ++ +F      +       ++ K F+  D D +G+
Sbjct: 2   AKDLLKADDIKKALDA--VKAEGSFNHKKFFALVGLKAMSA--NDVKKVFKAIDADASGF 57

Query: 428 ITVDELGKAFKDYGM-GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           I  +EL    K +   G D T A  K  +   D+D DG+I  DEF +++ 
Sbjct: 58  IEEEELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGKIGIDEFETLVH 107

>d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 109

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

 Score = 56.5 bits (136), Expect = 1e-10
 Identities = 24/68 (35%), Positives = 36/68 (52%), Gaps = 3/68 (4%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKL---GSMLTEFDVKQYMQAADIDGNGTIDYI 395
             +K+ F  +D D SG +  +ELK  L      G  LT+ + K +++AAD DG+G I   
Sbjct: 41  NDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGKIGID 100

Query: 396 EFITATMQ 403
           EF T   +
Sbjct: 101 EFETLVHE 108

>d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 107

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

 Score = 92.7 bits (230), Expect = 2e-23
 Identities = 30/106 (28%), Positives = 49/106 (46%), Gaps = 5/106 (4%)

Query: 372 LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVD 431
           L + DV   + A       +  + EF        K    +++ KAF   D+D +G+I  D
Sbjct: 5   LKDADVAAALAACSAAD--SFKHKEFFAKVGLASK--SLDDVKKAFYVIDQDKSGFIEED 60

Query: 432 ELGKAFKDYGM-GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           EL    +++       T A  K  +++ D+D DG I  DEF +M+K
Sbjct: 61  ELKLFLQNFSPSARALTDAETKAFLADGDKDGDGMIGVDEFAAMIK 106

>d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 107

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

 Score = 54.2 bits (130), Expect = 6e-10
 Identities = 22/70 (31%), Positives = 34/70 (48%), Gaps = 3/70 (4%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM---LTEFDVKQYMQAADIDGN 389
           L ++ +  +K+ F  +D D SG +  DELK  L         LT+ + K ++   D DG+
Sbjct: 34  LASKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKDGD 93

Query: 390 GTIDYIEFIT 399
           G I   EF  
Sbjct: 94  GMIGVDEFAA 103

>d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 178

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Kchip1, Kv4 potassium channel-interacting protein
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 93.3 bits (231), Expect = 6e-23
 Identities = 32/152 (21%), Positives = 59/152 (38%), Gaps = 13/152 (8%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYM-QAADIDGNGTIDY 394
            E+Q L   F   +   SG +  +  K   A+            Y+  A D    G++ +
Sbjct: 13  RELQVLYRGF--KNECPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKF 70

Query: 395 IEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYG----------MGD 444
            +F+TA     +    E L   F  +D + +GYI  +E+    K             + +
Sbjct: 71  EDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKE 130

Query: 445 DATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           D     +     ++D++KDG ++ DEF    +
Sbjct: 131 DTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQ 162

>d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 178

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Kchip1, Kv4 potassium channel-interacting protein
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 49.4 bits (117), Expect = 1e-07
 Identities = 19/108 (17%), Positives = 45/108 (41%), Gaps = 12/108 (11%)

Query: 345 FTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR 404
           F   DT  +G++ +++    L+ L        ++      DI+ +G I+  E +      
Sbjct: 57  FNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEMMDIVKAI 116

Query: 405 HKLQRF------------ENLYKAFQYFDKDNNGYITVDELGKAFKDY 440
           + +               +++   FQ  DK+ +G +T+DE  ++ ++ 
Sbjct: 117 YDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQED 164

>d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 178

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Kchip1, Kv4 potassium channel-interacting protein
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.6 bits (94), Expect = 1e-04
 Identities = 17/95 (17%), Positives = 35/95 (36%), Gaps = 18/95 (18%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM------------LTEFDVKQYMQAADI 386
           +KL+  F   D +  G +  +E+   +  +  M                 V  + Q  D 
Sbjct: 87  EKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDK 146

Query: 387 DGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFD 421
           + +G +   EF+ +       Q  +N+ ++ Q F 
Sbjct: 147 NKDGIVTLDEFLES------CQEDDNIMRSLQLFQ 175

>d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 183

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin B-like protein 2
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

 Score = 93.5 bits (231), Expect = 7e-23
 Identities = 35/164 (21%), Positives = 66/164 (40%), Gaps = 11/164 (6%)

Query: 336 EEIQKLKEKFTEMDTD--NSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTID 393
            EI+ L E F ++ +   + G +  +E +  L K     + F   +     D   NG + 
Sbjct: 14  SEIEALYELFKKISSAVIDDGLINKEEFQLALFKTNKKESLF-ADRVFDLFDTKHNGILG 72

Query: 394 YIEFITATMQRH-KLQRFENLYKAFQYFDKDNNGYITVDELGKAFKD------YGMGDDA 446
           + EF  A    H      + ++ +FQ +D    G+I   E+ +            + D  
Sbjct: 73  FEEFARALSVFHPNAPIDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTV 132

Query: 447 TIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ-LRALSSRSL 489
               I +   E D   DG+I  +E+RS++      L+ ++ + L
Sbjct: 133 IEDIIDKTFEEADTKHDGKIDKEEWRSLVLRHPSLLKNMTLQYL 176

>d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} Length = 109

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Leopard shark (Triakis semifasciata) [TaxId: 30493]

 Score = 89.6 bits (222), Expect = 3e-22
 Identities = 30/110 (27%), Positives = 49/110 (44%), Gaps = 5/110 (4%)

Query: 368 LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGY 427
           +  +L   D+ + + A      GT DY  F    +   K +    + + F+  DKD +G+
Sbjct: 2   MTKVLKADDINKAISA--FKDPGTFDYKRFFH--LVGLKGKTDAQVKEVFEILDKDQSGF 57

Query: 428 ITVDELGKAFKDYGM-GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           I  +EL    K +   G D      K +++  D D DG+I  DEF  M+ 
Sbjct: 58  IEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKIGADEFAKMVA 107

>d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} Length = 109

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Leopard shark (Triakis semifasciata) [TaxId: 30493]

 Score = 55.0 bits (132), Expect = 3e-10
 Identities = 22/68 (32%), Positives = 31/68 (45%), Gaps = 3/68 (4%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKL---GSMLTEFDVKQYMQAADIDGNGTIDYI 395
            ++KE F  +D D SG +  +ELK  L      G  L + + K  + A D D +G I   
Sbjct: 41  AQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKIGAD 100

Query: 396 EFITATMQ 403
           EF     Q
Sbjct: 101 EFAKMVAQ 108

>d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 108

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Oncomodulin
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 88.9 bits (220), Expect = 4e-22
 Identities = 26/110 (23%), Positives = 46/110 (41%), Gaps = 5/110 (4%)

Query: 368 LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGY 427
           +  +L+  D+   +Q  +     T +  +F   +           +   F++ D D +GY
Sbjct: 2   ITDILSAEDIAAALQ--ECQDPDTFEPQKFFQTSGLSKM--SASQVKDIFRFIDNDQSGY 57

Query: 428 ITVDELGKAF-KDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           +  DEL     K      + T +  K +M   D D DG+I  DEF+ M+ 
Sbjct: 58  LDGDELKYFLQKFQSDARELTESETKSLMDAADNDGDGKIGADEFQEMVH 107

>d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 108

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Oncomodulin
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 56.5 bits (136), Expect = 1e-10
 Identities = 28/69 (40%), Positives = 34/69 (49%), Gaps = 3/69 (4%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL---GSMLTEFDVKQYMQAADIDGN 389
           L      ++K+ F  +D D SG L  DELK  L K       LTE + K  M AAD DG+
Sbjct: 35  LSKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADNDGD 94

Query: 390 GTIDYIEFI 398
           G I   EF 
Sbjct: 95  GKIGADEFQ 103

>d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} Length = 174

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Sandworm (Nereis diversicolor) [TaxId: 126592]

 Score = 89.7 bits (221), Expect = 1e-21
 Identities = 29/157 (18%), Positives = 51/157 (32%), Gaps = 20/157 (12%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLT-----------EFDVKQYMQAA 384
             +QK+K  F  +D D  G +T  + ++   +                            
Sbjct: 3   LWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLT 62

Query: 385 DIDGNGTIDYIEFITATMQRHKLQRFEN-----LYKAFQYFDKDNNGYITVDELGKAFKD 439
            + G   ID   FI +  +  K    ++     L   F+  D + +  I+ DE G  F  
Sbjct: 63  AVAGGKGIDETTFINSMKEMVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGM 122

Query: 440 YGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
            G+               +D + DG +S +EF     
Sbjct: 123 LGLDKT----MAPASFDAIDTNNDGLLSLEEFVIAGS 155

>d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} Length = 174

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Sandworm (Nereis diversicolor) [TaxId: 126592]

 Score = 47.7 bits (112), Expect = 4e-07
 Identities = 12/76 (15%), Positives = 21/76 (27%), Gaps = 9/76 (11%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSE---------VDRD 461
           + +   F   D D +G IT  +     + +    +      K +M               
Sbjct: 6   QKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVA 65

Query: 462 KDGRISYDEFRSMMKC 477
               I    F + MK 
Sbjct: 66  GGKGIDETTFINSMKE 81

>d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} Length = 174

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Sandworm (Nereis diversicolor) [TaxId: 126592]

 Score = 36.6 bits (83), Expect = 0.003
 Identities = 11/47 (23%), Positives = 21/47 (44%)

Query: 445 DATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRALSSRSLAH 491
           D  +  +K   + +D DKDG I+  +F SM +   +   + +     
Sbjct: 2   DLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKV 48

>d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} Length = 139

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.5 bits (218), Expect = 1e-21
 Identities = 28/140 (20%), Positives = 54/140 (38%), Gaps = 8/140 (5%)

Query: 341 LKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN-----GTIDYI 395
            KE F   D    G + Y +    +  LG   T  +V + +     D           ++
Sbjct: 2   FKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFL 61

Query: 396 EFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIM 455
             + A  +      +E+  + F+ FDK+ NG +   EL        +G+  T   ++ ++
Sbjct: 62  PMLQAVAKNRGQGTYEDYLEGFRVFDKEGNGKVMGAELRHVL--TTLGEKMTEEEVETVL 119

Query: 456 SEVDRDKDGRISYDEFRSMM 475
                D +G I+Y+ F   +
Sbjct: 120 -AGHEDSNGCINYEAFLKHI 138

>d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} Length = 139

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.3 bits (106), Expect = 2e-06
 Identities = 19/68 (27%), Positives = 31/68 (45%), Gaps = 1/68 (1%)

Query: 335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDY 394
               +   E F   D + +G +   EL+  L  LG  +TE +V+  + A   D NG I+Y
Sbjct: 73  QGTYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVET-VLAGHEDSNGCINY 131

Query: 395 IEFITATM 402
             F+   +
Sbjct: 132 EAFLKHIL 139

>d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} Length = 139

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (88), Expect = 5e-04
 Identities = 13/65 (20%), Positives = 25/65 (38%)

Query: 413 LYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFR 472
             +AF+ FD+  +G I   + G   +  G               + D  K  R+ ++ F 
Sbjct: 2   FKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFL 61

Query: 473 SMMKC 477
            M++ 
Sbjct: 62  PMLQA 66

>d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} Length = 176

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calerythrin
species: Saccharopolyspora erythraea [TaxId: 1836]

 Score = 89.3 bits (220), Expect = 2e-21
 Identities = 28/164 (17%), Positives = 52/164 (31%), Gaps = 27/164 (16%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSML---------------TEFDVKQY 380
               +LK++F   D D +G L   + +     +                           
Sbjct: 4   IASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYL 63

Query: 381 MQAADIDGNGTIDYIEFITATMQRHKLQRF--------ENLYKAFQYFDKDNNGYITVDE 432
            + A +  +G++   +FI  T      Q            +       DK+ +G I  DE
Sbjct: 64  AKEAGVGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADE 123

Query: 433 LGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
                   GM          E  ++VD + +G +S DE  + ++
Sbjct: 124 FAAWLTALGMSKA----EAAEAFNQVDTNGNGELSLDELLTAVR 163

>d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} Length = 109

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Rat (Rattus rattus) [TaxId: 10117]

 Score = 86.6 bits (214), Expect = 3e-21
 Identities = 29/110 (26%), Positives = 54/110 (49%), Gaps = 5/110 (4%)

Query: 368 LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGY 427
           +  +L+  D+K+ + A       + D+ +F      + K    +++ K F   DKD +G+
Sbjct: 2   MTDLLSAEDIKKAIGA--FTAADSFDHKKFFQMVGLKKKSA--DDVKKVFHILDKDKSGF 57

Query: 428 ITVDELGKAFKDYG-MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           I  DELG   K +     D +    K +M+  D+D DG+I  +EF +++ 
Sbjct: 58  IEEDELGSILKGFSSDARDLSAKETKTLMAAGDKDGDGKIGVEEFSTLVA 107

>d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} Length = 109

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Rat (Rattus rattus) [TaxId: 10117]

 Score = 55.8 bits (134), Expect = 2e-10
 Identities = 24/71 (33%), Positives = 33/71 (46%), Gaps = 3/71 (4%)

Query: 332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM---LTEFDVKQYMQAADIDG 388
            L  +    +K+ F  +D D SG +  DEL + L    S    L+  + K  M A D DG
Sbjct: 34  GLKKKSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDKDG 93

Query: 389 NGTIDYIEFIT 399
           +G I   EF T
Sbjct: 94  DGKIGVEEFST 104

>d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} Length = 187

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]

 Score = 87.7 bits (216), Expect = 8e-21
 Identities = 32/161 (19%), Positives = 54/161 (33%), Gaps = 23/161 (14%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAK-----LGSMLTEFDVKQYMQAADIDGNG 390
             I + K  F  +D +++G ++ DE+    +      LG+   +    +    A   G G
Sbjct: 9   RWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAG 68

Query: 391 T-----IDYIEFITATMQRHKLQR-----------FENLYKAFQYFDKDNNGYITVDELG 434
                  D+  +I    +    +                   F   DKD NG IT+DE  
Sbjct: 69  MKYGVETDWPAYIEGWKKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWK 128

Query: 435 KAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMM 475
              K    G   +    +E     D D+ G++  DE     
Sbjct: 129 AYTKA--AGIIQSSEDCEETFRVCDIDESGQLDVDEMTRQH 167

>d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} Length = 187

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]

 Score = 48.8 bits (115), Expect = 2e-07
 Identities = 23/86 (26%), Positives = 36/86 (41%)

Query: 318 MNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDV 377
             KL    L+   +N PT         F  +D D +G +T DE KA     G + +  D 
Sbjct: 84  WKKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDC 143

Query: 378 KQYMQAADIDGNGTIDYIEFITATMQ 403
           ++  +  DID +G +D  E     + 
Sbjct: 144 EETFRVCDIDESGQLDVDEMTRQHLG 169

>d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} Length = 187

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]

 Score = 43.0 bits (100), Expect = 2e-05
 Identities = 24/143 (16%), Positives = 42/143 (29%), Gaps = 13/143 (9%)

Query: 318 MNKLKKLALKVIVENLPTEEIQKLKEK--FTEMDTDNSGTLTYDELKAGLAKLGSM---- 371
           + K   + +  +       +  K   +  F            +     G  KL +     
Sbjct: 35  VYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGMKYGVETDWPAYIEGWKKLATDELEK 94

Query: 372 -------LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDN 424
                  L            D D NG I   E+   T     +Q  E+  + F+  D D 
Sbjct: 95  YAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDE 154

Query: 425 NGYITVDELGKAFKDYGMGDDAT 447
           +G + VDE+ +    +    D  
Sbjct: 155 SGQLDVDEMTRQHLGFWYTMDPA 177

>d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} Length = 188

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]

 Score = 86.3 bits (213), Expect = 2e-20
 Identities = 30/154 (19%), Positives = 59/154 (38%), Gaps = 19/154 (12%)

Query: 331 ENLPTEEI-QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEF--------DVKQYM 381
           + L  EEI    K  F+++  D+   ++  EL+  L ++ S   +           +  +
Sbjct: 11  KVLSEEEIDDNFKTLFSKLAGDD-MEISVKELQTILNRIISKHKDLRTNGFSLESCRSMV 69

Query: 382 QAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYG 441
              D DGNG +  +EF     +             F+ FD D +G ++  E+  A +  G
Sbjct: 70  NLMDRDGNGKLGLVEFNILWNRIRNYLTI------FRKFDLDKSGSMSAYEMRMAIEAAG 123

Query: 442 MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMM 475
                    + +++     D +  I +D F   +
Sbjct: 124 FKLP---CQLHQVIVARFADDELIIDFDNFVRCL 154

>d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} Length = 188

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]

 Score = 68.6 bits (167), Expect = 4e-14
 Identities = 24/91 (26%), Positives = 40/91 (43%), Gaps = 7/91 (7%)

Query: 342 KEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITAT 401
              F + D D SG+++  E++  +   G  L    + Q + A   D    ID+  F+   
Sbjct: 96  LTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPC-QLHQVIVARFADDELIIDFDNFVRCL 154

Query: 402 MQRHKLQRFENLYKAFQYFDKDNNGYITVDE 432
           +      R E L+K F+  D +N G I +D 
Sbjct: 155 V------RLEILFKIFKQLDPENTGTIQLDL 179

>d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} Length = 188

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]

 Score = 45.5 bits (107), Expect = 3e-06
 Identities = 13/78 (16%), Positives = 29/78 (37%), Gaps = 7/78 (8%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYG------MGDDATIATIKEIMSEVDRDKDG 464
           +N    F     D+   I+V EL                +  ++ + + +++ +DRD +G
Sbjct: 20  DNFKTLFSKLAGDD-MEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDRDGNG 78

Query: 465 RISYDEFRSMMKCGTQLR 482
           ++   EF  +        
Sbjct: 79  KLGLVEFNILWNRIRNYL 96

>d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} Length = 188

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]

 Score = 38.9 bits (90), Expect = 5e-04
 Identities = 11/79 (13%), Positives = 31/79 (39%), Gaps = 8/79 (10%)

Query: 326 LKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAAD 385
           +++ +E    +   +L +       D+   + +D     L +L  +   F      +  D
Sbjct: 115 MRMAIEAAGFKLPCQLHQVIVARFADDELIIDFDNFVRCLVRLEILFKIF------KQLD 168

Query: 386 IDGNG--TIDYIEFITATM 402
            +  G   +D I +++ ++
Sbjct: 169 PENTGTIQLDLISWLSFSV 187

>d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} Length = 180

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium- and integrin-binding protein, CIB
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.0 bits (212), Expect = 3e-20
 Identities = 25/154 (16%), Positives = 56/154 (36%), Gaps = 13/154 (8%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD----VKQYMQAADID-GNG 390
           +EI     +F E+      ++          +    L E       ++  +         
Sbjct: 14  QEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILSLPELKANPFKERICRVFSTSPAKD 73

Query: 391 TIDYIEFITA-TMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFK-------DYGM 442
           ++ + +F+   ++           + AF+ FD D++G +  ++L +          D  +
Sbjct: 74  SLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRL 133

Query: 443 GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
                   I  I+ E D D+DG I+  EF+ ++ 
Sbjct: 134 SASEMKQLIDNILEESDIDRDGTINLSEFQHVIS 167

>d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} Length = 201

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Recoverin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 86.0 bits (212), Expect = 4e-20
 Identities = 30/177 (16%), Positives = 64/177 (36%), Gaps = 17/177 (9%)

Query: 316 TAMNKLKKLALKVIVE--NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLT 373
           +    L K  L+ +        EE+    + F  +    SG +T  E +   +K      
Sbjct: 3   SKSGALSKEILEELQLNTKFTEEELSSWYQSF--LKECPSGRITRQEFQTIYSKFFPEAD 60

Query: 374 -EFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDE 432
            +   +   ++ D + +GT+D+ E++ A       +  + L  AF  +D D NG I+ +E
Sbjct: 61  PKAYAQHVFRSFDANSDGTLDFKEYVIALHMTSAGKTNQKLEWAFSLYDVDGNGTISKNE 120

Query: 433 LGKAFKDYG------------MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC 477
           + +                    ++      ++I     +  D +++  EF      
Sbjct: 121 VLEIVTAIFKMISPEDTKHLPEDENTPEKRAEKIWGFFGKKDDDKLTEKEFIEGTLA 177

>d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} Length = 201

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Recoverin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 43.7 bits (102), Expect = 1e-05
 Identities = 24/121 (19%), Positives = 41/121 (33%), Gaps = 17/121 (14%)

Query: 334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTID 393
           P    Q +   F   D ++ GTL + E    L    +  T   ++      D+DGNGTI 
Sbjct: 61  PKAYAQHV---FRSFDANSDGTLDFKEYVIALHMTSAGKTNQKLEWAFSLYDVDGNGTIS 117

Query: 394 YIEF--------------ITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKD 439
             E                T  +   +    +   K + +F K ++  +T  E  +    
Sbjct: 118 KNEVLEIVTAIFKMISPEDTKHLPEDENTPEKRAEKIWGFFGKKDDDKLTEKEFIEGTLA 177

Query: 440 Y 440
            
Sbjct: 178 N 178

>d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} Length = 201

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Recoverin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 40.2 bits (93), Expect = 2e-04
 Identities = 16/86 (18%), Positives = 34/86 (39%), Gaps = 14/86 (16%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD--------------VKQYMQAA 384
           QKL+  F+  D D +GT++ +E+   +  +  M++  D               ++     
Sbjct: 99  QKLEWAFSLYDVDGNGTISKNEVLEIVTAIFKMISPEDTKHLPEDENTPEKRAEKIWGFF 158

Query: 385 DIDGNGTIDYIEFITATMQRHKLQRF 410
               +  +   EFI  T+   ++ R 
Sbjct: 159 GKKDDDKLTEKEFIEGTLANKEILRL 184

>d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} Length = 189

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]

 Score = 84.3 bits (207), Expect = 1e-19
 Identities = 32/162 (19%), Positives = 54/162 (33%), Gaps = 23/162 (14%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAK-----LGSMLTEFDVKQYMQAAD----- 385
             I++ K  F  +D + +G +T DE+ +  +      L +   +    Q    A      
Sbjct: 11  RWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCG 70

Query: 386 IDGNGTIDYIEFITATMQRHKLQRF-----------ENLYKAFQYFDKDNNGYITVDELG 434
           ++    I + +F+    Q    +             E     F  FDKD +G IT+DE  
Sbjct: 71  MEYGKEIAFPQFLDGWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWK 130

Query: 435 KAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
              K    G   +    +      D D  G +  DE      
Sbjct: 131 AYGKI--SGISPSQEDCEATFRHCDLDNAGDLDVDEMTRQHL 170

>d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} Length = 189

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]

 Score = 46.5 bits (109), Expect = 1e-06
 Identities = 27/114 (23%), Positives = 39/114 (34%)

Query: 290 HPWLKESGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMD 349
           H    E+            I   +      +L    LK    N PT   +     F   D
Sbjct: 58  HQVCVEAFFRGCGMEYGKEIAFPQFLDGWKQLATSELKKWARNEPTLIREWGDAVFDIFD 117

Query: 350 TDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQ 403
            D SGT+T DE KA     G   ++ D +   +  D+D  G +D  E     + 
Sbjct: 118 KDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDLDVDEMTRQHLG 171

>d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} Length = 189

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]

 Score = 37.3 bits (85), Expect = 0.002
 Identities = 21/140 (15%), Positives = 41/140 (29%), Gaps = 13/140 (9%)

Query: 321 LKKLALKVIVENLPTEEIQK--LKEKFTEMDTDNSGTLTYDELKAGLAKLGSM------- 371
                   +       +  +  ++  F     +    + + +   G  +L +        
Sbjct: 40  ASDDICAKLEATPEQTKRHQVCVEAFFRGCGMEYGKEIAFPQFLDGWKQLATSELKKWAR 99

Query: 372 ----LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGY 427
               L            D DG+GTI   E+             E+    F++ D DN G 
Sbjct: 100 NEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGD 159

Query: 428 ITVDELGKAFKDYGMGDDAT 447
           + VDE+ +    +    D  
Sbjct: 160 LDVDEMTRQHLGFWYTLDPE 179

>d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 185

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

 Score = 84.3 bits (207), Expect = 1e-19
 Identities = 18/169 (10%), Positives = 51/169 (30%), Gaps = 29/169 (17%)

Query: 333 LPTEEIQKLKEKFTEM-DTDNSGTLTYDELKAGLAKLGSMLT---------------EFD 376
           L   + QK+K  F    D ++ G++  ++ +  + +   +                 E +
Sbjct: 2   LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDE 61

Query: 377 VKQYMQAADIDGNGTIDY---------IEFITATMQRHKLQRFENLYKAFQYFDKDNNGY 427
            +     ADI+ +  + +               ++          +   F+  D   +G 
Sbjct: 62  WRDLKGRADINKDDVVSWEEYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGI 121

Query: 428 ITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           + ++E     K++ +      A    I              + ++ +  
Sbjct: 122 VDLEEFQNYCKNFQLQCADVPAVYNVI----TDGGKVTFDLNRYKELYY 166

>d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 185

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

 Score = 44.6 bits (104), Expect = 6e-06
 Identities = 13/117 (11%), Positives = 36/117 (30%), Gaps = 11/117 (9%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD---------VKQYMQAADIDGN 389
            + ++     D +    ++++E  A   K  +               +    +  D+ G+
Sbjct: 60  DEWRDLKGRADINKDDVVSWEEYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGD 119

Query: 390 GTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDA 446
           G +D  EF     +  +LQ   ++   +            ++   + +        A
Sbjct: 120 GIVDLEEFQNY-CKNFQLQC-ADVPAVYNVITDGGKVTFDLNRYKELYYRLLTSPAA 174

>d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 185

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

 Score = 42.3 bits (98), Expect = 3e-05
 Identities = 13/73 (17%), Positives = 21/73 (28%), Gaps = 2/73 (2%)

Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
            +LP     ++   F  MD    G +  +E +         L   DV          G  
Sbjct: 97  ADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCADVPAVYNVITDGGKV 154

Query: 391 TIDYIEFITATMQ 403
           T D   +     +
Sbjct: 155 TFDLNRYKELYYR 167

>d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 185

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

 Score = 41.1 bits (95), Expect = 8e-05
 Identities = 12/83 (14%), Positives = 33/83 (39%), Gaps = 15/83 (18%)

Query: 408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI-------------ATIKEI 454
           Q+ +  +  F   D +++G I  ++       Y   +  ++                +++
Sbjct: 8   QKIKFTFDFF--LDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDL 65

Query: 455 MSEVDRDKDGRISYDEFRSMMKC 477
               D +KD  +S++E+ +M + 
Sbjct: 66  KGRADINKDDVVSWEEYLAMWEK 88

>d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 87

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

 Score = 76.9 bits (189), Expect = 4e-18
 Identities = 45/76 (59%), Positives = 55/76 (72%)

Query: 327 KVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADI 386
           K + E L  EEI  LKE F  +DTDNSGT+T+DELK GL ++GS L E ++K  M AADI
Sbjct: 11  KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADI 70

Query: 387 DGNGTIDYIEFITATM 402
           D +GTIDY EFI AT+
Sbjct: 71  DKSGTIDYGEFIAATV 86

>d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 87

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

 Score = 65.7 bits (160), Expect = 3e-14
 Identities = 29/88 (32%), Positives = 41/88 (46%), Gaps = 4/88 (4%)

Query: 388 GNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
            +G ID  +   A  +R   +    L + F+  D DN+G IT DEL    K  G   +  
Sbjct: 2   SSGHIDDDDKHMA--ERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGS--ELM 57

Query: 448 IATIKEIMSEVDRDKDGRISYDEFRSMM 475
            + IK++M   D DK G I Y EF +  
Sbjct: 58  ESEIKDLMDAADIDKSGTIDYGEFIAAT 85

>d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} Length = 172

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Sorcin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.2 bits (192), Expect = 1e-17
 Identities = 31/157 (19%), Positives = 54/157 (34%), Gaps = 16/157 (10%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLG-----SMLTEFDVKQYMQAADID 387
            P +    L   F  +     G +  DEL+  L + G             +  +   D D
Sbjct: 1   FPGQTQDPLYGYFAAVA-GQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRD 59

Query: 388 GNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
            +GT+ + EF       +         + F  FD D +G +   EL KA     MG   +
Sbjct: 60  MSGTMGFNEFKELWAVLN------GWRQHFISFDTDRSGTVDPQELQKALTT--MGFRLS 111

Query: 448 IATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRAL 484
              +  I        +G+I++D++ +       L   
Sbjct: 112 PQAVNSIAKRYST--NGKITFDDYIACCVKLRALTDS 146

>d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} Length = 172

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Sorcin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.4 bits (138), Expect = 2e-10
 Identities = 20/89 (22%), Positives = 35/89 (39%), Gaps = 8/89 (8%)

Query: 343 EKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATM 402
           + F   DTD SGT+   EL+  L  +G  L+   V    +    +G   I + ++I   +
Sbjct: 81  QHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRYSTNGK--ITFDDYIACCV 138

Query: 403 QRHKLQRFENLYKAFQYFDKDNNGYITVD 431
                 +   L  +F+  D    G +   
Sbjct: 139 ------KLRALTDSFRRRDTAQQGVVNFP 161

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 78.3 bits (192), Expect = 2e-17
 Identities = 41/209 (19%), Positives = 66/209 (31%), Gaps = 35/209 (16%)

Query: 35  YTIGREVGRGEFGITYLCTENSTGLEFACK-------SIPKRKLVKDVEKDDVRRE---- 83
             IG+ +G G+    + C  +    E   K       S  K K  +D             
Sbjct: 2   DAIGKLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 84  ----IEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASV 139
                  ++ L G   + +  A   +     ++MEL    E                  V
Sbjct: 61  ARNEFRALQKLQG-LAVPKVYAWEGN----AVLMELIDAKE-------LYRVRVENPDEV 108

Query: 140 FRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAYREIVGS 199
             +I+  V   + +G++H DL   N L +       +   DF  S  + E      +   
Sbjct: 109 LDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG----IWIIDFPQSVEVGEEGWREILERD 164

Query: 200 PYYIAPEVLSQSYGKEADIWSAGVILYIL 228
              I     S++Y  E DI S   I  IL
Sbjct: 165 VRNII-TYFSRTYRTEKDINS--AIDRIL 190

>d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} Length = 165

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Grancalcin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.3 bits (190), Expect = 2e-17
 Identities = 26/130 (20%), Positives = 49/130 (37%), Gaps = 15/130 (11%)

Query: 351 DNSGTLTYDELKAGLAKLG-----SMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH 405
              G +  +EL+  L + G     S  +    +  +   D D  G + +  F       +
Sbjct: 11  GQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFKELWAALN 70

Query: 406 KLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGR 465
             +        F   D+D +G +   EL +A     MG   +  T+  I+      K+GR
Sbjct: 71  AWKEN------FMTVDQDGSGTVEHHELRQAIGL--MGYRLSPQTLTTIVKRY--SKNGR 120

Query: 466 ISYDEFRSMM 475
           I +D++ +  
Sbjct: 121 IFFDDYVACC 130

>d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} Length = 165

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Grancalcin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.4 bits (159), Expect = 3e-13
 Identities = 17/87 (19%), Positives = 34/87 (39%), Gaps = 8/87 (9%)

Query: 345 FTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR 404
           F  +D D SGT+ + EL+  +  +G  L+   +   ++      NG I + +++   +  
Sbjct: 76  FMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVK--RYSKNGRIFFDDYVACCV-- 131

Query: 405 HKLQRFENLYKAFQYFDKDNNGYITVD 431
               +   L   F+  D    G     
Sbjct: 132 ----KLRALTDFFRKRDHLQQGSANFI 154

>d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} Length = 165

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Grancalcin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.9 bits (124), Expect = 1e-08
 Identities = 12/66 (18%), Positives = 31/66 (46%), Gaps = 5/66 (7%)

Query: 417 FQYFDK--DNNGYITVDELGKAFKDYGMGDDAT---IATIKEIMSEVDRDKDGRISYDEF 471
           + YF      +G +  +EL +     G+    +   + T + +++ +DRD  G++ ++ F
Sbjct: 3   YTYFSAVAGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAF 62

Query: 472 RSMMKC 477
           + +   
Sbjct: 63  KELWAA 68

>d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} Length = 165

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Grancalcin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (92), Expect = 2e-04
 Identities = 14/82 (17%), Positives = 33/82 (40%), Gaps = 13/82 (15%)

Query: 323 KLALKVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQ 382
           + A+ ++   L  + +  + +++       +G + +D+  A   KL ++   F      +
Sbjct: 93  RQAIGLMGYRLSPQTLTTIVKRY-----SKNGRIFFDDYVACCVKLRALTDFF------R 141

Query: 383 AADIDGNG--TIDYIEFITATM 402
             D    G     Y +F+  TM
Sbjct: 142 KRDHLQQGSANFIYDDFLQGTM 163

>d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} Length = 186

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), M-type [TaxId: 10116]

 Score = 77.1 bits (189), Expect = 4e-17
 Identities = 24/148 (16%), Positives = 54/148 (36%), Gaps = 18/148 (12%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD--------VKQYMQAADID 387
           +     +  F ++       ++  EL+  L ++ +   +           K  +   D D
Sbjct: 15  DIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDED 73

Query: 388 GNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
           G+G +   EF     +  K Q+       ++  D D +G +   E+ KA ++ G      
Sbjct: 74  GSGKLGLKEFYILWTKIQKYQKI------YREIDVDRSGTMNSYEMRKALEEAGFKLP-- 125

Query: 448 IATIKEIMSEVDRDKDGRISYDEFRSMM 475
              + +++     D +  I +D F   +
Sbjct: 126 -CQLHQVIVARFADDELIIDFDNFVRCL 152

>d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} Length = 186

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), M-type [TaxId: 10116]

 Score = 62.5 bits (151), Expect = 5e-12
 Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 7/94 (7%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFI 398
           QK ++ + E+D D SGT+   E++  L + G  L    + Q + A   D    ID+  F+
Sbjct: 91  QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQ-LHQVIVARFADDELIIDFDNFV 149

Query: 399 TATMQRHKLQRFENLYKAFQYFDKDNNGYITVDE 432
              +      R E L+K F+  D +N G I +D 
Sbjct: 150 RCLV------RLEILFKIFKQLDPENTGTIQLDL 177

>d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} Length = 186

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), M-type [TaxId: 10116]

 Score = 46.3 bits (109), Expect = 2e-06
 Identities = 15/96 (15%), Positives = 34/96 (35%), Gaps = 7/96 (7%)

Query: 395 IEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM------GDDATI 448
           IE     ++ ++    +   + F       +  I+  EL    +           D  +I
Sbjct: 2   IEANIEEIEANEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSI 60

Query: 449 ATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRAL 484
            T K ++  +D D  G++   EF  +     + + +
Sbjct: 61  ETCKIMVDMLDEDGSGKLGLKEFYILWTKIQKYQKI 96

>d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 152

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

 Score = 75.5 bits (184), Expect = 8e-17
 Identities = 31/151 (20%), Positives = 57/151 (37%), Gaps = 7/151 (4%)

Query: 333 LPTEEIQKLKEKFTEMDT--DNSGTLTYDELKAGLAKLGSMLTEFDVKQ-YMQAADIDGN 389
           L  +EI  LK+ F   D      G +   +L      LG      DV          + +
Sbjct: 1   LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVGGTHKMGEKS 60

Query: 390 GTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIA 449
              +        +   +   F +  +AF+ FD++  G+I+  EL        +G+  +  
Sbjct: 61  LPFEEFLPAYEGLMDCEQGTFADYMEAFKTFDREGQGFISGAELRHVL--TALGERLSDE 118

Query: 450 TIKEIMSEVD--RDKDGRISYDEFRSMMKCG 478
            + EI+   D   D +G + Y++F   +  G
Sbjct: 119 DVDEIIKLTDLQEDLEGNVKYEDFVKKVMAG 149

>d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 140

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Cdc4p
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 74.7 bits (182), Expect = 1e-16
 Identities = 28/141 (19%), Positives = 54/141 (38%), Gaps = 4/141 (2%)

Query: 335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDY 394
           + +    K+ F+  D   +G +    +   L   G   T  ++ +       + +    +
Sbjct: 1   STDDSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIESTLPAEVD-MEQF 59

Query: 395 IEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI 454
           ++ +            E   K FQ FDKD  G I V EL        +G+  +   + E+
Sbjct: 60  LQVLNRPNGFDMPGDPEEFVKGFQVFDKDATGMIGVGELRYVL--TSLGEKLSNEEMDEL 117

Query: 455 MSEVDRDKDGRISYDEFRSMM 475
           +  V    DG ++Y +F  M+
Sbjct: 118 LKGVPVK-DGMVNYHDFVQMI 137

>d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 140

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Cdc4p
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 35.4 bits (80), Expect = 0.004
 Identities = 13/75 (17%), Positives = 22/75 (29%), Gaps = 1/75 (1%)

Query: 411 ENLYK-AFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYD 469
           ++ YK AF  FD+   G I    +G   +  G        T  E     + D +  +   
Sbjct: 4   DSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIESTLPAEVDMEQFLQVL 63

Query: 470 EFRSMMKCGTQLRAL 484
              +           
Sbjct: 64  NRPNGFDMPGDPEEF 78

>d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} Length = 165

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin regulatory subunit (B-chain)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.1 bits (183), Expect = 1e-16
 Identities = 45/145 (31%), Positives = 76/145 (52%), Gaps = 8/145 (5%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYI 395
           +EI++L ++F ++D DNSG+L+ +E  +      + L    V++ +   D DGNG +D+ 
Sbjct: 13  DEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQNPL----VQRVIDIFDTDGNGEVDFK 68

Query: 396 EFITATMQRHKLQRFEN-LYKAFQYFDKDNNGYITVDELG---KAFKDYGMGDDATIATI 451
           EFI    Q       E  L  AF+ +D D +GYI+  EL    K      + D      +
Sbjct: 69  EFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIV 128

Query: 452 KEIMSEVDRDKDGRISYDEFRSMMK 476
            + +   D+D DGRIS++EF +++ 
Sbjct: 129 DKTIINADKDGDGRISFEEFCAVVG 153

>d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 142

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

 Score = 74.3 bits (181), Expect = 1e-16
 Identities = 29/145 (20%), Positives = 69/145 (47%), Gaps = 8/145 (5%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           LP ++IQ++KE F+ +D D  G ++ +++KA   +LG    + ++   ++    +  G +
Sbjct: 1   LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK----EAPGPL 56

Query: 393 DYIEFITATMQRHKLQRFENLYKA-FQYFDKDNNGYITVDELGKAFKDYGMGDDATIATI 451
           ++  F++    +      E   +  F  FD+     + ++ +    ++  MGD+     +
Sbjct: 57  NFTMFLSIFSDKLSGTDSEETIRNAFAMFDEQETKKLNIEYIKDLLEN--MGDNFNKDEM 114

Query: 452 KEIMSEVDRDKDGRISYDEFRSMMK 476
           +    E   +  G+  Y +F +M+K
Sbjct: 115 RMTFKEAPVE-GGKFDYVKFTAMIK 138

>d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 77

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Caltractin (centrin 2)
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 72.2 bits (177), Expect = 2e-16
 Identities = 26/66 (39%), Positives = 43/66 (65%), Gaps = 2/66 (3%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE 470
           E + KAF+ FD DN+G IT+ +L +  K+  +G++ T   ++E+++E DR+ D  I  DE
Sbjct: 9   EEILKAFRLFDDDNSGTITIKDLRRVAKE--LGENLTEEELQEMIAEADRNDDNEIDEDE 66

Query: 471 FRSMMK 476
           F  +MK
Sbjct: 67  FIRIMK 72

>d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 77

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Caltractin (centrin 2)
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 61.4 bits (149), Expect = 9e-13
 Identities = 23/72 (31%), Positives = 41/72 (56%), Gaps = 1/72 (1%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYI 395
           +  +++ + F   D DNSGT+T  +L+    +LG  LTE ++++ +  AD + +  ID  
Sbjct: 6   DSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDED 65

Query: 396 EFITATMQRHKL 407
           EFI   M++  L
Sbjct: 66  EFIRI-MKKTSL 76

>d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 77

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Caltractin (centrin 2)
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 39.9 bits (93), Expect = 3e-05
 Identities = 11/60 (18%), Positives = 25/60 (41%)

Query: 373 TEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDE 432
           +  ++ +  +  D D +GTI   +      +  +    E L +     D++++  I  DE
Sbjct: 7   SREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDE 66

>d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 68

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

 Score = 71.8 bits (176), Expect = 2e-16
 Identities = 22/66 (33%), Positives = 34/66 (51%), Gaps = 1/66 (1%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE 470
           E + +AF+ FD + +G I  DE     +  G  +  T A ++E M E D D +G I   E
Sbjct: 2   EEILRAFKVFDANGDGVIDFDEFKFIMQKVG-EEPLTDAEVEEAMKEADEDGNGVIDIPE 60

Query: 471 FRSMMK 476
           F  ++K
Sbjct: 61  FMDLIK 66

>d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 68

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

 Score = 61.8 bits (150), Expect = 5e-13
 Identities = 22/67 (32%), Positives = 39/67 (58%), Gaps = 2/67 (2%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM-LTEFDVKQYMQAADIDGNGTIDYIEF 397
           +++   F   D +  G + +DE K  + K+G   LT+ +V++ M+ AD DGNG ID  EF
Sbjct: 2   EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEF 61

Query: 398 ITATMQR 404
           +   +++
Sbjct: 62  MDL-IKK 67

>d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Light Chain Mlc1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 74.0 bits (180), Expect = 2e-16
 Identities = 35/144 (24%), Positives = 57/144 (39%), Gaps = 9/144 (6%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGN-------GT 391
           +  K+ FT  D    G +  D L   L  +G   T   V+  + A     +         
Sbjct: 2   RANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLDQI 61

Query: 392 IDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATI 451
              IE     +      + E+  KAFQ FDK++ G ++V +L       G     T A +
Sbjct: 62  TGLIEVNEKELDATTKAKTEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGE--KLTDAEV 119

Query: 452 KEIMSEVDRDKDGRISYDEFRSMM 475
            E++  V+ D +G I Y +F   +
Sbjct: 120 DELLKGVEVDSNGEIDYKKFIEDV 143

>d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Light Chain Mlc1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 37.0 bits (84), Expect = 0.001
 Identities = 18/69 (26%), Positives = 39/69 (56%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYI 395
            + +   + F   D +++G ++  +L+  L  LG  LT+ +V + ++  ++D NG IDY 
Sbjct: 78  AKTEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYK 137

Query: 396 EFITATMQR 404
           +FI   +++
Sbjct: 138 KFIEDVLRQ 146

>d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Light Chain Mlc1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 35.8 bits (81), Expect = 0.004
 Identities = 6/26 (23%), Positives = 12/26 (46%)

Query: 451 IKEIMSEVDRDKDGRISYDEFRSMMK 476
            K+I +  D+   G I+ D     ++
Sbjct: 4   NKDIFTLFDKKGQGAIAKDSLGDYLR 29

>d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} Length = 134

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: EHCABP
species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]

 Score = 72.8 bits (177), Expect = 3e-16
 Identities = 35/134 (26%), Positives = 65/134 (48%), Gaps = 9/134 (6%)

Query: 345 FTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFIT---AT 401
           F E+D +  G ++Y+E+KA ++K  ++  E  ++   ++ D DGNG ID  EF     + 
Sbjct: 6   FKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSI 65

Query: 402 MQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRD 461
             +        L   ++  D D +G +T +E+   FK +G+        + E + + D +
Sbjct: 66  QGQDLSDDKIGLKVLYKLMDVDGDGKLTKEEVTSFFKKHGIEK------VAEQVMKADAN 119

Query: 462 KDGRISYDEFRSMM 475
            DG I+ +EF    
Sbjct: 120 GDGYITLEEFLEFS 133

>d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 75

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 70.3 bits (172), Expect = 6e-16
 Identities = 24/66 (36%), Positives = 40/66 (60%), Gaps = 2/66 (3%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE 470
           E L   F+ FDK+ +G+I ++ELG+  +  G         I+++M + D++ DGRI +DE
Sbjct: 9   EELANCFRIFDKNADGFIDIEELGEILRATGEHV--IEEDIEDLMKDSDKNNDGRIDFDE 66

Query: 471 FRSMMK 476
           F  MM+
Sbjct: 67  FLKMME 72

>d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 75

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 57.2 bits (138), Expect = 2e-11
 Identities = 17/61 (27%), Positives = 31/61 (50%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFI 398
           ++L   F   D +  G +  +EL   L   G  + E D++  M+ +D + +G ID+ EF+
Sbjct: 9   EELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNNDGRIDFDEFL 68

Query: 399 T 399
            
Sbjct: 69  K 69

>d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} Length = 78

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Pig (Sus scrofa) [TaxId: 9823]

 Score = 69.9 bits (171), Expect = 1e-15
 Identities = 14/72 (19%), Positives = 36/72 (50%), Gaps = 2/72 (2%)

Query: 411 ENLYKAFQYFD--KDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISY 468
             L   F+ +   + +   ++ +EL +  +           T+ ++  E+D++ DG +S+
Sbjct: 7   AELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSF 66

Query: 469 DEFRSMMKCGTQ 480
           +EF+ ++K  +Q
Sbjct: 67  EEFQVLVKKISQ 78

>d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} Length = 78

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Pig (Sus scrofa) [TaxId: 9823]

 Score = 53.7 bits (129), Expect = 5e-10
 Identities = 13/68 (19%), Positives = 26/68 (38%), Gaps = 4/68 (5%)

Query: 336 EEIQKLKEKFTEMDT--DNSGTLTYDELKAGLAKLGS--MLTEFDVKQYMQAADIDGNGT 391
           +   +LK  F +      +   L+ +ELK  +       +     +    Q  D +G+G 
Sbjct: 4   KSPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGE 63

Query: 392 IDYIEFIT 399
           + + EF  
Sbjct: 64  VSFEEFQV 71

>d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} Length = 81

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]

 Score = 68.1 bits (166), Expect = 4e-15
 Identities = 27/66 (40%), Positives = 39/66 (59%), Gaps = 2/66 (3%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE 470
           E L   F+ FDK+ +GYI ++EL    +    G+  T   I+E+M + D++ DGRI YDE
Sbjct: 15  EELSDLFRMFDKNADGYIDLEELKIMLQA--TGETITEDDIEELMKDGDKNNDGRIDYDE 72

Query: 471 FRSMMK 476
           F   MK
Sbjct: 73  FLEFMK 78

>d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} Length = 81

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]

 Score = 55.0 bits (132), Expect = 2e-10
 Identities = 20/61 (32%), Positives = 34/61 (55%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFI 398
           ++L + F   D +  G +  +ELK  L   G  +TE D+++ M+  D + +G IDY EF+
Sbjct: 15  EELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFL 74

Query: 399 T 399
            
Sbjct: 75  E 75

>d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} Length = 81

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]

 Score = 41.5 bits (97), Expect = 1e-05
 Identities = 14/60 (23%), Positives = 27/60 (45%)

Query: 373 TEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDE 432
           TE ++    +  D + +G ID  E         +    +++ +  +  DK+N+G I  DE
Sbjct: 13  TEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDE 72

>d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} Length = 170

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Phospholipase C-beta-2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.8 bits (173), Expect = 5e-15
 Identities = 12/142 (8%), Positives = 35/142 (24%), Gaps = 17/142 (11%)

Query: 348 MDTDNSGTLTYDELKAGLAKLGSML--TEFDVKQYMQAADIDGNGTIDYIEFITATMQRH 405
           M  ++ G +               +              D           + +      
Sbjct: 16  MQLNSEGKIPVKNFFQMFPADRKRVEAALSACHLPKGKNDAINPEDFPEPVYKSFL---M 72

Query: 406 KLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYG--------MGDDATIATIKEIMSE 457
            L     + + F  +      Y+T + L K              +   A    ++ ++ +
Sbjct: 73  SLCPRPEIDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDK 132

Query: 458 VDRD----KDGRISYDEFRSMM 475
            +      + G++S +     +
Sbjct: 133 YEPSGINAQRGQLSPEGMVWFL 154

>d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} Length = 170

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Phospholipase C-beta-2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.5 bits (115), Expect = 2e-07
 Identities = 9/70 (12%), Positives = 19/70 (27%), Gaps = 2/70 (2%)

Query: 413 LYKAFQ--YFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE 470
           L K         ++ G I V    + F       +A ++       + D           
Sbjct: 7   LDKILVKLKMQLNSEGKIPVKNFFQMFPADRKRVEAALSACHLPKGKNDAINPEDFPEPV 66

Query: 471 FRSMMKCGTQ 480
           ++S +     
Sbjct: 67  YKSFLMSLCP 76

>d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 67

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin-related protein T21P5.17
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

 Score = 66.5 bits (162), Expect = 1e-14
 Identities = 17/62 (27%), Positives = 32/62 (51%), Gaps = 2/62 (3%)

Query: 415 KAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSM 474
           + F+ FDK+ +G +++DE  +           T   I +   E+D D +G ++ DEF S 
Sbjct: 5   RVFEKFDKNKDGKLSLDEFREVALA--FSPYFTQEDIVKFFEEIDVDGNGELNADEFTSC 62

Query: 475 MK 476
           ++
Sbjct: 63  IE 64

>d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 67

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin-related protein T21P5.17
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

 Score = 56.5 bits (136), Expect = 3e-11
 Identities = 16/64 (25%), Positives = 32/64 (50%), Gaps = 1/64 (1%)

Query: 341 LKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITA 400
            K  F + D +  G L+ DE +          T+ D+ ++ +  D+DGNG ++  EF + 
Sbjct: 3   AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSC 62

Query: 401 TMQR 404
            +++
Sbjct: 63  -IEK 65

>d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 67

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin-related protein T21P5.17
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

 Score = 44.2 bits (104), Expect = 1e-06
 Identities = 14/63 (22%), Positives = 25/63 (39%)

Query: 376 DVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGK 435
             K+  +  D + +G +   EF    +        E++ K F+  D D NG +  DE   
Sbjct: 2   SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTS 61

Query: 436 AFK 438
             +
Sbjct: 62  CIE 64

>d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} Length = 321

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
species: Physarum polycephalum [TaxId: 5791]

 Score = 72.7 bits (177), Expect = 1e-14
 Identities = 17/84 (20%), Positives = 35/84 (41%), Gaps = 1/84 (1%)

Query: 392 IDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATI 451
            D  + +  +   H       L   + + D D +G ++ +E+ K  +D  +  ++     
Sbjct: 234 EDESDDVGFSEYVHLGLCLLVLRILYAFADFDKSGQLSKEEVQKVLEDAHI-PESARKKF 292

Query: 452 KEIMSEVDRDKDGRISYDEFRSMM 475
           +   S VD D    +SY EF  ++
Sbjct: 293 EHQFSVVDVDDSKSLSYQEFVMLV 316

>d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} Length = 321

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
species: Physarum polycephalum [TaxId: 5791]

 Score = 72.4 bits (176), Expect = 2e-14
 Identities = 34/264 (12%), Positives = 74/264 (28%), Gaps = 35/264 (13%)

Query: 248 LKGEINFQRDPFPSISSSAIELVRRM---LTQDPKRRITVAQVLEHPWLKE--------- 295
           +   +   +      S +  E   R+   + Q  + +       +     E         
Sbjct: 17  VHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAER 76

Query: 296 --SGEASDKPIDTAVIFRMKQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTDNS 353
                  D   +   +  + +    +      L+     L  E+   L++ F       S
Sbjct: 77  EREAARGDAAAEKQRLASLLKDLEDDASGYNRLRPSKPMLSEEDTNILRQLFLSSAVSGS 136

Query: 354 GTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENL 413
           G  ++ +LK  LAK    + E  +K+     + D  G + YI  +        L      
Sbjct: 137 GKFSFQDLKQVLAKYADTIPEGPLKKLFVMVENDTKGRMSYITLVAVANDLAALVADFRK 196

Query: 414 YKAFQY---------------------FDKDNNGYITVDELGKAFKDYGMGDDATIATIK 452
                                             Y   DE         +     +  ++
Sbjct: 197 IDTNSNGTLSRKEFREHFVRLGFDKKSVQDALFRYADEDESDDVGFSEYVHLGLCLLVLR 256

Query: 453 EIMSEVDRDKDGRISYDEFRSMMK 476
            + +  D DK G++S +E + +++
Sbjct: 257 ILYAFADFDKSGQLSKEEVQKVLE 280

>d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} Length = 321

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
species: Physarum polycephalum [TaxId: 5791]

 Score = 49.2 bits (116), Expect = 4e-07
 Identities = 12/55 (21%), Positives = 23/55 (41%), Gaps = 1/55 (1%)

Query: 345 FTEMDTDNSGTLTYDELKAGLAKLG-SMLTEFDVKQYMQAADIDGNGTIDYIEFI 398
           +   D D SG L+ +E++  L             +      D+D + ++ Y EF+
Sbjct: 259 YAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFV 313

>d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 77

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 66.6 bits (162), Expect = 2e-14
 Identities = 26/76 (34%), Positives = 41/76 (53%)

Query: 331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG 390
            NL  E+I + KE F   D DN+G+++  EL   +  LG   +E +V   M   D+DGN 
Sbjct: 2   SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNH 61

Query: 391 TIDYIEFITATMQRHK 406
            I++ EF+    ++ K
Sbjct: 62  QIEFSEFLALMSRQLK 77

>d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 77

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 61.6 bits (149), Expect = 9e-13
 Identities = 22/65 (33%), Positives = 37/65 (56%), Gaps = 2/65 (3%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE 470
               +AF  FDKDNNG I+  EL    +   +G   + A + ++M+E+D D + +I + E
Sbjct: 10  AEFKEAFALFDKDNNGSISSSELATVMRS--LGLSPSEAEVNDLMNEIDVDGNHQIEFSE 67

Query: 471 FRSMM 475
           F ++M
Sbjct: 68  FLALM 72

>d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} Length = 173

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain small (regulatory) subunit (domain VI)
species: Pig (Sus scrofa) [TaxId: 9823]

 Score = 69.2 bits (168), Expect = 2e-14
 Identities = 25/148 (16%), Positives = 55/148 (37%), Gaps = 18/148 (12%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD--------VKQYMQAADID 387
           EE+++ +  F ++  D+   ++  EL   L K+ +   +           +  +   D D
Sbjct: 1   EEVRQFRRLFAQLAGDD-MEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSD 59

Query: 388 GNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT 447
             G + +         ++     +     ++ FD D +G I   EL  AF+         
Sbjct: 60  TTGKLGF------EEFKYLWNNIKKWQAIYKQFDVDRSGTIGSSELPGAFEAA---GFHL 110

Query: 448 IATIKEIMSEVDRDKDGRISYDEFRSMM 475
              +  ++     D+ G + +D F S +
Sbjct: 111 NEHLYSMIIRRYSDEGGNMDFDNFISCL 138

>d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} Length = 173

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain small (regulatory) subunit (domain VI)
species: Pig (Sus scrofa) [TaxId: 9823]

 Score = 60.3 bits (145), Expect = 2e-11
 Identities = 23/91 (25%), Positives = 40/91 (43%), Gaps = 7/91 (7%)

Query: 342 KEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITAT 401
           +  + + D D SGT+   EL       G  L E      ++    D  G +D+  FI+  
Sbjct: 80  QAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRRYS-DEGGNMDFDNFISCL 138

Query: 402 MQRHKLQRFENLYKAFQYFDKDNNGYITVDE 432
           ++       + +++AF+  DKD  G I V+ 
Sbjct: 139 VRL------DAMFRAFKSLDKDGTGQIQVNI 163

>d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} Length = 76

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 65.7 bits (160), Expect = 3e-14
 Identities = 22/76 (28%), Positives = 41/76 (53%), Gaps = 2/76 (2%)

Query: 407 LQRFENLYKAFQYFDKD--NNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDG 464
           ++  E +  AF+ F     +   I+ +EL    +  G      ++T+ E++ EVD++ DG
Sbjct: 1   MKSPEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDG 60

Query: 465 RISYDEFRSMMKCGTQ 480
            +S++EF  MMK  +Q
Sbjct: 61  EVSFEEFLVMMKKISQ 76

>d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} Length = 76

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 49.9 bits (119), Expect = 9e-09
 Identities = 16/66 (24%), Positives = 31/66 (46%), Gaps = 3/66 (4%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLT--EFDVKQYMQAADIDGNGTID 393
           EEI+   E F      +   ++ +ELK  +  LG  L      + + ++  D +G+G + 
Sbjct: 5   EEIKGAFEVF-AAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVS 63

Query: 394 YIEFIT 399
           + EF+ 
Sbjct: 64  FEEFLV 69

>d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} Length = 81

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Polcalcin
domain: Polcalcin Che a 3
species: Pigweed (Chenopodium album) [TaxId: 3559]

 Score = 65.0 bits (158), Expect = 6e-14
 Identities = 22/66 (33%), Positives = 35/66 (53%), Gaps = 3/66 (4%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE 470
            +  + F+ FD + +G I+  ELG A K        T   ++ +M+E+D D DG IS+DE
Sbjct: 6   ADRERIFKRFDTNGDGKISSSELGDALKTL---GSVTPDEVRRMMAEIDTDGDGFISFDE 62

Query: 471 FRSMMK 476
           F    +
Sbjct: 63  FTDFAR 68

>d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} Length = 81

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Polcalcin
domain: Polcalcin Che a 3
species: Pigweed (Chenopodium album) [TaxId: 3559]

 Score = 62.6 bits (152), Expect = 3e-13
 Identities = 24/82 (29%), Positives = 39/82 (47%), Gaps = 3/82 (3%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYI 395
           ++I   +  F   DT+  G ++  EL   L  LGS+ T  +V++ M   D DG+G I + 
Sbjct: 3   QDIADRERIFKRFDTNGDGKISSSELGDALKTLGSV-TPDEVRRMMAEIDTDGDGFISFD 61

Query: 396 EFITATMQRHKLQRFENLYKAF 417
           EF      R      +++ K F
Sbjct: 62  EFT--DFARANRGLVKDVSKIF 81

>d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} Length = 81

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Polcalcin
domain: Polcalcin Che a 3
species: Pigweed (Chenopodium album) [TaxId: 3559]

 Score = 39.5 bits (92), Expect = 5e-05
 Identities = 16/79 (20%), Positives = 34/79 (43%), Gaps = 5/79 (6%)

Query: 376 DVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGK 435
           D ++  +  D +G+G I   E   A ++       + + +     D D +G+I+ DE   
Sbjct: 7   DRERIFKRFDTNGDGKISSSELGDA-LKTLGSVTPDEVRRMMAEIDTDGDGFISFDE--- 62

Query: 436 AFKDYGMGDDATIATIKEI 454
            F D+   +   +  + +I
Sbjct: 63  -FTDFARANRGLVKDVSKI 80

>d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} Length = 65

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 63.9 bits (155), Expect = 9e-14
 Identities = 26/65 (40%), Positives = 40/65 (61%), Gaps = 2/65 (3%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE 470
           E + +AF+ FDKD NGYI+  EL     +  +G+  T   + E++ E D D DG+++Y+E
Sbjct: 3   EEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDEEVDEMIREADIDGDGQVNYEE 60

Query: 471 FRSMM 475
           F  MM
Sbjct: 61  FVQMM 65

>d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} Length = 65

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 55.4 bits (133), Expect = 9e-11
 Identities = 21/61 (34%), Positives = 39/61 (63%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFI 398
           ++++E F   D D +G ++  EL+  +  LG  LT+ +V + ++ ADIDG+G ++Y EF+
Sbjct: 3   EEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFV 62

Query: 399 T 399
            
Sbjct: 63  Q 63

>d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 81

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 64.2 bits (156), Expect = 1e-13
 Identities = 23/74 (31%), Positives = 38/74 (51%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E I + K  F   D D  G ++  EL   +  LG   T+ ++   ++  D DG+GTI
Sbjct: 8   LSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTI 67

Query: 393 DYIEFITATMQRHK 406
           D+ EF+   +++ K
Sbjct: 68  DFEEFLVMMVRQMK 81

>d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 81

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 62.7 bits (152), Expect = 4e-13
 Identities = 23/65 (35%), Positives = 30/65 (46%), Gaps = 2/65 (3%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE 470
                AF  FD D  G I+  ELG   +  G   + T   +  I+ EVD D  G I ++E
Sbjct: 14  AEFKAAFDMFDADGGGDISTKELGTVMRMLGQ--NPTKEELDAIIEEVDEDGSGTIDFEE 71

Query: 471 FRSMM 475
           F  MM
Sbjct: 72  FLVMM 76

>d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} Length = 82

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

 Score = 63.5 bits (154), Expect = 2e-13
 Identities = 21/74 (28%), Positives = 36/74 (48%), Gaps = 1/74 (1%)

Query: 327 KVIVENLPTEEIQKLKEKFTEMDTDNS-GTLTYDELKAGLAKLGSMLTEFDVKQYMQAAD 385
           K  VE L  E+  + K  F         G+++  EL   +  LG   T  ++++ +   D
Sbjct: 3   KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVD 62

Query: 386 IDGNGTIDYIEFIT 399
            DG+GT+D+ EF+ 
Sbjct: 63  EDGSGTVDFDEFLV 76

>d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} Length = 82

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

 Score = 58.1 bits (140), Expect = 1e-11
 Identities = 22/66 (33%), Positives = 32/66 (48%), Gaps = 3/66 (4%)

Query: 411 ENLYKAFQYFDKDN-NGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYD 469
                AF  F     +G I+  ELGK  +  G   + T   ++E++ EVD D  G + +D
Sbjct: 15  NEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQ--NPTPEELQEMIDEVDEDGSGTVDFD 72

Query: 470 EFRSMM 475
           EF  MM
Sbjct: 73  EFLVMM 78

>d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} Length = 98

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a13 [TaxId: 9606]

 Score = 62.6 bits (152), Expect = 6e-13
 Identities = 9/67 (13%), Positives = 29/67 (43%), Gaps = 2/67 (2%)

Query: 411 ENLYKAFQ-YFDKD-NNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISY 468
           E +   F  +  ++     ++V+E  +            + ++ E M  +D ++D  + +
Sbjct: 14  ETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKF 73

Query: 469 DEFRSMM 475
           +E+  ++
Sbjct: 74  NEYWRLI 80

>d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} Length = 98

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a13 [TaxId: 9606]

 Score = 46.0 bits (109), Expect = 3e-07
 Identities = 9/68 (13%), Positives = 27/68 (39%), Gaps = 4/68 (5%)

Query: 336 EEIQKLKEKFTEMDT--DNSGTLTYDELKAGLAKLG--SMLTEFDVKQYMQAADIDGNGT 391
           E I+ +   F           +L+ +E K  + +     +     + + M++ D++ +  
Sbjct: 11  ESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSE 70

Query: 392 IDYIEFIT 399
           + + E+  
Sbjct: 71  LKFNEYWR 78

>d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} Length = 83

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: DJ-1-binding protein, DJBP
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.9 bits (147), Expect = 1e-12
 Identities = 14/78 (17%), Positives = 28/78 (35%), Gaps = 2/78 (2%)

Query: 398 ITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSE 457
           I A + +     +  + + F+ FD      I+ +E              T      + +E
Sbjct: 7   ILARLHKAVTSHYHAITQEFENFDTMKTNTISREEFRAIC--NRRVQILTDEQFDRLWNE 64

Query: 458 VDRDKDGRISYDEFRSMM 475
           +  +  GR+ Y +F S  
Sbjct: 65  MPVNAKGRLKYPDFLSRF 82

>d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} Length = 83

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: DJ-1-binding protein, DJBP
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.4 bits (130), Expect = 3e-10
 Identities = 12/66 (18%), Positives = 30/66 (45%)

Query: 335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDY 394
           T     + ++F   DT  + T++ +E +A   +   +LT+    +      ++  G + Y
Sbjct: 16  TSHYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKY 75

Query: 395 IEFITA 400
            +F++ 
Sbjct: 76  PDFLSR 81

>d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} Length = 73

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Rattus norvegicus [TaxId: 10116]

 Score = 60.8 bits (147), Expect = 2e-12
 Identities = 28/72 (38%), Positives = 41/72 (56%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           L  E+I + KE F+  D D  GT+T  EL   +  LG   TE +++  +   D DGNGTI
Sbjct: 2   LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTI 61

Query: 393 DYIEFITATMQR 404
           D+ EF+T   ++
Sbjct: 62  DFPEFLTMMARK 73

>d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} Length = 73

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Rattus norvegicus [TaxId: 10116]

 Score = 59.2 bits (143), Expect = 5e-12
 Identities = 25/65 (38%), Positives = 38/65 (58%), Gaps = 2/65 (3%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE 470
               +AF  FDKD +G IT  ELG   +  G   + T A ++++++EVD D +G I + E
Sbjct: 8   AEFKEAFSLFDKDGDGTITTKELGTVMRSLGQ--NPTEAELQDMINEVDADGNGTIDFPE 65

Query: 471 FRSMM 475
           F +MM
Sbjct: 66  FLTMM 70

>d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} Length = 93

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a4 [TaxId: 9606]

 Score = 61.0 bits (148), Expect = 2e-12
 Identities = 12/78 (15%), Positives = 30/78 (38%), Gaps = 5/78 (6%)

Query: 408 QRFENLYKAFQ-YFDKDNNGY-ITVDELGKAFKDYGMG---DDATIATIKEIMSEVDRDK 462
           +  + +   F  Y  K+ + + +   EL +                A  +++MS +D ++
Sbjct: 6   KALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNR 65

Query: 463 DGRISYDEFRSMMKCGTQ 480
           D  + + E+   + C   
Sbjct: 66  DNEVDFQEYCVFLSCIAM 83

>d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} Length = 93

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a4 [TaxId: 9606]

 Score = 48.3 bits (115), Expect = 6e-08
 Identities = 11/71 (15%), Positives = 24/71 (33%), Gaps = 7/71 (9%)

Query: 336 EEIQKLKEKFTEMDT--DNSGTLTYDELKAGLAKLGS-----MLTEFDVKQYMQAADIDG 388
           + +  +   F +      +   L   ELK  L +           E   ++ M   D + 
Sbjct: 6   KALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNR 65

Query: 389 NGTIDYIEFIT 399
           +  +D+ E+  
Sbjct: 66  DNEVDFQEYCV 76

>d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} Length = 182

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Programmed cell death 6 protein-like protein
species: Leishmania major [TaxId: 5664]

 Score = 63.1 bits (152), Expect = 3e-12
 Identities = 29/147 (19%), Positives = 58/147 (39%), Gaps = 8/147 (5%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYI 395
            + Q+L E F  +DTD SG ++  EL A L+  G   +    ++ +   D + +G I + 
Sbjct: 15  NDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGEITFD 74

Query: 396 EFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIM 455
           EF         ++       +      D+N                 G   +  T + +M
Sbjct: 75  EFKDLHHFILSMREGFRKRDSSGDGRLDSNEVRAALL--------SSGYQVSEQTFQALM 126

Query: 456 SEVDRDKDGRISYDEFRSMMKCGTQLR 482
            + DR + G + +D++  +     ++R
Sbjct: 127 RKFDRQRRGSLGFDDYVELSIFVCRVR 153

>d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} Length = 182

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Programmed cell death 6 protein-like protein
species: Leishmania major [TaxId: 5664]

 Score = 47.0 bits (110), Expect = 9e-07
 Identities = 9/65 (13%), Positives = 27/65 (41%), Gaps = 6/65 (9%)

Query: 367 KLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNG 426
             G  ++E   +  M+  D    G++ + +++  ++          +   F ++D++  G
Sbjct: 112 SSGYQVSEQTFQALMRKFDRQRRGSLGFDDYVELSI------FVCRVRNVFAFYDRERTG 165

Query: 427 YITVD 431
            +T  
Sbjct: 166 QVTFT 170

>d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} Length = 92

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]

 Score = 60.4 bits (146), Expect = 3e-12
 Identities = 16/76 (21%), Positives = 34/76 (44%), Gaps = 4/76 (5%)

Query: 408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYG---MGDDATIATIKEIMSEVDRDKDG 464
              E +   F  F  D  GY+T ++L    +      + +      + +IM ++D+ +DG
Sbjct: 6   HAMETMMFTFHKFAGDK-GYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDG 64

Query: 465 RISYDEFRSMMKCGTQ 480
           ++ +  F S++   T 
Sbjct: 65  KVGFQSFFSLIAGLTI 80

>d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} Length = 92

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]

 Score = 46.1 bits (109), Expect = 3e-07
 Identities = 12/69 (17%), Positives = 26/69 (37%), Gaps = 6/69 (8%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGS-----MLTEFDVKQYMQAADIDGNG 390
             ++ +   F +   D  G LT ++L+  + K              V + M+  D   +G
Sbjct: 6   HAMETMMFTFHKFAGDK-GYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDG 64

Query: 391 TIDYIEFIT 399
            + +  F +
Sbjct: 65  KVGFQSFFS 73

>d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} Length = 93

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a3 [TaxId: 9606]

 Score = 60.2 bits (146), Expect = 4e-12
 Identities = 14/80 (17%), Positives = 28/80 (35%), Gaps = 5/80 (6%)

Query: 407 LQRFENLYKAFQ-YFDKDNNGY-ITVDELGKAFKDYGMG---DDATIATIKEIMSEVDRD 461
            Q    +   FQ Y  +  + Y +   EL +  +         +       + MS +D +
Sbjct: 5   EQAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTN 64

Query: 462 KDGRISYDEFRSMMKCGTQL 481
           KD  + + E+   + C    
Sbjct: 65  KDCEVDFVEYVRSLACLCLY 84

>d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} Length = 93

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a3 [TaxId: 9606]

 Score = 38.7 bits (90), Expect = 1e-04
 Identities = 14/71 (19%), Positives = 27/71 (38%), Gaps = 7/71 (9%)

Query: 336 EEIQKLKEKFTE-MDTDNSG-TLTYDELKAGLAKLGS-----MLTEFDVKQYMQAADIDG 388
           + +  +   F E          L   ELK  L K  +        E D  ++M   D + 
Sbjct: 6   QAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNK 65

Query: 389 NGTIDYIEFIT 399
           +  +D++E++ 
Sbjct: 66  DCEVDFVEYVR 76

>d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} Length = 87

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]

 Score = 59.5 bits (144), Expect = 5e-12
 Identities = 11/72 (15%), Positives = 24/72 (33%), Gaps = 3/72 (4%)

Query: 411 ENLYKAFQ-YFDKDNNGYI-TVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISY 468
            ++   +  Y     N +    D+L K  +                  E+D + DG +++
Sbjct: 10  NSIIDVYHKYSLIKGNFHAVYRDDLKKLLETE-SPQYIRKKGADVWFKELDINTDGAVNF 68

Query: 469 DEFRSMMKCGTQ 480
            EF  ++     
Sbjct: 69  QEFLILVIKMGV 80

>d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} Length = 87

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]

 Score = 40.2 bits (94), Expect = 3e-05
 Identities = 9/67 (13%), Positives = 28/67 (41%), Gaps = 3/67 (4%)

Query: 336 EEIQKLKEKFTE-MDTDNSG-TLTYDELKAGLAKL-GSMLTEFDVKQYMQAADIDGNGTI 392
           + +  + + + +      +   +  D+LK  L       + +     + +  DI+ +G +
Sbjct: 7   KALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAV 66

Query: 393 DYIEFIT 399
           ++ EF+ 
Sbjct: 67  NFQEFLI 73

>d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} Length = 99

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Nucleobindin 1 (CALNUC)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.7 bits (144), Expect = 7e-12
 Identities = 13/89 (14%), Positives = 29/89 (32%), Gaps = 14/89 (15%)

Query: 402 MQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYG--------------MGDDAT 447
                     N    F   D +++G +   EL   F                    ++  
Sbjct: 7   ELDGLDPNRFNPKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEER 66

Query: 448 IATIKEIMSEVDRDKDGRISYDEFRSMMK 476
           +   + +M  VD ++D  ++ +EF +  +
Sbjct: 67  LRMREHVMKNVDTNQDRLVTLEEFLASTQ 95

>d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} Length = 99

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Nucleobindin 1 (CALNUC)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.4 bits (120), Expect = 1e-08
 Identities = 14/80 (17%), Positives = 27/80 (33%), Gaps = 16/80 (20%)

Query: 341 LKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLT----------------EFDVKQYMQAA 384
            K  F   D ++ G L   EL+A   K    +                     +  M+  
Sbjct: 18  PKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNV 77

Query: 385 DIDGNGTIDYIEFITATMQR 404
           D + +  +   EF+ +T ++
Sbjct: 78  DTNQDRLVTLEEFLASTQRK 97

>d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} Length = 61

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 58.1 bits (140), Expect = 9e-12
 Identities = 21/61 (34%), Positives = 35/61 (57%), Gaps = 2/61 (3%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDE 470
           E+  KAFQ FDK++ G ++V +L        +G+  T A + E++  V+ D +G I Y +
Sbjct: 1   EDFVKAFQVFDKESTGKVSVGDLRYMLTG--LGEKLTDAEVDELLKGVEVDSNGEIDYKK 58

Query: 471 F 471
           F
Sbjct: 59  F 59

>d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} Length = 61

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 52.7 bits (126), Expect = 6e-10
 Identities = 18/59 (30%), Positives = 34/59 (57%)

Query: 340 KLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFI 398
              + F   D +++G ++  +L+  L  LG  LT+ +V + ++  ++D NG IDY +FI
Sbjct: 2   DFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFI 60

>d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} Length = 93

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]

 Score = 58.4 bits (141), Expect = 2e-11
 Identities = 15/75 (20%), Positives = 30/75 (40%), Gaps = 5/75 (6%)

Query: 411 ENLYKAFQ-YFDKD-NNGYITVDELGKAFKDYG---MGDDATIATIKEIMSEVDRDKDGR 465
           E L   F  +  K+ +   ++  EL    +      +        + +IM E+D + DG 
Sbjct: 9   ETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGE 68

Query: 466 ISYDEFRSMMKCGTQ 480
           + + EF  ++   T 
Sbjct: 69  VDFQEFVVLVAALTV 83

>d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} Length = 93

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]

 Score = 44.5 bits (105), Expect = 1e-06
 Identities = 16/71 (22%), Positives = 27/71 (38%), Gaps = 7/71 (9%)

Query: 336 EEIQKLKEKFTEMDT--DNSGTLTYDELKAGLAKLGSM-----LTEFDVKQYMQAADIDG 388
             ++ L   F        +   L+  ELK  L    S           V + M+  D +G
Sbjct: 6   TAMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENG 65

Query: 389 NGTIDYIEFIT 399
           +G +D+ EF+ 
Sbjct: 66  DGEVDFQEFVV 76

>d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} Length = 181

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Apoptosis-linked protein alg-2
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 60.9 bits (146), Expect = 2e-11
 Identities = 18/144 (12%), Positives = 41/144 (28%), Gaps = 7/144 (4%)

Query: 332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGT 391
                +   L   F  +D D SG ++ +EL+  L+            + +  +  D    
Sbjct: 12  GAALPDQSFLWNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSII-SMFDRENK 70

Query: 392 IDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATI 451
                     + ++            +      +               G G   +    
Sbjct: 71  AGVNFSEFTGVWKYITDWQNVFRTYDRDNSGMIDKNELKQ------ALSGFGYRLSDQFH 124

Query: 452 KEIMSEVDRDKDGRISYDEFRSMM 475
             ++ + DR   G+I++D+F    
Sbjct: 125 DILIRKFDRQGRGQIAFDDFIQGC 148

>d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} Length = 181

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Apoptosis-linked protein alg-2
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 52.8 bits (125), Expect = 9e-09
 Identities = 15/66 (22%), Positives = 27/66 (40%), Gaps = 6/66 (9%)

Query: 367 KLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNG 426
             G  L++      ++  D  G G I + +FI   +        + L   F+ +D D +G
Sbjct: 114 GFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCI------VLQRLTDIFRRYDTDQDG 167

Query: 427 YITVDE 432
           +I V  
Sbjct: 168 WIQVSY 173

>d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} Length = 181

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Apoptosis-linked protein alg-2
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 36.2 bits (82), Expect = 0.004
 Identities = 11/63 (17%), Positives = 23/63 (36%), Gaps = 8/63 (12%)

Query: 339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNG--TIDYIE 396
           Q       + D    G + +D+   G   L  +   F      +  D D +G   + Y +
Sbjct: 122 QFHDILIRKFDRQGRGQIAFDDFIQGCIVLQRLTDIF------RRYDTDQDGWIQVSYEQ 175

Query: 397 FIT 399
           +++
Sbjct: 176 YLS 178

>d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} Length = 89

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a6 [TaxId: 9606]

 Score = 57.2 bits (138), Expect = 4e-11
 Identities = 14/73 (19%), Positives = 33/73 (45%), Gaps = 3/73 (4%)

Query: 411 ENLYKAFQ-YFDKDNNGY-ITVDELGKAFKD-YGMGDDATIATIKEIMSEVDRDKDGRIS 467
             L   F  Y  ++ + + ++  EL +  +    +G     A I  +M ++DR+KD  ++
Sbjct: 9   GLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVN 68

Query: 468 YDEFRSMMKCGTQ 480
           + E+ + +     
Sbjct: 69  FQEYVTFLGALAL 81

>d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} Length = 89

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a6 [TaxId: 9606]

 Score = 38.3 bits (89), Expect = 2e-04
 Identities = 16/69 (23%), Positives = 34/69 (49%), Gaps = 5/69 (7%)

Query: 336 EEIQKLKEKFTEM-DTDNSG-TLTYDELKAGLAK---LGSMLTEFDVKQYMQAADIDGNG 390
           + I  L   F +    +    TL+  ELK  + K   +GS L + ++ + M+  D + + 
Sbjct: 6   QAIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQ 65

Query: 391 TIDYIEFIT 399
            +++ E++T
Sbjct: 66  EVNFQEYVT 74

>d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} Length = 99

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 52.0 bits (124), Expect = 4e-09
 Identities = 13/62 (20%), Positives = 24/62 (38%), Gaps = 4/62 (6%)

Query: 415 KAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSM 474
           K ++  +  N G +   +     K  G+ D      + +I    D D  G +S  EF   
Sbjct: 15  KYYRQVEAGNTGRVLALDAAAFLKKSGLPDL----ILGKIWDLADTDGKGVLSKQEFFVA 70

Query: 475 MK 476
           ++
Sbjct: 71  LR 72

>d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} Length = 99

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 40.0 bits (93), Expect = 6e-05
 Identities = 14/56 (25%), Positives = 24/56 (42%), Gaps = 2/56 (3%)

Query: 345 FTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITA 400
           + +++  N+G +   +  A L K G       + +    AD DG G +   EF  A
Sbjct: 17  YRQVEAGNTGRVLALDAAAFLKKSGLPDLI--LGKIWDLADTDGKGVLSKQEFFVA 70

>d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} Length = 95

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.6 bits (123), Expect = 4e-09
 Identities = 14/68 (20%), Positives = 24/68 (35%), Gaps = 2/68 (2%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           +   E  K  E F + D D  G ++  E++     L + L    +       D    G +
Sbjct: 4   VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREI--FLKTGLPSTLLAHIWSLCDTKDCGKL 61

Query: 393 DYIEFITA 400
              +F  A
Sbjct: 62  SKDQFALA 69

>d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} Length = 95

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.6 bits (123), Expect = 4e-09
 Identities = 16/78 (20%), Positives = 33/78 (42%), Gaps = 7/78 (8%)

Query: 399 TATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEV 458
           T  +   +  +++ +   F   DKD +G+++  E+ + F   G+        +  I S  
Sbjct: 1   TWVVSPAEKAKYDEI---FLKTDKDMDGFVSGLEVREIFLKTGLPST----LLAHIWSLC 53

Query: 459 DRDKDGRISYDEFRSMMK 476
           D    G++S D+F     
Sbjct: 54  DTKDCGKLSKDQFALAFH 71

>d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} Length = 87

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]

 Score = 50.9 bits (122), Expect = 5e-09
 Identities = 14/75 (18%), Positives = 31/75 (41%), Gaps = 5/75 (6%)

Query: 411 ENLYKAFQ-YFDKDNNGY-ITVDELGKAFKD---YGMGDDATIATIKEIMSEVDRDKDGR 465
           E +   F  Y  +  +   ++  EL +         + +    A I EI   +D ++D +
Sbjct: 8   EGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQ 67

Query: 466 ISYDEFRSMMKCGTQ 480
           + + EF S++    +
Sbjct: 68  VDFQEFISLVAIALK 82

>d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} Length = 87

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]

 Score = 39.0 bits (91), Expect = 9e-05
 Identities = 15/71 (21%), Positives = 31/71 (43%), Gaps = 7/71 (9%)

Query: 336 EEIQKLKEKFTEMDT--DNSGTLTYDELKAGLAKLG-----SMLTEFDVKQYMQAADIDG 388
           E ++ +   F +      +  TL+  ELK  L K       ++  +  + +  Q  D + 
Sbjct: 5   EHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQ 64

Query: 389 NGTIDYIEFIT 399
           +  +D+ EFI+
Sbjct: 65  DEQVDFQEFIS 75

>d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} Length = 95

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.6 bits (118), Expect = 2e-08
 Identities = 17/68 (25%), Positives = 30/68 (44%), Gaps = 3/68 (4%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           +  E+  K    F  +    +G L+ D++K  L      L    + +  + +DID +G +
Sbjct: 4   VKPEDKAKYDAIFDSLS-PVNGFLSGDKVKPVLLNSK--LPVDILGRVWELSDIDHDGML 60

Query: 393 DYIEFITA 400
           D  EF  A
Sbjct: 61  DRDEFAVA 68

>d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} Length = 95

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (114), Expect = 7e-08
 Identities = 12/76 (15%), Positives = 30/76 (39%), Gaps = 8/76 (10%)

Query: 401 TMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDR 460
            ++     +++ ++ +        NG+++ D++     +  +  D     +  +    D 
Sbjct: 3   AVKPEDKAKYDAIFDSLS----PVNGFLSGDKVKPVLLNSKLPVD----ILGRVWELSDI 54

Query: 461 DKDGRISYDEFRSMMK 476
           D DG +  DEF   M 
Sbjct: 55  DHDGMLDRDEFAVAMF 70

>d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} Length = 100

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]

 Score = 49.2 bits (117), Expect = 3e-08
 Identities = 12/72 (16%), Positives = 27/72 (37%), Gaps = 7/72 (9%)

Query: 411 ENLYKAFQYFDK--DNNGYITVDELGKAFKD-----YGMGDDATIATIKEIMSEVDRDKD 463
            ++      F K    +  I    L    K+         D      + ++  + D+++D
Sbjct: 7   RSIIGMIDMFHKYTRRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNED 66

Query: 464 GRISYDEFRSMM 475
            +I + EF S++
Sbjct: 67  KKIDFSEFLSLL 78

>d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} Length = 100

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]

 Score = 41.1 bits (96), Expect = 2e-05
 Identities = 8/71 (11%), Positives = 21/71 (29%), Gaps = 8/71 (11%)

Query: 336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM-------LTEFDVKQYMQAADIDG 388
             I  + + F +        +    L   + +                +    +  D + 
Sbjct: 7   RSIIGMIDMFHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNE 65

Query: 389 NGTIDYIEFIT 399
           +  ID+ EF++
Sbjct: 66  DKKIDFSEFLS 76

>d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 92

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Reps1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 48.1 bits (114), Expect = 7e-08
 Identities = 15/68 (22%), Positives = 27/68 (39%), Gaps = 2/68 (2%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           +  E+ Q    +F  +  D +G +     K    K  S L   ++    + +D D +G +
Sbjct: 3   ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTK--SKLPILELSHIWELSDFDKDGAL 60

Query: 393 DYIEFITA 400
              EF  A
Sbjct: 61  TLDEFCAA 68

>d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 92

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Reps1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 46.2 bits (109), Expect = 3e-07
 Identities = 17/76 (22%), Positives = 28/76 (36%), Gaps = 7/76 (9%)

Query: 401 TMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDR 460
            +   + Q + N    F+    D NG+I      + F    +        +  I    D 
Sbjct: 2   KITDEQRQYYVNQ---FKTIQPDLNGFIPGSAAKEFFTKSKLPIL----ELSHIWELSDF 54

Query: 461 DKDGRISYDEFRSMMK 476
           DKDG ++ DEF +   
Sbjct: 55  DKDGALTLDEFCAAFH 70

>d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} Length = 33

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

 Score = 41.0 bits (97), Expect = 4e-06
 Identities = 14/31 (45%), Positives = 19/31 (61%)

Query: 411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYG 441
           E + +AF+ FDKD NGYI+  EL     + G
Sbjct: 3   EEIREAFRVFDKDGNGYISAAELRHVMTNLG 33

>d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} Length = 110

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Pob1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.5 bits (102), Expect = 4e-06
 Identities = 13/68 (19%), Positives = 27/68 (39%), Gaps = 2/68 (2%)

Query: 333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTI 392
           +  E+ +    +F  +  D S  ++    K       S L+  ++    + +D D +G +
Sbjct: 16  ITEEQREYYVNQFRSLQPDPSSFISGSVAKN--FFTKSKLSIPELSYIWELSDADCDGAL 73

Query: 393 DYIEFITA 400
              EF  A
Sbjct: 74  TLPEFCAA 81

>d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} Length = 110

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Pob1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.1 bits (101), Expect = 5e-06
 Identities = 12/76 (15%), Positives = 25/76 (32%), Gaps = 7/76 (9%)

Query: 401 TMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDR 460
            +   + + + N    F+    D + +I+       F    +        +  I    D 
Sbjct: 15  RITEEQREYYVNQ---FRSLQPDPSSFISGSVAKNFFTKSKLSIP----ELSYIWELSDA 67

Query: 461 DKDGRISYDEFRSMMK 476
           D DG ++  EF +   
Sbjct: 68  DCDGALTLPEFCAAFH 83

>d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} Length = 95

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]

 Score = 38.2 bits (89), Expect = 2e-04
 Identities = 16/70 (22%), Positives = 31/70 (44%), Gaps = 5/70 (7%)

Query: 411 ENLYKAFQ-YFDKD-NNGYITVDELGKAFKD---YGMGDDATIATIKEIMSEVDRDKDGR 465
           E+L   FQ +  +D NN  I+  E              +      +  +M ++D D DG+
Sbjct: 9   ESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQ 68

Query: 466 ISYDEFRSMM 475
           + + EF +++
Sbjct: 69  LDFQEFLNLI 78

>d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} Length = 95

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]

 Score = 34.3 bits (79), Expect = 0.004
 Identities = 9/53 (16%), Positives = 22/53 (41%), Gaps = 5/53 (9%)

Query: 352 NSGTLTYDELKAGLAK-----LGSMLTEFDVKQYMQAADIDGNGTIDYIEFIT 399
           N+  ++  E    +         +      + + M+  D+D +G +D+ EF+ 
Sbjct: 24  NNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFLN 76

>d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} Length = 90

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Cow (Bos taurus), s100b [TaxId: 9913]

 Score = 36.6 bits (85), Expect = 6e-04
 Identities = 12/72 (16%), Positives = 28/72 (38%), Gaps = 5/72 (6%)

Query: 411 ENLYKAFQ-YFDKD-NNGYITVDELGKAFKD---YGMGDDATIATIKEIMSEVDRDKDGR 465
             L   F  Y  ++ +   +   EL +   +   + + +      + ++M  +D D DG 
Sbjct: 9   VALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGE 68

Query: 466 ISYDEFRSMMKC 477
             + EF + +  
Sbjct: 69  CDFQEFMAFVAM 80

>d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} Length = 90

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Cow (Bos taurus), s100b [TaxId: 9913]

 Score = 34.3 bits (79), Expect = 0.004
 Identities = 14/54 (25%), Positives = 23/54 (42%), Gaps = 5/54 (9%)

Query: 351 DNSGTLTYDELKAGLAK-----LGSMLTEFDVKQYMQAADIDGNGTIDYIEFIT 399
            +   L   ELK  +       L  +  +  V + M+  D DG+G  D+ EF+ 
Sbjct: 23  GDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMA 76

>d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]} Length = 83

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]

 Score = 35.4 bits (82), Expect = 0.001
 Identities = 14/63 (22%), Positives = 30/63 (47%), Gaps = 5/63 (7%)

Query: 418 QYFDKD-NNGYITVDEL----GKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFR 472
           QY  K  +   +   E      K  +++   ++     I+ IM ++D + D ++S++EF 
Sbjct: 18  QYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFI 77

Query: 473 SMM 475
            +M
Sbjct: 78  MLM 80

>d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} Length = 94

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100p [TaxId: 9606]

 Score = 35.1 bits (81), Expect = 0.002
 Identities = 10/73 (13%), Positives = 27/73 (36%), Gaps = 7/73 (9%)

Query: 411 ENLYKAFQ-YFDKDNNGY-ITVDEL----GKAFKDYGMGDDATIATIKEIMSEVDRDKDG 464
             +   F  Y   + +   +T  EL     K    + +        + +++ ++D + D 
Sbjct: 9   GMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGF-LQSGKDKDAVDKLLKDLDANGDA 67

Query: 465 RISYDEFRSMMKC 477
           ++ + EF   +  
Sbjct: 68  QVDFSEFIVFVAA 80

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	494
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1exra_	146	Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI	99.9
d1wdcb_	142	Myosin Essential Chain {Bay scallop (Aequipecten i	99.89
d1lkja_	146	Calmodulin {Baker's yeast (Saccharomyces cerevisia	99.88
d2obha1	141	Calmodulin {Human (Homo sapiens) [TaxId: 9606]}	99.87
d1wdcc_	152	Myosin Regulatory Chain {Bay scallop (Aequipecten	99.87
d1topa_	162	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	99.87
d1dtla_	156	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	99.86
d2mysc_	145	Myosin Regulatory Chain {Chicken (Gallus gallus) [	99.86
d2mysb_	145	Myosin Essential Chain {Chicken (Gallus gallus) [T	99.85
d1s6ia_	182	Calcium-dependent protein kinase sk5 CLD {Soybean	99.85
d1ggwa_	140	Cdc4p {Fission yeast (Schizosaccharomyces pombe) [	99.84
d1m45a_	146	Myosin Light Chain Mlc1p {Baker's yeast (Saccharom	99.84
d1y1xa_	182	Programmed cell death 6 protein-like protein {Leis	99.83
d1jfja_	134	EHCABP {Entamoeba (Entamoeba histolytica) [TaxId:	99.83
d1auib_	165	Calcineurin regulatory subunit (B-chain) {Human (H	99.82
d2zfda1	183	Calcineurin B-like protein 2 {Thale cress (Arabido	99.82
d1hqva_	181	Apoptosis-linked protein alg-2 {Mouse (Mus musculu	99.81
d1jbaa_	189	Guanylate cyclase activating protein 2, GCAP-2 {Co	99.8
d1w7jb1	139	Myosin Essential Chain {Human (Homo sapiens) [TaxI	99.8
d1g8ia_	187	Frequenin (neuronal calcium sensor 1) {Human (Homo	99.8
d1bjfa_	181	Neurocalcin {Cow (Bos taurus) [TaxId: 9913]}	99.79
d1omra_	201	Recoverin {Cow (Bos taurus) [TaxId: 9913]}	99.78
d1fpwa_	190	Frequenin (neuronal calcium sensor 1) {Baker's yea	99.78
d1s6ca_	178	Kchip1, Kv4 potassium channel-interacting protein	99.77
d1k94a_	165	Grancalcin {Human (Homo sapiens) [TaxId: 9606]}	99.77
d1xo5a_	180	Calcium- and integrin-binding protein, CIB {Human	99.76
d1df0a1	186	Calpain large subunit, C-terminal domain (domain I	99.74
d1alva_	173	Calpain small (regulatory) subunit (domain VI) {Pi	99.74
d1qxpa2	188	Calpain large subunit, C-terminal domain (domain I	99.74
d1juoa_	172	Sorcin {Human (Homo sapiens) [TaxId: 9606]}	99.74
d1qv0a_	189	Calcium-regulated photoprotein {Hydrozoa (Obelia l	99.72
d5pala_	109	Parvalbumin {Leopard shark (Triakis semifasciata)	99.72
d1ij5a_	321	Cbp40 (plasmodial specific CaII-binding protein LA	99.71
d1pvaa_	109	Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}	99.7
d2sasa_	185	Sarcoplasmic calcium-binding protein {Amphioxus (B	99.69
d2scpa_	174	Sarcoplasmic calcium-binding protein {Sandworm (Ne	99.69
d1uhka1	187	Calcium-regulated photoprotein {Jellyfish (Aequore	99.68
d2pvba_	107	Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}	99.65
d1nyaa_	176	Calerythrin {Saccharopolyspora erythraea [TaxId: 1	99.65
d1rwya_	109	Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]}	99.61
d1rroa_	108	Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116	99.59
d1jc2a_	75	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	99.46
d2opoa1	81	Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta	99.44
d1f54a_	77	Calmodulin {Baker's yeast (Saccharomyces cerevisia	99.44
d1c7va_	68	Calcium vector protein {Amphioxus (Branchiostoma l	99.43
d1wrka1	82	Troponin C {Human (Homo sapiens), cardiac isoform	99.43
d1avsa_	81	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	99.43
d2pq3a1	73	Calmodulin {Rattus norvegicus [TaxId: 10116]}	99.42
d1fw4a_	65	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	99.42
d1fi5a_	81	Troponin C {Chicken (Gallus gallus), cardiac isofo	99.42
d1oqpa_	77	Caltractin (centrin 2) {Green algae (Chlamydomonas	99.41
d1tiza_	67	Calmodulin-related protein T21P5.17 {Thale cress (	99.41
d2fcea1	61	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	99.38
d1k94a_	165	Grancalcin {Human (Homo sapiens) [TaxId: 9606]}	99.38
d1avsa_	81	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	99.37
d2zkmx1	170	Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI	99.37
d1s6ja_	87	Calcium-dependent protein kinase sk5 CLD {Soybean	99.36
d2opoa1	81	Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta	99.35
d1s6ja_	87	Calcium-dependent protein kinase sk5 CLD {Soybean	99.34
d1wrka1	82	Troponin C {Human (Homo sapiens), cardiac isoform	99.34
d1f54a_	77	Calmodulin {Baker's yeast (Saccharomyces cerevisia	99.34
d1hqva_	181	Apoptosis-linked protein alg-2 {Mouse (Mus musculu	99.33
d1df0a1	186	Calpain large subunit, C-terminal domain (domain I	99.33
d2pq3a1	73	Calmodulin {Rattus norvegicus [TaxId: 10116]}	99.33
d1fw4a_	65	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	99.31
d1alva_	173	Calpain small (regulatory) subunit (domain VI) {Pi	99.3
d1jc2a_	75	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	99.29
d1juoa_	172	Sorcin {Human (Homo sapiens) [TaxId: 9606]}	99.28
d1tiza_	67	Calmodulin-related protein T21P5.17 {Thale cress (	99.27
d2fcea1	61	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	99.27
d1qxpa2	188	Calpain large subunit, C-terminal domain (domain I	99.26
d1oqpa_	77	Caltractin (centrin 2) {Green algae (Chlamydomonas	99.25
d1y1xa_	182	Programmed cell death 6 protein-like protein {Leis	99.25
d1fi5a_	81	Troponin C {Chicken (Gallus gallus), cardiac isofo	99.24
d1qx2a_	76	Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]}	99.23
d1fpwa_	190	Frequenin (neuronal calcium sensor 1) {Baker's yea	99.23
d1c7va_	68	Calcium vector protein {Amphioxus (Branchiostoma l	99.22
d1omra_	201	Recoverin {Cow (Bos taurus) [TaxId: 9913]}	99.18
d1jfja_	134	EHCABP {Entamoeba (Entamoeba histolytica) [TaxId:	99.16
d1jbaa_	189	Guanylate cyclase activating protein 2, GCAP-2 {Co	99.14
d1wlza1	83	DJ-1-binding protein, DJBP {Human (Homo sapiens) [	99.11
d1wlza1	83	DJ-1-binding protein, DJBP {Human (Homo sapiens) [	99.07
d1g8ia_	187	Frequenin (neuronal calcium sensor 1) {Human (Homo	99.07
d1cb1a_	78	Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]}	99.06
d1c07a_	95	Eps15 {Human (Homo sapiens) [TaxId: 9606]}	99.06
d5pala_	109	Parvalbumin {Leopard shark (Triakis semifasciata)	99.06
d1pvaa_	109	Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}	99.05
d1bjfa_	181	Neurocalcin {Cow (Bos taurus) [TaxId: 9913]}	99.05
d1exra_	146	Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI	99.05
d1fi6a_	92	Reps1 {Mouse (Mus musculus) [TaxId: 10090]}	99.04
d1rroa_	108	Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116	99.02
d2mysc_	145	Myosin Regulatory Chain {Chicken (Gallus gallus) [	99.02
d1yuta1	98	Calcyclin (S100) {Human (Homo sapiens), s100a13 [T	99.0
d1zfsa1	93	Calcyclin (S100) {Rat (Rattus norvegicus), s100a1	99.0
d2zfda1	183	Calcineurin B-like protein 2 {Thale cress (Arabido	98.98
d1qx2a_	76	Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]}	98.98
d2pvba_	107	Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}	98.98
d1auib_	165	Calcineurin regulatory subunit (B-chain) {Human (H	98.98
d3c1va1	93	Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta	98.96
d1wdcb_	142	Myosin Essential Chain {Bay scallop (Aequipecten i	98.95
d1rwya_	109	Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]}	98.95
d2obha1	141	Calmodulin {Human (Homo sapiens) [TaxId: 9606]}	98.93
d1s6ca_	178	Kchip1, Kv4 potassium channel-interacting protein	98.93
d1snla_	99	Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax	98.93
d1a4pa_	92	Calcyclin (S100) {Human (Homo sapiens), P11 s100a1	98.92
d1xo5a_	180	Calcium- and integrin-binding protein, CIB {Human	98.92
d1ksoa_	93	Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta	98.91
d1yuta1	98	Calcyclin (S100) {Human (Homo sapiens), s100a13 [T	98.91
d1c07a_	95	Eps15 {Human (Homo sapiens) [TaxId: 9606]}	98.9
d1lkja_	146	Calmodulin {Baker's yeast (Saccharomyces cerevisia	98.89
d1zfsa1	93	Calcyclin (S100) {Rat (Rattus norvegicus), s100a1	98.89
d1fi6a_	92	Reps1 {Mouse (Mus musculus) [TaxId: 10090]}	98.89
d2jxca1	95	Eps15 {Human (Homo sapiens) [TaxId: 9606]}	98.88
d1a4pa_	92	Calcyclin (S100) {Human (Homo sapiens), P11 s100a1	98.86
d3c1va1	93	Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta	98.84
d1ksoa_	93	Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta	98.84
d1k8ua_	89	Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta	98.84
d1xk4a1	87	Calcyclin (S100) {Human (Homo sapiens), calgranuli	98.83
d1wdcc_	152	Myosin Regulatory Chain {Bay scallop (Aequipecten	98.82
d1cb1a_	78	Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]}	98.81
d1m45a_	146	Myosin Light Chain Mlc1p {Baker's yeast (Saccharom	98.79
d1k8ua_	89	Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta	98.78
d1ggwa_	140	Cdc4p {Fission yeast (Schizosaccharomyces pombe) [	98.77
d2jxca1	95	Eps15 {Human (Homo sapiens) [TaxId: 9606]}	98.76
d1topa_	162	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	98.75
d1dtla_	156	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	98.75
d1qv0a_	189	Calcium-regulated photoprotein {Hydrozoa (Obelia l	98.75
d1iq3a_	110	Pob1 {Human (Homo sapiens) [TaxId: 9606]}	98.74
d1uhka1	187	Calcium-regulated photoprotein {Jellyfish (Aequore	98.74
d1s6ia_	182	Calcium-dependent protein kinase sk5 CLD {Soybean	98.73
d1xk4a1	87	Calcyclin (S100) {Human (Homo sapiens), calgranuli	98.7
d1e8aa_	87	Calcyclin (S100) {Human (Homo sapiens), calgranuli	98.7
d1e8aa_	87	Calcyclin (S100) {Human (Homo sapiens), calgranuli	98.66
d1psra_	100	Calcyclin (S100) {Human (Homo sapiens), psoriasin	98.66
d1qjta_	99	Eps15 {Mouse (Mus musculus) [TaxId: 10090]}	98.65
d2mysb_	145	Myosin Essential Chain {Chicken (Gallus gallus) [T	98.65
d1w7jb1	139	Myosin Essential Chain {Human (Homo sapiens) [TaxI	98.64
d1snla_	99	Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax	98.64
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.62
d1psra_	100	Calcyclin (S100) {Human (Homo sapiens), psoriasin	98.62
d1iq3a_	110	Pob1 {Human (Homo sapiens) [TaxId: 9606]}	98.62
d1qjta_	99	Eps15 {Mouse (Mus musculus) [TaxId: 10090]}	98.62
d2hf5a1	33	Troponin C {Human (Homo sapiens), cardiac isoform	98.61
d2scpa_	174	Sarcoplasmic calcium-binding protein {Sandworm (Ne	98.61
d2sasa_	185	Sarcoplasmic calcium-binding protein {Amphioxus (B	98.55
d1nyaa_	176	Calerythrin {Saccharopolyspora erythraea [TaxId: 1	98.52
d1ctda_	34	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	98.36
d3cr5x1	90	Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId:	98.34
d3cr5x1	90	Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId:	98.3
d2zkmx1	170	Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI	98.3
d1ij5a_	321	Cbp40 (plasmodial specific CaII-binding protein LA	98.28
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.25
d1qlsa_	95	Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1	98.16
d2hf5a1	33	Troponin C {Human (Homo sapiens), cardiac isoform	98.12
d1j55a_	94	Calcyclin (S100) {Human (Homo sapiens), s100p [Tax	98.08
d1qlsa_	95	Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1	98.02
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.0
d1j55a_	94	Calcyclin (S100) {Human (Homo sapiens), s100p [Tax	97.99
d1xk4c1	83	Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr	97.86
d1tuza_	118	Diacylglycerol kinase alpha, N-terminal domain {Hu	97.86
d1xk4c1	83	Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr	97.83
d1ctda_	34	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	97.75
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.44
d1tuza_	118	Diacylglycerol kinase alpha, N-terminal domain {Hu	97.03
d1sraa_	151	C-terminal (EC) domain of BM-40/SPARC/osteonectin	96.97
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.92
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.54
d1sraa_	151	C-terminal (EC) domain of BM-40/SPARC/osteonectin	95.79
d1qasa1	94	Phosphoinositide-specific phospholipase C, isozyme	94.85
d1h8ba_	73	alpha-Actinin {Human (Homo sapiens) [TaxId: 9606]}	94.79
d1j7qa_	86	Calcium vector protein {Amphioxus (Branchiostoma l	92.59
d1qasa1	94	Phosphoinositide-specific phospholipase C, isozyme	89.26
d2cclb1	59	Endo-1,4-beta-xylanase Y {Clostridium thermocellum	88.7
d1eg3a1	125	Dystrophin {Human (Homo sapiens) [TaxId: 9606]}	87.94
d1pula1	103	Hypothetical protein c32e8.3 {Caenorhabditis elega	86.65
d2cclb1	59	Endo-1,4-beta-xylanase Y {Clostridium thermocellum	86.52
d1j7qa_	86	Calcium vector protein {Amphioxus (Branchiostoma l	85.53
d1pula1	103	Hypothetical protein c32e8.3 {Caenorhabditis elega	83.47
d1dava_	71	Cellulosome endoglucanase SS {Clostridium thermoce	82.72
d1dava_	71	Cellulosome endoglucanase SS {Clostridium thermoce	82.09
d1wlma1	138	Protein cgi-38 {Mouse (Mus musculus) [TaxId: 10090	81.27

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-59  Score=445.87  Aligned_cols=266  Identities=39%  Similarity=0.730  Sum_probs=224.9

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .+++.++|++++.||+|+||+||+|.++.+|+.||+|++.+.....  ....+.+|+.+++++. ||||+++++++.+++
T Consensus         4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~   80 (307)
T d1a06a_           4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIK-HPNIVALDDIYESGG   80 (307)
T ss_dssp             CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred             CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence            4678889999999999999999999999999999999997655322  3466889999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .+|+|||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++...+.++.+||+|||++...
T Consensus        81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            99999999999999999998889999999999999999999999999999999999999976566789999999999877


Q ss_pred             ccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917          188 EEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (494)
                      .........+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+.+....++.+.++.+|+.+
T Consensus       161 ~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  240 (307)
T d1a06a_         161 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA  240 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             cCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence            66655667789999999999875 58999999999999999999999999999999999999988888777778899999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          267 IELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      .+||.+||..||++|||++|+|+||||+..
T Consensus       241 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999999863

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-58  Score=430.49  Aligned_cols=254  Identities=33%  Similarity=0.610  Sum_probs=231.1

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++++.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.++++++ ||||+++++++.+++..|+|
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCEEEEE
Confidence            57999999999999999999999999999999997655444445778899999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      ||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|...... .
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~-~  160 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSS-R  160 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCC-C
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCCC-c
Confidence            9999999999999988899999999999999999999999999999999999999   67889999999999866543 3


Q ss_pred             cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917          193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR  271 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  271 (494)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+.+....++    +.+|+.+.+||.
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  236 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS  236 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHH
T ss_pred             ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHHHH
Confidence            345689999999999976 489999999999999999999999999999988888888765544    358999999999


Q ss_pred             HhcccCCCCCCCHHHHhcCCccCc
Q 040917          272 RMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       272 ~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      +||..||++|||++|+|+||||++
T Consensus       237 ~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         237 RLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHccCCHhHCcCHHHHHcCcCcCC
Confidence            999999999999999999999975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-58  Score=427.31  Aligned_cols=259  Identities=28%  Similarity=0.536  Sum_probs=219.0

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      +.++|++++.||+|+||+||+|.++.+|+.||+|++......  ...+.+.+|+.++++++ ||||+++++++.+++..|
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~~~   79 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY   79 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCceeE
Confidence            346899999999999999999999999999999999765422  23456889999999995 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          111 IVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      +|||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|......
T Consensus        80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred             EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccC
Confidence            999999999999999888889999999999999999999999999999999999999   67789999999999876433


Q ss_pred             c---ccccccCCcCccChhhhcc-cC-CCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          191 K---AYREIVGSPYYIAPEVLSQ-SY-GKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       191 ~---~~~~~~~~~~y~aPE~~~~-~~-~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      .   .....+||+.|+|||++.+ .+ +.++||||+||++|+|++|+.||.................. ...+++.+++.
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~  235 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-YLNPWKKIDSA  235 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-TSTTGGGSCHH
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCccccCCHH
Confidence            2   2345679999999999865 34 67899999999999999999999776554333222222222 22334678999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      +.+||.+||..||++|||++|+|+||||++.
T Consensus       236 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         236 PLALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence            9999999999999999999999999999863

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-57  Score=429.68  Aligned_cols=267  Identities=37%  Similarity=0.715  Sum_probs=240.5

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC---hhhHHHHHHHHHHHHHccCCCCccEEeEEEE
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK---DVEKDDVRREIEIMRHLSGQPNIVQFKAAYE  104 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~  104 (494)
                      .+++.++|++++.||+|+||+||+|.++.+|+.||+|++.+.....   ....+.+.+|+.++++++ ||||+++++++.
T Consensus         5 ~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~   83 (293)
T d1jksa_           5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYE   83 (293)
T ss_dssp             CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             CCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE
Confidence            4567789999999999999999999999999999999997654322   224678999999999995 999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCC-CCCeEEEeecCC
Q 040917          105 DDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGD-ENAVVKATDFGL  183 (494)
Q Consensus       105 ~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~-~~~~~kL~Dfg~  183 (494)
                      +.+..|+|||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++ ....+||+|||+
T Consensus        84 ~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          84 NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             ECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence            9999999999999999999999888999999999999999999999999999999999999995422 234799999999


Q ss_pred             ccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          184 SAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       184 a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      +.....+.......+|+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+..+....+.+....++...++.+
T Consensus       164 a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (293)
T d1jksa_         164 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT  243 (293)
T ss_dssp             CEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             hhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCC
Confidence            988776666667789999999999975 5899999999999999999999999999999999988888777665555788


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      |+.+.+||.+||..||++|||++++|+||||+.
T Consensus       244 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  276 (293)
T d1jksa_         244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  276 (293)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            999999999999999999999999999999985

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-56  Score=423.69  Aligned_cols=259  Identities=31%  Similarity=0.495  Sum_probs=226.4

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      .++.++|++.+.||+|+||+||+|.++.+|+.||+|++.....   ...+.+.+|+.++++++ ||||+++++++.+++.
T Consensus        16 ~dp~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~   91 (293)
T d1yhwa1          16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDE   91 (293)
T ss_dssp             SCTTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred             CCcccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCC-CCCEeeEeEEEEECCE
Confidence            3456799999999999999999999999999999999975442   23567899999999995 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      +|+|||||+||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|....
T Consensus        92 ~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~  167 (293)
T d1yhwa1          92 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQIT  167 (293)
T ss_dssp             EEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred             EEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeec
Confidence            9999999999999998765 469999999999999999999999999999999999999   677899999999998764


Q ss_pred             cC-cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917          189 EG-KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       189 ~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (494)
                      .. ......+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+.......+........ ...+.+|+.+
T Consensus       168 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~  246 (293)
T d1yhwa1         168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSAIF  246 (293)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SSGGGSCHHH
T ss_pred             cccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-CCcccCCHHH
Confidence            43 33455679999999999975 589999999999999999999999998888777666654433222 2235689999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          267 IELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      ++||.+||..||.+|||+.|+|+||||+..
T Consensus       247 ~~li~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999999853

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-56  Score=435.22  Aligned_cols=265  Identities=35%  Similarity=0.638  Sum_probs=239.4

Q ss_pred             ccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           28 YEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        28 ~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      .+++.++|++++.||+|+||.||+|.++.+|+.||+|++....   ....+.+.+|+.++++|+ ||||+++++++.+++
T Consensus        21 ~~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~   96 (350)
T d1koaa2          21 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDN   96 (350)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETT
T ss_pred             CCCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence            3466789999999999999999999999999999999996543   335677899999999995 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          108 FVHIVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                      .+|+|||||+||+|.+++.. .+++++..+..++.||+.||.|||++||+||||||+|||+.. +.++.+||+|||++..
T Consensus        97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2          97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAH  175 (350)
T ss_dssp             EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchhee
Confidence            99999999999999999854 457999999999999999999999999999999999999953 2357899999999988


Q ss_pred             cccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          187 IEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ...........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+.+....++...++.+|+.
T Consensus       176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  255 (350)
T d1koaa2         176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED  255 (350)
T ss_dssp             CCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred             cccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            776666667889999999999875 5899999999999999999999999999999999999888877777666789999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      +.+||.+||..||.+|||+.|+|+||||+...
T Consensus       256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999999999998654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.7e-56  Score=418.99  Aligned_cols=262  Identities=35%  Similarity=0.678  Sum_probs=238.6

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCCh------hhHHHHHHHHHHHHHccCCCCccEEeEEEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKD------VEKDDVRREIEIMRHLSGQPNIVQFKAAYE  104 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~------~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~  104 (494)
                      +.++|++++.||+|+||+||+|++..+|+.||+|++.+......      ...+.+.+|+.+++++..||||+++++++.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            35799999999999999999999999999999999977654321      123568899999999977999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCc
Q 040917          105 DDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLS  184 (494)
Q Consensus       105 ~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a  184 (494)
                      +++..|+|||||+||+|.+++..++.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a  157 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFS  157 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred             cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchhe
Confidence            999999999999999999999998999999999999999999999999999999999999999   68899999999999


Q ss_pred             cccccCcccccccCCcCccChhhhcc-------cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCC
Q 040917          185 AFIEEGKAYREIVGSPYYIAPEVLSQ-------SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD  257 (494)
Q Consensus       185 ~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  257 (494)
                      .............||+.|+|||.+.+       .++.++||||+||++|+|++|+.||.+.+.......+.++...++..
T Consensus       158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  237 (277)
T d1phka_         158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP  237 (277)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence            88766655566789999999998852       36889999999999999999999999999999888888888777777


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          258 PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       258 ~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      .++.+|+.+.+||.+||+.||++|||++++|+||||+.
T Consensus       238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            77789999999999999999999999999999999985

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.8e-56  Score=432.88  Aligned_cols=265  Identities=33%  Similarity=0.615  Sum_probs=239.5

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      ..+.++|++++.||+|+||.||+|.++.+|+.||+|++....   ......+.+|+.++++|. ||||+++++++.+++.
T Consensus        25 ~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~  100 (352)
T d1koba_          25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYE  100 (352)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSE
T ss_pred             CCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCE
Confidence            345678999999999999999999999999999999997543   334567889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      +|+|||||+||+|.+++...+ ++++..+..++.||+.||.|||++||+||||||+|||++. ...+.+||+|||+|...
T Consensus       101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKL  179 (352)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceec
Confidence            999999999999998876544 6999999999999999999999999999999999999943 25689999999999987


Q ss_pred             ccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHH
Q 040917          188 EEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSA  266 (494)
Q Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (494)
                      ..........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+.+....++...++.+|+.+
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  259 (352)
T d1koba_         180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA  259 (352)
T ss_dssp             CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred             CCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            76666667889999999999875 58999999999999999999999999999999999999988888877778899999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCCccCccCc
Q 040917          267 IELVRRMLTQDPKRRITVAQVLEHPWLKESGE  298 (494)
Q Consensus       267 ~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~  298 (494)
                      .+||.+||..||.+|||+.|+|+||||+....
T Consensus       260 ~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~  291 (352)
T d1koba_         260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  291 (352)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence            99999999999999999999999999986543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-57  Score=425.22  Aligned_cols=256  Identities=30%  Similarity=0.563  Sum_probs=228.0

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++++.||+|+||+||+|.++.+|+.||||++.+...........+.+|+.+++++. ||||+++++++.+++.+|+|
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEEEEE
Confidence            57999999999999999999999999999999997655444445678999999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-  191 (494)
                      ||||+||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||+|....... 
T Consensus        87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC----
T ss_pred             EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecccCCc
Confidence            9999999999999988999999999999999999999999999999999999999   678899999999998764322 


Q ss_pred             --ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHH
Q 040917          192 --AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIE  268 (494)
Q Consensus       192 --~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  268 (494)
                        .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..++...+.+....++    ..+++.+.+
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  239 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD  239 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC----TTCCHHHHH
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC----ccCCHHHHH
Confidence              2345679999999999975 589999999999999999999999999999988888888765544    468999999


Q ss_pred             HHHHhcccCCCCCCCHHH------HhcCCccCcc
Q 040917          269 LVRRMLTQDPKRRITVAQ------VLEHPWLKES  296 (494)
Q Consensus       269 li~~~l~~dp~~Rps~~e------il~~~~~~~~  296 (494)
                      ||.+||..||.+|||++|      +++||||+..
T Consensus       240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            999999999999999988      5889999863

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-56  Score=416.15  Aligned_cols=255  Identities=23%  Similarity=0.418  Sum_probs=219.3

Q ss_pred             cce-EeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe----CC
Q 040917           33 LHY-TIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED----DQ  107 (494)
Q Consensus        33 ~~y-~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~----~~  107 (494)
                      ++| ++.+.||+|+||+||+|.++.+++.||+|++..... .....+.+.+|++++++++ ||||+++++++..    +.
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~   85 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK   85 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCE
T ss_pred             CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCC
Confidence            455 788899999999999999999999999999976553 3345678999999999995 9999999999865    45


Q ss_pred             eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          108 FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKG--VMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      .+|+|||||+||+|.+++.+...+++..+..++.||+.||.|||+++  |+||||||+|||++  +.++.+||+|||+|.
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred             EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcce
Confidence            68999999999999999998889999999999999999999999998  99999999999994  346899999999997


Q ss_pred             ccccCcccccccCCcCccChhhhcccCCCcchhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcCCccCCCCCCCCCCH
Q 040917          186 FIEEGKAYREIVGSPYYIAPEVLSQSYGKEADIWSAGVILYILLCGVPPFWAETDQ-GVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      ..... .....+||+.|+|||++.+.++.++|||||||++|+|++|+.||.+.... .+...+..+..+.  ......++
T Consensus       164 ~~~~~-~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~--~~~~~~~~  240 (270)
T d1t4ha_         164 LKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDKVAIP  240 (270)
T ss_dssp             GCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--GGGGCCCH
T ss_pred             eccCC-ccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc--ccCccCCH
Confidence            64333 33567899999999999999999999999999999999999999766544 4445554443222  12245789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCCccC
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLEHPWLK  294 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~~~~~~  294 (494)
                      .+.++|.+||..||++|||++|+|+||||+
T Consensus       241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            999999999999999999999999999996

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-56  Score=425.73  Aligned_cols=258  Identities=26%  Similarity=0.417  Sum_probs=230.2

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      ++..+|++++.||+|+||+||+|.+..+|+.||||++.............+.+|+.++++++ ||||+++++++.+++..
T Consensus        12 dp~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~   90 (309)
T d1u5ra_          12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTA   90 (309)
T ss_dssp             CHHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEE
T ss_pred             CcHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECCEE
Confidence            35567999999999999999999999999999999998766555556678999999999995 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      |+|||||+||+|..++...+++++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|.....
T Consensus        91 ~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS
T ss_pred             EEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeecccccccCC
Confidence            9999999999998877777889999999999999999999999999999999999999   5788999999999986543


Q ss_pred             CcccccccCCcCccChhhhc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          190 GKAYREIVGSPYYIAPEVLS----QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       190 ~~~~~~~~~~~~y~aPE~~~----~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      .   ....||+.|+|||++.    +.|+.++|||||||++|+|++|+.||.+....+....+.........  ...+|+.
T Consensus       168 ~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~  242 (309)
T d1u5ra_         168 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEY  242 (309)
T ss_dssp             B---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--CTTSCHH
T ss_pred             C---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCCCHH
Confidence            2   3567999999999985    35899999999999999999999999998888877777766544332  2468999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      +.+||.+||..||.+|||++++|+||||...
T Consensus       243 ~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence            9999999999999999999999999999863

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-56  Score=420.51  Aligned_cols=257  Identities=29%  Similarity=0.462  Sum_probs=225.3

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ..+.|++++.||+|+||+||+|.++.+|+.||+|++....   ....+.+.+|+.++++++ ||||+++++++.+++..+
T Consensus        10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~   85 (288)
T d2jfla1          10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLW   85 (288)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCeEE
Confidence            3467999999999999999999999999999999997543   234567889999999995 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          111 IVMELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      +|||||+||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|.....
T Consensus        86 lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          86 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHH
T ss_pred             EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCC
Confidence            99999999999998765 4569999999999999999999999999999999999999   6788999999999976543


Q ss_pred             Cc-ccccccCCcCccChhhhc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          190 GK-AYREIVGSPYYIAPEVLS------QSYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       190 ~~-~~~~~~~~~~y~aPE~~~------~~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      .. ......||+.|+|||++.      ..|+.++|||||||++|+|++|+.||.+.+..+....+.++...... ..+.+
T Consensus       163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~  241 (288)
T d2jfla1         163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA-QPSRW  241 (288)
T ss_dssp             HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS-SGGGS
T ss_pred             CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC-ccccC
Confidence            22 234567999999999983      34789999999999999999999999999888888887776543322 22568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      |+.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus       242 s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         242 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            999999999999999999999999999999984

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-55  Score=423.45  Aligned_cols=255  Identities=31%  Similarity=0.557  Sum_probs=232.2

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++++. ||||+++++++.+.+.+|+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeeccccccccc
Confidence            57999999999999999999999999999999997655434445678899999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc-Cc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE-GK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~-~~  191 (494)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++++||+|||+|..... ..
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccCCc
Confidence            9999999999999999999999999999999999999999999999999999999   6789999999999986543 33


Q ss_pred             ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          192 AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                      .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..++...+......++    ..+|+.+.+||
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dli  236 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLL  236 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHH
Confidence            4456789999999999875 599999999999999999999999999999999888888766554    46899999999


Q ss_pred             HHhcccCCCCCCC-----HHHHhcCCccCc
Q 040917          271 RRMLTQDPKRRIT-----VAQVLEHPWLKE  295 (494)
Q Consensus       271 ~~~l~~dp~~Rps-----~~eil~~~~~~~  295 (494)
                      .+||++||.+||+     ++++++||||+.
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HhhccCCchhhcccccccHHHHHcCccccc
Confidence            9999999999995     899999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=413.14  Aligned_cols=253  Identities=32%  Similarity=0.553  Sum_probs=212.8

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--CCeEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--DQFVH  110 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--~~~~~  110 (494)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++..... ++...+.+.+|+.+++++. ||||+++++++.+  ++.+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----CEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCEEE
Confidence            579999999999999999999999999999999977654 3445677899999999995 9999999999864  45689


Q ss_pred             EEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCceEEeeCCCCCeEEEeec
Q 040917          111 IVMELCAGGELFDRIVA----RGHYSERAAASVFRVIMNVVNVCHSKG-----VMHRDLKPENFLFTTGDENAVVKATDF  181 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~-----i~H~dikp~NIli~~~~~~~~~kL~Df  181 (494)
                      +|||||+||+|.+++.+    ...+++..++.++.||+.||.|||+.|     |+||||||+|||+   +.++.+||+||
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DF  158 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDF  158 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeec
Confidence            99999999999998864    357999999999999999999999976     9999999999999   67889999999


Q ss_pred             CCccccccCc-ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 040917          182 GLSAFIEEGK-AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPF  259 (494)
Q Consensus       182 g~a~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  259 (494)
                      |++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..++...+.++.....   .
T Consensus       159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~---~  235 (269)
T d2java1         159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---P  235 (269)
T ss_dssp             HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---C
T ss_pred             cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence            9998765433 2345789999999999865 589999999999999999999999999999888888877655432   2


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCcc
Q 040917          260 PSISSSAIELVRRMLTQDPKRRITVAQVLEHPWL  293 (494)
Q Consensus       260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~  293 (494)
                      ..+|+.+.+||.+||..||.+|||++|+|+|||+
T Consensus       236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            4689999999999999999999999999999996

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=423.80  Aligned_cols=262  Identities=31%  Similarity=0.617  Sum_probs=236.8

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      ++-++|++++.||+|+||+||+|.++.+|+.||+|++....    .....+.+|+.+|+.++ ||||+++++++.+++.+
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~   76 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEE
Confidence            45689999999999999999999999999999999997543    23456889999999995 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          110 HIVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      |+|||||+||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++. +....++|+|||++....
T Consensus        77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECC
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhhccc
Confidence            99999999999999997665 6999999999999999999999999999999999999953 245689999999998876


Q ss_pred             cCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          189 EGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      .........+++.|+|||.+.+ .++.++||||+||++|+|++|..||.+.+..++...+.+....++...++.+|+.+.
T Consensus       156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T d1tkia_         156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence            6666667789999999999865 589999999999999999999999999999999999998888777666678999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          268 ELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                      +||.+||..||.+|||++|+|+||||+...
T Consensus       236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~~  265 (321)
T d1tkia_         236 DFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence            999999999999999999999999998643

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.8e-55  Score=417.39  Aligned_cols=253  Identities=31%  Similarity=0.586  Sum_probs=230.3

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.++++++ ||||+++++++.+.+..|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCeeeeE
Confidence            57999999999999999999999999999999997654434445678999999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      ||||+||+|..++.....++...+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|......  
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC--
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEeccc--
Confidence            9999999999999998899999999999999999999999999999999999999   67899999999999876433  


Q ss_pred             cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917          193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR  271 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  271 (494)
                      ....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..+....+.++...++    +.+|+.+.++|.
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  233 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS  233 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred             cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            345789999999999976 589999999999999999999999999999999888888765544    468999999999


Q ss_pred             HhcccCCCCCC-----CHHHHhcCCccCc
Q 040917          272 RMLTQDPKRRI-----TVAQVLEHPWLKE  295 (494)
Q Consensus       272 ~~l~~dp~~Rp-----s~~eil~~~~~~~  295 (494)
                      +||..||.+||     |++++++||||++
T Consensus       234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         234 RLITRDLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             HHhhhCHHhccccchhhHHHHHcCccccc
Confidence            99999999996     9999999999986

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-55  Score=420.95  Aligned_cols=256  Identities=26%  Similarity=0.426  Sum_probs=217.0

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++++.||+|+||+||+|.++.+|+.||+|+++...  .......+.+|+.++++++ ||||+++++++.+...+|+
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEE
Confidence            468999999999999999999999999999999997543  3335678899999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      ||||++||+|.+++.+.+.+++..+..++.||+.||.|||+ +||+||||||+|||+   +.++.+||+|||+|......
T Consensus        82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHH
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccCCC
Confidence            99999999999999988899999999999999999999997 599999999999999   67889999999999865433


Q ss_pred             cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHH-----------------------
Q 040917          191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQA-----------------------  246 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~-----------------------  246 (494)
                       .....+||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.+.........                       
T Consensus       159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence             2345789999999999875 699999999999999999999999977654322110                       


Q ss_pred             -------------------HHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          247 -------------------ILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       247 -------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                                         +...  ..+..+...++.++.+||.+||..||.+|||++|+|+||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNE--PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             --------CCCCHHHHHHHHHTS--CCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccccccccchhHHHHHhhhhcc--CCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                               0000  00111112467899999999999999999999999999999863

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=424.53  Aligned_cols=268  Identities=34%  Similarity=0.642  Sum_probs=224.0

Q ss_pred             cccccceEeee-eecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--
Q 040917           29 EDVQLHYTIGR-EVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--  105 (494)
Q Consensus        29 ~~~~~~y~i~~-~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--  105 (494)
                      ..+.++|.+.+ .||+|+||+||+|.+..+++.||||++..        ...+.+|+.++.++.+||||++++++|.+  
T Consensus         7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~   78 (335)
T d2ozaa1           7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLY   78 (335)
T ss_dssp             SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             CCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence            34567899875 69999999999999999999999999853        24577899988776579999999999875  


Q ss_pred             --CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeec
Q 040917          106 --DQFVHIVMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDF  181 (494)
Q Consensus       106 --~~~~~iv~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Df  181 (494)
                        +..+|+|||||+||+|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++..+..+.+||+||
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence              46789999999999999999764  36899999999999999999999999999999999999976556789999999


Q ss_pred             CCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----cCCccCCC
Q 040917          182 GLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAIL----KGEINFQR  256 (494)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~----~~~~~~~~  256 (494)
                      |+|.............||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+.........+.    .....++.
T Consensus       159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  238 (335)
T ss_dssp             TTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred             ceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence            99987766666667889999999999876 59999999999999999999999998776544443332    33333444


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCC
Q 040917          257 DPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPI  304 (494)
Q Consensus       257 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~  304 (494)
                      ..++.+|+++.+||.+||..||++|||+.++|+||||.........+.
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~  286 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL  286 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCCEE
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCCCc
Confidence            444568999999999999999999999999999999987555444444

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-54  Score=418.10  Aligned_cols=254  Identities=30%  Similarity=0.558  Sum_probs=230.2

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++++.||+|+||.||+|.++.+|+.||||++.+...........+.+|+.+++.+. ||||+++++++......++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeecccccccccccccc
Confidence            78999999999999999999999999999999997654433445677899999999994 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCcc
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKA  192 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~  192 (494)
                      |||+.||+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++++||+|||+|......  
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC--
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeecccc--
Confidence            9999999999999988899999999999999999999999999999999999999   67889999999999876533  


Q ss_pred             cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHH
Q 040917          193 YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELVR  271 (494)
Q Consensus       193 ~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  271 (494)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+..+...++    ..+++.+.++|.
T Consensus       195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  270 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR  270 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHHHH
T ss_pred             cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHHH
Confidence            345689999999999875 589999999999999999999999999998888888887765443    468999999999


Q ss_pred             HhcccCCCCCC-----CHHHHhcCCccCcc
Q 040917          272 RMLTQDPKRRI-----TVAQVLEHPWLKES  296 (494)
Q Consensus       272 ~~l~~dp~~Rp-----s~~eil~~~~~~~~  296 (494)
                      +||..||.+|+     |++++++||||+..
T Consensus       271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHhhhCHHhccccccccHHHHHcCccccCC
Confidence            99999999994     99999999999863

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-54  Score=413.18  Aligned_cols=255  Identities=26%  Similarity=0.480  Sum_probs=226.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHH-HccCCCCccEEeEEEEeCCeEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMR-HLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~-~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      ++|.+++.||+|+||+||+|.++.+|+.||+|++++...........+.+|..++. .+ +||||+++++++.+++..|+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~-~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT-TCTTBCCEEEEEECSSEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhC-CCCcEEEEEEEEccCCceeE
Confidence            57999999999999999999999999999999997654333334566777777766 46 69999999999999999999


Q ss_pred             EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC-
Q 040917          112 VMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG-  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~-  190 (494)
                      ||||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +..+.+||+|||++...... 
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhccccc
Confidence            99999999999999998899999999999999999999999999999999999999   68899999999999865433 


Q ss_pred             cccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHH
Q 040917          191 KAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIEL  269 (494)
Q Consensus       191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  269 (494)
                      .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+...+...+......++    ..+|+.+.+|
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dl  233 (320)
T d1xjda_         158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDL  233 (320)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred             ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHH
Confidence            23345689999999999875 699999999999999999999999999999988888887755443    4689999999


Q ss_pred             HHHhcccCCCCCCCHH-HHhcCCccCc
Q 040917          270 VRRMLTQDPKRRITVA-QVLEHPWLKE  295 (494)
Q Consensus       270 i~~~l~~dp~~Rps~~-eil~~~~~~~  295 (494)
                      |.+||..||.+|||+. ++++||||+.
T Consensus       234 i~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         234 LVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             HHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             HHHhcccCCCCCcCHHHHHHhCchhcc
Confidence            9999999999999996 8999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2e-53  Score=414.93  Aligned_cols=257  Identities=28%  Similarity=0.448  Sum_probs=217.4

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHH---HHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRRE---IEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E---~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      ++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|   +.+++.+ +||||+++++++.+.+.+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEECCEE
Confidence            579999999999999999999999999999999975443333334445555   4555555 599999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      |+|||||+||+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|.....
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECSS
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecCC
Confidence            9999999999999999998899999999999999999999999999999999999999   6789999999999987654


Q ss_pred             CcccccccCCcCccChhhhc-c-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          190 GKAYREIVGSPYYIAPEVLS-Q-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       190 ~~~~~~~~~~~~y~aPE~~~-~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      .. .....||+.|+|||++. + .|+.++|||||||++|+|++|+.||.+.......... +............+|+.+.
T Consensus       160 ~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~  237 (364)
T d1omwa3         160 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVELPDSFSPELR  237 (364)
T ss_dssp             SC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH-HHSSSCCCCCCSSSCHHHH
T ss_pred             Cc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhcccCCCCCCCCCCHHHH
Confidence            43 34568999999999985 3 4899999999999999999999999876544333222 2222223333457899999


Q ss_pred             HHHHHhcccCCCCCCC-----HHHHhcCCccCc
Q 040917          268 ELVRRMLTQDPKRRIT-----VAQVLEHPWLKE  295 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps-----~~eil~~~~~~~  295 (494)
                      +||.+||..||.+|||     ++++++||||+.
T Consensus       238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             HHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence            9999999999999999     799999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-53  Score=396.35  Aligned_cols=253  Identities=30%  Similarity=0.568  Sum_probs=215.4

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChh---hHHHHHHHHHHHHHcc-CCCCccEEeEEEEeC
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDV---EKDDVRREIEIMRHLS-GQPNIVQFKAAYEDD  106 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~---~~~~~~~E~~~l~~l~-~hp~i~~~~~~~~~~  106 (494)
                      +.++|++++.||+|+||+||+|.+..+|+.||+|++.+.......   ....+.+|+.+++++. +||||+++++++.+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            467999999999999999999999999999999999765433221   1233668999999995 489999999999999


Q ss_pred             CeEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          107 QFVHIVMELCAG-GELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       107 ~~~~iv~e~~~g-~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      +..++||||+.+ +++.+++.....+++..+..++.||+.||.|||++||+||||||+||+++  .+.+.+||+|||+|.
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGA  159 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCE
T ss_pred             CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECccccce
Confidence            999999999986 57888888888999999999999999999999999999999999999995  345799999999998


Q ss_pred             ccccCcccccccCCcCccChhhhcc-c-CCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917          186 FIEEGKAYREIVGSPYYIAPEVLSQ-S-YGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~~~~-~-~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      ..... ......||+.|+|||++.+ . ++.++||||+||++|+|++|+.||.+..      .+.++...++    +.+|
T Consensus       160 ~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~----~~~s  228 (273)
T d1xwsa_         160 LLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR----QRVS  228 (273)
T ss_dssp             ECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS----SCCC
T ss_pred             ecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCC----CCCC
Confidence            65433 3456789999999999864 3 4677999999999999999999996532      2334433333    4689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCccCcc
Q 040917          264 SSAIELVRRMLTQDPKRRITVAQVLEHPWLKES  296 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~  296 (494)
                      +++.+||.+||..||++|||++|+|+||||++.
T Consensus       229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999999999864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-53  Score=402.81  Aligned_cols=259  Identities=25%  Similarity=0.378  Sum_probs=214.7

Q ss_pred             eeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCC--hhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEe
Q 040917           37 IGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVK--DVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVME  114 (494)
Q Consensus        37 i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e  114 (494)
                      .++.||+|+||+||+|.++.+|+.||+|++.......  ......+.+|+.+++++. ||||+++++++..++..|+|||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceeehhh
Confidence            4678999999999999999999999999997544221  112346889999999995 9999999999999999999999


Q ss_pred             ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-cc
Q 040917          115 LCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-AY  193 (494)
Q Consensus       115 ~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-~~  193 (494)
                      |+.|+++..+......+++..+..+++||+.||.|||++||+||||||+|||+   +.++.+||+|||++....... ..
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCC
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCcccc
Confidence            99988877776666779999999999999999999999999999999999999   688999999999997654432 33


Q ss_pred             ccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCC--------------
Q 040917          194 REIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD--------------  257 (494)
Q Consensus       194 ~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~--------------  257 (494)
                      ...+||+.|+|||++.+  .++.++||||+||++|+|++|..||.+.+..+....+.+....+...              
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence            45679999999999853  47999999999999999999999999999888777665321111000              


Q ss_pred             ----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917          258 ----------PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       258 ----------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  299 (494)
                                .++.+++.+.+||.+||..||++|||++|+|+||||++.+.+
T Consensus       238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence                      023568899999999999999999999999999999976543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.8e-52  Score=394.69  Aligned_cols=260  Identities=25%  Similarity=0.384  Sum_probs=221.1

Q ss_pred             ccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC--
Q 040917           30 DVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ--  107 (494)
Q Consensus        30 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~--  107 (494)
                      ++.++|++.+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++....  
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~~   82 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPA   82 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECSS
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccCC
Confidence            45688999999999999999999999999999999998776666666778999999999994 999999999987543  


Q ss_pred             --eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          108 --FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       108 --~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                        .+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +..+.++++|||.+.
T Consensus        83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll---~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIAR  159 (277)
T ss_dssp             SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTSCEEECCCTTCE
T ss_pred             CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc---Cccccceeehhhhhh
Confidence              489999999999999999988899999999999999999999999999999999999999   578899999999886


Q ss_pred             ccccCc----ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCC
Q 040917          186 FIEEGK----AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFP  260 (494)
Q Consensus       186 ~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (494)
                      ......    .....+||+.|+|||++.+ .+++++|||||||++|+|+||+.||.+.+..+....+.+....++....+
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE  239 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhcc
Confidence            543222    2345679999999999875 58999999999999999999999999999888888887777666655667


Q ss_pred             CCCHHHHHHHHHhcccCCCCCC-CHHHHhcCCccC
Q 040917          261 SISSSAIELVRRMLTQDPKRRI-TVAQVLEHPWLK  294 (494)
Q Consensus       261 ~~~~~l~~li~~~l~~dp~~Rp-s~~eil~~~~~~  294 (494)
                      .+|+.+.++|.+||..||.+|| |++++ .|+|.+
T Consensus       240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~r  273 (277)
T d1o6ya_         240 GLSADLDAVVLKALAKNPENRYQTAAEM-RADLVR  273 (277)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHHH
T ss_pred             CCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHHH
Confidence            8999999999999999999999 55555 455543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-52  Score=394.56  Aligned_cols=261  Identities=25%  Similarity=0.420  Sum_probs=216.1

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++++.||+|+||+||+|.+..+|+.||+|+++.... .......+.+|+.+++++. ||||+++++++.++...|+|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEEeccccccccceeEE
Confidence            589999999999999999999999999999999975442 2334578889999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          113 MELCAGGELFDRIVA--RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      |||+.| ++..++..  ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||.|......
T Consensus        80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCC
T ss_pred             EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCC
Confidence            999976 44444432  3569999999999999999999999999999999999999   67889999999999765432


Q ss_pred             -cccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCC----------
Q 040917          191 -KAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRD----------  257 (494)
Q Consensus       191 -~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~----------  257 (494)
                       .......||+.|+|||++..  .++.++||||+||++|+|++|+.||.+.+..+....+.+....+...          
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence             33345679999999998754  36889999999999999999999999888777666554321111110          


Q ss_pred             ---------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcC
Q 040917          258 ---------------PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEA  299 (494)
Q Consensus       258 ---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~  299 (494)
                                     ..+.+++.+.+||.+||..||++|||++|+|+||||++...|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence                           123567899999999999999999999999999999987655

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-51  Score=392.49  Aligned_cols=262  Identities=25%  Similarity=0.356  Sum_probs=215.9

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCC-CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc--CCCCccEEeEEEEe---
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENST-GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS--GQPNIVQFKAAYED---  105 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~-~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hp~i~~~~~~~~~---  105 (494)
                      .++|++++.||+|+||+||+|.+..+ ++.||||++....... .....+.+|+.+++.|+  +||||+++++++..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            37999999999999999999999766 6679999987543222 22334667888877764  59999999999853   


Q ss_pred             --CCeEEEEEeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecC
Q 040917          106 --DQFVHIVMELCAGGELFDRIV-ARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFG  182 (494)
Q Consensus       106 --~~~~~iv~e~~~g~sL~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg  182 (494)
                        ....+++||+++++.+..... ....+++..+..++.||+.||.|||++||+||||||+|||+   +..+.+||+|||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg  161 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG  161 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecchh
Confidence              347899999998876654433 33568999999999999999999999999999999999999   678899999999


Q ss_pred             CccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc--------
Q 040917          183 LSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN--------  253 (494)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~--------  253 (494)
                      ++.............||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.+.+..+....+.+....        
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  241 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence            9987766666667889999999998864 6999999999999999999999999999888777665431100        


Q ss_pred             ---------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          254 ---------------FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       254 ---------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                                     ........+++.+.+||.+||..||++|||+.|+|+||||++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence                           00112346789999999999999999999999999999999753

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=400.50  Aligned_cols=300  Identities=23%  Similarity=0.396  Sum_probs=229.1

Q ss_pred             hhhhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEe
Q 040917           21 DAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK  100 (494)
Q Consensus        21 ~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~  100 (494)
                      +..+++...++.++|++++.||+|+||+||+|.++.+|+.||+|++++.. .+......+.+|+.+|++++ ||||++++
T Consensus         6 ~~~~~~~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-hpniv~l~   83 (346)
T d1cm8a_           6 RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLL   83 (346)
T ss_dssp             CEECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCS
T ss_pred             EEeccCceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcC-CCCeeEEE
Confidence            34456666778999999999999999999999999999999999997543 34456778999999999995 99999999


Q ss_pred             EEEEeCC------eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917          101 AAYEDDQ------FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA  174 (494)
Q Consensus       101 ~~~~~~~------~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~  174 (494)
                      +++...+      .+|+||||+ |.+|...++ ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++
T Consensus        84 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~  158 (346)
T d1cm8a_          84 DVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDC  158 (346)
T ss_dssp             EEECSCSSTTTCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTC
T ss_pred             EEeccCccccccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---cccc
Confidence            9997654      579999999 557776654 4679999999999999999999999999999999999999   7889


Q ss_pred             eEEEeecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCc
Q 040917          175 VVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEI  252 (494)
Q Consensus       175 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  252 (494)
                      .+||+|||.|.....  ......||+.|+|||++.+  .++.++||||+||++|+|++|+.||.+.+.......+.....
T Consensus       159 ~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~  236 (346)
T d1cm8a_         159 ELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG  236 (346)
T ss_dssp             CEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccC
Confidence            999999999986543  3345779999999999864  478999999999999999999999988877665544322111


Q ss_pred             -----------------------cCC----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCCc
Q 040917          253 -----------------------NFQ----RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPID  305 (494)
Q Consensus       253 -----------------------~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~~  305 (494)
                                             ...    ....+.+++.+.+||.+||..||.+|||+.|+|+||||+....+.+.|..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~  316 (346)
T d1cm8a_         237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQV  316 (346)
T ss_dssp             CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CC
T ss_pred             CCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccC
Confidence                                   011    11234678999999999999999999999999999999875433322221


Q ss_pred             HH---HHHHHHHHhhhhHHHHHHHHhhhc
Q 040917          306 TA---VIFRMKQFTAMNKLKKLALKVIVE  331 (494)
Q Consensus       306 ~~---~~~~~~~~~~~~~~~~l~~~~~~~  331 (494)
                      ..   .+...  ..+.+++++++..++.+
T Consensus       317 ~~~~~~~~~~--~~~~~e~k~~~~~e~~~  343 (346)
T d1cm8a_         317 QKYDDSFDDV--DRTLDEWKRVTYKEVLS  343 (346)
T ss_dssp             CCCCCC-------CCHHHHHHHHHHHHHT
T ss_pred             CCCCCchhhh--hcCHHHHHHHHHHHhhc
Confidence            11   11111  23456666666666654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.1e-51  Score=386.85  Aligned_cols=257  Identities=30%  Similarity=0.454  Sum_probs=215.5

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++++.||+|+||+||+|.++ +|+.||+|++..... .......+.+|+.++++++ ||||+++++++..++..+++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCceeEE
Confidence            58999999999999999999986 789999999976543 3334678999999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-  191 (494)
                      ++++.++.+..+....+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||.+....... 
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCcc
Confidence            9999887777776667889999999999999999999999999999999999999   678999999999998754332 


Q ss_pred             ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC--------------
Q 040917          192 AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ--------------  255 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~--------------  255 (494)
                      ......+++.|+|||.+.+  .++.++||||+||++|+|++|+.||.+.+..+....+.+......              
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence            2344568999999999864  479999999999999999999999998887776665532111100              


Q ss_pred             -----------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          256 -----------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       256 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                                 ....+.+++.+.+||.+||..||++|||++|+|+||||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                       0113457889999999999999999999999999999974

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=389.14  Aligned_cols=264  Identities=24%  Similarity=0.375  Sum_probs=215.5

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe------
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED------  105 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~------  105 (494)
                      .++|++++.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.++++++ ||||+++++++..      
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhc-CCCccceEeeeeccccccc
Confidence            4899999999999999999999999999999999876543 2335567889999999995 9999999998854      


Q ss_pred             --CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCC
Q 040917          106 --DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL  183 (494)
Q Consensus       106 --~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~  183 (494)
                        +...++|||++.++.+.........++...++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~  163 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGL  163 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTT
T ss_pred             ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecce
Confidence              34689999999887666555556679999999999999999999999999999999999999   6788999999999


Q ss_pred             ccccccCc-----ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCC
Q 040917          184 SAFIEEGK-----AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQR  256 (494)
Q Consensus       184 a~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  256 (494)
                      +.......     .....+||+.|+|||++.+  .+++++||||+||++|+|++|+.||.+.........+.+....+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            97654221     2234578999999999864  5899999999999999999999999998887776666443222222


Q ss_pred             CCCCC----------------------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCC
Q 040917          257 DPFPS----------------------------ISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEAS  300 (494)
Q Consensus       257 ~~~~~----------------------------~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~  300 (494)
                      ..+..                            .++.+.+||.+||..||++|||++|+|+||||+..+.|+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~  315 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS  315 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCC
Confidence            11111                            266788999999999999999999999999999765544

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-50  Score=382.60  Aligned_cols=251  Identities=22%  Similarity=0.318  Sum_probs=212.7

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      ..+|++.+.||+|+||+||+|.++.+|+.||+|++....    ...+.+.+|+.++++++ ||||+++++++.+++..++
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCC-CCCEecCCccEeeCCeeEE
Confidence            368999999999999999999999999999999986543    24567999999999995 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          112 VMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      |||||++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|.....
T Consensus        91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCS
T ss_pred             EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceeecCC
Confidence            99999999999998764  468999999999999999999999999999999999999   6788999999999987654


Q ss_pred             Ccc--cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          190 GKA--YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPF-WAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       190 ~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ...  .....|++.|+|||++. +.++.++|||||||++|+|++|..|| .+.+...+.+.+..+ ...  .....+|+.
T Consensus       168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~~--~~~~~~~~~  244 (287)
T d1opja_         168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRM--ERPEGCPEK  244 (287)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCC--CCCTTCCHH
T ss_pred             CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CCC--CCCccchHH
Confidence            332  22345788999999876 56999999999999999999976655 455555555555443 222  223568999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                      +.+||.+||..||++|||+.++++  +|+.
T Consensus       245 l~~li~~cl~~dP~~Rps~~ei~~--~L~~  272 (287)
T d1opja_         245 VYELMRACWQWNPSDRPSFAEIHQ--AFET  272 (287)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHH--HHHH
Confidence            999999999999999999999976  4543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-50  Score=383.35  Aligned_cols=250  Identities=24%  Similarity=0.380  Sum_probs=205.0

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCc---EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGL---EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~---~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      ..+|++.+.||+|+||+||+|.++.+++   .||+|.+....  .....+.+.+|+.++++++ ||||+++++++..++.
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCE
Confidence            4789999999999999999999987765   58888876433  3445678999999999995 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .++|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++++||+|||++...
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred             EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEc
Confidence            99999999999999988764 468999999999999999999999999999999999999   67899999999999866


Q ss_pred             ccCccc------ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCC
Q 040917          188 EEGKAY------REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPF  259 (494)
Q Consensus       188 ~~~~~~------~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  259 (494)
                      ......      ....+|+.|+|||++. +.++.++|||||||++|+|+| |+.||.+.+..++...+.++....   ..
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~---~~  255 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP---PP  255 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CC
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CC
Confidence            433221      1235688999999986 469999999999999999998 899999999988888887654322   22


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          260 PSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       260 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      ..+|+.+.+++.+||..||++|||+.+++++
T Consensus       256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            5689999999999999999999999999873

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-51  Score=382.32  Aligned_cols=250  Identities=22%  Similarity=0.391  Sum_probs=206.0

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++++.||+|+||+||+|.+.   ..||||+++..... ......+.+|+.++++++ ||||+++++++.. ...++
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~-~~~~l   80 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTR-HVNILLFMGYSTA-PQLAI   80 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SSCEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCC-CCCEeeeeEEEec-cEEEE
Confidence            378999999999999999999854   36999999765433 345778999999999995 9999999998754 56789


Q ss_pred             EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccC
Q 040917          112 VMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEG  190 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~  190 (494)
                      |||||+||+|.+++... .++++..+..++.||+.||.|||+++|+||||||+|||+   +.++.+||+|||+|......
T Consensus        81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC----
T ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceeecccc
Confidence            99999999999999754 569999999999999999999999999999999999999   57889999999999765432


Q ss_pred             c---ccccccCCcCccChhhhcc----cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HcCCccCC-CCCCCC
Q 040917          191 K---AYREIVGSPYYIAPEVLSQ----SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAI-LKGEINFQ-RDPFPS  261 (494)
Q Consensus       191 ~---~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~-~~~~~~~~-~~~~~~  261 (494)
                      .   ......||+.|+|||++.+    .++.++|||||||++|+|+||+.||.+.+........ .++...+. ......
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~  237 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN  237 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence            2   2345678999999999853    4789999999999999999999999887766554443 33332221 223457


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      +|+.+.+++.+||..||++|||+.+++++
T Consensus       238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         238 CPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            89999999999999999999999999975

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=390.67  Aligned_cols=251  Identities=20%  Similarity=0.328  Sum_probs=211.2

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCc-----EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGL-----EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ  107 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~-----~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~  107 (494)
                      ++|++++.||+|+||+||+|.+..+++     .||+|.+....  .......+.+|+.++.++.+||||+++++++.+.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            689999999999999999999876554     69999986543  22345678899999999966999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 040917          108 FVHIVMELCAGGELFDRIVARG-----------------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPEN  164 (494)
Q Consensus       108 ~~~iv~e~~~g~sL~~~~~~~~-----------------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~N  164 (494)
                      ..++|||||+||+|.+++....                       .+++..+..++.||+.||.|||+++|+||||||+|
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N  194 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  194 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence            9999999999999999997542                       47889999999999999999999999999999999


Q ss_pred             eEEeeCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 040917          165 FLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAET  239 (494)
Q Consensus       165 Ili~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~  239 (494)
                      |++   +.++.+||+|||+|........   .....||+.|+|||++. +.++.++|||||||++|+|+| |..||.+.+
T Consensus       195 ill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         195 VLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             EEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            999   5789999999999986544332   23456799999999886 569999999999999999998 899998877


Q ss_pred             hHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          240 DQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      .......+......++.  ...+|+.+.+||.+||+.||++|||+++|++|
T Consensus       272 ~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         272 VDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            66655555555443332  25689999999999999999999999999974

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-50  Score=375.57  Aligned_cols=246  Identities=24%  Similarity=0.403  Sum_probs=204.1

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++++.||+|+||+||+|.+. +++.||||++....    ...+.+.+|+.++++++ ||||+++++++..++..++|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc----CcHHHHHHHHHHHHhcC-CCCcccccceeccCCceEEE
Confidence            57999999999999999999986 57789999997533    24567999999999995 99999999999998999999


Q ss_pred             EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      |||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+||++   +.++.+||+|||++.......
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC---------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCC
Confidence            9999999999988654 468899999999999999999999999999999999999   678899999999998654432


Q ss_pred             c--cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          192 A--YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       192 ~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      .  .....||+.|+|||++.+ .++.++|||||||++|+|+| |..||...+..++...+..+.....+   ...++.+.
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p---~~~~~~l~  232 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHVY  232 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCC---TTSCHHHH
T ss_pred             ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCc---cccCHHHH
Confidence            2  223568999999999874 69999999999999999999 56777777877788877776443322   45789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcC
Q 040917          268 ELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      +++.+||..||++|||+++++++
T Consensus       233 ~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         233 QIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999999984

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-50  Score=373.39  Aligned_cols=246  Identities=23%  Similarity=0.377  Sum_probs=215.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      .+|++++.||+|+||+||+|+++ +++.||||++++...    ..+.+.+|+.++++++ ||||+++++++.+++.+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEE
Confidence            57999999999999999999985 788999999976442    3567999999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVA-RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      |||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.......
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSS
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCC
Confidence            999999999988654 4568999999999999999999999999999999999999   678899999999997654433


Q ss_pred             cc--ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          192 AY--REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       192 ~~--~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      ..  ....+|+.|+|||++. +.++.++|||||||++|+|+| |+.||.+.+..++...+.++.....   ....++.+.
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~  231 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVY  231 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHH
T ss_pred             ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC---cccccHHHH
Confidence            22  2356889999999986 468999999999999999998 8999999999988888877543332   246889999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcC
Q 040917          268 ELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      +||.+||+.||++|||++++++|
T Consensus       232 ~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         232 TIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-50  Score=389.67  Aligned_cols=266  Identities=30%  Similarity=0.459  Sum_probs=214.9

Q ss_pred             cccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC-
Q 040917           29 EDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ-  107 (494)
Q Consensus        29 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~-  107 (494)
                      -++..+|++++.||+|+||+||+|.+..+|+.||||++.+..  .......+.+|+.+|++|+ ||||+++++++.... 
T Consensus         4 ~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTI   80 (345)
T ss_dssp             CCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSST
T ss_pred             cCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeeccc
Confidence            356789999999999999999999999999999999997543  3445677899999999995 999999999996543 


Q ss_pred             ----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCC
Q 040917          108 ----FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL  183 (494)
Q Consensus       108 ----~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~  183 (494)
                          .+++++ ++.|++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||+   +..+.+||+|||+
T Consensus        81 ~~~~~~~l~~-~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~  155 (345)
T d1pmea_          81 EQMKDVYLVT-HLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGL  155 (345)
T ss_dssp             TTCCCEEEEE-ECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred             cccceEEEEE-eecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCc
Confidence                355555 55688999998764 69999999999999999999999999999999999999   6788999999999


Q ss_pred             ccccccCcc----cccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc----
Q 040917          184 SAFIEEGKA----YREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN----  253 (494)
Q Consensus       184 a~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~----  253 (494)
                      +........    ....+||+.|+|||++..  .++.++||||+||++|+|++|+.||.+....+...........    
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (345)
T d1pmea_         156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  235 (345)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence            976543322    244678999999998753  4788999999999999999999999888766554443211000    


Q ss_pred             ----------------C---C----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCC
Q 040917          254 ----------------F---Q----RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDK  302 (494)
Q Consensus       254 ----------------~---~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~  302 (494)
                                      .   .    ...++.+++.+.+||.+||..||.+|||++++|+||||+....+.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~  307 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE  307 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGS
T ss_pred             hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccC
Confidence                            0   0    01235678899999999999999999999999999999976555443

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=378.97  Aligned_cols=251  Identities=20%  Similarity=0.326  Sum_probs=213.1

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++++.||+|+||.||+|.++ ++..||||++....    ...+.+.+|+.++++++ ||||+++++++.+ +..++
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhCC-CCCEeEEEeeecc-CCeEE
Confidence            478999999999999999999986 57889999996533    24567999999999995 9999999998755 45789


Q ss_pred             EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          112 VMELCAGGELFDRIVAR--GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      ||||+++|+|.+++...  .+++...+..++.||+.||.|||+++|+||||||+||++   +.++.+||+|||+|.....
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEEccC
Confidence            99999999999877543  358999999999999999999999999999999999999   6789999999999987654


Q ss_pred             Ccc--cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          190 GKA--YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCG-VPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       190 ~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ...  .....||+.|+|||++. +.++.++|||||||++|+|+|| ..|+......++...+..+.....+   ..+|+.
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p---~~~~~~  238 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP---DNCPEE  238 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---TTCCHH
T ss_pred             CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCc---ccChHH
Confidence            332  23456889999999986 4699999999999999999995 5666777777777777765433322   468999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc--CCccCc
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLE--HPWLKE  295 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~--~~~~~~  295 (494)
                      +.+++.+||+.||++|||++++++  ++||..
T Consensus       239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            999999999999999999999998  788764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=379.31  Aligned_cols=246  Identities=22%  Similarity=0.321  Sum_probs=206.6

Q ss_pred             eeecccCCeEEEEEEEC--CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEEEecc
Q 040917           39 REVGRGEFGITYLCTEN--STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIVMELC  116 (494)
Q Consensus        39 ~~lg~G~~g~Vy~a~~~--~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv~e~~  116 (494)
                      +.||+|+||+||+|.++  .+++.||+|+++.... +....+.+.+|+.++++++ ||||+++++++..+ ..++|||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~~-~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGICEAE-SWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEESS-SEEEEEECC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCC-CCCCceEEEEeccC-CEEEEEEcC
Confidence            46999999999999864  4567899999975442 3345678999999999995 99999999998654 578999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCccc---
Q 040917          117 AGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGKAY---  193 (494)
Q Consensus       117 ~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~~---  193 (494)
                      +||+|.+++.....+++..+..++.||+.||.|||+++|+||||||+||++   +.++.+||+|||++.........   
T Consensus        90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc---cccCcccccchhhhhhcccccccccc
Confidence            999999999998899999999999999999999999999999999999999   57889999999999865433221   


Q ss_pred             -ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHH
Q 040917          194 -REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAIELV  270 (494)
Q Consensus       194 -~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  270 (494)
                       ....||+.|+|||++. +.++.++|||||||++|+|+| |+.||.+.+..++...+.++.....   ...+|+.+.+++
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~~~~li  243 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PAGCPREMYDLM  243 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHHH
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC---CcccCHHHHHHH
Confidence             2346889999999886 468999999999999999997 8999999998888888877543322   246899999999


Q ss_pred             HHhcccCCCCCCCHHHHh---cCCcc
Q 040917          271 RRMLTQDPKRRITVAQVL---EHPWL  293 (494)
Q Consensus       271 ~~~l~~dp~~Rps~~eil---~~~~~  293 (494)
                      .+||..||++|||+.+++   +|+|+
T Consensus       244 ~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         244 NLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            999999999999999984   55554

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=9.2e-50  Score=385.80  Aligned_cols=255  Identities=26%  Similarity=0.490  Sum_probs=212.5

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe--CCeE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED--DQFV  109 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~--~~~~  109 (494)
                      .++|++++.||+|+||+||+|+++.+|+.||+|+++..      ....+.+|+.+|+.+++||||+++++++..  ....
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            47899999999999999999999999999999998643      256788999999999779999999999974  4569


Q ss_pred             EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          110 HIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      ++|||||++++|....   +.+++..+..+++||+.||.|||++||+||||||+|||++  .+++.++|+|||+|.....
T Consensus       108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCT
T ss_pred             eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccceeccC
Confidence            9999999999997653   5699999999999999999999999999999999999995  3456799999999987766


Q ss_pred             CcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH-------------cCCcc
Q 040917          190 GKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQG-VAQAIL-------------KGEIN  253 (494)
Q Consensus       190 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~-~~~~~~-------------~~~~~  253 (494)
                      ........+|+.|+|||++.+  .++.++||||+||++|+|++|+.||....... ....+.             .....
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence            666667789999999999864  47999999999999999999999997655322 111110             00000


Q ss_pred             --------------------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          254 --------------------FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       254 --------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                                          ........+++++.+||.+||..||.+|||++|+|+||||+...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                                01111234788999999999999999999999999999998743

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-50  Score=378.00  Aligned_cols=252  Identities=22%  Similarity=0.341  Sum_probs=213.7

Q ss_pred             cceEeeee-ecccCCeEEEEEEECC--CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           33 LHYTIGRE-VGRGEFGITYLCTENS--TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        33 ~~y~i~~~-lg~G~~g~Vy~a~~~~--~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      ++|.+.+. ||+|+||+||+|.++.  ++..||||+++...  .....+.+.+|+.++++++ ||||+++++++..+ ..
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~-~~   83 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQAE-AL   83 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-SE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCC-CCCEeeEeeeeccC-eE
Confidence            57888885 9999999999998764  45579999996543  3445678999999999995 99999999998754 57


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      ++|||||+||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++....
T Consensus        84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEECT
T ss_pred             EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee---ccCCceeeccchhhhccc
Confidence            8999999999999987653 579999999999999999999999999999999999999   567899999999998764


Q ss_pred             cCccc----ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          189 EGKAY----REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       189 ~~~~~----~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      .....    ....||+.|+|||++. +.++.++|||||||++|||+| |+.||.+.+..++...+.++.....   .+.+
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~  237 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPEC  237 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC---CTTC
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCcC
Confidence            43222    2346789999999986 568999999999999999998 8999999988888888877654322   2568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHH---hcCCccC
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQV---LEHPWLK  294 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~ei---l~~~~~~  294 (494)
                      |+.+.++|.+||..||++|||+.++   |+|+|+.
T Consensus       238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            9999999999999999999999988   5677765

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=395.16  Aligned_cols=274  Identities=25%  Similarity=0.416  Sum_probs=222.4

Q ss_pred             hhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEE
Q 040917           23 ILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAA  102 (494)
Q Consensus        23 ~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~  102 (494)
                      .+.....++.++|++++.||+|+||+||+|++..+|+.||||++.+.. .+......+.+|+.++++++ ||||++++++
T Consensus         8 ~~~~~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~   85 (348)
T d2gfsa1           8 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDV   85 (348)
T ss_dssp             ECSSSEEEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEE
T ss_pred             ecCCccccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcC-CCCeeeEEEE
Confidence            344556778899999999999999999999999999999999997644 34445677899999999995 9999999999


Q ss_pred             EEeC-----CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEE
Q 040917          103 YEDD-----QFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVK  177 (494)
Q Consensus       103 ~~~~-----~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~k  177 (494)
                      +...     ...+++++++.||+|.+++.. +++++..+..++.||+.||.|||++||+||||||+|||+   +.++.++
T Consensus        86 ~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~k  161 (348)
T d2gfsa1          86 FTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELK  161 (348)
T ss_dssp             ECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEE
T ss_pred             EeeccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---ccccccc
Confidence            8632     234556677789999998855 579999999999999999999999999999999999999   6789999


Q ss_pred             EeecCCccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCC
Q 040917          178 ATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQ  255 (494)
Q Consensus       178 L~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  255 (494)
                      ++|||.+.....  ......|++.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+.......+........
T Consensus       162 l~dfg~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~  239 (348)
T d2gfsa1         162 ILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  239 (348)
T ss_dssp             ECCC----CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccccchhcccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            999999875432  3345678999999998754  368899999999999999999999998887766665543211110


Q ss_pred             -----------------------CC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccCcCCCCCC
Q 040917          256 -----------------------RD----PFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESGEASDKPI  304 (494)
Q Consensus       256 -----------------------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~~~~~~~~  304 (494)
                                             ..    .+..+++.+.+||.+||..||.+|||+.|+|+||||+....+...|.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~  315 (348)
T d2gfsa1         240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV  315 (348)
T ss_dssp             HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCC
T ss_pred             hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCC
Confidence                                   00    12467899999999999999999999999999999997655554443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=386.37  Aligned_cols=255  Identities=28%  Similarity=0.445  Sum_probs=210.8

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe------C
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED------D  106 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~------~  106 (494)
                      .+|+.++.||+|+||+||+|++..+|+.||||++.....       ...+|+.++++++ ||||+++++++..      .
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~   91 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDE   91 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSC
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcC-CCCCCcEEEEEEecCccCCc
Confidence            479999999999999999999999999999999975432       1236999999994 9999999999853      3


Q ss_pred             CeEEEEEeccCCCchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCC
Q 040917          107 QFVHIVMELCAGGELFDR---IVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGL  183 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~  183 (494)
                      .+.++|||||+++.+..+   ......+++..+..+++||+.||.|||++||+||||||+|||++  .+...+||+|||+
T Consensus        92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~--~~~~~~kl~DFG~  169 (350)
T d1q5ka_          92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGS  169 (350)
T ss_dssp             CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC--TTTCCEEECCCTT
T ss_pred             eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEe--cCCCceeEecccc
Confidence            368999999987543332   23455799999999999999999999999999999999999994  2335899999999


Q ss_pred             ccccccCcccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC-----------
Q 040917          184 SAFIEEGKAYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG-----------  250 (494)
Q Consensus       184 a~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~-----------  250 (494)
                      +.............|++.|+|||.+.+  .++.++||||+||++|+|++|+.||...+..+....+.+.           
T Consensus       170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             hhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            987766666667889999999998753  5899999999999999999999999988877766555321           


Q ss_pred             ------CccCC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          251 ------EINFQ--------RDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       251 ------~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                            ...++        ....+.+++.+.+||.+||..||.+|||+.|+|+||||++..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence                  00000        112345789999999999999999999999999999998643

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-49  Score=374.08  Aligned_cols=260  Identities=24%  Similarity=0.400  Sum_probs=219.6

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      ++|++++.||+|+||+||+|++..+|+.||||+++.... .......+.+|+.++++++ ||||+++++++.+....+++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccceeEE
Confidence            589999999999999999999999999999999976543 4446788999999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc-
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK-  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~-  191 (494)
                      ++++.|++|..++...+.++...+..++.|++.||.|||++||+||||||+|||+   +..+.+||+|||.+....... 
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCS
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCc
Confidence            9999999998888888889999999999999999999999999999999999999   677899999999998765433 


Q ss_pred             ccccccCCcCccChhhhcc--cCCCcchhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHcCCcc---------------
Q 040917          192 AYREIVGSPYYIAPEVLSQ--SYGKEADIWSAGVILYILLCGVPPF-WAETDQGVAQAILKGEIN---------------  253 (494)
Q Consensus       192 ~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~il~~l~tg~~pf-~~~~~~~~~~~~~~~~~~---------------  253 (494)
                      ......+++.|.|||++.+  .++.++||||+||++|+|++|+.|| .+.+..+....+......               
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence            2234557889999998864  3689999999999999999999885 444444444444221111               


Q ss_pred             ----------CCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCccC
Q 040917          254 ----------FQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKESG  297 (494)
Q Consensus       254 ----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~~~  297 (494)
                                ......+.+++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                      01112345788999999999999999999999999999998644

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-50  Score=386.77  Aligned_cols=260  Identities=27%  Similarity=0.521  Sum_probs=220.4

Q ss_pred             cceEeeeeecccCCeEEEEEEE---CCCCcEEEEEEeccCCCC-ChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           33 LHYTIGREVGRGEFGITYLCTE---NSTGLEFACKSIPKRKLV-KDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~---~~~~~~valK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      ++|++++.||+|+||+||+|.+   +.+|+.||||++.+.... .....+.+.+|+.++++++.||||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999987   457899999998754422 222355678899999999755899999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          109 VHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      .+++|||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.++|+|||++....
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEECC
T ss_pred             eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhhhc
Confidence            99999999999999999998899999999999999999999999999999999999999   678899999999997654


Q ss_pred             cCc--ccccccCCcCccChhhhcc---cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917          189 EGK--AYREIVGSPYYIAPEVLSQ---SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       189 ~~~--~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      ...  ......|++.|+|||.+.+   .++.++|||||||++|+|++|+.||.+....+....+.+............++
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s  260 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS  260 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence            322  2345678999999999864   36889999999999999999999998776555544444433333333345789


Q ss_pred             HHHHHHHHHhcccCCCCCC-----CHHHHhcCCccCc
Q 040917          264 SSAIELVRRMLTQDPKRRI-----TVAQVLEHPWLKE  295 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rp-----s~~eil~~~~~~~  295 (494)
                      +.+.+||.+||..||.+||     +++|+|+||||+.
T Consensus       261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            9999999999999999999     4899999999985

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-50  Score=392.59  Aligned_cols=269  Identities=24%  Similarity=0.348  Sum_probs=208.3

Q ss_pred             hhhhcccccccccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEe
Q 040917           21 DAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFK  100 (494)
Q Consensus        21 ~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~  100 (494)
                      ...+++..-.+..+|++++.||+|+||+||+|.++.+|+.||||++.+... +......+.+|+.++++++ ||||++++
T Consensus         5 ~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~~~   82 (355)
T d2b1pa1           5 SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLL   82 (355)
T ss_dssp             EEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCS
T ss_pred             EEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcC-CCCeeEEE
Confidence            344555444566899999999999999999999999999999999976543 4445677899999999994 99999999


Q ss_pred             EEEEe------CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917          101 AAYED------DQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA  174 (494)
Q Consensus       101 ~~~~~------~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~  174 (494)
                      +++..      ..+.|+|||||.|+ +...+  ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++
T Consensus        83 ~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~  156 (355)
T d2b1pa1          83 NVFTPQKTLEEFQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDC  156 (355)
T ss_dssp             EEECSCCSTTTCCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTC
T ss_pred             EEEecccccccCceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---cccc
Confidence            99953      46899999999764 54444  3568999999999999999999999999999999999999   6788


Q ss_pred             eEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcCCcc
Q 040917          175 VVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKGEIN  253 (494)
Q Consensus       175 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  253 (494)
                      .++++|||.+.............+|+.|+|||++.+ .+++++||||+||++++|++|+.||.+.+.......+......
T Consensus       157 ~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~  236 (355)
T d2b1pa1         157 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT  236 (355)
T ss_dssp             CEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             ceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccC
Confidence            999999999887766666667789999999999875 5899999999999999999999999888776655444321110


Q ss_pred             ----------------------CCCCC----------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCccCc
Q 040917          254 ----------------------FQRDP----------------FPSISSSAIELVRRMLTQDPKRRITVAQVLEHPWLKE  295 (494)
Q Consensus       254 ----------------------~~~~~----------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~~~~~~  295 (494)
                                            .....                ....++.+.+||.+||..||++|||++|+|+||||+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence                                  00000                0013567899999999999999999999999999986


Q ss_pred             cC
Q 040917          296 SG  297 (494)
Q Consensus       296 ~~  297 (494)
                      ..
T Consensus       317 ~~  318 (355)
T d2b1pa1         317 WY  318 (355)
T ss_dssp             GC
T ss_pred             CC
Confidence            43

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=368.11  Aligned_cols=253  Identities=22%  Similarity=0.323  Sum_probs=208.5

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~i  111 (494)
                      .++|++++.||+|+||+||+|.++.+ +.||||++.....    ..+.+.+|+.++++++ ||||+++++++.+ +..++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~-~~~~l   88 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYI   88 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcc-cCCEeEEEEEEec-CCeEE
Confidence            37899999999999999999998755 5699999964432    3567999999999995 9999999999855 45789


Q ss_pred             EEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          112 VMELCAGGELFDRIVA--RGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      ||||+++|+|.+++..  .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIED  165 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC----
T ss_pred             EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccC
Confidence            9999999999988864  3569999999999999999999999999999999999999   6778999999999986543


Q ss_pred             Ccc--cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHH
Q 040917          190 GKA--YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCG-VPPFWAETDQGVAQAILKGEINFQRDPFPSISSS  265 (494)
Q Consensus       190 ~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (494)
                      ...  .....+|+.|+|||++. +.++.++|||||||++|+|++| ..|+......++...+.++....   ..+.+|+.
T Consensus       166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~---~~~~~~~~  242 (285)
T d1fmka3         166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---CPPECPES  242 (285)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTSCHH
T ss_pred             CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC---CCcccCHH
Confidence            322  23356899999999986 5699999999999999999995 45566667777777776653322   23578999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc--CCccCccC
Q 040917          266 AIELVRRMLTQDPKRRITVAQVLE--HPWLKESG  297 (494)
Q Consensus       266 l~~li~~~l~~dp~~Rps~~eil~--~~~~~~~~  297 (494)
                      +.++|.+||..||++|||++++++  ++||....
T Consensus       243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            999999999999999999999988  88988653

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=366.98  Aligned_cols=249  Identities=26%  Similarity=0.385  Sum_probs=203.5

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCC---CcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENST---GLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~---~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      .++|++++.||+|+||.||+|.+..+   +..||+|.+....  .......+.+|+.++++++ ||||+++++++. .+.
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SSS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe-cCe
Confidence            36899999999999999999998654   3468888885432  4455778999999999995 999999999986 457


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+||++   +.++.+||+|||++...
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC-------
T ss_pred             EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee---cCCCcEEEccchhheec
Confidence            89999999999999987654 468999999999999999999999999999999999999   56789999999999865


Q ss_pred             ccCcc--cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCC
Q 040917          188 EEGKA--YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSIS  263 (494)
Q Consensus       188 ~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (494)
                      .....  .....||+.|+|||++. +.++.++|||||||++|+|++ |..||.+.+..++...+.++....   ..+.+|
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~---~~~~~~  235 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNCP  235 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTCC
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCC
Confidence            43322  23456789999999986 568999999999999999987 899999999888888887765432   235789


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          264 SSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       264 ~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      +.+.+||.+||..||++|||+.+++++
T Consensus       236 ~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         236 PTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999999874

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-48  Score=364.48  Aligned_cols=248  Identities=24%  Similarity=0.356  Sum_probs=202.7

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCC----cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTG----LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~----~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      ..|++.++||+|+||.||+|.++.++    ..||||++....  .......+.+|+.++++++ ||||+++++++.....
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCCc
Confidence            57999999999999999999987654    479999986433  3345667899999999995 9999999999999899


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .++||||+.++++.+.+... ..++...+..++.||+.||.|||+++|+||||||+|||+   +.++.+||+|||++...
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC----
T ss_pred             eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhhcc
Confidence            99999999999999887654 569999999999999999999999999999999999999   67899999999999865


Q ss_pred             ccCcc----cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHcCCccCCCCCCCC
Q 040917          188 EEGKA----YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGV-PPFWAETDQGVAQAILKGEINFQRDPFPS  261 (494)
Q Consensus       188 ~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (494)
                      .....    .....||+.|+|||++.+ .++.++|||||||++|+|+++. .|+...+..++...+..+....   ....
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~---~~~~  237 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP---TPMD  237 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CCTT
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC---Cchh
Confidence            43322    123467899999998864 6899999999999999999964 5566666666777666553322   2246


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          262 ISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       262 ~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +|..+.++|.+||..||++|||+.++++
T Consensus       238 ~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         238 CPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            8899999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=366.20  Aligned_cols=250  Identities=22%  Similarity=0.348  Sum_probs=203.0

Q ss_pred             cceEeeeeecccCCeEEEEEEECC-CC--cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENS-TG--LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFV  109 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~-~~--~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~  109 (494)
                      ++|++.+.||+|+||.||+|.+.. ++  ..||+|++.+.........+.+.+|+.++++++ ||||+++++++.++ ..
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~~-~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTP-PM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSS-SC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeec-ch
Confidence            679999999999999999998643 33  368999998766556666788999999999994 99999999999754 57


Q ss_pred             EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccc
Q 040917          110 HIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIE  188 (494)
Q Consensus       110 ~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~  188 (494)
                      ++||||++++++.+.+... +.++...+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++....
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll---~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEECC
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc---ccccceeeccchhhhhcc
Confidence            8999999999999877654 569999999999999999999999999999999999999   457899999999998764


Q ss_pred             cCcc----cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          189 EGKA----YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       189 ~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      ....    .....++..|+|||++.+ .++.++|||||||++|+|+| |..||.+.+..+....+.+....++.  .+.+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~  240 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDC  240 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTTC
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC--cccc
Confidence            3322    223457789999999864 58899999999999999998 89999999999998888777654433  3578


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      |+.+.++|.+||..||++|||+.+|++
T Consensus       241 ~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         241 PQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999975

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=372.33  Aligned_cols=250  Identities=24%  Similarity=0.328  Sum_probs=211.1

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcE--EEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLE--FACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~--valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ++|++.+.||+|+||.||+|.++.+|..  ||||.+....  .....+.+.+|+.++.++.+||||+++++++.+++..+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            5899999999999999999999888775  6677764322  23345679999999999966999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCC
Q 040917          111 IVMELCAGGELFDRIVAR----------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENA  174 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~  174 (494)
                      +||||++||+|.+++...                ..++...+..++.||+.||.|||+++|+||||||+|||+   +.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCCC
Confidence            999999999999998654                468999999999999999999999999999999999999   6788


Q ss_pred             eEEEeecCCccccccCcccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHcCCc
Q 040917          175 VVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGV-PPFWAETDQGVAQAILKGEI  252 (494)
Q Consensus       175 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~-~pf~~~~~~~~~~~~~~~~~  252 (494)
                      .+||+|||++.............||+.|+|||.+. +.++.++|||||||++|+|++|. .||.+.+..++...+.++..
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~  244 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  244 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence            99999999998765555545567899999999986 46899999999999999999965 67888888888877766532


Q ss_pred             cCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          253 NFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       253 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                         ......+|+.+.+||.+||..||++|||+.+++++
T Consensus       245 ---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         245 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence               22235689999999999999999999999999985

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-48  Score=369.82  Aligned_cols=248  Identities=20%  Similarity=0.288  Sum_probs=205.6

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCc----EEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCe
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGL----EFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQF  108 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~----~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~  108 (494)
                      ++|++++.||+|+||+||+|.+..+|+    +||+|.+....  .....+.+.+|+.++++++ ||||+++++++.++ .
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~-~   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-S
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC-C
Confidence            479999999999999999999988876    57888775432  3335678999999999995 99999999999865 4


Q ss_pred             EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccc
Q 040917          109 VHIVMELCAGGELFDRIVAR-GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFI  187 (494)
Q Consensus       109 ~~iv~e~~~g~sL~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~  187 (494)
                      .+++++++.+++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+||++   +.++++||+|||++...
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCCSHHHHT
T ss_pred             eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee---CCCCCeEeeccccceec
Confidence            67888999999999887664 569999999999999999999999999999999999999   56789999999999876


Q ss_pred             ccCccc---ccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCC
Q 040917          188 EEGKAY---REIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSI  262 (494)
Q Consensus       188 ~~~~~~---~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (494)
                      ......   ....||+.|+|||++. +.++.++|||||||++|+|+| |..||.+.+..++...+.++.....   .+.+
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~---p~~~  238 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPIC  238 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC---CTTB
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---Cccc
Confidence            443322   2345799999999876 468999999999999999998 7999998888877777766543322   2468


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          263 SSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       263 ~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      |+.+.+++.+||..||.+|||+.++++|
T Consensus       239 ~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         239 TIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            8999999999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-48  Score=359.86  Aligned_cols=241  Identities=24%  Similarity=0.327  Sum_probs=201.0

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-CCeEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-DQFVHI  111 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-~~~~~i  111 (494)
                      ++|++++.||+|+||.||+|.++  |..||+|+++...     ..+.+.+|+.++++++ ||||+++++++.+ .+.+++
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~l   78 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI   78 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CCEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEecCCcEEE
Confidence            57999999999999999999985  7899999996433     4567899999999995 9999999998854 456899


Q ss_pred             EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          112 VMELCAGGELFDRIVARG--HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       112 v~e~~~g~sL~~~~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      ||||+++|+|.+++....  .+++..+..++.||+.||.|||+++|+||||||+||++   +.++.+||+|||++.....
T Consensus        79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC------
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccceecCC
Confidence            999999999999986543  48999999999999999999999999999999999999   6789999999999986543


Q ss_pred             CcccccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHcCCccCCCCCCCCCCHHHH
Q 040917          190 GKAYREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGVAQAILKGEINFQRDPFPSISSSAI  267 (494)
Q Consensus       190 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  267 (494)
                      .  .....+++.|+|||++. +.++.++|||||||++|+|+| |+.||...+..++...+.++....   ..+.+++.+.
T Consensus       156 ~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~~~  230 (262)
T d1byga_         156 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---APDGCPPAVY  230 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC---CCTTCCHHHH
T ss_pred             C--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCccCCHHHH
Confidence            3  23456789999999885 579999999999999999998 789998888888888876653322   2246889999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 040917          268 ELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       268 ~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ++|.+||..||.+|||+.++++
T Consensus       231 ~li~~cl~~dP~~Rps~~~l~~  252 (262)
T d1byga_         231 EVMKNCWHLDAAMRPSFLQLRE  252 (262)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcccCHhHCcCHHHHHH
Confidence            9999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-47  Score=363.53  Aligned_cols=250  Identities=22%  Similarity=0.308  Sum_probs=214.4

Q ss_pred             cccceEeeeeecccCCeEEEEEEEC-----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTEN-----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED  105 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~  105 (494)
                      ..++|++++.||+|+||+||+|+++     .+++.||||++....  .......+.+|+.++++++ ||||+++++++..
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~   87 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCAV   87 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcC-CCCcccceeeecc
Confidence            4568999999999999999999975     356789999986533  3445678999999999995 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 040917          106 DQFVHIVMELCAGGELFDRIVARG------------------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLK  161 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~~------------------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dik  161 (494)
                      .+..+++|||+++|+|.+++....                        .++...+..++.||+.||.|||+++|+|||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK  167 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  167 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence            999999999999999999986532                        37889999999999999999999999999999


Q ss_pred             CCceEEeeCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCC-CCCC
Q 040917          162 PENFLFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGV-PPFW  236 (494)
Q Consensus       162 p~NIli~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~-~pf~  236 (494)
                      |+|||+   +.++.+||+|||++....+...   .....+++.|+|||.+.+ .++.++|||||||++|+|++|. .||.
T Consensus       168 p~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         168 TRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             GGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             ccceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            999999   6788999999999976543322   234567899999999875 6999999999999999999985 6899


Q ss_pred             CCChHHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          237 AETDQGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +....++...+..+.....   ...+|+.+.+++.+||+.||++|||+.+|++
T Consensus       245 ~~~~~e~~~~v~~~~~~~~---p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         245 GMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHcCCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999988888877654322   2468999999999999999999999999976

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=365.16  Aligned_cols=251  Identities=21%  Similarity=0.333  Sum_probs=198.9

Q ss_pred             ccceEeeeeecccCCeEEEEEEECC-----CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENS-----TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-  105 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-  105 (494)
                      .++|++++.||+|+||.||+|.+..     +++.||+|++....  .......+.+|..++.++..||||+.+++++.. 
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            3689999999999999999999754     45689999986433  333466788889999988779999999998765 


Q ss_pred             CCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEee
Q 040917          106 DQFVHIVMELCAGGELFDRIVAR----------------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTT  169 (494)
Q Consensus       106 ~~~~~iv~e~~~g~sL~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~  169 (494)
                      +...++|||||+||+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+|||+  
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl--  167 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--  167 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE--
Confidence            44689999999999999999753                247899999999999999999999999999999999999  


Q ss_pred             CCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhC-CCCCCCCChHH-H
Q 040917          170 GDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCG-VPPFWAETDQG-V  243 (494)
Q Consensus       170 ~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg-~~pf~~~~~~~-~  243 (494)
                       +.++++||+|||+|........   .....||+.|+|||++.+ .++.++|||||||++|+|+++ ..||.+....+ .
T Consensus       168 -~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~  246 (299)
T d1ywna1         168 -SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  246 (299)
T ss_dssp             -CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             -CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence             6788999999999976543322   234578999999998864 589999999999999999987 46787765444 3


Q ss_pred             HHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          244 AQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      ...+..+... .  ....+++.+.+++.+||..||++|||+.++++|
T Consensus       247 ~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         247 CRRLKEGTRM-R--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHTCCC-C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCC-C--CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4444443322 2  224688999999999999999999999999985

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-47  Score=361.53  Aligned_cols=250  Identities=24%  Similarity=0.356  Sum_probs=210.3

Q ss_pred             ccceEeeeeecccCCeEEEEEEECCCC-------cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEE
Q 040917           32 QLHYTIGREVGRGEFGITYLCTENSTG-------LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYE  104 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~-------~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~  104 (494)
                      .++|.+++.||+|+||.||+|++..++       ..||+|+++...  .......+.+|...+.++.+||||+++++++.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            479999999999999999999876554       479999996543  34456778889999999967999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEe
Q 040917          105 DDQFVHIVMELCAGGELFDRIVARG----------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFT  168 (494)
Q Consensus       105 ~~~~~~iv~e~~~g~sL~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~  168 (494)
                      ++...++||||+++|+|.+++....                .++...+..++.||+.||.|||+++|+||||||+|||+ 
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl-  168 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV-  168 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee-
Confidence            9999999999999999999997543                48999999999999999999999999999999999999 


Q ss_pred             eCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 040917          169 TGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGV  243 (494)
Q Consensus       169 ~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~  243 (494)
                        +.++.+||+|||.+........   .....+++.|+|||.+. +.|+.++|||||||++|+|++ |..||.+.+...+
T Consensus       169 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~  246 (299)
T d1fgka_         169 --TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  246 (299)
T ss_dssp             --CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             --cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence              6788999999999987654332   23466889999999885 579999999999999999998 7899998888888


Q ss_pred             HHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          244 AQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      ...+.++....   ....+|+.+.++|.+||+.||.+|||+.++++
T Consensus       247 ~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         247 FKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHTTCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCCC---CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            77776653322   22468999999999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-47  Score=363.18  Aligned_cols=259  Identities=20%  Similarity=0.296  Sum_probs=205.4

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ++++|++++.||+|+||.||+|.+..+|+.||||++.....     ...+.+|+++++.+.+|++|+.+..++..+...+
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~   79 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   79 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence            45789999999999999999999999999999999875432     2347789999999975556777777888889999


Q ss_pred             EEEeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCcccccc
Q 040917          111 IVMELCAGGELFDRIV-ARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEE  189 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~  189 (494)
                      +||||+. ++|...+. ....++...+..++.|++.||.|||++||+||||||+||+++..+.+..++|+|||+|.....
T Consensus        80 ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          80 MVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             EEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            9999995 56666554 455799999999999999999999999999999999999996555677899999999987643


Q ss_pred             Ccc--------cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHcC---CccC-CC
Q 040917          190 GKA--------YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQGVAQAILKG---EINF-QR  256 (494)
Q Consensus       190 ~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~~~~~~~~~~---~~~~-~~  256 (494)
                      ...        .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........+.+.   .... .+
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  238 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence            221        234579999999999876 5899999999999999999999999877665443322211   1111 11


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHH---HhcCCccCc
Q 040917          257 DPFPSISSSAIELVRRMLTQDPKRRITVAQ---VLEHPWLKE  295 (494)
Q Consensus       257 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~e---il~~~~~~~  295 (494)
                      ...+.+|+++.+++.+||..+|++||++++   +|+|+|.+.
T Consensus       239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            123568999999999999999999999875   467766544

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=358.82  Aligned_cols=260  Identities=21%  Similarity=0.323  Sum_probs=218.7

Q ss_pred             hhhhcccccccccceEeeeeecccCCeEEEEEEECC-----CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCC
Q 040917           21 DAILGKAYEDVQLHYTIGREVGRGEFGITYLCTENS-----TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPN   95 (494)
Q Consensus        21 ~~~~~~~~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~   95 (494)
                      +.++.+..+-..++|++++.||+|+||+||+|.++.     ++..||||+++...  .......+.+|+.+++++. |||
T Consensus         8 ~~~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~-h~n   84 (308)
T d1p4oa_           8 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHH   84 (308)
T ss_dssp             SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTT
T ss_pred             cCcCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcC-CCC
Confidence            344434333334899999999999999999998753     35789999997433  3445667899999999995 999


Q ss_pred             ccEEeEEEEeCCeEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCce
Q 040917           96 IVQFKAAYEDDQFVHIVMELCAGGELFDRIVAR----------GHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENF  165 (494)
Q Consensus        96 i~~~~~~~~~~~~~~iv~e~~~g~sL~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NI  165 (494)
                      |+++++++..+...++||||+++|+|.+++...          ..++...+..++.+++.||.|||+++|+||||||+||
T Consensus        85 Iv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~Ni  164 (308)
T d1p4oa_          85 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC  164 (308)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGE
T ss_pred             EeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCce
Confidence            999999999888999999999999999988643          2468899999999999999999999999999999999


Q ss_pred             EEeeCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhC-CCCCCCCCh
Q 040917          166 LFTTGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCG-VPPFWAETD  240 (494)
Q Consensus       166 li~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg-~~pf~~~~~  240 (494)
                      |+   +.++++||+|||++........   .....+|+.|+|||.+.+ .++.++|||||||++|+|+|| ..||.+.+.
T Consensus       165 Ll---d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~  241 (308)
T d1p4oa_         165 MV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN  241 (308)
T ss_dssp             EE---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred             ee---cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH
Confidence            99   6889999999999986543322   233467899999999864 588999999999999999998 588999999


Q ss_pred             HHHHHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          241 QGVAQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .+....+.++.....   .+.+|+.+.++|.+||+.||++|||+.++++
T Consensus       242 ~~~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         242 EQVLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             HHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            888888877654322   2468899999999999999999999999987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=358.66  Aligned_cols=251  Identities=21%  Similarity=0.342  Sum_probs=211.7

Q ss_pred             ccceEeeeeecccCCeEEEEEEEC-----CCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeC
Q 040917           32 QLHYTIGREVGRGEFGITYLCTEN-----STGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDD  106 (494)
Q Consensus        32 ~~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~  106 (494)
                      .++|++++.||+|+||.||+|.+.     .+++.||||+++...  .......+.+|+.+++++.+||||+++++++.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            479999999999999999999863     567899999997543  3445667899999999997799999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEe
Q 040917          107 QFVHIVMELCAGGELFDRIVARG------------------HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFT  168 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~~~~~~~------------------~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~  168 (494)
                      ...++|||||++|+|.+++....                  .++...+..++.||+.|+.|||+++++||||||+||++ 
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~-  178 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL-  178 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc-
Confidence            99999999999999999987543                  58899999999999999999999999999999999999 


Q ss_pred             eCCCCCeEEEeecCCccccccCcc---cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 040917          169 TGDENAVVKATDFGLSAFIEEGKA---YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLC-GVPPFWAETDQGV  243 (494)
Q Consensus       169 ~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~t-g~~pf~~~~~~~~  243 (494)
                        +..+.++++|||.+........   .....||+.|+|||++. +.++.++|||||||++|+|+| |..||.+....+.
T Consensus       179 --~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         179 --THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             --ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             --cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence              5788999999999987654322   23457899999999886 568999999999999999998 5666766666555


Q ss_pred             HHHHHcCCccCCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          244 AQAILKGEINFQRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      +..+.........  ...+|+.+.+||.+||+.||.+|||+.+|++
T Consensus       257 ~~~~i~~~~~~~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         257 FYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            5554443332222  2468899999999999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-45  Score=347.66  Aligned_cols=245  Identities=22%  Similarity=0.303  Sum_probs=200.0

Q ss_pred             eeeeecccCCeEEEEEEECCCC---cEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEe-CCeEEEE
Q 040917           37 IGREVGRGEFGITYLCTENSTG---LEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYED-DQFVHIV  112 (494)
Q Consensus        37 i~~~lg~G~~g~Vy~a~~~~~~---~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~-~~~~~iv  112 (494)
                      ..+.||+|+||+||+|.+..++   ..||||+++..  .+......+.+|+.++++++ ||||+++++++.. +...++|
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceEEE
Confidence            3678999999999999986543   36899998642  34556788999999999995 9999999999765 5689999


Q ss_pred             EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEeecCCccccccCc
Q 040917          113 MELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKATDFGLSAFIEEGK  191 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~~~~~~  191 (494)
                      ||||++++|.+++.... .++...+..++.|++.||.|||+.+|+||||||+|||+   ++++.+||+|||++.......
T Consensus       108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTT
T ss_pred             EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhccccc
Confidence            99999999999887543 57788899999999999999999999999999999999   678999999999998654332


Q ss_pred             c-----cccccCCcCccChhhhc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHcCCccCCCCCCCCCCH
Q 040917          192 A-----YREIVGSPYYIAPEVLS-QSYGKEADIWSAGVILYILLCGVPPFWAET-DQGVAQAILKGEINFQRDPFPSISS  264 (494)
Q Consensus       192 ~-----~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~il~~l~tg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  264 (494)
                      .     .....||+.|+|||.+. +.++.++||||||+++|+|++|..||.... ..++...+..+.....+   +.+++
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p---~~~~~  261 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---EYCPD  261 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCC---TTCCH
T ss_pred             cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCc---ccCcH
Confidence            2     12346789999999876 579999999999999999999877775543 33455556555433222   46789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcC
Q 040917          265 SAIELVRRMLTQDPKRRITVAQVLEH  290 (494)
Q Consensus       265 ~l~~li~~~l~~dp~~Rps~~eil~~  290 (494)
                      .+.++|.+||..||++|||+.|++++
T Consensus       262 ~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         262 PLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3e-45  Score=347.44  Aligned_cols=253  Identities=20%  Similarity=0.300  Sum_probs=207.6

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ++++|++++.||+|+||+||+|++..+|+.||+|++.....     ...+.+|++.++.|.+|+|++.+++++..+...+
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence            56799999999999999999999999999999999865432     2346789999999986799999999999999999


Q ss_pred             EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeC--CCCCeEEEeecCCcccc
Q 040917          111 IVMELCAGGELFDRIVARG-HYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTG--DENAVVKATDFGLSAFI  187 (494)
Q Consensus       111 iv~e~~~g~sL~~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~--~~~~~~kL~Dfg~a~~~  187 (494)
                      +||||+ |++|.+++...+ .++..++..++.|++.||.|||++||+||||||+||+++..  ...+.++|+|||+|...
T Consensus        78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            999999 679999887654 69999999999999999999999999999999999999642  23678999999999865


Q ss_pred             ccCc--------ccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHcCCcc-C
Q 040917          188 EEGK--------AYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ---GVAQAILKGEIN-F  254 (494)
Q Consensus       188 ~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~---~~~~~~~~~~~~-~  254 (494)
                      ....        ......||+.|+|||++.+ .+++++|||||||++|+|++|+.||.+....   .....+...... .
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence            4221        1234579999999999876 5899999999999999999999999765432   222222222111 1


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          255 QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       255 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                      .....+.+|+.+.+++..|+..+|++||+++.+.+
T Consensus       237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            12223568899999999999999999999887654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-44  Score=340.67  Aligned_cols=248  Identities=21%  Similarity=0.265  Sum_probs=190.8

Q ss_pred             cccceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCC---
Q 040917           31 VQLHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQ---  107 (494)
Q Consensus        31 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~---  107 (494)
                      +..+|.+.+.||+|+||+||+|++  +|+.||||++....    ......+.|+..+.++ +||||+++++++...+   
T Consensus         1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~   73 (303)
T d1vjya_           1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVML-RHENILGFIAADNKDNGTW   73 (303)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSS
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcc
Confidence            346899999999999999999986  58999999986432    1222233455555677 4999999999997543   


Q ss_pred             -eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCceeccCCCCceEEeeCCCCCeEEE
Q 040917          108 -FVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS--------KGVMHRDLKPENFLFTTGDENAVVKA  178 (494)
Q Consensus       108 -~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--------~~i~H~dikp~NIli~~~~~~~~~kL  178 (494)
                       ..++||||+++|+|.+++.+. .++...+..++.+++.||.|||+        +||+||||||+|||+   +.++.+||
T Consensus        74 ~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl  149 (303)
T d1vjya_          74 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCI  149 (303)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEE
T ss_pred             eEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEE
Confidence             689999999999999999775 68999999999999999999996        599999999999999   67899999


Q ss_pred             eecCCccccccCcc-----cccccCCcCccChhhhccc-------CCCcchhHHHHHHHHHHHhCCCCCCCC--------
Q 040917          179 TDFGLSAFIEEGKA-----YREIVGSPYYIAPEVLSQS-------YGKEADIWSAGVILYILLCGVPPFWAE--------  238 (494)
Q Consensus       179 ~Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-------~~~~~Di~slG~il~~l~tg~~pf~~~--------  238 (494)
                      +|||++........     .....||+.|+|||++.+.       ++.++|||||||++|+|+||..||...        
T Consensus       150 ~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~  229 (303)
T d1vjya_         150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  229 (303)
T ss_dssp             CCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred             EecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence            99999987644321     2346789999999998643       567899999999999999998876322        


Q ss_pred             -------ChHHHHHHHHcCCccCCCC-CC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 040917          239 -------TDQGVAQAILKGEINFQRD-PF--PSISSSAIELVRRMLTQDPKRRITVAQVLE  289 (494)
Q Consensus       239 -------~~~~~~~~~~~~~~~~~~~-~~--~~~~~~l~~li~~~l~~dp~~Rps~~eil~  289 (494)
                             ........+......+..+ .+  ...+..+.+++.+||..||.+|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                   1222333332222211111 00  112345889999999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-42  Score=340.03  Aligned_cols=260  Identities=24%  Similarity=0.427  Sum_probs=195.1

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHcc----------CCCCccEEeEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLS----------GQPNIVQFKAA  102 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------~hp~i~~~~~~  102 (494)
                      +||++++.||+|+||+||+|++..+|+.||||++.+..    ...+.+.+|+.+++.+.          +||||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            67999999999999999999999999999999997532    24566788999888874          36889999988


Q ss_pred             EEe--CCeEEEEEeccCCCchHHH-HH--hcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCceEEeeCCC---C
Q 040917          103 YED--DQFVHIVMELCAGGELFDR-IV--ARGHYSERAAASVFRVIMNVVNVCHS-KGVMHRDLKPENFLFTTGDE---N  173 (494)
Q Consensus       103 ~~~--~~~~~iv~e~~~g~sL~~~-~~--~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~dikp~NIli~~~~~---~  173 (494)
                      +..  ....++++.++..+..... ..  ....++...+..++.||+.||.|||+ .||+||||||+|||++.++.   .
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence            754  4566667766655443322 22  33568999999999999999999998 89999999999999964222   2


Q ss_pred             CeEEEeecCCccccccCcccccccCCcCccChhhhcc-cCCCcchhHHHHHHHHHHHhCCCCCCCCChH------HHHHH
Q 040917          174 AVVKATDFGLSAFIEEGKAYREIVGSPYYIAPEVLSQ-SYGKEADIWSAGVILYILLCGVPPFWAETDQ------GVAQA  246 (494)
Q Consensus       174 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~il~~l~tg~~pf~~~~~~------~~~~~  246 (494)
                      ..++++|||.+.....  ......||+.|+|||++.+ .++.++|+||+||++++|++|+.||......      +....
T Consensus       169 ~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             ceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence            3599999999875433  3345679999999998864 6899999999999999999999999654321      11111


Q ss_pred             HHc--CC------------------ccC------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 040917          247 ILK--GE------------------INF------------------QRDPFPSISSSAIELVRRMLTQDPKRRITVAQVL  288 (494)
Q Consensus       247 ~~~--~~------------------~~~------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil  288 (494)
                      ...  +.                  ...                  ........++.+.+||.+||..||.+|||++|+|
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L  326 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  326 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            100  00                  000                  0000122457789999999999999999999999


Q ss_pred             cCCccCccCc
Q 040917          289 EHPWLKESGE  298 (494)
Q Consensus       289 ~~~~~~~~~~  298 (494)
                      +||||++...
T Consensus       327 ~Hp~f~~~~~  336 (362)
T d1q8ya_         327 NHPWLKDTLG  336 (362)
T ss_dssp             TCGGGTTCTT
T ss_pred             cCcccCCCCC
Confidence            9999997543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=2e-24  Score=190.19  Aligned_cols=166  Identities=22%  Similarity=0.221  Sum_probs=121.9

Q ss_pred             eEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCC---------------ChhhHHHHHHHHHHHHHccCCCCccEE
Q 040917           35 YTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLV---------------KDVEKDDVRREIEIMRHLSGQPNIVQF   99 (494)
Q Consensus        35 y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~~hp~i~~~   99 (494)
                      |.+++.||+|+||+||+|.+. +|+.||||+++.....               ..........|...+.++. +++++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceE
Confidence            568999999999999999985 6899999987532210               0112344557888999995 8899887


Q ss_pred             eEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCceEEeeCCCCCeEEEe
Q 040917          100 KAAYEDDQFVHIVMELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHSKGVMHRDLKPENFLFTTGDENAVVKAT  179 (494)
Q Consensus       100 ~~~~~~~~~~~iv~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~dikp~NIli~~~~~~~~~kL~  179 (494)
                      +++.  .  .+++||++++..+..       ++...+..++.|++.++.|||++||+||||||+|||++    ...++|+
T Consensus        80 ~~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~~~~~li  144 (191)
T d1zara2          80 YAWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWII  144 (191)
T ss_dssp             EEEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEEC
T ss_pred             EEec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----CCCEEEE
Confidence            7654  2  269999998865532       45556678999999999999999999999999999994    3458999


Q ss_pred             ecCCccccccCcccccccCCcCccC------hhhhcccCCCcchhHHHHHH
Q 040917          180 DFGLSAFIEEGKAYREIVGSPYYIA------PEVLSQSYGKEADIWSAGVI  224 (494)
Q Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~y~a------PE~~~~~~~~~~Di~slG~i  224 (494)
                      |||.|.....+...       .|..      .+.+...|+.++|+||+.--
T Consensus       145 DFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         145 DFPQSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCTTCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             ECCCcccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence            99998765322211       1211      12344678999999998643

>d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]

Probab=99.90  E-value=3.8e-23  Score=173.70  Aligned_cols=144  Identities=38%  Similarity=0.629  Sum_probs=133.0

Q ss_pred             cCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-hhHH
Q 040917          332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-LQRF  410 (494)
Q Consensus       332 ~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~~~~  410 (494)
                      .++.++++.++++|..+|++++|+|+.+||..++...+..++...+..++..+|.+++|.|+|+||+..+..... ....
T Consensus         2 ~lt~~e~~~l~~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~   81 (146)
T d1exra_           2 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLSLMARKMKEQDSE   81 (146)
T ss_dssp             CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCCCHHHHHHHHHhcCCCCCCcccHHHHHHHHHHHhhccChH
Confidence            467889999999999999999999999999999999999999999999999999999999999999998765443 3356


Q ss_pred             HHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +.++.+|+.+|.|++|+|+.+||+.++..  ++..++++++++++..+|.|+||+|+|+||+++|.+
T Consensus        82 ~~~~~~F~~~D~d~~G~i~~~e~~~~l~~--~~~~~~~~~~~~i~~~~D~d~dG~i~~~eF~~~l~s  146 (146)
T d1exra_          82 EELIEAFKVFDRDGNGLISAAELRHVMTN--LGEKLTDDEVDEMIREADIDGDGHINYEEFVRMMVS  146 (146)
T ss_dssp             HHHHHHHHHHSTTCSSCBCHHHHHHHHHH--TTCCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHHHC
T ss_pred             HHHHHHHHHhCCCCCCcCCHHHHHHHHHH--HhhcCCHHHHHHHHHHhCCCCCCeEeHHHHHHHhcC
Confidence            78999999999999999999999999999  677899999999999999999999999999998863

>d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

Probab=99.89  E-value=6.2e-23  Score=171.18  Aligned_cols=140  Identities=21%  Similarity=0.464  Sum_probs=126.7

Q ss_pred             CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-hhHHH
Q 040917          333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-LQRFE  411 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~~~~~  411 (494)
                      ++++++++++++|..+|.+++|.|+..||..+++.+|..++..++..++.    +++|.|+|++|+..+..... ....+
T Consensus         1 L~~~qi~e~~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~el~~~~~----~~~~~i~~~eF~~~~~~~~~~~~~~~   76 (142)
T d1wdcb_           1 LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK----EAPGPLNFTMFLSIFSDKLSGTDSEE   76 (142)
T ss_dssp             CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHT----TSSSCCCHHHHHHHHHHHTCSCCCHH
T ss_pred             CCHHHHHHHHHHHHHHcCCCCCcCChHHHHHHHHHhhcCCCHHHHHHHHH----hccCccccccccccccccccccchhh
Confidence            47889999999999999999999999999999999999999999888774    57899999999998876543 33467


Q ss_pred             HHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          412 NLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       412 ~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      .++.+|+.||.|++|+|+.+||+++|..  +|.+++++++++++..+|.| +|+|+|+||+++|+++.
T Consensus        77 ~l~~aF~~~D~d~~G~I~~~el~~~l~~--~g~~lt~~e~~~l~~~~d~~-~G~I~y~eF~~~l~~~~  141 (142)
T d1wdcb_          77 TIRNAFAMFDEQETKKLNIEYIKDLLEN--MGDNFNKDEMRMTFKEAPVE-GGKFDYVKFTAMIKGSG  141 (142)
T ss_dssp             HHHHHHHTTCTTCCSCEEHHHHHHHHHH--SSSCCCHHHHHHHHHHCCEE-TTEECHHHHHHHHHTSC
T ss_pred             hHHHhhhhhcccCCCcccHHHHHHHHHH--ccccCCHHHHHHHHHHhCCC-CCEEcHHHHHHHHhcCC
Confidence            8999999999999999999999999999  67889999999999999988 69999999999998754

>d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.88  E-value=2e-22  Score=169.18  Aligned_cols=144  Identities=31%  Similarity=0.564  Sum_probs=132.6

Q ss_pred             ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-hhH
Q 040917          331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-LQR  409 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~~~  409 (494)
                      ++++.+++..++.+|+.+|.|++|+|+.+||..++...|..++...+..++...+.++++.++|++|...+..... ..+
T Consensus         2 ~~ls~~~i~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (146)
T d1lkja_           2 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSNDS   81 (146)
T ss_dssp             CCCCHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCSSSCCEEEHHHHHHHHHHHTCCCCH
T ss_pred             CCCCHHHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhcCCCCCHHHHHHHHHHhccCCcccccHHHHHHHHHHhhccccH
Confidence            4678999999999999999999999999999999999999999999999999999999999999999988766433 335


Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .+.++.+|+.||.|++|+|+.+||+.+|..  +|..++++++++++..+| |+||+|+|+||.++|++
T Consensus        82 ~~~~~~aF~~~D~d~~G~I~~~el~~~l~~--~g~~~~~~~~~~~~~~~d-d~dG~I~~~eF~~~m~k  146 (146)
T d1lkja_          82 EQELLEAFKVFDKNGDGLISAAELKHVLTS--IGEKLTDAEVDDMLREVS-DGSGEINIQQFAALLSK  146 (146)
T ss_dssp             HHHHHHHHHHHCSSSSCEEEHHHHHHHHHH--HTCSCCHHHHHHHHHHHC-CSSSEEEHHHHHHHHCC
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHH--cCCcccHHHHHHHHHhcc-CCCCeEeHHHHHHHhCC
Confidence            678999999999999999999999999999  677899999999999999 99999999999998864

>d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=8.7e-22  Score=164.21  Aligned_cols=140  Identities=31%  Similarity=0.575  Sum_probs=129.0

Q ss_pred             chhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-hhHHHH
Q 040917          334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-LQRFEN  412 (494)
Q Consensus       334 ~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~~~~~~  412 (494)
                      +.++.++++++|..+|++++|+|+..||..+++..+..++...+..++..+|.+++|.|+++||+..+..... ......
T Consensus         1 t~~~~~elk~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~   80 (141)
T d2obha1           1 TEEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKDTKEE   80 (141)
T ss_dssp             CHHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHcCCCCCeEeHHHHHHHHHhcCCchhHHHHHHHHHhhccCCCCeechHHHHHHHHHHHhhhccHHH
Confidence            3567889999999999999999999999999999999999999999999999999999999999988765433 334567


Q ss_pred             HHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHH
Q 040917          413 LYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMM  475 (494)
Q Consensus       413 ~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~  475 (494)
                      ++.+|..+|.+++|+|+..+|..++..  +|..+++++++.+|..+|.|+||+|+|+||.++|
T Consensus        81 l~~~f~~~d~~~~G~i~~~el~~~l~~--~g~~l~~~e~~~l~~~~D~d~dG~i~~~EF~~~m  141 (141)
T d2obha1          81 ILKAFKLFDDDETGKISFKNLKRVAKE--LGENLTDEELQEMIDEADRDGDGEVSEQEFLRIM  141 (141)
T ss_dssp             HHHHHHHHCTTCSSSBCHHHHHHHHHH--TTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHH
T ss_pred             HHHHHHHhcccCCCCccHHHHHHHHHH--hCCCCCHHHHHHHHHHHCCCCCCCEeHHHHHHhC
Confidence            999999999999999999999999999  6789999999999999999999999999999876

>d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

Probab=99.87  E-value=3.4e-22  Score=168.79  Aligned_cols=144  Identities=24%  Similarity=0.381  Sum_probs=127.0

Q ss_pred             CchhHHHhhhhhhhccCC--CCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh--hh
Q 040917          333 LPTEEIQKLKEKFTEMDT--DNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK--LQ  408 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~--~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~--~~  408 (494)
                      ++.+++++++++|..||.  +++|+|+..||..+|+.+|..++.+++..+. ..|.+++|.|+|+||+..+.....  ..
T Consensus         1 Ls~eqi~~l~~~F~~fD~~~~~dG~I~~~el~~~l~~lG~~~t~~e~~~~~-~~~~~~~~~i~~~eFl~~~~~~~~~~~~   79 (152)
T d1wdcc_           1 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVG-GTHKMGEKSLPFEEFLPAYEGLMDCEQG   79 (152)
T ss_dssp             CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHTT-CCSSTTSCEECHHHHHHHHHHHTTSCCC
T ss_pred             CCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHhccCccHhhhhhhh-hhhccccccccccccccccccccccchh
Confidence            467889999999999995  8999999999999999999999999887754 467888999999999998876533  24


Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCC--CCCceeHHHHHHHHhccc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRD--KDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~--~dg~i~~~ef~~~~~~~~  479 (494)
                      ...++.++|+.||.+++|+|+.+||+++|..  +|.++++++++.++..+|.+  ++|+|+|+||++.|.++|
T Consensus        80 ~~~~l~~aF~~~D~~~~G~I~~~el~~~l~~--~g~~ls~~e~~~l~~~~d~~~d~~G~I~y~eF~~~~~~~p  150 (152)
T d1wdcc_          80 TFADYMEAFKTFDREGQGFISGAELRHVLTA--LGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFVKKVMAGP  150 (152)
T ss_dssp             CHHHHHHHHHTTCSSSSSEEEHHHHHHHHHH--SSSCCCHHHHHHHHHHHTCCCCTTSEEEHHHHHHHHHHCS
T ss_pred             HHHhhhhhhhccccccCccchHHHHHHHHHH--cCCCCCHHHHHHHHHHhccCCCCCCEEEHHHHHHHHhcCC
Confidence            5577999999999999999999999999999  67899999999999999864  568999999999988765

>d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.87  E-value=9.2e-22  Score=168.15  Aligned_cols=145  Identities=33%  Similarity=0.604  Sum_probs=131.7

Q ss_pred             ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh----
Q 040917          331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK----  406 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~----  406 (494)
                      ..++.+++.+++++|..+|++++|+|+..||..++...+..++...+..++..+|.+++|.+++.||+..+.....    
T Consensus        12 ~~ls~~~i~el~~~F~~~D~d~~G~Is~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~e~~~~~~~~~~~~~~   91 (162)
T d1topa_          12 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDAK   91 (162)
T ss_dssp             HHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTSCCEEEHHHHHHHHHHHHHHHHH
T ss_pred             ccCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHhccCCchhHHHHHhhhheeccCCCCCeeeehhhhhhhhhhhhhcc
Confidence            3468899999999999999999999999999999999999999999999999999999999999999887654322    


Q ss_pred             hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          407 LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       407 ~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ....+.++.+|+.+|.|++|+|+.+||++++..  .+...++++++.+|..+|.|+||.|+|+||+++|++
T Consensus        92 ~~~~~~~~~aF~~~D~d~~G~Is~~e~~~~l~~--~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~l~~  160 (162)
T d1topa_          92 GKSEEELANCFRIFDKNADGFIDIEELGEILRA--TGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMMEG  160 (162)
T ss_dssp             HHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHT--TTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHS
T ss_pred             cCcHHHHHHHHHHHCCCCCCCCcHHHHHHHHHh--hCCCCCHHHHHHHHHHhCCCCCCcEEHHHHHHHHHc
Confidence            234567888999999999999999999999998  667789999999999999999999999999999884

>d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.86  E-value=1.4e-21  Score=165.88  Aligned_cols=146  Identities=33%  Similarity=0.550  Sum_probs=130.4

Q ss_pred             hccCchhHHHhhhhhhhccCCCC-CCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh---
Q 040917          330 VENLPTEEIQKLKEKFTEMDTDN-SGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH---  405 (494)
Q Consensus       330 ~~~~~~~~~~~~~~~F~~~D~~~-~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~---  405 (494)
                      ...++.++++.++++|..+|.++ +|.|+..||..+|+.+|..++..++..++..++.+++|.+++.+|...+....   
T Consensus         5 ~~~Lt~~~~~~l~~~F~~~D~d~~dG~I~~~e~~~~l~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (156)
T d1dtla_           5 VEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDD   84 (156)
T ss_dssp             GGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHC--
T ss_pred             HHHCCHHHHHHHHHHHHHHcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhhccCCCccchhhhhhhhhhccccc
Confidence            45678899999999999999996 89999999999999999999999999999999999999999999987655432   


Q ss_pred             -hhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          406 -KLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       406 -~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                       .....+.++.+|+.||.|++|+|+.+||++++..  ++..+++++++.++..+|.|+||+|+|+||+++|++
T Consensus        85 ~~~~~~~~l~~~F~~~D~d~~G~I~~~e~~~~~~~--~~~~ls~~e~~~i~~~~D~d~dG~I~~~eF~~~l~g  155 (156)
T d1dtla_          85 SKGKSEEELSDLFRMFDKNADGYIDLEELKIMLQA--TGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKG  155 (156)
T ss_dssp             ---CHHHHHHHHHHHHCTTCSSEEEHHHHGGGGTT--C--CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHC
T ss_pred             ccccHHHHHHHHHHHhCcCCCCcCcHHHHHHHHhh--cCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHcC
Confidence             2345677999999999999999999999999998  778999999999999999999999999999999874

>d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.86  E-value=1.2e-21  Score=164.00  Aligned_cols=136  Identities=21%  Similarity=0.398  Sum_probs=120.5

Q ss_pred             HHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCC--CCCcccchHHHHHHHHhhh---hhHHHH
Q 040917          338 IQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADID--GNGTIDYIEFITATMQRHK---LQRFEN  412 (494)
Q Consensus       338 ~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~--~~g~i~~~ef~~~~~~~~~---~~~~~~  412 (494)
                      .++++++|..+|.|++|+|+..||..+|+.+|..++..++..++..++.+  ++|.|+|+||+..+.....   ......
T Consensus         3 ~eelke~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~   82 (145)
T d2mysc_           3 ADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNAAAITFEEFLPMLQAAANNKDQGTFED   82 (145)
T ss_pred             HHHHHHHHHHHcCCCCCeECHHHHHHHHHHhhhcchhhhhHHHHHHHhhcccccCccchhHHHHHHhhhhhccccchHHH
Confidence            45678899999999999999999999999999999999999999988665  6889999999988765432   235567


Q ss_pred             HHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          413 LYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       413 ~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      +..+|+.||.|++|+|+.+||+++|..  +|.++++++++.++.. +.|+||+|+|+||++.|.
T Consensus        83 l~~aF~~~D~d~~G~I~~~el~~~l~~--~g~~~~~~e~~~l~~~-~~d~dG~I~y~eF~~~ll  143 (145)
T d2mysc_          83 FVEGLRVFDKEGNGTVMGAELRHVLAT--LGEKMTEEEVEELMKG-QEDSNGCINYEAFVKHIM  143 (145)
T ss_pred             HHHHHHHhhcCCCCEEcHHHHHHHHHH--hCCCCCHHHHHHHHhh-cCCCCCeEEHHHHHHHHh
Confidence            999999999999999999999999999  6788999999999975 779999999999999875

>d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.85  E-value=1.9e-21  Score=162.74  Aligned_cols=142  Identities=23%  Similarity=0.386  Sum_probs=124.0

Q ss_pred             CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-hhHHH
Q 040917          333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-LQRFE  411 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-~~~~~  411 (494)
                      |+.+++..++++|..+|.+++|+|+.+||..+++.+|..++..+   ++..++.+.+|.|+|++|+..+..... ....+
T Consensus         1 f~~~qi~el~e~F~~~D~~~~G~I~~~e~~~~l~~lg~~~~~~~---~~~~~~~~~~g~i~~~eF~~~~~~~~~~~~~~~   77 (145)
T d2mysb_           1 FDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNE---ELDAMIKEASGPINFTVFLTMFGEKLKGADPED   77 (145)
T ss_pred             CCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCcchHH---HHHHHHHhccCceeechhhhhhhhcccccchHH
Confidence            56788999999999999999999999999999999986655443   344455678899999999998766433 34566


Q ss_pred             HHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          412 NLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       412 ~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      .++.+|+.||.+++|+|+.++|+++|+.  +|.+++++++++++..+|.|++|+|+|.+|.++|..+.
T Consensus        78 ~l~~aF~~fD~~~~g~I~~~el~~~l~~--~g~~ls~~e~~~~~~~~d~d~dg~I~y~eF~~~l~~~~  143 (145)
T d2mysb_          78 VIMGAFKVLDPDGKGSIKKSFLEELLTT--GGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYVITHGE  143 (145)
T ss_pred             HHHHHHHhhhhcccchhhHHHHHHHHHH--cCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHhccCC
Confidence            7999999999999999999999999999  67899999999999999999999999999999998764

>d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

Probab=99.85  E-value=1.8e-22  Score=175.78  Aligned_cols=156  Identities=51%  Similarity=0.806  Sum_probs=137.9

Q ss_pred             ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHH
Q 040917          331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRF  410 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~  410 (494)
                      ..++.+++..++++|+.+|.|++|+|+.+||..++..++..++..++..++..+|.+++|.|+|++|+..+.........
T Consensus         2 ~~Lt~~ei~~l~~~F~~~D~d~dG~Is~~e~~~~l~~l~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~   81 (182)
T d1s6ia_           2 ERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLERE   81 (182)
T ss_dssp             CSSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCCC
T ss_pred             CCCCHHHHHHHHHHHHHHcCCCcCCCCHHHHHHHHHHcCCccccccchhhhhhhhccccccchHHHHHHHHHhhcccccH
Confidence            46788899999999999999999999999999999999999999999999999999999999999999877665544455


Q ss_pred             HHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccccchhhhhhhh
Q 040917          411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRALSSRSLA  490 (494)
Q Consensus       411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~~~~~~~~~  490 (494)
                      +.++.+|..+|.+++|+|+..+|++++..++    +++++++.+|..+|.|+||+|+|+||+++|+..+.-..+.++.++
T Consensus        82 e~l~~aF~~~D~d~~G~i~~~el~~~l~~~g----l~~~ev~~~f~~~D~d~DG~Is~~EF~~~m~~~~~~~~~~~~~~~  157 (182)
T d1s6ia_          82 ENLVSAFSYFDKDGSGYITLDEIQQACKDFG----LDDIHIDDMIKEIDQDNDGQIDYGEFAAMMRKRKGNGGIGRRTMR  157 (182)
T ss_dssp             CSTHHHHHHTTTTCSSEEEHHHHHHTTTTTT----CCTTHHHHHHHHHCSSSSSEEETTHHHHTTSCCCSSTTCCSCTTS
T ss_pred             HHHHHHHHHHhhcCCCccchhhhhhhhhhcC----ccHHHHHHHHHHhhcCCCCeEeHHHHHHHHHhCcCCCCchHHHHH
Confidence            6789999999999999999999999998843    577899999999999999999999999999987655554444443

>d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Cdc4p
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.84  E-value=1.3e-21  Score=162.52  Aligned_cols=132  Identities=23%  Similarity=0.375  Sum_probs=117.8

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh---hhHHHHHHH
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK---LQRFENLYK  415 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~---~~~~~~~~~  415 (494)
                      ..++++|..+|.+++|+|+..||..+|+.+|..++.+++..    ++.+++|.|+|++|+..+.....   ....+.+.+
T Consensus         5 ~~fke~F~~~D~d~dG~I~~~el~~~l~~lg~~~t~~ei~~----~~~~~~~~i~~~eF~~~~~~~~~~~~~~~~~~l~~   80 (140)
T d1ggwa_           5 SPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITE----IESTLPAEVDMEQFLQVLNRPNGFDMPGDPEEFVK   80 (140)
T ss_dssp             TTTHHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHH----HHTTSCSSEEHHHHHHHHCTTSSSSSSCCHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCeECHHHHHHHHHHHHhhhHHHhhhh----hhccccccccchhhhhhhhhhhhcchhhHHHHHHH
Confidence            56789999999999999999999999999999999987665    46788999999999998865332   234567999


Q ss_pred             hccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          416 AFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       416 ~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +|+.+|.|++|+|+.+||+++|..  +|.+++++++++++..+|.| ||+|+|+||+++|.+
T Consensus        81 aF~~~D~d~~G~I~~~el~~~l~~--~g~~lt~~e~~~l~~~~d~~-dG~I~y~eF~~~m~s  139 (140)
T d1ggwa_          81 GFQVFDKDATGMIGVGELRYVLTS--LGEKLSNEEMDELLKGVPVK-DGMVNYHDFVQMILA  139 (140)
T ss_dssp             HHHTTCSSCSSCCCHHHHHHHHHH--HHSCSCHHHHHHHHHHTTCS-SCCSTTTHHHHHHHC
T ss_pred             HHHHHhccCCCcchHHHHHHHHHH--cCCCCCHHHHHHHHHhhCCC-CCEEeHHHHHHHHhc
Confidence            999999999999999999999999  66789999999999999988 999999999999875

>d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Light Chain Mlc1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.84  E-value=6e-21  Score=159.91  Aligned_cols=136  Identities=25%  Similarity=0.384  Sum_probs=118.4

Q ss_pred             hhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHH-hcCCCCCcccchHHHHHHHHhhh------hhHHHH
Q 040917          340 KLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQA-ADIDGNGTIDYIEFITATMQRHK------LQRFEN  412 (494)
Q Consensus       340 ~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~-~D~~~~g~i~~~ef~~~~~~~~~------~~~~~~  412 (494)
                      .++++|..+|.+++|+|+.+||..+++.+|..++.+++..++.. .+.+.+|.|+|++|...+.....      ....+.
T Consensus         3 ~~k~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~ei~~l~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~~~~   82 (146)
T d1m45a_           3 ANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLDQITGLIEVNEKELDATTKAKTED   82 (146)
T ss_dssp             CCTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGGCCCTHH
T ss_pred             HHHHHHHHHcCCCcCCCCHHHHHHHHHHcCCchhHHHHhhhhccccccccccccccchhhhhhhhhcccccccccchHHH
Confidence            46789999999999999999999999999999999999998875 45567889999999988764322      123467


Q ss_pred             HHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          413 LYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       413 ~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +..+|+.+|.+++|+|+.+||+.+|..  +|.++++++++.++..+|.|+||+|+|+||++.+.+
T Consensus        83 l~~~F~~~D~~~~G~I~~~el~~~l~~--~g~~l~~~ei~~l~~~~D~d~dG~I~y~eF~~~i~~  145 (146)
T d1m45a_          83 FVKAFQVFDKESTGKVSVGDLRYMLTG--LGEKLTDAEVDELLKGVEVDSNGEIDYKKFIEDVLR  145 (146)
T ss_dssp             HHHHHHTTCSSSSSEEEHHHHHHHHHH--STTCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHHC
T ss_pred             HHHHHHhhccccccccchhhhhhhhcc--cCCcchHHHHHHHHHHhCCCCCCcEEHHHHHHHHHc
Confidence            899999999999999999999999999  677899999999999999999999999999987764

>d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Programmed cell death 6 protein-like protein
species: Leishmania major [TaxId: 5664]

Probab=99.83  E-value=1e-20  Score=164.48  Aligned_cols=136  Identities=23%  Similarity=0.376  Sum_probs=124.5

Q ss_pred             hHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHH
Q 040917          336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYK  415 (494)
Q Consensus       336 ~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~  415 (494)
                      ++.++++++|+.+|.|++|+|+..||..+++.++..++.+++..++..+|.|++|.|+|++|...+...      ..+..
T Consensus        15 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~l~~~~s~~~~~~l~~~~d~d~~~~i~~~ef~~~~~~~------~~~~~   88 (182)
T d1y1xa_          15 NDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGEITFDEFKDLHHFI------LSMRE   88 (182)
T ss_dssp             CTTSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH------HHHHH
T ss_pred             CcHHHHHHHHHHHcCCCcCCCCHHHHHHHHHHhcccCchhhhhhhhccccccccccccccccccccccc------ccccc
Confidence            445689999999999999999999999999999999999999999999999999999999998876532      36788


Q ss_pred             hccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          416 AFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       416 ~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      +|+.+|.+++|+|+.+||+++|..  +|..+++++++.+++.+|.|+||.|+|+||+.++....
T Consensus        89 ~F~~~D~~~~g~I~~~el~~~l~~--~g~~ls~~e~~~i~~~~d~~~dg~I~~~eF~~~~~~l~  150 (182)
T d1y1xa_          89 GFRKRDSSGDGRLDSNEVRAALLS--SGYQVSEQTFQALMRKFDRQRRGSLGFDDYVELSIFVC  150 (182)
T ss_dssp             HHHHHCTTSSSCBCHHHHHHHHHT--TSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHH
T ss_pred             chhccccccchhhhhHHHHHHHHH--hCCchhHHHHHHHHhhcccCCCCCcCHHHHHHHHHHHH
Confidence            999999999999999999999998  67789999999999999999999999999999876433

>d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: EHCABP
species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]

Probab=99.83  E-value=9.9e-21  Score=156.18  Aligned_cols=128  Identities=28%  Similarity=0.426  Sum_probs=114.6

Q ss_pred             hhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh---hhHHHHHHHhcc
Q 040917          342 KEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK---LQRFENLYKAFQ  418 (494)
Q Consensus       342 ~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~---~~~~~~~~~~F~  418 (494)
                      ..+|+.+|.|++|.|+..||..++..++...+.+++..+|..+|.+++|.|+|+||+..+.....   ......++.+|+
T Consensus         3 e~~F~~~D~d~dG~is~~E~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~F~   82 (134)
T d1jfja_           3 EALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIGLKVLYK   82 (134)
T ss_dssp             HHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCcCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhhhccccccccccccccccccccccccccccccccccc
Confidence            57899999999999999999999999999999999999999999999999999999988765322   234567899999


Q ss_pred             ccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHH
Q 040917          419 YFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMM  475 (494)
Q Consensus       419 ~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~  475 (494)
                      .+|.|++|+|+.+|++.++..+  +    .+.+.++|..+|.|+||+|+|+||+++|
T Consensus        83 ~~D~~~~g~i~~~el~~~~~~~--~----~~~~~~~~~~~D~d~dG~is~~EF~~~~  133 (134)
T d1jfja_          83 LMDVDGDGKLTKEEVTSFFKKH--G----IEKVAEQVMKADANGDGYITLEEFLEFS  133 (134)
T ss_dssp             HHCCSSSSEEEHHHHHHHHTTT--T----CHHHHHHHHHHHCSSSSEEEHHHHHHHH
T ss_pred             ccccccCCcccHHHHHHHHHhc--C----cHHHHHHHHHHCCCCCCCCCHHHHHHHh
Confidence            9999999999999999999873  2    2478889999999999999999999987

>d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin regulatory subunit (B-chain)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=1.4e-20  Score=161.00  Aligned_cols=151  Identities=28%  Similarity=0.466  Sum_probs=126.3

Q ss_pred             hhhccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-
Q 040917          328 VIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-  406 (494)
Q Consensus       328 ~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-  406 (494)
                      .|.+.++.+++++++++|+.+|+|++|+|+.+||..++.....+    .+.++|..+|.+++|.|+|+||+..+..... 
T Consensus         5 ~~~t~ft~eei~~l~~~F~~~D~d~~G~I~~~E~~~~~~~~~~~----~~~~l~~~~d~~~~g~i~~~EFl~~~~~~~~~   80 (165)
T d1auib_           5 EMCSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQNP----LVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVK   80 (165)
T ss_dssp             CCCCSCCHHHHHHHHHHHHHHCTTCCSEECHHHHTTSHHHHTCT----THHHHHHHHCTTCSSSEEHHHHHHHHGGGCTT
T ss_pred             HHcCCCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHhhhccCCH----HHHHHHHHHccccchhhhhhhhhhhccccccc
Confidence            35678999999999999999999999999999998877654433    3567999999999999999999998877543 


Q ss_pred             hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCC----CCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccccc
Q 040917          407 LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGD----DATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLR  482 (494)
Q Consensus       407 ~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~----~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~  482 (494)
                      ......++.+|+.+|.|++|+|+.+|+.++++.. .+.    ...+..++.++..+|.|+||+|+++||.++|+....-.
T Consensus        81 ~~~~~~~~~~f~~~d~d~~g~Is~~el~~~l~~~-~~~~~~~~~~~~~~~~~~~~~D~~~dG~Is~~EF~~i~~~~~~~~  159 (165)
T d1auib_          81 GDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMM-VGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVVGGLDIHK  159 (165)
T ss_dssp             CCHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHH-HTTSSCHHHHHHHHHHHHHHHCTTSSSSEEHHHHHHHHGGGCGGG
T ss_pred             hhhHHHHHHHHHHhcccccccccHHHHHHHHHHh-ccccCchHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHHhcCChhh
Confidence            3456679999999999999999999999999763 233    34455678899999999999999999999998655433


Q ss_pred             h
Q 040917          483 A  483 (494)
Q Consensus       483 ~  483 (494)
                      +
T Consensus       160 k  160 (165)
T d1auib_         160 K  160 (165)
T ss_dssp             G
T ss_pred             C
Confidence            3

>d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin B-like protein 2
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

Probab=99.82  E-value=4.5e-20  Score=160.77  Aligned_cols=162  Identities=21%  Similarity=0.312  Sum_probs=132.2

Q ss_pred             hccCchhHHHhhhhhhhccCCC--CCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh-h
Q 040917          330 VENLPTEEIQKLKEKFTEMDTD--NSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH-K  406 (494)
Q Consensus       330 ~~~~~~~~~~~~~~~F~~~D~~--~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~-~  406 (494)
                      .+.|+.++++.+++.|..+|.+  ++|+|+.+||..++...+...+. .+..+|..+|.|++|.|+|+||+..+.... .
T Consensus         8 ~t~Fs~~ei~~L~~~F~~~d~~~~~~G~i~~~ef~~~l~~~~~~~~~-~~~~lf~~~d~~~dg~I~f~EFl~~l~~~~~~   86 (183)
T d2zfda1           8 DTVFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFKTNKKESL-FADRVFDLFDTKHNGILGFEEFARALSVFHPN   86 (183)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHHSCSSCCCH-HHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTT
T ss_pred             hCCCCHHHHHHHHHHHHHHCcCCCCCCcCcHHHHHHHHHhcCCCCCH-HHHHHHHHHccCCCCcCcHHHHHHHHHhhhcc
Confidence            5678999999999999999876  69999999999999888766554 578999999999999999999999887654 3


Q ss_pred             hhHHHHHHHhccccccCCCCceeHHHHHHHHhhc--CCCCCCcHHH----HHHHHHHhCCCCCCceeHHHHHHHHhcccc
Q 040917          407 LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDY--GMGDDATIAT----IKEIMSEVDRDKDGRISYDEFRSMMKCGTQ  480 (494)
Q Consensus       407 ~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~--~~~~~~~~~~----~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~  480 (494)
                      ....+.++.+|+.||.|++|+|+.+|++.++...  ..+...+++.    ++.+|..+|.|+||.|+|+||...++..|.
T Consensus        87 ~~~~~~~~~~F~~~D~d~~G~Is~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~Is~~EF~~~~~~~p~  166 (183)
T d2zfda1          87 APIDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKIDKEEWRSLVLRHPS  166 (183)
T ss_dssp             SCHHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEECHHHHHHHHHHSGG
T ss_pred             CcHHHHHHHhhcccccCCCCCccHHHHHHHHHHHHhhhhcccchHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHCHH
Confidence            4566779999999999999999999999988642  0233444444    566889999999999999999999998886


Q ss_pred             cch-hhhhhhhcc
Q 040917          481 LRA-LSSRSLAHV  492 (494)
Q Consensus       481 ~~~-~~~~~~~~~  492 (494)
                      +.+ +.-+.|..+
T Consensus       167 ~~~~~~l~~~~~~  179 (183)
T d2zfda1         167 LLKNMTLQYLKDI  179 (183)
T ss_dssp             GGGGGCCGGGGGH
T ss_pred             HHHHcCchhhccc
Confidence            444 444455444

>d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Apoptosis-linked protein alg-2
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.81  E-value=6.2e-20  Score=159.29  Aligned_cols=138  Identities=21%  Similarity=0.335  Sum_probs=123.2

Q ss_pred             hhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCC-CCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHH
Q 040917          335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM-LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENL  413 (494)
Q Consensus       335 ~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~  413 (494)
                      ..+...+.++|+.+|.+++|+|+.+||..+++.++.. .+.+++..+++.+|.+++|.|+|+||+..+...      ..+
T Consensus        15 ~~~~~~L~~iF~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EFl~~~~~~------~~~   88 (181)
T d1hqva_          15 LPDQSFLWNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKYI------TDW   88 (181)
T ss_dssp             CSCHHHHHHHHHHHCTTCCSSBCHHHHHHHCCCSSSSCCCHHHHHHHHHHHCCSSSSSBCHHHHHHHHHHH------HHH
T ss_pred             CccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCcccHHHHHHHhhccccccccchhhhHHHhhhhhc------ccc
Confidence            4555779999999999999999999999999988754 688899999999999999999999999877643      357


Q ss_pred             HHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccc
Q 040917          414 YKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ  480 (494)
Q Consensus       414 ~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~  480 (494)
                      +.+|+.+|.+++|+|+.+||++++..  .+..++++++++++..+|.+++|+|+|+||+.++.....
T Consensus        89 ~~~f~~~D~~~~G~i~~~el~~~l~~--~~~~l~~e~~~~~~~~~d~~~dg~Is~~eF~~~~~~l~~  153 (181)
T d1hqva_          89 QNVFRTYDRDNSGMIDKNELKQALSG--FGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVLQR  153 (181)
T ss_dssp             HHHHHHHCTTCCSSBCHHHHHHHHHH--HTBCCCHHHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHH
T ss_pred             ccccccccccccchhhhHHHHHHHHH--cCCcchhHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHH
Confidence            88999999999999999999999998  567899999999999999999999999999988765433

>d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Guanylate cyclase activating protein 2, GCAP-2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.80  E-value=8.3e-20  Score=159.90  Aligned_cols=151  Identities=25%  Similarity=0.271  Sum_probs=124.8

Q ss_pred             chhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHH
Q 040917          334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENL  413 (494)
Q Consensus       334 ~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~  413 (494)
                      ...+++++++.|..  .+++|+|+..||..++...+...+...+..+|..+|.|++|.|+|.||+..+.........+.+
T Consensus        19 ~~~ei~~~~~~F~~--~~~~G~i~~~Ef~~~l~~~~~~~~~~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~~~~~~~~   96 (189)
T d1jbaa_          19 DAAQLQEWYKKFLE--ECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKL   96 (189)
T ss_dssp             HHHHHHHHHHHHHS--SSTTCCEEHHHHHHHHHCCSSSTTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHH
T ss_pred             CHHHHHHHHHHhcc--cCCCCeeeHHHHHHHHHHcCCCccHHHHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHHH
Confidence            44455555555543  3368999999999999999998899999999999999999999999999999887666667789


Q ss_pred             HHhccccccCCCCceeHHHHHHHHhhcC---------------CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          414 YKAFQYFDKDNNGYITVDELGKAFKDYG---------------MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       414 ~~~F~~~D~d~~G~I~~~el~~~l~~~~---------------~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      +.+|+.||.|++|+|+..|+..++..+.               ......++.++.+|..+|.|+||+|+|+||...+++.
T Consensus        97 ~~~F~~~D~d~~g~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~if~~~D~d~dG~Is~~EF~~~~~~~  176 (189)
T d1jbaa_          97 KWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGARRD  176 (189)
T ss_dssp             HHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHHHHHTTT
T ss_pred             HHHHhhhccCCCCcccHhHHHHHHHHHHHhhccccccchhhhhccccchHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhC
Confidence            9999999999999999999999886420               0112335667899999999999999999999999998


Q ss_pred             cccchhhh
Q 040917          479 TQLRALSS  486 (494)
Q Consensus       479 ~~~~~~~~  486 (494)
                      |.+.++..
T Consensus       177 p~i~~~l~  184 (189)
T d1jbaa_         177 KWVMKMLQ  184 (189)
T ss_dssp             TTHHHHHH
T ss_pred             HHHHHHhc
Confidence            87665543

>d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=2e-20  Score=155.31  Aligned_cols=132  Identities=22%  Similarity=0.410  Sum_probs=114.6

Q ss_pred             hhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcC--CCCCcccchHHHHHHHHhhh---hhHHHHHHH
Q 040917          341 LKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADI--DGNGTIDYIEFITATMQRHK---LQRFENLYK  415 (494)
Q Consensus       341 ~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~--~~~g~i~~~ef~~~~~~~~~---~~~~~~~~~  415 (494)
                      ++++|..+|.+++|+|+..||..+|+.+|..++..++..++..++.  +++|.|+|.+|...+.....   ....+++..
T Consensus         2 ~ke~F~~~D~d~~G~I~~~el~~~l~~lg~~~t~~e~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~l~~   81 (139)
T d1w7jb1           2 FKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNRGQGTYEDYLE   81 (139)
T ss_dssp             HHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC--------CCHH
T ss_pred             HHHHHHHHhCCCCCeECHHHHHHHHHHhccCCCHHHHHHHHHHHhcccccCCceeeeccchhhHhhhhhccccHHHHHHH
Confidence            6789999999999999999999999999999999999998887763  57899999999988765432   223456889


Q ss_pred             hccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHH
Q 040917          416 AFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMM  475 (494)
Q Consensus       416 ~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~  475 (494)
                      +|+.+|.|++|+|+.+||+++|..  +|..+++++++.++.. +.|+||+|+|+||++.|
T Consensus        82 aF~~~D~d~~G~I~~~el~~~l~~--~g~~~~~~e~~~l~~~-~~d~dg~I~~~eF~~~l  138 (139)
T d1w7jb1          82 GFRVFDKEGNGKVMGAELRHVLTT--LGEKMTEEEVETVLAG-HEDSNGCINYEAFLKHI  138 (139)
T ss_dssp             HHHTTCTTSSSEEEHHHHHHHHHH--SSSCCCHHHHHHHHTT-CCCTTSEEEHHHHHHHT
T ss_pred             hhhhccCCCCCeEeHHHHHHHHHH--hCCCCCHHHHHHHHhh-CCCCCCeEeHHHHHHHh
Confidence            999999999999999999999999  6788999999998875 88999999999999875

>d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=4.3e-19  Score=155.03  Aligned_cols=151  Identities=21%  Similarity=0.292  Sum_probs=128.5

Q ss_pred             cCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHH-HHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHH
Q 040917          332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEF-DVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRF  410 (494)
Q Consensus       332 ~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~-~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~  410 (494)
                      .++..+++.+.+.|...  +++|.|+..++..++..++...... .+..+|..+|.+++|.|+|+||+..+.........
T Consensus        18 ~fs~~Ei~~l~~~F~~~--~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~if~~~d~~~dg~I~~~EF~~~l~~~~~~~~~   95 (187)
T d1g8ia_          18 YFTEKEVQQWYKGFIKD--CPSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLD   95 (187)
T ss_dssp             SSCHHHHHHHHHHHHHH--CTTSEEEHHHHHHHHHHHCTTSCTHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCHH
T ss_pred             CCCHHHHHHHHHHHHHH--CCCCCcCHHHHHHHHHHhcCCCCHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHhccCchh
Confidence            47899999999999654  5789999999999999987666544 45779999999999999999999998887766777


Q ss_pred             HHHHHhccccccCCCCceeHHHHHHHHhhc----------CCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccc
Q 040917          411 ENLYKAFQYFDKDNNGYITVDELGKAFKDY----------GMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ  480 (494)
Q Consensus       411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~----------~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~  480 (494)
                      +.++.+|+.||.|++|+|+.+|+..++..+          .......++.++.+|..+|.|+||+|+++||.+.+++.|.
T Consensus        96 e~l~~~F~~~D~d~dG~i~~~El~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d~dG~Is~~EF~~~~~~~p~  175 (187)
T d1g8ia_          96 EKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKLTLQEFQEGSKADPS  175 (187)
T ss_dssp             HHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSSCSSEEEHHHHHHHHHHCHH
T ss_pred             hhHHHHHHHHhcCCCCeEcHHHHHHHHHHHhhhhcccccCchhhccHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHCHH
Confidence            889999999999999999999999998742          1123445677899999999999999999999999998876


Q ss_pred             cchh
Q 040917          481 LRAL  484 (494)
Q Consensus       481 ~~~~  484 (494)
                      +.++
T Consensus       176 ~~~~  179 (187)
T d1g8ia_         176 IVQA  179 (187)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6554

>d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Neurocalcin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.79  E-value=3.2e-19  Score=155.04  Aligned_cols=152  Identities=24%  Similarity=0.345  Sum_probs=130.4

Q ss_pred             hccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCC-HHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhh
Q 040917          330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLT-EFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQ  408 (494)
Q Consensus       330 ~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~-~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~  408 (494)
                      .+.++..+++.+.+.|..  .+++|+|+..||..++..++.... ...+.++|..+|.+++|.|+|+||+..+.......
T Consensus        15 ~t~fs~~ei~~l~~~F~~--~~~~g~i~~~ef~~~l~~~~~~~~~~~~~~~lf~~~d~~~~g~i~~~eFl~~~~~~~~~~   92 (181)
T d1bjfa_          15 STDFTEHEIQEWYKGFLR--DCPSGHLSMEEFKKIYGNFFPYGDASKFAEHVFRTFDANGDGTIDFREFIIALSVTSRGK   92 (181)
T ss_dssp             HSSCCHHHHHHHHHHHHH--HSTTSEEEHHHHHHHHTTTSSSSCCHHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSC
T ss_pred             hcCCCHHHHHHHHHHHHh--hCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhcCCCCCCcEeHHHHHHHHHHHhhhc
Confidence            346889999999999854  567999999999999999875554 45678999999999999999999999988877767


Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcC----------CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYG----------MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~----------~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ..+.++.+|+.+|.|++|+|+.+|+..++..+.          .+....++.++.+|..+|.|+||.|+|+||.+.++..
T Consensus        93 ~~~~~~~~f~~~D~d~dg~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~Is~~EF~~~~~~~  172 (181)
T d1bjfa_          93 LEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRDGKLSLEEFIRGAKSD  172 (181)
T ss_dssp             HHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTTCSSEECHHHHHHHHHHC
T ss_pred             hHHHHHHHHHHhccCCCCeecHHHHHHHHHHHhhhccccccCCcccccHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhC
Confidence            778899999999999999999999999998531          1235667789999999999999999999999999988


Q ss_pred             cccch
Q 040917          479 TQLRA  483 (494)
Q Consensus       479 ~~~~~  483 (494)
                      |.+.+
T Consensus       173 p~~~~  177 (181)
T d1bjfa_         173 PSIVR  177 (181)
T ss_dssp             THHHH
T ss_pred             HHHHH
Confidence            86544

>d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Recoverin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.78  E-value=1.7e-19  Score=159.61  Aligned_cols=154  Identities=18%  Similarity=0.246  Sum_probs=127.9

Q ss_pred             hccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCC-HHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhh
Q 040917          330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLT-EFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQ  408 (494)
Q Consensus       330 ~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~-~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~  408 (494)
                      .+.++..+++.+.+.|.  +.+++|.|+.+||..++..++.... ...+..+|..+|.|++|.|+|.||+..+.......
T Consensus        19 ~t~f~~~ei~~l~~~F~--~~~~~G~is~~EF~~~l~~~~~~~~~~~~~~~if~~~D~~~~G~I~f~EF~~~~~~~~~~~   96 (201)
T d1omra_          19 NTKFTEEELSSWYQSFL--KECPSGRITRQEFQTIYSKFFPEADPKAYAQHVFRSFDANSDGTLDFKEYVIALHMTSAGK   96 (201)
T ss_dssp             GCSSCHHHHHHHHHHHH--HHCTTSEEEHHHHHHHHHHHCTTSCCHHHHHHHHHTTTSCSSSEEEHHHHHHHHHHHHSSC
T ss_pred             hCCCCHHHHHHHHHHHH--HHCcCCCccHHHHHHHHHHhcCCCCHHHHHHHHHHHhccCCCCeEeehhHHHHHHhhcccc
Confidence            45689999999999994  4567899999999999999876554 45568899999999999999999999887766555


Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCC------------CCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM------------GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~------------~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      ..+.++.+|+.||.|++|+|+.+|+..++..+..            .....+..++.+|..+|.|+||+|+|+||+..++
T Consensus        97 ~~~~l~~~F~~~D~d~~G~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~Is~~EF~~~~~  176 (201)
T d1omra_          97 TNQKLEWAFSLYDVDGNGTISKNEVLEIVTAIFKMISPEDTKHLPEDENTPEKRAEKIWGFFGKKDDDKLTEKEFIEGTL  176 (201)
T ss_dssp             GGGSHHHHHHHHCTTCSSSBCHHHHHHHHHHHHTTSCHHHHTTSCGGGSSHHHHHHHHHHHTTCCTTCCBCHHHHHHHHH
T ss_pred             hHHHHHHHHHHHccCCCCccCHHHHHHHHHHHHhhcChhhhhhhhhhhccHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Confidence            6677999999999999999999999999976311            1122345678999999999999999999999998


Q ss_pred             cccccchhh
Q 040917          477 CGTQLRALS  485 (494)
Q Consensus       477 ~~~~~~~~~  485 (494)
                      ..+.+.++.
T Consensus       177 ~~~~~~~~l  185 (201)
T d1omra_         177 ANKEILRLI  185 (201)
T ss_dssp             HCHHHHHHH
T ss_pred             HCHHHHHHh
Confidence            887665543

>d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.78  E-value=4.4e-19  Score=155.24  Aligned_cols=152  Identities=25%  Similarity=0.324  Sum_probs=128.4

Q ss_pred             ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCH-HHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhH
Q 040917          331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTE-FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQR  409 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~-~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~  409 (494)
                      +.++..+++.+.+.|.  +.+++|.|+..+|..++..++..... +.+.++|..+|.+++|.|+|+||+..+........
T Consensus        20 t~fs~~Ei~~l~~~F~--~~~~~G~i~~~ef~~~~~~~~~~~~~~~~~~~if~~~D~~~~G~I~~~Ef~~~~~~~~~~~~   97 (190)
T d1fpwa_          20 TYFDRREIQQWHKGFL--RDCPSGQLAREDFVKIYKQFFPFGSPEDFANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTL   97 (190)
T ss_dssp             CCSTHHHHHHHHHHHH--HHCTTCCEEHHHHHHHHHHHCTTSCCSHHHHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCS
T ss_pred             cCCCHHHHHHHHHHHH--HHCCCCCccHHHHHHHHHHHCCCCChHHHHHHHHHHhCcCCCCcccHHHHHHHHHHHccCch
Confidence            4588999999999994  45578999999999999988654443 45689999999999999999999998887666666


Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhhcC----------CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKDYG----------MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~----------~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      .+.++.+|+.||.|++|+|+.+|+..++....          ..+...+..++.+|..+|.|+||+|+++||.+.++..|
T Consensus        98 ~e~~~~~F~~~D~d~dG~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d~dG~Is~~EF~~~~~~~p  177 (190)
T d1fpwa_          98 EEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYITLDEFREGSKVDP  177 (190)
T ss_dssp             THHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTCSSEEEHHHHHHHHHSST
T ss_pred             HHHHHHHHHHhccCCCCcCcHHHHHHHHHHHHHhcccccCCCchhhhHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHCH
Confidence            78899999999999999999999999997531          11233467789999999999999999999999999988


Q ss_pred             ccchh
Q 040917          480 QLRAL  484 (494)
Q Consensus       480 ~~~~~  484 (494)
                      .+.++
T Consensus       178 ~i~~~  182 (190)
T d1fpwa_         178 SIIGA  182 (190)
T ss_dssp             THHHH
T ss_pred             HHHHH
Confidence            76553

>d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Kchip1, Kv4 potassium channel-interacting protein
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.77  E-value=9.8e-19  Score=151.46  Aligned_cols=154  Identities=21%  Similarity=0.318  Sum_probs=126.5

Q ss_pred             hccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCC-HHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhh
Q 040917          330 VENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLT-EFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQ  408 (494)
Q Consensus       330 ~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~-~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~  408 (494)
                      .+.++..+++.+.+.|..  .+++|.|+.+||..++..++.... ...+.++|..+|.+++|.|+|+||+..+.......
T Consensus         7 ~t~ft~~ei~~l~~~F~~--~~~~G~is~~ef~~~l~~~~~~~~~~~~~~~lf~~~D~~~~g~I~~~EFl~~~~~~~~~~   84 (178)
T d1s6ca_           7 QTNFTKRELQVLYRGFKN--ECPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGT   84 (178)
T ss_dssp             HSSCCHHHHHHHHHHHHH--HCTTSEECHHHHHHHHHHHSTTSCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCC
T ss_pred             cCCCCHHHHHHHHHHHHH--HCcCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHHhccc
Confidence            356789999999988854  456899999999999999876554 44568999999999999999999999887766666


Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhc----C------CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDY----G------MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~----~------~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ..+.++.+|+.||.|++|.|+.+|+..++...    +      +.....+..++.+|+.+|.|+||.||++||...++..
T Consensus        85 ~~~~~~~~f~~~D~~~~g~i~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~DG~Is~~EF~~~i~~~  164 (178)
T d1s6ca_          85 VHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQED  164 (178)
T ss_dssp             HHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTTCSSEECHHHHHHHTTSC
T ss_pred             hHHHHHHHHHhhccCCCCeecHHHHHHHHHHHHhhcccccccCCcHHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHC
Confidence            77889999999999999999999999887642    1      2223445667899999999999999999999999988


Q ss_pred             cccchhh
Q 040917          479 TQLRALS  485 (494)
Q Consensus       479 ~~~~~~~  485 (494)
                      +.+.++.
T Consensus       165 ~~~~~~l  171 (178)
T d1s6ca_         165 DNIMRSL  171 (178)
T ss_dssp             CHHHHHH
T ss_pred             HHHHHHh
Confidence            8665544

>d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Grancalcin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=7.7e-19  Score=148.96  Aligned_cols=129  Identities=19%  Similarity=0.271  Sum_probs=112.3

Q ss_pred             hhhhhhccCCCCCCcccHHHHHHHHHhcCCCC-----CHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHH
Q 040917          341 LKEKFTEMDTDNSGTLTYDELKAGLAKLGSML-----TEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYK  415 (494)
Q Consensus       341 ~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~-----~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~  415 (494)
                      +...|+.+ .+.+|.|+..||+.+|+..|...     +.+.++.++..+|.|++|.|+|+||+..+...      ..++.
T Consensus         2 ~~~~F~~~-a~~dG~I~~~EL~~~L~~~g~~~~~~~~s~~~~~~li~~~D~~~~G~i~~~EF~~l~~~~------~~~~~   74 (165)
T d1k94a_           2 VYTYFSAV-AGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFKELWAAL------NAWKE   74 (165)
T ss_dssp             HHHHHHHH-HGGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHH------HHHHH
T ss_pred             hHHHHHHh-cCCCCCCCHHHHHHHHHHcCCCCCcccCCHHHHHHHHHHhCCCCCCcCcHHHHHHHhhcc------chhHH
Confidence            45667777 57899999999999999987644     56789999999999999999999999877643      46889


Q ss_pred             hccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccc
Q 040917          416 AFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ  480 (494)
Q Consensus       416 ~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~  480 (494)
                      +|+.||.|++|+|+.+||+.+|..  .|..+++++++.++..+|.  +|.|+|+||+.++.+...
T Consensus        75 ~F~~fD~d~sG~I~~~El~~~l~~--~G~~l~~~~~~~l~~~~d~--~g~i~~~eFi~~~~~l~~  135 (165)
T d1k94a_          75 NFMTVDQDGSGTVEHHELRQAIGL--MGYRLSPQTLTTIVKRYSK--NGRIFFDDYVACCVKLRA  135 (165)
T ss_dssp             HHHHHCTTCCSBCCHHHHHHHHHH--TTCCCCHHHHHHHHHHHCB--TTBCBHHHHHHHHHHHHH
T ss_pred             HHHHhCCCCCCeEcHHHHHHHHHH--hhhcCCHHHHHHHHHHcCC--CCcCcHHHHHHHHHHHHH
Confidence            999999999999999999999999  6778999999999999964  689999999998876433

>d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium- and integrin-binding protein, CIB
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=1.2e-18  Score=150.53  Aligned_cols=155  Identities=15%  Similarity=0.237  Sum_probs=121.3

Q ss_pred             hccCchhHHHhhhhhhhccCCCCCCc--------ccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCC-CCCcccchHHHHH
Q 040917          330 VENLPTEEIQKLKEKFTEMDTDNSGT--------LTYDELKAGLAKLGSMLTEFDVKQYMQAADID-GNGTIDYIEFITA  400 (494)
Q Consensus       330 ~~~~~~~~~~~~~~~F~~~D~~~~g~--------i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~-~~g~i~~~ef~~~  400 (494)
                      .+.++.+++..+++.|..++++++|.        ++.+++..+......++    ..++|..+|.+ ++|.|+|+||+..
T Consensus         8 ~T~ft~~EI~~l~~~F~~l~~~~~~~~~~~~~~~i~~~e~~~~~~l~~~~~----~~rif~~fd~~~~~g~I~f~EFv~~   83 (180)
T d1xo5a_           8 LTFLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILSLPELKANPF----KERICRVFSTSPAKDSLSFEDFLDL   83 (180)
T ss_dssp             CCCSCHHHHHHHHHHHHTTSCGGGCSHHHHHHCCEEHHHHHTSHHHHTCTT----HHHHHHHHCCSTTCCEECHHHHHHH
T ss_pred             hcCCCHHHHHHHHHHHHHHCcCccccccccccceEcHHHHhcCcccccChH----HHHHHHhccCCCCCCcCcHHHHHHH
Confidence            35789999999999999999988775        55666655433222222    46899999987 6999999999999


Q ss_pred             HHHhh-hhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcC---CCCCCc----HHHHHHHHHHhCCCCCCceeHHHHH
Q 040917          401 TMQRH-KLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYG---MGDDAT----IATIKEIMSEVDRDKDGRISYDEFR  472 (494)
Q Consensus       401 ~~~~~-~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~---~~~~~~----~~~~~~~~~~~d~~~dg~i~~~ef~  472 (494)
                      +.... .....+.++.+|+.||.|++|+|+.+|+..++..+.   .+..++    ++.++.++..+|.|+||+|+|+||.
T Consensus        84 l~~~~~~~~~~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~dG~Is~~EF~  163 (180)
T d1xo5a_          84 LSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQ  163 (180)
T ss_dssp             HHHHSTTSCHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTHHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred             HHHHhhcCCHHHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHHHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence            87764 345677899999999999999999999999998641   122233    3346678999999999999999999


Q ss_pred             HHHhcccccchhhhhh
Q 040917          473 SMMKCGTQLRALSSRS  488 (494)
Q Consensus       473 ~~~~~~~~~~~~~~~~  488 (494)
                      +++...|.+..++...
T Consensus       164 ~~~~~~P~~~~~f~i~  179 (180)
T d1xo5a_         164 HVISRSPDFASSFKIV  179 (180)
T ss_dssp             HHHHHCHHHHHHHHHH
T ss_pred             HHHHhCHHHHhhCeec
Confidence            9999999877766543

>d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), M-type [TaxId: 10116]

Probab=99.74  E-value=1.3e-18  Score=151.62  Aligned_cols=140  Identities=19%  Similarity=0.236  Sum_probs=117.1

Q ss_pred             chhHH-HhhhhhhhccCCCCCCcccHHHHHHHHHhcC--------CCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          334 PTEEI-QKLKEKFTEMDTDNSGTLTYDELKAGLAKLG--------SMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       334 ~~~~~-~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~--------~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      +.+++ +.++.+|..+| +++|.|+..||..+|..+|        ..++.+.+..++..+|.|++|.|+|+||+..+...
T Consensus        12 ~~~~~~~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~d~~G~I~~~EF~~~~~~~   90 (186)
T d1df0a1          12 NEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDEDGSGKLGLKEFYILWTKI   90 (186)
T ss_dssp             CCSCSCHHHHHHHHHHH-GGGTCEEHHHHHHHHHHHHHC----CCCCCCHHHHHHHHHHHCCSSSSEECHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHc-CCCCeEcHHHHHHHHHHhcccccccccccCCHHHHHHHHHHHcCCCCCcccHHHHHHHHHhH
Confidence            34444 45788999998 9999999999999998864        33567889999999999999999999998877643


Q ss_pred             hhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccccch
Q 040917          405 HKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQLRA  483 (494)
Q Consensus       405 ~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~~  483 (494)
                            ..++.+|+.+|+|++|+|+.+||+.+|..  .|..++++.+ +++...|.|++|+|+|+||+.+|.+-..+..
T Consensus        91 ------~~~~~~F~~~D~d~sG~I~~~El~~~l~~--~g~~~~~~~~-~~~~~~d~d~dg~I~f~eFi~~~~~l~~~~~  160 (186)
T d1df0a1          91 ------QKYQKIYREIDVDRSGTMNSYEMRKALEE--AGFKLPCQLH-QVIVARFADDELIIDFDNFVRCLVRLEILFK  160 (186)
T ss_dssp             ------HHHHHHHHHHCTTCCSCEEGGGHHHHHHH--TTEECCHHHH-HHHHHHHCCSTTEECHHHHHHHHHHHHHHHH
T ss_pred             ------HHHHHHHHhhCCCCCCcccHHHHHHHHHH--HHhcccHHHH-HHHHHHHcCCCCeEeHHHHHHHHHHHHHHHH
Confidence                  46889999999999999999999999999  6677787655 5666789999999999999998876544333

>d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain small (regulatory) subunit (domain VI)
species: Pig (Sus scrofa) [TaxId: 9823]

Probab=99.74  E-value=1.8e-18  Score=148.87  Aligned_cols=135  Identities=21%  Similarity=0.278  Sum_probs=115.3

Q ss_pred             hHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCC--------CCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhh
Q 040917          336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM--------LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKL  407 (494)
Q Consensus       336 ~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~--------~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~  407 (494)
                      +++++++.+|..+|. .+|.|+..||+.+|..++..        .+.+.+..++..+|.|++|.|+|+||+..+...   
T Consensus         1 ee~~~~r~~F~~~d~-~dg~I~~~EL~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~~d~d~~g~i~~~ef~~~~~~~---   76 (173)
T d1alva_           1 EEVRQFRRLFAQLAG-DDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNNI---   76 (173)
T ss_dssp             CHHHHHHHHHHHHHG-GGTSBCHHHHHHHHHHHHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH---
T ss_pred             ChHHHHHHHHHHHcC-CCCcCCHHHHHHHHHHhCCCcchhhhccCCHHHHHHHHHHhccCCCCcccchhhhhhhhhh---
Confidence            478899999999995 48999999999999887432        456789999999999999999999998876533   


Q ss_pred             hHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccc
Q 040917          408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ  480 (494)
Q Consensus       408 ~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~  480 (494)
                         ..++.+|+.||.|++|+|+..||+.+|..  .|..++++.++.++ .+|.|++|.|+|+||+.+|.....
T Consensus        77 ---~~~~~~f~~~D~d~~G~I~~~el~~~L~~--~g~~~~~~~~~~~~-~~d~d~~G~i~~~EF~~~~~~~~~  143 (173)
T d1alva_          77 ---KKWQAIYKQFDVDRSGTIGSSELPGAFEA--AGFHLNEHLYSMII-RRYSDEGGNMDFDNFISCLVRLDA  143 (173)
T ss_dssp             ---HHHHHHHHHHCTTCCSSBCTTTHHHHHHH--HTCCCCHHHHHHHH-HHHTCSSSCBCHHHHHHHHHHHHH
T ss_pred             ---hHHHHHHHHhccCCCCeecHHHHHHHHHH--HHHhhHHHHHHHhh-ccccCCCCeEeHHHHHHHHHHHHH
Confidence               36788999999999999999999999999  67788888877666 455699999999999998875433

>d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]

Probab=99.74  E-value=1e-18  Score=151.56  Aligned_cols=135  Identities=22%  Similarity=0.309  Sum_probs=101.5

Q ss_pred             chhHH-HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCC--------CCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          334 PTEEI-QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM--------LTEFDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       334 ~~~~~-~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~--------~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      +.+++ +.++++|..+| +++|.|+..||+.+|...+..        ++.+.++.++..+|.|++|.|+|+||..++...
T Consensus        14 s~~~~~~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~e~~~~li~~~D~d~~G~i~~~EF~~l~~~~   92 (188)
T d1qxpa2          14 SEEEIDDNFKTLFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDRDGNGKLGLVEFNILWNRI   92 (188)
T ss_dssp             -------------CCCC-CSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC--CCCCCSSSHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHc-CCCCEECHHHHHHHHHHhCccccccccccCCHHHHHHHHHHhcCCCCCcccHHHHHHHHhhh
Confidence            44554 35888999999 458999999999998776433        456789999999999999999999999877543


Q ss_pred             hhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          405 HKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       405 ~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                            ..++.+|+.||+|++|+|+..||+.+|..  .|...+++.++.++.. +.|++|.|+|+||+.++.+-
T Consensus        93 ------~~~~~~F~~~D~d~sG~i~~~El~~~l~~--~g~~~~~~~~~~l~~~-~~~~dg~i~f~eFi~~~~~l  157 (188)
T d1qxpa2          93 ------RNYLTIFRKFDLDKSGSMSAYEMRMAIEA--AGFKLPCQLHQVIVAR-FADDELIIDFDNFVRCLVRL  157 (188)
T ss_dssp             ------HHHHHHHGGGCTTCCSCCBHHHHHHHHHH--TTEECCHHHHHHHHHH-TSCSSSBCCHHHHHHHHHHH
T ss_pred             ------HHHHHHHHHhCCCCCCEECHHHHHHHHHH--hhhcCCHHHHHHHHHH-hcCCCCcCCHHHHHHHHHHH
Confidence                  36889999999999999999999999999  6677788777766666 56999999999999988753

>d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Sorcin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=6.4e-18  Score=145.22  Aligned_cols=136  Identities=22%  Similarity=0.325  Sum_probs=117.4

Q ss_pred             chhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCC-----CCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhh
Q 040917          334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM-----LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQ  408 (494)
Q Consensus       334 ~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~-----~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~  408 (494)
                      |.++...++..|..++ ++||.|+..||+.+|+.+|..     ++.+.+..++..+|.|++|.|+|+||+..+...    
T Consensus         2 p~~~~~~~~~~F~~~~-~~dG~Is~~EL~~~L~~~g~~~~~~~~~~~~v~~l~~~~D~d~~G~I~f~EF~~~~~~~----   76 (172)
T d1juoa_           2 PGQTQDPLYGYFAAVA-GQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVL----   76 (172)
T ss_dssp             TTCCCCTTHHHHHHHH-TTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH----
T ss_pred             CcchHHHHHHHHHHhC-CCCCCCCHHHHHHHHHHcCCCCCcccCCHHHHHHHHHHHCCCCCCceehHHHHHHHHhh----
Confidence            4556677888998886 789999999999999998754     457889999999999999999999999877643    


Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcccc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGTQ  480 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~  480 (494)
                        .....+|+.+|.|++|+|+.+|++.+|..  ++..+++++++.++..+|  .+|.|+|++|+.+|.+...
T Consensus        77 --~~~~~~f~~~D~d~sG~i~~~El~~~l~~--~g~~ls~~~~~~l~~~~d--~~g~i~~~eF~~~~~~~~~  142 (172)
T d1juoa_          77 --NGWRQHFISFDTDRSGTVDPQELQKALTT--MGFRLSPQAVNSIAKRYS--TNGKITFDDYIACCVKLRA  142 (172)
T ss_dssp             --HHHHHHHHTTCTTCCSEECHHHHHHHHHH--TTCCCCHHHHHHHHHHTC--SSSSEEHHHHHHHHHHHHH
T ss_pred             --hhhhHHHHHhCcCCCCcCCHHHHHHHHHH--HHHhhhHHHHHHHHHHHH--hcCCcCHHHHHHHHHHHHH
Confidence              35678999999999999999999999999  677899999999999995  5688999999998876443

>d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]

Probab=99.72  E-value=2.5e-17  Score=143.97  Aligned_cols=142  Identities=23%  Similarity=0.270  Sum_probs=113.1

Q ss_pred             chhHHHhhhhhhhccCCCCCCcccHHHHHHHH-----HhcCCCCCHHHHHH-----HHHHhcCCCCCcccchHHHHHHHH
Q 040917          334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGL-----AKLGSMLTEFDVKQ-----YMQAADIDGNGTIDYIEFITATMQ  403 (494)
Q Consensus       334 ~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l-----~~~~~~~~~~~~~~-----~~~~~D~~~~g~i~~~ef~~~~~~  403 (494)
                      +++++++++++|..+|.|++|+|+.+||..++     +.++..++..+..+     .+...+...++.|++++|+..+..
T Consensus         9 ~~~~i~r~k~~F~~~D~d~dG~I~~~E~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~e~~~~~~~   88 (189)
T d1qv0a_           9 NPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGMEYGKEIAFPQFLDGWKQ   88 (189)
T ss_dssp             CHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHHHHHHTTCCTTCCBCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHHHhhhccccCCCceehHHHHHHHHH
Confidence            67889999999999999999999999998754     44576666555433     344556778999999999887755


Q ss_pred             hhh-----------hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHH
Q 040917          404 RHK-----------LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFR  472 (494)
Q Consensus       404 ~~~-----------~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~  472 (494)
                      ...           ......+..+|..+|.|++|+|+.+||+.++..  +|..+++++++.+|..+|.|+||.|+|+||+
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~is~~E~~~~l~~--~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~  166 (189)
T d1qv0a_          89 LATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKI--SGISPSQEDCEATFRHCDLDNAGDLDVDEMT  166 (189)
T ss_dssp             HHHHHHHHHHTTCCCHHHHHHHHHHHHTC----CEECHHHHHHHHHH--HSSCCCHHHHHHHHHHSCCCTTSCEEHHHHH
T ss_pred             HHHHhhhccccccHHHHHHHHHHHHHHHccCCCCcccchhhHHHHHh--cCCCCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence            321           112345677999999999999999999999999  5667899999999999999999999999999


Q ss_pred             HHHhc
Q 040917          473 SMMKC  477 (494)
Q Consensus       473 ~~~~~  477 (494)
                      +.+..
T Consensus       167 ~~~~~  171 (189)
T d1qv0a_         167 RQHLG  171 (189)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            98864

>d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Leopard shark (Triakis semifasciata) [TaxId: 30493]

Probab=99.72  E-value=1.1e-17  Score=130.70  Aligned_cols=104  Identities=29%  Similarity=0.462  Sum_probs=89.0

Q ss_pred             CCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcC-CCCCCcH
Q 040917          370 SMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYG-MGDDATI  448 (494)
Q Consensus       370 ~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~-~~~~~~~  448 (494)
                      ..++.+++.+++..+|  .+|.|+|+||+..+..  ...+.++++.+|+.||+|++|+|+.+||+++|..++ .|..+++
T Consensus         4 ~~l~~~di~~~~~~~~--~~G~idf~eF~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~~~~   79 (109)
T d5pala_           4 KVLKADDINKAISAFK--DPGTFDYKRFFHLVGL--KGKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLND   79 (109)
T ss_dssp             GTSCHHHHHHHHHHTC--STTCCCHHHHHHHHTC--TTCCHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCH
T ss_pred             hHccHHHHHHHHHhcC--CCCcCcHHHHHHHHHh--cCCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccCcCCH
Confidence            3467788999999886  4678999999987643  233557899999999999999999999999998743 3678999


Q ss_pred             HHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          449 ATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       449 ~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +++++++..+|.|+||+|+|+||+++|..
T Consensus        80 ~e~~~~~~~~D~d~dG~I~~~EF~~~m~~  108 (109)
T d5pala_          80 TETKALLAAGDSDHDGKIGADEFAKMVAQ  108 (109)
T ss_dssp             HHHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCEeHHHHHHHHHh
Confidence            99999999999999999999999999875

>d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
species: Physarum polycephalum [TaxId: 5791]

Probab=99.71  E-value=1.1e-17  Score=159.22  Aligned_cols=144  Identities=22%  Similarity=0.352  Sum_probs=121.7

Q ss_pred             cCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-----
Q 040917          332 NLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-----  406 (494)
Q Consensus       332 ~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-----  406 (494)
                      .++.++...++++|..+|.|++|.|+.+||..+|..+|..++..++..++..+|.|++|.|+|.||+..+.....     
T Consensus       115 ~l~~~~~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~F  194 (321)
T d1ij5a_         115 MLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVENDTKGRMSYITLVAVANDLAALVADF  194 (321)
T ss_dssp             CCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHHHCCSSTHHHHHHTTSHHHHHTSCCCH
T ss_pred             cCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHcCCcccHHHHHHHHHHHhhcCCccccchhhhhhhhhhhhhhHHH
Confidence            456788889999999999999999999999999999999999999999999999999999999999754321100     


Q ss_pred             ------------------------------------------------------hhHHHHHHHhccccccCCCCceeHHH
Q 040917          407 ------------------------------------------------------LQRFENLYKAFQYFDKDNNGYITVDE  432 (494)
Q Consensus       407 ------------------------------------------------------~~~~~~~~~~F~~~D~d~~G~I~~~e  432 (494)
                                                                            ......+..+|..+|.|++|+|+..|
T Consensus       195 ~~~d~d~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~F~~~D~d~~G~Is~~E  274 (321)
T d1ij5a_         195 RKIDTNSNGTLSRKEFREHFVRLGFDKKSVQDALFRYADEDESDDVGFSEYVHLGLCLLVLRILYAFADFDKSGQLSKEE  274 (321)
T ss_dssp             HHHCTTCCSEECHHHHHHHHHHTTCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHHHHHHHTCSSSCSSEEHHH
T ss_pred             HHHhhcccccchhHHHhhhhhcccccchHHHHHHHHhhhcccccccccccccchhhhhhHHHHHHHHHhcCCCCCCcHHH
Confidence                                                                  00112345589999999999999999


Q ss_pred             HHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          433 LGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       433 l~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      |+.+|..++. ..++++++..++..+|.|+||.|+|+||+.+|.
T Consensus       275 ~~~~l~~~~~-~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~ml  317 (321)
T d1ij5a_         275 VQKVLEDAHI-PESARKKFEHQFSVVDVDDSKSLSYQEFVMLVL  317 (321)
T ss_dssp             HHHHHHHTTC-CGGGCSTHHHHHHHHTTTTCSEECHHHHHHHHH
T ss_pred             HHHHHHHcCC-CcCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence            9999998432 247788999999999999999999999999875

>d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

Probab=99.70  E-value=1.8e-17  Score=129.45  Aligned_cols=102  Identities=27%  Similarity=0.476  Sum_probs=87.3

Q ss_pred             CCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCC-CCCCcHHH
Q 040917          372 LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM-GDDATIAT  450 (494)
Q Consensus       372 ~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~-~~~~~~~~  450 (494)
                      ++.++|..++..+|  ++|.|+|+||+..+....  .....++.+|+.||.|++|+|+.+||+.+|..++. |..+++++
T Consensus         6 l~~eeI~~~~~~~d--~dG~idf~EF~~~~~~~~--~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~ls~~e   81 (109)
T d1pvaa_           6 LKADDIKKALDAVK--AEGSFNHKKFFALVGLKA--MSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAE   81 (109)
T ss_dssp             SCHHHHHHHHHHTC--STTCCCHHHHHHHHTCTT--SCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHH
T ss_pred             CCHHHHHHHHHhcC--CCCCCcHHHHHHHHHHcc--CCHHHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCCCHHH
Confidence            56788888888775  567899999998775432  34567899999999999999999999999988532 67889999


Q ss_pred             HHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          451 IKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       451 ~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +++++..+|.|+||+|+|+||.++|..
T Consensus        82 v~~~~~~~D~d~dG~I~~~EF~~~m~~  108 (109)
T d1pvaa_          82 TKAFLKAADKDGDGKIGIDEFETLVHE  108 (109)
T ss_dssp             HHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred             HHHHHHHHCCCCcCcEeHHHHHHHHHh
Confidence            999999999999999999999999874

>d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=99.69  E-value=7.1e-18  Score=146.99  Aligned_cols=141  Identities=13%  Similarity=0.259  Sum_probs=114.3

Q ss_pred             CchhHHHhhhhhhhc-cCCCCCCcccHHHHHHHHHhcC----CCCCHHH-----------HHHHHHHhcCCCCCcccchH
Q 040917          333 LPTEEIQKLKEKFTE-MDTDNSGTLTYDELKAGLAKLG----SMLTEFD-----------VKQYMQAADIDGNGTIDYIE  396 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~-~D~~~~g~i~~~el~~~l~~~~----~~~~~~~-----------~~~~~~~~D~~~~g~i~~~e  396 (494)
                      ++..+.+++.++|+. +|.|++|+|+..||..++..++    .......           ...++...|.+++|.|++++
T Consensus         2 lt~~q~~~i~~~F~~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~i~~~~   81 (185)
T d2sasa_           2 LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEE   81 (185)
T ss_dssp             CCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHH
T ss_pred             cCHHHHHHHHHHHHHhhcCCCCCcCCHHHHHHHHHHhccccCCCcccHHHHHHHHHHHHHHHHHHHHhCcCCCCcEeeeH
Confidence            567888999999997 6999999999999999987652    1111111           23456777999999999999


Q ss_pred             HHHHHHHhhh---------hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCcee
Q 040917          397 FITATMQRHK---------LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRIS  467 (494)
Q Consensus       397 f~~~~~~~~~---------~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~  467 (494)
                      |...+.....         ......+..+|+.+|.|++|+|+.+||+.++..+|    +++++++.++..+|.|+||.|+
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~----l~~~~~~~~f~~~D~d~dG~i~  157 (185)
T d2sasa_          82 YLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ----LQCADVPAVYNVITDGGKVTFD  157 (185)
T ss_dssp             HHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC----CCCSSHHHHHHHHHTTTTSCCS
T ss_pred             hhHHHHHHhhhhhhhhhhhHHHHHHHHHHHHHHccCCCccCCHHHHHHHHHHcC----CCHHHHHHHHHHcCCCCCCCCc
Confidence            9988765321         12345688999999999999999999999999854    3567899999999999999999


Q ss_pred             HHHHHHHHhc
Q 040917          468 YDEFRSMMKC  477 (494)
Q Consensus       468 ~~ef~~~~~~  477 (494)
                      |+||..++..
T Consensus       158 ~~EF~~~~~~  167 (185)
T d2sasa_         158 LNRYKELYYR  167 (185)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999987753

>d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Sandworm (Nereis diversicolor) [TaxId: 126592]

Probab=99.69  E-value=7.3e-17  Score=138.97  Aligned_cols=139  Identities=21%  Similarity=0.248  Sum_probs=109.6

Q ss_pred             hhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcC----CCCCHHH-----HHHHHHHh--cCCCCCcccchHHHHHHHH
Q 040917          335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLG----SMLTEFD-----VKQYMQAA--DIDGNGTIDYIEFITATMQ  403 (494)
Q Consensus       335 ~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~----~~~~~~~-----~~~~~~~~--D~~~~g~i~~~ef~~~~~~  403 (494)
                      ..+.++++.+|..+|.|++|+|+..||..++..++    .......     ....+..+  +.+++|.|+++||+..+..
T Consensus         2 ~~~~~~l~~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ef~~~~~~   81 (174)
T d2scpa_           2 DLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVAGGKGIDETTFINSMKE   81 (174)
T ss_dssp             HHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCCCTTHHHHHHHHHHHHHHHTGGGTTTTSCEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHccCCCCcEeHHHHHHHHHHHhccccchhHHHHHhHHhhhhhccccccccCCCCcCcHHHHHHHHHh
Confidence            45678999999999999999999999999987652    2222221     12233332  6788999999999998876


Q ss_pred             hhh-----hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          404 RHK-----LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       404 ~~~-----~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...     ......+..+|+.+|.|++|+|+.+||..++..++    ++.++++.+|..+|.|+||+|+++||+.++..
T Consensus        82 ~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~~----~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~  156 (174)
T d2scpa_          82 MVKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLG----LDKTMAPASFDAIDTNNDGLLSLEEFVIAGSD  156 (174)
T ss_dssp             HTSCGGGTHHHHTHHHHHHHHHCTTCSSSEEHHHHHHHHHHTT----CCGGGHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred             hhcchhhHHHHHHHHHHHHHHHCCCccccCCHHHHHHHHHHHh----hhhHHHHHHHhhcCCCCCCcEeHHHHHHHHHH
Confidence            422     22345578899999999999999999999999854    35668999999999999999999999987764

>d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]

Probab=99.68  E-value=1.3e-16  Score=139.02  Aligned_cols=142  Identities=21%  Similarity=0.223  Sum_probs=113.8

Q ss_pred             chhHHHhhhhhhhccCCCCCCcccHHHHHHHHHh-----cCCCCCHHHHHH-----HHHHhcCCCCCcccchHHHHHHHH
Q 040917          334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAK-----LGSMLTEFDVKQ-----YMQAADIDGNGTIDYIEFITATMQ  403 (494)
Q Consensus       334 ~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~-----~~~~~~~~~~~~-----~~~~~D~~~~g~i~~~ef~~~~~~  403 (494)
                      ++.++++++++|+.+|.|++|+|+..||..++..     ++..++..++..     .+.......++.+++.+|+..+..
T Consensus         7 ~p~~~~~~k~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (187)
T d1uhka1           7 NPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGMKYGVETDWPAYIEGWKK   86 (187)
T ss_dssp             CHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHTTCCTTCEEEHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHhccCccHHHHHHHHHHhhhhcccccccccccHHHHHHHHHH
Confidence            5677899999999999999999999999776654     455555554333     333445566778999999877654


Q ss_pred             hhhh-----------hHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHH
Q 040917          404 RHKL-----------QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFR  472 (494)
Q Consensus       404 ~~~~-----------~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~  472 (494)
                      ....           .....+..+|+.+|.|++|+|+.+||+++|..  ++..+++++++.++..+|.|+||+|+|+||+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~--~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~  164 (187)
T d1uhka1          87 LATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKA--AGIIQSSEDCEETFRVCDIDESGQLDVDEMT  164 (187)
T ss_dssp             HHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH--HTSCCSHHHHHHHHHHSCCCTTSCEEHHHHH
T ss_pred             HHHHHHHhhhhhhHHHHHHHHHHHHHHHccCCCcccchHHHHHHHHH--hCCCccHHHHHHHHHHhCCCCCCCEeHHHHH
Confidence            3211           12345788999999999999999999999999  5567899999999999999999999999999


Q ss_pred             HHHhc
Q 040917          473 SMMKC  477 (494)
Q Consensus       473 ~~~~~  477 (494)
                      +++..
T Consensus       165 ~~~~~  169 (187)
T d1uhka1         165 RQHLG  169 (187)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            87754

>d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

Probab=99.65  E-value=3e-16  Score=122.06  Aligned_cols=103  Identities=28%  Similarity=0.427  Sum_probs=88.9

Q ss_pred             CCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCC-CCCCcHH
Q 040917          371 MLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM-GDDATIA  449 (494)
Q Consensus       371 ~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~-~~~~~~~  449 (494)
                      .++++++..++..++.+  |.|+|.||+..+..  .....++++.+|+.||.|++|+|+.+||+.++..++. +..++++
T Consensus         4 gls~~di~~~~~~~~~~--gsi~~~eF~~~~~l--~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~~~~   79 (107)
T d2pvba_           4 GLKDADVAAALAACSAA--DSFKHKEFFAKVGL--ASKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDA   79 (107)
T ss_dssp             TSCHHHHHHHHHHTCST--TCCCHHHHHHHHTG--GGSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHH
T ss_pred             CCCHHHHHHHHHhccCC--CCcCHHHHHHHHhc--ccCCHHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccccCCHH
Confidence            56889999999998654  56999999987653  2335568999999999999999999999999998643 4678999


Q ss_pred             HHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          450 TIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       450 ~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +++++|+.+|.|+||+|+|+||+.+|+.
T Consensus        80 ~~~~l~~~~D~d~dG~I~~~EF~~~m~a  107 (107)
T d2pvba_          80 ETKAFLADGDKDGDGMIGVDEFAAMIKA  107 (107)
T ss_dssp             HHHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred             HHHHHHHHhCCCCCCcEeHHHHHHHHcC
Confidence            9999999999999999999999998863

>d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calerythrin
species: Saccharopolyspora erythraea [TaxId: 1836]

Probab=99.65  E-value=1.1e-15  Score=131.46  Aligned_cols=137  Identities=21%  Similarity=0.311  Sum_probs=111.8

Q ss_pred             HHHhhhhhhhccCCCCCCcccHHHHHHHHHhc----CCCCCHHHH-----------HHHHHHhcCCCCCcccchHHHHHH
Q 040917          337 EIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL----GSMLTEFDV-----------KQYMQAADIDGNGTIDYIEFITAT  401 (494)
Q Consensus       337 ~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~----~~~~~~~~~-----------~~~~~~~D~~~~g~i~~~ef~~~~  401 (494)
                      ..+++.++|+.+|.|++|+|+..||..++..+    +......++           ..++...|.+++|.|++.++...+
T Consensus         5 ~~~~l~~~F~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~   84 (176)
T d1nyaa_           5 ASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFIRVT   84 (176)
T ss_dssp             HHHHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHcCCcccHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccHHHHHHHH
Confidence            34678999999999999999999999998775    333333332           345566689999999999998876


Q ss_pred             HHhhh--------hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHH
Q 040917          402 MQRHK--------LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRS  473 (494)
Q Consensus       402 ~~~~~--------~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~  473 (494)
                      .....        ......+..+|..+|.|++|+|+.+||+.++..++    +++++++.+|..+|.|+||.|+++||+.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~~~~~~----~~~~~~~~~f~~~D~d~dG~i~~~Ef~~  160 (176)
T d1nyaa_          85 ENLIFEQGEASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTALG----MSKAEAAEAFNQVDTNGNGELSLDELLT  160 (176)
T ss_dssp             HHHHSSSCHHHHHHHHHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT----CCHHHHHHHHHHHCTTCSSEEEHHHHHH
T ss_pred             hhhhhhhhhhhhHHHHHHHHHHHHHHHccCCChhhhHHHHHHHHHhcC----CcHHHHHHHHHHHCCCCCCcEeHHHHHH
Confidence            54321        12345678899999999999999999999999843    5788999999999999999999999999


Q ss_pred             HHhc
Q 040917          474 MMKC  477 (494)
Q Consensus       474 ~~~~  477 (494)
                      ++..
T Consensus       161 ~~~~  164 (176)
T d1nyaa_         161 AVRD  164 (176)
T ss_dssp             HHSC
T ss_pred             HHHH
Confidence            9875

>d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Rat (Rattus rattus) [TaxId: 10117]

Probab=99.61  E-value=1.1e-15  Score=119.42  Aligned_cols=103  Identities=27%  Similarity=0.493  Sum_probs=87.9

Q ss_pred             CCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCC-CCCCcHH
Q 040917          371 MLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM-GDDATIA  449 (494)
Q Consensus       371 ~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~-~~~~~~~  449 (494)
                      .++.+++..++..++.  +|.|+|++|+..+....  .....++.+|+.||.|++|+|+.+||+.+|..++. +..++++
T Consensus         5 ~~~~~~i~~~~~~~~~--~~~i~f~eF~~~~~~~~--~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~~~~~   80 (109)
T d1rwya_           5 LLSAEDIKKAIGAFTA--ADSFDHKKFFQMVGLKK--KSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAK   80 (109)
T ss_dssp             HSCHHHHHHHHHTTCS--TTCCCHHHHHHHHTGGG--SCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHH
T ss_pred             hcCHHHHHHHHHhccc--CCCcCHHHHHHHHcccc--CCHHHHHHHhhcccCCCCCcCcHHHHHHHHHHhccccccCCHH
Confidence            3567888888888754  57899999998875432  34567899999999999999999999999988543 4578999


Q ss_pred             HHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          450 TIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       450 ~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +++.++..+|.|+||+|+|+||..+|+.
T Consensus        81 e~~~~~~~~D~d~dG~i~~~EF~~~m~~  108 (109)
T d1rwya_          81 ETKTLMAAGDKDGDGKIGVEEFSTLVAE  108 (109)
T ss_dssp             HHHHHHHHHCTTCSSSEEHHHHHHHHHT
T ss_pred             HHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence            9999999999999999999999999875

>d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Oncomodulin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.59  E-value=1.7e-15  Score=118.03  Aligned_cols=106  Identities=24%  Similarity=0.425  Sum_probs=89.1

Q ss_pred             cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCC-CCCC
Q 040917          368 LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGM-GDDA  446 (494)
Q Consensus       368 ~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~-~~~~  446 (494)
                      ++..++.++|..+++.++  .+|.++|++|+..+..  .....+.++++|+.||.|++|+|+.+||+.+|..++. +..+
T Consensus         2 ~~d~ls~~dI~~~l~~~~--~~~s~~~~~F~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~l   77 (108)
T d1rroa_           2 ITDILSAEDIAAALQECQ--DPDTFEPQKFFQTSGL--SKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDAREL   77 (108)
T ss_dssp             GGGTSCHHHHHHHHHHTC--STTCCCHHHHHHHHSG--GGSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCC
T ss_pred             hhhhCCHHHHHHHHHhcc--cCCCccHHHHHHHHcc--CcCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhccCCC
Confidence            355678899999888875  4567999999776542  2335567999999999999999999999999998543 5678


Q ss_pred             cHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          447 TIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       447 ~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +++++++++..+|.|+||+|+|+||+.+|++
T Consensus        78 ~~~~~~~~~~~~D~d~dG~I~~~EF~~~m~s  108 (108)
T d1rroa_          78 TESETKSLMDAADNDGDGKIGADEFQEMVHS  108 (108)
T ss_dssp             CHHHHHHHHHHHCCSSSSSEEHHHHHHHHTC
T ss_pred             CHHHHHHHHHHhCCCCCCeEeHHHHHHHHcC
Confidence            9999999999999999999999999998863

>d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.46  E-value=4.9e-14  Score=101.73  Aligned_cols=68  Identities=35%  Similarity=0.745  Sum_probs=63.6

Q ss_pred             hHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       408 ~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .++++++.+|+.||.|++|+|+.+||+.+|+.  +|..+++++++.++..+|.|++|+|+|+||+++|+.
T Consensus         6 ~~eeel~~~F~~fD~~~~G~I~~~el~~~l~~--lg~~~~~~e~~~~~~~~D~d~dg~I~~~EF~~~m~~   73 (75)
T d1jc2a_           6 KSEEELANCFRIFDKNADGFIDIEELGEILRA--TGEHVIEEDIEDLMKDSDKNNDGRIDFDEFLKMMEG   73 (75)
T ss_dssp             CCHHHHHHHHHHHCCSTTSSEEHHHHHHHHHH--SSSCCCHHHHHHHHHHHCSSSCSEECHHHHHHHHHT
T ss_pred             CcHHHHHHHHHHHcCCCcCeEcHHHHHHHHHh--cCCCccHHHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence            35678999999999999999999999999999  677999999999999999999999999999999874

>d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Polcalcin
domain: Polcalcin Che a 3
species: Pigweed (Chenopodium album) [TaxId: 3559]

Probab=99.44  E-value=1.3e-13  Score=101.18  Aligned_cols=81  Identities=27%  Similarity=0.462  Sum_probs=69.7

Q ss_pred             chhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHH
Q 040917          334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENL  413 (494)
Q Consensus       334 ~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~  413 (494)
                      +++++..++++|+.+|+|++|+|+..||..+++.+| .++.+++..+|..+|.|++|.|+|+||+..+.....  ...++
T Consensus         1 T~ee~~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg-~~~~~ei~~~~~~~D~d~~G~I~~~EF~~~~~~~~~--~~~e~   77 (81)
T d2opoa1           1 TPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTDGDGFISFDEFTDFARANRG--LVKDV   77 (81)
T ss_dssp             CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCTTCSSEECHHHHHHHHHHCTT--THHHH
T ss_pred             CHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhh-cCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHCcc--chHHH
Confidence            468899999999999999999999999999999999 579999999999999999999999999987765332  22345


Q ss_pred             HHhc
Q 040917          414 YKAF  417 (494)
Q Consensus       414 ~~~F  417 (494)
                      .++|
T Consensus        78 ~~~F   81 (81)
T d2opoa1          78 SKIF   81 (81)
T ss_dssp             HHHC
T ss_pred             HhhC
Confidence            5554

>d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.44  E-value=7.4e-14  Score=101.69  Aligned_cols=73  Identities=34%  Similarity=0.587  Sum_probs=69.6

Q ss_pred             ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHH
Q 040917          331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQ  403 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~  403 (494)
                      +.++.+++..++.+|..+|.|++|+|+..||..+++.+|..++.+++..++..+|.+++|.|+|+||+..+..
T Consensus         2 ~~lt~eqi~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~D~~~~g~I~~~eF~~~m~~   74 (77)
T d1f54a_           2 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSR   74 (77)
T ss_dssp             CCCCHHHHHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTTCCSSCCEEEHHHHHHHHTT
T ss_pred             CCCCHHHHHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            5688999999999999999999999999999999999999999999999999999999999999999987754

>d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=99.43  E-value=4.3e-14  Score=99.87  Aligned_cols=66  Identities=33%  Similarity=0.574  Sum_probs=60.9

Q ss_pred             HHHHHhccccccCCCCceeHHHHHHHHhhcCCCC-CCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGD-DATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~-~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ++++++|+.||.|++|+|+.+||+.+|..  +|. ++++++++.++..+|.|+||.|+|+||+.+|+++
T Consensus         2 eel~~~F~~~D~d~~G~I~~~el~~~l~~--~g~~~~s~~e~~~~~~~~D~d~dG~i~~~EF~~~m~r~   68 (68)
T d1c7va_           2 EEILRAFKVFDANGDGVIDFDEFKFIMQK--VGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLIKKS   68 (68)
T ss_dssp             HHHHHHHHHHSCSGGGEECHHHHHHHSST--TTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHHHCC
T ss_pred             HHHHHHHHHHcCCCcCeEcHHHHHHHHHH--hCCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhC
Confidence            46899999999999999999999999999  555 4799999999999999999999999999999863

>d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

Probab=99.43  E-value=1.4e-13  Score=100.93  Aligned_cols=76  Identities=26%  Similarity=0.441  Sum_probs=70.7

Q ss_pred             hhccCchhHHHhhhhhhhccCCCC-CCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          329 IVENLPTEEIQKLKEKFTEMDTDN-SGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       329 ~~~~~~~~~~~~~~~~F~~~D~~~-~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      ....++.++++.++++|..+|+++ +|+|+..||..+++.+|..++++++.+++..+|.|++|.|+|+||+..+.+.
T Consensus         5 ~~~~ls~eq~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~~~t~~el~~~i~~~D~d~~G~I~f~eFl~im~~k   81 (82)
T d1wrka1           5 AVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRS   81 (82)
T ss_dssp             HHHHCCHHHHHHHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCCSSBCHHHHHHHHHHC
T ss_pred             HHhhCCHHHHHHHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHhh
Confidence            345678999999999999999995 7999999999999999999999999999999999999999999999988753

>d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.43  E-value=1.6e-13  Score=100.74  Aligned_cols=74  Identities=30%  Similarity=0.495  Sum_probs=69.9

Q ss_pred             ccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          331 ENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       331 ~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      +.++.+++.+++.+|..+|+|++|+|+..||..+++.+|..+++.++.+++..+|.|++|.|+|+||+.++...
T Consensus         6 ~~Lt~~~i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~D~d~~g~I~~~eF~~~m~~k   79 (81)
T d1avsa_           6 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQ   79 (81)
T ss_dssp             HHBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHHHH
T ss_pred             ccCCHHHHHHHHHHHHHHcCCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHh
Confidence            34688999999999999999999999999999999999999999999999999999999999999999988754

>d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Rattus norvegicus [TaxId: 10116]

Probab=99.42  E-value=1.8e-13  Score=98.28  Aligned_cols=71  Identities=39%  Similarity=0.631  Sum_probs=67.9

Q ss_pred             CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHH
Q 040917          333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQ  403 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~  403 (494)
                      ++++++..++.+|..+|++++|+|+..||..++..+|..++++++..++..+|.|++|.|+|+||+.++.+
T Consensus         2 Ls~eei~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~~~~D~d~~g~I~f~eF~~~m~~   72 (73)
T d2pq3a1           2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMAR   72 (73)
T ss_dssp             CCHHHHHHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHcCCCCceEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence            57899999999999999999999999999999999999999999999999999999999999999988764

>d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.42  E-value=1.2e-13  Score=96.76  Aligned_cols=63  Identities=41%  Similarity=0.780  Sum_probs=59.7

Q ss_pred             HHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHH
Q 040917          411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMM  475 (494)
Q Consensus       411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~  475 (494)
                      ++++.+|+.||.|++|+|+.+||+.++..  +|...++++++.++..+|.|++|.|+|+||.++|
T Consensus         3 eel~~aF~~fD~d~~G~I~~~el~~~l~~--lg~~~~~~e~~~l~~~~D~d~~g~I~~~eF~~~m   65 (65)
T d1fw4a_           3 EEIREAFRVFDKDGNGYISAAELRHVMTN--LGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMM   65 (65)
T ss_dssp             HHHHHHHHHHCTTCSSEECHHHHHHHHHH--TTCCCCHHHHHHHHHTTCTTCSSSEEHHHHHHHC
T ss_pred             HHHHHHHHHHcCCCCCcCCHHHHHHHHHH--hCCCCCHHHHHHHHHHcCCCCCCcEeHHHHHHHC
Confidence            57899999999999999999999999999  7788999999999999999999999999999864

>d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]

Probab=99.42  E-value=1.5e-13  Score=100.92  Aligned_cols=67  Identities=40%  Similarity=0.701  Sum_probs=63.1

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ++++++.+|+.||.|++|+|+.+||+.+|..  +|.++++++++.++..+|.|+||+|+|+||+.+|+.
T Consensus        13 ~ee~l~~~F~~~D~d~~G~I~~~el~~~l~~--~g~~~~~~ev~~~~~~~D~d~dg~I~~~EF~~~m~~   79 (81)
T d1fi5a_          13 TEEELSDLFRMFDKNADGYIDLEELKIMLQA--TGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKG   79 (81)
T ss_dssp             CHHHHHHHHHHHCSSCSSEECHHHHHHHHHT--SSSCCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHSC
T ss_pred             CHHHHHHHHHHHcCCCCCcccHHHHHHHHHh--cCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHh
Confidence            4568999999999999999999999999999  677899999999999999999999999999999875

>d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Caltractin (centrin 2)
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.41  E-value=1.7e-13  Score=99.74  Aligned_cols=69  Identities=38%  Similarity=0.661  Sum_probs=64.1

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      +.++++++|+.||.|++|+|+.+||+.+|..  ++.+++..++++++..+|.|++|.|+|+||+++|+++.
T Consensus         7 ~~e~l~~~F~~~D~d~~G~I~~~el~~~l~~--~g~~~~~~e~~~~~~~~D~d~~G~I~~~EF~~~m~k~~   75 (77)
T d1oqpa_           7 SREEILKAFRLFDDDNSGTITIKDLRRVAKE--LGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKKTS   75 (77)
T ss_dssp             HHHHHHHHHHHHCTTCSSSEEHHHHHHHHHH--HTCCCCHHHHHHHHHHHCCSSSSEECHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHcCCCCCEechHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHccC
Confidence            4568999999999999999999999999999  66688999999999999999999999999999998754

>d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin-related protein T21P5.17
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

Probab=99.41  E-value=2.2e-13  Score=96.03  Aligned_cols=64  Identities=27%  Similarity=0.458  Sum_probs=60.4

Q ss_pred             HHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          412 NLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       412 ~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .++++|+.||.|++|+|+..||+.++..  +|..++++++++++..+|.|+||.|+|+||..+|++
T Consensus         2 ~~r~~F~~~D~d~~G~I~~~El~~~l~~--lg~~~~~~~i~~~~~~~D~d~dg~I~~~EF~~~m~~   65 (67)
T d1tiza_           2 SAKRVFEKFDKNKDGKLSLDEFREVALA--FSPYFTQEDIVKFFEEIDVDGNGELNADEFTSCIEK   65 (67)
T ss_dssp             THHHHHHHHCTTSSSCEEHHHHHHHHHH--TCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHHHHT
T ss_pred             hHHHHHHHHCCCCcCcCcHHHHHHHHHH--hccccchHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            3688999999999999999999999999  677899999999999999999999999999999875

>d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.38  E-value=2.7e-13  Score=93.47  Aligned_cols=61  Identities=34%  Similarity=0.651  Sum_probs=57.6

Q ss_pred             HHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHH
Q 040917          411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRS  473 (494)
Q Consensus       411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~  473 (494)
                      ++++++|+.||++++|+|+.+||+.+|..  +|.++++.+++.++..+|.|++|+|+|+||+.
T Consensus         1 Eel~~aF~~fD~~~~G~I~~~el~~~l~~--~g~~~~~~ei~~l~~~~D~d~dg~I~~~eFl~   61 (61)
T d2fcea1           1 EDFVKAFQVFDKESTGKVSVGDLRYMLTG--LGEKLTDAEVDELLKGVEVDSNGEIDYKKFIE   61 (61)
T ss_dssp             HHHHHHHHHHCTTCCSCEEHHHHHHHHHH--TTCCCCHHHHHHHHTTCCCCTTSEECHHHHHH
T ss_pred             ChHHHHHHHHCCCCCCeEeHHHHHHHHHH--cCCCCCHHHHHHHHHHcCCCCCCcEeHHHhcC
Confidence            46899999999999999999999999999  67789999999999999999999999999974

>d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Grancalcin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.38  E-value=2.7e-12  Score=107.98  Aligned_cols=120  Identities=21%  Similarity=0.284  Sum_probs=83.7

Q ss_pred             hhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhcccc
Q 040917          341 LKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYF  420 (494)
Q Consensus       341 ~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~  420 (494)
                      ++.++..+|.+++|.|+.+||..+...+      +++..+|+.+|.|++|.|+.+|+..++.......+...+..+++.+
T Consensus        42 ~~~li~~~D~~~~G~i~~~EF~~l~~~~------~~~~~~F~~fD~d~sG~I~~~El~~~l~~~G~~l~~~~~~~l~~~~  115 (165)
T d1k94a_          42 CRIMIAMLDRDHTGKMGFNAFKELWAAL------NAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRY  115 (165)
T ss_dssp             HHHHHHHHCTTCSSCBCHHHHHHHHHHH------HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCcCcHHHHHHHhhcc------chhHHHHHHhCCCCCCeEcHHHHHHHHHHhhhcCCHHHHHHHHHHc
Confidence            4445556688888888888887776643      4567778888888888888888877776543333445677777777


Q ss_pred             ccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCce--eHHHHHHHHh
Q 040917          421 DKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRI--SYDEFRSMMK  476 (494)
Q Consensus       421 D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i--~~~ef~~~~~  476 (494)
                      |.  +|.|+.+||..++..  +      +.+.+.|+.+|++++|.|  +++||++++.
T Consensus       116 d~--~g~i~~~eFi~~~~~--l------~~~~~~F~~~D~d~~G~i~l~~~ef~~~~~  163 (165)
T d1k94a_         116 SK--NGRIFFDDYVACCVK--L------RALTDFFRKRDHLQQGSANFIYDDFLQGTM  163 (165)
T ss_dssp             CB--TTBCBHHHHHHHHHH--H------HHHHHHHHTTCTTCCSEEEEEHHHHHHHHH
T ss_pred             CC--CCcCcHHHHHHHHHH--H------HHHHHHHHHhCCCCCCcEEecHHHHHHHHH
Confidence            54  477888888777654  1      345667788888888866  6788877654

>d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.37  E-value=5.8e-13  Score=97.63  Aligned_cols=67  Identities=34%  Similarity=0.608  Sum_probs=62.1

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...+++++|..||.|++|+|+..||+.+|..  +|.++++.++++++..+|.|++|.|+|+||+.+|..
T Consensus        12 ~i~el~~~F~~~D~d~~G~I~~~el~~~l~~--~g~~~s~~e~~~~~~~~D~d~~g~I~~~eF~~~m~~   78 (81)
T d1avsa_          12 MIAEFKAAFDMFDADGGGDISTKELGTVMRM--LGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVR   78 (81)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHH--TTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCCeEchhHHHHHHHH--cCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            3457889999999999999999999999999  677899999999999999999999999999998863

>d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Phospholipase C-beta-2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.37  E-value=4.5e-14  Score=120.08  Aligned_cols=129  Identities=9%  Similarity=0.049  Sum_probs=88.4

Q ss_pred             cCCCCCCcccHHHHHHHHHhcCCCCC--HHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCC
Q 040917          348 MDTDNSGTLTYDELKAGLAKLGSMLT--EFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNN  425 (494)
Q Consensus       348 ~D~~~~g~i~~~el~~~l~~~~~~~~--~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~  425 (494)
                      +|.|++|.|+..||..++...+....  .+.+..++...|.+++|.|+|+||...+.....   ..++..+|..||.|++
T Consensus        16 ~d~n~dG~Is~~el~k~l~~~~~~~~~~~~~~~~~~~~~D~~~~~~i~F~eF~~~~~~l~~---r~ei~~~F~~~d~d~~   92 (170)
T d2zkmx1          16 MQLNSEGKIPVKNFFQMFPADRKRVEAALSACHLPKGKNDAINPEDFPEPVYKSFLMSLCP---RPEIDEIFTSYHAKAK   92 (170)
T ss_dssp             HSCCTTSCEEHHHHHHHSCSCHHHHHHHHHHTTCCCCTTCEECGGGCCHHHHHHHHHHHSC---CHHHHTTCC-------
T ss_pred             cccCCCCCCcHHHHHHHHHHhhhhHHHHHHHHhhhhccccccCCCccCHHHHHHHHhccCC---HHHHHHHHHHHcCCCC
Confidence            89999999999999999876543222  234555677779999999999999998875442   3568899999999999


Q ss_pred             CceeHHHHHHHHhhcCC--------CCCCcHHHHHHHHHHhCCCCC----CceeHHHHHHHHhccc
Q 040917          426 GYITVDELGKAFKDYGM--------GDDATIATIKEIMSEVDRDKD----GRISYDEFRSMMKCGT  479 (494)
Q Consensus       426 G~I~~~el~~~l~~~~~--------~~~~~~~~~~~~~~~~d~~~d----g~i~~~ef~~~~~~~~  479 (494)
                      |+|+.+||..+|.....        ....+.+.+.+++..+..+.+    |.|++++|..++.+..
T Consensus        93 ~~it~~el~~fL~~~Q~~~~~~e~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ls~d~F~~fL~S~e  158 (170)
T d2zkmx1          93 PYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYEPSGINAQRGQLSPEGMVWFLCGPE  158 (170)
T ss_dssp             -CCCHHHHHHHHHHTCC---------------CHHHHHHHHCCC--------CCHHHHHHHHHSTT
T ss_pred             CcccHHHHHHHHHHHhcchhhhhhccccCCHHHHHHHHHHHccccccccCCeECHHHHHHHHcCcc
Confidence            99999999999986211        113466778899999977654    8899999999887643

>d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

Probab=99.36  E-value=5.7e-14  Score=104.54  Aligned_cols=85  Identities=33%  Similarity=0.500  Sum_probs=69.4

Q ss_pred             CCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCce
Q 040917          387 DGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRI  466 (494)
Q Consensus       387 ~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i  466 (494)
                      +.+|.|+.++..  ++..........++.+|..||.|++|+|+.+||+.+|+.  +|..++++++++++..+|.|++|+|
T Consensus         1 ~~~g~id~~~~~--ma~~l~~~~i~~l~~~F~~~D~d~~G~I~~~el~~~l~~--lg~~~s~~e~~~l~~~~D~d~~g~I   76 (87)
T d1s6ja_           1 HSSGHIDDDDKH--MAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKR--VGSELMESEIKDLMDAADIDKSGTI   76 (87)
T ss_dssp             CCSSSSSSHHHH--SSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHT--TTSSCCHHHHHHHHHHHCTTCSSEE
T ss_pred             CCCCccCchHHH--HHhhCCHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHH--cCCCCCHHHHHHHHHHcCCCCCCeE
Confidence            357888887743  222222222345889999999999999999999999999  6778999999999999999999999


Q ss_pred             eHHHHHHHH
Q 040917          467 SYDEFRSMM  475 (494)
Q Consensus       467 ~~~ef~~~~  475 (494)
                      +|+||+.+|
T Consensus        77 ~~~EFl~am   85 (87)
T d1s6ja_          77 DYGEFIAAT   85 (87)
T ss_dssp             CHHHHTTCC
T ss_pred             eHHHHHHHH
Confidence            999998654

>d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Polcalcin
domain: Polcalcin Che a 3
species: Pigweed (Chenopodium album) [TaxId: 3559]

Probab=99.35  E-value=1.2e-12  Score=95.90  Aligned_cols=68  Identities=34%  Similarity=0.651  Sum_probs=61.4

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      ...+++++|+.||.|++|+|+..||+.+|..  +| ..+++++.+++..+|.|++|.|+|+||+.+|+...
T Consensus         4 e~~e~~~~F~~~D~d~~G~I~~~El~~~l~~--lg-~~~~~ei~~~~~~~D~d~~G~I~~~EF~~~~~~~~   71 (81)
T d2opoa1           4 DIADRERIFKRFDTNGDGKISSSELGDALKT--LG-SVTPDEVRRMMAEIDTDGDGFISFDEFTDFARANR   71 (81)
T ss_dssp             HHHHHHHHHHHHCTTCSSEEEHHHHHHHHHT--TT-TCCHHHHHHHHHHHCTTCSSEECHHHHHHHHHHCT
T ss_pred             HHHHHHHHHHHHCCCCCCCCcHHHHHHHHHH--hh-cCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHCc
Confidence            3457899999999999999999999999999  45 46889999999999999999999999999987644

>d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

Probab=99.34  E-value=1.3e-13  Score=102.47  Aligned_cols=75  Identities=60%  Similarity=0.844  Sum_probs=70.1

Q ss_pred             HhhhccCchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHH
Q 040917          327 KVIVENLPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITAT  401 (494)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~  401 (494)
                      ..++..++.+++..++++|..+|++++|+|+..||..+++.+|..++++++..+|+.+|.|++|.|+|+||+.++
T Consensus        11 ~~ma~~l~~~~i~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~e~~~l~~~~D~d~~g~I~~~EFl~am   85 (87)
T d1s6ja_          11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAAT   85 (87)
T ss_dssp             HHSSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSSEECHHHHTTCC
T ss_pred             HHHHhhCCHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCeEeHHHHHHHH
Confidence            456677889999999999999999999999999999999999999999999999999999999999999998653

>d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

Probab=99.34  E-value=1.6e-12  Score=95.27  Aligned_cols=68  Identities=32%  Similarity=0.581  Sum_probs=62.3

Q ss_pred             hHHHHHHHhccccccCC-CCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          408 QRFENLYKAFQYFDKDN-NGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       408 ~~~~~~~~~F~~~D~d~-~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .....++++|..||.|+ +|+|+..||+.+|+.  +|...+++++++++.++|.|++|.|+|+||+.+|.+
T Consensus        12 eq~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~--lg~~~t~~el~~~i~~~D~d~~G~I~f~eFl~im~~   80 (82)
T d1wrka1          12 EQKNEFKAAFDIFVLGAEDGSISTKELGKVMRM--LGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVR   80 (82)
T ss_dssp             HHHHHHHHHHHHHTTTCTTSSBCHHHHHHHHHH--TTCCCCHHHHHHHHHTTCTTCCSSBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCcCCCCeEeHHHHHHHHHH--cCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence            34467899999999995 799999999999999  778899999999999999999999999999999874

>d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.34  E-value=9.7e-13  Score=95.59  Aligned_cols=66  Identities=33%  Similarity=0.625  Sum_probs=61.5

Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ..+++++|+.||.|++|+|+.+||+.+|..  +|..+++.++.+++..+|.+++|.|+|+||+.+|.+
T Consensus         9 i~el~~~F~~~D~d~~G~I~~~el~~~l~~--~g~~~t~~e~~~~~~~~D~~~~g~I~~~eF~~~m~~   74 (77)
T d1f54a_           9 IAEFKEAFALFDKDNNGSISSSELATVMRS--LGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSR   74 (77)
T ss_dssp             HHHHHHHHHHTCTTCSSEEEHHHHHHHHHH--HTCCCCHHHHHHHHHTTCCSSCCEEEHHHHHHHHTT
T ss_pred             HHHHHHHHHHHcCCCCCeEChHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            357899999999999999999999999999  667899999999999999999999999999998864

>d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Apoptosis-linked protein alg-2
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.33  E-value=4.2e-12  Score=109.09  Aligned_cols=123  Identities=21%  Similarity=0.305  Sum_probs=99.5

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhcc
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQ  418 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~  418 (494)
                      ..+..+|..+|.+++|.|+.+||..++...      ..+...|..+|.+++|.|+.+||...+.......+.+.+..+++
T Consensus        56 ~~~~~l~~~~D~d~~g~i~~~EFl~~~~~~------~~~~~~f~~~D~~~~G~i~~~el~~~l~~~~~~l~~e~~~~~~~  129 (181)
T d1hqva_          56 VTVRSIISMFDRENKAGVNFSEFTGVWKYI------TDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIR  129 (181)
T ss_dssp             HHHHHHHHHHCCSSSSSBCHHHHHHHHHHH------HHHHHHHHHHCTTCCSSBCHHHHHHHHHHHTBCCCHHHHHHHHH
T ss_pred             HHHHHHhhccccccccchhhhHHHhhhhhc------cccccccccccccccchhhhHHHHHHHHHcCCcchhHHHHHHHH
Confidence            345566777899999999999999887653      45678899999999999999999888776554456677888999


Q ss_pred             ccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCce--eHHHHHHHH
Q 040917          419 YFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRI--SYDEFRSMM  475 (494)
Q Consensus       419 ~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i--~~~ef~~~~  475 (494)
                      .+|.+++|+|+.+||..++..        .+.+..+|..+|.++||.|  +++||+.+|
T Consensus       130 ~~d~~~dg~Is~~eF~~~~~~--------l~~l~~~F~~~D~~~dG~i~~~~~ef~~~~  180 (181)
T d1hqva_         130 KFDRQGRGQIAFDDFIQGCIV--------LQRLTDIFRRYDTDQDGWIQVSYEQYLSMV  180 (181)
T ss_dssp             HHCSSCSSCBCHHHHHHHHHH--------HHHHHHHHHHHCTTCSSCCCCCHHHHHHHH
T ss_pred             HhCCCCCCcCcHHHHHHHHHH--------HHHHHHHHHHhCCCCCCCEEecHHHHHHHh
Confidence            999999999999999888754        1357788999999999965  789998875

>d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), M-type [TaxId: 10116]

Probab=99.33  E-value=4.3e-12  Score=109.59  Aligned_cols=122  Identities=19%  Similarity=0.217  Sum_probs=98.4

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhcc
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQ  418 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~  418 (494)
                      ..+..++..+|.|++|.|+..||..+....      ..+...|..+|.|++|.|+.+|+..++.......+ .++.+++.
T Consensus        61 ~~~~~l~~~~D~d~~G~I~~~EF~~~~~~~------~~~~~~F~~~D~d~sG~I~~~El~~~l~~~g~~~~-~~~~~~~~  133 (186)
T d1df0a1          61 ETCKIMVDMLDEDGSGKLGLKEFYILWTKI------QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLP-CQLHQVIV  133 (186)
T ss_dssp             HHHHHHHHHHCCSSSSEECHHHHHHHHHHH------HHHHHHHHHHCTTCCSCEEGGGHHHHHHHTTEECC-HHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCcccHHHHHHHHHhH------HHHHHHHHhhCCCCCCcccHHHHHHHHHHHHhccc-HHHHHHHH
Confidence            345667778899999999999998887643      56788999999999999999999988876533222 24566777


Q ss_pred             ccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCce--eHHHHHHHH
Q 040917          419 YFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRI--SYDEFRSMM  475 (494)
Q Consensus       419 ~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i--~~~ef~~~~  475 (494)
                      .+|.|++|.|+.+||.+++..        .+.+.++|+.+|.|++|.|  ++++|+.+.
T Consensus       134 ~~d~d~dg~I~f~eFi~~~~~--------l~~~~~~F~~~D~~~~G~i~l~~~ef~~~~  184 (186)
T d1df0a1         134 ARFADDELIIDFDNFVRCLVR--------LEILFKIFKQLDPENTGTIQLDLISWLSFS  184 (186)
T ss_dssp             HHHCCSTTEECHHHHHHHHHH--------HHHHHHHHHHHCTTCCSEEEEEHHHHHHHH
T ss_pred             HHHcCCCCeEeHHHHHHHHHH--------HHHHHHHHHHhCCCCCCcEEecHHHHHHHh
Confidence            789999999999999888864        2578889999999999987  899998754

>d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Rattus norvegicus [TaxId: 10116]

Probab=99.33  E-value=1.2e-12  Score=93.97  Aligned_cols=66  Identities=38%  Similarity=0.715  Sum_probs=61.5

Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ..+++.+|+.||.|++|+|+..||+.+|..  +|...+++++.+++..+|.|++|.|+|+||+.+|.+
T Consensus         7 i~el~~~F~~~D~d~~G~I~~~el~~~l~~--~g~~~s~~~~~~~~~~~D~d~~g~I~f~eF~~~m~~   72 (73)
T d2pq3a1           7 IAEFKEAFSLFDKDGDGTITTKELGTVMRS--LGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMAR   72 (73)
T ss_dssp             HHHHHHHHHHTCTTSSSEEEGGGHHHHHHH--TTCCCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCceEeHHHHHHHHHH--hCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence            357899999999999999999999999999  677899999999999999999999999999998863

>d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.31  E-value=1.1e-12  Score=91.60  Aligned_cols=63  Identities=33%  Similarity=0.670  Sum_probs=59.6

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHH
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITAT  401 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~  401 (494)
                      ++++.+|+.+|++++|+|+.+||+.+++.+|..++..++..++..+|.|++|.|+|+||+..|
T Consensus         3 eel~~aF~~fD~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~D~d~~g~I~~~eF~~~m   65 (65)
T d1fw4a_           3 EEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMM   65 (65)
T ss_dssp             HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCSSSEEHHHHHHHC
T ss_pred             HHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcEeHHHHHHHC
Confidence            457899999999999999999999999999999999999999999999999999999998753

>d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain small (regulatory) subunit (domain VI)
species: Pig (Sus scrofa) [TaxId: 9823]

Probab=99.30  E-value=1e-11  Score=105.79  Aligned_cols=123  Identities=20%  Similarity=0.272  Sum_probs=98.6

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhcc
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQ  418 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~  418 (494)
                      +....++..+|.+++|.|+.+||..+....      ......|+.+|.|++|.|+..||...+.......+. +...+|.
T Consensus        47 ~~~~~l~~~~d~d~~g~i~~~ef~~~~~~~------~~~~~~f~~~D~d~~G~I~~~el~~~L~~~g~~~~~-~~~~~~~  119 (173)
T d1alva_          47 DTCRSMVAVMDSDTTGKLGFEEFKYLWNNI------KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNE-HLYSMII  119 (173)
T ss_dssp             HHHHHHHHHHCTTCSSSBCHHHHHHHHHHH------HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCH-HHHHHHH
T ss_pred             HHHHHHHHHhccCCCCcccchhhhhhhhhh------hHHHHHHHHhccCCCCeecHHHHHHHHHHHHHhhHH-HHHHHhh
Confidence            345567788999999999999999887643      346788999999999999999998887765433333 3455666


Q ss_pred             ccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCce--eHHHHHHHHh
Q 040917          419 YFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRI--SYDEFRSMMK  476 (494)
Q Consensus       419 ~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i--~~~ef~~~~~  476 (494)
                      .+|.|++|.|+.+||.+++..  +      +.+..+|..+|.|++|.|  +++||+++..
T Consensus       120 ~~d~d~~G~i~~~EF~~~~~~--~------~~~~~~f~~~D~d~~G~it~~~~efl~~~~  171 (173)
T d1alva_         120 RRYSDEGGNMDFDNFISCLVR--L------DAMFRAFKSLDKDGTGQIQVNIQEWLQLTM  171 (173)
T ss_dssp             HHHTCSSSCBCHHHHHHHHHH--H------HHHHHHHHHHSSSCCSEEEEEHHHHHHHHH
T ss_pred             ccccCCCCeEeHHHHHHHHHH--H------HHHHHHHHHhCCCCCCcEEecHHHHHHHHH
Confidence            777799999999999998865  2      467789999999999988  6899988654

>d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.29  E-value=2.9e-12  Score=92.26  Aligned_cols=64  Identities=27%  Similarity=0.456  Sum_probs=60.9

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHH
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATM  402 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~  402 (494)
                      +.+..+|+.||++++|+|+..||..+|+.+|..++.+++..++..+|.|++|.|+|+||+..+.
T Consensus         9 eel~~~F~~fD~~~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~D~d~dg~I~~~EF~~~m~   72 (75)
T d1jc2a_           9 EELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNNDGRIDFDEFLKMME   72 (75)
T ss_dssp             HHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSSCCCHHHHHHHHHHHCSSSCSEECHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCCCccHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence            4678899999999999999999999999999999999999999999999999999999998765

>d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Sorcin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.28  E-value=1.2e-11  Score=105.22  Aligned_cols=123  Identities=22%  Similarity=0.278  Sum_probs=99.6

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhcc
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQ  418 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~  418 (494)
                      +.++..+..+|.|++|.|+.+||..++...      ......|+.+|.+++|.|+.+|+..++.......+.+.+..+|+
T Consensus        47 ~~v~~l~~~~D~d~~G~I~f~EF~~~~~~~------~~~~~~f~~~D~d~sG~i~~~El~~~l~~~g~~ls~~~~~~l~~  120 (172)
T d1juoa_          47 ETCRLMVSMLDRDMSGTMGFNEFKELWAVL------NGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAK  120 (172)
T ss_dssp             HHHHHHHHHHCTTCSSCEEHHHHHHHHHHH------HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCceehHHHHHHHHhh------hhhhHHHHHhCcCCCCcCCHHHHHHHHHHHHHhhhHHHHHHHHH
Confidence            455667788999999999999999887643      44677899999999999999999888776544445567888888


Q ss_pred             ccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCce--eHHHHHHHHhc
Q 040917          419 YFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRI--SYDEFRSMMKC  477 (494)
Q Consensus       419 ~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i--~~~ef~~~~~~  477 (494)
                      .+|  ++|.|+.++|..++..+        ..+.++|..+|.|++|.|  +|+||+.++.+
T Consensus       121 ~~d--~~g~i~~~eF~~~~~~~--------~~~~~~f~~~D~d~~G~Itl~~~eFl~~~l~  171 (172)
T d1juoa_         121 RYS--TNGKITFDDYIACCVKL--------RALTDSFRRRDTAQQGVVNFPYDDFIQCVMS  171 (172)
T ss_dssp             HTC--SSSSEEHHHHHHHHHHH--------HHHHHHHHHTCTTCCSEEEEEHHHHHHHHTT
T ss_pred             HHH--hcCCcCHHHHHHHHHHH--------HHHHHHHHHhCCCCCCcEEecHHHHHHHHHc
Confidence            886  45889999999888752        367789999999999987  88999887653

>d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin-related protein T21P5.17
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

Probab=99.27  E-value=3e-12  Score=90.08  Aligned_cols=64  Identities=25%  Similarity=0.508  Sum_probs=60.3

Q ss_pred             hhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHH
Q 040917          340 KLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQ  403 (494)
Q Consensus       340 ~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~  403 (494)
                      .++++|+.+|.|++|+|+..||..+++.+|..++.+++..+|..+|.|++|.|+|+||+..+.+
T Consensus         2 ~~r~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~~i~~~~~~~D~d~dg~I~~~EF~~~m~~   65 (67)
T d1tiza_           2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSCIEK   65 (67)
T ss_dssp             THHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHHHHT
T ss_pred             hHHHHHHHHCCCCcCcCcHHHHHHHHHHhccccchHHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            3578999999999999999999999999999999999999999999999999999999987753

>d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.27  E-value=2.5e-12  Score=88.47  Aligned_cols=61  Identities=30%  Similarity=0.620  Sum_probs=58.1

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHH
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFIT  399 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~  399 (494)
                      ++++++|..+|++++|+|+..||..++..+|..++..++..+++.+|.|++|.|+|+||+.
T Consensus         1 Eel~~aF~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D~d~dg~I~~~eFl~   61 (61)
T d2fcea1           1 EDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIE   61 (61)
T ss_dssp             HHHHHHHHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCCCCTTSEECHHHHHH
T ss_pred             ChHHHHHHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHHHhcC
Confidence            3578899999999999999999999999999999999999999999999999999999974

>d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]

Probab=99.26  E-value=9.7e-12  Score=106.92  Aligned_cols=90  Identities=22%  Similarity=0.306  Sum_probs=66.9

Q ss_pred             HHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhc
Q 040917          338 IQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAF  417 (494)
Q Consensus       338 ~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F  417 (494)
                      ++.++..|+.+|+|++|+|+..||..++..+|..++.+.+..++.. |.|++|.|+|+||+.++....      .+..+|
T Consensus        92 ~~~~~~~F~~~D~d~sG~i~~~El~~~l~~~g~~~~~~~~~~l~~~-~~~~dg~i~f~eFi~~~~~l~------~~~~~F  164 (188)
T d1qxpa2          92 IRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVAR-FADDELIIDFDNFVRCLVRLE------ILFKIF  164 (188)
T ss_dssp             HHHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHH-TSCSSSBCCHHHHHHHHHHHH------HHHHHH
T ss_pred             hHHHHHHHHHhCCCCCCEECHHHHHHHHHHhhhcCCHHHHHHHHHH-hcCCCCcCCHHHHHHHHHHHH------HHHHHH
Confidence            4567778888888888888888888888888887777666655554 568888888888888776432      466788


Q ss_pred             cccccCCCCce--eHHHHH
Q 040917          418 QYFDKDNNGYI--TVDELG  434 (494)
Q Consensus       418 ~~~D~d~~G~I--~~~el~  434 (494)
                      +.+|++++|+|  +..||.
T Consensus       165 ~~~D~~~~G~i~l~~~efl  183 (188)
T d1qxpa2         165 KQLDPENTGTIQLDLISWL  183 (188)
T ss_dssp             HHSCSSCCSCEEEEHHHHH
T ss_pred             HHhCCCCCCeEEeeHHHHH
Confidence            88888888877  444443

>d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Caltractin (centrin 2)
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.25  E-value=6e-12  Score=91.29  Aligned_cols=68  Identities=31%  Similarity=0.465  Sum_probs=63.2

Q ss_pred             hHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHH
Q 040917          336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQ  403 (494)
Q Consensus       336 ~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~  403 (494)
                      +..+.++++|+.+|.|++|+|+..||..+++.+|..++.+++..+|+.+|.|++|.|+|+||+..+.+
T Consensus         6 d~~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~~~~~~D~d~~G~I~~~EF~~~m~k   73 (77)
T d1oqpa_           6 DSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKK   73 (77)
T ss_dssp             SHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSSSSEECHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHcCCCCCEechHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHc
Confidence            34457899999999999999999999999999999999999999999999999999999999988764

>d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Programmed cell death 6 protein-like protein
species: Leishmania major [TaxId: 5664]

Probab=99.25  E-value=1.9e-11  Score=105.01  Aligned_cols=118  Identities=19%  Similarity=0.335  Sum_probs=74.2

Q ss_pred             hhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccc
Q 040917          342 KEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFD  421 (494)
Q Consensus       342 ~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D  421 (494)
                      ..+|..+|.+++|.|+..+|...+..      ...+...|..+|.+++|.|+.+||...+.......+.+.+..+|+.+|
T Consensus        57 ~~l~~~~d~d~~~~i~~~ef~~~~~~------~~~~~~~F~~~D~~~~g~I~~~el~~~l~~~g~~ls~~e~~~i~~~~d  130 (182)
T d1y1xa_          57 EKLLHMYDKNHSGEITFDEFKDLHHF------ILSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFD  130 (182)
T ss_dssp             HHHHHHHCTTCSSSBCHHHHHHHHHH------HHHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHC
T ss_pred             hhhhcccccccccccccccccccccc------ccccccchhccccccchhhhhHHHHHHHHHhCCchhHHHHHHHHhhcc
Confidence            34455566777777777777665543      234556677777777777777777666654433334455666777777


Q ss_pred             cCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCce--eHHHHHH
Q 040917          422 KDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRI--SYDEFRS  473 (494)
Q Consensus       422 ~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i--~~~ef~~  473 (494)
                      .|++|.|+.+||..++..+        ..+.++|..+|.+++|.|  +|++|+.
T Consensus       131 ~~~dg~I~~~eF~~~~~~l--------~~~~~~F~~~D~~~~G~is~~~~~f~~  176 (182)
T d1y1xa_         131 RQRRGSLGFDDYVELSIFV--------CRVRNVFAFYDRERTGQVTFTFDTFIG  176 (182)
T ss_dssp             TTCSSSBCHHHHHHHHHHH--------HHHHHHHHHHCTTCCSEEEEEHHHHHH
T ss_pred             cCCCCCcCHHHHHHHHHHH--------HHHHHHHHHhCCCCCCcEEeeHHHHHH
Confidence            7777777777777766441        245666777777777774  5677755

>d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]

Probab=99.24  E-value=5.7e-12  Score=92.19  Aligned_cols=64  Identities=31%  Similarity=0.536  Sum_probs=60.6

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHH
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATM  402 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~  402 (494)
                      +.+..+|..+|++++|+|+..||..+++.+|..++.+++..+|..+|.|+||.|+|+||+..+.
T Consensus        15 e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~~D~d~dg~I~~~EF~~~m~   78 (81)
T d1fi5a_          15 EELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMK   78 (81)
T ss_dssp             HHHHHHHHHHCSSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHS
T ss_pred             HHHHHHHHHHcCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHH
Confidence            4688899999999999999999999999999999999999999999999999999999998764

>d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.23  E-value=1.8e-12  Score=93.72  Aligned_cols=71  Identities=30%  Similarity=0.461  Sum_probs=58.1

Q ss_pred             HHHHHHHhccccccC--CCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          409 RFENLYKAFQYFDKD--NNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d--~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      +.++++.+|+.||.+  ++|+|+.+||+.+|..+|.....++.++++++..+|.|+||+|+|+||+.+|.+..
T Consensus         3 s~eel~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d~dG~I~f~EF~~~m~~~~   75 (76)
T d1qx2a_           3 SPEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMMKKIS   75 (76)
T ss_dssp             CHHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcCCCCcCcHHHHHHHHHHHc
Confidence            356899999999664  47999999999999985432222345799999999999999999999999988643

>d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.23  E-value=1.3e-11  Score=106.84  Aligned_cols=99  Identities=26%  Similarity=0.370  Sum_probs=87.1

Q ss_pred             hhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh------------hh
Q 040917          341 LKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK------------LQ  408 (494)
Q Consensus       341 ~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~------------~~  408 (494)
                      ..++|+.+|.+++|.|+..||..++..+.....++.+..+|+.+|.|++|.|+++||...+.....            ..
T Consensus        65 ~~~if~~~D~~~~G~I~~~Ef~~~~~~~~~~~~~e~~~~~F~~~D~d~dG~is~~E~~~~~~~~~~~~~~~~~~~~~~~~  144 (190)
T d1fpwa_          65 ANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEAT  144 (190)
T ss_dssp             HHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCSTHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCC
T ss_pred             HHHHHHHhCcCCCCcccHHHHHHHHHHHccCchHHHHHHHHHHhccCCCCcCcHHHHHHHHHHHHHhcccccCCCchhhh
Confidence            467899999999999999999999999988788889999999999999999999999888765321            12


Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhh
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKD  439 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~  439 (494)
                      ....+..+|+.+|.|+||.|+.+||++++..
T Consensus       145 ~~~~v~~if~~~D~d~dG~Is~~EF~~~~~~  175 (190)
T d1fpwa_         145 PEMRVKKIFKLMDKNEDGYITLDEFREGSKV  175 (190)
T ss_dssp             HHHHHHHHHHHHTTTCSSEEEHHHHHHHHHS
T ss_pred             HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence            3466888999999999999999999999876

>d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=99.22  E-value=2.9e-12  Score=90.21  Aligned_cols=64  Identities=34%  Similarity=0.591  Sum_probs=59.5

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCC-CCHHHHHHHHHHhcCCCCCcccchHHHHHHH
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM-LTEFDVKQYMQAADIDGNGTIDYIEFITATM  402 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~-~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~  402 (494)
                      +.+.++|+.+|.+++|+|+.+||..++..+|.. ++.+++..++..+|.|+||.|+|+||+..+.
T Consensus         2 eel~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d~dG~i~~~EF~~~m~   66 (68)
T d1c7va_           2 EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLIK   66 (68)
T ss_dssp             HHHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence            357899999999999999999999999999875 7999999999999999999999999998765

>d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Recoverin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.18  E-value=1.9e-11  Score=106.92  Aligned_cols=122  Identities=21%  Similarity=0.208  Sum_probs=102.0

Q ss_pred             CCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHh-cCCCCCcccchHHHHHHHHhhhh-hHHHHHHHhccccccCCCCcee
Q 040917          352 NSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAA-DIDGNGTIDYIEFITATMQRHKL-QRFENLYKAFQYFDKDNNGYIT  429 (494)
Q Consensus       352 ~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~-D~~~~g~i~~~ef~~~~~~~~~~-~~~~~~~~~F~~~D~d~~G~I~  429 (494)
                      .+|.|+.+++..+.....  ++..++..++..+ +.+++|.|+++||...+...... .....+..+|+.+|.|++|.|+
T Consensus         4 ~~~~l~~e~l~~l~~~t~--f~~~ei~~l~~~F~~~~~~G~is~~EF~~~l~~~~~~~~~~~~~~~if~~~D~~~~G~I~   81 (201)
T d1omra_           4 KSGALSKEILEELQLNTK--FTEEELSSWYQSFLKECPSGRITRQEFQTIYSKFFPEADPKAYAQHVFRSFDANSDGTLD   81 (201)
T ss_dssp             SSCTHHHHHHHHHGGGCS--SCHHHHHHHHHHHHHHCTTSEEEHHHHHHHHHHHCTTSCCHHHHHHHHHTTTSCSSSEEE
T ss_pred             ccCCCCHHHHHHHHHhCC--CCHHHHHHHHHHHHHHCcCCCccHHHHHHHHHHhcCCCCHHHHHHHHHHHhccCCCCeEe
Confidence            578899999988887655  6888999888886 67789999999999988775442 3344567899999999999999


Q ss_pred             HHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          430 VDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       430 ~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ..||..++..+  .....++.++.+|..+|.|++|.|+++||...+..
T Consensus        82 f~EF~~~~~~~--~~~~~~~~l~~~F~~~D~d~~G~is~~E~~~~~~~  127 (201)
T d1omra_          82 FKEYVIALHMT--SAGKTNQKLEWAFSLYDVDGNGTISKNEVLEIVTA  127 (201)
T ss_dssp             HHHHHHHHHHH--HSSCGGGSHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred             ehhHHHHHHhh--cccchHHHHHHHHHHHccCCCCccCHHHHHHHHHH
Confidence            99999999873  34456667999999999999999999999988764

>d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: EHCABP
species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]

Probab=99.16  E-value=6.2e-11  Score=96.20  Aligned_cols=101  Identities=24%  Similarity=0.418  Sum_probs=84.8

Q ss_pred             HHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCc--HHHHHHH
Q 040917          377 VKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT--IATIKEI  454 (494)
Q Consensus       377 ~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~--~~~~~~~  454 (494)
                      ++.+|..+|.|+||.|++.||...+.........+.+..+|+.+|.|++|.|+.+||..++... ......  ...+..+
T Consensus         2 ae~~F~~~D~d~dG~is~~E~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~Ef~~~~~~~-~~~~~~~~~~~~~~~   80 (134)
T d1jfja_           2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSI-QGQDLSDDKIGLKVL   80 (134)
T ss_dssp             HHHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHCSSCCSEEEHHHHHHHTTCS-SCCSSHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCcCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhhhcccccccccccccccccc-ccccccccccccccc
Confidence            3579999999999999999999888776655677789999999999999999999999999763 222222  3456789


Q ss_pred             HHHhCCCCCCceeHHHHHHHHhcc
Q 040917          455 MSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       455 ~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      |..+|.+++|.|+.+||...+...
T Consensus        81 F~~~D~~~~g~i~~~el~~~~~~~  104 (134)
T d1jfja_          81 YKLMDVDGDGKLTKEEVTSFFKKH  104 (134)
T ss_dssp             HHHHCCSSSSEEEHHHHHHHHTTT
T ss_pred             ccccccccCCcccHHHHHHHHHhc
Confidence            999999999999999999988753

>d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Guanylate cyclase activating protein 2, GCAP-2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.14  E-value=6.6e-11  Score=102.28  Aligned_cols=101  Identities=24%  Similarity=0.300  Sum_probs=85.8

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh------------
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK------------  406 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~------------  406 (494)
                      ..+.++|..+|.|++|.|+..||..++..+.....++.+..+|+.+|.|++|.|++.||...+.....            
T Consensus        58 ~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~~~~~~~~~~~F~~~D~d~~g~i~~~E~~~~~~~~~~~~~~~~~~~~~~  137 (189)
T d1jbaa_          58 QYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAE  137 (189)
T ss_dssp             HHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSS
T ss_pred             HHHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHHHHHHHhhhccCCCCcccHhHHHHHHHHHHHhhccccccchhh
Confidence            44678899999999999999999999998877677788999999999999999999999876543211            


Q ss_pred             -----hhHHHHHHHhccccccCCCCceeHHHHHHHHhh
Q 040917          407 -----LQRFENLYKAFQYFDKDNNGYITVDELGKAFKD  439 (494)
Q Consensus       407 -----~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~  439 (494)
                           ....+.+..+|+.+|.|+||.|+.+||.++++.
T Consensus       138 ~~~~~~~~e~~~~~if~~~D~d~dG~Is~~EF~~~~~~  175 (189)
T d1jbaa_         138 QQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGARR  175 (189)
T ss_dssp             TTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHHHHHTT
T ss_pred             hhccccchHHHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence                 112456788999999999999999999999975

>d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: DJ-1-binding protein, DJBP
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.11  E-value=5.5e-11  Score=87.53  Aligned_cols=65  Identities=18%  Similarity=0.326  Sum_probs=59.9

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHH
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMM  475 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~  475 (494)
                      ....+.++|+.+|.+++|+|+.+||+++|..  .+..+++++++.++..+|.|++|.|+|.||+..+
T Consensus        18 ~~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~--~~~~l~~~e~~~l~~~~d~~~~g~I~y~eFl~~f   82 (83)
T d1wlza1          18 HYHAITQEFENFDTMKTNTISREEFRAICNR--RVQILTDEQFDRLWNEMPVNAKGRLKYPDFLSRF   82 (83)
T ss_dssp             THHHHHHHHHHHCTTCSSCBCHHHHHHHHHH--HTCCCCHHHHHHHHTTSCBCTTSCBCHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCceEChhHHHHHHHH--hCCCCChhHHHHHhhccccCCCCcEeHHHHHHHh
Confidence            3457899999999999999999999999999  5568999999999999999999999999998764

>d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: DJ-1-binding protein, DJBP
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.07  E-value=9.2e-11  Score=86.29  Aligned_cols=66  Identities=17%  Similarity=0.376  Sum_probs=61.7

Q ss_pred             hHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHH
Q 040917          336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITAT  401 (494)
Q Consensus       336 ~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~  401 (494)
                      .....+.+.|+.+|.+++|+|+..||..+|..++..++++++..++..+|.|++|.|+|.||+..+
T Consensus        17 ~~~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~~l~~~e~~~l~~~~d~~~~g~I~y~eFl~~f   82 (83)
T d1wlza1          17 SHYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKYPDFLSRF   82 (83)
T ss_dssp             HTHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTTSCBCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCceEChhHHHHHHHHhCCCCChhHHHHHhhccccCCCCcEeHHHHHHHh
Confidence            345678899999999999999999999999999999999999999999999999999999999764

>d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.07  E-value=2e-10  Score=98.96  Aligned_cols=99  Identities=17%  Similarity=0.255  Sum_probs=83.3

Q ss_pred             hhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh------------hhh
Q 040917          341 LKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH------------KLQ  408 (494)
Q Consensus       341 ~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~------------~~~  408 (494)
                      ..++|+.+|.+++|.|+..||..++........++.+..+|..+|.|++|.|+.+|+...+....            ...
T Consensus        62 ~~~if~~~d~~~dg~I~~~EF~~~l~~~~~~~~~e~l~~~F~~~D~d~dG~i~~~El~~~~~~~~~~~~~~~~~~~~~~~  141 (187)
T d1g8ia_          62 ATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENT  141 (187)
T ss_dssp             HHHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSS
T ss_pred             HHHHHHHhCcCCCCCCcHHHHHHHHHHhccCchhhhHHHHHHHHhcCCCCeEcHHHHHHHHHHHhhhhcccccCchhhcc
Confidence            45678999999999999999999998875555677799999999999999999999987765321            112


Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhh
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKD  439 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~  439 (494)
                      ..+.+..+|+.+|.|+||.|+.+||.+++..
T Consensus       142 ~~~~v~~if~~~D~d~dG~Is~~EF~~~~~~  172 (187)
T d1g8ia_         142 PEKRVDRIFAMMDKNADGKLTLQEFQEGSKA  172 (187)
T ss_dssp             HHHHHHHHHHHHCSSCSSEEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCcEeHHHHHHHHHH
Confidence            3456788999999999999999999999986

>d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Pig (Sus scrofa) [TaxId: 9823]

Probab=99.06  E-value=3.1e-11  Score=87.24  Aligned_cols=70  Identities=19%  Similarity=0.307  Sum_probs=59.6

Q ss_pred             HHHHHHHhcccccc--CCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          409 RFENLYKAFQYFDK--DNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       409 ~~~~~~~~F~~~D~--d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ..++++.+|..||.  ++.|+|+.+||+.+|.....+...+++++++++..+|.|+||+|+|+||..+|.+-
T Consensus         5 ~~~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~d~dG~Idf~EF~~l~~~l   76 (78)
T d1cb1a_           5 SPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQVLVKKI   76 (78)
T ss_dssp             CHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHH
Confidence            35689999999975  34589999999999998645566677789999999999999999999999998753

>d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.06  E-value=1.2e-10  Score=87.73  Aligned_cols=68  Identities=22%  Similarity=0.230  Sum_probs=62.6

Q ss_pred             CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHH
Q 040917          333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATM  402 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~  402 (494)
                      +++++.+++.++|+.+|+|++|+|+.+|+..++...+  ++.+++.++|+.+|.|++|.|+++||+.++.
T Consensus         4 lt~~e~~~~~~~F~~~D~d~~G~is~~e~~~~l~~~~--l~~~~l~~i~~~~D~d~dG~l~~~EF~~am~   71 (95)
T d1c07a_           4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG--LPSTLLAHIWSLCDTKDCGKLSKDQFALAFH   71 (95)
T ss_dssp             SCSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT--CCHHHHHHHHHHHCTTCSSSEETTTHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhcC--CCHHHHHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence            5688899999999999999999999999999999876  5788999999999999999999999987764

>d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Leopard shark (Triakis semifasciata) [TaxId: 30493]

Probab=99.06  E-value=4e-10  Score=87.05  Aligned_cols=99  Identities=20%  Similarity=0.196  Sum_probs=68.0

Q ss_pred             chhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh---hhHH
Q 040917          334 PTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK---LQRF  410 (494)
Q Consensus       334 ~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~---~~~~  410 (494)
                      +.+++.++..   .+|  .+|.|+..||..++..  ...+.+++..+|+.+|.|++|.|+.+|+...+.....   ..+.
T Consensus         7 ~~~di~~~~~---~~~--~~G~idf~eF~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~~~~   79 (109)
T d5pala_           7 KADDINKAIS---AFK--DPGTFDYKRFFHLVGL--KGKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLND   79 (109)
T ss_dssp             CHHHHHHHHH---HTC--STTCCCHHHHHHHHTC--TTCCHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCH
T ss_pred             cHHHHHHHHH---hcC--CCCcCcHHHHHHHHHh--cCCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccCcCCH
Confidence            4444444333   333  4577888888766542  2235677888888888888888888888776654321   2245


Q ss_pred             HHHHHhccccccCCCCceeHHHHHHHHhh
Q 040917          411 ENLYKAFQYFDKDNNGYITVDELGKAFKD  439 (494)
Q Consensus       411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~  439 (494)
                      +++..+|+.+|.|+||.|+.+||.+++..
T Consensus        80 ~e~~~~~~~~D~d~dG~I~~~EF~~~m~~  108 (109)
T d5pala_          80 TETKALLAAGDSDHDGKIGADEFAKMVAQ  108 (109)
T ss_dssp             HHHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCEeHHHHHHHHHh
Confidence            66888888888888888888888887753

>d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

Probab=99.05  E-value=9.5e-11  Score=90.62  Aligned_cols=86  Identities=21%  Similarity=0.198  Sum_probs=52.3

Q ss_pred             CCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh---hhHHHHHHHhccccccCCCCc
Q 040917          351 DNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK---LQRFENLYKAFQYFDKDNNGY  427 (494)
Q Consensus       351 ~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~---~~~~~~~~~~F~~~D~d~~G~  427 (494)
                      +.+|.|+..||..++...  ..+.++++++|..+|.|++|.|+.+|+...+.....   ..+.+++..+|+.+|.|+||.
T Consensus        19 d~dG~idf~EF~~~~~~~--~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~ls~~ev~~~~~~~D~d~dG~   96 (109)
T d1pvaa_          19 KAEGSFNHKKFFALVGLK--AMSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGK   96 (109)
T ss_dssp             CSTTCCCHHHHHHHHTCT--TSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHCTTCSSS
T ss_pred             CCCCCCcHHHHHHHHHHc--cCCHHHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCCCHHHHHHHHHHHCCCCcCc
Confidence            345667777776554322  234556667777777777777777776555443211   223455666777777777777


Q ss_pred             eeHHHHHHHHh
Q 040917          428 ITVDELGKAFK  438 (494)
Q Consensus       428 I~~~el~~~l~  438 (494)
                      |+.+||.+++.
T Consensus        97 I~~~EF~~~m~  107 (109)
T d1pvaa_          97 IGIDEFETLVH  107 (109)
T ss_dssp             BCHHHHHHHHH
T ss_pred             EeHHHHHHHHH
Confidence            77777776664

>d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Neurocalcin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.05  E-value=3.8e-10  Score=96.61  Aligned_cols=100  Identities=22%  Similarity=0.306  Sum_probs=86.0

Q ss_pred             hhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh------------h
Q 040917          340 KLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK------------L  407 (494)
Q Consensus       340 ~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~------------~  407 (494)
                      ...++|+.+|.+++|.|+.+||..++...-.....+.+..+|..+|.|++|.|+.+||...+.....            .
T Consensus        60 ~~~~lf~~~d~~~~g~i~~~eFl~~~~~~~~~~~~~~~~~~f~~~D~d~dg~i~~~E~~~~~~~~~~~~~~~~~~~~~~~  139 (181)
T d1bjfa_          60 FAEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDES  139 (181)
T ss_dssp             HHHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGS
T ss_pred             HHHHHHHhcCCCCCCcEeHHHHHHHHHHHhhhchHHHHHHHHHHhccCCCCeecHHHHHHHHHHHhhhccccccCCcccc
Confidence            3567899999999999999999999988766666778999999999999999999999888765321            2


Q ss_pred             hHHHHHHHhccccccCCCCceeHHHHHHHHhh
Q 040917          408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKD  439 (494)
Q Consensus       408 ~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~  439 (494)
                      .....+..+|+.+|.|+||.|+.+||.+++..
T Consensus       140 ~~~~~~~~if~~~D~d~dG~Is~~EF~~~~~~  171 (181)
T d1bjfa_         140 TPEKRTEKIFRQMDTNRDGKLSLEEFIRGAKS  171 (181)
T ss_dssp             SHHHHHHHHHHHSCTTCSSEECHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence            24566888999999999999999999999976

>d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]

Probab=99.05  E-value=1.2e-10  Score=96.04  Aligned_cols=102  Identities=26%  Similarity=0.279  Sum_probs=85.5

Q ss_pred             HHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHH
Q 040917          376 DVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIM  455 (494)
Q Consensus       376 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~  455 (494)
                      +++++|..+|.+++|.|+++||...+.......+...+..+|..+|.+++|.|+..|+..++... .......+.+..+|
T Consensus        10 ~l~~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~-~~~~~~~~~~~~~F   88 (146)
T d1exra_          10 EFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLSLMARK-MKEQDSEEELIEAF   88 (146)
T ss_dssp             HHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHH-HHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCCCHHHHHHHHHhcCCCCCCcccHHHHHHHHHHH-hhccChHHHHHHHH
Confidence            36778999999999999999999888776555566788999999999999999999999998652 11112355788999


Q ss_pred             HHhCCCCCCceeHHHHHHHHhcc
Q 040917          456 SEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       456 ~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ..+|.|++|.|+.+||...+...
T Consensus        89 ~~~D~d~~G~i~~~e~~~~l~~~  111 (146)
T d1exra_          89 KVFDRDGNGLISAAELRHVMTNL  111 (146)
T ss_dssp             HHHSTTCSSCBCHHHHHHHHHHT
T ss_pred             HHhCCCCCCcCCHHHHHHHHHHH
Confidence            99999999999999999998753

>d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Reps1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.04  E-value=2.2e-10  Score=85.78  Aligned_cols=68  Identities=21%  Similarity=0.292  Sum_probs=62.6

Q ss_pred             CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHH
Q 040917          333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATM  402 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~  402 (494)
                      +++++.+++.++|+.+|+|++|+|+.+|+..++...+  ++..++..+|+..|.|++|.|+|+||+.++.
T Consensus         3 ls~ee~~~y~~~F~~~D~d~~G~i~~~e~~~~l~~~~--l~~~~l~~i~~~~D~d~dG~l~~~EF~~a~~   70 (92)
T d1fi6a_           3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDFDKDGALTLDEFCAAFH   70 (92)
T ss_dssp             CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS--SCHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHHcc--CCHHHHHHHHHHhCCCCCCeecHHHHHHHHH
Confidence            5788999999999999999999999999999999976  5788999999999999999999999987554

>d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Oncomodulin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.02  E-value=1.1e-10  Score=90.19  Aligned_cols=67  Identities=40%  Similarity=0.472  Sum_probs=51.2

Q ss_pred             hhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhc---CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHH
Q 040917          335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL---GSMLTEFDVKQYMQAADIDGNGTIDYIEFITAT  401 (494)
Q Consensus       335 ~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~---~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~  401 (494)
                      ......++++|+.+|+|++|+|+.+||+.++..+   +..++++++..+++.+|.|+||.|+|+||+.++
T Consensus        37 ~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~l~~~~~~~~~~~~D~d~dG~I~~~EF~~~m  106 (108)
T d1rroa_          37 KMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADNDGDGKIGADEFQEMV  106 (108)
T ss_dssp             GSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCCSSSSSEEHHHHHHHH
T ss_pred             cCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhccCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence            3344566778888888888888888888888776   445677788888888888888888888887765

>d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.02  E-value=4e-10  Score=92.67  Aligned_cols=106  Identities=17%  Similarity=0.151  Sum_probs=84.7

Q ss_pred             CHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccC--CCCceeHHHHHHHHhhcCC-CCCCcHH
Q 040917          373 TEFDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKD--NNGYITVDELGKAFKDYGM-GDDATIA  449 (494)
Q Consensus       373 ~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d--~~G~I~~~el~~~l~~~~~-~~~~~~~  449 (494)
                      +.++++++|..+|.|++|.|+.+||..++.......+..++..++..++.+  ++|.|+..||..++..... ......+
T Consensus         2 ~~eelke~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~   81 (145)
T d2mysc_           2 AADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNAAAITFEEFLPMLQAAANNKDQGTFE   81 (145)
T ss_pred             CHHHHHHHHHHHcCCCCCeECHHHHHHHHHHhhhcchhhhhHHHHHHHhhcccccCccchhHHHHHHhhhhhccccchHH
Confidence            357899999999999999999999988886654445566777888777554  6899999999999875211 1123455


Q ss_pred             HHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          450 TIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       450 ~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ++.++|..+|.+++|.|+.+||..+++..
T Consensus        82 ~l~~aF~~~D~d~~G~I~~~el~~~l~~~  110 (145)
T d2mysc_          82 DFVEGLRVFDKEGNGTVMGAELRHVLATL  110 (145)
T ss_pred             HHHHHHHHhhcCCCCEEcHHHHHHHHHHh
Confidence            68899999999999999999999999863

>d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a13 [TaxId: 9606]

Probab=99.00  E-value=1.8e-10  Score=87.01  Aligned_cols=68  Identities=15%  Similarity=0.308  Sum_probs=57.9

Q ss_pred             HHHHHHhcccc-ccCCC-CceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          410 FENLYKAFQYF-DKDNN-GYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       410 ~~~~~~~F~~~-D~d~~-G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .+.+..+|..| |.|++ |+|+..||+++|...+.+...+++.+++++..+|.|+||+|+|+||+.+|.+
T Consensus        13 i~~l~~vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~d~DG~IdF~EF~~l~~~   82 (98)
T d1yuta1          13 IETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGE   82 (98)
T ss_dssp             HHHHHHHHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCTTCCSCBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHH
Confidence            45788899888 77775 9999999999998754444556677999999999999999999999998875

>d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]

Probab=99.00  E-value=3.8e-10  Score=84.56  Aligned_cols=69  Identities=20%  Similarity=0.375  Sum_probs=59.4

Q ss_pred             HHHHHHhcccc-ccCCC-CceeHHHHHHHHhhcC---CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          410 FENLYKAFQYF-DKDNN-GYITVDELGKAFKDYG---MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       410 ~~~~~~~F~~~-D~d~~-G~I~~~el~~~l~~~~---~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      .+.+.++|..| |.||+ |+|+.+||+++|...+   .....+++++++++..+|.|+||+|+|+||..+|.+.
T Consensus         8 i~~l~~~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~Idf~EF~~lm~~l   81 (93)
T d1zfsa1           8 METLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFVVLVAAL   81 (93)
T ss_dssp             HHHHHHHHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHTTTCCSEECSHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHH
Confidence            46788999988 88875 9999999999998753   2356788999999999999999999999999988753

>d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin B-like protein 2
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

Probab=98.98  E-value=9.7e-10  Score=94.19  Aligned_cols=100  Identities=18%  Similarity=0.206  Sum_probs=81.9

Q ss_pred             hhhhhhhccCCCCCCcccHHHHHHHHHhcCCCC-CHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh--------hhHH
Q 040917          340 KLKEKFTEMDTDNSGTLTYDELKAGLAKLGSML-TEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK--------LQRF  410 (494)
Q Consensus       340 ~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~-~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~--------~~~~  410 (494)
                      ...++|..+|.+++|.|+..||..++..+.... ..+.+..+|..+|.|++|.|+.+|+...+.....        ....
T Consensus        55 ~~~~lf~~~d~~~dg~I~f~EFl~~l~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~e~~~~~~~~~~~~~~~~~~~~~~  134 (183)
T d2zfda1          55 FADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIE  134 (183)
T ss_dssp             HHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHH
T ss_pred             HHHHHHHHHccCCCCcCcHHHHHHHHHhhhccCcHHHHHHHhhcccccCCCCCccHHHHHHHHHHHHhhhhcccchHHHH
Confidence            346789999999999999999999987764433 4566899999999999999999999887654311        1223


Q ss_pred             HHHHHhccccccCCCCceeHHHHHHHHhh
Q 040917          411 ENLYKAFQYFDKDNNGYITVDELGKAFKD  439 (494)
Q Consensus       411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~  439 (494)
                      +.+..+|+.+|.|++|.|+.+||.+++..
T Consensus       135 ~~~~~if~~~D~d~dG~Is~~EF~~~~~~  163 (183)
T d2zfda1         135 DIIDKTFEEADTKHDGKIDKEEWRSLVLR  163 (183)
T ss_dssp             HHHHHHHHHHCSSCSSEECHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCeEcHHHHHHHHHH
Confidence            44678999999999999999999999975

>d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.98  E-value=1.3e-10  Score=83.81  Aligned_cols=65  Identities=20%  Similarity=0.442  Sum_probs=54.7

Q ss_pred             HhhhhhhhccCCC--CCCcccHHHHHHHHHhcCCCCC--HHHHHHHHHHhcCCCCCcccchHHHHHHHH
Q 040917          339 QKLKEKFTEMDTD--NSGTLTYDELKAGLAKLGSMLT--EFDVKQYMQAADIDGNGTIDYIEFITATMQ  403 (494)
Q Consensus       339 ~~~~~~F~~~D~~--~~g~i~~~el~~~l~~~~~~~~--~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~  403 (494)
                      ++++.+|+.||.+  ++|+|+.+||..+++.+|..++  ..++..++..+|.|+||.|+|+||+..+.+
T Consensus         5 eel~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d~dG~I~f~EF~~~m~~   73 (76)
T d1qx2a_           5 EEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMMKK   73 (76)
T ss_dssp             HHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred             HHHHHHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcCCCCcCcHHHHHHHHHH
Confidence            4567777777554  5799999999999999987665  346999999999999999999999998764

>d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

Probab=98.98  E-value=2.4e-10  Score=88.02  Aligned_cols=65  Identities=32%  Similarity=0.508  Sum_probs=50.9

Q ss_pred             HHHhhhhhhhccCCCCCCcccHHHHHHHHHhcC---CCCCHHHHHHHHHHhcCCCCCcccchHHHHHH
Q 040917          337 EIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLG---SMLTEFDVKQYMQAADIDGNGTIDYIEFITAT  401 (494)
Q Consensus       337 ~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~---~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~  401 (494)
                      ....++.+|+.+|++++|+|+..||..++..++   ..++.+++..+|+.+|.|+||.|+|+||+.++
T Consensus        38 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~m  105 (107)
T d2pvba_          38 SLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKDGDGMIGVDEFAAMI  105 (107)
T ss_dssp             CHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred             CHHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccccCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence            334577788888888888888888888887763   45677888888888888888888888887665

>d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin regulatory subunit (B-chain)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.98  E-value=5.4e-10  Score=94.06  Aligned_cols=104  Identities=19%  Similarity=0.262  Sum_probs=85.2

Q ss_pred             hhhhhhccCCCCCCcccHHHHHHHHHhcCCCC-CHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-----hhHHHHHH
Q 040917          341 LKEKFTEMDTDNSGTLTYDELKAGLAKLGSML-TEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK-----LQRFENLY  414 (494)
Q Consensus       341 ~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~-~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-----~~~~~~~~  414 (494)
                      +.++|..+|.+++|.|+.+||..++....... ..+.+..+|..+|.|++|.|+.+|+...+.....     ......+.
T Consensus        50 ~~~l~~~~d~~~~g~i~~~EFl~~~~~~~~~~~~~~~~~~~f~~~d~d~~g~Is~~el~~~l~~~~~~~~~~~~~~~~~~  129 (165)
T d1auib_          50 VQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVD  129 (165)
T ss_dssp             HHHHHHHHCTTCSSSEEHHHHHHHHGGGCTTCCHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHTTSSCHHHHHHHHH
T ss_pred             HHHHHHHHccccchhhhhhhhhhhccccccchhhHHHHHHHHHHhcccccccccHHHHHHHHHHhccccCchHHHHHHHH
Confidence            45688899999999999999999998875443 4556899999999999999999999887754321     22345678


Q ss_pred             HhccccccCCCCceeHHHHHHHHhhcCCCC
Q 040917          415 KAFQYFDKDNNGYITVDELGKAFKDYGMGD  444 (494)
Q Consensus       415 ~~F~~~D~d~~G~I~~~el~~~l~~~~~~~  444 (494)
                      .+|..+|.|++|.|+.+||.+++..+.+..
T Consensus       130 ~~~~~~D~~~dG~Is~~EF~~i~~~~~~~~  159 (165)
T d1auib_         130 KTIINADKDGDGRISFEEFCAVVGGLDIHK  159 (165)
T ss_dssp             HHHHHHCTTSSSSEEHHHHHHHHGGGCGGG
T ss_pred             HHHHHcCCCCCCcEeHHHHHHHHhcCChhh
Confidence            899999999999999999999998744433

>d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a4 [TaxId: 9606]

Probab=98.96  E-value=6.3e-10  Score=83.01  Aligned_cols=70  Identities=17%  Similarity=0.419  Sum_probs=58.7

Q ss_pred             HHHHHHHhcccc-ccCCC-CceeHHHHHHHHhhcC---CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          409 RFENLYKAFQYF-DKDNN-GYITVDELGKAFKDYG---MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       409 ~~~~~~~~F~~~-D~d~~-G~I~~~el~~~l~~~~---~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ..+.+..+|..| |.|++ |+|+.+||+++|....   .+...+++++++++..+|.|+||+|+|+||..+|.+.
T Consensus         7 ~i~~l~~~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D~n~DG~I~F~EF~~lm~~l   81 (93)
T d3c1va1           7 ALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCI   81 (93)
T ss_dssp             HHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Confidence            446788999998 56665 4799999999998632   3456788999999999999999999999999988763

>d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

Probab=98.95  E-value=1.8e-09  Score=88.33  Aligned_cols=98  Identities=12%  Similarity=0.239  Sum_probs=81.1

Q ss_pred             HHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHH
Q 040917          376 DVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIM  455 (494)
Q Consensus       376 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~  455 (494)
                      +++++|..+|.+++|.|+.+||..++.......+..++..++.    +++|.|+..+|..++... +...-+++++..+|
T Consensus         8 e~~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~el~~~~~----~~~~~i~~~eF~~~~~~~-~~~~~~~~~l~~aF   82 (142)
T d1wdcb_           8 EMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK----EAPGPLNFTMFLSIFSDK-LSGTDSEETIRNAF   82 (142)
T ss_dssp             HHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHT----TSSSCCCHHHHHHHHHHH-TCSCCCHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCcCChHHHHHHHHHhhcCCCHHHHHHHHH----hccCcccccccccccccc-ccccchhhhHHHhh
Confidence            4677899999999999999999988876554455566777664    678999999999988753 33445678899999


Q ss_pred             HHhCCCCCCceeHHHHHHHHhcc
Q 040917          456 SEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       456 ~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      +.+|.|++|.|+.+||..++...
T Consensus        83 ~~~D~d~~G~I~~~el~~~l~~~  105 (142)
T d1wdcb_          83 AMFDEQETKKLNIEYIKDLLENM  105 (142)
T ss_dssp             HTTCTTCCSCEEHHHHHHHHHHS
T ss_pred             hhhcccCCCcccHHHHHHHHHHc
Confidence            99999999999999999988753

>d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Rat (Rattus rattus) [TaxId: 10117]

Probab=98.95  E-value=1.4e-09  Score=84.19  Aligned_cols=100  Identities=20%  Similarity=0.175  Sum_probs=68.4

Q ss_pred             CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhhh---hhH
Q 040917          333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRHK---LQR  409 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~---~~~  409 (494)
                      ++.+++.++...|     +.+|.|+..+|..++....  .+.++++.+|..+|.|++|.|+.+||...+.....   ...
T Consensus         6 ~~~~~i~~~~~~~-----~~~~~i~f~eF~~~~~~~~--~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~~~   78 (109)
T d1rwya_           6 LSAEDIKKAIGAF-----TAADSFDHKKFFQMVGLKK--KSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLS   78 (109)
T ss_dssp             SCHHHHHHHHHTT-----CSTTCCCHHHHHHHHTGGG--SCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCC
T ss_pred             cCHHHHHHHHHhc-----ccCCCcCHHHHHHHHcccc--CCHHHHHHHhhcccCCCCCcCcHHHHHHHHHHhccccccCC
Confidence            3445554444433     3346788888877665433  24667778888888888888888888777765422   224


Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhh
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKD  439 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~  439 (494)
                      ..++..+|+.+|.|+||.|+.+||.+++..
T Consensus        79 ~~e~~~~~~~~D~d~dG~i~~~EF~~~m~~  108 (109)
T d1rwya_          79 AKETKTLMAAGDKDGDGKIGVEEFSTLVAE  108 (109)
T ss_dssp             HHHHHHHHHHHCTTCSSSEEHHHHHHHHHT
T ss_pred             HHHHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence            556778888888888888888888887753

>d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.93  E-value=6e-10  Score=91.10  Aligned_cols=103  Identities=22%  Similarity=0.318  Sum_probs=86.8

Q ss_pred             HHHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHH
Q 040917          375 FDVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEI  454 (494)
Q Consensus       375 ~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~  454 (494)
                      ++++++|..+|.|++|.|++.||...+...........+...+..+|.+++|.|+..|+..++... .......+++..+
T Consensus         6 ~elk~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~-~~~~~~~~~l~~~   84 (141)
T d2obha1           6 QEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFGDFLTVMTQK-MSEKDTKEEILKA   84 (141)
T ss_dssp             HHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTTTCCSEEEHHHHHHHHHHH-HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCeEeHHHHHHHHHhcCCchhHHHHHHHHHhhccCCCCeechHHHHHHHHHH-HhhhccHHHHHHH
Confidence            468899999999999999999999887776555567788899999999999999999999998752 1112235568899


Q ss_pred             HHHhCCCCCCceeHHHHHHHHhcc
Q 040917          455 MSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       455 ~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      +..+|.+++|.|+.++|..++...
T Consensus        85 f~~~d~~~~G~i~~~el~~~l~~~  108 (141)
T d2obha1          85 FKLFDDDETGKISFKNLKRVAKEL  108 (141)
T ss_dssp             HHHHCTTCSSSBCHHHHHHHHHHT
T ss_pred             HHHhcccCCCCccHHHHHHHHHHh
Confidence            999999999999999999988864

>d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Kchip1, Kv4 potassium channel-interacting protein
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.93  E-value=7.9e-10  Score=94.31  Aligned_cols=105  Identities=15%  Similarity=0.179  Sum_probs=86.5

Q ss_pred             CCCHHHHHHHHHHh-cCCCCCcccchHHHHHHHHhhhh-hHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcH
Q 040917          371 MLTEFDVKQYMQAA-DIDGNGTIDYIEFITATMQRHKL-QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATI  448 (494)
Q Consensus       371 ~~~~~~~~~~~~~~-D~~~~g~i~~~ef~~~~~~~~~~-~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~  448 (494)
                      .++..++..+++.+ +.+++|.|+.+||...+...... .....+..+|..+|.|++|.|+.+||..++..  +.....+
T Consensus         9 ~ft~~ei~~l~~~F~~~~~~G~is~~ef~~~l~~~~~~~~~~~~~~~lf~~~D~~~~g~I~~~EFl~~~~~--~~~~~~~   86 (178)
T d1s6ca_           9 NFTKRELQVLYRGFKNECPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSI--LLRGTVH   86 (178)
T ss_dssp             SCCHHHHHHHHHHHHHHCTTSEECHHHHHHHHHHHSTTSCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHH--HHHCCHH
T ss_pred             CCCHHHHHHHHHHHHHHCcCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHHCCCCCCcccHHHHHHHHHH--HhccchH
Confidence            46888999988887 67789999999999888765432 23445688999999999999999999999876  3334567


Q ss_pred             HHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          449 ATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       449 ~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +.+..++..+|.|++|.|+++|+..++..
T Consensus        87 ~~~~~~f~~~D~~~~g~i~~~e~~~~~~~  115 (178)
T d1s6ca_          87 EKLRWTFNLYDINKDGYINKEEMMDIVKA  115 (178)
T ss_dssp             HHHHHHHHHHCTTCSSCEEHHHHHHHHHH
T ss_pred             HHHHHHHHhhccCCCCeecHHHHHHHHHH
Confidence            78899999999999999999999887654

>d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Nucleobindin 1 (CALNUC)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.93  E-value=3.6e-10  Score=86.02  Aligned_cols=66  Identities=18%  Similarity=0.294  Sum_probs=51.0

Q ss_pred             HHHhccccccCCCCceeHHHHHHHHhhcC--C------------CCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          413 LYKAFQYFDKDNNGYITVDELGKAFKDYG--M------------GDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       413 ~~~~F~~~D~d~~G~I~~~el~~~l~~~~--~------------~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ++.+|+.+|.|++|+|+.+||..++...+  +            .....+..++.+|..+|.|+||.||++||+..+++.
T Consensus        18 ~r~~F~~~D~DgdG~i~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~DG~Is~~EF~~~~~~~   97 (99)
T d1snla_          18 PKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTNQDRLVTLEEFLASTQRK   97 (99)
T ss_dssp             HHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSSCSSEEEHHHHHHHHHCC
T ss_pred             HHHHHHHHCCCCCCcCCHHHHHHHHHHHHHhcchhhhhhhhhhhhHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHhcC
Confidence            57788888888889999988888886421  0            011123457889999999999999999999988753

>d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]

Probab=98.92  E-value=2.5e-10  Score=85.05  Aligned_cols=68  Identities=22%  Similarity=0.484  Sum_probs=57.3

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcC---CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYG---MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~---~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ..+.+..+|..||.| +|+|+.+||+++|....   ++...++..+++++..+|.|+||+|+|+||..+|.+
T Consensus         7 ~ie~l~~~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~   77 (92)
T d1a4pa_           7 AMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAG   77 (92)
T ss_dssp             HHHHHHHHHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhCCCCCCCcHHHHHHHHHH
Confidence            346789999999987 79999999999998632   123346678999999999999999999999998875

>d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium- and integrin-binding protein, CIB
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.92  E-value=1e-09  Score=93.61  Aligned_cols=99  Identities=12%  Similarity=0.179  Sum_probs=80.7

Q ss_pred             hhhhhhccCCC-CCCcccHHHHHHHHHhcC-CCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh---------hhhH
Q 040917          341 LKEKFTEMDTD-NSGTLTYDELKAGLAKLG-SMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH---------KLQR  409 (494)
Q Consensus       341 ~~~~F~~~D~~-~~g~i~~~el~~~l~~~~-~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~---------~~~~  409 (494)
                      ..++|+.+|.+ ++|.|+.+||..++..+. ....++.+..+|+.+|.|++|.|+.+|+...+....         ...-
T Consensus        59 ~~rif~~fd~~~~~g~I~f~EFv~~l~~~~~~~~~~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~  138 (180)
T d1xo5a_          59 KERICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEM  138 (180)
T ss_dssp             HHHHHHHHCCSTTCCEECHHHHHHHHHHHSTTSCHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTH
T ss_pred             HHHHHHhccCCCCCCcCcHHHHHHHHHHHhhcCCHHHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHH
Confidence            45788899987 699999999999998764 334466799999999999999999999988765431         1112


Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhh
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKD  439 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~  439 (494)
                      .+-+..+|+.+|.|+||.|+.+||.+++..
T Consensus       139 ~~~v~~~~~~~D~d~dG~Is~~EF~~~~~~  168 (180)
T d1xo5a_         139 KQLIDNILEESDIDRDGTINLSEFQHVISR  168 (180)
T ss_dssp             HHHHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHh
Confidence            334667999999999999999999999986

>d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a3 [TaxId: 9606]

Probab=98.91  E-value=1e-09  Score=81.52  Aligned_cols=71  Identities=15%  Similarity=0.242  Sum_probs=60.0

Q ss_pred             HHHHHHHhcccc-ccCCCC-ceeHHHHHHHHhhcC---CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          409 RFENLYKAFQYF-DKDNNG-YITVDELGKAFKDYG---MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       409 ~~~~~~~~F~~~-D~d~~G-~I~~~el~~~l~~~~---~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      ....+..+|..| |.+|+| +|+.+||+++|+...   ++....+.++++++..+|.|+||+|+|+||..+|.+-.
T Consensus         7 ~i~~i~~vF~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~~~l~   82 (93)
T d1ksoa_           7 AVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLACLC   82 (93)
T ss_dssp             HHHHHHHHHHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHTTTCEECHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHH
Confidence            345788899987 999999 599999999998632   34556788999999999999999999999999888633

>d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a13 [TaxId: 9606]

Probab=98.91  E-value=4.6e-10  Score=84.68  Aligned_cols=70  Identities=13%  Similarity=0.232  Sum_probs=59.1

Q ss_pred             hHHHhhhhhhhcc-CCCCC-CcccHHHHHHHHHhcCC--CCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh
Q 040917          336 EEIQKLKEKFTEM-DTDNS-GTLTYDELKAGLAKLGS--MLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH  405 (494)
Q Consensus       336 ~~~~~~~~~F~~~-D~~~~-g~i~~~el~~~l~~~~~--~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~  405 (494)
                      +.+..+.++|..| |.+++ |+|+..||+.+++..+.  ..+.+++..++..+|.|+||.|+|+||+..+....
T Consensus        11 ~~i~~l~~vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~d~DG~IdF~EF~~l~~~l~   84 (98)
T d1yuta1          11 ESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGELA   84 (98)
T ss_dssp             HHHHHHHHHHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCTTCCSCBCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHH
Confidence            4467889999887 77875 99999999999998643  34556799999999999999999999999887654

>d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.90  E-value=8.7e-10  Score=82.93  Aligned_cols=63  Identities=24%  Similarity=0.324  Sum_probs=56.2

Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      ....+++|+.+|+|++|+|+.+|++.++...+    ++++++.+++..+|.|+||.|+++||..+|.
T Consensus         9 ~~~~~~~F~~~D~d~~G~is~~e~~~~l~~~~----l~~~~l~~i~~~~D~d~dG~l~~~EF~~am~   71 (95)
T d1c07a_           9 KAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG----LPSTLLAHIWSLCDTKDCGKLSKDQFALAFH   71 (95)
T ss_dssp             HHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT----CCHHHHHHHHHHHCTTCSSSEETTTHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCCcHHHHHHHHHhcC----CCHHHHHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence            35678899999999999999999999998843    5788999999999999999999999986653

>d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=98.89  E-value=5.1e-09  Score=85.94  Aligned_cols=106  Identities=22%  Similarity=0.208  Sum_probs=88.0

Q ss_pred             CCCHHH---HHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCc
Q 040917          371 MLTEFD---VKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDAT  447 (494)
Q Consensus       371 ~~~~~~---~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~  447 (494)
                      ++++++   +.++|+.+|.|++|.|+++||..++.......+...+...+..++.++.+.++..++..++..... ...+
T Consensus         3 ~ls~~~i~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~   81 (146)
T d1lkja_           3 NLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLK-SNDS   81 (146)
T ss_dssp             CCCHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCSSSCCEEEHHHHHHHHHHHTC-CCCH
T ss_pred             CCCHHHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhcCCCCCHHHHHHHHHHhccCCcccccHHHHHHHHHHhhc-cccH
Confidence            345555   456799999999999999999988877655556677888999999999999999999999887422 2335


Q ss_pred             HHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          448 IATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       448 ~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .+.+..+|+.+|.+++|.|+.+||..++..
T Consensus        82 ~~~~~~aF~~~D~d~~G~I~~~el~~~l~~  111 (146)
T d1lkja_          82 EQELLEAFKVFDKNGDGLISAAELKHVLTS  111 (146)
T ss_dssp             HHHHHHHHHHHCSSSSCEEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence            667899999999999999999999998864

>d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]

Probab=98.89  E-value=1.5e-09  Score=81.16  Aligned_cols=70  Identities=21%  Similarity=0.274  Sum_probs=59.7

Q ss_pred             hHHHhhhhhhhcc-CCCCC-CcccHHHHHHHHHhcC-----CCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh
Q 040917          336 EEIQKLKEKFTEM-DTDNS-GTLTYDELKAGLAKLG-----SMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH  405 (494)
Q Consensus       336 ~~~~~~~~~F~~~-D~~~~-g~i~~~el~~~l~~~~-----~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~  405 (494)
                      +.+..+.++|..+ |.|++ |+|+.+||+.+|...+     ...+.+++.++|+.+|.|+||.|+|+||+..+....
T Consensus         6 ~~i~~l~~~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~Idf~EF~~lm~~l~   82 (93)
T d1zfsa1           6 TAMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFVVLVAALT   82 (93)
T ss_dssp             HHHHHHHHHHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHTTTCCSEECSHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHH
Confidence            3457788999887 88875 9999999999998864     455788899999999999999999999999887544

>d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Reps1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.89  E-value=2.5e-09  Score=79.89  Aligned_cols=63  Identities=25%  Similarity=0.364  Sum_probs=56.1

Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      ....+.+|+.+|.|++|+|+.+|++.++...+    ++.+++..++..+|.|+||.|+++||..+|.
T Consensus         8 ~~~y~~~F~~~D~d~~G~i~~~e~~~~l~~~~----l~~~~l~~i~~~~D~d~dG~l~~~EF~~a~~   70 (92)
T d1fi6a_           8 RQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK----LPILELSHIWELSDFDKDGALTLDEFCAAFH   70 (92)
T ss_dssp             HHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS----SCHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCcccchhHHHHHHHHHHcc----CCHHHHHHHHHHhCCCCCCeecHHHHHHHHH
Confidence            34678999999999999999999999999843    5788999999999999999999999986443

>d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.88  E-value=1.6e-09  Score=81.32  Aligned_cols=67  Identities=25%  Similarity=0.302  Sum_probs=61.1

Q ss_pred             CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHH
Q 040917          333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATM  402 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~  402 (494)
                      +++++..++.++|..+| +++|+|+..|+..++...|  ++.+++..+|+..|.|++|.|+++||+.++.
T Consensus         4 ls~ee~~~y~~~F~~~D-~~~G~i~~~el~~~l~~~g--l~~~~L~~Iw~~~D~~~dG~l~~~EF~~a~~   70 (95)
T d2jxca1           4 VKPEDKAKYDAIFDSLS-PVNGFLSGDKVKPVLLNSK--LPVDILGRVWELSDIDHDGMLDRDEFAVAMF   70 (95)
T ss_dssp             SCHHHHHHHHHHHHHTC-CBTTEEEHHHHHHHHTTSS--CCHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHhC-CCCCceeHHHHHHHHHHcC--CCHHHHHHHHHHhcCCCCCeEcHHHHHHHHH
Confidence            57889999999999999 8999999999999999876  5778899999999999999999999987654

>d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]

Probab=98.86  E-value=1e-09  Score=81.61  Aligned_cols=69  Identities=17%  Similarity=0.292  Sum_probs=58.9

Q ss_pred             hHHHhhhhhhhccCCCCCCcccHHHHHHHHHhc-----CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh
Q 040917          336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL-----GSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH  405 (494)
Q Consensus       336 ~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~-----~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~  405 (494)
                      +.++.+..+|..+|.| +|+|+.+||..++...     +...+...+.++++.+|.|+||.|+|+||+..+....
T Consensus         6 ~~ie~l~~~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l~   79 (92)
T d1a4pa_           6 HAMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIAGLT   79 (92)
T ss_dssp             HHHHHHHHHHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHH
Confidence            4567899999999987 8999999999999874     3344667799999999999999999999998877543

>d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a4 [TaxId: 9606]

Probab=98.84  E-value=3.5e-09  Score=78.82  Aligned_cols=69  Identities=19%  Similarity=0.291  Sum_probs=59.0

Q ss_pred             HHHhhhhhhhcc-CCCCCC-cccHHHHHHHHHh-----cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh
Q 040917          337 EIQKLKEKFTEM-DTDNSG-TLTYDELKAGLAK-----LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH  405 (494)
Q Consensus       337 ~~~~~~~~F~~~-D~~~~g-~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~  405 (494)
                      .+..+.++|..+ |.|++| +|+.+||+.++..     ++...+.+++.++|..+|.|+||.|+|+||+..+....
T Consensus         7 ~i~~l~~~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D~n~DG~I~F~EF~~lm~~l~   82 (93)
T d3c1va1           7 ALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIA   82 (93)
T ss_dssp             HHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHHH
Confidence            467788999987 677655 7999999999987     35677889999999999999999999999999887643

>d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a3 [TaxId: 9606]

Probab=98.84  E-value=2.7e-09  Score=79.17  Aligned_cols=69  Identities=20%  Similarity=0.319  Sum_probs=59.8

Q ss_pred             hHHHhhhhhhhcc-CCCCCC-cccHHHHHHHHHhc-----CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          336 EEIQKLKEKFTEM-DTDNSG-TLTYDELKAGLAKL-----GSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       336 ~~~~~~~~~F~~~-D~~~~g-~i~~~el~~~l~~~-----~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      +.+..+..+|.++ |++|+| +|+.+||+.+++..     +...+..++.++++.+|.|+||.|+|+||+..+...
T Consensus         6 ~~i~~i~~vF~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~~~l   81 (93)
T d1ksoa_           6 QAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLACL   81 (93)
T ss_dssp             HHHHHHHHHHHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHTTTCEECHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHH
Confidence            4567888999887 999999 59999999999874     444568889999999999999999999999988754

>d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a6 [TaxId: 9606]

Probab=98.84  E-value=1.7e-09  Score=79.54  Aligned_cols=70  Identities=19%  Similarity=0.410  Sum_probs=59.5

Q ss_pred             HHHHHHHhcccc-ccCCCC-ceeHHHHHHHHhh-cCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          409 RFENLYKAFQYF-DKDNNG-YITVDELGKAFKD-YGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       409 ~~~~~~~~F~~~-D~d~~G-~I~~~el~~~l~~-~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ....+..+|..| |+|++| .|+..||+.++.. +..+...+++.+++++.++|.|+||+|+|+||..+|.+.
T Consensus         7 ai~~ii~vF~kya~~dg~~~~ls~~Elk~Ll~~e~~~~~~~~~~~~~~~~~~lD~d~Dg~IdF~EF~~l~~~l   79 (89)
T d1k8ua_           7 AIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVNFQEYVTFLGAL   79 (89)
T ss_dssp             HHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHTTTCEEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcccCCCCCeecHHHHHHHHHHHHHhhccCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHH
Confidence            345688899888 999998 6999999999986 234556678899999999999999999999999988753

>d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]

Probab=98.83  E-value=8e-10  Score=81.16  Aligned_cols=67  Identities=15%  Similarity=0.201  Sum_probs=57.2

Q ss_pred             HHHHHHhcccc-ccCCCCce-eHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          410 FENLYKAFQYF-DKDNNGYI-TVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       410 ~~~~~~~F~~~-D~d~~G~I-~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .+.+..+|..| |+||+|.+ +.+||+.+|... ++..+++.++++++.++|.|+||+|+|+||..+|.+
T Consensus         9 i~~ii~~F~kya~~dG~~~~l~~~Elk~ll~~e-~~~~~~~~~v~~i~~~~D~n~DG~IdF~EF~~l~~~   77 (87)
T d1xk4a1           9 LNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETE-SPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIK   77 (87)
T ss_dssp             HHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHH-SCHHHHTTCHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcccCCCCCccCHHHHHHHHHHh-cCCccchHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence            35688899888 88999865 899999999752 455667778999999999999999999999999885

>d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

Probab=98.82  E-value=9.5e-09  Score=84.90  Aligned_cols=102  Identities=20%  Similarity=0.208  Sum_probs=80.7

Q ss_pred             HHHHHHHHhc--CCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHH
Q 040917          376 DVKQYMQAAD--IDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKE  453 (494)
Q Consensus       376 ~~~~~~~~~D--~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~  453 (494)
                      +++++|..+|  .|++|.|+.+||..++.......+..++..+ ...|.+++|.|+.+||..++....-....+.+++.+
T Consensus         8 ~l~~~F~~fD~~~~~dG~I~~~el~~~l~~lG~~~t~~e~~~~-~~~~~~~~~~i~~~eFl~~~~~~~~~~~~~~~~l~~   86 (152)
T d1wdcc_           8 DLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAV-GGTHKMGEKSLPFEEFLPAYEGLMDCEQGTFADYME   86 (152)
T ss_dssp             HHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHT-TCCSSTTSCEECHHHHHHHHHHHTTSCCCCHHHHHH
T ss_pred             HHHHHHHHHCcCCCCCCeECHHHHHHHHHHhccCccHhhhhhh-hhhhccccccccccccccccccccccchhHHHhhhh
Confidence            3567899998  4889999999998888765433445556554 456788999999999999887642233456778999


Q ss_pred             HHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          454 IMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       454 ~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      +|+.+|.+++|.|+.+||..++...
T Consensus        87 aF~~~D~~~~G~I~~~el~~~l~~~  111 (152)
T d1wdcc_          87 AFKTFDREGQGFISGAELRHVLTAL  111 (152)
T ss_dssp             HHHTTCSSSSSEEEHHHHHHHHHHS
T ss_pred             hhhccccccCccchHHHHHHHHHHc
Confidence            9999999999999999999998753

>d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Pig (Sus scrofa) [TaxId: 9823]

Probab=98.81  E-value=6.3e-10  Score=80.18  Aligned_cols=69  Identities=19%  Similarity=0.291  Sum_probs=57.1

Q ss_pred             hHHHhhhhhhhccCC--CCCCcccHHHHHHHHHhc--CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          336 EEIQKLKEKFTEMDT--DNSGTLTYDELKAGLAKL--GSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       336 ~~~~~~~~~F~~~D~--~~~g~i~~~el~~~l~~~--~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      .....+..+|..||.  +++|+|+.+||+.+++..  +...+.+++..++..+|.|+||.|+|+||+..+...
T Consensus         4 ~~~~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~d~dG~Idf~EF~~l~~~l   76 (78)
T d1cb1a_           4 KSPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQVLVKKI   76 (78)
T ss_dssp             CCHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHH
Confidence            345678889998865  356899999999999997  444556678999999999999999999999887753

>d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Light Chain Mlc1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=98.79  E-value=2.8e-09  Score=87.60  Aligned_cols=65  Identities=28%  Similarity=0.591  Sum_probs=61.1

Q ss_pred             HHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHH
Q 040917          338 IQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATM  402 (494)
Q Consensus       338 ~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~  402 (494)
                      .+.+.++|+.+|.+++|+|+.+||..++..+|..++.+++..++..+|.|++|.|+|+||+..+.
T Consensus        80 ~~~l~~~F~~~D~~~~G~I~~~el~~~l~~~g~~l~~~ei~~l~~~~D~d~dG~I~y~eF~~~i~  144 (146)
T d1m45a_          80 TEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIEDVL  144 (146)
T ss_dssp             THHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHH
T ss_pred             HHHHHHHHHhhccccccccchhhhhhhhcccCCcchHHHHHHHHHHhCCCCCCcEEHHHHHHHHH
Confidence            35688899999999999999999999999999999999999999999999999999999998765

>d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a6 [TaxId: 9606]

Probab=98.78  E-value=2.9e-09  Score=78.33  Aligned_cols=69  Identities=23%  Similarity=0.365  Sum_probs=60.1

Q ss_pred             hHHHhhhhhhhcc-CCCCCC-cccHHHHHHHHHh---cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          336 EEIQKLKEKFTEM-DTDNSG-TLTYDELKAGLAK---LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       336 ~~~~~~~~~F~~~-D~~~~g-~i~~~el~~~l~~---~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      ..+..+..+|..+ |++++| +|+..||+.+++.   .+...+.+++.++++.+|.|+||.|+|+||+..+...
T Consensus         6 ~ai~~ii~vF~kya~~dg~~~~ls~~Elk~Ll~~e~~~~~~~~~~~~~~~~~~lD~d~Dg~IdF~EF~~l~~~l   79 (89)
T d1k8ua_           6 QAIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVNFQEYVTFLGAL   79 (89)
T ss_dssp             HHHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHTTTCEEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcccCCCCCeecHHHHHHHHHHHHHhhccCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHH
Confidence            4467788899887 999999 6999999999998   4666677889999999999999999999999988754

>d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Cdc4p
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.77  E-value=4.7e-09  Score=85.44  Aligned_cols=65  Identities=20%  Similarity=0.496  Sum_probs=58.5

Q ss_pred             HHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHH
Q 040917          337 EIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATM  402 (494)
Q Consensus       337 ~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~  402 (494)
                      ..+.+.++|+.+|.+++|+|+.+||..+|..+|.+++.+++..+++.+|.+ +|.|+|+||+..+.
T Consensus        74 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~~-dG~I~y~eF~~~m~  138 (140)
T d1ggwa_          74 DPEEFVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPVK-DGMVNYHDFVQMIL  138 (140)
T ss_dssp             CHHHHHHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTCS-SCCSTTTHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCcchHHHHHHHHHHcCCCCCHHHHHHHHHhhCCC-CCEEeHHHHHHHHh
Confidence            345678899999999999999999999999999999999999999999988 89999999998764

>d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.76  E-value=9.3e-09  Score=76.98  Aligned_cols=63  Identities=19%  Similarity=0.292  Sum_probs=54.9

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      ...+..++|..+| +++|+|+.+|++.+|...|    ++++++..++..+|.|+||.|+++||..+|.
T Consensus         8 e~~~y~~~F~~~D-~~~G~i~~~el~~~l~~~g----l~~~~L~~Iw~~~D~~~dG~l~~~EF~~a~~   70 (95)
T d2jxca1           8 DKAKYDAIFDSLS-PVNGFLSGDKVKPVLLNSK----LPVDILGRVWELSDIDHDGMLDRDEFAVAMF   70 (95)
T ss_dssp             HHHHHHHHHHHTC-CBTTEEEHHHHHHHHTTSS----CCHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred             HHHHHHHHHHHhC-CCCCceeHHHHHHHHHHcC----CCHHHHHHHHHHhcCCCCCeEcHHHHHHHHH
Confidence            3456788999999 8999999999999998743    5788999999999999999999999965444

>d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=98.75  E-value=6.3e-09  Score=87.04  Aligned_cols=104  Identities=19%  Similarity=0.229  Sum_probs=83.8

Q ss_pred             HHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcC--CCCCCcHHHHHH
Q 040917          376 DVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYG--MGDDATIATIKE  453 (494)
Q Consensus       376 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~--~~~~~~~~~~~~  453 (494)
                      ++.++|..+|.|++|.|+++||...+...........+..+|..+|.+++|.++..|+...+....  .......+++..
T Consensus        21 el~~~F~~~D~d~~G~Is~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~  100 (162)
T d1topa_          21 EFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDAKGKSEEELAN  100 (162)
T ss_dssp             HHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTSCCEEEHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCeEcHHHHHHHHhccCCchhHHHHHhhhheeccCCCCCeeeehhhhhhhhhhhhhcccCcHHHHHH
Confidence            467889999999999999999988777666556677889999999999999999999877664310  001124456778


Q ss_pred             HHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          454 IMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       454 ~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      +|..+|.|++|.|+.+||..++....
T Consensus       101 aF~~~D~d~~G~Is~~e~~~~l~~~~  126 (162)
T d1topa_         101 CFRIFDKNADGFIDIEELGEILRATG  126 (162)
T ss_dssp             HHHHHCTTCSSCBCHHHHHHHHHTTT
T ss_pred             HHHHHCCCCCCCCcHHHHHHHHHhhC
Confidence            89999999999999999999888643

>d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=98.75  E-value=4e-09  Score=87.70  Aligned_cols=65  Identities=31%  Similarity=0.514  Sum_probs=51.8

Q ss_pred             HHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHH
Q 040917          338 IQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATM  402 (494)
Q Consensus       338 ~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~  402 (494)
                      ..++..+|+.+|.+++|+|+.+||..++..+|..++++++..+|+.+|.|+||.|+|+||+..+.
T Consensus        90 ~~~l~~~F~~~D~d~~G~I~~~e~~~~~~~~~~~ls~~e~~~i~~~~D~d~dG~I~~~eF~~~l~  154 (156)
T d1dtla_          90 EEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMK  154 (156)
T ss_dssp             HHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHH
T ss_pred             HHHHHHHHHHhCcCCCCcCcHHHHHHHHhhcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHc
Confidence            35567788888888888888888888888888888888888888888888888888888887653

>d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]

Probab=98.75  E-value=1.3e-08  Score=87.34  Aligned_cols=69  Identities=28%  Similarity=0.263  Sum_probs=58.4

Q ss_pred             hhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHH
Q 040917          335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQ  403 (494)
Q Consensus       335 ~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~  403 (494)
                      ......+..+|..+|.|++|+|+.+||..++..+|..++.+++..+|..+|.|+||.|+|+||+..+..
T Consensus       103 ~~~~~~~~~~F~~~D~d~~G~is~~E~~~~l~~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~~~~  171 (189)
T d1qv0a_         103 TLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDLDVDEMTRQHLG  171 (189)
T ss_dssp             CHHHHHHHHHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCCTTSCEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHccCCCCcccchhhHHHHHhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHH
Confidence            334456777899999999999999999999999999999999999999999999999999999987654

>d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Pob1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.74  E-value=1.5e-09  Score=83.82  Aligned_cols=68  Identities=19%  Similarity=0.227  Sum_probs=61.1

Q ss_pred             CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHH
Q 040917          333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATM  402 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~  402 (494)
                      ++.++.+.+.++|+.+|+|++|+|+.+|+..++...|  ++.+++..+|+..|.|++|.|+++||+.++.
T Consensus        16 lt~ee~~~y~~lF~~~D~d~~G~Is~~e~~~~l~~s~--L~~~~L~~Iw~l~D~d~dG~l~~~EF~~am~   83 (110)
T d1iq3a_          16 ITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK--LSIPELSYIWELSDADCDGALTLPEFCAAFH   83 (110)
T ss_dssp             CSSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS--CSSCCHHHHHHHHCSSSCSEEEHHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHhhc--cchHHHHHHHHHhccCCCCeECHHHHHHHHH
Confidence            5678899999999999999999999999999998776  4556799999999999999999999987664

>d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]

Probab=98.74  E-value=1.6e-08  Score=86.71  Aligned_cols=71  Identities=27%  Similarity=0.305  Sum_probs=64.0

Q ss_pred             CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHH
Q 040917          333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQ  403 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~  403 (494)
                      ........+..+|..+|+|++|+|+.+||..++..+|..++.+++..+|..+|.|+||.|+|+||+..+..
T Consensus        99 ~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~~~~  169 (187)
T d1uhka1          99 EPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMTRQHLG  169 (187)
T ss_dssp             CCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCCTTSCEEHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHccCCCcccchHHHHHHHHHhCCCccHHHHHHHHHHhCCCCCCCEeHHHHHHHHHH
Confidence            34455566888999999999999999999999999999999999999999999999999999999876654

>d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

Probab=98.73  E-value=4.8e-09  Score=89.59  Aligned_cols=100  Identities=21%  Similarity=0.219  Sum_probs=84.9

Q ss_pred             HHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHH
Q 040917          376 DVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIM  455 (494)
Q Consensus       376 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~  455 (494)
                      +++++|..+|.|++|.|+++||...+.......+...+..+|..+|.+++|.|+..++..+....  ......+.+..+|
T Consensus        11 ~l~~~F~~~D~d~dG~Is~~e~~~~l~~l~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~--~~~~~~e~l~~aF   88 (182)
T d1s6ia_          11 GLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAATVHL--NKLEREENLVSAF   88 (182)
T ss_dssp             SHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTCTTCSSEECHHHHHHHHTTS--SSSCCCCSTHHHH
T ss_pred             HHHHHHHHHcCCCcCCCCHHHHHHHHHHcCCccccccchhhhhhhhccccccchHHHHHHHHHhh--cccccHHHHHHHH
Confidence            47889999999999999999999888765555566789999999999999999999999887763  2233445688899


Q ss_pred             HHhCCCCCCceeHHHHHHHHhc
Q 040917          456 SEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       456 ~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ..+|.+++|.|+.++|.+++..
T Consensus        89 ~~~D~d~~G~i~~~el~~~l~~  110 (182)
T d1s6ia_          89 SYFDKDGSGYITLDEIQQACKD  110 (182)
T ss_dssp             HHTTTTCSSEEEHHHHHHTTTT
T ss_pred             HHHhhcCCCccchhhhhhhhhh
Confidence            9999999999999999988774

>d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]

Probab=98.70  E-value=4.6e-09  Score=77.01  Aligned_cols=70  Identities=13%  Similarity=0.279  Sum_probs=59.3

Q ss_pred             hHHHhhhhhhhcc-CCCCCCc-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh
Q 040917          336 EEIQKLKEKFTEM-DTDNSGT-LTYDELKAGLAK-LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH  405 (494)
Q Consensus       336 ~~~~~~~~~F~~~-D~~~~g~-i~~~el~~~l~~-~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~  405 (494)
                      ..+..+..+|+.+ |++++|. ++.+||+.++.. ++...++.++..+++.+|.|+||.|+|+||+..+....
T Consensus         7 ~ai~~ii~~F~kya~~dG~~~~l~~~Elk~ll~~e~~~~~~~~~v~~i~~~~D~n~DG~IdF~EF~~l~~~la   79 (87)
T d1xk4a1           7 KALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIKMG   79 (87)
T ss_dssp             HHHHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTTCSSSBCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcccCCCCCccCHHHHHHHHHHhcCCccchHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHH
Confidence            4556788889887 9999996 599999999986 57666667799999999999999999999999887644

>d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]

Probab=98.70  E-value=2.2e-08  Score=72.93  Aligned_cols=69  Identities=22%  Similarity=0.285  Sum_probs=57.3

Q ss_pred             hHHHhhhhhhhcc-CCCCCC-cccHHHHHHHHHhc-----CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          336 EEIQKLKEKFTEM-DTDNSG-TLTYDELKAGLAKL-----GSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       336 ~~~~~~~~~F~~~-D~~~~g-~i~~~el~~~l~~~-----~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      ..+..+..+|.++ +.++++ +|+..||+.+++..     +...+.+.+.++++.+|.|+||.|+|+||+..+...
T Consensus         5 ~ai~~li~vF~kya~~~g~~~~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD~n~Dg~idF~EF~~li~~l   80 (87)
T d1e8aa_           5 EHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAIA   80 (87)
T ss_dssp             HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcccCCCCCeEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHH
Confidence            4567788999887 556554 79999999999883     445567889999999999999999999999888754

>d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]

Probab=98.66  E-value=3.5e-08  Score=71.85  Aligned_cols=68  Identities=19%  Similarity=0.344  Sum_probs=55.7

Q ss_pred             HHHHHHhcccc-ccCCCC-ceeHHHHHHHHhhcC---CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          410 FENLYKAFQYF-DKDNNG-YITVDELGKAFKDYG---MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       410 ~~~~~~~F~~~-D~d~~G-~I~~~el~~~l~~~~---~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...+..+|..| +.++++ +|+.+||+++|..-.   ++...+++.+++++..+|.|+||+|+|+||..++.+
T Consensus         7 i~~li~vF~kya~~~g~~~~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD~n~Dg~idF~EF~~li~~   79 (87)
T d1e8aa_           7 LEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAI   79 (87)
T ss_dssp             HHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHCTTCSSCEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcccCCCCCeEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHcCCCCCcCCHHHHHHHHHH
Confidence            45788899988 445554 699999999998621   334567889999999999999999999999998875

>d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]

Probab=98.66  E-value=3.5e-09  Score=80.20  Aligned_cols=67  Identities=16%  Similarity=0.306  Sum_probs=53.4

Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhhcCCC-----CCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMG-----DDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~-----~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...+..+|..|| +++|.|+..||+.+|+.....     ...++..+++++..+|.|+||+|+|+||+.+|.+
T Consensus         9 i~~l~~~F~~y~-~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~   80 (100)
T d1psra_           9 IIGMIDMFHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLGD   80 (100)
T ss_dssp             HHHHHHHHHHTC-CTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHc-CCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHH
Confidence            345677777776 789999999999999873211     1224456899999999999999999999998875

>d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.65  E-value=1.7e-08  Score=76.15  Aligned_cols=61  Identities=25%  Similarity=0.365  Sum_probs=55.8

Q ss_pred             hhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHH
Q 040917          340 KLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATM  402 (494)
Q Consensus       340 ~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~  402 (494)
                      .+.+.|+.+|.+++|+|+.+|+..++...|  ++..++..+|...|.|++|.|+++||+.++.
T Consensus        12 ~y~~~F~~~D~d~~G~i~~~e~~~~l~~s~--L~~~~L~~i~~~~D~d~dG~L~~~EF~~am~   72 (99)
T d1qjta_          12 VYEKYYRQVEAGNTGRVLALDAAAFLKKSG--LPDLILGKIWDLADTDGKGVLSKQEFFVALR   72 (99)
T ss_dssp             HHHHHHHHHCCTTSSCCCSHHHHHHHHTSS--SCHHHHHHHHHHHCCSSSSSCCSHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCcccHHHHHHHHHHcC--CcHHHHHHHHHHHcCCCCCccCHHHHHHHHH
Confidence            566889999999999999999999999876  5788999999999999999999999987765

>d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=98.65  E-value=1.8e-08  Score=82.38  Aligned_cols=65  Identities=22%  Similarity=0.265  Sum_probs=57.4

Q ss_pred             HHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHH
Q 040917          338 IQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATM  402 (494)
Q Consensus       338 ~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~  402 (494)
                      .+.+...|+.+|.+++|+|+.+||..++..+|..++++++..+++.+|.|++|.|+|.+|+..+.
T Consensus        76 ~~~l~~aF~~fD~~~~g~I~~~el~~~l~~~g~~ls~~e~~~~~~~~d~d~dg~I~y~eF~~~l~  140 (145)
T d2mysb_          76 EDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYVIT  140 (145)
T ss_pred             HHHHHHHHHhhhhcccchhhHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHhc
Confidence            34577789999999999999999999999999999999999999999999999999999988775

>d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.64  E-value=1.9e-08  Score=81.63  Aligned_cols=104  Identities=13%  Similarity=0.125  Sum_probs=81.6

Q ss_pred             HHHHHHHHhcCCCCCcccchHHHHHHHHhhhhhHHHHHHHhcccccc--CCCCceeHHHHHHHHhhcCCC-CCCcHHHHH
Q 040917          376 DVKQYMQAADIDGNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDK--DNNGYITVDELGKAFKDYGMG-DDATIATIK  452 (494)
Q Consensus       376 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~--d~~G~I~~~el~~~l~~~~~~-~~~~~~~~~  452 (494)
                      |+++.|..+|.+++|.|+.+|+..++.......+..++..++..++.  +++|.|+..++..++...... .....+++.
T Consensus         1 e~ke~F~~~D~d~~G~I~~~el~~~l~~lg~~~t~~e~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~l~   80 (139)
T d1w7jb1           1 EFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNRGQGTYEDYL   80 (139)
T ss_dssp             CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC--------CCH
T ss_pred             CHHHHHHHHhCCCCCeECHHHHHHHHHHhccCCCHHHHHHHHHHHhcccccCCceeeeccchhhHhhhhhccccHHHHHH
Confidence            36789999999999999999998888766555566788888888764  679999999999988753211 122334577


Q ss_pred             HHHHHhCCCCCCceeHHHHHHHHhccc
Q 040917          453 EIMSEVDRDKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       453 ~~~~~~d~~~dg~i~~~ef~~~~~~~~  479 (494)
                      ++|..+|.+++|.|+.+||..+++...
T Consensus        81 ~aF~~~D~d~~G~I~~~el~~~l~~~g  107 (139)
T d1w7jb1          81 EGFRVFDKEGNGKVMGAELRHVLTTLG  107 (139)
T ss_dssp             HHHHTTCTTSSSEEEHHHHHHHHHHSS
T ss_pred             HhhhhccCCCCCeEeHHHHHHHHHHhC
Confidence            889999999999999999999998643

>d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Nucleobindin 1 (CALNUC)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.64  E-value=1.1e-08  Score=77.54  Aligned_cols=28  Identities=32%  Similarity=0.312  Sum_probs=24.9

Q ss_pred             hhhhhhccCCCCCCcccHHHHHHHHHhc
Q 040917          341 LKEKFTEMDTDNSGTLTYDELKAGLAKL  368 (494)
Q Consensus       341 ~~~~F~~~D~~~~g~i~~~el~~~l~~~  368 (494)
                      ++.+|..+|.|++|+|+.+||..+++..
T Consensus        18 ~r~~F~~~D~DgdG~i~~~El~~~l~~~   45 (99)
T d1snla_          18 PKTFFILHDINSDGVLDEQELEALFTKE   45 (99)
T ss_dssp             HHHHHHHHCSSCCSEEEHHHHHHHHHHH
T ss_pred             HHHHHHHHCCCCCCcCCHHHHHHHHHHH
Confidence            5778999999999999999999998764

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.62  E-value=1.4e-07  Score=85.32  Aligned_cols=141  Identities=18%  Similarity=0.182  Sum_probs=97.0

Q ss_pred             cceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEEEE
Q 040917           33 LHYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVHIV  112 (494)
Q Consensus        33 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~iv  112 (494)
                      +.|+..+..+.++.+.||++.  ..++.+++|........   ....+.+|...+..|.++-.+.+++.+...++..++|
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv   88 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence            567777776666678999986  45677889987643322   2335778999999886555577888888888899999


Q ss_pred             EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 040917          113 MELCAGGELFDRIVARGHYSERAAASVFRVIMNVVNVCHS----------------------------------------  152 (494)
Q Consensus       113 ~e~~~g~sL~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~----------------------------------------  152 (494)
                      |++++|.++.+.....  ..   ...++.++...+..||+                                        
T Consensus        89 ~~~l~G~~~~~~~~~~--~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T d1j7la_          89 MSEADGVLCSEEYEDE--QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHTTTC--SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred             EEeccccccccccccc--cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence            9999998875543211  11   12233344444444442                                        


Q ss_pred             -------------C------CceeccCCCCceEEeeCCCCCeEEEeecCCccc
Q 040917          153 -------------K------GVMHRDLKPENFLFTTGDENAVVKATDFGLSAF  186 (494)
Q Consensus       153 -------------~------~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~~  186 (494)
                                   .      .++|+|+.|.||++   ++++.+-|+||+.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV---KDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEE---ETTEEEEECCCTTCEE
T ss_pred             chHHHHHHHHHHhcCCcCCcEEEEeeccCcceee---cCCceEEEeechhccc
Confidence                         1      27899999999999   4455556999998753

>d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]

Probab=98.62  E-value=8.5e-09  Score=78.02  Aligned_cols=70  Identities=11%  Similarity=0.112  Sum_probs=58.2

Q ss_pred             hhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCC-------CCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh
Q 040917          335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSM-------LTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH  405 (494)
Q Consensus       335 ~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~-------~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~  405 (494)
                      .+.+..+..+|..+| +++|.|+..||+.+++..+..       .+...+..+|+.+|.|+||.|+|+||+..+....
T Consensus         6 E~~i~~l~~~F~~y~-~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l~   82 (100)
T d1psra_           6 ERSIIGMIDMFHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLGDIA   82 (100)
T ss_dssp             HHHHHHHHHHHHHTC-CTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHc-CCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHH
Confidence            456778889999997 788999999999999986422       2334588999999999999999999999887644

>d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Pob1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.62  E-value=1.1e-08  Score=78.64  Aligned_cols=63  Identities=21%  Similarity=0.290  Sum_probs=55.3

Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      .+....+|+.+|+|++|+|+.+|++.+|...+    ++++++.+++..+|.|+||.|+++||..+|.
T Consensus        21 ~~~y~~lF~~~D~d~~G~Is~~e~~~~l~~s~----L~~~~L~~Iw~l~D~d~dG~l~~~EF~~am~   83 (110)
T d1iq3a_          21 REYYVNQFRSLQPDPSSFISGSVAKNFFTKSK----LSIPELSYIWELSDADCDGALTLPEFCAAFH   83 (110)
T ss_dssp             HHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS----CSSCCHHHHHHHHCSSSCSEEEHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCcccchhHHHHHHHHHhhc----cchHHHHHHHHHhccCCCCeECHHHHHHHHH
Confidence            45678999999999999999999999998743    4566799999999999999999999986554

>d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.62  E-value=1.6e-08  Score=76.35  Aligned_cols=61  Identities=20%  Similarity=0.250  Sum_probs=55.0

Q ss_pred             HHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          412 NLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       412 ~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      ....+|+.+|.|++|+|+.+|++.++...|    ++++++.+++..+|.|+||.|+++||..+|.
T Consensus        12 ~y~~~F~~~D~d~~G~i~~~e~~~~l~~s~----L~~~~L~~i~~~~D~d~dG~L~~~EF~~am~   72 (99)
T d1qjta_          12 VYEKYYRQVEAGNTGRVLALDAAAFLKKSG----LPDLILGKIWDLADTDGKGVLSKQEFFVALR   72 (99)
T ss_dssp             HHHHHHHHHCCTTSSCCCSHHHHHHHHTSS----SCHHHHHHHHHHHCCSSSSSCCSHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCcccHHHHHHHHHHcC----CcHHHHHHHHHHHcCCCCCccCHHHHHHHHH
Confidence            456789999999999999999999998733    6889999999999999999999999987775

>d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

Probab=98.61  E-value=6.4e-09  Score=59.51  Aligned_cols=31  Identities=42%  Similarity=0.724  Sum_probs=28.5

Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhhc
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKDY  440 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~  440 (494)
                      ++++++||+.||+|++|+|+..||+.+|..+
T Consensus         2 eeel~eAF~~FDkDg~G~Is~~EL~~vm~~l   32 (33)
T d2hf5a1           2 EEEIREAFRVFDKDGNGYISAAELRHVMTNL   32 (33)
T ss_dssp             HHHHHHHHHHHSSSCCSCBCHHHHHHHTTSC
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHc
Confidence            4689999999999999999999999999874

>d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Sandworm (Nereis diversicolor) [TaxId: 126592]

Probab=98.61  E-value=1.9e-07  Score=78.59  Aligned_cols=104  Identities=18%  Similarity=0.260  Sum_probs=74.6

Q ss_pred             HHHHHHHHHhcCCCCCcccchHHHHHHHHhhh-----hhH----HHHHHHhccc--cccCCCCceeHHHHHHHHhhcCCC
Q 040917          375 FDVKQYMQAADIDGNGTIDYIEFITATMQRHK-----LQR----FENLYKAFQY--FDKDNNGYITVDELGKAFKDYGMG  443 (494)
Q Consensus       375 ~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~-----~~~----~~~~~~~F~~--~D~d~~G~I~~~el~~~l~~~~~~  443 (494)
                      ++++.+|+.+|.|+||.|+++||...+.....     ...    .......+..  .|.+++|.|+.+|+...+......
T Consensus         6 ~~l~~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~~   85 (174)
T d2scpa_           6 QKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVAGGKGIDETTFINSMKEMVKN   85 (174)
T ss_dssp             HHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCCCTTHHHHHHHHHHHHHHHTGGGTTTTSCEEHHHHHHHHHHHTSC
T ss_pred             HHHHHHHHHHccCCCCcEeHHHHHHHHHHHhccccchhHHHHHhHHhhhhhccccccccCCCCcCcHHHHHHHHHhhhcc
Confidence            56889999999999999999999877654321     011    1112223332  367889999999999988764222


Q ss_pred             CCC---cHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          444 DDA---TIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       444 ~~~---~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ...   ....+..+|..+|.|+||.|+.+||..+++..
T Consensus        86 ~~~~~~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~  123 (174)
T d2scpa_          86 PEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGML  123 (174)
T ss_dssp             GGGTHHHHTHHHHHHHHHCTTCSSSEEHHHHHHHHHHT
T ss_pred             hhhHHHHHHHHHHHHHHHCCCccccCCHHHHHHHHHHH
Confidence            211   23346779999999999999999999988754

>d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=98.55  E-value=2.1e-07  Score=79.23  Aligned_cols=104  Identities=13%  Similarity=0.112  Sum_probs=77.3

Q ss_pred             HHHHHHHHH-hcCCCCCcccchHHHHHHHHhhhh-------h--------HHHHHHHhccccccCCCCceeHHHHHHHHh
Q 040917          375 FDVKQYMQA-ADIDGNGTIDYIEFITATMQRHKL-------Q--------RFENLYKAFQYFDKDNNGYITVDELGKAFK  438 (494)
Q Consensus       375 ~~~~~~~~~-~D~~~~g~i~~~ef~~~~~~~~~~-------~--------~~~~~~~~F~~~D~d~~G~I~~~el~~~l~  438 (494)
                      .++.++|.. +|.|+||.|+++||...+......       .        ........+...|.+++|.|+.+++..++.
T Consensus         8 ~~i~~~F~~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~i~~~~~~~~~~   87 (185)
T d2sasa_           8 QKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEEYLAMWE   87 (185)
T ss_dssp             HHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHH
T ss_pred             HHHHHHHHHhhcCCCCCcCCHHHHHHHHHHhccccCCCcccHHHHHHHHHHHHHHHHHHHHhCcCCCCcEeeeHhhHHHH
Confidence            458899997 499999999999998776543110       0        112234467788999999999999998886


Q ss_pred             hcC-------CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhcc
Q 040917          439 DYG-------MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKCG  478 (494)
Q Consensus       439 ~~~-------~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~  478 (494)
                      ...       .........+..+|..+|.|++|.|+.+||..++...
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~  134 (185)
T d2sasa_          88 KTIATCKSVADLPAWCQNRIPFLFKGMDVSGDGIVDLEEFQNYCKNF  134 (185)
T ss_dssp             HHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSSSCCCHHHHHHHTTSS
T ss_pred             HHhhhhhhhhhhhHHHHHHHHHHHHHHccCCCccCCHHHHHHHHHHc
Confidence            421       0112234457889999999999999999999988864

>d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calerythrin
species: Saccharopolyspora erythraea [TaxId: 1836]

Probab=98.52  E-value=6.6e-08  Score=81.59  Aligned_cols=65  Identities=25%  Similarity=0.358  Sum_probs=55.8

Q ss_pred             HHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHH
Q 040917          337 EIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQ  403 (494)
Q Consensus       337 ~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~  403 (494)
                      ....+..+|..+|.|++|+|+.+||..++..++  ++.+++..+|..+|.|+||.|+++||+..+..
T Consensus       100 ~~~~~~~~F~~~D~d~dG~Is~~E~~~~~~~~~--~~~~~~~~~f~~~D~d~dG~i~~~Ef~~~~~~  164 (176)
T d1nyaa_         100 LGPVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAAEAFNQVDTNGNGELSLDELLTAVRD  164 (176)
T ss_dssp             HHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCTTCSSEEEHHHHHHHHSC
T ss_pred             HHHHHHHHHHHHccCCChhhhHHHHHHHHHhcC--CcHHHHHHHHHHHCCCCCCcEeHHHHHHHHHH
Confidence            345577889999999999999999999998876  47788999999999999999999999877653

>d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=98.36  E-value=1.4e-07  Score=51.13  Aligned_cols=31  Identities=42%  Similarity=0.810  Sum_probs=26.8

Q ss_pred             HHHHHHHhccccccCCCCceeHHHHHHHHhh
Q 040917          409 RFENLYKAFQYFDKDNNGYITVDELGKAFKD  439 (494)
Q Consensus       409 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~  439 (494)
                      +++++.++|+.||+|.||+|+.+||..+|.+
T Consensus         2 sEeELae~FRifDkNaDGyiD~eEl~~ilr~   32 (34)
T d1ctda_           2 SEEELANAFRIFDKNADGYIDIEELGEILRA   32 (34)
T ss_dssp             HHHHHHHHHHTTCCSSSSCBCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHccCCcccccHHHHHHHHHh
Confidence            4567888999999999999999999988875

>d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Cow (Bos taurus), s100b [TaxId: 9913]

Probab=98.34  E-value=8.3e-07  Score=64.56  Aligned_cols=70  Identities=23%  Similarity=0.350  Sum_probs=55.7

Q ss_pred             hHHHhhhhhhhccC-CCCC-CcccHHHHHHHHHh-----cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh
Q 040917          336 EEIQKLKEKFTEMD-TDNS-GTLTYDELKAGLAK-----LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH  405 (494)
Q Consensus       336 ~~~~~~~~~F~~~D-~~~~-g~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~  405 (494)
                      ..+..+..+|.++. .+++ ++|+..||+.++..     ++.......+.++++.+|.|+||.|+|+||+..+....
T Consensus         6 ~ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~~d~~m~~LD~n~Dg~vdF~EF~~li~~la   82 (90)
T d3cr5x1           6 KAVVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAMIT   82 (90)
T ss_dssp             HHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHH
Confidence            34567788888874 4554 57999999999988     34444567799999999999999999999998877543

>d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Cow (Bos taurus), s100b [TaxId: 9913]

Probab=98.30  E-value=1e-06  Score=64.06  Aligned_cols=68  Identities=16%  Similarity=0.395  Sum_probs=54.7

Q ss_pred             HHHHHHhcccc-ccCCC-CceeHHHHHHHHhh-cC--CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          410 FENLYKAFQYF-DKDNN-GYITVDELGKAFKD-YG--MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       410 ~~~~~~~F~~~-D~d~~-G~I~~~el~~~l~~-~~--~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...+..+|..| ..+|+ ++++..||+++|.. ++  ++....+..+++++..+|.|+||+|+|+||..++.+
T Consensus         8 i~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~~d~~m~~LD~n~Dg~vdF~EF~~li~~   80 (90)
T d3cr5x1           8 VVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFVAM   80 (90)
T ss_dssp             HHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHH
Confidence            35678899988 34554 57999999999985 11  344556778999999999999999999999998875

>d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Phospholipase C-beta-2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.30  E-value=8.8e-08  Score=80.34  Aligned_cols=89  Identities=10%  Similarity=0.056  Sum_probs=66.8

Q ss_pred             hcCCCCCcccchHHHHHHHHhhh--hhHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCC
Q 040917          384 ADIDGNGTIDYIEFITATMQRHK--LQRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRD  461 (494)
Q Consensus       384 ~D~~~~g~i~~~ef~~~~~~~~~--~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~  461 (494)
                      +|.|++|.|+.+|+...+.....  ......+...|...|.+++|.|+.+||..++..+.     .+.++..+|..+|.|
T Consensus        16 ~d~n~dG~Is~~el~k~l~~~~~~~~~~~~~~~~~~~~~D~~~~~~i~F~eF~~~~~~l~-----~r~ei~~~F~~~d~d   90 (170)
T d2zkmx1          16 MQLNSEGKIPVKNFFQMFPADRKRVEAALSACHLPKGKNDAINPEDFPEPVYKSFLMSLC-----PRPEIDEIFTSYHAK   90 (170)
T ss_dssp             HSCCTTSCEEHHHHHHHSCSCHHHHHHHHHHTTCCCCTTCEECGGGCCHHHHHHHHHHHS-----CCHHHHTTCC-----
T ss_pred             cccCCCCCCcHHHHHHHHHHhhhhHHHHHHHHhhhhccccccCCCccCHHHHHHHHhccC-----CHHHHHHHHHHHcCC
Confidence            79999999999999887753222  23445677789999999999999999999999842     346899999999999


Q ss_pred             CCCceeHHHHHHHHhc
Q 040917          462 KDGRISYDEFRSMMKC  477 (494)
Q Consensus       462 ~dg~i~~~ef~~~~~~  477 (494)
                      ++|.||.+||.+.+..
T Consensus        91 ~~~~it~~el~~fL~~  106 (170)
T d2zkmx1          91 AKPYMTKEHLTKFINQ  106 (170)
T ss_dssp             ---CCCHHHHHHHHHH
T ss_pred             CCCcccHHHHHHHHHH
Confidence            9999999999998863

>d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
species: Physarum polycephalum [TaxId: 5791]

Probab=98.28  E-value=4.1e-07  Score=84.67  Aligned_cols=104  Identities=19%  Similarity=0.280  Sum_probs=81.4

Q ss_pred             hHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHH-----------------------------HHHHHHHhcC
Q 040917          336 EEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFD-----------------------------VKQYMQAADI  386 (494)
Q Consensus       336 ~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~-----------------------------~~~~~~~~D~  386 (494)
                      .....+...|+.+|.+++|.++..++..++...+.......                             +..+|..+|.
T Consensus       185 ~~~~~~~~~F~~~d~d~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~F~~~D~  264 (321)
T d1ij5a_         185 NDLAALVADFRKIDTNSNGTLSRKEFREHFVRLGFDKKSVQDALFRYADEDESDDVGFSEYVHLGLCLLVLRILYAFADF  264 (321)
T ss_dssp             HHHHTSCCCHHHHCTTCCSEECHHHHHHHHHHTTCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHHHHHHHTCS
T ss_pred             hhhhhhhHHHHHHhhcccccchhHHHhhhhhcccccchHHHHHHHHhhhcccccccccccccchhhhhhHHHHHHHHHhc
Confidence            33455677888999999999999999998888765533211                             1235778899


Q ss_pred             CCCCcccchHHHHHHHHhhh-hhHHHHHHHhccccccCCCCceeHHHHHHHHhh
Q 040917          387 DGNGTIDYIEFITATMQRHK-LQRFENLYKAFQYFDKDNNGYITVDELGKAFKD  439 (494)
Q Consensus       387 ~~~g~i~~~ef~~~~~~~~~-~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~  439 (494)
                      |++|.|+..||..++..... ..+...+..+|+.+|.|+||+|+.+||..+|..
T Consensus       265 d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~ml~  318 (321)
T d1ij5a_         265 DKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFVMLVLL  318 (321)
T ss_dssp             SSCSSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHTTTTCSEECHHHHHHHHHH
T ss_pred             CCCCCCcHHHHHHHHHHcCCCcCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence            99999999999888776542 234567899999999999999999999999864

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.25  E-value=2.2e-06  Score=81.99  Aligned_cols=82  Identities=15%  Similarity=0.152  Sum_probs=51.3

Q ss_pred             eeeecccCCeEEEEEEECCCCcEEEEEEeccCC--CC--ChhhHHHHHHHHHHHHHccCC-C-CccEEeEEEEeCCeEEE
Q 040917           38 GREVGRGEFGITYLCTENSTGLEFACKSIPKRK--LV--KDVEKDDVRREIEIMRHLSGQ-P-NIVQFKAAYEDDQFVHI  111 (494)
Q Consensus        38 ~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~--~~--~~~~~~~~~~E~~~l~~l~~h-p-~i~~~~~~~~~~~~~~i  111 (494)
                      .+.||.|....||++.+..+++.+++|......  ..  -....+....|+..|+.+..+ | .+++++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            456899999999999988888999999754211  00  011234456788888877543 2 34455544  3445569


Q ss_pred             EEeccCCCch
Q 040917          112 VMELCAGGEL  121 (494)
Q Consensus       112 v~e~~~g~sL  121 (494)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987655

>d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]

Probab=98.16  E-value=1.3e-06  Score=64.12  Aligned_cols=69  Identities=17%  Similarity=0.232  Sum_probs=54.6

Q ss_pred             HHHhhhhhhhccC-CCCC-CcccHHHHHHHHHh-----cCCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh
Q 040917          337 EIQKLKEKFTEMD-TDNS-GTLTYDELKAGLAK-----LGSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH  405 (494)
Q Consensus       337 ~~~~~~~~F~~~D-~~~~-g~i~~~el~~~l~~-----~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~  405 (494)
                      .+..+-.+|..+. ++|+ ++|+..||+.++..     ++.......+.++++.+|.|+||.|+|+||+..+....
T Consensus         7 ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~im~~LD~n~Dg~vdF~EF~~li~~la   82 (95)
T d1qlsa_           7 CIESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFLNLIGGLA   82 (95)
T ss_dssp             HHHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCcCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHH
Confidence            3556778887764 4454 68999999999976     34444567799999999999999999999998877543

>d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

Probab=98.12  E-value=4.8e-07  Score=51.56  Aligned_cols=31  Identities=29%  Similarity=0.607  Sum_probs=28.1

Q ss_pred             HhhhhhhhccCCCCCCcccHHHHHHHHHhcC
Q 040917          339 QKLKEKFTEMDTDNSGTLTYDELKAGLAKLG  369 (494)
Q Consensus       339 ~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~  369 (494)
                      +++++.|+.||+|++|+|+.+||+.+++.+|
T Consensus         3 eel~eAF~~FDkDg~G~Is~~EL~~vm~~lG   33 (33)
T d2hf5a1           3 EEIREAFRVFDKDGNGYISAAELRHVMTNLG   33 (33)
T ss_dssp             HHHHHHHHHHSSSCCSCBCHHHHHHHTTSCC
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC
Confidence            4678899999999999999999999998765

>d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100p [TaxId: 9606]

Probab=98.08  E-value=2.9e-06  Score=62.14  Aligned_cols=69  Identities=26%  Similarity=0.367  Sum_probs=51.3

Q ss_pred             HHHhhhhhhhccC-CCCC-CcccHHHHHHHHHh-c----CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHhh
Q 040917          337 EIQKLKEKFTEMD-TDNS-GTLTYDELKAGLAK-L----GSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQRH  405 (494)
Q Consensus       337 ~~~~~~~~F~~~D-~~~~-g~i~~~el~~~l~~-~----~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~  405 (494)
                      .+..+-.+|.++. .+++ ++++..||+.++.. +    +.......+..+++.+|.|+||.|+|+||+..+....
T Consensus         7 ai~~ii~vFhkYa~~~g~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~la   82 (94)
T d1j55a_           7 AMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAAIT   82 (94)
T ss_dssp             HHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcccCCCcccCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHH
Confidence            4556778888864 3443 58999999999987 2    3333345699999999999999999999998877543

>d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]

Probab=98.02  E-value=2.6e-06  Score=62.48  Aligned_cols=68  Identities=22%  Similarity=0.394  Sum_probs=52.7

Q ss_pred             HHHHHHhccccc-cCCC-CceeHHHHHHHHhh-cC--CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          410 FENLYKAFQYFD-KDNN-GYITVDELGKAFKD-YG--MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       410 ~~~~~~~F~~~D-~d~~-G~I~~~el~~~l~~-~~--~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...+..+|..|. .+|+ +.++..||+.+|.. ++  ++....++.+++++..+|.|+||+|+|+||..++.+
T Consensus         8 i~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~im~~LD~n~Dg~vdF~EF~~li~~   80 (95)
T d1qlsa_           8 IESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFLNLIGG   80 (95)
T ss_dssp             HHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCcCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHHH
Confidence            356778888874 3554 67999999999974 10  122345667999999999999999999999998875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.00  E-value=2.3e-05  Score=69.79  Aligned_cols=76  Identities=8%  Similarity=0.033  Sum_probs=53.7

Q ss_pred             eecccC-CeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCC-CCccEEeEEEEeCCeEEEEEeccC
Q 040917           40 EVGRGE-FGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ-PNIVQFKAAYEDDQFVHIVMELCA  117 (494)
Q Consensus        40 ~lg~G~-~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-p~i~~~~~~~~~~~~~~iv~e~~~  117 (494)
                      .+..|. .+.||++.. ..+..+++|......      ...+..|...++.|..+ -.+.+++.+..+++..++||++++
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   89 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence            445555 468999875 457778999875433      22467788888877633 225677888888888999999999


Q ss_pred             CCchH
Q 040917          118 GGELF  122 (494)
Q Consensus       118 g~sL~  122 (494)
                      |.++.
T Consensus        90 G~~~~   94 (255)
T d1nd4a_          90 GQDLL   94 (255)
T ss_dssp             SEETT
T ss_pred             ccccc
Confidence            87763

>d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100p [TaxId: 9606]

Probab=97.99  E-value=6.2e-06  Score=60.28  Aligned_cols=68  Identities=12%  Similarity=0.341  Sum_probs=50.5

Q ss_pred             HHHHHHhccccc-cCCC-CceeHHHHHHHHhh-cC--CCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          410 FENLYKAFQYFD-KDNN-GYITVDELGKAFKD-YG--MGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       410 ~~~~~~~F~~~D-~d~~-G~I~~~el~~~l~~-~~--~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      ...+..+|..|. .+++ ++++.+||+.+|.. ++  ++....+..+++++..+|.|+||+|+|+||..++.+
T Consensus         8 i~~ii~vFhkYa~~~g~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~   80 (94)
T d1j55a_           8 MGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAA   80 (94)
T ss_dssp             HHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcccCCCcccCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHH
Confidence            456788898883 3333 58999999999975 21  233445667999999999999999999999998865

>d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]

Probab=97.86  E-value=2e-05  Score=55.96  Aligned_cols=67  Identities=18%  Similarity=0.395  Sum_probs=51.6

Q ss_pred             HHHHHHhcccccc-CC-CCceeHHHHHHHHhh-cC--CCC-CCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          410 FENLYKAFQYFDK-DN-NGYITVDELGKAFKD-YG--MGD-DATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       410 ~~~~~~~F~~~D~-d~-~G~I~~~el~~~l~~-~~--~~~-~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      ...+..+|..|.. +| .+.++..||+.+|.. ++  +.. ...+..+++++..+|.|+||+|+|+||..++-
T Consensus         9 i~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~   81 (83)
T d1xk4c1           9 IETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMA   81 (83)
T ss_dssp             HHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCcCCCcccCCHHHHHHHHHHHhHHHhcCCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHh
Confidence            3467888988843 33 368999999999985 21  211 23556789999999999999999999998775

>d1tuza_ a.39.1.7 (A:) Diacylglycerol kinase alpha, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Diacylglycerol kinase alpha, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.86  E-value=2.5e-06  Score=65.90  Aligned_cols=76  Identities=7%  Similarity=-0.004  Sum_probs=59.1

Q ss_pred             cCchhHHHhhhhhhhccC---CCCCCcccHHHHHHHHHhcCC-C-CCHHHHHHHHHHhcCCCC--------CcccchHHH
Q 040917          332 NLPTEEIQKLKEKFTEMD---TDNSGTLTYDELKAGLAKLGS-M-LTEFDVKQYMQAADIDGN--------GTIDYIEFI  398 (494)
Q Consensus       332 ~~~~~~~~~~~~~F~~~D---~~~~g~i~~~el~~~l~~~~~-~-~~~~~~~~~~~~~D~~~~--------g~i~~~ef~  398 (494)
                      .++..+++.|++.|+...   .+.+|.|+.++|+.++..+.. . .++.-+.++|..+|.+++        |.|+|+||+
T Consensus        21 ~fs~~ei~~l~~~Fk~~~~~~~~p~g~i~~~~F~~~~~~~f~~~~~~~~l~~rlF~~FD~~~d~~~~~~~~g~I~f~efv  100 (118)
T d1tuza_          21 EYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVS  100 (118)
T ss_dssp             HHCCCCHHHHHHHHHTSGGGGGEETTEECHHHHHHHHHHHTTCSSCCHHHHHHHHHHSCCCCCTTCCCCCSCCEEHHHHH
T ss_pred             CCCHHHHHHHHHHHhccccccCCcccccCHHHHHHHHHHhCCCCCchHHHHHHHHHHHccccccccccCCCceeeHHHHH
Confidence            478899999999997553   257899999999999987643 2 245667889999999876        789999998


Q ss_pred             HHHHHhhhh
Q 040917          399 TATMQRHKL  407 (494)
Q Consensus       399 ~~~~~~~~~  407 (494)
                      ..+.....+
T Consensus       101 ~~LS~l~~G  109 (118)
T d1tuza_         101 CYFSLLEGG  109 (118)
T ss_dssp             HHHHHHHSC
T ss_pred             HHHHHHcCC
Confidence            887765443

>d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]

Probab=97.83  E-value=2.2e-05  Score=55.77  Aligned_cols=67  Identities=22%  Similarity=0.357  Sum_probs=51.3

Q ss_pred             HHHhhhhhhhccCC-CC-CCcccHHHHHHHHHh-cCCCC-----CHHHHHHHHHHhcCCCCCcccchHHHHHHHH
Q 040917          337 EIQKLKEKFTEMDT-DN-SGTLTYDELKAGLAK-LGSML-----TEFDVKQYMQAADIDGNGTIDYIEFITATMQ  403 (494)
Q Consensus       337 ~~~~~~~~F~~~D~-~~-~g~i~~~el~~~l~~-~~~~~-----~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~  403 (494)
                      .+..+-.+|..+.. ++ .++++..||+.++.. ++.-+     ....+..+++.+|.|+||.|+|+||+..+..
T Consensus         8 ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~   82 (83)
T d1xk4c1           8 NIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMAR   82 (83)
T ss_dssp             HHHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCcCCCcccCCHHHHHHHHHHHhHHHhcCCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHhh
Confidence            34567778887754 33 468999999999987 33222     3345899999999999999999999987753

>d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.75  E-value=1.3e-05  Score=43.36  Aligned_cols=31  Identities=16%  Similarity=0.415  Sum_probs=28.6

Q ss_pred             cHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          447 TIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       447 ~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +++++.+.|+.+|.|+||.|+.+||..++..
T Consensus         2 sEeELae~FRifDkNaDGyiD~eEl~~ilr~   32 (34)
T d1ctda_           2 SEEELANAFRIFDKNADGYIDIEELGEILRA   32 (34)
T ss_dssp             HHHHHHHHHHTTCCSSSSCBCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHccCCcccccHHHHHHHHHh
Confidence            6789999999999999999999999998875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.44  E-value=0.00029  Score=66.88  Aligned_cols=75  Identities=12%  Similarity=0.092  Sum_probs=53.6

Q ss_pred             eeeecccCCeEEEEEEECC-------CCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCCCccEEeEEEEeCCeEE
Q 040917           38 GREVGRGEFGITYLCTENS-------TGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQPNIVQFKAAYEDDQFVH  110 (494)
Q Consensus        38 ~~~lg~G~~g~Vy~a~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i~~~~~~~~~~~~~~  110 (494)
                      ++.|+.|-...+|++....       ..+.|++++.....     ..-...+|..+++.+..+.-..++++++.+    +
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-----~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-----hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence            5689999999999998653       34567777764211     233566899999999755445677777643    4


Q ss_pred             EEEeccCCCch
Q 040917          111 IVMELCAGGEL  121 (494)
Q Consensus       111 iv~e~~~g~sL  121 (494)
                      +|++|++|.+|
T Consensus       118 ~I~efi~g~~l  128 (395)
T d1nw1a_         118 RLEEYIPSRPL  128 (395)
T ss_dssp             EEECCCCEEEC
T ss_pred             eEEEEeccccC
Confidence            89999988665

>d1tuza_ a.39.1.7 (A:) Diacylglycerol kinase alpha, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Diacylglycerol kinase alpha, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.03  E-value=0.0014  Score=49.98  Aligned_cols=54  Identities=7%  Similarity=0.069  Sum_probs=38.5

Q ss_pred             CCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCC--------CceeHHHHHHHHh
Q 040917          423 DNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKD--------GRISYDEFRSMMK  476 (494)
Q Consensus       423 d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~d--------g~i~~~ef~~~~~  476 (494)
                      ..+|.|+.++|+.++..+......++.-++.+|..+|.|+|        |.|++.||+-.+.
T Consensus        43 ~p~g~i~~~~F~~~~~~~f~~~~~~~~l~~rlF~~FD~~~d~~~~~~~~g~I~f~efv~~LS  104 (118)
T d1tuza_          43 VQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVSCYFS  104 (118)
T ss_dssp             EETTEECHHHHHHHHHHHTTCSSCCHHHHHHHHHHSCCCCCTTCCCCCSCCEEHHHHHHHHH
T ss_pred             CcccccCHHHHHHHHHHhCCCCCchHHHHHHHHHHHccccccccccCCCceeeHHHHHHHHH
Confidence            35677888888888776433333456677888888888765        8899999977554

>d1sraa_ a.39.1.3 (A:) C-terminal (EC) domain of BM-40/SPARC/osteonectin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Osteonectin
domain: C-terminal (EC) domain of BM-40/SPARC/osteonectin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.97  E-value=9.5e-05  Score=58.40  Aligned_cols=62  Identities=19%  Similarity=0.247  Sum_probs=49.5

Q ss_pred             HHHHhccccccC-CCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          412 NLYKAFQYFDKD-NNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       412 ~~~~~F~~~D~d-~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      -+...|..+|.| +||+|+..||+.+...+    ...+.=+..++..+|.|+||.|++.||..++.-
T Consensus        78 ~v~W~F~~LD~n~~D~~L~~~EL~~l~~~L----~~~e~C~~~F~~~CD~n~D~~Is~~EW~~Cf~v  140 (151)
T d1sraa_          78 PVHWQFGQLDQHPIDGYLSHTELAPLRAPL----IPMEHCTTRFFETCDLDNDKYIALDEWAGCFGI  140 (151)
T ss_dssp             HHHHHHHHHCCTTCSSEECTTTTGGGGSTT----STTGGGHHHHHHHHCTTCSSSEEHHHHHHHTTC
T ss_pred             cceeehhhcCCCCCCCccCHHHHHHHHHhh----cCCchHHHHHHHHhcCCCCCcCCHHHHHHHcCC
Confidence            466789999999 59999999999876542    112223688999999999999999999988764

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.92  E-value=0.0032  Score=57.63  Aligned_cols=73  Identities=12%  Similarity=0.140  Sum_probs=48.0

Q ss_pred             cCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCCC-CccEEe-----EEEEeCCeEEEEEeccC
Q 040917           44 GEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQP-NIVQFK-----AAYEDDQFVHIVMELCA  117 (494)
Q Consensus        44 G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp-~i~~~~-----~~~~~~~~~~iv~e~~~  117 (494)
                      +--..||++.. .+|..|++|+.....    .+.+.+..|...+..|..+. .++...     ..+......+.++++++
T Consensus        33 s~EN~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~  107 (325)
T d1zyla1          33 SYENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  107 (325)
T ss_dssp             CSSSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             cccceeEEEEc-CCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence            44579999986 468899999986432    24567888999888886221 111111     12344667889999998


Q ss_pred             CCch
Q 040917          118 GGEL  121 (494)
Q Consensus       118 g~sL  121 (494)
                      |..+
T Consensus       108 G~~~  111 (325)
T d1zyla1         108 GRQF  111 (325)
T ss_dssp             CEEC
T ss_pred             CcCC
Confidence            7544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.54  E-value=0.0039  Score=56.69  Aligned_cols=142  Identities=19%  Similarity=0.197  Sum_probs=73.5

Q ss_pred             ceEeeeeecccCCeEEEEEEECCCCcEEEEEEeccCCCCChhhHHHHHHHHHHHHHccCC----CCccEEe---EEEEeC
Q 040917           34 HYTIGREVGRGEFGITYLCTENSTGLEFACKSIPKRKLVKDVEKDDVRREIEIMRHLSGQ----PNIVQFK---AAYEDD  106 (494)
Q Consensus        34 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~valK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h----p~i~~~~---~~~~~~  106 (494)
                      ...-.+.|..|--.+.|++...  +..+++|++....     ..+.+..|+.++..|..+    |..+...   .+....
T Consensus        19 ~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~-----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~   91 (316)
T d2ppqa1          19 SLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS   91 (316)
T ss_dssp             CEEEEEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred             CceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCC-----CHHHHHHHHHHHHhhhhccccccccceecCCCcceeee
Confidence            3444566778888999999865  3458999985432     223456677777777521    2211110   012234


Q ss_pred             CeEEEEEeccCCCchHH--------------HHHhcC---------CCCH------------------HHHHHHHHHHHH
Q 040917          107 QFVHIVMELCAGGELFD--------------RIVARG---------HYSE------------------RAAASVFRVIMN  145 (494)
Q Consensus       107 ~~~~iv~e~~~g~sL~~--------------~~~~~~---------~l~~------------------~~~~~i~~~i~~  145 (494)
                      .....++.+..|.....              .++...         ....                  ......+..+..
T Consensus        92 ~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  171 (316)
T d2ppqa1          92 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID  171 (316)
T ss_dssp             TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred             cccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHH
Confidence            45666777666643310              000000         0000                  001112222222


Q ss_pred             HHHHHH----HCCceeccCCCCceEEeeCCCCCeEEEeecCCcc
Q 040917          146 VVNVCH----SKGVMHRDLKPENFLFTTGDENAVVKATDFGLSA  185 (494)
Q Consensus       146 ~l~~LH----~~~i~H~dikp~NIli~~~~~~~~~kL~Dfg~a~  185 (494)
                      .+...+    ..|+||+|+.+.||+++   .+...-++||+.+.
T Consensus       172 ~~~~~~~~~L~~giIHgDl~~dNvl~~---~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         172 YLAAHWPKDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHCCCSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred             hhhccCccccccccccCCcchhhhhcc---cccceeEecccccc
Confidence            222222    14799999999999994   55566899999875

>d1sraa_ a.39.1.3 (A:) C-terminal (EC) domain of BM-40/SPARC/osteonectin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Osteonectin
domain: C-terminal (EC) domain of BM-40/SPARC/osteonectin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.79  E-value=0.0009  Score=52.65  Aligned_cols=60  Identities=22%  Similarity=0.218  Sum_probs=25.4

Q ss_pred             HHHHHHHhcCC-CCCcccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHh
Q 040917          377 VKQYMQAADID-GNGTIDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFK  438 (494)
Q Consensus       377 ~~~~~~~~D~~-~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~  438 (494)
                      +...|..+|.| .||.++..|...+.....  ..+.-++..|+..|.|+||.|+..|+...|.
T Consensus        79 v~W~F~~LD~n~~D~~L~~~EL~~l~~~L~--~~e~C~~~F~~~CD~n~D~~Is~~EW~~Cf~  139 (151)
T d1sraa_          79 VHWQFGQLDQHPIDGYLSHTELAPLRAPLI--PMEHCTTRFFETCDLDNDKYIALDEWAGCFG  139 (151)
T ss_dssp             HHHHHHHHCCTTCSSEECTTTTGGGGSTTS--TTGGGHHHHHHHHCTTCSSSEEHHHHHHHTT
T ss_pred             ceeehhhcCCCCCCCccCHHHHHHHHHhhc--CCchHHHHHHHHhcCCCCCcCCHHHHHHHcC
Confidence            34445555554 244455444433211111  1122344444444555555555555554443

>d1qasa1 a.39.1.7 (A:205-298) Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!) {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!)
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=94.85  E-value=0.025  Score=40.73  Aligned_cols=69  Identities=12%  Similarity=0.164  Sum_probs=53.3

Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCC----CCceeHHHHHHHHhccc
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDK----DGRISYDEFRSMMKCGT  479 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~----dg~i~~~ef~~~~~~~~  479 (494)
                      ..++..+|..+-. +.+.++.++|.++|..-=.....+++.+.++|..+.++.    .|.++.+.|.+++.+..
T Consensus         7 R~ei~~if~~ys~-~~~~mt~~~f~~FL~~eQ~~~~~~~~~~~~ii~~~e~~~~~~~~~~ls~~gF~~fL~S~~   79 (94)
T d1qasa1           7 RAEIDRAFEEAAG-SAETLSVERLVTFLQHQQREEEAGPALALSLIERYEPSETAKAQRQMTKDGFLMYLLSAD   79 (94)
T ss_dssp             CHHHHHHHHHHHT-TSSSCBHHHHHHHHHHTSCCTTCSHHHHHHHHHHHCCCHHHHHTTBCCHHHHHHHHHSST
T ss_pred             cHHHHHHHHHHhC-CCCccCHHHHHHHHHHHcCCccCCHHHHHHHHHHHcccHhhhhcCCcCHHHHHHHHcCcc
Confidence            3578888888844 457899999999998721123578888999999998764    36799999999998643

>d1h8ba_ a.39.1.7 (A:) alpha-Actinin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: alpha-Actinin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.79  E-value=0.039  Score=36.84  Aligned_cols=62  Identities=16%  Similarity=0.326  Sum_probs=49.0

Q ss_pred             hHHHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCC-----CCCCceeHHHHHHHHhccc
Q 040917          408 QRFENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDR-----DKDGRISYDEFRSMMKCGT  479 (494)
Q Consensus       408 ~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~-----~~dg~i~~~ef~~~~~~~~  479 (494)
                      .+.+++.++|+.+ .++..+|+..||++-|         ++++++-++..|-.     ...|..+|..|.+.+....
T Consensus         5 ~TaEqv~~aFr~l-A~~KpyVT~~dL~~~L---------~peqaeyc~~~M~~y~~~~~~~~ayDY~sF~~~l~ges   71 (73)
T d1h8ba_           5 DTAEQVIASFRIL-ASDKPYILAEELRREL---------PPDQAQYCIKRMPAYSGPGSVPGALDYAAFSSALYGES   71 (73)
T ss_dssp             STHHHHHHHHHHH-TTSCSSBCHHHHHHHS---------CHHHHHHHHHHSCSCCCSSCCTTCBCHHHHHHHHTCCS
T ss_pred             ccHHHHHHHHHHH-hCCCCeeCHHHHHhhc---------CHHHHHHHHHHCcccCCCCCCCCcccHHHHHHHHhccc
Confidence            3567899999999 5678999999999765         44678889998854     2367899999999877543

>d1j7qa_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=92.59  E-value=0.49  Score=29.93  Aligned_cols=72  Identities=22%  Similarity=0.262  Sum_probs=58.6

Q ss_pred             CchhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHh-cCCCC-CcccchHHHHHHHHh
Q 040917          333 LPTEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAA-DIDGN-GTIDYIEFITATMQR  404 (494)
Q Consensus       333 ~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~-D~~~~-g~i~~~ef~~~~~~~  404 (494)
                      +.+++..+-.++|..||.+........|-.++|..+|...+..+...+++.. ...+| ..|--+||+..+...
T Consensus         8 lgpeekdecmkifdifdrnaeniapvsdtmdmltklgqtytkreteaimkeargpkgdkknigpeewltlcskw   81 (86)
T d1j7qa_           8 LGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQTYTKRETEAIMKEARGPKGDKKNIGPEEWLTLCSKW   81 (86)
T ss_dssp             CSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSCCCSHHHHHHHHHHHHCSSCSSCCBCTTHHHHHHHHH
T ss_pred             cCchhHHHHHHHHHHHhccccccCCcchHHHHHHHhhhHHhHHHHHHHHHHhcCCCCccccCCHHHHHHHHHHH
Confidence            4567778888999999999999999999999999999999998888888766 23333 347888999887754

>d1qasa1 a.39.1.7 (A:205-298) Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!) {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Phosphoinositide-specific phospholipase C, isozyme D1 (PLC-D!)
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=89.26  E-value=0.28  Score=34.86  Aligned_cols=63  Identities=11%  Similarity=0.086  Sum_probs=40.2

Q ss_pred             hhhhhhhccCCCCCCcccHHHHHHHHHhcCC--CCCHHHHHHHHHHhcCCC----CCcccchHHHHHHHH
Q 040917          340 KLKEKFTEMDTDNSGTLTYDELKAGLAKLGS--MLTEFDVKQYMQAADIDG----NGTIDYIEFITATMQ  403 (494)
Q Consensus       340 ~~~~~F~~~D~~~~g~i~~~el~~~l~~~~~--~~~~~~~~~~~~~~D~~~----~g~i~~~ef~~~~~~  403 (494)
                      ++..+|..+-. +.+.++.++|..+|+.-..  ..+.+.+..++..+..+.    .+.++++.|...+..
T Consensus         9 ei~~if~~ys~-~~~~mt~~~f~~FL~~eQ~~~~~~~~~~~~ii~~~e~~~~~~~~~~ls~~gF~~fL~S   77 (94)
T d1qasa1           9 EIDRAFEEAAG-SAETLSVERLVTFLQHQQREEEAGPALALSLIERYEPSETAKAQRQMTKDGFLMYLLS   77 (94)
T ss_dssp             HHHHHHHHHHT-TSSSCBHHHHHHHHHHTSCCTTCSHHHHHHHHHHHCCCHHHHHTTBCCHHHHHHHHHS
T ss_pred             HHHHHHHHHhC-CCCccCHHHHHHHHHHHcCCccCCHHHHHHHHHHHcccHhhhhcCCcCHHHHHHHHcC
Confidence            44555555533 3467888888888887632  346666777777775542    255777777766654

>d2cclb1 a.139.1.1 (B:1-59) Endo-1,4-beta-xylanase Y {Clostridium thermocellum [TaxId: 1515]}

class: All alpha proteins
fold: Type I dockerin domain
superfamily: Type I dockerin domain
family: Type I dockerin domain
domain: Endo-1,4-beta-xylanase Y
species: Clostridium thermocellum [TaxId: 1515]

Probab=88.70  E-value=0.68  Score=29.44  Aligned_cols=52  Identities=19%  Similarity=0.189  Sum_probs=30.2

Q ss_pred             ccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHh
Q 040917          421 DKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       421 D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~  476 (494)
                      |.|+||.|+..++..+....--...+++.    -+...|.|+||.|+-.+...+.+
T Consensus         2 DvN~Dg~vni~D~~~l~~~il~~~~~~~~----~~~aaDvn~Dg~i~i~D~~~l~~   53 (59)
T d2cclb1           2 DVNGDGTINSTDLTMLKRSVLRAITLTDD----AKARADVDKNGSINAADVLLLSR   53 (59)
T ss_dssp             CTTCSSSCCHHHHHHHHHHHTTSSCCCHH----HHHHHCTTCSSCCSHHHHHHHHH
T ss_pred             CCCCCCCCcHHHHHHHHHHHhCCCCCChh----hhhccccCCCCCCCHHHHHHHHH
Confidence            56777777777777666542111122322    23446777777777777766554

>d1eg3a1 a.39.1.7 (A:85-209) Dystrophin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Dystrophin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=87.94  E-value=1.6  Score=32.26  Aligned_cols=102  Identities=12%  Similarity=0.169  Sum_probs=63.6

Q ss_pred             HHHhhhhHHHHHHHHhhhccCchhHHHhhhhhhhccCCC-CCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCc
Q 040917          313 KQFTAMNKLKKLALKVIVENLPTEEIQKLKEKFTEMDTD-NSGTLTYDELKAGLAKLGSMLTEFDVKQYMQAADIDGNGT  391 (494)
Q Consensus       313 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~F~~~D~~-~~g~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~  391 (494)
                      ..+++..+++.++.........-.   -+..+|+....+ ++..++..++..++..            +|........+.
T Consensus        20 saYRTA~KLR~vQK~~~l~lv~l~---~~~e~f~~~~l~~~d~~l~v~~l~~~L~~------------iy~~l~~~~~~~   84 (125)
T d1eg3a1          20 SAYRTAMKLRRLQKALCLDLLSLS---AACDALDQHNLKQNDQPMDILQIINCLTT------------IYDRLEQEHNNL   84 (125)
T ss_dssp             HHHHHHHHHHHHHHHTTGGGCCHH---HHHHHHHHTTCCCTTSEEEHHHHHHHHHH------------HHHHHHHHSTTT
T ss_pred             HHHHHHHHHHHHHHHHhcchhhHH---HHHHHHHHcCCCCCccCCCHHHHHHHHHH------------HHHHhhhhCccc
Confidence            445566666666655555544333   334444433332 4557888888887764            444444444555


Q ss_pred             ccchHHHHHHHHhhhhhHHHHHHHhccccccCCCCceeHHHHHHHHhhc
Q 040917          392 IDYIEFITATMQRHKLQRFENLYKAFQYFDKDNNGYITVDELGKAFKDY  440 (494)
Q Consensus       392 i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~  440 (494)
                      |+.+..+..           -+......||.+++|+|+.-.++-+|..+
T Consensus        85 v~vp~~~dl-----------~LN~LlnvYD~~rtG~i~vls~KvaL~~L  122 (125)
T d1eg3a1          85 VNVPLCVDM-----------CLNWLLNVYDTGRTGRIRVLSFKTGIISL  122 (125)
T ss_dssp             CCHHHHHHH-----------HHHHHHHHHCTTCCSEEEHHHHHHHHHHT
T ss_pred             CChHHHHHH-----------HHHHHHHHhCCCCCCeeeehHHHHHHHHH
Confidence            665544332           24677888999999999999999988764

>d1pula1 a.39.1.11 (A:18-120) Hypothetical protein c32e8.3 {Caenorhabditis elegans [TaxId: 6239]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: p25-alpha
domain: Hypothetical protein c32e8.3
species: Caenorhabditis elegans [TaxId: 6239]

Probab=86.65  E-value=1.4  Score=31.38  Aligned_cols=69  Identities=10%  Similarity=0.056  Sum_probs=54.1

Q ss_pred             hhHHHhhhhhhhccCCCCCCcccHHHHHHHHHhc----CCCCCHHHHHHHHHHhcCCCCCcccchHHHHHHHHh
Q 040917          335 TEEIQKLKEKFTEMDTDNSGTLTYDELKAGLAKL----GSMLTEFDVKQYMQAADIDGNGTIDYIEFITATMQR  404 (494)
Q Consensus       335 ~~~~~~~~~~F~~~D~~~~g~i~~~el~~~l~~~----~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~  404 (494)
                      ..+++.....|..|....+-.++...|..+++..    +..++..++.-+|..+- ....+|+|++|...+...
T Consensus         4 ~~~l~~~F~aF~~FG~~~~~em~~~~f~Kl~kdc~lid~K~~T~tdvDIiF~K~k-~k~~ri~f~~F~~aL~~l   76 (103)
T d1pula1           4 DADVKKRWDAFTKFGAATATEMTGKNFDKWLKDAGVLDNKAITGTMTGIAFSKVT-GPKKKATFDETKKVLAFV   76 (103)
T ss_dssp             HHHHHHHHHHHHHHTCSSSSCCCHHHHHHHHHHHTSCCSSSSCHHHHHHHHHHHT-CSSSCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCcCCCHHHHHHHHHHcCCCcCCCCCccchhhhhHhhc-CCCCCcCHHHHHHHHHHH
Confidence            4677888888888875544579999999999884    35688889999999984 345679999998877643

>d2cclb1 a.139.1.1 (B:1-59) Endo-1,4-beta-xylanase Y {Clostridium thermocellum [TaxId: 1515]}

class: All alpha proteins
fold: Type I dockerin domain
superfamily: Type I dockerin domain
family: Type I dockerin domain
domain: Endo-1,4-beta-xylanase Y
species: Clostridium thermocellum [TaxId: 1515]

Probab=86.52  E-value=0.55  Score=29.92  Aligned_cols=48  Identities=25%  Similarity=0.356  Sum_probs=29.6

Q ss_pred             CCCCCCcccHHHHHHHHHhc-CC-CCCHHHHHHHHHHhcCCCCCcccchHHHHH
Q 040917          349 DTDNSGTLTYDELKAGLAKL-GS-MLTEFDVKQYMQAADIDGNGTIDYIEFITA  400 (494)
Q Consensus       349 D~~~~g~i~~~el~~~l~~~-~~-~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~  400 (494)
                      |.|++|.++..|+..+.+.+ +. .++..    .+.+.|.|+||.|+..++...
T Consensus         2 DvN~Dg~vni~D~~~l~~~il~~~~~~~~----~~~aaDvn~Dg~i~i~D~~~l   51 (59)
T d2cclb1           2 DVNGDGTINSTDLTMLKRSVLRAITLTDD----AKARADVDKNGSINAADVLLL   51 (59)
T ss_dssp             CTTCSSSCCHHHHHHHHHHHTTSSCCCHH----HHHHHCTTCSSCCSHHHHHHH
T ss_pred             CCCCCCCCcHHHHHHHHHHHhCCCCCChh----hhhccccCCCCCCCHHHHHHH
Confidence            56777777777777776664 22 22321    245567777777776666543

>d1j7qa_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=85.53  E-value=1.6  Score=27.49  Aligned_cols=66  Identities=20%  Similarity=0.309  Sum_probs=52.0

Q ss_pred             HHHHHHhccccccCCCCceeHHHHHHHHhhcCCCCCCcHHHHHHHHHHhC-CCCC-CceeHHHHHHHHhc
Q 040917          410 FENLYKAFQYFDKDNNGYITVDELGKAFKDYGMGDDATIATIKEIMSEVD-RDKD-GRISYDEFRSMMKC  477 (494)
Q Consensus       410 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~~d-~~~d-g~i~~~ef~~~~~~  477 (494)
                      ..+-..+|.+||.|-.+--...+-..+|..  +|.-.+..+.+.++.+.- +.|| ..|.-+||+.++..
T Consensus        13 kdecmkifdifdrnaeniapvsdtmdmltk--lgqtytkreteaimkeargpkgdkknigpeewltlcsk   80 (86)
T d1j7qa_          13 KDECMKIFDIFDRNAENIAPVSDTMDMLTK--LGQTYTKRETEAIMKEARGPKGDKKNIGPEEWLTLCSK   80 (86)
T ss_dssp             HHHHHHHHHHHSTTTTSCBCHHHHHHHHHH--TSCCCSHHHHHHHHHHHHCSSCSSCCBCTTHHHHHHHH
T ss_pred             HHHHHHHHHHHhccccccCCcchHHHHHHH--hhhHHhHHHHHHHHHHhcCCCCccccCCHHHHHHHHHH
Confidence            345678999999999999999999999999  555667788888888873 3444 34889999987764

>d1pula1 a.39.1.11 (A:18-120) Hypothetical protein c32e8.3 {Caenorhabditis elegans [TaxId: 6239]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: p25-alpha
domain: Hypothetical protein c32e8.3
species: Caenorhabditis elegans [TaxId: 6239]

Probab=83.47  E-value=2.4  Score=30.12  Aligned_cols=66  Identities=21%  Similarity=0.289  Sum_probs=49.6

Q ss_pred             HHHHHhccccccCCCCceeHHHHHHHHhhcCC-C-CCCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          411 ENLYKAFQYFDKDNNGYITVDELGKAFKDYGM-G-DDATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       411 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~~~-~-~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      .....+|..|..-..-.++...|..+++..++ + ..++..+++-+|..+-..+ ..|+|++|...+..
T Consensus         8 ~~~F~aF~~FG~~~~~em~~~~f~Kl~kdc~lid~K~~T~tdvDIiF~K~k~k~-~ri~f~~F~~aL~~   75 (103)
T d1pula1           8 KKRWDAFTKFGAATATEMTGKNFDKWLKDAGVLDNKAITGTMTGIAFSKVTGPK-KKATFDETKKVLAF   75 (103)
T ss_dssp             HHHHHHHHHHTCSSSSCCCHHHHHHHHHHHTSCCSSSSCHHHHHHHHHHHTCSS-SCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCcCCCHHHHHHHHHHcCCCcCCCCCccchhhhhHhhcCCC-CCcCHHHHHHHHHH
Confidence            45566777775322236999999999998553 2 3589999999999997555 46999999988764

>d1dava_ a.139.1.1 (A:) Cellulosome endoglucanase SS {Clostridium thermocellum [TaxId: 1515]}

class: All alpha proteins
fold: Type I dockerin domain
superfamily: Type I dockerin domain
family: Type I dockerin domain
domain: Cellulosome endoglucanase SS
species: Clostridium thermocellum [TaxId: 1515]

Probab=82.72  E-value=0.21  Score=33.37  Aligned_cols=19  Identities=21%  Similarity=0.394  Sum_probs=9.6

Q ss_pred             cccCCCCceeHHHHHHHHh
Q 040917          420 FDKDNNGYITVDELGKAFK  438 (494)
Q Consensus       420 ~D~d~~G~I~~~el~~~l~  438 (494)
                      .|.|+||.|+..++..+.+
T Consensus        39 aDvn~DG~Id~~D~~~l~~   57 (71)
T d1dava_          39 ADLNEDGRVNSTDLGILKR   57 (71)
T ss_dssp             TCSSSSSSCSSHHHHHHHH
T ss_pred             eecCCCCCcCHHHHHHHHH
Confidence            3555555555555544444

>d1dava_ a.139.1.1 (A:) Cellulosome endoglucanase SS {Clostridium thermocellum [TaxId: 1515]}

class: All alpha proteins
fold: Type I dockerin domain
superfamily: Type I dockerin domain
family: Type I dockerin domain
domain: Cellulosome endoglucanase SS
species: Clostridium thermocellum [TaxId: 1515]

Probab=82.09  E-value=0.39  Score=31.98  Aligned_cols=19  Identities=21%  Similarity=0.529  Sum_probs=9.3

Q ss_pred             hCCCCCCceeHHHHHHHHh
Q 040917          458 VDRDKDGRISYDEFRSMMK  476 (494)
Q Consensus       458 ~d~~~dg~i~~~ef~~~~~  476 (494)
                      +|.|+||.|+..++..+.+
T Consensus        39 aDvn~DG~Id~~D~~~l~~   57 (71)
T d1dava_          39 ADLNEDGRVNSTDLGILKR   57 (71)
T ss_dssp             TCSSSSSSCSSHHHHHHHH
T ss_pred             eecCCCCCcCHHHHHHHHH
Confidence            3455555555555544443

>d1wlma1 a.39.1.11 (A:8-145) Protein cgi-38 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: p25-alpha
domain: Protein cgi-38
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=81.27  E-value=3.7  Score=30.93  Aligned_cols=67  Identities=19%  Similarity=0.330  Sum_probs=50.3

Q ss_pred             HHHHHhcccccc-CCC-CceeHHHHHHHHhhcCCCC--CCcHHHHHHHHHHhCCCCCCceeHHHHHHHHhc
Q 040917          411 ENLYKAFQYFDK-DNN-GYITVDELGKAFKDYGMGD--DATIATIKEIMSEVDRDKDGRISYDEFRSMMKC  477 (494)
Q Consensus       411 ~~~~~~F~~~D~-d~~-G~I~~~el~~~l~~~~~~~--~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~  477 (494)
                      +.+..+|..|.. ..+ -.++...|..+++..++-+  .++..+++-+|..+-.-+...|+|++|+..+..
T Consensus        11 ~~~F~~F~~fG~~k~~~~~m~~~~f~K~~kd~~lid~K~~T~t~~diiF~k~k~k~~r~i~f~~F~~aL~~   81 (138)
T d1wlma1          11 EESFRKFAIHGDPKASGQEMNGKNWAKLCKDCKVADGKAVTGTDVDIVFSKVKAKSARVINYEEFKKALEE   81 (138)
T ss_dssp             HHHHHHHHTSSCSSCCSSEEEHHHHHHHHHHTSCCCSSSSCHHHHHHHHHHHSCSSCSEEEHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCCcccCCHHHHHHHHHHcCCCcCCccchhhHHHHHHHhhcCCCcccCHHHHHHHHHH
Confidence            345566666653 122 3599999999999865433  589999999999987666778999999887764